id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
10081868|NCT02265510|11210421|FG000|STARTED|Overall Study||3
10081869|NCT02265510|11210422|FG001|STARTED|Overall Study||3
10081870|NCT02265510|11210423|FG002|STARTED|Overall Study||6
10081871|NCT02265510|11210424|FG003|STARTED|Overall Study||4
10081872|NCT02265510|11210425|FG004|STARTED|Overall Study||3
10081873|NCT02265510|11210426|FG005|STARTED|Overall Study||6
10081874|NCT02265510|11210427|FG006|STARTED|Overall Study||3
10081875|NCT02265510|11210428|FG007|STARTED|Overall Study||4
10081876|NCT02265510|11210429|FG008|STARTED|Overall Study||4
10081877|NCT02265510|11210430|FG009|STARTED|Overall Study||7
10081878|NCT02265510|11210431|FG010|STARTED|Overall Study||5
10081879|NCT02265510|11210432|FG011|STARTED|Overall Study||16
10081880|NCT02265510|11210433|FG012|STARTED|Overall Study||9
10081881|NCT02265510|11210434|FG013|STARTED|Overall Study||10
10081882|NCT02265510|11210421|FG000|COMPLETED|Overall Study||0
10081883|NCT02265510|11210422|FG001|COMPLETED|Overall Study||0
10081884|NCT02265510|11210423|FG002|COMPLETED|Overall Study||0
10081885|NCT02265510|11210424|FG003|COMPLETED|Overall Study||0
10081886|NCT02265510|11210425|FG004|COMPLETED|Overall Study||0
10081887|NCT02265510|11210426|FG005|COMPLETED|Overall Study||0
10081888|NCT02265510|11210427|FG006|COMPLETED|Overall Study||0
10081889|NCT02265510|11210428|FG007|COMPLETED|Overall Study||0
10081890|NCT02265510|11210429|FG008|COMPLETED|Overall Study||0
10081891|NCT02265510|11210430|FG009|COMPLETED|Overall Study||0
10081892|NCT02265510|11210431|FG010|COMPLETED|Overall Study||0
10081893|NCT02265510|11210432|FG011|COMPLETED|Overall Study||0
10081894|NCT02265510|11210433|FG012|COMPLETED|Overall Study||0
10081895|NCT02265510|11210434|FG013|COMPLETED|Overall Study||0
10081896|NCT02265510|11210421|FG000|NOT COMPLETED|Overall Study||3
10081897|NCT02265510|11210422|FG001|NOT COMPLETED|Overall Study||3
10081898|NCT02265510|11210423|FG002|NOT COMPLETED|Overall Study||6
10081899|NCT02265510|11210424|FG003|NOT COMPLETED|Overall Study||4
10081900|NCT02265510|11210425|FG004|NOT COMPLETED|Overall Study||3
10081901|NCT02265510|11210426|FG005|NOT COMPLETED|Overall Study||6
10081902|NCT02265510|11210427|FG006|NOT COMPLETED|Overall Study||3
10081903|NCT02265510|11210428|FG007|NOT COMPLETED|Overall Study||4
10081904|NCT02265510|11210429|FG008|NOT COMPLETED|Overall Study||4
10081905|NCT02265510|11210430|FG009|NOT COMPLETED|Overall Study||7
10081906|NCT02265510|11210431|FG010|NOT COMPLETED|Overall Study||5
10081907|NCT02265510|11210432|FG011|NOT COMPLETED|Overall Study||16
10081908|NCT02265510|11210433|FG012|NOT COMPLETED|Overall Study||9
10081909|NCT02265510|11210434|FG013|NOT COMPLETED|Overall Study||10
10081910|NCT02265705|11210492|FG000|STARTED|Treatment Period Week 0-24||145
10081911|NCT02265705|11210493|FG001|STARTED|Treatment Period Week 0-24||145
10081912|NCT02265705|11210494|FG002|STARTED|Treatment Period Week 0-24||0
10081913|NCT02265705|11210495|FG003|STARTED|Treatment Period Week 0-24||0
10081914|NCT02265705|11210496|FG004|STARTED|Treatment Period Week 0-24||0
10081915|NCT02265705|11210497|FG005|STARTED|Treatment Period Week 0-24||0
10081916|NCT02265705|11210498|FG006|STARTED|Treatment Period Week 0-24||0
10081917|NCT02265705|11210492|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
10081918|NCT02265705|11210493|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
10081919|NCT02265705|11210494|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10081920|NCT02265705|11210495|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10081921|NCT02265705|11210496|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10081922|NCT02265705|11210497|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10081923|NCT02265705|11210498|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10081924|NCT02265705|11210492|FG000|Rescued|Treatment Period Week 0-24||59
10081925|NCT02265705|11210493|FG001|Rescued|Treatment Period Week 0-24||17
10081926|NCT02265705|11210494|FG002|Rescued|Treatment Period Week 0-24||0
10081927|NCT02265705|11210495|FG003|Rescued|Treatment Period Week 0-24||0
10081928|NCT02265705|11210496|FG004|Rescued|Treatment Period Week 0-24||0
10081929|NCT02265705|11210497|FG005|Rescued|Treatment Period Week 0-24||0
10081930|NCT02265705|11210498|FG006|Rescued|Treatment Period Week 0-24||0
10081931|NCT02265705|11210492|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
10081932|NCT02265705|11210493|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
10081933|NCT02265705|11210494|FG002|COMPLETED|Treatment Period Week 0-24||0
10081934|NCT02265705|11210495|FG003|COMPLETED|Treatment Period Week 0-24||0
10081935|NCT02265705|11210496|FG004|COMPLETED|Treatment Period Week 0-24||0
10081936|NCT02265705|11210497|FG005|COMPLETED|Treatment Period Week 0-24||0
10081937|NCT02265705|11210498|FG006|COMPLETED|Treatment Period Week 0-24||0
10081938|NCT02265705|11210492|FG000|NOT COMPLETED|Treatment Period Week 0-24||12
10081939|NCT02265705|11210493|FG001|NOT COMPLETED|Treatment Period Week 0-24||9
10081940|NCT02265705|11210494|FG002|NOT COMPLETED|Treatment Period Week 0-24||0
10081941|NCT02265705|11210495|FG003|NOT COMPLETED|Treatment Period Week 0-24||0
10081942|NCT02265705|11210496|FG004|NOT COMPLETED|Treatment Period Week 0-24||0
10081943|NCT02265705|11210497|FG005|NOT COMPLETED|Treatment Period Week 0-24||0
10081944|NCT02265705|11210498|FG006|NOT COMPLETED|Treatment Period Week 0-24||0
10081945|NCT02265705|11210492|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10081946|NCT02265705|11210493|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10081947|NCT02265705|11210494|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
10081948|NCT02265705|11210495|FG003|STARTED|Rescue Period||0
10081949|NCT02265705|11210496|FG004|STARTED|Rescue Period||0
10081950|NCT02265705|11210497|FG005|STARTED|Rescue Period||0
10081951|NCT02265705|11210498|FG006|STARTED|Rescue Period||0
10081952|NCT02265705|11210492|FG000|COMPLETED|Rescue Period||0
10081953|NCT02265705|11210493|FG001|COMPLETED|Rescue Period||0
10081954|NCT02265705|11210494|FG002|COMPLETED|Rescue Period||74
10081955|NCT02265705|11210495|FG003|COMPLETED|Rescue Period||0
10081956|NCT02265705|11210496|FG004|COMPLETED|Rescue Period||0
10081957|NCT02265705|11210497|FG005|COMPLETED|Rescue Period||0
10081958|NCT02265705|11210498|FG006|COMPLETED|Rescue Period||0
10081959|NCT02265705|11210492|FG000|NOT COMPLETED|Rescue Period||0
10081960|NCT02265705|11210493|FG001|NOT COMPLETED|Rescue Period||0
10081961|NCT02265705|11210494|FG002|NOT COMPLETED|Rescue Period||3
10081962|NCT02265705|11210495|FG003|NOT COMPLETED|Rescue Period||0
10081963|NCT02265705|11210496|FG004|NOT COMPLETED|Rescue Period||0
10081964|NCT02265705|11210497|FG005|NOT COMPLETED|Rescue Period||0
10081965|NCT02265705|11210498|FG006|NOT COMPLETED|Rescue Period||0
10081966|NCT02265705|11210492|FG000|STARTED|Open Label Period||0
10081967|NCT02265705|11210493|FG001|STARTED|Open Label Period||0
10081968|NCT02265705|11210494|FG002|STARTED|Open Label Period||0
10081969|NCT02265705|11210495|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
10081970|NCT02265705|11210496|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
10081971|NCT02265705|11210497|FG005|STARTED|Open Label Period||0
10081972|NCT02265705|11210498|FG006|STARTED|Open Label Period||0
10081973|NCT02265705|11210492|FG000|COMPLETED|Open Label Period||0
10081974|NCT02265705|11210493|FG001|COMPLETED|Open Label Period||0
10081975|NCT02265705|11210494|FG002|COMPLETED|Open Label Period||0
10081976|NCT02265705|11210495|FG003|COMPLETED|Open Label Period||72
10081977|NCT02265705|11210496|FG004|COMPLETED|Open Label Period||115
10081978|NCT02265705|11210497|FG005|COMPLETED|Open Label Period||0
10081979|NCT02265705|11210498|FG006|COMPLETED|Open Label Period||0
10081980|NCT02265705|11210492|FG000|NOT COMPLETED|Open Label Period||0
10081981|NCT02265705|11210493|FG001|NOT COMPLETED|Open Label Period||0
10081982|NCT02265705|11210494|FG002|NOT COMPLETED|Open Label Period||0
10081983|NCT02265705|11210495|FG003|NOT COMPLETED|Open Label Period||2
10081984|NCT02265705|11210496|FG004|NOT COMPLETED|Open Label Period||5
10081985|NCT02265705|11210497|FG005|NOT COMPLETED|Open Label Period||0
10081986|NCT02265705|11210498|FG006|NOT COMPLETED|Open Label Period||0
10081987|NCT02265705|11210492|FG000|STARTED|Follow-up Period||0
10081988|NCT02265705|11210493|FG001|STARTED|Follow-up Period||0
10081989|NCT02265705|11210494|FG002|STARTED|Follow-up Period||0
10081990|NCT02265705|11210495|FG003|STARTED|Follow-up Period||0
10081991|NCT02265705|11210496|FG004|STARTED|Follow-up Period||0
10081992|NCT02265705|11210497|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
10081993|NCT02265705|11210498|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
10081994|NCT02265705|11210492|FG000|COMPLETED|Follow-up Period||0
10081995|NCT02265705|11210493|FG001|COMPLETED|Follow-up Period||0
10081996|NCT02265705|11210494|FG002|COMPLETED|Follow-up Period||0
10081997|NCT02265705|11210495|FG003|COMPLETED|Follow-up Period||0
10081998|NCT02265705|11210496|FG004|COMPLETED|Follow-up Period||0
10081999|NCT02265705|11210497|FG005|COMPLETED|Follow-up Period||1
10082000|NCT02265705|11210498|FG006|COMPLETED|Follow-up Period||47
10082001|NCT02265705|11210492|FG000|NOT COMPLETED|Follow-up Period||0
10082002|NCT02265705|11210493|FG001|NOT COMPLETED|Follow-up Period||0
10082003|NCT02265705|11210494|FG002|NOT COMPLETED|Follow-up Period||0
10082004|NCT02265705|11210495|FG003|NOT COMPLETED|Follow-up Period||0
10082005|NCT02265705|11210496|FG004|NOT COMPLETED|Follow-up Period||0
10197757|NCT03382509|11325801|FG000|STARTED|Overall Study||8
10197758|NCT03382509|11325802|FG001|STARTED|Overall Study||8
10197759|NCT03382509|11325801|FG000|COMPLETED|Overall Study||8
10197760|NCT03382509|11325802|FG001|COMPLETED|Overall Study||8
10197761|NCT03382509|11325801|FG000|NOT COMPLETED|Overall Study||0
10197762|NCT03382509|11325802|FG001|NOT COMPLETED|Overall Study||0
10197763|NCT03382665|11325809|FG000|STARTED|Overall Study||70
10197764|NCT03382665|11325809|FG000|Actual Enrollment|Overall Study||59
10197765|NCT03382665|11325809|FG000|5 Year Follow up|Overall Study||25
10197766|NCT03382665|11325809|FG000|COMPLETED|Overall Study||25
10197767|NCT03382665|11325809|FG000|NOT COMPLETED|Overall Study||45
10197768|NCT03382821|11325819|FG000|STARTED|Overall Study||60
10197769|NCT03382821|11325820|FG001|STARTED|Overall Study||60
10197770|NCT03382821|11325819|FG000|COMPLETED|Overall Study||60
10197771|NCT03382821|11325820|FG001|COMPLETED|Overall Study||57
10197772|NCT03382821|11325819|FG000|NOT COMPLETED|Overall Study||0
10197773|NCT03382821|11325820|FG001|NOT COMPLETED|Overall Study||3
10197774|NCT03382847|11325827|FG000|STARTED|Overall Study||25
10197775|NCT03382847|11325827|FG000|COMPLETED|Overall Study||25
10197776|NCT03382847|11325827|FG000|NOT COMPLETED|Overall Study||0
10082006|NCT02265705|11210497|FG005|NOT COMPLETED|Follow-up Period||1
10082007|NCT02265705|11210498|FG006|NOT COMPLETED|Follow-up Period||11
10082008|NCT02265744|11210514|FG000|STARTED|Overall Study||69
10082009|NCT02265744|11210515|FG001|STARTED|Overall Study||68
10082010|NCT02265744|11210516|FG002|STARTED|Overall Study||68
10197777|NCT03382899|11325833|FG000|STARTED|Overall Study||51
10197778|NCT03382899|11325834|FG001|STARTED|Overall Study||50
10197779|NCT03382899|11325833|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
10197780|NCT03382899|11325834|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48
10197781|NCT03382899|11325833|FG000|COMPLETED|Overall Study||20
10082011|NCT02265744|11210517|FG003|STARTED|Overall Study||70
10082012|NCT02265744|11210518|FG004|STARTED|Overall Study||71
10082013|NCT02265744|11210514|FG000|COMPLETED|Overall Study||49
10082014|NCT02265744|11210515|FG001|COMPLETED|Overall Study||53
10082015|NCT02265744|11210516|FG002|COMPLETED|Overall Study||51
10082016|NCT02265744|11210517|FG003|COMPLETED|Overall Study||47
10082017|NCT02265744|11210518|FG004|COMPLETED|Overall Study||58
10082018|NCT02265744|11210514|FG000|NOT COMPLETED|Overall Study||20
10082019|NCT02265744|11210515|FG001|NOT COMPLETED|Overall Study||15
10082020|NCT02265744|11210516|FG002|NOT COMPLETED|Overall Study||17
10082021|NCT02265744|11210517|FG003|NOT COMPLETED|Overall Study||23
10082022|NCT02265744|11210518|FG004|NOT COMPLETED|Overall Study||13
10082023|NCT02265783|11210530|FG000|STARTED|Overall Study||20
10197782|NCT03382899|11325834|FG001|COMPLETED|Overall Study||15
10197783|NCT03382899|11325833|FG000|NOT COMPLETED|Overall Study||31
10197784|NCT03382899|11325834|FG001|NOT COMPLETED|Overall Study||35
10197785|NCT03382912|11325842|FG000|STARTED|Overall Study||27
10197786|NCT03382912|11325843|FG001|STARTED|Overall Study||25
10197787|NCT03382912|11325842|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
10197788|NCT03382912|11325843|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
10197789|NCT03382912|11325842|FG000|COMPLETED|Overall Study||21
10197790|NCT03382912|11325843|FG001|COMPLETED|Overall Study||13
10197791|NCT03382912|11325842|FG000|NOT COMPLETED|Overall Study||6
10197792|NCT03382912|11325843|FG001|NOT COMPLETED|Overall Study||12
10238560|NCT00514813|11370000|FG002|STARTED|Overall Study||47
10238561|NCT00514813|11370001|FG003|STARTED|Overall Study||4
10238562|NCT00514813|11369998|FG000|COMPLETED|Overall Study||0
10238563|NCT00514813|11369999|FG001|COMPLETED|Overall Study||0
10238564|NCT00514813|11370000|FG002|COMPLETED|Overall Study||0
10238565|NCT00514813|11370001|FG003|COMPLETED|Overall Study||0
10238566|NCT00514813|11369998|FG000|NOT COMPLETED|Overall Study||15
10238567|NCT00514813|11369999|FG001|NOT COMPLETED|Overall Study||86
10238568|NCT00514813|11370000|FG002|NOT COMPLETED|Overall Study||47
10238569|NCT00514813|11370001|FG003|NOT COMPLETED|Overall Study||4
10238570|NCT00506064|11370013|FG000|STARTED|Overall Study||1
10238571|NCT00506064|11370014|FG001|STARTED|Overall Study||0
10238572|NCT00506064|11370013|FG000|COMPLETED|Overall Study||1
10238573|NCT00506064|11370014|FG001|COMPLETED|Overall Study||0
10238574|NCT00506064|11370013|FG000|NOT COMPLETED|Overall Study||0
10238575|NCT00506064|11370014|FG001|NOT COMPLETED|Overall Study||0
10238576|NCT00503880|11370020|FG000|STARTED|Overall Study||2
10238577|NCT00503880|11370021|FG001|STARTED|Overall Study||0
10238578|NCT00503880|11370022|FG002|STARTED|Overall Study||0
10238579|NCT00503880|11370023|FG003|STARTED|Overall Study||0
10238580|NCT00503880|11370024|FG004|STARTED|Overall Study||0
10238581|NCT00503880|11370020|FG000|COMPLETED|Overall Study||0
10238582|NCT00503880|11370021|FG001|COMPLETED|Overall Study||0
10238583|NCT00503880|11370022|FG002|COMPLETED|Overall Study||0
10238584|NCT00503880|11370023|FG003|COMPLETED|Overall Study||0
10238585|NCT00503880|11370024|FG004|COMPLETED|Overall Study||0
10238586|NCT00503880|11370020|FG000|NOT COMPLETED|Overall Study||2
10238587|NCT00503880|11370021|FG001|NOT COMPLETED|Overall Study||0
10238588|NCT00503880|11370022|FG002|NOT COMPLETED|Overall Study||0
10238589|NCT00503880|11370023|FG003|NOT COMPLETED|Overall Study||0
10238590|NCT00503880|11370024|FG004|NOT COMPLETED|Overall Study||0
10238591|NCT00511329|11370030|FG000|STARTED|Overall Study||0
10238592|NCT00511329|11370030|FG000|COMPLETED|Overall Study||0
10238593|NCT00511329|11370030|FG000|NOT COMPLETED|Overall Study||0
10238594|NCT00501228|11370034|FG000|STARTED|Overall Study||2
10238595|NCT00501228|11370034|FG000|COMPLETED|Overall Study||1
10238596|NCT00501228|11370034|FG000|NOT COMPLETED|Overall Study||1
10238597|NCT00496782|11370040|FG000|STARTED|Overall Study||9
10238598|NCT00496782|11370041|FG001|STARTED|Overall Study||7
10238599|NCT00496782|11370040|FG000|COMPLETED|Overall Study||8
10238600|NCT00496782|11370041|FG001|COMPLETED|Overall Study||5
10238601|NCT00496782|11370040|FG000|NOT COMPLETED|Overall Study||1
10238602|NCT00496782|11370041|FG001|NOT COMPLETED|Overall Study||2
10238603|NCT00506909|11370047|FG000|STARTED|Overall Study||0
10238604|NCT00506909|11370047|FG000|COMPLETED|Overall Study||0
10238605|NCT00506909|11370047|FG000|NOT COMPLETED|Overall Study||0
10238606|NCT00487578|11370053|FG000|STARTED|Overall Study||3
10238607|NCT00487578|11370054|FG001|STARTED|Overall Study||9
10238608|NCT00487578|11370053|FG000|COMPLETED|Overall Study||2
10238609|NCT00487578|11370054|FG001|COMPLETED|Overall Study||5
10238610|NCT00487578|11370053|FG000|NOT COMPLETED|Overall Study||1
10238611|NCT00487578|11370054|FG001|NOT COMPLETED|Overall Study||4
10238612|NCT00503009|11370063|FG000|STARTED|Overall Study||5
10238613|NCT00503009|11370064|FG001|STARTED|Overall Study||5
10238614|NCT00503009|11370065|FG002|STARTED|Overall Study||6
10238615|NCT00503009|11370063|FG000|COMPLETED|Overall Study||4
10082024|NCT02265783|11210530|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
10082025|NCT02265783|11210530|FG000|NOT COMPLETED|Overall Study||0
10082026|NCT02265796|11210536|FG000|STARTED|Overall Study||25
10082027|NCT02265796|11210537|FG001|STARTED|Overall Study||25
10082028|NCT02265796|11210536|FG000|COMPLETED|Overall Study||22
10238616|NCT00503009|11370064|FG001|COMPLETED|Overall Study||3
10238617|NCT00503009|11370065|FG002|COMPLETED|Overall Study||3
10238618|NCT00503009|11370063|FG000|NOT COMPLETED|Overall Study||1
10238619|NCT00503009|11370064|FG001|NOT COMPLETED|Overall Study||2
10238620|NCT00503009|11370065|FG002|NOT COMPLETED|Overall Study||3
10238621|NCT00500045|11370073|FG000|STARTED|Overall Study||0
10238622|NCT00500045|11370073|FG000|COMPLETED|Overall Study||0
10082029|NCT02265796|11210537|FG001|COMPLETED|Overall Study||24
10082030|NCT02265796|11210536|FG000|NOT COMPLETED|Overall Study||3
10082031|NCT02265796|11210537|FG001|NOT COMPLETED|Overall Study||1
10082032|NCT02265848|11210545|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
10082033|NCT02265848|11210546|FG001|STARTED|Overall Study||11
10082034|NCT02265848|11210545|FG000|COMPLETED|Overall Study||11
10082035|NCT02265848|11210546|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
10082036|NCT02265848|11210545|FG000|NOT COMPLETED|Overall Study||0
10082037|NCT02265848|11210546|FG001|NOT COMPLETED|Overall Study||0
10082038|NCT02265913|11210555|FG000|STARTED|Overall Study||1357
10082039|NCT02265913|11210556|FG001|STARTED|Overall Study||1361
10082040|NCT02265913|11210557|FG002|STARTED|Overall Study||1358
10082041|NCT02265913|11210555|FG000|COMPLETED|Overall Study||793
10082042|NCT02265913|11210556|FG001|COMPLETED|Overall Study||810
10082043|NCT02265913|11210557|FG002|COMPLETED|Overall Study||813
10082044|NCT02265913|11210555|FG000|NOT COMPLETED|Overall Study||564
10082045|NCT02265913|11210556|FG001|NOT COMPLETED|Overall Study||551
10082046|NCT02265913|11210557|FG002|NOT COMPLETED|Overall Study||545
10082047|NCT02265952|11210565|FG000|STARTED|Main Study Period||9
10082048|NCT02265952|11210566|FG001|STARTED|Main Study Period||0
10082049|NCT02265952|11210565|FG000|COMPLETED|Main Study Period||9
10082050|NCT02265952|11210566|FG001|COMPLETED|Main Study Period||0
10082051|NCT02265952|11210565|FG000|NOT COMPLETED|Main Study Period||0
10082052|NCT02265952|11210566|FG001|NOT COMPLETED|Main Study Period||0
10082053|NCT02265952|11210565|FG000|STARTED|Open Label Extension (OLE) Period||0
10082054|NCT02265952|11210566|FG001|STARTED|Open Label Extension (OLE) Period||8
10082055|NCT02265952|11210565|FG000|COMPLETED|Open Label Extension (OLE) Period||0
10082056|NCT02265952|11210566|FG001|COMPLETED|Open Label Extension (OLE) Period||0
10082057|NCT02265952|11210565|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
10082058|NCT02265952|11210566|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8
10082059|NCT02265965|11210574|FG000|STARTED|Overall Study||7
10082060|NCT02265965|11210575|FG001|STARTED|Overall Study||11
10082061|NCT02265965|11210574|FG000|COMPLETED|Overall Study||7
10082062|NCT02265965|11210575|FG001|COMPLETED|Overall Study||11
10082063|NCT02265965|11210574|FG000|NOT COMPLETED|Overall Study||0
10082064|NCT02265965|11210575|FG001|NOT COMPLETED|Overall Study||0
10082065|NCT02266004|11210581|FG000|STARTED|Overall Study||9
10082066|NCT02266004|11210581|FG000|COMPLETED|Overall Study||7
10082067|NCT02266004|11210581|FG000|NOT COMPLETED|Overall Study||2
10082068|NCT02266108|11210587|FG000|STARTED|Overall Study||80
10082069|NCT02266108|11210588|FG001|STARTED|Overall Study||71
10082070|NCT02266108|11210587|FG000|COMPLETED|Overall Study||80
10082071|NCT02266108|11210588|FG001|COMPLETED|Overall Study||71
10082072|NCT02266108|11210587|FG000|NOT COMPLETED|Overall Study||0
10082073|NCT02266108|11210588|FG001|NOT COMPLETED|Overall Study||0
10082074|NCT02266147|11210598|FG000|STARTED|PART 1: Dose Escalation||3
10082075|NCT02266147|11210599|FG001|STARTED|PART 1: Dose Escalation||3
10082076|NCT02266147|11210600|FG002|STARTED|PART 1: Dose Escalation||3
10082077|NCT02266147|11210601|FG003|STARTED|PART 1: Dose Escalation||4
10082078|NCT02266147|11210598|FG000|COMPLETED|PART 1: Dose Escalation||2
10082079|NCT02266147|11210599|FG001|COMPLETED|PART 1: Dose Escalation||0
10082080|NCT02266147|11210600|FG002|COMPLETED|PART 1: Dose Escalation||0
10082081|NCT02266147|11210601|FG003|COMPLETED|PART 1: Dose Escalation||0
10082082|NCT02266147|11210598|FG000|NOT COMPLETED|PART 1: Dose Escalation||1
10082083|NCT02266147|11210599|FG001|NOT COMPLETED|PART 1: Dose Escalation||3
10082084|NCT02266147|11210600|FG002|NOT COMPLETED|PART 1: Dose Escalation||3
10082085|NCT02266147|11210601|FG003|NOT COMPLETED|PART 1: Dose Escalation||4
10082086|NCT02266147|11210598|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
10082087|NCT02266147|11210599|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
10082088|NCT02266147|11210600|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
10082089|NCT02266147|11210601|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
10082090|NCT02266147|11210598|FG000|COMPLETED|PART 2: Dose Expansion||0
10082091|NCT02266147|11210599|FG001|COMPLETED|PART 2: Dose Expansion||0
10082092|NCT02266147|11210600|FG002|COMPLETED|PART 2: Dose Expansion||0
10082093|NCT02266147|11210601|FG003|COMPLETED|PART 2: Dose Expansion||0
10082094|NCT02266147|11210598|FG000|NOT COMPLETED|PART 2: Dose Expansion||7
10082095|NCT02266147|11210599|FG001|NOT COMPLETED|PART 2: Dose Expansion||0
10082096|NCT02266147|11210600|FG002|NOT COMPLETED|PART 2: Dose Expansion||0
10082097|NCT02266147|11210601|FG003|NOT COMPLETED|PART 2: Dose Expansion||9
10082098|NCT02266225|11210613|FG000|STARTED|Overall Study||48
10082099|NCT02266225|11210613|FG000|Enrolled in Intervention|Overall Study||44
10082100|NCT02266225|11210613|FG000|COMPLETED|Overall Study||32
10082101|NCT02266225|11210613|FG000|NOT COMPLETED|Overall Study||16
10082102|NCT02266277|11210624|FG000|STARTED|Overall Study||5000
10082103|NCT02266277|11210625|FG001|STARTED|Overall Study||5000
10082104|NCT02266277|11210626|FG002|STARTED|Overall Study||5000
10082105|NCT02266277|11210627|FG003|STARTED|Overall Study||5000
10082106|NCT02266277|11210628|FG004|STARTED|Overall Study||5000
10082107|NCT02266277|11210629|FG005|STARTED|Overall Study||5000
10082108|NCT02266277|11210624|FG000|COMPLETED|Overall Study||5000
10082109|NCT02266277|11210625|FG001|COMPLETED|Overall Study||5000
10082110|NCT02266277|11210626|FG002|COMPLETED|Overall Study||5000
10082111|NCT02266277|11210627|FG003|COMPLETED|Overall Study||5000
10082112|NCT02266277|11210628|FG004|COMPLETED|Overall Study||5000
10082113|NCT02266277|11210629|FG005|COMPLETED|Overall Study||5000
10082114|NCT02266277|11210624|FG000|NOT COMPLETED|Overall Study||0
10082115|NCT02266277|11210625|FG001|NOT COMPLETED|Overall Study||0
10082116|NCT02266277|11210626|FG002|NOT COMPLETED|Overall Study||0
10082117|NCT02266277|11210627|FG003|NOT COMPLETED|Overall Study||0
10082118|NCT02266277|11210628|FG004|NOT COMPLETED|Overall Study||0
10082119|NCT02266277|11210629|FG005|NOT COMPLETED|Overall Study||0
10082120|NCT02266381|11210648|FG000|STARTED|Overall Study||150
10082121|NCT02266381|11210649|FG001|STARTED|Overall Study||150
10082122|NCT02266381|11210650|FG002|STARTED|Overall Study||150
10082123|NCT02266381|11210648|FG000|COMPLETED|Overall Study||147
10082124|NCT02266381|11210649|FG001|COMPLETED|Overall Study||145
10082125|NCT02266381|11210650|FG002|COMPLETED|Overall Study||146
10082126|NCT02266381|11210648|FG000|NOT COMPLETED|Overall Study||3
10082127|NCT02266381|11210649|FG001|NOT COMPLETED|Overall Study||5
10082128|NCT02266381|11210650|FG002|NOT COMPLETED|Overall Study||4
10082129|NCT02266433|11210662|FG000|STARTED|Overall Study||127
10082130|NCT02266433|11210663|FG001|STARTED|Overall Study||118
10082131|NCT02266433|11210662|FG000|COMPLETED|Overall Study||68
10082132|NCT02266433|11210663|FG001|COMPLETED|Overall Study||65
10082133|NCT02266433|11210662|FG000|NOT COMPLETED|Overall Study||59
10082134|NCT02266433|11210663|FG001|NOT COMPLETED|Overall Study||53
10082135|NCT02266472|11210672|FG000|STARTED|Period 1+ Washout||15
10197793|NCT03383146|11325851|FG000|STARTED|Overall Study||148
10197794|NCT03383146|11325852|FG001|STARTED|Overall Study||302
10197795|NCT03383146|11325851|FG000|Safety Population|Overall Study||145
10197796|NCT03383146|11325852|FG001|Safety Population|Overall Study||299
10197797|NCT03383146|11325851|FG000|Run-in Period|Overall Study||91
10197798|NCT03383146|11325852|FG001|Run-in Period|Overall Study||207
10197799|NCT03383146|11325851|FG000|COMPLETED|Overall Study||63
10197800|NCT03383146|11325852|FG001|COMPLETED|Overall Study||118
10197801|NCT03383146|11325851|FG000|NOT COMPLETED|Overall Study||85
10197802|NCT03383146|11325852|FG001|NOT COMPLETED|Overall Study||184
10197803|NCT03383198|11325861|FG000|STARTED|Overall Study||4
10197804|NCT03383198|11325862|FG001|STARTED|Overall Study||1
10197805|NCT03383198|11325861|FG000|COMPLETED|Overall Study||4
10197806|NCT03383198|11325862|FG001|COMPLETED|Overall Study||1
10197807|NCT03383198|11325861|FG000|NOT COMPLETED|Overall Study||0
10197808|NCT03383198|11325862|FG001|NOT COMPLETED|Overall Study||0
10197809|NCT03383523|11325875|FG000|STARTED|Overall Study||11
10197810|NCT03383523|11325876|FG001|STARTED|Overall Study||11
10197811|NCT03383523|11325877|FG002|STARTED|Overall Study||10
10197812|NCT03383523|11325878|FG003|STARTED|Overall Study||12
10197813|NCT03383523|11325879|FG004|STARTED|Overall Study||11
10197814|NCT03383523|11325880|FG005|STARTED|Overall Study||12
10197815|NCT03383523|11325881|FG006|STARTED|Overall Study||10
10197816|NCT03383523|11325875|FG000|COMPLETED|Overall Study||10
10197817|NCT03383523|11325876|FG001|COMPLETED|Overall Study||11
10197818|NCT03383523|11325877|FG002|COMPLETED|Overall Study||9
10197819|NCT03383523|11325878|FG003|COMPLETED|Overall Study||12
10197820|NCT03383523|11325879|FG004|COMPLETED|Overall Study||11
10197821|NCT03383523|11325880|FG005|COMPLETED|Overall Study||12
10197822|NCT03383523|11325881|FG006|COMPLETED|Overall Study||10
10197823|NCT03383523|11325875|FG000|NOT COMPLETED|Overall Study||1
10197824|NCT03383523|11325876|FG001|NOT COMPLETED|Overall Study||0
10197825|NCT03383523|11325877|FG002|NOT COMPLETED|Overall Study||1
10197826|NCT03383523|11325878|FG003|NOT COMPLETED|Overall Study||0
10197827|NCT03383523|11325879|FG004|NOT COMPLETED|Overall Study||0
10197828|NCT03383523|11325880|FG005|NOT COMPLETED|Overall Study||0
10197829|NCT03383523|11325881|FG006|NOT COMPLETED|Overall Study||0
10197830|NCT03383588|11325900|FG000|STARTED|Overall Study||8
10197831|NCT03383588|11325901|FG001|STARTED|Overall Study||9
10197832|NCT03383588|11325902|FG002|STARTED|Overall Study||9
10197833|NCT03383588|11325900|FG000|COMPLETED|Overall Study||8
10197834|NCT03383588|11325901|FG001|COMPLETED|Overall Study||9
10197835|NCT03383588|11325902|FG002|COMPLETED|Overall Study||9
10197836|NCT03383588|11325900|FG000|NOT COMPLETED|Overall Study||0
10197837|NCT03383588|11325901|FG001|NOT COMPLETED|Overall Study||0
10197838|NCT03383588|11325902|FG002|NOT COMPLETED|Overall Study||0
10197839|NCT03383614|11325914|FG000|STARTED|Overall Study||6
10197840|NCT03383614|11325915|FG001|STARTED|Overall Study||6
10197841|NCT03383614|11325916|FG002|STARTED|Overall Study||6
10082136|NCT02266472|11210673|FG001|STARTED|Period 1+ Washout||15
10082137|NCT02266472|11210672|FG000|COMPLETED|Period 1+ Washout||15
10082138|NCT02266472|11210673|FG001|COMPLETED|Period 1+ Washout||15
10082139|NCT02266472|11210672|FG000|NOT COMPLETED|Period 1+ Washout||0
10082140|NCT02266472|11210673|FG001|NOT COMPLETED|Period 1+ Washout||0
10082141|NCT02266472|11210672|FG000|STARTED|Period 2+ Washout||15
10082142|NCT02266472|11210673|FG001|STARTED|Period 2+ Washout||15
10082143|NCT02266472|11210672|FG000|COMPLETED|Period 2+ Washout||15
10082144|NCT02266472|11210673|FG001|COMPLETED|Period 2+ Washout||15
10082145|NCT02266472|11210672|FG000|NOT COMPLETED|Period 2+ Washout||0
10082146|NCT02266472|11210673|FG001|NOT COMPLETED|Period 2+ Washout||0
10082147|NCT02266576|11210681|FG000|STARTED|Overall Study||102
10082148|NCT02266576|11210682|FG001|STARTED|Overall Study||105
10197842|NCT03383614|11325917|FG003|STARTED|Overall Study||6
10197843|NCT03383614|11325914|FG000|COMPLETED|Overall Study||6
10197844|NCT03383614|11325915|FG001|COMPLETED|Overall Study||5
10197845|NCT03383614|11325916|FG002|COMPLETED|Overall Study||6
10197846|NCT03383614|11325917|FG003|COMPLETED|Overall Study||6
10197847|NCT03383614|11325914|FG000|NOT COMPLETED|Overall Study||0
10197848|NCT03383614|11325915|FG001|NOT COMPLETED|Overall Study||1
10197849|NCT03383614|11325916|FG002|NOT COMPLETED|Overall Study||0
10082149|NCT02266576|11210681|FG000|COMPLETED|Overall Study||85
10082150|NCT02266576|11210682|FG001|COMPLETED|Overall Study||90
10082151|NCT02266576|11210681|FG000|NOT COMPLETED|Overall Study||17
10082152|NCT02266576|11210682|FG001|NOT COMPLETED|Overall Study||15
10082153|NCT02266706|11210697|FG000|STARTED|Overall Study||6
10082154|NCT02266706|11210698|FG001|STARTED|Overall Study||7
10082155|NCT02266706|11210699|FG002|STARTED|Overall Study||4
10082156|NCT02266706|11210700|FG003|STARTED|Overall Study||4
10082157|NCT02266706|11210701|FG004|STARTED|Overall Study||1
10082158|NCT02266706|11210702|FG005|STARTED|Overall Study||7
10082159|NCT02266706|11210703|FG006|STARTED|Overall Study||8
10082160|NCT02266706|11210704|FG007|STARTED|Overall Study||2
10082161|NCT02266706|11210705|FG008|STARTED|Overall Study||4
10082162|NCT02266706|11210697|FG000|Treated|Overall Study||6
10082163|NCT02266706|11210698|FG001|Treated|Overall Study||6
10082164|NCT02266706|11210699|FG002|Treated|Overall Study||3
10082165|NCT02266706|11210700|FG003|Treated|Overall Study||3
10082166|NCT02266706|11210701|FG004|Treated|Overall Study||1
10082167|NCT02266706|11210702|FG005|Treated|Overall Study||5
10082168|NCT02266706|11210703|FG006|Treated|Overall Study||7
10082169|NCT02266706|11210704|FG007|Treated|Overall Study||2
10082170|NCT02266706|11210705|FG008|Treated|Overall Study||4
10082171|NCT02266706|11210697|FG000|COMPLETED|Overall Study||6
10082172|NCT02266706|11210698|FG001|COMPLETED|Overall Study||6
10082173|NCT02266706|11210699|FG002|COMPLETED|Overall Study||3
10082174|NCT02266706|11210700|FG003|COMPLETED|Overall Study||3
10082175|NCT02266706|11210701|FG004|COMPLETED|Overall Study||1
10082176|NCT02266706|11210702|FG005|COMPLETED|Overall Study||5
10082177|NCT02266706|11210703|FG006|COMPLETED|Overall Study||7
10082178|NCT02266706|11210704|FG007|COMPLETED|Overall Study||2
10082179|NCT02266706|11210705|FG008|COMPLETED|Overall Study||4
10082180|NCT02266706|11210697|FG000|NOT COMPLETED|Overall Study||0
10082181|NCT02266706|11210698|FG001|NOT COMPLETED|Overall Study||1
10082182|NCT02266706|11210699|FG002|NOT COMPLETED|Overall Study||1
10082183|NCT02266706|11210700|FG003|NOT COMPLETED|Overall Study||1
10082184|NCT02266706|11210701|FG004|NOT COMPLETED|Overall Study||0
10082185|NCT02266706|11210702|FG005|NOT COMPLETED|Overall Study||2
10082186|NCT02266706|11210703|FG006|NOT COMPLETED|Overall Study||1
10082187|NCT02266706|11210704|FG007|NOT COMPLETED|Overall Study||0
10082188|NCT02266706|11210705|FG008|NOT COMPLETED|Overall Study||0
10082189|NCT02266810|11210727|FG000|STARTED|Overall Study|sinus sides|80
10082190|NCT02266810|11210728|FG001|STARTED|Overall Study|sinus sides|80
10082191|NCT02266810|11210727|FG000|COMPLETED|Overall Study|sinus sides|79
10082192|NCT02266810|11210728|FG001|COMPLETED|Overall Study|sinus sides|79
10082193|NCT02266810|11210727|FG000|NOT COMPLETED|Overall Study||1
10082194|NCT02266810|11210728|FG001|NOT COMPLETED|Overall Study||1
10082195|NCT02266875|11210745|FG000|STARTED|Overall Study||40
10082196|NCT02266875|11210746|FG001|STARTED|Overall Study||30
10082197|NCT02266875|11210745|FG000|COMPLETED|Overall Study||29
10082198|NCT02266875|11210746|FG001|COMPLETED|Overall Study||30
10082199|NCT02266875|11210745|FG000|NOT COMPLETED|Overall Study||11
10082200|NCT02266875|11210746|FG001|NOT COMPLETED|Overall Study||0
10112660|NCT02504320|11243578|FG000|STARTED|Treatment Period 4||19
10112661|NCT02504320|11243579|FG001|STARTED|Treatment Period 4||18
10112662|NCT02504320|11243580|FG002|STARTED|Treatment Period 4||18
10112663|NCT02504320|11243581|FG003|STARTED|Treatment Period 4||19
10112664|NCT02504320|11243578|FG000|COMPLETED|Treatment Period 4||19
10112665|NCT02504320|11243579|FG001|COMPLETED|Treatment Period 4||18
10112666|NCT02504320|11243580|FG002|COMPLETED|Treatment Period 4||18
10112667|NCT02504320|11243581|FG003|COMPLETED|Treatment Period 4||19
10112668|NCT02504320|11243578|FG000|NOT COMPLETED|Treatment Period 4||0
10112669|NCT02504320|11243579|FG001|NOT COMPLETED|Treatment Period 4||0
10112670|NCT02504320|11243580|FG002|NOT COMPLETED|Treatment Period 4||0
10112671|NCT02504320|11243581|FG003|NOT COMPLETED|Treatment Period 4||0
10112672|NCT02504424|11243591|FG000|STARTED|Overall Study||50
10112673|NCT02504424|11243591|FG000|COMPLETED|Overall Study||48
10112674|NCT02504424|11243591|FG000|NOT COMPLETED|Overall Study||2
10112675|NCT02504502|11243598|FG000|STARTED|Routine Care vs. Enhanced Report||24
10112676|NCT02504502|11243599|FG001|STARTED|Routine Care vs. Enhanced Report||28
10112677|NCT02504502|11243598|FG000|COMPLETED|Routine Care vs. Enhanced Report||20
10112678|NCT02504502|11243599|FG001|COMPLETED|Routine Care vs. Enhanced Report||21
10112679|NCT02504502|11243598|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4
10112680|NCT02504502|11243599|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7
10112681|NCT02504502|11243598|FG000|STARTED|Crossover to Enhanced Report||20
10112682|NCT02504502|11243599|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
10112683|NCT02504502|11243598|FG000|COMPLETED|Crossover to Enhanced Report||15
10112684|NCT02504502|11243599|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
10112685|NCT02504502|11243598|FG000|NOT COMPLETED|Crossover to Enhanced Report||5
10112686|NCT02504502|11243599|FG001|NOT COMPLETED|Crossover to Enhanced Report||0
10112687|NCT02504541|11243605|FG000|STARTED|Overall Study||133
10112688|NCT02504541|11243605|FG000|COMPLETED|Overall Study||113
10112689|NCT02504541|11243605|FG000|NOT COMPLETED|Overall Study||20
10112690|NCT02504554|11243611|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
10112691|NCT02504554|11243612|FG001|STARTED|Overall Study||6
10112692|NCT02504554|11243611|FG000|COMPLETED|Overall Study||12
10112693|NCT02504554|11243612|FG001|COMPLETED|Overall Study||6
10112694|NCT02504554|11243611|FG000|NOT COMPLETED|Overall Study||0
10082201|NCT02266888|11210754|FG000|STARTED|Overall Study||15
10082202|NCT02266888|11210755|FG001|STARTED|Overall Study||12
10082203|NCT02266888|11210756|FG002|STARTED|Overall Study||11
10082204|NCT02266888|11210757|FG003|STARTED|Overall Study||7
10082205|NCT02266888|11210754|FG000|COMPLETED|Overall Study||8
10082206|NCT02266888|11210755|FG001|COMPLETED|Overall Study||8
10082207|NCT02266888|11210756|FG002|COMPLETED|Overall Study||0
10082208|NCT02266888|11210757|FG003|COMPLETED|Overall Study||0
10082209|NCT02266888|11210754|FG000|NOT COMPLETED|Overall Study||7
10082210|NCT02266888|11210755|FG001|NOT COMPLETED|Overall Study||4
10082211|NCT02266888|11210756|FG002|NOT COMPLETED|Overall Study||11
10082212|NCT02266888|11210757|FG003|NOT COMPLETED|Overall Study||7
10082213|NCT02267083|11210765|FG000|STARTED|Overall Study||22
10082214|NCT02267083|11210765|FG000|COMPLETED|Overall Study||3
10082215|NCT02267083|11210765|FG000|NOT COMPLETED|Overall Study||19
10082216|NCT02267135|11210771|FG000|STARTED|Period 1 (Randomized Set)||51
10082217|NCT02267135|11210772|FG001|STARTED|Period 1 (Randomized Set)||51
10082218|NCT02267135|11210771|FG000|COMPLETED|Period 1 (Randomized Set)||50
10082219|NCT02267135|11210772|FG001|COMPLETED|Period 1 (Randomized Set)||47
10082220|NCT02267135|11210771|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1
10082221|NCT02267135|11210772|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4
10082222|NCT02267135|11210771|FG000|STARTED|Period 2 (Randomized Set)||50
10082223|NCT02267135|11210772|FG001|STARTED|Period 2 (Randomized Set)||47
10082224|NCT02267135|11210771|FG000|COMPLETED|Period 2 (Randomized Set)||46
10082225|NCT02267135|11210772|FG001|COMPLETED|Period 2 (Randomized Set)||46
10082226|NCT02267135|11210771|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4
10082227|NCT02267135|11210772|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1
10082228|NCT02267187|11210781|FG000|STARTED|Overall Study||15
10082229|NCT02267187|11210781|FG000|COMPLETED|Overall Study||10
10082230|NCT02267187|11210781|FG000|NOT COMPLETED|Overall Study||5
10082231|NCT02267226|11210785|FG000|STARTED|Overall Study||25
10082232|NCT02267226|11210785|FG000|SAFETY Population|Overall Study||25
10082233|NCT02267226|11210785|FG000|FAS-Bleeding Population|Overall Study||24
10082234|NCT02267226|11210785|FG000|Surgical Prophylaxis Population|Overall Study||9
10082235|NCT02267226|11210785|FG000|COMPLETED|Overall Study||18
10082236|NCT02267226|11210785|FG000|NOT COMPLETED|Overall Study||7
10082237|NCT02267278|11210804|FG000|STARTED|Overall Study||25
10082238|NCT02267278|11210804|FG000|COMPLETED|Overall Study||20
10082239|NCT02267278|11210804|FG000|NOT COMPLETED|Overall Study||5
10082240|NCT02267317|11210811|FG000|STARTED|Infusion1||8
10082241|NCT02267317|11210812|FG001|STARTED|Infusion1||3
10082242|NCT02267317|11210813|FG002|STARTED|Infusion1||1
10082243|NCT02267317|11210814|FG003|STARTED|Infusion1||2
10082244|NCT02267317|11210815|FG004|STARTED|Infusion1||0
10197850|NCT03383614|11325917|FG003|NOT COMPLETED|Overall Study||0
10197851|NCT03383627|11325932|FG000|STARTED|Overall Study||80
10197852|NCT03383627|11325932|FG000|COMPLETED|Overall Study||80
10197853|NCT03383627|11325932|FG000|NOT COMPLETED|Overall Study||0
10197854|NCT03383757|11325936|FG000|STARTED|Overall Study||117
10197855|NCT03383757|11325936|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56
10197856|NCT03383757|11325936|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59
10197857|NCT03383757|11325936|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52
10197858|NCT03383757|11325936|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
10197859|NCT03383757|11325936|FG000|COMPLETED|Overall Study||78
10197860|NCT03383757|11325936|FG000|NOT COMPLETED|Overall Study||39
10197861|NCT03383783|11325940|FG000|STARTED|Overall Study||27
10197862|NCT03383783|11325940|FG000|COMPLETED|Overall Study||25
10197863|NCT03383783|11325940|FG000|NOT COMPLETED|Overall Study||2
10197864|NCT03383887|11325956|FG000|STARTED|Overall Study||5
10197865|NCT03383887|11325957|FG001|STARTED|Overall Study||6
10197866|NCT03383887|11325956|FG000|COMPLETED|Overall Study||5
10197867|NCT03383887|11325957|FG001|COMPLETED|Overall Study||5
10197868|NCT03383887|11325956|FG000|NOT COMPLETED|Overall Study||0
10197869|NCT03383887|11325957|FG001|NOT COMPLETED|Overall Study||1
10197870|NCT03384173|11325965|FG000|STARTED|Overall Study||35
10197871|NCT03384173|11325965|FG000|COMPLETED|Overall Study||35
10197872|NCT03384173|11325965|FG000|NOT COMPLETED|Overall Study||0
10197873|NCT03384316|11325977|FG000|STARTED|Overall Study||6
10197874|NCT03384316|11325978|FG001|STARTED|Overall Study||5
10197875|NCT03384316|11325977|FG000|COMPLETED|Overall Study||6
10197876|NCT03384316|11325978|FG001|COMPLETED|Overall Study||4
10197877|NCT03384316|11325977|FG000|NOT COMPLETED|Overall Study||0
10197878|NCT03384316|11325978|FG001|NOT COMPLETED|Overall Study||1
10197879|NCT03384329|11325988|FG000|STARTED|Overall Study||11
10197880|NCT03384329|11325989|FG001|STARTED|Overall Study||11
10197881|NCT03384329|11325988|FG000|COMPLETED|Overall Study||11
10197882|NCT03384329|11325989|FG001|COMPLETED|Overall Study||11
10197883|NCT03384329|11325988|FG000|NOT COMPLETED|Overall Study||0
10082245|NCT02267317|11210816|FG005|STARTED|Infusion1||1
10082246|NCT02267317|11210811|FG000|COMPLETED|Infusion1||8
10082247|NCT02267317|11210812|FG001|COMPLETED|Infusion1||3
10082248|NCT02267317|11210813|FG002|COMPLETED|Infusion1||1
10082249|NCT02267317|11210814|FG003|COMPLETED|Infusion1||2
10082250|NCT02267317|11210815|FG004|COMPLETED|Infusion1||0
10082251|NCT02267317|11210816|FG005|COMPLETED|Infusion1||1
10082252|NCT02267317|11210811|FG000|NOT COMPLETED|Infusion1||0
10082253|NCT02267317|11210812|FG001|NOT COMPLETED|Infusion1||0
10082254|NCT02267317|11210813|FG002|NOT COMPLETED|Infusion1||0
10082255|NCT02267317|11210814|FG003|NOT COMPLETED|Infusion1||0
10082256|NCT02267317|11210815|FG004|NOT COMPLETED|Infusion1||0
10197884|NCT03384329|11325989|FG001|NOT COMPLETED|Overall Study||0
10197885|NCT03384693|11325995|FG000|STARTED|Overall Study||25
10197886|NCT03384693|11325995|FG000|COMPLETED|Overall Study||22
10197887|NCT03384693|11325995|FG000|NOT COMPLETED|Overall Study||3
10197888|NCT03384745|11326005|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52
10197889|NCT03384745|11326006|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52
10197890|NCT03384745|11326007|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53
10197891|NCT03384745|11326008|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51
10197892|NCT03384745|11326009|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52
10197893|NCT03384745|11326010|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53
10197894|NCT03384745|11326005|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
10197895|NCT03384745|11326006|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
10197896|NCT03384745|11326007|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
10197897|NCT03384745|11326008|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
10197898|NCT03384745|11326009|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
10197899|NCT03384745|11326010|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
10197900|NCT03384745|11326005|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
10197901|NCT03384745|11326006|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
10197902|NCT03384745|11326007|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
10197903|NCT03384745|11326008|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
10197904|NCT03384745|11326009|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
10197905|NCT03384745|11326010|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
10197906|NCT03384745|11326005|FG000|STARTED|Maintenance/Escalation (W12-W24)||52
10197907|NCT03384745|11326006|FG001|STARTED|Maintenance/Escalation (W12-W24)||51
10197908|NCT03384745|11326007|FG002|STARTED|Maintenance/Escalation (W12-W24)||50
10197909|NCT03384745|11326008|FG003|STARTED|Maintenance/Escalation (W12-W24)||49
10197910|NCT03384745|11326009|FG004|STARTED|Maintenance/Escalation (W12-W24)||49
10197911|NCT03384745|11326010|FG005|STARTED|Maintenance/Escalation (W12-W24)||51
10197912|NCT03384745|11326005|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52
10197913|NCT03384745|11326006|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51
10197914|NCT03384745|11326007|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49
10197915|NCT03384745|11326008|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47
10197916|NCT03384745|11326009|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47
10197917|NCT03384745|11326010|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51
10197918|NCT03384745|11326005|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
10197919|NCT03384745|11326006|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
10197920|NCT03384745|11326007|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
10197921|NCT03384745|11326008|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
10197922|NCT03384745|11326009|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
10197923|NCT03384745|11326010|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
10197924|NCT03384745|11326005|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52
10197925|NCT03384745|11326006|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51
10197926|NCT03384745|11326007|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49
10197927|NCT03384745|11326008|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47
10197928|NCT03384745|11326009|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47
10197929|NCT03384745|11326010|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51
10197930|NCT03384745|11326005|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
10197931|NCT03384745|11326006|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
10197932|NCT03384745|11326007|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
10197933|NCT03384745|11326008|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
10197934|NCT03384745|11326009|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
10197935|NCT03384745|11326010|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
10197936|NCT03384745|11326005|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
10197937|NCT03384745|11326006|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
10197938|NCT03384745|11326007|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
10197939|NCT03384745|11326008|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
10197940|NCT03384745|11326009|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
10197941|NCT03384745|11326010|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
10197942|NCT03384940|11326033|FG000|STARTED|Overall Study||53
10197943|NCT03384940|11326034|FG001|STARTED|Overall Study||15
10197944|NCT03384940|11326035|FG002|STARTED|Overall Study||18
10197945|NCT03384940|11326033|FG000|COMPLETED|Overall Study||0
10197946|NCT03384940|11326034|FG001|COMPLETED|Overall Study||0
10197947|NCT03384940|11326035|FG002|COMPLETED|Overall Study||0
10197948|NCT03384940|11326033|FG000|NOT COMPLETED|Overall Study||53
10197949|NCT03384940|11326034|FG001|NOT COMPLETED|Overall Study||15
10197950|NCT03384940|11326035|FG002|NOT COMPLETED|Overall Study||18
10197951|NCT03384953|11326045|FG000|STARTED|Overall Study||91
10197952|NCT03384953|11326046|FG001|STARTED|Overall Study||12
10197953|NCT03384953|11326045|FG000|Completed Treatment|Overall Study||68
10197954|NCT03384953|11326046|FG001|Completed Treatment|Overall Study||6
10197955|NCT03384953|11326045|FG000|COMPLETED|Overall Study||51
10197956|NCT03384953|11326046|FG001|COMPLETED|Overall Study||4
10197957|NCT03384953|11326045|FG000|NOT COMPLETED|Overall Study||40
10197958|NCT03384953|11326046|FG001|NOT COMPLETED|Overall Study||8
10197959|NCT03384966|11326055|FG000|STARTED|Randomized at End of Screening Period||115
10197960|NCT03384966|11326056|FG001|STARTED|Randomized at End of Screening Period||115
10197961|NCT03384966|11326057|FG002|STARTED|Randomized at End of Screening Period||116
10197962|NCT03384966|11326055|FG000|COMPLETED|Randomized at End of Screening Period||114
10238623|NCT00500045|11370073|FG000|NOT COMPLETED|Overall Study||0
10197963|NCT03384966|11326056|FG001|COMPLETED|Randomized at End of Screening Period||115
10197964|NCT03384966|11326057|FG002|COMPLETED|Randomized at End of Screening Period||116
10197965|NCT03384966|11326055|FG000|NOT COMPLETED|Randomized at End of Screening Period||1
10197966|NCT03384966|11326056|FG001|NOT COMPLETED|Randomized at End of Screening Period||0
10197967|NCT03384966|11326057|FG002|NOT COMPLETED|Randomized at End of Screening Period||0
10197968|NCT03384966|11326055|FG000|STARTED|Treatment Period||114
10197969|NCT03384966|11326056|FG001|STARTED|Treatment Period||115
10197970|NCT03384966|11326057|FG002|STARTED|Treatment Period||116
10197971|NCT03384966|11326055|FG000|Thigh Administration|Treatment Period||57
10197972|NCT03384966|11326056|FG001|Thigh Administration|Treatment Period||57
10197973|NCT03384966|11326057|FG002|Thigh Administration|Treatment Period||58
10197974|NCT03384966|11326055|FG000|Abdomen Administration|Treatment Period||57
10197975|NCT03384966|11326056|FG001|Abdomen Administration|Treatment Period||58
10197976|NCT03384966|11326057|FG002|Abdomen Administration|Treatment Period||58
10197977|NCT03384966|11326055|FG000|Per-protocol Analysis Set|Treatment Period||96
10197978|NCT03384966|11326056|FG001|Per-protocol Analysis Set|Treatment Period||90
10197979|NCT03384966|11326057|FG002|Per-protocol Analysis Set|Treatment Period||93
10197980|NCT03384966|11326055|FG000|Safety Analysis Set|Treatment Period||114
10197981|NCT03384966|11326056|FG001|Safety Analysis Set|Treatment Period||115
10197982|NCT03384966|11326057|FG002|Safety Analysis Set|Treatment Period||116
10197983|NCT03384966|11326055|FG000|Pharmacokinetic Analysis Set|Treatment Period||111
10197984|NCT03384966|11326056|FG001|Pharmacokinetic Analysis Set|Treatment Period||115
10197985|NCT03384966|11326057|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
10197986|NCT03384966|11326055|FG000|COMPLETED|Treatment Period||114
10197987|NCT03384966|11326056|FG001|COMPLETED|Treatment Period||115
10197988|NCT03384966|11326057|FG002|COMPLETED|Treatment Period||116
10197989|NCT03384966|11326055|FG000|NOT COMPLETED|Treatment Period||0
10197990|NCT03384966|11326056|FG001|NOT COMPLETED|Treatment Period||0
10197991|NCT03384966|11326057|FG002|NOT COMPLETED|Treatment Period||0
10197992|NCT03384966|11326055|FG000|STARTED|Follow-up Period||114
10082257|NCT02267317|11210816|FG005|NOT COMPLETED|Infusion1||0
10082258|NCT02267317|11210811|FG000|STARTED|Washout (3-4weeks Between Infusions)||8
10082259|NCT02267317|11210812|FG001|STARTED|Washout (3-4weeks Between Infusions)||3
10082260|NCT02267317|11210813|FG002|STARTED|Washout (3-4weeks Between Infusions)||1
10082261|NCT02267317|11210814|FG003|STARTED|Washout (3-4weeks Between Infusions)||2
10082262|NCT02267317|11210815|FG004|STARTED|Washout (3-4weeks Between Infusions)||0
10082263|NCT02267317|11210816|FG005|STARTED|Washout (3-4weeks Between Infusions)||1
10082264|NCT02267317|11210811|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6
10082265|NCT02267317|11210812|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3
10082266|NCT02267317|11210813|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1
10082267|NCT02267317|11210814|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2
10082268|NCT02267317|11210815|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0
10082269|NCT02267317|11210816|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1
10082270|NCT02267317|11210811|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
10082271|NCT02267317|11210812|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10082272|NCT02267317|11210813|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10082273|NCT02267317|11210814|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10082274|NCT02267317|11210815|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10082275|NCT02267317|11210816|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10082276|NCT02267317|11210811|FG000|STARTED|Infusion2||6
10082277|NCT02267317|11210812|FG001|STARTED|Infusion2||3
10082278|NCT02267317|11210813|FG002|STARTED|Infusion2||1
10082279|NCT02267317|11210814|FG003|STARTED|Infusion2||2
10082280|NCT02267317|11210815|FG004|STARTED|Infusion2||0
10082281|NCT02267317|11210816|FG005|STARTED|Infusion2||1
10082282|NCT02267317|11210811|FG000|COMPLETED|Infusion2||6
10082283|NCT02267317|11210812|FG001|COMPLETED|Infusion2||3
10082284|NCT02267317|11210813|FG002|COMPLETED|Infusion2||1
10082285|NCT02267317|11210814|FG003|COMPLETED|Infusion2||2
10082286|NCT02267317|11210815|FG004|COMPLETED|Infusion2||0
10082287|NCT02267317|11210816|FG005|COMPLETED|Infusion2||1
10082288|NCT02267317|11210811|FG000|NOT COMPLETED|Infusion2||0
10082289|NCT02267317|11210812|FG001|NOT COMPLETED|Infusion2||0
10082290|NCT02267317|11210813|FG002|NOT COMPLETED|Infusion2||0
10082291|NCT02267317|11210814|FG003|NOT COMPLETED|Infusion2||0
10082292|NCT02267317|11210815|FG004|NOT COMPLETED|Infusion2||0
10082293|NCT02267317|11210816|FG005|NOT COMPLETED|Infusion2||0
10082294|NCT02267356|11210835|FG000|STARTED|Initial Study||53
10082295|NCT02267356|11210836|FG001|STARTED|Initial Study||53
10082296|NCT02267356|11210837|FG002|STARTED|Initial Study||52
10082297|NCT02267356|11210838|FG003|STARTED|Initial Study||54
10082298|NCT02267356|11210839|FG004|STARTED|Initial Study||47
10082299|NCT02267356|11210835|FG000|COMPLETED|Initial Study||47
10082300|NCT02267356|11210836|FG001|COMPLETED|Initial Study||48
10082301|NCT02267356|11210837|FG002|COMPLETED|Initial Study||42
10197993|NCT03384966|11326056|FG001|STARTED|Follow-up Period||115
10082302|NCT02267356|11210838|FG003|COMPLETED|Initial Study||43
10082303|NCT02267356|11210839|FG004|COMPLETED|Initial Study||42
10082304|NCT02267356|11210835|FG000|NOT COMPLETED|Initial Study||6
10082305|NCT02267356|11210836|FG001|NOT COMPLETED|Initial Study||5
10082306|NCT02267356|11210837|FG002|NOT COMPLETED|Initial Study||10
10082307|NCT02267356|11210838|FG003|NOT COMPLETED|Initial Study||11
10082308|NCT02267356|11210839|FG004|NOT COMPLETED|Initial Study||5
10082309|NCT02267356|11210835|FG000|STARTED|Study Extension||33
10082310|NCT02267356|11210836|FG001|STARTED|Study Extension||37
10197994|NCT03384966|11326057|FG002|STARTED|Follow-up Period||116
10197995|NCT03384966|11326055|FG000|COMPLETED|Follow-up Period||113
10197996|NCT03384966|11326056|FG001|COMPLETED|Follow-up Period||115
10197997|NCT03384966|11326057|FG002|COMPLETED|Follow-up Period||116
10197998|NCT03384966|11326055|FG000|NOT COMPLETED|Follow-up Period||1
10197999|NCT03384966|11326056|FG001|NOT COMPLETED|Follow-up Period||0
10198000|NCT03384966|11326057|FG002|NOT COMPLETED|Follow-up Period||0
10198001|NCT03386032|11326077|FG000|STARTED|Overall Study||36
10198002|NCT03386032|11326078|FG001|STARTED|Overall Study||18
10198003|NCT03386032|11326079|FG002|STARTED|Overall Study||11
10198004|NCT03386032|11326077|FG000|COMPLETED|Overall Study||18
10198005|NCT03386032|11326078|FG001|COMPLETED|Overall Study||11
10198006|NCT03386032|11326079|FG002|COMPLETED|Overall Study||11
10198007|NCT03386032|11326077|FG000|NOT COMPLETED|Overall Study||18
10198008|NCT03386032|11326078|FG001|NOT COMPLETED|Overall Study||7
10198009|NCT03386032|11326079|FG002|NOT COMPLETED|Overall Study||0
10198010|NCT03386110|11326089|FG000|STARTED|Overall Study||56
10198011|NCT03386110|11326090|FG001|STARTED|Overall Study||44
10198012|NCT03386110|11326089|FG000|COMPLETED|Overall Study||41
10198013|NCT03386110|11326090|FG001|COMPLETED|Overall Study||38
10198014|NCT03386110|11326089|FG000|NOT COMPLETED|Overall Study||15
10198015|NCT03386110|11326090|FG001|NOT COMPLETED|Overall Study||6
10198016|NCT03386344|11326099|FG000|STARTED|Overall Study||126
10198017|NCT03386344|11326100|FG001|STARTED|Overall Study||125
10082311|NCT02267356|11210837|FG002|STARTED|Study Extension||30
10082312|NCT02267356|11210838|FG003|STARTED|Study Extension||32
10082313|NCT02267356|11210839|FG004|STARTED|Study Extension||26
10082314|NCT02267356|11210835|FG000|COMPLETED|Study Extension||32
10198018|NCT03386344|11326101|FG002|STARTED|Overall Study||125
10198019|NCT03386344|11326099|FG000|COMPLETED|Overall Study||9
10198020|NCT03386344|11326100|FG001|COMPLETED|Overall Study||9
10198021|NCT03386344|11326101|FG002|COMPLETED|Overall Study||9
10198022|NCT03386344|11326099|FG000|NOT COMPLETED|Overall Study||117
10198023|NCT03386344|11326100|FG001|NOT COMPLETED|Overall Study||116
10198024|NCT03386344|11326101|FG002|NOT COMPLETED|Overall Study||116
10198025|NCT03386435|11326111|FG000|STARTED|Overall Study||80
10198026|NCT03386435|11326112|FG001|STARTED|Overall Study||80
10198027|NCT03386435|11326111|FG000|COMPLETED|Overall Study||75
10198028|NCT03386435|11326112|FG001|COMPLETED|Overall Study||73
10198029|NCT03386435|11326111|FG000|NOT COMPLETED|Overall Study||5
10198030|NCT03386435|11326112|FG001|NOT COMPLETED|Overall Study||7
10198031|NCT03386448|11326120|FG000|STARTED|Overall Study||6
10198032|NCT03386448|11326121|FG001|STARTED|Overall Study||8
10198033|NCT03386448|11326120|FG000|COMPLETED|Overall Study||6
10198034|NCT03386448|11326121|FG001|COMPLETED|Overall Study||6
10198035|NCT03386448|11326120|FG000|NOT COMPLETED|Overall Study||0
10198036|NCT03386448|11326121|FG001|NOT COMPLETED|Overall Study||2
10198037|NCT03386474|11326129|FG000|STARTED|Overall Study||107
10198038|NCT03386474|11326130|FG001|STARTED|Overall Study||43
10198039|NCT03386474|11326129|FG000|COMPLETED|Overall Study||106
10198040|NCT03386474|11326130|FG001|COMPLETED|Overall Study||42
10198041|NCT03386474|11326129|FG000|NOT COMPLETED|Overall Study||1
10198042|NCT03386474|11326130|FG001|NOT COMPLETED|Overall Study||1
10198043|NCT03386994|11326144|FG000|STARTED|Overall Study||204
10198044|NCT03386994|11326144|FG000|COMPLETED|Overall Study||166
10198045|NCT03386994|11326144|FG000|NOT COMPLETED|Overall Study||38
10198046|NCT03387020|11326162|FG000|STARTED|Overall Study||13
10198047|NCT03387020|11326163|FG001|STARTED|Overall Study||3
10198048|NCT03387020|11326164|FG002|STARTED|Overall Study||5
10198049|NCT03387020|11326162|FG000|Received Treatment|Overall Study||12
10198050|NCT03387020|11326163|FG001|Received Treatment|Overall Study||3
10198051|NCT03387020|11326164|FG002|Received Treatment|Overall Study||5
10198052|NCT03387020|11326162|FG000|COMPLETED|Overall Study||11
10198053|NCT03387020|11326163|FG001|COMPLETED|Overall Study||1
10198054|NCT03387020|11326164|FG002|COMPLETED|Overall Study||5
10082315|NCT02267356|11210836|FG001|COMPLETED|Study Extension||37
10082316|NCT02267356|11210837|FG002|COMPLETED|Study Extension||29
10082317|NCT02267356|11210838|FG003|COMPLETED|Study Extension||30
10082318|NCT02267356|11210839|FG004|COMPLETED|Study Extension||26
10082319|NCT02267356|11210835|FG000|NOT COMPLETED|Study Extension||1
10082320|NCT02267356|11210836|FG001|NOT COMPLETED|Study Extension||0
10082321|NCT02267356|11210837|FG002|NOT COMPLETED|Study Extension||1
10082322|NCT02267356|11210838|FG003|NOT COMPLETED|Study Extension||2
10082323|NCT02267356|11210839|FG004|NOT COMPLETED|Study Extension||0
10082324|NCT02267382|11210856|FG000|STARTED|Overall Study||42
10082325|NCT02267382|11210857|FG001|STARTED|Overall Study||43
10082326|NCT02267382|11210858|FG002|STARTED|Overall Study||43
10082327|NCT02267382|11210859|FG003|STARTED|Overall Study||41
10082328|NCT02267382|11210860|FG004|STARTED|Overall Study||46
10082329|NCT02267382|11210856|FG000|COMPLETED|Overall Study||35
10082330|NCT02267382|11210857|FG001|COMPLETED|Overall Study||33
10082331|NCT02267382|11210858|FG002|COMPLETED|Overall Study||34
10082332|NCT02267382|11210859|FG003|COMPLETED|Overall Study||35
10082333|NCT02267382|11210860|FG004|COMPLETED|Overall Study||39
10082334|NCT02267382|11210856|FG000|NOT COMPLETED|Overall Study||7
10082335|NCT02267382|11210857|FG001|NOT COMPLETED|Overall Study||10
10082336|NCT02267382|11210858|FG002|NOT COMPLETED|Overall Study||9
10082337|NCT02267382|11210859|FG003|NOT COMPLETED|Overall Study||6
10082338|NCT02267382|11210860|FG004|NOT COMPLETED|Overall Study||7
10082339|NCT02267447|11210874|FG000|STARTED|Overall Study||77251
10082340|NCT02267447|11210875|FG001|STARTED|Overall Study||26968
10082341|NCT02267447|11210874|FG000|COMPLETED|Overall Study||77251
10198055|NCT03387020|11326162|FG000|NOT COMPLETED|Overall Study||2
10198056|NCT03387020|11326163|FG001|NOT COMPLETED|Overall Study||2
10198057|NCT03387020|11326164|FG002|NOT COMPLETED|Overall Study||0
10198058|NCT03387033|11326182|FG000|STARTED|Overall Study||20
10198059|NCT03387033|11326182|FG000|COMPLETED|Overall Study||20
10198060|NCT03387033|11326182|FG000|NOT COMPLETED|Overall Study||0
10198061|NCT03387046|11326188|FG000|STARTED|Overall Study||5
10198062|NCT03387046|11326189|FG001|STARTED|Overall Study||2
10198063|NCT03387046|11326188|FG000|COMPLETED|Overall Study||4
10198064|NCT03387046|11326189|FG001|COMPLETED|Overall Study||1
10198065|NCT03387046|11326188|FG000|NOT COMPLETED|Overall Study||1
10198066|NCT03387046|11326189|FG001|NOT COMPLETED|Overall Study||1
10198067|NCT03387267|11326195|FG000|STARTED|Overall Study||452
10198068|NCT03387267|11326195|FG000|COMPLETED|Overall Study||438
10198069|NCT03387267|11326195|FG000|NOT COMPLETED|Overall Study||14
10198070|NCT03387319|11326202|FG000|STARTED|Overall Study||25
10198071|NCT03387319|11326203|FG001|STARTED|Overall Study||25
10198072|NCT03387319|11326202|FG000|COMPLETED|Overall Study||25
10198073|NCT03387319|11326203|FG001|COMPLETED|Overall Study||25
10198074|NCT03387319|11326202|FG000|NOT COMPLETED|Overall Study||0
10198075|NCT03387319|11326203|FG001|NOT COMPLETED|Overall Study||0
10198076|NCT03387462|11326209|FG000|STARTED|Overall Study||20
10198077|NCT03387462|11326209|FG000|4 Weeks|Overall Study||20
10198078|NCT03387462|11326209|FG000|8 Weeks|Overall Study||19
10198079|NCT03387462|11326209|FG000|COMPLETED|Overall Study||19
10198080|NCT03387462|11326209|FG000|NOT COMPLETED|Overall Study||1
10198081|NCT03387683|11326215|FG000|STARTED|Overall Study||27
10198082|NCT03387683|11326216|FG001|STARTED|Overall Study||26
10198083|NCT03387683|11326215|FG000|COMPLETED|Overall Study||25
10198084|NCT03387683|11326216|FG001|COMPLETED|Overall Study||26
10198085|NCT03387683|11326215|FG000|NOT COMPLETED|Overall Study||2
10198086|NCT03387683|11326216|FG001|NOT COMPLETED|Overall Study||0
10198087|NCT03388008|11326224|FG000|STARTED|Overall Study||14
10198088|NCT03388008|11326225|FG001|STARTED|Overall Study||13
10198089|NCT03388008|11326224|FG000|COMPLETED|Overall Study||14
10198090|NCT03388008|11326225|FG001|COMPLETED|Overall Study||13
10198091|NCT03388008|11326224|FG000|NOT COMPLETED|Overall Study||0
10198092|NCT03388008|11326225|FG001|NOT COMPLETED|Overall Study||0
10198093|NCT03388164|11326233|FG000|STARTED|Overall Study||10
10198094|NCT03388164|11326234|FG001|STARTED|Overall Study||10
10198095|NCT03388164|11326233|FG000|COMPLETED|Overall Study||7
10198096|NCT03388164|11326234|FG001|COMPLETED|Overall Study||9
10198097|NCT03388164|11326233|FG000|NOT COMPLETED|Overall Study||3
10198098|NCT03388164|11326234|FG001|NOT COMPLETED|Overall Study||1
10198099|NCT03388268|11326242|FG000|STARTED|Overall Study||8
10198100|NCT03388268|11326243|FG001|STARTED|Overall Study||7
10198101|NCT03388268|11326242|FG000|COMPLETED|Overall Study||7
10198102|NCT03388268|11326243|FG001|COMPLETED|Overall Study||4
10198103|NCT03388268|11326242|FG000|NOT COMPLETED|Overall Study||1
10198104|NCT03388268|11326243|FG001|NOT COMPLETED|Overall Study||3
10198105|NCT03388294|11326251|FG000|STARTED|Overall Study||42
10198106|NCT03388294|11326252|FG001|STARTED|Overall Study||30
10198107|NCT03388294|11326251|FG000|Posttest 1|Overall Study||38
10198108|NCT03388294|11326252|FG001|Posttest 1|Overall Study||30
10082342|NCT02267447|11210875|FG001|COMPLETED|Overall Study||26968
10082343|NCT02267447|11210874|FG000|NOT COMPLETED|Overall Study||0
10082344|NCT02267447|11210875|FG001|NOT COMPLETED|Overall Study||0
10082345|NCT02267538|11210884|FG000|STARTED|Overall Study||142
10082346|NCT02267538|11210885|FG001|STARTED|Overall Study||143
10082347|NCT02267538|11210884|FG000|COMPLETED|Overall Study||142
10082348|NCT02267538|11210885|FG001|COMPLETED|Overall Study||143
10082349|NCT02267538|11210884|FG000|NOT COMPLETED|Overall Study||0
10082350|NCT02267538|11210885|FG001|NOT COMPLETED|Overall Study||0
10082351|NCT02267577|11210891|FG000|STARTED|Overall Study||85
10082352|NCT02267577|11210891|FG000|COMPLETED|Overall Study||81
10082353|NCT02267577|11210891|FG000|NOT COMPLETED|Overall Study||4
10082354|NCT02267629|11210896|FG000|STARTED|Overall Study||7
10082355|NCT02267629|11210896|FG000|COMPLETED|Overall Study||7
10082356|NCT02267629|11210896|FG000|NOT COMPLETED|Overall Study||0
10082357|NCT02267746|11210903|FG000|STARTED|Overall Study||298
10082358|NCT02267746|11210904|FG001|STARTED|Overall Study||296
10082359|NCT02267746|11210905|FG002|STARTED|Overall Study||299
10082360|NCT02267746|11210903|FG000|COMPLETED|Overall Study||277
10082361|NCT02267746|11210904|FG001|COMPLETED|Overall Study||274
10082362|NCT02267746|11210905|FG002|COMPLETED|Overall Study||278
10198109|NCT03388294|11326251|FG000|Posttest 2|Overall Study||38
10198110|NCT03388294|11326252|FG001|Posttest 2|Overall Study||30
10082363|NCT02267746|11210903|FG000|NOT COMPLETED|Overall Study||21
10082364|NCT02267746|11210904|FG001|NOT COMPLETED|Overall Study||22
10082365|NCT02267746|11210905|FG002|NOT COMPLETED|Overall Study||21
10198111|NCT03388294|11326251|FG000|COMPLETED|Overall Study||38
10198112|NCT03388294|11326252|FG001|COMPLETED|Overall Study||30
10198113|NCT03388294|11326251|FG000|NOT COMPLETED|Overall Study||4
10198114|NCT03388294|11326252|FG001|NOT COMPLETED|Overall Study||0
10198115|NCT03388645|11326260|FG000|STARTED|Low Dose RSV A2||4
10198116|NCT03388645|11326261|FG001|STARTED|Low Dose RSV A2||0
10198117|NCT03388645|11326260|FG000|COMPLETED|Low Dose RSV A2||4
10198118|NCT03388645|11326261|FG001|COMPLETED|Low Dose RSV A2||0
10082366|NCT02267772|11210917|FG000|STARTED|Overall Study||50
10198119|NCT03388645|11326260|FG000|NOT COMPLETED|Low Dose RSV A2||0
10198120|NCT03388645|11326261|FG001|NOT COMPLETED|Low Dose RSV A2||0
10198121|NCT03388645|11326260|FG000|STARTED|High Dose RSV A2||0
10198122|NCT03388645|11326261|FG001|STARTED|High Dose RSV A2||8
10198123|NCT03388645|11326260|FG000|COMPLETED|High Dose RSV A2||0
10198124|NCT03388645|11326261|FG001|COMPLETED|High Dose RSV A2||7
10198125|NCT03388645|11326260|FG000|NOT COMPLETED|High Dose RSV A2||0
10198126|NCT03388645|11326261|FG001|NOT COMPLETED|High Dose RSV A2||1
10198127|NCT03389308|11326267|FG000|STARTED|Overall Study||51
10198128|NCT03389308|11326267|FG000|COMPLETED|Overall Study||39
10198129|NCT03389308|11326267|FG000|NOT COMPLETED|Overall Study||12
10198130|NCT03389555|11326273|FG000|STARTED|Overall Study||103
10198131|NCT03389555|11326274|FG001|STARTED|Overall Study||102
10198132|NCT03389555|11326273|FG000|COMPLETED|Overall Study||101
10198133|NCT03389555|11326274|FG001|COMPLETED|Overall Study||99
10198134|NCT03389555|11326273|FG000|NOT COMPLETED|Overall Study||2
10198135|NCT03389555|11326274|FG001|NOT COMPLETED|Overall Study||3
10198136|NCT03389854|11326284|FG000|STARTED|Overall Study||28
10198137|NCT03389854|11326285|FG001|STARTED|Overall Study||27
10198138|NCT03389854|11326286|FG002|STARTED|Overall Study||28
10198139|NCT03389854|11326287|FG003|STARTED|Overall Study||27
10198140|NCT03389854|11326284|FG000|COMPLETED|Overall Study||27
10198141|NCT03389854|11326285|FG001|COMPLETED|Overall Study||21
10198142|NCT03389854|11326286|FG002|COMPLETED|Overall Study||23
10198143|NCT03389854|11326287|FG003|COMPLETED|Overall Study||19
10198144|NCT03389854|11326284|FG000|NOT COMPLETED|Overall Study||1
10198145|NCT03389854|11326285|FG001|NOT COMPLETED|Overall Study||6
10198146|NCT03389854|11326286|FG002|NOT COMPLETED|Overall Study||5
10198147|NCT03389854|11326287|FG003|NOT COMPLETED|Overall Study||8
10198148|NCT03389893|11326303|FG000|STARTED|Randomized Double Blind Period||46
10198149|NCT03389893|11326304|FG001|STARTED|Randomized Double Blind Period||26
10198150|NCT03389893|11326305|FG002|STARTED|Randomized Double Blind Period||0
10198151|NCT03389893|11326306|FG003|STARTED|Randomized Double Blind Period||0
10198152|NCT03389893|11326303|FG000|COMPLETED|Randomized Double Blind Period||45
10198153|NCT03389893|11326304|FG001|COMPLETED|Randomized Double Blind Period||26
10198154|NCT03389893|11326305|FG002|COMPLETED|Randomized Double Blind Period||0
10198155|NCT03389893|11326306|FG003|COMPLETED|Randomized Double Blind Period||0
10198156|NCT03389893|11326303|FG000|NOT COMPLETED|Randomized Double Blind Period||1
10198157|NCT03389893|11326304|FG001|NOT COMPLETED|Randomized Double Blind Period||0
10198158|NCT03389893|11326305|FG002|NOT COMPLETED|Randomized Double Blind Period||0
10198159|NCT03389893|11326306|FG003|NOT COMPLETED|Randomized Double Blind Period||0
10198160|NCT03389893|11326303|FG000|STARTED|Open Label Extension and Follow-Up||0
10198161|NCT03389893|11326304|FG001|STARTED|Open Label Extension and Follow-Up||0
10198162|NCT03389893|11326305|FG002|STARTED|Open Label Extension and Follow-Up||45
10198163|NCT03389893|11326306|FG003|STARTED|Open Label Extension and Follow-Up||26
10198164|NCT03389893|11326303|FG000|COMPLETED|Open Label Extension and Follow-Up||0
10198165|NCT03389893|11326304|FG001|COMPLETED|Open Label Extension and Follow-Up||0
10198166|NCT03389893|11326305|FG002|COMPLETED|Open Label Extension and Follow-Up||41
10198167|NCT03389893|11326306|FG003|COMPLETED|Open Label Extension and Follow-Up||25
10198168|NCT03389893|11326303|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0
10198169|NCT03389893|11326304|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0
10198170|NCT03389893|11326305|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4
10198171|NCT03389893|11326306|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1
10198172|NCT03390114|11326314|FG000|STARTED|Overall Study||10
10198173|NCT03390114|11326315|FG001|STARTED|Overall Study||10
10198174|NCT03390114|11326314|FG000|COMPLETED|Overall Study||6
10198175|NCT03390114|11326315|FG001|COMPLETED|Overall Study||8
10198176|NCT03390114|11326314|FG000|NOT COMPLETED|Overall Study||4
10198177|NCT03390114|11326315|FG001|NOT COMPLETED|Overall Study||2
10198178|NCT03390166|11326323|FG000|STARTED|Overall Study||630
10198179|NCT03390166|11326324|FG001|STARTED|Overall Study||315
10198180|NCT03390166|11326323|FG000|COMPLETED|Overall Study||618
10198181|NCT03390166|11326324|FG001|COMPLETED|Overall Study||305
10198182|NCT03390166|11326323|FG000|NOT COMPLETED|Overall Study||12
10198183|NCT03390166|11326324|FG001|NOT COMPLETED|Overall Study||10
10198184|NCT03390257|11326330|FG000|STARTED|Overall Study||14
10198185|NCT03390257|11326330|FG000|COMPLETED|Overall Study||14
10198186|NCT03390257|11326330|FG000|NOT COMPLETED|Overall Study||0
10198187|NCT03390426|11326338|FG000|STARTED|Overall Study||15
10198188|NCT03390426|11326339|FG001|STARTED|Overall Study||16
10198189|NCT03390426|11326338|FG000|COMPLETED|Overall Study||15
10198190|NCT03390426|11326339|FG001|COMPLETED|Overall Study||15
10198191|NCT03390426|11326338|FG000|NOT COMPLETED|Overall Study||0
10198192|NCT03390426|11326339|FG001|NOT COMPLETED|Overall Study||1
10198193|NCT03390842|11326347|FG000|STARTED|Overall Study||114
10198194|NCT03390842|11326348|FG001|STARTED|Overall Study||82
10198195|NCT03390842|11326347|FG000|COMPLETED|Overall Study||111
10198196|NCT03390842|11326348|FG001|COMPLETED|Overall Study||74
10198197|NCT03390842|11326347|FG000|NOT COMPLETED|Overall Study||3
10198198|NCT03390842|11326348|FG001|NOT COMPLETED|Overall Study||8
10198199|NCT03390907|11326354|FG000|STARTED|Overall Study||40
10198200|NCT03390907|11326354|FG000|COMPLETED|Overall Study||40
10198201|NCT03390907|11326354|FG000|NOT COMPLETED|Overall Study||0
10198202|NCT03391115|11326361|FG000|STARTED|Overall Study||20
10198203|NCT03391115|11326362|FG001|STARTED|Overall Study||18
10198204|NCT03391115|11326361|FG000|COMPLETED|Overall Study||20
10198205|NCT03391115|11326362|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
10198206|NCT03391115|11326361|FG000|NOT COMPLETED|Overall Study||0
10198207|NCT03391115|11326362|FG001|NOT COMPLETED|Overall Study||0
10198208|NCT03391765|11326372|FG000|STARTED|Overall Study||51
10198209|NCT03391765|11326373|FG001|STARTED|Overall Study||45
10198210|NCT03391765|11326374|FG002|STARTED|Overall Study||23
10198211|NCT03391765|11326375|FG003|STARTED|Overall Study||23
10198212|NCT03391765|11326372|FG000|COMPLETED|Overall Study||0
10198213|NCT03391765|11326373|FG001|COMPLETED|Overall Study||0
10198214|NCT03391765|11326374|FG002|COMPLETED|Overall Study||0
10198215|NCT03391765|11326375|FG003|COMPLETED|Overall Study||0
10198216|NCT03391765|11326372|FG000|NOT COMPLETED|Overall Study||51
10198217|NCT03391765|11326373|FG001|NOT COMPLETED|Overall Study||45
10198218|NCT03391765|11326374|FG002|NOT COMPLETED|Overall Study||23
10198219|NCT03391765|11326375|FG003|NOT COMPLETED|Overall Study||23
10198220|NCT03391986|11326388|FG000|STARTED|Overall Study||53
10198221|NCT03391986|11326389|FG001|STARTED|Overall Study||50
10198222|NCT03391986|11326390|FG002|STARTED|Overall Study||50
10198223|NCT03391986|11326388|FG000|COMPLETED|Overall Study||53
10198224|NCT03391986|11326389|FG001|COMPLETED|Overall Study||50
10198225|NCT03391986|11326390|FG002|COMPLETED|Overall Study||50
10198226|NCT03391986|11326388|FG000|NOT COMPLETED|Overall Study||0
10198227|NCT03391986|11326389|FG001|NOT COMPLETED|Overall Study||0
10198228|NCT03391986|11326390|FG002|NOT COMPLETED|Overall Study||0
10198229|NCT03392168|11326402|FG000|STARTED|Period 1: Cohort 1||8
10198230|NCT03392168|11326403|FG001|STARTED|Period 1: Cohort 1||0
9851469|NCT00876200|10964167|FG000|STARTED|Overall Study||9
9851470|NCT00876200|10964168|FG001|STARTED|Overall Study||12
9851471|NCT00876200|10964167|FG000|COMPLETED|Overall Study||8
9851472|NCT00876200|10964168|FG001|COMPLETED|Overall Study||9
9851473|NCT00876200|10964167|FG000|NOT COMPLETED|Overall Study||1
9851474|NCT00876200|10964168|FG001|NOT COMPLETED|Overall Study||3
9851475|NCT00876265|10964174|FG000|STARTED|Overall Study||118
9851476|NCT00876265|10964174|FG000|COMPLETED|Overall Study||106
9851477|NCT00876265|10964174|FG000|NOT COMPLETED|Overall Study||12
9851478|NCT00876343|10964183|FG000|STARTED|Overall Study||194
9851479|NCT00876343|10964184|FG001|STARTED|Overall Study||197
9851480|NCT00876343|10964185|FG002|STARTED|Overall Study||195
10198231|NCT03392168|11326404|FG002|STARTED|Period 1: Cohort 1||0
10198232|NCT03392168|11326405|FG003|STARTED|Period 1: Cohort 1||0
10198233|NCT03392168|11326402|FG000|COMPLETED|Period 1: Cohort 1||8
10198234|NCT03392168|11326403|FG001|COMPLETED|Period 1: Cohort 1||0
9851481|NCT00876343|10964183|FG000|COMPLETED|Overall Study||177
9851482|NCT00876343|10964184|FG001|COMPLETED|Overall Study||180
9851483|NCT00876343|10964185|FG002|COMPLETED|Overall Study||183
9851484|NCT00876343|10964183|FG000|NOT COMPLETED|Overall Study||17
9851485|NCT00876343|10964184|FG001|NOT COMPLETED|Overall Study||17
9851486|NCT00876343|10964185|FG002|NOT COMPLETED|Overall Study||12
9851487|NCT00876395|10964195|FG000|STARTED|Overall Study||480
9851488|NCT00876395|10964196|FG001|STARTED|Overall Study||239
9851489|NCT00876395|10964195|FG000|Untreated|Overall Study||8
9851490|NCT00876395|10964196|FG001|Untreated|Overall Study||1
9851491|NCT00876395|10964195|FG000|COMPLETED|Overall Study||0
9851492|NCT00876395|10964196|FG001|COMPLETED|Overall Study||0
9851493|NCT00876395|10964195|FG000|NOT COMPLETED|Overall Study||480
9851494|NCT00876395|10964196|FG001|NOT COMPLETED|Overall Study||239
9851495|NCT00876447|10964209|FG000|STARTED|Overall Study||185
9851496|NCT00876447|10964210|FG001|STARTED|Overall Study||203
9851497|NCT00876447|10964209|FG000|COMPLETED|Overall Study||105
9851498|NCT00876447|10964210|FG001|COMPLETED|Overall Study||122
9851499|NCT00876447|10964209|FG000|NOT COMPLETED|Overall Study||80
9851500|NCT00876447|10964210|FG001|NOT COMPLETED|Overall Study||81
9851501|NCT00876460|10964248|FG000|STARTED|Combination Therapy Phase||3
9851502|NCT00876460|10964249|FG001|STARTED|Combination Therapy Phase||7
9851503|NCT00876460|10964250|FG002|STARTED|Combination Therapy Phase||3
9851504|NCT00876460|10964251|FG003|STARTED|Combination Therapy Phase||6
9851505|NCT00876460|10964252|FG004|STARTED|Combination Therapy Phase||7
9851506|NCT00876460|10964253|FG005|STARTED|Combination Therapy Phase||3
9851507|NCT00876460|10964254|FG006|STARTED|Combination Therapy Phase||8
9851508|NCT00876460|10964255|FG007|STARTED|Combination Therapy Phase||6
9851509|NCT00876460|10964248|FG000|COMPLETED|Combination Therapy Phase||0
9851510|NCT00876460|10964249|FG001|COMPLETED|Combination Therapy Phase||0
9851511|NCT00876460|10964250|FG002|COMPLETED|Combination Therapy Phase||0
9851512|NCT00876460|10964251|FG003|COMPLETED|Combination Therapy Phase||0
9851513|NCT00876460|10964252|FG004|COMPLETED|Combination Therapy Phase||0
9851514|NCT00876460|10964253|FG005|COMPLETED|Combination Therapy Phase||0
9851515|NCT00876460|10964254|FG006|COMPLETED|Combination Therapy Phase||0
9851516|NCT00876460|10964255|FG007|COMPLETED|Combination Therapy Phase||0
9851517|NCT00876460|10964248|FG000|NOT COMPLETED|Combination Therapy Phase||3
9851518|NCT00876460|10964249|FG001|NOT COMPLETED|Combination Therapy Phase||7
9851519|NCT00876460|10964250|FG002|NOT COMPLETED|Combination Therapy Phase||3
9851520|NCT00876460|10964251|FG003|NOT COMPLETED|Combination Therapy Phase||6
9851521|NCT00876460|10964252|FG004|NOT COMPLETED|Combination Therapy Phase||7
10198235|NCT03392168|11326404|FG002|COMPLETED|Period 1: Cohort 1||0
9851522|NCT00876460|10964253|FG005|NOT COMPLETED|Combination Therapy Phase||3
9851523|NCT00876460|10964254|FG006|NOT COMPLETED|Combination Therapy Phase||8
9851524|NCT00876460|10964255|FG007|NOT COMPLETED|Combination Therapy Phase||6
9851525|NCT00876460|10964248|FG000|STARTED|Mono Therapy Phase||0
9851526|NCT00876460|10964249|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
10198236|NCT03392168|11326405|FG003|COMPLETED|Period 1: Cohort 1||0
10198237|NCT03392168|11326402|FG000|NOT COMPLETED|Period 1: Cohort 1||0
10198238|NCT03392168|11326403|FG001|NOT COMPLETED|Period 1: Cohort 1||0
10198239|NCT03392168|11326404|FG002|NOT COMPLETED|Period 1: Cohort 1||0
10198240|NCT03392168|11326405|FG003|NOT COMPLETED|Period 1: Cohort 1||0
9851527|NCT00876460|10964250|FG002|STARTED|Mono Therapy Phase||0
9851528|NCT00876460|10964251|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
9851529|NCT00876460|10964252|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
9851530|NCT00876460|10964253|FG005|STARTED|Mono Therapy Phase||0
9851531|NCT00876460|10964254|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
9851532|NCT00876460|10964255|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
9851533|NCT00876460|10964248|FG000|COMPLETED|Mono Therapy Phase||0
9851534|NCT00876460|10964249|FG001|COMPLETED|Mono Therapy Phase||0
9851535|NCT00876460|10964250|FG002|COMPLETED|Mono Therapy Phase||0
9851536|NCT00876460|10964251|FG003|COMPLETED|Mono Therapy Phase||0
9851537|NCT00876460|10964252|FG004|COMPLETED|Mono Therapy Phase||0
9851538|NCT00876460|10964253|FG005|COMPLETED|Mono Therapy Phase||0
9851539|NCT00876460|10964254|FG006|COMPLETED|Mono Therapy Phase||0
9851540|NCT00876460|10964255|FG007|COMPLETED|Mono Therapy Phase||0
9851541|NCT00876460|10964248|FG000|NOT COMPLETED|Mono Therapy Phase||0
9851542|NCT00876460|10964249|FG001|NOT COMPLETED|Mono Therapy Phase||1
9851543|NCT00876460|10964250|FG002|NOT COMPLETED|Mono Therapy Phase||0
9851544|NCT00876460|10964251|FG003|NOT COMPLETED|Mono Therapy Phase||1
9851545|NCT00876460|10964252|FG004|NOT COMPLETED|Mono Therapy Phase||2
9851546|NCT00876460|10964253|FG005|NOT COMPLETED|Mono Therapy Phase||0
9851547|NCT00876460|10964254|FG006|NOT COMPLETED|Mono Therapy Phase||1
9851548|NCT00876460|10964255|FG007|NOT COMPLETED|Mono Therapy Phase||3
9851549|NCT00876694|10964287|FG000|STARTED|Overall Study||125
9851550|NCT00876694|10964288|FG001|STARTED|Overall Study||61
9851551|NCT00876694|10964287|FG000|COMPLETED|Overall Study||104
9851552|NCT00876694|10964288|FG001|COMPLETED|Overall Study||49
9851553|NCT00876694|10964287|FG000|NOT COMPLETED|Overall Study||21
9851554|NCT00876694|10964288|FG001|NOT COMPLETED|Overall Study||12
9851555|NCT00876733|10964298|FG000|STARTED|Overall Study||288
9851556|NCT00876733|10964299|FG001|STARTED|Overall Study||203
9851557|NCT00876733|10964300|FG002|STARTED|Overall Study||93
9851558|NCT00876733|10964301|FG003|STARTED|Overall Study||21
9851559|NCT00876733|10964298|FG000|COMPLETED|Overall Study||197
9851560|NCT00876733|10964299|FG001|COMPLETED|Overall Study||161
9851561|NCT00876733|10964300|FG002|COMPLETED|Overall Study||63
9851562|NCT00876733|10964301|FG003|COMPLETED|Overall Study||14
9851563|NCT00876733|10964298|FG000|NOT COMPLETED|Overall Study||91
9851564|NCT00876733|10964299|FG001|NOT COMPLETED|Overall Study||42
9851565|NCT00876733|10964300|FG002|NOT COMPLETED|Overall Study||30
9851566|NCT00876733|10964301|FG003|NOT COMPLETED|Overall Study||7
9851567|NCT00876915|10964314|FG000|STARTED|Overall Study||50
9851568|NCT00876915|10964315|FG001|STARTED|Overall Study||48
9851569|NCT00876915|10964316|FG002|STARTED|Overall Study||101
9851570|NCT00876915|10964314|FG000|Week 4|Overall Study||38
9851571|NCT00876915|10964315|FG001|Week 4|Overall Study||45
9851572|NCT00876915|10964316|FG002|Week 4|Overall Study||0
9851573|NCT00876915|10964314|FG000|Week 8|Overall Study||33
9851574|NCT00876915|10964315|FG001|Week 8|Overall Study||36
9851575|NCT00876915|10964316|FG002|Week 8|Overall Study||0
9851576|NCT00876915|10964314|FG000|COMPLETED|Overall Study||31
9851577|NCT00876915|10964315|FG001|COMPLETED|Overall Study||34
9851578|NCT00876915|10964316|FG002|COMPLETED|Overall Study||101
9851579|NCT00876915|10964314|FG000|NOT COMPLETED|Overall Study||19
9851580|NCT00876915|10964315|FG001|NOT COMPLETED|Overall Study||14
9851581|NCT00876915|10964316|FG002|NOT COMPLETED|Overall Study||0
9851582|NCT00876928|10964326|FG000|STARTED|Overall Study||56
9851583|NCT00876928|10964327|FG001|STARTED|Overall Study||61
9851584|NCT00876928|10964326|FG000|COMPLETED|Overall Study||53
9851585|NCT00876928|10964327|FG001|COMPLETED|Overall Study||56
9851586|NCT00876928|10964326|FG000|NOT COMPLETED|Overall Study||3
9851587|NCT00876928|10964327|FG001|NOT COMPLETED|Overall Study||5
9851588|NCT00876993|10964338|FG000|STARTED|Overall Study||5
9851589|NCT00876993|10964339|FG001|STARTED|Overall Study||6
9851590|NCT00876993|10964340|FG002|STARTED|Overall Study||5
9851591|NCT00876993|10964341|FG003|STARTED|Overall Study||5
9851592|NCT00876993|10964342|FG004|STARTED|Overall Study||5
9851593|NCT00876993|10964338|FG000|COMPLETED|Overall Study||4
9851594|NCT00876993|10964339|FG001|COMPLETED|Overall Study||6
9851595|NCT00876993|10964340|FG002|COMPLETED|Overall Study||3
9851596|NCT00876993|10964341|FG003|COMPLETED|Overall Study||5
9851597|NCT00876993|10964342|FG004|COMPLETED|Overall Study||3
9851598|NCT00876993|10964338|FG000|NOT COMPLETED|Overall Study||1
9851599|NCT00876993|10964339|FG001|NOT COMPLETED|Overall Study||0
9851600|NCT00876993|10964340|FG002|NOT COMPLETED|Overall Study||2
9851601|NCT00876993|10964341|FG003|NOT COMPLETED|Overall Study||0
9851602|NCT00876993|10964342|FG004|NOT COMPLETED|Overall Study||2
9851603|NCT00877006|10964358|FG000|STARTED|Treatment Period||224
9851604|NCT00877006|10964359|FG001|STARTED|Treatment Period||223
9851605|NCT00877006|10964358|FG000|COMPLETED|Treatment Period||199
9851606|NCT00877006|10964359|FG001|COMPLETED|Treatment Period||196
9851607|NCT00877006|10964358|FG000|NOT COMPLETED|Treatment Period||25
9851608|NCT00877006|10964359|FG001|NOT COMPLETED|Treatment Period||27
9851609|NCT00877006|10964358|FG000|STARTED|Long-Term Follow-up Period||210
9851610|NCT00877006|10964359|FG001|STARTED|Long-Term Follow-up Period||209
9851611|NCT00877006|10964358|FG000|COMPLETED|Long-Term Follow-up Period||157
9851612|NCT00877006|10964359|FG001|COMPLETED|Long-Term Follow-up Period||154
9851613|NCT00877006|10964358|FG000|NOT COMPLETED|Long-Term Follow-up Period||53
9851614|NCT00877006|10964359|FG001|NOT COMPLETED|Long-Term Follow-up Period||55
9851615|NCT00877032|10964374|FG000|STARTED|Overall Study||6
9851616|NCT00877032|10964375|FG001|STARTED|Overall Study||6
9851617|NCT00877032|10964376|FG002|STARTED|Overall Study||6
9851618|NCT00877032|10964377|FG003|STARTED|Overall Study||7
9851619|NCT00877032|10964378|FG004|STARTED|Overall Study||6
9851620|NCT00877032|10964379|FG005|STARTED|Overall Study||6
9851621|NCT00877032|10964380|FG006|STARTED|Overall Study||20
9851622|NCT00877032|10964374|FG000|Treated|Overall Study||6
9851623|NCT00877032|10964375|FG001|Treated|Overall Study||6
9851624|NCT00877032|10964376|FG002|Treated|Overall Study||6
9851625|NCT00877032|10964377|FG003|Treated|Overall Study||6
9968074|NCT01518946|11088429|FG000|STARTED|Open-label Phase||24
9968075|NCT01518946|11088430|FG001|STARTED|Open-label Phase||0
9968076|NCT01518946|11088431|FG002|STARTED|Open-label Phase||0
9968077|NCT01518946|11088429|FG000|COMPLETED|Open-label Phase||20
9968078|NCT01518946|11088430|FG001|COMPLETED|Open-label Phase||0
9968079|NCT01518946|11088431|FG002|COMPLETED|Open-label Phase||0
9968080|NCT01518946|11088429|FG000|NOT COMPLETED|Open-label Phase||4
9968081|NCT01518946|11088430|FG001|NOT COMPLETED|Open-label Phase||0
9968082|NCT01518946|11088431|FG002|NOT COMPLETED|Open-label Phase||0
9968083|NCT01518946|11088429|FG000|STARTED|Randomized Phase (First Intervention)||0
10198241|NCT03392168|11326402|FG000|STARTED|Period 2: Cohort 2||0
10198242|NCT03392168|11326403|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
10198243|NCT03392168|11326404|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
10198244|NCT03392168|11326405|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
10198245|NCT03392168|11326402|FG000|COMPLETED|Period 2: Cohort 2||0
10198246|NCT03392168|11326403|FG001|COMPLETED|Period 2: Cohort 2||28
10198247|NCT03392168|11326404|FG002|COMPLETED|Period 2: Cohort 2||27
10198248|NCT03392168|11326405|FG003|COMPLETED|Period 2: Cohort 2||30
10198249|NCT03392168|11326402|FG000|NOT COMPLETED|Period 2: Cohort 2||0
10198250|NCT03392168|11326403|FG001|NOT COMPLETED|Period 2: Cohort 2||2
10198251|NCT03392168|11326404|FG002|NOT COMPLETED|Period 2: Cohort 2||1
10198252|NCT03392168|11326405|FG003|NOT COMPLETED|Period 2: Cohort 2||1
10198253|NCT03392194|11326416|FG000|STARTED|Overall Study||16
10198254|NCT03392194|11326417|FG001|STARTED|Overall Study||17
10198255|NCT03392194|11326416|FG000|COMPLETED|Overall Study||14
10198256|NCT03392194|11326417|FG001|COMPLETED|Overall Study||15
10198257|NCT03392194|11326416|FG000|NOT COMPLETED|Overall Study||2
10198258|NCT03392194|11326417|FG001|NOT COMPLETED|Overall Study||2
10198259|NCT03392532|11326423|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18
10198260|NCT03392532|11326424|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18
10198261|NCT03392532|11326423|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
10198262|NCT03392532|11326424|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
10198263|NCT03392532|11326423|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
10198264|NCT03392532|11326424|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
10198265|NCT03392532|11326423|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18
10198266|NCT03392532|11326424|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18
10198267|NCT03392532|11326423|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18
10198268|NCT03392532|11326424|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18
10198269|NCT03392532|11326423|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
10198270|NCT03392532|11326424|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
10198271|NCT03392935|11326430|FG000|STARTED|Overall Study||37
10198272|NCT03392935|11326430|FG000|COMPLETED|Overall Study||35
10198273|NCT03392935|11326430|FG000|NOT COMPLETED|Overall Study||2
10198274|NCT03392974|11326434|FG000|STARTED|Overall Study||1
10198275|NCT03392974|11326434|FG000|COMPLETED|Overall Study||1
10198276|NCT03392974|11326434|FG000|NOT COMPLETED|Overall Study||0
10198277|NCT03393000|11326439|FG000|STARTED|Overall Study|23 subjects screened|19
10198278|NCT03393000|11326439|FG000|COMPLETED|Overall Study|19 subjects treated|5
10198279|NCT03393000|11326439|FG000|NOT COMPLETED|Overall Study||14
10198280|NCT03393208|11326447|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13
10198281|NCT03393208|11326448|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13
9968084|NCT01518946|11088430|FG001|STARTED|Randomized Phase (First Intervention)||10
9968085|NCT01518946|11088431|FG002|STARTED|Randomized Phase (First Intervention)||10
9968086|NCT01518946|11088429|FG000|COMPLETED|Randomized Phase (First Intervention)||0
9968087|NCT01518946|11088430|FG001|COMPLETED|Randomized Phase (First Intervention)||9
9968088|NCT01518946|11088431|FG002|COMPLETED|Randomized Phase (First Intervention)||10
9968089|NCT01518946|11088429|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0
9968090|NCT01518946|11088430|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1
9968091|NCT01518946|11088431|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0
9968092|NCT01518946|11088429|FG000|STARTED|Randomized Phase (Second Intervention)||0
9968093|NCT01518946|11088430|FG001|STARTED|Randomized Phase (Second Intervention)||9
10198282|NCT03393208|11326449|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9
10198283|NCT03393208|11326450|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9
10198284|NCT03393208|11326447|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
10198285|NCT03393208|11326448|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
10198286|NCT03393208|11326449|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
10198287|NCT03393208|11326450|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
9851626|NCT00877032|10964378|FG004|Treated|Overall Study||6
9851627|NCT00877032|10964379|FG005|Treated|Overall Study||6
9851628|NCT00877032|10964380|FG006|Treated|Overall Study||18
9968094|NCT01518946|11088431|FG002|STARTED|Randomized Phase (Second Intervention)||10
9968095|NCT01518946|11088429|FG000|COMPLETED|Randomized Phase (Second Intervention)||0
9968096|NCT01518946|11088430|FG001|COMPLETED|Randomized Phase (Second Intervention)||9
9968097|NCT01518946|11088431|FG002|COMPLETED|Randomized Phase (Second Intervention)||10
9968098|NCT01518946|11088429|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0
9968099|NCT01518946|11088430|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0
9968100|NCT01518946|11088431|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0
9968101|NCT01518972|11088440|FG000|STARTED|Overall Study||15
9968102|NCT01518972|11088441|FG001|STARTED|Overall Study||15
10198288|NCT03393208|11326447|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10198289|NCT03393208|11326448|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10198290|NCT03393208|11326449|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10198291|NCT03393208|11326450|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10198292|NCT03393208|11326447|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13
10198293|NCT03393208|11326448|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13
10198294|NCT03393208|11326449|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9
10198295|NCT03393208|11326450|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9
10198296|NCT03393208|11326447|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
10198297|NCT03393208|11326448|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
10198298|NCT03393208|11326449|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
10198299|NCT03393208|11326450|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
10198300|NCT03393208|11326447|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10198301|NCT03393208|11326448|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10198302|NCT03393208|11326449|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10198303|NCT03393208|11326450|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10198304|NCT03393494|11326465|FG000|STARTED|Overall Study||329
10198305|NCT03393494|11326466|FG001|STARTED|Overall Study||331
10198306|NCT03393494|11326467|FG002|STARTED|Overall Study||165
10198307|NCT03393494|11326465|FG000|COMPLETED|Overall Study||261
10198308|NCT03393494|11326466|FG001|COMPLETED|Overall Study||256
10198309|NCT03393494|11326467|FG002|COMPLETED|Overall Study||140
10198310|NCT03393494|11326465|FG000|NOT COMPLETED|Overall Study||68
10198311|NCT03393494|11326466|FG001|NOT COMPLETED|Overall Study||75
10198312|NCT03393494|11326467|FG002|NOT COMPLETED|Overall Study||25
10198313|NCT03393754|11326477|FG000|STARTED|Overall Study||811
10198314|NCT03393754|11326478|FG001|STARTED|Overall Study||796
10198315|NCT03393754|11326477|FG000|COMPLETED|Overall Study||785
10198316|NCT03393754|11326478|FG001|COMPLETED|Overall Study||758
10198317|NCT03393754|11326477|FG000|NOT COMPLETED|Overall Study||26
10198318|NCT03393754|11326478|FG001|NOT COMPLETED|Overall Study||38
10198319|NCT03393806|11326486|FG000|STARTED|Overall Study||9
10198320|NCT03393806|11326487|FG001|STARTED|Overall Study||8
10198321|NCT03393806|11326486|FG000|COMPLETED|Overall Study||8
10198322|NCT03393806|11326487|FG001|COMPLETED|Overall Study||8
10198323|NCT03393806|11326486|FG000|NOT COMPLETED|Overall Study||1
10198324|NCT03393806|11326487|FG001|NOT COMPLETED|Overall Study||0
10198325|NCT03394391|11326496|FG000|STARTED|Overall Study||106
10198326|NCT03394391|11326497|FG001|STARTED|Overall Study||106
10198327|NCT03394391|11326496|FG000|COMPLETED|Overall Study||105
10198328|NCT03394391|11326497|FG001|COMPLETED|Overall Study||104
10198329|NCT03394391|11326496|FG000|NOT COMPLETED|Overall Study||1
10198330|NCT03394391|11326497|FG001|NOT COMPLETED|Overall Study||2
10198331|NCT03394508|11326505|FG000|STARTED|Overall Study||13
10198332|NCT03394508|11326506|FG001|STARTED|Overall Study||17
10198333|NCT03394508|11326505|FG000|COMPLETED|Overall Study||12
10198334|NCT03394508|11326506|FG001|COMPLETED|Overall Study||14
10198335|NCT03394508|11326505|FG000|NOT COMPLETED|Overall Study||1
10198336|NCT03394508|11326506|FG001|NOT COMPLETED|Overall Study||3
10198337|NCT03394768|11326516|FG000|STARTED|Overall Study||26
10198338|NCT03394768|11326516|FG000|COMPLETED|Overall Study||26
10198339|NCT03394768|11326516|FG000|NOT COMPLETED|Overall Study||0
10198340|NCT03394885|11326520|FG000|STARTED|Overall Study||18
10198341|NCT03394885|11326520|FG000|COMPLETED|Overall Study||3
10198342|NCT03394885|11326520|FG000|NOT COMPLETED|Overall Study||15
10198343|NCT03394924|11326527|FG000|STARTED|Overall Study||31
10198344|NCT03394924|11326528|FG001|STARTED|Overall Study||28
10198345|NCT03394924|11326529|FG002|STARTED|Overall Study||9
10198346|NCT03394924|11326527|FG000|COMPLETED|Overall Study||28
10198347|NCT03394924|11326528|FG001|COMPLETED|Overall Study||22
10198348|NCT03394924|11326529|FG002|COMPLETED|Overall Study||9
10198349|NCT03394924|11326527|FG000|NOT COMPLETED|Overall Study||3
10198350|NCT03394924|11326528|FG001|NOT COMPLETED|Overall Study||6
10198351|NCT03394924|11326529|FG002|NOT COMPLETED|Overall Study||0
10198352|NCT03395353|11326539|FG000|STARTED|Overall Study||151
10198353|NCT03395353|11326539|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150
10198354|NCT03395353|11326539|FG000|COMPLETED|Overall Study||64
10198355|NCT03395353|11326539|FG000|NOT COMPLETED|Overall Study||87
9968103|NCT01518972|11088440|FG000|COMPLETED|Overall Study||9
10198356|NCT03395808|11326547|FG000|STARTED|Overall Study||251
10198357|NCT03395808|11326547|FG000|COMPLETED|Overall Study||251
10198358|NCT03395808|11326547|FG000|NOT COMPLETED|Overall Study||0
10198359|NCT03395886|11326553|FG000|STARTED|Overall Study||52
10198360|NCT03395886|11326554|FG001|STARTED|Overall Study||38
10198361|NCT03395886|11326553|FG000|COMPLETED|Overall Study||0
10198362|NCT03395886|11326554|FG001|COMPLETED|Overall Study||0
10198363|NCT03395886|11326553|FG000|NOT COMPLETED|Overall Study||52
10198364|NCT03395886|11326554|FG001|NOT COMPLETED|Overall Study||38
9968104|NCT01518972|11088441|FG001|COMPLETED|Overall Study||11
9968105|NCT01518972|11088440|FG000|NOT COMPLETED|Overall Study||6
9968106|NCT01518972|11088441|FG001|NOT COMPLETED|Overall Study||4
9968107|NCT01519063|11088449|FG000|STARTED|Overall Study||26
9968108|NCT01519063|11088450|FG001|STARTED|Overall Study||30
9968109|NCT01519063|11088449|FG000|COMPLETED|Overall Study||19
9968110|NCT01519063|11088450|FG001|COMPLETED|Overall Study||25
9968111|NCT01519063|11088449|FG000|NOT COMPLETED|Overall Study||7
10198365|NCT03395990|11326562|FG000|STARTED|Overall Study||8
10198366|NCT03395990|11326563|FG001|STARTED|Overall Study||8
10198367|NCT03395990|11326562|FG000|COMPLETED|Overall Study||8
10198368|NCT03395990|11326563|FG001|COMPLETED|Overall Study||8
10198369|NCT03395990|11326562|FG000|NOT COMPLETED|Overall Study||0
10198370|NCT03395990|11326563|FG001|NOT COMPLETED|Overall Study||0
10198371|NCT03396432|11326571|FG000|STARTED|Overall Study||283
10198372|NCT03396432|11326572|FG001|STARTED|Overall Study||283
10198373|NCT03396432|11326571|FG000|COMPLETED|Overall Study||274
10198374|NCT03396432|11326572|FG001|COMPLETED|Overall Study||277
10198375|NCT03396432|11326571|FG000|NOT COMPLETED|Overall Study||9
10198376|NCT03396432|11326572|FG001|NOT COMPLETED|Overall Study||6
10198377|NCT03396835|11326580|FG000|STARTED|Overall Study||16
10198378|NCT03396835|11326580|FG000|COMPLETED|Overall Study||14
10198379|NCT03396835|11326580|FG000|NOT COMPLETED|Overall Study||2
10198380|NCT03396913|11326586|FG000|STARTED|Overall Study||43
10198381|NCT03396913|11326587|FG001|STARTED|Overall Study||45
10198382|NCT03396913|11326586|FG000|COMPLETED|Overall Study||43
10198383|NCT03396913|11326587|FG001|COMPLETED|Overall Study||39
10198384|NCT03396913|11326586|FG000|NOT COMPLETED|Overall Study||0
10198385|NCT03396913|11326587|FG001|NOT COMPLETED|Overall Study||6
10198386|NCT03397121|11326595|FG000|STARTED|Overall Study||242
10198387|NCT03397121|11326596|FG001|STARTED|Overall Study||240
10198388|NCT03397121|11326595|FG000|COMPLETED|Overall Study||235
10198389|NCT03397121|11326596|FG001|COMPLETED|Overall Study||231
10198390|NCT03397121|11326595|FG000|NOT COMPLETED|Overall Study||7
10198391|NCT03397121|11326596|FG001|NOT COMPLETED|Overall Study||9
10198392|NCT03397394|11326606|FG000|STARTED|Overall Study||47
10198393|NCT03397394|11326607|FG001|STARTED|Overall Study||30
10198394|NCT03397394|11326608|FG002|STARTED|Overall Study||20
10198395|NCT03397394|11326606|FG000|COMPLETED|Overall Study||47
10198396|NCT03397394|11326607|FG001|COMPLETED|Overall Study||30
10198397|NCT03397394|11326608|FG002|COMPLETED|Overall Study||20
10198398|NCT03397394|11326606|FG000|NOT COMPLETED|Overall Study||0
10198399|NCT03397394|11326607|FG001|NOT COMPLETED|Overall Study||0
10198400|NCT03397394|11326608|FG002|NOT COMPLETED|Overall Study||0
10198401|NCT03397771|11326620|FG000|STARTED|Overall Study||53
10198402|NCT03397771|11326621|FG001|STARTED|Overall Study||29
10198403|NCT03397771|11326620|FG000|COMPLETED|Overall Study||45
10198404|NCT03397771|11326621|FG001|COMPLETED|Overall Study||22
10198405|NCT03397771|11326620|FG000|NOT COMPLETED|Overall Study||8
10198406|NCT03397771|11326621|FG001|NOT COMPLETED|Overall Study||7
10198407|NCT03398213|11326630|FG000|STARTED|Overall Study||26
10198408|NCT03398213|11326631|FG001|STARTED|Overall Study||24
10198409|NCT03398213|11326632|FG002|STARTED|Overall Study||22
10198410|NCT03398213|11326630|FG000|COMPLETED|Overall Study||26
10198411|NCT03398213|11326631|FG001|COMPLETED|Overall Study||24
10198412|NCT03398213|11326632|FG002|COMPLETED|Overall Study||22
10198413|NCT03398213|11326630|FG000|NOT COMPLETED|Overall Study||0
10198414|NCT03398213|11326631|FG001|NOT COMPLETED|Overall Study||0
10198415|NCT03398213|11326632|FG002|NOT COMPLETED|Overall Study||0
10198416|NCT03398265|11326642|FG000|STARTED|Overall Study||7
10198417|NCT03398265|11326643|FG001|STARTED|Overall Study||8
10198418|NCT03398265|11326642|FG000|COMPLETED|Overall Study||7
10198419|NCT03398265|11326643|FG001|COMPLETED|Overall Study||8
10198420|NCT03398265|11326642|FG000|NOT COMPLETED|Overall Study||0
10198421|NCT03398265|11326643|FG001|NOT COMPLETED|Overall Study||0
10198422|NCT03398278|11326652|FG000|STARTED|Period 1||19
10198423|NCT03398278|11326653|FG001|STARTED|Period 1||19
10198424|NCT03398278|11326652|FG000|COMPLETED|Period 1||18
10198425|NCT03398278|11326653|FG001|COMPLETED|Period 1||19
10198426|NCT03398278|11326652|FG000|NOT COMPLETED|Period 1||1
10198427|NCT03398278|11326653|FG001|NOT COMPLETED|Period 1||0
10198428|NCT03398278|11326652|FG000|STARTED|Period 2||18
10198429|NCT03398278|11326653|FG001|STARTED|Period 2||19
10198430|NCT03398278|11326652|FG000|COMPLETED|Period 2||16
10198431|NCT03398278|11326653|FG001|COMPLETED|Period 2||17
10198432|NCT03398278|11326652|FG000|NOT COMPLETED|Period 2||2
10198433|NCT03398278|11326653|FG001|NOT COMPLETED|Period 2||2
10198434|NCT03398330|11326675|FG000|STARTED|Period 1||21
9968112|NCT01519063|11088450|FG001|NOT COMPLETED|Overall Study||5
9968113|NCT01519089|11088458|FG000|STARTED|Overall Study||47
9968114|NCT01519089|11088459|FG001|STARTED|Overall Study||48
9968115|NCT01519089|11088458|FG000|Received Treatment|Overall Study||47
10198435|NCT03398330|11326676|FG001|STARTED|Period 1||21
10198436|NCT03398330|11326675|FG000|COMPLETED|Period 1||20
10198437|NCT03398330|11326676|FG001|COMPLETED|Period 1||17
10198438|NCT03398330|11326675|FG000|NOT COMPLETED|Period 1||1
10198439|NCT03398330|11326676|FG001|NOT COMPLETED|Period 1||4
10198440|NCT03398330|11326675|FG000|STARTED|Period 2||20
10198441|NCT03398330|11326676|FG001|STARTED|Period 2||17
10198442|NCT03398330|11326675|FG000|COMPLETED|Period 2||19
10198443|NCT03398330|11326676|FG001|COMPLETED|Period 2||17
9968116|NCT01519089|11088459|FG001|Received Treatment|Overall Study||47
9968117|NCT01519089|11088458|FG000|COMPLETED|Overall Study||40
10198444|NCT03398330|11326675|FG000|NOT COMPLETED|Period 2||1
10198445|NCT03398330|11326676|FG001|NOT COMPLETED|Period 2||0
9968118|NCT01519089|11088459|FG001|COMPLETED|Overall Study||33
9968119|NCT01519089|11088458|FG000|NOT COMPLETED|Overall Study||7
9968120|NCT01519089|11088459|FG001|NOT COMPLETED|Overall Study||15
9968121|NCT01519167|11088469|FG000|STARTED|Overall Study||1
9968122|NCT01519167|11088470|FG001|STARTED|Overall Study||89
9968123|NCT01519167|11088469|FG000|COMPLETED|Overall Study||1
9968124|NCT01519167|11088470|FG001|COMPLETED|Overall Study||81
9968125|NCT01519167|11088469|FG000|NOT COMPLETED|Overall Study||0
9968126|NCT01519167|11088470|FG001|NOT COMPLETED|Overall Study||8
9968127|NCT01519206|11088476|FG000|STARTED|Overall Study||32
9968128|NCT01519206|11088476|FG000|COMPLETED|Overall Study||27
9968129|NCT01519206|11088476|FG000|NOT COMPLETED|Overall Study||5
9968130|NCT01519245|11088489|FG000|STARTED|Overall Study||24
9968131|NCT01519245|11088490|FG001|STARTED|Overall Study||20
9968132|NCT01519245|11088489|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
9968133|NCT01519245|11088490|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
9968134|NCT01519245|11088489|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
9968135|NCT01519245|11088490|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
9968136|NCT01519245|11088489|FG000|COMPLETED|Overall Study||23
9968137|NCT01519245|11088490|FG001|COMPLETED|Overall Study||18
9968138|NCT01519245|11088489|FG000|NOT COMPLETED|Overall Study||1
9968139|NCT01519245|11088490|FG001|NOT COMPLETED|Overall Study||2
9968140|NCT01519271|11088500|FG000|STARTED|Phase 1||14
9968141|NCT01519271|11088501|FG001|STARTED|Phase 1||14
9968142|NCT01519271|11088500|FG000|COMPLETED|Phase 1||14
9968143|NCT01519271|11088501|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
9968144|NCT01519271|11088500|FG000|NOT COMPLETED|Phase 1||0
10198446|NCT03398421|11326696|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20
10198447|NCT03398421|11326697|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0
10198448|NCT03398421|11326696|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
10198449|NCT03398421|11326697|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
10198450|NCT03398421|11326696|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
10198451|NCT03398421|11326697|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
10198452|NCT03398421|11326696|FG000|STARTED|Washout Period (Up to 14 Days)||20
10198453|NCT03398421|11326697|FG001|STARTED|Washout Period (Up to 14 Days)||0
10198454|NCT03398421|11326696|FG000|COMPLETED|Washout Period (Up to 14 Days)||20
10198455|NCT03398421|11326697|FG001|COMPLETED|Washout Period (Up to 14 Days)||0
10198456|NCT03398421|11326696|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10198457|NCT03398421|11326697|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10198458|NCT03398421|11326696|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0
10198459|NCT03398421|11326697|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20
10198460|NCT03398421|11326696|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
10198461|NCT03398421|11326697|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
10198462|NCT03398421|11326696|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
10198463|NCT03398421|11326697|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
10198464|NCT03398798|11326709|FG000|STARTED|Overall Study||9
10198465|NCT03398798|11326710|FG001|STARTED|Overall Study||9
10198466|NCT03398798|11326711|FG002|STARTED|Overall Study||9
10198467|NCT03398798|11326712|FG003|STARTED|Overall Study||9
10198468|NCT03398798|11326709|FG000|COMPLETED|Overall Study||9
10198469|NCT03398798|11326710|FG001|COMPLETED|Overall Study||9
10198470|NCT03398798|11326711|FG002|COMPLETED|Overall Study||9
10198471|NCT03398798|11326712|FG003|COMPLETED|Overall Study||9
10198472|NCT03398798|11326709|FG000|NOT COMPLETED|Overall Study||0
10198473|NCT03398798|11326710|FG001|NOT COMPLETED|Overall Study||0
9968145|NCT01519271|11088501|FG001|NOT COMPLETED|Phase 1||1
9968146|NCT01519271|11088500|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12
10198474|NCT03398798|11326711|FG002|NOT COMPLETED|Overall Study||0
10198475|NCT03398798|11326712|FG003|NOT COMPLETED|Overall Study||0
10198476|NCT03398928|11326724|FG000|STARTED|Overall Study||50
10198477|NCT03398928|11326725|FG001|STARTED|Overall Study||31
10198478|NCT03398928|11326724|FG000|COMPLETED|Overall Study||50
10198479|NCT03398928|11326725|FG001|COMPLETED|Overall Study||31
10198480|NCT03398928|11326724|FG000|NOT COMPLETED|Overall Study||0
10198481|NCT03398928|11326725|FG001|NOT COMPLETED|Overall Study||0
10198482|NCT03399370|11326733|FG000|STARTED|Overall Study||781
10198483|NCT03399370|11326734|FG001|STARTED|Overall Study||780
10198484|NCT03399370|11326733|FG000|COMPLETED|Overall Study||721
10198485|NCT03399370|11326734|FG001|COMPLETED|Overall Study||694
10198486|NCT03399370|11326733|FG000|NOT COMPLETED|Overall Study||60
10198487|NCT03399370|11326734|FG001|NOT COMPLETED|Overall Study||86
10198488|NCT03399786|11326743|FG000|STARTED|Double-blind Treatment Period (DBTP)||22
10198489|NCT03399786|11326744|FG001|STARTED|Double-blind Treatment Period (DBTP)||43
10198490|NCT03399786|11326745|FG002|STARTED|Double-blind Treatment Period (DBTP)||0
10198491|NCT03399786|11326746|FG003|STARTED|Double-blind Treatment Period (DBTP)||0
10198492|NCT03399786|11326743|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21
10198493|NCT03399786|11326744|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43
10198494|NCT03399786|11326745|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0
10198495|NCT03399786|11326746|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0
10198496|NCT03399786|11326743|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
9968147|NCT01519271|11088501|FG001|STARTED|Phase 2||14
9968148|NCT01519271|11088500|FG000|COMPLETED|Phase 2||12
9968149|NCT01519271|11088501|FG001|COMPLETED|Phase 2||14
9968150|NCT01519271|11088500|FG000|NOT COMPLETED|Phase 2||0
9968151|NCT01519271|11088501|FG001|NOT COMPLETED|Phase 2||0
9968152|NCT01519284|11088514|FG000|STARTED|Overall Study||16
9968153|NCT01519284|11088515|FG001|STARTED|Overall Study||16
9968154|NCT01519284|11088516|FG002|STARTED|Overall Study||18
9968155|NCT01519284|11088517|FG003|STARTED|Overall Study||16
9968156|NCT01519284|11088518|FG004|STARTED|Overall Study||16
9968157|NCT01519284|11088514|FG000|COMPLETED|Overall Study||16
9968158|NCT01519284|11088515|FG001|COMPLETED|Overall Study||16
9968159|NCT01519284|11088516|FG002|COMPLETED|Overall Study||16
9968160|NCT01519284|11088517|FG003|COMPLETED|Overall Study||16
9968161|NCT01519284|11088518|FG004|COMPLETED|Overall Study||16
9968162|NCT01519284|11088514|FG000|NOT COMPLETED|Overall Study||0
9968163|NCT01519284|11088515|FG001|NOT COMPLETED|Overall Study||0
9968164|NCT01519284|11088516|FG002|NOT COMPLETED|Overall Study||2
9968165|NCT01519284|11088517|FG003|NOT COMPLETED|Overall Study||0
9968166|NCT01519284|11088518|FG004|NOT COMPLETED|Overall Study||0
9968167|NCT01519323|11088530|FG000|STARTED|Overall Study||3
9968168|NCT01519323|11088531|FG001|STARTED|Overall Study||3
9968169|NCT01519323|11088530|FG000|COMPLETED|Overall Study||0
9968170|NCT01519323|11088531|FG001|COMPLETED|Overall Study||0
9968171|NCT01519323|11088530|FG000|NOT COMPLETED|Overall Study||3
9968172|NCT01519323|11088531|FG001|NOT COMPLETED|Overall Study||3
9968173|NCT01519414|11088539|FG000|STARTED|Pre Cross-over||52
9968174|NCT01519414|11088540|FG001|STARTED|Pre Cross-over||26
9968175|NCT01519414|11088541|FG002|STARTED|Pre Cross-over||0
9968176|NCT01519414|11088539|FG000|COMPLETED|Pre Cross-over||52
9968177|NCT01519414|11088540|FG001|COMPLETED|Pre Cross-over||26
9968178|NCT01519414|11088541|FG002|COMPLETED|Pre Cross-over||0
9968179|NCT01519414|11088539|FG000|NOT COMPLETED|Pre Cross-over||0
9968180|NCT01519414|11088540|FG001|NOT COMPLETED|Pre Cross-over||0
9968181|NCT01519414|11088541|FG002|NOT COMPLETED|Pre Cross-over||0
9968182|NCT01519414|11088539|FG000|STARTED|Post Cross-over||52
9968183|NCT01519414|11088540|FG001|STARTED|Post Cross-over||14
9968184|NCT01519414|11088541|FG002|STARTED|Post Cross-over||12
9968185|NCT01519414|11088539|FG000|COMPLETED|Post Cross-over||52
9968186|NCT01519414|11088540|FG001|COMPLETED|Post Cross-over||14
9968187|NCT01519414|11088541|FG002|COMPLETED|Post Cross-over||12
9968188|NCT01519414|11088539|FG000|NOT COMPLETED|Post Cross-over||0
9968189|NCT01519414|11088540|FG001|NOT COMPLETED|Post Cross-over||0
9968190|NCT01519414|11088541|FG002|NOT COMPLETED|Post Cross-over||0
9968191|NCT01519427|11088552|FG000|STARTED|Overall Study||2
9968192|NCT01519427|11088552|FG000|COMPLETED|Overall Study||0
9968193|NCT01519427|11088552|FG000|NOT COMPLETED|Overall Study||2
9968194|NCT01519453|11088558|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
10198497|NCT03399786|11326744|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
10198498|NCT03399786|11326745|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
10198499|NCT03399786|11326746|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
10198500|NCT03399786|11326743|FG000|STARTED|Open-label Treatment Period (OLTP)||0
10198501|NCT03399786|11326744|FG001|STARTED|Open-label Treatment Period (OLTP)||0
10198502|NCT03399786|11326745|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
10198503|NCT03399786|11326746|FG003|STARTED|Open-label Treatment Period (OLTP)||44
10198504|NCT03399786|11326743|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0
10198505|NCT03399786|11326744|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0
10198506|NCT03399786|11326745|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19
10198507|NCT03399786|11326746|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43
10198508|NCT03399786|11326743|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
10198509|NCT03399786|11326744|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
10198510|NCT03399786|11326745|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
10198511|NCT03399786|11326746|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
10198512|NCT03400033|11326756|FG000|STARTED|Overall Study||270
10198513|NCT03400033|11326757|FG001|STARTED|Overall Study||137
10198514|NCT03400033|11326756|FG000|COMPLETED|Overall Study||269
10198515|NCT03400033|11326757|FG001|COMPLETED|Overall Study||135
10198516|NCT03400033|11326756|FG000|NOT COMPLETED|Overall Study||1
10198517|NCT03400033|11326757|FG001|NOT COMPLETED|Overall Study||2
10198518|NCT03400163|11326774|FG000|STARTED|Treatment Period||1
10198519|NCT03400163|11326775|FG001|STARTED|Treatment Period||2
10198520|NCT03400163|11326774|FG000|COMPLETED|Treatment Period||1
10198521|NCT03400163|11326775|FG001|COMPLETED|Treatment Period||2
10198522|NCT03400163|11326774|FG000|NOT COMPLETED|Treatment Period||0
10198523|NCT03400163|11326775|FG001|NOT COMPLETED|Treatment Period||0
10198524|NCT03400163|11326774|FG000|STARTED|Follow-up Period||1
10198525|NCT03400163|11326775|FG001|STARTED|Follow-up Period||2
10198526|NCT03400163|11326774|FG000|COMPLETED|Follow-up Period||1
10198527|NCT03400163|11326775|FG001|COMPLETED|Follow-up Period||2
10198528|NCT03400163|11326774|FG000|NOT COMPLETED|Follow-up Period||0
10198529|NCT03400163|11326775|FG001|NOT COMPLETED|Follow-up Period||0
9968195|NCT01519453|11088559|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
9968196|NCT01519453|11088558|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
9968197|NCT01519453|11088559|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
9968198|NCT01519453|11088558|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
10198530|NCT03400449|11326783|FG000|STARTED|Overall Study||121
9968199|NCT01519453|11088559|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
9968200|NCT01519453|11088558|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
9968201|NCT01519453|11088559|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
9968202|NCT01519453|11088558|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
9968203|NCT01519453|11088559|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
9968204|NCT01519453|11088558|FG000|NOT COMPLETED|Overall Study||52
9968205|NCT01519453|11088559|FG001|NOT COMPLETED|Overall Study||36
9968206|NCT01519466|11088567|FG000|STARTED|Overall Study||33
9968207|NCT01519466|11088568|FG001|STARTED|Overall Study||16
9968208|NCT01519466|11088567|FG000|COMPLETED|Overall Study||33
9968209|NCT01519466|11088568|FG001|COMPLETED|Overall Study||16
9968210|NCT01519466|11088567|FG000|NOT COMPLETED|Overall Study||0
9968211|NCT01519466|11088568|FG001|NOT COMPLETED|Overall Study||0
9968212|NCT01519518|11088576|FG000|STARTED|Overall Study||914
9968213|NCT01519518|11088577|FG001|STARTED|Overall Study||915
9968214|NCT01519518|11088576|FG000|COMPLETED|Overall Study||907
9968215|NCT01519518|11088577|FG001|COMPLETED|Overall Study||905
9968216|NCT01519518|11088576|FG000|NOT COMPLETED|Overall Study||7
9968217|NCT01519518|11088577|FG001|NOT COMPLETED|Overall Study||10
9968218|NCT01519570|11088585|FG000|STARTED|Overall Study||500
9968219|NCT01519570|11088586|FG001|STARTED|Overall Study||2089
9968220|NCT01519570|11088585|FG000|COMPLETED|Overall Study||500
9968221|NCT01519570|11088586|FG001|COMPLETED|Overall Study||2089
9968222|NCT01519570|11088585|FG000|NOT COMPLETED|Overall Study||0
9968223|NCT01519570|11088586|FG001|NOT COMPLETED|Overall Study||0
9968224|NCT01519635|11088594|FG000|STARTED|Overall Study||12
9968225|NCT01519635|11088595|FG001|STARTED|Overall Study||12
9968226|NCT01519635|11088594|FG000|COMPLETED|Overall Study||11
9968227|NCT01519635|11088595|FG001|COMPLETED|Overall Study||9
9968228|NCT01519635|11088594|FG000|NOT COMPLETED|Overall Study||1
9968229|NCT01519635|11088595|FG001|NOT COMPLETED|Overall Study||3
9968230|NCT01519648|11088603|FG000|STARTED|Overall Study||502
9968231|NCT01519648|11088604|FG001|STARTED|Overall Study||306
9968232|NCT01519648|11088603|FG000|COMPLETED|Overall Study||502
9968233|NCT01519648|11088604|FG001|COMPLETED|Overall Study||306
9968234|NCT01519648|11088603|FG000|NOT COMPLETED|Overall Study||0
9968235|NCT01519648|11088604|FG001|NOT COMPLETED|Overall Study||0
9968236|NCT01519661|11088610|FG000|STARTED|Overall Study||157
9968237|NCT01519661|11088610|FG000|COMPLETED|Overall Study||96
9968238|NCT01519661|11088610|FG000|NOT COMPLETED|Overall Study||61
9968239|NCT01519674|11088618|FG000|STARTED|Overall Study||194
9968240|NCT01519674|11088619|FG001|STARTED|Overall Study||195
9968241|NCT01519674|11088620|FG002|STARTED|Overall Study||193
9968242|NCT01519674|11088618|FG000|Exposed|Overall Study||192
9968243|NCT01519674|11088619|FG001|Exposed|Overall Study||193
9968244|NCT01519674|11088620|FG002|Exposed|Overall Study||190
9968245|NCT01519674|11088618|FG000|COMPLETED|Overall Study||173
9968246|NCT01519674|11088619|FG001|COMPLETED|Overall Study||182
9968247|NCT01519674|11088620|FG002|COMPLETED|Overall Study||181
9968248|NCT01519674|11088618|FG000|NOT COMPLETED|Overall Study||21
9968249|NCT01519674|11088619|FG001|NOT COMPLETED|Overall Study||13
9968250|NCT01519674|11088620|FG002|NOT COMPLETED|Overall Study||12
9968251|NCT01519700|11088632|FG000|STARTED|Overall Study||54
9968252|NCT01519700|11088633|FG001|STARTED|Overall Study||55
9968253|NCT01519700|11088634|FG002|STARTED|Overall Study||55
9968254|NCT01519700|11088635|FG003|STARTED|Overall Study||54
9968255|NCT01519700|11088632|FG000|Treated Cycle 1 EP2006|Overall Study||53
9968256|NCT01519700|11088633|FG001|Treated Cycle 1 EP2006|Overall Study||54
9968257|NCT01519700|11088634|FG002|Treated Cycle 1 EP2006|Overall Study||0
9968258|NCT01519700|11088635|FG003|Treated Cycle 1 EP2006|Overall Study||0
9968259|NCT01519700|11088632|FG000|Treated Cycle 1 Neupogen|Overall Study||0
9968260|NCT01519700|11088633|FG001|Treated Cycle 1 Neupogen|Overall Study||0
9968261|NCT01519700|11088634|FG002|Treated Cycle 1 Neupogen|Overall Study||55
9968262|NCT01519700|11088635|FG003|Treated Cycle 1 Neupogen|Overall Study||52
9968263|NCT01519700|11088632|FG000|Treated Cycle 2 EP2006|Overall Study||52
10198531|NCT03400449|11326784|FG001|STARTED|Overall Study||119
9968264|NCT01519700|11088633|FG001|Treated Cycle 2 EP2006|Overall Study||0
9968265|NCT01519700|11088634|FG002|Treated Cycle 2 EP2006|Overall Study||55
10082367|NCT02267772|11210918|FG001|STARTED|Overall Study||52
10082368|NCT02267772|11210917|FG000|Randomized|Overall Study||50
10082369|NCT02267772|11210918|FG001|Randomized|Overall Study||52
10082370|NCT02267772|11210917|FG000|Received Study Drug|Overall Study||48
10082371|NCT02267772|11210918|FG001|Received Study Drug|Overall Study||52
10198532|NCT03400449|11326783|FG000|COMPLETED|Overall Study||120
10082372|NCT02267772|11210917|FG000|COMPLETED|Overall Study||48
10082373|NCT02267772|11210918|FG001|COMPLETED|Overall Study||52
10082374|NCT02267772|11210917|FG000|NOT COMPLETED|Overall Study||2
10082375|NCT02267772|11210918|FG001|NOT COMPLETED|Overall Study||0
10082376|NCT02267811|11210926|FG000|STARTED|Overall Study||16
10082377|NCT02267811|11210927|FG001|STARTED|Overall Study||17
10082378|NCT02267811|11210926|FG000|COMPLETED|Overall Study||15
10082379|NCT02267811|11210927|FG001|COMPLETED|Overall Study||15
10082380|NCT02267811|11210926|FG000|NOT COMPLETED|Overall Study||1
10198533|NCT03400449|11326784|FG001|COMPLETED|Overall Study||119
9968266|NCT01519700|11088635|FG003|Treated Cycle 2 EP2006|Overall Study||0
9968267|NCT01519700|11088632|FG000|Treated Cycle 2 Neupogen|Overall Study||0
9968268|NCT01519700|11088633|FG001|Treated Cycle 2 Neupogen|Overall Study||52
9968269|NCT01519700|11088634|FG002|Treated Cycle 2 Neupogen|Overall Study||0
9968270|NCT01519700|11088635|FG003|Treated Cycle 2 Neupogen|Overall Study||51
9968271|NCT01519700|11088632|FG000|Treated Cycle 3 EP2006|Overall Study||51
9968272|NCT01519700|11088633|FG001|Treated Cycle 3 EP2006|Overall Study||51
9968273|NCT01519700|11088634|FG002|Treated Cycle 3 EP2006|Overall Study||0
9968274|NCT01519700|11088635|FG003|Treated Cycle 3 EP2006|Overall Study||0
9968275|NCT01519700|11088632|FG000|Treated Cycle 3 Neupogen|Overall Study||0
9968276|NCT01519700|11088633|FG001|Treated Cycle 3 Neupogen|Overall Study||0
9968277|NCT01519700|11088634|FG002|Treated Cycle 3 Neupogen|Overall Study||54
9968278|NCT01519700|11088635|FG003|Treated Cycle 3 Neupogen|Overall Study||51
9968279|NCT01519700|11088632|FG000|Treated Cycle 4 EP2006|Overall Study||51
9968280|NCT01519700|11088633|FG001|Treated Cycle 4 EP2006|Overall Study||0
9968281|NCT01519700|11088634|FG002|Treated Cycle 4 EP2006|Overall Study||50
10198534|NCT03400449|11326783|FG000|NOT COMPLETED|Overall Study||1
10198535|NCT03400449|11326784|FG001|NOT COMPLETED|Overall Study||0
10198536|NCT03400475|11326794|FG000|STARTED|Overall Study||24
10198537|NCT03400475|11326795|FG001|STARTED|Overall Study||22
10198538|NCT03400475|11326794|FG000|COMPLETED|Overall Study||24
10198539|NCT03400475|11326795|FG001|COMPLETED|Overall Study||22
10198540|NCT03400475|11326794|FG000|NOT COMPLETED|Overall Study||0
10198541|NCT03400475|11326795|FG001|NOT COMPLETED|Overall Study||0
10198542|NCT03400579|11326802|FG000|STARTED|Overall Study||10
10198543|NCT03400579|11326802|FG000|COMPLETED|Overall Study||10
10198544|NCT03400579|11326802|FG000|NOT COMPLETED|Overall Study||0
10198545|NCT03400748|11326806|FG000|STARTED|Overall Study||6
10198546|NCT03400748|11326806|FG000|COMPLETED|Overall Study||6
10198547|NCT03400748|11326806|FG000|NOT COMPLETED|Overall Study||0
10198548|NCT03400787|11326812|FG000|STARTED|Overall Study||66
10198549|NCT03400787|11326813|FG001|STARTED|Overall Study||71
10198550|NCT03400787|11326812|FG000|3-Month Follow-up|Overall Study||64
10198551|NCT03400787|11326813|FG001|3-Month Follow-up|Overall Study||63
10198552|NCT03400787|11326812|FG000|COMPLETED|Overall Study||64
10198553|NCT03400787|11326813|FG001|COMPLETED|Overall Study||63
10198554|NCT03400787|11326812|FG000|NOT COMPLETED|Overall Study||2
10198555|NCT03400787|11326813|FG001|NOT COMPLETED|Overall Study||8
10198556|NCT03400800|11326821|FG000|STARTED|Overall Study||810
10198557|NCT03400800|11326822|FG001|STARTED|Overall Study||807
10198558|NCT03400800|11326821|FG000|COMPLETED|Overall Study||772
10198559|NCT03400800|11326822|FG001|COMPLETED|Overall Study||770
10198560|NCT03400800|11326821|FG000|NOT COMPLETED|Overall Study||38
10198561|NCT03400800|11326822|FG001|NOT COMPLETED|Overall Study||37
10198562|NCT03400852|11326830|FG000|STARTED|Blinded Treatment Period||29
10198563|NCT03400852|11326831|FG001|STARTED|Blinded Treatment Period||15
10198564|NCT03400852|11326832|FG002|STARTED|Blinded Treatment Period||0
10198565|NCT03400852|11326830|FG000|COMPLETED|Blinded Treatment Period||20
10198566|NCT03400852|11326831|FG001|COMPLETED|Blinded Treatment Period||9
10198567|NCT03400852|11326832|FG002|COMPLETED|Blinded Treatment Period||0
10198568|NCT03400852|11326830|FG000|NOT COMPLETED|Blinded Treatment Period||9
10198569|NCT03400852|11326831|FG001|NOT COMPLETED|Blinded Treatment Period||6
10198570|NCT03400852|11326832|FG002|NOT COMPLETED|Blinded Treatment Period||0
10198571|NCT03400852|11326830|FG000|STARTED|Open Label Period||0
10198572|NCT03400852|11326831|FG001|STARTED|Open Label Period||0
10198573|NCT03400852|11326832|FG002|STARTED|Open Label Period||24
10198574|NCT03400852|11326830|FG000|COMPLETED|Open Label Period||0
10198575|NCT03400852|11326831|FG001|COMPLETED|Open Label Period||0
10198576|NCT03400852|11326832|FG002|COMPLETED|Open Label Period||2
10198577|NCT03400852|11326830|FG000|NOT COMPLETED|Open Label Period||0
10198578|NCT03400852|11326831|FG001|NOT COMPLETED|Open Label Period||0
10198579|NCT03400852|11326832|FG002|NOT COMPLETED|Open Label Period||22
9968282|NCT01519700|11088635|FG003|Treated Cycle 4 EP2006|Overall Study||0
9968283|NCT01519700|11088632|FG000|Treated Cycle 4 Neupogen|Overall Study||0
9968284|NCT01519700|11088633|FG001|Treated Cycle 4 Neupogen|Overall Study||51
9968285|NCT01519700|11088634|FG002|Treated Cycle 4 Neupogen|Overall Study||0
9968286|NCT01519700|11088635|FG003|Treated Cycle 4 Neupogen|Overall Study||50
9968287|NCT01519700|11088632|FG000|Treated Cycle 5 EP2006|Overall Study||46
9968288|NCT01519700|11088633|FG001|Treated Cycle 5 EP2006|Overall Study||49
9968289|NCT01519700|11088634|FG002|Treated Cycle 5 EP2006|Overall Study||0
10198619|NCT03401229|11326858|FG000|STARTED|Overall Study||207
10198620|NCT03401229|11326859|FG001|STARTED|Overall Study||203
10198621|NCT03401229|11326858|FG000|COMPLETED|Overall Study||167
10198622|NCT03401229|11326859|FG001|COMPLETED|Overall Study||166
10198623|NCT03401229|11326858|FG000|NOT COMPLETED|Overall Study||40
10198624|NCT03401229|11326859|FG001|NOT COMPLETED|Overall Study||37
10198625|NCT03401450|11326867|FG000|STARTED|Overall Study||33
10198626|NCT03401450|11326868|FG001|STARTED|Overall Study||36
10198627|NCT03401450|11326867|FG000|COMPLETED|Overall Study||21
10198628|NCT03401450|11326868|FG001|COMPLETED|Overall Study||23
10198629|NCT03401450|11326867|FG000|NOT COMPLETED|Overall Study||12
10198630|NCT03401450|11326868|FG001|NOT COMPLETED|Overall Study||13
10198631|NCT03401671|11326876|FG000|STARTED|Overall Study||16
10198632|NCT03401671|11326877|FG001|STARTED|Overall Study||16
10198633|NCT03401671|11326876|FG000|COMPLETED|Overall Study||16
10198634|NCT03401671|11326877|FG001|COMPLETED|Overall Study||16
10198635|NCT03401671|11326876|FG000|NOT COMPLETED|Overall Study||0
10198636|NCT03401671|11326877|FG001|NOT COMPLETED|Overall Study||0
10198637|NCT03402126|11326883|FG000|STARTED|Overall Study||138
10198638|NCT03402126|11326883|FG000|COMPLETED|Overall Study||76
10198639|NCT03402126|11326883|FG000|NOT COMPLETED|Overall Study||62
10198640|NCT03402243|11326890|FG000|STARTED|Overall Study||16
10198641|NCT03402243|11326891|FG001|STARTED|Overall Study||15
10198642|NCT03402243|11326892|FG002|STARTED|Overall Study||16
10198643|NCT03402243|11326890|FG000|COMPLETED|Overall Study||13
10198644|NCT03402243|11326891|FG001|COMPLETED|Overall Study||12
10198645|NCT03402243|11326892|FG002|COMPLETED|Overall Study||14
10198646|NCT03402243|11326890|FG000|NOT COMPLETED|Overall Study||3
10198647|NCT03402243|11326891|FG001|NOT COMPLETED|Overall Study||3
10198648|NCT03402243|11326892|FG002|NOT COMPLETED|Overall Study||2
10198649|NCT03402386|11326900|FG000|STARTED|Overall Study||42
10198650|NCT03402386|11326900|FG000|Correction Group|Overall Study||2
10198651|NCT03402386|11326900|FG000|Conversion Group|Overall Study||40
10198652|NCT03402386|11326900|FG000|COMPLETED|Overall Study||36
10198653|NCT03402386|11326900|FG000|NOT COMPLETED|Overall Study||6
10198654|NCT03402555|11326904|FG000|STARTED|Overall Study||96
10198655|NCT03402555|11326904|FG000|COMPLETED|Overall Study||91
10198656|NCT03402555|11326904|FG000|NOT COMPLETED|Overall Study||5
10238624|NCT00499590|11370080|FG000|STARTED|Overall Study||113
10238625|NCT00499590|11370081|FG001|STARTED|Overall Study||112
10238626|NCT00499590|11370082|FG002|STARTED|Overall Study||113
10238627|NCT00499590|11370080|FG000|COMPLETED|Overall Study||0
10238628|NCT00499590|11370081|FG001|COMPLETED|Overall Study||0
10238629|NCT00499590|11370082|FG002|COMPLETED|Overall Study||0
10238630|NCT00499590|11370080|FG000|NOT COMPLETED|Overall Study||113
10238631|NCT00499590|11370081|FG001|NOT COMPLETED|Overall Study||112
10238632|NCT00499590|11370082|FG002|NOT COMPLETED|Overall Study||113
10238633|NCT00501345|11370091|FG000|STARTED|Overall Study||5
10238634|NCT00501345|11370091|FG000|COMPLETED|Overall Study||5
10238635|NCT00501345|11370091|FG000|NOT COMPLETED|Overall Study||0
10238636|NCT00496756|11370095|FG000|STARTED|Overall Study||14
10238637|NCT00496756|11370095|FG000|COMPLETED|Overall Study||11
10238638|NCT00496756|11370095|FG000|NOT COMPLETED|Overall Study||3
10238639|NCT00495716|11370101|FG000|STARTED|Overall Study||35
10238640|NCT00495716|11370102|FG001|STARTED|Overall Study||37
10238641|NCT00495716|11370101|FG000|COMPLETED|Overall Study||20
10238642|NCT00495716|11370102|FG001|COMPLETED|Overall Study||24
10238643|NCT00495716|11370101|FG000|NOT COMPLETED|Overall Study||15
10238644|NCT00495716|11370102|FG001|NOT COMPLETED|Overall Study||13
10238645|NCT00500890|11370110|FG000|STARTED|Overall Study||1
9968290|NCT01519700|11088635|FG003|Treated Cycle 5 EP2006|Overall Study||0
9968291|NCT01519700|11088632|FG000|Treated Cycle 5 Neupogen|Overall Study||0
9968292|NCT01519700|11088633|FG001|Treated Cycle 5 Neupogen|Overall Study||0
10238646|NCT00500890|11370111|FG001|STARTED|Overall Study||1
10238647|NCT00500890|11370110|FG000|COMPLETED|Overall Study||1
10238648|NCT00500890|11370111|FG001|COMPLETED|Overall Study||1
10238649|NCT00500890|11370110|FG000|NOT COMPLETED|Overall Study||0
10238650|NCT00500890|11370111|FG001|NOT COMPLETED|Overall Study||0
10238651|NCT00503841|11370117|FG000|STARTED|Overall Study||44
10238652|NCT00503841|11370117|FG000|COMPLETED|Overall Study||0
10238653|NCT00503841|11370117|FG000|NOT COMPLETED|Overall Study||44
10238654|NCT00493025|11370123|FG000|STARTED|Overall Study||19
10238655|NCT00493025|11370123|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
10238656|NCT00493025|11370123|FG000|NOT COMPLETED|Overall Study||19
10238657|NCT00491400|11370130|FG000|STARTED|Overall Study||15
10198657|NCT03402659|11326910|FG000|STARTED|Overall Study||83
10198658|NCT03402659|11326911|FG001|STARTED|Overall Study||78
10198659|NCT03402659|11326910|FG000|COMPLETED|Overall Study||78
9968293|NCT01519700|11088634|FG002|Treated Cycle 5 Neupogen|Overall Study||48
9968294|NCT01519700|11088635|FG003|Treated Cycle 5 Neupogen|Overall Study||50
9968295|NCT01519700|11088632|FG000|Treated Cycle 6 EP2006|Overall Study||45
9968296|NCT01519700|11088633|FG001|Treated Cycle 6 EP2006|Overall Study||0
9968297|NCT01519700|11088634|FG002|Treated Cycle 6 EP2006|Overall Study||48
9968298|NCT01519700|11088635|FG003|Treated Cycle 6 EP2006|Overall Study||0
9968299|NCT01519700|11088632|FG000|Treated Cycle 6 Neupogen|Overall Study||0
9968300|NCT01519700|11088633|FG001|Treated Cycle 6 Neupogen|Overall Study||49
9968301|NCT01519700|11088634|FG002|Treated Cycle 6 Neupogen|Overall Study||0
9968302|NCT01519700|11088635|FG003|Treated Cycle 6 Neupogen|Overall Study||49
9968303|NCT01519700|11088632|FG000|COMPLETED|Overall Study||45
9968304|NCT01519700|11088633|FG001|COMPLETED|Overall Study||49
9968305|NCT01519700|11088634|FG002|COMPLETED|Overall Study||48
9968306|NCT01519700|11088635|FG003|COMPLETED|Overall Study||47
9968307|NCT01519700|11088632|FG000|NOT COMPLETED|Overall Study||9
9968308|NCT01519700|11088633|FG001|NOT COMPLETED|Overall Study||6
9968309|NCT01519700|11088634|FG002|NOT COMPLETED|Overall Study||7
9968310|NCT01519700|11088635|FG003|NOT COMPLETED|Overall Study||7
9968311|NCT01519713|11088654|FG000|STARTED|Overall Study||194
9968312|NCT01519713|11088655|FG001|STARTED|Overall Study||2
9968313|NCT01519713|11088656|FG002|STARTED|Overall Study||4
9968314|NCT01519713|11088654|FG000|COMPLETED|Overall Study||194
9968315|NCT01519713|11088655|FG001|COMPLETED|Overall Study||2
9968316|NCT01519713|11088656|FG002|COMPLETED|Overall Study||4
9968317|NCT01519713|11088654|FG000|NOT COMPLETED|Overall Study||0
9968318|NCT01519713|11088655|FG001|NOT COMPLETED|Overall Study||0
9968319|NCT01519713|11088656|FG002|NOT COMPLETED|Overall Study||0
9968320|NCT01519765|11088666|FG000|STARTED|Overall Study||37
9968321|NCT01519765|11088667|FG001|STARTED|Overall Study||36
9968322|NCT01519765|11088666|FG000|COMPLETED|Overall Study||34
9968323|NCT01519765|11088667|FG001|COMPLETED|Overall Study||34
9968324|NCT01519765|11088666|FG000|NOT COMPLETED|Overall Study||3
9968325|NCT01519765|11088667|FG001|NOT COMPLETED|Overall Study||2
9968326|NCT01519778|11088674|FG000|STARTED|Overall Study||200
9968327|NCT01519778|11088674|FG000|COMPLETED|Overall Study||186
9968328|NCT01519778|11088674|FG000|NOT COMPLETED|Overall Study||14
9968329|NCT01519791|11088680|FG000|STARTED|Overall Study||219
9968330|NCT01519791|11088681|FG001|STARTED|Overall Study||660
9968331|NCT01519791|11088680|FG000|Completed Week 52|Overall Study||143
9968332|NCT01519791|11088681|FG001|Completed Week 52|Overall Study||500
9968333|NCT01519791|11088680|FG000|COMPLETED|Overall Study||67
9968334|NCT01519791|11088681|FG001|COMPLETED|Overall Study||292
9968335|NCT01519791|11088680|FG000|NOT COMPLETED|Overall Study||152
9968336|NCT01519791|11088681|FG001|NOT COMPLETED|Overall Study||368
9968337|NCT01519817|11088689|FG000|STARTED|Overall Study||4
9968338|NCT01519817|11088690|FG001|STARTED|Overall Study||3
9968339|NCT01519817|11088691|FG002|STARTED|Overall Study||16
9968340|NCT01519817|11088692|FG003|STARTED|Overall Study||11
9968341|NCT01519817|11088689|FG000|COMPLETED|Overall Study||3
9968342|NCT01519817|11088690|FG001|COMPLETED|Overall Study||3
10198660|NCT03402659|11326911|FG001|COMPLETED|Overall Study||73
10198661|NCT03402659|11326910|FG000|NOT COMPLETED|Overall Study||5
10198662|NCT03402659|11326911|FG001|NOT COMPLETED|Overall Study||5
10198663|NCT03402750|11326919|FG000|STARTED|Overall Study||20
10198664|NCT03402750|11326920|FG001|STARTED|Overall Study||20
10198665|NCT03402750|11326919|FG000|COMPLETED|Overall Study||18
10198666|NCT03402750|11326920|FG001|COMPLETED|Overall Study||19
10198667|NCT03402750|11326919|FG000|NOT COMPLETED|Overall Study||2
10198668|NCT03402750|11326920|FG001|NOT COMPLETED|Overall Study||1
10198669|NCT03402893|11326926|FG000|STARTED|Overall Study||21
10198670|NCT03402893|11326926|FG000|COMPLETED|Overall Study||20
10198671|NCT03402893|11326926|FG000|NOT COMPLETED|Overall Study||1
10198672|NCT03402932|11326935|FG000|STARTED|Overall Study||13
10198673|NCT03402932|11326936|FG001|STARTED|Overall Study||8
10198674|NCT03402932|11326937|FG002|STARTED|Overall Study||8
10198675|NCT03402932|11326938|FG003|STARTED|Overall Study||8
10198676|NCT03402932|11326935|FG000|COMPLETED|Overall Study||13
10198677|NCT03402932|11326936|FG001|COMPLETED|Overall Study||8
10198678|NCT03402932|11326937|FG002|COMPLETED|Overall Study||8
10198679|NCT03402932|11326938|FG003|COMPLETED|Overall Study||8
10198680|NCT03402932|11326935|FG000|NOT COMPLETED|Overall Study||0
10198681|NCT03402932|11326936|FG001|NOT COMPLETED|Overall Study||0
10198682|NCT03402932|11326937|FG002|NOT COMPLETED|Overall Study||0
9968343|NCT01519817|11088691|FG002|COMPLETED|Overall Study||16
9968344|NCT01519817|11088692|FG003|COMPLETED|Overall Study||10
9968345|NCT01519817|11088689|FG000|NOT COMPLETED|Overall Study||1
9968346|NCT01519817|11088690|FG001|NOT COMPLETED|Overall Study||0
9968347|NCT01519817|11088691|FG002|NOT COMPLETED|Overall Study||0
9968348|NCT01519817|11088692|FG003|NOT COMPLETED|Overall Study||1
9968349|NCT01519869|11088702|FG000|STARTED|Overall Study||28
9968350|NCT01519869|11088702|FG000|COMPLETED|Overall Study||27
10198683|NCT03402932|11326938|FG003|NOT COMPLETED|Overall Study||0
10198684|NCT03403036|11326952|FG000|STARTED|Overall Study||39
9968351|NCT01519869|11088702|FG000|NOT COMPLETED|Overall Study||1
9968352|NCT01519882|11088708|FG000|STARTED|Overall Study||1
9968353|NCT01519882|11088709|FG001|STARTED|Overall Study||0
9968354|NCT01519882|11088708|FG000|COMPLETED|Overall Study||1
9968355|NCT01519882|11088709|FG001|COMPLETED|Overall Study||0
10198685|NCT03403036|11326952|FG000|COMPLETED|Overall Study||34
9968356|NCT01519882|11088708|FG000|NOT COMPLETED|Overall Study||0
9968357|NCT01519882|11088709|FG001|NOT COMPLETED|Overall Study||0
9968358|NCT01519921|11088717|FG000|STARTED|Overall Study||86
9968359|NCT01519921|11088718|FG001|STARTED|Overall Study||64
9968360|NCT01519921|11088717|FG000|COMPLETED|Overall Study||65
9968361|NCT01519921|11088718|FG001|COMPLETED|Overall Study||49
9968362|NCT01519921|11088717|FG000|NOT COMPLETED|Overall Study||21
9968363|NCT01519921|11088718|FG001|NOT COMPLETED|Overall Study||15
9968364|NCT01519934|11088724|FG000|STARTED|Overall Study||48
9968365|NCT01519934|11088724|FG000|COMPLETED|Overall Study||45
9968366|NCT01519934|11088724|FG000|NOT COMPLETED|Overall Study||3
9968367|NCT01519947|11088732|FG000|STARTED|Overall Study||19
9968368|NCT01519947|11088733|FG001|STARTED|Overall Study||11
9968369|NCT01519947|11088734|FG002|STARTED|Overall Study||15
9968370|NCT01519947|11088735|FG003|STARTED|Overall Study||42
9968371|NCT01519947|11088732|FG000|COMPLETED|Overall Study||17
9968372|NCT01519947|11088733|FG001|COMPLETED|Overall Study||7
9968373|NCT01519947|11088734|FG002|COMPLETED|Overall Study||8
9968374|NCT01519947|11088735|FG003|COMPLETED|Overall Study||34
9968375|NCT01519947|11088732|FG000|NOT COMPLETED|Overall Study||2
9968376|NCT01519947|11088733|FG001|NOT COMPLETED|Overall Study||4
9968377|NCT01519947|11088734|FG002|NOT COMPLETED|Overall Study||7
9968378|NCT01519947|11088735|FG003|NOT COMPLETED|Overall Study||8
9968379|NCT01520038|11088745|FG000|STARTED|Overall Study||2
9968380|NCT01520038|11088745|FG000|COMPLETED|Overall Study||1
9968381|NCT01520038|11088745|FG000|NOT COMPLETED|Overall Study||1
9968382|NCT01520207|11088751|FG000|STARTED|Overall Study||27
9968383|NCT01520207|11088752|FG001|STARTED|Overall Study||25
9968384|NCT01520207|11088751|FG000|COMPLETED|Overall Study||25
9968385|NCT01520207|11088752|FG001|COMPLETED|Overall Study||25
9968386|NCT01520207|11088751|FG000|NOT COMPLETED|Overall Study||2
9968387|NCT01520207|11088752|FG001|NOT COMPLETED|Overall Study||0
9968388|NCT01520324|11088758|FG000|STARTED|Overall Study||53
9968389|NCT01520324|11088758|FG000|COMPLETED|Overall Study||52
9968390|NCT01520324|11088758|FG000|NOT COMPLETED|Overall Study||1
9968391|NCT01520363|11088764|FG000|STARTED|Overall Study||26
9968392|NCT01520363|11088765|FG001|STARTED|Overall Study||26
9968393|NCT01520363|11088764|FG000|COMPLETED|Overall Study||24
9968394|NCT01520363|11088765|FG001|COMPLETED|Overall Study||26
9968395|NCT01520363|11088764|FG000|NOT COMPLETED|Overall Study||2
9968396|NCT01520363|11088765|FG001|NOT COMPLETED|Overall Study||0
9968397|NCT01520402|11088795|FG000|STARTED|Overall Study||35
9968398|NCT01520402|11088795|FG000|COMPLETED|Overall Study||30
9968399|NCT01520402|11088795|FG000|NOT COMPLETED|Overall Study||5
9968400|NCT01520454|11088810|FG000|STARTED|Overall Study||9
9968401|NCT01520454|11088811|FG001|STARTED|Overall Study||6
9968402|NCT01520454|11088812|FG002|STARTED|Overall Study||5
9968403|NCT01520454|11088813|FG003|STARTED|Overall Study||6
9968404|NCT01520454|11088810|FG000|COMPLETED|Overall Study||9
9968405|NCT01520454|11088811|FG001|COMPLETED|Overall Study||6
9968406|NCT01520454|11088812|FG002|COMPLETED|Overall Study||5
9968407|NCT01520454|11088813|FG003|COMPLETED|Overall Study||6
9968408|NCT01520454|11088810|FG000|NOT COMPLETED|Overall Study||0
9968409|NCT01520454|11088811|FG001|NOT COMPLETED|Overall Study||0
9968410|NCT01520454|11088812|FG002|NOT COMPLETED|Overall Study||0
9968411|NCT01520454|11088813|FG003|NOT COMPLETED|Overall Study||0
9968412|NCT01520506|11088826|FG000|STARTED|Overall Study||50
9968413|NCT01520506|11088826|FG000|COMPLETED|Overall Study||44
9968414|NCT01520506|11088826|FG000|NOT COMPLETED|Overall Study||6
9968415|NCT01520519|11088830|FG000|STARTED|Overall Study||40
9968416|NCT01520519|11088830|FG000|COMPLETED|Overall Study||40
9968417|NCT01520519|11088830|FG000|NOT COMPLETED|Overall Study||0
9968418|NCT01520532|11088834|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
9968419|NCT01520532|11088834|FG000|COMPLETED|Overall Study||60
9968420|NCT01520532|11088834|FG000|NOT COMPLETED|Overall Study||0
9968421|NCT01520558|11088841|FG000|STARTED|Overall Study||3
9968422|NCT01520558|11088842|FG001|STARTED|Overall Study||3
9968423|NCT01520558|11088843|FG002|STARTED|Overall Study||6
9968424|NCT01520558|11088841|FG000|COMPLETED|Overall Study||1
9968425|NCT01520558|11088842|FG001|COMPLETED|Overall Study||1
9968426|NCT01520558|11088843|FG002|COMPLETED|Overall Study||3
9968427|NCT01520558|11088841|FG000|NOT COMPLETED|Overall Study||2
9968428|NCT01520558|11088842|FG001|NOT COMPLETED|Overall Study||2
9968429|NCT01520558|11088843|FG002|NOT COMPLETED|Overall Study||3
9968430|NCT01520688|11088851|FG000|STARTED|Overall Study||4
9968431|NCT01520688|11088852|FG001|STARTED|Overall Study||4
9968432|NCT01520688|11088853|FG002|STARTED|Overall Study||4
9968433|NCT01520688|11088854|FG003|STARTED|Overall Study||5
9968434|NCT01520688|11088855|FG004|STARTED|Overall Study||5
9968435|NCT01520688|11088856|FG005|STARTED|Overall Study||5
9968436|NCT01520688|11088857|FG006|STARTED|Overall Study||5
9968437|NCT01520688|11088851|FG000|COMPLETED|Overall Study||4
9968438|NCT01520688|11088852|FG001|COMPLETED|Overall Study||2
9968439|NCT01520688|11088853|FG002|COMPLETED|Overall Study||4
9968440|NCT01520688|11088854|FG003|COMPLETED|Overall Study||4
9968441|NCT01520688|11088855|FG004|COMPLETED|Overall Study||4
9968442|NCT01520688|11088856|FG005|COMPLETED|Overall Study||5
9968443|NCT01520688|11088857|FG006|COMPLETED|Overall Study||0
9968444|NCT01520688|11088851|FG000|NOT COMPLETED|Overall Study||0
9968445|NCT01520688|11088852|FG001|NOT COMPLETED|Overall Study||2
9968446|NCT01520688|11088853|FG002|NOT COMPLETED|Overall Study||0
9968447|NCT01520688|11088854|FG003|NOT COMPLETED|Overall Study||1
9968448|NCT01520688|11088855|FG004|NOT COMPLETED|Overall Study||1
9968449|NCT01520688|11088856|FG005|NOT COMPLETED|Overall Study||0
9968450|NCT01520688|11088857|FG006|NOT COMPLETED|Overall Study||5
9968451|NCT01520727|11088874|FG000|STARTED|Overall Study||6
9968452|NCT01520727|11088875|FG001|STARTED|Overall Study||6
9968453|NCT01520727|11088876|FG002|STARTED|Overall Study||6
9968454|NCT01520727|11088877|FG003|STARTED|Overall Study||6
9968455|NCT01520727|11088878|FG004|STARTED|Overall Study||6
9968456|NCT01520727|11088879|FG005|STARTED|Overall Study||6
9968457|NCT01520727|11088880|FG006|STARTED|Overall Study||6
9968458|NCT01520727|11088881|FG007|STARTED|Overall Study||6
9968459|NCT01520727|11088882|FG008|STARTED|Overall Study||16
9968460|NCT01520727|11088874|FG000|COMPLETED|Overall Study||6
9968461|NCT01520727|11088875|FG001|COMPLETED|Overall Study||6
9968462|NCT01520727|11088876|FG002|COMPLETED|Overall Study||6
9968463|NCT01520727|11088877|FG003|COMPLETED|Overall Study||6
9968464|NCT01520727|11088878|FG004|COMPLETED|Overall Study||6
9968465|NCT01520727|11088879|FG005|COMPLETED|Overall Study||6
9968466|NCT01520727|11088880|FG006|COMPLETED|Overall Study||6
9968467|NCT01520727|11088881|FG007|COMPLETED|Overall Study||6
9968468|NCT01520727|11088882|FG008|COMPLETED|Overall Study||16
9968469|NCT01520727|11088874|FG000|NOT COMPLETED|Overall Study||0
9968470|NCT01520727|11088875|FG001|NOT COMPLETED|Overall Study||0
9968471|NCT01520727|11088876|FG002|NOT COMPLETED|Overall Study||0
9968472|NCT01520727|11088877|FG003|NOT COMPLETED|Overall Study||0
9968473|NCT01520727|11088878|FG004|NOT COMPLETED|Overall Study||0
9968474|NCT01520727|11088879|FG005|NOT COMPLETED|Overall Study||0
9968475|NCT01520727|11088880|FG006|NOT COMPLETED|Overall Study||0
9968476|NCT01520727|11088881|FG007|NOT COMPLETED|Overall Study||0
9968477|NCT01520727|11088882|FG008|NOT COMPLETED|Overall Study||0
9968478|NCT01520870|11088902|FG000|STARTED|Overall Study||49
9968479|NCT01520870|11088902|FG000|COMPLETED|Overall Study||47
9968480|NCT01520870|11088902|FG000|NOT COMPLETED|Overall Study||2
9968481|NCT01520909|11088908|FG000|STARTED|Part 1 (Randomized Period)||29
9968482|NCT01520909|11088909|FG001|STARTED|Part 1 (Randomized Period)||63
9968483|NCT01520909|11088910|FG002|STARTED|Part 1 (Randomized Period)||0
9968484|NCT01520909|11088908|FG000|COMPLETED|Part 1 (Randomized Period)||28
9968485|NCT01520909|11088909|FG001|COMPLETED|Part 1 (Randomized Period)||61
9968486|NCT01520909|11088910|FG002|COMPLETED|Part 1 (Randomized Period)||0
9968487|NCT01520909|11088908|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1
9968488|NCT01520909|11088909|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2
9968489|NCT01520909|11088910|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0
9968490|NCT01520909|11088908|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
9968491|NCT01520909|11088909|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
9968492|NCT01520909|11088910|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
9968493|NCT01520909|11088908|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
9968494|NCT01520909|11088909|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
9968495|NCT01520909|11088910|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
9968496|NCT01520909|11088908|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
9968497|NCT01520909|11088909|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
9968498|NCT01520909|11088910|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
9968499|NCT01520922|11088932|FG000|STARTED|Treatment Phase||44
9968500|NCT01520922|11088933|FG001|STARTED|Treatment Phase||53
9968501|NCT01520922|11088932|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
9968502|NCT01520922|11088933|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
9968503|NCT01520922|11088932|FG000|NOT COMPLETED|Treatment Phase||5
9968504|NCT01520922|11088933|FG001|NOT COMPLETED|Treatment Phase||8
9968505|NCT01520922|11088932|FG000|STARTED|Follow up||44
9968506|NCT01520922|11088933|FG001|STARTED|Follow up||45
9968507|NCT01520922|11088932|FG000|COMPLETED|Follow up||44
9968508|NCT01520922|11088933|FG001|COMPLETED|Follow up||44
9968509|NCT01520922|11088932|FG000|NOT COMPLETED|Follow up||0
9968510|NCT01520922|11088933|FG001|NOT COMPLETED|Follow up||1
9968511|NCT01520922|11088932|FG000|STARTED|Survival Follow-up||21
9968512|NCT01520922|11088933|FG001|STARTED|Survival Follow-up||40
9968513|NCT01520922|11088932|FG000|COMPLETED|Survival Follow-up||20
9968514|NCT01520922|11088933|FG001|COMPLETED|Survival Follow-up||40
9968515|NCT01520922|11088932|FG000|NOT COMPLETED|Survival Follow-up||1
9968516|NCT01520922|11088933|FG001|NOT COMPLETED|Survival Follow-up||0
9968517|NCT01520987|11088947|FG000|STARTED|Overall Study||13
9968518|NCT01520987|11088948|FG001|STARTED|Overall Study||12
9968519|NCT01520987|11088949|FG002|STARTED|Overall Study||11
9968520|NCT01520987|11088950|FG003|STARTED|Overall Study||15
9968521|NCT01520987|11088951|FG004|STARTED|Overall Study||14
9968522|NCT01520987|11088952|FG005|STARTED|Overall Study||14
9968523|NCT01520987|11088953|FG006|STARTED|Overall Study||12
9968524|NCT01520987|11088954|FG007|STARTED|Overall Study||14
9968525|NCT01520987|11088947|FG000|Dosed|Overall Study||13
9968526|NCT01520987|11088948|FG001|Dosed|Overall Study||12
9968527|NCT01520987|11088949|FG002|Dosed|Overall Study||11
9968528|NCT01520987|11088950|FG003|Dosed|Overall Study||15
9968529|NCT01520987|11088951|FG004|Dosed|Overall Study||14
9968530|NCT01520987|11088952|FG005|Dosed|Overall Study||14
9968531|NCT01520987|11088953|FG006|Dosed|Overall Study||12
9968532|NCT01520987|11088954|FG007|Dosed|Overall Study||14
9968533|NCT01520987|11088947|FG000|COMPLETED|Overall Study||12
9968534|NCT01520987|11088948|FG001|COMPLETED|Overall Study||12
9968535|NCT01520987|11088949|FG002|COMPLETED|Overall Study||11
10082381|NCT02267811|11210927|FG001|NOT COMPLETED|Overall Study||2
9968536|NCT01520987|11088950|FG003|COMPLETED|Overall Study||15
9968537|NCT01520987|11088951|FG004|COMPLETED|Overall Study||14
9968538|NCT01520987|11088952|FG005|COMPLETED|Overall Study||13
9968539|NCT01520987|11088953|FG006|COMPLETED|Overall Study||12
9968540|NCT01520987|11088954|FG007|COMPLETED|Overall Study||14
9968541|NCT01520987|11088947|FG000|NOT COMPLETED|Overall Study||1
9968542|NCT01520987|11088948|FG001|NOT COMPLETED|Overall Study||0
9968543|NCT01520987|11088949|FG002|NOT COMPLETED|Overall Study||0
9968544|NCT01520987|11088950|FG003|NOT COMPLETED|Overall Study||0
9968545|NCT01520987|11088951|FG004|NOT COMPLETED|Overall Study||0
9968546|NCT01520987|11088952|FG005|NOT COMPLETED|Overall Study||1
9968547|NCT01520987|11088953|FG006|NOT COMPLETED|Overall Study||0
9968548|NCT01520987|11088954|FG007|NOT COMPLETED|Overall Study||0
9968549|NCT01521026|11088972|FG000|STARTED|Overall Study||38
9968550|NCT01521026|11088973|FG001|STARTED|Overall Study||31
9968551|NCT01521026|11088972|FG000|COMPLETED|Overall Study||23
9968552|NCT01521026|11088973|FG001|COMPLETED|Overall Study||28
9968553|NCT01521026|11088972|FG000|NOT COMPLETED|Overall Study||15
9968554|NCT01521026|11088973|FG001|NOT COMPLETED|Overall Study||3
9968555|NCT01521117|11088979|FG000|STARTED|First Intervention (6 Weeks)||10
9968556|NCT01521117|11088980|FG001|STARTED|First Intervention (6 Weeks)||11
9968557|NCT01521117|11088979|FG000|COMPLETED|First Intervention (6 Weeks)||5
9968558|NCT01521117|11088980|FG001|COMPLETED|First Intervention (6 Weeks)||8
10198686|NCT03403036|11326952|FG000|NOT COMPLETED|Overall Study||5
10198687|NCT03403192|11326960|FG000|STARTED|Overall Study||41
10198688|NCT03403192|11326961|FG001|STARTED|Overall Study||40
10198689|NCT03403192|11326962|FG002|STARTED|Overall Study||40
10198690|NCT03403192|11326963|FG003|STARTED|Overall Study||42
10198691|NCT03403192|11326960|FG000|COMPLETED|Overall Study||37
10198692|NCT03403192|11326961|FG001|COMPLETED|Overall Study||36
10198693|NCT03403192|11326962|FG002|COMPLETED|Overall Study||37
10198694|NCT03403192|11326963|FG003|COMPLETED|Overall Study||36
10198695|NCT03403192|11326960|FG000|NOT COMPLETED|Overall Study||4
10198696|NCT03403192|11326961|FG001|NOT COMPLETED|Overall Study||4
10198697|NCT03403192|11326962|FG002|NOT COMPLETED|Overall Study||3
10198698|NCT03403192|11326963|FG003|NOT COMPLETED|Overall Study||6
10198699|NCT03403231|11326989|FG000|STARTED|Overall Study||9
10198700|NCT03403231|11326990|FG001|STARTED|Overall Study||9
10198701|NCT03403231|11326991|FG002|STARTED|Overall Study||9
10198702|NCT03403231|11326992|FG003|STARTED|Overall Study||9
10198703|NCT03403231|11326993|FG004|STARTED|Overall Study||9
10198704|NCT03403231|11326994|FG005|STARTED|Overall Study||9
10198705|NCT03403231|11326995|FG006|STARTED|Overall Study||9
10198706|NCT03403231|11326996|FG007|STARTED|Overall Study||9
10198707|NCT03403231|11326997|FG008|STARTED|Overall Study||9
10198708|NCT03403231|11326998|FG009|STARTED|Overall Study||9
10198709|NCT03403231|11326999|FG010|STARTED|Overall Study||9
10198710|NCT03403231|11327000|FG011|STARTED|Overall Study||9
10198711|NCT03403231|11327001|FG012|STARTED|Overall Study||9
10198712|NCT03403231|11327002|FG013|STARTED|Overall Study||9
10198713|NCT03403231|11327003|FG014|STARTED|Overall Study||9
10198714|NCT03403231|11327004|FG015|STARTED|Overall Study||9
10198715|NCT03403231|11326989|FG000|COMPLETED|Overall Study||9
10198716|NCT03403231|11326990|FG001|COMPLETED|Overall Study||9
10198717|NCT03403231|11326991|FG002|COMPLETED|Overall Study||9
10198718|NCT03403231|11326992|FG003|COMPLETED|Overall Study||9
10198719|NCT03403231|11326993|FG004|COMPLETED|Overall Study||9
10198720|NCT03403231|11326994|FG005|COMPLETED|Overall Study||9
10198721|NCT03403231|11326995|FG006|COMPLETED|Overall Study||9
10198722|NCT03403231|11326996|FG007|COMPLETED|Overall Study||9
10198723|NCT03403231|11326997|FG008|COMPLETED|Overall Study||9
10198724|NCT03403231|11326998|FG009|COMPLETED|Overall Study||9
10198725|NCT03403231|11326999|FG010|COMPLETED|Overall Study||9
10198726|NCT03403231|11327000|FG011|COMPLETED|Overall Study||9
10198727|NCT03403231|11327001|FG012|COMPLETED|Overall Study||9
10198728|NCT03403231|11327002|FG013|COMPLETED|Overall Study||9
10198729|NCT03403231|11327003|FG014|COMPLETED|Overall Study||9
10198730|NCT03403231|11327004|FG015|COMPLETED|Overall Study||9
10198731|NCT03403231|11326989|FG000|NOT COMPLETED|Overall Study||0
10198732|NCT03403231|11326990|FG001|NOT COMPLETED|Overall Study||0
10198733|NCT03403231|11326991|FG002|NOT COMPLETED|Overall Study||0
10198734|NCT03403231|11326992|FG003|NOT COMPLETED|Overall Study||0
10198735|NCT03403231|11326993|FG004|NOT COMPLETED|Overall Study||0
10198736|NCT03403231|11326994|FG005|NOT COMPLETED|Overall Study||0
10198737|NCT03403231|11326995|FG006|NOT COMPLETED|Overall Study||0
9968559|NCT01521117|11088979|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5
9968560|NCT01521117|11088980|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
9968561|NCT01521117|11088979|FG000|STARTED|Washout (4 Weeks)||5
9968562|NCT01521117|11088980|FG001|STARTED|Washout (4 Weeks)||8
9968563|NCT01521117|11088979|FG000|COMPLETED|Washout (4 Weeks)||5
9968564|NCT01521117|11088980|FG001|COMPLETED|Washout (4 Weeks)||8
9968565|NCT01521117|11088979|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9968566|NCT01521117|11088980|FG001|NOT COMPLETED|Washout (4 Weeks)||0
9968567|NCT01521117|11088979|FG000|STARTED|Second Intervention (6 Weeks)||5
10198738|NCT03403231|11326996|FG007|NOT COMPLETED|Overall Study||0
10198739|NCT03403231|11326997|FG008|NOT COMPLETED|Overall Study||0
10198740|NCT03403231|11326998|FG009|NOT COMPLETED|Overall Study||0
10198741|NCT03403231|11326999|FG010|NOT COMPLETED|Overall Study||0
10198742|NCT03403231|11327000|FG011|NOT COMPLETED|Overall Study||0
10198743|NCT03403231|11327001|FG012|NOT COMPLETED|Overall Study||0
10198744|NCT03403231|11327002|FG013|NOT COMPLETED|Overall Study||0
10198745|NCT03403231|11327003|FG014|NOT COMPLETED|Overall Study||0
9968568|NCT01521117|11088980|FG001|STARTED|Second Intervention (6 Weeks)||8
9968569|NCT01521117|11088979|FG000|COMPLETED|Second Intervention (6 Weeks)||5
9968570|NCT01521117|11088980|FG001|COMPLETED|Second Intervention (6 Weeks)||5
9968571|NCT01521117|11088979|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9968572|NCT01521117|11088980|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
9968573|NCT01521260|11088988|FG000|STARTED|Overall Study||15
9968574|NCT01521260|11088989|FG001|STARTED|Overall Study||15
9968575|NCT01521260|11088988|FG000|COMPLETED|Overall Study||15
9968576|NCT01521260|11088989|FG001|COMPLETED|Overall Study||15
9968577|NCT01521260|11088988|FG000|NOT COMPLETED|Overall Study||0
9968578|NCT01521260|11088989|FG001|NOT COMPLETED|Overall Study||0
9968579|NCT01521364|11088995|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7
9968580|NCT01521364|11088995|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
9968581|NCT01521364|11088995|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
10198746|NCT03403231|11327004|FG015|NOT COMPLETED|Overall Study||0
10198747|NCT03403374|11327038|FG000|STARTED|Overall Study||30
10198748|NCT03403374|11327038|FG000|COMPLETED|Overall Study||29
10198749|NCT03403374|11327038|FG000|NOT COMPLETED|Overall Study||1
10198750|NCT03403400|11327045|FG000|STARTED|Overall Study||5
10198751|NCT03403400|11327046|FG001|STARTED|Overall Study||6
10198752|NCT03403400|11327047|FG002|STARTED|Overall Study||6
10198753|NCT03403400|11327045|FG000|COMPLETED|Overall Study||3
10198754|NCT03403400|11327046|FG001|COMPLETED|Overall Study||6
10198755|NCT03403400|11327047|FG002|COMPLETED|Overall Study||4
10198756|NCT03403400|11327045|FG000|NOT COMPLETED|Overall Study||2
10198757|NCT03403400|11327046|FG001|NOT COMPLETED|Overall Study||0
10198758|NCT03403400|11327047|FG002|NOT COMPLETED|Overall Study||2
10198759|NCT03403413|11327070|FG000|STARTED|Overall Study||5
10198760|NCT03403413|11327070|FG000|COMPLETED|Overall Study||3
10198761|NCT03403413|11327070|FG000|NOT COMPLETED|Overall Study||2
10198762|NCT03403426|11327076|FG000|STARTED|Overall Study||85
10198763|NCT03403426|11327076|FG000|COMPLETED|Overall Study||82
10198764|NCT03403426|11327076|FG000|NOT COMPLETED|Overall Study||3
10198765|NCT03403491|11327080|FG000|STARTED|Overall Study||20
10198766|NCT03403491|11327081|FG001|STARTED|Overall Study||23
10198767|NCT03403491|11327080|FG000|COMPLETED|Overall Study||17
10198768|NCT03403491|11327081|FG001|COMPLETED|Overall Study||18
10198769|NCT03403491|11327080|FG000|NOT COMPLETED|Overall Study||3
10198770|NCT03403491|11327081|FG001|NOT COMPLETED|Overall Study||5
10198771|NCT03403504|11327090|FG000|STARTED|Period 1||12
10198772|NCT03403504|11327091|FG001|STARTED|Period 1||12
10198773|NCT03403504|11327090|FG000|COMPLETED|Period 1||12
10198774|NCT03403504|11327091|FG001|COMPLETED|Period 1||11
10198775|NCT03403504|11327090|FG000|NOT COMPLETED|Period 1||0
10198776|NCT03403504|11327091|FG001|NOT COMPLETED|Period 1||1
10198777|NCT03403504|11327090|FG000|STARTED|Period 2||12
10198778|NCT03403504|11327091|FG001|STARTED|Period 2||11
10198779|NCT03403504|11327090|FG000|COMPLETED|Period 2||12
10198780|NCT03403504|11327091|FG001|COMPLETED|Period 2||11
10198781|NCT03403504|11327090|FG000|NOT COMPLETED|Period 2||0
10198782|NCT03403504|11327091|FG001|NOT COMPLETED|Period 2||0
10198783|NCT03403517|11327113|FG000|STARTED|Overall Study||88
10198784|NCT03403517|11327114|FG001|STARTED|Overall Study||86
10198785|NCT03403517|11327113|FG000|COMPLETED|Overall Study||88
10198786|NCT03403517|11327114|FG001|COMPLETED|Overall Study||86
10198787|NCT03403517|11327113|FG000|NOT COMPLETED|Overall Study||0
10198788|NCT03403517|11327114|FG001|NOT COMPLETED|Overall Study||0
10198789|NCT03403712|11327122|FG000|STARTED|Overall Study||200
10198790|NCT03403712|11327123|FG001|STARTED|Overall Study||202
10198791|NCT03403712|11327122|FG000|COMPLETED|Overall Study||95
10198792|NCT03403712|11327123|FG001|COMPLETED|Overall Study||102
10198793|NCT03403712|11327122|FG000|NOT COMPLETED|Overall Study||105
10198794|NCT03403712|11327123|FG001|NOT COMPLETED|Overall Study||100
10198795|NCT03403725|11327140|FG000|STARTED|Overall Study||1
10198796|NCT03403725|11327141|FG001|STARTED|Overall Study||1
10198797|NCT03403725|11327142|FG002|STARTED|Overall Study||1
10198798|NCT03403725|11327143|FG003|STARTED|Overall Study||1
10198799|NCT03403725|11327144|FG004|STARTED|Overall Study||1
10198800|NCT03403725|11327145|FG005|STARTED|Overall Study||6
10198801|NCT03403725|11327146|FG006|STARTED|Overall Study||6
10198802|NCT03403725|11327147|FG007|STARTED|Overall Study||3
10198803|NCT03403725|11327148|FG008|STARTED|Overall Study||3
10198804|NCT03403725|11327149|FG009|STARTED|Overall Study||4
10198805|NCT03403725|11327150|FG010|STARTED|Overall Study||1
10198806|NCT03403725|11327140|FG000|COMPLETED|Overall Study||1
10198807|NCT03403725|11327141|FG001|COMPLETED|Overall Study||1
10198808|NCT03403725|11327142|FG002|COMPLETED|Overall Study||1
9968582|NCT01521364|11088995|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
9968583|NCT01521364|11088995|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
10198809|NCT03403725|11327143|FG003|COMPLETED|Overall Study||1
10198810|NCT03403725|11327144|FG004|COMPLETED|Overall Study||1
10198811|NCT03403725|11327145|FG005|COMPLETED|Overall Study||6
10198812|NCT03403725|11327146|FG006|COMPLETED|Overall Study||6
10198813|NCT03403725|11327147|FG007|COMPLETED|Overall Study||3
10198814|NCT03403725|11327148|FG008|COMPLETED|Overall Study||3
10198815|NCT03403725|11327149|FG009|COMPLETED|Overall Study||4
10198816|NCT03403725|11327150|FG010|COMPLETED|Overall Study||1
10198817|NCT03403725|11327140|FG000|NOT COMPLETED|Overall Study||0
10198818|NCT03403725|11327141|FG001|NOT COMPLETED|Overall Study||0
10198819|NCT03403725|11327142|FG002|NOT COMPLETED|Overall Study||0
10198820|NCT03403725|11327143|FG003|NOT COMPLETED|Overall Study||0
10198821|NCT03403725|11327144|FG004|NOT COMPLETED|Overall Study||0
9968584|NCT01521364|11088995|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
9968585|NCT01521364|11088995|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
9968586|NCT01521364|11088995|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
9968587|NCT01521364|11088995|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
9968588|NCT01521494|11089011|FG000|STARTED|Overall Study||39
9968589|NCT01521494|11089012|FG001|STARTED|Overall Study||36
9968590|NCT01521494|11089013|FG002|STARTED|Overall Study||35
9968591|NCT01521494|11089014|FG003|STARTED|Overall Study||36
9968592|NCT01521494|11089015|FG004|STARTED|Overall Study||37
9968593|NCT01521494|11089011|FG000|COMPLETED|Overall Study||37
9968594|NCT01521494|11089012|FG001|COMPLETED|Overall Study||31
10198822|NCT03403725|11327145|FG005|NOT COMPLETED|Overall Study||0
10198823|NCT03403725|11327146|FG006|NOT COMPLETED|Overall Study||0
10198824|NCT03403725|11327147|FG007|NOT COMPLETED|Overall Study||0
10198825|NCT03403725|11327148|FG008|NOT COMPLETED|Overall Study||0
10198826|NCT03403725|11327149|FG009|NOT COMPLETED|Overall Study||0
10198827|NCT03403725|11327150|FG010|NOT COMPLETED|Overall Study||0
10198828|NCT03403751|11327178|FG000|STARTED|Overall Study||28
10198829|NCT03403751|11327179|FG001|STARTED|Overall Study||30
10198830|NCT03403751|11327178|FG000|COMPLETED|Overall Study||21
10198831|NCT03403751|11327179|FG001|COMPLETED|Overall Study||22
10198832|NCT03403751|11327178|FG000|NOT COMPLETED|Overall Study||7
10198833|NCT03403751|11327179|FG001|NOT COMPLETED|Overall Study||8
10198834|NCT03404167|11327187|FG000|STARTED|Overall Study||8
10198835|NCT03404167|11327187|FG000|COMPLETED|Overall Study||8
10198836|NCT03404167|11327187|FG000|NOT COMPLETED|Overall Study||0
10198837|NCT03404206|11327196|FG000|STARTED|Overall Study||166
10198838|NCT03404206|11327197|FG001|STARTED|Overall Study||166
10198839|NCT03404206|11327198|FG002|STARTED|Overall Study||55
10198840|NCT03404206|11327196|FG000|COMPLETED|Overall Study||162
10198841|NCT03404206|11327197|FG001|COMPLETED|Overall Study||164
10198842|NCT03404206|11327198|FG002|COMPLETED|Overall Study||55
10198843|NCT03404206|11327196|FG000|NOT COMPLETED|Overall Study||4
10198844|NCT03404206|11327197|FG001|NOT COMPLETED|Overall Study||2
10198845|NCT03404206|11327198|FG002|NOT COMPLETED|Overall Study||0
10198846|NCT03404219|11327206|FG000|STARTED|Overall Study||31
10198847|NCT03404219|11327206|FG000|COMPLETED|Overall Study||31
10198848|NCT03404219|11327206|FG000|NOT COMPLETED|Overall Study||0
10198849|NCT03404375|11327213|FG000|STARTED|Overall Study||70
10198850|NCT03404375|11327214|FG001|STARTED|Overall Study||172
10198851|NCT03404375|11327213|FG000|COMPLETED|Overall Study||70
10198852|NCT03404375|11327214|FG001|COMPLETED|Overall Study||172
10198853|NCT03404375|11327213|FG000|NOT COMPLETED|Overall Study||0
10198854|NCT03404375|11327214|FG001|NOT COMPLETED|Overall Study||0
10198855|NCT03404401|11327222|FG000|STARTED|Overall Study||281
10198856|NCT03404401|11327223|FG001|STARTED|Overall Study||271
10198857|NCT03404401|11327222|FG000|COMPLETED|Overall Study||263
10198858|NCT03404401|11327223|FG001|COMPLETED|Overall Study||252
10198859|NCT03404401|11327222|FG000|NOT COMPLETED|Overall Study||18
10198860|NCT03404401|11327223|FG001|NOT COMPLETED|Overall Study||19
10198861|NCT03404609|11327229|FG000|STARTED|Overall Study||7
10198862|NCT03404609|11327229|FG000|COMPLETED|Overall Study||7
10198863|NCT03404609|11327229|FG000|NOT COMPLETED|Overall Study||0
10198864|NCT03404648|11327233|FG000|STARTED|Overall Study||19
10198865|NCT03404648|11327233|FG000|COMPLETED|Overall Study||19
10198866|NCT03404648|11327233|FG000|NOT COMPLETED|Overall Study||0
10198867|NCT03404674|11327243|FG000|STARTED|Overall Study||5
10198868|NCT03404674|11327244|FG001|STARTED|Overall Study||5
10198869|NCT03404674|11327245|FG002|STARTED|Overall Study||10
10198870|NCT03404674|11327246|FG003|STARTED|Overall Study||10
10198871|NCT03404674|11327247|FG004|STARTED|Overall Study||10
10198872|NCT03404674|11327248|FG005|STARTED|Overall Study||10
10198873|NCT03404674|11327243|FG000|Received Dose 2|Overall Study||5
9968595|NCT01521494|11089013|FG002|COMPLETED|Overall Study||23
9968596|NCT01521494|11089014|FG003|COMPLETED|Overall Study||15
9968597|NCT01521494|11089015|FG004|COMPLETED|Overall Study||30
9968598|NCT01521494|11089011|FG000|NOT COMPLETED|Overall Study||2
10198874|NCT03404674|11327244|FG001|Received Dose 2|Overall Study||4
10198875|NCT03404674|11327245|FG002|Received Dose 2|Overall Study||10
10198876|NCT03404674|11327246|FG003|Received Dose 2|Overall Study||9
10198877|NCT03404674|11327247|FG004|Received Dose 2|Overall Study||10
10198878|NCT03404674|11327248|FG005|Received Dose 2|Overall Study||10
10198879|NCT03404674|11327243|FG000|Received Dose 3|Overall Study||5
10198880|NCT03404674|11327244|FG001|Received Dose 3|Overall Study||4
10198881|NCT03404674|11327245|FG002|Received Dose 3|Overall Study||9
10198882|NCT03404674|11327246|FG003|Received Dose 3|Overall Study||9
10198883|NCT03404674|11327247|FG004|Received Dose 3|Overall Study||10
10198884|NCT03404674|11327248|FG005|Received Dose 3|Overall Study||9
10198885|NCT03404674|11327243|FG000|COMPLETED|Overall Study||5
10198886|NCT03404674|11327244|FG001|COMPLETED|Overall Study||4
10198887|NCT03404674|11327245|FG002|COMPLETED|Overall Study||8
10198888|NCT03404674|11327246|FG003|COMPLETED|Overall Study||9
10198889|NCT03404674|11327247|FG004|COMPLETED|Overall Study||10
10198890|NCT03404674|11327248|FG005|COMPLETED|Overall Study||9
9968599|NCT01521494|11089012|FG001|NOT COMPLETED|Overall Study||5
9968600|NCT01521494|11089013|FG002|NOT COMPLETED|Overall Study||12
9968601|NCT01521494|11089014|FG003|NOT COMPLETED|Overall Study||21
10198891|NCT03404674|11327243|FG000|NOT COMPLETED|Overall Study||0
10198892|NCT03404674|11327244|FG001|NOT COMPLETED|Overall Study||1
10198893|NCT03404674|11327245|FG002|NOT COMPLETED|Overall Study||2
10198894|NCT03404674|11327246|FG003|NOT COMPLETED|Overall Study||1
9968602|NCT01521494|11089015|FG004|NOT COMPLETED|Overall Study||7
9968603|NCT01521507|11089029|FG000|STARTED|Stage 1: Randomized Design||101
9968604|NCT01521507|11089030|FG001|STARTED|Stage 1: Randomized Design||99
9968605|NCT01521507|11089029|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
10198895|NCT03404674|11327247|FG004|NOT COMPLETED|Overall Study||0
10198896|NCT03404674|11327248|FG005|NOT COMPLETED|Overall Study||1
10198897|NCT03404843|11327265|FG000|STARTED|Overall Study||17
10198898|NCT03404843|11327266|FG001|STARTED|Overall Study||14
10198899|NCT03404843|11327265|FG000|COMPLETED|Overall Study||13
10198900|NCT03404843|11327266|FG001|COMPLETED|Overall Study||13
10198901|NCT03404843|11327265|FG000|NOT COMPLETED|Overall Study||4
10198902|NCT03404843|11327266|FG001|NOT COMPLETED|Overall Study||1
10198903|NCT03405259|11327278|FG000|STARTED|Overall Study||11
10198904|NCT03405259|11327279|FG001|STARTED|Overall Study||11
10198905|NCT03405259|11327278|FG000|COMPLETED|Overall Study||11
10198906|NCT03405259|11327279|FG001|COMPLETED|Overall Study||11
10198907|NCT03405259|11327278|FG000|NOT COMPLETED|Overall Study||0
10198908|NCT03405259|11327279|FG001|NOT COMPLETED|Overall Study||0
10198909|NCT03405363|11327287|FG000|STARTED|Overall Study||14239
10198910|NCT03405363|11327288|FG001|STARTED|Overall Study||51167
10198911|NCT03405363|11327287|FG000|COMPLETED|Overall Study||14239
10198912|NCT03405363|11327288|FG001|COMPLETED|Overall Study||51167
10198913|NCT03405363|11327287|FG000|NOT COMPLETED|Overall Study||0
10198914|NCT03405363|11327288|FG001|NOT COMPLETED|Overall Study||0
10198915|NCT03405818|11327294|FG000|STARTED|Overall Study||55
10198916|NCT03405818|11327294|FG000|COMPLETED|Overall Study||47
10198917|NCT03405818|11327294|FG000|NOT COMPLETED|Overall Study||8
10198918|NCT03405935|11327298|FG000|STARTED|Overall Study||86
10198919|NCT03405935|11327298|FG000|COMPLETED|Overall Study||78
10198920|NCT03405935|11327298|FG000|NOT COMPLETED|Overall Study||8
10198921|NCT03406260|11327308|FG000|STARTED|Period 1||6
10198922|NCT03406260|11327309|FG001|STARTED|Period 1||6
10198923|NCT03406260|11327310|FG002|STARTED|Period 1||6
10198924|NCT03406260|11327311|FG003|STARTED|Period 1||6
10198925|NCT03406260|11327312|FG004|STARTED|Period 1||6
10198926|NCT03406260|11327313|FG005|STARTED|Period 1||6
10198927|NCT03406260|11327308|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
10198928|NCT03406260|11327309|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
10198929|NCT03406260|11327310|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
10198930|NCT03406260|11327311|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10198931|NCT03406260|11327312|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
10198932|NCT03406260|11327313|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
10198933|NCT03406260|11327308|FG000|COMPLETED|Period 1||6
10198934|NCT03406260|11327309|FG001|COMPLETED|Period 1||6
10198935|NCT03406260|11327310|FG002|COMPLETED|Period 1||6
10198936|NCT03406260|11327311|FG003|COMPLETED|Period 1||6
10198937|NCT03406260|11327312|FG004|COMPLETED|Period 1||5
10198938|NCT03406260|11327313|FG005|COMPLETED|Period 1||6
10198939|NCT03406260|11327308|FG000|NOT COMPLETED|Period 1||0
10198940|NCT03406260|11327309|FG001|NOT COMPLETED|Period 1||0
10198941|NCT03406260|11327310|FG002|NOT COMPLETED|Period 1||0
10198942|NCT03406260|11327311|FG003|NOT COMPLETED|Period 1||0
10198943|NCT03406260|11327312|FG004|NOT COMPLETED|Period 1||1
10198944|NCT03406260|11327313|FG005|NOT COMPLETED|Period 1||0
10198945|NCT03406260|11327308|FG000|STARTED|Period 2||6
10198946|NCT03406260|11327309|FG001|STARTED|Period 2||6
10198947|NCT03406260|11327310|FG002|STARTED|Period 2||6
10198948|NCT03406260|11327311|FG003|STARTED|Period 2||6
10198949|NCT03406260|11327312|FG004|STARTED|Period 2||5
10198950|NCT03406260|11327313|FG005|STARTED|Period 2||6
10198951|NCT03406260|11327308|FG000|COMPLETED|Period 2||6
10198952|NCT03406260|11327309|FG001|COMPLETED|Period 2||6
10198953|NCT03406260|11327310|FG002|COMPLETED|Period 2||6
10198954|NCT03406260|11327311|FG003|COMPLETED|Period 2||6
9968606|NCT01521507|11089030|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
9968607|NCT01521507|11089029|FG000|COMPLETED|Stage 1: Randomized Design||98
9968608|NCT01521507|11089030|FG001|COMPLETED|Stage 1: Randomized Design||94
10198955|NCT03406260|11327312|FG004|COMPLETED|Period 2||5
10198956|NCT03406260|11327313|FG005|COMPLETED|Period 2||6
10198957|NCT03406260|11327308|FG000|NOT COMPLETED|Period 2||0
10198958|NCT03406260|11327309|FG001|NOT COMPLETED|Period 2||0
10198959|NCT03406260|11327310|FG002|NOT COMPLETED|Period 2||0
10198960|NCT03406260|11327311|FG003|NOT COMPLETED|Period 2||0
10198961|NCT03406260|11327312|FG004|NOT COMPLETED|Period 2||0
10198962|NCT03406260|11327313|FG005|NOT COMPLETED|Period 2||0
10198963|NCT03406260|11327308|FG000|STARTED|Period 3||6
10198964|NCT03406260|11327309|FG001|STARTED|Period 3||6
10198965|NCT03406260|11327310|FG002|STARTED|Period 3||6
10198966|NCT03406260|11327311|FG003|STARTED|Period 3||6
10198967|NCT03406260|11327312|FG004|STARTED|Period 3||5
10198968|NCT03406260|11327313|FG005|STARTED|Period 3||6
10198969|NCT03406260|11327308|FG000|COMPLETED|Period 3||6
10198970|NCT03406260|11327309|FG001|COMPLETED|Period 3||6
10198971|NCT03406260|11327310|FG002|COMPLETED|Period 3||6
10198972|NCT03406260|11327311|FG003|COMPLETED|Period 3||6
10198973|NCT03406260|11327312|FG004|COMPLETED|Period 3||5
10198974|NCT03406260|11327313|FG005|COMPLETED|Period 3||6
10198975|NCT03406260|11327308|FG000|NOT COMPLETED|Period 3||0
10198976|NCT03406260|11327309|FG001|NOT COMPLETED|Period 3||0
10198977|NCT03406260|11327310|FG002|NOT COMPLETED|Period 3||0
10198978|NCT03406260|11327311|FG003|NOT COMPLETED|Period 3||0
10198979|NCT03406260|11327312|FG004|NOT COMPLETED|Period 3||0
10198980|NCT03406260|11327313|FG005|NOT COMPLETED|Period 3||0
10198981|NCT03406325|11327331|FG000|STARTED|Overall Study||12
9968609|NCT01521507|11089029|FG000|NOT COMPLETED|Stage 1: Randomized Design||3
9968610|NCT01521507|11089030|FG001|NOT COMPLETED|Stage 1: Randomized Design||5
10082382|NCT02267824|11210937|FG000|STARTED|Overall Study||83
10082383|NCT02267824|11210938|FG001|STARTED|Overall Study||18
10198982|NCT03406325|11327332|FG001|STARTED|Overall Study||1
10198983|NCT03406325|11327333|FG002|STARTED|Overall Study||1
10198984|NCT03406325|11327334|FG003|STARTED|Overall Study||1
10198985|NCT03406325|11327335|FG004|STARTED|Overall Study||1
10198986|NCT03406325|11327336|FG005|STARTED|Overall Study||1
10198987|NCT03406325|11327337|FG006|STARTED|Overall Study||1
10198988|NCT03406325|11327338|FG007|STARTED|Overall Study||1
10198989|NCT03406325|11327331|FG000|COMPLETED|Overall Study||12
10198990|NCT03406325|11327332|FG001|COMPLETED|Overall Study||1
9968611|NCT01521507|11089029|FG000|STARTED|Stage 2: Observational Design||98
9968612|NCT01521507|11089030|FG001|STARTED|Stage 2: Observational Design||94
9968613|NCT01521507|11089029|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
9968614|NCT01521507|11089030|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
9968615|NCT01521507|11089029|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
9968616|NCT01521507|11089030|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
9968617|NCT01521507|11089029|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
9968618|NCT01521507|11089030|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
9968619|NCT01521507|11089029|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
9968620|NCT01521507|11089030|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
9968621|NCT01521507|11089029|FG000|COMPLETED|Stage 2: Observational Design||94
9968622|NCT01521507|11089030|FG001|COMPLETED|Stage 2: Observational Design||92
9968623|NCT01521507|11089029|FG000|NOT COMPLETED|Stage 2: Observational Design||4
9968624|NCT01521507|11089030|FG001|NOT COMPLETED|Stage 2: Observational Design||2
9968625|NCT01521546|11089045|FG000|STARTED|Overall Study||22
9968626|NCT01521546|11089046|FG001|STARTED|Overall Study||20
9968627|NCT01521546|11089045|FG000|COMPLETED|Overall Study||20
9968628|NCT01521546|11089046|FG001|COMPLETED|Overall Study||20
9968629|NCT01521546|11089045|FG000|NOT COMPLETED|Overall Study||2
9968630|NCT01521546|11089046|FG001|NOT COMPLETED|Overall Study||0
9968631|NCT01521559|11089054|FG000|STARTED|Overall Study||92
9968632|NCT01521559|11089055|FG001|STARTED|Overall Study||91
9968633|NCT01521559|11089054|FG000|Completed Week 24|Overall Study||83
9968634|NCT01521559|11089055|FG001|Completed Week 24|Overall Study||85
9968635|NCT01521559|11089054|FG000|Completed Week 52|Overall Study||77
9968636|NCT01521559|11089055|FG001|Completed Week 52|Overall Study||73
9968637|NCT01521559|11089054|FG000|COMPLETED|Overall Study||77
9968638|NCT01521559|11089055|FG001|COMPLETED|Overall Study||73
9968639|NCT01521559|11089054|FG000|NOT COMPLETED|Overall Study||15
9968640|NCT01521559|11089055|FG001|NOT COMPLETED|Overall Study||18
9968641|NCT01521780|11089062|FG000|STARTED|Overall Study||9
9968642|NCT01521780|11089063|FG001|STARTED|Overall Study||1
9968643|NCT01521780|11089064|FG002|STARTED|Overall Study||2
9968644|NCT01521780|11089062|FG000|COMPLETED|Overall Study||9
9968645|NCT01521780|11089063|FG001|COMPLETED|Overall Study||1
9968646|NCT01521780|11089064|FG002|COMPLETED|Overall Study||2
9968647|NCT01521780|11089062|FG000|NOT COMPLETED|Overall Study||0
9968648|NCT01521780|11089063|FG001|NOT COMPLETED|Overall Study||0
9968649|NCT01521780|11089064|FG002|NOT COMPLETED|Overall Study||0
9968650|NCT01521845|11089075|FG000|STARTED|Overall Study||52
9968651|NCT01521845|11089076|FG001|STARTED|Overall Study||52
9968652|NCT01521845|11089075|FG000|COMPLETED|Overall Study||43
9968653|NCT01521845|11089076|FG001|COMPLETED|Overall Study||47
9968654|NCT01521845|11089075|FG000|NOT COMPLETED|Overall Study||9
9968655|NCT01521845|11089076|FG001|NOT COMPLETED|Overall Study||5
9968656|NCT01521871|11089084|FG000|STARTED|Overall Study||32
9968657|NCT01521871|11089085|FG001|STARTED|Overall Study||32
9968658|NCT01521871|11089084|FG000|COMPLETED|Overall Study||32
9968659|NCT01521871|11089085|FG001|COMPLETED|Overall Study||32
9968660|NCT01521871|11089084|FG000|NOT COMPLETED|Overall Study||0
9968661|NCT01521871|11089085|FG001|NOT COMPLETED|Overall Study||0
9968662|NCT01521884|11089091|FG000|STARTED|Overall Study||62
9968663|NCT01521884|11089091|FG000|COMPLETED|Overall Study||35
9968664|NCT01521884|11089091|FG000|NOT COMPLETED|Overall Study||27
9968665|NCT01521897|11089095|FG000|STARTED|Overall Study||1143
9968666|NCT01521897|11089095|FG000|COMPLETED|Overall Study||1120
9968667|NCT01521897|11089095|FG000|NOT COMPLETED|Overall Study||23
9968668|NCT01521923|11089103|FG000|STARTED|Overall Study||66
9968669|NCT01521923|11089104|FG001|STARTED|Overall Study||81
9968670|NCT01521923|11089105|FG002|STARTED|Overall Study||127
9968671|NCT01521923|11089106|FG003|STARTED|Overall Study||83
9968672|NCT01521923|11089103|FG000|COMPLETED|Overall Study||59
10198991|NCT03406325|11327333|FG002|COMPLETED|Overall Study||1
10198992|NCT03406325|11327334|FG003|COMPLETED|Overall Study||1
10198993|NCT03406325|11327335|FG004|COMPLETED|Overall Study||1
10198994|NCT03406325|11327336|FG005|COMPLETED|Overall Study||1
10198995|NCT03406325|11327337|FG006|COMPLETED|Overall Study||1
9968673|NCT01521923|11089104|FG001|COMPLETED|Overall Study||72
9968674|NCT01521923|11089105|FG002|COMPLETED|Overall Study||112
9968675|NCT01521923|11089106|FG003|COMPLETED|Overall Study||70
9968676|NCT01521923|11089103|FG000|NOT COMPLETED|Overall Study||7
10198996|NCT03406325|11327338|FG007|COMPLETED|Overall Study||1
10198997|NCT03406325|11327331|FG000|NOT COMPLETED|Overall Study||0
10198998|NCT03406325|11327332|FG001|NOT COMPLETED|Overall Study||0
10198999|NCT03406325|11327333|FG002|NOT COMPLETED|Overall Study||0
9968677|NCT01521923|11089104|FG001|NOT COMPLETED|Overall Study||9
9968678|NCT01521923|11089105|FG002|NOT COMPLETED|Overall Study||15
9968679|NCT01521923|11089106|FG003|NOT COMPLETED|Overall Study||13
9968680|NCT01521949|11089119|FG000|STARTED|Overall Study||21
9968681|NCT01521949|11089119|FG000|COMPLETED|Overall Study||21
9968682|NCT01521949|11089119|FG000|NOT COMPLETED|Overall Study||0
9968683|NCT01522131|11089125|FG000|STARTED|Overall Study||16
9968684|NCT01522131|11089126|FG001|STARTED|Overall Study||17
9968685|NCT01522131|11089125|FG000|COMPLETED|Overall Study||14
9968686|NCT01522131|11089126|FG001|COMPLETED|Overall Study||17
9968687|NCT01522131|11089125|FG000|NOT COMPLETED|Overall Study||2
9968688|NCT01522131|11089126|FG001|NOT COMPLETED|Overall Study||0
9968689|NCT01522235|11089134|FG000|STARTED|Overall Study||3
9968690|NCT01522235|11089135|FG001|STARTED|Overall Study||3
9968691|NCT01522235|11089134|FG000|Randomized|Overall Study||2
9968692|NCT01522235|11089135|FG001|Randomized|Overall Study||3
9968693|NCT01522235|11089134|FG000|COMPLETED|Overall Study||2
9968694|NCT01522235|11089135|FG001|COMPLETED|Overall Study||2
9968695|NCT01522235|11089134|FG000|NOT COMPLETED|Overall Study||1
9968696|NCT01522235|11089135|FG001|NOT COMPLETED|Overall Study||1
9968697|NCT01522248|11089147|FG000|STARTED|Overall Study||10
9968698|NCT01522248|11089148|FG001|STARTED|Overall Study||10
9968699|NCT01522248|11089147|FG000|COMPLETED|Overall Study||9
9968700|NCT01522248|11089148|FG001|COMPLETED|Overall Study||10
9968701|NCT01522248|11089147|FG000|NOT COMPLETED|Overall Study||1
9968702|NCT01522248|11089148|FG001|NOT COMPLETED|Overall Study||0
9968703|NCT01522339|11089159|FG000|STARTED|Overall Study||15
9968704|NCT01522339|11089159|FG000|COMPLETED|Overall Study||15
9968705|NCT01522339|11089159|FG000|NOT COMPLETED|Overall Study||0
9968706|NCT01522391|11089166|FG000|STARTED|Overall Study||20
9968707|NCT01522391|11089167|FG001|STARTED|Overall Study||21
9968708|NCT01522391|11089166|FG000|COMPLETED|Overall Study||19
9968709|NCT01522391|11089167|FG001|COMPLETED|Overall Study||20
9968710|NCT01522391|11089166|FG000|NOT COMPLETED|Overall Study||1
9968711|NCT01522391|11089167|FG001|NOT COMPLETED|Overall Study||1
9968712|NCT01522404|11089175|FG000|STARTED|First Intervention (up to Week 29)||20
9968713|NCT01522404|11089176|FG001|STARTED|First Intervention (up to Week 29)||19
9968714|NCT01522404|11089175|FG000|COMPLETED|First Intervention (up to Week 29)||18
9968715|NCT01522404|11089176|FG001|COMPLETED|First Intervention (up to Week 29)||19
10199000|NCT03406325|11327334|FG003|NOT COMPLETED|Overall Study||0
10199001|NCT03406325|11327335|FG004|NOT COMPLETED|Overall Study||0
10199002|NCT03406325|11327336|FG005|NOT COMPLETED|Overall Study||0
10199003|NCT03406325|11327337|FG006|NOT COMPLETED|Overall Study||0
10199004|NCT03406325|11327338|FG007|NOT COMPLETED|Overall Study||0
10199005|NCT03406377|11327372|FG000|STARTED|Overall Study||41
10199006|NCT03406377|11327373|FG001|STARTED|Overall Study||72
9851629|NCT00877032|10964374|FG000|COMPLETED|Overall Study||6
9851630|NCT00877032|10964375|FG001|COMPLETED|Overall Study||6
9851631|NCT00877032|10964376|FG002|COMPLETED|Overall Study||6
9851632|NCT00877032|10964377|FG003|COMPLETED|Overall Study||6
9851633|NCT00877032|10964378|FG004|COMPLETED|Overall Study||6
9851634|NCT00877032|10964379|FG005|COMPLETED|Overall Study||6
9851635|NCT00877032|10964380|FG006|COMPLETED|Overall Study||18
9851636|NCT00877032|10964374|FG000|NOT COMPLETED|Overall Study||0
9851637|NCT00877032|10964375|FG001|NOT COMPLETED|Overall Study||0
9851638|NCT00877032|10964376|FG002|NOT COMPLETED|Overall Study||0
9851639|NCT00877032|10964377|FG003|NOT COMPLETED|Overall Study||1
9851640|NCT00877032|10964378|FG004|NOT COMPLETED|Overall Study||0
9851641|NCT00877032|10964379|FG005|NOT COMPLETED|Overall Study||0
9851642|NCT00877032|10964380|FG006|NOT COMPLETED|Overall Study||2
9851643|NCT00877058|10964399|FG000|STARTED|Overall Study||174
9851644|NCT00877058|10964400|FG001|STARTED|Overall Study||171
9851645|NCT00877058|10964401|FG002|STARTED|Overall Study||114
9851646|NCT00877058|10964399|FG000|COMPLETED|Overall Study||137
9851647|NCT00877058|10964400|FG001|COMPLETED|Overall Study||131
9851648|NCT00877058|10964401|FG002|COMPLETED|Overall Study||75
9851649|NCT00877058|10964399|FG000|NOT COMPLETED|Overall Study||37
9851650|NCT00877058|10964400|FG001|NOT COMPLETED|Overall Study||40
9851651|NCT00877058|10964401|FG002|NOT COMPLETED|Overall Study||39
9851652|NCT00877370|10964409|FG000|STARTED|Overall Study||8
9851653|NCT00877370|10964409|FG000|COMPLETED|Overall Study||8
9851654|NCT00877370|10964409|FG000|NOT COMPLETED|Overall Study||0
9851655|NCT00877383|10964415|FG000|STARTED|Overall Study||572
9851656|NCT00877383|10964416|FG001|STARTED|Overall Study||570
9851657|NCT00877383|10964415|FG000|COMPLETED|Overall Study||543
9851658|NCT00877383|10964416|FG001|COMPLETED|Overall Study||533
9851659|NCT00877383|10964415|FG000|NOT COMPLETED|Overall Study||29
9851660|NCT00877383|10964416|FG001|NOT COMPLETED|Overall Study||37
9851661|NCT00877448|10964429|FG000|STARTED|Overall Study||10
9851662|NCT00877448|10964430|FG001|STARTED|Overall Study||10
9851663|NCT00877448|10964431|FG002|STARTED|Overall Study||10
9851664|NCT00877448|10964432|FG003|STARTED|Overall Study||10
9968716|NCT01522404|11089175|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2
9968717|NCT01522404|11089176|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0
9968718|NCT01522404|11089175|FG000|STARTED|Second Intervention (up to Week 58)||18
9851665|NCT00877448|10964433|FG004|STARTED|Overall Study||10
9968719|NCT01522404|11089176|FG001|STARTED|Second Intervention (up to Week 58)||19
9968720|NCT01522404|11089175|FG000|COMPLETED|Second Intervention (up to Week 58)||17
9968721|NCT01522404|11089176|FG001|COMPLETED|Second Intervention (up to Week 58)||19
9968722|NCT01522404|11089175|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1
9968723|NCT01522404|11089176|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0
9968724|NCT01522417|11089193|FG000|STARTED|Overall Study||209
9968725|NCT01522417|11089194|FG001|STARTED|Overall Study||202
9968726|NCT01522417|11089195|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
9968727|NCT01522417|11089193|FG000|COMPLETED|Overall Study||209
9968728|NCT01522417|11089194|FG001|COMPLETED|Overall Study||202
9968729|NCT01522417|11089195|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
9968730|NCT01522417|11089193|FG000|NOT COMPLETED|Overall Study||0
9968731|NCT01522417|11089194|FG001|NOT COMPLETED|Overall Study||0
9968732|NCT01522417|11089195|FG002|NOT COMPLETED|Overall Study||0
9968733|NCT01522443|11089205|FG000|STARTED|Overall Study||61
9968734|NCT01522443|11089206|FG001|STARTED|Overall Study||58
9968735|NCT01522443|11089205|FG000|COMPLETED|Overall Study||8
9968736|NCT01522443|11089206|FG001|COMPLETED|Overall Study||3
10199007|NCT03406377|11327372|FG000|COMPLETED|Overall Study||25
10199008|NCT03406377|11327373|FG001|COMPLETED|Overall Study||51
10199009|NCT03406377|11327372|FG000|NOT COMPLETED|Overall Study||16
10199010|NCT03406377|11327373|FG001|NOT COMPLETED|Overall Study||21
10199011|NCT03406962|11327379|FG000|STARTED|Overall Study||8
10199012|NCT03406962|11327379|FG000|COMPLETED|Overall Study||5
10199013|NCT03406962|11327379|FG000|NOT COMPLETED|Overall Study||3
10199014|NCT03407053|11327386|FG000|STARTED|Overall Study||10
10199015|NCT03407053|11327387|FG001|STARTED|Overall Study||10
10199016|NCT03407053|11327386|FG000|COMPLETED|Overall Study||10
10199017|NCT03407053|11327387|FG001|COMPLETED|Overall Study||10
10199018|NCT03407053|11327386|FG000|NOT COMPLETED|Overall Study||0
10199019|NCT03407053|11327387|FG001|NOT COMPLETED|Overall Study||0
10199020|NCT03407118|11327393|FG000|STARTED|Period 1||14
10199021|NCT03407118|11327394|FG001|STARTED|Period 1||17
10199022|NCT03407118|11327393|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
10199023|NCT03407118|11327394|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
10199024|NCT03407118|11327393|FG000|COMPLETED|Period 1||14
10199025|NCT03407118|11327394|FG001|COMPLETED|Period 1||17
10199026|NCT03407118|11327393|FG000|NOT COMPLETED|Period 1||0
10199027|NCT03407118|11327394|FG001|NOT COMPLETED|Period 1||0
10199028|NCT03407118|11327393|FG000|STARTED|Period 2||14
10199029|NCT03407118|11327394|FG001|STARTED|Period 2||17
10199030|NCT03407118|11327393|FG000|Received at Least 1 Dose of Study Drug|Period 2||13
10199031|NCT03407118|11327394|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
10199032|NCT03407118|11327393|FG000|COMPLETED|Period 2||13
10199033|NCT03407118|11327394|FG001|COMPLETED|Period 2||17
10199034|NCT03407118|11327393|FG000|NOT COMPLETED|Period 2||1
10199035|NCT03407118|11327394|FG001|NOT COMPLETED|Period 2||0
10199036|NCT03407170|11327400|FG000|STARTED|Overall Study||1
10199037|NCT03407170|11327400|FG000|COMPLETED|Overall Study||0
10199038|NCT03407170|11327400|FG000|NOT COMPLETED|Overall Study||1
10199039|NCT03407313|11327404|FG000|STARTED|Overall Study||68
10199040|NCT03407313|11327404|FG000|COMPLETED|Overall Study||66
10199041|NCT03407313|11327404|FG000|NOT COMPLETED|Overall Study||2
10199042|NCT03407430|11327410|FG000|STARTED|First Intervention||5
10199043|NCT03407430|11327411|FG001|STARTED|First Intervention||3
10199044|NCT03407430|11327410|FG000|COMPLETED|First Intervention||5
10199045|NCT03407430|11327411|FG001|COMPLETED|First Intervention||3
10199046|NCT03407430|11327410|FG000|NOT COMPLETED|First Intervention||0
10199047|NCT03407430|11327411|FG001|NOT COMPLETED|First Intervention||0
10199048|NCT03407430|11327410|FG000|STARTED|Washout||5
10199049|NCT03407430|11327411|FG001|STARTED|Washout||3
10199050|NCT03407430|11327410|FG000|COMPLETED|Washout||4
10199051|NCT03407430|11327411|FG001|COMPLETED|Washout||3
10199052|NCT03407430|11327410|FG000|NOT COMPLETED|Washout||1
10199053|NCT03407430|11327411|FG001|NOT COMPLETED|Washout||0
10199054|NCT03407430|11327410|FG000|STARTED|Second Intervention||4
10199055|NCT03407430|11327411|FG001|STARTED|Second Intervention||3
10199056|NCT03407430|11327410|FG000|COMPLETED|Second Intervention||4
10199057|NCT03407430|11327411|FG001|COMPLETED|Second Intervention||3
10199058|NCT03407430|11327410|FG000|NOT COMPLETED|Second Intervention||0
10199059|NCT03407430|11327411|FG001|NOT COMPLETED|Second Intervention||0
10199060|NCT03407482|11327424|FG000|STARTED|Overall Study||160
9968737|NCT01522443|11089205|FG000|NOT COMPLETED|Overall Study||53
9968738|NCT01522443|11089206|FG001|NOT COMPLETED|Overall Study||55
9968739|NCT01522456|11089212|FG000|STARTED|Overall Study||73
9968740|NCT01522456|11089212|FG000|COMPLETED|Overall Study||65
9968741|NCT01522456|11089212|FG000|NOT COMPLETED|Overall Study||8
9968742|NCT01522651|11089228|FG000|STARTED|Overall Study||26
10082384|NCT02267824|11210937|FG000|COMPLETED|Overall Study||73
10199061|NCT03407482|11327424|FG000|COMPLETED|Overall Study||29
10199062|NCT03407482|11327424|FG000|NOT COMPLETED|Overall Study||131
10199063|NCT03407612|11327430|FG000|STARTED|Overall Study||19
10199064|NCT03407612|11327431|FG001|STARTED|Overall Study||23
10199065|NCT03407612|11327430|FG000|COMPLETED|Overall Study||19
10199066|NCT03407612|11327431|FG001|COMPLETED|Overall Study||23
10199067|NCT03407612|11327430|FG000|NOT COMPLETED|Overall Study||0
10199068|NCT03407612|11327431|FG001|NOT COMPLETED|Overall Study||0
10199069|NCT03407625|11327439|FG000|STARTED|Overall Study||1117
9968743|NCT01522651|11089229|FG001|STARTED|Overall Study||27
9968744|NCT01522651|11089230|FG002|STARTED|Overall Study||26
10199070|NCT03407625|11327440|FG001|STARTED|Overall Study||1110
10199071|NCT03407625|11327439|FG000|COMPLETED|Overall Study||1117
10199072|NCT03407625|11327440|FG001|COMPLETED|Overall Study||1110
10199073|NCT03407625|11327439|FG000|NOT COMPLETED|Overall Study||0
9968745|NCT01522651|11089231|FG003|STARTED|Overall Study||28
9968746|NCT01522651|11089232|FG004|STARTED|Overall Study||27
9968747|NCT01522651|11089228|FG000|COMPLETED|Overall Study||17
9968748|NCT01522651|11089229|FG001|COMPLETED|Overall Study||19
9968749|NCT01522651|11089230|FG002|COMPLETED|Overall Study||22
9968750|NCT01522651|11089231|FG003|COMPLETED|Overall Study||20
9968751|NCT01522651|11089232|FG004|COMPLETED|Overall Study||21
9968752|NCT01522651|11089228|FG000|NOT COMPLETED|Overall Study||9
9968753|NCT01522651|11089229|FG001|NOT COMPLETED|Overall Study||8
9968754|NCT01522651|11089230|FG002|NOT COMPLETED|Overall Study||4
9968755|NCT01522651|11089231|FG003|NOT COMPLETED|Overall Study||8
9968756|NCT01522651|11089232|FG004|NOT COMPLETED|Overall Study||6
9968757|NCT01522703|11089246|FG000|STARTED|Overall Study||25
9968758|NCT01522703|11089247|FG001|STARTED|Overall Study||26
9968759|NCT01522703|11089246|FG000|COMPLETED|Overall Study||20
9968760|NCT01522703|11089247|FG001|COMPLETED|Overall Study||20
9968761|NCT01522703|11089246|FG000|NOT COMPLETED|Overall Study||5
9968762|NCT01522703|11089247|FG001|NOT COMPLETED|Overall Study||6
9968763|NCT01522755|11089253|FG000|STARTED|Overall Study||409
9968764|NCT01522755|11089253|FG000|COMPLETED|Overall Study||409
9968765|NCT01522755|11089253|FG000|NOT COMPLETED|Overall Study||0
9968766|NCT01522924|11089260|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
9968767|NCT01522924|11089261|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52
9968768|NCT01522924|11089260|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
9968769|NCT01522924|11089261|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
9968770|NCT01522924|11089260|FG000|NOT COMPLETED|Overall Study||0
9968771|NCT01522924|11089261|FG001|NOT COMPLETED|Overall Study||0
9968772|NCT01522937|11089267|FG000|STARTED|Overall Study||146
9968773|NCT01522937|11089267|FG000|COMPLETED|Overall Study||146
9968774|NCT01522937|11089267|FG000|NOT COMPLETED|Overall Study||0
9968775|NCT01522950|11089274|FG000|STARTED|Overall Study||26
9968776|NCT01522950|11089275|FG001|STARTED|Overall Study||23
9968777|NCT01522950|11089276|FG002|STARTED|Overall Study||27
9968778|NCT01522950|11089274|FG000|COMPLETED|Overall Study||20
9968779|NCT01522950|11089275|FG001|COMPLETED|Overall Study||18
9968780|NCT01522950|11089276|FG002|COMPLETED|Overall Study||22
9968781|NCT01522950|11089274|FG000|NOT COMPLETED|Overall Study||6
9968782|NCT01522950|11089275|FG001|NOT COMPLETED|Overall Study||5
9968783|NCT01522950|11089276|FG002|NOT COMPLETED|Overall Study||5
9968784|NCT01522963|11089288|FG000|STARTED|Overall Study||24
9968785|NCT01522963|11089289|FG001|STARTED|Overall Study||25
9968786|NCT01522963|11089290|FG002|STARTED|Overall Study||25
9968787|NCT01522963|11089291|FG003|STARTED|Overall Study||24
9968788|NCT01522963|11089288|FG000|COMPLETED|Overall Study||22
9968789|NCT01522963|11089289|FG001|COMPLETED|Overall Study||22
9968790|NCT01522963|11089290|FG002|COMPLETED|Overall Study||22
9968791|NCT01522963|11089291|FG003|COMPLETED|Overall Study||18
9968792|NCT01522963|11089288|FG000|NOT COMPLETED|Overall Study||2
9968793|NCT01522963|11089289|FG001|NOT COMPLETED|Overall Study||3
9968794|NCT01522963|11089290|FG002|NOT COMPLETED|Overall Study||3
9968795|NCT01522963|11089291|FG003|NOT COMPLETED|Overall Study||6
9968796|NCT01523275|11089301|FG000|STARTED|Overall Study||6
9968797|NCT01523275|11089302|FG001|STARTED|Overall Study||9
9968798|NCT01523275|11089301|FG000|COMPLETED|Overall Study||4
9968799|NCT01523275|11089302|FG001|COMPLETED|Overall Study||7
9968800|NCT01523275|11089301|FG000|NOT COMPLETED|Overall Study||2
9968801|NCT01523275|11089302|FG001|NOT COMPLETED|Overall Study||2
9968802|NCT01523301|11089310|FG000|STARTED|Overall Study||184
9968803|NCT01523301|11089311|FG001|STARTED|Overall Study||196
9968804|NCT01523301|11089310|FG000|COMPLETED|Overall Study||149
9968805|NCT01523301|11089311|FG001|COMPLETED|Overall Study||164
9968806|NCT01523301|11089310|FG000|NOT COMPLETED|Overall Study||35
9968807|NCT01523301|11089311|FG001|NOT COMPLETED|Overall Study||32
9968808|NCT01523366|11089319|FG000|STARTED|Treatment Period 1||20
9968809|NCT01523366|11089320|FG001|STARTED|Treatment Period 1||20
9968810|NCT01523366|11089319|FG000|COMPLETED|Treatment Period 1||19
9968811|NCT01523366|11089320|FG001|COMPLETED|Treatment Period 1||20
9968812|NCT01523366|11089319|FG000|NOT COMPLETED|Treatment Period 1||1
9968813|NCT01523366|11089320|FG001|NOT COMPLETED|Treatment Period 1||0
9968814|NCT01523366|11089319|FG000|STARTED|Washout Period - 10-14 Days||19
9968815|NCT01523366|11089320|FG001|STARTED|Washout Period - 10-14 Days||20
9968816|NCT01523366|11089319|FG000|COMPLETED|Washout Period - 10-14 Days||19
9968817|NCT01523366|11089320|FG001|COMPLETED|Washout Period - 10-14 Days||20
9968818|NCT01523366|11089319|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0
9968819|NCT01523366|11089320|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0
9968820|NCT01523366|11089319|FG000|STARTED|Treatment Period 2||19
9968821|NCT01523366|11089320|FG001|STARTED|Treatment Period 2||20
9968822|NCT01523366|11089319|FG000|COMPLETED|Treatment Period 2||18
9968823|NCT01523366|11089320|FG001|COMPLETED|Treatment Period 2||20
9968824|NCT01523366|11089319|FG000|NOT COMPLETED|Treatment Period 2||1
9968825|NCT01523366|11089320|FG001|NOT COMPLETED|Treatment Period 2||0
9968826|NCT01523392|11089330|FG000|STARTED|Treatment Period 1||20
9968827|NCT01523392|11089331|FG001|STARTED|Treatment Period 1||14
9968828|NCT01523392|11089330|FG000|COMPLETED|Treatment Period 1||17
9968829|NCT01523392|11089331|FG001|COMPLETED|Treatment Period 1||14
9968830|NCT01523392|11089330|FG000|NOT COMPLETED|Treatment Period 1||3
9968831|NCT01523392|11089331|FG001|NOT COMPLETED|Treatment Period 1||0
10017475|NCT01816906|11140380|FG001|COMPLETED|12 Months||14
9968832|NCT01523392|11089330|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
9968833|NCT01523392|11089331|FG001|STARTED|Washout Period - 10 to 14 Days||14
9968834|NCT01523392|11089330|FG000|COMPLETED|Washout Period - 10 to 14 Days||17
9968835|NCT01523392|11089331|FG001|COMPLETED|Washout Period - 10 to 14 Days||14
9968836|NCT01523392|11089330|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1
9968837|NCT01523392|11089331|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0
9968838|NCT01523392|11089330|FG000|STARTED|Treatment Period 2||17
9968839|NCT01523392|11089331|FG001|STARTED|Treatment Period 2||14
9968840|NCT01523392|11089330|FG000|COMPLETED|Treatment Period 2||17
9968841|NCT01523392|11089331|FG001|COMPLETED|Treatment Period 2||14
9968842|NCT01523392|11089330|FG000|NOT COMPLETED|Treatment Period 2||0
9968843|NCT01523392|11089331|FG001|NOT COMPLETED|Treatment Period 2||0
9968844|NCT01523457|11089341|FG000|STARTED|Overall Study||44
9968845|NCT01523457|11089342|FG001|STARTED|Overall Study||31
9968846|NCT01523457|11089341|FG000|COMPLETED|Overall Study||37
9968847|NCT01523457|11089342|FG001|COMPLETED|Overall Study||29
9968848|NCT01523457|11089341|FG000|NOT COMPLETED|Overall Study||7
9968849|NCT01523457|11089342|FG001|NOT COMPLETED|Overall Study||2
9968850|NCT01523496|11089352|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
9968851|NCT01523496|11089353|FG001|STARTED|Overall Study||36
9968852|NCT01523496|11089354|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
9968853|NCT01523496|11089355|FG003|STARTED|Overall Study||30
9968854|NCT01523496|11089352|FG000|COMPLETED|Overall Study||56
9968855|NCT01523496|11089353|FG001|COMPLETED|Overall Study||32
9968856|NCT01523496|11089354|FG002|COMPLETED|Overall Study||46
9968857|NCT01523496|11089355|FG003|COMPLETED|Overall Study||27
9968858|NCT01523496|11089352|FG000|NOT COMPLETED|Overall Study||10
9968859|NCT01523496|11089353|FG001|NOT COMPLETED|Overall Study||4
9968860|NCT01523496|11089354|FG002|NOT COMPLETED|Overall Study||12
9968861|NCT01523496|11089355|FG003|NOT COMPLETED|Overall Study||3
9968862|NCT01523587|11089371|FG000|STARTED|Overall Study||398
9968863|NCT01523587|11089372|FG001|STARTED|Overall Study||397
9968864|NCT01523587|11089371|FG000|Treated|Overall Study||392
9968865|NCT01523587|11089372|FG001|Treated|Overall Study||395
9968866|NCT01523587|11089371|FG000|COMPLETED|Overall Study||0
10199074|NCT03407625|11327440|FG001|NOT COMPLETED|Overall Study||0
10199075|NCT03407651|11327446|FG000|STARTED|Period 1: Part 1a||11
10199076|NCT03407651|11327446|FG000|COMPLETED|Period 1: Part 1a||10
10199077|NCT03407651|11327446|FG000|NOT COMPLETED|Period 1: Part 1a||1
10199078|NCT03407651|11327446|FG000|STARTED|Period 2: Part 1b||9
10199079|NCT03407651|11327446|FG000|COMPLETED|Period 2: Part 1b||9
10199080|NCT03407651|11327446|FG000|NOT COMPLETED|Period 2: Part 1b||0
10199081|NCT03407651|11327446|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11
10199082|NCT03407651|11327446|FG000|COMPLETED|Period 3: Part 2||8
10199083|NCT03407651|11327446|FG000|NOT COMPLETED|Period 3: Part 2||3
10199084|NCT03408171|11327468|FG000|STARTED|Overall Study||20
10199085|NCT03408171|11327469|FG001|STARTED|Overall Study||20
10199086|NCT03408171|11327468|FG000|COMPLETED|Overall Study||20
10199087|NCT03408171|11327469|FG001|COMPLETED|Overall Study||20
10199088|NCT03408171|11327468|FG000|NOT COMPLETED|Overall Study||0
10199089|NCT03408171|11327469|FG001|NOT COMPLETED|Overall Study||0
10199090|NCT03408392|11327475|FG000|STARTED|Treatment Period 1 (16 Days)||14
10199091|NCT03408392|11327476|FG001|STARTED|Treatment Period 1 (16 Days)||14
10199092|NCT03408392|11327475|FG000|COMPLETED|Treatment Period 1 (16 Days)||14
10199093|NCT03408392|11327476|FG001|COMPLETED|Treatment Period 1 (16 Days)||14
10199094|NCT03408392|11327475|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0
10199095|NCT03408392|11327476|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0
10199096|NCT03408392|11327475|FG000|STARTED|Wash-out Period (14 Days)||14
10199097|NCT03408392|11327476|FG001|STARTED|Wash-out Period (14 Days)||14
10199098|NCT03408392|11327475|FG000|COMPLETED|Wash-out Period (14 Days)||14
10199099|NCT03408392|11327476|FG001|COMPLETED|Wash-out Period (14 Days)||14
10199100|NCT03408392|11327475|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0
10199101|NCT03408392|11327476|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0
10199102|NCT03408392|11327475|FG000|STARTED|Treatment Period 2 (16 Days)||14
10199103|NCT03408392|11327476|FG001|STARTED|Treatment Period 2 (16 Days)||14
9968867|NCT01523587|11089372|FG001|COMPLETED|Overall Study||0
9968868|NCT01523587|11089371|FG000|NOT COMPLETED|Overall Study||398
9968869|NCT01523587|11089372|FG001|NOT COMPLETED|Overall Study||397
9968870|NCT01523613|11089381|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30
9968871|NCT01523613|11089382|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30
9968872|NCT01523613|11089383|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
9968873|NCT01523613|11089381|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23
9968874|NCT01523613|11089382|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25
9968875|NCT01523613|11089383|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
10199104|NCT03408392|11327475|FG000|COMPLETED|Treatment Period 2 (16 Days)||14
10199105|NCT03408392|11327476|FG001|COMPLETED|Treatment Period 2 (16 Days)||14
10199106|NCT03408392|11327475|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0
10199107|NCT03408392|11327476|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0
10199108|NCT03408483|11327484|FG000|STARTED|Overall Study||42
10199109|NCT03408483|11327485|FG001|STARTED|Overall Study||38
10199110|NCT03408483|11327484|FG000|COMPLETED|Overall Study||36
10199111|NCT03408483|11327485|FG001|COMPLETED|Overall Study||35
9968876|NCT01523613|11089381|FG000|NOT COMPLETED|Overall Study||7
9968877|NCT01523613|11089382|FG001|NOT COMPLETED|Overall Study||5
9968878|NCT01523613|11089383|FG002|NOT COMPLETED|Overall Study||12
9968879|NCT01523704|11089393|FG000|STARTED|Overall Study|January 2012|636
9968880|NCT01523704|11089394|FG001|STARTED|Overall Study|January 2012|638
9968881|NCT01523704|11089393|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
9968882|NCT01523704|11089394|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
9968883|NCT01523704|11089393|FG000|NOT COMPLETED|Overall Study||78
9968884|NCT01523704|11089394|FG001|NOT COMPLETED|Overall Study||88
9968885|NCT01523743|11089401|FG000|STARTED|Period 1||63
9968886|NCT01523743|11089402|FG001|STARTED|Period 1||62
9968887|NCT01523743|11089401|FG000|COMPLETED|Period 1||53
9968888|NCT01523743|11089402|FG001|COMPLETED|Period 1||60
9968889|NCT01523743|11089401|FG000|NOT COMPLETED|Period 1||10
9968890|NCT01523743|11089402|FG001|NOT COMPLETED|Period 1||2
9968891|NCT01523743|11089401|FG000|STARTED|Period 2||53
9968892|NCT01523743|11089402|FG001|STARTED|Period 2||60
9968893|NCT01523743|11089401|FG000|COMPLETED|Period 2||52
9968894|NCT01523743|11089402|FG001|COMPLETED|Period 2||58
9968895|NCT01523743|11089401|FG000|NOT COMPLETED|Period 2||1
9968896|NCT01523743|11089402|FG001|NOT COMPLETED|Period 2||2
9968897|NCT01523756|11089408|FG000|STARTED|Baseline Period||11
9968898|NCT01523756|11089409|FG001|STARTED|Baseline Period||9
9968899|NCT01523756|11089408|FG000|COMPLETED|Baseline Period||11
10082385|NCT02267824|11210938|FG001|COMPLETED|Overall Study||17
10082386|NCT02267824|11210937|FG000|NOT COMPLETED|Overall Study||10
10082387|NCT02267824|11210938|FG001|NOT COMPLETED|Overall Study||1
10082388|NCT02267837|11210946|FG000|STARTED|Overall Study||11
10082389|NCT02267837|11210947|FG001|STARTED|Overall Study||9
10082390|NCT02267837|11210946|FG000|COMPLETED|Overall Study||11
10082391|NCT02267837|11210947|FG001|COMPLETED|Overall Study||9
10082392|NCT02267837|11210946|FG000|NOT COMPLETED|Overall Study||0
10082393|NCT02267837|11210947|FG001|NOT COMPLETED|Overall Study||0
10082394|NCT02267850|11210955|FG000|STARTED|Overall Study||15
10082395|NCT02267850|11210956|FG001|STARTED|Overall Study||14
10082396|NCT02267850|11210955|FG000|COMPLETED|Overall Study||14
10082397|NCT02267850|11210956|FG001|COMPLETED|Overall Study||12
10082398|NCT02267850|11210955|FG000|NOT COMPLETED|Overall Study||1
10082399|NCT02267850|11210956|FG001|NOT COMPLETED|Overall Study||2
10082400|NCT02268045|11210964|FG000|STARTED|Overall Study||136
10082401|NCT02268045|11210965|FG001|STARTED|Overall Study||136
10082402|NCT02268045|11210964|FG000|COMPLETED|Overall Study||120
10082403|NCT02268045|11210965|FG001|COMPLETED|Overall Study||116
10082404|NCT02268045|11210964|FG000|NOT COMPLETED|Overall Study||16
10082405|NCT02268045|11210965|FG001|NOT COMPLETED|Overall Study||20
10082406|NCT02268058|11210977|FG000|STARTED|Overall Study||20
10082407|NCT02268058|11210978|FG001|STARTED|Overall Study||20
10082408|NCT02268058|11210979|FG002|STARTED|Overall Study||20
10082409|NCT02268058|11210980|FG003|STARTED|Overall Study||20
10082410|NCT02268058|11210977|FG000|COMPLETED|Overall Study||19
10082411|NCT02268058|11210978|FG001|COMPLETED|Overall Study||20
10082412|NCT02268058|11210979|FG002|COMPLETED|Overall Study||20
10082413|NCT02268058|11210980|FG003|COMPLETED|Overall Study||20
10082414|NCT02268058|11210977|FG000|NOT COMPLETED|Overall Study||1
10082415|NCT02268058|11210978|FG001|NOT COMPLETED|Overall Study||0
10082416|NCT02268058|11210979|FG002|NOT COMPLETED|Overall Study||0
10082417|NCT02268058|11210980|FG003|NOT COMPLETED|Overall Study||0
10082418|NCT02268084|11210992|FG000|STARTED|Overall Study||49
10082419|NCT02268084|11210993|FG001|STARTED|Overall Study||47
10082420|NCT02268084|11210992|FG000|COMPLETED|Overall Study||40
10082421|NCT02268084|11210993|FG001|COMPLETED|Overall Study||40
10082422|NCT02268084|11210992|FG000|NOT COMPLETED|Overall Study||9
10082423|NCT02268084|11210993|FG001|NOT COMPLETED|Overall Study||7
10082424|NCT02268214|11211008|FG000|STARTED|Overall Study||277
10199112|NCT03408483|11327484|FG000|NOT COMPLETED|Overall Study||6
10199113|NCT03408483|11327485|FG001|NOT COMPLETED|Overall Study||3
10199114|NCT03408639|11327493|FG000|STARTED|Overall Study||78
10199115|NCT03408639|11327494|FG001|STARTED|Overall Study||78
10199116|NCT03408639|11327493|FG000|COMPLETED|Overall Study||67
10082425|NCT02268214|11211009|FG001|STARTED|Overall Study||296
10082426|NCT02268214|11211010|FG002|STARTED|Overall Study||260
10082427|NCT02268214|11211008|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252
10082428|NCT02268214|11211009|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273
10082429|NCT02268214|11211010|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232
10082430|NCT02268214|11211008|FG000|COMPLETED|Overall Study||235
10082431|NCT02268214|11211009|FG001|COMPLETED|Overall Study||255
10082432|NCT02268214|11211010|FG002|COMPLETED|Overall Study||218
10082433|NCT02268214|11211008|FG000|NOT COMPLETED|Overall Study||42
10082434|NCT02268214|11211009|FG001|NOT COMPLETED|Overall Study||41
10082435|NCT02268214|11211010|FG002|NOT COMPLETED|Overall Study||42
10082436|NCT02268396|11211018|FG000|STARTED|Overall Study||138
10082437|NCT02268396|11211018|FG000|COMPLETED|Overall Study||126
10199117|NCT03408639|11327494|FG001|COMPLETED|Overall Study||56
10199118|NCT03408639|11327493|FG000|NOT COMPLETED|Overall Study||11
9968900|NCT01523756|11089409|FG001|COMPLETED|Baseline Period||8
10082438|NCT02268396|11211018|FG000|NOT COMPLETED|Overall Study||12
10082439|NCT02268500|11211024|FG000|STARTED|Overall Study||24
10082440|NCT02268500|11211025|FG001|STARTED|Overall Study||24
10082441|NCT02268500|11211024|FG000|COMPLETED|Overall Study||24
10082442|NCT02268500|11211025|FG001|COMPLETED|Overall Study||24
10082443|NCT02268500|11211024|FG000|NOT COMPLETED|Overall Study||0
10199119|NCT03408639|11327494|FG001|NOT COMPLETED|Overall Study||22
10082444|NCT02268500|11211025|FG001|NOT COMPLETED|Overall Study||0
10082445|NCT02268526|11211034|FG000|STARTED|Overall Study||6
10082446|NCT02268526|11211035|FG001|STARTED|Overall Study||59
10082447|NCT02268526|11211036|FG002|STARTED|Overall Study||21
10082448|NCT02268526|11211034|FG000|PD Analysis Set (Cohort 2)|Overall Study||0
10082449|NCT02268526|11211035|FG001|PD Analysis Set (Cohort 2)|Overall Study||42
10082450|NCT02268526|11211036|FG002|PD Analysis Set (Cohort 2)|Overall Study||17
10082451|NCT02268526|11211034|FG000|COMPLETED|Overall Study||5
10082452|NCT02268526|11211035|FG001|COMPLETED|Overall Study||38
10082453|NCT02268526|11211036|FG002|COMPLETED|Overall Study||16
10082454|NCT02268526|11211034|FG000|NOT COMPLETED|Overall Study||1
10082455|NCT02268526|11211035|FG001|NOT COMPLETED|Overall Study||21
10199120|NCT03408730|11327504|FG000|STARTED|Overall Study||712
10199121|NCT03408730|11327505|FG001|STARTED|Overall Study||711
10199122|NCT03408730|11327506|FG002|STARTED|Overall Study||709
10199123|NCT03408730|11327507|FG003|STARTED|Overall Study||706
10199124|NCT03408730|11327504|FG000|COMPLETED|Overall Study||643
10199125|NCT03408730|11327505|FG001|COMPLETED|Overall Study||636
10199126|NCT03408730|11327506|FG002|COMPLETED|Overall Study||637
10199127|NCT03408730|11327507|FG003|COMPLETED|Overall Study||625
10199128|NCT03408730|11327504|FG000|NOT COMPLETED|Overall Study||69
10199129|NCT03408730|11327505|FG001|NOT COMPLETED|Overall Study||75
10199130|NCT03408730|11327506|FG002|NOT COMPLETED|Overall Study||72
10199131|NCT03408730|11327507|FG003|NOT COMPLETED|Overall Study||81
10199132|NCT03408808|11327523|FG000|STARTED|Overall Study||8
10199133|NCT03408808|11327524|FG001|STARTED|Overall Study||9
10199134|NCT03408808|11327523|FG000|COMPLETED|Overall Study||8
10199135|NCT03408808|11327524|FG001|COMPLETED|Overall Study||8
10199136|NCT03408808|11327523|FG000|NOT COMPLETED|Overall Study||0
10199137|NCT03408808|11327524|FG001|NOT COMPLETED|Overall Study||1
10199138|NCT03409107|11327532|FG000|STARTED|Overall Study||307
10199139|NCT03409107|11327533|FG001|STARTED|Overall Study||307
10199140|NCT03409107|11327532|FG000|COMPLETED|Overall Study||290
10199141|NCT03409107|11327533|FG001|COMPLETED|Overall Study||300
10199142|NCT03409107|11327532|FG000|NOT COMPLETED|Overall Study||17
10199143|NCT03409107|11327533|FG001|NOT COMPLETED|Overall Study||7
10199144|NCT03410056|11327543|FG000|STARTED|Overall Study||8
10199145|NCT03410056|11327544|FG001|STARTED|Overall Study||6
10199146|NCT03410056|11327545|FG002|STARTED|Overall Study||11
10199147|NCT03410056|11327546|FG003|STARTED|Overall Study||11
10199148|NCT03410056|11327547|FG004|STARTED|Overall Study||0
10199149|NCT03410056|11327548|FG005|STARTED|Overall Study||0
10199150|NCT03410056|11327549|FG006|STARTED|Overall Study||0
10199151|NCT03410056|11327543|FG000|Received Treatment|Overall Study||8
10199152|NCT03410056|11327544|FG001|Received Treatment|Overall Study||6
10199153|NCT03410056|11327545|FG002|Received Treatment|Overall Study||11
10199154|NCT03410056|11327546|FG003|Received Treatment|Overall Study||11
10199155|NCT03410056|11327547|FG004|Received Treatment|Overall Study||0
10199156|NCT03410056|11327548|FG005|Received Treatment|Overall Study||0
10199157|NCT03410056|11327549|FG006|Received Treatment|Overall Study||0
10199158|NCT03410056|11327543|FG000|COMPLETED|Overall Study||8
10199159|NCT03410056|11327544|FG001|COMPLETED|Overall Study||4
10199160|NCT03410056|11327545|FG002|COMPLETED|Overall Study||3
10199161|NCT03410056|11327546|FG003|COMPLETED|Overall Study||6
10199162|NCT03410056|11327547|FG004|COMPLETED|Overall Study||0
10199163|NCT03410056|11327548|FG005|COMPLETED|Overall Study||0
10199164|NCT03410056|11327549|FG006|COMPLETED|Overall Study||0
10199165|NCT03410056|11327543|FG000|NOT COMPLETED|Overall Study||0
10199166|NCT03410056|11327544|FG001|NOT COMPLETED|Overall Study||2
10199167|NCT03410056|11327545|FG002|NOT COMPLETED|Overall Study||8
10199168|NCT03410056|11327546|FG003|NOT COMPLETED|Overall Study||5
10199169|NCT03410056|11327547|FG004|NOT COMPLETED|Overall Study||0
10199170|NCT03410056|11327548|FG005|NOT COMPLETED|Overall Study||0
10199171|NCT03410056|11327549|FG006|NOT COMPLETED|Overall Study||0
10199172|NCT03410628|11327565|FG000|STARTED|Overall Study||21
10199173|NCT03410628|11327565|FG000|COMPLETED|Overall Study||15
10199174|NCT03410628|11327565|FG000|NOT COMPLETED|Overall Study||6
10199175|NCT03410797|11327569|FG000|STARTED|Overall Study||11
10199176|NCT03410797|11327569|FG000|COMPLETED|Overall Study||11
10199177|NCT03410797|11327569|FG000|NOT COMPLETED|Overall Study||0
10082456|NCT02268526|11211036|FG002|NOT COMPLETED|Overall Study||5
10082457|NCT02268786|11211048|FG000|STARTED|Overall Study||330
10199178|NCT03410862|11327576|FG000|STARTED|Overall Study||43
10199179|NCT03410862|11327577|FG001|STARTED|Overall Study||44
10199180|NCT03410862|11327576|FG000|COMPLETED|Overall Study||41
10199181|NCT03410862|11327577|FG001|COMPLETED|Overall Study||42
10199182|NCT03410862|11327576|FG000|NOT COMPLETED|Overall Study||2
10199183|NCT03410862|11327577|FG001|NOT COMPLETED|Overall Study||2
10199184|NCT03410914|11327583|FG000|STARTED|Overall Study||52
10199185|NCT03410914|11327583|FG000|COMPLETED|Overall Study||52
10199186|NCT03410914|11327583|FG000|NOT COMPLETED|Overall Study||0
10082458|NCT02268786|11211049|FG001|STARTED|Overall Study||331
10082459|NCT02268786|11211048|FG000|COMPLETED|Overall Study||274
10199187|NCT03410953|11327587|FG000|STARTED|Overall Study|First patient recruited|67
10199188|NCT03410953|11327587|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
10199189|NCT03410953|11327587|FG000|NOT COMPLETED|Overall Study||0
10199190|NCT03411902|11327593|FG000|STARTED|Overall Study||11
10199191|NCT03411902|11327594|FG001|STARTED|Overall Study||13
10199192|NCT03411902|11327593|FG000|COMPLETED|Overall Study||8
10199193|NCT03411902|11327594|FG001|COMPLETED|Overall Study||13
10199194|NCT03411902|11327593|FG000|NOT COMPLETED|Overall Study||3
10199195|NCT03411902|11327594|FG001|NOT COMPLETED|Overall Study||0
10082460|NCT02268786|11211049|FG001|COMPLETED|Overall Study||313
10082461|NCT02268786|11211048|FG000|NOT COMPLETED|Overall Study||56
10082462|NCT02268786|11211049|FG001|NOT COMPLETED|Overall Study||18
10082463|NCT02268812|11211059|FG000|STARTED|Overall Study||77
10082464|NCT02268812|11211060|FG001|STARTED|Overall Study||72
10082465|NCT02268812|11211061|FG002|STARTED|Overall Study||30
10082466|NCT02268812|11211062|FG003|STARTED|Overall Study||40
10082467|NCT02268812|11211059|FG000|COMPLETED|Overall Study||61
10082468|NCT02268812|11211060|FG001|COMPLETED|Overall Study||40
10082469|NCT02268812|11211061|FG002|COMPLETED|Overall Study||21
10199196|NCT03412019|11327602|FG000|STARTED|Overall Study||11
10199197|NCT03412019|11327603|FG001|STARTED|Overall Study||11
10199198|NCT03412019|11327602|FG000|COMPLETED|Overall Study||10
10199199|NCT03412019|11327603|FG001|COMPLETED|Overall Study||10
10199200|NCT03412019|11327602|FG000|NOT COMPLETED|Overall Study||1
10199201|NCT03412019|11327603|FG001|NOT COMPLETED|Overall Study||1
10199202|NCT03412084|11327611|FG000|STARTED|Overall Study||48
10199203|NCT03412084|11327612|FG001|STARTED|Overall Study||36
10199204|NCT03412084|11327611|FG000|COMPLETED|Overall Study||44
10199205|NCT03412084|11327612|FG001|COMPLETED|Overall Study||35
10199206|NCT03412084|11327611|FG000|NOT COMPLETED|Overall Study||4
10199207|NCT03412084|11327612|FG001|NOT COMPLETED|Overall Study||1
10199208|NCT03412734|11327620|FG000|STARTED|Overall Study||47
10199209|NCT03412734|11327621|FG001|STARTED|Overall Study||41
10199210|NCT03412734|11327620|FG000|COMPLETED|Overall Study||44
10199211|NCT03412734|11327621|FG001|COMPLETED|Overall Study||41
10199212|NCT03412734|11327620|FG000|NOT COMPLETED|Overall Study||3
10199213|NCT03412734|11327621|FG001|NOT COMPLETED|Overall Study||0
10199214|NCT03412929|11327627|FG000|STARTED|Overall Study||8
10199215|NCT03412929|11327627|FG000|COMPLETED|Overall Study||5
10199216|NCT03412929|11327627|FG000|NOT COMPLETED|Overall Study||3
10199217|NCT03413618|11327633|FG000|STARTED|Overall Study||45
10199218|NCT03413618|11327634|FG001|STARTED|Overall Study||45
10199219|NCT03413618|11327633|FG000|COMPLETED|Overall Study||45
10199220|NCT03413618|11327634|FG001|COMPLETED|Overall Study||45
10199221|NCT03413618|11327633|FG000|NOT COMPLETED|Overall Study||0
10199222|NCT03413618|11327634|FG001|NOT COMPLETED|Overall Study||0
10199223|NCT03414047|11327644|FG000|STARTED|Overall Study||53
10199224|NCT03414047|11327645|FG001|STARTED|Overall Study||46
10199225|NCT03414047|11327646|FG002|STARTED|Overall Study||41
10199226|NCT03414047|11327647|FG003|STARTED|Overall Study||29
10199227|NCT03414047|11327644|FG000|Received at Least One Dose of Study Drug|Overall Study||53
10199228|NCT03414047|11327645|FG001|Received at Least One Dose of Study Drug|Overall Study||46
10238658|NCT00491400|11370131|FG001|STARTED|Overall Study||13
10082470|NCT02268812|11211062|FG003|COMPLETED|Overall Study||26
10082471|NCT02268812|11211059|FG000|NOT COMPLETED|Overall Study||16
10082472|NCT02268812|11211060|FG001|NOT COMPLETED|Overall Study||32
10082473|NCT02268812|11211061|FG002|NOT COMPLETED|Overall Study||9
10082474|NCT02268812|11211062|FG003|NOT COMPLETED|Overall Study||14
10082475|NCT02268851|11211078|FG000|STARTED|Overall Study||3
10082476|NCT02268851|11211079|FG001|STARTED|Overall Study||3
10082477|NCT02268851|11211080|FG002|STARTED|Overall Study||4
10082478|NCT02268851|11211081|FG003|STARTED|Overall Study||3
10082479|NCT02268851|11211082|FG004|STARTED|Overall Study||15
10082480|NCT02268851|11211083|FG005|STARTED|Overall Study||15
10082481|NCT02268851|11211078|FG000|COMPLETED|Overall Study||2
10082482|NCT02268851|11211079|FG001|COMPLETED|Overall Study||0
10082483|NCT02268851|11211080|FG002|COMPLETED|Overall Study||3
10082484|NCT02268851|11211081|FG003|COMPLETED|Overall Study||0
10082485|NCT02268851|11211082|FG004|COMPLETED|Overall Study||8
10082486|NCT02268851|11211083|FG005|COMPLETED|Overall Study||4
10082487|NCT02268851|11211078|FG000|NOT COMPLETED|Overall Study||1
10082488|NCT02268851|11211079|FG001|NOT COMPLETED|Overall Study||3
10082489|NCT02268851|11211080|FG002|NOT COMPLETED|Overall Study||1
10082490|NCT02268851|11211081|FG003|NOT COMPLETED|Overall Study||3
10082491|NCT02268851|11211082|FG004|NOT COMPLETED|Overall Study||7
10082492|NCT02268851|11211083|FG005|NOT COMPLETED|Overall Study||11
10082493|NCT02268864|11211100|FG000|STARTED|Overall Study||17
10082494|NCT02268864|11211101|FG001|STARTED|Overall Study||25
10082495|NCT02268864|11211102|FG002|STARTED|Overall Study||64
10082496|NCT02268864|11211100|FG000|COMPLETED|Overall Study||15
10082497|NCT02268864|11211101|FG001|COMPLETED|Overall Study||24
10082498|NCT02268864|11211102|FG002|COMPLETED|Overall Study||64
10082499|NCT02268864|11211100|FG000|NOT COMPLETED|Overall Study||2
10082500|NCT02268864|11211101|FG001|NOT COMPLETED|Overall Study||1
10082501|NCT02268864|11211102|FG002|NOT COMPLETED|Overall Study||0
10082502|NCT02268877|11211114|FG000|STARTED|Overall Study||122
10082503|NCT02268877|11211115|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111
10082504|NCT02268877|11211114|FG000|COMPLETED|Overall Study||118
10082505|NCT02268877|11211115|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106
10082506|NCT02268877|11211114|FG000|NOT COMPLETED|Overall Study||4
10082507|NCT02268877|11211115|FG001|NOT COMPLETED|Overall Study||5
10082508|NCT02268942|11211121|FG000|STARTED|Overall Study||144
10082509|NCT02268942|11211121|FG000|COMPLETED|Overall Study||144
10082510|NCT02268942|11211121|FG000|NOT COMPLETED|Overall Study||0
10082511|NCT02268955|11211127|FG000|STARTED|Overall Study||11
10082512|NCT02268955|11211128|FG001|STARTED|Overall Study||11
10082513|NCT02268955|11211127|FG000|COMPLETED|Overall Study||9
9735689|NCT00183469|10836251|FG000|STARTED|Overall Study||41
9735690|NCT00183469|10836252|FG001|STARTED|Overall Study||45
9735691|NCT00183469|10836251|FG000|COMPLETED|Overall Study||13
9735692|NCT00183469|10836252|FG001|COMPLETED|Overall Study||16
9735693|NCT00183469|10836251|FG000|NOT COMPLETED|Overall Study||28
9735694|NCT00183469|10836252|FG001|NOT COMPLETED|Overall Study||29
9735695|NCT00183625|10836260|FG000|STARTED|Overall Study||27
9735696|NCT00183625|10836261|FG001|STARTED|Overall Study||28
9735697|NCT00183625|10836262|FG002|STARTED|Overall Study||28
9735698|NCT00183625|10836263|FG003|STARTED|Overall Study||24
9735699|NCT00183625|10836260|FG000|Obtained Employment|Overall Study||21
9735700|NCT00183625|10836261|FG001|Obtained Employment|Overall Study||18
9735701|NCT00183625|10836262|FG002|Obtained Employment|Overall Study||14
9735702|NCT00183625|10836263|FG003|Obtained Employment|Overall Study||14
9735703|NCT00183625|10836260|FG000|COMPLETED|Overall Study||9
9735704|NCT00183625|10836261|FG001|COMPLETED|Overall Study||10
9735705|NCT00183625|10836262|FG002|COMPLETED|Overall Study||9
9735706|NCT00183625|10836263|FG003|COMPLETED|Overall Study||10
9735707|NCT00183625|10836260|FG000|NOT COMPLETED|Overall Study||18
9735708|NCT00183625|10836261|FG001|NOT COMPLETED|Overall Study||18
9735709|NCT00183625|10836262|FG002|NOT COMPLETED|Overall Study||19
9735710|NCT00183625|10836263|FG003|NOT COMPLETED|Overall Study||14
9735711|NCT00183677|10836271|FG000|STARTED|Overall Study||97
9735712|NCT00183677|10836271|FG000|COMPLETED|Overall Study||53
9735713|NCT00183677|10836271|FG000|NOT COMPLETED|Overall Study||44
9735714|NCT00183729|10836277|FG000|STARTED|Overall Study||17
9735715|NCT00183729|10836278|FG001|STARTED|Overall Study||18
9735716|NCT00183729|10836277|FG000|COMPLETED|Overall Study||14
9735717|NCT00183729|10836278|FG001|COMPLETED|Overall Study||13
9735718|NCT00183729|10836277|FG000|NOT COMPLETED|Overall Study||3
9735719|NCT00183729|10836278|FG001|NOT COMPLETED|Overall Study||5
9735720|NCT00183794|10836284|FG000|STARTED|Overall Study||20
9735721|NCT00183794|10836284|FG000|COMPLETED|Overall Study||20
9735722|NCT00183794|10836284|FG000|NOT COMPLETED|Overall Study||0
9735723|NCT00183872|10836288|FG000|STARTED|Overall Study||40
9735724|NCT00183872|10836288|FG000|COMPLETED|Overall Study||24
9735725|NCT00183872|10836288|FG000|NOT COMPLETED|Overall Study||16
9735726|NCT00184002|10836292|FG000|STARTED|Overall Study||68
9735727|NCT00184002|10836292|FG000|COMPLETED|Overall Study||51
9735728|NCT00184002|10836292|FG000|NOT COMPLETED|Overall Study||17
9735729|NCT00184028|10836296|FG000|STARTED|Overall Study||12
9735730|NCT00184028|10836296|FG000|COMPLETED|Overall Study||2
9735731|NCT00184028|10836296|FG000|NOT COMPLETED|Overall Study||10
10082514|NCT02268955|11211128|FG001|COMPLETED|Overall Study||9
10082515|NCT02268955|11211127|FG000|NOT COMPLETED|Overall Study||2
10082516|NCT02268955|11211128|FG001|NOT COMPLETED|Overall Study||2
10082517|NCT02268994|11211136|FG000|STARTED|Overall Study||117
10082518|NCT02268994|11211137|FG001|STARTED|Overall Study||116
10082519|NCT02268994|11211136|FG000|COMPLETED|Overall Study||86
10082520|NCT02268994|11211137|FG001|COMPLETED|Overall Study||81
10082521|NCT02268994|11211136|FG000|NOT COMPLETED|Overall Study||31
9735732|NCT00184054|10836301|FG000|STARTED|Overall Study||11
9735733|NCT00184054|10836301|FG000|COMPLETED|Overall Study||10
9735734|NCT00184054|10836301|FG000|NOT COMPLETED|Overall Study||1
9735735|NCT00184093|10836305|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
9735736|NCT00184093|10836305|FG000|COMPLETED|Overall Study||26
9735737|NCT00184093|10836305|FG000|NOT COMPLETED|Overall Study||9
9735738|NCT00184548|10836313|FG000|STARTED|Overall Study||226
9735739|NCT00184548|10836314|FG001|STARTED|Overall Study||255
9735740|NCT00184548|10836315|FG002|STARTED|Overall Study||47
10082522|NCT02268994|11211137|FG001|NOT COMPLETED|Overall Study||35
10082523|NCT02269098|11211148|FG000|STARTED|Overall Study||51
10082524|NCT02269098|11211149|FG001|STARTED|Overall Study||50
10082525|NCT02269098|11211148|FG000|COMPLETED|Overall Study||37
10082526|NCT02269098|11211149|FG001|COMPLETED|Overall Study||41
10082527|NCT02269098|11211148|FG000|NOT COMPLETED|Overall Study||14
10082528|NCT02269098|11211149|FG001|NOT COMPLETED|Overall Study||9
10082529|NCT02269124|11211158|FG000|STARTED|Overall Study||21
10082530|NCT02269124|11211159|FG001|STARTED|Overall Study||16
10082531|NCT02269124|11211158|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
10082532|NCT02269124|11211159|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
10082533|NCT02269124|11211158|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
10082534|NCT02269124|11211159|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
10082535|NCT02269124|11211158|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
10082536|NCT02269124|11211159|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
10082537|NCT02269124|11211158|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
10082538|NCT02269124|11211159|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
10082539|NCT02269124|11211158|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
10082540|NCT02269124|11211159|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
10082541|NCT02269124|11211158|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
10082542|NCT02269124|11211159|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
10082543|NCT02269124|11211158|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
10082544|NCT02269124|11211159|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
10082545|NCT02269124|11211158|FG000|NOT COMPLETED|Overall Study||1
10082546|NCT02269124|11211159|FG001|NOT COMPLETED|Overall Study||2
10082547|NCT02269163|11211168|FG000|STARTED|Overall Study||50
10199229|NCT03414047|11327646|FG002|Received at Least One Dose of Study Drug|Overall Study||41
10199230|NCT03414047|11327647|FG003|Received at Least One Dose of Study Drug|Overall Study||29
10199231|NCT03414047|11327644|FG000|COMPLETED|Overall Study||51
10199232|NCT03414047|11327645|FG001|COMPLETED|Overall Study||46
10199233|NCT03414047|11327646|FG002|COMPLETED|Overall Study||38
10199234|NCT03414047|11327647|FG003|COMPLETED|Overall Study||27
10199235|NCT03414047|11327644|FG000|NOT COMPLETED|Overall Study||2
10199236|NCT03414047|11327645|FG001|NOT COMPLETED|Overall Study||0
10199237|NCT03414047|11327646|FG002|NOT COMPLETED|Overall Study||3
10199238|NCT03414047|11327647|FG003|NOT COMPLETED|Overall Study||2
10199239|NCT03414359|11327660|FG000|STARTED|Overall Study||35
10199240|NCT03414359|11327661|FG001|STARTED|Overall Study||35
10199241|NCT03414359|11327660|FG000|COMPLETED|Overall Study||34
10199242|NCT03414359|11327661|FG001|COMPLETED|Overall Study||33
10199243|NCT03414359|11327660|FG000|NOT COMPLETED|Overall Study||1
10199244|NCT03414359|11327661|FG001|NOT COMPLETED|Overall Study||2
10199245|NCT03415152|11327667|FG000|STARTED|Overall Study||3000
10199246|NCT03415152|11327667|FG000|COMPLETED|Overall Study||1975
10199247|NCT03415152|11327667|FG000|NOT COMPLETED|Overall Study||1025
10199248|NCT03415178|11327676|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
10199249|NCT03415178|11327677|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
10199250|NCT03415178|11327676|FG000|Treated|Parallel-Arm Period (up to Week 4)||34
10199251|NCT03415178|11327677|FG001|Treated|Parallel-Arm Period (up to Week 4)||33
10199252|NCT03415178|11327676|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
10199253|NCT03415178|11327677|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
9735741|NCT00184548|10836316|FG003|STARTED|Overall Study||45
10082548|NCT02269163|11211169|FG001|STARTED|Overall Study||25
10082549|NCT02269163|11211168|FG000|COMPLETED|Overall Study||47
10082550|NCT02269163|11211169|FG001|COMPLETED|Overall Study||18
10082551|NCT02269163|11211168|FG000|NOT COMPLETED|Overall Study||3
10082552|NCT02269163|11211169|FG001|NOT COMPLETED|Overall Study||7
10082553|NCT02269241|11211177|FG000|STARTED|Overall Study||1552
10082554|NCT02269241|11211177|FG000|COMPLETED|Overall Study||352
10082555|NCT02269241|11211177|FG000|NOT COMPLETED|Overall Study||1200
10082556|NCT02269423|11211186|FG000|STARTED|Overall Study||10
10082557|NCT02269423|11211187|FG001|STARTED|Overall Study||10
10082558|NCT02269423|11211188|FG002|STARTED|Overall Study||10
10082559|NCT02269423|11211189|FG003|STARTED|Overall Study||9
10082560|NCT02269423|11211186|FG000|COMPLETED|Overall Study||10
10082561|NCT02269423|11211187|FG001|COMPLETED|Overall Study||9
10082562|NCT02269423|11211188|FG002|COMPLETED|Overall Study||10
10082563|NCT02269423|11211189|FG003|COMPLETED|Overall Study||8
10082564|NCT02269423|11211186|FG000|NOT COMPLETED|Overall Study||0
10082565|NCT02269423|11211187|FG001|NOT COMPLETED|Overall Study||1
10082566|NCT02269423|11211188|FG002|NOT COMPLETED|Overall Study||0
10082567|NCT02269423|11211189|FG003|NOT COMPLETED|Overall Study||1
10082568|NCT02269475|11211201|FG000|STARTED|Overall Study||868
10082569|NCT02269475|11211202|FG001|STARTED|Overall Study||433
10082570|NCT02269475|11211201|FG000|Received IP (Safety Population)|Overall Study||868
10082571|NCT02269475|11211202|FG001|Received IP (Safety Population)|Overall Study||433
10082572|NCT02269475|11211201|FG000|Per Protocol Population|Overall Study||849
10082573|NCT02269475|11211202|FG001|Per Protocol Population|Overall Study||430
10082574|NCT02269475|11211201|FG000|COMPLETED|Overall Study||865
10082575|NCT02269475|11211202|FG001|COMPLETED|Overall Study||432
10082576|NCT02269475|11211201|FG000|NOT COMPLETED|Overall Study||3
10082577|NCT02269475|11211202|FG001|NOT COMPLETED|Overall Study||1
10082578|NCT02269488|11211209|FG000|STARTED|Overall Study||100
10082579|NCT02269488|11211209|FG000|COMPLETED|Overall Study||100
10082580|NCT02269488|11211209|FG000|NOT COMPLETED|Overall Study||0
10082581|NCT02269631|11211215|FG000|STARTED|Overall Study||7
10082582|NCT02269631|11211216|FG001|STARTED|Overall Study||5
10082583|NCT02269631|11211215|FG000|COMPLETED|Overall Study||7
10082584|NCT02269631|11211216|FG001|COMPLETED|Overall Study||5
10082585|NCT02269631|11211215|FG000|NOT COMPLETED|Overall Study||0
10082586|NCT02269631|11211216|FG001|NOT COMPLETED|Overall Study||0
10082587|NCT02269657|11211222|FG000|STARTED|Overall Study||40
10082588|NCT02269657|11211222|FG000|COMPLETED|Overall Study||37
10082589|NCT02269657|11211222|FG000|NOT COMPLETED|Overall Study||3
10082590|NCT02269709|11211228|FG000|STARTED|Time of Enrollment||21
10082591|NCT02269709|11211228|FG000|COMPLETED|Time of Enrollment||18
10082592|NCT02269709|11211228|FG000|NOT COMPLETED|Time of Enrollment||3
10082593|NCT02269709|11211228|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
10082594|NCT02269709|11211228|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
10082595|NCT02269709|11211228|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
10082596|NCT02269709|11211228|FG000|STARTED|Prior to Hospital Discharge||17
10082597|NCT02269709|11211228|FG000|COMPLETED|Prior to Hospital Discharge||17
9828033|NCT00753766|10938740|FG000|STARTED|Overall Study||1
10082598|NCT02269709|11211228|FG000|NOT COMPLETED|Prior to Hospital Discharge||0
10082599|NCT02269709|11211228|FG000|STARTED|Six Month Follow-up||17
10082600|NCT02269709|11211228|FG000|COMPLETED|Six Month Follow-up||5
10082601|NCT02269709|11211228|FG000|NOT COMPLETED|Six Month Follow-up||12
10082602|NCT02269787|11211235|FG000|STARTED|Overall Study||148
10082603|NCT02269787|11211236|FG001|STARTED|Overall Study||150
10082604|NCT02269787|11211235|FG000|COMPLETED|Overall Study||126
10082605|NCT02269787|11211236|FG001|COMPLETED|Overall Study||140
10082606|NCT02269787|11211235|FG000|NOT COMPLETED|Overall Study||22
10082607|NCT02269787|11211236|FG001|NOT COMPLETED|Overall Study||10
10082608|NCT02269943|11211244|FG000|STARTED|Treatment Period||6
10082609|NCT02269943|11211245|FG001|STARTED|Treatment Period||30
10112695|NCT02504554|11243612|FG001|NOT COMPLETED|Overall Study||0
10082610|NCT02269943|11211244|FG000|Investigational Product (IP) Stopped|Treatment Period||6
10082611|NCT02269943|11211245|FG001|Investigational Product (IP) Stopped|Treatment Period||30
10082612|NCT02269943|11211244|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0
10082613|NCT02269943|11211245|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0
10082614|NCT02269943|11211244|FG000|NOT COMPLETED|Treatment Period||6
9828034|NCT00753766|10938741|FG001|STARTED|Overall Study||0
10082615|NCT02269943|11211245|FG001|NOT COMPLETED|Treatment Period||30
10082616|NCT02269943|11211244|FG000|STARTED|Follow-Up Survival Period||5
10082617|NCT02269943|11211245|FG001|STARTED|Follow-Up Survival Period||26
10082618|NCT02269943|11211244|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
10082619|NCT02269943|11211245|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
10082620|NCT02269943|11211244|FG000|NOT COMPLETED|Follow-Up Survival Period||5
10082621|NCT02269943|11211245|FG001|NOT COMPLETED|Follow-Up Survival Period||26
10082622|NCT02270060|11211254|FG000|STARTED|Overall Study||20
10082623|NCT02270060|11211255|FG001|STARTED|Overall Study||20
10082624|NCT02270060|11211256|FG002|STARTED|Overall Study||20
10082625|NCT02270060|11211254|FG000|COMPLETED|Overall Study||20
10082626|NCT02270060|11211255|FG001|COMPLETED|Overall Study||20
10199254|NCT03415178|11327676|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
10199255|NCT03415178|11327677|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
10199256|NCT03415178|11327676|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
10082627|NCT02270060|11211256|FG002|COMPLETED|Overall Study||20
10082628|NCT02270060|11211254|FG000|NOT COMPLETED|Overall Study||0
10082629|NCT02270060|11211255|FG001|NOT COMPLETED|Overall Study||0
10082630|NCT02270060|11211256|FG002|NOT COMPLETED|Overall Study||0
10082631|NCT02270242|11211266|FG000|STARTED|Overall Study||3555
10082632|NCT02270242|11211267|FG001|STARTED|Overall Study||3564
10082633|NCT02270242|11211266|FG000|COMPLETED|Overall Study||3496
10082634|NCT02270242|11211267|FG001|COMPLETED|Overall Study||3511
10082635|NCT02270242|11211266|FG000|NOT COMPLETED|Overall Study||59
10082636|NCT02270242|11211267|FG001|NOT COMPLETED|Overall Study||53
10082637|NCT02270255|11211275|FG000|STARTED|Overall Study||22
10082638|NCT02270255|11211276|FG001|STARTED|Overall Study||22
10082639|NCT02270255|11211275|FG000|Complete Data at Discharge PACU|Overall Study||22
10082640|NCT02270255|11211276|FG001|Complete Data at Discharge PACU|Overall Study||22
10082641|NCT02270255|11211275|FG000|Complete Data From Home Survey|Overall Study||21
10082642|NCT02270255|11211276|FG001|Complete Data From Home Survey|Overall Study||22
10082643|NCT02270255|11211275|FG000|COMPLETED|Overall Study||21
10082644|NCT02270255|11211276|FG001|COMPLETED|Overall Study||22
10082645|NCT02270255|11211275|FG000|NOT COMPLETED|Overall Study||1
10082646|NCT02270255|11211276|FG001|NOT COMPLETED|Overall Study||0
10082647|NCT02270515|11211282|FG000|STARTED|Intervention Period 1: 0-6 Months||175
10082648|NCT02270515|11211282|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159
10082649|NCT02270515|11211282|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
10082650|NCT02270515|11211282|FG000|STARTED|Intervention Period 2: 6-12 Months||159
10082651|NCT02270515|11211282|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127
10082652|NCT02270515|11211282|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
10082653|NCT02270515|11211282|FG000|STARTED|Intervention Period 3: 12-18 Months||127
10082654|NCT02270515|11211282|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103
10082655|NCT02270515|11211282|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
10082656|NCT02270645|11211295|FG000|STARTED|Overall Study||8
10082657|NCT02270645|11211296|FG001|STARTED|Overall Study||4
10082658|NCT02270645|11211295|FG000|COMPLETED|Overall Study||6
10082659|NCT02270645|11211296|FG001|COMPLETED|Overall Study||4
10082660|NCT02270645|11211295|FG000|NOT COMPLETED|Overall Study||2
10082661|NCT02270645|11211296|FG001|NOT COMPLETED|Overall Study||0
10082662|NCT02270671|11211304|FG000|STARTED|Overall Study||64
10082663|NCT02270671|11211305|FG001|STARTED|Overall Study||66
10082664|NCT02270671|11211304|FG000|COMPLETED|Overall Study||59
10082665|NCT02270671|11211305|FG001|COMPLETED|Overall Study||61
10082666|NCT02270671|11211304|FG000|NOT COMPLETED|Overall Study||5
10082667|NCT02270671|11211305|FG001|NOT COMPLETED|Overall Study||5
10082668|NCT02270736|11211314|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72
10082669|NCT02270736|11211315|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148
10082670|NCT02270736|11211316|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36
10082671|NCT02270736|11211317|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0
10082672|NCT02270736|11211318|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0
10082673|NCT02270736|11211314|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72
10082674|NCT02270736|11211315|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148
10082675|NCT02270736|11211316|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35
10082676|NCT02270736|11211317|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0
10082677|NCT02270736|11211318|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0
10082678|NCT02270736|11211314|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
10082679|NCT02270736|11211315|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
10082680|NCT02270736|11211316|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
10082681|NCT02270736|11211317|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10082682|NCT02270736|11211318|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10082683|NCT02270736|11211314|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
10082684|NCT02270736|11211315|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
10082685|NCT02270736|11211316|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
10082686|NCT02270736|11211317|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10082687|NCT02270736|11211318|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10082688|NCT02270736|11211314|FG000|STARTED|OLEX Period (up to 48 Weeks)||0
10082689|NCT02270736|11211315|FG001|STARTED|OLEX Period (up to 48 Weeks)||0
10082690|NCT02270736|11211316|FG002|STARTED|OLEX Period (up to 48 Weeks)||0
10082691|NCT02270736|11211317|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
10082692|NCT02270736|11211318|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
10082693|NCT02270736|11211314|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0
10082694|NCT02270736|11211315|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0
10082695|NCT02270736|11211316|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0
10082696|NCT02270736|11211317|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189
10082697|NCT02270736|11211318|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33
10082698|NCT02270736|11211314|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10082699|NCT02270736|11211315|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10082700|NCT02270736|11211316|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10082701|NCT02270736|11211317|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
10082702|NCT02270736|11211318|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10082703|NCT02270944|11211333|FG000|STARTED|Overall Study||529
10082704|NCT02270944|11211334|FG001|STARTED|Overall Study||521
10082705|NCT02270944|11211333|FG000|COMPLETED|Overall Study||518
10082706|NCT02270944|11211334|FG001|COMPLETED|Overall Study||516
10082707|NCT02270944|11211333|FG000|NOT COMPLETED|Overall Study||11
10082708|NCT02270944|11211334|FG001|NOT COMPLETED|Overall Study||5
10082709|NCT02270983|11211344|FG000|STARTED|Overall Study||79
10082710|NCT02270983|11211345|FG001|STARTED|Overall Study||87
10082711|NCT02270983|11211346|FG002|STARTED|Overall Study||88
10082712|NCT02270983|11211344|FG000|COMPLETED|Overall Study||70
10082713|NCT02270983|11211345|FG001|COMPLETED|Overall Study||80
10082714|NCT02270983|11211346|FG002|COMPLETED|Overall Study||76
10082715|NCT02270983|11211344|FG000|NOT COMPLETED|Overall Study||9
10082716|NCT02270983|11211345|FG001|NOT COMPLETED|Overall Study||7
10082717|NCT02270983|11211346|FG002|NOT COMPLETED|Overall Study||12
10082718|NCT02271217|11211357|FG000|STARTED|Overall Study||126
10082719|NCT02271217|11211358|FG001|STARTED|Overall Study||126
10082720|NCT02271217|11211359|FG002|STARTED|Overall Study||125
10082721|NCT02271217|11211357|FG000|COMPLETED|Overall Study||115
10082722|NCT02271217|11211358|FG001|COMPLETED|Overall Study||113
10082723|NCT02271217|11211359|FG002|COMPLETED|Overall Study||113
10082724|NCT02271217|11211357|FG000|NOT COMPLETED|Overall Study||11
10082725|NCT02271217|11211358|FG001|NOT COMPLETED|Overall Study||13
10082726|NCT02271217|11211359|FG002|NOT COMPLETED|Overall Study||12
10082727|NCT02271386|11211371|FG000|STARTED|Baseline Period- 8 Months||53
10082728|NCT02271386|11211372|FG001|STARTED|Baseline Period- 8 Months||52
10082729|NCT02271386|11211373|FG002|STARTED|Baseline Period- 8 Months||200
10082730|NCT02271386|11211374|FG003|STARTED|Baseline Period- 8 Months||191
10082731|NCT02271386|11211371|FG000|COMPLETED|Baseline Period- 8 Months||53
10082732|NCT02271386|11211372|FG001|COMPLETED|Baseline Period- 8 Months||52
10082733|NCT02271386|11211373|FG002|COMPLETED|Baseline Period- 8 Months||200
10082734|NCT02271386|11211374|FG003|COMPLETED|Baseline Period- 8 Months||191
10082735|NCT02271386|11211371|FG000|NOT COMPLETED|Baseline Period- 8 Months||0
9851666|NCT00877448|10964434|FG005|STARTED|Overall Study||10
9851667|NCT00877448|10964435|FG006|STARTED|Overall Study||3
9851668|NCT00877448|10964429|FG000|COMPLETED|Overall Study||10
10082736|NCT02271386|11211372|FG001|NOT COMPLETED|Baseline Period- 8 Months||0
10082737|NCT02271386|11211373|FG002|NOT COMPLETED|Baseline Period- 8 Months||0
10082738|NCT02271386|11211374|FG003|NOT COMPLETED|Baseline Period- 8 Months||0
9851669|NCT00877448|10964430|FG001|COMPLETED|Overall Study||9
10082739|NCT02271386|11211371|FG000|STARTED|Intervention Period- 8 Months||53
10082740|NCT02271386|11211372|FG001|STARTED|Intervention Period- 8 Months||52
10082741|NCT02271386|11211373|FG002|STARTED|Intervention Period- 8 Months||202
10082742|NCT02271386|11211374|FG003|STARTED|Intervention Period- 8 Months||197
10082743|NCT02271386|11211371|FG000|COMPLETED|Intervention Period- 8 Months||53
10082744|NCT02271386|11211372|FG001|COMPLETED|Intervention Period- 8 Months||52
10082745|NCT02271386|11211373|FG002|COMPLETED|Intervention Period- 8 Months||202
10082746|NCT02271386|11211374|FG003|COMPLETED|Intervention Period- 8 Months||197
10082747|NCT02271386|11211371|FG000|NOT COMPLETED|Intervention Period- 8 Months||0
10082748|NCT02271386|11211372|FG001|NOT COMPLETED|Intervention Period- 8 Months||0
10082749|NCT02271386|11211373|FG002|NOT COMPLETED|Intervention Period- 8 Months||0
9851670|NCT00877448|10964431|FG002|COMPLETED|Overall Study||10
9851671|NCT00877448|10964432|FG003|COMPLETED|Overall Study||9
10082750|NCT02271386|11211374|FG003|NOT COMPLETED|Intervention Period- 8 Months||0
10082751|NCT02271425|11211388|FG000|STARTED|Overall Study||8
10082752|NCT02271425|11211388|FG000|COMPLETED|Overall Study||8
10082753|NCT02271425|11211388|FG000|NOT COMPLETED|Overall Study||0
10082754|NCT02271451|11211395|FG000|STARTED|Overall Study||7
10082755|NCT02271451|11211396|FG001|STARTED|Overall Study||8
10082756|NCT02271451|11211395|FG000|COMPLETED|Overall Study||7
10082757|NCT02271451|11211396|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
10082758|NCT02271451|11211395|FG000|NOT COMPLETED|Overall Study||0
10082759|NCT02271451|11211396|FG001|NOT COMPLETED|Overall Study||1
10082760|NCT02271477|11211404|FG000|STARTED|Overall Study||80
10082761|NCT02271477|11211405|FG001|STARTED|Overall Study||80
10082762|NCT02271477|11211404|FG000|COMPLETED|Overall Study||80
10082763|NCT02271477|11211405|FG001|COMPLETED|Overall Study||80
10082764|NCT02271477|11211404|FG000|NOT COMPLETED|Overall Study||0
10082765|NCT02271477|11211405|FG001|NOT COMPLETED|Overall Study||0
10082766|NCT02271529|11211412|FG000|STARTED|Overall Study||40
10082767|NCT02271529|11211412|FG000|COMPLETED|Overall Study||39
10082768|NCT02271529|11211412|FG000|NOT COMPLETED|Overall Study||1
10082769|NCT02271698|11211420|FG000|STARTED|Overall Study||11
10082770|NCT02271698|11211421|FG001|STARTED|Overall Study||10
10082771|NCT02271698|11211422|FG002|STARTED|Overall Study||10
9851672|NCT00877448|10964433|FG004|COMPLETED|Overall Study||10
10082772|NCT02271698|11211423|FG003|STARTED|Overall Study||11
10082773|NCT02271698|11211420|FG000|COMPLETED|Overall Study||11
10082774|NCT02271698|11211421|FG001|COMPLETED|Overall Study||10
10082775|NCT02271698|11211422|FG002|COMPLETED|Overall Study||10
10082776|NCT02271698|11211423|FG003|COMPLETED|Overall Study||11
10199257|NCT03415178|11327677|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
10082777|NCT02271698|11211420|FG000|NOT COMPLETED|Overall Study||0
10199258|NCT03415178|11327676|FG000|COMPLETED|Single Arm Period (up to Week 16)||0
10199259|NCT03415178|11327677|FG001|COMPLETED|Single Arm Period (up to Week 16)||65
10199260|NCT03415178|11327676|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0
10199261|NCT03415178|11327677|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1
10199262|NCT03415243|11327689|FG000|STARTED|Overall Study||14
10199263|NCT03415243|11327690|FG001|STARTED|Overall Study||14
10199264|NCT03415243|11327689|FG000|COMPLETED|Overall Study||14
10199265|NCT03415243|11327690|FG001|COMPLETED|Overall Study||14
10199266|NCT03415243|11327689|FG000|NOT COMPLETED|Overall Study||0
10199267|NCT03415243|11327690|FG001|NOT COMPLETED|Overall Study||0
10199268|NCT03415581|11327698|FG000|STARTED|Overall Study||7
10199269|NCT03415581|11327699|FG001|STARTED|Overall Study||6
10199270|NCT03415581|11327698|FG000|COMPLETED|Overall Study||1
10199271|NCT03415581|11327699|FG001|COMPLETED|Overall Study||1
10199272|NCT03415581|11327698|FG000|NOT COMPLETED|Overall Study||6
10082778|NCT02271698|11211421|FG001|NOT COMPLETED|Overall Study||0
10082779|NCT02271698|11211422|FG002|NOT COMPLETED|Overall Study||0
10082780|NCT02271698|11211423|FG003|NOT COMPLETED|Overall Study||0
10082781|NCT02271854|11211433|FG000|STARTED|Overall Study||102
10082782|NCT02271854|11211433|FG000|COMPLETED|Overall Study||98
10082783|NCT02271854|11211433|FG000|NOT COMPLETED|Overall Study||4
10082784|NCT02271880|11211440|FG000|STARTED|Overall Study||3
10082785|NCT02271880|11211441|FG001|STARTED|Overall Study||4
10082786|NCT02271880|11211440|FG000|COMPLETED|Overall Study||0
10082787|NCT02271880|11211441|FG001|COMPLETED|Overall Study||0
10082788|NCT02271880|11211440|FG000|NOT COMPLETED|Overall Study||3
10082789|NCT02271880|11211441|FG001|NOT COMPLETED|Overall Study||4
10082790|NCT02271906|11211449|FG000|STARTED|Overall Study||2
10082791|NCT02271906|11211449|FG000|COMPLETED|Overall Study||2
10082792|NCT02271906|11211449|FG000|NOT COMPLETED|Overall Study||0
10082793|NCT02271945|11211455|FG000|STARTED|Overall Study||5
10082794|NCT02271945|11211456|FG001|STARTED|Overall Study||5
10082795|NCT02271945|11211455|FG000|COMPLETED|Overall Study||0
10082796|NCT02271945|11211456|FG001|COMPLETED|Overall Study||0
10082797|NCT02271945|11211455|FG000|NOT COMPLETED|Overall Study||5
10082798|NCT02271945|11211456|FG001|NOT COMPLETED|Overall Study||5
10082799|NCT02271984|11211462|FG000|STARTED|First Intervention Period (1 Day)||3
10082800|NCT02271984|11211463|FG001|STARTED|First Intervention Period (1 Day)||3
10082801|NCT02271984|11211464|FG002|STARTED|First Intervention Period (1 Day)||3
10082802|NCT02271984|11211465|FG003|STARTED|First Intervention Period (1 Day)||3
10082803|NCT02271984|11211466|FG004|STARTED|First Intervention Period (1 Day)||3
10082804|NCT02271984|11211467|FG005|STARTED|First Intervention Period (1 Day)||3
10082805|NCT02271984|11211468|FG006|STARTED|First Intervention Period (1 Day)||3
10082806|NCT02271984|11211469|FG007|STARTED|First Intervention Period (1 Day)||3
10082807|NCT02271984|11211470|FG008|STARTED|First Intervention Period (1 Day)||3
10082808|NCT02271984|11211471|FG009|STARTED|First Intervention Period (1 Day)||3
10082809|NCT02271984|11211472|FG010|STARTED|First Intervention Period (1 Day)||3
10082810|NCT02271984|11211473|FG011|STARTED|First Intervention Period (1 Day)||3
10082811|NCT02271984|11211462|FG000|COMPLETED|First Intervention Period (1 Day)||3
10082812|NCT02271984|11211463|FG001|COMPLETED|First Intervention Period (1 Day)||3
10082813|NCT02271984|11211464|FG002|COMPLETED|First Intervention Period (1 Day)||3
10082814|NCT02271984|11211465|FG003|COMPLETED|First Intervention Period (1 Day)||3
10082815|NCT02271984|11211466|FG004|COMPLETED|First Intervention Period (1 Day)||3
10082816|NCT02271984|11211467|FG005|COMPLETED|First Intervention Period (1 Day)||3
10082817|NCT02271984|11211468|FG006|COMPLETED|First Intervention Period (1 Day)||3
10082818|NCT02271984|11211469|FG007|COMPLETED|First Intervention Period (1 Day)||3
10082819|NCT02271984|11211470|FG008|COMPLETED|First Intervention Period (1 Day)||3
10082820|NCT02271984|11211471|FG009|COMPLETED|First Intervention Period (1 Day)||3
10082821|NCT02271984|11211472|FG010|COMPLETED|First Intervention Period (1 Day)||3
9735742|NCT00184548|10836313|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
9735743|NCT00184548|10836314|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
9735744|NCT00184548|10836315|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
9735745|NCT00184548|10836316|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
9735746|NCT00184548|10836313|FG000|COMPLETED|Overall Study||218
9735747|NCT00184548|10836314|FG001|COMPLETED|Overall Study||242
9735748|NCT00184548|10836315|FG002|COMPLETED|Overall Study||44
9735749|NCT00184548|10836316|FG003|COMPLETED|Overall Study||38
9735750|NCT00184548|10836313|FG000|NOT COMPLETED|Overall Study||8
9735751|NCT00184548|10836314|FG001|NOT COMPLETED|Overall Study||13
9735752|NCT00184548|10836315|FG002|NOT COMPLETED|Overall Study||3
9735753|NCT00184548|10836316|FG003|NOT COMPLETED|Overall Study||7
9735754|NCT00184600|10836329|FG000|STARTED|Overall Study||234
9735755|NCT00184600|10836330|FG001|STARTED|Overall Study||239
9735756|NCT00184600|10836331|FG002|STARTED|Overall Study||235
9735757|NCT00184600|10836329|FG000|COMPLETED|Overall Study||189
9735758|NCT00184600|10836330|FG001|COMPLETED|Overall Study||188
9735759|NCT00184600|10836331|FG002|COMPLETED|Overall Study||201
9735760|NCT00184600|10836329|FG000|NOT COMPLETED|Overall Study||45
9735761|NCT00184600|10836330|FG001|NOT COMPLETED|Overall Study||51
9735762|NCT00184600|10836331|FG002|NOT COMPLETED|Overall Study||34
9735763|NCT00184717|10836342|FG000|STARTED|Main Period (GHLIQUID-1516)||39
9735764|NCT00184717|10836343|FG001|STARTED|Main Period (GHLIQUID-1516)||38
9735765|NCT00184717|10836344|FG002|STARTED|Main Period (GHLIQUID-1516)||21
9735766|NCT00184717|10836345|FG003|STARTED|Main Period (GHLIQUID-1516)||0
9735767|NCT00184717|10836346|FG004|STARTED|Main Period (GHLIQUID-1516)||0
9735768|NCT00184717|10836342|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
9735769|NCT00184717|10836343|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
9735770|NCT00184717|10836344|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
10082822|NCT02271984|11211473|FG011|COMPLETED|First Intervention Period (1 Day)||3
10082823|NCT02271984|11211462|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
10082824|NCT02271984|11211463|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
10082825|NCT02271984|11211464|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
10082826|NCT02271984|11211465|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
10082827|NCT02271984|11211466|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
10082828|NCT02271984|11211467|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
10082829|NCT02271984|11211468|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
10082830|NCT02271984|11211469|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
10082831|NCT02271984|11211470|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
9735771|NCT00184717|10836345|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
9735772|NCT00184717|10836346|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
9735773|NCT00184717|10836342|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36
9735774|NCT00184717|10836343|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36
9735775|NCT00184717|10836344|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20
9735776|NCT00184717|10836345|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0
9735777|NCT00184717|10836346|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0
9735778|NCT00184717|10836342|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
9735779|NCT00184717|10836343|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
9735780|NCT00184717|10836344|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
9735781|NCT00184717|10836345|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
9735782|NCT00184717|10836346|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
9735783|NCT00184717|10836342|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
9735784|NCT00184717|10836343|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
9735785|NCT00184717|10836344|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
9735786|NCT00184717|10836345|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
9735787|NCT00184717|10836346|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
9735788|NCT00184717|10836342|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23
9735789|NCT00184717|10836343|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27
9735790|NCT00184717|10836344|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0
9735791|NCT00184717|10836345|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7
9735792|NCT00184717|10836346|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5
9735793|NCT00184717|10836342|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
9735794|NCT00184717|10836343|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
9735795|NCT00184717|10836344|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
9735796|NCT00184717|10836345|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
9735797|NCT00184717|10836346|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
9735798|NCT00185211|10836358|FG000|STARTED|Placebo-controlled Study (92012)||292
9735799|NCT00185211|10836359|FG001|STARTED|Placebo-controlled Study (92012)||176
9735800|NCT00185211|10836358|FG000|COMPLETED|Placebo-controlled Study (92012)||271
9735801|NCT00185211|10836359|FG001|COMPLETED|Placebo-controlled Study (92012)||166
9735802|NCT00185211|10836358|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21
9735803|NCT00185211|10836359|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10
9735804|NCT00185211|10836358|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
9735805|NCT00185211|10836359|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
9735806|NCT00185211|10836358|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235
9735807|NCT00185211|10836359|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123
9735808|NCT00185211|10836358|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
9735809|NCT00185211|10836359|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
9735810|NCT00185380|10836369|FG000|STARTED|Overall Study||240
9735811|NCT00185380|10836370|FG001|STARTED|Overall Study||246
9735812|NCT00185380|10836371|FG002|STARTED|Overall Study||256
9735813|NCT00185380|10836369|FG000|Subjects Received Treatment|Overall Study||239
9735814|NCT00185380|10836370|FG001|Subjects Received Treatment|Overall Study||245
9735815|NCT00185380|10836371|FG002|Subjects Received Treatment|Overall Study||254
9735816|NCT00185380|10836369|FG000|COMPLETED|Overall Study||174
9735817|NCT00185380|10836370|FG001|COMPLETED|Overall Study||174
9735818|NCT00185380|10836371|FG002|COMPLETED|Overall Study||182
9735819|NCT00185380|10836369|FG000|NOT COMPLETED|Overall Study||66
9735820|NCT00185380|10836370|FG001|NOT COMPLETED|Overall Study||72
9735821|NCT00185380|10836371|FG002|NOT COMPLETED|Overall Study||74
9735822|NCT00185458|10836379|FG000|STARTED|Contraception Phase||394
9735823|NCT00185458|10836379|FG000|COMPLETED|Contraception Phase||336
9735824|NCT00185458|10836379|FG000|NOT COMPLETED|Contraception Phase||58
9735825|NCT00185458|10836379|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
9735826|NCT00185458|10836379|FG000|COMPLETED|HRT Phase||141
9735827|NCT00185458|10836379|FG000|NOT COMPLETED|HRT Phase||27
9735828|NCT00185588|10836395|FG000|STARTED|Overall Study||6
9735829|NCT00185588|10836396|FG001|STARTED|Overall Study||4
9735830|NCT00185588|10836397|FG002|STARTED|Overall Study||6
9735831|NCT00185588|10836398|FG003|STARTED|Overall Study||17
9735832|NCT00185588|10836395|FG000|COMPLETED|Overall Study||3
9735833|NCT00185588|10836396|FG001|COMPLETED|Overall Study||2
9735834|NCT00185588|10836397|FG002|COMPLETED|Overall Study||0
9735835|NCT00185588|10836398|FG003|COMPLETED|Overall Study||13
9735836|NCT00185588|10836395|FG000|NOT COMPLETED|Overall Study||3
9735837|NCT00185588|10836396|FG001|NOT COMPLETED|Overall Study||2
9735838|NCT00185588|10836397|FG002|NOT COMPLETED|Overall Study||6
9735839|NCT00185588|10836398|FG003|NOT COMPLETED|Overall Study||4
9735840|NCT00185614|10836408|FG000|STARTED|Autologous HCT (Auto-HCT)||63
9735841|NCT00185614|10836408|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63
9735842|NCT00185614|10836408|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
9735843|NCT00185614|10836408|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
10082832|NCT02271984|11211471|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0
10082833|NCT02271984|11211472|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0
10082834|NCT02271984|11211473|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0
10082835|NCT02271984|11211462|FG000|STARTED|Washout Period 1 (7 Days)||3
10082836|NCT02271984|11211463|FG001|STARTED|Washout Period 1 (7 Days)||3
10082837|NCT02271984|11211464|FG002|STARTED|Washout Period 1 (7 Days)||3
10082838|NCT02271984|11211465|FG003|STARTED|Washout Period 1 (7 Days)||3
10082839|NCT02271984|11211466|FG004|STARTED|Washout Period 1 (7 Days)||3
10082840|NCT02271984|11211467|FG005|STARTED|Washout Period 1 (7 Days)||3
10082841|NCT02271984|11211468|FG006|STARTED|Washout Period 1 (7 Days)||3
9735844|NCT00185614|10836408|FG000|COMPLETED|Inter-treatment Period||59
9735845|NCT00185614|10836408|FG000|NOT COMPLETED|Inter-treatment Period||4
9735846|NCT00185614|10836408|FG000|STARTED|Allogenic HCT (Allo-HCT)||59
9735847|NCT00185614|10836408|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59
9735848|NCT00185614|10836408|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
9735849|NCT00185640|10836412|FG000|STARTED|Overall Study||303
9735850|NCT00185640|10836412|FG000|Transplanted|Overall Study||296
9735851|NCT00185640|10836412|FG000|90 Days Post-transplant|Overall Study||161
9735852|NCT00185640|10836412|FG000|COMPLETED|Overall Study||158
9735853|NCT00185640|10836412|FG000|NOT COMPLETED|Overall Study||145
9735854|NCT00185679|10836416|FG000|STARTED|Overall Study||13
9735855|NCT00185679|10836416|FG000|COMPLETED|Overall Study||13
9735856|NCT00185679|10836416|FG000|NOT COMPLETED|Overall Study||0
9735857|NCT00185692|10836420|FG000|STARTED|Overall Study||16
9735858|NCT00185692|10836420|FG000|COMPLETED|Overall Study||0
9735859|NCT00185692|10836420|FG000|NOT COMPLETED|Overall Study||16
9735860|NCT00185731|10836424|FG000|STARTED|Overall Study||25
9735861|NCT00185731|10836424|FG000|COMPLETED|Overall Study||23
9735862|NCT00185731|10836424|FG000|NOT COMPLETED|Overall Study||2
9735863|NCT00185900|10836432|FG000|STARTED|Overall Study||92
9735864|NCT00185900|10836433|FG001|STARTED|Overall Study||100
9735865|NCT00185900|10836432|FG000|COMPLETED|Overall Study||92
9735866|NCT00185900|10836433|FG001|COMPLETED|Overall Study||100
9735867|NCT00185900|10836432|FG000|NOT COMPLETED|Overall Study||0
9735868|NCT00185900|10836433|FG001|NOT COMPLETED|Overall Study||0
9735869|NCT00185965|10836441|FG000|STARTED|Overall Study||15
9735870|NCT00185965|10836442|FG001|STARTED|Overall Study||15
9735871|NCT00185965|10836441|FG000|COMPLETED|Overall Study||15
9735872|NCT00185965|10836442|FG001|COMPLETED|Overall Study||14
9735873|NCT00185965|10836441|FG000|NOT COMPLETED|Overall Study||0
9735874|NCT00185965|10836442|FG001|NOT COMPLETED|Overall Study||1
9735875|NCT00186017|10836450|FG000|STARTED|Overall Study||25
9735876|NCT00186017|10836451|FG001|STARTED|Overall Study||25
9735877|NCT00186017|10836450|FG000|COMPLETED|Overall Study||23
9735878|NCT00186017|10836451|FG001|COMPLETED|Overall Study||22
9735879|NCT00186017|10836450|FG000|NOT COMPLETED|Overall Study||2
9735880|NCT00186017|10836451|FG001|NOT COMPLETED|Overall Study||3
9735881|NCT00186043|10836460|FG000|STARTED|Overall Study||30
9735882|NCT00186043|10836461|FG001|STARTED|Overall Study||25
9735883|NCT00186043|10836460|FG000|COMPLETED|Overall Study||15
9735884|NCT00186043|10836461|FG001|COMPLETED|Overall Study||12
9735885|NCT00186043|10836460|FG000|NOT COMPLETED|Overall Study||15
9735886|NCT00186043|10836461|FG001|NOT COMPLETED|Overall Study||13
9735887|NCT00186056|10836469|FG000|STARTED|Overall Study||14
9735888|NCT00186056|10836470|FG001|STARTED|Overall Study||17
9735889|NCT00186056|10836469|FG000|COMPLETED|Overall Study||12
9735890|NCT00186056|10836470|FG001|COMPLETED|Overall Study||16
9735891|NCT00186056|10836469|FG000|NOT COMPLETED|Overall Study||2
9735892|NCT00186056|10836470|FG001|NOT COMPLETED|Overall Study||1
9735893|NCT00186069|10836478|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
9735894|NCT00186069|10836479|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
9735895|NCT00186069|10836478|FG000|COMPLETED|Overall Study||15
9735896|NCT00186069|10836479|FG001|COMPLETED|Overall Study||15
9735897|NCT00186069|10836478|FG000|NOT COMPLETED|Overall Study||0
9735898|NCT00186069|10836479|FG001|NOT COMPLETED|Overall Study||0
9735899|NCT00186121|10836485|FG000|STARTED|Overall Study||35
9851673|NCT00877448|10964434|FG005|COMPLETED|Overall Study||9
10082842|NCT02271984|11211469|FG007|STARTED|Washout Period 1 (7 Days)||3
9735900|NCT00186121|10836485|FG000|COMPLETED|Overall Study||32
9735901|NCT00186121|10836485|FG000|NOT COMPLETED|Overall Study||3
9735902|NCT00186186|10836489|FG000|STARTED|Overall Study||28
9735903|NCT00186186|10836489|FG000|COMPLETED|Overall Study||20
9735904|NCT00186186|10836489|FG000|NOT COMPLETED|Overall Study||8
9735905|NCT00186446|10836494|FG000|STARTED|Overall Study||20
9735906|NCT00186446|10836494|FG000|COMPLETED|Overall Study||11
9735907|NCT00186446|10836494|FG000|NOT COMPLETED|Overall Study||9
9735908|NCT00186485|10836500|FG000|STARTED|Overall Study||28
9735909|NCT00186485|10836500|FG000|COMPLETED|Overall Study||25
9735910|NCT00186485|10836500|FG000|NOT COMPLETED|Overall Study||3
9735911|NCT00186498|10836506|FG000|STARTED|Overall Study||6
9735912|NCT00186498|10836507|FG001|STARTED|Overall Study||5
9735913|NCT00186498|10836506|FG000|COMPLETED|Overall Study||4
9735914|NCT00186498|10836507|FG001|COMPLETED|Overall Study||3
9735915|NCT00186498|10836506|FG000|NOT COMPLETED|Overall Study||2
9851674|NCT00877448|10964435|FG006|COMPLETED|Overall Study||3
9735916|NCT00186498|10836507|FG001|NOT COMPLETED|Overall Study||2
9735917|NCT00186537|10836516|FG000|STARTED|Overall Study||19
9735918|NCT00186537|10836517|FG001|STARTED|Overall Study||12
10082843|NCT02271984|11211470|FG008|STARTED|Washout Period 1 (7 Days)||3
10082844|NCT02271984|11211471|FG009|STARTED|Washout Period 1 (7 Days)||3
10082845|NCT02271984|11211472|FG010|STARTED|Washout Period 1 (7 Days)||3
10082846|NCT02271984|11211473|FG011|STARTED|Washout Period 1 (7 Days)||3
10082847|NCT02271984|11211462|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10082848|NCT02271984|11211463|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10082849|NCT02271984|11211464|FG002|COMPLETED|Washout Period 1 (7 Days)||3
10082850|NCT02271984|11211465|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10082851|NCT02271984|11211466|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10082852|NCT02271984|11211467|FG005|COMPLETED|Washout Period 1 (7 Days)||3
10082853|NCT02271984|11211468|FG006|COMPLETED|Washout Period 1 (7 Days)||3
10082854|NCT02271984|11211469|FG007|COMPLETED|Washout Period 1 (7 Days)||3
10082855|NCT02271984|11211470|FG008|COMPLETED|Washout Period 1 (7 Days)||3
10082856|NCT02271984|11211471|FG009|COMPLETED|Washout Period 1 (7 Days)||3
10082857|NCT02271984|11211472|FG010|COMPLETED|Washout Period 1 (7 Days)||3
10082858|NCT02271984|11211473|FG011|COMPLETED|Washout Period 1 (7 Days)||3
10082859|NCT02271984|11211462|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082860|NCT02271984|11211463|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082861|NCT02271984|11211464|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082862|NCT02271984|11211465|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082863|NCT02271984|11211466|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082864|NCT02271984|11211467|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082865|NCT02271984|11211468|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082866|NCT02271984|11211469|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082867|NCT02271984|11211470|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082868|NCT02271984|11211471|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082869|NCT02271984|11211472|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082870|NCT02271984|11211473|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0
10082871|NCT02271984|11211462|FG000|STARTED|Second Intervention Period (1 Day)||3
10082872|NCT02271984|11211463|FG001|STARTED|Second Intervention Period (1 Day)||3
10082873|NCT02271984|11211464|FG002|STARTED|Second Intervention Period (1 Day)||3
10082874|NCT02271984|11211465|FG003|STARTED|Second Intervention Period (1 Day)||3
10082875|NCT02271984|11211466|FG004|STARTED|Second Intervention Period (1 Day)||3
10082876|NCT02271984|11211467|FG005|STARTED|Second Intervention Period (1 Day)||3
10082877|NCT02271984|11211468|FG006|STARTED|Second Intervention Period (1 Day)||3
9735919|NCT00186537|10836518|FG002|STARTED|Overall Study||16
9735920|NCT00186537|10836516|FG000|COMPLETED|Overall Study||12
9735921|NCT00186537|10836517|FG001|COMPLETED|Overall Study||12
9735922|NCT00186537|10836518|FG002|COMPLETED|Overall Study||13
9735923|NCT00186537|10836516|FG000|NOT COMPLETED|Overall Study||7
9735924|NCT00186537|10836517|FG001|NOT COMPLETED|Overall Study||0
9735925|NCT00186537|10836518|FG002|NOT COMPLETED|Overall Study||3
9735926|NCT00186628|10836526|FG000|STARTED|Overall Study||36
9735927|NCT00186628|10836526|FG000|COMPLETED|Overall Study||33
9735928|NCT00186628|10836526|FG000|NOT COMPLETED|Overall Study||3
9735929|NCT00186875|10836534|FG000|STARTED|Overall Study||26
9735930|NCT00186875|10836535|FG001|STARTED|Overall Study||14
9735931|NCT00186875|10836534|FG000|COMPLETED|Overall Study||26
9735932|NCT00186875|10836535|FG001|COMPLETED|Overall Study||14
9735933|NCT00186875|10836534|FG000|NOT COMPLETED|Overall Study||0
9735934|NCT00186875|10836535|FG001|NOT COMPLETED|Overall Study||0
9735935|NCT00186901|10836545|FG000|STARTED|Overall Study||134
9735936|NCT00186901|10836546|FG001|STARTED|Overall Study||141
9735937|NCT00186901|10836547|FG002|STARTED|Overall Study||149
9735938|NCT00186901|10836545|FG000|Baseline|Overall Study||134
9735939|NCT00186901|10836546|FG001|Baseline|Overall Study||141
9735940|NCT00186901|10836547|FG002|Baseline|Overall Study||0
9735941|NCT00186901|10836545|FG000|12 Month Follow-up|Overall Study||117
9735942|NCT00186901|10836546|FG001|12 Month Follow-up|Overall Study||122
9735943|NCT00186901|10836547|FG002|12 Month Follow-up|Overall Study||0
9735944|NCT00186901|10836545|FG000|24 Month Follow-up|Overall Study||106
9735945|NCT00186901|10836546|FG001|24 Month Follow-up|Overall Study||107
9735946|NCT00186901|10836547|FG002|24 Month Follow-up|Overall Study||0
9735947|NCT00186901|10836545|FG000|COMPLETED|Overall Study||85
10082878|NCT02271984|11211469|FG007|STARTED|Second Intervention Period (1 Day)||3
10082879|NCT02271984|11211470|FG008|STARTED|Second Intervention Period (1 Day)||3
10082880|NCT02271984|11211471|FG009|STARTED|Second Intervention Period (1 Day)||3
10082881|NCT02271984|11211472|FG010|STARTED|Second Intervention Period (1 Day)||3
10082882|NCT02271984|11211473|FG011|STARTED|Second Intervention Period (1 Day)||3
10082883|NCT02271984|11211462|FG000|COMPLETED|Second Intervention Period (1 Day)||3
10082884|NCT02271984|11211463|FG001|COMPLETED|Second Intervention Period (1 Day)||3
10082885|NCT02271984|11211464|FG002|COMPLETED|Second Intervention Period (1 Day)||3
10082886|NCT02271984|11211465|FG003|COMPLETED|Second Intervention Period (1 Day)||3
10082887|NCT02271984|11211466|FG004|COMPLETED|Second Intervention Period (1 Day)||3
10082888|NCT02271984|11211467|FG005|COMPLETED|Second Intervention Period (1 Day)||3
10082889|NCT02271984|11211468|FG006|COMPLETED|Second Intervention Period (1 Day)||3
9735948|NCT00186901|10836546|FG001|COMPLETED|Overall Study||96
9735949|NCT00186901|10836547|FG002|COMPLETED|Overall Study||0
9735950|NCT00186901|10836545|FG000|NOT COMPLETED|Overall Study||49
9735951|NCT00186901|10836546|FG001|NOT COMPLETED|Overall Study||45
9735952|NCT00186901|10836547|FG002|NOT COMPLETED|Overall Study||149
9735953|NCT00187096|10836587|FG000|STARTED|Overall Study||10
9735954|NCT00187096|10836588|FG001|STARTED|Overall Study||3
9735955|NCT00187096|10836589|FG002|STARTED|Overall Study||12
9735956|NCT00187096|10836587|FG000|COMPLETED|Overall Study||10
9735957|NCT00187096|10836588|FG001|COMPLETED|Overall Study||3
9735958|NCT00187096|10836589|FG002|COMPLETED|Overall Study||11
9735959|NCT00187096|10836587|FG000|NOT COMPLETED|Overall Study||0
10082890|NCT02271984|11211469|FG007|COMPLETED|Second Intervention Period (1 Day)||3
10082891|NCT02271984|11211470|FG008|COMPLETED|Second Intervention Period (1 Day)||3
10082892|NCT02271984|11211471|FG009|COMPLETED|Second Intervention Period (1 Day)||3
10082893|NCT02271984|11211472|FG010|COMPLETED|Second Intervention Period (1 Day)||3
10082894|NCT02271984|11211473|FG011|COMPLETED|Second Intervention Period (1 Day)||3
10082895|NCT02271984|11211462|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082896|NCT02271984|11211463|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082897|NCT02271984|11211464|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082898|NCT02271984|11211465|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082899|NCT02271984|11211466|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082900|NCT02271984|11211467|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082901|NCT02271984|11211468|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082902|NCT02271984|11211469|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082903|NCT02271984|11211470|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082904|NCT02271984|11211471|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082905|NCT02271984|11211472|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082906|NCT02271984|11211473|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0
10082907|NCT02271984|11211462|FG000|STARTED|Washout Period 2 (7 Days)||3
10082908|NCT02271984|11211463|FG001|STARTED|Washout Period 2 (7 Days)||3
10082909|NCT02271984|11211464|FG002|STARTED|Washout Period 2 (7 Days)||3
10082910|NCT02271984|11211465|FG003|STARTED|Washout Period 2 (7 Days)||3
10082911|NCT02271984|11211466|FG004|STARTED|Washout Period 2 (7 Days)||3
10082912|NCT02271984|11211467|FG005|STARTED|Washout Period 2 (7 Days)||3
10082913|NCT02271984|11211468|FG006|STARTED|Washout Period 2 (7 Days)||3
10082914|NCT02271984|11211469|FG007|STARTED|Washout Period 2 (7 Days)||3
10082915|NCT02271984|11211470|FG008|STARTED|Washout Period 2 (7 Days)||3
10082916|NCT02271984|11211471|FG009|STARTED|Washout Period 2 (7 Days)||3
10082917|NCT02271984|11211472|FG010|STARTED|Washout Period 2 (7 Days)||3
10082918|NCT02271984|11211473|FG011|STARTED|Washout Period 2 (7 Days)||3
10082919|NCT02271984|11211462|FG000|COMPLETED|Washout Period 2 (7 Days)||3
10082920|NCT02271984|11211463|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10082921|NCT02271984|11211464|FG002|COMPLETED|Washout Period 2 (7 Days)||3
10082922|NCT02271984|11211465|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10082923|NCT02271984|11211466|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10082924|NCT02271984|11211467|FG005|COMPLETED|Washout Period 2 (7 Days)||3
10082925|NCT02271984|11211468|FG006|COMPLETED|Washout Period 2 (7 Days)||3
10082926|NCT02271984|11211469|FG007|COMPLETED|Washout Period 2 (7 Days)||3
10082927|NCT02271984|11211470|FG008|COMPLETED|Washout Period 2 (7 Days)||3
10082928|NCT02271984|11211471|FG009|COMPLETED|Washout Period 2 (7 Days)||3
10082929|NCT02271984|11211472|FG010|COMPLETED|Washout Period 2 (7 Days)||3
10082930|NCT02271984|11211473|FG011|COMPLETED|Washout Period 2 (7 Days)||3
10082931|NCT02271984|11211462|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082932|NCT02271984|11211463|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082933|NCT02271984|11211464|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082934|NCT02271984|11211465|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082935|NCT02271984|11211466|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082936|NCT02271984|11211467|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082937|NCT02271984|11211468|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082938|NCT02271984|11211469|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082939|NCT02271984|11211470|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082940|NCT02271984|11211471|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082941|NCT02271984|11211472|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082942|NCT02271984|11211473|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0
10082943|NCT02271984|11211462|FG000|STARTED|Third Intervention Period (1 Day)||3
10082944|NCT02271984|11211463|FG001|STARTED|Third Intervention Period (1 Day)||3
10082945|NCT02271984|11211464|FG002|STARTED|Third Intervention Period (1 Day)||3
10082946|NCT02271984|11211465|FG003|STARTED|Third Intervention Period (1 Day)||3
10082947|NCT02271984|11211466|FG004|STARTED|Third Intervention Period (1 Day)||3
10082948|NCT02271984|11211467|FG005|STARTED|Third Intervention Period (1 Day)||3
10082949|NCT02271984|11211468|FG006|STARTED|Third Intervention Period (1 Day)||3
10082950|NCT02271984|11211469|FG007|STARTED|Third Intervention Period (1 Day)||3
10082951|NCT02271984|11211470|FG008|STARTED|Third Intervention Period (1 Day)||3
10082952|NCT02271984|11211471|FG009|STARTED|Third Intervention Period (1 Day)||3
10082953|NCT02271984|11211472|FG010|STARTED|Third Intervention Period (1 Day)||3
10082954|NCT02271984|11211473|FG011|STARTED|Third Intervention Period (1 Day)||3
10082955|NCT02271984|11211462|FG000|COMPLETED|Third Intervention Period (1 Day)||3
10082956|NCT02271984|11211463|FG001|COMPLETED|Third Intervention Period (1 Day)||3
10082957|NCT02271984|11211464|FG002|COMPLETED|Third Intervention Period (1 Day)||3
10082958|NCT02271984|11211465|FG003|COMPLETED|Third Intervention Period (1 Day)||3
10082959|NCT02271984|11211466|FG004|COMPLETED|Third Intervention Period (1 Day)||3
10082960|NCT02271984|11211467|FG005|COMPLETED|Third Intervention Period (1 Day)||3
10082961|NCT02271984|11211468|FG006|COMPLETED|Third Intervention Period (1 Day)||3
10082962|NCT02271984|11211469|FG007|COMPLETED|Third Intervention Period (1 Day)||3
10082963|NCT02271984|11211470|FG008|COMPLETED|Third Intervention Period (1 Day)||3
10082964|NCT02271984|11211471|FG009|COMPLETED|Third Intervention Period (1 Day)||3
10082965|NCT02271984|11211472|FG010|COMPLETED|Third Intervention Period (1 Day)||3
9851675|NCT00877448|10964429|FG000|NOT COMPLETED|Overall Study||0
10082966|NCT02271984|11211473|FG011|COMPLETED|Third Intervention Period (1 Day)||3
10082967|NCT02271984|11211462|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082968|NCT02271984|11211463|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082969|NCT02271984|11211464|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082970|NCT02271984|11211465|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082971|NCT02271984|11211466|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082972|NCT02271984|11211467|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082973|NCT02271984|11211468|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082974|NCT02271984|11211469|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082975|NCT02271984|11211470|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082976|NCT02271984|11211471|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082977|NCT02271984|11211472|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0
10082978|NCT02271984|11211473|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0
9735960|NCT00187096|10836588|FG001|NOT COMPLETED|Overall Study||0
9735961|NCT00187096|10836589|FG002|NOT COMPLETED|Overall Study||1
9735962|NCT00187135|10836603|FG000|STARTED|Visit One||30
9735963|NCT00187135|10836604|FG001|STARTED|Visit One||28
9735964|NCT00187135|10836605|FG002|STARTED|Visit One||25
9735965|NCT00187135|10836606|FG003|STARTED|Visit One||26
9735966|NCT00187135|10836607|FG004|STARTED|Visit One||25
9735967|NCT00187135|10836608|FG005|STARTED|Visit One||28
9735968|NCT00187135|10836603|FG000|COMPLETED|Visit One||26
9735969|NCT00187135|10836604|FG001|COMPLETED|Visit One||27
9735970|NCT00187135|10836605|FG002|COMPLETED|Visit One||25
9735971|NCT00187135|10836606|FG003|COMPLETED|Visit One||26
9735972|NCT00187135|10836607|FG004|COMPLETED|Visit One||25
9735973|NCT00187135|10836608|FG005|COMPLETED|Visit One||26
9735974|NCT00187135|10836603|FG000|NOT COMPLETED|Visit One||4
9735975|NCT00187135|10836604|FG001|NOT COMPLETED|Visit One||1
9735976|NCT00187135|10836605|FG002|NOT COMPLETED|Visit One||0
9735977|NCT00187135|10836606|FG003|NOT COMPLETED|Visit One||0
9735978|NCT00187135|10836607|FG004|NOT COMPLETED|Visit One||0
9735979|NCT00187135|10836608|FG005|NOT COMPLETED|Visit One||2
9735980|NCT00187135|10836603|FG000|STARTED|Visit Two||26
9735981|NCT00187135|10836604|FG001|STARTED|Visit Two||27
9735982|NCT00187135|10836605|FG002|STARTED|Visit Two||25
9735983|NCT00187135|10836606|FG003|STARTED|Visit Two||26
9735984|NCT00187135|10836607|FG004|STARTED|Visit Two||25
9735985|NCT00187135|10836608|FG005|STARTED|Visit Two||26
9735986|NCT00187135|10836603|FG000|COMPLETED|Visit Two||21
9735987|NCT00187135|10836604|FG001|COMPLETED|Visit Two||24
9735988|NCT00187135|10836605|FG002|COMPLETED|Visit Two||23
9735989|NCT00187135|10836606|FG003|COMPLETED|Visit Two||18
9735990|NCT00187135|10836607|FG004|COMPLETED|Visit Two||19
9735991|NCT00187135|10836608|FG005|COMPLETED|Visit Two||18
9735992|NCT00187135|10836603|FG000|NOT COMPLETED|Visit Two||5
9735993|NCT00187135|10836604|FG001|NOT COMPLETED|Visit Two||3
9735994|NCT00187135|10836605|FG002|NOT COMPLETED|Visit Two||2
9735995|NCT00187135|10836606|FG003|NOT COMPLETED|Visit Two||8
9735996|NCT00187135|10836607|FG004|NOT COMPLETED|Visit Two||6
9735997|NCT00187135|10836608|FG005|NOT COMPLETED|Visit Two||8
9735998|NCT00187135|10836603|FG000|STARTED|Visit Three||21
9735999|NCT00187135|10836604|FG001|STARTED|Visit Three||24
9736000|NCT00187135|10836605|FG002|STARTED|Visit Three||23
9736001|NCT00187135|10836606|FG003|STARTED|Visit Three||18
9736002|NCT00187135|10836607|FG004|STARTED|Visit Three||19
9736003|NCT00187135|10836608|FG005|STARTED|Visit Three||18
9736004|NCT00187135|10836603|FG000|COMPLETED|Visit Three||14
9736005|NCT00187135|10836604|FG001|COMPLETED|Visit Three||17
9736006|NCT00187135|10836605|FG002|COMPLETED|Visit Three||14
9736007|NCT00187135|10836606|FG003|COMPLETED|Visit Three||9
9736008|NCT00187135|10836607|FG004|COMPLETED|Visit Three||11
9736009|NCT00187135|10836608|FG005|COMPLETED|Visit Three||12
9736010|NCT00187135|10836603|FG000|NOT COMPLETED|Visit Three||7
9736011|NCT00187135|10836604|FG001|NOT COMPLETED|Visit Three||7
9736012|NCT00187135|10836605|FG002|NOT COMPLETED|Visit Three||9
9736013|NCT00187135|10836606|FG003|NOT COMPLETED|Visit Three||9
9736014|NCT00187135|10836607|FG004|NOT COMPLETED|Visit Three||8
9736015|NCT00187135|10836608|FG005|NOT COMPLETED|Visit Three||6
9736016|NCT00187200|10836622|FG000|STARTED|Overall Study||49
9736017|NCT00187200|10836623|FG001|STARTED|Overall Study||44
9736018|NCT00187200|10836622|FG000|COMPLETED|Overall Study||31
9736019|NCT00187200|10836623|FG001|COMPLETED|Overall Study||26
9736020|NCT00187200|10836622|FG000|NOT COMPLETED|Overall Study||18
9736021|NCT00187200|10836623|FG001|NOT COMPLETED|Overall Study||18
9736022|NCT00187278|10836633|FG000|STARTED|Overall Study||918
9736023|NCT00187278|10836634|FG001|STARTED|Overall Study||915
9736024|NCT00187278|10836633|FG000|COMPLETED|Overall Study||908
9736025|NCT00187278|10836634|FG001|COMPLETED|Overall Study||902
9736026|NCT00187278|10836633|FG000|NOT COMPLETED|Overall Study||10
9736027|NCT00187278|10836634|FG001|NOT COMPLETED|Overall Study||13
9736028|NCT00187369|10836644|FG000|STARTED|Mothers||1398
9736029|NCT00187369|10836645|FG001|STARTED|Mothers||1406
9736030|NCT00187369|10836644|FG000|Included in the Study|Mothers||1393
9736031|NCT00187369|10836645|FG001|Included in the Study|Mothers||1393
9736032|NCT00187369|10836644|FG000|COMPLETED|Mothers||1392
9736033|NCT00187369|10836645|FG001|COMPLETED|Mothers||1392
9736034|NCT00187369|10836644|FG000|NOT COMPLETED|Mothers||6
9736035|NCT00187369|10836645|FG001|NOT COMPLETED|Mothers||14
9736036|NCT00187369|10836644|FG000|STARTED|Fetuses or Infants||2795
9736037|NCT00187369|10836645|FG001|STARTED|Fetuses or Infants||2812
9736038|NCT00187369|10836644|FG000|Included in the Study|Fetuses or Infants||2785
9736039|NCT00187369|10836645|FG001|Included in the Study|Fetuses or Infants||2786
10082979|NCT02271984|11211462|FG000|STARTED|Washout Period 3 (7 Days)||3
10082980|NCT02271984|11211463|FG001|STARTED|Washout Period 3 (7 Days)||3
10082981|NCT02271984|11211464|FG002|STARTED|Washout Period 3 (7 Days)||3
10082982|NCT02271984|11211465|FG003|STARTED|Washout Period 3 (7 Days)||3
10082983|NCT02271984|11211466|FG004|STARTED|Washout Period 3 (7 Days)||3
10082984|NCT02271984|11211467|FG005|STARTED|Washout Period 3 (7 Days)||3
10082985|NCT02271984|11211468|FG006|STARTED|Washout Period 3 (7 Days)||3
10082986|NCT02271984|11211469|FG007|STARTED|Washout Period 3 (7 Days)||3
10082987|NCT02271984|11211470|FG008|STARTED|Washout Period 3 (7 Days)||3
10082988|NCT02271984|11211471|FG009|STARTED|Washout Period 3 (7 Days)||3
10082989|NCT02271984|11211472|FG010|STARTED|Washout Period 3 (7 Days)||3
10082990|NCT02271984|11211473|FG011|STARTED|Washout Period 3 (7 Days)||3
10082991|NCT02271984|11211462|FG000|COMPLETED|Washout Period 3 (7 Days)||3
10199273|NCT03415581|11327699|FG001|NOT COMPLETED|Overall Study||5
10199274|NCT03416127|11327710|FG000|STARTED|Overall Study||12
10199275|NCT03416127|11327711|FG001|STARTED|Overall Study||12
10199276|NCT03416127|11327712|FG002|STARTED|Overall Study||12
10199277|NCT03416127|11327710|FG000|COMPLETED|Overall Study||12
10199278|NCT03416127|11327711|FG001|COMPLETED|Overall Study||11
10199279|NCT03416127|11327712|FG002|COMPLETED|Overall Study||11
10199280|NCT03416127|11327710|FG000|NOT COMPLETED|Overall Study||0
10199281|NCT03416127|11327711|FG001|NOT COMPLETED|Overall Study||1
10199282|NCT03416127|11327712|FG002|NOT COMPLETED|Overall Study||1
10199283|NCT03416621|11327724|FG000|STARTED|Overall Study||13
10199284|NCT03416621|11327725|FG001|STARTED|Overall Study||12
10199285|NCT03416621|11327726|FG002|STARTED|Overall Study||6
10199286|NCT03416621|11327724|FG000|COMPLETED|Overall Study||13
10199287|NCT03416621|11327725|FG001|COMPLETED|Overall Study||11
10199288|NCT03416621|11327726|FG002|COMPLETED|Overall Study||1
10199289|NCT03416621|11327724|FG000|NOT COMPLETED|Overall Study||0
10199290|NCT03416621|11327725|FG001|NOT COMPLETED|Overall Study||1
10199291|NCT03416621|11327726|FG002|NOT COMPLETED|Overall Study||5
10199292|NCT03416946|11327738|FG000|STARTED|Overall Study||25
10199293|NCT03416946|11327739|FG001|STARTED|Overall Study||29
10199294|NCT03416946|11327738|FG000|COMPLETED|Overall Study||25
10199295|NCT03416946|11327739|FG001|COMPLETED|Overall Study||29
10199296|NCT03416946|11327738|FG000|NOT COMPLETED|Overall Study||0
10199297|NCT03416946|11327739|FG001|NOT COMPLETED|Overall Study||0
10199298|NCT03416985|11327748|FG000|STARTED|Overall Study||30
10199299|NCT03416985|11327749|FG001|STARTED|Overall Study||30
10199300|NCT03416985|11327750|FG002|STARTED|Overall Study||30
10199301|NCT03416985|11327748|FG000|COMPLETED|Overall Study||28
10199302|NCT03416985|11327749|FG001|COMPLETED|Overall Study||30
10199303|NCT03416985|11327750|FG002|COMPLETED|Overall Study||24
10199304|NCT03416985|11327748|FG000|NOT COMPLETED|Overall Study||2
10199305|NCT03416985|11327749|FG001|NOT COMPLETED|Overall Study||0
10199306|NCT03416985|11327750|FG002|NOT COMPLETED|Overall Study||6
10199307|NCT03417024|11327761|FG000|STARTED|Overall Study||13
10199308|NCT03417024|11327761|FG000|COMPLETED|Overall Study||0
10199309|NCT03417024|11327761|FG000|NOT COMPLETED|Overall Study||13
10199310|NCT03417141|11327765|FG000|STARTED|Overall Study||12
10199311|NCT03417141|11327765|FG000|COMPLETED|Overall Study||8
10199312|NCT03417141|11327765|FG000|NOT COMPLETED|Overall Study||4
10199313|NCT03417219|11327771|FG000|STARTED|Overall Study||8
10199314|NCT03417219|11327772|FG001|STARTED|Overall Study||8
10199315|NCT03417219|11327771|FG000|COMPLETED|Overall Study||8
10199316|NCT03417219|11327772|FG001|COMPLETED|Overall Study||5
10199317|NCT03417219|11327771|FG000|NOT COMPLETED|Overall Study||0
10199318|NCT03417219|11327772|FG001|NOT COMPLETED|Overall Study||3
10199319|NCT03417466|11327778|FG000|STARTED|Overall Study||66
10199320|NCT03417466|11327778|FG000|COMPLETED|Overall Study||66
10199321|NCT03417466|11327778|FG000|NOT COMPLETED|Overall Study||0
10199322|NCT03417505|11327782|FG000|STARTED|First Lens Type (30 Days)||9
10199323|NCT03417505|11327783|FG001|STARTED|First Lens Type (30 Days)||12
10199324|NCT03417505|11327782|FG000|COMPLETED|First Lens Type (30 Days)||8
10199325|NCT03417505|11327783|FG001|COMPLETED|First Lens Type (30 Days)||11
10199326|NCT03417505|11327782|FG000|NOT COMPLETED|First Lens Type (30 Days)||1
10199327|NCT03417505|11327783|FG001|NOT COMPLETED|First Lens Type (30 Days)||1
10199328|NCT03417505|11327782|FG000|STARTED|Washout Period (7 Days)||8
10199329|NCT03417505|11327783|FG001|STARTED|Washout Period (7 Days)||11
10199330|NCT03417505|11327782|FG000|COMPLETED|Washout Period (7 Days)||8
10199331|NCT03417505|11327783|FG001|COMPLETED|Washout Period (7 Days)||11
10199332|NCT03417505|11327782|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10199333|NCT03417505|11327783|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10199334|NCT03417505|11327782|FG000|STARTED|Second Lens Type (30 Days)||8
10199335|NCT03417505|11327783|FG001|STARTED|Second Lens Type (30 Days)||11
10199336|NCT03417505|11327782|FG000|COMPLETED|Second Lens Type (30 Days)||8
10199337|NCT03417505|11327783|FG001|COMPLETED|Second Lens Type (30 Days)||11
10199338|NCT03417505|11327782|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0
10199339|NCT03417505|11327783|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0
10082992|NCT02271984|11211463|FG001|COMPLETED|Washout Period 3 (7 Days)||3
10199340|NCT03417557|11327789|FG000|STARTED|1st Intervention (3 Hours)||8
10199341|NCT03417557|11327790|FG001|STARTED|1st Intervention (3 Hours)||9
10199342|NCT03417557|11327789|FG000|COMPLETED|1st Intervention (3 Hours)||8
10199343|NCT03417557|11327790|FG001|COMPLETED|1st Intervention (3 Hours)||9
10199344|NCT03417557|11327789|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0
10199345|NCT03417557|11327790|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0
10199346|NCT03417557|11327789|FG000|STARTED|2nd Intervention (3 Hours)||9
10199347|NCT03417557|11327790|FG001|STARTED|2nd Intervention (3 Hours)||8
10082993|NCT02271984|11211464|FG002|COMPLETED|Washout Period 3 (7 Days)||3
10082994|NCT02271984|11211465|FG003|COMPLETED|Washout Period 3 (7 Days)||3
10082995|NCT02271984|11211466|FG004|COMPLETED|Washout Period 3 (7 Days)||3
10082996|NCT02271984|11211467|FG005|COMPLETED|Washout Period 3 (7 Days)||3
10082997|NCT02271984|11211468|FG006|COMPLETED|Washout Period 3 (7 Days)||3
10082998|NCT02271984|11211469|FG007|COMPLETED|Washout Period 3 (7 Days)||3
10082999|NCT02271984|11211470|FG008|COMPLETED|Washout Period 3 (7 Days)||3
10083000|NCT02271984|11211471|FG009|COMPLETED|Washout Period 3 (7 Days)||3
10083001|NCT02271984|11211472|FG010|COMPLETED|Washout Period 3 (7 Days)||3
10083002|NCT02271984|11211473|FG011|COMPLETED|Washout Period 3 (7 Days)||3
10083003|NCT02271984|11211462|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083004|NCT02271984|11211463|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083005|NCT02271984|11211464|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
9736040|NCT00187369|10836644|FG000|COMPLETED|Fetuses or Infants||2783
9736041|NCT00187369|10836645|FG001|COMPLETED|Fetuses or Infants||2782
9736042|NCT00187369|10836644|FG000|NOT COMPLETED|Fetuses or Infants||12
9736043|NCT00187369|10836645|FG001|NOT COMPLETED|Fetuses or Infants||30
9736044|NCT00187486|10836657|FG000|STARTED|Overall Study||66
9736045|NCT00187486|10836657|FG000|COMPLETED|Overall Study||65
9736046|NCT00187486|10836657|FG000|NOT COMPLETED|Overall Study||1
9736047|NCT00187655|10836661|FG000|STARTED|Overall Study||24
9736048|NCT00187655|10836661|FG000|COMPLETED|Overall Study||24
9736049|NCT00187655|10836661|FG000|NOT COMPLETED|Overall Study||0
9736050|NCT00187681|10836668|FG000|STARTED|Overall Study||12
9736051|NCT00187681|10836669|FG001|STARTED|Overall Study||8
9736052|NCT00187681|10836668|FG000|COMPLETED|Overall Study||12
9736053|NCT00187681|10836669|FG001|COMPLETED|Overall Study||8
9736054|NCT00187681|10836668|FG000|NOT COMPLETED|Overall Study||0
9736055|NCT00187681|10836669|FG001|NOT COMPLETED|Overall Study||0
9736056|NCT00187720|10836679|FG000|STARTED|Overall Study||9
9736057|NCT00187720|10836680|FG001|STARTED|Overall Study||14
9736058|NCT00187720|10836679|FG000|COMPLETED|Overall Study||9
9736059|NCT00187720|10836680|FG001|COMPLETED|Overall Study||14
9736060|NCT00187720|10836679|FG000|NOT COMPLETED|Overall Study||0
9736061|NCT00187720|10836680|FG001|NOT COMPLETED|Overall Study||0
9736062|NCT00187876|10836688|FG000|STARTED|Overall Study||24
9736063|NCT00187876|10836689|FG001|STARTED|Overall Study||43
9736064|NCT00187876|10836688|FG000|COMPLETED|Overall Study||24
9736065|NCT00187876|10836689|FG001|COMPLETED|Overall Study||43
9736066|NCT00187876|10836688|FG000|NOT COMPLETED|Overall Study||0
9736067|NCT00187876|10836689|FG001|NOT COMPLETED|Overall Study||0
9736068|NCT00187889|10836697|FG000|STARTED|Overall Study||25
9736069|NCT00187889|10836698|FG001|STARTED|Overall Study||26
9736070|NCT00187889|10836697|FG000|COMPLETED|Overall Study||19
9736071|NCT00187889|10836698|FG001|COMPLETED|Overall Study||22
9736072|NCT00187889|10836697|FG000|NOT COMPLETED|Overall Study||6
9736073|NCT00187889|10836698|FG001|NOT COMPLETED|Overall Study||4
9736074|NCT00189098|10836707|FG000|STARTED|Overall Study||51
9736075|NCT00189098|10836708|FG001|STARTED|Overall Study||50
9736076|NCT00189098|10836707|FG000|COMPLETED|Overall Study||46
9736077|NCT00189098|10836708|FG001|COMPLETED|Overall Study||44
9736078|NCT00189098|10836707|FG000|NOT COMPLETED|Overall Study||5
9736079|NCT00189098|10836708|FG001|NOT COMPLETED|Overall Study||6
9736080|NCT00189137|10836718|FG000|STARTED|Overall Study||37
9736081|NCT00189137|10836719|FG001|STARTED|Overall Study||43
9736082|NCT00189137|10836718|FG000|COMPLETED|Overall Study||37
9736083|NCT00189137|10836719|FG001|COMPLETED|Overall Study||43
9736084|NCT00189137|10836718|FG000|NOT COMPLETED|Overall Study||0
9736085|NCT00189137|10836719|FG001|NOT COMPLETED|Overall Study||0
9736086|NCT00189202|10836725|FG000|STARTED|Overall Study||49
9736087|NCT00189202|10836725|FG000|COMPLETED|Overall Study||44
9736088|NCT00189202|10836725|FG000|NOT COMPLETED|Overall Study||5
9736089|NCT00189228|10836729|FG000|STARTED|Overall Study||18
9736090|NCT00189228|10836729|FG000|COMPLETED|Overall Study||18
9736091|NCT00189228|10836729|FG000|NOT COMPLETED|Overall Study||0
9736092|NCT00189306|10836733|FG000|STARTED|Treatment Period||169
9736093|NCT00189306|10836733|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
9736094|NCT00189306|10836733|FG000|NOT COMPLETED|Treatment Period||5
9736095|NCT00189306|10836733|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
9736096|NCT00189306|10836733|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
9736097|NCT00189306|10836733|FG000|NOT COMPLETED|Posttreatment Period||12
9736098|NCT00189306|10836733|FG000|STARTED|Long-Term Follow-up||157
10083006|NCT02271984|11211465|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
9736099|NCT00189306|10836733|FG000|COMPLETED|Long-Term Follow-up||119
9736100|NCT00189306|10836733|FG000|NOT COMPLETED|Long-Term Follow-up||38
9736101|NCT00189423|10836739|FG000|STARTED|Overall Study||813
9736102|NCT00189423|10836740|FG001|STARTED|Overall Study||840
9736103|NCT00189423|10836739|FG000|COMPLETED|Overall Study||48
9736104|NCT00189423|10836740|FG001|COMPLETED|Overall Study||74
9736105|NCT00189423|10836739|FG000|NOT COMPLETED|Overall Study||765
9736106|NCT00189423|10836740|FG001|NOT COMPLETED|Overall Study||766
9736107|NCT00189436|10836748|FG000|STARTED|Overall Study||31
9736108|NCT00189436|10836749|FG001|STARTED|Overall Study||30
9736109|NCT00189436|10836748|FG000|COMPLETED|Overall Study||23
9736110|NCT00189436|10836749|FG001|COMPLETED|Overall Study||25
9736111|NCT00189436|10836748|FG000|NOT COMPLETED|Overall Study||8
9736112|NCT00189436|10836749|FG001|NOT COMPLETED|Overall Study||5
9736113|NCT00189462|10836757|FG000|STARTED|Overall Study||50
10083007|NCT02271984|11211466|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083008|NCT02271984|11211467|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083009|NCT02271984|11211468|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083010|NCT02271984|11211469|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083011|NCT02271984|11211470|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083012|NCT02271984|11211471|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083013|NCT02271984|11211472|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083014|NCT02271984|11211473|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0
10083015|NCT02271984|11211462|FG000|STARTED|Fourth Intervention Period (Day 1)||3
10083016|NCT02271984|11211463|FG001|STARTED|Fourth Intervention Period (Day 1)||3
10083017|NCT02271984|11211464|FG002|STARTED|Fourth Intervention Period (Day 1)||3
10083018|NCT02271984|11211465|FG003|STARTED|Fourth Intervention Period (Day 1)||3
10083019|NCT02271984|11211466|FG004|STARTED|Fourth Intervention Period (Day 1)||3
10083020|NCT02271984|11211467|FG005|STARTED|Fourth Intervention Period (Day 1)||3
10083021|NCT02271984|11211468|FG006|STARTED|Fourth Intervention Period (Day 1)||3
10083022|NCT02271984|11211469|FG007|STARTED|Fourth Intervention Period (Day 1)||3
10083023|NCT02271984|11211470|FG008|STARTED|Fourth Intervention Period (Day 1)||3
10083024|NCT02271984|11211471|FG009|STARTED|Fourth Intervention Period (Day 1)||3
10083025|NCT02271984|11211472|FG010|STARTED|Fourth Intervention Period (Day 1)||3
10083026|NCT02271984|11211473|FG011|STARTED|Fourth Intervention Period (Day 1)||3
10083027|NCT02271984|11211462|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3
9736114|NCT00189462|10836758|FG001|STARTED|Overall Study||49
9736115|NCT00189462|10836757|FG000|COMPLETED|Overall Study||27
9736116|NCT00189462|10836758|FG001|COMPLETED|Overall Study||28
9736117|NCT00189462|10836757|FG000|NOT COMPLETED|Overall Study||23
9736118|NCT00189462|10836758|FG001|NOT COMPLETED|Overall Study||21
9736119|NCT00189475|10836766|FG000|STARTED|Overall Study||42
9736120|NCT00189475|10836767|FG001|STARTED|Overall Study||42
9736121|NCT00189475|10836766|FG000|COMPLETED|Overall Study||42
9736122|NCT00189475|10836767|FG001|COMPLETED|Overall Study||42
9736123|NCT00189475|10836766|FG000|NOT COMPLETED|Overall Study||0
9736124|NCT00189475|10836767|FG001|NOT COMPLETED|Overall Study||0
9736125|NCT00189488|10836775|FG000|STARTED|Overall Study||78
9736126|NCT00189488|10836776|FG001|STARTED|Overall Study||77
9736127|NCT00189488|10836775|FG000|Received Palifermin/Placebo|Overall Study||75
9736128|NCT00189488|10836776|FG001|Received Palifermin/Placebo|Overall Study||76
9736129|NCT00189488|10836775|FG000|COMPLETED|Overall Study||63
9736130|NCT00189488|10836776|FG001|COMPLETED|Overall Study||55
9736131|NCT00189488|10836775|FG000|NOT COMPLETED|Overall Study||15
9736132|NCT00189488|10836776|FG001|NOT COMPLETED|Overall Study||22
9736133|NCT00189540|10836785|FG000|STARTED|Overall Study||21
9736134|NCT00189540|10836786|FG001|STARTED|Overall Study||6
9736135|NCT00189540|10836785|FG000|COMPLETED|Overall Study||14
9736136|NCT00189540|10836786|FG001|COMPLETED|Overall Study||5
9736137|NCT00189540|10836785|FG000|NOT COMPLETED|Overall Study||7
9736138|NCT00189540|10836786|FG001|NOT COMPLETED|Overall Study||1
9736139|NCT00190671|10836794|FG000|STARTED|Overall Study||42
9736140|NCT00190671|10836795|FG001|STARTED|Overall Study||61
9736141|NCT00190671|10836794|FG000|COMPLETED|Overall Study||15
9736142|NCT00190671|10836795|FG001|COMPLETED|Overall Study||19
9736143|NCT00190671|10836794|FG000|NOT COMPLETED|Overall Study||27
9736144|NCT00190671|10836795|FG001|NOT COMPLETED|Overall Study||42
9736145|NCT00190684|10836802|FG000|STARTED|Overall Study||1553
9736146|NCT00190684|10836802|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
9736147|NCT00190684|10836802|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
9736148|NCT00190684|10836802|FG000|NOT COMPLETED|Overall Study||1489
9736149|NCT00190749|10836808|FG000|STARTED|Overall Study||68
9736150|NCT00190749|10836809|FG001|STARTED|Overall Study||62
9736151|NCT00190749|10836808|FG000|COMPLETED|Overall Study||42
9736152|NCT00190749|10836809|FG001|COMPLETED|Overall Study||31
9736153|NCT00190749|10836808|FG000|NOT COMPLETED|Overall Study||26
9736154|NCT00190749|10836809|FG001|NOT COMPLETED|Overall Study||31
9736155|NCT00190775|10836817|FG000|STARTED|Overall Study||268
9736156|NCT00190775|10836818|FG001|STARTED|Overall Study||234
9736157|NCT00190775|10836817|FG000|Received Study Drug|Overall Study||266
9736158|NCT00190775|10836818|FG001|Received Study Drug|Overall Study||234
9736159|NCT00190775|10836817|FG000|COMPLETED|Overall Study||119
9736160|NCT00190775|10836818|FG001|COMPLETED|Overall Study||134
9736161|NCT00190775|10836817|FG000|NOT COMPLETED|Overall Study||149
9736162|NCT00190775|10836818|FG001|NOT COMPLETED|Overall Study||100
10083028|NCT02271984|11211463|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3
10083029|NCT02271984|11211464|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3
9736163|NCT00190983|10836831|FG000|STARTED|Overall Study||29
9736164|NCT00190983|10836831|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
9736165|NCT00190983|10836831|FG000|NOT COMPLETED|Overall Study||2
9736166|NCT00191100|10836837|FG000|STARTED|Overall Study||259
9736167|NCT00191100|10836838|FG001|STARTED|Overall Study||256
9736168|NCT00191100|10836837|FG000|COMPLETED|Overall Study||217
9736169|NCT00191100|10836838|FG001|COMPLETED|Overall Study||244
9736170|NCT00191100|10836837|FG000|NOT COMPLETED|Overall Study||42
9736171|NCT00191100|10836838|FG001|NOT COMPLETED|Overall Study||12
9736172|NCT00191113|10836846|FG000|STARTED|Core Study||78
9736173|NCT00191113|10836847|FG001|STARTED|Core Study||76
9736174|NCT00191113|10836846|FG000|COMPLETED|Core Study||43
9736175|NCT00191113|10836847|FG001|COMPLETED|Core Study||61
10083030|NCT02271984|11211465|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3
10083031|NCT02271984|11211466|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3
10083032|NCT02271984|11211467|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3
10083033|NCT02271984|11211468|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3
10083034|NCT02271984|11211469|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3
10083035|NCT02271984|11211470|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3
10083036|NCT02271984|11211471|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3
10083037|NCT02271984|11211472|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3
10083038|NCT02271984|11211473|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3
10083039|NCT02271984|11211462|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083040|NCT02271984|11211463|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083041|NCT02271984|11211464|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083042|NCT02271984|11211465|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083043|NCT02271984|11211466|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083044|NCT02271984|11211467|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083045|NCT02271984|11211468|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083046|NCT02271984|11211469|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083047|NCT02271984|11211470|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083048|NCT02271984|11211471|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083049|NCT02271984|11211472|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083050|NCT02271984|11211473|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10083051|NCT02271984|11211462|FG000|STARTED|Washout Period 4 (7 Days)||3
10083052|NCT02271984|11211463|FG001|STARTED|Washout Period 4 (7 Days)||3
10083053|NCT02271984|11211464|FG002|STARTED|Washout Period 4 (7 Days)||3
10083054|NCT02271984|11211465|FG003|STARTED|Washout Period 4 (7 Days)||3
10083055|NCT02271984|11211466|FG004|STARTED|Washout Period 4 (7 Days)||3
10083056|NCT02271984|11211467|FG005|STARTED|Washout Period 4 (7 Days)||3
10083057|NCT02271984|11211468|FG006|STARTED|Washout Period 4 (7 Days)||3
10083058|NCT02271984|11211469|FG007|STARTED|Washout Period 4 (7 Days)||3
10083059|NCT02271984|11211470|FG008|STARTED|Washout Period 4 (7 Days)||3
10083060|NCT02271984|11211471|FG009|STARTED|Washout Period 4 (7 Days)||3
10083061|NCT02271984|11211472|FG010|STARTED|Washout Period 4 (7 Days)||3
10083062|NCT02271984|11211473|FG011|STARTED|Washout Period 4 (7 Days)||3
10083063|NCT02271984|11211462|FG000|COMPLETED|Washout Period 4 (7 Days)||3
10083064|NCT02271984|11211463|FG001|COMPLETED|Washout Period 4 (7 Days)||3
10083065|NCT02271984|11211464|FG002|COMPLETED|Washout Period 4 (7 Days)||3
10083066|NCT02271984|11211465|FG003|COMPLETED|Washout Period 4 (7 Days)||3
10083067|NCT02271984|11211466|FG004|COMPLETED|Washout Period 4 (7 Days)||3
10083068|NCT02271984|11211467|FG005|COMPLETED|Washout Period 4 (7 Days)||2
10199348|NCT03417557|11327789|FG000|COMPLETED|2nd Intervention (3 Hours)||9
10199349|NCT03417557|11327790|FG001|COMPLETED|2nd Intervention (3 Hours)||8
10199350|NCT03417557|11327789|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0
10199351|NCT03417557|11327790|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0
10199352|NCT03417713|11327796|FG000|STARTED|Overall Study||33
10199353|NCT03417713|11327796|FG000|COMPLETED|Overall Study||30
10199354|NCT03417713|11327796|FG000|NOT COMPLETED|Overall Study||3
10199355|NCT03417739|11327800|FG000|STARTED|Overall Study||13
10199356|NCT03417739|11327800|FG000|COMPLETED|Overall Study||13
10199357|NCT03417739|11327800|FG000|NOT COMPLETED|Overall Study||0
10199358|NCT03417752|11327807|FG000|STARTED|Overall Study||149
10199359|NCT03417752|11327808|FG001|STARTED|Overall Study||175
10199360|NCT03417752|11327809|FG002|STARTED|Overall Study||150
10199361|NCT03417752|11327807|FG000|COMPLETED|Overall Study||115
10199362|NCT03417752|11327808|FG001|COMPLETED|Overall Study||133
10199363|NCT03417752|11327809|FG002|COMPLETED|Overall Study||110
10199364|NCT03417752|11327807|FG000|NOT COMPLETED|Overall Study||34
10199365|NCT03417752|11327808|FG001|NOT COMPLETED|Overall Study||42
10199366|NCT03417752|11327809|FG002|NOT COMPLETED|Overall Study||40
10199367|NCT03417778|11327819|FG000|STARTED|Overall Study||10
10199368|NCT03417778|11327820|FG001|STARTED|Overall Study||10
10199369|NCT03417778|11327819|FG000|COMPLETED|Overall Study||10
10199370|NCT03417778|11327820|FG001|COMPLETED|Overall Study||10
10199371|NCT03417778|11327819|FG000|NOT COMPLETED|Overall Study||0
10199372|NCT03417778|11327820|FG001|NOT COMPLETED|Overall Study||0
10199373|NCT03417804|11327826|FG000|STARTED|Overall Study|at least 360 patients|366
10199374|NCT03417804|11327826|FG000|COMPLETED|Overall Study||366
10199375|NCT03417804|11327826|FG000|NOT COMPLETED|Overall Study||0
10199376|NCT03417830|11327833|FG000|STARTED|Part A (up to 26 Days)||2
10199377|NCT03417830|11327834|FG001|STARTED|Part A (up to 26 Days)||0
10199378|NCT03417830|11327833|FG000|COMPLETED|Part A (up to 26 Days)||1
10199379|NCT03417830|11327834|FG001|COMPLETED|Part A (up to 26 Days)||0
10199380|NCT03417830|11327833|FG000|NOT COMPLETED|Part A (up to 26 Days)||1
10199381|NCT03417830|11327834|FG001|NOT COMPLETED|Part A (up to 26 Days)||0
10199382|NCT03417830|11327833|FG000|STARTED|Part B (up to 26 Days)||0
10199383|NCT03417830|11327834|FG001|STARTED|Part B (up to 26 Days)||0
10199384|NCT03417830|11327833|FG000|COMPLETED|Part B (up to 26 Days)||0
10199385|NCT03417830|11327834|FG001|COMPLETED|Part B (up to 26 Days)||0
10199386|NCT03417830|11327833|FG000|NOT COMPLETED|Part B (up to 26 Days)||0
10199387|NCT03417830|11327834|FG001|NOT COMPLETED|Part B (up to 26 Days)||0
10199388|NCT03418051|11327844|FG000|STARTED|Overall Study||20
10199389|NCT03418051|11327845|FG001|STARTED|Overall Study||20
10199390|NCT03418051|11327846|FG002|STARTED|Overall Study||20
10199391|NCT03418051|11327844|FG000|COMPLETED|Overall Study||14
10199392|NCT03418051|11327845|FG001|COMPLETED|Overall Study||18
10199393|NCT03418051|11327846|FG002|COMPLETED|Overall Study||17
9736176|NCT00191113|10836846|FG000|NOT COMPLETED|Core Study||35
9736177|NCT00191113|10836847|FG001|NOT COMPLETED|Core Study||15
9736178|NCT00191113|10836846|FG000|STARTED|Addendum 1||2
9736179|NCT00191113|10836847|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
9736180|NCT00191113|10836846|FG000|COMPLETED|Addendum 1||2
9736181|NCT00191113|10836847|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
9736182|NCT00191113|10836846|FG000|NOT COMPLETED|Addendum 1||0
9736183|NCT00191113|10836847|FG001|NOT COMPLETED|Addendum 1||0
9736184|NCT00191113|10836846|FG000|STARTED|Addendum 2||28
9736185|NCT00191113|10836847|FG001|STARTED|Addendum 2||48
9736186|NCT00191113|10836846|FG000|COMPLETED|Addendum 2||18
9736187|NCT00191113|10836847|FG001|COMPLETED|Addendum 2||31
10083069|NCT02271984|11211468|FG006|COMPLETED|Washout Period 4 (7 Days)||3
10083070|NCT02271984|11211469|FG007|COMPLETED|Washout Period 4 (7 Days)||2
10083071|NCT02271984|11211470|FG008|COMPLETED|Washout Period 4 (7 Days)||3
10083072|NCT02271984|11211471|FG009|COMPLETED|Washout Period 4 (7 Days)||3
10083073|NCT02271984|11211472|FG010|COMPLETED|Washout Period 4 (7 Days)||3
10083074|NCT02271984|11211473|FG011|COMPLETED|Washout Period 4 (7 Days)||3
10083075|NCT02271984|11211462|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083076|NCT02271984|11211463|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083077|NCT02271984|11211464|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083078|NCT02271984|11211465|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083079|NCT02271984|11211466|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083080|NCT02271984|11211467|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1
10083081|NCT02271984|11211468|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083082|NCT02271984|11211469|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1
10083083|NCT02271984|11211470|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083084|NCT02271984|11211471|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083085|NCT02271984|11211472|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083086|NCT02271984|11211473|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0
10083087|NCT02271984|11211462|FG000|STARTED|Fifth Intervention Period (1 Day)||3
10083088|NCT02271984|11211463|FG001|STARTED|Fifth Intervention Period (1 Day)||3
10083089|NCT02271984|11211464|FG002|STARTED|Fifth Intervention Period (1 Day)||3
10083090|NCT02271984|11211465|FG003|STARTED|Fifth Intervention Period (1 Day)||3
10083091|NCT02271984|11211466|FG004|STARTED|Fifth Intervention Period (1 Day)||3
10083092|NCT02271984|11211467|FG005|STARTED|Fifth Intervention Period (1 Day)||2
10083093|NCT02271984|11211468|FG006|STARTED|Fifth Intervention Period (1 Day)||3
10083094|NCT02271984|11211469|FG007|STARTED|Fifth Intervention Period (1 Day)||2
10083095|NCT02271984|11211470|FG008|STARTED|Fifth Intervention Period (1 Day)||3
10083096|NCT02271984|11211471|FG009|STARTED|Fifth Intervention Period (1 Day)||3
10083097|NCT02271984|11211472|FG010|STARTED|Fifth Intervention Period (1 Day)||3
10083098|NCT02271984|11211473|FG011|STARTED|Fifth Intervention Period (1 Day)||3
10083099|NCT02271984|11211462|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3
10083100|NCT02271984|11211463|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3
10083101|NCT02271984|11211464|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3
10083102|NCT02271984|11211465|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3
10083103|NCT02271984|11211466|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3
10083104|NCT02271984|11211467|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2
10083105|NCT02271984|11211468|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3
10083106|NCT02271984|11211469|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2
10083107|NCT02271984|11211470|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3
10083108|NCT02271984|11211471|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3
10083109|NCT02271984|11211472|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3
10083110|NCT02271984|11211473|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3
10083111|NCT02271984|11211462|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083112|NCT02271984|11211463|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083113|NCT02271984|11211464|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083114|NCT02271984|11211465|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083115|NCT02271984|11211466|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083116|NCT02271984|11211467|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083117|NCT02271984|11211468|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083118|NCT02271984|11211469|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083119|NCT02271984|11211470|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083120|NCT02271984|11211471|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083121|NCT02271984|11211472|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083122|NCT02271984|11211473|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10083123|NCT02272244|11211490|FG000|STARTED|Overall Study||203
10083124|NCT02272244|11211491|FG001|STARTED|Overall Study||197
10083125|NCT02272244|11211490|FG000|COMPLETED|Overall Study||203
10083126|NCT02272244|11211491|FG001|COMPLETED|Overall Study||197
10083127|NCT02272244|11211490|FG000|NOT COMPLETED|Overall Study||0
10083128|NCT02272244|11211491|FG001|NOT COMPLETED|Overall Study||0
10083129|NCT02272413|11211499|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338
10083130|NCT02272413|11211500|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333
10083131|NCT02272413|11211499|FG000|Treated|Randomized Through Treatment Start||335
10083132|NCT02272413|11211500|FG001|Treated|Randomized Through Treatment Start||328
9736188|NCT00191113|10836846|FG000|NOT COMPLETED|Addendum 2||10
10083133|NCT02272413|11211499|FG000|COMPLETED|Randomized Through Treatment Start||335
10083134|NCT02272413|11211500|FG001|COMPLETED|Randomized Through Treatment Start||328
10083135|NCT02272413|11211499|FG000|NOT COMPLETED|Randomized Through Treatment Start||3
10083136|NCT02272413|11211500|FG001|NOT COMPLETED|Randomized Through Treatment Start||5
10083137|NCT02272413|11211499|FG000|STARTED|Pre-switch Period|Started for this period|335
9736189|NCT00191113|10836847|FG001|NOT COMPLETED|Addendum 2||17
9736190|NCT00191113|10836846|FG000|STARTED|Addendum 3||20
9736191|NCT00191113|10836847|FG001|STARTED|Addendum 3||37
10083138|NCT02272413|11211500|FG001|STARTED|Pre-switch Period|Started for this period|328
10083139|NCT02272413|11211499|FG000|COMPLETED|Pre-switch Period||42
10083140|NCT02272413|11211500|FG001|COMPLETED|Pre-switch Period||46
10083141|NCT02272413|11211499|FG000|NOT COMPLETED|Pre-switch Period||293
10083142|NCT02272413|11211500|FG001|NOT COMPLETED|Pre-switch Period||282
10083143|NCT02272413|11211499|FG000|STARTED|Post-switch Period|Started for this period|42
10083144|NCT02272413|11211500|FG001|STARTED|Post-switch Period|Started for this period|46
10083145|NCT02272413|11211499|FG000|COMPLETED|Post-switch Period||0
10083146|NCT02272413|11211500|FG001|COMPLETED|Post-switch Period||0
10083147|NCT02272413|11211499|FG000|NOT COMPLETED|Post-switch Period||42
10083148|NCT02272413|11211500|FG001|NOT COMPLETED|Post-switch Period||46
10083149|NCT02272634|11211511|FG000|STARTED|Overall Study||20
10083150|NCT02272634|11211512|FG001|STARTED|Overall Study||21
10083151|NCT02272634|11211513|FG002|STARTED|Overall Study||20
10083152|NCT02272634|11211511|FG000|COMPLETED|Overall Study||19
10083153|NCT02272634|11211512|FG001|COMPLETED|Overall Study||20
10083154|NCT02272634|11211513|FG002|COMPLETED|Overall Study||19
10083155|NCT02272634|11211511|FG000|NOT COMPLETED|Overall Study||1
10083156|NCT02272634|11211512|FG001|NOT COMPLETED|Overall Study||1
10083157|NCT02272634|11211513|FG002|NOT COMPLETED|Overall Study||1
10083158|NCT02272686|11211524|FG000|STARTED|Overall Study||1
10083159|NCT02272686|11211524|FG000|COMPLETED|Overall Study||1
10083160|NCT02272686|11211524|FG000|NOT COMPLETED|Overall Study||0
10083161|NCT02272725|11211530|FG000|STARTED|Overall Study||49
10083162|NCT02272725|11211531|FG001|STARTED|Overall Study||42
10083163|NCT02272725|11211530|FG000|COMPLETED|Overall Study||47
10083164|NCT02272725|11211531|FG001|COMPLETED|Overall Study||42
10083165|NCT02272725|11211530|FG000|NOT COMPLETED|Overall Study||2
10083166|NCT02272725|11211531|FG001|NOT COMPLETED|Overall Study||0
10083167|NCT02272777|11211539|FG000|STARTED|Overall Study||112
10083168|NCT02272777|11211540|FG001|STARTED|Overall Study||113
10083169|NCT02272777|11211539|FG000|COMPLETED|Overall Study||108
10083170|NCT02272777|11211540|FG001|COMPLETED|Overall Study||109
10083171|NCT02272777|11211539|FG000|NOT COMPLETED|Overall Study||4
10083172|NCT02272777|11211540|FG001|NOT COMPLETED|Overall Study||4
10083173|NCT02272816|11211546|FG000|STARTED|Overall Study||48
10083174|NCT02272816|11211546|FG000|COMPLETED|Overall Study||47
10083175|NCT02272816|11211546|FG000|NOT COMPLETED|Overall Study||1
10083176|NCT02272842|11211552|FG000|STARTED|Overall Study||300
10083177|NCT02272842|11211553|FG001|STARTED|Overall Study||300
10083178|NCT02272842|11211552|FG000|COMPLETED|Overall Study||284
10083179|NCT02272842|11211553|FG001|COMPLETED|Overall Study||290
9736192|NCT00191113|10836846|FG000|COMPLETED|Addendum 3||20
9736193|NCT00191113|10836847|FG001|COMPLETED|Addendum 3||37
9736194|NCT00191113|10836846|FG000|NOT COMPLETED|Addendum 3||0
9736195|NCT00191113|10836847|FG001|NOT COMPLETED|Addendum 3||0
9736196|NCT00191139|10836861|FG000|STARTED|Overall Study||32
9736197|NCT00191139|10836862|FG001|STARTED|Overall Study||32
9736198|NCT00191139|10836861|FG000|COMPLETED|Overall Study||27
9736199|NCT00191139|10836862|FG001|COMPLETED|Overall Study||20
9736200|NCT00191139|10836861|FG000|NOT COMPLETED|Overall Study||5
9736201|NCT00191139|10836862|FG001|NOT COMPLETED|Overall Study||12
9736202|NCT00191152|10836870|FG000|STARTED|Initial Treatment||239
9736203|NCT00191152|10836871|FG001|STARTED|Initial Treatment||236
9736204|NCT00191152|10836870|FG000|Received Initial Treatment|Initial Treatment||236
9736205|NCT00191152|10836871|FG001|Received Initial Treatment|Initial Treatment||227
9736206|NCT00191152|10836870|FG000|COMPLETED|Initial Treatment||98
9736207|NCT00191152|10836871|FG001|COMPLETED|Initial Treatment||83
9736208|NCT00191152|10836870|FG000|NOT COMPLETED|Initial Treatment||141
9736209|NCT00191152|10836871|FG001|NOT COMPLETED|Initial Treatment||153
9736210|NCT00191152|10836870|FG000|STARTED|Crossover Treatment||77
9736211|NCT00191152|10836871|FG001|STARTED|Crossover Treatment||81
9736212|NCT00191152|10836870|FG000|Received Treatment|Crossover Treatment||76
9736213|NCT00191152|10836871|FG001|Received Treatment|Crossover Treatment||80
9736214|NCT00191152|10836870|FG000|COMPLETED|Crossover Treatment||50
9736215|NCT00191152|10836871|FG001|COMPLETED|Crossover Treatment||53
9736216|NCT00191152|10836870|FG000|NOT COMPLETED|Crossover Treatment||27
9736217|NCT00191152|10836871|FG001|NOT COMPLETED|Crossover Treatment||28
9736218|NCT00191165|10836891|FG000|STARTED|Overall Study||14
9736219|NCT00191165|10836892|FG001|STARTED|Overall Study||13
9736220|NCT00191165|10836891|FG000|COMPLETED|Overall Study||12
9736221|NCT00191165|10836892|FG001|COMPLETED|Overall Study||11
9736222|NCT00191165|10836891|FG000|NOT COMPLETED|Overall Study||2
9736223|NCT00191165|10836892|FG001|NOT COMPLETED|Overall Study||2
10083180|NCT02272842|11211552|FG000|NOT COMPLETED|Overall Study||16
10083181|NCT02272842|11211553|FG001|NOT COMPLETED|Overall Study||10
10083182|NCT02272985|11211560|FG000|STARTED|Overall Study||15
10083183|NCT02272985|11211560|FG000|COMPLETED|Overall Study||12
9736224|NCT00191191|10836900|FG000|STARTED|Overall Study||114
9736225|NCT00191191|10836901|FG001|STARTED|Overall Study||112
9736226|NCT00191191|10836900|FG000|Safety Analysis Population|Overall Study||114
9736227|NCT00191191|10836901|FG001|Safety Analysis Population|Overall Study||111
10083184|NCT02272985|11211560|FG000|NOT COMPLETED|Overall Study||3
10083185|NCT02273037|11211567|FG000|STARTED|Overall Study||987
10083186|NCT02273037|11211568|FG001|STARTED|Overall Study||1000
10083187|NCT02273037|11211567|FG000|COMPLETED|Overall Study||979
10083188|NCT02273037|11211568|FG001|COMPLETED|Overall Study||992
10083189|NCT02273037|11211567|FG000|NOT COMPLETED|Overall Study||8
10083190|NCT02273037|11211568|FG001|NOT COMPLETED|Overall Study||8
10083191|NCT02273050|11211579|FG000|STARTED|Overall Study||210
10083192|NCT02273050|11211580|FG001|STARTED|Overall Study||216
10083193|NCT02273050|11211581|FG002|STARTED|Overall Study||214
10083194|NCT02273050|11211579|FG000|COMPLETED|Overall Study||186
10083195|NCT02273050|11211580|FG001|COMPLETED|Overall Study||194
9736228|NCT00191191|10836900|FG000|Full Analysis Set Population|Overall Study||108
9736229|NCT00191191|10836901|FG001|Full Analysis Set Population|Overall Study||108
9736230|NCT00191191|10836900|FG000|COMPLETED|Overall Study||0
10083196|NCT02273050|11211581|FG002|COMPLETED|Overall Study||185
10083197|NCT02273050|11211579|FG000|NOT COMPLETED|Overall Study||24
10083198|NCT02273050|11211580|FG001|NOT COMPLETED|Overall Study||22
10083199|NCT02273050|11211581|FG002|NOT COMPLETED|Overall Study||29
10083200|NCT02273063|11211589|FG000|STARTED|Overall Study||40
10083201|NCT02273063|11211589|FG000|COMPLETED|Overall Study||35
10083202|NCT02273063|11211589|FG000|NOT COMPLETED|Overall Study||5
10083203|NCT02273115|11211598|FG000|STARTED|Overall Study||94
10083204|NCT02273115|11211599|FG001|STARTED|Overall Study||90
10083205|NCT02273115|11211600|FG002|STARTED|Overall Study||67
10083206|NCT02273115|11211601|FG003|STARTED|Overall Study||72
10083207|NCT02273115|11211598|FG000|COMPLETED|Overall Study||94
10083208|NCT02273115|11211599|FG001|COMPLETED|Overall Study||90
10083209|NCT02273115|11211600|FG002|COMPLETED|Overall Study||67
10083210|NCT02273115|11211601|FG003|COMPLETED|Overall Study||71
10083211|NCT02273115|11211598|FG000|NOT COMPLETED|Overall Study||0
10083212|NCT02273115|11211599|FG001|NOT COMPLETED|Overall Study||0
10083213|NCT02273115|11211600|FG002|NOT COMPLETED|Overall Study||0
10083214|NCT02273115|11211601|FG003|NOT COMPLETED|Overall Study||1
10083215|NCT02273141|11211613|FG000|STARTED|Overall Study||257
10083216|NCT02273141|11211614|FG001|STARTED|Overall Study||258
10083217|NCT02273141|11211613|FG000|COMPLETED|Overall Study||240
10083218|NCT02273141|11211614|FG001|COMPLETED|Overall Study||233
10083219|NCT02273141|11211613|FG000|NOT COMPLETED|Overall Study||17
10083220|NCT02273141|11211614|FG001|NOT COMPLETED|Overall Study||25
10083221|NCT02273167|11211623|FG000|STARTED|Overall Study||283
10083222|NCT02273167|11211624|FG001|STARTED|Overall Study||283
10083223|NCT02273167|11211625|FG002|STARTED|Overall Study||283
10083224|NCT02273167|11211623|FG000|COMPLETED|Overall Study||259
10083225|NCT02273167|11211624|FG001|COMPLETED|Overall Study||260
10083226|NCT02273167|11211625|FG002|COMPLETED|Overall Study||262
10083227|NCT02273167|11211623|FG000|NOT COMPLETED|Overall Study||24
10083228|NCT02273167|11211624|FG001|NOT COMPLETED|Overall Study||23
10083229|NCT02273167|11211625|FG002|NOT COMPLETED|Overall Study||21
10083230|NCT02273180|11211636|FG000|STARTED|Overall Study||253
10083231|NCT02273180|11211637|FG001|STARTED|Overall Study||254
10083232|NCT02273180|11211636|FG000|Treated|Overall Study||252
10083233|NCT02273180|11211637|FG001|Treated|Overall Study||254
9736231|NCT00191191|10836901|FG001|COMPLETED|Overall Study||0
9736232|NCT00191191|10836900|FG000|NOT COMPLETED|Overall Study||114
9736233|NCT00191191|10836901|FG001|NOT COMPLETED|Overall Study||112
9736234|NCT00191269|10836909|FG000|STARTED|Overall Study||6
9736235|NCT00191269|10836910|FG001|STARTED|Overall Study||62
9736236|NCT00191269|10836909|FG000|COMPLETED|Overall Study||0
9736237|NCT00191269|10836910|FG001|COMPLETED|Overall Study||4
9736238|NCT00191269|10836909|FG000|NOT COMPLETED|Overall Study||6
9736239|NCT00191269|10836910|FG001|NOT COMPLETED|Overall Study||58
9736240|NCT00191282|10836919|FG000|STARTED|Overall Study||558
9736241|NCT00191282|10836920|FG001|STARTED|Overall Study||558
9736242|NCT00191282|10836919|FG000|COMPLETED|Overall Study||338
9736243|NCT00191282|10836920|FG001|COMPLETED|Overall Study||346
9736244|NCT00191282|10836919|FG000|NOT COMPLETED|Overall Study||220
9736245|NCT00191282|10836920|FG001|NOT COMPLETED|Overall Study||212
9736246|NCT00191308|10836926|FG000|STARTED|Overall Study||30
9736247|NCT00191308|10836926|FG000|COMPLETED|Overall Study||29
9736248|NCT00191308|10836926|FG000|NOT COMPLETED|Overall Study||1
9736249|NCT00191334|10836930|FG000|STARTED|Overall Study||50
10083234|NCT02273180|11211636|FG000|COMPLETED|Overall Study||226
10083235|NCT02273180|11211637|FG001|COMPLETED|Overall Study||235
9736250|NCT00191334|10836930|FG000|COMPLETED|Overall Study||33
9736251|NCT00191334|10836930|FG000|NOT COMPLETED|Overall Study||17
9736252|NCT00191386|10836934|FG000|STARTED|Overall Study||228
9736253|NCT00191386|10836934|FG000|6 Months|Overall Study||183
9736254|NCT00191386|10836934|FG000|12 Months|Overall Study||149
10083236|NCT02273180|11211636|FG000|NOT COMPLETED|Overall Study||27
10083237|NCT02273180|11211637|FG001|NOT COMPLETED|Overall Study||19
9736255|NCT00191386|10836934|FG000|2 Years|Overall Study||105
10083238|NCT02273206|11211645|FG000|STARTED|Overall Study||378
9736256|NCT00191386|10836934|FG000|3 Years|Overall Study||65
9736257|NCT00191386|10836934|FG000|COMPLETED|Overall Study||68
10083239|NCT02273206|11211646|FG001|STARTED|Overall Study||379
10083240|NCT02273206|11211645|FG000|COMPLETED|Overall Study||353
10083241|NCT02273206|11211646|FG001|COMPLETED|Overall Study||337
10083242|NCT02273206|11211645|FG000|NOT COMPLETED|Overall Study||25
10083243|NCT02273206|11211646|FG001|NOT COMPLETED|Overall Study||42
10199394|NCT03418051|11327844|FG000|NOT COMPLETED|Overall Study||6
10083244|NCT02273310|11211654|FG000|STARTED|Overall Study||42
10083245|NCT02273310|11211655|FG001|STARTED|Overall Study||41
10083246|NCT02273310|11211654|FG000|COMPLETED|Overall Study||24
9736258|NCT00191386|10836934|FG000|NOT COMPLETED|Overall Study||160
9736259|NCT00191451|10836941|FG000|STARTED|Overall Study||50
9736260|NCT00191451|10836942|FG001|STARTED|Overall Study||51
9736261|NCT00191451|10836943|FG002|STARTED|Overall Study||49
9736262|NCT00191451|10836941|FG000|Received at Least One Dose of Study Drug|Overall Study||50
9736263|NCT00191451|10836942|FG001|Received at Least One Dose of Study Drug|Overall Study||48
9736264|NCT00191451|10836943|FG002|Received at Least One Dose of Study Drug|Overall Study||47
9736265|NCT00191451|10836941|FG000|COMPLETED|Overall Study||43
9736266|NCT00191451|10836942|FG001|COMPLETED|Overall Study||37
9736267|NCT00191451|10836943|FG002|COMPLETED|Overall Study||35
9736268|NCT00191451|10836941|FG000|NOT COMPLETED|Overall Study||7
9736269|NCT00191451|10836942|FG001|NOT COMPLETED|Overall Study||14
9736270|NCT00191451|10836943|FG002|NOT COMPLETED|Overall Study||14
9736271|NCT00191477|10836953|FG000|STARTED|Overall Study||179
9736272|NCT00191477|10836954|FG001|STARTED|Overall Study||176
9736273|NCT00191477|10836953|FG000|Received Study Drug|Overall Study||166
9736274|NCT00191477|10836954|FG001|Received Study Drug|Overall Study||162
9736275|NCT00191477|10836953|FG000|COMPLETED|Overall Study||41
9736276|NCT00191477|10836954|FG001|COMPLETED|Overall Study||47
9736277|NCT00191477|10836953|FG000|NOT COMPLETED|Overall Study||138
9736278|NCT00191477|10836954|FG001|NOT COMPLETED|Overall Study||129
9736279|NCT00191646|10836962|FG000|STARTED|Overall Study||417
9736280|NCT00191646|10836963|FG001|STARTED|Overall Study||414
9736281|NCT00191646|10836962|FG000|Received Induction Therapy|Overall Study||411
9736282|NCT00191646|10836963|FG001|Received Induction Therapy|Overall Study||409
9736283|NCT00191646|10836962|FG000|Received Consolidation Therapy|Overall Study||169
9736284|NCT00191646|10836963|FG001|Received Consolidation Therapy|Overall Study||183
9736285|NCT00191646|10836962|FG000|Received Crossover Therapy|Overall Study||77
9736286|NCT00191646|10836963|FG001|Received Crossover Therapy|Overall Study||78
9736287|NCT00191646|10836962|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
9736288|NCT00191646|10836963|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
9736289|NCT00191646|10836962|FG000|NOT COMPLETED|Overall Study||171
9736290|NCT00191646|10836963|FG001|NOT COMPLETED|Overall Study||153
9736291|NCT00191724|10836982|FG000|STARTED|Overall Study||6
9736292|NCT00191724|10836983|FG001|STARTED|Overall Study||9
9736293|NCT00191724|10836984|FG002|STARTED|Overall Study||9
9736294|NCT00191724|10836985|FG003|STARTED|Overall Study||8
9736295|NCT00191724|10836986|FG004|STARTED|Overall Study||15
9736296|NCT00191724|10836982|FG000|COMPLETED|Overall Study||5
9736297|NCT00191724|10836983|FG001|COMPLETED|Overall Study||8
9736298|NCT00191724|10836984|FG002|COMPLETED|Overall Study||8
9736299|NCT00191724|10836985|FG003|COMPLETED|Overall Study||5
9736300|NCT00191724|10836986|FG004|COMPLETED|Overall Study||12
9736301|NCT00191724|10836982|FG000|NOT COMPLETED|Overall Study||1
9736302|NCT00191724|10836983|FG001|NOT COMPLETED|Overall Study||1
9736303|NCT00191724|10836984|FG002|NOT COMPLETED|Overall Study||1
9736304|NCT00191724|10836985|FG003|NOT COMPLETED|Overall Study||3
9736305|NCT00191724|10836986|FG004|NOT COMPLETED|Overall Study||3
9736306|NCT00191789|10836998|FG000|STARTED|Overall Study||65
9736307|NCT00191789|10836998|FG000|COMPLETED|Overall Study||40
9736308|NCT00191789|10836998|FG000|NOT COMPLETED|Overall Study||25
9828035|NCT00753766|10938740|FG000|COMPLETED|Overall Study||0
9828036|NCT00753766|10938741|FG001|COMPLETED|Overall Study||0
9828037|NCT00753766|10938740|FG000|NOT COMPLETED|Overall Study||1
9828038|NCT00753766|10938741|FG001|NOT COMPLETED|Overall Study||0
9828039|NCT00753896|10938748|FG000|STARTED|Overall Study||134
9828040|NCT00753896|10938748|FG000|COMPLETED|Overall Study||118
9828041|NCT00753896|10938748|FG000|NOT COMPLETED|Overall Study||16
9828042|NCT00753922|10938756|FG000|STARTED|Overall Study||552
9828043|NCT00753922|10938757|FG001|STARTED|Overall Study||251
9828044|NCT00753922|10938758|FG002|STARTED|Overall Study||145
9828045|NCT00753922|10938759|FG003|STARTED|Overall Study||60
9828046|NCT00753922|10938756|FG000|COMPLETED|Overall Study||306
9828047|NCT00753922|10938757|FG001|COMPLETED|Overall Study||157
9828048|NCT00753922|10938758|FG002|COMPLETED|Overall Study||82
9828049|NCT00753922|10938759|FG003|COMPLETED|Overall Study||37
9828050|NCT00753922|10938756|FG000|NOT COMPLETED|Overall Study||246
9828051|NCT00753922|10938757|FG001|NOT COMPLETED|Overall Study||94
9828052|NCT00753922|10938758|FG002|NOT COMPLETED|Overall Study||63
9828053|NCT00753922|10938759|FG003|NOT COMPLETED|Overall Study||23
9828054|NCT00753935|10938771|FG000|STARTED|Overall Study||45
9828055|NCT00753935|10938772|FG001|STARTED|Overall Study||47
9828056|NCT00753935|10938771|FG000|COMPLETED|Overall Study||45
9828057|NCT00753935|10938772|FG001|COMPLETED|Overall Study||47
9828058|NCT00753935|10938771|FG000|NOT COMPLETED|Overall Study||0
9828059|NCT00753935|10938772|FG001|NOT COMPLETED|Overall Study||0
9828060|NCT00753948|10938781|FG000|STARTED|Overall Study||9
10083247|NCT02273310|11211655|FG001|COMPLETED|Overall Study||38
10083248|NCT02273310|11211654|FG000|NOT COMPLETED|Overall Study||18
9828061|NCT00753948|10938782|FG001|STARTED|Overall Study||7
9828062|NCT00753948|10938783|FG002|STARTED|Overall Study||7
9828063|NCT00753948|10938781|FG000|COMPLETED|Overall Study||9
9828064|NCT00753948|10938782|FG001|COMPLETED|Overall Study||7
9828065|NCT00753948|10938783|FG002|COMPLETED|Overall Study||7
9828066|NCT00753948|10938781|FG000|NOT COMPLETED|Overall Study||0
9828067|NCT00753948|10938782|FG001|NOT COMPLETED|Overall Study||0
9828068|NCT00753948|10938783|FG002|NOT COMPLETED|Overall Study||0
9828069|NCT00754065|10938793|FG000|STARTED|Overall Study||203
9736309|NCT00191815|10837002|FG000|STARTED|Overall Study||70
9736310|NCT00191815|10837002|FG000|Treated|Overall Study||67
9736311|NCT00191815|10837002|FG000|COMPLETED|Overall Study||30
9736312|NCT00191815|10837002|FG000|NOT COMPLETED|Overall Study||40
10083249|NCT02273310|11211655|FG001|NOT COMPLETED|Overall Study||3
10083250|NCT02273323|11211662|FG000|STARTED|Overall Study||15
10083251|NCT02273323|11211663|FG001|STARTED|Overall Study||15
10083252|NCT02273323|11211662|FG000|COMPLETED|Overall Study||15
10083253|NCT02273323|11211663|FG001|COMPLETED|Overall Study||15
10083254|NCT02273323|11211662|FG000|NOT COMPLETED|Overall Study||0
10083255|NCT02273323|11211663|FG001|NOT COMPLETED|Overall Study||0
10083256|NCT02273596|11211669|FG000|STARTED|24-Week Treatment Period||29
10083257|NCT02273596|11211669|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28
10083258|NCT02273596|11211669|FG000|COMPLETED|24-Week Treatment Period||22
10083259|NCT02273596|11211669|FG000|NOT COMPLETED|24-Week Treatment Period||7
10083260|NCT02273596|11211669|FG000|STARTED|Extension Period||22
10083261|NCT02273596|11211669|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22
10083262|NCT02273596|11211669|FG000|COMPLETED|Extension Period||0
10083263|NCT02273596|11211669|FG000|NOT COMPLETED|Extension Period||22
10083264|NCT02273726|11211681|FG000|STARTED|Overall Study||370
10083265|NCT02273726|11211682|FG001|STARTED|Overall Study||371
10083266|NCT02273726|11211681|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370
10083267|NCT02273726|11211682|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370
10083268|NCT02273726|11211681|FG000|COMPLETED|Overall Study||127
10083269|NCT02273726|11211682|FG001|COMPLETED|Overall Study||183
10083270|NCT02273726|11211681|FG000|NOT COMPLETED|Overall Study||243
10083271|NCT02273726|11211682|FG001|NOT COMPLETED|Overall Study||188
10083272|NCT02273739|11211692|FG000|STARTED|Overall Study||3
10083273|NCT02273739|11211693|FG001|STARTED|Overall Study||4
10083274|NCT02273739|11211694|FG002|STARTED|Overall Study||7
10083275|NCT02273739|11211695|FG003|STARTED|Overall Study||7
10083276|NCT02273739|11211692|FG000|COMPLETED|Overall Study||0
10083277|NCT02273739|11211693|FG001|COMPLETED|Overall Study||0
10083278|NCT02273739|11211694|FG002|COMPLETED|Overall Study||0
10083279|NCT02273739|11211695|FG003|COMPLETED|Overall Study||0
10083280|NCT02273739|11211692|FG000|NOT COMPLETED|Overall Study||3
10083281|NCT02273739|11211693|FG001|NOT COMPLETED|Overall Study||4
10083282|NCT02273739|11211694|FG002|NOT COMPLETED|Overall Study||7
10083283|NCT02273739|11211695|FG003|NOT COMPLETED|Overall Study||7
10083284|NCT02273908|11211712|FG000|STARTED|Overall Study||157
10083285|NCT02273908|11211713|FG001|STARTED|Overall Study||174
10083286|NCT02273908|11211712|FG000|COMPLETED|Overall Study||124
10083287|NCT02273908|11211713|FG001|COMPLETED|Overall Study||169
10083288|NCT02273908|11211712|FG000|NOT COMPLETED|Overall Study||33
10083289|NCT02273908|11211713|FG001|NOT COMPLETED|Overall Study||5
10083290|NCT02273960|11211727|FG000|STARTED|Short Term Period||5
10083291|NCT02273960|11211728|FG001|STARTED|Short Term Period||6
10083292|NCT02273960|11211729|FG002|STARTED|Short Term Period||5
10083293|NCT02273960|11211730|FG003|STARTED|Short Term Period||10
10083294|NCT02273960|11211727|FG000|COMPLETED|Short Term Period||0
10083295|NCT02273960|11211728|FG001|COMPLETED|Short Term Period||0
10083296|NCT02273960|11211729|FG002|COMPLETED|Short Term Period||1
10083297|NCT02273960|11211730|FG003|COMPLETED|Short Term Period||4
10083298|NCT02273960|11211727|FG000|NOT COMPLETED|Short Term Period||5
10083299|NCT02273960|11211728|FG001|NOT COMPLETED|Short Term Period||6
10083300|NCT02273960|11211729|FG002|NOT COMPLETED|Short Term Period||4
10083301|NCT02273960|11211730|FG003|NOT COMPLETED|Short Term Period||6
10083302|NCT02273960|11211727|FG000|STARTED|Long Term Extension||0
10083303|NCT02273960|11211728|FG001|STARTED|Long Term Extension||0
10083304|NCT02273960|11211729|FG002|STARTED|Long Term Extension||1
10083305|NCT02273960|11211730|FG003|STARTED|Long Term Extension||4
10083306|NCT02273960|11211727|FG000|COMPLETED|Long Term Extension||0
10083307|NCT02273960|11211728|FG001|COMPLETED|Long Term Extension||0
10083308|NCT02273960|11211729|FG002|COMPLETED|Long Term Extension||1
10083309|NCT02273960|11211730|FG003|COMPLETED|Long Term Extension||3
10083310|NCT02273960|11211727|FG000|NOT COMPLETED|Long Term Extension||0
10083311|NCT02273960|11211728|FG001|NOT COMPLETED|Long Term Extension||0
10083312|NCT02273960|11211729|FG002|NOT COMPLETED|Long Term Extension||0
10083313|NCT02273960|11211730|FG003|NOT COMPLETED|Long Term Extension||1
10083314|NCT02273973|11211742|FG000|STARTED|Overall Study||166
10083315|NCT02273973|11211743|FG001|STARTED|Overall Study||168
10083316|NCT02273973|11211742|FG000|COMPLETED|Overall Study||157
10083317|NCT02273973|11211743|FG001|COMPLETED|Overall Study||160
10083318|NCT02273973|11211742|FG000|NOT COMPLETED|Overall Study||9
10083319|NCT02273973|11211743|FG001|NOT COMPLETED|Overall Study||8
10083320|NCT02274038|11211749|FG000|STARTED|Overall Study||3
10083321|NCT02274038|11211749|FG000|COMPLETED|Overall Study||2
10083322|NCT02274038|11211749|FG000|NOT COMPLETED|Overall Study||1
10083323|NCT02274311|11211755|FG000|STARTED|Three Months of Clomiphene Treatment||16
9736313|NCT00191854|10837009|FG000|STARTED|Overall Study||49
10083324|NCT02274311|11211755|FG000|COMPLETED|Three Months of Clomiphene Treatment||16
10083325|NCT02274311|11211755|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0
10083326|NCT02274311|11211755|FG000|STARTED|Three Months of Clomiphene Wash-out||16
10083327|NCT02274311|11211755|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15
10083328|NCT02274311|11211755|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
10083329|NCT02274493|11211761|FG000|STARTED|Overall Study||15
10083330|NCT02274493|11211761|FG000|COMPLETED|Overall Study||14
9736314|NCT00191854|10837010|FG001|STARTED|Overall Study||47
9736315|NCT00191854|10837011|FG002|STARTED|Overall Study||51
10083331|NCT02274493|11211761|FG000|NOT COMPLETED|Overall Study||1
10083332|NCT02274558|11211768|FG000|STARTED|Overall Study||78
10083333|NCT02274558|11211769|FG001|STARTED|Overall Study||76
10083334|NCT02274558|11211770|FG002|STARTED|Overall Study||80
10083335|NCT02274558|11211768|FG000|Included in the Safety Analysis Set|Overall Study||76
10083336|NCT02274558|11211769|FG001|Included in the Safety Analysis Set|Overall Study||72
9736316|NCT00191854|10837009|FG000|Received at Least One Dose of Study Drug|Overall Study||49
9736317|NCT00191854|10837010|FG001|Received at Least One Dose of Study Drug|Overall Study||47
10083337|NCT02274558|11211770|FG002|Included in the Safety Analysis Set|Overall Study||79
10083338|NCT02274558|11211768|FG000|COMPLETED|Overall Study||71
10083339|NCT02274558|11211769|FG001|COMPLETED|Overall Study||63
10083340|NCT02274558|11211770|FG002|COMPLETED|Overall Study||71
10083341|NCT02274558|11211768|FG000|NOT COMPLETED|Overall Study||7
10083342|NCT02274558|11211769|FG001|NOT COMPLETED|Overall Study||13
10083343|NCT02274558|11211770|FG002|NOT COMPLETED|Overall Study||9
10083344|NCT02274649|11211782|FG000|STARTED|Overall Study||101
10083345|NCT02274649|11211783|FG001|STARTED|Overall Study||93
10083346|NCT02274649|11211782|FG000|COMPLETED|Overall Study||77
10083347|NCT02274649|11211783|FG001|COMPLETED|Overall Study||81
9736318|NCT00191854|10837011|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
9736319|NCT00191854|10837009|FG000|COMPLETED|Overall Study||12
9736320|NCT00191854|10837010|FG001|COMPLETED|Overall Study||17
9736321|NCT00191854|10837011|FG002|COMPLETED|Overall Study||12
9736322|NCT00191854|10837009|FG000|NOT COMPLETED|Overall Study||37
9736323|NCT00191854|10837010|FG001|NOT COMPLETED|Overall Study||30
9736324|NCT00191854|10837011|FG002|NOT COMPLETED|Overall Study||39
9736325|NCT00191906|10837023|FG000|STARTED|Study Period II||39
9736326|NCT00191906|10837024|FG001|STARTED|Study Period II||37
9736327|NCT00191906|10837025|FG002|STARTED|Study Period II||27
9736328|NCT00191906|10837026|FG003|STARTED|Study Period II||18
9736329|NCT00191906|10837023|FG000|COMPLETED|Study Period II||39
9736330|NCT00191906|10837024|FG001|COMPLETED|Study Period II||32
9736331|NCT00191906|10837025|FG002|COMPLETED|Study Period II||26
9736332|NCT00191906|10837026|FG003|COMPLETED|Study Period II||18
9736333|NCT00191906|10837023|FG000|NOT COMPLETED|Study Period II||0
9736334|NCT00191906|10837024|FG001|NOT COMPLETED|Study Period II||5
9736335|NCT00191906|10837025|FG002|NOT COMPLETED|Study Period II||1
9736336|NCT00191906|10837026|FG003|NOT COMPLETED|Study Period II||0
9736337|NCT00191906|10837023|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
9736338|NCT00191906|10837024|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
9736339|NCT00191906|10837025|FG002|STARTED|Study Period III||0
9736340|NCT00191906|10837026|FG003|STARTED|Study Period III||0
9736341|NCT00191906|10837023|FG000|COMPLETED|Study Period III||9
9736342|NCT00191906|10837024|FG001|COMPLETED|Study Period III||7
9736343|NCT00191906|10837025|FG002|COMPLETED|Study Period III||0
9736344|NCT00191906|10837026|FG003|COMPLETED|Study Period III||0
9736345|NCT00191906|10837023|FG000|NOT COMPLETED|Study Period III||5
9736346|NCT00191906|10837024|FG001|NOT COMPLETED|Study Period III||4
9736347|NCT00191906|10837025|FG002|NOT COMPLETED|Study Period III||0
9736348|NCT00191906|10837026|FG003|NOT COMPLETED|Study Period III||0
9736349|NCT00191945|10837044|FG000|STARTED|Double-Blind Acute Treatment||100
9736350|NCT00191945|10837045|FG001|STARTED|Double-Blind Acute Treatment||51
9736351|NCT00191945|10837044|FG000|COMPLETED|Double-Blind Acute Treatment||94
9736352|NCT00191945|10837045|FG001|COMPLETED|Double-Blind Acute Treatment||48
9736353|NCT00191945|10837044|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6
9736354|NCT00191945|10837045|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3
9736355|NCT00191945|10837044|FG000|STARTED|Open-Label Treatment Extension||94
9736356|NCT00191945|10837045|FG001|STARTED|Open-Label Treatment Extension||48
9736357|NCT00191945|10837044|FG000|COMPLETED|Open-Label Treatment Extension||94
9736358|NCT00191945|10837045|FG001|COMPLETED|Open-Label Treatment Extension||48
9736359|NCT00191945|10837044|FG000|NOT COMPLETED|Open-Label Treatment Extension||0
9736360|NCT00191945|10837045|FG001|NOT COMPLETED|Open-Label Treatment Extension||0
9736361|NCT00191984|10837052|FG000|STARTED|Overall Study||46
9736362|NCT00191984|10837052|FG000|COMPLETED|Overall Study||7
9736363|NCT00191984|10837052|FG000|NOT COMPLETED|Overall Study||39
9736364|NCT00192023|10837058|FG000|STARTED|Period III - Double-Blind||107
9736365|NCT00192023|10837059|FG001|STARTED|Period III - Double-Blind||32
9736366|NCT00192023|10837058|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
9736367|NCT00192023|10837059|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
9736368|NCT00192023|10837058|FG000|NOT COMPLETED|Period III - Double-Blind||7
9736369|NCT00192023|10837059|FG001|NOT COMPLETED|Period III - Double-Blind||0
9736370|NCT00192023|10837058|FG000|STARTED|Period IV - Optional Open-Label||124
9736371|NCT00192023|10837059|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
9736372|NCT00192023|10837058|FG000|COMPLETED|Period IV - Optional Open-Label||49
9736373|NCT00192023|10837059|FG001|COMPLETED|Period IV - Optional Open-Label||0
10083348|NCT02274649|11211782|FG000|NOT COMPLETED|Overall Study||24
10083349|NCT02274649|11211783|FG001|NOT COMPLETED|Overall Study||12
10083350|NCT02274675|11211789|FG000|STARTED|Overall Study||7
10083351|NCT02274675|11211789|FG000|COMPLETED|Overall Study||7
10083352|NCT02274675|11211789|FG000|NOT COMPLETED|Overall Study||0
10083353|NCT02274688|11211795|FG000|STARTED|Overall Study||86
10083354|NCT02274688|11211796|FG001|STARTED|Overall Study||85
10083355|NCT02274688|11211795|FG000|COMPLETED|Overall Study||72
10083356|NCT02274688|11211796|FG001|COMPLETED|Overall Study||72
10083357|NCT02274688|11211795|FG000|NOT COMPLETED|Overall Study||14
10083358|NCT02274688|11211796|FG001|NOT COMPLETED|Overall Study||13
9736374|NCT00192023|10837058|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75
9736375|NCT00192023|10837059|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0
9736376|NCT00192036|10837065|FG000|STARTED|Overall Study||49
9736377|NCT00192036|10837065|FG000|COMPLETED|Overall Study||28
9736378|NCT00192036|10837065|FG000|NOT COMPLETED|Overall Study||21
9736379|NCT00192075|10837071|FG000|STARTED|Overall Study||42
9736380|NCT00192075|10837072|FG001|STARTED|Overall Study||42
9736381|NCT00192075|10837071|FG000|COMPLETED|Overall Study||3
9736382|NCT00192075|10837072|FG001|COMPLETED|Overall Study||23
9736383|NCT00192075|10837071|FG000|NOT COMPLETED|Overall Study||39
9736384|NCT00192075|10837072|FG001|NOT COMPLETED|Overall Study||19
9736385|NCT00192114|10837083|FG000|STARTED|Overall Study||28
9736386|NCT00192114|10837083|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28
9736387|NCT00192114|10837083|FG000|COMPLETED|Overall Study||4
9736388|NCT00192114|10837083|FG000|NOT COMPLETED|Overall Study||24
9736389|NCT00192296|10837091|FG000|STARTED|Overall Study||6
9736390|NCT00192296|10837092|FG001|STARTED|Overall Study||6
9736391|NCT00192296|10837093|FG002|STARTED|Overall Study||6
9736392|NCT00192296|10837094|FG003|STARTED|Overall Study||6
9736393|NCT00192296|10837091|FG000|COMPLETED|Overall Study||6
9736394|NCT00192296|10837092|FG001|COMPLETED|Overall Study||5
9736395|NCT00192296|10837093|FG002|COMPLETED|Overall Study||6
9736396|NCT00192296|10837094|FG003|COMPLETED|Overall Study||6
9736397|NCT00192296|10837091|FG000|NOT COMPLETED|Overall Study||0
9736398|NCT00192296|10837092|FG001|NOT COMPLETED|Overall Study||1
9736399|NCT00192296|10837093|FG002|NOT COMPLETED|Overall Study||0
9736400|NCT00192296|10837094|FG003|NOT COMPLETED|Overall Study||0
9736401|NCT00192504|10837108|FG000|STARTED|Overall Study||5
9736402|NCT00192504|10837109|FG001|STARTED|Overall Study||5
9736403|NCT00192504|10837110|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6
9736404|NCT00192504|10837111|FG003|STARTED|Overall Study||15
9736405|NCT00192504|10837108|FG000|COMPLETED|Overall Study||4
9736406|NCT00192504|10837109|FG001|COMPLETED|Overall Study||5
9736407|NCT00192504|10837110|FG002|COMPLETED|Overall Study||5
9736408|NCT00192504|10837111|FG003|COMPLETED|Overall Study||15
9736409|NCT00192504|10837108|FG000|NOT COMPLETED|Overall Study||1
9736410|NCT00192504|10837109|FG001|NOT COMPLETED|Overall Study||0
9736411|NCT00192504|10837110|FG002|NOT COMPLETED|Overall Study||1
9736412|NCT00192504|10837111|FG003|NOT COMPLETED|Overall Study||0
9736413|NCT00192647|10837123|FG000|STARTED|Overall Study||448
9736414|NCT00192647|10837124|FG001|STARTED|Overall Study||448
9736415|NCT00192647|10837123|FG000|Treated|Overall Study||433
9736416|NCT00192647|10837124|FG001|Treated|Overall Study||438
9736417|NCT00192647|10837123|FG000|COMPLETED|Overall Study||320
9736418|NCT00192647|10837124|FG001|COMPLETED|Overall Study||302
9736419|NCT00192647|10837123|FG000|NOT COMPLETED|Overall Study||128
9736420|NCT00192647|10837124|FG001|NOT COMPLETED|Overall Study||146
9736421|NCT00193037|10837132|FG000|STARTED|Randomized Treatment||50
9736422|NCT00193037|10837133|FG001|STARTED|Randomized Treatment||52
9736423|NCT00193037|10837132|FG000|COMPLETED|Randomized Treatment||32
9736424|NCT00193037|10837133|FG001|COMPLETED|Randomized Treatment||24
9736425|NCT00193037|10837132|FG000|NOT COMPLETED|Randomized Treatment||18
9736426|NCT00193037|10837133|FG001|NOT COMPLETED|Randomized Treatment||28
9736427|NCT00193037|10837132|FG000|STARTED|Crossover Treatment||32
9736428|NCT00193037|10837133|FG001|STARTED|Crossover Treatment||24
9736429|NCT00193037|10837132|FG000|COMPLETED|Crossover Treatment||32
9736430|NCT00193037|10837133|FG001|COMPLETED|Crossover Treatment||24
9736431|NCT00193037|10837132|FG000|NOT COMPLETED|Crossover Treatment||0
9736432|NCT00193037|10837133|FG001|NOT COMPLETED|Crossover Treatment||0
9736433|NCT00193050|10837139|FG000|STARTED|Neoadjuvant Treatment||110
9736434|NCT00193050|10837139|FG000|COMPLETED|Neoadjuvant Treatment||101
9736435|NCT00193050|10837139|FG000|NOT COMPLETED|Neoadjuvant Treatment||9
9736436|NCT00193050|10837139|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
9736437|NCT00193050|10837139|FG000|COMPLETED|Surgery||103
9736438|NCT00193050|10837139|FG000|NOT COMPLETED|Surgery||0
9736439|NCT00193050|10837139|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
9736440|NCT00193050|10837139|FG000|COMPLETED|Adjuvant||77
9736441|NCT00193050|10837139|FG000|NOT COMPLETED|Adjuvant||10
9736442|NCT00193063|10837144|FG000|STARTED|Overall Study||41
9736443|NCT00193063|10837144|FG000|COMPLETED|Overall Study||37
9736444|NCT00193063|10837144|FG000|NOT COMPLETED|Overall Study||4
9736445|NCT00193128|10837150|FG000|STARTED|Overall Study||10
9736446|NCT00193128|10837151|FG001|STARTED|Overall Study||49
9736447|NCT00193128|10837150|FG000|COMPLETED|Overall Study||10
9736448|NCT00193128|10837151|FG001|COMPLETED|Overall Study||39
9736449|NCT00193128|10837150|FG000|NOT COMPLETED|Overall Study||0
9736450|NCT00193128|10837151|FG001|NOT COMPLETED|Overall Study||10
9736451|NCT00193180|10837159|FG000|STARTED|Overall Study||37
10083359|NCT02274766|11211805|FG000|STARTED|Overall Study||39
9736452|NCT00193180|10837159|FG000|COMPLETED|Overall Study||27
9736453|NCT00193180|10837159|FG000|NOT COMPLETED|Overall Study||10
9736454|NCT00193206|10837164|FG000|STARTED|Preoperative Therapy||123
9736455|NCT00193206|10837164|FG000|COMPLETED|Preoperative Therapy||116
9736456|NCT00193206|10837164|FG000|NOT COMPLETED|Preoperative Therapy||7
10083360|NCT02274766|11211806|FG001|STARTED|Overall Study||38
10083361|NCT02274766|11211805|FG000|Received Study Drug|Overall Study||38
10083362|NCT02274766|11211806|FG001|Received Study Drug|Overall Study||37
10083363|NCT02274766|11211805|FG000|COMPLETED|Overall Study||35
10083364|NCT02274766|11211806|FG001|COMPLETED|Overall Study||29
10083365|NCT02274766|11211805|FG000|NOT COMPLETED|Overall Study||4
10083366|NCT02274766|11211806|FG001|NOT COMPLETED|Overall Study||9
10112696|NCT02504619|11243618|FG000|STARTED|Overall Study||1
10112697|NCT02504619|11243618|FG000|COMPLETED|Overall Study||1
10112698|NCT02504619|11243618|FG000|NOT COMPLETED|Overall Study||0
10112699|NCT02504645|11243625|FG000|STARTED|Overall Study||101
10112700|NCT02504645|11243626|FG001|STARTED|Overall Study||101
10112701|NCT02504645|11243625|FG000|COMPLETED|Overall Study||77
10112702|NCT02504645|11243626|FG001|COMPLETED|Overall Study||76
10112703|NCT02504645|11243625|FG000|NOT COMPLETED|Overall Study||24
10112704|NCT02504645|11243626|FG001|NOT COMPLETED|Overall Study||25
10112705|NCT02504671|11243638|FG000|STARTED|Overall Study||37
9736457|NCT00193206|10837164|FG000|STARTED|Surgery||116
9736458|NCT00193206|10837164|FG000|COMPLETED|Surgery||116
9736459|NCT00193206|10837164|FG000|NOT COMPLETED|Surgery||0
9736460|NCT00193206|10837164|FG000|STARTED|Postoperative Therapy||116
9736461|NCT00193206|10837164|FG000|COMPLETED|Postoperative Therapy||102
9736462|NCT00193206|10837164|FG000|NOT COMPLETED|Postoperative Therapy||14
9736463|NCT00193258|10837168|FG000|STARTED|Overall Study||94
9736464|NCT00193258|10837168|FG000|COMPLETED|Overall Study||94
9736465|NCT00193258|10837168|FG000|NOT COMPLETED|Overall Study||0
9736466|NCT00193375|10837172|FG000|STARTED|Overall Study||60
9736467|NCT00193375|10837172|FG000|COMPLETED|Overall Study||41
9736468|NCT00193375|10837172|FG000|NOT COMPLETED|Overall Study||19
9736469|NCT00193453|10837176|FG000|STARTED|Overall Study||69
9736470|NCT00193453|10837176|FG000|COMPLETED|Overall Study||21
9736471|NCT00193453|10837176|FG000|NOT COMPLETED|Overall Study||48
9736472|NCT00193492|10837182|FG000|STARTED|Overall Study||31
9736473|NCT00193492|10837183|FG001|STARTED|Overall Study||29
9736474|NCT00193492|10837182|FG000|COMPLETED|Overall Study||14
9736475|NCT00193492|10837183|FG001|COMPLETED|Overall Study||14
9736476|NCT00193492|10837182|FG000|NOT COMPLETED|Overall Study||17
9736477|NCT00193492|10837183|FG001|NOT COMPLETED|Overall Study||15
9736478|NCT00193596|10837191|FG000|STARTED|Overall Study||93
9736479|NCT00193596|10837192|FG001|STARTED|Overall Study||105
9736480|NCT00193596|10837191|FG000|COMPLETED|Overall Study||37
9736481|NCT00193596|10837192|FG001|COMPLETED|Overall Study||39
9736482|NCT00193596|10837191|FG000|NOT COMPLETED|Overall Study||56
9736483|NCT00193596|10837192|FG001|NOT COMPLETED|Overall Study||66
9736484|NCT00193609|10837198|FG000|STARTED|Overall Study||48
9736485|NCT00193609|10837198|FG000|COMPLETED|Overall Study||44
9736486|NCT00193609|10837198|FG000|NOT COMPLETED|Overall Study||4
9736487|NCT00194012|10837204|FG000|STARTED|Randomized Phase||31
9736488|NCT00194012|10837205|FG001|STARTED|Randomized Phase||31
9736489|NCT00194012|10837204|FG000|Received More Than One Dose|Randomized Phase||30
9736490|NCT00194012|10837205|FG001|Received More Than One Dose|Randomized Phase||29
9736491|NCT00194012|10837204|FG000|COMPLETED|Randomized Phase||15
9736492|NCT00194012|10837205|FG001|COMPLETED|Randomized Phase||6
9736493|NCT00194012|10837204|FG000|NOT COMPLETED|Randomized Phase||16
9736494|NCT00194012|10837205|FG001|NOT COMPLETED|Randomized Phase||25
9736495|NCT00194012|10837204|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
9736496|NCT00194012|10837205|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
9736497|NCT00194012|10837204|FG000|COMPLETED|Open Label Extension (OLE)||17
9736498|NCT00194012|10837205|FG001|COMPLETED|Open Label Extension (OLE)||15
9736499|NCT00194012|10837204|FG000|NOT COMPLETED|Open Label Extension (OLE)||5
9736500|NCT00194012|10837205|FG001|NOT COMPLETED|Open Label Extension (OLE)||6
9736501|NCT00194025|10837217|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
9736502|NCT00194025|10837217|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15
9736503|NCT00194025|10837217|FG000|NOT COMPLETED|Overall Study||5
9736504|NCT00194077|10837223|FG000|STARTED|Overall Study||30
9736505|NCT00194077|10837224|FG001|STARTED|Overall Study||30
9736506|NCT00194077|10837223|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
9736507|NCT00194077|10837224|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
9736508|NCT00194077|10837223|FG000|NOT COMPLETED|Overall Study||24
9736509|NCT00194077|10837224|FG001|NOT COMPLETED|Overall Study||30
9736510|NCT00194116|10837232|FG000|STARTED|Overall Study||26
9736511|NCT00194116|10837233|FG001|STARTED|Overall Study||28
9736512|NCT00194116|10837232|FG000|COMPLETED|Overall Study||13
9736513|NCT00194116|10837233|FG001|COMPLETED|Overall Study||13
9736514|NCT00194116|10837232|FG000|NOT COMPLETED|Overall Study||13
9736515|NCT00194116|10837233|FG001|NOT COMPLETED|Overall Study||15
10112706|NCT02504671|11243639|FG001|STARTED|Overall Study||37
10112707|NCT02504671|11243640|FG002|STARTED|Overall Study||37
10112708|NCT02504671|11243641|FG003|STARTED|Overall Study||37
10112709|NCT02504671|11243642|FG004|STARTED|Overall Study||37
10112710|NCT02504671|11243643|FG005|STARTED|Overall Study||37
10112711|NCT02504671|11243638|FG000|COMPLETED|Overall Study||25
9736516|NCT00194129|10837241|FG000|STARTED|Overall Study||15
9736517|NCT00194129|10837242|FG001|STARTED|Overall Study||16
9736518|NCT00194129|10837241|FG000|COMPLETED|Overall Study||5
10112712|NCT02504671|11243639|FG001|COMPLETED|Overall Study||23
10112713|NCT02504671|11243640|FG002|COMPLETED|Overall Study||27
10083367|NCT02274792|11211812|FG000|STARTED|Overall Study||132
10199395|NCT03418051|11327845|FG001|NOT COMPLETED|Overall Study||2
10199396|NCT03418051|11327846|FG002|NOT COMPLETED|Overall Study||3
10199397|NCT03418064|11327854|FG000|STARTED|First Intervention (1 Month)||21
10199398|NCT03418064|11327855|FG001|STARTED|First Intervention (1 Month)||21
10199399|NCT03418064|11327854|FG000|COMPLETED|First Intervention (1 Month)||21
9736519|NCT00194129|10837242|FG001|COMPLETED|Overall Study||3
9736520|NCT00194129|10837241|FG000|NOT COMPLETED|Overall Study||10
9736521|NCT00194129|10837242|FG001|NOT COMPLETED|Overall Study||13
9736522|NCT00194532|10837257|FG000|STARTED|Overall Study||150
10199400|NCT03418064|11327855|FG001|COMPLETED|First Intervention (1 Month)||21
10199401|NCT03418064|11327854|FG000|NOT COMPLETED|First Intervention (1 Month)||0
10199402|NCT03418064|11327855|FG001|NOT COMPLETED|First Intervention (1 Month)||0
10199403|NCT03418064|11327854|FG000|STARTED|Second Intervention (1 Month)||21
10199404|NCT03418064|11327855|FG001|STARTED|Second Intervention (1 Month)||21
10199405|NCT03418064|11327854|FG000|COMPLETED|Second Intervention (1 Month)||21
10199406|NCT03418064|11327855|FG001|COMPLETED|Second Intervention (1 Month)||21
10199407|NCT03418064|11327854|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
10199408|NCT03418064|11327855|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
10199409|NCT03418324|11327871|FG000|STARTED|Overall Study||3
10199410|NCT03418324|11327872|FG001|STARTED|Overall Study||8
10199411|NCT03418324|11327871|FG000|COMPLETED|Overall Study||2
10199412|NCT03418324|11327872|FG001|COMPLETED|Overall Study||6
10199413|NCT03418324|11327871|FG000|NOT COMPLETED|Overall Study||1
10199414|NCT03418324|11327872|FG001|NOT COMPLETED|Overall Study||2
10199415|NCT03418376|11327882|FG000|STARTED|Overall Study||12
10199416|NCT03418376|11327883|FG001|STARTED|Overall Study||11
10199417|NCT03418376|11327884|FG002|STARTED|Overall Study||11
10199418|NCT03418376|11327885|FG003|STARTED|Overall Study||11
10199419|NCT03418376|11327882|FG000|COMPLETED|Overall Study||11
10199420|NCT03418376|11327883|FG001|COMPLETED|Overall Study||6
10199421|NCT03418376|11327884|FG002|COMPLETED|Overall Study||8
10199422|NCT03418376|11327885|FG003|COMPLETED|Overall Study||10
10199423|NCT03418376|11327882|FG000|NOT COMPLETED|Overall Study||1
10199424|NCT03418376|11327883|FG001|NOT COMPLETED|Overall Study||5
10199425|NCT03418376|11327884|FG002|NOT COMPLETED|Overall Study||3
10199426|NCT03418376|11327885|FG003|NOT COMPLETED|Overall Study||1
10199427|NCT03418545|11327897|FG000|STARTED|Overall Study||35
10199428|NCT03418545|11327898|FG001|STARTED|Overall Study||105
10199429|NCT03418545|11327897|FG000|Safety Population|Overall Study||34
10199430|NCT03418545|11327898|FG001|Safety Population|Overall Study||105
10199431|NCT03418545|11327897|FG000|Received Optional or Repeat Treatment|Overall Study||29
10199432|NCT03418545|11327898|FG001|Received Optional or Repeat Treatment|Overall Study||37
10199433|NCT03418545|11327897|FG000|COMPLETED|Overall Study||30
10199434|NCT03418545|11327898|FG001|COMPLETED|Overall Study||94
10199435|NCT03418545|11327897|FG000|NOT COMPLETED|Overall Study||5
10199436|NCT03418545|11327898|FG001|NOT COMPLETED|Overall Study||11
10199437|NCT03418571|11327909|FG000|STARTED|Overall Study||12
10199438|NCT03418571|11327910|FG001|STARTED|Overall Study||3
10199439|NCT03418571|11327909|FG000|COMPLETED|Overall Study||11
10199440|NCT03418571|11327910|FG001|COMPLETED|Overall Study||3
10199441|NCT03418571|11327909|FG000|NOT COMPLETED|Overall Study||1
10199442|NCT03418571|11327910|FG001|NOT COMPLETED|Overall Study||0
10199443|NCT03418662|11327918|FG000|STARTED|Overall Study||287
10199444|NCT03418662|11327919|FG001|STARTED|Overall Study||282
10199445|NCT03418662|11327918|FG000|COMPLETED|Overall Study||284
10199446|NCT03418662|11327919|FG001|COMPLETED|Overall Study||278
10199447|NCT03418662|11327918|FG000|NOT COMPLETED|Overall Study||3
10199448|NCT03418662|11327919|FG001|NOT COMPLETED|Overall Study||4
10199449|NCT03418714|11327925|FG000|STARTED|Overall Study||13
10199450|NCT03418714|11327925|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
10199451|NCT03418714|11327925|FG000|NOT COMPLETED|Overall Study||1
10199452|NCT03419078|11327932|FG000|STARTED|Overall Study||245
10083368|NCT02274792|11211812|FG000|Received Treatment|Overall Study||131
10083369|NCT02274792|11211812|FG000|COMPLETED|Overall Study||107
10199453|NCT03419078|11327933|FG001|STARTED|Overall Study||148
10199454|NCT03419078|11327934|FG002|STARTED|Overall Study||91
10199455|NCT03419078|11327932|FG000|COMPLETED|Overall Study||245
10199456|NCT03419078|11327933|FG001|COMPLETED|Overall Study||148
10199457|NCT03419078|11327934|FG002|COMPLETED|Overall Study||91
10199458|NCT03419078|11327932|FG000|NOT COMPLETED|Overall Study||0
10199459|NCT03419078|11327933|FG001|NOT COMPLETED|Overall Study||0
10083370|NCT02274792|11211812|FG000|NOT COMPLETED|Overall Study||25
10083371|NCT02274844|11211818|FG000|STARTED|Overall Study||203
10083372|NCT02274844|11211819|FG001|STARTED|Overall Study||270
10083373|NCT02274844|11211818|FG000|COMPLETED|Overall Study||165
10083374|NCT02274844|11211819|FG001|COMPLETED|Overall Study||238
10083375|NCT02274844|11211818|FG000|NOT COMPLETED|Overall Study||38
10083376|NCT02274844|11211819|FG001|NOT COMPLETED|Overall Study||32
10083377|NCT02274857|11211827|FG000|STARTED|Overall Study||179
10083378|NCT02274857|11211828|FG001|STARTED|Overall Study||171
10083379|NCT02274857|11211827|FG000|Completed Per Protocol|Overall Study||102
10083380|NCT02274857|11211828|FG001|Completed Per Protocol|Overall Study||114
10083381|NCT02274857|11211827|FG000|COMPLETED|Overall Study||159
10083382|NCT02274857|11211828|FG001|COMPLETED|Overall Study||165
10083383|NCT02274857|11211827|FG000|NOT COMPLETED|Overall Study||20
10083384|NCT02274857|11211828|FG001|NOT COMPLETED|Overall Study||6
10083385|NCT02274870|11211837|FG000|STARTED|Overall Study||32
10083386|NCT02274870|11211838|FG001|STARTED|Overall Study||33
10083387|NCT02274870|11211837|FG000|COMPLETED|Overall Study||32
10083388|NCT02274870|11211838|FG001|COMPLETED|Overall Study||33
10083389|NCT02274870|11211837|FG000|NOT COMPLETED|Overall Study||0
10083390|NCT02274870|11211838|FG001|NOT COMPLETED|Overall Study||0
10083391|NCT02274948|11211849|FG000|STARTED|Overall Study||166
10083392|NCT02274948|11211850|FG001|STARTED|Overall Study||173
10083393|NCT02274948|11211849|FG000|COMPLETED|Overall Study||68
10083394|NCT02274948|11211850|FG001|COMPLETED|Overall Study||82
10083395|NCT02274948|11211849|FG000|NOT COMPLETED|Overall Study||98
10083396|NCT02274948|11211850|FG001|NOT COMPLETED|Overall Study||91
10083397|NCT02275026|11211857|FG000|STARTED|Overall Study||104
10083398|NCT02275026|11211857|FG000|COMPLETED|Overall Study||71
10083399|NCT02275026|11211857|FG000|NOT COMPLETED|Overall Study||33
9736523|NCT00194532|10837258|FG001|STARTED|Overall Study||150
9736524|NCT00194532|10837257|FG000|COMPLETED|Overall Study||150
9736525|NCT00194532|10837258|FG001|COMPLETED|Overall Study||150
9736526|NCT00194532|10837257|FG000|NOT COMPLETED|Overall Study||0
9736527|NCT00194532|10837258|FG001|NOT COMPLETED|Overall Study||0
9736528|NCT00194610|10837266|FG000|STARTED|Overall Study||11
9736529|NCT00194610|10837267|FG001|STARTED|Overall Study||9
9736530|NCT00194610|10837266|FG000|COMPLETED|Overall Study||11
9736531|NCT00194610|10837267|FG001|COMPLETED|Overall Study||9
9736532|NCT00194610|10837266|FG000|NOT COMPLETED|Overall Study||0
9736533|NCT00194610|10837267|FG001|NOT COMPLETED|Overall Study||0
9736534|NCT00194675|10837275|FG000|STARTED|Overall Study||27
9736535|NCT00194675|10837276|FG001|STARTED|Overall Study||26
9736536|NCT00194675|10837275|FG000|COMPLETED|Overall Study||22
9736537|NCT00194675|10837276|FG001|COMPLETED|Overall Study||24
9736538|NCT00194675|10837275|FG000|NOT COMPLETED|Overall Study||5
9736539|NCT00194675|10837276|FG001|NOT COMPLETED|Overall Study||2
9736540|NCT00194779|10837284|FG000|STARTED|Overall Study||50
10083400|NCT02275052|11211864|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
10083401|NCT02275052|11211865|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
10083402|NCT02275052|11211866|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
10083403|NCT02275052|11211867|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
10083404|NCT02275052|11211864|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
9736541|NCT00194779|10837284|FG000|COMPLETED|Overall Study||50
9736542|NCT00194779|10837284|FG000|NOT COMPLETED|Overall Study||0
9736543|NCT00194792|10837288|FG000|STARTED|Overall Study||28
9736544|NCT00194792|10837288|FG000|COMPLETED|Overall Study||27
9736545|NCT00194792|10837288|FG000|NOT COMPLETED|Overall Study||1
9736546|NCT00194896|10837296|FG000|STARTED|Overall Study||15
9736547|NCT00194896|10837297|FG001|STARTED|Overall Study||15
9736548|NCT00194896|10837298|FG002|STARTED|Overall Study||13
9736549|NCT00194896|10837299|FG003|STARTED|Overall Study||21
9736550|NCT00194896|10837296|FG000|COMPLETED|Overall Study||4
9736551|NCT00194896|10837297|FG001|COMPLETED|Overall Study||10
9736552|NCT00194896|10837298|FG002|COMPLETED|Overall Study||7
9736553|NCT00194896|10837299|FG003|COMPLETED|Overall Study||9
9736554|NCT00194896|10837296|FG000|NOT COMPLETED|Overall Study||11
9736555|NCT00194896|10837297|FG001|NOT COMPLETED|Overall Study||5
9736556|NCT00194896|10837298|FG002|NOT COMPLETED|Overall Study||6
9736557|NCT00194896|10837299|FG003|NOT COMPLETED|Overall Study||12
9736558|NCT00194987|10837311|FG000|STARTED|Overall Study||51
9736559|NCT00194987|10837312|FG001|STARTED|Overall Study||51
9736560|NCT00194987|10837311|FG000|COMPLETED|Overall Study||51
9736561|NCT00194987|10837312|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
9736562|NCT00194987|10837311|FG000|NOT COMPLETED|Overall Study||0
9736563|NCT00194987|10837312|FG001|NOT COMPLETED|Overall Study||3
9736564|NCT00195013|10837322|FG000|STARTED|Overall Study||14
9736565|NCT00195013|10837323|FG001|STARTED|Overall Study||16
9736566|NCT00195013|10837322|FG000|COMPLETED|Overall Study||12
10083405|NCT02275052|11211865|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
10083406|NCT02275052|11211866|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
10083407|NCT02275052|11211867|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
10083408|NCT02275052|11211864|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
10083409|NCT02275052|11211865|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
10083410|NCT02275052|11211866|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
9736567|NCT00195013|10837323|FG001|COMPLETED|Overall Study||15
9736568|NCT00195013|10837322|FG000|NOT COMPLETED|Overall Study||2
9736569|NCT00195013|10837323|FG001|NOT COMPLETED|Overall Study||1
9736570|NCT00195039|10837329|FG000|STARTED|Overall Study||47
10083411|NCT02275052|11211867|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
10083412|NCT02275052|11211864|FG000|STARTED|Washout Period (12-17 Days)||90
10083413|NCT02275052|11211865|FG001|STARTED|Washout Period (12-17 Days)||93
10083414|NCT02275052|11211866|FG002|STARTED|Washout Period (12-17 Days)||0
10083415|NCT02275052|11211867|FG003|STARTED|Washout Period (12-17 Days)||0
10083416|NCT02275052|11211864|FG000|COMPLETED|Washout Period (12-17 Days)||86
10083417|NCT02275052|11211865|FG001|COMPLETED|Washout Period (12-17 Days)||93
10083418|NCT02275052|11211866|FG002|COMPLETED|Washout Period (12-17 Days)||0
10083419|NCT02275052|11211867|FG003|COMPLETED|Washout Period (12-17 Days)||0
10083420|NCT02275052|11211864|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4
10083421|NCT02275052|11211865|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0
10083422|NCT02275052|11211866|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0
10083423|NCT02275052|11211867|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0
10083424|NCT02275052|11211864|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
10083425|NCT02275052|11211865|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
10083426|NCT02275052|11211866|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
10083427|NCT02275052|11211867|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
10083428|NCT02275052|11211864|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10083429|NCT02275052|11211865|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10083430|NCT02275052|11211866|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
10083431|NCT02275052|11211867|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
10083432|NCT02275052|11211864|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10083433|NCT02275052|11211865|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10083434|NCT02275052|11211866|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
10083435|NCT02275052|11211867|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
9736571|NCT00195039|10837329|FG000|COMPLETED|Overall Study||47
9736572|NCT00195039|10837329|FG000|NOT COMPLETED|Overall Study||0
9736573|NCT00195260|10837335|FG000|STARTED|Part 1: Dose Escalation||4
9736574|NCT00195260|10837336|FG001|STARTED|Part 1: Dose Escalation||4
9736575|NCT00195260|10837337|FG002|STARTED|Part 1: Dose Escalation||6
9736576|NCT00195260|10837338|FG003|STARTED|Part 1: Dose Escalation||7
9736577|NCT00195260|10837339|FG004|STARTED|Part 1: Dose Escalation||7
9736578|NCT00195260|10837340|FG005|STARTED|Part 1: Dose Escalation||7
9736579|NCT00195260|10837341|FG006|STARTED|Part 1: Dose Escalation||10
9736580|NCT00195260|10837342|FG007|STARTED|Part 1: Dose Escalation||6
9736581|NCT00195260|10837343|FG008|STARTED|Part 1: Dose Escalation||0
9736582|NCT00195260|10837344|FG009|STARTED|Part 1: Dose Escalation||0
9736583|NCT00195260|10837345|FG010|STARTED|Part 1: Dose Escalation||0
9736584|NCT00195260|10837335|FG000|COMPLETED|Part 1: Dose Escalation||0
9736585|NCT00195260|10837336|FG001|COMPLETED|Part 1: Dose Escalation||0
9736586|NCT00195260|10837337|FG002|COMPLETED|Part 1: Dose Escalation||0
9736587|NCT00195260|10837338|FG003|COMPLETED|Part 1: Dose Escalation||0
9736588|NCT00195260|10837339|FG004|COMPLETED|Part 1: Dose Escalation||0
9736589|NCT00195260|10837340|FG005|COMPLETED|Part 1: Dose Escalation||0
9736590|NCT00195260|10837341|FG006|COMPLETED|Part 1: Dose Escalation||0
9736591|NCT00195260|10837342|FG007|COMPLETED|Part 1: Dose Escalation||0
9736592|NCT00195260|10837343|FG008|COMPLETED|Part 1: Dose Escalation||0
9736593|NCT00195260|10837344|FG009|COMPLETED|Part 1: Dose Escalation||0
9736594|NCT00195260|10837345|FG010|COMPLETED|Part 1: Dose Escalation||0
9736595|NCT00195260|10837335|FG000|NOT COMPLETED|Part 1: Dose Escalation||4
9736596|NCT00195260|10837336|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
9736597|NCT00195260|10837337|FG002|NOT COMPLETED|Part 1: Dose Escalation||6
9736598|NCT00195260|10837338|FG003|NOT COMPLETED|Part 1: Dose Escalation||7
9736599|NCT00195260|10837339|FG004|NOT COMPLETED|Part 1: Dose Escalation||7
9736600|NCT00195260|10837340|FG005|NOT COMPLETED|Part 1: Dose Escalation||7
9736601|NCT00195260|10837341|FG006|NOT COMPLETED|Part 1: Dose Escalation||10
9736602|NCT00195260|10837342|FG007|NOT COMPLETED|Part 1: Dose Escalation||6
9736603|NCT00195260|10837343|FG008|NOT COMPLETED|Part 1: Dose Escalation||0
9736604|NCT00195260|10837344|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
9736605|NCT00195260|10837345|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
9736606|NCT00195260|10837335|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736607|NCT00195260|10837336|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736608|NCT00195260|10837337|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736609|NCT00195260|10837338|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736610|NCT00195260|10837339|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736611|NCT00195260|10837340|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736612|NCT00195260|10837341|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736613|NCT00195260|10837342|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736614|NCT00195260|10837343|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
9736615|NCT00195260|10837344|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
9736616|NCT00195260|10837345|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
9736617|NCT00195260|10837335|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736618|NCT00195260|10837336|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736619|NCT00195260|10837337|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736620|NCT00195260|10837338|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736621|NCT00195260|10837339|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736622|NCT00195260|10837340|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736623|NCT00195260|10837341|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736624|NCT00195260|10837342|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10083436|NCT02275065|11211878|FG000|STARTED|Overall Study||5
10083437|NCT02275065|11211879|FG001|STARTED|Overall Study||4
10083438|NCT02275065|11211880|FG002|STARTED|Overall Study||5
10083439|NCT02275065|11211881|FG003|STARTED|Overall Study||5
10083440|NCT02275065|11211882|FG004|STARTED|Overall Study||4
10083441|NCT02275065|11211878|FG000|COMPLETED|Overall Study||4
10083442|NCT02275065|11211879|FG001|COMPLETED|Overall Study||4
10083443|NCT02275065|11211880|FG002|COMPLETED|Overall Study||4
10083444|NCT02275065|11211881|FG003|COMPLETED|Overall Study||4
10083445|NCT02275065|11211882|FG004|COMPLETED|Overall Study||4
10083446|NCT02275065|11211878|FG000|NOT COMPLETED|Overall Study||1
10083447|NCT02275065|11211879|FG001|NOT COMPLETED|Overall Study||0
10083448|NCT02275065|11211880|FG002|NOT COMPLETED|Overall Study||1
10083449|NCT02275065|11211881|FG003|NOT COMPLETED|Overall Study||1
9736625|NCT00195260|10837343|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
9736626|NCT00195260|10837344|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736627|NCT00195260|10837345|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
9736628|NCT00195260|10837335|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736629|NCT00195260|10837336|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736630|NCT00195260|10837337|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736631|NCT00195260|10837338|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736632|NCT00195260|10837339|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736633|NCT00195260|10837340|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736634|NCT00195260|10837341|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736635|NCT00195260|10837342|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
9736636|NCT00195260|10837343|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
9736637|NCT00195260|10837344|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
9736638|NCT00195260|10837345|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
9736639|NCT00195273|10837375|FG000|STARTED|Overall Study||31
9736640|NCT00195273|10837376|FG001|STARTED|Overall Study||30
9736641|NCT00195273|10837375|FG000|COMPLETED|Overall Study||10
9736642|NCT00195273|10837376|FG001|COMPLETED|Overall Study||16
9736643|NCT00195273|10837375|FG000|NOT COMPLETED|Overall Study||21
9736644|NCT00195273|10837376|FG001|NOT COMPLETED|Overall Study||14
9736645|NCT00195338|10837382|FG000|STARTED|Overall Study||25
9736646|NCT00195338|10837382|FG000|COMPLETED|Overall Study||13
9736647|NCT00195338|10837382|FG000|NOT COMPLETED|Overall Study||12
9736648|NCT00195351|10837388|FG000|STARTED|Overall Study||236
9736649|NCT00195351|10837389|FG001|STARTED|Overall Study||231
9736650|NCT00195351|10837388|FG000|COMPLETED|Overall Study||215
9736651|NCT00195351|10837389|FG001|COMPLETED|Overall Study||215
9736652|NCT00195351|10837388|FG000|NOT COMPLETED|Overall Study||21
9736653|NCT00195351|10837389|FG001|NOT COMPLETED|Overall Study||16
9736654|NCT00195403|10837395|FG000|STARTED|Overall Study||1014
9736655|NCT00195403|10837395|FG000|COMPLETED|Overall Study||1014
9736656|NCT00195403|10837395|FG000|NOT COMPLETED|Overall Study||0
9736657|NCT00195429|10837401|FG000|STARTED|Overall Study||24
9736658|NCT00195429|10837402|FG001|STARTED|Overall Study||23
9736659|NCT00195429|10837401|FG000|COMPLETED|Overall Study||19
9736660|NCT00195429|10837402|FG001|COMPLETED|Overall Study||18
9736661|NCT00195429|10837401|FG000|NOT COMPLETED|Overall Study||5
9736662|NCT00195429|10837402|FG001|NOT COMPLETED|Overall Study||5
9736663|NCT00195442|10837408|FG000|STARTED|Overall Study||288
9736664|NCT00195442|10837408|FG000|COMPLETED|Overall Study||152
9736665|NCT00195442|10837408|FG000|NOT COMPLETED|Overall Study||136
9736666|NCT00195494|10837414|FG000|STARTED|Year 1||0
9736667|NCT00195494|10837415|FG001|STARTED|Year 1||0
9736668|NCT00195494|10837416|FG002|STARTED|Year 1||0
9736669|NCT00195494|10837417|FG003|STARTED|Year 1||0
9736670|NCT00195494|10837418|FG004|STARTED|Year 1||268
9736671|NCT00195494|10837419|FG005|STARTED|Year 1||274
9736672|NCT00195494|10837414|FG000|COMPLETED|Year 1||0
9736673|NCT00195494|10837415|FG001|COMPLETED|Year 1||0
9736674|NCT00195494|10837416|FG002|COMPLETED|Year 1||0
9736675|NCT00195494|10837417|FG003|COMPLETED|Year 1||0
9736676|NCT00195494|10837418|FG004|COMPLETED|Year 1||189
9736677|NCT00195494|10837419|FG005|COMPLETED|Year 1||221
9736678|NCT00195494|10837414|FG000|NOT COMPLETED|Year 1||0
9736679|NCT00195494|10837415|FG001|NOT COMPLETED|Year 1||0
9736680|NCT00195494|10837416|FG002|NOT COMPLETED|Year 1||0
9736681|NCT00195494|10837417|FG003|NOT COMPLETED|Year 1||0
9736682|NCT00195494|10837418|FG004|NOT COMPLETED|Year 1||79
9736683|NCT00195494|10837419|FG005|NOT COMPLETED|Year 1||53
9736684|NCT00195494|10837414|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
9736685|NCT00195494|10837415|FG001|STARTED|Year 2||90
9736686|NCT00195494|10837416|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
9736687|NCT00195494|10837417|FG003|STARTED|Year 2||99
9736688|NCT00195494|10837418|FG004|STARTED|Year 2||0
10083450|NCT02275065|11211882|FG004|NOT COMPLETED|Overall Study||0
10083451|NCT02275117|11211899|FG000|STARTED|Overall Study||131
10083452|NCT02275117|11211900|FG001|STARTED|Overall Study||133
9736689|NCT00195494|10837419|FG005|STARTED|Year 2||0
9736690|NCT00195494|10837414|FG000|COMPLETED|Year 2||104
9736691|NCT00195494|10837415|FG001|COMPLETED|Year 2||74
9736692|NCT00195494|10837416|FG002|COMPLETED|Year 2||93
9736693|NCT00195494|10837417|FG003|COMPLETED|Year 2||76
9736694|NCT00195494|10837418|FG004|COMPLETED|Year 2||0
9736695|NCT00195494|10837419|FG005|COMPLETED|Year 2||0
9736696|NCT00195494|10837414|FG000|NOT COMPLETED|Year 2||7
9736697|NCT00195494|10837415|FG001|NOT COMPLETED|Year 2||16
10083453|NCT02275117|11211901|FG002|STARTED|Overall Study||134
10083454|NCT02275117|11211902|FG003|STARTED|Overall Study||133
10083455|NCT02275117|11211903|FG004|STARTED|Overall Study||134
10083456|NCT02275117|11211899|FG000|Randomized and Treated|Overall Study||120
10083457|NCT02275117|11211900|FG001|Randomized and Treated|Overall Study||123
10083458|NCT02275117|11211901|FG002|Randomized and Treated|Overall Study||122
10083459|NCT02275117|11211902|FG003|Randomized and Treated|Overall Study||130
10083460|NCT02275117|11211903|FG004|Randomized and Treated|Overall Study||121
10083461|NCT02275117|11211899|FG000|COMPLETED|Overall Study||97
10083462|NCT02275117|11211900|FG001|COMPLETED|Overall Study||96
10083463|NCT02275117|11211901|FG002|COMPLETED|Overall Study||92
10083464|NCT02275117|11211902|FG003|COMPLETED|Overall Study||100
10083465|NCT02275117|11211903|FG004|COMPLETED|Overall Study||98
10083466|NCT02275117|11211899|FG000|NOT COMPLETED|Overall Study||34
10083467|NCT02275117|11211900|FG001|NOT COMPLETED|Overall Study||37
10083468|NCT02275117|11211901|FG002|NOT COMPLETED|Overall Study||42
10083469|NCT02275117|11211902|FG003|NOT COMPLETED|Overall Study||33
10083470|NCT02275117|11211903|FG004|NOT COMPLETED|Overall Study||36
10083471|NCT02275156|11211918|FG000|STARTED|Overall Study||6
10083472|NCT02275156|11211919|FG001|STARTED|Overall Study||6
10083473|NCT02275156|11211920|FG002|STARTED|Overall Study||6
10083474|NCT02275156|11211918|FG000|COMPLETED|Overall Study||6
10083475|NCT02275156|11211919|FG001|COMPLETED|Overall Study||6
10083476|NCT02275156|11211920|FG002|COMPLETED|Overall Study||6
10083477|NCT02275156|11211918|FG000|NOT COMPLETED|Overall Study||0
10083478|NCT02275156|11211919|FG001|NOT COMPLETED|Overall Study||0
10083479|NCT02275156|11211920|FG002|NOT COMPLETED|Overall Study||0
10083480|NCT02275338|11211929|FG000|STARTED|Overall Study||52
10083481|NCT02275338|11211929|FG000|Completed Phase 1|Overall Study||25
10083482|NCT02275338|11211929|FG000|Started Phase 2|Overall Study||21
10083483|NCT02275338|11211929|FG000|COMPLETED|Overall Study||19
10083484|NCT02275338|11211929|FG000|NOT COMPLETED|Overall Study||33
10083485|NCT02275364|11211934|FG000|STARTED|Period 1||14
10083486|NCT02275364|11211935|FG001|STARTED|Period 1||14
10083487|NCT02275364|11211934|FG000|COMPLETED|Period 1||12
10083488|NCT02275364|11211935|FG001|COMPLETED|Period 1||14
10083489|NCT02275364|11211934|FG000|NOT COMPLETED|Period 1||2
10083490|NCT02275364|11211935|FG001|NOT COMPLETED|Period 1||0
10083491|NCT02275364|11211934|FG000|STARTED|Washout Period 1||12
10083492|NCT02275364|11211935|FG001|STARTED|Washout Period 1||14
10083493|NCT02275364|11211934|FG000|COMPLETED|Washout Period 1||12
10083494|NCT02275364|11211935|FG001|COMPLETED|Washout Period 1||14
10083495|NCT02275364|11211934|FG000|NOT COMPLETED|Washout Period 1||0
10083496|NCT02275364|11211935|FG001|NOT COMPLETED|Washout Period 1||0
10083497|NCT02275364|11211934|FG000|STARTED|Period 2||12
10083498|NCT02275364|11211935|FG001|STARTED|Period 2||14
10083499|NCT02275364|11211934|FG000|COMPLETED|Period 2||12
10083500|NCT02275364|11211935|FG001|COMPLETED|Period 2||14
10083501|NCT02275364|11211934|FG000|NOT COMPLETED|Period 2||0
10083502|NCT02275364|11211935|FG001|NOT COMPLETED|Period 2||0
10083503|NCT02275364|11211934|FG000|STARTED|Washout Period 2||12
10083504|NCT02275364|11211935|FG001|STARTED|Washout Period 2||14
10083505|NCT02275364|11211934|FG000|COMPLETED|Washout Period 2||12
10083506|NCT02275364|11211935|FG001|COMPLETED|Washout Period 2||14
10083507|NCT02275364|11211934|FG000|NOT COMPLETED|Washout Period 2||0
10083508|NCT02275364|11211935|FG001|NOT COMPLETED|Washout Period 2||0
10083509|NCT02275364|11211934|FG000|STARTED|Period 3||12
10083510|NCT02275364|11211935|FG001|STARTED|Period 3||14
10083511|NCT02275364|11211934|FG000|COMPLETED|Period 3||12
10083512|NCT02275364|11211935|FG001|COMPLETED|Period 3||14
10083513|NCT02275364|11211934|FG000|NOT COMPLETED|Period 3||0
10083514|NCT02275364|11211935|FG001|NOT COMPLETED|Period 3||0
10083515|NCT02275364|11211934|FG000|STARTED|Period 4||12
10083516|NCT02275364|11211935|FG001|STARTED|Period 4||14
10083517|NCT02275364|11211934|FG000|COMPLETED|Period 4||12
10083518|NCT02275364|11211935|FG001|COMPLETED|Period 4||14
10083519|NCT02275364|11211934|FG000|NOT COMPLETED|Period 4||0
10083520|NCT02275364|11211935|FG001|NOT COMPLETED|Period 4||0
10083521|NCT02275611|11211956|FG000|STARTED|Inpatient Withdrawal||5
10083522|NCT02275611|11211957|FG001|STARTED|Inpatient Withdrawal||4
10083523|NCT02275611|11211958|FG002|STARTED|Inpatient Withdrawal||0
10083524|NCT02275611|11211959|FG003|STARTED|Inpatient Withdrawal||0
10083525|NCT02275611|11211956|FG000|COMPLETED|Inpatient Withdrawal||4
10083526|NCT02275611|11211957|FG001|COMPLETED|Inpatient Withdrawal||4
10083527|NCT02275611|11211958|FG002|COMPLETED|Inpatient Withdrawal||0
10083528|NCT02275611|11211959|FG003|COMPLETED|Inpatient Withdrawal||0
10083529|NCT02275611|11211956|FG000|NOT COMPLETED|Inpatient Withdrawal||1
10083530|NCT02275611|11211957|FG001|NOT COMPLETED|Inpatient Withdrawal||0
10083531|NCT02275611|11211958|FG002|NOT COMPLETED|Inpatient Withdrawal||0
10199460|NCT03419078|11327934|FG002|NOT COMPLETED|Overall Study||0
10083532|NCT02275611|11211959|FG003|NOT COMPLETED|Inpatient Withdrawal||0
10083533|NCT02275611|11211956|FG000|STARTED|Outpatient Drinking||0
10083534|NCT02275611|11211957|FG001|STARTED|Outpatient Drinking||0
10083535|NCT02275611|11211958|FG002|STARTED|Outpatient Drinking||6
10083536|NCT02275611|11211959|FG003|STARTED|Outpatient Drinking||3
10083537|NCT02275611|11211956|FG000|COMPLETED|Outpatient Drinking||0
10083538|NCT02275611|11211957|FG001|COMPLETED|Outpatient Drinking||0
10083539|NCT02275611|11211958|FG002|COMPLETED|Outpatient Drinking||6
10083540|NCT02275611|11211959|FG003|COMPLETED|Outpatient Drinking||3
10083541|NCT02275611|11211956|FG000|NOT COMPLETED|Outpatient Drinking||0
10083542|NCT02275611|11211957|FG001|NOT COMPLETED|Outpatient Drinking||0
10083543|NCT02275611|11211958|FG002|NOT COMPLETED|Outpatient Drinking||0
10083544|NCT02275611|11211959|FG003|NOT COMPLETED|Outpatient Drinking||0
10199461|NCT03419403|11327945|FG000|STARTED|Overall Study||14
9736698|NCT00195494|10837416|FG002|NOT COMPLETED|Year 2||18
9736699|NCT00195494|10837417|FG003|NOT COMPLETED|Year 2||23
9736700|NCT00195494|10837418|FG004|NOT COMPLETED|Year 2||0
9736701|NCT00195494|10837419|FG005|NOT COMPLETED|Year 2||0
9736702|NCT00195507|10837437|FG000|STARTED|Overall Study||357
9736703|NCT00195507|10837438|FG001|STARTED|Overall Study||363
9736704|NCT00195507|10837437|FG000|COMPLETED|Overall Study||258
9736705|NCT00195507|10837438|FG001|COMPLETED|Overall Study||245
9736706|NCT00195507|10837437|FG000|NOT COMPLETED|Overall Study||99
9736707|NCT00195507|10837438|FG001|NOT COMPLETED|Overall Study||118
9736708|NCT00195624|10837446|FG000|STARTED|Overall Study||5
9736709|NCT00195624|10837447|FG001|STARTED|Overall Study||42
9736710|NCT00195624|10837446|FG000|COMPLETED|Overall Study||5
9736711|NCT00195624|10837447|FG001|COMPLETED|Overall Study||42
9736712|NCT00195624|10837446|FG000|NOT COMPLETED|Overall Study||0
9736713|NCT00195624|10837447|FG001|NOT COMPLETED|Overall Study||0
9736714|NCT00195650|10837453|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
9736715|NCT00195650|10837453|FG000|COMPLETED|Overall Study||321
9736716|NCT00195650|10837453|FG000|NOT COMPLETED|Overall Study||525
9736717|NCT00195663|10837460|FG000|STARTED|2-year Double-blind Treatment Period||257
9736718|NCT00195663|10837461|FG001|STARTED|2-year Double-blind Treatment Period||274
9736719|NCT00195663|10837462|FG002|STARTED|2-year Double-blind Treatment Period||268
9736720|NCT00195663|10837460|FG000|COMPLETED|2-year Double-blind Treatment Period||164
9736721|NCT00195663|10837461|FG001|COMPLETED|2-year Double-blind Treatment Period||166
9736722|NCT00195663|10837462|FG002|COMPLETED|2-year Double-blind Treatment Period||196
9736723|NCT00195663|10837460|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93
9736724|NCT00195663|10837461|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108
9736725|NCT00195663|10837462|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72
9736726|NCT00195663|10837460|FG000|STARTED|Open-Label Extension Period||155
9736727|NCT00195663|10837461|FG001|STARTED|Open-Label Extension Period||159
9736728|NCT00195663|10837462|FG002|STARTED|Open-Label Extension Period||183
10199462|NCT03419403|11327946|FG001|STARTED|Overall Study||12
10199463|NCT03419403|11327947|FG002|STARTED|Overall Study||12
10199464|NCT03419403|11327948|FG003|STARTED|Overall Study||2
10199465|NCT03419403|11327945|FG000|COMPLETED|Overall Study||2
10199466|NCT03419403|11327946|FG001|COMPLETED|Overall Study||3
10199467|NCT03419403|11327947|FG002|COMPLETED|Overall Study||0
10199468|NCT03419403|11327948|FG003|COMPLETED|Overall Study||0
10199469|NCT03419403|11327945|FG000|NOT COMPLETED|Overall Study||12
10199470|NCT03419403|11327946|FG001|NOT COMPLETED|Overall Study||9
10199471|NCT03419403|11327947|FG002|NOT COMPLETED|Overall Study||12
10199472|NCT03419403|11327948|FG003|NOT COMPLETED|Overall Study||2
10199473|NCT03419533|11327958|FG000|STARTED|Overall Study||4107
10199474|NCT03419533|11327959|FG001|STARTED|Overall Study||2695
10199475|NCT03419533|11327958|FG000|COMPLETED|Overall Study||4107
10199476|NCT03419533|11327959|FG001|COMPLETED|Overall Study||2695
10199477|NCT03419533|11327958|FG000|NOT COMPLETED|Overall Study||0
10199478|NCT03419533|11327959|FG001|NOT COMPLETED|Overall Study||0
10199479|NCT03419598|11327973|FG000|STARTED|Overall Study||30
10199480|NCT03419598|11327973|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
10199481|NCT03419598|11327973|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
10199482|NCT03419598|11327973|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
10199483|NCT03419598|11327973|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
10199484|NCT03419598|11327973|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
10199485|NCT03419598|11327973|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
10199486|NCT03419598|11327973|FG000|COMPLETED|Overall Study||28
10199487|NCT03419598|11327973|FG000|NOT COMPLETED|Overall Study||2
9736729|NCT00195663|10837460|FG000|COMPLETED|Open-Label Extension Period||79
9736730|NCT00195663|10837461|FG001|COMPLETED|Open-Label Extension Period||85
9736731|NCT00195663|10837462|FG002|COMPLETED|Open-Label Extension Period||86
9736732|NCT00195663|10837460|FG000|NOT COMPLETED|Open-Label Extension Period||76
10199488|NCT03419780|11327981|FG000|STARTED|Overall Study||33
10083545|NCT02275767|11211974|FG000|STARTED|Overall Study||22
9736733|NCT00195663|10837461|FG001|NOT COMPLETED|Open-Label Extension Period||74
9736734|NCT00195663|10837462|FG002|NOT COMPLETED|Open-Label Extension Period||97
9736735|NCT00195676|10837480|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
9736736|NCT00195676|10837480|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
9736737|NCT00195676|10837480|FG000|NOT COMPLETED|Period O - Open-label Treatment||606
9736738|NCT00195676|10837480|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
9736739|NCT00195676|10837480|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
9736740|NCT00195676|10837480|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
9736741|NCT00195676|10837480|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
9736742|NCT00195676|10837480|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490
9736743|NCT00195676|10837480|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
9736744|NCT00195702|10837491|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
9736745|NCT00195702|10837492|FG001|STARTED|Double-blind Phase||207
9736746|NCT00195702|10837493|FG002|STARTED|Double-blind Phase||200
9736747|NCT00195702|10837494|FG003|STARTED|Double-blind Phase||0
9736748|NCT00195702|10837495|FG004|STARTED|Double-blind Phase||0
9736749|NCT00195702|10837496|FG005|STARTED|Double-blind Phase||0
9736750|NCT00195702|10837491|FG000|COMPLETED|Double-blind Phase||168
9736751|NCT00195702|10837492|FG001|COMPLETED|Double-blind Phase||159
9736752|NCT00195702|10837493|FG002|COMPLETED|Double-blind Phase||140
9736753|NCT00195702|10837494|FG003|COMPLETED|Double-blind Phase||0
9736754|NCT00195702|10837495|FG004|COMPLETED|Double-blind Phase||0
9736755|NCT00195702|10837496|FG005|COMPLETED|Double-blind Phase||0
9736756|NCT00195702|10837491|FG000|NOT COMPLETED|Double-blind Phase||44
9736757|NCT00195702|10837492|FG001|NOT COMPLETED|Double-blind Phase||48
9736758|NCT00195702|10837493|FG002|NOT COMPLETED|Double-blind Phase||60
9736759|NCT00195702|10837494|FG003|NOT COMPLETED|Double-blind Phase||0
9736760|NCT00195702|10837495|FG004|NOT COMPLETED|Double-blind Phase||0
9736761|NCT00195702|10837496|FG005|NOT COMPLETED|Double-blind Phase||0
9736762|NCT00195702|10837491|FG000|STARTED|Open-label Extension Phase||0
9736763|NCT00195702|10837492|FG001|STARTED|Open-label Extension Phase||0
9736764|NCT00195702|10837493|FG002|STARTED|Open-label Extension Phase||0
9736765|NCT00195702|10837494|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
9736766|NCT00195702|10837495|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
9736767|NCT00195702|10837496|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
9736768|NCT00195702|10837491|FG000|COMPLETED|Open-label Extension Phase||0
9736769|NCT00195702|10837492|FG001|COMPLETED|Open-label Extension Phase||0
9736770|NCT00195702|10837493|FG002|COMPLETED|Open-label Extension Phase||0
9736771|NCT00195702|10837494|FG003|COMPLETED|Open-label Extension Phase||66
9736772|NCT00195702|10837495|FG004|COMPLETED|Open-label Extension Phase||80
9736773|NCT00195702|10837496|FG005|COMPLETED|Open-label Extension Phase||56
9736774|NCT00195702|10837491|FG000|NOT COMPLETED|Open-label Extension Phase||0
9736775|NCT00195702|10837492|FG001|NOT COMPLETED|Open-label Extension Phase||0
9736776|NCT00195702|10837493|FG002|NOT COMPLETED|Open-label Extension Phase||0
9736777|NCT00195702|10837494|FG003|NOT COMPLETED|Open-label Extension Phase||99
9736778|NCT00195702|10837495|FG004|NOT COMPLETED|Open-label Extension Phase||78
9736779|NCT00195702|10837496|FG005|NOT COMPLETED|Open-label Extension Phase||78
9736780|NCT00195715|10837509|FG000|STARTED|Overall Study||777
9736781|NCT00195715|10837509|FG000|COMPLETED|Overall Study||400
9736782|NCT00195715|10837509|FG000|NOT COMPLETED|Overall Study||377
9736783|NCT00195819|10837513|FG000|STARTED|Double-Blind||44
9736784|NCT00195819|10837514|FG001|STARTED|Double-Blind||38
9736785|NCT00195819|10837513|FG000|COMPLETED|Double-Blind||42
9736786|NCT00195819|10837514|FG001|COMPLETED|Double-Blind||38
9736787|NCT00195819|10837513|FG000|NOT COMPLETED|Double-Blind||2
9736788|NCT00195819|10837514|FG001|NOT COMPLETED|Double-Blind||0
9736789|NCT00195819|10837513|FG000|STARTED|Open-label||0
9736790|NCT00195819|10837514|FG001|STARTED|Open-label||82
9736791|NCT00195819|10837513|FG000|COMPLETED|Open-label||0
9736792|NCT00195819|10837514|FG001|COMPLETED|Open-label||62
9736793|NCT00195819|10837513|FG000|NOT COMPLETED|Open-label||0
9736794|NCT00195819|10837514|FG001|NOT COMPLETED|Open-label||20
9736795|NCT00196105|10837529|FG000|STARTED|Overall Study||64
9736796|NCT00196105|10837530|FG001|STARTED|Overall Study||88
9736797|NCT00196105|10837531|FG002|STARTED|Overall Study||89
9736798|NCT00196105|10837529|FG000|COMPLETED|Overall Study||60
9736799|NCT00196105|10837530|FG001|COMPLETED|Overall Study||83
9736800|NCT00196105|10837531|FG002|COMPLETED|Overall Study||82
9736801|NCT00196105|10837529|FG000|NOT COMPLETED|Overall Study||4
9736802|NCT00196105|10837530|FG001|NOT COMPLETED|Overall Study||5
9736803|NCT00196105|10837531|FG002|NOT COMPLETED|Overall Study||7
9736804|NCT00196196|10837539|FG000|STARTED|Overall Study||274
9736805|NCT00196196|10837539|FG000|COMPLETED|Overall Study||267
9736806|NCT00196196|10837539|FG000|NOT COMPLETED|Overall Study||7
9736807|NCT00196313|10837545|FG000|STARTED|Overall Study||47
9851676|NCT00877448|10964430|FG001|NOT COMPLETED|Overall Study||1
10083546|NCT02275767|11211975|FG001|STARTED|Overall Study||22
10083547|NCT02275767|11211976|FG002|STARTED|Overall Study||22
10083548|NCT02275767|11211974|FG000|COMPLETED|Overall Study||20
10083549|NCT02275767|11211975|FG001|COMPLETED|Overall Study||18
10083550|NCT02275767|11211976|FG002|COMPLETED|Overall Study||19
10083551|NCT02275767|11211974|FG000|NOT COMPLETED|Overall Study||2
10083552|NCT02275767|11211975|FG001|NOT COMPLETED|Overall Study||4
10083553|NCT02275767|11211976|FG002|NOT COMPLETED|Overall Study||3
10083554|NCT02275780|11211986|FG000|STARTED|Base Study: 96 Weeks||385
10083555|NCT02275780|11211987|FG001|STARTED|Base Study: 96 Weeks||384
10083556|NCT02275780|11211986|FG000|Treated|Base Study: 96 Weeks||383
10083557|NCT02275780|11211987|FG001|Treated|Base Study: 96 Weeks||383
9736808|NCT00196313|10837546|FG001|STARTED|Overall Study||48
9736809|NCT00196313|10837545|FG000|COMPLETED|Overall Study||36
9736810|NCT00196313|10837546|FG001|COMPLETED|Overall Study||40
9736811|NCT00196313|10837545|FG000|NOT COMPLETED|Overall Study||11
9736812|NCT00196313|10837546|FG001|NOT COMPLETED|Overall Study||8
9736813|NCT00196326|10837553|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235
9736814|NCT00196326|10837553|FG000|Safety Population|Overall Study|Treated participants|2185
9736815|NCT00196326|10837553|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
9736816|NCT00196326|10837553|FG000|COMPLETED|Overall Study||1249
9736817|NCT00196326|10837553|FG000|NOT COMPLETED|Overall Study||986
9736818|NCT00196716|10837557|FG000|STARTED|1.0 mg/kg Period||21
9736819|NCT00196716|10837557|FG000|COMPLETED|1.0 mg/kg Period||21
9736820|NCT00196716|10837557|FG000|NOT COMPLETED|1.0 mg/kg Period||0
9736821|NCT00196716|10837557|FG000|STARTED|0.3 mg/kg Period||21
9736822|NCT00196716|10837557|FG000|COMPLETED|0.3 mg/kg Period||21
9736823|NCT00196716|10837557|FG000|NOT COMPLETED|0.3 mg/kg Period||0
9736824|NCT00196937|10837566|FG000|STARTED|Overall Study||229
9736825|NCT00196937|10837567|FG001|STARTED|Overall Study||226
9736826|NCT00196937|10837568|FG002|STARTED|Overall Study||211
9736827|NCT00196937|10837566|FG000|COMPLETED|Overall Study||220
9736828|NCT00196937|10837567|FG001|COMPLETED|Overall Study||221
9736829|NCT00196937|10837568|FG002|COMPLETED|Overall Study||204
9736830|NCT00196937|10837566|FG000|NOT COMPLETED|Overall Study||9
9736831|NCT00196937|10837567|FG001|NOT COMPLETED|Overall Study||5
9736832|NCT00196937|10837568|FG002|NOT COMPLETED|Overall Study||7
9736833|NCT00196976|10837591|FG000|STARTED|Primary Study||39
9736834|NCT00196976|10837592|FG001|STARTED|Primary Study||41
9736835|NCT00196976|10837593|FG002|STARTED|Primary Study||41
9736836|NCT00196976|10837594|FG003|STARTED|Primary Study||40
9736837|NCT00196976|10837595|FG004|STARTED|Primary Study||40
9736838|NCT00196976|10837596|FG005|STARTED|Primary Study||54
9736839|NCT00196976|10837597|FG006|STARTED|Primary Study||50
9736840|NCT00196976|10837598|FG007|STARTED|Primary Study||52
9736841|NCT00196976|10837599|FG008|STARTED|Primary Study||52
9736842|NCT00196976|10837600|FG009|STARTED|Primary Study||52
9736843|NCT00196976|10837601|FG010|STARTED|Primary Study||0
9736844|NCT00196976|10837602|FG011|STARTED|Primary Study||0
9736845|NCT00196976|10837603|FG012|STARTED|Primary Study||0
9736846|NCT00196976|10837604|FG013|STARTED|Primary Study||0
9736847|NCT00196976|10837591|FG000|COMPLETED|Primary Study||38
9736848|NCT00196976|10837592|FG001|COMPLETED|Primary Study||40
9736849|NCT00196976|10837593|FG002|COMPLETED|Primary Study||37
9736850|NCT00196976|10837594|FG003|COMPLETED|Primary Study||39
9736851|NCT00196976|10837595|FG004|COMPLETED|Primary Study||37
9736852|NCT00196976|10837596|FG005|COMPLETED|Primary Study||52
9736853|NCT00196976|10837597|FG006|COMPLETED|Primary Study||50
9736854|NCT00196976|10837598|FG007|COMPLETED|Primary Study||49
9736855|NCT00196976|10837599|FG008|COMPLETED|Primary Study||52
9736856|NCT00196976|10837600|FG009|COMPLETED|Primary Study||51
9736857|NCT00196976|10837601|FG010|COMPLETED|Primary Study||0
9736858|NCT00196976|10837602|FG011|COMPLETED|Primary Study||0
9736859|NCT00196976|10837603|FG012|COMPLETED|Primary Study||0
9736860|NCT00196976|10837604|FG013|COMPLETED|Primary Study||0
9736861|NCT00196976|10837591|FG000|NOT COMPLETED|Primary Study||1
9736862|NCT00196976|10837592|FG001|NOT COMPLETED|Primary Study||1
9736863|NCT00196976|10837593|FG002|NOT COMPLETED|Primary Study||4
9736864|NCT00196976|10837594|FG003|NOT COMPLETED|Primary Study||1
9736865|NCT00196976|10837595|FG004|NOT COMPLETED|Primary Study||3
9736866|NCT00196976|10837596|FG005|NOT COMPLETED|Primary Study||2
9736867|NCT00196976|10837597|FG006|NOT COMPLETED|Primary Study||0
9736868|NCT00196976|10837598|FG007|NOT COMPLETED|Primary Study||3
9736869|NCT00196976|10837599|FG008|NOT COMPLETED|Primary Study||0
9736870|NCT00196976|10837600|FG009|NOT COMPLETED|Primary Study||1
9736871|NCT00196976|10837601|FG010|NOT COMPLETED|Primary Study||0
9736872|NCT00196976|10837602|FG011|NOT COMPLETED|Primary Study||0
9736873|NCT00196976|10837603|FG012|NOT COMPLETED|Primary Study||0
9736874|NCT00196976|10837604|FG013|NOT COMPLETED|Primary Study||0
9736875|NCT00196976|10837591|FG000|STARTED|Booster Study||0
9736876|NCT00196976|10837592|FG001|STARTED|Booster Study||0
10083558|NCT02275780|11211986|FG000|COMPLETED|Base Study: 96 Weeks||292
10083559|NCT02275780|11211987|FG001|COMPLETED|Base Study: 96 Weeks||273
10083560|NCT02275780|11211986|FG000|NOT COMPLETED|Base Study: 96 Weeks||93
10083561|NCT02275780|11211987|FG001|NOT COMPLETED|Base Study: 96 Weeks||111
9736877|NCT00196976|10837593|FG002|STARTED|Booster Study||0
9736878|NCT00196976|10837594|FG003|STARTED|Booster Study||0
9736879|NCT00196976|10837595|FG004|STARTED|Booster Study||0
9736880|NCT00196976|10837596|FG005|STARTED|Booster Study||0
9736881|NCT00196976|10837597|FG006|STARTED|Booster Study||0
9736882|NCT00196976|10837598|FG007|STARTED|Booster Study||0
10083562|NCT02275780|11211986|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
10083563|NCT02275780|11211987|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
10083564|NCT02275780|11211986|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
10083565|NCT02275780|11211987|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
10083566|NCT02275780|11211986|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260
10083567|NCT02275780|11211987|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233
10083568|NCT02275819|11211995|FG000|STARTED|Overall Study||5
10083569|NCT02275819|11211996|FG001|STARTED|Overall Study||6
10083570|NCT02275819|11211995|FG000|COMPLETED|Overall Study||5
10083571|NCT02275819|11211996|FG001|COMPLETED|Overall Study||5
9736883|NCT00196976|10837599|FG008|STARTED|Booster Study||0
9736884|NCT00196976|10837600|FG009|STARTED|Booster Study||0
9736885|NCT00196976|10837601|FG010|STARTED|Booster Study||33
9736886|NCT00196976|10837602|FG011|STARTED|Booster Study||32
9736887|NCT00196976|10837603|FG012|STARTED|Booster Study||45
9736888|NCT00196976|10837604|FG013|STARTED|Booster Study||43
9736889|NCT00196976|10837591|FG000|COMPLETED|Booster Study||0
9736890|NCT00196976|10837592|FG001|COMPLETED|Booster Study||0
9736891|NCT00196976|10837593|FG002|COMPLETED|Booster Study||0
9736892|NCT00196976|10837594|FG003|COMPLETED|Booster Study||0
9736893|NCT00196976|10837595|FG004|COMPLETED|Booster Study||0
9736894|NCT00196976|10837596|FG005|COMPLETED|Booster Study||0
9736895|NCT00196976|10837597|FG006|COMPLETED|Booster Study||0
9736896|NCT00196976|10837598|FG007|COMPLETED|Booster Study||0
9736897|NCT00196976|10837599|FG008|COMPLETED|Booster Study||0
9736898|NCT00196976|10837600|FG009|COMPLETED|Booster Study||0
9851677|NCT00877448|10964431|FG002|NOT COMPLETED|Overall Study||0
9851678|NCT00877448|10964432|FG003|NOT COMPLETED|Overall Study||1
9851679|NCT00877448|10964433|FG004|NOT COMPLETED|Overall Study||0
9851680|NCT00877448|10964434|FG005|NOT COMPLETED|Overall Study||1
9851681|NCT00877448|10964435|FG006|NOT COMPLETED|Overall Study||0
9851682|NCT00877487|10964451|FG000|STARTED|Open-label Treatment Phase||123
9851683|NCT00877487|10964452|FG001|STARTED|Open-label Treatment Phase||0
9851684|NCT00877487|10964451|FG000|COMPLETED|Open-label Treatment Phase||116
9851685|NCT00877487|10964452|FG001|COMPLETED|Open-label Treatment Phase||0
9851686|NCT00877487|10964451|FG000|NOT COMPLETED|Open-label Treatment Phase||7
9851687|NCT00877487|10964452|FG001|NOT COMPLETED|Open-label Treatment Phase||0
9851688|NCT00877487|10964451|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56
10083572|NCT02275819|11211995|FG000|NOT COMPLETED|Overall Study||0
10083573|NCT02275819|11211996|FG001|NOT COMPLETED|Overall Study||1
10083574|NCT02275923|11212002|FG000|STARTED|Overall Study||9
10083575|NCT02275923|11212002|FG000|COMPLETED|Overall Study||7
10083576|NCT02275923|11212002|FG000|NOT COMPLETED|Overall Study||2
9851689|NCT00877487|10964452|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60
9851690|NCT00877487|10964451|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50
9851691|NCT00877487|10964452|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13
9851692|NCT00877487|10964451|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
9851693|NCT00877487|10964452|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
9851694|NCT00877604|10964460|FG000|STARTED|Overall Study||17
9851695|NCT00877604|10964461|FG001|STARTED|Overall Study||17
9851696|NCT00877604|10964460|FG000|COMPLETED|Overall Study||15
9851697|NCT00877604|10964461|FG001|COMPLETED|Overall Study||14
9851698|NCT00877604|10964460|FG000|NOT COMPLETED|Overall Study||2
9851699|NCT00877604|10964461|FG001|NOT COMPLETED|Overall Study||3
9851700|NCT00877773|10964467|FG000|STARTED|Overall Study||44
9851701|NCT00877773|10964467|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0
9851702|NCT00877773|10964467|FG000|NOT COMPLETED|Overall Study||44
9952937|NCT01424566|11071812|FG001|Met Randomization Criteria|Single-blind Treatment||0
9952938|NCT01424566|11071813|FG002|Met Randomization Criteria|Single-blind Treatment||0
9952939|NCT01424566|11071811|FG000|COMPLETED|Single-blind Treatment||206
9952940|NCT01424566|11071812|FG001|COMPLETED|Single-blind Treatment||0
9952941|NCT01424566|11071813|FG002|COMPLETED|Single-blind Treatment||0
9952942|NCT01424566|11071811|FG000|NOT COMPLETED|Single-blind Treatment||200
9952943|NCT01424566|11071812|FG001|NOT COMPLETED|Single-blind Treatment||0
9952944|NCT01424566|11071813|FG002|NOT COMPLETED|Single-blind Treatment||0
9952945|NCT01424566|11071811|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
9952946|NCT01424566|11071812|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
9952947|NCT01424566|11071813|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
9952948|NCT01424566|11071811|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
9952949|NCT01424566|11071812|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
9952950|NCT01424566|11071813|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
9952951|NCT01424566|11071811|FG000|Randomized Safety Population|Double-blind Treatment||0
9952952|NCT01424566|11071812|FG001|Randomized Safety Population|Double-blind Treatment||103
9952953|NCT01424566|11071813|FG002|Randomized Safety Population|Double-blind Treatment||103
9952954|NCT01424566|11071811|FG000|ITT Population|Double-blind Treatment||0
9952955|NCT01424566|11071812|FG001|ITT Population|Double-blind Treatment||103
10083577|NCT02276027|11212010|FG000|STARTED|Overall Study||2
10083578|NCT02276027|11212011|FG001|STARTED|Overall Study||16
10083579|NCT02276027|11212012|FG002|STARTED|Overall Study||26
9736899|NCT00196976|10837601|FG010|COMPLETED|Booster Study||31
10083580|NCT02276027|11212013|FG003|STARTED|Overall Study||22
10083581|NCT02276027|11212010|FG000|COMPLETED|Overall Study||0
10083582|NCT02276027|11212011|FG001|COMPLETED|Overall Study||0
10083583|NCT02276027|11212012|FG002|COMPLETED|Overall Study||6
10083584|NCT02276027|11212013|FG003|COMPLETED|Overall Study||0
10083585|NCT02276027|11212010|FG000|NOT COMPLETED|Overall Study||2
10083586|NCT02276027|11212011|FG001|NOT COMPLETED|Overall Study||16
10083587|NCT02276027|11212012|FG002|NOT COMPLETED|Overall Study||20
10083588|NCT02276027|11212013|FG003|NOT COMPLETED|Overall Study||22
10083589|NCT02276040|11212023|FG000|STARTED|Overall Study||26
10083590|NCT02276040|11212023|FG000|COMPLETED|Overall Study||11
10083591|NCT02276040|11212023|FG000|NOT COMPLETED|Overall Study||15
10083592|NCT02276053|11212027|FG000|STARTED|Overall Study||93
10083593|NCT02276053|11212027|FG000|COMPLETED|Overall Study||79
10083594|NCT02276053|11212027|FG000|NOT COMPLETED|Overall Study||14
10083595|NCT02276222|11212034|FG000|STARTED|Overall Study||621
10083596|NCT02276222|11212035|FG001|STARTED|Overall Study||466
10083597|NCT02276222|11212034|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
10083598|NCT02276222|11212035|FG001|COMPLETED|Overall Study||402
10083599|NCT02276222|11212034|FG000|NOT COMPLETED|Overall Study||185
10083600|NCT02276222|11212035|FG001|NOT COMPLETED|Overall Study||64
10083601|NCT02276274|11212043|FG000|STARTED|First Intervention Period||6
10083602|NCT02276274|11212044|FG001|STARTED|First Intervention Period||6
10083603|NCT02276274|11212043|FG000|COMPLETED|First Intervention Period||6
9851703|NCT00877799|10964476|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
9851704|NCT00877799|10964477|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
9851705|NCT00877799|10964478|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
9851706|NCT00877799|10964479|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
9851707|NCT00877799|10964480|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
9851708|NCT00877799|10964476|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
9851709|NCT00877799|10964477|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
9851710|NCT00877799|10964478|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
9851711|NCT00877799|10964479|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
9851712|NCT00877799|10964480|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
9851713|NCT00877799|10964476|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
9851714|NCT00877799|10964477|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
9851715|NCT00877799|10964478|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
9851716|NCT00877799|10964479|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
9851717|NCT00877799|10964480|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
9851718|NCT00877799|10964476|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
9851719|NCT00877799|10964477|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
9851720|NCT00877799|10964478|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
9851721|NCT00877799|10964479|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
9851722|NCT00877799|10964480|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
9851723|NCT00877799|10964476|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
9851724|NCT00877799|10964477|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
9851725|NCT00877799|10964478|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
9851726|NCT00877799|10964479|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
9851727|NCT00877799|10964480|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
9851728|NCT00877799|10964476|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
9851729|NCT00877799|10964477|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
9851730|NCT00877799|10964478|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
9851731|NCT00877799|10964479|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
9851732|NCT00877799|10964480|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
9851733|NCT00877877|10964491|FG000|STARTED|Year 5||397
9851734|NCT00877877|10964491|FG000|COMPLETED|Year 5||397
9851735|NCT00877877|10964491|FG000|NOT COMPLETED|Year 5||0
9851736|NCT00877877|10964491|FG000|STARTED|Year 6||529
9851737|NCT00877877|10964491|FG000|COMPLETED|Year 6||529
9851738|NCT00877877|10964491|FG000|NOT COMPLETED|Year 6||0
9851739|NCT00877877|10964491|FG000|STARTED|Year 7||523
9851740|NCT00877877|10964491|FG000|COMPLETED|Year 7||523
9851741|NCT00877877|10964491|FG000|NOT COMPLETED|Year 7||0
9851742|NCT00877877|10964491|FG000|STARTED|Year 8||522
9851743|NCT00877877|10964491|FG000|COMPLETED|Year 8||522
9851744|NCT00877877|10964491|FG000|NOT COMPLETED|Year 8||0
9851745|NCT00877877|10964491|FG000|STARTED|Year 9||507
9851746|NCT00877877|10964491|FG000|COMPLETED|Year 9||507
9851747|NCT00877877|10964491|FG000|NOT COMPLETED|Year 9||0
9851748|NCT00877877|10964491|FG000|STARTED|Year 10||495
9851749|NCT00877877|10964491|FG000|COMPLETED|Year 10||495
9851750|NCT00877877|10964491|FG000|NOT COMPLETED|Year 10||0
9851751|NCT00877890|10964502|FG000|STARTED|Overall Study||129
9851752|NCT00877890|10964503|FG001|STARTED|Overall Study||125
9851753|NCT00877890|10964502|FG000|Intent to Treat (ITT)|Overall Study||129
9851754|NCT00877890|10964503|FG001|Intent to Treat (ITT)|Overall Study||123
9851755|NCT00877890|10964502|FG000|COMPLETED|Overall Study||109
9851756|NCT00877890|10964503|FG001|COMPLETED|Overall Study||95
9851757|NCT00877890|10964502|FG000|NOT COMPLETED|Overall Study||20
9851758|NCT00877890|10964503|FG001|NOT COMPLETED|Overall Study||30
10083604|NCT02276274|11212044|FG001|COMPLETED|First Intervention Period||6
10083605|NCT02276274|11212043|FG000|NOT COMPLETED|First Intervention Period||0
10083606|NCT02276274|11212044|FG001|NOT COMPLETED|First Intervention Period||0
10083607|NCT02276274|11212043|FG000|STARTED|Washout Period (at Least 15 Days)||6
10083608|NCT02276274|11212044|FG001|STARTED|Washout Period (at Least 15 Days)||6
10083609|NCT02276274|11212043|FG000|COMPLETED|Washout Period (at Least 15 Days)||6
10083610|NCT02276274|11212044|FG001|COMPLETED|Washout Period (at Least 15 Days)||6
10083611|NCT02276274|11212043|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0
10083612|NCT02276274|11212044|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0
10083613|NCT02276274|11212043|FG000|STARTED|Second Intervention Period||6
10083614|NCT02276274|11212044|FG001|STARTED|Second Intervention Period||6
10083615|NCT02276274|11212043|FG000|COMPLETED|Second Intervention Period||6
10083616|NCT02276274|11212044|FG001|COMPLETED|Second Intervention Period||6
10083617|NCT02276274|11212043|FG000|NOT COMPLETED|Second Intervention Period||0
10083618|NCT02276274|11212044|FG001|NOT COMPLETED|Second Intervention Period||0
10083619|NCT02276482|11212052|FG000|STARTED|Overall Study||91
10083620|NCT02276482|11212053|FG001|STARTED|Overall Study||29
10083621|NCT02276482|11212052|FG000|COMPLETED|Overall Study||88
10083622|NCT02276482|11212053|FG001|COMPLETED|Overall Study||28
10083623|NCT02276482|11212052|FG000|NOT COMPLETED|Overall Study||3
10083624|NCT02276482|11212053|FG001|NOT COMPLETED|Overall Study||1
10083625|NCT02276612|11212061|FG000|STARTED|Overall Study||50
10083626|NCT02276612|11212062|FG001|STARTED|Overall Study||10
10083627|NCT02276612|11212061|FG000|COMPLETED|Overall Study||46
10083628|NCT02276612|11212062|FG001|COMPLETED|Overall Study||10
10083629|NCT02276612|11212061|FG000|NOT COMPLETED|Overall Study||4
10083630|NCT02276612|11212062|FG001|NOT COMPLETED|Overall Study||0
10083631|NCT02276638|11212071|FG000|STARTED|Overall Study||28
10083632|NCT02276638|11212072|FG001|STARTED|Overall Study||28
10083633|NCT02276638|11212073|FG002|STARTED|Overall Study||23
10083634|NCT02276638|11212071|FG000|COMPLETED|Overall Study||28
10083635|NCT02276638|11212072|FG001|COMPLETED|Overall Study||28
10083636|NCT02276638|11212073|FG002|COMPLETED|Overall Study||23
10083637|NCT02276638|11212071|FG000|NOT COMPLETED|Overall Study||0
10083638|NCT02276638|11212072|FG001|NOT COMPLETED|Overall Study||0
10083639|NCT02276638|11212073|FG002|NOT COMPLETED|Overall Study||0
10083640|NCT02276807|11212083|FG000|STARTED|Overall Study||68
10083641|NCT02276807|11212084|FG001|STARTED|Overall Study||72
10083642|NCT02276807|11212083|FG000|12-week Assessment|Overall Study||57
10083643|NCT02276807|11212084|FG001|12-week Assessment|Overall Study||63
10083644|NCT02276807|11212083|FG000|COMPLETED|Overall Study||50
10083645|NCT02276807|11212084|FG001|COMPLETED|Overall Study||55
10083646|NCT02276807|11212083|FG000|NOT COMPLETED|Overall Study||18
10083647|NCT02276807|11212084|FG001|NOT COMPLETED|Overall Study||17
10083648|NCT02276872|11212093|FG000|STARTED|Overall Study||10
10083649|NCT02276872|11212094|FG001|STARTED|Overall Study||10
10083650|NCT02276872|11212095|FG002|STARTED|Overall Study||12
10083651|NCT02276872|11212093|FG000|COMPLETED|Overall Study||9
10083652|NCT02276872|11212094|FG001|COMPLETED|Overall Study||10
10083653|NCT02276872|11212095|FG002|COMPLETED|Overall Study||12
10083654|NCT02276872|11212093|FG000|NOT COMPLETED|Overall Study||1
10083655|NCT02276872|11212094|FG001|NOT COMPLETED|Overall Study||0
10083656|NCT02276872|11212095|FG002|NOT COMPLETED|Overall Study||0
10083657|NCT02276963|11212108|FG000|STARTED|Overall Study||6
10083658|NCT02276963|11212108|FG000|COMPLETED|Overall Study||3
10083659|NCT02276963|11212108|FG000|NOT COMPLETED|Overall Study||3
10083660|NCT02277054|11212112|FG000|STARTED|Overall Study||5
10083661|NCT02277054|11212112|FG000|COMPLETED|Overall Study||5
9851759|NCT00877929|10964515|FG000|STARTED|Overall Study||352
9851760|NCT00877929|10964516|FG001|STARTED|Overall Study||354
9851761|NCT00877929|10964515|FG000|COMPLETED|Overall Study||332
9851762|NCT00877929|10964516|FG001|COMPLETED|Overall Study||319
9851763|NCT00877929|10964515|FG000|NOT COMPLETED|Overall Study||20
9851764|NCT00877929|10964516|FG001|NOT COMPLETED|Overall Study||35
9851765|NCT00878072|10964526|FG000|STARTED|Overall Study||53
9851766|NCT00878072|10964526|FG000|COMPLETED|Overall Study||51
9851767|NCT00878072|10964526|FG000|NOT COMPLETED|Overall Study||2
9851768|NCT00878189|10964537|FG000|STARTED|Overall Study||3
9851769|NCT00878189|10964538|FG001|STARTED|Overall Study||3
9851770|NCT00878189|10964539|FG002|STARTED|Overall Study||4
9851771|NCT00878189|10964540|FG003|STARTED|Overall Study||8
9851772|NCT00878189|10964541|FG004|STARTED|Overall Study||4
9851773|NCT00878189|10964542|FG005|STARTED|Overall Study||23
9851774|NCT00878189|10964543|FG006|STARTED|Overall Study||16
9851775|NCT00878189|10964544|FG007|STARTED|Overall Study||3
9851776|NCT00878189|10964545|FG008|STARTED|Overall Study||8
9851777|NCT00878189|10964537|FG000|COMPLETED|Overall Study||0
9851778|NCT00878189|10964538|FG001|COMPLETED|Overall Study||0
9851779|NCT00878189|10964539|FG002|COMPLETED|Overall Study||0
10083662|NCT02277054|11212112|FG000|NOT COMPLETED|Overall Study||0
10083663|NCT02277093|11212117|FG000|STARTED|Overall Study||11
10083664|NCT02277093|11212117|FG000|COMPLETED|Overall Study||11
10083665|NCT02277093|11212117|FG000|NOT COMPLETED|Overall Study||0
10083666|NCT02277249|11212123|FG000|STARTED|Overall Study||30
10083667|NCT02277249|11212124|FG001|STARTED|Overall Study||30
10083668|NCT02277249|11212123|FG000|COMPLETED|Overall Study||30
9851780|NCT00878189|10964540|FG003|COMPLETED|Overall Study||0
9851781|NCT00878189|10964541|FG004|COMPLETED|Overall Study||0
10083669|NCT02277249|11212124|FG001|COMPLETED|Overall Study||30
10083670|NCT02277249|11212123|FG000|NOT COMPLETED|Overall Study||0
10083671|NCT02277249|11212124|FG001|NOT COMPLETED|Overall Study||0
10083672|NCT02277548|11212132|FG000|STARTED|Overall Study||9
10083673|NCT02277548|11212133|FG001|STARTED|Overall Study||11
9851782|NCT00878189|10964542|FG005|COMPLETED|Overall Study||0
10083674|NCT02277548|11212132|FG000|COMPLETED|Overall Study||9
9851783|NCT00878189|10964543|FG006|COMPLETED|Overall Study||0
10083675|NCT02277548|11212133|FG001|COMPLETED|Overall Study||9
10083676|NCT02277548|11212132|FG000|NOT COMPLETED|Overall Study||0
10083677|NCT02277548|11212133|FG001|NOT COMPLETED|Overall Study||2
10083678|NCT02277626|11212139|FG000|STARTED|Overall Study||6
10083679|NCT02277626|11212140|FG001|STARTED|Overall Study||9
10083680|NCT02277626|11212139|FG000|COMPLETED|Overall Study||6
10083681|NCT02277626|11212140|FG001|COMPLETED|Overall Study||9
10083682|NCT02277626|11212139|FG000|NOT COMPLETED|Overall Study||0
10083683|NCT02277626|11212140|FG001|NOT COMPLETED|Overall Study||0
10083684|NCT02277639|11212153|FG000|STARTED|Overall Study||0
10083685|NCT02277639|11212154|FG001|STARTED|Overall Study||2
10083686|NCT02277639|11212153|FG000|COMPLETED|Overall Study||0
10083687|NCT02277639|11212154|FG001|COMPLETED|Overall Study||2
10083688|NCT02277639|11212153|FG000|NOT COMPLETED|Overall Study||0
10083689|NCT02277639|11212154|FG001|NOT COMPLETED|Overall Study||0
9851784|NCT00878189|10964544|FG007|COMPLETED|Overall Study||0
9851785|NCT00878189|10964545|FG008|COMPLETED|Overall Study||0
9851786|NCT00878189|10964537|FG000|NOT COMPLETED|Overall Study||3
9851787|NCT00878189|10964538|FG001|NOT COMPLETED|Overall Study||3
9851788|NCT00878189|10964539|FG002|NOT COMPLETED|Overall Study||4
9851789|NCT00878189|10964540|FG003|NOT COMPLETED|Overall Study||8
9851790|NCT00878189|10964541|FG004|NOT COMPLETED|Overall Study||4
9851791|NCT00878189|10964542|FG005|NOT COMPLETED|Overall Study||23
9851792|NCT00878189|10964543|FG006|NOT COMPLETED|Overall Study||16
9851793|NCT00878189|10964544|FG007|NOT COMPLETED|Overall Study||3
9851794|NCT00878189|10964545|FG008|NOT COMPLETED|Overall Study||8
9851795|NCT00878215|10964583|FG000|STARTED|Overall Study||21
9851796|NCT00878215|10964584|FG001|STARTED|Overall Study||19
9851797|NCT00878215|10964585|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
9851798|NCT00878215|10964586|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
9851799|NCT00878215|10964583|FG000|COMPLETED|Overall Study||21
9851800|NCT00878215|10964584|FG001|COMPLETED|Overall Study||9
9851801|NCT00878215|10964585|FG002|COMPLETED|Overall Study||0
9851802|NCT00878215|10964586|FG003|COMPLETED|Overall Study||0
9851803|NCT00878215|10964583|FG000|NOT COMPLETED|Overall Study||0
9851804|NCT00878215|10964584|FG001|NOT COMPLETED|Overall Study||10
9851805|NCT00878215|10964585|FG002|NOT COMPLETED|Overall Study||0
9851806|NCT00878215|10964586|FG003|NOT COMPLETED|Overall Study||0
9851807|NCT00878228|10964598|FG000|STARTED|Overall Study||49
9851808|NCT00878228|10964599|FG001|STARTED|Overall Study||49
9851809|NCT00878228|10964598|FG000|COMPLETED|Overall Study||39
9851810|NCT00878228|10964599|FG001|COMPLETED|Overall Study||37
9851811|NCT00878228|10964598|FG000|NOT COMPLETED|Overall Study||10
9851812|NCT00878228|10964599|FG001|NOT COMPLETED|Overall Study||12
9851813|NCT00878436|10964607|FG000|STARTED|Overall Study||28
9851814|NCT00878436|10964608|FG001|STARTED|Overall Study||24
9851815|NCT00878436|10964607|FG000|Completed 2 Cycles|Overall Study||21
9851816|NCT00878436|10964608|FG001|Completed 2 Cycles|Overall Study||20
9851817|NCT00878436|10964607|FG000|6 Months|Overall Study||8
9851818|NCT00878436|10964608|FG001|6 Months|Overall Study||0
9851819|NCT00878436|10964607|FG000|COMPLETED|Overall Study||5
9851820|NCT00878436|10964608|FG001|COMPLETED|Overall Study||0
9851821|NCT00878436|10964607|FG000|NOT COMPLETED|Overall Study||23
9851822|NCT00878436|10964608|FG001|NOT COMPLETED|Overall Study||24
9851823|NCT00878501|10964617|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
9851824|NCT00878501|10964618|FG001|STARTED|Overall Study||44
9851825|NCT00878501|10964619|FG002|STARTED|Overall Study||93
9851826|NCT00878501|10964617|FG000|Interim Analysis|Overall Study||83
9851827|NCT00878501|10964618|FG001|Interim Analysis|Overall Study||37
9851828|NCT00878501|10964619|FG002|Interim Analysis|Overall Study||81
9851829|NCT00878501|10964617|FG000|COMPLETED|Overall Study||87
9851830|NCT00878501|10964618|FG001|COMPLETED|Overall Study||37
9851831|NCT00878501|10964619|FG002|COMPLETED|Overall Study||85
9851832|NCT00878501|10964617|FG000|NOT COMPLETED|Overall Study||17
9851833|NCT00878501|10964618|FG001|NOT COMPLETED|Overall Study||7
9851834|NCT00878501|10964619|FG002|NOT COMPLETED|Overall Study||8
9851835|NCT00878553|10964631|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
9851836|NCT00878553|10964632|FG001|STARTED|Sleep Study||0
9851837|NCT00878553|10964633|FG002|STARTED|Sleep Study||0
10083690|NCT02277665|11212162|FG000|STARTED|Overall Study||33
10083691|NCT02277665|11212163|FG001|STARTED|Overall Study||34
10083692|NCT02277665|11212162|FG000|COMPLETED|Overall Study||33
10083693|NCT02277665|11212163|FG001|COMPLETED|Overall Study||34
10083694|NCT02277665|11212162|FG000|NOT COMPLETED|Overall Study||0
9851838|NCT00878553|10964634|FG003|STARTED|Sleep Study||0
9851839|NCT00878553|10964635|FG004|STARTED|Sleep Study||0
9851840|NCT00878553|10964631|FG000|Number of Patients Receiving Placebo|Sleep Study||66
9851841|NCT00878553|10964632|FG001|Number of Patients Receiving Placebo|Sleep Study||0
9851842|NCT00878553|10964633|FG002|Number of Patients Receiving Placebo|Sleep Study||0
9851843|NCT00878553|10964634|FG003|Number of Patients Receiving Placebo|Sleep Study||0
9851844|NCT00878553|10964635|FG004|Number of Patients Receiving Placebo|Sleep Study||0
9851845|NCT00878553|10964631|FG000|Number of Patients Receiving 10mg|Sleep Study||65
9851846|NCT00878553|10964632|FG001|Number of Patients Receiving 10mg|Sleep Study||0
9851847|NCT00878553|10964633|FG002|Number of Patients Receiving 10mg|Sleep Study||0
9851848|NCT00878553|10964634|FG003|Number of Patients Receiving 10mg|Sleep Study||0
9851849|NCT00878553|10964635|FG004|Number of Patients Receiving 10mg|Sleep Study||0
10083695|NCT02277665|11212163|FG001|NOT COMPLETED|Overall Study||0
9851850|NCT00878553|10964631|FG000|Number of Patients Receiving 15mg|Sleep Study||65
9851851|NCT00878553|10964632|FG001|Number of Patients Receiving 15mg|Sleep Study||0
9851852|NCT00878553|10964633|FG002|Number of Patients Receiving 15mg|Sleep Study||0
9851853|NCT00878553|10964634|FG003|Number of Patients Receiving 15mg|Sleep Study||0
9851854|NCT00878553|10964635|FG004|Number of Patients Receiving 15mg|Sleep Study||0
9851855|NCT00878553|10964631|FG000|Number of Patients Receiving 20mg|Sleep Study||65
9851856|NCT00878553|10964632|FG001|Number of Patients Receiving 20mg|Sleep Study||0
9851857|NCT00878553|10964633|FG002|Number of Patients Receiving 20mg|Sleep Study||0
9851858|NCT00878553|10964634|FG003|Number of Patients Receiving 20mg|Sleep Study||0
9851859|NCT00878553|10964635|FG004|Number of Patients Receiving 20mg|Sleep Study||0
9851860|NCT00878553|10964631|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
9851861|NCT00878553|10964632|FG001|COMPLETED|Sleep Study||0
9851862|NCT00878553|10964633|FG002|COMPLETED|Sleep Study||0
9851863|NCT00878553|10964634|FG003|COMPLETED|Sleep Study||0
9851864|NCT00878553|10964635|FG004|COMPLETED|Sleep Study||0
9851865|NCT00878553|10964631|FG000|NOT COMPLETED|Sleep Study||5
9851866|NCT00878553|10964632|FG001|NOT COMPLETED|Sleep Study||0
9851867|NCT00878553|10964633|FG002|NOT COMPLETED|Sleep Study||0
9851868|NCT00878553|10964634|FG003|NOT COMPLETED|Sleep Study||0
9851869|NCT00878553|10964635|FG004|NOT COMPLETED|Sleep Study||0
9851870|NCT00878553|10964631|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
9851871|NCT00878553|10964632|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
9851872|NCT00878553|10964633|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
9851873|NCT00878553|10964634|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
9851874|NCT00878553|10964635|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
9851875|NCT00878553|10964631|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
9851876|NCT00878553|10964632|FG001|COMPLETED|PK Study||16
9851877|NCT00878553|10964633|FG002|COMPLETED|PK Study||17
9851878|NCT00878553|10964634|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
9851879|NCT00878553|10964635|FG004|COMPLETED|PK Study||15
9851880|NCT00878553|10964631|FG000|NOT COMPLETED|PK Study||0
9851881|NCT00878553|10964632|FG001|NOT COMPLETED|PK Study||0
9851882|NCT00878553|10964633|FG002|NOT COMPLETED|PK Study||0
9851883|NCT00878553|10964634|FG003|NOT COMPLETED|PK Study||1
9851884|NCT00878553|10964635|FG004|NOT COMPLETED|PK Study||0
9851885|NCT00878644|10964654|FG000|STARTED|Overall Study||155
9851886|NCT00878644|10964655|FG001|STARTED|Overall Study||140
9851887|NCT00878644|10964654|FG000|COMPLETED|Overall Study||151
9851888|NCT00878644|10964655|FG001|COMPLETED|Overall Study||136
9851889|NCT00878644|10964654|FG000|NOT COMPLETED|Overall Study||4
9851890|NCT00878644|10964655|FG001|NOT COMPLETED|Overall Study||4
9851891|NCT00878709|10964663|FG000|STARTED|Overall Study||1420
9851892|NCT00878709|10964664|FG001|STARTED|Overall Study||1420
9851893|NCT00878709|10964663|FG000|COMPLETED|Overall Study||1095
9851894|NCT00878709|10964664|FG001|COMPLETED|Overall Study||1183
9851895|NCT00878709|10964663|FG000|NOT COMPLETED|Overall Study||325
9851896|NCT00878709|10964664|FG001|NOT COMPLETED|Overall Study||237
9851897|NCT00878722|10964679|FG000|STARTED|Overall Study||3
9851898|NCT00878722|10964680|FG001|STARTED|Overall Study||3
9851899|NCT00878722|10964681|FG002|STARTED|Overall Study||3
9851900|NCT00878722|10964682|FG003|STARTED|Overall Study||9
9851901|NCT00878722|10964683|FG004|STARTED|Overall Study||7
9851902|NCT00878722|10964684|FG005|STARTED|Overall Study||3
9851903|NCT00878722|10964685|FG006|STARTED|Overall Study||6
9851904|NCT00878722|10964686|FG007|STARTED|Overall Study||7
9851905|NCT00878722|10964679|FG000|COMPLETED|Overall Study||0
9851906|NCT00878722|10964680|FG001|COMPLETED|Overall Study||0
9851907|NCT00878722|10964681|FG002|COMPLETED|Overall Study||0
9851908|NCT00878722|10964682|FG003|COMPLETED|Overall Study||0
9851909|NCT00878722|10964683|FG004|COMPLETED|Overall Study||0
9851910|NCT00878722|10964684|FG005|COMPLETED|Overall Study||1
9851911|NCT00878722|10964685|FG006|COMPLETED|Overall Study||0
9851912|NCT00878722|10964686|FG007|COMPLETED|Overall Study||0
9851913|NCT00878722|10964679|FG000|NOT COMPLETED|Overall Study||3
9851914|NCT00878722|10964680|FG001|NOT COMPLETED|Overall Study||3
9851915|NCT00878722|10964681|FG002|NOT COMPLETED|Overall Study||3
9851916|NCT00878722|10964682|FG003|NOT COMPLETED|Overall Study||9
9851917|NCT00878722|10964683|FG004|NOT COMPLETED|Overall Study||7
9851918|NCT00878722|10964684|FG005|NOT COMPLETED|Overall Study||2
9851919|NCT00878722|10964685|FG006|NOT COMPLETED|Overall Study||6
9851920|NCT00878722|10964686|FG007|NOT COMPLETED|Overall Study||7
9851921|NCT00878800|10964712|FG000|STARTED|Overall Study||3
9851922|NCT00878800|10964713|FG001|STARTED|Overall Study||7
9851923|NCT00878800|10964714|FG002|STARTED|Overall Study||9
9851924|NCT00878800|10964715|FG003|STARTED|Overall Study||6
9851925|NCT00878800|10964716|FG004|STARTED|Overall Study||16
9851926|NCT00878800|10964712|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
9851927|NCT00878800|10964713|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
9851928|NCT00878800|10964714|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
9851929|NCT00878800|10964715|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
10083696|NCT02277691|11212171|FG000|STARTED|Overall Study||341
10083697|NCT02277691|11212171|FG000|COMPLETED|Overall Study||295
10083698|NCT02277691|11212171|FG000|NOT COMPLETED|Overall Study||46
9851930|NCT00878800|10964716|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
9851931|NCT00878800|10964712|FG000|NOT COMPLETED|Overall Study||3
9851932|NCT00878800|10964713|FG001|NOT COMPLETED|Overall Study||7
9851933|NCT00878800|10964714|FG002|NOT COMPLETED|Overall Study||9
9851934|NCT00878800|10964715|FG003|NOT COMPLETED|Overall Study||6
9851935|NCT00878800|10964716|FG004|NOT COMPLETED|Overall Study||16
9851936|NCT00878826|10964730|FG000|STARTED|Overall Study||3
9851937|NCT00878826|10964731|FG001|STARTED|Overall Study||6
9851938|NCT00878826|10964732|FG002|STARTED|Overall Study||2
9851939|NCT00878826|10964730|FG000|COMPLETED|Overall Study||3
9851940|NCT00878826|10964731|FG001|COMPLETED|Overall Study||6
9851941|NCT00878826|10964732|FG002|COMPLETED|Overall Study||2
9851942|NCT00878826|10964730|FG000|NOT COMPLETED|Overall Study||0
9851943|NCT00878826|10964731|FG001|NOT COMPLETED|Overall Study||0
9851944|NCT00878826|10964732|FG002|NOT COMPLETED|Overall Study||0
9851945|NCT00878878|10964742|FG000|STARTED|Overall Study||15
9851946|NCT00878878|10964743|FG001|STARTED|Overall Study||15
9851947|NCT00878878|10964742|FG000|COMPLETED|Overall Study||15
9851948|NCT00878878|10964743|FG001|COMPLETED|Overall Study||15
9851949|NCT00878878|10964742|FG000|NOT COMPLETED|Overall Study||0
9851950|NCT00878878|10964743|FG001|NOT COMPLETED|Overall Study||0
9851951|NCT00878995|10964753|FG000|STARTED|Baseline Study - Midpoint Study||12
9851952|NCT00878995|10964754|FG001|STARTED|Baseline Study - Midpoint Study||12
9851953|NCT00878995|10964753|FG000|Baseline Study|Baseline Study - Midpoint Study||12
9851954|NCT00878995|10964754|FG001|Baseline Study|Baseline Study - Midpoint Study||12
9851955|NCT00878995|10964753|FG000|COMPLETED|Baseline Study - Midpoint Study||12
9851956|NCT00878995|10964754|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
9851957|NCT00878995|10964753|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0
9851958|NCT00878995|10964754|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2
9851959|NCT00878995|10964753|FG000|STARTED|Midpoint Study - Post Study||12
9851960|NCT00878995|10964754|FG001|STARTED|Midpoint Study - Post Study||10
9851961|NCT00878995|10964753|FG000|COMPLETED|Midpoint Study - Post Study||12
9851962|NCT00878995|10964754|FG001|COMPLETED|Midpoint Study - Post Study||10
9851963|NCT00878995|10964753|FG000|NOT COMPLETED|Midpoint Study - Post Study||0
9851964|NCT00878995|10964754|FG001|NOT COMPLETED|Midpoint Study - Post Study||0
9851965|NCT00879034|10964760|FG000|STARTED|Overall Study||5
9851966|NCT00879034|10964760|FG000|Received Treatment|Overall Study||4
9851967|NCT00879034|10964760|FG000|COMPLETED|Overall Study||5
9851968|NCT00879034|10964760|FG000|NOT COMPLETED|Overall Study||0
9851969|NCT00879060|10964766|FG000|STARTED|Overall Study||26
9851970|NCT00879060|10964767|FG001|STARTED|Overall Study||27
9851971|NCT00879060|10964766|FG000|COMPLETED|Overall Study||26
9851972|NCT00879060|10964767|FG001|COMPLETED|Overall Study||27
9851973|NCT00879060|10964766|FG000|NOT COMPLETED|Overall Study||0
9851974|NCT00879060|10964767|FG001|NOT COMPLETED|Overall Study||0
9851975|NCT00879190|10964778|FG000|STARTED|Overall Study||43
9851976|NCT00879190|10964779|FG001|STARTED|Overall Study||49
9851977|NCT00879190|10964778|FG000|COMPLETED|Overall Study||43
9851978|NCT00879190|10964779|FG001|COMPLETED|Overall Study||49
9851979|NCT00879190|10964778|FG000|NOT COMPLETED|Overall Study||0
9851980|NCT00879190|10964779|FG001|NOT COMPLETED|Overall Study||0
9851981|NCT00879229|10964787|FG000|STARTED|Overall Study||25
9851982|NCT00879229|10964788|FG001|STARTED|Overall Study||15
9851983|NCT00879229|10964787|FG000|COMPLETED|Overall Study||3
9851984|NCT00879229|10964788|FG001|COMPLETED|Overall Study||1
9851985|NCT00879229|10964787|FG000|NOT COMPLETED|Overall Study||22
9851986|NCT00879229|10964788|FG001|NOT COMPLETED|Overall Study||14
9851987|NCT00879255|10964796|FG000|STARTED|Overall Study||61
9851988|NCT00879255|10964797|FG001|STARTED|Overall Study||64
9851989|NCT00879255|10964796|FG000|Received Allocated Intervention:|Overall Study||51
9851990|NCT00879255|10964797|FG001|Received Allocated Intervention:|Overall Study||56
9851991|NCT00879255|10964796|FG000|Completed Posttreatment Follow-up|Overall Study||50
9851992|NCT00879255|10964797|FG001|Completed Posttreatment Follow-up|Overall Study||55
9851993|NCT00879255|10964796|FG000|Completed 3-mo Follow-up|Overall Study||48
9851994|NCT00879255|10964797|FG001|Completed 3-mo Follow-up|Overall Study||49
9851995|NCT00879255|10964796|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45
9851996|NCT00879255|10964797|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45
9851997|NCT00879255|10964796|FG000|NOT COMPLETED|Overall Study||16
9851998|NCT00879255|10964797|FG001|NOT COMPLETED|Overall Study||19
9851999|NCT00879333|10964805|FG000|STARTED|Overall Study||439
9852000|NCT00879333|10964806|FG001|STARTED|Overall Study||217
9852001|NCT00879333|10964805|FG000|Discontinued Study Treatment|Overall Study||428
9852002|NCT00879333|10964806|FG001|Discontinued Study Treatment|Overall Study||217
9852003|NCT00879333|10964805|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
9852004|NCT00879333|10964806|FG001|COMPLETED|Overall Study||0
9852005|NCT00879333|10964805|FG000|NOT COMPLETED|Overall Study||428
9852006|NCT00879333|10964806|FG001|NOT COMPLETED|Overall Study||217
9852007|NCT00879359|10964814|FG000|STARTED|Overall Study||15
9852008|NCT00879359|10964814|FG000|COMPLETED|Overall Study||15
9852009|NCT00879359|10964814|FG000|NOT COMPLETED|Overall Study||0
9852010|NCT00879398|10964819|FG000|STARTED|Overall Study||3109
9852011|NCT00879398|10964819|FG000|COMPLETED|Overall Study||2434
9852012|NCT00879398|10964819|FG000|NOT COMPLETED|Overall Study||675
9852013|NCT00879411|10964823|FG000|STARTED|Overall Study||701
9852014|NCT00879411|10964823|FG000|COMPLETED|Overall Study||539
9852015|NCT00879411|10964823|FG000|NOT COMPLETED|Overall Study||162
9852016|NCT00879437|10964827|FG000|STARTED|Overall Study||20
9852017|NCT00879437|10964828|FG001|STARTED|Overall Study||18
10083699|NCT02277743|11212178|FG000|STARTED|Overall Study||224
10083700|NCT02277743|11212179|FG001|STARTED|Overall Study||224
10083701|NCT02277743|11212180|FG002|STARTED|Overall Study||223
10083702|NCT02277743|11212178|FG000|Treated|Overall Study||223
10083703|NCT02277743|11212179|FG001|Treated|Overall Study||223
10083704|NCT02277743|11212180|FG002|Treated|Overall Study||223
9852018|NCT00879437|10964827|FG000|COMPLETED|Overall Study||19
9852019|NCT00879437|10964828|FG001|COMPLETED|Overall Study||17
9852020|NCT00879437|10964827|FG000|NOT COMPLETED|Overall Study||1
10083705|NCT02277743|11212178|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
10083706|NCT02277743|11212179|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
10083707|NCT02277743|11212180|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
10083708|NCT02277743|11212178|FG000|COMPLETED|Overall Study||184
10083709|NCT02277743|11212179|FG001|COMPLETED|Overall Study||208
10083710|NCT02277743|11212180|FG002|COMPLETED|Overall Study||197
10083711|NCT02277743|11212178|FG000|NOT COMPLETED|Overall Study||40
10083712|NCT02277743|11212179|FG001|NOT COMPLETED|Overall Study||16
10083713|NCT02277743|11212180|FG002|NOT COMPLETED|Overall Study||26
10083714|NCT02277769|11212191|FG000|STARTED|Overall Study||236
10083715|NCT02277769|11212192|FG001|STARTED|Overall Study||233
10083716|NCT02277769|11212193|FG002|STARTED|Overall Study||239
10083717|NCT02277769|11212191|FG000|Treated|Overall Study||235
10083718|NCT02277769|11212192|FG001|Treated|Overall Study||233
10083719|NCT02277769|11212193|FG002|Treated|Overall Study||239
10083720|NCT02277769|11212191|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
10083721|NCT02277769|11212192|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
10083722|NCT02277769|11212193|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
10083723|NCT02277769|11212191|FG000|COMPLETED|Overall Study||190
10083724|NCT02277769|11212192|FG001|COMPLETED|Overall Study||220
10083725|NCT02277769|11212193|FG002|COMPLETED|Overall Study||221
10083726|NCT02277769|11212191|FG000|NOT COMPLETED|Overall Study||46
10083727|NCT02277769|11212192|FG001|NOT COMPLETED|Overall Study||13
10083728|NCT02277769|11212193|FG002|NOT COMPLETED|Overall Study||18
10083729|NCT02277925|11212203|FG000|STARTED|Overall Study||102
10083730|NCT02277925|11212204|FG001|STARTED|Overall Study||102
10083731|NCT02277925|11212203|FG000|Surgery|Overall Study||99
10199489|NCT03419780|11327982|FG001|STARTED|Overall Study||33
10199490|NCT03419780|11327981|FG000|COMPLETED|Overall Study||33
10199491|NCT03419780|11327982|FG001|COMPLETED|Overall Study||33
10199492|NCT03419780|11327981|FG000|NOT COMPLETED|Overall Study||0
10199493|NCT03419780|11327982|FG001|NOT COMPLETED|Overall Study||0
10199494|NCT03419962|11327988|FG000|STARTED|Overall Study||1359
10199495|NCT03419962|11327988|FG000|COMPLETED|Overall Study||1322
10199496|NCT03419962|11327988|FG000|NOT COMPLETED|Overall Study||37
10199497|NCT03420300|11327992|FG000|STARTED|Overall Study||40
10199498|NCT03420300|11327992|FG000|COMPLETED|Overall Study||38
10199499|NCT03420300|11327992|FG000|NOT COMPLETED|Overall Study||2
10199500|NCT03420625|11327996|FG000|STARTED|Overall Study||10
9852021|NCT00879437|10964828|FG001|NOT COMPLETED|Overall Study||1
9852022|NCT00879645|10964840|FG000|STARTED|Overall Study||9
9852023|NCT00879645|10964841|FG001|STARTED|Overall Study||6
9852024|NCT00879645|10964842|FG002|STARTED|Overall Study||6
9852025|NCT00879645|10964843|FG003|STARTED|Overall Study||7
9852026|NCT00879645|10964840|FG000|COMPLETED|Overall Study||8
10199501|NCT03420625|11327996|FG000|Baseline|Overall Study||10
10199502|NCT03420625|11327996|FG000|Foot IPC|Overall Study||10
10199503|NCT03420625|11327996|FG000|Rapid Calf IPC|Overall Study||10
10199504|NCT03420625|11327996|FG000|Slow Calf IPC|Overall Study||10
10199505|NCT03420625|11327996|FG000|Calf NMES|Overall Study||10
10199506|NCT03420625|11327996|FG000|COMPLETED|Overall Study||10
10199507|NCT03420625|11327996|FG000|NOT COMPLETED|Overall Study||0
10238659|NCT00491400|11370130|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
10238660|NCT00491400|11370131|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
10238661|NCT00491400|11370130|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
10238662|NCT00491400|11370131|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
10238663|NCT00491400|11370130|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12
10238664|NCT00491400|11370131|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9
10238665|NCT00491400|11370130|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
9852027|NCT00879645|10964841|FG001|COMPLETED|Overall Study||6
9852028|NCT00879645|10964842|FG002|COMPLETED|Overall Study||6
9852029|NCT00879645|10964843|FG003|COMPLETED|Overall Study||7
9852030|NCT00879645|10964840|FG000|NOT COMPLETED|Overall Study||1
9852031|NCT00879645|10964841|FG001|NOT COMPLETED|Overall Study||0
9852032|NCT00879645|10964842|FG002|NOT COMPLETED|Overall Study||0
9852033|NCT00879645|10964843|FG003|NOT COMPLETED|Overall Study||0
9852034|NCT00879658|10964860|FG000|STARTED|Overall Study||50
9852035|NCT00879658|10964861|FG001|STARTED|Overall Study||49
9852036|NCT00879658|10964862|FG002|STARTED|Overall Study||43
9852037|NCT00879658|10964863|FG003|STARTED|Overall Study||46
9852038|NCT00879658|10964864|FG004|STARTED|Overall Study||42
9852039|NCT00879658|10964865|FG005|STARTED|Overall Study||51
9852040|NCT00879658|10964866|FG006|STARTED|Overall Study||16
9852041|NCT00879658|10964860|FG000|COMPLETED|Overall Study||35
9852042|NCT00879658|10964861|FG001|COMPLETED|Overall Study||44
9852043|NCT00879658|10964862|FG002|COMPLETED|Overall Study||36
9852044|NCT00879658|10964863|FG003|COMPLETED|Overall Study||42
9852045|NCT00879658|10964864|FG004|COMPLETED|Overall Study||40
9852046|NCT00879658|10964865|FG005|COMPLETED|Overall Study||50
9852047|NCT00879658|10964866|FG006|COMPLETED|Overall Study||16
9852048|NCT00879658|10964860|FG000|NOT COMPLETED|Overall Study||15
9852049|NCT00879658|10964861|FG001|NOT COMPLETED|Overall Study||5
9852050|NCT00879658|10964862|FG002|NOT COMPLETED|Overall Study||7
9852051|NCT00879658|10964863|FG003|NOT COMPLETED|Overall Study||4
9852052|NCT00879658|10964864|FG004|NOT COMPLETED|Overall Study||2
9852053|NCT00879658|10964865|FG005|NOT COMPLETED|Overall Study||1
9852054|NCT00879658|10964866|FG006|NOT COMPLETED|Overall Study||0
9852055|NCT00879684|10964888|FG000|STARTED|Stage 1: Dose Escalation||3
9852056|NCT00879684|10964889|FG001|STARTED|Stage 1: Dose Escalation||3
9852057|NCT00879684|10964890|FG002|STARTED|Stage 1: Dose Escalation||3
9852058|NCT00879684|10964891|FG003|STARTED|Stage 1: Dose Escalation||6
9852059|NCT00879684|10964892|FG004|STARTED|Stage 1: Dose Escalation||3
9852060|NCT00879684|10964893|FG005|STARTED|Stage 1: Dose Escalation||3
9852061|NCT00879684|10964894|FG006|STARTED|Stage 1: Dose Escalation||0
9852062|NCT00879684|10964888|FG000|COMPLETED|Stage 1: Dose Escalation||0
9852063|NCT00879684|10964889|FG001|COMPLETED|Stage 1: Dose Escalation||0
9852064|NCT00879684|10964890|FG002|COMPLETED|Stage 1: Dose Escalation||0
9852065|NCT00879684|10964891|FG003|COMPLETED|Stage 1: Dose Escalation||0
10199508|NCT03421210|11328012|FG000|STARTED|Overall Study||88
10199509|NCT03421210|11328012|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
10199510|NCT03421210|11328012|FG000|COMPLETED|Overall Study||35
10199511|NCT03421210|11328012|FG000|NOT COMPLETED|Overall Study||53
10199512|NCT03421379|11328018|FG000|STARTED|Period 1||34
10199513|NCT03421379|11328019|FG001|STARTED|Period 1||41
10199514|NCT03421379|11328018|FG000|Received at Least One Dose of Study Drug|Period 1||33
10199515|NCT03421379|11328019|FG001|Received at Least One Dose of Study Drug|Period 1||39
10199516|NCT03421379|11328018|FG000|COMPLETED|Period 1||32
10199517|NCT03421379|11328019|FG001|COMPLETED|Period 1||37
10199518|NCT03421379|11328018|FG000|NOT COMPLETED|Period 1||2
10199519|NCT03421379|11328019|FG001|NOT COMPLETED|Period 1||4
10199520|NCT03421379|11328018|FG000|STARTED|Washout Period (3 to 14 Days)||32
10199521|NCT03421379|11328019|FG001|STARTED|Washout Period (3 to 14 Days)||37
10199522|NCT03421379|11328018|FG000|COMPLETED|Washout Period (3 to 14 Days)||32
10199523|NCT03421379|11328019|FG001|COMPLETED|Washout Period (3 to 14 Days)||37
10199524|NCT03421379|11328018|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0
10199525|NCT03421379|11328019|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0
10199526|NCT03421379|11328018|FG000|STARTED|Period 2||32
10199527|NCT03421379|11328019|FG001|STARTED|Period 2||37
10199528|NCT03421379|11328018|FG000|COMPLETED|Period 2||32
10199529|NCT03421379|11328019|FG001|COMPLETED|Period 2||37
10199530|NCT03421379|11328018|FG000|NOT COMPLETED|Period 2||0
10199531|NCT03421379|11328019|FG001|NOT COMPLETED|Period 2||0
10199532|NCT03421431|11328028|FG000|STARTED|Overall Study||24
9852066|NCT00879684|10964892|FG004|COMPLETED|Stage 1: Dose Escalation||0
9852067|NCT00879684|10964893|FG005|COMPLETED|Stage 1: Dose Escalation||0
9852068|NCT00879684|10964894|FG006|COMPLETED|Stage 1: Dose Escalation||0
9852069|NCT00879684|10964888|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3
9852070|NCT00879684|10964889|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3
9852071|NCT00879684|10964890|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3
9852072|NCT00879684|10964891|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6
9852073|NCT00879684|10964892|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3
9852074|NCT00879684|10964893|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3
9852075|NCT00879684|10964894|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
9852076|NCT00879684|10964888|FG000|STARTED|Stage 2: Expanded Cohort||0
9852077|NCT00879684|10964889|FG001|STARTED|Stage 2: Expanded Cohort||0
9852078|NCT00879684|10964890|FG002|STARTED|Stage 2: Expanded Cohort||0
9852079|NCT00879684|10964891|FG003|STARTED|Stage 2: Expanded Cohort||0
9852080|NCT00879684|10964892|FG004|STARTED|Stage 2: Expanded Cohort||0
9852081|NCT00879684|10964893|FG005|STARTED|Stage 2: Expanded Cohort||0
9852082|NCT00879684|10964894|FG006|STARTED|Stage 2: Expanded Cohort||13
9852083|NCT00879684|10964888|FG000|COMPLETED|Stage 2: Expanded Cohort||0
9852084|NCT00879684|10964889|FG001|COMPLETED|Stage 2: Expanded Cohort||0
9852085|NCT00879684|10964890|FG002|COMPLETED|Stage 2: Expanded Cohort||0
9852086|NCT00879684|10964891|FG003|COMPLETED|Stage 2: Expanded Cohort||0
9852087|NCT00879684|10964892|FG004|COMPLETED|Stage 2: Expanded Cohort||0
10199533|NCT03421431|11328029|FG001|STARTED|Overall Study||55
9852088|NCT00879684|10964893|FG005|COMPLETED|Stage 2: Expanded Cohort||0
9852089|NCT00879684|10964894|FG006|COMPLETED|Stage 2: Expanded Cohort||0
9852090|NCT00879684|10964888|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
9852091|NCT00879684|10964889|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
10199534|NCT03421431|11328030|FG002|STARTED|Overall Study||53
10199535|NCT03421431|11328028|FG000|COMPLETED|Overall Study||18
10199536|NCT03421431|11328029|FG001|COMPLETED|Overall Study||49
10199537|NCT03421431|11328030|FG002|COMPLETED|Overall Study||39
10199538|NCT03421431|11328028|FG000|NOT COMPLETED|Overall Study||6
10199539|NCT03421431|11328029|FG001|NOT COMPLETED|Overall Study||6
10199540|NCT03421431|11328030|FG002|NOT COMPLETED|Overall Study||14
10199541|NCT03421730|11328040|FG000|STARTED|First Intervention (Day 1, Visit 2)||1
10199542|NCT03421730|11328041|FG001|STARTED|First Intervention (Day 1, Visit 2)||3
10199543|NCT03421730|11328042|FG002|STARTED|First Intervention (Day 1, Visit 2)||1
10199544|NCT03421730|11328043|FG003|STARTED|First Intervention (Day 1, Visit 2)||1
10199545|NCT03421730|11328044|FG004|STARTED|First Intervention (Day 1, Visit 2)||3
10199546|NCT03421730|11328045|FG005|STARTED|First Intervention (Day 1, Visit 2)||1
10199547|NCT03421730|11328046|FG006|STARTED|First Intervention (Day 1, Visit 2)||1
10199548|NCT03421730|11328047|FG007|STARTED|First Intervention (Day 1, Visit 2)||1
10199549|NCT03421730|11328048|FG008|STARTED|First Intervention (Day 1, Visit 2)||1
10199550|NCT03421730|11328049|FG009|STARTED|First Intervention (Day 1, Visit 2)||2
10199551|NCT03421730|11328050|FG010|STARTED|First Intervention (Day 1, Visit 2)||1
10199552|NCT03421730|11328051|FG011|STARTED|First Intervention (Day 1, Visit 2)||1
10199553|NCT03421730|11328040|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199554|NCT03421730|11328041|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
10199555|NCT03421730|11328042|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199556|NCT03421730|11328043|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199557|NCT03421730|11328044|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3
10199558|NCT03421730|11328045|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199559|NCT03421730|11328046|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199560|NCT03421730|11328047|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199561|NCT03421730|11328048|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199562|NCT03421730|11328049|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2
10199563|NCT03421730|11328050|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199564|NCT03421730|11328051|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1
10199565|NCT03421730|11328040|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199566|NCT03421730|11328041|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
10199567|NCT03421730|11328042|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199568|NCT03421730|11328043|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199569|NCT03421730|11328044|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199570|NCT03421730|11328045|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199571|NCT03421730|11328046|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199572|NCT03421730|11328047|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199573|NCT03421730|11328048|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199574|NCT03421730|11328049|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199575|NCT03421730|11328050|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199576|NCT03421730|11328051|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10199577|NCT03421730|11328040|FG000|STARTED|Washout (Days 4 to 10)||1
10199578|NCT03421730|11328041|FG001|STARTED|Washout (Days 4 to 10)||1
10199579|NCT03421730|11328042|FG002|STARTED|Washout (Days 4 to 10)||1
10199580|NCT03421730|11328043|FG003|STARTED|Washout (Days 4 to 10)||1
10199581|NCT03421730|11328044|FG004|STARTED|Washout (Days 4 to 10)||3
10199582|NCT03421730|11328045|FG005|STARTED|Washout (Days 4 to 10)||1
10199583|NCT03421730|11328046|FG006|STARTED|Washout (Days 4 to 10)||1
10199584|NCT03421730|11328047|FG007|STARTED|Washout (Days 4 to 10)||1
10199585|NCT03421730|11328048|FG008|STARTED|Washout (Days 4 to 10)||1
10199586|NCT03421730|11328049|FG009|STARTED|Washout (Days 4 to 10)||2
10199587|NCT03421730|11328050|FG010|STARTED|Washout (Days 4 to 10)||1
10199588|NCT03421730|11328051|FG011|STARTED|Washout (Days 4 to 10)||1
10199589|NCT03421730|11328040|FG000|COMPLETED|Washout (Days 4 to 10)||1
10199590|NCT03421730|11328041|FG001|COMPLETED|Washout (Days 4 to 10)||1
10199591|NCT03421730|11328042|FG002|COMPLETED|Washout (Days 4 to 10)||1
10199592|NCT03421730|11328043|FG003|COMPLETED|Washout (Days 4 to 10)||1
10199593|NCT03421730|11328044|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
10199594|NCT03421730|11328045|FG005|COMPLETED|Washout (Days 4 to 10)||1
10199595|NCT03421730|11328046|FG006|COMPLETED|Washout (Days 4 to 10)||1
10199596|NCT03421730|11328047|FG007|COMPLETED|Washout (Days 4 to 10)||1
10199597|NCT03421730|11328048|FG008|COMPLETED|Washout (Days 4 to 10)||1
10199598|NCT03421730|11328049|FG009|COMPLETED|Washout (Days 4 to 10)||2
10199599|NCT03421730|11328050|FG010|COMPLETED|Washout (Days 4 to 10)||1
9852092|NCT00879684|10964890|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
9852093|NCT00879684|10964891|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0
9852094|NCT00879684|10964892|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0
9852095|NCT00879684|10964893|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0
9852096|NCT00879684|10964894|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13
9852097|NCT00879697|10964915|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
9852098|NCT00879697|10964916|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
9852099|NCT00879697|10964915|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15
10199600|NCT03421730|11328051|FG011|COMPLETED|Washout (Days 4 to 10)||1
10199601|NCT03421730|11328040|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0
10199602|NCT03421730|11328041|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0
10199603|NCT03421730|11328042|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0
10199604|NCT03421730|11328043|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0
10199605|NCT03421730|11328044|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2
10199606|NCT03421730|11328045|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0
10199607|NCT03421730|11328046|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0
10199608|NCT03421730|11328047|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0
10199609|NCT03421730|11328048|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0
10199610|NCT03421730|11328049|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0
10199611|NCT03421730|11328050|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0
10199612|NCT03421730|11328051|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0
10199613|NCT03421730|11328040|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199614|NCT03421730|11328041|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199615|NCT03421730|11328042|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199616|NCT03421730|11328043|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199617|NCT03421730|11328044|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199618|NCT03421730|11328045|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199619|NCT03421730|11328046|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199620|NCT03421730|11328047|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199621|NCT03421730|11328048|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199622|NCT03421730|11328049|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2
10199623|NCT03421730|11328050|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199624|NCT03421730|11328051|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10199625|NCT03421730|11328040|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199626|NCT03421730|11328041|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199627|NCT03421730|11328042|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9852100|NCT00879697|10964916|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15
9852101|NCT00879697|10964915|FG000|NOT COMPLETED|Overall Study||2
9852102|NCT00879697|10964916|FG001|NOT COMPLETED|Overall Study||2
10199628|NCT03421730|11328043|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199629|NCT03421730|11328044|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199630|NCT03421730|11328045|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199631|NCT03421730|11328046|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199632|NCT03421730|11328047|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199633|NCT03421730|11328048|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199634|NCT03421730|11328049|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
10199635|NCT03421730|11328050|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199636|NCT03421730|11328051|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10199637|NCT03421730|11328040|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199638|NCT03421730|11328041|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199639|NCT03421730|11328042|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199640|NCT03421730|11328043|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199641|NCT03421730|11328044|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199642|NCT03421730|11328045|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199643|NCT03421730|11328046|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199644|NCT03421730|11328047|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199645|NCT03421730|11328048|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199646|NCT03421730|11328049|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199647|NCT03421730|11328050|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199648|NCT03421730|11328051|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10199649|NCT03421886|11328067|FG000|STARTED|Overall Study||30
10199650|NCT03421886|11328068|FG001|STARTED|Overall Study||15
10199651|NCT03421886|11328067|FG000|COMPLETED|Overall Study||23
10199652|NCT03421886|11328068|FG001|COMPLETED|Overall Study||13
10199653|NCT03421886|11328067|FG000|NOT COMPLETED|Overall Study||7
10199654|NCT03421886|11328068|FG001|NOT COMPLETED|Overall Study||2
10199655|NCT03422159|11328076|FG000|STARTED|Overall Study||70
10199656|NCT03422159|11328077|FG001|STARTED|Overall Study||70
10199657|NCT03422159|11328076|FG000|COMPLETED|Overall Study||68
10199658|NCT03422159|11328077|FG001|COMPLETED|Overall Study||69
10199659|NCT03422159|11328076|FG000|NOT COMPLETED|Overall Study||2
10199660|NCT03422159|11328077|FG001|NOT COMPLETED|Overall Study||1
9852103|NCT00879710|10964924|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
9852104|NCT00879710|10964925|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
9852105|NCT00879710|10964926|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
9852106|NCT00879710|10964927|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
9852107|NCT00879710|10964924|FG000|COMPLETED|Phase 1 - 6 Weeks||10
9852108|NCT00879710|10964925|FG001|COMPLETED|Phase 1 - 6 Weeks||14
9852109|NCT00879710|10964926|FG002|COMPLETED|Phase 1 - 6 Weeks||9
9852110|NCT00879710|10964927|FG003|COMPLETED|Phase 1 - 6 Weeks||13
9852111|NCT00879710|10964924|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2
9852112|NCT00879710|10964925|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3
9852113|NCT00879710|10964926|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2
9852114|NCT00879710|10964927|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4
9852115|NCT00879710|10964924|FG000|STARTED|Wash Out Period of 4 Weeks||10
9852116|NCT00879710|10964925|FG001|STARTED|Wash Out Period of 4 Weeks||14
9852117|NCT00879710|10964926|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
9852118|NCT00879710|10964927|FG003|STARTED|Wash Out Period of 4 Weeks||13
9852119|NCT00879710|10964924|FG000|COMPLETED|Wash Out Period of 4 Weeks||10
9852120|NCT00879710|10964925|FG001|COMPLETED|Wash Out Period of 4 Weeks||14
9852121|NCT00879710|10964926|FG002|COMPLETED|Wash Out Period of 4 Weeks||10
10199661|NCT03422172|11328085|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48
10199662|NCT03422172|11328085|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47
10199663|NCT03422172|11328085|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
10199664|NCT03422172|11328085|FG000|STARTED|Washout (7 Days)||47
10199665|NCT03422172|11328085|FG000|COMPLETED|Washout (7 Days)||47
10199666|NCT03422172|11328085|FG000|NOT COMPLETED|Washout (7 Days)||0
10199667|NCT03422172|11328085|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47
10199668|NCT03422172|11328085|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43
10199669|NCT03422172|11328085|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
10199670|NCT03422172|11328085|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
10199671|NCT03422172|11328085|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
10199672|NCT03422172|11328085|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
10199673|NCT03422250|11328098|FG000|STARTED|Intervention||11
10199674|NCT03422250|11328099|FG001|STARTED|Intervention||11
9852122|NCT00879710|10964927|FG003|COMPLETED|Wash Out Period of 4 Weeks||13
9852123|NCT00879710|10964924|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0
10083732|NCT02277925|11212204|FG001|Surgery|Overall Study||101
10083733|NCT02277925|11212203|FG000|COMPLETED|Overall Study||95
10083734|NCT02277925|11212204|FG001|COMPLETED|Overall Study||87
10083735|NCT02277925|11212203|FG000|NOT COMPLETED|Overall Study||7
10083736|NCT02277925|11212204|FG001|NOT COMPLETED|Overall Study||15
10083737|NCT02277990|11212214|FG000|STARTED|Overall Study||3495
10083738|NCT02277990|11212215|FG001|STARTED|Overall Study||3488
10083739|NCT02277990|11212214|FG000|COMPLETED|Overall Study||3129
10083740|NCT02277990|11212215|FG001|COMPLETED|Overall Study||3112
10083741|NCT02277990|11212214|FG000|NOT COMPLETED|Overall Study||366
10083742|NCT02277990|11212215|FG001|NOT COMPLETED|Overall Study||376
10083743|NCT02278003|11212223|FG000|STARTED|Overall Study||49
10083744|NCT02278003|11212224|FG001|STARTED|Overall Study||20
10083745|NCT02278003|11212223|FG000|COMPLETED|Overall Study||30
10083746|NCT02278003|11212224|FG001|COMPLETED|Overall Study||20
10083747|NCT02278003|11212223|FG000|NOT COMPLETED|Overall Study||19
10083748|NCT02278003|11212224|FG001|NOT COMPLETED|Overall Study||0
10083749|NCT02278146|11212232|FG000|STARTED|Overall Study||6
10083750|NCT02278146|11212233|FG001|STARTED|Overall Study||10
10083751|NCT02278146|11212232|FG000|COMPLETED|Overall Study||6
10083752|NCT02278146|11212233|FG001|COMPLETED|Overall Study||8
10083753|NCT02278146|11212232|FG000|NOT COMPLETED|Overall Study||0
10083754|NCT02278146|11212233|FG001|NOT COMPLETED|Overall Study||2
10083755|NCT02278237|11212239|FG000|STARTED|Overall Study||90
10083756|NCT02278237|11212239|FG000|COMPLETED|Overall Study||83
10083757|NCT02278237|11212239|FG000|NOT COMPLETED|Overall Study||7
10083758|NCT02278263|11212246|FG000|STARTED|Overall Study||30
10083759|NCT02278263|11212247|FG001|STARTED|Overall Study||60
10083760|NCT02278263|11212248|FG002|STARTED|Overall Study||60
10083761|NCT02278263|11212246|FG000|COMPLETED|Overall Study||23
10083762|NCT02278263|11212247|FG001|COMPLETED|Overall Study|Correction|60
10083763|NCT02278263|11212248|FG002|COMPLETED|Overall Study||51
10083764|NCT02278263|11212246|FG000|NOT COMPLETED|Overall Study||7
10083765|NCT02278263|11212247|FG001|NOT COMPLETED|Overall Study||0
10083766|NCT02278263|11212248|FG002|NOT COMPLETED|Overall Study||9
10083767|NCT02278289|11212261|FG000|STARTED|Overall Study||30
10083768|NCT02278289|11212262|FG001|STARTED|Overall Study||30
10083769|NCT02278289|11212261|FG000|COMPLETED|Overall Study||24
10083770|NCT02278289|11212262|FG001|COMPLETED|Overall Study||23
10083771|NCT02278289|11212261|FG000|NOT COMPLETED|Overall Study||6
10083772|NCT02278289|11212262|FG001|NOT COMPLETED|Overall Study||7
10083773|NCT02278328|11212268|FG000|STARTED|Neuropsych Screening||10
10083774|NCT02278328|11212269|FG001|STARTED|Neuropsych Screening||7
10083775|NCT02278328|11212270|FG002|STARTED|Neuropsych Screening||8
10083776|NCT02278328|11212268|FG000|COMPLETED|Neuropsych Screening||9
10083777|NCT02278328|11212269|FG001|COMPLETED|Neuropsych Screening||6
10199675|NCT03422250|11328100|FG002|STARTED|Intervention||12
10199676|NCT03422250|11328101|FG003|STARTED|Intervention||11
9852124|NCT00879710|10964925|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0
9852125|NCT00879710|10964926|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0
9852126|NCT00879710|10964927|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0
9852127|NCT00879710|10964924|FG000|STARTED|Phase 2 6 Weeks||10
9852128|NCT00879710|10964925|FG001|STARTED|Phase 2 6 Weeks||14
9852129|NCT00879710|10964926|FG002|STARTED|Phase 2 6 Weeks||10
10083778|NCT02278328|11212270|FG002|COMPLETED|Neuropsych Screening||6
10083779|NCT02278328|11212268|FG000|NOT COMPLETED|Neuropsych Screening||1
10083780|NCT02278328|11212269|FG001|NOT COMPLETED|Neuropsych Screening||1
10083781|NCT02278328|11212270|FG002|NOT COMPLETED|Neuropsych Screening||2
10083782|NCT02278328|11212268|FG000|STARTED|First Intervention (1 Day)||9
10083783|NCT02278328|11212269|FG001|STARTED|First Intervention (1 Day)||6
10083784|NCT02278328|11212270|FG002|STARTED|First Intervention (1 Day)||6
10083785|NCT02278328|11212268|FG000|COMPLETED|First Intervention (1 Day)||9
10083786|NCT02278328|11212269|FG001|COMPLETED|First Intervention (1 Day)||6
10083787|NCT02278328|11212270|FG002|COMPLETED|First Intervention (1 Day)||6
9852130|NCT00879710|10964927|FG003|STARTED|Phase 2 6 Weeks||13
9852131|NCT00879710|10964924|FG000|COMPLETED|Phase 2 6 Weeks||10
9852132|NCT00879710|10964925|FG001|COMPLETED|Phase 2 6 Weeks||14
9852133|NCT00879710|10964926|FG002|COMPLETED|Phase 2 6 Weeks||10
9852134|NCT00879710|10964927|FG003|COMPLETED|Phase 2 6 Weeks||13
10083788|NCT02278328|11212268|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10083789|NCT02278328|11212269|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10083790|NCT02278328|11212270|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10199677|NCT03422250|11328098|FG000|COMPLETED|Intervention||10
10199678|NCT03422250|11328099|FG001|COMPLETED|Intervention||10
10199679|NCT03422250|11328100|FG002|COMPLETED|Intervention||10
10199680|NCT03422250|11328101|FG003|COMPLETED|Intervention||10
10199681|NCT03422250|11328098|FG000|NOT COMPLETED|Intervention||1
10199682|NCT03422250|11328099|FG001|NOT COMPLETED|Intervention||1
10199683|NCT03422250|11328100|FG002|NOT COMPLETED|Intervention||2
10199684|NCT03422250|11328101|FG003|NOT COMPLETED|Intervention||1
10199685|NCT03422250|11328098|FG000|STARTED|Follow-up||10
10199686|NCT03422250|11328099|FG001|STARTED|Follow-up||10
10199687|NCT03422250|11328100|FG002|STARTED|Follow-up||10
10199688|NCT03422250|11328101|FG003|STARTED|Follow-up||10
10199689|NCT03422250|11328098|FG000|COMPLETED|Follow-up||10
10199690|NCT03422250|11328099|FG001|COMPLETED|Follow-up||10
10199691|NCT03422250|11328100|FG002|COMPLETED|Follow-up||10
10199692|NCT03422250|11328101|FG003|COMPLETED|Follow-up||8
10199693|NCT03422250|11328098|FG000|NOT COMPLETED|Follow-up||0
10199694|NCT03422250|11328099|FG001|NOT COMPLETED|Follow-up||0
10199695|NCT03422250|11328100|FG002|NOT COMPLETED|Follow-up||0
10199696|NCT03422250|11328101|FG003|NOT COMPLETED|Follow-up||2
10199697|NCT03423082|11328113|FG000|STARTED|Overall Study||1
10199698|NCT03423082|11328113|FG000|COMPLETED|Overall Study||1
10199699|NCT03423082|11328113|FG000|NOT COMPLETED|Overall Study||0
10199700|NCT03423173|11328121|FG000|STARTED|Overall Study||132
10199701|NCT03423173|11328122|FG001|STARTED|Overall Study||263
10199702|NCT03423173|11328123|FG002|STARTED|Overall Study||264
10199703|NCT03423173|11328124|FG003|STARTED|Overall Study||264
10199704|NCT03423173|11328121|FG000|Received at Least 1 Dose of the IP|Overall Study||131
10199705|NCT03423173|11328122|FG001|Received at Least 1 Dose of the IP|Overall Study||263
10199706|NCT03423173|11328123|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
10199707|NCT03423173|11328124|FG003|Received at Least 1 Dose of the IP|Overall Study||263
10199708|NCT03423173|11328121|FG000|COMPLETED|Overall Study||113
10199709|NCT03423173|11328122|FG001|COMPLETED|Overall Study||228
10199710|NCT03423173|11328123|FG002|COMPLETED|Overall Study||237
10199711|NCT03423173|11328124|FG003|COMPLETED|Overall Study||234
10199712|NCT03423173|11328121|FG000|NOT COMPLETED|Overall Study||19
10199713|NCT03423173|11328122|FG001|NOT COMPLETED|Overall Study||35
10199714|NCT03423173|11328123|FG002|NOT COMPLETED|Overall Study||27
10199715|NCT03423173|11328124|FG003|NOT COMPLETED|Overall Study||30
10199716|NCT03423186|11328136|FG000|STARTED|Overall Study||3
10199717|NCT03423186|11328137|FG001|STARTED|Overall Study||3
10199718|NCT03423186|11328136|FG000|COMPLETED|Overall Study||3
10199719|NCT03423186|11328137|FG001|COMPLETED|Overall Study||3
10199720|NCT03423186|11328136|FG000|NOT COMPLETED|Overall Study||0
10199721|NCT03423186|11328137|FG001|NOT COMPLETED|Overall Study||0
10199722|NCT03423238|11328145|FG000|STARTED|Overall Study||19
10199723|NCT03423238|11328146|FG001|STARTED|Overall Study||19
10199724|NCT03423238|11328145|FG000|COMPLETED|Overall Study||17
10199725|NCT03423238|11328146|FG001|COMPLETED|Overall Study||19
10199726|NCT03423238|11328145|FG000|NOT COMPLETED|Overall Study||2
10199727|NCT03423238|11328146|FG001|NOT COMPLETED|Overall Study||0
10199728|NCT03423641|11328155|FG000|STARTED|Overall Study||15524
10083791|NCT02278328|11212268|FG000|STARTED|Washout (1 Week)||9
10083792|NCT02278328|11212269|FG001|STARTED|Washout (1 Week)||6
10083793|NCT02278328|11212270|FG002|STARTED|Washout (1 Week)||6
10083794|NCT02278328|11212268|FG000|COMPLETED|Washout (1 Week)||9
10083795|NCT02278328|11212269|FG001|COMPLETED|Washout (1 Week)||6
10083796|NCT02278328|11212270|FG002|COMPLETED|Washout (1 Week)||6
10083797|NCT02278328|11212268|FG000|NOT COMPLETED|Washout (1 Week)||0
10083798|NCT02278328|11212269|FG001|NOT COMPLETED|Washout (1 Week)||0
10083799|NCT02278328|11212270|FG002|NOT COMPLETED|Washout (1 Week)||0
10083800|NCT02278328|11212268|FG000|STARTED|Second Intervention (1 Day)||9
10083801|NCT02278328|11212269|FG001|STARTED|Second Intervention (1 Day)||6
10083802|NCT02278328|11212270|FG002|STARTED|Second Intervention (1 Day)||6
10083803|NCT02278328|11212268|FG000|COMPLETED|Second Intervention (1 Day)||9
10083804|NCT02278328|11212269|FG001|COMPLETED|Second Intervention (1 Day)||6
10083805|NCT02278328|11212270|FG002|COMPLETED|Second Intervention (1 Day)||6
10083806|NCT02278328|11212268|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10083807|NCT02278328|11212269|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10083808|NCT02278328|11212270|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10083809|NCT02278328|11212268|FG000|STARTED|Second Washout (1 Week)||9
10083810|NCT02278328|11212269|FG001|STARTED|Second Washout (1 Week)||6
10083811|NCT02278328|11212270|FG002|STARTED|Second Washout (1 Week)||6
10083812|NCT02278328|11212268|FG000|COMPLETED|Second Washout (1 Week)||9
10083813|NCT02278328|11212269|FG001|COMPLETED|Second Washout (1 Week)||6
10083814|NCT02278328|11212270|FG002|COMPLETED|Second Washout (1 Week)||6
10083815|NCT02278328|11212268|FG000|NOT COMPLETED|Second Washout (1 Week)||0
10083816|NCT02278328|11212269|FG001|NOT COMPLETED|Second Washout (1 Week)||0
10083817|NCT02278328|11212270|FG002|NOT COMPLETED|Second Washout (1 Week)||0
10083818|NCT02278328|11212268|FG000|STARTED|Third Intervention (1 Day)||9
10083819|NCT02278328|11212269|FG001|STARTED|Third Intervention (1 Day)||6
10083820|NCT02278328|11212270|FG002|STARTED|Third Intervention (1 Day)||6
10083821|NCT02278328|11212268|FG000|COMPLETED|Third Intervention (1 Day)||9
10199729|NCT03423641|11328156|FG001|STARTED|Overall Study||18284
10199730|NCT03423641|11328155|FG000|COMPLETED|Overall Study||15193
10199731|NCT03423641|11328156|FG001|COMPLETED|Overall Study||10210
10199732|NCT03423641|11328155|FG000|NOT COMPLETED|Overall Study||331
10199733|NCT03423641|11328156|FG001|NOT COMPLETED|Overall Study||8074
10199734|NCT03424044|11328162|FG000|STARTED|Dexcom Training Visit (1 Week)||4
10199735|NCT03424044|11328163|FG001|STARTED|Dexcom Training Visit (1 Week)||3
10199736|NCT03424044|11328164|FG002|STARTED|Dexcom Training Visit (1 Week)||3
10199737|NCT03424044|11328165|FG003|STARTED|Dexcom Training Visit (1 Week)||3
10199738|NCT03424044|11328166|FG004|STARTED|Dexcom Training Visit (1 Week)||3
10199739|NCT03424044|11328167|FG005|STARTED|Dexcom Training Visit (1 Week)||4
10199740|NCT03424044|11328168|FG006|STARTED|Dexcom Training Visit (1 Week)||1
10083822|NCT02278328|11212269|FG001|COMPLETED|Third Intervention (1 Day)||6
10083823|NCT02278328|11212270|FG002|COMPLETED|Third Intervention (1 Day)||6
10083824|NCT02278328|11212268|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10199741|NCT03424044|11328169|FG007|STARTED|Dexcom Training Visit (1 Week)||1
10199742|NCT03424044|11328170|FG008|STARTED|Dexcom Training Visit (1 Week)||1
10199743|NCT03424044|11328162|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4
10199744|NCT03424044|11328163|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3
10199745|NCT03424044|11328164|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3
10199746|NCT03424044|11328165|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3
10199747|NCT03424044|11328166|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3
10083825|NCT02278328|11212269|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10083826|NCT02278328|11212270|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10083827|NCT02278328|11212268|FG000|STARTED|Third Washout (1 Week)||9
10083828|NCT02278328|11212269|FG001|STARTED|Third Washout (1 Week)||6
10083829|NCT02278328|11212270|FG002|STARTED|Third Washout (1 Week)||6
10083830|NCT02278328|11212268|FG000|COMPLETED|Third Washout (1 Week)||9
10083831|NCT02278328|11212269|FG001|COMPLETED|Third Washout (1 Week)||6
10083832|NCT02278328|11212270|FG002|COMPLETED|Third Washout (1 Week)||6
10083833|NCT02278328|11212268|FG000|NOT COMPLETED|Third Washout (1 Week)||0
10083834|NCT02278328|11212269|FG001|NOT COMPLETED|Third Washout (1 Week)||0
10083835|NCT02278328|11212270|FG002|NOT COMPLETED|Third Washout (1 Week)||0
10083836|NCT02278341|11212278|FG000|STARTED|Overall Study||415
10083837|NCT02278341|11212279|FG001|STARTED|Overall Study||421
10083838|NCT02278341|11212278|FG000|Received Treatment|Overall Study||414
10083839|NCT02278341|11212279|FG001|Received Treatment|Overall Study||420
10083840|NCT02278341|11212278|FG000|COMPLETED|Overall Study||297
10083841|NCT02278341|11212279|FG001|COMPLETED|Overall Study||329
10083842|NCT02278341|11212278|FG000|NOT COMPLETED|Overall Study||118
10083843|NCT02278341|11212279|FG001|NOT COMPLETED|Overall Study||92
10083844|NCT02278354|11212288|FG000|STARTED|Overall Study||12
10083845|NCT02278354|11212289|FG001|STARTED|Overall Study||23
10083846|NCT02278354|11212288|FG000|Flortaucipir PET Scan|Overall Study||10
10083847|NCT02278354|11212289|FG001|Flortaucipir PET Scan|Overall Study||20
10083848|NCT02278354|11212288|FG000|COMPLETED|Overall Study||8
10083849|NCT02278354|11212289|FG001|COMPLETED|Overall Study||20
10083850|NCT02278354|11212288|FG000|NOT COMPLETED|Overall Study||4
10083851|NCT02278354|11212289|FG001|NOT COMPLETED|Overall Study||3
10083852|NCT02278367|11212299|FG000|STARTED|Overall Study||69
10083853|NCT02278367|11212300|FG001|STARTED|Overall Study||110
10083854|NCT02278367|11212299|FG000|COMPLETED|Overall Study||59
10083855|NCT02278367|11212300|FG001|COMPLETED|Overall Study||110
10083856|NCT02278367|11212299|FG000|NOT COMPLETED|Overall Study||10
10083857|NCT02278367|11212300|FG001|NOT COMPLETED|Overall Study||0
10083858|NCT02278471|11212308|FG000|STARTED|Overall Study||155
10083859|NCT02278471|11212309|FG001|STARTED|Overall Study||148
10083860|NCT02278471|11212308|FG000|COMPLETED|Overall Study||147
10083861|NCT02278471|11212309|FG001|COMPLETED|Overall Study||128
10083862|NCT02278471|11212308|FG000|NOT COMPLETED|Overall Study||8
10083863|NCT02278471|11212309|FG001|NOT COMPLETED|Overall Study||20
10083864|NCT02278484|11212316|FG000|STARTED|Overall Study||50
10083865|NCT02278484|11212316|FG000|COMPLETED|Overall Study||50
10083866|NCT02278484|11212316|FG000|NOT COMPLETED|Overall Study||0
10083867|NCT02278562|11212324|FG000|STARTED|Overall Study||9
10083868|NCT02278562|11212325|FG001|STARTED|Overall Study||7
10083869|NCT02278562|11212326|FG002|STARTED|Overall Study||8
10083870|NCT02278562|11212324|FG000|COMPLETED|Overall Study||9
10083871|NCT02278562|11212325|FG001|COMPLETED|Overall Study||7
10083872|NCT02278562|11212326|FG002|COMPLETED|Overall Study||8
10083873|NCT02278562|11212324|FG000|NOT COMPLETED|Overall Study||0
10083874|NCT02278562|11212325|FG001|NOT COMPLETED|Overall Study||0
10083875|NCT02278562|11212326|FG002|NOT COMPLETED|Overall Study||0
10083876|NCT02278614|11212336|FG000|STARTED|Overall Study||127
10083877|NCT02278614|11212337|FG001|STARTED|Overall Study||115
10083878|NCT02278614|11212336|FG000|COMPLETED|Overall Study||122
10083879|NCT02278614|11212337|FG001|COMPLETED|Overall Study||110
10083880|NCT02278614|11212336|FG000|NOT COMPLETED|Overall Study||5
10083881|NCT02278614|11212337|FG001|NOT COMPLETED|Overall Study||5
10083882|NCT02278640|11212343|FG000|STARTED|Overall Study||40
10083883|NCT02278640|11212343|FG000|COMPLETED|Overall Study||40
10083884|NCT02278640|11212343|FG000|NOT COMPLETED|Overall Study||0
10083885|NCT02278783|11212347|FG000|STARTED|Overall Study||1
10083886|NCT02278783|11212347|FG000|COMPLETED|Overall Study||1
10083887|NCT02278783|11212347|FG000|NOT COMPLETED|Overall Study||0
10083888|NCT02278939|11212353|FG000|STARTED|Overall Study||33
10199748|NCT03424044|11328167|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4
10199749|NCT03424044|11328168|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1
10083889|NCT02278939|11212354|FG001|STARTED|Overall Study||34
10083890|NCT02278939|11212353|FG000|COMPLETED|Overall Study||28
10083891|NCT02278939|11212354|FG001|COMPLETED|Overall Study||33
10083892|NCT02278939|11212353|FG000|NOT COMPLETED|Overall Study||5
10199750|NCT03424044|11328169|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1
10199751|NCT03424044|11328170|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1
10199752|NCT03424044|11328162|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199753|NCT03424044|11328163|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199754|NCT03424044|11328164|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199755|NCT03424044|11328165|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199756|NCT03424044|11328166|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199757|NCT03424044|11328167|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199758|NCT03424044|11328168|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199759|NCT03424044|11328169|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199760|NCT03424044|11328170|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10199761|NCT03424044|11328162|FG000|STARTED|First Rest Period (1-12 Weeks)||4
10199762|NCT03424044|11328163|FG001|STARTED|First Rest Period (1-12 Weeks)||3
10199763|NCT03424044|11328164|FG002|STARTED|First Rest Period (1-12 Weeks)||3
10199764|NCT03424044|11328165|FG003|STARTED|First Rest Period (1-12 Weeks)||3
10199765|NCT03424044|11328166|FG004|STARTED|First Rest Period (1-12 Weeks)||3
10199766|NCT03424044|11328167|FG005|STARTED|First Rest Period (1-12 Weeks)||4
10199767|NCT03424044|11328168|FG006|STARTED|First Rest Period (1-12 Weeks)||1
10199768|NCT03424044|11328169|FG007|STARTED|First Rest Period (1-12 Weeks)||1
10199769|NCT03424044|11328170|FG008|STARTED|First Rest Period (1-12 Weeks)||1
10199770|NCT03424044|11328162|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
10199771|NCT03424044|11328163|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3
10199772|NCT03424044|11328164|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2
10199773|NCT03424044|11328165|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3
10199774|NCT03424044|11328166|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3
10199775|NCT03424044|11328167|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4
10199776|NCT03424044|11328168|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
10199777|NCT03424044|11328169|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1
10199778|NCT03424044|11328170|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1
10199779|NCT03424044|11328162|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199780|NCT03424044|11328163|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199781|NCT03424044|11328164|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
10199782|NCT03424044|11328165|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199783|NCT03424044|11328166|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199784|NCT03424044|11328167|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199785|NCT03424044|11328168|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199786|NCT03424044|11328169|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199787|NCT03424044|11328170|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10199788|NCT03424044|11328162|FG000|STARTED|First Intervention (76 Hours)||4
10083893|NCT02278939|11212354|FG001|NOT COMPLETED|Overall Study||1
10083894|NCT02278952|11212360|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
10083895|NCT02278952|11212360|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
10199789|NCT03424044|11328163|FG001|STARTED|First Intervention (76 Hours)||3
10199790|NCT03424044|11328164|FG002|STARTED|First Intervention (76 Hours)||2
10199791|NCT03424044|11328165|FG003|STARTED|First Intervention (76 Hours)||3
10199792|NCT03424044|11328166|FG004|STARTED|First Intervention (76 Hours)||3
10199793|NCT03424044|11328167|FG005|STARTED|First Intervention (76 Hours)||4
10199794|NCT03424044|11328168|FG006|STARTED|First Intervention (76 Hours)||1
10083896|NCT02278952|11212360|FG000|NOT COMPLETED|Overall Study||6
10083897|NCT02279043|11212373|FG000|STARTED|Overall Study||175
10083898|NCT02279043|11212374|FG001|STARTED|Overall Study||315
10083899|NCT02279043|11212375|FG002|STARTED|Overall Study||140
10083900|NCT02279043|11212373|FG000|COMPLETED|Overall Study||128
10083901|NCT02279043|11212374|FG001|COMPLETED|Overall Study||226
10083902|NCT02279043|11212375|FG002|COMPLETED|Overall Study||140
10083903|NCT02279043|11212373|FG000|NOT COMPLETED|Overall Study||47
10083904|NCT02279043|11212374|FG001|NOT COMPLETED|Overall Study||89
10083905|NCT02279043|11212375|FG002|NOT COMPLETED|Overall Study||0
10083906|NCT02279082|11212381|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
10083907|NCT02279082|11212381|FG000|COMPLETED|Overall Study||134
10083908|NCT02279082|11212381|FG000|NOT COMPLETED|Overall Study||33
10083909|NCT02279108|11212387|FG000|STARTED|Overall Study||50
10083910|NCT02279108|11212388|FG001|STARTED|Overall Study||50
10083911|NCT02279108|11212387|FG000|COMPLETED|Overall Study||50
10083912|NCT02279108|11212388|FG001|COMPLETED|Overall Study||49
10083913|NCT02279108|11212387|FG000|NOT COMPLETED|Overall Study||0
10083914|NCT02279108|11212388|FG001|NOT COMPLETED|Overall Study||1
10083915|NCT02279160|11212396|FG000|STARTED|Overall Study||40
10083916|NCT02279160|11212397|FG001|STARTED|Overall Study||21
10083917|NCT02279160|11212396|FG000|COMPLETED|Overall Study||34
10083918|NCT02279160|11212397|FG001|COMPLETED|Overall Study||19
10083919|NCT02279160|11212396|FG000|NOT COMPLETED|Overall Study||6
10083920|NCT02279160|11212397|FG001|NOT COMPLETED|Overall Study||2
10083921|NCT02279407|11212407|FG000|STARTED|Overall Study||22
10083922|NCT02279407|11212408|FG001|STARTED|Overall Study||21
10083923|NCT02279407|11212409|FG002|STARTED|Overall Study||20
10083924|NCT02279407|11212410|FG003|STARTED|Overall Study||21
10083925|NCT02279407|11212407|FG000|COMPLETED|Overall Study||20
10083926|NCT02279407|11212408|FG001|COMPLETED|Overall Study||20
10083927|NCT02279407|11212409|FG002|COMPLETED|Overall Study||15
10083928|NCT02279407|11212410|FG003|COMPLETED|Overall Study||20
10083929|NCT02279407|11212407|FG000|NOT COMPLETED|Overall Study||2
10199795|NCT03424044|11328169|FG007|STARTED|First Intervention (76 Hours)||1
10199796|NCT03424044|11328170|FG008|STARTED|First Intervention (76 Hours)||1
10199797|NCT03424044|11328162|FG000|COMPLETED|First Intervention (76 Hours)||4
10199798|NCT03424044|11328163|FG001|COMPLETED|First Intervention (76 Hours)||3
10199799|NCT03424044|11328164|FG002|COMPLETED|First Intervention (76 Hours)||2
10199800|NCT03424044|11328165|FG003|COMPLETED|First Intervention (76 Hours)||3
10199801|NCT03424044|11328166|FG004|COMPLETED|First Intervention (76 Hours)||2
10199802|NCT03424044|11328167|FG005|COMPLETED|First Intervention (76 Hours)||4
10199803|NCT03424044|11328168|FG006|COMPLETED|First Intervention (76 Hours)||0
10199804|NCT03424044|11328169|FG007|COMPLETED|First Intervention (76 Hours)||0
10199805|NCT03424044|11328170|FG008|COMPLETED|First Intervention (76 Hours)||0
10199806|NCT03424044|11328162|FG000|NOT COMPLETED|First Intervention (76 Hours)||0
10199807|NCT03424044|11328163|FG001|NOT COMPLETED|First Intervention (76 Hours)||0
10199808|NCT03424044|11328164|FG002|NOT COMPLETED|First Intervention (76 Hours)||0
10199809|NCT03424044|11328165|FG003|NOT COMPLETED|First Intervention (76 Hours)||0
10199810|NCT03424044|11328166|FG004|NOT COMPLETED|First Intervention (76 Hours)||1
10083930|NCT02279407|11212408|FG001|NOT COMPLETED|Overall Study||1
10083931|NCT02279407|11212409|FG002|NOT COMPLETED|Overall Study||5
10083932|NCT02279407|11212410|FG003|NOT COMPLETED|Overall Study||1
10199811|NCT03424044|11328167|FG005|NOT COMPLETED|First Intervention (76 Hours)||0
10199812|NCT03424044|11328168|FG006|NOT COMPLETED|First Intervention (76 Hours)||1
10199813|NCT03424044|11328169|FG007|NOT COMPLETED|First Intervention (76 Hours)||1
10199814|NCT03424044|11328170|FG008|NOT COMPLETED|First Intervention (76 Hours)||1
10199815|NCT03424044|11328162|FG000|STARTED|Second Rest Period (7-45 Days)||4
10199816|NCT03424044|11328163|FG001|STARTED|Second Rest Period (7-45 Days)||3
10199817|NCT03424044|11328164|FG002|STARTED|Second Rest Period (7-45 Days)||2
10199818|NCT03424044|11328165|FG003|STARTED|Second Rest Period (7-45 Days)||3
10199819|NCT03424044|11328166|FG004|STARTED|Second Rest Period (7-45 Days)||2
10199820|NCT03424044|11328167|FG005|STARTED|Second Rest Period (7-45 Days)||4
10199821|NCT03424044|11328168|FG006|STARTED|Second Rest Period (7-45 Days)||1
10199822|NCT03424044|11328169|FG007|STARTED|Second Rest Period (7-45 Days)||1
10199823|NCT03424044|11328170|FG008|STARTED|Second Rest Period (7-45 Days)||1
10199824|NCT03424044|11328162|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
10199825|NCT03424044|11328163|FG001|COMPLETED|Second Rest Period (7-45 Days)||3
10199826|NCT03424044|11328164|FG002|COMPLETED|Second Rest Period (7-45 Days)||2
10199827|NCT03424044|11328165|FG003|COMPLETED|Second Rest Period (7-45 Days)||3
10199828|NCT03424044|11328166|FG004|COMPLETED|Second Rest Period (7-45 Days)||2
10199829|NCT03424044|11328167|FG005|COMPLETED|Second Rest Period (7-45 Days)||4
10199830|NCT03424044|11328168|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
10199831|NCT03424044|11328169|FG007|COMPLETED|Second Rest Period (7-45 Days)||1
10199832|NCT03424044|11328170|FG008|COMPLETED|Second Rest Period (7-45 Days)||1
10199833|NCT03424044|11328162|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199834|NCT03424044|11328163|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199835|NCT03424044|11328164|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199836|NCT03424044|11328165|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199837|NCT03424044|11328166|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199838|NCT03424044|11328167|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199839|NCT03424044|11328168|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199840|NCT03424044|11328169|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199841|NCT03424044|11328170|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10199842|NCT03424044|11328162|FG000|STARTED|Second Intervention (76 Hours)||4
10199843|NCT03424044|11328163|FG001|STARTED|Second Intervention (76 Hours)||3
10199844|NCT03424044|11328164|FG002|STARTED|Second Intervention (76 Hours)||2
10199845|NCT03424044|11328165|FG003|STARTED|Second Intervention (76 Hours)||3
10199846|NCT03424044|11328166|FG004|STARTED|Second Intervention (76 Hours)||2
10199847|NCT03424044|11328167|FG005|STARTED|Second Intervention (76 Hours)||4
10199848|NCT03424044|11328168|FG006|STARTED|Second Intervention (76 Hours)||1
10199849|NCT03424044|11328169|FG007|STARTED|Second Intervention (76 Hours)||1
10199850|NCT03424044|11328170|FG008|STARTED|Second Intervention (76 Hours)||1
10083933|NCT02279420|11212420|FG000|STARTED|Overall Study||73
10083934|NCT02279420|11212420|FG000|COMPLETED|Overall Study||50
10083935|NCT02279420|11212420|FG000|NOT COMPLETED|Overall Study||23
10083936|NCT02279498|11212426|FG000|STARTED|Overall Study||65
10083937|NCT02279498|11212427|FG001|STARTED|Overall Study||63
10083938|NCT02279498|11212426|FG000|COMPLETED|Overall Study||47
10083939|NCT02279498|11212427|FG001|COMPLETED|Overall Study||59
10083940|NCT02279498|11212426|FG000|NOT COMPLETED|Overall Study||18
10083941|NCT02279498|11212427|FG001|NOT COMPLETED|Overall Study||4
10083942|NCT02279524|11212437|FG000|STARTED|Overall Study||98
10083943|NCT02279524|11212438|FG001|STARTED|Overall Study||101
10083944|NCT02279524|11212439|FG002|STARTED|Overall Study||48
10083945|NCT02279524|11212437|FG000|COMPLETED|Overall Study||88
10083946|NCT02279524|11212438|FG001|COMPLETED|Overall Study||90
10083947|NCT02279524|11212439|FG002|COMPLETED|Overall Study||41
10083948|NCT02279524|11212437|FG000|NOT COMPLETED|Overall Study||10
10083949|NCT02279524|11212438|FG001|NOT COMPLETED|Overall Study||11
10083950|NCT02279524|11212439|FG002|NOT COMPLETED|Overall Study||7
10083951|NCT02279641|11212449|FG000|STARTED|Overall Study||6
10083952|NCT02279641|11212450|FG001|STARTED|Overall Study||6
10083953|NCT02279641|11212449|FG000|COMPLETED|Overall Study||6
10083954|NCT02279641|11212450|FG001|COMPLETED|Overall Study||6
10083955|NCT02279641|11212449|FG000|NOT COMPLETED|Overall Study||0
10199851|NCT03424044|11328162|FG000|COMPLETED|Second Intervention (76 Hours)||4
10199852|NCT03424044|11328163|FG001|COMPLETED|Second Intervention (76 Hours)||3
10199853|NCT03424044|11328164|FG002|COMPLETED|Second Intervention (76 Hours)||2
10199854|NCT03424044|11328165|FG003|COMPLETED|Second Intervention (76 Hours)||3
10199855|NCT03424044|11328166|FG004|COMPLETED|Second Intervention (76 Hours)||2
10199856|NCT03424044|11328167|FG005|COMPLETED|Second Intervention (76 Hours)||4
10083956|NCT02279641|11212450|FG001|NOT COMPLETED|Overall Study||0
10083957|NCT02279667|11212469|FG000|STARTED|Overall Study||6
10083958|NCT02279667|11212470|FG001|STARTED|Overall Study||6
10083959|NCT02279667|11212471|FG002|STARTED|Overall Study||6
10083960|NCT02279667|11212469|FG000|COMPLETED|Overall Study||6
10083961|NCT02279667|11212470|FG001|COMPLETED|Overall Study||6
10083962|NCT02279667|11212471|FG002|COMPLETED|Overall Study||6
10083963|NCT02279667|11212469|FG000|NOT COMPLETED|Overall Study||0
10083964|NCT02279667|11212470|FG001|NOT COMPLETED|Overall Study||0
10083965|NCT02279667|11212471|FG002|NOT COMPLETED|Overall Study||0
10083966|NCT02279732|11212482|FG000|STARTED|Overall Study||98
10083967|NCT02279732|11212483|FG001|STARTED|Overall Study||106
10083968|NCT02279732|11212482|FG000|COMPLETED|Overall Study||0
10083969|NCT02279732|11212483|FG001|COMPLETED|Overall Study||0
10083970|NCT02279732|11212482|FG000|NOT COMPLETED|Overall Study||98
10083971|NCT02279732|11212483|FG001|NOT COMPLETED|Overall Study||106
10083972|NCT02279862|11212491|FG000|STARTED|Overall Study||26
10083973|NCT02279862|11212492|FG001|STARTED|Overall Study||27
10083974|NCT02279862|11212491|FG000|Treated|Overall Study||25
10083975|NCT02279862|11212492|FG001|Treated|Overall Study||26
10083976|NCT02279862|11212491|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0
10083977|NCT02279862|11212492|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2
10083978|NCT02279862|11212491|FG000|NOT COMPLETED|Overall Study||26
10083979|NCT02279862|11212492|FG001|NOT COMPLETED|Overall Study||25
10083980|NCT02280044|11212500|FG000|STARTED|Overall Study||15
10083981|NCT02280044|11212501|FG001|STARTED|Overall Study||15
10083982|NCT02280044|11212500|FG000|COMPLETED|Overall Study||15
10083983|NCT02280044|11212501|FG001|COMPLETED|Overall Study||13
10083984|NCT02280044|11212500|FG000|NOT COMPLETED|Overall Study||0
10083985|NCT02280044|11212501|FG001|NOT COMPLETED|Overall Study||2
10083986|NCT02280096|11212509|FG000|STARTED|Overall Study||13
10083987|NCT02280096|11212510|FG001|STARTED|Overall Study||11
10083988|NCT02280096|11212509|FG000|COMPLETED|Overall Study||11
10083989|NCT02280096|11212510|FG001|COMPLETED|Overall Study||10
10083990|NCT02280096|11212509|FG000|NOT COMPLETED|Overall Study||2
10083991|NCT02280096|11212510|FG001|NOT COMPLETED|Overall Study||1
10083992|NCT02280122|11212527|FG000|STARTED|Overall Study||15
10083993|NCT02280122|11212528|FG001|STARTED|Overall Study||15
10083994|NCT02280122|11212529|FG002|STARTED|Overall Study||30
10083995|NCT02280122|11212527|FG000|COMPLETED|Overall Study||15
10083996|NCT02280122|11212528|FG001|COMPLETED|Overall Study||15
10083997|NCT02280122|11212529|FG002|COMPLETED|Overall Study||30
10083998|NCT02280122|11212527|FG000|NOT COMPLETED|Overall Study||0
10083999|NCT02280122|11212528|FG001|NOT COMPLETED|Overall Study||0
10084000|NCT02280122|11212529|FG002|NOT COMPLETED|Overall Study||0
10084001|NCT02280187|11212535|FG000|STARTED|Overall Study||400
10084002|NCT02280187|11212535|FG000|COMPLETED|Overall Study||182
10084003|NCT02280187|11212535|FG000|NOT COMPLETED|Overall Study||218
10084004|NCT02280200|11212541|FG000|STARTED|Overall Study||15
10084005|NCT02280200|11212542|FG001|STARTED|Overall Study||13
10084006|NCT02280200|11212541|FG000|COMPLETED|Overall Study||12
10084007|NCT02280200|11212542|FG001|COMPLETED|Overall Study||10
10084008|NCT02280200|11212541|FG000|NOT COMPLETED|Overall Study||3
10084009|NCT02280200|11212542|FG001|NOT COMPLETED|Overall Study||3
10084010|NCT02280226|11212548|FG000|STARTED|Overall Study||17
10084011|NCT02280226|11212548|FG000|COMPLETED|Overall Study||17
10084012|NCT02280226|11212548|FG000|NOT COMPLETED|Overall Study||0
10084013|NCT02280291|11212556|FG000|STARTED|Overall Study||25
10084014|NCT02280291|11212557|FG001|STARTED|Overall Study||25
10084015|NCT02280291|11212558|FG002|STARTED|Overall Study||24
10084016|NCT02280291|11212559|FG003|STARTED|Overall Study||26
10084017|NCT02280291|11212556|FG000|COMPLETED|Overall Study||21
10084018|NCT02280291|11212557|FG001|COMPLETED|Overall Study||23
10084019|NCT02280291|11212558|FG002|COMPLETED|Overall Study||21
10084020|NCT02280291|11212559|FG003|COMPLETED|Overall Study||18
10084021|NCT02280291|11212556|FG000|NOT COMPLETED|Overall Study||4
10084022|NCT02280291|11212557|FG001|NOT COMPLETED|Overall Study||2
10084023|NCT02280291|11212558|FG002|NOT COMPLETED|Overall Study||3
10084024|NCT02280291|11212559|FG003|NOT COMPLETED|Overall Study||8
10084025|NCT02280304|11212573|FG000|STARTED|Overall Study||19
10084026|NCT02280304|11212574|FG001|STARTED|Overall Study||18
10084027|NCT02280304|11212573|FG000|COMPLETED|Overall Study||12
10084028|NCT02280304|11212574|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
10084029|NCT02280304|11212573|FG000|NOT COMPLETED|Overall Study||7
10084030|NCT02280304|11212574|FG001|NOT COMPLETED|Overall Study||8
10084031|NCT02280317|11212592|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1
10084032|NCT02280317|11212593|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1
10084033|NCT02280317|11212594|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3
10084034|NCT02280317|11212595|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5
10084035|NCT02280317|11212596|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2
10199857|NCT03424044|11328168|FG006|COMPLETED|Second Intervention (76 Hours)||1
10084036|NCT02280317|11212592|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1
10199858|NCT03424044|11328169|FG007|COMPLETED|Second Intervention (76 Hours)||1
10199859|NCT03424044|11328170|FG008|COMPLETED|Second Intervention (76 Hours)||1
10084037|NCT02280317|11212593|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1
10084038|NCT02280317|11212594|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0
10084039|NCT02280317|11212595|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2
10084040|NCT02280317|11212596|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0
10084041|NCT02280317|11212592|FG000|NOT COMPLETED|Overall Study||0
10084042|NCT02280317|11212593|FG001|NOT COMPLETED|Overall Study||0
10084043|NCT02280317|11212594|FG002|NOT COMPLETED|Overall Study||3
10084044|NCT02280317|11212595|FG003|NOT COMPLETED|Overall Study||3
10084045|NCT02280317|11212596|FG004|NOT COMPLETED|Overall Study||2
10084046|NCT02280408|11212623|FG000|STARTED|Overall Study||10
10084047|NCT02280408|11212624|FG001|STARTED|Overall Study||10
10084048|NCT02280408|11212625|FG002|STARTED|Overall Study||10
10084049|NCT02280408|11212626|FG003|STARTED|Overall Study||9
10084050|NCT02280408|11212623|FG000|Vaccination 1|Overall Study||10
10084051|NCT02280408|11212624|FG001|Vaccination 1|Overall Study||10
10084052|NCT02280408|11212625|FG002|Vaccination 1|Overall Study||10
10084053|NCT02280408|11212626|FG003|Vaccination 1|Overall Study||9
10084054|NCT02280408|11212623|FG000|Vaccination 2|Overall Study||10
10084055|NCT02280408|11212624|FG001|Vaccination 2|Overall Study||10
10084056|NCT02280408|11212625|FG002|Vaccination 2|Overall Study||10
10084057|NCT02280408|11212626|FG003|Vaccination 2|Overall Study||9
10084058|NCT02280408|11212623|FG000|COMPLETED|Overall Study||10
10084059|NCT02280408|11212624|FG001|COMPLETED|Overall Study||8
10084060|NCT02280408|11212625|FG002|COMPLETED|Overall Study||10
10084061|NCT02280408|11212626|FG003|COMPLETED|Overall Study||9
10084062|NCT02280408|11212623|FG000|NOT COMPLETED|Overall Study||0
10084063|NCT02280408|11212624|FG001|NOT COMPLETED|Overall Study||2
10084064|NCT02280408|11212625|FG002|NOT COMPLETED|Overall Study||0
10084065|NCT02280408|11212626|FG003|NOT COMPLETED|Overall Study||0
10084066|NCT02280421|11212638|FG000|STARTED|First Intervention(2 Weeks)||12
10084067|NCT02280421|11212639|FG001|STARTED|First Intervention(2 Weeks)||12
10084068|NCT02280421|11212638|FG000|Received Intervention|First Intervention(2 Weeks)||12
10084069|NCT02280421|11212639|FG001|Received Intervention|First Intervention(2 Weeks)||12
10084070|NCT02280421|11212638|FG000|COMPLETED|First Intervention(2 Weeks)||12
10084071|NCT02280421|11212639|FG001|COMPLETED|First Intervention(2 Weeks)||12
10084072|NCT02280421|11212638|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0
10084073|NCT02280421|11212639|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0
10084074|NCT02280421|11212638|FG000|STARTED|Washout (2 Weeks)||12
10084075|NCT02280421|11212639|FG001|STARTED|Washout (2 Weeks)||12
10084076|NCT02280421|11212638|FG000|COMPLETED|Washout (2 Weeks)||11
10084077|NCT02280421|11212639|FG001|COMPLETED|Washout (2 Weeks)||11
10084078|NCT02280421|11212638|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10084079|NCT02280421|11212639|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10084080|NCT02280421|11212638|FG000|STARTED|Second Intervention(2 Weeks)||12
10084081|NCT02280421|11212639|FG001|STARTED|Second Intervention(2 Weeks)||12
10084082|NCT02280421|11212638|FG000|Received Intervention|Second Intervention(2 Weeks)||12
10084083|NCT02280421|11212639|FG001|Received Intervention|Second Intervention(2 Weeks)||12
10084084|NCT02280421|11212638|FG000|COMPLETED|Second Intervention(2 Weeks)||12
10084085|NCT02280421|11212639|FG001|COMPLETED|Second Intervention(2 Weeks)||12
10084086|NCT02280421|11212638|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0
10084087|NCT02280421|11212639|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0
10084088|NCT02280473|11212659|FG000|STARTED|Overall Study||94
10084089|NCT02280473|11212660|FG001|STARTED|Overall Study||94
10084090|NCT02280473|11212659|FG000|COMPLETED|Overall Study||93
10084091|NCT02280473|11212660|FG001|COMPLETED|Overall Study||91
10084092|NCT02280473|11212659|FG000|NOT COMPLETED|Overall Study||1
10084093|NCT02280473|11212660|FG001|NOT COMPLETED|Overall Study||3
10084094|NCT02280499|11212666|FG000|STARTED|Overall Study||87
10084095|NCT02280499|11212666|FG000|COMPLETED|Overall Study||26
10084096|NCT02280499|11212666|FG000|NOT COMPLETED|Overall Study||61
10084097|NCT02280655|11212672|FG000|STARTED|Overall Study||25
10084098|NCT02280655|11212673|FG001|STARTED|Overall Study||18
10084099|NCT02280655|11212672|FG000|COMPLETED|Overall Study||25
10084100|NCT02280655|11212673|FG001|COMPLETED|Overall Study||18
10084101|NCT02280655|11212672|FG000|NOT COMPLETED|Overall Study||0
10084102|NCT02280655|11212673|FG001|NOT COMPLETED|Overall Study||0
10084103|NCT02280811|11212684|FG000|STARTED|Drug Administration||1
10084104|NCT02280811|11212685|FG001|STARTED|Drug Administration||2
10084105|NCT02280811|11212686|FG002|STARTED|Drug Administration||1
10084106|NCT02280811|11212687|FG003|STARTED|Drug Administration||6
10084107|NCT02280811|11212688|FG004|STARTED|Drug Administration||2
10084108|NCT02280811|11212684|FG000|COMPLETED|Drug Administration||1
10084109|NCT02280811|11212685|FG001|COMPLETED|Drug Administration||2
10084110|NCT02280811|11212686|FG002|COMPLETED|Drug Administration||1
10084111|NCT02280811|11212687|FG003|COMPLETED|Drug Administration||6
10084112|NCT02280811|11212688|FG004|COMPLETED|Drug Administration||2
10084113|NCT02280811|11212684|FG000|NOT COMPLETED|Drug Administration||0
10084114|NCT02280811|11212685|FG001|NOT COMPLETED|Drug Administration||0
10084115|NCT02280811|11212686|FG002|NOT COMPLETED|Drug Administration||0
10084116|NCT02280811|11212687|FG003|NOT COMPLETED|Drug Administration||0
10084117|NCT02280811|11212688|FG004|NOT COMPLETED|Drug Administration||0
10084118|NCT02280811|11212684|FG000|STARTED|Retreated at the MTD||0
10084119|NCT02280811|11212685|FG001|STARTED|Retreated at the MTD||0
10084120|NCT02280811|11212686|FG002|STARTED|Retreated at the MTD||0
10084121|NCT02280811|11212687|FG003|STARTED|Retreated at the MTD||0
10084122|NCT02280811|11212688|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
10084123|NCT02280811|11212684|FG000|COMPLETED|Retreated at the MTD||0
10084124|NCT02280811|11212685|FG001|COMPLETED|Retreated at the MTD||0
10199860|NCT03424044|11328162|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0
10199861|NCT03424044|11328163|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0
10199862|NCT03424044|11328164|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0
10199863|NCT03424044|11328165|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0
10199864|NCT03424044|11328166|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0
10199865|NCT03424044|11328167|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0
10199866|NCT03424044|11328168|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0
10199867|NCT03424044|11328169|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0
10199868|NCT03424044|11328170|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0
10084125|NCT02280811|11212686|FG002|COMPLETED|Retreated at the MTD||0
10084126|NCT02280811|11212687|FG003|COMPLETED|Retreated at the MTD||0
10084127|NCT02280811|11212688|FG004|COMPLETED|Retreated at the MTD||1
10084128|NCT02280811|11212684|FG000|NOT COMPLETED|Retreated at the MTD||0
10084129|NCT02280811|11212685|FG001|NOT COMPLETED|Retreated at the MTD||0
10084130|NCT02280811|11212686|FG002|NOT COMPLETED|Retreated at the MTD||0
10084131|NCT02280811|11212687|FG003|NOT COMPLETED|Retreated at the MTD||0
10084132|NCT02280811|11212688|FG004|NOT COMPLETED|Retreated at the MTD||0
10084133|NCT02280863|11212704|FG000|STARTED|Android Platform||8
10084134|NCT02280863|11212705|FG001|STARTED|Android Platform||0
10084135|NCT02280863|11212704|FG000|COMPLETED|Android Platform||8
10084136|NCT02280863|11212705|FG001|COMPLETED|Android Platform||0
10084137|NCT02280863|11212704|FG000|NOT COMPLETED|Android Platform||0
10084138|NCT02280863|11212705|FG001|NOT COMPLETED|Android Platform||0
10084139|NCT02280863|11212704|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
10084140|NCT02280863|11212705|FG001|STARTED|Integrated Platform||15
10084141|NCT02280863|11212704|FG000|COMPLETED|Integrated Platform||9
10084142|NCT02280863|11212705|FG001|COMPLETED|Integrated Platform||14
10084143|NCT02280863|11212704|FG000|NOT COMPLETED|Integrated Platform||0
10084144|NCT02280863|11212705|FG001|NOT COMPLETED|Integrated Platform||1
10084145|NCT02281136|11212715|FG000|STARTED|Overall Study||29
10084146|NCT02281136|11212715|FG000|COMPLETED|Overall Study||29
10084147|NCT02281136|11212715|FG000|NOT COMPLETED|Overall Study||0
10084148|NCT02281318|11212721|FG000|STARTED|Overall Study||277
10084149|NCT02281318|11212722|FG001|STARTED|Overall Study||274
10084150|NCT02281318|11212721|FG000|COMPLETED|Overall Study||263
10084151|NCT02281318|11212722|FG001|COMPLETED|Overall Study||269
10084152|NCT02281318|11212721|FG000|NOT COMPLETED|Overall Study||14
10084153|NCT02281318|11212722|FG001|NOT COMPLETED|Overall Study||5
10084154|NCT02281344|11212728|FG000|STARTED|Overall Study||6
10084155|NCT02281344|11212728|FG000|COMPLETED|Overall Study||6
10084156|NCT02281344|11212728|FG000|NOT COMPLETED|Overall Study||0
10084157|NCT02281357|11212734|FG000|STARTED|Overall Study||70
10084158|NCT02281357|11212735|FG001|STARTED|Overall Study||70
10084159|NCT02281357|11212734|FG000|COMPLETED|Overall Study||63
10084160|NCT02281357|11212735|FG001|COMPLETED|Overall Study||66
10084161|NCT02281357|11212734|FG000|NOT COMPLETED|Overall Study||7
10084162|NCT02281357|11212735|FG001|NOT COMPLETED|Overall Study||4
10084163|NCT02281409|11212745|FG000|STARTED|Overall Study||3
10084164|NCT02281409|11212746|FG001|STARTED|Overall Study||3
10084165|NCT02281409|11212747|FG002|STARTED|Overall Study||5
10084166|NCT02281409|11212748|FG003|STARTED|Overall Study||6
10084167|NCT02281409|11212745|FG000|COMPLETED|Overall Study||3
10084168|NCT02281409|11212746|FG001|COMPLETED|Overall Study||3
10084169|NCT02281409|11212747|FG002|COMPLETED|Overall Study||5
10084170|NCT02281409|11212748|FG003|COMPLETED|Overall Study||6
10084171|NCT02281409|11212745|FG000|NOT COMPLETED|Overall Study||0
10084172|NCT02281409|11212746|FG001|NOT COMPLETED|Overall Study||0
10084173|NCT02281409|11212747|FG002|NOT COMPLETED|Overall Study||0
10084174|NCT02281409|11212748|FG003|NOT COMPLETED|Overall Study||0
10084175|NCT02281422|11212764|FG000|STARTED|Overall Study||8
10084176|NCT02281422|11212765|FG001|STARTED|Overall Study||8
10084177|NCT02281422|11212766|FG002|STARTED|Overall Study||8
10084178|NCT02281422|11212767|FG003|STARTED|Overall Study||8
10084179|NCT02281422|11212768|FG004|STARTED|Overall Study||8
10084180|NCT02281422|11212764|FG000|COMPLETED|Overall Study||8
10084181|NCT02281422|11212765|FG001|COMPLETED|Overall Study||8
10084182|NCT02281422|11212766|FG002|COMPLETED|Overall Study||8
10084183|NCT02281422|11212767|FG003|COMPLETED|Overall Study||8
10084184|NCT02281422|11212768|FG004|COMPLETED|Overall Study||8
10084185|NCT02281422|11212764|FG000|NOT COMPLETED|Overall Study||0
10084186|NCT02281422|11212765|FG001|NOT COMPLETED|Overall Study||0
10084187|NCT02281422|11212766|FG002|NOT COMPLETED|Overall Study||0
10084188|NCT02281422|11212767|FG003|NOT COMPLETED|Overall Study||0
10084189|NCT02281422|11212768|FG004|NOT COMPLETED|Overall Study||0
10084190|NCT02281448|11212782|FG000|STARTED|Overall Study||10
10084191|NCT02281448|11212783|FG001|STARTED|Overall Study||10
10084192|NCT02281448|11212782|FG000|COMPLETED|Overall Study||8
10084193|NCT02281448|11212783|FG001|COMPLETED|Overall Study||9
10084194|NCT02281448|11212782|FG000|NOT COMPLETED|Overall Study||2
10084195|NCT02281448|11212783|FG001|NOT COMPLETED|Overall Study||1
10084196|NCT02281526|11212791|FG000|STARTED|Overall Study||9
10084197|NCT02281526|11212792|FG001|STARTED|Overall Study||8
10084198|NCT02281526|11212791|FG000|COMPLETED|Overall Study||8
10084199|NCT02281526|11212792|FG001|COMPLETED|Overall Study||8
10199869|NCT03424044|11328162|FG000|STARTED|Third Rest Period (7-45 Days)||4
10199870|NCT03424044|11328163|FG001|STARTED|Third Rest Period (7-45 Days)||3
10199871|NCT03424044|11328164|FG002|STARTED|Third Rest Period (7-45 Days)||2
10199872|NCT03424044|11328165|FG003|STARTED|Third Rest Period (7-45 Days)||3
10199873|NCT03424044|11328166|FG004|STARTED|Third Rest Period (7-45 Days)||2
10199874|NCT03424044|11328167|FG005|STARTED|Third Rest Period (7-45 Days)||4
10199875|NCT03424044|11328168|FG006|STARTED|Third Rest Period (7-45 Days)||1
10199876|NCT03424044|11328169|FG007|STARTED|Third Rest Period (7-45 Days)||1
10199877|NCT03424044|11328170|FG008|STARTED|Third Rest Period (7-45 Days)||1
10199878|NCT03424044|11328162|FG000|COMPLETED|Third Rest Period (7-45 Days)||4
10199879|NCT03424044|11328163|FG001|COMPLETED|Third Rest Period (7-45 Days)||3
10199880|NCT03424044|11328164|FG002|COMPLETED|Third Rest Period (7-45 Days)||2
10199881|NCT03424044|11328165|FG003|COMPLETED|Third Rest Period (7-45 Days)||3
10199882|NCT03424044|11328166|FG004|COMPLETED|Third Rest Period (7-45 Days)||2
10199883|NCT03424044|11328167|FG005|COMPLETED|Third Rest Period (7-45 Days)||4
10199884|NCT03424044|11328168|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
10199885|NCT03424044|11328169|FG007|COMPLETED|Third Rest Period (7-45 Days)||1
10199886|NCT03424044|11328170|FG008|COMPLETED|Third Rest Period (7-45 Days)||1
10199887|NCT03424044|11328162|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199888|NCT03424044|11328163|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199889|NCT03424044|11328164|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199890|NCT03424044|11328165|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199891|NCT03424044|11328166|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199892|NCT03424044|11328167|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199893|NCT03424044|11328168|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199894|NCT03424044|11328169|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199895|NCT03424044|11328170|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10199896|NCT03424044|11328162|FG000|STARTED|Third Intervention (76 Hours)||4
10199897|NCT03424044|11328163|FG001|STARTED|Third Intervention (76 Hours)||3
10199898|NCT03424044|11328164|FG002|STARTED|Third Intervention (76 Hours)||2
10199899|NCT03424044|11328165|FG003|STARTED|Third Intervention (76 Hours)||3
10199900|NCT03424044|11328166|FG004|STARTED|Third Intervention (76 Hours)||2
10199901|NCT03424044|11328167|FG005|STARTED|Third Intervention (76 Hours)||4
10199902|NCT03424044|11328168|FG006|STARTED|Third Intervention (76 Hours)||1
10199903|NCT03424044|11328169|FG007|STARTED|Third Intervention (76 Hours)||1
10199904|NCT03424044|11328170|FG008|STARTED|Third Intervention (76 Hours)||1
10199905|NCT03424044|11328162|FG000|COMPLETED|Third Intervention (76 Hours)||3
10199906|NCT03424044|11328163|FG001|COMPLETED|Third Intervention (76 Hours)||3
10199907|NCT03424044|11328164|FG002|COMPLETED|Third Intervention (76 Hours)||2
10199908|NCT03424044|11328165|FG003|COMPLETED|Third Intervention (76 Hours)||2
10199909|NCT03424044|11328166|FG004|COMPLETED|Third Intervention (76 Hours)||2
10199910|NCT03424044|11328167|FG005|COMPLETED|Third Intervention (76 Hours)||4
10199911|NCT03424044|11328168|FG006|COMPLETED|Third Intervention (76 Hours)||0
10199912|NCT03424044|11328169|FG007|COMPLETED|Third Intervention (76 Hours)||1
10199913|NCT03424044|11328170|FG008|COMPLETED|Third Intervention (76 Hours)||1
10199914|NCT03424044|11328162|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1
10199915|NCT03424044|11328163|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0
10199916|NCT03424044|11328164|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0
10199917|NCT03424044|11328165|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1
10199918|NCT03424044|11328166|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0
10199919|NCT03424044|11328167|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0
10199920|NCT03424044|11328168|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1
10199921|NCT03424044|11328169|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0
10199922|NCT03424044|11328170|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0
10199923|NCT03424044|11328162|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10199924|NCT03424044|11328163|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10199925|NCT03424044|11328164|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10199926|NCT03424044|11328165|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0
9852135|NCT00879710|10964924|FG000|NOT COMPLETED|Phase 2 6 Weeks||0
9852136|NCT00879710|10964925|FG001|NOT COMPLETED|Phase 2 6 Weeks||0
9852137|NCT00879710|10964926|FG002|NOT COMPLETED|Phase 2 6 Weeks||0
9852138|NCT00879710|10964927|FG003|NOT COMPLETED|Phase 2 6 Weeks||0
9852139|NCT00879775|10964937|FG000|STARTED|Overall Study||20
9852140|NCT00879775|10964938|FG001|STARTED|Overall Study||21
9852141|NCT00879775|10964937|FG000|COMPLETED|Overall Study||18
9852142|NCT00879775|10964938|FG001|COMPLETED|Overall Study||20
9852143|NCT00879775|10964937|FG000|NOT COMPLETED|Overall Study||2
9852144|NCT00879775|10964938|FG001|NOT COMPLETED|Overall Study||1
9852145|NCT00879814|10964948|FG000|STARTED|Overall Study||12
9852146|NCT00879814|10964949|FG001|STARTED|Overall Study||12
9852147|NCT00879814|10964950|FG002|STARTED|Overall Study||12
9852148|NCT00879814|10964951|FG003|STARTED|Overall Study||12
9852149|NCT00879814|10964948|FG000|COMPLETED|Overall Study||8
9852150|NCT00879814|10964949|FG001|COMPLETED|Overall Study||10
9852151|NCT00879814|10964950|FG002|COMPLETED|Overall Study||9
9852152|NCT00879814|10964951|FG003|COMPLETED|Overall Study||7
9852153|NCT00879814|10964948|FG000|NOT COMPLETED|Overall Study||4
9852154|NCT00879814|10964949|FG001|NOT COMPLETED|Overall Study||2
9852155|NCT00879814|10964950|FG002|NOT COMPLETED|Overall Study||3
9852156|NCT00879814|10964951|FG003|NOT COMPLETED|Overall Study||5
9852157|NCT00879879|10964961|FG000|STARTED|Overall Study||20
9852158|NCT00879879|10964961|FG000|COMPLETED|Overall Study||17
10199927|NCT03424044|11328166|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10199928|NCT03424044|11328167|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10199929|NCT03424044|11328168|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10199930|NCT03424044|11328169|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1
10199931|NCT03424044|11328170|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1
10199932|NCT03424044|11328162|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199933|NCT03424044|11328163|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199934|NCT03424044|11328164|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199935|NCT03424044|11328165|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199936|NCT03424044|11328166|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199937|NCT03424044|11328167|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199938|NCT03424044|11328168|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199939|NCT03424044|11328169|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
10199940|NCT03424044|11328170|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
10199941|NCT03424044|11328162|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199942|NCT03424044|11328163|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199943|NCT03424044|11328164|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199944|NCT03424044|11328165|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199945|NCT03424044|11328166|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199946|NCT03424044|11328167|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199947|NCT03424044|11328168|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199948|NCT03424044|11328169|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199949|NCT03424044|11328170|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10199950|NCT03424044|11328162|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10199951|NCT03424044|11328163|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10199952|NCT03424044|11328164|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10199953|NCT03424044|11328165|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10199954|NCT03424044|11328166|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10199955|NCT03424044|11328167|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10199956|NCT03424044|11328168|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10199957|NCT03424044|11328169|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
10199958|NCT03424044|11328170|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
10199959|NCT03424044|11328162|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199960|NCT03424044|11328163|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199961|NCT03424044|11328164|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199962|NCT03424044|11328165|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199963|NCT03424044|11328166|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199964|NCT03424044|11328167|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199965|NCT03424044|11328168|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199966|NCT03424044|11328169|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
10199967|NCT03424044|11328170|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
10199968|NCT03424044|11328162|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199969|NCT03424044|11328163|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199970|NCT03424044|11328164|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10084200|NCT02281526|11212791|FG000|NOT COMPLETED|Overall Study||1
10084201|NCT02281526|11212792|FG001|NOT COMPLETED|Overall Study||0
10084202|NCT02281552|11212800|FG000|STARTED|Overall Study||104
10084203|NCT02281552|11212801|FG001|STARTED|Overall Study||105
10084204|NCT02281552|11212800|FG000|COMPLETED|Overall Study||100
10084205|NCT02281552|11212801|FG001|COMPLETED|Overall Study||95
10084206|NCT02281552|11212800|FG000|NOT COMPLETED|Overall Study||4
10084207|NCT02281552|11212801|FG001|NOT COMPLETED|Overall Study||10
10084208|NCT02281591|11212811|FG000|STARTED|Overall Study||8
10084209|NCT02281591|11212812|FG001|STARTED|Overall Study||8
10084210|NCT02281591|11212813|FG002|STARTED|Overall Study||8
10084211|NCT02281591|11212814|FG003|STARTED|Overall Study||8
10084212|NCT02281591|11212811|FG000|COMPLETED|Overall Study||8
10084213|NCT02281591|11212812|FG001|COMPLETED|Overall Study||8
10084214|NCT02281591|11212813|FG002|COMPLETED|Overall Study||8
10084215|NCT02281591|11212814|FG003|COMPLETED|Overall Study||8
10084216|NCT02281591|11212811|FG000|NOT COMPLETED|Overall Study||0
10084217|NCT02281591|11212812|FG001|NOT COMPLETED|Overall Study||0
10084218|NCT02281591|11212813|FG002|NOT COMPLETED|Overall Study||0
10084219|NCT02281591|11212814|FG003|NOT COMPLETED|Overall Study||0
10084220|NCT02281760|11212824|FG000|STARTED|Overall Study||6
10084221|NCT02281760|11212824|FG000|COMPLETED|Overall Study||5
10084222|NCT02281760|11212824|FG000|NOT COMPLETED|Overall Study||1
10084223|NCT02281773|11212833|FG000|STARTED|Overall Study||87
10084224|NCT02281773|11212834|FG001|STARTED|Overall Study|Started are the treated patients|85
10084225|NCT02281773|11212835|FG002|STARTED|Overall Study||85
10084226|NCT02281773|11212836|FG003|STARTED|Overall Study||86
10084227|NCT02281773|11212837|FG004|STARTED|Overall Study|Started are the treated patients|173
10084228|NCT02281773|11212833|FG000|COMPLETED|Overall Study||76
10084229|NCT02281773|11212834|FG001|COMPLETED|Overall Study||70
10084230|NCT02281773|11212835|FG002|COMPLETED|Overall Study||67
10084231|NCT02281773|11212836|FG003|COMPLETED|Overall Study||65
10084232|NCT02281773|11212837|FG004|COMPLETED|Overall Study||143
10084233|NCT02281773|11212833|FG000|NOT COMPLETED|Overall Study||11
10199971|NCT03424044|11328165|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199972|NCT03424044|11328166|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199973|NCT03424044|11328167|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199974|NCT03424044|11328168|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199975|NCT03424044|11328169|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199976|NCT03424044|11328170|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10199977|NCT03424187|11328186|FG000|STARTED|Overall Study||2
10199978|NCT03424187|11328187|FG001|STARTED|Overall Study||3
10199979|NCT03424187|11328188|FG002|STARTED|Overall Study||2
10199980|NCT03424187|11328189|FG003|STARTED|Overall Study||3
10199981|NCT03424187|11328190|FG004|STARTED|Overall Study||2
10199982|NCT03424187|11328191|FG005|STARTED|Overall Study||3
10199983|NCT03424187|11328186|FG000|COMPLETED|Overall Study||2
10199984|NCT03424187|11328187|FG001|COMPLETED|Overall Study||3
10199985|NCT03424187|11328188|FG002|COMPLETED|Overall Study||2
10199986|NCT03424187|11328189|FG003|COMPLETED|Overall Study||3
10199987|NCT03424187|11328190|FG004|COMPLETED|Overall Study||2
10199988|NCT03424187|11328191|FG005|COMPLETED|Overall Study||3
10199989|NCT03424187|11328186|FG000|NOT COMPLETED|Overall Study||0
10199990|NCT03424187|11328187|FG001|NOT COMPLETED|Overall Study||0
10199991|NCT03424187|11328188|FG002|NOT COMPLETED|Overall Study||0
10199992|NCT03424187|11328189|FG003|NOT COMPLETED|Overall Study||0
10199993|NCT03424187|11328190|FG004|NOT COMPLETED|Overall Study||0
10199994|NCT03424187|11328191|FG005|NOT COMPLETED|Overall Study||0
10199995|NCT03424239|11328204|FG000|STARTED|Overall Study||6
10199996|NCT03424239|11328204|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4
10199997|NCT03424239|11328204|FG000|2 Week Post-op|Overall Study||4
10199998|NCT03424239|11328204|FG000|12 Week Post-op|Overall Study||4
10199999|NCT03424239|11328204|FG000|24 Week Post-op|Overall Study||4
10200000|NCT03424239|11328204|FG000|COMPLETED|Overall Study||4
10200001|NCT03424239|11328204|FG000|NOT COMPLETED|Overall Study||2
10200002|NCT03424265|11328210|FG000|STARTED|Overall Study||29
10200003|NCT03424265|11328211|FG001|STARTED|Overall Study||34
10200004|NCT03424265|11328210|FG000|COMPLETED|Overall Study||28
10200005|NCT03424265|11328211|FG001|COMPLETED|Overall Study||32
10200006|NCT03424265|11328210|FG000|NOT COMPLETED|Overall Study||1
10200007|NCT03424265|11328211|FG001|NOT COMPLETED|Overall Study||2
10200008|NCT03424681|11328219|FG000|STARTED|Overall Study||6
10200009|NCT03424681|11328220|FG001|STARTED|Overall Study||6
10200010|NCT03424681|11328219|FG000|COMPLETED|Overall Study||6
10200011|NCT03424681|11328220|FG001|COMPLETED|Overall Study||5
10200012|NCT03424681|11328219|FG000|NOT COMPLETED|Overall Study||0
10200013|NCT03424681|11328220|FG001|NOT COMPLETED|Overall Study||1
10200014|NCT03425019|11328226|FG000|STARTED|Overall Study||20
10200015|NCT03425019|11328226|FG000|COMPLETED|Overall Study||20
10200016|NCT03425019|11328226|FG000|NOT COMPLETED|Overall Study||0
10200017|NCT03425097|11328231|FG000|STARTED|Treatment Period 1 (2 Weeks)||6
10200018|NCT03425097|11328232|FG001|STARTED|Treatment Period 1 (2 Weeks)||5
10200019|NCT03425097|11328231|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6
10200020|NCT03425097|11328232|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5
10200021|NCT03425097|11328231|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10200022|NCT03425097|11328232|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10200023|NCT03425097|11328231|FG000|STARTED|Washout Period (1 Week)||6
10200024|NCT03425097|11328232|FG001|STARTED|Washout Period (1 Week)||5
10200025|NCT03425097|11328231|FG000|COMPLETED|Washout Period (1 Week)||6
10200026|NCT03425097|11328232|FG001|COMPLETED|Washout Period (1 Week)||5
10200027|NCT03425097|11328231|FG000|NOT COMPLETED|Washout Period (1 Week)||0
10200028|NCT03425097|11328232|FG001|NOT COMPLETED|Washout Period (1 Week)||0
10200029|NCT03425097|11328231|FG000|STARTED|Second Treatment Period (2 Weeks)||6
10200030|NCT03425097|11328232|FG001|STARTED|Second Treatment Period (2 Weeks)||5
10200031|NCT03425097|11328231|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6
10200032|NCT03425097|11328232|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5
10200033|NCT03425097|11328231|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
10200034|NCT03425097|11328232|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
10200035|NCT03425188|11328241|FG000|STARTED|Overall Study||53
10200036|NCT03425188|11328241|FG000|COMPLETED|Overall Study||52
10200037|NCT03425188|11328241|FG000|NOT COMPLETED|Overall Study||1
10200038|NCT03425253|11328246|FG000|STARTED|Overall Study||58
10200039|NCT03425253|11328246|FG000|Safety Analysis Set|Overall Study||53
10200040|NCT03425253|11328246|FG000|FAS|Overall Study||53
10200041|NCT03425253|11328246|FG000|Evaluable Set (ES)|Overall Study||42
10200042|NCT03425253|11328246|FG000|COMPLETED|Overall Study||42
10200043|NCT03425253|11328246|FG000|NOT COMPLETED|Overall Study||16
10200044|NCT03425396|11328256|FG000|STARTED|Overall Study||55
10200045|NCT03425396|11328257|FG001|STARTED|Overall Study||54
10200046|NCT03425396|11328258|FG002|STARTED|Overall Study||54
10200047|NCT03425396|11328259|FG003|STARTED|Overall Study||8
10200048|NCT03425396|11328260|FG004|STARTED|Overall Study||54
10200049|NCT03425396|11328256|FG000|Completed End of Treatment Visit|Overall Study||53
10200050|NCT03425396|11328257|FG001|Completed End of Treatment Visit|Overall Study||52
10200051|NCT03425396|11328258|FG002|Completed End of Treatment Visit|Overall Study||51
10200052|NCT03425396|11328259|FG003|Completed End of Treatment Visit|Overall Study||7
10200053|NCT03425396|11328260|FG004|Completed End of Treatment Visit|Overall Study||53
10200054|NCT03425396|11328256|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53
10200055|NCT03425396|11328257|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49
10200056|NCT03425396|11328258|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51
10200057|NCT03425396|11328259|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7
10200058|NCT03425396|11328260|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54
10200059|NCT03425396|11328256|FG000|Completed Final Follow-up Visit|Overall Study||53
10200060|NCT03425396|11328257|FG001|Completed Final Follow-up Visit|Overall Study||47
10200061|NCT03425396|11328258|FG002|Completed Final Follow-up Visit|Overall Study||51
10200062|NCT03425396|11328259|FG003|Completed Final Follow-up Visit|Overall Study||7
10200063|NCT03425396|11328260|FG004|Completed Final Follow-up Visit|Overall Study||53
10200064|NCT03425396|11328256|FG000|COMPLETED|Overall Study||53
10200065|NCT03425396|11328257|FG001|COMPLETED|Overall Study||47
10200066|NCT03425396|11328258|FG002|COMPLETED|Overall Study||51
10200067|NCT03425396|11328259|FG003|COMPLETED|Overall Study||7
10200068|NCT03425396|11328260|FG004|COMPLETED|Overall Study||53
10200069|NCT03425396|11328256|FG000|NOT COMPLETED|Overall Study||2
10200070|NCT03425396|11328257|FG001|NOT COMPLETED|Overall Study||7
10200071|NCT03425396|11328258|FG002|NOT COMPLETED|Overall Study||3
10200072|NCT03425396|11328259|FG003|NOT COMPLETED|Overall Study||1
10200073|NCT03425396|11328260|FG004|NOT COMPLETED|Overall Study||1
10084234|NCT02281773|11212834|FG001|NOT COMPLETED|Overall Study||15
10084235|NCT02281773|11212835|FG002|NOT COMPLETED|Overall Study||18
10200074|NCT03426228|11328274|FG000|STARTED|Overall Study||158
10200075|NCT03426228|11328275|FG001|STARTED|Overall Study||191
10200076|NCT03426228|11328274|FG000|COMPLETED|Overall Study||117
10200077|NCT03426228|11328275|FG001|COMPLETED|Overall Study||158
10200078|NCT03426228|11328274|FG000|NOT COMPLETED|Overall Study||41
10084236|NCT02281773|11212836|FG003|NOT COMPLETED|Overall Study||21
10084237|NCT02281773|11212837|FG004|NOT COMPLETED|Overall Study||30
10084238|NCT02281851|11212851|FG000|STARTED|Overall Study||4
10084239|NCT02281851|11212852|FG001|STARTED|Overall Study||10
10084240|NCT02281851|11212851|FG000|COMPLETED|Overall Study||4
10084241|NCT02281851|11212852|FG001|COMPLETED|Overall Study||10
10084242|NCT02281851|11212851|FG000|NOT COMPLETED|Overall Study||0
10084243|NCT02281851|11212852|FG001|NOT COMPLETED|Overall Study||0
10084244|NCT02282111|11212860|FG000|STARTED|Overall Study||26
10084245|NCT02282111|11212861|FG001|STARTED|Overall Study||30
10084246|NCT02282111|11212860|FG000|COMPLETED|Overall Study||19
10084247|NCT02282111|11212861|FG001|COMPLETED|Overall Study||22
10084248|NCT02282111|11212860|FG000|NOT COMPLETED|Overall Study||7
10084249|NCT02282111|11212861|FG001|NOT COMPLETED|Overall Study||8
10084250|NCT02282163|11212867|FG000|STARTED|Overall Study||13
10084251|NCT02282163|11212867|FG000|COMPLETED|Overall Study||12
10084252|NCT02282163|11212867|FG000|NOT COMPLETED|Overall Study||1
10112714|NCT02504671|11243641|FG003|COMPLETED|Overall Study||27
10112715|NCT02504671|11243642|FG004|COMPLETED|Overall Study||25
10112716|NCT02504671|11243643|FG005|COMPLETED|Overall Study||23
10112717|NCT02504671|11243638|FG000|NOT COMPLETED|Overall Study||12
10112718|NCT02504671|11243639|FG001|NOT COMPLETED|Overall Study||14
10112719|NCT02504671|11243640|FG002|NOT COMPLETED|Overall Study||10
10112720|NCT02504671|11243641|FG003|NOT COMPLETED|Overall Study||10
10112721|NCT02504671|11243642|FG004|NOT COMPLETED|Overall Study||12
10112722|NCT02504671|11243643|FG005|NOT COMPLETED|Overall Study||14
10112723|NCT02504723|11243659|FG000|STARTED|Overall Study||60
10112724|NCT02504723|11243660|FG001|STARTED|Overall Study||61
10112725|NCT02504723|11243659|FG000|COMPLETED|Overall Study||60
10112726|NCT02504723|11243660|FG001|COMPLETED|Overall Study||61
10112727|NCT02504723|11243659|FG000|NOT COMPLETED|Overall Study||0
10112728|NCT02504723|11243660|FG001|NOT COMPLETED|Overall Study||0
10112729|NCT02504775|11243666|FG000|STARTED|Period 1||14
10112730|NCT02504775|11243667|FG001|STARTED|Period 1||14
10112731|NCT02504775|11243666|FG000|COMPLETED|Period 1||14
10112732|NCT02504775|11243667|FG001|COMPLETED|Period 1||14
10112733|NCT02504775|11243666|FG000|NOT COMPLETED|Period 1||0
10112734|NCT02504775|11243667|FG001|NOT COMPLETED|Period 1||0
10112735|NCT02504775|11243666|FG000|STARTED|Washout||14
10112736|NCT02504775|11243667|FG001|STARTED|Washout||14
10112737|NCT02504775|11243666|FG000|COMPLETED|Washout||14
10112738|NCT02504775|11243667|FG001|COMPLETED|Washout||14
10112739|NCT02504775|11243666|FG000|NOT COMPLETED|Washout||0
10112740|NCT02504775|11243667|FG001|NOT COMPLETED|Washout||0
10112741|NCT02504775|11243666|FG000|STARTED|Period 2||14
10112742|NCT02504775|11243667|FG001|STARTED|Period 2||14
10200079|NCT03426228|11328275|FG001|NOT COMPLETED|Overall Study||33
10200080|NCT03426267|11328285|FG000|STARTED|Overall Study||163
10200081|NCT03426267|11328286|FG001|STARTED|Overall Study||162
10200082|NCT03426267|11328285|FG000|Modified Intent-to-Treat Population|Overall Study||154
10200083|NCT03426267|11328286|FG001|Modified Intent-to-Treat Population|Overall Study||144
10200084|NCT03426267|11328285|FG000|COMPLETED|Overall Study||142
10112743|NCT02504775|11243666|FG000|COMPLETED|Period 2||14
10112744|NCT02504775|11243667|FG001|COMPLETED|Period 2||14
10112745|NCT02504775|11243666|FG000|NOT COMPLETED|Period 2||0
10112746|NCT02504775|11243667|FG001|NOT COMPLETED|Period 2||0
10112747|NCT02504827|11243675|FG000|STARTED|Overall Study||12
10200085|NCT03426267|11328286|FG001|COMPLETED|Overall Study||90
10112748|NCT02504827|11243675|FG000|COMPLETED|Overall Study||11
10112749|NCT02504827|11243675|FG000|NOT COMPLETED|Overall Study||1
10112750|NCT02504892|11243679|FG000|STARTED|Overall Study||3
10112751|NCT02504892|11243679|FG000|COMPLETED|Overall Study||1
10112752|NCT02504892|11243679|FG000|NOT COMPLETED|Overall Study||2
10112753|NCT02504931|11243685|FG000|STARTED|Overall Study||26
10112754|NCT02504931|11243686|FG001|STARTED|Overall Study||23
10112755|NCT02504931|11243685|FG000|COMPLETED|Overall Study||14
10112756|NCT02504931|11243686|FG001|COMPLETED|Overall Study||13
10200086|NCT03426267|11328285|FG000|NOT COMPLETED|Overall Study||21
10200087|NCT03426267|11328286|FG001|NOT COMPLETED|Overall Study||72
10200088|NCT03426345|11328294|FG000|STARTED|Overall Study||155
10200089|NCT03426345|11328295|FG001|STARTED|Overall Study||156
10200090|NCT03426345|11328294|FG000|Safety Population|Overall Study||152
10200091|NCT03426345|11328295|FG001|Safety Population|Overall Study||155
10200092|NCT03426345|11328294|FG000|COMPLETED|Overall Study||137
10200093|NCT03426345|11328295|FG001|COMPLETED|Overall Study||139
10200094|NCT03426345|11328294|FG000|NOT COMPLETED|Overall Study||18
10200095|NCT03426345|11328295|FG001|NOT COMPLETED|Overall Study||17
10200096|NCT03426436|11328302|FG000|STARTED|Overall Study||314
10200097|NCT03426436|11328302|FG000|COMPLETED|Overall Study||295
10200098|NCT03426436|11328302|FG000|NOT COMPLETED|Overall Study||19
10200099|NCT03426631|11328306|FG000|STARTED|Overall Study||7
10200100|NCT03426631|11328307|FG001|STARTED|Overall Study||6
10200101|NCT03426631|11328306|FG000|COMPLETED|Overall Study||7
10200102|NCT03426631|11328307|FG001|COMPLETED|Overall Study||5
10200103|NCT03426631|11328306|FG000|NOT COMPLETED|Overall Study||0
10200104|NCT03426631|11328307|FG001|NOT COMPLETED|Overall Study||1
10200105|NCT03426787|11328313|FG000|STARTED|Overall Study||70
10200106|NCT03426787|11328313|FG000|COMPLETED|Overall Study||56
10200107|NCT03426787|11328313|FG000|NOT COMPLETED|Overall Study||14
10200108|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200109|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
10200110|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
10200111|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
10200112|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
10200113|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
10200114|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200115|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200116|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200117|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200118|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200119|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200120|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200121|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200122|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200123|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10084253|NCT02282293|11212882|FG000|STARTED|Overall Study||100
10084254|NCT02282293|11212883|FG001|STARTED|Overall Study||100
10084255|NCT02282293|11212882|FG000|COMPLETED|Overall Study||97
10084256|NCT02282293|11212883|FG001|COMPLETED|Overall Study||97
10084257|NCT02282293|11212882|FG000|NOT COMPLETED|Overall Study||3
10084258|NCT02282293|11212883|FG001|NOT COMPLETED|Overall Study||3
10084259|NCT02282514|11212889|FG000|STARTED|Overall Study||23
10084260|NCT02282514|11212889|FG000|COMPLETED|Overall Study||23
10084261|NCT02282514|11212889|FG000|NOT COMPLETED|Overall Study||0
10084262|NCT02282527|11212895|FG000|STARTED|Overall Study||16
10084263|NCT02282527|11212896|FG001|STARTED|Overall Study||16
10084264|NCT02282527|11212895|FG000|COMPLETED|Overall Study||15
10084265|NCT02282527|11212896|FG001|COMPLETED|Overall Study||15
10084266|NCT02282527|11212895|FG000|NOT COMPLETED|Overall Study||1
10084267|NCT02282527|11212896|FG001|NOT COMPLETED|Overall Study||1
10084268|NCT02282605|11212908|FG000|STARTED|Overall Study||27
10084269|NCT02282605|11212909|FG001|STARTED|Overall Study||12
10084270|NCT02282605|11212910|FG002|STARTED|Overall Study||24
10084271|NCT02282605|11212908|FG000|COMPLETED|Overall Study||24
10084272|NCT02282605|11212909|FG001|COMPLETED|Overall Study||12
10084273|NCT02282605|11212910|FG002|COMPLETED|Overall Study||24
10084274|NCT02282605|11212908|FG000|NOT COMPLETED|Overall Study||3
10084275|NCT02282605|11212909|FG001|NOT COMPLETED|Overall Study||0
10084276|NCT02282605|11212910|FG002|NOT COMPLETED|Overall Study||0
10084277|NCT02282631|11212920|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
10084278|NCT02282631|11212921|FG001|STARTED|Overall Study||15
10084279|NCT02282631|11212920|FG000|COMPLETED|Overall Study||12
10084280|NCT02282631|11212921|FG001|COMPLETED|Overall Study||15
10084281|NCT02282631|11212920|FG000|NOT COMPLETED|Overall Study||2
10084282|NCT02282631|11212921|FG001|NOT COMPLETED|Overall Study||0
10084283|NCT02282722|11212935|FG000|STARTED|Overall Study||94
10084284|NCT02282722|11212936|FG001|STARTED|Overall Study||92
10084285|NCT02282722|11212935|FG000|2-week Assessment|Overall Study||79
10084286|NCT02282722|11212936|FG001|2-week Assessment|Overall Study||75
10084287|NCT02282722|11212935|FG000|3-month Assessment|Overall Study||71
10084288|NCT02282722|11212936|FG001|3-month Assessment|Overall Study||73
10084289|NCT02282722|11212935|FG000|COMPLETED|Overall Study||71
10084290|NCT02282722|11212936|FG001|COMPLETED|Overall Study||73
10084291|NCT02282722|11212935|FG000|NOT COMPLETED|Overall Study||23
10084292|NCT02282722|11212936|FG001|NOT COMPLETED|Overall Study||19
10084293|NCT02282813|11212945|FG000|STARTED|Overall Study|ITT Population|103
10084294|NCT02282813|11212946|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
10084295|NCT02282813|11212947|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
10084296|NCT02282813|11212945|FG000|COMPLETED|Overall Study||91
10084297|NCT02282813|11212946|FG001|COMPLETED|Overall Study||130
10084298|NCT02282813|11212947|FG002|COMPLETED|Overall Study||39
10200124|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200125|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10084299|NCT02282813|11212945|FG000|NOT COMPLETED|Overall Study||12
10200126|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10200127|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200128|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
10200129|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10084300|NCT02282813|11212946|FG001|NOT COMPLETED|Overall Study||23
10084301|NCT02282813|11212947|FG002|NOT COMPLETED|Overall Study||3
10084302|NCT02282904|11212957|FG000|STARTED|Overall Study||7
10084303|NCT02282904|11212957|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
10084304|NCT02282904|11212957|FG000|NOT COMPLETED|Overall Study||0
10084305|NCT02282930|11212961|FG000|STARTED|Overall Study||20
10084306|NCT02282930|11212961|FG000|COMPLETED|Overall Study||19
10084307|NCT02282930|11212961|FG000|NOT COMPLETED|Overall Study||1
10084308|NCT02282982|11212965|FG000|STARTED|Overall Study||359
10084309|NCT02282982|11212965|FG000|Attended Visit 1|Overall Study||359
10084310|NCT02282982|11212965|FG000|Attended Visit 2|Overall Study||341
10084311|NCT02282982|11212965|FG000|Attended Visit 3|Overall Study||298
10084312|NCT02282982|11212965|FG000|Attended Visit 4|Overall Study||194
10084313|NCT02282982|11212965|FG000|Attended Visit 5|Overall Study||83
10084314|NCT02282982|11212965|FG000|Attended Follow-up Visit|Overall Study||349
10084315|NCT02282982|11212965|FG000|COMPLETED|Overall Study||153
10084316|NCT02282982|11212965|FG000|NOT COMPLETED|Overall Study||206
10084317|NCT02283268|11212969|FG000|STARTED|Overall Study||15
10084318|NCT02283268|11212969|FG000|COMPLETED|Overall Study||14
10084319|NCT02283268|11212969|FG000|NOT COMPLETED|Overall Study||1
10084320|NCT02283294|11212983|FG000|STARTED|Overall Study||41
10084321|NCT02283294|11212984|FG001|STARTED|Overall Study||47
10084322|NCT02283294|11212983|FG000|Received Allocated Treatment Intervention|Overall Study||38
10084323|NCT02283294|11212984|FG001|Received Allocated Treatment Intervention|Overall Study||31
10084324|NCT02283294|11212983|FG000|COMPLETED|Overall Study||38
10084325|NCT02283294|11212984|FG001|COMPLETED|Overall Study||39
10084326|NCT02283294|11212983|FG000|NOT COMPLETED|Overall Study||3
10084327|NCT02283294|11212984|FG001|NOT COMPLETED|Overall Study||8
10084328|NCT02283333|11212993|FG000|STARTED|Overall Study||77
10084329|NCT02283333|11212994|FG001|STARTED|Overall Study||78
10084330|NCT02283333|11212993|FG000|COMPLETED|Overall Study||63
10084331|NCT02283333|11212994|FG001|COMPLETED|Overall Study||64
10084332|NCT02283333|11212993|FG000|NOT COMPLETED|Overall Study||14
10084333|NCT02283333|11212994|FG001|NOT COMPLETED|Overall Study||14
10084334|NCT02283411|11213000|FG000|STARTED|Overall Study||156
10084335|NCT02283411|11213000|FG000|COMPLETED|Overall Study||125
10084336|NCT02283411|11213000|FG000|NOT COMPLETED|Overall Study||31
10084337|NCT02283528|11213006|FG000|STARTED|Overall Study||26
10084338|NCT02283528|11213007|FG001|STARTED|Overall Study||24
10084339|NCT02283528|11213006|FG000|COMPLETED|Overall Study||26
10084340|NCT02283528|11213007|FG001|COMPLETED|Overall Study||24
10084341|NCT02283528|11213006|FG000|NOT COMPLETED|Overall Study||0
10084342|NCT02283528|11213007|FG001|NOT COMPLETED|Overall Study||0
10084343|NCT02283658|11213013|FG000|STARTED|Overall Study||20
10084344|NCT02283658|11213013|FG000|COMPLETED|Overall Study||19
10084345|NCT02283658|11213013|FG000|NOT COMPLETED|Overall Study||1
10084346|NCT02283749|11213017|FG000|STARTED|Overall Study||5
10084347|NCT02283749|11213017|FG000|COMPLETED|Overall Study||5
10084348|NCT02283749|11213017|FG000|NOT COMPLETED|Overall Study||0
10084349|NCT02283762|11213023|FG000|STARTED|Main Treatment Phase (MT)||60
10084350|NCT02283762|11213024|FG001|STARTED|Main Treatment Phase (MT)||61
10084351|NCT02283762|11213023|FG000|COMPLETED|Main Treatment Phase (MT)||42
10084352|NCT02283762|11213024|FG001|COMPLETED|Main Treatment Phase (MT)||46
10084353|NCT02283762|11213023|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18
10084354|NCT02283762|11213024|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15
10084355|NCT02283762|11213023|FG000|STARTED|Long-term Extension Phase (LTE)||42
10084356|NCT02283762|11213024|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
10084357|NCT02283762|11213023|FG000|COMPLETED|Long-term Extension Phase (LTE)||32
10084358|NCT02283762|11213024|FG001|COMPLETED|Long-term Extension Phase (LTE)||31
10084359|NCT02283762|11213023|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10
10084360|NCT02283762|11213024|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14
10084361|NCT02283788|11213036|FG000|STARTED|Overall Study||17
10084362|NCT02283788|11213037|FG001|STARTED|Overall Study||17
10084363|NCT02283788|11213038|FG002|STARTED|Overall Study||17
10084364|NCT02283788|11213039|FG003|STARTED|Overall Study||16
10084365|NCT02283788|11213036|FG000|COMPLETED|Overall Study||16
10084366|NCT02283788|11213037|FG001|COMPLETED|Overall Study||13
10084367|NCT02283788|11213038|FG002|COMPLETED|Overall Study||12
10084368|NCT02283788|11213039|FG003|COMPLETED|Overall Study||14
10084369|NCT02283788|11213036|FG000|NOT COMPLETED|Overall Study||1
10084370|NCT02283788|11213037|FG001|NOT COMPLETED|Overall Study||4
10084371|NCT02283788|11213038|FG002|NOT COMPLETED|Overall Study||5
10084372|NCT02283788|11213039|FG003|NOT COMPLETED|Overall Study||2
10084373|NCT02283814|11213051|FG000|STARTED|Overall Study||16
10084374|NCT02283814|11213052|FG001|STARTED|Overall Study||16
10084375|NCT02283814|11213051|FG000|COMPLETED|Overall Study||13
10200130|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
10084376|NCT02283814|11213052|FG001|COMPLETED|Overall Study||14
10084377|NCT02283814|11213051|FG000|NOT COMPLETED|Overall Study||3
10084378|NCT02283814|11213052|FG001|NOT COMPLETED|Overall Study||2
10084379|NCT02283827|11213060|FG000|STARTED|Overall Study||16
10084380|NCT02283827|11213061|FG001|STARTED|Overall Study||16
10084381|NCT02283827|11213060|FG000|COMPLETED|Overall Study||15
10084382|NCT02283827|11213061|FG001|COMPLETED|Overall Study||13
10200131|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
10200132|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
10200133|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200134|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200135|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10084383|NCT02283827|11213060|FG000|NOT COMPLETED|Overall Study||1
10084384|NCT02283827|11213061|FG001|NOT COMPLETED|Overall Study||3
10084385|NCT02283840|11213076|FG000|STARTED|Overall Study||20
10084386|NCT02283840|11213077|FG001|STARTED|Overall Study||20
10084387|NCT02283840|11213078|FG002|STARTED|Overall Study||20
10084388|NCT02283840|11213076|FG000|COMPLETED|Overall Study||20
10084389|NCT02283840|11213077|FG001|COMPLETED|Overall Study||19
10084390|NCT02283840|11213078|FG002|COMPLETED|Overall Study||20
10084391|NCT02283840|11213076|FG000|NOT COMPLETED|Overall Study||0
10084392|NCT02283840|11213077|FG001|NOT COMPLETED|Overall Study||1
10084393|NCT02283840|11213078|FG002|NOT COMPLETED|Overall Study||0
10084394|NCT02284009|11213091|FG000|STARTED|Overall Study||17
10084395|NCT02284009|11213092|FG001|STARTED|Overall Study||50
10084396|NCT02284009|11213091|FG000|COMPLETED|Overall Study||11
10084397|NCT02284009|11213092|FG001|COMPLETED|Overall Study||40
10084398|NCT02284009|11213091|FG000|NOT COMPLETED|Overall Study||6
10084399|NCT02284009|11213092|FG001|NOT COMPLETED|Overall Study||10
10084400|NCT02284126|11213102|FG000|STARTED|Overall Study||552
10084401|NCT02284126|11213103|FG001|STARTED|Overall Study||551
10084402|NCT02284126|11213102|FG000|COMPLETED|Overall Study||484
10084403|NCT02284126|11213103|FG001|COMPLETED|Overall Study||489
10084404|NCT02284126|11213102|FG000|NOT COMPLETED|Overall Study||68
10084405|NCT02284126|11213103|FG001|NOT COMPLETED|Overall Study||62
10084406|NCT02284165|11213112|FG000|STARTED|Overall Study||36448
10084407|NCT02284165|11213113|FG001|STARTED|Overall Study||40272
10084408|NCT02284165|11213114|FG002|STARTED|Overall Study||70996
10084409|NCT02284165|11213112|FG000|COMPLETED|Overall Study||36448
10084410|NCT02284165|11213113|FG001|COMPLETED|Overall Study||40272
10084411|NCT02284165|11213114|FG002|COMPLETED|Overall Study||70996
10084412|NCT02284165|11213112|FG000|NOT COMPLETED|Overall Study||0
10084413|NCT02284165|11213113|FG001|NOT COMPLETED|Overall Study||0
10084414|NCT02284165|11213114|FG002|NOT COMPLETED|Overall Study||0
10084415|NCT02284178|11213122|FG000|STARTED|Overall Study||255
10084416|NCT02284178|11213123|FG001|STARTED|Overall Study||258
10084417|NCT02284178|11213122|FG000|COMPLETED|Overall Study||206
10084418|NCT02284178|11213123|FG001|COMPLETED|Overall Study||204
10084419|NCT02284178|11213122|FG000|NOT COMPLETED|Overall Study||49
10084420|NCT02284178|11213123|FG001|NOT COMPLETED|Overall Study||54
10084421|NCT02284243|11213131|FG000|STARTED|Overall Study||84
10084422|NCT02284243|11213132|FG001|STARTED|Overall Study||84
10084423|NCT02284243|11213131|FG000|COMPLETED|Overall Study||80
10084424|NCT02284243|11213132|FG001|COMPLETED|Overall Study||81
10084425|NCT02284243|11213131|FG000|NOT COMPLETED|Overall Study||4
10084426|NCT02284243|11213132|FG001|NOT COMPLETED|Overall Study||3
10084427|NCT02284347|11213138|FG000|STARTED|Overall Study||51
10084428|NCT02284347|11213138|FG000|COMPLETED|Overall Study||48
10084429|NCT02284347|11213138|FG000|NOT COMPLETED|Overall Study||3
10084430|NCT02284386|11213142|FG000|STARTED|Overall Study||15
10084431|NCT02284386|11213142|FG000|COMPLETED|Overall Study||15
10084432|NCT02284386|11213142|FG000|NOT COMPLETED|Overall Study||0
10084433|NCT02284399|11213148|FG000|STARTED|Overall Study||1414
10084434|NCT02284399|11213149|FG001|STARTED|Overall Study||3074
10084435|NCT02284399|11213148|FG000|COMPLETED|Overall Study||1414
10084436|NCT02284399|11213149|FG001|COMPLETED|Overall Study||3074
10084437|NCT02284399|11213148|FG000|NOT COMPLETED|Overall Study||0
10084438|NCT02284399|11213149|FG001|NOT COMPLETED|Overall Study||0
10084439|NCT02284464|11213159|FG000|STARTED|Overall Study||52
10084440|NCT02284464|11213160|FG001|STARTED|Overall Study||53
10084441|NCT02284464|11213159|FG000|COMPLETED|Overall Study||39
10084442|NCT02284464|11213160|FG001|COMPLETED|Overall Study||36
10084443|NCT02284464|11213159|FG000|NOT COMPLETED|Overall Study||13
10084444|NCT02284464|11213160|FG001|NOT COMPLETED|Overall Study||17
10084445|NCT02284516|11213168|FG000|STARTED|Overall Study||356
10084446|NCT02284516|11213169|FG001|STARTED|Overall Study||355
10084447|NCT02284516|11213168|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
10084448|NCT02284516|11213169|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
10084449|NCT02284516|11213168|FG000|COMPLETED|Overall Study||318
10200136|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200137|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200138|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10084450|NCT02284516|11213169|FG001|COMPLETED|Overall Study||319
10084451|NCT02284516|11213168|FG000|NOT COMPLETED|Overall Study||38
10084452|NCT02284516|11213169|FG001|NOT COMPLETED|Overall Study||36
10084453|NCT02284555|11213175|FG000|STARTED|Overall Study||12
10084454|NCT02284555|11213175|FG000|COMPLETED|Overall Study||12
10084455|NCT02284555|11213175|FG000|NOT COMPLETED|Overall Study||0
10084456|NCT02284828|11213179|FG000|STARTED|Overall Study||26
10084457|NCT02284828|11213179|FG000|COMPLETED|Overall Study||22
10200139|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10084458|NCT02284828|11213179|FG000|NOT COMPLETED|Overall Study||4
10084459|NCT02284854|11213188|FG000|STARTED|Overall Study||23
10084460|NCT02284854|11213189|FG001|STARTED|Overall Study||20
10084461|NCT02284854|11213188|FG000|COMPLETED|Overall Study||18
10084462|NCT02284854|11213189|FG001|COMPLETED|Overall Study||20
10200140|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200141|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200142|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200143|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200144|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200145|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200146|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200147|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200148|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
10200149|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200150|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200151|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200152|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200153|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200154|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200155|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200156|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200157|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200158|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200159|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200160|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200161|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200162|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200163|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200164|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10200165|NCT03426995|11328342|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200166|NCT03426995|11328343|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10200167|NCT03426995|11328344|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200168|NCT03426995|11328345|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10200169|NCT03426995|11328346|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10200170|NCT03426995|11328347|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10200171|NCT03426995|11328348|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200172|NCT03426995|11328349|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200173|NCT03426995|11328350|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200174|NCT03426995|11328351|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200175|NCT03426995|11328352|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200176|NCT03426995|11328353|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200177|NCT03426995|11328354|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200178|NCT03426995|11328355|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200179|NCT03426995|11328356|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200180|NCT03426995|11328357|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200181|NCT03426995|11328358|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200182|NCT03426995|11328359|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200183|NCT03426995|11328360|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200184|NCT03426995|11328342|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200185|NCT03426995|11328343|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10200186|NCT03426995|11328344|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200187|NCT03426995|11328345|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10200188|NCT03426995|11328346|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10200189|NCT03426995|11328347|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10200190|NCT03426995|11328348|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10084463|NCT02284854|11213188|FG000|NOT COMPLETED|Overall Study||5
10084464|NCT02284854|11213189|FG001|NOT COMPLETED|Overall Study||0
10084465|NCT02284867|11213204|FG000|STARTED|Overall Study||30
10200191|NCT03426995|11328349|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200192|NCT03426995|11328350|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200193|NCT03426995|11328351|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10084466|NCT02284867|11213205|FG001|STARTED|Overall Study||30
10084467|NCT02284867|11213204|FG000|COMPLETED|Overall Study||30
10200194|NCT03426995|11328352|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200195|NCT03426995|11328353|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200196|NCT03426995|11328354|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200197|NCT03426995|11328355|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200198|NCT03426995|11328356|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200199|NCT03426995|11328357|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200200|NCT03426995|11328358|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200201|NCT03426995|11328359|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10084468|NCT02284867|11213205|FG001|COMPLETED|Overall Study||30
10084469|NCT02284867|11213204|FG000|NOT COMPLETED|Overall Study||0
10084470|NCT02284867|11213205|FG001|NOT COMPLETED|Overall Study||0
10084471|NCT02284880|11213213|FG000|STARTED|Overall Study||11
10084472|NCT02284880|11213214|FG001|STARTED|Overall Study||9
10084473|NCT02284880|11213215|FG002|STARTED|Overall Study||10
10084474|NCT02284880|11213216|FG003|STARTED|Overall Study||10
10084475|NCT02284880|11213213|FG000|First Period (4 Days)|Overall Study||11
10084476|NCT02284880|11213214|FG001|First Period (4 Days)|Overall Study||9
10200202|NCT03426995|11328360|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200203|NCT03426995|11328342|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200204|NCT03426995|11328343|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200205|NCT03426995|11328344|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200206|NCT03426995|11328345|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200207|NCT03426995|11328346|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200208|NCT03426995|11328347|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200209|NCT03426995|11328348|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200210|NCT03426995|11328349|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200211|NCT03426995|11328350|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200212|NCT03426995|11328351|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200213|NCT03426995|11328352|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200214|NCT03426995|11328353|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200215|NCT03426995|11328354|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200216|NCT03426995|11328355|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200217|NCT03426995|11328356|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200218|NCT03426995|11328357|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200219|NCT03426995|11328358|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200220|NCT03426995|11328359|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200221|NCT03426995|11328360|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10200222|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
10200223|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
10200224|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
10200225|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
10200226|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
10200227|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
10200228|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200229|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200230|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200231|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200232|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200233|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200234|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200235|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200236|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200237|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200238|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200239|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200240|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10200241|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10200242|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
10200243|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10200244|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
10084477|NCT02284880|11213215|FG002|First Period (4 Days)|Overall Study||10
10084478|NCT02284880|11213216|FG003|First Period (4 Days)|Overall Study||10
10084479|NCT02284880|11213213|FG000|Wash-out Period (7 Days)|Overall Study||11
10084480|NCT02284880|11213214|FG001|Wash-out Period (7 Days)|Overall Study||9
10084481|NCT02284880|11213215|FG002|Wash-out Period (7 Days)|Overall Study||10
10084482|NCT02284880|11213216|FG003|Wash-out Period (7 Days)|Overall Study||10
10200245|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200246|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10200247|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200248|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200249|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200250|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200251|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200252|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200253|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200254|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200255|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200256|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200257|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200258|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200259|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200260|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200261|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10084483|NCT02284880|11213213|FG000|Second Period (4 Days)|Overall Study||11
10084484|NCT02284880|11213214|FG001|Second Period (4 Days)|Overall Study||9
10084485|NCT02284880|11213215|FG002|Second Period (4 Days)|Overall Study||8
10084486|NCT02284880|11213216|FG003|Second Period (4 Days)|Overall Study||10
10084487|NCT02284880|11213213|FG000|COMPLETED|Overall Study||11
10084488|NCT02284880|11213214|FG001|COMPLETED|Overall Study||9
10084489|NCT02284880|11213215|FG002|COMPLETED|Overall Study||8
9736900|NCT00196976|10837602|FG011|COMPLETED|Booster Study||30
9736901|NCT00196976|10837603|FG012|COMPLETED|Booster Study||45
10084490|NCT02284880|11213216|FG003|COMPLETED|Overall Study||10
10084491|NCT02284880|11213213|FG000|NOT COMPLETED|Overall Study||0
10084492|NCT02284880|11213214|FG001|NOT COMPLETED|Overall Study||0
10084493|NCT02284880|11213215|FG002|NOT COMPLETED|Overall Study||2
10084494|NCT02284880|11213216|FG003|NOT COMPLETED|Overall Study||0
10084495|NCT02284893|11213228|FG000|STARTED|26 Week (Short Term)||232
10084496|NCT02284893|11213229|FG001|STARTED|26 Week (Short Term)||229
10084497|NCT02284893|11213228|FG000|COMPLETED|26 Week (Short Term)||213
10084498|NCT02284893|11213229|FG001|COMPLETED|26 Week (Short Term)||198
10084499|NCT02284893|11213228|FG000|NOT COMPLETED|26 Week (Short Term)||19
10084500|NCT02284893|11213229|FG001|NOT COMPLETED|26 Week (Short Term)||31
10084501|NCT02284893|11213228|FG000|STARTED|52 Week (Long Term)||209
9736902|NCT00196976|10837604|FG013|COMPLETED|Booster Study||43
9736903|NCT00196976|10837591|FG000|NOT COMPLETED|Booster Study||0
9736904|NCT00196976|10837592|FG001|NOT COMPLETED|Booster Study||0
9736905|NCT00196976|10837593|FG002|NOT COMPLETED|Booster Study||0
10200262|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200263|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200264|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10200265|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
10200266|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200267|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200268|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200269|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200270|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200271|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200272|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200273|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200274|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200275|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200276|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200277|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200278|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10200279|NCT03426995|11328342|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10200280|NCT03426995|11328343|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10200281|NCT03426995|11328344|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10200282|NCT03426995|11328345|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10200283|NCT03426995|11328346|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200284|NCT03426995|11328347|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10200285|NCT03426995|11328348|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200286|NCT03426995|11328349|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200287|NCT03426995|11328350|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200288|NCT03426995|11328351|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200289|NCT03426995|11328352|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200290|NCT03426995|11328353|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10084502|NCT02284893|11213229|FG001|STARTED|52 Week (Long Term)||193
10200291|NCT03426995|11328354|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200292|NCT03426995|11328355|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200293|NCT03426995|11328356|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200294|NCT03426995|11328357|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200295|NCT03426995|11328358|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200296|NCT03426995|11328359|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200297|NCT03426995|11328360|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200298|NCT03426995|11328342|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10200299|NCT03426995|11328343|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10200300|NCT03426995|11328344|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10200301|NCT03426995|11328345|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10200302|NCT03426995|11328346|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200303|NCT03426995|11328347|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10200304|NCT03426995|11328348|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200305|NCT03426995|11328349|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200306|NCT03426995|11328350|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200307|NCT03426995|11328351|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200308|NCT03426995|11328352|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200309|NCT03426995|11328353|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200310|NCT03426995|11328354|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200311|NCT03426995|11328355|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200312|NCT03426995|11328356|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200313|NCT03426995|11328357|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200314|NCT03426995|11328358|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200315|NCT03426995|11328359|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10084503|NCT02284893|11213228|FG000|COMPLETED|52 Week (Long Term)||198
10084504|NCT02284893|11213229|FG001|COMPLETED|52 Week (Long Term)||180
10084505|NCT02284893|11213228|FG000|NOT COMPLETED|52 Week (Long Term)||11
10084506|NCT02284893|11213229|FG001|NOT COMPLETED|52 Week (Long Term)||13
10084507|NCT02285010|11213237|FG000|STARTED|Overall Study||63
9736906|NCT00196976|10837594|FG003|NOT COMPLETED|Booster Study||0
10200316|NCT03426995|11328360|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200317|NCT03426995|11328342|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200318|NCT03426995|11328343|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200319|NCT03426995|11328344|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200320|NCT03426995|11328345|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200321|NCT03426995|11328346|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200322|NCT03426995|11328347|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200323|NCT03426995|11328348|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200324|NCT03426995|11328349|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200325|NCT03426995|11328350|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200326|NCT03426995|11328351|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200327|NCT03426995|11328352|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200328|NCT03426995|11328353|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200329|NCT03426995|11328354|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200330|NCT03426995|11328355|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200331|NCT03426995|11328356|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200332|NCT03426995|11328357|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200333|NCT03426995|11328358|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200334|NCT03426995|11328359|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200335|NCT03426995|11328360|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10200336|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
10200337|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
10200338|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
10200339|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
10200340|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
10200341|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
10200342|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200343|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200344|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200345|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200346|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200347|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200348|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200349|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200350|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200351|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200352|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200353|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200354|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10200355|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
10200356|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
10200357|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
10200358|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
10200359|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
10200360|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
10200361|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200362|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200363|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200364|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200365|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200366|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200367|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200368|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200369|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200370|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200371|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200372|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200373|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200374|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200375|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200376|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200377|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200378|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200379|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200380|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200381|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200382|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200383|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200384|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200385|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200386|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200387|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200388|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200389|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200390|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200391|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10200392|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10084508|NCT02285010|11213238|FG001|STARTED|Overall Study||62
10084509|NCT02285010|11213237|FG000|COMPLETED|Overall Study||58
10084510|NCT02285010|11213238|FG001|COMPLETED|Overall Study||61
10200393|NCT03426995|11328342|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10200394|NCT03426995|11328343|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10200395|NCT03426995|11328344|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10200396|NCT03426995|11328345|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10200397|NCT03426995|11328346|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10200398|NCT03426995|11328347|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10200399|NCT03426995|11328348|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200400|NCT03426995|11328349|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200401|NCT03426995|11328350|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200402|NCT03426995|11328351|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200403|NCT03426995|11328352|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200404|NCT03426995|11328353|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200405|NCT03426995|11328354|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200406|NCT03426995|11328355|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200407|NCT03426995|11328356|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200408|NCT03426995|11328357|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200409|NCT03426995|11328358|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200410|NCT03426995|11328359|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200411|NCT03426995|11328360|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200412|NCT03426995|11328342|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10200413|NCT03426995|11328343|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10084511|NCT02285010|11213237|FG000|NOT COMPLETED|Overall Study||5
10084512|NCT02285010|11213238|FG001|NOT COMPLETED|Overall Study||1
10084513|NCT02285023|11213244|FG000|STARTED|Overall Study||166
10084514|NCT02285023|11213244|FG000|COMPLETED|Overall Study||166
10084515|NCT02285023|11213244|FG000|NOT COMPLETED|Overall Study||0
10084516|NCT02285153|11213256|FG000|STARTED|Overall Study||7
10084517|NCT02285153|11213257|FG001|STARTED|Overall Study||8
10084518|NCT02285153|11213256|FG000|COMPLETED|Overall Study||6
10084519|NCT02285153|11213257|FG001|COMPLETED|Overall Study||8
10084520|NCT02285153|11213256|FG000|NOT COMPLETED|Overall Study||1
10084521|NCT02285153|11213257|FG001|NOT COMPLETED|Overall Study||0
10084522|NCT02285283|11213265|FG000|STARTED|Overall Study||29
10084523|NCT02285283|11213266|FG001|STARTED|Overall Study||29
10084524|NCT02285283|11213265|FG000|COMPLETED|Overall Study||25
10084525|NCT02285283|11213266|FG001|COMPLETED|Overall Study||20
10084526|NCT02285283|11213265|FG000|NOT COMPLETED|Overall Study||4
10084527|NCT02285283|11213266|FG001|NOT COMPLETED|Overall Study||9
10084528|NCT02285361|11213272|FG000|STARTED|Overall Study||1272
10084529|NCT02285361|11213272|FG000|COMPLETED|Overall Study||1221
10084530|NCT02285361|11213272|FG000|NOT COMPLETED|Overall Study||51
10084531|NCT02285634|11213280|FG000|STARTED|Overall Study||15
10084532|NCT02285634|11213281|FG001|STARTED|Overall Study||20
10084533|NCT02285634|11213282|FG002|STARTED|Overall Study||15
10084534|NCT02285634|11213283|FG003|STARTED|Overall Study||18
10084535|NCT02285634|11213280|FG000|COMPLETED|Overall Study||15
10084536|NCT02285634|11213281|FG001|COMPLETED|Overall Study||20
10084537|NCT02285634|11213282|FG002|COMPLETED|Overall Study||11
10084538|NCT02285634|11213283|FG003|COMPLETED|Overall Study||17
10084539|NCT02285634|11213280|FG000|NOT COMPLETED|Overall Study||0
10084540|NCT02285634|11213281|FG001|NOT COMPLETED|Overall Study||0
10084541|NCT02285634|11213282|FG002|NOT COMPLETED|Overall Study||4
10084542|NCT02285634|11213283|FG003|NOT COMPLETED|Overall Study||1
10084543|NCT02285777|11213296|FG000|STARTED|Overall Study||95
10084544|NCT02285777|11213297|FG001|STARTED|Overall Study||94
10084545|NCT02285777|11213296|FG000|COMPLETED|Overall Study||90
10084546|NCT02285777|11213297|FG001|COMPLETED|Overall Study||91
10084547|NCT02285777|11213296|FG000|NOT COMPLETED|Overall Study||5
10084548|NCT02285777|11213297|FG001|NOT COMPLETED|Overall Study||3
10084549|NCT02285855|11213305|FG000|STARTED|Overall Study||16
10084550|NCT02285855|11213306|FG001|STARTED|Overall Study||2
10084551|NCT02285855|11213305|FG000|Randomized|Overall Study||16
10084552|NCT02285855|11213306|FG001|Randomized|Overall Study||2
10084553|NCT02285855|11213305|FG000|COMPLETED|Overall Study||14
10084554|NCT02285855|11213306|FG001|COMPLETED|Overall Study||1
10084555|NCT02285855|11213305|FG000|NOT COMPLETED|Overall Study||2
10084556|NCT02285855|11213306|FG001|NOT COMPLETED|Overall Study||1
10084557|NCT02285907|11213312|FG000|STARTED|Overall Study||21
10084558|NCT02285907|11213312|FG000|Began 1st Intervention|Overall Study||21
10084559|NCT02285907|11213312|FG000|Began 2nd Intervention|Overall Study||21
10084560|NCT02285907|11213312|FG000|Began 3rd Intervention|Overall Study||21
10084561|NCT02285907|11213312|FG000|Began 4th Intervention|Overall Study||21
10200414|NCT03426995|11328344|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10084562|NCT02285907|11213312|FG000|COMPLETED|Overall Study||21
10084563|NCT02285907|11213312|FG000|NOT COMPLETED|Overall Study||0
10084564|NCT02285920|11213329|FG000|STARTED|Overall Study||51
10084565|NCT02285920|11213330|FG001|STARTED|Overall Study||27
10084566|NCT02285920|11213331|FG002|STARTED|Overall Study||26
10084567|NCT02285920|11213332|FG003|STARTED|Overall Study||25
10200415|NCT03426995|11328345|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10200416|NCT03426995|11328346|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10200417|NCT03426995|11328347|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10200418|NCT03426995|11328348|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200419|NCT03426995|11328349|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200420|NCT03426995|11328350|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200421|NCT03426995|11328351|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200422|NCT03426995|11328352|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200423|NCT03426995|11328353|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200424|NCT03426995|11328354|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200425|NCT03426995|11328355|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200426|NCT03426995|11328356|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200427|NCT03426995|11328357|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200428|NCT03426995|11328358|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200429|NCT03426995|11328359|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200430|NCT03426995|11328360|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200431|NCT03426995|11328342|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200432|NCT03426995|11328343|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200433|NCT03426995|11328344|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200434|NCT03426995|11328345|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200435|NCT03426995|11328346|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200436|NCT03426995|11328347|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200437|NCT03426995|11328348|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200438|NCT03426995|11328349|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200439|NCT03426995|11328350|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200440|NCT03426995|11328351|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200441|NCT03426995|11328352|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200442|NCT03426995|11328353|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200443|NCT03426995|11328354|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200444|NCT03426995|11328355|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200445|NCT03426995|11328356|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200446|NCT03426995|11328357|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200447|NCT03426995|11328358|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200448|NCT03426995|11328359|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200449|NCT03426995|11328360|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10200450|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
10200451|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
10200452|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
10200453|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
10200454|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
10200455|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
10200456|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200457|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10084568|NCT02285920|11213329|FG000|COMPLETED|Overall Study||47
10084569|NCT02285920|11213330|FG001|COMPLETED|Overall Study||23
10084570|NCT02285920|11213331|FG002|COMPLETED|Overall Study||21
10200458|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200459|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200460|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200461|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200462|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200463|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200464|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200465|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200466|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200467|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10200468|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10084571|NCT02285920|11213332|FG003|COMPLETED|Overall Study||24
10084572|NCT02285920|11213329|FG000|NOT COMPLETED|Overall Study||4
10084573|NCT02285920|11213330|FG001|NOT COMPLETED|Overall Study||4
10084574|NCT02285920|11213331|FG002|NOT COMPLETED|Overall Study||5
10084575|NCT02285920|11213332|FG003|NOT COMPLETED|Overall Study||1
10084576|NCT02285998|11213344|FG000|STARTED|Overall Study||4474
10084577|NCT02285998|11213345|FG001|STARTED|Overall Study||4489
10084578|NCT02285998|11213344|FG000|COMPLETED|Overall Study||4228
10084579|NCT02285998|11213345|FG001|COMPLETED|Overall Study||4236
10084580|NCT02285998|11213344|FG000|NOT COMPLETED|Overall Study||246
10084581|NCT02285998|11213345|FG001|NOT COMPLETED|Overall Study||253
10084582|NCT02286102|11213353|FG000|STARTED|Overall Study||36
10084583|NCT02286102|11213354|FG001|STARTED|Overall Study||34
10084584|NCT02286102|11213353|FG000|COMPLETED|Overall Study||35
10084585|NCT02286102|11213354|FG001|COMPLETED|Overall Study||33
10084586|NCT02286102|11213353|FG000|NOT COMPLETED|Overall Study||1
10084587|NCT02286102|11213354|FG001|NOT COMPLETED|Overall Study||1
10084588|NCT02286193|11213360|FG000|STARTED|Overall Study||622
10084589|NCT02286193|11213360|FG000|COMPLETED|Overall Study||418
10084590|NCT02286193|11213360|FG000|NOT COMPLETED|Overall Study||204
10084591|NCT02286466|11213367|FG000|STARTED|Overall Study||72
10200469|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
10200470|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
10200471|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
10084592|NCT02286466|11213368|FG001|STARTED|Overall Study||73
10084593|NCT02286466|11213367|FG000|Baseline Clinician Assessment|Overall Study||72
10084594|NCT02286466|11213368|FG001|Baseline Clinician Assessment|Overall Study||72
10084595|NCT02286466|11213367|FG000|Post Self-report|Overall Study||67
10084596|NCT02286466|11213368|FG001|Post Self-report|Overall Study||68
10084597|NCT02286466|11213367|FG000|COMPLETED|Overall Study||65
10084598|NCT02286466|11213368|FG001|COMPLETED|Overall Study||63
10084599|NCT02286466|11213367|FG000|NOT COMPLETED|Overall Study||7
10084600|NCT02286466|11213368|FG001|NOT COMPLETED|Overall Study||10
10084601|NCT02286518|11213388|FG000|STARTED|All Parts (16 Days)||6
10084602|NCT02286518|11213389|FG001|STARTED|All Parts (16 Days)||6
10084603|NCT02286518|11213390|FG002|STARTED|All Parts (16 Days)||6
10084604|NCT02286518|11213391|FG003|STARTED|All Parts (16 Days)||6
10084605|NCT02286518|11213392|FG004|STARTED|All Parts (16 Days)||6
10084606|NCT02286518|11213393|FG005|STARTED|All Parts (16 Days)||6
10084607|NCT02286518|11213394|FG006|STARTED|All Parts (16 Days)||6
10084608|NCT02286518|11213395|FG007|STARTED|All Parts (16 Days)||6
10084609|NCT02286518|11213396|FG008|STARTED|All Parts (16 Days)||6
10084610|NCT02286518|11213397|FG009|STARTED|All Parts (16 Days)||4
10084611|NCT02286518|11213398|FG010|STARTED|All Parts (16 Days)||6
10084612|NCT02286518|11213399|FG011|STARTED|All Parts (16 Days)||6
10084613|NCT02286518|11213400|FG012|STARTED|All Parts (16 Days)||6
10084614|NCT02286518|11213401|FG013|STARTED|All Parts (16 Days)||6
10084615|NCT02286518|11213388|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084616|NCT02286518|11213389|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084617|NCT02286518|11213390|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084618|NCT02286518|11213391|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084619|NCT02286518|11213392|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084620|NCT02286518|11213393|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084621|NCT02286518|11213394|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084622|NCT02286518|11213395|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
10084623|NCT02286518|11213396|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
10084624|NCT02286518|11213397|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
10084625|NCT02286518|11213398|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084626|NCT02286518|11213399|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084627|NCT02286518|11213400|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084628|NCT02286518|11213401|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10084629|NCT02286518|11213388|FG000|NOT COMPLETED|All Parts (16 Days)||0
10084630|NCT02286518|11213389|FG001|NOT COMPLETED|All Parts (16 Days)||0
10084631|NCT02286518|11213390|FG002|NOT COMPLETED|All Parts (16 Days)||0
10084632|NCT02286518|11213391|FG003|NOT COMPLETED|All Parts (16 Days)||0
10084633|NCT02286518|11213392|FG004|NOT COMPLETED|All Parts (16 Days)||0
10084634|NCT02286518|11213393|FG005|NOT COMPLETED|All Parts (16 Days)||0
10084635|NCT02286518|11213394|FG006|NOT COMPLETED|All Parts (16 Days)||0
10084636|NCT02286518|11213395|FG007|NOT COMPLETED|All Parts (16 Days)||0
10084637|NCT02286518|11213396|FG008|NOT COMPLETED|All Parts (16 Days)||0
10084638|NCT02286518|11213397|FG009|NOT COMPLETED|All Parts (16 Days)||0
10084639|NCT02286518|11213398|FG010|NOT COMPLETED|All Parts (16 Days)||0
10084640|NCT02286518|11213399|FG011|NOT COMPLETED|All Parts (16 Days)||0
10084641|NCT02286518|11213400|FG012|NOT COMPLETED|All Parts (16 Days)||0
10084642|NCT02286518|11213401|FG013|NOT COMPLETED|All Parts (16 Days)||0
10084643|NCT02286518|11213388|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084644|NCT02286518|11213389|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084645|NCT02286518|11213390|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084646|NCT02286518|11213391|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084647|NCT02286518|11213392|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084648|NCT02286518|11213393|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084649|NCT02286518|11213394|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084650|NCT02286518|11213395|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6
10084651|NCT02286518|11213396|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6
10084652|NCT02286518|11213397|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084653|NCT02286518|11213398|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10200472|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
10200473|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
10084654|NCT02286518|11213399|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084655|NCT02286518|11213400|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10084656|NCT02286518|11213401|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10200474|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
10200475|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200476|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200477|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200478|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10084657|NCT02286518|11213388|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084658|NCT02286518|11213389|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084659|NCT02286518|11213390|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084660|NCT02286518|11213391|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084661|NCT02286518|11213392|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084662|NCT02286518|11213393|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084663|NCT02286518|11213394|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084664|NCT02286518|11213395|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
10084665|NCT02286518|11213396|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
10084666|NCT02286518|11213397|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084667|NCT02286518|11213398|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084668|NCT02286518|11213399|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084669|NCT02286518|11213400|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084670|NCT02286518|11213401|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084671|NCT02286518|11213388|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084672|NCT02286518|11213389|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084673|NCT02286518|11213390|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084674|NCT02286518|11213391|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084675|NCT02286518|11213392|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084676|NCT02286518|11213393|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084677|NCT02286518|11213394|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084678|NCT02286518|11213395|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084679|NCT02286518|11213396|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084680|NCT02286518|11213397|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084681|NCT02286518|11213398|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084682|NCT02286518|11213399|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084683|NCT02286518|11213400|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084684|NCT02286518|11213401|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10084685|NCT02286518|11213388|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084686|NCT02286518|11213389|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084687|NCT02286518|11213390|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084688|NCT02286518|11213391|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084689|NCT02286518|11213392|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084690|NCT02286518|11213393|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084691|NCT02286518|11213394|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084692|NCT02286518|11213395|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6
10084693|NCT02286518|11213396|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6
10084694|NCT02286518|11213397|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084695|NCT02286518|11213398|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084696|NCT02286518|11213399|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084697|NCT02286518|11213400|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084698|NCT02286518|11213401|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10084699|NCT02286518|11213388|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084700|NCT02286518|11213389|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084701|NCT02286518|11213390|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084702|NCT02286518|11213391|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084703|NCT02286518|11213392|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084704|NCT02286518|11213393|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084705|NCT02286518|11213394|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084706|NCT02286518|11213395|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
10084707|NCT02286518|11213396|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
10084708|NCT02286518|11213397|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084709|NCT02286518|11213398|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084710|NCT02286518|11213399|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084711|NCT02286518|11213400|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084712|NCT02286518|11213401|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084713|NCT02286518|11213388|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084714|NCT02286518|11213389|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084715|NCT02286518|11213390|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084716|NCT02286518|11213391|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084717|NCT02286518|11213392|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084718|NCT02286518|11213393|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084719|NCT02286518|11213394|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084720|NCT02286518|11213395|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10200479|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200480|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200481|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200482|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200483|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200484|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200485|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200486|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200487|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200488|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200489|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200490|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200491|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200492|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200493|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200494|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200495|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200496|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10084721|NCT02286518|11213396|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084722|NCT02286518|11213397|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084723|NCT02286518|11213398|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084724|NCT02286518|11213399|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084725|NCT02286518|11213400|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084726|NCT02286518|11213401|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10084727|NCT02286713|11213449|FG000|STARTED|One Week Follow-Up||259
10084728|NCT02286713|11213450|FG001|STARTED|One Week Follow-Up||257
10084729|NCT02286713|11213449|FG000|COMPLETED|One Week Follow-Up||235
10084730|NCT02286713|11213450|FG001|COMPLETED|One Week Follow-Up||233
10084731|NCT02286713|11213449|FG000|NOT COMPLETED|One Week Follow-Up||24
10084732|NCT02286713|11213450|FG001|NOT COMPLETED|One Week Follow-Up||24
10084733|NCT02286713|11213449|FG000|STARTED|Three Month Follow-Up||252
10084734|NCT02286713|11213450|FG001|STARTED|Three Month Follow-Up||254
10084735|NCT02286713|11213449|FG000|COMPLETED|Three Month Follow-Up||224
10084736|NCT02286713|11213450|FG001|COMPLETED|Three Month Follow-Up||228
10084737|NCT02286713|11213449|FG000|NOT COMPLETED|Three Month Follow-Up||28
10084738|NCT02286713|11213450|FG001|NOT COMPLETED|Three Month Follow-Up||26
10084739|NCT02286713|11213449|FG000|STARTED|Six Month Follow-Up||250
10084740|NCT02286713|11213450|FG001|STARTED|Six Month Follow-Up||252
10084741|NCT02286713|11213449|FG000|COMPLETED|Six Month Follow-Up||218
10084742|NCT02286713|11213450|FG001|COMPLETED|Six Month Follow-Up||225
10084743|NCT02286713|11213449|FG000|NOT COMPLETED|Six Month Follow-Up||32
10084744|NCT02286713|11213450|FG001|NOT COMPLETED|Six Month Follow-Up||27
10084745|NCT02286726|11213459|FG000|STARTED|Overall Study||16
10084746|NCT02286726|11213460|FG001|STARTED|Overall Study||24
10084747|NCT02286726|11213461|FG002|STARTED|Overall Study||16
10084748|NCT02286726|11213459|FG000|COMPLETED|Overall Study||16
10084749|NCT02286726|11213460|FG001|COMPLETED|Overall Study||24
10084750|NCT02286726|11213461|FG002|COMPLETED|Overall Study||16
10084751|NCT02286726|11213459|FG000|NOT COMPLETED|Overall Study||0
10084752|NCT02286726|11213460|FG001|NOT COMPLETED|Overall Study||0
10084753|NCT02286726|11213461|FG002|NOT COMPLETED|Overall Study||0
10084754|NCT02286843|11213469|FG000|STARTED|Overall Study||49
10084755|NCT02286843|11213469|FG000|COMPLETED|Overall Study||43
10084756|NCT02286843|11213469|FG000|NOT COMPLETED|Overall Study||6
10084757|NCT02286895|11213475|FG000|STARTED|Randomized and Vaccinated||300
10084758|NCT02286895|11213476|FG001|STARTED|Randomized and Vaccinated||300
10084759|NCT02286895|11213475|FG000|COMPLETED|Randomized and Vaccinated||300
10084760|NCT02286895|11213476|FG001|COMPLETED|Randomized and Vaccinated||300
10084761|NCT02286895|11213475|FG000|NOT COMPLETED|Randomized and Vaccinated||0
10084762|NCT02286895|11213476|FG001|NOT COMPLETED|Randomized and Vaccinated||0
10084763|NCT02286895|11213475|FG000|STARTED|Assessed for Measles Seroconversion||300
10084764|NCT02286895|11213476|FG001|STARTED|Assessed for Measles Seroconversion||300
10084765|NCT02286895|11213475|FG000|COMPLETED|Assessed for Measles Seroconversion||252
10084766|NCT02286895|11213476|FG001|COMPLETED|Assessed for Measles Seroconversion||261
10084767|NCT02286895|11213475|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48
10084768|NCT02286895|11213476|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39
10084769|NCT02286921|11213484|FG000|STARTED|Overall Study||94
10084770|NCT02286921|11213485|FG001|STARTED|Overall Study||101
10084771|NCT02286921|11213484|FG000|COMPLETED|Overall Study||94
10084772|NCT02286921|11213485|FG001|COMPLETED|Overall Study||101
10084773|NCT02286921|11213484|FG000|NOT COMPLETED|Overall Study||0
10084774|NCT02286921|11213485|FG001|NOT COMPLETED|Overall Study||0
10084775|NCT02286947|11213491|FG000|STARTED|Overall Study||24
10084776|NCT02286947|11213491|FG000|COMPLETED|Overall Study||22
10084777|NCT02286947|11213491|FG000|NOT COMPLETED|Overall Study||2
10200497|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200498|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200499|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10084778|NCT02286960|11213499|FG000|STARTED|Overall Study||19
10084779|NCT02286960|11213500|FG001|STARTED|Overall Study||17
10084780|NCT02286960|11213499|FG000|COMPLETED|Overall Study||16
10084781|NCT02286960|11213500|FG001|COMPLETED|Overall Study||14
10084782|NCT02286960|11213499|FG000|NOT COMPLETED|Overall Study||3
10084783|NCT02286960|11213500|FG001|NOT COMPLETED|Overall Study||3
10084784|NCT02287038|11213508|FG000|STARTED|Overall Study||23
10084785|NCT02287038|11213509|FG001|STARTED|Overall Study||21
10200500|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200501|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200502|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200503|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200504|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200505|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200506|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10200507|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200508|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200509|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200510|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200511|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200512|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200513|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10200514|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
10200515|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10200516|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200517|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10200518|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10200519|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200520|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200521|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200522|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200523|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200524|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200525|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10200526|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200527|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200528|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200529|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200530|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200531|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200532|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10200533|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
10200534|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10200535|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200536|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10200537|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10200538|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200539|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200540|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200541|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200542|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200543|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200544|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200545|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200546|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200547|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200548|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200549|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200550|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200551|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200552|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200553|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200554|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200555|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200556|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200557|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200558|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200559|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200560|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200561|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200562|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200563|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10200564|NCT03426995|11328342|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10084786|NCT02287038|11213508|FG000|COMPLETED|Overall Study||18
10084787|NCT02287038|11213509|FG001|COMPLETED|Overall Study||18
10084788|NCT02287038|11213508|FG000|NOT COMPLETED|Overall Study||5
10084789|NCT02287038|11213509|FG001|NOT COMPLETED|Overall Study||3
10084790|NCT02287350|11213517|FG000|STARTED|Overall Study||51
10084791|NCT02287350|11213517|FG000|COMPLETED|Overall Study||48
10084792|NCT02287350|11213517|FG000|NOT COMPLETED|Overall Study||3
10084793|NCT02287376|11213521|FG000|STARTED|Overall Study||25
10084794|NCT02287376|11213521|FG000|COMPLETED|Overall Study||25
10084795|NCT02287376|11213521|FG000|NOT COMPLETED|Overall Study||0
10084796|NCT02287402|11213525|FG000|STARTED|Treatment Period||197
10084797|NCT02287402|11213525|FG000|COMPLETED|Treatment Period||170
10084798|NCT02287402|11213525|FG000|NOT COMPLETED|Treatment Period||27
10200565|NCT03426995|11328343|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200566|NCT03426995|11328344|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200567|NCT03426995|11328345|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200568|NCT03426995|11328346|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200569|NCT03426995|11328347|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200570|NCT03426995|11328348|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200571|NCT03426995|11328349|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
10200572|NCT03426995|11328350|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200573|NCT03426995|11328351|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200574|NCT03426995|11328352|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200575|NCT03426995|11328353|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200576|NCT03426995|11328354|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200577|NCT03426995|11328355|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200578|NCT03426995|11328356|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200579|NCT03426995|11328357|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200580|NCT03426995|11328358|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200581|NCT03426995|11328359|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200582|NCT03426995|11328360|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200583|NCT03426995|11328342|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200584|NCT03426995|11328343|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200585|NCT03426995|11328344|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200586|NCT03426995|11328345|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10084799|NCT02287402|11213525|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
10084800|NCT02287402|11213525|FG000|COMPLETED|Follow-up||103
10084801|NCT02287402|11213525|FG000|NOT COMPLETED|Follow-up||3
10084802|NCT02287415|11213529|FG000|STARTED|Overall Study||13
10084803|NCT02287415|11213529|FG000|COMPLETED|Overall Study||13
10084804|NCT02287415|11213529|FG000|NOT COMPLETED|Overall Study||0
10084805|NCT02287467|11213535|FG000|STARTED|Overall Study||168
10084806|NCT02287467|11213536|FG001|STARTED|Overall Study||161
10084807|NCT02287467|11213535|FG000|COMPLETED|Overall Study||156
10084808|NCT02287467|11213536|FG001|COMPLETED|Overall Study||152
10084809|NCT02287467|11213535|FG000|NOT COMPLETED|Overall Study||12
10084810|NCT02287467|11213536|FG001|NOT COMPLETED|Overall Study||9
10084811|NCT02287610|11213545|FG000|STARTED|Overall Study||64
10084812|NCT02287610|11213545|FG000|Per Protocol Follow-Up|Overall Study||56
10084813|NCT02287610|11213545|FG000|COMPLETED|Overall Study||48
10084814|NCT02287610|11213545|FG000|NOT COMPLETED|Overall Study||16
10084815|NCT02287623|11213551|FG000|STARTED|Overall Study||30
10084816|NCT02287623|11213552|FG001|STARTED|Overall Study||30
10084817|NCT02287623|11213551|FG000|COMPLETED|Overall Study||30
10084818|NCT02287623|11213552|FG001|COMPLETED|Overall Study||29
10084819|NCT02287623|11213551|FG000|NOT COMPLETED|Overall Study||0
10084820|NCT02287623|11213552|FG001|NOT COMPLETED|Overall Study||1
10084821|NCT02287675|11213560|FG000|STARTED|Overall Study||22
10084822|NCT02287675|11213561|FG001|STARTED|Overall Study||18
10084823|NCT02287675|11213560|FG000|COMPLETED|Overall Study||22
10084824|NCT02287675|11213561|FG001|COMPLETED|Overall Study||18
10084825|NCT02287675|11213560|FG000|NOT COMPLETED|Overall Study||0
10084826|NCT02287675|11213561|FG001|NOT COMPLETED|Overall Study||0
10084827|NCT02287688|11213567|FG000|STARTED|Overall Study||138
10084828|NCT02287688|11213567|FG000|COMPLETED|Overall Study||138
10084829|NCT02287688|11213567|FG000|NOT COMPLETED|Overall Study||0
10084830|NCT02287779|11213579|FG000|STARTED|Overall Study||21
10084831|NCT02287779|11213580|FG001|STARTED|Overall Study||9
10084832|NCT02287779|11213581|FG002|STARTED|Overall Study||9
10084833|NCT02287779|11213582|FG003|STARTED|Overall Study||9
10084834|NCT02287779|11213583|FG004|STARTED|Overall Study||9
10084835|NCT02287779|11213584|FG005|STARTED|Overall Study||9
10084836|NCT02287779|11213585|FG006|STARTED|Overall Study||9
10084837|NCT02287779|11213586|FG007|STARTED|Overall Study||9
10084838|NCT02287779|11213579|FG000|COMPLETED|Overall Study||21
10084839|NCT02287779|11213580|FG001|COMPLETED|Overall Study||9
10084840|NCT02287779|11213581|FG002|COMPLETED|Overall Study||9
10084841|NCT02287779|11213582|FG003|COMPLETED|Overall Study||9
10084842|NCT02287779|11213583|FG004|COMPLETED|Overall Study||9
10084843|NCT02287779|11213584|FG005|COMPLETED|Overall Study||9
10084844|NCT02287779|11213585|FG006|COMPLETED|Overall Study||9
10084845|NCT02287779|11213586|FG007|COMPLETED|Overall Study||9
10084846|NCT02287779|11213579|FG000|NOT COMPLETED|Overall Study||0
10084847|NCT02287779|11213580|FG001|NOT COMPLETED|Overall Study||0
10084848|NCT02287779|11213581|FG002|NOT COMPLETED|Overall Study||0
10084849|NCT02287779|11213582|FG003|NOT COMPLETED|Overall Study||0
10084850|NCT02287779|11213583|FG004|NOT COMPLETED|Overall Study||0
10084851|NCT02287779|11213584|FG005|NOT COMPLETED|Overall Study||0
10084852|NCT02287779|11213585|FG006|NOT COMPLETED|Overall Study||0
10084853|NCT02287779|11213586|FG007|NOT COMPLETED|Overall Study||0
10084860|NCT02287883|11213619|FG000|STARTED|Overall Study||1081
10084861|NCT02287883|11213620|FG001|STARTED|Overall Study||1095
10084862|NCT02287883|11213619|FG000|One-year Follow-up Survey|Overall Study||622
10200587|NCT03426995|11328346|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200588|NCT03426995|11328347|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200589|NCT03426995|11328348|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200590|NCT03426995|11328349|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
10084863|NCT02287883|11213620|FG001|One-year Follow-up Survey|Overall Study||669
10084864|NCT02287883|11213619|FG000|COMPLETED|Overall Study||622
10084865|NCT02287883|11213620|FG001|COMPLETED|Overall Study||669
10084866|NCT02287883|11213619|FG000|NOT COMPLETED|Overall Study||459
10084867|NCT02287883|11213620|FG001|NOT COMPLETED|Overall Study||426
10084868|NCT02287896|11213628|FG000|STARTED|Screening Visit V1||36
10084869|NCT02287896|11213629|FG001|STARTED|Screening Visit V1||26
10084870|NCT02287896|11213628|FG000|COMPLETED|Screening Visit V1||36
10084871|NCT02287896|11213629|FG001|COMPLETED|Screening Visit V1||26
10084872|NCT02287896|11213628|FG000|NOT COMPLETED|Screening Visit V1||0
10084873|NCT02287896|11213629|FG001|NOT COMPLETED|Screening Visit V1||0
10084874|NCT02287896|11213628|FG000|STARTED|First Injection Visit||36
10084875|NCT02287896|11213629|FG001|STARTED|First Injection Visit||26
10084876|NCT02287896|11213628|FG000|COMPLETED|First Injection Visit||36
10084877|NCT02287896|11213629|FG001|COMPLETED|First Injection Visit||26
10084878|NCT02287896|11213628|FG000|NOT COMPLETED|First Injection Visit||0
10084879|NCT02287896|11213629|FG001|NOT COMPLETED|First Injection Visit||0
10084880|NCT02287896|11213628|FG000|STARTED|Second Injection Visit||36
10084881|NCT02287896|11213629|FG001|STARTED|Second Injection Visit||26
10084882|NCT02287896|11213628|FG000|COMPLETED|Second Injection Visit||36
10084883|NCT02287896|11213629|FG001|COMPLETED|Second Injection Visit||25
10084884|NCT02287896|11213628|FG000|NOT COMPLETED|Second Injection Visit||0
10084885|NCT02287896|11213629|FG001|NOT COMPLETED|Second Injection Visit||1
10084886|NCT02287909|11213645|FG000|STARTED|Overall Study||20
10084887|NCT02287909|11213646|FG001|STARTED|Overall Study||20
10084888|NCT02287909|11213647|FG002|STARTED|Overall Study||20
10084889|NCT02287909|11213648|FG003|STARTED|Overall Study||20
10084890|NCT02287909|11213645|FG000|COMPLETED|Overall Study||18
10084891|NCT02287909|11213646|FG001|COMPLETED|Overall Study||19
10084892|NCT02287909|11213647|FG002|COMPLETED|Overall Study||20
10084893|NCT02287909|11213648|FG003|COMPLETED|Overall Study||19
10084894|NCT02287909|11213645|FG000|NOT COMPLETED|Overall Study||2
10084895|NCT02287909|11213646|FG001|NOT COMPLETED|Overall Study||1
10084896|NCT02287909|11213647|FG002|NOT COMPLETED|Overall Study||0
10084897|NCT02287909|11213648|FG003|NOT COMPLETED|Overall Study||1
10084898|NCT02287922|11213662|FG000|STARTED|Overall Study||62
10084899|NCT02287922|11213663|FG001|STARTED|Overall Study||62
10084900|NCT02287922|11213664|FG002|STARTED|Overall Study||63
10084901|NCT02287922|11213665|FG003|STARTED|Overall Study||64
10084902|NCT02287922|11213662|FG000|COMPLETED|Overall Study||59
10084903|NCT02287922|11213663|FG001|COMPLETED|Overall Study||60
10084904|NCT02287922|11213664|FG002|COMPLETED|Overall Study||56
10084905|NCT02287922|11213665|FG003|COMPLETED|Overall Study||57
10084906|NCT02287922|11213662|FG000|NOT COMPLETED|Overall Study||3
10084907|NCT02287922|11213663|FG001|NOT COMPLETED|Overall Study||2
10084908|NCT02287922|11213664|FG002|NOT COMPLETED|Overall Study||7
10084909|NCT02287922|11213665|FG003|NOT COMPLETED|Overall Study||7
10084910|NCT02288091|11213676|FG000|STARTED|Overall Study||32
10084911|NCT02288091|11213676|FG000|Randomized/Treated|Overall Study||25
10084912|NCT02288091|11213676|FG000|COMPLETED|Overall Study||24
10084913|NCT02288091|11213676|FG000|NOT COMPLETED|Overall Study||8
10084914|NCT02288156|11213684|FG000|STARTED|Overall Study||20
10084915|NCT02288156|11213685|FG001|STARTED|Overall Study||20
10084916|NCT02288156|11213686|FG002|STARTED|Overall Study||20
10084917|NCT02288156|11213687|FG003|STARTED|Overall Study||20
10084918|NCT02288156|11213684|FG000|COMPLETED|Overall Study||16
10084919|NCT02288156|11213685|FG001|COMPLETED|Overall Study||16
10084920|NCT02288156|11213686|FG002|COMPLETED|Overall Study||18
10084921|NCT02288156|11213687|FG003|COMPLETED|Overall Study||18
10084922|NCT02288156|11213684|FG000|NOT COMPLETED|Overall Study||4
10084923|NCT02288156|11213685|FG001|NOT COMPLETED|Overall Study||4
10084924|NCT02288156|11213686|FG002|NOT COMPLETED|Overall Study||2
10084925|NCT02288156|11213687|FG003|NOT COMPLETED|Overall Study||2
10084926|NCT02288182|11213701|FG000|STARTED|Overall Study||25
10084927|NCT02288182|11213702|FG001|STARTED|Overall Study||27
10084928|NCT02288182|11213701|FG000|COMPLETED|Overall Study||25
10084929|NCT02288182|11213702|FG001|COMPLETED|Overall Study||25
10084930|NCT02288182|11213701|FG000|NOT COMPLETED|Overall Study||0
10084931|NCT02288182|11213702|FG001|NOT COMPLETED|Overall Study||2
10084932|NCT02288273|11213712|FG000|STARTED|Overall Study||61
10084933|NCT02288273|11213713|FG001|STARTED|Overall Study||56
10084934|NCT02288273|11213712|FG000|COMPLETED|Overall Study||53
10084935|NCT02288273|11213713|FG001|COMPLETED|Overall Study||48
10084936|NCT02288273|11213712|FG000|NOT COMPLETED|Overall Study||8
10084937|NCT02288273|11213713|FG001|NOT COMPLETED|Overall Study||8
10084938|NCT02288312|11213722|FG000|STARTED|Overall Study||6
10084939|NCT02288312|11213723|FG001|STARTED|Overall Study||6
10084940|NCT02288312|11213724|FG002|STARTED|Overall Study||6
10084941|NCT02288312|11213722|FG000|COMPLETED|Overall Study||5
10084942|NCT02288312|11213723|FG001|COMPLETED|Overall Study||6
10084943|NCT02288312|11213724|FG002|COMPLETED|Overall Study||6
10084944|NCT02288312|11213722|FG000|NOT COMPLETED|Overall Study||1
10084945|NCT02288312|11213723|FG001|NOT COMPLETED|Overall Study||0
10084946|NCT02288312|11213724|FG002|NOT COMPLETED|Overall Study||0
10084947|NCT02288325|11213732|FG000|STARTED|Run-in Period||644
10084948|NCT02288325|11213733|FG001|STARTED|Run-in Period||0
10200591|NCT03426995|11328350|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200592|NCT03426995|11328351|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200593|NCT03426995|11328352|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200594|NCT03426995|11328353|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10200595|NCT03426995|11328354|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200596|NCT03426995|11328355|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200597|NCT03426995|11328356|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10084949|NCT02288325|11213734|FG002|STARTED|Run-in Period||0
10084950|NCT02288325|11213732|FG000|COMPLETED|Run-in Period||499
10084951|NCT02288325|11213733|FG001|COMPLETED|Run-in Period||0
10084952|NCT02288325|11213734|FG002|COMPLETED|Run-in Period||0
10084953|NCT02288325|11213732|FG000|NOT COMPLETED|Run-in Period||145
10084954|NCT02288325|11213733|FG001|NOT COMPLETED|Run-in Period||0
10084955|NCT02288325|11213734|FG002|NOT COMPLETED|Run-in Period||0
10084956|NCT02288325|11213732|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
10084957|NCT02288325|11213733|FG001|STARTED|Stabilization Period||0
10084958|NCT02288325|11213734|FG002|STARTED|Stabilization Period||0
10200598|NCT03426995|11328357|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200599|NCT03426995|11328358|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200600|NCT03426995|11328359|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10084959|NCT02288325|11213732|FG000|COMPLETED|Stabilization Period||331
10084960|NCT02288325|11213733|FG001|COMPLETED|Stabilization Period||0
10084961|NCT02288325|11213734|FG002|COMPLETED|Stabilization Period||0
10084962|NCT02288325|11213732|FG000|NOT COMPLETED|Stabilization Period||98
10084963|NCT02288325|11213733|FG001|NOT COMPLETED|Stabilization Period||0
10084964|NCT02288325|11213734|FG002|NOT COMPLETED|Stabilization Period||0
10084965|NCT02288325|11213732|FG000|STARTED|Double-blind Treatment Period||0
10084966|NCT02288325|11213733|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
10084967|NCT02288325|11213734|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
10084968|NCT02288325|11213732|FG000|COMPLETED|Double-blind Treatment Period||0
10084969|NCT02288325|11213733|FG001|COMPLETED|Double-blind Treatment Period||135
10084970|NCT02288325|11213734|FG002|COMPLETED|Double-blind Treatment Period||139
10084971|NCT02288325|11213732|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10084972|NCT02288325|11213733|FG001|NOT COMPLETED|Double-blind Treatment Period||24
10084973|NCT02288325|11213734|FG002|NOT COMPLETED|Double-blind Treatment Period||26
10084974|NCT02288364|11213743|FG000|STARTED|Overall Study||42
10084975|NCT02288364|11213744|FG001|STARTED|Overall Study||44
10084976|NCT02288364|11213743|FG000|COMPLETED|Overall Study||42
10084977|NCT02288364|11213744|FG001|COMPLETED|Overall Study||44
10084978|NCT02288364|11213743|FG000|NOT COMPLETED|Overall Study||0
10084979|NCT02288364|11213744|FG001|NOT COMPLETED|Overall Study||0
10084980|NCT02288377|11213752|FG000|STARTED|Overall Study||26
10084981|NCT02288377|11213753|FG001|STARTED|Overall Study||27
10084982|NCT02288377|11213752|FG000|COMPLETED|Overall Study||25
10084983|NCT02288377|11213753|FG001|COMPLETED|Overall Study||27
10084984|NCT02288377|11213752|FG000|NOT COMPLETED|Overall Study||1
10084985|NCT02288377|11213753|FG001|NOT COMPLETED|Overall Study||0
10084986|NCT02288559|11213763|FG000|STARTED|Overall Study||10
10084987|NCT02288559|11213764|FG001|STARTED|Overall Study||11
10084988|NCT02288559|11213765|FG002|STARTED|Overall Study||46
10084989|NCT02288559|11213766|FG003|STARTED|Overall Study||22
10084990|NCT02288559|11213763|FG000|COMPLETED|Overall Study||9
10084991|NCT02288559|11213764|FG001|COMPLETED|Overall Study||10
10084992|NCT02288559|11213765|FG002|COMPLETED|Overall Study||35
10084993|NCT02288559|11213766|FG003|COMPLETED|Overall Study||20
10084994|NCT02288559|11213763|FG000|NOT COMPLETED|Overall Study||1
10084995|NCT02288559|11213764|FG001|NOT COMPLETED|Overall Study||1
10084996|NCT02288559|11213765|FG002|NOT COMPLETED|Overall Study||11
10084997|NCT02288559|11213766|FG003|NOT COMPLETED|Overall Study||2
10084998|NCT02288819|11213778|FG000|STARTED|Overall Study||50
10084999|NCT02288819|11213778|FG000|COMPLETED|Overall Study||50
10085000|NCT02288819|11213778|FG000|NOT COMPLETED|Overall Study||0
10085001|NCT02289079|11213784|FG000|STARTED|Overall Study||30
10085002|NCT02289079|11213785|FG001|STARTED|Overall Study||30
10085003|NCT02289079|11213784|FG000|COMPLETED|Overall Study||28
10085004|NCT02289079|11213785|FG001|COMPLETED|Overall Study||29
10085005|NCT02289079|11213784|FG000|NOT COMPLETED|Overall Study||2
10085006|NCT02289079|11213785|FG001|NOT COMPLETED|Overall Study||1
10085007|NCT02289105|11213793|FG000|STARTED|Overall Study||642
10085008|NCT02289105|11213794|FG001|STARTED|Overall Study||637
10085009|NCT02289105|11213793|FG000|COMPLETED|Overall Study||642
10085010|NCT02289105|11213794|FG001|COMPLETED|Overall Study||637
10085011|NCT02289105|11213793|FG000|NOT COMPLETED|Overall Study||0
10085012|NCT02289105|11213794|FG001|NOT COMPLETED|Overall Study||0
10085013|NCT02289157|11213802|FG000|STARTED|Overall Study||222
10085014|NCT02289157|11213803|FG001|STARTED|Overall Study||219
10085015|NCT02289157|11213802|FG000|No Post op Check or Follow up Phone Call|Overall Study||2
10085016|NCT02289157|11213803|FG001|No Post op Check or Follow up Phone Call|Overall Study||4
10085017|NCT02289157|11213802|FG000|COMPLETED|Overall Study||222
10085018|NCT02289157|11213803|FG001|COMPLETED|Overall Study||219
10085019|NCT02289157|11213802|FG000|NOT COMPLETED|Overall Study||0
10085020|NCT02289157|11213803|FG001|NOT COMPLETED|Overall Study||0
10200601|NCT03426995|11328360|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200602|NCT03426995|11328342|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200603|NCT03426995|11328343|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200604|NCT03426995|11328344|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200605|NCT03426995|11328345|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200606|NCT03426995|11328346|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200607|NCT03426995|11328347|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200608|NCT03426995|11328348|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200609|NCT03426995|11328349|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200610|NCT03426995|11328350|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200611|NCT03426995|11328351|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200612|NCT03426995|11328352|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200613|NCT03426995|11328353|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200614|NCT03426995|11328354|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200615|NCT03426995|11328355|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200616|NCT03426995|11328356|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200617|NCT03426995|11328357|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200618|NCT03426995|11328358|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200619|NCT03426995|11328359|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200620|NCT03426995|11328360|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10200621|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200622|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200623|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200624|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200625|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200626|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200627|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
10200628|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
10200629|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
10085021|NCT02289222|11213809|FG000|STARTED|Overall Study||48
10085022|NCT02289222|11213809|FG000|COMPLETED|Overall Study||48
10085023|NCT02289222|11213809|FG000|NOT COMPLETED|Overall Study||0
10085024|NCT02289352|11213816|FG000|STARTED|Overall Study||199
10085025|NCT02289352|11213817|FG001|STARTED|Overall Study||199
10085026|NCT02289352|11213818|FG002|STARTED|Overall Study||64
10200630|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
10200631|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
10200632|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
10200633|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200634|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200635|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200636|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200637|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200638|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200639|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10200640|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200641|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200642|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200643|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200644|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200645|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200646|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
10200647|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
10200648|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
10200649|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
10200650|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
10200651|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
10200652|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200653|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200654|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200655|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200656|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200657|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200658|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200659|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200660|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200661|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200662|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200663|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200664|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200665|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200666|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200667|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10085027|NCT02289352|11213816|FG000|Safety Population|Overall Study||199
10085028|NCT02289352|11213817|FG001|Safety Population|Overall Study||199
10085029|NCT02289352|11213818|FG002|Safety Population|Overall Study||64
10200668|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200669|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200670|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200671|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200672|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200673|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200674|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200675|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200676|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200677|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10200678|NCT03426995|11328342|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200679|NCT03426995|11328343|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200680|NCT03426995|11328344|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200681|NCT03426995|11328345|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200682|NCT03426995|11328346|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200683|NCT03426995|11328347|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200684|NCT03426995|11328348|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10200685|NCT03426995|11328349|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10200686|NCT03426995|11328350|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10200687|NCT03426995|11328351|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10200688|NCT03426995|11328352|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10200689|NCT03426995|11328353|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10200690|NCT03426995|11328354|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200691|NCT03426995|11328355|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200692|NCT03426995|11328356|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200693|NCT03426995|11328357|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200694|NCT03426995|11328358|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200695|NCT03426995|11328359|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200696|NCT03426995|11328360|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200697|NCT03426995|11328342|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200698|NCT03426995|11328343|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200699|NCT03426995|11328344|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200700|NCT03426995|11328345|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200701|NCT03426995|11328346|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200702|NCT03426995|11328347|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200703|NCT03426995|11328348|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10200704|NCT03426995|11328349|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10200705|NCT03426995|11328350|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10200706|NCT03426995|11328351|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10200707|NCT03426995|11328352|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10200708|NCT03426995|11328353|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10200709|NCT03426995|11328354|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200710|NCT03426995|11328355|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200711|NCT03426995|11328356|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200712|NCT03426995|11328357|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200713|NCT03426995|11328358|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200714|NCT03426995|11328359|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200715|NCT03426995|11328360|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200716|NCT03426995|11328342|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200717|NCT03426995|11328343|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200718|NCT03426995|11328344|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200719|NCT03426995|11328345|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200720|NCT03426995|11328346|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200721|NCT03426995|11328347|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200722|NCT03426995|11328348|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200723|NCT03426995|11328349|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200724|NCT03426995|11328350|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200725|NCT03426995|11328351|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200726|NCT03426995|11328352|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200727|NCT03426995|11328353|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200728|NCT03426995|11328354|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200729|NCT03426995|11328355|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200730|NCT03426995|11328356|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200731|NCT03426995|11328357|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200732|NCT03426995|11328358|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200733|NCT03426995|11328359|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200734|NCT03426995|11328360|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10200735|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200736|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200737|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200738|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200739|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200740|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200741|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
10200742|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
10200743|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
10200744|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
10200745|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
10200746|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
10200747|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200748|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200749|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200750|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200751|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200752|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200753|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10200754|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200755|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200756|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200757|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200758|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200759|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200760|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
10200761|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
10085030|NCT02289352|11213816|FG000|mITT Population|Overall Study||191
10085031|NCT02289352|11213817|FG001|mITT Population|Overall Study||193
10085032|NCT02289352|11213818|FG002|mITT Population|Overall Study||58
10085033|NCT02289352|11213816|FG000|PP Population|Overall Study||173
10085034|NCT02289352|11213817|FG001|PP Population|Overall Study||173
10085035|NCT02289352|11213818|FG002|PP Population|Overall Study||54
10085036|NCT02289352|11213816|FG000|COMPLETED|Overall Study||198
10085037|NCT02289352|11213817|FG001|COMPLETED|Overall Study||198
10085038|NCT02289352|11213818|FG002|COMPLETED|Overall Study||64
10085039|NCT02289352|11213816|FG000|NOT COMPLETED|Overall Study||1
10085040|NCT02289352|11213817|FG001|NOT COMPLETED|Overall Study||1
10085041|NCT02289352|11213818|FG002|NOT COMPLETED|Overall Study||0
10085042|NCT02289417|11213830|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58
10085043|NCT02289417|11213831|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57
10085044|NCT02289417|11213832|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55
10085045|NCT02289417|11213833|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10085046|NCT02289417|11213834|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10085047|NCT02289417|11213835|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10085048|NCT02289417|11213836|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10085049|NCT02289417|11213837|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10085050|NCT02289417|11213838|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10085051|NCT02289417|11213830|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
10085052|NCT02289417|11213831|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
10085053|NCT02289417|11213832|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
10085054|NCT02289417|11213833|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085055|NCT02289417|11213834|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085056|NCT02289417|11213835|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085057|NCT02289417|11213836|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085058|NCT02289417|11213837|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085059|NCT02289417|11213838|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085060|NCT02289417|11213830|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
10085061|NCT02289417|11213831|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
10085062|NCT02289417|11213832|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
10085063|NCT02289417|11213833|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085064|NCT02289417|11213834|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085065|NCT02289417|11213835|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085066|NCT02289417|11213836|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085067|NCT02289417|11213837|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085068|NCT02289417|11213838|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10085069|NCT02289417|11213830|FG000|STARTED|Active Treatment Phase Weeks 12-52||0
10085070|NCT02289417|11213831|FG001|STARTED|Active Treatment Phase Weeks 12-52||41
10085071|NCT02289417|11213832|FG002|STARTED|Active Treatment Phase Weeks 12-52||42
10085072|NCT02289417|11213833|FG003|STARTED|Active Treatment Phase Weeks 12-52||26
10085073|NCT02289417|11213834|FG004|STARTED|Active Treatment Phase Weeks 12-52||25
10085074|NCT02289417|11213835|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
10085075|NCT02289417|11213836|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
10085076|NCT02289417|11213837|FG007|STARTED|Active Treatment Phase Weeks 12-52||0
10085077|NCT02289417|11213838|FG008|STARTED|Active Treatment Phase Weeks 12-52||0
10085078|NCT02289417|11213830|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0
10200762|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
10200763|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
10200764|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
10239817|NCT02376946|11371548|FG001|NOT COMPLETED|Overall Study||0
10200765|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
10200766|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200767|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200768|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200769|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200770|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200771|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200772|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200773|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10085079|NCT02289417|11213831|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39
10085080|NCT02289417|11213832|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32
10085081|NCT02289417|11213833|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17
10085082|NCT02289417|11213834|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20
10085083|NCT02289417|11213835|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7
10085084|NCT02289417|11213836|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5
10085085|NCT02289417|11213837|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0
10085086|NCT02289417|11213838|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0
10085087|NCT02289417|11213830|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
10085088|NCT02289417|11213831|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
10085089|NCT02289417|11213832|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
10085090|NCT02289417|11213833|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
10085091|NCT02289417|11213834|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
10085092|NCT02289417|11213835|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
10085093|NCT02289417|11213836|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
10085094|NCT02289417|11213837|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
10085095|NCT02289417|11213838|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
10085096|NCT02289417|11213830|FG000|STARTED|Extension Phase Weeks 52-104||0
10085097|NCT02289417|11213831|FG001|STARTED|Extension Phase Weeks 52-104||0
10085098|NCT02289417|11213832|FG002|STARTED|Extension Phase Weeks 52-104||0
10085099|NCT02289417|11213833|FG003|STARTED|Extension Phase Weeks 52-104||0
10085100|NCT02289417|11213834|FG004|STARTED|Extension Phase Weeks 52-104||0
10085101|NCT02289417|11213835|FG005|STARTED|Extension Phase Weeks 52-104||0
10085102|NCT02289417|11213836|FG006|STARTED|Extension Phase Weeks 52-104||0
10085103|NCT02289417|11213837|FG007|STARTED|Extension Phase Weeks 52-104||45
10085104|NCT02289417|11213838|FG008|STARTED|Extension Phase Weeks 52-104||54
10085105|NCT02289417|11213830|FG000|COMPLETED|Extension Phase Weeks 52-104||0
10085106|NCT02289417|11213831|FG001|COMPLETED|Extension Phase Weeks 52-104||0
10085107|NCT02289417|11213832|FG002|COMPLETED|Extension Phase Weeks 52-104||0
10085108|NCT02289417|11213833|FG003|COMPLETED|Extension Phase Weeks 52-104||0
10085109|NCT02289417|11213834|FG004|COMPLETED|Extension Phase Weeks 52-104||0
10085110|NCT02289417|11213835|FG005|COMPLETED|Extension Phase Weeks 52-104||0
10085111|NCT02289417|11213836|FG006|COMPLETED|Extension Phase Weeks 52-104||0
10085112|NCT02289417|11213837|FG007|COMPLETED|Extension Phase Weeks 52-104||38
10085113|NCT02289417|11213838|FG008|COMPLETED|Extension Phase Weeks 52-104||48
10085114|NCT02289417|11213830|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0
10085115|NCT02289417|11213831|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0
10085116|NCT02289417|11213832|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0
10085117|NCT02289417|11213833|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0
10085118|NCT02289417|11213834|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0
10085119|NCT02289417|11213835|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0
10085120|NCT02289417|11213836|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0
10085121|NCT02289417|11213837|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7
10085122|NCT02289417|11213838|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6
10085123|NCT02289456|11213854|FG000|STARTED|Induction Period||40
10085124|NCT02289456|11213854|FG000|Treated Population|Induction Period||40
10085125|NCT02289456|11213854|FG000|COMPLETED|Induction Period||16
10085126|NCT02289456|11213854|FG000|NOT COMPLETED|Induction Period||24
10085127|NCT02289456|11213854|FG000|STARTED|Monotherapy Period||16
10085128|NCT02289456|11213854|FG000|COMPLETED|Monotherapy Period||0
10085129|NCT02289456|11213854|FG000|NOT COMPLETED|Monotherapy Period||16
10085130|NCT02289469|11213865|FG000|STARTED|Overall Study||250
10085131|NCT02289469|11213866|FG001|STARTED|Overall Study||244
10085132|NCT02289469|11213865|FG000|COMPLETED|Overall Study||244
10085133|NCT02289469|11213866|FG001|COMPLETED|Overall Study||244
10085134|NCT02289469|11213865|FG000|NOT COMPLETED|Overall Study||6
10085135|NCT02289469|11213866|FG001|NOT COMPLETED|Overall Study||0
10085136|NCT02289690|11213882|FG000|STARTED|Overall Study||4
10085137|NCT02289690|11213883|FG001|STARTED|Overall Study||3
10085138|NCT02289690|11213884|FG002|STARTED|Overall Study||4
10085139|NCT02289690|11213885|FG003|STARTED|Overall Study||3
10085140|NCT02289690|11213886|FG004|STARTED|Overall Study||8
10085141|NCT02289690|11213887|FG005|STARTED|Overall Study||14
10085142|NCT02289690|11213888|FG006|STARTED|Overall Study||4
10085143|NCT02289690|11213889|FG007|STARTED|Overall Study||61
10085144|NCT02289690|11213890|FG008|STARTED|Overall Study||59
10085145|NCT02289690|11213891|FG009|STARTED|Overall Study||61
10085146|NCT02289690|11213882|FG000|Received Study Drug|Overall Study||4
10085147|NCT02289690|11213883|FG001|Received Study Drug|Overall Study||3
10085148|NCT02289690|11213884|FG002|Received Study Drug|Overall Study||4
10085149|NCT02289690|11213885|FG003|Received Study Drug|Overall Study||3
10085150|NCT02289690|11213886|FG004|Received Study Drug|Overall Study||8
10200774|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200775|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200776|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200777|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200778|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200779|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200780|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200781|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200782|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200783|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200784|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200785|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200786|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200787|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200788|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200789|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200790|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200791|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10200792|NCT03426995|11328342|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200793|NCT03426995|11328343|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200794|NCT03426995|11328344|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200795|NCT03426995|11328345|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200796|NCT03426995|11328346|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200797|NCT03426995|11328347|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200798|NCT03426995|11328348|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10200799|NCT03426995|11328349|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10200800|NCT03426995|11328350|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10200801|NCT03426995|11328351|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10200802|NCT03426995|11328352|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10200803|NCT03426995|11328353|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10200804|NCT03426995|11328354|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200805|NCT03426995|11328355|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200806|NCT03426995|11328356|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200807|NCT03426995|11328357|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200808|NCT03426995|11328358|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200809|NCT03426995|11328359|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200810|NCT03426995|11328360|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200811|NCT03426995|11328342|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10085151|NCT02289690|11213887|FG005|Received Study Drug|Overall Study||14
10085152|NCT02289690|11213888|FG006|Received Study Drug|Overall Study||4
10085153|NCT02289690|11213889|FG007|Received Study Drug|Overall Study||60
10085154|NCT02289690|11213890|FG008|Received Study Drug|Overall Study||58
10085155|NCT02289690|11213891|FG009|Received Study Drug|Overall Study||60
10085156|NCT02289690|11213882|FG000|COMPLETED|Overall Study||0
10085157|NCT02289690|11213883|FG001|COMPLETED|Overall Study||0
10085158|NCT02289690|11213884|FG002|COMPLETED|Overall Study||0
10085159|NCT02289690|11213885|FG003|COMPLETED|Overall Study||0
10085160|NCT02289690|11213886|FG004|COMPLETED|Overall Study||0
10085161|NCT02289690|11213887|FG005|COMPLETED|Overall Study||0
10085162|NCT02289690|11213888|FG006|COMPLETED|Overall Study||0
10085163|NCT02289690|11213889|FG007|COMPLETED|Overall Study||0
10085164|NCT02289690|11213890|FG008|COMPLETED|Overall Study||0
10085165|NCT02289690|11213891|FG009|COMPLETED|Overall Study||0
10085166|NCT02289690|11213882|FG000|NOT COMPLETED|Overall Study||4
10085167|NCT02289690|11213883|FG001|NOT COMPLETED|Overall Study||3
10085168|NCT02289690|11213884|FG002|NOT COMPLETED|Overall Study||4
10085169|NCT02289690|11213885|FG003|NOT COMPLETED|Overall Study||3
10085170|NCT02289690|11213886|FG004|NOT COMPLETED|Overall Study||8
10085171|NCT02289690|11213887|FG005|NOT COMPLETED|Overall Study||14
10200812|NCT03426995|11328343|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200813|NCT03426995|11328344|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200814|NCT03426995|11328345|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200815|NCT03426995|11328346|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200816|NCT03426995|11328347|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10085172|NCT02289690|11213888|FG006|NOT COMPLETED|Overall Study||4
10085173|NCT02289690|11213889|FG007|NOT COMPLETED|Overall Study||61
10200817|NCT03426995|11328348|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10200818|NCT03426995|11328349|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10200819|NCT03426995|11328350|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10200820|NCT03426995|11328351|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10200821|NCT03426995|11328352|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10200822|NCT03426995|11328353|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10200823|NCT03426995|11328354|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200824|NCT03426995|11328355|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10085174|NCT02289690|11213890|FG008|NOT COMPLETED|Overall Study||59
10085175|NCT02289690|11213891|FG009|NOT COMPLETED|Overall Study||61
10085176|NCT02289729|11213927|FG000|STARTED|Overall Study||59
10085177|NCT02289729|11213927|FG000|COMPLETED|Overall Study||53
10085178|NCT02289729|11213927|FG000|NOT COMPLETED|Overall Study||6
10085179|NCT02289742|11213933|FG000|STARTED|First Wear Period||11
10085180|NCT02289742|11213934|FG001|STARTED|First Wear Period||12
10200825|NCT03426995|11328356|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200826|NCT03426995|11328357|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200827|NCT03426995|11328358|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200828|NCT03426995|11328359|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200829|NCT03426995|11328360|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200830|NCT03426995|11328342|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200831|NCT03426995|11328343|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200832|NCT03426995|11328344|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200833|NCT03426995|11328345|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10085181|NCT02289742|11213935|FG002|STARTED|First Wear Period||12
10085182|NCT02289742|11213936|FG003|STARTED|First Wear Period||10
10085183|NCT02289742|11213933|FG000|Treated|First Wear Period||11
10085184|NCT02289742|11213934|FG001|Treated|First Wear Period||11
10085185|NCT02289742|11213935|FG002|Treated|First Wear Period||12
10085186|NCT02289742|11213936|FG003|Treated|First Wear Period||9
10085187|NCT02289742|11213933|FG000|COMPLETED|First Wear Period||11
10085188|NCT02289742|11213934|FG001|COMPLETED|First Wear Period||11
10085189|NCT02289742|11213935|FG002|COMPLETED|First Wear Period||11
10085190|NCT02289742|11213936|FG003|COMPLETED|First Wear Period||9
10085191|NCT02289742|11213933|FG000|NOT COMPLETED|First Wear Period||0
10085192|NCT02289742|11213934|FG001|NOT COMPLETED|First Wear Period||1
10085193|NCT02289742|11213935|FG002|NOT COMPLETED|First Wear Period||1
10085194|NCT02289742|11213936|FG003|NOT COMPLETED|First Wear Period||1
10085195|NCT02289742|11213933|FG000|STARTED|Second Wear Period||11
10085196|NCT02289742|11213934|FG001|STARTED|Second Wear Period||11
10085197|NCT02289742|11213935|FG002|STARTED|Second Wear Period||11
10085198|NCT02289742|11213936|FG003|STARTED|Second Wear Period||9
10085199|NCT02289742|11213933|FG000|COMPLETED|Second Wear Period||11
10085200|NCT02289742|11213934|FG001|COMPLETED|Second Wear Period||11
10085201|NCT02289742|11213935|FG002|COMPLETED|Second Wear Period||11
10085202|NCT02289742|11213936|FG003|COMPLETED|Second Wear Period||9
10085203|NCT02289742|11213933|FG000|NOT COMPLETED|Second Wear Period||0
10085204|NCT02289742|11213934|FG001|NOT COMPLETED|Second Wear Period||0
10200834|NCT03426995|11328346|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200835|NCT03426995|11328347|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200836|NCT03426995|11328348|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200837|NCT03426995|11328349|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200838|NCT03426995|11328350|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200839|NCT03426995|11328351|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200840|NCT03426995|11328352|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200841|NCT03426995|11328353|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200842|NCT03426995|11328354|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200843|NCT03426995|11328355|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200844|NCT03426995|11328356|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200845|NCT03426995|11328357|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200846|NCT03426995|11328358|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10200847|NCT03426995|11328359|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9736907|NCT00196976|10837595|FG004|NOT COMPLETED|Booster Study||0
9736908|NCT00196976|10837596|FG005|NOT COMPLETED|Booster Study||0
10085205|NCT02289742|11213935|FG002|NOT COMPLETED|Second Wear Period||0
10085206|NCT02289742|11213936|FG003|NOT COMPLETED|Second Wear Period||0
10085207|NCT02289742|11213933|FG000|STARTED|Third Wear Period||11
10085208|NCT02289742|11213934|FG001|STARTED|Third Wear Period||11
10085209|NCT02289742|11213935|FG002|STARTED|Third Wear Period||11
10085210|NCT02289742|11213936|FG003|STARTED|Third Wear Period||9
10085211|NCT02289742|11213933|FG000|COMPLETED|Third Wear Period||11
10085212|NCT02289742|11213934|FG001|COMPLETED|Third Wear Period||10
10085213|NCT02289742|11213935|FG002|COMPLETED|Third Wear Period||11
10085214|NCT02289742|11213936|FG003|COMPLETED|Third Wear Period||8
10085215|NCT02289742|11213933|FG000|NOT COMPLETED|Third Wear Period||0
10085216|NCT02289742|11213934|FG001|NOT COMPLETED|Third Wear Period||1
10200848|NCT03426995|11328360|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10085217|NCT02289742|11213935|FG002|NOT COMPLETED|Third Wear Period||0
10085218|NCT02289742|11213936|FG003|NOT COMPLETED|Third Wear Period||1
10085219|NCT02289755|11213950|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16
10085220|NCT02289755|11213950|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
10200849|NCT03426995|11328342|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200850|NCT03426995|11328343|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200851|NCT03426995|11328344|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200852|NCT03426995|11328345|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200853|NCT03426995|11328346|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200854|NCT03426995|11328347|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200855|NCT03426995|11328348|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
10200856|NCT03426995|11328349|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
10200857|NCT03426995|11328350|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
9736909|NCT00196976|10837597|FG006|NOT COMPLETED|Booster Study||0
9736910|NCT00196976|10837598|FG007|NOT COMPLETED|Booster Study||0
9736911|NCT00196976|10837599|FG008|NOT COMPLETED|Booster Study||0
9736912|NCT00196976|10837600|FG009|NOT COMPLETED|Booster Study||0
9736913|NCT00196976|10837601|FG010|NOT COMPLETED|Booster Study||2
9736914|NCT00196976|10837602|FG011|NOT COMPLETED|Booster Study||2
9736915|NCT00196976|10837603|FG012|NOT COMPLETED|Booster Study||0
9736916|NCT00196976|10837604|FG013|NOT COMPLETED|Booster Study||0
9736917|NCT00197002|10837647|FG000|STARTED|Overall Study||147
10085221|NCT02289755|11213950|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
10085222|NCT02289755|11213950|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16
10085223|NCT02289755|11213950|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
10085224|NCT02289755|11213950|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
10085225|NCT02289755|11213950|FG000|STARTED|Follow up Period [4 Days]||16
10200858|NCT03426995|11328351|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
9736918|NCT00197002|10837648|FG001|STARTED|Overall Study||137
9736919|NCT00197002|10837649|FG002|STARTED|Overall Study||149
9736920|NCT00197002|10837647|FG000|COMPLETED|Overall Study||125
9736921|NCT00197002|10837648|FG001|COMPLETED|Overall Study||119
9736922|NCT00197002|10837649|FG002|COMPLETED|Overall Study||132
9736923|NCT00197002|10837647|FG000|NOT COMPLETED|Overall Study||22
9736924|NCT00197002|10837648|FG001|NOT COMPLETED|Overall Study||18
9736925|NCT00197002|10837649|FG002|NOT COMPLETED|Overall Study||17
9736926|NCT00197015|10837663|FG000|STARTED|Overall Study||324
9736927|NCT00197015|10837664|FG001|STARTED|Overall Study||455
9736928|NCT00197015|10837665|FG002|STARTED|Overall Study||462
9736929|NCT00197015|10837663|FG000|COMPLETED|Overall Study||274
9736930|NCT00197015|10837664|FG001|COMPLETED|Overall Study||366
9736931|NCT00197015|10837665|FG002|COMPLETED|Overall Study||385
9736932|NCT00197015|10837663|FG000|NOT COMPLETED|Overall Study||50
9736933|NCT00197015|10837664|FG001|NOT COMPLETED|Overall Study||89
9736934|NCT00197015|10837665|FG002|NOT COMPLETED|Overall Study||77
9736935|NCT00197028|10837675|FG000|STARTED|Overall Study||107
9736936|NCT00197028|10837676|FG001|STARTED|Overall Study||107
9736937|NCT00197028|10837675|FG000|COMPLETED|Overall Study||91
9736938|NCT00197028|10837676|FG001|COMPLETED|Overall Study||86
9736939|NCT00197028|10837675|FG000|NOT COMPLETED|Overall Study||16
9736940|NCT00197028|10837676|FG001|NOT COMPLETED|Overall Study||21
9736941|NCT00197054|10837685|FG000|STARTED|Overall Study||85
9736942|NCT00197054|10837686|FG001|STARTED|Overall Study||85
9736943|NCT00197054|10837687|FG002|STARTED|Overall Study||85
9736944|NCT00197054|10837685|FG000|COMPLETED|Overall Study||68
9736945|NCT00197054|10837686|FG001|COMPLETED|Overall Study||64
9736946|NCT00197054|10837687|FG002|COMPLETED|Overall Study||73
9736947|NCT00197054|10837685|FG000|NOT COMPLETED|Overall Study||17
9736948|NCT00197054|10837686|FG001|NOT COMPLETED|Overall Study||21
9736949|NCT00197054|10837687|FG002|NOT COMPLETED|Overall Study||12
9736950|NCT00197106|10837707|FG000|STARTED|4-Week Run-In Period||257
9736951|NCT00197106|10837708|FG001|STARTED|4-Week Run-In Period||0
9736952|NCT00197106|10837709|FG002|STARTED|4-Week Run-In Period||0
9736953|NCT00197106|10837707|FG000|COMPLETED|4-Week Run-In Period||158
9736954|NCT00197106|10837708|FG001|COMPLETED|4-Week Run-In Period||0
9736955|NCT00197106|10837709|FG002|COMPLETED|4-Week Run-In Period||0
9736956|NCT00197106|10837707|FG000|NOT COMPLETED|4-Week Run-In Period||99
9736957|NCT00197106|10837708|FG001|NOT COMPLETED|4-Week Run-In Period||0
9736958|NCT00197106|10837709|FG002|NOT COMPLETED|4-Week Run-In Period||0
10085226|NCT02289755|11213950|FG000|COMPLETED|Follow up Period [4 Days]||16
10085227|NCT02289755|11213950|FG000|NOT COMPLETED|Follow up Period [4 Days]||0
10085228|NCT02289820|11213961|FG000|STARTED|Overall Study||39
10085229|NCT02289820|11213962|FG001|STARTED|Overall Study||20
10200859|NCT03426995|11328352|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
10200860|NCT03426995|11328353|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
10200861|NCT03426995|11328354|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200862|NCT03426995|11328355|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200863|NCT03426995|11328356|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9736959|NCT00197106|10837707|FG000|STARTED|Overall Treatment Period||0
10085230|NCT02289820|11213963|FG002|STARTED|Overall Study||44
10085231|NCT02289820|11213964|FG003|STARTED|Overall Study||39
10085232|NCT02289820|11213965|FG004|STARTED|Overall Study||40
10085233|NCT02289820|11213966|FG005|STARTED|Overall Study||40
10085234|NCT02289820|11213967|FG006|STARTED|Overall Study||39
10085235|NCT02289820|11213961|FG000|COMPLETED|Overall Study||37
10085236|NCT02289820|11213962|FG001|COMPLETED|Overall Study||18
10200864|NCT03426995|11328357|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200865|NCT03426995|11328358|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200866|NCT03426995|11328359|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200867|NCT03426995|11328360|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10200868|NCT03426995|11328342|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10085237|NCT02289820|11213963|FG002|COMPLETED|Overall Study||38
10085238|NCT02289820|11213964|FG003|COMPLETED|Overall Study||37
10085239|NCT02289820|11213965|FG004|COMPLETED|Overall Study||40
10085240|NCT02289820|11213966|FG005|COMPLETED|Overall Study||39
10085241|NCT02289820|11213967|FG006|COMPLETED|Overall Study||37
10085242|NCT02289820|11213961|FG000|NOT COMPLETED|Overall Study||2
10085243|NCT02289820|11213962|FG001|NOT COMPLETED|Overall Study||2
10085244|NCT02289820|11213963|FG002|NOT COMPLETED|Overall Study||6
10085245|NCT02289820|11213964|FG003|NOT COMPLETED|Overall Study||2
10085246|NCT02289820|11213965|FG004|NOT COMPLETED|Overall Study||0
10085247|NCT02289820|11213966|FG005|NOT COMPLETED|Overall Study||1
10085248|NCT02289820|11213967|FG006|NOT COMPLETED|Overall Study||2
10085249|NCT02289833|11213989|FG000|STARTED|Overall Study||29
10085250|NCT02289833|11213990|FG001|STARTED|Overall Study||20
10085251|NCT02289833|11213989|FG000|COMPLETED|Overall Study||2
10085252|NCT02289833|11213990|FG001|COMPLETED|Overall Study||3
10085253|NCT02289833|11213989|FG000|NOT COMPLETED|Overall Study||27
10085254|NCT02289833|11213990|FG001|NOT COMPLETED|Overall Study||17
10112757|NCT02504931|11243685|FG000|NOT COMPLETED|Overall Study||12
10112758|NCT02504931|11243686|FG001|NOT COMPLETED|Overall Study||10
10112759|NCT02505217|11243694|FG000|STARTED|Overall Study||105
10112760|NCT02505217|11243695|FG001|STARTED|Overall Study||95
10112761|NCT02505217|11243694|FG000|COMPLETED|Overall Study||104
10112762|NCT02505217|11243695|FG001|COMPLETED|Overall Study||93
10112763|NCT02505217|11243694|FG000|NOT COMPLETED|Overall Study||1
10112764|NCT02505217|11243695|FG001|NOT COMPLETED|Overall Study||2
10112765|NCT02505269|11243701|FG000|STARTED|Overall Study||34
10112766|NCT02505269|11243701|FG000|COMPLETED|Overall Study||34
10112767|NCT02505269|11243701|FG000|NOT COMPLETED|Overall Study||0
10200869|NCT03426995|11328343|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200870|NCT03426995|11328344|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200871|NCT03426995|11328345|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200872|NCT03426995|11328346|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200873|NCT03426995|11328347|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200874|NCT03426995|11328348|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10200875|NCT03426995|11328349|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
10200876|NCT03426995|11328350|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10200877|NCT03426995|11328351|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
10200878|NCT03426995|11328352|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200879|NCT03426995|11328353|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
10200880|NCT03426995|11328354|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200881|NCT03426995|11328355|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200882|NCT03426995|11328356|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200883|NCT03426995|11328357|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200884|NCT03426995|11328358|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200885|NCT03426995|11328359|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200886|NCT03426995|11328360|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200887|NCT03426995|11328342|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200888|NCT03426995|11328343|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200889|NCT03426995|11328344|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200890|NCT03426995|11328345|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200891|NCT03426995|11328346|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200892|NCT03426995|11328347|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200893|NCT03426995|11328348|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200894|NCT03426995|11328349|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10112768|NCT02505334|11243707|FG000|STARTED|Main Treatment Period||233
10112769|NCT02505334|11243708|FG001|STARTED|Main Treatment Period||233
10112770|NCT02505334|11243707|FG000|COMPLETED|Main Treatment Period||218
10112771|NCT02505334|11243708|FG001|COMPLETED|Main Treatment Period||194
10112772|NCT02505334|11243707|FG000|NOT COMPLETED|Main Treatment Period||15
10200895|NCT03426995|11328350|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200896|NCT03426995|11328351|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10085255|NCT02289898|11214001|FG000|STARTED|Overall Study||68
10085256|NCT02289898|11214002|FG001|STARTED|Overall Study||71
10085257|NCT02289898|11214003|FG002|STARTED|Overall Study||65
10085258|NCT02289898|11214001|FG000|COMPLETED|Overall Study||16
10085259|NCT02289898|11214002|FG001|COMPLETED|Overall Study||18
10085260|NCT02289898|11214003|FG002|COMPLETED|Overall Study||9
10085261|NCT02289898|11214001|FG000|NOT COMPLETED|Overall Study||52
10085262|NCT02289898|11214002|FG001|NOT COMPLETED|Overall Study||53
10085263|NCT02289898|11214003|FG002|NOT COMPLETED|Overall Study||56
10085264|NCT02289950|11214012|FG000|STARTED|Overall Study||142
10085265|NCT02289950|11214013|FG001|STARTED|Overall Study||72
10085266|NCT02289950|11214012|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140
10085267|NCT02289950|11214013|FG001|Treated|Overall Study||71
10085268|NCT02289950|11214012|FG000|COMPLETED|Overall Study||0
10085269|NCT02289950|11214013|FG001|COMPLETED|Overall Study||0
10085270|NCT02289950|11214012|FG000|NOT COMPLETED|Overall Study||142
10085271|NCT02289950|11214013|FG001|NOT COMPLETED|Overall Study||72
10085272|NCT02289963|11214021|FG000|STARTED|Overall Study|Randomized|102
10085273|NCT02289963|11214022|FG001|STARTED|Overall Study|Randomized|97
10085274|NCT02289963|11214021|FG000|Treated|Overall Study||102
10085275|NCT02289963|11214022|FG001|Treated|Overall Study||97
10085276|NCT02289963|11214021|FG000|COMPLETED|Overall Study||97
10085277|NCT02289963|11214022|FG001|COMPLETED|Overall Study||87
10085278|NCT02289963|11214021|FG000|NOT COMPLETED|Overall Study||5
10085279|NCT02289963|11214022|FG001|NOT COMPLETED|Overall Study||10
10085280|NCT02289989|11214030|FG000|STARTED|Overall Study||0
10085281|NCT02289989|11214031|FG001|STARTED|Overall Study||1
10085282|NCT02289989|11214030|FG000|COMPLETED|Overall Study||0
10085283|NCT02289989|11214031|FG001|COMPLETED|Overall Study||1
10085284|NCT02289989|11214030|FG000|NOT COMPLETED|Overall Study||0
10200897|NCT03426995|11328352|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10200898|NCT03426995|11328353|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200899|NCT03426995|11328354|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200900|NCT03426995|11328355|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200901|NCT03426995|11328356|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200902|NCT03426995|11328357|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200903|NCT03426995|11328358|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200904|NCT03426995|11328359|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200905|NCT03426995|11328360|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10200906|NCT03426995|11328342|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10085285|NCT02289989|11214031|FG001|NOT COMPLETED|Overall Study||0
10085286|NCT02290028|11214037|FG000|STARTED|Overall Study||2226
10085287|NCT02290028|11214037|FG000|COMPLETED|Overall Study||0
10085288|NCT02290028|11214037|FG000|NOT COMPLETED|Overall Study||2226
10085289|NCT02290106|11214046|FG000|STARTED|Overall Study||25
10085290|NCT02290106|11214047|FG001|STARTED|Overall Study||25
10085291|NCT02290106|11214046|FG000|COMPLETED|Overall Study||24
10085292|NCT02290106|11214047|FG001|COMPLETED|Overall Study||23
10085293|NCT02290106|11214046|FG000|NOT COMPLETED|Overall Study||1
10085294|NCT02290106|11214047|FG001|NOT COMPLETED|Overall Study||2
10085295|NCT02290184|11214055|FG000|STARTED|Overall Study||22
10200907|NCT03426995|11328343|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200908|NCT03426995|11328344|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200909|NCT03426995|11328345|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200910|NCT03426995|11328346|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200911|NCT03426995|11328347|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200912|NCT03426995|11328348|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200913|NCT03426995|11328349|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200914|NCT03426995|11328350|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200915|NCT03426995|11328351|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200916|NCT03426995|11328352|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200917|NCT03426995|11328353|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200918|NCT03426995|11328354|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200919|NCT03426995|11328355|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200920|NCT03426995|11328356|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200921|NCT03426995|11328357|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200922|NCT03426995|11328358|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200923|NCT03426995|11328359|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200924|NCT03426995|11328360|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10200925|NCT03426995|11328342|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200926|NCT03426995|11328343|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200927|NCT03426995|11328344|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200928|NCT03426995|11328345|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200929|NCT03426995|11328346|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200930|NCT03426995|11328347|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200931|NCT03426995|11328348|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200932|NCT03426995|11328349|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200933|NCT03426995|11328350|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200934|NCT03426995|11328351|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200935|NCT03426995|11328352|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200936|NCT03426995|11328353|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200937|NCT03426995|11328354|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200938|NCT03426995|11328355|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200939|NCT03426995|11328356|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200940|NCT03426995|11328357|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200941|NCT03426995|11328358|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200942|NCT03426995|11328359|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200943|NCT03426995|11328360|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200944|NCT03426995|11328342|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200945|NCT03426995|11328343|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200946|NCT03426995|11328344|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200947|NCT03426995|11328345|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200948|NCT03426995|11328346|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200949|NCT03426995|11328347|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200950|NCT03426995|11328348|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200951|NCT03426995|11328349|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200952|NCT03426995|11328350|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200953|NCT03426995|11328351|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200954|NCT03426995|11328352|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200955|NCT03426995|11328353|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200956|NCT03426995|11328354|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200957|NCT03426995|11328355|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200958|NCT03426995|11328356|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10085296|NCT02290184|11214056|FG001|STARTED|Overall Study||23
10085297|NCT02290184|11214055|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
10085298|NCT02290184|11214056|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
10085299|NCT02290184|11214055|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
10112773|NCT02505334|11243708|FG001|NOT COMPLETED|Main Treatment Period||39
10200959|NCT03426995|11328357|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200960|NCT03426995|11328358|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10085300|NCT02290184|11214056|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
10085301|NCT02290184|11214055|FG000|NOT COMPLETED|Overall Study||0
10085302|NCT02290184|11214056|FG001|NOT COMPLETED|Overall Study||0
10085303|NCT02290223|11214070|FG000|STARTED|Baseline||189
10085304|NCT02290223|11214071|FG001|STARTED|Baseline||187
10085305|NCT02290223|11214070|FG000|COMPLETED|Baseline||189
10085306|NCT02290223|11214071|FG001|COMPLETED|Baseline||187
10085307|NCT02290223|11214070|FG000|NOT COMPLETED|Baseline||0
10085308|NCT02290223|11214071|FG001|NOT COMPLETED|Baseline||0
10085309|NCT02290223|11214070|FG000|STARTED|6 Months||189
10085310|NCT02290223|11214071|FG001|STARTED|6 Months||187
10200961|NCT03426995|11328359|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200962|NCT03426995|11328360|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10200963|NCT03426995|11328342|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200964|NCT03426995|11328343|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200965|NCT03426995|11328344|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200966|NCT03426995|11328345|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200967|NCT03426995|11328346|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200968|NCT03426995|11328347|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200969|NCT03426995|11328348|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200970|NCT03426995|11328349|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200971|NCT03426995|11328350|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200972|NCT03426995|11328351|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200973|NCT03426995|11328352|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200974|NCT03426995|11328353|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200975|NCT03426995|11328354|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200976|NCT03426995|11328355|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200977|NCT03426995|11328356|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200978|NCT03426995|11328357|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200979|NCT03426995|11328358|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200980|NCT03426995|11328359|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200981|NCT03426995|11328360|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200982|NCT03426995|11328342|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200983|NCT03426995|11328343|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200984|NCT03426995|11328344|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200985|NCT03426995|11328345|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200986|NCT03426995|11328346|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200987|NCT03426995|11328347|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200988|NCT03426995|11328348|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200989|NCT03426995|11328349|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200990|NCT03426995|11328350|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200991|NCT03426995|11328351|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200992|NCT03426995|11328352|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200993|NCT03426995|11328353|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200994|NCT03426995|11328354|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200995|NCT03426995|11328355|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200996|NCT03426995|11328356|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200997|NCT03426995|11328357|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200998|NCT03426995|11328358|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10200999|NCT03426995|11328359|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201000|NCT03426995|11328360|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201001|NCT03426995|11328342|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201002|NCT03426995|11328343|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201003|NCT03426995|11328344|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201004|NCT03426995|11328345|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201005|NCT03426995|11328346|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201006|NCT03426995|11328347|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201007|NCT03426995|11328348|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201008|NCT03426995|11328349|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201009|NCT03426995|11328350|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201010|NCT03426995|11328351|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201011|NCT03426995|11328352|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201012|NCT03426995|11328353|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201013|NCT03426995|11328354|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201014|NCT03426995|11328355|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201015|NCT03426995|11328356|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201016|NCT03426995|11328357|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201017|NCT03426995|11328358|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201018|NCT03426995|11328359|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10239818|NCT01780636|11371554|FG000|STARTED|Overall Study||7
10085311|NCT02290223|11214070|FG000|COMPLETED|6 Months||173
10085312|NCT02290223|11214071|FG001|COMPLETED|6 Months||181
10085313|NCT02290223|11214070|FG000|NOT COMPLETED|6 Months||16
10085314|NCT02290223|11214071|FG001|NOT COMPLETED|6 Months||6
10113438|NCT02509117|11244194|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10085315|NCT02290223|11214070|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
10085316|NCT02290223|11214071|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
9736960|NCT00197106|10837708|FG001|STARTED|Overall Treatment Period||78
9736961|NCT00197106|10837709|FG002|STARTED|Overall Treatment Period||80
9852159|NCT00879879|10964961|FG000|NOT COMPLETED|Overall Study||3
10085317|NCT02290223|11214070|FG000|COMPLETED|12 Months||166
9736962|NCT00197106|10837707|FG000|COMPLETED|Overall Treatment Period||0
9736963|NCT00197106|10837708|FG001|COMPLETED|Overall Treatment Period||77
9736964|NCT00197106|10837709|FG002|COMPLETED|Overall Treatment Period||74
9736965|NCT00197106|10837707|FG000|NOT COMPLETED|Overall Treatment Period||0
10085318|NCT02290223|11214071|FG001|COMPLETED|12 Months||176
10085319|NCT02290223|11214070|FG000|NOT COMPLETED|12 Months||16
10085320|NCT02290223|11214071|FG001|NOT COMPLETED|12 Months||11
10085321|NCT02290340|11214081|FG000|STARTED|Overall Study||18
10085322|NCT02290340|11214082|FG001|STARTED|Overall Study||8
10085323|NCT02290340|11214083|FG002|STARTED|Overall Study||31
10085324|NCT02290340|11214084|FG003|STARTED|Overall Study||32
10085325|NCT02290340|11214081|FG000|COMPLETED|Overall Study||16
10085326|NCT02290340|11214082|FG001|COMPLETED|Overall Study||8
10085327|NCT02290340|11214083|FG002|COMPLETED|Overall Study||31
10085328|NCT02290340|11214084|FG003|COMPLETED|Overall Study||30
10085329|NCT02290340|11214081|FG000|NOT COMPLETED|Overall Study||2
10085330|NCT02290340|11214082|FG001|NOT COMPLETED|Overall Study||0
10085331|NCT02290340|11214083|FG002|NOT COMPLETED|Overall Study||0
10085332|NCT02290340|11214084|FG003|NOT COMPLETED|Overall Study||2
10085333|NCT02290405|11214099|FG000|STARTED|Overall Study||36
10085334|NCT02290405|11214100|FG001|STARTED|Overall Study||53
10085335|NCT02290405|11214099|FG000|COMPLETED|Overall Study||35
10085336|NCT02290405|11214100|FG001|COMPLETED|Overall Study||53
10085337|NCT02290405|11214099|FG000|NOT COMPLETED|Overall Study||1
10085338|NCT02290405|11214100|FG001|NOT COMPLETED|Overall Study||0
10085339|NCT02290444|11214108|FG000|STARTED|Overall Study||30
10085340|NCT02290444|11214109|FG001|STARTED|Overall Study||34
10085341|NCT02290444|11214108|FG000|COMPLETED|Overall Study||29
10085342|NCT02290444|11214109|FG001|COMPLETED|Overall Study||32
10085343|NCT02290444|11214108|FG000|NOT COMPLETED|Overall Study||1
10085344|NCT02290444|11214109|FG001|NOT COMPLETED|Overall Study||2
10085345|NCT02290509|11214117|FG000|STARTED|Overall Study||1011
10085346|NCT02290509|11214118|FG001|STARTED|Overall Study||339
10085347|NCT02290509|11214117|FG000|COMPLETED|Overall Study||962
10085348|NCT02290509|11214118|FG001|COMPLETED|Overall Study||325
10085349|NCT02290509|11214117|FG000|NOT COMPLETED|Overall Study||49
10085350|NCT02290509|11214118|FG001|NOT COMPLETED|Overall Study||14
10085351|NCT02290574|11214124|FG000|STARTED|Overall Study||14
10085352|NCT02290574|11214124|FG000|COMPLETED|Overall Study||13
10085353|NCT02290574|11214124|FG000|NOT COMPLETED|Overall Study||1
10085354|NCT02290613|11214131|FG000|STARTED|Overall Study||19
10085355|NCT02290613|11214132|FG001|STARTED|Overall Study||19
10085356|NCT02290613|11214131|FG000|COMPLETED|Overall Study||17
10085357|NCT02290613|11214132|FG001|COMPLETED|Overall Study||15
10085358|NCT02290613|11214131|FG000|NOT COMPLETED|Overall Study||2
10085359|NCT02290613|11214132|FG001|NOT COMPLETED|Overall Study||4
10085360|NCT02290691|11214140|FG000|STARTED|Overall Study||496
10085361|NCT02290691|11214141|FG001|STARTED|Overall Study||488
10085362|NCT02290691|11214140|FG000|COMPLETED|Overall Study||488
10085363|NCT02290691|11214141|FG001|COMPLETED|Overall Study||479
10085364|NCT02290691|11214140|FG000|NOT COMPLETED|Overall Study||8
10085365|NCT02290691|11214141|FG001|NOT COMPLETED|Overall Study||9
10085366|NCT02290821|11214149|FG000|STARTED|Overall Study||109
10085367|NCT02290821|11214150|FG001|STARTED|Overall Study||106
10085368|NCT02290821|11214149|FG000|COMPLETED|Overall Study||103
10085369|NCT02290821|11214150|FG001|COMPLETED|Overall Study||103
10085370|NCT02290821|11214149|FG000|NOT COMPLETED|Overall Study||6
10085371|NCT02290821|11214150|FG001|NOT COMPLETED|Overall Study||3
10085372|NCT02290873|11214159|FG000|STARTED|Overall Study||298
10085373|NCT02290873|11214160|FG001|STARTED|Overall Study||60
10085374|NCT02290873|11214161|FG002|STARTED|Overall Study||103
10085375|NCT02290873|11214159|FG000|Modified Intention to Treat (mITT)|Overall Study||296
10085376|NCT02290873|11214160|FG001|Modified Intention to Treat (mITT)|Overall Study||60
10085377|NCT02290873|11214161|FG002|Modified Intention to Treat (mITT)|Overall Study||102
10085378|NCT02290873|11214159|FG000|Safety Population|Overall Study||296
10085379|NCT02290873|11214160|FG001|Safety Population|Overall Study||60
10085380|NCT02290873|11214161|FG002|Safety Population|Overall Study||102
10085381|NCT02290873|11214159|FG000|COMPLETED|Overall Study||296
10085382|NCT02290873|11214160|FG001|COMPLETED|Overall Study||59
10085383|NCT02290873|11214161|FG002|COMPLETED|Overall Study||101
10085384|NCT02290873|11214159|FG000|NOT COMPLETED|Overall Study||2
10085385|NCT02290873|11214160|FG001|NOT COMPLETED|Overall Study||1
10085386|NCT02290873|11214161|FG002|NOT COMPLETED|Overall Study||2
10085387|NCT02290925|11214172|FG000|STARTED|First Period of Three Months||62
10085388|NCT02290925|11214173|FG001|STARTED|First Period of Three Months||71
10085389|NCT02290925|11214172|FG000|COMPLETED|First Period of Three Months||58
10085390|NCT02290925|11214173|FG001|COMPLETED|First Period of Three Months||69
10085391|NCT02290925|11214172|FG000|NOT COMPLETED|First Period of Three Months||4
10085392|NCT02290925|11214173|FG001|NOT COMPLETED|First Period of Three Months||2
10085393|NCT02290925|11214172|FG000|STARTED|Second Period of 3 Months||58
10085394|NCT02290925|11214173|FG001|STARTED|Second Period of 3 Months||69
10085395|NCT02290925|11214172|FG000|COMPLETED|Second Period of 3 Months||57
10085396|NCT02290925|11214173|FG001|COMPLETED|Second Period of 3 Months||65
10085397|NCT02290925|11214172|FG000|NOT COMPLETED|Second Period of 3 Months||1
10085398|NCT02290925|11214173|FG001|NOT COMPLETED|Second Period of 3 Months||4
10085399|NCT02291016|11214183|FG000|STARTED|Visit 1||2
10085400|NCT02291016|11214184|FG001|STARTED|Visit 1||5
10085401|NCT02291016|11214183|FG000|COMPLETED|Visit 1||2
10085402|NCT02291016|11214184|FG001|COMPLETED|Visit 1||5
10085403|NCT02291016|11214183|FG000|NOT COMPLETED|Visit 1||0
10085404|NCT02291016|11214184|FG001|NOT COMPLETED|Visit 1||0
10085405|NCT02291016|11214183|FG000|STARTED|Visit 2||2
10085406|NCT02291016|11214184|FG001|STARTED|Visit 2||5
10085407|NCT02291016|11214183|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
10085408|NCT02291016|11214184|FG001|COMPLETED|Visit 2||5
10085409|NCT02291016|11214183|FG000|NOT COMPLETED|Visit 2||1
10085410|NCT02291016|11214184|FG001|NOT COMPLETED|Visit 2||0
10085411|NCT02291029|11214197|FG000|STARTED|Overall Study||8
10085412|NCT02291029|11214198|FG001|STARTED|Overall Study||4
10085413|NCT02291029|11214199|FG002|STARTED|Overall Study||21
10085414|NCT02291029|11214200|FG003|STARTED|Overall Study||11
10085415|NCT02291029|11214201|FG004|STARTED|Overall Study||13
10085416|NCT02291029|11214202|FG005|STARTED|Overall Study||12
10085417|NCT02291029|11214197|FG000|COMPLETED|Overall Study||8
10085418|NCT02291029|11214198|FG001|COMPLETED|Overall Study||3
10085419|NCT02291029|11214199|FG002|COMPLETED|Overall Study||20
10085420|NCT02291029|11214200|FG003|COMPLETED|Overall Study||11
10085421|NCT02291029|11214201|FG004|COMPLETED|Overall Study||13
10085422|NCT02291029|11214202|FG005|COMPLETED|Overall Study||12
10085423|NCT02291029|11214197|FG000|NOT COMPLETED|Overall Study||0
10085424|NCT02291029|11214198|FG001|NOT COMPLETED|Overall Study||1
10085425|NCT02291029|11214199|FG002|NOT COMPLETED|Overall Study||1
10085426|NCT02291029|11214200|FG003|NOT COMPLETED|Overall Study||0
10201019|NCT03426995|11328360|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10201020|NCT03426995|11328342|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201021|NCT03426995|11328343|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201022|NCT03426995|11328344|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201023|NCT03426995|11328345|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201024|NCT03426995|11328346|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201025|NCT03426995|11328347|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10085427|NCT02291029|11214201|FG004|NOT COMPLETED|Overall Study||0
10085428|NCT02291029|11214202|FG005|NOT COMPLETED|Overall Study||0
10085429|NCT02291133|11214216|FG000|STARTED|Overall Study||25
10085430|NCT02291133|11214216|FG000|COMPLETED|Overall Study||24
10085431|NCT02291133|11214216|FG000|NOT COMPLETED|Overall Study||1
10201026|NCT03426995|11328348|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10085432|NCT02291237|11214222|FG000|STARTED|Overall Study||86
10085433|NCT02291237|11214223|FG001|STARTED|Overall Study||86
10085434|NCT02291237|11214222|FG000|COMPLETED|Overall Study||0
10085435|NCT02291237|11214223|FG001|COMPLETED|Overall Study||0
10085436|NCT02291237|11214222|FG000|NOT COMPLETED|Overall Study||86
10085437|NCT02291237|11214223|FG001|NOT COMPLETED|Overall Study||86
10085438|NCT02291289|11214233|FG000|STARTED|Induction Treatment||60
10085439|NCT02291289|11214234|FG001|STARTED|Induction Treatment||0
10085440|NCT02291289|11214235|FG002|STARTED|Induction Treatment||0
10085441|NCT02291289|11214236|FG003|STARTED|Induction Treatment||445
10085442|NCT02291289|11214237|FG004|STARTED|Induction Treatment||0
10085443|NCT02291289|11214238|FG005|STARTED|Induction Treatment||0
10085444|NCT02291289|11214239|FG006|STARTED|Induction Treatment||5
10085445|NCT02291289|11214240|FG007|STARTED|Induction Treatment||0
10085446|NCT02291289|11214241|FG008|STARTED|Induction Treatment||0
10085447|NCT02291289|11214242|FG009|STARTED|Induction Treatment||99
10085448|NCT02291289|11214243|FG010|STARTED|Induction Treatment||0
10085449|NCT02291289|11214244|FG011|STARTED|Induction Treatment||0
10085450|NCT02291289|11214233|FG000|COMPLETED|Induction Treatment||58
10085451|NCT02291289|11214234|FG001|COMPLETED|Induction Treatment||0
10085452|NCT02291289|11214235|FG002|COMPLETED|Induction Treatment||0
10085453|NCT02291289|11214236|FG003|COMPLETED|Induction Treatment||436
10085454|NCT02291289|11214237|FG004|COMPLETED|Induction Treatment||0
10085455|NCT02291289|11214238|FG005|COMPLETED|Induction Treatment||0
10085456|NCT02291289|11214239|FG006|COMPLETED|Induction Treatment||5
10085457|NCT02291289|11214240|FG007|COMPLETED|Induction Treatment||0
10085458|NCT02291289|11214241|FG008|COMPLETED|Induction Treatment||0
10085459|NCT02291289|11214242|FG009|COMPLETED|Induction Treatment||98
10085460|NCT02291289|11214243|FG010|COMPLETED|Induction Treatment||0
10085461|NCT02291289|11214244|FG011|COMPLETED|Induction Treatment||0
10085462|NCT02291289|11214233|FG000|NOT COMPLETED|Induction Treatment||2
10085463|NCT02291289|11214234|FG001|NOT COMPLETED|Induction Treatment||0
10085464|NCT02291289|11214235|FG002|NOT COMPLETED|Induction Treatment||0
10085465|NCT02291289|11214236|FG003|NOT COMPLETED|Induction Treatment||9
10085466|NCT02291289|11214237|FG004|NOT COMPLETED|Induction Treatment||0
10085467|NCT02291289|11214238|FG005|NOT COMPLETED|Induction Treatment||0
10085468|NCT02291289|11214239|FG006|NOT COMPLETED|Induction Treatment||0
10085469|NCT02291289|11214240|FG007|NOT COMPLETED|Induction Treatment||0
10085470|NCT02291289|11214241|FG008|NOT COMPLETED|Induction Treatment||0
10085471|NCT02291289|11214242|FG009|NOT COMPLETED|Induction Treatment||1
10085472|NCT02291289|11214243|FG010|NOT COMPLETED|Induction Treatment||0
10085473|NCT02291289|11214244|FG011|NOT COMPLETED|Induction Treatment||0
10085474|NCT02291289|11214233|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10085475|NCT02291289|11214234|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
10085476|NCT02291289|11214235|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
10085477|NCT02291289|11214236|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10085478|NCT02291289|11214237|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
10085479|NCT02291289|11214238|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
10085480|NCT02291289|11214239|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10085481|NCT02291289|11214240|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
10085482|NCT02291289|11214241|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
10085483|NCT02291289|11214242|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10085484|NCT02291289|11214243|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
10085485|NCT02291289|11214244|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
10085486|NCT02291289|11214233|FG000|Dosed|Maintenance Treatment Phase||0
10085487|NCT02291289|11214234|FG001|Dosed|Maintenance Treatment Phase||40
10085488|NCT02291289|11214235|FG002|Dosed|Maintenance Treatment Phase||18
10085489|NCT02291289|11214236|FG003|Dosed|Maintenance Treatment Phase||0
10085490|NCT02291289|11214237|FG004|Dosed|Maintenance Treatment Phase||293
10085491|NCT02291289|11214238|FG005|Dosed|Maintenance Treatment Phase||143
10085492|NCT02291289|11214239|FG006|Dosed|Maintenance Treatment Phase||0
10085493|NCT02291289|11214240|FG007|Dosed|Maintenance Treatment Phase||3
10085494|NCT02291289|11214241|FG008|Dosed|Maintenance Treatment Phase||2
10085495|NCT02291289|11214242|FG009|Dosed|Maintenance Treatment Phase||0
10085496|NCT02291289|11214243|FG010|Dosed|Maintenance Treatment Phase||64
10085497|NCT02291289|11214244|FG011|Dosed|Maintenance Treatment Phase||34
10085498|NCT02291289|11214233|FG000|COMPLETED|Maintenance Treatment Phase||0
10085499|NCT02291289|11214234|FG001|COMPLETED|Maintenance Treatment Phase||16
10085500|NCT02291289|11214235|FG002|COMPLETED|Maintenance Treatment Phase||4
10085501|NCT02291289|11214236|FG003|COMPLETED|Maintenance Treatment Phase||0
10085502|NCT02291289|11214237|FG004|COMPLETED|Maintenance Treatment Phase||45
10085503|NCT02291289|11214238|FG005|COMPLETED|Maintenance Treatment Phase||19
10085504|NCT02291289|11214239|FG006|COMPLETED|Maintenance Treatment Phase||0
10085505|NCT02291289|11214240|FG007|COMPLETED|Maintenance Treatment Phase||1
10085506|NCT02291289|11214241|FG008|COMPLETED|Maintenance Treatment Phase||0
10085507|NCT02291289|11214242|FG009|COMPLETED|Maintenance Treatment Phase||0
10085508|NCT02291289|11214243|FG010|COMPLETED|Maintenance Treatment Phase||34
10085509|NCT02291289|11214244|FG011|COMPLETED|Maintenance Treatment Phase||18
10201027|NCT03426995|11328349|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201028|NCT03426995|11328350|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201029|NCT03426995|11328351|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201030|NCT03426995|11328352|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201031|NCT03426995|11328353|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201032|NCT03426995|11328354|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201033|NCT03426995|11328355|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9736966|NCT00197106|10837708|FG001|NOT COMPLETED|Overall Treatment Period||1
9736967|NCT00197106|10837709|FG002|NOT COMPLETED|Overall Treatment Period||6
10085510|NCT02291289|11214233|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
10085511|NCT02291289|11214234|FG001|NOT COMPLETED|Maintenance Treatment Phase||24
10085512|NCT02291289|11214235|FG002|NOT COMPLETED|Maintenance Treatment Phase||16
10085513|NCT02291289|11214236|FG003|NOT COMPLETED|Maintenance Treatment Phase||0
10085514|NCT02291289|11214237|FG004|NOT COMPLETED|Maintenance Treatment Phase||252
10085515|NCT02291289|11214238|FG005|NOT COMPLETED|Maintenance Treatment Phase||129
10085516|NCT02291289|11214239|FG006|NOT COMPLETED|Maintenance Treatment Phase||0
10085517|NCT02291289|11214240|FG007|NOT COMPLETED|Maintenance Treatment Phase||2
10085518|NCT02291289|11214241|FG008|NOT COMPLETED|Maintenance Treatment Phase||2
10085519|NCT02291289|11214242|FG009|NOT COMPLETED|Maintenance Treatment Phase||0
10085520|NCT02291289|11214243|FG010|NOT COMPLETED|Maintenance Treatment Phase||31
10085521|NCT02291289|11214244|FG011|NOT COMPLETED|Maintenance Treatment Phase||16
10085522|NCT02291302|11214273|FG000|STARTED|Overall Study||59
10085523|NCT02291302|11214274|FG001|STARTED|Overall Study||59
10085524|NCT02291302|11214275|FG002|STARTED|Overall Study||59
10085525|NCT02291302|11214276|FG003|STARTED|Overall Study||59
10085526|NCT02291302|11214273|FG000|COMPLETED|Overall Study||59
10085527|NCT02291302|11214274|FG001|COMPLETED|Overall Study||59
10085528|NCT02291302|11214275|FG002|COMPLETED|Overall Study||59
10085529|NCT02291302|11214276|FG003|COMPLETED|Overall Study||59
10085530|NCT02291302|11214273|FG000|NOT COMPLETED|Overall Study||0
10085531|NCT02291302|11214274|FG001|NOT COMPLETED|Overall Study||0
10085532|NCT02291302|11214275|FG002|NOT COMPLETED|Overall Study||0
10085533|NCT02291302|11214276|FG003|NOT COMPLETED|Overall Study||0
10085534|NCT02291419|11214288|FG000|STARTED|Overall Study||1
10085535|NCT02291419|11214289|FG001|STARTED|Overall Study||5
10085536|NCT02291419|11214288|FG000|COMPLETED|Overall Study||0
10085537|NCT02291419|11214289|FG001|COMPLETED|Overall Study||0
10085538|NCT02291419|11214288|FG000|NOT COMPLETED|Overall Study||1
10085539|NCT02291419|11214289|FG001|NOT COMPLETED|Overall Study||5
10085540|NCT02291432|11214295|FG000|STARTED|Overall Study||25
10085541|NCT02291432|11214295|FG000|Muscle Biopsy|Overall Study||25
10085542|NCT02291432|11214295|FG000|AMDC Injection|Overall Study||23
10085543|NCT02291432|11214295|FG000|1-Month Follow Up|Overall Study||23
10085544|NCT02291432|11214295|FG000|3-Month Follow Up|Overall Study||23
10085545|NCT02291432|11214295|FG000|6-Month Follow Up|Overall Study||23
10085546|NCT02291432|11214295|FG000|12-Month Follow Up|Overall Study||23
10085547|NCT02291432|11214295|FG000|COMPLETED|Overall Study||23
10085548|NCT02291432|11214295|FG000|NOT COMPLETED|Overall Study||2
10085549|NCT02291510|11214303|FG000|STARTED|Overall Study||5
10085550|NCT02291510|11214304|FG001|STARTED|Overall Study||5
10085551|NCT02291510|11214305|FG002|STARTED|Overall Study||5
10085552|NCT02291510|11214306|FG003|STARTED|Overall Study||5
10085553|NCT02291510|11214303|FG000|Completed Treatment A|Overall Study||5
10201034|NCT03426995|11328356|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201035|NCT03426995|11328357|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201036|NCT03426995|11328358|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201037|NCT03426995|11328359|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201038|NCT03426995|11328360|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10201039|NCT03426995|11328342|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201040|NCT03426995|11328343|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201041|NCT03426995|11328344|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201042|NCT03426995|11328345|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201043|NCT03426995|11328346|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201044|NCT03426995|11328347|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201045|NCT03426995|11328348|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201046|NCT03426995|11328349|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201047|NCT03426995|11328350|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201048|NCT03426995|11328351|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201049|NCT03426995|11328352|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201050|NCT03426995|11328353|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201051|NCT03426995|11328354|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201052|NCT03426995|11328355|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201053|NCT03426995|11328356|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201054|NCT03426995|11328357|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201055|NCT03426995|11328358|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9736968|NCT00197119|10837717|FG000|STARTED|Year 6||126
9736969|NCT00197119|10837718|FG001|STARTED|Year 6||118
10085554|NCT02291510|11214304|FG001|Completed Treatment A|Overall Study||5
10085555|NCT02291510|11214305|FG002|Completed Treatment A|Overall Study||5
10085556|NCT02291510|11214306|FG003|Completed Treatment A|Overall Study||5
10085557|NCT02291510|11214303|FG000|Completed Treatment B|Overall Study||5
10085558|NCT02291510|11214304|FG001|Completed Treatment B|Overall Study||5
10085559|NCT02291510|11214305|FG002|Completed Treatment B|Overall Study||5
10085560|NCT02291510|11214306|FG003|Completed Treatment B|Overall Study||4
10085561|NCT02291510|11214303|FG000|Completed Treatment C|Overall Study||5
10085562|NCT02291510|11214304|FG001|Completed Treatment C|Overall Study||5
10085563|NCT02291510|11214305|FG002|Completed Treatment C|Overall Study||5
9736970|NCT00197119|10837717|FG000|COMPLETED|Year 6||126
10085564|NCT02291510|11214306|FG003|Completed Treatment C|Overall Study||4
10085565|NCT02291510|11214303|FG000|Completed Treatment D|Overall Study||5
10085566|NCT02291510|11214304|FG001|Completed Treatment D|Overall Study||5
10085567|NCT02291510|11214305|FG002|Completed Treatment D|Overall Study||5
10085568|NCT02291510|11214306|FG003|Completed Treatment D|Overall Study||5
10085569|NCT02291510|11214303|FG000|COMPLETED|Overall Study||5
10085570|NCT02291510|11214304|FG001|COMPLETED|Overall Study||5
10085571|NCT02291510|11214305|FG002|COMPLETED|Overall Study||5
10085572|NCT02291510|11214306|FG003|COMPLETED|Overall Study||4
10085573|NCT02291510|11214303|FG000|NOT COMPLETED|Overall Study||0
10085574|NCT02291510|11214304|FG001|NOT COMPLETED|Overall Study||0
10085575|NCT02291510|11214305|FG002|NOT COMPLETED|Overall Study||0
10085576|NCT02291510|11214306|FG003|NOT COMPLETED|Overall Study||1
10085577|NCT02291549|11214318|FG000|STARTED|Overall Study||201
10085578|NCT02291549|11214319|FG001|STARTED|Overall Study||99
10085579|NCT02291549|11214318|FG000|COMPLETED|Overall Study||200
10085580|NCT02291549|11214319|FG001|COMPLETED|Overall Study||98
10085581|NCT02291549|11214318|FG000|NOT COMPLETED|Overall Study||1
10085582|NCT02291549|11214319|FG001|NOT COMPLETED|Overall Study||1
10085583|NCT02291601|11214327|FG000|STARTED|Abdomen||638
10085584|NCT02291601|11214328|FG001|STARTED|Abdomen||108
10085585|NCT02291601|11214329|FG002|STARTED|Abdomen||642
10085586|NCT02291601|11214327|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305
10085587|NCT02291601|11214328|FG001|COMPLETED|Abdomen|108 participants received vehicle|54
10085588|NCT02291601|11214329|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303
10085589|NCT02291601|11214327|FG000|NOT COMPLETED|Abdomen||333
10085590|NCT02291601|11214328|FG001|NOT COMPLETED|Abdomen||54
10085591|NCT02291601|11214329|FG002|NOT COMPLETED|Abdomen||339
10085592|NCT02291601|11214327|FG000|STARTED|Groin||520
10085593|NCT02291601|11214328|FG001|STARTED|Groin||93
10085594|NCT02291601|11214329|FG002|STARTED|Groin||515
10085595|NCT02291601|11214327|FG000|COMPLETED|Groin|520 participants received CHG cloth|337
10085596|NCT02291601|11214328|FG001|COMPLETED|Groin|93 participants received vehicle|63
10085597|NCT02291601|11214329|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338
10085598|NCT02291601|11214327|FG000|NOT COMPLETED|Groin||183
10085599|NCT02291601|11214328|FG001|NOT COMPLETED|Groin||30
10085600|NCT02291601|11214329|FG002|NOT COMPLETED|Groin||177
10085601|NCT02291614|11214351|FG000|STARTED|Overall Study||3
10085602|NCT02291614|11214352|FG001|STARTED|Overall Study||3
10085603|NCT02291614|11214353|FG002|STARTED|Overall Study||3
10085604|NCT02291614|11214354|FG003|STARTED|Overall Study||5
10085605|NCT02291614|11214355|FG004|STARTED|Overall Study||3
10085606|NCT02291614|11214356|FG005|STARTED|Overall Study||3
10085607|NCT02291614|11214357|FG006|STARTED|Overall Study||6
10085608|NCT02291614|11214358|FG007|STARTED|Overall Study||3
10085609|NCT02291614|11214359|FG008|STARTED|Overall Study||3
10085610|NCT02291614|11214360|FG009|STARTED|Overall Study||11
10085611|NCT02291614|11214361|FG010|STARTED|Overall Study||2
10085612|NCT02291614|11214351|FG000|Received AMG 211|Overall Study||3
10085613|NCT02291614|11214352|FG001|Received AMG 211|Overall Study||3
10085614|NCT02291614|11214353|FG002|Received AMG 211|Overall Study||3
10085615|NCT02291614|11214354|FG003|Received AMG 211|Overall Study||5
10085616|NCT02291614|11214355|FG004|Received AMG 211|Overall Study||3
10085617|NCT02291614|11214356|FG005|Received AMG 211|Overall Study||3
10085618|NCT02291614|11214357|FG006|Received AMG 211|Overall Study||6
10085619|NCT02291614|11214358|FG007|Received AMG 211|Overall Study||3
10085620|NCT02291614|11214359|FG008|Received AMG 211|Overall Study||3
10085621|NCT02291614|11214360|FG009|Received AMG 211|Overall Study||10
10085622|NCT02291614|11214361|FG010|Received AMG 211|Overall Study||2
10085623|NCT02291614|11214351|FG000|COMPLETED|Overall Study||3
10085624|NCT02291614|11214352|FG001|COMPLETED|Overall Study||2
10085625|NCT02291614|11214353|FG002|COMPLETED|Overall Study||2
10085626|NCT02291614|11214354|FG003|COMPLETED|Overall Study||4
10085627|NCT02291614|11214355|FG004|COMPLETED|Overall Study||2
10085628|NCT02291614|11214356|FG005|COMPLETED|Overall Study||2
10085629|NCT02291614|11214357|FG006|COMPLETED|Overall Study||5
10085630|NCT02291614|11214358|FG007|COMPLETED|Overall Study||2
10085631|NCT02291614|11214359|FG008|COMPLETED|Overall Study||3
10085632|NCT02291614|11214360|FG009|COMPLETED|Overall Study||9
9736971|NCT00197119|10837718|FG001|COMPLETED|Year 6||118
9736972|NCT00197119|10837717|FG000|NOT COMPLETED|Year 6||0
10085633|NCT02291614|11214361|FG010|COMPLETED|Overall Study||0
10085634|NCT02291614|11214351|FG000|NOT COMPLETED|Overall Study||0
10085635|NCT02291614|11214352|FG001|NOT COMPLETED|Overall Study||1
10085636|NCT02291614|11214353|FG002|NOT COMPLETED|Overall Study||1
10085637|NCT02291614|11214354|FG003|NOT COMPLETED|Overall Study||1
10085638|NCT02291614|11214355|FG004|NOT COMPLETED|Overall Study||1
10085639|NCT02291614|11214356|FG005|NOT COMPLETED|Overall Study||1
10085640|NCT02291614|11214357|FG006|NOT COMPLETED|Overall Study||1
10085641|NCT02291614|11214358|FG007|NOT COMPLETED|Overall Study||1
10085642|NCT02291614|11214359|FG008|NOT COMPLETED|Overall Study||0
10085643|NCT02291614|11214360|FG009|NOT COMPLETED|Overall Study||2
10085644|NCT02291614|11214361|FG010|NOT COMPLETED|Overall Study||2
10085645|NCT02291679|11214394|FG000|STARTED|Overall Study||401
10085646|NCT02291679|11214395|FG001|STARTED|Overall Study||411
10085647|NCT02291679|11214396|FG002|STARTED|Overall Study||411
10085648|NCT02291679|11214394|FG000|COMPLETED|Overall Study||357
10085649|NCT02291679|11214395|FG001|COMPLETED|Overall Study||369
10085650|NCT02291679|11214396|FG002|COMPLETED|Overall Study||352
10085651|NCT02291679|11214394|FG000|NOT COMPLETED|Overall Study||44
10085652|NCT02291679|11214395|FG001|NOT COMPLETED|Overall Study||42
10201056|NCT03426995|11328359|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201057|NCT03426995|11328360|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201058|NCT03426995|11328342|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201059|NCT03426995|11328343|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201060|NCT03426995|11328344|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201061|NCT03426995|11328345|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201062|NCT03426995|11328346|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201063|NCT03426995|11328347|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201064|NCT03426995|11328348|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201065|NCT03426995|11328349|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201066|NCT03426995|11328350|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201067|NCT03426995|11328351|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201068|NCT03426995|11328352|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201069|NCT03426995|11328353|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201070|NCT03426995|11328354|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201071|NCT03426995|11328355|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201072|NCT03426995|11328356|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201073|NCT03426995|11328357|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10085653|NCT02291679|11214396|FG002|NOT COMPLETED|Overall Study||59
10085654|NCT02291718|11214406|FG000|STARTED|Overall Study||50
10085655|NCT02291718|11214407|FG001|STARTED|Overall Study||50
10201074|NCT03426995|11328358|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201075|NCT03426995|11328359|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201076|NCT03426995|11328360|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10201077|NCT03426995|11328342|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201078|NCT03426995|11328343|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201079|NCT03426995|11328344|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201080|NCT03426995|11328345|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201081|NCT03426995|11328346|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201082|NCT03426995|11328347|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201083|NCT03426995|11328348|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201084|NCT03426995|11328349|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201085|NCT03426995|11328350|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201086|NCT03426995|11328351|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201087|NCT03426995|11328352|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201088|NCT03426995|11328353|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201089|NCT03426995|11328354|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201090|NCT03426995|11328355|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201091|NCT03426995|11328356|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
10201092|NCT03426995|11328357|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
10201093|NCT03426995|11328358|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201094|NCT03426995|11328359|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201095|NCT03426995|11328360|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201096|NCT03426995|11328342|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201097|NCT03426995|11328343|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10085656|NCT02291718|11214408|FG002|STARTED|Overall Study||50
10085657|NCT02291718|11214406|FG000|COMPLETED|Overall Study||50
10085658|NCT02291718|11214407|FG001|COMPLETED|Overall Study||50
10085659|NCT02291718|11214408|FG002|COMPLETED|Overall Study||50
10085660|NCT02291718|11214406|FG000|NOT COMPLETED|Overall Study||0
10085661|NCT02291718|11214407|FG001|NOT COMPLETED|Overall Study||0
10085662|NCT02291718|11214408|FG002|NOT COMPLETED|Overall Study||0
10085663|NCT02291861|11214420|FG000|STARTED|Overall Study||74
10085664|NCT02291861|11214421|FG001|STARTED|Overall Study||75
10085665|NCT02291861|11214422|FG002|STARTED|Overall Study||74
10085666|NCT02291861|11214423|FG003|STARTED|Overall Study||75
10085667|NCT02291861|11214420|FG000|Safety Population|Overall Study||72
10085668|NCT02291861|11214421|FG001|Safety Population|Overall Study||74
10085669|NCT02291861|11214422|FG002|Safety Population|Overall Study||73
10085670|NCT02291861|11214423|FG003|Safety Population|Overall Study||74
10085671|NCT02291861|11214420|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58
10085672|NCT02291861|11214421|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60
10085673|NCT02291861|11214422|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49
10085674|NCT02291861|11214423|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55
10085675|NCT02291861|11214420|FG000|COMPLETED|Overall Study||67
10085676|NCT02291861|11214421|FG001|COMPLETED|Overall Study||67
10085677|NCT02291861|11214422|FG002|COMPLETED|Overall Study||65
10085678|NCT02291861|11214423|FG003|COMPLETED|Overall Study||65
10085679|NCT02291861|11214420|FG000|NOT COMPLETED|Overall Study||7
10085680|NCT02291861|11214421|FG001|NOT COMPLETED|Overall Study||8
9736973|NCT00197119|10837718|FG001|NOT COMPLETED|Year 6||0
9736974|NCT00197119|10837717|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
9736975|NCT00197119|10837718|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
9736976|NCT00197119|10837717|FG000|COMPLETED|Year 7||122
9736977|NCT00197119|10837718|FG001|COMPLETED|Year 7||114
9736978|NCT00197119|10837717|FG000|NOT COMPLETED|Year 7||0
9736979|NCT00197119|10837718|FG001|NOT COMPLETED|Year 7||0
9736980|NCT00197119|10837717|FG000|STARTED|Year 8||122
9736981|NCT00197119|10837718|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
9736982|NCT00197119|10837717|FG000|COMPLETED|Year 8||122
10085681|NCT02291861|11214422|FG002|NOT COMPLETED|Overall Study||9
10085682|NCT02291861|11214423|FG003|NOT COMPLETED|Overall Study||10
10201098|NCT03426995|11328344|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201099|NCT03426995|11328345|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201100|NCT03426995|11328346|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201101|NCT03426995|11328347|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9736983|NCT00197119|10837718|FG001|COMPLETED|Year 8||115
10085683|NCT02291913|11214433|FG000|STARTED|Overall Study||48
10085684|NCT02291913|11214433|FG000|COMPLETED|Overall Study||0
10085685|NCT02291913|11214433|FG000|NOT COMPLETED|Overall Study||48
10085686|NCT02292082|11214439|FG000|STARTED|Overall Study||56
10085687|NCT02292082|11214440|FG001|STARTED|Overall Study||55
10085688|NCT02292082|11214439|FG000|COMPLETED|Overall Study||56
10085689|NCT02292082|11214440|FG001|COMPLETED|Overall Study||55
10085690|NCT02292082|11214439|FG000|NOT COMPLETED|Overall Study||0
10085691|NCT02292082|11214440|FG001|NOT COMPLETED|Overall Study||0
10085692|NCT02292186|11214446|FG000|STARTED|Overall Study||25
10085693|NCT02292186|11214446|FG000|COMPLETED|Overall Study||7
10085694|NCT02292186|11214446|FG000|NOT COMPLETED|Overall Study||18
10085695|NCT02292212|11214450|FG000|STARTED|Pre-ViE Phase||17
10085696|NCT02292212|11214450|FG000|COMPLETED|Pre-ViE Phase||17
10085697|NCT02292212|11214450|FG000|NOT COMPLETED|Pre-ViE Phase||0
10085698|NCT02292212|11214450|FG000|STARTED|ViE Phase||17
10085699|NCT02292212|11214450|FG000|COMPLETED|ViE Phase||14
10085700|NCT02292212|11214450|FG000|NOT COMPLETED|ViE Phase||3
10085701|NCT02292212|11214450|FG000|STARTED|Post-ViE Phase||14
10085702|NCT02292212|11214450|FG000|COMPLETED|Post-ViE Phase||14
10085703|NCT02292212|11214450|FG000|NOT COMPLETED|Post-ViE Phase||0
10085704|NCT02292433|11214464|FG000|STARTED|First Intervention Period (7 Days)||4
10085705|NCT02292433|11214465|FG001|STARTED|First Intervention Period (7 Days)||4
10085706|NCT02292433|11214466|FG002|STARTED|First Intervention Period (7 Days)||4
10085707|NCT02292433|11214464|FG000|COMPLETED|First Intervention Period (7 Days)||4
10085708|NCT02292433|11214465|FG001|COMPLETED|First Intervention Period (7 Days)||4
10085709|NCT02292433|11214466|FG002|COMPLETED|First Intervention Period (7 Days)||4
10085710|NCT02292433|11214464|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0
10085711|NCT02292433|11214465|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0
10085712|NCT02292433|11214466|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0
10085713|NCT02292433|11214464|FG000|STARTED|First Washout Period (7 to 14 Days)||4
10085714|NCT02292433|11214465|FG001|STARTED|First Washout Period (7 to 14 Days)||4
10085715|NCT02292433|11214466|FG002|STARTED|First Washout Period (7 to 14 Days)||4
10085716|NCT02292433|11214464|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4
10085717|NCT02292433|11214465|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4
10085718|NCT02292433|11214466|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4
10201102|NCT03426995|11328348|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201103|NCT03426995|11328349|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201104|NCT03426995|11328350|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201105|NCT03426995|11328351|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201106|NCT03426995|11328352|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201107|NCT03426995|11328353|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201108|NCT03426995|11328354|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201109|NCT03426995|11328355|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201110|NCT03426995|11328356|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
10201111|NCT03426995|11328357|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
10201112|NCT03426995|11328358|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201113|NCT03426995|11328359|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201114|NCT03426995|11328360|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201115|NCT03426995|11328342|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201116|NCT03426995|11328343|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201117|NCT03426995|11328344|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201118|NCT03426995|11328345|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201119|NCT03426995|11328346|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201120|NCT03426995|11328347|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201121|NCT03426995|11328348|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201122|NCT03426995|11328349|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201123|NCT03426995|11328350|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201124|NCT03426995|11328351|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201125|NCT03426995|11328352|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201126|NCT03426995|11328353|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201127|NCT03426995|11328354|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201128|NCT03426995|11328355|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201129|NCT03426995|11328356|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
10201130|NCT03426995|11328357|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
10201131|NCT03426995|11328358|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201132|NCT03426995|11328359|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201133|NCT03426995|11328360|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10201134|NCT03427073|11328415|FG000|STARTED|Overall Study||1
10201135|NCT03427073|11328416|FG001|STARTED|Overall Study||1
10201136|NCT03427073|11328417|FG002|STARTED|Overall Study||1
10201137|NCT03427073|11328418|FG003|STARTED|Overall Study||3
10201138|NCT03427073|11328419|FG004|STARTED|Overall Study||3
10201139|NCT03427073|11328420|FG005|STARTED|Overall Study||4
10201140|NCT03427073|11328421|FG006|STARTED|Overall Study||3
10201141|NCT03427073|11328422|FG007|STARTED|Overall Study||4
10201142|NCT03427073|11328415|FG000|COMPLETED|Overall Study||0
10201143|NCT03427073|11328416|FG001|COMPLETED|Overall Study||0
10201144|NCT03427073|11328417|FG002|COMPLETED|Overall Study||0
10201145|NCT03427073|11328418|FG003|COMPLETED|Overall Study||0
10201146|NCT03427073|11328419|FG004|COMPLETED|Overall Study||0
10201147|NCT03427073|11328420|FG005|COMPLETED|Overall Study||0
10201148|NCT03427073|11328421|FG006|COMPLETED|Overall Study||0
10201149|NCT03427073|11328422|FG007|COMPLETED|Overall Study||0
10201150|NCT03427073|11328415|FG000|NOT COMPLETED|Overall Study||1
10201151|NCT03427073|11328416|FG001|NOT COMPLETED|Overall Study||1
10201152|NCT03427073|11328417|FG002|NOT COMPLETED|Overall Study||1
10201153|NCT03427073|11328418|FG003|NOT COMPLETED|Overall Study||3
10201154|NCT03427073|11328419|FG004|NOT COMPLETED|Overall Study||3
10201155|NCT03427073|11328420|FG005|NOT COMPLETED|Overall Study||4
10201156|NCT03427073|11328421|FG006|NOT COMPLETED|Overall Study||3
10201157|NCT03427073|11328422|FG007|NOT COMPLETED|Overall Study||4
10201158|NCT03427177|11328442|FG000|STARTED|Overall Study||125
10201159|NCT03427177|11328443|FG001|STARTED|Overall Study||132
10201160|NCT03427177|11328442|FG000|COMPLETED|Overall Study||92
10201161|NCT03427177|11328443|FG001|COMPLETED|Overall Study||105
10201162|NCT03427177|11328442|FG000|NOT COMPLETED|Overall Study||33
10085719|NCT02292433|11214464|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10085720|NCT02292433|11214465|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10085721|NCT02292433|11214466|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10085722|NCT02292433|11214464|FG000|STARTED|Second Intervention Period (7 Days)||4
10085723|NCT02292433|11214465|FG001|STARTED|Second Intervention Period (7 Days)||4
10085724|NCT02292433|11214466|FG002|STARTED|Second Intervention Period (7 Days)||4
10085725|NCT02292433|11214464|FG000|COMPLETED|Second Intervention Period (7 Days)||4
10085726|NCT02292433|11214465|FG001|COMPLETED|Second Intervention Period (7 Days)||4
10085727|NCT02292433|11214466|FG002|COMPLETED|Second Intervention Period (7 Days)||4
10085728|NCT02292433|11214464|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0
10085729|NCT02292433|11214465|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0
10085730|NCT02292433|11214466|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0
10085731|NCT02292433|11214464|FG000|STARTED|Second Washout Period (7 to 14 Days)||4
10085732|NCT02292433|11214465|FG001|STARTED|Second Washout Period (7 to 14 Days)||4
10085733|NCT02292433|11214466|FG002|STARTED|Second Washout Period (7 to 14 Days)||4
10085734|NCT02292433|11214464|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4
10085735|NCT02292433|11214465|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4
10085736|NCT02292433|11214466|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4
10085737|NCT02292433|11214464|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10085738|NCT02292433|11214465|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10085739|NCT02292433|11214466|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10085740|NCT02292433|11214464|FG000|STARTED|Third Intervention Period (7 Days)||4
10085741|NCT02292433|11214465|FG001|STARTED|Third Intervention Period (7 Days)||4
10085742|NCT02292433|11214466|FG002|STARTED|Third Intervention Period (7 Days)||4
10085743|NCT02292433|11214464|FG000|COMPLETED|Third Intervention Period (7 Days)||4
10085744|NCT02292433|11214465|FG001|COMPLETED|Third Intervention Period (7 Days)||4
10085745|NCT02292433|11214466|FG002|COMPLETED|Third Intervention Period (7 Days)||4
10085746|NCT02292433|11214464|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0
10085747|NCT02292433|11214465|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0
10085748|NCT02292433|11214466|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0
10085749|NCT02292446|11214474|FG000|STARTED|Overall Study||161
10085750|NCT02292446|11214474|FG000|COMPLETED|Overall Study||141
10085751|NCT02292446|11214474|FG000|NOT COMPLETED|Overall Study||20
10085752|NCT02292537|11214483|FG000|STARTED|Overall Study||42
10085753|NCT02292537|11214484|FG001|STARTED|Overall Study||84
10085754|NCT02292537|11214483|FG000|Completed Treatment|Overall Study||42
10085755|NCT02292537|11214484|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
10085756|NCT02292537|11214483|FG000|COMPLETED|Overall Study||42
10085757|NCT02292537|11214484|FG001|COMPLETED|Overall Study||84
10201163|NCT03427177|11328443|FG001|NOT COMPLETED|Overall Study||27
10201164|NCT03427268|11328449|FG000|STARTED|Overall Study||32
10201165|NCT03427268|11328449|FG000|COMPLETED|Overall Study||0
10201166|NCT03427268|11328449|FG000|NOT COMPLETED|Overall Study||32
10201167|NCT03427619|11328453|FG000|STARTED|Overall Study||275
10201168|NCT03427619|11328453|FG000|Safety Population|Overall Study||275
10201169|NCT03427619|11328453|FG000|Modified Intention to Treat Population|Overall Study||143
10201170|NCT03427619|11328453|FG000|COMPLETED|Overall Study||209
10201171|NCT03427619|11328453|FG000|NOT COMPLETED|Overall Study||66
10201172|NCT03427892|11328457|FG000|STARTED|Overall Study||21
10201173|NCT03427892|11328457|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
10201174|NCT03427892|11328457|FG000|NOT COMPLETED|Overall Study||2
10201175|NCT03427931|11328461|FG000|STARTED|Overall Study||7
10201176|NCT03427931|11328461|FG000|COMPLETED|Overall Study||5
10201177|NCT03427931|11328461|FG000|NOT COMPLETED|Overall Study||2
10201178|NCT03428152|11328467|FG000|STARTED|Overall Study||37
10201179|NCT03428152|11328468|FG001|STARTED|Overall Study||41
10201180|NCT03428152|11328467|FG000|COMPLETED|Overall Study||30
10201181|NCT03428152|11328468|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
10201182|NCT03428152|11328467|FG000|NOT COMPLETED|Overall Study||7
10201183|NCT03428152|11328468|FG001|NOT COMPLETED|Overall Study||11
10201184|NCT03428230|11328478|FG000|STARTED|Overall Study||15
10201185|NCT03428230|11328479|FG001|STARTED|Overall Study||15
10201186|NCT03428230|11328480|FG002|STARTED|Overall Study||15
10201187|NCT03428230|11328481|FG003|STARTED|Overall Study||15
10201188|NCT03428230|11328478|FG000|COMPLETED|Overall Study||15
10201189|NCT03428230|11328479|FG001|COMPLETED|Overall Study||15
10201190|NCT03428230|11328480|FG002|COMPLETED|Overall Study||15
10201191|NCT03428230|11328481|FG003|COMPLETED|Overall Study||15
10201192|NCT03428230|11328478|FG000|NOT COMPLETED|Overall Study||0
10201193|NCT03428230|11328479|FG001|NOT COMPLETED|Overall Study||0
10201194|NCT03428230|11328480|FG002|NOT COMPLETED|Overall Study||0
10201195|NCT03428230|11328481|FG003|NOT COMPLETED|Overall Study||0
10085758|NCT02292537|11214483|FG000|NOT COMPLETED|Overall Study||0
10085759|NCT02292537|11214484|FG001|NOT COMPLETED|Overall Study||0
10085760|NCT02292719|11214496|FG000|STARTED|Overall Study||9
10085761|NCT02292719|11214497|FG001|STARTED|Overall Study||11
10085762|NCT02292719|11214498|FG002|STARTED|Overall Study||10
10201196|NCT03428360|11328491|FG000|STARTED|Overall Study||130
10201197|NCT03428360|11328491|FG000|COMPLETED|Overall Study||90
10201198|NCT03428360|11328491|FG000|NOT COMPLETED|Overall Study||40
10201199|NCT03428750|11328501|FG000|STARTED|Overall Study||210
10201200|NCT03428750|11328502|FG001|STARTED|Overall Study||213
10201201|NCT03428750|11328501|FG000|COMPLETED|Overall Study||186
10201202|NCT03428750|11328502|FG001|COMPLETED|Overall Study||192
10201203|NCT03428750|11328501|FG000|NOT COMPLETED|Overall Study||24
10085763|NCT02292719|11214499|FG003|STARTED|Overall Study||9
10085764|NCT02292719|11214500|FG004|STARTED|Overall Study||21
10085765|NCT02292719|11214501|FG005|STARTED|Overall Study||10
10085766|NCT02292719|11214496|FG000|COMPLETED|Overall Study||9
10085767|NCT02292719|11214497|FG001|COMPLETED|Overall Study||11
10085768|NCT02292719|11214498|FG002|COMPLETED|Overall Study||9
10085769|NCT02292719|11214499|FG003|COMPLETED|Overall Study||8
10085770|NCT02292719|11214500|FG004|COMPLETED|Overall Study||20
10085771|NCT02292719|11214501|FG005|COMPLETED|Overall Study||10
10085772|NCT02292719|11214496|FG000|NOT COMPLETED|Overall Study||0
10085773|NCT02292719|11214497|FG001|NOT COMPLETED|Overall Study||0
10085774|NCT02292719|11214498|FG002|NOT COMPLETED|Overall Study||1
10085775|NCT02292719|11214499|FG003|NOT COMPLETED|Overall Study||1
10085776|NCT02292719|11214500|FG004|NOT COMPLETED|Overall Study||1
10085777|NCT02292719|11214501|FG005|NOT COMPLETED|Overall Study||0
10085778|NCT02292771|11214517|FG000|STARTED|Overall Study||47
10085779|NCT02292771|11214518|FG001|STARTED|Overall Study||50
10085780|NCT02292771|11214517|FG000|COMPLETED|Overall Study||43
10085781|NCT02292771|11214518|FG001|COMPLETED|Overall Study||48
10085782|NCT02292771|11214517|FG000|NOT COMPLETED|Overall Study||4
10085783|NCT02292771|11214518|FG001|NOT COMPLETED|Overall Study||2
10085784|NCT02292784|11214531|FG000|STARTED|Overall Study||5
10085785|NCT02292784|11214532|FG001|STARTED|Overall Study||44
10085786|NCT02292784|11214533|FG002|STARTED|Overall Study||49
10085787|NCT02292784|11214531|FG000|COMPLETED|Overall Study||4
10085788|NCT02292784|11214532|FG001|COMPLETED|Overall Study||24
10085789|NCT02292784|11214533|FG002|COMPLETED|Overall Study||28
10085790|NCT02292784|11214531|FG000|NOT COMPLETED|Overall Study||1
10085791|NCT02292784|11214532|FG001|NOT COMPLETED|Overall Study||20
10085792|NCT02292784|11214533|FG002|NOT COMPLETED|Overall Study||21
10085793|NCT02292849|11214544|FG000|STARTED|Overall Study||11
10085794|NCT02292849|11214545|FG001|STARTED|Overall Study||8
10085795|NCT02292849|11214546|FG002|STARTED|Overall Study||10
10085796|NCT02292849|11214544|FG000|COMPLETED|Overall Study||7
10085797|NCT02292849|11214545|FG001|COMPLETED|Overall Study||6
10085798|NCT02292849|11214546|FG002|COMPLETED|Overall Study||8
10085799|NCT02292849|11214544|FG000|NOT COMPLETED|Overall Study||4
10085800|NCT02292849|11214545|FG001|NOT COMPLETED|Overall Study||2
10085801|NCT02292849|11214546|FG002|NOT COMPLETED|Overall Study||2
10085802|NCT02292927|11214556|FG000|STARTED|Overall Study||13
10085803|NCT02292927|11214557|FG001|STARTED|Overall Study||12
10085804|NCT02292927|11214556|FG000|COMPLETED|Overall Study||0
10085805|NCT02292927|11214557|FG001|COMPLETED|Overall Study||5
10085806|NCT02292927|11214556|FG000|NOT COMPLETED|Overall Study||13
10085807|NCT02292927|11214557|FG001|NOT COMPLETED|Overall Study||7
10085808|NCT02292940|11214568|FG000|STARTED|Overall Study||165477
10085809|NCT02292940|11214569|FG001|STARTED|Overall Study||3000
10085810|NCT02292940|11214568|FG000|COMPLETED|Overall Study||165477
10085811|NCT02292940|11214569|FG001|COMPLETED|Overall Study||1824
10085812|NCT02292940|11214568|FG000|NOT COMPLETED|Overall Study||0
10085813|NCT02292940|11214569|FG001|NOT COMPLETED|Overall Study||1176
10085814|NCT02293044|11214576|FG000|STARTED|Overall Study||15
10085815|NCT02293044|11214576|FG000|COMPLETED|Overall Study||15
10085816|NCT02293044|11214576|FG000|NOT COMPLETED|Overall Study||0
10085817|NCT02293096|11214580|FG000|STARTED|Overall Study||140
10085818|NCT02293096|11214580|FG000|COMPLETED|Overall Study||140
10085819|NCT02293096|11214580|FG000|NOT COMPLETED|Overall Study||0
10085820|NCT02293395|11214586|FG000|STARTED|Overall Study||1519
10085821|NCT02293395|11214587|FG001|STARTED|Overall Study||1518
10085822|NCT02293395|11214586|FG000|Treated|Overall Study||1510
10085823|NCT02293395|11214587|FG001|Treated|Overall Study||1506
10085824|NCT02293395|11214586|FG000|COMPLETED|Overall Study||1510
10085825|NCT02293395|11214587|FG001|COMPLETED|Overall Study||1511
10085826|NCT02293395|11214586|FG000|NOT COMPLETED|Overall Study||9
10085827|NCT02293395|11214587|FG001|NOT COMPLETED|Overall Study||7
10085828|NCT02293460|11214593|FG000|STARTED|Overall Study||43
10085829|NCT02293460|11214593|FG000|COMPLETED|Overall Study||37
10085830|NCT02293460|11214593|FG000|NOT COMPLETED|Overall Study||6
10085831|NCT02293499|11214600|FG000|STARTED|Baseline - Enrollment||152
10085832|NCT02293499|11214601|FG001|STARTED|Baseline - Enrollment||168
10085833|NCT02293499|11214602|FG002|STARTED|Baseline - Enrollment||51
10085834|NCT02293499|11214600|FG000|COMPLETED|Baseline - Enrollment||152
10085835|NCT02293499|11214601|FG001|COMPLETED|Baseline - Enrollment||168
10085836|NCT02293499|11214602|FG002|COMPLETED|Baseline - Enrollment||51
10085837|NCT02293499|11214600|FG000|NOT COMPLETED|Baseline - Enrollment||0
10085838|NCT02293499|11214601|FG001|NOT COMPLETED|Baseline - Enrollment||0
10085839|NCT02293499|11214602|FG002|NOT COMPLETED|Baseline - Enrollment||0
10085840|NCT02293499|11214600|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
10085841|NCT02293499|11214601|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
10201204|NCT03428750|11328502|FG001|NOT COMPLETED|Overall Study||21
10085842|NCT02293499|11214602|FG002|STARTED|Training - Peer Leaders Only||51
10085843|NCT02293499|11214600|FG000|COMPLETED|Training - Peer Leaders Only||0
10085844|NCT02293499|11214601|FG001|COMPLETED|Training - Peer Leaders Only||0
10085845|NCT02293499|11214602|FG002|COMPLETED|Training - Peer Leaders Only||41
10085846|NCT02293499|11214600|FG000|NOT COMPLETED|Training - Peer Leaders Only||0
10085847|NCT02293499|11214601|FG001|NOT COMPLETED|Training - Peer Leaders Only||0
10085848|NCT02293499|11214602|FG002|NOT COMPLETED|Training - Peer Leaders Only||10
10085849|NCT02293499|11214600|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
10085850|NCT02293499|11214601|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
10085851|NCT02293499|11214602|FG002|STARTED|Intervention - Camp||41
10085852|NCT02293499|11214600|FG000|COMPLETED|Intervention - Camp||125
10085853|NCT02293499|11214601|FG001|COMPLETED|Intervention - Camp||134
10085854|NCT02293499|11214602|FG002|COMPLETED|Intervention - Camp||35
10085855|NCT02293499|11214600|FG000|NOT COMPLETED|Intervention - Camp||27
10085856|NCT02293499|11214601|FG001|NOT COMPLETED|Intervention - Camp||34
10085857|NCT02293499|11214602|FG002|NOT COMPLETED|Intervention - Camp||6
10085858|NCT02293499|11214600|FG000|STARTED|3 Month Follow Up||149
10085859|NCT02293499|11214601|FG001|STARTED|3 Month Follow Up||162
10085860|NCT02293499|11214602|FG002|STARTED|3 Month Follow Up||39
10085861|NCT02293499|11214600|FG000|COMPLETED|3 Month Follow Up||134
10085862|NCT02293499|11214601|FG001|COMPLETED|3 Month Follow Up||147
10085863|NCT02293499|11214602|FG002|COMPLETED|3 Month Follow Up||29
10085864|NCT02293499|11214600|FG000|NOT COMPLETED|3 Month Follow Up||15
10085865|NCT02293499|11214601|FG001|NOT COMPLETED|3 Month Follow Up||15
10085866|NCT02293499|11214602|FG002|NOT COMPLETED|3 Month Follow Up||10
10085867|NCT02293499|11214600|FG000|STARTED|6 Month Follow Up||148
10085868|NCT02293499|11214601|FG001|STARTED|6 Month Follow Up||162
10085869|NCT02293499|11214602|FG002|STARTED|6 Month Follow Up||35
10085870|NCT02293499|11214600|FG000|COMPLETED|6 Month Follow Up||131
10085871|NCT02293499|11214601|FG001|COMPLETED|6 Month Follow Up||135
10085872|NCT02293499|11214602|FG002|COMPLETED|6 Month Follow Up||28
10085873|NCT02293499|11214600|FG000|NOT COMPLETED|6 Month Follow Up||17
10085874|NCT02293499|11214601|FG001|NOT COMPLETED|6 Month Follow Up||27
10085875|NCT02293499|11214602|FG002|NOT COMPLETED|6 Month Follow Up||7
10085876|NCT02293499|11214600|FG000|STARTED|9 Month Follow Up||148
10085877|NCT02293499|11214601|FG001|STARTED|9 Month Follow Up||162
10085878|NCT02293499|11214602|FG002|STARTED|9 Month Follow Up||34
10085879|NCT02293499|11214600|FG000|COMPLETED|9 Month Follow Up||122
10085880|NCT02293499|11214601|FG001|COMPLETED|9 Month Follow Up||134
10085881|NCT02293499|11214602|FG002|COMPLETED|9 Month Follow Up||30
10085882|NCT02293499|11214600|FG000|NOT COMPLETED|9 Month Follow Up||26
10085883|NCT02293499|11214601|FG001|NOT COMPLETED|9 Month Follow Up||28
10085884|NCT02293499|11214602|FG002|NOT COMPLETED|9 Month Follow Up||4
10085885|NCT02293499|11214600|FG000|STARTED|12 Month Follow Up||146
10085886|NCT02293499|11214601|FG001|STARTED|12 Month Follow Up||162
10085887|NCT02293499|11214602|FG002|STARTED|12 Month Follow Up||34
10085888|NCT02293499|11214600|FG000|COMPLETED|12 Month Follow Up||120
10085889|NCT02293499|11214601|FG001|COMPLETED|12 Month Follow Up||136
10085890|NCT02293499|11214602|FG002|COMPLETED|12 Month Follow Up||28
10085891|NCT02293499|11214600|FG000|NOT COMPLETED|12 Month Follow Up||26
10085892|NCT02293499|11214601|FG001|NOT COMPLETED|12 Month Follow Up||26
10085893|NCT02293499|11214602|FG002|NOT COMPLETED|12 Month Follow Up||6
10085894|NCT02293499|11214600|FG000|STARTED|15 Month Follow Up||146
10085895|NCT02293499|11214601|FG001|STARTED|15 Month Follow Up||161
10085896|NCT02293499|11214602|FG002|STARTED|15 Month Follow Up||34
10085897|NCT02293499|11214600|FG000|COMPLETED|15 Month Follow Up||124
10085898|NCT02293499|11214601|FG001|COMPLETED|15 Month Follow Up||139
10085899|NCT02293499|11214602|FG002|COMPLETED|15 Month Follow Up||27
10085900|NCT02293499|11214600|FG000|NOT COMPLETED|15 Month Follow Up||22
10085901|NCT02293499|11214601|FG001|NOT COMPLETED|15 Month Follow Up||22
10085902|NCT02293499|11214602|FG002|NOT COMPLETED|15 Month Follow Up||7
10085903|NCT02293512|11214615|FG000|STARTED|Overall Study||10
10085904|NCT02293512|11214616|FG001|STARTED|Overall Study||10
10085905|NCT02293512|11214617|FG002|STARTED|Overall Study||10
10085906|NCT02293512|11214618|FG003|STARTED|Overall Study||10
10085907|NCT02293512|11214615|FG000|COMPLETED|Overall Study||6
10085908|NCT02293512|11214616|FG001|COMPLETED|Overall Study||4
10085909|NCT02293512|11214617|FG002|COMPLETED|Overall Study||7
10085910|NCT02293512|11214618|FG003|COMPLETED|Overall Study||8
10085911|NCT02293512|11214615|FG000|NOT COMPLETED|Overall Study||4
10085912|NCT02293512|11214616|FG001|NOT COMPLETED|Overall Study||6
10085913|NCT02293512|11214617|FG002|NOT COMPLETED|Overall Study||3
10085914|NCT02293512|11214618|FG003|NOT COMPLETED|Overall Study||2
10085915|NCT02293538|11214630|FG000|STARTED|Overall Study||73
10085916|NCT02293538|11214631|FG001|STARTED|Overall Study||71
10085917|NCT02293538|11214630|FG000|COMPLETED|Overall Study||72
10085918|NCT02293538|11214631|FG001|COMPLETED|Overall Study||69
10085919|NCT02293538|11214630|FG000|NOT COMPLETED|Overall Study||1
10085920|NCT02293538|11214631|FG001|NOT COMPLETED|Overall Study||2
10085921|NCT02293798|11214638|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
10085922|NCT02293798|11214638|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
10085923|NCT02293798|11214638|FG000|NOT COMPLETED|Overall Study||0
10085924|NCT02293837|11214646|FG000|STARTED|Overall Study||54
10085925|NCT02293837|11214647|FG001|STARTED|Overall Study||27
10085926|NCT02293837|11214648|FG002|STARTED|Overall Study|1 randomized adult was never treated|35
10085927|NCT02293837|11214649|FG003|STARTED|Overall Study||20
10085928|NCT02293837|11214646|FG000|COMPLETED|Overall Study||51
10085929|NCT02293837|11214647|FG001|COMPLETED|Overall Study||23
10085930|NCT02293837|11214648|FG002|COMPLETED|Overall Study||31
10085931|NCT02293837|11214649|FG003|COMPLETED|Overall Study||19
10085932|NCT02293837|11214646|FG000|NOT COMPLETED|Overall Study||3
10085933|NCT02293837|11214647|FG001|NOT COMPLETED|Overall Study||4
10201205|NCT03428815|11328533|FG000|STARTED|Overall Study||17
10201206|NCT03428815|11328534|FG001|STARTED|Overall Study||19
10201207|NCT03428815|11328533|FG000|COMPLETED|Overall Study||7
10201208|NCT03428815|11328534|FG001|COMPLETED|Overall Study||14
10201209|NCT03428815|11328533|FG000|NOT COMPLETED|Overall Study||10
10201210|NCT03428815|11328534|FG001|NOT COMPLETED|Overall Study||5
10201211|NCT03428997|11328540|FG000|STARTED|Overall Study||24
10201212|NCT03428997|11328540|FG000|COMPLETED|Overall Study||16
10201213|NCT03428997|11328540|FG000|NOT COMPLETED|Overall Study||8
10201214|NCT03429270|11328546|FG000|STARTED|Overall Study||28
10201215|NCT03429270|11328546|FG000|COMPLETED|Overall Study||28
10201216|NCT03429270|11328546|FG000|NOT COMPLETED|Overall Study||0
10201217|NCT03429348|11328552|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
10201218|NCT03429348|11328553|FG001|STARTED|Overall Study||12
10201219|NCT03429348|11328552|FG000|COMPLETED|Overall Study||12
10201220|NCT03429348|11328553|FG001|COMPLETED|Overall Study||12
10201221|NCT03429348|11328552|FG000|NOT COMPLETED|Overall Study||0
10201222|NCT03429348|11328553|FG001|NOT COMPLETED|Overall Study||0
10201223|NCT03429556|11328565|FG000|STARTED|Overall Study||12
10201224|NCT03429556|11328566|FG001|STARTED|Overall Study||4
10201225|NCT03429556|11328567|FG002|STARTED|Overall Study||4
10201226|NCT03429556|11328568|FG003|STARTED|Overall Study||3
10201227|NCT03429556|11328565|FG000|COMPLETED|Overall Study||12
10201228|NCT03429556|11328566|FG001|COMPLETED|Overall Study||3
10201229|NCT03429556|11328567|FG002|COMPLETED|Overall Study||4
10201230|NCT03429556|11328568|FG003|COMPLETED|Overall Study||3
10201231|NCT03429556|11328565|FG000|NOT COMPLETED|Overall Study||0
10085934|NCT02293837|11214648|FG002|NOT COMPLETED|Overall Study||4
10085935|NCT02293837|11214649|FG003|NOT COMPLETED|Overall Study||1
10085936|NCT02293863|11214666|FG000|STARTED|Overall Study||56
10085937|NCT02293863|11214667|FG001|STARTED|Overall Study||55
10085938|NCT02293863|11214668|FG002|STARTED|Overall Study||47
10085939|NCT02293863|11214666|FG000|COMPLETED|Overall Study||47
10085940|NCT02293863|11214667|FG001|COMPLETED|Overall Study||42
10085941|NCT02293863|11214668|FG002|COMPLETED|Overall Study||38
10085942|NCT02293863|11214666|FG000|NOT COMPLETED|Overall Study||9
10085943|NCT02293863|11214667|FG001|NOT COMPLETED|Overall Study||13
10085944|NCT02293863|11214668|FG002|NOT COMPLETED|Overall Study||9
10085945|NCT02293902|11214681|FG000|STARTED|Double-Blind Period (Up to Week 24)||82
10085946|NCT02293902|11214682|FG001|STARTED|Double-Blind Period (Up to Week 24)||81
10085947|NCT02293902|11214683|FG002|STARTED|Double-Blind Period (Up to Week 24)||80
10085948|NCT02293902|11214684|FG003|STARTED|Double-Blind Period (Up to Week 24)||0
10085949|NCT02293902|11214685|FG004|STARTED|Double-Blind Period (Up to Week 24)||0
10085950|NCT02293902|11214681|FG000|Treated|Double-Blind Period (Up to Week 24)||81
10085951|NCT02293902|11214682|FG001|Treated|Double-Blind Period (Up to Week 24)||81
10085952|NCT02293902|11214683|FG002|Treated|Double-Blind Period (Up to Week 24)||80
10085953|NCT02293902|11214684|FG003|Treated|Double-Blind Period (Up to Week 24)||0
10085954|NCT02293902|11214685|FG004|Treated|Double-Blind Period (Up to Week 24)||0
10085955|NCT02293902|11214681|FG000|Rescued|Double-Blind Period (Up to Week 24)||44
10085956|NCT02293902|11214682|FG001|Rescued|Double-Blind Period (Up to Week 24)||6
10085957|NCT02293902|11214683|FG002|Rescued|Double-Blind Period (Up to Week 24)||8
10085958|NCT02293902|11214684|FG003|Rescued|Double-Blind Period (Up to Week 24)||0
10085959|NCT02293902|11214685|FG004|Rescued|Double-Blind Period (Up to Week 24)||0
10085960|NCT02293902|11214681|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
10085961|NCT02293902|11214682|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
10085962|NCT02293902|11214683|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
10085963|NCT02293902|11214684|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0
10085964|NCT02293902|11214685|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0
10085965|NCT02293902|11214681|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
10085966|NCT02293902|11214682|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
10085967|NCT02293902|11214683|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
10085968|NCT02293902|11214684|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
10085969|NCT02293902|11214685|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
10085970|NCT02293902|11214681|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0
10201232|NCT03429556|11328566|FG001|NOT COMPLETED|Overall Study||1
10201233|NCT03429556|11328567|FG002|NOT COMPLETED|Overall Study||0
10201234|NCT03429556|11328568|FG003|NOT COMPLETED|Overall Study||0
10201235|NCT03430050|11328580|FG000|STARTED|Overall Study||3
10201236|NCT03430050|11328581|FG001|STARTED|Overall Study||5
10201237|NCT03430050|11328580|FG000|COMPLETED|Overall Study||3
10201238|NCT03430050|11328581|FG001|COMPLETED|Overall Study||5
10201239|NCT03430050|11328580|FG000|NOT COMPLETED|Overall Study||0
10201240|NCT03430050|11328581|FG001|NOT COMPLETED|Overall Study||0
10085971|NCT02293902|11214682|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
10085972|NCT02293902|11214683|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
10201241|NCT03430206|11328589|FG000|STARTED|Overall Study||40
10201242|NCT03430206|11328590|FG001|STARTED|Overall Study||38
10201243|NCT03430206|11328589|FG000|COMPLETED|Overall Study||18
10201244|NCT03430206|11328590|FG001|COMPLETED|Overall Study||21
10201245|NCT03430206|11328589|FG000|NOT COMPLETED|Overall Study||22
10201246|NCT03430206|11328590|FG001|NOT COMPLETED|Overall Study||17
10201247|NCT03430245|11328596|FG000|STARTED|Overall Study||16
10201248|NCT03430245|11328596|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
10201249|NCT03430245|11328596|FG000|NOT COMPLETED|Overall Study||7
10201250|NCT03430349|11328602|FG000|STARTED|Overall Study||15
10201251|NCT03430349|11328603|FG001|STARTED|Overall Study||15
10201252|NCT03430349|11328602|FG000|Received nOPV Vaccination|Overall Study||15
10085973|NCT02293902|11214684|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
10085974|NCT02293902|11214685|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
10085975|NCT02293902|11214681|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
10085976|NCT02293902|11214682|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
10085977|NCT02293902|11214683|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
10085978|NCT02293902|11214684|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
10085979|NCT02293902|11214685|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
10085980|NCT02293902|11214681|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
10085981|NCT02293902|11214682|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
10085982|NCT02293902|11214683|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
10085983|NCT02293902|11214684|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
10085984|NCT02293902|11214685|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
10085985|NCT02293993|11214707|FG000|STARTED|Course 1 (DLT Evaluation Period)||4
10085986|NCT02293993|11214708|FG001|STARTED|Course 1 (DLT Evaluation Period)||6
10085987|NCT02293993|11214709|FG002|STARTED|Course 1 (DLT Evaluation Period)||7
10085988|NCT02293993|11214710|FG003|STARTED|Course 1 (DLT Evaluation Period)||4
10085989|NCT02293993|11214707|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3
10085990|NCT02293993|11214708|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6
10085991|NCT02293993|11214709|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7
10085992|NCT02293993|11214710|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3
10085993|NCT02293993|11214707|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
10085994|NCT02293993|11214708|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
10085995|NCT02293993|11214709|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
10085996|NCT02293993|11214710|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
10085997|NCT02293993|11214707|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2
10085998|NCT02293993|11214708|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5
10085999|NCT02293993|11214709|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6
10086000|NCT02293993|11214710|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3
10086001|NCT02293993|11214707|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0
10086002|NCT02293993|11214708|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0
10086003|NCT02293993|11214709|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1
10086004|NCT02293993|11214710|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2
10086005|NCT02293993|11214707|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
10086006|NCT02293993|11214708|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
10086007|NCT02293993|11214709|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
10086008|NCT02293993|11214710|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
10086009|NCT02294019|11214728|FG000|STARTED|Overall Study||738
10086010|NCT02294019|11214728|FG000|COMPLETED|Overall Study||635
10086011|NCT02294019|11214728|FG000|NOT COMPLETED|Overall Study||103
10086012|NCT02294058|11214735|FG000|STARTED|Overall Study||448
10086013|NCT02294058|11214736|FG001|STARTED|Overall Study||451
10086014|NCT02294058|11214737|FG002|STARTED|Overall Study||447
10086015|NCT02294058|11214735|FG000|Safety Population|Overall Study||445
10086016|NCT02294058|11214736|FG001|Safety Population|Overall Study||453
10086017|NCT02294058|11214737|FG002|Safety Population|Overall Study||448
10086018|NCT02294058|11214735|FG000|COMPLETED|Overall Study||412
10086019|NCT02294058|11214736|FG001|COMPLETED|Overall Study||425
10086020|NCT02294058|11214737|FG002|COMPLETED|Overall Study||418
10086021|NCT02294058|11214735|FG000|NOT COMPLETED|Overall Study||36
10086022|NCT02294058|11214736|FG001|NOT COMPLETED|Overall Study||26
10086023|NCT02294058|11214737|FG002|NOT COMPLETED|Overall Study||29
10086024|NCT02294175|11214748|FG000|STARTED|Overall Study||23
10086025|NCT02294175|11214749|FG001|STARTED|Overall Study||22
10086026|NCT02294175|11214748|FG000|COMPLETED|Overall Study||18
10086027|NCT02294175|11214749|FG001|COMPLETED|Overall Study||16
10086028|NCT02294175|11214748|FG000|NOT COMPLETED|Overall Study||5
10086029|NCT02294175|11214749|FG001|NOT COMPLETED|Overall Study||6
10086030|NCT02294227|11214758|FG000|STARTED|Overall Study||114
10086031|NCT02294227|11214759|FG001|STARTED|Overall Study||113
10086032|NCT02294227|11214760|FG002|STARTED|Overall Study||114
10086033|NCT02294227|11214758|FG000|COMPLETED|Overall Study||89
10086034|NCT02294227|11214759|FG001|COMPLETED|Overall Study||88
10086035|NCT02294227|11214760|FG002|COMPLETED|Overall Study||95
10086036|NCT02294227|11214758|FG000|NOT COMPLETED|Overall Study||25
10086037|NCT02294227|11214759|FG001|NOT COMPLETED|Overall Study||25
10086038|NCT02294227|11214760|FG002|NOT COMPLETED|Overall Study||19
10086039|NCT02294253|11214770|FG000|STARTED|Overall Study||30
10086040|NCT02294253|11214770|FG000|COMPLETED|Overall Study||15
10086041|NCT02294253|11214770|FG000|NOT COMPLETED|Overall Study||15
10086042|NCT02294318|11214776|FG000|STARTED|Overall Study||24
10086043|NCT02294318|11214777|FG001|STARTED|Overall Study||23
10086044|NCT02294318|11214776|FG000|COMPLETED|Overall Study||21
10201253|NCT03430349|11328603|FG001|Received nOPV Vaccination|Overall Study||15
10201254|NCT03430349|11328602|FG000|COMPLETED|Overall Study||15
10201255|NCT03430349|11328603|FG001|COMPLETED|Overall Study||15
10201256|NCT03430349|11328602|FG000|NOT COMPLETED|Overall Study||0
10201257|NCT03430349|11328603|FG001|NOT COMPLETED|Overall Study||0
10201258|NCT03430856|11328613|FG000|STARTED|Overall Study||31
10201259|NCT03430856|11328614|FG001|STARTED|Overall Study||30
10201260|NCT03430856|11328615|FG002|STARTED|Overall Study||30
10201261|NCT03430856|11328613|FG000|Exposed|Overall Study||31
10086045|NCT02294318|11214777|FG001|COMPLETED|Overall Study||21
10086046|NCT02294318|11214776|FG000|NOT COMPLETED|Overall Study||3
10086047|NCT02294318|11214777|FG001|NOT COMPLETED|Overall Study||2
10201262|NCT03430856|11328614|FG001|Exposed|Overall Study||30
10201263|NCT03430856|11328615|FG002|Exposed|Overall Study||30
10201264|NCT03430856|11328613|FG000|COMPLETED|Overall Study||29
10201265|NCT03430856|11328614|FG001|COMPLETED|Overall Study||27
10201266|NCT03430856|11328615|FG002|COMPLETED|Overall Study||29
10201267|NCT03430856|11328613|FG000|NOT COMPLETED|Overall Study||2
10201268|NCT03430856|11328614|FG001|NOT COMPLETED|Overall Study||3
10201269|NCT03430856|11328615|FG002|NOT COMPLETED|Overall Study||1
10201270|NCT03430986|11328628|FG000|STARTED|24-week Control Period||42
10086048|NCT02294396|11214787|FG000|STARTED|Overall Study||167
10086049|NCT02294396|11214788|FG001|STARTED|Overall Study||161
10086050|NCT02294396|11214789|FG002|STARTED|Overall Study||161
10086051|NCT02294396|11214790|FG003|STARTED|Overall Study||160
10086052|NCT02294396|11214787|FG000|COMPLETED|Overall Study||127
10086053|NCT02294396|11214788|FG001|COMPLETED|Overall Study||128
10086054|NCT02294396|11214789|FG002|COMPLETED|Overall Study||126
10086055|NCT02294396|11214790|FG003|COMPLETED|Overall Study||123
10086056|NCT02294396|11214787|FG000|NOT COMPLETED|Overall Study||40
10086057|NCT02294396|11214788|FG001|NOT COMPLETED|Overall Study||33
10086058|NCT02294396|11214789|FG002|NOT COMPLETED|Overall Study||35
10086059|NCT02294396|11214790|FG003|NOT COMPLETED|Overall Study||37
10086060|NCT02294474|11214802|FG000|STARTED|Overall Study||253
10086061|NCT02294474|11214803|FG001|STARTED|Overall Study||252
10086062|NCT02294474|11214802|FG000|COMPLETED|Overall Study||228
10086063|NCT02294474|11214803|FG001|COMPLETED|Overall Study||230
10086064|NCT02294474|11214802|FG000|NOT COMPLETED|Overall Study||25
10086065|NCT02294474|11214803|FG001|NOT COMPLETED|Overall Study||22
10086066|NCT02294604|11214813|FG000|STARTED|Overall Study||80
10086067|NCT02294604|11214814|FG001|STARTED|Overall Study||80
10086068|NCT02294604|11214815|FG002|STARTED|Overall Study||80
10086069|NCT02294604|11214813|FG000|COMPLETED|Overall Study||79
10086070|NCT02294604|11214814|FG001|COMPLETED|Overall Study||77
10086071|NCT02294604|11214815|FG002|COMPLETED|Overall Study||80
10086072|NCT02294604|11214813|FG000|NOT COMPLETED|Overall Study||1
10086073|NCT02294604|11214814|FG001|NOT COMPLETED|Overall Study||3
10086074|NCT02294604|11214815|FG002|NOT COMPLETED|Overall Study||0
10086075|NCT02294630|11214827|FG000|STARTED|Overall Study||37
10086076|NCT02294630|11214828|FG001|STARTED|Overall Study||38
10086077|NCT02294630|11214829|FG002|STARTED|Overall Study||35
10086078|NCT02294630|11214830|FG003|STARTED|Overall Study||39
10086079|NCT02294630|11214827|FG000|COMPLETED|Overall Study||37
10086080|NCT02294630|11214828|FG001|COMPLETED|Overall Study||38
10086081|NCT02294630|11214829|FG002|COMPLETED|Overall Study||35
10086082|NCT02294630|11214830|FG003|COMPLETED|Overall Study||39
10086083|NCT02294630|11214827|FG000|NOT COMPLETED|Overall Study||0
10086084|NCT02294630|11214828|FG001|NOT COMPLETED|Overall Study||0
10086085|NCT02294630|11214829|FG002|NOT COMPLETED|Overall Study||0
10086086|NCT02294630|11214830|FG003|NOT COMPLETED|Overall Study||0
10086087|NCT02294682|11214842|FG000|STARTED|Overall Study||53
10086088|NCT02294682|11214843|FG001|STARTED|Overall Study||53
10086089|NCT02294682|11214842|FG000|COMPLETED|Overall Study||52
10086090|NCT02294682|11214843|FG001|COMPLETED|Overall Study||53
10086091|NCT02294682|11214842|FG000|NOT COMPLETED|Overall Study||1
10086092|NCT02294682|11214843|FG001|NOT COMPLETED|Overall Study||0
10086093|NCT02294734|11214851|FG000|STARTED|Overall Study||63
10086094|NCT02294734|11214852|FG001|STARTED|Overall Study||63
10086095|NCT02294734|11214851|FG000|COMPLETED|Overall Study||49
10086096|NCT02294734|11214852|FG001|COMPLETED|Overall Study||55
10086097|NCT02294734|11214851|FG000|NOT COMPLETED|Overall Study||14
10086098|NCT02294734|11214852|FG001|NOT COMPLETED|Overall Study||8
10086099|NCT02294773|11214862|FG000|STARTED|Overall Study||7
10086100|NCT02294773|11214863|FG001|STARTED|Overall Study||6
10086101|NCT02294773|11214862|FG000|COMPLETED|Overall Study||7
10086102|NCT02294773|11214863|FG001|COMPLETED|Overall Study||4
10086103|NCT02294773|11214862|FG000|NOT COMPLETED|Overall Study||0
10086104|NCT02294773|11214863|FG001|NOT COMPLETED|Overall Study||2
10086105|NCT02294786|11214871|FG000|STARTED|Overall Study||30
10086106|NCT02294786|11214872|FG001|STARTED|Overall Study||32
10201271|NCT03430986|11328629|FG001|STARTED|24-week Control Period||122
10086107|NCT02294786|11214871|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
10086108|NCT02294786|11214872|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
10086109|NCT02294786|11214871|FG000|ITT Population|Overall Study||30
10086110|NCT02294786|11214872|FG001|ITT Population|Overall Study||32
10086111|NCT02294786|11214871|FG000|COMPLETED|Overall Study||19
10086112|NCT02294786|11214872|FG001|COMPLETED|Overall Study||18
10086113|NCT02294786|11214871|FG000|NOT COMPLETED|Overall Study||11
10201272|NCT03430986|11328628|FG000|Treated as Randomized|24-week Control Period||42
10201273|NCT03430986|11328629|FG001|Treated as Randomized|24-week Control Period||120
10201274|NCT03430986|11328628|FG000|COMPLETED|24-week Control Period||34
10201275|NCT03430986|11328629|FG001|COMPLETED|24-week Control Period||118
10201276|NCT03430986|11328628|FG000|NOT COMPLETED|24-week Control Period||8
10201277|NCT03430986|11328629|FG001|NOT COMPLETED|24-week Control Period||4
10201278|NCT03430986|11328628|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
10201279|NCT03430986|11328629|FG001|STARTED|24-week Post-Control Period||118
10201280|NCT03430986|11328628|FG000|COMPLETED|24-week Post-Control Period||30
10201281|NCT03430986|11328629|FG001|COMPLETED|24-week Post-Control Period||116
10201282|NCT03430986|11328628|FG000|NOT COMPLETED|24-week Post-Control Period||1
10201283|NCT03430986|11328629|FG001|NOT COMPLETED|24-week Post-Control Period||2
10201284|NCT03431012|11328642|FG000|STARTED|Overall Study||47
10201285|NCT03431012|11328643|FG001|STARTED|Overall Study||60
10201286|NCT03431012|11328644|FG002|STARTED|Overall Study||56
10201287|NCT03431012|11328645|FG003|STARTED|Overall Study||53
10086114|NCT02294786|11214872|FG001|NOT COMPLETED|Overall Study||14
10086115|NCT02295020|11214881|FG000|STARTED|Overall Study||20
10086116|NCT02295020|11214882|FG001|STARTED|Overall Study||20
10086117|NCT02295020|11214881|FG000|COMPLETED|Overall Study||17
10086118|NCT02295020|11214882|FG001|COMPLETED|Overall Study||17
10086119|NCT02295020|11214881|FG000|NOT COMPLETED|Overall Study||3
10086120|NCT02295020|11214882|FG001|NOT COMPLETED|Overall Study||3
10086121|NCT02295280|11214896|FG000|STARTED|Overall Study||35
10086122|NCT02295280|11214897|FG001|STARTED|Overall Study||35
10086123|NCT02295280|11214896|FG000|COMPLETED|Overall Study||35
10086124|NCT02295280|11214897|FG001|COMPLETED|Overall Study||34
10086125|NCT02295280|11214896|FG000|NOT COMPLETED|Overall Study||0
10086126|NCT02295280|11214897|FG001|NOT COMPLETED|Overall Study||1
10086127|NCT02295553|11214907|FG000|STARTED|Overall Study||14
10086128|NCT02295553|11214908|FG001|STARTED|Overall Study||14
10086129|NCT02295553|11214909|FG002|STARTED|Overall Study||14
10086130|NCT02295553|11214910|FG003|STARTED|Overall Study||14
10086131|NCT02295553|11214907|FG000|COMPLETED|Overall Study||14
10086132|NCT02295553|11214908|FG001|COMPLETED|Overall Study||14
10086133|NCT02295553|11214909|FG002|COMPLETED|Overall Study||13
10086134|NCT02295553|11214910|FG003|COMPLETED|Overall Study||13
10086135|NCT02295553|11214907|FG000|NOT COMPLETED|Overall Study||0
10086136|NCT02295553|11214908|FG001|NOT COMPLETED|Overall Study||0
10086137|NCT02295553|11214909|FG002|NOT COMPLETED|Overall Study||1
10086138|NCT02295553|11214910|FG003|NOT COMPLETED|Overall Study||1
10086139|NCT02295644|11214924|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10086140|NCT02295644|11214925|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10086141|NCT02295644|11214926|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10086142|NCT02295644|11214927|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10086143|NCT02295644|11214924|FG000|COMPLETED|Overall Study||7
10086144|NCT02295644|11214925|FG001|COMPLETED|Overall Study||7
10086145|NCT02295644|11214926|FG002|COMPLETED|Overall Study||6
10086146|NCT02295644|11214927|FG003|COMPLETED|Overall Study||5
10086147|NCT02295644|11214924|FG000|NOT COMPLETED|Overall Study||0
10086148|NCT02295644|11214925|FG001|NOT COMPLETED|Overall Study||0
10201288|NCT03431012|11328642|FG000|COMPLETED|Overall Study||47
10201289|NCT03431012|11328643|FG001|COMPLETED|Overall Study||60
10201290|NCT03431012|11328644|FG002|COMPLETED|Overall Study||56
10201291|NCT03431012|11328645|FG003|COMPLETED|Overall Study||53
10086149|NCT02295644|11214926|FG002|NOT COMPLETED|Overall Study||1
10086150|NCT02295644|11214927|FG003|NOT COMPLETED|Overall Study||2
10086151|NCT02295735|11214939|FG000|STARTED|Overall Study||238
10086152|NCT02295735|11214940|FG001|STARTED|Overall Study||237
10086153|NCT02295735|11214939|FG000|COMPLETED|Overall Study||212
10086154|NCT02295735|11214940|FG001|COMPLETED|Overall Study||210
10086155|NCT02295735|11214939|FG000|NOT COMPLETED|Overall Study||26
10086156|NCT02295735|11214940|FG001|NOT COMPLETED|Overall Study||27
10086157|NCT02295774|11214946|FG000|STARTED|Overall Study||13
10086158|NCT02295774|11214946|FG000|COMPLETED|Overall Study||10
10086159|NCT02295774|11214946|FG000|NOT COMPLETED|Overall Study||3
10086160|NCT02295995|11214953|FG000|STARTED|Overall Study||36
10086161|NCT02295995|11214954|FG001|STARTED|Overall Study||18
10086162|NCT02295995|11214953|FG000|COMPLETED|Overall Study||31
10086163|NCT02295995|11214954|FG001|COMPLETED|Overall Study||17
10086164|NCT02295995|11214953|FG000|NOT COMPLETED|Overall Study||5
10086165|NCT02295995|11214954|FG001|NOT COMPLETED|Overall Study||1
10086166|NCT02296099|11214963|FG000|STARTED|Overall Study||57
10086167|NCT02296099|11214964|FG001|STARTED|Overall Study||57
10086168|NCT02296099|11214963|FG000|COMPLETED|Overall Study||54
10086169|NCT02296099|11214964|FG001|COMPLETED|Overall Study||55
10086170|NCT02296099|11214963|FG000|NOT COMPLETED|Overall Study||3
10086171|NCT02296099|11214964|FG001|NOT COMPLETED|Overall Study||2
10086172|NCT02296112|11214970|FG000|STARTED|Overall Study||9
10086173|NCT02296112|11214970|FG000|COMPLETED|Overall Study||0
10086174|NCT02296112|11214970|FG000|NOT COMPLETED|Overall Study||9
10086175|NCT02296138|11214981|FG000|STARTED|Overall Study||3952
10086176|NCT02296138|11214982|FG001|STARTED|Overall Study||3951
10086177|NCT02296138|11214981|FG000|Treated|Overall Study||3941
10086178|NCT02296138|11214982|FG001|Treated|Overall Study||3939
10086179|NCT02296138|11214981|FG000|COMPLETED|Overall Study||3291
10086180|NCT02296138|11214982|FG001|COMPLETED|Overall Study||3451
10086181|NCT02296138|11214981|FG000|NOT COMPLETED|Overall Study||661
10086182|NCT02296138|11214982|FG001|NOT COMPLETED|Overall Study||500
10086183|NCT02296164|11214988|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
10086184|NCT02296164|11214988|FG000|COMPLETED|Overall Study||188
10086185|NCT02296164|11214988|FG000|NOT COMPLETED|Overall Study||110
10086186|NCT02296190|11214998|FG000|STARTED|Overall Study||35
10086187|NCT02296190|11214999|FG001|STARTED|Overall Study||41
10086188|NCT02296190|11215000|FG002|STARTED|Overall Study||35
10086189|NCT02296190|11215001|FG003|STARTED|Overall Study||43
10086190|NCT02296190|11215002|FG004|STARTED|Overall Study||36
10086191|NCT02296190|11215003|FG005|STARTED|Overall Study||9
10086192|NCT02296190|11214998|FG000|COMPLETED|Overall Study||21
10086193|NCT02296190|11214999|FG001|COMPLETED|Overall Study||20
10086194|NCT02296190|11215000|FG002|COMPLETED|Overall Study||23
10086195|NCT02296190|11215001|FG003|COMPLETED|Overall Study||20
10086196|NCT02296190|11215002|FG004|COMPLETED|Overall Study||20
10086197|NCT02296190|11215003|FG005|COMPLETED|Overall Study||9
10086198|NCT02296190|11214998|FG000|NOT COMPLETED|Overall Study||14
10086199|NCT02296190|11214999|FG001|NOT COMPLETED|Overall Study||21
10086200|NCT02296190|11215000|FG002|NOT COMPLETED|Overall Study||12
10086201|NCT02296190|11215001|FG003|NOT COMPLETED|Overall Study||23
10086202|NCT02296190|11215002|FG004|NOT COMPLETED|Overall Study||16
10086203|NCT02296190|11215003|FG005|NOT COMPLETED|Overall Study||0
10086204|NCT02296242|11215021|FG000|STARTED|Overall Study||5
10086205|NCT02296242|11215022|FG001|STARTED|Overall Study||6
10086206|NCT02296242|11215023|FG002|STARTED|Overall Study||7
10086207|NCT02296242|11215024|FG003|STARTED|Overall Study||14
10086208|NCT02296242|11215025|FG004|STARTED|Overall Study||21
10086209|NCT02296242|11215021|FG000|COMPLETED|Overall Study||0
10086210|NCT02296242|11215022|FG001|COMPLETED|Overall Study||0
10086211|NCT02296242|11215023|FG002|COMPLETED|Overall Study||0
10086212|NCT02296242|11215024|FG003|COMPLETED|Overall Study||0
10086213|NCT02296242|11215025|FG004|COMPLETED|Overall Study||0
10086214|NCT02296242|11215021|FG000|NOT COMPLETED|Overall Study||5
10086215|NCT02296242|11215022|FG001|NOT COMPLETED|Overall Study||6
10086216|NCT02296242|11215023|FG002|NOT COMPLETED|Overall Study||7
10086217|NCT02296242|11215024|FG003|NOT COMPLETED|Overall Study||14
10086218|NCT02296242|11215025|FG004|NOT COMPLETED|Overall Study||21
10086219|NCT02296320|11215048|FG000|STARTED|Overall Study||102
10086220|NCT02296320|11215049|FG001|STARTED|Overall Study||15
10086221|NCT02296320|11215050|FG002|STARTED|Overall Study||96
10086222|NCT02296320|11215048|FG000|Treated|Overall Study||100
10086223|NCT02296320|11215049|FG001|Treated|Overall Study||15
10086224|NCT02296320|11215050|FG002|Treated|Overall Study||96
10086225|NCT02296320|11215048|FG000|COMPLETED|Overall Study||67
10086226|NCT02296320|11215049|FG001|COMPLETED|Overall Study||10
10086227|NCT02296320|11215050|FG002|COMPLETED|Overall Study||59
10086228|NCT02296320|11215048|FG000|NOT COMPLETED|Overall Study||35
10086229|NCT02296320|11215049|FG001|NOT COMPLETED|Overall Study||5
10086230|NCT02296320|11215050|FG002|NOT COMPLETED|Overall Study||37
10086231|NCT02296346|11215062|FG000|STARTED|Overall Study||7
10086232|NCT02296346|11215063|FG001|STARTED|Overall Study||6
10086233|NCT02296346|11215062|FG000|COMPLETED|Overall Study||2
10086234|NCT02296346|11215063|FG001|COMPLETED|Overall Study||0
10086235|NCT02296346|11215062|FG000|NOT COMPLETED|Overall Study||5
10086236|NCT02296346|11215063|FG001|NOT COMPLETED|Overall Study||6
10086237|NCT02296424|11215073|FG000|STARTED|Part 1|16 patients immediately went into Part II|84
10086238|NCT02296424|11215074|FG001|STARTED|Part 1||98
10086239|NCT02296424|11215075|FG002|STARTED|Part 1||0
10086240|NCT02296424|11215076|FG003|STARTED|Part 1||0
10086241|NCT02296424|11215073|FG000|COMPLETED|Part 1||61
10086242|NCT02296424|11215074|FG001|COMPLETED|Part 1||65
10086243|NCT02296424|11215075|FG002|COMPLETED|Part 1||0
10086244|NCT02296424|11215076|FG003|COMPLETED|Part 1||0
10086245|NCT02296424|11215073|FG000|NOT COMPLETED|Part 1||23
10086246|NCT02296424|11215074|FG001|NOT COMPLETED|Part 1||33
10086247|NCT02296424|11215075|FG002|NOT COMPLETED|Part 1||0
10086248|NCT02296424|11215076|FG003|NOT COMPLETED|Part 1||0
10086249|NCT02296424|11215073|FG000|STARTED|Part 2||0
10086250|NCT02296424|11215074|FG001|STARTED|Part 2||0
10086251|NCT02296424|11215075|FG002|STARTED|Part 2||38
10086252|NCT02296424|11215076|FG003|STARTED|Part 2||37
10086253|NCT02296424|11215073|FG000|COMPLETED|Part 2||0
10086254|NCT02296424|11215074|FG001|COMPLETED|Part 2||0
10086255|NCT02296424|11215075|FG002|COMPLETED|Part 2||35
10086256|NCT02296424|11215076|FG003|COMPLETED|Part 2||37
10086257|NCT02296424|11215073|FG000|NOT COMPLETED|Part 2||0
10086258|NCT02296424|11215074|FG001|NOT COMPLETED|Part 2||0
10086259|NCT02296424|11215075|FG002|NOT COMPLETED|Part 2||3
10086260|NCT02296424|11215076|FG003|NOT COMPLETED|Part 2||0
10086261|NCT02296476|11215087|FG000|STARTED|Overall Study||6
10086262|NCT02296476|11215088|FG001|STARTED|Overall Study||4
10086263|NCT02296476|11215089|FG002|STARTED|Overall Study||2
10086264|NCT02296476|11215087|FG000|COMPLETED|Overall Study||0
9736984|NCT00197119|10837717|FG000|NOT COMPLETED|Year 8||0
9736985|NCT00197119|10837718|FG001|NOT COMPLETED|Year 8||0
9736986|NCT00197119|10837717|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
9736987|NCT00197119|10837718|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
9736988|NCT00197119|10837717|FG000|COMPLETED|Year 9||121
9736989|NCT00197119|10837718|FG001|COMPLETED|Year 9||114
9736990|NCT00197119|10837717|FG000|NOT COMPLETED|Year 9||0
9736991|NCT00197119|10837718|FG001|NOT COMPLETED|Year 9||0
9736992|NCT00197119|10837717|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
9736993|NCT00197119|10837718|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
10086265|NCT02296476|11215088|FG001|COMPLETED|Overall Study||0
10086266|NCT02296476|11215089|FG002|COMPLETED|Overall Study||0
10086267|NCT02296476|11215087|FG000|NOT COMPLETED|Overall Study||6
10086268|NCT02296476|11215088|FG001|NOT COMPLETED|Overall Study||4
10086269|NCT02296476|11215089|FG002|NOT COMPLETED|Overall Study||2
10086270|NCT02296502|11215101|FG000|STARTED|Overall Study||248
10086271|NCT02296502|11215102|FG001|STARTED|Overall Study||1
10086272|NCT02296502|11215103|FG002|STARTED|Overall Study||30
10086273|NCT02296502|11215104|FG003|STARTED|Overall Study||160
10086274|NCT02296502|11215101|FG000|COMPLETED|Overall Study||248
10086275|NCT02296502|11215102|FG001|COMPLETED|Overall Study||1
10086276|NCT02296502|11215103|FG002|COMPLETED|Overall Study||30
10086277|NCT02296502|11215104|FG003|COMPLETED|Overall Study||160
10086278|NCT02296502|11215101|FG000|NOT COMPLETED|Overall Study||0
10086279|NCT02296502|11215102|FG001|NOT COMPLETED|Overall Study||0
10086280|NCT02296502|11215103|FG002|NOT COMPLETED|Overall Study||0
10086281|NCT02296502|11215104|FG003|NOT COMPLETED|Overall Study||0
10086282|NCT02296606|11215117|FG000|STARTED|Overall Study||127
10086283|NCT02296606|11215117|FG000|COMPLETED|Overall Study||127
10086284|NCT02296606|11215117|FG000|NOT COMPLETED|Overall Study||0
10086285|NCT02296775|11215124|FG000|STARTED|Treatment and Evaluation||91
10086286|NCT02296775|11215125|FG001|STARTED|Treatment and Evaluation||92
10086287|NCT02296775|11215126|FG002|STARTED|Treatment and Evaluation||93
10086288|NCT02296775|11215124|FG000|COMPLETED|Treatment and Evaluation||87
10086289|NCT02296775|11215125|FG001|COMPLETED|Treatment and Evaluation||84
10086290|NCT02296775|11215126|FG002|COMPLETED|Treatment and Evaluation||83
10086291|NCT02296775|11215124|FG000|NOT COMPLETED|Treatment and Evaluation||4
10086292|NCT02296775|11215125|FG001|NOT COMPLETED|Treatment and Evaluation||8
10086293|NCT02296775|11215126|FG002|NOT COMPLETED|Treatment and Evaluation||10
10086294|NCT02296775|11215124|FG000|STARTED|Recovery and Follow-up||87
10086295|NCT02296775|11215125|FG001|STARTED|Recovery and Follow-up||84
10086296|NCT02296775|11215126|FG002|STARTED|Recovery and Follow-up||83
10086297|NCT02296775|11215124|FG000|COMPLETED|Recovery and Follow-up||82
10086298|NCT02296775|11215125|FG001|COMPLETED|Recovery and Follow-up||79
10086299|NCT02296775|11215126|FG002|COMPLETED|Recovery and Follow-up||79
10086300|NCT02296775|11215124|FG000|NOT COMPLETED|Recovery and Follow-up||5
10086301|NCT02296775|11215125|FG001|NOT COMPLETED|Recovery and Follow-up||5
10086302|NCT02296775|11215126|FG002|NOT COMPLETED|Recovery and Follow-up||4
10086303|NCT02296840|11215136|FG000|STARTED|Overall Study||18
10086304|NCT02296840|11215137|FG001|STARTED|Overall Study||27
10086305|NCT02296840|11215136|FG000|COMPLETED|Overall Study||9
10086306|NCT02296840|11215137|FG001|COMPLETED|Overall Study||8
10086307|NCT02296840|11215136|FG000|NOT COMPLETED|Overall Study||9
10086308|NCT02296840|11215137|FG001|NOT COMPLETED|Overall Study||19
10086309|NCT02296853|11215145|FG000|STARTED|Overall Study||10
10086310|NCT02296853|11215146|FG001|STARTED|Overall Study||10
10086311|NCT02296853|11215145|FG000|COMPLETED|Overall Study||10
10086312|NCT02296853|11215146|FG001|COMPLETED|Overall Study||10
10086313|NCT02296853|11215145|FG000|NOT COMPLETED|Overall Study||0
10086314|NCT02296853|11215146|FG001|NOT COMPLETED|Overall Study||0
10086315|NCT02296892|11215155|FG000|STARTED|Overall Study||310
10086316|NCT02296892|11215156|FG001|STARTED|Overall Study||63
10086317|NCT02296892|11215157|FG002|STARTED|Overall Study||73
10086318|NCT02296892|11215155|FG000|Safety Population|Overall Study||303
10086319|NCT02296892|11215156|FG001|Safety Population|Overall Study||59
10086320|NCT02296892|11215157|FG002|Safety Population|Overall Study||69
10086321|NCT02296892|11215155|FG000|Complete Trial Treatment Period|Overall Study||303
10086322|NCT02296892|11215156|FG001|Complete Trial Treatment Period|Overall Study||59
10086323|NCT02296892|11215157|FG002|Complete Trial Treatment Period|Overall Study||69
10086324|NCT02296892|11215155|FG000|COMPLETED|Overall Study||298
10086325|NCT02296892|11215156|FG001|COMPLETED|Overall Study||59
10086326|NCT02296892|11215157|FG002|COMPLETED|Overall Study||68
10086327|NCT02296892|11215155|FG000|NOT COMPLETED|Overall Study||12
10086328|NCT02296892|11215156|FG001|NOT COMPLETED|Overall Study||4
10086329|NCT02296892|11215157|FG002|NOT COMPLETED|Overall Study||5
10086330|NCT02296931|11215167|FG000|STARTED|Overall Study||10
10086331|NCT02296931|11215168|FG001|STARTED|Overall Study||24
10086332|NCT02296931|11215167|FG000|COMPLETED|Overall Study||10
10086333|NCT02296931|11215168|FG001|COMPLETED|Overall Study||22
10086334|NCT02296931|11215167|FG000|NOT COMPLETED|Overall Study||0
10086335|NCT02296931|11215168|FG001|NOT COMPLETED|Overall Study||2
10086336|NCT02297100|11215176|FG000|STARTED|Overall Study||13
10086337|NCT02297100|11215177|FG001|STARTED|Overall Study||14
10086338|NCT02297100|11215176|FG000|COMPLETED|Overall Study||13
10086339|NCT02297100|11215177|FG001|COMPLETED|Overall Study||14
10086340|NCT02297100|11215176|FG000|NOT COMPLETED|Overall Study||0
10086341|NCT02297100|11215177|FG001|NOT COMPLETED|Overall Study||0
10086342|NCT02297308|11215183|FG000|STARTED|Overall Study||90
10086343|NCT02297308|11215183|FG000|COMPLETED|Overall Study||90
10086344|NCT02297308|11215183|FG000|NOT COMPLETED|Overall Study||0
10086345|NCT02297503|11215190|FG000|STARTED|Overall Study||30
10086346|NCT02297503|11215191|FG001|STARTED|Overall Study||31
10086347|NCT02297503|11215190|FG000|Initial Single Treatment|Overall Study||29
10086348|NCT02297503|11215191|FG001|Initial Single Treatment|Overall Study||31
10086349|NCT02297503|11215190|FG000|First Combined Treatment|Overall Study||28
10086350|NCT02297503|11215191|FG001|First Combined Treatment|Overall Study||28
10086351|NCT02297503|11215190|FG000|Second Combined Treatment|Overall Study||28
10086352|NCT02297503|11215191|FG001|Second Combined Treatment|Overall Study||28
10086353|NCT02297503|11215190|FG000|COMPLETED|Overall Study||28
10086354|NCT02297503|11215191|FG001|COMPLETED|Overall Study||27
10086355|NCT02297503|11215190|FG000|NOT COMPLETED|Overall Study||2
10086356|NCT02297503|11215191|FG001|NOT COMPLETED|Overall Study||4
10086357|NCT02297516|11215208|FG000|STARTED|Single Treatment Phase (6 Months)||32
10086358|NCT02297516|11215209|FG001|STARTED|Single Treatment Phase (6 Months)||33
10086359|NCT02297516|11215208|FG000|COMPLETED|Single Treatment Phase (6 Months)||31
10086360|NCT02297516|11215209|FG001|COMPLETED|Single Treatment Phase (6 Months)||31
10086361|NCT02297516|11215208|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1
10086362|NCT02297516|11215209|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2
10086363|NCT02297516|11215208|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31
10086364|NCT02297516|11215209|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31
10086365|NCT02297516|11215208|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31
10086366|NCT02297516|11215209|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30
10086367|NCT02297516|11215208|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
10086368|NCT02297516|11215209|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
10112774|NCT02505334|11243707|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
10112775|NCT02505334|11243708|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
10112776|NCT02505334|11243707|FG000|COMPLETED|Extension Treatment Period||194
10112777|NCT02505334|11243708|FG001|COMPLETED|Extension Treatment Period||0
10112778|NCT02505334|11243707|FG000|NOT COMPLETED|Extension Treatment Period||18
10112779|NCT02505334|11243708|FG001|NOT COMPLETED|Extension Treatment Period||0
10112780|NCT02505542|11243714|FG000|STARTED|Part A: Open-Label Period||736
10112781|NCT02505542|11243715|FG001|STARTED|Part A: Open-Label Period||0
10112782|NCT02505542|11243716|FG002|STARTED|Part A: Open-Label Period||0
10112783|NCT02505542|11243717|FG003|STARTED|Part A: Open-Label Period||0
10112784|NCT02505542|11243714|FG000|COMPLETED|Part A: Open-Label Period||659
10112785|NCT02505542|11243715|FG001|COMPLETED|Part A: Open-Label Period||0
10112786|NCT02505542|11243716|FG002|COMPLETED|Part A: Open-Label Period||0
10112787|NCT02505542|11243717|FG003|COMPLETED|Part A: Open-Label Period||0
10112788|NCT02505542|11243714|FG000|NOT COMPLETED|Part A: Open-Label Period||77
10112789|NCT02505542|11243715|FG001|NOT COMPLETED|Part A: Open-Label Period||0
10112790|NCT02505542|11243716|FG002|NOT COMPLETED|Part A: Open-Label Period||0
10112791|NCT02505542|11243717|FG003|NOT COMPLETED|Part A: Open-Label Period||0
10112792|NCT02505542|11243714|FG000|STARTED|Completed Part A, Did Not Enter Part B||659
10112793|NCT02505542|11243715|FG001|STARTED|Completed Part A, Did Not Enter Part B||0
10112794|NCT02505542|11243716|FG002|STARTED|Completed Part A, Did Not Enter Part B||0
10112795|NCT02505542|11243717|FG003|STARTED|Completed Part A, Did Not Enter Part B||0
10112796|NCT02505542|11243714|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313
10112797|NCT02505542|11243715|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0
10112798|NCT02505542|11243716|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0
10112799|NCT02505542|11243717|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0
10112800|NCT02505542|11243714|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
10112801|NCT02505542|11243715|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
10112802|NCT02505542|11243716|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
10112803|NCT02505542|11243717|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
10112804|NCT02505542|11243714|FG000|STARTED|Part B: Double-Blind Period||0
10112805|NCT02505542|11243715|FG001|STARTED|Part B: Double-Blind Period||104
10112806|NCT02505542|11243716|FG002|STARTED|Part B: Double-Blind Period||104
10112807|NCT02505542|11243717|FG003|STARTED|Part B: Double-Blind Period||105
10112808|NCT02505542|11243714|FG000|Started Escape Period|Part B: Double-Blind Period||0
10112809|NCT02505542|11243715|FG001|Started Escape Period|Part B: Double-Blind Period||73
10112810|NCT02505542|11243716|FG002|Started Escape Period|Part B: Double-Blind Period||7
10112811|NCT02505542|11243717|FG003|Started Escape Period|Part B: Double-Blind Period||15
10112812|NCT02505542|11243714|FG000|COMPLETED|Part B: Double-Blind Period||0
10112813|NCT02505542|11243715|FG001|COMPLETED|Part B: Double-Blind Period||92
10112814|NCT02505542|11243716|FG002|COMPLETED|Part B: Double-Blind Period||95
10112815|NCT02505542|11243717|FG003|COMPLETED|Part B: Double-Blind Period||98
10112816|NCT02505542|11243714|FG000|NOT COMPLETED|Part B: Double-Blind Period||0
10112817|NCT02505542|11243715|FG001|NOT COMPLETED|Part B: Double-Blind Period||12
10112818|NCT02505542|11243716|FG002|NOT COMPLETED|Part B: Double-Blind Period||9
10112819|NCT02505542|11243717|FG003|NOT COMPLETED|Part B: Double-Blind Period||7
10112820|NCT02505867|11243745|FG000|STARTED|Overall Study||6
10112821|NCT02505867|11243746|FG001|STARTED|Overall Study||6
10112822|NCT02505867|11243745|FG000|COMPLETED|Overall Study||0
10112823|NCT02505867|11243746|FG001|COMPLETED|Overall Study||0
10112824|NCT02505867|11243745|FG000|NOT COMPLETED|Overall Study||6
10112825|NCT02505867|11243746|FG001|NOT COMPLETED|Overall Study||6
10112826|NCT02505919|11243754|FG000|STARTED|Treatment||117
10112827|NCT02505919|11243755|FG001|STARTED|Treatment||67
10112828|NCT02505919|11243754|FG000|COMPLETED|Treatment||116
10112829|NCT02505919|11243755|FG001|COMPLETED|Treatment||65
10112830|NCT02505919|11243754|FG000|NOT COMPLETED|Treatment||1
10112831|NCT02505919|11243755|FG001|NOT COMPLETED|Treatment||2
10112832|NCT02505919|11243754|FG000|STARTED|1 Week Follow-Up||116
10112833|NCT02505919|11243755|FG001|STARTED|1 Week Follow-Up||65
10112834|NCT02505919|11243754|FG000|COMPLETED|1 Week Follow-Up||116
10112835|NCT02505919|11243755|FG001|COMPLETED|1 Week Follow-Up||65
10112836|NCT02505919|11243754|FG000|NOT COMPLETED|1 Week Follow-Up||0
10112837|NCT02505919|11243755|FG001|NOT COMPLETED|1 Week Follow-Up||0
10112838|NCT02505919|11243754|FG000|STARTED|1 Month Follow-Up||116
10112839|NCT02505919|11243755|FG001|STARTED|1 Month Follow-Up||65
10112840|NCT02505919|11243754|FG000|COMPLETED|1 Month Follow-Up||116
10112841|NCT02505919|11243755|FG001|COMPLETED|1 Month Follow-Up||65
10112842|NCT02505919|11243754|FG000|NOT COMPLETED|1 Month Follow-Up||0
10086369|NCT02297815|11215224|FG000|STARTED|Overall Study||1604
10086370|NCT02297815|11215225|FG001|STARTED|Overall Study||868
10086371|NCT02297815|11215224|FG000|5-10 Day Interview|Overall Study||1604
10086372|NCT02297815|11215225|FG001|5-10 Day Interview|Overall Study||868
10086373|NCT02297815|11215224|FG000|14-20 Day Interview|Overall Study||1368
10086374|NCT02297815|11215225|FG001|14-20 Day Interview|Overall Study||728
10086375|NCT02297815|11215224|FG000|COMPLETED|Overall Study||1368
10086376|NCT02297815|11215225|FG001|COMPLETED|Overall Study||728
10086377|NCT02297815|11215224|FG000|NOT COMPLETED|Overall Study||236
10086378|NCT02297815|11215225|FG001|NOT COMPLETED|Overall Study||140
10086379|NCT02297841|11215233|FG000|STARTED|Overall Study||209
10086380|NCT02297841|11215233|FG000|Induction Phase|Overall Study||209
10086381|NCT02297841|11215233|FG000|Challenge Phase|Overall Study||201
10086382|NCT02297841|11215233|FG000|COMPLETED|Overall Study||201
10086383|NCT02297841|11215233|FG000|NOT COMPLETED|Overall Study||8
10086384|NCT02298023|11215240|FG000|STARTED|Overall Study||8
10086385|NCT02298023|11215241|FG001|STARTED|Overall Study||8
10086386|NCT02298023|11215242|FG002|STARTED|Overall Study||8
10086387|NCT02298023|11215240|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7
10086388|NCT02298023|11215241|FG001|Intervention|Overall Study||8
10086389|NCT02298023|11215242|FG002|Intervention|Overall Study||8
10086390|NCT02298023|11215240|FG000|COMPLETED|Overall Study||7
10086391|NCT02298023|11215241|FG001|COMPLETED|Overall Study||8
10086392|NCT02298023|11215242|FG002|COMPLETED|Overall Study||8
10086393|NCT02298023|11215240|FG000|NOT COMPLETED|Overall Study||1
10086394|NCT02298023|11215241|FG001|NOT COMPLETED|Overall Study||0
10086395|NCT02298023|11215242|FG002|NOT COMPLETED|Overall Study||0
10086396|NCT02298179|11215265|FG000|STARTED|Overall Study||24
10086397|NCT02298179|11215266|FG001|STARTED|Overall Study||24
10086398|NCT02298179|11215267|FG002|STARTED|Overall Study||24
10086399|NCT02298179|11215268|FG003|STARTED|Overall Study||24
10086400|NCT02298179|11215269|FG004|STARTED|Overall Study||24
10086401|NCT02298179|11215270|FG005|STARTED|Overall Study||24
10086402|NCT02298179|11215271|FG006|STARTED|Overall Study||24
10086403|NCT02298179|11215272|FG007|STARTED|Overall Study||24
10086404|NCT02298179|11215273|FG008|STARTED|Overall Study||24
10086405|NCT02298179|11215274|FG009|STARTED|Overall Study||24
10086406|NCT02298179|11215275|FG010|STARTED|Overall Study||24
10086407|NCT02298179|11215276|FG011|STARTED|Overall Study||24
10086408|NCT02298179|11215265|FG000|COMPLETED|Overall Study||24
10086409|NCT02298179|11215266|FG001|COMPLETED|Overall Study||24
10086410|NCT02298179|11215267|FG002|COMPLETED|Overall Study||23
10086411|NCT02298179|11215268|FG003|COMPLETED|Overall Study||24
10086412|NCT02298179|11215269|FG004|COMPLETED|Overall Study||24
10086413|NCT02298179|11215270|FG005|COMPLETED|Overall Study||24
10086414|NCT02298179|11215271|FG006|COMPLETED|Overall Study||24
10086415|NCT02298179|11215272|FG007|COMPLETED|Overall Study||23
10086416|NCT02298179|11215273|FG008|COMPLETED|Overall Study||24
10086417|NCT02298179|11215274|FG009|COMPLETED|Overall Study||24
10086418|NCT02298179|11215275|FG010|COMPLETED|Overall Study||24
10086419|NCT02298179|11215276|FG011|COMPLETED|Overall Study||24
10086420|NCT02298179|11215265|FG000|NOT COMPLETED|Overall Study||0
10086421|NCT02298179|11215266|FG001|NOT COMPLETED|Overall Study||0
10086422|NCT02298179|11215267|FG002|NOT COMPLETED|Overall Study||1
10086423|NCT02298179|11215268|FG003|NOT COMPLETED|Overall Study||0
10086424|NCT02298179|11215269|FG004|NOT COMPLETED|Overall Study||0
10086425|NCT02298179|11215270|FG005|NOT COMPLETED|Overall Study||0
10086426|NCT02298179|11215271|FG006|NOT COMPLETED|Overall Study||0
10086427|NCT02298179|11215272|FG007|NOT COMPLETED|Overall Study||1
10086428|NCT02298179|11215273|FG008|NOT COMPLETED|Overall Study||0
10201292|NCT03431012|11328642|FG000|NOT COMPLETED|Overall Study||0
10201293|NCT03431012|11328643|FG001|NOT COMPLETED|Overall Study||0
10201294|NCT03431012|11328644|FG002|NOT COMPLETED|Overall Study||0
10201295|NCT03431012|11328645|FG003|NOT COMPLETED|Overall Study||0
10201296|NCT03431337|11328661|FG000|STARTED|Overall Study||78
10201297|NCT03431337|11328662|FG001|STARTED|Overall Study||79
10201298|NCT03431337|11328661|FG000|COMPLETED|Overall Study||49
10201299|NCT03431337|11328662|FG001|COMPLETED|Overall Study||57
10201300|NCT03431337|11328661|FG000|NOT COMPLETED|Overall Study||29
10201301|NCT03431337|11328662|FG001|NOT COMPLETED|Overall Study||22
10086429|NCT02298179|11215274|FG009|NOT COMPLETED|Overall Study||0
10086430|NCT02298179|11215275|FG010|NOT COMPLETED|Overall Study||0
10086431|NCT02298179|11215276|FG011|NOT COMPLETED|Overall Study||0
10086432|NCT02298192|11215304|FG000|STARTED|Overall Study||210
10086433|NCT02298192|11215305|FG001|STARTED|Overall Study||210
10086434|NCT02298192|11215304|FG000|COMPLETED|Overall Study||191
10086435|NCT02298192|11215305|FG001|COMPLETED|Overall Study||204
10086436|NCT02298192|11215304|FG000|NOT COMPLETED|Overall Study||19
10086437|NCT02298192|11215305|FG001|NOT COMPLETED|Overall Study||6
10086438|NCT02298322|11215311|FG000|STARTED|Overall Study||60
10086439|NCT02298322|11215311|FG000|COMPLETED|Overall Study||60
10086440|NCT02298322|11215311|FG000|NOT COMPLETED|Overall Study||0
10201302|NCT03431441|11328672|FG000|STARTED|Overall Study||24
10201303|NCT03431441|11328672|FG000|COMPLETED|Overall Study||19
10201304|NCT03431441|11328672|FG000|NOT COMPLETED|Overall Study||5
10086441|NCT02298361|11215321|FG000|STARTED|Overall Study||2240
10086442|NCT02298361|11215322|FG001|STARTED|Overall Study||12784
10086443|NCT02298361|11215323|FG002|STARTED|Overall Study||12227
10086444|NCT02298361|11215321|FG000|COMPLETED|Overall Study||2240
10086445|NCT02298361|11215322|FG001|COMPLETED|Overall Study||12784
10086446|NCT02298361|11215323|FG002|COMPLETED|Overall Study||12227
10086447|NCT02298361|11215321|FG000|NOT COMPLETED|Overall Study||0
10086448|NCT02298361|11215322|FG001|NOT COMPLETED|Overall Study||0
10086449|NCT02298361|11215323|FG002|NOT COMPLETED|Overall Study||0
10086450|NCT02298491|11215331|FG000|STARTED|Overall Study||4
9736994|NCT00197119|10837717|FG000|COMPLETED|Year 10||120
9736995|NCT00197119|10837718|FG001|COMPLETED|Year 10||108
9736996|NCT00197119|10837717|FG000|NOT COMPLETED|Year 10||0
9736997|NCT00197119|10837718|FG001|NOT COMPLETED|Year 10||0
9736998|NCT00197145|10837726|FG000|STARTED|Period 1: Randomized Treatment Phase||13
9736999|NCT00197145|10837727|FG001|STARTED|Period 1: Randomized Treatment Phase||11
9737000|NCT00197145|10837726|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0
9737001|NCT00197145|10837727|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0
9737002|NCT00197145|10837726|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
9737003|NCT00197145|10837727|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
9737004|NCT00197145|10837726|FG000|STARTED|Period 2 : Open Label Phase||10
9737005|NCT00197145|10837727|FG001|STARTED|Period 2 : Open Label Phase||0
9737006|NCT00197145|10837726|FG000|COMPLETED|Period 2 : Open Label Phase||0
9737007|NCT00197145|10837727|FG001|COMPLETED|Period 2 : Open Label Phase||0
9737008|NCT00197145|10837726|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10
9737009|NCT00197145|10837727|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0
9737010|NCT00197184|10837736|FG000|STARTED|Overall Study||139
9737011|NCT00197184|10837737|FG001|STARTED|Overall Study||137
9737012|NCT00197184|10837736|FG000|COMPLETED|Overall Study||139
9737013|NCT00197184|10837737|FG001|COMPLETED|Overall Study||137
9737014|NCT00197184|10837736|FG000|NOT COMPLETED|Overall Study||0
9737015|NCT00197184|10837737|FG001|NOT COMPLETED|Overall Study||0
9737016|NCT00197236|10837746|FG000|STARTED|Overall Study||135
9737017|NCT00197236|10837747|FG001|STARTED|Overall Study||127
9737018|NCT00197236|10837748|FG002|STARTED|Overall Study||132
9737019|NCT00197236|10837746|FG000|COMPLETED|Overall Study||121
9737020|NCT00197236|10837747|FG001|COMPLETED|Overall Study||110
9737021|NCT00197236|10837748|FG002|COMPLETED|Overall Study||109
9737022|NCT00197236|10837746|FG000|NOT COMPLETED|Overall Study||14
9737023|NCT00197236|10837747|FG001|NOT COMPLETED|Overall Study||17
9737024|NCT00197236|10837748|FG002|NOT COMPLETED|Overall Study||23
9737025|NCT00197392|10837761|FG000|STARTED|Overall Study||214
9737026|NCT00197392|10837762|FG001|STARTED|Overall Study||220
9737027|NCT00197392|10837761|FG000|Safety Population|Overall Study||214
9737028|NCT00197392|10837762|FG001|Safety Population|Overall Study||220
9737029|NCT00197392|10837761|FG000|Modified Intent to Treat|Overall Study||209
9737030|NCT00197392|10837762|FG001|Modified Intent to Treat|Overall Study||210
9737031|NCT00197392|10837761|FG000|Evaluable|Overall Study||176
9737032|NCT00197392|10837762|FG001|Evaluable|Overall Study||181
9737033|NCT00197392|10837761|FG000|Per Protocol|Overall Study||126
9737034|NCT00197392|10837762|FG001|Per Protocol|Overall Study||134
9737035|NCT00197392|10837761|FG000|COMPLETED|Overall Study||126
9737036|NCT00197392|10837762|FG001|COMPLETED|Overall Study||134
9737037|NCT00197392|10837761|FG000|NOT COMPLETED|Overall Study||88
9737038|NCT00197392|10837762|FG001|NOT COMPLETED|Overall Study||86
9737039|NCT00197496|10837786|FG000|STARTED|Baseline to Discharge||14
9737040|NCT00197496|10837787|FG001|STARTED|Baseline to Discharge||7
9737041|NCT00197496|10837786|FG000|COMPLETED|Baseline to Discharge||12
9737042|NCT00197496|10837787|FG001|COMPLETED|Baseline to Discharge||5
9737043|NCT00197496|10837786|FG000|NOT COMPLETED|Baseline to Discharge||2
9737044|NCT00197496|10837787|FG001|NOT COMPLETED|Baseline to Discharge||2
9737045|NCT00197496|10837786|FG000|STARTED|Follow-up||12
9737046|NCT00197496|10837787|FG001|STARTED|Follow-up||5
9737047|NCT00197496|10837786|FG000|COMPLETED|Follow-up||10
9737048|NCT00197496|10837787|FG001|COMPLETED|Follow-up||4
9737049|NCT00197496|10837786|FG000|NOT COMPLETED|Follow-up||2
9737050|NCT00197496|10837787|FG001|NOT COMPLETED|Follow-up||1
9737051|NCT00198029|10837793|FG000|STARTED|Overall Study||32
9737052|NCT00198029|10837793|FG000|COMPLETED|Overall Study||28
9737053|NCT00198029|10837793|FG000|NOT COMPLETED|Overall Study||4
9737054|NCT00198042|10837797|FG000|STARTED|Overall Study||18
9737055|NCT00198042|10837797|FG000|COMPLETED|Overall Study||18
9737056|NCT00198042|10837797|FG000|NOT COMPLETED|Overall Study||0
9737057|NCT00198081|10837803|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
9737058|NCT00198081|10837804|FG001|STARTED|Overall Study|No enrollment on this arm.|0
9737059|NCT00198081|10837803|FG000|COMPLETED|Overall Study||4
9737060|NCT00198081|10837804|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0
9737061|NCT00198081|10837803|FG000|NOT COMPLETED|Overall Study||1
9737062|NCT00198081|10837804|FG001|NOT COMPLETED|Overall Study||0
9737063|NCT00198107|10837817|FG000|STARTED|Double-Blind Period||41
9737064|NCT00198107|10837818|FG001|STARTED|Double-Blind Period||40
9737065|NCT00198107|10837819|FG002|STARTED|Double-Blind Period||0
9737066|NCT00198107|10837817|FG000|1 or More Follow-up Visits|Double-Blind Period||40
9737067|NCT00198107|10837818|FG001|1 or More Follow-up Visits|Double-Blind Period||38
9737068|NCT00198107|10837819|FG002|1 or More Follow-up Visits|Double-Blind Period||0
9737069|NCT00198107|10837817|FG000|COMPLETED|Double-Blind Period||35
9737070|NCT00198107|10837818|FG001|COMPLETED|Double-Blind Period||37
9737071|NCT00198107|10837819|FG002|COMPLETED|Double-Blind Period||0
9737072|NCT00198107|10837817|FG000|NOT COMPLETED|Double-Blind Period||6
9737073|NCT00198107|10837818|FG001|NOT COMPLETED|Double-Blind Period||3
9737074|NCT00198107|10837819|FG002|NOT COMPLETED|Double-Blind Period||0
9737075|NCT00198107|10837817|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
9737076|NCT00198107|10837818|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
9737077|NCT00198107|10837819|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
9737078|NCT00198107|10837817|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
9737079|NCT00198107|10837818|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
9737080|NCT00198107|10837819|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
9737081|NCT00198107|10837817|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
9737082|NCT00198107|10837818|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10086451|NCT02298491|11215331|FG000|COMPLETED|Overall Study||3
10086452|NCT02298491|11215331|FG000|NOT COMPLETED|Overall Study||1
10086453|NCT02298803|11215337|FG000|STARTED|Overall Study||30
10086454|NCT02298803|11215337|FG000|COMPLETED|Overall Study||30
10086455|NCT02298803|11215337|FG000|NOT COMPLETED|Overall Study||0
10086456|NCT02298842|11215348|FG000|STARTED|First Platelet Donation (Day 0)||44
10086457|NCT02298842|11215349|FG001|STARTED|First Platelet Donation (Day 0)||41
10086458|NCT02298842|11215348|FG000|COMPLETED|First Platelet Donation (Day 0)||38
10086459|NCT02298842|11215349|FG001|COMPLETED|First Platelet Donation (Day 0)||36
10086460|NCT02298842|11215348|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6
10086461|NCT02298842|11215349|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5
10086462|NCT02298842|11215348|FG000|STARTED|Second Platelet Donation (Day 6-8)||38
9737083|NCT00198107|10837819|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
9737084|NCT00198133|10837829|FG000|STARTED|Overall Study||16
10086463|NCT02298842|11215349|FG001|STARTED|Second Platelet Donation (Day 6-8)||36
10086464|NCT02298842|11215348|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30
10086465|NCT02298842|11215349|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30
10086466|NCT02298842|11215348|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
10086467|NCT02298842|11215349|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
10086468|NCT02298868|11215357|FG000|STARTED|Overall Study||10
10086469|NCT02298868|11215357|FG000|COMPLETED|Overall Study||7
10086470|NCT02298868|11215357|FG000|NOT COMPLETED|Overall Study||3
10086471|NCT02298933|11215361|FG000|STARTED|Overall Study||10
10086472|NCT02298933|11215361|FG000|COMPLETED|Overall Study||10
10086473|NCT02298933|11215361|FG000|NOT COMPLETED|Overall Study||0
10086474|NCT02298946|11215367|FG000|STARTED|Overall Study||8
10086475|NCT02298946|11215368|FG001|STARTED|Overall Study||9
10086476|NCT02298946|11215367|FG000|COMPLETED|Overall Study||4
10086477|NCT02298946|11215368|FG001|COMPLETED|Overall Study||8
10086478|NCT02298946|11215367|FG000|NOT COMPLETED|Overall Study||4
10086479|NCT02298946|11215368|FG001|NOT COMPLETED|Overall Study||1
10086480|NCT02299050|11215375|FG000|STARTED|Overall Study||23
10086481|NCT02299050|11215375|FG000|COMPLETED|Overall Study||15
10086482|NCT02299050|11215375|FG000|NOT COMPLETED|Overall Study||8
10086483|NCT02299076|11215381|FG000|STARTED|Overall Study||230
10086484|NCT02299076|11215382|FG001|STARTED|Overall Study||226
10086485|NCT02299076|11215381|FG000|COMPLETED|Overall Study||210
10086486|NCT02299076|11215382|FG001|COMPLETED|Overall Study||212
10086487|NCT02299076|11215381|FG000|NOT COMPLETED|Overall Study||20
10086488|NCT02299076|11215382|FG001|NOT COMPLETED|Overall Study||14
10086489|NCT02299089|11215392|FG000|STARTED|Overall Study||3
10086490|NCT02299089|11215393|FG001|STARTED|Overall Study||4
10086491|NCT02299089|11215394|FG002|STARTED|Overall Study||1
10086492|NCT02299089|11215395|FG003|STARTED|Overall Study||4
10086493|NCT02299089|11215392|FG000|COMPLETED|Overall Study||3
10086494|NCT02299089|11215393|FG001|COMPLETED|Overall Study||4
10086495|NCT02299089|11215394|FG002|COMPLETED|Overall Study||1
10086496|NCT02299089|11215395|FG003|COMPLETED|Overall Study||4
10086497|NCT02299089|11215392|FG000|NOT COMPLETED|Overall Study||0
10086498|NCT02299089|11215393|FG001|NOT COMPLETED|Overall Study||0
10086499|NCT02299089|11215394|FG002|NOT COMPLETED|Overall Study||0
10086500|NCT02299089|11215395|FG003|NOT COMPLETED|Overall Study||0
10086501|NCT02299141|11215415|FG000|STARTED|Overall Study||20
10086502|NCT02299141|11215415|FG000|COMPLETED|Overall Study||20
10086503|NCT02299141|11215415|FG000|NOT COMPLETED|Overall Study||0
10086504|NCT02299167|11215426|FG000|STARTED|Overall Study||35
10086505|NCT02299167|11215426|FG000|Dural Puncture|Overall Study||24
10086506|NCT02299167|11215426|FG000|Success Rate|Overall Study||24
10086507|NCT02299167|11215426|FG000|Adverse Effects|Overall Study||24
10086508|NCT02299167|11215426|FG000|COMPLETED|Overall Study||24
10086509|NCT02299167|11215426|FG000|NOT COMPLETED|Overall Study||11
10086510|NCT02299258|11215432|FG000|STARTED|Overall Study||32
10086511|NCT02299258|11215433|FG001|STARTED|Overall Study||31
10086512|NCT02299258|11215432|FG000|COMPLETED|Overall Study||31
10086513|NCT02299258|11215433|FG001|COMPLETED|Overall Study||30
10086514|NCT02299258|11215432|FG000|NOT COMPLETED|Overall Study||1
10086515|NCT02299258|11215433|FG001|NOT COMPLETED|Overall Study||1
10086516|NCT02299297|11215439|FG000|STARTED|Overall Study||12
10086517|NCT02299297|11215439|FG000|COMPLETED|Overall Study||11
10086518|NCT02299297|11215439|FG000|NOT COMPLETED|Overall Study||1
10086519|NCT02299336|11215443|FG000|STARTED|Overall Study||60
10086520|NCT02299336|11215443|FG000|COMPLETED|Overall Study||46
10086521|NCT02299336|11215443|FG000|NOT COMPLETED|Overall Study||14
10086522|NCT02299349|11215449|FG000|STARTED|Overall Study||35
10086523|NCT02299349|11215450|FG001|STARTED|Overall Study||35
10086524|NCT02299349|11215449|FG000|COMPLETED|Overall Study||35
10086525|NCT02299349|11215450|FG001|COMPLETED|Overall Study||35
10086526|NCT02299349|11215449|FG000|NOT COMPLETED|Overall Study||0
10086527|NCT02299349|11215450|FG001|NOT COMPLETED|Overall Study||0
10086528|NCT02299375|11215458|FG000|STARTED|Overall Study||94
10086529|NCT02299375|11215459|FG001|STARTED|Overall Study||90
10086530|NCT02299375|11215458|FG000|COMPLETED|Overall Study||14
10086531|NCT02299375|11215459|FG001|COMPLETED|Overall Study||10
10086532|NCT02299375|11215458|FG000|NOT COMPLETED|Overall Study||80
10086533|NCT02299375|11215459|FG001|NOT COMPLETED|Overall Study||80
10086534|NCT02299388|11215468|FG000|STARTED|Overall Study||6
10086535|NCT02299388|11215469|FG001|STARTED|Overall Study||5
10086536|NCT02299388|11215468|FG000|COMPLETED|Overall Study||6
10086537|NCT02299388|11215469|FG001|COMPLETED|Overall Study||4
10086538|NCT02299388|11215468|FG000|NOT COMPLETED|Overall Study||0
10086539|NCT02299388|11215469|FG001|NOT COMPLETED|Overall Study||1
10086540|NCT02299427|11215477|FG000|STARTED|Overall Study||35
10086541|NCT02299427|11215478|FG001|STARTED|Overall Study||34
10086542|NCT02299427|11215477|FG000|COMPLETED|Overall Study||12
10086543|NCT02299427|11215478|FG001|COMPLETED|Overall Study||31
10086544|NCT02299427|11215477|FG000|NOT COMPLETED|Overall Study||23
10086545|NCT02299427|11215478|FG001|NOT COMPLETED|Overall Study||3
10086546|NCT02299479|11215484|FG000|STARTED|Overall Study||20
10086547|NCT02299479|11215484|FG000|COMPLETED|Overall Study||18
10086548|NCT02299479|11215484|FG000|NOT COMPLETED|Overall Study||2
10086549|NCT02299570|11215491|FG000|STARTED|Overall Study||45
10086550|NCT02299570|11215492|FG001|STARTED|Overall Study||44
10086551|NCT02299570|11215493|FG002|STARTED|Overall Study||44
10086552|NCT02299570|11215491|FG000|COMPLETED|Overall Study||31
10086553|NCT02299570|11215492|FG001|COMPLETED|Overall Study||35
10086554|NCT02299570|11215493|FG002|COMPLETED|Overall Study||25
10086555|NCT02299570|11215491|FG000|NOT COMPLETED|Overall Study||14
10086556|NCT02299570|11215492|FG001|NOT COMPLETED|Overall Study||9
10086557|NCT02299570|11215493|FG002|NOT COMPLETED|Overall Study||19
10086558|NCT02299635|11215506|FG000|STARTED|Overall Study||19
10086559|NCT02299635|11215506|FG000|COMPLETED|Overall Study||0
10086560|NCT02299635|11215506|FG000|NOT COMPLETED|Overall Study||19
10086561|NCT02299791|11215512|FG000|STARTED|Overall Study||2053
10086562|NCT02299791|11215513|FG001|STARTED|Overall Study||2803
10086563|NCT02299791|11215512|FG000|COMPLETED|Overall Study||2053
10086564|NCT02299791|11215513|FG001|COMPLETED|Overall Study||2803
10086565|NCT02299791|11215512|FG000|NOT COMPLETED|Overall Study||0
10086566|NCT02299791|11215513|FG001|NOT COMPLETED|Overall Study||0
10086567|NCT02299869|11215523|FG000|STARTED|Overall Study||10
10086568|NCT02299869|11215524|FG001|STARTED|Overall Study||10
10086569|NCT02299869|11215525|FG002|STARTED|Overall Study||10
10086570|NCT02299869|11215526|FG003|STARTED|Overall Study||10
10086571|NCT02299869|11215523|FG000|COMPLETED|Overall Study||10
10086572|NCT02299869|11215524|FG001|COMPLETED|Overall Study||10
10086573|NCT02299869|11215525|FG002|COMPLETED|Overall Study||10
10086574|NCT02299869|11215526|FG003|COMPLETED|Overall Study||10
10086575|NCT02299869|11215523|FG000|NOT COMPLETED|Overall Study||0
10086576|NCT02299869|11215524|FG001|NOT COMPLETED|Overall Study||0
10086577|NCT02299869|11215525|FG002|NOT COMPLETED|Overall Study||0
10086578|NCT02299869|11215526|FG003|NOT COMPLETED|Overall Study||0
10086579|NCT02300025|11215537|FG000|STARTED|Overall Study||10
10086580|NCT02300025|11215538|FG001|STARTED|Overall Study||6
10086581|NCT02300025|11215539|FG002|STARTED|Overall Study||6
10086582|NCT02300025|11215540|FG003|STARTED|Overall Study||6
10086583|NCT02300025|11215537|FG000|COMPLETED|Overall Study||10
10086584|NCT02300025|11215538|FG001|COMPLETED|Overall Study||6
10086585|NCT02300025|11215539|FG002|COMPLETED|Overall Study||6
10086586|NCT02300025|11215540|FG003|COMPLETED|Overall Study||6
10086587|NCT02300025|11215537|FG000|NOT COMPLETED|Overall Study||0
10086588|NCT02300025|11215538|FG001|NOT COMPLETED|Overall Study||0
10086589|NCT02300025|11215539|FG002|NOT COMPLETED|Overall Study||0
10086590|NCT02300025|11215540|FG003|NOT COMPLETED|Overall Study||0
10086591|NCT02300077|11215554|FG000|STARTED|Overall Study||21
10086592|NCT02300077|11215555|FG001|STARTED|Overall Study||18
10086593|NCT02300077|11215556|FG002|STARTED|Overall Study||21
10086594|NCT02300077|11215554|FG000|COMPLETED|Overall Study||21
10086595|NCT02300077|11215555|FG001|COMPLETED|Overall Study||18
10086596|NCT02300077|11215556|FG002|COMPLETED|Overall Study||21
10086597|NCT02300077|11215554|FG000|NOT COMPLETED|Overall Study||0
10086598|NCT02300077|11215555|FG001|NOT COMPLETED|Overall Study||0
10086599|NCT02300077|11215556|FG002|NOT COMPLETED|Overall Study||0
10086600|NCT02300103|11215564|FG000|STARTED|Overall Study||69
10086601|NCT02300103|11215564|FG000|COMPLETED|Overall Study||63
10086602|NCT02300103|11215564|FG000|NOT COMPLETED|Overall Study||6
10086603|NCT02300129|11215568|FG000|STARTED|Period 1 Session 1 (Day 1)||11
10086604|NCT02300129|11215569|FG001|STARTED|Period 1 Session 1 (Day 1)||5
10086605|NCT02300129|11215570|FG002|STARTED|Period 1 Session 1 (Day 1)||7
10086606|NCT02300129|11215571|FG003|STARTED|Period 1 Session 1 (Day 1)||11
10086607|NCT02300129|11215568|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11
10086608|NCT02300129|11215569|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5
10086609|NCT02300129|11215570|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7
10201305|NCT03431857|11328676|FG000|STARTED|Overall Study||106
10201306|NCT03431857|11328676|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52
10086610|NCT02300129|11215571|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11
10086611|NCT02300129|11215568|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10086612|NCT02300129|11215569|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10086613|NCT02300129|11215570|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10086614|NCT02300129|11215571|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10086615|NCT02300129|11215568|FG000|STARTED|Period 1 Session 2 (Day 3)||11
10086616|NCT02300129|11215569|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
10086617|NCT02300129|11215570|FG002|STARTED|Period 1 Session 2 (Day 3)||7
10086618|NCT02300129|11215571|FG003|STARTED|Period 1 Session 2 (Day 3)||11
10086619|NCT02300129|11215568|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11
10086620|NCT02300129|11215569|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4
10086621|NCT02300129|11215570|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7
10086622|NCT02300129|11215571|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11
10086623|NCT02300129|11215568|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10086624|NCT02300129|11215569|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
10086625|NCT02300129|11215570|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10086626|NCT02300129|11215571|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10086627|NCT02300129|11215568|FG000|STARTED|Period 1 Session 3 (Day 5)||11
10086628|NCT02300129|11215569|FG001|STARTED|Period 1 Session 3 (Day 5)||4
10086629|NCT02300129|11215570|FG002|STARTED|Period 1 Session 3 (Day 5)||7
10086630|NCT02300129|11215571|FG003|STARTED|Period 1 Session 3 (Day 5)||11
10086631|NCT02300129|11215568|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11
10086632|NCT02300129|11215569|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4
10086633|NCT02300129|11215570|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7
10086634|NCT02300129|11215571|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11
10086635|NCT02300129|11215568|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10086636|NCT02300129|11215569|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10086637|NCT02300129|11215570|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10086638|NCT02300129|11215571|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10086639|NCT02300129|11215568|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11
10086640|NCT02300129|11215569|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4
10086641|NCT02300129|11215570|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7
10086642|NCT02300129|11215571|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
10086643|NCT02300129|11215568|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
10086644|NCT02300129|11215569|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
10086645|NCT02300129|11215570|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
10086646|NCT02300129|11215571|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
10086647|NCT02300129|11215568|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
10086648|NCT02300129|11215569|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
10086649|NCT02300129|11215570|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
10086650|NCT02300129|11215571|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
10086651|NCT02300129|11215568|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10
10086652|NCT02300129|11215569|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4
10086653|NCT02300129|11215570|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7
10086654|NCT02300129|11215571|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10
10086655|NCT02300129|11215568|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
10086656|NCT02300129|11215569|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
10086657|NCT02300129|11215570|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
10086658|NCT02300129|11215571|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
10086659|NCT02300129|11215568|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10086660|NCT02300129|11215569|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10086661|NCT02300129|11215570|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10086662|NCT02300129|11215571|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10086663|NCT02300220|11215583|FG000|STARTED|Overall Study||72
10086664|NCT02300220|11215584|FG001|STARTED|Overall Study||72
10086665|NCT02300220|11215583|FG000|COMPLETED|Overall Study||68
10086666|NCT02300220|11215584|FG001|COMPLETED|Overall Study||65
10086667|NCT02300220|11215583|FG000|NOT COMPLETED|Overall Study||4
10086668|NCT02300220|11215584|FG001|NOT COMPLETED|Overall Study||7
10086669|NCT02300259|11215593|FG000|STARTED|Period 1||16
10086670|NCT02300259|11215594|FG001|STARTED|Period 1||16
10086671|NCT02300259|11215595|FG002|STARTED|Period 1||16
10086672|NCT02300259|11215593|FG000|Received at Least One Dose of Study Drug|Period 1||16
10086673|NCT02300259|11215594|FG001|Received at Least One Dose of Study Drug|Period 1||16
10086674|NCT02300259|11215595|FG002|Received at Least One Dose of Study Drug|Period 1||16
10086675|NCT02300259|11215593|FG000|COMPLETED|Period 1||16
10086676|NCT02300259|11215594|FG001|COMPLETED|Period 1||16
10086677|NCT02300259|11215595|FG002|COMPLETED|Period 1||14
10086678|NCT02300259|11215593|FG000|NOT COMPLETED|Period 1||0
10086679|NCT02300259|11215594|FG001|NOT COMPLETED|Period 1||0
10086680|NCT02300259|11215595|FG002|NOT COMPLETED|Period 1||2
10086681|NCT02300259|11215593|FG000|STARTED|Period 2||16
10086682|NCT02300259|11215594|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0
10086683|NCT02300259|11215595|FG002|STARTED|Period 2||14
10086684|NCT02300259|11215593|FG000|COMPLETED|Period 2||15
10086685|NCT02300259|11215594|FG001|COMPLETED|Period 2||0
10086686|NCT02300259|11215595|FG002|COMPLETED|Period 2||13
10086687|NCT02300259|11215593|FG000|NOT COMPLETED|Period 2||1
10086688|NCT02300259|11215594|FG001|NOT COMPLETED|Period 2||0
10086689|NCT02300259|11215595|FG002|NOT COMPLETED|Period 2||1
10086690|NCT02300285|11215616|FG000|STARTED|Overall Study||3
10086691|NCT02300285|11215617|FG001|STARTED|Overall Study||3
10086692|NCT02300285|11215616|FG000|COMPLETED|Overall Study||3
10086693|NCT02300285|11215617|FG001|COMPLETED|Overall Study||3
10086694|NCT02300285|11215616|FG000|NOT COMPLETED|Overall Study||0
10086695|NCT02300285|11215617|FG001|NOT COMPLETED|Overall Study||0
10086696|NCT02300298|11215623|FG000|STARTED|Disposition for Nintedanib||10
10086697|NCT02300298|11215624|FG001|STARTED|Disposition for Nintedanib||0
10086698|NCT02300298|11215623|FG000|COMPLETED|Disposition for Nintedanib||0
10086699|NCT02300298|11215624|FG001|COMPLETED|Disposition for Nintedanib||0
10086700|NCT02300298|11215623|FG000|NOT COMPLETED|Disposition for Nintedanib||10
10086701|NCT02300298|11215624|FG001|NOT COMPLETED|Disposition for Nintedanib||0
10086702|NCT02300298|11215623|FG000|STARTED|Disposition for Docetaxel||0
10086703|NCT02300298|11215624|FG001|STARTED|Disposition for Docetaxel||10
10086704|NCT02300298|11215623|FG000|COMPLETED|Disposition for Docetaxel||0
10086705|NCT02300298|11215624|FG001|COMPLETED|Disposition for Docetaxel||0
10086706|NCT02300298|11215623|FG000|NOT COMPLETED|Disposition for Docetaxel||0
10086707|NCT02300298|11215624|FG001|NOT COMPLETED|Disposition for Docetaxel||10
10086708|NCT02300311|11215630|FG000|STARTED|Overall Study||69
10086709|NCT02300311|11215631|FG001|STARTED|Overall Study||69
10086710|NCT02300311|11215630|FG000|COMPLETED|Overall Study||50
10086711|NCT02300311|11215631|FG001|COMPLETED|Overall Study||69
10086712|NCT02300311|11215630|FG000|NOT COMPLETED|Overall Study||19
10086713|NCT02300311|11215631|FG001|NOT COMPLETED|Overall Study||0
10086714|NCT02300545|11215637|FG000|STARTED|Overall Study||56
10086715|NCT02300545|11215637|FG000|COMPLETED|Overall Study||56
10086716|NCT02300545|11215637|FG000|NOT COMPLETED|Overall Study||0
10086717|NCT02300558|11215641|FG000|STARTED|Single Blind Phase (24 Weeks)||41
10086718|NCT02300558|11215641|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35
10086719|NCT02300558|11215641|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
10086720|NCT02300558|11215641|FG000|STARTED|Open-Label (OL) Extension Phase||32
10086721|NCT02300558|11215641|FG000|COMPLETED|Open-Label (OL) Extension Phase||0
10086722|NCT02300558|11215641|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32
10086723|NCT02300610|11215652|FG000|STARTED|Overall Study||3
10086724|NCT02300610|11215653|FG001|STARTED|Overall Study||3
10086725|NCT02300610|11215654|FG002|STARTED|Overall Study||4
10086726|NCT02300610|11215652|FG000|COMPLETED|Overall Study||2
10086727|NCT02300610|11215653|FG001|COMPLETED|Overall Study||3
10086728|NCT02300610|11215654|FG002|COMPLETED|Overall Study||3
10086729|NCT02300610|11215652|FG000|NOT COMPLETED|Overall Study||1
10086730|NCT02300610|11215653|FG001|NOT COMPLETED|Overall Study||0
10086731|NCT02300610|11215654|FG002|NOT COMPLETED|Overall Study||1
10086732|NCT02300727|11215670|FG000|STARTED|Overall Study||0
10086733|NCT02300727|11215671|FG001|STARTED|Overall Study||0
10086734|NCT02300727|11215672|FG002|STARTED|Overall Study||3
10086735|NCT02300727|11215673|FG003|STARTED|Overall Study||3
10086736|NCT02300727|11215674|FG004|STARTED|Overall Study||0
10086737|NCT02300727|11215675|FG005|STARTED|Overall Study||0
10086738|NCT02300727|11215670|FG000|COMPLETED|Overall Study||0
10086739|NCT02300727|11215671|FG001|COMPLETED|Overall Study||0
10086740|NCT02300727|11215672|FG002|COMPLETED|Overall Study||3
10086741|NCT02300727|11215673|FG003|COMPLETED|Overall Study||2
10086742|NCT02300727|11215674|FG004|COMPLETED|Overall Study||0
10086743|NCT02300727|11215675|FG005|COMPLETED|Overall Study||0
10086744|NCT02300727|11215670|FG000|NOT COMPLETED|Overall Study||0
10086745|NCT02300727|11215671|FG001|NOT COMPLETED|Overall Study||0
10086746|NCT02300727|11215672|FG002|NOT COMPLETED|Overall Study||0
10086747|NCT02300727|11215673|FG003|NOT COMPLETED|Overall Study||1
10086748|NCT02300727|11215674|FG004|NOT COMPLETED|Overall Study||0
10086749|NCT02300727|11215675|FG005|NOT COMPLETED|Overall Study||0
10086750|NCT02300987|11215691|FG000|STARTED|Primary Phase : Prior to Cross-over||8
10086751|NCT02300987|11215692|FG001|STARTED|Primary Phase : Prior to Cross-over||2
10086752|NCT02300987|11215691|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2
10086753|NCT02300987|11215692|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0
10086754|NCT02300987|11215691|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
10086755|NCT02300987|11215692|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
10086756|NCT02300987|11215691|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1
10086757|NCT02300987|11215692|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2
10086758|NCT02300987|11215691|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0
10086759|NCT02300987|11215692|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1
10086760|NCT02300987|11215691|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
10086761|NCT02300987|11215692|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
10086762|NCT02301039|11215702|FG000|STARTED|Overall Study||42
10086763|NCT02301039|11215703|FG001|STARTED|Overall Study||42
10086764|NCT02301039|11215704|FG002|STARTED|Overall Study||60
10086765|NCT02301039|11215702|FG000|COMPLETED|Overall Study||42
10086766|NCT02301039|11215703|FG001|COMPLETED|Overall Study||42
10086767|NCT02301039|11215704|FG002|COMPLETED|Overall Study||60
10086768|NCT02301039|11215702|FG000|NOT COMPLETED|Overall Study||0
10086769|NCT02301039|11215703|FG001|NOT COMPLETED|Overall Study||0
10086770|NCT02301039|11215704|FG002|NOT COMPLETED|Overall Study||0
10086771|NCT02301143|11215712|FG000|STARTED|Induction Period||107
10086772|NCT02301143|11215713|FG001|STARTED|Induction Period||0
10086773|NCT02301143|11215712|FG000|COMPLETED|Induction Period||62
10086774|NCT02301143|11215713|FG001|COMPLETED|Induction Period||0
10086775|NCT02301143|11215712|FG000|NOT COMPLETED|Induction Period||45
10086776|NCT02301143|11215713|FG001|NOT COMPLETED|Induction Period||0
10086777|NCT02301143|11215712|FG000|STARTED|Investigator's Choice||0
10086778|NCT02301143|11215713|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
10086779|NCT02301143|11215712|FG000|COMPLETED|Investigator's Choice||0
10086780|NCT02301143|11215713|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
10086781|NCT02301143|11215712|FG000|NOT COMPLETED|Investigator's Choice||0
10086782|NCT02301143|11215713|FG001|NOT COMPLETED|Investigator's Choice||10
10086783|NCT02301169|11215726|FG000|STARTED|Overall Study||21
10086784|NCT02301169|11215727|FG001|STARTED|Overall Study||21
10086785|NCT02301169|11215726|FG000|COMPLETED|Overall Study||20
10086786|NCT02301169|11215727|FG001|COMPLETED|Overall Study||21
10086787|NCT02301169|11215726|FG000|NOT COMPLETED|Overall Study||1
10086788|NCT02301169|11215727|FG001|NOT COMPLETED|Overall Study||0
10086789|NCT02301299|11215733|FG000|STARTED|Overall Study||1322
10086790|NCT02301299|11215733|FG000|COMPLETED|Overall Study||1322
10086791|NCT02301299|11215733|FG000|NOT COMPLETED|Overall Study||0
10086792|NCT02301364|11215740|FG000|STARTED|Overall Study||4
10086793|NCT02301364|11215740|FG000|COMPLETED|Overall Study||4
10086794|NCT02301364|11215740|FG000|NOT COMPLETED|Overall Study||0
10086795|NCT02301377|11215746|FG000|STARTED|Overall Study||3
10086796|NCT02301377|11215747|FG001|STARTED|Overall Study||2
10086797|NCT02301377|11215746|FG000|COMPLETED|Overall Study||3
10086798|NCT02301377|11215747|FG001|COMPLETED|Overall Study||2
10086799|NCT02301377|11215746|FG000|NOT COMPLETED|Overall Study||0
10086800|NCT02301377|11215747|FG001|NOT COMPLETED|Overall Study||0
10086801|NCT02301390|11215755|FG000|STARTED|Overall Study||27
10086802|NCT02301390|11215756|FG001|STARTED|Overall Study||26
10086803|NCT02301390|11215755|FG000|COMPLETED|Overall Study||17
10086804|NCT02301390|11215756|FG001|COMPLETED|Overall Study||13
10086805|NCT02301390|11215755|FG000|NOT COMPLETED|Overall Study||10
10086806|NCT02301390|11215756|FG001|NOT COMPLETED|Overall Study||13
10086807|NCT02301403|11215764|FG000|STARTED|Overall Study||315
10086808|NCT02301403|11215765|FG001|STARTED|Overall Study||308
10086809|NCT02301403|11215764|FG000|COMPLETED|Overall Study||287
10086810|NCT02301403|11215765|FG001|COMPLETED|Overall Study||267
10086811|NCT02301403|11215764|FG000|NOT COMPLETED|Overall Study||28
10086812|NCT02301403|11215765|FG001|NOT COMPLETED|Overall Study||41
10086813|NCT02301416|11215773|FG000|STARTED|Overall Study||25
10086814|NCT02301416|11215774|FG001|STARTED|Overall Study||40
10086815|NCT02301416|11215773|FG000|COMPLETED|Overall Study||15
10086816|NCT02301416|11215774|FG001|COMPLETED|Overall Study||40
10086817|NCT02301416|11215773|FG000|NOT COMPLETED|Overall Study||10
10086818|NCT02301416|11215774|FG001|NOT COMPLETED|Overall Study||0
10086819|NCT02301429|11215780|FG000|STARTED|Overall Study||16
10086820|NCT02301429|11215780|FG000|COMPLETED|Overall Study||13
10086821|NCT02301429|11215780|FG000|NOT COMPLETED|Overall Study||3
10086822|NCT02301546|11215786|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73
10086823|NCT02301546|11215787|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73
10086824|NCT02301546|11215786|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
10086825|NCT02301546|11215787|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
10086826|NCT02301546|11215786|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
10086827|NCT02301546|11215787|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
10086828|NCT02301546|11215786|FG000|STARTED|Long Term Effectiveness (~1 Year)||55
10086829|NCT02301546|11215787|FG001|STARTED|Long Term Effectiveness (~1 Year)||58
10086830|NCT02301546|11215786|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43
10086831|NCT02301546|11215787|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51
10086832|NCT02301546|11215786|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
10086833|NCT02301546|11215787|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
10086834|NCT02301624|11215795|FG000|STARTED|Blind Induction Phase||56
10086835|NCT02301624|11215796|FG001|STARTED|Blind Induction Phase||61
10086836|NCT02301624|11215795|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
10086837|NCT02301624|11215796|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
10086838|NCT02301624|11215795|FG000|COMPLETED|Blind Induction Phase||55
10086839|NCT02301624|11215796|FG001|COMPLETED|Blind Induction Phase||61
10086840|NCT02301624|11215795|FG000|NOT COMPLETED|Blind Induction Phase||1
10086841|NCT02301624|11215796|FG001|NOT COMPLETED|Blind Induction Phase||0
10086842|NCT02301624|11215795|FG000|STARTED|Open-label Maintenance Phase||55
10086843|NCT02301624|11215796|FG001|STARTED|Open-label Maintenance Phase||61
10086844|NCT02301624|11215795|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
10086845|NCT02301624|11215796|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
10086846|NCT02301624|11215795|FG000|COMPLETED|Open-label Maintenance Phase||43
10086847|NCT02301624|11215796|FG001|COMPLETED|Open-label Maintenance Phase||44
10086848|NCT02301624|11215795|FG000|NOT COMPLETED|Open-label Maintenance Phase||12
10086849|NCT02301624|11215796|FG001|NOT COMPLETED|Open-label Maintenance Phase||17
10086850|NCT02301793|11215805|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|
10086851|NCT02301793|11215806|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|
10086852|NCT02301793|11215805|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
10086853|NCT02301793|11215806|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
10086854|NCT02301793|11215805|FG000|NOT COMPLETED|Pre Education Study Period||
10086855|NCT02301793|11215806|FG001|NOT COMPLETED|Pre Education Study Period||
10086856|NCT02301793|11215805|FG000|STARTED|During and Post Education Study Period||488
10086857|NCT02301793|11215806|FG001|STARTED|During and Post Education Study Period||445
10086858|NCT02301793|11215805|FG000|COMPLETED|During and Post Education Study Period||405
10086859|NCT02301793|11215806|FG001|COMPLETED|During and Post Education Study Period||396
10086860|NCT02301793|11215805|FG000|NOT COMPLETED|During and Post Education Study Period||83
10086861|NCT02301793|11215806|FG001|NOT COMPLETED|During and Post Education Study Period||49
10086862|NCT02301897|11215815|FG000|STARTED|Treatment Course 1||12
10086863|NCT02301897|11215816|FG001|STARTED|Treatment Course 1||17
10086864|NCT02301897|11215817|FG002|STARTED|Treatment Course 1||14
10086865|NCT02301897|11215815|FG000|COMPLETED|Treatment Course 1||9
10086866|NCT02301897|11215816|FG001|COMPLETED|Treatment Course 1||14
10086867|NCT02301897|11215817|FG002|COMPLETED|Treatment Course 1||8
10086868|NCT02301897|11215815|FG000|NOT COMPLETED|Treatment Course 1||3
10086869|NCT02301897|11215816|FG001|NOT COMPLETED|Treatment Course 1||3
10086870|NCT02301897|11215817|FG002|NOT COMPLETED|Treatment Course 1||6
10086871|NCT02301897|11215815|FG000|STARTED|Treatment Course 2||9
10086872|NCT02301897|11215816|FG001|STARTED|Treatment Course 2||14
10086873|NCT02301897|11215817|FG002|STARTED|Treatment Course 2||8
10086874|NCT02301897|11215815|FG000|COMPLETED|Treatment Course 2||8
10086875|NCT02301897|11215816|FG001|COMPLETED|Treatment Course 2||9
10086876|NCT02301897|11215817|FG002|COMPLETED|Treatment Course 2||7
10086877|NCT02301897|11215815|FG000|NOT COMPLETED|Treatment Course 2||1
10086878|NCT02301897|11215816|FG001|NOT COMPLETED|Treatment Course 2||5
10086879|NCT02301897|11215817|FG002|NOT COMPLETED|Treatment Course 2||1
10086880|NCT02301936|11215827|FG000|STARTED|Overall Study||9
10086881|NCT02301936|11215828|FG001|STARTED|Overall Study||1
10086882|NCT02301936|11215827|FG000|COMPLETED|Overall Study||8
10086883|NCT02301936|11215828|FG001|COMPLETED|Overall Study||1
10086884|NCT02301936|11215827|FG000|NOT COMPLETED|Overall Study||1
10086885|NCT02301936|11215828|FG001|NOT COMPLETED|Overall Study||0
10086886|NCT02301975|11215837|FG000|STARTED|Overall Study||504
10086887|NCT02301975|11215838|FG001|STARTED|Overall Study||501
10086888|NCT02301975|11215839|FG002|STARTED|Overall Study||499
10086889|NCT02301975|11215837|FG000|COMPLETED|Overall Study||473
10086890|NCT02301975|11215838|FG001|COMPLETED|Overall Study||476
10086891|NCT02301975|11215839|FG002|COMPLETED|Overall Study||477
10086892|NCT02301975|11215837|FG000|NOT COMPLETED|Overall Study||31
10086893|NCT02301975|11215838|FG001|NOT COMPLETED|Overall Study||25
10086894|NCT02301975|11215839|FG002|NOT COMPLETED|Overall Study||22
10086895|NCT02301988|11215849|FG000|STARTED|Overall Study||76
10086896|NCT02301988|11215850|FG001|STARTED|Overall Study||75
10086897|NCT02301988|11215849|FG000|COMPLETED|Overall Study||66
10086898|NCT02301988|11215850|FG001|COMPLETED|Overall Study||66
10086899|NCT02301988|11215849|FG000|NOT COMPLETED|Overall Study||10
10086900|NCT02301988|11215850|FG001|NOT COMPLETED|Overall Study||9
10086901|NCT02302066|11215860|FG000|STARTED|Overall Study||201
10086902|NCT02302066|11215861|FG001|STARTED|Overall Study||398
10086903|NCT02302066|11215862|FG002|STARTED|Overall Study||1002
10086904|NCT02302066|11215863|FG003|STARTED|Overall Study||199
10086905|NCT02302066|11215860|FG000|Safety Analysis Set|Overall Study||200
10086906|NCT02302066|11215861|FG001|Safety Analysis Set|Overall Study||398
10086907|NCT02302066|11215862|FG002|Safety Analysis Set|Overall Study||998
10086908|NCT02302066|11215863|FG003|Safety Analysis Set|Overall Study||198
10086909|NCT02302066|11215860|FG000|Immunogenicity Subset|Overall Study||92
10086910|NCT02302066|11215861|FG001|Immunogenicity Subset|Overall Study||187
10086911|NCT02302066|11215862|FG002|Immunogenicity Subset|Overall Study||192
10086912|NCT02302066|11215863|FG003|Immunogenicity Subset|Overall Study||94
10086913|NCT02302066|11215860|FG000|Per-Protocol Set (PPS)|Overall Study||83
10086914|NCT02302066|11215861|FG001|Per-Protocol Set (PPS)|Overall Study||171
10086915|NCT02302066|11215862|FG002|Per-Protocol Set (PPS)|Overall Study||174
10086916|NCT02302066|11215863|FG003|Per-Protocol Set (PPS)|Overall Study||81
10086917|NCT02302066|11215860|FG000|COMPLETED|Overall Study||168
10086918|NCT02302066|11215861|FG001|COMPLETED|Overall Study||323
10086919|NCT02302066|11215862|FG002|COMPLETED|Overall Study||830
10086920|NCT02302066|11215863|FG003|COMPLETED|Overall Study||158
10086921|NCT02302066|11215860|FG000|NOT COMPLETED|Overall Study||33
10086922|NCT02302066|11215861|FG001|NOT COMPLETED|Overall Study||75
10086923|NCT02302066|11215862|FG002|NOT COMPLETED|Overall Study||172
10086924|NCT02302066|11215863|FG003|NOT COMPLETED|Overall Study||41
10086925|NCT02302092|11215885|FG000|STARTED|Overall Study||6
10086926|NCT02302092|11215886|FG001|STARTED|Overall Study||7
10086927|NCT02302092|11215885|FG000|COMPLETED|Overall Study||6
10086928|NCT02302092|11215886|FG001|COMPLETED|Overall Study||7
10086929|NCT02302092|11215885|FG000|NOT COMPLETED|Overall Study||0
10086930|NCT02302092|11215886|FG001|NOT COMPLETED|Overall Study||0
10086931|NCT02302157|11215897|FG000|STARTED|Overall Study||3
10086932|NCT02302157|11215898|FG001|STARTED|Overall Study||6
10086933|NCT02302157|11215899|FG002|STARTED|Overall Study||6
10086934|NCT02302157|11215900|FG003|STARTED|Overall Study||6
10086935|NCT02302157|11215901|FG004|STARTED|Overall Study||4
10086936|NCT02302157|11215897|FG000|COMPLETED|Overall Study||3
10086937|NCT02302157|11215898|FG001|COMPLETED|Overall Study||6
10086938|NCT02302157|11215899|FG002|COMPLETED|Overall Study||6
10086939|NCT02302157|11215900|FG003|COMPLETED|Overall Study||6
10086940|NCT02302157|11215901|FG004|COMPLETED|Overall Study||4
10086941|NCT02302157|11215897|FG000|NOT COMPLETED|Overall Study||0
10086942|NCT02302157|11215898|FG001|NOT COMPLETED|Overall Study||0
10086943|NCT02302157|11215899|FG002|NOT COMPLETED|Overall Study||0
10086944|NCT02302157|11215900|FG003|NOT COMPLETED|Overall Study||0
10086945|NCT02302157|11215901|FG004|NOT COMPLETED|Overall Study||0
10086946|NCT02302222|11215920|FG000|STARTED|Overall Study||34
10086947|NCT02302222|11215921|FG001|STARTED|Overall Study||37
10086948|NCT02302222|11215920|FG000|COMPLETED|Overall Study||33
10086949|NCT02302222|11215921|FG001|COMPLETED|Overall Study||31
10086950|NCT02302222|11215920|FG000|NOT COMPLETED|Overall Study||1
10086951|NCT02302222|11215921|FG001|NOT COMPLETED|Overall Study||6
10086952|NCT02302339|11215931|FG000|STARTED|Overall Study||62
10086953|NCT02302339|11215932|FG001|STARTED|Overall Study||34
10086954|NCT02302339|11215933|FG002|STARTED|Overall Study||29
10086955|NCT02302339|11215934|FG003|STARTED|Overall Study||7
10086956|NCT02302339|11215931|FG000|COMPLETED|Overall Study||61
10086957|NCT02302339|11215932|FG001|COMPLETED|Overall Study||32
10086958|NCT02302339|11215933|FG002|COMPLETED|Overall Study||28
10086959|NCT02302339|11215934|FG003|COMPLETED|Overall Study||7
10086960|NCT02302339|11215931|FG000|NOT COMPLETED|Overall Study||1
10086961|NCT02302339|11215932|FG001|NOT COMPLETED|Overall Study||2
10086962|NCT02302339|11215933|FG002|NOT COMPLETED|Overall Study||1
10086963|NCT02302339|11215934|FG003|NOT COMPLETED|Overall Study||0
10086964|NCT02302365|11215945|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
10086965|NCT02302365|11215945|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
10086966|NCT02302365|11215945|FG000|NOT COMPLETED|0-2 Hour Period||2
10086967|NCT02302365|11215945|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
10086968|NCT02302365|11215945|FG000|COMPLETED|0-24 Hour Period||32
10086969|NCT02302365|11215945|FG000|NOT COMPLETED|0-24 Hour Period||0
10086970|NCT02302716|11215955|FG000|STARTED|Overall Study||249
10086971|NCT02302716|11215956|FG001|STARTED|Overall Study||244
10086972|NCT02302716|11215955|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
10086973|NCT02302716|11215956|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244
10086974|NCT02302716|11215955|FG000|COMPLETED|Overall Study||230
10086975|NCT02302716|11215956|FG001|COMPLETED|Overall Study||225
10086976|NCT02302716|11215955|FG000|NOT COMPLETED|Overall Study||19
10086977|NCT02302716|11215956|FG001|NOT COMPLETED|Overall Study||19
10086978|NCT02302807|11215964|FG000|STARTED|Overall Study||464
10086979|NCT02302807|11215965|FG001|STARTED|Overall Study||467
10086980|NCT02302807|11215964|FG000|Received Treatment|Overall Study||443
10086981|NCT02302807|11215965|FG001|Received Treatment|Overall Study||459
10086982|NCT02302807|11215964|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
10086983|NCT02302807|11215965|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
10086984|NCT02302807|11215964|FG000|NOT COMPLETED|Overall Study||464
10086985|NCT02302807|11215965|FG001|NOT COMPLETED|Overall Study||467
10086986|NCT02302846|11215984|FG000|STARTED|Overall Study||5
10086987|NCT02302846|11215984|FG000|COMPLETED|Overall Study||4
10086988|NCT02302846|11215984|FG000|NOT COMPLETED|Overall Study||1
10086989|NCT02303041|11215990|FG000|STARTED|Overall Study||4
10086990|NCT02303041|11215991|FG001|STARTED|Overall Study||6
10086991|NCT02303041|11215990|FG000|COMPLETED|Overall Study||3
10086992|NCT02303041|11215991|FG001|COMPLETED|Overall Study||4
10086993|NCT02303041|11215990|FG000|NOT COMPLETED|Overall Study||1
10086994|NCT02303041|11215991|FG001|NOT COMPLETED|Overall Study||2
10086995|NCT02303093|11215997|FG000|STARTED|Overall Study||344
10086996|NCT02303093|11215997|FG000|COMPLETED|Overall Study||344
10086997|NCT02303093|11215997|FG000|NOT COMPLETED|Overall Study||0
10086998|NCT02303184|11216015|FG000|STARTED|Overall Study||23
10086999|NCT02303184|11216016|FG001|STARTED|Overall Study||23
10087000|NCT02303184|11216015|FG000|COMPLETED|Overall Study||23
10087001|NCT02303184|11216016|FG001|COMPLETED|Overall Study||23
10087002|NCT02303184|11216015|FG000|NOT COMPLETED|Overall Study||0
10087003|NCT02303184|11216016|FG001|NOT COMPLETED|Overall Study||0
10087004|NCT02303262|11216022|FG000|STARTED|Overall Study||20
10087005|NCT02303262|11216022|FG000|COMPLETED|Overall Study||18
10087006|NCT02303262|11216022|FG000|NOT COMPLETED|Overall Study||2
10087007|NCT02303574|11216038|FG000|STARTED|Part 1a (Fasted State)- SAD||6
10087008|NCT02303574|11216039|FG001|STARTED|Part 1a (Fasted State)- SAD||6
10087009|NCT02303574|11216040|FG002|STARTED|Part 1a (Fasted State)- SAD||6
10087010|NCT02303574|11216041|FG003|STARTED|Part 1a (Fasted State)- SAD||6
10087011|NCT02303574|11216042|FG004|STARTED|Part 1a (Fasted State)- SAD||6
10201307|NCT03431857|11328676|FG000|NOT COMPLETED|Overall Study||54
10201308|NCT03432390|11328682|FG000|STARTED|Apnea Period||36
10201309|NCT03432390|11328683|FG001|STARTED|Apnea Period||36
10201310|NCT03432390|11328682|FG000|COMPLETED|Apnea Period||34
10201311|NCT03432390|11328683|FG001|COMPLETED|Apnea Period||34
10201312|NCT03432390|11328682|FG000|NOT COMPLETED|Apnea Period||2
10201313|NCT03432390|11328683|FG001|NOT COMPLETED|Apnea Period||2
10201314|NCT03432390|11328682|FG000|STARTED|Recovery Period||34
10201315|NCT03432390|11328683|FG001|STARTED|Recovery Period||34
10201316|NCT03432390|11328682|FG000|COMPLETED|Recovery Period||34
10201317|NCT03432390|11328683|FG001|COMPLETED|Recovery Period||34
10201318|NCT03432390|11328682|FG000|NOT COMPLETED|Recovery Period||0
10201319|NCT03432390|11328683|FG001|NOT COMPLETED|Recovery Period||0
10201320|NCT03432533|11328691|FG000|STARTED|Overall Study||141
10201321|NCT03432533|11328692|FG001|STARTED|Overall Study||142
10201322|NCT03432533|11328691|FG000|Completed 6-Month Treatment Period|Overall Study||136
10201323|NCT03432533|11328692|FG001|Completed 6-Month Treatment Period|Overall Study||137
10201324|NCT03432533|11328691|FG000|COMPLETED|Overall Study||126
10201325|NCT03432533|11328692|FG001|COMPLETED|Overall Study||131
10201326|NCT03432533|11328691|FG000|NOT COMPLETED|Overall Study||15
10201327|NCT03432533|11328692|FG001|NOT COMPLETED|Overall Study||11
10201328|NCT03432858|11328701|FG000|STARTED|Overall Study||12
10201329|NCT03432858|11328702|FG001|STARTED|Overall Study||83
10201330|NCT03432858|11328703|FG002|STARTED|Overall Study||89
10201331|NCT03432858|11328701|FG000|COMPLETED|Overall Study||10
10087012|NCT02303574|11216043|FG005|STARTED|Part 1a (Fasted State)- SAD||0
10087013|NCT02303574|11216044|FG006|STARTED|Part 1a (Fasted State)- SAD||0
10087014|NCT02303574|11216045|FG007|STARTED|Part 1a (Fasted State)- SAD||0
9737085|NCT00198133|10837830|FG001|STARTED|Overall Study||11
9737086|NCT00198133|10837829|FG000|COMPLETED|Overall Study||11
10087015|NCT02303574|11216046|FG008|STARTED|Part 1a (Fasted State)- SAD||0
10087016|NCT02303574|11216047|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
10087017|NCT02303574|11216038|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6
10087018|NCT02303574|11216039|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6
10087019|NCT02303574|11216040|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5
10087020|NCT02303574|11216041|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6
10087021|NCT02303574|11216042|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6
10087022|NCT02303574|11216043|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0
10087023|NCT02303574|11216044|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0
10087024|NCT02303574|11216045|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0
9737087|NCT00198133|10837830|FG001|COMPLETED|Overall Study||3
9737088|NCT00198133|10837829|FG000|NOT COMPLETED|Overall Study||5
9737089|NCT00198133|10837830|FG001|NOT COMPLETED|Overall Study||8
9737090|NCT00198822|10837839|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
9737091|NCT00198822|10837840|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
9737092|NCT00198822|10837841|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
9737093|NCT00198822|10837839|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
9737094|NCT00198822|10837840|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
9737095|NCT00198822|10837841|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
9737096|NCT00198822|10837839|FG000|NOT COMPLETED|Overall Study||14
9737097|NCT00198822|10837840|FG001|NOT COMPLETED|Overall Study||20
9737098|NCT00198822|10837841|FG002|NOT COMPLETED|Overall Study||21
9737099|NCT00199381|10837849|FG000|STARTED|Overall Study||504
9737100|NCT00199381|10837849|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
10087025|NCT02303574|11216046|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0
10087026|NCT02303574|11216047|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15
10087027|NCT02303574|11216038|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087028|NCT02303574|11216039|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087029|NCT02303574|11216040|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
10087030|NCT02303574|11216041|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087031|NCT02303574|11216042|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087032|NCT02303574|11216043|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087033|NCT02303574|11216044|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087034|NCT02303574|11216045|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087035|NCT02303574|11216046|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087036|NCT02303574|11216047|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10087037|NCT02303574|11216038|FG000|STARTED|Part 1b (Fed State) - SAD||0
10087038|NCT02303574|11216039|FG001|STARTED|Part 1b (Fed State) - SAD||0
10087039|NCT02303574|11216040|FG002|STARTED|Part 1b (Fed State) - SAD||0
10087040|NCT02303574|11216041|FG003|STARTED|Part 1b (Fed State) - SAD||0
10087041|NCT02303574|11216042|FG004|STARTED|Part 1b (Fed State) - SAD||0
10087042|NCT02303574|11216043|FG005|STARTED|Part 1b (Fed State) - SAD||5
10087043|NCT02303574|11216044|FG006|STARTED|Part 1b (Fed State) - SAD||0
10087044|NCT02303574|11216045|FG007|STARTED|Part 1b (Fed State) - SAD||0
10087045|NCT02303574|11216046|FG008|STARTED|Part 1b (Fed State) - SAD||0
10087046|NCT02303574|11216047|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
10087047|NCT02303574|11216038|FG000|COMPLETED|Part 1b (Fed State) - SAD||0
10087048|NCT02303574|11216039|FG001|COMPLETED|Part 1b (Fed State) - SAD||0
10087049|NCT02303574|11216040|FG002|COMPLETED|Part 1b (Fed State) - SAD||0
10087050|NCT02303574|11216041|FG003|COMPLETED|Part 1b (Fed State) - SAD||0
10087051|NCT02303574|11216042|FG004|COMPLETED|Part 1b (Fed State) - SAD||0
10087052|NCT02303574|11216043|FG005|COMPLETED|Part 1b (Fed State) - SAD||5
10087053|NCT02303574|11216044|FG006|COMPLETED|Part 1b (Fed State) - SAD||0
10087054|NCT02303574|11216045|FG007|COMPLETED|Part 1b (Fed State) - SAD||0
10087055|NCT02303574|11216046|FG008|COMPLETED|Part 1b (Fed State) - SAD||0
10087056|NCT02303574|11216047|FG009|COMPLETED|Part 1b (Fed State) - SAD||3
10087057|NCT02303574|11216038|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087058|NCT02303574|11216039|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087059|NCT02303574|11216040|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087060|NCT02303574|11216041|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087061|NCT02303574|11216042|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087062|NCT02303574|11216043|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087063|NCT02303574|11216044|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087064|NCT02303574|11216045|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087065|NCT02303574|11216046|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087066|NCT02303574|11216047|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10087067|NCT02303574|11216038|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10087068|NCT02303574|11216039|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10087069|NCT02303574|11216040|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10087070|NCT02303574|11216041|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10087071|NCT02303574|11216042|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10087072|NCT02303574|11216043|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10087073|NCT02303574|11216044|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
10087074|NCT02303574|11216045|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
10087075|NCT02303574|11216046|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
10087076|NCT02303574|11216047|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
10087077|NCT02303574|11216038|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087078|NCT02303574|11216039|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087079|NCT02303574|11216040|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087080|NCT02303574|11216041|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087081|NCT02303574|11216042|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087082|NCT02303574|11216043|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087083|NCT02303574|11216044|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
10087084|NCT02303574|11216045|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
10087085|NCT02303574|11216046|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
10087086|NCT02303574|11216047|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
10087087|NCT02303574|11216038|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087088|NCT02303574|11216039|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087089|NCT02303574|11216040|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087090|NCT02303574|11216041|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087091|NCT02303574|11216042|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087092|NCT02303574|11216043|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087093|NCT02303574|11216044|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087094|NCT02303574|11216045|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
10087095|NCT02303574|11216046|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087096|NCT02303574|11216047|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10087097|NCT02303704|11216082|FG000|STARTED|Overall Study||220
10087098|NCT02303704|11216083|FG001|STARTED|Overall Study||228
10087099|NCT02303704|11216082|FG000|COMPLETED|Overall Study||215
10087100|NCT02303704|11216083|FG001|COMPLETED|Overall Study||219
10087101|NCT02303704|11216082|FG000|NOT COMPLETED|Overall Study||5
10087102|NCT02303704|11216083|FG001|NOT COMPLETED|Overall Study||9
10087103|NCT02303743|11216091|FG000|STARTED|Overall Study||108
10087104|NCT02303743|11216092|FG001|STARTED|Overall Study||152
10087105|NCT02303743|11216091|FG000|COMPLETED|Overall Study||108
10087106|NCT02303743|11216092|FG001|COMPLETED|Overall Study||152
10087107|NCT02303743|11216091|FG000|NOT COMPLETED|Overall Study||0
10087108|NCT02303743|11216092|FG001|NOT COMPLETED|Overall Study||0
10087109|NCT02303977|11216098|FG000|STARTED|Overall Study||37
10087110|NCT02303977|11216098|FG000|COMPLETED|Overall Study||37
10087111|NCT02303977|11216098|FG000|NOT COMPLETED|Overall Study||0
10087112|NCT02303990|11216103|FG000|STARTED|Overall Study||59
10087113|NCT02303990|11216103|FG000|COMPLETED|Overall Study||59
10087114|NCT02303990|11216103|FG000|NOT COMPLETED|Overall Study||0
10087115|NCT02304159|11216109|FG000|STARTED|Overall Study||21
10087116|NCT02304159|11216110|FG001|STARTED|Overall Study||18
10087117|NCT02304159|11216109|FG000|COMPLETED|Overall Study||19
10087118|NCT02304159|11216110|FG001|COMPLETED|Overall Study||16
10087119|NCT02304159|11216109|FG000|NOT COMPLETED|Overall Study||2
10087120|NCT02304159|11216110|FG001|NOT COMPLETED|Overall Study||2
10087121|NCT02304380|11216122|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10087122|NCT02304380|11216123|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10087123|NCT02304380|11216124|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10087124|NCT02304380|11216125|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10087125|NCT02304380|11216126|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
10087126|NCT02304380|11216127|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
10087127|NCT02304380|11216122|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087128|NCT02304380|11216123|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087129|NCT02304380|11216124|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087130|NCT02304380|11216125|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087131|NCT02304380|11216126|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
10087132|NCT02304380|11216127|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
10087133|NCT02304380|11216122|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087134|NCT02304380|11216123|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087135|NCT02304380|11216124|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087136|NCT02304380|11216125|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087137|NCT02304380|11216126|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087138|NCT02304380|11216127|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10087139|NCT02304380|11216122|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087140|NCT02304380|11216123|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087141|NCT02304380|11216124|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087142|NCT02304380|11216125|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
10087143|NCT02304380|11216126|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087144|NCT02304380|11216127|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087145|NCT02304380|11216122|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087146|NCT02304380|11216123|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087147|NCT02304380|11216124|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087148|NCT02304380|11216125|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
10087149|NCT02304380|11216126|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087150|NCT02304380|11216127|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087151|NCT02304380|11216122|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087152|NCT02304380|11216123|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087153|NCT02304380|11216124|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087154|NCT02304380|11216125|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
10087155|NCT02304380|11216126|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087156|NCT02304380|11216127|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10087157|NCT02304380|11216122|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0
10087158|NCT02304380|11216123|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35
10087159|NCT02304380|11216124|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33
10087160|NCT02304380|11216125|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0
10087161|NCT02304380|11216126|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0
10087162|NCT02304380|11216127|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0
10087163|NCT02304380|11216122|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087164|NCT02304380|11216123|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35
10087165|NCT02304380|11216124|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33
10087166|NCT02304380|11216125|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087167|NCT02304380|11216126|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087168|NCT02304380|11216127|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087169|NCT02304380|11216122|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087170|NCT02304380|11216123|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087171|NCT02304380|11216124|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087172|NCT02304380|11216125|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087173|NCT02304380|11216126|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087174|NCT02304380|11216127|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10087175|NCT02304380|11216122|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24
10087176|NCT02304380|11216123|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10087177|NCT02304380|11216124|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10087178|NCT02304380|11216125|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10087179|NCT02304380|11216126|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10087180|NCT02304380|11216127|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10087181|NCT02304380|11216122|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
10087182|NCT02304380|11216123|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087183|NCT02304380|11216124|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087184|NCT02304380|11216125|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087185|NCT02304380|11216126|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087186|NCT02304380|11216127|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087187|NCT02304380|11216122|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087188|NCT02304380|11216123|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087189|NCT02304380|11216124|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087190|NCT02304380|11216125|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087191|NCT02304380|11216126|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087192|NCT02304380|11216127|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10087193|NCT02304406|11216141|FG000|STARTED|Overall Study||449
10087194|NCT02304406|11216141|FG000|COMPLETED|Overall Study||449
10087195|NCT02304406|11216141|FG000|NOT COMPLETED|Overall Study||0
10087196|NCT02304432|11216145|FG000|STARTED|Open Label DCS||2
10087197|NCT02304432|11216146|FG001|STARTED|Open Label DCS||0
10087198|NCT02304432|11216147|FG002|STARTED|Open Label DCS||0
10087199|NCT02304432|11216148|FG003|STARTED|Open Label DCS||0
10087200|NCT02304432|11216145|FG000|COMPLETED|Open Label DCS||2
10087201|NCT02304432|11216146|FG001|COMPLETED|Open Label DCS||0
10087202|NCT02304432|11216147|FG002|COMPLETED|Open Label DCS||0
10087203|NCT02304432|11216148|FG003|COMPLETED|Open Label DCS||0
10087204|NCT02304432|11216145|FG000|NOT COMPLETED|Open Label DCS||0
10087205|NCT02304432|11216146|FG001|NOT COMPLETED|Open Label DCS||0
10087206|NCT02304432|11216147|FG002|NOT COMPLETED|Open Label DCS||0
10087207|NCT02304432|11216148|FG003|NOT COMPLETED|Open Label DCS||0
10087208|NCT02304432|11216145|FG000|STARTED|Double-Blind DCS Placebo Crossover||0
10087209|NCT02304432|11216146|FG001|STARTED|Double-Blind DCS Placebo Crossover||1
10087210|NCT02304432|11216147|FG002|STARTED|Double-Blind DCS Placebo Crossover||1
10087211|NCT02304432|11216148|FG003|STARTED|Double-Blind DCS Placebo Crossover||0
10087212|NCT02304432|11216145|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0
10087213|NCT02304432|11216146|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1
10087214|NCT02304432|11216147|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1
10087215|NCT02304432|11216148|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0
10087216|NCT02304432|11216145|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10087217|NCT02304432|11216146|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10087218|NCT02304432|11216147|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10087219|NCT02304432|11216148|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10087220|NCT02304432|11216145|FG000|STARTED|Second Open Label DCS||0
10087221|NCT02304432|11216146|FG001|STARTED|Second Open Label DCS||0
10087222|NCT02304432|11216147|FG002|STARTED|Second Open Label DCS||0
10087223|NCT02304432|11216148|FG003|STARTED|Second Open Label DCS||2
10087224|NCT02304432|11216145|FG000|COMPLETED|Second Open Label DCS||0
10087225|NCT02304432|11216146|FG001|COMPLETED|Second Open Label DCS||0
10087226|NCT02304432|11216147|FG002|COMPLETED|Second Open Label DCS||0
10087227|NCT02304432|11216148|FG003|COMPLETED|Second Open Label DCS||2
10087228|NCT02304432|11216145|FG000|NOT COMPLETED|Second Open Label DCS||0
10087229|NCT02304432|11216146|FG001|NOT COMPLETED|Second Open Label DCS||0
10087230|NCT02304432|11216147|FG002|NOT COMPLETED|Second Open Label DCS||0
10087231|NCT02304432|11216148|FG003|NOT COMPLETED|Second Open Label DCS||0
10087232|NCT02304484|11216163|FG000|STARTED|Overall Study||770
10087233|NCT02304484|11216163|FG000|COMPLETED|Overall Study||745
10087234|NCT02304484|11216163|FG000|NOT COMPLETED|Overall Study||25
10087235|NCT02304705|11216169|FG000|STARTED|Overall Study||16
10087236|NCT02304705|11216170|FG001|STARTED|Overall Study||17
10087237|NCT02304705|11216169|FG000|COMPLETED|Overall Study||12
10087238|NCT02304705|11216170|FG001|COMPLETED|Overall Study||10
10087239|NCT02304705|11216169|FG000|NOT COMPLETED|Overall Study||4
10087240|NCT02304705|11216170|FG001|NOT COMPLETED|Overall Study||7
10087241|NCT02304757|11216178|FG000|STARTED|Overall Study||70
10087242|NCT02304757|11216179|FG001|STARTED|Overall Study||72
10087243|NCT02304757|11216178|FG000|COMPLETED|Overall Study||70
10087244|NCT02304757|11216179|FG001|COMPLETED|Overall Study||72
10087245|NCT02304757|11216178|FG000|NOT COMPLETED|Overall Study||0
10087246|NCT02304757|11216179|FG001|NOT COMPLETED|Overall Study||0
10087247|NCT02304926|11216187|FG000|STARTED|Overall Study||22
10087248|NCT02304926|11216188|FG001|STARTED|Overall Study||20
10087249|NCT02304926|11216187|FG000|COMPLETED|Overall Study||20
10087250|NCT02304926|11216188|FG001|COMPLETED|Overall Study||19
10087251|NCT02304926|11216187|FG000|NOT COMPLETED|Overall Study||2
10087252|NCT02304926|11216188|FG001|NOT COMPLETED|Overall Study||1
10087253|NCT02305017|11216198|FG000|STARTED|Overall Study||14
10087254|NCT02305017|11216199|FG001|STARTED|Overall Study||14
10087255|NCT02305017|11216198|FG000|COMPLETED|Overall Study||14
10087256|NCT02305017|11216199|FG001|COMPLETED|Overall Study||14
10087257|NCT02305017|11216198|FG000|NOT COMPLETED|Overall Study||0
10087258|NCT02305017|11216199|FG001|NOT COMPLETED|Overall Study||0
10087259|NCT02305238|11216212|FG000|STARTED|Overall Study||124
10087260|NCT02305238|11216213|FG001|STARTED|Overall Study||123
10087261|NCT02305238|11216214|FG002|STARTED|Overall Study||8
10087262|NCT02305238|11216212|FG000|Treated|Overall Study||124
10087263|NCT02305238|11216213|FG001|Treated|Overall Study||123
10087264|NCT02305238|11216214|FG002|Treated|Overall Study||7
10087265|NCT02305238|11216212|FG000|Randomized|Overall Study||124
10087266|NCT02305238|11216213|FG001|Randomized|Overall Study||123
10087267|NCT02305238|11216214|FG002|Randomized|Overall Study||0
10087268|NCT02305238|11216212|FG000|BCVA Post-randomization Assessment|Overall Study||123
10087269|NCT02305238|11216213|FG001|BCVA Post-randomization Assessment|Overall Study||123
10087270|NCT02305238|11216214|FG002|BCVA Post-randomization Assessment|Overall Study||0
10087271|NCT02305238|11216212|FG000|COMPLETED|Overall Study||108
10087272|NCT02305238|11216213|FG001|COMPLETED|Overall Study||104
10087273|NCT02305238|11216214|FG002|COMPLETED|Overall Study||0
10087274|NCT02305238|11216212|FG000|NOT COMPLETED|Overall Study||16
10087275|NCT02305238|11216213|FG001|NOT COMPLETED|Overall Study||19
10087276|NCT02305238|11216214|FG002|NOT COMPLETED|Overall Study||8
10087277|NCT02305277|11216227|FG000|STARTED|Overall Study||15
10087278|NCT02305277|11216228|FG001|STARTED|Overall Study||14
10087279|NCT02305277|11216229|FG002|STARTED|Overall Study||14
10087280|NCT02305277|11216230|FG003|STARTED|Overall Study||14
10087281|NCT02305277|11216231|FG004|STARTED|Overall Study||14
10087282|NCT02305277|11216232|FG005|STARTED|Overall Study||14
10087283|NCT02305277|11216227|FG000|Received CM|Overall Study||15
10087284|NCT02305277|11216228|FG001|Received CM|Overall Study||14
10087285|NCT02305277|11216229|FG002|Received CM|Overall Study||14
10087286|NCT02305277|11216230|FG003|Received CM|Overall Study||14
10087287|NCT02305277|11216231|FG004|Received CM|Overall Study||14
10087288|NCT02305277|11216232|FG005|Received CM|Overall Study||14
10087289|NCT02305277|11216227|FG000|Received TBM|Overall Study||15
10087290|NCT02305277|11216228|FG001|Received TBM|Overall Study||14
10087291|NCT02305277|11216229|FG002|Received TBM|Overall Study||14
10087292|NCT02305277|11216230|FG003|Received TBM|Overall Study||14
10087293|NCT02305277|11216231|FG004|Received TBM|Overall Study||14
10087294|NCT02305277|11216232|FG005|Received TBM|Overall Study||14
10087295|NCT02305277|11216227|FG000|COMPLETED|Overall Study||14
10087296|NCT02305277|11216228|FG001|COMPLETED|Overall Study||14
10087297|NCT02305277|11216229|FG002|COMPLETED|Overall Study||14
10087298|NCT02305277|11216230|FG003|COMPLETED|Overall Study||14
10087299|NCT02305277|11216231|FG004|COMPLETED|Overall Study||13
10087300|NCT02305277|11216232|FG005|COMPLETED|Overall Study||14
10087301|NCT02305277|11216227|FG000|NOT COMPLETED|Overall Study||1
10087302|NCT02305277|11216228|FG001|NOT COMPLETED|Overall Study||0
10087303|NCT02305277|11216229|FG002|NOT COMPLETED|Overall Study||0
10087304|NCT02305277|11216230|FG003|NOT COMPLETED|Overall Study||0
10087305|NCT02305277|11216231|FG004|NOT COMPLETED|Overall Study||1
10087306|NCT02305277|11216232|FG005|NOT COMPLETED|Overall Study||0
10087307|NCT02305316|11216248|FG000|STARTED|Overall Study||14
10087308|NCT02305316|11216249|FG001|STARTED|Overall Study||14
10087309|NCT02305316|11216248|FG000|COMPLETED|Overall Study||14
10087310|NCT02305316|11216249|FG001|COMPLETED|Overall Study||14
10087311|NCT02305316|11216248|FG000|NOT COMPLETED|Overall Study||0
10087312|NCT02305316|11216249|FG001|NOT COMPLETED|Overall Study||0
10087313|NCT02305329|11216259|FG000|STARTED|Overall Study||14
10087314|NCT02305329|11216260|FG001|STARTED|Overall Study||14
10087315|NCT02305329|11216261|FG002|STARTED|Overall Study||14
10087316|NCT02305329|11216262|FG003|STARTED|Overall Study||14
10087317|NCT02305329|11216259|FG000|Period 1|Overall Study||14
10087318|NCT02305329|11216260|FG001|Period 1|Overall Study||14
10087319|NCT02305329|11216261|FG002|Period 1|Overall Study||14
10087320|NCT02305329|11216262|FG003|Period 1|Overall Study||14
10087321|NCT02305329|11216259|FG000|Period 2|Overall Study||14
10087322|NCT02305329|11216260|FG001|Period 2|Overall Study||13
10087323|NCT02305329|11216261|FG002|Period 2|Overall Study||14
10087324|NCT02305329|11216262|FG003|Period 2|Overall Study||14
10087325|NCT02305329|11216259|FG000|COMPLETED|Overall Study||14
10087326|NCT02305329|11216260|FG001|COMPLETED|Overall Study||13
10087327|NCT02305329|11216261|FG002|COMPLETED|Overall Study||14
10087328|NCT02305329|11216262|FG003|COMPLETED|Overall Study||14
10087329|NCT02305329|11216259|FG000|NOT COMPLETED|Overall Study||0
10087330|NCT02305329|11216260|FG001|NOT COMPLETED|Overall Study||1
10087331|NCT02305329|11216261|FG002|NOT COMPLETED|Overall Study||0
10087332|NCT02305329|11216262|FG003|NOT COMPLETED|Overall Study||0
10087333|NCT02305381|11216275|FG000|STARTED|Overall Study||132
10087334|NCT02305381|11216276|FG001|STARTED|Overall Study||132
10087335|NCT02305381|11216277|FG002|STARTED|Overall Study||133
10087336|NCT02305381|11216275|FG000|Exposed|Overall Study||132
10087337|NCT02305381|11216276|FG001|Exposed|Overall Study||131
10087338|NCT02305381|11216277|FG002|Exposed|Overall Study||133
10087339|NCT02305381|11216275|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
10087340|NCT02305381|11216276|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
10087341|NCT02305381|11216277|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
10087342|NCT02305381|11216275|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127
10087343|NCT02305381|11216276|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127
10087344|NCT02305381|11216277|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126
10087345|NCT02305381|11216275|FG000|NOT COMPLETED|Overall Study||5
10087346|NCT02305381|11216276|FG001|NOT COMPLETED|Overall Study||5
10087347|NCT02305381|11216277|FG002|NOT COMPLETED|Overall Study||7
10087348|NCT02305446|11216285|FG000|STARTED|Overall Study||55
10087349|NCT02305446|11216285|FG000|COMPLETED|Overall Study||54
10087350|NCT02305446|11216285|FG000|NOT COMPLETED|Overall Study||1
10087351|NCT02305563|11216294|FG000|STARTED|Treatment Period||3
10087352|NCT02305563|11216295|FG001|STARTED|Treatment Period||3
10087353|NCT02305563|11216296|FG002|STARTED|Treatment Period||26
10087354|NCT02305563|11216297|FG003|STARTED|Treatment Period||14
10087355|NCT02305563|11216298|FG004|STARTED|Treatment Period||24
10112843|NCT02505919|11243755|FG001|NOT COMPLETED|1 Month Follow-Up||0
9737101|NCT00199381|10837849|FG000|NOT COMPLETED|Overall Study||504
10087356|NCT02305563|11216294|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
10087357|NCT02305563|11216295|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
10087358|NCT02305563|11216296|FG002|COMPLETED|Treatment Period||0
10087359|NCT02305563|11216297|FG003|COMPLETED|Treatment Period||0
10087360|NCT02305563|11216298|FG004|COMPLETED|Treatment Period||0
10087361|NCT02305563|11216294|FG000|NOT COMPLETED|Treatment Period||2
10087362|NCT02305563|11216295|FG001|NOT COMPLETED|Treatment Period||2
10087363|NCT02305563|11216296|FG002|NOT COMPLETED|Treatment Period||26
10087364|NCT02305563|11216297|FG003|NOT COMPLETED|Treatment Period||14
10087365|NCT02305563|11216298|FG004|NOT COMPLETED|Treatment Period||24
10087366|NCT02305563|11216294|FG000|STARTED|Follow-up Period||3
10087367|NCT02305563|11216295|FG001|STARTED|Follow-up Period||3
10087368|NCT02305563|11216296|FG002|STARTED|Follow-up Period||11
10087369|NCT02305563|11216297|FG003|STARTED|Follow-up Period||6
10087370|NCT02305563|11216298|FG004|STARTED|Follow-up Period||12
10087371|NCT02305563|11216294|FG000|COMPLETED|Follow-up Period||0
10087372|NCT02305563|11216295|FG001|COMPLETED|Follow-up Period||0
10087373|NCT02305563|11216296|FG002|COMPLETED|Follow-up Period||0
10087374|NCT02305563|11216297|FG003|COMPLETED|Follow-up Period||0
10087375|NCT02305563|11216298|FG004|COMPLETED|Follow-up Period||0
10087376|NCT02305563|11216294|FG000|NOT COMPLETED|Follow-up Period||3
10087377|NCT02305563|11216295|FG001|NOT COMPLETED|Follow-up Period||3
10087378|NCT02305563|11216296|FG002|NOT COMPLETED|Follow-up Period||11
10087379|NCT02305563|11216297|FG003|NOT COMPLETED|Follow-up Period||6
10087380|NCT02305563|11216298|FG004|NOT COMPLETED|Follow-up Period||12
10087381|NCT02305732|11216314|FG000|STARTED|Overall Study||90
10087382|NCT02305732|11216314|FG000|COMPLETED|Overall Study||72
10087383|NCT02305732|11216314|FG000|NOT COMPLETED|Overall Study||18
10087384|NCT02305758|11216321|FG000|STARTED|Overall Study||65
10087385|NCT02305758|11216322|FG001|STARTED|Overall Study||65
10087386|NCT02305758|11216321|FG000|COMPLETED|Overall Study||0
10087387|NCT02305758|11216322|FG001|COMPLETED|Overall Study||0
10087388|NCT02305758|11216321|FG000|NOT COMPLETED|Overall Study||65
10087389|NCT02305758|11216322|FG001|NOT COMPLETED|Overall Study||65
10087390|NCT02305797|11216330|FG000|STARTED|Overall Study||247
10087391|NCT02305797|11216331|FG001|STARTED|Overall Study||248
10087392|NCT02305797|11216330|FG000|COMPLETED|Overall Study||202
10087393|NCT02305797|11216331|FG001|COMPLETED|Overall Study||210
10087394|NCT02305797|11216330|FG000|NOT COMPLETED|Overall Study||45
10087395|NCT02305797|11216331|FG001|NOT COMPLETED|Overall Study||38
10087396|NCT02305849|11216340|FG000|STARTED|Overall Study||175
10087397|NCT02305849|11216341|FG001|STARTED|Overall Study||174
10087398|NCT02305849|11216342|FG002|STARTED|Overall Study||85
10087399|NCT02305849|11216343|FG003|STARTED|Overall Study||85
10087400|NCT02305849|11216340|FG000|COMPLETED|Overall Study||148
10087401|NCT02305849|11216341|FG001|COMPLETED|Overall Study||146
10087402|NCT02305849|11216342|FG002|COMPLETED|Overall Study||67
10087403|NCT02305849|11216343|FG003|COMPLETED|Overall Study||66
10087404|NCT02305849|11216340|FG000|NOT COMPLETED|Overall Study||27
10087405|NCT02305849|11216341|FG001|NOT COMPLETED|Overall Study||28
10087406|NCT02305849|11216342|FG002|NOT COMPLETED|Overall Study||18
10087407|NCT02305849|11216343|FG003|NOT COMPLETED|Overall Study||19
10087408|NCT02305888|11216377|FG000|STARTED|Overall Study||63
10087409|NCT02305888|11216378|FG001|STARTED|Overall Study||63
10087410|NCT02305888|11216379|FG002|STARTED|Overall Study||63
10087411|NCT02305888|11216377|FG000|COMPLETED|Overall Study||63
10087412|NCT02305888|11216378|FG001|COMPLETED|Overall Study||62
10087413|NCT02305888|11216379|FG002|COMPLETED|Overall Study||62
10087414|NCT02305888|11216377|FG000|NOT COMPLETED|Overall Study||0
10087415|NCT02305888|11216378|FG001|NOT COMPLETED|Overall Study||1
10087416|NCT02305888|11216379|FG002|NOT COMPLETED|Overall Study||1
10112844|NCT02505919|11243754|FG000|STARTED|3 Months Follow-Up||116
10112845|NCT02505919|11243755|FG001|STARTED|3 Months Follow-Up||65
10112846|NCT02505919|11243754|FG000|COMPLETED|3 Months Follow-Up||116
10112847|NCT02505919|11243755|FG001|COMPLETED|3 Months Follow-Up||65
10112848|NCT02505919|11243754|FG000|NOT COMPLETED|3 Months Follow-Up||0
10112849|NCT02505919|11243755|FG001|NOT COMPLETED|3 Months Follow-Up||0
10112850|NCT02505919|11243754|FG000|STARTED|6 Months Follow-Up||116
10112851|NCT02505919|11243755|FG001|STARTED|6 Months Follow-Up||65
10112852|NCT02505919|11243754|FG000|COMPLETED|6 Months Follow-Up||116
10112853|NCT02505919|11243755|FG001|COMPLETED|6 Months Follow-Up||63
10112854|NCT02505919|11243754|FG000|NOT COMPLETED|6 Months Follow-Up||0
10112855|NCT02505919|11243755|FG001|NOT COMPLETED|6 Months Follow-Up||2
10112856|NCT02505919|11243754|FG000|STARTED|12 Months Follow-Up||116
10112857|NCT02505919|11243755|FG001|STARTED|12 Months Follow-Up||63
10112858|NCT02505919|11243754|FG000|COMPLETED|12 Months Follow-Up||115
10087417|NCT02306265|11216387|FG000|STARTED|Overall Study||250
10087418|NCT02306265|11216387|FG000|COMPLETED|Overall Study||249
10087419|NCT02306265|11216387|FG000|NOT COMPLETED|Overall Study||1
10087420|NCT02306694|11216392|FG000|STARTED|Overall Study||16
10087421|NCT02306694|11216392|FG000|COMPLETED|Overall Study||12
10087422|NCT02306694|11216392|FG000|NOT COMPLETED|Overall Study||4
10087423|NCT02306759|11216398|FG000|STARTED|Overall Study||30
10087424|NCT02306759|11216399|FG001|STARTED|Overall Study||30
10087425|NCT02306759|11216398|FG000|COMPLETED|Overall Study||30
10087426|NCT02306759|11216399|FG001|COMPLETED|Overall Study||30
10087427|NCT02306759|11216398|FG000|NOT COMPLETED|Overall Study||0
10087428|NCT02306759|11216399|FG001|NOT COMPLETED|Overall Study||0
10087429|NCT02306850|11216407|FG000|STARTED|Overall Study||10
10087430|NCT02306850|11216407|FG000|COMPLETED|Overall Study||8
10087431|NCT02306850|11216407|FG000|NOT COMPLETED|Overall Study||2
10087432|NCT02306928|11216412|FG000|STARTED|Overall Study||15
10087433|NCT02306928|11216412|FG000|COMPLETED|Overall Study||15
10087434|NCT02306928|11216412|FG000|NOT COMPLETED|Overall Study||0
10087435|NCT02307123|11216416|FG000|STARTED|Overall Study||483
10087436|NCT02307123|11216416|FG000|COMPLETED|Overall Study||483
10087437|NCT02307123|11216416|FG000|NOT COMPLETED|Overall Study||0
10087438|NCT02307266|11216423|FG000|STARTED|Overall Study||33
10087439|NCT02307266|11216424|FG001|STARTED|Overall Study||33
10087440|NCT02307266|11216425|FG002|STARTED|Overall Study||31
10087441|NCT02307266|11216423|FG000|COMPLETED|Overall Study||25
10087442|NCT02307266|11216424|FG001|COMPLETED|Overall Study||32
10087443|NCT02307266|11216425|FG002|COMPLETED|Overall Study||25
10087444|NCT02307266|11216423|FG000|NOT COMPLETED|Overall Study||8
10087445|NCT02307266|11216424|FG001|NOT COMPLETED|Overall Study||1
10087446|NCT02307266|11216425|FG002|NOT COMPLETED|Overall Study||6
10087447|NCT02307318|11216433|FG000|STARTED|Overall Study||51
10087448|NCT02307318|11216433|FG000|COMPLETED|Overall Study||51
10087449|NCT02307318|11216433|FG000|NOT COMPLETED|Overall Study||0
10087450|NCT02307370|11216437|FG000|STARTED|Overall Study||44
10087451|NCT02307370|11216437|FG000|30 Day Follow-up|Overall Study||40
10087452|NCT02307370|11216437|FG000|180 Day Patient Telephone Contact|Overall Study||25
10087453|NCT02307370|11216437|FG000|COMPLETED|Overall Study||25
10087454|NCT02307370|11216437|FG000|NOT COMPLETED|Overall Study||19
10087455|NCT02307513|11216445|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
10087456|NCT02307513|11216446|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
10087457|NCT02307513|11216445|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
10087458|NCT02307513|11216446|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
10087459|NCT02307513|11216445|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
10087460|NCT02307513|11216446|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
10087461|NCT02307513|11216445|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83
10087462|NCT02307513|11216446|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
10087463|NCT02307513|11216445|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
10087464|NCT02307513|11216446|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
10087465|NCT02307513|11216445|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
10087466|NCT02307513|11216446|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
10087467|NCT02307513|11216445|FG000|STARTED|Long-term Extension||2
10087468|NCT02307513|11216446|FG001|STARTED|Long-term Extension||0
10087469|NCT02307513|11216445|FG000|COMPLETED|Long-term Extension||1
10087470|NCT02307513|11216446|FG001|COMPLETED|Long-term Extension||0
10087471|NCT02307513|11216445|FG000|NOT COMPLETED|Long-term Extension||1
10087472|NCT02307513|11216446|FG001|NOT COMPLETED|Long-term Extension||0
10087473|NCT02307526|11216456|FG000|STARTED|Day 1 - No Drug||10
10087474|NCT02307526|11216456|FG000|COMPLETED|Day 1 - No Drug||10
10087475|NCT02307526|11216456|FG000|NOT COMPLETED|Day 1 - No Drug||0
10087476|NCT02307526|11216456|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10
10087477|NCT02307526|11216456|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
10087478|NCT02307526|11216456|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
10087479|NCT02307552|11216462|FG000|STARTED|Overall Study||1
10087480|NCT02307552|11216462|FG000|COMPLETED|Overall Study||1
10087481|NCT02307552|11216462|FG000|NOT COMPLETED|Overall Study||0
10087482|NCT02307682|11216469|FG000|STARTED|Overall Study||360
10087483|NCT02307682|11216470|FG001|STARTED|Overall Study||361
10087484|NCT02307682|11216471|FG002|STARTED|Overall Study||361
10087485|NCT02307682|11216469|FG000|Randomized and Treated|Overall Study||358
10087486|NCT02307682|11216470|FG001|Randomized and Treated|Overall Study||360
10087487|NCT02307682|11216471|FG002|Randomized and Treated|Overall Study||360
10087488|NCT02307682|11216469|FG000|COMPLETED|Overall Study||310
10087489|NCT02307682|11216470|FG001|COMPLETED|Overall Study||304
10087490|NCT02307682|11216471|FG002|COMPLETED|Overall Study||297
10087491|NCT02307682|11216469|FG000|NOT COMPLETED|Overall Study||50
10087492|NCT02307682|11216470|FG001|NOT COMPLETED|Overall Study||57
10087493|NCT02307682|11216471|FG002|NOT COMPLETED|Overall Study||64
10087494|NCT02307838|11216482|FG000|STARTED|Overall Study||56
10087495|NCT02307838|11216483|FG001|STARTED|Overall Study||64
10087496|NCT02307838|11216484|FG002|STARTED|Overall Study||55
10087497|NCT02307838|11216482|FG000|COMPLETED|Overall Study||56
10087498|NCT02307838|11216483|FG001|COMPLETED|Overall Study||64
10087499|NCT02307838|11216484|FG002|COMPLETED|Overall Study||55
10087500|NCT02307838|11216482|FG000|NOT COMPLETED|Overall Study||0
10087501|NCT02307838|11216483|FG001|NOT COMPLETED|Overall Study||0
10087502|NCT02307838|11216484|FG002|NOT COMPLETED|Overall Study||0
10087503|NCT02307916|11216495|FG000|STARTED|Overall Study||42
10087504|NCT02307916|11216496|FG001|STARTED|Overall Study||15
10087505|NCT02307916|11216495|FG000|COMPLETED|Overall Study||40
10087506|NCT02307916|11216496|FG001|COMPLETED|Overall Study||14
10087507|NCT02307916|11216495|FG000|NOT COMPLETED|Overall Study||2
10087508|NCT02307916|11216496|FG001|NOT COMPLETED|Overall Study||1
10087509|NCT02308007|11216505|FG000|STARTED|Overall Study||159
10087510|NCT02308007|11216506|FG001|STARTED|Overall Study||159
10087511|NCT02308007|11216507|FG002|STARTED|Overall Study||157
10087512|NCT02308007|11216505|FG000|COMPLETED|Overall Study||83
10087513|NCT02308007|11216506|FG001|COMPLETED|Overall Study||84
10087514|NCT02308007|11216507|FG002|COMPLETED|Overall Study||82
10087515|NCT02308007|11216505|FG000|NOT COMPLETED|Overall Study||76
10087516|NCT02308007|11216506|FG001|NOT COMPLETED|Overall Study||75
10087517|NCT02308007|11216507|FG002|NOT COMPLETED|Overall Study||75
10087518|NCT02308020|11216521|FG000|STARTED|Overall Study||27
10087519|NCT02308020|11216522|FG001|STARTED|Overall Study||58
10087520|NCT02308020|11216523|FG002|STARTED|Overall Study||9
10087521|NCT02308020|11216524|FG003|STARTED|Overall Study||28
10087522|NCT02308020|11216525|FG004|STARTED|Overall Study||23
10087523|NCT02308020|11216526|FG005|STARTED|Overall Study||17
10087524|NCT02308020|11216521|FG000|Received at Least One Dose of Study Drug|Overall Study||27
10087525|NCT02308020|11216522|FG001|Received at Least One Dose of Study Drug|Overall Study||58
10087526|NCT02308020|11216523|FG002|Received at Least One Dose of Study Drug|Overall Study||9
10112859|NCT02505919|11243755|FG001|COMPLETED|12 Months Follow-Up||61
10087527|NCT02308020|11216524|FG003|Received at Least One Dose of Study Drug|Overall Study||28
10087528|NCT02308020|11216525|FG004|Received at Least One Dose of Study Drug|Overall Study||23
10087529|NCT02308020|11216526|FG005|Received at Least One Dose of Study Drug|Overall Study||17
10087530|NCT02308020|11216521|FG000|COMPLETED|Overall Study||23
10087531|NCT02308020|11216522|FG001|COMPLETED|Overall Study||38
10087532|NCT02308020|11216523|FG002|COMPLETED|Overall Study||6
10087533|NCT02308020|11216524|FG003|COMPLETED|Overall Study||24
10087534|NCT02308020|11216525|FG004|COMPLETED|Overall Study||19
10087535|NCT02308020|11216526|FG005|COMPLETED|Overall Study||12
10087536|NCT02308020|11216521|FG000|NOT COMPLETED|Overall Study||4
10087537|NCT02308020|11216522|FG001|NOT COMPLETED|Overall Study||20
10087538|NCT02308020|11216523|FG002|NOT COMPLETED|Overall Study||3
10087539|NCT02308020|11216524|FG003|NOT COMPLETED|Overall Study||4
10087540|NCT02308020|11216525|FG004|NOT COMPLETED|Overall Study||4
10087541|NCT02308020|11216526|FG005|NOT COMPLETED|Overall Study||5
10087542|NCT02308033|11216548|FG000|STARTED|Overall Study||102
10087543|NCT02308033|11216549|FG001|STARTED|Overall Study||102
10087544|NCT02308033|11216548|FG000|COMPLETED|Overall Study||76
10087545|NCT02308033|11216549|FG001|COMPLETED|Overall Study||83
10087546|NCT02308033|11216548|FG000|NOT COMPLETED|Overall Study||26
10087547|NCT02308033|11216549|FG001|NOT COMPLETED|Overall Study||19
10087548|NCT02308046|11216557|FG000|STARTED|Overall Study||107
10087549|NCT02308046|11216558|FG001|STARTED|Overall Study||105
10087550|NCT02308046|11216557|FG000|COMPLETED|Overall Study||73
10087551|NCT02308046|11216558|FG001|COMPLETED|Overall Study||67
10087552|NCT02308046|11216557|FG000|NOT COMPLETED|Overall Study||34
10087553|NCT02308046|11216558|FG001|NOT COMPLETED|Overall Study||38
10087554|NCT02308124|11216567|FG000|STARTED|Overall Study||29
10087555|NCT02308124|11216568|FG001|STARTED|Overall Study||29
10087556|NCT02308124|11216569|FG002|STARTED|Overall Study||29
10087557|NCT02308124|11216567|FG000|COMPLETED|Overall Study||23
10087558|NCT02308124|11216568|FG001|COMPLETED|Overall Study||21
10087559|NCT02308124|11216569|FG002|COMPLETED|Overall Study||21
10087560|NCT02308124|11216567|FG000|NOT COMPLETED|Overall Study||6
10087561|NCT02308124|11216568|FG001|NOT COMPLETED|Overall Study||8
10087562|NCT02308124|11216569|FG002|NOT COMPLETED|Overall Study||8
10087563|NCT02308163|11216581|FG000|STARTED|Overall Study||104
10087564|NCT02308163|11216582|FG001|STARTED|Overall Study||102
10087565|NCT02308163|11216583|FG002|STARTED|Overall Study||50
10087566|NCT02308163|11216584|FG003|STARTED|Overall Study||52
10087567|NCT02308163|11216585|FG004|STARTED|Overall Study||201
10087568|NCT02308163|11216581|FG000|COMPLETED|Overall Study||73
10087569|NCT02308163|11216582|FG001|COMPLETED|Overall Study||84
10087570|NCT02308163|11216583|FG002|COMPLETED|Overall Study||36
10087571|NCT02308163|11216584|FG003|COMPLETED|Overall Study||39
10087572|NCT02308163|11216585|FG004|COMPLETED|Overall Study||167
10087573|NCT02308163|11216581|FG000|NOT COMPLETED|Overall Study||31
10087574|NCT02308163|11216582|FG001|NOT COMPLETED|Overall Study||18
10087575|NCT02308163|11216583|FG002|NOT COMPLETED|Overall Study||14
10087576|NCT02308163|11216584|FG003|NOT COMPLETED|Overall Study||13
10087577|NCT02308163|11216585|FG004|NOT COMPLETED|Overall Study||34
10087578|NCT02308189|11216614|FG000|STARTED|Overall Study||17
10087579|NCT02308189|11216615|FG001|STARTED|Overall Study||15
10087580|NCT02308189|11216614|FG000|COMPLETED|Overall Study||16
10087581|NCT02308189|11216615|FG001|COMPLETED|Overall Study||14
10087582|NCT02308189|11216614|FG000|NOT COMPLETED|Overall Study||1
10087583|NCT02308189|11216615|FG001|NOT COMPLETED|Overall Study||1
10087584|NCT02308228|11216623|FG000|STARTED|Overall Study||54
10087585|NCT02308228|11216624|FG001|STARTED|Overall Study||55
10087586|NCT02308228|11216623|FG000|COMPLETED|Overall Study||46
10087587|NCT02308228|11216624|FG001|COMPLETED|Overall Study||48
10087588|NCT02308228|11216623|FG000|NOT COMPLETED|Overall Study||8
10087589|NCT02308228|11216624|FG001|NOT COMPLETED|Overall Study||7
10087590|NCT02308371|11216632|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
10087591|NCT02308371|11216633|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
10087592|NCT02308371|11216632|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
10087593|NCT02308371|11216633|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
10087594|NCT02308371|11216632|FG000|NOT COMPLETED|Overall Study||0
10087595|NCT02308371|11216633|FG001|NOT COMPLETED|Overall Study||0
10087596|NCT02308501|11216643|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
10087597|NCT02308501|11216644|FG001|STARTED|Overall Study||25
10087598|NCT02308501|11216643|FG000|Randomized Participant Eyes|Overall Study||25
10087599|NCT02308501|11216644|FG001|Randomized Participant Eyes|Overall Study||25
10087600|NCT02308501|11216643|FG000|COMPLETED|Overall Study||25
9737102|NCT00199797|10837853|FG000|STARTED|Overall Study||20
9737103|NCT00199797|10837853|FG000|COMPLETED|Overall Study||17
9737104|NCT00199797|10837853|FG000|NOT COMPLETED|Overall Study||3
10087601|NCT02308501|11216644|FG001|COMPLETED|Overall Study||25
10087602|NCT02308501|11216643|FG000|NOT COMPLETED|Overall Study||0
10087603|NCT02308501|11216644|FG001|NOT COMPLETED|Overall Study||0
10087604|NCT02308540|11216662|FG000|STARTED|Overall Study||17
10087605|NCT02308540|11216663|FG001|STARTED|Overall Study||17
10087606|NCT02308540|11216664|FG002|STARTED|Overall Study||56
10087607|NCT02308540|11216665|FG003|STARTED|Overall Study||56
10087608|NCT02308540|11216666|FG004|STARTED|Overall Study||100
10087609|NCT02308540|11216667|FG005|STARTED|Overall Study||100
10087610|NCT02308540|11216662|FG000|Randomized|Overall Study||17
10087611|NCT02308540|11216663|FG001|Randomized|Overall Study||17
10087612|NCT02308540|11216664|FG002|Randomized|Overall Study||56
10087613|NCT02308540|11216665|FG003|Randomized|Overall Study||56
10087614|NCT02308540|11216666|FG004|Randomized|Overall Study||100
10087615|NCT02308540|11216667|FG005|Randomized|Overall Study||100
10087616|NCT02308540|11216662|FG000|Vaccinated|Overall Study||17
10087617|NCT02308540|11216663|FG001|Vaccinated|Overall Study||17
10087618|NCT02308540|11216664|FG002|Vaccinated|Overall Study||56
10087619|NCT02308540|11216665|FG003|Vaccinated|Overall Study||56
10087620|NCT02308540|11216666|FG004|Vaccinated|Overall Study||100
10087621|NCT02308540|11216667|FG005|Vaccinated|Overall Study||100
10087622|NCT02308540|11216662|FG000|COMPLETED|Overall Study||17
10087623|NCT02308540|11216663|FG001|COMPLETED|Overall Study||17
10087624|NCT02308540|11216664|FG002|COMPLETED|Overall Study||56
10087625|NCT02308540|11216665|FG003|COMPLETED|Overall Study||56
10087626|NCT02308540|11216666|FG004|COMPLETED|Overall Study||100
10087627|NCT02308540|11216667|FG005|COMPLETED|Overall Study||99
10087628|NCT02308540|11216662|FG000|NOT COMPLETED|Overall Study||0
10087629|NCT02308540|11216663|FG001|NOT COMPLETED|Overall Study||0
10087630|NCT02308540|11216664|FG002|NOT COMPLETED|Overall Study||0
10087631|NCT02308540|11216665|FG003|NOT COMPLETED|Overall Study||0
10087632|NCT02308540|11216666|FG004|NOT COMPLETED|Overall Study||0
10087633|NCT02308540|11216667|FG005|NOT COMPLETED|Overall Study||1
10087634|NCT02308696|11216718|FG000|STARTED|Overall Study||222
10087635|NCT02308696|11216719|FG001|STARTED|Overall Study||234
10087636|NCT02308696|11216718|FG000|COMPLETED|Overall Study||169
10087637|NCT02308696|11216719|FG001|COMPLETED|Overall Study||203
10087638|NCT02308696|11216718|FG000|NOT COMPLETED|Overall Study||53
10087639|NCT02308696|11216719|FG001|NOT COMPLETED|Overall Study||31
10087640|NCT02308748|11216725|FG000|STARTED|Period 1||2
10087641|NCT02308748|11216726|FG001|STARTED|Period 1||2
10087642|NCT02308748|11216727|FG002|STARTED|Period 1||2
10087643|NCT02308748|11216728|FG003|STARTED|Period 1||2
10087644|NCT02308748|11216729|FG004|STARTED|Period 1||2
10087645|NCT02308748|11216730|FG005|STARTED|Period 1||3
10087646|NCT02308748|11216731|FG006|STARTED|Period 1||2
10087647|NCT02308748|11216732|FG007|STARTED|Period 1||2
10087648|NCT02308748|11216733|FG008|STARTED|Period 1||2
10087649|NCT02308748|11216734|FG009|STARTED|Period 1||3
9737105|NCT00199836|10837858|FG000|STARTED|Overall Study||14
9737106|NCT00199836|10837858|FG000|COMPLETED|Overall Study||8
9737107|NCT00199836|10837858|FG000|NOT COMPLETED|Overall Study||6
10087650|NCT02308748|11216725|FG000|COMPLETED|Period 1||2
10087651|NCT02308748|11216726|FG001|COMPLETED|Period 1||2
10087652|NCT02308748|11216727|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
10087653|NCT02308748|11216728|FG003|COMPLETED|Period 1||2
10087654|NCT02308748|11216729|FG004|COMPLETED|Period 1||2
10087655|NCT02308748|11216730|FG005|COMPLETED|Period 1||3
10087656|NCT02308748|11216731|FG006|COMPLETED|Period 1||2
10087657|NCT02308748|11216732|FG007|COMPLETED|Period 1||2
10087658|NCT02308748|11216733|FG008|COMPLETED|Period 1||2
10087659|NCT02308748|11216734|FG009|COMPLETED|Period 1||3
10087660|NCT02308748|11216725|FG000|NOT COMPLETED|Period 1||0
10087661|NCT02308748|11216726|FG001|NOT COMPLETED|Period 1||0
10087662|NCT02308748|11216727|FG002|NOT COMPLETED|Period 1||1
10087663|NCT02308748|11216728|FG003|NOT COMPLETED|Period 1||0
10087664|NCT02308748|11216729|FG004|NOT COMPLETED|Period 1||0
10087665|NCT02308748|11216730|FG005|NOT COMPLETED|Period 1||0
10087666|NCT02308748|11216731|FG006|NOT COMPLETED|Period 1||0
10087667|NCT02308748|11216732|FG007|NOT COMPLETED|Period 1||0
10087668|NCT02308748|11216733|FG008|NOT COMPLETED|Period 1||0
10087669|NCT02308748|11216734|FG009|NOT COMPLETED|Period 1||0
10087670|NCT02308748|11216725|FG000|STARTED|Period 2||2
10087671|NCT02308748|11216726|FG001|STARTED|Period 2||2
10087672|NCT02308748|11216727|FG002|STARTED|Period 2||1
10087673|NCT02308748|11216728|FG003|STARTED|Period 2||2
10087674|NCT02308748|11216729|FG004|STARTED|Period 2||2
10087675|NCT02308748|11216730|FG005|STARTED|Period 2||3
10087676|NCT02308748|11216731|FG006|STARTED|Period 2||2
9737108|NCT00199849|10837866|FG000|STARTED|Overall Study||3
9737109|NCT00199849|10837867|FG001|STARTED|Overall Study||7
10087677|NCT02308748|11216732|FG007|STARTED|Period 2||2
10087678|NCT02308748|11216733|FG008|STARTED|Period 2||2
10087679|NCT02308748|11216734|FG009|STARTED|Period 2||3
10087680|NCT02308748|11216725|FG000|COMPLETED|Period 2||2
10087681|NCT02308748|11216726|FG001|COMPLETED|Period 2||2
10087682|NCT02308748|11216727|FG002|COMPLETED|Period 2||1
10087683|NCT02308748|11216728|FG003|COMPLETED|Period 2||2
10087684|NCT02308748|11216729|FG004|COMPLETED|Period 2||2
10087685|NCT02308748|11216730|FG005|COMPLETED|Period 2||3
10087686|NCT02308748|11216731|FG006|COMPLETED|Period 2||2
10087687|NCT02308748|11216732|FG007|COMPLETED|Period 2||1
9737110|NCT00199849|10837868|FG002|STARTED|Overall Study||8
9737111|NCT00199849|10837866|FG000|COMPLETED|Overall Study||3
9737112|NCT00199849|10837867|FG001|COMPLETED|Overall Study||6
9737113|NCT00199849|10837868|FG002|COMPLETED|Overall Study||6
9737114|NCT00199849|10837866|FG000|NOT COMPLETED|Overall Study||0
9737115|NCT00199849|10837867|FG001|NOT COMPLETED|Overall Study||1
9737116|NCT00199849|10837868|FG002|NOT COMPLETED|Overall Study||2
9737117|NCT00199875|10837881|FG000|STARTED|Overall Study||3
9737118|NCT00199875|10837882|FG001|STARTED|Overall Study||3
9737119|NCT00199875|10837883|FG002|STARTED|Overall Study||6
9737120|NCT00199875|10837884|FG003|STARTED|Overall Study||3
9737121|NCT00199875|10837885|FG004|STARTED|Overall Study||3
9737122|NCT00199875|10837881|FG000|COMPLETED|Overall Study||3
9737123|NCT00199875|10837882|FG001|COMPLETED|Overall Study||3
9737124|NCT00199875|10837883|FG002|COMPLETED|Overall Study||6
9737125|NCT00199875|10837884|FG003|COMPLETED|Overall Study||3
9737126|NCT00199875|10837885|FG004|COMPLETED|Overall Study||2
9737127|NCT00199875|10837881|FG000|NOT COMPLETED|Overall Study||0
9737128|NCT00199875|10837882|FG001|NOT COMPLETED|Overall Study||0
9737129|NCT00199875|10837883|FG002|NOT COMPLETED|Overall Study||0
9737130|NCT00199875|10837884|FG003|NOT COMPLETED|Overall Study||0
9737131|NCT00199875|10837885|FG004|NOT COMPLETED|Overall Study||1
9737132|NCT00199888|10837897|FG000|STARTED|Overall Study||26
9737133|NCT00199888|10837897|FG000|COMPLETED|Overall Study||25
9737134|NCT00199888|10837897|FG000|NOT COMPLETED|Overall Study||1
9737135|NCT00199901|10837903|FG000|STARTED|Overall Study||56
9737136|NCT00199901|10837904|FG001|STARTED|Overall Study||54
9737137|NCT00199901|10837903|FG000|COMPLETED|Overall Study||29
9737138|NCT00199901|10837904|FG001|COMPLETED|Overall Study||30
9737139|NCT00199901|10837903|FG000|NOT COMPLETED|Overall Study||27
9737140|NCT00199901|10837904|FG001|NOT COMPLETED|Overall Study||24
9737141|NCT00199914|10837914|FG000|STARTED|Overall Study||53
9737142|NCT00199914|10837915|FG001|STARTED|Overall Study||60
9737143|NCT00199914|10837914|FG000|COMPLETED|Overall Study||50
9737144|NCT00199914|10837915|FG001|COMPLETED|Overall Study||54
9737145|NCT00199914|10837914|FG000|NOT COMPLETED|Overall Study||3
9737146|NCT00199914|10837915|FG001|NOT COMPLETED|Overall Study||6
9737147|NCT00200057|10837921|FG000|STARTED|Overall Study||120
9737148|NCT00200057|10837921|FG000|1 Month Follow-up|Overall Study||117
9737149|NCT00200057|10837921|FG000|3 Month Follow-up|Overall Study||116
9737150|NCT00200057|10837921|FG000|6 Month Follow-up|Overall Study||114
9737151|NCT00200057|10837921|FG000|12 Month Follow-up|Overall Study||111
9737152|NCT00200057|10837921|FG000|COMPLETED|Overall Study||111
9737153|NCT00200057|10837921|FG000|NOT COMPLETED|Overall Study||9
9737154|NCT00200161|10837927|FG000|STARTED|Overall Study||43
9737155|NCT00200161|10837928|FG001|STARTED|Overall Study||42
9737156|NCT00200161|10837927|FG000|COMPLETED|Overall Study||43
9737157|NCT00200161|10837928|FG001|COMPLETED|Overall Study||42
9737158|NCT00200161|10837927|FG000|NOT COMPLETED|Overall Study||0
9737159|NCT00200161|10837928|FG001|NOT COMPLETED|Overall Study||0
9737160|NCT00200343|10837937|FG000|STARTED|Overall Study||199
9737161|NCT00200343|10837938|FG001|STARTED|Overall Study||200
9737162|NCT00200343|10837939|FG002|STARTED|Overall Study||197
9737163|NCT00200343|10837937|FG000|COMPLETED|Overall Study||183
9737164|NCT00200343|10837938|FG001|COMPLETED|Overall Study||192
9737165|NCT00200343|10837939|FG002|COMPLETED|Overall Study||184
9737166|NCT00200343|10837937|FG000|NOT COMPLETED|Overall Study||16
9737167|NCT00200343|10837938|FG001|NOT COMPLETED|Overall Study||8
9737168|NCT00200343|10837939|FG002|NOT COMPLETED|Overall Study||13
10087688|NCT02308748|11216733|FG008|COMPLETED|Period 2||2
10087689|NCT02308748|11216734|FG009|COMPLETED|Period 2||3
10087690|NCT02308748|11216725|FG000|NOT COMPLETED|Period 2||0
10087691|NCT02308748|11216726|FG001|NOT COMPLETED|Period 2||0
10087692|NCT02308748|11216727|FG002|NOT COMPLETED|Period 2||0
10087693|NCT02308748|11216728|FG003|NOT COMPLETED|Period 2||0
10087694|NCT02308748|11216729|FG004|NOT COMPLETED|Period 2||0
10087695|NCT02308748|11216730|FG005|NOT COMPLETED|Period 2||0
9737169|NCT00200356|10837949|FG000|STARTED|Overall Study||199
9737170|NCT00200356|10837950|FG001|STARTED|Overall Study||202
9737171|NCT00200356|10837949|FG000|Safety Analysis Set|Overall Study||194
9737172|NCT00200356|10837950|FG001|Safety Analysis Set|Overall Study||198
9737173|NCT00200356|10837949|FG000|COMPLETED|Overall Study||191
9737174|NCT00200356|10837950|FG001|COMPLETED|Overall Study||195
9737175|NCT00200356|10837949|FG000|NOT COMPLETED|Overall Study||8
9737176|NCT00200356|10837950|FG001|NOT COMPLETED|Overall Study||7
9737177|NCT00200785|10837958|FG000|STARTED|First Intervention||9
10087696|NCT02308748|11216731|FG006|NOT COMPLETED|Period 2||0
10087697|NCT02308748|11216732|FG007|NOT COMPLETED|Period 2||1
10087698|NCT02308748|11216733|FG008|NOT COMPLETED|Period 2||0
9737178|NCT00200785|10837959|FG001|STARTED|First Intervention||6
9737179|NCT00200785|10837958|FG000|COMPLETED|First Intervention||9
9737180|NCT00200785|10837959|FG001|COMPLETED|First Intervention||6
9737181|NCT00200785|10837958|FG000|NOT COMPLETED|First Intervention||0
9737182|NCT00200785|10837959|FG001|NOT COMPLETED|First Intervention||0
9737183|NCT00200785|10837958|FG000|STARTED|Washout Period of 1 Week||9
9737184|NCT00200785|10837959|FG001|STARTED|Washout Period of 1 Week||6
9737185|NCT00200785|10837958|FG000|COMPLETED|Washout Period of 1 Week||9
9737186|NCT00200785|10837959|FG001|COMPLETED|Washout Period of 1 Week||6
9737187|NCT00200785|10837958|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9737188|NCT00200785|10837959|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9737189|NCT00200785|10837958|FG000|STARTED|Second Intervention||9
10087699|NCT02308748|11216734|FG009|NOT COMPLETED|Period 2||0
10087700|NCT02308748|11216725|FG000|STARTED|Period 3||2
10087701|NCT02308748|11216726|FG001|STARTED|Period 3||2
10087702|NCT02308748|11216727|FG002|STARTED|Period 3||1
10087703|NCT02308748|11216728|FG003|STARTED|Period 3||2
10087704|NCT02308748|11216729|FG004|STARTED|Period 3||2
10087705|NCT02308748|11216730|FG005|STARTED|Period 3||3
10087706|NCT02308748|11216731|FG006|STARTED|Period 3||2
10087707|NCT02308748|11216732|FG007|STARTED|Period 3||1
10087708|NCT02308748|11216733|FG008|STARTED|Period 3||2
10087709|NCT02308748|11216734|FG009|STARTED|Period 3||3
10087710|NCT02308748|11216725|FG000|COMPLETED|Period 3||2
10087711|NCT02308748|11216726|FG001|COMPLETED|Period 3||2
10087712|NCT02308748|11216727|FG002|COMPLETED|Period 3||1
10087713|NCT02308748|11216728|FG003|COMPLETED|Period 3||2
10087714|NCT02308748|11216729|FG004|COMPLETED|Period 3||2
10087715|NCT02308748|11216730|FG005|COMPLETED|Period 3||3
10087716|NCT02308748|11216731|FG006|COMPLETED|Period 3||2
10087717|NCT02308748|11216732|FG007|COMPLETED|Period 3||1
10087718|NCT02308748|11216733|FG008|COMPLETED|Period 3||2
10087719|NCT02308748|11216734|FG009|COMPLETED|Period 3||2
10087720|NCT02308748|11216725|FG000|NOT COMPLETED|Period 3||0
10087721|NCT02308748|11216726|FG001|NOT COMPLETED|Period 3||0
10087722|NCT02308748|11216727|FG002|NOT COMPLETED|Period 3||0
10087723|NCT02308748|11216728|FG003|NOT COMPLETED|Period 3||0
10087724|NCT02308748|11216729|FG004|NOT COMPLETED|Period 3||0
10087725|NCT02308748|11216730|FG005|NOT COMPLETED|Period 3||0
10087726|NCT02308748|11216731|FG006|NOT COMPLETED|Period 3||0
10087727|NCT02308748|11216732|FG007|NOT COMPLETED|Period 3||0
10087728|NCT02308748|11216733|FG008|NOT COMPLETED|Period 3||0
10087729|NCT02308748|11216734|FG009|NOT COMPLETED|Period 3||1
10087730|NCT02308748|11216725|FG000|STARTED|Period 4||2
10087731|NCT02308748|11216726|FG001|STARTED|Period 4||2
10087732|NCT02308748|11216727|FG002|STARTED|Period 4||1
10087733|NCT02308748|11216728|FG003|STARTED|Period 4||2
10087734|NCT02308748|11216729|FG004|STARTED|Period 4||2
10087735|NCT02308748|11216730|FG005|STARTED|Period 4||3
10087736|NCT02308748|11216731|FG006|STARTED|Period 4||2
10087737|NCT02308748|11216732|FG007|STARTED|Period 4||1
10087738|NCT02308748|11216733|FG008|STARTED|Period 4||2
10087739|NCT02308748|11216734|FG009|STARTED|Period 4||2
10087740|NCT02308748|11216725|FG000|COMPLETED|Period 4||2
10087741|NCT02308748|11216726|FG001|COMPLETED|Period 4||2
10087742|NCT02308748|11216727|FG002|COMPLETED|Period 4||1
10087743|NCT02308748|11216728|FG003|COMPLETED|Period 4||2
10087744|NCT02308748|11216729|FG004|COMPLETED|Period 4||2
10087745|NCT02308748|11216730|FG005|COMPLETED|Period 4||3
10087746|NCT02308748|11216731|FG006|COMPLETED|Period 4||2
10087747|NCT02308748|11216732|FG007|COMPLETED|Period 4||1
10087748|NCT02308748|11216733|FG008|COMPLETED|Period 4||2
10087749|NCT02308748|11216734|FG009|COMPLETED|Period 4||2
10087750|NCT02308748|11216725|FG000|NOT COMPLETED|Period 4||0
10087751|NCT02308748|11216726|FG001|NOT COMPLETED|Period 4||0
10087752|NCT02308748|11216727|FG002|NOT COMPLETED|Period 4||0
10087753|NCT02308748|11216728|FG003|NOT COMPLETED|Period 4||0
10087754|NCT02308748|11216729|FG004|NOT COMPLETED|Period 4||0
10087755|NCT02308748|11216730|FG005|NOT COMPLETED|Period 4||0
10087756|NCT02308748|11216731|FG006|NOT COMPLETED|Period 4||0
10087757|NCT02308748|11216732|FG007|NOT COMPLETED|Period 4||0
10087758|NCT02308748|11216733|FG008|NOT COMPLETED|Period 4||0
10087759|NCT02308748|11216734|FG009|NOT COMPLETED|Period 4||0
10087760|NCT02308748|11216725|FG000|STARTED|Period 5||2
10087761|NCT02308748|11216726|FG001|STARTED|Period 5||2
10087762|NCT02308748|11216727|FG002|STARTED|Period 5||1
10087763|NCT02308748|11216728|FG003|STARTED|Period 5||2
10087764|NCT02308748|11216729|FG004|STARTED|Period 5||2
10087765|NCT02308748|11216730|FG005|STARTED|Period 5||3
10087766|NCT02308748|11216731|FG006|STARTED|Period 5||2
10087767|NCT02308748|11216732|FG007|STARTED|Period 5||1
10087768|NCT02308748|11216733|FG008|STARTED|Period 5||2
10087769|NCT02308748|11216734|FG009|STARTED|Period 5||2
10087770|NCT02308748|11216725|FG000|COMPLETED|Period 5||1
10087771|NCT02308748|11216726|FG001|COMPLETED|Period 5||2
10087772|NCT02308748|11216727|FG002|COMPLETED|Period 5||1
10087773|NCT02308748|11216728|FG003|COMPLETED|Period 5||2
10087774|NCT02308748|11216729|FG004|COMPLETED|Period 5||2
10087775|NCT02308748|11216730|FG005|COMPLETED|Period 5||3
10087776|NCT02308748|11216731|FG006|COMPLETED|Period 5||2
10087777|NCT02308748|11216732|FG007|COMPLETED|Period 5||1
10087778|NCT02308748|11216733|FG008|COMPLETED|Period 5||1
10087779|NCT02308748|11216734|FG009|COMPLETED|Period 5||2
10087780|NCT02308748|11216725|FG000|NOT COMPLETED|Period 5||1
10087781|NCT02308748|11216726|FG001|NOT COMPLETED|Period 5||0
10087782|NCT02308748|11216727|FG002|NOT COMPLETED|Period 5||0
10087783|NCT02308748|11216728|FG003|NOT COMPLETED|Period 5||0
10087784|NCT02308748|11216729|FG004|NOT COMPLETED|Period 5||0
10087785|NCT02308748|11216730|FG005|NOT COMPLETED|Period 5||0
10087786|NCT02308748|11216731|FG006|NOT COMPLETED|Period 5||0
10087787|NCT02308748|11216732|FG007|NOT COMPLETED|Period 5||0
10087788|NCT02308748|11216733|FG008|NOT COMPLETED|Period 5||1
10087789|NCT02308748|11216734|FG009|NOT COMPLETED|Period 5||0
10087790|NCT02308787|11216746|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
10087791|NCT02308787|11216746|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
10087792|NCT02308787|11216746|FG000|NOT COMPLETED|Overall Study||0
10087793|NCT02308839|11216750|FG000|STARTED|Overall Study||181
10087794|NCT02308839|11216750|FG000|COMPLETED|Overall Study||72
10087795|NCT02308839|11216750|FG000|NOT COMPLETED|Overall Study||109
10087796|NCT02309099|11216756|FG000|STARTED|Overall Study||7
10087797|NCT02309099|11216757|FG001|STARTED|Overall Study||3
10087798|NCT02309099|11216756|FG000|Cochlear Implantation|Overall Study||7
10087799|NCT02309099|11216757|FG001|Cochlear Implantation|Overall Study||3
10087800|NCT02309099|11216756|FG000|Initial Activation|Overall Study||7
10087801|NCT02309099|11216757|FG001|Initial Activation|Overall Study||3
10087802|NCT02309099|11216756|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
10087803|NCT02309099|11216757|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3
10087804|NCT02309099|11216756|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
10087805|NCT02309099|11216757|FG001|COMPLETED|Overall Study||3
10087806|NCT02309099|11216756|FG000|NOT COMPLETED|Overall Study||2
10087807|NCT02309099|11216757|FG001|NOT COMPLETED|Overall Study||0
10087808|NCT02309112|11216766|FG000|STARTED|Overall Study||5
10087809|NCT02309112|11216767|FG001|STARTED|Overall Study||5
9737190|NCT00200785|10837959|FG001|STARTED|Second Intervention||6
9737191|NCT00200785|10837958|FG000|COMPLETED|Second Intervention||9
9737192|NCT00200785|10837959|FG001|COMPLETED|Second Intervention||6
9737193|NCT00200785|10837958|FG000|NOT COMPLETED|Second Intervention||0
9737194|NCT00200785|10837959|FG001|NOT COMPLETED|Second Intervention||0
9737195|NCT00200850|10837968|FG000|STARTED|Overall Study||10
9737196|NCT00200850|10837969|FG001|STARTED|Overall Study||10
9737197|NCT00200850|10837970|FG002|STARTED|Overall Study||11
9737198|NCT00200850|10837968|FG000|COMPLETED|Overall Study||7
9737199|NCT00200850|10837969|FG001|COMPLETED|Overall Study||9
9737200|NCT00200850|10837970|FG002|COMPLETED|Overall Study||5
9737201|NCT00200850|10837968|FG000|NOT COMPLETED|Overall Study||3
10087810|NCT02309112|11216768|FG002|STARTED|Overall Study||5
9852160|NCT00879970|10964970|FG000|STARTED|Period 1 TZD Randomization||541
9852161|NCT00879970|10964971|FG001|STARTED|Period 1 TZD Randomization||392
9852162|NCT00879970|10964972|FG002|STARTED|Period 1 TZD Randomization||399
9852163|NCT00879970|10964973|FG003|STARTED|Period 1 TZD Randomization||0
9852164|NCT00879970|10964974|FG004|STARTED|Period 1 TZD Randomization||0
9852165|NCT00879970|10964970|FG000|COMPLETED|Period 1 TZD Randomization||533
9852166|NCT00879970|10964971|FG001|COMPLETED|Period 1 TZD Randomization||388
9852167|NCT00879970|10964972|FG002|COMPLETED|Period 1 TZD Randomization||393
9852168|NCT00879970|10964973|FG003|COMPLETED|Period 1 TZD Randomization||0
9852169|NCT00879970|10964974|FG004|COMPLETED|Period 1 TZD Randomization||0
10087811|NCT02309112|11216766|FG000|Completed Yoga Intervention|Overall Study||4
10087812|NCT02309112|11216767|FG001|Completed Yoga Intervention|Overall Study||5
10087813|NCT02309112|11216768|FG002|Completed Yoga Intervention|Overall Study||4
10087814|NCT02309112|11216766|FG000|COMPLETED|Overall Study||4
10087815|NCT02309112|11216767|FG001|COMPLETED|Overall Study||4
10087816|NCT02309112|11216768|FG002|COMPLETED|Overall Study||4
10087817|NCT02309112|11216766|FG000|NOT COMPLETED|Overall Study||1
10087818|NCT02309112|11216767|FG001|NOT COMPLETED|Overall Study||1
10087819|NCT02309112|11216768|FG002|NOT COMPLETED|Overall Study||1
10087820|NCT02309138|11216780|FG000|STARTED|Overall Study||460
10087821|NCT02309138|11216781|FG001|STARTED|Overall Study||461
9737202|NCT00200850|10837969|FG001|NOT COMPLETED|Overall Study||1
9737203|NCT00200850|10837970|FG002|NOT COMPLETED|Overall Study||6
9852170|NCT00879970|10964970|FG000|NOT COMPLETED|Period 1 TZD Randomization||8
9852171|NCT00879970|10964971|FG001|NOT COMPLETED|Period 1 TZD Randomization||4
9852172|NCT00879970|10964972|FG002|NOT COMPLETED|Period 1 TZD Randomization||6
9852173|NCT00879970|10964973|FG003|NOT COMPLETED|Period 1 TZD Randomization||0
10087822|NCT02309138|11216780|FG000|COMPLETED|Overall Study||412
10087823|NCT02309138|11216781|FG001|COMPLETED|Overall Study||443
10087824|NCT02309138|11216780|FG000|NOT COMPLETED|Overall Study||48
10087825|NCT02309138|11216781|FG001|NOT COMPLETED|Overall Study||18
10087826|NCT02309294|11216797|FG000|STARTED|Overall Study||43
10087827|NCT02309294|11216797|FG000|COMPLETED|Overall Study||41
10087828|NCT02309294|11216797|FG000|NOT COMPLETED|Overall Study||2
10087829|NCT02309359|11216806|FG000|STARTED|Overall Study||69
10087830|NCT02309359|11216807|FG001|STARTED|Overall Study||70
10087831|NCT02309359|11216808|FG002|STARTED|Overall Study||68
10087832|NCT02309359|11216809|FG003|STARTED|Overall Study||69
10087833|NCT02309359|11216810|FG004|STARTED|Overall Study||69
10087834|NCT02309359|11216806|FG000|COMPLETED|Overall Study||57
10087835|NCT02309359|11216807|FG001|COMPLETED|Overall Study||62
10087836|NCT02309359|11216808|FG002|COMPLETED|Overall Study||57
10087837|NCT02309359|11216809|FG003|COMPLETED|Overall Study||57
10087838|NCT02309359|11216810|FG004|COMPLETED|Overall Study||60
10087839|NCT02309359|11216806|FG000|NOT COMPLETED|Overall Study||12
10087840|NCT02309359|11216807|FG001|NOT COMPLETED|Overall Study||8
10087841|NCT02309359|11216808|FG002|NOT COMPLETED|Overall Study||11
10087842|NCT02309359|11216809|FG003|NOT COMPLETED|Overall Study||12
10087843|NCT02309359|11216810|FG004|NOT COMPLETED|Overall Study||9
10087844|NCT02309372|11216825|FG000|STARTED|Overall Study||27
10087845|NCT02309372|11216826|FG001|STARTED|Overall Study||27
10087846|NCT02309372|11216825|FG000|COMPLETED|Overall Study||24
10087847|NCT02309372|11216826|FG001|COMPLETED|Overall Study||25
10087848|NCT02309372|11216825|FG000|NOT COMPLETED|Overall Study||3
10087849|NCT02309372|11216826|FG001|NOT COMPLETED|Overall Study||2
10087850|NCT02309411|11216835|FG000|STARTED|Overall Study||25
10087851|NCT02309411|11216836|FG001|STARTED|Overall Study||15
10087852|NCT02309411|11216837|FG002|STARTED|Overall Study||6
10087853|NCT02309411|11216835|FG000|COMPLETED|Overall Study||23
10087854|NCT02309411|11216836|FG001|COMPLETED|Overall Study||14
10087855|NCT02309411|11216837|FG002|COMPLETED|Overall Study||6
10087856|NCT02309411|11216835|FG000|NOT COMPLETED|Overall Study||2
10087857|NCT02309411|11216836|FG001|NOT COMPLETED|Overall Study||1
10087858|NCT02309411|11216837|FG002|NOT COMPLETED|Overall Study||0
10087859|NCT02309489|11216846|FG000|STARTED|Overall Study||583
10087860|NCT02309489|11216847|FG001|STARTED|Overall Study||561
10087861|NCT02309489|11216846|FG000|Follow-up at 3 Months Postpartum|Overall Study||560
10087862|NCT02309489|11216847|FG001|Follow-up at 3 Months Postpartum|Overall Study||541
10201332|NCT03432858|11328702|FG001|COMPLETED|Overall Study||72
10201333|NCT03432858|11328703|FG002|COMPLETED|Overall Study||72
10201334|NCT03432858|11328701|FG000|NOT COMPLETED|Overall Study||2
10201335|NCT03432858|11328702|FG001|NOT COMPLETED|Overall Study||11
10201336|NCT03432858|11328703|FG002|NOT COMPLETED|Overall Study||17
10201337|NCT03433482|11328715|FG000|STARTED|Overall Study||420
10201338|NCT03433482|11328716|FG001|STARTED|Overall Study||424
10201339|NCT03433482|11328717|FG002|STARTED|Overall Study||427
10201340|NCT03433482|11328718|FG003|STARTED|Overall Study||419
10201341|NCT03433482|11328715|FG000|COMPLETED|Overall Study||419
10201342|NCT03433482|11328716|FG001|COMPLETED|Overall Study||424
10201343|NCT03433482|11328717|FG002|COMPLETED|Overall Study||423
10201344|NCT03433482|11328718|FG003|COMPLETED|Overall Study||418
10201345|NCT03433482|11328715|FG000|NOT COMPLETED|Overall Study||1
10201346|NCT03433482|11328716|FG001|NOT COMPLETED|Overall Study||0
10201347|NCT03433482|11328717|FG002|NOT COMPLETED|Overall Study||4
10201348|NCT03433482|11328718|FG003|NOT COMPLETED|Overall Study||1
10201349|NCT03433677|11328730|FG000|STARTED|Period 1||24
10201350|NCT03433677|11328731|FG001|STARTED|Period 1||25
10201351|NCT03433677|11328730|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
10201352|NCT03433677|11328731|FG001|Received at Least 1 Dose of Study Drug|Period 1||25
10201353|NCT03433677|11328730|FG000|COMPLETED|Period 1||23
10201354|NCT03433677|11328731|FG001|COMPLETED|Period 1||25
10201355|NCT03433677|11328730|FG000|NOT COMPLETED|Period 1||1
10201356|NCT03433677|11328731|FG001|NOT COMPLETED|Period 1||0
10201357|NCT03433677|11328730|FG000|STARTED|Period 2||23
10087863|NCT02309489|11216846|FG000|COMPLETED|Overall Study||568
10087864|NCT02309489|11216847|FG001|COMPLETED|Overall Study||547
10087865|NCT02309489|11216846|FG000|NOT COMPLETED|Overall Study||15
10087866|NCT02309489|11216847|FG001|NOT COMPLETED|Overall Study||14
10087867|NCT02309515|11216855|FG000|STARTED|Overall Study||5
10087868|NCT02309515|11216856|FG001|STARTED|Overall Study||7
10087869|NCT02309515|11216855|FG000|COMPLETED|Overall Study||5
10087870|NCT02309515|11216856|FG001|COMPLETED|Overall Study||6
10087871|NCT02309515|11216855|FG000|NOT COMPLETED|Overall Study||0
10087872|NCT02309515|11216856|FG001|NOT COMPLETED|Overall Study||1
10087873|NCT02309723|11216865|FG000|STARTED|Overall Study||129
10087874|NCT02309723|11216866|FG001|STARTED|Overall Study||128
10201358|NCT03433677|11328731|FG001|STARTED|Period 2||25
10201359|NCT03433677|11328730|FG000|Received at Least 1 Dose of Study Drug|Period 2||23
10201360|NCT03433677|11328731|FG001|Received at Least 1 Dose of Study Drug|Period 2||25
10201361|NCT03433677|11328730|FG000|COMPLETED|Period 2||22
9737204|NCT00200902|10837981|FG000|STARTED|Overall Study||39
9737205|NCT00200902|10837982|FG001|STARTED|Overall Study||29
9737206|NCT00200902|10837983|FG002|STARTED|Overall Study||20
9737207|NCT00200902|10837981|FG000|COMPLETED|Overall Study||29
9737208|NCT00200902|10837982|FG001|COMPLETED|Overall Study||26
10087875|NCT02309723|11216867|FG002|STARTED|Overall Study||129
10087876|NCT02309723|11216865|FG000|COMPLETED|Overall Study||105
10087877|NCT02309723|11216866|FG001|COMPLETED|Overall Study||105
10087878|NCT02309723|11216867|FG002|COMPLETED|Overall Study||105
10087879|NCT02309723|11216865|FG000|NOT COMPLETED|Overall Study||24
10087880|NCT02309723|11216866|FG001|NOT COMPLETED|Overall Study||23
10087881|NCT02309723|11216867|FG002|NOT COMPLETED|Overall Study||24
10087882|NCT02309944|11216877|FG000|STARTED|Overall Study||38
10087883|NCT02309944|11216878|FG001|STARTED|Overall Study||43
10087884|NCT02309944|11216877|FG000|COMPLETED|Overall Study||38
10087885|NCT02309944|11216878|FG001|COMPLETED|Overall Study||43
10087886|NCT02309944|11216877|FG000|NOT COMPLETED|Overall Study||0
10087887|NCT02309944|11216878|FG001|NOT COMPLETED|Overall Study||0
10087888|NCT02310100|11216884|FG000|STARTED|Overall Study|First enrollment|178
10087889|NCT02310100|11216884|FG000|COMPLETED|Overall Study||160
10087890|NCT02310100|11216884|FG000|NOT COMPLETED|Overall Study||18
10087891|NCT02310126|11216891|FG000|STARTED|Period 1 (15 Minutes)||94
10087892|NCT02310126|11216892|FG001|STARTED|Period 1 (15 Minutes)||97
10087893|NCT02310126|11216891|FG000|Hyperopes|Period 1 (15 Minutes)||38
10087894|NCT02310126|11216892|FG001|Hyperopes|Period 1 (15 Minutes)||33
10087895|NCT02310126|11216891|FG000|Myopes|Period 1 (15 Minutes)||56
10087896|NCT02310126|11216892|FG001|Myopes|Period 1 (15 Minutes)||64
10087897|NCT02310126|11216891|FG000|COMPLETED|Period 1 (15 Minutes)||94
10087898|NCT02310126|11216892|FG001|COMPLETED|Period 1 (15 Minutes)||95
10087899|NCT02310126|11216891|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0
10087900|NCT02310126|11216892|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2
10087901|NCT02310126|11216891|FG000|STARTED|Period 2 (15 Minutes)||94
10087902|NCT02310126|11216892|FG001|STARTED|Period 2 (15 Minutes)||95
10087903|NCT02310126|11216891|FG000|Hyperopes|Period 2 (15 Minutes)||38
10087904|NCT02310126|11216892|FG001|Hyperopes|Period 2 (15 Minutes)||32
10087905|NCT02310126|11216891|FG000|Myopes|Period 2 (15 Minutes)||56
10087906|NCT02310126|11216892|FG001|Myopes|Period 2 (15 Minutes)||63
10087907|NCT02310126|11216891|FG000|COMPLETED|Period 2 (15 Minutes)||94
10087908|NCT02310126|11216892|FG001|COMPLETED|Period 2 (15 Minutes)||95
10087909|NCT02310126|11216891|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0
10087910|NCT02310126|11216892|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0
10087911|NCT02310568|11216903|FG000|STARTED|Stage 1 ( 4 Weeks)||15
10087912|NCT02310568|11216904|FG001|STARTED|Stage 1 ( 4 Weeks)||15
10087913|NCT02310568|11216905|FG002|STARTED|Stage 1 ( 4 Weeks)||15
10087914|NCT02310568|11216906|FG003|STARTED|Stage 1 ( 4 Weeks)||24
10087915|NCT02310568|11216907|FG004|STARTED|Stage 1 ( 4 Weeks)||21
10087916|NCT02310568|11216903|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12
10087917|NCT02310568|11216904|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13
10087918|NCT02310568|11216905|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14
10087919|NCT02310568|11216906|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22
10087920|NCT02310568|11216907|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20
10087921|NCT02310568|11216903|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
10087922|NCT02310568|11216904|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
10087923|NCT02310568|11216905|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
10087924|NCT02310568|11216906|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
10087925|NCT02310568|11216907|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
10087926|NCT02310568|11216903|FG000|STARTED|Stage 2 (4 Weeks)||12
10087927|NCT02310568|11216904|FG001|STARTED|Stage 2 (4 Weeks)||13
10087928|NCT02310568|11216905|FG002|STARTED|Stage 2 (4 Weeks)||14
10087929|NCT02310568|11216906|FG003|STARTED|Stage 2 (4 Weeks)||22
10087930|NCT02310568|11216907|FG004|STARTED|Stage 2 (4 Weeks)||20
10087931|NCT02310568|11216903|FG000|COMPLETED|Stage 2 (4 Weeks)||11
10087932|NCT02310568|11216904|FG001|COMPLETED|Stage 2 (4 Weeks)||12
10087933|NCT02310568|11216905|FG002|COMPLETED|Stage 2 (4 Weeks)||13
10087934|NCT02310568|11216906|FG003|COMPLETED|Stage 2 (4 Weeks)||17
9737209|NCT00200902|10837983|FG002|COMPLETED|Overall Study||12
9737210|NCT00200902|10837981|FG000|NOT COMPLETED|Overall Study||10
9737211|NCT00200902|10837982|FG001|NOT COMPLETED|Overall Study||3
10087935|NCT02310568|11216907|FG004|COMPLETED|Stage 2 (4 Weeks)||19
10087936|NCT02310568|11216903|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1
10087937|NCT02310568|11216904|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1
10087938|NCT02310568|11216905|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1
10087939|NCT02310568|11216906|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5
10087940|NCT02310568|11216907|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1
10087941|NCT02310581|11216929|FG000|STARTED|Overall Study||9
10087942|NCT02310581|11216930|FG001|STARTED|Overall Study||11
10087943|NCT02310581|11216931|FG002|STARTED|Overall Study||10
10087944|NCT02310581|11216932|FG003|STARTED|Overall Study||10
10087945|NCT02310581|11216929|FG000|COMPLETED|Overall Study||6
10087946|NCT02310581|11216930|FG001|COMPLETED|Overall Study||9
10087947|NCT02310581|11216931|FG002|COMPLETED|Overall Study||9
10087948|NCT02310581|11216932|FG003|COMPLETED|Overall Study||9
10087949|NCT02310581|11216929|FG000|NOT COMPLETED|Overall Study||3
10087950|NCT02310581|11216930|FG001|NOT COMPLETED|Overall Study||2
10087951|NCT02310581|11216931|FG002|NOT COMPLETED|Overall Study||1
9737212|NCT00200902|10837983|FG002|NOT COMPLETED|Overall Study||8
9737213|NCT00200967|10837999|FG000|STARTED|First Treatment Period||42
9737214|NCT00200967|10838000|FG001|STARTED|First Treatment Period||45
9737215|NCT00200967|10837999|FG000|First Treatment Period|First Treatment Period||42
9737216|NCT00200967|10838000|FG001|First Treatment Period|First Treatment Period||45
9737217|NCT00200967|10837999|FG000|COMPLETED|First Treatment Period||36
9737218|NCT00200967|10838000|FG001|COMPLETED|First Treatment Period||44
9737219|NCT00200967|10837999|FG000|NOT COMPLETED|First Treatment Period||6
9737220|NCT00200967|10838000|FG001|NOT COMPLETED|First Treatment Period||1
9737221|NCT00200967|10837999|FG000|STARTED|Wash-out Period||36
9737222|NCT00200967|10838000|FG001|STARTED|Wash-out Period||44
9737223|NCT00200967|10837999|FG000|COMPLETED|Wash-out Period||36
9737224|NCT00200967|10838000|FG001|COMPLETED|Wash-out Period||43
9737225|NCT00200967|10837999|FG000|NOT COMPLETED|Wash-out Period||0
9737226|NCT00200967|10838000|FG001|NOT COMPLETED|Wash-out Period||1
9737227|NCT00200967|10837999|FG000|STARTED|Second Treatment Period||36
9737228|NCT00200967|10838000|FG001|STARTED|Second Treatment Period||43
9737229|NCT00200967|10837999|FG000|COMPLETED|Second Treatment Period||35
9737230|NCT00200967|10838000|FG001|COMPLETED|Second Treatment Period||41
9737231|NCT00200967|10837999|FG000|NOT COMPLETED|Second Treatment Period||1
10087952|NCT02310581|11216932|FG003|NOT COMPLETED|Overall Study||1
10087953|NCT02310646|11216944|FG000|STARTED|First Intervention (Day 1 - Day 7)||109
9737232|NCT00200967|10838000|FG001|NOT COMPLETED|Second Treatment Period||2
9737233|NCT00200967|10837999|FG000|STARTED|Run-out Period||35
10112860|NCT02505919|11243754|FG000|NOT COMPLETED|12 Months Follow-Up||1
9737234|NCT00200967|10838000|FG001|STARTED|Run-out Period||41
9737235|NCT00200967|10837999|FG000|COMPLETED|Run-out Period||34
9737236|NCT00200967|10838000|FG001|COMPLETED|Run-out Period||41
10087954|NCT02310646|11216945|FG001|STARTED|First Intervention (Day 1 - Day 7)||104
10087955|NCT02310646|11216944|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107
10087956|NCT02310646|11216945|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104
10087957|NCT02310646|11216944|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
10087958|NCT02310646|11216945|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
9737237|NCT00200967|10837999|FG000|NOT COMPLETED|Run-out Period||1
9737238|NCT00200967|10838000|FG001|NOT COMPLETED|Run-out Period||0
9737239|NCT00201006|10838009|FG000|STARTED|Overall Study||83
9737240|NCT00201006|10838010|FG001|STARTED|Overall Study||72
9737241|NCT00201006|10838011|FG002|STARTED|Overall Study||79
9737242|NCT00201006|10838009|FG000|COMPLETED|Overall Study||75
9737243|NCT00201006|10838010|FG001|COMPLETED|Overall Study||70
9737244|NCT00201006|10838011|FG002|COMPLETED|Overall Study||75
9737245|NCT00201006|10838009|FG000|NOT COMPLETED|Overall Study||8
9737246|NCT00201006|10838010|FG001|NOT COMPLETED|Overall Study||2
9737247|NCT00201006|10838011|FG002|NOT COMPLETED|Overall Study||4
9737248|NCT00201123|10838022|FG000|STARTED|Overall Study||32
9737249|NCT00201123|10838023|FG001|STARTED|Overall Study||32
9737250|NCT00201123|10838024|FG002|STARTED|Overall Study||32
9737251|NCT00201123|10838022|FG000|Did Not Meet Continuation Criteria|Overall Study||2
9737252|NCT00201123|10838023|FG001|Did Not Meet Continuation Criteria|Overall Study||0
9737253|NCT00201123|10838024|FG002|Did Not Meet Continuation Criteria|Overall Study||5
9737254|NCT00201123|10838022|FG000|COMPLETED|Overall Study||26
9737255|NCT00201123|10838023|FG001|COMPLETED|Overall Study||28
9737256|NCT00201123|10838024|FG002|COMPLETED|Overall Study||23
9737257|NCT00201123|10838022|FG000|NOT COMPLETED|Overall Study||6
9737258|NCT00201123|10838023|FG001|NOT COMPLETED|Overall Study||4
10087959|NCT02310646|11216944|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107
10087960|NCT02310646|11216945|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104
10087961|NCT02310646|11216944|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107
10087962|NCT02310646|11216945|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104
10087963|NCT02310646|11216944|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
10087964|NCT02310646|11216945|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
10087965|NCT02310672|11216967|FG000|STARTED|Overall Study||87
10087966|NCT02310672|11216967|FG000|COMPLETED|Overall Study||72
10087967|NCT02310672|11216967|FG000|NOT COMPLETED|Overall Study||15
10087968|NCT02310750|11216982|FG000|STARTED|HP Period 1||7
10087969|NCT02310750|11216983|FG001|STARTED|HP Period 1||6
10087970|NCT02310750|11216984|FG002|STARTED|HP Period 1||6
10087971|NCT02310750|11216985|FG003|STARTED|HP Period 1||6
10087972|NCT02310750|11216986|FG004|STARTED|HP Period 1||8
10087973|NCT02310750|11216987|FG005|STARTED|HP Period 1||8
10087974|NCT02310750|11216988|FG006|STARTED|HP Period 1||13
10087975|NCT02310750|11216989|FG007|STARTED|HP Period 1||0
10087976|NCT02310750|11216990|FG008|STARTED|HP Period 1||0
10087977|NCT02310750|11216991|FG009|STARTED|HP Period 1||0
10087978|NCT02310750|11216992|FG010|STARTED|HP Period 1||2
10087979|NCT02310750|11216993|FG011|STARTED|HP Period 1||2
10087980|NCT02310750|11216994|FG012|STARTED|HP Period 1||2
10087981|NCT02310750|11216995|FG013|STARTED|HP Period 1||2
10087982|NCT02310750|11216996|FG014|STARTED|HP Period 1||2
10087983|NCT02310750|11216997|FG015|STARTED|HP Period 1||2
10087984|NCT02310750|11216982|FG000|COMPLETED|HP Period 1||6
10087985|NCT02310750|11216983|FG001|COMPLETED|HP Period 1||6
10087986|NCT02310750|11216984|FG002|COMPLETED|HP Period 1||6
10087987|NCT02310750|11216985|FG003|COMPLETED|HP Period 1||5
10087988|NCT02310750|11216986|FG004|COMPLETED|HP Period 1||8
10087989|NCT02310750|11216987|FG005|COMPLETED|HP Period 1||8
10087990|NCT02310750|11216988|FG006|COMPLETED|HP Period 1||12
10087991|NCT02310750|11216989|FG007|COMPLETED|HP Period 1||0
10087992|NCT02310750|11216990|FG008|COMPLETED|HP Period 1||0
10087993|NCT02310750|11216991|FG009|COMPLETED|HP Period 1||0
10087994|NCT02310750|11216992|FG010|COMPLETED|HP Period 1||2
10087995|NCT02310750|11216993|FG011|COMPLETED|HP Period 1||2
10087996|NCT02310750|11216994|FG012|COMPLETED|HP Period 1||2
10087997|NCT02310750|11216995|FG013|COMPLETED|HP Period 1||2
10087998|NCT02310750|11216996|FG014|COMPLETED|HP Period 1||2
9737259|NCT00201123|10838024|FG002|NOT COMPLETED|Overall Study||9
9737260|NCT00201201|10838038|FG000|STARTED|Overall Study||87
9737261|NCT00201201|10838039|FG001|STARTED|Overall Study||73
9737262|NCT00201201|10838038|FG000|COMPLETED|Overall Study||82
9737263|NCT00201201|10838039|FG001|COMPLETED|Overall Study||66
9737264|NCT00201201|10838038|FG000|NOT COMPLETED|Overall Study||5
9737265|NCT00201201|10838039|FG001|NOT COMPLETED|Overall Study||7
9737266|NCT00201240|10838045|FG000|STARTED|Overall Study||47
9737267|NCT00201240|10838045|FG000|COMPLETED|Overall Study||44
9737268|NCT00201240|10838045|FG000|NOT COMPLETED|Overall Study||3
9737269|NCT00201409|10838052|FG000|STARTED|Overall Study||65
10087999|NCT02310750|11216997|FG015|COMPLETED|HP Period 1||2
9737270|NCT00201409|10838053|FG001|STARTED|Overall Study||67
10088000|NCT02310750|11216982|FG000|NOT COMPLETED|HP Period 1||1
10088001|NCT02310750|11216983|FG001|NOT COMPLETED|HP Period 1||0
10088002|NCT02310750|11216984|FG002|NOT COMPLETED|HP Period 1||0
10088003|NCT02310750|11216985|FG003|NOT COMPLETED|HP Period 1||1
10088004|NCT02310750|11216986|FG004|NOT COMPLETED|HP Period 1||0
9737271|NCT00201409|10838052|FG000|COMPLETED|Overall Study||64
9737272|NCT00201409|10838053|FG001|COMPLETED|Overall Study||66
9737273|NCT00201409|10838052|FG000|NOT COMPLETED|Overall Study||1
9737274|NCT00201409|10838053|FG001|NOT COMPLETED|Overall Study||1
9737275|NCT00201448|10838061|FG000|STARTED|Overall Study||42
9737276|NCT00201448|10838062|FG001|STARTED|Overall Study||40
9737277|NCT00201448|10838061|FG000|COMPLETED|Overall Study||42
9737278|NCT00201448|10838062|FG001|COMPLETED|Overall Study||40
9737279|NCT00201448|10838061|FG000|NOT COMPLETED|Overall Study||0
9737280|NCT00201448|10838062|FG001|NOT COMPLETED|Overall Study||0
9828070|NCT00754065|10938794|FG001|STARTED|Overall Study||206
9828071|NCT00754065|10938793|FG000|Participants Received Treatment|Overall Study||191
9828072|NCT00754065|10938794|FG001|Participants Received Treatment|Overall Study||204
9828073|NCT00754065|10938793|FG000|Cycle 6|Overall Study||141
9828074|NCT00754065|10938794|FG001|Cycle 6|Overall Study||153
9828075|NCT00754065|10938793|FG000|COMPLETED|Overall Study||122
9828076|NCT00754065|10938794|FG001|COMPLETED|Overall Study||126
9828077|NCT00754065|10938793|FG000|NOT COMPLETED|Overall Study||81
9828078|NCT00754065|10938794|FG001|NOT COMPLETED|Overall Study||80
9828079|NCT00754130|10938806|FG000|STARTED|Period 1 (5 Days)||2
9828080|NCT00754130|10938807|FG001|STARTED|Period 1 (5 Days)||2
9828081|NCT00754130|10938808|FG002|STARTED|Period 1 (5 Days)||4
9828082|NCT00754130|10938809|FG003|STARTED|Period 1 (5 Days)||2
9828083|NCT00754130|10938810|FG004|STARTED|Period 1 (5 Days)||2
9828084|NCT00754130|10938811|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
9828085|NCT00754130|10938806|FG000|COMPLETED|Period 1 (5 Days)||2
9828086|NCT00754130|10938807|FG001|COMPLETED|Period 1 (5 Days)||2
9828087|NCT00754130|10938808|FG002|COMPLETED|Period 1 (5 Days)||4
9828088|NCT00754130|10938809|FG003|COMPLETED|Period 1 (5 Days)||2
9828089|NCT00754130|10938810|FG004|COMPLETED|Period 1 (5 Days)||2
9828090|NCT00754130|10938811|FG005|COMPLETED|Period 1 (5 Days)||4
9828091|NCT00754130|10938806|FG000|NOT COMPLETED|Period 1 (5 Days)||0
9828092|NCT00754130|10938807|FG001|NOT COMPLETED|Period 1 (5 Days)||0
9828093|NCT00754130|10938808|FG002|NOT COMPLETED|Period 1 (5 Days)||0
9828094|NCT00754130|10938809|FG003|NOT COMPLETED|Period 1 (5 Days)||0
9828095|NCT00754130|10938810|FG004|NOT COMPLETED|Period 1 (5 Days)||0
9828096|NCT00754130|10938811|FG005|NOT COMPLETED|Period 1 (5 Days)||0
9828097|NCT00754130|10938806|FG000|STARTED|Washout Period (>=8 Days)||2
9828098|NCT00754130|10938807|FG001|STARTED|Washout Period (>=8 Days)||2
9828099|NCT00754130|10938808|FG002|STARTED|Washout Period (>=8 Days)||4
9828100|NCT00754130|10938809|FG003|STARTED|Washout Period (>=8 Days)||2
9828101|NCT00754130|10938810|FG004|STARTED|Washout Period (>=8 Days)||2
9828102|NCT00754130|10938811|FG005|STARTED|Washout Period (>=8 Days)||4
9828103|NCT00754130|10938806|FG000|COMPLETED|Washout Period (>=8 Days)||2
9828104|NCT00754130|10938807|FG001|COMPLETED|Washout Period (>=8 Days)||2
9828105|NCT00754130|10938808|FG002|COMPLETED|Washout Period (>=8 Days)||4
9828106|NCT00754130|10938809|FG003|COMPLETED|Washout Period (>=8 Days)||2
9828107|NCT00754130|10938810|FG004|COMPLETED|Washout Period (>=8 Days)||2
9828108|NCT00754130|10938811|FG005|COMPLETED|Washout Period (>=8 Days)||4
9828109|NCT00754130|10938806|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0
9828110|NCT00754130|10938807|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0
9828111|NCT00754130|10938808|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0
9828112|NCT00754130|10938809|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0
9828113|NCT00754130|10938810|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0
9828114|NCT00754130|10938811|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0
9828115|NCT00754130|10938806|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
9828116|NCT00754130|10938807|FG001|STARTED|Period 2 (5 Days)||2
9828117|NCT00754130|10938808|FG002|STARTED|Period 2 (5 Days)||4
9828118|NCT00754130|10938809|FG003|STARTED|Period 2 (5 Days)||2
9828119|NCT00754130|10938810|FG004|STARTED|Period 2 (5 Days)||2
9828120|NCT00754130|10938811|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
9828121|NCT00754130|10938806|FG000|COMPLETED|Period 2 (5 Days)||2
9828122|NCT00754130|10938807|FG001|COMPLETED|Period 2 (5 Days)||2
9828123|NCT00754130|10938808|FG002|COMPLETED|Period 2 (5 Days)||4
9828124|NCT00754130|10938809|FG003|COMPLETED|Period 2 (5 Days)||2
9828125|NCT00754130|10938810|FG004|COMPLETED|Period 2 (5 Days)||2
9828126|NCT00754130|10938811|FG005|COMPLETED|Period 2 (5 Days)||4
9828127|NCT00754130|10938806|FG000|NOT COMPLETED|Period 2 (5 Days)||0
9828128|NCT00754130|10938807|FG001|NOT COMPLETED|Period 2 (5 Days)||0
9828129|NCT00754130|10938808|FG002|NOT COMPLETED|Period 2 (5 Days)||0
9828130|NCT00754130|10938809|FG003|NOT COMPLETED|Period 2 (5 Days)||0
9828131|NCT00754130|10938810|FG004|NOT COMPLETED|Period 2 (5 Days)||0
9828132|NCT00754130|10938811|FG005|NOT COMPLETED|Period 2 (5 Days)||0
9828133|NCT00754156|10938829|FG000|STARTED|Overall Study||8
9828134|NCT00754156|10938830|FG001|STARTED|Overall Study||6
9828135|NCT00754156|10938829|FG000|COMPLETED|Overall Study||8
9828136|NCT00754156|10938830|FG001|COMPLETED|Overall Study||6
9828137|NCT00754156|10938829|FG000|NOT COMPLETED|Overall Study||0
9828138|NCT00754156|10938830|FG001|NOT COMPLETED|Overall Study||0
9828139|NCT00754208|10938842|FG000|STARTED|Overall Study||7
9828140|NCT00754208|10938842|FG000|COMPLETED|Overall Study||7
9828141|NCT00754208|10938842|FG000|NOT COMPLETED|Overall Study||0
9828142|NCT00754234|10938847|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16
9828143|NCT00754234|10938847|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
9828144|NCT00754234|10938847|FG000|NOT COMPLETED|Overall Study||3
9828145|NCT00754247|10938854|FG000|STARTED|Overall Study||10
9828146|NCT00754247|10938855|FG001|STARTED|Overall Study||10
9828147|NCT00754247|10938856|FG002|STARTED|Overall Study||10
9828148|NCT00754247|10938854|FG000|COMPLETED|Overall Study||5
9737281|NCT00201643|10838072|FG000|STARTED|Overall Study||223
9737282|NCT00201643|10838073|FG001|STARTED|Overall Study||214
9737283|NCT00201643|10838072|FG000|COMPLETED|Overall Study||218
9737284|NCT00201643|10838073|FG001|COMPLETED|Overall Study||210
9737285|NCT00201643|10838072|FG000|NOT COMPLETED|Overall Study||5
9737286|NCT00201643|10838073|FG001|NOT COMPLETED|Overall Study||4
9737287|NCT00201734|10838081|FG000|STARTED|Overall Study||32
9737288|NCT00201734|10838082|FG001|STARTED|Overall Study||25
9737289|NCT00201734|10838081|FG000|Patients Not Evaluable|Overall Study||3
9737290|NCT00201734|10838082|FG001|Patients Not Evaluable|Overall Study||0
9737291|NCT00201734|10838081|FG000|COMPLETED|Overall Study||29
9737292|NCT00201734|10838082|FG001|COMPLETED|Overall Study||25
9737293|NCT00201734|10838081|FG000|NOT COMPLETED|Overall Study||3
9737294|NCT00201734|10838082|FG001|NOT COMPLETED|Overall Study||0
9737295|NCT00201760|10838091|FG000|STARTED|Overall Study||5
9852174|NCT00879970|10964974|FG004|NOT COMPLETED|Period 1 TZD Randomization||0
9852175|NCT00879970|10964970|FG000|STARTED|Period 2 Vitamin D Randomization||0
10088005|NCT02310750|11216987|FG005|NOT COMPLETED|HP Period 1||0
10088006|NCT02310750|11216988|FG006|NOT COMPLETED|HP Period 1||1
10088007|NCT02310750|11216989|FG007|NOT COMPLETED|HP Period 1||0
10088008|NCT02310750|11216990|FG008|NOT COMPLETED|HP Period 1||0
10088009|NCT02310750|11216991|FG009|NOT COMPLETED|HP Period 1||0
10088010|NCT02310750|11216992|FG010|NOT COMPLETED|HP Period 1||0
10088011|NCT02310750|11216993|FG011|NOT COMPLETED|HP Period 1||0
10088012|NCT02310750|11216994|FG012|NOT COMPLETED|HP Period 1||0
10088013|NCT02310750|11216995|FG013|NOT COMPLETED|HP Period 1||0
9852176|NCT00879970|10964971|FG001|STARTED|Period 2 Vitamin D Randomization||0
9852177|NCT00879970|10964972|FG002|STARTED|Period 2 Vitamin D Randomization||0
9852178|NCT00879970|10964973|FG003|STARTED|Period 2 Vitamin D Randomization||614
9852179|NCT00879970|10964974|FG004|STARTED|Period 2 Vitamin D Randomization||607
9852180|NCT00879970|10964970|FG000|COMPLETED|Period 2 Vitamin D Randomization||0
9852181|NCT00879970|10964971|FG001|COMPLETED|Period 2 Vitamin D Randomization||0
9852182|NCT00879970|10964972|FG002|COMPLETED|Period 2 Vitamin D Randomization||0
9852183|NCT00879970|10964973|FG003|COMPLETED|Period 2 Vitamin D Randomization||610
9852184|NCT00879970|10964974|FG004|COMPLETED|Period 2 Vitamin D Randomization||600
9852185|NCT00879970|10964970|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0
9852186|NCT00879970|10964971|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0
9852187|NCT00879970|10964972|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0
9852188|NCT00879970|10964973|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4
9852189|NCT00879970|10964974|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7
9852190|NCT00879996|10964994|FG000|STARTED|Overall Study||28
9852191|NCT00879996|10964995|FG001|STARTED|Overall Study||26
9852192|NCT00879996|10964994|FG000|COMPLETED|Overall Study||13
9852193|NCT00879996|10964995|FG001|COMPLETED|Overall Study||13
9852194|NCT00879996|10964994|FG000|NOT COMPLETED|Overall Study||15
9852195|NCT00879996|10964995|FG001|NOT COMPLETED|Overall Study||13
9852196|NCT00880009|10965003|FG000|STARTED|Overall Study||16
9852197|NCT00880009|10965003|FG000|COMPLETED|Overall Study||0
9852198|NCT00880009|10965003|FG000|NOT COMPLETED|Overall Study||16
9852199|NCT00880022|10965012|FG000|STARTED|Overall Study||23
9852200|NCT00880022|10965013|FG001|STARTED|Overall Study||24
9852201|NCT00880022|10965012|FG000|COMPLETED|Overall Study||21
9852202|NCT00880022|10965013|FG001|COMPLETED|Overall Study||21
9852203|NCT00880022|10965012|FG000|NOT COMPLETED|Overall Study||2
9852204|NCT00880022|10965013|FG001|NOT COMPLETED|Overall Study||3
10088014|NCT02310750|11216996|FG014|NOT COMPLETED|HP Period 1||0
10088015|NCT02310750|11216997|FG015|NOT COMPLETED|HP Period 1||0
10088016|NCT02310750|11216982|FG000|STARTED|HP Washout 1||0
10088017|NCT02310750|11216983|FG001|STARTED|HP Washout 1||0
10088018|NCT02310750|11216984|FG002|STARTED|HP Washout 1||6
10088019|NCT02310750|11216985|FG003|STARTED|HP Washout 1||5
10088020|NCT02310750|11216986|FG004|STARTED|HP Washout 1||8
10088021|NCT02310750|11216987|FG005|STARTED|HP Washout 1||8
10088022|NCT02310750|11216988|FG006|STARTED|HP Washout 1||12
10088023|NCT02310750|11216989|FG007|STARTED|HP Washout 1||0
10088024|NCT02310750|11216990|FG008|STARTED|HP Washout 1||0
10088025|NCT02310750|11216991|FG009|STARTED|HP Washout 1||0
10088026|NCT02310750|11216992|FG010|STARTED|HP Washout 1||2
10088027|NCT02310750|11216993|FG011|STARTED|HP Washout 1||2
10088028|NCT02310750|11216994|FG012|STARTED|HP Washout 1||2
10088029|NCT02310750|11216995|FG013|STARTED|HP Washout 1||2
10088030|NCT02310750|11216996|FG014|STARTED|HP Washout 1||2
10088031|NCT02310750|11216997|FG015|STARTED|HP Washout 1||2
10088032|NCT02310750|11216982|FG000|COMPLETED|HP Washout 1||0
10088033|NCT02310750|11216983|FG001|COMPLETED|HP Washout 1||0
10088034|NCT02310750|11216984|FG002|COMPLETED|HP Washout 1||5
10088035|NCT02310750|11216985|FG003|COMPLETED|HP Washout 1||4
10088036|NCT02310750|11216986|FG004|COMPLETED|HP Washout 1||6
10088037|NCT02310750|11216987|FG005|COMPLETED|HP Washout 1||6
10088038|NCT02310750|11216988|FG006|COMPLETED|HP Washout 1||9
9737296|NCT00201760|10838092|FG001|STARTED|Overall Study||5
9852205|NCT00880048|10965024|FG000|STARTED|Overall Study||116
9852206|NCT00880048|10965025|FG001|STARTED|Overall Study||115
9852207|NCT00880048|10965026|FG002|STARTED|Overall Study||112
9852208|NCT00880048|10965024|FG000|COMPLETED|Overall Study||88
9852209|NCT00880048|10965025|FG001|COMPLETED|Overall Study||82
9852210|NCT00880048|10965026|FG002|COMPLETED|Overall Study||77
10088039|NCT02310750|11216989|FG007|COMPLETED|HP Washout 1||0
10088040|NCT02310750|11216990|FG008|COMPLETED|HP Washout 1||0
9737297|NCT00201760|10838091|FG000|COMPLETED|Overall Study||5
10088041|NCT02310750|11216991|FG009|COMPLETED|HP Washout 1||0
9737298|NCT00201760|10838092|FG001|COMPLETED|Overall Study||5
9737299|NCT00201760|10838091|FG000|NOT COMPLETED|Overall Study||0
9737300|NCT00201760|10838092|FG001|NOT COMPLETED|Overall Study||0
9737301|NCT00201773|10838098|FG000|STARTED|Overall Study||22
9737302|NCT00201773|10838098|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16
9737303|NCT00201773|10838098|FG000|Received All Exemestane Therapy|Overall Study||5
9737304|NCT00201773|10838098|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1
9737305|NCT00201773|10838098|FG000|COMPLETED|Overall Study||16
9737306|NCT00201773|10838098|FG000|NOT COMPLETED|Overall Study||6
9737307|NCT00201825|10838105|FG000|STARTED|Overall Study||29
9737308|NCT00201825|10838105|FG000|COMPLETED|Overall Study||29
9737309|NCT00201825|10838105|FG000|NOT COMPLETED|Overall Study||0
9737310|NCT00201838|10838111|FG000|STARTED|Overall Study||30
9737311|NCT00201838|10838112|FG001|STARTED|Overall Study||8
9737312|NCT00201838|10838111|FG000|Treatment Cohort|Overall Study||30
10088042|NCT02310750|11216992|FG010|COMPLETED|HP Washout 1||2
10088043|NCT02310750|11216993|FG011|COMPLETED|HP Washout 1||2
10088044|NCT02310750|11216994|FG012|COMPLETED|HP Washout 1||2
9737313|NCT00201838|10838112|FG001|Treatment Cohort|Overall Study||8
9737314|NCT00201838|10838111|FG000|COMPLETED|Overall Study||30
9737315|NCT00201838|10838112|FG001|COMPLETED|Overall Study||8
9737316|NCT00201838|10838111|FG000|NOT COMPLETED|Overall Study||0
9737317|NCT00201838|10838112|FG001|NOT COMPLETED|Overall Study||0
9737318|NCT00201851|10838127|FG000|STARTED|Overall Study||252
9737319|NCT00201851|10838128|FG001|STARTED|Overall Study||257
9737320|NCT00201851|10838129|FG002|STARTED|Overall Study||231
9737321|NCT00201851|10838127|FG000|COMPLETED|Overall Study||244
9737322|NCT00201851|10838128|FG001|COMPLETED|Overall Study||255
9737323|NCT00201851|10838129|FG002|COMPLETED|Overall Study||230
9737324|NCT00201851|10838127|FG000|NOT COMPLETED|Overall Study||8
9737325|NCT00201851|10838128|FG001|NOT COMPLETED|Overall Study||2
9737326|NCT00201851|10838129|FG002|NOT COMPLETED|Overall Study||1
9737327|NCT00201864|10838137|FG000|STARTED|Overall Study||40
9737328|NCT00201864|10838137|FG000|COMPLETED|Overall Study||40
9737329|NCT00201864|10838137|FG000|NOT COMPLETED|Overall Study||0
9737330|NCT00201877|10838143|FG000|STARTED|Overall Study||25
9737331|NCT00201877|10838143|FG000|COMPLETED|Overall Study||25
9737332|NCT00201877|10838143|FG000|NOT COMPLETED|Overall Study||0
9737333|NCT00202449|10838151|FG000|STARTED|Overall Study||18
9737334|NCT00202449|10838152|FG001|STARTED|Overall Study||20
9737335|NCT00202449|10838153|FG002|STARTED|Overall Study||21
9737336|NCT00202449|10838151|FG000|COMPLETED|Overall Study||7
9737337|NCT00202449|10838152|FG001|COMPLETED|Overall Study||9
9737338|NCT00202449|10838153|FG002|COMPLETED|Overall Study||9
9737339|NCT00202449|10838151|FG000|NOT COMPLETED|Overall Study||11
9737340|NCT00202449|10838152|FG001|NOT COMPLETED|Overall Study||11
9737341|NCT00202449|10838153|FG002|NOT COMPLETED|Overall Study||12
9737342|NCT00202644|10838163|FG000|STARTED|Overall Study|One participant not randomized but treated.|76
9737343|NCT00202644|10838164|FG001|STARTED|Overall Study||70
9737344|NCT00202644|10838163|FG000|COMPLETED|Overall Study||41
9737345|NCT00202644|10838164|FG001|COMPLETED|Overall Study||43
10088045|NCT02310750|11216995|FG013|COMPLETED|HP Washout 1||2
10088046|NCT02310750|11216996|FG014|COMPLETED|HP Washout 1||2
10088047|NCT02310750|11216997|FG015|COMPLETED|HP Washout 1||2
10088048|NCT02310750|11216982|FG000|NOT COMPLETED|HP Washout 1||0
10088049|NCT02310750|11216983|FG001|NOT COMPLETED|HP Washout 1||0
10088050|NCT02310750|11216984|FG002|NOT COMPLETED|HP Washout 1||1
10088051|NCT02310750|11216985|FG003|NOT COMPLETED|HP Washout 1||1
10088052|NCT02310750|11216986|FG004|NOT COMPLETED|HP Washout 1||2
10088053|NCT02310750|11216987|FG005|NOT COMPLETED|HP Washout 1||2
9737346|NCT00202644|10838163|FG000|NOT COMPLETED|Overall Study||35
9737347|NCT00202644|10838164|FG001|NOT COMPLETED|Overall Study||27
9737348|NCT00202722|10838170|FG000|STARTED|Overall Study||41
9737349|NCT00202722|10838170|FG000|COMPLETED|Overall Study||41
9737350|NCT00202722|10838170|FG000|NOT COMPLETED|Overall Study||0
9737351|NCT00202839|10838177|FG000|STARTED|Overall Study||78
9737352|NCT00202839|10838178|FG001|STARTED|Overall Study||82
9737353|NCT00202839|10838177|FG000|COMPLETED|Overall Study||54
9737354|NCT00202839|10838178|FG001|COMPLETED|Overall Study||72
10088054|NCT02310750|11216988|FG006|NOT COMPLETED|HP Washout 1||3
10088055|NCT02310750|11216989|FG007|NOT COMPLETED|HP Washout 1||0
10088056|NCT02310750|11216990|FG008|NOT COMPLETED|HP Washout 1||0
10088057|NCT02310750|11216991|FG009|NOT COMPLETED|HP Washout 1||0
10088058|NCT02310750|11216992|FG010|NOT COMPLETED|HP Washout 1||0
10088059|NCT02310750|11216993|FG011|NOT COMPLETED|HP Washout 1||0
10088060|NCT02310750|11216994|FG012|NOT COMPLETED|HP Washout 1||0
10088061|NCT02310750|11216995|FG013|NOT COMPLETED|HP Washout 1||0
10088062|NCT02310750|11216996|FG014|NOT COMPLETED|HP Washout 1||0
9737355|NCT00202839|10838177|FG000|NOT COMPLETED|Overall Study||24
9737356|NCT00202839|10838178|FG001|NOT COMPLETED|Overall Study||10
9737357|NCT00202930|10838184|FG000|STARTED|Overall Study||4
9737358|NCT00202930|10838184|FG000|COMPLETED|Overall Study||4
9737359|NCT00202930|10838184|FG000|NOT COMPLETED|Overall Study||0
9737360|NCT00203021|10838190|FG000|STARTED|Overall Study||107
10088063|NCT02310750|11216997|FG015|NOT COMPLETED|HP Washout 1||0
10088064|NCT02310750|11216982|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088065|NCT02310750|11216983|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
9737361|NCT00203021|10838191|FG001|STARTED|Overall Study||101
9737362|NCT00203021|10838190|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107
9737363|NCT00203021|10838191|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
9737364|NCT00203021|10838190|FG000|COMPLETED|Overall Study||28
9737365|NCT00203021|10838191|FG001|COMPLETED|Overall Study||24
9737366|NCT00203021|10838190|FG000|NOT COMPLETED|Overall Study||79
9737367|NCT00203021|10838191|FG001|NOT COMPLETED|Overall Study||77
9737368|NCT00203047|10838199|FG000|STARTED|Overall Study||204
9737369|NCT00203047|10838200|FG001|STARTED|Overall Study||210
9737370|NCT00203047|10838199|FG000|In Database as of January 29, 2009|Overall Study||199
9737371|NCT00203047|10838200|FG001|In Database as of January 29, 2009|Overall Study||209
9737372|NCT00203047|10838199|FG000|COMPLETED|Overall Study||13
9737373|NCT00203047|10838200|FG001|COMPLETED|Overall Study||7
9737374|NCT00203047|10838199|FG000|NOT COMPLETED|Overall Study||191
9737375|NCT00203047|10838200|FG001|NOT COMPLETED|Overall Study||203
9737376|NCT00203203|10838208|FG000|STARTED|Overall Study||10
9737377|NCT00203203|10838209|FG001|STARTED|Overall Study||20
9737378|NCT00203203|10838208|FG000|COMPLETED|Overall Study||9
9737379|NCT00203203|10838209|FG001|COMPLETED|Overall Study||20
9737380|NCT00203203|10838208|FG000|NOT COMPLETED|Overall Study||1
9737381|NCT00203203|10838209|FG001|NOT COMPLETED|Overall Study||0
9737382|NCT00203216|10838215|FG000|STARTED|Overall Study||31
9737383|NCT00203216|10838215|FG000|COMPLETED|Overall Study||27
10088066|NCT02310750|11216984|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
10088067|NCT02310750|11216985|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10088068|NCT02310750|11216986|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10088069|NCT02310750|11216987|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10088070|NCT02310750|11216988|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10088071|NCT02310750|11216989|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10088072|NCT02310750|11216990|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
10088073|NCT02310750|11216991|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
10088074|NCT02310750|11216992|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088075|NCT02310750|11216993|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088076|NCT02310750|11216994|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088077|NCT02310750|11216995|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088078|NCT02310750|11216996|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088079|NCT02310750|11216997|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088080|NCT02310750|11216982|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088081|NCT02310750|11216983|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088082|NCT02310750|11216984|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
10088083|NCT02310750|11216985|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
10088084|NCT02310750|11216986|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10088085|NCT02310750|11216987|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10088086|NCT02310750|11216988|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10088087|NCT02310750|11216989|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
10088088|NCT02310750|11216990|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10088089|NCT02310750|11216991|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10201362|NCT03433677|11328731|FG001|COMPLETED|Period 2||24
10201363|NCT03433677|11328730|FG000|NOT COMPLETED|Period 2||1
10201364|NCT03433677|11328731|FG001|NOT COMPLETED|Period 2||1
10201365|NCT03433703|11328738|FG000|STARTED|Overall Study||2
10201366|NCT03433703|11328738|FG000|COMPLETED|Overall Study||0
10201367|NCT03433703|11328738|FG000|NOT COMPLETED|Overall Study||2
10201368|NCT03433755|11328746|FG000|STARTED|Overall Study||42
10201369|NCT03433755|11328747|FG001|STARTED|Overall Study||41
10201370|NCT03433755|11328748|FG002|STARTED|Overall Study||79
10201371|NCT03433755|11328749|FG003|STARTED|Overall Study||80
10201372|NCT03433755|11328746|FG000|Randomized and Treated|Overall Study||41
10201373|NCT03433755|11328747|FG001|Randomized and Treated|Overall Study||41
10201374|NCT03433755|11328748|FG002|Randomized and Treated|Overall Study||79
10201375|NCT03433755|11328749|FG003|Randomized and Treated|Overall Study||80
10201376|NCT03433755|11328746|FG000|COMPLETED|Overall Study||40
10201377|NCT03433755|11328747|FG001|COMPLETED|Overall Study||41
10201378|NCT03433755|11328748|FG002|COMPLETED|Overall Study||79
10201379|NCT03433755|11328749|FG003|COMPLETED|Overall Study||80
10201380|NCT03433755|11328746|FG000|NOT COMPLETED|Overall Study||2
10201381|NCT03433755|11328747|FG001|NOT COMPLETED|Overall Study||0
10201382|NCT03433755|11328748|FG002|NOT COMPLETED|Overall Study||0
10201383|NCT03433755|11328749|FG003|NOT COMPLETED|Overall Study||0
10201384|NCT03433794|11328764|FG000|STARTED|Baseline||183
10201385|NCT03433794|11328765|FG001|STARTED|Baseline||173
10201386|NCT03433794|11328766|FG002|STARTED|Baseline||181
10201387|NCT03433794|11328764|FG000|COMPLETED|Baseline||183
10201388|NCT03433794|11328765|FG001|COMPLETED|Baseline||173
10201389|NCT03433794|11328766|FG002|COMPLETED|Baseline||181
10201390|NCT03433794|11328764|FG000|NOT COMPLETED|Baseline||0
10201391|NCT03433794|11328765|FG001|NOT COMPLETED|Baseline||0
10201392|NCT03433794|11328766|FG002|NOT COMPLETED|Baseline||0
10201393|NCT03433794|11328764|FG000|STARTED|2-Week Assessment||183
10201394|NCT03433794|11328765|FG001|STARTED|2-Week Assessment||173
9737384|NCT00203216|10838215|FG000|NOT COMPLETED|Overall Study||4
9737385|NCT00203229|10838221|FG000|STARTED|Overall Study||10
9737386|NCT00203229|10838222|FG001|STARTED|Overall Study||10
10088090|NCT02310750|11216992|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10201395|NCT03433794|11328766|FG002|STARTED|2-Week Assessment||181
10201396|NCT03433794|11328764|FG000|COMPLETED|2-Week Assessment||117
10201397|NCT03433794|11328765|FG001|COMPLETED|2-Week Assessment||112
10201398|NCT03433794|11328766|FG002|COMPLETED|2-Week Assessment||109
10201399|NCT03433794|11328764|FG000|NOT COMPLETED|2-Week Assessment||66
10201400|NCT03433794|11328765|FG001|NOT COMPLETED|2-Week Assessment||61
9737387|NCT00203229|10838221|FG000|COMPLETED|Overall Study||7
9737388|NCT00203229|10838222|FG001|COMPLETED|Overall Study||7
9737389|NCT00203229|10838221|FG000|NOT COMPLETED|Overall Study||3
9737390|NCT00203229|10838222|FG001|NOT COMPLETED|Overall Study||3
9737391|NCT00203242|10838228|FG000|STARTED|Overall Study||15
9737392|NCT00203242|10838228|FG000|COMPLETED|Overall Study||14
9737393|NCT00203242|10838228|FG000|NOT COMPLETED|Overall Study||1
9737394|NCT00203268|10838232|FG000|STARTED|Early Treatment||13
9737395|NCT00203268|10838232|FG000|COMPLETED|Early Treatment||9
10088091|NCT02310750|11216993|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088092|NCT02310750|11216994|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088093|NCT02310750|11216995|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088094|NCT02310750|11216996|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088095|NCT02310750|11216997|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088096|NCT02310750|11216982|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088097|NCT02310750|11216983|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088098|NCT02310750|11216984|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088099|NCT02310750|11216985|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
10088100|NCT02310750|11216986|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088101|NCT02310750|11216987|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088102|NCT02310750|11216988|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088103|NCT02310750|11216989|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10088104|NCT02310750|11216990|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
10088105|NCT02310750|11216991|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
10088106|NCT02310750|11216992|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088107|NCT02310750|11216993|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088108|NCT02310750|11216994|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088109|NCT02310750|11216995|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088110|NCT02310750|11216996|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088111|NCT02310750|11216997|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10088112|NCT02310750|11216982|FG000|STARTED|HP Washout 2||0
10088113|NCT02310750|11216983|FG001|STARTED|HP Washout 2||0
10088114|NCT02310750|11216984|FG002|STARTED|HP Washout 2||0
10088115|NCT02310750|11216985|FG003|STARTED|HP Washout 2||0
10088116|NCT02310750|11216986|FG004|STARTED|HP Washout 2||6
10088117|NCT02310750|11216987|FG005|STARTED|HP Washout 2||0
10088118|NCT02310750|11216988|FG006|STARTED|HP Washout 2||9
10088119|NCT02310750|11216989|FG007|STARTED|HP Washout 2||0
10088120|NCT02310750|11216990|FG008|STARTED|HP Washout 2||0
10088121|NCT02310750|11216991|FG009|STARTED|HP Washout 2||0
10088122|NCT02310750|11216992|FG010|STARTED|HP Washout 2||2
10088123|NCT02310750|11216993|FG011|STARTED|HP Washout 2||2
10088124|NCT02310750|11216994|FG012|STARTED|HP Washout 2||2
10088125|NCT02310750|11216995|FG013|STARTED|HP Washout 2||2
10088126|NCT02310750|11216996|FG014|STARTED|HP Washout 2||2
10088127|NCT02310750|11216997|FG015|STARTED|HP Washout 2||2
10088128|NCT02310750|11216982|FG000|COMPLETED|HP Washout 2||0
10088129|NCT02310750|11216983|FG001|COMPLETED|HP Washout 2||0
10088130|NCT02310750|11216984|FG002|COMPLETED|HP Washout 2||0
10088131|NCT02310750|11216985|FG003|COMPLETED|HP Washout 2||0
10088132|NCT02310750|11216986|FG004|COMPLETED|HP Washout 2||5
10088133|NCT02310750|11216987|FG005|COMPLETED|HP Washout 2||0
10088134|NCT02310750|11216988|FG006|COMPLETED|HP Washout 2||2
10088135|NCT02310750|11216989|FG007|COMPLETED|HP Washout 2||0
10088136|NCT02310750|11216990|FG008|COMPLETED|HP Washout 2||0
10088137|NCT02310750|11216991|FG009|COMPLETED|HP Washout 2||0
10088138|NCT02310750|11216992|FG010|COMPLETED|HP Washout 2||2
10088139|NCT02310750|11216993|FG011|COMPLETED|HP Washout 2||2
10088140|NCT02310750|11216994|FG012|COMPLETED|HP Washout 2||2
10088141|NCT02310750|11216995|FG013|COMPLETED|HP Washout 2||2
10088142|NCT02310750|11216996|FG014|COMPLETED|HP Washout 2||2
10088143|NCT02310750|11216997|FG015|COMPLETED|HP Washout 2||2
10088144|NCT02310750|11216982|FG000|NOT COMPLETED|HP Washout 2||0
10088145|NCT02310750|11216983|FG001|NOT COMPLETED|HP Washout 2||0
10088146|NCT02310750|11216984|FG002|NOT COMPLETED|HP Washout 2||0
10088147|NCT02310750|11216985|FG003|NOT COMPLETED|HP Washout 2||0
10088148|NCT02310750|11216986|FG004|NOT COMPLETED|HP Washout 2||1
10088149|NCT02310750|11216987|FG005|NOT COMPLETED|HP Washout 2||0
10088150|NCT02310750|11216988|FG006|NOT COMPLETED|HP Washout 2||7
10088151|NCT02310750|11216989|FG007|NOT COMPLETED|HP Washout 2||0
10088152|NCT02310750|11216990|FG008|NOT COMPLETED|HP Washout 2||0
10088153|NCT02310750|11216991|FG009|NOT COMPLETED|HP Washout 2||0
10088154|NCT02310750|11216992|FG010|NOT COMPLETED|HP Washout 2||0
10088155|NCT02310750|11216993|FG011|NOT COMPLETED|HP Washout 2||0
10088156|NCT02310750|11216994|FG012|NOT COMPLETED|HP Washout 2||0
10088157|NCT02310750|11216995|FG013|NOT COMPLETED|HP Washout 2||0
10088158|NCT02310750|11216996|FG014|NOT COMPLETED|HP Washout 2||0
10088159|NCT02310750|11216997|FG015|NOT COMPLETED|HP Washout 2||0
10088160|NCT02310750|11216982|FG000|STARTED|HP MAD and Fasted/Fed||0
10088161|NCT02310750|11216983|FG001|STARTED|HP MAD and Fasted/Fed||0
10088162|NCT02310750|11216984|FG002|STARTED|HP MAD and Fasted/Fed||0
10088163|NCT02310750|11216985|FG003|STARTED|HP MAD and Fasted/Fed||0
10088164|NCT02310750|11216986|FG004|STARTED|HP MAD and Fasted/Fed||5
10088165|NCT02310750|11216987|FG005|STARTED|HP MAD and Fasted/Fed||0
10088166|NCT02310750|11216988|FG006|STARTED|HP MAD and Fasted/Fed||2
10088167|NCT02310750|11216989|FG007|STARTED|HP MAD and Fasted/Fed||0
10088168|NCT02310750|11216990|FG008|STARTED|HP MAD and Fasted/Fed||0
9737396|NCT00203268|10838232|FG000|NOT COMPLETED|Early Treatment||4
9737397|NCT00203268|10838232|FG000|STARTED|Late Treatment||9
9737398|NCT00203268|10838232|FG000|COMPLETED|Late Treatment||9
9737399|NCT00203268|10838232|FG000|NOT COMPLETED|Late Treatment||0
9737400|NCT00203294|10838240|FG000|STARTED|Overall Study||22
9737401|NCT00203294|10838241|FG001|STARTED|Overall Study||23
9737402|NCT00203294|10838240|FG000|COMPLETED|Overall Study||14
9737403|NCT00203294|10838241|FG001|COMPLETED|Overall Study||10
9737404|NCT00203294|10838240|FG000|NOT COMPLETED|Overall Study||8
9737405|NCT00203294|10838241|FG001|NOT COMPLETED|Overall Study||13
9737406|NCT00203307|10838249|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
9737407|NCT00203307|10838250|FG001|STARTED|First Intervention||0
9737408|NCT00203307|10838249|FG000|COMPLETED|First Intervention||1
9737409|NCT00203307|10838250|FG001|COMPLETED|First Intervention||0
9737410|NCT00203307|10838249|FG000|NOT COMPLETED|First Intervention||2
9737411|NCT00203307|10838250|FG001|NOT COMPLETED|First Intervention||0
9737412|NCT00203307|10838249|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
9737413|NCT00203307|10838250|FG001|STARTED|Second Intervention||0
9737414|NCT00203307|10838249|FG000|COMPLETED|Second Intervention||1
9737415|NCT00203307|10838250|FG001|COMPLETED|Second Intervention||0
9737416|NCT00203307|10838249|FG000|NOT COMPLETED|Second Intervention||0
9737417|NCT00203307|10838250|FG001|NOT COMPLETED|Second Intervention||0
9737418|NCT00203411|10838256|FG000|STARTED|Treatment Period||45
9737419|NCT00203411|10838256|FG000|COMPLETED|Treatment Period||45
9737420|NCT00203411|10838256|FG000|NOT COMPLETED|Treatment Period||0
9737421|NCT00203411|10838256|FG000|STARTED|Follow-up||45
9737422|NCT00203411|10838256|FG000|COMPLETED|Follow-up||41
9737423|NCT00203411|10838256|FG000|NOT COMPLETED|Follow-up||4
9737424|NCT00203424|10838261|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
9737425|NCT00203424|10838261|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
9737426|NCT00203424|10838261|FG000|NOT COMPLETED|Treatment Period||11
9737427|NCT00203424|10838261|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
9737428|NCT00203424|10838261|FG000|COMPLETED|Follow-up Period||10
9737429|NCT00203424|10838261|FG000|NOT COMPLETED|Follow-up Period||6
9737430|NCT00203476|10838268|FG000|STARTED|Overall Study||10
9737431|NCT00203476|10838269|FG001|STARTED|Overall Study||10
9737432|NCT00203476|10838270|FG002|STARTED|Overall Study||10
9737433|NCT00203476|10838268|FG000|COMPLETED|Overall Study||9
10088169|NCT02310750|11216991|FG009|STARTED|HP MAD and Fasted/Fed||0
10088170|NCT02310750|11216992|FG010|STARTED|HP MAD and Fasted/Fed||2
10088171|NCT02310750|11216993|FG011|STARTED|HP MAD and Fasted/Fed||2
10088172|NCT02310750|11216994|FG012|STARTED|HP MAD and Fasted/Fed||2
10088173|NCT02310750|11216995|FG013|STARTED|HP MAD and Fasted/Fed||2
10088174|NCT02310750|11216996|FG014|STARTED|HP MAD and Fasted/Fed||2
10088175|NCT02310750|11216997|FG015|STARTED|HP MAD and Fasted/Fed||2
10088176|NCT02310750|11216982|FG000|COMPLETED|HP MAD and Fasted/Fed||0
10088177|NCT02310750|11216983|FG001|COMPLETED|HP MAD and Fasted/Fed||0
10088178|NCT02310750|11216984|FG002|COMPLETED|HP MAD and Fasted/Fed||0
10088179|NCT02310750|11216985|FG003|COMPLETED|HP MAD and Fasted/Fed||0
10088180|NCT02310750|11216986|FG004|COMPLETED|HP MAD and Fasted/Fed||4
10088181|NCT02310750|11216987|FG005|COMPLETED|HP MAD and Fasted/Fed||0
10088182|NCT02310750|11216988|FG006|COMPLETED|HP MAD and Fasted/Fed||2
10088183|NCT02310750|11216989|FG007|COMPLETED|HP MAD and Fasted/Fed||0
10088184|NCT02310750|11216990|FG008|COMPLETED|HP MAD and Fasted/Fed||0
10088185|NCT02310750|11216991|FG009|COMPLETED|HP MAD and Fasted/Fed||0
10088186|NCT02310750|11216992|FG010|COMPLETED|HP MAD and Fasted/Fed||2
10088187|NCT02310750|11216993|FG011|COMPLETED|HP MAD and Fasted/Fed||2
10088188|NCT02310750|11216994|FG012|COMPLETED|HP MAD and Fasted/Fed||2
10088189|NCT02310750|11216995|FG013|COMPLETED|HP MAD and Fasted/Fed||2
10088190|NCT02310750|11216996|FG014|COMPLETED|HP MAD and Fasted/Fed||2
10088191|NCT02310750|11216997|FG015|COMPLETED|HP MAD and Fasted/Fed||2
10088192|NCT02310750|11216982|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088193|NCT02310750|11216983|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088194|NCT02310750|11216984|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088195|NCT02310750|11216985|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088196|NCT02310750|11216986|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1
10088197|NCT02310750|11216987|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088198|NCT02310750|11216988|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088199|NCT02310750|11216989|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088200|NCT02310750|11216990|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088201|NCT02310750|11216991|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088202|NCT02310750|11216992|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088203|NCT02310750|11216993|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088204|NCT02310750|11216994|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0
9737434|NCT00203476|10838269|FG001|COMPLETED|Overall Study||9
9737435|NCT00203476|10838270|FG002|COMPLETED|Overall Study||10
9737436|NCT00203476|10838268|FG000|NOT COMPLETED|Overall Study||1
9737437|NCT00203476|10838269|FG001|NOT COMPLETED|Overall Study||1
9737438|NCT00203476|10838270|FG002|NOT COMPLETED|Overall Study||0
9737439|NCT00203502|10838278|FG000|STARTED|Overall Study||40
9737440|NCT00203502|10838278|FG000|COMPLETED|Overall Study||39
9737441|NCT00203502|10838278|FG000|NOT COMPLETED|Overall Study||1
9737442|NCT00203892|10838285|FG000|STARTED|Overall Study||7
9737443|NCT00203892|10838286|FG001|STARTED|Overall Study||10
10088205|NCT02310750|11216995|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0
9737444|NCT00203892|10838287|FG002|STARTED|Overall Study||6
9737445|NCT00203892|10838285|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
9737446|NCT00203892|10838286|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
9737447|NCT00203892|10838287|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
9737448|NCT00203892|10838285|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
9737449|NCT00203892|10838286|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
9737450|NCT00203892|10838287|FG002|COMPLETED|Overall Study||6
9737451|NCT00203892|10838285|FG000|NOT COMPLETED|Overall Study||2
9737452|NCT00203892|10838286|FG001|NOT COMPLETED|Overall Study||2
9737453|NCT00203892|10838287|FG002|NOT COMPLETED|Overall Study||0
9737454|NCT00203931|10838297|FG000|STARTED|Overall Study||27
9737455|NCT00203931|10838298|FG001|STARTED|Overall Study||28
9737456|NCT00203931|10838297|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
9737457|NCT00203931|10838298|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
9737458|NCT00203931|10838297|FG000|NOT COMPLETED|Overall Study||7
9737459|NCT00203931|10838298|FG001|NOT COMPLETED|Overall Study||5
10088206|NCT02310750|11216996|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088207|NCT02310750|11216997|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0
10088208|NCT02310763|11217081|FG000|STARTED|Period 1 (Weeks 1 to 48)||41
10088209|NCT02310763|11217082|FG001|STARTED|Period 1 (Weeks 1 to 48)||39
10088210|NCT02310763|11217083|FG002|STARTED|Period 1 (Weeks 1 to 48)||40
10088211|NCT02310763|11217081|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38
10088212|NCT02310763|11217082|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37
10088213|NCT02310763|11217083|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38
10088214|NCT02310763|11217081|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
10088215|NCT02310763|11217082|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
10088216|NCT02310763|11217083|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
10088217|NCT02310763|11217081|FG000|STARTED|Period 2 (Weeks 49 to 96)||38
10088218|NCT02310763|11217082|FG001|STARTED|Period 2 (Weeks 49 to 96)||37
10088219|NCT02310763|11217083|FG002|STARTED|Period 2 (Weeks 49 to 96)||38
10088220|NCT02310763|11217081|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22
10088221|NCT02310763|11217082|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21
10088222|NCT02310763|11217083|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22
10088223|NCT02310763|11217081|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
10088224|NCT02310763|11217082|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
10088225|NCT02310763|11217083|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
10088226|NCT02310776|11217109|FG000|STARTED|Overall Study||501
10088227|NCT02310776|11217109|FG000|COMPLETED|Overall Study||501
10088228|NCT02310776|11217109|FG000|NOT COMPLETED|Overall Study||0
10088229|NCT02310789|11217113|FG000|STARTED|Overall Study||8
10088230|NCT02310789|11217113|FG000|COMPLETED|Overall Study||7
10088231|NCT02310789|11217113|FG000|NOT COMPLETED|Overall Study||1
10088232|NCT02310906|11217121|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
10088233|NCT02310906|11217122|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
10088234|NCT02310906|11217123|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
10088235|NCT02310906|11217124|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
10088236|NCT02310906|11217121|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088237|NCT02310906|11217122|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10088238|NCT02310906|11217123|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088239|NCT02310906|11217124|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088240|NCT02310906|11217121|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088241|NCT02310906|11217122|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10088242|NCT02310906|11217123|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088243|NCT02310906|11217124|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088244|NCT02310906|11217121|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088245|NCT02310906|11217122|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10088246|NCT02310906|11217123|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088247|NCT02310906|11217124|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088248|NCT02310906|11217121|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088249|NCT02310906|11217122|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10088250|NCT02310906|11217123|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088251|NCT02310906|11217124|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10088252|NCT02310906|11217121|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
10088253|NCT02310906|11217122|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
10088254|NCT02310906|11217123|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10088255|NCT02310906|11217124|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10088256|NCT02310906|11217121|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10088257|NCT02310906|11217122|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10088258|NCT02310906|11217123|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10088259|NCT02310906|11217124|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10088260|NCT02310906|11217121|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0
10088261|NCT02310906|11217122|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0
10112861|NCT02505919|11243755|FG001|NOT COMPLETED|12 Months Follow-Up||2
9737460|NCT00203996|10838314|FG000|STARTED|Overall Study||0
9852211|NCT00880048|10965024|FG000|NOT COMPLETED|Overall Study||28
9852212|NCT00880048|10965025|FG001|NOT COMPLETED|Overall Study||33
9852213|NCT00880048|10965026|FG002|NOT COMPLETED|Overall Study||35
9852214|NCT00880087|10965036|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
9852215|NCT00880087|10965037|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
9852216|NCT00880087|10965036|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
9852217|NCT00880087|10965037|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
9852218|NCT00880087|10965036|FG000|NOT COMPLETED|Overall Study||0
9852219|NCT00880087|10965037|FG001|NOT COMPLETED|Overall Study||2
9852220|NCT00880100|10965043|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
9852221|NCT00880100|10965043|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
9852222|NCT00880100|10965043|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
10088262|NCT02310906|11217123|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
10088263|NCT02310906|11217124|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14
10088264|NCT02310906|11217121|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10088265|NCT02310906|11217122|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10088266|NCT02310906|11217123|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
10088267|NCT02310906|11217124|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
10088268|NCT02310906|11217121|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10088269|NCT02310906|11217122|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10088270|NCT02310906|11217123|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
10088271|NCT02310906|11217124|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
10088272|NCT02311153|11217147|FG000|STARTED|Overall Study||53
10088273|NCT02311153|11217148|FG001|STARTED|Overall Study||49
10088274|NCT02311153|11217147|FG000|COMPLETED|Overall Study||48
10088275|NCT02311153|11217148|FG001|COMPLETED|Overall Study||42
10088276|NCT02311153|11217147|FG000|NOT COMPLETED|Overall Study||5
10088277|NCT02311153|11217148|FG001|NOT COMPLETED|Overall Study||7
10088278|NCT02311309|11217157|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
10088279|NCT02311309|11217158|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
10088280|NCT02311309|11217159|FG002|STARTED|Overall Study||863
10088281|NCT02311309|11217157|FG000|COMPLETED|Overall Study||541
10088282|NCT02311309|11217158|FG001|COMPLETED|Overall Study||35
10088283|NCT02311309|11217159|FG002|COMPLETED|Overall Study||863
10088284|NCT02311309|11217157|FG000|NOT COMPLETED|Overall Study||0
10088285|NCT02311309|11217158|FG001|NOT COMPLETED|Overall Study||0
10088286|NCT02311309|11217159|FG002|NOT COMPLETED|Overall Study||0
10088287|NCT02311361|11217171|FG000|STARTED|Overall Study||14
10088288|NCT02311361|11217172|FG001|STARTED|Overall Study||11
10088289|NCT02311361|11217173|FG002|STARTED|Overall Study||19
10088290|NCT02311361|11217174|FG003|STARTED|Overall Study||21
10088291|NCT02311361|11217171|FG000|Received Radiation Therapy Only|Overall Study||0
10088292|NCT02311361|11217172|FG001|Received Radiation Therapy Only|Overall Study||1
10088293|NCT02311361|11217173|FG002|Received Radiation Therapy Only|Overall Study||1
10088294|NCT02311361|11217174|FG003|Received Radiation Therapy Only|Overall Study||1
10088295|NCT02311361|11217171|FG000|COMPLETED|Overall Study||14
10088296|NCT02311361|11217172|FG001|COMPLETED|Overall Study||10
10088297|NCT02311361|11217173|FG002|COMPLETED|Overall Study||19
10088298|NCT02311361|11217174|FG003|COMPLETED|Overall Study||20
10088299|NCT02311361|11217171|FG000|NOT COMPLETED|Overall Study||0
10088300|NCT02311361|11217172|FG001|NOT COMPLETED|Overall Study||1
10088301|NCT02311361|11217173|FG002|NOT COMPLETED|Overall Study||0
10088302|NCT02311361|11217174|FG003|NOT COMPLETED|Overall Study||1
10088307|NCT02311881|11217195|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235
10088308|NCT02311881|11217196|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236
10088309|NCT02311881|11217197|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237
10088310|NCT02311881|11217195|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
10088311|NCT02311881|11217196|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
10088312|NCT02311881|11217197|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
10088313|NCT02311881|11217195|FG000|COMPLETED|Overall Study||200
10088314|NCT02311881|11217196|FG001|COMPLETED|Overall Study||193
10088315|NCT02311881|11217197|FG002|COMPLETED|Overall Study||196
10088316|NCT02311881|11217195|FG000|NOT COMPLETED|Overall Study||35
10088317|NCT02311881|11217196|FG001|NOT COMPLETED|Overall Study||43
10088318|NCT02311881|11217197|FG002|NOT COMPLETED|Overall Study||41
10088319|NCT02311894|11217208|FG000|STARTED|Overall Study||82
10088320|NCT02311894|11217208|FG000|Modified ITT Population|Overall Study||81
10088321|NCT02311894|11217208|FG000|COMPLETED|Overall Study||78
10088322|NCT02311894|11217208|FG000|NOT COMPLETED|Overall Study||4
10088323|NCT02311907|11217214|FG000|STARTED|Overall Study||94
10088324|NCT02311907|11217215|FG001|STARTED|Overall Study||91
10088325|NCT02311907|11217214|FG000|COMPLETED|Overall Study||94
10088326|NCT02311907|11217215|FG001|COMPLETED|Overall Study||91
10088327|NCT02311907|11217214|FG000|NOT COMPLETED|Overall Study||0
10088328|NCT02311907|11217215|FG001|NOT COMPLETED|Overall Study||0
10088329|NCT02311933|11217223|FG000|STARTED|Overall Study||41
10088330|NCT02311933|11217224|FG001|STARTED|Overall Study||40
10088331|NCT02311933|11217223|FG000|COMPLETED|Overall Study||41
10088332|NCT02311933|11217224|FG001|COMPLETED|Overall Study||40
10088333|NCT02311933|11217223|FG000|NOT COMPLETED|Overall Study||0
10088334|NCT02311933|11217224|FG001|NOT COMPLETED|Overall Study||0
10088335|NCT02311972|11217232|FG000|STARTED|Overall Study||12
10088336|NCT02311972|11217233|FG001|STARTED|Overall Study||8
10088337|NCT02311972|11217232|FG000|COMPLETED|Overall Study||12
10088338|NCT02311972|11217233|FG001|COMPLETED|Overall Study||8
10088339|NCT02311972|11217232|FG000|NOT COMPLETED|Overall Study||0
10088340|NCT02311972|11217233|FG001|NOT COMPLETED|Overall Study||0
10088341|NCT02312063|11217242|FG000|STARTED|Overall Study||23
10088342|NCT02312063|11217243|FG001|STARTED|Overall Study||25
10088343|NCT02312063|11217242|FG000|COMPLETED|Overall Study||23
10088344|NCT02312063|11217243|FG001|COMPLETED|Overall Study||24
10088345|NCT02312063|11217242|FG000|NOT COMPLETED|Overall Study||0
10088346|NCT02312063|11217243|FG001|NOT COMPLETED|Overall Study||1
10088347|NCT02312154|11217250|FG000|STARTED|Overall Study||25
10088348|NCT02312154|11217250|FG000|COMPLETED|Overall Study||24
10088349|NCT02312154|11217250|FG000|NOT COMPLETED|Overall Study||1
10088350|NCT02312206|11217257|FG000|STARTED|Overall Study||130
10088351|NCT02312206|11217258|FG001|STARTED|Overall Study||130
10088352|NCT02312206|11217257|FG000|Informed Consent Obtained|Overall Study||130
10088353|NCT02312206|11217258|FG001|Informed Consent Obtained|Overall Study||130
10088354|NCT02312206|11217257|FG000|COMPLETED|Overall Study||0
10088355|NCT02312206|11217258|FG001|COMPLETED|Overall Study||0
10088356|NCT02312206|11217257|FG000|NOT COMPLETED|Overall Study||130
10088357|NCT02312206|11217258|FG001|NOT COMPLETED|Overall Study||130
10088358|NCT02312219|11217266|FG000|STARTED|Overall Study||13
10088359|NCT02312219|11217267|FG001|STARTED|Overall Study||22
10088360|NCT02312219|11217266|FG000|COMPLETED|Overall Study||12
10088361|NCT02312219|11217267|FG001|COMPLETED|Overall Study||16
10088362|NCT02312219|11217266|FG000|NOT COMPLETED|Overall Study||1
10201401|NCT03433794|11328766|FG002|NOT COMPLETED|2-Week Assessment||72
10201402|NCT03433794|11328764|FG000|STARTED|4-Week Assessment||183
10201403|NCT03433794|11328765|FG001|STARTED|4-Week Assessment||173
10201404|NCT03433794|11328766|FG002|STARTED|4-Week Assessment||181
10201405|NCT03433794|11328764|FG000|COMPLETED|4-Week Assessment||98
10201406|NCT03433794|11328765|FG001|COMPLETED|4-Week Assessment||95
10201407|NCT03433794|11328766|FG002|COMPLETED|4-Week Assessment||91
10201408|NCT03433794|11328764|FG000|NOT COMPLETED|4-Week Assessment||85
10201409|NCT03433794|11328765|FG001|NOT COMPLETED|4-Week Assessment||78
10201410|NCT03433794|11328766|FG002|NOT COMPLETED|4-Week Assessment||90
10201411|NCT03433794|11328764|FG000|STARTED|6-Week Assessment||183
10201412|NCT03433794|11328765|FG001|STARTED|6-Week Assessment||173
10201413|NCT03433794|11328766|FG002|STARTED|6-Week Assessment||181
10201414|NCT03433794|11328764|FG000|COMPLETED|6-Week Assessment||94
10201415|NCT03433794|11328765|FG001|COMPLETED|6-Week Assessment||85
10201416|NCT03433794|11328766|FG002|COMPLETED|6-Week Assessment||80
10201417|NCT03433794|11328764|FG000|NOT COMPLETED|6-Week Assessment||89
10201418|NCT03433794|11328765|FG001|NOT COMPLETED|6-Week Assessment||88
10201419|NCT03433794|11328766|FG002|NOT COMPLETED|6-Week Assessment||101
10201420|NCT03433794|11328764|FG000|STARTED|3-Month Assessment||183
10201421|NCT03433794|11328765|FG001|STARTED|3-Month Assessment||173
10201422|NCT03433794|11328766|FG002|STARTED|3-Month Assessment||181
10201423|NCT03433794|11328764|FG000|COMPLETED|3-Month Assessment||69
10201424|NCT03433794|11328765|FG001|COMPLETED|3-Month Assessment||73
10201425|NCT03433794|11328766|FG002|COMPLETED|3-Month Assessment||71
10201426|NCT03433794|11328764|FG000|NOT COMPLETED|3-Month Assessment||114
10201427|NCT03433794|11328765|FG001|NOT COMPLETED|3-Month Assessment||100
10201428|NCT03433794|11328766|FG002|NOT COMPLETED|3-Month Assessment||110
10201429|NCT03433794|11328764|FG000|STARTED|6-Month Assessment||183
10201430|NCT03433794|11328765|FG001|STARTED|6-Month Assessment||173
10201431|NCT03433794|11328766|FG002|STARTED|6-Month Assessment||181
10201432|NCT03433794|11328764|FG000|COMPLETED|6-Month Assessment||65
10201433|NCT03433794|11328765|FG001|COMPLETED|6-Month Assessment||58
10201434|NCT03433794|11328766|FG002|COMPLETED|6-Month Assessment||50
10201435|NCT03433794|11328764|FG000|NOT COMPLETED|6-Month Assessment||118
10201436|NCT03433794|11328765|FG001|NOT COMPLETED|6-Month Assessment||115
10201437|NCT03433794|11328766|FG002|NOT COMPLETED|6-Month Assessment||131
10201438|NCT03433794|11328764|FG000|STARTED|9-Month Assessment||183
10201439|NCT03433794|11328765|FG001|STARTED|9-Month Assessment||173
10201440|NCT03433794|11328766|FG002|STARTED|9-Month Assessment||181
10201441|NCT03433794|11328764|FG000|COMPLETED|9-Month Assessment||49
10201442|NCT03433794|11328765|FG001|COMPLETED|9-Month Assessment||52
10201443|NCT03433794|11328766|FG002|COMPLETED|9-Month Assessment||39
10088363|NCT02312219|11217267|FG001|NOT COMPLETED|Overall Study||6
10088364|NCT02312310|11217277|FG000|STARTED|Overall Study||53
10201444|NCT03433794|11328764|FG000|NOT COMPLETED|9-Month Assessment||134
10088365|NCT02312310|11217278|FG001|STARTED|Overall Study||53
10088366|NCT02312310|11217279|FG002|STARTED|Overall Study||53
10088367|NCT02312310|11217280|FG003|STARTED|Overall Study||52
10088368|NCT02312310|11217277|FG000|COMPLETED|Overall Study||51
10201445|NCT03433794|11328765|FG001|NOT COMPLETED|9-Month Assessment||121
10201446|NCT03433794|11328766|FG002|NOT COMPLETED|9-Month Assessment||142
10201447|NCT03434249|11328776|FG000|STARTED|Overall Study||40
10201448|NCT03434249|11328777|FG001|STARTED|Overall Study||40
9737461|NCT00203996|10838315|FG001|STARTED|Overall Study||0
9737462|NCT00203996|10838316|FG002|STARTED|Overall Study||0
9737463|NCT00203996|10838317|FG003|STARTED|Overall Study||19
9737464|NCT00203996|10838318|FG004|STARTED|Overall Study||4
9737465|NCT00203996|10838319|FG005|STARTED|Overall Study||3
9737466|NCT00203996|10838320|FG006|STARTED|Overall Study||2
9737467|NCT00203996|10838321|FG007|STARTED|Overall Study||4
9737468|NCT00203996|10838322|FG008|STARTED|Overall Study||2
9737469|NCT00203996|10838323|FG009|STARTED|Overall Study||3
9737470|NCT00203996|10838314|FG000|Aim 3 Only: First Intervention|Overall Study||0
9737471|NCT00203996|10838315|FG001|Aim 3 Only: First Intervention|Overall Study||0
9737472|NCT00203996|10838316|FG002|Aim 3 Only: First Intervention|Overall Study||0
9737473|NCT00203996|10838317|FG003|Aim 3 Only: First Intervention|Overall Study||0
9737474|NCT00203996|10838318|FG004|Aim 3 Only: First Intervention|Overall Study||0
9737475|NCT00203996|10838319|FG005|Aim 3 Only: First Intervention|Overall Study||3
10088369|NCT02312310|11217278|FG001|COMPLETED|Overall Study||51
10088370|NCT02312310|11217279|FG002|COMPLETED|Overall Study||50
10088371|NCT02312310|11217280|FG003|COMPLETED|Overall Study||52
10088372|NCT02312310|11217277|FG000|NOT COMPLETED|Overall Study||2
10088373|NCT02312310|11217278|FG001|NOT COMPLETED|Overall Study||2
10088374|NCT02312310|11217279|FG002|NOT COMPLETED|Overall Study||3
10088375|NCT02312310|11217280|FG003|NOT COMPLETED|Overall Study||0
10088376|NCT02312622|11217297|FG000|STARTED|Overall Study||12
10088377|NCT02312622|11217298|FG001|STARTED|Overall Study||3
10088378|NCT02312622|11217299|FG002|STARTED|Overall Study||12
10088379|NCT02312622|11217297|FG000|COMPLETED|Overall Study||12
10088380|NCT02312622|11217298|FG001|COMPLETED|Overall Study||3
10088381|NCT02312622|11217299|FG002|COMPLETED|Overall Study||12
10088382|NCT02312622|11217297|FG000|NOT COMPLETED|Overall Study||0
10088383|NCT02312622|11217298|FG001|NOT COMPLETED|Overall Study||0
10088384|NCT02312622|11217299|FG002|NOT COMPLETED|Overall Study||0
10088385|NCT02312687|11217310|FG000|STARTED|Overall Study||20
10088386|NCT02312687|11217310|FG000|COMPLETED|Overall Study||19
10088387|NCT02312687|11217310|FG000|NOT COMPLETED|Overall Study||1
10088388|NCT02312713|11217317|FG000|STARTED|Overall Study||140
10088389|NCT02312713|11217318|FG001|STARTED|Overall Study||142
10088390|NCT02312713|11217319|FG002|STARTED|Overall Study||68
10088391|NCT02312713|11217317|FG000|COMPLETED|Overall Study||129
10088392|NCT02312713|11217318|FG001|COMPLETED|Overall Study||112
10088393|NCT02312713|11217319|FG002|COMPLETED|Overall Study||63
10088394|NCT02312713|11217317|FG000|NOT COMPLETED|Overall Study||11
10088395|NCT02312713|11217318|FG001|NOT COMPLETED|Overall Study||30
10088396|NCT02312713|11217319|FG002|NOT COMPLETED|Overall Study||5
10088397|NCT02312726|11217327|FG000|STARTED|Overall Study||38
10088398|NCT02312726|11217328|FG001|STARTED|Overall Study||30
10088399|NCT02312726|11217329|FG002|STARTED|Overall Study||67
10088400|NCT02312726|11217327|FG000|COMPLETED|Overall Study||38
10088401|NCT02312726|11217328|FG001|COMPLETED|Overall Study||30
10088402|NCT02312726|11217329|FG002|COMPLETED|Overall Study||0
10088403|NCT02312726|11217327|FG000|NOT COMPLETED|Overall Study||0
10088404|NCT02312726|11217328|FG001|NOT COMPLETED|Overall Study||0
10088405|NCT02312726|11217329|FG002|NOT COMPLETED|Overall Study||67
10088406|NCT02312739|11217338|FG000|STARTED|Overall Study||36
10088407|NCT02312739|11217339|FG001|STARTED|Overall Study||36
10088408|NCT02312739|11217338|FG000|Withdrawn Prior to Procedure|Overall Study||6
10088409|NCT02312739|11217339|FG001|Withdrawn Prior to Procedure|Overall Study||2
10088410|NCT02312739|11217338|FG000|COMPLETED|Overall Study||30
10088411|NCT02312739|11217339|FG001|COMPLETED|Overall Study||34
10088412|NCT02312739|11217338|FG000|NOT COMPLETED|Overall Study||6
10088413|NCT02312739|11217339|FG001|NOT COMPLETED|Overall Study||2
10088414|NCT02312765|11217347|FG000|STARTED|Overall Study||74
10088415|NCT02312765|11217348|FG001|STARTED|Overall Study||72
10088416|NCT02312765|11217347|FG000|COMPLETED|Overall Study||19
10088417|NCT02312765|11217348|FG001|COMPLETED|Overall Study||36
10088418|NCT02312765|11217347|FG000|NOT COMPLETED|Overall Study||55
10088419|NCT02312765|11217348|FG001|NOT COMPLETED|Overall Study||36
10088420|NCT02312856|11217354|FG000|STARTED|Overall Study||34
10088421|NCT02312856|11217354|FG000|COMPLETED|Overall Study||30
10088422|NCT02312856|11217354|FG000|NOT COMPLETED|Overall Study||4
10088423|NCT02312882|11217358|FG000|STARTED|Overall Study||40
10088424|NCT02312882|11217358|FG000|COMPLETED|Overall Study||36
10088425|NCT02312882|11217358|FG000|NOT COMPLETED|Overall Study||4
10088426|NCT02312934|11217364|FG000|STARTED|Overall Study||11
10088427|NCT02312934|11217365|FG001|STARTED|Overall Study||11
10088428|NCT02312934|11217364|FG000|COMPLETED|Overall Study||9
10088429|NCT02312934|11217365|FG001|COMPLETED|Overall Study||11
9737476|NCT00203996|10838320|FG006|Aim 3 Only: First Intervention|Overall Study||2
9737477|NCT00203996|10838321|FG007|Aim 3 Only: First Intervention|Overall Study||4
9737478|NCT00203996|10838322|FG008|Aim 3 Only: First Intervention|Overall Study||2
9737479|NCT00203996|10838323|FG009|Aim 3 Only: First Intervention|Overall Study||3
9737480|NCT00203996|10838314|FG000|Aim 3 Only: Washout|Overall Study||0
9737481|NCT00203996|10838315|FG001|Aim 3 Only: Washout|Overall Study||0
10088430|NCT02312934|11217364|FG000|NOT COMPLETED|Overall Study||2
10088431|NCT02312934|11217365|FG001|NOT COMPLETED|Overall Study||0
10088432|NCT02312986|11217372|FG000|STARTED|Overall Study||1
9737482|NCT00203996|10838316|FG002|Aim 3 Only: Washout|Overall Study||0
10088433|NCT02312986|11217372|FG000|COMPLETED|Overall Study||1
10088434|NCT02312986|11217372|FG000|NOT COMPLETED|Overall Study||0
10088435|NCT02313155|11217378|FG000|STARTED|Overall Study||55
10088436|NCT02313155|11217379|FG001|STARTED|Overall Study||55
10088437|NCT02313155|11217378|FG000|COMPLETED|Overall Study||55
9737483|NCT00203996|10838317|FG003|Aim 3 Only: Washout|Overall Study||0
9737484|NCT00203996|10838318|FG004|Aim 3 Only: Washout|Overall Study||0
9737485|NCT00203996|10838319|FG005|Aim 3 Only: Washout|Overall Study||3
9737486|NCT00203996|10838320|FG006|Aim 3 Only: Washout|Overall Study||2
9737487|NCT00203996|10838321|FG007|Aim 3 Only: Washout|Overall Study||2
9737488|NCT00203996|10838322|FG008|Aim 3 Only: Washout|Overall Study||2
9737489|NCT00203996|10838323|FG009|Aim 3 Only: Washout|Overall Study||2
9737490|NCT00203996|10838314|FG000|Aim 3 Only: Second Intervention|Overall Study||0
9737491|NCT00203996|10838315|FG001|Aim 3 Only: Second Intervention|Overall Study||0
9737492|NCT00203996|10838316|FG002|Aim 3 Only: Second Intervention|Overall Study||0
9737493|NCT00203996|10838317|FG003|Aim 3 Only: Second Intervention|Overall Study||0
9737494|NCT00203996|10838318|FG004|Aim 3 Only: Second Intervention|Overall Study||0
9737495|NCT00203996|10838319|FG005|Aim 3 Only: Second Intervention|Overall Study||3
9737496|NCT00203996|10838320|FG006|Aim 3 Only: Second Intervention|Overall Study||2
9737497|NCT00203996|10838321|FG007|Aim 3 Only: Second Intervention|Overall Study||2
9737498|NCT00203996|10838322|FG008|Aim 3 Only: Second Intervention|Overall Study||2
9737499|NCT00203996|10838323|FG009|Aim 3 Only: Second Intervention|Overall Study||2
9737500|NCT00203996|10838314|FG000|Aim 3 Only: Second Washout|Overall Study||0
9737501|NCT00203996|10838315|FG001|Aim 3 Only: Second Washout|Overall Study||0
9737502|NCT00203996|10838316|FG002|Aim 3 Only: Second Washout|Overall Study||0
9737503|NCT00203996|10838317|FG003|Aim 3 Only: Second Washout|Overall Study||0
9737504|NCT00203996|10838318|FG004|Aim 3 Only: Second Washout|Overall Study||0
9737505|NCT00203996|10838319|FG005|Aim 3 Only: Second Washout|Overall Study||3
9737506|NCT00203996|10838320|FG006|Aim 3 Only: Second Washout|Overall Study||2
9737507|NCT00203996|10838321|FG007|Aim 3 Only: Second Washout|Overall Study||2
9737508|NCT00203996|10838322|FG008|Aim 3 Only: Second Washout|Overall Study||2
9737509|NCT00203996|10838323|FG009|Aim 3 Only: Second Washout|Overall Study||2
9737510|NCT00203996|10838314|FG000|Aim 3 Only: Third Intervention|Overall Study||0
9737511|NCT00203996|10838315|FG001|Aim 3 Only: Third Intervention|Overall Study||0
9737512|NCT00203996|10838316|FG002|Aim 3 Only: Third Intervention|Overall Study||0
9737513|NCT00203996|10838317|FG003|Aim 3 Only: Third Intervention|Overall Study||0
9737514|NCT00203996|10838318|FG004|Aim 3 Only: Third Intervention|Overall Study||0
9737515|NCT00203996|10838319|FG005|Aim 3 Only: Third Intervention|Overall Study||3
9737516|NCT00203996|10838320|FG006|Aim 3 Only: Third Intervention|Overall Study||2
9737517|NCT00203996|10838321|FG007|Aim 3 Only: Third Intervention|Overall Study||2
9737518|NCT00203996|10838322|FG008|Aim 3 Only: Third Intervention|Overall Study||2
9737519|NCT00203996|10838323|FG009|Aim 3 Only: Third Intervention|Overall Study||2
9737520|NCT00203996|10838314|FG000|COMPLETED|Overall Study||0
10088438|NCT02313155|11217379|FG001|COMPLETED|Overall Study||54
10088439|NCT02313155|11217378|FG000|NOT COMPLETED|Overall Study||0
10088440|NCT02313155|11217379|FG001|NOT COMPLETED|Overall Study||1
10088441|NCT02313233|11217387|FG000|STARTED|Overall Study||20
10088442|NCT02313233|11217388|FG001|STARTED|Overall Study||21
10088443|NCT02313233|11217387|FG000|COMPLETED|Overall Study||18
10088444|NCT02313233|11217388|FG001|COMPLETED|Overall Study||18
10088445|NCT02313233|11217387|FG000|NOT COMPLETED|Overall Study||2
10088446|NCT02313233|11217388|FG001|NOT COMPLETED|Overall Study||3
10088447|NCT02313454|11217396|FG000|STARTED|Treatment 1||9
10088448|NCT02313454|11217397|FG001|STARTED|Treatment 1||11
10088449|NCT02313454|11217396|FG000|COMPLETED|Treatment 1||9
10088450|NCT02313454|11217397|FG001|COMPLETED|Treatment 1||11
10088451|NCT02313454|11217396|FG000|NOT COMPLETED|Treatment 1||0
10088452|NCT02313454|11217397|FG001|NOT COMPLETED|Treatment 1||0
10088453|NCT02313454|11217396|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8
10088454|NCT02313454|11217397|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10
10088455|NCT02313454|11217396|FG000|COMPLETED|Treatment 2||8
10088456|NCT02313454|11217397|FG001|COMPLETED|Treatment 2||10
10088457|NCT02313454|11217396|FG000|NOT COMPLETED|Treatment 2||0
10088458|NCT02313454|11217397|FG001|NOT COMPLETED|Treatment 2||0
10088459|NCT02313506|11217405|FG000|STARTED|Overall Study||17
10088460|NCT02313506|11217406|FG001|STARTED|Overall Study||17
10088461|NCT02313506|11217405|FG000|COMPLETED|Overall Study||17
10088462|NCT02313506|11217406|FG001|COMPLETED|Overall Study||17
10088463|NCT02313506|11217405|FG000|NOT COMPLETED|Overall Study||0
10088464|NCT02313506|11217406|FG001|NOT COMPLETED|Overall Study||0
10088465|NCT02313558|11217415|FG000|STARTED|Overall Study||50
10088466|NCT02313558|11217416|FG001|STARTED|Overall Study||50
10088467|NCT02313558|11217415|FG000|COMPLETED|Overall Study||44
10088468|NCT02313558|11217416|FG001|COMPLETED|Overall Study||46
10088469|NCT02313558|11217415|FG000|NOT COMPLETED|Overall Study||6
10088470|NCT02313558|11217416|FG001|NOT COMPLETED|Overall Study||4
10088471|NCT02313597|11217424|FG000|STARTED|Overall Study||40
10088472|NCT02313597|11217425|FG001|STARTED|Overall Study||40
10088473|NCT02313597|11217424|FG000|COMPLETED|Overall Study||40
10088474|NCT02313597|11217425|FG001|COMPLETED|Overall Study||40
10088475|NCT02313597|11217424|FG000|NOT COMPLETED|Overall Study||0
10088476|NCT02313597|11217425|FG001|NOT COMPLETED|Overall Study||0
10088477|NCT02313675|11217435|FG000|STARTED|Overall Study||11
10088478|NCT02313675|11217436|FG001|STARTED|Overall Study||11
10088479|NCT02313675|11217437|FG002|STARTED|Overall Study||11
10088480|NCT02313675|11217438|FG003|STARTED|Overall Study||11
10088481|NCT02313675|11217435|FG000|COMPLETED|Overall Study||11
10088482|NCT02313675|11217436|FG001|COMPLETED|Overall Study||11
10088483|NCT02313675|11217437|FG002|COMPLETED|Overall Study||11
10088484|NCT02313675|11217438|FG003|COMPLETED|Overall Study||11
10088485|NCT02313675|11217435|FG000|NOT COMPLETED|Overall Study||0
10088486|NCT02313675|11217436|FG001|NOT COMPLETED|Overall Study||0
10088487|NCT02313675|11217437|FG002|NOT COMPLETED|Overall Study||0
10088488|NCT02313675|11217438|FG003|NOT COMPLETED|Overall Study||0
10088489|NCT02313766|11217451|FG000|STARTED|Overall Study||50
10088490|NCT02313766|11217452|FG001|STARTED|Overall Study||50
10088491|NCT02313766|11217453|FG002|STARTED|Overall Study||50
10088492|NCT02313766|11217451|FG000|COMPLETED|Overall Study||49
10088493|NCT02313766|11217452|FG001|COMPLETED|Overall Study||47
10088494|NCT02313766|11217453|FG002|COMPLETED|Overall Study||50
10088495|NCT02313766|11217451|FG000|NOT COMPLETED|Overall Study||1
10088496|NCT02313766|11217452|FG001|NOT COMPLETED|Overall Study||3
10088497|NCT02313766|11217453|FG002|NOT COMPLETED|Overall Study||0
10088498|NCT02313909|11217463|FG000|STARTED|Overall Study||3609
10088499|NCT02313909|11217464|FG001|STARTED|Overall Study||3604
10088500|NCT02313909|11217463|FG000|Treated|Overall Study||3562
10088501|NCT02313909|11217464|FG001|Treated|Overall Study||3559
10088502|NCT02313909|11217463|FG000|COMPLETED|Overall Study||3552
10088503|NCT02313909|11217464|FG001|COMPLETED|Overall Study||3554
10088504|NCT02313909|11217463|FG000|NOT COMPLETED|Overall Study||57
10088505|NCT02313909|11217464|FG001|NOT COMPLETED|Overall Study||50
10088506|NCT02314000|11217472|FG000|STARTED|Overall Study||75
10088507|NCT02314000|11217473|FG001|STARTED|Overall Study||65
10088508|NCT02314000|11217472|FG000|COMPLETED|Overall Study||62
10088509|NCT02314000|11217473|FG001|COMPLETED|Overall Study||57
10088510|NCT02314000|11217472|FG000|NOT COMPLETED|Overall Study||13
10088511|NCT02314000|11217473|FG001|NOT COMPLETED|Overall Study||8
10088512|NCT02314026|11217480|FG000|STARTED|Overall Study||135
10088513|NCT02314026|11217480|FG000|COMPLETED|Overall Study||107
10088514|NCT02314026|11217480|FG000|NOT COMPLETED|Overall Study||28
10088515|NCT02314052|11217484|FG000|STARTED|Cycle One||3
10088516|NCT02314052|11217485|FG001|STARTED|Cycle One||3
10088517|NCT02314052|11217486|FG002|STARTED|Cycle One||3
10088518|NCT02314052|11217487|FG003|STARTED|Cycle One||3
10088519|NCT02314052|11217488|FG004|STARTED|Cycle One||6
10088520|NCT02314052|11217489|FG005|STARTED|Cycle One||3
10088521|NCT02314052|11217484|FG000|COMPLETED|Cycle One||3
10088522|NCT02314052|11217485|FG001|COMPLETED|Cycle One||3
10088523|NCT02314052|11217486|FG002|COMPLETED|Cycle One||3
10088524|NCT02314052|11217487|FG003|COMPLETED|Cycle One||2
10088525|NCT02314052|11217488|FG004|COMPLETED|Cycle One||6
10088526|NCT02314052|11217489|FG005|COMPLETED|Cycle One||3
10088527|NCT02314052|11217484|FG000|NOT COMPLETED|Cycle One||0
10088528|NCT02314052|11217485|FG001|NOT COMPLETED|Cycle One||0
10088529|NCT02314052|11217486|FG002|NOT COMPLETED|Cycle One||0
10088530|NCT02314052|11217487|FG003|NOT COMPLETED|Cycle One||1
10088531|NCT02314052|11217488|FG004|NOT COMPLETED|Cycle One||0
10088532|NCT02314052|11217489|FG005|NOT COMPLETED|Cycle One||0
10088533|NCT02314052|11217484|FG000|STARTED|Cycle Two||3
10088534|NCT02314052|11217485|FG001|STARTED|Cycle Two||3
10088535|NCT02314052|11217486|FG002|STARTED|Cycle Two||3
10088536|NCT02314052|11217487|FG003|STARTED|Cycle Two||2
10088537|NCT02314052|11217488|FG004|STARTED|Cycle Two||6
10088538|NCT02314052|11217489|FG005|STARTED|Cycle Two||3
10088539|NCT02314052|11217484|FG000|COMPLETED|Cycle Two||3
10088540|NCT02314052|11217485|FG001|COMPLETED|Cycle Two||2
10088541|NCT02314052|11217486|FG002|COMPLETED|Cycle Two||2
10088542|NCT02314052|11217487|FG003|COMPLETED|Cycle Two||1
10088543|NCT02314052|11217488|FG004|COMPLETED|Cycle Two||2
10088544|NCT02314052|11217489|FG005|COMPLETED|Cycle Two||3
10088545|NCT02314052|11217484|FG000|NOT COMPLETED|Cycle Two||0
10088546|NCT02314052|11217485|FG001|NOT COMPLETED|Cycle Two||1
10088547|NCT02314052|11217486|FG002|NOT COMPLETED|Cycle Two||1
10088548|NCT02314052|11217487|FG003|NOT COMPLETED|Cycle Two||1
10088549|NCT02314052|11217488|FG004|NOT COMPLETED|Cycle Two||4
10088550|NCT02314052|11217489|FG005|NOT COMPLETED|Cycle Two||0
10088551|NCT02314052|11217484|FG000|STARTED|Cycle Three||3
10088552|NCT02314052|11217485|FG001|STARTED|Cycle Three||2
10088553|NCT02314052|11217486|FG002|STARTED|Cycle Three||2
10088554|NCT02314052|11217487|FG003|STARTED|Cycle Three||1
10088555|NCT02314052|11217488|FG004|STARTED|Cycle Three||2
10088556|NCT02314052|11217489|FG005|STARTED|Cycle Three||3
10088557|NCT02314052|11217484|FG000|COMPLETED|Cycle Three||3
10088558|NCT02314052|11217485|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
10088559|NCT02314052|11217486|FG002|COMPLETED|Cycle Three||2
10088560|NCT02314052|11217487|FG003|COMPLETED|Cycle Three||1
10088561|NCT02314052|11217488|FG004|COMPLETED|Cycle Three||2
10088562|NCT02314052|11217489|FG005|COMPLETED|Cycle Three||3
10088563|NCT02314052|11217484|FG000|NOT COMPLETED|Cycle Three||0
10088564|NCT02314052|11217485|FG001|NOT COMPLETED|Cycle Three||0
10088565|NCT02314052|11217486|FG002|NOT COMPLETED|Cycle Three||0
10088566|NCT02314052|11217487|FG003|NOT COMPLETED|Cycle Three||0
10088567|NCT02314052|11217488|FG004|NOT COMPLETED|Cycle Three||0
10088568|NCT02314052|11217489|FG005|NOT COMPLETED|Cycle Three||0
10088569|NCT02314052|11217484|FG000|STARTED|Cycle Four||3
10088570|NCT02314052|11217485|FG001|STARTED|Cycle Four||2
10088571|NCT02314052|11217486|FG002|STARTED|Cycle Four||2
10088572|NCT02314052|11217487|FG003|STARTED|Cycle Four||1
10088573|NCT02314052|11217488|FG004|STARTED|Cycle Four||2
10088574|NCT02314052|11217489|FG005|STARTED|Cycle Four||3
10088575|NCT02314052|11217484|FG000|COMPLETED|Cycle Four||0
10088576|NCT02314052|11217485|FG001|COMPLETED|Cycle Four||2
10088577|NCT02314052|11217486|FG002|COMPLETED|Cycle Four||1
10088578|NCT02314052|11217487|FG003|COMPLETED|Cycle Four||0
10088579|NCT02314052|11217488|FG004|COMPLETED|Cycle Four||2
10088580|NCT02314052|11217489|FG005|COMPLETED|Cycle Four||0
10088581|NCT02314052|11217484|FG000|NOT COMPLETED|Cycle Four||3
9737521|NCT00203996|10838315|FG001|COMPLETED|Overall Study||0
9737522|NCT00203996|10838316|FG002|COMPLETED|Overall Study||0
9737523|NCT00203996|10838317|FG003|COMPLETED|Overall Study||9
9737524|NCT00203996|10838318|FG004|COMPLETED|Overall Study||3
9737525|NCT00203996|10838319|FG005|COMPLETED|Overall Study||3
10088582|NCT02314052|11217485|FG001|NOT COMPLETED|Cycle Four||0
10088583|NCT02314052|11217486|FG002|NOT COMPLETED|Cycle Four||1
10088584|NCT02314052|11217487|FG003|NOT COMPLETED|Cycle Four||1
10088585|NCT02314052|11217488|FG004|NOT COMPLETED|Cycle Four||0
10088586|NCT02314052|11217489|FG005|NOT COMPLETED|Cycle Four||3
10088587|NCT02314052|11217484|FG000|STARTED|Cycle Five||0
10088588|NCT02314052|11217485|FG001|STARTED|Cycle Five||2
10088589|NCT02314052|11217486|FG002|STARTED|Cycle Five||1
10088590|NCT02314052|11217487|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
10088591|NCT02314052|11217488|FG004|STARTED|Cycle Five||2
10088592|NCT02314052|11217489|FG005|STARTED|Cycle Five||0
10088593|NCT02314052|11217484|FG000|COMPLETED|Cycle Five||0
10088594|NCT02314052|11217485|FG001|COMPLETED|Cycle Five||0
10088595|NCT02314052|11217486|FG002|COMPLETED|Cycle Five||0
10088596|NCT02314052|11217487|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
10088597|NCT02314052|11217488|FG004|COMPLETED|Cycle Five||2
10088598|NCT02314052|11217489|FG005|COMPLETED|Cycle Five||0
10088599|NCT02314052|11217484|FG000|NOT COMPLETED|Cycle Five||0
10088600|NCT02314052|11217485|FG001|NOT COMPLETED|Cycle Five||2
10088601|NCT02314052|11217486|FG002|NOT COMPLETED|Cycle Five||1
10088602|NCT02314052|11217487|FG003|NOT COMPLETED|Cycle Five||0
10088603|NCT02314052|11217488|FG004|NOT COMPLETED|Cycle Five||0
10088604|NCT02314052|11217489|FG005|NOT COMPLETED|Cycle Five||0
10088605|NCT02314052|11217484|FG000|STARTED|Cycles 6 -10.5||0
10088606|NCT02314052|11217485|FG001|STARTED|Cycles 6 -10.5||0
10088607|NCT02314052|11217486|FG002|STARTED|Cycles 6 -10.5||0
10088608|NCT02314052|11217487|FG003|STARTED|Cycles 6 -10.5||1
10088609|NCT02314052|11217488|FG004|STARTED|Cycles 6 -10.5||2
10088610|NCT02314052|11217489|FG005|STARTED|Cycles 6 -10.5||0
10088611|NCT02314052|11217484|FG000|COMPLETED|Cycles 6 -10.5||0
10088612|NCT02314052|11217485|FG001|COMPLETED|Cycles 6 -10.5||0
10088613|NCT02314052|11217486|FG002|COMPLETED|Cycles 6 -10.5||0
10088614|NCT02314052|11217487|FG003|COMPLETED|Cycles 6 -10.5||1
10088615|NCT02314052|11217488|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
10088616|NCT02314052|11217489|FG005|COMPLETED|Cycles 6 -10.5||0
10088617|NCT02314052|11217484|FG000|NOT COMPLETED|Cycles 6 -10.5||0
10088618|NCT02314052|11217485|FG001|NOT COMPLETED|Cycles 6 -10.5||0
10088619|NCT02314052|11217486|FG002|NOT COMPLETED|Cycles 6 -10.5||0
10088620|NCT02314052|11217487|FG003|NOT COMPLETED|Cycles 6 -10.5||0
10088621|NCT02314052|11217488|FG004|NOT COMPLETED|Cycles 6 -10.5||0
10088622|NCT02314052|11217489|FG005|NOT COMPLETED|Cycles 6 -10.5||0
10088623|NCT02314104|11217506|FG000|STARTED|Overall Study||71
10088624|NCT02314104|11217507|FG001|STARTED|Overall Study||78
10088625|NCT02314104|11217508|FG002|STARTED|Overall Study||71
10088626|NCT02314104|11217506|FG000|COMPLETED|Overall Study||57
10088627|NCT02314104|11217507|FG001|COMPLETED|Overall Study||58
10201449|NCT03434249|11328776|FG000|COMPLETED|Overall Study||35
10201450|NCT03434249|11328777|FG001|COMPLETED|Overall Study||37
10201451|NCT03434249|11328776|FG000|NOT COMPLETED|Overall Study||5
10201452|NCT03434249|11328777|FG001|NOT COMPLETED|Overall Study||3
10201453|NCT03434457|11328783|FG000|STARTED|Overall Study||630
10201454|NCT03434457|11328783|FG000|COMPLETED|Overall Study||630
10201455|NCT03434457|11328783|FG000|NOT COMPLETED|Overall Study||0
10201456|NCT03434834|11328787|FG000|STARTED|Overall Study||53
10201457|NCT03434834|11328787|FG000|COMPLETED|Overall Study||37
9737526|NCT00203996|10838320|FG006|COMPLETED|Overall Study||2
10201458|NCT03434834|11328787|FG000|NOT COMPLETED|Overall Study||16
10201459|NCT03434977|11328793|FG000|STARTED|Intervention Period 1 (6 Days)||6
10201460|NCT03434977|11328794|FG001|STARTED|Intervention Period 1 (6 Days)||6
10201461|NCT03434977|11328793|FG000|COMPLETED|Intervention Period 1 (6 Days)||6
10201462|NCT03434977|11328794|FG001|COMPLETED|Intervention Period 1 (6 Days)||6
10201463|NCT03434977|11328793|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10201464|NCT03434977|11328794|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10201465|NCT03434977|11328793|FG000|STARTED|Washout Period (at Least 6 Days)||6
10201466|NCT03434977|11328794|FG001|STARTED|Washout Period (at Least 6 Days)||6
10201467|NCT03434977|11328793|FG000|COMPLETED|Washout Period (at Least 6 Days)||6
10201468|NCT03434977|11328794|FG001|COMPLETED|Washout Period (at Least 6 Days)||5
10201469|NCT03434977|11328793|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
10201470|NCT03434977|11328794|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
10201471|NCT03434977|11328793|FG000|STARTED|Intervention Period 2 (6 Days)||6
10201472|NCT03434977|11328794|FG001|STARTED|Intervention Period 2 (6 Days)||5
10201473|NCT03434977|11328793|FG000|COMPLETED|Intervention Period 2 (6 Days)||6
10201474|NCT03434977|11328794|FG001|COMPLETED|Intervention Period 2 (6 Days)||5
10201475|NCT03434977|11328793|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10201476|NCT03434977|11328794|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10088628|NCT02314104|11217508|FG002|COMPLETED|Overall Study||53
10088629|NCT02314104|11217506|FG000|NOT COMPLETED|Overall Study||14
10088630|NCT02314104|11217507|FG001|NOT COMPLETED|Overall Study||20
10201477|NCT03435055|11328800|FG000|STARTED|Screening||21
10088631|NCT02314104|11217508|FG002|NOT COMPLETED|Overall Study||18
10088632|NCT02314117|11217518|FG000|STARTED|Overall Study||326
9737527|NCT00203996|10838321|FG007|COMPLETED|Overall Study||2
10088633|NCT02314117|11217519|FG001|STARTED|Overall Study||319
10088634|NCT02314117|11217518|FG000|Received at Least One Dose of Study Drug|Overall Study||323
9737528|NCT00203996|10838322|FG008|COMPLETED|Overall Study||2
9737529|NCT00203996|10838323|FG009|COMPLETED|Overall Study||2
9737530|NCT00203996|10838314|FG000|NOT COMPLETED|Overall Study||0
9737531|NCT00203996|10838315|FG001|NOT COMPLETED|Overall Study||0
9737532|NCT00203996|10838316|FG002|NOT COMPLETED|Overall Study||0
9737533|NCT00203996|10838317|FG003|NOT COMPLETED|Overall Study||10
9737534|NCT00203996|10838318|FG004|NOT COMPLETED|Overall Study||1
9737535|NCT00203996|10838319|FG005|NOT COMPLETED|Overall Study||0
10088635|NCT02314117|11217519|FG001|Received at Least One Dose of Study Drug|Overall Study||315
10088636|NCT02314117|11217518|FG000|COMPLETED|Overall Study||314
10088637|NCT02314117|11217519|FG001|COMPLETED|Overall Study||303
10088638|NCT02314117|11217518|FG000|NOT COMPLETED|Overall Study||12
10088639|NCT02314117|11217519|FG001|NOT COMPLETED|Overall Study||16
10088640|NCT02314143|11217529|FG000|STARTED|Overall Study||16
10088641|NCT02314143|11217530|FG001|STARTED|Overall Study||16
10088642|NCT02314143|11217531|FG002|STARTED|Overall Study||16
10088643|NCT02314143|11217529|FG000|COMPLETED|Overall Study||8
10088644|NCT02314143|11217530|FG001|COMPLETED|Overall Study||6
10088645|NCT02314143|11217531|FG002|COMPLETED|Overall Study||7
10088646|NCT02314143|11217529|FG000|NOT COMPLETED|Overall Study||8
10088647|NCT02314143|11217530|FG001|NOT COMPLETED|Overall Study||10
10088648|NCT02314143|11217531|FG002|NOT COMPLETED|Overall Study||9
10088649|NCT02314247|11217542|FG000|STARTED|Overall Study||9
10088650|NCT02314247|11217543|FG001|STARTED|Overall Study||6
10088651|NCT02314247|11217544|FG002|STARTED|Overall Study||1
10088652|NCT02314247|11217542|FG000|COMPLETED|Overall Study||0
10088653|NCT02314247|11217543|FG001|COMPLETED|Overall Study||0
10088654|NCT02314247|11217544|FG002|COMPLETED|Overall Study||0
10088655|NCT02314247|11217542|FG000|NOT COMPLETED|Overall Study||9
10088656|NCT02314247|11217543|FG001|NOT COMPLETED|Overall Study||6
10088657|NCT02314247|11217544|FG002|NOT COMPLETED|Overall Study||1
10088658|NCT02314260|11217554|FG000|STARTED|Overall Study||80
10088659|NCT02314260|11217554|FG000|COMPLETED|Overall Study||80
10088660|NCT02314260|11217554|FG000|NOT COMPLETED|Overall Study||0
10088661|NCT02314403|11217558|FG000|STARTED|Overall Study||2
10088662|NCT02314403|11217558|FG000|COMPLETED|Overall Study||2
10088663|NCT02314403|11217558|FG000|NOT COMPLETED|Overall Study||0
10088664|NCT02314520|11217564|FG000|STARTED|Overall Study||72
10088665|NCT02314520|11217565|FG001|STARTED|Overall Study||80
10088666|NCT02314520|11217564|FG000|COMPLETED|Overall Study||72
10088667|NCT02314520|11217565|FG001|COMPLETED|Overall Study||80
10088668|NCT02314520|11217564|FG000|NOT COMPLETED|Overall Study||0
10088669|NCT02314520|11217565|FG001|NOT COMPLETED|Overall Study||0
10088670|NCT02314546|11217574|FG000|STARTED|Overall Study||5
10088671|NCT02314546|11217575|FG001|STARTED|Overall Study||5
10088672|NCT02314546|11217576|FG002|STARTED|Overall Study||5
10088673|NCT02314546|11217574|FG000|COMPLETED|Overall Study||5
10088674|NCT02314546|11217575|FG001|COMPLETED|Overall Study||5
10088675|NCT02314546|11217576|FG002|COMPLETED|Overall Study||5
10088676|NCT02314546|11217574|FG000|NOT COMPLETED|Overall Study||0
10088677|NCT02314546|11217575|FG001|NOT COMPLETED|Overall Study||0
10088678|NCT02314546|11217576|FG002|NOT COMPLETED|Overall Study||0
10088679|NCT02314598|11217585|FG000|STARTED|Overall Study||46
10088680|NCT02314598|11217585|FG000|COMPLETED|Overall Study||46
10088681|NCT02314598|11217585|FG000|NOT COMPLETED|Overall Study||0
10088682|NCT02314637|11217591|FG000|STARTED|Overall Study||151
10088683|NCT02314637|11217592|FG001|STARTED|Overall Study||89
10088684|NCT02314637|11217591|FG000|COMPLETED|Overall Study||135
10088685|NCT02314637|11217592|FG001|COMPLETED|Overall Study||75
10088686|NCT02314637|11217591|FG000|NOT COMPLETED|Overall Study||16
10088687|NCT02314637|11217592|FG001|NOT COMPLETED|Overall Study||14
10088688|NCT02314689|11217598|FG000|STARTED|Overall Study||4
10088689|NCT02314689|11217598|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
10088690|NCT02314689|11217598|FG000|NOT COMPLETED|Overall Study||0
10088691|NCT02314728|11217604|FG000|STARTED|Overall Study||117
10088692|NCT02314728|11217605|FG001|STARTED|Overall Study||113
10088693|NCT02314728|11217604|FG000|COMPLETED|Overall Study||116
10088694|NCT02314728|11217605|FG001|COMPLETED|Overall Study||112
10088695|NCT02314728|11217604|FG000|NOT COMPLETED|Overall Study||1
10088696|NCT02314728|11217605|FG001|NOT COMPLETED|Overall Study||1
10112862|NCT02505919|11243754|FG000|STARTED|24 Months Follow-Up||115
10112863|NCT02505919|11243755|FG001|STARTED|24 Months Follow-Up||61
10112864|NCT02505919|11243754|FG000|COMPLETED|24 Months Follow-Up||112
10112865|NCT02505919|11243755|FG001|COMPLETED|24 Months Follow-Up||60
10112866|NCT02505919|11243754|FG000|NOT COMPLETED|24 Months Follow-Up||3
10112867|NCT02505919|11243755|FG001|NOT COMPLETED|24 Months Follow-Up||1
10112868|NCT02505919|11243754|FG000|STARTED|36 Months Follow-Up||112
9737536|NCT00203996|10838320|FG006|NOT COMPLETED|Overall Study||0
10112869|NCT02505919|11243755|FG001|STARTED|36 Months Follow-Up||60
10112870|NCT02505919|11243754|FG000|COMPLETED|36 Months Follow-Up||97
10112871|NCT02505919|11243755|FG001|COMPLETED|36 Months Follow-Up||55
10112872|NCT02505919|11243754|FG000|NOT COMPLETED|36 Months Follow-Up||15
10112873|NCT02505919|11243755|FG001|NOT COMPLETED|36 Months Follow-Up||5
10112874|NCT02505945|11243763|FG000|STARTED|Overall Study||102
10112875|NCT02505945|11243764|FG001|STARTED|Overall Study||50
9737537|NCT00203996|10838321|FG007|NOT COMPLETED|Overall Study||2
10112876|NCT02505945|11243763|FG000|COMPLETED|Overall Study||80
10112877|NCT02505945|11243764|FG001|COMPLETED|Overall Study||46
10112878|NCT02505945|11243763|FG000|NOT COMPLETED|Overall Study||22
10112879|NCT02505945|11243764|FG001|NOT COMPLETED|Overall Study||4
10112880|NCT02506036|11243772|FG000|STARTED|First Intervention (4-6 Weeks)||3
9737538|NCT00203996|10838322|FG008|NOT COMPLETED|Overall Study||0
9737539|NCT00203996|10838323|FG009|NOT COMPLETED|Overall Study||1
9737540|NCT00204373|10838339|FG000|STARTED|Overall Study||72
9737541|NCT00204373|10838339|FG000|COMPLETED|Overall Study||72
9737542|NCT00204373|10838339|FG000|NOT COMPLETED|Overall Study||0
9737543|NCT00204932|10838345|FG000|STARTED|Overall Study||24
9737544|NCT00204932|10838346|FG001|STARTED|Overall Study||24
9737545|NCT00204932|10838345|FG000|COMPLETED|Overall Study||22
9737546|NCT00204932|10838346|FG001|COMPLETED|Overall Study||18
9737547|NCT00204932|10838345|FG000|NOT COMPLETED|Overall Study||2
9737548|NCT00204932|10838346|FG001|NOT COMPLETED|Overall Study||6
9737549|NCT00205179|10838354|FG000|STARTED|Overall Study||32
10088697|NCT02314780|11217616|FG000|STARTED|Overall Study||9
10088698|NCT02314780|11217617|FG001|STARTED|Overall Study||10
10088699|NCT02314780|11217618|FG002|STARTED|Overall Study||8
10088700|NCT02314780|11217616|FG000|COMPLETED|Overall Study||9
10088701|NCT02314780|11217617|FG001|COMPLETED|Overall Study||7
10088702|NCT02314780|11217618|FG002|COMPLETED|Overall Study||8
10088703|NCT02314780|11217616|FG000|NOT COMPLETED|Overall Study||0
10088704|NCT02314780|11217617|FG001|NOT COMPLETED|Overall Study||3
10088705|NCT02314780|11217618|FG002|NOT COMPLETED|Overall Study||0
10088706|NCT02314936|11217630|FG000|STARTED|Overall Study||48
10088707|NCT02314936|11217631|FG001|STARTED|Overall Study||48
10088708|NCT02314936|11217632|FG002|STARTED|Overall Study||48
10088709|NCT02314936|11217633|FG003|STARTED|Overall Study||48
10088710|NCT02314936|11217630|FG000|COMPLETED|Overall Study||48
10088711|NCT02314936|11217631|FG001|COMPLETED|Overall Study||48
10088712|NCT02314936|11217632|FG002|COMPLETED|Overall Study||46
10088713|NCT02314936|11217633|FG003|COMPLETED|Overall Study||48
10088714|NCT02314936|11217630|FG000|NOT COMPLETED|Overall Study||0
10088715|NCT02314936|11217631|FG001|NOT COMPLETED|Overall Study||0
10088716|NCT02314936|11217632|FG002|NOT COMPLETED|Overall Study||2
10088717|NCT02314936|11217633|FG003|NOT COMPLETED|Overall Study||0
10088718|NCT02315170|11217643|FG000|STARTED|Overall Study||50
10088719|NCT02315170|11217644|FG001|STARTED|Overall Study||50
10088720|NCT02315170|11217643|FG000|COMPLETED|Overall Study||50
10088721|NCT02315170|11217644|FG001|COMPLETED|Overall Study||50
10088722|NCT02315170|11217643|FG000|NOT COMPLETED|Overall Study||0
10088723|NCT02315170|11217644|FG001|NOT COMPLETED|Overall Study||0
10088724|NCT02315261|11217650|FG000|STARTED|Overall Study||364
10088725|NCT02315261|11217650|FG000|COMPLETED|Overall Study||364
10088726|NCT02315261|11217650|FG000|NOT COMPLETED|Overall Study||0
10088727|NCT02315352|11217656|FG000|STARTED|First Intervention (Day 1)||24
10088728|NCT02315352|11217657|FG001|STARTED|First Intervention (Day 1)||24
10088729|NCT02315352|11217658|FG002|STARTED|First Intervention (Day 1)||0
10088730|NCT02315352|11217659|FG003|STARTED|First Intervention (Day 1)||0
10088731|NCT02315352|11217660|FG004|STARTED|First Intervention (Day 1)||0
10088732|NCT02315352|11217661|FG005|STARTED|First Intervention (Day 1)||0
10088733|NCT02315352|11217662|FG006|STARTED|First Intervention (Day 1)||0
10088734|NCT02315352|11217663|FG007|STARTED|First Intervention (Day 1)||0
10088735|NCT02315352|11217656|FG000|COMPLETED|First Intervention (Day 1)||24
10088736|NCT02315352|11217657|FG001|COMPLETED|First Intervention (Day 1)||24
10088737|NCT02315352|11217658|FG002|COMPLETED|First Intervention (Day 1)||0
10088738|NCT02315352|11217659|FG003|COMPLETED|First Intervention (Day 1)||0
10088739|NCT02315352|11217660|FG004|COMPLETED|First Intervention (Day 1)||0
10088740|NCT02315352|11217661|FG005|COMPLETED|First Intervention (Day 1)||0
10088741|NCT02315352|11217662|FG006|COMPLETED|First Intervention (Day 1)||0
10088742|NCT02315352|11217663|FG007|COMPLETED|First Intervention (Day 1)||0
10088743|NCT02315352|11217656|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10088744|NCT02315352|11217657|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10088745|NCT02315352|11217658|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10088746|NCT02315352|11217659|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10088747|NCT02315352|11217660|FG004|NOT COMPLETED|First Intervention (Day 1)||0
10088748|NCT02315352|11217661|FG005|NOT COMPLETED|First Intervention (Day 1)||0
10088749|NCT02315352|11217662|FG006|NOT COMPLETED|First Intervention (Day 1)||0
10088750|NCT02315352|11217663|FG007|NOT COMPLETED|First Intervention (Day 1)||0
10088751|NCT02315352|11217656|FG000|STARTED|Second Intervention (Day 1)||24
10088752|NCT02315352|11217657|FG001|STARTED|Second Intervention (Day 1)||24
10201478|NCT03435055|11328800|FG000|COMPLETED|Screening||19
10201479|NCT03435055|11328800|FG000|NOT COMPLETED|Screening||2
10201480|NCT03435055|11328800|FG000|STARTED|Received Intervention||19
10201481|NCT03435055|11328800|FG000|COMPLETED|Received Intervention||16
10201482|NCT03435055|11328800|FG000|NOT COMPLETED|Received Intervention||3
10201483|NCT03435081|11328814|FG000|STARTED|Overall Study||147
10201484|NCT03435081|11328815|FG001|STARTED|Overall Study||147
10201485|NCT03435081|11328816|FG002|STARTED|Overall Study||146
10201486|NCT03435081|11328814|FG000|Received at Least One Dose of Study Drug|Overall Study||147
10201487|NCT03435081|11328815|FG001|Received at Least One Dose of Study Drug|Overall Study||147
10201488|NCT03435081|11328816|FG002|Received at Least One Dose of Study Drug|Overall Study||146
9737550|NCT00205179|10838355|FG001|STARTED|Overall Study||33
10088753|NCT02315352|11217658|FG002|STARTED|Second Intervention (Day 1)||0
10088754|NCT02315352|11217659|FG003|STARTED|Second Intervention (Day 1)||0
10201489|NCT03435081|11328814|FG000|COMPLETED|Overall Study||126
10201490|NCT03435081|11328815|FG001|COMPLETED|Overall Study||131
9737551|NCT00205179|10838354|FG000|COMPLETED|Overall Study||30
10201491|NCT03435081|11328816|FG002|COMPLETED|Overall Study||127
9737552|NCT00205179|10838355|FG001|COMPLETED|Overall Study||29
9737553|NCT00205179|10838354|FG000|NOT COMPLETED|Overall Study||2
9737554|NCT00205179|10838355|FG001|NOT COMPLETED|Overall Study||4
9737555|NCT00205348|10838362|FG000|STARTED|Overall Study||146
9737556|NCT00205348|10838362|FG000|COMPLETED|Overall Study||116
9737557|NCT00205348|10838362|FG000|NOT COMPLETED|Overall Study||30
9737558|NCT00205374|10838368|FG000|STARTED|Overall Study||10
9737559|NCT00205374|10838369|FG001|STARTED|Overall Study||9
9737560|NCT00205374|10838368|FG000|COMPLETED|Overall Study||10
9737561|NCT00205374|10838369|FG001|COMPLETED|Overall Study||9
9737562|NCT00205374|10838368|FG000|NOT COMPLETED|Overall Study||0
9737563|NCT00205374|10838369|FG001|NOT COMPLETED|Overall Study||0
9737564|NCT00205504|10838377|FG000|STARTED|Overall Study||21
9737565|NCT00205504|10838378|FG001|STARTED|Overall Study||15
9737566|NCT00205504|10838377|FG000|COMPLETED|Overall Study||14
9737567|NCT00205504|10838378|FG001|COMPLETED|Overall Study||15
9737568|NCT00205504|10838377|FG000|NOT COMPLETED|Overall Study||7
9737569|NCT00205504|10838378|FG001|NOT COMPLETED|Overall Study||0
9737570|NCT00205660|10838390|FG000|STARTED|Overall Study||14
9737571|NCT00205660|10838391|FG001|STARTED|Overall Study||37
9737572|NCT00205660|10838390|FG000|COMPLETED|Overall Study||12
9737573|NCT00205660|10838391|FG001|COMPLETED|Overall Study||35
9737574|NCT00205660|10838390|FG000|NOT COMPLETED|Overall Study||2
9737575|NCT00205660|10838391|FG001|NOT COMPLETED|Overall Study||2
9737576|NCT00205699|10838401|FG000|STARTED|Overall Study||49
9737577|NCT00205699|10838402|FG001|STARTED|Overall Study||46
9737578|NCT00205699|10838403|FG002|STARTED|Overall Study||49
9737579|NCT00205699|10838401|FG000|COMPLETED|Overall Study||46
9737580|NCT00205699|10838402|FG001|COMPLETED|Overall Study||40
9737581|NCT00205699|10838403|FG002|COMPLETED|Overall Study||43
9737582|NCT00205699|10838401|FG000|NOT COMPLETED|Overall Study||3
9737583|NCT00205699|10838402|FG001|NOT COMPLETED|Overall Study||6
9737584|NCT00205699|10838403|FG002|NOT COMPLETED|Overall Study||6
9737585|NCT00205712|10838416|FG000|STARTED|Overall Study||20
9737586|NCT00205712|10838417|FG001|STARTED|Overall Study||20
9737587|NCT00205712|10838416|FG000|COMPLETED|Overall Study||20
9737588|NCT00205712|10838417|FG001|COMPLETED|Overall Study||19
9737589|NCT00205712|10838416|FG000|NOT COMPLETED|Overall Study||0
9737590|NCT00205712|10838417|FG001|NOT COMPLETED|Overall Study||1
9737591|NCT00205777|10838429|FG000|STARTED|Core Study (Up to 3 Years)||1907
9737592|NCT00205777|10838430|FG001|STARTED|Core Study (Up to 3 Years)||1904
9737593|NCT00205777|10838431|FG002|STARTED|Core Study (Up to 3 Years)||1884
9737594|NCT00205777|10838432|FG003|STARTED|Core Study (Up to 3 Years)||1914
9737595|NCT00205777|10838433|FG004|STARTED|Core Study (Up to 3 Years)||0
9737596|NCT00205777|10838434|FG005|STARTED|Core Study (Up to 3 Years)||0
9737597|NCT00205777|10838429|FG000|TREATED|Core Study (Up to 3 Years)||1886
9737598|NCT00205777|10838430|FG001|TREATED|Core Study (Up to 3 Years)||1872
9737599|NCT00205777|10838431|FG002|TREATED|Core Study (Up to 3 Years)||1849
9737600|NCT00205777|10838432|FG003|TREATED|Core Study (Up to 3 Years)||1885
9737601|NCT00205777|10838433|FG004|TREATED|Core Study (Up to 3 Years)||0
9737602|NCT00205777|10838434|FG005|TREATED|Core Study (Up to 3 Years)||0
9737603|NCT00205777|10838429|FG000|COMPLETED|Core Study (Up to 3 Years)||1279
9737604|NCT00205777|10838430|FG001|COMPLETED|Core Study (Up to 3 Years)||1245
9737605|NCT00205777|10838431|FG002|COMPLETED|Core Study (Up to 3 Years)||1277
9737606|NCT00205777|10838432|FG003|COMPLETED|Core Study (Up to 3 Years)||1282
9737607|NCT00205777|10838433|FG004|COMPLETED|Core Study (Up to 3 Years)||0
9737608|NCT00205777|10838434|FG005|COMPLETED|Core Study (Up to 3 Years)||0
9737609|NCT00205777|10838429|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628
9737610|NCT00205777|10838430|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659
9737611|NCT00205777|10838431|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607
9737612|NCT00205777|10838432|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632
9737613|NCT00205777|10838433|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0
9737614|NCT00205777|10838434|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0
9737615|NCT00205777|10838429|FG000|STARTED|Completed Core Study, Entered SE I||1279
9737616|NCT00205777|10838430|FG001|STARTED|Completed Core Study, Entered SE I||1245
9737617|NCT00205777|10838431|FG002|STARTED|Completed Core Study, Entered SE I||1277
9737618|NCT00205777|10838432|FG003|STARTED|Completed Core Study, Entered SE I||1282
9737619|NCT00205777|10838433|FG004|STARTED|Completed Core Study, Entered SE I||0
9737620|NCT00205777|10838434|FG005|STARTED|Completed Core Study, Entered SE I||0
9737621|NCT00205777|10838429|FG000|COMPLETED|Completed Core Study, Entered SE I||1047
9737622|NCT00205777|10838430|FG001|COMPLETED|Completed Core Study, Entered SE I||1041
9737623|NCT00205777|10838431|FG002|COMPLETED|Completed Core Study, Entered SE I||1070
9737624|NCT00205777|10838432|FG003|COMPLETED|Completed Core Study, Entered SE I||1058
9737625|NCT00205777|10838433|FG004|COMPLETED|Completed Core Study, Entered SE I||0
9737626|NCT00205777|10838434|FG005|COMPLETED|Completed Core Study, Entered SE I||0
9737627|NCT00205777|10838429|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232
9737628|NCT00205777|10838430|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204
9737629|NCT00205777|10838431|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207
9737630|NCT00205777|10838432|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224
9737631|NCT00205777|10838433|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0
9737632|NCT00205777|10838434|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0
9737633|NCT00205777|10838429|FG000|STARTED|Study Extension I||1047
9852223|NCT00880100|10965043|FG000|STARTED|Treatment Phase With Ultrase® MT12||48
9737634|NCT00205777|10838430|FG001|STARTED|Study Extension I||0
9737635|NCT00205777|10838431|FG002|STARTED|Study Extension I||1070
9737636|NCT00205777|10838432|FG003|STARTED|Study Extension I||1058
9737637|NCT00205777|10838433|FG004|STARTED|Study Extension I||1041
9737638|NCT00205777|10838434|FG005|STARTED|Study Extension I||0
9737639|NCT00205777|10838429|FG000|COMPLETED|Study Extension I||833
9737640|NCT00205777|10838430|FG001|COMPLETED|Study Extension I||0
9737641|NCT00205777|10838431|FG002|COMPLETED|Study Extension I||0
9737642|NCT00205777|10838432|FG003|COMPLETED|Study Extension I||830
9737643|NCT00205777|10838433|FG004|COMPLETED|Study Extension I||840
9737644|NCT00205777|10838434|FG005|COMPLETED|Study Extension I||0
9737645|NCT00205777|10838429|FG000|NOT COMPLETED|Study Extension I||214
9737646|NCT00205777|10838430|FG001|NOT COMPLETED|Study Extension I||0
9737647|NCT00205777|10838431|FG002|NOT COMPLETED|Study Extension I||1070
9737648|NCT00205777|10838432|FG003|NOT COMPLETED|Study Extension I||228
9737649|NCT00205777|10838433|FG004|NOT COMPLETED|Study Extension I||201
9737650|NCT00205777|10838434|FG005|NOT COMPLETED|Study Extension I||0
9737651|NCT00205777|10838429|FG000|STARTED|Completed SE I, Entered Extension SE II||833
9737652|NCT00205777|10838430|FG001|STARTED|Completed SE I, Entered Extension SE II||0
9737653|NCT00205777|10838431|FG002|STARTED|Completed SE I, Entered Extension SE II||0
9737654|NCT00205777|10838432|FG003|STARTED|Completed SE I, Entered Extension SE II||830
9737655|NCT00205777|10838433|FG004|STARTED|Completed SE I, Entered Extension SE II||840
9737656|NCT00205777|10838434|FG005|STARTED|Completed SE I, Entered Extension SE II||0
9737657|NCT00205777|10838429|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560
9737658|NCT00205777|10838430|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0
9737659|NCT00205777|10838431|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0
9737660|NCT00205777|10838432|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590
9737661|NCT00205777|10838433|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582
9737662|NCT00205777|10838434|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0
9737663|NCT00205777|10838429|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
9737664|NCT00205777|10838430|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
9737665|NCT00205777|10838431|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
9737666|NCT00205777|10838432|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
9737667|NCT00205777|10838433|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
10088755|NCT02315352|11217660|FG004|STARTED|Second Intervention (Day 1)||0
10088756|NCT02315352|11217661|FG005|STARTED|Second Intervention (Day 1)||0
10088757|NCT02315352|11217662|FG006|STARTED|Second Intervention (Day 1)||0
10088758|NCT02315352|11217663|FG007|STARTED|Second Intervention (Day 1)||0
10088759|NCT02315352|11217656|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
10088760|NCT02315352|11217657|FG001|COMPLETED|Second Intervention (Day 1)||24
10088761|NCT02315352|11217658|FG002|COMPLETED|Second Intervention (Day 1)||0
10088762|NCT02315352|11217659|FG003|COMPLETED|Second Intervention (Day 1)||0
10088763|NCT02315352|11217660|FG004|COMPLETED|Second Intervention (Day 1)||0
10088764|NCT02315352|11217661|FG005|COMPLETED|Second Intervention (Day 1)||0
10088765|NCT02315352|11217662|FG006|COMPLETED|Second Intervention (Day 1)||0
10088766|NCT02315352|11217663|FG007|COMPLETED|Second Intervention (Day 1)||0
10088767|NCT02315352|11217656|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
10088768|NCT02315352|11217657|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
10088769|NCT02315352|11217658|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
10088770|NCT02315352|11217659|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
10088771|NCT02315352|11217660|FG004|NOT COMPLETED|Second Intervention (Day 1)||0
10088772|NCT02315352|11217661|FG005|NOT COMPLETED|Second Intervention (Day 1)||0
10088773|NCT02315352|11217662|FG006|NOT COMPLETED|Second Intervention (Day 1)||0
10088774|NCT02315352|11217663|FG007|NOT COMPLETED|Second Intervention (Day 1)||0
10088775|NCT02315352|11217656|FG000|STARTED|Third Intervention (Day 2)||0
10088776|NCT02315352|11217657|FG001|STARTED|Third Intervention (Day 2)||0
10088777|NCT02315352|11217658|FG002|STARTED|Third Intervention (Day 2)||7
10088778|NCT02315352|11217659|FG003|STARTED|Third Intervention (Day 2)||8
10088779|NCT02315352|11217660|FG004|STARTED|Third Intervention (Day 2)||8
10088780|NCT02315352|11217661|FG005|STARTED|Third Intervention (Day 2)||7
10088781|NCT02315352|11217662|FG006|STARTED|Third Intervention (Day 2)||9
10088782|NCT02315352|11217663|FG007|STARTED|Third Intervention (Day 2)||8
10088783|NCT02315352|11217656|FG000|COMPLETED|Third Intervention (Day 2)||0
10088784|NCT02315352|11217657|FG001|COMPLETED|Third Intervention (Day 2)||0
10088785|NCT02315352|11217658|FG002|COMPLETED|Third Intervention (Day 2)||7
10088786|NCT02315352|11217659|FG003|COMPLETED|Third Intervention (Day 2)||8
10088787|NCT02315352|11217660|FG004|COMPLETED|Third Intervention (Day 2)||8
10088788|NCT02315352|11217661|FG005|COMPLETED|Third Intervention (Day 2)||7
10088789|NCT02315352|11217662|FG006|COMPLETED|Third Intervention (Day 2)||9
10088790|NCT02315352|11217663|FG007|COMPLETED|Third Intervention (Day 2)||8
10088791|NCT02315352|11217656|FG000|NOT COMPLETED|Third Intervention (Day 2)||0
10088792|NCT02315352|11217657|FG001|NOT COMPLETED|Third Intervention (Day 2)||0
10088793|NCT02315352|11217658|FG002|NOT COMPLETED|Third Intervention (Day 2)||0
10088794|NCT02315352|11217659|FG003|NOT COMPLETED|Third Intervention (Day 2)||0
10088795|NCT02315352|11217660|FG004|NOT COMPLETED|Third Intervention (Day 2)||0
10088796|NCT02315352|11217661|FG005|NOT COMPLETED|Third Intervention (Day 2)||0
10088797|NCT02315352|11217662|FG006|NOT COMPLETED|Third Intervention (Day 2)||0
9737668|NCT00205777|10838434|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
10088798|NCT02315352|11217663|FG007|NOT COMPLETED|Third Intervention (Day 2)||0
10088799|NCT02315352|11217656|FG000|STARTED|Fourth Intervention (Day 2)||0
10088800|NCT02315352|11217657|FG001|STARTED|Fourth Intervention (Day 2)||0
10088801|NCT02315352|11217658|FG002|STARTED|Fourth Intervention (Day 2)||7
10088802|NCT02315352|11217659|FG003|STARTED|Fourth Intervention (Day 2)||8
9737669|NCT00205777|10838429|FG000|STARTED|Study Extension II||0
9737670|NCT00205777|10838430|FG001|STARTED|Study Extension II||0
9737671|NCT00205777|10838431|FG002|STARTED|Study Extension II||0
9737672|NCT00205777|10838432|FG003|STARTED|Study Extension II||590
9737673|NCT00205777|10838433|FG004|STARTED|Study Extension II||0
9737674|NCT00205777|10838434|FG005|STARTED|Study Extension II||1142
9737675|NCT00205777|10838429|FG000|TREATED|Study Extension II||0
9737676|NCT00205777|10838430|FG001|TREATED|Study Extension II||0
9737677|NCT00205777|10838431|FG002|TREATED|Study Extension II||0
9737678|NCT00205777|10838432|FG003|TREATED|Study Extension II||519
9737679|NCT00205777|10838433|FG004|TREATED|Study Extension II||0
9737680|NCT00205777|10838434|FG005|TREATED|Study Extension II||1011
9737681|NCT00205777|10838429|FG000|COMPLETED|Study Extension II||0
9737682|NCT00205777|10838430|FG001|COMPLETED|Study Extension II||0
9737683|NCT00205777|10838431|FG002|COMPLETED|Study Extension II||0
9737684|NCT00205777|10838432|FG003|COMPLETED|Study Extension II||441
9737685|NCT00205777|10838433|FG004|COMPLETED|Study Extension II||0
9737686|NCT00205777|10838434|FG005|COMPLETED|Study Extension II||860
9737687|NCT00205777|10838429|FG000|NOT COMPLETED|Study Extension II||0
9737688|NCT00205777|10838430|FG001|NOT COMPLETED|Study Extension II||0
9737689|NCT00205777|10838431|FG002|NOT COMPLETED|Study Extension II||0
9737690|NCT00205777|10838432|FG003|NOT COMPLETED|Study Extension II||149
9737691|NCT00205777|10838433|FG004|NOT COMPLETED|Study Extension II||0
9737692|NCT00205777|10838434|FG005|NOT COMPLETED|Study Extension II||282
9737693|NCT00205803|10838451|FG000|STARTED|Infant Series||122
9737694|NCT00205803|10838452|FG001|STARTED|Infant Series||127
9737695|NCT00205803|10838451|FG000|Vaccinated Dose 1|Infant Series||121
9737696|NCT00205803|10838452|FG001|Vaccinated Dose 1|Infant Series||126
9737697|NCT00205803|10838451|FG000|Vaccinated Dose 2|Infant Series||115
9737698|NCT00205803|10838452|FG001|Vaccinated Dose 2|Infant Series||122
9737699|NCT00205803|10838451|FG000|Vaccinated Dose 3|Infant Series||110
9737700|NCT00205803|10838452|FG001|Vaccinated Dose 3|Infant Series||118
9737701|NCT00205803|10838451|FG000|COMPLETED|Infant Series||104
9737702|NCT00205803|10838452|FG001|COMPLETED|Infant Series||116
9737703|NCT00205803|10838451|FG000|NOT COMPLETED|Infant Series||18
9737704|NCT00205803|10838452|FG001|NOT COMPLETED|Infant Series||11
9737705|NCT00205803|10838451|FG000|STARTED|After Infant Series||104
9737706|NCT00205803|10838452|FG001|STARTED|After Infant Series||116
9737707|NCT00205803|10838451|FG000|COMPLETED|After Infant Series||86
9737708|NCT00205803|10838452|FG001|COMPLETED|After Infant Series||103
9737709|NCT00205803|10838451|FG000|NOT COMPLETED|After Infant Series||18
9737710|NCT00205803|10838452|FG001|NOT COMPLETED|After Infant Series||13
9737711|NCT00205803|10838451|FG000|STARTED|Toddler Dose||86
9737712|NCT00205803|10838452|FG001|STARTED|Toddler Dose||103
9737713|NCT00205803|10838451|FG000|COMPLETED|Toddler Dose||84
9737714|NCT00205803|10838452|FG001|COMPLETED|Toddler Dose||100
9737715|NCT00205803|10838451|FG000|NOT COMPLETED|Toddler Dose||2
9737716|NCT00205803|10838452|FG001|NOT COMPLETED|Toddler Dose||3
9737717|NCT00205855|10838476|FG000|STARTED|Overall Study||65
9737718|NCT00205855|10838476|FG000|COMPLETED|Overall Study||44
9737719|NCT00205855|10838476|FG000|NOT COMPLETED|Overall Study||21
9737720|NCT00205881|10838480|FG000|STARTED|Overall Study||32
9737721|NCT00205881|10838480|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
9737722|NCT00205881|10838480|FG000|NOT COMPLETED|Overall Study||16
9737723|NCT00206076|10838487|FG000|STARTED|Overall Study||9
9737724|NCT00206076|10838488|FG001|STARTED|Overall Study||10
9737725|NCT00206076|10838487|FG000|COMPLETED|Overall Study||6
9737726|NCT00206076|10838488|FG001|COMPLETED|Overall Study||9
9737727|NCT00206076|10838487|FG000|NOT COMPLETED|Overall Study||3
9737728|NCT00206076|10838488|FG001|NOT COMPLETED|Overall Study||1
9737729|NCT00206102|10838498|FG000|STARTED|Overall Study||596
9737730|NCT00206102|10838499|FG001|STARTED|Overall Study||502
9737731|NCT00206102|10838498|FG000|COMPLETED|Overall Study||188
9737732|NCT00206102|10838499|FG001|COMPLETED|Overall Study||187
9737733|NCT00206102|10838498|FG000|NOT COMPLETED|Overall Study||408
9737734|NCT00206102|10838499|FG001|NOT COMPLETED|Overall Study||315
9737735|NCT00206323|10838507|FG000|STARTED|Overall Study||14
9737736|NCT00206323|10838508|FG001|STARTED|Overall Study||15
9737737|NCT00206323|10838507|FG000|COMPLETED|Overall Study||8
9737738|NCT00206323|10838508|FG001|COMPLETED|Overall Study||12
9737739|NCT00206323|10838507|FG000|NOT COMPLETED|Overall Study||6
9737740|NCT00206323|10838508|FG001|NOT COMPLETED|Overall Study||3
9737741|NCT00206336|10838514|FG000|STARTED|Overall Study||20
9737742|NCT00206336|10838514|FG000|COMPLETED|Overall Study||20
9737743|NCT00206336|10838514|FG000|NOT COMPLETED|Overall Study||0
10088803|NCT02315352|11217660|FG004|STARTED|Fourth Intervention (Day 2)||8
10088804|NCT02315352|11217661|FG005|STARTED|Fourth Intervention (Day 2)||7
9737744|NCT00206427|10838518|FG000|STARTED|Overall Study|Received First Dose|49
9737745|NCT00206427|10838518|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47
9737746|NCT00206427|10838518|FG000|NOT COMPLETED|Overall Study||2
9737747|NCT00206440|10838524|FG000|STARTED|Overall Study||21
9737748|NCT00206440|10838525|FG001|STARTED|Overall Study||22
9737749|NCT00206440|10838524|FG000|COMPLETED|Overall Study||16
9737750|NCT00206440|10838525|FG001|COMPLETED|Overall Study||18
9737751|NCT00206440|10838524|FG000|NOT COMPLETED|Overall Study||5
9737752|NCT00206440|10838525|FG001|NOT COMPLETED|Overall Study||4
9737753|NCT00206518|10838533|FG000|STARTED|Overall Study||83
9737754|NCT00206518|10838534|FG001|STARTED|Overall Study||84
9737755|NCT00206518|10838533|FG000|COMPLETED|Overall Study||73
9737756|NCT00206518|10838534|FG001|COMPLETED|Overall Study||78
9737757|NCT00206518|10838533|FG000|NOT COMPLETED|Overall Study||10
9737758|NCT00206518|10838534|FG001|NOT COMPLETED|Overall Study||6
9737759|NCT00206726|10838540|FG000|STARTED|Overall Study||60
9737760|NCT00206726|10838540|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
9737761|NCT00206726|10838540|FG000|4 Cycles Completed|Overall Study|per protocol population|41
9737762|NCT00206726|10838540|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
9737763|NCT00206726|10838540|FG000|NOT COMPLETED|Overall Study||51
9737764|NCT00207090|10838544|FG000|STARTED|Overall Study|Number of participants treated|15
9737765|NCT00207090|10838544|FG000|COMPLETED|Overall Study||8
9737766|NCT00207090|10838544|FG000|NOT COMPLETED|Overall Study||7
9737767|NCT00207142|10838556|FG000|STARTED|Induction Phase||252
9737768|NCT00207142|10838557|FG001|STARTED|Induction Phase||0
9737769|NCT00207142|10838558|FG002|STARTED|Induction Phase||0
9737770|NCT00207142|10838559|FG003|STARTED|Induction Phase||0
9737771|NCT00207142|10838556|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
9737772|NCT00207142|10838557|FG001|COMPLETED|Induction Phase||0
9737773|NCT00207142|10838558|FG002|COMPLETED|Induction Phase||0
9737774|NCT00207142|10838559|FG003|COMPLETED|Induction Phase||0
9737775|NCT00207142|10838556|FG000|NOT COMPLETED|Induction Phase||30
9737776|NCT00207142|10838557|FG001|NOT COMPLETED|Induction Phase||0
9737777|NCT00207142|10838558|FG002|NOT COMPLETED|Induction Phase||0
9737778|NCT00207142|10838559|FG003|NOT COMPLETED|Induction Phase||0
9737779|NCT00207142|10838556|FG000|STARTED|Maintenance Phase/Rescue Phase||0
9737780|NCT00207142|10838557|FG001|STARTED|Maintenance Phase/Rescue Phase||87
9737781|NCT00207142|10838558|FG002|STARTED|Maintenance Phase/Rescue Phase||85
9737782|NCT00207142|10838559|FG003|STARTED|Maintenance Phase/Rescue Phase||50
9737783|NCT00207142|10838556|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0
9737784|NCT00207142|10838557|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78
9737785|NCT00207142|10838558|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72
9737786|NCT00207142|10838559|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41
9737787|NCT00207142|10838556|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
9737788|NCT00207142|10838557|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
9737789|NCT00207142|10838558|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
9737790|NCT00207142|10838559|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
9737791|NCT00207714|10838579|FG000|STARTED|Overall Study||35
9737792|NCT00207714|10838580|FG001|STARTED|Overall Study||35
9737793|NCT00207714|10838581|FG002|STARTED|Overall Study||34
9737794|NCT00207714|10838582|FG003|STARTED|Overall Study||34
9737795|NCT00207714|10838583|FG004|STARTED|Overall Study||34
9737796|NCT00207714|10838579|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
9737797|NCT00207714|10838580|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
9737798|NCT00207714|10838581|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
9737799|NCT00207714|10838582|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
9737800|NCT00207714|10838583|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
9737801|NCT00207714|10838579|FG000|NOT COMPLETED|Overall Study||14
9737802|NCT00207714|10838580|FG001|NOT COMPLETED|Overall Study||7
9737803|NCT00207714|10838581|FG002|NOT COMPLETED|Overall Study||10
9737804|NCT00207714|10838582|FG003|NOT COMPLETED|Overall Study||8
9737805|NCT00207714|10838583|FG004|NOT COMPLETED|Overall Study||5
9737806|NCT00207727|10838607|FG000|STARTED|Overall Study||49
9737807|NCT00207727|10838608|FG001|STARTED|Overall Study||50
9737808|NCT00207727|10838609|FG002|STARTED|Overall Study||50
9737809|NCT00207727|10838610|FG003|STARTED|Overall Study||50
9737810|NCT00207727|10838611|FG004|STARTED|Overall Study||50
9737811|NCT00207727|10838607|FG000|COMPLETED|Overall Study||11
9737812|NCT00207727|10838608|FG001|COMPLETED|Overall Study||8
9737813|NCT00207727|10838609|FG002|COMPLETED|Overall Study||9
9737814|NCT00207727|10838610|FG003|COMPLETED|Overall Study||13
9737815|NCT00207727|10838611|FG004|COMPLETED|Overall Study||16
9737816|NCT00207727|10838607|FG000|NOT COMPLETED|Overall Study||38
9737817|NCT00207727|10838608|FG001|NOT COMPLETED|Overall Study||42
9737818|NCT00207727|10838609|FG002|NOT COMPLETED|Overall Study||41
9737819|NCT00207727|10838610|FG003|NOT COMPLETED|Overall Study||37
9737820|NCT00207727|10838611|FG004|NOT COMPLETED|Overall Study||34
9737821|NCT00207740|10838627|FG000|STARTED|Overall Study||78
9737822|NCT00207740|10838628|FG001|STARTED|Overall Study||77
9737823|NCT00207740|10838629|FG002|STARTED|Overall Study||76
9737824|NCT00207740|10838630|FG003|STARTED|Overall Study||78
9737825|NCT00207740|10838627|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
9737826|NCT00207740|10838628|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
9737827|NCT00207740|10838629|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
9737828|NCT00207740|10838630|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
9737829|NCT00207740|10838627|FG000|NOT COMPLETED|Overall Study||29
9737830|NCT00207740|10838628|FG001|NOT COMPLETED|Overall Study||41
9737831|NCT00207740|10838629|FG002|NOT COMPLETED|Overall Study||40
9737832|NCT00207740|10838630|FG003|NOT COMPLETED|Overall Study||43
9737833|NCT00207883|10838646|FG000|STARTED|Overall Study||93
9737834|NCT00207883|10838647|FG001|STARTED|Overall Study||119
9737835|NCT00207883|10838646|FG000|COMPLETED|Overall Study||93
9737836|NCT00207883|10838647|FG001|COMPLETED|Overall Study||119
9737837|NCT00207883|10838646|FG000|NOT COMPLETED|Overall Study||0
9737838|NCT00207883|10838647|FG001|NOT COMPLETED|Overall Study||0
9737839|NCT00208026|10838653|FG000|STARTED|Overall Study||3
9737840|NCT00208026|10838653|FG000|COMPLETED|Overall Study||3
9737841|NCT00208026|10838653|FG000|NOT COMPLETED|Overall Study||0
9737842|NCT00208091|10838659|FG000|STARTED|Overall Study||16
9737843|NCT00208091|10838659|FG000|COMPLETED|Overall Study||16
9737844|NCT00208091|10838659|FG000|NOT COMPLETED|Overall Study||0
9737845|NCT00208325|10838671|FG000|STARTED|Overall Study||193
9737846|NCT00208325|10838672|FG001|STARTED|Overall Study||196
9737847|NCT00208325|10838673|FG002|STARTED|Overall Study||170
9737848|NCT00208325|10838674|FG003|STARTED|Overall Study||161
9737849|NCT00208325|10838671|FG000|COMPLETED|Overall Study||142
9737850|NCT00208325|10838672|FG001|COMPLETED|Overall Study||142
9737851|NCT00208325|10838673|FG002|COMPLETED|Overall Study||156
10088805|NCT02315352|11217662|FG006|STARTED|Fourth Intervention (Day 2)||9
10088806|NCT02315352|11217663|FG007|STARTED|Fourth Intervention (Day 2)||8
10088807|NCT02315352|11217656|FG000|COMPLETED|Fourth Intervention (Day 2)||0
10088808|NCT02315352|11217657|FG001|COMPLETED|Fourth Intervention (Day 2)||0
10088809|NCT02315352|11217658|FG002|COMPLETED|Fourth Intervention (Day 2)||7
10088810|NCT02315352|11217659|FG003|COMPLETED|Fourth Intervention (Day 2)||8
10088811|NCT02315352|11217660|FG004|COMPLETED|Fourth Intervention (Day 2)||8
10088812|NCT02315352|11217661|FG005|COMPLETED|Fourth Intervention (Day 2)||7
10088813|NCT02315352|11217662|FG006|COMPLETED|Fourth Intervention (Day 2)||9
10088814|NCT02315352|11217663|FG007|COMPLETED|Fourth Intervention (Day 2)||8
10088815|NCT02315352|11217656|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088816|NCT02315352|11217657|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088817|NCT02315352|11217658|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088818|NCT02315352|11217659|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088819|NCT02315352|11217660|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088820|NCT02315352|11217661|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088821|NCT02315352|11217662|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088822|NCT02315352|11217663|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0
10088823|NCT02315352|11217656|FG000|STARTED|Fifth Intervention (Day 2)||0
10088824|NCT02315352|11217657|FG001|STARTED|Fifth Intervention (Day 2)||0
10088825|NCT02315352|11217658|FG002|STARTED|Fifth Intervention (Day 2)||7
10088826|NCT02315352|11217659|FG003|STARTED|Fifth Intervention (Day 2)||8
10088827|NCT02315352|11217660|FG004|STARTED|Fifth Intervention (Day 2)||8
10088828|NCT02315352|11217661|FG005|STARTED|Fifth Intervention (Day 2)||7
10088829|NCT02315352|11217662|FG006|STARTED|Fifth Intervention (Day 2)||9
10088830|NCT02315352|11217663|FG007|STARTED|Fifth Intervention (Day 2)||8
10088831|NCT02315352|11217656|FG000|COMPLETED|Fifth Intervention (Day 2)||0
10088832|NCT02315352|11217657|FG001|COMPLETED|Fifth Intervention (Day 2)||0
10088833|NCT02315352|11217658|FG002|COMPLETED|Fifth Intervention (Day 2)||7
10088834|NCT02315352|11217659|FG003|COMPLETED|Fifth Intervention (Day 2)||8
10088835|NCT02315352|11217660|FG004|COMPLETED|Fifth Intervention (Day 2)||8
10088836|NCT02315352|11217661|FG005|COMPLETED|Fifth Intervention (Day 2)||7
10088837|NCT02315352|11217662|FG006|COMPLETED|Fifth Intervention (Day 2)||9
10088838|NCT02315352|11217663|FG007|COMPLETED|Fifth Intervention (Day 2)||8
10088839|NCT02315352|11217656|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088840|NCT02315352|11217657|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088841|NCT02315352|11217658|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088842|NCT02315352|11217659|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088843|NCT02315352|11217660|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088844|NCT02315352|11217661|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088845|NCT02315352|11217662|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088846|NCT02315352|11217663|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0
10088847|NCT02315430|11217675|FG000|STARTED|Overall Study||13
10088848|NCT02315430|11217675|FG000|COMPLETED|Overall Study||13
10088849|NCT02315430|11217675|FG000|NOT COMPLETED|Overall Study||0
10088850|NCT02315560|11217679|FG000|STARTED|Overall Study||25
10088851|NCT02315560|11217679|FG000|COMPLETED|Overall Study||22
10088852|NCT02315560|11217679|FG000|NOT COMPLETED|Overall Study||3
10088853|NCT02315625|11217685|FG000|STARTED|First Intervention||14
10088854|NCT02315625|11217686|FG001|STARTED|First Intervention||2
10088855|NCT02315625|11217685|FG000|COMPLETED|First Intervention||13
10088856|NCT02315625|11217686|FG001|COMPLETED|First Intervention||2
10088857|NCT02315625|11217685|FG000|NOT COMPLETED|First Intervention||1
9737852|NCT00208325|10838674|FG003|COMPLETED|Overall Study||147
9737853|NCT00208325|10838671|FG000|NOT COMPLETED|Overall Study||51
9737854|NCT00208325|10838672|FG001|NOT COMPLETED|Overall Study||54
9737855|NCT00208325|10838673|FG002|NOT COMPLETED|Overall Study||14
9737856|NCT00208325|10838674|FG003|NOT COMPLETED|Overall Study||14
9737857|NCT00208494|10838686|FG000|STARTED|Overall Study||194
9737858|NCT00208494|10838687|FG001|STARTED|Overall Study||196
9737859|NCT00208494|10838686|FG000|COMPLETED|Overall Study||164
9737860|NCT00208494|10838687|FG001|COMPLETED|Overall Study||162
9737861|NCT00208494|10838686|FG000|NOT COMPLETED|Overall Study||30
10088858|NCT02315625|11217686|FG001|NOT COMPLETED|First Intervention||0
10088859|NCT02315625|11217685|FG000|STARTED|Second Intervention||13
10088860|NCT02315625|11217686|FG001|STARTED|Second Intervention||2
10088861|NCT02315625|11217685|FG000|COMPLETED|Second Intervention||9
9737862|NCT00208494|10838687|FG001|NOT COMPLETED|Overall Study||34
9737863|NCT00208507|10838695|FG000|STARTED|Overall Study||177
9737864|NCT00208507|10838696|FG001|STARTED|Overall Study||87
9737865|NCT00208507|10838695|FG000|COMPLETED|Overall Study||163
9737866|NCT00208507|10838696|FG001|COMPLETED|Overall Study||79
9737867|NCT00208507|10838695|FG000|NOT COMPLETED|Overall Study||14
9737868|NCT00208507|10838696|FG001|NOT COMPLETED|Overall Study||8
9737869|NCT00208767|10838704|FG000|STARTED|Overall Study||80
9737870|NCT00208767|10838705|FG001|STARTED|Overall Study||40
9737871|NCT00208767|10838704|FG000|COMPLETED|Overall Study||53
9737872|NCT00208767|10838705|FG001|COMPLETED|Overall Study||33
9737873|NCT00208767|10838704|FG000|NOT COMPLETED|Overall Study||27
9737874|NCT00208767|10838705|FG001|NOT COMPLETED|Overall Study||7
9737875|NCT00208949|10838713|FG000|STARTED|Overall Study||25
9737876|NCT00208949|10838714|FG001|STARTED|Overall Study||25
9737877|NCT00208949|10838713|FG000|COMPLETED|Overall Study||25
9737878|NCT00208949|10838714|FG001|COMPLETED|Overall Study||25
9737879|NCT00208949|10838713|FG000|NOT COMPLETED|Overall Study||0
9737880|NCT00208949|10838714|FG001|NOT COMPLETED|Overall Study||0
9737881|NCT00208975|10838720|FG000|STARTED|Overall Study||15
9737882|NCT00208975|10838720|FG000|COMPLETED|Overall Study||15
9737883|NCT00208975|10838720|FG000|NOT COMPLETED|Overall Study||0
10088862|NCT02315625|11217686|FG001|COMPLETED|Second Intervention||1
10088863|NCT02315625|11217685|FG000|NOT COMPLETED|Second Intervention||4
10088864|NCT02315625|11217686|FG001|NOT COMPLETED|Second Intervention||1
10088865|NCT02315664|11217696|FG000|STARTED|Overall Study||30
10088866|NCT02315664|11217697|FG001|STARTED|Overall Study||31
10088867|NCT02315664|11217696|FG000|COMPLETED|Overall Study||29
10088868|NCT02315664|11217697|FG001|COMPLETED|Overall Study||27
10088869|NCT02315664|11217696|FG000|NOT COMPLETED|Overall Study||1
10088870|NCT02315664|11217697|FG001|NOT COMPLETED|Overall Study||4
10088871|NCT02315755|11217703|FG000|STARTED|Overall Study||102
10088872|NCT02315755|11217703|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
10088873|NCT02315755|11217703|FG000|NOT COMPLETED|Overall Study||0
10088874|NCT02315872|11217709|FG000|STARTED|Overall Study||4
10088875|NCT02315872|11217710|FG001|STARTED|Overall Study||4
10088876|NCT02315872|11217709|FG000|COMPLETED|Overall Study||1
10088877|NCT02315872|11217710|FG001|COMPLETED|Overall Study||3
10088878|NCT02315872|11217709|FG000|NOT COMPLETED|Overall Study||3
10088879|NCT02315872|11217710|FG001|NOT COMPLETED|Overall Study||1
10088880|NCT02315989|11217716|FG000|STARTED|Overall Study||6
10088881|NCT02315989|11217716|FG000|COMPLETED|Overall Study||6
10088882|NCT02315989|11217716|FG000|NOT COMPLETED|Overall Study||0
10088883|NCT02316171|11217726|FG000|STARTED|Overall Study||4
10088884|NCT02316171|11217727|FG001|STARTED|Overall Study||6
10088885|NCT02316171|11217728|FG002|STARTED|Overall Study||3
10088886|NCT02316171|11217729|FG003|STARTED|Overall Study||3
10088887|NCT02316171|11217726|FG000|COMPLETED|Overall Study||3
10088888|NCT02316171|11217727|FG001|COMPLETED|Overall Study||6
10088889|NCT02316171|11217728|FG002|COMPLETED|Overall Study||3
10088890|NCT02316171|11217729|FG003|COMPLETED|Overall Study||3
10088891|NCT02316171|11217726|FG000|NOT COMPLETED|Overall Study||1
10088892|NCT02316171|11217727|FG001|NOT COMPLETED|Overall Study||0
10088893|NCT02316171|11217728|FG002|NOT COMPLETED|Overall Study||0
10088894|NCT02316171|11217729|FG003|NOT COMPLETED|Overall Study||0
10088895|NCT02316223|11217738|FG000|STARTED|Overall Study||134
10088896|NCT02316223|11217739|FG001|STARTED|Overall Study||133
10088897|NCT02316223|11217740|FG002|STARTED|Overall Study||139
10088898|NCT02316223|11217738|FG000|COMPLETED|Overall Study||90
10088899|NCT02316223|11217739|FG001|COMPLETED|Overall Study||76
10088900|NCT02316223|11217740|FG002|COMPLETED|Overall Study||95
10088901|NCT02316223|11217738|FG000|NOT COMPLETED|Overall Study||44
10088902|NCT02316223|11217739|FG001|NOT COMPLETED|Overall Study||57
10088903|NCT02316223|11217740|FG002|NOT COMPLETED|Overall Study||44
10088904|NCT02316353|11217750|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
10088905|NCT02316353|11217751|FG001|STARTED|Overall Study||63
10088906|NCT02316353|11217750|FG000|COMPLETED|Overall Study||55
10088907|NCT02316353|11217751|FG001|COMPLETED|Overall Study||55
10088908|NCT02316353|11217750|FG000|NOT COMPLETED|Overall Study||8
10088909|NCT02316353|11217751|FG001|NOT COMPLETED|Overall Study||8
10088910|NCT02316366|11217762|FG000|STARTED|Overall Study||40
10088911|NCT02316366|11217763|FG001|STARTED|Overall Study||40
9737884|NCT00209092|10838727|FG000|STARTED|Overall Study||25
9737885|NCT00209092|10838728|FG001|STARTED|Overall Study||26
9737886|NCT00209092|10838727|FG000|COMPLETED|Overall Study||17
9737887|NCT00209092|10838728|FG001|COMPLETED|Overall Study||24
9852224|NCT00880100|10965043|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45
9737888|NCT00209092|10838727|FG000|NOT COMPLETED|Overall Study||8
9737889|NCT00209092|10838728|FG001|NOT COMPLETED|Overall Study||2
9737890|NCT00209170|10838736|FG000|STARTED|Overall Study||7
10088912|NCT02316366|11217762|FG000|COMPLETED|Overall Study||40
10088913|NCT02316366|11217763|FG001|COMPLETED|Overall Study||40
10088914|NCT02316366|11217762|FG000|NOT COMPLETED|Overall Study||0
10088915|NCT02316366|11217763|FG001|NOT COMPLETED|Overall Study||0
10088916|NCT02316470|11217773|FG000|STARTED|Overall Study||148
10088917|NCT02316470|11217774|FG001|STARTED|Overall Study||152
10088918|NCT02316470|11217775|FG002|STARTED|Overall Study||152
10088919|NCT02316470|11217776|FG003|STARTED|Overall Study||48
10088920|NCT02316470|11217773|FG000|COMPLETED|Overall Study||143
10088921|NCT02316470|11217774|FG001|COMPLETED|Overall Study||146
10088922|NCT02316470|11217775|FG002|COMPLETED|Overall Study||147
10088923|NCT02316470|11217776|FG003|COMPLETED|Overall Study||46
9737891|NCT00209170|10838737|FG001|STARTED|Overall Study||7
10088924|NCT02316470|11217773|FG000|NOT COMPLETED|Overall Study||5
10088925|NCT02316470|11217774|FG001|NOT COMPLETED|Overall Study||6
10088926|NCT02316470|11217775|FG002|NOT COMPLETED|Overall Study||5
10088927|NCT02316470|11217776|FG003|NOT COMPLETED|Overall Study||2
10088928|NCT02316548|11217788|FG000|STARTED|Overall Study|Randomized|6
10088929|NCT02316548|11217789|FG001|STARTED|Overall Study|Randomized|7
9737892|NCT00209170|10838736|FG000|COMPLETED|Overall Study||5
9737893|NCT00209170|10838737|FG001|COMPLETED|Overall Study||4
9737894|NCT00209170|10838736|FG000|NOT COMPLETED|Overall Study||2
9737895|NCT00209170|10838737|FG001|NOT COMPLETED|Overall Study||3
9737896|NCT00209274|10838745|FG000|STARTED|Overall Study||184
9737897|NCT00209274|10838746|FG001|STARTED|Overall Study||95
9737898|NCT00209274|10838745|FG000|COMPLETED|Overall Study||113
9737899|NCT00209274|10838746|FG001|COMPLETED|Overall Study||48
9737900|NCT00209274|10838745|FG000|NOT COMPLETED|Overall Study||71
9737901|NCT00209274|10838746|FG001|NOT COMPLETED|Overall Study||47
9737902|NCT00209339|10838752|FG000|STARTED|At 12 Months Follow-up||55
9737903|NCT00209339|10838752|FG000|COMPLETED|At 12 Months Follow-up||40
9737904|NCT00209339|10838752|FG000|NOT COMPLETED|At 12 Months Follow-up||15
9737905|NCT00209339|10838752|FG000|STARTED|At 24 Months Follow-up||40
9737906|NCT00209339|10838752|FG000|COMPLETED|At 24 Months Follow-up||29
9737907|NCT00209339|10838752|FG000|NOT COMPLETED|At 24 Months Follow-up||11
9737908|NCT00209339|10838752|FG000|STARTED|At 3 Years Follow-up||29
9737909|NCT00209339|10838752|FG000|COMPLETED|At 3 Years Follow-up||28
9737910|NCT00209339|10838752|FG000|NOT COMPLETED|At 3 Years Follow-up||1
9737911|NCT00209339|10838752|FG000|STARTED|At 4 Years Follow-up||28
9737912|NCT00209339|10838752|FG000|COMPLETED|At 4 Years Follow-up||23
9737913|NCT00209339|10838752|FG000|NOT COMPLETED|At 4 Years Follow-up||5
9737914|NCT00209339|10838752|FG000|STARTED|At 5 Years Follow-up||23
9737915|NCT00209339|10838752|FG000|COMPLETED|At 5 Years Follow-up||15
9737916|NCT00209339|10838752|FG000|NOT COMPLETED|At 5 Years Follow-up||8
9737917|NCT00209417|10838758|FG000|STARTED|Overall Study||321
9737918|NCT00209417|10838759|FG001|STARTED|Overall Study||327
9737919|NCT00209417|10838758|FG000|COMPLETED|Overall Study||321
9737920|NCT00209417|10838759|FG001|COMPLETED|Overall Study||327
9737921|NCT00209417|10838758|FG000|NOT COMPLETED|Overall Study||0
9737922|NCT00209417|10838759|FG001|NOT COMPLETED|Overall Study||0
9737923|NCT00209560|10838767|FG000|STARTED|Overall Study||121
9737924|NCT00209560|10838768|FG001|STARTED|Overall Study||42
9737925|NCT00209560|10838767|FG000|COMPLETED|Overall Study||120
9737926|NCT00209560|10838768|FG001|COMPLETED|Overall Study||42
9737927|NCT00209560|10838767|FG000|NOT COMPLETED|Overall Study||1
9737928|NCT00209560|10838768|FG001|NOT COMPLETED|Overall Study||0
9737929|NCT00210106|10838774|FG000|STARTED|Overall Study||52
9737930|NCT00210106|10838774|FG000|Safety Population|Overall Study||49
9737931|NCT00210106|10838774|FG000|COMPLETED|Overall Study||38
9737932|NCT00210106|10838774|FG000|NOT COMPLETED|Overall Study||14
9737933|NCT00210119|10838779|FG000|STARTED|Overall Study||19
9737934|NCT00210119|10838779|FG000|COMPLETED|Overall Study||17
9737935|NCT00210119|10838779|FG000|NOT COMPLETED|Overall Study||2
9737936|NCT00210184|10838783|FG000|STARTED|Overall Study||42
9737937|NCT00210184|10838783|FG000|COMPLETED|Overall Study||40
9737938|NCT00210184|10838783|FG000|NOT COMPLETED|Overall Study||2
9737939|NCT00210353|10838790|FG000|STARTED|Overall Study||151
9737940|NCT00210353|10838791|FG001|STARTED|Overall Study||152
9737941|NCT00210353|10838792|FG002|STARTED|Overall Study||151
9737942|NCT00210353|10838790|FG000|COMPLETED|Overall Study||113
9737943|NCT00210353|10838791|FG001|COMPLETED|Overall Study||107
9737944|NCT00210353|10838792|FG002|COMPLETED|Overall Study||125
9737945|NCT00210353|10838790|FG000|NOT COMPLETED|Overall Study||38
9737946|NCT00210353|10838791|FG001|NOT COMPLETED|Overall Study||45
9737947|NCT00210353|10838792|FG002|NOT COMPLETED|Overall Study||26
9737948|NCT00210470|10838805|FG000|STARTED|Overall Study||27
9737949|NCT00210470|10838805|FG000|COMPLETED|Overall Study||27
9737950|NCT00210470|10838805|FG000|NOT COMPLETED|Overall Study||0
9737951|NCT00210626|10838814|FG000|STARTED|Overall Study||97
9737952|NCT00210626|10838815|FG001|STARTED|Overall Study||95
9737953|NCT00210626|10838814|FG000|COMPLETED|Overall Study||49
9737954|NCT00210626|10838815|FG001|COMPLETED|Overall Study||50
9737955|NCT00210626|10838814|FG000|NOT COMPLETED|Overall Study||48
9737956|NCT00210626|10838815|FG001|NOT COMPLETED|Overall Study||45
9737957|NCT00210639|10838823|FG000|STARTED|Overall Study||124
9737958|NCT00210639|10838824|FG001|STARTED|Overall Study||83
9737959|NCT00210639|10838823|FG000|COMPLETED|Overall Study||61
9737960|NCT00210639|10838824|FG001|COMPLETED|Overall Study||41
9737961|NCT00210639|10838823|FG000|NOT COMPLETED|Overall Study||63
9737962|NCT00210639|10838824|FG001|NOT COMPLETED|Overall Study||42
9737963|NCT00211081|10838830|FG000|STARTED|Overall Study||12
9737964|NCT00211081|10838830|FG000|COMPLETED|Overall Study||10
9737965|NCT00211081|10838830|FG000|NOT COMPLETED|Overall Study||2
9737966|NCT00211172|10838836|FG000|STARTED|Overall Study||449
9737967|NCT00211172|10838837|FG001|STARTED|Overall Study||458
9737968|NCT00211172|10838836|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
9737969|NCT00211172|10838837|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
9737970|NCT00211172|10838836|FG000|NOT COMPLETED|Overall Study||39
9737971|NCT00211172|10838837|FG001|NOT COMPLETED|Overall Study||32
9737972|NCT00211185|10838843|FG000|STARTED|Overall Study||49
9737973|NCT00211185|10838843|FG000|COMPLETED|Overall Study||29
9737974|NCT00211185|10838843|FG000|NOT COMPLETED|Overall Study||20
10088930|NCT02316548|11217788|FG000|Eligible Population|Overall Study||6
9737975|NCT00211237|10838849|FG000|STARTED|Baseline||70
9737976|NCT00211237|10838850|FG001|STARTED|Baseline||64
9737977|NCT00211237|10838851|FG002|STARTED|Baseline||0
9737978|NCT00211237|10838849|FG000|COMPLETED|Baseline||68
9737979|NCT00211237|10838850|FG001|COMPLETED|Baseline||61
9737980|NCT00211237|10838851|FG002|COMPLETED|Baseline||0
9737981|NCT00211237|10838849|FG000|NOT COMPLETED|Baseline||2
9737982|NCT00211237|10838850|FG001|NOT COMPLETED|Baseline||3
9737983|NCT00211237|10838851|FG002|NOT COMPLETED|Baseline||0
9737984|NCT00211237|10838849|FG000|STARTED|1 Month||68
9737985|NCT00211237|10838850|FG001|STARTED|1 Month||61
9737986|NCT00211237|10838851|FG002|STARTED|1 Month||0
9737987|NCT00211237|10838849|FG000|COMPLETED|1 Month||65
9737988|NCT00211237|10838850|FG001|COMPLETED|1 Month||52
9737989|NCT00211237|10838851|FG002|COMPLETED|1 Month||0
9737990|NCT00211237|10838849|FG000|NOT COMPLETED|1 Month||3
9737991|NCT00211237|10838850|FG001|NOT COMPLETED|1 Month||9
9852225|NCT00880100|10965043|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
9852226|NCT00880165|10965049|FG000|STARTED|Overall Study||148
9852227|NCT00880165|10965050|FG001|STARTED|Overall Study||148
9852228|NCT00880165|10965049|FG000|COMPLETED|Overall Study||86
9852229|NCT00880165|10965050|FG001|COMPLETED|Overall Study||98
9852230|NCT00880165|10965049|FG000|NOT COMPLETED|Overall Study||62
9852231|NCT00880165|10965050|FG001|NOT COMPLETED|Overall Study||50
9852232|NCT00880191|10965058|FG000|STARTED|Overall Study||207
9852233|NCT00880191|10965059|FG001|STARTED|Overall Study||206
9852234|NCT00880191|10965058|FG000|Available for Primary Endpoint Analysis|Overall Study||207
9852235|NCT00880191|10965059|FG001|Available for Primary Endpoint Analysis|Overall Study||206
9852236|NCT00880191|10965058|FG000|COMPLETED|Overall Study||194
9852237|NCT00880191|10965059|FG001|COMPLETED|Overall Study||198
10088931|NCT02316548|11217789|FG001|Eligible Population|Overall Study||6
10088932|NCT02316548|11217788|FG000|Eligible With Disease Assessment|Overall Study||4
10088933|NCT02316548|11217789|FG001|Eligible With Disease Assessment|Overall Study||1
10088934|NCT02316548|11217788|FG000|Eligible With Adverse Event Data|Overall Study||4
10088935|NCT02316548|11217789|FG001|Eligible With Adverse Event Data|Overall Study||2
10088936|NCT02316548|11217788|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6
10088937|NCT02316548|11217789|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6
10088938|NCT02316548|11217788|FG000|NOT COMPLETED|Overall Study||0
10088939|NCT02316548|11217789|FG001|NOT COMPLETED|Overall Study||1
10088940|NCT02316613|11217795|FG000|STARTED|Overall Study||260
10088941|NCT02316613|11217795|FG000|Safety Population|Overall Study||255
10088942|NCT02316613|11217795|FG000|Overall Population|Overall Study||241
10088943|NCT02316613|11217795|FG000|COMPLETED|Overall Study||156
10088944|NCT02316613|11217795|FG000|NOT COMPLETED|Overall Study||104
10088945|NCT02316678|11217812|FG000|STARTED|Overall Study||1879
10088946|NCT02316678|11217813|FG001|STARTED|Overall Study||7694
10088947|NCT02316678|11217812|FG000|COMPLETED|Overall Study||1879
10088948|NCT02316678|11217813|FG001|COMPLETED|Overall Study||7694
10088949|NCT02316678|11217812|FG000|NOT COMPLETED|Overall Study||0
10088950|NCT02316678|11217813|FG001|NOT COMPLETED|Overall Study||0
10088951|NCT02316717|11217822|FG000|STARTED|Overall Study||43
10088952|NCT02316717|11217823|FG001|STARTED|Overall Study||46
10088953|NCT02316717|11217824|FG002|STARTED|Overall Study||44
10088954|NCT02316717|11217822|FG000|COMPLETED|Overall Study||32
10088955|NCT02316717|11217823|FG001|COMPLETED|Overall Study||39
10088956|NCT02316717|11217824|FG002|COMPLETED|Overall Study||41
10088957|NCT02316717|11217822|FG000|NOT COMPLETED|Overall Study||11
10088958|NCT02316717|11217823|FG001|NOT COMPLETED|Overall Study||7
10088959|NCT02316717|11217824|FG002|NOT COMPLETED|Overall Study||3
10088960|NCT02316769|11217837|FG000|STARTED|Overall Study||33
10088961|NCT02316769|11217838|FG001|STARTED|Overall Study||33
10088962|NCT02316769|11217837|FG000|COMPLETED|Overall Study||31
10088963|NCT02316769|11217838|FG001|COMPLETED|Overall Study||33
10088964|NCT02316769|11217837|FG000|NOT COMPLETED|Overall Study||2
10088965|NCT02316769|11217838|FG001|NOT COMPLETED|Overall Study||0
10088966|NCT02316847|11217846|FG000|STARTED|Overall Study||9
10088967|NCT02316847|11217847|FG001|STARTED|Overall Study||99
10088968|NCT02316847|11217846|FG000|COMPLETED|Overall Study||0
10088969|NCT02316847|11217847|FG001|COMPLETED|Overall Study||13
9737992|NCT00211237|10838851|FG002|NOT COMPLETED|1 Month||0
9852238|NCT00880191|10965058|FG000|NOT COMPLETED|Overall Study||13
9852239|NCT00880191|10965059|FG001|NOT COMPLETED|Overall Study||8
9852240|NCT00880230|10965065|FG000|STARTED|Overall Study||141
9852241|NCT00880230|10965065|FG000|COMPLETED|Overall Study||134
9852242|NCT00880230|10965065|FG000|NOT COMPLETED|Overall Study||7
9852243|NCT00880256|10965069|FG000|STARTED|Overall Study||93
9852244|NCT00880256|10965069|FG000|COMPLETED|Overall Study||65
9737993|NCT00211237|10838849|FG000|STARTED|3 Months||65
9737994|NCT00211237|10838850|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
9737995|NCT00211237|10838851|FG002|STARTED|3 Months||34
9737996|NCT00211237|10838849|FG000|COMPLETED|3 Months||57
9737997|NCT00211237|10838850|FG001|COMPLETED|3 Months||14
9737998|NCT00211237|10838851|FG002|COMPLETED|3 Months||33
9737999|NCT00211237|10838849|FG000|NOT COMPLETED|3 Months||8
9738000|NCT00211237|10838850|FG001|NOT COMPLETED|3 Months||4
9852245|NCT00880256|10965069|FG000|NOT COMPLETED|Overall Study||28
10088970|NCT02316847|11217846|FG000|NOT COMPLETED|Overall Study||9
10088971|NCT02316847|11217847|FG001|NOT COMPLETED|Overall Study||86
10088972|NCT02317016|11217855|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
9738001|NCT00211237|10838851|FG002|NOT COMPLETED|3 Months||1
9738002|NCT00211237|10838849|FG000|STARTED|6 Months||57
9738003|NCT00211237|10838850|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
9738004|NCT00211237|10838851|FG002|STARTED|6 Months||36
9738005|NCT00211237|10838849|FG000|COMPLETED|6 Months||49
9738006|NCT00211237|10838850|FG001|COMPLETED|6 Months||9
9738007|NCT00211237|10838851|FG002|COMPLETED|6 Months||33
9738008|NCT00211237|10838849|FG000|NOT COMPLETED|6 Months||8
9738009|NCT00211237|10838850|FG001|NOT COMPLETED|6 Months||2
9738010|NCT00211237|10838851|FG002|NOT COMPLETED|6 Months||3
9738011|NCT00211237|10838849|FG000|STARTED|12 Months||49
9738012|NCT00211237|10838850|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
9738013|NCT00211237|10838851|FG002|STARTED|12 Months||34
9738014|NCT00211237|10838849|FG000|COMPLETED|12 Months||40
9738015|NCT00211237|10838850|FG001|COMPLETED|12 Months||6
9738016|NCT00211237|10838851|FG002|COMPLETED|12 Months||28
9738017|NCT00211237|10838849|FG000|NOT COMPLETED|12 Months||9
9738018|NCT00211237|10838850|FG001|NOT COMPLETED|12 Months||2
9738019|NCT00211237|10838851|FG002|NOT COMPLETED|12 Months||6
9738020|NCT00211510|10838870|FG000|STARTED|Overall Study||72
9738021|NCT00211510|10838871|FG001|STARTED|Overall Study||74
9738022|NCT00211510|10838870|FG000|COMPLETED|Overall Study||66
9738023|NCT00211510|10838871|FG001|COMPLETED|Overall Study||72
9738024|NCT00211510|10838870|FG000|NOT COMPLETED|Overall Study||6
9738025|NCT00211510|10838871|FG001|NOT COMPLETED|Overall Study||2
9738026|NCT00211536|10838882|FG000|STARTED|Overall Study||53
9738027|NCT00211536|10838883|FG001|STARTED|Overall Study||54
9738028|NCT00211536|10838882|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
9738029|NCT00211536|10838883|FG001|As Treated Data Analysis Set|Overall Study||48
9738030|NCT00211536|10838882|FG000|COMPLETED|Overall Study||49
9738031|NCT00211536|10838883|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
9738032|NCT00211536|10838882|FG000|NOT COMPLETED|Overall Study||4
9738033|NCT00211536|10838883|FG001|NOT COMPLETED|Overall Study||7
9738034|NCT00211692|10838891|FG000|STARTED|Overall Study||33
9738035|NCT00211692|10838892|FG001|STARTED|Overall Study||31
9738036|NCT00211692|10838891|FG000|COMPLETED|Overall Study||33
9738037|NCT00211692|10838892|FG001|COMPLETED|Overall Study||31
9738038|NCT00211692|10838891|FG000|NOT COMPLETED|Overall Study||0
9738039|NCT00211692|10838892|FG001|NOT COMPLETED|Overall Study||0
9738040|NCT00211757|10838900|FG000|STARTED|Overall Study||11
9738041|NCT00211757|10838901|FG001|STARTED|Overall Study||16
9738042|NCT00211757|10838900|FG000|COMPLETED|Overall Study||10
9738043|NCT00211757|10838901|FG001|COMPLETED|Overall Study||14
10088973|NCT02317016|11217855|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
10088974|NCT02317016|11217855|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
10088975|NCT02317016|11217855|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
10088976|NCT02317016|11217855|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
10088977|NCT02317016|11217855|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
10088978|NCT02317016|11217855|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
10088979|NCT02317016|11217855|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
10088980|NCT02317016|11217855|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
10088981|NCT02317016|11217855|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
10088982|NCT02317016|11217855|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
10088983|NCT02317016|11217855|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
10088984|NCT02317042|11217863|FG000|STARTED|Overall Study||11
10088985|NCT02317042|11217864|FG001|STARTED|Overall Study||14
10088986|NCT02317042|11217863|FG000|COMPLETED|Overall Study||11
10088987|NCT02317042|11217864|FG001|COMPLETED|Overall Study||14
10088988|NCT02317042|11217863|FG000|NOT COMPLETED|Overall Study||0
10088989|NCT02317042|11217864|FG001|NOT COMPLETED|Overall Study||0
10088990|NCT02317432|11217874|FG000|STARTED|Overall Study||153
10088991|NCT02317432|11217875|FG001|STARTED|Overall Study||154
10088992|NCT02317432|11217874|FG000|Completed CBT|Overall Study||118
10088993|NCT02317432|11217875|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
10088994|NCT02317432|11217874|FG000|Completed InVEST|Overall Study||63
10088995|NCT02317432|11217875|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
10088996|NCT02317432|11217874|FG000|Completed CBT + InVEST Exercise|Overall Study||122
10088997|NCT02317432|11217875|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
10088998|NCT02317432|11217874|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
10088999|NCT02317432|11217875|FG001|Completed Enhanced Usual Care|Overall Study||148
10089000|NCT02317432|11217874|FG000|COMPLETED|Overall Study||122
10089001|NCT02317432|11217875|FG001|COMPLETED|Overall Study||148
10089002|NCT02317432|11217874|FG000|NOT COMPLETED|Overall Study||31
10089003|NCT02317432|11217875|FG001|NOT COMPLETED|Overall Study||6
10089004|NCT02317510|11217883|FG000|STARTED|Overall Study||25
10089005|NCT02317510|11217884|FG001|STARTED|Overall Study||25
9738044|NCT00211757|10838900|FG000|NOT COMPLETED|Overall Study||1
9738045|NCT00211757|10838901|FG001|NOT COMPLETED|Overall Study||2
9738046|NCT00211809|10838909|FG000|STARTED|Overall Study||17
9738047|NCT00211809|10838909|FG000|COMPLETED|Overall Study||11
9738048|NCT00211809|10838909|FG000|NOT COMPLETED|Overall Study||6
9738049|NCT00211887|10838918|FG000|STARTED|Overall Study||499
9738050|NCT00211887|10838919|FG001|STARTED|Overall Study||250
9738051|NCT00211887|10838920|FG002|STARTED|Overall Study||259
9738052|NCT00211887|10838918|FG000|COMPLETED|Overall Study||397
9738053|NCT00211887|10838919|FG001|COMPLETED|Overall Study||194
9738054|NCT00211887|10838920|FG002|COMPLETED|Overall Study||223
9738055|NCT00211887|10838918|FG000|NOT COMPLETED|Overall Study||102
9738056|NCT00211887|10838919|FG001|NOT COMPLETED|Overall Study||56
9738057|NCT00211887|10838920|FG002|NOT COMPLETED|Overall Study||36
9738058|NCT00212134|10838930|FG000|STARTED|Phase 1 (to Age 1 Year)||57
9738059|NCT00212134|10838931|FG001|STARTED|Phase 1 (to Age 1 Year)||57
9738060|NCT00212134|10838930|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
9738061|NCT00212134|10838931|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
9738062|NCT00212134|10838930|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
9738063|NCT00212134|10838931|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
9738064|NCT00212134|10838930|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
9738065|NCT00212134|10838931|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
9738066|NCT00212134|10838930|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
9738067|NCT00212134|10838931|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
9738068|NCT00212134|10838930|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
9738069|NCT00212134|10838931|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
9738070|NCT00212134|10838930|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
9738071|NCT00212134|10838931|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
9738072|NCT00212134|10838930|FG000|STARTED|Phase 3 (Age 10 Years)||57
9738073|NCT00212134|10838931|FG001|STARTED|Phase 3 (Age 10 Years)||56
9738074|NCT00212134|10838930|FG000|COMPLETED|Phase 3 (Age 10 Years)||55
9738075|NCT00212134|10838931|FG001|COMPLETED|Phase 3 (Age 10 Years)||55
9738076|NCT00212134|10838930|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2
9738077|NCT00212134|10838931|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1
9738078|NCT00212264|10838944|FG000|STARTED|Overall Study||70
9738079|NCT00212264|10838945|FG001|STARTED|Overall Study||70
9738080|NCT00212264|10838946|FG002|STARTED|Overall Study||68
9738081|NCT00212264|10838944|FG000|COMPLETED|Overall Study||58
9738082|NCT00212264|10838945|FG001|COMPLETED|Overall Study||54
9738083|NCT00212264|10838946|FG002|COMPLETED|Overall Study||64
9738084|NCT00212264|10838944|FG000|NOT COMPLETED|Overall Study||12
9738085|NCT00212264|10838945|FG001|NOT COMPLETED|Overall Study||16
9738086|NCT00212264|10838946|FG002|NOT COMPLETED|Overall Study||4
9738087|NCT00212355|10838954|FG000|STARTED|Overall Study||37
9738088|NCT00212355|10838954|FG000|COMPLETED|Overall Study||34
9738089|NCT00212355|10838954|FG000|NOT COMPLETED|Overall Study||3
9738090|NCT00212446|10838958|FG000|STARTED|Overall Study||8
9738091|NCT00212446|10838958|FG000|COMPLETED|Overall Study||8
9738092|NCT00212446|10838958|FG000|NOT COMPLETED|Overall Study||0
10089006|NCT02317510|11217883|FG000|COMPLETED|Overall Study||25
10089007|NCT02317510|11217884|FG001|COMPLETED|Overall Study||24
10089008|NCT02317510|11217883|FG000|NOT COMPLETED|Overall Study||0
10089009|NCT02317510|11217884|FG001|NOT COMPLETED|Overall Study||1
10089010|NCT02317549|11217895|FG000|STARTED|Overall Study||5
10089011|NCT02317549|11217896|FG001|STARTED|Overall Study||3
10089012|NCT02317549|11217895|FG000|COMPLETED|Overall Study||5
10089013|NCT02317549|11217896|FG001|COMPLETED|Overall Study||3
10089014|NCT02317549|11217895|FG000|NOT COMPLETED|Overall Study||0
10089015|NCT02317549|11217896|FG001|NOT COMPLETED|Overall Study||0
10089016|NCT02317562|11217902|FG000|STARTED|Overall Study||19
10089017|NCT02317562|11217902|FG000|COMPLETED|Overall Study||5
10089018|NCT02317562|11217902|FG000|NOT COMPLETED|Overall Study||14
10089019|NCT02317575|11217906|FG000|STARTED|Period 1||5
10089020|NCT02317575|11217907|FG001|STARTED|Period 1||6
10089021|NCT02317575|11217908|FG002|STARTED|Period 1||6
10089022|NCT02317575|11217909|FG003|STARTED|Period 1||6
10089023|NCT02317575|11217910|FG004|STARTED|Period 1||6
10089024|NCT02317575|11217906|FG000|Received at Least 1 Dose of Study Drug|Period 1||5
10089025|NCT02317575|11217907|FG001|Received at Least 1 Dose of Study Drug|Period 1||5
10089026|NCT02317575|11217908|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
10089027|NCT02317575|11217909|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10089028|NCT02317575|11217910|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
10089029|NCT02317575|11217906|FG000|COMPLETED|Period 1||4
10089030|NCT02317575|11217907|FG001|COMPLETED|Period 1||5
10089031|NCT02317575|11217908|FG002|COMPLETED|Period 1||6
10089032|NCT02317575|11217909|FG003|COMPLETED|Period 1||6
10089033|NCT02317575|11217910|FG004|COMPLETED|Period 1||6
10089034|NCT02317575|11217906|FG000|NOT COMPLETED|Period 1||1
10089035|NCT02317575|11217907|FG001|NOT COMPLETED|Period 1||1
9738093|NCT00212758|10838962|FG000|STARTED|First Intervention (7 Days)||8
9738094|NCT00212758|10838963|FG001|STARTED|First Intervention (7 Days)||9
9738095|NCT00212758|10838962|FG000|COMPLETED|First Intervention (7 Days)||8
9738096|NCT00212758|10838963|FG001|COMPLETED|First Intervention (7 Days)||9
9738097|NCT00212758|10838962|FG000|NOT COMPLETED|First Intervention (7 Days)||0
9738098|NCT00212758|10838963|FG001|NOT COMPLETED|First Intervention (7 Days)||0
9738099|NCT00212758|10838962|FG000|STARTED|Wash Out Period (2 Weeks)||8
9738100|NCT00212758|10838963|FG001|STARTED|Wash Out Period (2 Weeks)||9
9738101|NCT00212758|10838962|FG000|COMPLETED|Wash Out Period (2 Weeks)||8
9738102|NCT00212758|10838963|FG001|COMPLETED|Wash Out Period (2 Weeks)||9
9738103|NCT00212758|10838962|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0
10089036|NCT02317575|11217908|FG002|NOT COMPLETED|Period 1||0
10089037|NCT02317575|11217909|FG003|NOT COMPLETED|Period 1||0
10089038|NCT02317575|11217910|FG004|NOT COMPLETED|Period 1||0
10089039|NCT02317575|11217906|FG000|STARTED|Period 2||4
10089040|NCT02317575|11217907|FG001|STARTED|Period 2||5
10089041|NCT02317575|11217908|FG002|STARTED|Period 2||6
10089042|NCT02317575|11217909|FG003|STARTED|Period 2||6
10089043|NCT02317575|11217910|FG004|STARTED|Period 2||6
10089044|NCT02317575|11217906|FG000|COMPLETED|Period 2||4
9738104|NCT00212758|10838963|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0
9738105|NCT00212758|10838962|FG000|STARTED|Second Intervention (7 Days)||8
9738106|NCT00212758|10838963|FG001|STARTED|Second Intervention (7 Days)||9
9738107|NCT00212758|10838962|FG000|COMPLETED|Second Intervention (7 Days)||8
9738108|NCT00212758|10838963|FG001|COMPLETED|Second Intervention (7 Days)||9
9738109|NCT00212758|10838962|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
9738110|NCT00212758|10838963|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
9738111|NCT00212758|10838962|FG000|STARTED|Standard Therapy of GH (12 Months)||8
9738112|NCT00212758|10838963|FG001|STARTED|Standard Therapy of GH (12 Months)||9
9738113|NCT00212758|10838962|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6
9738114|NCT00212758|10838963|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8
9738115|NCT00212758|10838962|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
9738116|NCT00212758|10838963|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
9738117|NCT00212888|10838972|FG000|STARTED|Overall Study||19
9738118|NCT00212888|10838973|FG001|STARTED|Overall Study||18
9738119|NCT00212888|10838974|FG002|STARTED|Overall Study||15
9738120|NCT00212888|10838972|FG000|COMPLETED|Overall Study||16
9738121|NCT00212888|10838973|FG001|COMPLETED|Overall Study||18
9738122|NCT00212888|10838974|FG002|COMPLETED|Overall Study||14
9738123|NCT00212888|10838972|FG000|NOT COMPLETED|Overall Study||3
9738124|NCT00212888|10838973|FG001|NOT COMPLETED|Overall Study||0
9738125|NCT00212888|10838974|FG002|NOT COMPLETED|Overall Study||1
9738126|NCT00213135|10838987|FG000|STARTED|Overall Study||456
9738127|NCT00213135|10838988|FG001|STARTED|Overall Study||433
9738128|NCT00213135|10838989|FG002|STARTED|Overall Study||437
9738129|NCT00213135|10838987|FG000|COMPLETED|Overall Study||406
9738130|NCT00213135|10838988|FG001|COMPLETED|Overall Study||398
10089045|NCT02317575|11217907|FG001|COMPLETED|Period 2||5
10089046|NCT02317575|11217908|FG002|COMPLETED|Period 2||6
10089047|NCT02317575|11217909|FG003|COMPLETED|Period 2||6
10089048|NCT02317575|11217910|FG004|COMPLETED|Period 2||6
10089049|NCT02317575|11217906|FG000|NOT COMPLETED|Period 2||0
10089050|NCT02317575|11217907|FG001|NOT COMPLETED|Period 2||0
10089051|NCT02317575|11217908|FG002|NOT COMPLETED|Period 2||0
10089052|NCT02317575|11217909|FG003|NOT COMPLETED|Period 2||0
10089053|NCT02317575|11217910|FG004|NOT COMPLETED|Period 2||0
10089054|NCT02317575|11217906|FG000|STARTED|Period 3||4
10089055|NCT02317575|11217907|FG001|STARTED|Period 3||5
10089056|NCT02317575|11217908|FG002|STARTED|Period 3||6
10089057|NCT02317575|11217909|FG003|STARTED|Period 3||6
10089058|NCT02317575|11217910|FG004|STARTED|Period 3||6
10089059|NCT02317575|11217906|FG000|COMPLETED|Period 3||4
10089060|NCT02317575|11217907|FG001|COMPLETED|Period 3||5
10089061|NCT02317575|11217908|FG002|COMPLETED|Period 3||6
10089062|NCT02317575|11217909|FG003|COMPLETED|Period 3||6
10089063|NCT02317575|11217910|FG004|COMPLETED|Period 3||6
10089064|NCT02317575|11217906|FG000|NOT COMPLETED|Period 3||0
10089065|NCT02317575|11217907|FG001|NOT COMPLETED|Period 3||0
10089066|NCT02317575|11217908|FG002|NOT COMPLETED|Period 3||0
10089067|NCT02317575|11217909|FG003|NOT COMPLETED|Period 3||0
10089068|NCT02317575|11217910|FG004|NOT COMPLETED|Period 3||0
10089069|NCT02317575|11217906|FG000|STARTED|Period 4||4
10089070|NCT02317575|11217907|FG001|STARTED|Period 4||5
10089071|NCT02317575|11217908|FG002|STARTED|Period 4||6
10089072|NCT02317575|11217909|FG003|STARTED|Period 4||6
10089073|NCT02317575|11217910|FG004|STARTED|Period 4||6
10089074|NCT02317575|11217906|FG000|COMPLETED|Period 4||4
10089075|NCT02317575|11217907|FG001|COMPLETED|Period 4||5
10089076|NCT02317575|11217908|FG002|COMPLETED|Period 4||6
10089077|NCT02317575|11217909|FG003|COMPLETED|Period 4||6
10089078|NCT02317575|11217910|FG004|COMPLETED|Period 4||6
10089079|NCT02317575|11217906|FG000|NOT COMPLETED|Period 4||0
10089080|NCT02317575|11217907|FG001|NOT COMPLETED|Period 4||0
10089081|NCT02317575|11217908|FG002|NOT COMPLETED|Period 4||0
10089082|NCT02317575|11217909|FG003|NOT COMPLETED|Period 4||0
9738131|NCT00213135|10838989|FG002|COMPLETED|Overall Study||380
9738132|NCT00213135|10838987|FG000|NOT COMPLETED|Overall Study||50
9738133|NCT00213135|10838988|FG001|NOT COMPLETED|Overall Study||35
9738134|NCT00213135|10838989|FG002|NOT COMPLETED|Overall Study||57
9738135|NCT00213148|10839001|FG000|STARTED|Cycle 1 (1 Month)||77
9738136|NCT00213148|10839002|FG001|STARTED|Cycle 1 (1 Month)||0
9738137|NCT00213148|10839003|FG002|STARTED|Cycle 1 (1 Month)||79
9738138|NCT00213148|10839004|FG003|STARTED|Cycle 1 (1 Month)||76
9738139|NCT00213148|10839005|FG004|STARTED|Cycle 1 (1 Month)||39
10089083|NCT02317575|11217910|FG004|NOT COMPLETED|Period 4||0
10089084|NCT02317575|11217906|FG000|STARTED|Period 5||4
10089085|NCT02317575|11217907|FG001|STARTED|Period 5||5
10089086|NCT02317575|11217908|FG002|STARTED|Period 5||6
10089087|NCT02317575|11217909|FG003|STARTED|Period 5||6
10089088|NCT02317575|11217910|FG004|STARTED|Period 5||6
10089089|NCT02317575|11217906|FG000|COMPLETED|Period 5||4
10089090|NCT02317575|11217907|FG001|COMPLETED|Period 5||5
10089091|NCT02317575|11217908|FG002|COMPLETED|Period 5||6
10089092|NCT02317575|11217909|FG003|COMPLETED|Period 5||6
10089093|NCT02317575|11217910|FG004|COMPLETED|Period 5||6
10089094|NCT02317575|11217906|FG000|NOT COMPLETED|Period 5||0
10089095|NCT02317575|11217907|FG001|NOT COMPLETED|Period 5||0
10089096|NCT02317575|11217908|FG002|NOT COMPLETED|Period 5||0
10089097|NCT02317575|11217909|FG003|NOT COMPLETED|Period 5||0
9738140|NCT00213148|10839001|FG000|COMPLETED|Cycle 1 (1 Month)||53
9738141|NCT00213148|10839002|FG001|COMPLETED|Cycle 1 (1 Month)||0
9738142|NCT00213148|10839003|FG002|COMPLETED|Cycle 1 (1 Month)||60
9738143|NCT00213148|10839004|FG003|COMPLETED|Cycle 1 (1 Month)||58
9738144|NCT00213148|10839005|FG004|COMPLETED|Cycle 1 (1 Month)||17
9738145|NCT00213148|10839001|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24
9738146|NCT00213148|10839002|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0
9738147|NCT00213148|10839003|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19
9738148|NCT00213148|10839004|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18
9738149|NCT00213148|10839005|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22
9738150|NCT00213148|10839001|FG000|STARTED|Cycle 2 (1 Month)||43
9738151|NCT00213148|10839002|FG001|STARTED|Cycle 2 (1 Month)||10
9738152|NCT00213148|10839003|FG002|STARTED|Cycle 2 (1 Month)||42
9738153|NCT00213148|10839004|FG003|STARTED|Cycle 2 (1 Month)||52
9738154|NCT00213148|10839005|FG004|STARTED|Cycle 2 (1 Month)||41
9738155|NCT00213148|10839001|FG000|COMPLETED|Cycle 2 (1 Month)||29
9738156|NCT00213148|10839002|FG001|COMPLETED|Cycle 2 (1 Month)||4
9738157|NCT00213148|10839003|FG002|COMPLETED|Cycle 2 (1 Month)||28
9738158|NCT00213148|10839004|FG003|COMPLETED|Cycle 2 (1 Month)||33
9738159|NCT00213148|10839005|FG004|COMPLETED|Cycle 2 (1 Month)||11
9738160|NCT00213148|10839001|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14
9738161|NCT00213148|10839002|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6
9738162|NCT00213148|10839003|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14
9738163|NCT00213148|10839004|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19
9738164|NCT00213148|10839005|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30
9738165|NCT00213148|10839001|FG000|STARTED|Cycle 3 (1 Month)||23
9738166|NCT00213148|10839002|FG001|STARTED|Cycle 3 (1 Month)||10
9738167|NCT00213148|10839003|FG002|STARTED|Cycle 3 (1 Month)||26
9738168|NCT00213148|10839004|FG003|STARTED|Cycle 3 (1 Month)||24
9738169|NCT00213148|10839005|FG004|STARTED|Cycle 3 (1 Month)||22
10089098|NCT02317575|11217910|FG004|NOT COMPLETED|Period 5||0
10089099|NCT02317614|11217930|FG000|STARTED|Overall Study||26
10089100|NCT02317614|11217931|FG001|STARTED|Overall Study||25
9738170|NCT00213148|10839001|FG000|COMPLETED|Cycle 3 (1 Month)||23
9738171|NCT00213148|10839002|FG001|COMPLETED|Cycle 3 (1 Month)||8
10089101|NCT02317614|11217930|FG000|COMPLETED|Overall Study||23
10089102|NCT02317614|11217931|FG001|COMPLETED|Overall Study||23
10089103|NCT02317614|11217930|FG000|NOT COMPLETED|Overall Study||3
10089104|NCT02317614|11217931|FG001|NOT COMPLETED|Overall Study||2
10089105|NCT02317692|11217939|FG000|STARTED|Overall Study||69
10089106|NCT02317692|11217940|FG001|STARTED|Overall Study||77
10089107|NCT02317692|11217939|FG000|COMPLETED|Overall Study||63
10089108|NCT02317692|11217940|FG001|COMPLETED|Overall Study||77
10089109|NCT02317692|11217939|FG000|NOT COMPLETED|Overall Study||6
10089110|NCT02317692|11217940|FG001|NOT COMPLETED|Overall Study||0
10089111|NCT02317744|11217948|FG000|STARTED|Overall Study||12
10089112|NCT02317744|11217949|FG001|STARTED|Overall Study||10
10089113|NCT02317744|11217948|FG000|Completed Treatment|Overall Study||10
10089114|NCT02317744|11217949|FG001|Completed Treatment|Overall Study||7
10089115|NCT02317744|11217948|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
10089116|NCT02317744|11217949|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
10089117|NCT02317744|11217948|FG000|NOT COMPLETED|Overall Study||1
10089118|NCT02317744|11217949|FG001|NOT COMPLETED|Overall Study||2
10089119|NCT02317809|11217955|FG000|STARTED|First Intervention Period (8 Days)||17
10089120|NCT02317809|11217956|FG001|STARTED|First Intervention Period (8 Days)||17
10089121|NCT02317809|11217955|FG000|COMPLETED|First Intervention Period (8 Days)||14
10089122|NCT02317809|11217956|FG001|COMPLETED|First Intervention Period (8 Days)||17
10089123|NCT02317809|11217955|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3
10089124|NCT02317809|11217956|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
10089125|NCT02317809|11217955|FG000|STARTED|Second Intervention Period (8 Days)||14
10089126|NCT02317809|11217956|FG001|STARTED|Second Intervention Period (8 Days)||17
10089127|NCT02317809|11217955|FG000|COMPLETED|Second Intervention Period (8 Days)||14
10089128|NCT02317809|11217956|FG001|COMPLETED|Second Intervention Period (8 Days)||17
10089129|NCT02317809|11217955|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
10089130|NCT02317809|11217956|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
10089131|NCT02318134|11217967|FG000|STARTED|Overall Study||30
10089132|NCT02318134|11217968|FG001|STARTED|Overall Study||30
10089133|NCT02318134|11217967|FG000|COMPLETED|Overall Study||28
10089134|NCT02318134|11217968|FG001|COMPLETED|Overall Study||29
10089135|NCT02318134|11217967|FG000|NOT COMPLETED|Overall Study||2
9738172|NCT00213148|10839003|FG002|COMPLETED|Cycle 3 (1 Month)||25
10089136|NCT02318134|11217968|FG001|NOT COMPLETED|Overall Study||1
10089137|NCT02318303|11217983|FG000|STARTED|Overall Study||159
10089138|NCT02318303|11217984|FG001|STARTED|Overall Study||158
10089139|NCT02318303|11217985|FG002|STARTED|Overall Study||160
10089140|NCT02318303|11217986|FG003|STARTED|Overall Study||158
10089141|NCT02318303|11217987|FG004|STARTED|Overall Study||157
9738173|NCT00213148|10839004|FG003|COMPLETED|Cycle 3 (1 Month)||23
9738174|NCT00213148|10839005|FG004|COMPLETED|Cycle 3 (1 Month)||21
9738175|NCT00213148|10839001|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0
9738176|NCT00213148|10839002|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2
9738177|NCT00213148|10839003|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1
9738178|NCT00213148|10839004|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1
9738179|NCT00213148|10839005|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1
9738180|NCT00213239|10839027|FG000|STARTED|Overall Study||32
9738181|NCT00213239|10839028|FG001|STARTED|Overall Study||32
9738182|NCT00213239|10839027|FG000|COMPLETED|Overall Study||32
9738183|NCT00213239|10839028|FG001|COMPLETED|Overall Study||32
10089142|NCT02318303|11217988|FG005|STARTED|Overall Study||159
10089143|NCT02318303|11217989|FG006|STARTED|Overall Study||160
10089144|NCT02318303|11217983|FG000|COMPLETED|Overall Study||155
10089145|NCT02318303|11217984|FG001|COMPLETED|Overall Study||155
10089146|NCT02318303|11217985|FG002|COMPLETED|Overall Study||157
10089147|NCT02318303|11217986|FG003|COMPLETED|Overall Study||155
10089148|NCT02318303|11217987|FG004|COMPLETED|Overall Study||152
10089149|NCT02318303|11217988|FG005|COMPLETED|Overall Study||153
10089150|NCT02318303|11217989|FG006|COMPLETED|Overall Study||158
10089151|NCT02318303|11217983|FG000|NOT COMPLETED|Overall Study||4
10089152|NCT02318303|11217984|FG001|NOT COMPLETED|Overall Study||3
10089153|NCT02318303|11217985|FG002|NOT COMPLETED|Overall Study||3
10089154|NCT02318303|11217986|FG003|NOT COMPLETED|Overall Study||3
10089155|NCT02318303|11217987|FG004|NOT COMPLETED|Overall Study||5
10089156|NCT02318303|11217988|FG005|NOT COMPLETED|Overall Study||6
10089157|NCT02318303|11217989|FG006|NOT COMPLETED|Overall Study||2
10089158|NCT02318368|11218007|FG000|STARTED|Overall Study||7
10089159|NCT02318368|11218008|FG001|STARTED|Overall Study||3
10089160|NCT02318368|11218007|FG000|COMPLETED|Overall Study||0
10089161|NCT02318368|11218008|FG001|COMPLETED|Overall Study||0
10089162|NCT02318368|11218007|FG000|NOT COMPLETED|Overall Study||7
10089163|NCT02318368|11218008|FG001|NOT COMPLETED|Overall Study||3
10089164|NCT02318550|11218014|FG000|STARTED|Overall Study||262
10089165|NCT02318550|11218014|FG000|COMPLETED|Overall Study||262
10089166|NCT02318550|11218014|FG000|NOT COMPLETED|Overall Study||0
10089167|NCT02318602|11218021|FG000|STARTED|Overall Study||9
10089168|NCT02318602|11218022|FG001|STARTED|Overall Study||26
10089169|NCT02318602|11218023|FG002|STARTED|Overall Study||17
10089170|NCT02318602|11218021|FG000|COMPLETED|Overall Study||8
10089171|NCT02318602|11218022|FG001|COMPLETED|Overall Study||22
10089172|NCT02318602|11218023|FG002|COMPLETED|Overall Study||15
10089173|NCT02318602|11218021|FG000|NOT COMPLETED|Overall Study||1
10089174|NCT02318602|11218022|FG001|NOT COMPLETED|Overall Study||4
10089175|NCT02318602|11218023|FG002|NOT COMPLETED|Overall Study||2
10089176|NCT02318667|11218037|FG000|STARTED|Overall Study||38
10089177|NCT02318667|11218037|FG000|COMPLETED|Overall Study||29
10089178|NCT02318667|11218037|FG000|NOT COMPLETED|Overall Study||9
10089179|NCT02318693|11218047|FG000|STARTED|Overall Study||26
10089180|NCT02318693|11218048|FG001|STARTED|Overall Study||27
10089181|NCT02318693|11218047|FG000|Treated|Overall Study||26
10089182|NCT02318693|11218048|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26
10089183|NCT02318693|11218047|FG000|COMPLETED|Overall Study||26
10089184|NCT02318693|11218048|FG001|COMPLETED|Overall Study||26
10089185|NCT02318693|11218047|FG000|NOT COMPLETED|Overall Study||0
10089186|NCT02318693|11218048|FG001|NOT COMPLETED|Overall Study||1
10089187|NCT02318706|11218058|FG000|STARTED|Double-blind Phase||334
10089188|NCT02318706|11218059|FG001|STARTED|Double-blind Phase||166
10201492|NCT03435081|11328814|FG000|NOT COMPLETED|Overall Study||21
10201493|NCT03435081|11328815|FG001|NOT COMPLETED|Overall Study||16
10201494|NCT03435081|11328816|FG002|NOT COMPLETED|Overall Study||19
10201495|NCT03435211|11328825|FG000|STARTED|Overall Study||26
10201496|NCT03435211|11328825|FG000|COMPLETED|Overall Study||25
10201497|NCT03435211|11328825|FG000|NOT COMPLETED|Overall Study||1
10201498|NCT03435224|11328829|FG000|STARTED|Overall Study||29
10201499|NCT03435224|11328829|FG000|COMPLETED|Overall Study||25
10201500|NCT03435224|11328829|FG000|NOT COMPLETED|Overall Study||4
10201501|NCT03435497|11328835|FG000|STARTED|Overall Study||51
10201502|NCT03435497|11328836|FG001|STARTED|Overall Study||47
10201503|NCT03435497|11328835|FG000|COMPLETED|Overall Study||49
10201504|NCT03435497|11328836|FG001|COMPLETED|Overall Study||41
10201505|NCT03435497|11328835|FG000|NOT COMPLETED|Overall Study||2
10201506|NCT03435497|11328836|FG001|NOT COMPLETED|Overall Study||6
10201507|NCT03435562|11328842|FG000|STARTED|Overall Study||22
10201508|NCT03435562|11328842|FG000|COMPLETED|Overall Study||18
10201509|NCT03435562|11328842|FG000|NOT COMPLETED|Overall Study||4
10201510|NCT03435614|11328855|FG000|STARTED|Overall Study||6
10201511|NCT03435614|11328856|FG001|STARTED|Overall Study||23
10201512|NCT03435614|11328855|FG000|COMPLETED|Overall Study||6
10201513|NCT03435614|11328856|FG001|COMPLETED|Overall Study||23
10201514|NCT03435614|11328855|FG000|NOT COMPLETED|Overall Study||0
10201515|NCT03435614|11328856|FG001|NOT COMPLETED|Overall Study||0
10201516|NCT03435692|11328866|FG000|STARTED|Overall Study||17
10201517|NCT03435692|11328867|FG001|STARTED|Overall Study||18
10201518|NCT03435692|11328868|FG002|STARTED|Overall Study||7
10201519|NCT03435692|11328866|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15
10201520|NCT03435692|11328867|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16
10201521|NCT03435692|11328868|FG002|COMPLETED|Overall Study||7
10201522|NCT03435692|11328866|FG000|NOT COMPLETED|Overall Study||2
10089189|NCT02318706|11218060|FG002|STARTED|Double-blind Phase||168
10089190|NCT02318706|11218061|FG003|STARTED|Double-blind Phase||166
10089191|NCT02318706|11218062|FG004|STARTED|Double-blind Phase||0
10089192|NCT02318706|11218058|FG000|COMPLETED|Double-blind Phase||309
10089193|NCT02318706|11218059|FG001|COMPLETED|Double-blind Phase||154
9738184|NCT00213239|10839027|FG000|NOT COMPLETED|Overall Study||0
9738185|NCT00213239|10839028|FG001|NOT COMPLETED|Overall Study||0
9738186|NCT00213980|10839036|FG000|STARTED|Overall Study||32
9738187|NCT00213980|10839037|FG001|STARTED|Overall Study||36
9738188|NCT00213980|10839036|FG000|COMPLETED|Overall Study||26
9738189|NCT00213980|10839037|FG001|COMPLETED|Overall Study||29
9738190|NCT00213980|10839036|FG000|NOT COMPLETED|Overall Study||6
9738191|NCT00213980|10839037|FG001|NOT COMPLETED|Overall Study||7
9738192|NCT00214019|10839043|FG000|STARTED|Overall Study||36
9738193|NCT00214019|10839043|FG000|Placebo/Placebo Arm|Overall Study||6
9738194|NCT00214019|10839043|FG000|Placebo/Salmeterol Arm|Overall Study||6
9738195|NCT00214019|10839043|FG000|Fluticasone/Placebo Arm|Overall Study||6
9738196|NCT00214019|10839043|FG000|Fluticason/Salmeterol Arm|Overall Study||6
9738197|NCT00214019|10839043|FG000|COMPLETED|Overall Study||6
9738198|NCT00214019|10839043|FG000|NOT COMPLETED|Overall Study||30
9738199|NCT00214045|10839052|FG000|STARTED|Overall Study||18
9738200|NCT00214045|10839053|FG001|STARTED|Overall Study||18
9738201|NCT00214045|10839052|FG000|COMPLETED|Overall Study||18
9738202|NCT00214045|10839053|FG001|COMPLETED|Overall Study||18
9738203|NCT00214045|10839052|FG000|NOT COMPLETED|Overall Study||0
9738204|NCT00214045|10839053|FG001|NOT COMPLETED|Overall Study||0
9828149|NCT00754247|10938855|FG001|COMPLETED|Overall Study||5
9828150|NCT00754247|10938856|FG002|COMPLETED|Overall Study||5
9828151|NCT00754247|10938854|FG000|NOT COMPLETED|Overall Study||5
9828152|NCT00754247|10938855|FG001|NOT COMPLETED|Overall Study||5
9828153|NCT00754247|10938856|FG002|NOT COMPLETED|Overall Study||5
9828154|NCT00754325|10938866|FG000|STARTED|Initial Treatment||50
9828155|NCT00754325|10938867|FG001|STARTED|Initial Treatment||49
9828156|NCT00754325|10938866|FG000|COMPLETED|Initial Treatment||0
9828157|NCT00754325|10938867|FG001|COMPLETED|Initial Treatment||0
9828158|NCT00754325|10938866|FG000|NOT COMPLETED|Initial Treatment||50
9828159|NCT00754325|10938867|FG001|NOT COMPLETED|Initial Treatment||49
9828160|NCT00754325|10938866|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
10089194|NCT02318706|11218060|FG002|COMPLETED|Double-blind Phase||150
10089195|NCT02318706|11218061|FG003|COMPLETED|Double-blind Phase||142
10089196|NCT02318706|11218062|FG004|COMPLETED|Double-blind Phase||0
10089197|NCT02318706|11218058|FG000|NOT COMPLETED|Double-blind Phase||25
10089198|NCT02318706|11218059|FG001|NOT COMPLETED|Double-blind Phase||12
10089199|NCT02318706|11218060|FG002|NOT COMPLETED|Double-blind Phase||18
10089200|NCT02318706|11218061|FG003|NOT COMPLETED|Double-blind Phase||24
10089201|NCT02318706|11218062|FG004|NOT COMPLETED|Double-blind Phase||0
10089202|NCT02318706|11218058|FG000|STARTED|Open-label Extension Phase||0
10089203|NCT02318706|11218059|FG001|STARTED|Open-label Extension Phase||0
10089204|NCT02318706|11218060|FG002|STARTED|Open-label Extension Phase||0
10089205|NCT02318706|11218061|FG003|STARTED|Open-label Extension Phase||0
10089206|NCT02318706|11218062|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
10089207|NCT02318706|11218058|FG000|COMPLETED|Open-label Extension Phase||0
10089208|NCT02318706|11218059|FG001|COMPLETED|Open-label Extension Phase||0
10089209|NCT02318706|11218060|FG002|COMPLETED|Open-label Extension Phase||0
10089210|NCT02318706|11218061|FG003|COMPLETED|Open-label Extension Phase||0
10089211|NCT02318706|11218062|FG004|COMPLETED|Open-label Extension Phase||172
10089212|NCT02318706|11218058|FG000|NOT COMPLETED|Open-label Extension Phase||0
10089213|NCT02318706|11218059|FG001|NOT COMPLETED|Open-label Extension Phase||0
10089214|NCT02318706|11218060|FG002|NOT COMPLETED|Open-label Extension Phase||0
10089215|NCT02318706|11218061|FG003|NOT COMPLETED|Open-label Extension Phase||0
10089216|NCT02318706|11218062|FG004|NOT COMPLETED|Open-label Extension Phase||42
10089217|NCT02318719|11218078|FG000|STARTED|Double-blind Phase||304
10089218|NCT02318719|11218079|FG001|STARTED|Double-blind Phase||153
10089219|NCT02318719|11218080|FG002|STARTED|Double-blind Phase||153
10089220|NCT02318719|11218081|FG003|STARTED|Double-blind Phase||155
10089221|NCT02318719|11218082|FG004|STARTED|Double-blind Phase||0
10089222|NCT02318719|11218078|FG000|Did Not Receive Treatment|Double-blind Phase||1
10089223|NCT02318719|11218079|FG001|Did Not Receive Treatment|Double-blind Phase||1
10089224|NCT02318719|11218080|FG002|Did Not Receive Treatment|Double-blind Phase||0
10089225|NCT02318719|11218081|FG003|Did Not Receive Treatment|Double-blind Phase||0
10089226|NCT02318719|11218082|FG004|Did Not Receive Treatment|Double-blind Phase||0
10089227|NCT02318719|11218078|FG000|COMPLETED|Double-blind Phase||266
10089228|NCT02318719|11218079|FG001|COMPLETED|Double-blind Phase||137
10089229|NCT02318719|11218080|FG002|COMPLETED|Double-blind Phase||128
10089230|NCT02318719|11218081|FG003|COMPLETED|Double-blind Phase||140
10089231|NCT02318719|11218082|FG004|COMPLETED|Double-blind Phase||0
10089232|NCT02318719|11218078|FG000|NOT COMPLETED|Double-blind Phase||38
9828161|NCT00754325|10938867|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
9828162|NCT00754325|10938866|FG000|COMPLETED|Progression and Cross-over||0
9828163|NCT00754325|10938867|FG001|COMPLETED|Progression and Cross-over||0
9828164|NCT00754325|10938866|FG000|NOT COMPLETED|Progression and Cross-over||0
9828165|NCT00754325|10938867|FG001|NOT COMPLETED|Progression and Cross-over||21
9828166|NCT00754338|10938878|FG000|STARTED|First Intervention for Phase1&Phase2||17
9828167|NCT00754338|10938879|FG001|STARTED|First Intervention for Phase1&Phase2||21
9828168|NCT00754338|10938880|FG002|STARTED|First Intervention for Phase1&Phase2||19
10089233|NCT02318719|11218079|FG001|NOT COMPLETED|Double-blind Phase||16
10089234|NCT02318719|11218080|FG002|NOT COMPLETED|Double-blind Phase||25
9738205|NCT00214097|10839062|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
9738206|NCT00214097|10839063|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
9738207|NCT00214097|10839064|FG002|STARTED|Overall Study||135
9738208|NCT00214097|10839062|FG000|COMPLETED|Overall Study||101
9738209|NCT00214097|10839063|FG001|COMPLETED|Overall Study||111
9738210|NCT00214097|10839064|FG002|COMPLETED|Overall Study||135
9852246|NCT00880269|10965075|FG000|STARTED|Overall Study||32
9852247|NCT00880269|10965076|FG001|STARTED|Overall Study||27
10089235|NCT02318719|11218081|FG003|NOT COMPLETED|Double-blind Phase||15
10089236|NCT02318719|11218082|FG004|NOT COMPLETED|Double-blind Phase||0
10089237|NCT02318719|11218078|FG000|STARTED|Open-label Extension Phase||0
10089238|NCT02318719|11218079|FG001|STARTED|Open-label Extension Phase||0
10089239|NCT02318719|11218080|FG002|STARTED|Open-label Extension Phase||0
10089240|NCT02318719|11218081|FG003|STARTED|Open-label Extension Phase||0
10089241|NCT02318719|11218082|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
10089242|NCT02318719|11218078|FG000|COMPLETED|Open-label Extension Phase||0
10201523|NCT03435692|11328867|FG001|NOT COMPLETED|Overall Study||2
10201524|NCT03435692|11328868|FG002|NOT COMPLETED|Overall Study||0
10201525|NCT03435783|11328882|FG000|STARTED|Overall Study||20
10201526|NCT03435783|11328883|FG001|STARTED|Overall Study||20
10201527|NCT03435783|11328882|FG000|COMPLETED|Overall Study||20
10201528|NCT03435783|11328883|FG001|COMPLETED|Overall Study||19
10201529|NCT03435783|11328882|FG000|NOT COMPLETED|Overall Study||0
10201530|NCT03435783|11328883|FG001|NOT COMPLETED|Overall Study||1
10201531|NCT03436082|11328891|FG000|STARTED|Overall Study||30
10201532|NCT03436082|11328892|FG001|STARTED|Overall Study||30
10201533|NCT03436082|11328891|FG000|COMPLETED|Overall Study|Had procedure|29
10201534|NCT03436082|11328892|FG001|COMPLETED|Overall Study|Had procedure|30
10201535|NCT03436082|11328891|FG000|NOT COMPLETED|Overall Study||1
10201536|NCT03436082|11328892|FG001|NOT COMPLETED|Overall Study||0
10201537|NCT03436147|11328900|FG000|STARTED|Overall Study||19
10201538|NCT03436147|11328901|FG001|STARTED|Overall Study||30
10201539|NCT03436147|11328900|FG000|COMPLETED|Overall Study||15
10201540|NCT03436147|11328901|FG001|COMPLETED|Overall Study||19
10201541|NCT03436147|11328900|FG000|NOT COMPLETED|Overall Study||4
10201542|NCT03436147|11328901|FG001|NOT COMPLETED|Overall Study||11
10201543|NCT03436420|11328909|FG000|STARTED|Overall Study||6
10201544|NCT03436420|11328909|FG000|COMPLETED|Overall Study||3
10201545|NCT03436420|11328909|FG000|NOT COMPLETED|Overall Study||3
10201546|NCT03436732|11328915|FG000|STARTED|Overall Study||4
10201547|NCT03436732|11328916|FG001|STARTED|Overall Study||1
10201548|NCT03436732|11328915|FG000|COMPLETED|Overall Study||0
10201549|NCT03436732|11328916|FG001|COMPLETED|Overall Study||0
10201550|NCT03436732|11328915|FG000|NOT COMPLETED|Overall Study||4
10201551|NCT03436732|11328916|FG001|NOT COMPLETED|Overall Study||1
10201552|NCT03436810|11328925|FG000|STARTED|Overall Study||20
10201553|NCT03436810|11328926|FG001|STARTED|Overall Study||20
10201554|NCT03436810|11328925|FG000|COMPLETED|Overall Study||20
10201555|NCT03436810|11328926|FG001|COMPLETED|Overall Study||20
10201556|NCT03436810|11328925|FG000|NOT COMPLETED|Overall Study||0
10201557|NCT03436810|11328926|FG001|NOT COMPLETED|Overall Study||0
10201558|NCT03437031|11328934|FG000|STARTED|Overall Study||19
10201559|NCT03437031|11328935|FG001|STARTED|Overall Study||21
10201560|NCT03437031|11328934|FG000|COMPLETED|Overall Study||19
10201561|NCT03437031|11328935|FG001|COMPLETED|Overall Study||21
10089243|NCT02318719|11218079|FG001|COMPLETED|Open-label Extension Phase||0
10201562|NCT03437031|11328934|FG000|NOT COMPLETED|Overall Study||0
10201563|NCT03437031|11328935|FG001|NOT COMPLETED|Overall Study||0
10201564|NCT03437044|11328945|FG000|STARTED|Overall Study||20
10201565|NCT03437044|11328946|FG001|STARTED|Overall Study||20
10201566|NCT03437044|11328945|FG000|COMPLETED|Overall Study||17
10201567|NCT03437044|11328946|FG001|COMPLETED|Overall Study||18
10201568|NCT03437044|11328945|FG000|NOT COMPLETED|Overall Study||3
10201569|NCT03437044|11328946|FG001|NOT COMPLETED|Overall Study||2
10089244|NCT02318719|11218080|FG002|COMPLETED|Open-label Extension Phase||0
10089245|NCT02318719|11218081|FG003|COMPLETED|Open-label Extension Phase||0
10089246|NCT02318719|11218082|FG004|COMPLETED|Open-label Extension Phase||184
10089247|NCT02318719|11218078|FG000|NOT COMPLETED|Open-label Extension Phase||0
10089248|NCT02318719|11218079|FG001|NOT COMPLETED|Open-label Extension Phase||0
10089249|NCT02318719|11218080|FG002|NOT COMPLETED|Open-label Extension Phase||0
10201570|NCT03437265|11328952|FG000|STARTED|Overall Study||19
10201571|NCT03437265|11328952|FG000|COMPLETED|Overall Study||13
10201572|NCT03437265|11328952|FG000|NOT COMPLETED|Overall Study||6
10201573|NCT03437447|11328959|FG000|STARTED|Treatment Period 1||20
10201574|NCT03437447|11328960|FG001|STARTED|Treatment Period 1||20
10201575|NCT03437447|11328961|FG002|STARTED|Treatment Period 1||20
10201576|NCT03437447|11328959|FG000|COMPLETED|Treatment Period 1||20
10201577|NCT03437447|11328960|FG001|COMPLETED|Treatment Period 1||20
10201578|NCT03437447|11328961|FG002|COMPLETED|Treatment Period 1||19
10201579|NCT03437447|11328959|FG000|NOT COMPLETED|Treatment Period 1||0
10201580|NCT03437447|11328960|FG001|NOT COMPLETED|Treatment Period 1||0
10201581|NCT03437447|11328961|FG002|NOT COMPLETED|Treatment Period 1||1
10201582|NCT03437447|11328959|FG000|STARTED|Treatment Period 2||20
10201583|NCT03437447|11328960|FG001|STARTED|Treatment Period 2||20
10201584|NCT03437447|11328961|FG002|STARTED|Treatment Period 2||19
10201585|NCT03437447|11328959|FG000|COMPLETED|Treatment Period 2||20
9738211|NCT00214097|10839062|FG000|NOT COMPLETED|Overall Study||0
9738212|NCT00214097|10839063|FG001|NOT COMPLETED|Overall Study||0
9738213|NCT00214097|10839064|FG002|NOT COMPLETED|Overall Study||0
9738214|NCT00214136|10839078|FG000|STARTED|Overall Study||30
9738215|NCT00214136|10839078|FG000|COMPLETED|Overall Study||25
9738216|NCT00214136|10839078|FG000|NOT COMPLETED|Overall Study||5
9738217|NCT00214201|10839084|FG000|STARTED|Overall Study||20
9738218|NCT00214201|10839085|FG001|STARTED|Overall Study||20
9738219|NCT00214201|10839084|FG000|COMPLETED|Overall Study||18
9738220|NCT00214201|10839085|FG001|COMPLETED|Overall Study||18
9738221|NCT00214201|10839084|FG000|NOT COMPLETED|Overall Study||2
9738222|NCT00214201|10839085|FG001|NOT COMPLETED|Overall Study||2
10089250|NCT02318719|11218081|FG003|NOT COMPLETED|Open-label Extension Phase||0
10089251|NCT02318719|11218082|FG004|NOT COMPLETED|Open-label Extension Phase||55
10089252|NCT02318797|11218096|FG000|STARTED|Overall Study||516
10089253|NCT02318797|11218097|FG001|STARTED|Overall Study||713
10089254|NCT02318797|11218096|FG000|COMPLETED|Overall Study||428
10089255|NCT02318797|11218097|FG001|COMPLETED|Overall Study||611
10089256|NCT02318797|11218096|FG000|NOT COMPLETED|Overall Study||88
10089257|NCT02318797|11218097|FG001|NOT COMPLETED|Overall Study||102
10089258|NCT02318940|11218105|FG000|STARTED|Overall Study|in the last patient we lost the record.|50
10201586|NCT03437447|11328960|FG001|COMPLETED|Treatment Period 2||20
10201587|NCT03437447|11328961|FG002|COMPLETED|Treatment Period 2||19
10201588|NCT03437447|11328959|FG000|NOT COMPLETED|Treatment Period 2||0
10201589|NCT03437447|11328960|FG001|NOT COMPLETED|Treatment Period 2||0
10201590|NCT03437447|11328961|FG002|NOT COMPLETED|Treatment Period 2||0
10201591|NCT03437447|11328959|FG000|STARTED|Treatment Period 3||20
10201592|NCT03437447|11328960|FG001|STARTED|Treatment Period 3||20
10201593|NCT03437447|11328961|FG002|STARTED|Treatment Period 3||19
10201594|NCT03437447|11328959|FG000|COMPLETED|Treatment Period 3||20
10201595|NCT03437447|11328960|FG001|COMPLETED|Treatment Period 3||20
10201596|NCT03437447|11328961|FG002|COMPLETED|Treatment Period 3||19
10201597|NCT03437447|11328959|FG000|NOT COMPLETED|Treatment Period 3||0
10201598|NCT03437447|11328960|FG001|NOT COMPLETED|Treatment Period 3||0
10201599|NCT03437447|11328961|FG002|NOT COMPLETED|Treatment Period 3||0
10201600|NCT03437512|11328971|FG000|STARTED|Randomized||12
10201601|NCT03437512|11328972|FG001|STARTED|Randomized||13
10201602|NCT03437512|11328971|FG000|COMPLETED|Randomized||12
10201603|NCT03437512|11328972|FG001|COMPLETED|Randomized||11
10201604|NCT03437512|11328971|FG000|NOT COMPLETED|Randomized||0
10201605|NCT03437512|11328972|FG001|NOT COMPLETED|Randomized||2
10201606|NCT03437512|11328971|FG000|STARTED|Received First tDCS Session||12
10201607|NCT03437512|11328972|FG001|STARTED|Received First tDCS Session||11
10201608|NCT03437512|11328971|FG000|COMPLETED|Received First tDCS Session||12
10201609|NCT03437512|11328972|FG001|COMPLETED|Received First tDCS Session||11
10201610|NCT03437512|11328971|FG000|NOT COMPLETED|Received First tDCS Session||0
10201611|NCT03437512|11328972|FG001|NOT COMPLETED|Received First tDCS Session||0
10201612|NCT03437512|11328971|FG000|STARTED|Received Final tDCS Session||12
10201613|NCT03437512|11328972|FG001|STARTED|Received Final tDCS Session||11
10201614|NCT03437512|11328971|FG000|COMPLETED|Received Final tDCS Session||12
10201615|NCT03437512|11328972|FG001|COMPLETED|Received Final tDCS Session||11
10201616|NCT03437512|11328971|FG000|NOT COMPLETED|Received Final tDCS Session||0
10201617|NCT03437512|11328972|FG001|NOT COMPLETED|Received Final tDCS Session||0
10201618|NCT03437512|11328971|FG000|STARTED|Completed Study Follow up||12
10201619|NCT03437512|11328972|FG001|STARTED|Completed Study Follow up||11
10201620|NCT03437512|11328971|FG000|COMPLETED|Completed Study Follow up||10
10201621|NCT03437512|11328972|FG001|COMPLETED|Completed Study Follow up||10
10201622|NCT03437512|11328971|FG000|NOT COMPLETED|Completed Study Follow up||2
10201623|NCT03437512|11328972|FG001|NOT COMPLETED|Completed Study Follow up||1
10201624|NCT03437564|11328980|FG000|STARTED|Overall Study||14
10201625|NCT03437564|11328981|FG001|STARTED|Overall Study||14
10201626|NCT03437564|11328980|FG000|COMPLETED|Overall Study||14
10201627|NCT03437564|11328981|FG001|COMPLETED|Overall Study||14
10201628|NCT03437564|11328980|FG000|NOT COMPLETED|Overall Study||0
10201629|NCT03437564|11328981|FG001|NOT COMPLETED|Overall Study||0
10201630|NCT03437577|11328990|FG000|STARTED|Pre-Randomization||0
10201631|NCT03437577|11328991|FG001|STARTED|Pre-Randomization||0
10201632|NCT03437577|11328992|FG002|STARTED|Pre-Randomization||10
10201633|NCT03437577|11328990|FG000|COMPLETED|Pre-Randomization||0
10201634|NCT03437577|11328991|FG001|COMPLETED|Pre-Randomization||0
10201635|NCT03437577|11328992|FG002|COMPLETED|Pre-Randomization||0
10201636|NCT03437577|11328990|FG000|NOT COMPLETED|Pre-Randomization||0
10201637|NCT03437577|11328991|FG001|NOT COMPLETED|Pre-Randomization||0
10201638|NCT03437577|11328992|FG002|NOT COMPLETED|Pre-Randomization||10
10201639|NCT03437577|11328990|FG000|STARTED|Post-Randomization||3
10201640|NCT03437577|11328991|FG001|STARTED|Post-Randomization||5
10201641|NCT03437577|11328992|FG002|STARTED|Post-Randomization||0
10201642|NCT03437577|11328990|FG000|COMPLETED|Post-Randomization||3
10201643|NCT03437577|11328991|FG001|COMPLETED|Post-Randomization||3
10201644|NCT03437577|11328992|FG002|COMPLETED|Post-Randomization||0
9738223|NCT00214383|10839094|FG000|STARTED|Overall Study||148
9738224|NCT00214383|10839095|FG001|STARTED|Overall Study||153
9738225|NCT00214383|10839094|FG000|COMPLETED|Overall Study||132
9738226|NCT00214383|10839095|FG001|COMPLETED|Overall Study||127
9738227|NCT00214383|10839094|FG000|NOT COMPLETED|Overall Study||16
9738228|NCT00214383|10839095|FG001|NOT COMPLETED|Overall Study||26
9738229|NCT00214422|10839104|FG000|STARTED|Overall Study||12
9738230|NCT00214422|10839105|FG001|STARTED|Overall Study||3
9738231|NCT00214422|10839106|FG002|STARTED|Overall Study||4
9738232|NCT00214422|10839104|FG000|COMPLETED|Overall Study||7
9738233|NCT00214422|10839105|FG001|COMPLETED|Overall Study||2
9738234|NCT00214422|10839106|FG002|COMPLETED|Overall Study||3
9738235|NCT00214422|10839104|FG000|NOT COMPLETED|Overall Study||5
9738236|NCT00214422|10839105|FG001|NOT COMPLETED|Overall Study||1
9738237|NCT00214422|10839106|FG002|NOT COMPLETED|Overall Study||1
9738238|NCT00214461|10839122|FG000|STARTED|Overall Study||12
9738239|NCT00214461|10839123|FG001|STARTED|Overall Study||12
9738240|NCT00214461|10839124|FG002|STARTED|Overall Study||12
9738241|NCT00214461|10839125|FG003|STARTED|Overall Study||12
9738242|NCT00214461|10839122|FG000|COMPLETED|Overall Study||12
9738243|NCT00214461|10839123|FG001|COMPLETED|Overall Study||12
9738244|NCT00214461|10839124|FG002|COMPLETED|Overall Study||10
9738245|NCT00214461|10839125|FG003|COMPLETED|Overall Study||11
9738246|NCT00214461|10839122|FG000|NOT COMPLETED|Overall Study||0
9738247|NCT00214461|10839123|FG001|NOT COMPLETED|Overall Study||0
9738248|NCT00214461|10839124|FG002|NOT COMPLETED|Overall Study||2
9738249|NCT00214461|10839125|FG003|NOT COMPLETED|Overall Study||1
9738250|NCT00214487|10839137|FG000|STARTED|Overall Study||43
9738251|NCT00214487|10839138|FG001|STARTED|Overall Study||43
9738252|NCT00214487|10839137|FG000|COMPLETED|Overall Study||38
9738253|NCT00214487|10839138|FG001|COMPLETED|Overall Study||40
9738254|NCT00214487|10839137|FG000|NOT COMPLETED|Overall Study||5
9738255|NCT00214487|10839138|FG001|NOT COMPLETED|Overall Study||3
9738256|NCT00214526|10839146|FG000|STARTED|Randomized||56
9738257|NCT00214526|10839147|FG001|STARTED|Randomized||56
9738258|NCT00214526|10839146|FG000|COMPLETED|Randomized||55
9738259|NCT00214526|10839147|FG001|COMPLETED|Randomized||54
9738260|NCT00214526|10839146|FG000|NOT COMPLETED|Randomized||1
9738261|NCT00214526|10839147|FG001|NOT COMPLETED|Randomized||2
9738262|NCT00214526|10839146|FG000|STARTED|Treatment Period||55
9738263|NCT00214526|10839147|FG001|STARTED|Treatment Period||54
9738264|NCT00214526|10839146|FG000|COMPLETED|Treatment Period||53
9738265|NCT00214526|10839147|FG001|COMPLETED|Treatment Period||49
9738266|NCT00214526|10839146|FG000|NOT COMPLETED|Treatment Period||2
9738267|NCT00214526|10839147|FG001|NOT COMPLETED|Treatment Period||5
9738268|NCT00214526|10839146|FG000|STARTED|Post-Treatment Period||53
9738269|NCT00214526|10839147|FG001|STARTED|Post-Treatment Period||49
9738270|NCT00214526|10839146|FG000|COMPLETED|Post-Treatment Period||52
9738271|NCT00214526|10839147|FG001|COMPLETED|Post-Treatment Period||49
9738272|NCT00214526|10839146|FG000|NOT COMPLETED|Post-Treatment Period||1
9738273|NCT00214526|10839147|FG001|NOT COMPLETED|Post-Treatment Period||0
9738274|NCT00214539|10839157|FG000|STARTED|Randomized||17
9738275|NCT00214539|10839158|FG001|STARTED|Randomized||17
9738276|NCT00214539|10839157|FG000|COMPLETED|Randomized||15
9738277|NCT00214539|10839158|FG001|COMPLETED|Randomized||17
10089259|NCT02318940|11218106|FG001|STARTED|Overall Study||50
10089260|NCT02318940|11218105|FG000|COMPLETED|Overall Study||49
10089261|NCT02318940|11218106|FG001|COMPLETED|Overall Study||50
10089262|NCT02318940|11218105|FG000|NOT COMPLETED|Overall Study||1
10089263|NCT02318940|11218106|FG001|NOT COMPLETED|Overall Study||0
10089264|NCT02318979|11218114|FG000|STARTED|Overall Study||15
10089265|NCT02318979|11218115|FG001|STARTED|Overall Study||15
10089266|NCT02318979|11218114|FG000|COMPLETED|Overall Study||15
10089267|NCT02318979|11218115|FG001|COMPLETED|Overall Study||15
10089268|NCT02318979|11218114|FG000|NOT COMPLETED|Overall Study||0
10089269|NCT02318979|11218115|FG001|NOT COMPLETED|Overall Study||0
10089270|NCT02318992|11218128|FG000|STARTED|Overall Study||27
10089271|NCT02318992|11218129|FG001|STARTED|Overall Study||27
10089272|NCT02318992|11218130|FG002|STARTED|Overall Study||24
10089273|NCT02318992|11218128|FG000|COMPLETED|Overall Study||25
10089274|NCT02318992|11218129|FG001|COMPLETED|Overall Study||25
10089275|NCT02318992|11218130|FG002|COMPLETED|Overall Study||20
10089276|NCT02318992|11218128|FG000|NOT COMPLETED|Overall Study||2
10089277|NCT02318992|11218129|FG001|NOT COMPLETED|Overall Study||2
10089278|NCT02318992|11218130|FG002|NOT COMPLETED|Overall Study||4
10089279|NCT02319031|11218140|FG000|STARTED|Treatment Period||24
10089280|NCT02319031|11218141|FG001|STARTED|Treatment Period||26
10089281|NCT02319031|11218140|FG000|COMPLETED|Treatment Period||23
10089282|NCT02319031|11218141|FG001|COMPLETED|Treatment Period||26
10089283|NCT02319031|11218140|FG000|NOT COMPLETED|Treatment Period||1
10089284|NCT02319031|11218141|FG001|NOT COMPLETED|Treatment Period||0
10089285|NCT02319031|11218140|FG000|STARTED|Follow-Up Period||23
10089286|NCT02319031|11218141|FG001|STARTED|Follow-Up Period||26
10089287|NCT02319031|11218140|FG000|COMPLETED|Follow-Up Period||23
10089288|NCT02319031|11218141|FG001|COMPLETED|Follow-Up Period||26
10089289|NCT02319031|11218140|FG000|NOT COMPLETED|Follow-Up Period||0
10089290|NCT02319031|11218141|FG001|NOT COMPLETED|Follow-Up Period||0
10089291|NCT02319044|11218150|FG000|STARTED|Overall Study||133
10089292|NCT02319044|11218151|FG001|STARTED|Overall Study||67
10089293|NCT02319044|11218152|FG002|STARTED|Overall Study||67
10089294|NCT02319044|11218150|FG000|COMPLETED|Overall Study||11
10089295|NCT02319044|11218151|FG001|COMPLETED|Overall Study||7
10089296|NCT02319044|11218152|FG002|COMPLETED|Overall Study||0
9738278|NCT00214539|10839157|FG000|NOT COMPLETED|Randomized||2
9738279|NCT00214539|10839158|FG001|NOT COMPLETED|Randomized||0
9738280|NCT00214539|10839157|FG000|STARTED|Treatment Period||15
9738281|NCT00214539|10839158|FG001|STARTED|Treatment Period||17
9738282|NCT00214539|10839157|FG000|COMPLETED|Treatment Period||15
9738283|NCT00214539|10839158|FG001|COMPLETED|Treatment Period||17
9738284|NCT00214539|10839157|FG000|NOT COMPLETED|Treatment Period||0
9738285|NCT00214539|10839158|FG001|NOT COMPLETED|Treatment Period||0
10089297|NCT02319044|11218150|FG000|NOT COMPLETED|Overall Study||122
10089298|NCT02319044|11218151|FG001|NOT COMPLETED|Overall Study||60
9738286|NCT00214539|10839157|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
9738287|NCT00214539|10839158|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
9738288|NCT00214539|10839157|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
10089299|NCT02319044|11218152|FG002|NOT COMPLETED|Overall Study||67
10089300|NCT02319148|11218164|FG000|STARTED|First Intervention Period||22
10089301|NCT02319148|11218165|FG001|STARTED|First Intervention Period||0
10089302|NCT02319148|11218166|FG002|STARTED|First Intervention Period||0
10089303|NCT02319148|11218167|FG003|STARTED|First Intervention Period||0
10089304|NCT02319148|11218164|FG000|COMPLETED|First Intervention Period||22
10089305|NCT02319148|11218165|FG001|COMPLETED|First Intervention Period||0
10089306|NCT02319148|11218166|FG002|COMPLETED|First Intervention Period||0
10089307|NCT02319148|11218167|FG003|COMPLETED|First Intervention Period||0
10089308|NCT02319148|11218164|FG000|NOT COMPLETED|First Intervention Period||0
10089309|NCT02319148|11218165|FG001|NOT COMPLETED|First Intervention Period||0
10089310|NCT02319148|11218166|FG002|NOT COMPLETED|First Intervention Period||0
10089311|NCT02319148|11218167|FG003|NOT COMPLETED|First Intervention Period||0
10089312|NCT02319148|11218164|FG000|STARTED|Washout Period 4 Days||22
10089313|NCT02319148|11218165|FG001|STARTED|Washout Period 4 Days||0
10089314|NCT02319148|11218166|FG002|STARTED|Washout Period 4 Days||0
10089315|NCT02319148|11218167|FG003|STARTED|Washout Period 4 Days||0
10089316|NCT02319148|11218164|FG000|COMPLETED|Washout Period 4 Days||22
10089317|NCT02319148|11218165|FG001|COMPLETED|Washout Period 4 Days||0
10089318|NCT02319148|11218166|FG002|COMPLETED|Washout Period 4 Days||0
10089319|NCT02319148|11218167|FG003|COMPLETED|Washout Period 4 Days||0
10089320|NCT02319148|11218164|FG000|NOT COMPLETED|Washout Period 4 Days||0
10089321|NCT02319148|11218165|FG001|NOT COMPLETED|Washout Period 4 Days||0
10089322|NCT02319148|11218166|FG002|NOT COMPLETED|Washout Period 4 Days||0
10089323|NCT02319148|11218167|FG003|NOT COMPLETED|Washout Period 4 Days||0
10089324|NCT02319148|11218164|FG000|STARTED|Second Intervention Period||0
10089325|NCT02319148|11218165|FG001|STARTED|Second Intervention Period||7
10089326|NCT02319148|11218166|FG002|STARTED|Second Intervention Period||7
10089327|NCT02319148|11218167|FG003|STARTED|Second Intervention Period||8
10089328|NCT02319148|11218164|FG000|COMPLETED|Second Intervention Period||0
10089329|NCT02319148|11218165|FG001|COMPLETED|Second Intervention Period||6
10089330|NCT02319148|11218166|FG002|COMPLETED|Second Intervention Period||6
10089331|NCT02319148|11218167|FG003|COMPLETED|Second Intervention Period||6
10089332|NCT02319148|11218164|FG000|NOT COMPLETED|Second Intervention Period||0
10089333|NCT02319148|11218165|FG001|NOT COMPLETED|Second Intervention Period||1
10089334|NCT02319148|11218166|FG002|NOT COMPLETED|Second Intervention Period||1
10089335|NCT02319148|11218167|FG003|NOT COMPLETED|Second Intervention Period||2
10089336|NCT02319174|11218186|FG000|STARTED|Overall Study||43
10089337|NCT02319174|11218186|FG000|COMPLETED|Overall Study||42
10089338|NCT02319174|11218186|FG000|NOT COMPLETED|Overall Study||1
10089339|NCT02319304|11218191|FG000|STARTED|Overall Study||3
10089340|NCT02319304|11218191|FG000|COMPLETED|Overall Study||2
10089341|NCT02319304|11218191|FG000|NOT COMPLETED|Overall Study||1
10089342|NCT02319317|11218197|FG000|STARTED|Overall Study||31
10089343|NCT02319317|11218198|FG001|STARTED|Overall Study||29
10089344|NCT02319317|11218197|FG000|COMPLETED|Overall Study||31
10201645|NCT03437577|11328990|FG000|NOT COMPLETED|Post-Randomization||0
10201646|NCT03437577|11328991|FG001|NOT COMPLETED|Post-Randomization||2
10201647|NCT03437577|11328992|FG002|NOT COMPLETED|Post-Randomization||0
10201648|NCT03437733|11329000|FG000|STARTED|Overall Study||8
10201649|NCT03437733|11329001|FG001|STARTED|Overall Study||90
10201650|NCT03437733|11329000|FG000|Safety|Overall Study||8
10201651|NCT03437733|11329001|FG001|Safety|Overall Study||87
10201652|NCT03437733|11329000|FG000|COMPLETED|Overall Study||8
10201653|NCT03437733|11329001|FG001|COMPLETED|Overall Study||87
10201654|NCT03437733|11329000|FG000|NOT COMPLETED|Overall Study||0
10201655|NCT03437733|11329001|FG001|NOT COMPLETED|Overall Study||3
10201656|NCT03437863|11329006|FG000|STARTED|Overall Study||12
10201657|NCT03437863|11329006|FG000|COMPLETED|Overall Study||12
10201658|NCT03437863|11329006|FG000|NOT COMPLETED|Overall Study||0
10201659|NCT03438006|11329010|FG000|STARTED|Overall Study||3013
10201660|NCT03438006|11329010|FG000|COMPLETED|Overall Study||2895
10201661|NCT03438006|11329010|FG000|NOT COMPLETED|Overall Study||118
10201662|NCT03438045|11329014|FG000|STARTED|Overall Study||75
10201663|NCT03438045|11329014|FG000|COMPLETED|Overall Study||75
10201664|NCT03438045|11329014|FG000|NOT COMPLETED|Overall Study||0
10201665|NCT03438266|11329018|FG000|STARTED|Overall Study||60
10201666|NCT03438266|11329018|FG000|COMPLETED|Overall Study||60
10201667|NCT03438266|11329018|FG000|NOT COMPLETED|Overall Study||0
10201668|NCT03438383|11329026|FG000|STARTED|Overall Study||23
10201669|NCT03438383|11329027|FG001|STARTED|Overall Study||24
10201670|NCT03438383|11329026|FG000|COMPLETED|Overall Study||14
10201671|NCT03438383|11329027|FG001|COMPLETED|Overall Study||21
10201672|NCT03438383|11329026|FG000|NOT COMPLETED|Overall Study||9
10201673|NCT03438383|11329027|FG001|NOT COMPLETED|Overall Study||3
9738289|NCT00214539|10839158|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
10201674|NCT03438396|11329033|FG000|STARTED|Overall Study||102
10201675|NCT03438396|11329033|FG000|Treated|Overall Study||101
10201676|NCT03438396|11329033|FG000|COMPLETED|Overall Study||0
10201677|NCT03438396|11329033|FG000|NOT COMPLETED|Overall Study||102
10201678|NCT03438539|11329043|FG000|STARTED|Overall Study||76
10201679|NCT03438539|11329044|FG001|STARTED|Overall Study||72
10201680|NCT03438539|11329045|FG002|STARTED|Overall Study||76
10201681|NCT03438539|11329046|FG003|STARTED|Overall Study||73
10201682|NCT03438539|11329047|FG004|STARTED|Overall Study||73
9738290|NCT00214539|10839157|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
9738291|NCT00214539|10839158|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
9738292|NCT00214539|10839157|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
9738293|NCT00214539|10839158|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
9738294|NCT00214539|10839157|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
9738295|NCT00214539|10839158|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
9738296|NCT00214539|10839157|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
9738297|NCT00214539|10839158|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
9738298|NCT00214786|10839168|FG000|STARTED|Overall Study||4
10089345|NCT02319317|11218198|FG001|COMPLETED|Overall Study||29
10089346|NCT02319317|11218197|FG000|NOT COMPLETED|Overall Study||0
10089347|NCT02319317|11218198|FG001|NOT COMPLETED|Overall Study||0
10089348|NCT02319369|11218217|FG000|STARTED|Overall Study||7
10089349|NCT02319369|11218218|FG001|STARTED|Overall Study||6
10089350|NCT02319369|11218219|FG002|STARTED|Overall Study||11
10089351|NCT02319369|11218220|FG003|STARTED|Overall Study||8
10089352|NCT02319369|11218221|FG004|STARTED|Overall Study||5
10089353|NCT02319369|11218222|FG005|STARTED|Overall Study||7
10089354|NCT02319369|11218223|FG006|STARTED|Overall Study||3
10089355|NCT02319369|11218224|FG007|STARTED|Overall Study||6
10089356|NCT02319369|11218225|FG008|STARTED|Overall Study||4
10089357|NCT02319369|11218226|FG009|STARTED|Overall Study||9
10089358|NCT02319369|11218227|FG010|STARTED|Overall Study||3
10089359|NCT02319369|11218228|FG011|STARTED|Overall Study||4
10089360|NCT02319369|11218229|FG012|STARTED|Overall Study||1
10089361|NCT02319369|11218217|FG000|COMPLETED|Overall Study||7
10089362|NCT02319369|11218218|FG001|COMPLETED|Overall Study||6
10089363|NCT02319369|11218219|FG002|COMPLETED|Overall Study||11
10089364|NCT02319369|11218220|FG003|COMPLETED|Overall Study||8
10089365|NCT02319369|11218221|FG004|COMPLETED|Overall Study||5
10089366|NCT02319369|11218222|FG005|COMPLETED|Overall Study||7
10089367|NCT02319369|11218223|FG006|COMPLETED|Overall Study||3
10089368|NCT02319369|11218224|FG007|COMPLETED|Overall Study||6
10089369|NCT02319369|11218225|FG008|COMPLETED|Overall Study||4
10089370|NCT02319369|11218226|FG009|COMPLETED|Overall Study||9
10089371|NCT02319369|11218227|FG010|COMPLETED|Overall Study||3
10089372|NCT02319369|11218228|FG011|COMPLETED|Overall Study||4
10089373|NCT02319369|11218229|FG012|COMPLETED|Overall Study||1
10089374|NCT02319369|11218217|FG000|NOT COMPLETED|Overall Study||0
10089375|NCT02319369|11218218|FG001|NOT COMPLETED|Overall Study||0
10089376|NCT02319369|11218219|FG002|NOT COMPLETED|Overall Study||0
10089377|NCT02319369|11218220|FG003|NOT COMPLETED|Overall Study||0
10089378|NCT02319369|11218221|FG004|NOT COMPLETED|Overall Study||0
10089379|NCT02319369|11218222|FG005|NOT COMPLETED|Overall Study||0
10089380|NCT02319369|11218223|FG006|NOT COMPLETED|Overall Study||0
10089381|NCT02319369|11218224|FG007|NOT COMPLETED|Overall Study||0
10089382|NCT02319369|11218225|FG008|NOT COMPLETED|Overall Study||0
10089383|NCT02319369|11218226|FG009|NOT COMPLETED|Overall Study||0
10089384|NCT02319369|11218227|FG010|NOT COMPLETED|Overall Study||0
10089385|NCT02319369|11218228|FG011|NOT COMPLETED|Overall Study||0
10089386|NCT02319369|11218229|FG012|NOT COMPLETED|Overall Study||0
10089387|NCT02319486|11218267|FG000|STARTED|Overall Study||26
10089388|NCT02319486|11218267|FG000|COMPLETED|Overall Study||26
10089389|NCT02319486|11218267|FG000|NOT COMPLETED|Overall Study||0
10089390|NCT02319525|11218275|FG000|STARTED|Overall Study||153
10089391|NCT02319525|11218276|FG001|STARTED|Overall Study||148
10089392|NCT02319525|11218275|FG000|Primary Research Completion|Overall Study||151
10089393|NCT02319525|11218276|FG001|Primary Research Completion|Overall Study||147
10089394|NCT02319525|11218275|FG000|COMPLETED|Overall Study||151
10089395|NCT02319525|11218276|FG001|COMPLETED|Overall Study||147
10089396|NCT02319525|11218275|FG000|NOT COMPLETED|Overall Study||2
10089397|NCT02319525|11218276|FG001|NOT COMPLETED|Overall Study||1
10089398|NCT02319642|11218284|FG000|STARTED|Overall Study||95
10089399|NCT02319642|11218285|FG001|STARTED|Overall Study||251
10089400|NCT02319642|11218284|FG000|COMPLETED|Overall Study||91
10089401|NCT02319642|11218285|FG001|COMPLETED|Overall Study||245
10089402|NCT02319642|11218284|FG000|NOT COMPLETED|Overall Study||4
10089403|NCT02319642|11218285|FG001|NOT COMPLETED|Overall Study||6
10089404|NCT02319668|11218295|FG000|STARTED|Overall Study||19
10089405|NCT02319668|11218296|FG001|STARTED|Overall Study||19
10089406|NCT02319668|11218295|FG000|COMPLETED|Overall Study||19
10089407|NCT02319668|11218296|FG001|COMPLETED|Overall Study||17
10089408|NCT02319668|11218295|FG000|NOT COMPLETED|Overall Study||0
10089409|NCT02319668|11218296|FG001|NOT COMPLETED|Overall Study||2
10089410|NCT02319759|11218307|FG000|STARTED|Week 0 - 16||49
10089411|NCT02319759|11218308|FG001|STARTED|Week 0 - 16||0
9738299|NCT00214786|10839168|FG000|COMPLETED|Overall Study||1
9738300|NCT00214786|10839168|FG000|NOT COMPLETED|Overall Study||3
9738301|NCT00214890|10839174|FG000|STARTED|Overall Study||10
9738302|NCT00214890|10839175|FG001|STARTED|Overall Study||11
10089412|NCT02319759|11218309|FG002|STARTED|Week 0 - 16||100
10089413|NCT02319759|11218310|FG003|STARTED|Week 0 - 16||0
10089414|NCT02319759|11218311|FG004|STARTED|Week 0 - 16||0
10089415|NCT02319759|11218307|FG000|COMPLETED|Week 0 - 16||48
10089416|NCT02319759|11218308|FG001|COMPLETED|Week 0 - 16||0
10089417|NCT02319759|11218309|FG002|COMPLETED|Week 0 - 16||99
10089418|NCT02319759|11218310|FG003|COMPLETED|Week 0 - 16||0
10089419|NCT02319759|11218311|FG004|COMPLETED|Week 0 - 16||0
10089420|NCT02319759|11218307|FG000|NOT COMPLETED|Week 0 - 16||1
10089421|NCT02319759|11218308|FG001|NOT COMPLETED|Week 0 - 16||0
10089422|NCT02319759|11218309|FG002|NOT COMPLETED|Week 0 - 16||1
9738303|NCT00214890|10839174|FG000|COMPLETED|Overall Study||10
9738304|NCT00214890|10839175|FG001|COMPLETED|Overall Study||11
9738305|NCT00214890|10839174|FG000|NOT COMPLETED|Overall Study||0
9738306|NCT00214890|10839175|FG001|NOT COMPLETED|Overall Study||0
9738307|NCT00214903|10839185|FG000|STARTED|Overall Study||10043
9738308|NCT00214903|10839186|FG001|STARTED|Overall Study||13384
10089423|NCT02319759|11218310|FG003|NOT COMPLETED|Week 0 - 16||0
10089424|NCT02319759|11218311|FG004|NOT COMPLETED|Week 0 - 16||0
10089425|NCT02319759|11218307|FG000|STARTED|Week 16 - 24||31
10089426|NCT02319759|11218308|FG001|STARTED|Week 16 - 24||0
10089427|NCT02319759|11218309|FG002|STARTED|Week 16 - 24||89
10089428|NCT02319759|11218310|FG003|STARTED|Week 16 - 24||17
10089429|NCT02319759|11218311|FG004|STARTED|Week 16 - 24||10
10089430|NCT02319759|11218307|FG000|COMPLETED|Week 16 - 24||29
10089431|NCT02319759|11218308|FG001|COMPLETED|Week 16 - 24||0
10089432|NCT02319759|11218309|FG002|COMPLETED|Week 16 - 24||86
10089433|NCT02319759|11218310|FG003|COMPLETED|Week 16 - 24||17
10089434|NCT02319759|11218311|FG004|COMPLETED|Week 16 - 24||10
10089435|NCT02319759|11218307|FG000|NOT COMPLETED|Week 16 - 24||2
10089436|NCT02319759|11218308|FG001|NOT COMPLETED|Week 16 - 24||0
10089437|NCT02319759|11218309|FG002|NOT COMPLETED|Week 16 - 24||3
10089438|NCT02319759|11218310|FG003|NOT COMPLETED|Week 16 - 24||0
10089439|NCT02319759|11218311|FG004|NOT COMPLETED|Week 16 - 24||0
10089440|NCT02319759|11218307|FG000|STARTED|Week 24 - 56||0
10089441|NCT02319759|11218308|FG001|STARTED|Week 24 - 56||29
10089442|NCT02319759|11218309|FG002|STARTED|Week 24 - 56||86
10089443|NCT02319759|11218310|FG003|STARTED|Week 24 - 56||17
10089444|NCT02319759|11218311|FG004|STARTED|Week 24 - 56||10
10089445|NCT02319759|11218307|FG000|COMPLETED|Week 24 - 56||0
10089446|NCT02319759|11218308|FG001|COMPLETED|Week 24 - 56||28
10089447|NCT02319759|11218309|FG002|COMPLETED|Week 24 - 56||84
10089448|NCT02319759|11218310|FG003|COMPLETED|Week 24 - 56||15
10089449|NCT02319759|11218311|FG004|COMPLETED|Week 24 - 56||8
10089450|NCT02319759|11218307|FG000|NOT COMPLETED|Week 24 - 56||0
10089451|NCT02319759|11218308|FG001|NOT COMPLETED|Week 24 - 56||1
10089452|NCT02319759|11218309|FG002|NOT COMPLETED|Week 24 - 56||2
10089453|NCT02319759|11218310|FG003|NOT COMPLETED|Week 24 - 56||2
10089454|NCT02319759|11218311|FG004|NOT COMPLETED|Week 24 - 56||2
10089455|NCT02319824|11218324|FG000|STARTED|Overall Study||2
10089456|NCT02319824|11218324|FG000|COMPLETED|Overall Study||2
10089457|NCT02319824|11218324|FG000|NOT COMPLETED|Overall Study||0
10089458|NCT02319967|11218332|FG000|STARTED|Overall Study||126
10089459|NCT02319967|11218333|FG001|STARTED|Overall Study||126
10089460|NCT02319967|11218334|FG002|STARTED|Overall Study||121
10089461|NCT02319967|11218332|FG000|COMPLETED|Overall Study||78
10089462|NCT02319967|11218333|FG001|COMPLETED|Overall Study||82
10089463|NCT02319967|11218334|FG002|COMPLETED|Overall Study||76
10089464|NCT02319967|11218332|FG000|NOT COMPLETED|Overall Study||48
10089465|NCT02319967|11218333|FG001|NOT COMPLETED|Overall Study||44
10089466|NCT02319967|11218334|FG002|NOT COMPLETED|Overall Study||45
10089467|NCT02320058|11218344|FG000|STARTED|Overall Study||101
10089468|NCT02320058|11218345|FG001|STARTED|Overall Study||18
10089469|NCT02320058|11218344|FG000|COMPLETED|Overall Study||59
10089470|NCT02320058|11218345|FG001|COMPLETED|Overall Study||5
10089471|NCT02320058|11218344|FG000|NOT COMPLETED|Overall Study||42
10089472|NCT02320058|11218345|FG001|NOT COMPLETED|Overall Study||13
10089473|NCT02320123|11218353|FG000|STARTED|Overall Study||10
10089474|NCT02320123|11218354|FG001|STARTED|Overall Study||12
10089475|NCT02320123|11218353|FG000|COMPLETED|Overall Study||0
10089476|NCT02320123|11218354|FG001|COMPLETED|Overall Study||1
10089477|NCT02320123|11218353|FG000|NOT COMPLETED|Overall Study||10
10089478|NCT02320123|11218354|FG001|NOT COMPLETED|Overall Study||11
10089479|NCT02320149|11218366|FG000|STARTED|Overall Study||483
10089480|NCT02320149|11218367|FG001|STARTED|Overall Study||485
10089481|NCT02320149|11218366|FG000|COMPLETED|Overall Study||420
10089482|NCT02320149|11218367|FG001|COMPLETED|Overall Study||405
10089483|NCT02320149|11218366|FG000|NOT COMPLETED|Overall Study||63
10089484|NCT02320149|11218367|FG001|NOT COMPLETED|Overall Study||80
10089485|NCT02320175|11218375|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
10089486|NCT02320175|11218376|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
10089487|NCT02320175|11218375|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
10089488|NCT02320175|11218376|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
9738309|NCT00214903|10839187|FG002|STARTED|Overall Study||4113
10089489|NCT02320175|11218375|FG000|NOT COMPLETED|Overall Study||0
10089490|NCT02320175|11218376|FG001|NOT COMPLETED|Overall Study||0
10089491|NCT02320214|11218385|FG000|STARTED|Overall Study||30
10089492|NCT02320214|11218385|FG000|COMPLETED|Overall Study||30
9738310|NCT00214903|10839188|FG003|STARTED|Overall Study||3057
9738311|NCT00214903|10839185|FG000|COMPLETED|Overall Study||10043
10089493|NCT02320214|11218385|FG000|NOT COMPLETED|Overall Study||0
10089494|NCT02320227|11218389|FG000|STARTED|Overall Study||30
10089495|NCT02320227|11218389|FG000|COMPLETED|Overall Study||30
10089496|NCT02320227|11218389|FG000|NOT COMPLETED|Overall Study||0
10089497|NCT02320253|11218397|FG000|STARTED|Overall Study||69
10089498|NCT02320253|11218398|FG001|STARTED|Overall Study||70
10089499|NCT02320253|11218399|FG002|STARTED|Overall Study||72
10089500|NCT02320253|11218397|FG000|COMPLETED|Overall Study||63
10089501|NCT02320253|11218398|FG001|COMPLETED|Overall Study||68
10089502|NCT02320253|11218399|FG002|COMPLETED|Overall Study||70
9738312|NCT00214903|10839186|FG001|COMPLETED|Overall Study||13384
9738313|NCT00214903|10839187|FG002|COMPLETED|Overall Study||4113
9738314|NCT00214903|10839188|FG003|COMPLETED|Overall Study||3057
9738315|NCT00214903|10839185|FG000|NOT COMPLETED|Overall Study||0
9738316|NCT00214903|10839186|FG001|NOT COMPLETED|Overall Study||0
9738317|NCT00214903|10839187|FG002|NOT COMPLETED|Overall Study||0
9738318|NCT00214903|10839188|FG003|NOT COMPLETED|Overall Study||0
9738319|NCT00215137|10839198|FG000|STARTED|Open Label Escitalopram||14
9738320|NCT00215137|10839199|FG001|STARTED|Open Label Escitalopram||0
9738321|NCT00215137|10839200|FG002|STARTED|Open Label Escitalopram||0
9738322|NCT00215137|10839198|FG000|COMPLETED|Open Label Escitalopram||13
9738323|NCT00215137|10839199|FG001|COMPLETED|Open Label Escitalopram||0
9738324|NCT00215137|10839200|FG002|COMPLETED|Open Label Escitalopram||0
9738325|NCT00215137|10839198|FG000|NOT COMPLETED|Open Label Escitalopram||1
9738326|NCT00215137|10839199|FG001|NOT COMPLETED|Open Label Escitalopram||0
9738327|NCT00215137|10839200|FG002|NOT COMPLETED|Open Label Escitalopram||0
9738328|NCT00215137|10839198|FG000|STARTED|Randomization Period||0
9738329|NCT00215137|10839199|FG001|STARTED|Randomization Period||7
9738330|NCT00215137|10839200|FG002|STARTED|Randomization Period||5
9738331|NCT00215137|10839198|FG000|COMPLETED|Randomization Period||0
9738332|NCT00215137|10839199|FG001|COMPLETED|Randomization Period||5
9738333|NCT00215137|10839200|FG002|COMPLETED|Randomization Period||5
9738334|NCT00215137|10839198|FG000|NOT COMPLETED|Randomization Period||0
9738335|NCT00215137|10839199|FG001|NOT COMPLETED|Randomization Period||2
9738336|NCT00215137|10839200|FG002|NOT COMPLETED|Randomization Period||0
9738337|NCT00215150|10839208|FG000|STARTED|Open Label Phase|Number of subjects consented|51
9738338|NCT00215150|10839208|FG000|COMPLETED|Open Label Phase||21
9738339|NCT00215150|10839208|FG000|NOT COMPLETED|Open Label Phase||30
9738340|NCT00215150|10839208|FG000|STARTED|Randomization Phase Ziprasidone||10
10089503|NCT02320253|11218397|FG000|NOT COMPLETED|Overall Study||6
10089504|NCT02320253|11218398|FG001|NOT COMPLETED|Overall Study||2
10089505|NCT02320253|11218399|FG002|NOT COMPLETED|Overall Study||2
10089506|NCT02320487|11218407|FG000|STARTED|Overall Study||102
10089507|NCT02320487|11218407|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
10089508|NCT02320487|11218407|FG000|NOT COMPLETED|Overall Study||21
10089509|NCT02320695|11218411|FG000|STARTED|Overall Study||60
10089510|NCT02320695|11218411|FG000|Saline|Overall Study||60
10089511|NCT02320695|11218411|FG000|Alcohol|Overall Study||60
10089512|NCT02320695|11218411|FG000|Pain Relieving Cream|Overall Study||59
10089513|NCT02320695|11218411|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60
10089514|NCT02320695|11218411|FG000|Original Ointment|Overall Study||60
10089515|NCT02320695|11218411|FG000|Pain Relief Ointment|Overall Study||60
10089516|NCT02320695|11218411|FG000|COMPLETED|Overall Study||60
10089517|NCT02320695|11218411|FG000|NOT COMPLETED|Overall Study||0
10089518|NCT02320721|11218422|FG000|STARTED|Overall Study||508
10089519|NCT02320721|11218423|FG001|STARTED|Overall Study||506
10089520|NCT02320721|11218422|FG000|Treated (Safety Population)|Overall Study||508
10089521|NCT02320721|11218423|FG001|Treated (Safety Population)|Overall Study||505
10089522|NCT02320721|11218422|FG000|COMPLETED|Overall Study||481
10089523|NCT02320721|11218423|FG001|COMPLETED|Overall Study||472
10089524|NCT02320721|11218422|FG000|NOT COMPLETED|Overall Study||27
10089525|NCT02320721|11218423|FG001|NOT COMPLETED|Overall Study||34
10089526|NCT02320812|11218429|FG000|STARTED|Overall Study||28
10089527|NCT02320812|11218429|FG000|COMPLETED|Overall Study||28
10089528|NCT02320812|11218429|FG000|NOT COMPLETED|Overall Study||0
10089529|NCT02320838|11218437|FG000|STARTED|First Intervention (1 Day)||8
10089530|NCT02320838|11218438|FG001|STARTED|First Intervention (1 Day)||8
10089531|NCT02320838|11218439|FG002|STARTED|First Intervention (1 Day)||8
10089532|NCT02320838|11218440|FG003|STARTED|First Intervention (1 Day)||7
10089533|NCT02320838|11218441|FG004|STARTED|First Intervention (1 Day)||7
10089534|NCT02320838|11218437|FG000|COMPLETED|First Intervention (1 Day)||8
10089535|NCT02320838|11218438|FG001|COMPLETED|First Intervention (1 Day)||8
10089536|NCT02320838|11218439|FG002|COMPLETED|First Intervention (1 Day)||8
10089537|NCT02320838|11218440|FG003|COMPLETED|First Intervention (1 Day)||7
10089538|NCT02320838|11218441|FG004|COMPLETED|First Intervention (1 Day)||7
10089539|NCT02320838|11218437|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10089540|NCT02320838|11218438|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10089541|NCT02320838|11218439|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10089542|NCT02320838|11218440|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10089543|NCT02320838|11218441|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10089544|NCT02320838|11218437|FG000|STARTED|Washout (1 Day)||8
10089545|NCT02320838|11218438|FG001|STARTED|Washout (1 Day)||8
10089546|NCT02320838|11218439|FG002|STARTED|Washout (1 Day)||8
10089547|NCT02320838|11218440|FG003|STARTED|Washout (1 Day)||7
9738341|NCT00215150|10839208|FG000|COMPLETED|Randomization Phase Ziprasidone||7
9738342|NCT00215150|10839208|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3
9738343|NCT00215150|10839208|FG000|STARTED|Randomization Phase Placebo||11
9738344|NCT00215150|10839208|FG000|COMPLETED|Randomization Phase Placebo||10
9738345|NCT00215150|10839208|FG000|NOT COMPLETED|Randomization Phase Placebo||1
9738346|NCT00215540|10839219|FG000|STARTED|Overall Study||45
9738347|NCT00215540|10839220|FG001|STARTED|Overall Study||47
10089548|NCT02320838|11218441|FG004|STARTED|Washout (1 Day)||7
10089549|NCT02320838|11218437|FG000|COMPLETED|Washout (1 Day)||8
10089550|NCT02320838|11218438|FG001|COMPLETED|Washout (1 Day)||8
10089551|NCT02320838|11218439|FG002|COMPLETED|Washout (1 Day)||8
10089552|NCT02320838|11218440|FG003|COMPLETED|Washout (1 Day)||7
10089553|NCT02320838|11218441|FG004|COMPLETED|Washout (1 Day)||7
9738348|NCT00215540|10839221|FG002|STARTED|Overall Study||44
9738349|NCT00215540|10839219|FG000|COMPLETED|Overall Study||44
9738350|NCT00215540|10839220|FG001|COMPLETED|Overall Study||47
9738351|NCT00215540|10839221|FG002|COMPLETED|Overall Study||44
9738352|NCT00215540|10839219|FG000|NOT COMPLETED|Overall Study||1
10089554|NCT02320838|11218437|FG000|NOT COMPLETED|Washout (1 Day)||0
10089555|NCT02320838|11218438|FG001|NOT COMPLETED|Washout (1 Day)||0
10089556|NCT02320838|11218439|FG002|NOT COMPLETED|Washout (1 Day)||0
10089557|NCT02320838|11218440|FG003|NOT COMPLETED|Washout (1 Day)||0
10089558|NCT02320838|11218441|FG004|NOT COMPLETED|Washout (1 Day)||0
10089559|NCT02320838|11218437|FG000|STARTED|Second Intervention (1 Day)||8
10089560|NCT02320838|11218438|FG001|STARTED|Second Intervention (1 Day)||8
10089561|NCT02320838|11218439|FG002|STARTED|Second Intervention (1 Day)||8
10089562|NCT02320838|11218440|FG003|STARTED|Second Intervention (1 Day)||7
10089563|NCT02320838|11218441|FG004|STARTED|Second Intervention (1 Day)||7
10089564|NCT02320838|11218437|FG000|COMPLETED|Second Intervention (1 Day)||8
10089565|NCT02320838|11218438|FG001|COMPLETED|Second Intervention (1 Day)||8
10089566|NCT02320838|11218439|FG002|COMPLETED|Second Intervention (1 Day)||8
10089567|NCT02320838|11218440|FG003|COMPLETED|Second Intervention (1 Day)||7
10089568|NCT02320838|11218441|FG004|COMPLETED|Second Intervention (1 Day)||7
10089569|NCT02320838|11218437|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10089570|NCT02320838|11218438|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10089571|NCT02320838|11218439|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10089572|NCT02320838|11218440|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10089573|NCT02320838|11218441|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10089574|NCT02320838|11218437|FG000|STARTED|Washout (1 Day)||8
10089575|NCT02320838|11218438|FG001|STARTED|Washout (1 Day)||8
9738353|NCT00215540|10839220|FG001|NOT COMPLETED|Overall Study||0
9738354|NCT00215540|10839221|FG002|NOT COMPLETED|Overall Study||0
10089576|NCT02320838|11218439|FG002|STARTED|Washout (1 Day)||8
10089577|NCT02320838|11218440|FG003|STARTED|Washout (1 Day)||7
10089578|NCT02320838|11218441|FG004|STARTED|Washout (1 Day)||7
10089579|NCT02320838|11218437|FG000|COMPLETED|Washout (1 Day)||8
10089580|NCT02320838|11218438|FG001|COMPLETED|Washout (1 Day)||8
10089581|NCT02320838|11218439|FG002|COMPLETED|Washout (1 Day)||8
10089582|NCT02320838|11218440|FG003|COMPLETED|Washout (1 Day)||7
10089583|NCT02320838|11218441|FG004|COMPLETED|Washout (1 Day)||7
10089584|NCT02320838|11218437|FG000|NOT COMPLETED|Washout (1 Day)||0
10089585|NCT02320838|11218438|FG001|NOT COMPLETED|Washout (1 Day)||0
10089586|NCT02320838|11218439|FG002|NOT COMPLETED|Washout (1 Day)||0
10089587|NCT02320838|11218440|FG003|NOT COMPLETED|Washout (1 Day)||0
10089588|NCT02320838|11218441|FG004|NOT COMPLETED|Washout (1 Day)||0
10089589|NCT02320838|11218437|FG000|STARTED|Third Intervention (1 Day)||8
10089590|NCT02320838|11218438|FG001|STARTED|Third Intervention (1 Day)||8
10089591|NCT02320838|11218439|FG002|STARTED|Third Intervention (1 Day)||8
10089592|NCT02320838|11218440|FG003|STARTED|Third Intervention (1 Day)||7
10089593|NCT02320838|11218441|FG004|STARTED|Third Intervention (1 Day)||7
10089594|NCT02320838|11218437|FG000|COMPLETED|Third Intervention (1 Day)||8
10089595|NCT02320838|11218438|FG001|COMPLETED|Third Intervention (1 Day)||8
10089596|NCT02320838|11218439|FG002|COMPLETED|Third Intervention (1 Day)||8
10089597|NCT02320838|11218440|FG003|COMPLETED|Third Intervention (1 Day)||7
10089598|NCT02320838|11218441|FG004|COMPLETED|Third Intervention (1 Day)||7
10089599|NCT02320838|11218437|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10089600|NCT02320838|11218438|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10089601|NCT02320838|11218439|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10089602|NCT02320838|11218440|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10089603|NCT02320838|11218441|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10089604|NCT02320903|11218452|FG000|STARTED|Overall Study||24
10089605|NCT02320903|11218453|FG001|STARTED|Overall Study||32
10089606|NCT02320903|11218454|FG002|STARTED|Overall Study||32
10089607|NCT02320903|11218452|FG000|COMPLETED|Overall Study||16
10089608|NCT02320903|11218453|FG001|COMPLETED|Overall Study||16
10089609|NCT02320903|11218454|FG002|COMPLETED|Overall Study||16
10089610|NCT02320903|11218452|FG000|NOT COMPLETED|Overall Study||8
10089611|NCT02320903|11218453|FG001|NOT COMPLETED|Overall Study||16
10089612|NCT02320903|11218454|FG002|NOT COMPLETED|Overall Study||16
10089613|NCT02321098|11218466|FG000|STARTED|12 Weeks Treament||26
10089614|NCT02321098|11218467|FG001|STARTED|12 Weeks Treament||24
10089615|NCT02321098|11218468|FG002|STARTED|12 Weeks Treament||0
10089616|NCT02321098|11218466|FG000|COMPLETED|12 Weeks Treament||25
10089617|NCT02321098|11218467|FG001|COMPLETED|12 Weeks Treament||23
10089618|NCT02321098|11218468|FG002|COMPLETED|12 Weeks Treament||0
10089619|NCT02321098|11218466|FG000|NOT COMPLETED|12 Weeks Treament||1
9738355|NCT00215553|10839236|FG000|STARTED|Overall Study||5
10089620|NCT02321098|11218467|FG001|NOT COMPLETED|12 Weeks Treament||1
10089621|NCT02321098|11218468|FG002|NOT COMPLETED|12 Weeks Treament||0
10089622|NCT02321098|11218466|FG000|STARTED|Additional 15 Months Treatment||0
10089623|NCT02321098|11218467|FG001|STARTED|Additional 15 Months Treatment||0
10089624|NCT02321098|11218468|FG002|STARTED|Additional 15 Months Treatment||29
10089625|NCT02321098|11218466|FG000|COMPLETED|Additional 15 Months Treatment||0
10089626|NCT02321098|11218467|FG001|COMPLETED|Additional 15 Months Treatment||0
10089627|NCT02321098|11218468|FG002|COMPLETED|Additional 15 Months Treatment||21
10089628|NCT02321098|11218466|FG000|NOT COMPLETED|Additional 15 Months Treatment||0
10089629|NCT02321098|11218467|FG001|NOT COMPLETED|Additional 15 Months Treatment||0
9738356|NCT00215553|10839237|FG001|STARTED|Overall Study||6
9738357|NCT00215553|10839238|FG002|STARTED|Overall Study||6
9738358|NCT00215553|10839239|FG003|STARTED|Overall Study||5
9738359|NCT00215553|10839240|FG004|STARTED|Overall Study||28
9738360|NCT00215553|10839241|FG005|STARTED|Overall Study||38
9738361|NCT00215553|10839242|FG006|STARTED|Overall Study||36
9738362|NCT00215553|10839236|FG000|COMPLETED|Overall Study||5
9738363|NCT00215553|10839237|FG001|COMPLETED|Overall Study||5
9738364|NCT00215553|10839238|FG002|COMPLETED|Overall Study||4
9738365|NCT00215553|10839239|FG003|COMPLETED|Overall Study||4
9738366|NCT00215553|10839240|FG004|COMPLETED|Overall Study||26
9738367|NCT00215553|10839241|FG005|COMPLETED|Overall Study||32
9738368|NCT00215553|10839242|FG006|COMPLETED|Overall Study||36
9738369|NCT00215553|10839236|FG000|NOT COMPLETED|Overall Study||0
10089630|NCT02321098|11218468|FG002|NOT COMPLETED|Additional 15 Months Treatment||8
10089631|NCT02321111|11218477|FG000|STARTED|Infusion1||1
10089632|NCT02321111|11218478|FG001|STARTED|Infusion1||4
10089633|NCT02321111|11218479|FG002|STARTED|Infusion1||4
10089634|NCT02321111|11218480|FG003|STARTED|Infusion1||1
10089635|NCT02321111|11218481|FG004|STARTED|Infusion1||0
10089636|NCT02321111|11218482|FG005|STARTED|Infusion1||0
10089637|NCT02321111|11218477|FG000|COMPLETED|Infusion1||1
10089638|NCT02321111|11218478|FG001|COMPLETED|Infusion1||4
10089639|NCT02321111|11218479|FG002|COMPLETED|Infusion1||4
10089640|NCT02321111|11218480|FG003|COMPLETED|Infusion1||1
10089641|NCT02321111|11218481|FG004|COMPLETED|Infusion1||0
10089642|NCT02321111|11218482|FG005|COMPLETED|Infusion1||0
10089643|NCT02321111|11218477|FG000|NOT COMPLETED|Infusion1||0
10089644|NCT02321111|11218478|FG001|NOT COMPLETED|Infusion1||0
10089645|NCT02321111|11218479|FG002|NOT COMPLETED|Infusion1||0
10089646|NCT02321111|11218480|FG003|NOT COMPLETED|Infusion1||0
10089647|NCT02321111|11218481|FG004|NOT COMPLETED|Infusion1||0
10089648|NCT02321111|11218482|FG005|NOT COMPLETED|Infusion1||0
10089649|NCT02321111|11218477|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1
10089650|NCT02321111|11218478|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4
10089651|NCT02321111|11218479|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4
10089652|NCT02321111|11218480|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1
10089653|NCT02321111|11218481|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0
10089654|NCT02321111|11218482|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0
10089655|NCT02321111|11218477|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
10089656|NCT02321111|11218478|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
10089657|NCT02321111|11218479|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
10089658|NCT02321111|11218480|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
10089659|NCT02321111|11218481|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089660|NCT02321111|11218482|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089661|NCT02321111|11218477|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089662|NCT02321111|11218478|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089663|NCT02321111|11218479|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089664|NCT02321111|11218480|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089665|NCT02321111|11218481|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089666|NCT02321111|11218482|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10089667|NCT02321111|11218477|FG000|STARTED|Infusion2||1
10089668|NCT02321111|11218478|FG001|STARTED|Infusion2||4
10089669|NCT02321111|11218479|FG002|STARTED|Infusion2||4
10089670|NCT02321111|11218480|FG003|STARTED|Infusion2||1
10089671|NCT02321111|11218481|FG004|STARTED|Infusion2||0
10089672|NCT02321111|11218482|FG005|STARTED|Infusion2||0
10089673|NCT02321111|11218477|FG000|COMPLETED|Infusion2||1
10089674|NCT02321111|11218478|FG001|COMPLETED|Infusion2||4
10089675|NCT02321111|11218479|FG002|COMPLETED|Infusion2||4
10089676|NCT02321111|11218480|FG003|COMPLETED|Infusion2||1
10089677|NCT02321111|11218481|FG004|COMPLETED|Infusion2||0
10089678|NCT02321111|11218482|FG005|COMPLETED|Infusion2||0
10089679|NCT02321111|11218477|FG000|NOT COMPLETED|Infusion2||0
10089680|NCT02321111|11218478|FG001|NOT COMPLETED|Infusion2||0
10089681|NCT02321111|11218479|FG002|NOT COMPLETED|Infusion2||0
10089682|NCT02321111|11218480|FG003|NOT COMPLETED|Infusion2||0
10089683|NCT02321111|11218481|FG004|NOT COMPLETED|Infusion2||0
10089684|NCT02321111|11218482|FG005|NOT COMPLETED|Infusion2||0
10089685|NCT02321111|11218477|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1
10089686|NCT02321111|11218478|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4
10089687|NCT02321111|11218479|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4
10089688|NCT02321111|11218480|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1
9738370|NCT00215553|10839237|FG001|NOT COMPLETED|Overall Study||1
9738371|NCT00215553|10839238|FG002|NOT COMPLETED|Overall Study||2
10089689|NCT02321111|11218481|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0
10089690|NCT02321111|11218482|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0
10089691|NCT02321111|11218477|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
10089692|NCT02321111|11218478|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
10089693|NCT02321111|11218479|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
10089694|NCT02321111|11218480|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
10089695|NCT02321111|11218481|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10089696|NCT02321111|11218482|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10089697|NCT02321111|11218477|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
9738372|NCT00215553|10839239|FG003|NOT COMPLETED|Overall Study||1
9738373|NCT00215553|10839240|FG004|NOT COMPLETED|Overall Study||2
9738374|NCT00215553|10839241|FG005|NOT COMPLETED|Overall Study||6
9738375|NCT00215553|10839242|FG006|NOT COMPLETED|Overall Study||0
9738376|NCT00215644|10839260|FG000|STARTED|Overall Study||36
9738377|NCT00215644|10839261|FG001|STARTED|Overall Study||36
9738378|NCT00215644|10839260|FG000|Treated|Overall Study||35
9738379|NCT00215644|10839261|FG001|Treated|Overall Study||36
9738380|NCT00215644|10839260|FG000|COMPLETED|Overall Study||0
9738381|NCT00215644|10839261|FG001|COMPLETED|Overall Study||0
9738382|NCT00215644|10839260|FG000|NOT COMPLETED|Overall Study||36
10089698|NCT02321111|11218478|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10089699|NCT02321111|11218479|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10089700|NCT02321111|11218480|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10089701|NCT02321111|11218481|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10089702|NCT02321111|11218482|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10089703|NCT02321111|11218477|FG000|STARTED|Infusion3||1
10089704|NCT02321111|11218478|FG001|STARTED|Infusion3||4
10089705|NCT02321111|11218479|FG002|STARTED|Infusion3||4
10089706|NCT02321111|11218480|FG003|STARTED|Infusion3||1
10089707|NCT02321111|11218481|FG004|STARTED|Infusion3||0
10089708|NCT02321111|11218482|FG005|STARTED|Infusion3||0
10089709|NCT02321111|11218477|FG000|COMPLETED|Infusion3||1
10089710|NCT02321111|11218478|FG001|COMPLETED|Infusion3||4
10089711|NCT02321111|11218479|FG002|COMPLETED|Infusion3||4
10089712|NCT02321111|11218480|FG003|COMPLETED|Infusion3||1
10089713|NCT02321111|11218481|FG004|COMPLETED|Infusion3||0
10089714|NCT02321111|11218482|FG005|COMPLETED|Infusion3||0
10089715|NCT02321111|11218477|FG000|NOT COMPLETED|Infusion3||0
10089716|NCT02321111|11218478|FG001|NOT COMPLETED|Infusion3||0
10089717|NCT02321111|11218479|FG002|NOT COMPLETED|Infusion3||0
10089718|NCT02321111|11218480|FG003|NOT COMPLETED|Infusion3||0
10089719|NCT02321111|11218481|FG004|NOT COMPLETED|Infusion3||0
10089720|NCT02321111|11218482|FG005|NOT COMPLETED|Infusion3||0
10089721|NCT02321319|11218490|FG000|STARTED|Overall Study||5
10089722|NCT02321319|11218490|FG000|COMPLETED|Overall Study||0
10089723|NCT02321319|11218490|FG000|NOT COMPLETED|Overall Study||5
10089724|NCT02321436|11218496|FG000|STARTED|Overall Study||28
10089725|NCT02321436|11218497|FG001|STARTED|Overall Study||14
10089726|NCT02321436|11218496|FG000|COMPLETED|Overall Study||27
10089727|NCT02321436|11218497|FG001|COMPLETED|Overall Study||13
10089728|NCT02321436|11218496|FG000|NOT COMPLETED|Overall Study||1
10089729|NCT02321436|11218497|FG001|NOT COMPLETED|Overall Study||1
10089730|NCT02321462|11218506|FG000|STARTED|Overall Study||147
10089731|NCT02321462|11218507|FG001|STARTED|Overall Study||149
10089732|NCT02321462|11218506|FG000|ITT Population|Overall Study||146
10089733|NCT02321462|11218507|FG001|ITT Population|Overall Study||148
10089734|NCT02321462|11218506|FG000|Treated Patients|Overall Study||147
10089735|NCT02321462|11218507|FG001|Treated Patients|Overall Study||147
10089736|NCT02321462|11218506|FG000|Safety Population|Overall Study||147
10089737|NCT02321462|11218507|FG001|Safety Population|Overall Study||147
10089738|NCT02321462|11218506|FG000|COMPLETED|Overall Study||141
10089739|NCT02321462|11218507|FG001|COMPLETED|Overall Study||146
10089740|NCT02321462|11218506|FG000|NOT COMPLETED|Overall Study||6
10089741|NCT02321462|11218507|FG001|NOT COMPLETED|Overall Study||3
10089742|NCT02321527|11218514|FG000|STARTED|Overall Study||21
10089743|NCT02321527|11218514|FG000|COMPLETED|Overall Study||20
10089744|NCT02321527|11218514|FG000|NOT COMPLETED|Overall Study||1
10089745|NCT02321748|11218520|FG000|STARTED|Overall Study||12
10089746|NCT02321748|11218521|FG001|STARTED|Overall Study||12
10089747|NCT02321748|11218520|FG000|First Intervention (4 Days)|Overall Study||12
10089748|NCT02321748|11218521|FG001|First Intervention (4 Days)|Overall Study||12
10089749|NCT02321748|11218520|FG000|Wasout (2weeks)|Overall Study||12
10089750|NCT02321748|11218521|FG001|Wasout (2weeks)|Overall Study||12
10089751|NCT02321748|11218520|FG000|Second Intervention (4 Days)|Overall Study||12
10089752|NCT02321748|11218521|FG001|Second Intervention (4 Days)|Overall Study||12
10089753|NCT02321748|11218520|FG000|COMPLETED|Overall Study||12
10089754|NCT02321748|11218521|FG001|COMPLETED|Overall Study||12
10089755|NCT02321748|11218520|FG000|NOT COMPLETED|Overall Study||0
10089756|NCT02321748|11218521|FG001|NOT COMPLETED|Overall Study||0
10089757|NCT02321800|11218532|FG000|STARTED|Overall Study||303
10089758|NCT02321800|11218533|FG001|STARTED|Overall Study||149
10089759|NCT02321800|11218532|FG000|Received Study Drug|Overall Study||300
10089760|NCT02321800|11218533|FG001|Received Study Drug|Overall Study||148
10089761|NCT02321800|11218532|FG000|COMPLETED|Overall Study||283
10089762|NCT02321800|11218533|FG001|COMPLETED|Overall Study||138
10089763|NCT02321800|11218532|FG000|NOT COMPLETED|Overall Study||20
10089764|NCT02321800|11218533|FG001|NOT COMPLETED|Overall Study||11
10089765|NCT02321930|11218539|FG000|STARTED|Overall Study||25
10089766|NCT02321930|11218539|FG000|COMPLETED|Overall Study||24
10089767|NCT02321930|11218539|FG000|NOT COMPLETED|Overall Study||1
9738383|NCT00215644|10839261|FG001|NOT COMPLETED|Overall Study||36
10089768|NCT02322021|11218547|FG000|STARTED|Core Phase||17
10089769|NCT02322021|11218548|FG001|STARTED|Core Phase||17
9738384|NCT00215657|10839275|FG000|STARTED|Overall Study||26
9738385|NCT00215657|10839276|FG001|STARTED|Overall Study||12
10089770|NCT02322021|11218549|FG002|STARTED|Core Phase||19
10089771|NCT02322021|11218550|FG003|STARTED|Core Phase||17
10089772|NCT02322021|11218551|FG004|STARTED|Core Phase||0
10089773|NCT02322021|11218547|FG000|COMPLETED|Core Phase||12
10089774|NCT02322021|11218548|FG001|COMPLETED|Core Phase||9
10089775|NCT02322021|11218549|FG002|COMPLETED|Core Phase||10
10089776|NCT02322021|11218550|FG003|COMPLETED|Core Phase||12
10089777|NCT02322021|11218551|FG004|COMPLETED|Core Phase||0
10089778|NCT02322021|11218547|FG000|NOT COMPLETED|Core Phase||5
9738386|NCT00215657|10839277|FG002|STARTED|Overall Study||13
9738387|NCT00215657|10839278|FG003|STARTED|Overall Study||24
9738388|NCT00215657|10839279|FG004|STARTED|Overall Study||27
9738389|NCT00215657|10839280|FG005|STARTED|Overall Study||24
9738390|NCT00215657|10839281|FG006|STARTED|Overall Study||27
9738391|NCT00215657|10839282|FG007|STARTED|Overall Study||27
9738392|NCT00215657|10839275|FG000|Intention-to-treat Population|Overall Study||25
9738393|NCT00215657|10839276|FG001|Intention-to-treat Population|Overall Study||12
9738394|NCT00215657|10839277|FG002|Intention-to-treat Population|Overall Study||12
9738395|NCT00215657|10839278|FG003|Intention-to-treat Population|Overall Study||24
9738396|NCT00215657|10839279|FG004|Intention-to-treat Population|Overall Study||24
9738397|NCT00215657|10839280|FG005|Intention-to-treat Population|Overall Study||24
9738398|NCT00215657|10839281|FG006|Intention-to-treat Population|Overall Study||24
9738399|NCT00215657|10839282|FG007|Intention-to-treat Population|Overall Study||27
9738400|NCT00215657|10839275|FG000|Started FE200486 CS07A|Overall Study||20
9738401|NCT00215657|10839276|FG001|Started FE200486 CS07A|Overall Study||6
9738402|NCT00215657|10839277|FG002|Started FE200486 CS07A|Overall Study||7
9738403|NCT00215657|10839278|FG003|Started FE200486 CS07A|Overall Study||24
9738404|NCT00215657|10839279|FG004|Started FE200486 CS07A|Overall Study||17
9738405|NCT00215657|10839280|FG005|Started FE200486 CS07A|Overall Study||20
9738406|NCT00215657|10839281|FG006|Started FE200486 CS07A|Overall Study||14
9738407|NCT00215657|10839282|FG007|Started FE200486 CS07A|Overall Study||23
9738408|NCT00215657|10839275|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
9738409|NCT00215657|10839276|FG001|COMPLETED|Overall Study||1
9738410|NCT00215657|10839277|FG002|COMPLETED|Overall Study||2
9738411|NCT00215657|10839278|FG003|COMPLETED|Overall Study||6
9738412|NCT00215657|10839279|FG004|COMPLETED|Overall Study||4
9738413|NCT00215657|10839280|FG005|COMPLETED|Overall Study||4
9738414|NCT00215657|10839281|FG006|COMPLETED|Overall Study||4
9738415|NCT00215657|10839282|FG007|COMPLETED|Overall Study||11
9738416|NCT00215657|10839275|FG000|NOT COMPLETED|Overall Study||22
9738417|NCT00215657|10839276|FG001|NOT COMPLETED|Overall Study||11
9738418|NCT00215657|10839277|FG002|NOT COMPLETED|Overall Study||11
9738419|NCT00215657|10839278|FG003|NOT COMPLETED|Overall Study||18
9738420|NCT00215657|10839279|FG004|NOT COMPLETED|Overall Study||23
9738421|NCT00215657|10839280|FG005|NOT COMPLETED|Overall Study||20
9738422|NCT00215657|10839281|FG006|NOT COMPLETED|Overall Study||23
9738423|NCT00215657|10839282|FG007|NOT COMPLETED|Overall Study||16
9738424|NCT00215683|10839303|FG000|STARTED|Overall Study|Safety analysis set|45
9738425|NCT00215683|10839304|FG001|STARTED|Overall Study||48
9738426|NCT00215683|10839305|FG002|STARTED|Overall Study||44
9738427|NCT00215683|10839303|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
9738428|NCT00215683|10839304|FG001|Switched to 160 mg|Overall Study||41
9738429|NCT00215683|10839305|FG002|Switched to 160 mg|Overall Study||36
9738430|NCT00215683|10839303|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
9738431|NCT00215683|10839304|FG001|COMPLETED|Overall Study||22
9738432|NCT00215683|10839305|FG002|COMPLETED|Overall Study||12
9738433|NCT00215683|10839303|FG000|NOT COMPLETED|Overall Study||29
9738434|NCT00215683|10839304|FG001|NOT COMPLETED|Overall Study||26
9738435|NCT00215683|10839305|FG002|NOT COMPLETED|Overall Study||32
9738436|NCT00215787|10839313|FG000|STARTED|Overall Study||20
9738437|NCT00215787|10839313|FG000|COMPLETED|Overall Study||20
9738438|NCT00215787|10839313|FG000|NOT COMPLETED|Overall Study||0
9738439|NCT00215930|10839317|FG000|STARTED|Overall Study||53
9738440|NCT00215930|10839317|FG000|COMPLETED|Overall Study||53
9738441|NCT00215930|10839317|FG000|NOT COMPLETED|Overall Study||0
9738442|NCT00215943|10839324|FG000|STARTED|Overall Study||36
9738443|NCT00215943|10839325|FG001|STARTED|Overall Study||37
9738444|NCT00215943|10839324|FG000|COMPLETED|Overall Study||27
9738445|NCT00215943|10839325|FG001|COMPLETED|Overall Study||23
9738446|NCT00215943|10839324|FG000|NOT COMPLETED|Overall Study||9
9738447|NCT00215943|10839325|FG001|NOT COMPLETED|Overall Study||14
9738448|NCT00216060|10839333|FG000|STARTED|Overall Study||32
9738449|NCT00216060|10839334|FG001|STARTED|Overall Study||31
9738450|NCT00216060|10839333|FG000|COMPLETED|Overall Study||32
9738451|NCT00216060|10839334|FG001|COMPLETED|Overall Study||31
9738452|NCT00216060|10839333|FG000|NOT COMPLETED|Overall Study||0
9738453|NCT00216060|10839334|FG001|NOT COMPLETED|Overall Study||0
9738454|NCT00216086|10839342|FG000|STARTED|Overall Study||22
9738455|NCT00216086|10839342|FG000|COMPLETED|Overall Study||18
9738456|NCT00216086|10839342|FG000|NOT COMPLETED|Overall Study||4
9738457|NCT00216099|10839346|FG000|STARTED|Overall Study||49
9738458|NCT00216099|10839346|FG000|Toxicity Analysis|Overall Study||49
9738459|NCT00216099|10839346|FG000|Response Analysis|Overall Study||48
9738460|NCT00216099|10839346|FG000|COMPLETED|Overall Study||48
9738461|NCT00216099|10839346|FG000|NOT COMPLETED|Overall Study||1
9738462|NCT00216125|10839350|FG000|STARTED|Pre-Randomization Phase||243
9738463|NCT00216125|10839351|FG001|STARTED|Pre-Randomization Phase||0
9738464|NCT00216125|10839352|FG002|STARTED|Pre-Randomization Phase||0
9738465|NCT00216125|10839350|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203
9738466|NCT00216125|10839351|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0
9738467|NCT00216125|10839352|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0
9738468|NCT00216125|10839350|FG000|COMPLETED|Pre-Randomization Phase||166
9738469|NCT00216125|10839351|FG001|COMPLETED|Pre-Randomization Phase||0
9738470|NCT00216125|10839352|FG002|COMPLETED|Pre-Randomization Phase||0
9738471|NCT00216125|10839350|FG000|NOT COMPLETED|Pre-Randomization Phase||77
9738472|NCT00216125|10839351|FG001|NOT COMPLETED|Pre-Randomization Phase||0
9738473|NCT00216125|10839352|FG002|NOT COMPLETED|Pre-Randomization Phase||0
9738474|NCT00216125|10839350|FG000|STARTED|Randomization Phase||0
9738475|NCT00216125|10839351|FG001|STARTED|Randomization Phase||84
9738476|NCT00216125|10839352|FG002|STARTED|Randomization Phase||82
9738477|NCT00216125|10839350|FG000|DSMB Cohort for Futility|Randomization Phase||0
9738478|NCT00216125|10839351|FG001|DSMB Cohort for Futility|Randomization Phase||73
9738479|NCT00216125|10839352|FG002|DSMB Cohort for Futility|Randomization Phase||74
9738480|NCT00216125|10839350|FG000|COMPLETED|Randomization Phase||0
9738481|NCT00216125|10839351|FG001|COMPLETED|Randomization Phase||73
9738482|NCT00216125|10839352|FG002|COMPLETED|Randomization Phase||74
9738483|NCT00216125|10839350|FG000|NOT COMPLETED|Randomization Phase||0
9738484|NCT00216125|10839351|FG001|NOT COMPLETED|Randomization Phase||11
9738485|NCT00216125|10839352|FG002|NOT COMPLETED|Randomization Phase||8
9738486|NCT00216203|10839359|FG000|STARTED|Overall Study||36
9738487|NCT00216203|10839359|FG000|COMPLETED|Overall Study||34
9738488|NCT00216203|10839359|FG000|NOT COMPLETED|Overall Study||2
9738489|NCT00216320|10839367|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43
9738490|NCT00216320|10839368|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39
9738491|NCT00216320|10839369|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30
9738492|NCT00216320|10839367|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43
9738493|NCT00216320|10839368|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35
9738494|NCT00216320|10839369|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25
9738495|NCT00216320|10839367|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
9738496|NCT00216320|10839368|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
9738497|NCT00216320|10839369|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
9738498|NCT00216320|10839367|FG000|STARTED|Phase 2 (Weeks 6 -12)||43
9738499|NCT00216320|10839368|FG001|STARTED|Phase 2 (Weeks 6 -12)||35
9738500|NCT00216320|10839369|FG002|STARTED|Phase 2 (Weeks 6 -12)||25
10089779|NCT02322021|11218548|FG001|NOT COMPLETED|Core Phase||8
10089780|NCT02322021|11218549|FG002|NOT COMPLETED|Core Phase||9
10089781|NCT02322021|11218550|FG003|NOT COMPLETED|Core Phase||5
10089782|NCT02322021|11218551|FG004|NOT COMPLETED|Core Phase||0
10089783|NCT02322021|11218547|FG000|STARTED|Extension Phase||0
10089784|NCT02322021|11218548|FG001|STARTED|Extension Phase||0
10089785|NCT02322021|11218549|FG002|STARTED|Extension Phase||0
10089786|NCT02322021|11218550|FG003|STARTED|Extension Phase||0
10089787|NCT02322021|11218551|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
10089788|NCT02322021|11218547|FG000|COMPLETED|Extension Phase||0
9738501|NCT00216320|10839367|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38
9738502|NCT00216320|10839368|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31
9738503|NCT00216320|10839369|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24
9738504|NCT00216320|10839367|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
9738505|NCT00216320|10839368|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
9738506|NCT00216320|10839369|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
9738507|NCT00216476|10839380|FG000|STARTED|Overall Study||329
9738508|NCT00216476|10839381|FG001|STARTED|Overall Study||337
9738509|NCT00216476|10839382|FG002|STARTED|Overall Study||45
9738510|NCT00216476|10839380|FG000|COMPLETED|Overall Study||224
9738511|NCT00216476|10839381|FG001|COMPLETED|Overall Study||230
9738512|NCT00216476|10839382|FG002|COMPLETED|Overall Study||28
9738513|NCT00216476|10839380|FG000|NOT COMPLETED|Overall Study||105
9738514|NCT00216476|10839381|FG001|NOT COMPLETED|Overall Study||107
9738515|NCT00216476|10839382|FG002|NOT COMPLETED|Overall Study||17
9738516|NCT00216671|10839395|FG000|STARTED|Overall Study||110
9738517|NCT00216671|10839396|FG001|STARTED|Overall Study||110
9738518|NCT00216671|10839395|FG000|COMPLETED|Overall Study||75
9738519|NCT00216671|10839396|FG001|COMPLETED|Overall Study||60
9738520|NCT00216671|10839395|FG000|NOT COMPLETED|Overall Study||35
9738521|NCT00216671|10839396|FG001|NOT COMPLETED|Overall Study||50
9738522|NCT00216736|10839404|FG000|STARTED|Overall Study||32
9738523|NCT00216736|10839405|FG001|STARTED|Overall Study||31
9738524|NCT00216736|10839404|FG000|COMPLETED|Overall Study||31
9738525|NCT00216736|10839405|FG001|COMPLETED|Overall Study||30
9738526|NCT00216736|10839404|FG000|NOT COMPLETED|Overall Study||1
9738527|NCT00216736|10839405|FG001|NOT COMPLETED|Overall Study||1
9738528|NCT00217022|10839413|FG000|STARTED|Overall Study||12
9738529|NCT00217022|10839414|FG001|STARTED|Overall Study||4
9738530|NCT00217022|10839413|FG000|COMPLETED|Overall Study||11
9738531|NCT00217022|10839414|FG001|COMPLETED|Overall Study||3
9738532|NCT00217022|10839413|FG000|NOT COMPLETED|Overall Study||1
9738533|NCT00217022|10839414|FG001|NOT COMPLETED|Overall Study||1
9738534|NCT00217087|10839422|FG000|STARTED|Overall Study||36
9738535|NCT00217087|10839423|FG001|STARTED|Overall Study||37
9738536|NCT00217087|10839422|FG000|COMPLETED|Overall Study||25
9738537|NCT00217087|10839423|FG001|COMPLETED|Overall Study||17
9738538|NCT00217087|10839422|FG000|NOT COMPLETED|Overall Study||11
9738539|NCT00217087|10839423|FG001|NOT COMPLETED|Overall Study||20
9738540|NCT00217399|10839435|FG000|STARTED|Overall Study||35
9738541|NCT00217399|10839435|FG000|COMPLETED|Overall Study||35
9738542|NCT00217399|10839435|FG000|NOT COMPLETED|Overall Study||0
9738543|NCT00217425|10839441|FG000|STARTED|Overall Study||46
9738544|NCT00217425|10839441|FG000|Treated|Overall Study||44
9738545|NCT00217425|10839441|FG000|Eligible and Treated|Overall Study||39
9738546|NCT00217425|10839441|FG000|COMPLETED|Overall Study||9
9738547|NCT00217425|10839441|FG000|NOT COMPLETED|Overall Study||37
9738548|NCT00217438|10839447|FG000|STARTED|Overall Study||66
9738549|NCT00217438|10839448|FG001|STARTED|Overall Study||64
9738550|NCT00217438|10839447|FG000|COMPLETED|Overall Study||66
9738551|NCT00217438|10839448|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
9738552|NCT00217438|10839447|FG000|NOT COMPLETED|Overall Study||0
9738553|NCT00217438|10839448|FG001|NOT COMPLETED|Overall Study||1
9738554|NCT00217464|10839454|FG000|STARTED|Overall Study||17
9738555|NCT00217464|10839454|FG000|COMPLETED|Overall Study||0
10089789|NCT02322021|11218548|FG001|COMPLETED|Extension Phase||0
10089790|NCT02322021|11218549|FG002|COMPLETED|Extension Phase||0
10089791|NCT02322021|11218550|FG003|COMPLETED|Extension Phase||0
9738556|NCT00217464|10839454|FG000|NOT COMPLETED|Overall Study||17
9738557|NCT00217490|10839462|FG000|STARTED|Overall Study||154
9738558|NCT00217490|10839463|FG001|STARTED|Overall Study||153
9738559|NCT00217490|10839464|FG002|STARTED|Overall Study||155
9738560|NCT00217490|10839465|FG003|STARTED|Overall Study||153
9738561|NCT00217490|10839462|FG000|COMPLETED|Overall Study||137
9738562|NCT00217490|10839463|FG001|COMPLETED|Overall Study||128
9738563|NCT00217490|10839464|FG002|COMPLETED|Overall Study||131
9738564|NCT00217490|10839465|FG003|COMPLETED|Overall Study||130
9738565|NCT00217490|10839462|FG000|NOT COMPLETED|Overall Study||17
9738566|NCT00217490|10839463|FG001|NOT COMPLETED|Overall Study||25
9738567|NCT00217490|10839464|FG002|NOT COMPLETED|Overall Study||24
9738568|NCT00217490|10839465|FG003|NOT COMPLETED|Overall Study||23
9738569|NCT00217581|10839479|FG000|STARTED|Overall Study||39
9738570|NCT00217581|10839479|FG000|COMPLETED|Overall Study||38
9738571|NCT00217581|10839479|FG000|NOT COMPLETED|Overall Study||1
9738572|NCT00217594|10839484|FG000|STARTED|Overall Study||31
9738573|NCT00217594|10839484|FG000|COMPLETED|Overall Study||31
9738574|NCT00217594|10839484|FG000|NOT COMPLETED|Overall Study||0
9738575|NCT00217620|10839488|FG000|STARTED|Overall Study||51
9738576|NCT00217620|10839488|FG000|Eligible|Overall Study||38
9738577|NCT00217620|10839488|FG000|Eligible and Began Protocol Therapy|Overall Study||37
9738578|NCT00217620|10839488|FG000|COMPLETED|Overall Study||0
10089792|NCT02322021|11218551|FG004|COMPLETED|Extension Phase||0
10089793|NCT02322021|11218547|FG000|NOT COMPLETED|Extension Phase||0
10089794|NCT02322021|11218548|FG001|NOT COMPLETED|Extension Phase||0
10089795|NCT02322021|11218549|FG002|NOT COMPLETED|Extension Phase||0
10089796|NCT02322021|11218550|FG003|NOT COMPLETED|Extension Phase||0
10089797|NCT02322021|11218551|FG004|NOT COMPLETED|Extension Phase||41
10089798|NCT02322047|11218570|FG000|STARTED|Overall Study||8
10089799|NCT02322047|11218571|FG001|STARTED|Overall Study||7
10089800|NCT02322047|11218572|FG002|STARTED|Overall Study||7
10089801|NCT02322047|11218573|FG003|STARTED|Overall Study||9
10089802|NCT02322047|11218570|FG000|COMPLETED|Overall Study||6
10089803|NCT02322047|11218571|FG001|COMPLETED|Overall Study||6
10089804|NCT02322047|11218572|FG002|COMPLETED|Overall Study||6
10089805|NCT02322047|11218573|FG003|COMPLETED|Overall Study||7
10201683|NCT03438539|11329048|FG005|STARTED|Overall Study||74
10201684|NCT03438539|11329043|FG000|COMPLETED|Overall Study||68
10201685|NCT03438539|11329044|FG001|COMPLETED|Overall Study||68
10201686|NCT03438539|11329045|FG002|COMPLETED|Overall Study||66
10201687|NCT03438539|11329046|FG003|COMPLETED|Overall Study||64
10201688|NCT03438539|11329047|FG004|COMPLETED|Overall Study||70
10201689|NCT03438539|11329048|FG005|COMPLETED|Overall Study||66
10201690|NCT03438539|11329043|FG000|NOT COMPLETED|Overall Study||8
10201691|NCT03438539|11329044|FG001|NOT COMPLETED|Overall Study||4
10201692|NCT03438539|11329045|FG002|NOT COMPLETED|Overall Study||10
10201693|NCT03438539|11329046|FG003|NOT COMPLETED|Overall Study||9
10201694|NCT03438539|11329047|FG004|NOT COMPLETED|Overall Study||3
10201695|NCT03438539|11329048|FG005|NOT COMPLETED|Overall Study||8
10201696|NCT03438578|11329064|FG000|STARTED|Overall Study||100
10201697|NCT03438578|11329065|FG001|STARTED|Overall Study||100
10201698|NCT03438578|11329064|FG000|COMPLETED|Overall Study||99
10201699|NCT03438578|11329065|FG001|COMPLETED|Overall Study||96
10201700|NCT03438578|11329064|FG000|NOT COMPLETED|Overall Study||1
10201701|NCT03438578|11329065|FG001|NOT COMPLETED|Overall Study||4
10201702|NCT03439072|11329071|FG000|STARTED|Overall Study||41
10201703|NCT03439072|11329072|FG001|STARTED|Overall Study||40
10201704|NCT03439072|11329071|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
10201705|NCT03439072|11329072|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
10201706|NCT03439072|11329071|FG000|NOT COMPLETED|Overall Study||2
10201707|NCT03439072|11329072|FG001|NOT COMPLETED|Overall Study||4
10201708|NCT03439137|11329080|FG000|STARTED|Overall Study||162
10201709|NCT03439137|11329081|FG001|STARTED|Overall Study||161
10201710|NCT03439137|11329080|FG000|COMPLETED|Overall Study||120
10201711|NCT03439137|11329081|FG001|COMPLETED|Overall Study||135
10201712|NCT03439137|11329080|FG000|NOT COMPLETED|Overall Study||42
10089806|NCT02322047|11218570|FG000|NOT COMPLETED|Overall Study||2
10089807|NCT02322047|11218571|FG001|NOT COMPLETED|Overall Study||1
10201713|NCT03439137|11329081|FG001|NOT COMPLETED|Overall Study||26
10201714|NCT03439189|11329087|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343
9738579|NCT00217620|10839488|FG000|NOT COMPLETED|Overall Study||51
9738580|NCT00217672|10839496|FG000|STARTED|Allocation||69
9738581|NCT00217672|10839497|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
9738582|NCT00217672|10839496|FG000|COMPLETED|Allocation||67
9738583|NCT00217672|10839497|FG001|COMPLETED|Allocation||7
9738584|NCT00217672|10839496|FG000|NOT COMPLETED|Allocation||2
9738585|NCT00217672|10839497|FG001|NOT COMPLETED|Allocation||0
9738586|NCT00217672|10839496|FG000|STARTED|Treatment||67
9738587|NCT00217672|10839497|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
9738588|NCT00217672|10839496|FG000|COMPLETED|Treatment||0
9738589|NCT00217672|10839497|FG001|COMPLETED|Treatment||0
9738590|NCT00217672|10839496|FG000|NOT COMPLETED|Treatment||67
9738591|NCT00217672|10839497|FG001|NOT COMPLETED|Treatment||7
9738592|NCT00217672|10839496|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
9738593|NCT00217672|10839497|FG001|STARTED|Follow-up||0
9738594|NCT00217672|10839496|FG000|COMPLETED|Follow-up||69
9738595|NCT00217672|10839497|FG001|COMPLETED|Follow-up||0
9738596|NCT00217672|10839496|FG000|NOT COMPLETED|Follow-up||5
9738597|NCT00217672|10839497|FG001|NOT COMPLETED|Follow-up||0
9738598|NCT00217724|10839501|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8
9738599|NCT00217724|10839502|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10
9738600|NCT00217724|10839501|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
9738601|NCT00217724|10839502|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
9738602|NCT00217724|10839501|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
9738603|NCT00217724|10839502|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
9738604|NCT00217724|10839501|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
9738605|NCT00217724|10839502|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
9738606|NCT00217724|10839501|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
9738607|NCT00217724|10839502|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
9738608|NCT00217724|10839501|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
9738609|NCT00217724|10839502|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
9738610|NCT00217971|10839510|FG000|STARTED|Overall Study||79
9738611|NCT00217971|10839511|FG001|STARTED|Overall Study||77
9738612|NCT00217971|10839510|FG000|COMPLETED|Overall Study||55
9738613|NCT00217971|10839511|FG001|COMPLETED|Overall Study||44
9738614|NCT00217971|10839510|FG000|NOT COMPLETED|Overall Study||24
9738615|NCT00217971|10839511|FG001|NOT COMPLETED|Overall Study||33
9738616|NCT00218023|10839521|FG000|STARTED|Overall Study||22
9738617|NCT00218023|10839522|FG001|STARTED|Overall Study||25
9738618|NCT00218023|10839523|FG002|STARTED|Overall Study||16
9738619|NCT00218023|10839524|FG003|STARTED|Overall Study||18
9738620|NCT00218023|10839521|FG000|Received Drug or Placebo in Phase II|Overall Study||18
9738621|NCT00218023|10839522|FG001|Received Drug or Placebo in Phase II|Overall Study||24
9738622|NCT00218023|10839523|FG002|Received Drug or Placebo in Phase II|Overall Study||15
9738623|NCT00218023|10839524|FG003|Received Drug or Placebo in Phase II|Overall Study||18
9738624|NCT00218023|10839521|FG000|COMPLETED|Overall Study||9
9738625|NCT00218023|10839522|FG001|COMPLETED|Overall Study||10
9738626|NCT00218023|10839523|FG002|COMPLETED|Overall Study||6
9738627|NCT00218023|10839524|FG003|COMPLETED|Overall Study||11
9738628|NCT00218023|10839521|FG000|NOT COMPLETED|Overall Study||13
9738629|NCT00218023|10839522|FG001|NOT COMPLETED|Overall Study||15
9738630|NCT00218023|10839523|FG002|NOT COMPLETED|Overall Study||10
9738631|NCT00218023|10839524|FG003|NOT COMPLETED|Overall Study||7
9738632|NCT00218062|10839538|FG000|STARTED|Overall Study||22
9738633|NCT00218062|10839539|FG001|STARTED|Overall Study||20
9738634|NCT00218062|10839540|FG002|STARTED|Overall Study||15
9738635|NCT00218062|10839541|FG003|STARTED|Overall Study||16
9738636|NCT00218062|10839538|FG000|Received First Dose of Study Medication|Overall Study||16
9738637|NCT00218062|10839539|FG001|Received First Dose of Study Medication|Overall Study||11
9738638|NCT00218062|10839540|FG002|Received First Dose of Study Medication|Overall Study||10
9738639|NCT00218062|10839541|FG003|Received First Dose of Study Medication|Overall Study||12
9738640|NCT00218062|10839538|FG000|COMPLETED|Overall Study||7
9738641|NCT00218062|10839539|FG001|COMPLETED|Overall Study||4
9738642|NCT00218062|10839540|FG002|COMPLETED|Overall Study||3
9738643|NCT00218062|10839541|FG003|COMPLETED|Overall Study||3
9738644|NCT00218062|10839538|FG000|NOT COMPLETED|Overall Study||15
9738645|NCT00218062|10839539|FG001|NOT COMPLETED|Overall Study||16
9738646|NCT00218062|10839540|FG002|NOT COMPLETED|Overall Study||12
9738647|NCT00218062|10839541|FG003|NOT COMPLETED|Overall Study||13
9738648|NCT00218257|10839551|FG000|STARTED|Intervention 1||23
9738649|NCT00218257|10839552|FG001|STARTED|Intervention 1||22
9738650|NCT00218257|10839551|FG000|COMPLETED|Intervention 1||23
9738651|NCT00218257|10839552|FG001|COMPLETED|Intervention 1||22
9738652|NCT00218257|10839551|FG000|NOT COMPLETED|Intervention 1||0
9738653|NCT00218257|10839552|FG001|NOT COMPLETED|Intervention 1||0
9738654|NCT00218257|10839551|FG000|STARTED|Period Between Visit 1 and 2||23
9738655|NCT00218257|10839552|FG001|STARTED|Period Between Visit 1 and 2||22
9738656|NCT00218257|10839551|FG000|COMPLETED|Period Between Visit 1 and 2||19
9738657|NCT00218257|10839552|FG001|COMPLETED|Period Between Visit 1 and 2||19
9738658|NCT00218257|10839551|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4
9738659|NCT00218257|10839552|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3
9738660|NCT00218257|10839551|FG000|STARTED|Intervention 2||19
9738661|NCT00218257|10839552|FG001|STARTED|Intervention 2||19
9738662|NCT00218257|10839551|FG000|COMPLETED|Intervention 2||19
9738663|NCT00218257|10839552|FG001|COMPLETED|Intervention 2||19
9738664|NCT00218257|10839551|FG000|NOT COMPLETED|Intervention 2||0
9738665|NCT00218257|10839552|FG001|NOT COMPLETED|Intervention 2||0
9738666|NCT00218296|10839563|FG000|STARTED|Overall Study||163
9738667|NCT00218296|10839564|FG001|STARTED|Overall Study||169
9738668|NCT00218296|10839563|FG000|Attended Visti|Overall Study||97
9738669|NCT00218296|10839564|FG001|Attended Visti|Overall Study||102
9738670|NCT00218296|10839563|FG000|COMPLETED|Overall Study||52
9738671|NCT00218296|10839564|FG001|COMPLETED|Overall Study||48
9738672|NCT00218296|10839563|FG000|NOT COMPLETED|Overall Study||111
9738673|NCT00218296|10839564|FG001|NOT COMPLETED|Overall Study||121
9738674|NCT00218335|10839576|FG000|STARTED|Overall Study||114
9738675|NCT00218335|10839577|FG001|STARTED|Overall Study||113
9738676|NCT00218335|10839578|FG002|STARTED|Overall Study||373
9738677|NCT00218335|10839579|FG003|STARTED|Overall Study||424
9738678|NCT00218335|10839576|FG000|6 Month Follow-up|Overall Study||103
9738679|NCT00218335|10839577|FG001|6 Month Follow-up|Overall Study||99
9738680|NCT00218335|10839578|FG002|6 Month Follow-up|Overall Study||219
9738681|NCT00218335|10839579|FG003|6 Month Follow-up|Overall Study||301
9738682|NCT00218335|10839576|FG000|12 Month Follow-up|Overall Study||95
9738683|NCT00218335|10839577|FG001|12 Month Follow-up|Overall Study||102
9738684|NCT00218335|10839578|FG002|12 Month Follow-up|Overall Study||244
9738685|NCT00218335|10839579|FG003|12 Month Follow-up|Overall Study||303
9738686|NCT00218335|10839576|FG000|18 Month Follow-up|Overall Study||101
9738687|NCT00218335|10839577|FG001|18 Month Follow-up|Overall Study||108
9738688|NCT00218335|10839578|FG002|18 Month Follow-up|Overall Study||296
9738689|NCT00218335|10839579|FG003|18 Month Follow-up|Overall Study||368
9738690|NCT00218335|10839576|FG000|COMPLETED|Overall Study||108
9738691|NCT00218335|10839577|FG001|COMPLETED|Overall Study||110
9738692|NCT00218335|10839578|FG002|COMPLETED|Overall Study||319
9738693|NCT00218335|10839579|FG003|COMPLETED|Overall Study||388
9738694|NCT00218335|10839576|FG000|NOT COMPLETED|Overall Study||6
9738695|NCT00218335|10839577|FG001|NOT COMPLETED|Overall Study||3
9738696|NCT00218335|10839578|FG002|NOT COMPLETED|Overall Study||54
9738697|NCT00218335|10839579|FG003|NOT COMPLETED|Overall Study||36
9738698|NCT00218387|10839594|FG000|STARTED|Overall Study||40
9738699|NCT00218387|10839595|FG001|STARTED|Overall Study||43
9738700|NCT00218387|10839596|FG002|STARTED|Overall Study||40
9738701|NCT00218387|10839594|FG000|COMPLETED|Overall Study||25
9738702|NCT00218387|10839595|FG001|COMPLETED|Overall Study||25
9738703|NCT00218387|10839596|FG002|COMPLETED|Overall Study||17
9738704|NCT00218387|10839594|FG000|NOT COMPLETED|Overall Study||15
9738705|NCT00218387|10839595|FG001|NOT COMPLETED|Overall Study||18
9738706|NCT00218387|10839596|FG002|NOT COMPLETED|Overall Study||23
9738707|NCT00218426|10839607|FG000|STARTED|Overall Study||102
9738708|NCT00218426|10839608|FG001|STARTED|Overall Study||102
10089808|NCT02322047|11218572|FG002|NOT COMPLETED|Overall Study||1
10089809|NCT02322047|11218573|FG003|NOT COMPLETED|Overall Study||2
10089810|NCT02322125|11218583|FG000|STARTED|Overall Study||12
10089811|NCT02322125|11218583|FG000|COMPLETED|Overall Study||10
10089812|NCT02322125|11218583|FG000|NOT COMPLETED|Overall Study||2
10089813|NCT02322190|11218587|FG000|STARTED|Overall Study||5
10089814|NCT02322190|11218588|FG001|STARTED|Overall Study||0
10089815|NCT02322190|11218587|FG000|COMPLETED|Overall Study||4
10089816|NCT02322190|11218588|FG001|COMPLETED|Overall Study||0
10089817|NCT02322190|11218587|FG000|NOT COMPLETED|Overall Study||1
10089818|NCT02322190|11218588|FG001|NOT COMPLETED|Overall Study||0
10089819|NCT02322216|11218595|FG000|STARTED|Overall Study||126
10089820|NCT02322216|11218596|FG001|STARTED|Overall Study||127
10089821|NCT02322216|11218595|FG000|Treated (Safety Set)|Overall Study||126
10089822|NCT02322216|11218596|FG001|Treated (Safety Set)|Overall Study||126
10089823|NCT02322216|11218595|FG000|Per Protocol Set (PPS)|Overall Study||123
10089824|NCT02322216|11218596|FG001|Per Protocol Set (PPS)|Overall Study||122
10089825|NCT02322216|11218595|FG000|COMPLETED|Overall Study||124
9738709|NCT00218426|10839609|FG002|STARTED|Overall Study||102
9738710|NCT00218426|10839607|FG000|COMPLETED|Overall Study||54
9738711|NCT00218426|10839608|FG001|COMPLETED|Overall Study||16
9738712|NCT00218426|10839609|FG002|COMPLETED|Overall Study||11
9738713|NCT00218426|10839607|FG000|NOT COMPLETED|Overall Study||48
9738714|NCT00218426|10839608|FG001|NOT COMPLETED|Overall Study||86
9738715|NCT00218426|10839609|FG002|NOT COMPLETED|Overall Study||91
9738716|NCT00218439|10839622|FG000|STARTED|First Intervention (4 Weeks)||58
10089826|NCT02322216|11218596|FG001|COMPLETED|Overall Study||123
10089827|NCT02322216|11218595|FG000|NOT COMPLETED|Overall Study||2
10089828|NCT02322216|11218596|FG001|NOT COMPLETED|Overall Study||4
10089829|NCT02322229|11218603|FG000|STARTED|Overall Study||52
10089830|NCT02322229|11218603|FG000|COMPLETED|Overall Study||50
10089831|NCT02322229|11218603|FG000|NOT COMPLETED|Overall Study||2
10089832|NCT02322242|11218610|FG000|STARTED|Overall Study||92
10089833|NCT02322242|11218611|FG001|STARTED|Overall Study||90
10089834|NCT02322242|11218610|FG000|Primary Outcome|Overall Study||92
10089835|NCT02322242|11218611|FG001|Primary Outcome|Overall Study||90
10089836|NCT02322242|11218610|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
10089837|NCT02322242|11218611|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
9738717|NCT00218439|10839623|FG001|STARTED|First Intervention (4 Weeks)||47
9738718|NCT00218439|10839622|FG000|COMPLETED|First Intervention (4 Weeks)||40
9738719|NCT00218439|10839623|FG001|COMPLETED|First Intervention (4 Weeks)||35
9738720|NCT00218439|10839622|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18
9738721|NCT00218439|10839623|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12
9738722|NCT00218439|10839622|FG000|STARTED|Second Intervention (4 Weeks)||40
10089838|NCT02322242|11218610|FG000|COMPLETED|Overall Study||92
9738723|NCT00218439|10839623|FG001|STARTED|Second Intervention (4 Weeks)||35
10089839|NCT02322242|11218611|FG001|COMPLETED|Overall Study||90
10089840|NCT02322242|11218610|FG000|NOT COMPLETED|Overall Study||0
10089841|NCT02322242|11218611|FG001|NOT COMPLETED|Overall Study||0
9738724|NCT00218439|10839622|FG000|COMPLETED|Second Intervention (4 Weeks)||33
9738725|NCT00218439|10839623|FG001|COMPLETED|Second Intervention (4 Weeks)||30
9738726|NCT00218439|10839622|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7
9738727|NCT00218439|10839623|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5
9738728|NCT00218465|10839639|FG000|STARTED|Overall Study||50
9738729|NCT00218465|10839640|FG001|STARTED|Overall Study||48
9738730|NCT00218465|10839639|FG000|COMPLETED|Overall Study||33
9738731|NCT00218465|10839640|FG001|COMPLETED|Overall Study||30
9738732|NCT00218465|10839639|FG000|NOT COMPLETED|Overall Study||17
9738733|NCT00218465|10839640|FG001|NOT COMPLETED|Overall Study||18
9738734|NCT00218491|10839649|FG000|STARTED|Overall Study||40
9738735|NCT00218491|10839650|FG001|STARTED|Overall Study||33
9738736|NCT00218491|10839651|FG002|STARTED|Overall Study||38
9738737|NCT00218491|10839649|FG000|COMPLETED|Overall Study||40
9738738|NCT00218491|10839650|FG001|COMPLETED|Overall Study||33
9738739|NCT00218491|10839651|FG002|COMPLETED|Overall Study||38
9738740|NCT00218491|10839649|FG000|NOT COMPLETED|Overall Study||0
9738741|NCT00218491|10839650|FG001|NOT COMPLETED|Overall Study||0
9738742|NCT00218491|10839651|FG002|NOT COMPLETED|Overall Study||0
9738743|NCT00218543|10839659|FG000|STARTED|Overall Study||20
9738744|NCT00218543|10839659|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
9738745|NCT00218543|10839659|FG000|NOT COMPLETED|Overall Study||15
9738746|NCT00218634|10839665|FG000|STARTED|Overall Study||44
9738747|NCT00218634|10839666|FG001|STARTED|Overall Study||45
9738748|NCT00218634|10839665|FG000|COMPLETED|Overall Study||36
9738749|NCT00218634|10839666|FG001|COMPLETED|Overall Study||30
9738750|NCT00218634|10839665|FG000|NOT COMPLETED|Overall Study||8
9738751|NCT00218634|10839666|FG001|NOT COMPLETED|Overall Study||15
9738752|NCT00219141|10839678|FG000|STARTED|Overall Study||154
9738753|NCT00219141|10839679|FG001|STARTED|Overall Study||152
9738754|NCT00219141|10839680|FG002|STARTED|Overall Study||154
9738755|NCT00219141|10839678|FG000|COMPLETED|Overall Study||140
9738756|NCT00219141|10839679|FG001|COMPLETED|Overall Study||131
9738757|NCT00219141|10839680|FG002|COMPLETED|Overall Study||142
10089842|NCT02322281|11218620|FG000|STARTED|Overall Study||53
10089843|NCT02322281|11218621|FG001|STARTED|Overall Study||22
9738758|NCT00219141|10839678|FG000|NOT COMPLETED|Overall Study||14
9738759|NCT00219141|10839679|FG001|NOT COMPLETED|Overall Study||21
9738760|NCT00219141|10839680|FG002|NOT COMPLETED|Overall Study||12
9738761|NCT00219284|10839690|FG000|STARTED|Treatment Phase - 16 Weeks||180
9738762|NCT00219284|10839691|FG001|STARTED|Treatment Phase - 16 Weeks||179
9738763|NCT00219284|10839690|FG000|COMPLETED|Treatment Phase - 16 Weeks||136
9738764|NCT00219284|10839691|FG001|COMPLETED|Treatment Phase - 16 Weeks||128
9738765|NCT00219284|10839690|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44
9738766|NCT00219284|10839691|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51
9738767|NCT00219284|10839690|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
9738768|NCT00219284|10839691|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
9738769|NCT00219284|10839690|FG000|COMPLETED|Extension Phase - 8 Weeks||112
9738770|NCT00219284|10839691|FG001|COMPLETED|Extension Phase - 8 Weeks||99
9738771|NCT00219284|10839690|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2
9738772|NCT00219284|10839691|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7
9738773|NCT00219349|10839697|FG000|STARTED|Cognitive Behavioral Therapy Phase||25
9738774|NCT00219349|10839697|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15
9738775|NCT00219349|10839697|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
9738776|NCT00219349|10839697|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
9738777|NCT00219349|10839697|FG000|COMPLETED|Escitalopram Phase||4
9738778|NCT00219349|10839697|FG000|NOT COMPLETED|Escitalopram Phase||3
9738779|NCT00219544|10839701|FG000|STARTED|Single Blind Treatment Period||256
9738780|NCT00219544|10839702|FG001|STARTED|Single Blind Treatment Period||0
9738781|NCT00219544|10839701|FG000|COMPLETED|Single Blind Treatment Period||234
9738782|NCT00219544|10839702|FG001|COMPLETED|Single Blind Treatment Period||0
9738783|NCT00219544|10839701|FG000|NOT COMPLETED|Single Blind Treatment Period||22
9738784|NCT00219544|10839702|FG001|NOT COMPLETED|Single Blind Treatment Period||0
9738785|NCT00219544|10839701|FG000|STARTED|Double Blind Treatment Period||80
9738786|NCT00219544|10839702|FG001|STARTED|Double Blind Treatment Period||77
9738787|NCT00219544|10839701|FG000|COMPLETED|Double Blind Treatment Period||80
9738788|NCT00219544|10839702|FG001|COMPLETED|Double Blind Treatment Period||77
9738789|NCT00219544|10839701|FG000|NOT COMPLETED|Double Blind Treatment Period||0
9738790|NCT00219544|10839702|FG001|NOT COMPLETED|Double Blind Treatment Period||0
9738791|NCT00219557|10839713|FG000|STARTED|Phase 1||8
9738792|NCT00219557|10839714|FG001|STARTED|Phase 1||0
9738793|NCT00219557|10839715|FG002|STARTED|Phase 1||0
9738794|NCT00219557|10839713|FG000|COMPLETED|Phase 1||1
9738795|NCT00219557|10839714|FG001|COMPLETED|Phase 1||0
9738796|NCT00219557|10839715|FG002|COMPLETED|Phase 1||0
9738797|NCT00219557|10839713|FG000|NOT COMPLETED|Phase 1||7
9738798|NCT00219557|10839714|FG001|NOT COMPLETED|Phase 1||0
9738799|NCT00219557|10839715|FG002|NOT COMPLETED|Phase 1||0
9738800|NCT00219557|10839713|FG000|STARTED|Phase 2||0
9738801|NCT00219557|10839714|FG001|STARTED|Phase 2||69
9738802|NCT00219557|10839715|FG002|STARTED|Phase 2||34
9738803|NCT00219557|10839713|FG000|Treated|Phase 2||0
9738804|NCT00219557|10839714|FG001|Treated|Phase 2||68
9738805|NCT00219557|10839715|FG002|Treated|Phase 2||31
9738806|NCT00219557|10839713|FG000|COMPLETED|Phase 2||0
9738807|NCT00219557|10839714|FG001|COMPLETED|Phase 2||0
9738808|NCT00219557|10839715|FG002|COMPLETED|Phase 2||1
9738809|NCT00219557|10839713|FG000|NOT COMPLETED|Phase 2||0
9738810|NCT00219557|10839714|FG001|NOT COMPLETED|Phase 2||69
9738811|NCT00219557|10839715|FG002|NOT COMPLETED|Phase 2||33
9738812|NCT00220636|10839724|FG000|STARTED|Overall Study||15
9738813|NCT00220636|10839724|FG000|COMPLETED|Overall Study||11
9738814|NCT00220636|10839724|FG000|NOT COMPLETED|Overall Study||4
9738815|NCT00220701|10839731|FG000|STARTED|Overall Study||17
9738816|NCT00220701|10839732|FG001|STARTED|Overall Study||17
9738817|NCT00220701|10839731|FG000|COMPLETED|Overall Study||12
9738818|NCT00220701|10839732|FG001|COMPLETED|Overall Study||13
9738819|NCT00220701|10839731|FG000|NOT COMPLETED|Overall Study||5
9738820|NCT00220701|10839732|FG001|NOT COMPLETED|Overall Study||4
9738821|NCT00220727|10839740|FG000|STARTED|First Infusion (Week 0)||4
9738822|NCT00220727|10839741|FG001|STARTED|First Infusion (Week 0)||4
9738823|NCT00220727|10839740|FG000|COMPLETED|First Infusion (Week 0)||4
9738824|NCT00220727|10839741|FG001|COMPLETED|First Infusion (Week 0)||4
9738825|NCT00220727|10839740|FG000|NOT COMPLETED|First Infusion (Week 0)||0
9738826|NCT00220727|10839741|FG001|NOT COMPLETED|First Infusion (Week 0)||0
9738827|NCT00220727|10839740|FG000|STARTED|Second Infusion (Week <6)||4
9738828|NCT00220727|10839741|FG001|STARTED|Second Infusion (Week <6)||4
9738829|NCT00220727|10839740|FG000|COMPLETED|Second Infusion (Week <6)||3
9738830|NCT00220727|10839741|FG001|COMPLETED|Second Infusion (Week <6)||4
9738831|NCT00220727|10839740|FG000|NOT COMPLETED|Second Infusion (Week <6)||1
9738832|NCT00220727|10839741|FG001|NOT COMPLETED|Second Infusion (Week <6)||0
9738833|NCT00220740|10839751|FG000|STARTED|Efficacy Period||59
9738834|NCT00220740|10839752|FG001|STARTED|Efficacy Period||58
9738835|NCT00220740|10839751|FG000|COMPLETED|Efficacy Period||33
9738836|NCT00220740|10839752|FG001|COMPLETED|Efficacy Period||12
9738837|NCT00220740|10839751|FG000|NOT COMPLETED|Efficacy Period||26
9738838|NCT00220740|10839752|FG001|NOT COMPLETED|Efficacy Period||46
9738839|NCT00220740|10839751|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
9738840|NCT00220740|10839752|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
9738841|NCT00220740|10839751|FG000|COMPLETED|Rescue Treatment||26
9738842|NCT00220740|10839752|FG001|COMPLETED|Rescue Treatment||5
9738843|NCT00220740|10839751|FG000|NOT COMPLETED|Rescue Treatment||19
9738844|NCT00220740|10839752|FG001|NOT COMPLETED|Rescue Treatment||18
9738845|NCT00220740|10839751|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
9738846|NCT00220740|10839752|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
9738847|NCT00220740|10839751|FG000|COMPLETED|Withdrawal Period||37
9738848|NCT00220740|10839752|FG001|COMPLETED|Withdrawal Period||16
9738849|NCT00220740|10839751|FG000|NOT COMPLETED|Withdrawal Period||6
9738850|NCT00220740|10839752|FG001|NOT COMPLETED|Withdrawal Period||15
9738851|NCT00220779|10839763|FG000|STARTED|Overall Study||45
9738852|NCT00220779|10839764|FG001|STARTED|Overall Study||42
9738853|NCT00220779|10839765|FG002|STARTED|Overall Study||41
9738854|NCT00220779|10839763|FG000|COMPLETED|Overall Study||38
9738855|NCT00220779|10839764|FG001|COMPLETED|Overall Study||38
9738856|NCT00220779|10839765|FG002|COMPLETED|Overall Study||37
9738857|NCT00220779|10839763|FG000|NOT COMPLETED|Overall Study||7
9738858|NCT00220779|10839764|FG001|NOT COMPLETED|Overall Study||4
9738859|NCT00220779|10839765|FG002|NOT COMPLETED|Overall Study||4
9738860|NCT00220805|10839775|FG000|STARTED|Overall Study||30
9738861|NCT00220805|10839776|FG001|STARTED|Overall Study||27
9738862|NCT00220805|10839775|FG000|COMPLETED|Overall Study||22
9738863|NCT00220805|10839776|FG001|COMPLETED|Overall Study||16
9738864|NCT00220805|10839775|FG000|NOT COMPLETED|Overall Study||8
9738865|NCT00220805|10839776|FG001|NOT COMPLETED|Overall Study||11
9738866|NCT00220961|10839784|FG000|STARTED|Overall Study||299
9738867|NCT00220961|10839785|FG001|STARTED|Overall Study||303
9738868|NCT00220961|10839784|FG000|COMPLETED|Overall Study||228
9738869|NCT00220961|10839785|FG001|COMPLETED|Overall Study||213
10089844|NCT02322281|11218622|FG002|STARTED|Overall Study||74
10089845|NCT02322281|11218620|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
10089846|NCT02322281|11218621|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
10089847|NCT02322281|11218622|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
10089848|NCT02322281|11218620|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
10089849|NCT02322281|11218621|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
10089850|NCT02322281|11218622|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
10089851|NCT02322281|11218620|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10089852|NCT02322281|11218621|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10089853|NCT02322281|11218622|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10089854|NCT02322281|11218620|FG000|NOT COMPLETED|Overall Study||53
10089855|NCT02322281|11218621|FG001|NOT COMPLETED|Overall Study||22
9738870|NCT00220961|10839784|FG000|NOT COMPLETED|Overall Study||71
10089856|NCT02322281|11218622|FG002|NOT COMPLETED|Overall Study||74
10089857|NCT02322320|11218635|FG000|STARTED|Overall Study||98
10089858|NCT02322320|11218636|FG001|STARTED|Overall Study||86
10089859|NCT02322320|11218637|FG002|STARTED|Overall Study||89
10089860|NCT02322320|11218635|FG000|COMPLETED|Overall Study||98
10089861|NCT02322320|11218636|FG001|COMPLETED|Overall Study||86
9738871|NCT00220961|10839785|FG001|NOT COMPLETED|Overall Study||90
9738872|NCT00221104|10839793|FG000|STARTED|Overall Study||793
9738873|NCT00221104|10839794|FG001|STARTED|Overall Study||785
9738874|NCT00221104|10839793|FG000|COMPLETED|Overall Study||710
9738875|NCT00221104|10839794|FG001|COMPLETED|Overall Study||709
9738876|NCT00221104|10839793|FG000|NOT COMPLETED|Overall Study||83
9738877|NCT00221104|10839794|FG001|NOT COMPLETED|Overall Study||76
9738878|NCT00221117|10839804|FG000|STARTED|Overall Study||12
9738879|NCT00221117|10839805|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
9738880|NCT00221117|10839804|FG000|COMPLETED|Overall Study||12
9738881|NCT00221117|10839805|FG001|COMPLETED|Overall Study||9
9738882|NCT00221117|10839804|FG000|NOT COMPLETED|Overall Study||0
9738883|NCT00221117|10839805|FG001|NOT COMPLETED|Overall Study||0
9738884|NCT00221195|10839815|FG000|STARTED|Therapy 1 (Months 1-6)||17
9738885|NCT00221195|10839816|FG001|STARTED|Therapy 1 (Months 1-6)||17
9738886|NCT00221195|10839815|FG000|COMPLETED|Therapy 1 (Months 1-6)||14
9738887|NCT00221195|10839816|FG001|COMPLETED|Therapy 1 (Months 1-6)||15
9738888|NCT00221195|10839815|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3
9738889|NCT00221195|10839816|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2
9738890|NCT00221195|10839815|FG000|STARTED|Washout Period (Months 7-9)||14
9738891|NCT00221195|10839816|FG001|STARTED|Washout Period (Months 7-9)||15
9738892|NCT00221195|10839815|FG000|COMPLETED|Washout Period (Months 7-9)||14
9738893|NCT00221195|10839816|FG001|COMPLETED|Washout Period (Months 7-9)||14
9738894|NCT00221195|10839815|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0
9738895|NCT00221195|10839816|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1
9738896|NCT00221195|10839815|FG000|STARTED|Therapy 2 (Months 10-15)||14
9738897|NCT00221195|10839816|FG001|STARTED|Therapy 2 (Months 10-15)||14
9738898|NCT00221195|10839815|FG000|COMPLETED|Therapy 2 (Months 10-15)||12
9738899|NCT00221195|10839816|FG001|COMPLETED|Therapy 2 (Months 10-15)||14
9738900|NCT00221195|10839815|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2
9738901|NCT00221195|10839816|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0
9738902|NCT00221299|10839826|FG000|STARTED|Overall Study||11
9738903|NCT00221299|10839827|FG001|STARTED|Overall Study||13
9738904|NCT00221299|10839828|FG002|STARTED|Overall Study||14
9738905|NCT00221299|10839829|FG003|STARTED|Overall Study||11
9738906|NCT00221299|10839826|FG000|COMPLETED|Overall Study||10
9738907|NCT00221299|10839827|FG001|COMPLETED|Overall Study||11
9738908|NCT00221299|10839828|FG002|COMPLETED|Overall Study||14
9738909|NCT00221299|10839829|FG003|COMPLETED|Overall Study||10
9738910|NCT00221299|10839826|FG000|NOT COMPLETED|Overall Study||1
9738911|NCT00221299|10839827|FG001|NOT COMPLETED|Overall Study||2
9738912|NCT00221299|10839828|FG002|NOT COMPLETED|Overall Study||0
9738913|NCT00221299|10839829|FG003|NOT COMPLETED|Overall Study||1
9738914|NCT00221338|10839839|FG000|STARTED|Overall Study||374
9738915|NCT00221338|10839840|FG001|STARTED|Overall Study||376
9738916|NCT00221338|10839839|FG000|COMPLETED|Overall Study||350
9738917|NCT00221338|10839840|FG001|COMPLETED|Overall Study||347
9738918|NCT00221338|10839839|FG000|NOT COMPLETED|Overall Study||24
9738919|NCT00221338|10839840|FG001|NOT COMPLETED|Overall Study||29
9738920|NCT00221403|10839849|FG000|STARTED|Overall Study||18
9738921|NCT00221403|10839850|FG001|STARTED|Overall Study||21
9738922|NCT00221403|10839851|FG002|STARTED|Overall Study||7
9738923|NCT00221403|10839849|FG000|COMPLETED|Overall Study||16
9738924|NCT00221403|10839850|FG001|COMPLETED|Overall Study||16
9738925|NCT00221403|10839851|FG002|COMPLETED|Overall Study||7
9738926|NCT00221403|10839849|FG000|NOT COMPLETED|Overall Study||2
9738927|NCT00221403|10839850|FG001|NOT COMPLETED|Overall Study||5
9738928|NCT00221403|10839851|FG002|NOT COMPLETED|Overall Study||0
9738929|NCT00222105|10839859|FG000|STARTED|Overall Study||25
9738930|NCT00222105|10839859|FG000|COMPLETED|Overall Study||11
9738931|NCT00222105|10839859|FG000|NOT COMPLETED|Overall Study||14
9738932|NCT00222131|10839865|FG000|STARTED|Overall Study||38
9738933|NCT00222131|10839866|FG001|STARTED|Overall Study||35
9738934|NCT00222131|10839865|FG000|COMPLETED|Overall Study||38
9738935|NCT00222131|10839866|FG001|COMPLETED|Overall Study||35
9738936|NCT00222131|10839865|FG000|NOT COMPLETED|Overall Study||0
9738937|NCT00222131|10839866|FG001|NOT COMPLETED|Overall Study||0
9738938|NCT00222729|10839872|FG000|STARTED|Overall Study||40
9738939|NCT00222729|10839872|FG000|COMPLETED|Overall Study||37
9738940|NCT00222729|10839872|FG000|NOT COMPLETED|Overall Study||3
9738941|NCT00223080|10839878|FG000|STARTED|Overall Study||8197
9738942|NCT00223080|10839879|FG001|STARTED|Overall Study||8198
9738943|NCT00223080|10839878|FG000|COMPLETED|Overall Study||7401
9738944|NCT00223080|10839879|FG001|COMPLETED|Overall Study||7401
9738945|NCT00223080|10839878|FG000|NOT COMPLETED|Overall Study||796
9738946|NCT00223080|10839879|FG001|NOT COMPLETED|Overall Study||797
9738947|NCT00223236|10839887|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
9738948|NCT00223236|10839888|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
9738949|NCT00223236|10839887|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9
9738950|NCT00223236|10839888|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4
9852248|NCT00880269|10965075|FG000|Discontinued Treatment|Overall Study||32
9738951|NCT00223236|10839887|FG000|NOT COMPLETED|Overall Study||7
9738952|NCT00223236|10839888|FG001|NOT COMPLETED|Overall Study||14
9738953|NCT00223262|10839896|FG000|STARTED|Overall Study||16
9738954|NCT00223262|10839897|FG001|STARTED|Overall Study||12
9738955|NCT00223262|10839896|FG000|COMPLETED|Overall Study||8
9738956|NCT00223262|10839897|FG001|COMPLETED|Overall Study||11
9738957|NCT00223262|10839896|FG000|NOT COMPLETED|Overall Study||8
9738958|NCT00223262|10839897|FG001|NOT COMPLETED|Overall Study||1
9738959|NCT00223496|10839903|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32
9738960|NCT00223496|10839903|FG000|COMPLETED|Overall Study||10
9738961|NCT00223496|10839903|FG000|NOT COMPLETED|Overall Study||22
9738962|NCT00223652|10839909|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
9738963|NCT00223652|10839910|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
9738964|NCT00223652|10839909|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
9738965|NCT00223652|10839910|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
9738966|NCT00223652|10839909|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
9738967|NCT00223652|10839910|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
9738968|NCT00223652|10839909|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
9738969|NCT00223652|10839910|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
9852249|NCT00880269|10965076|FG001|Discontinued Treatment|Overall Study||27
9852250|NCT00880269|10965075|FG000|COMPLETED|Overall Study||0
9852251|NCT00880269|10965076|FG001|COMPLETED|Overall Study||0
9852252|NCT00880269|10965075|FG000|NOT COMPLETED|Overall Study||32
9852253|NCT00880269|10965076|FG001|NOT COMPLETED|Overall Study||27
9852254|NCT00880334|10965084|FG000|STARTED|Randomized Phase||74
9852255|NCT00880334|10965085|FG001|STARTED|Randomized Phase||75
9852256|NCT00880334|10965084|FG000|Eligible & Treated|Randomized Phase||70
9852257|NCT00880334|10965085|FG001|Eligible & Treated|Randomized Phase||72
9852258|NCT00880334|10965084|FG000|COMPLETED|Randomized Phase||70
9852259|NCT00880334|10965085|FG001|COMPLETED|Randomized Phase||35
9852260|NCT00880334|10965084|FG000|NOT COMPLETED|Randomized Phase||4
9852261|NCT00880334|10965085|FG001|NOT COMPLETED|Randomized Phase||40
9852262|NCT00880334|10965084|FG000|STARTED|Crossover Phase||0
9852263|NCT00880334|10965085|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
9852264|NCT00880334|10965084|FG000|COMPLETED|Crossover Phase||0
9852265|NCT00880334|10965085|FG001|COMPLETED|Crossover Phase||37
9852266|NCT00880334|10965084|FG000|NOT COMPLETED|Crossover Phase||0
9852267|NCT00880334|10965085|FG001|NOT COMPLETED|Crossover Phase||0
9852268|NCT00880360|10965095|FG000|STARTED|Overall Study||19
9852269|NCT00880360|10965095|FG000|COMPLETED|Overall Study||19
9852270|NCT00880360|10965095|FG000|NOT COMPLETED|Overall Study||0
9852271|NCT00880399|10965103|FG000|STARTED|Overall Study||108
9852272|NCT00880399|10965104|FG001|STARTED|Overall Study||113
9852273|NCT00880399|10965105|FG002|STARTED|Overall Study||107
9852274|NCT00880399|10965103|FG000|COMPLETED|Overall Study||77
9852275|NCT00880399|10965104|FG001|COMPLETED|Overall Study||84
9852276|NCT00880399|10965105|FG002|COMPLETED|Overall Study||81
9852277|NCT00880399|10965103|FG000|NOT COMPLETED|Overall Study||31
9852278|NCT00880399|10965104|FG001|NOT COMPLETED|Overall Study||29
9852279|NCT00880399|10965105|FG002|NOT COMPLETED|Overall Study||26
9852280|NCT00880425|10965113|FG000|STARTED|Overall Study||18
9852281|NCT00880425|10965114|FG001|STARTED|Overall Study||27
9852282|NCT00880425|10965113|FG000|COMPLETED|Overall Study||18
9852283|NCT00880425|10965114|FG001|COMPLETED|Overall Study||27
9852284|NCT00880425|10965113|FG000|NOT COMPLETED|Overall Study||0
9852285|NCT00880425|10965114|FG001|NOT COMPLETED|Overall Study||0
9852286|NCT00880464|10965120|FG000|STARTED|Overall Study||7
9852287|NCT00880464|10965120|FG000|COMPLETED|Overall Study||7
9852288|NCT00880464|10965120|FG000|NOT COMPLETED|Overall Study||0
9852289|NCT00880555|10965127|FG000|STARTED|Overall Study||23
9852290|NCT00880555|10965128|FG001|STARTED|Overall Study||40
9852291|NCT00880555|10965129|FG002|STARTED|Overall Study||11
9852292|NCT00880555|10965130|FG003|STARTED|Overall Study||2
9852293|NCT00880555|10965131|FG004|STARTED|Overall Study||1
9852294|NCT00880555|10965132|FG005|STARTED|Overall Study||1
9852295|NCT00880555|10965127|FG000|COMPLETED|Overall Study||13
9852296|NCT00880555|10965128|FG001|COMPLETED|Overall Study||23
9852297|NCT00880555|10965129|FG002|COMPLETED|Overall Study||6
9852298|NCT00880555|10965130|FG003|COMPLETED|Overall Study||0
9852299|NCT00880555|10965131|FG004|COMPLETED|Overall Study||0
9852300|NCT00880555|10965132|FG005|COMPLETED|Overall Study||0
9852301|NCT00880555|10965127|FG000|NOT COMPLETED|Overall Study||10
9852302|NCT00880555|10965128|FG001|NOT COMPLETED|Overall Study||17
9852303|NCT00880555|10965129|FG002|NOT COMPLETED|Overall Study||5
9852304|NCT00880555|10965130|FG003|NOT COMPLETED|Overall Study||2
9852305|NCT00880555|10965131|FG004|NOT COMPLETED|Overall Study||1
9852306|NCT00880555|10965132|FG005|NOT COMPLETED|Overall Study||1
9852307|NCT00880568|10965152|FG000|STARTED|Overall Study||3
9852308|NCT00880568|10965153|FG001|STARTED|Overall Study||3
9852309|NCT00880568|10965154|FG002|STARTED|Overall Study||3
9852310|NCT00880568|10965155|FG003|STARTED|Overall Study||1
9852311|NCT00880568|10965156|FG004|STARTED|Overall Study||3
9852312|NCT00880568|10965157|FG005|STARTED|Overall Study||3
9852313|NCT00880568|10965158|FG006|STARTED|Overall Study||6
9852314|NCT00880568|10965159|FG007|STARTED|Overall Study||2
9852315|NCT00880568|10965160|FG008|STARTED|Overall Study||3
9852316|NCT00880568|10965152|FG000|COMPLETED|Overall Study||0
9738970|NCT00223652|10839909|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
9852317|NCT00880568|10965153|FG001|COMPLETED|Overall Study||0
9852318|NCT00880568|10965154|FG002|COMPLETED|Overall Study||0
9852319|NCT00880568|10965155|FG003|COMPLETED|Overall Study||0
9852320|NCT00880568|10965156|FG004|COMPLETED|Overall Study||0
9852321|NCT00880568|10965157|FG005|COMPLETED|Overall Study||0
9852322|NCT00880568|10965158|FG006|COMPLETED|Overall Study||0
9852323|NCT00880568|10965159|FG007|COMPLETED|Overall Study||0
9852324|NCT00880568|10965160|FG008|COMPLETED|Overall Study||0
9852325|NCT00880568|10965152|FG000|NOT COMPLETED|Overall Study||3
9852326|NCT00880568|10965153|FG001|NOT COMPLETED|Overall Study||3
9852327|NCT00880568|10965154|FG002|NOT COMPLETED|Overall Study||3
9738971|NCT00223652|10839910|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
9738972|NCT00223652|10839909|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
9738973|NCT00223652|10839910|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
9738974|NCT00223652|10839909|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40
9738975|NCT00223652|10839910|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41
9738976|NCT00223652|10839909|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
9738977|NCT00223652|10839910|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
9738978|NCT00223652|10839909|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
9738979|NCT00223652|10839910|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
9738980|NCT00223665|10839917|FG000|STARTED|Overall Study||102
9738981|NCT00223665|10839917|FG000|COMPLETED|Overall Study||102
9738982|NCT00223665|10839917|FG000|NOT COMPLETED|Overall Study||0
9738983|NCT00223678|10839924|FG000|STARTED|Overall Study||13
9738984|NCT00223678|10839925|FG001|STARTED|Overall Study||7
9738985|NCT00223678|10839924|FG000|COMPLETED|Overall Study||13
9738986|NCT00223678|10839925|FG001|COMPLETED|Overall Study||7
9738987|NCT00223678|10839924|FG000|NOT COMPLETED|Overall Study||0
9738988|NCT00223678|10839925|FG001|NOT COMPLETED|Overall Study||0
9738989|NCT00223704|10839934|FG000|STARTED|Overall Study||38
9738990|NCT00223704|10839935|FG001|STARTED|Overall Study||37
9738991|NCT00223704|10839936|FG002|STARTED|Overall Study||40
9738992|NCT00223704|10839934|FG000|COMPLETED|Overall Study||38
9738993|NCT00223704|10839935|FG001|COMPLETED|Overall Study||37
9738994|NCT00223704|10839936|FG002|COMPLETED|Overall Study||40
9738995|NCT00223704|10839934|FG000|NOT COMPLETED|Overall Study||0
9738996|NCT00223704|10839935|FG001|NOT COMPLETED|Overall Study||0
9738997|NCT00223704|10839936|FG002|NOT COMPLETED|Overall Study||0
9738998|NCT00223795|10839944|FG000|STARTED|First Intervention - Eight Weeks||26
9738999|NCT00223795|10839945|FG001|STARTED|First Intervention - Eight Weeks||27
9739000|NCT00223795|10839944|FG000|COMPLETED|First Intervention - Eight Weeks||19
9739001|NCT00223795|10839945|FG001|COMPLETED|First Intervention - Eight Weeks||18
9739002|NCT00223795|10839944|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7
9739003|NCT00223795|10839945|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9
9739004|NCT00223795|10839944|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19
9739005|NCT00223795|10839945|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18
9852328|NCT00880568|10965155|FG003|NOT COMPLETED|Overall Study||1
9852329|NCT00880568|10965156|FG004|NOT COMPLETED|Overall Study||3
9852330|NCT00880568|10965157|FG005|NOT COMPLETED|Overall Study||3
10089862|NCT02322320|11218637|FG002|COMPLETED|Overall Study||89
9739006|NCT00223795|10839944|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18
9739007|NCT00223795|10839945|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17
9739008|NCT00223795|10839944|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
9739009|NCT00223795|10839945|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
9739010|NCT00223808|10839955|FG000|STARTED|Overall Study||22
9739011|NCT00223808|10839956|FG001|STARTED|Overall Study||22
9739012|NCT00223808|10839957|FG002|STARTED|Overall Study||23
9739013|NCT00223808|10839955|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
9739014|NCT00223808|10839956|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
9739015|NCT00223808|10839957|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
9739016|NCT00223808|10839955|FG000|NOT COMPLETED|Overall Study||3
9739017|NCT00223808|10839956|FG001|NOT COMPLETED|Overall Study||5
9739018|NCT00223808|10839957|FG002|NOT COMPLETED|Overall Study||5
9739019|NCT00223821|10839967|FG000|STARTED|Overall Study||32
9739020|NCT00223821|10839968|FG001|STARTED|Overall Study||32
9739021|NCT00223821|10839967|FG000|Completed Therapy|Overall Study||31
9739022|NCT00223821|10839968|FG001|Completed Therapy|Overall Study||28
9739023|NCT00223821|10839967|FG000|Completed Post-treatment Assessment|Overall Study||31
9739024|NCT00223821|10839968|FG001|Completed Post-treatment Assessment|Overall Study||27
9739025|NCT00223821|10839967|FG000|Completed 6-month Follow-up|Overall Study||28
9739026|NCT00223821|10839968|FG001|Completed 6-month Follow-up|Overall Study||25
9739027|NCT00223821|10839967|FG000|COMPLETED|Overall Study||28
9739028|NCT00223821|10839968|FG001|COMPLETED|Overall Study||22
9739029|NCT00223821|10839967|FG000|NOT COMPLETED|Overall Study||4
9739030|NCT00223821|10839968|FG001|NOT COMPLETED|Overall Study||10
9739031|NCT00223977|10839977|FG000|STARTED|Overall Study||46
9739032|NCT00223977|10839978|FG001|STARTED|Overall Study||58
9739033|NCT00223977|10839979|FG002|STARTED|Overall Study||42
9739034|NCT00223977|10839977|FG000|COMPLETED|Overall Study||37
9739035|NCT00223977|10839978|FG001|COMPLETED|Overall Study||47
9852331|NCT00880568|10965158|FG006|NOT COMPLETED|Overall Study||6
9852332|NCT00880568|10965159|FG007|NOT COMPLETED|Overall Study||2
9852333|NCT00880568|10965160|FG008|NOT COMPLETED|Overall Study||3
9852334|NCT00880581|10965185|FG000|STARTED|Cycle 1||30
9852335|NCT00880581|10965185|FG000|COMPLETED|Cycle 1||30
9852336|NCT00880581|10965185|FG000|NOT COMPLETED|Cycle 1||0
9852337|NCT00880581|10965185|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
9852338|NCT00880581|10965185|FG000|COMPLETED|Cycle 2 Re-treatment||24
10089863|NCT02322320|11218635|FG000|NOT COMPLETED|Overall Study||0
9852339|NCT00880581|10965185|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0
9852340|NCT00880607|10965191|FG000|STARTED|Overall Study||44
9852341|NCT00880607|10965192|FG001|STARTED|Overall Study||37
9852342|NCT00880607|10965191|FG000|Observation After Receiving Medication|Overall Study||42
10089864|NCT02322320|11218636|FG001|NOT COMPLETED|Overall Study||0
9739036|NCT00223977|10839979|FG002|COMPLETED|Overall Study||39
9739037|NCT00223977|10839977|FG000|NOT COMPLETED|Overall Study||9
9739038|NCT00223977|10839978|FG001|NOT COMPLETED|Overall Study||11
9739039|NCT00223977|10839979|FG002|NOT COMPLETED|Overall Study||3
9739040|NCT00223990|10839989|FG000|STARTED|Overall Study||200
9739041|NCT00223990|10839990|FG001|STARTED|Overall Study||200
9739042|NCT00223990|10839989|FG000|COMPLETED|Overall Study||193
9739043|NCT00223990|10839990|FG001|COMPLETED|Overall Study||191
9739044|NCT00223990|10839989|FG000|NOT COMPLETED|Overall Study||7
9739045|NCT00223990|10839990|FG001|NOT COMPLETED|Overall Study||9
9739046|NCT00224016|10839998|FG000|STARTED|Titration Period||39
9739047|NCT00224016|10839999|FG001|STARTED|Titration Period||16
9739048|NCT00224016|10839998|FG000|COMPLETED|Titration Period||38
9739049|NCT00224016|10839999|FG001|COMPLETED|Titration Period||15
9739050|NCT00224016|10839998|FG000|NOT COMPLETED|Titration Period||1
9739051|NCT00224016|10839999|FG001|NOT COMPLETED|Titration Period||1
9739052|NCT00224016|10839998|FG000|STARTED|Maintenance Period||38
9739053|NCT00224016|10839999|FG001|STARTED|Maintenance Period||15
9739054|NCT00224016|10839998|FG000|COMPLETED|Maintenance Period||36
9739055|NCT00224016|10839999|FG001|COMPLETED|Maintenance Period||14
9739056|NCT00224016|10839998|FG000|NOT COMPLETED|Maintenance Period||2
9739057|NCT00224016|10839999|FG001|NOT COMPLETED|Maintenance Period||1
9739058|NCT00224016|10839998|FG000|STARTED|Follow-Up Period||35
9739059|NCT00224016|10839999|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
9739060|NCT00224016|10839998|FG000|COMPLETED|Follow-Up Period||35
9739061|NCT00224016|10839999|FG001|COMPLETED|Follow-Up Period||0
9739062|NCT00224016|10839998|FG000|NOT COMPLETED|Follow-Up Period||0
10089865|NCT02322320|11218637|FG002|NOT COMPLETED|Overall Study||0
10089866|NCT02322333|11218647|FG000|STARTED|Overall Study||80
10089867|NCT02322333|11218648|FG001|STARTED|Overall Study||77
10089868|NCT02322333|11218647|FG000|COMPLETED|Overall Study||63
10089869|NCT02322333|11218648|FG001|COMPLETED|Overall Study||61
10089870|NCT02322333|11218647|FG000|NOT COMPLETED|Overall Study||17
10089871|NCT02322333|11218648|FG001|NOT COMPLETED|Overall Study||16
10089872|NCT02322411|11218656|FG000|STARTED|Overall Study||14
10089873|NCT02322411|11218657|FG001|STARTED|Overall Study||16
10089874|NCT02322411|11218656|FG000|Randomized|Overall Study||14
10089875|NCT02322411|11218657|FG001|Randomized|Overall Study||16
10089876|NCT02322411|11218656|FG000|All Baseline Measures Analyzed|Overall Study||13
10089877|NCT02322411|11218657|FG001|All Baseline Measures Analyzed|Overall Study||16
10089878|NCT02322411|11218656|FG000|COMPLETED|Overall Study||9
10089879|NCT02322411|11218657|FG001|COMPLETED|Overall Study||9
10089880|NCT02322411|11218656|FG000|NOT COMPLETED|Overall Study||5
10089881|NCT02322411|11218657|FG001|NOT COMPLETED|Overall Study||7
10089882|NCT02322528|11218663|FG000|STARTED|Overall Study||10
10089883|NCT02322528|11218663|FG000|COMPLETED|Overall Study||10
10089884|NCT02322528|11218663|FG000|NOT COMPLETED|Overall Study||0
10089885|NCT02322749|11218667|FG000|STARTED|Period 1||8
10089886|NCT02322749|11218668|FG001|STARTED|Period 1||8
10089887|NCT02322749|11218669|FG002|STARTED|Period 1||8
10089888|NCT02322749|11218670|FG003|STARTED|Period 1||8
10089889|NCT02322749|11218671|FG004|STARTED|Period 1||8
10089890|NCT02322749|11218672|FG005|STARTED|Period 1||8
10089891|NCT02322749|11218667|FG000|COMPLETED|Period 1||8
10089892|NCT02322749|11218668|FG001|COMPLETED|Period 1||8
10089893|NCT02322749|11218669|FG002|COMPLETED|Period 1||8
10089894|NCT02322749|11218670|FG003|COMPLETED|Period 1||8
10089895|NCT02322749|11218671|FG004|COMPLETED|Period 1||8
10089896|NCT02322749|11218672|FG005|COMPLETED|Period 1||8
10089897|NCT02322749|11218667|FG000|NOT COMPLETED|Period 1||0
10089898|NCT02322749|11218668|FG001|NOT COMPLETED|Period 1||0
10089899|NCT02322749|11218669|FG002|NOT COMPLETED|Period 1||0
10089900|NCT02322749|11218670|FG003|NOT COMPLETED|Period 1||0
10089901|NCT02322749|11218671|FG004|NOT COMPLETED|Period 1||0
10089902|NCT02322749|11218672|FG005|NOT COMPLETED|Period 1||0
10089903|NCT02322749|11218667|FG000|STARTED|Period 2||8
10089904|NCT02322749|11218668|FG001|STARTED|Period 2||8
10089905|NCT02322749|11218669|FG002|STARTED|Period 2||8
10089906|NCT02322749|11218670|FG003|STARTED|Period 2||8
10089907|NCT02322749|11218671|FG004|STARTED|Period 2||8
10089908|NCT02322749|11218672|FG005|STARTED|Period 2||8
10089909|NCT02322749|11218667|FG000|COMPLETED|Period 2||8
10089910|NCT02322749|11218668|FG001|COMPLETED|Period 2||8
10089911|NCT02322749|11218669|FG002|COMPLETED|Period 2||8
10089912|NCT02322749|11218670|FG003|COMPLETED|Period 2||6
10089913|NCT02322749|11218671|FG004|COMPLETED|Period 2||8
10089914|NCT02322749|11218672|FG005|COMPLETED|Period 2||8
10089915|NCT02322749|11218667|FG000|NOT COMPLETED|Period 2||0
10089916|NCT02322749|11218668|FG001|NOT COMPLETED|Period 2||0
10089917|NCT02322749|11218669|FG002|NOT COMPLETED|Period 2||0
10089918|NCT02322749|11218670|FG003|NOT COMPLETED|Period 2||2
10089919|NCT02322749|11218671|FG004|NOT COMPLETED|Period 2||0
10089920|NCT02322749|11218672|FG005|NOT COMPLETED|Period 2||0
10089921|NCT02322749|11218667|FG000|STARTED|Period 3||8
10089922|NCT02322749|11218668|FG001|STARTED|Period 3||8
10089923|NCT02322749|11218669|FG002|STARTED|Period 3||8
10089924|NCT02322749|11218670|FG003|STARTED|Period 3||6
10089925|NCT02322749|11218671|FG004|STARTED|Period 3||8
10089926|NCT02322749|11218672|FG005|STARTED|Period 3||8
9739063|NCT00224016|10839999|FG001|NOT COMPLETED|Follow-Up Period||0
9739064|NCT00224029|10840005|FG000|STARTED|Overall Study||24
10089927|NCT02322749|11218667|FG000|COMPLETED|Period 3||8
10089928|NCT02322749|11218668|FG001|COMPLETED|Period 3||8
10089929|NCT02322749|11218669|FG002|COMPLETED|Period 3||7
10089930|NCT02322749|11218670|FG003|COMPLETED|Period 3||6
9739065|NCT00224029|10840005|FG000|COMPLETED|Overall Study||18
9739066|NCT00224029|10840005|FG000|NOT COMPLETED|Overall Study||6
9739067|NCT00224042|10840011|FG000|STARTED|Overall Study||26
9739068|NCT00224042|10840012|FG001|STARTED|Overall Study||26
9739069|NCT00224042|10840011|FG000|COMPLETED|Overall Study||20
9739070|NCT00224042|10840012|FG001|COMPLETED|Overall Study||20
9739071|NCT00224042|10840011|FG000|NOT COMPLETED|Overall Study||6
9739072|NCT00224042|10840012|FG001|NOT COMPLETED|Overall Study||6
9739073|NCT00224055|10840020|FG000|STARTED|Overall Study||44
9739074|NCT00224055|10840021|FG001|STARTED|Overall Study||45
9739075|NCT00224055|10840020|FG000|COMPLETED|Overall Study||29
9739076|NCT00224055|10840021|FG001|COMPLETED|Overall Study||31
9739077|NCT00224055|10840020|FG000|NOT COMPLETED|Overall Study||15
9739078|NCT00224055|10840021|FG001|NOT COMPLETED|Overall Study||14
9739079|NCT00224107|10840029|FG000|STARTED|Overall Study||233
9739080|NCT00224107|10840030|FG001|STARTED|Overall Study||228
9739081|NCT00224107|10840029|FG000|COMPLETED|Overall Study||202
9739082|NCT00224107|10840030|FG001|COMPLETED|Overall Study||214
9739083|NCT00224107|10840029|FG000|NOT COMPLETED|Overall Study||31
9739084|NCT00224107|10840030|FG001|NOT COMPLETED|Overall Study||14
9739085|NCT00224120|10840038|FG000|STARTED|Overall Study||233
9739086|NCT00224120|10840039|FG001|STARTED|Overall Study||229
9739087|NCT00224120|10840038|FG000|COMPLETED|Overall Study||211
9739088|NCT00224120|10840039|FG001|COMPLETED|Overall Study||205
9739089|NCT00224120|10840038|FG000|NOT COMPLETED|Overall Study||22
9739090|NCT00224120|10840039|FG001|NOT COMPLETED|Overall Study||24
9739091|NCT00224133|10840045|FG000|STARTED|Overall Study||661
9739092|NCT00224133|10840045|FG000|COMPLETED|Overall Study||435
9739093|NCT00224133|10840045|FG000|NOT COMPLETED|Overall Study||226
9739094|NCT00224289|10840049|FG000|STARTED|Overall Study||17
9739095|NCT00224289|10840049|FG000|COMPLETED|Overall Study||17
9739096|NCT00224289|10840049|FG000|NOT COMPLETED|Overall Study||0
9739097|NCT00224484|10840056|FG000|STARTED|Overall Study||2977
9739098|NCT00224484|10840057|FG001|STARTED|Overall Study||1491
9739099|NCT00224484|10840058|FG002|STARTED|Overall Study||1487
9739100|NCT00224484|10840056|FG000|COMPLETED|Overall Study||2831
9739101|NCT00224484|10840057|FG001|COMPLETED|Overall Study||1426
9739102|NCT00224484|10840058|FG002|COMPLETED|Overall Study||1425
9739103|NCT00224484|10840056|FG000|NOT COMPLETED|Overall Study||146
9739104|NCT00224484|10840057|FG001|NOT COMPLETED|Overall Study||65
9739105|NCT00224484|10840058|FG002|NOT COMPLETED|Overall Study||62
9739106|NCT00224770|10840072|FG000|STARTED|Overall Study||42
9739107|NCT00224770|10840073|FG001|STARTED|Overall Study||54
9739108|NCT00224770|10840074|FG002|STARTED|Overall Study||14
9739109|NCT00224770|10840072|FG000|COMPLETED|Overall Study||38
9739110|NCT00224770|10840073|FG001|COMPLETED|Overall Study||52
9739111|NCT00224770|10840074|FG002|COMPLETED|Overall Study||14
9739112|NCT00224770|10840072|FG000|NOT COMPLETED|Overall Study||4
9739113|NCT00224770|10840073|FG001|NOT COMPLETED|Overall Study||2
9739114|NCT00224770|10840074|FG002|NOT COMPLETED|Overall Study||0
9828169|NCT00754338|10938881|FG003|STARTED|First Intervention for Phase1&Phase2||19
9828170|NCT00754338|10938878|FG000|COMPLETED|First Intervention for Phase1&Phase2||17
9828171|NCT00754338|10938879|FG001|COMPLETED|First Intervention for Phase1&Phase2||18
9828172|NCT00754338|10938880|FG002|COMPLETED|First Intervention for Phase1&Phase2||16
9828173|NCT00754338|10938881|FG003|COMPLETED|First Intervention for Phase1&Phase2||19
9828174|NCT00754338|10938878|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0
9828175|NCT00754338|10938879|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3
9828176|NCT00754338|10938880|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3
9828177|NCT00754338|10938881|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0
10089931|NCT02322749|11218671|FG004|COMPLETED|Period 3||8
10089932|NCT02322749|11218672|FG005|COMPLETED|Period 3||8
10089933|NCT02322749|11218667|FG000|NOT COMPLETED|Period 3||0
10089934|NCT02322749|11218668|FG001|NOT COMPLETED|Period 3||0
10089935|NCT02322749|11218669|FG002|NOT COMPLETED|Period 3||1
10089936|NCT02322749|11218670|FG003|NOT COMPLETED|Period 3||0
10089937|NCT02322749|11218671|FG004|NOT COMPLETED|Period 3||0
9828178|NCT00754338|10938878|FG000|STARTED|Second Intervention for Phase1&Phase2||17
9828179|NCT00754338|10938879|FG001|STARTED|Second Intervention for Phase1&Phase2||18
9828180|NCT00754338|10938880|FG002|STARTED|Second Intervention for Phase1&Phase2||16
9828181|NCT00754338|10938881|FG003|STARTED|Second Intervention for Phase1&Phase2||19
9828182|NCT00754338|10938878|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17
9828183|NCT00754338|10938879|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17
9828184|NCT00754338|10938880|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16
9828185|NCT00754338|10938881|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18
9828186|NCT00754338|10938878|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
10089938|NCT02322749|11218672|FG005|NOT COMPLETED|Period 3||0
10089939|NCT02322775|11218683|FG000|STARTED|Overall Study||106
10089940|NCT02322775|11218684|FG001|STARTED|Overall Study||105
10089941|NCT02322775|11218683|FG000|COMPLETED|Overall Study||101
10089942|NCT02322775|11218684|FG001|COMPLETED|Overall Study||99
9828187|NCT00754338|10938879|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
9828188|NCT00754338|10938880|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
9828189|NCT00754338|10938881|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
9828190|NCT00754377|10938895|FG000|STARTED|Overall Study||50
9828191|NCT00754377|10938896|FG001|STARTED|Overall Study||42
9828192|NCT00754377|10938895|FG000|COMPLETED|Overall Study||50
9828193|NCT00754377|10938896|FG001|COMPLETED|Overall Study||42
9828194|NCT00754377|10938895|FG000|NOT COMPLETED|Overall Study||0
9739115|NCT00224874|10840087|FG000|STARTED|Overall Study||46
9739116|NCT00224874|10840088|FG001|STARTED|Overall Study||45
9739117|NCT00224874|10840089|FG002|STARTED|Overall Study||47
9739118|NCT00224874|10840090|FG003|STARTED|Overall Study||42
9739119|NCT00224874|10840087|FG000|COMPLETED|Overall Study||46
9739120|NCT00224874|10840088|FG001|COMPLETED|Overall Study||45
9739121|NCT00224874|10840089|FG002|COMPLETED|Overall Study||46
9739122|NCT00224874|10840090|FG003|COMPLETED|Overall Study||42
9739123|NCT00224874|10840087|FG000|NOT COMPLETED|Overall Study||0
9739124|NCT00224874|10840088|FG001|NOT COMPLETED|Overall Study||0
9739125|NCT00224874|10840089|FG002|NOT COMPLETED|Overall Study||1
9739126|NCT00224874|10840090|FG003|NOT COMPLETED|Overall Study||0
9739127|NCT00224887|10840102|FG000|STARTED|Overall Study||154
9739128|NCT00224887|10840103|FG001|STARTED|Overall Study||153
9739129|NCT00224887|10840102|FG000|COMPLETED|Overall Study||148
9739130|NCT00224887|10840103|FG001|COMPLETED|Overall Study||147
9739131|NCT00224887|10840102|FG000|NOT COMPLETED|Overall Study||6
9739132|NCT00224887|10840103|FG001|NOT COMPLETED|Overall Study||6
9739133|NCT00224952|10840112|FG000|STARTED|Overall Study||53
9739134|NCT00224952|10840113|FG001|STARTED|Overall Study||87
9739135|NCT00224952|10840114|FG002|STARTED|Overall Study||134
9739136|NCT00224952|10840112|FG000|COMPLETED|Overall Study||53
9739137|NCT00224952|10840113|FG001|COMPLETED|Overall Study||87
9739138|NCT00224952|10840114|FG002|COMPLETED|Overall Study||134
9739139|NCT00224952|10840112|FG000|NOT COMPLETED|Overall Study||0
9739140|NCT00224952|10840113|FG001|NOT COMPLETED|Overall Study||0
9739141|NCT00224952|10840114|FG002|NOT COMPLETED|Overall Study||0
9739142|NCT00225017|10840125|FG000|STARTED|Overall Study||26
9739143|NCT00225017|10840126|FG001|STARTED|Overall Study||24
9739144|NCT00225017|10840125|FG000|COMPLETED|Overall Study||26
9739145|NCT00225017|10840126|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
9739146|NCT00225017|10840125|FG000|NOT COMPLETED|Overall Study||0
9739147|NCT00225017|10840126|FG001|NOT COMPLETED|Overall Study||1
9739148|NCT00225147|10840136|FG000|STARTED|Double-blind Phase||13
9739149|NCT00225147|10840137|FG001|STARTED|Double-blind Phase||12
9739150|NCT00225147|10840138|FG002|STARTED|Double-blind Phase||13
9739151|NCT00225147|10840139|FG003|STARTED|Double-blind Phase||0
9739152|NCT00225147|10840136|FG000|COMPLETED|Double-blind Phase||13
9739153|NCT00225147|10840137|FG001|COMPLETED|Double-blind Phase||12
9739154|NCT00225147|10840138|FG002|COMPLETED|Double-blind Phase||13
9739155|NCT00225147|10840139|FG003|COMPLETED|Double-blind Phase||0
9739156|NCT00225147|10840136|FG000|NOT COMPLETED|Double-blind Phase||0
9739157|NCT00225147|10840137|FG001|NOT COMPLETED|Double-blind Phase||0
9739158|NCT00225147|10840138|FG002|NOT COMPLETED|Double-blind Phase||0
9739159|NCT00225147|10840139|FG003|NOT COMPLETED|Double-blind Phase||0
9739160|NCT00225147|10840136|FG000|STARTED|Open-label Phase||0
9739161|NCT00225147|10840137|FG001|STARTED|Open-label Phase||0
9739162|NCT00225147|10840138|FG002|STARTED|Open-label Phase||0
9739163|NCT00225147|10840139|FG003|STARTED|Open-label Phase||62
9739164|NCT00225147|10840136|FG000|COMPLETED|Open-label Phase||0
9739165|NCT00225147|10840137|FG001|COMPLETED|Open-label Phase||0
9739166|NCT00225147|10840138|FG002|COMPLETED|Open-label Phase||0
9739167|NCT00225147|10840139|FG003|COMPLETED|Open-label Phase||52
9739168|NCT00225147|10840136|FG000|NOT COMPLETED|Open-label Phase||0
9739169|NCT00225147|10840137|FG001|NOT COMPLETED|Open-label Phase||0
9739170|NCT00225147|10840138|FG002|NOT COMPLETED|Open-label Phase||0
9739171|NCT00225147|10840139|FG003|NOT COMPLETED|Open-label Phase||10
9739172|NCT00225212|10840151|FG000|STARTED|Overall Study||35
9739173|NCT00225212|10840151|FG000|COMPLETED|Overall Study||29
9739174|NCT00225212|10840151|FG000|NOT COMPLETED|Overall Study||6
9739175|NCT00225251|10840157|FG000|STARTED|Overall Study||11
9739176|NCT00225251|10840158|FG001|STARTED|Overall Study||7
9739177|NCT00225251|10840157|FG000|COMPLETED|Overall Study||10
9739178|NCT00225251|10840158|FG001|COMPLETED|Overall Study||6
9739179|NCT00225251|10840157|FG000|NOT COMPLETED|Overall Study||1
9739180|NCT00225251|10840158|FG001|NOT COMPLETED|Overall Study||1
9739181|NCT00225277|10840166|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
9739182|NCT00225277|10840167|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
9739183|NCT00225277|10840166|FG000|COMPLETED|Overall Study||177
9739184|NCT00225277|10840167|FG001|COMPLETED|Overall Study||178
9739185|NCT00225277|10840166|FG000|NOT COMPLETED|Overall Study||97
9739186|NCT00225277|10840167|FG001|NOT COMPLETED|Overall Study||95
9739187|NCT00225420|10840173|FG000|STARTED|Overall Study||9
9739188|NCT00225420|10840174|FG001|STARTED|Overall Study||6
9739189|NCT00225420|10840175|FG002|STARTED|Overall Study||3
9739190|NCT00225420|10840173|FG000|COMPLETED|Overall Study||9
9739191|NCT00225420|10840174|FG001|COMPLETED|Overall Study||6
9739192|NCT00225420|10840175|FG002|COMPLETED|Overall Study||3
9739193|NCT00225420|10840173|FG000|NOT COMPLETED|Overall Study||0
9739194|NCT00225420|10840174|FG001|NOT COMPLETED|Overall Study||0
9739195|NCT00225420|10840175|FG002|NOT COMPLETED|Overall Study||0
9739196|NCT00225498|10840182|FG000|STARTED|Overall Study||10
9739197|NCT00225498|10840182|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
9739198|NCT00225498|10840182|FG000|NOT COMPLETED|Overall Study||0
9739199|NCT00225732|10840188|FG000|STARTED|Overall Study||153
9739200|NCT00225732|10840189|FG001|STARTED|Overall Study||166
9739201|NCT00225732|10840188|FG000|COMPLETED|Overall Study||153
9739202|NCT00225732|10840189|FG001|COMPLETED|Overall Study||166
9739203|NCT00225732|10840188|FG000|NOT COMPLETED|Overall Study||0
9739204|NCT00225732|10840189|FG001|NOT COMPLETED|Overall Study||0
9739205|NCT00225758|10840195|FG000|STARTED|Overall Study||27
9739206|NCT00225758|10840195|FG000|COMPLETED|Overall Study||23
9739207|NCT00225758|10840195|FG000|NOT COMPLETED|Overall Study||4
9739208|NCT00225784|10840201|FG000|STARTED|Overall Study||37
9739209|NCT00225784|10840201|FG000|COMPLETED|Overall Study||33
9739210|NCT00225784|10840201|FG000|NOT COMPLETED|Overall Study||4
9739211|NCT00226239|10840208|FG000|STARTED|TPE, Induction Therapy||39
9739212|NCT00226239|10840208|FG000|COMPLETED|TPE, Induction Therapy||37
9739213|NCT00226239|10840208|FG000|NOT COMPLETED|TPE, Induction Therapy||2
9739214|NCT00226239|10840208|FG000|STARTED|XPE, Definitive Therapy||37
9739215|NCT00226239|10840208|FG000|COMPLETED|XPE, Definitive Therapy||33
9739216|NCT00226239|10840208|FG000|NOT COMPLETED|XPE, Definitive Therapy||4
9739217|NCT00226239|10840208|FG000|STARTED|Maintenance Cetuximab||31
10089943|NCT02322775|11218683|FG000|NOT COMPLETED|Overall Study||5
10089944|NCT02322775|11218684|FG001|NOT COMPLETED|Overall Study||6
10089945|NCT02322788|11218690|FG000|STARTED|Visit 3||15
10089946|NCT02322788|11218691|FG001|STARTED|Visit 3||15
10089947|NCT02322788|11218692|FG002|STARTED|Visit 3||14
10089948|NCT02322788|11218693|FG003|STARTED|Visit 3||16
10089949|NCT02322788|11218690|FG000|COMPLETED|Visit 3||15
10089950|NCT02322788|11218691|FG001|COMPLETED|Visit 3||15
10089951|NCT02322788|11218692|FG002|COMPLETED|Visit 3||14
10089952|NCT02322788|11218693|FG003|COMPLETED|Visit 3||16
10089953|NCT02322788|11218690|FG000|NOT COMPLETED|Visit 3||0
10089954|NCT02322788|11218691|FG001|NOT COMPLETED|Visit 3||0
10089955|NCT02322788|11218692|FG002|NOT COMPLETED|Visit 3||0
10089956|NCT02322788|11218693|FG003|NOT COMPLETED|Visit 3||0
10089957|NCT02322788|11218690|FG000|STARTED|Visit 4||15
10089958|NCT02322788|11218691|FG001|STARTED|Visit 4||14
10089959|NCT02322788|11218692|FG002|STARTED|Visit 4||16
10089960|NCT02322788|11218693|FG003|STARTED|Visit 4||15
10089961|NCT02322788|11218690|FG000|COMPLETED|Visit 4||15
10089962|NCT02322788|11218691|FG001|COMPLETED|Visit 4||14
10089963|NCT02322788|11218692|FG002|COMPLETED|Visit 4||16
10089964|NCT02322788|11218693|FG003|COMPLETED|Visit 4||15
10089965|NCT02322788|11218690|FG000|NOT COMPLETED|Visit 4||0
10089966|NCT02322788|11218691|FG001|NOT COMPLETED|Visit 4||0
10089967|NCT02322788|11218692|FG002|NOT COMPLETED|Visit 4||0
10089968|NCT02322788|11218693|FG003|NOT COMPLETED|Visit 4||0
10089969|NCT02322788|11218690|FG000|STARTED|Visit 5||16
10089970|NCT02322788|11218691|FG001|STARTED|Visit 5||15
10089971|NCT02322788|11218692|FG002|STARTED|Visit 5||15
10089972|NCT02322788|11218693|FG003|STARTED|Visit 5||14
10089973|NCT02322788|11218690|FG000|COMPLETED|Visit 5||16
10089974|NCT02322788|11218691|FG001|COMPLETED|Visit 5||15
10089975|NCT02322788|11218692|FG002|COMPLETED|Visit 5||15
10089976|NCT02322788|11218693|FG003|COMPLETED|Visit 5||14
10089977|NCT02322788|11218690|FG000|NOT COMPLETED|Visit 5||0
10089978|NCT02322788|11218691|FG001|NOT COMPLETED|Visit 5||0
10089979|NCT02322788|11218692|FG002|NOT COMPLETED|Visit 5||0
10089980|NCT02322788|11218693|FG003|NOT COMPLETED|Visit 5||0
10089981|NCT02322788|11218690|FG000|STARTED|Visit 6||14
10089982|NCT02322788|11218691|FG001|STARTED|Visit 6||16
10089983|NCT02322788|11218692|FG002|STARTED|Visit 6||15
10089984|NCT02322788|11218693|FG003|STARTED|Visit 6||15
10089985|NCT02322788|11218690|FG000|COMPLETED|Visit 6||14
10089986|NCT02322788|11218691|FG001|COMPLETED|Visit 6||16
10089987|NCT02322788|11218692|FG002|COMPLETED|Visit 6||15
10089988|NCT02322788|11218693|FG003|COMPLETED|Visit 6||15
10089989|NCT02322788|11218690|FG000|NOT COMPLETED|Visit 6||0
10089990|NCT02322788|11218691|FG001|NOT COMPLETED|Visit 6||0
10089991|NCT02322788|11218692|FG002|NOT COMPLETED|Visit 6||0
10089992|NCT02322788|11218693|FG003|NOT COMPLETED|Visit 6||0
10089993|NCT02322814|11218708|FG000|STARTED|Overall Study||16
10089994|NCT02322814|11218709|FG001|STARTED|Overall Study||43
10089995|NCT02322814|11218710|FG002|STARTED|Overall Study||47
10089996|NCT02322814|11218711|FG003|STARTED|Overall Study||32
10089997|NCT02322814|11218712|FG004|STARTED|Overall Study||31
10089998|NCT02322814|11218708|FG000|COMPLETED|Overall Study||0
9739218|NCT00226239|10840208|FG000|COMPLETED|Maintenance Cetuximab||17
9739219|NCT00226239|10840208|FG000|NOT COMPLETED|Maintenance Cetuximab||14
9739220|NCT00226499|10840216|FG000|STARTED|Overall Study||2489
10089999|NCT02322814|11218709|FG001|COMPLETED|Overall Study||0
10090000|NCT02322814|11218710|FG002|COMPLETED|Overall Study||0
10090001|NCT02322814|11218711|FG003|COMPLETED|Overall Study||0
10090002|NCT02322814|11218712|FG004|COMPLETED|Overall Study||0
10090003|NCT02322814|11218708|FG000|NOT COMPLETED|Overall Study||16
10090004|NCT02322814|11218709|FG001|NOT COMPLETED|Overall Study||43
10090005|NCT02322814|11218710|FG002|NOT COMPLETED|Overall Study||47
10090006|NCT02322814|11218711|FG003|NOT COMPLETED|Overall Study||32
10090007|NCT02322814|11218712|FG004|NOT COMPLETED|Overall Study||31
10090008|NCT02322866|11218725|FG000|STARTED|Overall Study||515
10090009|NCT02322866|11218726|FG001|STARTED|Overall Study||519
10090010|NCT02322866|11218725|FG000|COMPLETED|Overall Study||444
10090011|NCT02322866|11218726|FG001|COMPLETED|Overall Study||433
10090012|NCT02322866|11218725|FG000|NOT COMPLETED|Overall Study||71
10090013|NCT02322866|11218726|FG001|NOT COMPLETED|Overall Study||86
9739221|NCT00226499|10840217|FG001|STARTED|Overall Study||2487
9739222|NCT00226499|10840218|FG002|STARTED|Overall Study||827
9739223|NCT00226499|10840216|FG000|COMPLETED|Overall Study||1415
10112881|NCT02506036|11243773|FG001|STARTED|First Intervention (4-6 Weeks)||3
10112882|NCT02506036|11243772|FG000|COMPLETED|First Intervention (4-6 Weeks)||2
10112883|NCT02506036|11243773|FG001|COMPLETED|First Intervention (4-6 Weeks)||1
10112884|NCT02506036|11243772|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1
10112885|NCT02506036|11243773|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2
9739224|NCT00226499|10840217|FG001|COMPLETED|Overall Study||1415
9739225|NCT00226499|10840218|FG002|COMPLETED|Overall Study||468
9739226|NCT00226499|10840216|FG000|NOT COMPLETED|Overall Study||1074
9739227|NCT00226499|10840217|FG001|NOT COMPLETED|Overall Study||1072
9739228|NCT00226499|10840218|FG002|NOT COMPLETED|Overall Study||359
9739229|NCT00226577|10840228|FG000|STARTED|Overall Study||52
9739230|NCT00226577|10840228|FG000|COMPLETED|Overall Study||52
9739231|NCT00226577|10840228|FG000|NOT COMPLETED|Overall Study||0
9739232|NCT00226590|10840232|FG000|STARTED|Overall Study||39
9739233|NCT00226590|10840232|FG000|COMPLETED|Overall Study||39
9739234|NCT00226590|10840232|FG000|NOT COMPLETED|Overall Study||0
9739235|NCT00226655|10840237|FG000|STARTED|Overall Study||112
10090014|NCT02322879|11218734|FG000|STARTED|First Intervention||11
10090015|NCT02322879|11218735|FG001|STARTED|First Intervention||10
10090016|NCT02322879|11218734|FG000|COMPLETED|First Intervention||10
10090017|NCT02322879|11218735|FG001|COMPLETED|First Intervention||10
10090018|NCT02322879|11218734|FG000|NOT COMPLETED|First Intervention||1
10090019|NCT02322879|11218735|FG001|NOT COMPLETED|First Intervention||0
10090020|NCT02322879|11218734|FG000|STARTED|Washout||10
10090021|NCT02322879|11218735|FG001|STARTED|Washout||10
10090022|NCT02322879|11218734|FG000|COMPLETED|Washout||10
10090023|NCT02322879|11218735|FG001|COMPLETED|Washout||10
10090024|NCT02322879|11218734|FG000|NOT COMPLETED|Washout||0
10090025|NCT02322879|11218735|FG001|NOT COMPLETED|Washout||0
10090026|NCT02322879|11218734|FG000|STARTED|Second Intervention||10
10090027|NCT02322879|11218735|FG001|STARTED|Second Intervention||10
10090028|NCT02322879|11218734|FG000|COMPLETED|Second Intervention||10
10090029|NCT02322879|11218735|FG001|COMPLETED|Second Intervention||10
10090030|NCT02322879|11218734|FG000|NOT COMPLETED|Second Intervention||0
10090031|NCT02322879|11218735|FG001|NOT COMPLETED|Second Intervention||0
10090032|NCT02322892|11218743|FG000|STARTED|Overall Study|Number randomized|35
10090033|NCT02322892|11218744|FG001|STARTED|Overall Study|Number randomized|34
10090034|NCT02322892|11218743|FG000|COMPLETED|Overall Study|Received placebo|33
10090035|NCT02322892|11218744|FG001|COMPLETED|Overall Study|Received thiamine|31
10090036|NCT02322892|11218743|FG000|NOT COMPLETED|Overall Study||2
10090037|NCT02322892|11218744|FG001|NOT COMPLETED|Overall Study||3
10090038|NCT02323048|11218755|FG000|STARTED|Overall Study||25
10090039|NCT02323048|11218756|FG001|STARTED|Overall Study||26
10090040|NCT02323048|11218757|FG002|STARTED|Overall Study||23
10090041|NCT02323048|11218758|FG003|STARTED|Overall Study||7
10090042|NCT02323048|11218759|FG004|STARTED|Overall Study||9
10090043|NCT02323048|11218755|FG000|COMPLETED|Overall Study||24
10090044|NCT02323048|11218756|FG001|COMPLETED|Overall Study||24
10090045|NCT02323048|11218757|FG002|COMPLETED|Overall Study||23
10090046|NCT02323048|11218758|FG003|COMPLETED|Overall Study||7
10090047|NCT02323048|11218759|FG004|COMPLETED|Overall Study||9
10090048|NCT02323048|11218755|FG000|NOT COMPLETED|Overall Study||1
10090049|NCT02323048|11218756|FG001|NOT COMPLETED|Overall Study||2
10090050|NCT02323048|11218757|FG002|NOT COMPLETED|Overall Study||0
10090051|NCT02323048|11218758|FG003|NOT COMPLETED|Overall Study||0
10090052|NCT02323048|11218759|FG004|NOT COMPLETED|Overall Study||0
10090053|NCT02323113|11218778|FG000|STARTED|Overall Study||4
10090054|NCT02323113|11218779|FG001|STARTED|Overall Study||7
10090055|NCT02323113|11218780|FG002|STARTED|Overall Study||4
10090056|NCT02323113|11218781|FG003|STARTED|Overall Study||5
10090057|NCT02323113|11218782|FG004|STARTED|Overall Study||9
10090058|NCT02323113|11218783|FG005|STARTED|Overall Study||8
10090059|NCT02323113|11218784|FG006|STARTED|Overall Study||6
10090060|NCT02323113|11218785|FG007|STARTED|Overall Study||0
10090061|NCT02323113|11218778|FG000|COMPLETED|Overall Study||0
10090062|NCT02323113|11218779|FG001|COMPLETED|Overall Study||0
10090063|NCT02323113|11218780|FG002|COMPLETED|Overall Study||0
10090064|NCT02323113|11218781|FG003|COMPLETED|Overall Study||0
10090065|NCT02323113|11218782|FG004|COMPLETED|Overall Study||0
10090066|NCT02323113|11218783|FG005|COMPLETED|Overall Study||0
10090067|NCT02323113|11218784|FG006|COMPLETED|Overall Study||0
10090068|NCT02323113|11218785|FG007|COMPLETED|Overall Study||0
10090069|NCT02323113|11218778|FG000|NOT COMPLETED|Overall Study||4
10090070|NCT02323113|11218779|FG001|NOT COMPLETED|Overall Study||7
10090071|NCT02323113|11218780|FG002|NOT COMPLETED|Overall Study||4
10090072|NCT02323113|11218781|FG003|NOT COMPLETED|Overall Study||5
10090073|NCT02323113|11218782|FG004|NOT COMPLETED|Overall Study||9
9739236|NCT00226655|10840237|FG000|COMPLETED|Overall Study||33
9739237|NCT00226655|10840237|FG000|NOT COMPLETED|Overall Study||79
10090074|NCT02323113|11218783|FG005|NOT COMPLETED|Overall Study||8
10090075|NCT02323113|11218784|FG006|NOT COMPLETED|Overall Study||6
10090076|NCT02323113|11218785|FG007|NOT COMPLETED|Overall Study||0
10090077|NCT02323204|11218808|FG000|STARTED|Baseline Survey Completion||155
10090078|NCT02323204|11218809|FG001|STARTED|Baseline Survey Completion||155
10090079|NCT02323204|11218810|FG002|STARTED|Baseline Survey Completion||159
10090080|NCT02323204|11218811|FG003|STARTED|Baseline Survey Completion||159
10090081|NCT02323204|11218808|FG000|COMPLETED|Baseline Survey Completion||145
10090082|NCT02323204|11218809|FG001|COMPLETED|Baseline Survey Completion||146
10090083|NCT02323204|11218810|FG002|COMPLETED|Baseline Survey Completion||154
10090084|NCT02323204|11218811|FG003|COMPLETED|Baseline Survey Completion||156
10090085|NCT02323204|11218808|FG000|NOT COMPLETED|Baseline Survey Completion||10
10090086|NCT02323204|11218809|FG001|NOT COMPLETED|Baseline Survey Completion||9
9739238|NCT00226811|10840241|FG000|STARTED|Overall Study||78
9739239|NCT00226811|10840241|FG000|COMPLETED|Overall Study||2
9739240|NCT00226811|10840241|FG000|NOT COMPLETED|Overall Study||76
10090087|NCT02323204|11218810|FG002|NOT COMPLETED|Baseline Survey Completion||5
9739241|NCT00226941|10840249|FG000|STARTED|Overall Study||6
9739242|NCT00226941|10840250|FG001|STARTED|Overall Study||6
9739243|NCT00226941|10840251|FG002|STARTED|Overall Study||4
9739244|NCT00226941|10840252|FG003|STARTED|Overall Study||7
9739245|NCT00226941|10840249|FG000|COMPLETED|Overall Study||6
9739246|NCT00226941|10840250|FG001|COMPLETED|Overall Study||6
9739247|NCT00226941|10840251|FG002|COMPLETED|Overall Study||4
9739248|NCT00226941|10840252|FG003|COMPLETED|Overall Study||5
9739249|NCT00226941|10840249|FG000|NOT COMPLETED|Overall Study||0
9739250|NCT00226941|10840250|FG001|NOT COMPLETED|Overall Study||0
9739251|NCT00226941|10840251|FG002|NOT COMPLETED|Overall Study||0
9739252|NCT00226941|10840252|FG003|NOT COMPLETED|Overall Study||2
9739253|NCT00227019|10840268|FG000|STARTED|Overall Study||16
9852343|NCT00880607|10965192|FG001|Observation After Receiving Medication|Overall Study||35
9852344|NCT00880607|10965191|FG000|COMPLETED|Overall Study||37
9852345|NCT00880607|10965192|FG001|COMPLETED|Overall Study||34
9852346|NCT00880607|10965191|FG000|NOT COMPLETED|Overall Study||7
9852347|NCT00880607|10965192|FG001|NOT COMPLETED|Overall Study||3
9852348|NCT00880620|10965204|FG000|STARTED|Overall Study||92
9852349|NCT00880620|10965205|FG001|STARTED|Overall Study||87
9852350|NCT00880620|10965206|FG002|STARTED|Overall Study||104
9852351|NCT00880620|10965207|FG003|STARTED|Overall Study||98
9852352|NCT00880620|10965204|FG000|Week 4|Overall Study||88
9852353|NCT00880620|10965205|FG001|Week 4|Overall Study||79
9852354|NCT00880620|10965206|FG002|Week 4|Overall Study||94
9852355|NCT00880620|10965207|FG003|Week 4|Overall Study||86
9852356|NCT00880620|10965204|FG000|Week 9|Overall Study||80
9852357|NCT00880620|10965205|FG001|Week 9|Overall Study||73
9852358|NCT00880620|10965206|FG002|Week 9|Overall Study||88
9852359|NCT00880620|10965207|FG003|Week 9|Overall Study||78
9852360|NCT00880620|10965204|FG000|Week 16|Overall Study||74
9852361|NCT00880620|10965205|FG001|Week 16|Overall Study||73
9852362|NCT00880620|10965206|FG002|Week 16|Overall Study||87
9852363|NCT00880620|10965207|FG003|Week 16|Overall Study||74
9852364|NCT00880620|10965204|FG000|Week 23|Overall Study||71
9852365|NCT00880620|10965205|FG001|Week 23|Overall Study||72
9852366|NCT00880620|10965206|FG002|Week 23|Overall Study||85
9852367|NCT00880620|10965207|FG003|Week 23|Overall Study||74
9852368|NCT00880620|10965204|FG000|COMPLETED|Overall Study||71
9852369|NCT00880620|10965205|FG001|COMPLETED|Overall Study||72
9852370|NCT00880620|10965206|FG002|COMPLETED|Overall Study||83
9852371|NCT00880620|10965207|FG003|COMPLETED|Overall Study||74
9852372|NCT00880620|10965204|FG000|NOT COMPLETED|Overall Study||21
9852373|NCT00880620|10965205|FG001|NOT COMPLETED|Overall Study||15
9852374|NCT00880620|10965206|FG002|NOT COMPLETED|Overall Study||21
9852375|NCT00880620|10965207|FG003|NOT COMPLETED|Overall Study||24
9852376|NCT00880685|10965221|FG000|STARTED|Memantine 10mg||12
9852377|NCT00880685|10965221|FG000|COMPLETED|Memantine 10mg||10
9852378|NCT00880685|10965221|FG000|NOT COMPLETED|Memantine 10mg||2
9852379|NCT00880685|10965221|FG000|STARTED|Memantine 20mg||10
9852380|NCT00880685|10965221|FG000|COMPLETED|Memantine 20mg||9
9852381|NCT00880685|10965221|FG000|NOT COMPLETED|Memantine 20mg||1
9852382|NCT00880685|10965221|FG000|STARTED|Memantine 30mg||9
9852383|NCT00880685|10965221|FG000|COMPLETED|Memantine 30mg||9
9852384|NCT00880685|10965221|FG000|NOT COMPLETED|Memantine 30mg||0
9852385|NCT00880698|10965232|FG000|STARTED|Overall Study||62
9852386|NCT00880698|10965233|FG001|STARTED|Overall Study||64
9852387|NCT00880698|10965234|FG002|STARTED|Overall Study||37
9852388|NCT00880698|10965235|FG003|STARTED|Overall Study||39
9852389|NCT00880698|10965232|FG000|COMPLETED|Overall Study||61
9852390|NCT00880698|10965233|FG001|COMPLETED|Overall Study||61
9852391|NCT00880698|10965234|FG002|COMPLETED|Overall Study||36
9852392|NCT00880698|10965235|FG003|COMPLETED|Overall Study||36
9852393|NCT00880698|10965232|FG000|NOT COMPLETED|Overall Study||1
9852394|NCT00880698|10965233|FG001|NOT COMPLETED|Overall Study||3
9852395|NCT00880698|10965234|FG002|NOT COMPLETED|Overall Study||1
9852396|NCT00880698|10965235|FG003|NOT COMPLETED|Overall Study||3
9852397|NCT00880750|10965249|FG000|STARTED|First Intervention||39
9852398|NCT00880750|10965250|FG001|STARTED|First Intervention||33
9852399|NCT00880750|10965249|FG000|COMPLETED|First Intervention||30
9852400|NCT00880750|10965250|FG001|COMPLETED|First Intervention||32
9852401|NCT00880750|10965249|FG000|NOT COMPLETED|First Intervention||9
9852402|NCT00880750|10965250|FG001|NOT COMPLETED|First Intervention||1
9852403|NCT00880750|10965249|FG000|STARTED|Washout Period||30
9852404|NCT00880750|10965250|FG001|STARTED|Washout Period||32
9852405|NCT00880750|10965249|FG000|COMPLETED|Washout Period||30
9852406|NCT00880750|10965250|FG001|COMPLETED|Washout Period||32
9739254|NCT00227019|10840268|FG000|COMPLETED|Overall Study||16
9739255|NCT00227019|10840268|FG000|NOT COMPLETED|Overall Study||0
9852407|NCT00880750|10965249|FG000|NOT COMPLETED|Washout Period||0
9852408|NCT00880750|10965250|FG001|NOT COMPLETED|Washout Period||0
9852409|NCT00880750|10965249|FG000|STARTED|Second Intervention||30
9852410|NCT00880750|10965250|FG001|STARTED|Second Intervention||32
9852411|NCT00880750|10965249|FG000|COMPLETED|Second Intervention||26
9852412|NCT00880750|10965250|FG001|COMPLETED|Second Intervention||30
9852413|NCT00880750|10965249|FG000|NOT COMPLETED|Second Intervention||4
9852414|NCT00880750|10965250|FG001|NOT COMPLETED|Second Intervention||2
9852415|NCT00880763|10965260|FG000|STARTED|Initial Treatment Period (Part 1)||23
9739256|NCT00227266|10840276|FG000|STARTED|Overall Study||31
9739257|NCT00227266|10840277|FG001|STARTED|Overall Study||30
9739258|NCT00227266|10840278|FG002|STARTED|Overall Study||33
9739259|NCT00227266|10840276|FG000|COMPLETED|Overall Study||30
9852416|NCT00880763|10965261|FG001|STARTED|Initial Treatment Period (Part 1)||22
9739260|NCT00227266|10840277|FG001|COMPLETED|Overall Study||30
9739261|NCT00227266|10840278|FG002|COMPLETED|Overall Study||29
9739262|NCT00227266|10840276|FG000|NOT COMPLETED|Overall Study||1
9739263|NCT00227266|10840277|FG001|NOT COMPLETED|Overall Study||0
9739264|NCT00227266|10840278|FG002|NOT COMPLETED|Overall Study||4
9739265|NCT00227305|10840289|FG000|STARTED|Overall Study|enrolled|381
9739266|NCT00227305|10840289|FG000|Drug Received|Overall Study|safety population|380
9739267|NCT00227305|10840289|FG000|COMPLETED|Overall Study|Completed 26 weeks|237
9739268|NCT00227305|10840289|FG000|NOT COMPLETED|Overall Study||144
9739269|NCT00227344|10840295|FG000|STARTED|Overall Study||87
9739270|NCT00227344|10840296|FG001|STARTED|Overall Study||42
10090088|NCT02323204|11218811|FG003|NOT COMPLETED|Baseline Survey Completion||3
10090089|NCT02323204|11218808|FG000|STARTED|6-week Follow-up Survey Completion||145
10090090|NCT02323204|11218809|FG001|STARTED|6-week Follow-up Survey Completion||146
10090091|NCT02323204|11218810|FG002|STARTED|6-week Follow-up Survey Completion||154
10090092|NCT02323204|11218811|FG003|STARTED|6-week Follow-up Survey Completion||156
10090093|NCT02323204|11218808|FG000|COMPLETED|6-week Follow-up Survey Completion||104
9739271|NCT00227344|10840295|FG000|COMPLETED|Overall Study||75
9739272|NCT00227344|10840296|FG001|COMPLETED|Overall Study||37
9739273|NCT00227344|10840295|FG000|NOT COMPLETED|Overall Study||12
9739274|NCT00227344|10840296|FG001|NOT COMPLETED|Overall Study||5
9739275|NCT00227370|10840304|FG000|STARTED|Overall Study|Placebo Group|66
9739276|NCT00227370|10840305|FG001|STARTED|Overall Study|Treatment Group|70
9739277|NCT00227370|10840304|FG000|COMPLETED|Overall Study||45
10090094|NCT02323204|11218809|FG001|COMPLETED|6-week Follow-up Survey Completion||110
10090095|NCT02323204|11218810|FG002|COMPLETED|6-week Follow-up Survey Completion||112
10090096|NCT02323204|11218811|FG003|COMPLETED|6-week Follow-up Survey Completion||119
10090097|NCT02323204|11218808|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41
10090098|NCT02323204|11218809|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36
10090099|NCT02323204|11218810|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42
10090100|NCT02323204|11218811|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37
10090101|NCT02323204|11218808|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
10090102|NCT02323204|11218809|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
10090103|NCT02323204|11218810|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
10090104|NCT02323204|11218811|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
10090105|NCT02323204|11218808|FG000|COMPLETED|6-week Follow-up Intervention Booster||0
10090106|NCT02323204|11218809|FG001|COMPLETED|6-week Follow-up Intervention Booster||103
10090107|NCT02323204|11218810|FG002|COMPLETED|6-week Follow-up Intervention Booster||0
10090108|NCT02323204|11218811|FG003|COMPLETED|6-week Follow-up Intervention Booster||120
10090109|NCT02323204|11218808|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0
10090110|NCT02323204|11218809|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43
10090111|NCT02323204|11218810|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0
10090112|NCT02323204|11218811|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36
10090113|NCT02323204|11218808|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
10090114|NCT02323204|11218809|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
10090115|NCT02323204|11218810|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
10090116|NCT02323204|11218811|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
10090117|NCT02323204|11218808|FG000|COMPLETED|3-month Follow-up Survey Completion||91
10090118|NCT02323204|11218809|FG001|COMPLETED|3-month Follow-up Survey Completion||99
10090119|NCT02323204|11218810|FG002|COMPLETED|3-month Follow-up Survey Completion||113
10090120|NCT02323204|11218811|FG003|COMPLETED|3-month Follow-up Survey Completion||112
10090121|NCT02323204|11218808|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54
10090122|NCT02323204|11218809|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47
10090123|NCT02323204|11218810|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41
10090124|NCT02323204|11218811|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44
10090125|NCT02323204|11218808|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
10090126|NCT02323204|11218809|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
10090127|NCT02323204|11218810|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
10090128|NCT02323204|11218811|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
10090129|NCT02323204|11218808|FG000|COMPLETED|6-month Follow-up Survey Completion||96
10090130|NCT02323204|11218809|FG001|COMPLETED|6-month Follow-up Survey Completion||96
10090131|NCT02323204|11218810|FG002|COMPLETED|6-month Follow-up Survey Completion||113
10090132|NCT02323204|11218811|FG003|COMPLETED|6-month Follow-up Survey Completion||112
9739278|NCT00227370|10840305|FG001|COMPLETED|Overall Study||46
9739279|NCT00227370|10840304|FG000|NOT COMPLETED|Overall Study||21
9739280|NCT00227370|10840305|FG001|NOT COMPLETED|Overall Study||24
9739281|NCT00227539|10840311|FG000|STARTED|Overall Study||25
9739282|NCT00227539|10840311|FG000|COMPLETED|Overall Study||24
9739283|NCT00227539|10840311|FG000|NOT COMPLETED|Overall Study||1
9739284|NCT00227591|10840315|FG000|STARTED|Overall Study|48 pts registered to the study|48
10090133|NCT02323204|11218808|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49
10090134|NCT02323204|11218809|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50
10090135|NCT02323204|11218810|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41
10090136|NCT02323204|11218811|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44
10090137|NCT02323217|11218821|FG000|STARTED|Overall Study||18
10090138|NCT02323217|11218821|FG000|COMPLETED|Overall Study||18
10090139|NCT02323217|11218821|FG000|NOT COMPLETED|Overall Study||0
10090140|NCT02323334|11218835|FG000|STARTED|Period 1||4
10090141|NCT02323334|11218836|FG001|STARTED|Period 1||4
10090142|NCT02323334|11218837|FG002|STARTED|Period 1||4
10090143|NCT02323334|11218838|FG003|STARTED|Period 1||4
10090144|NCT02323334|11218839|FG004|STARTED|Period 1||4
10090145|NCT02323334|11218840|FG005|STARTED|Period 1||4
10090146|NCT02323334|11218841|FG006|STARTED|Period 1||6
10090147|NCT02323334|11218842|FG007|STARTED|Period 1||6
10090148|NCT02323334|11218843|FG008|STARTED|Period 1||5
10090149|NCT02323334|11218844|FG009|STARTED|Period 1||7
10090150|NCT02323334|11218845|FG010|STARTED|Period 1||5
10090151|NCT02323334|11218846|FG011|STARTED|Period 1||3
10090152|NCT02323334|11218847|FG012|STARTED|Period 1||9
10090153|NCT02323334|11218848|FG013|STARTED|Period 1||9
10090154|NCT02323334|11218849|FG014|STARTED|Period 1||9
10090155|NCT02323334|11218850|FG015|STARTED|Period 1||9
10090156|NCT02323334|11218851|FG016|STARTED|Period 1||2
10090157|NCT02323334|11218835|FG000|Received at Least One Dose of Study Drug|Period 1||4
10090158|NCT02323334|11218836|FG001|Received at Least One Dose of Study Drug|Period 1||4
10090159|NCT02323334|11218837|FG002|Received at Least One Dose of Study Drug|Period 1||4
10090160|NCT02323334|11218838|FG003|Received at Least One Dose of Study Drug|Period 1||4
10090161|NCT02323334|11218839|FG004|Received at Least One Dose of Study Drug|Period 1||4
10090162|NCT02323334|11218840|FG005|Received at Least One Dose of Study Drug|Period 1||4
10090163|NCT02323334|11218841|FG006|Received at Least One Dose of Study Drug|Period 1||6
10090164|NCT02323334|11218842|FG007|Received at Least One Dose of Study Drug|Period 1||6
10090165|NCT02323334|11218843|FG008|Received at Least One Dose of Study Drug|Period 1||5
10090166|NCT02323334|11218844|FG009|Received at Least One Dose of Study Drug|Period 1||7
10090167|NCT02323334|11218845|FG010|Received at Least One Dose of Study Drug|Period 1||5
10090168|NCT02323334|11218846|FG011|Received at Least One Dose of Study Drug|Period 1||3
10090169|NCT02323334|11218847|FG012|Received at Least One Dose of Study Drug|Period 1||9
10090170|NCT02323334|11218848|FG013|Received at Least One Dose of Study Drug|Period 1||9
10090171|NCT02323334|11218849|FG014|Received at Least One Dose of Study Drug|Period 1||9
10090172|NCT02323334|11218850|FG015|Received at Least One Dose of Study Drug|Period 1||9
10090173|NCT02323334|11218851|FG016|Received at Least One Dose of Study Drug|Period 1||2
10090174|NCT02323334|11218835|FG000|COMPLETED|Period 1||4
10090175|NCT02323334|11218836|FG001|COMPLETED|Period 1||4
10090176|NCT02323334|11218837|FG002|COMPLETED|Period 1||4
10090177|NCT02323334|11218838|FG003|COMPLETED|Period 1||4
10090178|NCT02323334|11218839|FG004|COMPLETED|Period 1||4
10090179|NCT02323334|11218840|FG005|COMPLETED|Period 1||4
10090180|NCT02323334|11218841|FG006|COMPLETED|Period 1||6
10090181|NCT02323334|11218842|FG007|COMPLETED|Period 1||6
10090182|NCT02323334|11218843|FG008|COMPLETED|Period 1||5
10090183|NCT02323334|11218844|FG009|COMPLETED|Period 1||7
10090184|NCT02323334|11218845|FG010|COMPLETED|Period 1||5
10090185|NCT02323334|11218846|FG011|COMPLETED|Period 1||3
10090186|NCT02323334|11218847|FG012|COMPLETED|Period 1||9
10090187|NCT02323334|11218848|FG013|COMPLETED|Period 1||9
10090188|NCT02323334|11218849|FG014|COMPLETED|Period 1||9
10090189|NCT02323334|11218850|FG015|COMPLETED|Period 1||9
10090190|NCT02323334|11218851|FG016|COMPLETED|Period 1||2
10090191|NCT02323334|11218835|FG000|NOT COMPLETED|Period 1||0
10090192|NCT02323334|11218836|FG001|NOT COMPLETED|Period 1||0
10090193|NCT02323334|11218837|FG002|NOT COMPLETED|Period 1||0
10090194|NCT02323334|11218838|FG003|NOT COMPLETED|Period 1||0
10090195|NCT02323334|11218839|FG004|NOT COMPLETED|Period 1||0
10090196|NCT02323334|11218840|FG005|NOT COMPLETED|Period 1||0
10090197|NCT02323334|11218841|FG006|NOT COMPLETED|Period 1||0
10090198|NCT02323334|11218842|FG007|NOT COMPLETED|Period 1||0
10090199|NCT02323334|11218843|FG008|NOT COMPLETED|Period 1||0
10090200|NCT02323334|11218844|FG009|NOT COMPLETED|Period 1||0
10090201|NCT02323334|11218845|FG010|NOT COMPLETED|Period 1||0
10090202|NCT02323334|11218846|FG011|NOT COMPLETED|Period 1||0
10090203|NCT02323334|11218847|FG012|NOT COMPLETED|Period 1||0
10090204|NCT02323334|11218848|FG013|NOT COMPLETED|Period 1||0
10090205|NCT02323334|11218849|FG014|NOT COMPLETED|Period 1||0
10090206|NCT02323334|11218850|FG015|NOT COMPLETED|Period 1||0
10090207|NCT02323334|11218851|FG016|NOT COMPLETED|Period 1||0
10090208|NCT02323334|11218835|FG000|STARTED|Period 2||4
10090209|NCT02323334|11218836|FG001|STARTED|Period 2||4
10090210|NCT02323334|11218837|FG002|STARTED|Period 2||4
10090211|NCT02323334|11218838|FG003|STARTED|Period 2||4
10090212|NCT02323334|11218839|FG004|STARTED|Period 2||4
10090213|NCT02323334|11218840|FG005|STARTED|Period 2||4
10090214|NCT02323334|11218841|FG006|STARTED|Period 2||6
10090215|NCT02323334|11218842|FG007|STARTED|Period 2||6
10090216|NCT02323334|11218843|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090217|NCT02323334|11218844|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090218|NCT02323334|11218845|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
9739285|NCT00227591|10840315|FG000|Began Treatment|Overall Study||47
9739286|NCT00227591|10840315|FG000|COMPLETED|Overall Study||47
9739287|NCT00227591|10840315|FG000|NOT COMPLETED|Overall Study||1
9739288|NCT00227617|10840319|FG000|STARTED|Stage 1||22
9739289|NCT00227617|10840320|FG001|STARTED|Stage 1||12
9739290|NCT00227617|10840321|FG002|STARTED|Stage 1||2
9739291|NCT00227617|10840319|FG000|COMPLETED|Stage 1||22
9739292|NCT00227617|10840320|FG001|COMPLETED|Stage 1||12
9739293|NCT00227617|10840321|FG002|COMPLETED|Stage 1||2
9739294|NCT00227617|10840319|FG000|NOT COMPLETED|Stage 1||0
9739295|NCT00227617|10840320|FG001|NOT COMPLETED|Stage 1||0
9739296|NCT00227617|10840321|FG002|NOT COMPLETED|Stage 1||0
9739297|NCT00227617|10840319|FG000|STARTED|Stage 2||0
9739298|NCT00227617|10840320|FG001|STARTED|Stage 2||0
9739299|NCT00227617|10840321|FG002|STARTED|Stage 2||0
9739300|NCT00227617|10840319|FG000|COMPLETED|Stage 2||0
9739301|NCT00227617|10840320|FG001|COMPLETED|Stage 2||0
9739302|NCT00227617|10840321|FG002|COMPLETED|Stage 2||0
9739303|NCT00227617|10840319|FG000|NOT COMPLETED|Stage 2||0
9739304|NCT00227617|10840320|FG001|NOT COMPLETED|Stage 2||0
9739305|NCT00227617|10840321|FG002|NOT COMPLETED|Stage 2||0
9739306|NCT00227721|10840333|FG000|STARTED|Overall Study||30
9739307|NCT00227721|10840333|FG000|COMPLETED|Overall Study||29
9739308|NCT00227721|10840333|FG000|NOT COMPLETED|Overall Study||1
9739309|NCT00227760|10840337|FG000|STARTED|Overall Study||44
9739310|NCT00227760|10840337|FG000|COMPLETED|Overall Study||44
9739311|NCT00227760|10840337|FG000|NOT COMPLETED|Overall Study||0
9739312|NCT00227877|10840345|FG000|STARTED|Pre-visit Assessment||1075
9739313|NCT00227877|10840346|FG001|STARTED|Pre-visit Assessment||1031
9739314|NCT00227877|10840347|FG002|STARTED|Pre-visit Assessment||297
9739315|NCT00227877|10840348|FG003|STARTED|Pre-visit Assessment||292
9739316|NCT00227877|10840345|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
9739317|NCT00227877|10840346|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
9739318|NCT00227877|10840347|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297
9739319|NCT00227877|10840348|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292
9739320|NCT00227877|10840345|FG000|NOT COMPLETED|Pre-visit Assessment||7
9739321|NCT00227877|10840346|FG001|NOT COMPLETED|Pre-visit Assessment||3
9739322|NCT00227877|10840347|FG002|NOT COMPLETED|Pre-visit Assessment||0
9739323|NCT00227877|10840348|FG003|NOT COMPLETED|Pre-visit Assessment||0
9739324|NCT00227877|10840345|FG000|STARTED|Post-visit Checklist||1068
9739325|NCT00227877|10840346|FG001|STARTED|Post-visit Checklist||1028
9739326|NCT00227877|10840347|FG002|STARTED|Post-visit Checklist||297
9739327|NCT00227877|10840348|FG003|STARTED|Post-visit Checklist||292
9739328|NCT00227877|10840345|FG000|COMPLETED|Post-visit Checklist||1044
9739329|NCT00227877|10840346|FG001|COMPLETED|Post-visit Checklist||1015
9739330|NCT00227877|10840347|FG002|COMPLETED|Post-visit Checklist||296
10090219|NCT02323334|11218846|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090220|NCT02323334|11218847|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090221|NCT02323334|11218848|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090222|NCT02323334|11218849|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090223|NCT02323334|11218850|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090224|NCT02323334|11218851|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10090225|NCT02323334|11218835|FG000|COMPLETED|Period 2||4
10090226|NCT02323334|11218836|FG001|COMPLETED|Period 2||4
10090227|NCT02323334|11218837|FG002|COMPLETED|Period 2||4
10090228|NCT02323334|11218838|FG003|COMPLETED|Period 2||4
10090229|NCT02323334|11218839|FG004|COMPLETED|Period 2||4
10090230|NCT02323334|11218840|FG005|COMPLETED|Period 2||4
10090231|NCT02323334|11218841|FG006|COMPLETED|Period 2||6
10090232|NCT02323334|11218842|FG007|COMPLETED|Period 2||6
10090233|NCT02323334|11218843|FG008|COMPLETED|Period 2||0
10090234|NCT02323334|11218844|FG009|COMPLETED|Period 2||0
10090235|NCT02323334|11218845|FG010|COMPLETED|Period 2||0
10090236|NCT02323334|11218846|FG011|COMPLETED|Period 2||0
10090237|NCT02323334|11218847|FG012|COMPLETED|Period 2||0
10090238|NCT02323334|11218848|FG013|COMPLETED|Period 2||0
10090239|NCT02323334|11218849|FG014|COMPLETED|Period 2||0
10090240|NCT02323334|11218850|FG015|COMPLETED|Period 2||0
10090241|NCT02323334|11218851|FG016|COMPLETED|Period 2||0
10090242|NCT02323334|11218835|FG000|NOT COMPLETED|Period 2||0
10090243|NCT02323334|11218836|FG001|NOT COMPLETED|Period 2||0
10090244|NCT02323334|11218837|FG002|NOT COMPLETED|Period 2||0
10090245|NCT02323334|11218838|FG003|NOT COMPLETED|Period 2||0
10090246|NCT02323334|11218839|FG004|NOT COMPLETED|Period 2||0
10090247|NCT02323334|11218840|FG005|NOT COMPLETED|Period 2||0
10090248|NCT02323334|11218841|FG006|NOT COMPLETED|Period 2||0
10090249|NCT02323334|11218842|FG007|NOT COMPLETED|Period 2||0
10090250|NCT02323334|11218843|FG008|NOT COMPLETED|Period 2||0
10090251|NCT02323334|11218844|FG009|NOT COMPLETED|Period 2||0
9739331|NCT00227877|10840348|FG003|COMPLETED|Post-visit Checklist||292
9739332|NCT00227877|10840345|FG000|NOT COMPLETED|Post-visit Checklist||24
9739333|NCT00227877|10840346|FG001|NOT COMPLETED|Post-visit Checklist||13
9739334|NCT00227877|10840347|FG002|NOT COMPLETED|Post-visit Checklist||1
9739335|NCT00227877|10840348|FG003|NOT COMPLETED|Post-visit Checklist||0
9739336|NCT00227877|10840345|FG000|STARTED|3-months Follow-up||1068
9739337|NCT00227877|10840346|FG001|STARTED|3-months Follow-up||1028
9739338|NCT00227877|10840347|FG002|STARTED|3-months Follow-up||297
9739339|NCT00227877|10840348|FG003|STARTED|3-months Follow-up||292
9739340|NCT00227877|10840345|FG000|COMPLETED|3-months Follow-up||755
9739341|NCT00227877|10840346|FG001|COMPLETED|3-months Follow-up||761
9739342|NCT00227877|10840347|FG002|COMPLETED|3-months Follow-up||245
9739343|NCT00227877|10840348|FG003|COMPLETED|3-months Follow-up||271
9739344|NCT00227877|10840345|FG000|NOT COMPLETED|3-months Follow-up||313
9739345|NCT00227877|10840346|FG001|NOT COMPLETED|3-months Follow-up||267
9739346|NCT00227877|10840347|FG002|NOT COMPLETED|3-months Follow-up||52
9739347|NCT00227877|10840348|FG003|NOT COMPLETED|3-months Follow-up||21
9739348|NCT00227877|10840345|FG000|STARTED|12-months Follow-up||1068
9739349|NCT00227877|10840346|FG001|STARTED|12-months Follow-up||1028
9739350|NCT00227877|10840347|FG002|STARTED|12-months Follow-up||297
9739351|NCT00227877|10840348|FG003|STARTED|12-months Follow-up||292
9739352|NCT00227877|10840345|FG000|COMPLETED|12-months Follow-up||758
9739353|NCT00227877|10840346|FG001|COMPLETED|12-months Follow-up||765
9739354|NCT00227877|10840347|FG002|COMPLETED|12-months Follow-up||266
9739355|NCT00227877|10840348|FG003|COMPLETED|12-months Follow-up||266
9739356|NCT00227877|10840345|FG000|NOT COMPLETED|12-months Follow-up||310
9739357|NCT00227877|10840346|FG001|NOT COMPLETED|12-months Follow-up||263
9739358|NCT00227877|10840347|FG002|NOT COMPLETED|12-months Follow-up||31
9739359|NCT00227877|10840348|FG003|NOT COMPLETED|12-months Follow-up||26
9739360|NCT00227903|10840362|FG000|STARTED|Overall Study||91
9739361|NCT00227903|10840363|FG001|STARTED|Overall Study||92
9739362|NCT00227903|10840362|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
9739363|NCT00227903|10840363|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
9739364|NCT00227903|10840362|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
9739365|NCT00227903|10840363|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
9739366|NCT00227903|10840362|FG000|NOT COMPLETED|Overall Study||5
9739367|NCT00227903|10840363|FG001|NOT COMPLETED|Overall Study||10
9739368|NCT00227994|10840371|FG000|STARTED|Overall Study||20
9739369|NCT00227994|10840372|FG001|STARTED|Overall Study||20
9739370|NCT00227994|10840371|FG000|COMPLETED|Overall Study||13
9739371|NCT00227994|10840372|FG001|COMPLETED|Overall Study||13
9739372|NCT00227994|10840371|FG000|NOT COMPLETED|Overall Study||7
9739373|NCT00227994|10840372|FG001|NOT COMPLETED|Overall Study||7
9739374|NCT00228384|10840380|FG000|STARTED|Overall Study||72
9739375|NCT00228384|10840381|FG001|STARTED|Overall Study||76
9739376|NCT00228384|10840380|FG000|Baseline|Overall Study||72
9739377|NCT00228384|10840381|FG001|Baseline|Overall Study||76
9739378|NCT00228384|10840380|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69
9739379|NCT00228384|10840381|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72
9739380|NCT00228384|10840380|FG000|Three Year Follow-up (Final)|Overall Study||43
9739381|NCT00228384|10840381|FG001|Three Year Follow-up (Final)|Overall Study||47
9739382|NCT00228384|10840380|FG000|COMPLETED|Overall Study||43
9739383|NCT00228384|10840381|FG001|COMPLETED|Overall Study||47
9739384|NCT00228384|10840380|FG000|NOT COMPLETED|Overall Study||29
9739385|NCT00228384|10840381|FG001|NOT COMPLETED|Overall Study||29
9739386|NCT00228423|10840389|FG000|STARTED|Overall Study||56
9739387|NCT00228423|10840390|FG001|STARTED|Overall Study||57
9739388|NCT00228423|10840389|FG000|COMPLETED|Overall Study||46
9739389|NCT00228423|10840390|FG001|COMPLETED|Overall Study||45
9739390|NCT00228423|10840389|FG000|NOT COMPLETED|Overall Study||10
9739391|NCT00228423|10840390|FG001|NOT COMPLETED|Overall Study||12
9739392|NCT00228553|10840396|FG000|STARTED|Overall Study||743
9739393|NCT00228553|10840396|FG000|COMPLETED|Overall Study||313
9739394|NCT00228553|10840396|FG000|NOT COMPLETED|Overall Study||430
9739395|NCT00228566|10840400|FG000|STARTED|Overall Study||247
9739396|NCT00228566|10840400|FG000|COMPLETED|Overall Study||176
9739397|NCT00228566|10840400|FG000|NOT COMPLETED|Overall Study||71
9739398|NCT00228813|10840404|FG000|STARTED|Overall Study||8
9739399|NCT00228813|10840404|FG000|COMPLETED|Overall Study||4
9739400|NCT00228813|10840404|FG000|NOT COMPLETED|Overall Study||4
9739401|NCT00228917|10840416|FG000|STARTED|Overall Study||193
9739402|NCT00228917|10840417|FG001|STARTED|Overall Study||96
9739403|NCT00228917|10840418|FG002|STARTED|Overall Study||65
9739404|NCT00228917|10840419|FG003|STARTED|Overall Study||33
9739405|NCT00228917|10840420|FG004|STARTED|Overall Study||205
9739406|NCT00228917|10840421|FG005|STARTED|Overall Study||104
9739407|NCT00228917|10840422|FG006|STARTED|Overall Study||69
9739408|NCT00228917|10840423|FG007|STARTED|Overall Study||33
9739409|NCT00228917|10840416|FG000|COMPLETED|Overall Study||193
9739410|NCT00228917|10840417|FG001|COMPLETED|Overall Study||96
9739411|NCT00228917|10840418|FG002|COMPLETED|Overall Study||65
9739412|NCT00228917|10840419|FG003|COMPLETED|Overall Study||33
9739413|NCT00228917|10840420|FG004|COMPLETED|Overall Study||205
9739414|NCT00228917|10840421|FG005|COMPLETED|Overall Study||102
9739415|NCT00228917|10840422|FG006|COMPLETED|Overall Study||69
9739416|NCT00228917|10840423|FG007|COMPLETED|Overall Study||33
9739417|NCT00228917|10840416|FG000|NOT COMPLETED|Overall Study||0
9739418|NCT00228917|10840417|FG001|NOT COMPLETED|Overall Study||0
9739419|NCT00228917|10840418|FG002|NOT COMPLETED|Overall Study||0
9739420|NCT00228917|10840419|FG003|NOT COMPLETED|Overall Study||0
9739421|NCT00228917|10840420|FG004|NOT COMPLETED|Overall Study||0
9739422|NCT00228917|10840421|FG005|NOT COMPLETED|Overall Study||2
9739423|NCT00228917|10840422|FG006|NOT COMPLETED|Overall Study||0
9739424|NCT00228917|10840423|FG007|NOT COMPLETED|Overall Study||0
9739425|NCT00228943|10840437|FG000|STARTED|Week 1||28
9739426|NCT00228943|10840437|FG000|COMPLETED|Week 1||28
9739427|NCT00228943|10840437|FG000|NOT COMPLETED|Week 1||0
10090252|NCT02323334|11218845|FG010|NOT COMPLETED|Period 2||0
10090253|NCT02323334|11218846|FG011|NOT COMPLETED|Period 2||0
10090254|NCT02323334|11218847|FG012|NOT COMPLETED|Period 2||0
10090255|NCT02323334|11218848|FG013|NOT COMPLETED|Period 2||0
10090256|NCT02323334|11218849|FG014|NOT COMPLETED|Period 2||0
10090257|NCT02323334|11218850|FG015|NOT COMPLETED|Period 2||0
10090258|NCT02323334|11218851|FG016|NOT COMPLETED|Period 2||0
10090259|NCT02323334|11218835|FG000|STARTED|Period 3||4
10090260|NCT02323334|11218836|FG001|STARTED|Period 3||4
10090261|NCT02323334|11218837|FG002|STARTED|Period 3||4
10090262|NCT02323334|11218838|FG003|STARTED|Period 3||4
10090263|NCT02323334|11218839|FG004|STARTED|Period 3||4
10090264|NCT02323334|11218840|FG005|STARTED|Period 3||4
10090265|NCT02323334|11218841|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
10090266|NCT02323334|11218842|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
10090267|NCT02323334|11218843|FG008|STARTED|Period 3||0
10090268|NCT02323334|11218844|FG009|STARTED|Period 3||0
10090269|NCT02323334|11218845|FG010|STARTED|Period 3||0
10090270|NCT02323334|11218846|FG011|STARTED|Period 3||0
10090271|NCT02323334|11218847|FG012|STARTED|Period 3||0
10090272|NCT02323334|11218848|FG013|STARTED|Period 3||0
10090273|NCT02323334|11218849|FG014|STARTED|Period 3||0
10090274|NCT02323334|11218850|FG015|STARTED|Period 3||0
10090275|NCT02323334|11218851|FG016|STARTED|Period 3||0
10090276|NCT02323334|11218835|FG000|COMPLETED|Period 3||3
10090277|NCT02323334|11218836|FG001|COMPLETED|Period 3||4
10090278|NCT02323334|11218837|FG002|COMPLETED|Period 3||3
10090279|NCT02323334|11218838|FG003|COMPLETED|Period 3||4
10090280|NCT02323334|11218839|FG004|COMPLETED|Period 3||4
10090281|NCT02323334|11218840|FG005|COMPLETED|Period 3||4
10090282|NCT02323334|11218841|FG006|COMPLETED|Period 3||0
10090283|NCT02323334|11218842|FG007|COMPLETED|Period 3||0
10090284|NCT02323334|11218843|FG008|COMPLETED|Period 3||0
10090285|NCT02323334|11218844|FG009|COMPLETED|Period 3||0
10090286|NCT02323334|11218845|FG010|COMPLETED|Period 3||0
10090287|NCT02323334|11218846|FG011|COMPLETED|Period 3||0
10090288|NCT02323334|11218847|FG012|COMPLETED|Period 3||0
10090289|NCT02323334|11218848|FG013|COMPLETED|Period 3||0
10090290|NCT02323334|11218849|FG014|COMPLETED|Period 3||0
10090291|NCT02323334|11218850|FG015|COMPLETED|Period 3||0
10090292|NCT02323334|11218851|FG016|COMPLETED|Period 3||0
10090293|NCT02323334|11218835|FG000|NOT COMPLETED|Period 3||1
10090294|NCT02323334|11218836|FG001|NOT COMPLETED|Period 3||0
10090295|NCT02323334|11218837|FG002|NOT COMPLETED|Period 3||1
10090296|NCT02323334|11218838|FG003|NOT COMPLETED|Period 3||0
10090297|NCT02323334|11218839|FG004|NOT COMPLETED|Period 3||0
10090298|NCT02323334|11218840|FG005|NOT COMPLETED|Period 3||0
10090299|NCT02323334|11218841|FG006|NOT COMPLETED|Period 3||0
10090300|NCT02323334|11218842|FG007|NOT COMPLETED|Period 3||0
10090301|NCT02323334|11218843|FG008|NOT COMPLETED|Period 3||0
10090302|NCT02323334|11218844|FG009|NOT COMPLETED|Period 3||0
10090303|NCT02323334|11218845|FG010|NOT COMPLETED|Period 3||0
10090304|NCT02323334|11218846|FG011|NOT COMPLETED|Period 3||0
10090305|NCT02323334|11218847|FG012|NOT COMPLETED|Period 3||0
10090306|NCT02323334|11218848|FG013|NOT COMPLETED|Period 3||0
10090307|NCT02323334|11218849|FG014|NOT COMPLETED|Period 3||0
10090308|NCT02323334|11218850|FG015|NOT COMPLETED|Period 3||0
10090309|NCT02323334|11218851|FG016|NOT COMPLETED|Period 3||0
10090310|NCT02323334|11218835|FG000|STARTED|Period 4||3
10090311|NCT02323334|11218836|FG001|STARTED|Period 4||4
10090312|NCT02323334|11218837|FG002|STARTED|Period 4||3
10090313|NCT02323334|11218838|FG003|STARTED|Period 4||4
10090314|NCT02323334|11218839|FG004|STARTED|Period 4||4
10090315|NCT02323334|11218840|FG005|STARTED|Period 4||4
10090316|NCT02323334|11218841|FG006|STARTED|Period 4||0
10090317|NCT02323334|11218842|FG007|STARTED|Period 4||0
10090318|NCT02323334|11218843|FG008|STARTED|Period 4||0
10090319|NCT02323334|11218844|FG009|STARTED|Period 4||0
10090320|NCT02323334|11218845|FG010|STARTED|Period 4||0
10090321|NCT02323334|11218846|FG011|STARTED|Period 4||0
10090322|NCT02323334|11218847|FG012|STARTED|Period 4||0
10090323|NCT02323334|11218848|FG013|STARTED|Period 4||0
10090324|NCT02323334|11218849|FG014|STARTED|Period 4||0
10090325|NCT02323334|11218850|FG015|STARTED|Period 4||0
10090326|NCT02323334|11218851|FG016|STARTED|Period 4||0
10090327|NCT02323334|11218835|FG000|COMPLETED|Period 4||3
10090328|NCT02323334|11218836|FG001|COMPLETED|Period 4||4
10090329|NCT02323334|11218837|FG002|COMPLETED|Period 4||3
10090330|NCT02323334|11218838|FG003|COMPLETED|Period 4||4
10090331|NCT02323334|11218839|FG004|COMPLETED|Period 4||4
10090332|NCT02323334|11218840|FG005|COMPLETED|Period 4||4
10090333|NCT02323334|11218841|FG006|COMPLETED|Period 4||0
10090334|NCT02323334|11218842|FG007|COMPLETED|Period 4||0
10090335|NCT02323334|11218843|FG008|COMPLETED|Period 4||0
10090336|NCT02323334|11218844|FG009|COMPLETED|Period 4||0
10090337|NCT02323334|11218845|FG010|COMPLETED|Period 4||0
10090338|NCT02323334|11218846|FG011|COMPLETED|Period 4||0
9739428|NCT00228943|10840437|FG000|STARTED|Week 2||28
10090339|NCT02323334|11218847|FG012|COMPLETED|Period 4||0
10090340|NCT02323334|11218848|FG013|COMPLETED|Period 4||0
10090341|NCT02323334|11218849|FG014|COMPLETED|Period 4||0
10090342|NCT02323334|11218850|FG015|COMPLETED|Period 4||0
10090343|NCT02323334|11218851|FG016|COMPLETED|Period 4||0
10090344|NCT02323334|11218835|FG000|NOT COMPLETED|Period 4||0
9739429|NCT00228943|10840437|FG000|COMPLETED|Week 2||27
10090345|NCT02323334|11218836|FG001|NOT COMPLETED|Period 4||0
10090346|NCT02323334|11218837|FG002|NOT COMPLETED|Period 4||0
9739430|NCT00228943|10840437|FG000|NOT COMPLETED|Week 2||1
9739431|NCT00229203|10840445|FG000|STARTED|Overall Study||32
9739432|NCT00229203|10840446|FG001|STARTED|Overall Study||19
9739433|NCT00229203|10840445|FG000|COMPLETED|Overall Study||0
9739434|NCT00229203|10840446|FG001|COMPLETED|Overall Study||0
9739435|NCT00229203|10840445|FG000|NOT COMPLETED|Overall Study||32
9739436|NCT00229203|10840446|FG001|NOT COMPLETED|Overall Study||19
9739437|NCT00229619|10840452|FG000|STARTED|Overall Study||11
10090347|NCT02323334|11218838|FG003|NOT COMPLETED|Period 4||0
10090348|NCT02323334|11218839|FG004|NOT COMPLETED|Period 4||0
10090349|NCT02323334|11218840|FG005|NOT COMPLETED|Period 4||0
10090350|NCT02323334|11218841|FG006|NOT COMPLETED|Period 4||0
10090351|NCT02323334|11218842|FG007|NOT COMPLETED|Period 4||0
10090352|NCT02323334|11218843|FG008|NOT COMPLETED|Period 4||0
10090353|NCT02323334|11218844|FG009|NOT COMPLETED|Period 4||0
10090354|NCT02323334|11218845|FG010|NOT COMPLETED|Period 4||0
10090355|NCT02323334|11218846|FG011|NOT COMPLETED|Period 4||0
10090356|NCT02323334|11218847|FG012|NOT COMPLETED|Period 4||0
10090357|NCT02323334|11218848|FG013|NOT COMPLETED|Period 4||0
10090358|NCT02323334|11218849|FG014|NOT COMPLETED|Period 4||0
10090359|NCT02323334|11218850|FG015|NOT COMPLETED|Period 4||0
10090360|NCT02323334|11218851|FG016|NOT COMPLETED|Period 4||0
10090361|NCT02323646|11218916|FG000|STARTED|Treatment Course 1||14
10090362|NCT02323646|11218917|FG001|STARTED|Treatment Course 1||13
10090363|NCT02323646|11218918|FG002|STARTED|Treatment Course 1||15
10090364|NCT02323646|11218916|FG000|COMPLETED|Treatment Course 1||11
10090365|NCT02323646|11218917|FG001|COMPLETED|Treatment Course 1||10
10090366|NCT02323646|11218918|FG002|COMPLETED|Treatment Course 1||12
10090367|NCT02323646|11218916|FG000|NOT COMPLETED|Treatment Course 1||3
10090368|NCT02323646|11218917|FG001|NOT COMPLETED|Treatment Course 1||3
10090369|NCT02323646|11218918|FG002|NOT COMPLETED|Treatment Course 1||3
10090370|NCT02323646|11218916|FG000|STARTED|Treatment Course 2||11
10090371|NCT02323646|11218917|FG001|STARTED|Treatment Course 2||10
10090372|NCT02323646|11218918|FG002|STARTED|Treatment Course 2||12
10090373|NCT02323646|11218916|FG000|COMPLETED|Treatment Course 2||10
10090374|NCT02323646|11218917|FG001|COMPLETED|Treatment Course 2||9
10090375|NCT02323646|11218918|FG002|COMPLETED|Treatment Course 2||9
10090376|NCT02323646|11218916|FG000|NOT COMPLETED|Treatment Course 2||1
10090377|NCT02323646|11218917|FG001|NOT COMPLETED|Treatment Course 2||1
10090378|NCT02323646|11218918|FG002|NOT COMPLETED|Treatment Course 2||3
10090379|NCT02323854|11218926|FG000|STARTED|Overall Study||15
10090380|NCT02323854|11218926|FG000|COMPLETED|Overall Study||15
10090381|NCT02323854|11218926|FG000|NOT COMPLETED|Overall Study||0
10090382|NCT02324049|11218930|FG000|STARTED|Part A||11
10090383|NCT02324049|11218930|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
10090384|NCT02324049|11218930|FG000|COMPLETED|Part A||11
10090385|NCT02324049|11218930|FG000|NOT COMPLETED|Part A||0
10090386|NCT02324049|11218930|FG000|STARTED|Part B||11
10090387|NCT02324049|11218930|FG000|Safety Analysis Set|Part B||11
10090388|NCT02324049|11218930|FG000|COMPLETED|Part B||11
10090389|NCT02324049|11218930|FG000|NOT COMPLETED|Part B||0
10090390|NCT02324049|11218930|FG000|STARTED|Part C||11
10090391|NCT02324049|11218930|FG000|Safety Analysis Set|Part C||11
10090392|NCT02324049|11218930|FG000|COMPLETED|Part C||0
10090393|NCT02324049|11218930|FG000|NOT COMPLETED|Part C||11
10090394|NCT02324075|11218936|FG000|STARTED|Overall Study||612
10090395|NCT02324075|11218937|FG001|STARTED|Overall Study||614
10090396|NCT02324075|11218936|FG000|COMPLETED|Overall Study||609
10090397|NCT02324075|11218937|FG001|COMPLETED|Overall Study||605
10090398|NCT02324075|11218936|FG000|NOT COMPLETED|Overall Study||3
10090399|NCT02324075|11218937|FG001|NOT COMPLETED|Overall Study||9
10090400|NCT02324153|11218946|FG000|STARTED|Overall Study||41
10090401|NCT02324153|11218947|FG001|STARTED|Overall Study||39
10090402|NCT02324153|11218946|FG000|COMPLETED|Overall Study||33
10090403|NCT02324153|11218947|FG001|COMPLETED|Overall Study||38
10090404|NCT02324153|11218946|FG000|NOT COMPLETED|Overall Study||8
10090405|NCT02324153|11218947|FG001|NOT COMPLETED|Overall Study||1
10090406|NCT02324205|11218953|FG000|STARTED|Overall Study||196
10090407|NCT02324205|11218953|FG000|COMPLETED|Overall Study||159
10090408|NCT02324205|11218953|FG000|NOT COMPLETED|Overall Study||37
10090409|NCT02324270|11218960|FG000|STARTED|Overall Study||218
10090410|NCT02324270|11218961|FG001|STARTED|Overall Study||219
10090411|NCT02324270|11218962|FG002|STARTED|Overall Study||221
9739438|NCT00229619|10840452|FG000|COMPLETED|Overall Study||11
9739439|NCT00229619|10840452|FG000|NOT COMPLETED|Overall Study||0
10090412|NCT02324270|11218960|FG000|Safety Population|Overall Study||214
10090413|NCT02324270|11218961|FG001|Safety Population|Overall Study||216
10090414|NCT02324270|11218962|FG002|Safety Population|Overall Study||217
10090415|NCT02324270|11218960|FG000|mITT Population|Overall Study||214
10090416|NCT02324270|11218961|FG001|mITT Population|Overall Study||216
10090417|NCT02324270|11218962|FG002|mITT Population|Overall Study||217
10090418|NCT02324270|11218960|FG000|PP Population|Overall Study||180
10090419|NCT02324270|11218961|FG001|PP Population|Overall Study||177
10090420|NCT02324270|11218962|FG002|PP Population|Overall Study||171
10090421|NCT02324270|11218960|FG000|COMPLETED|Overall Study||213
10090422|NCT02324270|11218961|FG001|COMPLETED|Overall Study||212
10090423|NCT02324270|11218962|FG002|COMPLETED|Overall Study||216
10090424|NCT02324270|11218960|FG000|NOT COMPLETED|Overall Study||5
10090425|NCT02324270|11218961|FG001|NOT COMPLETED|Overall Study||7
10090426|NCT02324270|11218962|FG002|NOT COMPLETED|Overall Study||5
10090427|NCT02324335|11218972|FG000|STARTED|Overall Study||30
9739440|NCT00229658|10840460|FG000|STARTED|Overall Study||766
10090428|NCT02324335|11218973|FG001|STARTED|Overall Study||29
10090429|NCT02324335|11218972|FG000|COMPLETED|Overall Study||21
10090430|NCT02324335|11218973|FG001|COMPLETED|Overall Study||20
10090431|NCT02324335|11218972|FG000|NOT COMPLETED|Overall Study||9
10090432|NCT02324335|11218973|FG001|NOT COMPLETED|Overall Study||9
10090433|NCT02324361|11218981|FG000|STARTED|Overall Study||24
10090434|NCT02324361|11218982|FG001|STARTED|Overall Study||24
10090435|NCT02324361|11218981|FG000|COMPLETED|Overall Study||19
10090436|NCT02324361|11218982|FG001|COMPLETED|Overall Study||22
10090437|NCT02324361|11218981|FG000|NOT COMPLETED|Overall Study||5
10090438|NCT02324361|11218982|FG001|NOT COMPLETED|Overall Study||2
10090439|NCT02324465|11218990|FG000|STARTED|Overall Study||18
10090440|NCT02324465|11218991|FG001|STARTED|Overall Study||22
10090441|NCT02324465|11218990|FG000|COMPLETED|Overall Study||18
10090442|NCT02324465|11218991|FG001|COMPLETED|Overall Study||21
10090443|NCT02324465|11218990|FG000|NOT COMPLETED|Overall Study||0
10090444|NCT02324465|11218991|FG001|NOT COMPLETED|Overall Study||1
10090445|NCT02324504|11218997|FG000|STARTED|Overall Study||60
10090446|NCT02324504|11218997|FG000|COMPLETED|Overall Study||60
10090447|NCT02324504|11218997|FG000|NOT COMPLETED|Overall Study||0
10090448|NCT02324543|11219010|FG000|STARTED|Overall Study||6
10090449|NCT02324543|11219011|FG001|STARTED|Overall Study||6
10090450|NCT02324543|11219012|FG002|STARTED|Overall Study||3
10090451|NCT02324543|11219013|FG003|STARTED|Overall Study||4
10090452|NCT02324543|11219014|FG004|STARTED|Overall Study||4
10090453|NCT02324543|11219015|FG005|STARTED|Overall Study||24
10090454|NCT02324543|11219010|FG000|COMPLETED|Overall Study||6
10090455|NCT02324543|11219011|FG001|COMPLETED|Overall Study||6
10090456|NCT02324543|11219012|FG002|COMPLETED|Overall Study||3
10090457|NCT02324543|11219013|FG003|COMPLETED|Overall Study||4
10090458|NCT02324543|11219014|FG004|COMPLETED|Overall Study||4
10090459|NCT02324543|11219015|FG005|COMPLETED|Overall Study||24
10090460|NCT02324543|11219010|FG000|NOT COMPLETED|Overall Study||0
10090461|NCT02324543|11219011|FG001|NOT COMPLETED|Overall Study||0
10090462|NCT02324543|11219012|FG002|NOT COMPLETED|Overall Study||0
10090463|NCT02324543|11219013|FG003|NOT COMPLETED|Overall Study||0
10090464|NCT02324543|11219014|FG004|NOT COMPLETED|Overall Study||0
10090465|NCT02324543|11219015|FG005|NOT COMPLETED|Overall Study||0
10090466|NCT02324569|11219027|FG000|STARTED|Overall Study||116
10090467|NCT02324569|11219028|FG001|STARTED|Overall Study||124
10090468|NCT02324569|11219027|FG000|COMPLETED|Overall Study||100
10090469|NCT02324569|11219028|FG001|COMPLETED|Overall Study||103
10090470|NCT02324569|11219027|FG000|NOT COMPLETED|Overall Study||16
10090471|NCT02324569|11219028|FG001|NOT COMPLETED|Overall Study||21
10090472|NCT02324660|11219034|FG000|STARTED|Overall Study||169
10090473|NCT02324660|11219034|FG000|COMPLETED|Overall Study||137
10090474|NCT02324660|11219034|FG000|NOT COMPLETED|Overall Study||32
10090475|NCT02324673|11219042|FG000|STARTED|Overall Study||20
10090476|NCT02324673|11219043|FG001|STARTED|Overall Study||20
10090477|NCT02324673|11219044|FG002|STARTED|Overall Study||21
10090478|NCT02324673|11219042|FG000|COMPLETED|Overall Study||20
10090479|NCT02324673|11219043|FG001|COMPLETED|Overall Study||20
10090480|NCT02324673|11219044|FG002|COMPLETED|Overall Study||21
10090481|NCT02324673|11219042|FG000|NOT COMPLETED|Overall Study||0
10090482|NCT02324673|11219043|FG001|NOT COMPLETED|Overall Study||0
10090483|NCT02324673|11219044|FG002|NOT COMPLETED|Overall Study||0
10090484|NCT02324699|11219052|FG000|STARTED|Overall Study||1
10090485|NCT02324699|11219052|FG000|COMPLETED|Overall Study||0
10090486|NCT02324699|11219052|FG000|NOT COMPLETED|Overall Study||1
10090487|NCT02324842|11219059|FG000|STARTED|Overall Study||15
10090488|NCT02324842|11219060|FG001|STARTED|Overall Study||15
10090489|NCT02324842|11219061|FG002|STARTED|Overall Study||15
10090490|NCT02324842|11219059|FG000|COMPLETED|Overall Study||14
10090491|NCT02324842|11219060|FG001|COMPLETED|Overall Study||14
10090492|NCT02324842|11219061|FG002|COMPLETED|Overall Study||13
10090493|NCT02324842|11219059|FG000|NOT COMPLETED|Overall Study||1
10090494|NCT02324842|11219060|FG001|NOT COMPLETED|Overall Study||1
10090495|NCT02324842|11219061|FG002|NOT COMPLETED|Overall Study||2
10090496|NCT02324920|11219071|FG000|STARTED|Overall Study||64
10090497|NCT02324920|11219072|FG001|STARTED|Overall Study||64
10090498|NCT02324920|11219071|FG000|COMPLETED|Overall Study||63
10090499|NCT02324920|11219072|FG001|COMPLETED|Overall Study||64
10090500|NCT02324920|11219071|FG000|NOT COMPLETED|Overall Study||1
10090501|NCT02324920|11219072|FG001|NOT COMPLETED|Overall Study||0
10090502|NCT02324972|11219080|FG000|STARTED|Overall Study||26
10090503|NCT02324972|11219081|FG001|STARTED|Overall Study||28
10090504|NCT02324972|11219080|FG000|COMPLETED|Overall Study||19
10090505|NCT02324972|11219081|FG001|COMPLETED|Overall Study||23
10090506|NCT02324972|11219080|FG000|NOT COMPLETED|Overall Study||7
10090507|NCT02324972|11219081|FG001|NOT COMPLETED|Overall Study||5
10090508|NCT02325219|11219090|FG000|STARTED|Controlled Period (Week 0 - 16)||64
10090509|NCT02325219|11219091|FG001|STARTED|Controlled Period (Week 0 - 16)||65
10090510|NCT02325219|11219092|FG002|STARTED|Controlled Period (Week 0 - 16)||63
10090511|NCT02325219|11219093|FG003|STARTED|Controlled Period (Week 0 - 16)||0
10090512|NCT02325219|11219094|FG004|STARTED|Controlled Period (Week 0 - 16)||0
10090513|NCT02325219|11219090|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52
10090514|NCT02325219|11219091|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63
10090515|NCT02325219|11219092|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62
10090516|NCT02325219|11219093|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0
10090517|NCT02325219|11219094|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0
10090518|NCT02325219|11219090|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
9739441|NCT00229658|10840461|FG001|STARTED|Overall Study||531
9739442|NCT00229658|10840460|FG000|COMPLETED|Overall Study||541
9739443|NCT00229658|10840461|FG001|COMPLETED|Overall Study||364
9739444|NCT00229658|10840460|FG000|NOT COMPLETED|Overall Study||225
9739445|NCT00229658|10840461|FG001|NOT COMPLETED|Overall Study||167
9739446|NCT00229723|10840474|FG000|STARTED|Concomitant Phase|Received randomized treatment|60
9739447|NCT00229723|10840475|FG001|STARTED|Concomitant Phase|Received randomized treatment|24
9739448|NCT00229723|10840476|FG002|STARTED|Concomitant Phase|Received randomized treatment|31
9739449|NCT00229723|10840477|FG003|STARTED|Concomitant Phase|Received randomized treatment|31
9739450|NCT00229723|10840478|FG004|STARTED|Concomitant Phase|Received randomized treatment|24
9739451|NCT00229723|10840479|FG005|STARTED|Concomitant Phase|Received randomized treatment|34
9739452|NCT00229723|10840480|FG006|STARTED|Concomitant Phase|Received randomized treatment|22
9739453|NCT00229723|10840474|FG000|COMPLETED|Concomitant Phase||50
9739454|NCT00229723|10840475|FG001|COMPLETED|Concomitant Phase||19
9739455|NCT00229723|10840476|FG002|COMPLETED|Concomitant Phase||25
9739456|NCT00229723|10840477|FG003|COMPLETED|Concomitant Phase||26
9739457|NCT00229723|10840478|FG004|COMPLETED|Concomitant Phase||22
9739458|NCT00229723|10840479|FG005|COMPLETED|Concomitant Phase||31
9739459|NCT00229723|10840480|FG006|COMPLETED|Concomitant Phase||19
9739460|NCT00229723|10840474|FG000|NOT COMPLETED|Concomitant Phase||10
9739461|NCT00229723|10840475|FG001|NOT COMPLETED|Concomitant Phase||5
9739462|NCT00229723|10840476|FG002|NOT COMPLETED|Concomitant Phase||6
9739463|NCT00229723|10840477|FG003|NOT COMPLETED|Concomitant Phase||5
9739464|NCT00229723|10840478|FG004|NOT COMPLETED|Concomitant Phase||2
9739465|NCT00229723|10840479|FG005|NOT COMPLETED|Concomitant Phase||3
9739466|NCT00229723|10840480|FG006|NOT COMPLETED|Concomitant Phase||3
9739467|NCT00229723|10840474|FG000|STARTED|Maintenance Phase||50
9739468|NCT00229723|10840475|FG001|STARTED|Maintenance Phase||19
9739469|NCT00229723|10840476|FG002|STARTED|Maintenance Phase||25
9739470|NCT00229723|10840477|FG003|STARTED|Maintenance Phase||26
9739471|NCT00229723|10840478|FG004|STARTED|Maintenance Phase||22
9739472|NCT00229723|10840479|FG005|STARTED|Maintenance Phase||31
9739473|NCT00229723|10840480|FG006|STARTED|Maintenance Phase||19
9739474|NCT00229723|10840474|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
9739475|NCT00229723|10840475|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
9739476|NCT00229723|10840476|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
9739477|NCT00229723|10840477|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
9739478|NCT00229723|10840478|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
9739479|NCT00229723|10840479|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
9739480|NCT00229723|10840480|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
9739481|NCT00229723|10840474|FG000|NOT COMPLETED|Maintenance Phase||25
9739482|NCT00229723|10840475|FG001|NOT COMPLETED|Maintenance Phase||14
10090519|NCT02325219|11219091|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
10090520|NCT02325219|11219092|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
9739483|NCT00229723|10840476|FG002|NOT COMPLETED|Maintenance Phase||9
9739484|NCT00229723|10840477|FG003|NOT COMPLETED|Maintenance Phase||17
9739485|NCT00229723|10840478|FG004|NOT COMPLETED|Maintenance Phase||15
9739486|NCT00229723|10840479|FG005|NOT COMPLETED|Maintenance Phase||19
9739487|NCT00229723|10840480|FG006|NOT COMPLETED|Maintenance Phase||10
9739488|NCT00229957|10840498|FG000|STARTED|Overall Study||152
9739489|NCT00229957|10840499|FG001|STARTED|Overall Study||151
9739490|NCT00229957|10840498|FG000|COMPLETED|Overall Study||132
9739491|NCT00229957|10840499|FG001|COMPLETED|Overall Study||139
9739492|NCT00229957|10840498|FG000|NOT COMPLETED|Overall Study||20
9739493|NCT00229957|10840499|FG001|NOT COMPLETED|Overall Study||12
9739494|NCT00230009|10840507|FG000|STARTED|Single Session Intervention/Control||50
9739495|NCT00230009|10840508|FG001|STARTED|Single Session Intervention/Control||50
9739496|NCT00230009|10840507|FG000|COMPLETED|Single Session Intervention/Control||50
9739497|NCT00230009|10840508|FG001|COMPLETED|Single Session Intervention/Control||50
9739498|NCT00230009|10840507|FG000|NOT COMPLETED|Single Session Intervention/Control||0
9739499|NCT00230009|10840508|FG001|NOT COMPLETED|Single Session Intervention/Control||0
9739500|NCT00230009|10840507|FG000|STARTED|Follow-up||50
9739501|NCT00230009|10840508|FG001|STARTED|Follow-up||50
9739502|NCT00230009|10840507|FG000|COMPLETED|Follow-up||19
9739503|NCT00230009|10840508|FG001|COMPLETED|Follow-up||24
9739504|NCT00230009|10840507|FG000|NOT COMPLETED|Follow-up||31
9739505|NCT00230009|10840508|FG001|NOT COMPLETED|Follow-up||26
9739506|NCT00230022|10840516|FG000|STARTED|Overall Study||15
9739507|NCT00230022|10840517|FG001|STARTED|Overall Study||15
9739508|NCT00230022|10840516|FG000|COMPLETED|Overall Study||15
9739509|NCT00230022|10840517|FG001|COMPLETED|Overall Study||15
9739510|NCT00230022|10840516|FG000|NOT COMPLETED|Overall Study||0
9739511|NCT00230022|10840517|FG001|NOT COMPLETED|Overall Study||0
9739512|NCT00230048|10840525|FG000|STARTED|Overall Study||52
9739513|NCT00230048|10840526|FG001|STARTED|Overall Study||55
9739514|NCT00230048|10840525|FG000|Completed Intervention/Control Session|Overall Study||52
9739515|NCT00230048|10840526|FG001|Completed Intervention/Control Session|Overall Study||55
9739516|NCT00230048|10840525|FG000|COMPLETED|Overall Study||39
9739517|NCT00230048|10840526|FG001|COMPLETED|Overall Study||37
9739518|NCT00230048|10840525|FG000|NOT COMPLETED|Overall Study||13
9739519|NCT00230048|10840526|FG001|NOT COMPLETED|Overall Study||18
9739520|NCT00230100|10840536|FG000|STARTED|Overall Study||29
9739521|NCT00230100|10840537|FG001|STARTED|Overall Study||17
9739522|NCT00230100|10840536|FG000|COMPLETED|Overall Study||29
9739523|NCT00230100|10840537|FG001|COMPLETED|Overall Study||17
9739524|NCT00230100|10840536|FG000|NOT COMPLETED|Overall Study||0
9739525|NCT00230100|10840537|FG001|NOT COMPLETED|Overall Study||0
9739526|NCT00230126|10840545|FG000|STARTED|Overall Study||30
9739527|NCT00230126|10840546|FG001|STARTED|Overall Study||28
9739528|NCT00230126|10840545|FG000|COMPLETED|Overall Study||28
9739529|NCT00230126|10840546|FG001|COMPLETED|Overall Study||27
9739530|NCT00230126|10840545|FG000|NOT COMPLETED|Overall Study||2
9739531|NCT00230126|10840546|FG001|NOT COMPLETED|Overall Study||1
9739532|NCT00230178|10840557|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
9739533|NCT00230178|10840558|FG001|STARTED|Overall Study||93
9739534|NCT00230178|10840559|FG002|STARTED|Overall Study||93
9739535|NCT00230178|10840557|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
9739536|NCT00230178|10840558|FG001|Treated|Overall Study||92
9739537|NCT00230178|10840559|FG002|Treated|Overall Study||91
9739538|NCT00230178|10840557|FG000|COMPLETED|Overall Study||90
9739539|NCT00230178|10840558|FG001|COMPLETED|Overall Study||86
9739540|NCT00230178|10840559|FG002|COMPLETED|Overall Study||86
9739541|NCT00230178|10840557|FG000|NOT COMPLETED|Overall Study||4
10090521|NCT02325219|11219093|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
10090522|NCT02325219|11219094|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
10090523|NCT02325219|11219090|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
10090524|NCT02325219|11219091|FG001|STARTED|After Controlled Period (Week 16 - 52)||63
10090525|NCT02325219|11219092|FG002|STARTED|After Controlled Period (Week 16 - 52)||62
10090526|NCT02325219|11219093|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
10090527|NCT02325219|11219094|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
10090528|NCT02325219|11219090|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
10090529|NCT02325219|11219091|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60
10090530|NCT02325219|11219092|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62
10090531|NCT02325219|11219093|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26
10090532|NCT02325219|11219094|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25
10090533|NCT02325219|11219090|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10090534|NCT02325219|11219091|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
10090535|NCT02325219|11219092|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10090536|NCT02325219|11219093|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10090537|NCT02325219|11219094|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
10090538|NCT02325401|11219110|FG000|STARTED|Overall Study||6
10090539|NCT02325401|11219111|FG001|STARTED|Overall Study||9
10090540|NCT02325401|11219112|FG002|STARTED|Overall Study||5
10090541|NCT02325401|11219110|FG000|COMPLETED|Overall Study||6
10090542|NCT02325401|11219111|FG001|COMPLETED|Overall Study||8
10090543|NCT02325401|11219112|FG002|COMPLETED|Overall Study||4
10090544|NCT02325401|11219110|FG000|NOT COMPLETED|Overall Study||0
10090545|NCT02325401|11219111|FG001|NOT COMPLETED|Overall Study||1
10090546|NCT02325401|11219112|FG002|NOT COMPLETED|Overall Study||1
10090547|NCT02325414|11219128|FG000|STARTED|Overall Study||30
10090548|NCT02325414|11219129|FG001|STARTED|Overall Study||30
10090549|NCT02325414|11219128|FG000|COMPLETED|Overall Study||22
10090550|NCT02325414|11219129|FG001|COMPLETED|Overall Study||24
10090551|NCT02325414|11219128|FG000|NOT COMPLETED|Overall Study||8
10090552|NCT02325414|11219129|FG001|NOT COMPLETED|Overall Study||6
10090553|NCT02325518|11219139|FG000|STARTED|Overall Study||98
10090554|NCT02325518|11219140|FG001|STARTED|Overall Study||103
10090555|NCT02325518|11219139|FG000|Safety Set|Overall Study||98
10090556|NCT02325518|11219140|FG001|Safety Set|Overall Study||103
10090557|NCT02325518|11219139|FG000|Full Analysis Set (FAS)|Overall Study||98
9739542|NCT00230178|10840558|FG001|NOT COMPLETED|Overall Study||7
9739543|NCT00230178|10840559|FG002|NOT COMPLETED|Overall Study||7
9739544|NCT00230282|10840567|FG000|STARTED|Fludarabine + Cyclophosphamide||25
9739545|NCT00230282|10840567|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17
9739546|NCT00230282|10840567|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
9739547|NCT00230282|10840567|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17
9739548|NCT00230282|10840567|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17
9739549|NCT00230282|10840567|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
9739550|NCT00230737|10840574|FG000|STARTED|Overall Study||9
9739551|NCT00230737|10840575|FG001|STARTED|Overall Study||10
9739552|NCT00230737|10840576|FG002|STARTED|Overall Study||8
9739553|NCT00230737|10840574|FG000|COMPLETED|Overall Study||9
9739554|NCT00230737|10840575|FG001|COMPLETED|Overall Study||10
10090558|NCT02325518|11219140|FG001|Full Analysis Set (FAS)|Overall Study||101
10090559|NCT02325518|11219139|FG000|Per Protocol Set (PPS)|Overall Study||92
10090560|NCT02325518|11219140|FG001|Per Protocol Set (PPS)|Overall Study||97
10090561|NCT02325518|11219139|FG000|COMPLETED|Overall Study||94
10090562|NCT02325518|11219140|FG001|COMPLETED|Overall Study||100
9739555|NCT00230737|10840576|FG002|COMPLETED|Overall Study||8
9739556|NCT00230737|10840574|FG000|NOT COMPLETED|Overall Study||0
9739557|NCT00230737|10840575|FG001|NOT COMPLETED|Overall Study||0
9739558|NCT00230737|10840576|FG002|NOT COMPLETED|Overall Study||0
9739559|NCT00230802|10840586|FG000|STARTED|Overall Study||25
9739560|NCT00230802|10840587|FG001|STARTED|Overall Study||23
9739561|NCT00230802|10840586|FG000|COMPLETED|Overall Study||25
9739562|NCT00230802|10840587|FG001|COMPLETED|Overall Study||23
9739563|NCT00230802|10840586|FG000|NOT COMPLETED|Overall Study||0
9739564|NCT00230802|10840587|FG001|NOT COMPLETED|Overall Study||0
9739565|NCT00230971|10840597|FG000|STARTED|Randomization||235
9739566|NCT00230971|10840598|FG001|STARTED|Randomization||238
9739567|NCT00230971|10840597|FG000|COMPLETED|Randomization||232
9739568|NCT00230971|10840598|FG001|COMPLETED|Randomization||235
9739569|NCT00230971|10840597|FG000|NOT COMPLETED|Randomization||3
9739570|NCT00230971|10840598|FG001|NOT COMPLETED|Randomization||3
9739571|NCT00230971|10840597|FG000|STARTED|Baseline Participants||232
9739572|NCT00230971|10840598|FG001|STARTED|Baseline Participants||235
9739573|NCT00230971|10840597|FG000|COMPLETED|Baseline Participants||210
9739574|NCT00230971|10840598|FG001|COMPLETED|Baseline Participants||216
9739575|NCT00230971|10840597|FG000|NOT COMPLETED|Baseline Participants||22
9739576|NCT00230971|10840598|FG001|NOT COMPLETED|Baseline Participants||19
9739577|NCT00231062|10840604|FG000|STARTED|Overall Study||115
9739578|NCT00231062|10840604|FG000|COMPLETED|Overall Study||109
9739579|NCT00231062|10840604|FG000|NOT COMPLETED|Overall Study||6
9739580|NCT00231114|10840610|FG000|STARTED|Randomized||196
9739581|NCT00231114|10840611|FG001|STARTED|Randomized||101
9739582|NCT00231114|10840610|FG000|COMPLETED|Randomized||190
9739583|NCT00231114|10840611|FG001|COMPLETED|Randomized||98
9739584|NCT00231114|10840610|FG000|NOT COMPLETED|Randomized||6
9739585|NCT00231114|10840611|FG001|NOT COMPLETED|Randomized||3
9739586|NCT00231114|10840610|FG000|STARTED|Treatment Period||190
9739587|NCT00231114|10840611|FG001|STARTED|Treatment Period||98
10090563|NCT02325518|11219139|FG000|NOT COMPLETED|Overall Study||4
10090564|NCT02325518|11219140|FG001|NOT COMPLETED|Overall Study||3
9739588|NCT00231114|10840610|FG000|COMPLETED|Treatment Period||189
9739589|NCT00231114|10840611|FG001|COMPLETED|Treatment Period||98
9739590|NCT00231114|10840610|FG000|NOT COMPLETED|Treatment Period||1
9739591|NCT00231114|10840611|FG001|NOT COMPLETED|Treatment Period||0
9739592|NCT00231114|10840610|FG000|STARTED|Post-Treatment Period||189
9739593|NCT00231114|10840611|FG001|STARTED|Post-Treatment Period||98
9739594|NCT00231114|10840610|FG000|COMPLETED|Post-Treatment Period||181
9739595|NCT00231114|10840611|FG001|COMPLETED|Post-Treatment Period||97
9739596|NCT00231114|10840610|FG000|NOT COMPLETED|Post-Treatment Period||8
9739597|NCT00231114|10840611|FG001|NOT COMPLETED|Post-Treatment Period||1
9739598|NCT00231179|10840621|FG000|STARTED|Overall Study||152
9739599|NCT00231179|10840622|FG001|STARTED|Overall Study||150
9739600|NCT00231179|10840621|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
9739601|NCT00231179|10840622|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
9739602|NCT00231179|10840621|FG000|NOT COMPLETED|Overall Study||24
9739603|NCT00231179|10840622|FG001|NOT COMPLETED|Overall Study||24
9739604|NCT00231283|10840628|FG000|STARTED|Overall Study||100
9739605|NCT00231283|10840628|FG000|COMPLETED|Overall Study||95
9739606|NCT00231283|10840628|FG000|NOT COMPLETED|Overall Study||5
9739607|NCT00231309|10840632|FG000|STARTED|Overall Study||10
9739608|NCT00231309|10840632|FG000|COMPLETED|Overall Study||10
9739609|NCT00231309|10840632|FG000|NOT COMPLETED|Overall Study||0
9739610|NCT00231413|10840644|FG000|STARTED|Overall Study||88
9739611|NCT00231413|10840645|FG001|STARTED|Overall Study||50
9739612|NCT00231413|10840646|FG002|STARTED|Overall Study||49
9739613|NCT00231413|10840647|FG003|STARTED|Overall Study||48
9739614|NCT00231413|10840648|FG004|STARTED|Overall Study||48
9739615|NCT00231413|10840649|FG005|STARTED|Overall Study||50
9739616|NCT00231413|10840650|FG006|STARTED|Overall Study||50
9739617|NCT00231413|10840644|FG000|COMPLETED|Overall Study||80
9739618|NCT00231413|10840645|FG001|COMPLETED|Overall Study||45
9739619|NCT00231413|10840646|FG002|COMPLETED|Overall Study||42
9739620|NCT00231413|10840647|FG003|COMPLETED|Overall Study||45
9739621|NCT00231413|10840648|FG004|COMPLETED|Overall Study||45
9739622|NCT00231413|10840649|FG005|COMPLETED|Overall Study||45
9739623|NCT00231413|10840650|FG006|COMPLETED|Overall Study||46
9739624|NCT00231413|10840644|FG000|NOT COMPLETED|Overall Study||8
9739625|NCT00231413|10840645|FG001|NOT COMPLETED|Overall Study||5
9739626|NCT00231413|10840646|FG002|NOT COMPLETED|Overall Study||7
9739627|NCT00231413|10840647|FG003|NOT COMPLETED|Overall Study||3
9739628|NCT00231413|10840648|FG004|NOT COMPLETED|Overall Study||3
9739629|NCT00231413|10840649|FG005|NOT COMPLETED|Overall Study||5
9739630|NCT00231413|10840650|FG006|NOT COMPLETED|Overall Study||4
9739631|NCT00231465|10840666|FG000|STARTED|Overall Study||44
9739632|NCT00231465|10840666|FG000|COMPLETED|Overall Study||42
9739633|NCT00231465|10840666|FG000|NOT COMPLETED|Overall Study||2
9739634|NCT00231478|10840672|FG000|STARTED|Overall Study||87
10090565|NCT02325687|11219150|FG000|STARTED|Overall Study||16
9739635|NCT00231478|10840673|FG001|STARTED|Overall Study||84
9739636|NCT00231478|10840672|FG000|COMPLETED|Overall Study||79
9739637|NCT00231478|10840673|FG001|COMPLETED|Overall Study||78
9739638|NCT00231478|10840672|FG000|NOT COMPLETED|Overall Study||8
9739639|NCT00231478|10840673|FG001|NOT COMPLETED|Overall Study||6
9739640|NCT00231777|10840681|FG000|STARTED|Overall Study||170
9739641|NCT00231777|10840682|FG001|STARTED|Overall Study||46
9739642|NCT00231777|10840681|FG000|COMPLETED|Overall Study||164
9739643|NCT00231777|10840682|FG001|COMPLETED|Overall Study||44
9739644|NCT00231777|10840681|FG000|NOT COMPLETED|Overall Study||6
9739645|NCT00231777|10840682|FG001|NOT COMPLETED|Overall Study||2
9739646|NCT00231816|10840690|FG000|STARTED|Overall Study||382
9739647|NCT00231816|10840691|FG001|STARTED|Overall Study||381
9739648|NCT00231816|10840690|FG000|Vaccinated at Visit 1|Overall Study||382
9739649|NCT00231816|10840691|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
10090566|NCT02325687|11219151|FG001|STARTED|Overall Study||15
9739650|NCT00231816|10840690|FG000|Vaccinated at Visit 2|Overall Study||369
9739651|NCT00231816|10840691|FG001|Vaccinated at Visit 2|Overall Study||371
9739652|NCT00231816|10840690|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
9739653|NCT00231816|10840691|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
9739654|NCT00231816|10840690|FG000|NOT COMPLETED|Overall Study||16
10090567|NCT02325687|11219152|FG002|STARTED|Overall Study||19
10090568|NCT02325687|11219150|FG000|COMPLETED|Overall Study||12
10090569|NCT02325687|11219151|FG001|COMPLETED|Overall Study||12
10090570|NCT02325687|11219152|FG002|COMPLETED|Overall Study||13
10090571|NCT02325687|11219150|FG000|NOT COMPLETED|Overall Study||4
10090572|NCT02325687|11219151|FG001|NOT COMPLETED|Overall Study||3
10090573|NCT02325687|11219152|FG002|NOT COMPLETED|Overall Study||6
10090574|NCT02325713|11219176|FG000|STARTED|Intervention Period 1 (2 Days)||2
10090575|NCT02325713|11219177|FG001|STARTED|Intervention Period 1 (2 Days)||2
10090576|NCT02325713|11219178|FG002|STARTED|Intervention Period 1 (2 Days)||2
10090577|NCT02325713|11219179|FG003|STARTED|Intervention Period 1 (2 Days)||2
10090578|NCT02325713|11219180|FG004|STARTED|Intervention Period 1 (2 Days)||2
10090579|NCT02325713|11219181|FG005|STARTED|Intervention Period 1 (2 Days)||2
10090580|NCT02325713|11219182|FG006|STARTED|Intervention Period 1 (2 Days)||2
10090581|NCT02325713|11219183|FG007|STARTED|Intervention Period 1 (2 Days)||2
10090582|NCT02325713|11219184|FG008|STARTED|Intervention Period 1 (2 Days)||2
10090583|NCT02325713|11219185|FG009|STARTED|Intervention Period 1 (2 Days)||2
10090584|NCT02325713|11219186|FG010|STARTED|Intervention Period 1 (2 Days)||2
10090585|NCT02325713|11219187|FG011|STARTED|Intervention Period 1 (2 Days)||2
10090586|NCT02325713|11219188|FG012|STARTED|Intervention Period 1 (2 Days)||2
10201715|NCT03439189|11329087|FG000|COMPLETED|Overall Study||261
10201716|NCT03439189|11329087|FG000|NOT COMPLETED|Overall Study||82
10238666|NCT00491400|11370131|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
10238667|NCT00491400|11370130|FG000|COMPLETED|Overall Study||10
10238668|NCT00491400|11370131|FG001|COMPLETED|Overall Study||9
10238669|NCT00491400|11370130|FG000|NOT COMPLETED|Overall Study||5
10238670|NCT00491400|11370131|FG001|NOT COMPLETED|Overall Study||4
10238671|NCT00490776|11370139|FG000|STARTED|Overall Study||9
10238672|NCT00490776|11370139|FG000|COMPLETED|Overall Study||0
10238673|NCT00490776|11370139|FG000|NOT COMPLETED|Overall Study||9
10238674|NCT00487162|11370145|FG000|STARTED|Overall Study||30
10238675|NCT00487162|11370146|FG001|STARTED|Overall Study||26
10238676|NCT00487162|11370145|FG000|COMPLETED|Overall Study||28
10238677|NCT00487162|11370146|FG001|COMPLETED|Overall Study||21
10238678|NCT00487162|11370145|FG000|NOT COMPLETED|Overall Study||2
10238679|NCT00487162|11370146|FG001|NOT COMPLETED|Overall Study||5
10238680|NCT00487981|11370152|FG000|STARTED|Overall Study||1
10238681|NCT00487981|11370152|FG000|COMPLETED|Overall Study||0
10238682|NCT00487981|11370152|FG000|NOT COMPLETED|Overall Study||1
10238683|NCT00491387|11370156|FG000|STARTED|Overall Study||24
10238684|NCT00491387|11370156|FG000|Study Enrollment|Overall Study||24
10238685|NCT00491387|11370156|FG000|COMPLETED|Overall Study||4
10238686|NCT00491387|11370156|FG000|NOT COMPLETED|Overall Study||20
10238687|NCT00475332|11370160|FG000|STARTED|Overall Study||2
10238688|NCT00475332|11370160|FG000|COMPLETED|Overall Study||2
10238689|NCT00475332|11370160|FG000|NOT COMPLETED|Overall Study||0
10238690|NCT00483119|11370167|FG000|STARTED|Overall Study||5
10238691|NCT00483119|11370168|FG001|STARTED|Overall Study||4
10238692|NCT00483119|11370167|FG000|COMPLETED|Overall Study||4
10238693|NCT00483119|11370168|FG001|COMPLETED|Overall Study||3
10238694|NCT00483119|11370167|FG000|NOT COMPLETED|Overall Study||1
10238695|NCT00483119|11370168|FG001|NOT COMPLETED|Overall Study||1
10238696|NCT00487461|11370177|FG000|STARTED|Overall Study||2
10238697|NCT00487461|11370178|FG001|STARTED|Overall Study||12
10238698|NCT00487461|11370179|FG002|STARTED|Overall Study||11
10238699|NCT00487461|11370177|FG000|COMPLETED|Overall Study||2
10238700|NCT00487461|11370178|FG001|COMPLETED|Overall Study||10
10238701|NCT00487461|11370179|FG002|COMPLETED|Overall Study||7
9739655|NCT00231816|10840691|FG001|NOT COMPLETED|Overall Study||12
10090587|NCT02325713|11219189|FG013|STARTED|Intervention Period 1 (2 Days)||2
10090588|NCT02325713|11219190|FG014|STARTED|Intervention Period 1 (2 Days)||2
10090589|NCT02325713|11219191|FG015|STARTED|Intervention Period 1 (2 Days)||2
10090590|NCT02325713|11219176|FG000|COMPLETED|Intervention Period 1 (2 Days)||2
10090591|NCT02325713|11219177|FG001|COMPLETED|Intervention Period 1 (2 Days)||2
10090592|NCT02325713|11219178|FG002|COMPLETED|Intervention Period 1 (2 Days)||2
10238702|NCT00487461|11370177|FG000|NOT COMPLETED|Overall Study||0
10238703|NCT00487461|11370178|FG001|NOT COMPLETED|Overall Study||2
10238704|NCT00487461|11370179|FG002|NOT COMPLETED|Overall Study||4
10238705|NCT00484718|11370187|FG000|STARTED|Treatment Period 1 (2 Weeks)||1
10238706|NCT00484718|11370188|FG001|STARTED|Treatment Period 1 (2 Weeks)||1
10238707|NCT00484718|11370189|FG002|STARTED|Treatment Period 1 (2 Weeks)||1
10238708|NCT00484718|11370190|FG003|STARTED|Treatment Period 1 (2 Weeks)||1
10238709|NCT00484718|11370191|FG004|STARTED|Treatment Period 1 (2 Weeks)||1
10238710|NCT00484718|11370192|FG005|STARTED|Treatment Period 1 (2 Weeks)||1
10238711|NCT00484718|11370187|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1
10238712|NCT00484718|11370188|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1
10238713|NCT00484718|11370189|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1
10238714|NCT00484718|11370190|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1
10238715|NCT00484718|11370191|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1
10238716|NCT00484718|11370192|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1
9739656|NCT00231842|10840698|FG000|STARTED|Overall Study||30
9739657|NCT00231842|10840698|FG000|Initiated Therapy|Overall Study||27
9739658|NCT00231842|10840698|FG000|Completed First 3 Cycles|Overall Study||27
9739659|NCT00231842|10840698|FG000|Completed Prescribed RT|Overall Study||27
9739660|NCT00231842|10840698|FG000|Completed Full Prescribed Therapy|Overall Study||19
9739661|NCT00231842|10840698|FG000|COMPLETED|Overall Study||19
9739662|NCT00231842|10840698|FG000|NOT COMPLETED|Overall Study||11
9739663|NCT00231868|10840703|FG000|STARTED|Overall Study||81
9739664|NCT00231868|10840703|FG000|COMPLETED|Overall Study||65
9739665|NCT00231868|10840703|FG000|NOT COMPLETED|Overall Study||16
9739666|NCT00231894|10840709|FG000|STARTED|Overall Study||31
9739667|NCT00231894|10840710|FG001|STARTED|Overall Study||25
9739668|NCT00231894|10840709|FG000|COMPLETED|Overall Study||30
9739669|NCT00231894|10840710|FG001|COMPLETED|Overall Study||24
9739670|NCT00231894|10840709|FG000|NOT COMPLETED|Overall Study||1
9739671|NCT00231894|10840710|FG001|NOT COMPLETED|Overall Study||1
9739672|NCT00232180|10840724|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
9739673|NCT00232180|10840725|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
9739674|NCT00232180|10840726|FG002|STARTED|Double-blind (DB) Phase||0
9739675|NCT00232180|10840724|FG000|Treated|Double-blind (DB) Phase||1364
9739676|NCT00232180|10840725|FG001|Treated|Double-blind (DB) Phase||1372
9739677|NCT00232180|10840726|FG002|Treated|Double-blind (DB) Phase||0
9739678|NCT00232180|10840724|FG000|COMPLETED|Double-blind (DB) Phase||826
9739679|NCT00232180|10840725|FG001|COMPLETED|Double-blind (DB) Phase||771
9739680|NCT00232180|10840726|FG002|COMPLETED|Double-blind (DB) Phase||0
9739681|NCT00232180|10840724|FG000|NOT COMPLETED|Double-blind (DB) Phase||541
9739682|NCT00232180|10840725|FG001|NOT COMPLETED|Double-blind (DB) Phase||605
9739683|NCT00232180|10840726|FG002|NOT COMPLETED|Double-blind (DB) Phase||0
9739684|NCT00232180|10840724|FG000|STARTED|Open Label Phase||0
9739685|NCT00232180|10840725|FG001|STARTED|Open Label Phase||0
9739686|NCT00232180|10840726|FG002|STARTED|Open Label Phase||1246
9739687|NCT00232180|10840724|FG000|Treated|Open Label Phase||0
9739688|NCT00232180|10840725|FG001|Treated|Open Label Phase||0
9739689|NCT00232180|10840726|FG002|Treated|Open Label Phase||1245
9739690|NCT00232180|10840724|FG000|COMPLETED|Open Label Phase||0
9739691|NCT00232180|10840725|FG001|COMPLETED|Open Label Phase||0
9739692|NCT00232180|10840726|FG002|COMPLETED|Open Label Phase||1098
9739693|NCT00232180|10840724|FG000|NOT COMPLETED|Open Label Phase||0
9739694|NCT00232180|10840725|FG001|NOT COMPLETED|Open Label Phase||0
9739695|NCT00232180|10840726|FG002|NOT COMPLETED|Open Label Phase||148
9739696|NCT00232479|10840735|FG000|STARTED|Overall Study||44
9739697|NCT00232479|10840735|FG000|COMPLETED|Overall Study||44
9739698|NCT00232479|10840735|FG000|NOT COMPLETED|Overall Study||0
9739699|NCT00232505|10840742|FG000|STARTED|Overall Study||31
9739700|NCT00232505|10840743|FG001|STARTED|Overall Study||71
9739701|NCT00232505|10840742|FG000|Not Evaluable|Overall Study||0
9739702|NCT00232505|10840743|FG001|Not Evaluable|Overall Study||6
9739703|NCT00232505|10840742|FG000|Early Progressors|Overall Study||2
9739704|NCT00232505|10840743|FG001|Early Progressors|Overall Study||5
9739705|NCT00232505|10840742|FG000|Off Protocol|Overall Study||5
9739706|NCT00232505|10840743|FG001|Off Protocol|Overall Study||0
9739707|NCT00232505|10840742|FG000|COMPLETED|Overall Study||26
9739708|NCT00232505|10840743|FG001|COMPLETED|Overall Study||60
9739709|NCT00232505|10840742|FG000|NOT COMPLETED|Overall Study||5
9739710|NCT00232505|10840743|FG001|NOT COMPLETED|Overall Study||11
9739711|NCT00232544|10840755|FG000|STARTED|Overall Study||124
9739712|NCT00232544|10840756|FG001|STARTED|Overall Study||126
9739713|NCT00232544|10840755|FG000|COMPLETED|Overall Study||104
9739714|NCT00232544|10840756|FG001|COMPLETED|Overall Study||111
9739715|NCT00232544|10840755|FG000|NOT COMPLETED|Overall Study||20
9739716|NCT00232544|10840756|FG001|NOT COMPLETED|Overall Study||15
9739717|NCT00232557|10840764|FG000|STARTED|Overall Study||71
9739718|NCT00232557|10840765|FG001|STARTED|Overall Study||65
9739719|NCT00232557|10840764|FG000|COMPLETED|Overall Study||68
9739720|NCT00232557|10840765|FG001|COMPLETED|Overall Study||60
9852417|NCT00880763|10965262|FG002|STARTED|Initial Treatment Period (Part 1)||23
9739721|NCT00232557|10840764|FG000|NOT COMPLETED|Overall Study||3
9739722|NCT00232557|10840765|FG001|NOT COMPLETED|Overall Study||5
9739723|NCT00232583|10840773|FG000|STARTED|Overall Study||29
9739724|NCT00232583|10840774|FG001|STARTED|Overall Study||29
9739725|NCT00232583|10840773|FG000|COMPLETED|Overall Study||19
9739726|NCT00232583|10840774|FG001|COMPLETED|Overall Study||16
9852418|NCT00880763|10965263|FG003|STARTED|Initial Treatment Period (Part 1)||22
9739727|NCT00232583|10840773|FG000|NOT COMPLETED|Overall Study||10
9739728|NCT00232583|10840774|FG001|NOT COMPLETED|Overall Study||13
9739729|NCT00232596|10840786|FG000|STARTED|6-Week Titration Phase||152
9739730|NCT00232596|10840787|FG001|STARTED|6-Week Titration Phase||154
9739731|NCT00232596|10840786|FG000|COMPLETED|6-Week Titration Phase||138
9739732|NCT00232596|10840787|FG001|COMPLETED|6-Week Titration Phase||125
9739733|NCT00232596|10840786|FG000|NOT COMPLETED|6-Week Titration Phase||14
9739734|NCT00232596|10840787|FG001|NOT COMPLETED|6-Week Titration Phase||29
9739735|NCT00232596|10840786|FG000|STARTED|12-Week Maintenance Phase||138
9739736|NCT00232596|10840787|FG001|STARTED|12-Week Maintenance Phase||125
9739737|NCT00232596|10840786|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
9739738|NCT00232596|10840787|FG001|COMPLETED|12-Week Maintenance Phase||97
9739739|NCT00232596|10840786|FG000|NOT COMPLETED|12-Week Maintenance Phase||12
9739740|NCT00232596|10840787|FG001|NOT COMPLETED|12-Week Maintenance Phase||28
9739741|NCT00232739|10840805|FG000|STARTED|Overall Study||100
9739742|NCT00232739|10840805|FG000|COMPLETED|Overall Study||91
9739743|NCT00232739|10840805|FG000|NOT COMPLETED|Overall Study||9
9739744|NCT00233064|10840811|FG000|STARTED|Overall Study||211
9739745|NCT00233064|10840812|FG001|STARTED|Overall Study||202
9739746|NCT00233064|10840811|FG000|COMPLETED|Overall Study||197
9739747|NCT00233064|10840812|FG001|COMPLETED|Overall Study||190
9739748|NCT00233064|10840811|FG000|NOT COMPLETED|Overall Study||14
9739749|NCT00233064|10840812|FG001|NOT COMPLETED|Overall Study||12
9739750|NCT00233103|10840821|FG000|STARTED|Overall Study||27
9739751|NCT00233103|10840822|FG001|STARTED|Overall Study||25
9739752|NCT00233103|10840821|FG000|COMPLETED|Overall Study||22
9739753|NCT00233103|10840822|FG001|COMPLETED|Overall Study||19
9739754|NCT00233103|10840821|FG000|NOT COMPLETED|Overall Study||5
9739755|NCT00233103|10840822|FG001|NOT COMPLETED|Overall Study||6
9739756|NCT00233324|10840832|FG000|STARTED|Main Study||318
9739757|NCT00233324|10840833|FG001|STARTED|Main Study||335
9739758|NCT00233324|10840834|FG002|STARTED|Main Study||336
9739759|NCT00233324|10840835|FG003|STARTED|Main Study||327
9739760|NCT00233324|10840832|FG000|COMPLETED|Main Study||250
9739761|NCT00233324|10840833|FG001|COMPLETED|Main Study||275
9739762|NCT00233324|10840834|FG002|COMPLETED|Main Study||274
9739763|NCT00233324|10840835|FG003|COMPLETED|Main Study||280
9739764|NCT00233324|10840832|FG000|NOT COMPLETED|Main Study||68
9739765|NCT00233324|10840833|FG001|NOT COMPLETED|Main Study||60
9739766|NCT00233324|10840834|FG002|NOT COMPLETED|Main Study||62
9739767|NCT00233324|10840835|FG003|NOT COMPLETED|Main Study||47
9739768|NCT00233324|10840832|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250
9739769|NCT00233324|10840833|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275
9739770|NCT00233324|10840834|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274
9739771|NCT00233324|10840835|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280
9739772|NCT00233324|10840832|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237
9739773|NCT00233324|10840833|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261
9739774|NCT00233324|10840834|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256
9739775|NCT00233324|10840835|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269
9739776|NCT00233324|10840832|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
9739777|NCT00233324|10840833|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
9739778|NCT00233324|10840834|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
9739779|NCT00233324|10840835|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
9739780|NCT00233363|10840854|FG000|STARTED|Overall Study||53
9739781|NCT00233363|10840855|FG001|STARTED|Overall Study||51
9739782|NCT00233363|10840854|FG000|COMPLETED|Overall Study||50
9739783|NCT00233363|10840855|FG001|COMPLETED|Overall Study||46
9739784|NCT00233363|10840854|FG000|NOT COMPLETED|Overall Study||3
9739785|NCT00233363|10840855|FG001|NOT COMPLETED|Overall Study||5
9739786|NCT00233389|10840863|FG000|STARTED|Overall Study||154
9739787|NCT00233389|10840864|FG001|STARTED|Overall Study||147
9739788|NCT00233389|10840863|FG000|COMPLETED|Overall Study||136
9739789|NCT00233389|10840864|FG001|COMPLETED|Overall Study||131
9739790|NCT00233389|10840863|FG000|NOT COMPLETED|Overall Study||18
9739791|NCT00233389|10840864|FG001|NOT COMPLETED|Overall Study||16
9739792|NCT00233402|10840872|FG000|STARTED|Overall Study||384
9739793|NCT00233402|10840873|FG001|STARTED|Overall Study||395
9739794|NCT00233402|10840872|FG000|COMPLETED|Overall Study||280
9739795|NCT00233402|10840873|FG001|COMPLETED|Overall Study||271
9739796|NCT00233402|10840872|FG000|NOT COMPLETED|Overall Study||104
9739797|NCT00233402|10840873|FG001|NOT COMPLETED|Overall Study||124
9739798|NCT00233454|10840881|FG000|STARTED|Overall Study||26
9739799|NCT00233454|10840881|FG000|2 Months (for Response Rate)|Overall Study||26
9739800|NCT00233454|10840881|FG000|COMPLETED|Overall Study||20
9739801|NCT00233454|10840881|FG000|NOT COMPLETED|Overall Study||6
9739802|NCT00233480|10840887|FG000|STARTED|Overall Study||14
9739803|NCT00233480|10840888|FG001|STARTED|Overall Study||13
9739804|NCT00233480|10840887|FG000|COMPLETED|Overall Study||14
9739805|NCT00233480|10840888|FG001|COMPLETED|Overall Study||12
9739806|NCT00233480|10840887|FG000|NOT COMPLETED|Overall Study||0
9739807|NCT00233480|10840888|FG001|NOT COMPLETED|Overall Study||1
9739808|NCT00233519|10840898|FG000|STARTED|Overall Study||7
9739809|NCT00233519|10840899|FG001|STARTED|Overall Study||10
9739810|NCT00233519|10840898|FG000|COMPLETED|Overall Study||6
9739811|NCT00233519|10840899|FG001|COMPLETED|Overall Study||9
9739812|NCT00233519|10840898|FG000|NOT COMPLETED|Overall Study||1
9739813|NCT00233519|10840899|FG001|NOT COMPLETED|Overall Study||1
9739814|NCT00233948|10840907|FG000|STARTED|Overall Study||4
9739815|NCT00233948|10840908|FG001|STARTED|Overall Study||3
9739816|NCT00233948|10840909|FG002|STARTED|Overall Study||3
9739817|NCT00233948|10840910|FG003|STARTED|Overall Study||3
9739818|NCT00233948|10840911|FG004|STARTED|Overall Study||4
9739819|NCT00233948|10840912|FG005|STARTED|Overall Study||12
9739820|NCT00233948|10840907|FG000|COMPLETED|Overall Study||3
9739821|NCT00233948|10840908|FG001|COMPLETED|Overall Study||3
9739822|NCT00233948|10840909|FG002|COMPLETED|Overall Study||3
9739823|NCT00233948|10840910|FG003|COMPLETED|Overall Study||3
9739824|NCT00233948|10840911|FG004|COMPLETED|Overall Study||4
9739825|NCT00233948|10840912|FG005|COMPLETED|Overall Study||12
9739826|NCT00233948|10840907|FG000|NOT COMPLETED|Overall Study||1
9739827|NCT00233948|10840908|FG001|NOT COMPLETED|Overall Study||0
9739828|NCT00233948|10840909|FG002|NOT COMPLETED|Overall Study||0
9739829|NCT00233948|10840910|FG003|NOT COMPLETED|Overall Study||0
9739830|NCT00233948|10840911|FG004|NOT COMPLETED|Overall Study||0
9739831|NCT00233948|10840912|FG005|NOT COMPLETED|Overall Study||0
9739832|NCT00233987|10840927|FG000|STARTED|Overall Study||98
9739833|NCT00233987|10840927|FG000|Eligible|Overall Study||94
9739834|NCT00233987|10840927|FG000|Eligible and Treated|Overall Study||92
9739835|NCT00233987|10840927|FG000|COMPLETED|Overall Study||83
9739836|NCT00233987|10840927|FG000|NOT COMPLETED|Overall Study||15
9739837|NCT00234039|10840931|FG000|STARTED|Overall Study||58
9739838|NCT00234039|10840931|FG000|Eligible|Overall Study||49
9739839|NCT00234039|10840931|FG000|Eligible and Began Protocol Therapy|Overall Study||47
9739840|NCT00234039|10840931|FG000|COMPLETED|Overall Study||8
9739841|NCT00234039|10840931|FG000|NOT COMPLETED|Overall Study||50
9739842|NCT00234052|10840935|FG000|STARTED|Treatment||51
9739843|NCT00234052|10840935|FG000|Started Treatment|Treatment||50
9739844|NCT00234052|10840935|FG000|Completed 6 Cycles|Treatment||33
9739845|NCT00234052|10840935|FG000|Went Into Maintenance Phase|Treatment||30
9739846|NCT00234052|10840935|FG000|COMPLETED|Treatment||30
9739847|NCT00234052|10840935|FG000|NOT COMPLETED|Treatment||21
9739848|NCT00234052|10840935|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
9739849|NCT00234052|10840935|FG000|COMPLETED|Follow-up for 5 Years||1
9739850|NCT00234052|10840935|FG000|NOT COMPLETED|Follow-up for 5 Years||49
9739851|NCT00234065|10840941|FG000|STARTED|Overall Study||1356
9739852|NCT00234065|10840942|FG001|STARTED|Overall Study||1360
9739853|NCT00234065|10840941|FG000|COMPLETED|Overall Study||881
9739854|NCT00234065|10840942|FG001|COMPLETED|Overall Study||1004
9739855|NCT00234065|10840941|FG000|NOT COMPLETED|Overall Study||475
9739856|NCT00234065|10840942|FG001|NOT COMPLETED|Overall Study||356
9739857|NCT00234078|10840952|FG000|STARTED|Overall Study||72
9739858|NCT00234078|10840953|FG001|STARTED|Overall Study||72
10090593|NCT02325713|11219179|FG003|COMPLETED|Intervention Period 1 (2 Days)||2
10090594|NCT02325713|11219180|FG004|COMPLETED|Intervention Period 1 (2 Days)||2
10090595|NCT02325713|11219181|FG005|COMPLETED|Intervention Period 1 (2 Days)||2
10090596|NCT02325713|11219182|FG006|COMPLETED|Intervention Period 1 (2 Days)||2
10090597|NCT02325713|11219183|FG007|COMPLETED|Intervention Period 1 (2 Days)||2
10090598|NCT02325713|11219184|FG008|COMPLETED|Intervention Period 1 (2 Days)||2
10090599|NCT02325713|11219185|FG009|COMPLETED|Intervention Period 1 (2 Days)||2
9739859|NCT00234078|10840954|FG002|STARTED|Overall Study||74
9739860|NCT00234078|10840955|FG003|STARTED|Overall Study||72
9739861|NCT00234078|10840952|FG000|COMPLETED|Overall Study||66
9739862|NCT00234078|10840953|FG001|COMPLETED|Overall Study||63
9739863|NCT00234078|10840954|FG002|COMPLETED|Overall Study||64
9739864|NCT00234078|10840955|FG003|COMPLETED|Overall Study||68
9739865|NCT00234078|10840952|FG000|NOT COMPLETED|Overall Study||6
9739866|NCT00234078|10840953|FG001|NOT COMPLETED|Overall Study||9
9739867|NCT00234078|10840954|FG002|NOT COMPLETED|Overall Study||10
9739868|NCT00234078|10840955|FG003|NOT COMPLETED|Overall Study||4
9739869|NCT00234104|10840969|FG000|STARTED|Overall Study||30
9739870|NCT00234104|10840970|FG001|STARTED|Overall Study||29
9739871|NCT00234104|10840971|FG002|STARTED|Overall Study||34
9739872|NCT00234104|10840972|FG003|STARTED|Overall Study||29
9739873|NCT00234104|10840969|FG000|COMPLETED|Overall Study||26
9739874|NCT00234104|10840970|FG001|COMPLETED|Overall Study||28
9739875|NCT00234104|10840971|FG002|COMPLETED|Overall Study||29
9739876|NCT00234104|10840972|FG003|COMPLETED|Overall Study||21
9739877|NCT00234104|10840969|FG000|NOT COMPLETED|Overall Study||4
9739878|NCT00234104|10840970|FG001|NOT COMPLETED|Overall Study||1
9739879|NCT00234104|10840971|FG002|NOT COMPLETED|Overall Study||5
9739880|NCT00234104|10840972|FG003|NOT COMPLETED|Overall Study||8
9739881|NCT00234286|10840982|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
9739882|NCT00234286|10840982|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
9739883|NCT00234286|10840982|FG000|NOT COMPLETED|Overall Study||0
9739884|NCT00234494|10841015|FG000|STARTED|Overall Study||45
9739885|NCT00234494|10841015|FG000|COMPLETED|Overall Study||43
9739886|NCT00234494|10841015|FG000|NOT COMPLETED|Overall Study||2
9739887|NCT00234533|10841019|FG000|STARTED|Overall Study||251
9739888|NCT00234533|10841019|FG000|COMPLETED|Overall Study||240
9739889|NCT00234533|10841019|FG000|NOT COMPLETED|Overall Study||11
9739890|NCT00234832|10841026|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
9739891|NCT00234832|10841027|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
9739892|NCT00234832|10841026|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
9739893|NCT00234832|10841027|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
9739894|NCT00234832|10841026|FG000|NOT COMPLETED|Overall Study||1016
9739895|NCT00234832|10841027|FG001|NOT COMPLETED|Overall Study||996
9739896|NCT00234884|10841040|FG000|STARTED|Overall Study||3435
9739897|NCT00234884|10841040|FG000|COMPLETED|Overall Study||1805
9739898|NCT00234884|10841040|FG000|NOT COMPLETED|Overall Study||1630
10090600|NCT02325713|11219186|FG010|COMPLETED|Intervention Period 1 (2 Days)||1
9739899|NCT00235391|10841050|FG000|STARTED|Overall Study||97
9739900|NCT00235391|10841051|FG001|STARTED|Overall Study||200
9739901|NCT00235391|10841052|FG002|STARTED|Overall Study||172
9739902|NCT00235391|10841053|FG003|STARTED|Overall Study||1164
9739903|NCT00235391|10841054|FG004|STARTED|Overall Study||43
9739904|NCT00235391|10841055|FG005|STARTED|Overall Study||7
9739905|NCT00235391|10841050|FG000|Deferasirox Treatment|Overall Study||97
9739906|NCT00235391|10841051|FG001|Deferasirox Treatment|Overall Study||200
9739907|NCT00235391|10841052|FG002|Deferasirox Treatment|Overall Study||172
10090601|NCT02325713|11219187|FG011|COMPLETED|Intervention Period 1 (2 Days)||2
10090602|NCT02325713|11219188|FG012|COMPLETED|Intervention Period 1 (2 Days)||2
10090603|NCT02325713|11219189|FG013|COMPLETED|Intervention Period 1 (2 Days)||2
9739908|NCT00235391|10841053|FG003|Deferasirox Treatment|Overall Study||1164
9739909|NCT00235391|10841054|FG004|Deferasirox Treatment|Overall Study||43
9739910|NCT00235391|10841055|FG005|Deferasirox Treatment|Overall Study||7
9739911|NCT00235391|10841050|FG000|COMPLETED|Overall Study||85
9739912|NCT00235391|10841051|FG001|COMPLETED|Overall Study||182
9739913|NCT00235391|10841052|FG002|COMPLETED|Overall Study||148
9739914|NCT00235391|10841053|FG003|COMPLETED|Overall Study||944
9739915|NCT00235391|10841054|FG004|COMPLETED|Overall Study||31
9739916|NCT00235391|10841055|FG005|COMPLETED|Overall Study||3
9739917|NCT00235391|10841050|FG000|NOT COMPLETED|Overall Study||12
9739918|NCT00235391|10841051|FG001|NOT COMPLETED|Overall Study||18
9739919|NCT00235391|10841052|FG002|NOT COMPLETED|Overall Study||24
9739920|NCT00235391|10841053|FG003|NOT COMPLETED|Overall Study||220
9739921|NCT00235391|10841054|FG004|NOT COMPLETED|Overall Study||12
9739922|NCT00235391|10841055|FG005|NOT COMPLETED|Overall Study||4
9739923|NCT00235443|10841070|FG000|STARTED|Overall Study||11
9739924|NCT00235443|10841071|FG001|STARTED|Overall Study||57
9739925|NCT00235443|10841072|FG002|STARTED|Overall Study||85
9739926|NCT00235443|10841073|FG003|STARTED|Overall Study||205
9739927|NCT00235443|10841074|FG004|STARTED|Overall Study||39
9739928|NCT00235443|10841075|FG005|STARTED|Overall Study||54
9739929|NCT00235443|10841070|FG000|COMPLETED|Overall Study||3
9739930|NCT00235443|10841071|FG001|COMPLETED|Overall Study||19
9739931|NCT00235443|10841072|FG002|COMPLETED|Overall Study||23
9739932|NCT00235443|10841073|FG003|COMPLETED|Overall Study||108
9739933|NCT00235443|10841074|FG004|COMPLETED|Overall Study||9
9739934|NCT00235443|10841075|FG005|COMPLETED|Overall Study||9
9739935|NCT00235443|10841070|FG000|NOT COMPLETED|Overall Study||8
9739936|NCT00235443|10841071|FG001|NOT COMPLETED|Overall Study||38
9739937|NCT00235443|10841072|FG002|NOT COMPLETED|Overall Study||62
9739938|NCT00235443|10841073|FG003|NOT COMPLETED|Overall Study||97
9739939|NCT00235443|10841074|FG004|NOT COMPLETED|Overall Study||30
9739940|NCT00235443|10841075|FG005|NOT COMPLETED|Overall Study||45
9739941|NCT00235456|10841093|FG000|STARTED|Overall Study||150
9739942|NCT00235456|10841094|FG001|STARTED|Overall Study||150
9739943|NCT00235456|10841093|FG000|COMPLETED|Overall Study||148
10090604|NCT02325713|11219190|FG014|COMPLETED|Intervention Period 1 (2 Days)||2
10090605|NCT02325713|11219191|FG015|COMPLETED|Intervention Period 1 (2 Days)||2
10090606|NCT02325713|11219176|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090607|NCT02325713|11219177|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090608|NCT02325713|11219178|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090609|NCT02325713|11219179|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090610|NCT02325713|11219180|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090611|NCT02325713|11219181|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090612|NCT02325713|11219182|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090613|NCT02325713|11219183|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090614|NCT02325713|11219184|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090615|NCT02325713|11219185|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090616|NCT02325713|11219186|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1
10090617|NCT02325713|11219187|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090618|NCT02325713|11219188|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090619|NCT02325713|11219189|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090620|NCT02325713|11219190|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090621|NCT02325713|11219191|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10090622|NCT02325713|11219176|FG000|STARTED|Intervention Period 2 (2 Days)||2
10090623|NCT02325713|11219177|FG001|STARTED|Intervention Period 2 (2 Days)||2
10090624|NCT02325713|11219178|FG002|STARTED|Intervention Period 2 (2 Days)||2
10090625|NCT02325713|11219179|FG003|STARTED|Intervention Period 2 (2 Days)||2
10090626|NCT02325713|11219180|FG004|STARTED|Intervention Period 2 (2 Days)||2
10090627|NCT02325713|11219181|FG005|STARTED|Intervention Period 2 (2 Days)||2
10090628|NCT02325713|11219182|FG006|STARTED|Intervention Period 2 (2 Days)||2
10090629|NCT02325713|11219183|FG007|STARTED|Intervention Period 2 (2 Days)||2
10090630|NCT02325713|11219184|FG008|STARTED|Intervention Period 2 (2 Days)||2
10090631|NCT02325713|11219185|FG009|STARTED|Intervention Period 2 (2 Days)||2
10090632|NCT02325713|11219186|FG010|STARTED|Intervention Period 2 (2 Days)||1
10090633|NCT02325713|11219187|FG011|STARTED|Intervention Period 2 (2 Days)||2
10090634|NCT02325713|11219188|FG012|STARTED|Intervention Period 2 (2 Days)||2
10090635|NCT02325713|11219189|FG013|STARTED|Intervention Period 2 (2 Days)||2
10090636|NCT02325713|11219190|FG014|STARTED|Intervention Period 2 (2 Days)||2
10090637|NCT02325713|11219191|FG015|STARTED|Intervention Period 2 (2 Days)||2
10090638|NCT02325713|11219176|FG000|COMPLETED|Intervention Period 2 (2 Days)||1
10090639|NCT02325713|11219177|FG001|COMPLETED|Intervention Period 2 (2 Days)||2
10090640|NCT02325713|11219178|FG002|COMPLETED|Intervention Period 2 (2 Days)||2
10090641|NCT02325713|11219179|FG003|COMPLETED|Intervention Period 2 (2 Days)||2
10090642|NCT02325713|11219180|FG004|COMPLETED|Intervention Period 2 (2 Days)||2
9739944|NCT00235456|10841094|FG001|COMPLETED|Overall Study||143
9739945|NCT00235456|10841093|FG000|NOT COMPLETED|Overall Study||2
9739946|NCT00235456|10841094|FG001|NOT COMPLETED|Overall Study||7
9828195|NCT00754377|10938896|FG001|NOT COMPLETED|Overall Study||0
9828196|NCT00754390|10938904|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
9828197|NCT00754390|10938904|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
9739947|NCT00235495|10841102|FG000|STARTED|Overall Study||422
9739948|NCT00235495|10841103|FG001|STARTED|Overall Study||419
9739949|NCT00235495|10841102|FG000|COMPLETED|Overall Study||354
9739950|NCT00235495|10841103|FG001|COMPLETED|Overall Study||351
9739951|NCT00235495|10841102|FG000|NOT COMPLETED|Overall Study||68
9739952|NCT00235495|10841103|FG001|NOT COMPLETED|Overall Study||68
9739953|NCT00235547|10841111|FG000|STARTED|2 Month Follow-up Survey||154
9739954|NCT00235547|10841112|FG001|STARTED|2 Month Follow-up Survey||144
9739955|NCT00235547|10841111|FG000|COMPLETED|2 Month Follow-up Survey||108
9739956|NCT00235547|10841112|FG001|COMPLETED|2 Month Follow-up Survey||104
9739957|NCT00235547|10841111|FG000|NOT COMPLETED|2 Month Follow-up Survey||46
9739958|NCT00235547|10841112|FG001|NOT COMPLETED|2 Month Follow-up Survey||40
9739959|NCT00235547|10841111|FG000|STARTED|6 Month Follow-up Survey||154
9739960|NCT00235547|10841112|FG001|STARTED|6 Month Follow-up Survey||144
9739961|NCT00235547|10841111|FG000|COMPLETED|6 Month Follow-up Survey||83
9739962|NCT00235547|10841112|FG001|COMPLETED|6 Month Follow-up Survey||76
9739963|NCT00235547|10841111|FG000|NOT COMPLETED|6 Month Follow-up Survey||71
9739964|NCT00235547|10841112|FG001|NOT COMPLETED|6 Month Follow-up Survey||68
9739965|NCT00235573|10841118|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
9739966|NCT00235573|10841118|FG000|COMPLETED|Overall Study||21
9739967|NCT00235573|10841118|FG000|NOT COMPLETED|Overall Study||0
9739968|NCT00235716|10841126|FG000|STARTED|Overall Study||152
9739969|NCT00235716|10841127|FG001|STARTED|Overall Study||155
9739970|NCT00235716|10841128|FG002|STARTED|Overall Study||154
9739971|NCT00235716|10841129|FG003|STARTED|Overall Study||152
9739972|NCT00235716|10841126|FG000|COMPLETED|Overall Study||90
9739973|NCT00235716|10841127|FG001|COMPLETED|Overall Study||88
9739974|NCT00235716|10841128|FG002|COMPLETED|Overall Study||89
9739975|NCT00235716|10841129|FG003|COMPLETED|Overall Study||90
9739976|NCT00235716|10841126|FG000|NOT COMPLETED|Overall Study||62
9739977|NCT00235716|10841127|FG001|NOT COMPLETED|Overall Study||67
9739978|NCT00235716|10841128|FG002|NOT COMPLETED|Overall Study||65
9739979|NCT00235716|10841129|FG003|NOT COMPLETED|Overall Study||62
9739980|NCT00235755|10841142|FG000|STARTED|4-Week Titration Phase||179
9739981|NCT00235755|10841143|FG001|STARTED|4-Week Titration Phase||181
9739982|NCT00235755|10841144|FG002|STARTED|4-Week Titration Phase||179
9739983|NCT00235755|10841142|FG000|COMPLETED|4-Week Titration Phase||168
9739984|NCT00235755|10841143|FG001|COMPLETED|4-Week Titration Phase||162
9739985|NCT00235755|10841144|FG002|COMPLETED|4-Week Titration Phase||153
9739986|NCT00235755|10841142|FG000|NOT COMPLETED|4-Week Titration Phase||11
9739987|NCT00235755|10841143|FG001|NOT COMPLETED|4-Week Titration Phase||19
9739988|NCT00235755|10841144|FG002|NOT COMPLETED|4-Week Titration Phase||26
9739989|NCT00235755|10841142|FG000|STARTED|12-Week Maintenance Phase||168
9739990|NCT00235755|10841143|FG001|STARTED|12-Week Maintenance Phase||162
9739991|NCT00235755|10841144|FG002|STARTED|12-Week Maintenance Phase||153
9739992|NCT00235755|10841142|FG000|COMPLETED|12-Week Maintenance Phase||152
9739993|NCT00235755|10841143|FG001|COMPLETED|12-Week Maintenance Phase||135
9739994|NCT00235755|10841144|FG002|COMPLETED|12-Week Maintenance Phase||122
9739995|NCT00235755|10841142|FG000|NOT COMPLETED|12-Week Maintenance Phase||16
9739996|NCT00235755|10841143|FG001|NOT COMPLETED|12-Week Maintenance Phase||27
9739997|NCT00235755|10841144|FG002|NOT COMPLETED|12-Week Maintenance Phase||31
9739998|NCT00235833|10841167|FG000|STARTED|Overall Study||25
9739999|NCT00235833|10841167|FG000|COMPLETED|Overall Study||9
9740000|NCT00235833|10841167|FG000|NOT COMPLETED|Overall Study||16
9740001|NCT00235872|10841171|FG000|STARTED|Overall Study||309
9740002|NCT00235872|10841171|FG000|COMPLETED|Overall Study||162
9740003|NCT00235872|10841171|FG000|NOT COMPLETED|Overall Study||147
10090643|NCT02325713|11219181|FG005|COMPLETED|Intervention Period 2 (2 Days)||2
10090644|NCT02325713|11219182|FG006|COMPLETED|Intervention Period 2 (2 Days)||2
10090645|NCT02325713|11219183|FG007|COMPLETED|Intervention Period 2 (2 Days)||2
10090646|NCT02325713|11219184|FG008|COMPLETED|Intervention Period 2 (2 Days)||2
10090647|NCT02325713|11219185|FG009|COMPLETED|Intervention Period 2 (2 Days)||2
10090648|NCT02325713|11219186|FG010|COMPLETED|Intervention Period 2 (2 Days)||1
10090649|NCT02325713|11219187|FG011|COMPLETED|Intervention Period 2 (2 Days)||2
10090650|NCT02325713|11219188|FG012|COMPLETED|Intervention Period 2 (2 Days)||2
10090651|NCT02325713|11219189|FG013|COMPLETED|Intervention Period 2 (2 Days)||2
10090652|NCT02325713|11219190|FG014|COMPLETED|Intervention Period 2 (2 Days)||2
10090653|NCT02325713|11219191|FG015|COMPLETED|Intervention Period 2 (2 Days)||2
10090654|NCT02325713|11219176|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
10090655|NCT02325713|11219177|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090656|NCT02325713|11219178|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090657|NCT02325713|11219179|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090658|NCT02325713|11219180|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9740004|NCT00235989|10841179|FG000|STARTED|Core Treatment Period (CT)||0
9740005|NCT00235989|10841180|FG001|STARTED|Core Treatment Period (CT)||0
9740006|NCT00235989|10841181|FG002|STARTED|Core Treatment Period (CT)||0
9740007|NCT00235989|10841182|FG003|STARTED|Core Treatment Period (CT)||0
9740008|NCT00235989|10841183|FG004|STARTED|Core Treatment Period (CT)||36
9740009|NCT00235989|10841184|FG005|STARTED|Core Treatment Period (CT)||27
9740010|NCT00235989|10841179|FG000|COMPLETED|Core Treatment Period (CT)||0
9740011|NCT00235989|10841180|FG001|COMPLETED|Core Treatment Period (CT)||0
9740012|NCT00235989|10841181|FG002|COMPLETED|Core Treatment Period (CT)||0
9740013|NCT00235989|10841182|FG003|COMPLETED|Core Treatment Period (CT)||0
9740014|NCT00235989|10841183|FG004|COMPLETED|Core Treatment Period (CT)||36
9740015|NCT00235989|10841184|FG005|COMPLETED|Core Treatment Period (CT)||25
9740016|NCT00235989|10841179|FG000|NOT COMPLETED|Core Treatment Period (CT)||0
9740017|NCT00235989|10841180|FG001|NOT COMPLETED|Core Treatment Period (CT)||0
9740018|NCT00235989|10841181|FG002|NOT COMPLETED|Core Treatment Period (CT)||0
9740019|NCT00235989|10841182|FG003|NOT COMPLETED|Core Treatment Period (CT)||0
9740020|NCT00235989|10841183|FG004|NOT COMPLETED|Core Treatment Period (CT)||0
9740021|NCT00235989|10841184|FG005|NOT COMPLETED|Core Treatment Period (CT)||2
9740022|NCT00235989|10841179|FG000|STARTED|Extension Treatment Period (ET)||16
9740023|NCT00235989|10841180|FG001|STARTED|Extension Treatment Period (ET)||6
9740024|NCT00235989|10841181|FG002|STARTED|Extension Treatment Period (ET)||19
9740025|NCT00235989|10841182|FG003|STARTED|Extension Treatment Period (ET)||20
9740026|NCT00235989|10841183|FG004|STARTED|Extension Treatment Period (ET)||0
9740027|NCT00235989|10841184|FG005|STARTED|Extension Treatment Period (ET)||0
9740028|NCT00235989|10841179|FG000|COMPLETED|Extension Treatment Period (ET)||8
9740029|NCT00235989|10841180|FG001|COMPLETED|Extension Treatment Period (ET)||2
9740030|NCT00235989|10841181|FG002|COMPLETED|Extension Treatment Period (ET)||14
9740031|NCT00235989|10841182|FG003|COMPLETED|Extension Treatment Period (ET)||14
9740032|NCT00235989|10841183|FG004|COMPLETED|Extension Treatment Period (ET)||0
9740033|NCT00235989|10841184|FG005|COMPLETED|Extension Treatment Period (ET)||0
9740034|NCT00235989|10841179|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8
9740035|NCT00235989|10841180|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4
9740036|NCT00235989|10841181|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5
9740037|NCT00235989|10841182|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6
9740038|NCT00235989|10841183|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0
9740039|NCT00235989|10841184|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0
9740040|NCT00236080|10841199|FG000|STARTED|Overall Study||29
9740041|NCT00236080|10841200|FG001|STARTED|Overall Study||28
9740042|NCT00236080|10841201|FG002|STARTED|Overall Study||27
9740043|NCT00236080|10841202|FG003|STARTED|Overall Study||25
9740044|NCT00236080|10841203|FG004|STARTED|Overall Study||27
9740045|NCT00236080|10841199|FG000|COMPLETED|Overall Study||27
9740046|NCT00236080|10841200|FG001|COMPLETED|Overall Study||27
9740047|NCT00236080|10841201|FG002|COMPLETED|Overall Study||22
9740048|NCT00236080|10841202|FG003|COMPLETED|Overall Study||23
9740049|NCT00236080|10841203|FG004|COMPLETED|Overall Study||26
9740050|NCT00236080|10841199|FG000|NOT COMPLETED|Overall Study||2
10090659|NCT02325713|11219181|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090660|NCT02325713|11219182|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090661|NCT02325713|11219183|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090662|NCT02325713|11219184|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090663|NCT02325713|11219185|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090664|NCT02325713|11219186|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090665|NCT02325713|11219187|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090666|NCT02325713|11219188|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090667|NCT02325713|11219189|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090668|NCT02325713|11219190|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090669|NCT02325713|11219191|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10090670|NCT02325713|11219176|FG000|STARTED|Intervention Period 3 (2 Days)||1
10090671|NCT02325713|11219177|FG001|STARTED|Intervention Period 3 (2 Days)||2
10090672|NCT02325713|11219178|FG002|STARTED|Intervention Period 3 (2 Days)||2
10090673|NCT02325713|11219179|FG003|STARTED|Intervention Period 3 (2 Days)||2
10090674|NCT02325713|11219180|FG004|STARTED|Intervention Period 3 (2 Days)||2
10090675|NCT02325713|11219181|FG005|STARTED|Intervention Period 3 (2 Days)||2
10090676|NCT02325713|11219182|FG006|STARTED|Intervention Period 3 (2 Days)||2
10090677|NCT02325713|11219183|FG007|STARTED|Intervention Period 3 (2 Days)||2
10090678|NCT02325713|11219184|FG008|STARTED|Intervention Period 3 (2 Days)||2
10090679|NCT02325713|11219185|FG009|STARTED|Intervention Period 3 (2 Days)||2
10090680|NCT02325713|11219186|FG010|STARTED|Intervention Period 3 (2 Days)||1
10090681|NCT02325713|11219187|FG011|STARTED|Intervention Period 3 (2 Days)||2
10090682|NCT02325713|11219188|FG012|STARTED|Intervention Period 3 (2 Days)||2
10090683|NCT02325713|11219189|FG013|STARTED|Intervention Period 3 (2 Days)||2
10090684|NCT02325713|11219190|FG014|STARTED|Intervention Period 3 (2 Days)||2
10090685|NCT02325713|11219191|FG015|STARTED|Intervention Period 3 (2 Days)||2
10090686|NCT02325713|11219176|FG000|COMPLETED|Intervention Period 3 (2 Days)||1
10090687|NCT02325713|11219177|FG001|COMPLETED|Intervention Period 3 (2 Days)||2
10090688|NCT02325713|11219178|FG002|COMPLETED|Intervention Period 3 (2 Days)||2
10090689|NCT02325713|11219179|FG003|COMPLETED|Intervention Period 3 (2 Days)||2
10090690|NCT02325713|11219180|FG004|COMPLETED|Intervention Period 3 (2 Days)||2
10090691|NCT02325713|11219181|FG005|COMPLETED|Intervention Period 3 (2 Days)||2
10090692|NCT02325713|11219182|FG006|COMPLETED|Intervention Period 3 (2 Days)||2
10090693|NCT02325713|11219183|FG007|COMPLETED|Intervention Period 3 (2 Days)||2
10090694|NCT02325713|11219184|FG008|COMPLETED|Intervention Period 3 (2 Days)||2
10090695|NCT02325713|11219185|FG009|COMPLETED|Intervention Period 3 (2 Days)||1
10090696|NCT02325713|11219186|FG010|COMPLETED|Intervention Period 3 (2 Days)||1
10090697|NCT02325713|11219187|FG011|COMPLETED|Intervention Period 3 (2 Days)||2
9740051|NCT00236080|10841200|FG001|NOT COMPLETED|Overall Study||1
9740052|NCT00236080|10841201|FG002|NOT COMPLETED|Overall Study||5
9740053|NCT00236080|10841202|FG003|NOT COMPLETED|Overall Study||2
9740054|NCT00236080|10841203|FG004|NOT COMPLETED|Overall Study||1
9740055|NCT00236184|10841217|FG000|STARTED|Overall Study||310
9740056|NCT00236184|10841218|FG001|STARTED|Overall Study||319
9740057|NCT00236184|10841217|FG000|COMPLETED|Overall Study||292
9740058|NCT00236184|10841218|FG001|COMPLETED|Overall Study||308
9740059|NCT00236184|10841217|FG000|NOT COMPLETED|Overall Study||18
9740060|NCT00236184|10841218|FG001|NOT COMPLETED|Overall Study||11
9740061|NCT00236197|10841226|FG000|STARTED|Overall Study||312
9740062|NCT00236197|10841227|FG001|STARTED|Overall Study||307
9740063|NCT00236197|10841226|FG000|COMPLETED|Overall Study||307
9740064|NCT00236197|10841227|FG001|COMPLETED|Overall Study||293
9740065|NCT00236197|10841226|FG000|NOT COMPLETED|Overall Study||5
9740066|NCT00236197|10841227|FG001|NOT COMPLETED|Overall Study||14
9740067|NCT00236899|10841237|FG000|STARTED|Overall Study||60
9740068|NCT00236899|10841238|FG001|STARTED|Overall Study||64
9740069|NCT00236899|10841239|FG002|STARTED|Overall Study||58
9740070|NCT00236899|10841240|FG003|STARTED|Overall Study||59
9740071|NCT00236899|10841237|FG000|COMPLETED|Overall Study||18
9740072|NCT00236899|10841238|FG001|COMPLETED|Overall Study||24
9740073|NCT00236899|10841239|FG002|COMPLETED|Overall Study||14
9740074|NCT00236899|10841240|FG003|COMPLETED|Overall Study||19
9740075|NCT00236899|10841237|FG000|NOT COMPLETED|Overall Study||42
9740076|NCT00236899|10841238|FG001|NOT COMPLETED|Overall Study||40
9740077|NCT00236899|10841239|FG002|NOT COMPLETED|Overall Study||44
9740078|NCT00236899|10841240|FG003|NOT COMPLETED|Overall Study||40
9740079|NCT00236938|10841259|FG000|STARTED|Overall Study||75
9740080|NCT00236938|10841260|FG001|STARTED|Overall Study||46
9740081|NCT00236938|10841259|FG000|COMPLETED|Overall Study||62
9740082|NCT00236938|10841260|FG001|COMPLETED|Overall Study||26
10090698|NCT02325713|11219188|FG012|COMPLETED|Intervention Period 3 (2 Days)||2
10090699|NCT02325713|11219189|FG013|COMPLETED|Intervention Period 3 (2 Days)||2
10090700|NCT02325713|11219190|FG014|COMPLETED|Intervention Period 3 (2 Days)||2
10090701|NCT02325713|11219191|FG015|COMPLETED|Intervention Period 3 (2 Days)||2
10090702|NCT02325713|11219176|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090703|NCT02325713|11219177|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090704|NCT02325713|11219178|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090705|NCT02325713|11219179|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090706|NCT02325713|11219180|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090707|NCT02325713|11219181|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090708|NCT02325713|11219182|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090709|NCT02325713|11219183|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090710|NCT02325713|11219184|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090711|NCT02325713|11219185|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1
10090712|NCT02325713|11219186|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090713|NCT02325713|11219187|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090714|NCT02325713|11219188|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090715|NCT02325713|11219189|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090716|NCT02325713|11219190|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090717|NCT02325713|11219191|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10090718|NCT02325713|11219176|FG000|STARTED|Intervention Period 4 (2 Days)||1
10090719|NCT02325713|11219177|FG001|STARTED|Intervention Period 4 (2 Days)||2
10090720|NCT02325713|11219178|FG002|STARTED|Intervention Period 4 (2 Days)||2
10090721|NCT02325713|11219179|FG003|STARTED|Intervention Period 4 (2 Days)||2
10090722|NCT02325713|11219180|FG004|STARTED|Intervention Period 4 (2 Days)||2
10090723|NCT02325713|11219181|FG005|STARTED|Intervention Period 4 (2 Days)||2
10090724|NCT02325713|11219182|FG006|STARTED|Intervention Period 4 (2 Days)||2
10090725|NCT02325713|11219183|FG007|STARTED|Intervention Period 4 (2 Days)||2
10090726|NCT02325713|11219184|FG008|STARTED|Intervention Period 4 (2 Days)||2
10090727|NCT02325713|11219185|FG009|STARTED|Intervention Period 4 (2 Days)||1
10090728|NCT02325713|11219186|FG010|STARTED|Intervention Period 4 (2 Days)||1
10090729|NCT02325713|11219187|FG011|STARTED|Intervention Period 4 (2 Days)||2
10090730|NCT02325713|11219188|FG012|STARTED|Intervention Period 4 (2 Days)||2
10090731|NCT02325713|11219189|FG013|STARTED|Intervention Period 4 (2 Days)||2
10090732|NCT02325713|11219190|FG014|STARTED|Intervention Period 4 (2 Days)||2
10090733|NCT02325713|11219191|FG015|STARTED|Intervention Period 4 (2 Days)||2
10090734|NCT02325713|11219176|FG000|COMPLETED|Intervention Period 4 (2 Days)||1
10090735|NCT02325713|11219177|FG001|COMPLETED|Intervention Period 4 (2 Days)||2
10090736|NCT02325713|11219178|FG002|COMPLETED|Intervention Period 4 (2 Days)||2
10090737|NCT02325713|11219179|FG003|COMPLETED|Intervention Period 4 (2 Days)||2
10090738|NCT02325713|11219180|FG004|COMPLETED|Intervention Period 4 (2 Days)||2
10090739|NCT02325713|11219181|FG005|COMPLETED|Intervention Period 4 (2 Days)||2
10090740|NCT02325713|11219182|FG006|COMPLETED|Intervention Period 4 (2 Days)||2
10090741|NCT02325713|11219183|FG007|COMPLETED|Intervention Period 4 (2 Days)||2
10090742|NCT02325713|11219184|FG008|COMPLETED|Intervention Period 4 (2 Days)||2
10090743|NCT02325713|11219185|FG009|COMPLETED|Intervention Period 4 (2 Days)||1
10090744|NCT02325713|11219186|FG010|COMPLETED|Intervention Period 4 (2 Days)||1
10090745|NCT02325713|11219187|FG011|COMPLETED|Intervention Period 4 (2 Days)||2
10090746|NCT02325713|11219188|FG012|COMPLETED|Intervention Period 4 (2 Days)||2
10201717|NCT03440229|11329094|FG000|STARTED|Overall Study||9
10090747|NCT02325713|11219189|FG013|COMPLETED|Intervention Period 4 (2 Days)||2
10090748|NCT02325713|11219190|FG014|COMPLETED|Intervention Period 4 (2 Days)||2
9740083|NCT00236938|10841259|FG000|NOT COMPLETED|Overall Study||13
9740084|NCT00236938|10841260|FG001|NOT COMPLETED|Overall Study||20
9740085|NCT00236951|10841270|FG000|STARTED|Overall Study||59
9740086|NCT00236951|10841271|FG001|STARTED|Overall Study||77
9740087|NCT00236951|10841272|FG002|STARTED|Overall Study||40
9740088|NCT00236951|10841273|FG003|STARTED|Overall Study||48
9740089|NCT00236951|10841270|FG000|COMPLETED|Overall Study||33
9740090|NCT00236951|10841271|FG001|COMPLETED|Overall Study||46
9740091|NCT00236951|10841272|FG002|COMPLETED|Overall Study||21
9740092|NCT00236951|10841273|FG003|COMPLETED|Overall Study||17
9740093|NCT00236951|10841270|FG000|NOT COMPLETED|Overall Study||26
9740094|NCT00236951|10841271|FG001|NOT COMPLETED|Overall Study||31
9740095|NCT00236951|10841272|FG002|NOT COMPLETED|Overall Study||19
9740096|NCT00236951|10841273|FG003|NOT COMPLETED|Overall Study||31
9740097|NCT00236977|10841285|FG000|STARTED|Overall Study||91
9740098|NCT00236977|10841286|FG001|STARTED|Overall Study||91
9740099|NCT00236977|10841285|FG000|COMPLETED|Overall Study||70
9740100|NCT00236977|10841286|FG001|COMPLETED|Overall Study||72
9740101|NCT00236977|10841285|FG000|NOT COMPLETED|Overall Study||21
9740102|NCT00236977|10841286|FG001|NOT COMPLETED|Overall Study||19
9740103|NCT00237042|10841295|FG000|STARTED|Treatment||60
9740104|NCT00237042|10841296|FG001|STARTED|Treatment||57
9740105|NCT00237042|10841297|FG002|STARTED|Treatment||74
9740106|NCT00237042|10841295|FG000|COMPLETED|Treatment||54
9740107|NCT00237042|10841296|FG001|COMPLETED|Treatment||50
9740108|NCT00237042|10841297|FG002|COMPLETED|Treatment||36
9740109|NCT00237042|10841295|FG000|NOT COMPLETED|Treatment||6
9740110|NCT00237042|10841296|FG001|NOT COMPLETED|Treatment||7
9740111|NCT00237042|10841297|FG002|NOT COMPLETED|Treatment||38
9740112|NCT00237042|10841295|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
9740113|NCT00237042|10841296|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
9740114|NCT00237042|10841297|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
9740115|NCT00237042|10841295|FG000|COMPLETED|Short Term (6 Month) Follow up||50
9740116|NCT00237042|10841296|FG001|COMPLETED|Short Term (6 Month) Follow up||47
9740117|NCT00237042|10841297|FG002|COMPLETED|Short Term (6 Month) Follow up||46
9740118|NCT00237042|10841295|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9
9740119|NCT00237042|10841296|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8
10090749|NCT02325713|11219191|FG015|COMPLETED|Intervention Period 4 (2 Days)||2
10090750|NCT02325713|11219176|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090751|NCT02325713|11219177|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090752|NCT02325713|11219178|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090753|NCT02325713|11219179|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090754|NCT02325713|11219180|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090755|NCT02325713|11219181|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090756|NCT02325713|11219182|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090757|NCT02325713|11219183|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090758|NCT02325713|11219184|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090759|NCT02325713|11219185|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090760|NCT02325713|11219186|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090761|NCT02325713|11219187|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090762|NCT02325713|11219188|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090763|NCT02325713|11219189|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090764|NCT02325713|11219190|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090765|NCT02325713|11219191|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10090766|NCT02325739|11219217|FG000|STARTED|Phase I Part||11
10090767|NCT02325739|11219218|FG001|STARTED|Phase I Part||6
10090768|NCT02325739|11219219|FG002|STARTED|Phase I Part||5
10090769|NCT02325739|11219220|FG003|STARTED|Phase I Part||26
10090770|NCT02325739|11219221|FG004|STARTED|Phase I Part||19
10090771|NCT02325739|11219222|FG005|STARTED|Phase I Part||7
10090772|NCT02325739|11219223|FG006|STARTED|Phase I Part||6
10090773|NCT02325739|11219224|FG007|STARTED|Phase I Part||6
10090774|NCT02325739|11219225|FG008|STARTED|Phase I Part||0
10090775|NCT02325739|11219226|FG009|STARTED|Phase I Part||0
10090776|NCT02325739|11219227|FG010|STARTED|Phase I Part||0
10090777|NCT02325739|11219217|FG000|COMPLETED|Phase I Part||0
10090778|NCT02325739|11219218|FG001|COMPLETED|Phase I Part||0
10090779|NCT02325739|11219219|FG002|COMPLETED|Phase I Part||0
10090780|NCT02325739|11219220|FG003|COMPLETED|Phase I Part||0
10090781|NCT02325739|11219221|FG004|COMPLETED|Phase I Part||0
10090782|NCT02325739|11219222|FG005|COMPLETED|Phase I Part||0
10090783|NCT02325739|11219223|FG006|COMPLETED|Phase I Part||0
10090784|NCT02325739|11219224|FG007|COMPLETED|Phase I Part||0
10090785|NCT02325739|11219225|FG008|COMPLETED|Phase I Part||0
10090786|NCT02325739|11219226|FG009|COMPLETED|Phase I Part||0
10090787|NCT02325739|11219227|FG010|COMPLETED|Phase I Part||0
10090788|NCT02325739|11219217|FG000|NOT COMPLETED|Phase I Part||11
10090789|NCT02325739|11219218|FG001|NOT COMPLETED|Phase I Part||6
10090790|NCT02325739|11219219|FG002|NOT COMPLETED|Phase I Part||5
10090791|NCT02325739|11219220|FG003|NOT COMPLETED|Phase I Part||26
10090792|NCT02325739|11219221|FG004|NOT COMPLETED|Phase I Part||19
9740120|NCT00237042|10841297|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11
9740121|NCT00237042|10841295|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
10090793|NCT02325739|11219222|FG005|NOT COMPLETED|Phase I Part||7
10090794|NCT02325739|11219223|FG006|NOT COMPLETED|Phase I Part||6
10090795|NCT02325739|11219224|FG007|NOT COMPLETED|Phase I Part||6
10090796|NCT02325739|11219225|FG008|NOT COMPLETED|Phase I Part||0
9740122|NCT00237042|10841296|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
9740123|NCT00237042|10841297|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
9740124|NCT00237042|10841295|FG000|COMPLETED|Long Term (12 Month) Follow up||48
9740125|NCT00237042|10841296|FG001|COMPLETED|Long Term (12 Month) Follow up||46
9740126|NCT00237042|10841297|FG002|COMPLETED|Long Term (12 Month) Follow up||48
9740127|NCT00237042|10841295|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11
9740128|NCT00237042|10841296|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9
9740129|NCT00237042|10841297|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9
9740130|NCT00237185|10841307|FG000|STARTED|Core||74
9740131|NCT00237185|10841308|FG001|STARTED|Core||74
9740132|NCT00237185|10841307|FG000|Treated Participants|Core||73
9740133|NCT00237185|10841308|FG001|Treated Participants|Core||74
9740134|NCT00237185|10841307|FG000|COMPLETED|Core||30
9740135|NCT00237185|10841308|FG001|COMPLETED|Core||37
9740136|NCT00237185|10841307|FG000|NOT COMPLETED|Core||44
9740137|NCT00237185|10841308|FG001|NOT COMPLETED|Core||37
9740138|NCT00237185|10841307|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
9740139|NCT00237185|10841308|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
9740140|NCT00237185|10841307|FG000|COMPLETED|Extension||8
9740141|NCT00237185|10841308|FG001|COMPLETED|Extension||13
9740142|NCT00237185|10841307|FG000|NOT COMPLETED|Extension||16
9740143|NCT00237185|10841308|FG001|NOT COMPLETED|Extension||19
10090797|NCT02325739|11219226|FG009|NOT COMPLETED|Phase I Part||0
10090798|NCT02325739|11219227|FG010|NOT COMPLETED|Phase I Part||0
10090799|NCT02325739|11219217|FG000|STARTED|Phase II Part||0
10090800|NCT02325739|11219218|FG001|STARTED|Phase II Part||0
10090801|NCT02325739|11219219|FG002|STARTED|Phase II Part||0
10090802|NCT02325739|11219220|FG003|STARTED|Phase II Part||0
10090803|NCT02325739|11219221|FG004|STARTED|Phase II Part||0
10090804|NCT02325739|11219222|FG005|STARTED|Phase II Part||0
10090805|NCT02325739|11219223|FG006|STARTED|Phase II Part||0
10090806|NCT02325739|11219224|FG007|STARTED|Phase II Part||0
10090807|NCT02325739|11219225|FG008|STARTED|Phase II Part||30
10090808|NCT02325739|11219226|FG009|STARTED|Phase II Part||36
10090809|NCT02325739|11219227|FG010|STARTED|Phase II Part||20
10090810|NCT02325739|11219217|FG000|COMPLETED|Phase II Part||0
10090811|NCT02325739|11219218|FG001|COMPLETED|Phase II Part||0
10090812|NCT02325739|11219219|FG002|COMPLETED|Phase II Part||0
10090813|NCT02325739|11219220|FG003|COMPLETED|Phase II Part||0
10090814|NCT02325739|11219221|FG004|COMPLETED|Phase II Part||0
10090815|NCT02325739|11219222|FG005|COMPLETED|Phase II Part||0
10090816|NCT02325739|11219223|FG006|COMPLETED|Phase II Part||0
10090817|NCT02325739|11219224|FG007|COMPLETED|Phase II Part||0
10090818|NCT02325739|11219225|FG008|COMPLETED|Phase II Part||0
10090819|NCT02325739|11219226|FG009|COMPLETED|Phase II Part||0
10090820|NCT02325739|11219227|FG010|COMPLETED|Phase II Part||0
10090821|NCT02325739|11219217|FG000|NOT COMPLETED|Phase II Part||0
10090822|NCT02325739|11219218|FG001|NOT COMPLETED|Phase II Part||0
10090823|NCT02325739|11219219|FG002|NOT COMPLETED|Phase II Part||0
10090824|NCT02325739|11219220|FG003|NOT COMPLETED|Phase II Part||0
10090825|NCT02325739|11219221|FG004|NOT COMPLETED|Phase II Part||0
10090826|NCT02325739|11219222|FG005|NOT COMPLETED|Phase II Part||0
10090827|NCT02325739|11219223|FG006|NOT COMPLETED|Phase II Part||0
10090828|NCT02325739|11219224|FG007|NOT COMPLETED|Phase II Part||0
10090829|NCT02325739|11219225|FG008|NOT COMPLETED|Phase II Part||30
10090830|NCT02325739|11219226|FG009|NOT COMPLETED|Phase II Part||36
10090831|NCT02325739|11219227|FG010|NOT COMPLETED|Phase II Part||20
10090832|NCT02325791|11219276|FG000|STARTED|Overall Study||23
10090833|NCT02325791|11219277|FG001|STARTED|Overall Study||383
10090834|NCT02325791|11219278|FG002|STARTED|Overall Study||385
10090835|NCT02325791|11219279|FG003|STARTED|Overall Study||381
10090836|NCT02325791|11219276|FG000|COMPLETED|Overall Study||23
10090837|NCT02325791|11219277|FG001|COMPLETED|Overall Study||358
10090838|NCT02325791|11219278|FG002|COMPLETED|Overall Study||360
10090839|NCT02325791|11219279|FG003|COMPLETED|Overall Study||355
10090840|NCT02325791|11219276|FG000|NOT COMPLETED|Overall Study||0
10090841|NCT02325791|11219277|FG001|NOT COMPLETED|Overall Study||25
10090842|NCT02325791|11219278|FG002|NOT COMPLETED|Overall Study||25
10090843|NCT02325791|11219279|FG003|NOT COMPLETED|Overall Study||26
10090844|NCT02325856|11219294|FG000|STARTED|Overall Study||148
10090845|NCT02325856|11219295|FG001|STARTED|Overall Study||150
10090846|NCT02325856|11219294|FG000|COMPLETED|Overall Study||128
10090847|NCT02325856|11219295|FG001|COMPLETED|Overall Study||123
10090848|NCT02325856|11219294|FG000|NOT COMPLETED|Overall Study||20
10090849|NCT02325856|11219295|FG001|NOT COMPLETED|Overall Study||27
10090850|NCT02326025|11219303|FG000|STARTED|Overall Study||25
10090851|NCT02326025|11219304|FG001|STARTED|Overall Study||24
10090852|NCT02326025|11219303|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
10090853|NCT02326025|11219304|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
10090854|NCT02326025|11219303|FG000|COMPLETED|Overall Study||20
10090855|NCT02326025|11219304|FG001|COMPLETED|Overall Study||19
10090856|NCT02326025|11219303|FG000|NOT COMPLETED|Overall Study||5
10090857|NCT02326025|11219304|FG001|NOT COMPLETED|Overall Study||5
10090858|NCT02326220|11219325|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
9740144|NCT00237458|10841314|FG000|STARTED|Overall Study||7
9740145|NCT00237458|10841314|FG000|COMPLETED|Overall Study||4
9740146|NCT00237458|10841314|FG000|NOT COMPLETED|Overall Study||3
9740147|NCT00237666|10841318|FG000|STARTED|Overall Study||30
9740148|NCT00237666|10841318|FG000|COMPLETED|Overall Study||24
10090859|NCT02326220|11219326|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
9740149|NCT00237666|10841318|FG000|NOT COMPLETED|Overall Study||6
9740150|NCT00237692|10841326|FG000|STARTED|Overall Study||147
9740151|NCT00237692|10841327|FG001|STARTED|Overall Study||148
9740152|NCT00237692|10841328|FG002|STARTED|Overall Study||149
9740153|NCT00237692|10841329|FG003|STARTED|Overall Study||147
9740154|NCT00237692|10841326|FG000|6 Month f/u|Overall Study||132
9740155|NCT00237692|10841327|FG001|6 Month f/u|Overall Study||134
9740156|NCT00237692|10841328|FG002|6 Month f/u|Overall Study||135
9740157|NCT00237692|10841329|FG003|6 Month f/u|Overall Study||134
9740158|NCT00237692|10841326|FG000|12 Month f/u|Overall Study||137
9740159|NCT00237692|10841327|FG001|12 Month f/u|Overall Study||127
9740160|NCT00237692|10841328|FG002|12 Month f/u|Overall Study||132
9740161|NCT00237692|10841329|FG003|12 Month f/u|Overall Study||127
9740162|NCT00237692|10841326|FG000|18 Month f/u|Overall Study||124
9740163|NCT00237692|10841327|FG001|18 Month f/u|Overall Study||131
9740164|NCT00237692|10841328|FG002|18 Month f/u|Overall Study||126
9740165|NCT00237692|10841329|FG003|18 Month f/u|Overall Study||122
9740166|NCT00237692|10841326|FG000|COMPLETED|Overall Study||129
9740167|NCT00237692|10841327|FG001|COMPLETED|Overall Study||134
9740168|NCT00237692|10841328|FG002|COMPLETED|Overall Study||127
9740169|NCT00237692|10841329|FG003|COMPLETED|Overall Study||128
9740170|NCT00237692|10841326|FG000|NOT COMPLETED|Overall Study||18
9740171|NCT00237692|10841327|FG001|NOT COMPLETED|Overall Study||14
9740172|NCT00237692|10841328|FG002|NOT COMPLETED|Overall Study||22
9740173|NCT00237692|10841329|FG003|NOT COMPLETED|Overall Study||19
9740174|NCT00237718|10841341|FG000|STARTED|Overall Study||160
9740175|NCT00237718|10841342|FG001|STARTED|Overall Study||165
9740176|NCT00237718|10841341|FG000|COMPLETED|Overall Study||114
9740177|NCT00237718|10841342|FG001|COMPLETED|Overall Study||124
9740178|NCT00237718|10841341|FG000|NOT COMPLETED|Overall Study||46
9740179|NCT00237718|10841342|FG001|NOT COMPLETED|Overall Study||41
9740180|NCT00237744|10841351|FG000|STARTED|Overall Study||11
9740181|NCT00237744|10841352|FG001|STARTED|Overall Study||11
9740182|NCT00237744|10841353|FG002|STARTED|Overall Study||18
9740183|NCT00237744|10841351|FG000|COMPLETED|Overall Study||8
9740184|NCT00237744|10841352|FG001|COMPLETED|Overall Study||10
9740185|NCT00237744|10841353|FG002|COMPLETED|Overall Study||18
9740186|NCT00237744|10841351|FG000|NOT COMPLETED|Overall Study||3
9740187|NCT00237744|10841352|FG001|NOT COMPLETED|Overall Study||1
9740188|NCT00237744|10841353|FG002|NOT COMPLETED|Overall Study||0
9740189|NCT00237770|10841366|FG000|STARTED|Overall Study||9
9740190|NCT00237770|10841367|FG001|STARTED|Overall Study||7
10090860|NCT02326220|11219327|FG002|STARTED|Double-blind Treatment Period||0
10090861|NCT02326220|11219325|FG000|COMPLETED|Double-blind Treatment Period||20
10090862|NCT02326220|11219326|FG001|COMPLETED|Double-blind Treatment Period||37
10090863|NCT02326220|11219327|FG002|COMPLETED|Double-blind Treatment Period||0
10090864|NCT02326220|11219325|FG000|NOT COMPLETED|Double-blind Treatment Period||1
10090865|NCT02326220|11219326|FG001|NOT COMPLETED|Double-blind Treatment Period||4
10090866|NCT02326220|11219327|FG002|NOT COMPLETED|Double-blind Treatment Period||0
10090867|NCT02326220|11219325|FG000|STARTED|Open-label Treatment Period||0
10090868|NCT02326220|11219326|FG001|STARTED|Open-label Treatment Period||0
10090869|NCT02326220|11219327|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
10090870|NCT02326220|11219325|FG000|COMPLETED|Open-label Treatment Period||0
10090871|NCT02326220|11219326|FG001|COMPLETED|Open-label Treatment Period||0
10090872|NCT02326220|11219327|FG002|COMPLETED|Open-label Treatment Period||27
10090873|NCT02326220|11219325|FG000|NOT COMPLETED|Open-label Treatment Period||0
10090874|NCT02326220|11219326|FG001|NOT COMPLETED|Open-label Treatment Period||0
10090875|NCT02326220|11219327|FG002|NOT COMPLETED|Open-label Treatment Period||2
10090876|NCT02326233|11219339|FG000|STARTED|Overall Study||95
10090877|NCT02326233|11219340|FG001|STARTED|Overall Study||95
10090878|NCT02326233|11219339|FG000|COMPLETED|Overall Study||95
10090879|NCT02326233|11219340|FG001|COMPLETED|Overall Study||94
10090880|NCT02326233|11219339|FG000|NOT COMPLETED|Overall Study||0
10090881|NCT02326233|11219340|FG001|NOT COMPLETED|Overall Study||1
9740191|NCT00237770|10841366|FG000|COMPLETED|Overall Study||9
10090882|NCT02326272|11219349|FG000|STARTED|Initial Period (Week 0 to Week 16)||49
10090883|NCT02326272|11219350|FG001|STARTED|Initial Period (Week 0 to Week 16)||91
10090884|NCT02326272|11219351|FG002|STARTED|Initial Period (Week 0 to Week 16)||87
10090885|NCT02326272|11219352|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
10090886|NCT02326272|11219353|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
10090887|NCT02326272|11219354|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
10090888|NCT02326272|11219355|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
10090889|NCT02326272|11219356|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
10090890|NCT02326272|11219357|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
10090891|NCT02326272|11219358|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
10090892|NCT02326272|11219359|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
9740192|NCT00237770|10841367|FG001|COMPLETED|Overall Study||7
9740193|NCT00237770|10841366|FG000|NOT COMPLETED|Overall Study||0
9740194|NCT00237770|10841367|FG001|NOT COMPLETED|Overall Study||0
9740195|NCT00237796|10841379|FG000|STARTED|Overall Study||41
9740196|NCT00237796|10841380|FG001|STARTED|Overall Study||38
9740197|NCT00237796|10841379|FG000|COMPLETED|Overall Study||31
9740198|NCT00237796|10841380|FG001|COMPLETED|Overall Study||33
9740199|NCT00237796|10841379|FG000|NOT COMPLETED|Overall Study||10
9740200|NCT00237796|10841380|FG001|NOT COMPLETED|Overall Study||5
9740201|NCT00237809|10841391|FG000|STARTED|Overall Study||27
9740202|NCT00237809|10841392|FG001|STARTED|Overall Study||27
9740203|NCT00237809|10841393|FG002|STARTED|Overall Study||24
9740204|NCT00237809|10841394|FG003|STARTED|Overall Study||26
9740205|NCT00237809|10841391|FG000|COMPLETED|Overall Study||16
9740206|NCT00237809|10841392|FG001|COMPLETED|Overall Study||17
9740207|NCT00237809|10841393|FG002|COMPLETED|Overall Study||15
9740208|NCT00237809|10841394|FG003|COMPLETED|Overall Study||17
9740209|NCT00237809|10841391|FG000|NOT COMPLETED|Overall Study||11
9740210|NCT00237809|10841392|FG001|NOT COMPLETED|Overall Study||10
9740211|NCT00237809|10841393|FG002|NOT COMPLETED|Overall Study||9
9740212|NCT00237809|10841394|FG003|NOT COMPLETED|Overall Study||9
9740213|NCT00238108|10841406|FG000|STARTED|Overall Study||8
9740214|NCT00238108|10841407|FG001|STARTED|Overall Study||8
9740215|NCT00238108|10841406|FG000|COMPLETED|Overall Study||8
9740216|NCT00238108|10841407|FG001|COMPLETED|Overall Study||8
9740217|NCT00238108|10841406|FG000|NOT COMPLETED|Overall Study||0
10090893|NCT02326272|11219360|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
10090894|NCT02326272|11219361|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
10090895|NCT02326272|11219362|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
10090896|NCT02326272|11219363|FG014|STARTED|Initial Period (Week 0 to Week 16)||0
10090897|NCT02326272|11219349|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45
10090898|NCT02326272|11219350|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84
10090899|NCT02326272|11219351|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83
10090900|NCT02326272|11219352|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090901|NCT02326272|11219353|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090902|NCT02326272|11219354|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090903|NCT02326272|11219355|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090904|NCT02326272|11219356|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090905|NCT02326272|11219357|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090906|NCT02326272|11219358|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090907|NCT02326272|11219359|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090908|NCT02326272|11219360|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090909|NCT02326272|11219361|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090910|NCT02326272|11219362|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090911|NCT02326272|11219363|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10090912|NCT02326272|11219349|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
10090913|NCT02326272|11219350|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
10090914|NCT02326272|11219351|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
10090915|NCT02326272|11219352|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090916|NCT02326272|11219353|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090917|NCT02326272|11219354|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090918|NCT02326272|11219355|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090919|NCT02326272|11219356|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090920|NCT02326272|11219357|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090921|NCT02326272|11219358|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090922|NCT02326272|11219359|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090923|NCT02326272|11219360|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090924|NCT02326272|11219361|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090925|NCT02326272|11219362|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090926|NCT02326272|11219363|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10090927|NCT02326272|11219349|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45
10090928|NCT02326272|11219350|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84
10090929|NCT02326272|11219351|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81
10090930|NCT02326272|11219352|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090931|NCT02326272|11219353|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090932|NCT02326272|11219354|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090933|NCT02326272|11219355|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090934|NCT02326272|11219356|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090935|NCT02326272|11219357|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090936|NCT02326272|11219358|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090937|NCT02326272|11219359|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090938|NCT02326272|11219360|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090939|NCT02326272|11219361|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090940|NCT02326272|11219362|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090941|NCT02326272|11219363|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0
10090942|NCT02326272|11219349|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
9740218|NCT00238108|10841407|FG001|NOT COMPLETED|Overall Study||0
9740219|NCT00238121|10841415|FG000|STARTED|Overall Study||40
9740220|NCT00238121|10841416|FG001|STARTED|Overall Study||16
9740221|NCT00238121|10841415|FG000|COMPLETED|Overall Study||37
9740222|NCT00238121|10841416|FG001|COMPLETED|Overall Study||14
9740223|NCT00238121|10841415|FG000|NOT COMPLETED|Overall Study||3
9740224|NCT00238121|10841416|FG001|NOT COMPLETED|Overall Study||2
9740225|NCT00238238|10841424|FG000|STARTED|Overall Study||3
9740226|NCT00238238|10841425|FG001|STARTED|Overall Study||48
9740227|NCT00238238|10841426|FG002|STARTED|Overall Study||46
9740228|NCT00238238|10841424|FG000|COMPLETED|Overall Study||3
9740229|NCT00238238|10841425|FG001|COMPLETED|Overall Study||45
9740230|NCT00238238|10841426|FG002|COMPLETED|Overall Study||46
9740231|NCT00238238|10841424|FG000|NOT COMPLETED|Overall Study||0
9740232|NCT00238238|10841425|FG001|NOT COMPLETED|Overall Study||3
9740233|NCT00238238|10841426|FG002|NOT COMPLETED|Overall Study||0
9740234|NCT00238264|10841434|FG000|STARTED|Overall Study||92
10090943|NCT02326272|11219350|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
10090944|NCT02326272|11219351|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
10090945|NCT02326272|11219352|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090946|NCT02326272|11219353|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090947|NCT02326272|11219354|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090948|NCT02326272|11219355|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
9740235|NCT00238264|10841434|FG000|COMPLETED|Overall Study||56
9740236|NCT00238264|10841434|FG000|NOT COMPLETED|Overall Study||36
9740237|NCT00238303|10841441|FG000|STARTED|Overall Study||68
9740238|NCT00238303|10841442|FG001|STARTED|Overall Study||15
9740239|NCT00238303|10841443|FG002|STARTED|Overall Study||20
9740240|NCT00238303|10841441|FG000|COMPLETED|Overall Study||53
10090949|NCT02326272|11219356|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090950|NCT02326272|11219357|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090951|NCT02326272|11219358|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090952|NCT02326272|11219359|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090953|NCT02326272|11219360|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090954|NCT02326272|11219361|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090955|NCT02326272|11219362|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090956|NCT02326272|11219363|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10090957|NCT02326272|11219349|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090958|NCT02326272|11219350|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090959|NCT02326272|11219351|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090960|NCT02326272|11219352|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6
10090961|NCT02326272|11219353|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
10090962|NCT02326272|11219354|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76
10090963|NCT02326272|11219355|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69
10090964|NCT02326272|11219356|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34
10090965|NCT02326272|11219357|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8
10090966|NCT02326272|11219358|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12
10090967|NCT02326272|11219359|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090968|NCT02326272|11219360|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090969|NCT02326272|11219361|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090970|NCT02326272|11219362|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090971|NCT02326272|11219363|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0
10090972|NCT02326272|11219349|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090973|NCT02326272|11219350|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090974|NCT02326272|11219351|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090975|NCT02326272|11219352|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
10090976|NCT02326272|11219353|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
10090977|NCT02326272|11219354|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
10090978|NCT02326272|11219355|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
10090979|NCT02326272|11219356|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
10090980|NCT02326272|11219357|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
10090981|NCT02326272|11219358|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
10090982|NCT02326272|11219359|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090983|NCT02326272|11219360|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090984|NCT02326272|11219361|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090985|NCT02326272|11219362|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090986|NCT02326272|11219363|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10090987|NCT02326272|11219349|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10090988|NCT02326272|11219350|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10090989|NCT02326272|11219351|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10090990|NCT02326272|11219352|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
10090991|NCT02326272|11219353|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
10090992|NCT02326272|11219354|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
10090993|NCT02326272|11219355|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
10090994|NCT02326272|11219356|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
10090995|NCT02326272|11219357|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
9740241|NCT00238303|10841442|FG001|COMPLETED|Overall Study||13
9740242|NCT00238303|10841443|FG002|COMPLETED|Overall Study||11
9740243|NCT00238303|10841441|FG000|NOT COMPLETED|Overall Study||15
9740244|NCT00238303|10841442|FG001|NOT COMPLETED|Overall Study||2
9740245|NCT00238303|10841443|FG002|NOT COMPLETED|Overall Study||9
9740246|NCT00238355|10841452|FG000|STARTED|Overall Study||13
9740247|NCT00238355|10841452|FG000|COMPLETED|Overall Study||10
9740248|NCT00238355|10841452|FG000|NOT COMPLETED|Overall Study||3
9740249|NCT00238433|10841456|FG000|STARTED|Overall Study||37
9740250|NCT00238433|10841456|FG000|COMPLETED|Overall Study||34
9740251|NCT00238433|10841456|FG000|NOT COMPLETED|Overall Study||3
9740252|NCT00238615|10841461|FG000|STARTED|Overall Study||13
9740253|NCT00238615|10841461|FG000|COMPLETED|Overall Study||13
9740254|NCT00238615|10841461|FG000|NOT COMPLETED|Overall Study||0
9740255|NCT00239005|10841469|FG000|STARTED|Overall Study||69
9740256|NCT00239005|10841470|FG001|STARTED|Overall Study||65
9740257|NCT00239005|10841469|FG000|Intention-to-treat Population (ITT)|Overall Study||68
9740258|NCT00239005|10841470|FG001|Intention-to-treat Population (ITT)|Overall Study||61
9740259|NCT00239005|10841469|FG000|COMPLETED|Overall Study||57
9740260|NCT00239005|10841470|FG001|COMPLETED|Overall Study||53
9740261|NCT00239005|10841469|FG000|NOT COMPLETED|Overall Study||12
9740262|NCT00239005|10841470|FG001|NOT COMPLETED|Overall Study||12
9740263|NCT00239226|10841480|FG000|STARTED|Overall Study||30
9740264|NCT00239226|10841481|FG001|STARTED|Overall Study||18
9740265|NCT00239226|10841482|FG002|STARTED|Overall Study||37
9740266|NCT00239226|10841483|FG003|STARTED|Overall Study||17
9740267|NCT00239226|10841480|FG000|COMPLETED|Overall Study||29
9740268|NCT00239226|10841481|FG001|COMPLETED|Overall Study||18
9740269|NCT00239226|10841482|FG002|COMPLETED|Overall Study||36
9740270|NCT00239226|10841483|FG003|COMPLETED|Overall Study||14
9740271|NCT00239226|10841480|FG000|NOT COMPLETED|Overall Study||1
9740272|NCT00239226|10841481|FG001|NOT COMPLETED|Overall Study||0
9740273|NCT00239226|10841482|FG002|NOT COMPLETED|Overall Study||1
9740274|NCT00239226|10841483|FG003|NOT COMPLETED|Overall Study||3
9740275|NCT00239356|10841495|FG000|STARTED|Overall Study||97
9740276|NCT00239356|10841496|FG001|STARTED|Overall Study||20
9740277|NCT00239356|10841495|FG000|COMPLETED|Overall Study||58
9740278|NCT00239356|10841496|FG001|COMPLETED|Overall Study||11
9740279|NCT00239356|10841495|FG000|NOT COMPLETED|Overall Study||39
9740280|NCT00239356|10841496|FG001|NOT COMPLETED|Overall Study||9
9740281|NCT00239577|10841506|FG000|STARTED|Primary Phase||22
9740282|NCT00239577|10841507|FG001|STARTED|Primary Phase||22
9740283|NCT00239577|10841508|FG002|STARTED|Primary Phase||21
9740284|NCT00239577|10841509|FG003|STARTED|Primary Phase||21
9740285|NCT00239577|10841506|FG000|COMPLETED|Primary Phase||17
9740286|NCT00239577|10841507|FG001|COMPLETED|Primary Phase||19
9740287|NCT00239577|10841508|FG002|COMPLETED|Primary Phase||18
9740288|NCT00239577|10841509|FG003|COMPLETED|Primary Phase||21
9740289|NCT00239577|10841506|FG000|NOT COMPLETED|Primary Phase||5
9740290|NCT00239577|10841507|FG001|NOT COMPLETED|Primary Phase||3
9740291|NCT00239577|10841508|FG002|NOT COMPLETED|Primary Phase||3
9740292|NCT00239577|10841509|FG003|NOT COMPLETED|Primary Phase||0
9740293|NCT00239577|10841506|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
9740294|NCT00239577|10841507|FG001|STARTED|Booster Phase||9
9740295|NCT00239577|10841508|FG002|STARTED|Booster Phase||12
9740296|NCT00239577|10841509|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
9740297|NCT00239577|10841506|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
9740298|NCT00239577|10841507|FG001|COMPLETED|Booster Phase||9
9740299|NCT00239577|10841508|FG002|COMPLETED|Booster Phase||12
9740300|NCT00239577|10841509|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
9740301|NCT00239577|10841506|FG000|NOT COMPLETED|Booster Phase||0
9740302|NCT00239577|10841507|FG001|NOT COMPLETED|Booster Phase||0
9740303|NCT00239577|10841508|FG002|NOT COMPLETED|Booster Phase||0
9740304|NCT00239577|10841509|FG003|NOT COMPLETED|Booster Phase||0
9740305|NCT00239590|10841521|FG000|STARTED|Randomized||14
9740306|NCT00239590|10841522|FG001|STARTED|Randomized||14
9740307|NCT00239590|10841521|FG000|COMPLETED|Randomized||14
9740308|NCT00239590|10841522|FG001|COMPLETED|Randomized||12
9740309|NCT00239590|10841521|FG000|NOT COMPLETED|Randomized||0
9740310|NCT00239590|10841522|FG001|NOT COMPLETED|Randomized||2
9740311|NCT00239590|10841521|FG000|STARTED|Started Intervention After Randomization||14
9740312|NCT00239590|10841522|FG001|STARTED|Started Intervention After Randomization||12
9740313|NCT00239590|10841521|FG000|COMPLETED|Started Intervention After Randomization||14
9740314|NCT00239590|10841522|FG001|COMPLETED|Started Intervention After Randomization||12
9740315|NCT00239590|10841521|FG000|NOT COMPLETED|Started Intervention After Randomization||0
9740316|NCT00239590|10841522|FG001|NOT COMPLETED|Started Intervention After Randomization||0
9740317|NCT00239590|10841521|FG000|STARTED|Completed Study Protocol||14
9740318|NCT00239590|10841522|FG001|STARTED|Completed Study Protocol||12
9740319|NCT00239590|10841521|FG000|COMPLETED|Completed Study Protocol||13
9740320|NCT00239590|10841522|FG001|COMPLETED|Completed Study Protocol||10
9740321|NCT00239590|10841521|FG000|NOT COMPLETED|Completed Study Protocol||1
9740322|NCT00239590|10841522|FG001|NOT COMPLETED|Completed Study Protocol||2
9740323|NCT00239642|10841533|FG000|STARTED|Overall Study||49
9740324|NCT00239642|10841534|FG001|STARTED|Overall Study||47
9740325|NCT00239642|10841535|FG002|STARTED|Overall Study||49
9740326|NCT00239642|10841533|FG000|COMPLETED|Overall Study||47
9740327|NCT00239642|10841534|FG001|COMPLETED|Overall Study||47
9740328|NCT00239642|10841535|FG002|COMPLETED|Overall Study||47
9740329|NCT00239642|10841533|FG000|NOT COMPLETED|Overall Study||2
9740330|NCT00239642|10841534|FG001|NOT COMPLETED|Overall Study||0
9740331|NCT00239642|10841535|FG002|NOT COMPLETED|Overall Study||2
9740332|NCT00239681|10841545|FG000|STARTED|Overall Study||8901
9740333|NCT00239681|10841546|FG001|STARTED|Overall Study||8901
10201718|NCT03440229|11329095|FG001|STARTED|Overall Study||7
9740334|NCT00239681|10841545|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869
9740335|NCT00239681|10841546|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864
9740336|NCT00239681|10841545|FG000|COMPLETED|Overall Study||8208
9740337|NCT00239681|10841546|FG001|COMPLETED|Overall Study||8186
9740338|NCT00239681|10841545|FG000|NOT COMPLETED|Overall Study||693
9740339|NCT00239681|10841546|FG001|NOT COMPLETED|Overall Study||715
9740340|NCT00239733|10841552|FG000|STARTED|Overall Study||6
9740341|NCT00239733|10841552|FG000|COMPLETED|Overall Study||6
9740342|NCT00239733|10841552|FG000|NOT COMPLETED|Overall Study||0
9740343|NCT00239837|10841558|FG000|STARTED|Overall Study||48
9740344|NCT00239837|10841559|FG001|STARTED|Overall Study||52
9740345|NCT00239837|10841558|FG000|6 Months|Overall Study||48
9740346|NCT00239837|10841559|FG001|6 Months|Overall Study||50
9740347|NCT00239837|10841558|FG000|COMPLETED|Overall Study|3-year follow-up|45
9740348|NCT00239837|10841559|FG001|COMPLETED|Overall Study|3-year follow-up|45
9740349|NCT00239837|10841558|FG000|NOT COMPLETED|Overall Study||3
9740350|NCT00239837|10841559|FG001|NOT COMPLETED|Overall Study||7
9740351|NCT00239928|10841567|FG000|STARTED|Overall Study||61
9740352|NCT00239928|10841567|FG000|COMPLETED|Overall Study||51
9740353|NCT00239928|10841567|FG000|NOT COMPLETED|Overall Study||10
9740354|NCT00240071|10841571|FG000|STARTED|Overall Study||30
9740355|NCT00240071|10841571|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
9740356|NCT00240071|10841571|FG000|NOT COMPLETED|Overall Study||3
9740357|NCT00240097|10841576|FG000|STARTED|Part I||30
9740358|NCT00240097|10841576|FG000|COMPLETED|Part I||26
9740359|NCT00240097|10841576|FG000|NOT COMPLETED|Part I||4
9740360|NCT00240097|10841576|FG000|STARTED|Part II||26
9740361|NCT00240097|10841576|FG000|COMPLETED|Part II||3
9740362|NCT00240097|10841576|FG000|NOT COMPLETED|Part II||23
9740363|NCT00240110|10841586|FG000|STARTED|Overall Study||13
9740364|NCT00240110|10841587|FG001|STARTED|Overall Study||13
9740365|NCT00240110|10841586|FG000|COMPLETED|Overall Study||7
9740366|NCT00240110|10841587|FG001|COMPLETED|Overall Study||6
9740367|NCT00240110|10841586|FG000|NOT COMPLETED|Overall Study||6
9740368|NCT00240110|10841587|FG001|NOT COMPLETED|Overall Study||7
9740369|NCT00240162|10841595|FG000|STARTED|Overall Study||21
9740370|NCT00240162|10841595|FG000|COMPLETED|Overall Study||21
9740371|NCT00240162|10841595|FG000|NOT COMPLETED|Overall Study||0
9740372|NCT00240331|10841601|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
9740373|NCT00240331|10841602|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
9740374|NCT00240331|10841601|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
9740375|NCT00240331|10841602|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
9740376|NCT00240331|10841601|FG000|NOT COMPLETED|Overall Study||126
9740377|NCT00240331|10841602|FG001|NOT COMPLETED|Overall Study||134
9740378|NCT00240487|10841610|FG000|STARTED|Overall Study||24
9740379|NCT00240487|10841611|FG001|STARTED|Overall Study||28
9740380|NCT00240487|10841610|FG000|COMPLETED|Overall Study||24
9740381|NCT00240487|10841611|FG001|COMPLETED|Overall Study||28
9740382|NCT00240487|10841610|FG000|NOT COMPLETED|Overall Study||0
9740383|NCT00240487|10841611|FG001|NOT COMPLETED|Overall Study||0
9740384|NCT00240526|10841621|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
9740385|NCT00240526|10841622|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
9740386|NCT00240526|10841623|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
9740387|NCT00240526|10841624|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
9740388|NCT00240526|10841621|FG000|COMPLETED|Year 15||19
9740389|NCT00240526|10841622|FG001|COMPLETED|Year 15||19
9740390|NCT00240526|10841623|FG002|COMPLETED|Year 15||14
9740391|NCT00240526|10841624|FG003|COMPLETED|Year 15||21
9740392|NCT00240526|10841621|FG000|NOT COMPLETED|Year 15||0
9740393|NCT00240526|10841622|FG001|NOT COMPLETED|Year 15||0
9740394|NCT00240526|10841623|FG002|NOT COMPLETED|Year 15||0
9740395|NCT00240526|10841624|FG003|NOT COMPLETED|Year 15||0
9740396|NCT00240526|10841621|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
9740397|NCT00240526|10841622|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
9740398|NCT00240526|10841623|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
9740399|NCT00240526|10841624|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
9852419|NCT00880763|10965260|FG000|COMPLETED|Initial Treatment Period (Part 1)||23
9852420|NCT00880763|10965261|FG001|COMPLETED|Initial Treatment Period (Part 1)||22
9852421|NCT00880763|10965262|FG002|COMPLETED|Initial Treatment Period (Part 1)||23
9852422|NCT00880763|10965263|FG003|COMPLETED|Initial Treatment Period (Part 1)||22
9852423|NCT00880763|10965260|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0
9852424|NCT00880763|10965261|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0
9852425|NCT00880763|10965262|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0
10201719|NCT03440229|11329094|FG000|COMPLETED|Overall Study||9
9740400|NCT00240526|10841621|FG000|COMPLETED|Year 16||17
9740401|NCT00240526|10841622|FG001|COMPLETED|Year 16||19
9740402|NCT00240526|10841623|FG002|COMPLETED|Year 16||16
9740403|NCT00240526|10841624|FG003|COMPLETED|Year 16||22
9740404|NCT00240526|10841621|FG000|NOT COMPLETED|Year 16||0
9740405|NCT00240526|10841622|FG001|NOT COMPLETED|Year 16||0
9740406|NCT00240526|10841623|FG002|NOT COMPLETED|Year 16||0
9740407|NCT00240526|10841624|FG003|NOT COMPLETED|Year 16||0
9740408|NCT00240526|10841621|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
9740409|NCT00240526|10841622|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
9740410|NCT00240526|10841623|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
9740411|NCT00240526|10841624|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
9740412|NCT00240526|10841621|FG000|COMPLETED|Year 17||19
9740413|NCT00240526|10841622|FG001|COMPLETED|Year 17||17
10090996|NCT02326272|11219358|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
10090997|NCT02326272|11219359|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10090998|NCT02326272|11219360|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10090999|NCT02326272|11219361|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091000|NCT02326272|11219362|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091001|NCT02326272|11219363|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091002|NCT02326272|11219349|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091003|NCT02326272|11219350|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091004|NCT02326272|11219351|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091005|NCT02326272|11219352|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10091006|NCT02326272|11219353|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10091007|NCT02326272|11219354|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
10091008|NCT02326272|11219355|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
10091009|NCT02326272|11219356|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
10091010|NCT02326272|11219357|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10091011|NCT02326272|11219358|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
10091012|NCT02326272|11219359|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091013|NCT02326272|11219360|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091014|NCT02326272|11219361|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091015|NCT02326272|11219362|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091016|NCT02326272|11219363|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091017|NCT02326272|11219349|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091018|NCT02326272|11219350|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091019|NCT02326272|11219351|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091020|NCT02326272|11219352|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10091021|NCT02326272|11219353|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10091022|NCT02326272|11219354|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
10091023|NCT02326272|11219355|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
10091024|NCT02326272|11219356|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10091025|NCT02326272|11219357|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10091026|NCT02326272|11219358|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10091027|NCT02326272|11219359|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091028|NCT02326272|11219360|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091029|NCT02326272|11219361|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091030|NCT02326272|11219362|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091031|NCT02326272|11219363|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091032|NCT02326272|11219349|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
10091033|NCT02326272|11219350|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
10091034|NCT02326272|11219351|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
10091035|NCT02326272|11219352|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
10091036|NCT02326272|11219353|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
10091037|NCT02326272|11219354|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
10091038|NCT02326272|11219355|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
10091039|NCT02326272|11219356|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
10091040|NCT02326272|11219357|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
10091041|NCT02326272|11219358|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
10091042|NCT02326272|11219359|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5
10091043|NCT02326272|11219360|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66
10091044|NCT02326272|11219361|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59
10091045|NCT02326272|11219362|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1
10091046|NCT02326272|11219363|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40
10091047|NCT02326272|11219349|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091048|NCT02326272|11219350|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091049|NCT02326272|11219351|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091050|NCT02326272|11219352|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091051|NCT02326272|11219353|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091052|NCT02326272|11219354|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091053|NCT02326272|11219355|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091054|NCT02326272|11219356|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091055|NCT02326272|11219357|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091056|NCT02326272|11219358|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091057|NCT02326272|11219359|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2
9740414|NCT00240526|10841623|FG002|COMPLETED|Year 17||13
9740415|NCT00240526|10841624|FG003|COMPLETED|Year 17||20
9740416|NCT00240526|10841621|FG000|NOT COMPLETED|Year 17||0
9740417|NCT00240526|10841622|FG001|NOT COMPLETED|Year 17||0
9740418|NCT00240526|10841623|FG002|NOT COMPLETED|Year 17||0
9740419|NCT00240526|10841624|FG003|NOT COMPLETED|Year 17||0
9740420|NCT00240526|10841621|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
9740421|NCT00240526|10841622|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
9740422|NCT00240526|10841623|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
9740423|NCT00240526|10841624|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
9740424|NCT00240526|10841621|FG000|COMPLETED|Year 18||16
9740425|NCT00240526|10841622|FG001|COMPLETED|Year 18||17
9740426|NCT00240526|10841623|FG002|COMPLETED|Year 18||14
9740427|NCT00240526|10841624|FG003|COMPLETED|Year 18||20
9740428|NCT00240526|10841621|FG000|NOT COMPLETED|Year 18||0
9740429|NCT00240526|10841622|FG001|NOT COMPLETED|Year 18||0
9740430|NCT00240526|10841623|FG002|NOT COMPLETED|Year 18||0
9740431|NCT00240526|10841624|FG003|NOT COMPLETED|Year 18||0
9740432|NCT00240526|10841621|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
9740433|NCT00240526|10841622|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
9740434|NCT00240526|10841623|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
9740435|NCT00240526|10841624|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
9740436|NCT00240526|10841621|FG000|COMPLETED|Year 19||17
9740437|NCT00240526|10841622|FG001|COMPLETED|Year 19||16
9740438|NCT00240526|10841623|FG002|COMPLETED|Year 19||12
9740439|NCT00240526|10841624|FG003|COMPLETED|Year 19||18
9740440|NCT00240526|10841621|FG000|NOT COMPLETED|Year 19||0
9740441|NCT00240526|10841622|FG001|NOT COMPLETED|Year 19||0
9740442|NCT00240526|10841623|FG002|NOT COMPLETED|Year 19||0
9740443|NCT00240526|10841624|FG003|NOT COMPLETED|Year 19||0
9740444|NCT00240526|10841621|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
9740445|NCT00240526|10841622|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
9740446|NCT00240526|10841623|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
9740447|NCT00240526|10841624|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
9740448|NCT00240526|10841621|FG000|COMPLETED|Year 20||19
9740449|NCT00240526|10841622|FG001|COMPLETED|Year 20||17
9740450|NCT00240526|10841623|FG002|COMPLETED|Year 20||13
9740451|NCT00240526|10841624|FG003|COMPLETED|Year 20||20
9740452|NCT00240526|10841621|FG000|NOT COMPLETED|Year 20||0
9740453|NCT00240526|10841622|FG001|NOT COMPLETED|Year 20||0
9740454|NCT00240526|10841623|FG002|NOT COMPLETED|Year 20||0
9740455|NCT00240526|10841624|FG003|NOT COMPLETED|Year 20||0
9740456|NCT00240539|10841642|FG000|STARTED|Overall Study||2
9740457|NCT00240539|10841643|FG001|STARTED|Overall Study||2
9740458|NCT00240539|10841644|FG002|STARTED|Overall Study||31
9740459|NCT00240539|10841645|FG003|STARTED|Overall Study||1
9740460|NCT00240539|10841642|FG000|COMPLETED|Overall Study||2
9740461|NCT00240539|10841643|FG001|COMPLETED|Overall Study||2
9740462|NCT00240539|10841644|FG002|COMPLETED|Overall Study||31
9740463|NCT00240539|10841645|FG003|COMPLETED|Overall Study||1
9740464|NCT00240539|10841642|FG000|NOT COMPLETED|Overall Study||0
10091058|NCT02326272|11219360|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51
10091059|NCT02326272|11219361|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48
10091060|NCT02326272|11219362|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1
10091061|NCT02326272|11219363|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31
10091062|NCT02326272|11219349|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091063|NCT02326272|11219350|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091064|NCT02326272|11219351|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091065|NCT02326272|11219352|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091066|NCT02326272|11219353|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091067|NCT02326272|11219354|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091068|NCT02326272|11219355|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091069|NCT02326272|11219356|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091070|NCT02326272|11219357|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091071|NCT02326272|11219358|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091072|NCT02326272|11219359|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
10091073|NCT02326272|11219360|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
10091074|NCT02326272|11219361|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
10091075|NCT02326272|11219362|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091076|NCT02326272|11219363|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
10091077|NCT02326298|11219375|FG000|STARTED|Initial Period (Week 0 to Week 16)||51
10091078|NCT02326298|11219376|FG001|STARTED|Initial Period (Week 0 to Week 16)||95
10091079|NCT02326298|11219377|FG002|STARTED|Initial Period (Week 0 to Week 16)||88
9740465|NCT00240539|10841643|FG001|NOT COMPLETED|Overall Study||0
9740466|NCT00240539|10841644|FG002|NOT COMPLETED|Overall Study||0
9740467|NCT00240539|10841645|FG003|NOT COMPLETED|Overall Study||0
9740468|NCT00240981|10841657|FG000|STARTED|Overall Study||106
9740469|NCT00240981|10841658|FG001|STARTED|Overall Study||103
9740470|NCT00240981|10841657|FG000|Intent to Treat Sample|Overall Study||82
10091080|NCT02326298|11219378|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
10091081|NCT02326298|11219379|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
9740471|NCT00240981|10841658|FG001|Intent to Treat Sample|Overall Study||83
9740472|NCT00240981|10841657|FG000|COMPLETED|Overall Study||68
9740473|NCT00240981|10841658|FG001|COMPLETED|Overall Study||70
10091082|NCT02326298|11219380|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
10091083|NCT02326298|11219381|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
10091084|NCT02326298|11219382|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
10091085|NCT02326298|11219383|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
10091086|NCT02326298|11219384|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
10091087|NCT02326298|11219385|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
10091088|NCT02326298|11219386|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
10091089|NCT02326298|11219387|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
10091090|NCT02326298|11219388|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
10091091|NCT02326298|11219375|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46
10091092|NCT02326298|11219376|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92
10091093|NCT02326298|11219377|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87
10091094|NCT02326298|11219378|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091095|NCT02326298|11219379|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091096|NCT02326298|11219380|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091097|NCT02326298|11219381|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091098|NCT02326298|11219382|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091099|NCT02326298|11219383|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091100|NCT02326298|11219384|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091101|NCT02326298|11219385|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091102|NCT02326298|11219386|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091103|NCT02326298|11219387|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091104|NCT02326298|11219388|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10091105|NCT02326298|11219375|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
10091106|NCT02326298|11219376|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
10091107|NCT02326298|11219377|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
10091108|NCT02326298|11219378|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091109|NCT02326298|11219379|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091110|NCT02326298|11219380|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091111|NCT02326298|11219381|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091112|NCT02326298|11219382|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091113|NCT02326298|11219383|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091114|NCT02326298|11219384|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091115|NCT02326298|11219385|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091116|NCT02326298|11219386|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091117|NCT02326298|11219387|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091118|NCT02326298|11219388|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10091119|NCT02326298|11219375|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46
10091120|NCT02326298|11219376|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92
10091121|NCT02326298|11219377|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85
10091122|NCT02326298|11219378|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091123|NCT02326298|11219379|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091124|NCT02326298|11219380|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091125|NCT02326298|11219381|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091126|NCT02326298|11219382|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091127|NCT02326298|11219383|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091128|NCT02326298|11219384|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091129|NCT02326298|11219385|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091130|NCT02326298|11219386|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091131|NCT02326298|11219387|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091132|NCT02326298|11219388|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
10091133|NCT02326298|11219375|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
10091134|NCT02326298|11219376|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
10091135|NCT02326298|11219377|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
10091136|NCT02326298|11219378|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091137|NCT02326298|11219379|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091138|NCT02326298|11219380|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091139|NCT02326298|11219381|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091140|NCT02326298|11219382|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091141|NCT02326298|11219383|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091142|NCT02326298|11219384|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091143|NCT02326298|11219385|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10112886|NCT02506036|11243772|FG000|STARTED|Washout (1-2 Weeks)||2
9740474|NCT00240981|10841657|FG000|NOT COMPLETED|Overall Study||38
9740475|NCT00240981|10841658|FG001|NOT COMPLETED|Overall Study||33
9740476|NCT00240994|10841665|FG000|STARTED|Overall Study||35
9740477|NCT00240994|10841665|FG000|COMPLETED|Overall Study||32
9740478|NCT00240994|10841665|FG000|NOT COMPLETED|Overall Study||3
9740479|NCT00241176|10841669|FG000|STARTED|Overall Study||11
9740480|NCT00241176|10841669|FG000|COMPLETED|Overall Study||11
9740481|NCT00241176|10841669|FG000|NOT COMPLETED|Overall Study||0
9740482|NCT00241280|10841676|FG000|STARTED|Overall Study||247
10091144|NCT02326298|11219386|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091145|NCT02326298|11219387|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091146|NCT02326298|11219388|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10091147|NCT02326298|11219375|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
10091148|NCT02326298|11219376|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
10091149|NCT02326298|11219377|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
10091150|NCT02326298|11219378|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3
10091151|NCT02326298|11219379|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
10091152|NCT02326298|11219380|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74
10091153|NCT02326298|11219381|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77
10091154|NCT02326298|11219382|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38
10091155|NCT02326298|11219383|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18
10091156|NCT02326298|11219384|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8
10091157|NCT02326298|11219385|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
10091158|NCT02326298|11219386|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
10091159|NCT02326298|11219387|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
10091160|NCT02326298|11219388|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
10091161|NCT02326298|11219375|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10091162|NCT02326298|11219376|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10091163|NCT02326298|11219377|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10091164|NCT02326298|11219378|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
10091165|NCT02326298|11219379|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
10091166|NCT02326298|11219380|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
10091167|NCT02326298|11219381|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
10091168|NCT02326298|11219382|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
10091169|NCT02326298|11219383|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
10091170|NCT02326298|11219384|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
10091171|NCT02326298|11219385|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10091172|NCT02326298|11219386|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10091173|NCT02326298|11219387|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10091174|NCT02326298|11219388|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10091175|NCT02326298|11219375|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091176|NCT02326298|11219376|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091177|NCT02326298|11219377|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091178|NCT02326298|11219378|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
10091179|NCT02326298|11219379|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
10091180|NCT02326298|11219380|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
10091181|NCT02326298|11219381|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
10091182|NCT02326298|11219382|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
10091183|NCT02326298|11219383|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
10091184|NCT02326298|11219384|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
10091185|NCT02326298|11219385|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091186|NCT02326298|11219386|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091187|NCT02326298|11219387|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091188|NCT02326298|11219388|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10091189|NCT02326298|11219375|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091190|NCT02326298|11219376|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091191|NCT02326298|11219377|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091192|NCT02326298|11219378|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10091193|NCT02326298|11219379|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10091194|NCT02326298|11219380|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
10091195|NCT02326298|11219381|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
10091196|NCT02326298|11219382|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
10091197|NCT02326298|11219383|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
10091198|NCT02326298|11219384|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10091199|NCT02326298|11219385|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091200|NCT02326298|11219386|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091201|NCT02326298|11219387|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091202|NCT02326298|11219388|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091203|NCT02326298|11219375|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091204|NCT02326298|11219376|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091205|NCT02326298|11219377|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091206|NCT02326298|11219378|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091207|NCT02326298|11219379|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091208|NCT02326298|11219380|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
9740483|NCT00241280|10841677|FG001|STARTED|Overall Study||254
9740484|NCT00241280|10841676|FG000|COMPLETED|Overall Study||199
9740485|NCT00241280|10841677|FG001|COMPLETED|Overall Study||186
9740486|NCT00241280|10841676|FG000|NOT COMPLETED|Overall Study||48
9740487|NCT00241280|10841677|FG001|NOT COMPLETED|Overall Study||68
9740488|NCT00241358|10841687|FG000|STARTED|Overall Study||25
9740489|NCT00241358|10841688|FG001|STARTED|Overall Study||46
9740490|NCT00241358|10841689|FG002|STARTED|Overall Study||21
9740491|NCT00241358|10841687|FG000|COMPLETED|Overall Study||25
9740492|NCT00241358|10841688|FG001|COMPLETED|Overall Study||45
9740493|NCT00241358|10841689|FG002|COMPLETED|Overall Study||20
9740494|NCT00241358|10841687|FG000|NOT COMPLETED|Overall Study||0
9740495|NCT00241358|10841688|FG001|NOT COMPLETED|Overall Study||1
9740496|NCT00241358|10841689|FG002|NOT COMPLETED|Overall Study||1
9740497|NCT00241631|10841698|FG000|STARTED|Run in (2 Weeks)||25
9740498|NCT00241631|10841699|FG001|STARTED|Run in (2 Weeks)||24
9740499|NCT00241631|10841698|FG000|COMPLETED|Run in (2 Weeks)||22
9740500|NCT00241631|10841699|FG001|COMPLETED|Run in (2 Weeks)||21
9740501|NCT00241631|10841698|FG000|NOT COMPLETED|Run in (2 Weeks)||3
9740502|NCT00241631|10841699|FG001|NOT COMPLETED|Run in (2 Weeks)||3
9740503|NCT00241631|10841698|FG000|STARTED|Phase 1 (4 Weeks)||22
9740504|NCT00241631|10841699|FG001|STARTED|Phase 1 (4 Weeks)||21
9740505|NCT00241631|10841698|FG000|COMPLETED|Phase 1 (4 Weeks)||14
9740506|NCT00241631|10841699|FG001|COMPLETED|Phase 1 (4 Weeks)||16
9740507|NCT00241631|10841698|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8
9740508|NCT00241631|10841699|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
9740509|NCT00241631|10841698|FG000|STARTED|Wash Out (2 Weeks)||14
9740510|NCT00241631|10841699|FG001|STARTED|Wash Out (2 Weeks)||16
9740511|NCT00241631|10841698|FG000|COMPLETED|Wash Out (2 Weeks)||14
9740512|NCT00241631|10841699|FG001|COMPLETED|Wash Out (2 Weeks)||16
9740513|NCT00241631|10841698|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
9740514|NCT00241631|10841699|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
9740515|NCT00241631|10841698|FG000|STARTED|Phase 2 (4 Weeks)||14
9740516|NCT00241631|10841699|FG001|STARTED|Phase 2 (4 Weeks)||16
9740517|NCT00241631|10841698|FG000|COMPLETED|Phase 2 (4 Weeks)||14
9740518|NCT00241631|10841699|FG001|COMPLETED|Phase 2 (4 Weeks)||16
9740519|NCT00241631|10841698|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0
9740520|NCT00241631|10841699|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0
9740521|NCT00241644|10841709|FG000|STARTED|First Efficacy Period (Year 1)||1647
9740522|NCT00241644|10841710|FG001|STARTED|First Efficacy Period (Year 1)||1651
9740523|NCT00241644|10841711|FG002|STARTED|First Efficacy Period (Year 1)||1641
10091209|NCT02326298|11219381|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10091210|NCT02326298|11219382|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10091211|NCT02326298|11219383|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10091212|NCT02326298|11219384|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10091213|NCT02326298|11219385|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091214|NCT02326298|11219386|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091215|NCT02326298|11219387|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091216|NCT02326298|11219388|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10091217|NCT02326298|11219375|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
10091218|NCT02326298|11219376|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
10091219|NCT02326298|11219377|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
10091220|NCT02326298|11219378|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
10091221|NCT02326298|11219379|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
10091222|NCT02326298|11219380|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
10091223|NCT02326298|11219381|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
10091224|NCT02326298|11219382|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
10091225|NCT02326298|11219383|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
10091226|NCT02326298|11219384|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
10091227|NCT02326298|11219385|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3
10091228|NCT02326298|11219386|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74
10091229|NCT02326298|11219387|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70
10091230|NCT02326298|11219388|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53
10091231|NCT02326298|11219375|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091232|NCT02326298|11219376|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091233|NCT02326298|11219377|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091234|NCT02326298|11219378|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091235|NCT02326298|11219379|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091236|NCT02326298|11219380|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091237|NCT02326298|11219381|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091238|NCT02326298|11219382|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091239|NCT02326298|11219383|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091240|NCT02326298|11219384|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
9740524|NCT00241644|10841712|FG003|STARTED|First Efficacy Period (Year 1)||3298
9740525|NCT00241644|10841709|FG000|COMPLETED|First Efficacy Period (Year 1)||1420
9740526|NCT00241644|10841710|FG001|COMPLETED|First Efficacy Period (Year 1)||1383
9740527|NCT00241644|10841711|FG002|COMPLETED|First Efficacy Period (Year 1)||1392
9740528|NCT00241644|10841712|FG003|COMPLETED|First Efficacy Period (Year 1)||2803
9740529|NCT00241644|10841709|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227
9740530|NCT00241644|10841710|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268
9740531|NCT00241644|10841711|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249
9740532|NCT00241644|10841712|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495
9740533|NCT00241644|10841709|FG000|STARTED|Second Efficacy Period (Year 2)||771
9740534|NCT00241644|10841710|FG001|STARTED|Second Efficacy Period (Year 2)||754
9740535|NCT00241644|10841711|FG002|STARTED|Second Efficacy Period (Year 2)||746
9740536|NCT00241644|10841712|FG003|STARTED|Second Efficacy Period (Year 2)||1525
9740537|NCT00241644|10841709|FG000|COMPLETED|Second Efficacy Period (Year 2)||710
9740538|NCT00241644|10841710|FG001|COMPLETED|Second Efficacy Period (Year 2)||697
9740539|NCT00241644|10841711|FG002|COMPLETED|Second Efficacy Period (Year 2)||682
9740540|NCT00241644|10841712|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407
9740541|NCT00241644|10841709|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61
10091241|NCT02326298|11219385|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3
10091242|NCT02326298|11219386|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54
10091243|NCT02326298|11219387|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51
10091244|NCT02326298|11219388|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44
10091245|NCT02326298|11219375|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091246|NCT02326298|11219376|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091247|NCT02326298|11219377|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091248|NCT02326298|11219378|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091249|NCT02326298|11219379|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091250|NCT02326298|11219380|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091251|NCT02326298|11219381|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091252|NCT02326298|11219382|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091253|NCT02326298|11219383|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091254|NCT02326298|11219384|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091255|NCT02326298|11219385|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10091256|NCT02326298|11219386|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
10091257|NCT02326298|11219387|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
10091258|NCT02326298|11219388|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
10091259|NCT02326363|11219399|FG000|STARTED|Overall Study||98
10091260|NCT02326363|11219400|FG001|STARTED|Overall Study||106
10091261|NCT02326363|11219399|FG000|COMPLETED|Overall Study||47
10091262|NCT02326363|11219400|FG001|COMPLETED|Overall Study||50
10091263|NCT02326363|11219399|FG000|NOT COMPLETED|Overall Study||51
10091264|NCT02326363|11219400|FG001|NOT COMPLETED|Overall Study||56
10091265|NCT02326467|11219408|FG000|STARTED|Overall Study||10
10091266|NCT02326467|11219408|FG000|COMPLETED|Overall Study||9
10091267|NCT02326467|11219408|FG000|NOT COMPLETED|Overall Study||1
10091268|NCT02326597|11219415|FG000|STARTED|Overall Study||60
10091269|NCT02326597|11219416|FG001|STARTED|Overall Study||60
10091270|NCT02326597|11219415|FG000|COMPLETED|Overall Study||18
10091271|NCT02326597|11219416|FG001|COMPLETED|Overall Study||28
10091272|NCT02326597|11219415|FG000|NOT COMPLETED|Overall Study||42
10091273|NCT02326597|11219416|FG001|NOT COMPLETED|Overall Study||32
10091274|NCT02326649|11219424|FG000|STARTED|Overall Study||33
10091275|NCT02326649|11219424|FG000|COMPLETED|Overall Study||21
10091276|NCT02326649|11219424|FG000|NOT COMPLETED|Overall Study||12
10091277|NCT02326805|11219430|FG000|STARTED|Overall Study||106
10091278|NCT02326805|11219431|FG001|STARTED|Overall Study||48
10091279|NCT02326805|11219430|FG000|COMPLETED|Overall Study||103
10091280|NCT02326805|11219431|FG001|COMPLETED|Overall Study||47
10091281|NCT02326805|11219430|FG000|NOT COMPLETED|Overall Study||3
10091282|NCT02326805|11219431|FG001|NOT COMPLETED|Overall Study||1
10091283|NCT02326844|11219437|FG000|STARTED|Overall Study||3
10091284|NCT02326844|11219437|FG000|COMPLETED|Overall Study||3
10091285|NCT02326844|11219437|FG000|NOT COMPLETED|Overall Study||0
10091286|NCT02326883|11219444|FG000|STARTED|Overall Study||6314
10091287|NCT02326883|11219445|FG001|STARTED|Overall Study||6312
10091288|NCT02326883|11219446|FG002|STARTED|Overall Study||6256
10091289|NCT02326883|11219444|FG000|COMPLETED|Overall Study||6230
10091290|NCT02326883|11219445|FG001|COMPLETED|Overall Study||6227
10091291|NCT02326883|11219446|FG002|COMPLETED|Overall Study||6187
10091292|NCT02326883|11219444|FG000|NOT COMPLETED|Overall Study||84
10091293|NCT02326883|11219445|FG001|NOT COMPLETED|Overall Study||85
10091294|NCT02326883|11219446|FG002|NOT COMPLETED|Overall Study||69
10091295|NCT02327013|11219457|FG000|STARTED|Overall Study||49
10091296|NCT02327013|11219458|FG001|STARTED|Overall Study||45
10091297|NCT02327013|11219459|FG002|STARTED|Overall Study||96
10091298|NCT02327013|11219460|FG003|STARTED|Overall Study||21
10091299|NCT02327013|11219461|FG004|STARTED|Overall Study||16
10091300|NCT02327013|11219457|FG000|COMPLETED|Overall Study||36
10091301|NCT02327013|11219458|FG001|COMPLETED|Overall Study||29
10091302|NCT02327013|11219459|FG002|COMPLETED|Overall Study||54
10091303|NCT02327013|11219460|FG003|COMPLETED|Overall Study||20
10091304|NCT02327013|11219461|FG004|COMPLETED|Overall Study||12
10091305|NCT02327013|11219457|FG000|NOT COMPLETED|Overall Study||13
10091306|NCT02327013|11219458|FG001|NOT COMPLETED|Overall Study||16
10091307|NCT02327013|11219459|FG002|NOT COMPLETED|Overall Study||42
10091308|NCT02327013|11219460|FG003|NOT COMPLETED|Overall Study||1
10091309|NCT02327013|11219461|FG004|NOT COMPLETED|Overall Study||4
10091310|NCT02327052|11219481|FG000|STARTED|Overall Study||58
10091311|NCT02327052|11219481|FG000|COMPLETED|Overall Study||58
10091312|NCT02327052|11219481|FG000|NOT COMPLETED|Overall Study||0
9832401|NCT00772967|10943206|FG002|STARTED|Crossover Treatment 2||3
10091313|NCT02327117|11219487|FG000|STARTED|Overall Study||45
10091314|NCT02327117|11219488|FG001|STARTED|Overall Study||45
10091315|NCT02327117|11219487|FG000|COMPLETED|Overall Study||45
10091316|NCT02327117|11219488|FG001|COMPLETED|Overall Study||45
9740542|NCT00241644|10841710|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57
9740543|NCT00241644|10841711|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64
9740544|NCT00241644|10841712|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118
9740545|NCT00241839|10841724|FG000|STARTED|Overall Study||71
9740546|NCT00241839|10841725|FG001|STARTED|Overall Study||71
10091317|NCT02327117|11219487|FG000|NOT COMPLETED|Overall Study||0
10091318|NCT02327117|11219488|FG001|NOT COMPLETED|Overall Study||0
10091319|NCT02327130|11219494|FG000|STARTED|Overall Study||32
10091320|NCT02327130|11219494|FG000|COMPLETED|Overall Study||20
10091321|NCT02327130|11219494|FG000|NOT COMPLETED|Overall Study||12
10091322|NCT02327143|11219501|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
10091323|NCT02327143|11219502|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
10091324|NCT02327143|11219501|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
10091325|NCT02327143|11219502|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
10091326|NCT02327143|11219501|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
10091327|NCT02327143|11219502|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
10091328|NCT02327143|11219501|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0
10091329|NCT02327143|11219502|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11
10091330|NCT02327143|11219501|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
10091331|NCT02327143|11219502|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
10091332|NCT02327143|11219501|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
10091333|NCT02327143|11219502|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
10091334|NCT02327169|11219523|FG000|STARTED|Overall Study||4
10091335|NCT02327169|11219524|FG001|STARTED|Overall Study||3
10091336|NCT02327169|11219525|FG002|STARTED|Overall Study||7
10091337|NCT02327169|11219526|FG003|STARTED|Overall Study||3
10091338|NCT02327169|11219527|FG004|STARTED|Overall Study||8
10091339|NCT02327169|11219528|FG005|STARTED|Overall Study||4
10091340|NCT02327169|11219529|FG006|STARTED|Overall Study||3
10091341|NCT02327169|11219530|FG007|STARTED|Overall Study||4
10091342|NCT02327169|11219531|FG008|STARTED|Overall Study||6
10091343|NCT02327169|11219532|FG009|STARTED|Overall Study||8
10091344|NCT02327169|11219533|FG010|STARTED|Overall Study||6
10091345|NCT02327169|11219534|FG011|STARTED|Overall Study||7
10091346|NCT02327169|11219535|FG012|STARTED|Overall Study||1
10091347|NCT02327169|11219536|FG013|STARTED|Overall Study||7
10091348|NCT02327169|11219537|FG014|STARTED|Overall Study||10
10091349|NCT02327169|11219523|FG000|COMPLETED|Overall Study||0
10091350|NCT02327169|11219524|FG001|COMPLETED|Overall Study||0
10091351|NCT02327169|11219525|FG002|COMPLETED|Overall Study||0
10091352|NCT02327169|11219526|FG003|COMPLETED|Overall Study||0
10091353|NCT02327169|11219527|FG004|COMPLETED|Overall Study||0
10091354|NCT02327169|11219528|FG005|COMPLETED|Overall Study||0
10091355|NCT02327169|11219529|FG006|COMPLETED|Overall Study||0
10091356|NCT02327169|11219530|FG007|COMPLETED|Overall Study||0
10091357|NCT02327169|11219531|FG008|COMPLETED|Overall Study||0
10091358|NCT02327169|11219532|FG009|COMPLETED|Overall Study||0
10091359|NCT02327169|11219533|FG010|COMPLETED|Overall Study||0
10091360|NCT02327169|11219534|FG011|COMPLETED|Overall Study||0
10091361|NCT02327169|11219535|FG012|COMPLETED|Overall Study||0
10091362|NCT02327169|11219536|FG013|COMPLETED|Overall Study||0
10091363|NCT02327169|11219537|FG014|COMPLETED|Overall Study||0
10091364|NCT02327169|11219523|FG000|NOT COMPLETED|Overall Study||4
10091365|NCT02327169|11219524|FG001|NOT COMPLETED|Overall Study||3
10091366|NCT02327169|11219525|FG002|NOT COMPLETED|Overall Study||7
10091367|NCT02327169|11219526|FG003|NOT COMPLETED|Overall Study||3
10091368|NCT02327169|11219527|FG004|NOT COMPLETED|Overall Study||8
10091369|NCT02327169|11219528|FG005|NOT COMPLETED|Overall Study||4
10091370|NCT02327169|11219529|FG006|NOT COMPLETED|Overall Study||3
10091371|NCT02327169|11219530|FG007|NOT COMPLETED|Overall Study||4
10091372|NCT02327169|11219531|FG008|NOT COMPLETED|Overall Study||6
10091373|NCT02327169|11219532|FG009|NOT COMPLETED|Overall Study||8
10091374|NCT02327169|11219533|FG010|NOT COMPLETED|Overall Study||6
10091375|NCT02327169|11219534|FG011|NOT COMPLETED|Overall Study||7
10091376|NCT02327169|11219535|FG012|NOT COMPLETED|Overall Study||1
10091377|NCT02327169|11219536|FG013|NOT COMPLETED|Overall Study||7
10091378|NCT02327169|11219537|FG014|NOT COMPLETED|Overall Study||10
10091379|NCT02327260|11219582|FG000|STARTED|Overall Study||20
10091380|NCT02327260|11219583|FG001|STARTED|Overall Study||24
10091381|NCT02327260|11219584|FG002|STARTED|Overall Study||17
10091382|NCT02327260|11219582|FG000|COMPLETED|Overall Study||14
10091383|NCT02327260|11219583|FG001|COMPLETED|Overall Study||20
10091384|NCT02327260|11219584|FG002|COMPLETED|Overall Study||15
10091385|NCT02327260|11219582|FG000|NOT COMPLETED|Overall Study||6
10091386|NCT02327260|11219583|FG001|NOT COMPLETED|Overall Study||4
10091387|NCT02327260|11219584|FG002|NOT COMPLETED|Overall Study||2
10091388|NCT02327325|11219596|FG000|STARTED|Overall Study||20
9740547|NCT00241839|10841724|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
9828198|NCT00754390|10938904|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
10091389|NCT02327325|11219597|FG001|STARTED|Overall Study||20
10091390|NCT02327325|11219598|FG002|STARTED|Overall Study||20
10091391|NCT02327325|11219596|FG000|COMPLETED|Overall Study||19
10091392|NCT02327325|11219597|FG001|COMPLETED|Overall Study||16
10091393|NCT02327325|11219598|FG002|COMPLETED|Overall Study||15
10091394|NCT02327325|11219596|FG000|NOT COMPLETED|Overall Study||1
10091395|NCT02327325|11219597|FG001|NOT COMPLETED|Overall Study||4
10091396|NCT02327325|11219598|FG002|NOT COMPLETED|Overall Study||5
10091397|NCT02327351|11219606|FG000|STARTED|Overall Study||98
10091398|NCT02327351|11219606|FG000|COMPLETED|Overall Study||98
9740548|NCT00241839|10841725|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
10091399|NCT02327351|11219606|FG000|NOT COMPLETED|Overall Study||0
10091400|NCT02327429|11219614|FG000|STARTED|Overall Study||19
10091401|NCT02327429|11219614|FG000|COMPLETED|Overall Study||17
10091402|NCT02327429|11219614|FG000|NOT COMPLETED|Overall Study||2
10091403|NCT02327741|11219620|FG000|STARTED|Overall Study||502
10091404|NCT02327741|11219621|FG001|STARTED|Overall Study||508
10091405|NCT02327741|11219620|FG000|COMPLETED|Overall Study||502
10091406|NCT02327741|11219621|FG001|COMPLETED|Overall Study||508
10091407|NCT02327741|11219620|FG000|NOT COMPLETED|Overall Study||0
10091408|NCT02327741|11219621|FG001|NOT COMPLETED|Overall Study||0
10091409|NCT02328027|11219629|FG000|STARTED|Overall Study||5
10091410|NCT02328027|11219630|FG001|STARTED|Overall Study||11
10091411|NCT02328027|11219629|FG000|COMPLETED|Overall Study||5
10091412|NCT02328027|11219630|FG001|COMPLETED|Overall Study||10
10091413|NCT02328027|11219629|FG000|NOT COMPLETED|Overall Study||0
10091414|NCT02328027|11219630|FG001|NOT COMPLETED|Overall Study||1
10091415|NCT02328040|11219637|FG000|STARTED|First Intervention (2 Days)||8
10091416|NCT02328040|11219638|FG001|STARTED|First Intervention (2 Days)||9
10091417|NCT02328040|11219637|FG000|COMPLETED|First Intervention (2 Days)||7
10091418|NCT02328040|11219638|FG001|COMPLETED|First Intervention (2 Days)||8
10091419|NCT02328040|11219637|FG000|NOT COMPLETED|First Intervention (2 Days)||1
10091420|NCT02328040|11219638|FG001|NOT COMPLETED|First Intervention (2 Days)||1
10091421|NCT02328040|11219637|FG000|STARTED|Second Intervention (2 Days)||7
10091422|NCT02328040|11219638|FG001|STARTED|Second Intervention (2 Days)||8
10091423|NCT02328040|11219637|FG000|COMPLETED|Second Intervention (2 Days)||7
10091424|NCT02328040|11219638|FG001|COMPLETED|Second Intervention (2 Days)||8
10091425|NCT02328040|11219637|FG000|NOT COMPLETED|Second Intervention (2 Days)||0
10091426|NCT02328040|11219638|FG001|NOT COMPLETED|Second Intervention (2 Days)||0
10091427|NCT02328326|11219646|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
10091428|NCT02328326|11219647|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
10091429|NCT02328326|11219646|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
10091430|NCT02328326|11219647|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
10091431|NCT02328326|11219646|FG000|COMPLETED|Overall Study||224
10091432|NCT02328326|11219647|FG001|COMPLETED|Overall Study||224
10091433|NCT02328326|11219646|FG000|NOT COMPLETED|Overall Study||22
10091434|NCT02328326|11219647|FG001|NOT COMPLETED|Overall Study||8
10091435|NCT02328404|11219657|FG000|STARTED|Overall Study||30
10091436|NCT02328404|11219658|FG001|STARTED|Overall Study||30
10091437|NCT02328404|11219657|FG000|COMPLETED|Overall Study||29
10091438|NCT02328404|11219658|FG001|COMPLETED|Overall Study||29
10091439|NCT02328404|11219657|FG000|NOT COMPLETED|Overall Study||1
10091440|NCT02328404|11219658|FG001|NOT COMPLETED|Overall Study||1
10091441|NCT02328547|11219670|FG000|STARTED|First Intervention (12 Weeks)||25
10091442|NCT02328547|11219671|FG001|STARTED|First Intervention (12 Weeks)||23
10091443|NCT02328547|11219670|FG000|COMPLETED|First Intervention (12 Weeks)||22
10091444|NCT02328547|11219671|FG001|COMPLETED|First Intervention (12 Weeks)||23
10091445|NCT02328547|11219670|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3
10091446|NCT02328547|11219671|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
10091447|NCT02328547|11219670|FG000|STARTED|Second Intervention (12 Weeks)||22
10091448|NCT02328547|11219671|FG001|STARTED|Second Intervention (12 Weeks)||23
10091449|NCT02328547|11219670|FG000|COMPLETED|Second Intervention (12 Weeks)||22
10091450|NCT02328547|11219671|FG001|COMPLETED|Second Intervention (12 Weeks)||23
10091451|NCT02328547|11219670|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10091452|NCT02328547|11219671|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10091453|NCT02328755|11219685|FG000|STARTED|Overall Study||3
10091454|NCT02328755|11219686|FG001|STARTED|Overall Study||33
10091455|NCT02328755|11219685|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0
10091456|NCT02328755|11219686|FG001|COMPLETED|Overall Study||31
10091457|NCT02328755|11219685|FG000|NOT COMPLETED|Overall Study||3
10091458|NCT02328755|11219686|FG001|NOT COMPLETED|Overall Study||2
10091459|NCT02328807|11219698|FG000|STARTED|Overall Study||6
10091460|NCT02328807|11219698|FG000|COMPLETED|Overall Study||6
10091461|NCT02328807|11219698|FG000|NOT COMPLETED|Overall Study||0
10091462|NCT02328937|11219704|FG000|STARTED|Period 1||7
10091463|NCT02328937|11219705|FG001|STARTED|Period 1||6
10091464|NCT02328937|11219706|FG002|STARTED|Period 1||7
10091465|NCT02328937|11219707|FG003|STARTED|Period 1||6
10091466|NCT02328937|11219708|FG004|STARTED|Period 1||6
10091467|NCT02328937|11219709|FG005|STARTED|Period 1||6
10091468|NCT02328937|11219704|FG000|COMPLETED|Period 1||7
10091469|NCT02328937|11219705|FG001|COMPLETED|Period 1||6
10091470|NCT02328937|11219706|FG002|COMPLETED|Period 1||7
10091471|NCT02328937|11219707|FG003|COMPLETED|Period 1||5
10091472|NCT02328937|11219708|FG004|COMPLETED|Period 1||6
10091473|NCT02328937|11219709|FG005|COMPLETED|Period 1||6
10091474|NCT02328937|11219704|FG000|NOT COMPLETED|Period 1||0
10091475|NCT02328937|11219705|FG001|NOT COMPLETED|Period 1||0
10091476|NCT02328937|11219706|FG002|NOT COMPLETED|Period 1||0
10091477|NCT02328937|11219707|FG003|NOT COMPLETED|Period 1||1
10091478|NCT02328937|11219708|FG004|NOT COMPLETED|Period 1||0
10091479|NCT02328937|11219709|FG005|NOT COMPLETED|Period 1||0
10091480|NCT02328937|11219704|FG000|STARTED|Period 2||7
10091481|NCT02328937|11219705|FG001|STARTED|Period 2||6
9740549|NCT00241839|10841724|FG000|NOT COMPLETED|Overall Study||19
9740550|NCT00241839|10841725|FG001|NOT COMPLETED|Overall Study||18
9740551|NCT00241904|10841733|FG000|STARTED|Overall Study||261
9740552|NCT00241904|10841734|FG001|STARTED|Overall Study||264
9740553|NCT00241904|10841733|FG000|COMPLETED|Overall Study||227
9740554|NCT00241904|10841734|FG001|COMPLETED|Overall Study||240
9740555|NCT00241904|10841733|FG000|NOT COMPLETED|Overall Study||34
9740556|NCT00241904|10841734|FG001|NOT COMPLETED|Overall Study||24
9740557|NCT00241969|10841743|FG000|STARTED|Overall Study||36
9740558|NCT00241969|10841744|FG001|STARTED|Overall Study||42
9740559|NCT00241969|10841743|FG000|COMPLETED|Overall Study||36
9740560|NCT00241969|10841744|FG001|COMPLETED|Overall Study||42
9740561|NCT00241969|10841743|FG000|NOT COMPLETED|Overall Study||0
9740562|NCT00241969|10841744|FG001|NOT COMPLETED|Overall Study||0
9740563|NCT00242216|10841752|FG000|STARTED|Overall Study||39
9740564|NCT00242216|10841753|FG001|STARTED|Overall Study||37
9740565|NCT00242216|10841752|FG000|COMPLETED|Overall Study||21
9740566|NCT00242216|10841753|FG001|COMPLETED|Overall Study||15
9740567|NCT00242216|10841752|FG000|NOT COMPLETED|Overall Study||18
9740568|NCT00242216|10841753|FG001|NOT COMPLETED|Overall Study||22
9740569|NCT00242385|10841759|FG000|STARTED|Period 1||14
9740570|NCT00242385|10841760|FG001|STARTED|Period 1||11
9740571|NCT00242385|10841759|FG000|COMPLETED|Period 1||14
9740572|NCT00242385|10841760|FG001|COMPLETED|Period 1||11
9740573|NCT00242385|10841759|FG000|NOT COMPLETED|Period 1||0
9740574|NCT00242385|10841760|FG001|NOT COMPLETED|Period 1||0
9740575|NCT00242385|10841759|FG000|STARTED|Period 2||14
9740576|NCT00242385|10841760|FG001|STARTED|Period 2||11
9740577|NCT00242385|10841759|FG000|COMPLETED|Period 2||14
9740578|NCT00242385|10841760|FG001|COMPLETED|Period 2||11
9740579|NCT00242385|10841759|FG000|NOT COMPLETED|Period 2||0
9740580|NCT00242385|10841760|FG001|NOT COMPLETED|Period 2||0
9740581|NCT00242502|10841766|FG000|STARTED|Overall Study||59
9740582|NCT00242502|10841766|FG000|COMPLETED|Overall Study||59
9740583|NCT00242502|10841766|FG000|NOT COMPLETED|Overall Study||0
9740584|NCT00242567|10841772|FG000|STARTED|Overall Study||259
9740585|NCT00242567|10841773|FG001|STARTED|Overall Study||263
9740586|NCT00242567|10841772|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259
9740587|NCT00242567|10841773|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
9740588|NCT00242567|10841772|FG000|Never Received Study Drug|Overall Study||0
9740589|NCT00242567|10841773|FG001|Never Received Study Drug|Overall Study||191
9740590|NCT00242567|10841772|FG000|COMPLETED|Overall Study||93
9740591|NCT00242567|10841773|FG001|COMPLETED|Overall Study||123
9740592|NCT00242567|10841772|FG000|NOT COMPLETED|Overall Study||166
9740593|NCT00242567|10841773|FG001|NOT COMPLETED|Overall Study||140
9740594|NCT00242580|10841784|FG000|STARTED|Overall Study||32
9740595|NCT00242580|10841785|FG001|STARTED|Overall Study||41
9740596|NCT00242580|10841786|FG002|STARTED|Overall Study||38
9740597|NCT00242580|10841784|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
9740598|NCT00242580|10841785|FG001|COMPLETED|Overall Study||29
9740599|NCT00242580|10841786|FG002|COMPLETED|Overall Study||24
9740600|NCT00242580|10841784|FG000|NOT COMPLETED|Overall Study||10
9740601|NCT00242580|10841785|FG001|NOT COMPLETED|Overall Study||12
9740602|NCT00242580|10841786|FG002|NOT COMPLETED|Overall Study||14
9740603|NCT00242619|10841796|FG000|STARTED|Overall Study||8
9740604|NCT00242619|10841797|FG001|STARTED|Overall Study||4
9740605|NCT00242619|10841796|FG000|COMPLETED|Overall Study||8
9740606|NCT00242619|10841797|FG001|COMPLETED|Overall Study||4
9740607|NCT00242619|10841796|FG000|NOT COMPLETED|Overall Study||0
9740608|NCT00242619|10841797|FG001|NOT COMPLETED|Overall Study||0
9740609|NCT00242632|10841807|FG000|STARTED|Overall Study||11
9740610|NCT00242632|10841808|FG001|STARTED|Overall Study||11
9740611|NCT00242632|10841807|FG000|COMPLETED|Overall Study||11
9740612|NCT00242632|10841808|FG001|COMPLETED|Overall Study||11
9740613|NCT00242632|10841807|FG000|NOT COMPLETED|Overall Study||0
9740614|NCT00242632|10841808|FG001|NOT COMPLETED|Overall Study||0
9740615|NCT00242658|10841815|FG000|STARTED|Overall Study||187
9740616|NCT00242658|10841816|FG001|STARTED|Overall Study||207
9740617|NCT00242658|10841815|FG000|COMPLETED|Overall Study||165
9740618|NCT00242658|10841816|FG001|COMPLETED|Overall Study||188
9740619|NCT00242658|10841815|FG000|NOT COMPLETED|Overall Study||22
9740620|NCT00242658|10841816|FG001|NOT COMPLETED|Overall Study||19
9740621|NCT00242684|10841822|FG000|STARTED|Overall Study||446
9740622|NCT00242684|10841822|FG000|COMPLETED|Overall Study||446
9740623|NCT00242684|10841822|FG000|NOT COMPLETED|Overall Study||0
9740624|NCT00242710|10841830|FG000|STARTED|Core Study (up to Year 1)||373
9740625|NCT00242710|10841831|FG001|STARTED|Core Study (up to Year 1)||353
9740626|NCT00242710|10841832|FG002|STARTED|Core Study (up to Year 1)||183
9740627|NCT00242710|10841833|FG003|STARTED|Core Study (up to Year 1)||174
9740628|NCT00242710|10841830|FG000|Treated|Core Study (up to Year 1)||361
9740629|NCT00242710|10841831|FG001|Treated|Core Study (up to Year 1)||349
9740630|NCT00242710|10841832|FG002|Treated|Core Study (up to Year 1)||179
9740631|NCT00242710|10841833|FG003|Treated|Core Study (up to Year 1)||172
9740632|NCT00242710|10841830|FG000|COMPLETED|Core Study (up to Year 1)||287
9740633|NCT00242710|10841831|FG001|COMPLETED|Core Study (up to Year 1)||289
9740634|NCT00242710|10841832|FG002|COMPLETED|Core Study (up to Year 1)||132
9740635|NCT00242710|10841833|FG003|COMPLETED|Core Study (up to Year 1)||143
9740636|NCT00242710|10841830|FG000|NOT COMPLETED|Core Study (up to Year 1)||86
9740637|NCT00242710|10841831|FG001|NOT COMPLETED|Core Study (up to Year 1)||64
9740638|NCT00242710|10841832|FG002|NOT COMPLETED|Core Study (up to Year 1)||51
9740639|NCT00242710|10841833|FG003|NOT COMPLETED|Core Study (up to Year 1)||31
9740640|NCT00242710|10841830|FG000|STARTED|Period Between Core Study and Extension||287
9740641|NCT00242710|10841831|FG001|STARTED|Period Between Core Study and Extension||289
9740642|NCT00242710|10841832|FG002|STARTED|Period Between Core Study and Extension||132
9740643|NCT00242710|10841833|FG003|STARTED|Period Between Core Study and Extension||143
9740644|NCT00242710|10841830|FG000|COMPLETED|Period Between Core Study and Extension||168
9740645|NCT00242710|10841831|FG001|COMPLETED|Period Between Core Study and Extension||177
9740646|NCT00242710|10841832|FG002|COMPLETED|Period Between Core Study and Extension||84
9740647|NCT00242710|10841833|FG003|COMPLETED|Period Between Core Study and Extension||94
9740648|NCT00242710|10841830|FG000|NOT COMPLETED|Period Between Core Study and Extension||119
9740649|NCT00242710|10841831|FG001|NOT COMPLETED|Period Between Core Study and Extension||112
9740650|NCT00242710|10841832|FG002|NOT COMPLETED|Period Between Core Study and Extension||48
9740651|NCT00242710|10841833|FG003|NOT COMPLETED|Period Between Core Study and Extension||49
9740652|NCT00242710|10841830|FG000|STARTED|Study Extension (up to Year 2)||168
9740653|NCT00242710|10841831|FG001|STARTED|Study Extension (up to Year 2)||177
9740654|NCT00242710|10841832|FG002|STARTED|Study Extension (up to Year 2)||84
9740655|NCT00242710|10841833|FG003|STARTED|Study Extension (up to Year 2)||94
9740656|NCT00242710|10841830|FG000|COMPLETED|Study Extension (up to Year 2)||141
9740657|NCT00242710|10841831|FG001|COMPLETED|Study Extension (up to Year 2)||148
9740658|NCT00242710|10841832|FG002|COMPLETED|Study Extension (up to Year 2)||69
9740659|NCT00242710|10841833|FG003|COMPLETED|Study Extension (up to Year 2)||84
9740660|NCT00242710|10841830|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27
9740661|NCT00242710|10841831|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29
9740662|NCT00242710|10841832|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15
9740663|NCT00242710|10841833|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10
9740664|NCT00243022|10841845|FG000|STARTED|Overall Study||7
9740665|NCT00243022|10841846|FG001|STARTED|Overall Study||5
9740666|NCT00243022|10841845|FG000|COMPLETED|Overall Study||5
9740667|NCT00243022|10841846|FG001|COMPLETED|Overall Study||4
9740668|NCT00243022|10841845|FG000|NOT COMPLETED|Overall Study||2
9740669|NCT00243022|10841846|FG001|NOT COMPLETED|Overall Study||1
9740670|NCT00243061|10841853|FG000|STARTED|Overall Study||24
9740671|NCT00243061|10841853|FG000|COMPLETED|Overall Study||24
9740672|NCT00243061|10841853|FG000|NOT COMPLETED|Overall Study||0
9740673|NCT00243074|10841858|FG000|STARTED|Overall Study||54
9740674|NCT00243074|10841858|FG000|COMPLETED|Overall Study||0
9740675|NCT00243074|10841858|FG000|NOT COMPLETED|Overall Study||54
9740676|NCT00243152|10841863|FG000|STARTED|Overall Study||3
9740677|NCT00243152|10841864|FG001|STARTED|Overall Study||3
9740678|NCT00243152|10841863|FG000|Scan 1: Drug or Placebo|Overall Study||3
9740679|NCT00243152|10841864|FG001|Scan 1: Drug or Placebo|Overall Study||3
9740680|NCT00243152|10841863|FG000|Scan 2: Placebo or Drug|Overall Study||3
9740681|NCT00243152|10841864|FG001|Scan 2: Placebo or Drug|Overall Study||3
9740682|NCT00243152|10841863|FG000|COMPLETED|Overall Study||3
9740683|NCT00243152|10841864|FG001|COMPLETED|Overall Study||3
9740684|NCT00243152|10841863|FG000|NOT COMPLETED|Overall Study||0
9740685|NCT00243152|10841864|FG001|NOT COMPLETED|Overall Study||0
9740686|NCT00243191|10841871|FG000|STARTED|Overall Study||18
9740687|NCT00243191|10841871|FG000|COMPLETED|Overall Study||18
9740688|NCT00243191|10841871|FG000|NOT COMPLETED|Overall Study||0
9740689|NCT00243230|10841878|FG000|STARTED|Double-Blind Period||39
9740690|NCT00243230|10841879|FG001|STARTED|Double-Blind Period||40
9740691|NCT00243230|10841880|FG002|STARTED|Double-Blind Period||37
9740692|NCT00243230|10841881|FG003|STARTED|Double-Blind Period||0
10091482|NCT02328937|11219706|FG002|STARTED|Period 2||7
10091483|NCT02328937|11219707|FG003|STARTED|Period 2||5
10091484|NCT02328937|11219708|FG004|STARTED|Period 2||6
10091485|NCT02328937|11219709|FG005|STARTED|Period 2||6
10091486|NCT02328937|11219704|FG000|COMPLETED|Period 2||7
10091487|NCT02328937|11219705|FG001|COMPLETED|Period 2||6
10091488|NCT02328937|11219706|FG002|COMPLETED|Period 2||6
10091489|NCT02328937|11219707|FG003|COMPLETED|Period 2||5
10091490|NCT02328937|11219708|FG004|COMPLETED|Period 2||6
10091491|NCT02328937|11219709|FG005|COMPLETED|Period 2||6
10091492|NCT02328937|11219704|FG000|NOT COMPLETED|Period 2||0
10091493|NCT02328937|11219705|FG001|NOT COMPLETED|Period 2||0
10091494|NCT02328937|11219706|FG002|NOT COMPLETED|Period 2||1
10091495|NCT02328937|11219707|FG003|NOT COMPLETED|Period 2||0
10091496|NCT02328937|11219708|FG004|NOT COMPLETED|Period 2||0
10091497|NCT02328937|11219709|FG005|NOT COMPLETED|Period 2||0
10091498|NCT02328937|11219704|FG000|STARTED|Period 3||7
10091499|NCT02328937|11219705|FG001|STARTED|Period 3||6
10091500|NCT02328937|11219706|FG002|STARTED|Period 3||6
10091501|NCT02328937|11219707|FG003|STARTED|Period 3||5
10091502|NCT02328937|11219708|FG004|STARTED|Period 3||6
10091503|NCT02328937|11219709|FG005|STARTED|Period 3||6
9740693|NCT00243230|10841878|FG000|Treated|Double-Blind Period||39
9740694|NCT00243230|10841879|FG001|Treated|Double-Blind Period||40
9740695|NCT00243230|10841880|FG002|Treated|Double-Blind Period||35
9740696|NCT00243230|10841881|FG003|Treated|Double-Blind Period||0
9740697|NCT00243230|10841878|FG000|COMPLETED|Double-Blind Period||33
9740698|NCT00243230|10841879|FG001|COMPLETED|Double-Blind Period||35
9740699|NCT00243230|10841880|FG002|COMPLETED|Double-Blind Period||18
9740700|NCT00243230|10841881|FG003|COMPLETED|Double-Blind Period||0
9740701|NCT00243230|10841878|FG000|NOT COMPLETED|Double-Blind Period||6
10091504|NCT02328937|11219704|FG000|COMPLETED|Period 3||7
10091505|NCT02328937|11219705|FG001|COMPLETED|Period 3||6
10091506|NCT02328937|11219706|FG002|COMPLETED|Period 3||6
10091507|NCT02328937|11219707|FG003|COMPLETED|Period 3||5
10091508|NCT02328937|11219708|FG004|COMPLETED|Period 3||6
10091509|NCT02328937|11219709|FG005|COMPLETED|Period 3||6
10091510|NCT02328937|11219704|FG000|NOT COMPLETED|Period 3||0
10091511|NCT02328937|11219705|FG001|NOT COMPLETED|Period 3||0
10091512|NCT02328937|11219706|FG002|NOT COMPLETED|Period 3||0
10091513|NCT02328937|11219707|FG003|NOT COMPLETED|Period 3||0
10091514|NCT02328937|11219708|FG004|NOT COMPLETED|Period 3||0
10091515|NCT02328937|11219709|FG005|NOT COMPLETED|Period 3||0
9740702|NCT00243230|10841879|FG001|NOT COMPLETED|Double-Blind Period||5
9740703|NCT00243230|10841880|FG002|NOT COMPLETED|Double-Blind Period||19
9740704|NCT00243230|10841881|FG003|NOT COMPLETED|Double-Blind Period||0
9740705|NCT00243230|10841878|FG000|STARTED|Open Label Period||0
9740706|NCT00243230|10841879|FG001|STARTED|Open Label Period||0
9740707|NCT00243230|10841880|FG002|STARTED|Open Label Period||0
9740708|NCT00243230|10841881|FG003|STARTED|Open Label Period||85
9740709|NCT00243230|10841878|FG000|COMPLETED|Open Label Period||0
9740710|NCT00243230|10841879|FG001|COMPLETED|Open Label Period||0
9740711|NCT00243230|10841880|FG002|COMPLETED|Open Label Period||0
9740712|NCT00243230|10841881|FG003|COMPLETED|Open Label Period||0
9740713|NCT00243230|10841878|FG000|NOT COMPLETED|Open Label Period||0
9740714|NCT00243230|10841879|FG001|NOT COMPLETED|Open Label Period||0
9740715|NCT00243230|10841880|FG002|NOT COMPLETED|Open Label Period||0
9740716|NCT00243230|10841881|FG003|NOT COMPLETED|Open Label Period||85
9740717|NCT00243243|10841893|FG000|STARTED|Overall Study||10
9740718|NCT00243243|10841894|FG001|STARTED|Overall Study||10
9740719|NCT00243243|10841893|FG000|COMPLETED|Overall Study||10
9740720|NCT00243243|10841894|FG001|COMPLETED|Overall Study||10
9740721|NCT00243243|10841893|FG000|NOT COMPLETED|Overall Study||0
9740722|NCT00243243|10841894|FG001|NOT COMPLETED|Overall Study||0
9740723|NCT00243269|10841904|FG000|STARTED|Overall Study||31
9740724|NCT00243269|10841905|FG001|STARTED|Overall Study||11
9740725|NCT00243269|10841906|FG002|STARTED|Overall Study||12
9740726|NCT00243269|10841907|FG003|STARTED|Overall Study||29
9740727|NCT00243269|10841904|FG000|COMPLETED|Overall Study||28
9740728|NCT00243269|10841905|FG001|COMPLETED|Overall Study||10
9740729|NCT00243269|10841906|FG002|COMPLETED|Overall Study||11
9740730|NCT00243269|10841907|FG003|COMPLETED|Overall Study||25
9740731|NCT00243269|10841904|FG000|NOT COMPLETED|Overall Study||3
9740732|NCT00243269|10841905|FG001|NOT COMPLETED|Overall Study||1
9740733|NCT00243269|10841906|FG002|NOT COMPLETED|Overall Study||1
9740734|NCT00243269|10841907|FG003|NOT COMPLETED|Overall Study||4
9740735|NCT00243347|10841917|FG000|STARTED|Overall Study|Treated|19
9740736|NCT00243347|10841917|FG000|COMPLETED|Overall Study|Completed study|0
9740737|NCT00243347|10841917|FG000|NOT COMPLETED|Overall Study||19
9740738|NCT00243386|10841921|FG000|STARTED|On-Demand Regimen (Study Part 1)||73
9740739|NCT00243386|10841922|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
9740740|NCT00243386|10841923|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
9740741|NCT00243386|10841921|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69
9740742|NCT00243386|10841922|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0
9740743|NCT00243386|10841923|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0
9740744|NCT00243386|10841921|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
9740745|NCT00243386|10841922|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
9740746|NCT00243386|10841923|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
9740747|NCT00243386|10841921|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69
9740748|NCT00243386|10841922|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
9740749|NCT00243386|10841923|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
9740750|NCT00243386|10841921|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
9740751|NCT00243386|10841922|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
9740752|NCT00243386|10841923|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
9740753|NCT00243386|10841921|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
9740754|NCT00243386|10841922|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
9740755|NCT00243386|10841923|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
9740756|NCT00243386|10841921|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
9740757|NCT00243386|10841922|FG001|STARTED|PK-Driven or Standard Prophylaxis||34
9740758|NCT00243386|10841923|FG002|STARTED|PK-Driven or Standard Prophylaxis||32
9740759|NCT00243386|10841921|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0
9740760|NCT00243386|10841922|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31
9740761|NCT00243386|10841923|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32
9740762|NCT00243386|10841921|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
9740763|NCT00243386|10841922|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
9740764|NCT00243386|10841923|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
9740765|NCT00243412|10841961|FG000|STARTED|Overall Study|Intent to treat|21
9740766|NCT00243412|10841962|FG001|STARTED|Overall Study|Intent to treat|21
9740767|NCT00243412|10841961|FG000|Safety Evaluable|Overall Study||21
9740768|NCT00243412|10841962|FG001|Safety Evaluable|Overall Study||20
9740769|NCT00243412|10841961|FG000|COMPLETED|Overall Study|Completed Week 104|11
10091516|NCT02329015|11219719|FG000|STARTED|Overall Study||48
10091517|NCT02329015|11219720|FG001|STARTED|Overall Study||64
10091518|NCT02329015|11219719|FG000|COMPLETED|Overall Study||48
9740770|NCT00243412|10841962|FG001|COMPLETED|Overall Study|Completed Week 104|10
9740771|NCT00243412|10841961|FG000|NOT COMPLETED|Overall Study||10
9740772|NCT00243412|10841962|FG001|NOT COMPLETED|Overall Study||11
9740773|NCT00243503|10841968|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
9740774|NCT00243503|10841968|FG000|COMPLETED|Overall Study||2
9740775|NCT00243503|10841968|FG000|NOT COMPLETED|Overall Study||58
9740776|NCT00243659|10841975|FG000|STARTED|Overall Study||22
9740777|NCT00243659|10841976|FG001|STARTED|Overall Study||8
9740778|NCT00243659|10841975|FG000|COMPLETED|Overall Study||20
9740779|NCT00243659|10841976|FG001|COMPLETED|Overall Study||5
9740780|NCT00243659|10841975|FG000|NOT COMPLETED|Overall Study||2
9740781|NCT00243659|10841976|FG001|NOT COMPLETED|Overall Study||3
9740782|NCT00243841|10841985|FG000|STARTED|Overall Study||3
9740783|NCT00243841|10841986|FG001|STARTED|Overall Study||6
9740784|NCT00243841|10841987|FG002|STARTED|Overall Study||5
9740785|NCT00243841|10841988|FG003|STARTED|Overall Study||3
9740786|NCT00243841|10841989|FG004|STARTED|Overall Study||39
9740787|NCT00243841|10841990|FG005|STARTED|Overall Study||21
9740788|NCT00243841|10841985|FG000|COMPLETED|Overall Study||3
9740789|NCT00243841|10841986|FG001|COMPLETED|Overall Study||6
9740790|NCT00243841|10841987|FG002|COMPLETED|Overall Study||4
9740791|NCT00243841|10841988|FG003|COMPLETED|Overall Study||3
9740792|NCT00243841|10841989|FG004|COMPLETED|Overall Study||39
9740793|NCT00243841|10841990|FG005|COMPLETED|Overall Study||19
9740794|NCT00243841|10841985|FG000|NOT COMPLETED|Overall Study||0
9740795|NCT00243841|10841986|FG001|NOT COMPLETED|Overall Study||0
9740796|NCT00243841|10841987|FG002|NOT COMPLETED|Overall Study||1
9740797|NCT00243841|10841988|FG003|NOT COMPLETED|Overall Study||0
9740798|NCT00243841|10841989|FG004|NOT COMPLETED|Overall Study||0
9740799|NCT00243841|10841990|FG005|NOT COMPLETED|Overall Study||2
9740800|NCT00243919|10842009|FG000|STARTED|Overall Study||139
9740801|NCT00243919|10842010|FG001|STARTED|Overall Study||143
9740802|NCT00243919|10842011|FG002|STARTED|Overall Study||126
9740803|NCT00243919|10842009|FG000|COMPLETED|Overall Study||122
9740804|NCT00243919|10842010|FG001|COMPLETED|Overall Study||125
9740805|NCT00243919|10842011|FG002|COMPLETED|Overall Study||115
9740806|NCT00243919|10842009|FG000|NOT COMPLETED|Overall Study||17
9740807|NCT00243919|10842010|FG001|NOT COMPLETED|Overall Study||18
9740808|NCT00243919|10842011|FG002|NOT COMPLETED|Overall Study||11
9740809|NCT00243932|10842022|FG000|STARTED|Stage 1: Dose Selection||35
9740810|NCT00243932|10842023|FG001|STARTED|Stage 1: Dose Selection||35
9740811|NCT00243932|10842024|FG002|STARTED|Stage 1: Dose Selection||35
9740812|NCT00243932|10842022|FG000|COMPLETED|Stage 1: Dose Selection||33
9740813|NCT00243932|10842023|FG001|COMPLETED|Stage 1: Dose Selection||35
9740814|NCT00243932|10842024|FG002|COMPLETED|Stage 1: Dose Selection||35
9740815|NCT00243932|10842022|FG000|NOT COMPLETED|Stage 1: Dose Selection||2
9740816|NCT00243932|10842023|FG001|NOT COMPLETED|Stage 1: Dose Selection||0
9740817|NCT00243932|10842024|FG002|NOT COMPLETED|Stage 1: Dose Selection||0
9740818|NCT00243932|10842022|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
9740819|NCT00243932|10842023|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
9740820|NCT00243932|10842024|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
9740821|NCT00243932|10842022|FG000|COMPLETED|Stage 2: Efficacy||40
9740822|NCT00243932|10842023|FG001|COMPLETED|Stage 2: Efficacy||40
9740823|NCT00243932|10842024|FG002|COMPLETED|Stage 2: Efficacy||0
9740824|NCT00243932|10842022|FG000|NOT COMPLETED|Stage 2: Efficacy||0
9740825|NCT00243932|10842023|FG001|NOT COMPLETED|Stage 2: Efficacy||0
9740826|NCT00243932|10842024|FG002|NOT COMPLETED|Stage 2: Efficacy||0
9740827|NCT00244101|10842035|FG000|STARTED|Overall Study||209
9740828|NCT00244101|10842036|FG001|STARTED|Overall Study||223
9740829|NCT00244101|10842037|FG002|STARTED|Overall Study||216
9740830|NCT00244101|10842035|FG000|COMPLETED|Overall Study||209
9740831|NCT00244101|10842036|FG001|COMPLETED|Overall Study||223
9740832|NCT00244101|10842037|FG002|COMPLETED|Overall Study||216
9740833|NCT00244101|10842035|FG000|NOT COMPLETED|Overall Study||0
9740834|NCT00244101|10842036|FG001|NOT COMPLETED|Overall Study||0
9740835|NCT00244101|10842037|FG002|NOT COMPLETED|Overall Study||0
9740836|NCT00244140|10842047|FG000|STARTED|Overall Study||412
9740837|NCT00244140|10842048|FG001|STARTED|Overall Study||22
9740838|NCT00244140|10842047|FG000|COMPLETED|Overall Study||412
9740839|NCT00244140|10842048|FG001|COMPLETED|Overall Study||22
9740840|NCT00244140|10842047|FG000|NOT COMPLETED|Overall Study||0
9740841|NCT00244140|10842048|FG001|NOT COMPLETED|Overall Study||0
9740842|NCT00244374|10842054|FG000|STARTED|Pre-Randomization Cross-sectional Study||546
9740843|NCT00244374|10842055|FG001|STARTED|Pre-Randomization Cross-sectional Study||0
9740844|NCT00244374|10842056|FG002|STARTED|Pre-Randomization Cross-sectional Study||0
9740845|NCT00244374|10842057|FG003|STARTED|Pre-Randomization Cross-sectional Study||0
9740846|NCT00244374|10842058|FG004|STARTED|Pre-Randomization Cross-sectional Study||0
9740847|NCT00244374|10842054|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409
9740848|NCT00244374|10842055|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0
9740849|NCT00244374|10842056|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0
9740850|NCT00244374|10842057|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0
9740851|NCT00244374|10842058|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0
9740852|NCT00244374|10842054|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
9740853|NCT00244374|10842055|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
9740854|NCT00244374|10842056|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
9740855|NCT00244374|10842057|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
9740856|NCT00244374|10842058|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
9740857|NCT00244374|10842054|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
9740858|NCT00244374|10842055|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0
9740859|NCT00244374|10842056|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0
9740860|NCT00244374|10842057|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0
9740861|NCT00244374|10842058|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0
9740862|NCT00244374|10842054|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
9740863|NCT00244374|10842055|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
9740864|NCT00244374|10842056|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
9740865|NCT00244374|10842057|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
9740866|NCT00244374|10842058|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
9740867|NCT00244374|10842054|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
9740868|NCT00244374|10842055|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10091519|NCT02329015|11219720|FG001|COMPLETED|Overall Study||64
10091520|NCT02329015|11219719|FG000|NOT COMPLETED|Overall Study||0
10091521|NCT02329015|11219720|FG001|NOT COMPLETED|Overall Study||0
10091522|NCT02329223|11219729|FG000|STARTED|Overall Study||73
10091523|NCT02329223|11219730|FG001|STARTED|Overall Study||71
10091524|NCT02329223|11219731|FG002|STARTED|Overall Study||74
10091525|NCT02329223|11219729|FG000|Full Analysis Set|Overall Study||73
10091526|NCT02329223|11219730|FG001|Full Analysis Set|Overall Study||70
10091527|NCT02329223|11219731|FG002|Full Analysis Set|Overall Study||74
10091528|NCT02329223|11219729|FG000|Safety Set|Overall Study||73
10091529|NCT02329223|11219730|FG001|Safety Set|Overall Study||71
10091530|NCT02329223|11219731|FG002|Safety Set|Overall Study||74
10091531|NCT02329223|11219729|FG000|COMPLETED|Overall Study||72
10091532|NCT02329223|11219730|FG001|COMPLETED|Overall Study||68
10091533|NCT02329223|11219731|FG002|COMPLETED|Overall Study||68
10091534|NCT02329223|11219729|FG000|NOT COMPLETED|Overall Study||1
10091535|NCT02329223|11219730|FG001|NOT COMPLETED|Overall Study||3
10091536|NCT02329223|11219731|FG002|NOT COMPLETED|Overall Study||6
10091537|NCT02329431|11219741|FG000|STARTED|Overall Study||92
10091538|NCT02329431|11219742|FG001|STARTED|Overall Study||89
10091539|NCT02329431|11219741|FG000|Baseline Interview|Overall Study||87
10091540|NCT02329431|11219742|FG001|Baseline Interview|Overall Study||85
10091541|NCT02329431|11219741|FG000|COMPLETED|Overall Study||72
10091542|NCT02329431|11219742|FG001|COMPLETED|Overall Study||76
10091543|NCT02329431|11219741|FG000|NOT COMPLETED|Overall Study||20
10091544|NCT02329431|11219742|FG001|NOT COMPLETED|Overall Study||13
10091545|NCT02329587|11219750|FG000|STARTED|Baseline Thru Post-treatment Assessment||5
10091546|NCT02329587|11219751|FG001|STARTED|Baseline Thru Post-treatment Assessment||7
10091547|NCT02329587|11219750|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
10091548|NCT02329587|11219751|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
10091549|NCT02329587|11219750|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4
10091550|NCT02329587|11219751|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6
10091551|NCT02329587|11219750|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
10091552|NCT02329587|11219751|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
10091553|NCT02329587|11219750|FG000|STARTED|1-month Follow-up||4
10091554|NCT02329587|11219751|FG001|STARTED|1-month Follow-up||6
10091555|NCT02329587|11219750|FG000|COMPLETED|1-month Follow-up||4
10091556|NCT02329587|11219751|FG001|COMPLETED|1-month Follow-up||5
10091557|NCT02329587|11219750|FG000|NOT COMPLETED|1-month Follow-up||0
10091558|NCT02329587|11219751|FG001|NOT COMPLETED|1-month Follow-up||1
10091559|NCT02329600|11219760|FG000|STARTED|Overall Study||10
10091560|NCT02329600|11219761|FG001|STARTED|Overall Study||15
10091561|NCT02329600|11219762|FG002|STARTED|Overall Study||15
10091562|NCT02329600|11219760|FG000|COMPLETED|Overall Study||10
10091563|NCT02329600|11219761|FG001|COMPLETED|Overall Study||15
10091564|NCT02329600|11219762|FG002|COMPLETED|Overall Study||15
9740869|NCT00244374|10842056|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
9740870|NCT00244374|10842057|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
9740871|NCT00244374|10842058|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
9740872|NCT00244374|10842054|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
9740873|NCT00244374|10842055|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
9740874|NCT00244374|10842056|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
9740875|NCT00244374|10842057|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
9740876|NCT00244374|10842058|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
9740877|NCT00244374|10842054|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
9740878|NCT00244374|10842055|FG001|STARTED|Vaccine Adherence Cohort||47
10091565|NCT02329600|11219760|FG000|NOT COMPLETED|Overall Study||0
10091566|NCT02329600|11219761|FG001|NOT COMPLETED|Overall Study||0
10091567|NCT02329600|11219762|FG002|NOT COMPLETED|Overall Study||0
10091568|NCT02329730|11219774|FG000|STARTED|Overall Study||14
10091569|NCT02329730|11219775|FG001|STARTED|Overall Study||14
10091570|NCT02329730|11219776|FG002|STARTED|Overall Study||14
10091571|NCT02329730|11219777|FG003|STARTED|Overall Study||14
10091572|NCT02329730|11219778|FG004|STARTED|Overall Study||14
10091573|NCT02329730|11219779|FG005|STARTED|Overall Study||14
10091574|NCT02329730|11219780|FG006|STARTED|Overall Study||14
9740879|NCT00244374|10842056|FG002|STARTED|Vaccine Adherence Cohort||43
9740880|NCT00244374|10842057|FG003|STARTED|Vaccine Adherence Cohort||36
9740881|NCT00244374|10842058|FG004|STARTED|Vaccine Adherence Cohort||41
9740882|NCT00244374|10842054|FG000|COMPLETED|Vaccine Adherence Cohort||0
9740883|NCT00244374|10842055|FG001|COMPLETED|Vaccine Adherence Cohort||47
9740884|NCT00244374|10842056|FG002|COMPLETED|Vaccine Adherence Cohort||43
9740885|NCT00244374|10842057|FG003|COMPLETED|Vaccine Adherence Cohort||36
9740886|NCT00244374|10842058|FG004|COMPLETED|Vaccine Adherence Cohort||41
9740887|NCT00244374|10842054|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0
9740888|NCT00244374|10842055|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0
9740889|NCT00244374|10842056|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0
9740890|NCT00244374|10842057|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0
9740891|NCT00244374|10842058|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0
9740892|NCT00244621|10842077|FG000|STARTED|Double-blind Treatment Period||29
9740893|NCT00244621|10842078|FG001|STARTED|Double-blind Treatment Period||32
9740894|NCT00244621|10842079|FG002|STARTED|Double-blind Treatment Period||32
9740895|NCT00244621|10842077|FG000|COMPLETED|Double-blind Treatment Period||27
9740896|NCT00244621|10842078|FG001|COMPLETED|Double-blind Treatment Period||29
9740897|NCT00244621|10842079|FG002|COMPLETED|Double-blind Treatment Period||30
9740898|NCT00244621|10842077|FG000|NOT COMPLETED|Double-blind Treatment Period||2
9740899|NCT00244621|10842078|FG001|NOT COMPLETED|Double-blind Treatment Period||3
9740900|NCT00244621|10842079|FG002|NOT COMPLETED|Double-blind Treatment Period||2
9740901|NCT00244621|10842077|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
9740902|NCT00244621|10842078|FG001|STARTED|Open-label Treatment Period||29
9740903|NCT00244621|10842079|FG002|STARTED|Open-label Treatment Period||30
9740904|NCT00244621|10842077|FG000|COMPLETED|Open-label Treatment Period||25
9740905|NCT00244621|10842078|FG001|COMPLETED|Open-label Treatment Period||28
9740906|NCT00244621|10842079|FG002|COMPLETED|Open-label Treatment Period||28
9740907|NCT00244621|10842077|FG000|NOT COMPLETED|Open-label Treatment Period||1
9740908|NCT00244621|10842078|FG001|NOT COMPLETED|Open-label Treatment Period||1
9740909|NCT00244621|10842079|FG002|NOT COMPLETED|Open-label Treatment Period||2
9740910|NCT00244712|10842089|FG000|STARTED|Overall Study||343
9740911|NCT00244712|10842090|FG001|STARTED|Overall Study||345
9740912|NCT00244712|10842089|FG000|COMPLETED|Overall Study||234
9740913|NCT00244712|10842090|FG001|COMPLETED|Overall Study||221
9740914|NCT00244712|10842089|FG000|NOT COMPLETED|Overall Study||109
9740915|NCT00244712|10842090|FG001|NOT COMPLETED|Overall Study||124
9740916|NCT00244725|10842100|FG000|STARTED|Overall Study||237
9740917|NCT00244725|10842101|FG001|STARTED|Overall Study||245
9740918|NCT00244725|10842102|FG002|STARTED|Overall Study||239
9740919|NCT00244725|10842103|FG003|STARTED|Overall Study||237
9740920|NCT00244725|10842100|FG000|COMPLETED|Overall Study||214
9740921|NCT00244725|10842101|FG001|COMPLETED|Overall Study||226
9740922|NCT00244725|10842102|FG002|COMPLETED|Overall Study||215
9740923|NCT00244725|10842103|FG003|COMPLETED|Overall Study||216
9740924|NCT00244725|10842100|FG000|NOT COMPLETED|Overall Study||23
9740925|NCT00244725|10842101|FG001|NOT COMPLETED|Overall Study||19
9740926|NCT00244725|10842102|FG002|NOT COMPLETED|Overall Study||24
9740927|NCT00244725|10842103|FG003|NOT COMPLETED|Overall Study||21
9740928|NCT00244751|10842116|FG000|STARTED|Overall Study||88
9740929|NCT00244751|10842117|FG001|STARTED|Overall Study||89
9740930|NCT00244751|10842118|FG002|STARTED|Overall Study||88
9740931|NCT00244751|10842116|FG000|COMPLETED|Overall Study||72
9740932|NCT00244751|10842117|FG001|COMPLETED|Overall Study||74
10091575|NCT02329730|11219781|FG007|STARTED|Overall Study||14
10091576|NCT02329730|11219782|FG008|STARTED|Overall Study||8
10091577|NCT02329730|11219783|FG009|STARTED|Overall Study||8
9740933|NCT00244751|10842118|FG002|COMPLETED|Overall Study||78
9740934|NCT00244751|10842116|FG000|NOT COMPLETED|Overall Study||16
9740935|NCT00244751|10842117|FG001|NOT COMPLETED|Overall Study||15
9740936|NCT00244751|10842118|FG002|NOT COMPLETED|Overall Study||10
9740937|NCT00244764|10842135|FG000|STARTED|Overall Study||225
9740938|NCT00244764|10842135|FG000|COMPLETED|Overall Study||129
9740939|NCT00244764|10842135|FG000|NOT COMPLETED|Overall Study||96
9740940|NCT00244855|10842142|FG000|STARTED|Overall Study||7
9740941|NCT00244855|10842143|FG001|STARTED|Overall Study||25
9740942|NCT00244855|10842142|FG000|COMPLETED|Overall Study||7
9740943|NCT00244855|10842143|FG001|COMPLETED|Overall Study||24
9740944|NCT00244855|10842142|FG000|NOT COMPLETED|Overall Study||0
9740945|NCT00244855|10842143|FG001|NOT COMPLETED|Overall Study||1
9740946|NCT00244881|10842151|FG000|STARTED|Overall Study||26
9740947|NCT00244881|10842151|FG000|COMPLETED|Overall Study||23
9740948|NCT00244881|10842151|FG000|NOT COMPLETED|Overall Study||3
9740949|NCT00244933|10842155|FG000|STARTED|Overall Study||19
9740950|NCT00244933|10842155|FG000|COMPLETED|Overall Study||17
9740951|NCT00244933|10842155|FG000|NOT COMPLETED|Overall Study||2
9740952|NCT00244985|10842159|FG000|STARTED|Overall Study||42
9740953|NCT00244985|10842159|FG000|COMPLETED|Overall Study||42
9740954|NCT00244985|10842159|FG000|NOT COMPLETED|Overall Study||0
9740955|NCT00245011|10842163|FG000|STARTED|Overall Study||11
9740956|NCT00245011|10842163|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
9740957|NCT00245011|10842163|FG000|NOT COMPLETED|Overall Study||1
9828199|NCT00754390|10938904|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
9828200|NCT00754390|10938904|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
9828201|NCT00754390|10938904|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
9740958|NCT00245037|10842167|FG000|STARTED|Overall Study||147
9740959|NCT00245037|10842167|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130
9740960|NCT00245037|10842167|FG000|NOT COMPLETED|Overall Study||17
9740961|NCT00245050|10842173|FG000|STARTED|Overall Study||18
9740962|NCT00245050|10842174|FG001|STARTED|Overall Study||16
9740963|NCT00245050|10842173|FG000|COMPLETED|Overall Study||15
9740964|NCT00245050|10842174|FG001|COMPLETED|Overall Study||14
9740965|NCT00245050|10842173|FG000|NOT COMPLETED|Overall Study||3
9740966|NCT00245050|10842174|FG001|NOT COMPLETED|Overall Study||2
9740967|NCT00245063|10842182|FG000|STARTED|Overall Study||12
9740968|NCT00245063|10842183|FG001|STARTED|Overall Study||13
9740969|NCT00245063|10842182|FG000|COMPLETED|Overall Study||5
9740970|NCT00245063|10842183|FG001|COMPLETED|Overall Study||8
9740971|NCT00245063|10842182|FG000|NOT COMPLETED|Overall Study||7
9740972|NCT00245063|10842183|FG001|NOT COMPLETED|Overall Study||5
9740973|NCT00245102|10842195|FG000|STARTED|Overall Study||44
9740974|NCT00245102|10842196|FG001|STARTED|Overall Study||16
9740975|NCT00245102|10842197|FG002|STARTED|Overall Study||46
9740976|NCT00245102|10842198|FG003|STARTED|Overall Study||13
9740977|NCT00245102|10842199|FG004|STARTED|Overall Study||5
9740978|NCT00245102|10842200|FG005|STARTED|Overall Study||23
9740979|NCT00245102|10842195|FG000|COMPLETED|Overall Study||37
9740980|NCT00245102|10842196|FG001|COMPLETED|Overall Study||12
9740981|NCT00245102|10842197|FG002|COMPLETED|Overall Study||39
9740982|NCT00245102|10842198|FG003|COMPLETED|Overall Study||10
9740983|NCT00245102|10842199|FG004|COMPLETED|Overall Study||5
9740984|NCT00245102|10842200|FG005|COMPLETED|Overall Study||19
9740985|NCT00245102|10842195|FG000|NOT COMPLETED|Overall Study||7
9740986|NCT00245102|10842196|FG001|NOT COMPLETED|Overall Study||4
9740987|NCT00245102|10842197|FG002|NOT COMPLETED|Overall Study||7
9740988|NCT00245102|10842198|FG003|NOT COMPLETED|Overall Study||3
9740989|NCT00245102|10842199|FG004|NOT COMPLETED|Overall Study||0
9740990|NCT00245102|10842200|FG005|NOT COMPLETED|Overall Study||4
9740991|NCT00245219|10842217|FG000|STARTED|Overall Study||91
9740992|NCT00245219|10842218|FG001|STARTED|Overall Study||94
9740993|NCT00245219|10842219|FG002|STARTED|Overall Study||60
9740994|NCT00245219|10842217|FG000|COMPLETED|Overall Study||85
9740995|NCT00245219|10842218|FG001|COMPLETED|Overall Study||88
9740996|NCT00245219|10842219|FG002|COMPLETED|Overall Study||58
9740997|NCT00245219|10842217|FG000|NOT COMPLETED|Overall Study||6
9740998|NCT00245219|10842218|FG001|NOT COMPLETED|Overall Study||6
9740999|NCT00245219|10842219|FG002|NOT COMPLETED|Overall Study||2
9741000|NCT00245466|10842230|FG000|STARTED|Overall Study||43
9741001|NCT00245466|10842231|FG001|STARTED|Overall Study||46
9741002|NCT00245466|10842232|FG002|STARTED|Overall Study||40
9741003|NCT00245466|10842230|FG000|Started FE200486 CS02A|Overall Study||32
9741004|NCT00245466|10842231|FG001|Started FE200486 CS02A|Overall Study||30
9741005|NCT00245466|10842232|FG002|Started FE200486 CS02A|Overall Study||26
9741006|NCT00245466|10842230|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
9741007|NCT00245466|10842231|FG001|COMPLETED|Overall Study||2
9741008|NCT00245466|10842232|FG002|COMPLETED|Overall Study||3
9741009|NCT00245466|10842230|FG000|NOT COMPLETED|Overall Study||36
9741010|NCT00245466|10842231|FG001|NOT COMPLETED|Overall Study||44
9741011|NCT00245466|10842232|FG002|NOT COMPLETED|Overall Study||37
9741012|NCT00245518|10842242|FG000|STARTED|Overall Study||17
9741013|NCT00245518|10842243|FG001|STARTED|Overall Study||16
10091578|NCT02329730|11219784|FG010|STARTED|Overall Study||8
10091579|NCT02329730|11219785|FG011|STARTED|Overall Study||8
10091580|NCT02329730|11219774|FG000|COMPLETED|Overall Study||14
10091581|NCT02329730|11219775|FG001|COMPLETED|Overall Study||14
10091582|NCT02329730|11219776|FG002|COMPLETED|Overall Study||14
10091583|NCT02329730|11219777|FG003|COMPLETED|Overall Study||14
9741014|NCT00245518|10842242|FG000|COMPLETED|Overall Study||17
9741015|NCT00245518|10842243|FG001|COMPLETED|Overall Study||16
9741016|NCT00245518|10842242|FG000|NOT COMPLETED|Overall Study||0
9741017|NCT00245518|10842243|FG001|NOT COMPLETED|Overall Study||0
9741018|NCT00245557|10842251|FG000|STARTED|Overall Study||17
10091584|NCT02329730|11219778|FG004|COMPLETED|Overall Study||11
10091585|NCT02329730|11219779|FG005|COMPLETED|Overall Study||12
10091586|NCT02329730|11219780|FG006|COMPLETED|Overall Study||13
10091587|NCT02329730|11219781|FG007|COMPLETED|Overall Study||13
10091588|NCT02329730|11219782|FG008|COMPLETED|Overall Study||7
10091589|NCT02329730|11219783|FG009|COMPLETED|Overall Study||7
10091590|NCT02329730|11219784|FG010|COMPLETED|Overall Study||8
10091591|NCT02329730|11219785|FG011|COMPLETED|Overall Study||8
10091592|NCT02329730|11219774|FG000|NOT COMPLETED|Overall Study||0
10091593|NCT02329730|11219775|FG001|NOT COMPLETED|Overall Study||0
10091594|NCT02329730|11219776|FG002|NOT COMPLETED|Overall Study||0
10091595|NCT02329730|11219777|FG003|NOT COMPLETED|Overall Study||0
9741019|NCT00245557|10842252|FG001|STARTED|Overall Study||26
9741020|NCT00245557|10842251|FG000|COMPLETED|Overall Study||11
9741021|NCT00245557|10842252|FG001|COMPLETED|Overall Study||10
9741022|NCT00245557|10842251|FG000|NOT COMPLETED|Overall Study||6
9741023|NCT00245557|10842252|FG001|NOT COMPLETED|Overall Study||16
10091596|NCT02329730|11219778|FG004|NOT COMPLETED|Overall Study||3
10091597|NCT02329730|11219779|FG005|NOT COMPLETED|Overall Study||2
10091598|NCT02329730|11219780|FG006|NOT COMPLETED|Overall Study||1
9741024|NCT00245583|10842261|FG000|STARTED|Overall Study||20
9741025|NCT00245583|10842262|FG001|STARTED|Overall Study||22
9741026|NCT00245583|10842261|FG000|COMPLETED|Overall Study||14
10091599|NCT02329730|11219781|FG007|NOT COMPLETED|Overall Study||1
9741027|NCT00245583|10842262|FG001|COMPLETED|Overall Study||13
9741028|NCT00245583|10842261|FG000|NOT COMPLETED|Overall Study||6
9741029|NCT00245583|10842262|FG001|NOT COMPLETED|Overall Study||9
9741030|NCT00245635|10842270|FG000|STARTED|Overall Study||25
9741031|NCT00245635|10842271|FG001|STARTED|Overall Study||18
9741032|NCT00245635|10842270|FG000|COMPLETED|Overall Study||25
9741033|NCT00245635|10842271|FG001|COMPLETED|Overall Study||18
9741034|NCT00245635|10842270|FG000|NOT COMPLETED|Overall Study||0
9741035|NCT00245635|10842271|FG001|NOT COMPLETED|Overall Study||0
9741036|NCT00245765|10842280|FG000|STARTED|Overall Study||59
9741037|NCT00245765|10842281|FG001|STARTED|Overall Study||59
9741038|NCT00245765|10842282|FG002|STARTED|Overall Study||58
9741039|NCT00245765|10842280|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
9741040|NCT00245765|10842281|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
9741041|NCT00245765|10842282|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
9741042|NCT00245765|10842280|FG000|COMPLETED|Overall Study||27
9741043|NCT00245765|10842281|FG001|COMPLETED|Overall Study||45
9741044|NCT00245765|10842282|FG002|COMPLETED|Overall Study||50
9741045|NCT00245765|10842280|FG000|NOT COMPLETED|Overall Study||32
9741046|NCT00245765|10842281|FG001|NOT COMPLETED|Overall Study||14
9741047|NCT00245765|10842282|FG002|NOT COMPLETED|Overall Study||8
9741048|NCT00245856|10842290|FG000|STARTED|Period One||28
9741049|NCT00245856|10842291|FG001|STARTED|Period One||0
9741050|NCT00245856|10842290|FG000|COMPLETED|Period One||28
9741051|NCT00245856|10842291|FG001|COMPLETED|Period One||0
9741052|NCT00245856|10842290|FG000|NOT COMPLETED|Period One||0
9741053|NCT00245856|10842291|FG001|NOT COMPLETED|Period One||0
9741054|NCT00245856|10842290|FG000|STARTED|Period Two||0
9741055|NCT00245856|10842291|FG001|STARTED|Period Two||39
9741056|NCT00245856|10842290|FG000|COMPLETED|Period Two||0
9741057|NCT00245856|10842291|FG001|COMPLETED|Period Two||38
9741058|NCT00245856|10842290|FG000|NOT COMPLETED|Period Two||0
9741059|NCT00245856|10842291|FG001|NOT COMPLETED|Period Two||1
9741060|NCT00246012|10842307|FG000|STARTED|Overall Study||3
9741061|NCT00246012|10842308|FG001|STARTED|Overall Study||3
9741062|NCT00246012|10842309|FG002|STARTED|Overall Study||3
9741063|NCT00246012|10842310|FG003|STARTED|Overall Study||3
9741064|NCT00246012|10842311|FG004|STARTED|Overall Study||3
9741065|NCT00246012|10842312|FG005|STARTED|Overall Study||32
9741066|NCT00246012|10842313|FG006|STARTED|Overall Study||32
9741067|NCT00246012|10842314|FG007|STARTED|Overall Study||33
9741068|NCT00246012|10842315|FG008|STARTED|Overall Study||32
9741069|NCT00246012|10842307|FG000|Treated|Overall Study||3
9741070|NCT00246012|10842308|FG001|Treated|Overall Study||3
9741071|NCT00246012|10842309|FG002|Treated|Overall Study||3
9741072|NCT00246012|10842310|FG003|Treated|Overall Study||3
9741073|NCT00246012|10842311|FG004|Treated|Overall Study||3
9741074|NCT00246012|10842312|FG005|Treated|Overall Study||31
9741075|NCT00246012|10842313|FG006|Treated|Overall Study||31
9741076|NCT00246012|10842314|FG007|Treated|Overall Study||33
9741077|NCT00246012|10842315|FG008|Treated|Overall Study||32
9741078|NCT00246012|10842307|FG000|COMPLETED|Overall Study||0
9741079|NCT00246012|10842308|FG001|COMPLETED|Overall Study||2
9741080|NCT00246012|10842309|FG002|COMPLETED|Overall Study||1
9741081|NCT00246012|10842310|FG003|COMPLETED|Overall Study||0
9741082|NCT00246012|10842311|FG004|COMPLETED|Overall Study||0
9741083|NCT00246012|10842312|FG005|COMPLETED|Overall Study||4
9741084|NCT00246012|10842313|FG006|COMPLETED|Overall Study||1
9741085|NCT00246012|10842314|FG007|COMPLETED|Overall Study||5
9741086|NCT00246012|10842315|FG008|COMPLETED|Overall Study||4
9741087|NCT00246012|10842307|FG000|NOT COMPLETED|Overall Study||3
9741088|NCT00246012|10842308|FG001|NOT COMPLETED|Overall Study||1
9741089|NCT00246012|10842309|FG002|NOT COMPLETED|Overall Study||2
9741090|NCT00246012|10842310|FG003|NOT COMPLETED|Overall Study||3
9741091|NCT00246012|10842311|FG004|NOT COMPLETED|Overall Study||3
9741092|NCT00246012|10842312|FG005|NOT COMPLETED|Overall Study||28
9741093|NCT00246012|10842313|FG006|NOT COMPLETED|Overall Study||31
9741094|NCT00246012|10842314|FG007|NOT COMPLETED|Overall Study||28
9741095|NCT00246012|10842315|FG008|NOT COMPLETED|Overall Study||28
9741096|NCT00246025|10842341|FG000|STARTED|Overall Study||124
9741097|NCT00246025|10842342|FG001|STARTED|Overall Study||133
9741098|NCT00246025|10842343|FG002|STARTED|Overall Study||126
9741099|NCT00246025|10842344|FG003|STARTED|Overall Study||129
9741100|NCT00246025|10842341|FG000|COMPLETED|Overall Study||114
9741101|NCT00246025|10842342|FG001|COMPLETED|Overall Study||124
9741102|NCT00246025|10842343|FG002|COMPLETED|Overall Study||116
9741103|NCT00246025|10842344|FG003|COMPLETED|Overall Study||116
9741104|NCT00246025|10842341|FG000|NOT COMPLETED|Overall Study||10
9741105|NCT00246025|10842342|FG001|NOT COMPLETED|Overall Study||9
9741106|NCT00246025|10842343|FG002|NOT COMPLETED|Overall Study||10
9741107|NCT00246025|10842344|FG003|NOT COMPLETED|Overall Study||13
9741108|NCT00246090|10842354|FG000|STARTED|Overall Study||298
9741109|NCT00246090|10842354|FG000|COMPLETED|Overall Study||3
9741110|NCT00246090|10842354|FG000|NOT COMPLETED|Overall Study||295
9741111|NCT00246129|10842360|FG000|STARTED|Overall Study||82
9741112|NCT00246129|10842361|FG001|STARTED|Overall Study||41
9741113|NCT00246129|10842360|FG000|COMPLETED|Overall Study||75
9741114|NCT00246129|10842361|FG001|COMPLETED|Overall Study||39
9741115|NCT00246129|10842360|FG000|NOT COMPLETED|Overall Study||7
9741116|NCT00246129|10842361|FG001|NOT COMPLETED|Overall Study||2
9741117|NCT00246259|10842372|FG000|STARTED|Overall Study||44
9741118|NCT00246259|10842373|FG001|STARTED|Overall Study||41
9741119|NCT00246259|10842372|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42
9741120|NCT00246259|10842373|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35
9741121|NCT00246259|10842372|FG000|COMPLETED|Overall Study||16
9741122|NCT00246259|10842373|FG001|COMPLETED|Overall Study||15
9741123|NCT00246259|10842372|FG000|NOT COMPLETED|Overall Study||28
9741124|NCT00246259|10842373|FG001|NOT COMPLETED|Overall Study||26
9741125|NCT00246324|10842379|FG000|STARTED|Overall Study||16
9741126|NCT00246324|10842379|FG000|COMPLETED|Overall Study||15
9741127|NCT00246324|10842379|FG000|NOT COMPLETED|Overall Study||1
9741128|NCT00246337|10842392|FG000|STARTED|Overall Study||147
9741129|NCT00246337|10842393|FG001|STARTED|Overall Study||16
9741130|NCT00246337|10842394|FG002|STARTED|Overall Study||18
9741131|NCT00246337|10842395|FG003|STARTED|Overall Study||17
9741132|NCT00246337|10842396|FG004|STARTED|Overall Study||16
9741133|NCT00246337|10842397|FG005|STARTED|Overall Study||54
9741134|NCT00246337|10842398|FG006|STARTED|Overall Study||54
9741135|NCT00246337|10842399|FG007|STARTED|Overall Study||53
9741136|NCT00246337|10842400|FG008|STARTED|Overall Study||45
9741137|NCT00246337|10842392|FG000|Completed Period (Initial Dose)|Overall Study||46
9741138|NCT00246337|10842393|FG001|Completed Period (Initial Dose)|Overall Study||4
9741139|NCT00246337|10842394|FG002|Completed Period (Initial Dose)|Overall Study||9
9741140|NCT00246337|10842395|FG003|Completed Period (Initial Dose)|Overall Study||5
9741141|NCT00246337|10842396|FG004|Completed Period (Initial Dose)|Overall Study||8
9741142|NCT00246337|10842397|FG005|Completed Period (Initial Dose)|Overall Study||29
9741143|NCT00246337|10842398|FG006|Completed Period (Initial Dose)|Overall Study||29
9741144|NCT00246337|10842399|FG007|Completed Period (Initial Dose)|Overall Study||27
9741145|NCT00246337|10842400|FG008|Completed Period (Initial Dose)|Overall Study||19
9741146|NCT00246337|10842392|FG000|Completed Period (Both Doses)|Overall Study||69
9741147|NCT00246337|10842393|FG001|Completed Period (Both Doses)|Overall Study||10
9741148|NCT00246337|10842394|FG002|Completed Period (Both Doses)|Overall Study||6
9741149|NCT00246337|10842395|FG003|Completed Period (Both Doses)|Overall Study||11
9741150|NCT00246337|10842396|FG004|Completed Period (Both Doses)|Overall Study||4
9741151|NCT00246337|10842397|FG005|Completed Period (Both Doses)|Overall Study||10
9741152|NCT00246337|10842398|FG006|Completed Period (Both Doses)|Overall Study||16
9741153|NCT00246337|10842399|FG007|Completed Period (Both Doses)|Overall Study||13
9741154|NCT00246337|10842400|FG008|Completed Period (Both Doses)|Overall Study||15
9741155|NCT00246337|10842392|FG000|COMPLETED|Overall Study||115
9741156|NCT00246337|10842393|FG001|COMPLETED|Overall Study||14
9741157|NCT00246337|10842394|FG002|COMPLETED|Overall Study||15
9741158|NCT00246337|10842395|FG003|COMPLETED|Overall Study||16
9741159|NCT00246337|10842396|FG004|COMPLETED|Overall Study||12
9741160|NCT00246337|10842397|FG005|COMPLETED|Overall Study||39
9741161|NCT00246337|10842398|FG006|COMPLETED|Overall Study||45
9741162|NCT00246337|10842399|FG007|COMPLETED|Overall Study||40
9741163|NCT00246337|10842400|FG008|COMPLETED|Overall Study||34
9741164|NCT00246337|10842392|FG000|NOT COMPLETED|Overall Study||32
9741165|NCT00246337|10842393|FG001|NOT COMPLETED|Overall Study||2
9741166|NCT00246337|10842394|FG002|NOT COMPLETED|Overall Study||3
9741167|NCT00246337|10842395|FG003|NOT COMPLETED|Overall Study||1
9741168|NCT00246337|10842396|FG004|NOT COMPLETED|Overall Study||4
9741169|NCT00246337|10842397|FG005|NOT COMPLETED|Overall Study||15
9741170|NCT00246337|10842398|FG006|NOT COMPLETED|Overall Study||9
9741171|NCT00246337|10842399|FG007|NOT COMPLETED|Overall Study||13
9741172|NCT00246337|10842400|FG008|NOT COMPLETED|Overall Study||11
9741173|NCT00246376|10842425|FG000|STARTED|Overall Study||41
9741174|NCT00246376|10842426|FG001|STARTED|Overall Study||43
9741175|NCT00246376|10842427|FG002|STARTED|Overall Study||45
9741176|NCT00246376|10842428|FG003|STARTED|Overall Study||47
9741177|NCT00246376|10842429|FG004|STARTED|Overall Study||45
9741178|NCT00246376|10842425|FG000|After Dietary run-in at Two Weeks|Overall Study||30
9741179|NCT00246376|10842426|FG001|After Dietary run-in at Two Weeks|Overall Study||38
9741180|NCT00246376|10842427|FG002|After Dietary run-in at Two Weeks|Overall Study||41
9741181|NCT00246376|10842428|FG003|After Dietary run-in at Two Weeks|Overall Study||40
9741182|NCT00246376|10842429|FG004|After Dietary run-in at Two Weeks|Overall Study||42
9741183|NCT00246376|10842425|FG000|COMPLETED|Overall Study||26
9741184|NCT00246376|10842426|FG001|COMPLETED|Overall Study||24
9741185|NCT00246376|10842427|FG002|COMPLETED|Overall Study||29
9741186|NCT00246376|10842428|FG003|COMPLETED|Overall Study||21
9741187|NCT00246376|10842429|FG004|COMPLETED|Overall Study||28
9741188|NCT00246376|10842425|FG000|NOT COMPLETED|Overall Study||15
9741189|NCT00246376|10842426|FG001|NOT COMPLETED|Overall Study||19
9741190|NCT00246376|10842427|FG002|NOT COMPLETED|Overall Study||16
9741191|NCT00246376|10842428|FG003|NOT COMPLETED|Overall Study||26
9741192|NCT00246376|10842429|FG004|NOT COMPLETED|Overall Study||17
9741193|NCT00246441|10842449|FG000|STARTED|Overall Study||20
9741194|NCT00246441|10842450|FG001|STARTED|Overall Study||22
9741195|NCT00246441|10842449|FG000|COMPLETED|Overall Study||19
9741196|NCT00246441|10842450|FG001|COMPLETED|Overall Study||22
9741197|NCT00246441|10842449|FG000|NOT COMPLETED|Overall Study||1
9741198|NCT00246441|10842450|FG001|NOT COMPLETED|Overall Study||0
9741199|NCT00246519|10842458|FG000|STARTED|Overall Study||442
9741200|NCT00246519|10842459|FG001|STARTED|Overall Study||446
9741201|NCT00246519|10842458|FG000|COMPLETED|Overall Study||386
9741202|NCT00246519|10842459|FG001|COMPLETED|Overall Study||382
9741203|NCT00246519|10842458|FG000|NOT COMPLETED|Overall Study||56
9741204|NCT00246519|10842459|FG001|NOT COMPLETED|Overall Study||64
9741205|NCT00246571|10842467|FG000|STARTED|Overall Study||113
9741206|NCT00246571|10842468|FG001|STARTED|Overall Study||104
10091600|NCT02329730|11219782|FG008|NOT COMPLETED|Overall Study||1
9741207|NCT00246571|10842467|FG000|Randomized But Not Treated|Overall Study||3
9741208|NCT00246571|10842468|FG001|Randomized But Not Treated|Overall Study||1
9741209|NCT00246571|10842467|FG000|COMPLETED|Overall Study||0
9741210|NCT00246571|10842468|FG001|COMPLETED|Overall Study||0
9741211|NCT00246571|10842467|FG000|NOT COMPLETED|Overall Study||113
9741212|NCT00246571|10842468|FG001|NOT COMPLETED|Overall Study||104
9741213|NCT00246740|10842476|FG000|STARTED|Initial Enrollment||28
9741214|NCT00246740|10842477|FG001|STARTED|Initial Enrollment||28
9741215|NCT00246740|10842476|FG000|COMPLETED|Initial Enrollment||22
9741216|NCT00246740|10842477|FG001|COMPLETED|Initial Enrollment||20
9741217|NCT00246740|10842476|FG000|NOT COMPLETED|Initial Enrollment||6
9741218|NCT00246740|10842477|FG001|NOT COMPLETED|Initial Enrollment||8
9741219|NCT00246740|10842476|FG000|STARTED|Experimental Phase||22
9741220|NCT00246740|10842477|FG001|STARTED|Experimental Phase||20
9741221|NCT00246740|10842476|FG000|COMPLETED|Experimental Phase||22
9741222|NCT00246740|10842477|FG001|COMPLETED|Experimental Phase||20
9741223|NCT00246740|10842476|FG000|NOT COMPLETED|Experimental Phase||0
9741224|NCT00246740|10842477|FG001|NOT COMPLETED|Experimental Phase||0
9741225|NCT00246753|10842483|FG000|STARTED|Overall Study||29
9741226|NCT00246753|10842483|FG000|COMPLETED|Overall Study||21
9741227|NCT00246753|10842483|FG000|NOT COMPLETED|Overall Study||8
9741228|NCT00246805|10842489|FG000|STARTED|Phase 1||34
9741229|NCT00246805|10842490|FG001|STARTED|Phase 1||33
9741230|NCT00246805|10842489|FG000|COMPLETED|Phase 1||33
10091601|NCT02329730|11219783|FG009|NOT COMPLETED|Overall Study||1
9741231|NCT00246805|10842490|FG001|COMPLETED|Phase 1||33
9741232|NCT00246805|10842489|FG000|NOT COMPLETED|Phase 1||1
9741233|NCT00246805|10842490|FG001|NOT COMPLETED|Phase 1||0
9741234|NCT00246805|10842489|FG000|STARTED|Phase 2||33
9741235|NCT00246805|10842490|FG001|STARTED|Phase 2||33
9741236|NCT00246805|10842489|FG000|COMPLETED|Phase 2||33
9741237|NCT00246805|10842490|FG001|COMPLETED|Phase 2||33
9741238|NCT00246805|10842489|FG000|NOT COMPLETED|Phase 2||0
9741239|NCT00246805|10842490|FG001|NOT COMPLETED|Phase 2||0
9741240|NCT00247273|10842498|FG000|STARTED|Overall Study||644
9741241|NCT00247273|10842499|FG001|STARTED|Overall Study||650
9741242|NCT00247273|10842498|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
9741243|NCT00247273|10842499|FG001|Intent to Treat Population|Overall Study||650
9741244|NCT00247273|10842498|FG000|COMPLETED|Overall Study||498
9741245|NCT00247273|10842499|FG001|COMPLETED|Overall Study||513
9741246|NCT00247273|10842498|FG000|NOT COMPLETED|Overall Study||146
9741247|NCT00247273|10842499|FG001|NOT COMPLETED|Overall Study||137
9741248|NCT00247377|10842507|FG000|STARTED|Overall Study||111
9741249|NCT00247377|10842508|FG001|STARTED|Overall Study||86
9741250|NCT00247377|10842507|FG000|COMPLETED|Overall Study||111
9741251|NCT00247377|10842508|FG001|COMPLETED|Overall Study||86
9741252|NCT00247377|10842507|FG000|NOT COMPLETED|Overall Study||0
9741253|NCT00247377|10842508|FG001|NOT COMPLETED|Overall Study||0
9741254|NCT00247416|10842516|FG000|STARTED|Overall Study||26
9741255|NCT00247416|10842517|FG001|STARTED|Overall Study||33
9741256|NCT00247416|10842516|FG000|COMPLETED|Overall Study||25
9741257|NCT00247416|10842517|FG001|COMPLETED|Overall Study||31
9741258|NCT00247416|10842516|FG000|NOT COMPLETED|Overall Study||1
9741259|NCT00247416|10842517|FG001|NOT COMPLETED|Overall Study||2
9741260|NCT00247611|10842527|FG000|STARTED|Baselined|Participants randomized|304
9741261|NCT00247611|10842528|FG001|STARTED|Baselined|Participants randomized|290
9741262|NCT00247611|10842527|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
9741263|NCT00247611|10842528|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
9741264|NCT00247611|10842527|FG000|NOT COMPLETED|Baselined||17
9741265|NCT00247611|10842528|FG001|NOT COMPLETED|Baselined||13
9741266|NCT00247611|10842527|FG000|STARTED|Intention to Treat Sample|Participants randomized|304
9741267|NCT00247611|10842528|FG001|STARTED|Intention to Treat Sample|Participants randomized|290
9741268|NCT00247611|10842527|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
9741269|NCT00247611|10842528|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
9741270|NCT00247611|10842527|FG000|NOT COMPLETED|Intention to Treat Sample||17
9741271|NCT00247611|10842528|FG001|NOT COMPLETED|Intention to Treat Sample||13
9741272|NCT00247611|10842527|FG000|STARTED|On Protocol Sample|ITT sample participants|287
9741273|NCT00247611|10842528|FG001|STARTED|On Protocol Sample|ITT sample participants|277
9741274|NCT00247611|10842527|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
9741275|NCT00247611|10842528|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
9741276|NCT00247611|10842527|FG000|NOT COMPLETED|On Protocol Sample||111
9741277|NCT00247611|10842528|FG001|NOT COMPLETED|On Protocol Sample||125
9741278|NCT00247624|10842542|FG000|STARTED|Overall Study||30
9741279|NCT00247624|10842543|FG001|STARTED|Overall Study||30
10091602|NCT02329730|11219784|FG010|NOT COMPLETED|Overall Study||0
10091603|NCT02329730|11219785|FG011|NOT COMPLETED|Overall Study||0
9741280|NCT00247624|10842542|FG000|COMPLETED|Overall Study||25
9741281|NCT00247624|10842543|FG001|COMPLETED|Overall Study||26
9741282|NCT00247624|10842542|FG000|NOT COMPLETED|Overall Study||5
9741283|NCT00247624|10842543|FG001|NOT COMPLETED|Overall Study||4
9741284|NCT00247676|10842549|FG000|STARTED|Overall Study||37
9741285|NCT00247676|10842549|FG000|COMPLETED|Overall Study||1
9741286|NCT00247676|10842549|FG000|NOT COMPLETED|Overall Study||36
9741287|NCT00247962|10842555|FG000|STARTED|Overall Study||379
9741288|NCT00247962|10842556|FG001|STARTED|Overall Study||187
9741289|NCT00247962|10842555|FG000|COMPLETED|Overall Study||353
9741290|NCT00247962|10842556|FG001|COMPLETED|Overall Study||168
9741291|NCT00247962|10842555|FG000|NOT COMPLETED|Overall Study||26
9741292|NCT00247962|10842556|FG001|NOT COMPLETED|Overall Study||19
9741293|NCT00248040|10842565|FG000|STARTED|Overall Study||25
9741294|NCT00248040|10842566|FG001|STARTED|Overall Study||23
9741295|NCT00248040|10842567|FG002|STARTED|Overall Study||26
9741296|NCT00248040|10842565|FG000|COMPLETED|Overall Study||22
9741297|NCT00248040|10842566|FG001|COMPLETED|Overall Study||22
9741298|NCT00248040|10842567|FG002|COMPLETED|Overall Study||22
9741299|NCT00248040|10842565|FG000|NOT COMPLETED|Overall Study||3
9741300|NCT00248040|10842566|FG001|NOT COMPLETED|Overall Study||1
9741301|NCT00248040|10842567|FG002|NOT COMPLETED|Overall Study||4
9741302|NCT00248170|10842578|FG000|STARTED|Overall Study||2078
9741303|NCT00248170|10842579|FG001|STARTED|Overall Study||2094
9741304|NCT00248170|10842578|FG000|Intent-to-treat (ITT)|Overall Study||2061
9741305|NCT00248170|10842579|FG001|Intent-to-treat (ITT)|Overall Study||2075
9741306|NCT00248170|10842578|FG000|Safety Set|Overall Study||2049
9741307|NCT00248170|10842579|FG001|Safety Set|Overall Study||2062
9741308|NCT00248170|10842578|FG000|COMPLETED|Overall Study||1317
10091604|NCT02329743|11219806|FG000|STARTED|Overall Study||84
10091605|NCT02329743|11219807|FG001|STARTED|Overall Study||87
10091606|NCT02329743|11219808|FG002|STARTED|Overall Study||85
9741309|NCT00248170|10842579|FG001|COMPLETED|Overall Study||1286
9741310|NCT00248170|10842578|FG000|NOT COMPLETED|Overall Study||761
9741311|NCT00248170|10842579|FG001|NOT COMPLETED|Overall Study||808
9741312|NCT00248495|10842585|FG000|STARTED|Overall Study||38
9741313|NCT00248495|10842585|FG000|COMPLETED|Overall Study||37
9741314|NCT00248495|10842585|FG000|NOT COMPLETED|Overall Study||1
9741315|NCT00248534|10842589|FG000|STARTED|Overall Study||16
10091607|NCT02329743|11219806|FG000|COMPLETED|Overall Study||78
10091608|NCT02329743|11219807|FG001|COMPLETED|Overall Study||80
10091609|NCT02329743|11219808|FG002|COMPLETED|Overall Study||77
10091610|NCT02329743|11219806|FG000|NOT COMPLETED|Overall Study||6
10091611|NCT02329743|11219807|FG001|NOT COMPLETED|Overall Study||7
10091612|NCT02329743|11219808|FG002|NOT COMPLETED|Overall Study||8
10091613|NCT02329964|11219818|FG000|STARTED|Overall Study||40
10091614|NCT02329964|11219819|FG001|STARTED|Overall Study||40
10091615|NCT02329964|11219818|FG000|COMPLETED|Overall Study||40
10091616|NCT02329964|11219819|FG001|COMPLETED|Overall Study||40
10091617|NCT02329964|11219818|FG000|NOT COMPLETED|Overall Study||0
10091618|NCT02329964|11219819|FG001|NOT COMPLETED|Overall Study||0
10091619|NCT02330055|11219827|FG000|STARTED|Overall Study||50
10091620|NCT02330055|11219828|FG001|STARTED|Overall Study||49
10091621|NCT02330055|11219827|FG000|COMPLETED|Overall Study||40
10091622|NCT02330055|11219828|FG001|COMPLETED|Overall Study||40
10091623|NCT02330055|11219827|FG000|NOT COMPLETED|Overall Study||10
10091624|NCT02330055|11219828|FG001|NOT COMPLETED|Overall Study||9
10091625|NCT02330081|11219834|FG000|STARTED|Overall Study||22
10091626|NCT02330081|11219834|FG000|COMPLETED|Overall Study||14
10091627|NCT02330081|11219834|FG000|NOT COMPLETED|Overall Study||8
10091628|NCT02330094|11219843|FG000|STARTED|Overall Study||8
10091629|NCT02330094|11219844|FG001|STARTED|Overall Study||8
10091630|NCT02330094|11219843|FG000|COMPLETED|Overall Study||8
10091631|NCT02330094|11219844|FG001|COMPLETED|Overall Study||8
10091632|NCT02330094|11219843|FG000|NOT COMPLETED|Overall Study||0
9741316|NCT00248534|10842589|FG000|COMPLETED|Overall Study||16
9741317|NCT00248534|10842589|FG000|NOT COMPLETED|Overall Study||0
9741318|NCT00248547|10842595|FG000|STARTED|Overall Study||20
9741319|NCT00248547|10842596|FG001|STARTED|Overall Study||20
9741320|NCT00248547|10842595|FG000|COMPLETED|Overall Study||20
9741321|NCT00248547|10842596|FG001|COMPLETED|Overall Study||20
9741322|NCT00248547|10842595|FG000|NOT COMPLETED|Overall Study||0
9741323|NCT00248547|10842596|FG001|NOT COMPLETED|Overall Study||0
9741324|NCT00248560|10842602|FG000|STARTED|Overall Study||36
9741325|NCT00248560|10842602|FG000|COMPLETED|Overall Study||36
9741326|NCT00248560|10842602|FG000|NOT COMPLETED|Overall Study||0
9741327|NCT00248612|10842611|FG000|STARTED|Overall Study||24
9852426|NCT00880763|10965263|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0
9741328|NCT00248612|10842612|FG001|STARTED|Overall Study||21
9741329|NCT00248612|10842613|FG002|STARTED|Overall Study||14
9741330|NCT00248612|10842614|FG003|STARTED|Overall Study||22
9741331|NCT00248612|10842611|FG000|COMPLETED|Overall Study||24
9741332|NCT00248612|10842612|FG001|COMPLETED|Overall Study||21
9741333|NCT00248612|10842613|FG002|COMPLETED|Overall Study||14
9741334|NCT00248612|10842614|FG003|COMPLETED|Overall Study||22
9741335|NCT00248612|10842611|FG000|NOT COMPLETED|Overall Study||0
9741336|NCT00248612|10842612|FG001|NOT COMPLETED|Overall Study||0
9741337|NCT00248612|10842613|FG002|NOT COMPLETED|Overall Study||0
10091633|NCT02330094|11219844|FG001|NOT COMPLETED|Overall Study||0
10091634|NCT02330172|11219852|FG000|STARTED|Overall Study||22
10091635|NCT02330172|11219853|FG001|STARTED|Overall Study||22
10091636|NCT02330172|11219852|FG000|COMPLETED|Overall Study||19
10091637|NCT02330172|11219853|FG001|COMPLETED|Overall Study||21
10091638|NCT02330172|11219852|FG000|NOT COMPLETED|Overall Study||3
10091639|NCT02330172|11219853|FG001|NOT COMPLETED|Overall Study||1
10091640|NCT02330276|11219862|FG000|STARTED|Overall Study||4
10091641|NCT02330276|11219863|FG001|STARTED|Overall Study||4
9741338|NCT00248612|10842614|FG003|NOT COMPLETED|Overall Study||0
9741339|NCT00248625|10842628|FG000|STARTED|Overall Study||92
9741340|NCT00248625|10842629|FG001|STARTED|Overall Study||92
9741341|NCT00248625|10842628|FG000|COMPLETED|Overall Study||92
9741342|NCT00248625|10842629|FG001|COMPLETED|Overall Study||90
9741343|NCT00248625|10842628|FG000|NOT COMPLETED|Overall Study||0
9741344|NCT00248625|10842629|FG001|NOT COMPLETED|Overall Study||2
9741345|NCT00248638|10842637|FG000|STARTED|Overall Study||75
9741346|NCT00248638|10842638|FG001|STARTED|Overall Study||75
9741347|NCT00248638|10842637|FG000|COMPLETED|Overall Study||75
9741348|NCT00248638|10842638|FG001|COMPLETED|Overall Study||75
9741349|NCT00248638|10842637|FG000|NOT COMPLETED|Overall Study||0
9741350|NCT00248638|10842638|FG001|NOT COMPLETED|Overall Study||0
9741351|NCT00248651|10842649|FG000|STARTED|Overall Study||97
9741352|NCT00248651|10842650|FG001|STARTED|Overall Study||98
9741353|NCT00248651|10842651|FG002|STARTED|Overall Study||97
9741354|NCT00248651|10842649|FG000|Completed 12 Weeks of Treatment|Overall Study||78
9741355|NCT00248651|10842650|FG001|Completed 12 Weeks of Treatment|Overall Study||66
9741356|NCT00248651|10842651|FG002|Completed 12 Weeks of Treatment|Overall Study||75
9741357|NCT00248651|10842649|FG000|COMPLETED|Overall Study||69
9741358|NCT00248651|10842650|FG001|COMPLETED|Overall Study||58
9741359|NCT00248651|10842651|FG002|COMPLETED|Overall Study||65
9741360|NCT00248651|10842649|FG000|NOT COMPLETED|Overall Study||28
9741361|NCT00248651|10842650|FG001|NOT COMPLETED|Overall Study||40
9741362|NCT00248651|10842651|FG002|NOT COMPLETED|Overall Study||32
9741363|NCT00248781|10842661|FG000|STARTED|Overall Study||52
9741364|NCT00248781|10842662|FG001|STARTED|Overall Study||51
9741365|NCT00248781|10842661|FG000|COMPLETED|Overall Study||42
9741366|NCT00248781|10842662|FG001|COMPLETED|Overall Study||47
9741367|NCT00248781|10842661|FG000|NOT COMPLETED|Overall Study||10
9741368|NCT00248781|10842662|FG001|NOT COMPLETED|Overall Study||4
9741369|NCT00248794|10842671|FG000|STARTED|Overall Study||25
9741370|NCT00248794|10842672|FG001|STARTED|Overall Study||24
9741371|NCT00248794|10842673|FG002|STARTED|Overall Study||10
9741372|NCT00248794|10842671|FG000|COMPLETED|Overall Study||19
9741373|NCT00248794|10842672|FG001|COMPLETED|Overall Study||16
9741374|NCT00248794|10842673|FG002|COMPLETED|Overall Study||7
9741375|NCT00248794|10842671|FG000|NOT COMPLETED|Overall Study||6
9741376|NCT00248794|10842672|FG001|NOT COMPLETED|Overall Study||8
9741377|NCT00248794|10842673|FG002|NOT COMPLETED|Overall Study||3
9741378|NCT00248807|10842689|FG000|STARTED|Overall Study||19
9741379|NCT00248807|10842690|FG001|STARTED|Overall Study||11
9741380|NCT00248807|10842689|FG000|COMPLETED|Overall Study||19
9741381|NCT00248807|10842690|FG001|COMPLETED|Overall Study||11
9741382|NCT00248807|10842689|FG000|NOT COMPLETED|Overall Study||0
9741383|NCT00248807|10842690|FG001|NOT COMPLETED|Overall Study||0
9741384|NCT00248833|10842705|FG000|STARTED|Overall Study||12
9741385|NCT00248833|10842706|FG001|STARTED|Overall Study||11
9741386|NCT00248833|10842707|FG002|STARTED|Overall Study||11
9741387|NCT00248833|10842705|FG000|COMPLETED|Overall Study||9
9741388|NCT00248833|10842706|FG001|COMPLETED|Overall Study||8
9741389|NCT00248833|10842707|FG002|COMPLETED|Overall Study||9
9741390|NCT00248833|10842705|FG000|NOT COMPLETED|Overall Study||3
9741391|NCT00248833|10842706|FG001|NOT COMPLETED|Overall Study||3
9741392|NCT00248833|10842707|FG002|NOT COMPLETED|Overall Study||2
9741393|NCT00249002|10842717|FG000|STARTED|Overall Study||9
9741394|NCT00249002|10842717|FG000|COMPLETED|Overall Study||2
9741395|NCT00249002|10842717|FG000|NOT COMPLETED|Overall Study||7
9741396|NCT00249249|10842725|FG000|STARTED|Overall Study||321
9741397|NCT00249249|10842726|FG001|STARTED|Overall Study||103
9741398|NCT00249249|10842727|FG002|STARTED|Overall Study||303
9741399|NCT00249249|10842728|FG003|STARTED|Overall Study||103
9741400|NCT00249249|10842725|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
9741401|NCT00249249|10842726|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
9741402|NCT00249249|10842727|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
9741403|NCT00249249|10842728|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
9741404|NCT00249249|10842725|FG000|COMPLETED|Overall Study||301
9741405|NCT00249249|10842726|FG001|COMPLETED|Overall Study||98
9741406|NCT00249249|10842727|FG002|COMPLETED|Overall Study||288
9741407|NCT00249249|10842728|FG003|COMPLETED|Overall Study||100
9741408|NCT00249249|10842725|FG000|NOT COMPLETED|Overall Study||20
9741409|NCT00249249|10842726|FG001|NOT COMPLETED|Overall Study||5
9741410|NCT00249249|10842727|FG002|NOT COMPLETED|Overall Study||15
9741411|NCT00249249|10842728|FG003|NOT COMPLETED|Overall Study||3
9741412|NCT00249288|10842740|FG000|STARTED|Overall Study||19
9741413|NCT00249288|10842741|FG001|STARTED|Overall Study||19
9741414|NCT00249288|10842740|FG000|Initiated Treatment|Overall Study||17
9741415|NCT00249288|10842741|FG001|Initiated Treatment|Overall Study||15
9741416|NCT00249288|10842740|FG000|COMPLETED|Overall Study||14
9741417|NCT00249288|10842741|FG001|COMPLETED|Overall Study||14
9741418|NCT00249288|10842740|FG000|NOT COMPLETED|Overall Study||5
9741419|NCT00249288|10842741|FG001|NOT COMPLETED|Overall Study||5
9741420|NCT00249379|10842757|FG000|STARTED|Overall Study||14
9741421|NCT00249379|10842758|FG001|STARTED|Overall Study||12
9741422|NCT00249379|10842757|FG000|COMPLETED|Overall Study||6
9741423|NCT00249379|10842758|FG001|COMPLETED|Overall Study||4
9741424|NCT00249379|10842757|FG000|NOT COMPLETED|Overall Study||8
9741425|NCT00249379|10842758|FG001|NOT COMPLETED|Overall Study||8
9741426|NCT00249444|10842766|FG000|STARTED|Overall Study||42
9741427|NCT00249444|10842767|FG001|STARTED|Overall Study||44
9741428|NCT00249444|10842766|FG000|COMPLETED|Overall Study||30
9741429|NCT00249444|10842767|FG001|COMPLETED|Overall Study||29
9741430|NCT00249444|10842766|FG000|NOT COMPLETED|Overall Study||12
9741431|NCT00249444|10842767|FG001|NOT COMPLETED|Overall Study||15
9741432|NCT00249470|10842775|FG000|STARTED|Overall Study||28
9741433|NCT00249470|10842776|FG001|STARTED|Overall Study||28
9741434|NCT00249470|10842775|FG000|COMPLETED|Overall Study||28
9741435|NCT00249470|10842776|FG001|COMPLETED|Overall Study||28
9741436|NCT00249470|10842775|FG000|NOT COMPLETED|Overall Study||0
9741437|NCT00249470|10842776|FG001|NOT COMPLETED|Overall Study||0
9741438|NCT00249496|10842784|FG000|STARTED|Overall Study||24
9741439|NCT00249496|10842785|FG001|STARTED|Overall Study||27
9741440|NCT00249496|10842784|FG000|COMPLETED|Overall Study||24
9741441|NCT00249496|10842785|FG001|COMPLETED|Overall Study||26
9741442|NCT00249496|10842784|FG000|NOT COMPLETED|Overall Study||0
9741443|NCT00249496|10842785|FG001|NOT COMPLETED|Overall Study||1
9741444|NCT00249613|10842795|FG000|STARTED|Baseline||152
9741445|NCT00249613|10842796|FG001|STARTED|Baseline||139
9741446|NCT00249613|10842795|FG000|COMPLETED|Baseline||152
9741447|NCT00249613|10842796|FG001|COMPLETED|Baseline||139
9741448|NCT00249613|10842795|FG000|NOT COMPLETED|Baseline||0
9741449|NCT00249613|10842796|FG001|NOT COMPLETED|Baseline||0
9741450|NCT00249613|10842795|FG000|STARTED|12 Month Follow-up||152
9741451|NCT00249613|10842796|FG001|STARTED|12 Month Follow-up||139
9741452|NCT00249613|10842795|FG000|COMPLETED|12 Month Follow-up||135
9741453|NCT00249613|10842796|FG001|COMPLETED|12 Month Follow-up||124
9741454|NCT00249613|10842795|FG000|NOT COMPLETED|12 Month Follow-up||17
9741455|NCT00249613|10842796|FG001|NOT COMPLETED|12 Month Follow-up||15
9741456|NCT00249769|10842808|FG000|STARTED|Overall Study||100
9741457|NCT00249769|10842809|FG001|STARTED|Overall Study||250
9741458|NCT00249769|10842810|FG002|STARTED|Overall Study||250
9741459|NCT00249769|10842808|FG000|Received LJEV|Overall Study||100
9741460|NCT00249769|10842809|FG001|Received LJEV|Overall Study||236
9741461|NCT00249769|10842810|FG002|Received LJEV|Overall Study||224
9741462|NCT00249769|10842808|FG000|Received Measles Vaccine|Overall Study||97
9741463|NCT00249769|10842809|FG001|Received Measles Vaccine|Overall Study||236
9741464|NCT00249769|10842810|FG002|Received Measles Vaccine|Overall Study||235
9741465|NCT00249769|10842808|FG000|COMPLETED|Overall Study||98
9741466|NCT00249769|10842809|FG001|COMPLETED|Overall Study||235
9741467|NCT00249769|10842810|FG002|COMPLETED|Overall Study||222
9741468|NCT00249769|10842808|FG000|NOT COMPLETED|Overall Study||2
9741469|NCT00249769|10842809|FG001|NOT COMPLETED|Overall Study||15
9741470|NCT00249769|10842810|FG002|NOT COMPLETED|Overall Study||28
9741471|NCT00249795|10842820|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
9741472|NCT00249795|10842821|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
9741473|NCT00249795|10842820|FG000|COMPLETED|Overall Study|started and completed study drug|3124
9741474|NCT00249795|10842821|FG001|COMPLETED|Overall Study|started and completed study drug|3108
9741475|NCT00249795|10842820|FG000|NOT COMPLETED|Overall Study||1394
9741476|NCT00249795|10842821|FG001|NOT COMPLETED|Overall Study||1390
9741477|NCT00249808|10842827|FG000|STARTED|Overall Study||1266
9741478|NCT00249808|10842827|FG000|COMPLETED|Overall Study||1084
9741479|NCT00249808|10842827|FG000|NOT COMPLETED|Overall Study||182
9741480|NCT00249821|10842833|FG000|STARTED|Overall Study||10
9741481|NCT00249821|10842834|FG001|STARTED|Overall Study||12
9741482|NCT00249821|10842833|FG000|COMPLETED|Overall Study||10
9741483|NCT00249821|10842834|FG001|COMPLETED|Overall Study||11
9741484|NCT00249821|10842833|FG000|NOT COMPLETED|Overall Study||0
9741485|NCT00249821|10842834|FG001|NOT COMPLETED|Overall Study||1
9741486|NCT00249834|10842848|FG000|STARTED|Overall Study||1
9741487|NCT00249834|10842849|FG001|STARTED|Overall Study||48
9741488|NCT00249834|10842850|FG002|STARTED|Overall Study||45
9741489|NCT00249834|10842851|FG003|STARTED|Overall Study||34
9741490|NCT00249834|10842852|FG004|STARTED|Overall Study||24
9741491|NCT00249834|10842853|FG005|STARTED|Overall Study||10
9741492|NCT00249834|10842854|FG006|STARTED|Overall Study||2
9741493|NCT00249834|10842855|FG007|STARTED|Overall Study||2
10091642|NCT02330276|11219864|FG002|STARTED|Overall Study||4
9741494|NCT00249834|10842848|FG000|COMPLETED|Overall Study||0
9741495|NCT00249834|10842849|FG001|COMPLETED|Overall Study||29
9741496|NCT00249834|10842850|FG002|COMPLETED|Overall Study||31
9741497|NCT00249834|10842851|FG003|COMPLETED|Overall Study||26
9741498|NCT00249834|10842852|FG004|COMPLETED|Overall Study||19
10091643|NCT02330276|11219862|FG000|COMPLETED|Overall Study||4
9741499|NCT00249834|10842853|FG005|COMPLETED|Overall Study||8
9741500|NCT00249834|10842854|FG006|COMPLETED|Overall Study||1
9741501|NCT00249834|10842855|FG007|COMPLETED|Overall Study||2
9741502|NCT00249834|10842848|FG000|NOT COMPLETED|Overall Study||1
9741503|NCT00249834|10842849|FG001|NOT COMPLETED|Overall Study||19
9741504|NCT00249834|10842850|FG002|NOT COMPLETED|Overall Study||14
9741505|NCT00249834|10842851|FG003|NOT COMPLETED|Overall Study||8
9741506|NCT00249834|10842852|FG004|NOT COMPLETED|Overall Study||5
9741507|NCT00249834|10842853|FG005|NOT COMPLETED|Overall Study||2
9741508|NCT00249834|10842854|FG006|NOT COMPLETED|Overall Study||1
9741509|NCT00249834|10842855|FG007|NOT COMPLETED|Overall Study||0
9741510|NCT00249873|10842869|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
9741511|NCT00249873|10842870|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
9741512|NCT00249873|10842869|FG000|COMPLETED|Overall Study|started and completed study drug|2442
9741513|NCT00249873|10842870|FG001|COMPLETED|Overall Study|started and completed study drug|2528
9741514|NCT00249873|10842869|FG000|NOT COMPLETED|Overall Study||1330
9741515|NCT00249873|10842870|FG001|NOT COMPLETED|Overall Study||1254
9741516|NCT00250276|10842880|FG000|STARTED|Overall Study||199
9741517|NCT00250276|10842881|FG001|STARTED|Overall Study||198
9741518|NCT00250276|10842882|FG002|STARTED|Overall Study||201
9741519|NCT00250276|10842883|FG003|STARTED|Overall Study||200
9741520|NCT00250276|10842880|FG000|COMPLETED|Overall Study||182
9741521|NCT00250276|10842881|FG001|COMPLETED|Overall Study||177
9741522|NCT00250276|10842882|FG002|COMPLETED|Overall Study||182
9741523|NCT00250276|10842883|FG003|COMPLETED|Overall Study||181
9741524|NCT00250276|10842880|FG000|NOT COMPLETED|Overall Study||17
10091644|NCT02330276|11219863|FG001|COMPLETED|Overall Study||4
10091645|NCT02330276|11219864|FG002|COMPLETED|Overall Study||4
10091646|NCT02330276|11219862|FG000|NOT COMPLETED|Overall Study||0
10091647|NCT02330276|11219863|FG001|NOT COMPLETED|Overall Study||0
10091648|NCT02330276|11219864|FG002|NOT COMPLETED|Overall Study||0
10091649|NCT02330341|11219874|FG000|STARTED|Overall Study||12
10091650|NCT02330341|11219875|FG001|STARTED|Overall Study||12
10091651|NCT02330341|11219874|FG000|COMPLETED|Overall Study||12
10091652|NCT02330341|11219875|FG001|COMPLETED|Overall Study||11
10091653|NCT02330341|11219874|FG000|NOT COMPLETED|Overall Study||0
10091654|NCT02330341|11219875|FG001|NOT COMPLETED|Overall Study||1
9741525|NCT00250276|10842881|FG001|NOT COMPLETED|Overall Study||21
9741526|NCT00250276|10842882|FG002|NOT COMPLETED|Overall Study||19
9741527|NCT00250276|10842883|FG003|NOT COMPLETED|Overall Study||19
9741528|NCT00250432|10842900|FG000|STARTED|Overall Study||104
9852427|NCT00880763|10965260|FG000|STARTED|Extension Period (Part 2)||23
9852428|NCT00880763|10965261|FG001|STARTED|Extension Period (Part 2)||22
9852429|NCT00880763|10965262|FG002|STARTED|Extension Period (Part 2)||23
9852430|NCT00880763|10965263|FG003|STARTED|Extension Period (Part 2)||22
9852431|NCT00880763|10965260|FG000|COMPLETED|Extension Period (Part 2)||23
9852432|NCT00880763|10965261|FG001|COMPLETED|Extension Period (Part 2)||19
9852433|NCT00880763|10965262|FG002|COMPLETED|Extension Period (Part 2)||20
9852434|NCT00880763|10965263|FG003|COMPLETED|Extension Period (Part 2)||19
9852435|NCT00880763|10965260|FG000|NOT COMPLETED|Extension Period (Part 2)||0
9852436|NCT00880763|10965261|FG001|NOT COMPLETED|Extension Period (Part 2)||3
9852437|NCT00880763|10965262|FG002|NOT COMPLETED|Extension Period (Part 2)||3
9852438|NCT00880763|10965263|FG003|NOT COMPLETED|Extension Period (Part 2)||3
9852439|NCT00880906|10965275|FG000|STARTED|Overall Study||29
9852440|NCT00880906|10965276|FG001|STARTED|Overall Study||21
9852441|NCT00880906|10965275|FG000|COMPLETED|Overall Study||17
9852442|NCT00880906|10965276|FG001|COMPLETED|Overall Study||14
9852443|NCT00880906|10965275|FG000|NOT COMPLETED|Overall Study||12
9852444|NCT00880906|10965276|FG001|NOT COMPLETED|Overall Study||7
9852445|NCT00880919|10965285|FG000|STARTED|Overall Study||33
9852446|NCT00880919|10965286|FG001|STARTED|Overall Study||33
9852447|NCT00880919|10965287|FG002|STARTED|Overall Study||29
9852448|NCT00880919|10965285|FG000|COMPLETED|Overall Study||18
9852449|NCT00880919|10965286|FG001|COMPLETED|Overall Study||19
9852450|NCT00880919|10965287|FG002|COMPLETED|Overall Study||23
9852451|NCT00880919|10965285|FG000|NOT COMPLETED|Overall Study||15
9852452|NCT00880919|10965286|FG001|NOT COMPLETED|Overall Study||14
9852453|NCT00880919|10965287|FG002|NOT COMPLETED|Overall Study||6
9852454|NCT00880997|10965301|FG000|STARTED|Overall Study||9
9852455|NCT00880997|10965302|FG001|STARTED|Overall Study||8
9852456|NCT00880997|10965303|FG002|STARTED|Overall Study||13
9852457|NCT00880997|10965301|FG000|COMPLETED|Overall Study||6
9852458|NCT00880997|10965302|FG001|COMPLETED|Overall Study||6
9852459|NCT00880997|10965303|FG002|COMPLETED|Overall Study||5
9852460|NCT00880997|10965301|FG000|NOT COMPLETED|Overall Study||3
9852461|NCT00880997|10965302|FG001|NOT COMPLETED|Overall Study||2
9852462|NCT00880997|10965303|FG002|NOT COMPLETED|Overall Study||8
9852463|NCT00881335|10965313|FG000|STARTED|Overall Study||30
9852464|NCT00881335|10965314|FG001|STARTED|Overall Study||30
9852465|NCT00881335|10965313|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27
9852466|NCT00881335|10965314|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28
9852467|NCT00881335|10965313|FG000|NOT COMPLETED|Overall Study||3
9852468|NCT00881335|10965314|FG001|NOT COMPLETED|Overall Study||2
9852469|NCT00881361|10965322|FG000|STARTED|Overall Study||707
9852470|NCT00881361|10965323|FG001|STARTED|Overall Study||47
9852471|NCT00881361|10965324|FG002|STARTED|Overall Study||2
9852472|NCT00881361|10965322|FG000|COMPLETED|Overall Study||663
9852473|NCT00881361|10965323|FG001|COMPLETED|Overall Study||38
10091655|NCT02330523|11219883|FG000|STARTED|Overall Study||21
10091656|NCT02330523|11219884|FG001|STARTED|Overall Study||19
10091657|NCT02330523|11219883|FG000|COMPLETED|Overall Study||21
9741529|NCT00250432|10842901|FG001|STARTED|Overall Study||100
9741530|NCT00250432|10842900|FG000|COMPLETED|Overall Study||59
9741531|NCT00250432|10842901|FG001|COMPLETED|Overall Study||53
9741532|NCT00250432|10842900|FG000|NOT COMPLETED|Overall Study||45
9852474|NCT00881361|10965324|FG002|COMPLETED|Overall Study||0
9852475|NCT00881361|10965322|FG000|NOT COMPLETED|Overall Study||44
9852476|NCT00881361|10965323|FG001|NOT COMPLETED|Overall Study||9
9741533|NCT00250432|10842901|FG001|NOT COMPLETED|Overall Study||47
9741534|NCT00250484|10842909|FG000|STARTED|Overall Study||9
9741535|NCT00250484|10842910|FG001|STARTED|Overall Study||8
10091658|NCT02330523|11219884|FG001|COMPLETED|Overall Study||19
10091659|NCT02330523|11219883|FG000|NOT COMPLETED|Overall Study||0
9741536|NCT00250484|10842909|FG000|COMPLETED|Overall Study||9
9741537|NCT00250484|10842910|FG001|COMPLETED|Overall Study||8
9741538|NCT00250484|10842909|FG000|NOT COMPLETED|Overall Study||0
9741539|NCT00250484|10842910|FG001|NOT COMPLETED|Overall Study||0
9741540|NCT00250497|10842918|FG000|STARTED|Overall Study||182
9741541|NCT00250497|10842919|FG001|STARTED|Overall Study||174
9741542|NCT00250497|10842918|FG000|COMPLETED|Overall Study||177
9741543|NCT00250497|10842919|FG001|COMPLETED|Overall Study||159
9741544|NCT00250497|10842918|FG000|NOT COMPLETED|Overall Study||5
9741545|NCT00250497|10842919|FG001|NOT COMPLETED|Overall Study||15
9741546|NCT00250588|10842928|FG000|STARTED|Overall Study||81
10091660|NCT02330523|11219884|FG001|NOT COMPLETED|Overall Study||0
10091661|NCT02330549|11219892|FG000|STARTED|Overall Study||20
10091662|NCT02330549|11219893|FG001|STARTED|Overall Study||25
10091663|NCT02330549|11219892|FG000|COMPLETED|Overall Study||16
10091664|NCT02330549|11219893|FG001|COMPLETED|Overall Study||24
10091665|NCT02330549|11219892|FG000|NOT COMPLETED|Overall Study||4
10091666|NCT02330549|11219893|FG001|NOT COMPLETED|Overall Study||1
10091667|NCT02330588|11219904|FG000|STARTED|Overall Study||44
10091668|NCT02330588|11219905|FG001|STARTED|Overall Study||43
10091669|NCT02330588|11219906|FG002|STARTED|Overall Study||46
10091670|NCT02330588|11219907|FG003|STARTED|Overall Study||46
9741547|NCT00250588|10842929|FG001|STARTED|Overall Study||84
9741548|NCT00250588|10842930|FG002|STARTED|Overall Study||87
9741549|NCT00250588|10842928|FG000|COMPLETED|Overall Study||72
9741550|NCT00250588|10842929|FG001|COMPLETED|Overall Study||65
9741551|NCT00250588|10842930|FG002|COMPLETED|Overall Study||74
9741552|NCT00250588|10842928|FG000|NOT COMPLETED|Overall Study||9
9741553|NCT00250588|10842929|FG001|NOT COMPLETED|Overall Study||19
9741554|NCT00250588|10842930|FG002|NOT COMPLETED|Overall Study||13
9741555|NCT00250679|10842941|FG000|STARTED|Overall Study||147
9741556|NCT00250679|10842942|FG001|STARTED|Overall Study||149
9741557|NCT00250679|10842943|FG002|STARTED|Overall Study||147
9741558|NCT00250679|10842941|FG000|COMPLETED|Overall Study||108
9741559|NCT00250679|10842942|FG001|COMPLETED|Overall Study||100
9741560|NCT00250679|10842943|FG002|COMPLETED|Overall Study||103
9741561|NCT00250679|10842941|FG000|NOT COMPLETED|Overall Study||39
9741562|NCT00250679|10842942|FG001|NOT COMPLETED|Overall Study||49
9741563|NCT00250679|10842943|FG002|NOT COMPLETED|Overall Study||44
9741564|NCT00250705|10842951|FG000|STARTED|Overall Study||12
9741565|NCT00250705|10842951|FG000|COMPLETED|Overall Study||10
9741566|NCT00250705|10842951|FG000|NOT COMPLETED|Overall Study||2
9741567|NCT00250835|10842957|FG000|STARTED|Overall Study||38
9741568|NCT00250835|10842957|FG000|COMPLETED|Overall Study||37
9741569|NCT00250835|10842957|FG000|NOT COMPLETED|Overall Study||1
9741570|NCT00250926|10842961|FG000|STARTED|Overall Study||23
9741571|NCT00250926|10842961|FG000|COMPLETED|Overall Study||23
9741572|NCT00250926|10842961|FG000|NOT COMPLETED|Overall Study||0
9741573|NCT00251004|10842969|FG000|STARTED|Overall Study||277
9741574|NCT00251004|10842970|FG001|STARTED|Overall Study||279
9741575|NCT00251004|10842971|FG002|STARTED|Overall Study||277
9741576|NCT00251004|10842969|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
9741577|NCT00251004|10842970|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
9741578|NCT00251004|10842971|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
9741579|NCT00251004|10842969|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
9741580|NCT00251004|10842970|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
9741581|NCT00251004|10842971|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
9741582|NCT00251004|10842969|FG000|COMPLETED|Overall Study||232
9741583|NCT00251004|10842970|FG001|COMPLETED|Overall Study||238
9741584|NCT00251004|10842971|FG002|COMPLETED|Overall Study||246
9741585|NCT00251004|10842969|FG000|NOT COMPLETED|Overall Study||45
9741586|NCT00251004|10842970|FG001|NOT COMPLETED|Overall Study||41
9741587|NCT00251004|10842971|FG002|NOT COMPLETED|Overall Study||31
9741588|NCT00251225|10842979|FG000|STARTED|Overall Study||49
9741589|NCT00251225|10842979|FG000|COMPLETED|Overall Study||49
9741590|NCT00251225|10842979|FG000|NOT COMPLETED|Overall Study||0
9741591|NCT00251238|10842985|FG000|STARTED|Overall Study||21
9741592|NCT00251238|10842986|FG001|STARTED|Overall Study||20
9741593|NCT00251238|10842985|FG000|COMPLETED|Overall Study||21
9741594|NCT00251238|10842986|FG001|COMPLETED|Overall Study||20
9741595|NCT00251238|10842985|FG000|NOT COMPLETED|Overall Study||0
9741596|NCT00251238|10842986|FG001|NOT COMPLETED|Overall Study||0
9741597|NCT00251303|10842994|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
9741598|NCT00251303|10842995|FG001|STARTED|Overall Study||30
9741599|NCT00251303|10842994|FG000|COMPLETED|Overall Study||22
9741600|NCT00251303|10842995|FG001|COMPLETED|Overall Study||29
9741601|NCT00251303|10842994|FG000|NOT COMPLETED|Overall Study||8
9741602|NCT00251303|10842995|FG001|NOT COMPLETED|Overall Study||1
9741603|NCT00251316|10843005|FG000|STARTED|Overall Study||17
9741604|NCT00251316|10843006|FG001|STARTED|Overall Study||17
9741605|NCT00251316|10843005|FG000|COMPLETED|Overall Study||15
10091671|NCT02330588|11219908|FG004|STARTED|Overall Study||47
10091672|NCT02330588|11219904|FG000|COMPLETED|Overall Study||28
10091673|NCT02330588|11219905|FG001|COMPLETED|Overall Study||25
10091674|NCT02330588|11219906|FG002|COMPLETED|Overall Study||31
10091675|NCT02330588|11219907|FG003|COMPLETED|Overall Study||24
10091676|NCT02330588|11219908|FG004|COMPLETED|Overall Study||28
9741606|NCT00251316|10843006|FG001|COMPLETED|Overall Study||14
9741607|NCT00251316|10843005|FG000|NOT COMPLETED|Overall Study||2
9741608|NCT00251316|10843006|FG001|NOT COMPLETED|Overall Study||3
9741609|NCT00251589|10843016|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
9741610|NCT00251589|10843017|FG001|STARTED|Overall Study||3
9741611|NCT00251589|10843018|FG002|STARTED|Overall Study||2
9741612|NCT00251589|10843019|FG003|STARTED|Overall Study||2
9741613|NCT00251589|10843016|FG000|COMPLETED|Overall Study||1
9741614|NCT00251589|10843017|FG001|COMPLETED|Overall Study||0
9741615|NCT00251589|10843018|FG002|COMPLETED|Overall Study||0
9741616|NCT00251589|10843019|FG003|COMPLETED|Overall Study||0
9741617|NCT00251589|10843016|FG000|NOT COMPLETED|Overall Study||15
9741618|NCT00251589|10843017|FG001|NOT COMPLETED|Overall Study||3
9741619|NCT00251589|10843018|FG002|NOT COMPLETED|Overall Study||2
9741620|NCT00251589|10843019|FG003|NOT COMPLETED|Overall Study||2
9741621|NCT00251641|10843031|FG000|STARTED|Overall Study||653
9741622|NCT00251641|10843032|FG001|STARTED|Overall Study||215
9741623|NCT00251641|10843031|FG000|COMPLETED|Overall Study||541
9741624|NCT00251641|10843032|FG001|COMPLETED|Overall Study||127
9741625|NCT00251641|10843031|FG000|NOT COMPLETED|Overall Study||112
9741626|NCT00251641|10843032|FG001|NOT COMPLETED|Overall Study||88
9741627|NCT00251693|10843043|FG000|STARTED|Overall Study||680
9741628|NCT00251693|10843044|FG001|STARTED|Overall Study||668
9741629|NCT00251693|10843045|FG002|STARTED|Overall Study||690
9741630|NCT00251693|10843043|FG000|COMPLETED|Overall Study||629
9741631|NCT00251693|10843044|FG001|COMPLETED|Overall Study||624
9741632|NCT00251693|10843045|FG002|COMPLETED|Overall Study||644
9741633|NCT00251693|10843043|FG000|NOT COMPLETED|Overall Study||51
9741634|NCT00251693|10843044|FG001|NOT COMPLETED|Overall Study||44
9741635|NCT00251693|10843045|FG002|NOT COMPLETED|Overall Study||46
9741636|NCT00251719|10843056|FG000|STARTED|Overall Study||694
9741637|NCT00251719|10843057|FG001|STARTED|Overall Study||687
9741638|NCT00251719|10843058|FG002|STARTED|Overall Study||673
9741639|NCT00251719|10843056|FG000|COMPLETED|Overall Study||641
9741640|NCT00251719|10843057|FG001|COMPLETED|Overall Study||642
9741641|NCT00251719|10843058|FG002|COMPLETED|Overall Study||643
9741642|NCT00251719|10843056|FG000|NOT COMPLETED|Overall Study||53
9741643|NCT00251719|10843057|FG001|NOT COMPLETED|Overall Study||45
9741644|NCT00251719|10843058|FG002|NOT COMPLETED|Overall Study||30
9741645|NCT00251745|10843069|FG000|STARTED|Overall Study||292
9741646|NCT00251745|10843070|FG001|STARTED|Overall Study||312
9741647|NCT00251745|10843071|FG002|STARTED|Overall Study||304
9741648|NCT00251745|10843069|FG000|COMPLETED|Overall Study||264
9741649|NCT00251745|10843070|FG001|COMPLETED|Overall Study||285
9741650|NCT00251745|10843071|FG002|COMPLETED|Overall Study||277
9741651|NCT00251745|10843069|FG000|NOT COMPLETED|Overall Study||28
9741652|NCT00251745|10843070|FG001|NOT COMPLETED|Overall Study||27
9741653|NCT00251745|10843071|FG002|NOT COMPLETED|Overall Study||27
9741654|NCT00251758|10843082|FG000|STARTED|Overall Study||292
9741655|NCT00251758|10843083|FG001|STARTED|Overall Study||312
9741656|NCT00251758|10843084|FG002|STARTED|Overall Study||304
9741657|NCT00251758|10843082|FG000|COMPLETED|Overall Study||264
9741658|NCT00251758|10843083|FG001|COMPLETED|Overall Study||285
9741659|NCT00251758|10843084|FG002|COMPLETED|Overall Study||277
9741660|NCT00251758|10843082|FG000|NOT COMPLETED|Overall Study||28
9741661|NCT00251758|10843083|FG001|NOT COMPLETED|Overall Study||27
9741662|NCT00251758|10843084|FG002|NOT COMPLETED|Overall Study||27
9741663|NCT00251862|10843095|FG000|STARTED|Overall Study||280
9741664|NCT00251862|10843096|FG001|STARTED|Overall Study||269
9741665|NCT00251862|10843097|FG002|STARTED|Overall Study||276
9741666|NCT00251862|10843095|FG000|COMPLETED|Overall Study||280
9741667|NCT00251862|10843096|FG001|COMPLETED|Overall Study||269
9741668|NCT00251862|10843097|FG002|COMPLETED|Overall Study||276
9741669|NCT00251862|10843095|FG000|NOT COMPLETED|Overall Study||0
9741670|NCT00251862|10843096|FG001|NOT COMPLETED|Overall Study||0
9741671|NCT00251862|10843097|FG002|NOT COMPLETED|Overall Study||0
9741672|NCT00251927|10843107|FG000|STARTED|Overall Study|Randomised|288
9741673|NCT00251927|10843108|FG001|STARTED|Overall Study|Randomised|266
9741674|NCT00251927|10843107|FG000|COMPLETED|Overall Study|Completed 5 year visit|180
9741675|NCT00251927|10843108|FG001|COMPLETED|Overall Study|Completed 5 year visit|192
9741676|NCT00251927|10843107|FG000|NOT COMPLETED|Overall Study||108
9741677|NCT00251927|10843108|FG001|NOT COMPLETED|Overall Study||74
9741678|NCT00251979|10843117|FG000|STARTED|Overall Study|ITT population|375
9741679|NCT00251979|10843118|FG001|STARTED|Overall Study|ITT population|389
9741680|NCT00251979|10843117|FG000|COMPLETED|Overall Study||337
9741681|NCT00251979|10843118|FG001|COMPLETED|Overall Study||349
9741682|NCT00251979|10843117|FG000|NOT COMPLETED|Overall Study||38
9741683|NCT00251979|10843118|FG001|NOT COMPLETED|Overall Study||40
9741684|NCT00252057|10843126|FG000|STARTED|Overall Study||373
9741685|NCT00252057|10843127|FG001|STARTED|Overall Study||376
9741686|NCT00252057|10843126|FG000|COMPLETED|Overall Study||370
9741687|NCT00252057|10843127|FG001|COMPLETED|Overall Study||368
9741688|NCT00252057|10843126|FG000|NOT COMPLETED|Overall Study||3
9741689|NCT00252057|10843127|FG001|NOT COMPLETED|Overall Study||8
9741690|NCT00252187|10843135|FG000|STARTED|Overall Study||24
9741691|NCT00252187|10843136|FG001|STARTED|Overall Study||21
9741692|NCT00252187|10843135|FG000|COMPLETED|Overall Study||20
9741693|NCT00252187|10843136|FG001|COMPLETED|Overall Study||20
9741694|NCT00252187|10843135|FG000|NOT COMPLETED|Overall Study||4
9741695|NCT00252187|10843136|FG001|NOT COMPLETED|Overall Study||1
9741696|NCT00252239|10843146|FG000|STARTED|Overall Study||31
9741697|NCT00252239|10843147|FG001|STARTED|Overall Study||31
9741698|NCT00252239|10843148|FG002|STARTED|Overall Study||19
9741699|NCT00252239|10843149|FG003|STARTED|Overall Study||31
9741700|NCT00252239|10843146|FG000|COMPLETED|Overall Study||30
9741701|NCT00252239|10843147|FG001|COMPLETED|Overall Study||31
9741702|NCT00252239|10843148|FG002|COMPLETED|Overall Study||17
9741703|NCT00252239|10843149|FG003|COMPLETED|Overall Study||30
9741704|NCT00252239|10843146|FG000|NOT COMPLETED|Overall Study||1
9741705|NCT00252239|10843147|FG001|NOT COMPLETED|Overall Study||0
9741706|NCT00252239|10843148|FG002|NOT COMPLETED|Overall Study||2
9741707|NCT00252239|10843149|FG003|NOT COMPLETED|Overall Study||1
9741708|NCT00252382|10843159|FG000|STARTED|Overall Study||31
9741709|NCT00252382|10843159|FG000|COMPLETED|Overall Study||5
9741710|NCT00252382|10843159|FG000|NOT COMPLETED|Overall Study||26
9741711|NCT00252499|10843166|FG000|STARTED|Overall Study||5
9741712|NCT00252499|10843167|FG001|STARTED|Overall Study||2
9741713|NCT00252499|10843168|FG002|STARTED|Overall Study||6
9741714|NCT00252499|10843166|FG000|COMPLETED|Overall Study||4
9741715|NCT00252499|10843167|FG001|COMPLETED|Overall Study||2
9741716|NCT00252499|10843168|FG002|COMPLETED|Overall Study||6
9741717|NCT00252499|10843166|FG000|NOT COMPLETED|Overall Study||1
9741718|NCT00252499|10843167|FG001|NOT COMPLETED|Overall Study||0
9741719|NCT00252499|10843168|FG002|NOT COMPLETED|Overall Study||0
9741720|NCT00252512|10843178|FG000|STARTED|Intervention||165
9741721|NCT00252512|10843179|FG001|STARTED|Intervention||165
9741722|NCT00252512|10843178|FG000|COMPLETED|Intervention||136
9741723|NCT00252512|10843179|FG001|COMPLETED|Intervention||134
9741724|NCT00252512|10843178|FG000|NOT COMPLETED|Intervention||29
9741725|NCT00252512|10843179|FG001|NOT COMPLETED|Intervention||31
9741726|NCT00252512|10843178|FG000|STARTED|Six Month Follow up||136
9741727|NCT00252512|10843179|FG001|STARTED|Six Month Follow up||134
9741728|NCT00252512|10843178|FG000|COMPLETED|Six Month Follow up||132
9741729|NCT00252512|10843179|FG001|COMPLETED|Six Month Follow up||122
9741730|NCT00252512|10843178|FG000|NOT COMPLETED|Six Month Follow up||4
9741731|NCT00252512|10843179|FG001|NOT COMPLETED|Six Month Follow up||12
9741732|NCT00252512|10843178|FG000|STARTED|12 Month Follow up||132
9741733|NCT00252512|10843179|FG001|STARTED|12 Month Follow up||122
9741734|NCT00252512|10843178|FG000|COMPLETED|12 Month Follow up||123
9741735|NCT00252512|10843179|FG001|COMPLETED|12 Month Follow up||121
9741736|NCT00252512|10843178|FG000|NOT COMPLETED|12 Month Follow up||9
9741737|NCT00252512|10843179|FG001|NOT COMPLETED|12 Month Follow up||1
9741738|NCT00252538|10843185|FG000|STARTED|Overall Study||19
9741739|NCT00252538|10843186|FG001|STARTED|Overall Study||114
9741740|NCT00252538|10843185|FG000|COMPLETED|Overall Study||19
9741741|NCT00252538|10843186|FG001|COMPLETED|Overall Study||114
9741742|NCT00252538|10843185|FG000|NOT COMPLETED|Overall Study||0
9741743|NCT00252538|10843186|FG001|NOT COMPLETED|Overall Study||0
9741744|NCT00252564|10843193|FG000|STARTED|Overall Study|From randomization|124
9741745|NCT00252564|10843194|FG001|STARTED|Overall Study|From randomization|123
9741746|NCT00252564|10843193|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
9741747|NCT00252564|10843194|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
9741748|NCT00252564|10843193|FG000|NOT COMPLETED|Overall Study||39
9852477|NCT00881361|10965324|FG002|NOT COMPLETED|Overall Study||2
9852478|NCT00881465|10965335|FG000|STARTED|Overall Study||16
9852479|NCT00881465|10965336|FG001|STARTED|Overall Study||15
9852480|NCT00881465|10965335|FG000|COMPLETED|Overall Study||14
9852481|NCT00881465|10965336|FG001|COMPLETED|Overall Study||15
9852482|NCT00881465|10965335|FG000|NOT COMPLETED|Overall Study||2
9852483|NCT00881465|10965336|FG001|NOT COMPLETED|Overall Study||0
9852484|NCT00881504|10965342|FG000|STARTED|Overall Study||9
9852485|NCT00881504|10965342|FG000|COMPLETED|Overall Study||8
9852486|NCT00881504|10965342|FG000|NOT COMPLETED|Overall Study||1
9852487|NCT00881530|10965352|FG000|STARTED|Overall Study||106
9852488|NCT00881530|10965353|FG001|STARTED|Overall Study||109
9741749|NCT00252564|10843194|FG001|NOT COMPLETED|Overall Study||44
9741750|NCT00252577|10843200|FG000|STARTED|Overall Study||130
9741751|NCT00252577|10843200|FG000|COMPLETED|Overall Study||110
9741752|NCT00252577|10843200|FG000|NOT COMPLETED|Overall Study||20
9741753|NCT00252590|10843207|FG000|STARTED|Overall Study||35
9741754|NCT00252590|10843208|FG001|STARTED|Overall Study||30
9741755|NCT00252590|10843209|FG002|STARTED|Overall Study||34
9741756|NCT00252590|10843207|FG000|COMPLETED|Overall Study||33
9741757|NCT00252590|10843208|FG001|COMPLETED|Overall Study||28
9741758|NCT00252590|10843209|FG002|COMPLETED|Overall Study||31
9852489|NCT00881530|10965354|FG002|STARTED|Overall Study||56
9741759|NCT00252590|10843207|FG000|NOT COMPLETED|Overall Study||2
9741760|NCT00252590|10843208|FG001|NOT COMPLETED|Overall Study||2
9741761|NCT00252590|10843209|FG002|NOT COMPLETED|Overall Study||3
9741762|NCT00252629|10843220|FG000|STARTED|Overall Study||9
9741763|NCT00252629|10843221|FG001|STARTED|Overall Study||9
9741764|NCT00252629|10843222|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
9741765|NCT00252629|10843220|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
9741766|NCT00252629|10843221|FG001|COMPLETED|Overall Study||9
9741767|NCT00252629|10843222|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
9741768|NCT00252629|10843220|FG000|NOT COMPLETED|Overall Study||1
9852490|NCT00881530|10965355|FG003|STARTED|Overall Study||166
9852491|NCT00881530|10965356|FG004|STARTED|Overall Study||166
9852492|NCT00881530|10965357|FG005|STARTED|Overall Study||56
9741769|NCT00252629|10843221|FG001|NOT COMPLETED|Overall Study||0
9741770|NCT00252629|10843222|FG002|NOT COMPLETED|Overall Study||0
9741771|NCT00252694|10843237|FG000|STARTED|Overall Study||951
9741772|NCT00252694|10843238|FG001|STARTED|Overall Study||954
9741773|NCT00252694|10843237|FG000|COMPLETED|Overall Study||807
9741774|NCT00252694|10843238|FG001|COMPLETED|Overall Study||800
9741775|NCT00252694|10843237|FG000|NOT COMPLETED|Overall Study||144
9741776|NCT00252694|10843238|FG001|NOT COMPLETED|Overall Study||154
9741777|NCT00252720|10843246|FG000|STARTED|Overall Study||951
9741778|NCT00252720|10843247|FG001|STARTED|Overall Study||954
9741779|NCT00252720|10843246|FG000|COMPLETED|Overall Study||819
9741780|NCT00252720|10843247|FG001|COMPLETED|Overall Study||789
9741781|NCT00252720|10843246|FG000|NOT COMPLETED|Overall Study||132
9741782|NCT00252720|10843247|FG001|NOT COMPLETED|Overall Study||165
9741783|NCT00252733|10843255|FG000|STARTED|Overall Study||711
9741784|NCT00252733|10843256|FG001|STARTED|Overall Study||710
9741785|NCT00252733|10843255|FG000|COMPLETED|Overall Study||605
9741786|NCT00252733|10843256|FG001|COMPLETED|Overall Study||618
9741787|NCT00252733|10843255|FG000|NOT COMPLETED|Overall Study||106
9741788|NCT00252733|10843256|FG001|NOT COMPLETED|Overall Study||92
9741789|NCT00252967|10843264|FG000|STARTED|Overall Study||31
9741790|NCT00252967|10843265|FG001|STARTED|Overall Study||33
9741791|NCT00252967|10843264|FG000|COMPLETED|Overall Study||31
9741792|NCT00252967|10843265|FG001|COMPLETED|Overall Study||33
9741793|NCT00252967|10843264|FG000|NOT COMPLETED|Overall Study||0
9741794|NCT00252967|10843265|FG001|NOT COMPLETED|Overall Study||0
9741795|NCT00253019|10843274|FG000|STARTED|Overall Study||111
9741796|NCT00253019|10843275|FG001|STARTED|Overall Study||109
9741797|NCT00253019|10843276|FG002|STARTED|Overall Study||101
9741798|NCT00253019|10843274|FG000|COMPLETED|Overall Study||82
9741799|NCT00253019|10843275|FG001|COMPLETED|Overall Study||78
9741800|NCT00253019|10843276|FG002|COMPLETED|Overall Study||83
9741801|NCT00253019|10843274|FG000|NOT COMPLETED|Overall Study||29
9741802|NCT00253019|10843275|FG001|NOT COMPLETED|Overall Study||31
9741803|NCT00253019|10843276|FG002|NOT COMPLETED|Overall Study||18
9828202|NCT00754390|10938904|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
9828203|NCT00754390|10938904|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
9828204|NCT00754390|10938904|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
9828205|NCT00754390|10938904|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
9828206|NCT00754390|10938904|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
9828207|NCT00754390|10938904|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
9828208|NCT00754442|10938913|FG000|STARTED|Overall Study|controls 11|11
9828209|NCT00754442|10938914|FG001|STARTED|Overall Study|patients 9|9
9828210|NCT00754442|10938913|FG000|COMPLETED|Overall Study||6
9828211|NCT00754442|10938914|FG001|COMPLETED|Overall Study||6
9828212|NCT00754442|10938913|FG000|NOT COMPLETED|Overall Study||5
9828213|NCT00754442|10938914|FG001|NOT COMPLETED|Overall Study||3
9828214|NCT00754468|10938923|FG000|STARTED|Overall Study||4
9828215|NCT00754468|10938924|FG001|STARTED|Overall Study||3
9828216|NCT00754468|10938923|FG000|COMPLETED|Overall Study||4
9828217|NCT00754468|10938924|FG001|COMPLETED|Overall Study||3
9828218|NCT00754468|10938923|FG000|NOT COMPLETED|Overall Study||0
9828219|NCT00754468|10938924|FG001|NOT COMPLETED|Overall Study||0
9828220|NCT00754494|10938935|FG000|STARTED|Overall Study||15
9828221|NCT00754494|10938936|FG001|STARTED|Overall Study||15
9828222|NCT00754494|10938937|FG002|STARTED|Overall Study||15
9828223|NCT00754494|10938935|FG000|COMPLETED|Overall Study||13
9828224|NCT00754494|10938936|FG001|COMPLETED|Overall Study||15
9828225|NCT00754494|10938937|FG002|COMPLETED|Overall Study||14
9828226|NCT00754494|10938935|FG000|NOT COMPLETED|Overall Study||2
9828227|NCT00754494|10938936|FG001|NOT COMPLETED|Overall Study||0
9828228|NCT00754494|10938937|FG002|NOT COMPLETED|Overall Study||1
9828229|NCT00754546|10938945|FG000|STARTED|Overall Study||20
9828230|NCT00754546|10938945|FG000|COMPLETED|Overall Study||20
9828231|NCT00754546|10938945|FG000|NOT COMPLETED|Overall Study||0
9828232|NCT00754559|10938955|FG000|STARTED|Overall Study||286
9828233|NCT00754559|10938955|FG000|COMPLETED|Overall Study||239
9828234|NCT00754559|10938955|FG000|NOT COMPLETED|Overall Study||47
9828235|NCT00754572|10938962|FG000|STARTED|Overall Study||418
9828236|NCT00754572|10938962|FG000|COMPLETED|Overall Study||347
9828237|NCT00754572|10938962|FG000|NOT COMPLETED|Overall Study||71
9832402|NCT00772967|10943207|FG003|STARTED|Crossover Treatment 2||3
9832403|NCT00772967|10943208|FG004|STARTED|Crossover Treatment 2||4
9832404|NCT00772967|10943209|FG005|STARTED|Crossover Treatment 2||3
9832405|NCT00772967|10943204|FG000|COMPLETED|Crossover Treatment 2||3
9832406|NCT00772967|10943205|FG001|COMPLETED|Crossover Treatment 2||4
9832407|NCT00772967|10943206|FG002|COMPLETED|Crossover Treatment 2||3
9832408|NCT00772967|10943207|FG003|COMPLETED|Crossover Treatment 2||3
9832409|NCT00772967|10943208|FG004|COMPLETED|Crossover Treatment 2||4
9832410|NCT00772967|10943209|FG005|COMPLETED|Crossover Treatment 2||3
9832411|NCT00772967|10943204|FG000|NOT COMPLETED|Crossover Treatment 2||0
9832412|NCT00772967|10943205|FG001|NOT COMPLETED|Crossover Treatment 2||0
9832413|NCT00772967|10943206|FG002|NOT COMPLETED|Crossover Treatment 2||0
9832414|NCT00772967|10943207|FG003|NOT COMPLETED|Crossover Treatment 2||0
9832415|NCT00772967|10943208|FG004|NOT COMPLETED|Crossover Treatment 2||0
9832416|NCT00772967|10943209|FG005|NOT COMPLETED|Crossover Treatment 2||0
9832417|NCT00772967|10943204|FG000|STARTED|Break 2 (4-7 Days)||3
9832418|NCT00772967|10943205|FG001|STARTED|Break 2 (4-7 Days)||4
9832419|NCT00772967|10943206|FG002|STARTED|Break 2 (4-7 Days)||3
9832420|NCT00772967|10943207|FG003|STARTED|Break 2 (4-7 Days)||3
9741804|NCT00253370|10843284|FG000|STARTED|Overall Study||44
9741805|NCT00253370|10843284|FG000|COMPLETED|Overall Study||1
9741806|NCT00253370|10843284|FG000|NOT COMPLETED|Overall Study||43
9741807|NCT00253435|10843291|FG000|STARTED|Overall Study|Total number is 42|42
9741808|NCT00253435|10843292|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
9741809|NCT00253435|10843291|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
9741810|NCT00253435|10843292|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
9741811|NCT00253435|10843291|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
9741812|NCT00253435|10843292|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
9741813|NCT00253435|10843291|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
9741814|NCT00253435|10843292|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
9741815|NCT00253435|10843291|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
9741816|NCT00253435|10843292|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
9741817|NCT00253435|10843291|FG000|NOT COMPLETED|Overall Study||0
9741818|NCT00253435|10843292|FG001|NOT COMPLETED|Overall Study||0
9741819|NCT00253448|10843298|FG000|STARTED|Overall Study||35
9741820|NCT00253448|10843298|FG000|COMPLETED|Overall Study||34
9741821|NCT00253448|10843298|FG000|NOT COMPLETED|Overall Study||1
9741822|NCT00253513|10843302|FG000|STARTED|Overall Study||60
9741823|NCT00253513|10843302|FG000|COMPLETED|Overall Study||60
9741824|NCT00253513|10843302|FG000|NOT COMPLETED|Overall Study||0
9741825|NCT00253630|10843306|FG000|STARTED|Overall Study||37
9741826|NCT00253630|10843306|FG000|COMPLETED|Overall Study||35
9741827|NCT00253630|10843306|FG000|NOT COMPLETED|Overall Study||2
9741828|NCT00253643|10843314|FG000|STARTED|Overall Study||14
9741829|NCT00253643|10843315|FG001|STARTED|Overall Study||15
9741830|NCT00253643|10843316|FG002|STARTED|Overall Study||29
9741831|NCT00253643|10843317|FG003|STARTED|Overall Study||31
9741832|NCT00253643|10843314|FG000|COMPLETED|Overall Study||14
9741833|NCT00253643|10843315|FG001|COMPLETED|Overall Study||15
9741834|NCT00253643|10843316|FG002|COMPLETED|Overall Study||28
9741835|NCT00253643|10843317|FG003|COMPLETED|Overall Study||28
9741836|NCT00253643|10843314|FG000|NOT COMPLETED|Overall Study||0
9741837|NCT00253643|10843315|FG001|NOT COMPLETED|Overall Study||0
9741838|NCT00253643|10843316|FG002|NOT COMPLETED|Overall Study||1
9741839|NCT00253643|10843317|FG003|NOT COMPLETED|Overall Study||3
9741840|NCT00253708|10843330|FG000|STARTED|Overall Study||20
10091677|NCT02330588|11219904|FG000|NOT COMPLETED|Overall Study||16
10091678|NCT02330588|11219905|FG001|NOT COMPLETED|Overall Study||18
10091679|NCT02330588|11219906|FG002|NOT COMPLETED|Overall Study||15
9741841|NCT00253708|10843331|FG001|STARTED|Overall Study||10
9741842|NCT00253708|10843332|FG002|STARTED|Overall Study||9
9741843|NCT00253708|10843330|FG000|COMPLETED|Overall Study||20
9741844|NCT00253708|10843331|FG001|COMPLETED|Overall Study||10
9741845|NCT00253708|10843332|FG002|COMPLETED|Overall Study||8
9741846|NCT00253708|10843330|FG000|NOT COMPLETED|Overall Study||0
9741847|NCT00253708|10843331|FG001|NOT COMPLETED|Overall Study||0
9741848|NCT00253708|10843332|FG002|NOT COMPLETED|Overall Study||1
9741849|NCT00253747|10843342|FG000|STARTED|Overall Study||127
9741850|NCT00253747|10843343|FG001|STARTED|Overall Study||128
9741851|NCT00253747|10843342|FG000|COMPLETED|Overall Study||103
9741852|NCT00253747|10843343|FG001|COMPLETED|Overall Study||101
9741853|NCT00253747|10843342|FG000|NOT COMPLETED|Overall Study||24
9741854|NCT00253747|10843343|FG001|NOT COMPLETED|Overall Study||27
9741855|NCT00253890|10843361|FG000|STARTED|Overall Study||69
9741856|NCT00253890|10843362|FG001|STARTED|Overall Study||68
9741857|NCT00253890|10843361|FG000|COMPLETED|Overall Study||62
9741858|NCT00253890|10843362|FG001|COMPLETED|Overall Study||61
9741859|NCT00253890|10843361|FG000|NOT COMPLETED|Overall Study||7
9741860|NCT00253890|10843362|FG001|NOT COMPLETED|Overall Study||7
9741861|NCT00254072|10843370|FG000|STARTED|Overall Study||180
9741862|NCT00254072|10843371|FG001|STARTED|Overall Study||175
9741863|NCT00254072|10843370|FG000|COMPLETED|Overall Study||180
9741864|NCT00254072|10843371|FG001|COMPLETED|Overall Study||175
9741865|NCT00254072|10843370|FG000|NOT COMPLETED|Overall Study||0
9741866|NCT00254072|10843371|FG001|NOT COMPLETED|Overall Study||0
9741867|NCT00254163|10843379|FG000|STARTED|Overall Study||92
9741868|NCT00254163|10843380|FG001|STARTED|Overall Study||92
9741869|NCT00254163|10843379|FG000|COMPLETED|Overall Study||47
9741870|NCT00254163|10843380|FG001|COMPLETED|Overall Study||46
9741871|NCT00254163|10843379|FG000|NOT COMPLETED|Overall Study||45
9741872|NCT00254163|10843380|FG001|NOT COMPLETED|Overall Study||46
9741873|NCT00254293|10843392|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7
9741874|NCT00254293|10843393|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4
10091680|NCT02330588|11219907|FG003|NOT COMPLETED|Overall Study||22
10091681|NCT02330588|11219908|FG004|NOT COMPLETED|Overall Study||19
9741875|NCT00254293|10843394|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29
9741876|NCT00254293|10843395|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6
9741877|NCT00254293|10843396|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5
9741878|NCT00254293|10843397|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
9741879|NCT00254293|10843398|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0
10091682|NCT02330627|11219930|FG000|STARTED|Overall Study||16
9741880|NCT00254293|10843392|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7
9741881|NCT00254293|10843393|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3
9741882|NCT00254293|10843394|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26
9741883|NCT00254293|10843395|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5
9741884|NCT00254293|10843396|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5
9741885|NCT00254293|10843397|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17
9741886|NCT00254293|10843398|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0
9741887|NCT00254293|10843392|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
9741888|NCT00254293|10843393|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
9741889|NCT00254293|10843394|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
9741890|NCT00254293|10843395|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
9741891|NCT00254293|10843396|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
9741892|NCT00254293|10843397|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
9741893|NCT00254293|10843398|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
9741894|NCT00254293|10843392|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
9741895|NCT00254293|10843393|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
9741896|NCT00254293|10843394|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
9741897|NCT00254293|10843395|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
9741898|NCT00254293|10843396|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
9741899|NCT00254293|10843397|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
9741900|NCT00254293|10843398|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
9741901|NCT00254293|10843392|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8
9741902|NCT00254293|10843393|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0
9741903|NCT00254293|10843394|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32
9741904|NCT00254293|10843395|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0
9741905|NCT00254293|10843396|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8
9741906|NCT00254293|10843397|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0
9741907|NCT00254293|10843398|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0
9741908|NCT00254293|10843392|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
9741909|NCT00254293|10843393|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
9741910|NCT00254293|10843394|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
9741911|NCT00254293|10843395|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
9741912|NCT00254293|10843396|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
9741913|NCT00254293|10843397|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
9741914|NCT00254293|10843398|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
9741915|NCT00254293|10843392|FG000|STARTED|LTE Open Label Fixed Dosing||0
9741916|NCT00254293|10843393|FG001|STARTED|LTE Open Label Fixed Dosing||0
9741917|NCT00254293|10843394|FG002|STARTED|LTE Open Label Fixed Dosing||0
9741918|NCT00254293|10843395|FG003|STARTED|LTE Open Label Fixed Dosing||0
9741919|NCT00254293|10843396|FG004|STARTED|LTE Open Label Fixed Dosing||0
9741920|NCT00254293|10843397|FG005|STARTED|LTE Open Label Fixed Dosing||0
9741921|NCT00254293|10843398|FG006|STARTED|LTE Open Label Fixed Dosing||48
9741922|NCT00254293|10843392|FG000|COMPLETED|LTE Open Label Fixed Dosing||0
9741923|NCT00254293|10843393|FG001|COMPLETED|LTE Open Label Fixed Dosing||0
9741924|NCT00254293|10843394|FG002|COMPLETED|LTE Open Label Fixed Dosing||0
9741925|NCT00254293|10843395|FG003|COMPLETED|LTE Open Label Fixed Dosing||0
9741926|NCT00254293|10843396|FG004|COMPLETED|LTE Open Label Fixed Dosing||0
9741927|NCT00254293|10843397|FG005|COMPLETED|LTE Open Label Fixed Dosing||0
9741928|NCT00254293|10843398|FG006|COMPLETED|LTE Open Label Fixed Dosing||35
9741929|NCT00254293|10843392|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0
9741930|NCT00254293|10843393|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0
9741931|NCT00254293|10843394|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0
9741932|NCT00254293|10843395|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0
9741933|NCT00254293|10843396|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0
9741934|NCT00254293|10843397|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0
9741935|NCT00254293|10843398|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13
9741936|NCT00254397|10843445|FG000|STARTED|Overall Study||10
9741937|NCT00254397|10843446|FG001|STARTED|Overall Study||6
9741938|NCT00254397|10843447|FG002|STARTED|Overall Study||37
9741939|NCT00254397|10843448|FG003|STARTED|Overall Study||45
9741940|NCT00254397|10843445|FG000|COMPLETED|Overall Study||4
9741941|NCT00254397|10843446|FG001|COMPLETED|Overall Study||5
9741942|NCT00254397|10843447|FG002|COMPLETED|Overall Study||18
9741943|NCT00254397|10843448|FG003|COMPLETED|Overall Study||20
9741944|NCT00254397|10843445|FG000|NOT COMPLETED|Overall Study||6
9741945|NCT00254397|10843446|FG001|NOT COMPLETED|Overall Study||1
9741946|NCT00254397|10843447|FG002|NOT COMPLETED|Overall Study||19
9741947|NCT00254397|10843448|FG003|NOT COMPLETED|Overall Study||25
9741948|NCT00254410|10843457|FG000|STARTED|Overall Study||30
9741949|NCT00254410|10843457|FG000|COMPLETED|Overall Study||30
9741950|NCT00254410|10843457|FG000|NOT COMPLETED|Overall Study||0
9741951|NCT00254462|10843463|FG000|STARTED|Overall Study||44
9741952|NCT00254462|10843464|FG001|STARTED|Overall Study||49
9741953|NCT00254462|10843463|FG000|COMPLETED|Overall Study||36
9741954|NCT00254462|10843464|FG001|COMPLETED|Overall Study||39
9741955|NCT00254462|10843463|FG000|NOT COMPLETED|Overall Study||8
9741956|NCT00254462|10843464|FG001|NOT COMPLETED|Overall Study||10
9741957|NCT00254488|10843474|FG000|STARTED|Overall Study||112
9741958|NCT00254488|10843475|FG001|STARTED|Overall Study||112
9741959|NCT00254488|10843474|FG000|COMPLETED|Overall Study||55
9741960|NCT00254488|10843475|FG001|COMPLETED|Overall Study||63
9741961|NCT00254488|10843474|FG000|NOT COMPLETED|Overall Study||57
9741962|NCT00254488|10843475|FG001|NOT COMPLETED|Overall Study||49
9741963|NCT00254501|10843483|FG000|STARTED|Overall Study||32
9741964|NCT00254501|10843484|FG001|STARTED|Overall Study||37
9741965|NCT00254501|10843483|FG000|COMPLETED|Overall Study||31
9741966|NCT00254501|10843484|FG001|COMPLETED|Overall Study||36
9741967|NCT00254501|10843483|FG000|NOT COMPLETED|Overall Study||1
9741968|NCT00254501|10843484|FG001|NOT COMPLETED|Overall Study||1
9741969|NCT00254540|10843494|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
9741970|NCT00254540|10843495|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
9741971|NCT00254540|10843494|FG000|COMPLETED|Overall Study||6
9741972|NCT00254540|10843495|FG001|COMPLETED|Overall Study||4
9741973|NCT00254540|10843494|FG000|NOT COMPLETED|Overall Study||19
9741974|NCT00254540|10843495|FG001|NOT COMPLETED|Overall Study||22
9741975|NCT00254566|10843504|FG000|STARTED|Overall Study||198
9741976|NCT00254566|10843505|FG001|STARTED|Overall Study||198
9741977|NCT00254566|10843504|FG000|COMPLETED|Overall Study||167
9741978|NCT00254566|10843505|FG001|COMPLETED|Overall Study||172
9741979|NCT00254566|10843504|FG000|NOT COMPLETED|Overall Study||31
9741980|NCT00254566|10843505|FG001|NOT COMPLETED|Overall Study||26
9741981|NCT00254592|10843511|FG000|STARTED|Overall Study||43
9741982|NCT00254592|10843511|FG000|COMPLETED|Overall Study||41
9741983|NCT00254592|10843511|FG000|NOT COMPLETED|Overall Study||2
9741984|NCT00254982|10843517|FG000|STARTED|Overall Study||297
9741985|NCT00254982|10843518|FG001|STARTED|Overall Study||296
9741986|NCT00254982|10843517|FG000|COMPLETED|Overall Study||261
9741987|NCT00254982|10843518|FG001|COMPLETED|Overall Study||265
9741988|NCT00254982|10843517|FG000|NOT COMPLETED|Overall Study||36
9741989|NCT00254982|10843518|FG001|NOT COMPLETED|Overall Study||31
9741990|NCT00254995|10843526|FG000|STARTED|Overall Study||31561
9741991|NCT00254995|10843527|FG001|STARTED|Overall Study||31065
9741992|NCT00254995|10843526|FG000|COMPLETED|Overall Study||31561
9741993|NCT00254995|10843527|FG001|COMPLETED|Overall Study||31065
9741994|NCT00254995|10843526|FG000|NOT COMPLETED|Overall Study||0
9741995|NCT00254995|10843527|FG001|NOT COMPLETED|Overall Study||0
9741996|NCT00255008|10843539|FG000|STARTED|Overall Study||45
9741997|NCT00255008|10843540|FG001|STARTED|Overall Study||9
9741998|NCT00255008|10843541|FG002|STARTED|Overall Study||33
9741999|NCT00255008|10843542|FG003|STARTED|Overall Study||34
10091683|NCT02330627|11219931|FG001|STARTED|Overall Study||13
10091684|NCT02330627|11219930|FG000|COMPLETED|Overall Study||15
9742000|NCT00255008|10843539|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
9742001|NCT00255008|10843540|FG001|COMPLETED|Overall Study||0
9742002|NCT00255008|10843541|FG002|COMPLETED|Overall Study||17
9742003|NCT00255008|10843542|FG003|COMPLETED|Overall Study||12
9742004|NCT00255008|10843539|FG000|NOT COMPLETED|Overall Study||32
9742005|NCT00255008|10843540|FG001|NOT COMPLETED|Overall Study||9
10091685|NCT02330627|11219931|FG001|COMPLETED|Overall Study||12
10091686|NCT02330627|11219930|FG000|NOT COMPLETED|Overall Study||1
10091687|NCT02330627|11219931|FG001|NOT COMPLETED|Overall Study||1
9742006|NCT00255008|10843541|FG002|NOT COMPLETED|Overall Study||16
9742007|NCT00255008|10843542|FG003|NOT COMPLETED|Overall Study||22
9742008|NCT00255034|10843554|FG000|STARTED|Overall Study||79
9742009|NCT00255034|10843555|FG001|STARTED|Overall Study||64
9742010|NCT00255034|10843554|FG000|COMPLETED|Overall Study||64
9742011|NCT00255034|10843555|FG001|COMPLETED|Overall Study||26
9742012|NCT00255034|10843554|FG000|NOT COMPLETED|Overall Study||15
9742013|NCT00255034|10843555|FG001|NOT COMPLETED|Overall Study||38
9742014|NCT00255047|10843565|FG000|STARTED|Overall Study||538
9742015|NCT00255047|10843566|FG001|STARTED|Overall Study||535
9742016|NCT00255047|10843567|FG002|STARTED|Overall Study||546
9742017|NCT00255047|10843568|FG003|STARTED|Overall Study||548
9742018|NCT00255047|10843565|FG000|COMPLETED|Overall Study||490
9742019|NCT00255047|10843566|FG001|COMPLETED|Overall Study||487
9742020|NCT00255047|10843567|FG002|COMPLETED|Overall Study||496
9742021|NCT00255047|10843568|FG003|COMPLETED|Overall Study||502
9742022|NCT00255047|10843565|FG000|NOT COMPLETED|Overall Study||48
9742023|NCT00255047|10843566|FG001|NOT COMPLETED|Overall Study||48
9742024|NCT00255047|10843567|FG002|NOT COMPLETED|Overall Study||50
9742025|NCT00255047|10843568|FG003|NOT COMPLETED|Overall Study||46
9742026|NCT00255086|10843580|FG000|STARTED|Overall Study||9
9742027|NCT00255086|10843581|FG001|STARTED|Overall Study||8
9742028|NCT00255086|10843580|FG000|COMPLETED|Overall Study||7
9742029|NCT00255086|10843581|FG001|COMPLETED|Overall Study||6
9742030|NCT00255086|10843580|FG000|NOT COMPLETED|Overall Study||2
9742031|NCT00255086|10843581|FG001|NOT COMPLETED|Overall Study||2
9742032|NCT00255125|10843590|FG000|STARTED|Overall Study||42
9742033|NCT00255125|10843591|FG001|STARTED|Overall Study||44
9742034|NCT00255125|10843590|FG000|COMPLETED|Overall Study||42
9742035|NCT00255125|10843591|FG001|COMPLETED|Overall Study||44
9742036|NCT00255125|10843590|FG000|NOT COMPLETED|Overall Study||0
9742037|NCT00255125|10843591|FG001|NOT COMPLETED|Overall Study||0
10091688|NCT02330978|11219937|FG000|STARTED|The First Patient Included at Study||1
9742038|NCT00255151|10843602|FG000|STARTED|Overall Study||140
9742039|NCT00255151|10843603|FG001|STARTED|Overall Study||159
9742040|NCT00255151|10843604|FG002|STARTED|Overall Study||152
9742041|NCT00255151|10843602|FG000|COMPLETED|Overall Study||17
9742042|NCT00255151|10843603|FG001|COMPLETED|Overall Study||110
9742043|NCT00255151|10843604|FG002|COMPLETED|Overall Study||103
9742044|NCT00255151|10843602|FG000|NOT COMPLETED|Overall Study||123
9742045|NCT00255151|10843603|FG001|NOT COMPLETED|Overall Study||49
9742046|NCT00255151|10843604|FG002|NOT COMPLETED|Overall Study||49
9742047|NCT00255164|10843615|FG000|STARTED|Overall Study||140
9742048|NCT00255164|10843616|FG001|STARTED|Overall Study||159
9742049|NCT00255164|10843617|FG002|STARTED|Overall Study||152
9742050|NCT00255164|10843615|FG000|COMPLETED|Overall Study||17
9742051|NCT00255164|10843616|FG001|COMPLETED|Overall Study||110
9742052|NCT00255164|10843617|FG002|COMPLETED|Overall Study||103
9742053|NCT00255164|10843615|FG000|NOT COMPLETED|Overall Study||123
9742054|NCT00255164|10843616|FG001|NOT COMPLETED|Overall Study||49
9742055|NCT00255164|10843617|FG002|NOT COMPLETED|Overall Study||49
9742056|NCT00255177|10843629|FG000|STARTED|Overall Study||11
9742057|NCT00255177|10843630|FG001|STARTED|Overall Study||14
9742058|NCT00255177|10843631|FG002|STARTED|Overall Study||13
9742059|NCT00255177|10843632|FG003|STARTED|Overall Study||6
9742060|NCT00255177|10843629|FG000|COMPLETED|Overall Study||9
9742061|NCT00255177|10843630|FG001|COMPLETED|Overall Study||13
9742062|NCT00255177|10843631|FG002|COMPLETED|Overall Study||12
9742063|NCT00255177|10843632|FG003|COMPLETED|Overall Study||4
9742064|NCT00255177|10843629|FG000|NOT COMPLETED|Overall Study||2
9742065|NCT00255177|10843630|FG001|NOT COMPLETED|Overall Study||1
9742066|NCT00255177|10843631|FG002|NOT COMPLETED|Overall Study||1
9742067|NCT00255177|10843632|FG003|NOT COMPLETED|Overall Study||2
9742068|NCT00255190|10843644|FG000|STARTED|Overall Study||153
9742069|NCT00255190|10843645|FG001|STARTED|Overall Study||438
9742070|NCT00255190|10843644|FG000|COMPLETED|Overall Study||103
9742071|NCT00255190|10843645|FG001|COMPLETED|Overall Study||281
9742072|NCT00255190|10843644|FG000|NOT COMPLETED|Overall Study||50
9742073|NCT00255190|10843645|FG001|NOT COMPLETED|Overall Study||157
9742074|NCT00255346|10843656|FG000|STARTED|Overall Study||10
9742075|NCT00255346|10843657|FG001|STARTED|Overall Study||6
9742076|NCT00255346|10843658|FG002|STARTED|Overall Study||8
9742077|NCT00255346|10843659|FG003|STARTED|Overall Study||11
9742078|NCT00255346|10843660|FG004|STARTED|Overall Study||33
9742079|NCT00255346|10843656|FG000|COMPLETED|Overall Study||9
9742080|NCT00255346|10843657|FG001|COMPLETED|Overall Study||6
9742081|NCT00255346|10843658|FG002|COMPLETED|Overall Study||8
9742082|NCT00255346|10843659|FG003|COMPLETED|Overall Study||11
9742083|NCT00255346|10843660|FG004|COMPLETED|Overall Study||33
10091689|NCT02330978|11219937|FG000|COMPLETED|The First Patient Included at Study||1
10091690|NCT02330978|11219937|FG000|NOT COMPLETED|The First Patient Included at Study||0
10091691|NCT02330978|11219937|FG000|STARTED|The Second Patient Included at Study||1
10091692|NCT02330978|11219937|FG000|COMPLETED|The Second Patient Included at Study||1
9742084|NCT00255346|10843656|FG000|NOT COMPLETED|Overall Study||1
9742085|NCT00255346|10843657|FG001|NOT COMPLETED|Overall Study||0
9742086|NCT00255346|10843658|FG002|NOT COMPLETED|Overall Study||0
9742087|NCT00255346|10843659|FG003|NOT COMPLETED|Overall Study||0
9742088|NCT00255346|10843660|FG004|NOT COMPLETED|Overall Study||0
9742089|NCT00255684|10843668|FG000|STARTED|Overall Study||16
9742090|NCT00255684|10843668|FG000|COMPLETED|Overall Study||16
9742091|NCT00255684|10843668|FG000|NOT COMPLETED|Overall Study||0
9742092|NCT00255723|10843674|FG000|STARTED|Overall Study||56
9742093|NCT00255723|10843675|FG001|STARTED|Overall Study||41
9742094|NCT00255723|10843674|FG000|COMPLETED|Overall Study||54
9742095|NCT00255723|10843675|FG001|COMPLETED|Overall Study||39
9742096|NCT00255723|10843674|FG000|NOT COMPLETED|Overall Study||2
9742097|NCT00255723|10843675|FG001|NOT COMPLETED|Overall Study||2
9742098|NCT00255801|10843681|FG000|STARTED|Overall Study||37
9742099|NCT00255801|10843681|FG000|COMPLETED|Overall Study||37
9742100|NCT00255801|10843681|FG000|NOT COMPLETED|Overall Study||0
9742101|NCT00255840|10843687|FG000|STARTED|Overall Study||408
9742102|NCT00255840|10843688|FG001|STARTED|Overall Study||404
9742103|NCT00255840|10843687|FG000|COMPLETED|Overall Study||345
9742104|NCT00255840|10843688|FG001|COMPLETED|Overall Study||334
10091693|NCT02330978|11219937|FG000|NOT COMPLETED|The Second Patient Included at Study||0
9742105|NCT00255840|10843687|FG000|NOT COMPLETED|Overall Study||63
9742106|NCT00255840|10843688|FG001|NOT COMPLETED|Overall Study||70
9742107|NCT00255944|10843696|FG000|STARTED|Overall Study||1311
9742108|NCT00255944|10843697|FG001|STARTED|Overall Study||1311
9742109|NCT00255944|10843696|FG000|COMPLETED|Overall Study||514
9742110|NCT00255944|10843697|FG001|COMPLETED|Overall Study||477
9742111|NCT00255944|10843696|FG000|NOT COMPLETED|Overall Study||797
9742112|NCT00255944|10843697|FG001|NOT COMPLETED|Overall Study||834
9742113|NCT00255970|10843705|FG000|STARTED|Overall Study||21
9742114|NCT00255970|10843706|FG001|STARTED|Overall Study||19
9742115|NCT00255970|10843705|FG000|Screening Visit|Overall Study||21
9742116|NCT00255970|10843706|FG001|Screening Visit|Overall Study||19
9742117|NCT00255970|10843705|FG000|Final Visit Week 24|Overall Study||21
9742118|NCT00255970|10843706|FG001|Final Visit Week 24|Overall Study||19
9742119|NCT00255970|10843705|FG000|COMPLETED|Overall Study||21
9742120|NCT00255970|10843706|FG001|COMPLETED|Overall Study||19
9742121|NCT00255970|10843705|FG000|NOT COMPLETED|Overall Study||0
9742122|NCT00255970|10843706|FG001|NOT COMPLETED|Overall Study||0
9742123|NCT00256126|10843714|FG000|STARTED|Overall Study||149
10091694|NCT02331095|11219943|FG000|STARTED|Overall Study||11
9742124|NCT00256126|10843715|FG001|STARTED|Overall Study||169
9742125|NCT00256126|10843714|FG000|COMPLETED|Overall Study||147
9742126|NCT00256126|10843715|FG001|COMPLETED|Overall Study||167
9742127|NCT00256126|10843714|FG000|NOT COMPLETED|Overall Study||2
9742128|NCT00256126|10843715|FG001|NOT COMPLETED|Overall Study||2
9742129|NCT00256204|10843725|FG000|STARTED|Overall Study||298
9742130|NCT00256204|10843726|FG001|STARTED|Overall Study||288
9742131|NCT00256204|10843727|FG002|STARTED|Overall Study||295
9742132|NCT00256204|10843728|FG003|STARTED|Overall Study||293
9742133|NCT00256204|10843725|FG000|COMPLETED|Overall Study||231
9742134|NCT00256204|10843726|FG001|COMPLETED|Overall Study||238
9742135|NCT00256204|10843727|FG002|COMPLETED|Overall Study||241
9742136|NCT00256204|10843728|FG003|COMPLETED|Overall Study||244
9742137|NCT00256204|10843725|FG000|NOT COMPLETED|Overall Study||67
9742138|NCT00256204|10843726|FG001|NOT COMPLETED|Overall Study||50
9742139|NCT00256204|10843727|FG002|NOT COMPLETED|Overall Study||54
9742140|NCT00256204|10843728|FG003|NOT COMPLETED|Overall Study||49
9742141|NCT00256217|10843741|FG000|STARTED|Overall Study||42
9742142|NCT00256217|10843741|FG000|COMPLETED|Overall Study||34
9742143|NCT00256217|10843741|FG000|NOT COMPLETED|Overall Study||8
9742144|NCT00256243|10843745|FG000|STARTED|Overall Study||48
9742145|NCT00256243|10843745|FG000|COMPLETED|Overall Study||38
9742146|NCT00256243|10843745|FG000|NOT COMPLETED|Overall Study||10
9742147|NCT00256282|10843750|FG000|STARTED|Overall Study||52
9742148|NCT00256282|10843750|FG000|COMPLETED|Overall Study||36
9742149|NCT00256282|10843750|FG000|NOT COMPLETED|Overall Study||16
9742150|NCT00256308|10843754|FG000|STARTED|Overall Study||6
9742151|NCT00256308|10843754|FG000|COMPLETED|Overall Study||4
9742152|NCT00256308|10843754|FG000|NOT COMPLETED|Overall Study||2
9742153|NCT00256451|10843758|FG000|STARTED|Session1||10
9742154|NCT00256451|10843759|FG001|STARTED|Session1||11
9742155|NCT00256451|10843760|FG002|STARTED|Session1||11
9742156|NCT00256451|10843761|FG003|STARTED|Session1||11
9742157|NCT00256451|10843758|FG000|COMPLETED|Session1||10
9742158|NCT00256451|10843759|FG001|COMPLETED|Session1||11
9742159|NCT00256451|10843760|FG002|COMPLETED|Session1||11
9742160|NCT00256451|10843761|FG003|COMPLETED|Session1||11
9742161|NCT00256451|10843758|FG000|NOT COMPLETED|Session1||0
9742162|NCT00256451|10843759|FG001|NOT COMPLETED|Session1||0
9742163|NCT00256451|10843760|FG002|NOT COMPLETED|Session1||0
9742164|NCT00256451|10843761|FG003|NOT COMPLETED|Session1||0
9742165|NCT00256451|10843758|FG000|STARTED|Session2||9
9742166|NCT00256451|10843759|FG001|STARTED|Session2||11
9742167|NCT00256451|10843760|FG002|STARTED|Session2||10
9742168|NCT00256451|10843761|FG003|STARTED|Session2||10
9742169|NCT00256451|10843758|FG000|COMPLETED|Session2||9
9742170|NCT00256451|10843759|FG001|COMPLETED|Session2||11
9742171|NCT00256451|10843760|FG002|COMPLETED|Session2||10
9742172|NCT00256451|10843761|FG003|COMPLETED|Session2||10
9742173|NCT00256451|10843758|FG000|NOT COMPLETED|Session2||0
9742174|NCT00256451|10843759|FG001|NOT COMPLETED|Session2||0
9742175|NCT00256451|10843760|FG002|NOT COMPLETED|Session2||0
9742176|NCT00256451|10843761|FG003|NOT COMPLETED|Session2||0
9742177|NCT00256451|10843758|FG000|STARTED|Session3||9
9742178|NCT00256451|10843759|FG001|STARTED|Session3||9
9742179|NCT00256451|10843760|FG002|STARTED|Session3||10
9742180|NCT00256451|10843761|FG003|STARTED|Session3||9
9742181|NCT00256451|10843758|FG000|COMPLETED|Session3||9
9742182|NCT00256451|10843759|FG001|COMPLETED|Session3||9
9742183|NCT00256451|10843760|FG002|COMPLETED|Session3||10
9742184|NCT00256451|10843761|FG003|COMPLETED|Session3||9
9742185|NCT00256451|10843758|FG000|NOT COMPLETED|Session3||0
9742186|NCT00256451|10843759|FG001|NOT COMPLETED|Session3||0
9742187|NCT00256451|10843760|FG002|NOT COMPLETED|Session3||0
9742188|NCT00256451|10843761|FG003|NOT COMPLETED|Session3||0
9742189|NCT00256451|10843758|FG000|STARTED|Session4||9
9742190|NCT00256451|10843759|FG001|STARTED|Session4||8
9742191|NCT00256451|10843760|FG002|STARTED|Session4||10
9742192|NCT00256451|10843761|FG003|STARTED|Session4||8
9742193|NCT00256451|10843758|FG000|COMPLETED|Session4||9
9742194|NCT00256451|10843759|FG001|COMPLETED|Session4||8
9742195|NCT00256451|10843760|FG002|COMPLETED|Session4||10
9742196|NCT00256451|10843761|FG003|COMPLETED|Session4||8
9742197|NCT00256451|10843758|FG000|NOT COMPLETED|Session4||0
9742198|NCT00256451|10843759|FG001|NOT COMPLETED|Session4||0
9742199|NCT00256451|10843760|FG002|NOT COMPLETED|Session4||0
9742200|NCT00256451|10843761|FG003|NOT COMPLETED|Session4||0
9742201|NCT00256698|10843773|FG000|STARTED|Overall Study||258
9742202|NCT00256698|10843774|FG001|STARTED|Overall Study||256
9742203|NCT00256698|10843773|FG000|COMPLETED|Overall Study||91
9742204|NCT00256698|10843774|FG001|COMPLETED|Overall Study||84
9742205|NCT00256698|10843773|FG000|NOT COMPLETED|Overall Study||167
9742206|NCT00256698|10843774|FG001|NOT COMPLETED|Overall Study||172
9742207|NCT00256724|10843782|FG000|STARTED|Overall Study||23
9742208|NCT00256724|10843783|FG001|STARTED|Overall Study||24
9742209|NCT00256724|10843782|FG000|COMPLETED|Overall Study||18
9742210|NCT00256724|10843783|FG001|COMPLETED|Overall Study||16
9742211|NCT00256724|10843782|FG000|NOT COMPLETED|Overall Study||5
9742212|NCT00256724|10843783|FG001|NOT COMPLETED|Overall Study||8
9742213|NCT00256750|10843792|FG000|STARTED|Transplanted Pre-Treatment||221
9742214|NCT00256750|10843793|FG001|STARTED|Transplanted Pre-Treatment||226
9742215|NCT00256750|10843794|FG002|STARTED|Transplanted Pre-Treatment||219
9742216|NCT00256750|10843792|FG000|COMPLETED|Transplanted Pre-Treatment||215
9742217|NCT00256750|10843793|FG001|COMPLETED|Transplanted Pre-Treatment||226
9742218|NCT00256750|10843794|FG002|COMPLETED|Transplanted Pre-Treatment||219
9742219|NCT00256750|10843792|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6
9742220|NCT00256750|10843793|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0
9742221|NCT00256750|10843794|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0
9852493|NCT00881530|10965352|FG000|COMPLETED|Overall Study||92
9742222|NCT00256750|10843792|FG000|STARTED|Post-Transplant Treated (12 Months)||215
9742223|NCT00256750|10843793|FG001|STARTED|Post-Transplant Treated (12 Months)||226
9742224|NCT00256750|10843794|FG002|STARTED|Post-Transplant Treated (12 Months)||219
9742225|NCT00256750|10843792|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174
9742226|NCT00256750|10843793|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183
9742227|NCT00256750|10843794|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173
9742228|NCT00256750|10843792|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
9742229|NCT00256750|10843793|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
9742230|NCT00256750|10843794|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
9742231|NCT00256750|10843792|FG000|STARTED|Post-Transplant Treated (24 Months)||174
9742232|NCT00256750|10843793|FG001|STARTED|Post-Transplant Treated (24 Months)||183
9742233|NCT00256750|10843794|FG002|STARTED|Post-Transplant Treated (24 Months)||173
9742234|NCT00256750|10843792|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153
9742235|NCT00256750|10843793|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176
9742236|NCT00256750|10843794|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164
9742237|NCT00256750|10843792|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
9742238|NCT00256750|10843793|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
9742239|NCT00256750|10843794|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
9742240|NCT00256750|10843792|FG000|STARTED|Post-Transplant Treated (36 Months)||153
9742241|NCT00256750|10843793|FG001|STARTED|Post-Transplant Treated (36 Months)||176
9742242|NCT00256750|10843794|FG002|STARTED|Post-Transplant Treated (36 Months)||164
9742243|NCT00256750|10843792|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143
9742244|NCT00256750|10843793|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170
9742245|NCT00256750|10843794|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158
9742246|NCT00256750|10843792|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
9742247|NCT00256750|10843793|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
9742248|NCT00256750|10843794|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
9742249|NCT00256750|10843792|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
9742250|NCT00256750|10843793|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
9742251|NCT00256750|10843794|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
9742252|NCT00256750|10843792|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89
9742253|NCT00256750|10843793|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136
9742254|NCT00256750|10843794|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127
9742255|NCT00256750|10843792|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
9742256|NCT00256750|10843793|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
9742257|NCT00256750|10843794|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
9742258|NCT00256776|10843805|FG000|STARTED|Overall Study||135
9742259|NCT00256776|10843806|FG001|STARTED|Overall Study||134
9742260|NCT00256776|10843805|FG000|COMPLETED|Overall Study||52
9742261|NCT00256776|10843806|FG001|COMPLETED|Overall Study||54
9742262|NCT00256776|10843805|FG000|NOT COMPLETED|Overall Study||83
9742263|NCT00256776|10843806|FG001|NOT COMPLETED|Overall Study||80
9742264|NCT00256854|10843820|FG000|STARTED|Overall Study||26
9742265|NCT00256854|10843821|FG001|STARTED|Overall Study||26
9742266|NCT00256854|10843822|FG002|STARTED|Overall Study||26
9742267|NCT00256854|10843823|FG003|STARTED|Overall Study||27
9742268|NCT00256854|10843824|FG004|STARTED|Overall Study||16
9742269|NCT00256854|10843825|FG005|STARTED|Overall Study||14
9742270|NCT00256854|10843820|FG000|COMPLETED|Overall Study||23
9742271|NCT00256854|10843821|FG001|COMPLETED|Overall Study||22
9742272|NCT00256854|10843822|FG002|COMPLETED|Overall Study||23
9742273|NCT00256854|10843823|FG003|COMPLETED|Overall Study||24
9742274|NCT00256854|10843824|FG004|COMPLETED|Overall Study||15
9742275|NCT00256854|10843825|FG005|COMPLETED|Overall Study||13
9742276|NCT00256854|10843820|FG000|NOT COMPLETED|Overall Study||3
9742277|NCT00256854|10843821|FG001|NOT COMPLETED|Overall Study||4
9742278|NCT00256854|10843822|FG002|NOT COMPLETED|Overall Study||3
9742279|NCT00256854|10843823|FG003|NOT COMPLETED|Overall Study||3
9742280|NCT00256854|10843824|FG004|NOT COMPLETED|Overall Study||1
9742281|NCT00256854|10843825|FG005|NOT COMPLETED|Overall Study||1
9742282|NCT00256867|10843848|FG000|STARTED|Overall Study||47
9742283|NCT00256867|10843849|FG001|STARTED|Overall Study||44
9742284|NCT00256867|10843850|FG002|STARTED|Overall Study||45
9742285|NCT00256867|10843851|FG003|STARTED|Overall Study||46
9742286|NCT00256867|10843852|FG004|STARTED|Overall Study||48
9742287|NCT00256867|10843853|FG005|STARTED|Overall Study||46
9742288|NCT00256867|10843854|FG006|STARTED|Overall Study||46
9742289|NCT00256867|10843855|FG007|STARTED|Overall Study||47
9742290|NCT00256867|10843848|FG000|COMPLETED|Overall Study||45
9742291|NCT00256867|10843849|FG001|COMPLETED|Overall Study||39
9742292|NCT00256867|10843850|FG002|COMPLETED|Overall Study||40
9742293|NCT00256867|10843851|FG003|COMPLETED|Overall Study||40
9742294|NCT00256867|10843852|FG004|COMPLETED|Overall Study||41
9742295|NCT00256867|10843853|FG005|COMPLETED|Overall Study||40
9742296|NCT00256867|10843854|FG006|COMPLETED|Overall Study||41
9742297|NCT00256867|10843855|FG007|COMPLETED|Overall Study||36
9742298|NCT00256867|10843848|FG000|NOT COMPLETED|Overall Study||2
9852494|NCT00881530|10965353|FG001|COMPLETED|Overall Study||104
9742299|NCT00256867|10843849|FG001|NOT COMPLETED|Overall Study||5
9742300|NCT00256867|10843850|FG002|NOT COMPLETED|Overall Study||5
9742301|NCT00256867|10843851|FG003|NOT COMPLETED|Overall Study||6
9742302|NCT00256867|10843852|FG004|NOT COMPLETED|Overall Study||7
9742303|NCT00256867|10843853|FG005|NOT COMPLETED|Overall Study||6
9742304|NCT00256867|10843854|FG006|NOT COMPLETED|Overall Study||5
9742305|NCT00256867|10843855|FG007|NOT COMPLETED|Overall Study||11
9742306|NCT00256984|10843878|FG000|STARTED|Overall Study||75
9742307|NCT00256984|10843878|FG000|COMPLETED|Overall Study||59
9742308|NCT00256984|10843878|FG000|NOT COMPLETED|Overall Study||16
9742309|NCT00256997|10843884|FG000|STARTED|Overall Study||81
9742310|NCT00256997|10843885|FG001|STARTED|Overall Study||86
9742311|NCT00256997|10843884|FG000|Treated|Overall Study||79
9742312|NCT00256997|10843885|FG001|Treated|Overall Study||86
9742313|NCT00256997|10843884|FG000|COMPLETED|Overall Study||33
9742314|NCT00256997|10843885|FG001|COMPLETED|Overall Study||31
9742315|NCT00256997|10843884|FG000|NOT COMPLETED|Overall Study||48
9742316|NCT00256997|10843885|FG001|NOT COMPLETED|Overall Study||55
9742317|NCT00257010|10843892|FG000|STARTED|Overall Study||447
9742318|NCT00257010|10843892|FG000|COMPLETED|Overall Study||319
9742319|NCT00257010|10843892|FG000|NOT COMPLETED|Overall Study||128
9742320|NCT00257166|10843898|FG000|STARTED|Overall Study||150
9742321|NCT00257166|10843899|FG001|STARTED|Overall Study||88
9742322|NCT00257166|10843898|FG000|Treated|Overall Study||149
9742323|NCT00257166|10843899|FG001|Treated|Overall Study||88
9742324|NCT00257166|10843898|FG000|COMPLETED|Overall Study||97
9742325|NCT00257166|10843899|FG001|COMPLETED|Overall Study||51
9742326|NCT00257166|10843898|FG000|NOT COMPLETED|Overall Study||53
9742327|NCT00257166|10843899|FG001|NOT COMPLETED|Overall Study||37
9742328|NCT00257192|10843907|FG000|STARTED|Overall Study||193
9742329|NCT00257192|10843908|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
9742330|NCT00257192|10843907|FG000|Received Study Treatment|Overall Study||193
9742331|NCT00257192|10843908|FG001|Received Study Treatment|Overall Study||90
9742332|NCT00257192|10843907|FG000|COMPLETED|Overall Study||135
9742333|NCT00257192|10843908|FG001|COMPLETED|Overall Study||52
9742334|NCT00257192|10843907|FG000|NOT COMPLETED|Overall Study||58
9852495|NCT00881530|10965354|FG002|COMPLETED|Overall Study||51
9852496|NCT00881530|10965355|FG003|COMPLETED|Overall Study||157
9852497|NCT00881530|10965356|FG004|COMPLETED|Overall Study||152
9852498|NCT00881530|10965357|FG005|COMPLETED|Overall Study||51
9852499|NCT00881530|10965352|FG000|NOT COMPLETED|Overall Study||14
9852500|NCT00881530|10965353|FG001|NOT COMPLETED|Overall Study||5
10091695|NCT02331095|11219944|FG001|STARTED|Overall Study||10
9852501|NCT00881530|10965354|FG002|NOT COMPLETED|Overall Study||5
9852502|NCT00881530|10965355|FG003|NOT COMPLETED|Overall Study||9
9852503|NCT00881530|10965356|FG004|NOT COMPLETED|Overall Study||14
9852504|NCT00881530|10965357|FG005|NOT COMPLETED|Overall Study||5
9852505|NCT00881569|10965373|FG000|STARTED|Overall Study||1
9852506|NCT00881569|10965374|FG001|STARTED|Overall Study||1
9852507|NCT00881569|10965373|FG000|COMPLETED|Overall Study||0
9852508|NCT00881569|10965374|FG001|COMPLETED|Overall Study||0
9852509|NCT00881569|10965373|FG000|NOT COMPLETED|Overall Study||1
9852510|NCT00881569|10965374|FG001|NOT COMPLETED|Overall Study||1
9852511|NCT00881621|10965380|FG000|STARTED|Overall Study||51
9852512|NCT00881621|10965380|FG000|COMPLETED|Overall Study||17
9852513|NCT00881621|10965380|FG000|NOT COMPLETED|Overall Study||34
9742335|NCT00257192|10843908|FG001|NOT COMPLETED|Overall Study||39
9742336|NCT00257309|10843916|FG000|STARTED|Overall Study||134
9742337|NCT00257309|10843917|FG001|STARTED|Overall Study||132
9742338|NCT00257309|10843916|FG000|COMPLETED|Overall Study||132
9742339|NCT00257309|10843917|FG001|COMPLETED|Overall Study||130
9742340|NCT00257309|10843916|FG000|NOT COMPLETED|Overall Study||2
9742341|NCT00257309|10843917|FG001|NOT COMPLETED|Overall Study||2
9742342|NCT00257322|10843923|FG000|STARTED|Overall Study|20 subjects accrued.|20
9742343|NCT00257322|10843923|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
9742344|NCT00257322|10843923|FG000|NOT COMPLETED|Overall Study||4
9742345|NCT00257556|10843929|FG000|STARTED|Overall Study||38
9742346|NCT00257556|10843930|FG001|STARTED|Overall Study||42
9742347|NCT00257556|10843929|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
9742348|NCT00257556|10843930|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
9742349|NCT00257556|10843929|FG000|COMPLETED|Overall Study||24
9742350|NCT00257556|10843930|FG001|COMPLETED|Overall Study||32
9742351|NCT00257556|10843929|FG000|NOT COMPLETED|Overall Study||14
9742352|NCT00257556|10843930|FG001|NOT COMPLETED|Overall Study||10
9742353|NCT00257608|10843938|FG000|STARTED|Chemotherapy Phase||1145
9742354|NCT00257608|10843939|FG001|STARTED|Chemotherapy Phase||0
9742355|NCT00257608|10843940|FG002|STARTED|Chemotherapy Phase||0
9742356|NCT00257608|10843938|FG000|COMPLETED|Chemotherapy Phase||769
9742357|NCT00257608|10843939|FG001|COMPLETED|Chemotherapy Phase||0
9742358|NCT00257608|10843940|FG002|COMPLETED|Chemotherapy Phase||0
9742359|NCT00257608|10843938|FG000|NOT COMPLETED|Chemotherapy Phase||376
9742360|NCT00257608|10843939|FG001|NOT COMPLETED|Chemotherapy Phase||0
9742361|NCT00257608|10843940|FG002|NOT COMPLETED|Chemotherapy Phase||0
9742362|NCT00257608|10843938|FG000|STARTED|Post Chemotherapy Phase||0
9852514|NCT00881647|10965386|FG000|STARTED|Overall Study||29
9742363|NCT00257608|10843939|FG001|STARTED|Post Chemotherapy Phase||373
9852515|NCT00881647|10965387|FG001|STARTED|Overall Study||16
9852516|NCT00881647|10965386|FG000|COMPLETED|Overall Study||27
9742364|NCT00257608|10843940|FG002|STARTED|Post Chemotherapy Phase||370
9742365|NCT00257608|10843938|FG000|COMPLETED|Post Chemotherapy Phase||0
9742366|NCT00257608|10843939|FG001|COMPLETED|Post Chemotherapy Phase||109
9742367|NCT00257608|10843940|FG002|COMPLETED|Post Chemotherapy Phase||126
9742368|NCT00257608|10843938|FG000|NOT COMPLETED|Post Chemotherapy Phase||0
9742369|NCT00257608|10843939|FG001|NOT COMPLETED|Post Chemotherapy Phase||264
9742370|NCT00257608|10843940|FG002|NOT COMPLETED|Post Chemotherapy Phase||244
9742371|NCT00257660|10843955|FG000|STARTED|Overall Study||55
9742372|NCT00257660|10843956|FG001|STARTED|Overall Study||61
9742373|NCT00257660|10843955|FG000|COMPLETED|Overall Study||45
9742374|NCT00257660|10843956|FG001|COMPLETED|Overall Study||38
9742375|NCT00257660|10843955|FG000|NOT COMPLETED|Overall Study||10
9742376|NCT00257660|10843956|FG001|NOT COMPLETED|Overall Study||23
9742377|NCT00257686|10843968|FG000|STARTED|Overall Study||209
9742378|NCT00257686|10843969|FG001|STARTED|Overall Study||108
9742379|NCT00257686|10843970|FG002|STARTED|Overall Study||226
9742380|NCT00257686|10843971|FG003|STARTED|Overall Study||99
9742381|NCT00257686|10843972|FG004|STARTED|Overall Study||216
9742382|NCT00257686|10843973|FG005|STARTED|Overall Study||104
10091696|NCT02331095|11219943|FG000|COMPLETED|Overall Study||7
10091697|NCT02331095|11219944|FG001|COMPLETED|Overall Study||9
10091698|NCT02331095|11219943|FG000|NOT COMPLETED|Overall Study||4
10091699|NCT02331095|11219944|FG001|NOT COMPLETED|Overall Study||1
10091700|NCT02331108|11219960|FG000|STARTED|Overall Study||51
10091701|NCT02331108|11219961|FG001|STARTED|Overall Study||52
9742383|NCT00257686|10843968|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
9742384|NCT00257686|10843969|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
9742385|NCT00257686|10843970|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
9742386|NCT00257686|10843971|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
9742387|NCT00257686|10843972|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
9742388|NCT00257686|10843973|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
10091702|NCT02331108|11219962|FG002|STARTED|Overall Study||51
10091703|NCT02331108|11219963|FG003|STARTED|Overall Study||51
10091704|NCT02331108|11219964|FG004|STARTED|Overall Study||52
10091705|NCT02331108|11219965|FG005|STARTED|Overall Study||52
10091706|NCT02331108|11219960|FG000|COMPLETED|Overall Study||50
10091707|NCT02331108|11219961|FG001|COMPLETED|Overall Study||50
10091708|NCT02331108|11219962|FG002|COMPLETED|Overall Study||50
10091709|NCT02331108|11219963|FG003|COMPLETED|Overall Study||50
10091710|NCT02331108|11219964|FG004|COMPLETED|Overall Study||50
10091711|NCT02331108|11219965|FG005|COMPLETED|Overall Study||50
10091712|NCT02331108|11219960|FG000|NOT COMPLETED|Overall Study||1
9742389|NCT00257686|10843968|FG000|COMPLETED|Overall Study||188
9742390|NCT00257686|10843969|FG001|COMPLETED|Overall Study||89
9742391|NCT00257686|10843970|FG002|COMPLETED|Overall Study||208
9742392|NCT00257686|10843971|FG003|COMPLETED|Overall Study||88
9742393|NCT00257686|10843972|FG004|COMPLETED|Overall Study||194
9742394|NCT00257686|10843973|FG005|COMPLETED|Overall Study||95
9742395|NCT00257686|10843968|FG000|NOT COMPLETED|Overall Study||21
9742396|NCT00257686|10843969|FG001|NOT COMPLETED|Overall Study||19
9742397|NCT00257686|10843970|FG002|NOT COMPLETED|Overall Study||18
9742398|NCT00257686|10843971|FG003|NOT COMPLETED|Overall Study||11
9742399|NCT00257686|10843972|FG004|NOT COMPLETED|Overall Study||22
9742400|NCT00257686|10843973|FG005|NOT COMPLETED|Overall Study||9
9742401|NCT00257725|10843987|FG000|STARTED|Overall Study||11
10091713|NCT02331108|11219961|FG001|NOT COMPLETED|Overall Study||2
10091714|NCT02331108|11219962|FG002|NOT COMPLETED|Overall Study||1
10091715|NCT02331108|11219963|FG003|NOT COMPLETED|Overall Study||1
10091716|NCT02331108|11219964|FG004|NOT COMPLETED|Overall Study||2
10091717|NCT02331108|11219965|FG005|NOT COMPLETED|Overall Study||2
9742402|NCT00257725|10843987|FG000|COMPLETED|Overall Study||8
9742403|NCT00257725|10843987|FG000|NOT COMPLETED|Overall Study||3
9742404|NCT00257894|10843994|FG000|STARTED|Overall Study||21
9742405|NCT00257894|10843995|FG001|STARTED|Overall Study||20
9742406|NCT00257894|10843994|FG000|COMPLETED|Overall Study||17
9742407|NCT00257894|10843995|FG001|COMPLETED|Overall Study||15
9742408|NCT00257894|10843994|FG000|NOT COMPLETED|Overall Study||4
9742409|NCT00257894|10843995|FG001|NOT COMPLETED|Overall Study||5
9742410|NCT00257920|10844003|FG000|STARTED|Period: First Intervention||21
9742411|NCT00257920|10844004|FG001|STARTED|Period: First Intervention||20
9742412|NCT00257920|10844003|FG000|COMPLETED|Period: First Intervention||21
9742413|NCT00257920|10844004|FG001|COMPLETED|Period: First Intervention||20
9742414|NCT00257920|10844003|FG000|NOT COMPLETED|Period: First Intervention||0
9742415|NCT00257920|10844004|FG001|NOT COMPLETED|Period: First Intervention||0
9742416|NCT00257920|10844003|FG000|STARTED|Period: Washout Period of Two Weeks||21
9742417|NCT00257920|10844004|FG001|STARTED|Period: Washout Period of Two Weeks||20
9742418|NCT00257920|10844003|FG000|COMPLETED|Period: Washout Period of Two Weeks||21
9742419|NCT00257920|10844004|FG001|COMPLETED|Period: Washout Period of Two Weeks||19
9742420|NCT00257920|10844003|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0
9742421|NCT00257920|10844004|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1
9742422|NCT00257920|10844003|FG000|STARTED|Period: Second Intervention||21
9742423|NCT00257920|10844004|FG001|STARTED|Period: Second Intervention||19
10091718|NCT02331368|11219981|FG000|STARTED|Overall Study||32
10091719|NCT02331368|11219981|FG000|COMPLETED|Overall Study||29
10091720|NCT02331368|11219981|FG000|NOT COMPLETED|Overall Study||3
9742424|NCT00257920|10844003|FG000|COMPLETED|Period: Second Intervention||19
9742425|NCT00257920|10844004|FG001|COMPLETED|Period: Second Intervention||18
9742426|NCT00257920|10844003|FG000|NOT COMPLETED|Period: Second Intervention||2
9742427|NCT00257920|10844004|FG001|NOT COMPLETED|Period: Second Intervention||1
9742428|NCT00257933|10844013|FG000|STARTED|Overall Study||74
9742429|NCT00257933|10844014|FG001|STARTED|Overall Study||78
9742430|NCT00257933|10844013|FG000|COMPLETED|Overall Study||74
9742431|NCT00257933|10844014|FG001|COMPLETED|Overall Study||78
9742432|NCT00257933|10844013|FG000|NOT COMPLETED|Overall Study||0
9742433|NCT00257933|10844014|FG001|NOT COMPLETED|Overall Study||0
9742434|NCT00258011|10844020|FG000|STARTED|Overall Study||3
9742435|NCT00258011|10844020|FG000|COMPLETED|Overall Study||3
9742436|NCT00258011|10844020|FG000|NOT COMPLETED|Overall Study||0
9852517|NCT00881647|10965387|FG001|COMPLETED|Overall Study||15
9852518|NCT00881647|10965386|FG000|NOT COMPLETED|Overall Study||2
9852519|NCT00881647|10965387|FG001|NOT COMPLETED|Overall Study||1
9852520|NCT00881712|10965396|FG000|STARTED|Overall Study||15
9852521|NCT00881712|10965397|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
9852522|NCT00881712|10965398|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
9852523|NCT00881712|10965396|FG000|COMPLETED|Overall Study||13
9852524|NCT00881712|10965397|FG001|COMPLETED|Overall Study||0
9852525|NCT00881712|10965398|FG002|COMPLETED|Overall Study||0
9852526|NCT00881712|10965396|FG000|NOT COMPLETED|Overall Study||2
9852527|NCT00881712|10965397|FG001|NOT COMPLETED|Overall Study||0
9852528|NCT00881712|10965398|FG002|NOT COMPLETED|Overall Study||0
9852529|NCT00881751|10965408|FG000|STARTED|Overall Study||47
9852530|NCT00881751|10965409|FG001|STARTED|Overall Study||48
9852531|NCT00881751|10965408|FG000|COMPLETED|Overall Study||47
9852532|NCT00881751|10965409|FG001|COMPLETED|Overall Study||43
9852533|NCT00881751|10965408|FG000|NOT COMPLETED|Overall Study||0
9852534|NCT00881751|10965409|FG001|NOT COMPLETED|Overall Study||5
9852535|NCT00881868|10965417|FG000|STARTED|Overall Study||41
9852536|NCT00881868|10965418|FG001|STARTED|Overall Study||40
9852537|NCT00881868|10965417|FG000|COMPLETED|Overall Study||33
9852538|NCT00881868|10965418|FG001|COMPLETED|Overall Study||38
9852539|NCT00881868|10965417|FG000|NOT COMPLETED|Overall Study||8
9852540|NCT00881868|10965418|FG001|NOT COMPLETED|Overall Study||2
9852541|NCT00881894|10965426|FG000|STARTED|Overall Study||26
9852542|NCT00881894|10965427|FG001|STARTED|Overall Study||26
9852543|NCT00881894|10965426|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
9852544|NCT00881894|10965427|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
9852545|NCT00881894|10965426|FG000|COMPLETED|Overall Study||25
9852546|NCT00881894|10965427|FG001|COMPLETED|Overall Study||23
9852547|NCT00881894|10965426|FG000|NOT COMPLETED|Overall Study||1
9852548|NCT00881894|10965427|FG001|NOT COMPLETED|Overall Study||3
9852549|NCT00881959|10965435|FG000|STARTED|Overall Study||38
9852550|NCT00881959|10965436|FG001|STARTED|Overall Study||42
9852551|NCT00881959|10965435|FG000|COMPLETED|Overall Study||36
9852552|NCT00881959|10965436|FG001|COMPLETED|Overall Study||38
9852553|NCT00881959|10965435|FG000|NOT COMPLETED|Overall Study||2
9852554|NCT00881959|10965436|FG001|NOT COMPLETED|Overall Study||4
9852555|NCT00882102|10965442|FG000|STARTED|Overall Study||40
9852556|NCT00882102|10965442|FG000|COMPLETED|Overall Study||40
9852557|NCT00882102|10965442|FG000|NOT COMPLETED|Overall Study||0
9852558|NCT00882115|10965446|FG000|STARTED|Overall Study||38
9852559|NCT00882115|10965446|FG000|COMPLETED|Overall Study||29
9742437|NCT00258128|10844026|FG000|STARTED|Overall Study||8
9742438|NCT00258128|10844027|FG001|STARTED|Overall Study||9
9742439|NCT00258128|10844026|FG000|COMPLETED|Overall Study||8
9742440|NCT00258128|10844027|FG001|COMPLETED|Overall Study||9
9742441|NCT00258128|10844026|FG000|NOT COMPLETED|Overall Study||0
9742442|NCT00258128|10844027|FG001|NOT COMPLETED|Overall Study||0
9742443|NCT00258154|10844037|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
9742444|NCT00258154|10844038|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
9742445|NCT00258154|10844037|FG000|Vaccinated at Visit 1|Overall Study||201
9742446|NCT00258154|10844038|FG001|Vaccinated at Visit 1|Overall Study||202
9742447|NCT00258154|10844037|FG000|Vaccinated at Visit 2|Overall Study||198
9742448|NCT00258154|10844038|FG001|Vaccinated at Visit 2|Overall Study||198
9742449|NCT00258154|10844037|FG000|Vaccinated at Visit 3|Overall Study||195
9742450|NCT00258154|10844038|FG001|Vaccinated at Visit 3|Overall Study||197
9742451|NCT00258154|10844037|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192
9742452|NCT00258154|10844038|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195
9742453|NCT00258154|10844037|FG000|NOT COMPLETED|Overall Study||9
9742454|NCT00258154|10844038|FG001|NOT COMPLETED|Overall Study||7
9742455|NCT00258180|10844044|FG000|STARTED|Overall Study||2
9742456|NCT00258180|10844044|FG000|COMPLETED|Overall Study||2
9742457|NCT00258180|10844044|FG000|NOT COMPLETED|Overall Study||0
9742458|NCT00258206|10844049|FG000|STARTED|Overall Study||21
9742459|NCT00258206|10844049|FG000|COMPLETED|Overall Study||21
9742460|NCT00258206|10844049|FG000|NOT COMPLETED|Overall Study||0
9742461|NCT00258310|10844053|FG000|STARTED|Overall Study||35
9742462|NCT00258310|10844053|FG000|COMPLETED|Overall Study||35
9742463|NCT00258310|10844053|FG000|NOT COMPLETED|Overall Study||0
9742464|NCT00258349|10844057|FG000|STARTED|Overall Study||16
9742465|NCT00258349|10844057|FG000|HER2-positive by Central Review|Overall Study||10
9742466|NCT00258349|10844057|FG000|COMPLETED|Overall Study||16
9742467|NCT00258349|10844057|FG000|NOT COMPLETED|Overall Study||0
9742468|NCT00258362|10844063|FG000|STARTED|Overall Study||41
9742469|NCT00258362|10844063|FG000|COMPLETED|Overall Study||41
9742470|NCT00258362|10844063|FG000|NOT COMPLETED|Overall Study||0
9742471|NCT00258440|10844071|FG000|STARTED|Overall Study||1
9742472|NCT00258440|10844072|FG001|STARTED|Overall Study||0
9742473|NCT00258440|10844073|FG002|STARTED|Overall Study||6
9742474|NCT00258440|10844071|FG000|COMPLETED|Overall Study||1
9742475|NCT00258440|10844072|FG001|COMPLETED|Overall Study||0
9742476|NCT00258440|10844073|FG002|COMPLETED|Overall Study||5
9742477|NCT00258440|10844071|FG000|NOT COMPLETED|Overall Study||0
9742478|NCT00258440|10844072|FG001|NOT COMPLETED|Overall Study||0
9742479|NCT00258440|10844073|FG002|NOT COMPLETED|Overall Study||1
9742480|NCT00258674|10844084|FG000|STARTED|Overall Study||597
9742481|NCT00258674|10844085|FG001|STARTED|Overall Study||811
9742482|NCT00258674|10844086|FG002|STARTED|Overall Study||602
9742483|NCT00258674|10844084|FG000|COMPLETED|Overall Study||565
9742484|NCT00258674|10844085|FG001|COMPLETED|Overall Study||758
9742485|NCT00258674|10844086|FG002|COMPLETED|Overall Study||568
9742486|NCT00258674|10844084|FG000|NOT COMPLETED|Overall Study||32
9742487|NCT00258674|10844085|FG001|NOT COMPLETED|Overall Study||53
9742488|NCT00258674|10844086|FG002|NOT COMPLETED|Overall Study||34
9742489|NCT00258817|10844096|FG000|STARTED|Overall Study||15
9742490|NCT00258817|10844097|FG001|STARTED|Overall Study||15
9742491|NCT00258817|10844096|FG000|COMPLETED|Overall Study||15
9742492|NCT00258817|10844097|FG001|COMPLETED|Overall Study||15
9742493|NCT00258817|10844096|FG000|NOT COMPLETED|Overall Study||0
9742494|NCT00258817|10844097|FG001|NOT COMPLETED|Overall Study||0
9742495|NCT00258830|10844105|FG000|STARTED|Overall Study||60
9742496|NCT00258830|10844106|FG001|STARTED|Overall Study||60
9742497|NCT00258830|10844105|FG000|COMPLETED|Overall Study||60
9742498|NCT00258830|10844106|FG001|COMPLETED|Overall Study||60
9742499|NCT00258830|10844105|FG000|NOT COMPLETED|Overall Study||0
9742500|NCT00258830|10844106|FG001|NOT COMPLETED|Overall Study||0
9742501|NCT00258856|10844116|FG000|STARTED|Overall Study||59
9742502|NCT00258856|10844117|FG001|STARTED|Overall Study||58
9742503|NCT00258856|10844118|FG002|STARTED|Overall Study||58
9742504|NCT00258856|10844119|FG003|STARTED|Overall Study||59
9742505|NCT00258856|10844116|FG000|COMPLETED|Overall Study||56
9742506|NCT00258856|10844117|FG001|COMPLETED|Overall Study||58
9742507|NCT00258856|10844118|FG002|COMPLETED|Overall Study||56
9742508|NCT00258856|10844119|FG003|COMPLETED|Overall Study||58
9742509|NCT00258856|10844116|FG000|NOT COMPLETED|Overall Study||3
9742510|NCT00258856|10844117|FG001|NOT COMPLETED|Overall Study||0
9742511|NCT00258856|10844118|FG002|NOT COMPLETED|Overall Study||2
9742512|NCT00258856|10844119|FG003|NOT COMPLETED|Overall Study||1
9742513|NCT00258882|10844131|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139
9742514|NCT00258882|10844132|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154
9742515|NCT00258882|10844131|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139
9742516|NCT00258882|10844132|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154
9742517|NCT00258882|10844131|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
9742518|NCT00258882|10844132|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
9742519|NCT00258882|10844131|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139
9742520|NCT00258882|10844132|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
9742521|NCT00258882|10844131|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139
9742522|NCT00258882|10844132|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0
9742523|NCT00258882|10844131|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
9742524|NCT00258882|10844132|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
9742525|NCT00258882|10844131|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
10091721|NCT02331394|11219985|FG000|STARTED|Overall Study||15
10091722|NCT02331394|11219985|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14
9742526|NCT00258882|10844132|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
9742527|NCT00258882|10844131|FG000|COMPLETED|Pregnancy Surveillance||225
9742528|NCT00258882|10844132|FG001|COMPLETED|Pregnancy Surveillance||675
9742529|NCT00258882|10844131|FG000|NOT COMPLETED|Pregnancy Surveillance||0
9742530|NCT00258882|10844132|FG001|NOT COMPLETED|Pregnancy Surveillance||0
9742531|NCT00258895|10844142|FG000|STARTED|Overall Study||487
9742532|NCT00258895|10844143|FG001|STARTED|Overall Study||162
9742533|NCT00258895|10844142|FG000|COMPLETED|Overall Study||477
9742534|NCT00258895|10844143|FG001|COMPLETED|Overall Study||159
9742535|NCT00258895|10844142|FG000|NOT COMPLETED|Overall Study||10
9742536|NCT00258895|10844143|FG001|NOT COMPLETED|Overall Study||3
9742537|NCT00258908|10844149|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
9742538|NCT00258908|10844149|FG000|COMPLETED|Overall Study||112
9742539|NCT00258908|10844149|FG000|NOT COMPLETED|Overall Study||0
9742540|NCT00258960|10844153|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
9742541|NCT00258960|10844153|FG000|COMPLETED|Overall Study||32
9742542|NCT00258960|10844153|FG000|NOT COMPLETED|Overall Study||17
9742543|NCT00259012|10844159|FG000|STARTED|Overall Study||33
9742544|NCT00259012|10844160|FG001|STARTED|Overall Study||34
9742545|NCT00259012|10844159|FG000|COMPLETED|Overall Study||31
9742546|NCT00259012|10844160|FG001|COMPLETED|Overall Study||30
9742547|NCT00259012|10844159|FG000|NOT COMPLETED|Overall Study||2
9742548|NCT00259012|10844160|FG001|NOT COMPLETED|Overall Study||4
9742549|NCT00259090|10844169|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
9742550|NCT00259090|10844170|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
9742551|NCT00259090|10844171|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
9742552|NCT00259090|10844169|FG000|COMPLETED|Overall Study||35
9742553|NCT00259090|10844170|FG001|COMPLETED|Overall Study||31
9742554|NCT00259090|10844171|FG002|COMPLETED|Overall Study||37
9742555|NCT00259090|10844169|FG000|NOT COMPLETED|Overall Study||0
9742556|NCT00259090|10844170|FG001|NOT COMPLETED|Overall Study||0
9742557|NCT00259090|10844171|FG002|NOT COMPLETED|Overall Study||0
9742558|NCT00259272|10844183|FG000|STARTED|Overall Study||36
9742559|NCT00259272|10844184|FG001|STARTED|Overall Study||31
9742560|NCT00259272|10844185|FG002|STARTED|Overall Study||26
9742561|NCT00259272|10844186|FG003|STARTED|Overall Study||48
9742562|NCT00259272|10844183|FG000|COMPLETED|Overall Study||21
9742563|NCT00259272|10844184|FG001|COMPLETED|Overall Study||24
9742564|NCT00259272|10844185|FG002|COMPLETED|Overall Study||21
9742565|NCT00259272|10844186|FG003|COMPLETED|Overall Study||27
9742566|NCT00259272|10844183|FG000|NOT COMPLETED|Overall Study||15
9742567|NCT00259272|10844184|FG001|NOT COMPLETED|Overall Study||7
9742568|NCT00259272|10844185|FG002|NOT COMPLETED|Overall Study||5
9742569|NCT00259272|10844186|FG003|NOT COMPLETED|Overall Study||21
9742570|NCT00259285|10844201|FG000|STARTED|Overall Study||10
9742571|NCT00259285|10844201|FG000|COMPLETED|Overall Study||10
9742572|NCT00259285|10844201|FG000|NOT COMPLETED|Overall Study||0
9742573|NCT00259298|10844205|FG000|STARTED|Overall Study||12
9742574|NCT00259298|10844205|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
9742575|NCT00259298|10844205|FG000|COMPLETED|Overall Study||9
9742576|NCT00259298|10844205|FG000|NOT COMPLETED|Overall Study||3
9742577|NCT00259610|10844213|FG000|STARTED|Overall Study||244
9742578|NCT00259610|10844214|FG001|STARTED|Overall Study||132
9742579|NCT00259610|10844215|FG002|STARTED|Overall Study||255
9742580|NCT00259610|10844216|FG003|STARTED|Overall Study||124
9742581|NCT00259610|10844213|FG000|COMPLETED|Overall Study||168
9742582|NCT00259610|10844214|FG001|COMPLETED|Overall Study||86
9742583|NCT00259610|10844215|FG002|COMPLETED|Overall Study||182
9742584|NCT00259610|10844216|FG003|COMPLETED|Overall Study||81
9742585|NCT00259610|10844213|FG000|NOT COMPLETED|Overall Study||76
9742586|NCT00259610|10844214|FG001|NOT COMPLETED|Overall Study||46
9742587|NCT00259610|10844215|FG002|NOT COMPLETED|Overall Study||73
9742588|NCT00259610|10844216|FG003|NOT COMPLETED|Overall Study||43
9742589|NCT00259649|10844226|FG000|STARTED|Overall Study||71
9742590|NCT00259649|10844226|FG000|COMPLETED|Overall Study||61
9742591|NCT00259649|10844226|FG000|NOT COMPLETED|Overall Study||10
10091723|NCT02331394|11219985|FG000|NOT COMPLETED|Overall Study||1
10091724|NCT02331407|11219996|FG000|STARTED|Overall Study||9
9742592|NCT00259740|10844232|FG000|STARTED|Overall Study||43
9742593|NCT00259740|10844233|FG001|STARTED|Overall Study||53
9742594|NCT00259740|10844232|FG000|Received Study Medication|Overall Study||42
9742595|NCT00259740|10844233|FG001|Received Study Medication|Overall Study||53
9742596|NCT00259740|10844232|FG000|COMPLETED|Overall Study||0
9742597|NCT00259740|10844233|FG001|COMPLETED|Overall Study||0
9742598|NCT00259740|10844232|FG000|NOT COMPLETED|Overall Study||43
9742599|NCT00259740|10844233|FG001|NOT COMPLETED|Overall Study||53
9742600|NCT00259857|10844241|FG000|STARTED|12 Months Treatment||11
10091725|NCT02331407|11219996|FG000|COMPLETED|Overall Study||9
9742601|NCT00259857|10844242|FG001|STARTED|12 Months Treatment||11
9742602|NCT00259857|10844241|FG000|COMPLETED|12 Months Treatment||10
9742603|NCT00259857|10844242|FG001|COMPLETED|12 Months Treatment||9
9742604|NCT00259857|10844241|FG000|NOT COMPLETED|12 Months Treatment||1
9742605|NCT00259857|10844242|FG001|NOT COMPLETED|12 Months Treatment||2
9742606|NCT00259857|10844241|FG000|STARTED|24 Months Treatment||10
9742607|NCT00259857|10844242|FG001|STARTED|24 Months Treatment||9
9742608|NCT00259857|10844241|FG000|COMPLETED|24 Months Treatment||10
9742609|NCT00259857|10844242|FG001|COMPLETED|24 Months Treatment||6
9742610|NCT00259857|10844241|FG000|NOT COMPLETED|24 Months Treatment||0
9742611|NCT00259857|10844242|FG001|NOT COMPLETED|24 Months Treatment||3
9742612|NCT00260065|10844248|FG000|STARTED|Overall Study||99
9742613|NCT00260065|10844248|FG000|COMPLETED|Overall Study||6
9742614|NCT00260065|10844248|FG000|NOT COMPLETED|Overall Study||93
9742615|NCT00260195|10844254|FG000|STARTED|Overall Study||39
9742616|NCT00260195|10844255|FG001|STARTED|Overall Study||37
9742617|NCT00260195|10844254|FG000|COMPLETED|Overall Study||39
9742618|NCT00260195|10844255|FG001|COMPLETED|Overall Study||37
9742619|NCT00260195|10844254|FG000|NOT COMPLETED|Overall Study||0
9742620|NCT00260195|10844255|FG001|NOT COMPLETED|Overall Study||0
9742621|NCT00260208|10844264|FG000|STARTED|Overall Study|"Started indicates safety population."|184
9742622|NCT00260208|10844265|FG001|STARTED|Overall Study||172
9742623|NCT00260208|10844264|FG000|Intent to Treat (ITT) Population|Overall Study||182
9742624|NCT00260208|10844265|FG001|Intent to Treat (ITT) Population|Overall Study||169
9742625|NCT00260208|10844264|FG000|Modified ITT|Overall Study||101
9742626|NCT00260208|10844265|FG001|Modified ITT|Overall Study||96
9742627|NCT00260208|10844264|FG000|COMPLETED|Overall Study||137
9742628|NCT00260208|10844265|FG001|COMPLETED|Overall Study||138
9742629|NCT00260208|10844264|FG000|NOT COMPLETED|Overall Study||47
9742630|NCT00260208|10844265|FG001|NOT COMPLETED|Overall Study||34
9742631|NCT00260429|10844273|FG000|STARTED|Overall Study||23
9742632|NCT00260429|10844274|FG001|STARTED|Overall Study||12
9742633|NCT00260429|10844273|FG000|COMPLETED|Overall Study||21
9742634|NCT00260429|10844274|FG001|COMPLETED|Overall Study||12
9742635|NCT00260429|10844273|FG000|NOT COMPLETED|Overall Study||2
9742636|NCT00260429|10844274|FG001|NOT COMPLETED|Overall Study||0
9742637|NCT00260533|10844282|FG000|STARTED|Overall Study||14
9742638|NCT00260533|10844283|FG001|STARTED|Overall Study||13
9742639|NCT00260533|10844282|FG000|COMPLETED|Overall Study||11
9742640|NCT00260533|10844283|FG001|COMPLETED|Overall Study||10
9742641|NCT00260533|10844282|FG000|NOT COMPLETED|Overall Study||3
9742642|NCT00260533|10844283|FG001|NOT COMPLETED|Overall Study||3
9742643|NCT00260689|10844292|FG000|STARTED|Overall Study||60
9742644|NCT00260689|10844293|FG001|STARTED|Overall Study||60
9742645|NCT00260689|10844294|FG002|STARTED|Overall Study||16
9742646|NCT00260689|10844292|FG000|COMPLETED|Overall Study||19
9742647|NCT00260689|10844293|FG001|COMPLETED|Overall Study||11
9742648|NCT00260689|10844294|FG002|COMPLETED|Overall Study||1
9742649|NCT00260689|10844292|FG000|NOT COMPLETED|Overall Study||41
9742650|NCT00260689|10844293|FG001|NOT COMPLETED|Overall Study||49
9742651|NCT00260689|10844294|FG002|NOT COMPLETED|Overall Study||15
9742652|NCT00260832|10844304|FG000|STARTED|Overall Study||243
9742653|NCT00260832|10844305|FG001|STARTED|Overall Study||242
9742654|NCT00260832|10844304|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
9742655|NCT00260832|10844305|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
9742656|NCT00260832|10844304|FG000|NOT COMPLETED|Overall Study||228
9742657|NCT00260832|10844305|FG001|NOT COMPLETED|Overall Study||211
9742658|NCT00260962|10844313|FG000|STARTED|Overall Study||18
9742659|NCT00260962|10844314|FG001|STARTED|Overall Study||16
9742660|NCT00260962|10844313|FG000|COMPLETED|Overall Study||14
9742661|NCT00260962|10844314|FG001|COMPLETED|Overall Study||14
9742662|NCT00260962|10844313|FG000|NOT COMPLETED|Overall Study||4
9742663|NCT00260962|10844314|FG001|NOT COMPLETED|Overall Study||2
9828238|NCT00754624|10938966|FG000|STARTED|Overall Study||229
9828239|NCT00754624|10938966|FG000|COMPLETED|Overall Study||160
9828240|NCT00754624|10938966|FG000|NOT COMPLETED|Overall Study||69
9828241|NCT00754650|10938970|FG000|STARTED|Overall Study||2
9828242|NCT00754650|10938970|FG000|COMPLETED|Overall Study||0
9828243|NCT00754650|10938970|FG000|NOT COMPLETED|Overall Study||2
9828244|NCT00754741|10938977|FG000|STARTED|Overall Study||567
9828245|NCT00754741|10938978|FG001|STARTED|Overall Study||569
9828246|NCT00754741|10938979|FG002|STARTED|Overall Study||556
9828247|NCT00754741|10938977|FG000|COMPLETED|Overall Study||510
9828248|NCT00754741|10938978|FG001|COMPLETED|Overall Study||500
9828249|NCT00754741|10938979|FG002|COMPLETED|Overall Study||502
9828250|NCT00754741|10938977|FG000|NOT COMPLETED|Overall Study||57
9828251|NCT00754741|10938978|FG001|NOT COMPLETED|Overall Study||69
9828252|NCT00754741|10938979|FG002|NOT COMPLETED|Overall Study||54
9828253|NCT00754832|10938987|FG000|STARTED|First 6 Weeks Intervention||26
9828254|NCT00754832|10938988|FG001|STARTED|First 6 Weeks Intervention||30
9828255|NCT00754832|10938987|FG000|COMPLETED|First 6 Weeks Intervention||18
9828256|NCT00754832|10938988|FG001|COMPLETED|First 6 Weeks Intervention||28
9828257|NCT00754832|10938987|FG000|NOT COMPLETED|First 6 Weeks Intervention||8
9828258|NCT00754832|10938988|FG001|NOT COMPLETED|First 6 Weeks Intervention||2
9828259|NCT00754832|10938987|FG000|STARTED|2 Weeks Washout||18
9828260|NCT00754832|10938988|FG001|STARTED|2 Weeks Washout||28
9828261|NCT00754832|10938987|FG000|COMPLETED|2 Weeks Washout||17
9828262|NCT00754832|10938988|FG001|COMPLETED|2 Weeks Washout||26
9828263|NCT00754832|10938987|FG000|NOT COMPLETED|2 Weeks Washout||1
9742664|NCT00261040|10844322|FG000|STARTED|Overall Study||20
9742665|NCT00261040|10844323|FG001|STARTED|Overall Study||20
9742666|NCT00261040|10844322|FG000|COMPLETED|Overall Study||19
9742667|NCT00261040|10844323|FG001|COMPLETED|Overall Study||20
9742668|NCT00261040|10844322|FG000|NOT COMPLETED|Overall Study||1
9742669|NCT00261040|10844323|FG001|NOT COMPLETED|Overall Study||0
9742670|NCT00261443|10844331|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270
9742671|NCT00261443|10844332|FG001|STARTED|1: Confirmation of Partial Nonresponse||0
9742672|NCT00261443|10844333|FG002|STARTED|1: Confirmation of Partial Nonresponse||0
9742673|NCT00261443|10844331|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686
9742674|NCT00261443|10844332|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0
9742675|NCT00261443|10844333|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0
9742676|NCT00261443|10844331|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
9742677|NCT00261443|10844332|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
9742678|NCT00261443|10844333|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
9742679|NCT00261443|10844331|FG000|STARTED|2: Stability & Maintenance of Stability||686
9742680|NCT00261443|10844332|FG001|STARTED|2: Stability & Maintenance of Stability||0
9742681|NCT00261443|10844333|FG002|STARTED|2: Stability & Maintenance of Stability||0
9742682|NCT00261443|10844331|FG000|COMPLETED|2: Stability & Maintenance of Stability||346
9742683|NCT00261443|10844332|FG001|COMPLETED|2: Stability & Maintenance of Stability||0
9742684|NCT00261443|10844333|FG002|COMPLETED|2: Stability & Maintenance of Stability||0
9742685|NCT00261443|10844331|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340
9742686|NCT00261443|10844332|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0
9742687|NCT00261443|10844333|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0
9742688|NCT00261443|10844331|FG000|STARTED|3: Assessment of Relapse||0
9742689|NCT00261443|10844332|FG001|STARTED|3: Assessment of Relapse||169
9742690|NCT00261443|10844333|FG002|STARTED|3: Assessment of Relapse||168
9742691|NCT00261443|10844331|FG000|COMPLETED|3: Assessment of Relapse||0
9742692|NCT00261443|10844332|FG001|COMPLETED|3: Assessment of Relapse||89
9742693|NCT00261443|10844333|FG002|COMPLETED|3: Assessment of Relapse||103
9742694|NCT00261443|10844331|FG000|NOT COMPLETED|3: Assessment of Relapse||0
9742695|NCT00261443|10844332|FG001|NOT COMPLETED|3: Assessment of Relapse||80
9742696|NCT00261443|10844333|FG002|NOT COMPLETED|3: Assessment of Relapse||65
9742697|NCT00261443|10844331|FG000|STARTED|4: Extension Phase||0
9742698|NCT00261443|10844332|FG001|STARTED|4: Extension Phase||19
9742699|NCT00261443|10844333|FG002|STARTED|4: Extension Phase||23
9742700|NCT00261443|10844331|FG000|COMPLETED|4: Extension Phase||0
9742701|NCT00261443|10844332|FG001|COMPLETED|4: Extension Phase||16
9742702|NCT00261443|10844333|FG002|COMPLETED|4: Extension Phase||21
9742703|NCT00261443|10844331|FG000|NOT COMPLETED|4: Extension Phase||0
9742704|NCT00261443|10844332|FG001|NOT COMPLETED|4: Extension Phase||3
9742705|NCT00261443|10844333|FG002|NOT COMPLETED|4: Extension Phase||2
9742706|NCT00261495|10844346|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254
9742707|NCT00261495|10844347|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250
9742708|NCT00261495|10844346|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206
9742709|NCT00261495|10844347|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185
9742710|NCT00261495|10844346|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
9742711|NCT00261495|10844347|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
9852560|NCT00882115|10965446|FG000|NOT COMPLETED|Overall Study||9
9852561|NCT00882206|10965450|FG000|STARTED|Overall Study||13
9852562|NCT00882206|10965450|FG000|COMPLETED|Overall Study||13
9852563|NCT00882206|10965450|FG000|NOT COMPLETED|Overall Study||0
9852564|NCT00882362|10965457|FG000|STARTED|Overall Study||122
9852565|NCT00882362|10965458|FG001|STARTED|Overall Study||33
9852566|NCT00882362|10965457|FG000|COMPLETED|Overall Study||73
9852567|NCT00882362|10965458|FG001|COMPLETED|Overall Study||10
9852568|NCT00882362|10965457|FG000|NOT COMPLETED|Overall Study||49
9852569|NCT00882362|10965458|FG001|NOT COMPLETED|Overall Study||23
9852570|NCT00882518|10965466|FG000|STARTED|Overall Study||196
9852571|NCT00882518|10965467|FG001|STARTED|Overall Study||192
9852572|NCT00882518|10965466|FG000|COMPLETED|Overall Study||158
9852573|NCT00882518|10965467|FG001|COMPLETED|Overall Study||148
9852574|NCT00882518|10965466|FG000|NOT COMPLETED|Overall Study||38
9852575|NCT00882518|10965467|FG001|NOT COMPLETED|Overall Study||44
9852576|NCT00882557|10965475|FG000|STARTED|Overall Study||8
9852577|NCT00882557|10965476|FG001|STARTED|Overall Study||8
9852578|NCT00882557|10965475|FG000|Completed Dose 1|Overall Study||8
9852579|NCT00882557|10965476|FG001|Completed Dose 1|Overall Study||7
9852580|NCT00882557|10965475|FG000|Completed Dose 2|Overall Study||6
9852581|NCT00882557|10965476|FG001|Completed Dose 2|Overall Study||7
9852582|NCT00882557|10965475|FG000|COMPLETED|Overall Study||6
9852583|NCT00882557|10965476|FG001|COMPLETED|Overall Study||7
9852584|NCT00882557|10965475|FG000|NOT COMPLETED|Overall Study||2
9852585|NCT00882557|10965476|FG001|NOT COMPLETED|Overall Study||1
9852586|NCT00882583|10965484|FG000|STARTED|Overall Study||7
9852587|NCT00882583|10965485|FG001|STARTED|Overall Study||12
9852588|NCT00882583|10965484|FG000|COMPLETED|Overall Study||6
9852589|NCT00882583|10965485|FG001|COMPLETED|Overall Study||11
9852590|NCT00882583|10965484|FG000|NOT COMPLETED|Overall Study||1
9852591|NCT00882583|10965485|FG001|NOT COMPLETED|Overall Study||1
9852592|NCT00882661|10965494|FG000|STARTED|Investigational Training||89
9852593|NCT00882661|10965495|FG001|STARTED|Investigational Training||0
9852594|NCT00882661|10965494|FG000|COMPLETED|Investigational Training||79
9852595|NCT00882661|10965495|FG001|COMPLETED|Investigational Training||0
9852596|NCT00882661|10965494|FG000|NOT COMPLETED|Investigational Training||10
9742712|NCT00261495|10844346|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206
9742713|NCT00261495|10844347|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185
9742714|NCT00261495|10844346|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
9742715|NCT00261495|10844347|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
9742716|NCT00261495|10844346|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
9742717|NCT00261495|10844347|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
9742718|NCT00261495|10844346|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
9742719|NCT00261495|10844347|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
9742720|NCT00261495|10844346|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50
9742721|NCT00261495|10844347|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47
9742722|NCT00261495|10844346|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
9742723|NCT00261495|10844347|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
9742724|NCT00261716|10844355|FG000|STARTED|Overall Study||17
9742725|NCT00261716|10844356|FG001|STARTED|Overall Study||21
9742726|NCT00261716|10844355|FG000|COMPLETED|Overall Study||11
9742727|NCT00261716|10844356|FG001|COMPLETED|Overall Study||11
9742728|NCT00261716|10844355|FG000|NOT COMPLETED|Overall Study||6
9742729|NCT00261716|10844356|FG001|NOT COMPLETED|Overall Study||10
9742730|NCT00261833|10844368|FG000|STARTED|Overall Study||93
9742731|NCT00261833|10844369|FG001|STARTED|Overall Study||87
9742732|NCT00261833|10844368|FG000|COMPLETED|Overall Study||84
9742733|NCT00261833|10844369|FG001|COMPLETED|Overall Study||69
9742734|NCT00261833|10844368|FG000|NOT COMPLETED|Overall Study||9
9742735|NCT00261833|10844369|FG001|NOT COMPLETED|Overall Study||18
9742736|NCT00261846|10844385|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3
9742737|NCT00261846|10844386|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3
9742738|NCT00261846|10844387|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12
9742739|NCT00261846|10844388|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742740|NCT00261846|10844389|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742741|NCT00261846|10844390|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742742|NCT00261846|10844391|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742743|NCT00261846|10844392|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742744|NCT00261846|10844393|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742745|NCT00261846|10844394|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742746|NCT00261846|10844395|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742747|NCT00261846|10844396|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0
9742748|NCT00261846|10844385|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742749|NCT00261846|10844386|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742750|NCT00261846|10844387|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742751|NCT00261846|10844388|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742752|NCT00261846|10844389|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742753|NCT00261846|10844390|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742754|NCT00261846|10844391|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742755|NCT00261846|10844392|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742756|NCT00261846|10844393|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742757|NCT00261846|10844394|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742758|NCT00261846|10844395|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742759|NCT00261846|10844396|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742760|NCT00261846|10844385|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
9742761|NCT00261846|10844386|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
9742762|NCT00261846|10844387|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
9742763|NCT00261846|10844388|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742764|NCT00261846|10844389|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742765|NCT00261846|10844390|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742766|NCT00261846|10844391|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742767|NCT00261846|10844392|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742768|NCT00261846|10844393|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742769|NCT00261846|10844394|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742770|NCT00261846|10844395|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742771|NCT00261846|10844396|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
9742772|NCT00261846|10844385|FG000|STARTED|Period 2: Part 2 (Efficacy)||0
9742773|NCT00261846|10844386|FG001|STARTED|Period 2: Part 2 (Efficacy)||0
9742774|NCT00261846|10844387|FG002|STARTED|Period 2: Part 2 (Efficacy)||0
9742775|NCT00261846|10844388|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
10091726|NCT02331407|11219996|FG000|NOT COMPLETED|Overall Study||0
10091727|NCT02331446|11220004|FG000|STARTED|Overall Study||9
10091728|NCT02331446|11220005|FG001|STARTED|Overall Study||11
10091729|NCT02331446|11220006|FG002|STARTED|Overall Study||11
10091730|NCT02331446|11220007|FG003|STARTED|Overall Study||11
10091731|NCT02331446|11220004|FG000|COMPLETED|Overall Study||5
10091732|NCT02331446|11220005|FG001|COMPLETED|Overall Study||6
9742776|NCT00261846|10844389|FG004|STARTED|Period 2: Part 2 (Efficacy)||89
9742777|NCT00261846|10844390|FG005|STARTED|Period 2: Part 2 (Efficacy)||5
9742778|NCT00261846|10844391|FG006|STARTED|Period 2: Part 2 (Efficacy)||38
9742779|NCT00261846|10844392|FG007|STARTED|Period 2: Part 2 (Efficacy)||50
10091733|NCT02331446|11220006|FG002|COMPLETED|Overall Study||8
10091734|NCT02331446|11220007|FG003|COMPLETED|Overall Study||8
9742780|NCT00261846|10844393|FG008|STARTED|Period 2: Part 2 (Efficacy)||26
10091735|NCT02331446|11220004|FG000|NOT COMPLETED|Overall Study||4
10091736|NCT02331446|11220005|FG001|NOT COMPLETED|Overall Study||5
10091737|NCT02331446|11220006|FG002|NOT COMPLETED|Overall Study||3
10091738|NCT02331446|11220007|FG003|NOT COMPLETED|Overall Study||3
10091739|NCT02331589|11220019|FG000|STARTED|Overall Study||39
10091740|NCT02331589|11220020|FG001|STARTED|Overall Study||36
10091741|NCT02331589|11220019|FG000|COMPLETED|Overall Study||34
10091742|NCT02331589|11220020|FG001|COMPLETED|Overall Study||31
10091743|NCT02331589|11220019|FG000|NOT COMPLETED|Overall Study||5
10201720|NCT03440229|11329095|FG001|COMPLETED|Overall Study||7
10201721|NCT03440229|11329094|FG000|NOT COMPLETED|Overall Study||0
10201722|NCT03440229|11329095|FG001|NOT COMPLETED|Overall Study||0
10201723|NCT03440320|11329105|FG000|STARTED|Overall Study||18
10201724|NCT03440320|11329106|FG001|STARTED|Overall Study||14
10201725|NCT03440320|11329105|FG000|COMPLETED|Overall Study||18
9742781|NCT00261846|10844394|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
9742782|NCT00261846|10844395|FG010|STARTED|Period 2: Part 2 (Efficacy)||64
9742783|NCT00261846|10844396|FG011|STARTED|Period 2: Part 2 (Efficacy)||24
9742784|NCT00261846|10844385|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0
9742785|NCT00261846|10844386|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0
9742786|NCT00261846|10844387|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0
9742787|NCT00261846|10844388|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60
9742788|NCT00261846|10844389|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39
9742789|NCT00261846|10844390|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3
9742790|NCT00261846|10844391|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16
9742791|NCT00261846|10844392|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21
9742792|NCT00261846|10844393|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12
9742793|NCT00261846|10844394|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30
9742794|NCT00261846|10844395|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15
9742795|NCT00261846|10844396|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1
9742796|NCT00261846|10844385|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
9742797|NCT00261846|10844386|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
9742798|NCT00261846|10844387|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
9742799|NCT00261846|10844388|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
9742800|NCT00261846|10844389|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
9742801|NCT00261846|10844390|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
9742802|NCT00261846|10844391|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
9742803|NCT00261846|10844392|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
9742804|NCT00261846|10844393|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
9742805|NCT00261846|10844394|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
9742806|NCT00261846|10844395|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
9742807|NCT00261846|10844396|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
9742808|NCT00261950|10844435|FG000|STARTED|Overall Study||110
9742809|NCT00261950|10844435|FG000|COMPLETED|Overall Study||84
9742810|NCT00261950|10844435|FG000|NOT COMPLETED|Overall Study||26
9742811|NCT00262002|10844446|FG000|STARTED|Overall Study||90
9742812|NCT00262002|10844447|FG001|STARTED|Overall Study||90
9742813|NCT00262002|10844448|FG002|STARTED|Overall Study||45
9742814|NCT00262002|10844449|FG003|STARTED|Overall Study||98
9742815|NCT00262002|10844450|FG004|STARTED|Overall Study||98
9742816|NCT00262002|10844451|FG005|STARTED|Overall Study||90
9742817|NCT00262002|10844452|FG006|STARTED|Overall Study||90
9742818|NCT00262002|10844446|FG000|COMPLETED|Overall Study||79
9742819|NCT00262002|10844447|FG001|COMPLETED|Overall Study||84
9742820|NCT00262002|10844448|FG002|COMPLETED|Overall Study||45
9742821|NCT00262002|10844449|FG003|COMPLETED|Overall Study||93
9742822|NCT00262002|10844450|FG004|COMPLETED|Overall Study||91
9742823|NCT00262002|10844451|FG005|COMPLETED|Overall Study||83
9742824|NCT00262002|10844452|FG006|COMPLETED|Overall Study||84
9742825|NCT00262002|10844446|FG000|NOT COMPLETED|Overall Study||11
9742826|NCT00262002|10844447|FG001|NOT COMPLETED|Overall Study||6
9742827|NCT00262002|10844448|FG002|NOT COMPLETED|Overall Study||0
9742828|NCT00262002|10844449|FG003|NOT COMPLETED|Overall Study||5
9742829|NCT00262002|10844450|FG004|NOT COMPLETED|Overall Study||7
9742830|NCT00262002|10844451|FG005|NOT COMPLETED|Overall Study||7
9742831|NCT00262002|10844452|FG006|NOT COMPLETED|Overall Study||6
9742832|NCT00262028|10844526|FG000|STARTED|Overall Study||152
9742833|NCT00262028|10844527|FG001|STARTED|Overall Study||153
9742834|NCT00262028|10844528|FG002|STARTED|Overall Study||157
9742835|NCT00262028|10844529|FG003|STARTED|Overall Study||157
9742836|NCT00262028|10844530|FG004|STARTED|Overall Study||74
9742837|NCT00262028|10844531|FG005|STARTED|Overall Study||73
9742838|NCT00262028|10844532|FG006|STARTED|Overall Study||71
9742839|NCT00262028|10844533|FG007|STARTED|Overall Study||73
9742840|NCT00262028|10844534|FG008|STARTED|Overall Study||100
9742841|NCT00262028|10844526|FG000|COMPLETED|Overall Study||128
9742842|NCT00262028|10844527|FG001|COMPLETED|Overall Study||126
9742843|NCT00262028|10844528|FG002|COMPLETED|Overall Study||137
9742844|NCT00262028|10844529|FG003|COMPLETED|Overall Study||134
9742845|NCT00262028|10844530|FG004|COMPLETED|Overall Study||62
9742846|NCT00262028|10844531|FG005|COMPLETED|Overall Study||60
9742847|NCT00262028|10844532|FG006|COMPLETED|Overall Study||59
9742848|NCT00262028|10844533|FG007|COMPLETED|Overall Study||55
10201726|NCT03440320|11329106|FG001|COMPLETED|Overall Study||13
10091744|NCT02331589|11220020|FG001|NOT COMPLETED|Overall Study||5
10091745|NCT02331680|11220029|FG000|STARTED|Overall Study||40
10201727|NCT03440320|11329105|FG000|NOT COMPLETED|Overall Study||0
9742849|NCT00262028|10844534|FG008|COMPLETED|Overall Study||81
9742850|NCT00262028|10844526|FG000|NOT COMPLETED|Overall Study||24
9742851|NCT00262028|10844527|FG001|NOT COMPLETED|Overall Study||27
9742852|NCT00262028|10844528|FG002|NOT COMPLETED|Overall Study||20
9742853|NCT00262028|10844529|FG003|NOT COMPLETED|Overall Study||23
9742854|NCT00262028|10844530|FG004|NOT COMPLETED|Overall Study||12
9742855|NCT00262028|10844531|FG005|NOT COMPLETED|Overall Study||13
9742856|NCT00262028|10844532|FG006|NOT COMPLETED|Overall Study||12
9742857|NCT00262028|10844533|FG007|NOT COMPLETED|Overall Study||18
9742858|NCT00262028|10844534|FG008|NOT COMPLETED|Overall Study||19
9742859|NCT00262041|10844580|FG000|STARTED|Overall Study||164
9742860|NCT00262041|10844581|FG001|STARTED|Overall Study||151
9742861|NCT00262041|10844582|FG002|STARTED|Overall Study||209
9742862|NCT00262041|10844580|FG000|COMPLETED|Overall Study||162
9742863|NCT00262041|10844581|FG001|COMPLETED|Overall Study||147
9742864|NCT00262041|10844582|FG002|COMPLETED|Overall Study||203
9742865|NCT00262041|10844580|FG000|NOT COMPLETED|Overall Study||2
9742866|NCT00262041|10844581|FG001|NOT COMPLETED|Overall Study||4
9742867|NCT00262041|10844582|FG002|NOT COMPLETED|Overall Study||6
9742868|NCT00262067|10844600|FG000|STARTED|Overall Study||415
9742869|NCT00262067|10844601|FG001|STARTED|Overall Study||207
9742870|NCT00262067|10844602|FG002|STARTED|Overall Study||409
9742871|NCT00262067|10844603|FG003|STARTED|Overall Study||206
9742872|NCT00262067|10844600|FG000|COMPLETED|Overall Study||196
9742873|NCT00262067|10844601|FG001|COMPLETED|Overall Study||107
9742874|NCT00262067|10844602|FG002|COMPLETED|Overall Study||193
9742875|NCT00262067|10844603|FG003|COMPLETED|Overall Study||93
9742876|NCT00262067|10844600|FG000|NOT COMPLETED|Overall Study||219
9742877|NCT00262067|10844601|FG001|NOT COMPLETED|Overall Study||100
9742878|NCT00262067|10844602|FG002|NOT COMPLETED|Overall Study||216
9742879|NCT00262067|10844603|FG003|NOT COMPLETED|Overall Study||113
9742880|NCT00262080|10844616|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
9742881|NCT00262080|10844617|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
9742882|NCT00262080|10844618|FG002|STARTED|Double Blind Treatment Period||0
9742883|NCT00262080|10844616|FG000|COMPLETED|Double Blind Treatment Period||35
9742884|NCT00262080|10844617|FG001|COMPLETED|Double Blind Treatment Period||36
9742885|NCT00262080|10844618|FG002|COMPLETED|Double Blind Treatment Period||0
9742886|NCT00262080|10844616|FG000|NOT COMPLETED|Double Blind Treatment Period||1
9742887|NCT00262080|10844617|FG001|NOT COMPLETED|Double Blind Treatment Period||0
9742888|NCT00262080|10844618|FG002|NOT COMPLETED|Double Blind Treatment Period||0
9742889|NCT00262080|10844616|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
9742890|NCT00262080|10844617|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
9742891|NCT00262080|10844618|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
9742892|NCT00262080|10844616|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
9742893|NCT00262080|10844617|FG001|COMPLETED|Repeat Dose Treatment Period||25
9742894|NCT00262080|10844618|FG002|COMPLETED|Repeat Dose Treatment Period||14
9742895|NCT00262080|10844616|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4
9742896|NCT00262080|10844617|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1
9742897|NCT00262080|10844618|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5
9742898|NCT00262119|10844629|FG000|STARTED|Overall Study||385
9742899|NCT00262119|10844630|FG001|STARTED|Overall Study||398
9742900|NCT00262119|10844631|FG002|STARTED|Overall Study||383
9742901|NCT00262119|10844629|FG000|COMPLETED|Overall Study||327
9742902|NCT00262119|10844630|FG001|COMPLETED|Overall Study||328
9742903|NCT00262119|10844631|FG002|COMPLETED|Overall Study||325
9742904|NCT00262119|10844629|FG000|NOT COMPLETED|Overall Study||58
9742905|NCT00262119|10844630|FG001|NOT COMPLETED|Overall Study||70
9742906|NCT00262119|10844631|FG002|NOT COMPLETED|Overall Study||58
9742907|NCT00262223|10844641|FG000|STARTED|Treatment Phase||32
9742908|NCT00262223|10844642|FG001|STARTED|Treatment Phase||37
9742909|NCT00262223|10844641|FG000|COMPLETED|Treatment Phase||28
9742910|NCT00262223|10844642|FG001|COMPLETED|Treatment Phase||29
9742911|NCT00262223|10844641|FG000|NOT COMPLETED|Treatment Phase||4
9742912|NCT00262223|10844642|FG001|NOT COMPLETED|Treatment Phase||8
9742913|NCT00262223|10844641|FG000|STARTED|1-week Post-treatment Follow-up||28
9742914|NCT00262223|10844642|FG001|STARTED|1-week Post-treatment Follow-up||29
9742915|NCT00262223|10844641|FG000|COMPLETED|1-week Post-treatment Follow-up||24
9742916|NCT00262223|10844642|FG001|COMPLETED|1-week Post-treatment Follow-up||25
9742917|NCT00262223|10844641|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4
9742918|NCT00262223|10844642|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4
9742919|NCT00262223|10844641|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
9742920|NCT00262223|10844642|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
9742921|NCT00262223|10844641|FG000|COMPLETED|6-month Post-treatment Follow-up||22
10091746|NCT02331680|11220030|FG001|STARTED|Overall Study||40
10091747|NCT02331680|11220031|FG002|STARTED|Overall Study||44
9742922|NCT00262223|10844642|FG001|COMPLETED|6-month Post-treatment Follow-up||28
9828264|NCT00754832|10938988|FG001|NOT COMPLETED|2 Weeks Washout||2
10091748|NCT02331680|11220029|FG000|COMPLETED|Overall Study||34
10091749|NCT02331680|11220030|FG001|COMPLETED|Overall Study||36
9742923|NCT00262223|10844641|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6
9742924|NCT00262223|10844642|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1
9742925|NCT00262223|10844641|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
9742926|NCT00262223|10844642|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
9742927|NCT00262223|10844641|FG000|COMPLETED|12-month Post-treatment Follow-up||21
9742928|NCT00262223|10844642|FG001|COMPLETED|12-month Post-treatment Follow-up||22
9742929|NCT00262223|10844641|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7
9742930|NCT00262223|10844642|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7
9742931|NCT00262301|10844652|FG000|STARTED|Double-blind Phase||16
9742932|NCT00262301|10844653|FG001|STARTED|Double-blind Phase||16
9742933|NCT00262301|10844654|FG002|STARTED|Double-blind Phase||0
9742934|NCT00262301|10844652|FG000|COMPLETED|Double-blind Phase||15
9742935|NCT00262301|10844653|FG001|COMPLETED|Double-blind Phase||15
9742936|NCT00262301|10844654|FG002|COMPLETED|Double-blind Phase||0
9742937|NCT00262301|10844652|FG000|NOT COMPLETED|Double-blind Phase||1
9742938|NCT00262301|10844653|FG001|NOT COMPLETED|Double-blind Phase||1
9742939|NCT00262301|10844654|FG002|NOT COMPLETED|Double-blind Phase||0
9742940|NCT00262301|10844652|FG000|STARTED|Open-label Phase||0
9742941|NCT00262301|10844653|FG001|STARTED|Open-label Phase||0
9742942|NCT00262301|10844654|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
9742943|NCT00262301|10844652|FG000|COMPLETED|Open-label Phase||0
9742944|NCT00262301|10844653|FG001|COMPLETED|Open-label Phase||0
9742945|NCT00262301|10844654|FG002|COMPLETED|Open-label Phase||57
9742946|NCT00262301|10844652|FG000|NOT COMPLETED|Open-label Phase||0
9742947|NCT00262301|10844653|FG001|NOT COMPLETED|Open-label Phase||0
9742948|NCT00262301|10844654|FG002|NOT COMPLETED|Open-label Phase||0
9742949|NCT00262314|10844662|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
9742950|NCT00262314|10844662|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
9742951|NCT00262314|10844662|FG000|NOT COMPLETED|Overall Study||337
9742952|NCT00262509|10844668|FG000|STARTED|Overall Study||8
9742953|NCT00262509|10844669|FG001|STARTED|Overall Study||9
9742954|NCT00262509|10844668|FG000|COMPLETED|Overall Study||8
9742955|NCT00262509|10844669|FG001|COMPLETED|Overall Study||9
9742956|NCT00262509|10844668|FG000|NOT COMPLETED|Overall Study||0
9742957|NCT00262509|10844669|FG001|NOT COMPLETED|Overall Study||0
9742958|NCT00262522|10844679|FG000|STARTED|Study Start Through 8 Weeks||167
9742959|NCT00262522|10844680|FG001|STARTED|Study Start Through 8 Weeks||166
9742960|NCT00262522|10844681|FG002|STARTED|Study Start Through 8 Weeks||166
9742961|NCT00262522|10844682|FG003|STARTED|Study Start Through 8 Weeks||165
9742962|NCT00262522|10844679|FG000|COMPLETED|Study Start Through 8 Weeks||163
9742963|NCT00262522|10844680|FG001|COMPLETED|Study Start Through 8 Weeks||161
9742964|NCT00262522|10844681|FG002|COMPLETED|Study Start Through 8 Weeks||155
9742965|NCT00262522|10844682|FG003|COMPLETED|Study Start Through 8 Weeks||160
9742966|NCT00262522|10844679|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4
9742967|NCT00262522|10844680|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5
9742968|NCT00262522|10844681|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11
9742969|NCT00262522|10844682|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5
9742970|NCT00262522|10844679|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
9742971|NCT00262522|10844680|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
9742972|NCT00262522|10844681|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
9742973|NCT00262522|10844682|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
9742974|NCT00262522|10844679|FG000|COMPLETED|Study Start Through 48 Weeks||284
9742975|NCT00262522|10844680|FG001|COMPLETED|Study Start Through 48 Weeks||0
9742976|NCT00262522|10844681|FG002|COMPLETED|Study Start Through 48 Weeks||276
9742977|NCT00262522|10844682|FG003|COMPLETED|Study Start Through 48 Weeks||0
9742978|NCT00262522|10844679|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49
9742979|NCT00262522|10844680|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0
9742980|NCT00262522|10844681|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55
9742981|NCT00262522|10844682|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0
9742982|NCT00262522|10844679|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
9742983|NCT00262522|10844680|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
9742984|NCT00262522|10844681|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
10201728|NCT03440320|11329106|FG001|NOT COMPLETED|Overall Study||1
10201729|NCT03440411|11329118|FG000|STARTED|Overall Study||3
10201730|NCT03440411|11329119|FG001|STARTED|Overall Study||1
10201731|NCT03440411|11329120|FG002|STARTED|Overall Study||2
9742985|NCT00262522|10844682|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
9742986|NCT00262522|10844679|FG000|COMPLETED|Study Start Through 96 Weeks||256
9742987|NCT00262522|10844680|FG001|COMPLETED|Study Start Through 96 Weeks||0
9742988|NCT00262522|10844681|FG002|COMPLETED|Study Start Through 96 Weeks||254
10201732|NCT03440411|11329121|FG003|STARTED|Overall Study||2
9742989|NCT00262522|10844682|FG003|COMPLETED|Study Start Through 96 Weeks||0
9742990|NCT00262522|10844679|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77
9742991|NCT00262522|10844680|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0
9742992|NCT00262522|10844681|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77
9742993|NCT00262522|10844682|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0
9742994|NCT00262600|10844693|FG000|STARTED|Overall Study||6015
9742995|NCT00262600|10844694|FG001|STARTED|Overall Study||6076
9742996|NCT00262600|10844695|FG002|STARTED|Overall Study||6022
9742997|NCT00262600|10844693|FG000|COMPLETED|Overall Study||5780
9742998|NCT00262600|10844694|FG001|COMPLETED|Overall Study||5824
9742999|NCT00262600|10844695|FG002|COMPLETED|Overall Study||5756
9743000|NCT00262600|10844693|FG000|NOT COMPLETED|Overall Study||235
9743001|NCT00262600|10844694|FG001|NOT COMPLETED|Overall Study||252
9743002|NCT00262600|10844695|FG002|NOT COMPLETED|Overall Study||266
9743003|NCT00262639|10844707|FG000|STARTED|Overall Study||18
9743004|NCT00262639|10844708|FG001|STARTED|Overall Study||26
9743005|NCT00262639|10844709|FG002|STARTED|Overall Study||9
9743006|NCT00262639|10844710|FG003|STARTED|Overall Study||7
9743007|NCT00262639|10844707|FG000|COMPLETED|Overall Study||18
9743008|NCT00262639|10844708|FG001|COMPLETED|Overall Study||26
9743009|NCT00262639|10844709|FG002|COMPLETED|Overall Study||9
9743010|NCT00262639|10844710|FG003|COMPLETED|Overall Study||7
9743011|NCT00262639|10844707|FG000|NOT COMPLETED|Overall Study||0
9743012|NCT00262639|10844708|FG001|NOT COMPLETED|Overall Study||0
9743013|NCT00262639|10844709|FG002|NOT COMPLETED|Overall Study||0
9743014|NCT00262639|10844710|FG003|NOT COMPLETED|Overall Study||0
9743015|NCT00262730|10844720|FG000|STARTED|Overall Study||97
9743016|NCT00262730|10844720|FG000|COMPLETED|Overall Study||97
9743017|NCT00262730|10844720|FG000|NOT COMPLETED|Overall Study||0
9743018|NCT00262743|10844726|FG000|STARTED|Overall Study||27
9743019|NCT00262743|10844727|FG001|STARTED|Overall Study||42
9743020|NCT00262743|10844726|FG000|COMPLETED|Overall Study||27
9743021|NCT00262743|10844727|FG001|COMPLETED|Overall Study||30
9743022|NCT00262743|10844726|FG000|NOT COMPLETED|Overall Study||0
9743023|NCT00262743|10844727|FG001|NOT COMPLETED|Overall Study||12
9743024|NCT00262821|10844733|FG000|STARTED|Overall Study||198
9743025|NCT00262821|10844734|FG001|STARTED|Overall Study||204
9743026|NCT00262821|10844733|FG000|COMPLETED|Overall Study||194
9743027|NCT00262821|10844734|FG001|COMPLETED|Overall Study||185
9743028|NCT00262821|10844733|FG000|NOT COMPLETED|Overall Study||4
9743029|NCT00262821|10844734|FG001|NOT COMPLETED|Overall Study||19
9743030|NCT00262834|10844742|FG000|STARTED|Overall Study||25
9743031|NCT00262834|10844743|FG001|STARTED|Overall Study||29
9743032|NCT00262834|10844742|FG000|COMPLETED|Overall Study||24
9743033|NCT00262834|10844743|FG001|COMPLETED|Overall Study||25
9743034|NCT00262834|10844742|FG000|NOT COMPLETED|Overall Study||1
9743035|NCT00262834|10844743|FG001|NOT COMPLETED|Overall Study||4
9743036|NCT00262847|10844752|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
9743037|NCT00262847|10844753|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
9743038|NCT00262847|10844754|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
9743039|NCT00262847|10844752|FG000|COMPLETED|Overall Study||107
9743040|NCT00262847|10844753|FG001|COMPLETED|Overall Study||112
9743041|NCT00262847|10844754|FG002|COMPLETED|Overall Study||227
9743042|NCT00262847|10844752|FG000|NOT COMPLETED|Overall Study||518
9743043|NCT00262847|10844753|FG001|NOT COMPLETED|Overall Study||513
9743044|NCT00262847|10844754|FG002|NOT COMPLETED|Overall Study||396
9743045|NCT00262860|10844765|FG000|STARTED|Overall Study||18
9743046|NCT00262860|10844765|FG000|COMPLETED|Overall Study||16
9743047|NCT00262860|10844765|FG000|NOT COMPLETED|Overall Study||2
9743048|NCT00262873|10844769|FG000|STARTED|Overall Study||8
9743049|NCT00262873|10844769|FG000|COMPLETED|Overall Study||0
9743050|NCT00262873|10844769|FG000|NOT COMPLETED|Overall Study||8
9743051|NCT00262925|10844773|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
9743052|NCT00262925|10844773|FG000|COMPLETED|Overall Study||1
9743053|NCT00262925|10844773|FG000|NOT COMPLETED|Overall Study||11
9743054|NCT00262951|10844779|FG000|STARTED|Overall Study||23
9743055|NCT00262951|10844779|FG000|COMPLETED|Overall Study||7
9743056|NCT00262951|10844779|FG000|NOT COMPLETED|Overall Study||16
9743057|NCT00262964|10844785|FG000|STARTED|Overall Study||11
9743058|NCT00262964|10844786|FG001|STARTED|Overall Study||11
9743059|NCT00262964|10844787|FG002|STARTED|Overall Study||17
9743060|NCT00262964|10844788|FG003|STARTED|Overall Study||12
9743061|NCT00262964|10844785|FG000|COMPLETED|Overall Study||11
9743062|NCT00262964|10844786|FG001|COMPLETED|Overall Study||11
9743063|NCT00262964|10844787|FG002|COMPLETED|Overall Study||17
9743064|NCT00262964|10844788|FG003|COMPLETED|Overall Study||12
9743065|NCT00262964|10844785|FG000|NOT COMPLETED|Overall Study||0
9743066|NCT00262964|10844786|FG001|NOT COMPLETED|Overall Study||0
9743067|NCT00262964|10844787|FG002|NOT COMPLETED|Overall Study||0
9743068|NCT00262964|10844788|FG003|NOT COMPLETED|Overall Study||0
9743069|NCT00263211|10844812|FG000|STARTED|Overall Study||24
9743070|NCT00263211|10844813|FG001|STARTED|Overall Study||24
9743071|NCT00263211|10844812|FG000|COMPLETED|Overall Study||19
9743072|NCT00263211|10844813|FG001|COMPLETED|Overall Study||23
9743073|NCT00263211|10844812|FG000|NOT COMPLETED|Overall Study||5
9743074|NCT00263211|10844813|FG001|NOT COMPLETED|Overall Study||1
9743075|NCT00263328|10844825|FG000|STARTED|Overall Study||18
9743076|NCT00263328|10844826|FG001|STARTED|Overall Study||14
9743077|NCT00263328|10844827|FG002|STARTED|Overall Study||13
9743078|NCT00263328|10844825|FG000|COMPLETED|Overall Study||10
9743079|NCT00263328|10844826|FG001|COMPLETED|Overall Study||12
9743080|NCT00263328|10844827|FG002|COMPLETED|Overall Study||6
9743081|NCT00263328|10844825|FG000|NOT COMPLETED|Overall Study||8
9743082|NCT00263328|10844826|FG001|NOT COMPLETED|Overall Study||2
9743083|NCT00263328|10844827|FG002|NOT COMPLETED|Overall Study||7
9743084|NCT00263562|10844839|FG000|STARTED|Overall Study||9
9743085|NCT00263562|10844840|FG001|STARTED|Overall Study||9
9743086|NCT00263562|10844839|FG000|COMPLETED|Overall Study||6
9743087|NCT00263562|10844840|FG001|COMPLETED|Overall Study||9
9743088|NCT00263562|10844839|FG000|NOT COMPLETED|Overall Study||3
9743089|NCT00263562|10844840|FG001|NOT COMPLETED|Overall Study||0
9743090|NCT00263575|10844848|FG000|STARTED|Titration Period||139
9743091|NCT00263575|10844848|FG000|COMPLETED|Titration Period||96
9743092|NCT00263575|10844848|FG000|NOT COMPLETED|Titration Period||43
9743093|NCT00263575|10844848|FG000|STARTED|Maintence Period||96
9743094|NCT00263575|10844848|FG000|COMPLETED|Maintence Period||19
9743095|NCT00263575|10844848|FG000|NOT COMPLETED|Maintence Period||77
9743096|NCT00263588|10844856|FG000|STARTED|Overall Study||95
9743097|NCT00263588|10844857|FG001|STARTED|Overall Study||147
9743098|NCT00263588|10844856|FG000|COMPLETED|Overall Study||14
9743099|NCT00263588|10844857|FG001|COMPLETED|Overall Study||15
9743100|NCT00263588|10844856|FG000|NOT COMPLETED|Overall Study||81
9743101|NCT00263588|10844857|FG001|NOT COMPLETED|Overall Study||132
9743102|NCT00263666|10844866|FG000|STARTED|Overall Study||50
9743103|NCT00263666|10844867|FG001|STARTED|Overall Study||50
9743104|NCT00263666|10844866|FG000|COMPLETED|Overall Study||43
9743105|NCT00263666|10844867|FG001|COMPLETED|Overall Study||39
9743106|NCT00263666|10844866|FG000|NOT COMPLETED|Overall Study||7
9743107|NCT00263666|10844867|FG001|NOT COMPLETED|Overall Study||11
9743108|NCT00263757|10844875|FG000|STARTED|Overall Study||12
9743109|NCT00263757|10844876|FG001|STARTED|Overall Study||13
9743110|NCT00263757|10844875|FG000|COMPLETED|Overall Study||4
9743111|NCT00263757|10844876|FG001|COMPLETED|Overall Study||5
9743112|NCT00263757|10844875|FG000|NOT COMPLETED|Overall Study||8
9743113|NCT00263757|10844876|FG001|NOT COMPLETED|Overall Study||8
9743114|NCT00263887|10844884|FG000|STARTED|Overall Study||38
9743115|NCT00263887|10844885|FG001|STARTED|Overall Study||39
9743116|NCT00263887|10844884|FG000|COMPLETED|Overall Study||35
9743117|NCT00263887|10844885|FG001|COMPLETED|Overall Study||32
9743118|NCT00263887|10844884|FG000|NOT COMPLETED|Overall Study||3
9743119|NCT00263887|10844885|FG001|NOT COMPLETED|Overall Study||7
9743120|NCT00264004|10844895|FG000|STARTED|Overall Study|Randomised|30
9743121|NCT00264004|10844896|FG001|STARTED|Overall Study|Randomised|32
9743122|NCT00264004|10844897|FG002|STARTED|Overall Study|Randomised|30
9743123|NCT00264004|10844898|FG003|STARTED|Overall Study|Randomised|34
9743124|NCT00264004|10844895|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13
9743125|NCT00264004|10844896|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21
9743126|NCT00264004|10844897|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16
9743127|NCT00264004|10844898|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19
9743128|NCT00264004|10844895|FG000|NOT COMPLETED|Overall Study||17
9743129|NCT00264004|10844896|FG001|NOT COMPLETED|Overall Study||11
9743130|NCT00264004|10844897|FG002|NOT COMPLETED|Overall Study||14
9743131|NCT00264004|10844898|FG003|NOT COMPLETED|Overall Study||15
9743132|NCT00264238|10844908|FG000|STARTED|Overall Study||15
9743133|NCT00264238|10844908|FG000|COMPLETED|Overall Study||14
9743134|NCT00264238|10844908|FG000|NOT COMPLETED|Overall Study||1
9743135|NCT00264290|10844916|FG000|STARTED|Intervention (8 Weeks)||16
9743136|NCT00264290|10844917|FG001|STARTED|Intervention (8 Weeks)||14
9743137|NCT00264290|10844916|FG000|COMPLETED|Intervention (8 Weeks)||15
9743138|NCT00264290|10844917|FG001|COMPLETED|Intervention (8 Weeks)||14
9743139|NCT00264290|10844916|FG000|NOT COMPLETED|Intervention (8 Weeks)||1
9743140|NCT00264290|10844917|FG001|NOT COMPLETED|Intervention (8 Weeks)||0
9743141|NCT00264290|10844916|FG000|STARTED|Observation (4 Weeks)||15
9743142|NCT00264290|10844917|FG001|STARTED|Observation (4 Weeks)||14
9743143|NCT00264290|10844916|FG000|COMPLETED|Observation (4 Weeks)||15
9743144|NCT00264290|10844917|FG001|COMPLETED|Observation (4 Weeks)||14
9743145|NCT00264290|10844916|FG000|NOT COMPLETED|Observation (4 Weeks)||0
9743146|NCT00264290|10844917|FG001|NOT COMPLETED|Observation (4 Weeks)||0
9743147|NCT00264303|10844929|FG000|STARTED|Overall Study||438
9743148|NCT00264303|10844930|FG001|STARTED|Overall Study||448
9743149|NCT00264303|10844929|FG000|COMPLETED|Overall Study||413
9743150|NCT00264303|10844930|FG001|COMPLETED|Overall Study||419
9743151|NCT00264303|10844929|FG000|NOT COMPLETED|Overall Study||25
9743152|NCT00264303|10844930|FG001|NOT COMPLETED|Overall Study||29
9743153|NCT00264381|10844938|FG000|STARTED|Overall Study||35
9743154|NCT00264381|10844939|FG001|STARTED|Overall Study||37
9743155|NCT00264381|10844938|FG000|COMPLETED|Overall Study||35
9743156|NCT00264381|10844939|FG001|COMPLETED|Overall Study||37
9743157|NCT00264381|10844938|FG000|NOT COMPLETED|Overall Study||0
9743158|NCT00264381|10844939|FG001|NOT COMPLETED|Overall Study||0
9743159|NCT00264498|10844947|FG000|STARTED|Randomized Treatment||17
9743160|NCT00264498|10844948|FG001|STARTED|Randomized Treatment||18
9743161|NCT00264498|10844947|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
9743162|NCT00264498|10844948|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
9743163|NCT00264498|10844947|FG000|NOT COMPLETED|Randomized Treatment||17
9743164|NCT00264498|10844948|FG001|NOT COMPLETED|Randomized Treatment||18
9743165|NCT00264498|10844947|FG000|STARTED|Crossover Treatment||6
9743166|NCT00264498|10844948|FG001|STARTED|Crossover Treatment||9
9743167|NCT00264498|10844947|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
9743168|NCT00264498|10844948|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
9743169|NCT00264498|10844947|FG000|NOT COMPLETED|Crossover Treatment||6
9743170|NCT00264498|10844948|FG001|NOT COMPLETED|Crossover Treatment||9
9743171|NCT00264537|10844958|FG000|STARTED|Overall Study||160
9743172|NCT00264537|10844959|FG001|STARTED|Overall Study||159
9743173|NCT00264537|10844960|FG002|STARTED|Overall Study||159
9743174|NCT00264537|10844961|FG003|STARTED|Overall Study||159
9743175|NCT00264537|10844958|FG000|COMPLETED|Overall Study||110
9743176|NCT00264537|10844959|FG001|COMPLETED|Overall Study||101
9743177|NCT00264537|10844960|FG002|COMPLETED|Overall Study||109
9743178|NCT00264537|10844961|FG003|COMPLETED|Overall Study||99
9743179|NCT00264537|10844958|FG000|NOT COMPLETED|Overall Study||50
9743180|NCT00264537|10844959|FG001|NOT COMPLETED|Overall Study||58
9743181|NCT00264537|10844960|FG002|NOT COMPLETED|Overall Study||50
9743182|NCT00264537|10844961|FG003|NOT COMPLETED|Overall Study||60
9743183|NCT00264550|10844977|FG000|STARTED|Overall Study||133
9743184|NCT00264550|10844978|FG001|STARTED|Overall Study||133
9743185|NCT00264550|10844979|FG002|STARTED|Overall Study||89
9743186|NCT00264550|10844980|FG003|STARTED|Overall Study||89
9743187|NCT00264550|10844977|FG000|COMPLETED|Overall Study||90
9743188|NCT00264550|10844978|FG001|COMPLETED|Overall Study||92
9743189|NCT00264550|10844979|FG002|COMPLETED|Overall Study||72
9743190|NCT00264550|10844980|FG003|COMPLETED|Overall Study||59
9743191|NCT00264550|10844977|FG000|NOT COMPLETED|Overall Study||43
9743192|NCT00264550|10844978|FG001|NOT COMPLETED|Overall Study||41
9743193|NCT00264550|10844979|FG002|NOT COMPLETED|Overall Study||17
9743194|NCT00264550|10844980|FG003|NOT COMPLETED|Overall Study||30
9743195|NCT00264576|10844992|FG000|STARTED|Overall Study||308
9743196|NCT00264576|10844993|FG001|STARTED|Overall Study||305
9743197|NCT00264576|10844992|FG000|COMPLETED|Overall Study||307
9743198|NCT00264576|10844993|FG001|COMPLETED|Overall Study||304
9743199|NCT00264576|10844992|FG000|NOT COMPLETED|Overall Study||1
9743200|NCT00264576|10844993|FG001|NOT COMPLETED|Overall Study||1
9743201|NCT00264641|10845002|FG000|STARTED|Overall Study||10
9743202|NCT00264641|10845003|FG001|STARTED|Overall Study||10
9743203|NCT00264641|10845002|FG000|Initiation of the Study|Overall Study||10
9743204|NCT00264641|10845003|FG001|Initiation of the Study|Overall Study||10
9743205|NCT00264641|10845002|FG000|COMPLETED|Overall Study||10
9743206|NCT00264641|10845003|FG001|COMPLETED|Overall Study||10
9743207|NCT00264641|10845002|FG000|NOT COMPLETED|Overall Study||0
9743208|NCT00264641|10845003|FG001|NOT COMPLETED|Overall Study||0
9743209|NCT00264797|10845010|FG000|STARTED|Overall Study||151
9743210|NCT00264797|10845011|FG001|STARTED|Overall Study||152
9743211|NCT00264797|10845010|FG000|COMPLETED|Overall Study||118
9852597|NCT00882661|10965495|FG001|NOT COMPLETED|Investigational Training||0
9852598|NCT00882661|10965494|FG000|STARTED|Treatment||151
9852599|NCT00882661|10965495|FG001|STARTED|Treatment||140
9852600|NCT00882661|10965494|FG000|COMPLETED|Treatment||141
9852601|NCT00882661|10965495|FG001|COMPLETED|Treatment||114
9852602|NCT00882661|10965494|FG000|NOT COMPLETED|Treatment||10
9852603|NCT00882661|10965495|FG001|NOT COMPLETED|Treatment||26
9852604|NCT00882687|10965507|FG000|STARTED|Overall Study||15
9852605|NCT00882687|10965508|FG001|STARTED|Overall Study||15
9852606|NCT00882687|10965509|FG002|STARTED|Overall Study||15
9852607|NCT00882687|10965510|FG003|STARTED|Overall Study||15
9852608|NCT00882687|10965507|FG000|COMPLETED|Overall Study||13
9852609|NCT00882687|10965508|FG001|COMPLETED|Overall Study||13
9852610|NCT00882687|10965509|FG002|COMPLETED|Overall Study||12
9852611|NCT00882687|10965510|FG003|COMPLETED|Overall Study||13
9852612|NCT00882687|10965507|FG000|NOT COMPLETED|Overall Study||2
9852613|NCT00882687|10965508|FG001|NOT COMPLETED|Overall Study||2
9852614|NCT00882687|10965509|FG002|NOT COMPLETED|Overall Study||3
9852615|NCT00882687|10965510|FG003|NOT COMPLETED|Overall Study||2
9852616|NCT00882713|10965520|FG000|STARTED|Overall Study||194
10091750|NCT02331680|11220031|FG002|COMPLETED|Overall Study||29
10091751|NCT02331680|11220029|FG000|NOT COMPLETED|Overall Study||6
10091752|NCT02331680|11220030|FG001|NOT COMPLETED|Overall Study||4
10091753|NCT02331680|11220031|FG002|NOT COMPLETED|Overall Study||15
10091754|NCT02331940|11220041|FG000|STARTED|Overall Study||100
10091755|NCT02331940|11220042|FG001|STARTED|Overall Study||100
10091756|NCT02331940|11220041|FG000|COMPLETED|Overall Study||93
10091757|NCT02331940|11220042|FG001|COMPLETED|Overall Study||95
10091758|NCT02331940|11220041|FG000|NOT COMPLETED|Overall Study||7
10091759|NCT02331940|11220042|FG001|NOT COMPLETED|Overall Study||5
10091760|NCT02331992|11220048|FG000|STARTED|Overall Study||34
9743212|NCT00264797|10845011|FG001|COMPLETED|Overall Study||109
9743213|NCT00264797|10845010|FG000|NOT COMPLETED|Overall Study||33
9743214|NCT00264797|10845011|FG001|NOT COMPLETED|Overall Study||43
9743215|NCT00264810|10845019|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
9743216|NCT00264810|10845020|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
9743217|NCT00264810|10845019|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
9743218|NCT00264810|10845020|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
9743219|NCT00264810|10845019|FG000|NOT COMPLETED|Baseline||23
9852617|NCT00882713|10965520|FG000|COMPLETED|Overall Study||172
9852618|NCT00882713|10965520|FG000|NOT COMPLETED|Overall Study||22
9743220|NCT00264810|10845020|FG001|NOT COMPLETED|Baseline||26
9743221|NCT00264810|10845019|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
9743222|NCT00264810|10845020|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
9743223|NCT00264810|10845019|FG000|COMPLETED|Post-Operative Stabilization Period||97
9743224|NCT00264810|10845020|FG001|COMPLETED|Post-Operative Stabilization Period||94
9743225|NCT00264810|10845019|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0
9743226|NCT00264810|10845020|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0
9743227|NCT00264810|10845019|FG000|STARTED|Stimulation Optimization Period||97
9743228|NCT00264810|10845020|FG001|STARTED|Stimulation Optimization Period||94
9743229|NCT00264810|10845019|FG000|COMPLETED|Stimulation Optimization Period||96
9743230|NCT00264810|10845020|FG001|COMPLETED|Stimulation Optimization Period||93
9743231|NCT00264810|10845019|FG000|NOT COMPLETED|Stimulation Optimization Period||1
9743232|NCT00264810|10845020|FG001|NOT COMPLETED|Stimulation Optimization Period||1
9743233|NCT00264810|10845019|FG000|STARTED|Blinded Evaluation Period||96
9743234|NCT00264810|10845020|FG001|STARTED|Blinded Evaluation Period||93
9743235|NCT00264810|10845019|FG000|COMPLETED|Blinded Evaluation Period||95
9743236|NCT00264810|10845020|FG001|COMPLETED|Blinded Evaluation Period||92
9743237|NCT00264810|10845019|FG000|NOT COMPLETED|Blinded Evaluation Period||1
9743238|NCT00264810|10845020|FG001|NOT COMPLETED|Blinded Evaluation Period||1
9743239|NCT00264810|10845019|FG000|STARTED|Open Label Evaluation Period||95
9743240|NCT00264810|10845020|FG001|STARTED|Open Label Evaluation Period||92
9743241|NCT00264810|10845019|FG000|1-year Post-implant|Open Label Evaluation Period||92
9743242|NCT00264810|10845020|FG001|1-year Post-implant|Open Label Evaluation Period||90
9743243|NCT00264810|10845019|FG000|COMPLETED|Open Label Evaluation Period||89
9743244|NCT00264810|10845020|FG001|COMPLETED|Open Label Evaluation Period||86
9743245|NCT00264810|10845019|FG000|NOT COMPLETED|Open Label Evaluation Period||6
9743246|NCT00264810|10845020|FG001|NOT COMPLETED|Open Label Evaluation Period||6
9743247|NCT00264849|10845030|FG000|STARTED|Overall Study||275
9743248|NCT00264849|10845031|FG001|STARTED|Overall Study||131
9743249|NCT00264849|10845030|FG000|COMPLETED|Overall Study||253
9743250|NCT00264849|10845031|FG001|COMPLETED|Overall Study||106
9743251|NCT00264849|10845030|FG000|NOT COMPLETED|Overall Study||22
9743252|NCT00264849|10845031|FG001|NOT COMPLETED|Overall Study||25
9743253|NCT00264875|10845037|FG000|STARTED|Overall Study||220
9743254|NCT00264875|10845037|FG000|COMPLETED|Overall Study||190
9743255|NCT00264875|10845037|FG000|NOT COMPLETED|Overall Study||30
9743256|NCT00265083|10845044|FG000|STARTED|Overall Study||78
9743257|NCT00265083|10845045|FG001|STARTED|Overall Study|One patient did not receive study agent.|138
9743258|NCT00265083|10845046|FG002|STARTED|Overall Study||140
9743259|NCT00265083|10845044|FG000|COMPLETED|Overall Study||61
9743260|NCT00265083|10845045|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96
9743261|NCT00265083|10845046|FG002|COMPLETED|Overall Study||98
9743262|NCT00265083|10845044|FG000|NOT COMPLETED|Overall Study||17
9743263|NCT00265083|10845045|FG001|NOT COMPLETED|Overall Study||42
9743264|NCT00265083|10845046|FG002|NOT COMPLETED|Overall Study||42
9743265|NCT00265096|10845058|FG000|STARTED|Overall Study||113
9743266|NCT00265096|10845059|FG001|STARTED|Overall Study||146
9743267|NCT00265096|10845060|FG002|STARTED|Overall Study||146
9743268|NCT00265096|10845058|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
9743269|NCT00265096|10845059|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
9743270|NCT00265096|10845060|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
9743271|NCT00265096|10845058|FG000|NOT COMPLETED|Overall Study||36
9743272|NCT00265096|10845059|FG001|NOT COMPLETED|Overall Study||51
9743273|NCT00265096|10845060|FG002|NOT COMPLETED|Overall Study||39
9743274|NCT00265109|10845070|FG000|STARTED|Overall Study||17
9743275|NCT00265109|10845070|FG000|COMPLETED|Overall Study||11
9743276|NCT00265109|10845070|FG000|NOT COMPLETED|Overall Study||6
9743277|NCT00265122|10845081|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
9743278|NCT00265122|10845082|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
9743279|NCT00265122|10845083|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
9743280|NCT00265122|10845084|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
9743281|NCT00265122|10845085|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
9743282|NCT00265122|10845086|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
9743283|NCT00265122|10845081|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
9743284|NCT00265122|10845082|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
9743285|NCT00265122|10845083|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
9743286|NCT00265122|10845084|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
9743287|NCT00265122|10845085|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
9743288|NCT00265122|10845086|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
9743289|NCT00265122|10845081|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
9743290|NCT00265122|10845082|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
9743291|NCT00265122|10845083|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
9743292|NCT00265122|10845084|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
9743293|NCT00265122|10845085|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
9743294|NCT00265122|10845086|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
9743295|NCT00265122|10845081|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
9743296|NCT00265122|10845082|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
9743297|NCT00265122|10845083|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
9743298|NCT00265122|10845084|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
9743299|NCT00265122|10845085|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
9743300|NCT00265122|10845086|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
9743301|NCT00265122|10845081|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
9743302|NCT00265122|10845082|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
9743303|NCT00265122|10845083|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
9743304|NCT00265122|10845084|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
9743305|NCT00265122|10845085|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
9743306|NCT00265122|10845086|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
9743307|NCT00265122|10845081|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
9743308|NCT00265122|10845082|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
9743309|NCT00265122|10845083|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
9743310|NCT00265122|10845084|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
9743311|NCT00265122|10845085|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
9743312|NCT00265122|10845086|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
9743313|NCT00265148|10845107|FG000|STARTED|Overall Study||40
9743314|NCT00265148|10845108|FG001|STARTED|Overall Study||40
9743315|NCT00265148|10845107|FG000|COMPLETED|Overall Study||31
9743316|NCT00265148|10845108|FG001|COMPLETED|Overall Study||31
9743317|NCT00265148|10845107|FG000|NOT COMPLETED|Overall Study||9
9743318|NCT00265148|10845108|FG001|NOT COMPLETED|Overall Study||9
9743319|NCT00265200|10845115|FG000|STARTED|Overall Study||28
9743320|NCT00265200|10845115|FG000|COMPLETED|Overall Study||24
9743321|NCT00265200|10845115|FG000|NOT COMPLETED|Overall Study||4
9743322|NCT00265239|10845121|FG000|STARTED|Overall Study||52
9743323|NCT00265239|10845122|FG001|STARTED|Overall Study||52
9743324|NCT00265239|10845121|FG000|COMPLETED|Overall Study||50
9743325|NCT00265239|10845122|FG001|COMPLETED|Overall Study||51
9743326|NCT00265239|10845121|FG000|NOT COMPLETED|Overall Study||2
9743327|NCT00265239|10845122|FG001|NOT COMPLETED|Overall Study||1
9743328|NCT00265317|10845132|FG000|STARTED|Lead-In||13
9743329|NCT00265317|10845133|FG001|STARTED|Lead-In||17
9743330|NCT00265317|10845134|FG002|STARTED|Lead-In||0
9743331|NCT00265317|10845135|FG003|STARTED|Lead-In||0
9743332|NCT00265317|10845132|FG000|COMPLETED|Lead-In||1
9743333|NCT00265317|10845133|FG001|COMPLETED|Lead-In||0
9743334|NCT00265317|10845134|FG002|COMPLETED|Lead-In||0
9743335|NCT00265317|10845135|FG003|COMPLETED|Lead-In||0
9743336|NCT00265317|10845132|FG000|NOT COMPLETED|Lead-In||12
9743337|NCT00265317|10845133|FG001|NOT COMPLETED|Lead-In||17
9743338|NCT00265317|10845134|FG002|NOT COMPLETED|Lead-In||0
9743339|NCT00265317|10845135|FG003|NOT COMPLETED|Lead-In||0
10091761|NCT02331992|11220048|FG000|COMPLETED|Overall Study||34
10091762|NCT02331992|11220048|FG000|NOT COMPLETED|Overall Study||0
10091763|NCT02332239|11220054|FG000|STARTED|Overall Study||58
10091764|NCT02332239|11220055|FG001|STARTED|Overall Study||58
10091765|NCT02332239|11220054|FG000|COMPLETED|Overall Study||54
10091766|NCT02332239|11220055|FG001|COMPLETED|Overall Study||52
10091767|NCT02332239|11220054|FG000|NOT COMPLETED|Overall Study||4
10091768|NCT02332239|11220055|FG001|NOT COMPLETED|Overall Study||6
9743340|NCT00265317|10845132|FG000|STARTED|Phase 2||0
9743341|NCT00265317|10845133|FG001|STARTED|Phase 2||0
9743342|NCT00265317|10845134|FG002|STARTED|Phase 2||65
9743343|NCT00265317|10845135|FG003|STARTED|Phase 2||67
9743344|NCT00265317|10845132|FG000|COMPLETED|Phase 2||0
9743345|NCT00265317|10845133|FG001|COMPLETED|Phase 2||0
9743346|NCT00265317|10845134|FG002|COMPLETED|Phase 2||1
9743347|NCT00265317|10845135|FG003|COMPLETED|Phase 2||2
9743348|NCT00265317|10845132|FG000|NOT COMPLETED|Phase 2||0
9743349|NCT00265317|10845133|FG001|NOT COMPLETED|Phase 2||0
9743350|NCT00265317|10845134|FG002|NOT COMPLETED|Phase 2||64
9743351|NCT00265317|10845135|FG003|NOT COMPLETED|Phase 2||65
9743352|NCT00265330|10845154|FG000|STARTED|Overall Study||162
9743353|NCT00265330|10845154|FG000|COMPLETED|Overall Study||67
9743354|NCT00265330|10845154|FG000|NOT COMPLETED|Overall Study||95
9743355|NCT00265382|10845158|FG000|STARTED|Overall Study||221
9743356|NCT00265382|10845158|FG000|COMPLETED|Overall Study||76
9743357|NCT00265382|10845158|FG000|NOT COMPLETED|Overall Study||145
9743358|NCT00265395|10845164|FG000|STARTED|Overall Study||86
9743359|NCT00265395|10845165|FG001|STARTED|Overall Study||73
9743360|NCT00265395|10845164|FG000|COMPLETED|Overall Study||78
9743361|NCT00265395|10845165|FG001|COMPLETED|Overall Study||56
9743362|NCT00265395|10845164|FG000|NOT COMPLETED|Overall Study||8
9743363|NCT00265395|10845165|FG001|NOT COMPLETED|Overall Study||17
9743364|NCT00265473|10845170|FG000|STARTED|Overall Study||5
9743365|NCT00265473|10845170|FG000|COMPLETED|Overall Study||5
9743366|NCT00265473|10845170|FG000|NOT COMPLETED|Overall Study||0
9743367|NCT00265512|10845177|FG000|STARTED|Overall Study||213
9743368|NCT00265512|10845178|FG001|STARTED|Overall Study||454
9743369|NCT00265512|10845177|FG000|COMPLETED|Overall Study||168
10091769|NCT02332291|11220065|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63
10091770|NCT02332291|11220066|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32
10091771|NCT02332291|11220065|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59
9743370|NCT00265512|10845178|FG001|COMPLETED|Overall Study||359
9743371|NCT00265512|10845177|FG000|NOT COMPLETED|Overall Study||45
9743372|NCT00265512|10845178|FG001|NOT COMPLETED|Overall Study||95
9743373|NCT00265538|10845186|FG000|STARTED|Overall Study||196
9743374|NCT00265538|10845187|FG001|STARTED|Overall Study||170
9743375|NCT00265538|10845188|FG002|STARTED|Overall Study||182
9743376|NCT00265538|10845189|FG003|STARTED|Overall Study||286
9743377|NCT00265538|10845186|FG000|COMPLETED|Overall Study||186
9743378|NCT00265538|10845187|FG001|COMPLETED|Overall Study||161
9743379|NCT00265538|10845188|FG002|COMPLETED|Overall Study||171
9743380|NCT00265538|10845189|FG003|COMPLETED|Overall Study||267
9743381|NCT00265538|10845186|FG000|NOT COMPLETED|Overall Study||10
9743382|NCT00265538|10845187|FG001|NOT COMPLETED|Overall Study||9
9743383|NCT00265538|10845188|FG002|NOT COMPLETED|Overall Study||11
9743384|NCT00265538|10845189|FG003|NOT COMPLETED|Overall Study||19
9743385|NCT00265564|10845203|FG000|STARTED|Overall Study||59
9743386|NCT00265564|10845204|FG001|STARTED|Overall Study||58
9743387|NCT00265564|10845203|FG000|COMPLETED|Overall Study||49
9743388|NCT00265564|10845204|FG001|COMPLETED|Overall Study||49
9743389|NCT00265564|10845203|FG000|NOT COMPLETED|Overall Study||10
9743390|NCT00265564|10845204|FG001|NOT COMPLETED|Overall Study||9
9743391|NCT00265616|10845212|FG000|STARTED|Overall Study||14
9743392|NCT00265616|10845213|FG001|STARTED|Overall Study||9
9743393|NCT00265616|10845212|FG000|COMPLETED|Overall Study||14
9743394|NCT00265616|10845213|FG001|COMPLETED|Overall Study||9
9743395|NCT00265616|10845212|FG000|NOT COMPLETED|Overall Study||0
9743396|NCT00265616|10845213|FG001|NOT COMPLETED|Overall Study||0
9743397|NCT00265759|10845225|FG000|STARTED|Overall Study||124
9743398|NCT00265759|10845226|FG001|STARTED|Overall Study||128
9743399|NCT00265759|10845227|FG002|STARTED|Overall Study||125
9743400|NCT00265759|10845228|FG003|STARTED|Overall Study||245
9743401|NCT00265759|10845225|FG000|COMPLETED|Overall Study||124
9743402|NCT00265759|10845226|FG001|COMPLETED|Overall Study||127
9743403|NCT00265759|10845227|FG002|COMPLETED|Overall Study||123
9743404|NCT00265759|10845228|FG003|COMPLETED|Overall Study||236
9743405|NCT00265759|10845225|FG000|NOT COMPLETED|Overall Study||0
9743406|NCT00265759|10845226|FG001|NOT COMPLETED|Overall Study||1
9743407|NCT00265759|10845227|FG002|NOT COMPLETED|Overall Study||2
9743408|NCT00265759|10845228|FG003|NOT COMPLETED|Overall Study||9
9743409|NCT00265785|10845239|FG000|STARTED|Overall Study||27
9743410|NCT00265785|10845239|FG000|Eligible|Overall Study||26
9743411|NCT00265785|10845239|FG000|Eligible and Began Protocol Treatment|Overall Study||24
9743412|NCT00265785|10845239|FG000|COMPLETED|Overall Study||0
9743413|NCT00265785|10845239|FG000|NOT COMPLETED|Overall Study||27
9743414|NCT00265850|10845246|FG000|STARTED|Overall Study||899
9743415|NCT00265850|10845247|FG001|STARTED|Overall Study||902
9743416|NCT00265850|10845248|FG002|STARTED|Overall Study||533
9743417|NCT00265850|10845246|FG000|COMPLETED|Overall Study||899
9743418|NCT00265850|10845247|FG001|COMPLETED|Overall Study||902
9743419|NCT00265850|10845248|FG002|COMPLETED|Overall Study||533
9743420|NCT00265850|10845246|FG000|NOT COMPLETED|Overall Study||0
9743421|NCT00265850|10845247|FG001|NOT COMPLETED|Overall Study||0
9743422|NCT00265850|10845248|FG002|NOT COMPLETED|Overall Study||0
9743423|NCT00265889|10845255|FG000|STARTED|Overall Study||42
9743424|NCT00265889|10845255|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37
9743425|NCT00265889|10845255|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
9743426|NCT00265889|10845255|FG000|COMPLETED|Overall Study||37
9743427|NCT00265889|10845255|FG000|NOT COMPLETED|Overall Study||5
9743428|NCT00265980|10845259|FG000|STARTED|Overall Study||22
9743429|NCT00265980|10845259|FG000|Weight Initial|Overall Study||22
9743430|NCT00265980|10845259|FG000|Weight -10% Placebo|Overall Study||22
9743431|NCT00265980|10845259|FG000|Weight -10% Leptin|Overall Study||22
9743432|NCT00265980|10845259|FG000|COMPLETED|Overall Study||22
9743433|NCT00265980|10845259|FG000|NOT COMPLETED|Overall Study||0
9743434|NCT00266032|10845266|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
9743435|NCT00266032|10845267|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
9743436|NCT00266032|10845268|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
9743437|NCT00266032|10845266|FG000|Patients Treated|Treatment||684
9743438|NCT00266032|10845267|FG001|Patients Treated|Treatment||221
9743439|NCT00266032|10845268|FG002|Patients Treated|Treatment||229
9743440|NCT00266032|10845266|FG000|Patients Treated and in FAS|Treatment|FAS|642
9743441|NCT00266032|10845267|FG001|Patients Treated and in FAS|Treatment|FAS|209
9743442|NCT00266032|10845268|FG002|Patients Treated and in FAS|Treatment|FAS|216
9743443|NCT00266032|10845266|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
9743444|NCT00266032|10845267|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
9743445|NCT00266032|10845268|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
9743446|NCT00266032|10845266|FG000|NOT COMPLETED|Treatment||111
9743447|NCT00266032|10845267|FG001|NOT COMPLETED|Treatment||64
9743448|NCT00266032|10845268|FG002|NOT COMPLETED|Treatment||47
9743449|NCT00266032|10845266|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
9743450|NCT00266032|10845267|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
9743451|NCT00266032|10845268|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
9743452|NCT00266032|10845266|FG000|COMPLETED|Open-label Safety Extension||448
9743453|NCT00266032|10845267|FG001|COMPLETED|Open-label Safety Extension||115
9743454|NCT00266032|10845268|FG002|COMPLETED|Open-label Safety Extension||140
9743455|NCT00266032|10845266|FG000|NOT COMPLETED|Open-label Safety Extension||41
9743456|NCT00266032|10845267|FG001|NOT COMPLETED|Open-label Safety Extension||14
9743457|NCT00266032|10845268|FG002|NOT COMPLETED|Open-label Safety Extension||25
9743458|NCT00266110|10845276|FG000|STARTED|Overall Study||17
9743459|NCT00266110|10845276|FG000|COMPLETED|Overall Study||10
9743460|NCT00266110|10845276|FG000|NOT COMPLETED|Overall Study||7
9743461|NCT00266227|10845283|FG000|STARTED|Initial Treatment||0
9743462|NCT00266227|10845284|FG001|STARTED|Initial Treatment||0
9743463|NCT00266227|10845285|FG002|STARTED|Initial Treatment||559
9743464|NCT00266227|10845283|FG000|COMPLETED|Initial Treatment||0
9743465|NCT00266227|10845284|FG001|COMPLETED|Initial Treatment||0
10091772|NCT02332291|11220066|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23
9743466|NCT00266227|10845285|FG002|COMPLETED|Initial Treatment||482
9743467|NCT00266227|10845283|FG000|NOT COMPLETED|Initial Treatment||0
9743468|NCT00266227|10845284|FG001|NOT COMPLETED|Initial Treatment||0
9743469|NCT00266227|10845285|FG002|NOT COMPLETED|Initial Treatment||77
9743470|NCT00266227|10845283|FG000|STARTED|Retreatment: Up to Week 48||318
9743471|NCT00266227|10845284|FG001|STARTED|Retreatment: Up to Week 48||157
9743472|NCT00266227|10845285|FG002|STARTED|Retreatment: Up to Week 48||0
9743473|NCT00266227|10845283|FG000|COMPLETED|Retreatment: Up to Week 48||291
9743474|NCT00266227|10845284|FG001|COMPLETED|Retreatment: Up to Week 48||134
9743475|NCT00266227|10845285|FG002|COMPLETED|Retreatment: Up to Week 48||0
9743476|NCT00266227|10845283|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27
9743477|NCT00266227|10845284|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23
9743478|NCT00266227|10845285|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0
9743479|NCT00266227|10845283|FG000|STARTED|Retreatment: Week 48 to Week 72||291
9743480|NCT00266227|10845284|FG001|STARTED|Retreatment: Week 48 to Week 72||134
9743481|NCT00266227|10845285|FG002|STARTED|Retreatment: Week 48 to Week 72||0
9743482|NCT00266227|10845283|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227
9743483|NCT00266227|10845284|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92
9743484|NCT00266227|10845285|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0
9743485|NCT00266227|10845283|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
9743486|NCT00266227|10845284|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
9743487|NCT00266227|10845285|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
9743488|NCT00266279|10845294|FG000|STARTED|Overall Study||17
9743489|NCT00266279|10845294|FG000|COMPLETED|Overall Study||15
9743490|NCT00266279|10845294|FG000|NOT COMPLETED|Overall Study||2
9743491|NCT00266409|10845303|FG000|STARTED|Overall Study||137
9743492|NCT00266409|10845304|FG001|STARTED|Overall Study||138
9743493|NCT00266409|10845305|FG002|STARTED|Overall Study||72
9743494|NCT00266409|10845306|FG003|STARTED|Overall Study||71
9743495|NCT00266409|10845303|FG000|COMPLETED|Overall Study||92
9743496|NCT00266409|10845304|FG001|COMPLETED|Overall Study||92
10091773|NCT02332291|11220065|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4
10091774|NCT02332291|11220066|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9
10091775|NCT02332291|11220065|FG000|STARTED|Phase 2: Open-Label Bupropion||22
9743497|NCT00266409|10845305|FG002|COMPLETED|Overall Study||55
9743498|NCT00266409|10845306|FG003|COMPLETED|Overall Study||49
9743499|NCT00266409|10845303|FG000|NOT COMPLETED|Overall Study||45
9743500|NCT00266409|10845304|FG001|NOT COMPLETED|Overall Study||46
9743501|NCT00266409|10845305|FG002|NOT COMPLETED|Overall Study||17
9743502|NCT00266409|10845306|FG003|NOT COMPLETED|Overall Study||22
9743503|NCT00266630|10845318|FG000|STARTED|Overall Study||100
9743504|NCT00266630|10845319|FG001|STARTED|Overall Study||39
9743505|NCT00266630|10845318|FG000|COMPLETED|Overall Study||58
9743506|NCT00266630|10845319|FG001|COMPLETED|Overall Study||11
9743507|NCT00266630|10845318|FG000|NOT COMPLETED|Overall Study||42
9743508|NCT00266630|10845319|FG001|NOT COMPLETED|Overall Study||28
9743509|NCT00266656|10845329|FG000|STARTED|Overall Study||36
9743510|NCT00266656|10845330|FG001|STARTED|Overall Study||33
9743511|NCT00266656|10845329|FG000|COMPLETED|Overall Study||22
9743512|NCT00266656|10845330|FG001|COMPLETED|Overall Study||20
9743513|NCT00266656|10845329|FG000|NOT COMPLETED|Overall Study||14
9743514|NCT00266656|10845330|FG001|NOT COMPLETED|Overall Study||13
9743515|NCT00266695|10845336|FG000|STARTED|Overall Study||203
9743516|NCT00266695|10845336|FG000|COMPLETED|Overall Study||174
9743517|NCT00266695|10845336|FG000|NOT COMPLETED|Overall Study||29
9743518|NCT00266708|10845342|FG000|STARTED|Overall Study||20
9743519|NCT00266708|10845343|FG001|STARTED|Overall Study||22
9743520|NCT00266708|10845342|FG000|COMPLETED|Overall Study||16
9743521|NCT00266708|10845343|FG001|COMPLETED|Overall Study||13
9743522|NCT00266708|10845342|FG000|NOT COMPLETED|Overall Study||4
9743523|NCT00266708|10845343|FG001|NOT COMPLETED|Overall Study||9
9743524|NCT00266799|10845351|FG000|STARTED|Overall Study||98
9743525|NCT00266799|10845352|FG001|STARTED|Overall Study||102
9743526|NCT00266799|10845351|FG000|COMPLETED|Overall Study||62
9743527|NCT00266799|10845352|FG001|COMPLETED|Overall Study||68
9743528|NCT00266799|10845351|FG000|NOT COMPLETED|Overall Study||36
9743529|NCT00266799|10845352|FG001|NOT COMPLETED|Overall Study||34
9743530|NCT00266812|10845360|FG000|STARTED|Overall Study||22
9743531|NCT00266812|10845361|FG001|STARTED|Overall Study||13
9743532|NCT00266812|10845360|FG000|COMPLETED|Overall Study||1
9743533|NCT00266812|10845361|FG001|COMPLETED|Overall Study||2
9743534|NCT00266812|10845360|FG000|NOT COMPLETED|Overall Study||21
9743535|NCT00266812|10845361|FG001|NOT COMPLETED|Overall Study||11
9743536|NCT00266825|10845369|FG000|STARTED|Enrolled and Allocated Intervention||172
9743537|NCT00266825|10845370|FG001|STARTED|Enrolled and Allocated Intervention||178
9743538|NCT00266825|10845369|FG000|COMPLETED|Enrolled and Allocated Intervention||172
10091776|NCT02332291|11220066|FG001|STARTED|Phase 2: Open-Label Bupropion||19
9743539|NCT00266825|10845370|FG001|COMPLETED|Enrolled and Allocated Intervention||178
9743540|NCT00266825|10845369|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0
9743541|NCT00266825|10845370|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0
9743542|NCT00266825|10845369|FG000|STARTED|Completed Follow-Up||172
9743543|NCT00266825|10845370|FG001|STARTED|Completed Follow-Up||178
9743544|NCT00266825|10845369|FG000|COMPLETED|Completed Follow-Up||147
9743545|NCT00266825|10845370|FG001|COMPLETED|Completed Follow-Up||154
9743546|NCT00266825|10845369|FG000|NOT COMPLETED|Completed Follow-Up||25
9743547|NCT00266825|10845370|FG001|NOT COMPLETED|Completed Follow-Up||24
9743548|NCT00266851|10845381|FG000|STARTED|Overall Study||37
9743549|NCT00266851|10845382|FG001|STARTED|Overall Study||38
9743550|NCT00266851|10845383|FG002|STARTED|Overall Study||22
9743551|NCT00266851|10845381|FG000|Completed 3 Month Follow up|Overall Study||26
9743552|NCT00266851|10845382|FG001|Completed 3 Month Follow up|Overall Study||22
9743553|NCT00266851|10845383|FG002|Completed 3 Month Follow up|Overall Study||15
9743554|NCT00266851|10845381|FG000|Completed 6 Month Follow up|Overall Study||27
9743555|NCT00266851|10845382|FG001|Completed 6 Month Follow up|Overall Study||22
9743556|NCT00266851|10845383|FG002|Completed 6 Month Follow up|Overall Study||17
9743557|NCT00266851|10845381|FG000|Completed 9 Month Follow up|Overall Study||22
9743558|NCT00266851|10845382|FG001|Completed 9 Month Follow up|Overall Study||23
9743559|NCT00266851|10845383|FG002|Completed 9 Month Follow up|Overall Study||15
9743560|NCT00266851|10845381|FG000|Completed 12 Month Follow up|Overall Study||25
9743561|NCT00266851|10845382|FG001|Completed 12 Month Follow up|Overall Study||19
9743562|NCT00266851|10845383|FG002|Completed 12 Month Follow up|Overall Study||13
9743563|NCT00266851|10845381|FG000|COMPLETED|Overall Study||37
9743564|NCT00266851|10845382|FG001|COMPLETED|Overall Study||38
9743565|NCT00266851|10845383|FG002|COMPLETED|Overall Study||22
9743566|NCT00266851|10845381|FG000|NOT COMPLETED|Overall Study||0
9743567|NCT00266851|10845382|FG001|NOT COMPLETED|Overall Study||0
9743568|NCT00266851|10845383|FG002|NOT COMPLETED|Overall Study||0
9743569|NCT00266864|10845397|FG000|STARTED|Overall Study||18
9743570|NCT00266864|10845398|FG001|STARTED|Overall Study||13
9743571|NCT00266864|10845397|FG000|COMPLETED|Overall Study||13
9743572|NCT00266864|10845398|FG001|COMPLETED|Overall Study||11
9743573|NCT00266864|10845397|FG000|NOT COMPLETED|Overall Study||5
9743574|NCT00266864|10845398|FG001|NOT COMPLETED|Overall Study||2
9743575|NCT00266877|10845407|FG000|STARTED|Overall Study||91
9743576|NCT00266877|10845408|FG001|STARTED|Overall Study||48
9743577|NCT00266877|10845409|FG002|STARTED|Overall Study||28
9743578|NCT00266877|10845407|FG000|COMPLETED|Overall Study||0
9743579|NCT00266877|10845408|FG001|COMPLETED|Overall Study||0
9743580|NCT00266877|10845409|FG002|COMPLETED|Overall Study||0
9743581|NCT00266877|10845407|FG000|NOT COMPLETED|Overall Study||91
9743582|NCT00266877|10845408|FG001|NOT COMPLETED|Overall Study||48
9743583|NCT00266877|10845409|FG002|NOT COMPLETED|Overall Study||28
9743584|NCT00267007|10845419|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
9743585|NCT00267007|10845420|FG001|STARTED|Overall Study||11
9743586|NCT00267007|10845419|FG000|COMPLETED|Overall Study||11
9743587|NCT00267007|10845420|FG001|COMPLETED|Overall Study||10
9743588|NCT00267007|10845419|FG000|NOT COMPLETED|Overall Study||8
9743589|NCT00267007|10845420|FG001|NOT COMPLETED|Overall Study||1
9743590|NCT00267020|10845428|FG000|STARTED|Overall Study||86
9743591|NCT00267020|10845429|FG001|STARTED|Overall Study||44
9743592|NCT00267020|10845428|FG000|Received at Least 1 Dose|Overall Study||82
9743593|NCT00267020|10845429|FG001|Received at Least 1 Dose|Overall Study||39
9743594|NCT00267020|10845428|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
9743595|NCT00267020|10845429|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
9743596|NCT00267020|10845428|FG000|COMPLETED|Overall Study||0
9743597|NCT00267020|10845429|FG001|COMPLETED|Overall Study||1
9743598|NCT00267020|10845428|FG000|NOT COMPLETED|Overall Study||86
9743599|NCT00267020|10845429|FG001|NOT COMPLETED|Overall Study||43
9743600|NCT00267046|10845437|FG000|STARTED|Overall Study||32
9743601|NCT00267046|10845438|FG001|STARTED|Overall Study||16
9743602|NCT00267046|10845437|FG000|COMPLETED|Overall Study||20
9743603|NCT00267046|10845438|FG001|COMPLETED|Overall Study||5
9743604|NCT00267046|10845437|FG000|NOT COMPLETED|Overall Study||12
9743605|NCT00267046|10845438|FG001|NOT COMPLETED|Overall Study||11
9743606|NCT00267059|10845444|FG000|STARTED|Overall Study||44
9743607|NCT00267059|10845444|FG000|COMPLETED|Overall Study||44
9743608|NCT00267059|10845444|FG000|NOT COMPLETED|Overall Study||0
9743609|NCT00267085|10845448|FG000|STARTED|Overall Study||10
9743610|NCT00267085|10845448|FG000|COMPLETED|Overall Study||10
9743611|NCT00267085|10845448|FG000|NOT COMPLETED|Overall Study||0
9743612|NCT00267098|10845460|FG000|STARTED|Overall Study||109
9743613|NCT00267098|10845461|FG001|STARTED|Overall Study||51
9743614|NCT00267098|10845462|FG002|STARTED|Overall Study||243
9743615|NCT00267098|10845463|FG003|STARTED|Overall Study||241
9743616|NCT00267098|10845464|FG004|STARTED|Overall Study||47
9743617|NCT00267098|10845465|FG005|STARTED|Overall Study||106
9743618|NCT00267098|10845466|FG006|STARTED|Overall Study||101
9743619|NCT00267098|10845467|FG007|STARTED|Overall Study||20
9743620|NCT00267098|10845460|FG000|COMPLETED|Overall Study||0
9743621|NCT00267098|10845461|FG001|COMPLETED|Overall Study||0
9743622|NCT00267098|10845462|FG002|COMPLETED|Overall Study||149
9743623|NCT00267098|10845463|FG003|COMPLETED|Overall Study||135
9743624|NCT00267098|10845464|FG004|COMPLETED|Overall Study||10
9743625|NCT00267098|10845465|FG005|COMPLETED|Overall Study||66
9743626|NCT00267098|10845466|FG006|COMPLETED|Overall Study||55
9743627|NCT00267098|10845467|FG007|COMPLETED|Overall Study||5
9743628|NCT00267098|10845460|FG000|NOT COMPLETED|Overall Study||109
9743629|NCT00267098|10845461|FG001|NOT COMPLETED|Overall Study||51
9743630|NCT00267098|10845462|FG002|NOT COMPLETED|Overall Study||94
9743631|NCT00267098|10845463|FG003|NOT COMPLETED|Overall Study||106
9743632|NCT00267098|10845464|FG004|NOT COMPLETED|Overall Study||37
9743633|NCT00267098|10845465|FG005|NOT COMPLETED|Overall Study||40
9743634|NCT00267098|10845466|FG006|NOT COMPLETED|Overall Study||46
9743635|NCT00267098|10845467|FG007|NOT COMPLETED|Overall Study||15
9743636|NCT00267111|10845492|FG000|STARTED|Overall Study||55
9743637|NCT00267111|10845493|FG001|STARTED|Overall Study||55
9743638|NCT00267111|10845492|FG000|COMPLETED|Overall Study||55
9743639|NCT00267111|10845493|FG001|COMPLETED|Overall Study||55
9743640|NCT00267111|10845492|FG000|NOT COMPLETED|Overall Study||0
9743641|NCT00267111|10845493|FG001|NOT COMPLETED|Overall Study||0
9743642|NCT00267150|10845500|FG000|STARTED|Overall Study||31
9743643|NCT00267150|10845500|FG000|COMPLETED|Overall Study||30
9743644|NCT00267150|10845500|FG000|NOT COMPLETED|Overall Study||1
9743645|NCT00267189|10845506|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72
9743646|NCT00267189|10845507|FG001|STARTED|Overall Study||73
9743647|NCT00267189|10845506|FG000|Completed Study Medication|Overall Study||54
9743648|NCT00267189|10845507|FG001|Completed Study Medication|Overall Study||72
9743649|NCT00267189|10845506|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67
9743650|NCT00267189|10845507|FG001|COMPLETED|Overall Study||72
9743651|NCT00267189|10845506|FG000|NOT COMPLETED|Overall Study||5
9743652|NCT00267189|10845507|FG001|NOT COMPLETED|Overall Study||1
9743653|NCT00267202|10845515|FG000|STARTED|Overall Study||136
9743654|NCT00267202|10845516|FG001|STARTED|Overall Study||139
9743655|NCT00267202|10845515|FG000|COMPLETED|Overall Study||83
9743656|NCT00267202|10845516|FG001|COMPLETED|Overall Study||105
9743657|NCT00267202|10845515|FG000|NOT COMPLETED|Overall Study||53
9743658|NCT00267202|10845516|FG001|NOT COMPLETED|Overall Study||34
9743659|NCT00267293|10845526|FG000|STARTED|Overall Study||20
9743660|NCT00267293|10845527|FG001|STARTED|Overall Study||20
9743661|NCT00267293|10845528|FG002|STARTED|Overall Study||20
9743662|NCT00267293|10845526|FG000|COMPLETED|Overall Study||20
9743663|NCT00267293|10845527|FG001|COMPLETED|Overall Study||20
9743664|NCT00267293|10845528|FG002|COMPLETED|Overall Study||20
9743665|NCT00267293|10845526|FG000|NOT COMPLETED|Overall Study||0
9743666|NCT00267293|10845527|FG001|NOT COMPLETED|Overall Study||0
9743667|NCT00267293|10845528|FG002|NOT COMPLETED|Overall Study||0
9743668|NCT00267488|10845536|FG000|STARTED|Overall Study||37
9743669|NCT00267488|10845536|FG000|COMPLETED|Overall Study||26
9743670|NCT00267488|10845536|FG000|NOT COMPLETED|Overall Study||11
9828265|NCT00754832|10938987|FG000|STARTED|Second 6 Weeks Intervention||17
9828266|NCT00754832|10938988|FG001|STARTED|Second 6 Weeks Intervention||26
9828267|NCT00754832|10938987|FG000|COMPLETED|Second 6 Weeks Intervention||17
9828268|NCT00754832|10938988|FG001|COMPLETED|Second 6 Weeks Intervention||24
9828269|NCT00754832|10938987|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0
9828270|NCT00754832|10938988|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2
9828271|NCT00754845|10938996|FG000|STARTED|Overall Study||959
9828272|NCT00754845|10938997|FG001|STARTED|Overall Study||959
9828273|NCT00754845|10938996|FG000|COMPLETED|Overall Study||959
9828274|NCT00754845|10938997|FG001|COMPLETED|Overall Study||959
9828275|NCT00754845|10938996|FG000|NOT COMPLETED|Overall Study||0
9828276|NCT00754845|10938997|FG001|NOT COMPLETED|Overall Study||0
9828277|NCT00754923|10939005|FG000|STARTED|Overall Study||11
9828278|NCT00754923|10939005|FG000|COMPLETED|Overall Study||11
9828279|NCT00754923|10939005|FG000|NOT COMPLETED|Overall Study||0
9828280|NCT00754936|10939009|FG000|STARTED|Overall Study||71
10091777|NCT02332291|11220065|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19
10091778|NCT02332291|11220066|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11
10091779|NCT02332291|11220065|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3
9828281|NCT00754936|10939009|FG000|COMPLETED|Overall Study||59
9828282|NCT00754936|10939009|FG000|NOT COMPLETED|Overall Study||12
9828283|NCT00755040|10939015|FG000|STARTED|Overall Study||83
9828284|NCT00755040|10939016|FG001|STARTED|Overall Study||81
9828285|NCT00755040|10939015|FG000|COMPLETED|Overall Study||40
9828286|NCT00755040|10939016|FG001|COMPLETED|Overall Study||47
9828287|NCT00755040|10939015|FG000|NOT COMPLETED|Overall Study||43
9828288|NCT00755040|10939016|FG001|NOT COMPLETED|Overall Study||34
9828289|NCT00755079|10939024|FG000|STARTED|Overall Study||18
9828290|NCT00755079|10939025|FG001|STARTED|Overall Study||22
9828291|NCT00755079|10939024|FG000|COMPLETED|Overall Study||17
9828292|NCT00755079|10939025|FG001|COMPLETED|Overall Study||16
9828293|NCT00755079|10939024|FG000|NOT COMPLETED|Overall Study||1
9828294|NCT00755079|10939025|FG001|NOT COMPLETED|Overall Study||6
9828295|NCT00755105|10939034|FG000|STARTED|Overall Study||38
9828296|NCT00755105|10939035|FG001|STARTED|Overall Study||30
9828297|NCT00755105|10939036|FG002|STARTED|Overall Study||9
9828298|NCT00755105|10939034|FG000|COMPLETED|Overall Study||29
10091780|NCT02332291|11220066|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8
10091781|NCT02332707|11220094|FG000|STARTED|Overall Study||23
9828299|NCT00755105|10939035|FG001|COMPLETED|Overall Study||19
9828300|NCT00755105|10939036|FG002|COMPLETED|Overall Study||5
9828301|NCT00755105|10939034|FG000|NOT COMPLETED|Overall Study||9
9828302|NCT00755105|10939035|FG001|NOT COMPLETED|Overall Study||11
9828303|NCT00755105|10939036|FG002|NOT COMPLETED|Overall Study||4
9828304|NCT00755131|10939046|FG000|STARTED|Overall Study||37
9828305|NCT00755131|10939047|FG001|STARTED|Overall Study||38
9828306|NCT00755131|10939046|FG000|COMPLETED|Overall Study||37
9828307|NCT00755131|10939047|FG001|COMPLETED|Overall Study||38
10091782|NCT02332707|11220095|FG001|STARTED|Overall Study||24
9743671|NCT00267631|10845542|FG000|STARTED|Overall Study||2361
9743672|NCT00267631|10845543|FG001|STARTED|Overall Study||3031
9743673|NCT00267631|10845542|FG000|COMPLETED|Overall Study||2361
9743674|NCT00267631|10845543|FG001|COMPLETED|Overall Study||3031
9743675|NCT00267631|10845542|FG000|NOT COMPLETED|Overall Study||0
9743676|NCT00267631|10845543|FG001|NOT COMPLETED|Overall Study||0
9743677|NCT00267644|10845551|FG000|STARTED|Overall Study||13
9743678|NCT00267644|10845552|FG001|STARTED|Overall Study||63
9743679|NCT00267644|10845551|FG000|COMPLETED|Overall Study||13
9743680|NCT00267644|10845552|FG001|COMPLETED|Overall Study||63
9743681|NCT00267644|10845551|FG000|NOT COMPLETED|Overall Study||0
9743682|NCT00267644|10845552|FG001|NOT COMPLETED|Overall Study||0
10091783|NCT02332707|11220096|FG002|STARTED|Overall Study||16
10091784|NCT02332707|11220097|FG003|STARTED|Overall Study||14
10091785|NCT02332707|11220098|FG004|STARTED|Overall Study||23
10091786|NCT02332707|11220099|FG005|STARTED|Overall Study||23
9743683|NCT00267670|10845562|FG000|STARTED|Overall Study||19
9743684|NCT00267670|10845563|FG001|STARTED|Overall Study||7
9743685|NCT00267670|10845562|FG000|COMPLETED|Overall Study||15
9743686|NCT00267670|10845563|FG001|COMPLETED|Overall Study||7
9743687|NCT00267670|10845562|FG000|NOT COMPLETED|Overall Study||4
9743688|NCT00267670|10845563|FG001|NOT COMPLETED|Overall Study||0
9743689|NCT00267696|10845570|FG000|STARTED|Overall Study||45
9743690|NCT00267696|10845570|FG000|COMPLETED|Overall Study||45
9743691|NCT00267696|10845570|FG000|NOT COMPLETED|Overall Study||0
9743692|NCT00267748|10845577|FG000|STARTED|Non-randomized Period||25
9743693|NCT00267748|10845578|FG001|STARTED|Non-randomized Period||0
9743694|NCT00267748|10845579|FG002|STARTED|Non-randomized Period||0
9743695|NCT00267748|10845577|FG000|COMPLETED|Non-randomized Period||2
9743696|NCT00267748|10845578|FG001|COMPLETED|Non-randomized Period||0
9743697|NCT00267748|10845579|FG002|COMPLETED|Non-randomized Period||0
9743698|NCT00267748|10845577|FG000|NOT COMPLETED|Non-randomized Period||23
9743699|NCT00267748|10845578|FG001|NOT COMPLETED|Non-randomized Period||0
9743700|NCT00267748|10845579|FG002|NOT COMPLETED|Non-randomized Period||0
9743701|NCT00267748|10845577|FG000|STARTED|Randomized Period||0
9743702|NCT00267748|10845578|FG001|STARTED|Randomized Period||146
9743703|NCT00267748|10845579|FG002|STARTED|Randomized Period||146
9743704|NCT00267748|10845577|FG000|Treated|Randomized Period||0
9743705|NCT00267748|10845578|FG001|Treated|Randomized Period||146
9743706|NCT00267748|10845579|FG002|Treated|Randomized Period||143
9743707|NCT00267748|10845577|FG000|COMPLETED|Randomized Period||0
9743708|NCT00267748|10845578|FG001|COMPLETED|Randomized Period||19
9743709|NCT00267748|10845579|FG002|COMPLETED|Randomized Period||14
9743710|NCT00267748|10845577|FG000|NOT COMPLETED|Randomized Period||0
9743711|NCT00267748|10845578|FG001|NOT COMPLETED|Randomized Period||127
9743712|NCT00267748|10845579|FG002|NOT COMPLETED|Randomized Period||132
9743713|NCT00267774|10845588|FG000|STARTED|Overall Study||509
9743714|NCT00267774|10845589|FG001|STARTED|Overall Study||496
9743715|NCT00267774|10845588|FG000|COMPLETED|Overall Study||509
9743716|NCT00267774|10845589|FG001|COMPLETED|Overall Study||496
9743717|NCT00267774|10845588|FG000|NOT COMPLETED|Overall Study||0
9743718|NCT00267774|10845589|FG001|NOT COMPLETED|Overall Study||0
9743719|NCT00267865|10845595|FG000|STARTED|Induction Treatment||12
9743720|NCT00267865|10845595|FG000|COMPLETED|Induction Treatment||9
9743721|NCT00267865|10845595|FG000|NOT COMPLETED|Induction Treatment||3
9743722|NCT00267865|10845595|FG000|STARTED|Consolidation Treatment||5
9743723|NCT00267865|10845595|FG000|COMPLETED|Consolidation Treatment||5
9743724|NCT00267865|10845595|FG000|NOT COMPLETED|Consolidation Treatment||0
9743725|NCT00267956|10845601|FG000|STARTED|Controlled Period||70
9743726|NCT00267956|10845602|FG001|STARTED|Controlled Period||76
9743727|NCT00267956|10845603|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9743728|NCT00267956|10845604|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9743729|NCT00267956|10845601|FG000|COMPLETED|Controlled Period||57
9743730|NCT00267956|10845602|FG001|COMPLETED|Controlled Period||72
9743731|NCT00267956|10845603|FG002|COMPLETED|Controlled Period||0
9743732|NCT00267956|10845604|FG003|COMPLETED|Controlled Period||0
9743733|NCT00267956|10845601|FG000|NOT COMPLETED|Controlled Period||13
9743734|NCT00267956|10845602|FG001|NOT COMPLETED|Controlled Period||4
9743735|NCT00267956|10845603|FG002|NOT COMPLETED|Controlled Period||0
9743736|NCT00267956|10845604|FG003|NOT COMPLETED|Controlled Period||0
9743737|NCT00267956|10845601|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9743738|NCT00267956|10845602|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9743739|NCT00267956|10845603|FG002|STARTED|After Controlled Period||57
9743740|NCT00267956|10845604|FG003|STARTED|After Controlled Period||72
9743741|NCT00267956|10845601|FG000|COMPLETED|After Controlled Period||0
9743742|NCT00267956|10845602|FG001|COMPLETED|After Controlled Period||0
9743743|NCT00267956|10845603|FG002|COMPLETED|After Controlled Period||52
9743744|NCT00267956|10845604|FG003|COMPLETED|After Controlled Period||70
9743745|NCT00267956|10845601|FG000|NOT COMPLETED|After Controlled Period||0
10091787|NCT02332707|11220100|FG006|STARTED|Overall Study||15
10091788|NCT02332707|11220101|FG007|STARTED|Overall Study||16
9743746|NCT00267956|10845602|FG001|NOT COMPLETED|After Controlled Period||0
9743747|NCT00267956|10845603|FG002|NOT COMPLETED|After Controlled Period||5
9743748|NCT00267956|10845604|FG003|NOT COMPLETED|After Controlled Period||2
9743749|NCT00267969|10845615|FG000|STARTED|Controlled Period|Number of patients randomized|255
9743750|NCT00267969|10845616|FG001|STARTED|Controlled Period|Number of patients randomized|255
9743751|NCT00267969|10845617|FG002|STARTED|Controlled Period|Number of patients randomized|256
9743752|NCT00267969|10845618|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9743753|NCT00267969|10845619|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9743754|NCT00267969|10845620|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9743755|NCT00267969|10845621|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9743756|NCT00267969|10845615|FG000|COMPLETED|Controlled Period||243
9743757|NCT00267969|10845616|FG001|COMPLETED|Controlled Period||254
9743758|NCT00267969|10845617|FG002|COMPLETED|Controlled Period||245
9743759|NCT00267969|10845618|FG003|COMPLETED|Controlled Period||0
9743760|NCT00267969|10845619|FG004|COMPLETED|Controlled Period||0
9743761|NCT00267969|10845620|FG005|COMPLETED|Controlled Period||0
9743762|NCT00267969|10845621|FG006|COMPLETED|Controlled Period||0
9743763|NCT00267969|10845615|FG000|NOT COMPLETED|Controlled Period||12
9743764|NCT00267969|10845616|FG001|NOT COMPLETED|Controlled Period||1
9743765|NCT00267969|10845617|FG002|NOT COMPLETED|Controlled Period||11
9743766|NCT00267969|10845618|FG003|NOT COMPLETED|Controlled Period||0
9743767|NCT00267969|10845619|FG004|NOT COMPLETED|Controlled Period||0
9743768|NCT00267969|10845620|FG005|NOT COMPLETED|Controlled Period||0
9743769|NCT00267969|10845621|FG006|NOT COMPLETED|Controlled Period||0
9743770|NCT00267969|10845615|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9743771|NCT00267969|10845616|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9743772|NCT00267969|10845617|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9743773|NCT00267969|10845618|FG003|STARTED|After Controlled Period||123
9743774|NCT00267969|10845619|FG004|STARTED|After Controlled Period||120
9743775|NCT00267969|10845620|FG005|STARTED|After Controlled Period||254
9743776|NCT00267969|10845621|FG006|STARTED|After Controlled Period||245
9743777|NCT00267969|10845615|FG000|COMPLETED|After Controlled Period||0
9743778|NCT00267969|10845616|FG001|COMPLETED|After Controlled Period||0
9743779|NCT00267969|10845617|FG002|COMPLETED|After Controlled Period||0
9743780|NCT00267969|10845618|FG003|COMPLETED|After Controlled Period||87
9743781|NCT00267969|10845619|FG004|COMPLETED|After Controlled Period||85
9743782|NCT00267969|10845620|FG005|COMPLETED|After Controlled Period||172
9743783|NCT00267969|10845621|FG006|COMPLETED|After Controlled Period||173
9743784|NCT00267969|10845615|FG000|NOT COMPLETED|After Controlled Period||0
9743785|NCT00267969|10845616|FG001|NOT COMPLETED|After Controlled Period||0
9743786|NCT00267969|10845617|FG002|NOT COMPLETED|After Controlled Period||0
9743787|NCT00267969|10845618|FG003|NOT COMPLETED|After Controlled Period||36
9743788|NCT00267969|10845619|FG004|NOT COMPLETED|After Controlled Period||35
9743789|NCT00267969|10845620|FG005|NOT COMPLETED|After Controlled Period||82
9743790|NCT00267969|10845621|FG006|NOT COMPLETED|After Controlled Period||72
9743791|NCT00268203|10845639|FG000|STARTED|Overall Study||765
9743792|NCT00268203|10845639|FG000|Completed 2 Years of Follow-up|Overall Study||62
9743793|NCT00268203|10845639|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
9743794|NCT00268203|10845639|FG000|NOT COMPLETED|Overall Study||647
9743795|NCT00268242|10845643|FG000|STARTED|Overall Study||24
9743796|NCT00268242|10845643|FG000|COMPLETED|Overall Study||23
9743797|NCT00268242|10845643|FG000|NOT COMPLETED|Overall Study||1
9743798|NCT00268346|10845649|FG000|STARTED|Overall Study||18
9743799|NCT00268346|10845650|FG001|STARTED|Overall Study||40
9743800|NCT00268346|10845649|FG000|Started Treatment|Overall Study||18
9743801|NCT00268346|10845650|FG001|Started Treatment|Overall Study||40
9743802|NCT00268346|10845649|FG000|COMPLETED|Overall Study||18
9743803|NCT00268346|10845650|FG001|COMPLETED|Overall Study||37
9743804|NCT00268346|10845649|FG000|NOT COMPLETED|Overall Study||0
9743805|NCT00268346|10845650|FG001|NOT COMPLETED|Overall Study||3
9743806|NCT00268437|10845656|FG000|STARTED|Overall Study||27
9743807|NCT00268437|10845656|FG000|COMPLETED|Overall Study||26
9743808|NCT00268437|10845656|FG000|NOT COMPLETED|Overall Study||1
9743809|NCT00268762|10845661|FG000|STARTED|Overall Study||65
9743810|NCT00268762|10845661|FG000|COMPLETED|Overall Study||65
9743811|NCT00268762|10845661|FG000|NOT COMPLETED|Overall Study||0
9743812|NCT00268892|10845668|FG000|STARTED|Overall Study||90
9743813|NCT00268892|10845669|FG001|STARTED|Overall Study||95
9743814|NCT00268892|10845670|FG002|STARTED|Overall Study||93
9743815|NCT00268892|10845668|FG000|Switched to Higher Dose|Overall Study||59
9743816|NCT00268892|10845669|FG001|Switched to Higher Dose|Overall Study||68
9743817|NCT00268892|10845670|FG002|Switched to Higher Dose|Overall Study||76
9743818|NCT00268892|10845668|FG000|COMPLETED|Overall Study||51
9743819|NCT00268892|10845669|FG001|COMPLETED|Overall Study||53
9743820|NCT00268892|10845670|FG002|COMPLETED|Overall Study||54
9743821|NCT00268892|10845668|FG000|NOT COMPLETED|Overall Study||39
9743822|NCT00268892|10845669|FG001|NOT COMPLETED|Overall Study||42
9743823|NCT00268892|10845670|FG002|NOT COMPLETED|Overall Study||39
9743824|NCT00268905|10845681|FG000|STARTED|Overall Study||43
9743825|NCT00268905|10845682|FG001|STARTED|Overall Study||9
9743826|NCT00268905|10845683|FG002|STARTED|Overall Study||12
9743827|NCT00268905|10845681|FG000|COMPLETED|Overall Study||0
9743828|NCT00268905|10845682|FG001|COMPLETED|Overall Study||0
9743829|NCT00268905|10845683|FG002|COMPLETED|Overall Study||0
9743830|NCT00268905|10845681|FG000|NOT COMPLETED|Overall Study||43
9743831|NCT00268905|10845682|FG001|NOT COMPLETED|Overall Study||9
9743832|NCT00268905|10845683|FG002|NOT COMPLETED|Overall Study||12
9743833|NCT00268983|10845693|FG000|STARTED|Overall Study||6
9743834|NCT00268983|10845694|FG001|STARTED|Overall Study||8
9743835|NCT00268983|10845693|FG000|COMPLETED|Overall Study||3
9743836|NCT00268983|10845694|FG001|COMPLETED|Overall Study||8
9743837|NCT00268983|10845693|FG000|NOT COMPLETED|Overall Study||3
9743838|NCT00268983|10845694|FG001|NOT COMPLETED|Overall Study||0
9743839|NCT00268996|10845702|FG000|STARTED|Overall Study||151
9743840|NCT00268996|10845703|FG001|STARTED|Overall Study||172
9743841|NCT00268996|10845702|FG000|COMPLETED|Overall Study||130
9743842|NCT00268996|10845703|FG001|COMPLETED|Overall Study||152
9743843|NCT00268996|10845702|FG000|NOT COMPLETED|Overall Study||21
9743844|NCT00268996|10845703|FG001|NOT COMPLETED|Overall Study||20
9743845|NCT00269087|10845711|FG000|STARTED|Overall Study||122
9743846|NCT00269087|10845711|FG000|COMPLETED|Overall Study||88
9743847|NCT00269087|10845711|FG000|NOT COMPLETED|Overall Study||34
9743848|NCT00269113|10845717|FG000|STARTED|Overall Study||177
9743849|NCT00269113|10845718|FG001|STARTED|Overall Study||183
9743850|NCT00269113|10845717|FG000|COMPLETED|Overall Study||103
9743851|NCT00269113|10845718|FG001|COMPLETED|Overall Study||146
9743852|NCT00269113|10845717|FG000|NOT COMPLETED|Overall Study||74
9743853|NCT00269113|10845718|FG001|NOT COMPLETED|Overall Study||37
9743854|NCT00269152|10845726|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
9743855|NCT00269152|10845727|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
9743856|NCT00269152|10845726|FG000|COMPLETED|Overall Study||45
9743857|NCT00269152|10845727|FG001|COMPLETED|Overall Study||49
9743858|NCT00269152|10845726|FG000|NOT COMPLETED|Overall Study||18
9743859|NCT00269152|10845727|FG001|NOT COMPLETED|Overall Study||10
9743860|NCT00269399|10845735|FG000|STARTED|Overall Study||119
9743861|NCT00269399|10845736|FG001|STARTED|Overall Study||118
9743862|NCT00269399|10845735|FG000|COMPLETED|Overall Study||78
9743863|NCT00269399|10845736|FG001|COMPLETED|Overall Study||91
9743864|NCT00269399|10845735|FG000|NOT COMPLETED|Overall Study||41
9743865|NCT00269399|10845736|FG001|NOT COMPLETED|Overall Study||27
9743866|NCT00269477|10845746|FG000|STARTED|Overall Study||9
9743867|NCT00269477|10845747|FG001|STARTED|Overall Study||18
9743868|NCT00269477|10845748|FG002|STARTED|Overall Study||58
9743869|NCT00269477|10845749|FG003|STARTED|Overall Study||60
9743870|NCT00269477|10845746|FG000|COMPLETED|Overall Study||4
9743871|NCT00269477|10845747|FG001|COMPLETED|Overall Study||12
9743872|NCT00269477|10845748|FG002|COMPLETED|Overall Study||57
9743873|NCT00269477|10845749|FG003|COMPLETED|Overall Study||60
9743874|NCT00269477|10845746|FG000|NOT COMPLETED|Overall Study||5
9743875|NCT00269477|10845747|FG001|NOT COMPLETED|Overall Study||6
9743876|NCT00269477|10845748|FG002|NOT COMPLETED|Overall Study||1
9743877|NCT00269477|10845749|FG003|NOT COMPLETED|Overall Study||0
9743878|NCT00269633|10845761|FG000|STARTED|Overall Study||4
9743879|NCT00269633|10845762|FG001|STARTED|Overall Study||5
9743880|NCT00269633|10845761|FG000|COMPLETED|Overall Study||3
9743881|NCT00269633|10845762|FG001|COMPLETED|Overall Study||5
9743882|NCT00269633|10845761|FG000|NOT COMPLETED|Overall Study||1
9743883|NCT00269633|10845762|FG001|NOT COMPLETED|Overall Study||0
9743884|NCT00269919|10845768|FG000|STARTED|Overall Study||40
9743885|NCT00269919|10845768|FG000|Treated|Overall Study||39
9743886|NCT00269919|10845768|FG000|COMPLETED|Overall Study||13
9743887|NCT00269919|10845768|FG000|NOT COMPLETED|Overall Study||27
9743888|NCT00270205|10845777|FG000|STARTED|Overall Study||6
9743889|NCT00270205|10845778|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
9743890|NCT00270205|10845779|FG002|STARTED|Overall Study||6
9743891|NCT00270205|10845780|FG003|STARTED|Overall Study||7
9743892|NCT00270205|10845777|FG000|COMPLETED|Overall Study||5
9852619|NCT00882778|10965525|FG000|STARTED|Overall Study||86
9852620|NCT00882778|10965525|FG000|COMPLETED|Overall Study||86
9852621|NCT00882778|10965525|FG000|NOT COMPLETED|Overall Study||0
9852622|NCT00882908|10965534|FG000|STARTED|Overall Study||78
9852623|NCT00882908|10965535|FG001|STARTED|Overall Study||75
9852624|NCT00882908|10965536|FG002|STARTED|Overall Study||77
9852625|NCT00882908|10965537|FG003|STARTED|Overall Study||79
9852626|NCT00882908|10965538|FG004|STARTED|Overall Study||77
9852627|NCT00882908|10965534|FG000|COMPLETED|Overall Study||75
9852628|NCT00882908|10965535|FG001|COMPLETED|Overall Study||69
9743893|NCT00270205|10845778|FG001|COMPLETED|Overall Study||6
9743894|NCT00270205|10845779|FG002|COMPLETED|Overall Study||6
9743895|NCT00270205|10845780|FG003|COMPLETED|Overall Study||6
9743896|NCT00270205|10845777|FG000|NOT COMPLETED|Overall Study||1
9743897|NCT00270205|10845778|FG001|NOT COMPLETED|Overall Study||0
9743898|NCT00270205|10845779|FG002|NOT COMPLETED|Overall Study||0
9743899|NCT00270205|10845780|FG003|NOT COMPLETED|Overall Study||1
9743900|NCT00270231|10845790|FG000|STARTED|First Intervention||32
9743901|NCT00270231|10845791|FG001|STARTED|First Intervention||32
9743902|NCT00270231|10845790|FG000|COMPLETED|First Intervention||31
9743903|NCT00270231|10845791|FG001|COMPLETED|First Intervention||31
9743904|NCT00270231|10845790|FG000|NOT COMPLETED|First Intervention||1
9743905|NCT00270231|10845791|FG001|NOT COMPLETED|First Intervention||1
9743906|NCT00270231|10845790|FG000|STARTED|Washout Period||31
9743907|NCT00270231|10845791|FG001|STARTED|Washout Period||31
9743908|NCT00270231|10845790|FG000|COMPLETED|Washout Period||30
9743909|NCT00270231|10845791|FG001|COMPLETED|Washout Period||31
9852629|NCT00882908|10965536|FG002|COMPLETED|Overall Study||70
9852630|NCT00882908|10965537|FG003|COMPLETED|Overall Study||72
9743910|NCT00270231|10845790|FG000|NOT COMPLETED|Washout Period||1
9743911|NCT00270231|10845791|FG001|NOT COMPLETED|Washout Period||0
9743912|NCT00270231|10845790|FG000|STARTED|Second Intervention||30
9743913|NCT00270231|10845791|FG001|STARTED|Second Intervention||31
9743914|NCT00270231|10845790|FG000|COMPLETED|Second Intervention||30
9743915|NCT00270231|10845791|FG001|COMPLETED|Second Intervention||30
9743916|NCT00270231|10845790|FG000|NOT COMPLETED|Second Intervention||0
9743917|NCT00270231|10845791|FG001|NOT COMPLETED|Second Intervention||1
9743918|NCT00270257|10845799|FG000|STARTED|Overall Study||623
9743919|NCT00270257|10845800|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
9743920|NCT00270257|10845799|FG000|Week 8|Overall Study||510
9743921|NCT00270257|10845800|FG001|Week 8|Overall Study||443
9743922|NCT00270257|10845799|FG000|Week 26|Overall Study||460
9743923|NCT00270257|10845800|FG001|Week 26|Overall Study||440
9743924|NCT00270257|10845799|FG000|Week 52|Overall Study||362
9743925|NCT00270257|10845800|FG001|Week 52|Overall Study||340
9743926|NCT00270257|10845799|FG000|Week 78|Overall Study||283
9743927|NCT00270257|10845800|FG001|Week 78|Overall Study||285
9743928|NCT00270257|10845799|FG000|Visit 104|Overall Study||211
9743929|NCT00270257|10845800|FG001|Visit 104|Overall Study||204
9743930|NCT00270257|10845799|FG000|COMPLETED|Overall Study||211
9743931|NCT00270257|10845800|FG001|COMPLETED|Overall Study||204
9743932|NCT00270257|10845799|FG000|NOT COMPLETED|Overall Study||412
9743933|NCT00270257|10845800|FG001|NOT COMPLETED|Overall Study||424
9743934|NCT00270296|10845811|FG000|STARTED|Overall Study||285
9743935|NCT00270296|10845812|FG001|STARTED|Overall Study||275
9743936|NCT00270296|10845813|FG002|STARTED|Overall Study||170
9743937|NCT00270296|10845811|FG000|COMPLETED|Overall Study||186
9743938|NCT00270296|10845812|FG001|COMPLETED|Overall Study||185
9743939|NCT00270296|10845813|FG002|COMPLETED|Overall Study||109
9743940|NCT00270296|10845811|FG000|NOT COMPLETED|Overall Study||99
9743941|NCT00270296|10845812|FG001|NOT COMPLETED|Overall Study||90
9743942|NCT00270296|10845813|FG002|NOT COMPLETED|Overall Study||61
9743943|NCT00270634|10845825|FG000|STARTED|Overall Study||87
9743944|NCT00270634|10845826|FG001|STARTED|Overall Study||77
9743945|NCT00270634|10845827|FG002|STARTED|Overall Study||84
9743946|NCT00270634|10845828|FG003|STARTED|Overall Study||86
9743947|NCT00270634|10845825|FG000|COMPLETED|Overall Study||70
9743948|NCT00270634|10845826|FG001|COMPLETED|Overall Study||64
9743949|NCT00270634|10845827|FG002|COMPLETED|Overall Study||62
9743950|NCT00270634|10845828|FG003|COMPLETED|Overall Study||81
9743951|NCT00270634|10845825|FG000|NOT COMPLETED|Overall Study||17
9743952|NCT00270634|10845826|FG001|NOT COMPLETED|Overall Study||13
9743953|NCT00270634|10845827|FG002|NOT COMPLETED|Overall Study||22
9743954|NCT00270634|10845828|FG003|NOT COMPLETED|Overall Study||5
9743955|NCT00270790|10845842|FG000|STARTED|Overall Study||21
9743956|NCT00270790|10845842|FG000|COMPLETED|Overall Study||16
9743957|NCT00270790|10845842|FG000|NOT COMPLETED|Overall Study||5
9743958|NCT00270842|10845849|FG000|STARTED|Overall Study||33
9743959|NCT00270842|10845850|FG001|STARTED|Overall Study||34
9743960|NCT00270842|10845851|FG002|STARTED|Overall Study||34
9743961|NCT00270842|10845849|FG000|COMPLETED|Overall Study||18
9743962|NCT00270842|10845850|FG001|COMPLETED|Overall Study||18
9743963|NCT00270842|10845851|FG002|COMPLETED|Overall Study||18
9743964|NCT00270842|10845849|FG000|NOT COMPLETED|Overall Study||15
9743965|NCT00270842|10845850|FG001|NOT COMPLETED|Overall Study||16
9743966|NCT00270842|10845851|FG002|NOT COMPLETED|Overall Study||16
9743967|NCT00270855|10845861|FG000|STARTED|Overall Study||15
9743968|NCT00270855|10845862|FG001|STARTED|Overall Study||14
9743969|NCT00270855|10845861|FG000|COMPLETED|Overall Study||7
9743970|NCT00270855|10845862|FG001|COMPLETED|Overall Study||6
9743971|NCT00270855|10845861|FG000|NOT COMPLETED|Overall Study||8
9743972|NCT00270855|10845862|FG001|NOT COMPLETED|Overall Study||8
9743973|NCT00270894|10845870|FG000|STARTED|Overall Study||30
9743974|NCT00270894|10845870|FG000|COMPLETED|Overall Study||28
9743975|NCT00270894|10845870|FG000|NOT COMPLETED|Overall Study||2
9743976|NCT00270998|10845877|FG000|STARTED|3 Month Follow-up||149
9743977|NCT00270998|10845878|FG001|STARTED|3 Month Follow-up||146
9743978|NCT00270998|10845879|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
9743979|NCT00270998|10845877|FG000|COMPLETED|3 Month Follow-up||110
9743980|NCT00270998|10845878|FG001|COMPLETED|3 Month Follow-up||124
9743981|NCT00270998|10845879|FG002|COMPLETED|3 Month Follow-up||132
9743982|NCT00270998|10845877|FG000|NOT COMPLETED|3 Month Follow-up||39
9743983|NCT00270998|10845878|FG001|NOT COMPLETED|3 Month Follow-up||22
9743984|NCT00270998|10845879|FG002|NOT COMPLETED|3 Month Follow-up||18
9743985|NCT00270998|10845877|FG000|STARTED|12 Month Follow-up||110
9743986|NCT00270998|10845878|FG001|STARTED|12 Month Follow-up||124
9743987|NCT00270998|10845879|FG002|STARTED|12 Month Follow-up||132
9743988|NCT00270998|10845877|FG000|COMPLETED|12 Month Follow-up||96
9743989|NCT00270998|10845878|FG001|COMPLETED|12 Month Follow-up||99
9743990|NCT00270998|10845879|FG002|COMPLETED|12 Month Follow-up||111
9743991|NCT00270998|10845877|FG000|NOT COMPLETED|12 Month Follow-up||14
9743992|NCT00270998|10845878|FG001|NOT COMPLETED|12 Month Follow-up||25
9743993|NCT00270998|10845879|FG002|NOT COMPLETED|12 Month Follow-up||21
9743994|NCT00271024|10845893|FG000|STARTED|Overall Study||80
9743995|NCT00271024|10845894|FG001|STARTED|Overall Study||77
9743996|NCT00271024|10845895|FG002|STARTED|Overall Study||88
9743997|NCT00271024|10845896|FG003|STARTED|Overall Study||88
9743998|NCT00271024|10845893|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
9743999|NCT00271024|10845894|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
9744000|NCT00271024|10845895|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
9744001|NCT00271024|10845896|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
9744002|NCT00271024|10845893|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
9744003|NCT00271024|10845894|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
9744004|NCT00271024|10845895|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
9744005|NCT00271024|10845896|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
9744006|NCT00271024|10845893|FG000|NOT COMPLETED|Overall Study||22
9744007|NCT00271024|10845894|FG001|NOT COMPLETED|Overall Study||26
9744008|NCT00271024|10845895|FG002|NOT COMPLETED|Overall Study||23
9744009|NCT00271024|10845896|FG003|NOT COMPLETED|Overall Study||24
9744010|NCT00271154|10845908|FG000|STARTED|Overall Study||191
9744011|NCT00271154|10845909|FG001|STARTED|Overall Study||419
9744012|NCT00271154|10845908|FG000|COMPLETED|Overall Study||191
9744013|NCT00271154|10845909|FG001|COMPLETED|Overall Study||419
9744014|NCT00271154|10845908|FG000|NOT COMPLETED|Overall Study||0
9744015|NCT00271154|10845909|FG001|NOT COMPLETED|Overall Study||0
9744016|NCT00271219|10845918|FG000|STARTED|Overall Study||89
9744017|NCT00271219|10845919|FG001|STARTED|Overall Study||86
9744018|NCT00271219|10845918|FG000|COMPLETED|Overall Study||73
9744019|NCT00271219|10845919|FG001|COMPLETED|Overall Study||58
9744020|NCT00271219|10845918|FG000|NOT COMPLETED|Overall Study||16
9744021|NCT00271219|10845919|FG001|NOT COMPLETED|Overall Study||28
9744022|NCT00271375|10845932|FG000|STARTED|Overall Study||114
9744023|NCT00271375|10845933|FG001|STARTED|Overall Study||83
9744024|NCT00271375|10845934|FG002|STARTED|Overall Study||57
9744025|NCT00271375|10845932|FG000|COMPLETED|Overall Study||114
9744026|NCT00271375|10845933|FG001|COMPLETED|Overall Study||83
9744027|NCT00271375|10845934|FG002|COMPLETED|Overall Study||57
9744028|NCT00271375|10845932|FG000|NOT COMPLETED|Overall Study||0
9744029|NCT00271375|10845933|FG001|NOT COMPLETED|Overall Study||0
9744030|NCT00271375|10845934|FG002|NOT COMPLETED|Overall Study||0
9744031|NCT00271505|10845943|FG000|STARTED|Overall Study||43
9744032|NCT00271505|10845943|FG000|COMPLETED|Overall Study||38
9744033|NCT00271505|10845943|FG000|NOT COMPLETED|Overall Study||5
9744034|NCT00271570|10845950|FG000|STARTED|Overall Study||12
9744035|NCT00271570|10845951|FG001|STARTED|Overall Study||12
9744036|NCT00271570|10845950|FG000|COMPLETED|Overall Study||12
9744037|NCT00271570|10845951|FG001|COMPLETED|Overall Study||12
9744038|NCT00271570|10845950|FG000|NOT COMPLETED|Overall Study||0
9744039|NCT00271570|10845951|FG001|NOT COMPLETED|Overall Study||0
9744040|NCT00271596|10845959|FG000|STARTED|Overall Study||17
9744041|NCT00271596|10845960|FG001|STARTED|Overall Study||16
9744042|NCT00271596|10845959|FG000|COMPLETED|Overall Study||16
9744043|NCT00271596|10845960|FG001|COMPLETED|Overall Study||15
9744044|NCT00271596|10845959|FG000|NOT COMPLETED|Overall Study||1
9744045|NCT00271596|10845960|FG001|NOT COMPLETED|Overall Study||1
9744046|NCT00271609|10845968|FG000|STARTED|Overall Study||56
9744047|NCT00271609|10845969|FG001|STARTED|Overall Study||32
9744048|NCT00271609|10845968|FG000|COMPLETED|Overall Study||43
9744049|NCT00271609|10845969|FG001|COMPLETED|Overall Study||29
9744050|NCT00271609|10845968|FG000|NOT COMPLETED|Overall Study||13
9744051|NCT00271609|10845969|FG001|NOT COMPLETED|Overall Study||3
9744052|NCT00271739|10845977|FG000|STARTED|Overall Study||844
9744053|NCT00271739|10845978|FG001|STARTED|Overall Study||821
9744054|NCT00271739|10845977|FG000|COMPLETED|Overall Study||729
9744055|NCT00271739|10845978|FG001|COMPLETED|Overall Study||716
9744056|NCT00271739|10845977|FG000|NOT COMPLETED|Overall Study||115
9744057|NCT00271739|10845978|FG001|NOT COMPLETED|Overall Study||105
9744058|NCT00271856|10845986|FG000|STARTED|Overall Study||89
9744059|NCT00271856|10845987|FG001|STARTED|Overall Study||88
9744060|NCT00271856|10845986|FG000|COMPLETED|Overall Study||78
9744061|NCT00271856|10845987|FG001|COMPLETED|Overall Study||70
9744062|NCT00271856|10845986|FG000|NOT COMPLETED|Overall Study||11
9744063|NCT00271856|10845987|FG001|NOT COMPLETED|Overall Study||18
9744064|NCT00272038|10845993|FG000|STARTED|Overall Study||29
9744065|NCT00272038|10845993|FG000|COMPLETED|Overall Study||22
9744066|NCT00272038|10845993|FG000|NOT COMPLETED|Overall Study||7
9744067|NCT00272168|10846000|FG000|STARTED|Overall Study||47
9744068|NCT00272168|10846001|FG001|STARTED|Overall Study||41
9744069|NCT00272168|10846000|FG000|COMPLETED|Overall Study||37
9744070|NCT00272168|10846001|FG001|COMPLETED|Overall Study||31
9744071|NCT00272168|10846000|FG000|NOT COMPLETED|Overall Study||10
9744072|NCT00272168|10846001|FG001|NOT COMPLETED|Overall Study||10
9744073|NCT00272311|10846012|FG000|STARTED|Overall Study||14
9744074|NCT00272311|10846013|FG001|STARTED|Overall Study||14
9744075|NCT00272311|10846014|FG002|STARTED|Overall Study||14
9744076|NCT00272311|10846015|FG003|STARTED|Overall Study||14
9744077|NCT00272311|10846016|FG004|STARTED|Overall Study||14
9744078|NCT00272311|10846012|FG000|COMPLETED|Overall Study||14
9744079|NCT00272311|10846013|FG001|COMPLETED|Overall Study||14
9744080|NCT00272311|10846014|FG002|COMPLETED|Overall Study||14
9744081|NCT00272311|10846015|FG003|COMPLETED|Overall Study||14
9744082|NCT00272311|10846016|FG004|COMPLETED|Overall Study||14
9744083|NCT00272311|10846012|FG000|NOT COMPLETED|Overall Study||0
9744084|NCT00272311|10846013|FG001|NOT COMPLETED|Overall Study||0
9744085|NCT00272311|10846014|FG002|NOT COMPLETED|Overall Study||0
9744086|NCT00272311|10846015|FG003|NOT COMPLETED|Overall Study||0
9744087|NCT00272311|10846016|FG004|NOT COMPLETED|Overall Study||0
9744088|NCT00272337|10846033|FG000|STARTED|Overall Study||8
9744089|NCT00272337|10846034|FG001|STARTED|Overall Study||7
9744090|NCT00272337|10846035|FG002|STARTED|Overall Study||7
9744091|NCT00272337|10846036|FG003|STARTED|Overall Study||7
9744092|NCT00272337|10846037|FG004|STARTED|Overall Study||8
9744093|NCT00272337|10846033|FG000|COMPLETED|Overall Study||8
9744094|NCT00272337|10846034|FG001|COMPLETED|Overall Study||7
9744095|NCT00272337|10846035|FG002|COMPLETED|Overall Study||7
9744096|NCT00272337|10846036|FG003|COMPLETED|Overall Study||7
9744097|NCT00272337|10846037|FG004|COMPLETED|Overall Study||8
9744098|NCT00272337|10846033|FG000|NOT COMPLETED|Overall Study||0
9744099|NCT00272337|10846034|FG001|NOT COMPLETED|Overall Study||0
9744100|NCT00272337|10846035|FG002|NOT COMPLETED|Overall Study||0
9744101|NCT00272337|10846036|FG003|NOT COMPLETED|Overall Study||0
9744102|NCT00272337|10846037|FG004|NOT COMPLETED|Overall Study||0
9744103|NCT00272779|10846051|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
9744104|NCT00272779|10846052|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
9744105|NCT00272779|10846051|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
9744106|NCT00272779|10846052|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
9744107|NCT00272779|10846051|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438
9744108|NCT00272779|10846052|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440
9744109|NCT00272779|10846051|FG000|Discontinued Before Week 48|Baseline Through Week 48||39
9744110|NCT00272779|10846052|FG001|Discontinued Before Week 48|Baseline Through Week 48||58
9744111|NCT00272779|10846051|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14
9744112|NCT00272779|10846052|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14
9744113|NCT00272779|10846051|FG000|STILL ON TREATMENT|Baseline Through Week 48||385
9744114|NCT00272779|10846052|FG001|STILL ON TREATMENT|Baseline Through Week 48||368
9744115|NCT00272779|10846051|FG000|COMPLETED|Baseline Through Week 48||0
9744116|NCT00272779|10846052|FG001|COMPLETED|Baseline Through Week 48||0
9744117|NCT00272779|10846051|FG000|NOT COMPLETED|Baseline Through Week 48||440
9744118|NCT00272779|10846052|FG001|NOT COMPLETED|Baseline Through Week 48||443
9744119|NCT00272779|10846051|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440
9744120|NCT00272779|10846052|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443
9744121|NCT00272779|10846051|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
9744122|NCT00272779|10846052|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
9744123|NCT00272779|10846051|FG000|COMPLETED|Baseline Through Week 96||301
9744124|NCT00272779|10846052|FG001|COMPLETED|Baseline Through Week 96||307
9744125|NCT00272779|10846051|FG000|NOT COMPLETED|Baseline Through Week 96||139
9744126|NCT00272779|10846052|FG001|NOT COMPLETED|Baseline Through Week 96||136
9852631|NCT00882908|10965538|FG004|COMPLETED|Overall Study||71
9852632|NCT00882908|10965534|FG000|NOT COMPLETED|Overall Study||3
9852633|NCT00882908|10965535|FG001|NOT COMPLETED|Overall Study||6
9852634|NCT00882908|10965536|FG002|NOT COMPLETED|Overall Study||7
9852635|NCT00882908|10965537|FG003|NOT COMPLETED|Overall Study||7
9852636|NCT00882908|10965538|FG004|NOT COMPLETED|Overall Study||6
9852637|NCT00882921|10965551|FG000|STARTED|Overall Study||26
9852638|NCT00882921|10965551|FG000|COMPLETED|Overall Study||15
9852639|NCT00882921|10965551|FG000|NOT COMPLETED|Overall Study||11
9852640|NCT00882999|10965563|FG000|STARTED|Overall Study||35
9852641|NCT00882999|10965564|FG001|STARTED|Overall Study||34
9852642|NCT00882999|10965565|FG002|STARTED|Overall Study||34
9852643|NCT00882999|10965566|FG003|STARTED|Overall Study||36
9852644|NCT00882999|10965567|FG004|STARTED|Overall Study||36
9852645|NCT00882999|10965568|FG005|STARTED|Overall Study||35
9852646|NCT00882999|10965569|FG006|STARTED|Overall Study||35
9852647|NCT00882999|10965563|FG000|Received Any Amount of Study Drug|Overall Study||35
9852648|NCT00882999|10965564|FG001|Received Any Amount of Study Drug|Overall Study||34
9852649|NCT00882999|10965565|FG002|Received Any Amount of Study Drug|Overall Study||34
9852650|NCT00882999|10965566|FG003|Received Any Amount of Study Drug|Overall Study||36
9852651|NCT00882999|10965567|FG004|Received Any Amount of Study Drug|Overall Study||36
9852652|NCT00882999|10965568|FG005|Received Any Amount of Study Drug|Overall Study||35
9852653|NCT00882999|10965569|FG006|Received Any Amount of Study Drug|Overall Study||35
9852654|NCT00882999|10965563|FG000|Completed Study Treatment|Overall Study||29
9852655|NCT00882999|10965564|FG001|Completed Study Treatment|Overall Study||29
9852656|NCT00882999|10965565|FG002|Completed Study Treatment|Overall Study||31
9852657|NCT00882999|10965566|FG003|Completed Study Treatment|Overall Study||33
9852658|NCT00882999|10965567|FG004|Completed Study Treatment|Overall Study||29
9852659|NCT00882999|10965568|FG005|Completed Study Treatment|Overall Study||30
10091789|NCT02332707|11220102|FG008|STARTED|Overall Study||48
10091790|NCT02332707|11220103|FG009|STARTED|Overall Study||31
10091791|NCT02332707|11220104|FG010|STARTED|Overall Study||31
10091792|NCT02332707|11220105|FG011|STARTED|Overall Study||35
9744127|NCT00272792|10846061|FG000|STARTED|Part 1: Responsiveness||90
9744128|NCT00272792|10846062|FG001|STARTED|Part 1: Responsiveness||0
9852660|NCT00882999|10965569|FG006|Completed Study Treatment|Overall Study||31
9852661|NCT00882999|10965563|FG000|COMPLETED|Overall Study||27
9852662|NCT00882999|10965564|FG001|COMPLETED|Overall Study||26
9744129|NCT00272792|10846061|FG000|COMPLETED|Part 1: Responsiveness||89
9744130|NCT00272792|10846062|FG001|COMPLETED|Part 1: Responsiveness||0
9744131|NCT00272792|10846061|FG000|NOT COMPLETED|Part 1: Responsiveness||1
9744132|NCT00272792|10846062|FG001|NOT COMPLETED|Part 1: Responsiveness||0
9744133|NCT00272792|10846061|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33
9744134|NCT00272792|10846062|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12
9744135|NCT00272792|10846061|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32
9744136|NCT00272792|10846062|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9
9744137|NCT00272792|10846061|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
9744138|NCT00272792|10846062|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
9744139|NCT00272844|10846068|FG000|STARTED|Overall Study||23
9744140|NCT00272844|10846068|FG000|COMPLETED|Overall Study||18
9744141|NCT00272844|10846068|FG000|NOT COMPLETED|Overall Study||5
9744142|NCT00272961|10846077|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60
9744143|NCT00272961|10846078|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0
9744144|NCT00272961|10846079|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0
9744145|NCT00272961|10846080|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0
9744146|NCT00272961|10846081|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0
9744147|NCT00272961|10846077|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
9744148|NCT00272961|10846078|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744149|NCT00272961|10846079|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744150|NCT00272961|10846080|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744151|NCT00272961|10846081|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744152|NCT00272961|10846077|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
9744153|NCT00272961|10846078|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744154|NCT00272961|10846079|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744155|NCT00272961|10846080|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744156|NCT00272961|10846081|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
9744157|NCT00272961|10846077|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10
9744158|NCT00272961|10846078|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8
9744159|NCT00272961|10846079|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11
9744160|NCT00272961|10846080|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10
9744161|NCT00272961|10846081|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10
9744162|NCT00272961|10846077|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
9744163|NCT00272961|10846078|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
9744164|NCT00272961|10846079|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
9744165|NCT00272961|10846080|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
9744166|NCT00272961|10846081|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
9744167|NCT00272961|10846077|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
9744168|NCT00272961|10846078|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
9744169|NCT00272961|10846079|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
9744170|NCT00272961|10846080|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
9744171|NCT00272961|10846081|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
9744172|NCT00272987|10846096|FG000|STARTED|Overall Study||29
9744173|NCT00272987|10846097|FG001|STARTED|Overall Study||14
9744174|NCT00272987|10846098|FG002|STARTED|Overall Study||20
9744175|NCT00272987|10846096|FG000|COMPLETED|Overall Study||20
9744176|NCT00272987|10846097|FG001|COMPLETED|Overall Study||10
9744177|NCT00272987|10846098|FG002|COMPLETED|Overall Study||9
9744178|NCT00272987|10846096|FG000|NOT COMPLETED|Overall Study||9
9744179|NCT00272987|10846097|FG001|NOT COMPLETED|Overall Study||4
9744180|NCT00272987|10846098|FG002|NOT COMPLETED|Overall Study||11
9744181|NCT00273052|10846108|FG000|STARTED|Overall Study||290
9744182|NCT00273052|10846109|FG001|STARTED|Overall Study||278
9744183|NCT00273052|10846108|FG000|COMPLETED|Overall Study||221
9744184|NCT00273052|10846109|FG001|COMPLETED|Overall Study||190
9744185|NCT00273052|10846108|FG000|NOT COMPLETED|Overall Study||69
9744186|NCT00273052|10846109|FG001|NOT COMPLETED|Overall Study||88
9744187|NCT00273182|10846115|FG000|STARTED|Overall Study||1999
9744188|NCT00273182|10846115|FG000|COMPLETED|Overall Study||1014
9744189|NCT00273182|10846115|FG000|NOT COMPLETED|Overall Study||985
9744190|NCT00273364|10846122|FG000|STARTED|Overall Study||55
9744191|NCT00273364|10846123|FG001|STARTED|Overall Study||55
9744192|NCT00273364|10846122|FG000|COMPLETED|Overall Study||55
9744193|NCT00273364|10846123|FG001|COMPLETED|Overall Study||55
9744194|NCT00273364|10846122|FG000|NOT COMPLETED|Overall Study||0
9744195|NCT00273364|10846123|FG001|NOT COMPLETED|Overall Study||0
9744196|NCT00273754|10846131|FG000|STARTED|Overall Study||36
9744197|NCT00273754|10846132|FG001|STARTED|Overall Study||36
9744198|NCT00273754|10846131|FG000|COMPLETED|Overall Study||36
9744199|NCT00273754|10846132|FG001|COMPLETED|Overall Study||36
9744200|NCT00273754|10846131|FG000|NOT COMPLETED|Overall Study||0
9744201|NCT00273754|10846132|FG001|NOT COMPLETED|Overall Study||0
9744202|NCT00273793|10846144|FG000|STARTED|Overall Study||36
9744203|NCT00273793|10846145|FG001|STARTED|Overall Study||38
9744204|NCT00273793|10846146|FG002|STARTED|Overall Study||18
9744205|NCT00273793|10846147|FG003|STARTED|Overall Study||60
9744206|NCT00273793|10846148|FG004|STARTED|Overall Study||58
9744207|NCT00273793|10846149|FG005|STARTED|Overall Study||29
9744208|NCT00273793|10846144|FG000|COMPLETED|Overall Study||36
9744209|NCT00273793|10846145|FG001|COMPLETED|Overall Study||38
9744210|NCT00273793|10846146|FG002|COMPLETED|Overall Study||18
9744211|NCT00273793|10846147|FG003|COMPLETED|Overall Study||60
9744212|NCT00273793|10846148|FG004|COMPLETED|Overall Study||58
9744213|NCT00273793|10846149|FG005|COMPLETED|Overall Study||29
9744214|NCT00273793|10846144|FG000|NOT COMPLETED|Overall Study||0
9744215|NCT00273793|10846145|FG001|NOT COMPLETED|Overall Study||0
9744216|NCT00273793|10846146|FG002|NOT COMPLETED|Overall Study||0
9744217|NCT00273793|10846147|FG003|NOT COMPLETED|Overall Study||0
9744218|NCT00273793|10846148|FG004|NOT COMPLETED|Overall Study||0
9744219|NCT00273793|10846149|FG005|NOT COMPLETED|Overall Study||0
9744220|NCT00273858|10846163|FG000|STARTED|Overall Study||880
9744221|NCT00273858|10846163|FG000|COMPLETED|Overall Study||343
9744222|NCT00273858|10846163|FG000|NOT COMPLETED|Overall Study||537
9744223|NCT00273910|10846173|FG000|STARTED|Overall Study||19
9744224|NCT00273910|10846174|FG001|STARTED|Overall Study||19
9744225|NCT00273910|10846175|FG002|STARTED|Overall Study||18
9744226|NCT00273910|10846176|FG003|STARTED|Overall Study||19
9744227|NCT00273910|10846177|FG004|STARTED|Overall Study||15
9744228|NCT00273910|10846178|FG005|STARTED|Overall Study||14
9744229|NCT00273910|10846173|FG000|COMPLETED|Overall Study||19
9744230|NCT00273910|10846174|FG001|COMPLETED|Overall Study||19
9744231|NCT00273910|10846175|FG002|COMPLETED|Overall Study||18
9744232|NCT00273910|10846176|FG003|COMPLETED|Overall Study||19
9744233|NCT00273910|10846177|FG004|COMPLETED|Overall Study||15
9744234|NCT00273910|10846178|FG005|COMPLETED|Overall Study||14
9744235|NCT00273910|10846173|FG000|NOT COMPLETED|Overall Study||0
9744236|NCT00273910|10846174|FG001|NOT COMPLETED|Overall Study||0
9744237|NCT00273910|10846175|FG002|NOT COMPLETED|Overall Study||0
9744238|NCT00273910|10846176|FG003|NOT COMPLETED|Overall Study||0
9744239|NCT00273910|10846177|FG004|NOT COMPLETED|Overall Study||0
9744240|NCT00273910|10846178|FG005|NOT COMPLETED|Overall Study||0
9744241|NCT00274261|10846194|FG000|STARTED|Overall Study||932
9744242|NCT00274261|10846195|FG001|STARTED|Overall Study||633
9744243|NCT00274261|10846194|FG000|COMPLETED|Overall Study||443
9744244|NCT00274261|10846195|FG001|COMPLETED|Overall Study||296
9744245|NCT00274261|10846194|FG000|NOT COMPLETED|Overall Study||489
9744246|NCT00274261|10846195|FG001|NOT COMPLETED|Overall Study||337
9744247|NCT00274287|10846203|FG000|STARTED|Overall Study||15
9744248|NCT00274287|10846203|FG000|COMPLETED|Overall Study||13
9744249|NCT00274287|10846203|FG000|NOT COMPLETED|Overall Study||2
9744250|NCT00274456|10846212|FG000|STARTED|Overall Study||76
9744251|NCT00274456|10846213|FG001|STARTED|Overall Study||76
9744252|NCT00274456|10846214|FG002|STARTED|Overall Study||74
9744253|NCT00274456|10846215|FG003|STARTED|Overall Study||74
9744254|NCT00274456|10846212|FG000|At Least One Response Assessment|Overall Study||73
9744255|NCT00274456|10846213|FG001|At Least One Response Assessment|Overall Study||76
9744256|NCT00274456|10846214|FG002|At Least One Response Assessment|Overall Study||73
9744257|NCT00274456|10846215|FG003|At Least One Response Assessment|Overall Study||70
9744258|NCT00274456|10846212|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
9744259|NCT00274456|10846213|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
9744260|NCT00274456|10846214|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
9744261|NCT00274456|10846215|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
9744262|NCT00274456|10846212|FG000|NOT COMPLETED|Overall Study||37
9744263|NCT00274456|10846213|FG001|NOT COMPLETED|Overall Study||27
9744264|NCT00274456|10846214|FG002|NOT COMPLETED|Overall Study||35
9744265|NCT00274456|10846215|FG003|NOT COMPLETED|Overall Study||45
9744266|NCT00274469|10846227|FG000|STARTED|Overall Study|Number of patients randomized|102
9744267|NCT00274469|10846228|FG001|STARTED|Overall Study|Number of patients randomized|103
9744268|NCT00274469|10846227|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
9744269|NCT00274469|10846228|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
9744270|NCT00274469|10846227|FG000|NOT COMPLETED|Overall Study||79
9744271|NCT00274469|10846228|FG001|NOT COMPLETED|Overall Study||93
9744272|NCT00274625|10846236|FG000|STARTED|Overall Study||199
9744273|NCT00274625|10846237|FG001|STARTED|Overall Study||203
9744274|NCT00274625|10846236|FG000|COMPLETED|Overall Study||139
9744275|NCT00274625|10846237|FG001|COMPLETED|Overall Study||141
9744276|NCT00274625|10846236|FG000|NOT COMPLETED|Overall Study||60
9744277|NCT00274625|10846237|FG001|NOT COMPLETED|Overall Study||62
9744278|NCT00274651|10846245|FG000|STARTED|Overall Study||29
9744279|NCT00274651|10846246|FG001|STARTED|Overall Study||24
9744280|NCT00274651|10846245|FG000|COMPLETED|Overall Study||1
9744281|NCT00274651|10846246|FG001|COMPLETED|Overall Study||4
9744282|NCT00274651|10846245|FG000|NOT COMPLETED|Overall Study||28
9744283|NCT00274651|10846246|FG001|NOT COMPLETED|Overall Study||20
9744284|NCT00274716|10846259|FG000|STARTED|Phase A||54
9744285|NCT00274716|10846260|FG001|STARTED|Phase A||54
9744286|NCT00274716|10846261|FG002|STARTED|Phase A||52
9744287|NCT00274716|10846262|FG003|STARTED|Phase A||51
9744288|NCT00274716|10846263|FG004|STARTED|Phase A||19
9744289|NCT00274716|10846264|FG005|STARTED|Phase A||19
9744290|NCT00274716|10846259|FG000|COMPLETED|Phase A||43
9744291|NCT00274716|10846260|FG001|COMPLETED|Phase A||44
9744292|NCT00274716|10846261|FG002|COMPLETED|Phase A||44
9744293|NCT00274716|10846262|FG003|COMPLETED|Phase A||42
9744294|NCT00274716|10846263|FG004|COMPLETED|Phase A||16
9744295|NCT00274716|10846264|FG005|COMPLETED|Phase A||15
9744296|NCT00274716|10846259|FG000|NOT COMPLETED|Phase A||11
9744297|NCT00274716|10846260|FG001|NOT COMPLETED|Phase A||10
9744298|NCT00274716|10846261|FG002|NOT COMPLETED|Phase A||8
9744299|NCT00274716|10846262|FG003|NOT COMPLETED|Phase A||9
9744300|NCT00274716|10846263|FG004|NOT COMPLETED|Phase A||3
9744301|NCT00274716|10846264|FG005|NOT COMPLETED|Phase A||4
9744302|NCT00274716|10846259|FG000|STARTED|Phase B||43
9744303|NCT00274716|10846260|FG001|STARTED|Phase B||44
9744304|NCT00274716|10846261|FG002|STARTED|Phase B||44
9744305|NCT00274716|10846262|FG003|STARTED|Phase B||42
9744306|NCT00274716|10846263|FG004|STARTED|Phase B||16
9744307|NCT00274716|10846264|FG005|STARTED|Phase B||15
9744308|NCT00274716|10846259|FG000|COMPLETED|Phase B||42
9744309|NCT00274716|10846260|FG001|COMPLETED|Phase B||40
9744310|NCT00274716|10846261|FG002|COMPLETED|Phase B||41
9744311|NCT00274716|10846262|FG003|COMPLETED|Phase B||41
9744312|NCT00274716|10846263|FG004|COMPLETED|Phase B||16
9744313|NCT00274716|10846264|FG005|COMPLETED|Phase B||14
9744314|NCT00274716|10846259|FG000|NOT COMPLETED|Phase B||1
9744315|NCT00274716|10846260|FG001|NOT COMPLETED|Phase B||4
9744316|NCT00274716|10846261|FG002|NOT COMPLETED|Phase B||3
9744317|NCT00274716|10846262|FG003|NOT COMPLETED|Phase B||1
9744318|NCT00274716|10846263|FG004|NOT COMPLETED|Phase B||0
9744319|NCT00274716|10846264|FG005|NOT COMPLETED|Phase B||1
9744320|NCT00274742|10846288|FG000|STARTED|Overall Study||12
9744321|NCT00274742|10846289|FG001|STARTED|Overall Study||13
9744322|NCT00274742|10846290|FG002|STARTED|Overall Study||6
9744323|NCT00274742|10846291|FG003|STARTED|Overall Study||9
9744324|NCT00274742|10846292|FG004|STARTED|Overall Study||32
9744325|NCT00274742|10846293|FG005|STARTED|Overall Study||4
9744326|NCT00274742|10846288|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
9744327|NCT00274742|10846289|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
9744328|NCT00274742|10846290|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
9744329|NCT00274742|10846291|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
9744330|NCT00274742|10846292|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
9744331|NCT00274742|10846293|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
9744332|NCT00274742|10846288|FG000|NOT COMPLETED|Overall Study||0
9744333|NCT00274742|10846289|FG001|NOT COMPLETED|Overall Study||8
9744334|NCT00274742|10846290|FG002|NOT COMPLETED|Overall Study||2
9744335|NCT00274742|10846291|FG003|NOT COMPLETED|Overall Study||5
9744336|NCT00274742|10846292|FG004|NOT COMPLETED|Overall Study||16
9744337|NCT00274742|10846293|FG005|NOT COMPLETED|Overall Study||3
9744338|NCT00274768|10846313|FG000|STARTED|Overall Study||26
9744339|NCT00274768|10846313|FG000|COMPLETED|Overall Study||26
9744340|NCT00274768|10846313|FG000|NOT COMPLETED|Overall Study||0
9744341|NCT00274781|10846317|FG000|STARTED|Overall Study||30
9852663|NCT00882999|10965565|FG002|COMPLETED|Overall Study||30
9852664|NCT00882999|10965566|FG003|COMPLETED|Overall Study||31
9744342|NCT00274781|10846317|FG000|COMPLETED|Overall Study||30
9744343|NCT00274781|10846317|FG000|NOT COMPLETED|Overall Study||0
9744344|NCT00274846|10846322|FG000|STARTED|Overall Study||21
9744345|NCT00274846|10846322|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
9744346|NCT00274846|10846322|FG000|NOT COMPLETED|Overall Study||1
9744347|NCT00274924|10846330|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
9744348|NCT00274924|10846331|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
9744349|NCT00274924|10846332|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
9744350|NCT00274924|10846330|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17
9744351|NCT00274924|10846331|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77
9744352|NCT00274924|10846332|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5
9744353|NCT00274924|10846330|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
9744354|NCT00274924|10846331|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
9744355|NCT00274924|10846332|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
9744356|NCT00274924|10846330|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
9744357|NCT00274924|10846331|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
9744358|NCT00274924|10846332|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
9744359|NCT00274924|10846330|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
9744360|NCT00274924|10846331|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
9744361|NCT00274924|10846332|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
9744362|NCT00274924|10846330|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
9744363|NCT00274924|10846331|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
9744364|NCT00274924|10846332|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
9744365|NCT00274924|10846330|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
9744366|NCT00274924|10846331|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
9744367|NCT00274924|10846332|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
9744368|NCT00274924|10846330|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
9744369|NCT00274924|10846331|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
9744370|NCT00274924|10846332|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
9744371|NCT00274924|10846330|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
9744372|NCT00274924|10846331|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
9744373|NCT00274924|10846332|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
9744374|NCT00274937|10846339|FG000|STARTED|Overall Study||111
9744375|NCT00274937|10846339|FG000|COMPLETED|Overall Study||91
9744376|NCT00274937|10846339|FG000|NOT COMPLETED|Overall Study||20
9744377|NCT00275002|10846345|FG000|STARTED|Overall Study||25
9744378|NCT00275002|10846346|FG001|STARTED|Overall Study||16
9744379|NCT00275002|10846345|FG000|COMPLETED|Overall Study||3
9744380|NCT00275002|10846346|FG001|COMPLETED|Overall Study||0
9852665|NCT00882999|10965567|FG004|COMPLETED|Overall Study||28
9852666|NCT00882999|10965568|FG005|COMPLETED|Overall Study||28
9744381|NCT00275002|10846345|FG000|NOT COMPLETED|Overall Study||22
9744382|NCT00275002|10846346|FG001|NOT COMPLETED|Overall Study||16
9744383|NCT00275028|10846352|FG000|STARTED|Overall Study||47
9744384|NCT00275028|10846352|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
9744385|NCT00275028|10846352|FG000|NOT COMPLETED|Overall Study||47
9744386|NCT00275262|10846358|FG000|STARTED|Overall Study||12
9744387|NCT00275262|10846359|FG001|STARTED|Overall Study||13
9744388|NCT00275262|10846358|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
9744389|NCT00275262|10846359|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
9744390|NCT00275262|10846358|FG000|NOT COMPLETED|Overall Study||6
9744391|NCT00275262|10846359|FG001|NOT COMPLETED|Overall Study||9
9744392|NCT00275275|10846368|FG000|STARTED|Overall Study||20
9744393|NCT00275275|10846369|FG001|STARTED|Overall Study||20
9744394|NCT00275275|10846370|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
9744395|NCT00275275|10846368|FG000|COMPLETED|Overall Study||14
9744396|NCT00275275|10846369|FG001|COMPLETED|Overall Study||18
9744397|NCT00275275|10846370|FG002|COMPLETED|Overall Study||15
9744398|NCT00275275|10846368|FG000|NOT COMPLETED|Overall Study||6
9744399|NCT00275275|10846369|FG001|NOT COMPLETED|Overall Study||2
9744400|NCT00275275|10846370|FG002|NOT COMPLETED|Overall Study||6
9744401|NCT00275301|10846378|FG000|STARTED|Overall Study||19
9744402|NCT00275301|10846378|FG000|COMPLETED|Overall Study||14
9744403|NCT00275301|10846378|FG000|NOT COMPLETED|Overall Study||5
9744404|NCT00275392|10846384|FG000|STARTED|Overall Study||20
9744405|NCT00275392|10846385|FG001|STARTED|Overall Study||19
9744406|NCT00275392|10846384|FG000|COMPLETED|Overall Study||20
9744407|NCT00275392|10846385|FG001|COMPLETED|Overall Study||17
9744408|NCT00275392|10846384|FG000|NOT COMPLETED|Overall Study||0
9744409|NCT00275392|10846385|FG001|NOT COMPLETED|Overall Study||2
9744410|NCT00275509|10846393|FG000|STARTED|Overall Study||30
9744411|NCT00275509|10846394|FG001|STARTED|Overall Study||26
9744412|NCT00275509|10846393|FG000|COMPLETED|Overall Study||30
9744413|NCT00275509|10846394|FG001|COMPLETED|Overall Study||25
9744414|NCT00275509|10846393|FG000|NOT COMPLETED|Overall Study||0
9744415|NCT00275509|10846394|FG001|NOT COMPLETED|Overall Study||1
9744416|NCT00275561|10846402|FG000|STARTED|Overall Study||21
9744417|NCT00275561|10846403|FG001|STARTED|Overall Study||21
9744418|NCT00275561|10846402|FG000|COMPLETED|Overall Study||19
9744419|NCT00275561|10846403|FG001|COMPLETED|Overall Study||15
9744420|NCT00275561|10846402|FG000|NOT COMPLETED|Overall Study||2
9744421|NCT00275561|10846403|FG001|NOT COMPLETED|Overall Study||6
9744422|NCT00275821|10846412|FG000|STARTED|Overall Study||120
9744423|NCT00275821|10846413|FG001|STARTED|Overall Study||118
9744424|NCT00275821|10846414|FG002|STARTED|Overall Study||115
9744425|NCT00275821|10846412|FG000|COMPLETED|Overall Study||106
9744426|NCT00275821|10846413|FG001|COMPLETED|Overall Study||95
9744427|NCT00275821|10846414|FG002|COMPLETED|Overall Study||103
9744428|NCT00275821|10846412|FG000|NOT COMPLETED|Overall Study||14
9744429|NCT00275821|10846413|FG001|NOT COMPLETED|Overall Study||23
9744430|NCT00275821|10846414|FG002|NOT COMPLETED|Overall Study||12
9744431|NCT00275834|10846425|FG000|STARTED|Overall Study||74
9744432|NCT00275834|10846426|FG001|STARTED|Overall Study||76
9744433|NCT00275834|10846427|FG002|STARTED|Overall Study||75
9744434|NCT00275834|10846425|FG000|Completed Study While on Study Drug|Overall Study||54
9744435|NCT00275834|10846426|FG001|Completed Study While on Study Drug|Overall Study||51
9744436|NCT00275834|10846427|FG002|Completed Study While on Study Drug|Overall Study||62
9744437|NCT00275834|10846425|FG000|COMPLETED|Overall Study||71
9744438|NCT00275834|10846426|FG001|COMPLETED|Overall Study||73
9744439|NCT00275834|10846427|FG002|COMPLETED|Overall Study||74
9744440|NCT00275834|10846425|FG000|NOT COMPLETED|Overall Study||3
9744441|NCT00275834|10846426|FG001|NOT COMPLETED|Overall Study||3
9744442|NCT00275834|10846427|FG002|NOT COMPLETED|Overall Study||1
9744443|NCT00276094|10846440|FG000|STARTED|Overall Study||282
9744444|NCT00276094|10846441|FG001|STARTED|Overall Study||276
9744445|NCT00276094|10846442|FG002|STARTED|Overall Study||268
9744446|NCT00276094|10846440|FG000|COMPLETED|Overall Study||225
9744447|NCT00276094|10846441|FG001|COMPLETED|Overall Study||234
9744448|NCT00276094|10846442|FG002|COMPLETED|Overall Study||230
9744449|NCT00276094|10846440|FG000|NOT COMPLETED|Overall Study||57
9744450|NCT00276094|10846441|FG001|NOT COMPLETED|Overall Study||42
9744451|NCT00276094|10846442|FG002|NOT COMPLETED|Overall Study||38
9744452|NCT00276159|10846450|FG000|STARTED|Overall Study||6
9744453|NCT00276159|10846450|FG000|COMPLETED|Overall Study||0
9744454|NCT00276159|10846450|FG000|NOT COMPLETED|Overall Study||6
9744455|NCT00276250|10846457|FG000|STARTED|Overall Study||4
9744456|NCT00276250|10846458|FG001|STARTED|Overall Study||1
9744457|NCT00276250|10846459|FG002|STARTED|Overall Study||0
9744458|NCT00276250|10846457|FG000|COMPLETED|Overall Study||4
9744459|NCT00276250|10846458|FG001|COMPLETED|Overall Study||1
9744460|NCT00276250|10846459|FG002|COMPLETED|Overall Study||0
9744461|NCT00276250|10846457|FG000|NOT COMPLETED|Overall Study||0
9744462|NCT00276250|10846458|FG001|NOT COMPLETED|Overall Study||0
9744463|NCT00276250|10846459|FG002|NOT COMPLETED|Overall Study||0
9744464|NCT00276380|10846469|FG000|STARTED|Overall Study||102
9744465|NCT00276380|10846470|FG001|STARTED|Overall Study||102
9744466|NCT00276380|10846469|FG000|COMPLETED|Overall Study||88
9744467|NCT00276380|10846470|FG001|COMPLETED|Overall Study||88
9744468|NCT00276380|10846469|FG000|NOT COMPLETED|Overall Study||14
9744469|NCT00276380|10846470|FG001|NOT COMPLETED|Overall Study||14
9744470|NCT00276406|10846479|FG000|STARTED|Overall Study||16
9744471|NCT00276406|10846480|FG001|STARTED|Overall Study||14
9744472|NCT00276406|10846479|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
9744473|NCT00276406|10846480|FG001|COMPLETED|Overall Study||14
9744474|NCT00276406|10846479|FG000|NOT COMPLETED|Overall Study||0
9744475|NCT00276406|10846480|FG001|NOT COMPLETED|Overall Study||0
9744476|NCT00276549|10846486|FG000|STARTED|Overall Study||35
9744477|NCT00276549|10846486|FG000|COMPLETED|Overall Study||35
9744478|NCT00276549|10846486|FG000|NOT COMPLETED|Overall Study||0
9744479|NCT00276614|10846490|FG000|STARTED|Overall Study||4
9744480|NCT00276614|10846490|FG000|COMPLETED|Overall Study||1
9744481|NCT00276614|10846490|FG000|NOT COMPLETED|Overall Study||3
9744482|NCT00276744|10846494|FG000|STARTED|PART A||240
9744483|NCT00276744|10846494|FG000|COMPLETED|PART A||142
9744484|NCT00276744|10846494|FG000|NOT COMPLETED|PART A||98
9744485|NCT00276744|10846494|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
9744486|NCT00276744|10846494|FG000|COMPLETED|PART B||0
9744487|NCT00276744|10846494|FG000|NOT COMPLETED|PART B||0
9744488|NCT00276861|10846498|FG000|STARTED|Overall Study||10
9744489|NCT00276861|10846498|FG000|COMPLETED|Overall Study||10
9744490|NCT00276861|10846498|FG000|NOT COMPLETED|Overall Study||0
9744491|NCT00277095|10846503|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
9744492|NCT00277095|10846503|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
9744493|NCT00277095|10846503|FG000|NOT COMPLETED|Overall Study||21
9744494|NCT00277212|10846507|FG000|STARTED|Phase 1 - Single-Blind Treatment||787
9744495|NCT00277212|10846508|FG001|STARTED|Phase 1 - Single-Blind Treatment||0
9744496|NCT00277212|10846509|FG002|STARTED|Phase 1 - Single-Blind Treatment||0
9744497|NCT00277212|10846507|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
9744498|NCT00277212|10846508|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
9744499|NCT00277212|10846509|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
9744500|NCT00277212|10846507|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
9744501|NCT00277212|10846508|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
9744502|NCT00277212|10846509|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
9744503|NCT00277212|10846507|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352
9744504|NCT00277212|10846508|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0
9744505|NCT00277212|10846509|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0
9744506|NCT00277212|10846507|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
9744507|NCT00277212|10846508|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
9744508|NCT00277212|10846509|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
9744509|NCT00277212|10846507|FG000|STARTED|Phase 2 - Double-Blind Treatment||0
9744510|NCT00277212|10846508|FG001|STARTED|Phase 2 - Double-Blind Treatment||173
9744511|NCT00277212|10846509|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
9744512|NCT00277212|10846507|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
9744513|NCT00277212|10846508|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
9744514|NCT00277212|10846509|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
9744515|NCT00277212|10846507|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
9744516|NCT00277212|10846508|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
9744517|NCT00277212|10846509|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
9744518|NCT00277212|10846507|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0
9744519|NCT00277212|10846508|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53
9744520|NCT00277212|10846509|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65
9744521|NCT00277212|10846507|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
9744522|NCT00277212|10846508|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
9744523|NCT00277212|10846509|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
9744524|NCT00277355|10846519|FG000|STARTED|Overall Study||87
9744525|NCT00277355|10846520|FG001|STARTED|Overall Study||27
9744526|NCT00277355|10846519|FG000|COMPLETED|Overall Study||73
9744527|NCT00277355|10846520|FG001|COMPLETED|Overall Study||22
9744528|NCT00277355|10846519|FG000|NOT COMPLETED|Overall Study||14
9744529|NCT00277355|10846520|FG001|NOT COMPLETED|Overall Study||5
9744530|NCT00277394|10846529|FG000|STARTED|Overall Study||269
9744531|NCT00277394|10846530|FG001|STARTED|Overall Study||270
9744532|NCT00277394|10846529|FG000|COMPLETED|Overall Study||232
9744533|NCT00277394|10846530|FG001|COMPLETED|Overall Study||246
9744534|NCT00277394|10846529|FG000|NOT COMPLETED|Overall Study||37
9744535|NCT00277394|10846530|FG001|NOT COMPLETED|Overall Study||24
9744536|NCT00277446|10846536|FG000|STARTED|Overall Study||13
9744537|NCT00277446|10846536|FG000|COMPLETED|Overall Study||13
9744538|NCT00277446|10846536|FG000|NOT COMPLETED|Overall Study||0
9744539|NCT00277524|10846540|FG000|STARTED|Overall Study||621
9744540|NCT00277524|10846541|FG001|STARTED|Overall Study||324
9744541|NCT00277524|10846542|FG002|STARTED|Overall Study||1088
9744542|NCT00277524|10846543|FG003|STARTED|Overall Study||850
9744543|NCT00277524|10846540|FG000|COMPLETED|Overall Study||621
9744544|NCT00277524|10846541|FG001|COMPLETED|Overall Study||324
9744545|NCT00277524|10846542|FG002|COMPLETED|Overall Study||1088
9744546|NCT00277524|10846543|FG003|COMPLETED|Overall Study||850
9744547|NCT00277524|10846540|FG000|NOT COMPLETED|Overall Study||0
9744548|NCT00277524|10846541|FG001|NOT COMPLETED|Overall Study||0
9744549|NCT00277524|10846542|FG002|NOT COMPLETED|Overall Study||0
9744550|NCT00277524|10846543|FG003|NOT COMPLETED|Overall Study||0
9744551|NCT00278109|10846561|FG000|STARTED|Overall Study||25
9744552|NCT00278109|10846561|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25
9744553|NCT00278109|10846561|FG000|COMPLETED|Overall Study||21
9744554|NCT00278109|10846561|FG000|NOT COMPLETED|Overall Study||4
9828308|NCT00755131|10939046|FG000|NOT COMPLETED|Overall Study||0
9828309|NCT00755131|10939047|FG001|NOT COMPLETED|Overall Study||0
9828310|NCT00755183|10939055|FG000|STARTED|Overall Study||30
9828311|NCT00755183|10939056|FG001|STARTED|Overall Study||30
9828312|NCT00755183|10939055|FG000|COMPLETED|Overall Study||23
9828313|NCT00755183|10939056|FG001|COMPLETED|Overall Study||24
9828314|NCT00755183|10939055|FG000|NOT COMPLETED|Overall Study||7
9828315|NCT00755183|10939056|FG001|NOT COMPLETED|Overall Study||6
9828316|NCT00755196|10939064|FG000|STARTED|Overall Study||30
9828317|NCT00755196|10939064|FG000|COMPLETED|Overall Study||28
9828318|NCT00755196|10939064|FG000|NOT COMPLETED|Overall Study||2
9828319|NCT00755222|10939071|FG000|STARTED|Overall Study||111
9828320|NCT00755222|10939072|FG001|STARTED|Overall Study||36
9828321|NCT00755222|10939071|FG000|COMPLETED|Overall Study||103
9828322|NCT00755222|10939072|FG001|COMPLETED|Overall Study||34
9828323|NCT00755222|10939071|FG000|NOT COMPLETED|Overall Study||8
9828324|NCT00755222|10939072|FG001|NOT COMPLETED|Overall Study||2
9828325|NCT00755235|10939080|FG000|STARTED|Overall Study||106
9828326|NCT00755235|10939081|FG001|STARTED|Overall Study||102
9828327|NCT00755235|10939080|FG000|COMPLETED|Overall Study||104
9828328|NCT00755235|10939081|FG001|COMPLETED|Overall Study||93
9828329|NCT00755235|10939080|FG000|NOT COMPLETED|Overall Study||2
9828330|NCT00755235|10939081|FG001|NOT COMPLETED|Overall Study||9
9828331|NCT00755274|10939089|FG000|STARTED|Overall Study||24
9828332|NCT00755274|10939090|FG001|STARTED|Overall Study||8
9828333|NCT00755274|10939089|FG000|COMPLETED|Overall Study||24
9828334|NCT00755274|10939090|FG001|COMPLETED|Overall Study||8
9828335|NCT00755274|10939089|FG000|NOT COMPLETED|Overall Study||0
9828336|NCT00755274|10939090|FG001|NOT COMPLETED|Overall Study||0
9828337|NCT00755326|10939098|FG000|STARTED|Overall Study||47
9828338|NCT00755326|10939099|FG001|STARTED|Overall Study||45
9828339|NCT00755326|10939098|FG000|COMPLETED|Overall Study||45
9828340|NCT00755326|10939099|FG001|COMPLETED|Overall Study||42
9828341|NCT00755326|10939098|FG000|NOT COMPLETED|Overall Study||2
9828342|NCT00755326|10939099|FG001|NOT COMPLETED|Overall Study||3
9828343|NCT00755417|10939109|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
9828344|NCT00755417|10939110|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
9828345|NCT00755417|10939111|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
9828346|NCT00755417|10939109|FG000|COMPLETED|Overall Study||112
9828347|NCT00755417|10939110|FG001|COMPLETED|Overall Study||126
9828348|NCT00755417|10939111|FG002|COMPLETED|Overall Study||135
9828349|NCT00755417|10939109|FG000|NOT COMPLETED|Overall Study||62
9828350|NCT00755417|10939110|FG001|NOT COMPLETED|Overall Study||55
9828351|NCT00755417|10939111|FG002|NOT COMPLETED|Overall Study||42
9828352|NCT00755716|10939122|FG000|STARTED|Overall Study||19
9828353|NCT00755716|10939123|FG001|STARTED|Overall Study||19
9828354|NCT00755716|10939124|FG002|STARTED|Overall Study||19
9828355|NCT00755716|10939122|FG000|COMPLETED|Overall Study||11
9828356|NCT00755716|10939123|FG001|COMPLETED|Overall Study||11
9828357|NCT00755716|10939124|FG002|COMPLETED|Overall Study||16
9828358|NCT00755716|10939122|FG000|NOT COMPLETED|Overall Study||8
9828359|NCT00755716|10939123|FG001|NOT COMPLETED|Overall Study||8
9828360|NCT00755716|10939124|FG002|NOT COMPLETED|Overall Study||3
9828361|NCT00755755|10939135|FG000|STARTED|Overall Study|Safety population|95
9828362|NCT00755755|10939136|FG001|STARTED|Overall Study|Safety population|98
9828363|NCT00755755|10939137|FG002|STARTED|Overall Study|Safety population|48
9828364|NCT00755755|10939135|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
9828365|NCT00755755|10939136|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
9828366|NCT00755755|10939137|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
9828367|NCT00755755|10939135|FG000|NOT COMPLETED|Overall Study||6
9828368|NCT00755755|10939136|FG001|NOT COMPLETED|Overall Study||8
9828369|NCT00755755|10939137|FG002|NOT COMPLETED|Overall Study||3
9828370|NCT00755807|10939147|FG000|STARTED|Acute Phase||118
9828371|NCT00755807|10939148|FG001|STARTED|Acute Phase||121
9828372|NCT00755807|10939147|FG000|COMPLETED|Acute Phase||100
9828373|NCT00755807|10939148|FG001|COMPLETED|Acute Phase||109
9828374|NCT00755807|10939147|FG000|NOT COMPLETED|Acute Phase||18
9828375|NCT00755807|10939148|FG001|NOT COMPLETED|Acute Phase||12
9828376|NCT00755807|10939147|FG000|STARTED|Open-label Extension Phase||100
9828377|NCT00755807|10939148|FG001|STARTED|Open-label Extension Phase||109
9828378|NCT00755807|10939147|FG000|COMPLETED|Open-label Extension Phase||82
9828379|NCT00755807|10939148|FG001|COMPLETED|Open-label Extension Phase||93
9828380|NCT00755807|10939147|FG000|NOT COMPLETED|Open-label Extension Phase||18
9828381|NCT00755807|10939148|FG001|NOT COMPLETED|Open-label Extension Phase||16
9828382|NCT00755846|10939164|FG000|STARTED|Overall Study||43
9828383|NCT00755846|10939165|FG001|STARTED|Overall Study||44
9828384|NCT00755846|10939166|FG002|STARTED|Overall Study||44
9828385|NCT00755846|10939167|FG003|STARTED|Overall Study||45
9828386|NCT00755846|10939168|FG004|STARTED|Overall Study||44
9828387|NCT00755846|10939169|FG005|STARTED|Overall Study||45
9828388|NCT00755846|10939164|FG000|COMPLETED|Overall Study||18
9828389|NCT00755846|10939165|FG001|COMPLETED|Overall Study||27
9828390|NCT00755846|10939166|FG002|COMPLETED|Overall Study||32
9744555|NCT00278148|10846565|FG000|STARTED|Phase I - Dose Escalation||4
9744556|NCT00278148|10846566|FG001|STARTED|Phase I - Dose Escalation||2
9744557|NCT00278148|10846567|FG002|STARTED|Phase I - Dose Escalation||3
9744558|NCT00278148|10846565|FG000|COMPLETED|Phase I - Dose Escalation||4
9744559|NCT00278148|10846566|FG001|COMPLETED|Phase I - Dose Escalation||2
9744560|NCT00278148|10846567|FG002|COMPLETED|Phase I - Dose Escalation||3
9744561|NCT00278148|10846565|FG000|NOT COMPLETED|Phase I - Dose Escalation||0
9744562|NCT00278148|10846566|FG001|NOT COMPLETED|Phase I - Dose Escalation||0
9744563|NCT00278148|10846567|FG002|NOT COMPLETED|Phase I - Dose Escalation||0
9744564|NCT00278148|10846565|FG000|STARTED|Phase II - Expansion Phase||0
9744565|NCT00278148|10846566|FG001|STARTED|Phase II - Expansion Phase||0
9744566|NCT00278148|10846567|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
9744567|NCT00278148|10846565|FG000|COMPLETED|Phase II - Expansion Phase||0
9744568|NCT00278148|10846566|FG001|COMPLETED|Phase II - Expansion Phase||0
9744569|NCT00278148|10846567|FG002|COMPLETED|Phase II - Expansion Phase||20
9744570|NCT00278148|10846565|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
9744571|NCT00278148|10846566|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
9744572|NCT00278148|10846567|FG002|NOT COMPLETED|Phase II - Expansion Phase||6
9744573|NCT00278161|10846574|FG000|STARTED|Overall Study||81
9744574|NCT00278161|10846574|FG000|COMPLETED|Overall Study||70
9744575|NCT00278161|10846574|FG000|NOT COMPLETED|Overall Study||11
9744576|NCT00278200|10846580|FG000|STARTED|Overall Study||2
9744577|NCT00278200|10846581|FG001|STARTED|Overall Study||12
9744578|NCT00278200|10846580|FG000|COMPLETED|Overall Study||1
9744579|NCT00278200|10846581|FG001|COMPLETED|Overall Study||8
9744580|NCT00278200|10846580|FG000|NOT COMPLETED|Overall Study||1
9744581|NCT00278200|10846581|FG001|NOT COMPLETED|Overall Study||4
9744582|NCT00278395|10846587|FG000|STARTED|Overall Study||14
9744583|NCT00278395|10846587|FG000|COMPLETED|Overall Study||11
9744584|NCT00278395|10846587|FG000|NOT COMPLETED|Overall Study||3
9744585|NCT00278473|10846596|FG000|STARTED|Overall Study||45
9744586|NCT00278473|10846597|FG001|STARTED|Overall Study||43
9744587|NCT00278473|10846596|FG000|COMPLETED|Overall Study||41
9744588|NCT00278473|10846597|FG001|COMPLETED|Overall Study||40
9744589|NCT00278473|10846596|FG000|NOT COMPLETED|Overall Study||4
9744590|NCT00278473|10846597|FG001|NOT COMPLETED|Overall Study||3
9744591|NCT00278512|10846605|FG000|STARTED|Overall Study||7
9744592|NCT00278512|10846606|FG001|STARTED|Overall Study||0
9744593|NCT00278512|10846605|FG000|COMPLETED|Overall Study||6
9744594|NCT00278512|10846606|FG001|COMPLETED|Overall Study||0
9744595|NCT00278512|10846605|FG000|NOT COMPLETED|Overall Study||1
9744596|NCT00278512|10846606|FG001|NOT COMPLETED|Overall Study||0
9744597|NCT00278525|10846614|FG000|STARTED|Overall Study||9
9744598|NCT00278525|10846615|FG001|STARTED|Overall Study||10
9744599|NCT00278525|10846614|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
9744600|NCT00278525|10846615|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
9744601|NCT00278525|10846614|FG000|NOT COMPLETED|Overall Study||0
9744602|NCT00278525|10846615|FG001|NOT COMPLETED|Overall Study||0
9744603|NCT00278538|10846621|FG000|STARTED|Overall Study||32
9744604|NCT00278538|10846621|FG000|COMPLETED|Overall Study||30
9744605|NCT00278538|10846621|FG000|NOT COMPLETED|Overall Study||2
9744606|NCT00278564|10846625|FG000|STARTED|Overall Study||7
9744607|NCT00278564|10846625|FG000|COMPLETED|Overall Study||3
9744608|NCT00278564|10846625|FG000|NOT COMPLETED|Overall Study||4
9744609|NCT00278629|10846629|FG000|STARTED|Overall Study||80
9744610|NCT00278629|10846629|FG000|COMPLETED|Overall Study||66
9744611|NCT00278629|10846629|FG000|NOT COMPLETED|Overall Study||14
9744612|NCT00278655|10846634|FG000|STARTED|Overall Study||21
9744613|NCT00278655|10846634|FG000|COMPLETED|Overall Study||21
9744614|NCT00278655|10846634|FG000|NOT COMPLETED|Overall Study||0
9744615|NCT00278863|10846641|FG000|STARTED|Overall Study||49
9744616|NCT00278863|10846642|FG001|STARTED|Overall Study||47
9744617|NCT00278863|10846641|FG000|COMPLETED|Overall Study||44
9744618|NCT00278863|10846642|FG001|COMPLETED|Overall Study||45
9744619|NCT00278863|10846641|FG000|NOT COMPLETED|Overall Study||5
9744620|NCT00278863|10846642|FG001|NOT COMPLETED|Overall Study||2
9744621|NCT00278876|10846648|FG000|STARTED|Overall Study||47
9744622|NCT00278876|10846648|FG000|COMPLETED|Overall Study||38
9744623|NCT00278876|10846648|FG000|NOT COMPLETED|Overall Study||9
9744624|NCT00278889|10846655|FG000|STARTED|Overall Study|Randomised|73
9744625|NCT00278889|10846656|FG001|STARTED|Overall Study|Randomised|74
9744626|NCT00278889|10846657|FG002|STARTED|Overall Study|Randomised|68
9744627|NCT00278889|10846655|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
9744628|NCT00278889|10846656|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
9744629|NCT00278889|10846657|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
9744630|NCT00278889|10846655|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
9744631|NCT00278889|10846656|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
9744632|NCT00278889|10846657|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
9744633|NCT00278889|10846655|FG000|NOT COMPLETED|Overall Study||25
9744634|NCT00278889|10846656|FG001|NOT COMPLETED|Overall Study||27
9744635|NCT00278889|10846657|FG002|NOT COMPLETED|Overall Study||20
9744636|NCT00278954|10846665|FG000|STARTED|Overall Study||50
9744637|NCT00278954|10846665|FG000|COMPLETED|Overall Study||45
9744638|NCT00278954|10846665|FG000|NOT COMPLETED|Overall Study||5
9744639|NCT00278993|10846669|FG000|STARTED|Overall Study||108
9744640|NCT00278993|10846669|FG000|COMPLETED|Overall Study||1
9744641|NCT00278993|10846669|FG000|NOT COMPLETED|Overall Study||107
9744642|NCT00279201|10846675|FG000|STARTED|Initiation||1046
9744643|NCT00279201|10846676|FG001|STARTED|Initiation||1045
9744644|NCT00279201|10846677|FG002|STARTED|Initiation||0
9744645|NCT00279201|10846678|FG003|STARTED|Initiation||0
9744646|NCT00279201|10846679|FG004|STARTED|Initiation||0
9744647|NCT00279201|10846680|FG005|STARTED|Initiation||0
9744648|NCT00279201|10846675|FG000|COMPLETED|Initiation||918
9744649|NCT00279201|10846676|FG001|COMPLETED|Initiation||900
9744650|NCT00279201|10846677|FG002|COMPLETED|Initiation||0
9744651|NCT00279201|10846678|FG003|COMPLETED|Initiation||0
9744652|NCT00279201|10846679|FG004|COMPLETED|Initiation||0
9744653|NCT00279201|10846680|FG005|COMPLETED|Initiation||0
9744654|NCT00279201|10846675|FG000|NOT COMPLETED|Initiation||128
9744655|NCT00279201|10846676|FG001|NOT COMPLETED|Initiation||145
9744656|NCT00279201|10846677|FG002|NOT COMPLETED|Initiation||0
9744657|NCT00279201|10846678|FG003|NOT COMPLETED|Initiation||0
9744658|NCT00279201|10846679|FG004|NOT COMPLETED|Initiation||0
9744659|NCT00279201|10846680|FG005|NOT COMPLETED|Initiation||0
9744660|NCT00279201|10846675|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
9744661|NCT00279201|10846676|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
9744662|NCT00279201|10846677|FG002|STARTED|Maintenance||0
9744663|NCT00279201|10846678|FG003|STARTED|Maintenance||0
9744664|NCT00279201|10846679|FG004|STARTED|Maintenance||0
9744665|NCT00279201|10846680|FG005|STARTED|Maintenance||0
9744666|NCT00279201|10846675|FG000|COMPLETED|Maintenance||188
9744667|NCT00279201|10846676|FG001|COMPLETED|Maintenance||239
9744668|NCT00279201|10846677|FG002|COMPLETED|Maintenance||0
9744669|NCT00279201|10846678|FG003|COMPLETED|Maintenance||0
9744670|NCT00279201|10846679|FG004|COMPLETED|Maintenance||0
9744671|NCT00279201|10846680|FG005|COMPLETED|Maintenance||0
9744672|NCT00279201|10846675|FG000|NOT COMPLETED|Maintenance||231
9744673|NCT00279201|10846676|FG001|NOT COMPLETED|Maintenance||234
9744674|NCT00279201|10846677|FG002|NOT COMPLETED|Maintenance||0
9744675|NCT00279201|10846678|FG003|NOT COMPLETED|Maintenance||0
9744676|NCT00279201|10846679|FG004|NOT COMPLETED|Maintenance||0
9744677|NCT00279201|10846680|FG005|NOT COMPLETED|Maintenance||0
9744678|NCT00279201|10846675|FG000|STARTED|Intensification Addendum||0
9744679|NCT00279201|10846676|FG001|STARTED|Intensification Addendum||0
9744680|NCT00279201|10846677|FG002|STARTED|Intensification Addendum||174
9744681|NCT00279201|10846678|FG003|STARTED|Intensification Addendum||200
9744682|NCT00279201|10846679|FG004|STARTED|Intensification Addendum||171
9744683|NCT00279201|10846680|FG005|STARTED|Intensification Addendum||199
9744684|NCT00279201|10846675|FG000|COMPLETED|Intensification Addendum||0
9744685|NCT00279201|10846676|FG001|COMPLETED|Intensification Addendum||0
9744686|NCT00279201|10846677|FG002|COMPLETED|Intensification Addendum||151
9744687|NCT00279201|10846678|FG003|COMPLETED|Intensification Addendum||172
9744688|NCT00279201|10846679|FG004|COMPLETED|Intensification Addendum||142
9744689|NCT00279201|10846680|FG005|COMPLETED|Intensification Addendum||162
9744690|NCT00279201|10846675|FG000|NOT COMPLETED|Intensification Addendum||0
9744691|NCT00279201|10846676|FG001|NOT COMPLETED|Intensification Addendum||0
9744692|NCT00279201|10846677|FG002|NOT COMPLETED|Intensification Addendum||23
9744693|NCT00279201|10846678|FG003|NOT COMPLETED|Intensification Addendum||28
9744694|NCT00279201|10846679|FG004|NOT COMPLETED|Intensification Addendum||29
9744695|NCT00279201|10846680|FG005|NOT COMPLETED|Intensification Addendum||37
9744696|NCT00279214|10846715|FG000|STARTED|Overall Study||22
9744697|NCT00279214|10846716|FG001|STARTED|Overall Study||21
9744698|NCT00279214|10846715|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
9744699|NCT00279214|10846716|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
9744700|NCT00279214|10846715|FG000|NOT COMPLETED|Overall Study||3
9744701|NCT00279214|10846716|FG001|NOT COMPLETED|Overall Study||2
9744702|NCT00279305|10846724|FG000|STARTED|Overall Study||57
9744703|NCT00279305|10846725|FG001|STARTED|Overall Study||30
9744704|NCT00279305|10846724|FG000|COMPLETED|Overall Study||49
9744705|NCT00279305|10846725|FG001|COMPLETED|Overall Study||29
9744706|NCT00279305|10846724|FG000|NOT COMPLETED|Overall Study||8
9744707|NCT00279305|10846725|FG001|NOT COMPLETED|Overall Study||1
9744708|NCT00279500|10846731|FG000|STARTED|Overall Study|6 patients treated|6
9744709|NCT00279500|10846731|FG000|COMPLETED|Overall Study|6 patients treated|6
9744710|NCT00279500|10846731|FG000|NOT COMPLETED|Overall Study||0
9744711|NCT00279591|10846737|FG000|STARTED|Overall Study||48
9744712|NCT00279591|10846738|FG001|STARTED|Overall Study||46
9744713|NCT00279591|10846737|FG000|COMPLETED|Overall Study||48
9744714|NCT00279591|10846738|FG001|COMPLETED|Overall Study||46
9744715|NCT00279591|10846737|FG000|NOT COMPLETED|Overall Study||0
9744716|NCT00279591|10846738|FG001|NOT COMPLETED|Overall Study||0
9744717|NCT00279708|10846748|FG000|STARTED|Overall Study|"Started meaning randomized"|27
9744718|NCT00279708|10846749|FG001|STARTED|Overall Study||28
9744719|NCT00279708|10846748|FG000|COMPLETED|Overall Study||24
9744720|NCT00279708|10846749|FG001|COMPLETED|Overall Study||24
9744721|NCT00279708|10846748|FG000|NOT COMPLETED|Overall Study||3
9744722|NCT00279708|10846749|FG001|NOT COMPLETED|Overall Study||4
9744723|NCT00279812|10846761|FG000|STARTED|Overall Study||21
9744724|NCT00279812|10846762|FG001|STARTED|Overall Study||26
9744725|NCT00279812|10846763|FG002|STARTED|Overall Study||24
9744726|NCT00279812|10846764|FG003|STARTED|Overall Study||23
9744727|NCT00279812|10846765|FG004|STARTED|Overall Study||20
9744728|NCT00279812|10846766|FG005|STARTED|Overall Study||19
9744729|NCT00279812|10846761|FG000|COMPLETED|Overall Study||20
9744730|NCT00279812|10846762|FG001|COMPLETED|Overall Study||20
9744731|NCT00279812|10846763|FG002|COMPLETED|Overall Study||21
9744732|NCT00279812|10846764|FG003|COMPLETED|Overall Study||23
9744733|NCT00279812|10846765|FG004|COMPLETED|Overall Study||17
9744734|NCT00279812|10846766|FG005|COMPLETED|Overall Study||18
9744735|NCT00279812|10846761|FG000|NOT COMPLETED|Overall Study||1
9744736|NCT00279812|10846762|FG001|NOT COMPLETED|Overall Study||6
9744737|NCT00279812|10846763|FG002|NOT COMPLETED|Overall Study||3
9744738|NCT00279812|10846764|FG003|NOT COMPLETED|Overall Study||0
9744739|NCT00279812|10846765|FG004|NOT COMPLETED|Overall Study||3
9744740|NCT00279812|10846766|FG005|NOT COMPLETED|Overall Study||1
9744741|NCT00279916|10846782|FG000|STARTED|Overall Study||45
9744742|NCT00279916|10846783|FG001|STARTED|Overall Study||46
9744743|NCT00279916|10846782|FG000|COMPLETED|Overall Study||38
9744744|NCT00279916|10846783|FG001|COMPLETED|Overall Study||41
9744745|NCT00279916|10846782|FG000|NOT COMPLETED|Overall Study||7
9744746|NCT00279916|10846783|FG001|NOT COMPLETED|Overall Study||5
9744747|NCT00279955|10846792|FG000|STARTED|Overall Study||157
9744748|NCT00279955|10846793|FG001|STARTED|Overall Study||486
9744749|NCT00279955|10846794|FG002|STARTED|Overall Study||358
9744750|NCT00279955|10846792|FG000|COMPLETED|Overall Study||157
9744751|NCT00279955|10846793|FG001|COMPLETED|Overall Study||486
9744752|NCT00279955|10846794|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
9744753|NCT00279955|10846792|FG000|NOT COMPLETED|Overall Study||0
9744754|NCT00279955|10846793|FG001|NOT COMPLETED|Overall Study||0
9744755|NCT00279955|10846794|FG002|NOT COMPLETED|Overall Study||0
9744756|NCT00280059|10846803|FG000|STARTED|Efficacy Assessment Phase||330
9744757|NCT00280059|10846804|FG001|STARTED|Efficacy Assessment Phase||330
9744758|NCT00280059|10846803|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
9744759|NCT00280059|10846804|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
9744760|NCT00280059|10846803|FG000|NOT COMPLETED|Efficacy Assessment Phase||94
9744761|NCT00280059|10846804|FG001|NOT COMPLETED|Efficacy Assessment Phase||80
9744762|NCT00280059|10846803|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
9744763|NCT00280059|10846804|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
9744764|NCT00280059|10846803|FG000|COMPLETED|Extension Phase||145
9744765|NCT00280059|10846804|FG001|COMPLETED|Extension Phase||177
9744766|NCT00280059|10846803|FG000|NOT COMPLETED|Extension Phase||49
9744767|NCT00280059|10846804|FG001|NOT COMPLETED|Extension Phase||38
9744768|NCT00280150|10846822|FG000|STARTED|Overall Study||5
9744769|NCT00280150|10846823|FG001|STARTED|Overall Study||5
9744770|NCT00280150|10846824|FG002|STARTED|Overall Study||6
9744771|NCT00280150|10846825|FG003|STARTED|Overall Study||30
9744772|NCT00280150|10846822|FG000|Cohort Induction|Overall Study||5
9744773|NCT00280150|10846823|FG001|Cohort Induction|Overall Study||5
9744774|NCT00280150|10846824|FG002|Cohort Induction|Overall Study||6
9744775|NCT00280150|10846825|FG003|Cohort Induction|Overall Study||30
9744776|NCT00280150|10846822|FG000|Consolidation Therapy|Overall Study||2
9744777|NCT00280150|10846823|FG001|Consolidation Therapy|Overall Study||5
9744778|NCT00280150|10846824|FG002|Consolidation Therapy|Overall Study||3
9744779|NCT00280150|10846825|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
9744780|NCT00280150|10846822|FG000|COMPLETED|Overall Study||2
9744781|NCT00280150|10846823|FG001|COMPLETED|Overall Study||4
9744782|NCT00280150|10846824|FG002|COMPLETED|Overall Study||1
9744783|NCT00280150|10846825|FG003|COMPLETED|Overall Study||20
9744784|NCT00280150|10846822|FG000|NOT COMPLETED|Overall Study||3
9744785|NCT00280150|10846823|FG001|NOT COMPLETED|Overall Study||1
9744786|NCT00280150|10846824|FG002|NOT COMPLETED|Overall Study||5
9744787|NCT00280150|10846825|FG003|NOT COMPLETED|Overall Study||10
9744788|NCT00280241|10846836|FG000|STARTED|Overall Study||65
9744789|NCT00280241|10846836|FG000|COMPLETED|Overall Study||55
9744790|NCT00280241|10846836|FG000|NOT COMPLETED|Overall Study||10
9852667|NCT00882999|10965569|FG006|COMPLETED|Overall Study||27
9852668|NCT00882999|10965563|FG000|NOT COMPLETED|Overall Study||8
9852669|NCT00882999|10965564|FG001|NOT COMPLETED|Overall Study||8
9852670|NCT00882999|10965565|FG002|NOT COMPLETED|Overall Study||4
9852671|NCT00882999|10965566|FG003|NOT COMPLETED|Overall Study||5
9852672|NCT00882999|10965567|FG004|NOT COMPLETED|Overall Study||8
9852673|NCT00882999|10965568|FG005|NOT COMPLETED|Overall Study||7
9852674|NCT00882999|10965569|FG006|NOT COMPLETED|Overall Study||8
9852675|NCT00883051|10965597|FG000|STARTED|Overall Study||106
9852676|NCT00883051|10965598|FG001|STARTED|Overall Study||104
9852677|NCT00883051|10965599|FG002|STARTED|Overall Study||100
9852678|NCT00883051|10965600|FG003|STARTED|Overall Study||99
9852679|NCT00883051|10965601|FG004|STARTED|Overall Study||103
9852680|NCT00883051|10965597|FG000|No Study Medication Used|Overall Study||24
9744791|NCT00280293|10846842|FG000|STARTED|Overall Study||55
9744792|NCT00280293|10846843|FG001|STARTED|Overall Study||57
9744793|NCT00280293|10846842|FG000|COMPLETED|Overall Study||29
9744794|NCT00280293|10846843|FG001|COMPLETED|Overall Study||34
9744795|NCT00280293|10846842|FG000|NOT COMPLETED|Overall Study||26
9852681|NCT00883051|10965598|FG001|No Study Medication Used|Overall Study||22
9852682|NCT00883051|10965599|FG002|No Study Medication Used|Overall Study||29
9744796|NCT00280293|10846843|FG001|NOT COMPLETED|Overall Study||23
9744797|NCT00280384|10846857|FG000|STARTED|Overall Study||6
9744798|NCT00280384|10846858|FG001|STARTED|Overall Study||6
9744799|NCT00280384|10846859|FG002|STARTED|Overall Study||6
9744800|NCT00280384|10846860|FG003|STARTED|Overall Study||6
9744801|NCT00280384|10846861|FG004|STARTED|Overall Study||6
9744802|NCT00280384|10846862|FG005|STARTED|Overall Study||6
9744803|NCT00280384|10846863|FG006|STARTED|Overall Study||6
9744804|NCT00280384|10846864|FG007|STARTED|Overall Study||6
9744805|NCT00280384|10846857|FG000|COMPLETED|Overall Study||6
9744806|NCT00280384|10846858|FG001|COMPLETED|Overall Study||6
9744807|NCT00280384|10846859|FG002|COMPLETED|Overall Study||6
9744808|NCT00280384|10846860|FG003|COMPLETED|Overall Study||6
9744809|NCT00280384|10846861|FG004|COMPLETED|Overall Study||6
9744810|NCT00280384|10846862|FG005|COMPLETED|Overall Study||6
9744811|NCT00280384|10846863|FG006|COMPLETED|Overall Study||6
9744812|NCT00280384|10846864|FG007|COMPLETED|Overall Study||6
9744813|NCT00280384|10846857|FG000|NOT COMPLETED|Overall Study||0
9744814|NCT00280384|10846858|FG001|NOT COMPLETED|Overall Study||0
9744815|NCT00280384|10846859|FG002|NOT COMPLETED|Overall Study||0
9744816|NCT00280384|10846860|FG003|NOT COMPLETED|Overall Study||0
9744817|NCT00280384|10846861|FG004|NOT COMPLETED|Overall Study||0
9744818|NCT00280384|10846862|FG005|NOT COMPLETED|Overall Study||0
9744819|NCT00280384|10846863|FG006|NOT COMPLETED|Overall Study||0
9744820|NCT00280384|10846864|FG007|NOT COMPLETED|Overall Study||0
9744821|NCT00280397|10846882|FG000|STARTED|Overall Study||27
9744822|NCT00280397|10846882|FG000|COMPLETED|Overall Study||26
9744823|NCT00280397|10846882|FG000|NOT COMPLETED|Overall Study||1
9744824|NCT00280566|10846890|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
9744825|NCT00280566|10846891|FG001|STARTED|Period 1 Open Label Ziprasidone||0
9744826|NCT00280566|10846892|FG002|STARTED|Period 1 Open Label Ziprasidone||0
9744827|NCT00280566|10846890|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
9744828|NCT00280566|10846891|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0
9744829|NCT00280566|10846892|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0
9744830|NCT00280566|10846890|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
9744831|NCT00280566|10846891|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
9744832|NCT00280566|10846892|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
9744833|NCT00280566|10846890|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
9744834|NCT00280566|10846891|FG001|STARTED|Period 2 Double Blind||127
9744835|NCT00280566|10846892|FG002|STARTED|Period 2 Double Blind||111
9744836|NCT00280566|10846890|FG000|COMPLETED|Period 2 Double Blind||0
9744837|NCT00280566|10846891|FG001|COMPLETED|Period 2 Double Blind||84
9744838|NCT00280566|10846892|FG002|COMPLETED|Period 2 Double Blind||54
9744839|NCT00280566|10846890|FG000|NOT COMPLETED|Period 2 Double Blind||0
9744840|NCT00280566|10846891|FG001|NOT COMPLETED|Period 2 Double Blind||43
9744841|NCT00280566|10846892|FG002|NOT COMPLETED|Period 2 Double Blind||57
9744842|NCT00280683|10846901|FG000|STARTED|Overall Study||10
9744843|NCT00280683|10846902|FG001|STARTED|Overall Study||10
10091793|NCT02332707|11220106|FG012|STARTED|Overall Study||40
10091794|NCT02332707|11220107|FG013|STARTED|Overall Study||15
9744844|NCT00280683|10846901|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
9744845|NCT00280683|10846902|FG001|COMPLETED|Overall Study||7
9744846|NCT00280683|10846901|FG000|NOT COMPLETED|Overall Study||2
9744847|NCT00280683|10846902|FG001|NOT COMPLETED|Overall Study||3
9744848|NCT00280735|10846910|FG000|STARTED|Overall Study||75
9744849|NCT00280735|10846910|FG000|Received Treatment|Overall Study||72
9744850|NCT00280735|10846910|FG000|Received Adequate Exposure|Overall Study||57
9744851|NCT00280735|10846910|FG000|COMPLETED|Overall Study||57
9744852|NCT00280735|10846910|FG000|NOT COMPLETED|Overall Study||18
9744853|NCT00280748|10846918|FG000|STARTED|Overall Study||10
9744854|NCT00280748|10846918|FG000|COMPLETED|Overall Study||6
9744855|NCT00280748|10846918|FG000|NOT COMPLETED|Overall Study||4
9744856|NCT00280826|10846922|FG000|STARTED|Overall Study||6
9744857|NCT00280826|10846922|FG000|COMPLETED|Overall Study||6
9744858|NCT00280826|10846922|FG000|NOT COMPLETED|Overall Study||0
9744859|NCT00280904|10846926|FG000|STARTED|Overall Study||433
9744860|NCT00280904|10846926|FG000|COMPLETED|Overall Study||433
9744861|NCT00280904|10846926|FG000|NOT COMPLETED|Overall Study||0
9744862|NCT00280917|10846935|FG000|STARTED|Overall Study||65
9744863|NCT00280917|10846936|FG001|STARTED|Overall Study||63
9744864|NCT00280917|10846937|FG002|STARTED|Overall Study||63
9744865|NCT00280917|10846938|FG003|STARTED|Overall Study||63
9744866|NCT00280917|10846935|FG000|COMPLETED|Overall Study||63
9744867|NCT00280917|10846936|FG001|COMPLETED|Overall Study||57
9744868|NCT00280917|10846937|FG002|COMPLETED|Overall Study||57
9744869|NCT00280917|10846938|FG003|COMPLETED|Overall Study||61
9744870|NCT00280917|10846935|FG000|NOT COMPLETED|Overall Study||2
10091795|NCT02332707|11220108|FG014|STARTED|Overall Study||16
10091796|NCT02332707|11220109|FG015|STARTED|Overall Study||26
9744871|NCT00280917|10846936|FG001|NOT COMPLETED|Overall Study||6
9744872|NCT00280917|10846937|FG002|NOT COMPLETED|Overall Study||6
9744873|NCT00280917|10846938|FG003|NOT COMPLETED|Overall Study||2
9744874|NCT00281021|10846948|FG000|STARTED|Overall Study||26
9744875|NCT00281021|10846948|FG000|COMPLETED|Overall Study||24
9744876|NCT00281021|10846948|FG000|NOT COMPLETED|Overall Study||2
9744877|NCT00281099|10846954|FG000|STARTED|Overall Study||513
10091797|NCT02332707|11220110|FG016|STARTED|Overall Study||30
9744878|NCT00281099|10846955|FG001|STARTED|Overall Study||518
9744879|NCT00281099|10846954|FG000|COMPLETED|Overall Study||308
9744880|NCT00281099|10846955|FG001|COMPLETED|Overall Study||296
9744881|NCT00281099|10846954|FG000|NOT COMPLETED|Overall Study||205
9744882|NCT00281099|10846955|FG001|NOT COMPLETED|Overall Study||222
9744883|NCT00281463|10846962|FG000|STARTED|Overall Study||45
9744884|NCT00281463|10846962|FG000|COMPLETED|Overall Study||45
9744885|NCT00281463|10846962|FG000|NOT COMPLETED|Overall Study||0
9744886|NCT00281528|10846969|FG000|STARTED|Overall Study||75
9744887|NCT00281528|10846970|FG001|STARTED|Overall Study||54
9744888|NCT00281528|10846971|FG002|STARTED|Overall Study||79
9744889|NCT00281528|10846969|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
9744890|NCT00281528|10846970|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
9744891|NCT00281528|10846971|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
9744892|NCT00281528|10846969|FG000|NOT COMPLETED|Overall Study||75
9744893|NCT00281528|10846970|FG001|NOT COMPLETED|Overall Study||54
9744894|NCT00281528|10846971|FG002|NOT COMPLETED|Overall Study||79
9744895|NCT00281580|10846995|FG000|STARTED|Overall Study||46
9744896|NCT00281580|10846996|FG001|STARTED|Overall Study||42
9744897|NCT00281580|10846997|FG002|STARTED|Overall Study||130
9744898|NCT00281580|10846998|FG003|STARTED|Overall Study||135
9744899|NCT00281580|10846999|FG004|STARTED|Overall Study||44
9744900|NCT00281580|10847000|FG005|STARTED|Overall Study||46
9744901|NCT00281580|10847001|FG006|STARTED|Overall Study||44
9744902|NCT00281580|10847002|FG007|STARTED|Overall Study||47
9744903|NCT00281580|10847003|FG008|STARTED|Overall Study||143
9744904|NCT00281580|10847004|FG009|STARTED|Overall Study||129
9744905|NCT00281580|10847005|FG010|STARTED|Overall Study||48
9744906|NCT00281580|10847006|FG011|STARTED|Overall Study||146
9744907|NCT00281580|10847007|FG012|STARTED|Overall Study||142
9744908|NCT00281580|10847008|FG013|STARTED|Overall Study||50
9744909|NCT00281580|10847009|FG014|STARTED|Overall Study||140
9744910|NCT00281580|10847010|FG015|STARTED|Overall Study||129
9744911|NCT00281580|10846995|FG000|COMPLETED|Overall Study||39
9744912|NCT00281580|10846996|FG001|COMPLETED|Overall Study||41
9744913|NCT00281580|10846997|FG002|COMPLETED|Overall Study||125
9744914|NCT00281580|10846998|FG003|COMPLETED|Overall Study||118
9744915|NCT00281580|10846999|FG004|COMPLETED|Overall Study||40
9744916|NCT00281580|10847000|FG005|COMPLETED|Overall Study||43
9744917|NCT00281580|10847001|FG006|COMPLETED|Overall Study||39
9744918|NCT00281580|10847002|FG007|COMPLETED|Overall Study||46
9744919|NCT00281580|10847003|FG008|COMPLETED|Overall Study||135
9744920|NCT00281580|10847004|FG009|COMPLETED|Overall Study||117
9744921|NCT00281580|10847005|FG010|COMPLETED|Overall Study||44
9744922|NCT00281580|10847006|FG011|COMPLETED|Overall Study||136
9744923|NCT00281580|10847007|FG012|COMPLETED|Overall Study||129
9744924|NCT00281580|10847008|FG013|COMPLETED|Overall Study||43
9744925|NCT00281580|10847009|FG014|COMPLETED|Overall Study||133
9744926|NCT00281580|10847010|FG015|COMPLETED|Overall Study||116
9744927|NCT00281580|10846995|FG000|NOT COMPLETED|Overall Study||7
9744928|NCT00281580|10846996|FG001|NOT COMPLETED|Overall Study||1
9744929|NCT00281580|10846997|FG002|NOT COMPLETED|Overall Study||5
9744930|NCT00281580|10846998|FG003|NOT COMPLETED|Overall Study||17
9744931|NCT00281580|10846999|FG004|NOT COMPLETED|Overall Study||4
9744932|NCT00281580|10847000|FG005|NOT COMPLETED|Overall Study||3
9744933|NCT00281580|10847001|FG006|NOT COMPLETED|Overall Study||5
9744934|NCT00281580|10847002|FG007|NOT COMPLETED|Overall Study||1
9744935|NCT00281580|10847003|FG008|NOT COMPLETED|Overall Study||8
9744936|NCT00281580|10847004|FG009|NOT COMPLETED|Overall Study||12
9744937|NCT00281580|10847005|FG010|NOT COMPLETED|Overall Study||4
9744938|NCT00281580|10847006|FG011|NOT COMPLETED|Overall Study||10
9744939|NCT00281580|10847007|FG012|NOT COMPLETED|Overall Study||13
9744940|NCT00281580|10847008|FG013|NOT COMPLETED|Overall Study||7
9744941|NCT00281580|10847009|FG014|NOT COMPLETED|Overall Study||7
9744942|NCT00281580|10847010|FG015|NOT COMPLETED|Overall Study||13
9744943|NCT00281632|10847079|FG000|STARTED|Overall Study||36
9744944|NCT00281632|10847079|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
9744945|NCT00281632|10847079|FG000|NOT COMPLETED|Overall Study||36
9744946|NCT00281671|10847091|FG000|STARTED|Overall Study||5
9744947|NCT00281671|10847092|FG001|STARTED|Overall Study||4
9744948|NCT00281671|10847091|FG000|COMPLETED|Overall Study||5
9744949|NCT00281671|10847092|FG001|COMPLETED|Overall Study||4
9744950|NCT00281671|10847091|FG000|NOT COMPLETED|Overall Study||0
9744951|NCT00281671|10847092|FG001|NOT COMPLETED|Overall Study||0
9744952|NCT00281684|10847105|FG000|STARTED|Overall Study||37
9744953|NCT00281684|10847106|FG001|STARTED|Overall Study||36
9744954|NCT00281684|10847107|FG002|STARTED|Overall Study||34
9744955|NCT00281684|10847108|FG003|STARTED|Overall Study||38
9744956|NCT00281684|10847105|FG000|COMPLETED|Overall Study||36
9744957|NCT00281684|10847106|FG001|COMPLETED|Overall Study||36
9744958|NCT00281684|10847107|FG002|COMPLETED|Overall Study||33
9744959|NCT00281684|10847108|FG003|COMPLETED|Overall Study||38
9744960|NCT00281684|10847105|FG000|NOT COMPLETED|Overall Study||1
9744961|NCT00281684|10847106|FG001|NOT COMPLETED|Overall Study||0
9744962|NCT00281684|10847107|FG002|NOT COMPLETED|Overall Study||1
9744963|NCT00281684|10847108|FG003|NOT COMPLETED|Overall Study||0
9744964|NCT00281697|10847122|FG000|STARTED|Overall Study||459
9744965|NCT00281697|10847123|FG001|STARTED|Overall Study||225
9744966|NCT00281697|10847122|FG000|COMPLETED|Overall Study||58
9744967|NCT00281697|10847123|FG001|COMPLETED|Overall Study||28
9744968|NCT00281697|10847122|FG000|NOT COMPLETED|Overall Study||401
9744969|NCT00281697|10847123|FG001|NOT COMPLETED|Overall Study||197
9744970|NCT00281827|10847129|FG000|STARTED|Overall Study||22
9744971|NCT00281827|10847129|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
9744972|NCT00281827|10847129|FG000|NOT COMPLETED|Overall Study||0
9744973|NCT00281840|10847135|FG000|STARTED|Overall Study||30
9744974|NCT00281840|10847135|FG000|COMPLETED|Overall Study||5
9744975|NCT00281840|10847135|FG000|NOT COMPLETED|Overall Study||25
9744976|NCT00281918|10847142|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
9744977|NCT00281918|10847143|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
9744978|NCT00281918|10847142|FG000|Safety Population; Received Study Drug|Overall Study||398
9744979|NCT00281918|10847143|FG001|Safety Population; Received Study Drug|Overall Study||402
9744980|NCT00281918|10847142|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
9744981|NCT00281918|10847143|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
9744982|NCT00281918|10847142|FG000|NOT COMPLETED|Overall Study||142
9744983|NCT00281918|10847143|FG001|NOT COMPLETED|Overall Study||108
9744984|NCT00281957|10847151|FG000|STARTED|Overall Study||67
9744985|NCT00281957|10847152|FG001|STARTED|Overall Study||42
9744986|NCT00281957|10847151|FG000|Eligible|Overall Study||66
9744987|NCT00281957|10847152|FG001|Eligible|Overall Study||40
9744988|NCT00281957|10847151|FG000|Eligible and Received Treatment|Overall Study||63
9744989|NCT00281957|10847152|FG001|Eligible and Received Treatment|Overall Study||39
9744990|NCT00281957|10847151|FG000|COMPLETED|Overall Study||0
9744991|NCT00281957|10847152|FG001|COMPLETED|Overall Study||0
9744992|NCT00281957|10847151|FG000|NOT COMPLETED|Overall Study||67
9744993|NCT00281957|10847152|FG001|NOT COMPLETED|Overall Study||42
9744994|NCT00282048|10847160|FG000|STARTED|Overall Study||62
9744995|NCT00282048|10847160|FG000|COMPLETED|Overall Study||0
9744996|NCT00282048|10847160|FG000|NOT COMPLETED|Overall Study||62
9744997|NCT00282087|10847164|FG000|STARTED|Overall Study||47
9744998|NCT00282087|10847164|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
9744999|NCT00282087|10847164|FG000|NOT COMPLETED|Overall Study||1
9745000|NCT00282113|10847172|FG000|STARTED|Overall Study||31
9745001|NCT00282113|10847173|FG001|STARTED|Overall Study||30
9745002|NCT00282113|10847174|FG002|STARTED|Overall Study||29
9745003|NCT00282113|10847172|FG000|COMPLETED|Overall Study||30
9745004|NCT00282113|10847173|FG001|COMPLETED|Overall Study||30
9745005|NCT00282113|10847174|FG002|COMPLETED|Overall Study||29
9745006|NCT00282113|10847172|FG000|NOT COMPLETED|Overall Study||1
9745007|NCT00282113|10847173|FG001|NOT COMPLETED|Overall Study||0
9745008|NCT00282113|10847174|FG002|NOT COMPLETED|Overall Study||0
9745009|NCT00282152|10847184|FG000|STARTED|Overall Study||15
9745010|NCT00282152|10847185|FG001|STARTED|Overall Study||15
9745011|NCT00282152|10847184|FG000|COMPLETED|Overall Study||14
9745012|NCT00282152|10847185|FG001|COMPLETED|Overall Study||15
9745013|NCT00282152|10847184|FG000|NOT COMPLETED|Overall Study||1
9745014|NCT00282152|10847185|FG001|NOT COMPLETED|Overall Study||0
9745015|NCT00282243|10847192|FG000|STARTED|Pharmacokinetic Treatment Period||70
9745016|NCT00282243|10847192|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70
9745017|NCT00282243|10847192|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
9745018|NCT00282243|10847192|FG000|COMPLETED|Pharmacokinetic Treatment Period||65
9745019|NCT00282243|10847192|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5
9745020|NCT00282243|10847192|FG000|STARTED|Extension Treatment Period||65
9745021|NCT00282243|10847192|FG000|COMPLETED|Extension Treatment Period||43
9745022|NCT00282243|10847192|FG000|NOT COMPLETED|Extension Treatment Period||22
9745023|NCT00282256|10847196|FG000|STARTED|Pharmacokinetic Treatment Period||19
9745024|NCT00282256|10847196|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19
9745025|NCT00282256|10847196|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
9745026|NCT00282256|10847196|FG000|COMPLETED|Pharmacokinetic Treatment Period||18
9745027|NCT00282256|10847196|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1
9745028|NCT00282256|10847196|FG000|STARTED|Extension Treatment Period||18
9745029|NCT00282256|10847196|FG000|COMPLETED|Extension Treatment Period||16
9745030|NCT00282256|10847196|FG000|NOT COMPLETED|Extension Treatment Period||2
9745031|NCT00282282|10847200|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
9745032|NCT00282282|10847200|FG000|COMPLETED|Overall Study||29
9745033|NCT00282282|10847200|FG000|NOT COMPLETED|Overall Study||0
9745034|NCT00282295|10847208|FG000|STARTED|Overall Study||446
9745035|NCT00282295|10847209|FG001|STARTED|Overall Study||446
9745036|NCT00282295|10847210|FG002|STARTED|Overall Study||449
9745037|NCT00282295|10847208|FG000|COMPLETED|Overall Study||443
9745038|NCT00282295|10847209|FG001|COMPLETED|Overall Study||429
9745039|NCT00282295|10847210|FG002|COMPLETED|Overall Study||441
9745040|NCT00282295|10847208|FG000|NOT COMPLETED|Overall Study||3
9745041|NCT00282295|10847209|FG001|NOT COMPLETED|Overall Study||17
9745042|NCT00282295|10847210|FG002|NOT COMPLETED|Overall Study||8
9745043|NCT00282308|10847225|FG000|STARTED|Treatment Period||69
9745044|NCT00282308|10847226|FG001|STARTED|Treatment Period||34
9745045|NCT00282308|10847227|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
9745046|NCT00282308|10847225|FG000|COMPLETED|Treatment Period||65
9745047|NCT00282308|10847226|FG001|COMPLETED|Treatment Period||28
9745048|NCT00282308|10847227|FG002|COMPLETED|Treatment Period||0
9745049|NCT00282308|10847225|FG000|NOT COMPLETED|Treatment Period||4
9745050|NCT00282308|10847226|FG001|NOT COMPLETED|Treatment Period||6
9745051|NCT00282308|10847227|FG002|NOT COMPLETED|Treatment Period||0
9745052|NCT00282308|10847225|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
9745053|NCT00282308|10847226|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
9828391|NCT00755846|10939167|FG003|COMPLETED|Overall Study||32
9828392|NCT00755846|10939168|FG004|COMPLETED|Overall Study||27
9852683|NCT00883051|10965600|FG003|No Study Medication Used|Overall Study||29
9828393|NCT00755846|10939169|FG005|COMPLETED|Overall Study||31
9828394|NCT00755846|10939164|FG000|NOT COMPLETED|Overall Study||25
9828395|NCT00755846|10939165|FG001|NOT COMPLETED|Overall Study||17
9828396|NCT00755846|10939166|FG002|NOT COMPLETED|Overall Study||12
9828397|NCT00755846|10939167|FG003|NOT COMPLETED|Overall Study||13
9828398|NCT00755846|10939168|FG004|NOT COMPLETED|Overall Study||17
9828399|NCT00755846|10939169|FG005|NOT COMPLETED|Overall Study||14
9828400|NCT00755911|10939185|FG000|STARTED|Overall Study||12
9828401|NCT00755911|10939186|FG001|STARTED|Overall Study||12
9828402|NCT00755911|10939185|FG000|COMPLETED|Overall Study||12
9828403|NCT00755911|10939186|FG001|COMPLETED|Overall Study||12
9828404|NCT00755911|10939185|FG000|NOT COMPLETED|Overall Study||0
9828405|NCT00755911|10939186|FG001|NOT COMPLETED|Overall Study||0
9828406|NCT00755937|10939192|FG000|STARTED|Recruitment|Subjects registered in the program|556
9828407|NCT00755937|10939192|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
9828408|NCT00755937|10939192|FG000|NOT COMPLETED|Recruitment||164
9828409|NCT00755937|10939192|FG000|STARTED|Observational Follow-up||392
9828410|NCT00755937|10939192|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
9828411|NCT00755937|10939192|FG000|NOT COMPLETED|Observational Follow-up||148
9828412|NCT00756002|10939198|FG000|STARTED|Placebo Run-in||488
9828413|NCT00756002|10939199|FG001|STARTED|Placebo Run-in||0
9828414|NCT00756002|10939198|FG000|COMPLETED|Placebo Run-in||259
9828415|NCT00756002|10939199|FG001|COMPLETED|Placebo Run-in||0
9828416|NCT00756002|10939198|FG000|NOT COMPLETED|Placebo Run-in||229
9828417|NCT00756002|10939199|FG001|NOT COMPLETED|Placebo Run-in||0
9828418|NCT00756002|10939198|FG000|STARTED|Double-Blind Treatment Period||129
9828419|NCT00756002|10939199|FG001|STARTED|Double-Blind Treatment Period||130
9828420|NCT00756002|10939198|FG000|COMPLETED|Double-Blind Treatment Period||114
9828421|NCT00756002|10939199|FG001|COMPLETED|Double-Blind Treatment Period||115
9828422|NCT00756002|10939198|FG000|NOT COMPLETED|Double-Blind Treatment Period||15
9828423|NCT00756002|10939199|FG001|NOT COMPLETED|Double-Blind Treatment Period||15
9828424|NCT00756002|10939198|FG000|STARTED|Placebo Run-out||114
9828425|NCT00756002|10939199|FG001|STARTED|Placebo Run-out||0
9828426|NCT00756002|10939198|FG000|COMPLETED|Placebo Run-out||114
9828427|NCT00756002|10939199|FG001|COMPLETED|Placebo Run-out||0
9828428|NCT00756002|10939198|FG000|NOT COMPLETED|Placebo Run-out||0
9828429|NCT00756002|10939199|FG001|NOT COMPLETED|Placebo Run-out||0
9828430|NCT00756093|10939205|FG000|STARTED|First Intervention||5
9828431|NCT00756093|10939206|FG001|STARTED|First Intervention||5
9828432|NCT00756093|10939207|FG002|STARTED|First Intervention||5
9828433|NCT00756093|10939208|FG003|STARTED|First Intervention||5
9828434|NCT00756093|10939205|FG000|COMPLETED|First Intervention||5
9828435|NCT00756093|10939206|FG001|COMPLETED|First Intervention||5
9828436|NCT00756093|10939207|FG002|COMPLETED|First Intervention||5
9828437|NCT00756093|10939208|FG003|COMPLETED|First Intervention||5
9828438|NCT00756093|10939205|FG000|NOT COMPLETED|First Intervention||0
9828439|NCT00756093|10939206|FG001|NOT COMPLETED|First Intervention||0
9828440|NCT00756093|10939207|FG002|NOT COMPLETED|First Intervention||0
9828441|NCT00756093|10939208|FG003|NOT COMPLETED|First Intervention||0
9828442|NCT00756093|10939205|FG000|STARTED|Second Intervention||5
9828443|NCT00756093|10939206|FG001|STARTED|Second Intervention||5
9828444|NCT00756093|10939207|FG002|STARTED|Second Intervention||5
9828445|NCT00756093|10939208|FG003|STARTED|Second Intervention||5
9828446|NCT00756093|10939205|FG000|COMPLETED|Second Intervention||5
9828447|NCT00756093|10939206|FG001|COMPLETED|Second Intervention||5
9828448|NCT00756093|10939207|FG002|COMPLETED|Second Intervention||5
9828449|NCT00756093|10939208|FG003|COMPLETED|Second Intervention||5
9828450|NCT00756093|10939205|FG000|NOT COMPLETED|Second Intervention||0
9828451|NCT00756093|10939206|FG001|NOT COMPLETED|Second Intervention||0
9828452|NCT00756093|10939207|FG002|NOT COMPLETED|Second Intervention||0
9828453|NCT00756093|10939208|FG003|NOT COMPLETED|Second Intervention||0
9828454|NCT00756093|10939205|FG000|STARTED|Third Intervention||5
9828455|NCT00756093|10939206|FG001|STARTED|Third Intervention||5
9828456|NCT00756093|10939207|FG002|STARTED|Third Intervention||5
9828457|NCT00756093|10939208|FG003|STARTED|Third Intervention||5
9828458|NCT00756093|10939205|FG000|COMPLETED|Third Intervention||5
9828459|NCT00756093|10939206|FG001|COMPLETED|Third Intervention||5
9828460|NCT00756093|10939207|FG002|COMPLETED|Third Intervention||5
9828461|NCT00756093|10939208|FG003|COMPLETED|Third Intervention||5
9828462|NCT00756093|10939205|FG000|NOT COMPLETED|Third Intervention||0
9828463|NCT00756093|10939206|FG001|NOT COMPLETED|Third Intervention||0
9828464|NCT00756093|10939207|FG002|NOT COMPLETED|Third Intervention||0
9745054|NCT00282308|10847227|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
9745055|NCT00282308|10847225|FG000|COMPLETED|Optional Extension Re-treatment Period||0
9745056|NCT00282308|10847226|FG001|COMPLETED|Optional Extension Re-treatment Period||0
9745057|NCT00282308|10847227|FG002|COMPLETED|Optional Extension Re-treatment Period||72
9745058|NCT00282308|10847225|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0
9745059|NCT00282308|10847226|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0
9745060|NCT00282308|10847227|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6
9745061|NCT00282308|10847225|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
9745062|NCT00282308|10847226|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
9745063|NCT00282308|10847227|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
9745064|NCT00282308|10847225|FG000|COMPLETED|Safety Follow-up Period||0
9745065|NCT00282308|10847226|FG001|COMPLETED|Safety Follow-up Period||0
9745066|NCT00282308|10847227|FG002|COMPLETED|Safety Follow-up Period||81
9745067|NCT00282308|10847225|FG000|NOT COMPLETED|Safety Follow-up Period||0
9745068|NCT00282308|10847226|FG001|NOT COMPLETED|Safety Follow-up Period||0
9745069|NCT00282308|10847227|FG002|NOT COMPLETED|Safety Follow-up Period||19
9745070|NCT00282334|10847239|FG000|STARTED|Overall Study||113
9745071|NCT00282334|10847240|FG001|STARTED|Overall Study||123
9745072|NCT00282334|10847239|FG000|COMPLETED|Overall Study||105
9745073|NCT00282334|10847240|FG001|COMPLETED|Overall Study||118
9745074|NCT00282334|10847239|FG000|NOT COMPLETED|Overall Study||8
9745075|NCT00282334|10847240|FG001|NOT COMPLETED|Overall Study||5
9745076|NCT00282347|10847248|FG000|STARTED|Treatment Period||72
9745077|NCT00282347|10847249|FG001|STARTED|Treatment Period||72
9745078|NCT00282347|10847248|FG000|COMPLETED|Treatment Period||67
9745079|NCT00282347|10847249|FG001|COMPLETED|Treatment Period||63
9745080|NCT00282347|10847248|FG000|NOT COMPLETED|Treatment Period||5
9745081|NCT00282347|10847249|FG001|NOT COMPLETED|Treatment Period||9
9745082|NCT00282347|10847248|FG000|STARTED|Safety Follow-up Period||67
9745083|NCT00282347|10847249|FG001|STARTED|Safety Follow-up Period||63
9745084|NCT00282347|10847248|FG000|COMPLETED|Safety Follow-up Period||64
9745085|NCT00282347|10847249|FG001|COMPLETED|Safety Follow-up Period||57
9745086|NCT00282347|10847248|FG000|NOT COMPLETED|Safety Follow-up Period||3
9745087|NCT00282347|10847249|FG001|NOT COMPLETED|Safety Follow-up Period||6
9745088|NCT00282347|10847248|FG000|STARTED|B Cell Follow-up Period||20
9745089|NCT00282347|10847249|FG001|STARTED|B Cell Follow-up Period||4
9745090|NCT00282347|10847248|FG000|COMPLETED|B Cell Follow-up Period||15
9745091|NCT00282347|10847249|FG001|COMPLETED|B Cell Follow-up Period||4
9745092|NCT00282347|10847248|FG000|NOT COMPLETED|B Cell Follow-up Period||5
9745093|NCT00282347|10847249|FG001|NOT COMPLETED|B Cell Follow-up Period||0
9745094|NCT00282412|10847257|FG000|STARTED|Overall Study||4
9745095|NCT00282412|10847257|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
9745096|NCT00282412|10847257|FG000|NOT COMPLETED|Overall Study||2
9745097|NCT00282438|10847263|FG000|STARTED|Overall Study||1
9852684|NCT00883051|10965601|FG004|No Study Medication Used|Overall Study||17
9852685|NCT00883051|10965597|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
9852686|NCT00883051|10965598|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
9852687|NCT00883051|10965599|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
9852688|NCT00883051|10965600|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70
9852689|NCT00883051|10965601|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86
9852690|NCT00883051|10965597|FG000|COMPLETED|Overall Study||82
9852691|NCT00883051|10965598|FG001|COMPLETED|Overall Study||82
9852692|NCT00883051|10965599|FG002|COMPLETED|Overall Study||71
9852693|NCT00883051|10965600|FG003|COMPLETED|Overall Study||70
9852694|NCT00883051|10965601|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
9852695|NCT00883051|10965597|FG000|NOT COMPLETED|Overall Study||24
9852696|NCT00883051|10965598|FG001|NOT COMPLETED|Overall Study||22
9852697|NCT00883051|10965599|FG002|NOT COMPLETED|Overall Study||29
9852698|NCT00883051|10965600|FG003|NOT COMPLETED|Overall Study||29
9852699|NCT00883051|10965601|FG004|NOT COMPLETED|Overall Study||18
9852700|NCT00883090|10965613|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
9852701|NCT00883090|10965613|FG000|COMPLETED|Overall Study||13
9852702|NCT00883090|10965613|FG000|NOT COMPLETED|Overall Study||2
9852703|NCT00883103|10965619|FG000|STARTED|Overall Study||69
9852704|NCT00883103|10965620|FG001|STARTED|Overall Study||68
9852705|NCT00883103|10965619|FG000|COMPLETED|Overall Study||69
9852706|NCT00883103|10965620|FG001|COMPLETED|Overall Study||68
9852707|NCT00883103|10965619|FG000|NOT COMPLETED|Overall Study||0
9852708|NCT00883103|10965620|FG001|NOT COMPLETED|Overall Study||0
9852709|NCT00883116|10965628|FG000|STARTED|Overall Study||248
9852710|NCT00883116|10965629|FG001|STARTED|Overall Study||248
10201733|NCT03440411|11329118|FG000|COMPLETED|Overall Study||0
9745098|NCT00282438|10847264|FG001|STARTED|Overall Study||1
9745099|NCT00282438|10847263|FG000|COMPLETED|Overall Study||0
9852711|NCT00883116|10965628|FG000|Received Treatment|Overall Study||248
9852712|NCT00883116|10965629|FG001|Received Treatment|Overall Study||239
9852713|NCT00883116|10965628|FG000|COMPLETED|Overall Study||39
9852714|NCT00883116|10965629|FG001|COMPLETED|Overall Study||29
9852715|NCT00883116|10965628|FG000|NOT COMPLETED|Overall Study||209
9852716|NCT00883116|10965629|FG001|NOT COMPLETED|Overall Study||219
10201734|NCT03440411|11329119|FG001|COMPLETED|Overall Study||0
10201735|NCT03440411|11329120|FG002|COMPLETED|Overall Study||0
10201736|NCT03440411|11329121|FG003|COMPLETED|Overall Study||0
10201737|NCT03440411|11329118|FG000|NOT COMPLETED|Overall Study||3
9852717|NCT00883129|10965639|FG000|STARTED|Overall Study||69
9852718|NCT00883129|10965640|FG001|STARTED|Overall Study||73
9852719|NCT00883129|10965639|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
9852720|NCT00883129|10965640|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
9852721|NCT00883129|10965639|FG000|NOT COMPLETED|Overall Study||20
9852722|NCT00883129|10965640|FG001|NOT COMPLETED|Overall Study||36
9852723|NCT00883168|10965650|FG000|STARTED|Overall Study||448
9852724|NCT00883168|10965651|FG001|STARTED|Overall Study||445
9852725|NCT00883168|10965652|FG002|STARTED|Overall Study||450
9852726|NCT00883168|10965653|FG003|STARTED|Overall Study||448
9852727|NCT00883168|10965650|FG000|COMPLETED|Overall Study||434
9852728|NCT00883168|10965651|FG001|COMPLETED|Overall Study||430
9852729|NCT00883168|10965652|FG002|COMPLETED|Overall Study||431
9852730|NCT00883168|10965653|FG003|COMPLETED|Overall Study||433
9852731|NCT00883168|10965650|FG000|NOT COMPLETED|Overall Study||14
9852732|NCT00883168|10965651|FG001|NOT COMPLETED|Overall Study||15
9852733|NCT00883168|10965652|FG002|NOT COMPLETED|Overall Study||19
9852734|NCT00883168|10965653|FG003|NOT COMPLETED|Overall Study||15
9852735|NCT00883181|10965663|FG000|STARTED|Overall Study|Full analysis set|1347
9852736|NCT00883181|10965663|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069
9852737|NCT00883181|10965663|FG000|NOT COMPLETED|Overall Study||278
9852738|NCT00883233|10965684|FG000|STARTED|Overall Study||32
9852739|NCT00883233|10965685|FG001|STARTED|Overall Study||32
9852740|NCT00883233|10965686|FG002|STARTED|Overall Study||29
9852741|NCT00883233|10965687|FG003|STARTED|Overall Study||30
9852742|NCT00883233|10965684|FG000|COMPLETED|Overall Study||27
9852743|NCT00883233|10965685|FG001|COMPLETED|Overall Study||28
9852744|NCT00883233|10965686|FG002|COMPLETED|Overall Study||25
9852745|NCT00883233|10965687|FG003|COMPLETED|Overall Study||25
9852746|NCT00883233|10965684|FG000|NOT COMPLETED|Overall Study||5
9852747|NCT00883233|10965685|FG001|NOT COMPLETED|Overall Study||4
9852748|NCT00883233|10965686|FG002|NOT COMPLETED|Overall Study||4
9852749|NCT00883233|10965687|FG003|NOT COMPLETED|Overall Study||5
9952956|NCT01424566|11071813|FG002|ITT Population|Double-blind Treatment||103
9952957|NCT01424566|11071811|FG000|COMPLETED|Double-blind Treatment||0
9952958|NCT01424566|11071812|FG001|COMPLETED|Double-blind Treatment||78
9952959|NCT01424566|11071813|FG002|COMPLETED|Double-blind Treatment||88
9952960|NCT01424566|11071811|FG000|NOT COMPLETED|Double-blind Treatment||0
9952961|NCT01424566|11071812|FG001|NOT COMPLETED|Double-blind Treatment||25
9952962|NCT01424566|11071813|FG002|NOT COMPLETED|Double-blind Treatment||15
9952963|NCT01424644|11071822|FG000|STARTED|Overall Study||402
9952964|NCT01424644|11071823|FG001|STARTED|Overall Study||399
9952965|NCT01424644|11071822|FG000|COMPLETED|Overall Study||369
9952966|NCT01424644|11071823|FG001|COMPLETED|Overall Study||372
9952967|NCT01424644|11071822|FG000|NOT COMPLETED|Overall Study||33
9952968|NCT01424644|11071823|FG001|NOT COMPLETED|Overall Study||27
9952969|NCT01424670|11071831|FG000|STARTED|6-Month Intensive Period (182 Days)||341
9952970|NCT01424670|11071832|FG001|STARTED|6-Month Intensive Period (182 Days)||170
9952971|NCT01424670|11071831|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
9952972|NCT01424670|11071832|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
9952973|NCT01424670|11071831|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322
9952974|NCT01424670|11071832|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156
9952975|NCT01424670|11071831|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
9952976|NCT01424670|11071832|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
9952977|NCT01424670|11071831|FG000|STARTED|Continuation Period||322
9952978|NCT01424670|11071832|FG001|STARTED|Continuation Period||156
9952979|NCT01424670|11071831|FG000|COMPLETED|Continuation Period||288
9952980|NCT01424670|11071832|FG001|COMPLETED|Continuation Period||142
9952981|NCT01424670|11071831|FG000|NOT COMPLETED|Continuation Period||34
9952982|NCT01424670|11071832|FG001|NOT COMPLETED|Continuation Period||14
9952983|NCT01424722|11071840|FG000|STARTED|Overall Study||2258
9952984|NCT01424722|11071840|FG000|COMPLETED|Overall Study||0
9952985|NCT01424722|11071840|FG000|NOT COMPLETED|Overall Study||2258
9952986|NCT01424813|11071846|FG000|STARTED|Overall Study||79
9952987|NCT01424813|11071847|FG001|STARTED|Overall Study||79
10201738|NCT03440411|11329119|FG001|NOT COMPLETED|Overall Study||1
9952988|NCT01424813|11071846|FG000|Treated|Overall Study|Safety set and full analysis set|79
9952989|NCT01424813|11071847|FG001|Treated|Overall Study|Safety set and full analysis set|78
9952990|NCT01424813|11071846|FG000|COMPLETED|Overall Study||74
9952991|NCT01424813|11071847|FG001|COMPLETED|Overall Study||77
9952992|NCT01424813|11071846|FG000|NOT COMPLETED|Overall Study||5
9952993|NCT01424813|11071847|FG001|NOT COMPLETED|Overall Study||2
9952994|NCT01424930|11071855|FG000|STARTED|Overall Study||7
9952995|NCT01424930|11071856|FG001|STARTED|Overall Study||18
9952996|NCT01424930|11071855|FG000|Completed Food Safety Evaluation|Overall Study||6
9952997|NCT01424930|11071856|FG001|Completed Food Safety Evaluation|Overall Study||18
9952998|NCT01424930|11071855|FG000|COMPLETED|Overall Study||3
9952999|NCT01424930|11071856|FG001|COMPLETED|Overall Study||4
9953000|NCT01424930|11071855|FG000|NOT COMPLETED|Overall Study||4
9953001|NCT01424930|11071856|FG001|NOT COMPLETED|Overall Study||14
9953002|NCT01424943|11071864|FG000|STARTED|Overall Study||25
9852750|NCT00883246|10965697|FG000|STARTED|Overall Study||799
9852751|NCT00883246|10965697|FG000|COMPLETED|Overall Study||626
9852752|NCT00883246|10965697|FG000|NOT COMPLETED|Overall Study||173
9852753|NCT00883337|10965710|FG000|STARTED|Core Treatment Period||109
9852754|NCT00883337|10965711|FG001|STARTED|Core Treatment Period||111
9852755|NCT00883337|10965712|FG002|STARTED|Core Treatment Period||104
9852756|NCT00883337|10965710|FG000|Treated|Core Treatment Period||109
9852757|NCT00883337|10965711|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
9852758|NCT00883337|10965712|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
9852759|NCT00883337|10965710|FG000|COMPLETED|Core Treatment Period||89
9852760|NCT00883337|10965711|FG001|COMPLETED|Core Treatment Period||89
9852761|NCT00883337|10965712|FG002|COMPLETED|Core Treatment Period||71
9852762|NCT00883337|10965710|FG000|NOT COMPLETED|Core Treatment Period||20
9852763|NCT00883337|10965711|FG001|NOT COMPLETED|Core Treatment Period||22
9852764|NCT00883337|10965712|FG002|NOT COMPLETED|Core Treatment Period||33
9852765|NCT00883337|10965710|FG000|STARTED|Extension Treatment Period||89
9852766|NCT00883337|10965711|FG001|STARTED|Extension Treatment Period||89
9852767|NCT00883337|10965712|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
9852768|NCT00883337|10965710|FG000|COMPLETED|Extension Treatment Period||61
9852769|NCT00883337|10965711|FG001|COMPLETED|Extension Treatment Period||66
9852770|NCT00883337|10965712|FG002|COMPLETED|Extension Treatment Period||40
9852771|NCT00883337|10965710|FG000|NOT COMPLETED|Extension Treatment Period||28
9852772|NCT00883337|10965711|FG001|NOT COMPLETED|Extension Treatment Period||23
9852773|NCT00883337|10965712|FG002|NOT COMPLETED|Extension Treatment Period||19
9852774|NCT00883389|10965726|FG000|STARTED|Overall Study||26
9852775|NCT00883389|10965726|FG000|COMPLETED|Overall Study||26
9852776|NCT00883389|10965726|FG000|NOT COMPLETED|Overall Study||0
9852777|NCT00883415|10965730|FG000|STARTED|Overall Study||20
9852778|NCT00883415|10965730|FG000|COMPLETED|Overall Study||18
9852779|NCT00883415|10965730|FG000|NOT COMPLETED|Overall Study||2
9852780|NCT00883493|10965736|FG000|STARTED|Overall Study||212
9852781|NCT00883493|10965737|FG001|STARTED|Overall Study||209
9852782|NCT00883493|10965736|FG000|Intention To Treat Analysis Population|Overall Study||204
9852783|NCT00883493|10965737|FG001|Intention To Treat Analysis Population|Overall Study||195
9852784|NCT00883493|10965736|FG000|Per Protocol Analysis Population|Overall Study||162
9852785|NCT00883493|10965737|FG001|Per Protocol Analysis Population|Overall Study||155
9852786|NCT00883493|10965736|FG000|COMPLETED|Overall Study||166
9852787|NCT00883493|10965737|FG001|COMPLETED|Overall Study||159
9852788|NCT00883493|10965736|FG000|NOT COMPLETED|Overall Study||46
9852789|NCT00883493|10965737|FG001|NOT COMPLETED|Overall Study||50
9852790|NCT00883558|10965743|FG000|STARTED|Titration Period (Weeks 0 to 4)||48
9852791|NCT00883558|10965744|FG001|STARTED|Titration Period (Weeks 0 to 4)||0
9852792|NCT00883558|10965745|FG002|STARTED|Titration Period (Weeks 0 to 4)||0
9852793|NCT00883558|10965743|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46
9852794|NCT00883558|10965744|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0
9852795|NCT00883558|10965745|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0
9852796|NCT00883558|10965743|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
9852797|NCT00883558|10965744|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
9852798|NCT00883558|10965745|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
9852799|NCT00883558|10965743|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
9852800|NCT00883558|10965744|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
9852801|NCT00883558|10965745|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
9852802|NCT00883558|10965743|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
9852803|NCT00883558|10965744|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
9852804|NCT00883558|10965745|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
9852805|NCT00883558|10965743|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
9852806|NCT00883558|10965744|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
9852807|NCT00883558|10965745|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
9852808|NCT00883558|10965743|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
9852809|NCT00883558|10965744|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
9852810|NCT00883558|10965745|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
9852811|NCT00883558|10965743|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
9852812|NCT00883558|10965744|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
9852813|NCT00883558|10965745|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
9852814|NCT00883558|10965743|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
9852815|NCT00883558|10965744|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
9852816|NCT00883558|10965745|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
9852817|NCT00883558|10965743|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
9852818|NCT00883558|10965744|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
9852819|NCT00883558|10965745|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
9852820|NCT00883558|10965743|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
9852821|NCT00883558|10965744|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
9852822|NCT00883558|10965745|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
9852823|NCT00883675|10965751|FG000|STARTED|Overall Study||133
9852824|NCT00883675|10965751|FG000|COMPLETED|Overall Study||133
9852825|NCT00883675|10965751|FG000|NOT COMPLETED|Overall Study||0
9852826|NCT00883688|10965755|FG000|STARTED|Overall Study||24
9852827|NCT00883688|10965755|FG000|COMPLETED|Overall Study||22
9852828|NCT00883688|10965755|FG000|NOT COMPLETED|Overall Study||2
9852829|NCT00883740|10965759|FG000|STARTED|First Intervention||60
9852830|NCT00883740|10965760|FG001|STARTED|First Intervention||59
9852831|NCT00883740|10965759|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
9852832|NCT00883740|10965760|FG001|COMPLETED|First Intervention||51
9852833|NCT00883740|10965759|FG000|NOT COMPLETED|First Intervention||7
9852834|NCT00883740|10965760|FG001|NOT COMPLETED|First Intervention||8
9852835|NCT00883740|10965759|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
9852836|NCT00883740|10965760|FG001|STARTED|Taper and Washout Period (2 Weeks)||51
9852837|NCT00883740|10965759|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54
9852838|NCT00883740|10965760|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51
9852839|NCT00883740|10965759|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
9745100|NCT00282438|10847264|FG001|COMPLETED|Overall Study||0
9745101|NCT00282438|10847263|FG000|NOT COMPLETED|Overall Study||1
9745102|NCT00282438|10847264|FG001|NOT COMPLETED|Overall Study||1
9745103|NCT00282464|10847272|FG000|STARTED|Overall Study||185
9745104|NCT00282464|10847273|FG001|STARTED|Overall Study||196
9745105|NCT00282464|10847272|FG000|COMPLETED|Overall Study||112
9745106|NCT00282464|10847273|FG001|COMPLETED|Overall Study||134
9745107|NCT00282464|10847272|FG000|NOT COMPLETED|Overall Study||73
9745108|NCT00282464|10847273|FG001|NOT COMPLETED|Overall Study||62
9745109|NCT00282568|10847279|FG000|STARTED|Pharmacokinetic Treatment Period||70
9745110|NCT00282568|10847279|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68
9745111|NCT00282568|10847279|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
9745112|NCT00282568|10847279|FG000|COMPLETED|Pharmacokinetic Treatment Period||67
9745113|NCT00282568|10847279|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3
9745114|NCT00282568|10847279|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
9852840|NCT00883740|10965760|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
9852841|NCT00883740|10965759|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
9852842|NCT00883740|10965760|FG001|STARTED|Second Intervention||51
9852843|NCT00883740|10965759|FG000|COMPLETED|Second Intervention||52
9852844|NCT00883740|10965760|FG001|COMPLETED|Second Intervention||50
9852845|NCT00883740|10965759|FG000|NOT COMPLETED|Second Intervention||1
9852846|NCT00883740|10965760|FG001|NOT COMPLETED|Second Intervention||1
9852847|NCT00883753|10965766|FG000|STARTED|Overall Study||934
9852848|NCT00883753|10965766|FG000|COMPLETED|Overall Study||827
9852849|NCT00883753|10965766|FG000|NOT COMPLETED|Overall Study||107
9852850|NCT00883779|10965775|FG000|STARTED|Primary Study Treatment Phase||225
9852851|NCT00883779|10965776|FG001|STARTED|Primary Study Treatment Phase||226
9852852|NCT00883779|10965775|FG000|COMPLETED|Primary Study Treatment Phase||120
9852853|NCT00883779|10965776|FG001|COMPLETED|Primary Study Treatment Phase||140
9852854|NCT00883779|10965775|FG000|NOT COMPLETED|Primary Study Treatment Phase||105
9852855|NCT00883779|10965776|FG001|NOT COMPLETED|Primary Study Treatment Phase||86
9852856|NCT00883779|10965775|FG000|STARTED|Post-Study Treatment Phase||112
9852857|NCT00883779|10965776|FG001|STARTED|Post-Study Treatment Phase||135
9852858|NCT00883779|10965775|FG000|COMPLETED|Post-Study Treatment Phase||0
9852859|NCT00883779|10965776|FG001|COMPLETED|Post-Study Treatment Phase||0
9852860|NCT00883779|10965775|FG000|NOT COMPLETED|Post-Study Treatment Phase||112
9852861|NCT00883779|10965776|FG001|NOT COMPLETED|Post-Study Treatment Phase||135
9852862|NCT00883779|10965775|FG000|STARTED|Off-study Phase||209
9852863|NCT00883779|10965776|FG001|STARTED|Off-study Phase||202
9852864|NCT00883779|10965775|FG000|COMPLETED|Off-study Phase||0
9852865|NCT00883779|10965776|FG001|COMPLETED|Off-study Phase||0
9852866|NCT00883779|10965775|FG000|NOT COMPLETED|Off-study Phase||209
9852867|NCT00883779|10965776|FG001|NOT COMPLETED|Off-study Phase||202
9852868|NCT00884039|10965784|FG000|STARTED|Overall Study||5
9852869|NCT00884039|10965785|FG001|STARTED|Overall Study||2
9852870|NCT00884039|10965784|FG000|COMPLETED|Overall Study||3
9852871|NCT00884039|10965785|FG001|COMPLETED|Overall Study||1
9852872|NCT00884039|10965784|FG000|NOT COMPLETED|Overall Study||2
9852873|NCT00884039|10965785|FG001|NOT COMPLETED|Overall Study||1
9852874|NCT00884052|10965791|FG000|STARTED|Overall Study||6
9852875|NCT00884052|10965792|FG001|STARTED|Overall Study||12
9852876|NCT00884052|10965791|FG000|COMPLETED|Overall Study||6
9852877|NCT00884052|10965792|FG001|COMPLETED|Overall Study||12
9852878|NCT00884052|10965791|FG000|NOT COMPLETED|Overall Study||0
9852879|NCT00884052|10965792|FG001|NOT COMPLETED|Overall Study||0
9852880|NCT00884065|10965800|FG000|STARTED|Overall Study||25
9852881|NCT00884065|10965801|FG001|STARTED|Overall Study||25
9852882|NCT00884065|10965800|FG000|COMPLETED|Overall Study||25
9852883|NCT00884065|10965801|FG001|COMPLETED|Overall Study||25
9852884|NCT00884065|10965800|FG000|NOT COMPLETED|Overall Study||0
9852885|NCT00884065|10965801|FG001|NOT COMPLETED|Overall Study||0
9852886|NCT00884117|10965807|FG000|STARTED|Overall Study||4561
9852887|NCT00884117|10965807|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
9852888|NCT00884117|10965807|FG000|NOT COMPLETED|Overall Study||249
9852889|NCT00884221|10965826|FG000|STARTED|Overall Study||374
9852890|NCT00884221|10965827|FG001|STARTED|Overall Study||375
9852891|NCT00884221|10965826|FG000|COMPLETED|Overall Study||340
9852892|NCT00884221|10965827|FG001|COMPLETED|Overall Study||343
9745115|NCT00282568|10847279|FG000|COMPLETED|Extended Treatment Period||42
9745116|NCT00282568|10847279|FG000|NOT COMPLETED|Extended Treatment Period||24
9745117|NCT00282672|10847287|FG000|STARTED|1 Year||22
9745118|NCT00282672|10847288|FG001|STARTED|1 Year||42
9745119|NCT00282672|10847289|FG002|STARTED|1 Year||21
9745120|NCT00282672|10847290|FG003|STARTED|1 Year||42
9745121|NCT00282672|10847287|FG000|COMPLETED|1 Year||19
9745122|NCT00282672|10847288|FG001|COMPLETED|1 Year||40
9745123|NCT00282672|10847289|FG002|COMPLETED|1 Year||20
9745124|NCT00282672|10847290|FG003|COMPLETED|1 Year||38
9745125|NCT00282672|10847287|FG000|NOT COMPLETED|1 Year||3
9745126|NCT00282672|10847288|FG001|NOT COMPLETED|1 Year||2
9745127|NCT00282672|10847289|FG002|NOT COMPLETED|1 Year||1
9745128|NCT00282672|10847290|FG003|NOT COMPLETED|1 Year||4
9745129|NCT00282672|10847287|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
9745130|NCT00282672|10847288|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40
9745131|NCT00282672|10847289|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
9745132|NCT00282672|10847290|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38
9745133|NCT00282672|10847287|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16
9745134|NCT00282672|10847288|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39
9745135|NCT00282672|10847289|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15
9745136|NCT00282672|10847290|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36
9745137|NCT00282672|10847287|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
9745138|NCT00282672|10847288|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
9745139|NCT00282672|10847289|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
9745140|NCT00282672|10847290|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
9745141|NCT00282672|10847287|FG000|STARTED|5 Year: Follow up|1 withdrew|15
9745142|NCT00282672|10847288|FG001|STARTED|5 Year: Follow up|7 withdrew|32
9745143|NCT00282672|10847289|FG002|STARTED|5 Year: Follow up|3 withdrew|12
9745144|NCT00282672|10847290|FG003|STARTED|5 Year: Follow up|11 withdrew|25
9745145|NCT00282672|10847287|FG000|COMPLETED|5 Year: Follow up||14
9745146|NCT00282672|10847288|FG001|COMPLETED|5 Year: Follow up||27
9745147|NCT00282672|10847289|FG002|COMPLETED|5 Year: Follow up||12
9745148|NCT00282672|10847290|FG003|COMPLETED|5 Year: Follow up||20
9745149|NCT00282672|10847287|FG000|NOT COMPLETED|5 Year: Follow up||1
9745150|NCT00282672|10847288|FG001|NOT COMPLETED|5 Year: Follow up||5
9745151|NCT00282672|10847289|FG002|NOT COMPLETED|5 Year: Follow up||0
9745152|NCT00282672|10847290|FG003|NOT COMPLETED|5 Year: Follow up||5
9745153|NCT00282815|10847326|FG000|STARTED|Overall Study||15
9745154|NCT00282815|10847327|FG001|STARTED|Overall Study||17
9745155|NCT00282815|10847326|FG000|COMPLETED|Overall Study||8
9745156|NCT00282815|10847327|FG001|COMPLETED|Overall Study||11
9745157|NCT00282815|10847326|FG000|NOT COMPLETED|Overall Study||7
9745158|NCT00282815|10847327|FG001|NOT COMPLETED|Overall Study||6
9745159|NCT00282828|10847339|FG000|STARTED|Overall Study||63
9745160|NCT00282828|10847340|FG001|STARTED|Overall Study||59
9745161|NCT00282828|10847341|FG002|STARTED|Overall Study||59
9745162|NCT00282828|10847339|FG000|COMPLETED|Overall Study||57
9745163|NCT00282828|10847340|FG001|COMPLETED|Overall Study||47
9745164|NCT00282828|10847341|FG002|COMPLETED|Overall Study||50
9745165|NCT00282828|10847339|FG000|NOT COMPLETED|Overall Study||6
9745166|NCT00282828|10847340|FG001|NOT COMPLETED|Overall Study||12
9745167|NCT00282828|10847341|FG002|NOT COMPLETED|Overall Study||9
9745168|NCT00282841|10847349|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
9745169|NCT00282841|10847349|FG000|COMPLETED|Overall Study||61
9745170|NCT00282841|10847349|FG000|NOT COMPLETED|Overall Study||0
9745171|NCT00282919|10847354|FG000|STARTED|Overall Study||110
9745172|NCT00282919|10847354|FG000|COMPLETED|Overall Study||103
9745173|NCT00282919|10847354|FG000|NOT COMPLETED|Overall Study||7
9745174|NCT00282971|10847360|FG000|STARTED|Overall Study||180
9745175|NCT00282971|10847361|FG001|STARTED|Overall Study||171
9745176|NCT00282971|10847360|FG000|COMPLETED|Overall Study||146
9745177|NCT00282971|10847361|FG001|COMPLETED|Overall Study||149
9745178|NCT00282971|10847360|FG000|NOT COMPLETED|Overall Study||34
9745179|NCT00282971|10847361|FG001|NOT COMPLETED|Overall Study||22
9745180|NCT00282984|10847369|FG000|STARTED|Overall Study||353
9745181|NCT00282984|10847370|FG001|STARTED|Overall Study||350
9745182|NCT00282984|10847369|FG000|COMPLETED|Overall Study||302
9745183|NCT00282984|10847370|FG001|COMPLETED|Overall Study||289
9745184|NCT00282984|10847369|FG000|NOT COMPLETED|Overall Study||51
9745185|NCT00282984|10847370|FG001|NOT COMPLETED|Overall Study||61
9745186|NCT00283049|10847379|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
9745187|NCT00283049|10847380|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
9745188|NCT00283049|10847381|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
9745189|NCT00283049|10847379|FG000|COMPLETED|Overall Study||70
9745190|NCT00283049|10847380|FG001|COMPLETED|Overall Study||83
9745191|NCT00283049|10847381|FG002|COMPLETED|Overall Study||76
9745192|NCT00283049|10847379|FG000|NOT COMPLETED|Overall Study||58
9745193|NCT00283049|10847380|FG001|NOT COMPLETED|Overall Study||45
9745194|NCT00283049|10847381|FG002|NOT COMPLETED|Overall Study||54
9745195|NCT00283062|10847393|FG000|STARTED|Overall Study||55
9745196|NCT00283062|10847394|FG001|STARTED|Overall Study||55
9745197|NCT00283062|10847395|FG002|STARTED|Overall Study||56
9745198|NCT00283062|10847396|FG003|STARTED|Overall Study||62
9745199|NCT00283062|10847393|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50
9745200|NCT00283062|10847394|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51
9852893|NCT00884221|10965826|FG000|NOT COMPLETED|Overall Study||34
9852894|NCT00884221|10965827|FG001|NOT COMPLETED|Overall Study||32
9852895|NCT00884273|10965837|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
9852896|NCT00884273|10965838|FG001|STARTED|Overall Study|ITT population.|98
9745201|NCT00283062|10847395|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20
9745202|NCT00283062|10847396|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17
9745203|NCT00283062|10847393|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
9745204|NCT00283062|10847394|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
9745205|NCT00283062|10847395|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
9745206|NCT00283062|10847396|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
9745207|NCT00283062|10847393|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
9745208|NCT00283062|10847394|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
9745209|NCT00283062|10847395|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
9745210|NCT00283062|10847396|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
9745211|NCT00283062|10847393|FG000|COMPLETED|Overall Study||43
9745212|NCT00283062|10847394|FG001|COMPLETED|Overall Study||48
9745213|NCT00283062|10847395|FG002|COMPLETED|Overall Study||15
9745214|NCT00283062|10847396|FG003|COMPLETED|Overall Study||13
9852897|NCT00884273|10965837|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
9852898|NCT00884273|10965838|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
9852899|NCT00884273|10965837|FG000|Per Protocol (PP) Analysis Set|Overall Study||81
9852900|NCT00884273|10965838|FG001|Per Protocol (PP) Analysis Set|Overall Study||92
9852901|NCT00884273|10965837|FG000|Safety Analysis Set|Overall Study||84
9852902|NCT00884273|10965838|FG001|Safety Analysis Set|Overall Study||98
9852903|NCT00884273|10965837|FG000|COMPLETED|Overall Study||82
9852904|NCT00884273|10965838|FG001|COMPLETED|Overall Study||93
9852905|NCT00884273|10965837|FG000|NOT COMPLETED|Overall Study||2
9852906|NCT00884273|10965838|FG001|NOT COMPLETED|Overall Study||5
9852907|NCT00884286|10965846|FG000|STARTED|Overall Study||34
9852908|NCT00884286|10965847|FG001|STARTED|Overall Study||33
9852909|NCT00884286|10965846|FG000|COMPLETED|Overall Study||2
9852910|NCT00884286|10965847|FG001|COMPLETED|Overall Study||0
9852911|NCT00884286|10965846|FG000|NOT COMPLETED|Overall Study||32
9852912|NCT00884286|10965847|FG001|NOT COMPLETED|Overall Study||33
9852913|NCT00884312|10965856|FG000|STARTED|Overall Study||9
9852914|NCT00884312|10965857|FG001|STARTED|Overall Study||92
9852915|NCT00884312|10965856|FG000|Received Treatment|Overall Study||9
9852916|NCT00884312|10965857|FG001|Received Treatment|Overall Study||91
10091798|NCT02332707|11220111|FG017|STARTED|Overall Study||16
10091799|NCT02332707|11220094|FG000|COMPLETED|Overall Study||23
9745215|NCT00283062|10847393|FG000|NOT COMPLETED|Overall Study||12
9745216|NCT00283062|10847394|FG001|NOT COMPLETED|Overall Study||7
9745217|NCT00283062|10847395|FG002|NOT COMPLETED|Overall Study||41
9745218|NCT00283062|10847396|FG003|NOT COMPLETED|Overall Study||49
9745219|NCT00283075|10847406|FG000|STARTED|Overall Study||25
9745220|NCT00283075|10847407|FG001|STARTED|Overall Study||6
9745221|NCT00283075|10847406|FG000|COMPLETED|Overall Study||25
9745222|NCT00283075|10847407|FG001|COMPLETED|Overall Study||6
9745223|NCT00283075|10847406|FG000|NOT COMPLETED|Overall Study||0
9745224|NCT00283075|10847407|FG001|NOT COMPLETED|Overall Study||0
9745225|NCT00283244|10847421|FG000|STARTED|Overall Study||44
9745226|NCT00283244|10847422|FG001|STARTED|Overall Study||51
9745227|NCT00283244|10847423|FG002|STARTED|Overall Study||51
9745228|NCT00283244|10847421|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
9745229|NCT00283244|10847422|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
9745230|NCT00283244|10847423|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
10091800|NCT02332707|11220095|FG001|COMPLETED|Overall Study||24
10091801|NCT02332707|11220096|FG002|COMPLETED|Overall Study||15
10091802|NCT02332707|11220097|FG003|COMPLETED|Overall Study||13
10091803|NCT02332707|11220098|FG004|COMPLETED|Overall Study||23
9745231|NCT00283244|10847421|FG000|NOT COMPLETED|Overall Study||18
9745232|NCT00283244|10847422|FG001|NOT COMPLETED|Overall Study||51
9745233|NCT00283244|10847423|FG002|NOT COMPLETED|Overall Study||51
9745234|NCT00283283|10847436|FG000|STARTED|Overall Study||274
9745235|NCT00283283|10847437|FG001|STARTED|Overall Study||284
9745236|NCT00283283|10847438|FG002|STARTED|Overall Study||280
9745237|NCT00283283|10847439|FG003|STARTED|Overall Study||276
9745238|NCT00283283|10847436|FG000|COMPLETED|Overall Study||274
9745239|NCT00283283|10847437|FG001|COMPLETED|Overall Study||284
9745240|NCT00283283|10847438|FG002|COMPLETED|Overall Study||280
9745241|NCT00283283|10847439|FG003|COMPLETED|Overall Study||276
9745242|NCT00283283|10847436|FG000|NOT COMPLETED|Overall Study||0
9745243|NCT00283283|10847437|FG001|NOT COMPLETED|Overall Study||0
9852917|NCT00884312|10965856|FG000|COMPLETED|Overall Study||7
9852918|NCT00884312|10965857|FG001|COMPLETED|Overall Study||67
9852919|NCT00884312|10965856|FG000|NOT COMPLETED|Overall Study||2
9852920|NCT00884312|10965857|FG001|NOT COMPLETED|Overall Study||25
9852921|NCT00884325|10965865|FG000|STARTED|Overall Study||20
10091804|NCT02332707|11220099|FG005|COMPLETED|Overall Study||22
10091805|NCT02332707|11220100|FG006|COMPLETED|Overall Study||15
10091806|NCT02332707|11220101|FG007|COMPLETED|Overall Study||16
10091807|NCT02332707|11220102|FG008|COMPLETED|Overall Study||48
9852922|NCT00884325|10965866|FG001|STARTED|Overall Study||20
9852923|NCT00884325|10965865|FG000|COMPLETED|Overall Study||17
10091808|NCT02332707|11220103|FG009|COMPLETED|Overall Study||28
10091809|NCT02332707|11220104|FG010|COMPLETED|Overall Study||29
10091810|NCT02332707|11220105|FG011|COMPLETED|Overall Study||35
10091811|NCT02332707|11220106|FG012|COMPLETED|Overall Study||35
9745244|NCT00283283|10847438|FG002|NOT COMPLETED|Overall Study||0
9745245|NCT00283283|10847439|FG003|NOT COMPLETED|Overall Study||0
9745246|NCT00283296|10847454|FG000|STARTED|Overall Study||14
9745247|NCT00283296|10847454|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
9745248|NCT00283296|10847454|FG000|NOT COMPLETED|Overall Study||5
9745249|NCT00283387|10847459|FG000|STARTED|First Intervention||6
9745250|NCT00283387|10847460|FG001|STARTED|First Intervention||7
9745251|NCT00283387|10847459|FG000|COMPLETED|First Intervention||5
9745252|NCT00283387|10847460|FG001|COMPLETED|First Intervention||5
9745253|NCT00283387|10847459|FG000|NOT COMPLETED|First Intervention||1
9745254|NCT00283387|10847460|FG001|NOT COMPLETED|First Intervention||2
9745255|NCT00283387|10847459|FG000|STARTED|Washout Period of 2 Months||5
9745256|NCT00283387|10847460|FG001|STARTED|Washout Period of 2 Months||5
9745257|NCT00283387|10847459|FG000|COMPLETED|Washout Period of 2 Months||5
9745258|NCT00283387|10847460|FG001|COMPLETED|Washout Period of 2 Months||5
9745259|NCT00283387|10847459|FG000|NOT COMPLETED|Washout Period of 2 Months||0
9745260|NCT00283387|10847460|FG001|NOT COMPLETED|Washout Period of 2 Months||0
9745261|NCT00283387|10847459|FG000|STARTED|Second Intervention||5
9745262|NCT00283387|10847460|FG001|STARTED|Second Intervention||5
9745263|NCT00283387|10847459|FG000|COMPLETED|Second Intervention||5
9745264|NCT00283387|10847460|FG001|COMPLETED|Second Intervention||5
9745265|NCT00283387|10847459|FG000|NOT COMPLETED|Second Intervention||0
9745266|NCT00283387|10847460|FG001|NOT COMPLETED|Second Intervention||0
9745267|NCT00283400|10847470|FG000|STARTED|Overall Study||20
9745268|NCT00283400|10847471|FG001|STARTED|Overall Study||20
9745269|NCT00283400|10847472|FG002|STARTED|Overall Study||7
9745270|NCT00283400|10847473|FG003|STARTED|Overall Study||0
9745271|NCT00283400|10847470|FG000|COMPLETED|Overall Study||18
9745272|NCT00283400|10847471|FG001|COMPLETED|Overall Study||19
9745273|NCT00283400|10847472|FG002|COMPLETED|Overall Study||6
9745274|NCT00283400|10847473|FG003|COMPLETED|Overall Study||0
9745275|NCT00283400|10847470|FG000|NOT COMPLETED|Overall Study||2
9745276|NCT00283400|10847471|FG001|NOT COMPLETED|Overall Study||1
9745277|NCT00283400|10847472|FG002|NOT COMPLETED|Overall Study||1
9745278|NCT00283400|10847473|FG003|NOT COMPLETED|Overall Study||0
9745279|NCT00283439|10847487|FG000|STARTED|Overall Study||8
9745280|NCT00283439|10847488|FG001|STARTED|Overall Study||11
9745281|NCT00283439|10847489|FG002|STARTED|Overall Study||11
9745282|NCT00283439|10847490|FG003|STARTED|Overall Study||9
9745283|NCT00283439|10847487|FG000|COMPLETED|Overall Study||0
9745284|NCT00283439|10847488|FG001|COMPLETED|Overall Study||0
9745285|NCT00283439|10847489|FG002|COMPLETED|Overall Study||0
9745286|NCT00283439|10847490|FG003|COMPLETED|Overall Study||0
9745287|NCT00283439|10847487|FG000|NOT COMPLETED|Overall Study||8
9745288|NCT00283439|10847488|FG001|NOT COMPLETED|Overall Study||11
9745289|NCT00283439|10847489|FG002|NOT COMPLETED|Overall Study||11
9745290|NCT00283439|10847490|FG003|NOT COMPLETED|Overall Study||9
9745291|NCT00283504|10847502|FG000|STARTED|Overall Study||7
9745292|NCT00283504|10847503|FG001|STARTED|Overall Study||6
9745293|NCT00283504|10847502|FG000|COMPLETED|Overall Study||7
9745294|NCT00283504|10847503|FG001|COMPLETED|Overall Study||6
9745295|NCT00283504|10847502|FG000|NOT COMPLETED|Overall Study||0
9745296|NCT00283504|10847503|FG001|NOT COMPLETED|Overall Study||0
9745297|NCT00283595|10847513|FG000|STARTED|Overall Study||10
9745298|NCT00283595|10847514|FG001|STARTED|Overall Study||11
9745299|NCT00283595|10847513|FG000|COMPLETED|Overall Study||9
9745300|NCT00283595|10847514|FG001|COMPLETED|Overall Study||9
9745301|NCT00283595|10847513|FG000|NOT COMPLETED|Overall Study||1
9745302|NCT00283595|10847514|FG001|NOT COMPLETED|Overall Study||2
9745303|NCT00283686|10847524|FG000|STARTED|Overall Study||140
9745304|NCT00283686|10847525|FG001|STARTED|Overall Study||133
9745305|NCT00283686|10847526|FG002|STARTED|Overall Study||144
9745306|NCT00283686|10847527|FG003|STARTED|Overall Study||141
9745307|NCT00283686|10847524|FG000|COMPLETED|Overall Study||111
9745308|NCT00283686|10847525|FG001|COMPLETED|Overall Study||92
9745309|NCT00283686|10847526|FG002|COMPLETED|Overall Study||111
9745310|NCT00283686|10847527|FG003|COMPLETED|Overall Study||109
9745311|NCT00283686|10847524|FG000|NOT COMPLETED|Overall Study||29
9745312|NCT00283686|10847525|FG001|NOT COMPLETED|Overall Study||41
9745313|NCT00283686|10847526|FG002|NOT COMPLETED|Overall Study||33
9745314|NCT00283686|10847527|FG003|NOT COMPLETED|Overall Study||32
9745315|NCT00283712|10847539|FG000|STARTED|Overall Study||10
9745316|NCT00283712|10847540|FG001|STARTED|Overall Study||10
9745317|NCT00283712|10847539|FG000|Intent-to-treat Sample|Overall Study||10
9745318|NCT00283712|10847540|FG001|Intent-to-treat Sample|Overall Study||10
9852924|NCT00884325|10965866|FG001|COMPLETED|Overall Study||16
9745319|NCT00283712|10847539|FG000|Safety Sample|Overall Study||10
9745320|NCT00283712|10847540|FG001|Safety Sample|Overall Study||10
9852925|NCT00884325|10965865|FG000|NOT COMPLETED|Overall Study||3
9745321|NCT00283712|10847539|FG000|Per-Protocol Sample|Overall Study||6
9745322|NCT00283712|10847540|FG001|Per-Protocol Sample|Overall Study||7
9745323|NCT00283712|10847539|FG000|COMPLETED|Overall Study||10
10091812|NCT02332707|11220107|FG013|COMPLETED|Overall Study||15
10091813|NCT02332707|11220108|FG014|COMPLETED|Overall Study||16
10091814|NCT02332707|11220109|FG015|COMPLETED|Overall Study||26
9745324|NCT00283712|10847540|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
9745325|NCT00283712|10847539|FG000|NOT COMPLETED|Overall Study||0
9745326|NCT00283712|10847540|FG001|NOT COMPLETED|Overall Study||1
9745327|NCT00283803|10847546|FG000|STARTED|Overall Study||32
9745328|NCT00283803|10847546|FG000|COMPLETED|Overall Study||19
9745329|NCT00283803|10847546|FG000|NOT COMPLETED|Overall Study||13
9745330|NCT00283816|10847552|FG000|STARTED|Overall Study||18
9745331|NCT00283816|10847553|FG001|STARTED|Overall Study||18
9745332|NCT00283816|10847552|FG000|COMPLETED|Overall Study||16
9745333|NCT00283816|10847553|FG001|COMPLETED|Overall Study||16
9745334|NCT00283816|10847552|FG000|NOT COMPLETED|Overall Study||2
10091815|NCT02332707|11220110|FG016|COMPLETED|Overall Study||30
10091816|NCT02332707|11220111|FG017|COMPLETED|Overall Study||16
10091817|NCT02332707|11220094|FG000|NOT COMPLETED|Overall Study||0
10091818|NCT02332707|11220095|FG001|NOT COMPLETED|Overall Study||0
10091819|NCT02332707|11220096|FG002|NOT COMPLETED|Overall Study||1
10091820|NCT02332707|11220097|FG003|NOT COMPLETED|Overall Study||1
9745335|NCT00283816|10847553|FG001|NOT COMPLETED|Overall Study||2
9745336|NCT00283842|10847566|FG000|STARTED|Overall Study||63
9745337|NCT00283842|10847567|FG001|STARTED|Overall Study||87
9745338|NCT00283842|10847568|FG002|STARTED|Overall Study||99
9745339|NCT00283842|10847569|FG003|STARTED|Overall Study||69
9745340|NCT00283842|10847570|FG004|STARTED|Overall Study||90
9745341|NCT00283842|10847566|FG000|COMPLETED|Overall Study||51
9745342|NCT00283842|10847567|FG001|COMPLETED|Overall Study||69
9745343|NCT00283842|10847568|FG002|COMPLETED|Overall Study||68
9745344|NCT00283842|10847569|FG003|COMPLETED|Overall Study||42
9745345|NCT00283842|10847570|FG004|COMPLETED|Overall Study||75
9745346|NCT00283842|10847566|FG000|NOT COMPLETED|Overall Study||12
9745347|NCT00283842|10847567|FG001|NOT COMPLETED|Overall Study||18
9745348|NCT00283842|10847568|FG002|NOT COMPLETED|Overall Study||31
9745349|NCT00283842|10847569|FG003|NOT COMPLETED|Overall Study||27
9745350|NCT00283842|10847570|FG004|NOT COMPLETED|Overall Study||15
9745351|NCT00283933|10847582|FG000|STARTED|Treatment Period||5
9745352|NCT00283933|10847582|FG000|Safety Population|Treatment Period||5
9745353|NCT00283933|10847582|FG000|Pharmacodynamic (PD) Population|Treatment Period||5
9745354|NCT00283933|10847582|FG000|COMPLETED|Treatment Period||5
9745355|NCT00283933|10847582|FG000|NOT COMPLETED|Treatment Period||0
9745356|NCT00283933|10847582|FG000|STARTED|Extension Period||5
9745357|NCT00283933|10847582|FG000|COMPLETED|Extension Period||5
9745358|NCT00283933|10847582|FG000|NOT COMPLETED|Extension Period||0
9745359|NCT00284050|10847589|FG000|STARTED|Overall Study||51
9745360|NCT00284050|10847590|FG001|STARTED|Overall Study||51
9745361|NCT00284050|10847591|FG002|STARTED|Overall Study||49
9745362|NCT00284050|10847589|FG000|COMPLETED|Overall Study||46
10091821|NCT02332707|11220098|FG004|NOT COMPLETED|Overall Study||0
10091822|NCT02332707|11220099|FG005|NOT COMPLETED|Overall Study||1
10091823|NCT02332707|11220100|FG006|NOT COMPLETED|Overall Study||0
10091824|NCT02332707|11220101|FG007|NOT COMPLETED|Overall Study||0
10091825|NCT02332707|11220102|FG008|NOT COMPLETED|Overall Study||0
10091826|NCT02332707|11220103|FG009|NOT COMPLETED|Overall Study||3
10091827|NCT02332707|11220104|FG010|NOT COMPLETED|Overall Study||2
10091828|NCT02332707|11220105|FG011|NOT COMPLETED|Overall Study||0
10091829|NCT02332707|11220106|FG012|NOT COMPLETED|Overall Study||5
10091830|NCT02332707|11220107|FG013|NOT COMPLETED|Overall Study||0
10091831|NCT02332707|11220108|FG014|NOT COMPLETED|Overall Study||0
10091832|NCT02332707|11220109|FG015|NOT COMPLETED|Overall Study||0
10091833|NCT02332707|11220110|FG016|NOT COMPLETED|Overall Study||0
10091834|NCT02332707|11220111|FG017|NOT COMPLETED|Overall Study||0
10091835|NCT02332720|11220172|FG000|STARTED|Part A and Part B||21
10091836|NCT02332720|11220173|FG001|STARTED|Part A and Part B||21
10091837|NCT02332720|11220174|FG002|STARTED|Part A and Part B||22
10091838|NCT02332720|11220175|FG003|STARTED|Part A and Part B||22
10091839|NCT02332720|11220176|FG004|STARTED|Part A and Part B||16
9745363|NCT00284050|10847590|FG001|COMPLETED|Overall Study||46
9745364|NCT00284050|10847591|FG002|COMPLETED|Overall Study||40
9745365|NCT00284050|10847589|FG000|NOT COMPLETED|Overall Study||5
10091840|NCT02332720|11220177|FG005|STARTED|Part A and Part B||36
10091841|NCT02332720|11220178|FG006|STARTED|Part A and Part B||37
10091842|NCT02332720|11220179|FG007|STARTED|Part A and Part B||35
10091843|NCT02332720|11220180|FG008|STARTED|Part A and Part B||15
10091844|NCT02332720|11220181|FG009|STARTED|Part A and Part B||14
10091845|NCT02332720|11220182|FG010|STARTED|Part A and Part B||14
9745366|NCT00284050|10847590|FG001|NOT COMPLETED|Overall Study||5
10091846|NCT02332720|11220183|FG011|STARTED|Part A and Part B||15
10091847|NCT02332720|11220184|FG012|STARTED|Part A and Part B||16
10091848|NCT02332720|11220185|FG013|STARTED|Part A and Part B||13
9745367|NCT00284050|10847591|FG002|NOT COMPLETED|Overall Study||9
9745368|NCT00284089|10847603|FG000|STARTED|Single Dose Phase||6
10091849|NCT02332720|11220186|FG014|STARTED|Part A and Part B||16
9745369|NCT00284089|10847604|FG001|STARTED|Single Dose Phase||6
9745370|NCT00284089|10847605|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
9745371|NCT00284089|10847606|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
9745372|NCT00284089|10847603|FG000|COMPLETED|Single Dose Phase||6
9745373|NCT00284089|10847604|FG001|COMPLETED|Single Dose Phase||6
10091850|NCT02332720|11220187|FG015|STARTED|Part A and Part B||14
10091851|NCT02332720|11220188|FG016|STARTED|Part A and Part B||15
10091852|NCT02332720|11220189|FG017|STARTED|Part A and Part B||14
10091853|NCT02332720|11220190|FG018|STARTED|Part A and Part B||21
10091854|NCT02332720|11220191|FG019|STARTED|Part A and Part B||25
9745374|NCT00284089|10847605|FG002|COMPLETED|Single Dose Phase||0
9745375|NCT00284089|10847606|FG003|COMPLETED|Single Dose Phase||0
9745376|NCT00284089|10847603|FG000|NOT COMPLETED|Single Dose Phase||0
9745377|NCT00284089|10847604|FG001|NOT COMPLETED|Single Dose Phase||0
9745378|NCT00284089|10847605|FG002|NOT COMPLETED|Single Dose Phase||0
9745379|NCT00284089|10847606|FG003|NOT COMPLETED|Single Dose Phase||0
9745380|NCT00284089|10847603|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
9745381|NCT00284089|10847604|FG001|STARTED|Multiple Dose Phase||6
9745382|NCT00284089|10847605|FG002|STARTED|Multiple Dose Phase||35
9745383|NCT00284089|10847606|FG003|STARTED|Multiple Dose Phase||41
9745384|NCT00284089|10847603|FG000|COMPLETED|Multiple Dose Phase||4
9745385|NCT00284089|10847604|FG001|COMPLETED|Multiple Dose Phase||6
9745386|NCT00284089|10847605|FG002|COMPLETED|Multiple Dose Phase||31
9745387|NCT00284089|10847606|FG003|COMPLETED|Multiple Dose Phase||37
9745388|NCT00284089|10847603|FG000|NOT COMPLETED|Multiple Dose Phase||1
9745389|NCT00284089|10847604|FG001|NOT COMPLETED|Multiple Dose Phase||0
9745390|NCT00284089|10847605|FG002|NOT COMPLETED|Multiple Dose Phase||4
9745391|NCT00284089|10847606|FG003|NOT COMPLETED|Multiple Dose Phase||4
9745392|NCT00284089|10847603|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
9745393|NCT00284089|10847604|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
9745394|NCT00284089|10847605|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
9745395|NCT00284089|10847606|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
9745396|NCT00284089|10847603|FG000|COMPLETED|Extension Phase||1
9745397|NCT00284089|10847604|FG001|COMPLETED|Extension Phase||6
9745398|NCT00284089|10847605|FG002|COMPLETED|Extension Phase||22
9745399|NCT00284089|10847606|FG003|COMPLETED|Extension Phase||21
9745400|NCT00284089|10847603|FG000|NOT COMPLETED|Extension Phase||2
9745401|NCT00284089|10847604|FG001|NOT COMPLETED|Extension Phase||0
9745402|NCT00284089|10847605|FG002|NOT COMPLETED|Extension Phase||6
9745403|NCT00284089|10847606|FG003|NOT COMPLETED|Extension Phase||12
9745404|NCT00284141|10847616|FG000|STARTED|Overall Study||98
9745405|NCT00284141|10847616|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
9745406|NCT00284141|10847616|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
9745407|NCT00284141|10847616|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
9745408|NCT00284141|10847616|FG000|NOT COMPLETED|Overall Study||98
9745409|NCT00284154|10847622|FG000|STARTED|Overall Study||51
9745410|NCT00284154|10847622|FG000|COMPLETED|Overall Study||9
9745411|NCT00284154|10847622|FG000|NOT COMPLETED|Overall Study||42
9745412|NCT00284180|10847628|FG000|STARTED|Overall Study||11
9745413|NCT00284180|10847629|FG001|STARTED|Overall Study||21
9745414|NCT00284180|10847628|FG000|COMPLETED|Overall Study||11
9745415|NCT00284180|10847629|FG001|COMPLETED|Overall Study||17
9745416|NCT00284180|10847628|FG000|NOT COMPLETED|Overall Study||0
9745417|NCT00284180|10847629|FG001|NOT COMPLETED|Overall Study||4
9745418|NCT00284518|10847639|FG000|STARTED|Overall Study||97
9745419|NCT00284518|10847640|FG001|STARTED|Overall Study||94
9745420|NCT00284518|10847641|FG002|STARTED|Overall Study||95
9745421|NCT00284518|10847642|FG003|STARTED|Overall Study||94
9745422|NCT00284518|10847639|FG000|COMPLETED|Overall Study||71
9745423|NCT00284518|10847640|FG001|COMPLETED|Overall Study||66
9745424|NCT00284518|10847641|FG002|COMPLETED|Overall Study||67
9745425|NCT00284518|10847642|FG003|COMPLETED|Overall Study||61
9745426|NCT00284518|10847639|FG000|NOT COMPLETED|Overall Study||26
9745427|NCT00284518|10847640|FG001|NOT COMPLETED|Overall Study||28
9745428|NCT00284518|10847641|FG002|NOT COMPLETED|Overall Study||28
9745429|NCT00284518|10847642|FG003|NOT COMPLETED|Overall Study||33
9745430|NCT00284557|10847654|FG000|STARTED|Overall Study||67
9745431|NCT00284557|10847655|FG001|STARTED|Overall Study||63
9745432|NCT00284557|10847654|FG000|COMPLETED|Overall Study||58
9745433|NCT00284557|10847655|FG001|COMPLETED|Overall Study||50
9745434|NCT00284557|10847654|FG000|NOT COMPLETED|Overall Study||9
9745435|NCT00284557|10847655|FG001|NOT COMPLETED|Overall Study||13
9745436|NCT00284739|10847663|FG000|STARTED|Overall Study||11
9745437|NCT00284739|10847664|FG001|STARTED|Overall Study||9
9745438|NCT00284739|10847663|FG000|COMPLETED|Overall Study||11
9745439|NCT00284739|10847664|FG001|COMPLETED|Overall Study||9
9745440|NCT00284739|10847663|FG000|NOT COMPLETED|Overall Study||0
9745441|NCT00284739|10847664|FG001|NOT COMPLETED|Overall Study||0
9745442|NCT00284934|10847672|FG000|STARTED|Overall Study||48
9745443|NCT00284934|10847673|FG001|STARTED|Overall Study||46
9745444|NCT00284934|10847672|FG000|Intent-to-treat Population (ITT)|Overall Study||47
9745445|NCT00284934|10847673|FG001|Intent-to-treat Population (ITT)|Overall Study||45
9745446|NCT00284934|10847672|FG000|COMPLETED|Overall Study||44
9745447|NCT00284934|10847673|FG001|COMPLETED|Overall Study||43
9745448|NCT00284934|10847672|FG000|NOT COMPLETED|Overall Study||4
9745449|NCT00284934|10847673|FG001|NOT COMPLETED|Overall Study||3
9745450|NCT00285012|10847681|FG000|STARTED|Assigned to Study Treatment (Tx)||250
9745451|NCT00285012|10847682|FG001|STARTED|Assigned to Study Treatment (Tx)||254
9745452|NCT00285012|10847681|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248
9745453|NCT00285012|10847682|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251
9745454|NCT00285012|10847681|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
9828465|NCT00756093|10939208|FG003|NOT COMPLETED|Third Intervention||0
9745455|NCT00285012|10847682|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
9745456|NCT00285012|10847681|FG000|STARTED|Received Study Tx||248
9745457|NCT00285012|10847682|FG001|STARTED|Received Study Tx||251
9745458|NCT00285012|10847681|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
9745459|NCT00285012|10847682|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
9745460|NCT00285012|10847681|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
9745461|NCT00285012|10847682|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
9745462|NCT00285012|10847681|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
9745463|NCT00285012|10847682|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
9745464|NCT00285012|10847681|FG000|NOT COMPLETED|Received Study Tx||72
9745465|NCT00285012|10847682|FG001|NOT COMPLETED|Received Study Tx||94
9828466|NCT00756093|10939205|FG000|STARTED|Fourth Intervention||5
9828467|NCT00756093|10939206|FG001|STARTED|Fourth Intervention||5
9828468|NCT00756093|10939207|FG002|STARTED|Fourth Intervention||5
9828469|NCT00756093|10939208|FG003|STARTED|Fourth Intervention||5
9828470|NCT00756093|10939205|FG000|COMPLETED|Fourth Intervention||5
9828471|NCT00756093|10939206|FG001|COMPLETED|Fourth Intervention||5
9828472|NCT00756093|10939207|FG002|COMPLETED|Fourth Intervention||5
9828473|NCT00756093|10939208|FG003|COMPLETED|Fourth Intervention||5
9828474|NCT00756093|10939205|FG000|NOT COMPLETED|Fourth Intervention||0
9828475|NCT00756093|10939206|FG001|NOT COMPLETED|Fourth Intervention||0
9828476|NCT00756093|10939207|FG002|NOT COMPLETED|Fourth Intervention||0
9828477|NCT00756093|10939208|FG003|NOT COMPLETED|Fourth Intervention||0
9828478|NCT00756106|10939218|FG000|STARTED|Overall Study||15
9828479|NCT00756106|10939218|FG000|COMPLETED|Overall Study||3
9828480|NCT00756106|10939218|FG000|NOT COMPLETED|Overall Study||12
9828481|NCT00756236|10939225|FG000|STARTED|Overall Study||20
9828482|NCT00756236|10939226|FG001|STARTED|Overall Study||20
9828483|NCT00756236|10939227|FG002|STARTED|Overall Study||20
9828484|NCT00756236|10939225|FG000|COMPLETED|Overall Study||20
9828485|NCT00756236|10939226|FG001|COMPLETED|Overall Study||20
9828486|NCT00756236|10939227|FG002|COMPLETED|Overall Study||20
9828487|NCT00756236|10939225|FG000|NOT COMPLETED|Overall Study||0
9828488|NCT00756236|10939226|FG001|NOT COMPLETED|Overall Study||0
9828489|NCT00756236|10939227|FG002|NOT COMPLETED|Overall Study||0
9828490|NCT00756275|10939237|FG000|STARTED|Overall Study||60
9828491|NCT00756275|10939238|FG001|STARTED|Overall Study||77
9828492|NCT00756275|10939237|FG000|COMPLETED|Overall Study||31
9828493|NCT00756275|10939238|FG001|COMPLETED|Overall Study||49
9828494|NCT00756275|10939237|FG000|NOT COMPLETED|Overall Study||29
9828495|NCT00756275|10939238|FG001|NOT COMPLETED|Overall Study||28
9828496|NCT00756314|10939246|FG000|STARTED|Overall Study||123
9828497|NCT00756314|10939247|FG001|STARTED|Overall Study||123
9828498|NCT00756314|10939246|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
9828499|NCT00756314|10939247|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
9828500|NCT00756314|10939246|FG000|NOT COMPLETED|Overall Study||2
9828501|NCT00756314|10939247|FG001|NOT COMPLETED|Overall Study||59
9828502|NCT00756444|10939255|FG000|STARTED|Overall Study||33
9828503|NCT00756444|10939256|FG001|STARTED|Overall Study||34
9828504|NCT00756444|10939255|FG000|COMPLETED|Overall Study||18
9828505|NCT00756444|10939256|FG001|COMPLETED|Overall Study||13
9828506|NCT00756444|10939255|FG000|NOT COMPLETED|Overall Study||15
9828507|NCT00756444|10939256|FG001|NOT COMPLETED|Overall Study||21
9828508|NCT00756457|10939265|FG000|STARTED|Overall Study||20
9828509|NCT00756457|10939266|FG001|STARTED|Overall Study||19
9828510|NCT00756457|10939265|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
9828511|NCT00756457|10939266|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
9828512|NCT00756457|10939265|FG000|NOT COMPLETED|Overall Study||1
9828513|NCT00756457|10939266|FG001|NOT COMPLETED|Overall Study||2
9828514|NCT00756470|10939288|FG000|STARTED|Overall Study||15
9828515|NCT00756470|10939288|FG000|COMPLETED|Overall Study||10
9828516|NCT00756470|10939288|FG000|NOT COMPLETED|Overall Study||5
9828517|NCT00756496|10939292|FG000|STARTED|Overall Study||442
9828518|NCT00756496|10939292|FG000|COMPLETED|Overall Study||442
9828519|NCT00756496|10939292|FG000|NOT COMPLETED|Overall Study||0
9828520|NCT00756548|10939299|FG000|STARTED|Overall Study||186
9828521|NCT00756548|10939300|FG001|STARTED|Overall Study||185
9828522|NCT00756548|10939299|FG000|COMPLETED|Overall Study||184
9828523|NCT00756548|10939300|FG001|COMPLETED|Overall Study||185
9828524|NCT00756548|10939299|FG000|NOT COMPLETED|Overall Study||2
9828525|NCT00756548|10939300|FG001|NOT COMPLETED|Overall Study||0
9828526|NCT00756561|10939308|FG000|STARTED|Overall Study||10
9828527|NCT00756561|10939308|FG000|COMPLETED|Overall Study||10
9828528|NCT00756561|10939308|FG000|NOT COMPLETED|Overall Study||0
9828529|NCT00756600|10939315|FG000|STARTED|Overall Study||287
9828530|NCT00756600|10939316|FG001|STARTED|Overall Study||356
9828531|NCT00756600|10939315|FG000|COMPLETED|Overall Study||287
9828532|NCT00756600|10939316|FG001|COMPLETED|Overall Study||356
9828533|NCT00756600|10939315|FG000|NOT COMPLETED|Overall Study||0
9828534|NCT00756600|10939316|FG001|NOT COMPLETED|Overall Study||0
9745466|NCT00285207|10847690|FG000|STARTED|Overall Study||70
9745467|NCT00285207|10847691|FG001|STARTED|Overall Study||77
9745468|NCT00285207|10847690|FG000|Treated|Overall Study||63
9745469|NCT00285207|10847691|FG001|Treated|Overall Study||75
9745470|NCT00285207|10847690|FG000|COMPLETED|Overall Study||61
9745471|NCT00285207|10847691|FG001|COMPLETED|Overall Study||71
9745472|NCT00285207|10847690|FG000|NOT COMPLETED|Overall Study||9
9745473|NCT00285207|10847691|FG001|NOT COMPLETED|Overall Study||6
9745474|NCT00285246|10847697|FG000|STARTED|Overall Study||838
9745475|NCT00285246|10847697|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
9745476|NCT00285246|10847697|FG000|NOT COMPLETED|Overall Study||48
9745477|NCT00285467|10847703|FG000|STARTED|Overall Study||25
9745478|NCT00285467|10847704|FG001|STARTED|Overall Study||22
9745479|NCT00285467|10847703|FG000|COMPLETED|Overall Study||25
9745480|NCT00285467|10847704|FG001|COMPLETED|Overall Study||22
9852926|NCT00884325|10965866|FG001|NOT COMPLETED|Overall Study||4
9852927|NCT00884377|10965874|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
9852928|NCT00884377|10965875|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
9745481|NCT00285467|10847703|FG000|NOT COMPLETED|Overall Study||0
9745482|NCT00285467|10847704|FG001|NOT COMPLETED|Overall Study||0
9745483|NCT00285584|10847712|FG000|STARTED|Enrollment (Month 0)||20
9745484|NCT00285584|10847713|FG001|STARTED|Enrollment (Month 0)||21
9745485|NCT00285584|10847712|FG000|COMPLETED|Enrollment (Month 0)||20
9745486|NCT00285584|10847713|FG001|COMPLETED|Enrollment (Month 0)||21
9745487|NCT00285584|10847712|FG000|NOT COMPLETED|Enrollment (Month 0)||0
9745488|NCT00285584|10847713|FG001|NOT COMPLETED|Enrollment (Month 0)||0
9745489|NCT00285584|10847712|FG000|STARTED|Month 3||20
9745490|NCT00285584|10847713|FG001|STARTED|Month 3||21
9745491|NCT00285584|10847712|FG000|COMPLETED|Month 3||16
9745492|NCT00285584|10847713|FG001|COMPLETED|Month 3||18
9745493|NCT00285584|10847712|FG000|NOT COMPLETED|Month 3||4
9745494|NCT00285584|10847713|FG001|NOT COMPLETED|Month 3||3
9745495|NCT00285584|10847712|FG000|STARTED|Month 6||16
9745496|NCT00285584|10847713|FG001|STARTED|Month 6||18
9745497|NCT00285584|10847712|FG000|COMPLETED|Month 6||16
9745498|NCT00285584|10847713|FG001|COMPLETED|Month 6||17
9745499|NCT00285584|10847712|FG000|NOT COMPLETED|Month 6||0
9745500|NCT00285584|10847713|FG001|NOT COMPLETED|Month 6||1
9745501|NCT00285584|10847712|FG000|STARTED|Month 9||16
9745502|NCT00285584|10847713|FG001|STARTED|Month 9||17
9745503|NCT00285584|10847712|FG000|COMPLETED|Month 9||15
9745504|NCT00285584|10847713|FG001|COMPLETED|Month 9||14
9745505|NCT00285584|10847712|FG000|NOT COMPLETED|Month 9||1
9745506|NCT00285584|10847713|FG001|NOT COMPLETED|Month 9||3
9745507|NCT00285649|10847726|FG000|STARTED|Overall Study||72
9745508|NCT00285649|10847727|FG001|STARTED|Overall Study||72
9745509|NCT00285649|10847728|FG002|STARTED|Overall Study||48
9745510|NCT00285649|10847726|FG000|COMPLETED|Overall Study||63
9745511|NCT00285649|10847727|FG001|COMPLETED|Overall Study||66
9745512|NCT00285649|10847728|FG002|COMPLETED|Overall Study||42
9745513|NCT00285649|10847726|FG000|NOT COMPLETED|Overall Study||9
9745514|NCT00285649|10847727|FG001|NOT COMPLETED|Overall Study||6
9745515|NCT00285649|10847728|FG002|NOT COMPLETED|Overall Study||6
9745516|NCT00285779|10847738|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14
9745517|NCT00285779|10847739|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13
9745518|NCT00285779|10847738|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11
9745519|NCT00285779|10847739|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12
9745520|NCT00285779|10847738|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
9745521|NCT00285779|10847739|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
9745522|NCT00285779|10847738|FG000|STARTED|Open Label Period (wk 12-24)||11
9745523|NCT00285779|10847739|FG001|STARTED|Open Label Period (wk 12-24)||12
9745524|NCT00285779|10847738|FG000|COMPLETED|Open Label Period (wk 12-24)||9
9745525|NCT00285779|10847739|FG001|COMPLETED|Open Label Period (wk 12-24)||10
9745526|NCT00285779|10847738|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2
9852929|NCT00884377|10965874|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
9852930|NCT00884377|10965875|FG001|COMPLETED|Overall Study||27
9852931|NCT00884377|10965874|FG000|NOT COMPLETED|Overall Study||2
9852932|NCT00884377|10965875|FG001|NOT COMPLETED|Overall Study||1
9852933|NCT00884390|10965889|FG000|STARTED|Overall Study||146
9852934|NCT00884390|10965890|FG001|STARTED|Overall Study||62
9852935|NCT00884390|10965889|FG000|COMPLETED|Overall Study||123
9852936|NCT00884390|10965890|FG001|COMPLETED|Overall Study||54
9852937|NCT00884390|10965889|FG000|NOT COMPLETED|Overall Study||23
9745527|NCT00285779|10847739|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2
9745528|NCT00285779|10847738|FG000|STARTED|Follow-up Period (wk 24-32)||9
9745529|NCT00285779|10847739|FG001|STARTED|Follow-up Period (wk 24-32)||10
9745530|NCT00285779|10847738|FG000|COMPLETED|Follow-up Period (wk 24-32)||8
9745531|NCT00285779|10847739|FG001|COMPLETED|Follow-up Period (wk 24-32)||10
9745532|NCT00285779|10847738|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1
9745533|NCT00285779|10847739|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0
9745534|NCT00285818|10847747|FG000|STARTED|Overall Study||6
9745535|NCT00285818|10847748|FG001|STARTED|Overall Study||5
9745536|NCT00285818|10847747|FG000|COMPLETED|Overall Study||2
9745537|NCT00285818|10847748|FG001|COMPLETED|Overall Study||3
9745538|NCT00285818|10847747|FG000|NOT COMPLETED|Overall Study||4
9745539|NCT00285818|10847748|FG001|NOT COMPLETED|Overall Study||2
9745540|NCT00285857|10847754|FG000|STARTED|Overall Study||30
9745541|NCT00285857|10847754|FG000|COMPLETED|Overall Study||26
9745542|NCT00285857|10847754|FG000|NOT COMPLETED|Overall Study||4
9745543|NCT00286078|10847765|FG000|STARTED|Overall Study||72
9745544|NCT00286078|10847766|FG001|STARTED|Overall Study||68
9745545|NCT00286078|10847765|FG000|12 Weeks|Overall Study||63
9745546|NCT00286078|10847766|FG001|12 Weeks|Overall Study||62
9745547|NCT00286078|10847765|FG000|COMPLETED|Overall Study||40
9745548|NCT00286078|10847766|FG001|COMPLETED|Overall Study||34
9745549|NCT00286078|10847765|FG000|NOT COMPLETED|Overall Study||32
9745550|NCT00286078|10847766|FG001|NOT COMPLETED|Overall Study||34
9745551|NCT00286091|10847774|FG000|STARTED|Double-blind Treatment Phase||716
9745552|NCT00286091|10847775|FG001|STARTED|Double-blind Treatment Phase||716
9745553|NCT00286091|10847774|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
9745554|NCT00286091|10847775|FG001|Received Treatment|Double-blind Treatment Phase||716
9745555|NCT00286091|10847774|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
9745556|NCT00286091|10847775|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
9745557|NCT00286091|10847774|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
9745558|NCT00286091|10847775|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
10091855|NCT02332720|11220192|FG020|STARTED|Part A and Part B||7
10091856|NCT02332720|11220193|FG021|STARTED|Part A and Part B||0
10091857|NCT02332720|11220194|FG022|STARTED|Part A and Part B||4
10091858|NCT02332720|11220172|FG000|Treated|Part A and Part B||21
10091859|NCT02332720|11220173|FG001|Treated|Part A and Part B||21
9745559|NCT00286091|10847774|FG000|NOT COMPLETED|Double-blind Treatment Phase||584
9745560|NCT00286091|10847775|FG001|NOT COMPLETED|Double-blind Treatment Phase||593
9745561|NCT00286091|10847774|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
9745562|NCT00286091|10847775|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
9745563|NCT00286091|10847774|FG000|Received Treatment|Open-label Treatment Phase||109
9745564|NCT00286091|10847775|FG001|Received Treatment|Open-label Treatment Phase||101
9745565|NCT00286091|10847774|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
9745566|NCT00286091|10847775|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
9745567|NCT00286091|10847774|FG000|NOT COMPLETED|Open-label Treatment Phase||77
9745568|NCT00286091|10847775|FG001|NOT COMPLETED|Open-label Treatment Phase||71
9745569|NCT00286156|10847786|FG000|STARTED|Overall Study||10
9745570|NCT00286156|10847787|FG001|STARTED|Overall Study||10
9745571|NCT00286156|10847788|FG002|STARTED|Overall Study||10
9745572|NCT00286156|10847786|FG000|COMPLETED|Overall Study||8
9745573|NCT00286156|10847787|FG001|COMPLETED|Overall Study||9
9745574|NCT00286156|10847788|FG002|COMPLETED|Overall Study||9
9745575|NCT00286156|10847786|FG000|NOT COMPLETED|Overall Study||2
9745576|NCT00286156|10847787|FG001|NOT COMPLETED|Overall Study||1
9745577|NCT00286156|10847788|FG002|NOT COMPLETED|Overall Study||1
9745578|NCT00286182|10847798|FG000|STARTED|Overall Study||28
9745579|NCT00286182|10847799|FG001|STARTED|Overall Study||28
9745580|NCT00286182|10847798|FG000|COMPLETED|Overall Study||23
9745581|NCT00286182|10847799|FG001|COMPLETED|Overall Study||25
9745582|NCT00286182|10847798|FG000|NOT COMPLETED|Overall Study||5
9745583|NCT00286182|10847799|FG001|NOT COMPLETED|Overall Study||3
9745584|NCT00286221|10847809|FG000|STARTED|Overall Study||39
9745585|NCT00286221|10847810|FG001|STARTED|Overall Study||40
9745586|NCT00286221|10847811|FG002|STARTED|Overall Study||40
9745587|NCT00286221|10847812|FG003|STARTED|Overall Study||40
9745588|NCT00286221|10847809|FG000|COMPLETED|Overall Study||29
9745589|NCT00286221|10847810|FG001|COMPLETED|Overall Study||35
9745590|NCT00286221|10847811|FG002|COMPLETED|Overall Study||31
9745591|NCT00286221|10847812|FG003|COMPLETED|Overall Study||34
9745592|NCT00286221|10847809|FG000|NOT COMPLETED|Overall Study||10
9745593|NCT00286221|10847810|FG001|NOT COMPLETED|Overall Study||5
9745594|NCT00286221|10847811|FG002|NOT COMPLETED|Overall Study||9
9745595|NCT00286221|10847812|FG003|NOT COMPLETED|Overall Study||6
9745596|NCT00286234|10847826|FG000|STARTED|Overall Study||17
9745597|NCT00286234|10847827|FG001|STARTED|Overall Study||17
9745598|NCT00286234|10847828|FG002|STARTED|Overall Study||17
9745599|NCT00286234|10847829|FG003|STARTED|Overall Study||17
9745600|NCT00286234|10847826|FG000|COMPLETED|Overall Study||15
9745601|NCT00286234|10847827|FG001|COMPLETED|Overall Study||15
9745602|NCT00286234|10847828|FG002|COMPLETED|Overall Study||17
9745603|NCT00286234|10847829|FG003|COMPLETED|Overall Study||13
9745604|NCT00286234|10847826|FG000|NOT COMPLETED|Overall Study||2
9745605|NCT00286234|10847827|FG001|NOT COMPLETED|Overall Study||2
9745606|NCT00286234|10847828|FG002|NOT COMPLETED|Overall Study||0
9852938|NCT00884390|10965890|FG001|NOT COMPLETED|Overall Study||8
9852939|NCT00884585|10965906|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89
9852940|NCT00884585|10965907|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87
9852941|NCT00884585|10965906|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
9852942|NCT00884585|10965907|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
9852943|NCT00884585|10965906|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
9852944|NCT00884585|10965907|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
10091860|NCT02332720|11220174|FG002|Treated|Part A and Part B||22
10091861|NCT02332720|11220175|FG003|Treated|Part A and Part B||22
9745607|NCT00286234|10847829|FG003|NOT COMPLETED|Overall Study||4
9745608|NCT00286325|10847839|FG000|STARTED|Overall Study||8
9745609|NCT00286325|10847839|FG000|COMPLETED|Overall Study||8
9745610|NCT00286325|10847839|FG000|NOT COMPLETED|Overall Study||0
9745611|NCT00286429|10847846|FG000|STARTED|Overall Study||130
9745612|NCT00286429|10847847|FG001|STARTED|Overall Study||131
9745613|NCT00286429|10847848|FG002|STARTED|Overall Study||129
9745614|NCT00286429|10847846|FG000|COMPLETED|Overall Study||55
9745615|NCT00286429|10847847|FG001|COMPLETED|Overall Study||83
9745616|NCT00286429|10847848|FG002|COMPLETED|Overall Study||77
9745617|NCT00286429|10847846|FG000|NOT COMPLETED|Overall Study||75
9745618|NCT00286429|10847847|FG001|NOT COMPLETED|Overall Study||48
9745619|NCT00286429|10847848|FG002|NOT COMPLETED|Overall Study||52
9745620|NCT00286442|10847859|FG000|STARTED|Overall Study||213
9745621|NCT00286442|10847860|FG001|STARTED|Overall Study||210
9745622|NCT00286442|10847861|FG002|STARTED|Overall Study||104
9745623|NCT00286442|10847859|FG000|COMPLETED|Overall Study||176
9745624|NCT00286442|10847860|FG001|COMPLETED|Overall Study||165
9745625|NCT00286442|10847861|FG002|COMPLETED|Overall Study||72
9745626|NCT00286442|10847859|FG000|NOT COMPLETED|Overall Study||37
9745627|NCT00286442|10847860|FG001|NOT COMPLETED|Overall Study||45
9745628|NCT00286442|10847861|FG002|NOT COMPLETED|Overall Study||32
9745629|NCT00286455|10847872|FG000|STARTED|Overall Study||65
9745630|NCT00286455|10847873|FG001|STARTED|Overall Study||133
9745631|NCT00286455|10847874|FG002|STARTED|Overall Study||131
9745632|NCT00286455|10847872|FG000|COMPLETED|Overall Study||40
9745633|NCT00286455|10847873|FG001|COMPLETED|Overall Study||105
9745634|NCT00286455|10847874|FG002|COMPLETED|Overall Study||107
9745635|NCT00286455|10847872|FG000|NOT COMPLETED|Overall Study||25
9745636|NCT00286455|10847873|FG001|NOT COMPLETED|Overall Study||28
9745637|NCT00286455|10847874|FG002|NOT COMPLETED|Overall Study||24
9745638|NCT00286468|10847885|FG000|STARTED|Overall Study||99
9745639|NCT00286468|10847886|FG001|STARTED|Overall Study||203
9745640|NCT00286468|10847887|FG002|STARTED|Overall Study||198
9745641|NCT00286468|10847885|FG000|COMPLETED|Overall Study||62
9745642|NCT00286468|10847886|FG001|COMPLETED|Overall Study||153
9745643|NCT00286468|10847887|FG002|COMPLETED|Overall Study||148
9745644|NCT00286468|10847885|FG000|NOT COMPLETED|Overall Study||37
9745645|NCT00286468|10847886|FG001|NOT COMPLETED|Overall Study||50
9745646|NCT00286468|10847887|FG002|NOT COMPLETED|Overall Study||50
9745647|NCT00286494|10847898|FG000|STARTED|Overall Study||97
9745648|NCT00286494|10847899|FG001|STARTED|Overall Study||197
9745649|NCT00286494|10847900|FG002|STARTED|Overall Study||199
9745650|NCT00286494|10847898|FG000|COMPLETED|Overall Study||71
9745651|NCT00286494|10847899|FG001|COMPLETED|Overall Study||153
9745652|NCT00286494|10847900|FG002|COMPLETED|Overall Study||160
9745653|NCT00286494|10847898|FG000|NOT COMPLETED|Overall Study||26
9745654|NCT00286494|10847899|FG001|NOT COMPLETED|Overall Study||44
9745655|NCT00286494|10847900|FG002|NOT COMPLETED|Overall Study||39
9745656|NCT00286728|10847910|FG000|STARTED|Overall Study||142
9745657|NCT00286728|10847911|FG001|STARTED|Overall Study||145
9745658|NCT00286728|10847910|FG000|COMPLETED|Overall Study||106
9745659|NCT00286728|10847911|FG001|COMPLETED|Overall Study||116
9745660|NCT00286728|10847910|FG000|NOT COMPLETED|Overall Study||36
9745661|NCT00286728|10847911|FG001|NOT COMPLETED|Overall Study||29
9745662|NCT00286741|10847919|FG000|STARTED|Overall Study||133
9745663|NCT00286741|10847920|FG001|STARTED|Overall Study||106
9745664|NCT00286741|10847919|FG000|COMPLETED|Overall Study||122
9745665|NCT00286741|10847920|FG001|COMPLETED|Overall Study||89
9745666|NCT00286741|10847919|FG000|NOT COMPLETED|Overall Study||11
9745667|NCT00286741|10847920|FG001|NOT COMPLETED|Overall Study||17
9852945|NCT00884585|10965906|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
9953003|NCT01424943|11071865|FG001|STARTED|Overall Study||24
9745668|NCT00286754|10847932|FG000|STARTED|Overall Study||176
9745669|NCT00286754|10847933|FG001|STARTED|Overall Study||177
9745670|NCT00286754|10847934|FG002|STARTED|Overall Study||180
9745671|NCT00286754|10847932|FG000|COMPLETED|Overall Study||156
9745672|NCT00286754|10847933|FG001|COMPLETED|Overall Study||159
9745673|NCT00286754|10847934|FG002|COMPLETED|Overall Study||170
9745674|NCT00286754|10847932|FG000|NOT COMPLETED|Overall Study||20
9745675|NCT00286754|10847933|FG001|NOT COMPLETED|Overall Study||18
9745676|NCT00286754|10847934|FG002|NOT COMPLETED|Overall Study||10
9745677|NCT00286949|10847948|FG000|STARTED|Overall Study||12
9745678|NCT00286949|10847948|FG000|COMPLETED|Overall Study||12
9745679|NCT00286949|10847948|FG000|NOT COMPLETED|Overall Study||0
9745680|NCT00287053|10847956|FG000|STARTED|Overall Study||30
9745681|NCT00287053|10847957|FG001|STARTED|Overall Study||27
9745682|NCT00287053|10847956|FG000|COMPLETED|Overall Study||26
9745683|NCT00287053|10847957|FG001|COMPLETED|Overall Study||26
9745684|NCT00287053|10847956|FG000|NOT COMPLETED|Overall Study||4
9745685|NCT00287053|10847957|FG001|NOT COMPLETED|Overall Study||1
9745686|NCT00287079|10847965|FG000|STARTED|Overall Study||32
9745687|NCT00287079|10847966|FG001|STARTED|Overall Study||3
9745688|NCT00287079|10847965|FG000|COMPLETED|Overall Study||10
9745689|NCT00287079|10847966|FG001|COMPLETED|Overall Study||2
9745690|NCT00287079|10847965|FG000|NOT COMPLETED|Overall Study||22
9745691|NCT00287079|10847966|FG001|NOT COMPLETED|Overall Study||1
9745692|NCT00287118|10847972|FG000|STARTED|Overall Study||189
9745693|NCT00287118|10847972|FG000|COMPLETED|Overall Study||137
9745694|NCT00287118|10847972|FG000|NOT COMPLETED|Overall Study||52
9745695|NCT00287222|10847976|FG000|STARTED|Overall Study||21
9745696|NCT00287222|10847976|FG000|COMPLETED|Overall Study||21
9745697|NCT00287222|10847976|FG000|NOT COMPLETED|Overall Study||0
9745698|NCT00287287|10847980|FG000|STARTED|Overall Study||25
9745699|NCT00287287|10847980|FG000|COMPLETED|Overall Study||25
9745700|NCT00287287|10847980|FG000|NOT COMPLETED|Overall Study||0
9745701|NCT00287339|10847986|FG000|STARTED|Overall Study||22
9745702|NCT00287339|10847987|FG001|STARTED|Overall Study||18
9745703|NCT00287339|10847986|FG000|COMPLETED|Overall Study||22
9745704|NCT00287339|10847987|FG001|COMPLETED|Overall Study||18
9745705|NCT00287339|10847986|FG000|NOT COMPLETED|Overall Study||0
9745706|NCT00287339|10847987|FG001|NOT COMPLETED|Overall Study||0
9745707|NCT00287365|10847993|FG000|STARTED|Overall Study||25
9745708|NCT00287365|10847993|FG000|COMPLETED|Overall Study||12
9745709|NCT00287365|10847993|FG000|NOT COMPLETED|Overall Study||13
9745710|NCT00287469|10848000|FG000|STARTED|Overall Study||1000
9745711|NCT00287469|10848001|FG001|STARTED|Overall Study||1000
9745712|NCT00287469|10848000|FG000|COMPLETED|Overall Study||780
9745713|NCT00287469|10848001|FG001|COMPLETED|Overall Study||786
9745714|NCT00287469|10848000|FG000|NOT COMPLETED|Overall Study||220
9745715|NCT00287469|10848001|FG001|NOT COMPLETED|Overall Study||214
9745716|NCT00287586|10848011|FG000|STARTED|Overall Study||156
9745717|NCT00287586|10848012|FG001|STARTED|Overall Study||152
9745718|NCT00287586|10848011|FG000|Intent-to-treat: Received Study Drug|Overall Study||155
9745719|NCT00287586|10848012|FG001|Intent-to-treat: Received Study Drug|Overall Study||151
9745720|NCT00287586|10848011|FG000|COMPLETED|Overall Study||111
9745721|NCT00287586|10848012|FG001|COMPLETED|Overall Study||100
9745722|NCT00287586|10848011|FG000|NOT COMPLETED|Overall Study||45
9745723|NCT00287586|10848012|FG001|NOT COMPLETED|Overall Study||52
9745724|NCT00287690|10848020|FG000|STARTED|Overall Study||33
9745725|NCT00287690|10848021|FG001|STARTED|Overall Study||38
9745726|NCT00287690|10848020|FG000|COMPLETED|Overall Study||13
9745727|NCT00287690|10848021|FG001|COMPLETED|Overall Study||12
9745728|NCT00287690|10848020|FG000|NOT COMPLETED|Overall Study||20
9745729|NCT00287690|10848021|FG001|NOT COMPLETED|Overall Study||26
9745730|NCT00287716|10848030|FG000|STARTED|Overall Study||174
9745731|NCT00287716|10848031|FG001|STARTED|Overall Study||87
9745732|NCT00287716|10848032|FG002|STARTED|Overall Study||174
9745733|NCT00287716|10848030|FG000|COMPLETED|Overall Study||136
9745734|NCT00287716|10848031|FG001|COMPLETED|Overall Study||70
9745735|NCT00287716|10848032|FG002|COMPLETED|Overall Study||143
9745736|NCT00287716|10848030|FG000|NOT COMPLETED|Overall Study||38
9745737|NCT00287716|10848031|FG001|NOT COMPLETED|Overall Study||17
9745738|NCT00287716|10848032|FG002|NOT COMPLETED|Overall Study||31
9745739|NCT00287729|10848042|FG000|STARTED|Overall Study||171
10091862|NCT02332720|11220176|FG004|Treated|Part A and Part B||16
10091863|NCT02332720|11220177|FG005|Treated|Part A and Part B||36
10091864|NCT02332720|11220178|FG006|Treated|Part A and Part B||37
10091865|NCT02332720|11220179|FG007|Treated|Part A and Part B||35
10091866|NCT02332720|11220180|FG008|Treated|Part A and Part B||15
10091867|NCT02332720|11220181|FG009|Treated|Part A and Part B||14
10091868|NCT02332720|11220182|FG010|Treated|Part A and Part B||14
10091869|NCT02332720|11220183|FG011|Treated|Part A and Part B||15
10091870|NCT02332720|11220184|FG012|Treated|Part A and Part B||16
10091871|NCT02332720|11220185|FG013|Treated|Part A and Part B||13
9852946|NCT00884585|10965907|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
9852947|NCT00884585|10965906|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147
9852948|NCT00884585|10965907|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0
9852949|NCT00884585|10965906|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
9852950|NCT00884585|10965907|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
9852951|NCT00884585|10965906|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147
9852952|NCT00884585|10965907|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0
9852953|NCT00884585|10965906|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144
9852954|NCT00884585|10965907|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0
9852955|NCT00884585|10965906|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
9852956|NCT00884585|10965907|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
9852957|NCT00884611|10965913|FG000|STARTED|Overall Study||20
9852958|NCT00884611|10965913|FG000|Enrolled, Not Treated|Overall Study||1
9852959|NCT00884611|10965913|FG000|COMPLETED|Overall Study||19
9852960|NCT00884611|10965913|FG000|NOT COMPLETED|Overall Study||1
9852961|NCT00884650|10965925|FG000|STARTED|Overall Study||25
9852962|NCT00884650|10965926|FG001|STARTED|Overall Study||29
9852963|NCT00884650|10965925|FG000|COMPLETED|Overall Study||16
9852964|NCT00884650|10965926|FG001|COMPLETED|Overall Study||21
9852965|NCT00884650|10965925|FG000|NOT COMPLETED|Overall Study||9
9852966|NCT00884650|10965926|FG001|NOT COMPLETED|Overall Study||8
9852967|NCT00884741|10965936|FG000|STARTED|Step 1 Registration: Tissue Screening||978
10091872|NCT02332720|11220186|FG014|Treated|Part A and Part B||16
10091873|NCT02332720|11220187|FG015|Treated|Part A and Part B||14
10091874|NCT02332720|11220188|FG016|Treated|Part A and Part B||15
9745740|NCT00287729|10848043|FG001|STARTED|Overall Study||173
9745741|NCT00287729|10848042|FG000|COMPLETED|Overall Study||137
9745742|NCT00287729|10848043|FG001|COMPLETED|Overall Study||142
9852968|NCT00884741|10965937|FG001|STARTED|Step 1 Registration: Tissue Screening||0
10091875|NCT02332720|11220189|FG017|Treated|Part A and Part B||14
10091876|NCT02332720|11220190|FG018|Treated|Part A and Part B||20
10091877|NCT02332720|11220191|FG019|Treated|Part A and Part B||25
9745743|NCT00287729|10848042|FG000|NOT COMPLETED|Overall Study||34
10091878|NCT02332720|11220192|FG020|Treated|Part A and Part B||7
10091879|NCT02332720|11220193|FG021|Treated|Part A and Part B||0
9745744|NCT00287729|10848043|FG001|NOT COMPLETED|Overall Study||31
9745745|NCT00287872|10848049|FG000|STARTED|Overall Study||30
9745746|NCT00287872|10848049|FG000|COMPLETED|Overall Study||30
9745747|NCT00287872|10848049|FG000|NOT COMPLETED|Overall Study||0
9745748|NCT00287989|10848057|FG000|STARTED|Overall Study||28
9745749|NCT00287989|10848058|FG001|STARTED|Overall Study||29
9745750|NCT00287989|10848059|FG002|STARTED|Overall Study||29
9745751|NCT00287989|10848057|FG000|COMPLETED|Overall Study||28
9745752|NCT00287989|10848058|FG001|COMPLETED|Overall Study||29
9745753|NCT00287989|10848059|FG002|COMPLETED|Overall Study||29
9745754|NCT00287989|10848057|FG000|NOT COMPLETED|Overall Study||0
9745755|NCT00287989|10848058|FG001|NOT COMPLETED|Overall Study||0
9745756|NCT00287989|10848059|FG002|NOT COMPLETED|Overall Study||0
9745757|NCT00288015|10848067|FG000|STARTED|Registered to Study||32
9745758|NCT00288015|10848067|FG000|COMPLETED|Registered to Study||32
9745759|NCT00288015|10848067|FG000|NOT COMPLETED|Registered to Study||0
9745760|NCT00288015|10848067|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32
9745761|NCT00288015|10848067|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
9745762|NCT00288015|10848067|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
9745763|NCT00288015|10848067|FG000|STARTED|First Response Assessment||30
9745764|NCT00288015|10848067|FG000|COMPLETED|First Response Assessment||26
9745765|NCT00288015|10848067|FG000|NOT COMPLETED|First Response Assessment||4
9745766|NCT00288015|10848067|FG000|STARTED|Continued Bevacizumab Cycle 3+||26
9745767|NCT00288015|10848067|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19
9745768|NCT00288015|10848067|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
9745769|NCT00288015|10848067|FG000|STARTED|Follow up for Survival x 2 Years||29
9745770|NCT00288015|10848067|FG000|COMPLETED|Follow up for Survival x 2 Years||3
9745771|NCT00288015|10848067|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26
9745772|NCT00288054|10848071|FG000|STARTED|Overall Study||24
9745773|NCT00288054|10848071|FG000|COMPLETED|Overall Study||0
9745774|NCT00288054|10848071|FG000|NOT COMPLETED|Overall Study||24
9745775|NCT00288067|10848077|FG000|STARTED|Overall Study||32
9745776|NCT00288067|10848077|FG000|COMPLETED|Overall Study||32
9745777|NCT00288067|10848077|FG000|NOT COMPLETED|Overall Study||0
9745778|NCT00288366|10848085|FG000|STARTED|Overall Study||23
9745779|NCT00288366|10848086|FG001|STARTED|Overall Study||26
9745780|NCT00288366|10848085|FG000|COMPLETED|Overall Study||23
9745781|NCT00288366|10848086|FG001|COMPLETED|Overall Study||26
9745782|NCT00288366|10848085|FG000|NOT COMPLETED|Overall Study||0
9745783|NCT00288366|10848086|FG001|NOT COMPLETED|Overall Study||0
9745784|NCT00288509|10848092|FG000|STARTED|Treatment Cycle 1||108
9745785|NCT00288509|10848092|FG000|COMPLETED|Treatment Cycle 1||102
9745786|NCT00288509|10848092|FG000|NOT COMPLETED|Treatment Cycle 1||6
9745787|NCT00288509|10848092|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
9745788|NCT00288509|10848092|FG000|COMPLETED|Treatment Cycle 2||97
9745789|NCT00288509|10848092|FG000|NOT COMPLETED|Treatment Cycle 2||3
9745790|NCT00288509|10848092|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
9745791|NCT00288509|10848092|FG000|COMPLETED|Treatment Cycle 3||91
9745792|NCT00288509|10848092|FG000|NOT COMPLETED|Treatment Cycle 3||5
9745793|NCT00288509|10848092|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
9745794|NCT00288509|10848092|FG000|COMPLETED|Treatment Cycle 4||80
9745795|NCT00288509|10848092|FG000|NOT COMPLETED|Treatment Cycle 4||8
9745796|NCT00288574|10848098|FG000|STARTED|Overall Study||49
9745797|NCT00288574|10848099|FG001|STARTED|Overall Study||44
9745798|NCT00288574|10848098|FG000|COMPLETED|Overall Study||49
9745799|NCT00288574|10848099|FG001|COMPLETED|Overall Study||44
9745800|NCT00288574|10848098|FG000|NOT COMPLETED|Overall Study||0
9745801|NCT00288574|10848099|FG001|NOT COMPLETED|Overall Study||0
9745802|NCT00288587|10848110|FG000|STARTED|Overall Study||19
9745803|NCT00288587|10848111|FG001|STARTED|Overall Study||17
9745804|NCT00288587|10848110|FG000|COMPLETED|Overall Study||14
9745805|NCT00288587|10848111|FG001|COMPLETED|Overall Study||7
9745806|NCT00288587|10848110|FG000|NOT COMPLETED|Overall Study||5
9745807|NCT00288587|10848111|FG001|NOT COMPLETED|Overall Study||10
9745808|NCT00288600|10848119|FG000|STARTED|Overall Study||46
9745809|NCT00288600|10848120|FG001|STARTED|Overall Study||46
9745810|NCT00288600|10848119|FG000|COMPLETED|Overall Study||46
9745811|NCT00288600|10848120|FG001|COMPLETED|Overall Study||46
9745812|NCT00288600|10848119|FG000|NOT COMPLETED|Overall Study||0
9745813|NCT00288600|10848120|FG001|NOT COMPLETED|Overall Study||0
9745814|NCT00288626|10848126|FG000|STARTED|Overall Study||24
9745815|NCT00288626|10848126|FG000|COMPLETED|Overall Study||17
9745816|NCT00288626|10848126|FG000|NOT COMPLETED|Overall Study||7
9745817|NCT00288639|10848132|FG000|STARTED|Overall Study||98
9745818|NCT00288639|10848132|FG000|COMPLETED|Overall Study||86
9745819|NCT00288639|10848132|FG000|NOT COMPLETED|Overall Study||12
9745820|NCT00288704|10848139|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24
9745821|NCT00288704|10848140|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23
9745822|NCT00288704|10848141|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
9745823|NCT00288704|10848139|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24
9745824|NCT00288704|10848140|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22
9745825|NCT00288704|10848141|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0
9745826|NCT00288704|10848139|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
9745827|NCT00288704|10848140|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
9745828|NCT00288704|10848141|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
9745829|NCT00288704|10848139|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
9745830|NCT00288704|10848140|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
9745831|NCT00288704|10848141|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
9745832|NCT00288704|10848139|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
9745833|NCT00288704|10848140|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
9745834|NCT00288704|10848141|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
9745835|NCT00288704|10848139|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
9745836|NCT00288704|10848140|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
9745837|NCT00288704|10848141|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
9745838|NCT00288704|10848139|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
9745839|NCT00288704|10848140|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
9745840|NCT00288704|10848141|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
9745841|NCT00288704|10848139|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
9745842|NCT00288704|10848140|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
9745843|NCT00288704|10848141|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
9745844|NCT00288704|10848139|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
9745845|NCT00288704|10848140|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
9745846|NCT00288704|10848141|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
9745847|NCT00288860|10848150|FG000|STARTED|Overall Study||412
9745848|NCT00288860|10848151|FG001|STARTED|Overall Study||425
9745849|NCT00288860|10848150|FG000|Completed Intake Survey|Overall Study||408
9745850|NCT00288860|10848151|FG001|Completed Intake Survey|Overall Study||417
9745851|NCT00288860|10848150|FG000|Completed 4 Month fu Survey|Overall Study||275
9745852|NCT00288860|10848151|FG001|Completed 4 Month fu Survey|Overall Study||299
9745853|NCT00288860|10848150|FG000|Completed 12 Month fu Survey|Overall Study||257
9745854|NCT00288860|10848151|FG001|Completed 12 Month fu Survey|Overall Study||281
9745855|NCT00288860|10848150|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
9745856|NCT00288860|10848151|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
9745857|NCT00288860|10848150|FG000|NOT COMPLETED|Overall Study||102
9745858|NCT00288860|10848151|FG001|NOT COMPLETED|Overall Study||97
9745859|NCT00288886|10848162|FG000|STARTED|Overall Study||91
9745860|NCT00288886|10848163|FG001|STARTED|Overall Study||92
9745861|NCT00288886|10848162|FG000|3-month Follow Up|Overall Study||82
9745862|NCT00288886|10848163|FG001|3-month Follow Up|Overall Study||85
9745863|NCT00288886|10848162|FG000|6-month Follow Up|Overall Study||85
9745864|NCT00288886|10848163|FG001|6-month Follow Up|Overall Study||84
9745865|NCT00288886|10848162|FG000|12-month Follow Up|Overall Study||80
9745866|NCT00288886|10848163|FG001|12-month Follow Up|Overall Study||81
9745867|NCT00288886|10848162|FG000|COMPLETED|Overall Study||80
9745868|NCT00288886|10848163|FG001|COMPLETED|Overall Study||81
9745869|NCT00288886|10848162|FG000|NOT COMPLETED|Overall Study||11
9745870|NCT00288886|10848163|FG001|NOT COMPLETED|Overall Study||11
9745871|NCT00288912|10848172|FG000|STARTED|Overall Study||175
9745872|NCT00288912|10848173|FG001|STARTED|Overall Study||174
9745873|NCT00288912|10848174|FG002|STARTED|Overall Study||174
9745874|NCT00288912|10848172|FG000|COMPLETED|Overall Study||158
9745875|NCT00288912|10848173|FG001|COMPLETED|Overall Study||157
9745876|NCT00288912|10848174|FG002|COMPLETED|Overall Study||146
9745877|NCT00288912|10848172|FG000|NOT COMPLETED|Overall Study||17
9745878|NCT00288912|10848173|FG001|NOT COMPLETED|Overall Study||17
9745879|NCT00288912|10848174|FG002|NOT COMPLETED|Overall Study||28
9745880|NCT00289016|10848182|FG000|STARTED|Overall Study||50
9745881|NCT00289016|10848182|FG000|COMPLETED|Overall Study||13
9745882|NCT00289016|10848182|FG000|NOT COMPLETED|Overall Study||37
9745883|NCT00289094|10848188|FG000|STARTED|Overall Study||50
9745884|NCT00289094|10848189|FG001|STARTED|Overall Study||49
9745885|NCT00289094|10848188|FG000|COMPLETED|Overall Study||3
9745886|NCT00289094|10848189|FG001|COMPLETED|Overall Study||2
10091880|NCT02332720|11220194|FG022|Treated|Part A and Part B||4
10091881|NCT02332720|11220172|FG000|COMPLETED|Part A and Part B||20
10091882|NCT02332720|11220173|FG001|COMPLETED|Part A and Part B||21
10091883|NCT02332720|11220174|FG002|COMPLETED|Part A and Part B||22
10091884|NCT02332720|11220175|FG003|COMPLETED|Part A and Part B||22
10091885|NCT02332720|11220176|FG004|COMPLETED|Part A and Part B||16
10091886|NCT02332720|11220177|FG005|COMPLETED|Part A and Part B||33
10091887|NCT02332720|11220178|FG006|COMPLETED|Part A and Part B||36
10091888|NCT02332720|11220179|FG007|COMPLETED|Part A and Part B||34
10091889|NCT02332720|11220180|FG008|COMPLETED|Part A and Part B||15
9745887|NCT00289094|10848188|FG000|NOT COMPLETED|Overall Study||47
9745888|NCT00289094|10848189|FG001|NOT COMPLETED|Overall Study||47
9745889|NCT00289107|10848197|FG000|STARTED|Overall Study||77
10091890|NCT02332720|11220181|FG009|COMPLETED|Part A and Part B||14
10091891|NCT02332720|11220182|FG010|COMPLETED|Part A and Part B||14
9745890|NCT00289107|10848198|FG001|STARTED|Overall Study||72
9745891|NCT00289107|10848197|FG000|COMPLETED|Overall Study||24
9745892|NCT00289107|10848198|FG001|COMPLETED|Overall Study||28
9745893|NCT00289107|10848197|FG000|NOT COMPLETED|Overall Study||53
9745894|NCT00289107|10848198|FG001|NOT COMPLETED|Overall Study||44
9745895|NCT00289120|10848204|FG000|STARTED|Overall Study||13
9745896|NCT00289120|10848204|FG000|COMPLETED|Overall Study||13
10091892|NCT02332720|11220183|FG011|COMPLETED|Part A and Part B||15
10091893|NCT02332720|11220184|FG012|COMPLETED|Part A and Part B||16
9745897|NCT00289120|10848204|FG000|NOT COMPLETED|Overall Study||0
9745898|NCT00289133|10848214|FG000|STARTED|Overall Study||461
9745899|NCT00289133|10848215|FG001|STARTED|Overall Study||477
9745900|NCT00289133|10848214|FG000|COMPLETED|Overall Study||189
9745901|NCT00289133|10848215|FG001|COMPLETED|Overall Study||179
9745902|NCT00289133|10848214|FG000|NOT COMPLETED|Overall Study||272
9745903|NCT00289133|10848215|FG001|NOT COMPLETED|Overall Study||298
9745904|NCT00289185|10848227|FG000|STARTED|Overall Study||170
9745905|NCT00289185|10848228|FG001|STARTED|Overall Study||170
9745906|NCT00289185|10848227|FG000|COMPLETED|Overall Study||142
9745907|NCT00289185|10848228|FG001|COMPLETED|Overall Study||144
9745908|NCT00289185|10848227|FG000|NOT COMPLETED|Overall Study||28
9745909|NCT00289185|10848228|FG001|NOT COMPLETED|Overall Study||26
9745910|NCT00289198|10848237|FG000|STARTED|Overall Study||151
9745911|NCT00289198|10848238|FG001|STARTED|Overall Study||151
9745912|NCT00289198|10848237|FG000|COMPLETED|Overall Study||120
9745913|NCT00289198|10848238|FG001|COMPLETED|Overall Study||121
9745914|NCT00289198|10848237|FG000|NOT COMPLETED|Overall Study||31
9745915|NCT00289198|10848238|FG001|NOT COMPLETED|Overall Study||30
9745916|NCT00289211|10848248|FG000|STARTED|Overall Study||36
9745917|NCT00289211|10848249|FG001|STARTED|Overall Study||35
9745918|NCT00289211|10848250|FG002|STARTED|Overall Study||12
9745919|NCT00289211|10848248|FG000|COMPLETED|Overall Study||36
9745920|NCT00289211|10848249|FG001|COMPLETED|Overall Study||34
9745921|NCT00289211|10848250|FG002|COMPLETED|Overall Study||2
9745922|NCT00289211|10848248|FG000|NOT COMPLETED|Overall Study||0
9745923|NCT00289211|10848249|FG001|NOT COMPLETED|Overall Study||1
9745924|NCT00289211|10848250|FG002|NOT COMPLETED|Overall Study||10
9745925|NCT00289276|10848258|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
9745926|NCT00289276|10848259|FG001|STARTED|First Part of FAST Study (Pivotal)||0
9745927|NCT00289276|10848258|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47
9745928|NCT00289276|10848259|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0
9745929|NCT00289276|10848258|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
9745930|NCT00289276|10848259|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
9745931|NCT00289276|10848258|FG000|STARTED|Second Part of FAST Study (Expansion)||0
9745932|NCT00289276|10848259|FG001|STARTED|Second Part of FAST Study (Expansion)||109
9745933|NCT00289276|10848258|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0
9745934|NCT00289276|10848259|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106
9745935|NCT00289276|10848258|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
9745936|NCT00289276|10848259|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
9852969|NCT00884741|10965938|FG002|STARTED|Step 1 Registration: Tissue Screening||0
9852970|NCT00884741|10965939|FG003|STARTED|Step 1 Registration: Tissue Screening||0
9852971|NCT00884741|10965936|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666
9852972|NCT00884741|10965937|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0
9745937|NCT00289289|10848268|FG000|STARTED|Overall Study||132
9745938|NCT00289289|10848269|FG001|STARTED|Overall Study||124
9745939|NCT00289289|10848270|FG002|STARTED|Overall Study||144
9745940|NCT00289289|10848268|FG000|COMPLETED|Overall Study||113
9745941|NCT00289289|10848269|FG001|COMPLETED|Overall Study||114
9745942|NCT00289289|10848270|FG002|COMPLETED|Overall Study||95
9745943|NCT00289289|10848268|FG000|NOT COMPLETED|Overall Study||19
9745944|NCT00289289|10848269|FG001|NOT COMPLETED|Overall Study||10
9745945|NCT00289289|10848270|FG002|NOT COMPLETED|Overall Study||49
9745946|NCT00289315|10848280|FG000|STARTED|Overall Study||713
9745947|NCT00289315|10848281|FG001|STARTED|Overall Study||760
9745948|NCT00289315|10848282|FG002|STARTED|Overall Study||587
9745949|NCT00289315|10848280|FG000|COMPLETED|Overall Study||612
9745950|NCT00289315|10848281|FG001|COMPLETED|Overall Study||638
9745951|NCT00289315|10848282|FG002|COMPLETED|Overall Study||447
9745952|NCT00289315|10848280|FG000|NOT COMPLETED|Overall Study||101
9745953|NCT00289315|10848281|FG001|NOT COMPLETED|Overall Study||122
9745954|NCT00289315|10848282|FG002|NOT COMPLETED|Overall Study||140
9745955|NCT00289341|10848292|FG000|STARTED|Overall Study||12
9745956|NCT00289341|10848293|FG001|STARTED|Overall Study||12
9745957|NCT00289341|10848292|FG000|COMPLETED|Overall Study||12
9745958|NCT00289341|10848293|FG001|COMPLETED|Overall Study||12
9745959|NCT00289341|10848292|FG000|NOT COMPLETED|Overall Study||0
9745960|NCT00289341|10848293|FG001|NOT COMPLETED|Overall Study||0
9745961|NCT00289458|10848306|FG000|STARTED|Overall Study||25
9745962|NCT00289458|10848307|FG001|STARTED|Overall Study||26
9745963|NCT00289458|10848308|FG002|STARTED|Overall Study||28
9745964|NCT00289458|10848306|FG000|COMPLETED|Overall Study||19
9745965|NCT00289458|10848307|FG001|COMPLETED|Overall Study||20
9745966|NCT00289458|10848308|FG002|COMPLETED|Overall Study||22
9745967|NCT00289458|10848306|FG000|NOT COMPLETED|Overall Study||6
9745968|NCT00289458|10848307|FG001|NOT COMPLETED|Overall Study||6
9745969|NCT00289458|10848308|FG002|NOT COMPLETED|Overall Study||6
9745970|NCT00289471|10848316|FG000|STARTED|Overall Study||630
9745971|NCT00289471|10848316|FG000|COMPLETED|Overall Study||630
9745972|NCT00289471|10848316|FG000|NOT COMPLETED|Overall Study||0
9745973|NCT00289536|10848320|FG000|STARTED|Period 1||9
9745974|NCT00289536|10848321|FG001|STARTED|Period 1||8
9745975|NCT00289536|10848322|FG002|STARTED|Period 1||9
9745976|NCT00289536|10848320|FG000|COMPLETED|Period 1||9
9745977|NCT00289536|10848321|FG001|COMPLETED|Period 1||8
9745978|NCT00289536|10848322|FG002|COMPLETED|Period 1||9
9745979|NCT00289536|10848320|FG000|NOT COMPLETED|Period 1||0
9745980|NCT00289536|10848321|FG001|NOT COMPLETED|Period 1||0
9745981|NCT00289536|10848322|FG002|NOT COMPLETED|Period 1||0
9745982|NCT00289536|10848320|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
9745983|NCT00289536|10848321|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
9745984|NCT00289536|10848322|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
9745985|NCT00289536|10848320|FG000|COMPLETED|Period 2||10
9745986|NCT00289536|10848321|FG001|COMPLETED|Period 2||9
9745987|NCT00289536|10848322|FG002|COMPLETED|Period 2||7
9745988|NCT00289536|10848320|FG000|NOT COMPLETED|Period 2||0
10091894|NCT02332720|11220185|FG013|COMPLETED|Part A and Part B||13
9745989|NCT00289536|10848321|FG001|NOT COMPLETED|Period 2||0
9745990|NCT00289536|10848322|FG002|NOT COMPLETED|Period 2||0
9745991|NCT00289536|10848320|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
9745992|NCT00289536|10848321|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
9745993|NCT00289536|10848322|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
9745994|NCT00289536|10848320|FG000|COMPLETED|Period 3||7
9745995|NCT00289536|10848321|FG001|COMPLETED|Period 3||9
9745996|NCT00289536|10848322|FG002|COMPLETED|Period 3||9
9745997|NCT00289536|10848320|FG000|NOT COMPLETED|Period 3||0
9745998|NCT00289536|10848321|FG001|NOT COMPLETED|Period 3||0
9745999|NCT00289536|10848322|FG002|NOT COMPLETED|Period 3||1
9746000|NCT00289653|10848328|FG000|STARTED|Overall Study||23
9746001|NCT00289653|10848328|FG000|COMPLETED|Overall Study||12
9746002|NCT00289653|10848328|FG000|NOT COMPLETED|Overall Study||11
9746003|NCT00289718|10848333|FG000|STARTED|Overall Study||51
9746004|NCT00289718|10848333|FG000|COMPLETED|Overall Study||51
9746005|NCT00289718|10848333|FG000|NOT COMPLETED|Overall Study||0
9746006|NCT00289731|10848345|FG000|STARTED|Overall Study||199
9746007|NCT00289731|10848346|FG001|STARTED|Overall Study||200
9746008|NCT00289731|10848347|FG002|STARTED|Overall Study||197
9746009|NCT00289731|10848345|FG000|COMPLETED|Overall Study||197
9746010|NCT00289731|10848346|FG001|COMPLETED|Overall Study||198
9746011|NCT00289731|10848347|FG002|COMPLETED|Overall Study||195
9746012|NCT00289731|10848345|FG000|NOT COMPLETED|Overall Study||2
9746013|NCT00289731|10848346|FG001|NOT COMPLETED|Overall Study||2
9746014|NCT00289731|10848347|FG002|NOT COMPLETED|Overall Study||2
9746015|NCT00289744|10848357|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
9746016|NCT00289744|10848358|FG001|STARTED|Year 6 Long-term Follow-up||0
9746017|NCT00289744|10848359|FG002|STARTED|Year 6 Long-term Follow-up||0
9746018|NCT00289744|10848357|FG000|COMPLETED|Year 6 Long-term Follow-up||178
9852973|NCT00884741|10965938|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0
9852974|NCT00884741|10965939|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0
9852975|NCT00884741|10965936|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
9852976|NCT00884741|10965937|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
9852977|NCT00884741|10965938|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
9852978|NCT00884741|10965939|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
9852979|NCT00884741|10965936|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
9852980|NCT00884741|10965937|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
9852981|NCT00884741|10965938|FG002|STARTED|Step 2 Registration: Tissue Analysis||0
9852982|NCT00884741|10965939|FG003|STARTED|Step 2 Registration: Tissue Analysis||0
9746019|NCT00289744|10848358|FG001|COMPLETED|Year 6 Long-term Follow-up||0
9746020|NCT00289744|10848359|FG002|COMPLETED|Year 6 Long-term Follow-up||0
9746021|NCT00289744|10848357|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0
9746022|NCT00289744|10848358|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0
9746023|NCT00289744|10848359|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0
9746024|NCT00289744|10848357|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
9746025|NCT00289744|10848358|FG001|STARTED|Year 7 Long-term Follow-up||0
9746026|NCT00289744|10848359|FG002|STARTED|Year 7 Long-term Follow-up||0
9746027|NCT00289744|10848357|FG000|COMPLETED|Year 7 Long-term Follow-up||175
9746028|NCT00289744|10848358|FG001|COMPLETED|Year 7 Long-term Follow-up||0
9746029|NCT00289744|10848359|FG002|COMPLETED|Year 7 Long-term Follow-up||0
9746030|NCT00289744|10848357|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0
9746031|NCT00289744|10848358|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0
9746032|NCT00289744|10848359|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0
9746033|NCT00289744|10848357|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
9746034|NCT00289744|10848358|FG001|STARTED|Year 8 Long-term Follow-up||0
9746035|NCT00289744|10848359|FG002|STARTED|Year 8 Long-term Follow-up||0
9746036|NCT00289744|10848357|FG000|COMPLETED|Year 8 Long-term Follow-up||174
9746037|NCT00289744|10848358|FG001|COMPLETED|Year 8 Long-term Follow-up||0
9746038|NCT00289744|10848359|FG002|COMPLETED|Year 8 Long-term Follow-up||0
9746039|NCT00289744|10848357|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0
9746040|NCT00289744|10848358|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0
9746041|NCT00289744|10848359|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0
9746042|NCT00289744|10848357|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
9746043|NCT00289744|10848358|FG001|STARTED|Year 9 Long-term Follow-up||0
9746044|NCT00289744|10848359|FG002|STARTED|Year 9 Long-term Follow-up||0
9746045|NCT00289744|10848357|FG000|COMPLETED|Year 9 Long-term Follow-up||173
9746046|NCT00289744|10848358|FG001|COMPLETED|Year 9 Long-term Follow-up||0
9746047|NCT00289744|10848359|FG002|COMPLETED|Year 9 Long-term Follow-up||0
9746048|NCT00289744|10848357|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0
9746049|NCT00289744|10848358|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0
9746050|NCT00289744|10848359|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0
9746051|NCT00289744|10848357|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
9746052|NCT00289744|10848358|FG001|STARTED|Year 10 Long-term Follow-up||0
9746053|NCT00289744|10848359|FG002|STARTED|Year 10 Long-term Follow-up||0
9746054|NCT00289744|10848357|FG000|COMPLETED|Year 10 Long-term Follow-up||171
9746055|NCT00289744|10848358|FG001|COMPLETED|Year 10 Long-term Follow-up||0
9746056|NCT00289744|10848359|FG002|COMPLETED|Year 10 Long-term Follow-up||0
9746057|NCT00289744|10848357|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0
9746058|NCT00289744|10848358|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0
9746059|NCT00289744|10848359|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0
9746060|NCT00289744|10848357|FG000|STARTED|Additional Dose Phase||0
9746061|NCT00289744|10848358|FG001|STARTED|Additional Dose Phase||19
9746062|NCT00289744|10848359|FG002|STARTED|Additional Dose Phase||6
9746063|NCT00289744|10848357|FG000|COMPLETED|Additional Dose Phase||0
9746064|NCT00289744|10848358|FG001|COMPLETED|Additional Dose Phase||19
9746065|NCT00289744|10848359|FG002|COMPLETED|Additional Dose Phase||6
9746066|NCT00289744|10848357|FG000|NOT COMPLETED|Additional Dose Phase||0
9746067|NCT00289744|10848358|FG001|NOT COMPLETED|Additional Dose Phase||0
9746068|NCT00289744|10848359|FG002|NOT COMPLETED|Additional Dose Phase||0
9746069|NCT00289757|10848367|FG000|STARTED|Overall Study||78
9746070|NCT00289757|10848367|FG000|COMPLETED|Overall Study||78
9746071|NCT00289757|10848367|FG000|NOT COMPLETED|Overall Study||0
9746072|NCT00289770|10848371|FG000|STARTED|Year 11||37
9746073|NCT00289770|10848371|FG000|COMPLETED|Year 11||37
9746074|NCT00289770|10848371|FG000|NOT COMPLETED|Year 11||0
9746075|NCT00289770|10848371|FG000|STARTED|Year 12||40
9746076|NCT00289770|10848371|FG000|COMPLETED|Year 12||40
9746077|NCT00289770|10848371|FG000|NOT COMPLETED|Year 12||0
9746078|NCT00289770|10848371|FG000|STARTED|Year 13||37
9746079|NCT00289770|10848371|FG000|COMPLETED|Year 13||37
9746080|NCT00289770|10848371|FG000|NOT COMPLETED|Year 13||0
9746081|NCT00289770|10848371|FG000|STARTED|Year 14||43
9746082|NCT00289770|10848371|FG000|COMPLETED|Year 14||43
9746083|NCT00289770|10848371|FG000|NOT COMPLETED|Year 14||0
9746084|NCT00289770|10848371|FG000|STARTED|Year 15||50
9746085|NCT00289770|10848371|FG000|COMPLETED|Year 15||49
9746086|NCT00289770|10848371|FG000|NOT COMPLETED|Year 15||1
9746087|NCT00289783|10848377|FG000|STARTED|Primary Phase||3136
9746088|NCT00289783|10848378|FG001|STARTED|Primary Phase||1044
9746089|NCT00289783|10848377|FG000|COMPLETED|Primary Phase||2888
9746090|NCT00289783|10848378|FG001|COMPLETED|Primary Phase||961
9746091|NCT00289783|10848377|FG000|NOT COMPLETED|Primary Phase||248
9746092|NCT00289783|10848378|FG001|NOT COMPLETED|Primary Phase||83
9746093|NCT00289783|10848377|FG000|STARTED|Fourth Dose Phase||2769
9746094|NCT00289783|10848378|FG001|STARTED|Fourth Dose Phase||923
9746095|NCT00289783|10848377|FG000|COMPLETED|Fourth Dose Phase||2682
9746096|NCT00289783|10848378|FG001|COMPLETED|Fourth Dose Phase||899
9746097|NCT00289783|10848377|FG000|NOT COMPLETED|Fourth Dose Phase||87
9746098|NCT00289783|10848378|FG001|NOT COMPLETED|Fourth Dose Phase||24
9746099|NCT00289848|10848394|FG000|STARTED|Overall Study||352
9746100|NCT00289848|10848395|FG001|STARTED|Overall Study||178
9746101|NCT00289848|10848394|FG000|COMPLETED|Overall Study||306
9746102|NCT00289848|10848395|FG001|COMPLETED|Overall Study||133
9746103|NCT00289848|10848394|FG000|NOT COMPLETED|Overall Study||46
9746104|NCT00289848|10848395|FG001|NOT COMPLETED|Overall Study||45
9746105|NCT00289900|10848407|FG000|STARTED|Overall Study||297
9746106|NCT00289900|10848408|FG001|STARTED|Overall Study||436
9746107|NCT00289900|10848409|FG002|STARTED|Overall Study||298
9746108|NCT00289900|10848410|FG003|STARTED|Overall Study||439
9746109|NCT00289900|10848411|FG004|STARTED|Overall Study||437
9746110|NCT00289900|10848412|FG005|STARTED|Overall Study||433
9746111|NCT00289900|10848407|FG000|Treated|Overall Study||297
9746112|NCT00289900|10848408|FG001|Treated|Overall Study||435
9746113|NCT00289900|10848409|FG002|Treated|Overall Study||298
9746114|NCT00289900|10848410|FG003|Treated|Overall Study||439
9746115|NCT00289900|10848411|FG004|Treated|Overall Study||437
9746116|NCT00289900|10848412|FG005|Treated|Overall Study||433
9746117|NCT00289900|10848407|FG000|COMPLETED|Overall Study||229
9746118|NCT00289900|10848408|FG001|COMPLETED|Overall Study||316
9746119|NCT00289900|10848409|FG002|COMPLETED|Overall Study||265
9746120|NCT00289900|10848410|FG003|COMPLETED|Overall Study||380
9746121|NCT00289900|10848411|FG004|COMPLETED|Overall Study||392
9746122|NCT00289900|10848412|FG005|COMPLETED|Overall Study||372
9746123|NCT00289900|10848407|FG000|NOT COMPLETED|Overall Study||68
9746124|NCT00289900|10848408|FG001|NOT COMPLETED|Overall Study||120
9746125|NCT00289900|10848409|FG002|NOT COMPLETED|Overall Study||33
9746126|NCT00289900|10848410|FG003|NOT COMPLETED|Overall Study||59
9746127|NCT00289900|10848411|FG004|NOT COMPLETED|Overall Study||45
9746128|NCT00289900|10848412|FG005|NOT COMPLETED|Overall Study||61
9746129|NCT00289913|10848434|FG000|STARTED|Visit 1 (Stage I and Stage II)||155
9746130|NCT00289913|10848435|FG001|STARTED|Visit 1 (Stage I and Stage II)||151
9746131|NCT00289913|10848436|FG002|STARTED|Visit 1 (Stage I and Stage II)||159
9746132|NCT00289913|10848437|FG003|STARTED|Visit 1 (Stage I and Stage II)||152
9746133|NCT00289913|10848438|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
9746134|NCT00289913|10848434|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146
9746135|NCT00289913|10848435|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135
9746136|NCT00289913|10848436|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150
9746137|NCT00289913|10848437|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141
9746138|NCT00289913|10848438|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645
9746139|NCT00289913|10848434|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
9746140|NCT00289913|10848435|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
9746141|NCT00289913|10848436|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
9746142|NCT00289913|10848437|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
9746143|NCT00289913|10848438|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
9746144|NCT00289913|10848434|FG000|STARTED|Visit 2 (Stage I and Stage II)||146
9746145|NCT00289913|10848435|FG001|STARTED|Visit 2 (Stage I and Stage II)||135
9746146|NCT00289913|10848436|FG002|STARTED|Visit 2 (Stage I and Stage II)||150
9746147|NCT00289913|10848437|FG003|STARTED|Visit 2 (Stage I and Stage II)||141
9746148|NCT00289913|10848438|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
9746149|NCT00289913|10848434|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131
9746150|NCT00289913|10848435|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114
9746151|NCT00289913|10848436|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140
9746152|NCT00289913|10848437|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135
9852983|NCT00884741|10965936|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0
9852984|NCT00884741|10965937|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637
9852985|NCT00884741|10965938|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0
9852986|NCT00884741|10965939|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0
9746153|NCT00289913|10848438|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605
9746154|NCT00289913|10848434|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
9746155|NCT00289913|10848435|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
9746156|NCT00289913|10848436|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
9746157|NCT00289913|10848437|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
9746158|NCT00289913|10848438|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
9746159|NCT00289913|10848434|FG000|STARTED|Visit 3 (Stage I and Stage II)||131
9746160|NCT00289913|10848435|FG001|STARTED|Visit 3 (Stage I and Stage II)||114
9746161|NCT00289913|10848436|FG002|STARTED|Visit 3 (Stage I and Stage II)||140
9746162|NCT00289913|10848437|FG003|STARTED|Visit 3 (Stage I and Stage II)||135
9746163|NCT00289913|10848438|FG004|STARTED|Visit 3 (Stage I and Stage II)||605
9746164|NCT00289913|10848434|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122
9746165|NCT00289913|10848435|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106
9852987|NCT00884741|10965936|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
9852988|NCT00884741|10965937|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
9852989|NCT00884741|10965938|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
9852990|NCT00884741|10965939|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
9852991|NCT00884741|10965936|FG000|STARTED|Randomization||0
9852992|NCT00884741|10965937|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
9852993|NCT00884741|10965938|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
9852994|NCT00884741|10965939|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
9852995|NCT00884741|10965936|FG000|COMPLETED|Randomization||0
9852996|NCT00884741|10965937|FG001|COMPLETED|Randomization||0
9852997|NCT00884741|10965938|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
9852998|NCT00884741|10965939|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
9852999|NCT00884741|10965936|FG000|NOT COMPLETED|Randomization||0
9853000|NCT00884741|10965937|FG001|NOT COMPLETED|Randomization||0
9853001|NCT00884741|10965938|FG002|NOT COMPLETED|Randomization||8
9853002|NCT00884741|10965939|FG003|NOT COMPLETED|Randomization||8
9853003|NCT00884754|10965948|FG000|STARTED|Overall Study||30
9853004|NCT00884754|10965949|FG001|STARTED|Overall Study||30
9853005|NCT00884754|10965948|FG000|COMPLETED|Overall Study||30
9853006|NCT00884754|10965949|FG001|COMPLETED|Overall Study||30
9853007|NCT00884754|10965948|FG000|NOT COMPLETED|Overall Study||0
9853008|NCT00884754|10965949|FG001|NOT COMPLETED|Overall Study||0
9853009|NCT00884793|10965955|FG000|STARTED|Overall Study||8
9853010|NCT00884793|10965955|FG000|COMPLETED|Overall Study||7
9853011|NCT00884793|10965955|FG000|NOT COMPLETED|Overall Study||1
9853012|NCT00884806|10965959|FG000|STARTED|Overall Study||110
9853013|NCT00884806|10965959|FG000|COMPLETED|Overall Study||110
9853014|NCT00884806|10965959|FG000|NOT COMPLETED|Overall Study||0
9853015|NCT00884832|10965965|FG000|STARTED|Overall Study||22
9853016|NCT00884832|10965966|FG001|STARTED|Overall Study||22
9853017|NCT00884832|10965965|FG000|COMPLETED|Overall Study||22
9853018|NCT00884832|10965966|FG001|COMPLETED|Overall Study||21
9853019|NCT00884832|10965965|FG000|NOT COMPLETED|Overall Study||0
9853020|NCT00884832|10965966|FG001|NOT COMPLETED|Overall Study||1
9853021|NCT00884897|10965974|FG000|STARTED|Overall Study||13
9853022|NCT00884897|10965975|FG001|STARTED|Overall Study||15
9853023|NCT00884897|10965974|FG000|COMPLETED|Overall Study||13
9853024|NCT00884897|10965975|FG001|COMPLETED|Overall Study||15
9853025|NCT00884897|10965974|FG000|NOT COMPLETED|Overall Study||0
9853026|NCT00884897|10965975|FG001|NOT COMPLETED|Overall Study||0
9853027|NCT00884910|10965981|FG000|STARTED|Overall Study||33
9853028|NCT00884910|10965981|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
9853029|NCT00884910|10965981|FG000|NOT COMPLETED|Overall Study||1
9853030|NCT00884949|10965985|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
9746166|NCT00289913|10848436|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138
9746167|NCT00289913|10848437|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131
9746168|NCT00289913|10848438|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597
9746169|NCT00289913|10848434|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
9746170|NCT00289913|10848435|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
9746171|NCT00289913|10848436|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
9746172|NCT00289913|10848437|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
9746173|NCT00289913|10848438|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
9746174|NCT00289913|10848434|FG000|STARTED|Visit 4 (Stage I and Stage II)||122
9746175|NCT00289913|10848435|FG001|STARTED|Visit 4 (Stage I and Stage II)||106
9746176|NCT00289913|10848436|FG002|STARTED|Visit 4 (Stage I and Stage II)||138
9746177|NCT00289913|10848437|FG003|STARTED|Visit 4 (Stage I and Stage II)||131
9746178|NCT00289913|10848438|FG004|STARTED|Visit 4 (Stage I and Stage II)||597
9746179|NCT00289913|10848434|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122
9746180|NCT00289913|10848435|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106
9746181|NCT00289913|10848436|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138
9746182|NCT00289913|10848437|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131
9746183|NCT00289913|10848438|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597
9746184|NCT00289913|10848434|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
9746185|NCT00289913|10848435|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
9746186|NCT00289913|10848436|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
9746187|NCT00289913|10848437|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
9746188|NCT00289913|10848438|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
9746189|NCT00289978|10848456|FG000|STARTED|Overall Study||429
9746190|NCT00289978|10848457|FG001|STARTED|Overall Study||425
9746191|NCT00289978|10848458|FG002|STARTED|Overall Study||418
9746192|NCT00289978|10848456|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
9746193|NCT00289978|10848457|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
9746194|NCT00289978|10848458|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
9746195|NCT00289978|10848456|FG000|NOT COMPLETED|Overall Study||97
9746196|NCT00289978|10848457|FG001|NOT COMPLETED|Overall Study||56
9746197|NCT00289978|10848458|FG002|NOT COMPLETED|Overall Study||86
9746198|NCT00289991|10848468|FG000|STARTED|Overall Study||234
9746199|NCT00289991|10848469|FG001|STARTED|Overall Study||255
9746200|NCT00289991|10848468|FG000|COMPLETED|Overall Study||176
9746201|NCT00289991|10848469|FG001|COMPLETED|Overall Study||175
9746202|NCT00289991|10848468|FG000|NOT COMPLETED|Overall Study||58
9746203|NCT00289991|10848469|FG001|NOT COMPLETED|Overall Study||80
9746204|NCT00290147|10848477|FG000|STARTED|Overall Study||10
9746205|NCT00290147|10848478|FG001|STARTED|Overall Study||12
9746206|NCT00290147|10848477|FG000|COMPLETED|Overall Study||10
9746207|NCT00290147|10848478|FG001|COMPLETED|Overall Study||12
9746208|NCT00290147|10848477|FG000|NOT COMPLETED|Overall Study||0
9746209|NCT00290147|10848478|FG001|NOT COMPLETED|Overall Study||0
9746210|NCT00290186|10848486|FG000|STARTED|Overall Study||25
9746211|NCT00290186|10848487|FG001|STARTED|Overall Study||24
9746212|NCT00290186|10848486|FG000|Completed Baseline Assessments|Overall Study||25
9746213|NCT00290186|10848487|FG001|Completed Baseline Assessments|Overall Study||24
9746214|NCT00290186|10848486|FG000|Completed 8 Weeks of Treatment|Overall Study||24
9746215|NCT00290186|10848487|FG001|Completed 8 Weeks of Treatment|Overall Study||22
9746216|NCT00290186|10848486|FG000|Completed Post-treatment Assessments|Overall Study||24
9746217|NCT00290186|10848487|FG001|Completed Post-treatment Assessments|Overall Study||22
9746218|NCT00290186|10848486|FG000|Completed 3-month Followup Assessments|Overall Study||20
9746219|NCT00290186|10848487|FG001|Completed 3-month Followup Assessments|Overall Study||21
9746220|NCT00290186|10848486|FG000|Completed 6-month Followup Assessments|Overall Study||20
9746221|NCT00290186|10848487|FG001|Completed 6-month Followup Assessments|Overall Study||19
9746222|NCT00290186|10848486|FG000|COMPLETED|Overall Study||20
9746223|NCT00290186|10848487|FG001|COMPLETED|Overall Study||19
9746224|NCT00290186|10848486|FG000|NOT COMPLETED|Overall Study||5
9746225|NCT00290186|10848487|FG001|NOT COMPLETED|Overall Study||5
9746226|NCT00290199|10848497|FG000|STARTED|Overall Study||87
9746227|NCT00290199|10848498|FG001|STARTED|Overall Study||82
9746228|NCT00290199|10848497|FG000|COMPLETED|Overall Study||87
9746229|NCT00290199|10848498|FG001|COMPLETED|Overall Study||82
9746230|NCT00290199|10848497|FG000|NOT COMPLETED|Overall Study||0
9746231|NCT00290199|10848498|FG001|NOT COMPLETED|Overall Study||0
9746232|NCT00290238|10848508|FG000|STARTED|Overall Study||57
9746233|NCT00290238|10848509|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
9746234|NCT00290238|10848508|FG000|COMPLETED|Overall Study||15
9746235|NCT00290238|10848509|FG001|COMPLETED|Overall Study||24
9746236|NCT00290238|10848508|FG000|NOT COMPLETED|Overall Study||42
9746237|NCT00290238|10848509|FG001|NOT COMPLETED|Overall Study||41
9746238|NCT00290290|10848517|FG000|STARTED|Overall Study||440
9746239|NCT00290290|10848518|FG001|STARTED|Overall Study||409
9746240|NCT00290290|10848517|FG000|COMPLETED|Overall Study||422
9746241|NCT00290290|10848518|FG001|COMPLETED|Overall Study||391
9746242|NCT00290290|10848517|FG000|NOT COMPLETED|Overall Study||18
9746243|NCT00290290|10848518|FG001|NOT COMPLETED|Overall Study||18
9746244|NCT00290329|10848527|FG000|STARTED|Overall Study||102
9746245|NCT00290329|10848528|FG001|STARTED|Overall Study||86
9746246|NCT00290329|10848529|FG002|STARTED|Overall Study||61
9746247|NCT00290329|10848527|FG000|COMPLETED|Overall Study||102
9746248|NCT00290329|10848528|FG001|COMPLETED|Overall Study||86
9746249|NCT00290329|10848529|FG002|COMPLETED|Overall Study||61
9746250|NCT00290329|10848527|FG000|NOT COMPLETED|Overall Study||0
9746251|NCT00290329|10848528|FG001|NOT COMPLETED|Overall Study||0
9746252|NCT00290329|10848529|FG002|NOT COMPLETED|Overall Study||0
9746253|NCT00290342|10848541|FG000|STARTED|Overall Study||224
9746254|NCT00290342|10848542|FG001|STARTED|Overall Study||228
9746255|NCT00290342|10848541|FG000|COMPLETED|Overall Study||217
9746256|NCT00290342|10848542|FG001|COMPLETED|Overall Study||223
9746257|NCT00290342|10848541|FG000|NOT COMPLETED|Overall Study||7
9746258|NCT00290342|10848542|FG001|NOT COMPLETED|Overall Study||5
9746259|NCT00290355|10848550|FG000|STARTED|Overall Study||122
9746260|NCT00290355|10848551|FG001|STARTED|Overall Study||60
9746261|NCT00290355|10848550|FG000|COMPLETED|Overall Study||105
9746262|NCT00290355|10848551|FG001|COMPLETED|Overall Study||55
9746263|NCT00290355|10848550|FG000|NOT COMPLETED|Overall Study||17
9746264|NCT00290355|10848551|FG001|NOT COMPLETED|Overall Study||5
9746265|NCT00290433|10848557|FG000|STARTED|Overall Study||53
9746266|NCT00290433|10848557|FG000|COMPLETED|Overall Study||17
9746267|NCT00290433|10848557|FG000|NOT COMPLETED|Overall Study||36
9746268|NCT00290472|10848564|FG000|STARTED|Overall Study||32
9746269|NCT00290472|10848565|FG001|STARTED|Overall Study||39
9746270|NCT00290472|10848566|FG002|STARTED|Overall Study||18
9746271|NCT00290472|10848564|FG000|COMPLETED|Overall Study||32
9746272|NCT00290472|10848565|FG001|COMPLETED|Overall Study||39
9746273|NCT00290472|10848566|FG002|COMPLETED|Overall Study||18
9746274|NCT00290472|10848564|FG000|NOT COMPLETED|Overall Study||0
9746275|NCT00290472|10848565|FG001|NOT COMPLETED|Overall Study||0
9746276|NCT00290472|10848566|FG002|NOT COMPLETED|Overall Study||0
9746277|NCT00290498|10848574|FG000|STARTED|Overall Study||49
9746278|NCT00290498|10848575|FG001|STARTED|Overall Study||10
9746279|NCT00290498|10848574|FG000|COMPLETED|Overall Study||41
9746280|NCT00290498|10848575|FG001|COMPLETED|Overall Study||10
9746281|NCT00290498|10848574|FG000|NOT COMPLETED|Overall Study||8
9746282|NCT00290498|10848575|FG001|NOT COMPLETED|Overall Study||0
9746283|NCT00290537|10848582|FG000|STARTED|Overall Study||4
9746284|NCT00290537|10848583|FG001|STARTED|Overall Study||0
9746285|NCT00290537|10848582|FG000|COMPLETED|Overall Study||4
9746286|NCT00290537|10848583|FG001|COMPLETED|Overall Study||0
9746287|NCT00290537|10848582|FG000|NOT COMPLETED|Overall Study||0
9746288|NCT00290537|10848583|FG001|NOT COMPLETED|Overall Study||0
9746289|NCT00290589|10848590|FG000|STARTED|Overall Study||39
9746290|NCT00290589|10848591|FG001|STARTED|Overall Study||43
9746291|NCT00290589|10848590|FG000|COMPLETED|Overall Study||37
9746292|NCT00290589|10848591|FG001|COMPLETED|Overall Study||41
9746293|NCT00290589|10848590|FG000|NOT COMPLETED|Overall Study||2
9746294|NCT00290589|10848591|FG001|NOT COMPLETED|Overall Study||2
9746295|NCT00290615|10848597|FG000|STARTED|Overall Study||30
9746296|NCT00290615|10848597|FG000|COMPLETED|Overall Study||30
9746297|NCT00290615|10848597|FG000|NOT COMPLETED|Overall Study||0
9746298|NCT00290654|10848601|FG000|STARTED|Overall Study||41
9746299|NCT00290654|10848601|FG000|COMPLETED|Overall Study||41
9746300|NCT00290654|10848601|FG000|NOT COMPLETED|Overall Study||0
9746301|NCT00290693|10848605|FG000|STARTED|Overall Study||45
9746302|NCT00290693|10848605|FG000|COMPLETED|Overall Study||43
9746303|NCT00290693|10848605|FG000|NOT COMPLETED|Overall Study||2
9746304|NCT00290706|10848614|FG000|STARTED|Overall Study||5
9746305|NCT00290706|10848615|FG001|STARTED|Overall Study||6
9746306|NCT00290706|10848616|FG002|STARTED|Overall Study||7
9746307|NCT00290706|10848617|FG003|STARTED|Overall Study||14
9746308|NCT00290706|10848614|FG000|Attempted1st Cycle|Overall Study||5
9746309|NCT00290706|10848615|FG001|Attempted1st Cycle|Overall Study||6
9746310|NCT00290706|10848616|FG002|Attempted1st Cycle|Overall Study||7
9746311|NCT00290706|10848617|FG003|Attempted1st Cycle|Overall Study||14
9746312|NCT00290706|10848614|FG000|Reached 1st Response/Cycle 3|Overall Study||0
9853031|NCT00884949|10965985|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
9853032|NCT00884949|10965985|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
9853033|NCT00884949|10965985|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
9853034|NCT00884949|10965985|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
9853035|NCT00884949|10965985|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
9853036|NCT00884949|10965985|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
9853037|NCT00884949|10965985|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
9853038|NCT00884949|10965985|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
9853039|NCT00884949|10965985|FG000|STARTED|Continuation Period||18
9853040|NCT00884949|10965985|FG000|COMPLETED|Continuation Period||18
9853041|NCT00884949|10965985|FG000|NOT COMPLETED|Continuation Period||0
9853042|NCT00885079|10966000|FG000|STARTED|Overall Study||93
9746313|NCT00290706|10848615|FG001|Reached 1st Response/Cycle 3|Overall Study||0
9746314|NCT00290706|10848616|FG002|Reached 1st Response/Cycle 3|Overall Study||1
9746315|NCT00290706|10848617|FG003|Reached 1st Response/Cycle 3|Overall Study||2
9746316|NCT00290706|10848614|FG000|COMPLETED|Overall Study||0
9746317|NCT00290706|10848615|FG001|COMPLETED|Overall Study||0
9746318|NCT00290706|10848616|FG002|COMPLETED|Overall Study||1
9746319|NCT00290706|10848617|FG003|COMPLETED|Overall Study||2
9746320|NCT00290706|10848614|FG000|NOT COMPLETED|Overall Study||5
9746321|NCT00290706|10848615|FG001|NOT COMPLETED|Overall Study||6
9746322|NCT00290706|10848616|FG002|NOT COMPLETED|Overall Study||6
9746323|NCT00290706|10848617|FG003|NOT COMPLETED|Overall Study||12
9746324|NCT00290732|10848630|FG000|STARTED|Overall Study||3
9746325|NCT00290732|10848631|FG001|STARTED|Overall Study||4
9746326|NCT00290732|10848632|FG002|STARTED|Overall Study||4
9746327|NCT00290732|10848633|FG003|STARTED|Overall Study||6
9853043|NCT00885079|10966001|FG001|STARTED|Overall Study||95
9853044|NCT00885079|10966000|FG000|COMPLETED|Overall Study||91
9853045|NCT00885079|10966001|FG001|COMPLETED|Overall Study||91
9853046|NCT00885079|10966000|FG000|NOT COMPLETED|Overall Study||2
9853047|NCT00885079|10966001|FG001|NOT COMPLETED|Overall Study||4
9853048|NCT00885092|10966009|FG000|STARTED|Period 1, 7 Days||20
9746328|NCT00290732|10848634|FG004|STARTED|Overall Study||3
9746329|NCT00290732|10848630|FG000|COMPLETED|Overall Study||3
9746330|NCT00290732|10848631|FG001|COMPLETED|Overall Study||3
9746331|NCT00290732|10848632|FG002|COMPLETED|Overall Study||3
9746332|NCT00290732|10848633|FG003|COMPLETED|Overall Study||6
9746333|NCT00290732|10848634|FG004|COMPLETED|Overall Study||3
9746334|NCT00290732|10848630|FG000|NOT COMPLETED|Overall Study||0
9746335|NCT00290732|10848631|FG001|NOT COMPLETED|Overall Study||1
9746336|NCT00290732|10848632|FG002|NOT COMPLETED|Overall Study||1
9746337|NCT00290732|10848633|FG003|NOT COMPLETED|Overall Study||0
9746338|NCT00290732|10848634|FG004|NOT COMPLETED|Overall Study||0
9746339|NCT00290745|10848647|FG000|STARTED|Overall Study||79
9746340|NCT00290745|10848647|FG000|COMPLETED|Overall Study||67
9746341|NCT00290745|10848647|FG000|NOT COMPLETED|Overall Study||12
9746342|NCT00290771|10848653|FG000|STARTED|Overall Study||131
9746343|NCT00290771|10848654|FG001|STARTED|Overall Study||100
9746344|NCT00290771|10848653|FG000|COMPLETED|Overall Study||4
9746345|NCT00290771|10848654|FG001|COMPLETED|Overall Study||3
9853049|NCT00885092|10966010|FG001|STARTED|Period 1, 7 Days||20
9853050|NCT00885092|10966009|FG000|COMPLETED|Period 1, 7 Days||20
9853051|NCT00885092|10966010|FG001|COMPLETED|Period 1, 7 Days||20
9853052|NCT00885092|10966009|FG000|NOT COMPLETED|Period 1, 7 Days||0
9853053|NCT00885092|10966010|FG001|NOT COMPLETED|Period 1, 7 Days||0
9853054|NCT00885092|10966009|FG000|STARTED|Period 2, 7 Days||20
9746346|NCT00290771|10848653|FG000|NOT COMPLETED|Overall Study||127
9746347|NCT00290771|10848654|FG001|NOT COMPLETED|Overall Study||97
9746348|NCT00290810|10848661|FG000|STARTED|Overall Study||12
9746349|NCT00290810|10848661|FG000|COMPLETED|Overall Study||12
9746350|NCT00290810|10848661|FG000|NOT COMPLETED|Overall Study||0
9828535|NCT00756613|10939325|FG000|STARTED|Overall Study||512
9828536|NCT00756613|10939326|FG001|STARTED|Overall Study||532
9828537|NCT00756613|10939325|FG000|COMPLETED|Overall Study||426
9828538|NCT00756613|10939326|FG001|COMPLETED|Overall Study||462
9828539|NCT00756613|10939325|FG000|NOT COMPLETED|Overall Study||86
9828540|NCT00756613|10939326|FG001|NOT COMPLETED|Overall Study||70
9828541|NCT00756652|10939335|FG000|STARTED|Original Phase||41452
9828542|NCT00756652|10939336|FG001|STARTED|Original Phase||1039
9828543|NCT00756652|10939335|FG000|COMPLETED|Original Phase|At Year 7|6063
9828544|NCT00756652|10939336|FG001|COMPLETED|Original Phase||118
9828545|NCT00756652|10939335|FG000|NOT COMPLETED|Original Phase||35389
9828546|NCT00756652|10939336|FG001|NOT COMPLETED|Original Phase||921
9828547|NCT00756652|10939335|FG000|STARTED|Re-Op Phase||11101
9828548|NCT00756652|10939336|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
9828549|NCT00756652|10939335|FG000|COMPLETED|Re-Op Phase||8225
9828550|NCT00756652|10939336|FG001|COMPLETED|Re-Op Phase||0
9828551|NCT00756652|10939335|FG000|NOT COMPLETED|Re-Op Phase||2876
9828552|NCT00756652|10939336|FG001|NOT COMPLETED|Re-Op Phase||0
9853055|NCT00885092|10966010|FG001|STARTED|Period 2, 7 Days||20
9853056|NCT00885092|10966009|FG000|COMPLETED|Period 2, 7 Days||20
9853057|NCT00885092|10966010|FG001|COMPLETED|Period 2, 7 Days||20
9853058|NCT00885092|10966009|FG000|NOT COMPLETED|Period 2, 7 Days||0
9853059|NCT00885092|10966010|FG001|NOT COMPLETED|Period 2, 7 Days||0
9853060|NCT00885105|10966018|FG000|STARTED|Overall Study||112
9853061|NCT00885105|10966019|FG001|STARTED|Overall Study||130
9853062|NCT00885105|10966018|FG000|COMPLETED|Overall Study||111
9853063|NCT00885105|10966019|FG001|COMPLETED|Overall Study||120
9853064|NCT00885105|10966018|FG000|NOT COMPLETED|Overall Study||1
9853065|NCT00885105|10966019|FG001|NOT COMPLETED|Overall Study||10
9853066|NCT00885118|10966030|FG000|STARTED|Overall Study||21
9853067|NCT00885118|10966031|FG001|STARTED|Overall Study||19
9853068|NCT00885118|10966032|FG002|STARTED|Overall Study||21
9853069|NCT00885118|10966033|FG003|STARTED|Overall Study||20
9853070|NCT00885118|10966034|FG004|STARTED|Overall Study||19
9853071|NCT00885118|10966030|FG000|COMPLETED|Overall Study||20
9853072|NCT00885118|10966031|FG001|COMPLETED|Overall Study||19
9853073|NCT00885118|10966032|FG002|COMPLETED|Overall Study||20
9853074|NCT00885118|10966033|FG003|COMPLETED|Overall Study||20
10091895|NCT02332720|11220186|FG014|COMPLETED|Part A and Part B||16
10091896|NCT02332720|11220187|FG015|COMPLETED|Part A and Part B||13
10091897|NCT02332720|11220188|FG016|COMPLETED|Part A and Part B||15
10091898|NCT02332720|11220189|FG017|COMPLETED|Part A and Part B||13
9828553|NCT00756678|10939340|FG000|STARTED|Overall Study||51
9828554|NCT00756678|10939340|FG000|COMPLETED|Overall Study||50
9828555|NCT00756678|10939340|FG000|NOT COMPLETED|Overall Study||1
9828556|NCT00756717|10939345|FG000|STARTED|Overall Study||22
9828557|NCT00756717|10939345|FG000|COMPLETED|Overall Study||20
9828558|NCT00756717|10939345|FG000|NOT COMPLETED|Overall Study||2
9853075|NCT00885118|10966034|FG004|COMPLETED|Overall Study||18
9853076|NCT00885118|10966030|FG000|NOT COMPLETED|Overall Study||1
9828559|NCT00756730|10939351|FG000|STARTED|Overall Study||25
9828560|NCT00756730|10939352|FG001|STARTED|Overall Study||24
9828561|NCT00756730|10939351|FG000|COMPLETED|Overall Study||25
9828562|NCT00756730|10939352|FG001|COMPLETED|Overall Study||22
9828563|NCT00756730|10939351|FG000|NOT COMPLETED|Overall Study||0
9853077|NCT00885118|10966031|FG001|NOT COMPLETED|Overall Study||0
9853078|NCT00885118|10966032|FG002|NOT COMPLETED|Overall Study||1
9853079|NCT00885118|10966033|FG003|NOT COMPLETED|Overall Study||0
9853080|NCT00885118|10966034|FG004|NOT COMPLETED|Overall Study||1
9853081|NCT00885170|10966052|FG000|STARTED|Overall Study||124
9853082|NCT00885170|10966053|FG001|STARTED|Overall Study||122
9853083|NCT00885170|10966052|FG000|Treated|Overall Study||122
9853084|NCT00885170|10966053|FG001|Treated|Overall Study||121
9853085|NCT00885170|10966052|FG000|COMPLETED|Overall Study||86
9853086|NCT00885170|10966053|FG001|COMPLETED|Overall Study||99
9853087|NCT00885170|10966052|FG000|NOT COMPLETED|Overall Study||38
9853088|NCT00885170|10966053|FG001|NOT COMPLETED|Overall Study||23
9853089|NCT00885352|10966061|FG000|STARTED|Overall Study||157
9853090|NCT00885352|10966062|FG001|STARTED|Overall Study||156
9853091|NCT00885352|10966061|FG000|COMPLETED|Overall Study||149
9853092|NCT00885352|10966062|FG001|COMPLETED|Overall Study||136
9853093|NCT00885352|10966061|FG000|NOT COMPLETED|Overall Study||8
9853094|NCT00885352|10966062|FG001|NOT COMPLETED|Overall Study||20
9853095|NCT00885365|10966070|FG000|STARTED|4 Weeks ON Treatment||159
9853096|NCT00885365|10966071|FG001|STARTED|4 Weeks ON Treatment||165
9853097|NCT00885365|10966070|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
9853098|NCT00885365|10966071|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163
9853099|NCT00885365|10966070|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
9853100|NCT00885365|10966071|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
9853101|NCT00885365|10966070|FG000|COMPLETED|4 Weeks ON Treatment||155
9853102|NCT00885365|10966071|FG001|COMPLETED|4 Weeks ON Treatment||159
9853103|NCT00885365|10966070|FG000|NOT COMPLETED|4 Weeks ON Treatment||4
9853104|NCT00885365|10966071|FG001|NOT COMPLETED|4 Weeks ON Treatment||6
9853105|NCT00885365|10966070|FG000|STARTED|4 Weeks OFF Treatment||155
9853106|NCT00885365|10966071|FG001|STARTED|4 Weeks OFF Treatment||159
9853107|NCT00885365|10966070|FG000|COMPLETED|4 Weeks OFF Treatment||155
9853108|NCT00885365|10966071|FG001|COMPLETED|4 Weeks OFF Treatment||159
9853109|NCT00885365|10966070|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0
9853110|NCT00885365|10966071|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0
9853111|NCT00885378|10966079|FG000|STARTED|Overall Study|Number randomized.|74
9853112|NCT00885378|10966080|FG001|STARTED|Overall Study|Number randomized.|86
9853113|NCT00885378|10966079|FG000|COMPLETED|Overall Study||66
9853114|NCT00885378|10966080|FG001|COMPLETED|Overall Study||78
9853115|NCT00885378|10966079|FG000|NOT COMPLETED|Overall Study||8
9853116|NCT00885378|10966080|FG001|NOT COMPLETED|Overall Study||8
9853117|NCT00885482|10966086|FG000|STARTED|Overall Study||40
9853118|NCT00885482|10966086|FG000|COMPLETED|Overall Study||36
9853119|NCT00885482|10966086|FG000|NOT COMPLETED|Overall Study||4
9853120|NCT00885534|10966090|FG000|STARTED|Overall Study||7
9853121|NCT00885534|10966090|FG000|COMPLETED|Overall Study||6
9853122|NCT00885534|10966090|FG000|NOT COMPLETED|Overall Study||1
9853123|NCT00885638|10966094|FG000|STARTED|Overall Study||6
9853124|NCT00885638|10966095|FG001|STARTED|Overall Study||6
9853125|NCT00885638|10966094|FG000|COMPLETED|Overall Study||6
9853126|NCT00885638|10966095|FG001|COMPLETED|Overall Study||6
9853127|NCT00885638|10966094|FG000|NOT COMPLETED|Overall Study||0
9853128|NCT00885638|10966095|FG001|NOT COMPLETED|Overall Study||0
9853129|NCT00885677|10966104|FG000|STARTED|Overall Study||462
9853130|NCT00885677|10966105|FG001|STARTED|Overall Study||455
9853131|NCT00885677|10966104|FG000|Intention To Treat|Overall Study||437
9853132|NCT00885677|10966105|FG001|Intention To Treat|Overall Study||428
9853133|NCT00885677|10966104|FG000|COMPLETED|Overall Study||279
9853134|NCT00885677|10966105|FG001|COMPLETED|Overall Study||277
9853135|NCT00885677|10966104|FG000|NOT COMPLETED|Overall Study||183
9853136|NCT00885677|10966105|FG001|NOT COMPLETED|Overall Study||178
9853137|NCT00885703|10966118|FG000|STARTED|Overall Study||22
9853138|NCT00885703|10966119|FG001|STARTED|Overall Study||26
9853139|NCT00885703|10966120|FG002|STARTED|Overall Study||24
9853140|NCT00885703|10966121|FG003|STARTED|Overall Study||24
9853141|NCT00885703|10966122|FG004|STARTED|Overall Study||24
9853142|NCT00885703|10966123|FG005|STARTED|Overall Study||24
9853143|NCT00885703|10966124|FG006|STARTED|Overall Study||24
9853144|NCT00885703|10966118|FG000|COMPLETED|Overall Study||12
9853145|NCT00885703|10966119|FG001|COMPLETED|Overall Study||16
9853146|NCT00885703|10966120|FG002|COMPLETED|Overall Study||13
9853147|NCT00885703|10966121|FG003|COMPLETED|Overall Study||15
9853148|NCT00885703|10966122|FG004|COMPLETED|Overall Study||12
9853149|NCT00885703|10966123|FG005|COMPLETED|Overall Study||11
9853150|NCT00885703|10966124|FG006|COMPLETED|Overall Study||18
9853151|NCT00885703|10966118|FG000|NOT COMPLETED|Overall Study||10
9853152|NCT00885703|10966119|FG001|NOT COMPLETED|Overall Study||10
9853153|NCT00885703|10966120|FG002|NOT COMPLETED|Overall Study||11
9853154|NCT00885703|10966121|FG003|NOT COMPLETED|Overall Study||9
9853155|NCT00885703|10966122|FG004|NOT COMPLETED|Overall Study||12
9853156|NCT00885703|10966123|FG005|NOT COMPLETED|Overall Study||13
9853157|NCT00885703|10966124|FG006|NOT COMPLETED|Overall Study||6
9853158|NCT00885742|10966144|FG000|STARTED|Overall Study||41
9853159|NCT00885742|10966144|FG000|COMPLETED|Overall Study||41
9853160|NCT00885742|10966144|FG000|NOT COMPLETED|Overall Study||0
9853161|NCT00885755|10966151|FG000|STARTED|Part I: Trastuzumab+Taxane||31
9853162|NCT00885755|10966152|FG001|STARTED|Part I: Trastuzumab+Taxane||1
9853163|NCT00885755|10966153|FG002|STARTED|Part I: Trastuzumab+Taxane||1
9853164|NCT00885755|10966151|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13
9853165|NCT00885755|10966152|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1
9853166|NCT00885755|10966153|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0
9746351|NCT00290888|10848667|FG000|STARTED|Overall Study||41
9746352|NCT00290888|10848668|FG001|STARTED|Overall Study||45
9746353|NCT00290888|10848667|FG000|COMPLETED|Overall Study||38
9746354|NCT00290888|10848668|FG001|COMPLETED|Overall Study||44
9746355|NCT00290888|10848667|FG000|NOT COMPLETED|Overall Study||3
9746356|NCT00290888|10848668|FG001|NOT COMPLETED|Overall Study||1
9746357|NCT00291018|10848678|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
9746358|NCT00291018|10848679|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
9746359|NCT00291018|10848680|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
9746360|NCT00291018|10848678|FG000|Evaluated at 24 Months|Overall Study||99
9746361|NCT00291018|10848679|FG001|Evaluated at 24 Months|Overall Study||92
9746362|NCT00291018|10848680|FG002|Evaluated at 24 Months|Overall Study||105
9746363|NCT00291018|10848678|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78
9746364|NCT00291018|10848679|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64
9746365|NCT00291018|10848680|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93
9746366|NCT00291018|10848678|FG000|NOT COMPLETED|Overall Study||25
9746367|NCT00291018|10848679|FG001|NOT COMPLETED|Overall Study||42
9746368|NCT00291018|10848680|FG002|NOT COMPLETED|Overall Study||43
9746369|NCT00291135|10848691|FG000|STARTED|Overall Study||42
9746370|NCT00291135|10848691|FG000|COMPLETED|Overall Study||42
9746371|NCT00291135|10848691|FG000|NOT COMPLETED|Overall Study||0
9746372|NCT00291161|10848699|FG000|STARTED|Overall Study||316
9746373|NCT00291161|10848700|FG001|STARTED|Overall Study||192
9746374|NCT00291161|10848701|FG002|STARTED|Overall Study||299
9746375|NCT00291161|10848702|FG003|STARTED|Overall Study||187
9746376|NCT00291161|10848699|FG000|COMPLETED|Overall Study||235
9746377|NCT00291161|10848700|FG001|COMPLETED|Overall Study||134
9746378|NCT00291161|10848701|FG002|COMPLETED|Overall Study||206
9746379|NCT00291161|10848702|FG003|COMPLETED|Overall Study||122
9746380|NCT00291161|10848699|FG000|NOT COMPLETED|Overall Study||81
9746381|NCT00291161|10848700|FG001|NOT COMPLETED|Overall Study||58
9746382|NCT00291161|10848701|FG002|NOT COMPLETED|Overall Study||93
9746383|NCT00291161|10848702|FG003|NOT COMPLETED|Overall Study||65
9746384|NCT00291187|10848714|FG000|STARTED|Overall Study||103
9746385|NCT00291187|10848715|FG001|STARTED|Overall Study||100
9746386|NCT00291187|10848716|FG002|STARTED|Overall Study||103
9746387|NCT00291187|10848717|FG003|STARTED|Overall Study||106
9746388|NCT00291187|10848714|FG000|COMPLETED|Overall Study||103
9746389|NCT00291187|10848715|FG001|COMPLETED|Overall Study||100
9746390|NCT00291187|10848716|FG002|COMPLETED|Overall Study||102
9746391|NCT00291187|10848717|FG003|COMPLETED|Overall Study||106
9746392|NCT00291187|10848714|FG000|NOT COMPLETED|Overall Study||0
9746393|NCT00291187|10848715|FG001|NOT COMPLETED|Overall Study||0
9746394|NCT00291187|10848716|FG002|NOT COMPLETED|Overall Study||1
9746395|NCT00291187|10848717|FG003|NOT COMPLETED|Overall Study||0
9746396|NCT00291226|10848733|FG000|STARTED|Overall Study||4
9746397|NCT00291226|10848734|FG001|STARTED|Overall Study||4
9746398|NCT00291226|10848733|FG000|COMPLETED|Overall Study||3
9746399|NCT00291226|10848734|FG001|COMPLETED|Overall Study||3
9746400|NCT00291226|10848733|FG000|NOT COMPLETED|Overall Study||1
9746401|NCT00291226|10848734|FG001|NOT COMPLETED|Overall Study||1
9746402|NCT00291317|10848740|FG000|STARTED|Overall Study||6
9746403|NCT00291317|10848740|FG000|COMPLETED|Overall Study||6
9746404|NCT00291317|10848740|FG000|NOT COMPLETED|Overall Study||0
9746405|NCT00291330|10848747|FG000|STARTED|Overall Study|Started Treatment|1273
9746406|NCT00291330|10848748|FG001|STARTED|Overall Study|Started Treatment|1266
9746407|NCT00291330|10848747|FG000|COMPLETED|Overall Study|Completed planned observation time|1172
9746408|NCT00291330|10848748|FG001|COMPLETED|Overall Study|Completed planned observation time|1169
9746409|NCT00291330|10848747|FG000|NOT COMPLETED|Overall Study||101
9746410|NCT00291330|10848748|FG001|NOT COMPLETED|Overall Study||97
9746411|NCT00291343|10848756|FG000|STARTED|Overall Study||203
9746412|NCT00291343|10848757|FG001|STARTED|Overall Study||93
9746413|NCT00291343|10848756|FG000|COMPLETED|Overall Study||203
9746414|NCT00291343|10848757|FG001|COMPLETED|Overall Study||93
9746415|NCT00291343|10848756|FG000|NOT COMPLETED|Overall Study||0
9746416|NCT00291343|10848757|FG001|NOT COMPLETED|Overall Study||0
9746417|NCT00291447|10848767|FG000|STARTED|Overall Study||2
9746418|NCT00291447|10848768|FG001|STARTED|Overall Study||2
9746419|NCT00291447|10848769|FG002|STARTED|Overall Study||2
9746420|NCT00291447|10848770|FG003|STARTED|Overall Study||2
9746421|NCT00291447|10848767|FG000|COMPLETED|Overall Study||2
9746422|NCT00291447|10848768|FG001|COMPLETED|Overall Study||2
9746423|NCT00291447|10848769|FG002|COMPLETED|Overall Study||2
9746424|NCT00291447|10848770|FG003|COMPLETED|Overall Study||2
9746425|NCT00291447|10848767|FG000|NOT COMPLETED|Overall Study||0
9746426|NCT00291447|10848768|FG001|NOT COMPLETED|Overall Study||0
9746427|NCT00291447|10848769|FG002|NOT COMPLETED|Overall Study||0
9746428|NCT00291447|10848770|FG003|NOT COMPLETED|Overall Study||0
9746429|NCT00291499|10848783|FG000|STARTED|Overall Study||81
9746430|NCT00291499|10848784|FG001|STARTED|Overall Study||82
9746431|NCT00291499|10848783|FG000|Intention to Treat (ITT)|Overall Study||80
9746432|NCT00291499|10848784|FG001|Intention to Treat (ITT)|Overall Study||82
9746433|NCT00291499|10848783|FG000|Per Protocol (PP)|Overall Study||72
9746434|NCT00291499|10848784|FG001|Per Protocol (PP)|Overall Study||67
9746435|NCT00291499|10848783|FG000|Safety Population|Overall Study||81
9746436|NCT00291499|10848784|FG001|Safety Population|Overall Study||82
9746437|NCT00291499|10848783|FG000|COMPLETED|Overall Study||72
9746438|NCT00291499|10848784|FG001|COMPLETED|Overall Study||67
9746439|NCT00291499|10848783|FG000|NOT COMPLETED|Overall Study||9
9746440|NCT00291499|10848784|FG001|NOT COMPLETED|Overall Study||15
9746441|NCT00291551|10848790|FG000|STARTED|Overall Study||39
9746442|NCT00291551|10848790|FG000|COMPLETED|Overall Study||26
9746443|NCT00291551|10848790|FG000|NOT COMPLETED|Overall Study||13
9746444|NCT00291577|10848795|FG000|STARTED|Overall Study||22
9746445|NCT00291577|10848795|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
9746446|NCT00291577|10848795|FG000|NOT COMPLETED|Overall Study||21
9746447|NCT00291642|10848804|FG000|STARTED|Overall Study||78
9746448|NCT00291642|10848805|FG001|STARTED|Overall Study||116
9746449|NCT00291642|10848806|FG002|STARTED|Overall Study||119
9746450|NCT00291642|10848807|FG003|STARTED|Overall Study||119
9746451|NCT00291642|10848808|FG004|STARTED|Overall Study||119
9746452|NCT00291642|10848804|FG000|COMPLETED|Overall Study||76
9746453|NCT00291642|10848805|FG001|COMPLETED|Overall Study||116
9746454|NCT00291642|10848806|FG002|COMPLETED|Overall Study||117
9746455|NCT00291642|10848807|FG003|COMPLETED|Overall Study||119
9853167|NCT00885755|10966151|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
9853168|NCT00885755|10966152|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
9853169|NCT00885755|10966153|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
9853170|NCT00885755|10966151|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13
9853171|NCT00885755|10966152|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1
9853172|NCT00885755|10966153|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0
9853173|NCT00885755|10966151|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
9853174|NCT00885755|10966152|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
9853175|NCT00885755|10966153|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
9853176|NCT00885755|10966151|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
9853177|NCT00885755|10966152|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
9853178|NCT00885755|10966153|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
9746456|NCT00291642|10848808|FG004|COMPLETED|Overall Study||118
9746457|NCT00291642|10848804|FG000|NOT COMPLETED|Overall Study||2
9746458|NCT00291642|10848805|FG001|NOT COMPLETED|Overall Study||0
9953004|NCT01424943|11071864|FG000|COMPLETED|Overall Study||12
10091899|NCT02332720|11220190|FG018|COMPLETED|Part A and Part B||20
10091900|NCT02332720|11220191|FG019|COMPLETED|Part A and Part B||24
10091901|NCT02332720|11220192|FG020|COMPLETED|Part A and Part B||7
10091902|NCT02332720|11220193|FG021|COMPLETED|Part A and Part B||0
10091903|NCT02332720|11220194|FG022|COMPLETED|Part A and Part B||4
10091904|NCT02332720|11220172|FG000|NOT COMPLETED|Part A and Part B||1
10091905|NCT02332720|11220173|FG001|NOT COMPLETED|Part A and Part B||0
10091906|NCT02332720|11220174|FG002|NOT COMPLETED|Part A and Part B||0
10091907|NCT02332720|11220175|FG003|NOT COMPLETED|Part A and Part B||0
10091908|NCT02332720|11220176|FG004|NOT COMPLETED|Part A and Part B||0
10091909|NCT02332720|11220177|FG005|NOT COMPLETED|Part A and Part B||3
10091910|NCT02332720|11220178|FG006|NOT COMPLETED|Part A and Part B||1
10091911|NCT02332720|11220179|FG007|NOT COMPLETED|Part A and Part B||1
10091912|NCT02332720|11220180|FG008|NOT COMPLETED|Part A and Part B||0
9746459|NCT00291642|10848806|FG002|NOT COMPLETED|Overall Study||2
9746460|NCT00291642|10848807|FG003|NOT COMPLETED|Overall Study||0
9746461|NCT00291642|10848808|FG004|NOT COMPLETED|Overall Study||1
9746462|NCT00291655|10848820|FG000|STARTED|Overall Study||130
9746463|NCT00291655|10848820|FG000|COMPLETED|Overall Study||115
9746464|NCT00291655|10848820|FG000|NOT COMPLETED|Overall Study||15
9746465|NCT00291668|10848827|FG000|STARTED|Overall Study||32
9746466|NCT00291668|10848828|FG001|STARTED|Overall Study||30
9746467|NCT00291668|10848829|FG002|STARTED|Overall Study||32
9746468|NCT00291668|10848827|FG000|COMPLETED|Overall Study||28
9746469|NCT00291668|10848828|FG001|COMPLETED|Overall Study||29
9746470|NCT00291668|10848829|FG002|COMPLETED|Overall Study||31
9746471|NCT00291668|10848827|FG000|NOT COMPLETED|Overall Study||4
9746472|NCT00291668|10848828|FG001|NOT COMPLETED|Overall Study||1
9746473|NCT00291668|10848829|FG002|NOT COMPLETED|Overall Study||1
9746474|NCT00291694|10848839|FG000|STARTED|Overall Study||24
9746475|NCT00291694|10848840|FG001|STARTED|Overall Study||48
9746476|NCT00291694|10848839|FG000|COMPLETED|Overall Study||21
9746477|NCT00291694|10848840|FG001|COMPLETED|Overall Study||43
9746478|NCT00291694|10848839|FG000|NOT COMPLETED|Overall Study||3
9746479|NCT00291694|10848840|FG001|NOT COMPLETED|Overall Study||5
9746480|NCT00291876|10848848|FG000|STARTED|Month 138||107
9746481|NCT00291876|10848848|FG000|COMPLETED|Month 138||107
9746482|NCT00291876|10848848|FG000|NOT COMPLETED|Month 138||0
9746483|NCT00291876|10848848|FG000|STARTED|Month 150||117
9746484|NCT00291876|10848848|FG000|COMPLETED|Month 150||117
9746485|NCT00291876|10848848|FG000|NOT COMPLETED|Month 150||0
9746486|NCT00291876|10848848|FG000|STARTED|Month 162||127
9746487|NCT00291876|10848848|FG000|COMPLETED|Month 162||127
9746488|NCT00291876|10848848|FG000|NOT COMPLETED|Month 162||0
9746489|NCT00291876|10848848|FG000|STARTED|Month 174||127
9746490|NCT00291876|10848848|FG000|COMPLETED|Month 174||127
9746491|NCT00291876|10848848|FG000|NOT COMPLETED|Month 174||0
9746492|NCT00291876|10848848|FG000|STARTED|Month 186||129
9746493|NCT00291876|10848848|FG000|COMPLETED|Month 186||129
9746494|NCT00291876|10848848|FG000|NOT COMPLETED|Month 186||0
9746495|NCT00291876|10848848|FG000|STARTED|Month 198||135
9746496|NCT00291876|10848848|FG000|COMPLETED|Month 198||135
9746497|NCT00291876|10848848|FG000|NOT COMPLETED|Month 198||0
9746498|NCT00291876|10848848|FG000|STARTED|Month 210||124
9746499|NCT00291876|10848848|FG000|COMPLETED|Month 210||124
9746500|NCT00291876|10848848|FG000|NOT COMPLETED|Month 210||0
9746501|NCT00291876|10848848|FG000|STARTED|Month 222||114
9746502|NCT00291876|10848848|FG000|COMPLETED|Month 222||114
9853179|NCT00885768|10966161|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
9853180|NCT00885768|10966161|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146
9853181|NCT00885768|10966161|FG000|NOT COMPLETED|Overall Study||0
10091913|NCT02332720|11220181|FG009|NOT COMPLETED|Part A and Part B||0
10091914|NCT02332720|11220182|FG010|NOT COMPLETED|Part A and Part B||0
10091915|NCT02332720|11220183|FG011|NOT COMPLETED|Part A and Part B||0
9746503|NCT00291876|10848848|FG000|NOT COMPLETED|Month 222||0
9746504|NCT00291876|10848848|FG000|STARTED|Month 234||110
9746505|NCT00291876|10848848|FG000|COMPLETED|Month 234||110
9746506|NCT00291876|10848848|FG000|NOT COMPLETED|Month 234||0
9746507|NCT00291876|10848848|FG000|STARTED|Month 246||116
9746508|NCT00291876|10848848|FG000|COMPLETED|Month 246||116
9746509|NCT00291876|10848848|FG000|NOT COMPLETED|Month 246||0
9746510|NCT00292045|10848852|FG000|STARTED|Core Study (Through Week 13)||15
9746511|NCT00292045|10848852|FG000|COMPLETED|Core Study (Through Week 13)||13
9746512|NCT00292045|10848852|FG000|NOT COMPLETED|Core Study (Through Week 13)||2
9746513|NCT00292045|10848852|FG000|STARTED|Extended Treatment Beyond Week 13||10
9746514|NCT00292045|10848852|FG000|COMPLETED|Extended Treatment Beyond Week 13||10
9746515|NCT00292045|10848852|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0
9746516|NCT00292162|10848858|FG000|STARTED|Overall Study||19
9746517|NCT00292162|10848859|FG001|STARTED|Overall Study||22
9746518|NCT00292162|10848858|FG000|COMPLETED|Overall Study||18
9746519|NCT00292162|10848859|FG001|COMPLETED|Overall Study||20
9746520|NCT00292162|10848858|FG000|NOT COMPLETED|Overall Study||1
9746521|NCT00292162|10848859|FG001|NOT COMPLETED|Overall Study||2
9746522|NCT00292188|10848867|FG000|STARTED|Single-Blind||368
9746523|NCT00292188|10848868|FG001|STARTED|Single-Blind||0
9746524|NCT00292188|10848869|FG002|STARTED|Single-Blind||0
9746525|NCT00292188|10848867|FG000|Received Treatment|Single-Blind||367
9746526|NCT00292188|10848868|FG001|Received Treatment|Single-Blind||0
9746527|NCT00292188|10848869|FG002|Received Treatment|Single-Blind||0
9746528|NCT00292188|10848867|FG000|COMPLETED|Single-Blind||254
9746529|NCT00292188|10848868|FG001|COMPLETED|Single-Blind||0
9746530|NCT00292188|10848869|FG002|COMPLETED|Single-Blind||0
9746531|NCT00292188|10848867|FG000|NOT COMPLETED|Single-Blind||114
9746532|NCT00292188|10848868|FG001|NOT COMPLETED|Single-Blind||0
9746533|NCT00292188|10848869|FG002|NOT COMPLETED|Single-Blind||0
9746534|NCT00292188|10848867|FG000|STARTED|Double-Blind||0
9746535|NCT00292188|10848868|FG001|STARTED|Double-Blind||127
9746536|NCT00292188|10848869|FG002|STARTED|Double-Blind||127
9746537|NCT00292188|10848867|FG000|COMPLETED|Double-Blind||0
9746538|NCT00292188|10848868|FG001|COMPLETED|Double-Blind||96
9746539|NCT00292188|10848869|FG002|COMPLETED|Double-Blind||98
9746540|NCT00292188|10848867|FG000|NOT COMPLETED|Double-Blind||0
9746541|NCT00292188|10848868|FG001|NOT COMPLETED|Double-Blind||31
9746542|NCT00292188|10848869|FG002|NOT COMPLETED|Double-Blind||29
9746543|NCT00292227|10848878|FG000|STARTED|Patch Period||66
9746544|NCT00292227|10848879|FG001|STARTED|Patch Period||31
9746545|NCT00292227|10848880|FG002|STARTED|Patch Period||33
9746546|NCT00292227|10848878|FG000|COMPLETED|Patch Period||65
9746547|NCT00292227|10848879|FG001|COMPLETED|Patch Period||31
9746548|NCT00292227|10848880|FG002|COMPLETED|Patch Period||30
9746549|NCT00292227|10848878|FG000|NOT COMPLETED|Patch Period||1
9746550|NCT00292227|10848879|FG001|NOT COMPLETED|Patch Period||0
9746551|NCT00292227|10848880|FG002|NOT COMPLETED|Patch Period||3
9746552|NCT00292227|10848878|FG000|STARTED|Cross-over Period 1 (Day 32)||65
9746553|NCT00292227|10848879|FG001|STARTED|Cross-over Period 1 (Day 32)||31
9746554|NCT00292227|10848880|FG002|STARTED|Cross-over Period 1 (Day 32)||30
9746555|NCT00292227|10848878|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65
9746556|NCT00292227|10848879|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31
9746557|NCT00292227|10848880|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30
9746558|NCT00292227|10848878|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
9746559|NCT00292227|10848879|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
9746560|NCT00292227|10848880|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
9746561|NCT00292227|10848878|FG000|STARTED|Cross-over Period 2 (Day 39)||65
9746562|NCT00292227|10848879|FG001|STARTED|Cross-over Period 2 (Day 39)||31
9746563|NCT00292227|10848880|FG002|STARTED|Cross-over Period 2 (Day 39)||30
9746564|NCT00292227|10848878|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65
9746565|NCT00292227|10848879|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31
9746566|NCT00292227|10848880|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30
9746567|NCT00292227|10848878|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
9746568|NCT00292227|10848879|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
9746569|NCT00292227|10848880|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
9746570|NCT00292318|10848890|FG000|STARTED|Overall Study||4
9746571|NCT00292318|10848891|FG001|STARTED|Overall Study||3
9746572|NCT00292318|10848890|FG000|COMPLETED|Overall Study||2
9746573|NCT00292318|10848891|FG001|COMPLETED|Overall Study||2
10091916|NCT02332720|11220184|FG012|NOT COMPLETED|Part A and Part B||0
9746574|NCT00292318|10848890|FG000|NOT COMPLETED|Overall Study||2
9746575|NCT00292318|10848891|FG001|NOT COMPLETED|Overall Study||1
9746576|NCT00292370|10848900|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
9746577|NCT00292370|10848901|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
9746578|NCT00292370|10848902|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
9746579|NCT00292370|10848900|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
9746580|NCT00292370|10848901|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
9746581|NCT00292370|10848902|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
9746582|NCT00292370|10848900|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
9746583|NCT00292370|10848901|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
9746584|NCT00292370|10848902|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
9746585|NCT00292370|10848900|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
9746586|NCT00292370|10848901|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
9853182|NCT00885846|10966168|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
9853183|NCT00885846|10966169|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
9853184|NCT00885846|10966170|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
9746587|NCT00292370|10848902|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
9746588|NCT00292370|10848900|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
9746589|NCT00292370|10848901|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
9746590|NCT00292370|10848902|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
9746591|NCT00292370|10848900|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
9746592|NCT00292370|10848901|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
9746593|NCT00292370|10848902|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
9746594|NCT00292461|10848911|FG000|STARTED|Overall Study||34
9746595|NCT00292461|10848912|FG001|STARTED|Overall Study||30
9746596|NCT00292461|10848911|FG000|COMPLETED|Overall Study||24
9746597|NCT00292461|10848912|FG001|COMPLETED|Overall Study||24
9746598|NCT00292461|10848911|FG000|NOT COMPLETED|Overall Study||10
9746599|NCT00292461|10848912|FG001|NOT COMPLETED|Overall Study||6
9746600|NCT00292591|10848921|FG000|STARTED|Overall Study||166
9746601|NCT00292591|10848922|FG001|STARTED|Overall Study||167
9746602|NCT00292591|10848923|FG002|STARTED|Overall Study||168
9746603|NCT00292591|10848921|FG000|COMPLETED|Overall Study||102
9746604|NCT00292591|10848922|FG001|COMPLETED|Overall Study||111
9746605|NCT00292591|10848923|FG002|COMPLETED|Overall Study||110
9746606|NCT00292591|10848921|FG000|NOT COMPLETED|Overall Study||64
9746607|NCT00292591|10848922|FG001|NOT COMPLETED|Overall Study||56
9746608|NCT00292591|10848923|FG002|NOT COMPLETED|Overall Study||58
9746609|NCT00292942|10848935|FG000|STARTED|Overall Study||6
9746610|NCT00292942|10848936|FG001|STARTED|Overall Study||6
9746611|NCT00292942|10848937|FG002|STARTED|Overall Study||7
9746612|NCT00292942|10848938|FG003|STARTED|Overall Study||7
9746613|NCT00292942|10848935|FG000|COMPLETED|Overall Study||6
9746614|NCT00292942|10848936|FG001|COMPLETED|Overall Study||6
9746615|NCT00292942|10848937|FG002|COMPLETED|Overall Study||6
9746616|NCT00292942|10848938|FG003|COMPLETED|Overall Study||6
9746617|NCT00292942|10848935|FG000|NOT COMPLETED|Overall Study||0
9746618|NCT00292942|10848936|FG001|NOT COMPLETED|Overall Study||0
9746619|NCT00292942|10848937|FG002|NOT COMPLETED|Overall Study||1
9746620|NCT00292942|10848938|FG003|NOT COMPLETED|Overall Study||1
9746621|NCT00292981|10848951|FG000|STARTED|Overall Study||57
9746622|NCT00292981|10848951|FG000|COMPLETED|Overall Study||18
9746623|NCT00292981|10848951|FG000|NOT COMPLETED|Overall Study||39
9746624|NCT00293020|10848955|FG000|STARTED|Overall Study||244
9746625|NCT00293020|10848955|FG000|COMPLETED|Overall Study||82
9853185|NCT00885846|10966168|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
10091917|NCT02332720|11220185|FG013|NOT COMPLETED|Part A and Part B||0
10091918|NCT02332720|11220186|FG014|NOT COMPLETED|Part A and Part B||0
10091919|NCT02332720|11220187|FG015|NOT COMPLETED|Part A and Part B||1
10091920|NCT02332720|11220188|FG016|NOT COMPLETED|Part A and Part B||0
10091921|NCT02332720|11220189|FG017|NOT COMPLETED|Part A and Part B||1
10091922|NCT02332720|11220190|FG018|NOT COMPLETED|Part A and Part B||1
10091923|NCT02332720|11220191|FG019|NOT COMPLETED|Part A and Part B||1
10091924|NCT02332720|11220192|FG020|NOT COMPLETED|Part A and Part B||0
10091925|NCT02332720|11220193|FG021|NOT COMPLETED|Part A and Part B||0
10091926|NCT02332720|11220194|FG022|NOT COMPLETED|Part A and Part B||0
10091927|NCT02332720|11220172|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
10091928|NCT02332720|11220173|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
10091929|NCT02332720|11220174|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
10091930|NCT02332720|11220175|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
10091931|NCT02332720|11220176|FG004|STARTED|Part C|Part B participants were not included in Part C.|0
10091932|NCT02332720|11220177|FG005|STARTED|Part C|Part B participants were not included in Part C.|0
9746626|NCT00293020|10848955|FG000|NOT COMPLETED|Overall Study||162
9746627|NCT00293033|10848959|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
9746628|NCT00293033|10848959|FG000|COMPLETED|Open-label Titration Period||82
9746629|NCT00293033|10848959|FG000|NOT COMPLETED|Open-label Titration Period||69
9746630|NCT00293033|10848959|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
9746631|NCT00293033|10848959|FG000|COMPLETED|Double-blind Treatment Period||70
9746632|NCT00293033|10848959|FG000|NOT COMPLETED|Double-blind Treatment Period||12
9746633|NCT00293059|10848969|FG000|STARTED|Overall Study||120
9746634|NCT00293059|10848970|FG001|STARTED|Overall Study||70
9746635|NCT00293059|10848969|FG000|Subjects Received Treatment|Overall Study||119
9746636|NCT00293059|10848970|FG001|Subjects Received Treatment|Overall Study||66
10091933|NCT02332720|11220178|FG006|STARTED|Part C|Part B participants were not included in Part C.|0
10091934|NCT02332720|11220179|FG007|STARTED|Part C|Part B participants were not included in Part C.|0
10091935|NCT02332720|11220180|FG008|STARTED|Part C|Part B participants were not included in Part C.|0
10091936|NCT02332720|11220181|FG009|STARTED|Part C|Part B participants were not included in Part C.|0
10091937|NCT02332720|11220182|FG010|STARTED|Part C|Part B participants were not included in Part C.|0
10091938|NCT02332720|11220183|FG011|STARTED|Part C|Part B participants were not included in Part C.|0
10091939|NCT02332720|11220184|FG012|STARTED|Part C|Part B participants were not included in Part C.|0
10091940|NCT02332720|11220185|FG013|STARTED|Part C|Part B participants were not included in Part C.|0
10091941|NCT02332720|11220186|FG014|STARTED|Part C|Part B participants were not included in Part C.|0
10091942|NCT02332720|11220187|FG015|STARTED|Part C|Part B participants were not included in Part C.|0
9746637|NCT00293059|10848969|FG000|Cycle 1/Treatment Day 28|Overall Study||115
9746638|NCT00293059|10848970|FG001|Cycle 1/Treatment Day 28|Overall Study||64
9746639|NCT00293059|10848969|FG000|Cycle 3/Treatment Day 84|Overall Study||100
9746640|NCT00293059|10848970|FG001|Cycle 3/Treatment Day 84|Overall Study||55
9746641|NCT00293059|10848969|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
9746642|NCT00293059|10848970|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
9746643|NCT00293059|10848969|FG000|COMPLETED|Overall Study||85
9746644|NCT00293059|10848970|FG001|COMPLETED|Overall Study||51
9746645|NCT00293059|10848969|FG000|NOT COMPLETED|Overall Study||35
9746646|NCT00293059|10848970|FG001|NOT COMPLETED|Overall Study||19
9746647|NCT00293202|10848978|FG000|STARTED|Overall Study||5
9746648|NCT00293202|10848979|FG001|STARTED|Overall Study||5
9746649|NCT00293202|10848978|FG000|COMPLETED|Overall Study||2
9746650|NCT00293202|10848979|FG001|COMPLETED|Overall Study||3
9746651|NCT00293202|10848978|FG000|NOT COMPLETED|Overall Study||3
9746652|NCT00293202|10848979|FG001|NOT COMPLETED|Overall Study||2
9746653|NCT00293215|10848991|FG000|STARTED|Overall Study||6
9746654|NCT00293215|10848992|FG001|STARTED|Overall Study||3
9746655|NCT00293215|10848991|FG000|COMPLETED|Overall Study||1
9746656|NCT00293215|10848992|FG001|COMPLETED|Overall Study||0
9746657|NCT00293215|10848991|FG000|NOT COMPLETED|Overall Study||5
9746658|NCT00293215|10848992|FG001|NOT COMPLETED|Overall Study||3
9746659|NCT00293241|10849000|FG000|STARTED|Overall Study||299
9746660|NCT00293241|10849001|FG001|STARTED|Overall Study||306
9746661|NCT00293241|10849000|FG000|COMPLETED|Overall Study||263
9746662|NCT00293241|10849001|FG001|COMPLETED|Overall Study||265
9746663|NCT00293241|10849000|FG000|NOT COMPLETED|Overall Study||36
9746664|NCT00293241|10849001|FG001|NOT COMPLETED|Overall Study||41
9746665|NCT00293254|10849012|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232
9746666|NCT00293254|10849013|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119
9746667|NCT00293254|10849012|FG000|Treated|Primary Study - Double-Blind Week 0-48||230
9746668|NCT00293254|10849013|FG001|Treated|Primary Study - Double-Blind Week 0-48||119
9746669|NCT00293254|10849012|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
9746670|NCT00293254|10849013|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
9746671|NCT00293254|10849012|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177
9746672|NCT00293254|10849013|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55
9746673|NCT00293254|10849012|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
9746674|NCT00293254|10849013|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
9746675|NCT00293254|10849012|FG000|STARTED|Extension - Double-Blind Week 49-156||177
9746676|NCT00293254|10849013|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
9746677|NCT00293254|10849012|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120
9746678|NCT00293254|10849013|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25
9746679|NCT00293254|10849012|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
9746680|NCT00293254|10849013|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
9746681|NCT00293254|10849012|FG000|STARTED|Extension - Open-Label Week 157-240||120
9746682|NCT00293254|10849013|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
9746683|NCT00293254|10849012|FG000|COMPLETED|Extension - Open-Label Week 157-240||110
9746684|NCT00293254|10849013|FG001|COMPLETED|Extension - Open-Label Week 157-240||18
9746685|NCT00293254|10849012|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10
9746686|NCT00293254|10849013|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1
9746687|NCT00293254|10849012|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
9746688|NCT00293254|10849013|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
9746689|NCT00293254|10849012|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19
9746690|NCT00293254|10849013|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37
9746691|NCT00293254|10849012|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
9746692|NCT00293254|10849013|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
9746693|NCT00293267|10849023|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234
9746694|NCT00293267|10849024|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118
9746695|NCT00293267|10849023|FG000|Treated|Primary Study - Double-Blind Week 0-48||232
9746696|NCT00293267|10849024|FG001|Treated|Primary Study - Double-Blind Week 0-48||118
9746697|NCT00293267|10849023|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
9746698|NCT00293267|10849024|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
9746699|NCT00293267|10849023|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193
9746700|NCT00293267|10849024|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50
9746701|NCT00293267|10849023|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
9746702|NCT00293267|10849024|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
9746703|NCT00293267|10849023|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
9853186|NCT00885846|10966169|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
9853187|NCT00885846|10966170|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
9853188|NCT00885846|10966168|FG000|NOT COMPLETED|Overall Study||2
9853189|NCT00885846|10966169|FG001|NOT COMPLETED|Overall Study||5
9853190|NCT00885846|10966170|FG002|NOT COMPLETED|Overall Study||2
9853191|NCT00886015|10966180|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674
9853192|NCT00886015|10966181|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671
9853193|NCT00886015|10966180|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
9853194|NCT00886015|10966181|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
9853195|NCT00886015|10966180|FG000|NOT COMPLETED|Overall Study||0
9853196|NCT00886015|10966181|FG001|NOT COMPLETED|Overall Study||2
9853197|NCT00886119|10966187|FG000|STARTED|Period 1||24
9853198|NCT00886119|10966188|FG001|STARTED|Period 1||22
9853199|NCT00886119|10966187|FG000|COMPLETED|Period 1||23
9853200|NCT00886119|10966188|FG001|COMPLETED|Period 1||22
9853201|NCT00886119|10966187|FG000|NOT COMPLETED|Period 1||1
9853202|NCT00886119|10966188|FG001|NOT COMPLETED|Period 1||0
9853203|NCT00886119|10966187|FG000|STARTED|Period 2||23
9853204|NCT00886119|10966188|FG001|STARTED|Period 2||22
9853205|NCT00886119|10966187|FG000|COMPLETED|Period 2||23
9853206|NCT00886119|10966188|FG001|COMPLETED|Period 2||22
9853207|NCT00886119|10966187|FG000|NOT COMPLETED|Period 2||0
9853208|NCT00886119|10966188|FG001|NOT COMPLETED|Period 2||0
9853209|NCT00886145|10966194|FG000|STARTED|Overall Study||1
9853210|NCT00886145|10966194|FG000|COMPLETED|Overall Study||1
9853211|NCT00886145|10966194|FG000|NOT COMPLETED|Overall Study||0
9853212|NCT00886236|10966203|FG000|STARTED|Overall Study||20
9853213|NCT00886236|10966204|FG001|STARTED|Overall Study||21
9853214|NCT00886236|10966205|FG002|STARTED|Overall Study||21
9853215|NCT00886236|10966203|FG000|COMPLETED|Overall Study||18
9853216|NCT00886236|10966204|FG001|COMPLETED|Overall Study||17
9853217|NCT00886236|10966205|FG002|COMPLETED|Overall Study||17
9853218|NCT00886236|10966203|FG000|NOT COMPLETED|Overall Study||2
9853219|NCT00886236|10966204|FG001|NOT COMPLETED|Overall Study||4
9853220|NCT00886236|10966205|FG002|NOT COMPLETED|Overall Study||4
9853221|NCT00886262|10966215|FG000|STARTED|Overall Study||8
9853222|NCT00886262|10966216|FG001|STARTED|Overall Study||10
9853223|NCT00886262|10966215|FG000|COMPLETED|Overall Study||8
9853224|NCT00886262|10966216|FG001|COMPLETED|Overall Study||7
9853225|NCT00886262|10966215|FG000|NOT COMPLETED|Overall Study||0
9853226|NCT00886262|10966216|FG001|NOT COMPLETED|Overall Study||3
9853227|NCT00886288|10966224|FG000|STARTED|Overall Study|Baseline Population|2027
9853228|NCT00886288|10966225|FG001|STARTED|Overall Study|Baseline Population|684
9853229|NCT00886288|10966224|FG000|COMPLETED|Overall Study||1284
9853230|NCT00886288|10966225|FG001|COMPLETED|Overall Study||457
9853231|NCT00886288|10966224|FG000|NOT COMPLETED|Overall Study||743
9853232|NCT00886288|10966225|FG001|NOT COMPLETED|Overall Study||227
9853233|NCT00886340|10966235|FG000|STARTED|Overall Study||27
9853234|NCT00886340|10966236|FG001|STARTED|Overall Study||31
9853235|NCT00886340|10966235|FG000|COMPLETED|Overall Study||27
9853236|NCT00886340|10966236|FG001|COMPLETED|Overall Study||24
9853237|NCT00886340|10966235|FG000|NOT COMPLETED|Overall Study||0
9853238|NCT00886340|10966236|FG001|NOT COMPLETED|Overall Study||7
9853239|NCT00886379|10966247|FG000|STARTED|Overall Study||104
9853240|NCT00886379|10966248|FG001|STARTED|Overall Study||143
9853241|NCT00886379|10966249|FG002|STARTED|Overall Study||143
9853242|NCT00886379|10966250|FG003|STARTED|Overall Study||112
9853243|NCT00886379|10966251|FG004|STARTED|Overall Study||95
9853244|NCT00886379|10966247|FG000|COMPLETED|Overall Study||101
9853245|NCT00886379|10966248|FG001|COMPLETED|Overall Study||140
9853246|NCT00886379|10966249|FG002|COMPLETED|Overall Study||137
9853247|NCT00886379|10966250|FG003|COMPLETED|Overall Study||109
9853248|NCT00886379|10966251|FG004|COMPLETED|Overall Study||92
9853249|NCT00886379|10966247|FG000|NOT COMPLETED|Overall Study||3
9853250|NCT00886379|10966248|FG001|NOT COMPLETED|Overall Study||3
9853251|NCT00886379|10966249|FG002|NOT COMPLETED|Overall Study||6
9853252|NCT00886379|10966250|FG003|NOT COMPLETED|Overall Study||3
9853253|NCT00886379|10966251|FG004|NOT COMPLETED|Overall Study||3
9853254|NCT00886483|10966265|FG000|STARTED|Overall Study||26
9853255|NCT00886483|10966266|FG001|STARTED|Overall Study||13
9853256|NCT00886483|10966265|FG000|Completed 20 Treatments|Overall Study||25
9853257|NCT00886483|10966266|FG001|Completed 20 Treatments|Overall Study||11
9853258|NCT00886483|10966265|FG000|COMPLETED|Overall Study||24
9853259|NCT00886483|10966266|FG001|COMPLETED|Overall Study||10
9853260|NCT00886483|10966265|FG000|NOT COMPLETED|Overall Study||2
9853261|NCT00886483|10966266|FG001|NOT COMPLETED|Overall Study||3
9853262|NCT00886587|10966282|FG000|STARTED|Overall Study||41
9853263|NCT00886587|10966283|FG001|STARTED|Overall Study||41
9853264|NCT00886587|10966282|FG000|COMPLETED|Overall Study||37
9853265|NCT00886587|10966283|FG001|COMPLETED|Overall Study||39
9853266|NCT00886587|10966282|FG000|NOT COMPLETED|Overall Study||4
9853267|NCT00886587|10966283|FG001|NOT COMPLETED|Overall Study||2
9853268|NCT00886613|10966292|FG000|STARTED|Overall Study||41
9853269|NCT00886613|10966293|FG001|STARTED|Overall Study||39
9853270|NCT00886613|10966294|FG002|STARTED|Overall Study||40
9853271|NCT00886613|10966292|FG000|COMPLETED|Overall Study||39
9853272|NCT00886613|10966293|FG001|COMPLETED|Overall Study||39
9853273|NCT00886613|10966294|FG002|COMPLETED|Overall Study||37
9853274|NCT00886613|10966292|FG000|NOT COMPLETED|Overall Study||2
9853275|NCT00886613|10966293|FG001|NOT COMPLETED|Overall Study||0
9853276|NCT00886613|10966294|FG002|NOT COMPLETED|Overall Study||3
10091943|NCT02332720|11220188|FG016|STARTED|Part C|Part B participants were not included in Part C.|0
10091944|NCT02332720|11220189|FG017|STARTED|Part C|Part B participants were not included in Part C.|0
10091945|NCT02332720|11220190|FG018|STARTED|Part C|Part B participants were not included in Part C.|0
10091946|NCT02332720|11220191|FG019|STARTED|Part C|Part B participants were not included in Part C.|0
10091947|NCT02332720|11220192|FG020|STARTED|Part C|Part B participants were not included in Part C.|0
9746704|NCT00293267|10849024|FG001|STARTED|Extension - Double-Blind Week 49-156||50
9746705|NCT00293267|10849023|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139
9746706|NCT00293267|10849024|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35
9746707|NCT00293267|10849023|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
9746708|NCT00293267|10849024|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
9746709|NCT00293267|10849023|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
9746710|NCT00293267|10849024|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
9746711|NCT00293267|10849023|FG000|COMPLETED|Extension - Open-Label Week 157-240||111
9746712|NCT00293267|10849024|FG001|COMPLETED|Extension - Open-Label Week 157-240||26
9746713|NCT00293267|10849023|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20
9746714|NCT00293267|10849024|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2
9746715|NCT00293267|10849023|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
9746716|NCT00293267|10849024|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
9746717|NCT00293267|10849023|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15
9746718|NCT00293267|10849024|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29
9746719|NCT00293267|10849023|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
9746720|NCT00293267|10849024|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
9746721|NCT00293293|10849034|FG000|STARTED|Overall Study||20
9746722|NCT00293293|10849035|FG001|STARTED|Overall Study||23
9746723|NCT00293293|10849034|FG000|COMPLETED|Overall Study||18
9746724|NCT00293293|10849035|FG001|COMPLETED|Overall Study||21
9746725|NCT00293293|10849034|FG000|NOT COMPLETED|Overall Study||2
9746726|NCT00293293|10849035|FG001|NOT COMPLETED|Overall Study||2
9746727|NCT00293384|10849042|FG000|STARTED|Overall Study||40
9746728|NCT00293384|10849042|FG000|COMPLETED|Overall Study||35
9746729|NCT00293384|10849042|FG000|NOT COMPLETED|Overall Study||5
9746730|NCT00293397|10849046|FG000|STARTED|Overall Study||20
9746731|NCT00293397|10849046|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
9746732|NCT00293397|10849046|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
9746733|NCT00293397|10849046|FG000|NOT COMPLETED|Overall Study||2
9746734|NCT00293423|10849053|FG000|STARTED|Surgical Resection||28
9746735|NCT00293423|10849054|FG001|STARTED|Surgical Resection||68
9746736|NCT00293423|10849053|FG000|COMPLETED|Surgical Resection||12
9746737|NCT00293423|10849054|FG001|COMPLETED|Surgical Resection||41
9746738|NCT00293423|10849053|FG000|NOT COMPLETED|Surgical Resection||16
9746739|NCT00293423|10849054|FG001|NOT COMPLETED|Surgical Resection||27
9746740|NCT00293423|10849053|FG000|STARTED|Vaccination Treatment Period||12
9746741|NCT00293423|10849054|FG001|STARTED|Vaccination Treatment Period||41
9746742|NCT00293423|10849053|FG000|COMPLETED|Vaccination Treatment Period||12
9746743|NCT00293423|10849054|FG001|COMPLETED|Vaccination Treatment Period||38
9746744|NCT00293423|10849053|FG000|NOT COMPLETED|Vaccination Treatment Period||0
9746745|NCT00293423|10849054|FG001|NOT COMPLETED|Vaccination Treatment Period||3
9746746|NCT00293462|10849063|FG000|STARTED|Overall Study||31
9746747|NCT00293462|10849064|FG001|STARTED|Overall Study||29
9746748|NCT00293462|10849065|FG002|STARTED|Overall Study||31
9746749|NCT00293462|10849063|FG000|COMPLETED|Overall Study||24
9746750|NCT00293462|10849064|FG001|COMPLETED|Overall Study||21
9746751|NCT00293462|10849065|FG002|COMPLETED|Overall Study||19
9746752|NCT00293462|10849063|FG000|NOT COMPLETED|Overall Study||7
9746753|NCT00293462|10849064|FG001|NOT COMPLETED|Overall Study||8
9746754|NCT00293462|10849065|FG002|NOT COMPLETED|Overall Study||12
9746755|NCT00293540|10849075|FG000|STARTED|Overall Study||122
9746756|NCT00293540|10849076|FG001|STARTED|Overall Study||127
9746757|NCT00293540|10849075|FG000|COMPLETED|Overall Study||115
9746758|NCT00293540|10849076|FG001|COMPLETED|Overall Study||119
9746759|NCT00293540|10849075|FG000|NOT COMPLETED|Overall Study||7
9853277|NCT00886626|10966305|FG000|STARTED|Period 1 (90 Days)||6
9853278|NCT00886626|10966306|FG001|STARTED|Period 1 (90 Days)||6
9853279|NCT00886626|10966305|FG000|COMPLETED|Period 1 (90 Days)||5
9853280|NCT00886626|10966306|FG001|COMPLETED|Period 1 (90 Days)||6
9853281|NCT00886626|10966305|FG000|NOT COMPLETED|Period 1 (90 Days)||1
9746760|NCT00293540|10849076|FG001|NOT COMPLETED|Overall Study||8
9746761|NCT00293579|10849082|FG000|STARTED|Overall Study||5
9746762|NCT00293579|10849082|FG000|COMPLETED|Overall Study||4
9746763|NCT00293579|10849082|FG000|NOT COMPLETED|Overall Study||1
9746764|NCT00293709|10849087|FG000|STARTED|Overall Study||149
9746765|NCT00293709|10849087|FG000|COMPLETED|Overall Study||102
9746766|NCT00293709|10849087|FG000|NOT COMPLETED|Overall Study||47
9746767|NCT00293722|10849091|FG000|STARTED|Overall Study||1291
9746768|NCT00293722|10849091|FG000|COMPLETED|Overall Study||864
9746769|NCT00293722|10849091|FG000|NOT COMPLETED|Overall Study||427
9746770|NCT00293813|10849098|FG000|STARTED|Overall Study||82
9746771|NCT00293813|10849099|FG001|STARTED|Overall Study||83
9746772|NCT00293813|10849100|FG002|STARTED|Overall Study||82
9746773|NCT00293813|10849098|FG000|COMPLETED|Overall Study||69
9746774|NCT00293813|10849099|FG001|COMPLETED|Overall Study||74
9746775|NCT00293813|10849100|FG002|COMPLETED|Overall Study||74
9746776|NCT00293813|10849098|FG000|NOT COMPLETED|Overall Study||13
9746777|NCT00293813|10849099|FG001|NOT COMPLETED|Overall Study||9
9746778|NCT00293813|10849100|FG002|NOT COMPLETED|Overall Study||8
9746779|NCT00294047|10849110|FG000|STARTED|Month 48||2881
9746780|NCT00294047|10849111|FG001|STARTED|Month 48||2871
9746781|NCT00294047|10849110|FG000|Participated up to Month 48|Month 48||2305
9746782|NCT00294047|10849111|FG001|Participated up to Month 48|Month 48||2281
9746783|NCT00294047|10849110|FG000|COMPLETED|Month 48||2456
9746784|NCT00294047|10849111|FG001|COMPLETED|Month 48||2438
9746785|NCT00294047|10849110|FG000|NOT COMPLETED|Month 48||425
9746786|NCT00294047|10849111|FG001|NOT COMPLETED|Month 48||433
9746787|NCT00294047|10849110|FG000|STARTED|Month 84||2877
9746788|NCT00294047|10849111|FG001|STARTED|Month 84||2870
9746789|NCT00294047|10849110|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
9746790|NCT00294047|10849111|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
9746791|NCT00294047|10849110|FG000|NOT COMPLETED|Month 84||973
9746792|NCT00294047|10849111|FG001|NOT COMPLETED|Month 84||989
9746793|NCT00294060|10849118|FG000|STARTED|Overall Study||2013
9746794|NCT00294060|10849118|FG000|COMPLETED|Overall Study||840
9746795|NCT00294060|10849118|FG000|NOT COMPLETED|Overall Study||1173
9746796|NCT00294398|10849124|FG000|STARTED|Overall Study||78
9746797|NCT00294398|10849125|FG001|STARTED|Overall Study||74
9746798|NCT00294398|10849124|FG000|COMPLETED|Overall Study||57
9746799|NCT00294398|10849125|FG001|COMPLETED|Overall Study||48
9746800|NCT00294398|10849124|FG000|NOT COMPLETED|Overall Study||21
9746801|NCT00294398|10849125|FG001|NOT COMPLETED|Overall Study||26
9746802|NCT00294515|10849133|FG000|STARTED|Overall Study|Randomized|166
9746803|NCT00294515|10849134|FG001|STARTED|Overall Study|Randomized|160
9746804|NCT00294515|10849133|FG000|COMPLETED|Overall Study||132
9746805|NCT00294515|10849134|FG001|COMPLETED|Overall Study||132
9853282|NCT00886626|10966306|FG001|NOT COMPLETED|Period 1 (90 Days)||0
9853283|NCT00886626|10966305|FG000|STARTED|Period 2 (90 Days)||5
9853284|NCT00886626|10966306|FG001|STARTED|Period 2 (90 Days)||6
9853285|NCT00886626|10966305|FG000|COMPLETED|Period 2 (90 Days)||5
9853286|NCT00886626|10966306|FG001|COMPLETED|Period 2 (90 Days)||6
9853287|NCT00886626|10966305|FG000|NOT COMPLETED|Period 2 (90 Days)||0
9746806|NCT00294515|10849133|FG000|NOT COMPLETED|Overall Study||34
9746807|NCT00294515|10849134|FG001|NOT COMPLETED|Overall Study||28
9746808|NCT00294554|10849142|FG000|STARTED|Overall Study||10
9746809|NCT00294554|10849143|FG001|STARTED|Overall Study||10
9746810|NCT00294554|10849142|FG000|COMPLETED|Overall Study||10
9746811|NCT00294554|10849143|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
9746812|NCT00294554|10849142|FG000|NOT COMPLETED|Overall Study||0
9746813|NCT00294554|10849143|FG001|NOT COMPLETED|Overall Study||2
9746814|NCT00294632|10849151|FG000|STARTED|Phase I Dose Escalation Period||14
9746815|NCT00294632|10849152|FG001|STARTED|Phase I Dose Escalation Period||0
9746816|NCT00294632|10849151|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
9746817|NCT00294632|10849152|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
9746818|NCT00294632|10849151|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
9746819|NCT00294632|10849152|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
9746820|NCT00294632|10849151|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
9746821|NCT00294632|10849152|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
9746822|NCT00294632|10849151|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
9746823|NCT00294632|10849152|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
9746824|NCT00294632|10849151|FG000|COMPLETED|Phase I Dose Escalation Period||14
9746825|NCT00294632|10849152|FG001|COMPLETED|Phase I Dose Escalation Period||0
9746826|NCT00294632|10849151|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0
9746827|NCT00294632|10849152|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0
9746828|NCT00294632|10849151|FG000|STARTED|Phase II: 20 mg Lenalidomide||6
9746829|NCT00294632|10849152|FG001|STARTED|Phase II: 20 mg Lenalidomide||38
9746830|NCT00294632|10849151|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6
9746831|NCT00294632|10849152|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38
9746832|NCT00294632|10849151|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
9746833|NCT00294632|10849152|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
9746834|NCT00294645|10849161|FG000|STARTED|Overall Study||295
9746835|NCT00294645|10849162|FG001|STARTED|Overall Study||602
9853288|NCT00886626|10966306|FG001|NOT COMPLETED|Period 2 (90 Days)||0
9853289|NCT00886639|10966312|FG000|STARTED|Overall Study||127
9746836|NCT00294645|10849161|FG000|COMPLETED|Overall Study||247
9746837|NCT00294645|10849162|FG001|COMPLETED|Overall Study||510
9746838|NCT00294645|10849161|FG000|NOT COMPLETED|Overall Study||48
9746839|NCT00294645|10849162|FG001|NOT COMPLETED|Overall Study||92
9746840|NCT00294658|10849170|FG000|STARTED|Overall Study||66
9746841|NCT00294658|10849171|FG001|STARTED|Overall Study||60
9746842|NCT00294658|10849170|FG000|COMPLETED|Overall Study||60
9746843|NCT00294658|10849171|FG001|COMPLETED|Overall Study||51
9746844|NCT00294658|10849170|FG000|NOT COMPLETED|Overall Study||6
9746845|NCT00294658|10849171|FG001|NOT COMPLETED|Overall Study||9
9746846|NCT00294671|10849179|FG000|STARTED|Overall Study||64
9746847|NCT00294671|10849180|FG001|STARTED|Overall Study||66
9746848|NCT00294671|10849179|FG000|COMPLETED|Overall Study||37
9746849|NCT00294671|10849180|FG001|COMPLETED|Overall Study||26
9746850|NCT00294671|10849179|FG000|NOT COMPLETED|Overall Study||27
9746851|NCT00294671|10849180|FG001|NOT COMPLETED|Overall Study||40
9746852|NCT00294684|10849188|FG000|STARTED|Overall Study||70
9746853|NCT00294684|10849189|FG001|STARTED|Overall Study||70
9746854|NCT00294684|10849188|FG000|COMPLETED|Overall Study||65
9746855|NCT00294684|10849189|FG001|COMPLETED|Overall Study||62
9746856|NCT00294684|10849188|FG000|NOT COMPLETED|Overall Study||5
9746857|NCT00294684|10849189|FG001|NOT COMPLETED|Overall Study||8
9746858|NCT00294723|10849198|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247
9746859|NCT00294723|10849199|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251
9746860|NCT00294723|10849200|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248
9746861|NCT00294723|10849198|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
9746862|NCT00294723|10849199|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
9746863|NCT00294723|10849200|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
9746864|NCT00294723|10849198|FG000|COMPLETED|Double-Blind Period 52 Weeks||173
9746865|NCT00294723|10849199|FG001|COMPLETED|Double-Blind Period 52 Weeks||162
9746866|NCT00294723|10849200|FG002|COMPLETED|Double-Blind Period 52 Weeks||152
9746867|NCT00294723|10849198|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74
9746868|NCT00294723|10849199|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89
9746869|NCT00294723|10849200|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96
9746870|NCT00294723|10849198|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
9746871|NCT00294723|10849199|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
9746872|NCT00294723|10849200|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
9746873|NCT00294723|10849198|FG000|COMPLETED|Open-Label Extension 52 Weeks||114
9746874|NCT00294723|10849199|FG001|COMPLETED|Open-Label Extension 52 Weeks||110
9746875|NCT00294723|10849200|FG002|COMPLETED|Open-Label Extension 52 Weeks||97
9746876|NCT00294723|10849198|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40
9746877|NCT00294723|10849199|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39
9746878|NCT00294723|10849200|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40
9746879|NCT00294723|10849198|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
9746880|NCT00294723|10849199|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
9746881|NCT00294723|10849200|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
9746882|NCT00294723|10849198|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34
9746883|NCT00294723|10849199|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32
9746884|NCT00294723|10849200|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8
9746885|NCT00294723|10849198|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
9746886|NCT00294723|10849199|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
9746887|NCT00294723|10849200|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
9746888|NCT00294762|10849213|FG000|STARTED|Overall Study||72
9746889|NCT00294762|10849214|FG001|STARTED|Overall Study||71
9746890|NCT00294762|10849213|FG000|COMPLETED|Overall Study||69
9746891|NCT00294762|10849214|FG001|COMPLETED|Overall Study||68
9746892|NCT00294762|10849213|FG000|NOT COMPLETED|Overall Study||3
9746893|NCT00294762|10849214|FG001|NOT COMPLETED|Overall Study||3
9746894|NCT00295009|10849226|FG000|STARTED|Overall Study||93
9746895|NCT00295009|10849227|FG001|STARTED|Overall Study||183
9746896|NCT00295009|10849228|FG002|STARTED|Overall Study||51
9746897|NCT00295009|10849229|FG003|STARTED|Overall Study||82
9746898|NCT00295009|10849230|FG004|STARTED|Overall Study||174
9746899|NCT00295009|10849231|FG005|STARTED|Overall Study||269
9746900|NCT00295009|10849226|FG000|Treated|Overall Study||80
9746901|NCT00295009|10849227|FG001|Treated|Overall Study||162
9746902|NCT00295009|10849228|FG002|Treated|Overall Study||50
9746903|NCT00295009|10849229|FG003|Treated|Overall Study||72
9746904|NCT00295009|10849230|FG004|Treated|Overall Study||165
9746905|NCT00295009|10849231|FG005|Treated|Overall Study||259
9746906|NCT00295009|10849226|FG000|Completed 24 Month Analysis|Overall Study||71
9746907|NCT00295009|10849227|FG001|Completed 24 Month Analysis|Overall Study||148
9746908|NCT00295009|10849228|FG002|Completed 24 Month Analysis|Overall Study||45
9746909|NCT00295009|10849229|FG003|Completed 24 Month Analysis|Overall Study||60
9746910|NCT00295009|10849230|FG004|Completed 24 Month Analysis|Overall Study||133
9746911|NCT00295009|10849231|FG005|Completed 24 Month Analysis|Overall Study||198
9746912|NCT00295009|10849226|FG000|COMPLETED|Overall Study|Completed 60 month visit|52
9746913|NCT00295009|10849227|FG001|COMPLETED|Overall Study|Completed 60 month visit|134
9746914|NCT00295009|10849228|FG002|COMPLETED|Overall Study|Completed 60 month visit|39
9746915|NCT00295009|10849229|FG003|COMPLETED|Overall Study|Completed 60 month visit|57
9746916|NCT00295009|10849230|FG004|COMPLETED|Overall Study|Completed 60 month visit|116
9746917|NCT00295009|10849231|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
9746918|NCT00295009|10849226|FG000|NOT COMPLETED|Overall Study||41
9746919|NCT00295009|10849227|FG001|NOT COMPLETED|Overall Study||49
9746920|NCT00295009|10849228|FG002|NOT COMPLETED|Overall Study||12
9746921|NCT00295009|10849229|FG003|NOT COMPLETED|Overall Study||25
9746922|NCT00295009|10849230|FG004|NOT COMPLETED|Overall Study||58
9746923|NCT00295009|10849231|FG005|NOT COMPLETED|Overall Study||269
9746924|NCT00295022|10849248|FG000|STARTED|Overall Study||105
9746925|NCT00295022|10849249|FG001|STARTED|Overall Study||157
9746926|NCT00295022|10849250|FG002|STARTED|Overall Study||156
9746927|NCT00295022|10849248|FG000|COMPLETED|Overall Study||104
9746928|NCT00295022|10849249|FG001|COMPLETED|Overall Study||156
9746929|NCT00295022|10849250|FG002|COMPLETED|Overall Study||151
9746930|NCT00295022|10849248|FG000|NOT COMPLETED|Overall Study||1
9746931|NCT00295022|10849249|FG001|NOT COMPLETED|Overall Study||1
9746932|NCT00295022|10849250|FG002|NOT COMPLETED|Overall Study||5
9853290|NCT00886639|10966312|FG000|COMPLETED|Overall Study||111
9853291|NCT00886639|10966312|FG000|NOT COMPLETED|Overall Study||16
9853292|NCT00886704|10966318|FG000|STARTED|Overall Study||40
9746933|NCT00295061|10849262|FG000|STARTED|Overall Study||12
9746934|NCT00295061|10849263|FG001|STARTED|Overall Study||12
9746935|NCT00295061|10849262|FG000|COMPLETED|Overall Study||12
9746936|NCT00295061|10849263|FG001|COMPLETED|Overall Study||12
9746937|NCT00295061|10849262|FG000|NOT COMPLETED|Overall Study||0
9746938|NCT00295061|10849263|FG001|NOT COMPLETED|Overall Study||0
9746939|NCT00295503|10849269|FG000|STARTED|Overall Study||53
9746940|NCT00295503|10849269|FG000|COMPLETED|Overall Study||53
9746941|NCT00295503|10849269|FG000|NOT COMPLETED|Overall Study||0
9746942|NCT00295620|10849276|FG000|STARTED|Overall Study||1732
9746943|NCT00295620|10849277|FG001|STARTED|Overall Study||1738
9746944|NCT00295620|10849276|FG000|Safety Analysis Set|Overall Study||1705
9746945|NCT00295620|10849277|FG001|Safety Analysis Set|Overall Study||1710
9746946|NCT00295620|10849276|FG000|COMPLETED|Overall Study||860
9746947|NCT00295620|10849277|FG001|COMPLETED|Overall Study||842
9746948|NCT00295620|10849276|FG000|NOT COMPLETED|Overall Study||872
9746949|NCT00295620|10849277|FG001|NOT COMPLETED|Overall Study||896
9746950|NCT00295633|10849286|FG000|STARTED|Overall Study||195
9746951|NCT00295633|10849287|FG001|STARTED|Overall Study||186
9746952|NCT00295633|10849288|FG002|STARTED|Overall Study||184
9746953|NCT00295633|10849286|FG000|Completed Study Without Being Rescued|Overall Study||88
9746954|NCT00295633|10849287|FG001|Completed Study Without Being Rescued|Overall Study||82
9746955|NCT00295633|10849288|FG002|Completed Study Without Being Rescued|Overall Study||51
9746956|NCT00295633|10849286|FG000|COMPLETED|Overall Study||133
9746957|NCT00295633|10849287|FG001|COMPLETED|Overall Study||119
9746958|NCT00295633|10849288|FG002|COMPLETED|Overall Study||108
9746959|NCT00295633|10849286|FG000|NOT COMPLETED|Overall Study||62
9746960|NCT00295633|10849287|FG001|NOT COMPLETED|Overall Study||67
9746961|NCT00295633|10849288|FG002|NOT COMPLETED|Overall Study||76
9746962|NCT00295750|10849299|FG000|STARTED|Overall Study|randomized|206
9746963|NCT00295750|10849300|FG001|STARTED|Overall Study|randomized|210
9746964|NCT00295750|10849301|FG002|STARTED|Overall Study|randomized|204
9746965|NCT00295750|10849299|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
9746966|NCT00295750|10849300|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
9746967|NCT00295750|10849301|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
9746968|NCT00295750|10849299|FG000|COMPLETED|Overall Study||163
9746969|NCT00295750|10849300|FG001|COMPLETED|Overall Study||169
9746970|NCT00295750|10849301|FG002|COMPLETED|Overall Study||172
9746971|NCT00295750|10849299|FG000|NOT COMPLETED|Overall Study||43
9746972|NCT00295750|10849300|FG001|NOT COMPLETED|Overall Study||41
9746973|NCT00295750|10849301|FG002|NOT COMPLETED|Overall Study||32
9746974|NCT00295854|10849312|FG000|STARTED|Overall Study||95
9746975|NCT00295854|10849313|FG001|STARTED|Overall Study||108
9746976|NCT00295854|10849314|FG002|STARTED|Overall Study||102
9746977|NCT00295854|10849312|FG000|Safety Population (N=304)|Overall Study||95
9746978|NCT00295854|10849313|FG001|Safety Population (N=304)|Overall Study||108
9746979|NCT00295854|10849314|FG002|Safety Population (N=304)|Overall Study||101
9746980|NCT00295854|10849312|FG000|ITT Population (N=296)|Overall Study||92
9746981|NCT00295854|10849313|FG001|ITT Population (N=296)|Overall Study||105
9746982|NCT00295854|10849314|FG002|ITT Population (N=296)|Overall Study||99
9746983|NCT00295854|10849312|FG000|COMPLETED|Overall Study||77
9746984|NCT00295854|10849313|FG001|COMPLETED|Overall Study||87
9746985|NCT00295854|10849314|FG002|COMPLETED|Overall Study||87
9746986|NCT00295854|10849312|FG000|NOT COMPLETED|Overall Study||18
9853293|NCT00886704|10966319|FG001|STARTED|Overall Study||10
9853294|NCT00886704|10966318|FG000|COMPLETED|Overall Study||40
9853295|NCT00886704|10966319|FG001|COMPLETED|Overall Study||10
9853296|NCT00886704|10966318|FG000|NOT COMPLETED|Overall Study||0
9853297|NCT00886704|10966319|FG001|NOT COMPLETED|Overall Study||0
9853298|NCT00886743|10966327|FG000|STARTED|Overall Study|Received treatment|19
9853299|NCT00886743|10966327|FG000|COMPLETED|Overall Study||15
9853300|NCT00886743|10966327|FG000|NOT COMPLETED|Overall Study||4
9853301|NCT00886769|10966333|FG000|STARTED|Overall Study||43
9746987|NCT00295854|10849313|FG001|NOT COMPLETED|Overall Study||21
9746988|NCT00295854|10849314|FG002|NOT COMPLETED|Overall Study||15
9853302|NCT00886769|10966334|FG001|STARTED|Overall Study||41
9853303|NCT00886769|10966333|FG000|COMPLETED|Overall Study||37
9853304|NCT00886769|10966334|FG001|COMPLETED|Overall Study||4
9853305|NCT00886769|10966333|FG000|NOT COMPLETED|Overall Study||6
9746989|NCT00295867|10849322|FG000|STARTED|Overall Study||45
9746990|NCT00295867|10849322|FG000|COMPLETED|Overall Study||34
9746991|NCT00295867|10849322|FG000|NOT COMPLETED|Overall Study||11
9746992|NCT00295880|10849326|FG000|STARTED|Overall Study||12
9746993|NCT00295880|10849326|FG000|COMPLETED|Overall Study||10
9746994|NCT00295880|10849326|FG000|NOT COMPLETED|Overall Study||2
9746995|NCT00295932|10849341|FG000|STARTED|Overall Study||4
9746996|NCT00295932|10849342|FG001|STARTED|Overall Study||6
9746997|NCT00295932|10849343|FG002|STARTED|Overall Study||3
9746998|NCT00295932|10849344|FG003|STARTED|Overall Study||4
9746999|NCT00295932|10849345|FG004|STARTED|Overall Study||2
9747000|NCT00295932|10849346|FG005|STARTED|Overall Study||18
9747001|NCT00295932|10849347|FG006|STARTED|Overall Study||3
9747002|NCT00295932|10849348|FG007|STARTED|Overall Study||4
9747003|NCT00295932|10849349|FG008|STARTED|Overall Study||10
9747004|NCT00295932|10849350|FG009|STARTED|Overall Study||12
9747005|NCT00295932|10849351|FG010|STARTED|Overall Study||13
9747006|NCT00295932|10849341|FG000|COMPLETED|Overall Study||4
9747007|NCT00295932|10849342|FG001|COMPLETED|Overall Study||6
9747008|NCT00295932|10849343|FG002|COMPLETED|Overall Study||3
9747009|NCT00295932|10849344|FG003|COMPLETED|Overall Study||4
9747010|NCT00295932|10849345|FG004|COMPLETED|Overall Study||2
9747011|NCT00295932|10849346|FG005|COMPLETED|Overall Study||18
9747012|NCT00295932|10849347|FG006|COMPLETED|Overall Study||3
9747013|NCT00295932|10849348|FG007|COMPLETED|Overall Study||4
9747014|NCT00295932|10849349|FG008|COMPLETED|Overall Study||10
9747015|NCT00295932|10849350|FG009|COMPLETED|Overall Study||12
9747016|NCT00295932|10849351|FG010|COMPLETED|Overall Study||12
9747017|NCT00295932|10849341|FG000|NOT COMPLETED|Overall Study||0
9747018|NCT00295932|10849342|FG001|NOT COMPLETED|Overall Study||0
9747019|NCT00295932|10849343|FG002|NOT COMPLETED|Overall Study||0
9747020|NCT00295932|10849344|FG003|NOT COMPLETED|Overall Study||0
9747021|NCT00295932|10849345|FG004|NOT COMPLETED|Overall Study||0
9747022|NCT00295932|10849346|FG005|NOT COMPLETED|Overall Study||0
9747023|NCT00295932|10849347|FG006|NOT COMPLETED|Overall Study||0
9747024|NCT00295932|10849348|FG007|NOT COMPLETED|Overall Study||0
9747025|NCT00295932|10849349|FG008|NOT COMPLETED|Overall Study||0
9747026|NCT00295932|10849350|FG009|NOT COMPLETED|Overall Study||0
9747027|NCT00295932|10849351|FG010|NOT COMPLETED|Overall Study||1
9747028|NCT00296036|10849379|FG000|STARTED|Overall Study||19
9747029|NCT00296036|10849380|FG001|STARTED|Overall Study||18
9747030|NCT00296036|10849381|FG002|STARTED|Overall Study||18
9747031|NCT00296036|10849382|FG003|STARTED|Overall Study||17
9747032|NCT00296036|10849383|FG004|STARTED|Overall Study||33
9747033|NCT00296036|10849384|FG005|STARTED|Overall Study||32
9747034|NCT00296036|10849379|FG000|COMPLETED|Overall Study||18
9747035|NCT00296036|10849380|FG001|COMPLETED|Overall Study||18
9747036|NCT00296036|10849381|FG002|COMPLETED|Overall Study||16
9747037|NCT00296036|10849382|FG003|COMPLETED|Overall Study||16
9747038|NCT00296036|10849383|FG004|COMPLETED|Overall Study||31
9747039|NCT00296036|10849384|FG005|COMPLETED|Overall Study||28
9747040|NCT00296036|10849379|FG000|NOT COMPLETED|Overall Study||1
9747041|NCT00296036|10849380|FG001|NOT COMPLETED|Overall Study||0
9747042|NCT00296036|10849381|FG002|NOT COMPLETED|Overall Study||2
9747043|NCT00296036|10849382|FG003|NOT COMPLETED|Overall Study||1
9747044|NCT00296036|10849383|FG004|NOT COMPLETED|Overall Study||2
9747045|NCT00296036|10849384|FG005|NOT COMPLETED|Overall Study||4
9747046|NCT00296140|10849403|FG000|STARTED|Overall Study||33
9747047|NCT00296140|10849404|FG001|STARTED|Overall Study||33
9747048|NCT00296140|10849403|FG000|COMPLETED|Overall Study||30
9853306|NCT00886769|10966334|FG001|NOT COMPLETED|Overall Study||37
9853307|NCT00886795|10966340|FG000|STARTED|Overall Study||4
9853308|NCT00886795|10966340|FG000|COMPLETED|Overall Study||3
9853309|NCT00886795|10966340|FG000|NOT COMPLETED|Overall Study||1
9853310|NCT00886821|10966359|FG000|STARTED|Stage 1||7
9853311|NCT00886821|10966360|FG001|STARTED|Stage 1||6
9853312|NCT00886821|10966361|FG002|STARTED|Stage 1||6
9853313|NCT00886821|10966362|FG003|STARTED|Stage 1||7
9747049|NCT00296140|10849404|FG001|COMPLETED|Overall Study||33
9747050|NCT00296140|10849403|FG000|NOT COMPLETED|Overall Study||3
9853314|NCT00886821|10966363|FG004|STARTED|Stage 1||6
9853315|NCT00886821|10966364|FG005|STARTED|Stage 1||6
9853316|NCT00886821|10966365|FG006|STARTED|Stage 1||6
9747051|NCT00296140|10849404|FG001|NOT COMPLETED|Overall Study||0
9747052|NCT00296192|10849415|FG000|STARTED|Overall Study||17
9747053|NCT00296192|10849416|FG001|STARTED|Overall Study||16
9747054|NCT00296192|10849417|FG002|STARTED|Overall Study||16
9747055|NCT00296192|10849418|FG003|STARTED|Overall Study||17
9747056|NCT00296192|10849419|FG004|STARTED|Overall Study||16
9747057|NCT00296192|10849415|FG000|COMPLETED|Overall Study||17
9747058|NCT00296192|10849416|FG001|COMPLETED|Overall Study||16
9853317|NCT00886821|10966366|FG007|STARTED|Stage 1||6
9853318|NCT00886821|10966367|FG008|STARTED|Stage 1||6
9853319|NCT00886821|10966368|FG009|STARTED|Stage 1||18
9853320|NCT00886821|10966369|FG010|STARTED|Stage 1||0
9853321|NCT00886821|10966370|FG011|STARTED|Stage 1||0
9747059|NCT00296192|10849417|FG002|COMPLETED|Overall Study||16
9747060|NCT00296192|10849418|FG003|COMPLETED|Overall Study||17
9747061|NCT00296192|10849419|FG004|COMPLETED|Overall Study||16
9747062|NCT00296192|10849415|FG000|NOT COMPLETED|Overall Study||0
9747063|NCT00296192|10849416|FG001|NOT COMPLETED|Overall Study||0
9747064|NCT00296192|10849417|FG002|NOT COMPLETED|Overall Study||0
9747065|NCT00296192|10849418|FG003|NOT COMPLETED|Overall Study||0
9747066|NCT00296192|10849419|FG004|NOT COMPLETED|Overall Study||0
9853322|NCT00886821|10966371|FG012|STARTED|Stage 1||0
9747067|NCT00296231|10849431|FG000|STARTED|Overall Study||14
9747068|NCT00296231|10849431|FG000|COMPLETED|Overall Study||14
9747069|NCT00296231|10849431|FG000|NOT COMPLETED|Overall Study||0
9747070|NCT00296244|10849437|FG000|STARTED|Overall Study||20
9747071|NCT00296244|10849438|FG001|STARTED|Overall Study||20
9747072|NCT00296244|10849437|FG000|COMPLETED|Overall Study||20
9747073|NCT00296244|10849438|FG001|COMPLETED|Overall Study||19
9747074|NCT00296244|10849437|FG000|NOT COMPLETED|Overall Study||0
9747075|NCT00296244|10849438|FG001|NOT COMPLETED|Overall Study||1
9747076|NCT00296296|10849451|FG000|STARTED|Overall Study||11
9747077|NCT00296296|10849452|FG001|STARTED|Overall Study||18
9747078|NCT00296296|10849451|FG000|COMPLETED|Overall Study||9
9747079|NCT00296296|10849452|FG001|COMPLETED|Overall Study||5
9747080|NCT00296296|10849451|FG000|NOT COMPLETED|Overall Study||2
9747081|NCT00296296|10849452|FG001|NOT COMPLETED|Overall Study||13
9747082|NCT00296322|10849460|FG000|STARTED|Overall Study||258
9747083|NCT00296322|10849461|FG001|STARTED|Overall Study||263
9747084|NCT00296322|10849460|FG000|COMPLETED|Overall Study||237
9747085|NCT00296322|10849461|FG001|COMPLETED|Overall Study||184
9747086|NCT00296322|10849460|FG000|NOT COMPLETED|Overall Study||21
9747087|NCT00296322|10849461|FG001|NOT COMPLETED|Overall Study||79
9747088|NCT00296335|10849469|FG000|STARTED|Overall Study||424
9747089|NCT00296335|10849470|FG001|STARTED|Overall Study||431
9747090|NCT00296335|10849469|FG000|COMPLETED|Overall Study||394
9747091|NCT00296335|10849470|FG001|COMPLETED|Overall Study||309
9747092|NCT00296335|10849469|FG000|NOT COMPLETED|Overall Study||30
9747093|NCT00296335|10849470|FG001|NOT COMPLETED|Overall Study||122
9747094|NCT00296374|10849481|FG000|STARTED|Overall Study||118
9853323|NCT00886821|10966372|FG013|STARTED|Stage 1||0
9853324|NCT00886821|10966359|FG000|COMPLETED|Stage 1||7
9853325|NCT00886821|10966360|FG001|COMPLETED|Stage 1||6
9853326|NCT00886821|10966361|FG002|COMPLETED|Stage 1||6
9853327|NCT00886821|10966362|FG003|COMPLETED|Stage 1||7
9853328|NCT00886821|10966363|FG004|COMPLETED|Stage 1||6
9853329|NCT00886821|10966364|FG005|COMPLETED|Stage 1||6
9853330|NCT00886821|10966365|FG006|COMPLETED|Stage 1||6
9853331|NCT00886821|10966366|FG007|COMPLETED|Stage 1||6
9853332|NCT00886821|10966367|FG008|COMPLETED|Stage 1||6
9853333|NCT00886821|10966368|FG009|COMPLETED|Stage 1||18
9853334|NCT00886821|10966369|FG010|COMPLETED|Stage 1||0
9853335|NCT00886821|10966370|FG011|COMPLETED|Stage 1||0
9853336|NCT00886821|10966371|FG012|COMPLETED|Stage 1||0
9853337|NCT00886821|10966372|FG013|COMPLETED|Stage 1||0
9853338|NCT00886821|10966359|FG000|NOT COMPLETED|Stage 1||0
9747095|NCT00296374|10849482|FG001|STARTED|Overall Study||124
9747096|NCT00296374|10849483|FG002|STARTED|Overall Study||111
9747097|NCT00296374|10849481|FG000|COMPLETED|Overall Study||93
9747098|NCT00296374|10849482|FG001|COMPLETED|Overall Study||101
9747099|NCT00296374|10849483|FG002|COMPLETED|Overall Study||82
9747100|NCT00296374|10849481|FG000|NOT COMPLETED|Overall Study||25
9747101|NCT00296374|10849482|FG001|NOT COMPLETED|Overall Study||23
9747102|NCT00296374|10849483|FG002|NOT COMPLETED|Overall Study||29
9747103|NCT00296400|10849500|FG000|STARTED|Overall Study||70
9747104|NCT00296400|10849501|FG001|STARTED|Overall Study||87
9747105|NCT00296400|10849502|FG002|STARTED|Overall Study||80
9747106|NCT00296400|10849500|FG000|COMPLETED|Overall Study||53
9747107|NCT00296400|10849501|FG001|COMPLETED|Overall Study||69
9747108|NCT00296400|10849502|FG002|COMPLETED|Overall Study||67
9747109|NCT00296400|10849500|FG000|NOT COMPLETED|Overall Study||17
9747110|NCT00296400|10849501|FG001|NOT COMPLETED|Overall Study||18
9747111|NCT00296400|10849502|FG002|NOT COMPLETED|Overall Study||13
9747112|NCT00296491|10849517|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
9747113|NCT00296491|10849518|FG001|STARTED|Overall Study||182
9747114|NCT00296491|10849519|FG002|STARTED|Overall Study||180
9747115|NCT00296491|10849520|FG003|STARTED|Overall Study||181
9747116|NCT00296491|10849517|FG000|COMPLETED|Overall Study||140
9747117|NCT00296491|10849518|FG001|COMPLETED|Overall Study||129
9747118|NCT00296491|10849519|FG002|COMPLETED|Overall Study||137
9747119|NCT00296491|10849520|FG003|COMPLETED|Overall Study||138
9747120|NCT00296491|10849517|FG000|NOT COMPLETED|Overall Study||42
9747121|NCT00296491|10849518|FG001|NOT COMPLETED|Overall Study||53
9747122|NCT00296491|10849519|FG002|NOT COMPLETED|Overall Study||43
9747123|NCT00296491|10849520|FG003|NOT COMPLETED|Overall Study||43
9747124|NCT00296504|10849545|FG000|STARTED|Interim Analysis||119
9747125|NCT00296504|10849546|FG001|STARTED|Interim Analysis||18
9747126|NCT00296504|10849547|FG002|STARTED|Interim Analysis||221
9747127|NCT00296504|10849548|FG003|STARTED|Interim Analysis||54
9853339|NCT00886821|10966360|FG001|NOT COMPLETED|Stage 1||0
9853340|NCT00886821|10966361|FG002|NOT COMPLETED|Stage 1||0
9853341|NCT00886821|10966362|FG003|NOT COMPLETED|Stage 1||0
9853342|NCT00886821|10966363|FG004|NOT COMPLETED|Stage 1||0
9747128|NCT00296504|10849549|FG004|STARTED|Interim Analysis||73
9747129|NCT00296504|10849550|FG005|STARTED|Interim Analysis||78
9747130|NCT00296504|10849551|FG006|STARTED|Interim Analysis||104
9747131|NCT00296504|10849552|FG007|STARTED|Interim Analysis||86
9747132|NCT00296504|10849553|FG008|STARTED|Interim Analysis||0
9747133|NCT00296504|10849545|FG000|Ongoing|Interim Analysis||32
9747134|NCT00296504|10849546|FG001|Ongoing|Interim Analysis||12
9747135|NCT00296504|10849547|FG002|Ongoing|Interim Analysis||16
9747136|NCT00296504|10849548|FG003|Ongoing|Interim Analysis||22
9747137|NCT00296504|10849549|FG004|Ongoing|Interim Analysis||0
9853343|NCT00886821|10966364|FG005|NOT COMPLETED|Stage 1||0
9853344|NCT00886821|10966365|FG006|NOT COMPLETED|Stage 1||0
9853345|NCT00886821|10966366|FG007|NOT COMPLETED|Stage 1||0
9853346|NCT00886821|10966367|FG008|NOT COMPLETED|Stage 1||0
9747138|NCT00296504|10849550|FG005|Ongoing|Interim Analysis||0
9747139|NCT00296504|10849551|FG006|Ongoing|Interim Analysis||30
9747140|NCT00296504|10849552|FG007|Ongoing|Interim Analysis||1
9747141|NCT00296504|10849553|FG008|Ongoing|Interim Analysis||0
9747142|NCT00296504|10849545|FG000|COMPLETED|Interim Analysis||43
9747143|NCT00296504|10849546|FG001|COMPLETED|Interim Analysis||0
9747144|NCT00296504|10849547|FG002|COMPLETED|Interim Analysis||116
9747145|NCT00296504|10849548|FG003|COMPLETED|Interim Analysis||11
9747146|NCT00296504|10849549|FG004|COMPLETED|Interim Analysis||36
9747147|NCT00296504|10849550|FG005|COMPLETED|Interim Analysis||41
9747148|NCT00296504|10849551|FG006|COMPLETED|Interim Analysis||30
9747149|NCT00296504|10849552|FG007|COMPLETED|Interim Analysis||37
9747150|NCT00296504|10849553|FG008|COMPLETED|Interim Analysis||0
9747151|NCT00296504|10849545|FG000|NOT COMPLETED|Interim Analysis||76
9747152|NCT00296504|10849546|FG001|NOT COMPLETED|Interim Analysis||18
9747153|NCT00296504|10849547|FG002|NOT COMPLETED|Interim Analysis||105
9747154|NCT00296504|10849548|FG003|NOT COMPLETED|Interim Analysis||43
9747155|NCT00296504|10849549|FG004|NOT COMPLETED|Interim Analysis||37
9747156|NCT00296504|10849550|FG005|NOT COMPLETED|Interim Analysis||37
9747157|NCT00296504|10849551|FG006|NOT COMPLETED|Interim Analysis||74
9747158|NCT00296504|10849552|FG007|NOT COMPLETED|Interim Analysis||49
9747159|NCT00296504|10849553|FG008|NOT COMPLETED|Interim Analysis||0
9747160|NCT00296504|10849545|FG000|STARTED|Final Analysis||0
9747161|NCT00296504|10849546|FG001|STARTED|Final Analysis||0
9747162|NCT00296504|10849547|FG002|STARTED|Final Analysis||0
9747163|NCT00296504|10849548|FG003|STARTED|Final Analysis||0
9747164|NCT00296504|10849549|FG004|STARTED|Final Analysis||0
9747165|NCT00296504|10849550|FG005|STARTED|Final Analysis||0
9747166|NCT00296504|10849551|FG006|STARTED|Final Analysis||0
9747167|NCT00296504|10849552|FG007|STARTED|Final Analysis||0
9747168|NCT00296504|10849553|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
9747169|NCT00296504|10849545|FG000|COMPLETED|Final Analysis||0
9747170|NCT00296504|10849546|FG001|COMPLETED|Final Analysis||0
9747171|NCT00296504|10849547|FG002|COMPLETED|Final Analysis||0
9747172|NCT00296504|10849548|FG003|COMPLETED|Final Analysis||0
9747173|NCT00296504|10849549|FG004|COMPLETED|Final Analysis||0
9747174|NCT00296504|10849550|FG005|COMPLETED|Final Analysis||0
9747175|NCT00296504|10849551|FG006|COMPLETED|Final Analysis||0
9747176|NCT00296504|10849552|FG007|COMPLETED|Final Analysis||0
9747177|NCT00296504|10849553|FG008|COMPLETED|Final Analysis||90
9747178|NCT00296504|10849545|FG000|NOT COMPLETED|Final Analysis||0
9747179|NCT00296504|10849546|FG001|NOT COMPLETED|Final Analysis||0
9747180|NCT00296504|10849547|FG002|NOT COMPLETED|Final Analysis||0
9747181|NCT00296504|10849548|FG003|NOT COMPLETED|Final Analysis||0
10091948|NCT02332720|11220193|FG021|STARTED|Part C||0
10091949|NCT02332720|11220194|FG022|STARTED|Part C|Part B participants were not included in Part C.|0
10091950|NCT02332720|11220172|FG000|COMPLETED|Part C||2
10091951|NCT02332720|11220173|FG001|COMPLETED|Part C||1
10091952|NCT02332720|11220174|FG002|COMPLETED|Part C||3
10091953|NCT02332720|11220175|FG003|COMPLETED|Part C||2
10091954|NCT02332720|11220176|FG004|COMPLETED|Part C||0
10091955|NCT02332720|11220177|FG005|COMPLETED|Part C||0
10091956|NCT02332720|11220178|FG006|COMPLETED|Part C||0
10091957|NCT02332720|11220179|FG007|COMPLETED|Part C||0
10091958|NCT02332720|11220180|FG008|COMPLETED|Part C||0
9747182|NCT00296504|10849549|FG004|NOT COMPLETED|Final Analysis||0
9747183|NCT00296504|10849550|FG005|NOT COMPLETED|Final Analysis||0
9747184|NCT00296504|10849551|FG006|NOT COMPLETED|Final Analysis||0
9747185|NCT00296504|10849552|FG007|NOT COMPLETED|Final Analysis||0
9747186|NCT00296504|10849553|FG008|NOT COMPLETED|Final Analysis||21
9747187|NCT00296517|10849580|FG000|STARTED|Dose Level 1 - Week 1||159
9747188|NCT00296517|10849581|FG001|STARTED|Dose Level 1 - Week 1||166
9747189|NCT00296517|10849580|FG000|COMPLETED|Dose Level 1 - Week 1||159
9747190|NCT00296517|10849581|FG001|COMPLETED|Dose Level 1 - Week 1||166
9747191|NCT00296517|10849580|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0
9747192|NCT00296517|10849581|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0
9747193|NCT00296517|10849580|FG000|STARTED|Dose Level 2 - Week 2||159
9747194|NCT00296517|10849581|FG001|STARTED|Dose Level 2 - Week 2||166
9747195|NCT00296517|10849580|FG000|COMPLETED|Dose Level 2 - Week 2||157
9747196|NCT00296517|10849581|FG001|COMPLETED|Dose Level 2 - Week 2||161
9747197|NCT00296517|10849580|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2
9747198|NCT00296517|10849581|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5
10091959|NCT02332720|11220181|FG009|COMPLETED|Part C||0
10091960|NCT02332720|11220182|FG010|COMPLETED|Part C||0
10091961|NCT02332720|11220183|FG011|COMPLETED|Part C||0
9747199|NCT00296517|10849580|FG000|STARTED|Dose Level 3 - Weeks 3-12||157
10091962|NCT02332720|11220184|FG012|COMPLETED|Part C||0
10091963|NCT02332720|11220185|FG013|COMPLETED|Part C||0
9747200|NCT00296517|10849581|FG001|STARTED|Dose Level 3 - Weeks 3-12||161
9747201|NCT00296517|10849580|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112
9747202|NCT00296517|10849581|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99
9747203|NCT00296517|10849580|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
9747204|NCT00296517|10849581|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
9747205|NCT00296647|10849592|FG000|STARTED|Overall Study||282
9747206|NCT00296647|10849593|FG001|STARTED|Overall Study||261
9747207|NCT00296647|10849594|FG002|STARTED|Overall Study||256
10091964|NCT02332720|11220186|FG014|COMPLETED|Part C||0
10091965|NCT02332720|11220187|FG015|COMPLETED|Part C||0
10091966|NCT02332720|11220188|FG016|COMPLETED|Part C||0
10091967|NCT02332720|11220189|FG017|COMPLETED|Part C||0
10091968|NCT02332720|11220190|FG018|COMPLETED|Part C||0
10091969|NCT02332720|11220191|FG019|COMPLETED|Part C||0
9747208|NCT00296647|10849595|FG003|STARTED|Overall Study||279
9747209|NCT00296647|10849596|FG004|STARTED|Overall Study||268
9747210|NCT00296647|10849592|FG000|COMPLETED|Overall Study||250
9747211|NCT00296647|10849593|FG001|COMPLETED|Overall Study||233
9747212|NCT00296647|10849594|FG002|COMPLETED|Overall Study||222
9747213|NCT00296647|10849595|FG003|COMPLETED|Overall Study||262
9747214|NCT00296647|10849596|FG004|COMPLETED|Overall Study||248
9747215|NCT00296647|10849592|FG000|NOT COMPLETED|Overall Study||32
9747216|NCT00296647|10849593|FG001|NOT COMPLETED|Overall Study||28
9747217|NCT00296647|10849594|FG002|NOT COMPLETED|Overall Study||34
9747218|NCT00296647|10849595|FG003|NOT COMPLETED|Overall Study||17
9747219|NCT00296647|10849596|FG004|NOT COMPLETED|Overall Study||20
9747220|NCT00296725|10849608|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
9747221|NCT00296725|10849608|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
9747222|NCT00296725|10849608|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
9747223|NCT00296725|10849608|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
9747224|NCT00296725|10849608|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
9747225|NCT00296725|10849608|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
9747226|NCT00296816|10849616|FG000|STARTED|Overall Study||132
9747227|NCT00296816|10849616|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
9747228|NCT00296816|10849616|FG000|NOT COMPLETED|Overall Study||74
9747229|NCT00297037|10849622|FG000|STARTED|Overall Study||10
9747230|NCT00297037|10849623|FG001|STARTED|Overall Study||11
9747231|NCT00297037|10849622|FG000|COMPLETED|Overall Study||8
9747232|NCT00297037|10849623|FG001|COMPLETED|Overall Study||11
9747233|NCT00297037|10849622|FG000|NOT COMPLETED|Overall Study||2
9747234|NCT00297037|10849623|FG001|NOT COMPLETED|Overall Study||0
9747235|NCT00297102|10849633|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
9747236|NCT00297102|10849634|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
9747237|NCT00297102|10849633|FG000|COMPLETED|Overall Study||502
9747238|NCT00297102|10849634|FG001|COMPLETED|Overall Study||525
9747239|NCT00297102|10849633|FG000|NOT COMPLETED|Overall Study||263
9747240|NCT00297102|10849634|FG001|NOT COMPLETED|Overall Study||233
9747241|NCT00297115|10849642|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
9747242|NCT00297115|10849643|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
9747243|NCT00297115|10849642|FG000|COMPLETED|Overall Study||527
9747244|NCT00297115|10849643|FG001|COMPLETED|Overall Study||550
9747245|NCT00297115|10849642|FG000|NOT COMPLETED|Overall Study||245
9747246|NCT00297115|10849643|FG001|NOT COMPLETED|Overall Study||246
9747247|NCT00297167|10849649|FG000|STARTED|First Double-blind Intervention Period||17
9747248|NCT00297167|10849650|FG001|STARTED|First Double-blind Intervention Period||16
9747249|NCT00297167|10849651|FG002|STARTED|First Double-blind Intervention Period||0
9747250|NCT00297167|10849649|FG000|COMPLETED|First Double-blind Intervention Period||17
9747251|NCT00297167|10849650|FG001|COMPLETED|First Double-blind Intervention Period||16
9747252|NCT00297167|10849651|FG002|COMPLETED|First Double-blind Intervention Period||0
9747253|NCT00297167|10849649|FG000|NOT COMPLETED|First Double-blind Intervention Period||0
9747254|NCT00297167|10849650|FG001|NOT COMPLETED|First Double-blind Intervention Period||0
9747255|NCT00297167|10849651|FG002|NOT COMPLETED|First Double-blind Intervention Period||0
9747256|NCT00297167|10849649|FG000|STARTED|Open-label Dose Normalization Period 1||0
9747257|NCT00297167|10849650|FG001|STARTED|Open-label Dose Normalization Period 1||0
9747258|NCT00297167|10849651|FG002|STARTED|Open-label Dose Normalization Period 1||33
9747259|NCT00297167|10849649|FG000|COMPLETED|Open-label Dose Normalization Period 1||0
9747260|NCT00297167|10849650|FG001|COMPLETED|Open-label Dose Normalization Period 1||0
9747261|NCT00297167|10849651|FG002|COMPLETED|Open-label Dose Normalization Period 1||32
9747262|NCT00297167|10849649|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0
9747263|NCT00297167|10849650|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0
9747264|NCT00297167|10849651|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1
9747265|NCT00297167|10849649|FG000|STARTED|Second Double-blind Intervention Period||17
9747266|NCT00297167|10849650|FG001|STARTED|Second Double-blind Intervention Period||15
9747267|NCT00297167|10849651|FG002|STARTED|Second Double-blind Intervention Period||0
9747268|NCT00297167|10849649|FG000|COMPLETED|Second Double-blind Intervention Period||16
9747269|NCT00297167|10849650|FG001|COMPLETED|Second Double-blind Intervention Period||15
9747270|NCT00297167|10849651|FG002|COMPLETED|Second Double-blind Intervention Period||0
9747271|NCT00297167|10849649|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1
9747272|NCT00297167|10849650|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0
9747273|NCT00297167|10849651|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
9747274|NCT00297167|10849649|FG000|STARTED|Open-label Dose Normalization Period 2||0
9747275|NCT00297167|10849650|FG001|STARTED|Open-label Dose Normalization Period 2||0
9747276|NCT00297167|10849651|FG002|STARTED|Open-label Dose Normalization Period 2||31
9747277|NCT00297167|10849649|FG000|COMPLETED|Open-label Dose Normalization Period 2||0
9747278|NCT00297167|10849650|FG001|COMPLETED|Open-label Dose Normalization Period 2||0
9747279|NCT00297167|10849651|FG002|COMPLETED|Open-label Dose Normalization Period 2||31
9747280|NCT00297167|10849649|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0
9747281|NCT00297167|10849650|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0
9747282|NCT00297167|10849651|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0
9747283|NCT00297232|10849658|FG000|STARTED|Overall Study||1094
9747284|NCT00297232|10849658|FG000|COMPLETED|Overall Study||489
9747285|NCT00297232|10849658|FG000|NOT COMPLETED|Overall Study||605
9747286|NCT00297258|10849662|FG000|STARTED|Overall Study||142
9747287|NCT00297258|10849662|FG000|COMPLETED|Overall Study||0
9747288|NCT00297258|10849662|FG000|NOT COMPLETED|Overall Study||142
9747289|NCT00297427|10849671|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
9747290|NCT00297427|10849672|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
9747291|NCT00297427|10849671|FG000|COMPLETED|Phase 1: Initial Intervention||56
9747292|NCT00297427|10849672|FG001|COMPLETED|Phase 1: Initial Intervention||54
9747293|NCT00297427|10849671|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
9747294|NCT00297427|10849672|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9
9747295|NCT00297427|10849671|FG000|STARTED|Phase 2: Optional Crossover for Sham||54
9747296|NCT00297427|10849672|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
10091970|NCT02332720|11220192|FG020|COMPLETED|Part C||0
10091971|NCT02332720|11220193|FG021|COMPLETED|Part C||0
10091972|NCT02332720|11220194|FG022|COMPLETED|Part C||0
10091973|NCT02332720|11220172|FG000|NOT COMPLETED|Part C||0
10091974|NCT02332720|11220173|FG001|NOT COMPLETED|Part C||0
9747297|NCT00297427|10849671|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
9747298|NCT00297427|10849672|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
9747299|NCT00297427|10849671|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38
9747300|NCT00297427|10849672|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
9747301|NCT00297427|10849671|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
9747302|NCT00297427|10849672|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
9747303|NCT00297427|10849671|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
9747304|NCT00297427|10849672|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
9747305|NCT00297427|10849671|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
9747306|NCT00297427|10849672|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
9747307|NCT00297427|10849671|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
9747308|NCT00297427|10849672|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
9747309|NCT00297479|10849689|FG000|STARTED|Overall Study||103
9747310|NCT00297479|10849690|FG001|STARTED|Overall Study||155
9747311|NCT00297479|10849691|FG002|STARTED|Overall Study||154
9747312|NCT00297479|10849689|FG000|4-Week Follow Up|Overall Study||78
9747313|NCT00297479|10849690|FG001|4-Week Follow Up|Overall Study||132
9747314|NCT00297479|10849691|FG002|4-Week Follow Up|Overall Study||128
9747315|NCT00297479|10849689|FG000|26- Week Follow Up|Overall Study||66
9747316|NCT00297479|10849690|FG001|26- Week Follow Up|Overall Study||101
9747317|NCT00297479|10849691|FG002|26- Week Follow Up|Overall Study||103
9747318|NCT00297479|10849689|FG000|COMPLETED|Overall Study||66
9747319|NCT00297479|10849690|FG001|COMPLETED|Overall Study||101
9747320|NCT00297479|10849691|FG002|COMPLETED|Overall Study||103
9747321|NCT00297479|10849689|FG000|NOT COMPLETED|Overall Study||37
9747322|NCT00297479|10849690|FG001|NOT COMPLETED|Overall Study||54
9747323|NCT00297479|10849691|FG002|NOT COMPLETED|Overall Study||51
9747324|NCT00297492|10849702|FG000|STARTED|Set Quit Date||297
9747325|NCT00297492|10849703|FG001|STARTED|Set Quit Date||299
9747326|NCT00297492|10849704|FG002|STARTED|Set Quit Date||150
9747327|NCT00297492|10849702|FG000|COMPLETED|Set Quit Date||290
9747328|NCT00297492|10849703|FG001|COMPLETED|Set Quit Date||286
9747329|NCT00297492|10849704|FG002|COMPLETED|Set Quit Date||145
9747330|NCT00297492|10849702|FG000|NOT COMPLETED|Set Quit Date||7
9747331|NCT00297492|10849703|FG001|NOT COMPLETED|Set Quit Date||13
9747332|NCT00297492|10849704|FG002|NOT COMPLETED|Set Quit Date||5
9747333|NCT00297492|10849702|FG000|STARTED|6 Month Follow-up||290
9747334|NCT00297492|10849703|FG001|STARTED|6 Month Follow-up||286
9747335|NCT00297492|10849704|FG002|STARTED|6 Month Follow-up||145
9747336|NCT00297492|10849702|FG000|COMPLETED|6 Month Follow-up||227
9747337|NCT00297492|10849703|FG001|COMPLETED|6 Month Follow-up||237
9747338|NCT00297492|10849704|FG002|COMPLETED|6 Month Follow-up||118
9747339|NCT00297492|10849702|FG000|NOT COMPLETED|6 Month Follow-up||63
9747340|NCT00297492|10849703|FG001|NOT COMPLETED|6 Month Follow-up||49
9747341|NCT00297492|10849704|FG002|NOT COMPLETED|6 Month Follow-up||27
9747342|NCT00297596|10849712|FG000|STARTED|Overall Study||25
9747343|NCT00297596|10849712|FG000|COMPLETED|Overall Study||25
9747344|NCT00297596|10849712|FG000|NOT COMPLETED|Overall Study||0
9747345|NCT00297648|10849716|FG000|STARTED|Overall Study||89
9747346|NCT00297648|10849716|FG000|COMPLETED|Overall Study||53
9747347|NCT00297648|10849716|FG000|NOT COMPLETED|Overall Study||36
9747348|NCT00297778|10849722|FG000|STARTED|Overall Study||152
9747349|NCT00297778|10849723|FG001|STARTED|Overall Study||144
9747350|NCT00297778|10849722|FG000|COMPLETED|Overall Study||133
9747351|NCT00297778|10849723|FG001|COMPLETED|Overall Study||124
9747352|NCT00297778|10849722|FG000|NOT COMPLETED|Overall Study||19
9747353|NCT00297778|10849723|FG001|NOT COMPLETED|Overall Study||20
9747354|NCT00297830|10849732|FG000|STARTED|Baseline||41
9747355|NCT00297830|10849733|FG001|STARTED|Baseline||43
9747356|NCT00297830|10849734|FG002|STARTED|Baseline||27
10091975|NCT02332720|11220174|FG002|NOT COMPLETED|Part C||0
10091976|NCT02332720|11220175|FG003|NOT COMPLETED|Part C||0
9747357|NCT00297830|10849732|FG000|COMPLETED|Baseline||41
9747358|NCT00297830|10849733|FG001|COMPLETED|Baseline||43
9747359|NCT00297830|10849734|FG002|COMPLETED|Baseline||27
9747360|NCT00297830|10849732|FG000|NOT COMPLETED|Baseline||0
9747361|NCT00297830|10849733|FG001|NOT COMPLETED|Baseline||0
9747362|NCT00297830|10849734|FG002|NOT COMPLETED|Baseline||0
9747363|NCT00297830|10849732|FG000|STARTED|6 Month Visit||41
9747364|NCT00297830|10849733|FG001|STARTED|6 Month Visit||43
9747365|NCT00297830|10849734|FG002|STARTED|6 Month Visit||27
9747366|NCT00297830|10849732|FG000|COMPLETED|6 Month Visit||38
9747367|NCT00297830|10849733|FG001|COMPLETED|6 Month Visit||41
9747368|NCT00297830|10849734|FG002|COMPLETED|6 Month Visit||24
9747369|NCT00297830|10849732|FG000|NOT COMPLETED|6 Month Visit||3
9747370|NCT00297830|10849733|FG001|NOT COMPLETED|6 Month Visit||2
9747371|NCT00297830|10849734|FG002|NOT COMPLETED|6 Month Visit||3
9747372|NCT00297830|10849732|FG000|STARTED|12 Month Visit||38
9747373|NCT00297830|10849733|FG001|STARTED|12 Month Visit||41
9747374|NCT00297830|10849734|FG002|STARTED|12 Month Visit||24
9747375|NCT00297830|10849732|FG000|COMPLETED|12 Month Visit||37
9747376|NCT00297830|10849733|FG001|COMPLETED|12 Month Visit||35
9747377|NCT00297830|10849734|FG002|COMPLETED|12 Month Visit||24
9747378|NCT00297830|10849732|FG000|NOT COMPLETED|12 Month Visit||1
9747379|NCT00297830|10849733|FG001|NOT COMPLETED|12 Month Visit||6
9747380|NCT00297830|10849734|FG002|NOT COMPLETED|12 Month Visit||0
9747381|NCT00297882|10849744|FG000|STARTED|Day 14||204
9747382|NCT00297882|10849745|FG001|STARTED|Day 14||612
9747383|NCT00297882|10849744|FG000|COMPLETED|Day 14||192
9747384|NCT00297882|10849745|FG001|COMPLETED|Day 14||563
9747385|NCT00297882|10849744|FG000|NOT COMPLETED|Day 14||12
9747386|NCT00297882|10849745|FG001|NOT COMPLETED|Day 14||49
9747387|NCT00297882|10849744|FG000|STARTED|Day 28||192
9747388|NCT00297882|10849745|FG001|STARTED|Day 28||563
9747389|NCT00297882|10849744|FG000|COMPLETED|Day 28||176
9747390|NCT00297882|10849745|FG001|COMPLETED|Day 28||540
9747391|NCT00297882|10849744|FG000|NOT COMPLETED|Day 28||16
9747392|NCT00297882|10849745|FG001|NOT COMPLETED|Day 28||23
9747393|NCT00298038|10849755|FG000|STARTED|Overall Study||140
9747394|NCT00298038|10849756|FG001|STARTED|Overall Study||159
9747395|NCT00298038|10849755|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140
9747396|NCT00298038|10849756|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159
9747397|NCT00298038|10849755|FG000|COMPLETED|Overall Study||88
9747398|NCT00298038|10849756|FG001|COMPLETED|Overall Study||66
9747399|NCT00298038|10849755|FG000|NOT COMPLETED|Overall Study||52
9747400|NCT00298038|10849756|FG001|NOT COMPLETED|Overall Study||93
9828564|NCT00756730|10939352|FG001|NOT COMPLETED|Overall Study||2
9828565|NCT00756886|10939360|FG000|STARTED|Overall Study||41
9828566|NCT00756886|10939361|FG001|STARTED|Overall Study||32
9828567|NCT00756886|10939360|FG000|COMPLETED|Overall Study||30
9828568|NCT00756886|10939361|FG001|COMPLETED|Overall Study||25
9828569|NCT00756886|10939360|FG000|NOT COMPLETED|Overall Study||11
9828570|NCT00756886|10939361|FG001|NOT COMPLETED|Overall Study||7
9828571|NCT00756964|10939369|FG000|STARTED|Overall Study||13
9828572|NCT00756964|10939370|FG001|STARTED|Overall Study||13
9828573|NCT00756964|10939369|FG000|COMPLETED|Overall Study||13
9828574|NCT00756964|10939370|FG001|COMPLETED|Overall Study||13
9828575|NCT00756964|10939369|FG000|NOT COMPLETED|Overall Study||0
9828576|NCT00756964|10939370|FG001|NOT COMPLETED|Overall Study||0
9828577|NCT00756977|10939378|FG000|STARTED|Overall Study||196
9828578|NCT00756977|10939379|FG001|STARTED|Overall Study||198
9828579|NCT00756977|10939378|FG000|COMPLETED|Overall Study||175
9828580|NCT00756977|10939379|FG001|COMPLETED|Overall Study||187
9828581|NCT00756977|10939378|FG000|NOT COMPLETED|Overall Study||21
9828582|NCT00756977|10939379|FG001|NOT COMPLETED|Overall Study||11
9828583|NCT00757003|10939385|FG000|STARTED|Overall Study||100
9828584|NCT00757003|10939385|FG000|COMPLETED|Overall Study||51
9828585|NCT00757003|10939385|FG000|NOT COMPLETED|Overall Study||49
9828586|NCT00757172|10939390|FG000|STARTED|Overall Study||65
9828587|NCT00757172|10939390|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54
9828588|NCT00757172|10939390|FG000|NOT COMPLETED|Overall Study||11
9828589|NCT00757237|10939396|FG000|STARTED|Overall Study||137
9828590|NCT00757237|10939397|FG001|STARTED|Overall Study||136
9828591|NCT00757237|10939396|FG000|Treated|Overall Study||136
9828592|NCT00757237|10939397|FG001|Treated|Overall Study||132
9828593|NCT00757237|10939396|FG000|COMPLETED|Overall Study||124
9828594|NCT00757237|10939397|FG001|COMPLETED|Overall Study||111
9828595|NCT00757237|10939396|FG000|NOT COMPLETED|Overall Study||13
9828596|NCT00757237|10939397|FG001|NOT COMPLETED|Overall Study||25
9828597|NCT00757484|10939403|FG000|STARTED|Overall Study||491
9828598|NCT00757484|10939403|FG000|COMPLETED|Overall Study||491
9828599|NCT00757484|10939403|FG000|NOT COMPLETED|Overall Study||0
9828600|NCT00757588|10939411|FG000|STARTED|Period 1: Short-term (24-week) Phase||304
9828601|NCT00757588|10939412|FG001|STARTED|Period 1: Short-term (24-week) Phase||151
9828602|NCT00757588|10939411|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
9828603|NCT00757588|10939412|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134
9828604|NCT00757588|10939411|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
9828605|NCT00757588|10939412|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
9828606|NCT00757588|10939411|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
9828607|NCT00757588|10939412|FG001|STARTED|Period 2: Long-term (52-week) Phase||134
9828608|NCT00757588|10939411|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246
9747401|NCT00298090|10849762|FG000|STARTED|Overall Study||47
9747402|NCT00298090|10849762|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
9747403|NCT00298090|10849762|FG000|NOT COMPLETED|Overall Study||18
9747404|NCT00298155|10849769|FG000|STARTED|Overall Study||12
9747405|NCT00298155|10849770|FG001|STARTED|Overall Study||10
9747406|NCT00298155|10849771|FG002|STARTED|Overall Study||13
9747407|NCT00298155|10849769|FG000|COMPLETED|Overall Study||12
9747408|NCT00298155|10849770|FG001|COMPLETED|Overall Study||10
9747409|NCT00298155|10849771|FG002|COMPLETED|Overall Study||13
9747410|NCT00298155|10849769|FG000|NOT COMPLETED|Overall Study||0
9747411|NCT00298155|10849770|FG001|NOT COMPLETED|Overall Study||0
9747412|NCT00298155|10849771|FG002|NOT COMPLETED|Overall Study||0
9747413|NCT00298233|10849781|FG000|STARTED|Overall Study||39
9747414|NCT00298233|10849782|FG001|STARTED|Overall Study||41
9747415|NCT00298233|10849783|FG002|STARTED|Overall Study||122
9747416|NCT00298233|10849784|FG003|STARTED|Overall Study||124
9747417|NCT00298233|10849781|FG000|COMPLETED|Overall Study||39
9747418|NCT00298233|10849782|FG001|COMPLETED|Overall Study||41
9747419|NCT00298233|10849783|FG002|COMPLETED|Overall Study||122
9747420|NCT00298233|10849784|FG003|COMPLETED|Overall Study||124
9747421|NCT00298233|10849781|FG000|NOT COMPLETED|Overall Study||0
9747422|NCT00298233|10849782|FG001|NOT COMPLETED|Overall Study||0
9747423|NCT00298233|10849783|FG002|NOT COMPLETED|Overall Study||0
9747424|NCT00298233|10849784|FG003|NOT COMPLETED|Overall Study||0
9747425|NCT00298272|10849792|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
9747426|NCT00298272|10849793|FG001|STARTED|Double-blind Phase||18
9747427|NCT00298272|10849792|FG000|Safety Population|Double-blind Phase|received treatment|33
9853347|NCT00886821|10966368|FG009|NOT COMPLETED|Stage 1||0
9747428|NCT00298272|10849793|FG001|Safety Population|Double-blind Phase||18
9747429|NCT00298272|10849792|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
9747430|NCT00298272|10849793|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
9747431|NCT00298272|10849792|FG000|Completed to Week 56|Double-blind Phase||8
9747432|NCT00298272|10849793|FG001|Completed to Week 56|Double-blind Phase||3
9747433|NCT00298272|10849792|FG000|COMPLETED|Double-blind Phase||28
9747434|NCT00298272|10849793|FG001|COMPLETED|Double-blind Phase||18
9747435|NCT00298272|10849792|FG000|NOT COMPLETED|Double-blind Phase||8
9747436|NCT00298272|10849793|FG001|NOT COMPLETED|Double-blind Phase||0
9747437|NCT00298272|10849792|FG000|STARTED|Open Label Retreatment Phase||22
9747438|NCT00298272|10849793|FG001|STARTED|Open Label Retreatment Phase||16
9747439|NCT00298272|10849792|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
9747440|NCT00298272|10849793|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
9747441|NCT00298272|10849792|FG000|Completed to Week 56|Open Label Retreatment Phase||13
9747442|NCT00298272|10849793|FG001|Completed to Week 56|Open Label Retreatment Phase||12
9747443|NCT00298272|10849792|FG000|COMPLETED|Open Label Retreatment Phase||13
9747444|NCT00298272|10849793|FG001|COMPLETED|Open Label Retreatment Phase||12
9747445|NCT00298272|10849792|FG000|NOT COMPLETED|Open Label Retreatment Phase||9
9747446|NCT00298272|10849793|FG001|NOT COMPLETED|Open Label Retreatment Phase||4
9747447|NCT00298272|10849792|FG000|STARTED|Safety Follow-up Phase||22
9747448|NCT00298272|10849793|FG001|STARTED|Safety Follow-up Phase||17
9747449|NCT00298272|10849792|FG000|COMPLETED|Safety Follow-up Phase||18
9747450|NCT00298272|10849793|FG001|COMPLETED|Safety Follow-up Phase||13
9747451|NCT00298272|10849792|FG000|NOT COMPLETED|Safety Follow-up Phase||4
9747452|NCT00298272|10849793|FG001|NOT COMPLETED|Safety Follow-up Phase||4
9747453|NCT00298363|10849805|FG000|STARTED|Overall Study||45
9747454|NCT00298363|10849806|FG001|STARTED|Overall Study||45
9747455|NCT00298363|10849807|FG002|STARTED|Overall Study||22
9747456|NCT00298363|10849805|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
9747457|NCT00298363|10849806|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
9747458|NCT00298363|10849807|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
9747459|NCT00298363|10849805|FG000|NOT COMPLETED|Overall Study||17
9747460|NCT00298363|10849806|FG001|NOT COMPLETED|Overall Study||8
9747461|NCT00298363|10849807|FG002|NOT COMPLETED|Overall Study||6
9747462|NCT00298389|10849824|FG000|STARTED|Overall Study||20
9747463|NCT00298389|10849825|FG001|STARTED|Overall Study||17
9747464|NCT00298389|10849826|FG002|STARTED|Overall Study||19
9747465|NCT00298389|10849824|FG000|COMPLETED|Overall Study||20
9747466|NCT00298389|10849825|FG001|COMPLETED|Overall Study||17
9747467|NCT00298389|10849826|FG002|COMPLETED|Overall Study||19
9747468|NCT00298389|10849824|FG000|NOT COMPLETED|Overall Study||0
9747469|NCT00298389|10849825|FG001|NOT COMPLETED|Overall Study||0
9747470|NCT00298389|10849826|FG002|NOT COMPLETED|Overall Study||0
9747471|NCT00298558|10849838|FG000|STARTED|Baseline||711
9747472|NCT00298558|10849839|FG001|STARTED|Baseline||705
9747473|NCT00298558|10849840|FG002|STARTED|Baseline||712
9747474|NCT00298558|10849841|FG003|STARTED|Baseline||704
9747475|NCT00298558|10849838|FG000|COMPLETED|Baseline||711
9747476|NCT00298558|10849839|FG001|COMPLETED|Baseline||705
9747477|NCT00298558|10849840|FG002|COMPLETED|Baseline||712
9747478|NCT00298558|10849841|FG003|COMPLETED|Baseline||704
9747479|NCT00298558|10849838|FG000|NOT COMPLETED|Baseline||0
9747480|NCT00298558|10849839|FG001|NOT COMPLETED|Baseline||0
9747481|NCT00298558|10849840|FG002|NOT COMPLETED|Baseline||0
9747482|NCT00298558|10849841|FG003|NOT COMPLETED|Baseline||0
9747483|NCT00298558|10849838|FG000|STARTED|Intervention||711
9747484|NCT00298558|10849839|FG001|STARTED|Intervention||705
9747485|NCT00298558|10849840|FG002|STARTED|Intervention||712
9747486|NCT00298558|10849841|FG003|STARTED|Intervention||704
9747487|NCT00298558|10849838|FG000|COMPLETED|Intervention||620
9747488|NCT00298558|10849839|FG001|COMPLETED|Intervention||627
9747489|NCT00298558|10849840|FG002|COMPLETED|Intervention||637
9747490|NCT00298558|10849841|FG003|COMPLETED|Intervention||285
9747491|NCT00298558|10849838|FG000|NOT COMPLETED|Intervention||91
9747492|NCT00298558|10849839|FG001|NOT COMPLETED|Intervention||78
9747493|NCT00298558|10849840|FG002|NOT COMPLETED|Intervention||75
9747494|NCT00298558|10849841|FG003|NOT COMPLETED|Intervention||419
9747495|NCT00298558|10849838|FG000|STARTED|Immediate Post Test||711
9747496|NCT00298558|10849839|FG001|STARTED|Immediate Post Test||705
9747497|NCT00298558|10849840|FG002|STARTED|Immediate Post Test||712
9747498|NCT00298558|10849841|FG003|STARTED|Immediate Post Test||704
9747499|NCT00298558|10849838|FG000|COMPLETED|Immediate Post Test||640
9747500|NCT00298558|10849839|FG001|COMPLETED|Immediate Post Test||629
9747501|NCT00298558|10849840|FG002|COMPLETED|Immediate Post Test||653
9747502|NCT00298558|10849841|FG003|COMPLETED|Immediate Post Test||639
9747503|NCT00298558|10849838|FG000|NOT COMPLETED|Immediate Post Test||71
9747504|NCT00298558|10849839|FG001|NOT COMPLETED|Immediate Post Test||76
9747505|NCT00298558|10849840|FG002|NOT COMPLETED|Immediate Post Test||59
9747506|NCT00298558|10849841|FG003|NOT COMPLETED|Immediate Post Test||65
9747507|NCT00298558|10849838|FG000|STARTED|Booster||372
9747508|NCT00298558|10849839|FG001|STARTED|Booster||371
9747509|NCT00298558|10849840|FG002|STARTED|Booster||370
9747510|NCT00298558|10849841|FG003|STARTED|Booster||0
9747511|NCT00298558|10849838|FG000|COMPLETED|Booster||283
9747512|NCT00298558|10849839|FG001|COMPLETED|Booster||301
9747513|NCT00298558|10849840|FG002|COMPLETED|Booster||295
9747514|NCT00298558|10849841|FG003|COMPLETED|Booster||0
9747515|NCT00298558|10849838|FG000|NOT COMPLETED|Booster||89
9747516|NCT00298558|10849839|FG001|NOT COMPLETED|Booster||70
9747517|NCT00298558|10849840|FG002|NOT COMPLETED|Booster||75
9747518|NCT00298558|10849841|FG003|NOT COMPLETED|Booster||0
9747519|NCT00298558|10849838|FG000|STARTED|1st Annual (A1)||640
9853348|NCT00886821|10966369|FG010|NOT COMPLETED|Stage 1||0
9853349|NCT00886821|10966370|FG011|NOT COMPLETED|Stage 1||0
9853350|NCT00886821|10966371|FG012|NOT COMPLETED|Stage 1||0
9853351|NCT00886821|10966372|FG013|NOT COMPLETED|Stage 1||0
9747520|NCT00298558|10849839|FG001|STARTED|1st Annual (A1)||629
9747521|NCT00298558|10849840|FG002|STARTED|1st Annual (A1)||653
9747522|NCT00298558|10849841|FG003|STARTED|1st Annual (A1)||639
9747523|NCT00298558|10849838|FG000|COMPLETED|1st Annual (A1)||585
9747524|NCT00298558|10849839|FG001|COMPLETED|1st Annual (A1)||566
9747525|NCT00298558|10849840|FG002|COMPLETED|1st Annual (A1)||601
9747526|NCT00298558|10849841|FG003|COMPLETED|1st Annual (A1)||584
9747527|NCT00298558|10849838|FG000|NOT COMPLETED|1st Annual (A1)||55
9747528|NCT00298558|10849839|FG001|NOT COMPLETED|1st Annual (A1)||63
9747529|NCT00298558|10849840|FG002|NOT COMPLETED|1st Annual (A1)||52
9747530|NCT00298558|10849841|FG003|NOT COMPLETED|1st Annual (A1)||55
9853352|NCT00886821|10966359|FG000|STARTED|Stage 2||0
9853353|NCT00886821|10966360|FG001|STARTED|Stage 2||0
9853354|NCT00886821|10966361|FG002|STARTED|Stage 2||0
9853355|NCT00886821|10966362|FG003|STARTED|Stage 2||0
9853356|NCT00886821|10966363|FG004|STARTED|Stage 2||0
9853357|NCT00886821|10966364|FG005|STARTED|Stage 2||0
9853358|NCT00886821|10966365|FG006|STARTED|Stage 2||0
9853359|NCT00886821|10966366|FG007|STARTED|Stage 2||0
9853360|NCT00886821|10966367|FG008|STARTED|Stage 2||0
9853361|NCT00886821|10966368|FG009|STARTED|Stage 2||0
9853362|NCT00886821|10966369|FG010|STARTED|Stage 2||9
9853363|NCT00886821|10966370|FG011|STARTED|Stage 2||9
9853364|NCT00886821|10966371|FG012|STARTED|Stage 2||13
9853365|NCT00886821|10966372|FG013|STARTED|Stage 2||9
9853366|NCT00886821|10966359|FG000|COMPLETED|Stage 2||0
9853367|NCT00886821|10966360|FG001|COMPLETED|Stage 2||0
9853368|NCT00886821|10966361|FG002|COMPLETED|Stage 2||0
9853369|NCT00886821|10966362|FG003|COMPLETED|Stage 2||0
9853370|NCT00886821|10966363|FG004|COMPLETED|Stage 2||0
9853371|NCT00886821|10966364|FG005|COMPLETED|Stage 2||0
9853372|NCT00886821|10966365|FG006|COMPLETED|Stage 2||0
9853373|NCT00886821|10966366|FG007|COMPLETED|Stage 2||0
9747531|NCT00298558|10849838|FG000|STARTED|2nd Annual (A2)||585
9747532|NCT00298558|10849839|FG001|STARTED|2nd Annual (A2)||566
9747533|NCT00298558|10849840|FG002|STARTED|2nd Annual (A2)||601
9747534|NCT00298558|10849841|FG003|STARTED|2nd Annual (A2)||584
9747535|NCT00298558|10849838|FG000|COMPLETED|2nd Annual (A2)||563
9747536|NCT00298558|10849839|FG001|COMPLETED|2nd Annual (A2)||555
9747537|NCT00298558|10849840|FG002|COMPLETED|2nd Annual (A2)||574
9747538|NCT00298558|10849841|FG003|COMPLETED|2nd Annual (A2)||552
9747539|NCT00298558|10849838|FG000|NOT COMPLETED|2nd Annual (A2)||22
9747540|NCT00298558|10849839|FG001|NOT COMPLETED|2nd Annual (A2)||11
9747541|NCT00298558|10849840|FG002|NOT COMPLETED|2nd Annual (A2)||27
9747542|NCT00298558|10849841|FG003|NOT COMPLETED|2nd Annual (A2)||32
9853374|NCT00886821|10966367|FG008|COMPLETED|Stage 2||0
9747543|NCT00298558|10849838|FG000|STARTED|3rd Annual Booster||372
9747544|NCT00298558|10849839|FG001|STARTED|3rd Annual Booster||371
9747545|NCT00298558|10849840|FG002|STARTED|3rd Annual Booster||370
9853375|NCT00886821|10966368|FG009|COMPLETED|Stage 2||0
9853376|NCT00886821|10966369|FG010|COMPLETED|Stage 2||9
9853377|NCT00886821|10966370|FG011|COMPLETED|Stage 2||8
9853378|NCT00886821|10966371|FG012|COMPLETED|Stage 2||8
9853379|NCT00886821|10966372|FG013|COMPLETED|Stage 2||8
9853380|NCT00886821|10966359|FG000|NOT COMPLETED|Stage 2||0
9853381|NCT00886821|10966360|FG001|NOT COMPLETED|Stage 2||0
9853382|NCT00886821|10966361|FG002|NOT COMPLETED|Stage 2||0
9747546|NCT00298558|10849841|FG003|STARTED|3rd Annual Booster||0
9747547|NCT00298558|10849838|FG000|COMPLETED|3rd Annual Booster||250
9747548|NCT00298558|10849839|FG001|COMPLETED|3rd Annual Booster||243
9747549|NCT00298558|10849840|FG002|COMPLETED|3rd Annual Booster||230
9747550|NCT00298558|10849841|FG003|COMPLETED|3rd Annual Booster||0
9747551|NCT00298558|10849838|FG000|NOT COMPLETED|3rd Annual Booster||122
9747552|NCT00298558|10849839|FG001|NOT COMPLETED|3rd Annual Booster||128
9747553|NCT00298558|10849840|FG002|NOT COMPLETED|3rd Annual Booster||140
9747554|NCT00298558|10849841|FG003|NOT COMPLETED|3rd Annual Booster||0
9747555|NCT00298558|10849838|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
9747556|NCT00298558|10849839|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
9747557|NCT00298558|10849840|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
9747558|NCT00298558|10849841|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
9747559|NCT00298558|10849838|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
9747560|NCT00298558|10849839|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
9747561|NCT00298558|10849840|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
9747562|NCT00298558|10849841|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
9747563|NCT00298558|10849838|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
9747564|NCT00298558|10849839|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
9747565|NCT00298558|10849840|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
9747566|NCT00298558|10849841|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
9747567|NCT00298558|10849838|FG000|STARTED|10th Annual (A10)||472
9747568|NCT00298558|10849839|FG001|STARTED|10th Annual (A10)||469
9747569|NCT00298558|10849840|FG002|STARTED|10th Annual (A10)||490
9747570|NCT00298558|10849841|FG003|STARTED|10th Annual (A10)||448
9747571|NCT00298558|10849838|FG000|COMPLETED|10th Annual (A10)||300
9747572|NCT00298558|10849839|FG001|COMPLETED|10th Annual (A10)||316
9747573|NCT00298558|10849840|FG002|COMPLETED|10th Annual (A10)||319
9747574|NCT00298558|10849841|FG003|COMPLETED|10th Annual (A10)||285
9747575|NCT00298558|10849838|FG000|NOT COMPLETED|10th Annual (A10)||172
9747576|NCT00298558|10849839|FG001|NOT COMPLETED|10th Annual (A10)||153
9747577|NCT00298558|10849840|FG002|NOT COMPLETED|10th Annual (A10)||171
9747578|NCT00298558|10849841|FG003|NOT COMPLETED|10th Annual (A10)||163
9747579|NCT00298610|10849851|FG000|STARTED|Overall Study||30
9747580|NCT00298610|10849851|FG000|COMPLETED|Overall Study||30
9747581|NCT00298610|10849851|FG000|NOT COMPLETED|Overall Study||0
9747582|NCT00298766|10849855|FG000|STARTED|Overall Study||70
9747583|NCT00298766|10849855|FG000|COMPLETED|Overall Study||24
9747584|NCT00298766|10849855|FG000|NOT COMPLETED|Overall Study||46
9747585|NCT00298831|10849859|FG000|STARTED|Overall Study||224
9747586|NCT00298831|10849859|FG000|Treated|Overall Study||197
9747587|NCT00298831|10849859|FG000|COMPLETED|Overall Study||192
9747588|NCT00298831|10849859|FG000|NOT COMPLETED|Overall Study||32
9747589|NCT00298896|10849863|FG000|STARTED|Overall Study||55
9747590|NCT00298896|10849863|FG000|COMPLETED|Overall Study||5
9747591|NCT00298896|10849863|FG000|NOT COMPLETED|Overall Study||50
9747592|NCT00299000|10849869|FG000|STARTED|Overall Study||2
9747593|NCT00299000|10849870|FG001|STARTED|Overall Study||2
9747594|NCT00299000|10849869|FG000|COMPLETED|Overall Study||2
9747595|NCT00299000|10849870|FG001|COMPLETED|Overall Study||2
9747596|NCT00299000|10849869|FG000|NOT COMPLETED|Overall Study||0
9747597|NCT00299000|10849870|FG001|NOT COMPLETED|Overall Study||0
9747598|NCT00299104|10849879|FG000|STARTED|Treatment Period||251
9747599|NCT00299104|10849880|FG001|STARTED|Treatment Period||252
9747600|NCT00299104|10849881|FG002|STARTED|Treatment Period||252
9747601|NCT00299104|10849879|FG000|Safety/ITT: Received Study Drug|Treatment Period||249
9747602|NCT00299104|10849880|FG001|Safety/ITT: Received Study Drug|Treatment Period||249
9747603|NCT00299104|10849881|FG002|Safety/ITT: Received Study Drug|Treatment Period||250
9747604|NCT00299104|10849879|FG000|Completed Week 24|Treatment Period||227
9747605|NCT00299104|10849880|FG001|Completed Week 24|Treatment Period||240
9747606|NCT00299104|10849881|FG002|Completed Week 24|Treatment Period||241
9747607|NCT00299104|10849879|FG000|Completed Week 52|Treatment Period||213
9747608|NCT00299104|10849880|FG001|Completed Week 52|Treatment Period||227
9747609|NCT00299104|10849881|FG002|Completed Week 52|Treatment Period||232
9747610|NCT00299104|10849879|FG000|Completed Week 104|Treatment Period||178
9747611|NCT00299104|10849880|FG001|Completed Week 104|Treatment Period||213
9747612|NCT00299104|10849881|FG002|Completed Week 104|Treatment Period||216
9747613|NCT00299104|10849879|FG000|COMPLETED|Treatment Period|Completed Week 152|62
9747614|NCT00299104|10849880|FG001|COMPLETED|Treatment Period||77
9747615|NCT00299104|10849881|FG002|COMPLETED|Treatment Period||80
9747616|NCT00299104|10849879|FG000|NOT COMPLETED|Treatment Period||189
9747617|NCT00299104|10849880|FG001|NOT COMPLETED|Treatment Period||175
9747618|NCT00299104|10849881|FG002|NOT COMPLETED|Treatment Period||172
9828609|NCT00757588|10939412|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125
9828610|NCT00757588|10939411|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
9828611|NCT00757588|10939412|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
9828612|NCT00757601|10939418|FG000|STARTED|Period 1||2
9828613|NCT00757601|10939419|FG001|STARTED|Period 1||2
9828614|NCT00757601|10939420|FG002|STARTED|Period 1||2
9828615|NCT00757601|10939421|FG003|STARTED|Period 1||2
9828616|NCT00757601|10939422|FG004|STARTED|Period 1||2
9828617|NCT00757601|10939423|FG005|STARTED|Period 1||2
9828618|NCT00757601|10939424|FG006|STARTED|Period 1||2
9828619|NCT00757601|10939425|FG007|STARTED|Period 1||2
9828620|NCT00757601|10939426|FG008|STARTED|Period 1||2
9828621|NCT00757601|10939427|FG009|STARTED|Period 1||2
9828622|NCT00757601|10939428|FG010|STARTED|Period 1||2
9828623|NCT00757601|10939429|FG011|STARTED|Period 1||3
9747619|NCT00299104|10849879|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
9747620|NCT00299104|10849880|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
9747621|NCT00299104|10849881|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
9747622|NCT00299104|10849879|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129
9747623|NCT00299104|10849880|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171
9747624|NCT00299104|10849881|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176
9747625|NCT00299104|10849879|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
9747626|NCT00299104|10849880|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
9747627|NCT00299104|10849881|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
9747628|NCT00299104|10849879|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
9747629|NCT00299104|10849880|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
9747630|NCT00299104|10849881|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
9747631|NCT00299104|10849879|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
9747632|NCT00299104|10849880|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
9747633|NCT00299104|10849881|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
9747634|NCT00299104|10849879|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
9747635|NCT00299104|10849880|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
9747636|NCT00299104|10849881|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
9747637|NCT00299130|10849892|FG000|STARTED|Treatment Period (up to 5 Years)||172
9747638|NCT00299130|10849893|FG001|STARTED|Treatment Period (up to 5 Years)||168
9747639|NCT00299130|10849894|FG002|STARTED|Treatment Period (up to 5 Years)||171
9747640|NCT00299130|10849892|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
9747641|NCT00299130|10849893|FG001|Treated|Treatment Period (up to 5 Years)||167
9747642|NCT00299130|10849894|FG002|Treated|Treatment Period (up to 5 Years)||170
9747643|NCT00299130|10849892|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
9747644|NCT00299130|10849893|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
9747645|NCT00299130|10849894|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
9747646|NCT00299130|10849892|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
9747647|NCT00299130|10849893|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
9747648|NCT00299130|10849894|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
9747649|NCT00299130|10849892|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
9747650|NCT00299130|10849893|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
9747651|NCT00299130|10849894|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
9747652|NCT00299130|10849892|FG000|COMPLETED|Treatment Period (up to 5 Years)||119
9747653|NCT00299130|10849893|FG001|COMPLETED|Treatment Period (up to 5 Years)||125
9747654|NCT00299130|10849894|FG002|COMPLETED|Treatment Period (up to 5 Years)||121
9747655|NCT00299130|10849892|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53
9747656|NCT00299130|10849893|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43
9747657|NCT00299130|10849894|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50
9747658|NCT00299130|10849892|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
9747659|NCT00299130|10849893|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
9747660|NCT00299130|10849894|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
9747661|NCT00299130|10849892|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
9747662|NCT00299130|10849893|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
9747663|NCT00299130|10849894|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
9747664|NCT00299130|10849892|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
9747665|NCT00299130|10849893|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
9747666|NCT00299130|10849894|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
10091977|NCT02332720|11220176|FG004|NOT COMPLETED|Part C||0
10091978|NCT02332720|11220177|FG005|NOT COMPLETED|Part C||0
10091979|NCT02332720|11220178|FG006|NOT COMPLETED|Part C||0
9747667|NCT00299130|10849892|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
9747668|NCT00299130|10849893|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
9747669|NCT00299130|10849894|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
9747670|NCT00299130|10849892|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
9747671|NCT00299130|10849893|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
9747672|NCT00299130|10849894|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
9747673|NCT00299130|10849892|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
9747674|NCT00299130|10849893|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
9747675|NCT00299130|10849894|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
9747676|NCT00299156|10849912|FG000|STARTED|Period 1 (Non-Randomized)||32
9747677|NCT00299156|10849913|FG001|STARTED|Period 1 (Non-Randomized)||0
9747678|NCT00299156|10849914|FG002|STARTED|Period 1 (Non-Randomized)||0
9747679|NCT00299156|10849912|FG000|COMPLETED|Period 1 (Non-Randomized)||32
9747680|NCT00299156|10849913|FG001|COMPLETED|Period 1 (Non-Randomized)||0
9747681|NCT00299156|10849914|FG002|COMPLETED|Period 1 (Non-Randomized)||0
9747682|NCT00299156|10849912|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0
9747683|NCT00299156|10849913|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0
10091980|NCT02332720|11220179|FG007|NOT COMPLETED|Part C||0
10091981|NCT02332720|11220180|FG008|NOT COMPLETED|Part C||0
9747684|NCT00299156|10849914|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0
9747685|NCT00299156|10849912|FG000|STARTED|Period 2 (Randomized)||0
9747686|NCT00299156|10849913|FG001|STARTED|Period 2 (Randomized)||17
9747687|NCT00299156|10849914|FG002|STARTED|Period 2 (Randomized)||16
9747688|NCT00299156|10849912|FG000|COMPLETED|Period 2 (Randomized)||0
9747689|NCT00299156|10849913|FG001|COMPLETED|Period 2 (Randomized)||16
9853383|NCT00886821|10966362|FG003|NOT COMPLETED|Stage 2||0
9853384|NCT00886821|10966363|FG004|NOT COMPLETED|Stage 2||0
9853385|NCT00886821|10966364|FG005|NOT COMPLETED|Stage 2||0
9853386|NCT00886821|10966365|FG006|NOT COMPLETED|Stage 2||0
9853387|NCT00886821|10966366|FG007|NOT COMPLETED|Stage 2||0
9853388|NCT00886821|10966367|FG008|NOT COMPLETED|Stage 2||0
9747690|NCT00299156|10849914|FG002|COMPLETED|Period 2 (Randomized)||16
9747691|NCT00299156|10849912|FG000|NOT COMPLETED|Period 2 (Randomized)||0
9747692|NCT00299156|10849913|FG001|NOT COMPLETED|Period 2 (Randomized)||1
9747693|NCT00299156|10849914|FG002|NOT COMPLETED|Period 2 (Randomized)||0
9747694|NCT00299182|10849929|FG000|STARTED|Overall Study||6
9747695|NCT00299182|10849930|FG001|STARTED|Overall Study||4
9747696|NCT00299182|10849931|FG002|STARTED|Overall Study||6
9747697|NCT00299182|10849932|FG003|STARTED|Overall Study||14
9747698|NCT00299182|10849933|FG004|STARTED|Overall Study||8
9747699|NCT00299182|10849934|FG005|STARTED|Overall Study||7
9747700|NCT00299182|10849935|FG006|STARTED|Overall Study||5
9747701|NCT00299182|10849929|FG000|COMPLETED|Overall Study||6
9853389|NCT00886821|10966368|FG009|NOT COMPLETED|Stage 2||0
9853390|NCT00886821|10966369|FG010|NOT COMPLETED|Stage 2||0
9853391|NCT00886821|10966370|FG011|NOT COMPLETED|Stage 2||1
9747702|NCT00299182|10849930|FG001|COMPLETED|Overall Study||4
9747703|NCT00299182|10849931|FG002|COMPLETED|Overall Study||4
9747704|NCT00299182|10849932|FG003|COMPLETED|Overall Study||14
9747705|NCT00299182|10849933|FG004|COMPLETED|Overall Study||5
9747706|NCT00299182|10849934|FG005|COMPLETED|Overall Study||4
9747707|NCT00299182|10849935|FG006|COMPLETED|Overall Study||4
9747708|NCT00299182|10849929|FG000|NOT COMPLETED|Overall Study||0
9747709|NCT00299182|10849930|FG001|NOT COMPLETED|Overall Study||0
9747710|NCT00299182|10849931|FG002|NOT COMPLETED|Overall Study||2
9747711|NCT00299182|10849932|FG003|NOT COMPLETED|Overall Study||0
9747712|NCT00299182|10849933|FG004|NOT COMPLETED|Overall Study||3
9747713|NCT00299182|10849934|FG005|NOT COMPLETED|Overall Study||3
9747714|NCT00299182|10849935|FG006|NOT COMPLETED|Overall Study||1
9747715|NCT00299221|10849955|FG000|STARTED|Overall Study||79
9747716|NCT00299221|10849956|FG001|STARTED|Overall Study||71
9853392|NCT00886821|10966371|FG012|NOT COMPLETED|Stage 2||5
9853393|NCT00886821|10966372|FG013|NOT COMPLETED|Stage 2||1
9853394|NCT00886834|10966418|FG000|STARTED|Overall Study||54
9853395|NCT00886834|10966419|FG001|STARTED|Overall Study||54
9853396|NCT00886834|10966418|FG000|COMPLETED|Overall Study||54
9853397|NCT00886834|10966419|FG001|COMPLETED|Overall Study||51
9853398|NCT00886834|10966418|FG000|NOT COMPLETED|Overall Study||0
9747717|NCT00299221|10849955|FG000|COMPLETED|Overall Study||79
9747718|NCT00299221|10849956|FG001|COMPLETED|Overall Study||71
9747719|NCT00299221|10849955|FG000|NOT COMPLETED|Overall Study||0
9747720|NCT00299221|10849956|FG001|NOT COMPLETED|Overall Study||0
9747721|NCT00299416|10849962|FG000|STARTED|Overall Study||30
9747722|NCT00299416|10849962|FG000|COMPLETED|Overall Study||30
9747723|NCT00299416|10849962|FG000|NOT COMPLETED|Overall Study||0
9747724|NCT00299494|10849972|FG000|STARTED|Overall Study||5
9747725|NCT00299494|10849973|FG001|STARTED|Overall Study||3
9747726|NCT00299494|10849974|FG002|STARTED|Overall Study||7
9747727|NCT00299494|10849975|FG003|STARTED|Overall Study||34
9747728|NCT00299494|10849976|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
9747729|NCT00299494|10849977|FG005|STARTED|Overall Study||30
9747730|NCT00299494|10849972|FG000|COMPLETED|Overall Study||2
9747731|NCT00299494|10849973|FG001|COMPLETED|Overall Study||2
9747732|NCT00299494|10849974|FG002|COMPLETED|Overall Study||3
9747733|NCT00299494|10849975|FG003|COMPLETED|Overall Study||24
9747734|NCT00299494|10849976|FG004|COMPLETED|Overall Study||13
9747735|NCT00299494|10849977|FG005|COMPLETED|Overall Study||4
9747736|NCT00299494|10849972|FG000|NOT COMPLETED|Overall Study||3
9747737|NCT00299494|10849973|FG001|NOT COMPLETED|Overall Study||1
9747738|NCT00299494|10849974|FG002|NOT COMPLETED|Overall Study||4
9747739|NCT00299494|10849975|FG003|NOT COMPLETED|Overall Study||10
9747740|NCT00299494|10849976|FG004|NOT COMPLETED|Overall Study||27
9747741|NCT00299494|10849977|FG005|NOT COMPLETED|Overall Study||26
9747742|NCT00299546|10850005|FG000|STARTED|Overall Study||155
9747743|NCT00299546|10850006|FG001|STARTED|Overall Study||153
9747744|NCT00299546|10850007|FG002|STARTED|Overall Study||153
9747745|NCT00299546|10850005|FG000|COMPLETED|Overall Study||55
9747746|NCT00299546|10850006|FG001|COMPLETED|Overall Study||61
9747747|NCT00299546|10850007|FG002|COMPLETED|Overall Study||67
9747748|NCT00299546|10850005|FG000|NOT COMPLETED|Overall Study||100
9747749|NCT00299546|10850006|FG001|NOT COMPLETED|Overall Study||92
9747750|NCT00299546|10850007|FG002|NOT COMPLETED|Overall Study||86
9747751|NCT00299689|10850016|FG000|STARTED|Overall Study||69
9747752|NCT00299689|10850016|FG000|COMPLETED|Overall Study||69
9747753|NCT00299689|10850016|FG000|NOT COMPLETED|Overall Study||0
9747754|NCT00299702|10850022|FG000|STARTED|Overall Study||179
9853399|NCT00886834|10966419|FG001|NOT COMPLETED|Overall Study||3
9853400|NCT00886899|10966425|FG000|STARTED|Overall Study||147
9853401|NCT00886899|10966425|FG000|COMPLETED|Overall Study||147
9853402|NCT00886899|10966425|FG000|NOT COMPLETED|Overall Study||0
9853403|NCT00886938|10966429|FG000|STARTED|Overall Study||12
9747755|NCT00299702|10850023|FG001|STARTED|Overall Study||176
9747756|NCT00299702|10850022|FG000|COMPLETED|Overall Study||126
9747757|NCT00299702|10850023|FG001|COMPLETED|Overall Study||126
9747758|NCT00299702|10850022|FG000|NOT COMPLETED|Overall Study||53
9747759|NCT00299702|10850023|FG001|NOT COMPLETED|Overall Study||50
9747760|NCT00299741|10850029|FG000|STARTED|Overall Study||36
9747761|NCT00299741|10850029|FG000|COMPLETED|Overall Study||36
9747762|NCT00299741|10850029|FG000|NOT COMPLETED|Overall Study||0
9747763|NCT00299975|10850036|FG000|STARTED|Overall Study||32
9747764|NCT00299975|10850037|FG001|STARTED|Overall Study||32
9747765|NCT00299975|10850038|FG002|STARTED|Overall Study||33
9747766|NCT00299975|10850036|FG000|Received Allocated Intervention|Overall Study||32
9747767|NCT00299975|10850037|FG001|Received Allocated Intervention|Overall Study||32
9747768|NCT00299975|10850038|FG002|Received Allocated Intervention|Overall Study||32
9747769|NCT00299975|10850036|FG000|COMPLETED|Overall Study||29
9747770|NCT00299975|10850037|FG001|COMPLETED|Overall Study||31
9747771|NCT00299975|10850038|FG002|COMPLETED|Overall Study||25
9747772|NCT00299975|10850036|FG000|NOT COMPLETED|Overall Study||3
9747773|NCT00299975|10850037|FG001|NOT COMPLETED|Overall Study||1
9747774|NCT00299975|10850038|FG002|NOT COMPLETED|Overall Study||8
9747775|NCT00299988|10850048|FG000|STARTED|Overall Study||16
9747776|NCT00299988|10850049|FG001|STARTED|Overall Study||8
9747777|NCT00299988|10850048|FG000|COMPLETED|Overall Study||16
9747778|NCT00299988|10850049|FG001|COMPLETED|Overall Study||8
9747779|NCT00299988|10850048|FG000|NOT COMPLETED|Overall Study||0
9747780|NCT00299988|10850049|FG001|NOT COMPLETED|Overall Study||0
9747781|NCT00300053|10850059|FG000|STARTED|Overall Study|started = randomized and treated/injected|55
9747782|NCT00300053|10850060|FG001|STARTED|Overall Study|started = randomized and treated/injected|56
9747783|NCT00300053|10850061|FG002|STARTED|Overall Study|started = randomized and treated/injected|56
9747784|NCT00300053|10850059|FG000|3-Month Evaluation|Overall Study||55
9747785|NCT00300053|10850060|FG001|3-Month Evaluation|Overall Study||56
9747786|NCT00300053|10850061|FG002|3-Month Evaluation|Overall Study||54
9747787|NCT00300053|10850059|FG000|6-Month Evaluation|Overall Study||54
9747788|NCT00300053|10850060|FG001|6-Month Evaluation|Overall Study||55
9747789|NCT00300053|10850061|FG002|6-Month Evaluation|Overall Study||53
9747790|NCT00300053|10850059|FG000|COMPLETED|Overall Study||53
9747791|NCT00300053|10850060|FG001|COMPLETED|Overall Study||53
9747792|NCT00300053|10850061|FG002|COMPLETED|Overall Study||50
9747793|NCT00300053|10850059|FG000|NOT COMPLETED|Overall Study||2
9747794|NCT00300053|10850060|FG001|NOT COMPLETED|Overall Study||3
9747795|NCT00300053|10850061|FG002|NOT COMPLETED|Overall Study||6
9747796|NCT00300235|10850075|FG000|STARTED|Overall Study||208
9747797|NCT00300235|10850076|FG001|STARTED|Overall Study||240
9747798|NCT00300235|10850077|FG002|STARTED|Overall Study||398
9747799|NCT00300235|10850078|FG003|STARTED|Overall Study||362
9747800|NCT00300235|10850079|FG004|STARTED|Overall Study||251
9747801|NCT00300235|10850075|FG000|COMPLETED|Overall Study||208
9747802|NCT00300235|10850076|FG001|COMPLETED|Overall Study||240
9853404|NCT00886938|10966429|FG000|COMPLETED|Overall Study||10
9853405|NCT00886938|10966429|FG000|NOT COMPLETED|Overall Study||2
9853406|NCT00887068|10966435|FG000|STARTED|Overall Study||93
9853407|NCT00887068|10966436|FG001|STARTED|Overall Study||94
9853408|NCT00887068|10966435|FG000|COMPLETED|Overall Study||87
9747803|NCT00300235|10850077|FG002|COMPLETED|Overall Study||398
9747804|NCT00300235|10850078|FG003|COMPLETED|Overall Study||362
9747805|NCT00300235|10850079|FG004|COMPLETED|Overall Study||251
9747806|NCT00300235|10850075|FG000|NOT COMPLETED|Overall Study||0
9747807|NCT00300235|10850076|FG001|NOT COMPLETED|Overall Study||0
9747808|NCT00300235|10850077|FG002|NOT COMPLETED|Overall Study||0
9747809|NCT00300235|10850078|FG003|NOT COMPLETED|Overall Study||0
9747810|NCT00300235|10850079|FG004|NOT COMPLETED|Overall Study||0
9747811|NCT00300274|10850094|FG000|STARTED|Overall Study||282
9747812|NCT00300274|10850095|FG001|STARTED|Overall Study||168
9747813|NCT00300274|10850096|FG002|STARTED|Overall Study||271
9747814|NCT00300274|10850094|FG000|Completed 12 Month|Overall Study||250
9747815|NCT00300274|10850095|FG001|Completed 12 Month|Overall Study||149
9747816|NCT00300274|10850096|FG002|Completed 12 Month|Overall Study||248
9747817|NCT00300274|10850094|FG000|COMPLETED|Overall Study||236
9747818|NCT00300274|10850095|FG001|COMPLETED|Overall Study||141
9747819|NCT00300274|10850096|FG002|COMPLETED|Overall Study||226
9747820|NCT00300274|10850094|FG000|NOT COMPLETED|Overall Study||46
9747821|NCT00300274|10850095|FG001|NOT COMPLETED|Overall Study||27
9747822|NCT00300274|10850096|FG002|NOT COMPLETED|Overall Study||45
9747823|NCT00300365|10850106|FG000|STARTED|Overall Study||38
9747824|NCT00300365|10850107|FG001|STARTED|Overall Study||40
9747825|NCT00300365|10850106|FG000|COMPLETED|Overall Study||34
9853409|NCT00887068|10966436|FG001|COMPLETED|Overall Study||94
9853410|NCT00887068|10966435|FG000|NOT COMPLETED|Overall Study||6
9747826|NCT00300365|10850107|FG001|COMPLETED|Overall Study||38
9747827|NCT00300365|10850106|FG000|NOT COMPLETED|Overall Study||4
9747828|NCT00300365|10850107|FG001|NOT COMPLETED|Overall Study||2
9747829|NCT00300391|10850115|FG000|STARTED|Overall Study||16
9747830|NCT00300391|10850116|FG001|STARTED|Overall Study||14
9747831|NCT00300391|10850115|FG000|COMPLETED|Overall Study||16
9747832|NCT00300391|10850116|FG001|COMPLETED|Overall Study||14
9747833|NCT00300391|10850115|FG000|NOT COMPLETED|Overall Study||0
9747834|NCT00300391|10850116|FG001|NOT COMPLETED|Overall Study||0
9747835|NCT00300430|10850126|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
9853411|NCT00887068|10966436|FG001|NOT COMPLETED|Overall Study||0
9853412|NCT00887159|10966445|FG000|STARTED|Overall Study||56
9747836|NCT00300430|10850127|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
9747837|NCT00300430|10850128|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
9747838|NCT00300430|10850126|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
9747839|NCT00300430|10850127|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
9747840|NCT00300430|10850128|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
9747841|NCT00300430|10850126|FG000|NOT COMPLETED|Overall Study||367
9747842|NCT00300430|10850127|FG001|NOT COMPLETED|Overall Study||169
9747843|NCT00300430|10850128|FG002|NOT COMPLETED|Overall Study||151
9747844|NCT00300456|10850142|FG000|STARTED|Overall Study|"For all arms, started means treated."|119
9747845|NCT00300456|10850143|FG001|STARTED|Overall Study||118
9747846|NCT00300456|10850144|FG002|STARTED|Overall Study||119
9747847|NCT00300456|10850145|FG003|STARTED|Overall Study||119
9747848|NCT00300456|10850146|FG004|STARTED|Overall Study||116
9747849|NCT00300456|10850147|FG005|STARTED|Overall Study||59
9747850|NCT00300456|10850142|FG000|COMPLETED|Overall Study||103
9747851|NCT00300456|10850143|FG001|COMPLETED|Overall Study||102
9747852|NCT00300456|10850144|FG002|COMPLETED|Overall Study||98
9747853|NCT00300456|10850145|FG003|COMPLETED|Overall Study||105
9747854|NCT00300456|10850146|FG004|COMPLETED|Overall Study||99
9747855|NCT00300456|10850147|FG005|COMPLETED|Overall Study||48
10091982|NCT02332720|11220181|FG009|NOT COMPLETED|Part C||0
10091983|NCT02332720|11220182|FG010|NOT COMPLETED|Part C||0
10091984|NCT02332720|11220183|FG011|NOT COMPLETED|Part C||0
10091985|NCT02332720|11220184|FG012|NOT COMPLETED|Part C||0
9747856|NCT00300456|10850142|FG000|NOT COMPLETED|Overall Study||16
9747857|NCT00300456|10850143|FG001|NOT COMPLETED|Overall Study||16
9747858|NCT00300456|10850144|FG002|NOT COMPLETED|Overall Study||21
9747859|NCT00300456|10850145|FG003|NOT COMPLETED|Overall Study||14
9747860|NCT00300456|10850146|FG004|NOT COMPLETED|Overall Study||17
9747861|NCT00300456|10850147|FG005|NOT COMPLETED|Overall Study||11
9747862|NCT00300469|10850167|FG000|STARTED|Overall Study|"For all arms, started means treated."|110
9747863|NCT00300469|10850168|FG001|STARTED|Overall Study||110
9747864|NCT00300469|10850169|FG002|STARTED|Overall Study||112
9747865|NCT00300469|10850170|FG003|STARTED|Overall Study||113
9747866|NCT00300469|10850171|FG004|STARTED|Overall Study||109
9747867|NCT00300469|10850172|FG005|STARTED|Overall Study||55
9747868|NCT00300469|10850167|FG000|COMPLETED|Overall Study||89
9747869|NCT00300469|10850168|FG001|COMPLETED|Overall Study||89
9747870|NCT00300469|10850169|FG002|COMPLETED|Overall Study||95
9747871|NCT00300469|10850170|FG003|COMPLETED|Overall Study||104
9747872|NCT00300469|10850171|FG004|COMPLETED|Overall Study||95
9747873|NCT00300469|10850172|FG005|COMPLETED|Overall Study||46
9747874|NCT00300469|10850167|FG000|NOT COMPLETED|Overall Study||21
9747875|NCT00300469|10850168|FG001|NOT COMPLETED|Overall Study||21
9747876|NCT00300469|10850169|FG002|NOT COMPLETED|Overall Study||17
9747877|NCT00300469|10850170|FG003|NOT COMPLETED|Overall Study||9
9747878|NCT00300469|10850171|FG004|NOT COMPLETED|Overall Study||14
9747879|NCT00300469|10850172|FG005|NOT COMPLETED|Overall Study||9
9747880|NCT00300482|10850192|FG000|STARTED|Overall Study|"For all arms, started means treated."|261
9747881|NCT00300482|10850193|FG001|STARTED|Overall Study||261
9747882|NCT00300482|10850194|FG002|STARTED|Overall Study||259
9747883|NCT00300482|10850195|FG003|STARTED|Overall Study||261
9853413|NCT00887159|10966446|FG001|STARTED|Overall Study||56
9853414|NCT00887159|10966447|FG002|STARTED|Overall Study||56
9853415|NCT00887159|10966445|FG000|Patients Who Started Assigned Treatment|Overall Study||53
9853416|NCT00887159|10966446|FG001|Patients Who Started Assigned Treatment|Overall Study||53
9853417|NCT00887159|10966447|FG002|Patients Who Started Assigned Treatment|Overall Study||52
9853418|NCT00887159|10966445|FG000|Eligible and Treated Patients|Overall Study||48
9853419|NCT00887159|10966446|FG001|Eligible and Treated Patients|Overall Study||52
9853420|NCT00887159|10966447|FG002|Eligible and Treated Patients|Overall Study||52
9853421|NCT00887159|10966445|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40
9853422|NCT00887159|10966446|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42
9853423|NCT00887159|10966447|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38
9853424|NCT00887159|10966445|FG000|COMPLETED|Overall Study||27
9853425|NCT00887159|10966446|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
10091986|NCT02332720|11220185|FG013|NOT COMPLETED|Part C||0
10091987|NCT02332720|11220186|FG014|NOT COMPLETED|Part C||0
10091988|NCT02332720|11220187|FG015|NOT COMPLETED|Part C||0
10091989|NCT02332720|11220188|FG016|NOT COMPLETED|Part C||0
10091990|NCT02332720|11220189|FG017|NOT COMPLETED|Part C||0
10091991|NCT02332720|11220190|FG018|NOT COMPLETED|Part C||0
10091992|NCT02332720|11220191|FG019|NOT COMPLETED|Part C||0
9747884|NCT00300482|10850196|FG004|STARTED|Overall Study||266
9747885|NCT00300482|10850197|FG005|STARTED|Overall Study||131
9747886|NCT00300482|10850192|FG000|COMPLETED|Overall Study||220
9747887|NCT00300482|10850193|FG001|COMPLETED|Overall Study||220
9747888|NCT00300482|10850194|FG002|COMPLETED|Overall Study||208
9747889|NCT00300482|10850195|FG003|COMPLETED|Overall Study||237
9747890|NCT00300482|10850196|FG004|COMPLETED|Overall Study||243
9747891|NCT00300482|10850197|FG005|COMPLETED|Overall Study||115
9747892|NCT00300482|10850192|FG000|NOT COMPLETED|Overall Study||41
9747893|NCT00300482|10850193|FG001|NOT COMPLETED|Overall Study||41
10091993|NCT02332720|11220192|FG020|NOT COMPLETED|Part C||0
10091994|NCT02332720|11220193|FG021|NOT COMPLETED|Part C||0
10091995|NCT02332720|11220194|FG022|NOT COMPLETED|Part C||0
9747894|NCT00300482|10850194|FG002|NOT COMPLETED|Overall Study||51
9747895|NCT00300482|10850195|FG003|NOT COMPLETED|Overall Study||24
9747896|NCT00300482|10850196|FG004|NOT COMPLETED|Overall Study||23
9747897|NCT00300482|10850197|FG005|NOT COMPLETED|Overall Study||16
9747898|NCT00300495|10850213|FG000|STARTED|Overall Study||10
9747899|NCT00300495|10850214|FG001|STARTED|Overall Study||9
9747900|NCT00300495|10850213|FG000|COMPLETED|Overall Study||6
9747901|NCT00300495|10850214|FG001|COMPLETED|Overall Study||8
9747902|NCT00300495|10850213|FG000|NOT COMPLETED|Overall Study||4
9747903|NCT00300495|10850214|FG001|NOT COMPLETED|Overall Study||1
9747904|NCT00300677|10850220|FG000|STARTED|Overall Study||12
9747905|NCT00300677|10850220|FG000|COMPLETED|Overall Study||12
9747906|NCT00300677|10850220|FG000|NOT COMPLETED|Overall Study||0
9747907|NCT00300742|10850224|FG000|STARTED|Overall Study||5
9747908|NCT00300742|10850224|FG000|COMPLETED|Overall Study||3
9747909|NCT00300742|10850224|FG000|NOT COMPLETED|Overall Study||2
9747910|NCT00300755|10850232|FG000|STARTED|Overall Study||18
9747911|NCT00300755|10850233|FG001|STARTED|Overall Study||21
9747912|NCT00300755|10850234|FG002|STARTED|Overall Study||21
9747913|NCT00300755|10850232|FG000|COMPLETED|Overall Study||17
9747914|NCT00300755|10850233|FG001|COMPLETED|Overall Study||17
9747915|NCT00300755|10850234|FG002|COMPLETED|Overall Study||19
9747916|NCT00300755|10850232|FG000|NOT COMPLETED|Overall Study||1
9747917|NCT00300755|10850233|FG001|NOT COMPLETED|Overall Study||4
9747918|NCT00300755|10850234|FG002|NOT COMPLETED|Overall Study||2
9747919|NCT00300781|10850244|FG000|STARTED|Overall Study||66
9747920|NCT00300781|10850245|FG001|STARTED|Overall Study||70
9747921|NCT00300781|10850244|FG000|COMPLETED|Overall Study||3
9747922|NCT00300781|10850245|FG001|COMPLETED|Overall Study||8
9747923|NCT00300781|10850244|FG000|NOT COMPLETED|Overall Study||63
9747924|NCT00300781|10850245|FG001|NOT COMPLETED|Overall Study||62
9747925|NCT00300885|10850253|FG000|STARTED|Treatment||464
9747926|NCT00300885|10850254|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
9747927|NCT00300885|10850253|FG000|Received Treatment|Treatment||463
9747928|NCT00300885|10850254|FG001|Received Treatment|Treatment||459
9747929|NCT00300885|10850253|FG000|COMPLETED|Treatment||91
9747930|NCT00300885|10850254|FG001|COMPLETED|Treatment||88
9747931|NCT00300885|10850253|FG000|NOT COMPLETED|Treatment||373
9747932|NCT00300885|10850254|FG001|NOT COMPLETED|Treatment||374
9747933|NCT00300885|10850253|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
9747934|NCT00300885|10850254|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
9747935|NCT00300885|10850253|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
9747936|NCT00300885|10850254|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
9747937|NCT00300885|10850253|FG000|NOT COMPLETED|Follow-up||178
9747938|NCT00300885|10850254|FG001|NOT COMPLETED|Follow-up||195
9747939|NCT00301028|10850260|FG000|STARTED|Overall Study||47
9747940|NCT00301028|10850260|FG000|COMPLETED|Overall Study||47
9747941|NCT00301028|10850260|FG000|NOT COMPLETED|Overall Study||0
9747942|NCT00301067|10850264|FG000|STARTED|Completed DLT Period/1st Cycle||4
9747943|NCT00301067|10850265|FG001|STARTED|Completed DLT Period/1st Cycle||3
9747944|NCT00301067|10850266|FG002|STARTED|Completed DLT Period/1st Cycle||3
9747945|NCT00301067|10850267|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
9747946|NCT00301067|10850264|FG000|COMPLETED|Completed DLT Period/1st Cycle||3
9747947|NCT00301067|10850265|FG001|COMPLETED|Completed DLT Period/1st Cycle||3
9747948|NCT00301067|10850266|FG002|COMPLETED|Completed DLT Period/1st Cycle||3
9747949|NCT00301067|10850267|FG003|COMPLETED|Completed DLT Period/1st Cycle||9
9747950|NCT00301067|10850264|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1
9747951|NCT00301067|10850265|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0
9747952|NCT00301067|10850266|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0
9747953|NCT00301067|10850267|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1
9747954|NCT00301067|10850264|FG000|STARTED|Reached 1st Response/2 Cycles||3
9747955|NCT00301067|10850265|FG001|STARTED|Reached 1st Response/2 Cycles||3
9747956|NCT00301067|10850266|FG002|STARTED|Reached 1st Response/2 Cycles||3
9747957|NCT00301067|10850267|FG003|STARTED|Reached 1st Response/2 Cycles||9
9747958|NCT00301067|10850264|FG000|COMPLETED|Reached 1st Response/2 Cycles||1
9747959|NCT00301067|10850265|FG001|COMPLETED|Reached 1st Response/2 Cycles||2
9747960|NCT00301067|10850266|FG002|COMPLETED|Reached 1st Response/2 Cycles||2
9747961|NCT00301067|10850267|FG003|COMPLETED|Reached 1st Response/2 Cycles||7
9747962|NCT00301067|10850264|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
9747963|NCT00301067|10850265|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1
9747964|NCT00301067|10850266|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1
9747965|NCT00301067|10850267|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2
9747966|NCT00301067|10850264|FG000|STARTED|Completed 4 Cycles of Treatment||1
9747967|NCT00301067|10850265|FG001|STARTED|Completed 4 Cycles of Treatment||2
9747968|NCT00301067|10850266|FG002|STARTED|Completed 4 Cycles of Treatment||2
9747969|NCT00301067|10850267|FG003|STARTED|Completed 4 Cycles of Treatment||7
9747970|NCT00301067|10850264|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
9747971|NCT00301067|10850265|FG001|COMPLETED|Completed 4 Cycles of Treatment||1
9747972|NCT00301067|10850266|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
9747973|NCT00301067|10850267|FG003|COMPLETED|Completed 4 Cycles of Treatment||2
9747974|NCT00301067|10850264|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1
9747975|NCT00301067|10850265|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1
9747976|NCT00301067|10850266|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2
9747977|NCT00301067|10850267|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5
9747978|NCT00301067|10850264|FG000|STARTED|Completed 12 Cycles of Treatment||0
9853426|NCT00887159|10966447|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
9853427|NCT00887159|10966445|FG000|NOT COMPLETED|Overall Study||29
9853428|NCT00887159|10966446|FG001|NOT COMPLETED|Overall Study||56
9853429|NCT00887159|10966447|FG002|NOT COMPLETED|Overall Study||56
9853430|NCT00887198|10966459|FG000|STARTED|Randomized Period||546
9853431|NCT00887198|10966460|FG001|STARTED|Randomized Period||542
9747979|NCT00301067|10850265|FG001|STARTED|Completed 12 Cycles of Treatment||1
9747980|NCT00301067|10850266|FG002|STARTED|Completed 12 Cycles of Treatment||0
9747981|NCT00301067|10850267|FG003|STARTED|Completed 12 Cycles of Treatment||2
9747982|NCT00301067|10850264|FG000|COMPLETED|Completed 12 Cycles of Treatment||0
9747983|NCT00301067|10850265|FG001|COMPLETED|Completed 12 Cycles of Treatment||0
9747984|NCT00301067|10850266|FG002|COMPLETED|Completed 12 Cycles of Treatment||0
9747985|NCT00301067|10850267|FG003|COMPLETED|Completed 12 Cycles of Treatment||0
9747986|NCT00301067|10850264|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0
9747987|NCT00301067|10850265|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1
9747988|NCT00301067|10850266|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0
9747989|NCT00301067|10850267|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2
9747990|NCT00301067|10850264|FG000|STARTED|Follow up Until Death||4
9747991|NCT00301067|10850265|FG001|STARTED|Follow up Until Death||3
9747992|NCT00301067|10850266|FG002|STARTED|Follow up Until Death||3
9747993|NCT00301067|10850267|FG003|STARTED|Follow up Until Death||3
9747994|NCT00301067|10850264|FG000|COMPLETED|Follow up Until Death||3
9747995|NCT00301067|10850265|FG001|COMPLETED|Follow up Until Death||3
9747996|NCT00301067|10850266|FG002|COMPLETED|Follow up Until Death||3
9853432|NCT00887198|10966461|FG002|STARTED|Randomized Period||0
9853433|NCT00887198|10966459|FG000|Treated|Randomized Period||542
9853434|NCT00887198|10966460|FG001|Treated|Randomized Period||540
10091996|NCT02332798|11220259|FG000|STARTED|Overall Study||13
9747997|NCT00301067|10850267|FG003|COMPLETED|Follow up Until Death||2
9747998|NCT00301067|10850264|FG000|NOT COMPLETED|Follow up Until Death||1
9747999|NCT00301067|10850265|FG001|NOT COMPLETED|Follow up Until Death||0
9748000|NCT00301067|10850266|FG002|NOT COMPLETED|Follow up Until Death||0
9748001|NCT00301067|10850267|FG003|NOT COMPLETED|Follow up Until Death||1
9748002|NCT00301366|10850278|FG000|STARTED|Overall Study||38
9748003|NCT00301366|10850278|FG000|COMPLETED|Overall Study||37
9748004|NCT00301366|10850278|FG000|NOT COMPLETED|Overall Study||1
9748005|NCT00301418|10850282|FG000|STARTED|Overall Study||11
9748006|NCT00301418|10850282|FG000|COMPLETED|Overall Study||11
9748007|NCT00301418|10850282|FG000|NOT COMPLETED|Overall Study||0
9748008|NCT00301756|10850286|FG000|STARTED|Overall Study||32
9748009|NCT00301756|10850286|FG000|COMPLETED|Overall Study||32
9748010|NCT00301756|10850286|FG000|NOT COMPLETED|Overall Study||0
9748011|NCT00301808|10850292|FG000|STARTED|Overall Study||29
9748012|NCT00301808|10850292|FG000|COMPLETED|Overall Study||17
9748013|NCT00301808|10850292|FG000|NOT COMPLETED|Overall Study||12
9748014|NCT00301821|10850296|FG000|STARTED|Overall Study||107
9748015|NCT00301821|10850296|FG000|COMPLETED|Overall Study||81
9748016|NCT00301821|10850296|FG000|NOT COMPLETED|Overall Study||26
9748017|NCT00301834|10850300|FG000|STARTED|Overall Study||35
9748018|NCT00301834|10850300|FG000|COMPLETED|Overall Study||34
9748019|NCT00301834|10850300|FG000|NOT COMPLETED|Overall Study||1
9748020|NCT00301873|10850307|FG000|STARTED|Overall Study||59
9748021|NCT00301873|10850307|FG000|COMPLETED|Overall Study||59
9748022|NCT00301873|10850307|FG000|NOT COMPLETED|Overall Study||0
9748023|NCT00301964|10850311|FG000|STARTED|Overall Study||56
9748024|NCT00301964|10850311|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
9748025|NCT00301964|10850311|FG000|NOT COMPLETED|Overall Study||4
9748026|NCT00302003|10850321|FG000|STARTED|Overall Study||287
9748027|NCT00302003|10850321|FG000|COMPLETED|Overall Study||207
9748028|NCT00302003|10850321|FG000|NOT COMPLETED|Overall Study||80
9748029|NCT00302042|10850327|FG000|STARTED|Overall Study||46
9748030|NCT00302042|10850328|FG001|STARTED|Overall Study||46
9748031|NCT00302042|10850327|FG000|COMPLETED|Overall Study||39
9748032|NCT00302042|10850328|FG001|COMPLETED|Overall Study||38
9748033|NCT00302042|10850327|FG000|NOT COMPLETED|Overall Study||7
9748034|NCT00302042|10850328|FG001|NOT COMPLETED|Overall Study||8
9853435|NCT00887198|10966461|FG002|Treated|Randomized Period||0
9853436|NCT00887198|10966459|FG000|COMPLETED|Randomized Period||0
9853437|NCT00887198|10966460|FG001|COMPLETED|Randomized Period||0
9853438|NCT00887198|10966461|FG002|COMPLETED|Randomized Period||0
9853439|NCT00887198|10966459|FG000|NOT COMPLETED|Randomized Period||546
10091997|NCT02332798|11220260|FG001|STARTED|Overall Study||14
9748035|NCT00302055|10850336|FG000|STARTED|Overall Study||23
9748036|NCT00302055|10850337|FG001|STARTED|Overall Study||49
9748037|NCT00302055|10850336|FG000|COMPLETED|Overall Study||14
9748038|NCT00302055|10850337|FG001|COMPLETED|Overall Study||36
9748039|NCT00302055|10850336|FG000|NOT COMPLETED|Overall Study||9
9748040|NCT00302055|10850337|FG001|NOT COMPLETED|Overall Study||13
9748041|NCT00302068|10850346|FG000|STARTED|Overall Study||37
9748042|NCT00302068|10850347|FG001|STARTED|Overall Study||40
9748043|NCT00302068|10850348|FG002|STARTED|Overall Study||24
9748044|NCT00302068|10850346|FG000|COMPLETED|Overall Study||36
9853440|NCT00887198|10966460|FG001|NOT COMPLETED|Randomized Period||542
9853441|NCT00887198|10966461|FG002|NOT COMPLETED|Randomized Period||0
10091998|NCT02332798|11220261|FG002|STARTED|Overall Study||12
9748045|NCT00302068|10850347|FG001|COMPLETED|Overall Study||36
9748046|NCT00302068|10850348|FG002|COMPLETED|Overall Study||23
9748047|NCT00302068|10850346|FG000|NOT COMPLETED|Overall Study||1
9748048|NCT00302068|10850347|FG001|NOT COMPLETED|Overall Study||4
9748049|NCT00302068|10850348|FG002|NOT COMPLETED|Overall Study||1
9748050|NCT00302081|10850360|FG000|STARTED|Overall Study||237
9748051|NCT00302081|10850361|FG001|STARTED|Overall Study||229
9748052|NCT00302081|10850362|FG002|STARTED|Overall Study||230
9748053|NCT00302081|10850360|FG000|COMPLETED|Overall Study||181
9748054|NCT00302081|10850361|FG001|COMPLETED|Overall Study||186
9748055|NCT00302081|10850362|FG002|COMPLETED|Overall Study||178
9748056|NCT00302081|10850360|FG000|NOT COMPLETED|Overall Study||56
9748057|NCT00302081|10850361|FG001|NOT COMPLETED|Overall Study||43
9748058|NCT00302081|10850362|FG002|NOT COMPLETED|Overall Study||52
9748059|NCT00302107|10850372|FG000|STARTED|Overall Study||39
9748060|NCT00302107|10850373|FG001|STARTED|Overall Study||39
9748061|NCT00302107|10850372|FG000|COMPLETED|Overall Study||31
9748062|NCT00302107|10850373|FG001|COMPLETED|Overall Study||30
9748063|NCT00302107|10850372|FG000|NOT COMPLETED|Overall Study||8
9748064|NCT00302107|10850373|FG001|NOT COMPLETED|Overall Study||9
9748065|NCT00302133|10850381|FG000|STARTED|Overall Study||9
9748066|NCT00302133|10850382|FG001|STARTED|Overall Study||9
9748067|NCT00302133|10850381|FG000|COMPLETED|Overall Study||5
9748068|NCT00302133|10850382|FG001|COMPLETED|Overall Study||5
9748069|NCT00302133|10850381|FG000|NOT COMPLETED|Overall Study||4
9748070|NCT00302133|10850382|FG001|NOT COMPLETED|Overall Study||4
9748071|NCT00302159|10850388|FG000|STARTED|Overall Study||43
9748072|NCT00302159|10850388|FG000|COMPLETED|Overall Study||41
9748073|NCT00302159|10850388|FG000|NOT COMPLETED|Overall Study||2
9748074|NCT00302211|10850396|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
9748075|NCT00302211|10850397|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
9748076|NCT00302211|10850398|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
9748077|NCT00302211|10850399|FG003|STARTED|Double Blind Period (New Patients)||0
9748078|NCT00302211|10850400|FG004|STARTED|Double Blind Period (New Patients)||0
9748079|NCT00302211|10850396|FG000|COMPLETED|Double Blind Period (New Patients)||23
9748080|NCT00302211|10850397|FG001|COMPLETED|Double Blind Period (New Patients)||25
9748081|NCT00302211|10850398|FG002|COMPLETED|Double Blind Period (New Patients)||10
9748082|NCT00302211|10850399|FG003|COMPLETED|Double Blind Period (New Patients)||0
9748083|NCT00302211|10850400|FG004|COMPLETED|Double Blind Period (New Patients)||0
9748084|NCT00302211|10850396|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3
9748085|NCT00302211|10850397|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2
9748086|NCT00302211|10850398|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4
9748087|NCT00302211|10850399|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0
9748088|NCT00302211|10850400|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0
9748089|NCT00302211|10850396|FG000|STARTED|Open Label-Patients From Double-Blind||0
9748090|NCT00302211|10850397|FG001|STARTED|Open Label-Patients From Double-Blind||0
10091999|NCT02332798|11220259|FG000|COMPLETED|Overall Study||12
10092000|NCT02332798|11220260|FG001|COMPLETED|Overall Study||12
10092001|NCT02332798|11220261|FG002|COMPLETED|Overall Study||11
10092002|NCT02332798|11220259|FG000|NOT COMPLETED|Overall Study||1
10092003|NCT02332798|11220260|FG001|NOT COMPLETED|Overall Study||2
10092004|NCT02332798|11220261|FG002|NOT COMPLETED|Overall Study||1
9748091|NCT00302211|10850398|FG002|STARTED|Open Label-Patients From Double-Blind||0
9748092|NCT00302211|10850399|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
9748093|NCT00302211|10850400|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
9748094|NCT00302211|10850396|FG000|COMPLETED|Open Label-Patients From Double-Blind||0
9748095|NCT00302211|10850397|FG001|COMPLETED|Open Label-Patients From Double-Blind||0
9748096|NCT00302211|10850398|FG002|COMPLETED|Open Label-Patients From Double-Blind||0
10112887|NCT02506036|11243773|FG001|STARTED|Washout (1-2 Weeks)||1
10112888|NCT02506036|11243772|FG000|COMPLETED|Washout (1-2 Weeks)||2
10112889|NCT02506036|11243773|FG001|COMPLETED|Washout (1-2 Weeks)||1
10112890|NCT02506036|11243772|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
10112891|NCT02506036|11243773|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
10112892|NCT02506036|11243772|FG000|STARTED|Second Intervention (4-6 Weeks)||2
10112893|NCT02506036|11243773|FG001|STARTED|Second Intervention (4-6 Weeks)||1
10112894|NCT02506036|11243772|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2
10112895|NCT02506036|11243773|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1
9748097|NCT00302211|10850399|FG003|COMPLETED|Open Label-Patients From Double-Blind||18
9748098|NCT00302211|10850400|FG004|COMPLETED|Open Label-Patients From Double-Blind||24
9748099|NCT00302211|10850396|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0
9748100|NCT00302211|10850397|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0
9853442|NCT00887198|10966459|FG000|STARTED|Cross Over (Placebo to AA)||0
9853443|NCT00887198|10966460|FG001|STARTED|Cross Over (Placebo to AA)||0
9953005|NCT01424943|11071865|FG001|COMPLETED|Overall Study||23
9748101|NCT00302211|10850398|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0
10112896|NCT02506036|11243772|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
10112897|NCT02506036|11243773|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
10112898|NCT02506114|11243782|FG000|STARTED|Overall Study||5
10112899|NCT02506114|11243783|FG001|STARTED|Overall Study||4
9748102|NCT00302211|10850399|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8
9748103|NCT00302211|10850400|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8
9748104|NCT00302328|10850415|FG000|STARTED|Overall Study||25
9748105|NCT00302328|10850416|FG001|STARTED|Overall Study||35
9748106|NCT00302328|10850417|FG002|STARTED|Overall Study||18
9748107|NCT00302328|10850415|FG000|COMPLETED|Overall Study||25
9748108|NCT00302328|10850416|FG001|COMPLETED|Overall Study|developed cancer during the study|34
9748109|NCT00302328|10850417|FG002|COMPLETED|Overall Study||18
9748110|NCT00302328|10850415|FG000|NOT COMPLETED|Overall Study||0
9748111|NCT00302328|10850416|FG001|NOT COMPLETED|Overall Study||1
9748112|NCT00302328|10850417|FG002|NOT COMPLETED|Overall Study||0
9748113|NCT00302458|10850428|FG000|STARTED|Overall Study||29
9748114|NCT00302458|10850428|FG000|COMPLETED|Overall Study||26
9748115|NCT00302458|10850428|FG000|NOT COMPLETED|Overall Study||3
9748116|NCT00302718|10850440|FG000|STARTED|Overall Study||20
9748117|NCT00302718|10850441|FG001|STARTED|Overall Study||21
9748118|NCT00302718|10850442|FG002|STARTED|Overall Study||21
9748119|NCT00302718|10850443|FG003|STARTED|Overall Study||21
9748120|NCT00302718|10850440|FG000|COMPLETED|Overall Study||19
9748121|NCT00302718|10850441|FG001|COMPLETED|Overall Study||20
9748122|NCT00302718|10850442|FG002|COMPLETED|Overall Study||19
9748123|NCT00302718|10850443|FG003|COMPLETED|Overall Study||19
9748124|NCT00302718|10850440|FG000|NOT COMPLETED|Overall Study||1
9748125|NCT00302718|10850441|FG001|NOT COMPLETED|Overall Study||1
9748126|NCT00302718|10850442|FG002|NOT COMPLETED|Overall Study||2
9748127|NCT00302718|10850443|FG003|NOT COMPLETED|Overall Study||2
9748128|NCT00302731|10850462|FG000|STARTED|Overall Study||6
9748129|NCT00302731|10850463|FG001|STARTED|Overall Study||6
9748130|NCT00302731|10850464|FG002|STARTED|Overall Study||5
9748131|NCT00302731|10850465|FG003|STARTED|Overall Study||4
9748132|NCT00302731|10850462|FG000|COMPLETED|Overall Study||2
9748133|NCT00302731|10850463|FG001|COMPLETED|Overall Study||1
9748134|NCT00302731|10850464|FG002|COMPLETED|Overall Study||2
9748135|NCT00302731|10850465|FG003|COMPLETED|Overall Study||4
9748136|NCT00302731|10850462|FG000|NOT COMPLETED|Overall Study||4
9748137|NCT00302731|10850463|FG001|NOT COMPLETED|Overall Study||5
9748138|NCT00302731|10850464|FG002|NOT COMPLETED|Overall Study||3
9748139|NCT00302731|10850465|FG003|NOT COMPLETED|Overall Study||0
9748140|NCT00302848|10850478|FG000|STARTED|Overall Study||16534
9748141|NCT00302848|10850479|FG001|STARTED|Overall Study||15428
9748142|NCT00302848|10850480|FG002|STARTED|Overall Study||26341
9748143|NCT00302848|10850478|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
9748144|NCT00302848|10850479|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
9748145|NCT00302848|10850480|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
9748146|NCT00302848|10850478|FG000|NOT COMPLETED|Overall Study||401
9748147|NCT00302848|10850479|FG001|NOT COMPLETED|Overall Study||419
9748148|NCT00302848|10850480|FG002|NOT COMPLETED|Overall Study||579
9748149|NCT00302952|10850489|FG000|STARTED|Overall Study||34
9748150|NCT00302952|10850490|FG001|STARTED|Overall Study||30
9748151|NCT00302952|10850489|FG000|Started Intent-to-Treat (ITT)|Overall Study||34
9748152|NCT00302952|10850490|FG001|Started Intent-to-Treat (ITT)|Overall Study||30
9748153|NCT00302952|10850489|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34
9748154|NCT00302952|10850490|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
9748155|NCT00302952|10850489|FG000|COMPLETED|Overall Study||31
9748156|NCT00302952|10850490|FG001|COMPLETED|Overall Study||25
9748157|NCT00302952|10850489|FG000|NOT COMPLETED|Overall Study||3
9748158|NCT00302952|10850490|FG001|NOT COMPLETED|Overall Study||5
9748159|NCT00303069|10850500|FG000|STARTED|Overall Study||31
9748160|NCT00303069|10850501|FG001|STARTED|Overall Study||28
9748161|NCT00303069|10850502|FG002|STARTED|Overall Study||34
9748162|NCT00303069|10850503|FG003|STARTED|Overall Study||31
9748163|NCT00303069|10850500|FG000|COMPLETED|Overall Study||29
9748164|NCT00303069|10850501|FG001|COMPLETED|Overall Study||28
9748165|NCT00303069|10850502|FG002|COMPLETED|Overall Study||33
9748166|NCT00303069|10850503|FG003|COMPLETED|Overall Study||29
9748167|NCT00303069|10850500|FG000|NOT COMPLETED|Overall Study||2
9748168|NCT00303069|10850501|FG001|NOT COMPLETED|Overall Study||0
9748169|NCT00303069|10850502|FG002|NOT COMPLETED|Overall Study||1
9748170|NCT00303069|10850503|FG003|NOT COMPLETED|Overall Study||2
9748171|NCT00303108|10850516|FG000|STARTED|Overall Study||43
9748172|NCT00303108|10850517|FG001|STARTED|Overall Study||46
9748173|NCT00303108|10850518|FG002|STARTED|Overall Study||47
9748174|NCT00303108|10850516|FG000|COMPLETED|Overall Study||31
9748175|NCT00303108|10850517|FG001|COMPLETED|Overall Study||37
9748176|NCT00303108|10850518|FG002|COMPLETED|Overall Study||31
9748177|NCT00303108|10850516|FG000|NOT COMPLETED|Overall Study||12
9748178|NCT00303108|10850517|FG001|NOT COMPLETED|Overall Study||9
9748179|NCT00303108|10850518|FG002|NOT COMPLETED|Overall Study||16
9748180|NCT00303186|10850525|FG000|STARTED|Overall Study||107
9748181|NCT00303186|10850525|FG000|COMPLETED|Overall Study||55
9748182|NCT00303186|10850525|FG000|NOT COMPLETED|Overall Study||52
9748183|NCT00303316|10850531|FG000|STARTED|Overall Study||232
9748184|NCT00303316|10850532|FG001|STARTED|Overall Study||226
9748185|NCT00303316|10850531|FG000|COMPLETED|Overall Study||230
9748186|NCT00303316|10850532|FG001|COMPLETED|Overall Study||223
9748187|NCT00303316|10850531|FG000|NOT COMPLETED|Overall Study||2
9748188|NCT00303316|10850532|FG001|NOT COMPLETED|Overall Study||3
9748189|NCT00303329|10850540|FG000|STARTED|Overall Study||85
9748190|NCT00303329|10850541|FG001|STARTED|Overall Study||99
9748191|NCT00303329|10850540|FG000|COMPLETED|Overall Study||50
9748192|NCT00303329|10850541|FG001|COMPLETED|Overall Study||37
9748193|NCT00303329|10850540|FG000|NOT COMPLETED|Overall Study||35
9748194|NCT00303329|10850541|FG001|NOT COMPLETED|Overall Study||62
9748195|NCT00303446|10850549|FG000|STARTED|Overall Study||25
9748196|NCT00303446|10850550|FG001|STARTED|Overall Study||25
9748197|NCT00303446|10850549|FG000|COMPLETED|Overall Study||23
9748198|NCT00303446|10850550|FG001|COMPLETED|Overall Study||21
9748199|NCT00303446|10850549|FG000|NOT COMPLETED|Overall Study||2
9748200|NCT00303446|10850550|FG001|NOT COMPLETED|Overall Study||4
9748201|NCT00303459|10850558|FG000|STARTED|Overall Study||159
9748202|NCT00303459|10850559|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
9748203|NCT00303459|10850558|FG000|COMPLETED|Overall Study||76
9748204|NCT00303459|10850559|FG001|COMPLETED|Overall Study||86
9748205|NCT00303459|10850558|FG000|NOT COMPLETED|Overall Study||83
9748206|NCT00303459|10850559|FG001|NOT COMPLETED|Overall Study||89
9748207|NCT00303472|10850573|FG000|STARTED|Treatment Period||6
9748208|NCT00303472|10850574|FG001|STARTED|Treatment Period||11
9748209|NCT00303472|10850575|FG002|STARTED|Treatment Period||11
9748210|NCT00303472|10850576|FG003|STARTED|Treatment Period||16
9748211|NCT00303472|10850577|FG004|STARTED|Treatment Period||11
9748212|NCT00303472|10850578|FG005|STARTED|Treatment Period||12
9748213|NCT00303472|10850579|FG006|STARTED|Treatment Period||5
9748214|NCT00303472|10850573|FG000|COMPLETED|Treatment Period||6
9748215|NCT00303472|10850574|FG001|COMPLETED|Treatment Period||11
9748216|NCT00303472|10850575|FG002|COMPLETED|Treatment Period||11
9748217|NCT00303472|10850576|FG003|COMPLETED|Treatment Period||14
9748218|NCT00303472|10850577|FG004|COMPLETED|Treatment Period||8
9748219|NCT00303472|10850578|FG005|COMPLETED|Treatment Period||11
9748220|NCT00303472|10850579|FG006|COMPLETED|Treatment Period||3
9748221|NCT00303472|10850573|FG000|NOT COMPLETED|Treatment Period||0
9853444|NCT00887198|10966461|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
9853445|NCT00887198|10966459|FG000|COMPLETED|Cross Over (Placebo to AA)||0
9853446|NCT00887198|10966460|FG001|COMPLETED|Cross Over (Placebo to AA)||0
9853447|NCT00887198|10966461|FG002|COMPLETED|Cross Over (Placebo to AA)||0
9853448|NCT00887198|10966459|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0
9853449|NCT00887198|10966460|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0
9853450|NCT00887198|10966461|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93
9853451|NCT00887224|10966472|FG000|STARTED|Open-label Response (OLR) Phase||874
9853452|NCT00887224|10966473|FG001|STARTED|Open-label Response (OLR) Phase||0
9853453|NCT00887224|10966474|FG002|STARTED|Open-label Response (OLR) Phase||0
9853454|NCT00887224|10966472|FG000|COMPLETED|Open-label Response (OLR) Phase||752
9853455|NCT00887224|10966473|FG001|COMPLETED|Open-label Response (OLR) Phase||0
9853456|NCT00887224|10966474|FG002|COMPLETED|Open-label Response (OLR) Phase||0
9853457|NCT00887224|10966472|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122
9853458|NCT00887224|10966473|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0
9853459|NCT00887224|10966474|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0
9853460|NCT00887224|10966472|FG000|STARTED|Between OLR and OLS Phases||752
9853461|NCT00887224|10966473|FG001|STARTED|Between OLR and OLS Phases||0
9853462|NCT00887224|10966474|FG002|STARTED|Between OLR and OLS Phases||0
9853463|NCT00887224|10966472|FG000|COMPLETED|Between OLR and OLS Phases||659
9853464|NCT00887224|10966473|FG001|COMPLETED|Between OLR and OLS Phases||0
9853465|NCT00887224|10966474|FG002|COMPLETED|Between OLR and OLS Phases||0
9853466|NCT00887224|10966472|FG000|NOT COMPLETED|Between OLR and OLS Phases||93
9853467|NCT00887224|10966473|FG001|NOT COMPLETED|Between OLR and OLS Phases||0
9853468|NCT00887224|10966474|FG002|NOT COMPLETED|Between OLR and OLS Phases||0
9853469|NCT00887224|10966472|FG000|STARTED|Open-label Stability (OLS) Phase||659
9853470|NCT00887224|10966473|FG001|STARTED|Open-label Stability (OLS) Phase||0
9853471|NCT00887224|10966474|FG002|STARTED|Open-label Stability (OLS) Phase||0
9853472|NCT00887224|10966472|FG000|COMPLETED|Open-label Stability (OLS) Phase||576
9853473|NCT00887224|10966473|FG001|COMPLETED|Open-label Stability (OLS) Phase||0
10092005|NCT02332824|11220275|FG000|STARTED|Overall Study||67
10092006|NCT02332824|11220276|FG001|STARTED|Overall Study||67
10092007|NCT02332824|11220277|FG002|STARTED|Overall Study||74
10092008|NCT02332824|11220278|FG003|STARTED|Overall Study||68
10092009|NCT02332824|11220279|FG004|STARTED|Overall Study||69
10092010|NCT02332824|11220280|FG005|STARTED|Overall Study||70
10092011|NCT02332824|11220275|FG000|COMPLETED|Overall Study||61
9748222|NCT00303472|10850574|FG001|NOT COMPLETED|Treatment Period||0
9748223|NCT00303472|10850575|FG002|NOT COMPLETED|Treatment Period||0
9748224|NCT00303472|10850576|FG003|NOT COMPLETED|Treatment Period||2
9748225|NCT00303472|10850577|FG004|NOT COMPLETED|Treatment Period||3
9748226|NCT00303472|10850578|FG005|NOT COMPLETED|Treatment Period||1
9748227|NCT00303472|10850579|FG006|NOT COMPLETED|Treatment Period||2
9748228|NCT00303472|10850573|FG000|STARTED|Treatment Extension (Optional)||6
9853474|NCT00887224|10966474|FG002|COMPLETED|Open-label Stability (OLS) Phase||0
9853475|NCT00887224|10966472|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83
9853476|NCT00887224|10966473|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0
9853477|NCT00887224|10966474|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0
9853478|NCT00887224|10966472|FG000|STARTED|Between OLS and DB Phases||576
10092012|NCT02332824|11220276|FG001|COMPLETED|Overall Study||66
10092013|NCT02332824|11220277|FG002|COMPLETED|Overall Study||72
9853479|NCT00887224|10966473|FG001|STARTED|Between OLS and DB Phases||0
9853480|NCT00887224|10966474|FG002|STARTED|Between OLS and DB Phases||0
9853481|NCT00887224|10966472|FG000|COMPLETED|Between OLS and DB Phases||548
9853482|NCT00887224|10966473|FG001|COMPLETED|Between OLS and DB Phases||0
9853483|NCT00887224|10966474|FG002|COMPLETED|Between OLS and DB Phases||0
9853484|NCT00887224|10966472|FG000|NOT COMPLETED|Between OLS and DB Phases||28
9748229|NCT00303472|10850574|FG001|STARTED|Treatment Extension (Optional)||11
9748230|NCT00303472|10850575|FG002|STARTED|Treatment Extension (Optional)||11
9748231|NCT00303472|10850576|FG003|STARTED|Treatment Extension (Optional)||13
9748232|NCT00303472|10850577|FG004|STARTED|Treatment Extension (Optional)||5
9748233|NCT00303472|10850578|FG005|STARTED|Treatment Extension (Optional)||5
9748234|NCT00303472|10850579|FG006|STARTED|Treatment Extension (Optional)||1
9748235|NCT00303472|10850573|FG000|COMPLETED|Treatment Extension (Optional)||1
9748236|NCT00303472|10850574|FG001|COMPLETED|Treatment Extension (Optional)||5
9748237|NCT00303472|10850575|FG002|COMPLETED|Treatment Extension (Optional)||2
9748238|NCT00303472|10850576|FG003|COMPLETED|Treatment Extension (Optional)||5
9748239|NCT00303472|10850577|FG004|COMPLETED|Treatment Extension (Optional)||1
9748240|NCT00303472|10850578|FG005|COMPLETED|Treatment Extension (Optional)||4
9748241|NCT00303472|10850579|FG006|COMPLETED|Treatment Extension (Optional)||1
9748242|NCT00303472|10850573|FG000|NOT COMPLETED|Treatment Extension (Optional)||5
9748243|NCT00303472|10850574|FG001|NOT COMPLETED|Treatment Extension (Optional)||6
9748244|NCT00303472|10850575|FG002|NOT COMPLETED|Treatment Extension (Optional)||9
9748245|NCT00303472|10850576|FG003|NOT COMPLETED|Treatment Extension (Optional)||8
9748246|NCT00303472|10850577|FG004|NOT COMPLETED|Treatment Extension (Optional)||4
9748247|NCT00303472|10850578|FG005|NOT COMPLETED|Treatment Extension (Optional)||1
9748248|NCT00303472|10850579|FG006|NOT COMPLETED|Treatment Extension (Optional)||0
9748249|NCT00303485|10850597|FG000|STARTED|Overall Study||49
9748250|NCT00303485|10850598|FG001|STARTED|Overall Study||17
9748251|NCT00303485|10850597|FG000|COMPLETED|Overall Study||48
9748252|NCT00303485|10850598|FG001|COMPLETED|Overall Study||15
9748253|NCT00303485|10850597|FG000|NOT COMPLETED|Overall Study||1
9748254|NCT00303485|10850598|FG001|NOT COMPLETED|Overall Study||2
9748255|NCT00303511|10850604|FG000|STARTED|Overall Study||10
9853485|NCT00887224|10966473|FG001|NOT COMPLETED|Between OLS and DB Phases||0
9853486|NCT00887224|10966474|FG002|NOT COMPLETED|Between OLS and DB Phases||0
9853487|NCT00887224|10966472|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
9853488|NCT00887224|10966473|FG001|STARTED|OL Taper Phase / OL Follow Up||0
9853489|NCT00887224|10966474|FG002|STARTED|OL Taper Phase / OL Follow Up||0
9853490|NCT00887224|10966472|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
9853491|NCT00887224|10966473|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
9748256|NCT00303511|10850604|FG000|COMPLETED|Overall Study||10
9748257|NCT00303511|10850604|FG000|NOT COMPLETED|Overall Study||0
9748258|NCT00303602|10850610|FG000|STARTED|Overall Study||84
9748259|NCT00303602|10850611|FG001|STARTED|Overall Study||65
9748260|NCT00303602|10850610|FG000|COMPLETED|Overall Study||65
9748261|NCT00303602|10850611|FG001|COMPLETED|Overall Study||50
9748262|NCT00303602|10850610|FG000|NOT COMPLETED|Overall Study||19
9748263|NCT00303602|10850611|FG001|NOT COMPLETED|Overall Study||15
9748264|NCT00303628|10850619|FG000|STARTED|Overall Study||176
9748265|NCT00303628|10850620|FG001|STARTED|Overall Study||179
9748266|NCT00303628|10850619|FG000|Eligible|Overall Study||171
9748267|NCT00303628|10850620|FG001|Eligible|Overall Study||177
9748268|NCT00303628|10850619|FG000|Treated|Overall Study||173
9748269|NCT00303628|10850620|FG001|Treated|Overall Study||174
9748270|NCT00303628|10850619|FG000|COMPLETED|Overall Study||126
9748271|NCT00303628|10850620|FG001|COMPLETED|Overall Study||106
9748272|NCT00303628|10850619|FG000|NOT COMPLETED|Overall Study||50
9748273|NCT00303628|10850620|FG001|NOT COMPLETED|Overall Study||73
9748274|NCT00303667|10850628|FG000|STARTED|Overall Study||8
9748275|NCT00303667|10850629|FG001|STARTED|Overall Study||39
9748276|NCT00303667|10850628|FG000|COMPLETED|Overall Study||8
9748277|NCT00303667|10850629|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
9748278|NCT00303667|10850628|FG000|NOT COMPLETED|Overall Study||0
9748279|NCT00303667|10850629|FG001|NOT COMPLETED|Overall Study||4
9748280|NCT00303719|10850637|FG000|STARTED|Overall Study||13
9748281|NCT00303719|10850638|FG001|STARTED|Overall Study||329
9748282|NCT00303719|10850637|FG000|COMPLETED|Overall Study||13
9748283|NCT00303719|10850638|FG001|COMPLETED|Overall Study||292
9748284|NCT00303719|10850637|FG000|NOT COMPLETED|Overall Study||0
9748285|NCT00303719|10850638|FG001|NOT COMPLETED|Overall Study||37
9748286|NCT00303823|10850647|FG000|STARTED|Overall Study||50
9748287|NCT00303823|10850648|FG001|STARTED|Overall Study||48
9748288|NCT00303823|10850647|FG000|COMPLETED|Overall Study||35
9748289|NCT00303823|10850648|FG001|COMPLETED|Overall Study||38
9748290|NCT00303823|10850647|FG000|NOT COMPLETED|Overall Study||15
9748291|NCT00303823|10850648|FG001|NOT COMPLETED|Overall Study||10
9748292|NCT00303862|10850654|FG000|STARTED|Overall Study||10
9748293|NCT00303862|10850654|FG000|COMPLETED|Overall Study||10
9748294|NCT00303862|10850654|FG000|NOT COMPLETED|Overall Study||0
9748295|NCT00303901|10850658|FG000|STARTED|Overall Study||40
9748296|NCT00303901|10850658|FG000|COMPLETED|Overall Study||40
9748297|NCT00303901|10850658|FG000|NOT COMPLETED|Overall Study||0
9748298|NCT00303953|10850662|FG000|STARTED|Overall Study||22
9748299|NCT00303953|10850662|FG000|Eligible|Overall Study||21
9748300|NCT00303953|10850662|FG000|Eligible and Treated|Overall Study||20
9748301|NCT00303953|10850662|FG000|COMPLETED|Overall Study||3
9748302|NCT00303953|10850662|FG000|NOT COMPLETED|Overall Study||19
9748303|NCT00303966|10850666|FG000|STARTED|Overall Study||5
9748304|NCT00303966|10850666|FG000|COMPLETED|Overall Study||5
9748305|NCT00303966|10850666|FG000|NOT COMPLETED|Overall Study||0
9748306|NCT00303979|10850673|FG000|STARTED|Overall Study|at baseline|15177
9748307|NCT00303979|10850674|FG001|STARTED|Overall Study|at 6 months|9992
9748308|NCT00303979|10850675|FG002|STARTED|Overall Study|at 18 months|9641
9748309|NCT00303979|10850673|FG000|COMPLETED|Overall Study|at 24 Months|7605
9748310|NCT00303979|10850674|FG001|COMPLETED|Overall Study|at 6 months|9992
9748311|NCT00303979|10850675|FG002|COMPLETED|Overall Study|at 18 months|9641
9748312|NCT00303979|10850673|FG000|NOT COMPLETED|Overall Study||7572
9748313|NCT00303979|10850674|FG001|NOT COMPLETED|Overall Study||0
9748314|NCT00303979|10850675|FG002|NOT COMPLETED|Overall Study||0
9748315|NCT00304031|10850695|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
9748316|NCT00304031|10850696|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
9748317|NCT00304031|10850697|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
9748318|NCT00304031|10850695|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
9748319|NCT00304031|10850696|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
9748320|NCT00304031|10850697|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
9748321|NCT00304031|10850695|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
9748322|NCT00304031|10850696|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
9748323|NCT00304031|10850697|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
9748324|NCT00304031|10850695|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
9748325|NCT00304031|10850696|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
9748326|NCT00304031|10850697|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
9748327|NCT00304031|10850695|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
9748328|NCT00304031|10850696|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
9748329|NCT00304031|10850697|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
9748330|NCT00304031|10850695|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0
9748331|NCT00304031|10850696|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411
9748332|NCT00304031|10850697|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422
9748333|NCT00304031|10850695|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0
9748334|NCT00304031|10850696|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411
9748335|NCT00304031|10850697|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420
9748336|NCT00304031|10850695|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
9748337|NCT00304031|10850696|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
9748338|NCT00304031|10850697|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
9748339|NCT00304031|10850695|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
9748340|NCT00304031|10850696|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
9748341|NCT00304031|10850697|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
9748342|NCT00304031|10850695|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
9748343|NCT00304031|10850696|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
9748344|NCT00304031|10850697|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
9748345|NCT00304031|10850695|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0
9748346|NCT00304031|10850696|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
9748347|NCT00304031|10850697|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
9748348|NCT00304031|10850695|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
9748349|NCT00304031|10850696|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
9748350|NCT00304031|10850697|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
9748351|NCT00304083|10850714|FG000|STARTED|Overall Study||34
9748352|NCT00304083|10850715|FG001|STARTED|Overall Study||14
9748353|NCT00304083|10850714|FG000|Completed 4 Cycles|Overall Study||22
9748354|NCT00304083|10850715|FG001|Completed 4 Cycles|Overall Study||7
9748355|NCT00304083|10850714|FG000|Patients Treated With Surgery|Overall Study||7
9748356|NCT00304083|10850715|FG001|Patients Treated With Surgery|Overall Study||3
9748357|NCT00304083|10850714|FG000|Patients Treated With Surgery and RT|Overall Study||5
9748358|NCT00304083|10850715|FG001|Patients Treated With Surgery and RT|Overall Study||1
9748359|NCT00304083|10850714|FG000|Patients Treated With RT Only|Overall Study||4
9748360|NCT00304083|10850715|FG001|Patients Treated With RT Only|Overall Study||2
9748361|NCT00304083|10850714|FG000|Patients Had Neither RT or Surgery|Overall Study||6
9748362|NCT00304083|10850715|FG001|Patients Had Neither RT or Surgery|Overall Study||1
9748363|NCT00304083|10850714|FG000|COMPLETED|Overall Study||12
9748364|NCT00304083|10850715|FG001|COMPLETED|Overall Study||6
9748365|NCT00304083|10850714|FG000|NOT COMPLETED|Overall Study||22
9748366|NCT00304083|10850715|FG001|NOT COMPLETED|Overall Study||8
9748367|NCT00304096|10850723|FG000|STARTED|Overall Study||6
9748368|NCT00304096|10850724|FG001|STARTED|Overall Study||5
9748369|NCT00304096|10850723|FG000|COMPLETED|Overall Study||6
9748370|NCT00304096|10850724|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
9748371|NCT00304096|10850723|FG000|NOT COMPLETED|Overall Study||0
9748372|NCT00304096|10850724|FG001|NOT COMPLETED|Overall Study||0
9748373|NCT00304161|10850732|FG000|STARTED|Overall Study||28
9748374|NCT00304161|10850733|FG001|STARTED|Overall Study||27
9748375|NCT00304161|10850732|FG000|COMPLETED|Overall Study||22
9748376|NCT00304161|10850733|FG001|COMPLETED|Overall Study||21
9748377|NCT00304161|10850732|FG000|NOT COMPLETED|Overall Study||6
9748378|NCT00304161|10850733|FG001|NOT COMPLETED|Overall Study||6
9748379|NCT00304187|10850741|FG000|STARTED|Overall Study||15
9748380|NCT00304187|10850742|FG001|STARTED|Overall Study||14
9748381|NCT00304187|10850741|FG000|COMPLETED|Overall Study||13
9748382|NCT00304187|10850742|FG001|COMPLETED|Overall Study||13
9748383|NCT00304187|10850741|FG000|NOT COMPLETED|Overall Study||2
9748384|NCT00304187|10850742|FG001|NOT COMPLETED|Overall Study||1
9748385|NCT00304265|10850752|FG000|STARTED|Overall Study||117
9748386|NCT00304265|10850753|FG001|STARTED|Overall Study||98
9748387|NCT00304265|10850752|FG000|COMPLETED|Overall Study||117
9748388|NCT00304265|10850753|FG001|COMPLETED|Overall Study||98
9748389|NCT00304265|10850752|FG000|NOT COMPLETED|Overall Study||0
9748390|NCT00304265|10850753|FG001|NOT COMPLETED|Overall Study||0
9748391|NCT00304278|10850759|FG000|STARTED|Overall Study||21
9748392|NCT00304278|10850759|FG000|COMPLETED|Overall Study||19
9748393|NCT00304278|10850759|FG000|NOT COMPLETED|Overall Study||2
9748394|NCT00304356|10850763|FG000|STARTED|Nitazoxanide||27
9748395|NCT00304356|10850763|FG000|COMPLETED|Nitazoxanide||22
9748396|NCT00304356|10850763|FG000|NOT COMPLETED|Nitazoxanide||5
9748397|NCT00304356|10850763|FG000|STARTED|Nitazoxanide||27
9748398|NCT00304356|10850763|FG000|COMPLETED|Nitazoxanide||22
9748399|NCT00304356|10850763|FG000|NOT COMPLETED|Nitazoxanide||5
9748400|NCT00304512|10850770|FG000|STARTED|Treatment Period||2
9748401|NCT00304512|10850771|FG001|STARTED|Treatment Period||4
9748402|NCT00304512|10850772|FG002|STARTED|Treatment Period||3
9748403|NCT00304512|10850770|FG000|Safety Population|Treatment Period||2
9748404|NCT00304512|10850771|FG001|Safety Population|Treatment Period||4
9748405|NCT00304512|10850772|FG002|Safety Population|Treatment Period||3
9748406|NCT00304512|10850770|FG000|Pharmacokinetic (PK) Population|Treatment Period||2
9748407|NCT00304512|10850771|FG001|Pharmacokinetic (PK) Population|Treatment Period||4
9748408|NCT00304512|10850772|FG002|Pharmacokinetic (PK) Population|Treatment Period||3
9748409|NCT00304512|10850770|FG000|Pharmacodynamic (PD) Population|Treatment Period||2
9748410|NCT00304512|10850771|FG001|Pharmacodynamic (PD) Population|Treatment Period||4
9748411|NCT00304512|10850772|FG002|Pharmacodynamic (PD) Population|Treatment Period||3
9748412|NCT00304512|10850770|FG000|COMPLETED|Treatment Period||2
9748413|NCT00304512|10850771|FG001|COMPLETED|Treatment Period||4
9748414|NCT00304512|10850772|FG002|COMPLETED|Treatment Period||3
9748415|NCT00304512|10850770|FG000|NOT COMPLETED|Treatment Period||0
9748416|NCT00304512|10850771|FG001|NOT COMPLETED|Treatment Period||0
9748417|NCT00304512|10850772|FG002|NOT COMPLETED|Treatment Period||0
9748418|NCT00304512|10850770|FG000|STARTED|Extension Period||2
9748419|NCT00304512|10850771|FG001|STARTED|Extension Period||4
9748420|NCT00304512|10850772|FG002|STARTED|Extension Period||3
9748421|NCT00304512|10850770|FG000|COMPLETED|Extension Period||2
9748422|NCT00304512|10850771|FG001|COMPLETED|Extension Period||4
9853492|NCT00887224|10966474|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
9853493|NCT00887224|10966472|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163
9853494|NCT00887224|10966473|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0
9853495|NCT00887224|10966474|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0
9853496|NCT00887224|10966472|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
9853497|NCT00887224|10966473|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
9853498|NCT00887224|10966474|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
9853499|NCT00887224|10966472|FG000|STARTED|Double-blind (DB) Phase||0
9853500|NCT00887224|10966473|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
9853501|NCT00887224|10966474|FG002|STARTED|Double-blind (DB) Phase||272
9853502|NCT00887224|10966472|FG000|COMPLETED|Double-blind (DB) Phase||0
9853503|NCT00887224|10966473|FG001|COMPLETED|Double-blind (DB) Phase||176
9853504|NCT00887224|10966474|FG002|COMPLETED|Double-blind (DB) Phase||210
9853505|NCT00887224|10966472|FG000|NOT COMPLETED|Double-blind (DB) Phase||0
9853506|NCT00887224|10966473|FG001|NOT COMPLETED|Double-blind (DB) Phase||100
9748423|NCT00304512|10850772|FG002|COMPLETED|Extension Period||3
9748424|NCT00304512|10850770|FG000|NOT COMPLETED|Extension Period||0
9748425|NCT00304512|10850771|FG001|NOT COMPLETED|Extension Period||0
9748426|NCT00304512|10850772|FG002|NOT COMPLETED|Extension Period||0
9748427|NCT00304707|10850782|FG000|STARTED|Overall Study||73
9748428|NCT00304707|10850783|FG001|STARTED|Overall Study||70
9748429|NCT00304707|10850782|FG000|COMPLETED|Overall Study||66
9748430|NCT00304707|10850783|FG001|COMPLETED|Overall Study||64
9748431|NCT00304707|10850782|FG000|NOT COMPLETED|Overall Study||7
9748432|NCT00304707|10850783|FG001|NOT COMPLETED|Overall Study||6
9748433|NCT00304746|10850791|FG000|STARTED|Overall Study||50
9748434|NCT00304746|10850792|FG001|STARTED|Overall Study||50
9748435|NCT00304746|10850791|FG000|COMPLETED|Overall Study||50
9748436|NCT00304746|10850792|FG001|COMPLETED|Overall Study||50
9748437|NCT00304746|10850791|FG000|NOT COMPLETED|Overall Study||0
9748438|NCT00304746|10850792|FG001|NOT COMPLETED|Overall Study||0
9828624|NCT00757601|10939418|FG000|COMPLETED|Period 1||2
9828625|NCT00757601|10939419|FG001|COMPLETED|Period 1||2
9828626|NCT00757601|10939420|FG002|COMPLETED|Period 1||2
9828627|NCT00757601|10939421|FG003|COMPLETED|Period 1||2
9828628|NCT00757601|10939422|FG004|COMPLETED|Period 1||2
9853507|NCT00887224|10966474|FG002|NOT COMPLETED|Double-blind (DB) Phase||62
9853508|NCT00887224|10966472|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0
9853509|NCT00887224|10966473|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
9853510|NCT00887224|10966474|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265
9853511|NCT00887224|10966472|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
9853512|NCT00887224|10966473|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
9853513|NCT00887224|10966474|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
9853514|NCT00887224|10966472|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
9853515|NCT00887224|10966473|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
10092014|NCT02332824|11220278|FG003|COMPLETED|Overall Study||66
10092015|NCT02332824|11220279|FG004|COMPLETED|Overall Study||65
10092016|NCT02332824|11220280|FG005|COMPLETED|Overall Study||69
10092017|NCT02332824|11220275|FG000|NOT COMPLETED|Overall Study||6
10092018|NCT02332824|11220276|FG001|NOT COMPLETED|Overall Study||1
10092019|NCT02332824|11220277|FG002|NOT COMPLETED|Overall Study||2
10092020|NCT02332824|11220278|FG003|NOT COMPLETED|Overall Study||2
9828629|NCT00757601|10939423|FG005|COMPLETED|Period 1||2
9828630|NCT00757601|10939424|FG006|COMPLETED|Period 1||2
9828631|NCT00757601|10939425|FG007|COMPLETED|Period 1||2
9828632|NCT00757601|10939426|FG008|COMPLETED|Period 1||2
9828633|NCT00757601|10939427|FG009|COMPLETED|Period 1||2
9828634|NCT00757601|10939428|FG010|COMPLETED|Period 1||2
9828635|NCT00757601|10939429|FG011|COMPLETED|Period 1||3
9828636|NCT00757601|10939418|FG000|NOT COMPLETED|Period 1||0
9828637|NCT00757601|10939419|FG001|NOT COMPLETED|Period 1||0
9828638|NCT00757601|10939420|FG002|NOT COMPLETED|Period 1||0
9828639|NCT00757601|10939421|FG003|NOT COMPLETED|Period 1||0
9828640|NCT00757601|10939422|FG004|NOT COMPLETED|Period 1||0
9828641|NCT00757601|10939423|FG005|NOT COMPLETED|Period 1||0
9828642|NCT00757601|10939424|FG006|NOT COMPLETED|Period 1||0
9828643|NCT00757601|10939425|FG007|NOT COMPLETED|Period 1||0
9828644|NCT00757601|10939426|FG008|NOT COMPLETED|Period 1||0
9828645|NCT00757601|10939427|FG009|NOT COMPLETED|Period 1||0
9828646|NCT00757601|10939428|FG010|NOT COMPLETED|Period 1||0
9828647|NCT00757601|10939429|FG011|NOT COMPLETED|Period 1||0
9828648|NCT00757601|10939418|FG000|STARTED|Period 2||2
9828649|NCT00757601|10939419|FG001|STARTED|Period 2||2
9828650|NCT00757601|10939420|FG002|STARTED|Period 2||2
9828651|NCT00757601|10939421|FG003|STARTED|Period 2||2
9828652|NCT00757601|10939422|FG004|STARTED|Period 2||2
9828653|NCT00757601|10939423|FG005|STARTED|Period 2||2
9828654|NCT00757601|10939424|FG006|STARTED|Period 2||2
9828655|NCT00757601|10939425|FG007|STARTED|Period 2||2
9828656|NCT00757601|10939426|FG008|STARTED|Period 2||2
9828657|NCT00757601|10939427|FG009|STARTED|Period 2||2
9828658|NCT00757601|10939428|FG010|STARTED|Period 2||2
9828659|NCT00757601|10939429|FG011|STARTED|Period 2||3
9828660|NCT00757601|10939418|FG000|COMPLETED|Period 2||2
9828661|NCT00757601|10939419|FG001|COMPLETED|Period 2||2
9828662|NCT00757601|10939420|FG002|COMPLETED|Period 2||2
9828663|NCT00757601|10939421|FG003|COMPLETED|Period 2||2
9828664|NCT00757601|10939422|FG004|COMPLETED|Period 2||2
9828665|NCT00757601|10939423|FG005|COMPLETED|Period 2||2
9828666|NCT00757601|10939424|FG006|COMPLETED|Period 2||2
9828667|NCT00757601|10939425|FG007|COMPLETED|Period 2||2
9828668|NCT00757601|10939426|FG008|COMPLETED|Period 2||2
9828669|NCT00757601|10939427|FG009|COMPLETED|Period 2||2
9828670|NCT00757601|10939428|FG010|COMPLETED|Period 2||2
9828671|NCT00757601|10939429|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
9828672|NCT00757601|10939418|FG000|NOT COMPLETED|Period 2||0
9828673|NCT00757601|10939419|FG001|NOT COMPLETED|Period 2||0
9828674|NCT00757601|10939420|FG002|NOT COMPLETED|Period 2||0
9828675|NCT00757601|10939421|FG003|NOT COMPLETED|Period 2||0
9828676|NCT00757601|10939422|FG004|NOT COMPLETED|Period 2||0
9828677|NCT00757601|10939423|FG005|NOT COMPLETED|Period 2||0
9828678|NCT00757601|10939424|FG006|NOT COMPLETED|Period 2||0
9828679|NCT00757601|10939425|FG007|NOT COMPLETED|Period 2||0
10092021|NCT02332824|11220279|FG004|NOT COMPLETED|Overall Study||4
10092022|NCT02332824|11220280|FG005|NOT COMPLETED|Overall Study||1
10092023|NCT02332863|11220296|FG000|STARTED|Overall Study||22
9828680|NCT00757601|10939426|FG008|NOT COMPLETED|Period 2||0
9828681|NCT00757601|10939427|FG009|NOT COMPLETED|Period 2||0
9828682|NCT00757601|10939428|FG010|NOT COMPLETED|Period 2||0
9828683|NCT00757601|10939429|FG011|NOT COMPLETED|Period 2||1
9828684|NCT00757601|10939418|FG000|STARTED|Period 3||2
9828685|NCT00757601|10939419|FG001|STARTED|Period 3||2
9828686|NCT00757601|10939420|FG002|STARTED|Period 3||2
9828687|NCT00757601|10939421|FG003|STARTED|Period 3||2
9828688|NCT00757601|10939422|FG004|STARTED|Period 3||2
9828689|NCT00757601|10939423|FG005|STARTED|Period 3||2
9828690|NCT00757601|10939424|FG006|STARTED|Period 3||2
9828691|NCT00757601|10939425|FG007|STARTED|Period 3||2
9828692|NCT00757601|10939426|FG008|STARTED|Period 3||2
9748439|NCT04721171|10850800|FG000|STARTED|Overall Study||2
9748440|NCT04721171|10850801|FG001|STARTED|Overall Study||2
10092024|NCT02332863|11220297|FG001|STARTED|Overall Study||22
9853516|NCT00887224|10966474|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
9853517|NCT00887224|10966472|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0
9853518|NCT00887224|10966473|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226
9853519|NCT00887224|10966474|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235
9853520|NCT00887224|10966472|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
9853521|NCT00887224|10966473|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
9853522|NCT00887224|10966474|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
9853523|NCT00887289|10966486|FG000|STARTED|Overall Study||1504
9853524|NCT00887289|10966486|FG000|COMPLETED|Overall Study||1409
9853525|NCT00887289|10966486|FG000|NOT COMPLETED|Overall Study||95
9853526|NCT00887341|10966492|FG000|STARTED|Overall Study||37
9853527|NCT00887341|10966493|FG001|STARTED|Overall Study||39
9853528|NCT00887341|10966492|FG000|COMPLETED|Overall Study||35
9853529|NCT00887341|10966493|FG001|COMPLETED|Overall Study||36
9853530|NCT00887341|10966492|FG000|NOT COMPLETED|Overall Study||2
9853531|NCT00887341|10966493|FG001|NOT COMPLETED|Overall Study||3
9853532|NCT00887354|10966501|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111
9853533|NCT00887354|10966502|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113
9853534|NCT00887354|10966501|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
9853535|NCT00887354|10966502|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
9748441|NCT04721171|10850800|FG000|COMPLETED|Overall Study||2
9748442|NCT04721171|10850801|FG001|COMPLETED|Overall Study||2
9748443|NCT04721171|10850800|FG000|NOT COMPLETED|Overall Study||0
9748444|NCT04721171|10850801|FG001|NOT COMPLETED|Overall Study||0
9748445|NCT04717323|10850811|FG000|STARTED|Overall Study||0
9748446|NCT04717323|10850812|FG001|STARTED|Overall Study||10
9748447|NCT04717323|10850811|FG000|COMPLETED|Overall Study||0
9748448|NCT04717323|10850812|FG001|COMPLETED|Overall Study||10
9748449|NCT04717323|10850811|FG000|NOT COMPLETED|Overall Study||0
9748450|NCT04717323|10850812|FG001|NOT COMPLETED|Overall Study||0
9748451|NCT04511338|10850820|FG000|STARTED|Period 1||8
9748452|NCT04511338|10850821|FG001|STARTED|Period 1||8
9748453|NCT04511338|10850820|FG000|COMPLETED|Period 1||7
9748454|NCT04511338|10850821|FG001|COMPLETED|Period 1||8
9748455|NCT04511338|10850820|FG000|NOT COMPLETED|Period 1||1
9748456|NCT04511338|10850821|FG001|NOT COMPLETED|Period 1||0
9748457|NCT04511338|10850820|FG000|STARTED|Washout|"We followed the rules in protocol (brief version in SARP sec. 3.1) to withdraw or move subjects to the next period.~Period 1:~Dialyzer with Endexo has grade 4 clotting, subjects is withdrawn from the study~CombiSet with grade 4 clotting only (not the dialyzer): subjects end Period 1, move to Washout, and then Period 2~There was a subject with CombiSet bloodline grade 4 clotting in the 50% heparin reduction HD. The subject was moved to washout period without any heparin free sessions."|8
9748458|NCT04511338|10850821|FG001|STARTED|Washout||8
9748459|NCT04511338|10850820|FG000|COMPLETED|Washout||8
9748460|NCT04511338|10850821|FG001|COMPLETED|Washout||8
9748461|NCT04511338|10850820|FG000|NOT COMPLETED|Washout||0
9748462|NCT04511338|10850821|FG001|NOT COMPLETED|Washout||0
9748463|NCT04511338|10850820|FG000|STARTED|Period 2||8
9748464|NCT04511338|10850821|FG001|STARTED|Period 2||8
9748465|NCT04511338|10850820|FG000|COMPLETED|Period 2||8
9748466|NCT04511338|10850821|FG001|COMPLETED|Period 2||5
9748467|NCT04511338|10850820|FG000|NOT COMPLETED|Period 2||0
9748468|NCT04511338|10850821|FG001|NOT COMPLETED|Period 2||3
9748469|NCT04496414|10850827|FG000|STARTED|Overall Study||50
9748470|NCT04496414|10850827|FG000|COMPLETED|Overall Study||50
9748471|NCT04496414|10850827|FG000|NOT COMPLETED|Overall Study||0
9748472|NCT04493931|10850838|FG000|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||14
9748473|NCT04493931|10850839|FG001|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748474|NCT04493931|10850840|FG002|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748475|NCT04493931|10850841|FG003|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748476|NCT04493931|10850842|FG004|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748477|NCT04493931|10850843|FG005|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748478|NCT04493931|10850844|FG006|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748479|NCT04493931|10850838|FG000|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||13
9748480|NCT04493931|10850839|FG001|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748481|NCT04493931|10850840|FG002|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748482|NCT04493931|10850841|FG003|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748483|NCT04493931|10850842|FG004|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748484|NCT04493931|10850843|FG005|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748485|NCT04493931|10850844|FG006|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748486|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||1
9748487|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748488|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9853536|NCT00887354|10966501|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
9853537|NCT00887354|10966502|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
9853538|NCT00887354|10966501|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
9853539|NCT00887354|10966502|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
9748489|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748490|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748491|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748492|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
9748493|NCT04493931|10850838|FG000|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
9748494|NCT04493931|10850839|FG001|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748495|NCT04493931|10850840|FG002|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748496|NCT04493931|10850841|FG003|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748497|NCT04493931|10850842|FG004|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748498|NCT04493931|10850843|FG005|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748499|NCT04493931|10850844|FG006|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748500|NCT04493931|10850838|FG000|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
9748501|NCT04493931|10850839|FG001|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748502|NCT04493931|10850840|FG002|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748503|NCT04493931|10850841|FG003|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748504|NCT04493931|10850842|FG004|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748505|NCT04493931|10850843|FG005|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748506|NCT04493931|10850844|FG006|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9853540|NCT00887354|10966501|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
9853541|NCT00887354|10966502|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
9853542|NCT00887354|10966501|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60
9853543|NCT00887354|10966502|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65
9853544|NCT00887354|10966501|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
9853545|NCT00887354|10966502|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
9853546|NCT00887354|10966501|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
9853547|NCT00887354|10966502|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
9853548|NCT00887432|10966511|FG000|STARTED|Overall Study||58
9853549|NCT00887432|10966512|FG001|STARTED|Overall Study||74
9853550|NCT00887432|10966511|FG000|COMPLETED|Overall Study||43
9853551|NCT00887432|10966512|FG001|COMPLETED|Overall Study||60
9853552|NCT00887432|10966511|FG000|NOT COMPLETED|Overall Study||15
9853553|NCT00887432|10966512|FG001|NOT COMPLETED|Overall Study||14
9853554|NCT00887458|10966520|FG000|STARTED|Overall Study||17
9853555|NCT00887458|10966521|FG001|STARTED|Overall Study||29
9853556|NCT00887458|10966520|FG000|COMPLETED|Overall Study||17
9853557|NCT00887458|10966521|FG001|COMPLETED|Overall Study||25
9748507|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748508|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748509|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748510|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748511|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748512|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748513|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
9748514|NCT04493931|10850838|FG000|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||13
9748515|NCT04493931|10850839|FG001|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748516|NCT04493931|10850840|FG002|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748517|NCT04493931|10850841|FG003|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748518|NCT04493931|10850842|FG004|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748519|NCT04493931|10850843|FG005|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748520|NCT04493931|10850844|FG006|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748521|NCT04493931|10850838|FG000|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||13
9748522|NCT04493931|10850839|FG001|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748523|NCT04493931|10850840|FG002|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748524|NCT04493931|10850841|FG003|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748525|NCT04493931|10850842|FG004|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748526|NCT04493931|10850843|FG005|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748527|NCT04493931|10850844|FG006|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748528|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748529|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748530|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748531|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748532|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748533|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748534|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
9748535|NCT04493931|10850838|FG000|STARTED|Cohort 1: Follow-up (Up to 7 Days)||13
9748536|NCT04493931|10850839|FG001|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
9748537|NCT04493931|10850840|FG002|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
9748538|NCT04493931|10850841|FG003|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
9748539|NCT04493931|10850842|FG004|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
9748540|NCT04493931|10850843|FG005|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
9748541|NCT04493931|10850844|FG006|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
9748542|NCT04493931|10850838|FG000|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||13
9748543|NCT04493931|10850839|FG001|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9853558|NCT00887458|10966520|FG000|NOT COMPLETED|Overall Study||0
9853559|NCT00887458|10966521|FG001|NOT COMPLETED|Overall Study||4
9853560|NCT00887471|10966531|FG000|STARTED|Overall Study||15
9853561|NCT00887471|10966532|FG001|STARTED|Overall Study||15
9748544|NCT04493931|10850840|FG002|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748545|NCT04493931|10850841|FG003|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748546|NCT04493931|10850842|FG004|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748547|NCT04493931|10850843|FG005|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748548|NCT04493931|10850844|FG006|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748549|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748550|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748551|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748552|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748553|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748554|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748555|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
9748556|NCT04493931|10850838|FG000|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748557|NCT04493931|10850839|FG001|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||17
9748558|NCT04493931|10850840|FG002|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748559|NCT04493931|10850841|FG003|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748560|NCT04493931|10850842|FG004|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748561|NCT04493931|10850843|FG005|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748562|NCT04493931|10850844|FG006|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748563|NCT04493931|10850838|FG000|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748564|NCT04493931|10850839|FG001|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||17
9748565|NCT04493931|10850840|FG002|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748566|NCT04493931|10850841|FG003|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748567|NCT04493931|10850842|FG004|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748568|NCT04493931|10850843|FG005|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748569|NCT04493931|10850844|FG006|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748570|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748571|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748572|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748573|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748574|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748575|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748576|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
9748577|NCT04493931|10850838|FG000|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9853562|NCT00887471|10966531|FG000|COMPLETED|Overall Study||15
9853563|NCT00887471|10966532|FG001|COMPLETED|Overall Study||15
9853564|NCT00887471|10966531|FG000|NOT COMPLETED|Overall Study||0
9853565|NCT00887471|10966532|FG001|NOT COMPLETED|Overall Study||0
9853566|NCT00887484|10966538|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48
10092025|NCT02332863|11220296|FG000|COMPLETED|Overall Study||22
9748578|NCT04493931|10850839|FG001|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||17
9748579|NCT04493931|10850840|FG002|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748580|NCT04493931|10850841|FG003|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748581|NCT04493931|10850842|FG004|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748582|NCT04493931|10850843|FG005|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748583|NCT04493931|10850844|FG006|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748584|NCT04493931|10850838|FG000|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748585|NCT04493931|10850839|FG001|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||17
9748586|NCT04493931|10850840|FG002|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748587|NCT04493931|10850841|FG003|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748588|NCT04493931|10850842|FG004|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748589|NCT04493931|10850843|FG005|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748590|NCT04493931|10850844|FG006|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748591|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10092026|NCT02332863|11220297|FG001|COMPLETED|Overall Study||22
10092027|NCT02332863|11220296|FG000|NOT COMPLETED|Overall Study||0
10092028|NCT02332863|11220297|FG001|NOT COMPLETED|Overall Study||0
10092029|NCT02332876|11220305|FG000|STARTED|Overall Study||43
9748592|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748593|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748594|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748595|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748596|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748597|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
9748598|NCT04493931|10850838|FG000|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748599|NCT04493931|10850839|FG001|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||17
9748600|NCT04493931|10850840|FG002|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748601|NCT04493931|10850841|FG003|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748602|NCT04493931|10850842|FG004|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748603|NCT04493931|10850843|FG005|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
9853567|NCT00887484|10966538|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
9853568|NCT00887484|10966538|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
9853569|NCT00887484|10966538|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48
10092030|NCT02332876|11220306|FG001|STARTED|Overall Study||44
10092031|NCT02332876|11220305|FG000|COMPLETED|Overall Study||42
9853570|NCT00887484|10966538|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
9853571|NCT00887484|10966538|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
9853572|NCT00887510|10966549|FG000|STARTED|Overall Study||12
9853573|NCT00887510|10966550|FG001|STARTED|Overall Study||12
9853574|NCT00887510|10966549|FG000|COMPLETED|Overall Study||12
10092032|NCT02332876|11220306|FG001|COMPLETED|Overall Study||43
10092033|NCT02332876|11220305|FG000|NOT COMPLETED|Overall Study||1
10092034|NCT02332876|11220306|FG001|NOT COMPLETED|Overall Study||1
10092035|NCT02332889|11220312|FG000|STARTED|Overall Study||1
10092036|NCT02332889|11220312|FG000|COMPLETED|Overall Study||0
9748604|NCT04493931|10850844|FG006|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748605|NCT04493931|10850838|FG000|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748606|NCT04493931|10850839|FG001|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||14
9748607|NCT04493931|10850840|FG002|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748608|NCT04493931|10850841|FG003|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748609|NCT04493931|10850842|FG004|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748610|NCT04493931|10850843|FG005|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748611|NCT04493931|10850844|FG006|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748612|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748613|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||3
9748614|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748615|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748616|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748617|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748618|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
9748619|NCT04493931|10850838|FG000|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
9748620|NCT04493931|10850839|FG001|STARTED|Cohort 2: Follow-up (Up to 10 Days)||14
9748621|NCT04493931|10850840|FG002|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
9748622|NCT04493931|10850841|FG003|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
9748623|NCT04493931|10850842|FG004|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
9748624|NCT04493931|10850843|FG005|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
9748625|NCT04493931|10850844|FG006|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
9748626|NCT04493931|10850838|FG000|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748627|NCT04493931|10850839|FG001|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||14
9748628|NCT04493931|10850840|FG002|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748629|NCT04493931|10850841|FG003|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748630|NCT04493931|10850842|FG004|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748631|NCT04493931|10850843|FG005|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748632|NCT04493931|10850844|FG006|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748633|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748634|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748635|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748636|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748637|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748638|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748639|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
9748640|NCT04493931|10850838|FG000|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748641|NCT04493931|10850839|FG001|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748642|NCT04493931|10850840|FG002|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||10
9748643|NCT04493931|10850841|FG003|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||9
9748644|NCT04493931|10850842|FG004|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748645|NCT04493931|10850843|FG005|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748646|NCT04493931|10850844|FG006|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748647|NCT04493931|10850838|FG000|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748648|NCT04493931|10850839|FG001|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748649|NCT04493931|10850840|FG002|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
9748650|NCT04493931|10850841|FG003|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
9748651|NCT04493931|10850842|FG004|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748652|NCT04493931|10850843|FG005|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748653|NCT04493931|10850844|FG006|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748654|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748655|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9853575|NCT00887510|10966550|FG001|COMPLETED|Overall Study||12
9853576|NCT00887510|10966549|FG000|NOT COMPLETED|Overall Study||0
9853577|NCT00887510|10966550|FG001|NOT COMPLETED|Overall Study||0
9853578|NCT00887549|10966556|FG000|STARTED|Induction Therapy||70
9853579|NCT00887549|10966556|FG000|COMPLETED|Induction Therapy||43
9853580|NCT00887549|10966556|FG000|NOT COMPLETED|Induction Therapy||27
10092037|NCT02332889|11220312|FG000|NOT COMPLETED|Overall Study||1
10092038|NCT02332902|11220316|FG000|STARTED|Overall Study||24
10092039|NCT02332902|11220316|FG000|COMPLETED|Overall Study||17
9853581|NCT00887549|10966556|FG000|STARTED|Maintenance Therapy||43
9853582|NCT00887549|10966556|FG000|COMPLETED|Maintenance Therapy||0
9853583|NCT00887549|10966556|FG000|NOT COMPLETED|Maintenance Therapy||43
9853584|NCT00887562|10966563|FG000|STARTED|Overall Study||10
10092040|NCT02332902|11220316|FG000|NOT COMPLETED|Overall Study||7
10092041|NCT02332915|11220322|FG000|STARTED|Overall Study||18
9748656|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||1
9748657|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748658|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748659|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748660|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
9748661|NCT04493931|10850838|FG000|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748662|NCT04493931|10850839|FG001|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748663|NCT04493931|10850840|FG002|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
9748664|NCT04493931|10850841|FG003|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
9748665|NCT04493931|10850842|FG004|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748666|NCT04493931|10850843|FG005|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748667|NCT04493931|10850844|FG006|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748668|NCT04493931|10850838|FG000|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748669|NCT04493931|10850839|FG001|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748670|NCT04493931|10850840|FG002|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
9748671|NCT04493931|10850841|FG003|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
9748672|NCT04493931|10850842|FG004|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748673|NCT04493931|10850843|FG005|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748674|NCT04493931|10850844|FG006|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748675|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748676|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748677|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748678|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748679|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748680|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748681|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
9748682|NCT04493931|10850838|FG000|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748683|NCT04493931|10850839|FG001|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748684|NCT04493931|10850840|FG002|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
9748685|NCT04493931|10850841|FG003|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
9748686|NCT04493931|10850842|FG004|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748687|NCT04493931|10850843|FG005|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748688|NCT04493931|10850844|FG006|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748689|NCT04493931|10850838|FG000|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748690|NCT04493931|10850839|FG001|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748691|NCT04493931|10850840|FG002|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
9748692|NCT04493931|10850841|FG003|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
9748693|NCT04493931|10850842|FG004|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748694|NCT04493931|10850843|FG005|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748695|NCT04493931|10850844|FG006|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748696|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748697|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748698|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748699|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748700|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748701|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748702|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
9748703|NCT04493931|10850838|FG000|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
9748704|NCT04493931|10850839|FG001|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
9748705|NCT04493931|10850840|FG002|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
9748706|NCT04493931|10850841|FG003|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
9748707|NCT04493931|10850842|FG004|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
9748708|NCT04493931|10850843|FG005|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
9748709|NCT04493931|10850844|FG006|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
9748710|NCT04493931|10850838|FG000|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748711|NCT04493931|10850839|FG001|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748712|NCT04493931|10850840|FG002|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
9748713|NCT04493931|10850841|FG003|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
9748714|NCT04493931|10850842|FG004|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748715|NCT04493931|10850843|FG005|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748716|NCT04493931|10850844|FG006|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748717|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748718|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748719|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748720|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748721|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748722|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748723|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
9748724|NCT04493931|10850838|FG000|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748725|NCT04493931|10850839|FG001|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748726|NCT04493931|10850840|FG002|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748727|NCT04493931|10850841|FG003|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748728|NCT04493931|10850842|FG004|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||6
9748729|NCT04493931|10850843|FG005|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||5
9748730|NCT04493931|10850844|FG006|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||3
9748731|NCT04493931|10850838|FG000|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748732|NCT04493931|10850839|FG001|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748733|NCT04493931|10850840|FG002|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748734|NCT04493931|10850841|FG003|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748735|NCT04493931|10850842|FG004|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||6
9748736|NCT04493931|10850843|FG005|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||5
9748737|NCT04493931|10850844|FG006|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||3
9748738|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748739|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10092042|NCT02332915|11220323|FG001|STARTED|Overall Study||18
10092043|NCT02332915|11220322|FG000|COMPLETED|Overall Study||12
10092044|NCT02332915|11220323|FG001|COMPLETED|Overall Study||12
10092045|NCT02332915|11220322|FG000|NOT COMPLETED|Overall Study||6
10092046|NCT02332915|11220323|FG001|NOT COMPLETED|Overall Study||6
10092047|NCT02333045|11220333|FG000|STARTED|Overall Study||1
10092048|NCT02333045|11220334|FG001|STARTED|Overall Study||3
10092049|NCT02333045|11220333|FG000|COMPLETED|Overall Study||1
10092050|NCT02333045|11220334|FG001|COMPLETED|Overall Study||3
10092051|NCT02333045|11220333|FG000|NOT COMPLETED|Overall Study||0
9748740|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748741|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748742|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748743|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748744|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
9748745|NCT04493931|10850838|FG000|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748746|NCT04493931|10850839|FG001|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748747|NCT04493931|10850840|FG002|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748748|NCT04493931|10850841|FG003|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748749|NCT04493931|10850842|FG004|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||6
9748750|NCT04493931|10850843|FG005|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||5
9748751|NCT04493931|10850844|FG006|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||3
9748752|NCT04493931|10850838|FG000|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748753|NCT04493931|10850839|FG001|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748754|NCT04493931|10850840|FG002|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748755|NCT04493931|10850841|FG003|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748756|NCT04493931|10850842|FG004|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||6
9748757|NCT04493931|10850843|FG005|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||5
9748758|NCT04493931|10850844|FG006|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||3
9748759|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748760|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748761|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748762|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748763|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748764|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748765|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
9748766|NCT04493931|10850838|FG000|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748767|NCT04493931|10850839|FG001|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748768|NCT04493931|10850840|FG002|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748769|NCT04493931|10850841|FG003|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748770|NCT04493931|10850842|FG004|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||6
9748771|NCT04493931|10850843|FG005|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||5
9748772|NCT04493931|10850844|FG006|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||3
9748773|NCT04493931|10850838|FG000|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748774|NCT04493931|10850839|FG001|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748775|NCT04493931|10850840|FG002|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748776|NCT04493931|10850841|FG003|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748777|NCT04493931|10850842|FG004|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||6
9748778|NCT04493931|10850843|FG005|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||5
9748779|NCT04493931|10850844|FG006|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||3
9748780|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748781|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748782|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748783|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748784|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748785|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748786|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
9748787|NCT04493931|10850838|FG000|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10092052|NCT02333045|11220334|FG001|NOT COMPLETED|Overall Study||0
10092053|NCT02333071|11220342|FG000|STARTED|Core Study||326
10092054|NCT02333071|11220343|FG001|STARTED|Core Study||327
10092055|NCT02333071|11220342|FG000|Received Intervention|Core Study||319
10092056|NCT02333071|11220343|FG001|Received Intervention|Core Study||324
9748788|NCT04493931|10850839|FG001|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748789|NCT04493931|10850840|FG002|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748790|NCT04493931|10850841|FG003|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748791|NCT04493931|10850842|FG004|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||6
9748792|NCT04493931|10850843|FG005|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||5
9748793|NCT04493931|10850844|FG006|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||3
9748794|NCT04493931|10850838|FG000|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748795|NCT04493931|10850839|FG001|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748796|NCT04493931|10850840|FG002|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748797|NCT04493931|10850841|FG003|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748798|NCT04493931|10850842|FG004|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||6
9748799|NCT04493931|10850843|FG005|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||5
9748800|NCT04493931|10850844|FG006|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||3
9748801|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748802|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748803|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748804|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748805|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748806|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748807|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
9748808|NCT04493931|10850838|FG000|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748809|NCT04493931|10850839|FG001|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748810|NCT04493931|10850840|FG002|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748811|NCT04493931|10850841|FG003|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748812|NCT04493931|10850842|FG004|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||6
9748813|NCT04493931|10850843|FG005|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||5
9748814|NCT04493931|10850844|FG006|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||3
9748815|NCT04493931|10850838|FG000|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748816|NCT04493931|10850839|FG001|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748817|NCT04493931|10850840|FG002|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748818|NCT04493931|10850841|FG003|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748819|NCT04493931|10850842|FG004|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||6
9748820|NCT04493931|10850843|FG005|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||5
9748821|NCT04493931|10850844|FG006|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||3
9748822|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748823|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748824|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748825|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748826|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748827|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748828|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
9748829|NCT04493931|10850838|FG000|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
9748830|NCT04493931|10850839|FG001|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
9748831|NCT04493931|10850840|FG002|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
9748832|NCT04493931|10850841|FG003|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
9748833|NCT04493931|10850842|FG004|STARTED|Cohort 4: Follow-up (Up to 7 Days)||6
9748834|NCT04493931|10850843|FG005|STARTED|Cohort 4: Follow-up (Up to 7 Days)||5
9748835|NCT04493931|10850844|FG006|STARTED|Cohort 4: Follow-up (Up to 7 Days)||3
9748836|NCT04493931|10850838|FG000|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748837|NCT04493931|10850839|FG001|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748838|NCT04493931|10850840|FG002|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748839|NCT04493931|10850841|FG003|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748840|NCT04493931|10850842|FG004|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||6
9748841|NCT04493931|10850843|FG005|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||5
9748842|NCT04493931|10850844|FG006|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||3
9748843|NCT04493931|10850838|FG000|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748844|NCT04493931|10850839|FG001|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748845|NCT04493931|10850840|FG002|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748846|NCT04493931|10850841|FG003|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748847|NCT04493931|10850842|FG004|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748848|NCT04493931|10850843|FG005|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748849|NCT04493931|10850844|FG006|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
9748850|NCT04428034|10850874|FG000|STARTED|Enrollment to Intervention Completion||45
9748851|NCT04428034|10850874|FG000|Attended at Least 2 Intervention Sessions in One Cohort|Enrollment to Intervention Completion|"Forty-five (45) participants enrolled and completed the baseline survey. Of those who completed they baseline survey, six participants of those who completed the baseline survey did not attend at least 2 sessions. Three participants started the intervention in one cohort, but completed in another (off-protocol). One participant was found to be a fraudulent case, identified through none-varying (straight line) responses to survey questions."|35
9748852|NCT04428034|10850874|FG000|COMPLETED|Enrollment to Intervention Completion||35
9748853|NCT04428034|10850874|FG000|NOT COMPLETED|Enrollment to Intervention Completion||10
9748854|NCT04428034|10850874|FG000|STARTED|4-Week Follow Up Survey||35
9748855|NCT04428034|10850874|FG000|COMPLETED|4-Week Follow Up Survey||29
9853585|NCT00887562|10966564|FG001|STARTED|Overall Study||9
9853586|NCT00887562|10966565|FG002|STARTED|Overall Study||8
9853587|NCT00887562|10966563|FG000|COMPLETED|Overall Study||7
9853588|NCT00887562|10966564|FG001|COMPLETED|Overall Study||7
9853589|NCT00887562|10966565|FG002|COMPLETED|Overall Study||7
9853590|NCT00887562|10966563|FG000|NOT COMPLETED|Overall Study||3
9853591|NCT00887562|10966564|FG001|NOT COMPLETED|Overall Study||2
9853592|NCT00887562|10966565|FG002|NOT COMPLETED|Overall Study||1
9853593|NCT00887575|10966575|FG000|STARTED|Phase I||6
9853594|NCT00887575|10966576|FG001|STARTED|Phase I||6
9748856|NCT04428034|10850874|FG000|NOT COMPLETED|4-Week Follow Up Survey||6
9748857|NCT04428034|10850874|FG000|STARTED|8-Week Follow Up Survey||29
9748858|NCT04428034|10850874|FG000|COMPLETED|8-Week Follow Up Survey|Of those 27 who completed the 8-week follow up survey, one participant skipped the 4-week follow up survey but completed the 8-week survey.|27
9748859|NCT04428034|10850874|FG000|NOT COMPLETED|8-Week Follow Up Survey||2
9828693|NCT00757601|10939427|FG009|STARTED|Period 3||2
9828694|NCT00757601|10939428|FG010|STARTED|Period 3||2
9828695|NCT00757601|10939429|FG011|STARTED|Period 3||2
9828696|NCT00757601|10939418|FG000|COMPLETED|Period 3||2
9828697|NCT00757601|10939419|FG001|COMPLETED|Period 3||2
9828698|NCT00757601|10939420|FG002|COMPLETED|Period 3||2
9828699|NCT00757601|10939421|FG003|COMPLETED|Period 3||2
9828700|NCT00757601|10939422|FG004|COMPLETED|Period 3||2
9828701|NCT00757601|10939423|FG005|COMPLETED|Period 3||2
9828702|NCT00757601|10939424|FG006|COMPLETED|Period 3||2
9828703|NCT00757601|10939425|FG007|COMPLETED|Period 3||2
9828704|NCT00757601|10939426|FG008|COMPLETED|Period 3||2
9828705|NCT00757601|10939427|FG009|COMPLETED|Period 3||2
9828706|NCT00757601|10939428|FG010|COMPLETED|Period 3||2
9828707|NCT00757601|10939429|FG011|COMPLETED|Period 3||2
9828708|NCT00757601|10939418|FG000|NOT COMPLETED|Period 3||0
9828709|NCT00757601|10939419|FG001|NOT COMPLETED|Period 3||0
9828710|NCT00757601|10939420|FG002|NOT COMPLETED|Period 3||0
9828711|NCT00757601|10939421|FG003|NOT COMPLETED|Period 3||0
9828712|NCT00757601|10939422|FG004|NOT COMPLETED|Period 3||0
9828713|NCT00757601|10939423|FG005|NOT COMPLETED|Period 3||0
9828714|NCT00757601|10939424|FG006|NOT COMPLETED|Period 3||0
9828715|NCT00757601|10939425|FG007|NOT COMPLETED|Period 3||0
9828716|NCT00757601|10939426|FG008|NOT COMPLETED|Period 3||0
9828717|NCT00757601|10939427|FG009|NOT COMPLETED|Period 3||0
9828718|NCT00757601|10939428|FG010|NOT COMPLETED|Period 3||0
9828719|NCT00757601|10939429|FG011|NOT COMPLETED|Period 3||0
9828720|NCT00757601|10939418|FG000|STARTED|Period 4||2
9828721|NCT00757601|10939419|FG001|STARTED|Period 4||2
9828722|NCT00757601|10939420|FG002|STARTED|Period 4||2
9828723|NCT00757601|10939421|FG003|STARTED|Period 4||2
9828724|NCT00757601|10939422|FG004|STARTED|Period 4||2
9828725|NCT00757601|10939423|FG005|STARTED|Period 4||2
9828726|NCT00757601|10939424|FG006|STARTED|Period 4||2
9828727|NCT00757601|10939425|FG007|STARTED|Period 4||2
9828728|NCT00757601|10939426|FG008|STARTED|Period 4||2
9828729|NCT00757601|10939427|FG009|STARTED|Period 4||2
9828730|NCT00757601|10939428|FG010|STARTED|Period 4||2
9828731|NCT00757601|10939429|FG011|STARTED|Period 4||2
9828732|NCT00757601|10939418|FG000|COMPLETED|Period 4||2
9828733|NCT00757601|10939419|FG001|COMPLETED|Period 4||2
9828734|NCT00757601|10939420|FG002|COMPLETED|Period 4||2
9828735|NCT00757601|10939421|FG003|COMPLETED|Period 4||2
9828736|NCT00757601|10939422|FG004|COMPLETED|Period 4||2
9828737|NCT00757601|10939423|FG005|COMPLETED|Period 4||2
9828738|NCT00757601|10939424|FG006|COMPLETED|Period 4||2
9828739|NCT00757601|10939425|FG007|COMPLETED|Period 4||2
9828740|NCT00757601|10939426|FG008|COMPLETED|Period 4||2
9828741|NCT00757601|10939427|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
9828742|NCT00757601|10939428|FG010|COMPLETED|Period 4||2
9828743|NCT00757601|10939429|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
9828744|NCT00757601|10939418|FG000|NOT COMPLETED|Period 4||0
9828745|NCT00757601|10939419|FG001|NOT COMPLETED|Period 4||0
9828746|NCT00757601|10939420|FG002|NOT COMPLETED|Period 4||0
9828747|NCT00757601|10939421|FG003|NOT COMPLETED|Period 4||0
9828748|NCT00757601|10939422|FG004|NOT COMPLETED|Period 4||0
9828749|NCT00757601|10939423|FG005|NOT COMPLETED|Period 4||0
9828750|NCT00757601|10939424|FG006|NOT COMPLETED|Period 4||0
9828751|NCT00757601|10939425|FG007|NOT COMPLETED|Period 4||0
9828752|NCT00757601|10939426|FG008|NOT COMPLETED|Period 4||0
9828753|NCT00757601|10939427|FG009|NOT COMPLETED|Period 4||1
9828754|NCT00757601|10939428|FG010|NOT COMPLETED|Period 4||0
9828755|NCT00757601|10939429|FG011|NOT COMPLETED|Period 4||1
9828756|NCT00757601|10939418|FG000|STARTED|Period 5||2
9828757|NCT00757601|10939419|FG001|STARTED|Period 5||2
9828758|NCT00757601|10939420|FG002|STARTED|Period 5||2
9828759|NCT00757601|10939421|FG003|STARTED|Period 5||2
9853595|NCT00887575|10966577|FG002|STARTED|Phase I||3
9828760|NCT00757601|10939422|FG004|STARTED|Period 5||2
9828761|NCT00757601|10939423|FG005|STARTED|Period 5||2
9853596|NCT00887575|10966575|FG000|COMPLETED|Phase I||6
9853597|NCT00887575|10966576|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
9828762|NCT00757601|10939424|FG006|STARTED|Period 5||2
9828763|NCT00757601|10939425|FG007|STARTED|Period 5||2
9828764|NCT00757601|10939426|FG008|STARTED|Period 5||2
9828765|NCT00757601|10939427|FG009|STARTED|Period 5||1
9828766|NCT00757601|10939428|FG010|STARTED|Period 5||2
9828767|NCT00757601|10939429|FG011|STARTED|Period 5||1
9828768|NCT00757601|10939418|FG000|COMPLETED|Period 5||2
9953006|NCT01424943|11071864|FG000|NOT COMPLETED|Overall Study||13
9748860|NCT04262947|10850881|FG000|STARTED|Overall Study||13
9748861|NCT04262947|10850882|FG001|STARTED|Overall Study||13
9748862|NCT04262947|10850883|FG002|STARTED|Overall Study||12
9748863|NCT04262947|10850881|FG000|COMPLETED|Overall Study||13
9748864|NCT04262947|10850882|FG001|COMPLETED|Overall Study||13
9748865|NCT04262947|10850883|FG002|COMPLETED|Overall Study||12
9748866|NCT04262947|10850881|FG000|NOT COMPLETED|Overall Study||0
9748867|NCT04262947|10850882|FG001|NOT COMPLETED|Overall Study||0
9748868|NCT04262947|10850883|FG002|NOT COMPLETED|Overall Study||0
9748869|NCT04177680|10850891|FG000|STARTED|Overall Study||49
9748870|NCT04177680|10850892|FG001|STARTED|Overall Study||51
9748871|NCT04177680|10850891|FG000|COMPLETED|Overall Study||47
9748872|NCT04177680|10850892|FG001|COMPLETED|Overall Study||48
9748873|NCT04177680|10850891|FG000|NOT COMPLETED|Overall Study||2
9748874|NCT04177680|10850892|FG001|NOT COMPLETED|Overall Study||3
9748875|NCT03999554|10850903|FG000|STARTED|Overall Study||42
9748876|NCT03999554|10850904|FG001|STARTED|Overall Study||41
9748877|NCT03999554|10850905|FG002|STARTED|Overall Study||40
9748878|NCT03999554|10850906|FG003|STARTED|Overall Study||42
9748879|NCT03999554|10850907|FG004|STARTED|Overall Study||41
9748880|NCT03999554|10850903|FG000|COMPLETED|Overall Study||36
9748881|NCT03999554|10850904|FG001|COMPLETED|Overall Study||34
9748882|NCT03999554|10850905|FG002|COMPLETED|Overall Study||28
9748883|NCT03999554|10850906|FG003|COMPLETED|Overall Study||35
9748884|NCT03999554|10850907|FG004|COMPLETED|Overall Study||32
9748885|NCT03999554|10850903|FG000|NOT COMPLETED|Overall Study||6
9748886|NCT03999554|10850904|FG001|NOT COMPLETED|Overall Study||7
9748887|NCT03999554|10850905|FG002|NOT COMPLETED|Overall Study||12
9748888|NCT03999554|10850906|FG003|NOT COMPLETED|Overall Study||7
9748889|NCT03999554|10850907|FG004|NOT COMPLETED|Overall Study||9
9748890|NCT03651622|10850923|FG000|STARTED|Diet Period 1 (Randomization 1)||23
9748891|NCT03651622|10850924|FG001|STARTED|Diet Period 1 (Randomization 1)||24
9748892|NCT03651622|10850925|FG002|STARTED|Diet Period 1 (Randomization 1)||21
9748893|NCT03651622|10850923|FG000|COMPLETED|Diet Period 1 (Randomization 1)||19
9748894|NCT03651622|10850924|FG001|COMPLETED|Diet Period 1 (Randomization 1)||17
9748895|NCT03651622|10850925|FG002|COMPLETED|Diet Period 1 (Randomization 1)||12
9748896|NCT03651622|10850923|FG000|NOT COMPLETED|Diet Period 1 (Randomization 1)||4
9748897|NCT03651622|10850924|FG001|NOT COMPLETED|Diet Period 1 (Randomization 1)||7
9748898|NCT03651622|10850925|FG002|NOT COMPLETED|Diet Period 1 (Randomization 1)||9
9748899|NCT03651622|10850923|FG000|STARTED|Diet Period 2 (Randomization 2)||19
9748900|NCT03651622|10850924|FG001|STARTED|Diet Period 2 (Randomization 2)||15
9748901|NCT03651622|10850925|FG002|STARTED|Diet Period 2 (Randomization 2)||14
9748902|NCT03651622|10850923|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||0
9748903|NCT03651622|10850924|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
9748904|NCT03651622|10850925|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
9748905|NCT03651622|10850923|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||5
9748906|NCT03651622|10850924|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||0
9748907|NCT03651622|10850925|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||6
9748908|NCT03651622|10850923|FG000|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||5
9748909|NCT03651622|10850924|FG001|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||4
9748910|NCT03651622|10850925|FG002|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||0
9748911|NCT03651622|10850923|FG000|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||9
9748912|NCT03651622|10850924|FG001|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||6
9748913|NCT03651622|10850925|FG002|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||3
9748914|NCT03651622|10850923|FG000|COMPLETED|Diet Period 2 (Randomization 2)||17
9748915|NCT03651622|10850924|FG001|COMPLETED|Diet Period 2 (Randomization 2)||13
9748916|NCT03651622|10850925|FG002|COMPLETED|Diet Period 2 (Randomization 2)||11
9748917|NCT03651622|10850923|FG000|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
9748918|NCT03651622|10850924|FG001|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
9748919|NCT03651622|10850925|FG002|NOT COMPLETED|Diet Period 2 (Randomization 2)||3
9748920|NCT03651622|10850923|FG000|STARTED|Diet Period 3 (Randomization 3)||14
9748921|NCT03651622|10850924|FG001|STARTED|Diet Period 3 (Randomization 3)||9
9748922|NCT03651622|10850925|FG002|STARTED|Diet Period 3 (Randomization 3)||18
9748923|NCT03651622|10850923|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||0
9748924|NCT03651622|10850924|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||2
9828769|NCT00757601|10939419|FG001|COMPLETED|Period 5||2
9828770|NCT00757601|10939420|FG002|COMPLETED|Period 5||2
9828771|NCT00757601|10939421|FG003|COMPLETED|Period 5||2
9828772|NCT00757601|10939422|FG004|COMPLETED|Period 5||2
9828773|NCT00757601|10939423|FG005|COMPLETED|Period 5||2
9828774|NCT00757601|10939424|FG006|COMPLETED|Period 5||2
9828775|NCT00757601|10939425|FG007|COMPLETED|Period 5||2
9828776|NCT00757601|10939426|FG008|COMPLETED|Period 5||2
9828777|NCT00757601|10939427|FG009|COMPLETED|Period 5||1
9828778|NCT00757601|10939428|FG010|COMPLETED|Period 5||2
9828779|NCT00757601|10939429|FG011|COMPLETED|Period 5||1
9828780|NCT00757601|10939418|FG000|NOT COMPLETED|Period 5||0
9748925|NCT03651622|10850925|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||10
9748926|NCT03651622|10850923|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||4
9748927|NCT03651622|10850924|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||0
9748928|NCT03651622|10850925|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||6
9748929|NCT03651622|10850923|FG000|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||6
9748930|NCT03651622|10850924|FG001|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||4
9748931|NCT03651622|10850925|FG002|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||0
9748932|NCT03651622|10850923|FG000|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||4
9853598|NCT00887575|10966577|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
9853599|NCT00887575|10966575|FG000|NOT COMPLETED|Phase I||0
9853600|NCT00887575|10966576|FG001|NOT COMPLETED|Phase I||6
9748933|NCT03651622|10850924|FG001|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||3
9748934|NCT03651622|10850925|FG002|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||2
9748935|NCT03651622|10850923|FG000|COMPLETED|Diet Period 3 (Randomization 3)||14
9748936|NCT03651622|10850924|FG001|COMPLETED|Diet Period 3 (Randomization 3)||9
9748937|NCT03651622|10850925|FG002|COMPLETED|Diet Period 3 (Randomization 3)||17
9748938|NCT03651622|10850923|FG000|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
9748939|NCT03651622|10850924|FG001|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
9748940|NCT03651622|10850925|FG002|NOT COMPLETED|Diet Period 3 (Randomization 3)||1
9828781|NCT00757601|10939419|FG001|NOT COMPLETED|Period 5||0
9828782|NCT00757601|10939420|FG002|NOT COMPLETED|Period 5||0
9828783|NCT00757601|10939421|FG003|NOT COMPLETED|Period 5||0
9828784|NCT00757601|10939422|FG004|NOT COMPLETED|Period 5||0
9853601|NCT00887575|10966577|FG002|NOT COMPLETED|Phase I||3
9853602|NCT00887575|10966575|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
9853603|NCT00887575|10966576|FG001|STARTED|Phase II - Neoadjuvant Therapy||0
9853604|NCT00887575|10966577|FG002|STARTED|Phase II - Neoadjuvant Therapy||0
9853605|NCT00887575|10966575|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16
9853606|NCT00887575|10966576|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0
9853607|NCT00887575|10966577|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0
9853608|NCT00887575|10966575|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
9853609|NCT00887575|10966576|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
9853610|NCT00887575|10966577|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
9853611|NCT00887575|10966575|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
9853612|NCT00887575|10966576|FG001|STARTED|Phase II - Maintenance Therapy||0
9828785|NCT00757601|10939423|FG005|NOT COMPLETED|Period 5||0
9828786|NCT00757601|10939424|FG006|NOT COMPLETED|Period 5||0
9828787|NCT00757601|10939425|FG007|NOT COMPLETED|Period 5||0
9828788|NCT00757601|10939426|FG008|NOT COMPLETED|Period 5||0
9828789|NCT00757601|10939427|FG009|NOT COMPLETED|Period 5||0
9828790|NCT00757601|10939428|FG010|NOT COMPLETED|Period 5||0
9828791|NCT00757601|10939429|FG011|NOT COMPLETED|Period 5||0
9828792|NCT00757666|10939461|FG000|STARTED|Overall Study||34
9828793|NCT00757666|10939462|FG001|STARTED|Overall Study||34
9828794|NCT00757666|10939461|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
9828795|NCT00757666|10939462|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
9828796|NCT00757666|10939461|FG000|NOT COMPLETED|Overall Study||22
9828797|NCT00757666|10939462|FG001|NOT COMPLETED|Overall Study||23
9828798|NCT00757705|10939472|FG000|STARTED|Overall Study||299
9828799|NCT00757705|10939472|FG000|COMPLETED|Overall Study||178
9828800|NCT00757705|10939472|FG000|NOT COMPLETED|Overall Study||121
9828801|NCT00757783|10939478|FG000|STARTED|Overall Study||34
9828802|NCT00757783|10939479|FG001|STARTED|Overall Study||31
9828803|NCT00757783|10939478|FG000|COMPLETED|Overall Study||29
9828804|NCT00757783|10939479|FG001|COMPLETED|Overall Study||25
9853613|NCT00887575|10966577|FG002|STARTED|Phase II - Maintenance Therapy||0
9853614|NCT00887575|10966575|FG000|COMPLETED|Phase II - Maintenance Therapy||6
9853615|NCT00887575|10966576|FG001|COMPLETED|Phase II - Maintenance Therapy||0
9853616|NCT00887575|10966577|FG002|COMPLETED|Phase II - Maintenance Therapy||0
9853617|NCT00887575|10966575|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2
9853618|NCT00887575|10966576|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0
9853619|NCT00887575|10966577|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0
9853620|NCT00887588|10966584|FG000|STARTED|Core Period||149
9853621|NCT00887588|10966585|FG001|STARTED|Core Period||152
9853622|NCT00887588|10966584|FG000|Extension Efficacy Set|Core Period||127
9853623|NCT00887588|10966585|FG001|Extension Efficacy Set|Core Period||125
9853624|NCT00887588|10966584|FG000|Full Analysis Set|Core Period||148
9853625|NCT00887588|10966585|FG001|Full Analysis Set|Core Period||146
9853626|NCT00887588|10966584|FG000|Arterial Stiffness Set|Core Period||86
9828805|NCT00757783|10939478|FG000|NOT COMPLETED|Overall Study||5
9828806|NCT00757783|10939479|FG001|NOT COMPLETED|Overall Study||6
9828807|NCT00757822|10939487|FG000|STARTED|Overall Study||92
9828808|NCT00757822|10939488|FG001|STARTED|Overall Study||88
9828809|NCT00757822|10939487|FG000|Day of Surgery (DOS) Assessment|Overall Study||92
9828810|NCT00757822|10939488|FG001|Day of Surgery (DOS) Assessment|Overall Study||88
9853627|NCT00887588|10966585|FG001|Arterial Stiffness Set|Core Period||94
9853628|NCT00887588|10966584|FG000|COMPLETED|Core Period||130
9853629|NCT00887588|10966585|FG001|COMPLETED|Core Period||131
9853630|NCT00887588|10966584|FG000|NOT COMPLETED|Core Period||19
9853631|NCT00887588|10966585|FG001|NOT COMPLETED|Core Period||21
9853632|NCT00887588|10966584|FG000|STARTED|Extension Period||127
9853633|NCT00887588|10966585|FG001|STARTED|Extension Period||125
9853634|NCT00887588|10966584|FG000|Arterial Stiffness Set|Extension Period||86
9853635|NCT00887588|10966585|FG001|Arterial Stiffness Set|Extension Period||94
9853636|NCT00887588|10966584|FG000|COMPLETED|Extension Period||121
9853637|NCT00887588|10966585|FG001|COMPLETED|Extension Period||120
9853638|NCT00887588|10966584|FG000|NOT COMPLETED|Extension Period||6
9853639|NCT00887588|10966585|FG001|NOT COMPLETED|Extension Period||5
9748941|NCT03410992|10850935|FG000|STARTED|Initial Treatment Period: up to Wk16||86
9748942|NCT03410992|10850936|FG001|STARTED|Initial Treatment Period: up to Wk16||349
9748943|NCT03410992|10850937|FG002|STARTED|Initial Treatment Period: up to Wk16||0
9748944|NCT03410992|10850938|FG003|STARTED|Initial Treatment Period: up to Wk16||0
9748945|NCT03410992|10850939|FG004|STARTED|Initial Treatment Period: up to Wk16||0
9748946|NCT03410992|10850940|FG005|STARTED|Initial Treatment Period: up to Wk16||0
9748947|NCT03410992|10850941|FG006|STARTED|Initial Treatment Period: up to Wk16||0
9748948|NCT03410992|10850942|FG007|STARTED|Initial Treatment Period: up to Wk16||0
9748949|NCT03410992|10850943|FG008|STARTED|Initial Treatment Period: up to Wk16||0
9748950|NCT03410992|10850944|FG009|STARTED|Initial Treatment Period: up to Wk16||0
9748951|NCT03410992|10850945|FG010|STARTED|Initial Treatment Period: up to Wk16||0
9748952|NCT03410992|10850935|FG000|COMPLETED|Initial Treatment Period: up to Wk16||82
9748953|NCT03410992|10850936|FG001|COMPLETED|Initial Treatment Period: up to Wk16||340
9748954|NCT03410992|10850937|FG002|COMPLETED|Initial Treatment Period: up to Wk16||0
9748955|NCT03410992|10850938|FG003|COMPLETED|Initial Treatment Period: up to Wk16||0
9748956|NCT03410992|10850939|FG004|COMPLETED|Initial Treatment Period: up to Wk16||0
9748957|NCT03410992|10850940|FG005|COMPLETED|Initial Treatment Period: up to Wk16||0
9748958|NCT03410992|10850941|FG006|COMPLETED|Initial Treatment Period: up to Wk16||0
9748959|NCT03410992|10850942|FG007|COMPLETED|Initial Treatment Period: up to Wk16||0
9748960|NCT03410992|10850943|FG008|COMPLETED|Initial Treatment Period: up to Wk16||0
9748961|NCT03410992|10850944|FG009|COMPLETED|Initial Treatment Period: up to Wk16||0
9748962|NCT03410992|10850945|FG010|COMPLETED|Initial Treatment Period: up to Wk16||0
9748963|NCT03410992|10850935|FG000|NOT COMPLETED|Initial Treatment Period: up to Wk16||4
9748964|NCT03410992|10850936|FG001|NOT COMPLETED|Initial Treatment Period: up to Wk16||9
9748965|NCT03410992|10850937|FG002|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748966|NCT03410992|10850938|FG003|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748967|NCT03410992|10850939|FG004|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748968|NCT03410992|10850940|FG005|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748969|NCT03410992|10850941|FG006|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748970|NCT03410992|10850942|FG007|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748971|NCT03410992|10850943|FG008|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748972|NCT03410992|10850944|FG009|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748973|NCT03410992|10850945|FG010|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
9748974|NCT03410992|10850935|FG000|STARTED|Week 16 Assessment||82
9748975|NCT03410992|10850936|FG001|STARTED|Week 16 Assessment||340
9748976|NCT03410992|10850937|FG002|STARTED|Week 16 Assessment||0
9748977|NCT03410992|10850938|FG003|STARTED|Week 16 Assessment||0
9748978|NCT03410992|10850939|FG004|STARTED|Week 16 Assessment||0
9748979|NCT03410992|10850940|FG005|STARTED|Week 16 Assessment||0
9748980|NCT03410992|10850941|FG006|STARTED|Week 16 Assessment||0
9748981|NCT03410992|10850942|FG007|STARTED|Week 16 Assessment||0
9853640|NCT00887640|10966591|FG000|STARTED|Overall Study||11
9853641|NCT00887640|10966591|FG000|COMPLETED|Overall Study||11
9748982|NCT03410992|10850943|FG008|STARTED|Week 16 Assessment||0
9748983|NCT03410992|10850944|FG009|STARTED|Week 16 Assessment||0
9748984|NCT03410992|10850945|FG010|STARTED|Week 16 Assessment||0
9748985|NCT03410992|10850935|FG000|Received Escape Treatment|Week 16 Assessment||81
9748986|NCT03410992|10850936|FG001|Received Escape Treatment|Week 16 Assessment||23
9748987|NCT03410992|10850937|FG002|Received Escape Treatment|Week 16 Assessment||0
9748988|NCT03410992|10850938|FG003|Received Escape Treatment|Week 16 Assessment||0
9748989|NCT03410992|10850939|FG004|Received Escape Treatment|Week 16 Assessment||0
9748990|NCT03410992|10850940|FG005|Received Escape Treatment|Week 16 Assessment||0
9748991|NCT03410992|10850941|FG006|Received Escape Treatment|Week 16 Assessment||0
9748992|NCT03410992|10850942|FG007|Received Escape Treatment|Week 16 Assessment||0
9748993|NCT03410992|10850943|FG008|Received Escape Treatment|Week 16 Assessment||0
9748994|NCT03410992|10850944|FG009|Received Escape Treatment|Week 16 Assessment||0
9748995|NCT03410992|10850945|FG010|Received Escape Treatment|Week 16 Assessment||0
9748996|NCT03410992|10850935|FG000|COMPLETED|Week 16 Assessment||1
9853642|NCT00887640|10966591|FG000|NOT COMPLETED|Overall Study||0
9853643|NCT00887653|10966595|FG000|STARTED|Overall Study||20
9748997|NCT03410992|10850936|FG001|COMPLETED|Week 16 Assessment||311
9853644|NCT00887653|10966595|FG000|COMPLETED|Overall Study||20
9853645|NCT00887653|10966595|FG000|NOT COMPLETED|Overall Study||0
9853646|NCT00887679|10966599|FG000|STARTED|Overall Study||30
9853647|NCT00887679|10966599|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20
9853648|NCT00887679|10966599|FG000|NOT COMPLETED|Overall Study||10
9748998|NCT03410992|10850937|FG002|COMPLETED|Week 16 Assessment||0
9748999|NCT03410992|10850938|FG003|COMPLETED|Week 16 Assessment||0
9749000|NCT03410992|10850939|FG004|COMPLETED|Week 16 Assessment||0
9749001|NCT03410992|10850940|FG005|COMPLETED|Week 16 Assessment||0
9749002|NCT03410992|10850941|FG006|COMPLETED|Week 16 Assessment||0
9749003|NCT03410992|10850942|FG007|COMPLETED|Week 16 Assessment||0
9749004|NCT03410992|10850943|FG008|COMPLETED|Week 16 Assessment||0
9749005|NCT03410992|10850944|FG009|COMPLETED|Week 16 Assessment||0
9749006|NCT03410992|10850945|FG010|COMPLETED|Week 16 Assessment||0
9749007|NCT03410992|10850935|FG000|NOT COMPLETED|Week 16 Assessment||81
9749008|NCT03410992|10850936|FG001|NOT COMPLETED|Week 16 Assessment||29
9749009|NCT03410992|10850937|FG002|NOT COMPLETED|Week 16 Assessment||0
9749010|NCT03410992|10850938|FG003|NOT COMPLETED|Week 16 Assessment||0
9749011|NCT03410992|10850939|FG004|NOT COMPLETED|Week 16 Assessment||0
9749012|NCT03410992|10850940|FG005|NOT COMPLETED|Week 16 Assessment||0
9749013|NCT03410992|10850941|FG006|NOT COMPLETED|Week 16 Assessment||0
9749014|NCT03410992|10850942|FG007|NOT COMPLETED|Week 16 Assessment||0
9749015|NCT03410992|10850943|FG008|NOT COMPLETED|Week 16 Assessment||0
9749016|NCT03410992|10850944|FG009|NOT COMPLETED|Week 16 Assessment||0
9749017|NCT03410992|10850945|FG010|NOT COMPLETED|Week 16 Assessment||0
9749018|NCT03410992|10850935|FG000|STARTED|Randomized-Withdrawal Period: up to Wk56||0
9749019|NCT03410992|10850936|FG001|STARTED|Randomized-Withdrawal Period: up to Wk56||0
9749020|NCT03410992|10850937|FG002|STARTED|Randomized-Withdrawal Period: up to Wk56||1
9749021|NCT03410992|10850938|FG003|STARTED|Randomized-Withdrawal Period: up to Wk56||105
9749022|NCT03410992|10850939|FG004|STARTED|Randomized-Withdrawal Period: up to Wk56||100
9749023|NCT03410992|10850940|FG005|STARTED|Randomized-Withdrawal Period: up to Wk56||106
9749024|NCT03410992|10850941|FG006|STARTED|Randomized-Withdrawal Period: up to Wk56||0
9749025|NCT03410992|10850942|FG007|STARTED|Randomized-Withdrawal Period: up to Wk56||0
9749026|NCT03410992|10850943|FG008|STARTED|Randomized-Withdrawal Period: up to Wk56||0
9749027|NCT03410992|10850944|FG009|STARTED|Randomized-Withdrawal Period: up to Wk56||0
9749028|NCT03410992|10850945|FG010|STARTED|Randomized-Withdrawal Period: up to Wk56||0
9749029|NCT03410992|10850935|FG000|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749030|NCT03410992|10850936|FG001|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749031|NCT03410992|10850937|FG002|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749032|NCT03410992|10850938|FG003|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||67
9749033|NCT03410992|10850939|FG004|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||4
9749034|NCT03410992|10850940|FG005|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||7
9749035|NCT03410992|10850941|FG006|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749036|NCT03410992|10850942|FG007|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749037|NCT03410992|10850943|FG008|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749038|NCT03410992|10850944|FG009|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749039|NCT03410992|10850945|FG010|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
9749040|NCT03410992|10850935|FG000|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749041|NCT03410992|10850936|FG001|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749042|NCT03410992|10850937|FG002|COMPLETED|Randomized-Withdrawal Period: up to Wk56||1
9749043|NCT03410992|10850938|FG003|COMPLETED|Randomized-Withdrawal Period: up to Wk56||33
9749044|NCT03410992|10850939|FG004|COMPLETED|Randomized-Withdrawal Period: up to Wk56||93
9749045|NCT03410992|10850940|FG005|COMPLETED|Randomized-Withdrawal Period: up to Wk56||94
9749046|NCT03410992|10850941|FG006|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9853649|NCT00887744|10966604|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
9853650|NCT00887744|10966604|FG000|COMPLETED|Overall Study||128
9853651|NCT00887744|10966604|FG000|NOT COMPLETED|Overall Study||34
9853652|NCT00887809|10966610|FG000|STARTED|Overall Study||37
9853653|NCT00887809|10966611|FG001|STARTED|Overall Study||10
9853654|NCT00887809|10966610|FG000|COMPLETED|Overall Study||33
9853655|NCT00887809|10966611|FG001|COMPLETED|Overall Study||10
9749047|NCT03410992|10850942|FG007|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749048|NCT03410992|10850943|FG008|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749049|NCT03410992|10850944|FG009|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749050|NCT03410992|10850945|FG010|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749051|NCT03410992|10850935|FG000|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749052|NCT03410992|10850936|FG001|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749053|NCT03410992|10850937|FG002|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749054|NCT03410992|10850938|FG003|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||72
9749055|NCT03410992|10850939|FG004|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||7
9749056|NCT03410992|10850940|FG005|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||12
9749057|NCT03410992|10850941|FG006|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749058|NCT03410992|10850942|FG007|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749059|NCT03410992|10850943|FG008|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9853656|NCT00887809|10966610|FG000|NOT COMPLETED|Overall Study||4
9853657|NCT00887809|10966611|FG001|NOT COMPLETED|Overall Study||0
9853658|NCT00887822|10966619|FG000|STARTED|Overall Study||100
9853659|NCT00887822|10966620|FG001|STARTED|Overall Study||102
9853660|NCT00887822|10966619|FG000|Treated (Safety Population)|Overall Study||100
9853661|NCT00887822|10966620|FG001|Treated (Safety Population)|Overall Study||101
9749060|NCT03410992|10850944|FG009|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749061|NCT03410992|10850945|FG010|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
9749062|NCT03410992|10850935|FG000|STARTED|Escape Treatment: 12 Weeks||0
9749063|NCT03410992|10850936|FG001|STARTED|Escape Treatment: 12 Weeks||0
9749064|NCT03410992|10850937|FG002|STARTED|Escape Treatment: 12 Weeks||0
9749065|NCT03410992|10850938|FG003|STARTED|Escape Treatment: 12 Weeks||0
9749066|NCT03410992|10850939|FG004|STARTED|Escape Treatment: 12 Weeks||0
9749067|NCT03410992|10850940|FG005|STARTED|Escape Treatment: 12 Weeks||0
9749068|NCT03410992|10850941|FG006|STARTED|Escape Treatment: 12 Weeks||81
9749069|NCT03410992|10850942|FG007|STARTED|Escape Treatment: 12 Weeks||23
9749070|NCT03410992|10850943|FG008|STARTED|Escape Treatment: 12 Weeks||67
9749071|NCT03410992|10850944|FG009|STARTED|Escape Treatment: 12 Weeks||4
9749072|NCT03410992|10850945|FG010|STARTED|Escape Treatment: 12 Weeks||7
9749073|NCT03410992|10850935|FG000|COMPLETED|Escape Treatment: 12 Weeks||0
9749074|NCT03410992|10850936|FG001|COMPLETED|Escape Treatment: 12 Weeks||0
9749075|NCT03410992|10850937|FG002|COMPLETED|Escape Treatment: 12 Weeks||0
9749076|NCT03410992|10850938|FG003|COMPLETED|Escape Treatment: 12 Weeks||0
9749077|NCT03410992|10850939|FG004|COMPLETED|Escape Treatment: 12 Weeks||0
9749078|NCT03410992|10850940|FG005|COMPLETED|Escape Treatment: 12 Weeks||0
9749079|NCT03410992|10850941|FG006|COMPLETED|Escape Treatment: 12 Weeks||81
9749080|NCT03410992|10850942|FG007|COMPLETED|Escape Treatment: 12 Weeks||22
9749081|NCT03410992|10850943|FG008|COMPLETED|Escape Treatment: 12 Weeks||66
9749082|NCT03410992|10850944|FG009|COMPLETED|Escape Treatment: 12 Weeks||4
9749083|NCT03410992|10850945|FG010|COMPLETED|Escape Treatment: 12 Weeks||7
9749084|NCT03410992|10850935|FG000|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749085|NCT03410992|10850936|FG001|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749086|NCT03410992|10850937|FG002|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749087|NCT03410992|10850938|FG003|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749088|NCT03410992|10850939|FG004|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749089|NCT03410992|10850940|FG005|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749090|NCT03410992|10850941|FG006|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749091|NCT03410992|10850942|FG007|NOT COMPLETED|Escape Treatment: 12 Weeks||1
9749092|NCT03410992|10850943|FG008|NOT COMPLETED|Escape Treatment: 12 Weeks||1
9749093|NCT03410992|10850944|FG009|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749094|NCT03410992|10850945|FG010|NOT COMPLETED|Escape Treatment: 12 Weeks||0
9749095|NCT03138096|10850980|FG000|STARTED|Overall Study||3
9749096|NCT03138096|10850981|FG001|STARTED|Overall Study||3
9749097|NCT03138096|10850982|FG002|STARTED|Overall Study||12
9749098|NCT03138096|10850983|FG003|STARTED|Overall Study||6
9749099|NCT03138096|10850984|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0
9749100|NCT03138096|10850980|FG000|COMPLETED|Overall Study||3
9853662|NCT00887822|10966619|FG000|COMPLETED|Overall Study||3
9749101|NCT03138096|10850981|FG001|COMPLETED|Overall Study||3
9749102|NCT03138096|10850982|FG002|COMPLETED|Overall Study||12
9749103|NCT03138096|10850983|FG003|COMPLETED|Overall Study||6
9749104|NCT03138096|10850984|FG004|COMPLETED|Overall Study||0
9749105|NCT03138096|10850980|FG000|NOT COMPLETED|Overall Study||0
9749106|NCT03138096|10850981|FG001|NOT COMPLETED|Overall Study||0
9749107|NCT03138096|10850982|FG002|NOT COMPLETED|Overall Study||0
9749108|NCT03138096|10850983|FG003|NOT COMPLETED|Overall Study||0
9749109|NCT03138096|10850984|FG004|NOT COMPLETED|Overall Study||0
9749110|NCT02678351|10851007|FG000|STARTED|Overall Study||74
9749111|NCT02678351|10851007|FG000|COMPLETED|Overall Study||73
9749112|NCT02678351|10851007|FG000|NOT COMPLETED|Overall Study||1
9749113|NCT02578732|10851011|FG000|STARTED|Overall Study||28
9749114|NCT02578732|10851011|FG000|COMPLETED|Overall Study||28
9749115|NCT02578732|10851011|FG000|NOT COMPLETED|Overall Study||0
9749116|NCT02272790|10851021|FG000|STARTED|Overall Study||9
9749117|NCT02272790|10851022|FG001|STARTED|Overall Study||39
9749118|NCT02272790|10851023|FG002|STARTED|Overall Study||23
9749119|NCT02272790|10851024|FG003|STARTED|Overall Study||12
9749120|NCT02272790|10851025|FG004|STARTED|Overall Study||6
9749121|NCT02272790|10851026|FG005|STARTED|Overall Study||6
9749122|NCT02272790|10851021|FG000|COMPLETED|Overall Study||9
9749123|NCT02272790|10851022|FG001|COMPLETED|Overall Study||38
9749124|NCT02272790|10851023|FG002|COMPLETED|Overall Study||23
9749125|NCT02272790|10851024|FG003|COMPLETED|Overall Study||12
9749126|NCT02272790|10851025|FG004|COMPLETED|Overall Study||6
9749127|NCT02272790|10851026|FG005|COMPLETED|Overall Study||6
9749128|NCT02272790|10851021|FG000|NOT COMPLETED|Overall Study||0
9749129|NCT02272790|10851022|FG001|NOT COMPLETED|Overall Study||1
9749130|NCT02272790|10851023|FG002|NOT COMPLETED|Overall Study||0
9749131|NCT02272790|10851024|FG003|NOT COMPLETED|Overall Study||0
9749132|NCT02272790|10851025|FG004|NOT COMPLETED|Overall Study||0
9749133|NCT02272790|10851026|FG005|NOT COMPLETED|Overall Study||0
9749134|NCT01961531|10851046|FG000|STARTED|Overall Study||40
9749135|NCT01961531|10851046|FG000|COMPLETED|Overall Study||40
9749136|NCT01961531|10851046|FG000|NOT COMPLETED|Overall Study||0
9749137|NCT01880541|10851052|FG000|STARTED|Overall Study||10
9749138|NCT01880541|10851053|FG001|STARTED|Overall Study||20
9749139|NCT01880541|10851052|FG000|COMPLETED|Overall Study||10
9749140|NCT01880541|10851053|FG001|COMPLETED|Overall Study||20
9749141|NCT01880541|10851052|FG000|NOT COMPLETED|Overall Study||0
9749142|NCT01880541|10851053|FG001|NOT COMPLETED|Overall Study||0
9749143|NCT01693692|10851062|FG000|STARTED|Overall Study||130
9749144|NCT01693692|10851063|FG001|STARTED|Overall Study||131
9749145|NCT01693692|10851064|FG002|STARTED|Overall Study||131
9749146|NCT01693692|10851062|FG000|Received Study Drug|Overall Study||128
9749147|NCT01693692|10851063|FG001|Received Study Drug|Overall Study||127
9749148|NCT01693692|10851064|FG002|Received Study Drug|Overall Study||128
9749149|NCT01693692|10851062|FG000|COMPLETED|Overall Study||100
9749150|NCT01693692|10851063|FG001|COMPLETED|Overall Study||97
9749151|NCT01693692|10851064|FG002|COMPLETED|Overall Study||95
9749152|NCT01693692|10851062|FG000|NOT COMPLETED|Overall Study||30
9749153|NCT01693692|10851063|FG001|NOT COMPLETED|Overall Study||34
9749154|NCT01693692|10851064|FG002|NOT COMPLETED|Overall Study||36
9749155|NCT01685606|10851072|FG000|STARTED|Overall Study||6
9749156|NCT01685606|10851072|FG000|COMPLETED|Overall Study||5
9749157|NCT01685606|10851072|FG000|NOT COMPLETED|Overall Study||1
9749158|NCT01650350|10851076|FG000|STARTED|Overall Study||7
9749159|NCT01650350|10851076|FG000|COMPLETED|Overall Study||7
9749160|NCT01650350|10851076|FG000|NOT COMPLETED|Overall Study||0
9749161|NCT01650285|10851082|FG000|STARTED|Overall Study||5
9749162|NCT01650285|10851082|FG000|COMPLETED|Overall Study||4
9749163|NCT01650285|10851082|FG000|NOT COMPLETED|Overall Study||1
9749164|NCT01083771|10851086|FG000|STARTED|Overall Study||21
9749165|NCT01083771|10851086|FG000|COMPLETED|Overall Study||16
9749166|NCT01083771|10851086|FG000|NOT COMPLETED|Overall Study||5
9749167|NCT00743197|10851092|FG000|STARTED|Overall Study||1
9749168|NCT00743197|10851093|FG001|STARTED|Overall Study||2
9749169|NCT00743197|10851092|FG000|COMPLETED|Overall Study||0
9749170|NCT00743197|10851093|FG001|COMPLETED|Overall Study||0
9749171|NCT00743197|10851092|FG000|NOT COMPLETED|Overall Study||1
9749172|NCT00743197|10851093|FG001|NOT COMPLETED|Overall Study||2
9749173|NCT00304915|10851101|FG000|STARTED|Overall Study||123
9749174|NCT00304915|10851102|FG001|STARTED|Overall Study||126
9749175|NCT00304915|10851101|FG000|COMPLETED|Overall Study||105
9749176|NCT00304915|10851102|FG001|COMPLETED|Overall Study||110
9749177|NCT00304915|10851101|FG000|NOT COMPLETED|Overall Study||18
9749178|NCT00304915|10851102|FG001|NOT COMPLETED|Overall Study||16
9749179|NCT00304954|10851112|FG000|STARTED|Overall Study||4
9749180|NCT00304954|10851113|FG001|STARTED|Overall Study||3
9749181|NCT00304954|10851114|FG002|STARTED|Overall Study||3
9749182|NCT00304954|10851115|FG003|STARTED|Overall Study||3
9749183|NCT00304954|10851112|FG000|COMPLETED|Overall Study||3
9749184|NCT00304954|10851113|FG001|COMPLETED|Overall Study||3
9749185|NCT00304954|10851114|FG002|COMPLETED|Overall Study||2
9749186|NCT00304954|10851115|FG003|COMPLETED|Overall Study||3
9749187|NCT00304954|10851112|FG000|NOT COMPLETED|Overall Study||1
9749188|NCT00304954|10851113|FG001|NOT COMPLETED|Overall Study||0
9749189|NCT00304954|10851114|FG002|NOT COMPLETED|Overall Study||1
9749190|NCT00304954|10851115|FG003|NOT COMPLETED|Overall Study||0
9749191|NCT00305006|10851135|FG000|STARTED|Overall Study||22
9749192|NCT00305006|10851136|FG001|STARTED|Overall Study||22
9749193|NCT00305006|10851135|FG000|COMPLETED|Overall Study||21
9749194|NCT00305006|10851136|FG001|COMPLETED|Overall Study||21
9749195|NCT00305006|10851135|FG000|NOT COMPLETED|Overall Study||1
9749196|NCT00305006|10851136|FG001|NOT COMPLETED|Overall Study||1
9749197|NCT00305058|10851144|FG000|STARTED|Overall Study||97
9749198|NCT00305058|10851145|FG001|STARTED|Overall Study||97
9749199|NCT00305058|10851144|FG000|Inclusion/Exclusion Verification|Overall Study||96
9749200|NCT00305058|10851145|FG001|Inclusion/Exclusion Verification|Overall Study||97
9749201|NCT00305058|10851144|FG000|All Outcome Data Collected|Overall Study||93
9749202|NCT00305058|10851145|FG001|All Outcome Data Collected|Overall Study||95
9749203|NCT00305058|10851144|FG000|Data Collection Forms Filed for Analysis|Overall Study||90
9749204|NCT00305058|10851145|FG001|Data Collection Forms Filed for Analysis|Overall Study||93
9749205|NCT00305058|10851144|FG000|COMPLETED|Overall Study||90
9749206|NCT00305058|10851145|FG001|COMPLETED|Overall Study||93
9749207|NCT00305058|10851144|FG000|NOT COMPLETED|Overall Study||7
9749208|NCT00305058|10851145|FG001|NOT COMPLETED|Overall Study||4
9749209|NCT00305084|10851156|FG000|STARTED|Overall Study||3
9749210|NCT00305084|10851157|FG001|STARTED|Overall Study||3
9749211|NCT00305084|10851158|FG002|STARTED|Overall Study||3
9749212|NCT00305084|10851159|FG003|STARTED|Overall Study||3
9749213|NCT00305084|10851160|FG004|STARTED|Overall Study||3
9749214|NCT00305084|10851156|FG000|COMPLETED|Overall Study||3
9749215|NCT00305084|10851157|FG001|COMPLETED|Overall Study||3
9749216|NCT00305084|10851158|FG002|COMPLETED|Overall Study||3
9749217|NCT00305084|10851159|FG003|COMPLETED|Overall Study||3
9749218|NCT00305084|10851160|FG004|COMPLETED|Overall Study||3
9749219|NCT00305084|10851156|FG000|NOT COMPLETED|Overall Study||0
9749220|NCT00305084|10851157|FG001|NOT COMPLETED|Overall Study||0
9749221|NCT00305084|10851158|FG002|NOT COMPLETED|Overall Study||0
9749222|NCT00305084|10851159|FG003|NOT COMPLETED|Overall Study||0
9749223|NCT00305084|10851160|FG004|NOT COMPLETED|Overall Study||0
9749224|NCT00305110|10851200|FG000|STARTED|Overall Study||298
9749225|NCT00305110|10851200|FG000|All Necessary Data Collected|Overall Study||269
9749226|NCT00305110|10851200|FG000|COMPLETED|Overall Study||269
9749227|NCT00305110|10851200|FG000|NOT COMPLETED|Overall Study||29
9749228|NCT00305162|10851206|FG000|STARTED|48 Hour Follow-up Period||4435
9749229|NCT00305162|10851207|FG001|STARTED|48 Hour Follow-up Period||4447
9749230|NCT00305162|10851206|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
9749231|NCT00305162|10851207|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
9749232|NCT00305162|10851206|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
9832421|NCT00772967|10943208|FG004|STARTED|Break 2 (4-7 Days)||4
9749233|NCT00305162|10851207|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
9749234|NCT00305162|10851206|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
9749235|NCT00305162|10851207|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
9749236|NCT00305162|10851206|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
9749237|NCT00305162|10851207|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
9749238|NCT00305162|10851206|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
9749239|NCT00305162|10851207|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
9749240|NCT00305162|10851206|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
9749241|NCT00305162|10851207|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
9749242|NCT00305162|10851206|FG000|NOT COMPLETED|48 Hour Follow-up Period||20
9749243|NCT00305162|10851207|FG001|NOT COMPLETED|48 Hour Follow-up Period||16
9749244|NCT00305162|10851206|FG000|STARTED|30-day Follow-up Period||4435
9749245|NCT00305162|10851207|FG001|STARTED|30-day Follow-up Period||4447
9749246|NCT00305162|10851206|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
9749247|NCT00305162|10851207|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
9749248|NCT00305162|10851206|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
9749249|NCT00305162|10851207|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
9749250|NCT00305162|10851206|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
9749251|NCT00305162|10851207|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
9749252|NCT00305162|10851206|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
9749253|NCT00305162|10851207|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
9749254|NCT00305162|10851206|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
9749255|NCT00305162|10851207|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
9749256|NCT00305162|10851206|FG000|NOT COMPLETED|30-day Follow-up Period||62
9749257|NCT00305162|10851207|FG001|NOT COMPLETED|30-day Follow-up Period||63
9749258|NCT00305162|10851206|FG000|STARTED|1 Year Follow-up Period||4435
9749259|NCT00305162|10851207|FG001|STARTED|1 Year Follow-up Period||4447
9749260|NCT00305162|10851206|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
9749261|NCT00305162|10851207|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
9749262|NCT00305162|10851206|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
9749263|NCT00305162|10851207|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
9749264|NCT00305162|10851206|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
9749265|NCT00305162|10851207|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
9749266|NCT00305162|10851206|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
9749267|NCT00305162|10851207|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
9749268|NCT00305162|10851206|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
9749269|NCT00305162|10851207|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
9749270|NCT00305162|10851206|FG000|NOT COMPLETED|1 Year Follow-up Period||55
9749271|NCT00305162|10851207|FG001|NOT COMPLETED|1 Year Follow-up Period||65
9828811|NCT00757822|10939487|FG000|Withdrawal by Subject-no Intervention|Overall Study||1
9828812|NCT00757822|10939488|FG001|Withdrawal by Subject-no Intervention|Overall Study||3
9828813|NCT00757822|10939487|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
9828814|NCT00757822|10939488|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
9828815|NCT00757822|10939487|FG000|Received Study Intervention|Overall Study||85
9828816|NCT00757822|10939488|FG001|Received Study Intervention|Overall Study||74
9828817|NCT00757822|10939487|FG000|DOS: Post-operative Assessments|Overall Study||85
9828818|NCT00757822|10939488|FG001|DOS: Post-operative Assessments|Overall Study||74
9828819|NCT00757822|10939487|FG000|24-48 hr Telephone Assessment|Overall Study||85
9828820|NCT00757822|10939488|FG001|24-48 hr Telephone Assessment|Overall Study||74
9828821|NCT00757822|10939487|FG000|2-6 wk Post-op Assessment|Overall Study||85
9828822|NCT00757822|10939488|FG001|2-6 wk Post-op Assessment|Overall Study||74
9828823|NCT00757822|10939487|FG000|Data Entry, QC Assessment|Overall Study||85
9828824|NCT00757822|10939488|FG001|Data Entry, QC Assessment|Overall Study||74
9828825|NCT00757822|10939487|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
9828826|NCT00757822|10939488|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
9853663|NCT00887822|10966620|FG001|COMPLETED|Overall Study||0
9853664|NCT00887822|10966619|FG000|NOT COMPLETED|Overall Study||97
9853665|NCT00887822|10966620|FG001|NOT COMPLETED|Overall Study||102
9853666|NCT00887913|10966626|FG000|STARTED|Overall Study||69
9853667|NCT00887913|10966626|FG000|COMPLETED|Overall Study||63
10092057|NCT02333071|11220342|FG000|COMPLETED|Core Study||274
9749272|NCT00305227|10851216|FG000|STARTED|Overall Study||50
9749273|NCT00305227|10851217|FG001|STARTED|Overall Study||50
9749274|NCT00305227|10851216|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43
9749275|NCT00305227|10851217|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44
9749276|NCT00305227|10851216|FG000|NOT COMPLETED|Overall Study||7
9749277|NCT00305227|10851217|FG001|NOT COMPLETED|Overall Study||6
9749278|NCT00305253|10851225|FG000|STARTED|Overall Study||432
9749279|NCT00305253|10851226|FG001|STARTED|Overall Study||559
9749280|NCT00305253|10851225|FG000|COMPLETED|Overall Study||432
9749281|NCT00305253|10851226|FG001|COMPLETED|Overall Study||558
9749282|NCT00305253|10851225|FG000|NOT COMPLETED|Overall Study||0
9749283|NCT00305253|10851226|FG001|NOT COMPLETED|Overall Study||1
9749284|NCT00305448|10851235|FG000|STARTED|Overall Study||45
9749285|NCT00305448|10851236|FG001|STARTED|Overall Study||51
9749286|NCT00305448|10851237|FG002|STARTED|Overall Study||47
9749287|NCT00305448|10851235|FG000|COMPLETED|Overall Study||14
10092058|NCT02333071|11220343|FG001|COMPLETED|Core Study||190
10092059|NCT02333071|11220342|FG000|NOT COMPLETED|Core Study||52
10092060|NCT02333071|11220343|FG001|NOT COMPLETED|Core Study||137
10092061|NCT02333071|11220342|FG000|STARTED|Open Label Extension||239
10092062|NCT02333071|11220343|FG001|STARTED|Open Label Extension||124
10092063|NCT02333071|11220342|FG000|COMPLETED|Open Label Extension||95
10092064|NCT02333071|11220343|FG001|COMPLETED|Open Label Extension||49
10092065|NCT02333071|11220342|FG000|NOT COMPLETED|Open Label Extension||144
10092066|NCT02333071|11220343|FG001|NOT COMPLETED|Open Label Extension||75
10092067|NCT02333331|11220358|FG000|STARTED|Overall Study||19
10092068|NCT02333331|11220359|FG001|STARTED|Overall Study||18
10092069|NCT02333331|11220360|FG002|STARTED|Overall Study||113
10092070|NCT02333331|11220361|FG003|STARTED|Overall Study||67
10092071|NCT02333331|11220358|FG000|COMPLETED|Overall Study||17
10092072|NCT02333331|11220359|FG001|COMPLETED|Overall Study||12
10092073|NCT02333331|11220360|FG002|COMPLETED|Overall Study||95
10092074|NCT02333331|11220361|FG003|COMPLETED|Overall Study||64
9749288|NCT00305448|10851236|FG001|COMPLETED|Overall Study||17
9749289|NCT00305448|10851237|FG002|COMPLETED|Overall Study||14
9749290|NCT00305448|10851235|FG000|NOT COMPLETED|Overall Study||31
9749291|NCT00305448|10851236|FG001|NOT COMPLETED|Overall Study||34
9749292|NCT00305448|10851237|FG002|NOT COMPLETED|Overall Study||33
9749293|NCT00305565|10851249|FG000|STARTED|Overall Study (Safety Population)||111
9749294|NCT00305565|10851250|FG001|STARTED|Overall Study (Safety Population)||107
9749295|NCT00305565|10851251|FG002|STARTED|Overall Study (Safety Population)||113
9749296|NCT00305565|10851249|FG000|COMPLETED|Overall Study (Safety Population)||97
9749297|NCT00305565|10851250|FG001|COMPLETED|Overall Study (Safety Population)||95
9749298|NCT00305565|10851251|FG002|COMPLETED|Overall Study (Safety Population)||106
9749299|NCT00305565|10851249|FG000|NOT COMPLETED|Overall Study (Safety Population)||14
9749300|NCT00305565|10851250|FG001|NOT COMPLETED|Overall Study (Safety Population)||12
9749301|NCT00305565|10851251|FG002|NOT COMPLETED|Overall Study (Safety Population)||7
9749302|NCT00305565|10851249|FG000|STARTED|Overall Study (ITT Population)||102
9749303|NCT00305565|10851250|FG001|STARTED|Overall Study (ITT Population)||101
9749304|NCT00305565|10851251|FG002|STARTED|Overall Study (ITT Population)||107
9749305|NCT00305565|10851249|FG000|COMPLETED|Overall Study (ITT Population)||89
9749306|NCT00305565|10851250|FG001|COMPLETED|Overall Study (ITT Population)||90
9749307|NCT00305565|10851251|FG002|COMPLETED|Overall Study (ITT Population)||102
9749308|NCT00305565|10851249|FG000|NOT COMPLETED|Overall Study (ITT Population)||13
9749309|NCT00305565|10851250|FG001|NOT COMPLETED|Overall Study (ITT Population)||11
9749310|NCT00305565|10851251|FG002|NOT COMPLETED|Overall Study (ITT Population)||5
9749311|NCT00305578|10851262|FG000|STARTED|Overall Study||15
9749312|NCT00305578|10851263|FG001|STARTED|Overall Study||14
9749313|NCT00305578|10851262|FG000|COMPLETED|Overall Study||12
9749314|NCT00305578|10851263|FG001|COMPLETED|Overall Study||12
9749315|NCT00305578|10851262|FG000|NOT COMPLETED|Overall Study||3
9749316|NCT00305578|10851263|FG001|NOT COMPLETED|Overall Study||2
9749317|NCT00305604|10851271|FG000|STARTED|Overall Study||102
9749318|NCT00305604|10851272|FG001|STARTED|Overall Study||104
9749319|NCT00305604|10851271|FG000|COMPLETED|Overall Study||70
9749320|NCT00305604|10851272|FG001|COMPLETED|Overall Study||57
9749321|NCT00305604|10851271|FG000|NOT COMPLETED|Overall Study||32
9749322|NCT00305604|10851272|FG001|NOT COMPLETED|Overall Study||47
9749323|NCT00305682|10851284|FG000|STARTED|Overall Study||98
9749324|NCT00305682|10851285|FG001|STARTED|Overall Study||71
9749325|NCT00305682|10851286|FG002|STARTED|Overall Study||7
9749326|NCT00305682|10851287|FG003|STARTED|Overall Study||34
9749327|NCT00305682|10851288|FG004|STARTED|Overall Study||39
9749328|NCT00305682|10851289|FG005|STARTED|Overall Study||35
9749329|NCT00305682|10851284|FG000|COMPLETED|Overall Study||98
9853668|NCT00887913|10966626|FG000|NOT COMPLETED|Overall Study||6
9853669|NCT00887926|10966634|FG000|STARTED|Overall Study||3
9853670|NCT00887926|10966635|FG001|STARTED|Overall Study||14
10092075|NCT02333331|11220358|FG000|NOT COMPLETED|Overall Study||2
10092076|NCT02333331|11220359|FG001|NOT COMPLETED|Overall Study||6
10092077|NCT02333331|11220360|FG002|NOT COMPLETED|Overall Study||18
10092078|NCT02333331|11220361|FG003|NOT COMPLETED|Overall Study||3
10092079|NCT02333383|11220371|FG000|STARTED|Overall Study||201
10092080|NCT02333383|11220371|FG000|COMPLETED|Overall Study||160
10092081|NCT02333383|11220371|FG000|NOT COMPLETED|Overall Study||41
10092082|NCT02333487|11220378|FG000|STARTED|Overall Study||6
10092083|NCT02333487|11220379|FG001|STARTED|Overall Study||8
10092084|NCT02333487|11220380|FG002|STARTED|Overall Study||8
10092085|NCT02333487|11220378|FG000|COMPLETED|Overall Study||6
10092086|NCT02333487|11220379|FG001|COMPLETED|Overall Study||6
10092087|NCT02333487|11220380|FG002|COMPLETED|Overall Study||8
10092088|NCT02333487|11220378|FG000|NOT COMPLETED|Overall Study||0
10092089|NCT02333487|11220379|FG001|NOT COMPLETED|Overall Study||2
10092090|NCT02333487|11220380|FG002|NOT COMPLETED|Overall Study||0
10092091|NCT02333630|11220391|FG000|STARTED|Overall Study||100
10092092|NCT02333630|11220392|FG001|STARTED|Overall Study||100
9749330|NCT00305682|10851285|FG001|COMPLETED|Overall Study||71
9749331|NCT00305682|10851286|FG002|COMPLETED|Overall Study||7
9749332|NCT00305682|10851287|FG003|COMPLETED|Overall Study||34
9749333|NCT00305682|10851288|FG004|COMPLETED|Overall Study||39
9749334|NCT00305682|10851289|FG005|COMPLETED|Overall Study||35
9749335|NCT00305682|10851284|FG000|NOT COMPLETED|Overall Study||0
9749336|NCT00305682|10851285|FG001|NOT COMPLETED|Overall Study||0
9749337|NCT00305682|10851286|FG002|NOT COMPLETED|Overall Study||0
9749338|NCT00305682|10851287|FG003|NOT COMPLETED|Overall Study||0
9749339|NCT00305682|10851288|FG004|NOT COMPLETED|Overall Study||0
9749340|NCT00305682|10851289|FG005|NOT COMPLETED|Overall Study||0
9749341|NCT00305695|10851305|FG000|STARTED|Overall Study||81
9749342|NCT00305695|10851306|FG001|STARTED|Overall Study||79
9749343|NCT00305695|10851305|FG000|COMPLETED|Overall Study||40
9749344|NCT00305695|10851306|FG001|COMPLETED|Overall Study||52
9749345|NCT00305695|10851305|FG000|NOT COMPLETED|Overall Study||41
9749346|NCT00305695|10851306|FG001|NOT COMPLETED|Overall Study||27
9749347|NCT00305760|10851312|FG000|STARTED|Overall Study||60
9749348|NCT00305760|10851312|FG000|COMPLETED|Overall Study||13
9749349|NCT00305760|10851312|FG000|NOT COMPLETED|Overall Study||47
9749350|NCT00305773|10851318|FG000|STARTED|Overall Study||15
9749351|NCT00305773|10851319|FG001|STARTED|Overall Study||22
9749352|NCT00305773|10851318|FG000|COMPLETED|Overall Study||1
9749353|NCT00305773|10851319|FG001|COMPLETED|Overall Study||4
9749354|NCT00305773|10851318|FG000|NOT COMPLETED|Overall Study||14
9749355|NCT00305773|10851319|FG001|NOT COMPLETED|Overall Study||18
9749356|NCT00305864|10851329|FG000|STARTED|Overall Study||7
9749357|NCT00305864|10851330|FG001|STARTED|Overall Study||10
9749358|NCT00305864|10851331|FG002|STARTED|Overall Study||7
9749359|NCT00305864|10851332|FG003|STARTED|Overall Study||94
9749360|NCT00305864|10851329|FG000|COMPLETED|Overall Study||7
9749361|NCT00305864|10851330|FG001|COMPLETED|Overall Study||9
9749362|NCT00305864|10851331|FG002|COMPLETED|Overall Study||6
9749363|NCT00305864|10851332|FG003|COMPLETED|Overall Study||81
9749364|NCT00305864|10851329|FG000|NOT COMPLETED|Overall Study||0
9749365|NCT00305864|10851330|FG001|NOT COMPLETED|Overall Study||1
9749366|NCT00305864|10851331|FG002|NOT COMPLETED|Overall Study||1
9749367|NCT00305864|10851332|FG003|NOT COMPLETED|Overall Study||13
9749368|NCT00305877|10851344|FG000|STARTED|Overall Study||69
9749369|NCT00305877|10851345|FG001|STARTED|Overall Study||68
9749370|NCT00305877|10851344|FG000|Treated|Overall Study||67
9749371|NCT00305877|10851345|FG001|Treated|Overall Study||63
9749372|NCT00305877|10851344|FG000|Eligible|Overall Study||66
9749373|NCT00305877|10851345|FG001|Eligible|Overall Study||66
9749374|NCT00305877|10851344|FG000|Included in Efficacy Analysis|Overall Study||65
9749375|NCT00305877|10851345|FG001|Included in Efficacy Analysis|Overall Study||62
9749376|NCT00305877|10851344|FG000|COMPLETED|Overall Study||45
9749377|NCT00305877|10851345|FG001|COMPLETED|Overall Study||34
9749378|NCT00305877|10851344|FG000|NOT COMPLETED|Overall Study||24
9749379|NCT00305877|10851345|FG001|NOT COMPLETED|Overall Study||34
9749380|NCT00305942|10851351|FG000|STARTED|Overall Study||61
9749381|NCT00305942|10851351|FG000|COMPLETED|Overall Study||23
9749382|NCT00305942|10851351|FG000|NOT COMPLETED|Overall Study||38
9749383|NCT00306163|10851357|FG000|STARTED|Overall Study||19
9749384|NCT00306163|10851358|FG001|STARTED|Overall Study||18
9749385|NCT00306163|10851357|FG000|COMPLETED|Overall Study||19
9749386|NCT00306163|10851358|FG001|COMPLETED|Overall Study||18
9749387|NCT00306163|10851357|FG000|NOT COMPLETED|Overall Study||0
9749388|NCT00306163|10851358|FG001|NOT COMPLETED|Overall Study||0
9749389|NCT00306189|10851368|FG000|STARTED|Overall Study||57
9749390|NCT00306189|10851369|FG001|STARTED|Overall Study||56
9749391|NCT00306189|10851370|FG002|STARTED|Overall Study||56
9749392|NCT00306189|10851371|FG003|STARTED|Overall Study||57
9749393|NCT00306189|10851368|FG000|COMPLETED|Overall Study||48
9749394|NCT00306189|10851369|FG001|COMPLETED|Overall Study||50
9749395|NCT00306189|10851370|FG002|COMPLETED|Overall Study||45
9749396|NCT00306189|10851371|FG003|COMPLETED|Overall Study||52
9749397|NCT00306189|10851368|FG000|NOT COMPLETED|Overall Study||9
9749398|NCT00306189|10851369|FG001|NOT COMPLETED|Overall Study||6
9749399|NCT00306189|10851370|FG002|NOT COMPLETED|Overall Study||11
9749400|NCT00306189|10851371|FG003|NOT COMPLETED|Overall Study||5
9749401|NCT00306202|10851384|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
9749402|NCT00306202|10851385|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
10092093|NCT02333630|11220391|FG000|COMPLETED|Overall Study||95
10092094|NCT02333630|11220392|FG001|COMPLETED|Overall Study||98
10092095|NCT02333630|11220391|FG000|NOT COMPLETED|Overall Study||5
10092096|NCT02333630|11220392|FG001|NOT COMPLETED|Overall Study||2
9749403|NCT00306202|10851386|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
9749404|NCT00306202|10851384|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17
9749405|NCT00306202|10851385|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17
9749406|NCT00306202|10851386|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24
9749407|NCT00306202|10851384|FG000|NOT COMPLETED|Overall Study||0
9749408|NCT00306202|10851385|FG001|NOT COMPLETED|Overall Study||0
9749409|NCT00306202|10851386|FG002|NOT COMPLETED|Overall Study||0
9749410|NCT00306293|10851432|FG000|STARTED|Period 1 (Day 1 to Day 60)||35
9749411|NCT00306293|10851433|FG001|STARTED|Period 1 (Day 1 to Day 60)||35
9749412|NCT00306293|10851432|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27
9749413|NCT00306293|10851433|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27
9749414|NCT00306293|10851432|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
9749415|NCT00306293|10851433|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
9749416|NCT00306293|10851432|FG000|STARTED|Washout (Day 61 to Day 66)||27
9749417|NCT00306293|10851433|FG001|STARTED|Washout (Day 61 to Day 66)||27
9749418|NCT00306293|10851432|FG000|COMPLETED|Washout (Day 61 to Day 66)||27
9749419|NCT00306293|10851433|FG001|COMPLETED|Washout (Day 61 to Day 66)||27
9749420|NCT00306293|10851432|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0
9749421|NCT00306293|10851433|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0
9749422|NCT00306293|10851432|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27
9749423|NCT00306293|10851433|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27
9749424|NCT00306293|10851432|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24
9749425|NCT00306293|10851433|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26
9749426|NCT00306293|10851432|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
9749427|NCT00306293|10851433|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
9749428|NCT00306384|10851444|FG000|STARTED|Overall Study||1396
9749429|NCT00306384|10851445|FG001|STARTED|Overall Study||1399
9749430|NCT00306384|10851446|FG002|STARTED|Overall Study||528
9749431|NCT00306384|10851444|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
9749432|NCT00306384|10851445|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
9749433|NCT00306384|10851446|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
9749434|NCT00306384|10851444|FG000|COMPLETED|Overall Study||854
9749435|NCT00306384|10851445|FG001|COMPLETED|Overall Study||891
9749436|NCT00306384|10851446|FG002|COMPLETED|Overall Study||251
9749437|NCT00306384|10851444|FG000|NOT COMPLETED|Overall Study||542
9749438|NCT00306384|10851445|FG001|NOT COMPLETED|Overall Study||508
9749439|NCT00306384|10851446|FG002|NOT COMPLETED|Overall Study||277
9749440|NCT00306488|10851454|FG000|STARTED|Overall Study||11
9749441|NCT00306488|10851454|FG000|COMPLETED|Overall Study||10
9749442|NCT00306488|10851454|FG000|NOT COMPLETED|Overall Study||1
9749443|NCT00306527|10851463|FG000|STARTED|Overall Study||533
9749444|NCT00306527|10851464|FG001|STARTED|Overall Study||534
9749445|NCT00306527|10851465|FG002|STARTED|Overall Study||572
9749446|NCT00306527|10851466|FG003|STARTED|Overall Study||596
9749447|NCT00306527|10851463|FG000|COMPLETED|Overall Study||527
9749448|NCT00306527|10851464|FG001|COMPLETED|Overall Study||527
9749449|NCT00306527|10851465|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
9749450|NCT00306527|10851466|FG003|COMPLETED|Overall Study||590
9749451|NCT00306527|10851463|FG000|NOT COMPLETED|Overall Study||6
9749452|NCT00306527|10851464|FG001|NOT COMPLETED|Overall Study||7
9749453|NCT00306527|10851465|FG002|NOT COMPLETED|Overall Study||5
9749454|NCT00306527|10851466|FG003|NOT COMPLETED|Overall Study||6
9749455|NCT00306592|10851480|FG000|STARTED|Overall Study||404
9749456|NCT00306592|10851481|FG001|STARTED|Overall Study||690
9749457|NCT00306592|10851480|FG000|Completed at 24 Weeks|Overall Study||207
9749458|NCT00306592|10851481|FG001|Completed at 24 Weeks|Overall Study||0
9749459|NCT00306592|10851480|FG000|Completed Between 24 and 48 Weeks|Overall Study||85
9749460|NCT00306592|10851481|FG001|Completed Between 24 and 48 Weeks|Overall Study||0
9749461|NCT00306592|10851480|FG000|Completed at 48 Weeks|Overall Study||81
9749462|NCT00306592|10851481|FG001|Completed at 48 Weeks|Overall Study||632
9749463|NCT00306592|10851480|FG000|Entered 101-MS-321 Extension Study|Overall Study||22
9749464|NCT00306592|10851481|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
9749465|NCT00306592|10851480|FG000|COMPLETED|Overall Study||373
9749466|NCT00306592|10851481|FG001|COMPLETED|Overall Study||632
9749467|NCT00306592|10851480|FG000|NOT COMPLETED|Overall Study||31
9749468|NCT00306592|10851481|FG001|NOT COMPLETED|Overall Study||58
9749469|NCT00306670|10851487|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
9749470|NCT00306670|10851488|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
9749471|NCT00306670|10851487|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
9749472|NCT00306670|10851488|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
9749473|NCT00306670|10851487|FG000|NOT COMPLETED|Overall Study||0
9749474|NCT00306670|10851488|FG001|NOT COMPLETED|Overall Study||2
9749475|NCT00306787|10851496|FG000|STARTED|Overall Study||579
9749476|NCT00306787|10851497|FG001|STARTED|Overall Study||600
9749477|NCT00306787|10851496|FG000|Received Study Drug (Safety Population)|Overall Study||371
9749478|NCT00306787|10851497|FG001|Received Study Drug (Safety Population)|Overall Study||385
9749479|NCT00306787|10851496|FG000|Intent to Treat (ITT) Population|Overall Study||370
9749480|NCT00306787|10851497|FG001|Intent to Treat (ITT) Population|Overall Study||381
9749481|NCT00306787|10851496|FG000|COMPLETED|Overall Study||345
9749482|NCT00306787|10851497|FG001|COMPLETED|Overall Study||359
9749483|NCT00306787|10851496|FG000|NOT COMPLETED|Overall Study||234
9749484|NCT00306787|10851497|FG001|NOT COMPLETED|Overall Study||241
9749485|NCT00306852|10851505|FG000|STARTED|Overall Study||105
9749486|NCT00306852|10851506|FG001|STARTED|Overall Study||107
9749487|NCT00306852|10851505|FG000|COMPLETED|Overall Study||76
9749488|NCT00306852|10851506|FG001|COMPLETED|Overall Study||69
9749489|NCT00306852|10851505|FG000|NOT COMPLETED|Overall Study||29
9749490|NCT00306852|10851506|FG001|NOT COMPLETED|Overall Study||38
9749491|NCT00306891|10851516|FG000|STARTED|Part A||23
9749492|NCT00306891|10851517|FG001|STARTED|Part A||22
9749493|NCT00306891|10851518|FG002|STARTED|Part A||0
9749494|NCT00306891|10851519|FG003|STARTED|Part A||0
9749495|NCT00306891|10851516|FG000|COMPLETED|Part A||18
9749496|NCT00306891|10851517|FG001|COMPLETED|Part A||16
9749497|NCT00306891|10851518|FG002|COMPLETED|Part A||0
9749498|NCT00306891|10851519|FG003|COMPLETED|Part A||0
9749499|NCT00306891|10851516|FG000|NOT COMPLETED|Part A||5
9749500|NCT00306891|10851517|FG001|NOT COMPLETED|Part A||6
9749501|NCT00306891|10851518|FG002|NOT COMPLETED|Part A||0
9749502|NCT00306891|10851519|FG003|NOT COMPLETED|Part A||0
9749503|NCT00306891|10851516|FG000|STARTED|Part B||0
9749504|NCT00306891|10851517|FG001|STARTED|Part B||0
9749505|NCT00306891|10851518|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
9749506|NCT00306891|10851519|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
9749507|NCT00306891|10851516|FG000|COMPLETED|Part B||0
9749508|NCT00306891|10851517|FG001|COMPLETED|Part B||0
9749509|NCT00306891|10851518|FG002|COMPLETED|Part B||5
9749510|NCT00306891|10851519|FG003|COMPLETED|Part B||14
9749511|NCT00306891|10851516|FG000|NOT COMPLETED|Part B||0
9749512|NCT00306891|10851517|FG001|NOT COMPLETED|Part B||0
9749513|NCT00306891|10851518|FG002|NOT COMPLETED|Part B||11
9749514|NCT00306891|10851519|FG003|NOT COMPLETED|Part B||17
9749515|NCT00306917|10851532|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
9749516|NCT00306917|10851533|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
9749517|NCT00306917|10851532|FG000|Postoperative to 6 Month Follow up|Overall Study||93
9749518|NCT00306917|10851533|FG001|Postoperative to 6 Month Follow up|Overall Study||100
9749519|NCT00306917|10851532|FG000|12 Month Follow|Overall Study||86
9749520|NCT00306917|10851533|FG001|12 Month Follow|Overall Study||94
9749521|NCT00306917|10851532|FG000|24 Month Follow up|Overall Study||60
9749522|NCT00306917|10851533|FG001|24 Month Follow up|Overall Study||71
9853671|NCT00887926|10966636|FG002|STARTED|Overall Study||3
9853672|NCT00887926|10966637|FG003|STARTED|Overall Study||5
9853673|NCT00887926|10966634|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9853674|NCT00887926|10966635|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10092097|NCT02334059|11220405|FG000|STARTED|Overall Study||37
10092098|NCT02334059|11220406|FG001|STARTED|Overall Study||34
9749523|NCT00306917|10851532|FG000|36 Month Follow up|Overall Study||56
9749524|NCT00306917|10851533|FG001|36 Month Follow up|Overall Study||42
9749525|NCT00306917|10851532|FG000|48 Month Follow up|Overall Study||29
9749526|NCT00306917|10851533|FG001|48 Month Follow up|Overall Study||22
9749527|NCT00306917|10851532|FG000|60 Month Follow up|Overall Study||13
9749528|NCT00306917|10851533|FG001|60 Month Follow up|Overall Study||15
9749529|NCT00306917|10851532|FG000|COMPLETED|Overall Study||13
9749530|NCT00306917|10851533|FG001|COMPLETED|Overall Study||15
9749531|NCT00306917|10851532|FG000|NOT COMPLETED|Overall Study||108
9749532|NCT00306917|10851533|FG001|NOT COMPLETED|Overall Study||109
9749533|NCT00306995|10851546|FG000|STARTED|Study Part I||55
9749534|NCT00306995|10851547|FG001|STARTED|Study Part I||55
9749535|NCT00306995|10851548|FG002|STARTED|Study Part I||55
9749536|NCT00306995|10851549|FG003|STARTED|Study Part I||55
9749537|NCT00306995|10851550|FG004|STARTED|Study Part I||55
9749538|NCT00306995|10851551|FG005|STARTED|Study Part I||55
9749539|NCT00306995|10851552|FG006|STARTED|Study Part I||55
9853675|NCT00887926|10966636|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9853676|NCT00887926|10966637|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
9853677|NCT00887926|10966634|FG000|COMPLETED|Overall Study||3
9853678|NCT00887926|10966635|FG001|COMPLETED|Overall Study||13
10092099|NCT02334059|11220407|FG002|STARTED|Overall Study||37
9749540|NCT00306995|10851546|FG000|COMPLETED|Study Part I||55
9749541|NCT00306995|10851547|FG001|COMPLETED|Study Part I||55
9749542|NCT00306995|10851548|FG002|COMPLETED|Study Part I||55
9749543|NCT00306995|10851549|FG003|COMPLETED|Study Part I||55
9749544|NCT00306995|10851550|FG004|COMPLETED|Study Part I||55
9749545|NCT00306995|10851551|FG005|COMPLETED|Study Part I||55
9749546|NCT00306995|10851552|FG006|COMPLETED|Study Part I||54
9749547|NCT00306995|10851546|FG000|NOT COMPLETED|Study Part I||0
9749548|NCT00306995|10851547|FG001|NOT COMPLETED|Study Part I||0
9749549|NCT00306995|10851548|FG002|NOT COMPLETED|Study Part I||0
9749550|NCT00306995|10851549|FG003|NOT COMPLETED|Study Part I||0
9749551|NCT00306995|10851550|FG004|NOT COMPLETED|Study Part I||0
10092100|NCT02334059|11220405|FG000|COMPLETED|Overall Study||37
9749552|NCT00306995|10851551|FG005|NOT COMPLETED|Study Part I||0
9749553|NCT00306995|10851552|FG006|NOT COMPLETED|Study Part I||1
9749554|NCT00306995|10851546|FG000|STARTED|Study Part II for Subset 1||27
9749555|NCT00306995|10851547|FG001|STARTED|Study Part II for Subset 1||26
9749556|NCT00306995|10851548|FG002|STARTED|Study Part II for Subset 1||27
9749557|NCT00306995|10851549|FG003|STARTED|Study Part II for Subset 1||27
9749558|NCT00306995|10851550|FG004|STARTED|Study Part II for Subset 1||27
9749559|NCT00306995|10851551|FG005|STARTED|Study Part II for Subset 1||26
9749560|NCT00306995|10851552|FG006|STARTED|Study Part II for Subset 1||23
9749561|NCT00306995|10851546|FG000|COMPLETED|Study Part II for Subset 1||27
9749562|NCT00306995|10851547|FG001|COMPLETED|Study Part II for Subset 1||26
9749563|NCT00306995|10851548|FG002|COMPLETED|Study Part II for Subset 1||27
9749564|NCT00306995|10851549|FG003|COMPLETED|Study Part II for Subset 1||27
9749565|NCT00306995|10851550|FG004|COMPLETED|Study Part II for Subset 1||27
9749566|NCT00306995|10851551|FG005|COMPLETED|Study Part II for Subset 1||26
9749567|NCT00306995|10851552|FG006|COMPLETED|Study Part II for Subset 1||23
9749568|NCT00306995|10851546|FG000|NOT COMPLETED|Study Part II for Subset 1||0
9749569|NCT00306995|10851547|FG001|NOT COMPLETED|Study Part II for Subset 1||0
9749570|NCT00306995|10851548|FG002|NOT COMPLETED|Study Part II for Subset 1||0
9749571|NCT00306995|10851549|FG003|NOT COMPLETED|Study Part II for Subset 1||0
9749572|NCT00306995|10851550|FG004|NOT COMPLETED|Study Part II for Subset 1||0
9749573|NCT00306995|10851551|FG005|NOT COMPLETED|Study Part II for Subset 1||0
9749574|NCT00306995|10851552|FG006|NOT COMPLETED|Study Part II for Subset 1||0
9749575|NCT00306995|10851546|FG000|STARTED|Study Part II for Subset 2||23
9749576|NCT00306995|10851547|FG001|STARTED|Study Part II for Subset 2||24
9749577|NCT00306995|10851548|FG002|STARTED|Study Part II for Subset 2||23
9749578|NCT00306995|10851549|FG003|STARTED|Study Part II for Subset 2||22
9749579|NCT00306995|10851550|FG004|STARTED|Study Part II for Subset 2||23
9749580|NCT00306995|10851551|FG005|STARTED|Study Part II for Subset 2||26
9749581|NCT00306995|10851552|FG006|STARTED|Study Part II for Subset 2||24
9749582|NCT00306995|10851546|FG000|COMPLETED|Study Part II for Subset 2||23
9749583|NCT00306995|10851547|FG001|COMPLETED|Study Part II for Subset 2||23
9749584|NCT00306995|10851548|FG002|COMPLETED|Study Part II for Subset 2||23
9749585|NCT00306995|10851549|FG003|COMPLETED|Study Part II for Subset 2||22
9749586|NCT00306995|10851550|FG004|COMPLETED|Study Part II for Subset 2||23
9749587|NCT00306995|10851551|FG005|COMPLETED|Study Part II for Subset 2||26
9749588|NCT00306995|10851552|FG006|COMPLETED|Study Part II for Subset 2||24
9749589|NCT00306995|10851546|FG000|NOT COMPLETED|Study Part II for Subset 2||0
9749590|NCT00306995|10851547|FG001|NOT COMPLETED|Study Part II for Subset 2||1
9749591|NCT00306995|10851548|FG002|NOT COMPLETED|Study Part II for Subset 2||0
9749592|NCT00306995|10851549|FG003|NOT COMPLETED|Study Part II for Subset 2||0
9749593|NCT00306995|10851550|FG004|NOT COMPLETED|Study Part II for Subset 2||0
9749594|NCT00306995|10851551|FG005|NOT COMPLETED|Study Part II for Subset 2||0
9749595|NCT00306995|10851552|FG006|NOT COMPLETED|Study Part II for Subset 2||0
9749596|NCT00307034|10851599|FG000|STARTED|Overall Study||175
9749597|NCT00307034|10851600|FG001|STARTED|Overall Study||176
9749598|NCT00307034|10851599|FG000|COMPLETED|Overall Study||173
9749599|NCT00307034|10851600|FG001|COMPLETED|Overall Study||169
9749600|NCT00307034|10851599|FG000|NOT COMPLETED|Overall Study||2
9749601|NCT00307034|10851600|FG001|NOT COMPLETED|Overall Study||7
9749602|NCT00307047|10851608|FG000|STARTED|Overall Study||2458
9749603|NCT00307047|10851609|FG001|STARTED|Overall Study||1229
9749604|NCT00307047|10851608|FG000|COMPLETED|Overall Study||2389
9749605|NCT00307047|10851609|FG001|COMPLETED|Overall Study||1180
9749606|NCT00307047|10851608|FG000|NOT COMPLETED|Overall Study||69
9749607|NCT00307047|10851609|FG001|NOT COMPLETED|Overall Study||49
9749608|NCT00307086|10851615|FG000|STARTED|Overall Study||30
9749609|NCT00307086|10851615|FG000|COMPLETED|Overall Study||25
9749610|NCT00307086|10851615|FG000|NOT COMPLETED|Overall Study||5
9749611|NCT00307125|10851621|FG000|STARTED|Screening Phase||757
9749612|NCT00307125|10851622|FG001|STARTED|Screening Phase||0
9749613|NCT00307125|10851623|FG002|STARTED|Screening Phase||0
9749614|NCT00307125|10851621|FG000|COMPLETED|Screening Phase||303
9749615|NCT00307125|10851622|FG001|COMPLETED|Screening Phase||0
9749616|NCT00307125|10851623|FG002|COMPLETED|Screening Phase||0
9749617|NCT00307125|10851621|FG000|NOT COMPLETED|Screening Phase||454
9749618|NCT00307125|10851622|FG001|NOT COMPLETED|Screening Phase||0
9749619|NCT00307125|10851623|FG002|NOT COMPLETED|Screening Phase||0
9749620|NCT00307125|10851621|FG000|STARTED|Pilot Phase||0
9749621|NCT00307125|10851622|FG001|STARTED|Pilot Phase||15
9749622|NCT00307125|10851623|FG002|STARTED|Pilot Phase||7
9749623|NCT00307125|10851621|FG000|COMPLETED|Pilot Phase||0
9749624|NCT00307125|10851622|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
9749625|NCT00307125|10851623|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
9749626|NCT00307125|10851621|FG000|NOT COMPLETED|Pilot Phase||0
9749627|NCT00307125|10851622|FG001|NOT COMPLETED|Pilot Phase||2
9749628|NCT00307125|10851623|FG002|NOT COMPLETED|Pilot Phase||1
9749629|NCT00307151|10851637|FG000|STARTED|Overall Study||82
9749630|NCT00307151|10851638|FG001|STARTED|Overall Study||82
9749631|NCT00307151|10851639|FG002|STARTED|Overall Study||147
9749632|NCT00307151|10851640|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
9749633|NCT00307151|10851637|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
9749634|NCT00307151|10851638|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
9749635|NCT00307151|10851639|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
9749636|NCT00307151|10851640|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
9749637|NCT00307151|10851637|FG000|NOT COMPLETED|Overall Study||11
9749638|NCT00307151|10851638|FG001|NOT COMPLETED|Overall Study||7
9749639|NCT00307151|10851639|FG002|NOT COMPLETED|Overall Study||20
9749640|NCT00307151|10851640|FG003|NOT COMPLETED|Overall Study||11
9749641|NCT00307164|10851652|FG000|STARTED|Overall Study||83
9749642|NCT00307164|10851653|FG001|STARTED|Overall Study||82
9749643|NCT00307164|10851652|FG000|COMPLETED|Overall Study||68
9749644|NCT00307164|10851653|FG001|COMPLETED|Overall Study||68
9749645|NCT00307164|10851652|FG000|NOT COMPLETED|Overall Study||15
9749646|NCT00307164|10851653|FG001|NOT COMPLETED|Overall Study||14
9749647|NCT00307294|10851659|FG000|STARTED|Overall Study||40
9749648|NCT00307294|10851659|FG000|COMPLETED|Overall Study||39
10092101|NCT02334059|11220406|FG001|COMPLETED|Overall Study||34
10092102|NCT02334059|11220407|FG002|COMPLETED|Overall Study||37
10092103|NCT02334059|11220405|FG000|NOT COMPLETED|Overall Study||0
10092104|NCT02334059|11220406|FG001|NOT COMPLETED|Overall Study||0
10092105|NCT02334059|11220407|FG002|NOT COMPLETED|Overall Study||0
10092106|NCT02334215|11220418|FG000|STARTED|Overall Study||75
10092107|NCT02334215|11220419|FG001|STARTED|Overall Study||74
10092108|NCT02334215|11220420|FG002|STARTED|Overall Study||76
10092109|NCT02334215|11220418|FG000|COMPLETED|Overall Study||68
10092110|NCT02334215|11220419|FG001|COMPLETED|Overall Study||68
10092111|NCT02334215|11220420|FG002|COMPLETED|Overall Study||61
10092112|NCT02334215|11220418|FG000|NOT COMPLETED|Overall Study||7
10092113|NCT02334215|11220419|FG001|NOT COMPLETED|Overall Study||6
10092114|NCT02334215|11220420|FG002|NOT COMPLETED|Overall Study||15
10092115|NCT02334267|11220430|FG000|STARTED|Overall Study||6
9749649|NCT00307294|10851659|FG000|NOT COMPLETED|Overall Study||1
10092116|NCT02334267|11220431|FG001|STARTED|Overall Study||5
10092117|NCT02334267|11220430|FG000|COMPLETED|Overall Study||5
10092118|NCT02334267|11220431|FG001|COMPLETED|Overall Study||5
10092119|NCT02334267|11220430|FG000|NOT COMPLETED|Overall Study||1
9749650|NCT00307333|10851666|FG000|STARTED|Overall Study||1511
9749651|NCT00307333|10851667|FG001|STARTED|Overall Study||1492
10092120|NCT02334267|11220431|FG001|NOT COMPLETED|Overall Study||0
10092121|NCT02334306|11220445|FG000|STARTED|Double-blind Period||16
10092122|NCT02334306|11220446|FG001|STARTED|Double-blind Period||16
9749652|NCT00307333|10851666|FG000|COMPLETED|Overall Study||1500
9749653|NCT00307333|10851667|FG001|COMPLETED|Overall Study||1489
9749654|NCT00307333|10851666|FG000|NOT COMPLETED|Overall Study||11
9749655|NCT00307333|10851667|FG001|NOT COMPLETED|Overall Study||3
9749656|NCT00307437|10851676|FG000|STARTED|Controlled Period||410
9749657|NCT00307437|10851677|FG001|STARTED|Controlled Period||409
9749658|NCT00307437|10851678|FG002|STARTED|Controlled Period||411
9749659|NCT00307437|10851679|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9832422|NCT00772967|10943209|FG005|STARTED|Break 2 (4-7 Days)||3
9832423|NCT00772967|10943204|FG000|COMPLETED|Break 2 (4-7 Days)||3
9832424|NCT00772967|10943205|FG001|COMPLETED|Break 2 (4-7 Days)||4
9832425|NCT00772967|10943206|FG002|COMPLETED|Break 2 (4-7 Days)||3
9832426|NCT00772967|10943207|FG003|COMPLETED|Break 2 (4-7 Days)||3
9832427|NCT00772967|10943208|FG004|COMPLETED|Break 2 (4-7 Days)||4
9832428|NCT00772967|10943209|FG005|COMPLETED|Break 2 (4-7 Days)||3
9832429|NCT00772967|10943204|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0
9832430|NCT00772967|10943205|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0
9832431|NCT00772967|10943206|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0
9832432|NCT00772967|10943207|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0
9832433|NCT00772967|10943208|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0
9832434|NCT00772967|10943209|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0
9832435|NCT00772967|10943204|FG000|STARTED|Crossover Treatment 3||3
9832436|NCT00772967|10943205|FG001|STARTED|Crossover Treatment 3||4
9832437|NCT00772967|10943206|FG002|STARTED|Crossover Treatment 3||3
9832438|NCT00772967|10943207|FG003|STARTED|Crossover Treatment 3||3
9832439|NCT00772967|10943208|FG004|STARTED|Crossover Treatment 3||4
9832440|NCT00772967|10943209|FG005|STARTED|Crossover Treatment 3||3
9832441|NCT00772967|10943204|FG000|COMPLETED|Crossover Treatment 3||3
9832442|NCT00772967|10943205|FG001|COMPLETED|Crossover Treatment 3||4
9832443|NCT00772967|10943206|FG002|COMPLETED|Crossover Treatment 3||3
9832444|NCT00772967|10943207|FG003|COMPLETED|Crossover Treatment 3||3
9832445|NCT00772967|10943208|FG004|COMPLETED|Crossover Treatment 3||3
9832446|NCT00772967|10943209|FG005|COMPLETED|Crossover Treatment 3||3
9832447|NCT00772967|10943204|FG000|NOT COMPLETED|Crossover Treatment 3||0
9832448|NCT00772967|10943205|FG001|NOT COMPLETED|Crossover Treatment 3||0
9832449|NCT00772967|10943206|FG002|NOT COMPLETED|Crossover Treatment 3||0
9832450|NCT00772967|10943207|FG003|NOT COMPLETED|Crossover Treatment 3||0
9832451|NCT00772967|10943208|FG004|NOT COMPLETED|Crossover Treatment 3||1
9832452|NCT00772967|10943209|FG005|NOT COMPLETED|Crossover Treatment 3||0
9832453|NCT00773097|10943217|FG000|STARTED|Overall Study||46
9832454|NCT00773097|10943217|FG000|COMPLETED|Overall Study||39
9832455|NCT00773097|10943217|FG000|NOT COMPLETED|Overall Study||7
9832456|NCT00773136|10943221|FG000|STARTED|Overall Study||21
9832457|NCT00773136|10943221|FG000|COMPLETED|Overall Study||19
9832458|NCT00773136|10943221|FG000|NOT COMPLETED|Overall Study||2
9832459|NCT00773175|10943228|FG000|STARTED|Overall Study||73
9832460|NCT00773175|10943229|FG001|STARTED|Overall Study||75
9832461|NCT00773175|10943228|FG000|Initial Fluids Via Randomized Route|Overall Study||73
9832462|NCT00773175|10943229|FG001|Initial Fluids Via Randomized Route|Overall Study||59
9832463|NCT00773175|10943228|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
9832464|NCT00773175|10943229|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
9832465|NCT00773175|10943228|FG000|No Fluids Received|Overall Study||0
9749660|NCT00307437|10851680|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9749661|NCT00307437|10851681|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9749662|NCT00307437|10851682|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9749663|NCT00307437|10851676|FG000|COMPLETED|Controlled Period||394
9749664|NCT00307437|10851677|FG001|COMPLETED|Controlled Period||403
9749665|NCT00307437|10851678|FG002|COMPLETED|Controlled Period||402
9749666|NCT00307437|10851679|FG003|COMPLETED|Controlled Period||0
9749667|NCT00307437|10851680|FG004|COMPLETED|Controlled Period||0
9749668|NCT00307437|10851681|FG005|COMPLETED|Controlled Period||0
9749669|NCT00307437|10851682|FG006|COMPLETED|Controlled Period||0
9749670|NCT00307437|10851676|FG000|NOT COMPLETED|Controlled Period||16
9749671|NCT00307437|10851677|FG001|NOT COMPLETED|Controlled Period||6
9749672|NCT00307437|10851678|FG002|NOT COMPLETED|Controlled Period||9
9749673|NCT00307437|10851679|FG003|NOT COMPLETED|Controlled Period||0
9749674|NCT00307437|10851680|FG004|NOT COMPLETED|Controlled Period||0
9749675|NCT00307437|10851681|FG005|NOT COMPLETED|Controlled Period||0
9749676|NCT00307437|10851682|FG006|NOT COMPLETED|Controlled Period||0
9749677|NCT00307437|10851676|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9749678|NCT00307437|10851677|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9749679|NCT00307437|10851678|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9749680|NCT00307437|10851679|FG003|STARTED|After Controlled Period||197
9749681|NCT00307437|10851680|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
9749682|NCT00307437|10851681|FG005|STARTED|After Controlled Period||403
9749683|NCT00307437|10851682|FG006|STARTED|After Controlled Period||402
9749684|NCT00307437|10851676|FG000|COMPLETED|After Controlled Period||0
9749685|NCT00307437|10851677|FG001|COMPLETED|After Controlled Period||0
9749686|NCT00307437|10851678|FG002|COMPLETED|After Controlled Period||0
9749687|NCT00307437|10851679|FG003|COMPLETED|After Controlled Period||139
9749688|NCT00307437|10851680|FG004|COMPLETED|After Controlled Period||140
9749689|NCT00307437|10851681|FG005|COMPLETED|After Controlled Period||281
9749690|NCT00307437|10851682|FG006|COMPLETED|After Controlled Period||289
9749691|NCT00307437|10851676|FG000|NOT COMPLETED|After Controlled Period||0
9749692|NCT00307437|10851677|FG001|NOT COMPLETED|After Controlled Period||0
9749693|NCT00307437|10851678|FG002|NOT COMPLETED|After Controlled Period||0
9749694|NCT00307437|10851679|FG003|NOT COMPLETED|After Controlled Period||58
9749695|NCT00307437|10851680|FG004|NOT COMPLETED|After Controlled Period||55
9749696|NCT00307437|10851681|FG005|NOT COMPLETED|After Controlled Period||122
9749697|NCT00307437|10851682|FG006|NOT COMPLETED|After Controlled Period||113
9749698|NCT00307489|10851706|FG000|STARTED|Baseline Through Week 48||53
9749699|NCT00307489|10851707|FG001|STARTED|Baseline Through Week 48||52
9749700|NCT00307489|10851706|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
9749701|NCT00307489|10851707|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
9749702|NCT00307489|10851706|FG000|NOT COMPLETED|Baseline Through Week 48||1
9749703|NCT00307489|10851707|FG001|NOT COMPLETED|Baseline Through Week 48||2
9749704|NCT00307489|10851706|FG000|STARTED|Week 48 Through Week 168||52
9749705|NCT00307489|10851707|FG001|STARTED|Week 48 Through Week 168||50
9749706|NCT00307489|10851706|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
9749707|NCT00307489|10851707|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
9749708|NCT00307489|10851706|FG000|NOT COMPLETED|Week 48 Through Week 168||6
9749709|NCT00307489|10851707|FG001|NOT COMPLETED|Week 48 Through Week 168||6
9749710|NCT00307684|10851713|FG000|STARTED|Open Label Phase||0
9749711|NCT00307684|10851714|FG001|STARTED|Open Label Phase||0
9749712|NCT00307684|10851715|FG002|STARTED|Open Label Phase|1 screening failure|155
9749713|NCT00307684|10851713|FG000|COMPLETED|Open Label Phase||0
9749714|NCT00307684|10851714|FG001|COMPLETED|Open Label Phase||0
9749715|NCT00307684|10851715|FG002|COMPLETED|Open Label Phase||99
9749716|NCT00307684|10851713|FG000|NOT COMPLETED|Open Label Phase||0
9749717|NCT00307684|10851714|FG001|NOT COMPLETED|Open Label Phase||0
9749718|NCT00307684|10851715|FG002|NOT COMPLETED|Open Label Phase||56
9749719|NCT00307684|10851713|FG000|STARTED|Double Blind Phase||23
9749720|NCT00307684|10851714|FG001|STARTED|Double Blind Phase||22
9749721|NCT00307684|10851715|FG002|STARTED|Double Blind Phase||0
9749722|NCT00307684|10851713|FG000|COMPLETED|Double Blind Phase||21
9749723|NCT00307684|10851714|FG001|COMPLETED|Double Blind Phase||17
9749724|NCT00307684|10851715|FG002|COMPLETED|Double Blind Phase||0
9749725|NCT00307684|10851713|FG000|NOT COMPLETED|Double Blind Phase||2
9749726|NCT00307684|10851714|FG001|NOT COMPLETED|Double Blind Phase||5
9749727|NCT00307684|10851715|FG002|NOT COMPLETED|Double Blind Phase||0
9749728|NCT00307736|10851723|FG000|STARTED|Overall Study||3
9749729|NCT00307736|10851724|FG001|STARTED|Overall Study||3
9749730|NCT00307736|10851725|FG002|STARTED|Overall Study||3
9749731|NCT00307736|10851726|FG003|STARTED|Overall Study||23
9749732|NCT00307736|10851723|FG000|COMPLETED|Overall Study||3
9749733|NCT00307736|10851724|FG001|COMPLETED|Overall Study||3
9749734|NCT00307736|10851725|FG002|COMPLETED|Overall Study||0
9749735|NCT00307736|10851726|FG003|COMPLETED|Overall Study||20
9749736|NCT00307736|10851723|FG000|NOT COMPLETED|Overall Study||0
9749737|NCT00307736|10851724|FG001|NOT COMPLETED|Overall Study||0
9749738|NCT00307736|10851725|FG002|NOT COMPLETED|Overall Study||3
10201739|NCT03440411|11329120|FG002|NOT COMPLETED|Overall Study||2
10201740|NCT03440411|11329121|FG003|NOT COMPLETED|Overall Study||2
10201741|NCT03440424|11329139|FG000|STARTED|Overall Study||8
10201742|NCT03440424|11329140|FG001|STARTED|Overall Study||8
10201743|NCT03440424|11329141|FG002|STARTED|Overall Study||8
10201744|NCT03440424|11329139|FG000|COMPLETED|Overall Study||8
10201745|NCT03440424|11329140|FG001|COMPLETED|Overall Study||8
10201746|NCT03440424|11329141|FG002|COMPLETED|Overall Study||8
10201747|NCT03440424|11329139|FG000|NOT COMPLETED|Overall Study||0
10201748|NCT03440424|11329140|FG001|NOT COMPLETED|Overall Study||0
10201749|NCT03440424|11329141|FG002|NOT COMPLETED|Overall Study||0
10092123|NCT02334306|11220445|FG000|COMPLETED|Double-blind Period||15
10092124|NCT02334306|11220446|FG001|COMPLETED|Double-blind Period||14
10201750|NCT03440619|11329149|FG000|STARTED|Overall Study||28
10092125|NCT02334306|11220445|FG000|NOT COMPLETED|Double-blind Period||1
10092126|NCT02334306|11220446|FG001|NOT COMPLETED|Double-blind Period||2
10092127|NCT02334306|11220445|FG000|STARTED|Open-label Period||15
10092128|NCT02334306|11220446|FG001|STARTED|Open-label Period||14
10092129|NCT02334306|11220445|FG000|COMPLETED|Open-label Period||15
10092130|NCT02334306|11220446|FG001|COMPLETED|Open-label Period||14
10201751|NCT03440619|11329149|FG000|COMPLETED|Overall Study||28
10201752|NCT03440619|11329149|FG000|NOT COMPLETED|Overall Study||0
10201753|NCT03440723|11329155|FG000|STARTED|Overall Study||21
9749739|NCT00307736|10851726|FG003|NOT COMPLETED|Overall Study||3
9749740|NCT00307801|10851739|FG000|STARTED|Overall Study||149
9749741|NCT00307801|10851740|FG001|STARTED|Overall Study||82
9749742|NCT00307801|10851739|FG000|Subjects Received Treatment|Overall Study||145
9749743|NCT00307801|10851740|FG001|Subjects Received Treatment|Overall Study||81
9749744|NCT00307801|10851739|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145
9749745|NCT00307801|10851740|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81
9749746|NCT00307801|10851739|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
9749747|NCT00307801|10851740|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
9749748|NCT00307801|10851739|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
9749749|NCT00307801|10851740|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
9749750|NCT00307801|10851739|FG000|COMPLETED|Overall Study||117
9749751|NCT00307801|10851740|FG001|COMPLETED|Overall Study||65
9749752|NCT00307801|10851739|FG000|NOT COMPLETED|Overall Study||32
9749753|NCT00307801|10851740|FG001|NOT COMPLETED|Overall Study||17
10092131|NCT02334306|11220445|FG000|NOT COMPLETED|Open-label Period||0
10092132|NCT02334306|11220446|FG001|NOT COMPLETED|Open-label Period||0
10092133|NCT02334358|11220453|FG000|STARTED|Overall Study||503
10092134|NCT02334358|11220453|FG000|COMPLETED|Overall Study||494
9749754|NCT00307931|10851747|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
9749755|NCT00307931|10851747|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
9749756|NCT00307931|10851747|FG000|NOT COMPLETED|Overall Study||1
9749757|NCT00308061|10851753|FG000|STARTED|Overall Study||20
9749758|NCT00308061|10851754|FG001|STARTED|Overall Study||20
9749759|NCT00308061|10851753|FG000|COMPLETED|Overall Study||20
9749760|NCT00308061|10851754|FG001|COMPLETED|Overall Study||20
9749761|NCT00308061|10851753|FG000|NOT COMPLETED|Overall Study||0
9749762|NCT00308061|10851754|FG001|NOT COMPLETED|Overall Study||0
9749763|NCT00308074|10851761|FG000|STARTED|Overall Study||14
9749764|NCT00308074|10851761|FG000|COMPLETED|Overall Study||13
9749765|NCT00308074|10851761|FG000|NOT COMPLETED|Overall Study||1
9749766|NCT00308087|10851767|FG000|STARTED|Overall Study||37
10092135|NCT02334358|11220453|FG000|NOT COMPLETED|Overall Study||9
10092136|NCT02334384|11220459|FG000|STARTED|Overall Study||4
10092137|NCT02334384|11220460|FG001|STARTED|Overall Study||2
10201754|NCT03440723|11329156|FG001|STARTED|Overall Study||21
10201755|NCT03440723|11329155|FG000|COMPLETED|Overall Study||21
10201756|NCT03440723|11329156|FG001|COMPLETED|Overall Study||21
10201757|NCT03440723|11329155|FG000|NOT COMPLETED|Overall Study||0
10201758|NCT03440723|11329156|FG001|NOT COMPLETED|Overall Study||0
9749767|NCT00308087|10851768|FG001|STARTED|Overall Study||38
9749768|NCT00308087|10851767|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
9749769|NCT00308087|10851768|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
9749770|NCT00308087|10851767|FG000|NOT COMPLETED|Overall Study||36
9749771|NCT00308087|10851768|FG001|NOT COMPLETED|Overall Study||37
9749772|NCT00308139|10851776|FG000|STARTED|Overall Study||152
9749773|NCT00308139|10851777|FG001|STARTED|Overall Study||151
9832466|NCT00773175|10943229|FG001|No Fluids Received|Overall Study||1
9832467|NCT00773175|10943228|FG000|COMPLETED|Overall Study||71
9832468|NCT00773175|10943229|FG001|COMPLETED|Overall Study||73
9832469|NCT00773175|10943228|FG000|NOT COMPLETED|Overall Study||2
9832470|NCT00773175|10943229|FG001|NOT COMPLETED|Overall Study||2
9832471|NCT00773253|10943242|FG000|STARTED|First Intervention (Week 0-24)||5
9832472|NCT00773253|10943243|FG001|STARTED|First Intervention (Week 0-24)||5
9832473|NCT00773253|10943242|FG000|COMPLETED|First Intervention (Week 0-24)||5
9832474|NCT00773253|10943243|FG001|COMPLETED|First Intervention (Week 0-24)||4
9832475|NCT00773253|10943242|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0
9832476|NCT00773253|10943243|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1
9832477|NCT00773253|10943242|FG000|STARTED|Second Intervention (Week 24-48)||5
9832478|NCT00773253|10943243|FG001|STARTED|Second Intervention (Week 24-48)||4
9749774|NCT00308139|10851776|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
9749775|NCT00308139|10851777|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
9749776|NCT00308139|10851776|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
9749777|NCT00308139|10851777|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
9749778|NCT00308139|10851776|FG000|Pharmacokinetics Population|Overall Study||129
9749779|NCT00308139|10851777|FG001|Pharmacokinetics Population|Overall Study||0
9749780|NCT00308139|10851776|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27
9749781|NCT00308139|10851777|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24
9749782|NCT00308139|10851776|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
9749783|NCT00308139|10851777|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
9749784|NCT00308139|10851776|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
9749785|NCT00308139|10851777|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
9749786|NCT00308139|10851776|FG000|NOT COMPLETED|Overall Study||94
9749787|NCT00308139|10851777|FG001|NOT COMPLETED|Overall Study||87
9749788|NCT00308230|10851806|FG000|STARTED|Overall Study||6
9749789|NCT00308230|10851807|FG001|STARTED|Overall Study||8
9749790|NCT00308230|10851808|FG002|STARTED|Overall Study||20
9749791|NCT00308230|10851806|FG000|COMPLETED|Overall Study||6
9749792|NCT00308230|10851807|FG001|COMPLETED|Overall Study||8
9749793|NCT00308230|10851808|FG002|COMPLETED|Overall Study||20
9749794|NCT00308230|10851806|FG000|NOT COMPLETED|Overall Study||0
9749795|NCT00308230|10851807|FG001|NOT COMPLETED|Overall Study||0
9749796|NCT00308230|10851808|FG002|NOT COMPLETED|Overall Study||0
9749797|NCT00308282|10851820|FG000|STARTED|Overall Study||34
9749798|NCT00308282|10851821|FG001|STARTED|Overall Study||34
9749799|NCT00308282|10851822|FG002|STARTED|Overall Study||34
9749800|NCT00308282|10851823|FG003|STARTED|Overall Study||34
9749801|NCT00308282|10851820|FG000|Received at Least One Dose of Study Drug|Overall Study||34
9749802|NCT00308282|10851821|FG001|Received at Least One Dose of Study Drug|Overall Study||34
9749803|NCT00308282|10851822|FG002|Received at Least One Dose of Study Drug|Overall Study||34
9749804|NCT00308282|10851823|FG003|Received at Least One Dose of Study Drug|Overall Study||34
9749805|NCT00308282|10851820|FG000|COMPLETED|Overall Study||31
9749806|NCT00308282|10851821|FG001|COMPLETED|Overall Study||30
9749807|NCT00308282|10851822|FG002|COMPLETED|Overall Study||33
9749808|NCT00308282|10851823|FG003|COMPLETED|Overall Study||32
9749809|NCT00308282|10851820|FG000|NOT COMPLETED|Overall Study||3
9749810|NCT00308282|10851821|FG001|NOT COMPLETED|Overall Study||4
9749811|NCT00308282|10851822|FG002|NOT COMPLETED|Overall Study||1
9749812|NCT00308282|10851823|FG003|NOT COMPLETED|Overall Study||2
9749813|NCT00308308|10851838|FG000|STARTED|Overall Study||301
9749814|NCT00308308|10851839|FG001|STARTED|Overall Study||288
9749815|NCT00308308|10851838|FG000|COMPLETED|Overall Study||198
9853679|NCT00887926|10966636|FG002|COMPLETED|Overall Study||3
9853680|NCT00887926|10966637|FG003|COMPLETED|Overall Study||5
9853681|NCT00887926|10966634|FG000|NOT COMPLETED|Overall Study||0
9853682|NCT00887926|10966635|FG001|NOT COMPLETED|Overall Study||1
9853683|NCT00887926|10966636|FG002|NOT COMPLETED|Overall Study||0
9853684|NCT00887926|10966637|FG003|NOT COMPLETED|Overall Study||0
9853685|NCT00887965|10966649|FG000|STARTED|Overall Study||15
9853686|NCT00887965|10966649|FG000|COMPLETED|Overall Study||15
9853687|NCT00887965|10966649|FG000|NOT COMPLETED|Overall Study||0
9853688|NCT00887978|10966655|FG000|STARTED|Overall Study||157
9853689|NCT00887978|10966656|FG001|STARTED|Overall Study||153
9853690|NCT00887978|10966655|FG000|COMPLETED|Overall Study||132
9853691|NCT00887978|10966656|FG001|COMPLETED|Overall Study||138
9853692|NCT00887978|10966655|FG000|NOT COMPLETED|Overall Study||25
9853693|NCT00887978|10966656|FG001|NOT COMPLETED|Overall Study||15
9853694|NCT00888134|10966662|FG000|STARTED|Treatment With Study Drug||28
9853695|NCT00888134|10966662|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
9853696|NCT00888134|10966662|FG000|NOT COMPLETED|Treatment With Study Drug||1
9853697|NCT00888134|10966662|FG000|STARTED|Follow-up||27
9853698|NCT00888134|10966662|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
9853699|NCT00888134|10966662|FG000|NOT COMPLETED|Follow-up||1
9853700|NCT00888173|10966667|FG000|STARTED|Overall Study||45
9853701|NCT00888173|10966667|FG000|COMPLETED|Overall Study||43
9853702|NCT00888173|10966667|FG000|NOT COMPLETED|Overall Study||2
9853703|NCT00888238|10966671|FG000|STARTED|First Period of Treatment Intervention||4
9853704|NCT00888238|10966672|FG001|STARTED|First Period of Treatment Intervention||4
9853705|NCT00888238|10966673|FG002|STARTED|First Period of Treatment Intervention||4
9853706|NCT00888238|10966671|FG000|COMPLETED|First Period of Treatment Intervention||4
9853707|NCT00888238|10966672|FG001|COMPLETED|First Period of Treatment Intervention||4
9853708|NCT00888238|10966673|FG002|COMPLETED|First Period of Treatment Intervention||4
9853709|NCT00888238|10966671|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
9853710|NCT00888238|10966672|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
9853711|NCT00888238|10966673|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
9853712|NCT00888238|10966671|FG000|STARTED|Washout Period After Period 1||4
9749816|NCT00308308|10851839|FG001|COMPLETED|Overall Study||220
9749817|NCT00308308|10851838|FG000|NOT COMPLETED|Overall Study||103
9749818|NCT00308308|10851839|FG001|NOT COMPLETED|Overall Study||68
9749819|NCT00308555|10851847|FG000|STARTED|Overall Study||13
9749820|NCT00308555|10851848|FG001|STARTED|Overall Study||11
9749821|NCT00308555|10851847|FG000|COMPLETED|Overall Study||10
9749822|NCT00308555|10851848|FG001|COMPLETED|Overall Study||11
9749823|NCT00308555|10851847|FG000|NOT COMPLETED|Overall Study||3
9749824|NCT00308555|10851848|FG001|NOT COMPLETED|Overall Study||0
9749825|NCT00308581|10851854|FG000|STARTED|Induction Phase|Not applicable in this period|0
9749826|NCT00308581|10851855|FG001|STARTED|Induction Phase|Not applicable in this period|0
9749827|NCT00308581|10851856|FG002|STARTED|Induction Phase||539
9749828|NCT00308581|10851854|FG000|COMPLETED|Induction Phase|Not applicable in this period|0
9749829|NCT00308581|10851855|FG001|COMPLETED|Induction Phase|Not applicable in this period|0
9749830|NCT00308581|10851856|FG002|COMPLETED|Induction Phase||373
9749831|NCT00308581|10851854|FG000|NOT COMPLETED|Induction Phase||0
9749832|NCT00308581|10851855|FG001|NOT COMPLETED|Induction Phase||0
9749833|NCT00308581|10851856|FG002|NOT COMPLETED|Induction Phase||166
9749834|NCT00308581|10851854|FG000|STARTED|Randomized Maintenance Phase||187
9749835|NCT00308581|10851855|FG001|STARTED|Randomized Maintenance Phase||186
9749836|NCT00308581|10851856|FG002|STARTED|Randomized Maintenance Phase||0
9749837|NCT00308581|10851854|FG000|COMPLETED|Randomized Maintenance Phase||82
9749838|NCT00308581|10851855|FG001|COMPLETED|Randomized Maintenance Phase||83
9749839|NCT00308581|10851856|FG002|COMPLETED|Randomized Maintenance Phase||0
9749840|NCT00308581|10851854|FG000|NOT COMPLETED|Randomized Maintenance Phase||105
9749841|NCT00308581|10851855|FG001|NOT COMPLETED|Randomized Maintenance Phase||103
9749842|NCT00308581|10851856|FG002|NOT COMPLETED|Randomized Maintenance Phase||0
9749843|NCT00308620|10851867|FG000|STARTED|Overall Study||3
9749844|NCT00308620|10851868|FG001|STARTED|Overall Study||4
9749845|NCT00308620|10851869|FG002|STARTED|Overall Study||6
9749846|NCT00308620|10851867|FG000|COMPLETED|Overall Study||2
9749847|NCT00308620|10851868|FG001|COMPLETED|Overall Study||3
9749848|NCT00308620|10851869|FG002|COMPLETED|Overall Study||5
9749849|NCT00308620|10851867|FG000|NOT COMPLETED|Overall Study||1
9749850|NCT00308620|10851868|FG001|NOT COMPLETED|Overall Study||1
9749851|NCT00308620|10851869|FG002|NOT COMPLETED|Overall Study||1
9749852|NCT00308711|10851880|FG000|STARTED|Overall Study||428
9749853|NCT00308711|10851881|FG001|STARTED|Overall Study||444
9749854|NCT00308711|10851882|FG002|STARTED|Overall Study||436
9749855|NCT00308711|10851880|FG000|COMPLETED|Overall Study||426
9749856|NCT00308711|10851881|FG001|COMPLETED|Overall Study||440
9749857|NCT00308711|10851882|FG002|COMPLETED|Overall Study||431
9749858|NCT00308711|10851880|FG000|NOT COMPLETED|Overall Study||2
9749859|NCT00308711|10851881|FG001|NOT COMPLETED|Overall Study||4
9749860|NCT00308711|10851882|FG002|NOT COMPLETED|Overall Study||5
9749861|NCT00308737|10851893|FG000|STARTED|Overall Study||938
9749862|NCT00308737|10851894|FG001|STARTED|Overall Study||951
9749863|NCT00308737|10851895|FG002|STARTED|Overall Study||164
9749864|NCT00308737|10851893|FG000|COMPLETED|Overall Study||475
9749865|NCT00308737|10851894|FG001|COMPLETED|Overall Study||662
9749866|NCT00308737|10851895|FG002|COMPLETED|Overall Study||127
9749867|NCT00308737|10851893|FG000|NOT COMPLETED|Overall Study||463
9749868|NCT00308737|10851894|FG001|NOT COMPLETED|Overall Study||289
10092138|NCT02334384|11220459|FG000|COMPLETED|Overall Study||3
10092139|NCT02334384|11220460|FG001|COMPLETED|Overall Study||1
10092140|NCT02334384|11220459|FG000|NOT COMPLETED|Overall Study||1
10092141|NCT02334384|11220460|FG001|NOT COMPLETED|Overall Study||1
10092142|NCT02334423|11220468|FG000|STARTED|Overall Study||246
10092143|NCT02334423|11220469|FG001|STARTED|Overall Study||84
10092144|NCT02334423|11220468|FG000|COMPLETED|Overall Study||236
10092145|NCT02334423|11220469|FG001|COMPLETED|Overall Study||81
9749869|NCT00308737|10851895|FG002|NOT COMPLETED|Overall Study||37
9749870|NCT00308750|10851906|FG000|STARTED|Overall Study||72
9749871|NCT00308750|10851907|FG001|STARTED|Overall Study||74
9749872|NCT00308750|10851908|FG002|STARTED|Overall Study||72
9749873|NCT00308750|10851906|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67
9749874|NCT00308750|10851907|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
9749875|NCT00308750|10851908|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
9749876|NCT00308750|10851906|FG000|COMPLETED|Overall Study||0
9749877|NCT00308750|10851907|FG001|COMPLETED|Overall Study||34
10092146|NCT02334423|11220468|FG000|NOT COMPLETED|Overall Study||10
10092147|NCT02334423|11220469|FG001|NOT COMPLETED|Overall Study||3
9749878|NCT00308750|10851908|FG002|COMPLETED|Overall Study||23
9749879|NCT00308750|10851906|FG000|NOT COMPLETED|Overall Study||72
9749880|NCT00308750|10851907|FG001|NOT COMPLETED|Overall Study||40
9749881|NCT00308750|10851908|FG002|NOT COMPLETED|Overall Study||49
9749882|NCT00308997|10851919|FG000|STARTED|Overall Study||56
9749883|NCT00308997|10851920|FG001|STARTED|Overall Study||29
9749884|NCT00308997|10851919|FG000|COMPLETED|Overall Study||55
9749885|NCT00308997|10851920|FG001|COMPLETED|Overall Study||28
9749886|NCT00308997|10851919|FG000|NOT COMPLETED|Overall Study||1
9749887|NCT00308997|10851920|FG001|NOT COMPLETED|Overall Study||1
9749888|NCT00309140|10851926|FG000|STARTED|Overall Study||23
9749889|NCT00309140|10851926|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
9749890|NCT00309140|10851926|FG000|COMPLETED|Overall Study||23
9749891|NCT00309140|10851926|FG000|NOT COMPLETED|Overall Study||0
9749892|NCT00309166|10851932|FG000|STARTED|Overall Study||181
9749893|NCT00309166|10851933|FG001|STARTED|Overall Study||89
9749894|NCT00309166|10851932|FG000|COMPLETED|Overall Study||176
9749895|NCT00309166|10851933|FG001|COMPLETED|Overall Study||86
9749896|NCT00309166|10851932|FG000|NOT COMPLETED|Overall Study||5
9749897|NCT00309166|10851933|FG001|NOT COMPLETED|Overall Study||3
9749898|NCT00309244|10851941|FG000|STARTED|Overall Study||334
9749899|NCT00309244|10851942|FG001|STARTED|Overall Study||343
9749900|NCT00309244|10851941|FG000|COMPLETED|Overall Study||216
9749901|NCT00309244|10851942|FG001|COMPLETED|Overall Study||246
9749902|NCT00309244|10851941|FG000|NOT COMPLETED|Overall Study||118
9749903|NCT00309244|10851942|FG001|NOT COMPLETED|Overall Study||97
9749904|NCT00309387|10851950|FG000|STARTED|Overall Study||510
9749905|NCT00309387|10851951|FG001|STARTED|Overall Study||510
9749906|NCT00309387|10851950|FG000|COMPLETED|Overall Study||368
9749907|NCT00309387|10851951|FG001|COMPLETED|Overall Study||351
9749908|NCT00309387|10851950|FG000|NOT COMPLETED|Overall Study||142
9749909|NCT00309387|10851951|FG001|NOT COMPLETED|Overall Study||159
9749910|NCT00309452|10851960|FG000|STARTED|Overall Study||60
9749911|NCT00309452|10851961|FG001|STARTED|Overall Study||60
9749912|NCT00309452|10851960|FG000|COMPLETED|Overall Study||57
9749913|NCT00309452|10851961|FG001|COMPLETED|Overall Study||60
9749914|NCT00309452|10851960|FG000|NOT COMPLETED|Overall Study||3
9749915|NCT00309452|10851961|FG001|NOT COMPLETED|Overall Study||0
9749916|NCT00309465|10851973|FG000|STARTED|Overall Study||58
9749917|NCT00309465|10851974|FG001|STARTED|Overall Study||58
9749918|NCT00309465|10851975|FG002|STARTED|Overall Study||58
9749919|NCT00309465|10851976|FG003|STARTED|Overall Study||76
9749920|NCT00309465|10851977|FG004|STARTED|Overall Study||76
9749921|NCT00309465|10851978|FG005|STARTED|Overall Study||76
9749922|NCT00309465|10851973|FG000|COMPLETED|Overall Study||58
9749923|NCT00309465|10851974|FG001|COMPLETED|Overall Study||58
9749924|NCT00309465|10851975|FG002|COMPLETED|Overall Study||58
9749925|NCT00309465|10851976|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
9749926|NCT00309465|10851977|FG004|COMPLETED|Overall Study||76
9749927|NCT00309465|10851978|FG005|COMPLETED|Overall Study||76
9749928|NCT00309465|10851973|FG000|NOT COMPLETED|Overall Study||0
9749929|NCT00309465|10851974|FG001|NOT COMPLETED|Overall Study||0
9749930|NCT00309465|10851975|FG002|NOT COMPLETED|Overall Study||0
9749931|NCT00309465|10851976|FG003|NOT COMPLETED|Overall Study||1
9749932|NCT00309465|10851977|FG004|NOT COMPLETED|Overall Study||0
9749933|NCT00309465|10851978|FG005|NOT COMPLETED|Overall Study||0
9749934|NCT00309608|10851997|FG000|STARTED|Overall Study||71
9749935|NCT00309608|10851998|FG001|STARTED|Overall Study||65
9749936|NCT00309608|10851999|FG002|STARTED|Overall Study||66
9749937|NCT00309608|10852000|FG003|STARTED|Overall Study||66
9749938|NCT00309608|10852001|FG004|STARTED|Overall Study||65
9749939|NCT00309608|10851997|FG000|COMPLETED|Overall Study||57
9749940|NCT00309608|10851998|FG001|COMPLETED|Overall Study||52
9749941|NCT00309608|10851999|FG002|COMPLETED|Overall Study||56
9749942|NCT00309608|10852000|FG003|COMPLETED|Overall Study||60
9749943|NCT00309608|10852001|FG004|COMPLETED|Overall Study||61
9749944|NCT00309608|10851997|FG000|NOT COMPLETED|Overall Study||14
9749945|NCT00309608|10851998|FG001|NOT COMPLETED|Overall Study||13
9749946|NCT00309608|10851999|FG002|NOT COMPLETED|Overall Study||10
9749947|NCT00309608|10852000|FG003|NOT COMPLETED|Overall Study||6
9749948|NCT00309608|10852001|FG004|NOT COMPLETED|Overall Study||4
9749949|NCT00309738|10852015|FG000|STARTED|Overall Study||236
9749950|NCT00309738|10852016|FG001|STARTED|Overall Study||119
9749951|NCT00309738|10852015|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
9749952|NCT00309738|10852016|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
9749953|NCT00309738|10852015|FG000|COMPLETED|Overall Study||223
9749954|NCT00309738|10852016|FG001|COMPLETED|Overall Study||107
9749955|NCT00309738|10852015|FG000|NOT COMPLETED|Overall Study||13
9749956|NCT00309738|10852016|FG001|NOT COMPLETED|Overall Study||12
9749957|NCT00309751|10852024|FG000|STARTED|Overall Study||279
9749958|NCT00309751|10852025|FG001|STARTED|Overall Study||139
9749959|NCT00309751|10852024|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
9749960|NCT00309751|10852025|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
9749961|NCT00309751|10852024|FG000|COMPLETED|Overall Study||248
9749962|NCT00309751|10852025|FG001|COMPLETED|Overall Study||124
9749963|NCT00309751|10852024|FG000|NOT COMPLETED|Overall Study||31
9749964|NCT00309751|10852025|FG001|NOT COMPLETED|Overall Study||15
9749965|NCT00309777|10852035|FG000|STARTED|Overall Study||315
9749966|NCT00309777|10852036|FG001|STARTED|Overall Study||108
9749967|NCT00309777|10852037|FG002|STARTED|Overall Study||323
9749968|NCT00309777|10852038|FG003|STARTED|Overall Study||111
9749969|NCT00309777|10852035|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
9749970|NCT00309777|10852036|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
9749971|NCT00309777|10852037|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
9749972|NCT00309777|10852038|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
9749973|NCT00309777|10852035|FG000|COMPLETED|Overall Study||292
9749974|NCT00309777|10852036|FG001|COMPLETED|Overall Study||99
9749975|NCT00309777|10852037|FG002|COMPLETED|Overall Study||304
9749976|NCT00309777|10852038|FG003|COMPLETED|Overall Study||107
9749977|NCT00309777|10852035|FG000|NOT COMPLETED|Overall Study||23
9749978|NCT00309777|10852036|FG001|NOT COMPLETED|Overall Study||9
9749979|NCT00309777|10852037|FG002|NOT COMPLETED|Overall Study||19
9749980|NCT00309777|10852038|FG003|NOT COMPLETED|Overall Study||4
9749981|NCT00309842|10852048|FG000|STARTED|Overall Study||213
9749982|NCT00309842|10852048|FG000|COMPLETED|Overall Study||212
9749983|NCT00309842|10852048|FG000|NOT COMPLETED|Overall Study||1
9749984|NCT00309907|10852052|FG000|STARTED|Overall Study||39
9749985|NCT00309907|10852052|FG000|COMPLETED|Overall Study||19
9749986|NCT00309907|10852052|FG000|NOT COMPLETED|Overall Study||20
9749987|NCT00309946|10852057|FG000|STARTED|Overall Study||51
9749988|NCT00309946|10852057|FG000|COMPLETED|Overall Study||50
9749989|NCT00309946|10852057|FG000|NOT COMPLETED|Overall Study||1
9749990|NCT00309959|10852061|FG000|STARTED|Overall Study||37
9749991|NCT00309959|10852061|FG000|COMPLETED|Overall Study||35
9853713|NCT00888238|10966672|FG001|STARTED|Washout Period After Period 1||4
9853714|NCT00888238|10966673|FG002|STARTED|Washout Period After Period 1||4
9853715|NCT00888238|10966671|FG000|COMPLETED|Washout Period After Period 1||4
9853716|NCT00888238|10966672|FG001|COMPLETED|Washout Period After Period 1||4
9853717|NCT00888238|10966673|FG002|COMPLETED|Washout Period After Period 1||4
9853718|NCT00888238|10966671|FG000|NOT COMPLETED|Washout Period After Period 1||0
9853719|NCT00888238|10966672|FG001|NOT COMPLETED|Washout Period After Period 1||0
9853720|NCT00888238|10966673|FG002|NOT COMPLETED|Washout Period After Period 1||0
9749992|NCT00309959|10852061|FG000|NOT COMPLETED|Overall Study||2
9749993|NCT00310037|10852072|FG000|STARTED|Overall Study||52
9749994|NCT00310037|10852073|FG001|STARTED|Overall Study||50
9749995|NCT00310037|10852072|FG000|COMPLETED|Overall Study||34
9749996|NCT00310037|10852073|FG001|COMPLETED|Overall Study||33
9749997|NCT00310037|10852072|FG000|NOT COMPLETED|Overall Study||18
9749998|NCT00310037|10852073|FG001|NOT COMPLETED|Overall Study||17
9749999|NCT00310050|10852079|FG000|STARTED|Overall Study||4
9750000|NCT00310050|10852079|FG000|COMPLETED|Overall Study||3
9750001|NCT00310050|10852079|FG000|NOT COMPLETED|Overall Study||1
9750002|NCT00310076|10852083|FG000|STARTED|Overall Study||29
9750003|NCT00310076|10852083|FG000|COMPLETED|Overall Study||26
9750004|NCT00310076|10852083|FG000|NOT COMPLETED|Overall Study||3
9750005|NCT00310310|10852089|FG000|STARTED|Overall Study||120
9750006|NCT00310310|10852090|FG001|STARTED|Overall Study||120
9750007|NCT00310310|10852089|FG000|COMPLETED|Overall Study||90
9750008|NCT00310310|10852090|FG001|COMPLETED|Overall Study||100
9750009|NCT00310310|10852089|FG000|NOT COMPLETED|Overall Study||30
9750010|NCT00310310|10852090|FG001|NOT COMPLETED|Overall Study||20
9750011|NCT00310362|10852099|FG000|STARTED|Overall Study||1199
9750012|NCT00310362|10852100|FG001|STARTED|Overall Study||1205
9750013|NCT00310362|10852101|FG002|STARTED|Overall Study||1206
9750014|NCT00310362|10852099|FG000|COMPLETED|Overall Study||1199
9750015|NCT00310362|10852100|FG001|COMPLETED|Overall Study||1205
9750016|NCT00310362|10852101|FG002|COMPLETED|Overall Study||1206
9750017|NCT00310362|10852099|FG000|NOT COMPLETED|Overall Study||0
9750018|NCT00310362|10852100|FG001|NOT COMPLETED|Overall Study||0
9750019|NCT00310362|10852101|FG002|NOT COMPLETED|Overall Study||0
9750020|NCT00310375|10852117|FG000|STARTED|Primary Reporting Phase||102
9750021|NCT00310375|10852118|FG001|STARTED|Primary Reporting Phase||79
9750022|NCT00310375|10852119|FG002|STARTED|Primary Reporting Phase||0
9750023|NCT00310375|10852117|FG000|COMPLETED|Primary Reporting Phase||11
9750024|NCT00310375|10852118|FG001|COMPLETED|Primary Reporting Phase||11
9750025|NCT00310375|10852119|FG002|COMPLETED|Primary Reporting Phase||0
9750026|NCT00310375|10852117|FG000|NOT COMPLETED|Primary Reporting Phase||91
9750027|NCT00310375|10852118|FG001|NOT COMPLETED|Primary Reporting Phase||68
9750028|NCT00310375|10852119|FG002|NOT COMPLETED|Primary Reporting Phase||0
9750029|NCT00310375|10852117|FG000|STARTED|Safety Follow-up Continuation Phase||0
9750030|NCT00310375|10852118|FG001|STARTED|Safety Follow-up Continuation Phase||0
9750031|NCT00310375|10852119|FG002|STARTED|Safety Follow-up Continuation Phase||19
9750032|NCT00310375|10852117|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
9750033|NCT00310375|10852118|FG001|COMPLETED|Safety Follow-up Continuation Phase||0
9750034|NCT00310375|10852119|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
9750035|NCT00310375|10852117|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
9750036|NCT00310375|10852118|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0
9750037|NCT00310375|10852119|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1
9750038|NCT00310401|10852130|FG000|STARTED|Overall Study||260
9750039|NCT00310401|10852131|FG001|STARTED|Overall Study||246
9750040|NCT00310401|10852130|FG000|COMPLETED|Overall Study||260
9750041|NCT00310401|10852131|FG001|COMPLETED|Overall Study||246
9750042|NCT00310401|10852130|FG000|NOT COMPLETED|Overall Study||0
9750043|NCT00310401|10852131|FG001|NOT COMPLETED|Overall Study||0
9750044|NCT00310427|10852141|FG000|STARTED|Overall Study||27
9750045|NCT00310427|10852142|FG001|STARTED|Overall Study||26
9750046|NCT00310427|10852141|FG000|COMPLETED|Overall Study||25
9750047|NCT00310427|10852142|FG001|COMPLETED|Overall Study||25
9853721|NCT00888238|10966671|FG000|STARTED|Second Period of Treatment Intervention||4
9853722|NCT00888238|10966672|FG001|STARTED|Second Period of Treatment Intervention||4
9853723|NCT00888238|10966673|FG002|STARTED|Second Period of Treatment Intervention||4
9750048|NCT00310427|10852141|FG000|NOT COMPLETED|Overall Study||2
9750049|NCT00310427|10852142|FG001|NOT COMPLETED|Overall Study||1
9750050|NCT00310440|10852150|FG000|STARTED|Overall Study||165
9750051|NCT00310440|10852151|FG001|STARTED|Overall Study||154
9750052|NCT00310440|10852150|FG000|COMPLETED|Overall Study||139
9750053|NCT00310440|10852151|FG001|COMPLETED|Overall Study||141
9750054|NCT00310440|10852150|FG000|NOT COMPLETED|Overall Study||26
9750055|NCT00310440|10852151|FG001|NOT COMPLETED|Overall Study||13
9750056|NCT00310466|10852159|FG000|STARTED|Overall Study||113
9750057|NCT00310466|10852160|FG001|STARTED|Overall Study||113
9750058|NCT00310466|10852159|FG000|COMPLETED|Overall Study||95
9750059|NCT00310466|10852160|FG001|COMPLETED|Overall Study||101
9750060|NCT00310466|10852159|FG000|NOT COMPLETED|Overall Study||18
9750061|NCT00310466|10852160|FG001|NOT COMPLETED|Overall Study||12
9750062|NCT00310791|10852168|FG000|STARTED|Overall Study||40
9750063|NCT00310791|10852169|FG001|STARTED|Overall Study||40
9750064|NCT00310791|10852168|FG000|COMPLETED|Overall Study||30
9750065|NCT00310791|10852169|FG001|COMPLETED|Overall Study||30
9750066|NCT00310791|10852168|FG000|NOT COMPLETED|Overall Study||10
9750067|NCT00310791|10852169|FG001|NOT COMPLETED|Overall Study||10
9750068|NCT00310804|10852177|FG000|STARTED|Overall Study||1029
9750069|NCT00310804|10852178|FG001|STARTED|Overall Study||171
9750070|NCT00310804|10852177|FG000|COMPLETED|Overall Study||1024
9750071|NCT00310804|10852178|FG001|COMPLETED|Overall Study||171
9750072|NCT00310804|10852177|FG000|NOT COMPLETED|Overall Study||5
9750073|NCT00310804|10852178|FG001|NOT COMPLETED|Overall Study||0
9750074|NCT00310817|10852202|FG000|STARTED|Overall Study||207
9750075|NCT00310817|10852203|FG001|STARTED|Overall Study||206
9750076|NCT00310817|10852204|FG002|STARTED|Overall Study||128
9750077|NCT00310817|10852205|FG003|STARTED|Overall Study||82
9750078|NCT00310817|10852202|FG000|COMPLETED|Overall Study||196
9750079|NCT00310817|10852203|FG001|COMPLETED|Overall Study||198
9750080|NCT00310817|10852204|FG002|COMPLETED|Overall Study||120
9750081|NCT00310817|10852205|FG003|COMPLETED|Overall Study||74
9750082|NCT00310817|10852202|FG000|NOT COMPLETED|Overall Study||11
9750083|NCT00310817|10852203|FG001|NOT COMPLETED|Overall Study||8
9750084|NCT00310817|10852204|FG002|NOT COMPLETED|Overall Study||8
9750085|NCT00310817|10852205|FG003|NOT COMPLETED|Overall Study||8
9750086|NCT00310856|10852251|FG000|STARTED|Overall Study||64
9750087|NCT00310856|10852252|FG001|STARTED|Overall Study||61
9750088|NCT00310856|10852253|FG002|STARTED|Overall Study||50
9750089|NCT00310856|10852251|FG000|COMPLETED|Overall Study||59
9750090|NCT00310856|10852252|FG001|COMPLETED|Overall Study||56
9750091|NCT00310856|10852253|FG002|COMPLETED|Overall Study||42
9750092|NCT00310856|10852251|FG000|NOT COMPLETED|Overall Study||5
9750093|NCT00310856|10852252|FG001|NOT COMPLETED|Overall Study||5
9750094|NCT00310856|10852253|FG002|NOT COMPLETED|Overall Study||8
9750095|NCT00311155|10852262|FG000|STARTED|Overall Study||694
9750096|NCT00311155|10852262|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
9750097|NCT00311155|10852262|FG000|NOT COMPLETED|Overall Study||93
9750098|NCT00311168|10852268|FG000|STARTED|First Intervention||66
9750099|NCT00311168|10852269|FG001|STARTED|First Intervention||68
9750100|NCT00311168|10852268|FG000|COMPLETED|First Intervention||59
9750101|NCT00311168|10852269|FG001|COMPLETED|First Intervention||62
9750102|NCT00311168|10852268|FG000|NOT COMPLETED|First Intervention||7
9750103|NCT00311168|10852269|FG001|NOT COMPLETED|First Intervention||6
9750104|NCT00311168|10852268|FG000|STARTED|Second Intervention||59
9750105|NCT00311168|10852269|FG001|STARTED|Second Intervention||62
9750106|NCT00311168|10852268|FG000|COMPLETED|Second Intervention||49
9750107|NCT00311168|10852269|FG001|COMPLETED|Second Intervention||58
9750108|NCT00311168|10852268|FG000|NOT COMPLETED|Second Intervention||10
9750109|NCT00311168|10852269|FG001|NOT COMPLETED|Second Intervention||4
9750110|NCT00311181|10852277|FG000|STARTED|Overall Study||217
9750111|NCT00311181|10852277|FG000|COMPLETED|Overall Study||121
9750112|NCT00311181|10852277|FG000|NOT COMPLETED|Overall Study||96
9750113|NCT00311246|10852281|FG000|STARTED|Overall Study||11
9750114|NCT00311246|10852281|FG000|COMPLETED|Overall Study||11
9750115|NCT00311246|10852281|FG000|NOT COMPLETED|Overall Study||0
9750116|NCT00311311|10852290|FG000|STARTED|Overall Study||37
9750117|NCT00311311|10852291|FG001|STARTED|Overall Study||35
9750118|NCT00311311|10852290|FG000|COMPLETED|Overall Study||29
9750119|NCT00311311|10852291|FG001|COMPLETED|Overall Study||26
9750120|NCT00311311|10852290|FG000|NOT COMPLETED|Overall Study||8
9750121|NCT00311311|10852291|FG001|NOT COMPLETED|Overall Study||9
9750122|NCT00311363|10852300|FG000|STARTED|24-Week Single-Blind Treatment Period||327
9750123|NCT00311363|10852301|FG001|STARTED|24-Week Single-Blind Treatment Period||0
9750124|NCT00311363|10852302|FG002|STARTED|24-Week Single-Blind Treatment Period||0
9750125|NCT00311363|10852300|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221
9750126|NCT00311363|10852301|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0
9750127|NCT00311363|10852302|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0
9750128|NCT00311363|10852300|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
9750129|NCT00311363|10852301|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
9750130|NCT00311363|10852302|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
9750131|NCT00311363|10852300|FG000|STARTED|12-Week Double-Blind Treatment Period||0
9750132|NCT00311363|10852301|FG001|STARTED|12-Week Double-Blind Treatment Period||98
9750133|NCT00311363|10852302|FG002|STARTED|12-Week Double-Blind Treatment Period||96
9750134|NCT00311363|10852300|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0
9750135|NCT00311363|10852301|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84
9750136|NCT00311363|10852302|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84
9750137|NCT00311363|10852300|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
9750138|NCT00311363|10852301|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
9750139|NCT00311363|10852302|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
9750140|NCT00311376|10852315|FG000|STARTED|Treatment Cycle 1||132
9750141|NCT00311376|10852316|FG001|STARTED|Treatment Cycle 1||135
9750142|NCT00311376|10852317|FG002|STARTED|Treatment Cycle 1||149
9750143|NCT00311376|10852315|FG000|COMPLETED|Treatment Cycle 1||105
9750144|NCT00311376|10852316|FG001|COMPLETED|Treatment Cycle 1||118
9750145|NCT00311376|10852317|FG002|COMPLETED|Treatment Cycle 1||132
9750146|NCT00311376|10852315|FG000|NOT COMPLETED|Treatment Cycle 1||27
9750147|NCT00311376|10852316|FG001|NOT COMPLETED|Treatment Cycle 1||17
9750148|NCT00311376|10852317|FG002|NOT COMPLETED|Treatment Cycle 1||17
9750149|NCT00311376|10852315|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
10092148|NCT02334436|11220477|FG000|STARTED|Overall Study||246
10092149|NCT02334436|11220478|FG001|STARTED|Overall Study||78
10092150|NCT02334436|11220477|FG000|COMPLETED|Overall Study||237
10092151|NCT02334436|11220478|FG001|COMPLETED|Overall Study||77
10092152|NCT02334436|11220477|FG000|NOT COMPLETED|Overall Study||9
10092153|NCT02334436|11220478|FG001|NOT COMPLETED|Overall Study||1
10092154|NCT02334527|11220484|FG000|STARTED|Overall Study||12
10092155|NCT02334527|11220484|FG000|COMPLETED|Overall Study||12
9750150|NCT00311376|10852316|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
9750151|NCT00311376|10852317|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
9750152|NCT00311376|10852315|FG000|COMPLETED|Treatment Cycle 2||106
9750153|NCT00311376|10852316|FG001|COMPLETED|Treatment Cycle 2||112
9750154|NCT00311376|10852317|FG002|COMPLETED|Treatment Cycle 2||0
9750155|NCT00311376|10852315|FG000|NOT COMPLETED|Treatment Cycle 2||9
9750156|NCT00311376|10852316|FG001|NOT COMPLETED|Treatment Cycle 2||13
9750157|NCT00311376|10852317|FG002|NOT COMPLETED|Treatment Cycle 2||0
10092156|NCT02334527|11220484|FG000|NOT COMPLETED|Overall Study||0
10092157|NCT02334683|11220494|FG000|STARTED|First 12 Week Period||10
9750158|NCT00311402|10852327|FG000|STARTED|Overall Study||655
9750159|NCT00311402|10852328|FG001|STARTED|Overall Study||639
9750160|NCT00311402|10852327|FG000|COMPLETED|Overall Study||445
9750161|NCT00311402|10852328|FG001|COMPLETED|Overall Study||462
9750162|NCT00311402|10852327|FG000|NOT COMPLETED|Overall Study||210
9750163|NCT00311402|10852328|FG001|NOT COMPLETED|Overall Study||177
9750164|NCT00311584|10852336|FG000|STARTED|Overall Study||29
9750165|NCT00311584|10852337|FG001|STARTED|Overall Study||30
9750166|NCT00311584|10852336|FG000|COMPLETED|Overall Study||9
9750167|NCT00311584|10852337|FG001|COMPLETED|Overall Study||7
9750168|NCT00311584|10852336|FG000|NOT COMPLETED|Overall Study||20
9750169|NCT00311584|10852337|FG001|NOT COMPLETED|Overall Study||23
9750170|NCT00311623|10852346|FG000|STARTED|Overall Study||10
9750171|NCT00311623|10852347|FG001|STARTED|Overall Study||20
9750172|NCT00311623|10852348|FG002|STARTED|Overall Study||2
9750173|NCT00311623|10852346|FG000|COMPLETED|Overall Study||10
9750174|NCT00311623|10852347|FG001|COMPLETED|Overall Study||20
9750175|NCT00311623|10852348|FG002|COMPLETED|Overall Study||0
9750176|NCT00311623|10852346|FG000|NOT COMPLETED|Overall Study||0
9750177|NCT00311623|10852347|FG001|NOT COMPLETED|Overall Study||0
9750178|NCT00311623|10852348|FG002|NOT COMPLETED|Overall Study||2
9750179|NCT00311766|10852359|FG000|STARTED|Overall Study||8
9750180|NCT00311766|10852360|FG001|STARTED|Overall Study||22
9750181|NCT00311766|10852359|FG000|COMPLETED|Overall Study||8
9750182|NCT00311766|10852360|FG001|COMPLETED|Overall Study||17
9750183|NCT00311766|10852359|FG000|NOT COMPLETED|Overall Study||0
9750184|NCT00311766|10852360|FG001|NOT COMPLETED|Overall Study||5
9750185|NCT00312195|10852368|FG000|STARTED|Overall Study||138
9750186|NCT00312195|10852369|FG001|STARTED|Overall Study||129
9750187|NCT00312195|10852368|FG000|COMPLETED|Overall Study||132
9750188|NCT00312195|10852369|FG001|COMPLETED|Overall Study||123
9750189|NCT00312195|10852368|FG000|NOT COMPLETED|Overall Study||6
9750190|NCT00312195|10852369|FG001|NOT COMPLETED|Overall Study||6
9750191|NCT00312208|10852379|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
9750192|NCT00312208|10852380|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
9750193|NCT00312208|10852379|FG000|COMPLETED|Overall Study||1477
9750194|NCT00312208|10852380|FG001|COMPLETED|Overall Study||1526
9750195|NCT00312208|10852379|FG000|NOT COMPLETED|Overall Study||172
9750196|NCT00312208|10852380|FG001|NOT COMPLETED|Overall Study||123
9750197|NCT00312221|10852389|FG000|STARTED|Open-label Run-in Period||652
9750198|NCT00312221|10852390|FG001|STARTED|Open-label Run-in Period||0
9750199|NCT00312221|10852391|FG002|STARTED|Open-label Run-in Period||0
9750200|NCT00312221|10852392|FG003|STARTED|Open-label Run-in Period||0
9750201|NCT00312221|10852389|FG000|COMPLETED|Open-label Run-in Period||418
9750202|NCT00312221|10852390|FG001|COMPLETED|Open-label Run-in Period||0
9750203|NCT00312221|10852391|FG002|COMPLETED|Open-label Run-in Period||0
9750204|NCT00312221|10852392|FG003|COMPLETED|Open-label Run-in Period||0
9853724|NCT00888238|10966671|FG000|COMPLETED|Second Period of Treatment Intervention||4
9853725|NCT00888238|10966672|FG001|COMPLETED|Second Period of Treatment Intervention||4
9853726|NCT00888238|10966673|FG002|COMPLETED|Second Period of Treatment Intervention||4
9853727|NCT00888238|10966671|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
9853728|NCT00888238|10966672|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
9853729|NCT00888238|10966673|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
10092158|NCT02334683|11220495|FG001|STARTED|First 12 Week Period||10
10092159|NCT02334683|11220494|FG000|COMPLETED|First 12 Week Period||9
10092160|NCT02334683|11220495|FG001|COMPLETED|First 12 Week Period||10
9750205|NCT00312221|10852389|FG000|NOT COMPLETED|Open-label Run-in Period||234
9750206|NCT00312221|10852390|FG001|NOT COMPLETED|Open-label Run-in Period||0
9750207|NCT00312221|10852391|FG002|NOT COMPLETED|Open-label Run-in Period||0
9750208|NCT00312221|10852392|FG003|NOT COMPLETED|Open-label Run-in Period||0
9750209|NCT00312221|10852389|FG000|STARTED|Double-blind Phase||0
9750210|NCT00312221|10852390|FG001|STARTED|Double-blind Phase||136
9750211|NCT00312221|10852391|FG002|STARTED|Double-blind Phase||149
9750212|NCT00312221|10852392|FG003|STARTED|Double-blind Phase||133
9750213|NCT00312221|10852389|FG000|COMPLETED|Double-blind Phase||0
9750214|NCT00312221|10852390|FG001|COMPLETED|Double-blind Phase||77
9750215|NCT00312221|10852391|FG002|COMPLETED|Double-blind Phase||77
9750216|NCT00312221|10852392|FG003|COMPLETED|Double-blind Phase||63
9750217|NCT00312221|10852389|FG000|NOT COMPLETED|Double-blind Phase||0
9750218|NCT00312221|10852390|FG001|NOT COMPLETED|Double-blind Phase||59
9750219|NCT00312221|10852391|FG002|NOT COMPLETED|Double-blind Phase||72
9750220|NCT00312221|10852392|FG003|NOT COMPLETED|Double-blind Phase||70
9750221|NCT00312338|10852403|FG000|STARTED|Overall Study||105
9750222|NCT00312338|10852404|FG001|STARTED|Overall Study||57
9750223|NCT00312338|10852403|FG000|COMPLETED|Overall Study||83
9750224|NCT00312338|10852404|FG001|COMPLETED|Overall Study||54
9750225|NCT00312338|10852403|FG000|NOT COMPLETED|Overall Study||22
9750226|NCT00312338|10852404|FG001|NOT COMPLETED|Overall Study||3
9750227|NCT00312377|10852412|FG000|STARTED|Overall Study|randomised patients|694
9750228|NCT00312377|10852413|FG001|STARTED|Overall Study|randomised patients|697
9750229|NCT00312377|10852412|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
9750230|NCT00312377|10852413|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
9750231|NCT00312377|10852412|FG000|NOT COMPLETED|Overall Study||644
9750232|NCT00312377|10852413|FG001|NOT COMPLETED|Overall Study||668
9750233|NCT00312494|10852422|FG000|STARTED|Overall Study||232
9750234|NCT00312494|10852423|FG001|STARTED|Overall Study||226
9750235|NCT00312494|10852424|FG002|STARTED|Overall Study||222
9750236|NCT00312494|10852422|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
9750237|NCT00312494|10852423|FG001|Received Study Treatment|Overall Study||216
9750238|NCT00312494|10852424|FG002|Received Study Treatment|Overall Study||217
9750239|NCT00312494|10852422|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
9750240|NCT00312494|10852423|FG001|COMPLETED|Overall Study||168
9750241|NCT00312494|10852424|FG002|COMPLETED|Overall Study||179
9750242|NCT00312494|10852422|FG000|NOT COMPLETED|Overall Study||71
9750243|NCT00312494|10852423|FG001|NOT COMPLETED|Overall Study||58
9750244|NCT00312494|10852424|FG002|NOT COMPLETED|Overall Study||43
9828827|NCT00757822|10939487|FG000|Withdrawn-protocol Deviation|Overall Study||9
9828828|NCT00757822|10939488|FG001|Withdrawn-protocol Deviation|Overall Study||8
9828829|NCT00757822|10939487|FG000|Data Lock, Unblinding Analysis|Overall Study||64
9828830|NCT00757822|10939488|FG001|Data Lock, Unblinding Analysis|Overall Study||57
9828831|NCT00757822|10939487|FG000|COMPLETED|Overall Study||64
9828832|NCT00757822|10939488|FG001|COMPLETED|Overall Study||57
9828833|NCT00757822|10939487|FG000|NOT COMPLETED|Overall Study||28
9828834|NCT00757822|10939488|FG001|NOT COMPLETED|Overall Study||31
9828835|NCT00757848|10939499|FG000|STARTED|Overall Study||27
9828836|NCT00757848|10939500|FG001|STARTED|Overall Study||29
9828837|NCT00757848|10939499|FG000|COMPLETED|Overall Study||24
9828838|NCT00757848|10939500|FG001|COMPLETED|Overall Study||27
9828839|NCT00757848|10939499|FG000|NOT COMPLETED|Overall Study||3
9828840|NCT00757848|10939500|FG001|NOT COMPLETED|Overall Study||2
9828841|NCT00758043|10939510|FG000|STARTED|Overall Study||162
9828842|NCT00758043|10939511|FG001|STARTED|Overall Study||160
9828843|NCT00758043|10939512|FG002|STARTED|Overall Study||118
9828844|NCT00758043|10939513|FG003|STARTED|Overall Study||100
9828845|NCT00758043|10939510|FG000|COMPLETED|Overall Study||161
9828846|NCT00758043|10939511|FG001|COMPLETED|Overall Study||119
9828847|NCT00758043|10939512|FG002|COMPLETED|Overall Study||79
9828848|NCT00758043|10939513|FG003|COMPLETED|Overall Study||0
9828849|NCT00758043|10939510|FG000|NOT COMPLETED|Overall Study||1
9828850|NCT00758043|10939511|FG001|NOT COMPLETED|Overall Study||41
9828851|NCT00758043|10939512|FG002|NOT COMPLETED|Overall Study||39
9828852|NCT00758043|10939513|FG003|NOT COMPLETED|Overall Study||100
9828853|NCT00758069|10939532|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
9828854|NCT00758069|10939533|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
9828855|NCT00758069|10939534|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
9828856|NCT00758069|10939532|FG000|COMPLETED|Overall Study||26
9828857|NCT00758069|10939533|FG001|COMPLETED|Overall Study||25
9828858|NCT00758069|10939534|FG002|COMPLETED|Overall Study||27
9828859|NCT00758069|10939532|FG000|NOT COMPLETED|Overall Study||1
9828860|NCT00758069|10939533|FG001|NOT COMPLETED|Overall Study||0
9828861|NCT00758069|10939534|FG002|NOT COMPLETED|Overall Study||1
9828862|NCT00758160|10939542|FG000|STARTED|Overall Study||296
9828863|NCT00758160|10939542|FG000|COMPLETED|Overall Study||230
9828864|NCT00758160|10939542|FG000|NOT COMPLETED|Overall Study||66
9828865|NCT00758264|10939553|FG000|STARTED|Active Phase||182
9828866|NCT00758264|10939554|FG001|STARTED|Active Phase||91
9828867|NCT00758264|10939555|FG002|STARTED|Active Phase||90
9828868|NCT00758264|10939553|FG000|COMPLETED|Active Phase||181
9828869|NCT00758264|10939554|FG001|COMPLETED|Active Phase||91
9828870|NCT00758264|10939555|FG002|COMPLETED|Active Phase||85
9828871|NCT00758264|10939553|FG000|NOT COMPLETED|Active Phase||1
9828872|NCT00758264|10939554|FG001|NOT COMPLETED|Active Phase||0
9828873|NCT00758264|10939555|FG002|NOT COMPLETED|Active Phase||5
9828874|NCT00758264|10939553|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181
9828875|NCT00758264|10939554|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90
9828876|NCT00758264|10939555|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89
9828877|NCT00758264|10939553|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
9828878|NCT00758264|10939554|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
9828879|NCT00758264|10939555|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
9750245|NCT00312572|10852434|FG000|STARTED|Overall Study||101
9750246|NCT00312572|10852435|FG001|STARTED|Overall Study||103
9750247|NCT00312572|10852434|FG000|COMPLETED|Overall Study||85
9750248|NCT00312572|10852435|FG001|COMPLETED|Overall Study||82
9750249|NCT00312572|10852434|FG000|NOT COMPLETED|Overall Study||16
9750250|NCT00312572|10852435|FG001|NOT COMPLETED|Overall Study||21
9750251|NCT00312663|10852446|FG000|STARTED|Immunization Phase||5
9750252|NCT00312663|10852447|FG001|STARTED|Immunization Phase||13
9750253|NCT00312663|10852448|FG002|STARTED|Immunization Phase||0
9750254|NCT00312663|10852446|FG000|COMPLETED|Immunization Phase||5
9750255|NCT00312663|10852447|FG001|COMPLETED|Immunization Phase||12
9750256|NCT00312663|10852448|FG002|COMPLETED|Immunization Phase||0
9750257|NCT00312663|10852446|FG000|NOT COMPLETED|Immunization Phase||0
9750258|NCT00312663|10852447|FG001|NOT COMPLETED|Immunization Phase||1
9750259|NCT00312663|10852448|FG002|NOT COMPLETED|Immunization Phase||0
9750260|NCT00312663|10852446|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
9750261|NCT00312663|10852447|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
9750262|NCT00312663|10852448|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
9750263|NCT00312663|10852446|FG000|COMPLETED|Challenge Phase||0
9750264|NCT00312663|10852447|FG001|COMPLETED|Challenge Phase||10
9750265|NCT00312663|10852448|FG002|COMPLETED|Challenge Phase||6
9750266|NCT00312663|10852446|FG000|NOT COMPLETED|Challenge Phase||0
9750267|NCT00312663|10852447|FG001|NOT COMPLETED|Challenge Phase||0
9750268|NCT00312663|10852448|FG002|NOT COMPLETED|Challenge Phase||0
9750269|NCT00312702|10852460|FG000|STARTED|Immunization Phase||5
9750270|NCT00312702|10852461|FG001|STARTED|Immunization Phase||13
9750271|NCT00312702|10852462|FG002|STARTED|Immunization Phase||0
9750272|NCT00312702|10852460|FG000|COMPLETED|Immunization Phase||5
9750273|NCT00312702|10852461|FG001|COMPLETED|Immunization Phase||12
9750274|NCT00312702|10852462|FG002|COMPLETED|Immunization Phase||0
9750275|NCT00312702|10852460|FG000|NOT COMPLETED|Immunization Phase||0
9750276|NCT00312702|10852461|FG001|NOT COMPLETED|Immunization Phase||1
9750277|NCT00312702|10852462|FG002|NOT COMPLETED|Immunization Phase||0
9750278|NCT00312702|10852460|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
9750279|NCT00312702|10852461|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
9750280|NCT00312702|10852462|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
9750281|NCT00312702|10852460|FG000|COMPLETED|Challenge Phase||0
9750282|NCT00312702|10852461|FG001|COMPLETED|Challenge Phase||12
9750283|NCT00312702|10852462|FG002|COMPLETED|Challenge Phase||1
9853730|NCT00888238|10966671|FG000|STARTED|Washout Period After Period 2||4
9853731|NCT00888238|10966672|FG001|STARTED|Washout Period After Period 2||4
9853732|NCT00888238|10966673|FG002|STARTED|Washout Period After Period 2||4
9853733|NCT00888238|10966671|FG000|COMPLETED|Washout Period After Period 2||4
9853734|NCT00888238|10966672|FG001|COMPLETED|Washout Period After Period 2||4
9853735|NCT00888238|10966673|FG002|COMPLETED|Washout Period After Period 2||3
9853736|NCT00888238|10966671|FG000|NOT COMPLETED|Washout Period After Period 2||0
9853737|NCT00888238|10966672|FG001|NOT COMPLETED|Washout Period After Period 2||0
9853738|NCT00888238|10966673|FG002|NOT COMPLETED|Washout Period After Period 2||1
9853739|NCT00888238|10966671|FG000|STARTED|Third Period of Treatment Intervention||4
9853740|NCT00888238|10966672|FG001|STARTED|Third Period of Treatment Intervention||4
9853741|NCT00888238|10966673|FG002|STARTED|Third Period of Treatment Intervention||3
9853742|NCT00888238|10966671|FG000|COMPLETED|Third Period of Treatment Intervention||4
9853743|NCT00888238|10966672|FG001|COMPLETED|Third Period of Treatment Intervention||4
9853744|NCT00888238|10966673|FG002|COMPLETED|Third Period of Treatment Intervention||3
9853745|NCT00888238|10966671|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
9853746|NCT00888238|10966672|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
9853747|NCT00888238|10966673|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
9953007|NCT01424943|11071865|FG001|NOT COMPLETED|Overall Study||1
9953008|NCT01425190|11071874|FG000|STARTED|Overall Study||16
9953009|NCT01425190|11071875|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
9953010|NCT01425190|11071876|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
9953011|NCT01425190|11071874|FG000|COMPLETED|Overall Study||15
9953012|NCT01425190|11071875|FG001|COMPLETED|Overall Study||0
9953013|NCT01425190|11071876|FG002|COMPLETED|Overall Study||0
9953014|NCT01425190|11071874|FG000|NOT COMPLETED|Overall Study||1
9953015|NCT01425190|11071875|FG001|NOT COMPLETED|Overall Study||0
9953016|NCT01425190|11071876|FG002|NOT COMPLETED|Overall Study||0
9953017|NCT01425203|11071886|FG000|STARTED|Treatment Phase||159
9953018|NCT01425203|11071887|FG001|STARTED|Treatment Phase||79
9953019|NCT01425203|11071888|FG002|STARTED|Treatment Phase||0
9953020|NCT01425203|11071886|FG000|Treated (FAS)|Treatment Phase||159
9953021|NCT01425203|11071887|FG001|Treated (FAS)|Treatment Phase||78
9953022|NCT01425203|11071888|FG002|Treated (FAS)|Treatment Phase||0
9953023|NCT01425203|11071886|FG000|COMPLETED|Treatment Phase||132
9953024|NCT01425203|11071887|FG001|COMPLETED|Treatment Phase||42
9750284|NCT00312702|10852460|FG000|NOT COMPLETED|Challenge Phase||0
9750285|NCT00312702|10852461|FG001|NOT COMPLETED|Challenge Phase||0
9750286|NCT00312702|10852462|FG002|NOT COMPLETED|Challenge Phase||0
9750287|NCT00312728|10852470|FG000|STARTED|Overall Study||115
9750288|NCT00312728|10852470|FG000|COMPLETED|Overall Study||5
9750289|NCT00312728|10852470|FG000|NOT COMPLETED|Overall Study||110
10092161|NCT02334683|11220494|FG000|NOT COMPLETED|First 12 Week Period||1
9750290|NCT00312845|10852476|FG000|STARTED|Overall Study||336
9750291|NCT00312845|10852477|FG001|STARTED|Overall Study||340
9750292|NCT00312845|10852476|FG000|COMPLETED|Overall Study||237
9750293|NCT00312845|10852477|FG001|COMPLETED|Overall Study||245
9750294|NCT00312845|10852476|FG000|NOT COMPLETED|Overall Study||99
9750295|NCT00312845|10852477|FG001|NOT COMPLETED|Overall Study||95
9750296|NCT00312858|10852485|FG000|STARTED|Overall Study||330
9750297|NCT00312858|10852486|FG001|STARTED|Overall Study||323
9750298|NCT00312858|10852485|FG000|Visit 1|Overall Study||330
9750299|NCT00312858|10852486|FG001|Visit 1|Overall Study||323
9750300|NCT00312858|10852485|FG000|Visit 2|Overall Study||305
9750301|NCT00312858|10852486|FG001|Visit 2|Overall Study||294
9750302|NCT00312858|10852485|FG000|Visit 3|Overall Study||273
9750303|NCT00312858|10852486|FG001|Visit 3|Overall Study||261
9750304|NCT00312858|10852485|FG000|Visit 4|Overall Study||262
9750305|NCT00312858|10852486|FG001|Visit 4|Overall Study||240
9750306|NCT00312858|10852485|FG000|COMPLETED|Overall Study||262
9750307|NCT00312858|10852486|FG001|COMPLETED|Overall Study||230
9750308|NCT00312858|10852485|FG000|NOT COMPLETED|Overall Study||68
9750309|NCT00312858|10852486|FG001|NOT COMPLETED|Overall Study||93
9750310|NCT00312884|10852494|FG000|STARTED|Overall Study||91
9750311|NCT00312884|10852495|FG001|STARTED|Overall Study||91
9750312|NCT00312884|10852494|FG000|COMPLETED|Overall Study||74
9750313|NCT00312884|10852495|FG001|COMPLETED|Overall Study||79
9750314|NCT00312884|10852494|FG000|NOT COMPLETED|Overall Study||17
9750315|NCT00312884|10852495|FG001|NOT COMPLETED|Overall Study||12
9750316|NCT00312897|10852503|FG000|STARTED|Overall Study||27
9750317|NCT00312897|10852504|FG001|STARTED|Overall Study||24
9750318|NCT00312897|10852503|FG000|COMPLETED|Overall Study||21
9750319|NCT00312897|10852504|FG001|COMPLETED|Overall Study||18
9750320|NCT00312897|10852503|FG000|NOT COMPLETED|Overall Study||6
9750321|NCT00312897|10852504|FG001|NOT COMPLETED|Overall Study||6
9750322|NCT00312923|10852512|FG000|STARTED|Overall Study||28
9750323|NCT00312923|10852513|FG001|STARTED|Overall Study||26
9750324|NCT00312923|10852512|FG000|COMPLETED|Overall Study||19
9750325|NCT00312923|10852513|FG001|COMPLETED|Overall Study||20
9750326|NCT00312923|10852512|FG000|NOT COMPLETED|Overall Study||9
9750327|NCT00312923|10852513|FG001|NOT COMPLETED|Overall Study||6
9750328|NCT00313014|10852522|FG000|STARTED|Overall Study||221
9750329|NCT00313014|10852523|FG001|STARTED|Overall Study||219
9750330|NCT00313014|10852524|FG002|STARTED|Overall Study||220
9750331|NCT00313014|10852522|FG000|COMPLETED|Overall Study||128
9750332|NCT00313014|10852523|FG001|COMPLETED|Overall Study||146
9750333|NCT00313014|10852524|FG002|COMPLETED|Overall Study||159
9750334|NCT00313014|10852522|FG000|NOT COMPLETED|Overall Study||93
9750335|NCT00313014|10852523|FG001|NOT COMPLETED|Overall Study||73
9750336|NCT00313014|10852524|FG002|NOT COMPLETED|Overall Study||61
9750337|NCT00313144|10852533|FG000|STARTED|Overall Study||127
9750338|NCT00313144|10852533|FG000|COMPLETED|Overall Study||17
9750339|NCT00313144|10852533|FG000|NOT COMPLETED|Overall Study||110
9750340|NCT00313170|10852549|FG000|STARTED|Overall Study||47
9750341|NCT00313170|10852550|FG001|STARTED|Overall Study||51
9750342|NCT00313170|10852551|FG002|STARTED|Overall Study||46
9750343|NCT00313170|10852549|FG000|COMPLETED|Overall Study||11
9750344|NCT00313170|10852550|FG001|COMPLETED|Overall Study||17
9750345|NCT00313170|10852551|FG002|COMPLETED|Overall Study||14
9750346|NCT00313170|10852549|FG000|NOT COMPLETED|Overall Study||36
9750347|NCT00313170|10852550|FG001|NOT COMPLETED|Overall Study||34
9750348|NCT00313170|10852551|FG002|NOT COMPLETED|Overall Study||32
9750349|NCT00313209|10852562|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
9750350|NCT00313209|10852563|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
9750351|NCT00313209|10852562|FG000|COMPLETED|Overall Study||359
9750352|NCT00313209|10852563|FG001|COMPLETED|Overall Study||385
9750353|NCT00313209|10852562|FG000|NOT COMPLETED|Overall Study||107
9750354|NCT00313209|10852563|FG001|NOT COMPLETED|Overall Study||82
9750355|NCT00313300|10852574|FG000|STARTED|Randomized in Phase A (26 Weeks)||184
9750356|NCT00313300|10852575|FG001|STARTED|Randomized in Phase A (26 Weeks)||179
9750357|NCT00313300|10852576|FG002|STARTED|Randomized in Phase A (26 Weeks)||184
9750358|NCT00313300|10852577|FG003|STARTED|Randomized in Phase A (26 Weeks)||0
9750359|NCT00313300|10852578|FG004|STARTED|Randomized in Phase A (26 Weeks)||0
9750360|NCT00313300|10852574|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130
9750361|NCT00313300|10852575|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140
9750362|NCT00313300|10852576|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149
9750363|NCT00313300|10852577|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0
9750364|NCT00313300|10852578|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0
9750365|NCT00313300|10852574|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
9750366|NCT00313300|10852575|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
9750367|NCT00313300|10852576|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
9750368|NCT00313300|10852577|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
9750369|NCT00313300|10852578|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
9750370|NCT00313300|10852574|FG000|STARTED|Randomized in Phase B (26 Weeks)||427
9750371|NCT00313300|10852575|FG001|STARTED|Randomized in Phase B (26 Weeks)||138
9750372|NCT00313300|10852576|FG002|STARTED|Randomized in Phase B (26 Weeks)||134
9750373|NCT00313300|10852577|FG003|STARTED|Randomized in Phase B (26 Weeks)||248
9750374|NCT00313300|10852578|FG004|STARTED|Randomized in Phase B (26 Weeks)||221
10092162|NCT02334683|11220495|FG001|NOT COMPLETED|First 12 Week Period||0
9750375|NCT00313300|10852574|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
9853748|NCT00888329|10966681|FG000|STARTED|Overall Study||125
9853749|NCT00888329|10966682|FG001|STARTED|Overall Study||131
9853750|NCT00888329|10966681|FG000|COMPLETED|Overall Study||119
9853751|NCT00888329|10966682|FG001|COMPLETED|Overall Study||122
9853752|NCT00888329|10966681|FG000|NOT COMPLETED|Overall Study||6
9853753|NCT00888329|10966682|FG001|NOT COMPLETED|Overall Study||9
9750376|NCT00313300|10852575|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
9750377|NCT00313300|10852576|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
9750378|NCT00313300|10852577|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
9750379|NCT00313300|10852578|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
9750380|NCT00313300|10852574|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333
9750381|NCT00313300|10852575|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105
9750382|NCT00313300|10852576|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94
9750383|NCT00313300|10852577|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15
9750384|NCT00313300|10852578|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13
9750385|NCT00313300|10852574|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
9750386|NCT00313300|10852575|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
9853754|NCT00888381|10966690|FG000|STARTED|Overall Study||60
9853755|NCT00888381|10966691|FG001|STARTED|Overall Study||60
9853756|NCT00888381|10966690|FG000|COMPLETED|Overall Study||60
9853757|NCT00888381|10966691|FG001|COMPLETED|Overall Study||59
9853758|NCT00888381|10966690|FG000|NOT COMPLETED|Overall Study||0
9853759|NCT00888381|10966691|FG001|NOT COMPLETED|Overall Study||1
9853760|NCT00888433|10966699|FG000|STARTED|Overall Study||52
9853761|NCT00888433|10966700|FG001|STARTED|Overall Study||54
9853762|NCT00888433|10966699|FG000|COMPLETED|Overall Study||49
9853763|NCT00888433|10966700|FG001|COMPLETED|Overall Study||51
9853764|NCT00888433|10966699|FG000|NOT COMPLETED|Overall Study||3
9853765|NCT00888433|10966700|FG001|NOT COMPLETED|Overall Study||3
9750387|NCT00313300|10852576|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
9750388|NCT00313300|10852577|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
9750389|NCT00313300|10852578|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
9750390|NCT00313300|10852574|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163
9750391|NCT00313300|10852575|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162
9750392|NCT00313300|10852576|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174
9750393|NCT00313300|10852577|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0
9750394|NCT00313300|10852578|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0
9750395|NCT00313300|10852574|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
9750396|NCT00313300|10852575|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
9750397|NCT00313300|10852576|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
9750398|NCT00313300|10852577|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
9750399|NCT00313300|10852578|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
9750400|NCT00313300|10852574|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
9750401|NCT00313300|10852575|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
9750402|NCT00313300|10852576|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
9750403|NCT00313300|10852577|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
9750404|NCT00313300|10852578|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
9750405|NCT00313300|10852574|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383
9750406|NCT00313300|10852575|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123
9750407|NCT00313300|10852576|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119
9750408|NCT00313300|10852577|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222
9750409|NCT00313300|10852578|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201
9750410|NCT00313300|10852574|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
9750411|NCT00313300|10852575|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
9750412|NCT00313300|10852576|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
9750413|NCT00313300|10852577|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
9750414|NCT00313300|10852578|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
9750415|NCT00313300|10852574|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
9750416|NCT00313300|10852575|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
9750417|NCT00313300|10852576|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
9750418|NCT00313300|10852577|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
9750419|NCT00313300|10852578|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
9750420|NCT00313313|10852599|FG000|STARTED|Overall Study||248
9750421|NCT00313313|10852600|FG001|STARTED|Overall Study||253
9750422|NCT00313313|10852601|FG002|STARTED|Overall Study||267
9750423|NCT00313313|10852599|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
9853766|NCT00888459|10966708|FG000|STARTED|Overall Study||30
9853767|NCT00888459|10966709|FG001|STARTED|Overall Study||30
9853768|NCT00888459|10966708|FG000|COMPLETED|Overall Study||30
9853769|NCT00888459|10966709|FG001|COMPLETED|Overall Study||30
9750424|NCT00313313|10852600|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
9853770|NCT00888459|10966708|FG000|NOT COMPLETED|Overall Study||0
9853771|NCT00888459|10966709|FG001|NOT COMPLETED|Overall Study||0
9853772|NCT00888511|10966715|FG000|STARTED|Overall Study||15
9853773|NCT00888511|10966715|FG000|COMPLETED|Overall Study||15
9853774|NCT00888511|10966715|FG000|NOT COMPLETED|Overall Study||0
9853775|NCT00888615|10966719|FG000|STARTED|Overall Study||58
9853776|NCT00888615|10966719|FG000|COMPLETED|Overall Study||56
9750425|NCT00313313|10852601|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
9750426|NCT00313313|10852599|FG000|NOT COMPLETED|Overall Study||63
9750427|NCT00313313|10852600|FG001|NOT COMPLETED|Overall Study||66
9750428|NCT00313313|10852601|FG002|NOT COMPLETED|Overall Study||82
9750429|NCT00313443|10852609|FG000|STARTED|Overall Study||30
9750430|NCT00313443|10852609|FG000|COMPLETED|Overall Study||30
9750431|NCT00313443|10852609|FG000|NOT COMPLETED|Overall Study||0
9750432|NCT00313560|10852613|FG000|STARTED|Overall Study||48
9750433|NCT00313560|10852613|FG000|COMPLETED|Overall Study||48
9750434|NCT00313560|10852613|FG000|NOT COMPLETED|Overall Study||0
9750435|NCT00313586|10852625|FG000|STARTED|Overall Study||75
9750436|NCT00313586|10852626|FG001|STARTED|Overall Study||75
9750437|NCT00313586|10852627|FG002|STARTED|Overall Study||24
9750438|NCT00313586|10852628|FG003|STARTED|Overall Study||23
9750439|NCT00313586|10852625|FG000|Treated|Overall Study||74
9750440|NCT00313586|10852626|FG001|Treated|Overall Study||75
9750441|NCT00313586|10852627|FG002|Treated|Overall Study||24
9750442|NCT00313586|10852628|FG003|Treated|Overall Study||23
9750443|NCT00313586|10852625|FG000|COMPLETED|Overall Study||5
9750444|NCT00313586|10852626|FG001|COMPLETED|Overall Study||5
9750445|NCT00313586|10852627|FG002|COMPLETED|Overall Study||0
9750446|NCT00313586|10852628|FG003|COMPLETED|Overall Study||0
9750447|NCT00313586|10852625|FG000|NOT COMPLETED|Overall Study||70
9750448|NCT00313586|10852626|FG001|NOT COMPLETED|Overall Study||70
9750449|NCT00313586|10852627|FG002|NOT COMPLETED|Overall Study||24
9750450|NCT00313586|10852628|FG003|NOT COMPLETED|Overall Study||23
9750451|NCT00313612|10852638|FG000|STARTED|Overall Study||19
9750452|NCT00313612|10852639|FG001|STARTED|Overall Study||20
9750453|NCT00313612|10852638|FG000|COMPLETED|Overall Study||19
9750454|NCT00313612|10852639|FG001|COMPLETED|Overall Study||19
9750455|NCT00313612|10852638|FG000|NOT COMPLETED|Overall Study||0
9750456|NCT00313612|10852639|FG001|NOT COMPLETED|Overall Study||1
9750457|NCT00313703|10852649|FG000|STARTED|Overall Study||186
9750458|NCT00313703|10852650|FG001|STARTED|Overall Study||34
9750459|NCT00313703|10852651|FG002|STARTED|Overall Study||77
9750460|NCT00313703|10852652|FG003|STARTED|Overall Study||12
9750461|NCT00313703|10852649|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175
9750462|NCT00313703|10852650|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
9750463|NCT00313703|10852651|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
9750464|NCT00313703|10852652|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
9750465|NCT00313703|10852649|FG000|NOT COMPLETED|Overall Study||11
9750466|NCT00313703|10852650|FG001|NOT COMPLETED|Overall Study||2
9750467|NCT00313703|10852651|FG002|NOT COMPLETED|Overall Study||5
9750468|NCT00313703|10852652|FG003|NOT COMPLETED|Overall Study||12
9750469|NCT00313716|10852668|FG000|STARTED|Overall Study||18
9750470|NCT00313716|10852669|FG001|STARTED|Overall Study||31
9750471|NCT00313716|10852670|FG002|STARTED|Overall Study||50
9750472|NCT00313716|10852671|FG003|STARTED|Overall Study||20
9750473|NCT00313716|10852672|FG004|STARTED|Overall Study||33
9750474|NCT00313716|10852673|FG005|STARTED|Overall Study||48
9750475|NCT00313716|10852668|FG000|COMPLETED|Overall Study||13
9750476|NCT00313716|10852669|FG001|COMPLETED|Overall Study||23
9750477|NCT00313716|10852670|FG002|COMPLETED|Overall Study||38
9750478|NCT00313716|10852671|FG003|COMPLETED|Overall Study||16
9750479|NCT00313716|10852672|FG004|COMPLETED|Overall Study||27
9750480|NCT00313716|10852673|FG005|COMPLETED|Overall Study||35
9750481|NCT00313716|10852668|FG000|NOT COMPLETED|Overall Study||5
9750482|NCT00313716|10852669|FG001|NOT COMPLETED|Overall Study||8
9750483|NCT00313716|10852670|FG002|NOT COMPLETED|Overall Study||12
9750484|NCT00313716|10852671|FG003|NOT COMPLETED|Overall Study||4
9750485|NCT00313716|10852672|FG004|NOT COMPLETED|Overall Study||6
9750486|NCT00313716|10852673|FG005|NOT COMPLETED|Overall Study||13
9750487|NCT00313729|10852691|FG000|STARTED|Overall Study||120
9750488|NCT00313729|10852691|FG000|COMPLETED|Overall Study||120
9750489|NCT00313729|10852691|FG000|NOT COMPLETED|Overall Study||0
9750490|NCT00313781|10852697|FG000|STARTED|Before Crossover||102
9750491|NCT00313781|10852698|FG001|STARTED|Before Crossover||102
9750492|NCT00313781|10852699|FG002|STARTED|Before Crossover||0
9750493|NCT00313781|10852697|FG000|Treated|Before Crossover||97
9750494|NCT00313781|10852698|FG001|Treated|Before Crossover||102
9750495|NCT00313781|10852699|FG002|Treated|Before Crossover||0
9750496|NCT00313781|10852697|FG000|COMPLETED|Before Crossover||27
9750497|NCT00313781|10852698|FG001|COMPLETED|Before Crossover||23
9750498|NCT00313781|10852699|FG002|COMPLETED|Before Crossover||0
9750499|NCT00313781|10852697|FG000|NOT COMPLETED|Before Crossover||75
9750500|NCT00313781|10852698|FG001|NOT COMPLETED|Before Crossover||79
9750501|NCT00313781|10852699|FG002|NOT COMPLETED|Before Crossover||0
9750502|NCT00313781|10852697|FG000|STARTED|After Crossover||0
9750503|NCT00313781|10852698|FG001|STARTED|After Crossover||0
9750504|NCT00313781|10852699|FG002|STARTED|After Crossover||37
9750505|NCT00313781|10852697|FG000|COMPLETED|After Crossover||0
9750506|NCT00313781|10852698|FG001|COMPLETED|After Crossover||0
9750507|NCT00313781|10852699|FG002|COMPLETED|After Crossover||10
9750508|NCT00313781|10852697|FG000|NOT COMPLETED|After Crossover||0
9750509|NCT00313781|10852698|FG001|NOT COMPLETED|After Crossover||0
9750510|NCT00313781|10852699|FG002|NOT COMPLETED|After Crossover||27
9750511|NCT00313820|10852710|FG000|STARTED|Assigned to Treatment||111
9750512|NCT00313820|10852711|FG001|STARTED|Assigned to Treatment||109
9750513|NCT00313820|10852710|FG000|COMPLETED|Assigned to Treatment||110
10092163|NCT02334683|11220494|FG000|STARTED|Second 12 Week Period||9
9750514|NCT00313820|10852711|FG001|COMPLETED|Assigned to Treatment||109
9750515|NCT00313820|10852710|FG000|NOT COMPLETED|Assigned to Treatment||1
9750516|NCT00313820|10852711|FG001|NOT COMPLETED|Assigned to Treatment||0
9750517|NCT00313820|10852710|FG000|STARTED|Pregabalin or Placebo Treatment Period||110
9750518|NCT00313820|10852711|FG001|STARTED|Pregabalin or Placebo Treatment Period||109
9750519|NCT00313820|10852710|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93
9750520|NCT00313820|10852711|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90
9750521|NCT00313820|10852710|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
9750522|NCT00313820|10852711|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
9750523|NCT00313846|10852719|FG000|STARTED|Overall Study||162
9750524|NCT00313846|10852720|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
9750525|NCT00313846|10852719|FG000|COMPLETED|Overall Study||157
9750526|NCT00313846|10852720|FG001|COMPLETED|Overall Study||153
9750527|NCT00313846|10852719|FG000|NOT COMPLETED|Overall Study||5
9750528|NCT00313846|10852720|FG001|NOT COMPLETED|Overall Study||11
9750529|NCT00313911|10852729|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
9750530|NCT00313911|10852730|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
9750531|NCT00313911|10852729|FG000|COMPLETED|Overall Study||1328
9750532|NCT00313911|10852730|FG001|COMPLETED|Overall Study||670
9750533|NCT00313911|10852729|FG000|NOT COMPLETED|Overall Study||94
9750534|NCT00313911|10852730|FG001|NOT COMPLETED|Overall Study||41
9750535|NCT00314106|10852738|FG000|STARTED|Overall Study||18
9750536|NCT00314106|10852739|FG001|STARTED|Overall Study||8
9750537|NCT00314106|10852738|FG000|COMPLETED|Overall Study||18
9750538|NCT00314106|10852739|FG001|COMPLETED|Overall Study||8
9750539|NCT00314106|10852738|FG000|NOT COMPLETED|Overall Study||0
9750540|NCT00314106|10852739|FG001|NOT COMPLETED|Overall Study||0
9750541|NCT00314132|10852747|FG000|STARTED|Overall Study||403
9750542|NCT00314132|10852748|FG001|STARTED|Overall Study||1601
9750543|NCT00314132|10852747|FG000|COMPLETED|Overall Study||395
9750544|NCT00314132|10852748|FG001|COMPLETED|Overall Study||1583
9750545|NCT00314132|10852747|FG000|NOT COMPLETED|Overall Study||8
9750546|NCT00314132|10852748|FG001|NOT COMPLETED|Overall Study||18
9750547|NCT00314145|10852758|FG000|STARTED|Overall Study||410
9750548|NCT00314145|10852759|FG001|STARTED|Overall Study||410
9750549|NCT00314145|10852758|FG000|COMPLETED|Overall Study||389
9750550|NCT00314145|10852759|FG001|COMPLETED|Overall Study||381
9750551|NCT00314145|10852758|FG000|NOT COMPLETED|Overall Study||21
9750552|NCT00314145|10852759|FG001|NOT COMPLETED|Overall Study||29
9750553|NCT00314236|10852768|FG000|STARTED|Overall Study||41
9750554|NCT00314236|10852769|FG001|STARTED|Overall Study||39
9750555|NCT00314236|10852768|FG000|COMPLETED|Overall Study||41
9750556|NCT00314236|10852769|FG001|COMPLETED|Overall Study||37
9750557|NCT00314236|10852768|FG000|NOT COMPLETED|Overall Study||0
9750558|NCT00314236|10852769|FG001|NOT COMPLETED|Overall Study||2
9750559|NCT00314249|10852777|FG000|STARTED|Overall Study||509
9750560|NCT00314249|10852778|FG001|STARTED|Overall Study||516
9750561|NCT00314249|10852777|FG000|COMPLETED|Overall Study||357
9750562|NCT00314249|10852778|FG001|COMPLETED|Overall Study||353
9750563|NCT00314249|10852777|FG000|NOT COMPLETED|Overall Study||152
9750564|NCT00314249|10852778|FG001|NOT COMPLETED|Overall Study||163
9750565|NCT00314262|10852784|FG000|STARTED|Overall Study||12
9750566|NCT00314262|10852784|FG000|COMPLETED|Overall Study||7
9750567|NCT00314262|10852784|FG000|NOT COMPLETED|Overall Study||5
9750568|NCT00314340|10852788|FG000|STARTED|Overall Study||12
9750569|NCT00314340|10852788|FG000|ER Morphine|Overall Study||11
9750570|NCT00314340|10852788|FG000|Hydrocodone Plus APAP|Overall Study||12
9750571|NCT00314340|10852788|FG000|Placebo|Overall Study||12
9750572|NCT00314340|10852788|FG000|COMPLETED|Overall Study||11
9750573|NCT00314340|10852788|FG000|NOT COMPLETED|Overall Study||1
9853777|NCT00888615|10966719|FG000|NOT COMPLETED|Overall Study||2
9853778|NCT00888628|10966723|FG000|STARTED|Overall Study||7
9853779|NCT00888628|10966723|FG000|Enrolled|Overall Study||7
9853780|NCT00888628|10966723|FG000|Screen Failure|Overall Study||2
9853781|NCT00888628|10966723|FG000|Withdrawn|Overall Study||1
9853782|NCT00888628|10966723|FG000|Transplanted|Overall Study||4
9853783|NCT00888628|10966723|FG000|COMPLETED|Overall Study||4
9853784|NCT00888628|10966723|FG000|NOT COMPLETED|Overall Study||3
9853785|NCT00888654|10966727|FG000|STARTED|Overall Study||41
9853786|NCT00888654|10966727|FG000|COMPLETED|Overall Study||31
9853787|NCT00888654|10966727|FG000|NOT COMPLETED|Overall Study||10
9853788|NCT00888849|10966733|FG000|STARTED|Overall Study||142
9853789|NCT00888849|10966734|FG001|STARTED|Overall Study||138
9853790|NCT00888849|10966733|FG000|COMPLETED|Overall Study||137
9853791|NCT00888849|10966734|FG001|COMPLETED|Overall Study||129
9853792|NCT00888849|10966733|FG000|NOT COMPLETED|Overall Study||5
9853793|NCT00888849|10966734|FG001|NOT COMPLETED|Overall Study||9
9853794|NCT00888927|10966744|FG000|STARTED|Overall Study||3
9750574|NCT00314574|10852796|FG000|STARTED|Overall Study||423
9750575|NCT00314574|10852797|FG001|STARTED|Overall Study||427
9750576|NCT00314574|10852796|FG000|Received at Least One Dose of Study Drug|Overall Study||421
9750577|NCT00314574|10852797|FG001|Received at Least One Dose of Study Drug|Overall Study||427
9853795|NCT00888927|10966745|FG001|STARTED|Overall Study||3
9853796|NCT00888927|10966746|FG002|STARTED|Overall Study||3
9853797|NCT00888927|10966747|FG003|STARTED|Overall Study||33
9750578|NCT00314574|10852796|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
9750579|NCT00314574|10852797|FG001|Safety Population|Overall Study||428
9750580|NCT00314574|10852796|FG000|COMPLETED|Overall Study||329
9750581|NCT00314574|10852797|FG001|COMPLETED|Overall Study||344
9750582|NCT00314574|10852796|FG000|NOT COMPLETED|Overall Study||94
9750583|NCT00314574|10852797|FG001|NOT COMPLETED|Overall Study||83
9750584|NCT00314795|10852803|FG000|STARTED|Overall Study||22
9750585|NCT00314795|10852803|FG000|COMPLETED|Overall Study||2
9750586|NCT00314795|10852803|FG000|NOT COMPLETED|Overall Study||20
9750587|NCT00314808|10852807|FG000|STARTED|Overall Study||33
9750588|NCT00314808|10852807|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
9750589|NCT00314808|10852807|FG000|NOT COMPLETED|Overall Study||8
9750590|NCT00314951|10852813|FG000|STARTED|Enrollment||323
9750591|NCT00314951|10852814|FG001|STARTED|Enrollment||306
9750592|NCT00314951|10852813|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
9750593|NCT00314951|10852814|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
9750594|NCT00314951|10852813|FG000|NOT COMPLETED|Enrollment||0
9750595|NCT00314951|10852814|FG001|NOT COMPLETED|Enrollment||6
9750596|NCT00314951|10852813|FG000|STARTED|Treatment||323
9750597|NCT00314951|10852814|FG001|STARTED|Treatment||300
9750598|NCT00314951|10852813|FG000|COMPLETED|Treatment||307
9750599|NCT00314951|10852814|FG001|COMPLETED|Treatment||289
9750600|NCT00314951|10852813|FG000|NOT COMPLETED|Treatment||16
9750601|NCT00314951|10852814|FG001|NOT COMPLETED|Treatment||11
9750602|NCT00314951|10852813|FG000|STARTED|Follow-up||307
9750603|NCT00314951|10852814|FG001|STARTED|Follow-up||289
9750604|NCT00314951|10852813|FG000|COMPLETED|Follow-up||263
9750605|NCT00314951|10852814|FG001|COMPLETED|Follow-up||255
9750606|NCT00314951|10852813|FG000|NOT COMPLETED|Follow-up||44
9750607|NCT00314951|10852814|FG001|NOT COMPLETED|Follow-up||34
9750608|NCT00315055|10852822|FG000|STARTED|Overall Study||155
9750609|NCT00315055|10852823|FG001|STARTED|Overall Study||155
9750610|NCT00315055|10852822|FG000|COMPLETED|Overall Study||152
9750611|NCT00315055|10852823|FG001|COMPLETED|Overall Study||150
9750612|NCT00315055|10852822|FG000|NOT COMPLETED|Overall Study||3
9750613|NCT00315055|10852823|FG001|NOT COMPLETED|Overall Study||5
9750614|NCT00315120|10852836|FG000|STARTED|Overall Study||115
9750615|NCT00315120|10852837|FG001|STARTED|Overall Study||118
9750616|NCT00315120|10852838|FG002|STARTED|Overall Study||115
9750617|NCT00315120|10852839|FG003|STARTED|Overall Study||107
9750618|NCT00315120|10852836|FG000|COMPLETED|Overall Study||115
9750619|NCT00315120|10852837|FG001|COMPLETED|Overall Study||118
9750620|NCT00315120|10852838|FG002|COMPLETED|Overall Study||115
9750621|NCT00315120|10852839|FG003|COMPLETED|Overall Study||107
9750622|NCT00315120|10852836|FG000|NOT COMPLETED|Overall Study||0
9750623|NCT00315120|10852837|FG001|NOT COMPLETED|Overall Study||0
9750624|NCT00315120|10852838|FG002|NOT COMPLETED|Overall Study||0
9750625|NCT00315120|10852839|FG003|NOT COMPLETED|Overall Study||0
9750626|NCT00315146|10852855|FG000|STARTED|Overall Study||22
9750627|NCT00315146|10852856|FG001|STARTED|Overall Study||22
9750628|NCT00315146|10852857|FG002|STARTED|Overall Study||22
9750629|NCT00315146|10852858|FG003|STARTED|Overall Study||22
9750630|NCT00315146|10852855|FG000|COMPLETED|Overall Study||20
9750631|NCT00315146|10852856|FG001|COMPLETED|Overall Study||19
9750632|NCT00315146|10852857|FG002|COMPLETED|Overall Study||20
9750633|NCT00315146|10852858|FG003|COMPLETED|Overall Study||22
10092164|NCT02334683|11220495|FG001|STARTED|Second 12 Week Period||10
10092165|NCT02334683|11220494|FG000|COMPLETED|Second 12 Week Period||9
10092166|NCT02334683|11220495|FG001|COMPLETED|Second 12 Week Period||9
10092167|NCT02334683|11220494|FG000|NOT COMPLETED|Second 12 Week Period||0
10092168|NCT02334683|11220495|FG001|NOT COMPLETED|Second 12 Week Period||1
10092169|NCT02334748|11220501|FG000|STARTED|Overall Study||31
10092170|NCT02334748|11220501|FG000|COMPLETED|Overall Study||23
10092171|NCT02334748|11220501|FG000|NOT COMPLETED|Overall Study||8
10092172|NCT02334787|11220509|FG000|STARTED|Overall Study||8
9750634|NCT00315146|10852855|FG000|NOT COMPLETED|Overall Study||2
9750635|NCT00315146|10852856|FG001|NOT COMPLETED|Overall Study||3
9750636|NCT00315146|10852857|FG002|NOT COMPLETED|Overall Study||2
9750637|NCT00315146|10852858|FG003|NOT COMPLETED|Overall Study||0
9750638|NCT00315302|10852876|FG000|STARTED|Overall Study||90
9750639|NCT00315302|10852877|FG001|STARTED|Overall Study||90
9750640|NCT00315302|10852878|FG002|STARTED|Overall Study||26
9750641|NCT00315302|10852879|FG003|STARTED|Overall Study||34
9750642|NCT00315302|10852876|FG000|5 Week Visit|Overall Study||85
9750643|NCT00315302|10852877|FG001|5 Week Visit|Overall Study||86
9750644|NCT00315302|10852878|FG002|5 Week Visit|Overall Study||26
9750645|NCT00315302|10852879|FG003|5 Week Visit|Overall Study||30
9750646|NCT00315302|10852876|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
9750647|NCT00315302|10852877|FG001|10 Week Visit|Overall Study||85
9750648|NCT00315302|10852878|FG002|10 Week Visit|Overall Study||24
9750649|NCT00315302|10852879|FG003|10 Week Visit|Overall Study||29
9750650|NCT00315302|10852876|FG000|18 Week Primary Outcome Visit|Overall Study||84
9750651|NCT00315302|10852877|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
10092173|NCT02334787|11220510|FG001|STARTED|Overall Study||8
10092174|NCT02334787|11220511|FG002|STARTED|Overall Study||8
10092175|NCT02334787|11220512|FG003|STARTED|Overall Study||8
9750652|NCT00315302|10852878|FG002|18 Week Primary Outcome Visit|Overall Study||24
9750653|NCT00315302|10852879|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
9750654|NCT00315302|10852876|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
9750655|NCT00315302|10852877|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
9853798|NCT00888927|10966744|FG000|COMPLETED|Overall Study||3
9853799|NCT00888927|10966745|FG001|COMPLETED|Overall Study||3
9853800|NCT00888927|10966746|FG002|COMPLETED|Overall Study||3
9750656|NCT00315302|10852878|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
9750657|NCT00315302|10852879|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
9750658|NCT00315302|10852876|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
9853801|NCT00888927|10966747|FG003|COMPLETED|Overall Study||31
9853802|NCT00888927|10966744|FG000|NOT COMPLETED|Overall Study||0
9853803|NCT00888927|10966745|FG001|NOT COMPLETED|Overall Study||0
9853804|NCT00888927|10966746|FG002|NOT COMPLETED|Overall Study||0
9750659|NCT00315302|10852877|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
9750660|NCT00315302|10852878|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
9750661|NCT00315302|10852879|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
9750662|NCT00315302|10852876|FG000|NOT COMPLETED|Overall Study||6
9750663|NCT00315302|10852877|FG001|NOT COMPLETED|Overall Study||2
9750664|NCT00315302|10852878|FG002|NOT COMPLETED|Overall Study||2
9750665|NCT00315302|10852879|FG003|NOT COMPLETED|Overall Study||3
9750666|NCT00315328|10852893|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
9750667|NCT00315328|10852894|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
9750668|NCT00315328|10852895|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
9750669|NCT00315328|10852896|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
9750670|NCT00315328|10852893|FG000|5 Week Visit|Overall Study||91
9750671|NCT00315328|10852894|FG001|5 Week Visit|Overall Study||89
9750672|NCT00315328|10852895|FG002|5 Week Visit|Overall Study||17
9750673|NCT00315328|10852896|FG003|5 Week Visit|Overall Study||19
9750674|NCT00315328|10852893|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
9750675|NCT00315328|10852894|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
9750676|NCT00315328|10852895|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
9750677|NCT00315328|10852896|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
9750678|NCT00315328|10852893|FG000|NOT COMPLETED|Overall Study||14
9750679|NCT00315328|10852894|FG001|NOT COMPLETED|Overall Study||7
9750680|NCT00315328|10852895|FG002|NOT COMPLETED|Overall Study||5
9750681|NCT00315328|10852896|FG003|NOT COMPLETED|Overall Study||2
9750682|NCT00315341|10852908|FG000|STARTED|Overall Study||740
9750683|NCT00315341|10852909|FG001|STARTED|Overall Study||529
9750684|NCT00315341|10852908|FG000|COMPLETED|Overall Study||340
9750685|NCT00315341|10852909|FG001|COMPLETED|Overall Study||391
9750686|NCT00315341|10852908|FG000|NOT COMPLETED|Overall Study||400
9750687|NCT00315341|10852909|FG001|NOT COMPLETED|Overall Study||138
9750688|NCT00315445|10852918|FG000|STARTED|Overall Study||45
9750689|NCT00315445|10852919|FG001|STARTED|Overall Study||43
9750690|NCT00315445|10852920|FG002|STARTED|Overall Study||46
9750691|NCT00315445|10852918|FG000|COMPLETED|Overall Study||18
9750692|NCT00315445|10852919|FG001|COMPLETED|Overall Study||27
9750693|NCT00315445|10852920|FG002|COMPLETED|Overall Study||22
9750694|NCT00315445|10852918|FG000|NOT COMPLETED|Overall Study||27
9750695|NCT00315445|10852919|FG001|NOT COMPLETED|Overall Study||16
9750696|NCT00315445|10852920|FG002|NOT COMPLETED|Overall Study||24
9750697|NCT00315458|10852930|FG000|STARTED|Overall Study||51
9750698|NCT00315458|10852931|FG001|STARTED|Overall Study||56
9750699|NCT00315458|10852932|FG002|STARTED|Overall Study||159
9750700|NCT00315458|10852933|FG003|STARTED|Overall Study||39
9750701|NCT00315458|10852930|FG000|COMPLETED|Overall Study||48
9750702|NCT00315458|10852931|FG001|COMPLETED|Overall Study||44
9750703|NCT00315458|10852932|FG002|COMPLETED|Overall Study||107
9750704|NCT00315458|10852933|FG003|COMPLETED|Overall Study||10
9750705|NCT00315458|10852930|FG000|NOT COMPLETED|Overall Study||3
9750706|NCT00315458|10852931|FG001|NOT COMPLETED|Overall Study||12
9750707|NCT00315458|10852932|FG002|NOT COMPLETED|Overall Study||52
9750708|NCT00315458|10852933|FG003|NOT COMPLETED|Overall Study||29
9750709|NCT00315588|10852943|FG000|STARTED|Overall Study||7
9750710|NCT00315588|10852943|FG000|COMPLETED|Overall Study||7
9750711|NCT00315588|10852943|FG000|NOT COMPLETED|Overall Study||0
9750712|NCT00315614|10852949|FG000|STARTED|Overall Study||3
9750713|NCT00315614|10852949|FG000|COMPLETED|Overall Study||3
9750714|NCT00315614|10852949|FG000|NOT COMPLETED|Overall Study||0
9750715|NCT00315627|10852954|FG000|STARTED|Overall Study||3
9750716|NCT00315627|10852954|FG000|COMPLETED|Overall Study||3
9750717|NCT00315627|10852954|FG000|NOT COMPLETED|Overall Study||0
9853805|NCT00888927|10966747|FG003|NOT COMPLETED|Overall Study||2
9853806|NCT00888940|10966759|FG000|STARTED|Overall Study||120
9853807|NCT00888940|10966760|FG001|STARTED|Overall Study||122
9853808|NCT00888940|10966759|FG000|Completed Therapy|Overall Study||107
9750718|NCT00315705|10852962|FG000|STARTED|Phase 1||25
9750719|NCT00315705|10852962|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
9750720|NCT00315705|10852962|FG000|NOT COMPLETED|Phase 1||25
9750721|NCT00315705|10852962|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
9750722|NCT00315705|10852962|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
9750723|NCT00315705|10852962|FG000|NOT COMPLETED|Phase 2||25
9750724|NCT00315731|10852979|FG000|STARTED|Overall Study||15
9750725|NCT00315731|10852979|FG000|COMPLETED|Overall Study||9
9750726|NCT00315731|10852979|FG000|NOT COMPLETED|Overall Study||6
9750727|NCT00315822|10852987|FG000|STARTED|Overall Study||198
9750728|NCT00315822|10852988|FG001|STARTED|Overall Study||202
9750729|NCT00315822|10852987|FG000|COMPLETED|Overall Study||198
9750730|NCT00315822|10852988|FG001|COMPLETED|Overall Study||202
9750731|NCT00315822|10852987|FG000|NOT COMPLETED|Overall Study||0
9750732|NCT00315822|10852988|FG001|NOT COMPLETED|Overall Study||0
9750733|NCT00315939|10852996|FG000|STARTED|Admission 1 (3 Months)||59
9750734|NCT00315939|10852997|FG001|STARTED|Admission 1 (3 Months)||61
9750735|NCT00315939|10852996|FG000|COMPLETED|Admission 1 (3 Months)||56
9750736|NCT00315939|10852997|FG001|COMPLETED|Admission 1 (3 Months)||55
9750737|NCT00315939|10852996|FG000|NOT COMPLETED|Admission 1 (3 Months)||3
9750738|NCT00315939|10852997|FG001|NOT COMPLETED|Admission 1 (3 Months)||6
9750739|NCT00315939|10852996|FG000|STARTED|Admission 2 (3 Months)||56
9750740|NCT00315939|10852997|FG001|STARTED|Admission 2 (3 Months)||55
9750741|NCT00315939|10852996|FG000|COMPLETED|Admission 2 (3 Months)||52
9750742|NCT00315939|10852997|FG001|COMPLETED|Admission 2 (3 Months)||51
9750743|NCT00315939|10852996|FG000|NOT COMPLETED|Admission 2 (3 Months)||4
9750744|NCT00315939|10852997|FG001|NOT COMPLETED|Admission 2 (3 Months)||4
9750745|NCT00315939|10852996|FG000|STARTED|Admission 3 (3 Months)||52
9750746|NCT00315939|10852997|FG001|STARTED|Admission 3 (3 Months)||51
9750747|NCT00315939|10852996|FG000|COMPLETED|Admission 3 (3 Months)||48
9750748|NCT00315939|10852997|FG001|COMPLETED|Admission 3 (3 Months)||49
9750749|NCT00315939|10852996|FG000|NOT COMPLETED|Admission 3 (3 Months)||4
9750750|NCT00315939|10852997|FG001|NOT COMPLETED|Admission 3 (3 Months)||2
9750751|NCT00316004|10853005|FG000|STARTED|Overall Study||373
9750752|NCT00316004|10853006|FG001|STARTED|Overall Study||355
9750753|NCT00316004|10853007|FG002|STARTED|Overall Study||603
9750754|NCT00316004|10853005|FG000|COMPLETED|Overall Study||359
9750755|NCT00316004|10853006|FG001|COMPLETED|Overall Study||341
9750756|NCT00316004|10853007|FG002|COMPLETED|Overall Study||582
9750757|NCT00316004|10853005|FG000|NOT COMPLETED|Overall Study||14
9750758|NCT00316004|10853006|FG001|NOT COMPLETED|Overall Study||14
9750759|NCT00316004|10853007|FG002|NOT COMPLETED|Overall Study||21
9750760|NCT00316017|10853018|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
9750761|NCT00316017|10853019|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
9750762|NCT00316017|10853020|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395
9750763|NCT00316017|10853018|FG000|COMPLETED|Overall Study||220
9750764|NCT00316017|10853019|FG001|COMPLETED|Overall Study||256
9750765|NCT00316017|10853020|FG002|COMPLETED|Overall Study||376
9750766|NCT00316017|10853018|FG000|NOT COMPLETED|Overall Study||11
9750767|NCT00316017|10853019|FG001|NOT COMPLETED|Overall Study||13
9750768|NCT00316017|10853020|FG002|NOT COMPLETED|Overall Study||19
9750769|NCT00316082|10853033|FG000|STARTED|Overall Study||74
9750770|NCT00316082|10853034|FG001|STARTED|Overall Study||74
9750771|NCT00316082|10853035|FG002|STARTED|Overall Study||71
9750772|NCT00316082|10853036|FG003|STARTED|Overall Study||72
9750773|NCT00316082|10853037|FG004|STARTED|Overall Study||74
9750774|NCT00316082|10853033|FG000|Completed Study Without Being Rescued|Overall Study||25
9750775|NCT00316082|10853034|FG001|Completed Study Without Being Rescued|Overall Study||35
9750776|NCT00316082|10853035|FG002|Completed Study Without Being Rescued|Overall Study||29
9750777|NCT00316082|10853036|FG003|Completed Study Without Being Rescued|Overall Study||27
9750778|NCT00316082|10853037|FG004|Completed Study Without Being Rescued|Overall Study||31
9750779|NCT00316082|10853033|FG000|COMPLETED|Overall Study||41
9750780|NCT00316082|10853034|FG001|COMPLETED|Overall Study||52
9750781|NCT00316082|10853035|FG002|COMPLETED|Overall Study||44
9750782|NCT00316082|10853036|FG003|COMPLETED|Overall Study||46
9750783|NCT00316082|10853037|FG004|COMPLETED|Overall Study||48
9750784|NCT00316082|10853033|FG000|NOT COMPLETED|Overall Study||33
9750785|NCT00316082|10853034|FG001|NOT COMPLETED|Overall Study||22
9750786|NCT00316082|10853035|FG002|NOT COMPLETED|Overall Study||27
9750787|NCT00316082|10853036|FG003|NOT COMPLETED|Overall Study||26
9750788|NCT00316082|10853037|FG004|NOT COMPLETED|Overall Study||26
9750789|NCT00316121|10853055|FG000|STARTED|Overall Study||92
9750790|NCT00316121|10853056|FG001|STARTED|Overall Study||46
9750791|NCT00316121|10853055|FG000|COMPLETED|Overall Study||70
9750792|NCT00316121|10853056|FG001|COMPLETED|Overall Study||37
9750793|NCT00316121|10853055|FG000|NOT COMPLETED|Overall Study||22
9750794|NCT00316121|10853056|FG001|NOT COMPLETED|Overall Study||9
9750795|NCT00316173|10853064|FG000|STARTED|Run-in Phase||22
9750796|NCT00316173|10853065|FG001|STARTED|Run-in Phase||0
9750797|NCT00316173|10853064|FG000|COMPLETED|Run-in Phase||15
9750798|NCT00316173|10853065|FG001|COMPLETED|Run-in Phase||0
9750799|NCT00316173|10853064|FG000|NOT COMPLETED|Run-in Phase||7
9750800|NCT00316173|10853065|FG001|NOT COMPLETED|Run-in Phase||0
9750801|NCT00316173|10853064|FG000|STARTED|Treatment Phase||0
9750802|NCT00316173|10853065|FG001|STARTED|Treatment Phase||55
9750803|NCT00316173|10853064|FG000|COMPLETED|Treatment Phase||0
9750804|NCT00316173|10853065|FG001|COMPLETED|Treatment Phase||13
9750805|NCT00316173|10853064|FG000|NOT COMPLETED|Treatment Phase||0
9750806|NCT00316173|10853065|FG001|NOT COMPLETED|Treatment Phase||42
9750807|NCT00316186|10853070|FG000|STARTED|Overall Study||33
9750808|NCT00316186|10853070|FG000|COMPLETED|Overall Study||21
9750809|NCT00316186|10853070|FG000|NOT COMPLETED|Overall Study||12
9750810|NCT00316199|10853074|FG000|STARTED|Overall Study||60
9750811|NCT00316199|10853074|FG000|COMPLETED|Overall Study||48
9750812|NCT00316199|10853074|FG000|NOT COMPLETED|Overall Study||12
9750813|NCT00316225|10853078|FG000|STARTED|Overall Study||31
9750814|NCT00316225|10853078|FG000|COMPLETED|Overall Study||6
9750815|NCT00316225|10853078|FG000|NOT COMPLETED|Overall Study||25
9750816|NCT00316264|10853085|FG000|STARTED|Overall Study||83
9750817|NCT00316264|10853086|FG001|STARTED|Overall Study||84
9750818|NCT00316264|10853087|FG002|STARTED|Overall Study||93
9750819|NCT00316264|10853085|FG000|COMPLETED|Overall Study||77
9750820|NCT00316264|10853086|FG001|COMPLETED|Overall Study||77
9750821|NCT00316264|10853087|FG002|COMPLETED|Overall Study||87
9750822|NCT00316264|10853085|FG000|NOT COMPLETED|Overall Study||6
9750823|NCT00316264|10853086|FG001|NOT COMPLETED|Overall Study||7
9750824|NCT00316264|10853087|FG002|NOT COMPLETED|Overall Study||6
9750825|NCT00316277|10853097|FG000|STARTED|Phase 1 (12 Weeks)||329
9750826|NCT00316277|10853098|FG001|STARTED|Phase 1 (12 Weeks)||324
9750827|NCT00316277|10853097|FG000|COMPLETED|Phase 1 (12 Weeks)||19
9750828|NCT00316277|10853098|FG001|COMPLETED|Phase 1 (12 Weeks)||24
9750829|NCT00316277|10853097|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310
9750830|NCT00316277|10853098|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300
9750831|NCT00316277|10853097|FG000|STARTED|Phase 2 (24 Weeks)||180
9750832|NCT00316277|10853098|FG001|STARTED|Phase 2 (24 Weeks)||180
9750833|NCT00316277|10853097|FG000|COMPLETED|Phase 2 (24 Weeks)||161
9750834|NCT00316277|10853098|FG001|COMPLETED|Phase 2 (24 Weeks)||161
9750835|NCT00316277|10853097|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19
9750836|NCT00316277|10853098|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19
9750837|NCT00316303|10853114|FG000|STARTED|Overall Study||118
9750838|NCT00316303|10853115|FG001|STARTED|Overall Study||118
9750839|NCT00316303|10853114|FG000|COMPLETED|Overall Study||107
9750840|NCT00316303|10853115|FG001|COMPLETED|Overall Study||102
9750841|NCT00316303|10853114|FG000|NOT COMPLETED|Overall Study||11
9750842|NCT00316303|10853115|FG001|NOT COMPLETED|Overall Study||16
9750843|NCT00316355|10853126|FG000|STARTED|Overall Study||15
9750844|NCT00316355|10853127|FG001|STARTED|Overall Study||19
9750845|NCT00316355|10853126|FG000|Started Treatment|Overall Study||12
9750846|NCT00316355|10853127|FG001|Started Treatment|Overall Study||18
9750847|NCT00316355|10853126|FG000|COMPLETED|Overall Study||10
9750848|NCT00316355|10853127|FG001|COMPLETED|Overall Study||12
9750849|NCT00316355|10853126|FG000|NOT COMPLETED|Overall Study||5
9750850|NCT00316355|10853127|FG001|NOT COMPLETED|Overall Study||7
9750851|NCT00316524|10853137|FG000|STARTED|Overall Study||183
9750852|NCT00316524|10853138|FG001|STARTED|Overall Study||181
9750853|NCT00316524|10853139|FG002|STARTED|Overall Study||181
9750854|NCT00316524|10853140|FG003|STARTED|Overall Study||200
9750855|NCT00316524|10853137|FG000|COMPLETED|Overall Study||175
9750856|NCT00316524|10853138|FG001|COMPLETED|Overall Study||173
9750857|NCT00316524|10853139|FG002|COMPLETED|Overall Study||175
9750858|NCT00316524|10853140|FG003|COMPLETED|Overall Study||200
9750859|NCT00316524|10853137|FG000|NOT COMPLETED|Overall Study||8
9750860|NCT00316524|10853138|FG001|NOT COMPLETED|Overall Study||8
9750861|NCT00316524|10853139|FG002|NOT COMPLETED|Overall Study||6
9750862|NCT00316524|10853140|FG003|NOT COMPLETED|Overall Study||0
9750863|NCT00316589|10853158|FG000|STARTED|Overall Study||88
9750864|NCT00316589|10853159|FG001|STARTED|Overall Study||352
9750865|NCT00316589|10853160|FG002|STARTED|Overall Study||9
9750866|NCT00316589|10853161|FG003|STARTED|Overall Study||132
9750867|NCT00316589|10853158|FG000|COMPLETED|Overall Study||87
9750868|NCT00316589|10853159|FG001|COMPLETED|Overall Study||328
9750869|NCT00316589|10853160|FG002|COMPLETED|Overall Study||8
9750870|NCT00316589|10853161|FG003|COMPLETED|Overall Study||127
9750871|NCT00316589|10853158|FG000|NOT COMPLETED|Overall Study||1
9750872|NCT00316589|10853159|FG001|NOT COMPLETED|Overall Study||24
9750873|NCT00316589|10853160|FG002|NOT COMPLETED|Overall Study||1
9750874|NCT00316589|10853161|FG003|NOT COMPLETED|Overall Study||5
9750875|NCT00316602|10853175|FG000|STARTED|Overall Study||282
9750876|NCT00316602|10853176|FG001|STARTED|Overall Study||350
9750877|NCT00316602|10853175|FG000|COMPLETED|Overall Study||272
9750878|NCT00316602|10853176|FG001|COMPLETED|Overall Study||325
9750879|NCT00316602|10853175|FG000|NOT COMPLETED|Overall Study||10
9750880|NCT00316602|10853176|FG001|NOT COMPLETED|Overall Study||25
9750881|NCT00316693|10853184|FG000|STARTED|Overall Study||519
9750882|NCT00316693|10853185|FG001|STARTED|Overall Study||521
9750883|NCT00316693|10853184|FG000|COMPLETED|Overall Study||442
9750884|NCT00316693|10853185|FG001|COMPLETED|Overall Study||436
9750885|NCT00316693|10853184|FG000|NOT COMPLETED|Overall Study||77
9750886|NCT00316693|10853185|FG001|NOT COMPLETED|Overall Study||85
9750887|NCT00316706|10853193|FG000|STARTED|Overall Study||626
9750888|NCT00316706|10853194|FG001|STARTED|Overall Study||619
9750889|NCT00316706|10853193|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
9750890|NCT00316706|10853194|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
9750891|NCT00316706|10853193|FG000|NOT COMPLETED|Overall Study||38
9750892|NCT00316706|10853194|FG001|NOT COMPLETED|Overall Study||48
9750893|NCT00316719|10853202|FG000|STARTED|Overall Study||52
9750894|NCT00316719|10853203|FG001|STARTED|Overall Study||53
9750895|NCT00316719|10853202|FG000|COMPLETED|Overall Study||50
9750896|NCT00316719|10853203|FG001|COMPLETED|Overall Study||47
9750897|NCT00316719|10853202|FG000|NOT COMPLETED|Overall Study||2
9750898|NCT00316719|10853203|FG001|NOT COMPLETED|Overall Study||6
9750899|NCT00316862|10853209|FG000|STARTED|Overall Study||82
9750900|NCT00316862|10853209|FG000|COMPLETED|Overall Study||82
9750901|NCT00316862|10853209|FG000|NOT COMPLETED|Overall Study||0
9750916|NCT00316914|10853224|FG000|STARTED|Overall Study||50
9750917|NCT00316914|10853225|FG001|STARTED|Overall Study||52
9750918|NCT00316914|10853224|FG000|COMPLETED|Overall Study||17
9750919|NCT00316914|10853225|FG001|COMPLETED|Overall Study||16
9750920|NCT00316914|10853224|FG000|NOT COMPLETED|Overall Study||33
9750921|NCT00316914|10853225|FG001|NOT COMPLETED|Overall Study||36
9750922|NCT00317044|10853234|FG000|STARTED|Overall Study||320
9750923|NCT00317044|10853235|FG001|STARTED|Overall Study||313
9750924|NCT00317044|10853236|FG002|STARTED|Overall Study||328
9750925|NCT00317044|10853234|FG000|COMPLETED|Overall Study||272
9750926|NCT00317044|10853235|FG001|COMPLETED|Overall Study||273
9750927|NCT00317044|10853236|FG002|COMPLETED|Overall Study||283
9750928|NCT00317044|10853234|FG000|NOT COMPLETED|Overall Study||48
9750929|NCT00317044|10853235|FG001|NOT COMPLETED|Overall Study||40
9750930|NCT00317044|10853236|FG002|NOT COMPLETED|Overall Study||45
10092176|NCT02334787|11220509|FG000|COMPLETED|Overall Study||8
9750931|NCT00317109|10853246|FG000|STARTED|Overall Study||84
9750932|NCT00317109|10853247|FG001|STARTED|Overall Study||84
9750933|NCT00317109|10853246|FG000|COMPLETED|Overall Study||81
9750934|NCT00317109|10853247|FG001|COMPLETED|Overall Study||84
9750935|NCT00317109|10853246|FG000|NOT COMPLETED|Overall Study||3
9750936|NCT00317109|10853247|FG001|NOT COMPLETED|Overall Study||0
9750937|NCT00317226|10853253|FG000|STARTED|Overall Study||127
9750938|NCT00317226|10853253|FG000|COMPLETED|Overall Study||104
9750939|NCT00317226|10853253|FG000|NOT COMPLETED|Overall Study||23
9750940|NCT00317239|10853259|FG000|STARTED|Overall Study||147
9750941|NCT00317239|10853260|FG001|STARTED|Overall Study||103
9750942|NCT00317239|10853259|FG000|COMPLETED|Overall Study||134
9750943|NCT00317239|10853260|FG001|COMPLETED|Overall Study||84
9750944|NCT00317239|10853259|FG000|NOT COMPLETED|Overall Study||13
9750945|NCT00317239|10853260|FG001|NOT COMPLETED|Overall Study||19
9750946|NCT00317356|10853270|FG000|STARTED|Overall Study||11
9750947|NCT00317356|10853271|FG001|STARTED|Overall Study||11
9750948|NCT00317356|10853272|FG002|STARTED|Overall Study||10
9750949|NCT00317356|10853273|FG003|STARTED|Overall Study||11
9750950|NCT00317356|10853270|FG000|COMPLETED|Overall Study||10
9750951|NCT00317356|10853271|FG001|COMPLETED|Overall Study||9
9750952|NCT00317356|10853272|FG002|COMPLETED|Overall Study||9
9750953|NCT00317356|10853273|FG003|COMPLETED|Overall Study||8
9750954|NCT00317356|10853270|FG000|NOT COMPLETED|Overall Study||1
9750955|NCT00317356|10853271|FG001|NOT COMPLETED|Overall Study||2
9750956|NCT00317356|10853272|FG002|NOT COMPLETED|Overall Study||1
9750957|NCT00317356|10853273|FG003|NOT COMPLETED|Overall Study||3
9750958|NCT00317369|10853286|FG000|STARTED|Overall Study||10
9750959|NCT00317369|10853287|FG001|STARTED|Overall Study||9
9750960|NCT00317369|10853288|FG002|STARTED|Overall Study||10
9750961|NCT00317369|10853286|FG000|COMPLETED|Overall Study||8
9750962|NCT00317369|10853287|FG001|COMPLETED|Overall Study||7
9750963|NCT00317369|10853288|FG002|COMPLETED|Overall Study||8
9750964|NCT00317369|10853286|FG000|NOT COMPLETED|Overall Study||2
9750965|NCT00317369|10853287|FG001|NOT COMPLETED|Overall Study||2
9750966|NCT00317369|10853288|FG002|NOT COMPLETED|Overall Study||2
9750967|NCT00317473|10853302|FG000|STARTED|Overall Study||30
9750968|NCT00317473|10853303|FG001|STARTED|Overall Study||15
9750969|NCT00317473|10853304|FG002|STARTED|Overall Study||30
9750970|NCT00317473|10853305|FG003|STARTED|Overall Study||15
9750971|NCT00317473|10853306|FG004|STARTED|Overall Study||30
9750972|NCT00317473|10853307|FG005|STARTED|Overall Study||15
9750973|NCT00317473|10853302|FG000|COMPLETED|Overall Study||26
9750974|NCT00317473|10853303|FG001|COMPLETED|Overall Study||12
9750975|NCT00317473|10853304|FG002|COMPLETED|Overall Study||27
9750976|NCT00317473|10853305|FG003|COMPLETED|Overall Study||13
9750977|NCT00317473|10853306|FG004|COMPLETED|Overall Study||22
9750978|NCT00317473|10853307|FG005|COMPLETED|Overall Study||12
9750979|NCT00317473|10853302|FG000|NOT COMPLETED|Overall Study||4
9750980|NCT00317473|10853303|FG001|NOT COMPLETED|Overall Study||3
9750981|NCT00317473|10853304|FG002|NOT COMPLETED|Overall Study||3
9750982|NCT00317473|10853305|FG003|NOT COMPLETED|Overall Study||2
9750983|NCT00317473|10853306|FG004|NOT COMPLETED|Overall Study||8
10092177|NCT02334787|11220510|FG001|COMPLETED|Overall Study||8
9750984|NCT00317473|10853307|FG005|NOT COMPLETED|Overall Study||3
9750985|NCT00317603|10853331|FG000|STARTED|Overall Study||15
9750986|NCT00317603|10853331|FG000|Treated|Overall Study||12
9750987|NCT00317603|10853331|FG000|COMPLETED|Overall Study||12
9750988|NCT00317603|10853331|FG000|NOT COMPLETED|Overall Study||3
9750989|NCT00317642|10853337|FG000|STARTED|Overall Study||163
9750990|NCT00317642|10853338|FG001|STARTED|Overall Study||163
9750991|NCT00317642|10853337|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
9750992|NCT00317642|10853338|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
9750993|NCT00317642|10853337|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161
9750994|NCT00317642|10853338|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155
9750995|NCT00317642|10853337|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41
9750996|NCT00317642|10853338|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28
9750997|NCT00317642|10853337|FG000|NOT COMPLETED|Overall Study||122
9750998|NCT00317642|10853338|FG001|NOT COMPLETED|Overall Study||135
9750999|NCT00317720|10853351|FG000|STARTED|Overall Study||40
9751000|NCT00317720|10853352|FG001|STARTED|Overall Study||7
9751001|NCT00317720|10853351|FG000|COMPLETED|Overall Study||40
9751002|NCT00317720|10853352|FG001|COMPLETED|Overall Study||7
9751003|NCT00317720|10853351|FG000|NOT COMPLETED|Overall Study||0
9751004|NCT00317720|10853352|FG001|NOT COMPLETED|Overall Study||0
9751005|NCT00317941|10853358|FG000|STARTED|Overall Study||73
9751006|NCT00317941|10853359|FG001|STARTED|Overall Study||79
9751007|NCT00317941|10853360|FG002|STARTED|Overall Study||68
9751008|NCT00317941|10853358|FG000|Participants Received Treatment|Overall Study||73
9751009|NCT00317941|10853359|FG001|Participants Received Treatment|Overall Study||79
9853809|NCT00888940|10966760|FG001|Completed Therapy|Overall Study||106
9853810|NCT00888940|10966759|FG000|COMPLETED|Overall Study||92
9853811|NCT00888940|10966760|FG001|COMPLETED|Overall Study||101
9853812|NCT00888940|10966759|FG000|NOT COMPLETED|Overall Study||28
9853813|NCT00888940|10966760|FG001|NOT COMPLETED|Overall Study||21
9853814|NCT00888979|10966766|FG000|STARTED|Overall Study||10
9853815|NCT00888979|10966766|FG000|Received the Inhaler/Counseling|Overall Study||8
9853816|NCT00888979|10966766|FG000|COMPLETED|Overall Study||6
9853817|NCT00888979|10966766|FG000|NOT COMPLETED|Overall Study||4
9853818|NCT00889005|10966772|FG000|STARTED|Overall Study||65
9853819|NCT00889005|10966773|FG001|STARTED|Overall Study||74
9853820|NCT00889005|10966772|FG000|COMPLETED|Overall Study||57
9853821|NCT00889005|10966773|FG001|COMPLETED|Overall Study||72
9853822|NCT00889005|10966772|FG000|NOT COMPLETED|Overall Study||8
9853823|NCT00889005|10966773|FG001|NOT COMPLETED|Overall Study||2
9853824|NCT00889187|10966779|FG000|STARTED|Overall Study||3
9751010|NCT00317941|10853360|FG002|Participants Received Treatment|Overall Study||68
9751011|NCT00317941|10853358|FG000|Fulfilled Requirement Safety Population|Overall Study||73
9751012|NCT00317941|10853359|FG001|Fulfilled Requirement Safety Population|Overall Study||77
9751013|NCT00317941|10853360|FG002|Fulfilled Requirement Safety Population|Overall Study||65
9751014|NCT00317941|10853358|FG000|Fulfilled Requirements PP Population|Overall Study||66
9751015|NCT00317941|10853359|FG001|Fulfilled Requirements PP Population|Overall Study||76
9751016|NCT00317941|10853360|FG002|Fulfilled Requirements PP Population|Overall Study||63
9751017|NCT00317941|10853358|FG000|COMPLETED|Overall Study||66
9751018|NCT00317941|10853359|FG001|COMPLETED|Overall Study||74
9751019|NCT00317941|10853360|FG002|COMPLETED|Overall Study||60
9751020|NCT00317941|10853358|FG000|NOT COMPLETED|Overall Study||7
9751021|NCT00317941|10853359|FG001|NOT COMPLETED|Overall Study||5
9751022|NCT00317941|10853360|FG002|NOT COMPLETED|Overall Study||8
9751023|NCT00318136|10853369|FG000|STARTED|Overall Study||47
9751024|NCT00318136|10853369|FG000|COMPLETED|Overall Study||2
9751025|NCT00318136|10853369|FG000|NOT COMPLETED|Overall Study||45
9751026|NCT00318149|10853379|FG000|STARTED|Overall Study||75
9751027|NCT00318149|10853380|FG001|STARTED|Overall Study||50
9751028|NCT00318149|10853381|FG002|STARTED|Overall Study||75
9751029|NCT00318149|10853382|FG003|STARTED|Overall Study||75
9751030|NCT00318149|10853383|FG004|STARTED|Overall Study||75
9751031|NCT00318149|10853384|FG005|STARTED|Overall Study||75
9751032|NCT00318149|10853379|FG000|COMPLETED|Overall Study||75
9751033|NCT00318149|10853380|FG001|COMPLETED|Overall Study||50
9751034|NCT00318149|10853381|FG002|COMPLETED|Overall Study||75
9751035|NCT00318149|10853382|FG003|COMPLETED|Overall Study||75
9751036|NCT00318149|10853383|FG004|COMPLETED|Overall Study||75
9751037|NCT00318149|10853384|FG005|COMPLETED|Overall Study||73
9751038|NCT00318149|10853379|FG000|NOT COMPLETED|Overall Study||0
9853825|NCT00889187|10966780|FG001|STARTED|Overall Study||3
9751039|NCT00318149|10853380|FG001|NOT COMPLETED|Overall Study||0
9751040|NCT00318149|10853381|FG002|NOT COMPLETED|Overall Study||0
9751041|NCT00318149|10853382|FG003|NOT COMPLETED|Overall Study||0
9751042|NCT00318149|10853383|FG004|NOT COMPLETED|Overall Study||0
9751043|NCT00318149|10853384|FG005|NOT COMPLETED|Overall Study||2
9751044|NCT00318292|10853402|FG000|STARTED|Overall Study||45
9751045|NCT00318292|10853403|FG001|STARTED|Overall Study||45
9751046|NCT00318292|10853402|FG000|COMPLETED|Overall Study||45
9751047|NCT00318292|10853403|FG001|COMPLETED|Overall Study||45
9751048|NCT00318292|10853402|FG000|NOT COMPLETED|Overall Study||0
9751049|NCT00318292|10853403|FG001|NOT COMPLETED|Overall Study||0
9751050|NCT00318357|10853411|FG000|STARTED|Overall Study||173
9853826|NCT00889187|10966781|FG002|STARTED|Overall Study||4
9853827|NCT00889187|10966782|FG003|STARTED|Overall Study||0
9853828|NCT00889187|10966779|FG000|COMPLETED|Overall Study||3
9751051|NCT00318357|10853412|FG001|STARTED|Overall Study||136
9751052|NCT00318357|10853411|FG000|COMPLETED|Overall Study||134
9751053|NCT00318357|10853412|FG001|COMPLETED|Overall Study||104
9751054|NCT00318357|10853411|FG000|NOT COMPLETED|Overall Study||39
9751055|NCT00318357|10853412|FG001|NOT COMPLETED|Overall Study||32
9751056|NCT00318370|10853418|FG000|STARTED|Period 1||28
9751057|NCT00318370|10853419|FG001|STARTED|Period 1||0
9751058|NCT00318370|10853420|FG002|STARTED|Period 1||0
9751059|NCT00318370|10853418|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
9751060|NCT00318370|10853419|FG001|COMPLETED|Period 1||0
9751061|NCT00318370|10853420|FG002|COMPLETED|Period 1||0
9751062|NCT00318370|10853418|FG000|NOT COMPLETED|Period 1||7
9751063|NCT00318370|10853419|FG001|NOT COMPLETED|Period 1||0
9751064|NCT00318370|10853420|FG002|NOT COMPLETED|Period 1||0
9751065|NCT00318370|10853418|FG000|STARTED|Period 2||0
9751066|NCT00318370|10853419|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
9751067|NCT00318370|10853420|FG002|STARTED|Period 2||0
9751068|NCT00318370|10853418|FG000|COMPLETED|Period 2||0
9751069|NCT00318370|10853419|FG001|COMPLETED|Period 2||36
9751070|NCT00318370|10853420|FG002|COMPLETED|Period 2||0
9751071|NCT00318370|10853418|FG000|NOT COMPLETED|Period 2||0
9751072|NCT00318370|10853419|FG001|NOT COMPLETED|Period 2||11
9751073|NCT00318370|10853420|FG002|NOT COMPLETED|Period 2||0
9751074|NCT00318370|10853418|FG000|STARTED|Period 3||0
9751075|NCT00318370|10853419|FG001|STARTED|Period 3||0
9751076|NCT00318370|10853420|FG002|STARTED|Period 3||36
9751077|NCT00318370|10853418|FG000|COMPLETED|Period 3||0
9751078|NCT00318370|10853419|FG001|COMPLETED|Period 3||0
9751079|NCT00318370|10853420|FG002|COMPLETED|Period 3||3
9751080|NCT00318370|10853418|FG000|NOT COMPLETED|Period 3||0
9751081|NCT00318370|10853419|FG001|NOT COMPLETED|Period 3||0
9751082|NCT00318370|10853420|FG002|NOT COMPLETED|Period 3||33
9751083|NCT00318409|10853428|FG000|STARTED|Overall Study||20
9751084|NCT00318409|10853429|FG001|STARTED|Overall Study||10
9751085|NCT00318409|10853428|FG000|COMPLETED|Overall Study||18
9751086|NCT00318409|10853429|FG001|COMPLETED|Overall Study||9
9751087|NCT00318409|10853428|FG000|NOT COMPLETED|Overall Study||2
9751088|NCT00318409|10853429|FG001|NOT COMPLETED|Overall Study||1
9751089|NCT00318461|10853441|FG000|STARTED|Double-Blind, 6 Months|Randomised|242
9751090|NCT00318461|10853442|FG001|STARTED|Double-Blind, 6 Months|Randomised|241
9751091|NCT00318461|10853443|FG002|STARTED|Double-Blind, 6 Months|Randomised|242
9751092|NCT00318461|10853444|FG003|STARTED|Double-Blind, 6 Months|Randomised|122
9751093|NCT00318461|10853445|FG004|STARTED|Double-Blind, 6 Months|Randomised|244
9751094|NCT00318461|10853441|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242
9751095|NCT00318461|10853442|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
9751096|NCT00318461|10853443|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242
9751097|NCT00318461|10853444|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
9751098|NCT00318461|10853445|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
9751099|NCT00318461|10853441|FG000|COMPLETED|Double-Blind, 6 Months||208
9751100|NCT00318461|10853442|FG001|COMPLETED|Double-Blind, 6 Months||197
9751101|NCT00318461|10853443|FG002|COMPLETED|Double-Blind, 6 Months||191
9751102|NCT00318461|10853444|FG003|COMPLETED|Double-Blind, 6 Months||74
9751103|NCT00318461|10853445|FG004|COMPLETED|Double-Blind, 6 Months||210
9751104|NCT00318461|10853441|FG000|NOT COMPLETED|Double-Blind, 6 Months||34
9751105|NCT00318461|10853442|FG001|NOT COMPLETED|Double-Blind, 6 Months||44
9751106|NCT00318461|10853443|FG002|NOT COMPLETED|Double-Blind, 6 Months||51
9751107|NCT00318461|10853444|FG003|NOT COMPLETED|Double-Blind, 6 Months||48
9751108|NCT00318461|10853445|FG004|NOT COMPLETED|Double-Blind, 6 Months||34
9751109|NCT00318461|10853441|FG000|STARTED|Open-Label Extension, 18 Months||208
9751110|NCT00318461|10853442|FG001|STARTED|Open-Label Extension, 18 Months||197
9751111|NCT00318461|10853443|FG002|STARTED|Open-Label Extension, 18 Months||191
9751112|NCT00318461|10853444|FG003|STARTED|Open-Label Extension, 18 Months||74
9751113|NCT00318461|10853445|FG004|STARTED|Open-Label Extension, 18 Months||210
9751114|NCT00318461|10853441|FG000|COMPLETED|Open-Label Extension, 18 Months||130
9751115|NCT00318461|10853442|FG001|COMPLETED|Open-Label Extension, 18 Months||137
9751116|NCT00318461|10853443|FG002|COMPLETED|Open-Label Extension, 18 Months||118
9751117|NCT00318461|10853444|FG003|COMPLETED|Open-Label Extension, 18 Months||31
9751118|NCT00318461|10853445|FG004|COMPLETED|Open-Label Extension, 18 Months||113
9751119|NCT00318461|10853441|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78
9751120|NCT00318461|10853442|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60
9751121|NCT00318461|10853443|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73
9751122|NCT00318461|10853444|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43
9751123|NCT00318461|10853445|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97
9751124|NCT00318474|10853459|FG000|STARTED|Overall Study||25
9751125|NCT00318474|10853460|FG001|STARTED|Overall Study||27
9751126|NCT00318474|10853459|FG000|COMPLETED|Overall Study||7
9751127|NCT00318474|10853460|FG001|COMPLETED|Overall Study||10
9751128|NCT00318474|10853459|FG000|NOT COMPLETED|Overall Study||18
9751129|NCT00318474|10853460|FG001|NOT COMPLETED|Overall Study||17
9751130|NCT00318565|10853466|FG000|STARTED|Overall Study||291
9751131|NCT00318565|10853466|FG000|COMPLETED|Overall Study||267
9751132|NCT00318565|10853466|FG000|NOT COMPLETED|Overall Study||24
9751133|NCT00318591|10853472|FG000|STARTED|Overall Study||105
9751134|NCT00318591|10853473|FG001|STARTED|Overall Study||114
9751135|NCT00318591|10853472|FG000|COMPLETED|Overall Study||45
9751136|NCT00318591|10853473|FG001|COMPLETED|Overall Study||69
9751137|NCT00318591|10853472|FG000|NOT COMPLETED|Overall Study||60
9751138|NCT00318591|10853473|FG001|NOT COMPLETED|Overall Study||45
9751139|NCT00318643|10853486|FG000|STARTED|Overall Study||3
9751140|NCT00318643|10853487|FG001|STARTED|Overall Study||3
9751141|NCT00318643|10853488|FG002|STARTED|Overall Study||6
9751142|NCT00318643|10853489|FG003|STARTED|Overall Study||3
9751143|NCT00318643|10853490|FG004|STARTED|Overall Study||12
9751144|NCT00318643|10853486|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9751145|NCT00318643|10853487|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9751146|NCT00318643|10853488|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9751147|NCT00318643|10853489|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
9751148|NCT00318643|10853490|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
9751149|NCT00318643|10853486|FG000|COMPLETED|Overall Study||3
9751150|NCT00318643|10853487|FG001|COMPLETED|Overall Study||3
9751151|NCT00318643|10853488|FG002|COMPLETED|Overall Study||6
9751152|NCT00318643|10853489|FG003|COMPLETED|Overall Study||3
9751153|NCT00318643|10853490|FG004|COMPLETED|Overall Study||9
9751154|NCT00318643|10853486|FG000|NOT COMPLETED|Overall Study||0
9751155|NCT00318643|10853487|FG001|NOT COMPLETED|Overall Study||0
9751156|NCT00318643|10853488|FG002|NOT COMPLETED|Overall Study||0
9751157|NCT00318643|10853489|FG003|NOT COMPLETED|Overall Study||0
9751158|NCT00318643|10853490|FG004|NOT COMPLETED|Overall Study||3
9751159|NCT00318708|10853505|FG000|STARTED|Overall Study||47
9751160|NCT00318708|10853506|FG001|STARTED|Overall Study||45
9751161|NCT00318708|10853505|FG000|8-week Milestone|Overall Study||42
9751162|NCT00318708|10853506|FG001|8-week Milestone|Overall Study||42
9751163|NCT00318708|10853505|FG000|COMPLETED|Overall Study||39
9751164|NCT00318708|10853506|FG001|COMPLETED|Overall Study||40
9751165|NCT00318708|10853505|FG000|NOT COMPLETED|Overall Study||8
9751166|NCT00318708|10853506|FG001|NOT COMPLETED|Overall Study||5
9751167|NCT00318812|10853518|FG000|STARTED|Overall Study||18
9751168|NCT00318812|10853519|FG001|STARTED|Overall Study||22
9751169|NCT00318812|10853518|FG000|COMPLETED|Overall Study||18
9751170|NCT00318812|10853519|FG001|COMPLETED|Overall Study||22
9751171|NCT00318812|10853518|FG000|NOT COMPLETED|Overall Study||0
9751172|NCT00318812|10853519|FG001|NOT COMPLETED|Overall Study||0
9751173|NCT00318929|10853525|FG000|STARTED|Overall Study||14
9751174|NCT00318929|10853525|FG000|COMPLETED|Overall Study||14
9751175|NCT00318929|10853525|FG000|NOT COMPLETED|Overall Study||0
9751176|NCT00319020|10853531|FG000|STARTED|Overall Study||15
9751177|NCT00319020|10853532|FG001|STARTED|Overall Study||21
9751178|NCT00319020|10853531|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13
9751179|NCT00319020|10853532|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20
9751180|NCT00319020|10853531|FG000|COMPLETED|Overall Study||8
9751181|NCT00319020|10853532|FG001|COMPLETED|Overall Study||8
9751182|NCT00319020|10853531|FG000|NOT COMPLETED|Overall Study||7
9751183|NCT00319020|10853532|FG001|NOT COMPLETED|Overall Study||13
9751184|NCT00319046|10853540|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
9751185|NCT00319046|10853540|FG000|COMPLETED|Overall Study||34
9751186|NCT00319046|10853540|FG000|NOT COMPLETED|Overall Study||8
9828880|NCT00758264|10939553|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
9828881|NCT00758264|10939554|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
9828882|NCT00758264|10939555|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
9828883|NCT00758342|10939565|FG000|STARTED|Overall Study||19
9828884|NCT00758342|10939566|FG001|STARTED|Overall Study||18
9828885|NCT00758342|10939565|FG000|COMPLETED|Overall Study||15
9828886|NCT00758342|10939566|FG001|COMPLETED|Overall Study||17
9828887|NCT00758342|10939565|FG000|NOT COMPLETED|Overall Study||4
9828888|NCT00758342|10939566|FG001|NOT COMPLETED|Overall Study||1
9828889|NCT00758394|10939576|FG000|STARTED|1st Intervention||8
9828890|NCT00758394|10939577|FG001|STARTED|1st Intervention||7
9828891|NCT00758394|10939578|FG002|STARTED|1st Intervention||6
9828892|NCT00758394|10939579|FG003|STARTED|1st Intervention||8
9828893|NCT00758394|10939576|FG000|COMPLETED|1st Intervention||8
9828894|NCT00758394|10939577|FG001|COMPLETED|1st Intervention||7
9828895|NCT00758394|10939578|FG002|COMPLETED|1st Intervention||6
9828896|NCT00758394|10939579|FG003|COMPLETED|1st Intervention||8
9828897|NCT00758394|10939576|FG000|NOT COMPLETED|1st Intervention||0
9828898|NCT00758394|10939577|FG001|NOT COMPLETED|1st Intervention||0
9828899|NCT00758394|10939578|FG002|NOT COMPLETED|1st Intervention||0
9828900|NCT00758394|10939579|FG003|NOT COMPLETED|1st Intervention||0
9828901|NCT00758394|10939576|FG000|STARTED|Washout After 1st Intervention||8
9828902|NCT00758394|10939577|FG001|STARTED|Washout After 1st Intervention||7
9828903|NCT00758394|10939578|FG002|STARTED|Washout After 1st Intervention||6
9828904|NCT00758394|10939579|FG003|STARTED|Washout After 1st Intervention||8
9828905|NCT00758394|10939576|FG000|COMPLETED|Washout After 1st Intervention||8
9828906|NCT00758394|10939577|FG001|COMPLETED|Washout After 1st Intervention||7
9828907|NCT00758394|10939578|FG002|COMPLETED|Washout After 1st Intervention||6
9828908|NCT00758394|10939579|FG003|COMPLETED|Washout After 1st Intervention||8
9828909|NCT00758394|10939576|FG000|NOT COMPLETED|Washout After 1st Intervention||0
9828910|NCT00758394|10939577|FG001|NOT COMPLETED|Washout After 1st Intervention||0
9828911|NCT00758394|10939578|FG002|NOT COMPLETED|Washout After 1st Intervention||0
9828912|NCT00758394|10939579|FG003|NOT COMPLETED|Washout After 1st Intervention||0
9828913|NCT00758394|10939576|FG000|STARTED|2nd Intervention Order||8
9751187|NCT00319098|10853548|FG000|STARTED|Overall Study||3802
9751188|NCT00319098|10853549|FG001|STARTED|Overall Study||1269
9751189|NCT00319098|10853548|FG000|COMPLETED|Overall Study||3667
9751190|NCT00319098|10853549|FG001|COMPLETED|Overall Study||1237
9751191|NCT00319098|10853548|FG000|NOT COMPLETED|Overall Study||135
9751192|NCT00319098|10853549|FG001|NOT COMPLETED|Overall Study||32
9751193|NCT00319111|10853559|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
9751194|NCT00319111|10853559|FG000|COMPLETED|Overall Study||104
9751195|NCT00319111|10853559|FG000|NOT COMPLETED|Overall Study||47
9751196|NCT00319254|10853563|FG000|STARTED|Overall Study||75
9751197|NCT00319254|10853563|FG000|Treated|Overall Study||73
9751198|NCT00319254|10853563|FG000|COMPLETED|Overall Study||21
9751199|NCT00319254|10853563|FG000|NOT COMPLETED|Overall Study||54
9751200|NCT00319436|10853569|FG000|STARTED|Overall Study||23
10092178|NCT02334787|11220511|FG002|COMPLETED|Overall Study||8
10092179|NCT02334787|11220512|FG003|COMPLETED|Overall Study||8
10092180|NCT02334787|11220509|FG000|NOT COMPLETED|Overall Study||0
10092181|NCT02334787|11220510|FG001|NOT COMPLETED|Overall Study||0
10092182|NCT02334787|11220511|FG002|NOT COMPLETED|Overall Study||0
9751201|NCT00319436|10853570|FG001|STARTED|Overall Study||24
9751202|NCT00319436|10853569|FG000|COMPLETED|Overall Study||17
9751203|NCT00319436|10853570|FG001|COMPLETED|Overall Study||17
9751204|NCT00319436|10853569|FG000|NOT COMPLETED|Overall Study||6
9751205|NCT00319436|10853570|FG001|NOT COMPLETED|Overall Study||7
9751206|NCT00319501|10853578|FG000|STARTED|Double-blind Period|Randomized participants|124
9751207|NCT00319501|10853579|FG001|STARTED|Double-blind Period|Randomized participants|110
9751208|NCT00319501|10853578|FG000|Received Treatment|Double-blind Period||82
9751209|NCT00319501|10853579|FG001|Received Treatment|Double-blind Period||81
9751210|NCT00319501|10853578|FG000|COMPLETED|Double-blind Period||81
9751211|NCT00319501|10853579|FG001|COMPLETED|Double-blind Period||78
9751212|NCT00319501|10853578|FG000|NOT COMPLETED|Double-blind Period||43
9751213|NCT00319501|10853579|FG001|NOT COMPLETED|Double-blind Period||32
9751214|NCT00319501|10853578|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
9751215|NCT00319501|10853579|FG001|STARTED|Open-label Period||0
9751216|NCT00319501|10853578|FG000|Received Treatment|Open-label Period||128
9751217|NCT00319501|10853579|FG001|Received Treatment|Open-label Period||0
9751218|NCT00319501|10853578|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45
9751219|NCT00319501|10853579|FG001|COMPLETED|Open-label Period||0
9751220|NCT00319501|10853578|FG000|NOT COMPLETED|Open-label Period||116
9751221|NCT00319501|10853579|FG001|NOT COMPLETED|Open-label Period||0
9751222|NCT00319501|10853578|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
9751223|NCT00319501|10853579|FG001|STARTED|Open-label Extension Period||0
9751224|NCT00319501|10853578|FG000|Received Treatment|Open-label Extension Period||33
9751225|NCT00319501|10853579|FG001|Received Treatment|Open-label Extension Period||0
9751226|NCT00319501|10853578|FG000|COMPLETED|Open-label Extension Period||0
9751227|NCT00319501|10853579|FG001|COMPLETED|Open-label Extension Period||0
9751228|NCT00319501|10853578|FG000|NOT COMPLETED|Open-label Extension Period||51
9751229|NCT00319501|10853579|FG001|NOT COMPLETED|Open-label Extension Period||0
9751230|NCT00319553|10853592|FG000|STARTED|Overall Study||323
9751231|NCT00319553|10853593|FG001|STARTED|Overall Study||321
9751232|NCT00319553|10853592|FG000|COMPLETED|Overall Study||319
9751233|NCT00319553|10853593|FG001|COMPLETED|Overall Study||317
9751234|NCT00319553|10853592|FG000|NOT COMPLETED|Overall Study||4
9751235|NCT00319553|10853593|FG001|NOT COMPLETED|Overall Study||4
9751236|NCT00319592|10853601|FG000|STARTED|Overall Study||30
9751237|NCT00319592|10853602|FG001|STARTED|Overall Study||30
9751238|NCT00319592|10853601|FG000|COMPLETED|Overall Study||29
10092183|NCT02334787|11220512|FG003|NOT COMPLETED|Overall Study||0
10092184|NCT02334800|11220532|FG000|STARTED|Overall Study||7
10092185|NCT02334800|11220533|FG001|STARTED|Overall Study||7
10092186|NCT02334800|11220534|FG002|STARTED|Overall Study||7
10092187|NCT02334800|11220535|FG003|STARTED|Overall Study||7
10092188|NCT02334800|11220532|FG000|Received Treatment|Overall Study||7
10092189|NCT02334800|11220533|FG001|Received Treatment|Overall Study||7
9751239|NCT00319592|10853602|FG001|COMPLETED|Overall Study||29
9751240|NCT00319592|10853601|FG000|NOT COMPLETED|Overall Study||1
9751241|NCT00319592|10853602|FG001|NOT COMPLETED|Overall Study||1
10092190|NCT02334800|11220534|FG002|Received Treatment|Overall Study||7
9751242|NCT00319644|10853610|FG000|STARTED|Overall Study||21
9751243|NCT00319644|10853611|FG001|STARTED|Overall Study||16
9751244|NCT00319644|10853610|FG000|COMPLETED|Overall Study||21
9751245|NCT00319644|10853611|FG001|COMPLETED|Overall Study||16
9751246|NCT00319644|10853610|FG000|NOT COMPLETED|Overall Study||0
9751247|NCT00319644|10853611|FG001|NOT COMPLETED|Overall Study||0
9751248|NCT00319696|10853617|FG000|STARTED|Overall Study||116
9751249|NCT00319696|10853617|FG000|COMPLETED|Overall Study||56
9751250|NCT00319696|10853617|FG000|NOT COMPLETED|Overall Study||60
9751251|NCT00319735|10853627|FG000|STARTED|Overall Study||41
9751252|NCT00319735|10853627|FG000|COMPLETED|Overall Study||39
9751253|NCT00319735|10853627|FG000|NOT COMPLETED|Overall Study||2
10092191|NCT02334800|11220535|FG003|Received Treatment|Overall Study||7
9751254|NCT00319748|10853632|FG000|STARTED|Overall Study||13
9751255|NCT00319748|10853632|FG000|COMPLETED|Overall Study||13
10092192|NCT02334800|11220532|FG000|COMPLETED|Overall Study||7
10092193|NCT02334800|11220533|FG001|COMPLETED|Overall Study||7
10092194|NCT02334800|11220534|FG002|COMPLETED|Overall Study||7
10092195|NCT02334800|11220535|FG003|COMPLETED|Overall Study||7
10092196|NCT02334800|11220532|FG000|NOT COMPLETED|Overall Study||0
9751256|NCT00319748|10853632|FG000|NOT COMPLETED|Overall Study||0
9751257|NCT00319956|10853644|FG000|STARTED|Overall Study||111
9751258|NCT00319956|10853645|FG001|STARTED|Overall Study||109
9751259|NCT00319956|10853644|FG000|COMPLETED|Overall Study||91
9751260|NCT00319956|10853645|FG001|COMPLETED|Overall Study||85
9751261|NCT00319956|10853644|FG000|NOT COMPLETED|Overall Study||20
9751262|NCT00319956|10853645|FG001|NOT COMPLETED|Overall Study||24
9751263|NCT00319982|10853653|FG000|STARTED|Overall Study||19
9751264|NCT00319982|10853654|FG001|STARTED|Overall Study||20
9751265|NCT00319982|10853653|FG000|COMPLETED|Overall Study||18
9751266|NCT00319982|10853654|FG001|COMPLETED|Overall Study||20
9751267|NCT00319982|10853653|FG000|NOT COMPLETED|Overall Study||1
9751268|NCT00319982|10853654|FG001|NOT COMPLETED|Overall Study||0
9751269|NCT00320112|10853662|FG000|STARTED|Overall Study||125
9751270|NCT00320112|10853663|FG001|STARTED|Overall Study||119
9751271|NCT00320112|10853662|FG000|COMPLETED|Overall Study||117
9751272|NCT00320112|10853663|FG001|COMPLETED|Overall Study||114
9751273|NCT00320112|10853662|FG000|NOT COMPLETED|Overall Study||8
9751274|NCT00320112|10853663|FG001|NOT COMPLETED|Overall Study||5
9751275|NCT00320190|10853677|FG000|STARTED|First 12 Months||19
9751276|NCT00320190|10853678|FG001|STARTED|First 12 Months||13
9751277|NCT00320190|10853677|FG000|COMPLETED|First 12 Months||11
9751278|NCT00320190|10853678|FG001|COMPLETED|First 12 Months||3
9751279|NCT00320190|10853677|FG000|NOT COMPLETED|First 12 Months||8
9751280|NCT00320190|10853678|FG001|NOT COMPLETED|First 12 Months||10
9751281|NCT00320190|10853677|FG000|STARTED|Long-term (12-month) Extension||11
9751282|NCT00320190|10853678|FG001|STARTED|Long-term (12-month) Extension||3
10092197|NCT02334800|11220533|FG001|NOT COMPLETED|Overall Study||0
9751283|NCT00320190|10853677|FG000|COMPLETED|Long-term (12-month) Extension||2
9751284|NCT00320190|10853678|FG001|COMPLETED|Long-term (12-month) Extension||1
9751285|NCT00320190|10853677|FG000|NOT COMPLETED|Long-term (12-month) Extension||9
9751286|NCT00320190|10853678|FG001|NOT COMPLETED|Long-term (12-month) Extension||2
9751287|NCT00320216|10853689|FG000|STARTED|Overall Study||64
9751288|NCT00320216|10853690|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
9751289|NCT00320216|10853691|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
9751290|NCT00320216|10853692|FG003|STARTED|Overall Study||64
9751291|NCT00320216|10853693|FG004|STARTED|Overall Study||64
9751292|NCT00320216|10853689|FG000|COMPLETED|Overall Study||48
9751293|NCT00320216|10853690|FG001|COMPLETED|Overall Study||54
9751294|NCT00320216|10853691|FG002|COMPLETED|Overall Study||58
9751295|NCT00320216|10853692|FG003|COMPLETED|Overall Study||61
9751296|NCT00320216|10853693|FG004|COMPLETED|Overall Study||58
9751297|NCT00320216|10853689|FG000|NOT COMPLETED|Overall Study||16
9751298|NCT00320216|10853690|FG001|NOT COMPLETED|Overall Study||10
9751299|NCT00320216|10853691|FG002|NOT COMPLETED|Overall Study||6
9751300|NCT00320216|10853692|FG003|NOT COMPLETED|Overall Study||3
9751301|NCT00320216|10853693|FG004|NOT COMPLETED|Overall Study||6
9751302|NCT00320242|10853710|FG000|STARTED|Overall Study||16
9751303|NCT00320242|10853711|FG001|STARTED|Overall Study||16
9751304|NCT00320242|10853710|FG000|COMPLETED|Overall Study||14
9751305|NCT00320242|10853711|FG001|COMPLETED|Overall Study||12
9751306|NCT00320242|10853710|FG000|NOT COMPLETED|Overall Study||2
9751307|NCT00320242|10853711|FG001|NOT COMPLETED|Overall Study||4
9751308|NCT00320255|10853724|FG000|STARTED|Overall Study||30
9751309|NCT00320255|10853725|FG001|STARTED|Overall Study||32
9751310|NCT00320255|10853726|FG002|STARTED|Overall Study||30
9751311|NCT00320255|10853727|FG003|STARTED|Overall Study||33
9751312|NCT00320255|10853728|FG004|STARTED|Overall Study||2
9751313|NCT00320255|10853729|FG005|STARTED|Overall Study||3
9751314|NCT00320255|10853724|FG000|Received Treatment|Overall Study||29
9751315|NCT00320255|10853725|FG001|Received Treatment|Overall Study||32
9751316|NCT00320255|10853726|FG002|Received Treatment|Overall Study||29
9751317|NCT00320255|10853727|FG003|Received Treatment|Overall Study||32
9853829|NCT00889187|10966780|FG001|COMPLETED|Overall Study||3
9853830|NCT00889187|10966781|FG002|COMPLETED|Overall Study||4
9853831|NCT00889187|10966782|FG003|COMPLETED|Overall Study||0
9751318|NCT00320255|10853728|FG004|Received Treatment|Overall Study||2
9751319|NCT00320255|10853729|FG005|Received Treatment|Overall Study||3
9751320|NCT00320255|10853724|FG000|COMPLETED|Overall Study||19
9751321|NCT00320255|10853725|FG001|COMPLETED|Overall Study||25
9751322|NCT00320255|10853726|FG002|COMPLETED|Overall Study||24
9853832|NCT00889187|10966779|FG000|NOT COMPLETED|Overall Study||0
9853833|NCT00889187|10966780|FG001|NOT COMPLETED|Overall Study||0
9853834|NCT00889187|10966781|FG002|NOT COMPLETED|Overall Study||0
9853835|NCT00889187|10966782|FG003|NOT COMPLETED|Overall Study||0
9853836|NCT00889200|10966792|FG000|STARTED|Overall Study||12
9853837|NCT00889200|10966792|FG000|COMPLETED|Overall Study||12
10092198|NCT02334800|11220534|FG002|NOT COMPLETED|Overall Study||0
9751323|NCT00320255|10853727|FG003|COMPLETED|Overall Study||25
9751324|NCT00320255|10853728|FG004|COMPLETED|Overall Study||2
9751325|NCT00320255|10853729|FG005|COMPLETED|Overall Study||3
9751326|NCT00320255|10853724|FG000|NOT COMPLETED|Overall Study||11
9751327|NCT00320255|10853725|FG001|NOT COMPLETED|Overall Study||7
9751328|NCT00320255|10853726|FG002|NOT COMPLETED|Overall Study||6
9751329|NCT00320255|10853727|FG003|NOT COMPLETED|Overall Study||8
9751330|NCT00320255|10853728|FG004|NOT COMPLETED|Overall Study||0
9751331|NCT00320255|10853729|FG005|NOT COMPLETED|Overall Study||0
9751332|NCT00320281|10853746|FG000|STARTED|Overall Study||10
9751333|NCT00320281|10853747|FG001|STARTED|Overall Study||9
10092199|NCT02334800|11220535|FG003|NOT COMPLETED|Overall Study||0
9751334|NCT00320281|10853746|FG000|COMPLETED|Overall Study||10
9751335|NCT00320281|10853747|FG001|COMPLETED|Overall Study||9
9751336|NCT00320281|10853746|FG000|NOT COMPLETED|Overall Study||0
9751337|NCT00320281|10853747|FG001|NOT COMPLETED|Overall Study||0
9751338|NCT00320372|10853758|FG000|STARTED|Overall Study||494
9751339|NCT00320372|10853759|FG001|STARTED|Overall Study||301
9751340|NCT00320372|10853758|FG000|VNS Therapy D-23 Original|Overall Study||335
9751341|NCT00320372|10853759|FG001|VNS Therapy D-23 Original|Overall Study||0
9751342|NCT00320372|10853758|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
9751343|NCT00320372|10853759|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
9751344|NCT00320372|10853758|FG000|COMPLETED|Overall Study||299
9751345|NCT00320372|10853759|FG001|COMPLETED|Overall Study||138
9751346|NCT00320372|10853758|FG000|NOT COMPLETED|Overall Study||195
9751347|NCT00320372|10853759|FG001|NOT COMPLETED|Overall Study||163
9751348|NCT00320385|10853775|FG000|STARTED|Overall Study||148
9751349|NCT00320385|10853776|FG001|STARTED|Overall Study||148
9751350|NCT00320385|10853775|FG000|COMPLETED|Overall Study||130
9751351|NCT00320385|10853776|FG001|COMPLETED|Overall Study||126
9751352|NCT00320385|10853775|FG000|NOT COMPLETED|Overall Study||18
9751353|NCT00320385|10853776|FG001|NOT COMPLETED|Overall Study||22
9751354|NCT00320398|10853784|FG000|STARTED|Overall Study||58
9751355|NCT00320398|10853785|FG001|STARTED|Overall Study||56
9751356|NCT00320398|10853784|FG000|COMPLETED|Overall Study||56
9751357|NCT00320398|10853785|FG001|COMPLETED|Overall Study||52
9751358|NCT00320398|10853784|FG000|NOT COMPLETED|Overall Study||2
9751359|NCT00320398|10853785|FG001|NOT COMPLETED|Overall Study||4
9751360|NCT00320411|10853792|FG000|STARTED|Overall Study||62
9751361|NCT00320411|10853792|FG000|COMPLETED|Overall Study||58
9751362|NCT00320411|10853792|FG000|NOT COMPLETED|Overall Study||4
10092200|NCT02334813|11220547|FG000|STARTED|Overall Study||12
9751363|NCT00320424|10853796|FG000|STARTED|Overall Study||48
9751364|NCT00320424|10853796|FG000|COMPLETED|Overall Study||42
9853838|NCT00889200|10966792|FG000|NOT COMPLETED|Overall Study||0
9853839|NCT00889226|10966798|FG000|STARTED|Overall Study||83
9751365|NCT00320424|10853796|FG000|NOT COMPLETED|Overall Study||6
9751366|NCT00320489|10853802|FG000|STARTED|Overall Study||264
9751367|NCT00320489|10853803|FG001|STARTED|Overall Study||260
9751368|NCT00320489|10853802|FG000|COMPLETED|Overall Study||119
9751369|NCT00320489|10853803|FG001|COMPLETED|Overall Study||124
9751370|NCT00320489|10853802|FG000|NOT COMPLETED|Overall Study||145
9751371|NCT00320489|10853803|FG001|NOT COMPLETED|Overall Study||136
9751372|NCT00320515|10853809|FG000|STARTED|Overall Study||69
9751373|NCT00320515|10853809|FG000|COMPLETED|Overall Study||20
9751374|NCT00320515|10853809|FG000|NOT COMPLETED|Overall Study||49
9751375|NCT00320528|10853816|FG000|STARTED|Study Period II||98
9751376|NCT00320528|10853817|FG001|STARTED|Study Period II||41
9751377|NCT00320528|10853818|FG002|STARTED|Study Period II||130
9751378|NCT00320528|10853816|FG000|Received at Least One Dose of Study Drug|Study Period II||97
9751379|NCT00320528|10853817|FG001|Received at Least One Dose of Study Drug|Study Period II||38
9751380|NCT00320528|10853818|FG002|Received at Least One Dose of Study Drug|Study Period II||128
9751381|NCT00320528|10853816|FG000|COMPLETED|Study Period II||87
9751382|NCT00320528|10853817|FG001|COMPLETED|Study Period II||31
9751383|NCT00320528|10853818|FG002|COMPLETED|Study Period II||108
9751384|NCT00320528|10853816|FG000|NOT COMPLETED|Study Period II||11
9751385|NCT00320528|10853817|FG001|NOT COMPLETED|Study Period II||10
9751386|NCT00320528|10853818|FG002|NOT COMPLETED|Study Period II||22
9751387|NCT00320528|10853816|FG000|STARTED|Study Period III||87
9751388|NCT00320528|10853817|FG001|STARTED|Study Period III||31
9751389|NCT00320528|10853818|FG002|STARTED|Study Period III||108
9751390|NCT00320528|10853816|FG000|COMPLETED|Study Period III||0
9751391|NCT00320528|10853817|FG001|COMPLETED|Study Period III||0
9751392|NCT00320528|10853818|FG002|COMPLETED|Study Period III||2
9751393|NCT00320528|10853816|FG000|NOT COMPLETED|Study Period III||87
9751394|NCT00320528|10853817|FG001|NOT COMPLETED|Study Period III||31
9751395|NCT00320528|10853818|FG002|NOT COMPLETED|Study Period III||106
9751396|NCT00320541|10853828|FG000|STARTED|Overall Study||94
9751397|NCT00320541|10853829|FG001|STARTED|Overall Study||93
9751398|NCT00320541|10853828|FG000|COMPLETED|Overall Study||44
9751399|NCT00320541|10853829|FG001|COMPLETED|Overall Study||36
9751400|NCT00320541|10853828|FG000|NOT COMPLETED|Overall Study||50
9751401|NCT00320541|10853829|FG001|NOT COMPLETED|Overall Study||57
9751402|NCT00320593|10853837|FG000|STARTED|Overall Study||59
9751403|NCT00320593|10853838|FG001|STARTED|Overall Study||59
9853840|NCT00889226|10966799|FG001|STARTED|Overall Study||78
10092201|NCT02334813|11220548|FG001|STARTED|Overall Study||14
9751404|NCT00320593|10853837|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
9751405|NCT00320593|10853838|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
9751406|NCT00320593|10853837|FG000|NOT COMPLETED|Overall Study||7
9751407|NCT00320593|10853838|FG001|NOT COMPLETED|Overall Study||1
9751408|NCT00320606|10853844|FG000|STARTED|Overall Study||20
9751409|NCT00320606|10853844|FG000|COMPLETED|Overall Study||17
9853841|NCT00889226|10966798|FG000|COMPLETED|Overall Study||58
9853842|NCT00889226|10966799|FG001|COMPLETED|Overall Study||43
10092202|NCT02334813|11220547|FG000|COMPLETED|Overall Study||9
9751410|NCT00320606|10853844|FG000|NOT COMPLETED|Overall Study||3
9751411|NCT00320671|10853851|FG000|STARTED|Overall Study||102
9751412|NCT00320671|10853852|FG001|STARTED|Overall Study||96
9751413|NCT00320671|10853851|FG000|COMPLETED|Overall Study||69
9751414|NCT00320671|10853852|FG001|COMPLETED|Overall Study||58
9751415|NCT00320671|10853851|FG000|NOT COMPLETED|Overall Study||33
9751416|NCT00320671|10853852|FG001|NOT COMPLETED|Overall Study||38
9751417|NCT00320710|10853861|FG000|STARTED|Overall Study||200
9751418|NCT00320710|10853862|FG001|STARTED|Overall Study||203
9751419|NCT00320710|10853863|FG002|STARTED|Overall Study||13
9751420|NCT00320710|10853861|FG000|Treated (Safety Set)|Overall Study||198
9751421|NCT00320710|10853862|FG001|Treated (Safety Set)|Overall Study||202
9751422|NCT00320710|10853863|FG002|Treated (Safety Set)|Overall Study||13
9751423|NCT00320710|10853861|FG000|COMPLETED|Overall Study||106
9751424|NCT00320710|10853862|FG001|COMPLETED|Overall Study||127
9751425|NCT00320710|10853863|FG002|COMPLETED|Overall Study||8
9751426|NCT00320710|10853861|FG000|NOT COMPLETED|Overall Study||94
9751427|NCT00320710|10853862|FG001|NOT COMPLETED|Overall Study||76
9751428|NCT00320710|10853863|FG002|NOT COMPLETED|Overall Study||5
9751429|NCT00320749|10853870|FG000|STARTED|Overall Study||3
9751430|NCT00320749|10853871|FG001|STARTED|Overall Study||8
9751431|NCT00320749|10853872|FG002|STARTED|Overall Study||10
9751432|NCT00320749|10853870|FG000|COMPLETED|Overall Study||3
9751433|NCT00320749|10853871|FG001|COMPLETED|Overall Study||6
9751434|NCT00320749|10853872|FG002|COMPLETED|Overall Study||1
9751435|NCT00320749|10853870|FG000|NOT COMPLETED|Overall Study||0
9751436|NCT00320749|10853871|FG001|NOT COMPLETED|Overall Study||2
9751437|NCT00320749|10853872|FG002|NOT COMPLETED|Overall Study||9
9751438|NCT00320788|10853882|FG000|STARTED|Overall Study||32
9751439|NCT00320788|10853883|FG001|STARTED|Overall Study||32
9751440|NCT00320788|10853884|FG002|STARTED|Overall Study||32
9751441|NCT00320788|10853885|FG003|STARTED|Overall Study|Participants Randomized|32
9751442|NCT00320788|10853886|FG004|STARTED|Overall Study||31
9751443|NCT00320788|10853882|FG000|Participants Received Treatment (SAF)|Overall Study||32
9751444|NCT00320788|10853883|FG001|Participants Received Treatment (SAF)|Overall Study||32
9751445|NCT00320788|10853884|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
9751446|NCT00320788|10853885|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
9751447|NCT00320788|10853886|FG004|Participants Received Treatment (SAF)|Overall Study||31
9751448|NCT00320788|10853882|FG000|COMPLETED|Overall Study||26
9751449|NCT00320788|10853883|FG001|COMPLETED|Overall Study||26
9751450|NCT00320788|10853884|FG002|COMPLETED|Overall Study||29
9751451|NCT00320788|10853885|FG003|COMPLETED|Overall Study||27
9751452|NCT00320788|10853886|FG004|COMPLETED|Overall Study||26
9751453|NCT00320788|10853882|FG000|NOT COMPLETED|Overall Study||6
9751454|NCT00320788|10853883|FG001|NOT COMPLETED|Overall Study||6
9751455|NCT00320788|10853884|FG002|NOT COMPLETED|Overall Study||3
9751456|NCT00320788|10853885|FG003|NOT COMPLETED|Overall Study||5
9751457|NCT00320788|10853886|FG004|NOT COMPLETED|Overall Study||5
9751458|NCT00320801|10853906|FG000|STARTED|Open-label Run-in Period||188
9751459|NCT00320801|10853907|FG001|STARTED|Open-label Run-in Period||0
9751460|NCT00320801|10853908|FG002|STARTED|Open-label Run-in Period||0
9751461|NCT00320801|10853909|FG003|STARTED|Open-label Run-in Period||0
9751462|NCT00320801|10853906|FG000|COMPLETED|Open-label Run-in Period||96
9751463|NCT00320801|10853907|FG001|COMPLETED|Open-label Run-in Period||0
9751464|NCT00320801|10853908|FG002|COMPLETED|Open-label Run-in Period||0
9751465|NCT00320801|10853909|FG003|COMPLETED|Open-label Run-in Period||0
9751466|NCT00320801|10853906|FG000|NOT COMPLETED|Open-label Run-in Period||92
9751467|NCT00320801|10853907|FG001|NOT COMPLETED|Open-label Run-in Period||0
9751468|NCT00320801|10853908|FG002|NOT COMPLETED|Open-label Run-in Period||0
9751469|NCT00320801|10853909|FG003|NOT COMPLETED|Open-label Run-in Period||0
9751470|NCT00320801|10853906|FG000|STARTED|Double-blind Phase||0
9751471|NCT00320801|10853907|FG001|STARTED|Double-blind Phase||47
9751472|NCT00320801|10853908|FG002|STARTED|Double-blind Phase||49
9751473|NCT00320801|10853909|FG003|STARTED|Double-blind Phase||0
9751474|NCT00320801|10853906|FG000|COMPLETED|Double-blind Phase||0
9751475|NCT00320801|10853907|FG001|COMPLETED|Double-blind Phase||36
9751476|NCT00320801|10853908|FG002|COMPLETED|Double-blind Phase||35
9751477|NCT00320801|10853909|FG003|COMPLETED|Double-blind Phase||0
9751478|NCT00320801|10853906|FG000|NOT COMPLETED|Double-blind Phase||0
9751479|NCT00320801|10853907|FG001|NOT COMPLETED|Double-blind Phase||11
9853843|NCT00889226|10966798|FG000|NOT COMPLETED|Overall Study||25
9751480|NCT00320801|10853908|FG002|NOT COMPLETED|Double-blind Phase||14
9751481|NCT00320801|10853909|FG003|NOT COMPLETED|Double-blind Phase||0
9751482|NCT00320801|10853906|FG000|STARTED|Extension Phase||0
9751483|NCT00320801|10853907|FG001|STARTED|Extension Phase||0
9751484|NCT00320801|10853908|FG002|STARTED|Extension Phase||0
9751485|NCT00320801|10853909|FG003|STARTED|Extension Phase||55
9751486|NCT00320801|10853906|FG000|COMPLETED|Extension Phase||0
9751487|NCT00320801|10853907|FG001|COMPLETED|Extension Phase||0
9853844|NCT00889226|10966799|FG001|NOT COMPLETED|Overall Study||35
9853845|NCT00889252|10966807|FG000|STARTED|Overall Study||168
9751488|NCT00320801|10853908|FG002|COMPLETED|Extension Phase||0
9751489|NCT00320801|10853909|FG003|COMPLETED|Extension Phase||7
9751490|NCT00320801|10853906|FG000|NOT COMPLETED|Extension Phase||0
9751491|NCT00320801|10853907|FG001|NOT COMPLETED|Extension Phase||0
9751492|NCT00320801|10853908|FG002|NOT COMPLETED|Extension Phase||0
9751493|NCT00320801|10853909|FG003|NOT COMPLETED|Extension Phase||48
9751494|NCT00321048|10853921|FG000|STARTED|Overall Study||28
9751495|NCT00321048|10853922|FG001|STARTED|Overall Study||29
9751496|NCT00321048|10853921|FG000|COMPLETED|Overall Study||22
9751497|NCT00321048|10853922|FG001|COMPLETED|Overall Study||21
9751498|NCT00321048|10853921|FG000|NOT COMPLETED|Overall Study||6
9751499|NCT00321048|10853922|FG001|NOT COMPLETED|Overall Study||8
9751500|NCT00321269|10853930|FG000|STARTED|Overall Study||74
9751501|NCT00321269|10853931|FG001|STARTED|Overall Study||74
9751502|NCT00321269|10853930|FG000|COMPLETED|Overall Study||66
9751503|NCT00321269|10853931|FG001|COMPLETED|Overall Study||68
9751504|NCT00321269|10853930|FG000|NOT COMPLETED|Overall Study||8
9751505|NCT00321269|10853931|FG001|NOT COMPLETED|Overall Study||6
10092203|NCT02334813|11220548|FG001|COMPLETED|Overall Study||13
10092204|NCT02334813|11220547|FG000|NOT COMPLETED|Overall Study||3
10092205|NCT02334813|11220548|FG001|NOT COMPLETED|Overall Study||1
10092206|NCT02334982|11220561|FG000|STARTED|Overall Study||6
10092207|NCT02334982|11220562|FG001|STARTED|Overall Study||5
10092208|NCT02334982|11220563|FG002|STARTED|Overall Study||6
10092209|NCT02334982|11220564|FG003|STARTED|Overall Study||6
10092210|NCT02334982|11220565|FG004|STARTED|Overall Study||6
10092211|NCT02334982|11220566|FG005|STARTED|Overall Study||6
10092212|NCT02334982|11220567|FG006|STARTED|Overall Study||12
10092213|NCT02334982|11220561|FG000|COMPLETED|Overall Study||6
10092214|NCT02334982|11220562|FG001|COMPLETED|Overall Study||5
10092215|NCT02334982|11220563|FG002|COMPLETED|Overall Study||6
10092216|NCT02334982|11220564|FG003|COMPLETED|Overall Study||6
10092217|NCT02334982|11220565|FG004|COMPLETED|Overall Study||6
9751506|NCT00321321|10853939|FG000|STARTED|Overall Study||12
9751507|NCT00321321|10853939|FG000|COMPLETED|Overall Study||12
9751508|NCT00321321|10853939|FG000|NOT COMPLETED|Overall Study||0
9751509|NCT00321373|10853946|FG000|STARTED|Overall Study||407
9751510|NCT00321373|10853947|FG001|STARTED|Overall Study||406
9751511|NCT00321373|10853948|FG002|STARTED|Overall Study||407
9751512|NCT00321373|10853946|FG000|COMPLETED|Overall Study||405
9751513|NCT00321373|10853947|FG001|COMPLETED|Overall Study||406
9751514|NCT00321373|10853948|FG002|COMPLETED|Overall Study||404
9751515|NCT00321373|10853946|FG000|NOT COMPLETED|Overall Study||2
9751516|NCT00321373|10853947|FG001|NOT COMPLETED|Overall Study||0
9751517|NCT00321373|10853948|FG002|NOT COMPLETED|Overall Study||3
9751518|NCT00321464|10853958|FG000|STARTED|Overall Study||1020
9751519|NCT00321464|10853959|FG001|STARTED|Overall Study||1026
9751520|NCT00321464|10853958|FG000|Received Investigational Product|Overall Study||1014
9751521|NCT00321464|10853959|FG001|Received Investigational Product|Overall Study||1019
9751522|NCT00321464|10853958|FG000|COMPLETED|Overall Study||461
9751523|NCT00321464|10853959|FG001|COMPLETED|Overall Study||468
9751524|NCT00321464|10853958|FG000|NOT COMPLETED|Overall Study||559
9751525|NCT00321464|10853959|FG001|NOT COMPLETED|Overall Study||558
9751526|NCT00321594|10853967|FG000|STARTED|Phase I, Level 1-4||3
9751527|NCT00321594|10853968|FG001|STARTED|Phase I, Level 1-4||3
9751528|NCT00321594|10853969|FG002|STARTED|Phase I, Level 1-4||6
9751529|NCT00321594|10853970|FG003|STARTED|Phase I, Level 1-4||6
9751530|NCT00321594|10853971|FG004|STARTED|Phase I, Level 1-4||0
9751531|NCT00321594|10853967|FG000|COMPLETED|Phase I, Level 1-4||3
9751532|NCT00321594|10853968|FG001|COMPLETED|Phase I, Level 1-4||3
9751533|NCT00321594|10853969|FG002|COMPLETED|Phase I, Level 1-4||6
9751534|NCT00321594|10853970|FG003|COMPLETED|Phase I, Level 1-4||6
9751535|NCT00321594|10853971|FG004|COMPLETED|Phase I, Level 1-4||0
9853846|NCT00889252|10966808|FG001|STARTED|Overall Study||82
9853847|NCT00889252|10966807|FG000|COMPLETED|Overall Study||161
9853848|NCT00889252|10966808|FG001|COMPLETED|Overall Study||78
9853849|NCT00889252|10966807|FG000|NOT COMPLETED|Overall Study||7
9853850|NCT00889252|10966808|FG001|NOT COMPLETED|Overall Study||4
9853851|NCT00889265|10966814|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
9853852|NCT00889265|10966814|FG000|COMPLETED|Overall Study||44
9853853|NCT00889265|10966814|FG000|NOT COMPLETED|Overall Study||7
9853854|NCT00889330|10966820|FG000|STARTED|Overall Study||30
9853855|NCT00889330|10966821|FG001|STARTED|Overall Study||30
10092218|NCT02334982|11220566|FG005|COMPLETED|Overall Study||6
10092219|NCT02334982|11220567|FG006|COMPLETED|Overall Study||12
10092220|NCT02334982|11220561|FG000|NOT COMPLETED|Overall Study||0
10092221|NCT02334982|11220562|FG001|NOT COMPLETED|Overall Study||0
10092222|NCT02334982|11220563|FG002|NOT COMPLETED|Overall Study||0
10092223|NCT02334982|11220564|FG003|NOT COMPLETED|Overall Study||0
10092224|NCT02334982|11220565|FG004|NOT COMPLETED|Overall Study||0
9751536|NCT00321594|10853967|FG000|NOT COMPLETED|Phase I, Level 1-4||0
9751537|NCT00321594|10853968|FG001|NOT COMPLETED|Phase I, Level 1-4||0
9751538|NCT00321594|10853969|FG002|NOT COMPLETED|Phase I, Level 1-4||0
9751539|NCT00321594|10853970|FG003|NOT COMPLETED|Phase I, Level 1-4||0
9751540|NCT00321594|10853971|FG004|NOT COMPLETED|Phase I, Level 1-4||0
9751541|NCT00321594|10853967|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
9751542|NCT00321594|10853968|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
9751543|NCT00321594|10853969|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
9751544|NCT00321594|10853970|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
9751545|NCT00321594|10853971|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
9751546|NCT00321594|10853967|FG000|COMPLETED|Phase II, MTD Dose||0
9751547|NCT00321594|10853968|FG001|COMPLETED|Phase II, MTD Dose||0
9751548|NCT00321594|10853969|FG002|COMPLETED|Phase II, MTD Dose||0
9751549|NCT00321594|10853970|FG003|COMPLETED|Phase II, MTD Dose||6
9751550|NCT00321594|10853971|FG004|COMPLETED|Phase II, MTD Dose||36
9751551|NCT00321594|10853967|FG000|NOT COMPLETED|Phase II, MTD Dose||0
9853856|NCT00889330|10966820|FG000|COMPLETED|Overall Study||30
9751552|NCT00321594|10853968|FG001|NOT COMPLETED|Phase II, MTD Dose||0
9751553|NCT00321594|10853969|FG002|NOT COMPLETED|Phase II, MTD Dose||0
9751554|NCT00321594|10853970|FG003|NOT COMPLETED|Phase II, MTD Dose||0
9751555|NCT00321594|10853971|FG004|NOT COMPLETED|Phase II, MTD Dose||0
9751556|NCT00321620|10853985|FG000|STARTED|Overall Study||951
9751557|NCT00321620|10853986|FG001|STARTED|Overall Study||950
9751558|NCT00321620|10853985|FG000|Received Investigational Product|Overall Study||946
9751559|NCT00321620|10853986|FG001|Received Investigational Product|Overall Study||942
9751560|NCT00321620|10853985|FG000|COMPLETED|Overall Study||208
9751561|NCT00321620|10853986|FG001|COMPLETED|Overall Study||228
9751562|NCT00321620|10853985|FG000|NOT COMPLETED|Overall Study||743
9751563|NCT00321620|10853986|FG001|NOT COMPLETED|Overall Study||722
9751564|NCT00321646|10853992|FG000|STARTED|Neoadjuvant Chemotherapy||42
9751565|NCT00321646|10853992|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
9751566|NCT00321646|10853992|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4
9751567|NCT00321646|10853992|FG000|STARTED|Prostatectomy||37
9751568|NCT00321646|10853992|FG000|COMPLETED|Prostatectomy||37
9751569|NCT00321646|10853992|FG000|NOT COMPLETED|Prostatectomy||0
9751570|NCT00321672|10854000|FG000|STARTED|Overall Study||165
9751571|NCT00321672|10854001|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
9751572|NCT00321672|10854002|FG002|STARTED|Overall Study||167
9751573|NCT00321672|10854003|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
9751574|NCT00321672|10854000|FG000|COMPLETED|Overall Study||153
9751575|NCT00321672|10854001|FG001|COMPLETED|Overall Study||81
9751576|NCT00321672|10854002|FG002|COMPLETED|Overall Study||156
9751577|NCT00321672|10854003|FG003|COMPLETED|Overall Study||71
9751578|NCT00321672|10854000|FG000|NOT COMPLETED|Overall Study||12
9751579|NCT00321672|10854001|FG001|NOT COMPLETED|Overall Study||8
9751580|NCT00321672|10854002|FG002|NOT COMPLETED|Overall Study||11
9751581|NCT00321672|10854003|FG003|NOT COMPLETED|Overall Study||2
9751582|NCT00321685|10854017|FG000|STARTED|Overall Study||57
9751583|NCT00321685|10854017|FG000|Eligible|Overall Study||55
9751584|NCT00321685|10854017|FG000|Started Protocol Therapy|Overall Study||55
9751585|NCT00321685|10854017|FG000|Eligible and Treated|Overall Study||53
9853857|NCT00889330|10966821|FG001|COMPLETED|Overall Study||30
9853858|NCT00889330|10966820|FG000|NOT COMPLETED|Overall Study||0
9853859|NCT00889330|10966821|FG001|NOT COMPLETED|Overall Study||0
9853860|NCT00889512|10966829|FG000|STARTED|Overall Study||5
9853861|NCT00889512|10966830|FG001|STARTED|Overall Study||9
9853862|NCT00889512|10966829|FG000|COMPLETED|Overall Study||5
9853863|NCT00889512|10966830|FG001|COMPLETED|Overall Study||9
9853864|NCT00889512|10966829|FG000|NOT COMPLETED|Overall Study||0
9853865|NCT00889512|10966830|FG001|NOT COMPLETED|Overall Study||0
9853866|NCT00889603|10966836|FG000|STARTED|Overall Study||370
9853867|NCT00889603|10966836|FG000|COMPLETED|Overall Study||333
9853868|NCT00889603|10966836|FG000|NOT COMPLETED|Overall Study||37
9853869|NCT00889681|10966840|FG000|STARTED|Overall Study||81
9853870|NCT00889681|10966840|FG000|Received Treatment|Overall Study||78
9853871|NCT00889681|10966840|FG000|COMPLETED|Overall Study||78
9853872|NCT00889681|10966840|FG000|NOT COMPLETED|Overall Study||3
9853873|NCT00889707|10966846|FG000|STARTED|Overall Study||61
9853874|NCT00889707|10966847|FG001|STARTED|Overall Study||31
9853875|NCT00889707|10966846|FG000|COMPLETED|Overall Study||54
9853876|NCT00889707|10966847|FG001|COMPLETED|Overall Study||21
9853877|NCT00889707|10966846|FG000|NOT COMPLETED|Overall Study||7
9853878|NCT00889707|10966847|FG001|NOT COMPLETED|Overall Study||10
9853879|NCT00889720|10966853|FG000|STARTED|Overall Study||16
9853880|NCT00889720|10966853|FG000|Surgical Population|Overall Study||12
9853881|NCT00889720|10966853|FG000|COMPLETED|Overall Study||8
9853882|NCT00889720|10966853|FG000|NOT COMPLETED|Overall Study||8
9853883|NCT00889824|10966857|FG000|STARTED|Overall Study||5
9853884|NCT00889824|10966857|FG000|COMPLETED|Overall Study||5
9853885|NCT00889824|10966857|FG000|NOT COMPLETED|Overall Study||0
9853886|NCT00889863|10966861|FG000|STARTED|Part I: Open Label||177
9853887|NCT00889863|10966862|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
9853888|NCT00889863|10966861|FG000|Entered Part Ia|Part I: Open Label||145
9853889|NCT00889863|10966862|FG001|Entered Part Ia|Part I: Open Label||0
9853890|NCT00889863|10966861|FG000|Entered Part Ib|Part I: Open Label||142
9853891|NCT00889863|10966862|FG001|Entered Part Ib|Part I: Open Label||0
9853892|NCT00889863|10966861|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
9853893|NCT00889863|10966862|FG001|Entered Part Ic|Part I: Open Label||0
9853894|NCT00889863|10966861|FG000|Entered Part 1d|Part I: Open Label||103
9853895|NCT00889863|10966862|FG001|Entered Part 1d|Part I: Open Label||0
9853896|NCT00889863|10966861|FG000|COMPLETED|Part I: Open Label||100
9751586|NCT00321685|10854017|FG000|COMPLETED|Overall Study||18
9751587|NCT00321685|10854017|FG000|NOT COMPLETED|Overall Study||39
9751588|NCT00321711|10854026|FG000|STARTED|Part A||13
9751589|NCT00321711|10854027|FG001|STARTED|Part A||13
9853897|NCT00889863|10966862|FG001|COMPLETED|Part I: Open Label||0
9853898|NCT00889863|10966861|FG000|NOT COMPLETED|Part I: Open Label||77
9853899|NCT00889863|10966862|FG001|NOT COMPLETED|Part I: Open Label||0
9853900|NCT00889863|10966861|FG000|STARTED|Part II: Randomized Double Blind||50
9751590|NCT00321711|10854028|FG002|STARTED|Part A||14
9751591|NCT00321711|10854029|FG003|STARTED|Part A||0
9853901|NCT00889863|10966862|FG001|STARTED|Part II: Randomized Double Blind||50
9751592|NCT00321711|10854030|FG004|STARTED|Part A||0
9751593|NCT00321711|10854026|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
9751594|NCT00321711|10854027|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
9751595|NCT00321711|10854028|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
9751596|NCT00321711|10854029|FG003|COMPLETED|Part A||0
9751597|NCT00321711|10854030|FG004|COMPLETED|Part A||0
9751598|NCT00321711|10854026|FG000|NOT COMPLETED|Part A||5
9751599|NCT00321711|10854027|FG001|NOT COMPLETED|Part A||10
9751600|NCT00321711|10854028|FG002|NOT COMPLETED|Part A||11
9751601|NCT00321711|10854029|FG003|NOT COMPLETED|Part A||0
9751602|NCT00321711|10854030|FG004|NOT COMPLETED|Part A||0
9751603|NCT00321711|10854026|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
9751604|NCT00321711|10854027|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
9751605|NCT00321711|10854028|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
9751606|NCT00321711|10854029|FG003|STARTED|Part B||14
9751607|NCT00321711|10854030|FG004|STARTED|Part B||15
9751608|NCT00321711|10854026|FG000|COMPLETED|Part B||0
9751609|NCT00321711|10854027|FG001|COMPLETED|Part B||0
9751610|NCT00321711|10854028|FG002|COMPLETED|Part B||0
9751611|NCT00321711|10854029|FG003|COMPLETED|Part B||8
9751612|NCT00321711|10854030|FG004|COMPLETED|Part B||10
9751613|NCT00321711|10854026|FG000|NOT COMPLETED|Part B||0
9751614|NCT00321711|10854027|FG001|NOT COMPLETED|Part B||0
9751615|NCT00321711|10854028|FG002|NOT COMPLETED|Part B||0
9751616|NCT00321711|10854029|FG003|NOT COMPLETED|Part B||6
9751617|NCT00321711|10854030|FG004|NOT COMPLETED|Part B||5
9751618|NCT00321737|10854045|FG000|STARTED|Overall Study||147
9751619|NCT00321737|10854046|FG001|STARTED|Overall Study||140
10092225|NCT02334982|11220566|FG005|NOT COMPLETED|Overall Study||0
10092226|NCT02334982|11220567|FG006|NOT COMPLETED|Overall Study||0
10092227|NCT02335125|11220596|FG000|STARTED|Overall Study||20
10092228|NCT02335125|11220597|FG001|STARTED|Overall Study||20
10092229|NCT02335125|11220596|FG000|COMPLETED|Overall Study||20
10092230|NCT02335125|11220597|FG001|COMPLETED|Overall Study||20
10092231|NCT02335125|11220596|FG000|NOT COMPLETED|Overall Study||0
10092232|NCT02335125|11220597|FG001|NOT COMPLETED|Overall Study||0
10092233|NCT02335216|11220603|FG000|STARTED|Overall Study||22
10092234|NCT02335216|11220603|FG000|Received Trial System|Overall Study||16
10092235|NCT02335216|11220603|FG000|Received Permanent System|Overall Study||13
10092236|NCT02335216|11220603|FG000|COMPLETED|Overall Study||9
10092237|NCT02335216|11220603|FG000|NOT COMPLETED|Overall Study||13
10092238|NCT02335229|11220607|FG000|STARTED|Overall Study||30
10092239|NCT02335229|11220607|FG000|Received Trial System|Overall Study||10
10092240|NCT02335229|11220607|FG000|Received Permanent System|Overall Study||26
10092241|NCT02335229|11220607|FG000|COMPLETED|Overall Study||23
10092242|NCT02335229|11220607|FG000|NOT COMPLETED|Overall Study||7
10092243|NCT02335294|11220617|FG000|STARTED|Overall Study||39
10092244|NCT02335294|11220618|FG001|STARTED|Overall Study||42
10092245|NCT02335294|11220619|FG002|STARTED|Overall Study||19
10092246|NCT02335294|11220620|FG003|STARTED|Overall Study||39
10092247|NCT02335294|11220621|FG004|STARTED|Overall Study||41
10092248|NCT02335294|11220622|FG005|STARTED|Overall Study||20
10092249|NCT02335294|11220617|FG000|COMPLETED|Overall Study||36
10092250|NCT02335294|11220618|FG001|COMPLETED|Overall Study||38
10092251|NCT02335294|11220619|FG002|COMPLETED|Overall Study||18
10092252|NCT02335294|11220620|FG003|COMPLETED|Overall Study||36
10092253|NCT02335294|11220621|FG004|COMPLETED|Overall Study||39
10092254|NCT02335294|11220622|FG005|COMPLETED|Overall Study||19
10092255|NCT02335294|11220617|FG000|NOT COMPLETED|Overall Study||3
9751620|NCT00321737|10854047|FG002|STARTED|Overall Study||158
9751621|NCT00321737|10854045|FG000|COMPLETED|Overall Study||25
9751622|NCT00321737|10854046|FG001|COMPLETED|Overall Study||92
9853902|NCT00889863|10966861|FG000|COMPLETED|Part II: Randomized Double Blind||39
9853903|NCT00889863|10966862|FG001|COMPLETED|Part II: Randomized Double Blind||24
9853904|NCT00889863|10966861|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11
9853905|NCT00889863|10966862|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26
9853906|NCT00889915|10966874|FG000|STARTED|Overall Study||37
9853907|NCT00889915|10966875|FG001|STARTED|Overall Study||76
9751623|NCT00321737|10854047|FG002|COMPLETED|Overall Study||104
9751624|NCT00321737|10854045|FG000|NOT COMPLETED|Overall Study||122
9751625|NCT00321737|10854046|FG001|NOT COMPLETED|Overall Study||48
10092256|NCT02335294|11220618|FG001|NOT COMPLETED|Overall Study||4
10092257|NCT02335294|11220619|FG002|NOT COMPLETED|Overall Study||1
10201759|NCT03440918|11329165|FG000|STARTED|Overall Study||133
9751626|NCT00321737|10854047|FG002|NOT COMPLETED|Overall Study||54
9751627|NCT00321763|10854059|FG000|STARTED|Overall Study||850
9751628|NCT00321763|10854060|FG001|STARTED|Overall Study||850
9751629|NCT00321763|10854061|FG002|STARTED|Overall Study||854
9751630|NCT00321763|10854062|FG003|STARTED|Overall Study||570
9751631|NCT00321763|10854059|FG000|COMPLETED|Overall Study||844
9853908|NCT00889915|10966876|FG002|STARTED|Overall Study||67
9853909|NCT00889915|10966877|FG003|STARTED|Overall Study||48
10092258|NCT02335294|11220620|FG003|NOT COMPLETED|Overall Study||3
10092259|NCT02335294|11220621|FG004|NOT COMPLETED|Overall Study||2
10092260|NCT02335294|11220622|FG005|NOT COMPLETED|Overall Study||1
10092261|NCT02335346|11220636|FG000|STARTED|Overall Study||93
10201760|NCT03440918|11329166|FG001|STARTED|Overall Study||138
9751632|NCT00321763|10854060|FG001|COMPLETED|Overall Study||848
9751633|NCT00321763|10854061|FG002|COMPLETED|Overall Study||848
9751634|NCT00321763|10854062|FG003|COMPLETED|Overall Study||565
9751635|NCT00321763|10854059|FG000|NOT COMPLETED|Overall Study||6
9751636|NCT00321763|10854060|FG001|NOT COMPLETED|Overall Study||2
9751637|NCT00321763|10854061|FG002|NOT COMPLETED|Overall Study||6
9751638|NCT00321763|10854062|FG003|NOT COMPLETED|Overall Study||5
9751639|NCT00321789|10854076|FG000|STARTED|Overall Study||127
9751640|NCT00321789|10854077|FG001|STARTED|Overall Study||128
9751641|NCT00321789|10854076|FG000|COMPLETED|Overall Study||112
9751642|NCT00321789|10854077|FG001|COMPLETED|Overall Study||112
9751643|NCT00321789|10854076|FG000|NOT COMPLETED|Overall Study||15
9751644|NCT00321789|10854077|FG001|NOT COMPLETED|Overall Study||16
9751645|NCT00321828|10854083|FG000|STARTED|Overall Study||90
9751646|NCT00321828|10854083|FG000|COMPLETED|Overall Study||86
9751647|NCT00321828|10854083|FG000|NOT COMPLETED|Overall Study||4
9751648|NCT00321854|10854089|FG000|STARTED|Overall Study||261
9751649|NCT00321854|10854090|FG001|STARTED|Overall Study||274
9751650|NCT00321854|10854089|FG000|COMPLETED|Overall Study||198
9751651|NCT00321854|10854090|FG001|COMPLETED|Overall Study||192
9751652|NCT00321854|10854089|FG000|NOT COMPLETED|Overall Study||63
9751653|NCT00321854|10854090|FG001|NOT COMPLETED|Overall Study||82
9751654|NCT00321893|10854100|FG000|STARTED|Overall Study||101
9751655|NCT00321893|10854101|FG001|STARTED|Overall Study||101
9751656|NCT00321893|10854100|FG000|COMPLETED|Overall Study||77
9751657|NCT00321893|10854101|FG001|COMPLETED|Overall Study||87
9751658|NCT00321893|10854100|FG000|NOT COMPLETED|Overall Study||24
9751659|NCT00321893|10854101|FG001|NOT COMPLETED|Overall Study||14
9751660|NCT00321906|10854109|FG000|STARTED|Overall Study||94
9751661|NCT00321906|10854110|FG001|STARTED|Overall Study||87
9751662|NCT00321906|10854109|FG000|COMPLETED|Overall Study||48
9751663|NCT00321906|10854110|FG001|COMPLETED|Overall Study||31
9751664|NCT00321906|10854109|FG000|NOT COMPLETED|Overall Study||46
9751665|NCT00321906|10854110|FG001|NOT COMPLETED|Overall Study||56
9751666|NCT00321919|10854118|FG000|STARTED|Overall Study||301
9751667|NCT00321919|10854119|FG001|STARTED|Overall Study||302
9751668|NCT00321919|10854118|FG000|COMPLETED|Overall Study||226
9751669|NCT00321919|10854119|FG001|COMPLETED|Overall Study||250
9751670|NCT00321919|10854118|FG000|NOT COMPLETED|Overall Study||75
9751671|NCT00321919|10854119|FG001|NOT COMPLETED|Overall Study||52
9751672|NCT00321932|10854128|FG000|STARTED|Overall Study||29
9751673|NCT00321932|10854129|FG001|STARTED|Overall Study||32
9751674|NCT00321932|10854128|FG000|COMPLETED|Overall Study||19
9751675|NCT00321932|10854129|FG001|COMPLETED|Overall Study||11
9751676|NCT00321932|10854128|FG000|NOT COMPLETED|Overall Study||10
9751677|NCT00321932|10854129|FG001|NOT COMPLETED|Overall Study||21
9751678|NCT00321971|10854138|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
9751679|NCT00321971|10854139|FG001|STARTED|Overall Study||37
9751680|NCT00321971|10854138|FG000|COMPLETED|Overall Study||28
9751681|NCT00321971|10854139|FG001|COMPLETED|Overall Study||26
9751682|NCT00321971|10854138|FG000|NOT COMPLETED|Overall Study||8
9751683|NCT00321971|10854139|FG001|NOT COMPLETED|Overall Study||11
9751684|NCT00321984|10854148|FG000|STARTED|Overall Study||317
9751685|NCT00321984|10854149|FG001|STARTED|Overall Study||315
9751686|NCT00321984|10854150|FG002|STARTED|Overall Study||315
9751687|NCT00321984|10854148|FG000|COMPLETED|Overall Study||290
9751688|NCT00321984|10854149|FG001|COMPLETED|Overall Study||294
9751689|NCT00321984|10854150|FG002|COMPLETED|Overall Study||289
9751690|NCT00321984|10854148|FG000|NOT COMPLETED|Overall Study||27
9751691|NCT00321984|10854149|FG001|NOT COMPLETED|Overall Study||21
9751692|NCT00321984|10854150|FG002|NOT COMPLETED|Overall Study||26
9751693|NCT00322023|10854161|FG000|STARTED|Overall Study||12
9751694|NCT00322023|10854162|FG001|STARTED|Overall Study||21
9751695|NCT00322023|10854163|FG002|STARTED|Overall Study||22
9751696|NCT00322023|10854161|FG000|COMPLETED|Overall Study||12
9751697|NCT00322023|10854162|FG001|COMPLETED|Overall Study||19
9751698|NCT00322023|10854163|FG002|COMPLETED|Overall Study||16
9751699|NCT00322023|10854161|FG000|NOT COMPLETED|Overall Study||0
9751700|NCT00322023|10854162|FG001|NOT COMPLETED|Overall Study||2
9751701|NCT00322023|10854163|FG002|NOT COMPLETED|Overall Study||6
9751702|NCT00322049|10854175|FG000|STARTED|Overall Study||4
9751703|NCT00322049|10854176|FG001|STARTED|Overall Study||10
9751704|NCT00322049|10854177|FG002|STARTED|Overall Study||20
9751705|NCT00322049|10854178|FG003|STARTED|Overall Study||17
9751706|NCT00322049|10854175|FG000|COMPLETED|Overall Study||4
9751707|NCT00322049|10854176|FG001|COMPLETED|Overall Study||9
9751708|NCT00322049|10854177|FG002|COMPLETED|Overall Study||20
9751709|NCT00322049|10854178|FG003|COMPLETED|Overall Study||16
9751710|NCT00322049|10854175|FG000|NOT COMPLETED|Overall Study||0
9751711|NCT00322049|10854176|FG001|NOT COMPLETED|Overall Study||1
9751712|NCT00322049|10854177|FG002|NOT COMPLETED|Overall Study||0
9751713|NCT00322049|10854178|FG003|NOT COMPLETED|Overall Study||1
9751714|NCT00322101|10854199|FG000|STARTED|Overall Study||14
9751715|NCT00322101|10854200|FG001|STARTED|Overall Study||11
9751716|NCT00322101|10854199|FG000|COMPLETED|Overall Study||14
9751717|NCT00322101|10854200|FG001|COMPLETED|Overall Study||11
9751718|NCT00322101|10854199|FG000|NOT COMPLETED|Overall Study||0
9751719|NCT00322101|10854200|FG001|NOT COMPLETED|Overall Study||0
9751720|NCT00322153|10854208|FG000|STARTED|Overall Study|Randomized to placebo|335
9751721|NCT00322153|10854209|FG001|STARTED|Overall Study|Randomized to Memantine ER|342
9751722|NCT00322153|10854208|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
9751723|NCT00322153|10854209|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
9751724|NCT00322153|10854208|FG000|COMPLETED|Overall Study||272
9751725|NCT00322153|10854209|FG001|COMPLETED|Overall Study||273
9751726|NCT00322153|10854208|FG000|NOT COMPLETED|Overall Study||63
9751727|NCT00322153|10854209|FG001|NOT COMPLETED|Overall Study||69
9751728|NCT00322231|10854217|FG000|STARTED|Period 1||51
9751729|NCT00322231|10854218|FG001|STARTED|Period 1||50
9751730|NCT00322231|10854217|FG000|COMPLETED|Period 1||51
9751731|NCT00322231|10854218|FG001|COMPLETED|Period 1||50
9751732|NCT00322231|10854217|FG000|NOT COMPLETED|Period 1||0
9751733|NCT00322231|10854218|FG001|NOT COMPLETED|Period 1||0
9751734|NCT00322231|10854217|FG000|STARTED|Period 2||51
9751735|NCT00322231|10854218|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
9751736|NCT00322231|10854217|FG000|COMPLETED|Period 2||51
9751737|NCT00322231|10854218|FG001|COMPLETED|Period 2||49
9751738|NCT00322231|10854217|FG000|NOT COMPLETED|Period 2||0
9751739|NCT00322231|10854218|FG001|NOT COMPLETED|Period 2||0
9751740|NCT00322309|10854230|FG000|STARTED|Overall Study||11
9751741|NCT00322309|10854231|FG001|STARTED|Overall Study||13
9751742|NCT00322309|10854230|FG000|COMPLETED|Overall Study||9
9751743|NCT00322309|10854231|FG001|COMPLETED|Overall Study||9
9751744|NCT00322309|10854230|FG000|NOT COMPLETED|Overall Study||2
9751745|NCT00322309|10854231|FG001|NOT COMPLETED|Overall Study||4
9751746|NCT00322335|10854243|FG000|STARTED|Subjects 18 Months After Booster Dose||58
9751747|NCT00322335|10854244|FG001|STARTED|Subjects 18 Months After Booster Dose||123
9751748|NCT00322335|10854245|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
9751749|NCT00322335|10854243|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58
9751750|NCT00322335|10854244|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123
9751751|NCT00322335|10854245|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3
9751752|NCT00322335|10854243|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
9751753|NCT00322335|10854244|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
9751754|NCT00322335|10854245|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
9751755|NCT00322335|10854243|FG000|STARTED|Subjects 30 Months After Booster Dose||54
9751756|NCT00322335|10854244|FG001|STARTED|Subjects 30 Months After Booster Dose||119
9751757|NCT00322335|10854245|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
9751758|NCT00322335|10854243|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54
9751759|NCT00322335|10854244|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119
9751760|NCT00322335|10854245|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57
9751761|NCT00322335|10854243|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
9751762|NCT00322335|10854244|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
9751763|NCT00322335|10854245|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
9751764|NCT00322335|10854243|FG000|STARTED|Subjects 42 Months After Booster Dose||51
9751765|NCT00322335|10854244|FG001|STARTED|Subjects 42 Months After Booster Dose||113
9751766|NCT00322335|10854245|FG002|STARTED|Subjects 42 Months After Booster Dose||56
9751767|NCT00322335|10854243|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51
9751768|NCT00322335|10854244|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113
9751769|NCT00322335|10854245|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56
9751770|NCT00322335|10854243|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
9751771|NCT00322335|10854244|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
9751772|NCT00322335|10854245|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
9751773|NCT00322335|10854243|FG000|STARTED|Subjects 54 Months After Booster Dose||50
9751774|NCT00322335|10854244|FG001|STARTED|Subjects 54 Months After Booster Dose||108
9751775|NCT00322335|10854245|FG002|STARTED|Subjects 54 Months After Booster Dose||56
9751776|NCT00322335|10854243|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50
9751777|NCT00322335|10854244|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108
9751778|NCT00322335|10854245|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56
9751779|NCT00322335|10854243|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
9751780|NCT00322335|10854244|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
9751781|NCT00322335|10854245|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
9751782|NCT00322335|10854243|FG000|STARTED|Subjects 66 Months After Booster Dose||48
9751783|NCT00322335|10854244|FG001|STARTED|Subjects 66 Months After Booster Dose||104
9751784|NCT00322335|10854245|FG002|STARTED|Subjects 66 Months After Booster Dose||53
9751785|NCT00322335|10854243|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48
9751786|NCT00322335|10854244|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104
9751787|NCT00322335|10854245|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53
9751788|NCT00322335|10854243|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
9751789|NCT00322335|10854244|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
9751790|NCT00322335|10854245|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
9751791|NCT00322348|10854255|FG000|STARTED|Overall Study||49
9751792|NCT00322348|10854256|FG001|STARTED|Overall Study||49
9751793|NCT00322348|10854255|FG000|Received Study Treatment|Overall Study||50
9751794|NCT00322348|10854256|FG001|Received Study Treatment|Overall Study||48
9751795|NCT00322348|10854255|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
9751796|NCT00322348|10854256|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
9751797|NCT00322348|10854255|FG000|NOT COMPLETED|Overall Study||37
9751798|NCT00322348|10854256|FG001|NOT COMPLETED|Overall Study||33
9751799|NCT00322374|10854265|FG000|STARTED|Enrollment||0
9751800|NCT00322374|10854266|FG001|STARTED|Enrollment||0
9751801|NCT00322374|10854267|FG002|STARTED|Enrollment||0
9751802|NCT00322374|10854268|FG003|STARTED|Enrollment||42
9751803|NCT00322374|10854265|FG000|COMPLETED|Enrollment||0
9751804|NCT00322374|10854266|FG001|COMPLETED|Enrollment||0
9751805|NCT00322374|10854267|FG002|COMPLETED|Enrollment||0
9751806|NCT00322374|10854268|FG003|COMPLETED|Enrollment||42
9751807|NCT00322374|10854265|FG000|NOT COMPLETED|Enrollment||0
9751808|NCT00322374|10854266|FG001|NOT COMPLETED|Enrollment||0
9751809|NCT00322374|10854267|FG002|NOT COMPLETED|Enrollment||0
9751810|NCT00322374|10854268|FG003|NOT COMPLETED|Enrollment||0
9751811|NCT00322374|10854265|FG000|STARTED|Starting Dose||6
9751812|NCT00322374|10854266|FG001|STARTED|Starting Dose||0
9751813|NCT00322374|10854267|FG002|STARTED|Starting Dose||0
9751814|NCT00322374|10854268|FG003|STARTED|Starting Dose||0
9751815|NCT00322374|10854265|FG000|COMPLETED|Starting Dose||0
9751816|NCT00322374|10854266|FG001|COMPLETED|Starting Dose||0
9751817|NCT00322374|10854267|FG002|COMPLETED|Starting Dose||0
9751818|NCT00322374|10854268|FG003|COMPLETED|Starting Dose||0
9751819|NCT00322374|10854265|FG000|NOT COMPLETED|Starting Dose||6
9751820|NCT00322374|10854266|FG001|NOT COMPLETED|Starting Dose||0
9751821|NCT00322374|10854267|FG002|NOT COMPLETED|Starting Dose||0
9751822|NCT00322374|10854268|FG003|NOT COMPLETED|Starting Dose||0
9751823|NCT00322374|10854265|FG000|STARTED|First Escalation||0
9751824|NCT00322374|10854266|FG001|STARTED|First Escalation||30
9751825|NCT00322374|10854267|FG002|STARTED|First Escalation||0
9751826|NCT00322374|10854268|FG003|STARTED|First Escalation||0
9751827|NCT00322374|10854265|FG000|COMPLETED|First Escalation||0
9751828|NCT00322374|10854266|FG001|COMPLETED|First Escalation||0
9751829|NCT00322374|10854267|FG002|COMPLETED|First Escalation||0
9751830|NCT00322374|10854268|FG003|COMPLETED|First Escalation||0
9751831|NCT00322374|10854265|FG000|NOT COMPLETED|First Escalation||0
9751832|NCT00322374|10854266|FG001|NOT COMPLETED|First Escalation||30
9751833|NCT00322374|10854267|FG002|NOT COMPLETED|First Escalation||0
9751834|NCT00322374|10854268|FG003|NOT COMPLETED|First Escalation||0
9751835|NCT00322374|10854265|FG000|STARTED|Second Escalation||0
9751836|NCT00322374|10854266|FG001|STARTED|Second Escalation||0
9751837|NCT00322374|10854267|FG002|STARTED|Second Escalation||6
9751838|NCT00322374|10854268|FG003|STARTED|Second Escalation||0
9751839|NCT00322374|10854265|FG000|COMPLETED|Second Escalation||0
9751840|NCT00322374|10854266|FG001|COMPLETED|Second Escalation||0
9751841|NCT00322374|10854267|FG002|COMPLETED|Second Escalation||0
9751842|NCT00322374|10854268|FG003|COMPLETED|Second Escalation||0
9751843|NCT00322374|10854265|FG000|NOT COMPLETED|Second Escalation||0
9751844|NCT00322374|10854266|FG001|NOT COMPLETED|Second Escalation||0
9751845|NCT00322374|10854267|FG002|NOT COMPLETED|Second Escalation||6
9751846|NCT00322374|10854268|FG003|NOT COMPLETED|Second Escalation||0
9751847|NCT00322387|10854283|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
9751848|NCT00322387|10854284|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
9751849|NCT00322387|10854283|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
9751850|NCT00322387|10854284|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
9751851|NCT00322387|10854283|FG000|NOT COMPLETED|Treatment Period||0
9751852|NCT00322387|10854284|FG001|NOT COMPLETED|Treatment Period||1
9751853|NCT00322387|10854283|FG000|STARTED|Follow-up Period|Participants who had transplants|14
9751854|NCT00322387|10854284|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
9751855|NCT00322387|10854283|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
9751856|NCT00322387|10854284|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
9751857|NCT00322387|10854283|FG000|NOT COMPLETED|Follow-up Period||2
9751858|NCT00322387|10854284|FG001|NOT COMPLETED|Follow-up Period||3
9751859|NCT00322439|10854301|FG000|STARTED|Overall Study||2511
9751860|NCT00322439|10854301|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510
9751861|NCT00322439|10854301|FG000|COMPLETED|Overall Study||1455
9751862|NCT00322439|10854301|FG000|NOT COMPLETED|Overall Study||1056
9751863|NCT00322452|10854307|FG000|STARTED|Overall Study|Number of patients randomized|609
9751864|NCT00322452|10854308|FG001|STARTED|Overall Study|Number of patients randomized|608
9751865|NCT00322452|10854307|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
9751866|NCT00322452|10854308|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
9751867|NCT00322452|10854307|FG000|NOT COMPLETED|Overall Study||247
9751868|NCT00322452|10854308|FG001|NOT COMPLETED|Overall Study||276
9751869|NCT00322465|10854318|FG000|STARTED|Overall Study|Randomized|76
9751870|NCT00322465|10854319|FG001|STARTED|Overall Study|Randomized|73
9751871|NCT00322465|10854320|FG002|STARTED|Overall Study|Randomized|77
9751872|NCT00322465|10854321|FG003|STARTED|Overall Study|Randomized|79
9751873|NCT00322465|10854318|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
9751874|NCT00322465|10854319|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
9751875|NCT00322465|10854320|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
9751876|NCT00322465|10854321|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
9751877|NCT00322465|10854318|FG000|NOT COMPLETED|Overall Study||20
9751878|NCT00322465|10854319|FG001|NOT COMPLETED|Overall Study||24
9751879|NCT00322465|10854320|FG002|NOT COMPLETED|Overall Study||26
9751880|NCT00322465|10854321|FG003|NOT COMPLETED|Overall Study||26
9751881|NCT00322491|10854336|FG000|STARTED|Overall Study||23
9751882|NCT00322491|10854337|FG001|STARTED|Overall Study||26
9751883|NCT00322491|10854336|FG000|COMPLETED|Overall Study||21
9751884|NCT00322491|10854337|FG001|COMPLETED|Overall Study||24
9751885|NCT00322491|10854336|FG000|NOT COMPLETED|Overall Study||2
9751886|NCT00322491|10854337|FG001|NOT COMPLETED|Overall Study||2
9751887|NCT00322556|10854344|FG000|STARTED|Overall Study||55
9751888|NCT00322556|10854344|FG000|COMPLETED|Overall Study||43
9751889|NCT00322556|10854344|FG000|NOT COMPLETED|Overall Study||12
9828914|NCT00758394|10939577|FG001|STARTED|2nd Intervention Order||7
9828915|NCT00758394|10939578|FG002|STARTED|2nd Intervention Order||6
9828916|NCT00758394|10939579|FG003|STARTED|2nd Intervention Order||8
9828917|NCT00758394|10939576|FG000|COMPLETED|2nd Intervention Order||8
9828918|NCT00758394|10939577|FG001|COMPLETED|2nd Intervention Order||6
9828919|NCT00758394|10939578|FG002|COMPLETED|2nd Intervention Order||6
9828920|NCT00758394|10939579|FG003|COMPLETED|2nd Intervention Order||8
9828921|NCT00758394|10939576|FG000|NOT COMPLETED|2nd Intervention Order||0
9828922|NCT00758394|10939577|FG001|NOT COMPLETED|2nd Intervention Order||1
9828923|NCT00758394|10939578|FG002|NOT COMPLETED|2nd Intervention Order||0
9828924|NCT00758394|10939579|FG003|NOT COMPLETED|2nd Intervention Order||0
9828925|NCT00758394|10939576|FG000|STARTED|Washout After 2nd Intervention||8
9828926|NCT00758394|10939577|FG001|STARTED|Washout After 2nd Intervention||6
9828927|NCT00758394|10939578|FG002|STARTED|Washout After 2nd Intervention||6
9828928|NCT00758394|10939579|FG003|STARTED|Washout After 2nd Intervention||8
9828929|NCT00758394|10939576|FG000|COMPLETED|Washout After 2nd Intervention||8
9828930|NCT00758394|10939577|FG001|COMPLETED|Washout After 2nd Intervention||6
9828931|NCT00758394|10939578|FG002|COMPLETED|Washout After 2nd Intervention||6
9828932|NCT00758394|10939579|FG003|COMPLETED|Washout After 2nd Intervention||8
9828933|NCT00758394|10939576|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
9828934|NCT00758394|10939577|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
9828935|NCT00758394|10939578|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
9828936|NCT00758394|10939579|FG003|NOT COMPLETED|Washout After 2nd Intervention||0
9828937|NCT00758394|10939576|FG000|STARTED|3rd Intervention||8
9828938|NCT00758394|10939577|FG001|STARTED|3rd Intervention||6
9828939|NCT00758394|10939578|FG002|STARTED|3rd Intervention||6
9828940|NCT00758394|10939579|FG003|STARTED|3rd Intervention||8
9828941|NCT00758394|10939576|FG000|COMPLETED|3rd Intervention||7
9828942|NCT00758394|10939577|FG001|COMPLETED|3rd Intervention||6
9828943|NCT00758394|10939578|FG002|COMPLETED|3rd Intervention||6
9828944|NCT00758394|10939579|FG003|COMPLETED|3rd Intervention||7
9828945|NCT00758394|10939576|FG000|NOT COMPLETED|3rd Intervention||1
9828946|NCT00758394|10939577|FG001|NOT COMPLETED|3rd Intervention||0
9828947|NCT00758394|10939578|FG002|NOT COMPLETED|3rd Intervention||0
9828948|NCT00758394|10939579|FG003|NOT COMPLETED|3rd Intervention||1
9828949|NCT00758394|10939576|FG000|STARTED|Washout After 3rd Intervention||7
9828950|NCT00758394|10939577|FG001|STARTED|Washout After 3rd Intervention||6
9828951|NCT00758394|10939578|FG002|STARTED|Washout After 3rd Intervention||6
9828952|NCT00758394|10939579|FG003|STARTED|Washout After 3rd Intervention||7
9828953|NCT00758394|10939576|FG000|COMPLETED|Washout After 3rd Intervention||7
9828954|NCT00758394|10939577|FG001|COMPLETED|Washout After 3rd Intervention||6
9828955|NCT00758394|10939578|FG002|COMPLETED|Washout After 3rd Intervention||6
9828956|NCT00758394|10939579|FG003|COMPLETED|Washout After 3rd Intervention||7
9828957|NCT00758394|10939576|FG000|NOT COMPLETED|Washout After 3rd Intervention||0
9828958|NCT00758394|10939577|FG001|NOT COMPLETED|Washout After 3rd Intervention||0
9828959|NCT00758394|10939578|FG002|NOT COMPLETED|Washout After 3rd Intervention||0
9828960|NCT00758394|10939579|FG003|NOT COMPLETED|Washout After 3rd Intervention||0
9828961|NCT00758394|10939576|FG000|STARTED|4th Intervention||7
9828962|NCT00758394|10939577|FG001|STARTED|4th Intervention||6
9828963|NCT00758394|10939578|FG002|STARTED|4th Intervention||6
9828964|NCT00758394|10939579|FG003|STARTED|4th Intervention||7
9828965|NCT00758394|10939576|FG000|COMPLETED|4th Intervention||7
9828966|NCT00758394|10939577|FG001|COMPLETED|4th Intervention||6
9828967|NCT00758394|10939578|FG002|COMPLETED|4th Intervention||6
9828968|NCT00758394|10939579|FG003|COMPLETED|4th Intervention||7
9828969|NCT00758394|10939576|FG000|NOT COMPLETED|4th Intervention||0
9828970|NCT00758394|10939577|FG001|NOT COMPLETED|4th Intervention||0
9828971|NCT00758394|10939578|FG002|NOT COMPLETED|4th Intervention||0
9828972|NCT00758394|10939579|FG003|NOT COMPLETED|4th Intervention||0
9828973|NCT00758420|10939591|FG000|STARTED|Overall Study||39
9828974|NCT00758420|10939592|FG001|STARTED|Overall Study||38
9828975|NCT00758420|10939591|FG000|COMPLETED|Overall Study||39
9828976|NCT00758420|10939592|FG001|COMPLETED|Overall Study||38
9828977|NCT00758420|10939591|FG000|NOT COMPLETED|Overall Study||0
9828978|NCT00758420|10939592|FG001|NOT COMPLETED|Overall Study||0
9828979|NCT00758459|10939600|FG000|STARTED|Overall Study||35
9828980|NCT00758459|10939601|FG001|STARTED|Overall Study||39
9828981|NCT00758459|10939600|FG000|COMPLETED|Overall Study||32
9828982|NCT00758459|10939601|FG001|COMPLETED|Overall Study||35
9828983|NCT00758459|10939600|FG000|NOT COMPLETED|Overall Study||3
9828984|NCT00758459|10939601|FG001|NOT COMPLETED|Overall Study||4
9828985|NCT00758485|10939609|FG000|STARTED|Overall Study||70
9828986|NCT00758485|10939610|FG001|STARTED|Overall Study||70
9828987|NCT00758485|10939609|FG000|TREATED|Overall Study||69
9828988|NCT00758485|10939610|FG001|TREATED|Overall Study||68
9828989|NCT00758485|10939609|FG000|COMPLETED|Overall Study||69
9828990|NCT00758485|10939610|FG001|COMPLETED|Overall Study||67
9828991|NCT00758485|10939609|FG000|NOT COMPLETED|Overall Study||1
9751890|NCT00322621|10854351|FG000|STARTED|Period II - Acute Therapy Phase||216
9751891|NCT00322621|10854352|FG001|STARTED|Period II - Acute Therapy Phase||0
9751892|NCT00322621|10854353|FG002|STARTED|Period II - Acute Therapy Phase||0
9751893|NCT00322621|10854351|FG000|COMPLETED|Period II - Acute Therapy Phase||184
9751894|NCT00322621|10854352|FG001|COMPLETED|Period II - Acute Therapy Phase||0
9751895|NCT00322621|10854353|FG002|COMPLETED|Period II - Acute Therapy Phase||0
9751896|NCT00322621|10854351|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32
9751897|NCT00322621|10854352|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0
9751898|NCT00322621|10854353|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0
9751899|NCT00322621|10854351|FG000|STARTED|Period III - Maintenance / Rescue Phase||0
9751900|NCT00322621|10854352|FG001|STARTED|Period III - Maintenance / Rescue Phase||115
9751901|NCT00322621|10854353|FG002|STARTED|Period III - Maintenance / Rescue Phase||69
9751902|NCT00322621|10854351|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0
9751903|NCT00322621|10854352|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86
9751904|NCT00322621|10854353|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33
9751905|NCT00322621|10854351|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
9751906|NCT00322621|10854352|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
9751907|NCT00322621|10854353|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
9751908|NCT00322712|10854366|FG000|STARTED|Overall Study||12
9751909|NCT00322712|10854366|FG000|COMPLETED|Overall Study||11
9751910|NCT00322712|10854366|FG000|NOT COMPLETED|Overall Study||1
9751911|NCT00322777|10854372|FG000|STARTED|Overall Study||39
9751912|NCT00322777|10854373|FG001|STARTED|Overall Study||45
9751913|NCT00322777|10854372|FG000|"Data Collection at BASELINE|"|Overall Study||39
9751914|NCT00322777|10854373|FG001|"Data Collection at BASELINE|"|Overall Study||45
9751915|NCT00322777|10854372|FG000|Data Collection at Week 8|Overall Study||39
9751916|NCT00322777|10854373|FG001|Data Collection at Week 8|Overall Study||45
9751917|NCT00322777|10854372|FG000|Data Collection at Week 16|Overall Study||39
9751918|NCT00322777|10854373|FG001|Data Collection at Week 16|Overall Study||45
9751919|NCT00322777|10854372|FG000|Data Collection at Week 24|Overall Study||39
9751920|NCT00322777|10854373|FG001|Data Collection at Week 24|Overall Study||45
9751921|NCT00322777|10854372|FG000|COMPLETED|Overall Study||39
9751922|NCT00322777|10854373|FG001|COMPLETED|Overall Study||45
9751923|NCT00322777|10854372|FG000|NOT COMPLETED|Overall Study||0
9751924|NCT00322777|10854373|FG001|NOT COMPLETED|Overall Study||0
9751925|NCT00322842|10854381|FG000|STARTED|Overall Study||4
9751926|NCT00322842|10854382|FG001|STARTED|Overall Study||31
9751927|NCT00322842|10854381|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
9751928|NCT00322842|10854382|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
9751929|NCT00322842|10854381|FG000|NOT COMPLETED|Overall Study||2
9751930|NCT00322842|10854382|FG001|NOT COMPLETED|Overall Study||2
9751931|NCT00322868|10854389|FG000|STARTED|Overall Study||21
9751932|NCT00322868|10854389|FG000|COMPLETED|Overall Study||20
9751933|NCT00322868|10854389|FG000|NOT COMPLETED|Overall Study||1
9751934|NCT00322881|10854394|FG000|STARTED|Overall Study||12
9751935|NCT00322881|10854394|FG000|COMPLETED|Overall Study||7
9751936|NCT00322881|10854394|FG000|NOT COMPLETED|Overall Study||5
9751937|NCT00323063|10854400|FG000|STARTED|Overall Study||26
9751938|NCT00323063|10854401|FG001|STARTED|Overall Study||23
9751939|NCT00323063|10854400|FG000|COMPLETED|Overall Study||24
9751940|NCT00323063|10854401|FG001|COMPLETED|Overall Study||23
9751941|NCT00323063|10854400|FG000|NOT COMPLETED|Overall Study||2
9751942|NCT00323063|10854401|FG001|NOT COMPLETED|Overall Study||0
9751943|NCT00323115|10854407|FG000|STARTED|Vaccine Administration||11
9751944|NCT00323115|10854407|FG000|COMPLETED|Vaccine Administration||10
9751945|NCT00323115|10854407|FG000|NOT COMPLETED|Vaccine Administration||1
9751946|NCT00323115|10854407|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10
9751947|NCT00323115|10854407|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
9751948|NCT00323115|10854407|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
9751949|NCT00323193|10854418|FG000|STARTED|Overall Study||53
9751950|NCT00323193|10854419|FG001|STARTED|Overall Study||56
9751951|NCT00323193|10854418|FG000|COMPLETED|Overall Study||30
9751952|NCT00323193|10854419|FG001|COMPLETED|Overall Study||41
9751953|NCT00323193|10854418|FG000|NOT COMPLETED|Overall Study||23
9751954|NCT00323193|10854419|FG001|NOT COMPLETED|Overall Study||15
9751955|NCT00323258|10854427|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71
9751956|NCT00323258|10854428|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72
9751957|NCT00323258|10854427|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
9751958|NCT00323258|10854428|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
9751959|NCT00323258|10854427|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
9751960|NCT00323258|10854428|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
9751961|NCT00323258|10854427|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71
9751962|NCT00323258|10854428|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72
9751963|NCT00323258|10854427|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
9751964|NCT00323258|10854428|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
9751965|NCT00323258|10854427|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
9751966|NCT00323258|10854428|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
9751967|NCT00323271|10854436|FG000|STARTED|Overall Study||13
9751968|NCT00323271|10854437|FG001|STARTED|Overall Study||12
9751969|NCT00323271|10854436|FG000|COMPLETED|Overall Study||11
9751970|NCT00323271|10854437|FG001|COMPLETED|Overall Study||9
9751971|NCT00323271|10854436|FG000|NOT COMPLETED|Overall Study||2
9751972|NCT00323271|10854437|FG001|NOT COMPLETED|Overall Study||3
9751973|NCT00323284|10854445|FG000|STARTED|12 Months Follow-up||116
9751974|NCT00323284|10854446|FG001|STARTED|12 Months Follow-up||123
9751975|NCT00323284|10854445|FG000|COMPLETED|12 Months Follow-up||111
9751976|NCT00323284|10854446|FG001|COMPLETED|12 Months Follow-up||114
9751977|NCT00323284|10854445|FG000|NOT COMPLETED|12 Months Follow-up||5
9751978|NCT00323284|10854446|FG001|NOT COMPLETED|12 Months Follow-up||9
9751979|NCT00323284|10854445|FG000|STARTED|24 Months Follow-up||116
9751980|NCT00323284|10854446|FG001|STARTED|24 Months Follow-up||123
9751981|NCT00323284|10854445|FG000|COMPLETED|24 Months Follow-up||98
9751982|NCT00323284|10854446|FG001|COMPLETED|24 Months Follow-up||101
9751983|NCT00323284|10854445|FG000|NOT COMPLETED|24 Months Follow-up||18
9751984|NCT00323284|10854446|FG001|NOT COMPLETED|24 Months Follow-up||22
9751985|NCT00323297|10854454|FG000|STARTED|Part A (Double Blind Randomized)||53
9751986|NCT00323297|10854455|FG001|STARTED|Part A (Double Blind Randomized)||50
9751987|NCT00323297|10854454|FG000|COMPLETED|Part A (Double Blind Randomized)||48
9751988|NCT00323297|10854455|FG001|COMPLETED|Part A (Double Blind Randomized)||43
9751989|NCT00323297|10854454|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5
9751990|NCT00323297|10854455|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7
9751991|NCT00323297|10854454|FG000|STARTED|Part B (Open-label)||48
9751992|NCT00323297|10854455|FG001|STARTED|Part B (Open-label)||43
9751993|NCT00323297|10854454|FG000|COMPLETED|Part B (Open-label)||39
9751994|NCT00323297|10854455|FG001|COMPLETED|Part B (Open-label)||31
9751995|NCT00323297|10854454|FG000|NOT COMPLETED|Part B (Open-label)||9
9751996|NCT00323297|10854455|FG001|NOT COMPLETED|Part B (Open-label)||12
9751997|NCT00323310|10854461|FG000|STARTED|Overall Study||92
9751998|NCT00323310|10854461|FG000|COMPLETED|Overall Study||89
9751999|NCT00323310|10854461|FG000|NOT COMPLETED|Overall Study||3
9752000|NCT00323362|10854465|FG000|STARTED|Overall Study||17
9752001|NCT00323362|10854465|FG000|COMPLETED|Overall Study||17
9752002|NCT00323362|10854465|FG000|NOT COMPLETED|Overall Study||0
9752003|NCT00323414|10854471|FG000|STARTED|Overall Study||18
9752004|NCT00323414|10854472|FG001|STARTED|Overall Study||19
9752005|NCT00323414|10854471|FG000|COMPLETED|Overall Study||18
9752006|NCT00323414|10854472|FG001|COMPLETED|Overall Study||18
9752007|NCT00323414|10854471|FG000|NOT COMPLETED|Overall Study||0
9752008|NCT00323414|10854472|FG001|NOT COMPLETED|Overall Study||1
9752009|NCT00323427|10854480|FG000|STARTED|Overall Study||69
9752010|NCT00323427|10854481|FG001|STARTED|Overall Study||66
9752011|NCT00323427|10854480|FG000|COMPLETED|Overall Study||38
9752012|NCT00323427|10854481|FG001|COMPLETED|Overall Study||43
9752013|NCT00323427|10854480|FG000|NOT COMPLETED|Overall Study||31
9752014|NCT00323427|10854481|FG001|NOT COMPLETED|Overall Study||23
9752015|NCT00323453|10854489|FG000|STARTED|Overall Study||61
9752016|NCT00323453|10854490|FG001|STARTED|Overall Study||48
9752017|NCT00323453|10854489|FG000|COMPLETED|Overall Study||61
9752018|NCT00323453|10854490|FG001|COMPLETED|Overall Study||48
9752019|NCT00323453|10854489|FG000|NOT COMPLETED|Overall Study||0
9752020|NCT00323453|10854490|FG001|NOT COMPLETED|Overall Study||0
9752021|NCT00323479|10854496|FG000|STARTED|Overall Study||114
9752022|NCT00323479|10854496|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
9752023|NCT00323479|10854496|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
9752024|NCT00323479|10854496|FG000|NOT COMPLETED|Overall Study||8
9752025|NCT00323492|10854502|FG000|STARTED|Study Phase 1||47
9752026|NCT00323492|10854503|FG001|STARTED|Study Phase 1||45
9752027|NCT00323492|10854504|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0
9752028|NCT00323492|10854502|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
9752029|NCT00323492|10854503|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
9752030|NCT00323492|10854504|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
9752031|NCT00323492|10854502|FG000|COMPLETED|Study Phase 1||45
9752032|NCT00323492|10854503|FG001|COMPLETED|Study Phase 1||45
9752033|NCT00323492|10854504|FG002|COMPLETED|Study Phase 1||0
9752034|NCT00323492|10854502|FG000|NOT COMPLETED|Study Phase 1||2
9752035|NCT00323492|10854503|FG001|NOT COMPLETED|Study Phase 1||0
9752036|NCT00323492|10854504|FG002|NOT COMPLETED|Study Phase 1||0
9752037|NCT00323492|10854502|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
9752038|NCT00323492|10854503|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
9752039|NCT00323492|10854504|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
9752040|NCT00323492|10854502|FG000|COMPLETED|Study Phase 2||40
9752041|NCT00323492|10854503|FG001|COMPLETED|Study Phase 2||17
9752042|NCT00323492|10854504|FG002|COMPLETED|Study Phase 2||24
9752043|NCT00323492|10854502|FG000|NOT COMPLETED|Study Phase 2||4
9752044|NCT00323492|10854503|FG001|NOT COMPLETED|Study Phase 2||1
9752045|NCT00323492|10854504|FG002|NOT COMPLETED|Study Phase 2||1
9752046|NCT00323557|10854513|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
9752047|NCT00323557|10854514|FG001|STARTED|Overall Study||7
9752048|NCT00323557|10854513|FG000|COMPLETED|Overall Study||24
9752049|NCT00323557|10854514|FG001|COMPLETED|Overall Study||7
9752050|NCT00323557|10854513|FG000|NOT COMPLETED|Overall Study||1
9752051|NCT00323557|10854514|FG001|NOT COMPLETED|Overall Study||0
9752052|NCT00323609|10854523|FG000|STARTED|Overall Study||191
9752053|NCT00323609|10854524|FG001|STARTED|Overall Study||190
9752054|NCT00323609|10854525|FG002|STARTED|Overall Study||8
9752055|NCT00323609|10854526|FG003|STARTED|Overall Study||15
9752056|NCT00323609|10854523|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
9752057|NCT00323609|10854524|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
9752058|NCT00323609|10854525|FG002|COMPLETED|Overall Study||0
9752059|NCT00323609|10854526|FG003|COMPLETED|Overall Study||0
9752060|NCT00323609|10854523|FG000|NOT COMPLETED|Overall Study||91
9752061|NCT00323609|10854524|FG001|NOT COMPLETED|Overall Study||99
9752062|NCT00323609|10854525|FG002|NOT COMPLETED|Overall Study||8
9752063|NCT00323609|10854526|FG003|NOT COMPLETED|Overall Study||15
9752064|NCT00323622|10854540|FG000|STARTED|Overall Study||176
9752065|NCT00323622|10854541|FG001|STARTED|Overall Study||515
9752066|NCT00323622|10854542|FG002|STARTED|Overall Study||42
9752067|NCT00323622|10854543|FG003|STARTED|Overall Study||134
9752068|NCT00323622|10854544|FG004|STARTED|Overall Study||159
9752069|NCT00323622|10854545|FG005|STARTED|Overall Study||528
9752070|NCT00323622|10854546|FG006|STARTED|Overall Study||43
9752071|NCT00323622|10854547|FG007|STARTED|Overall Study||140
9752072|NCT00323622|10854540|FG000|COMPLETED|Overall Study||145
9752073|NCT00323622|10854541|FG001|COMPLETED|Overall Study||423
9752074|NCT00323622|10854542|FG002|COMPLETED|Overall Study||38
9752075|NCT00323622|10854543|FG003|COMPLETED|Overall Study||122
9752076|NCT00323622|10854544|FG004|COMPLETED|Overall Study||120
9752077|NCT00323622|10854545|FG005|COMPLETED|Overall Study||454
9752078|NCT00323622|10854546|FG006|COMPLETED|Overall Study||38
9752079|NCT00323622|10854547|FG007|COMPLETED|Overall Study||125
9752080|NCT00323622|10854540|FG000|NOT COMPLETED|Overall Study||31
9752081|NCT00323622|10854541|FG001|NOT COMPLETED|Overall Study||92
9752082|NCT00323622|10854542|FG002|NOT COMPLETED|Overall Study||4
9752083|NCT00323622|10854543|FG003|NOT COMPLETED|Overall Study||12
9752084|NCT00323622|10854544|FG004|NOT COMPLETED|Overall Study||39
9752085|NCT00323622|10854545|FG005|NOT COMPLETED|Overall Study||74
10092262|NCT02335346|11220636|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93
10092263|NCT02335346|11220636|FG000|COMPLETED|Overall Study||81
10092264|NCT02335346|11220636|FG000|NOT COMPLETED|Overall Study||12
10092265|NCT02335450|11220640|FG000|STARTED|Overall Study||5
9752086|NCT00323622|10854546|FG006|NOT COMPLETED|Overall Study||5
9752087|NCT00323622|10854547|FG007|NOT COMPLETED|Overall Study||15
9752088|NCT00323739|10854573|FG000|STARTED|Overall Study||80
9752089|NCT00323739|10854573|FG000|COMPLETED|Overall Study||80
9752090|NCT00323739|10854573|FG000|NOT COMPLETED|Overall Study||0
9752091|NCT00323869|10854577|FG000|STARTED|Overall Study|Enrollment|48
9752092|NCT00323869|10854577|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
9752093|NCT00323869|10854577|FG000|COMPLETED|Overall Study||47
9752094|NCT00323869|10854577|FG000|NOT COMPLETED|Overall Study||1
9752095|NCT00323882|10854586|FG000|STARTED|Overall Study||8
9752096|NCT00323882|10854587|FG001|STARTED|Overall Study||6
9752097|NCT00323882|10854588|FG002|STARTED|Overall Study||16
9752098|NCT00323882|10854589|FG003|STARTED|Overall Study||7
9752099|NCT00323882|10854590|FG004|STARTED|Overall Study||34
9752100|NCT00323882|10854586|FG000|COMPLETED|Overall Study||0
9752101|NCT00323882|10854587|FG001|COMPLETED|Overall Study||0
9752102|NCT00323882|10854588|FG002|COMPLETED|Overall Study||3
9752103|NCT00323882|10854589|FG003|COMPLETED|Overall Study||0
9752104|NCT00323882|10854590|FG004|COMPLETED|Overall Study||2
9752105|NCT00323882|10854586|FG000|NOT COMPLETED|Overall Study||8
9752106|NCT00323882|10854587|FG001|NOT COMPLETED|Overall Study||6
9752107|NCT00323882|10854588|FG002|NOT COMPLETED|Overall Study||13
9752108|NCT00323882|10854589|FG003|NOT COMPLETED|Overall Study||7
9752109|NCT00323882|10854590|FG004|NOT COMPLETED|Overall Study||32
9752110|NCT00323960|10854614|FG000|STARTED|Overall Study||47
9752111|NCT00323960|10854615|FG001|STARTED|Overall Study||46
9752112|NCT00323960|10854616|FG002|STARTED|Overall Study||46
9752113|NCT00323960|10854614|FG000|COMPLETED|Overall Study||47
9752114|NCT00323960|10854615|FG001|COMPLETED|Overall Study||46
9752115|NCT00323960|10854616|FG002|COMPLETED|Overall Study||46
9752116|NCT00323960|10854614|FG000|NOT COMPLETED|Overall Study||0
9752117|NCT00323960|10854615|FG001|NOT COMPLETED|Overall Study||0
9752118|NCT00323960|10854616|FG002|NOT COMPLETED|Overall Study||0
9752119|NCT00324038|10854629|FG000|STARTED|Overall Study||110
9752120|NCT00324038|10854630|FG001|STARTED|Overall Study||109
9752121|NCT00324038|10854629|FG000|COMPLETED|Overall Study||61
9752122|NCT00324038|10854630|FG001|COMPLETED|Overall Study||58
9752123|NCT00324038|10854629|FG000|NOT COMPLETED|Overall Study||49
9752124|NCT00324038|10854630|FG001|NOT COMPLETED|Overall Study||51
10092266|NCT02335450|11220640|FG000|COMPLETED|Overall Study||4
10092267|NCT02335450|11220640|FG000|NOT COMPLETED|Overall Study||1
10092268|NCT02335489|11220650|FG000|STARTED|Overall Study||10
10092269|NCT02335489|11220650|FG000|Received Trial System|Overall Study||9
10092270|NCT02335489|11220650|FG000|Receiving Permanent System|Overall Study||8
10092271|NCT02335489|11220650|FG000|COMPLETED|Overall Study||0
10092272|NCT02335489|11220650|FG000|NOT COMPLETED|Overall Study||10
10092273|NCT02335502|11220654|FG000|STARTED|Overall Study||66
10092274|NCT02335502|11220654|FG000|Received Trial System|Overall Study||65
10092275|NCT02335502|11220654|FG000|Receiving Permanent System|Overall Study||56
9828992|NCT00758485|10939610|FG001|NOT COMPLETED|Overall Study||3
9828993|NCT00758498|10939620|FG000|STARTED|Overall Study||142
9828994|NCT00758498|10939621|FG001|STARTED|Overall Study||143
9828995|NCT00758498|10939622|FG002|STARTED|Overall Study||142
9828996|NCT00758498|10939620|FG000|COMPLETED|Overall Study||139
9828997|NCT00758498|10939621|FG001|COMPLETED|Overall Study||141
10092276|NCT02335502|11220654|FG000|COMPLETED|Overall Study||49
10092277|NCT02335502|11220654|FG000|NOT COMPLETED|Overall Study||17
10092278|NCT02335710|11220660|FG000|STARTED|Overall Study||40
10092279|NCT02335710|11220661|FG001|STARTED|Overall Study||10
10092280|NCT02335710|11220660|FG000|COMPLETED|Overall Study||40
10092281|NCT02335710|11220661|FG001|COMPLETED|Overall Study||10
10092282|NCT02335710|11220660|FG000|NOT COMPLETED|Overall Study||0
10092283|NCT02335710|11220661|FG001|NOT COMPLETED|Overall Study||0
10092284|NCT02335905|11220667|FG000|STARTED|Overall Study||11
10092285|NCT02335905|11220667|FG000|COMPLETED|Overall Study||7
10092286|NCT02335905|11220667|FG000|NOT COMPLETED|Overall Study||4
10092287|NCT02335983|11220677|FG000|STARTED|Overall Study||10
10092288|NCT02335983|11220678|FG001|STARTED|Overall Study||12
10092289|NCT02335983|11220679|FG002|STARTED|Overall Study||34
10092290|NCT02335983|11220680|FG003|STARTED|Overall Study||9
10092291|NCT02335983|11220681|FG004|STARTED|Overall Study||9
10092292|NCT02335983|11220682|FG005|STARTED|Overall Study||33
9752125|NCT00324116|10854636|FG000|STARTED|Overall Study|subjects received treatment|81
9752126|NCT00324116|10854636|FG000|COMPLETED|Overall Study||49
9752127|NCT00324116|10854636|FG000|NOT COMPLETED|Overall Study||32
9752128|NCT00324155|10854642|FG000|STARTED|Enrolled and Randomized||250
9752129|NCT00324155|10854643|FG001|STARTED|Enrolled and Randomized||252
9752130|NCT00324155|10854642|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
9752131|NCT00324155|10854643|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
9752132|NCT00324155|10854642|FG000|NOT COMPLETED|Enrolled and Randomized||3
9752133|NCT00324155|10854643|FG001|NOT COMPLETED|Enrolled and Randomized||1
9752134|NCT00324155|10854642|FG000|STARTED|Received Treatment in Induction Phase||247
9752135|NCT00324155|10854643|FG001|STARTED|Received Treatment in Induction Phase||251
9752136|NCT00324155|10854642|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
9752137|NCT00324155|10854643|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
9752138|NCT00324155|10854642|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202
9752139|NCT00324155|10854643|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197
9752140|NCT00324155|10854642|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
9752141|NCT00324155|10854643|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
9752142|NCT00324155|10854642|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
9853910|NCT00889915|10966874|FG000|COMPLETED|Overall Study||35
9853911|NCT00889915|10966875|FG001|COMPLETED|Overall Study||71
9853912|NCT00889915|10966876|FG002|COMPLETED|Overall Study||54
9853913|NCT00889915|10966877|FG003|COMPLETED|Overall Study||40
9853914|NCT00889915|10966874|FG000|NOT COMPLETED|Overall Study||2
9853915|NCT00889915|10966875|FG001|NOT COMPLETED|Overall Study||5
9853916|NCT00889915|10966876|FG002|NOT COMPLETED|Overall Study||13
9853917|NCT00889915|10966877|FG003|NOT COMPLETED|Overall Study||8
9853918|NCT00889928|10966887|FG000|STARTED|Overall Study||7
9853919|NCT00889928|10966887|FG000|COMPLETED|Overall Study||7
9853920|NCT00889928|10966887|FG000|NOT COMPLETED|Overall Study||0
9853921|NCT00890045|10966893|FG000|STARTED|Overall Study||20
9853922|NCT00890045|10966894|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
9853923|NCT00890045|10966893|FG000|COMPLETED|Overall Study||15
9853924|NCT00890045|10966894|FG001|COMPLETED|Overall Study||42
9853925|NCT00890045|10966893|FG000|NOT COMPLETED|Overall Study||5
9853926|NCT00890045|10966894|FG001|NOT COMPLETED|Overall Study||10
9853927|NCT00890084|10966900|FG000|STARTED|Overall Study||2913
9853928|NCT00890084|10966900|FG000|COMPLETED|Overall Study||2771
9853929|NCT00890084|10966900|FG000|NOT COMPLETED|Overall Study||142
9853930|NCT00890097|10966907|FG000|STARTED|Overall Study||252
9853931|NCT00890097|10966908|FG001|STARTED|Overall Study||259
9853932|NCT00890097|10966909|FG002|STARTED|Overall Study||261
9853933|NCT00890097|10966907|FG000|COMPLETED|Overall Study||184
9853934|NCT00890097|10966908|FG001|COMPLETED|Overall Study||173
9853935|NCT00890097|10966909|FG002|COMPLETED|Overall Study||184
9853936|NCT00890097|10966907|FG000|NOT COMPLETED|Overall Study||68
9853937|NCT00890097|10966908|FG001|NOT COMPLETED|Overall Study||86
9853938|NCT00890097|10966909|FG002|NOT COMPLETED|Overall Study||77
9853939|NCT00890162|10966919|FG000|STARTED|Overall Study||8
9853940|NCT00890162|10966920|FG001|STARTED|Overall Study||8
9853941|NCT00890162|10966919|FG000|COMPLETED|Overall Study||6
9853942|NCT00890162|10966920|FG001|COMPLETED|Overall Study||7
9853943|NCT00890162|10966919|FG000|NOT COMPLETED|Overall Study||2
9853944|NCT00890162|10966920|FG001|NOT COMPLETED|Overall Study||1
9853945|NCT00890201|10966928|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
9853946|NCT00890201|10966929|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
9853947|NCT00890201|10966928|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
9853948|NCT00890201|10966929|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
9853949|NCT00890201|10966928|FG000|NOT COMPLETED|Overall Study||5
10092293|NCT02335983|11220677|FG000|COMPLETED|Overall Study||2
10092294|NCT02335983|11220678|FG001|COMPLETED|Overall Study||3
10092295|NCT02335983|11220679|FG002|COMPLETED|Overall Study||2
10092296|NCT02335983|11220680|FG003|COMPLETED|Overall Study||0
10092297|NCT02335983|11220681|FG004|COMPLETED|Overall Study||1
9752143|NCT00324155|10854643|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
9752144|NCT00324155|10854642|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32
9752145|NCT00324155|10854643|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47
9752146|NCT00324155|10854642|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
9752147|NCT00324155|10854643|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
9752148|NCT00324155|10854642|FG000|COMPLETED|Follow-up Phase||236
9752149|NCT00324155|10854643|FG001|COMPLETED|Follow-up Phase||245
9752150|NCT00324155|10854642|FG000|NOT COMPLETED|Follow-up Phase||11
9752151|NCT00324155|10854643|FG001|NOT COMPLETED|Follow-up Phase||6
9752152|NCT00324168|10854664|FG000|STARTED|Overall Study||250
9752153|NCT00324168|10854665|FG001|STARTED|Overall Study||250
9752154|NCT00324168|10854664|FG000|COMPLETED|Overall Study||222
9752155|NCT00324168|10854665|FG001|COMPLETED|Overall Study||220
9752156|NCT00324168|10854664|FG000|NOT COMPLETED|Overall Study||28
9752157|NCT00324168|10854665|FG001|NOT COMPLETED|Overall Study||30
9752158|NCT00324233|10854673|FG000|STARTED|First Period||18
9752159|NCT00324233|10854674|FG001|STARTED|First Period||18
9752160|NCT00324233|10854673|FG000|COMPLETED|First Period||17
9752161|NCT00324233|10854674|FG001|COMPLETED|First Period||18
9752162|NCT00324233|10854673|FG000|NOT COMPLETED|First Period||1
9752163|NCT00324233|10854674|FG001|NOT COMPLETED|First Period||0
9752164|NCT00324233|10854673|FG000|STARTED|Second Period||17
10092298|NCT02335983|11220682|FG005|COMPLETED|Overall Study||1
10092299|NCT02335983|11220677|FG000|NOT COMPLETED|Overall Study||8
10092300|NCT02335983|11220678|FG001|NOT COMPLETED|Overall Study||9
10092301|NCT02335983|11220679|FG002|NOT COMPLETED|Overall Study||32
9752165|NCT00324233|10854674|FG001|STARTED|Second Period||18
9752166|NCT00324233|10854673|FG000|COMPLETED|Second Period||12
9752167|NCT00324233|10854674|FG001|COMPLETED|Second Period||11
9752168|NCT00324233|10854673|FG000|NOT COMPLETED|Second Period||5
9752169|NCT00324233|10854674|FG001|NOT COMPLETED|Second Period||7
9752170|NCT00324259|10854682|FG000|STARTED|Overall Study||34
9752171|NCT00324259|10854683|FG001|STARTED|Overall Study||32
9752172|NCT00324259|10854682|FG000|COMPLETED|Overall Study||34
9752173|NCT00324259|10854683|FG001|COMPLETED|Overall Study||32
9752174|NCT00324259|10854682|FG000|NOT COMPLETED|Overall Study||0
9752175|NCT00324259|10854683|FG001|NOT COMPLETED|Overall Study||0
9752176|NCT00324272|10854694|FG000|STARTED|Overall Study||18
9752177|NCT00324272|10854695|FG001|STARTED|Overall Study||20
9752178|NCT00324272|10854696|FG002|STARTED|Overall Study||18
9752179|NCT00324272|10854697|FG003|STARTED|Overall Study||18
9752180|NCT00324272|10854694|FG000|COMPLETED|Overall Study||18
9752181|NCT00324272|10854695|FG001|COMPLETED|Overall Study||20
9752182|NCT00324272|10854696|FG002|COMPLETED|Overall Study||18
9752183|NCT00324272|10854697|FG003|COMPLETED|Overall Study||18
9752184|NCT00324272|10854694|FG000|NOT COMPLETED|Overall Study||0
9752185|NCT00324272|10854695|FG001|NOT COMPLETED|Overall Study||0
9752186|NCT00324272|10854696|FG002|NOT COMPLETED|Overall Study||0
9752187|NCT00324272|10854697|FG003|NOT COMPLETED|Overall Study||0
9752188|NCT00324350|10854709|FG000|STARTED|Overall Study||3655
9752189|NCT00324350|10854710|FG001|STARTED|Overall Study||3632
9752190|NCT00324350|10854709|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655
9752191|NCT00324350|10854710|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632
9752192|NCT00324350|10854709|FG000|Falls Follow-Up|Overall Study||3364
9752193|NCT00324350|10854710|FG001|Falls Follow-Up|Overall Study||3418
9752194|NCT00324350|10854709|FG000|COMPLETED|Overall Study||3655
9752195|NCT00324350|10854710|FG001|COMPLETED|Overall Study||3632
9752196|NCT00324350|10854709|FG000|NOT COMPLETED|Overall Study||0
9752197|NCT00324350|10854710|FG001|NOT COMPLETED|Overall Study||0
9752198|NCT00324415|10854717|FG000|STARTED|Overall Study||45
9752199|NCT00324415|10854717|FG000|COMPLETED|Overall Study||45
9752200|NCT00324415|10854717|FG000|NOT COMPLETED|Overall Study||0
9752201|NCT00324649|10854724|FG000|STARTED|Overall Study||39
9752202|NCT00324649|10854725|FG001|STARTED|Overall Study||41
9752203|NCT00324649|10854724|FG000|COMPLETED|Overall Study||37
9752204|NCT00324649|10854725|FG001|COMPLETED|Overall Study||36
9752205|NCT00324649|10854724|FG000|NOT COMPLETED|Overall Study||2
9752206|NCT00324649|10854725|FG001|NOT COMPLETED|Overall Study||5
9752207|NCT00324675|10854733|FG000|STARTED|Overall Study||14
9752208|NCT00324675|10854734|FG001|STARTED|Overall Study||14
9752209|NCT00324675|10854733|FG000|COMPLETED|Overall Study||13
9752210|NCT00324675|10854734|FG001|COMPLETED|Overall Study||14
9752211|NCT00324675|10854733|FG000|NOT COMPLETED|Overall Study||1
9752212|NCT00324675|10854734|FG001|NOT COMPLETED|Overall Study||0
9752213|NCT00324701|10854742|FG000|STARTED|Overall Study||120
9752214|NCT00324701|10854743|FG001|STARTED|Overall Study||121
9752215|NCT00324701|10854742|FG000|Week 8 Assessment|Overall Study||108
9752216|NCT00324701|10854743|FG001|Week 8 Assessment|Overall Study||107
9752217|NCT00324701|10854742|FG000|COMPLETED|Overall Study||100
9752218|NCT00324701|10854743|FG001|COMPLETED|Overall Study||104
9752219|NCT00324701|10854742|FG000|NOT COMPLETED|Overall Study||20
9752220|NCT00324701|10854743|FG001|NOT COMPLETED|Overall Study||17
9752221|NCT00324740|10854749|FG000|STARTED|Overall Study||7
9752222|NCT00324740|10854750|FG001|STARTED|Overall Study||3
9752223|NCT00324740|10854751|FG002|STARTED|Overall Study||4
9752224|NCT00324740|10854749|FG000|COMPLETED|Overall Study||6
9752225|NCT00324740|10854750|FG001|COMPLETED|Overall Study||3
9752226|NCT00324740|10854751|FG002|COMPLETED|Overall Study||3
10092302|NCT02335983|11220680|FG003|NOT COMPLETED|Overall Study||9
9752227|NCT00324740|10854749|FG000|NOT COMPLETED|Overall Study||1
9752228|NCT00324740|10854750|FG001|NOT COMPLETED|Overall Study||0
9752229|NCT00324740|10854751|FG002|NOT COMPLETED|Overall Study||1
9752230|NCT00324753|10854760|FG000|STARTED|Overall Study||190
9752231|NCT00324753|10854761|FG001|STARTED|Overall Study||264
9752232|NCT00324753|10854760|FG000|COMPLETED|Overall Study||190
9752233|NCT00324753|10854761|FG001|COMPLETED|Overall Study||264
9752234|NCT00324753|10854760|FG000|NOT COMPLETED|Overall Study||0
9752235|NCT00324753|10854761|FG001|NOT COMPLETED|Overall Study||0
9752236|NCT00324857|10854773|FG000|STARTED|Overall Study||167
9752237|NCT00324857|10854774|FG001|STARTED|Overall Study||168
9752238|NCT00324857|10854775|FG002|STARTED|Overall Study||165
9752239|NCT00324857|10854776|FG003|STARTED|Overall Study||163
9752240|NCT00324857|10854773|FG000|COMPLETED|Overall Study||161
9752241|NCT00324857|10854774|FG001|COMPLETED|Overall Study||162
9752242|NCT00324857|10854775|FG002|COMPLETED|Overall Study||158
9752243|NCT00324857|10854776|FG003|COMPLETED|Overall Study||158
9752244|NCT00324857|10854773|FG000|NOT COMPLETED|Overall Study||6
9752245|NCT00324857|10854774|FG001|NOT COMPLETED|Overall Study||6
9752246|NCT00324857|10854775|FG002|NOT COMPLETED|Overall Study||7
9752247|NCT00324857|10854776|FG003|NOT COMPLETED|Overall Study||5
9752248|NCT00324870|10854790|FG000|STARTED|Overall Study||37
9752249|NCT00324870|10854790|FG000|COMPLETED|Overall Study||37
9752250|NCT00324870|10854790|FG000|NOT COMPLETED|Overall Study||0
9752251|NCT00324896|10854796|FG000|STARTED|Overall Study||15
9752252|NCT00324896|10854797|FG001|STARTED|Overall Study||15
9752253|NCT00324896|10854796|FG000|COMPLETED|Overall Study||12
9752254|NCT00324896|10854797|FG001|COMPLETED|Overall Study||7
9752255|NCT00324896|10854796|FG000|NOT COMPLETED|Overall Study||3
9752256|NCT00324896|10854797|FG001|NOT COMPLETED|Overall Study||8
9752257|NCT00324961|10854803|FG000|STARTED|Overall Study||533
9752258|NCT00324961|10854803|FG000|COMPLETED|Overall Study||490
9752259|NCT00324961|10854803|FG000|NOT COMPLETED|Overall Study||43
9752260|NCT00324987|10854811|FG000|STARTED|Overall Study||6
9752261|NCT00324987|10854812|FG001|STARTED|Overall Study||6
9752262|NCT00324987|10854811|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0
9752263|NCT00324987|10854812|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0
9752264|NCT00324987|10854811|FG000|NOT COMPLETED|Overall Study||6
9752265|NCT00324987|10854812|FG001|NOT COMPLETED|Overall Study||6
9752266|NCT00325039|10854820|FG000|STARTED|Overall Study||298
9752267|NCT00325039|10854821|FG001|STARTED|Overall Study||299
9752268|NCT00325039|10854820|FG000|COMPLETED|Overall Study||280
9752269|NCT00325039|10854821|FG001|COMPLETED|Overall Study||285
9752270|NCT00325039|10854820|FG000|NOT COMPLETED|Overall Study||18
9752271|NCT00325039|10854821|FG001|NOT COMPLETED|Overall Study||14
9853950|NCT00890201|10966929|FG001|NOT COMPLETED|Overall Study||56
9853951|NCT00890396|10966937|FG000|STARTED|Overall Study||127
9853952|NCT00890396|10966938|FG001|STARTED|Overall Study||36
9853953|NCT00890396|10966937|FG000|COMPLETED|Overall Study||122
9853954|NCT00890396|10966938|FG001|COMPLETED|Overall Study||34
9853955|NCT00890396|10966937|FG000|NOT COMPLETED|Overall Study||5
9853956|NCT00890396|10966938|FG001|NOT COMPLETED|Overall Study||2
9853957|NCT00890552|10966947|FG000|STARTED|Enrollment and Pre-treatment||25
9853958|NCT00890552|10966947|FG000|COMPLETED|Enrollment and Pre-treatment||24
9853959|NCT00890552|10966947|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1
9853960|NCT00890552|10966947|FG000|STARTED|On-treatment||24
9853961|NCT00890552|10966947|FG000|COMPLETED|On-treatment||14
9853962|NCT00890552|10966947|FG000|NOT COMPLETED|On-treatment||10
9853963|NCT00890617|10966951|FG000|STARTED|Overall Study||9
9853964|NCT00890617|10966951|FG000|COMPLETED|Overall Study||9
9853965|NCT00890617|10966951|FG000|NOT COMPLETED|Overall Study||0
9853966|NCT00890656|10966955|FG000|STARTED|Overall Study||90
9853967|NCT00890656|10966955|FG000|COMPLETED|Overall Study||90
9853968|NCT00890656|10966955|FG000|NOT COMPLETED|Overall Study||0
9853969|NCT00890682|10966961|FG000|STARTED|Overall Study||97
9853970|NCT00890682|10966962|FG001|STARTED|Overall Study||96
9853971|NCT00890682|10966961|FG000|COMPLETED|Overall Study||93
9853972|NCT00890682|10966962|FG001|COMPLETED|Overall Study||94
9853973|NCT00890682|10966961|FG000|NOT COMPLETED|Overall Study||4
10092303|NCT02335983|11220681|FG004|NOT COMPLETED|Overall Study||8
10092304|NCT02335983|11220682|FG005|NOT COMPLETED|Overall Study||32
10092305|NCT02336074|11220707|FG000|STARTED|Overall Study||30
10092306|NCT02336074|11220708|FG001|STARTED|Overall Study||30
9752272|NCT00325078|10854830|FG000|STARTED|Overall Study||8
9752273|NCT00325078|10854831|FG001|STARTED|Overall Study||7
9752274|NCT00325078|10854832|FG002|STARTED|Overall Study||25
9752275|NCT00325078|10854830|FG000|COMPLETED|Overall Study||3
9752276|NCT00325078|10854831|FG001|COMPLETED|Overall Study||2
9752277|NCT00325078|10854832|FG002|COMPLETED|Overall Study||23
9752278|NCT00325078|10854830|FG000|NOT COMPLETED|Overall Study||5
9752279|NCT00325078|10854831|FG001|NOT COMPLETED|Overall Study||5
9752280|NCT00325078|10854832|FG002|NOT COMPLETED|Overall Study||2
9752281|NCT00325130|10854843|FG000|STARTED|Overall Study||518
9853974|NCT00890682|10966962|FG001|NOT COMPLETED|Overall Study||2
9853975|NCT00890695|10966970|FG000|STARTED|Overall Study||32
9853976|NCT00890695|10966971|FG001|STARTED|Overall Study||33
9853977|NCT00890695|10966970|FG000|COMPLETED|Overall Study||31
9752282|NCT00325130|10854844|FG001|STARTED|Overall Study||524
9752283|NCT00325130|10854843|FG000|COMPLETED|Overall Study||499
9752284|NCT00325130|10854844|FG001|COMPLETED|Overall Study||494
9752285|NCT00325130|10854843|FG000|NOT COMPLETED|Overall Study||19
9853978|NCT00890695|10966971|FG001|COMPLETED|Overall Study||33
10092307|NCT02336074|11220707|FG000|COMPLETED|Overall Study||30
9752286|NCT00325130|10854844|FG001|NOT COMPLETED|Overall Study||30
9752287|NCT00325143|10854850|FG000|STARTED|Overall Study||702
9752288|NCT00325143|10854850|FG000|COMPLETED|Overall Study||676
9752289|NCT00325143|10854850|FG000|NOT COMPLETED|Overall Study||26
9752290|NCT00325156|10854854|FG000|STARTED|Overall Study||2590
9752291|NCT00325156|10854854|FG000|COMPLETED|Overall Study||2478
9752292|NCT00325156|10854854|FG000|NOT COMPLETED|Overall Study||112
9752293|NCT00325195|10854861|FG000|STARTED|Randomized||90
9752294|NCT00325195|10854862|FG001|STARTED|Randomized||89
9752295|NCT00325195|10854863|FG002|STARTED|Randomized||46
9752296|NCT00325195|10854861|FG000|COMPLETED|Randomized||85
9752297|NCT00325195|10854862|FG001|COMPLETED|Randomized||84
9752298|NCT00325195|10854863|FG002|COMPLETED|Randomized||43
9752299|NCT00325195|10854861|FG000|NOT COMPLETED|Randomized||5
9752300|NCT00325195|10854862|FG001|NOT COMPLETED|Randomized||5
9752301|NCT00325195|10854863|FG002|NOT COMPLETED|Randomized||3
9752302|NCT00325195|10854861|FG000|STARTED|Received Intervention: ITT Population||85
9752303|NCT00325195|10854862|FG001|STARTED|Received Intervention: ITT Population||84
9752304|NCT00325195|10854863|FG002|STARTED|Received Intervention: ITT Population||43
9752305|NCT00325195|10854861|FG000|COMPLETED|Received Intervention: ITT Population||59
9752306|NCT00325195|10854862|FG001|COMPLETED|Received Intervention: ITT Population||59
9752307|NCT00325195|10854863|FG002|COMPLETED|Received Intervention: ITT Population||39
9752308|NCT00325195|10854861|FG000|NOT COMPLETED|Received Intervention: ITT Population||26
9752309|NCT00325195|10854862|FG001|NOT COMPLETED|Received Intervention: ITT Population||25
9752310|NCT00325195|10854863|FG002|NOT COMPLETED|Received Intervention: ITT Population||4
9752311|NCT00325234|10854873|FG000|STARTED|Overall Study||69
9752312|NCT00325234|10854874|FG001|STARTED|Overall Study||66
9752313|NCT00325234|10854873|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65
9752314|NCT00325234|10854874|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66
9752315|NCT00325234|10854873|FG000|COMPLETED|Overall Study||0
9752316|NCT00325234|10854874|FG001|COMPLETED|Overall Study||0
9752317|NCT00325234|10854873|FG000|NOT COMPLETED|Overall Study||69
9752318|NCT00325234|10854874|FG001|NOT COMPLETED|Overall Study||66
9752319|NCT00325403|10854884|FG000|STARTED|Overall Study||116
9752320|NCT00325403|10854885|FG001|STARTED|Overall Study||233
9752321|NCT00325403|10854884|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
9752322|NCT00325403|10854885|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
9752323|NCT00325403|10854884|FG000|NOT COMPLETED|Overall Study||18
9752324|NCT00325403|10854885|FG001|NOT COMPLETED|Overall Study||51
9752325|NCT00325416|10854895|FG000|STARTED|Phase I: Dose Escalation||70
9752326|NCT00325416|10854896|FG001|STARTED|Phase I: Dose Escalation||60
9752327|NCT00325416|10854895|FG000|COMPLETED|Phase I: Dose Escalation||48
9752328|NCT00325416|10854896|FG001|COMPLETED|Phase I: Dose Escalation||44
9752329|NCT00325416|10854895|FG000|NOT COMPLETED|Phase I: Dose Escalation||22
9752330|NCT00325416|10854896|FG001|NOT COMPLETED|Phase I: Dose Escalation||16
9752331|NCT00325416|10854895|FG000|STARTED|Phase II: Treatment at MTD||78
9752332|NCT00325416|10854896|FG001|STARTED|Phase II: Treatment at MTD||42
9752333|NCT00325416|10854895|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
9752334|NCT00325416|10854896|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
9752335|NCT00325416|10854895|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40
9752336|NCT00325416|10854896|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8
10092308|NCT02336074|11220708|FG001|COMPLETED|Overall Study||28
10092309|NCT02336074|11220707|FG000|NOT COMPLETED|Overall Study||0
10092310|NCT02336074|11220708|FG001|NOT COMPLETED|Overall Study||2
10092311|NCT02336165|11220724|FG000|STARTED|Overall Study||40
10092312|NCT02336165|11220725|FG001|STARTED|Overall Study||31
10092313|NCT02336165|11220726|FG002|STARTED|Overall Study||33
10092314|NCT02336165|11220727|FG003|STARTED|Overall Study||33
10092315|NCT02336165|11220728|FG004|STARTED|Overall Study||22
10092316|NCT02336165|11220724|FG000|COMPLETED|Overall Study||6
10092317|NCT02336165|11220725|FG001|COMPLETED|Overall Study||6
10092318|NCT02336165|11220726|FG002|COMPLETED|Overall Study||2
10092319|NCT02336165|11220727|FG003|COMPLETED|Overall Study||2
10092320|NCT02336165|11220728|FG004|COMPLETED|Overall Study||0
10092321|NCT02336165|11220724|FG000|NOT COMPLETED|Overall Study||34
10092322|NCT02336165|11220725|FG001|NOT COMPLETED|Overall Study||25
10092323|NCT02336165|11220726|FG002|NOT COMPLETED|Overall Study||31
10092324|NCT02336165|11220727|FG003|NOT COMPLETED|Overall Study||31
10092325|NCT02336165|11220728|FG004|NOT COMPLETED|Overall Study||22
10092326|NCT02336178|11220744|FG000|STARTED|Overall Study||70
10092327|NCT02336178|11220744|FG000|COMPLETED|Overall Study||66
10092328|NCT02336178|11220744|FG000|NOT COMPLETED|Overall Study||4
10092329|NCT02336282|11220756|FG000|STARTED|Overall Study||33
9752337|NCT00325416|10854895|FG000|COMPLETED|Phase II: Treatment at MTD||78
9752338|NCT00325416|10854896|FG001|COMPLETED|Phase II: Treatment at MTD||40
9752339|NCT00325416|10854895|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0
9752340|NCT00325416|10854896|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2
10092330|NCT02336282|11220756|FG000|COMPLETED|Overall Study||28
10092331|NCT02336282|11220756|FG000|NOT COMPLETED|Overall Study||5
10092332|NCT02336360|11220768|FG000|STARTED|Overall Study||6
10092333|NCT02336360|11220768|FG000|COMPLETED|Overall Study||6
10092334|NCT02336360|11220768|FG000|NOT COMPLETED|Overall Study||0
10092335|NCT02336373|11220772|FG000|STARTED|Overall Study||32
10092336|NCT02336373|11220772|FG000|COMPLETED|Overall Study||14
10092337|NCT02336373|11220772|FG000|NOT COMPLETED|Overall Study||18
9752341|NCT00325442|10854904|FG000|STARTED|Overall Study||176
9752342|NCT00325442|10854905|FG001|STARTED|Overall Study||174
9752343|NCT00325442|10854904|FG000|COMPLETED|Overall Study||167
9752344|NCT00325442|10854905|FG001|COMPLETED|Overall Study||153
9752345|NCT00325442|10854904|FG000|NOT COMPLETED|Overall Study||9
9752346|NCT00325442|10854905|FG001|NOT COMPLETED|Overall Study||21
9752347|NCT00325468|10854919|FG000|STARTED|Overall Study||23
9752348|NCT00325468|10854920|FG001|STARTED|Overall Study||17
9752349|NCT00325468|10854921|FG002|STARTED|Overall Study||14
9752350|NCT00325468|10854922|FG003|STARTED|Overall Study||124
9752351|NCT00325468|10854923|FG004|STARTED|Overall Study||22
9752352|NCT00325468|10854919|FG000|COMPLETED|Overall Study||12
9752353|NCT00325468|10854920|FG001|COMPLETED|Overall Study||12
9752354|NCT00325468|10854921|FG002|COMPLETED|Overall Study||10
9752355|NCT00325468|10854922|FG003|COMPLETED|Overall Study||90
9752356|NCT00325468|10854923|FG004|COMPLETED|Overall Study||14
9752357|NCT00325468|10854919|FG000|NOT COMPLETED|Overall Study||11
9752358|NCT00325468|10854920|FG001|NOT COMPLETED|Overall Study||5
9752359|NCT00325468|10854921|FG002|NOT COMPLETED|Overall Study||4
9752360|NCT00325468|10854922|FG003|NOT COMPLETED|Overall Study||34
9752361|NCT00325468|10854923|FG004|NOT COMPLETED|Overall Study||8
9752362|NCT00325598|10854938|FG000|STARTED|Overall Study||50
9752363|NCT00325598|10854939|FG001|STARTED|Overall Study||50
9752364|NCT00325598|10854938|FG000|COMPLETED|Overall Study||50
9752365|NCT00325598|10854939|FG001|COMPLETED|Overall Study||50
9752366|NCT00325598|10854938|FG000|NOT COMPLETED|Overall Study||0
9752367|NCT00325598|10854939|FG001|NOT COMPLETED|Overall Study||0
9752368|NCT00325754|10854949|FG000|STARTED|Overall Study||11
9752369|NCT00325754|10854950|FG001|STARTED|Overall Study||11
9752370|NCT00325754|10854949|FG000|COMPLETED|Overall Study||7
9752371|NCT00325754|10854950|FG001|COMPLETED|Overall Study||10
9752372|NCT00325754|10854949|FG000|NOT COMPLETED|Overall Study||4
9752373|NCT00325754|10854950|FG001|NOT COMPLETED|Overall Study||1
9752374|NCT00325780|10854956|FG000|STARTED|Overall Study||1355
9752375|NCT00325780|10854956|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
9752376|NCT00325780|10854956|FG000|COMPLETED|Overall Study||1200
9752377|NCT00325780|10854956|FG000|NOT COMPLETED|Overall Study||155
9752378|NCT00325819|10854962|FG000|STARTED|Overall Study||185
9752379|NCT00325819|10854963|FG001|STARTED|Overall Study||189
9752380|NCT00325819|10854962|FG000|COMPLETED|Overall Study||176
9752381|NCT00325819|10854963|FG001|COMPLETED|Overall Study||176
9752382|NCT00325819|10854962|FG000|NOT COMPLETED|Overall Study||9
9752383|NCT00325819|10854963|FG001|NOT COMPLETED|Overall Study||13
9752384|NCT00325897|10854973|FG000|STARTED|Overall Study||570
9752385|NCT00325897|10854974|FG001|STARTED|Overall Study||572
9752386|NCT00325897|10854973|FG000|COMPLETED|Overall Study||558
9752387|NCT00325897|10854974|FG001|COMPLETED|Overall Study||559
9752388|NCT00325897|10854973|FG000|NOT COMPLETED|Overall Study||12
9752389|NCT00325897|10854974|FG001|NOT COMPLETED|Overall Study||13
9752390|NCT00326001|10854985|FG000|STARTED|Overall Study||236
9752391|NCT00326001|10854986|FG001|STARTED|Overall Study||227
9752392|NCT00326001|10854985|FG000|COMPLETED|Overall Study||229
9752393|NCT00326001|10854986|FG001|COMPLETED|Overall Study||219
9752394|NCT00326001|10854985|FG000|NOT COMPLETED|Overall Study||7
9752395|NCT00326001|10854986|FG001|NOT COMPLETED|Overall Study||8
9752396|NCT00326118|10854994|FG000|STARTED|Active Phase||324
9752397|NCT00326118|10854995|FG001|STARTED|Active Phase||109
9752398|NCT00326118|10854994|FG000|COMPLETED|Active Phase||320
9752399|NCT00326118|10854995|FG001|COMPLETED|Active Phase||108
9752400|NCT00326118|10854994|FG000|NOT COMPLETED|Active Phase||4
9752401|NCT00326118|10854995|FG001|NOT COMPLETED|Active Phase||1
9752402|NCT00326118|10854994|FG000|STARTED|Year 1 Follow-up||295
9752403|NCT00326118|10854995|FG001|STARTED|Year 1 Follow-up||100
9752404|NCT00326118|10854994|FG000|COMPLETED|Year 1 Follow-up||295
9752405|NCT00326118|10854995|FG001|COMPLETED|Year 1 Follow-up||100
9752406|NCT00326118|10854994|FG000|NOT COMPLETED|Year 1 Follow-up||0
9752407|NCT00326118|10854995|FG001|NOT COMPLETED|Year 1 Follow-up||0
9752408|NCT00326118|10854994|FG000|STARTED|Year 2 Follow-up||270
9752409|NCT00326118|10854995|FG001|STARTED|Year 2 Follow-up||92
9752410|NCT00326118|10854994|FG000|COMPLETED|Year 2 Follow-up||270
9752411|NCT00326118|10854995|FG001|COMPLETED|Year 2 Follow-up||92
9752412|NCT00326118|10854994|FG000|NOT COMPLETED|Year 2 Follow-up||0
9752413|NCT00326118|10854995|FG001|NOT COMPLETED|Year 2 Follow-up||0
9752414|NCT00326118|10854994|FG000|STARTED|Year 3 Follow-up||256
9752415|NCT00326118|10854995|FG001|STARTED|Year 3 Follow-up||89
9752416|NCT00326118|10854994|FG000|COMPLETED|Year 3 Follow-up||256
9752417|NCT00326118|10854995|FG001|COMPLETED|Year 3 Follow-up||89
9752418|NCT00326118|10854994|FG000|NOT COMPLETED|Year 3 Follow-up||0
9752419|NCT00326118|10854995|FG001|NOT COMPLETED|Year 3 Follow-up||0
9752420|NCT00326118|10854994|FG000|STARTED|Year 4 Follow-up||228
9752421|NCT00326118|10854995|FG001|STARTED|Year 4 Follow-up||80
9752422|NCT00326118|10854994|FG000|COMPLETED|Year 4 Follow-up||228
9752423|NCT00326118|10854995|FG001|COMPLETED|Year 4 Follow-up||80
9752424|NCT00326118|10854994|FG000|NOT COMPLETED|Year 4 Follow-up||0
9752425|NCT00326118|10854995|FG001|NOT COMPLETED|Year 4 Follow-up||0
9752426|NCT00326118|10854994|FG000|STARTED|Year 5 Follow up||217
9752427|NCT00326118|10854995|FG001|STARTED|Year 5 Follow up||78
9752428|NCT00326118|10854994|FG000|COMPLETED|Year 5 Follow up||217
10092338|NCT02336438|11220778|FG000|STARTED|Overall Study||11
9752429|NCT00326118|10854995|FG001|COMPLETED|Year 5 Follow up||78
9752430|NCT00326118|10854994|FG000|NOT COMPLETED|Year 5 Follow up||0
9752431|NCT00326118|10854995|FG001|NOT COMPLETED|Year 5 Follow up||0
9752432|NCT00326170|10855002|FG000|STARTED|Overall Study||34
9752433|NCT00326170|10855002|FG000|COMPLETED|Overall Study||34
9752434|NCT00326170|10855002|FG000|NOT COMPLETED|Overall Study||0
9752435|NCT00326196|10855008|FG000|STARTED|Overall Study||101
9752436|NCT00326196|10855009|FG001|STARTED|Overall Study||97
9752437|NCT00326196|10855008|FG000|COMPLETED|Overall Study||101
9752438|NCT00326196|10855009|FG001|COMPLETED|Overall Study||97
9752439|NCT00326196|10855008|FG000|NOT COMPLETED|Overall Study||0
9752440|NCT00326196|10855009|FG001|NOT COMPLETED|Overall Study||0
9752441|NCT00326209|10855015|FG000|STARTED|Overall Study||393
9752442|NCT00326209|10855015|FG000|Safety Population|Overall Study||388
9752443|NCT00326209|10855015|FG000|COMPLETED|Overall Study||111
9752444|NCT00326209|10855015|FG000|NOT COMPLETED|Overall Study||282
9752445|NCT00326417|10855021|FG000|STARTED|Overall Study||14
9752446|NCT00326417|10855022|FG001|STARTED|Overall Study||41
9752447|NCT00326417|10855023|FG002|STARTED|Overall Study||39
9752448|NCT00326417|10855024|FG003|STARTED|Overall Study||3
9752449|NCT00326417|10855021|FG000|Phase I|Overall Study||6
9752450|NCT00326417|10855022|FG001|Phase I|Overall Study||6
9752451|NCT00326417|10855023|FG002|Phase I|Overall Study||6
9752452|NCT00326417|10855024|FG003|Phase I|Overall Study||3
9752453|NCT00326417|10855021|FG000|Phase II|Overall Study||8
9752454|NCT00326417|10855022|FG001|Phase II|Overall Study||35
9752455|NCT00326417|10855023|FG002|Phase II|Overall Study||33
9752456|NCT00326417|10855024|FG003|Phase II|Overall Study||0
9752457|NCT00326417|10855021|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
9752458|NCT00326417|10855022|FG001|COMPLETED|Overall Study||41
9752459|NCT00326417|10855023|FG002|COMPLETED|Overall Study||38
9752460|NCT00326417|10855024|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
9752461|NCT00326417|10855021|FG000|NOT COMPLETED|Overall Study||14
9752462|NCT00326417|10855022|FG001|NOT COMPLETED|Overall Study||0
9752463|NCT00326417|10855023|FG002|NOT COMPLETED|Overall Study||1
9752464|NCT00326417|10855024|FG003|NOT COMPLETED|Overall Study||3
9752465|NCT00326495|10855032|FG000|STARTED|Overall Study||51
9752466|NCT00326495|10855032|FG000|COMPLETED|Overall Study||46
9752467|NCT00326495|10855032|FG000|NOT COMPLETED|Overall Study||5
9752468|NCT00326599|10855040|FG000|STARTED|Overall Study||6
9752469|NCT00326599|10855041|FG001|STARTED|Overall Study||3
9752470|NCT00326599|10855042|FG002|STARTED|Overall Study||58
9752471|NCT00326599|10855043|FG003|STARTED|Overall Study||29
9752472|NCT00326599|10855040|FG000|COMPLETED|Overall Study||0
9752473|NCT00326599|10855041|FG001|COMPLETED|Overall Study||2
9752474|NCT00326599|10855042|FG002|COMPLETED|Overall Study||5
9752475|NCT00326599|10855043|FG003|COMPLETED|Overall Study||10
9752476|NCT00326599|10855040|FG000|NOT COMPLETED|Overall Study||6
9752477|NCT00326599|10855041|FG001|NOT COMPLETED|Overall Study||1
9752478|NCT00326599|10855042|FG002|NOT COMPLETED|Overall Study||53
9752479|NCT00326599|10855043|FG003|NOT COMPLETED|Overall Study||19
9752480|NCT00326612|10855054|FG000|STARTED|Overall Study||179
9752481|NCT00326612|10855055|FG001|STARTED|Overall Study||179
9752482|NCT00326612|10855054|FG000|COMPLETED|Overall Study||50
9752483|NCT00326612|10855055|FG001|COMPLETED|Overall Study||42
9752484|NCT00326612|10855054|FG000|NOT COMPLETED|Overall Study||129
9752485|NCT00326612|10855055|FG001|NOT COMPLETED|Overall Study||137
9752486|NCT00326625|10855067|FG000|STARTED|Overall Study||184
9752487|NCT00326625|10855068|FG001|STARTED|Overall Study||182
9752488|NCT00326625|10855067|FG000|COMPLETED|Overall Study||130
9752489|NCT00326625|10855068|FG001|COMPLETED|Overall Study||144
9752490|NCT00326625|10855067|FG000|NOT COMPLETED|Overall Study||54
9752491|NCT00326625|10855068|FG001|NOT COMPLETED|Overall Study||38
9752492|NCT00326716|10855076|FG000|STARTED|Pre-Natal Mothers||20
9752493|NCT00326716|10855077|FG001|STARTED|Pre-Natal Mothers||21
9752494|NCT00326716|10855078|FG002|STARTED|Pre-Natal Mothers||0
9752495|NCT00326716|10855079|FG003|STARTED|Pre-Natal Mothers||0
9752496|NCT00326716|10855076|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
9752497|NCT00326716|10855077|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
9752498|NCT00326716|10855078|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
9752499|NCT00326716|10855079|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
9752500|NCT00326716|10855076|FG000|NOT COMPLETED|Pre-Natal Mothers||1
9752501|NCT00326716|10855077|FG001|NOT COMPLETED|Pre-Natal Mothers||2
9752502|NCT00326716|10855078|FG002|NOT COMPLETED|Pre-Natal Mothers||0
9752503|NCT00326716|10855079|FG003|NOT COMPLETED|Pre-Natal Mothers||0
9752504|NCT00326716|10855076|FG000|STARTED|Infants||0
9752505|NCT00326716|10855077|FG001|STARTED|Infants||0
9752506|NCT00326716|10855078|FG002|STARTED|Infants|All infants were followed.|20
9752507|NCT00326716|10855079|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
9752508|NCT00326716|10855076|FG000|COMPLETED|Infants||0
9752509|NCT00326716|10855077|FG001|COMPLETED|Infants||0
9752510|NCT00326716|10855078|FG002|COMPLETED|Infants||20
9752511|NCT00326716|10855079|FG003|COMPLETED|Infants||20
9752512|NCT00326716|10855076|FG000|NOT COMPLETED|Infants||0
9752513|NCT00326716|10855077|FG001|NOT COMPLETED|Infants||0
9752514|NCT00326716|10855078|FG002|NOT COMPLETED|Infants||0
9752515|NCT00326716|10855079|FG003|NOT COMPLETED|Infants||0
9752516|NCT00326781|10855111|FG000|STARTED|Overall Study||344
9752517|NCT00326781|10855112|FG001|STARTED|Overall Study||330
9752518|NCT00326781|10855111|FG000|COMPLETED|Overall Study||302
9752519|NCT00326781|10855112|FG001|COMPLETED|Overall Study||298
9752520|NCT00326781|10855111|FG000|NOT COMPLETED|Overall Study||42
9752521|NCT00326781|10855112|FG001|NOT COMPLETED|Overall Study||32
9752522|NCT00326872|10855118|FG000|STARTED|Overall Study||26
9752523|NCT00326872|10855118|FG000|COMPLETED|Overall Study||26
9752524|NCT00326872|10855118|FG000|NOT COMPLETED|Overall Study||0
9752525|NCT00326885|10855122|FG000|STARTED|Overall Study||32
9752526|NCT00326885|10855122|FG000|COMPLETED|Overall Study||25
9752527|NCT00326885|10855122|FG000|NOT COMPLETED|Overall Study||7
9752528|NCT00326911|10855129|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30
9752529|NCT00326911|10855130|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31
9752530|NCT00326911|10855129|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29
9752531|NCT00326911|10855130|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29
9752532|NCT00326911|10855129|FG000|NOT COMPLETED|Overall Study||1
9752533|NCT00326911|10855130|FG001|NOT COMPLETED|Overall Study||2
9752534|NCT00326924|10855138|FG000|STARTED|Overall Study||188
9752535|NCT00326924|10855139|FG001|STARTED|Overall Study||189
9752536|NCT00326924|10855138|FG000|COMPLETED|Overall Study||187
9752537|NCT00326924|10855139|FG001|COMPLETED|Overall Study||188
9752538|NCT00326924|10855138|FG000|NOT COMPLETED|Overall Study||1
9752539|NCT00326924|10855139|FG001|NOT COMPLETED|Overall Study||1
9752540|NCT00326950|10855145|FG000|STARTED|Overall Study||15
9752541|NCT00326950|10855145|FG000|COMPLETED|Overall Study||14
9752542|NCT00326950|10855145|FG000|NOT COMPLETED|Overall Study||1
9752543|NCT00326963|10855149|FG000|STARTED|Overall Study||140
9752544|NCT00326963|10855149|FG000|COMPLETED|Overall Study||107
9752545|NCT00326963|10855149|FG000|NOT COMPLETED|Overall Study||33
9752546|NCT00327015|10855158|FG000|STARTED|Overall Study||320
9752547|NCT00327015|10855159|FG001|STARTED|Overall Study||323
9752548|NCT00327015|10855160|FG002|STARTED|Overall Study||335
9752549|NCT00327015|10855161|FG003|STARTED|Overall Study||328
9752550|NCT00327015|10855158|FG000|Completed Study Without Being Rescued|Overall Study||179
9752551|NCT00327015|10855159|FG001|Completed Study Without Being Rescued|Overall Study||177
9752552|NCT00327015|10855160|FG002|Completed Study Without Being Rescued|Overall Study||113
9752553|NCT00327015|10855161|FG003|Completed Study Without Being Rescued|Overall Study||144
9752554|NCT00327015|10855158|FG000|COMPLETED|Overall Study||229
9752555|NCT00327015|10855159|FG001|COMPLETED|Overall Study||231
9752556|NCT00327015|10855160|FG002|COMPLETED|Overall Study||209
9752557|NCT00327015|10855161|FG003|COMPLETED|Overall Study||219
9752558|NCT00327015|10855158|FG000|NOT COMPLETED|Overall Study||91
9752559|NCT00327015|10855159|FG001|NOT COMPLETED|Overall Study||92
9752560|NCT00327015|10855160|FG002|NOT COMPLETED|Overall Study||126
9752561|NCT00327015|10855161|FG003|NOT COMPLETED|Overall Study||109
9752562|NCT00327171|10855173|FG000|STARTED|Overall Study||109
9752563|NCT00327171|10855174|FG001|STARTED|Overall Study||109
9752564|NCT00327171|10855173|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
9752565|NCT00327171|10855174|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
9752566|NCT00327171|10855173|FG000|NOT COMPLETED|Overall Study||108
9752567|NCT00327171|10855174|FG001|NOT COMPLETED|Overall Study||109
9752568|NCT00327340|10855182|FG000|STARTED|Overall Study||23
9752569|NCT00327340|10855183|FG001|STARTED|Overall Study||46
9752570|NCT00327340|10855182|FG000|COMPLETED|Overall Study||8
9752571|NCT00327340|10855183|FG001|COMPLETED|Overall Study||16
9752572|NCT00327340|10855182|FG000|NOT COMPLETED|Overall Study||15
9752573|NCT00327340|10855183|FG001|NOT COMPLETED|Overall Study||30
9752574|NCT00327392|10855191|FG000|STARTED|Overall Study||123
9752575|NCT00327392|10855191|FG000|COMPLETED|Overall Study||123
9752576|NCT00327392|10855191|FG000|NOT COMPLETED|Overall Study||0
9752577|NCT00327444|10855197|FG000|STARTED|Double Blind Treatment (DB) Period||26
9752578|NCT00327444|10855198|FG001|STARTED|Double Blind Treatment (DB) Period||29
9752579|NCT00327444|10855197|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
9752580|NCT00327444|10855198|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
9752581|NCT00327444|10855197|FG000|COMPLETED|Double Blind Treatment (DB) Period||0
9752582|NCT00327444|10855198|FG001|COMPLETED|Double Blind Treatment (DB) Period||0
9752583|NCT00327444|10855197|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26
9752584|NCT00327444|10855198|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29
9752585|NCT00327444|10855197|FG000|STARTED|Open Label Treatment (OL) Period||11
9752586|NCT00327444|10855198|FG001|STARTED|Open Label Treatment (OL) Period||10
9752587|NCT00327444|10855197|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
9752588|NCT00327444|10855198|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
9752589|NCT00327444|10855197|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
9752590|NCT00327444|10855198|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
9752591|NCT00327444|10855197|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11
9752592|NCT00327444|10855198|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10
9752593|NCT00327470|10855208|FG000|STARTED|Overall Study||107
9752594|NCT00327470|10855209|FG001|STARTED|Overall Study||181
9752595|NCT00327470|10855208|FG000|Treated|Overall Study||107
9752596|NCT00327470|10855209|FG001|Treated|Overall Study||179
9752597|NCT00327470|10855208|FG000|COMPLETED|Overall Study||78
9752598|NCT00327470|10855209|FG001|COMPLETED|Overall Study||118
9752599|NCT00327470|10855208|FG000|NOT COMPLETED|Overall Study||29
9752600|NCT00327470|10855209|FG001|NOT COMPLETED|Overall Study||63
9752601|NCT00327717|10855217|FG000|STARTED|Overall Study||120
9752602|NCT00327717|10855218|FG001|STARTED|Overall Study||120
9752603|NCT00327717|10855217|FG000|COMPLETED|Overall Study||111
9752604|NCT00327717|10855218|FG001|COMPLETED|Overall Study||106
9752605|NCT00327717|10855217|FG000|NOT COMPLETED|Overall Study||9
9752606|NCT00327717|10855218|FG001|NOT COMPLETED|Overall Study||14
9752607|NCT00328016|10855226|FG000|STARTED|Overall Study||23
9752608|NCT00328016|10855227|FG001|STARTED|Overall Study||21
9752609|NCT00328016|10855226|FG000|COMPLETED|Overall Study||23
9752610|NCT00328016|10855227|FG001|COMPLETED|Overall Study||21
9752611|NCT00328016|10855226|FG000|NOT COMPLETED|Overall Study||0
9752612|NCT00328016|10855227|FG001|NOT COMPLETED|Overall Study||0
9752613|NCT00328042|10855236|FG000|STARTED|Overall Study||69
9752614|NCT00328042|10855237|FG001|STARTED|Overall Study||65
9752615|NCT00328042|10855236|FG000|COMPLETED|Overall Study||69
9752616|NCT00328042|10855237|FG001|COMPLETED|Overall Study||63
9752617|NCT00328042|10855236|FG000|NOT COMPLETED|Overall Study||0
9752618|NCT00328042|10855237|FG001|NOT COMPLETED|Overall Study||2
9752619|NCT00328094|10855247|FG000|STARTED|Overall Study||117
9752620|NCT00328094|10855248|FG001|STARTED|Overall Study||125
9752621|NCT00328094|10855247|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
9752622|NCT00328094|10855248|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
9752623|NCT00328094|10855247|FG000|NOT COMPLETED|Overall Study||3
9752624|NCT00328094|10855248|FG001|NOT COMPLETED|Overall Study||3
9752625|NCT00328172|10855259|FG000|STARTED|Overall Study||67
9752626|NCT00328172|10855260|FG001|STARTED|Overall Study||58
9752627|NCT00328172|10855261|FG002|STARTED|Overall Study||57
9752628|NCT00328172|10855262|FG003|STARTED|Overall Study||55
9752629|NCT00328172|10855263|FG004|STARTED|Overall Study||65
9752630|NCT00328172|10855259|FG000|COMPLETED|Overall Study||45
9752631|NCT00328172|10855260|FG001|COMPLETED|Overall Study||44
9752632|NCT00328172|10855261|FG002|COMPLETED|Overall Study||47
9752633|NCT00328172|10855262|FG003|COMPLETED|Overall Study||42
9752634|NCT00328172|10855263|FG004|COMPLETED|Overall Study||60
9752635|NCT00328172|10855259|FG000|NOT COMPLETED|Overall Study||22
9752636|NCT00328172|10855260|FG001|NOT COMPLETED|Overall Study||14
9752637|NCT00328172|10855261|FG002|NOT COMPLETED|Overall Study||10
9752638|NCT00328172|10855262|FG003|NOT COMPLETED|Overall Study||13
9752639|NCT00328172|10855263|FG004|NOT COMPLETED|Overall Study||5
9752640|NCT00328198|10855275|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
9752641|NCT00328198|10855275|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
9752642|NCT00328198|10855275|FG000|NOT COMPLETED|Treatment||38
9752643|NCT00328198|10855275|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78
9752644|NCT00328198|10855275|FG000|COMPLETED|Follow-up||43
9752645|NCT00328198|10855275|FG000|NOT COMPLETED|Follow-up||35
9752646|NCT00328263|10855281|FG000|STARTED|Overall Study||216
9752647|NCT00328263|10855282|FG001|STARTED|Overall Study||221
9752648|NCT00328263|10855281|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
9752649|NCT00328263|10855282|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
9752650|NCT00328263|10855281|FG000|NOT COMPLETED|Overall Study||3
9752651|NCT00328263|10855282|FG001|NOT COMPLETED|Overall Study||4
9752652|NCT00328510|10855290|FG000|STARTED|Overall Study||42
9752653|NCT00328510|10855291|FG001|STARTED|Overall Study||41
9752654|NCT00328510|10855290|FG000|COMPLETED|Overall Study||32
9752655|NCT00328510|10855291|FG001|COMPLETED|Overall Study||37
9752656|NCT00328510|10855290|FG000|NOT COMPLETED|Overall Study||10
9752657|NCT00328510|10855291|FG001|NOT COMPLETED|Overall Study||4
9752658|NCT00328562|10855297|FG000|STARTED|Overall Study||13
9752659|NCT00328562|10855297|FG000|COMPLETED|Overall Study||12
9752660|NCT00328562|10855297|FG000|NOT COMPLETED|Overall Study||1
9752661|NCT00328614|10855307|FG000|STARTED|Overall Study||4
9752662|NCT00328614|10855308|FG001|STARTED|Overall Study||4
9752663|NCT00328614|10855309|FG002|STARTED|Overall Study||6
9752664|NCT00328614|10855310|FG003|STARTED|Overall Study||6
9752665|NCT00328614|10855311|FG004|STARTED|Overall Study||6
9752666|NCT00328614|10855312|FG005|STARTED|Overall Study||6
9752667|NCT00328614|10855307|FG000|COMPLETED|Overall Study||4
9752668|NCT00328614|10855308|FG001|COMPLETED|Overall Study||4
9752669|NCT00328614|10855309|FG002|COMPLETED|Overall Study||6
9752670|NCT00328614|10855310|FG003|COMPLETED|Overall Study||5
9752671|NCT00328614|10855311|FG004|COMPLETED|Overall Study||5
9752672|NCT00328614|10855312|FG005|COMPLETED|Overall Study||5
9853979|NCT00890695|10966970|FG000|NOT COMPLETED|Overall Study||1
9853980|NCT00890695|10966971|FG001|NOT COMPLETED|Overall Study||0
9853981|NCT00890721|10966979|FG000|STARTED|Overall Study||95
9853982|NCT00890721|10966980|FG001|STARTED|Overall Study||94
9752673|NCT00328614|10855307|FG000|NOT COMPLETED|Overall Study||0
9752674|NCT00328614|10855308|FG001|NOT COMPLETED|Overall Study||0
9752675|NCT00328614|10855309|FG002|NOT COMPLETED|Overall Study||0
9752676|NCT00328614|10855310|FG003|NOT COMPLETED|Overall Study||1
9752677|NCT00328614|10855311|FG004|NOT COMPLETED|Overall Study||1
9752678|NCT00328614|10855312|FG005|NOT COMPLETED|Overall Study||1
9853983|NCT00890721|10966979|FG000|COMPLETED|Overall Study||94
9853984|NCT00890721|10966980|FG001|COMPLETED|Overall Study||93
9853985|NCT00890721|10966979|FG000|NOT COMPLETED|Overall Study||1
9752679|NCT00328627|10855333|FG000|STARTED|Overall Study||129
9752680|NCT00328627|10855334|FG001|STARTED|Overall Study||128
9752681|NCT00328627|10855335|FG002|STARTED|Overall Study||129
9752682|NCT00328627|10855336|FG003|STARTED|Overall Study||130
9752683|NCT00328627|10855337|FG004|STARTED|Overall Study||130
9752684|NCT00328627|10855338|FG005|STARTED|Overall Study||130
9752685|NCT00328627|10855339|FG006|STARTED|Overall Study||129
9752686|NCT00328627|10855340|FG007|STARTED|Overall Study||130
9752687|NCT00328627|10855341|FG008|STARTED|Overall Study||130
9752688|NCT00328627|10855342|FG009|STARTED|Overall Study||129
9752689|NCT00328627|10855343|FG010|STARTED|Overall Study||130
9752690|NCT00328627|10855344|FG011|STARTED|Overall Study||130
9752691|NCT00328627|10855333|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
9752692|NCT00328627|10855334|FG001|Safety Set|Overall Study||128
9752693|NCT00328627|10855335|FG002|Safety Set|Overall Study||129
9752694|NCT00328627|10855336|FG003|Safety Set|Overall Study||129
9752695|NCT00328627|10855337|FG004|Safety Set|Overall Study||130
9752696|NCT00328627|10855338|FG005|Safety Set|Overall Study||130
9752697|NCT00328627|10855339|FG006|Safety Set|Overall Study||129
9752698|NCT00328627|10855340|FG007|Safety Set|Overall Study||130
9752699|NCT00328627|10855341|FG008|Safety Set|Overall Study||130
9752700|NCT00328627|10855342|FG009|Safety Set|Overall Study||129
9752701|NCT00328627|10855343|FG010|Safety Set|Overall Study||130
9752702|NCT00328627|10855344|FG011|Safety Set|Overall Study||130
9752703|NCT00328627|10855333|FG000|COMPLETED|Overall Study||70
9752704|NCT00328627|10855334|FG001|COMPLETED|Overall Study||97
9752705|NCT00328627|10855335|FG002|COMPLETED|Overall Study||101
9752706|NCT00328627|10855336|FG003|COMPLETED|Overall Study||93
9752707|NCT00328627|10855337|FG004|COMPLETED|Overall Study||115
9752708|NCT00328627|10855338|FG005|COMPLETED|Overall Study||110
9752709|NCT00328627|10855339|FG006|COMPLETED|Overall Study||94
9752710|NCT00328627|10855340|FG007|COMPLETED|Overall Study||116
9752711|NCT00328627|10855341|FG008|COMPLETED|Overall Study||113
9752712|NCT00328627|10855342|FG009|COMPLETED|Overall Study||97
9752713|NCT00328627|10855343|FG010|COMPLETED|Overall Study||112
9752714|NCT00328627|10855344|FG011|COMPLETED|Overall Study||114
9752715|NCT00328627|10855333|FG000|NOT COMPLETED|Overall Study||59
9752716|NCT00328627|10855334|FG001|NOT COMPLETED|Overall Study||31
9752717|NCT00328627|10855335|FG002|NOT COMPLETED|Overall Study||28
9752718|NCT00328627|10855336|FG003|NOT COMPLETED|Overall Study||37
9752719|NCT00328627|10855337|FG004|NOT COMPLETED|Overall Study||15
9752720|NCT00328627|10855338|FG005|NOT COMPLETED|Overall Study||20
9752721|NCT00328627|10855339|FG006|NOT COMPLETED|Overall Study||35
9752722|NCT00328627|10855340|FG007|NOT COMPLETED|Overall Study||14
9752723|NCT00328627|10855341|FG008|NOT COMPLETED|Overall Study||17
9752724|NCT00328627|10855342|FG009|NOT COMPLETED|Overall Study||32
9752725|NCT00328627|10855343|FG010|NOT COMPLETED|Overall Study||18
9752726|NCT00328627|10855344|FG011|NOT COMPLETED|Overall Study||16
9752727|NCT00328770|10855378|FG000|STARTED|Overall Study||70
9752728|NCT00328770|10855378|FG000|COMPLETED|Overall Study||70
9752729|NCT00328770|10855378|FG000|NOT COMPLETED|Overall Study||0
9752730|NCT00328783|10855383|FG000|STARTED|Overall Study||112
9752731|NCT00328783|10855383|FG000|COMPLETED|Overall Study||86
9752732|NCT00328783|10855383|FG000|NOT COMPLETED|Overall Study||26
9752733|NCT00328861|10855391|FG000|STARTED|Overall Study||7
9752734|NCT00328861|10855392|FG001|STARTED|Overall Study||1
9752735|NCT00328861|10855391|FG000|COMPLETED|Overall Study||7
9752736|NCT00328861|10855392|FG001|COMPLETED|Overall Study||1
9752737|NCT00328861|10855391|FG000|NOT COMPLETED|Overall Study||0
9752738|NCT00328861|10855392|FG001|NOT COMPLETED|Overall Study||0
9752739|NCT00328926|10855401|FG000|STARTED|Overall Study||5
9752740|NCT00328926|10855402|FG001|STARTED|Overall Study||3
9752741|NCT00328926|10855403|FG002|STARTED|Overall Study||3
9752742|NCT00328926|10855401|FG000|COMPLETED|Overall Study||3
9752743|NCT00328926|10855402|FG001|COMPLETED|Overall Study||0
9752744|NCT00328926|10855403|FG002|COMPLETED|Overall Study||1
9752745|NCT00328926|10855401|FG000|NOT COMPLETED|Overall Study||2
9752746|NCT00328926|10855402|FG001|NOT COMPLETED|Overall Study||3
9752747|NCT00328926|10855403|FG002|NOT COMPLETED|Overall Study||2
9752748|NCT00329030|10855413|FG000|STARTED|Overall Study||111
9752749|NCT00329030|10855414|FG001|STARTED|Overall Study||113
9752750|NCT00329030|10855413|FG000|COMPLETED|Overall Study||103
9752751|NCT00329030|10855414|FG001|COMPLETED|Overall Study||107
9752752|NCT00329030|10855413|FG000|NOT COMPLETED|Overall Study||8
9752753|NCT00329030|10855414|FG001|NOT COMPLETED|Overall Study||6
9752754|NCT00329160|10855420|FG000|STARTED|Overall Study||214
9752755|NCT00329160|10855420|FG000|Observation Period|Overall Study||214
9752756|NCT00329160|10855420|FG000|Treatment Period|Overall Study||214
9752757|NCT00329160|10855420|FG000|COMPLETED|Overall Study||126
9752758|NCT00329160|10855420|FG000|NOT COMPLETED|Overall Study||88
9752759|NCT00329238|10855426|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
9752760|NCT00329238|10855427|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
9752761|NCT00329238|10855426|FG000|COMPLETED|Overall Study||1154
9752762|NCT00329238|10855427|FG001|COMPLETED|Overall Study||1145
9752763|NCT00329238|10855426|FG000|NOT COMPLETED|Overall Study||276
9752764|NCT00329238|10855427|FG001|NOT COMPLETED|Overall Study||281
9752765|NCT00329303|10855437|FG000|STARTED|Overall Study||34
9752766|NCT00329303|10855438|FG001|STARTED|Overall Study||37
9752767|NCT00329303|10855437|FG000|COMPLETED|Overall Study||32
9752768|NCT00329303|10855438|FG001|COMPLETED|Overall Study||35
9752769|NCT00329303|10855437|FG000|NOT COMPLETED|Overall Study||2
9752770|NCT00329303|10855438|FG001|NOT COMPLETED|Overall Study||2
9752771|NCT00329407|10855445|FG000|STARTED|Overall Study||10
9752772|NCT00329407|10855445|FG000|COMPLETED|Overall Study||9
9752773|NCT00329407|10855445|FG000|NOT COMPLETED|Overall Study||1
9752774|NCT00329420|10855452|FG000|STARTED|Re-induction Phase||18
9752775|NCT00329420|10855453|FG001|STARTED|Re-induction Phase||13
9752776|NCT00329420|10855454|FG002|STARTED|Re-induction Phase||15
9752777|NCT00329420|10855452|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
9752778|NCT00329420|10855453|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
9752779|NCT00329420|10855454|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
9752780|NCT00329420|10855452|FG000|NOT COMPLETED|Re-induction Phase||6
9752781|NCT00329420|10855453|FG001|NOT COMPLETED|Re-induction Phase||6
9752782|NCT00329420|10855454|FG002|NOT COMPLETED|Re-induction Phase||8
9752783|NCT00329420|10855452|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12
9752784|NCT00329420|10855453|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7
9752785|NCT00329420|10855454|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7
9752786|NCT00329420|10855452|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
9752787|NCT00329420|10855453|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
9752788|NCT00329420|10855454|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
9752789|NCT00329420|10855452|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
9752790|NCT00329420|10855453|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
9752791|NCT00329420|10855454|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
9752792|NCT00329433|10855466|FG000|STARTED|Overall Study||61
9752793|NCT00329433|10855467|FG001|STARTED|Overall Study||59
9752794|NCT00329433|10855466|FG000|COMPLETED|Overall Study||61
9752795|NCT00329433|10855467|FG001|COMPLETED|Overall Study||59
9752796|NCT00329433|10855466|FG000|NOT COMPLETED|Overall Study||0
9752797|NCT00329433|10855467|FG001|NOT COMPLETED|Overall Study||0
9752798|NCT00329524|10855473|FG000|STARTED|Overall Study||5
9752799|NCT00329524|10855473|FG000|COMPLETED|Overall Study||5
9752800|NCT00329524|10855473|FG000|NOT COMPLETED|Overall Study||0
9752801|NCT00329550|10855480|FG000|STARTED|Overall Study||9
9752802|NCT00329550|10855481|FG001|STARTED|Overall Study||15
9752803|NCT00329550|10855482|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
9752804|NCT00329550|10855480|FG000|COMPLETED|Overall Study||5
9752805|NCT00329550|10855481|FG001|COMPLETED|Overall Study||11
9752806|NCT00329550|10855482|FG002|COMPLETED|Overall Study||12
9752807|NCT00329550|10855480|FG000|NOT COMPLETED|Overall Study||4
9752808|NCT00329550|10855481|FG001|NOT COMPLETED|Overall Study||4
9752809|NCT00329550|10855482|FG002|NOT COMPLETED|Overall Study||4
9752810|NCT00329602|10855494|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
9752811|NCT00329602|10855495|FG001|STARTED|26-Week Double-Blind Treatment Phase||197
9752812|NCT00329602|10855496|FG002|STARTED|26-Week Double-Blind Treatment Phase||0
9752813|NCT00329602|10855494|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88
9752814|NCT00329602|10855495|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98
9752815|NCT00329602|10855496|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0
9752816|NCT00329602|10855494|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
9752817|NCT00329602|10855495|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
9752818|NCT00329602|10855496|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
9752819|NCT00329602|10855494|FG000|STARTED|40-Week Open-Label Treatment Phase||0
9752820|NCT00329602|10855495|FG001|STARTED|40-Week Open-Label Treatment Phase||0
9752821|NCT00329602|10855496|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
9752822|NCT00329602|10855494|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0
9752823|NCT00329602|10855495|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0
9752824|NCT00329602|10855496|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233
9752825|NCT00329602|10855494|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
9752826|NCT00329602|10855495|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
9752827|NCT00329602|10855496|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
9752828|NCT00329641|10855512|FG000|STARTED|Overall Study||25
9752829|NCT00329641|10855512|FG000|Eligible|Overall Study||25
9752830|NCT00329641|10855512|FG000|Eligible and Received Treatment|Overall Study||24
9752831|NCT00329641|10855512|FG000|COMPLETED|Overall Study||19
9752832|NCT00329641|10855512|FG000|NOT COMPLETED|Overall Study||6
9752833|NCT00329719|10855521|FG000|STARTED|Overall Study||12
9752834|NCT00329719|10855522|FG001|STARTED|Overall Study||49
9752835|NCT00329719|10855523|FG002|STARTED|Overall Study||9
9752836|NCT00329719|10855524|FG003|STARTED|Overall Study||45
9752837|NCT00329719|10855521|FG000|COMPLETED|Overall Study||12
9752838|NCT00329719|10855522|FG001|COMPLETED|Overall Study||49
9752839|NCT00329719|10855523|FG002|COMPLETED|Overall Study||9
9752840|NCT00329719|10855524|FG003|COMPLETED|Overall Study||44
9752841|NCT00329719|10855521|FG000|NOT COMPLETED|Overall Study||0
9752842|NCT00329719|10855522|FG001|NOT COMPLETED|Overall Study||0
9752843|NCT00329719|10855523|FG002|NOT COMPLETED|Overall Study||0
9752844|NCT00329719|10855524|FG003|NOT COMPLETED|Overall Study||1
9752845|NCT00329745|10855536|FG000|STARTED|Overall Study||4359
9752846|NCT00329745|10855537|FG001|STARTED|Overall Study||4328
9752847|NCT00329745|10855536|FG000|COMPLETED|Overall Study||4272
9752848|NCT00329745|10855537|FG001|COMPLETED|Overall Study||4226
9752849|NCT00329745|10855536|FG000|NOT COMPLETED|Overall Study||87
9752850|NCT00329745|10855537|FG001|NOT COMPLETED|Overall Study||102
9752851|NCT00329771|10855543|FG000|STARTED|Overall Study||28
9752852|NCT00329771|10855543|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
9752853|NCT00329771|10855543|FG000|NOT COMPLETED|Overall Study||3
9752854|NCT00329784|10855551|FG000|STARTED|Overall Study||270
9752855|NCT00329784|10855552|FG001|STARTED|Overall Study||272
9752856|NCT00329784|10855553|FG002|STARTED|Overall Study||51
9752857|NCT00329784|10855554|FG003|STARTED|Overall Study||47
9752858|NCT00329784|10855551|FG000|COMPLETED|Overall Study||265
9752859|NCT00329784|10855552|FG001|COMPLETED|Overall Study||267
9752860|NCT00329784|10855553|FG002|COMPLETED|Overall Study||51
9752861|NCT00329784|10855554|FG003|COMPLETED|Overall Study||47
9752862|NCT00329784|10855551|FG000|NOT COMPLETED|Overall Study||5
9752863|NCT00329784|10855552|FG001|NOT COMPLETED|Overall Study||5
9752864|NCT00329784|10855553|FG002|NOT COMPLETED|Overall Study||0
9752865|NCT00329784|10855554|FG003|NOT COMPLETED|Overall Study||0
9752866|NCT00329797|10855568|FG000|STARTED|Overall Study||57
9752867|NCT00329797|10855569|FG001|STARTED|Overall Study||52
9752868|NCT00329797|10855568|FG000|COMPLETED|Overall Study||50
9752869|NCT00329797|10855569|FG001|COMPLETED|Overall Study||46
9752870|NCT00329797|10855568|FG000|NOT COMPLETED|Overall Study||7
9752871|NCT00329797|10855569|FG001|NOT COMPLETED|Overall Study||6
9752872|NCT00329836|10855575|FG000|STARTED|Overall Study||41
9752873|NCT00329836|10855575|FG000|COMPLETED|Overall Study||41
9752874|NCT00329836|10855575|FG000|NOT COMPLETED|Overall Study||0
9752875|NCT00329849|10855581|FG000|STARTED|Overall Study||950
9752876|NCT00329849|10855582|FG001|STARTED|Overall Study||550
9752877|NCT00329849|10855581|FG000|COMPLETED|Overall Study||944
9752878|NCT00329849|10855582|FG001|COMPLETED|Overall Study||546
9752879|NCT00329849|10855581|FG000|NOT COMPLETED|Overall Study||6
9752880|NCT00329849|10855582|FG001|NOT COMPLETED|Overall Study||4
9752881|NCT00329901|10855595|FG000|STARTED|Overall Study||361
9752882|NCT00329901|10855596|FG001|STARTED|Overall Study||354
9752883|NCT00329901|10855597|FG002|STARTED|Overall Study||357
9752884|NCT00329901|10855595|FG000|COMPLETED|Overall Study||352
9752885|NCT00329901|10855596|FG001|COMPLETED|Overall Study||349
9752886|NCT00329901|10855597|FG002|COMPLETED|Overall Study||353
9752887|NCT00329901|10855595|FG000|NOT COMPLETED|Overall Study||9
9752888|NCT00329901|10855596|FG001|NOT COMPLETED|Overall Study||5
9752889|NCT00329901|10855597|FG002|NOT COMPLETED|Overall Study||4
9752890|NCT00330161|10855609|FG000|STARTED|Overall Study||29
9752891|NCT00330161|10855609|FG000|COMPLETED|Overall Study||29
9752892|NCT00330161|10855609|FG000|NOT COMPLETED|Overall Study||0
9752893|NCT00330174|10855615|FG000|STARTED|Overall Study||45
9752894|NCT00330174|10855616|FG001|STARTED|Overall Study||45
9752895|NCT00330174|10855615|FG000|COMPLETED|Overall Study||23
9752896|NCT00330174|10855616|FG001|COMPLETED|Overall Study||26
9752897|NCT00330174|10855615|FG000|NOT COMPLETED|Overall Study||22
9752898|NCT00330174|10855616|FG001|NOT COMPLETED|Overall Study||19
9752899|NCT00330187|10855626|FG000|STARTED|Overall Study||37
9752900|NCT00330187|10855627|FG001|STARTED|Overall Study||36
9752901|NCT00330187|10855628|FG002|STARTED|Overall Study||29
9752902|NCT00330187|10855629|FG003|STARTED|Overall Study||32
9752903|NCT00330187|10855626|FG000|COMPLETED|Overall Study||17
9752904|NCT00330187|10855627|FG001|COMPLETED|Overall Study||18
9752905|NCT00330187|10855628|FG002|COMPLETED|Overall Study||11
9752906|NCT00330187|10855629|FG003|COMPLETED|Overall Study||18
9752907|NCT00330187|10855626|FG000|NOT COMPLETED|Overall Study||20
9752908|NCT00330187|10855627|FG001|NOT COMPLETED|Overall Study||18
9752909|NCT00330187|10855628|FG002|NOT COMPLETED|Overall Study||18
9752910|NCT00330187|10855629|FG003|NOT COMPLETED|Overall Study||14
9752911|NCT00330343|10855639|FG000|STARTED|Overall Study||64
9752912|NCT00330343|10855639|FG000|COMPLETED|Overall Study||59
9752913|NCT00330343|10855639|FG000|NOT COMPLETED|Overall Study||5
9752914|NCT00330382|10855645|FG000|STARTED|Overall Study||67
9752915|NCT00330382|10855646|FG001|STARTED|Overall Study||65
9752916|NCT00330382|10855645|FG000|COMPLETED|Overall Study||43
9752917|NCT00330382|10855646|FG001|COMPLETED|Overall Study||48
9752918|NCT00330382|10855645|FG000|NOT COMPLETED|Overall Study||24
9752919|NCT00330382|10855646|FG001|NOT COMPLETED|Overall Study||17
9752920|NCT00330421|10855653|FG000|STARTED|Overall Study||15
9752921|NCT00330421|10855654|FG001|STARTED|Overall Study||0
9752922|NCT00330421|10855653|FG000|COMPLETED|Overall Study||15
9752923|NCT00330421|10855654|FG001|COMPLETED|Overall Study||0
9752924|NCT00330421|10855653|FG000|NOT COMPLETED|Overall Study||0
9752925|NCT00330421|10855654|FG001|NOT COMPLETED|Overall Study||0
9752926|NCT00330460|10855660|FG000|STARTED|Overall Study||595
9752927|NCT00330460|10855661|FG001|STARTED|Overall Study||594
9752928|NCT00330460|10855660|FG000|COMPLETED|Overall Study||553
9752929|NCT00330460|10855661|FG001|COMPLETED|Overall Study||561
9752930|NCT00330460|10855660|FG000|NOT COMPLETED|Overall Study||42
9752931|NCT00330460|10855661|FG001|NOT COMPLETED|Overall Study||33
9752932|NCT00330551|10855669|FG000|STARTED|Overall Study||40
9752933|NCT00330551|10855670|FG001|STARTED|Overall Study||43
9752934|NCT00330551|10855669|FG000|COMPLETED|Overall Study||30
9752935|NCT00330551|10855670|FG001|COMPLETED|Overall Study||27
9752936|NCT00330551|10855669|FG000|NOT COMPLETED|Overall Study||10
9752937|NCT00330551|10855670|FG001|NOT COMPLETED|Overall Study||16
9828998|NCT00758498|10939622|FG002|COMPLETED|Overall Study||137
9828999|NCT00758498|10939620|FG000|NOT COMPLETED|Overall Study||3
9829000|NCT00758498|10939621|FG001|NOT COMPLETED|Overall Study||2
9752938|NCT00330564|10855678|FG000|STARTED|Overall Study||15
9752939|NCT00330564|10855678|FG000|COMPLETED|Overall Study||15
9752940|NCT00330564|10855678|FG000|NOT COMPLETED|Overall Study||0
9752941|NCT00330616|10855682|FG000|STARTED|Overall Study||35
9752942|NCT00330616|10855682|FG000|COMPLETED|Overall Study||14
9752943|NCT00330616|10855682|FG000|NOT COMPLETED|Overall Study||21
9752944|NCT00330668|10855686|FG000|STARTED|BID Dosing Period||114
9752945|NCT00330668|10855686|FG000|COMPLETED|BID Dosing Period||78
9752946|NCT00330668|10855686|FG000|NOT COMPLETED|BID Dosing Period||36
9752947|NCT00330668|10855686|FG000|STARTED|QD Dosing Period||78
9752948|NCT00330668|10855686|FG000|COMPLETED|QD Dosing Period||0
9752949|NCT00330668|10855686|FG000|NOT COMPLETED|QD Dosing Period||78
9752950|NCT00330681|10855692|FG000|STARTED|Overall Study||102
9752951|NCT00330681|10855693|FG001|STARTED|Overall Study||104
9752952|NCT00330681|10855692|FG000|COMPLETED|Overall Study||93
9752953|NCT00330681|10855693|FG001|COMPLETED|Overall Study||90
9752954|NCT00330681|10855692|FG000|NOT COMPLETED|Overall Study||9
9752955|NCT00330681|10855693|FG001|NOT COMPLETED|Overall Study||14
9752956|NCT00330733|10855701|FG000|STARTED|Overall Study||37
9752957|NCT00330733|10855702|FG001|STARTED|Overall Study||34
9752958|NCT00330733|10855701|FG000|Received Study Medication|Overall Study||36
9752959|NCT00330733|10855702|FG001|Received Study Medication|Overall Study||34
9752960|NCT00330733|10855701|FG000|COMPLETED|Overall Study||30
9752961|NCT00330733|10855702|FG001|COMPLETED|Overall Study||29
9752962|NCT00330733|10855701|FG000|NOT COMPLETED|Overall Study||7
9752963|NCT00330733|10855702|FG001|NOT COMPLETED|Overall Study||5
9752964|NCT00330759|10855710|FG000|STARTED|Overall Study||890
9752965|NCT00330759|10855711|FG001|STARTED|Overall Study||886
9752966|NCT00330759|10855710|FG000|Received Investigational Product|Overall Study||878
9752967|NCT00330759|10855711|FG001|Received Investigational Product|Overall Study||878
9752968|NCT00330759|10855710|FG000|COMPLETED|Overall Study||178
9752969|NCT00330759|10855711|FG001|COMPLETED|Overall Study||180
9752970|NCT00330759|10855710|FG000|NOT COMPLETED|Overall Study||712
9752971|NCT00330759|10855711|FG001|NOT COMPLETED|Overall Study||706
9752972|NCT00330863|10855719|FG000|STARTED|Overall Study||153
9752973|NCT00330863|10855720|FG001|STARTED|Overall Study||152
9752974|NCT00330863|10855719|FG000|COMPLETED|Overall Study||72
9752975|NCT00330863|10855720|FG001|COMPLETED|Overall Study||72
9752976|NCT00330863|10855719|FG000|NOT COMPLETED|Overall Study||81
9752977|NCT00330863|10855720|FG001|NOT COMPLETED|Overall Study||80
9752978|NCT00330876|10855726|FG000|STARTED|Overall Study||449
9752979|NCT00330876|10855727|FG001|STARTED|Overall Study||90
9752980|NCT00330876|10855726|FG000|COMPLETED|Overall Study||378
9752981|NCT00330876|10855727|FG001|COMPLETED|Overall Study||77
9752982|NCT00330876|10855726|FG000|NOT COMPLETED|Overall Study||71
9752983|NCT00330876|10855727|FG001|NOT COMPLETED|Overall Study||13
9752984|NCT00330915|10855733|FG000|STARTED|Overall Study||37
9752985|NCT00330915|10855733|FG000|COMPLETED|Overall Study||37
9752986|NCT00330915|10855733|FG000|NOT COMPLETED|Overall Study||0
9752987|NCT00330928|10855737|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
9752988|NCT00330928|10855737|FG000|7 Day Phone Contact|Overall Study||99
9752989|NCT00330928|10855737|FG000|1 Year Phone Contact|Overall Study||89
9752990|NCT00330928|10855737|FG000|COMPLETED|Overall Study||89
9752991|NCT00330928|10855737|FG000|NOT COMPLETED|Overall Study||17
9752992|NCT00330967|10855743|FG000|STARTED|Overall Study||0
9752993|NCT00330967|10855744|FG001|STARTED|Overall Study||25
9752994|NCT00330967|10855743|FG000|COMPLETED|Overall Study||0
9752995|NCT00330967|10855744|FG001|COMPLETED|Overall Study||11
9752996|NCT00330967|10855743|FG000|NOT COMPLETED|Overall Study||0
9752997|NCT00330967|10855744|FG001|NOT COMPLETED|Overall Study||14
9752998|NCT00331006|10855750|FG000|STARTED|Screening Phase||23
9752999|NCT00331006|10855750|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
9753000|NCT00331006|10855750|FG000|NOT COMPLETED|Screening Phase||7
9753001|NCT00331006|10855750|FG000|STARTED|Treatment Phase||16
9753002|NCT00331006|10855750|FG000|COMPLETED|Treatment Phase||15
9753003|NCT00331006|10855750|FG000|NOT COMPLETED|Treatment Phase||1
9753004|NCT00331006|10855750|FG000|STARTED|Follow-Up Phase I||15
9753005|NCT00331006|10855750|FG000|COMPLETED|Follow-Up Phase I||14
9753006|NCT00331006|10855750|FG000|NOT COMPLETED|Follow-Up Phase I||1
9753007|NCT00331006|10855750|FG000|STARTED|Follow-Up Phase II||14
9753008|NCT00331006|10855750|FG000|COMPLETED|Follow-Up Phase II||11
9753009|NCT00331006|10855750|FG000|NOT COMPLETED|Follow-Up Phase II||3
9753010|NCT00331136|10855758|FG000|STARTED|Overall Study||15
9753011|NCT00331136|10855759|FG001|STARTED|Overall Study||15
9753012|NCT00331136|10855760|FG002|STARTED|Overall Study||15
9753013|NCT00331136|10855761|FG003|STARTED|Overall Study||15
9753014|NCT00331136|10855758|FG000|COMPLETED|Overall Study||10
9753015|NCT00331136|10855759|FG001|COMPLETED|Overall Study||8
9753016|NCT00331136|10855760|FG002|COMPLETED|Overall Study||15
9753017|NCT00331136|10855761|FG003|COMPLETED|Overall Study||14
9753018|NCT00331136|10855758|FG000|NOT COMPLETED|Overall Study||5
9753019|NCT00331136|10855759|FG001|NOT COMPLETED|Overall Study||7
9753020|NCT00331136|10855760|FG002|NOT COMPLETED|Overall Study||0
9753021|NCT00331136|10855761|FG003|NOT COMPLETED|Overall Study||1
9753022|NCT00331162|10855773|FG000|STARTED|Overall Study||113
9753023|NCT00331162|10855774|FG001|STARTED|Overall Study||109
9753024|NCT00331162|10855773|FG000|COMPLETED|Overall Study||113
9753025|NCT00331162|10855774|FG001|COMPLETED|Overall Study||109
9753026|NCT00331162|10855773|FG000|NOT COMPLETED|Overall Study||0
9753027|NCT00331162|10855774|FG001|NOT COMPLETED|Overall Study||0
9753028|NCT00331344|10855780|FG000|STARTED|Phase I||3
9753029|NCT00331344|10855781|FG001|STARTED|Phase I||3
9753030|NCT00331344|10855782|FG002|STARTED|Phase I||3
9753031|NCT00331344|10855783|FG003|STARTED|Phase I||6
9753032|NCT00331344|10855784|FG004|STARTED|Phase I||6
9753033|NCT00331344|10855785|FG005|STARTED|Phase I||5
9753034|NCT00331344|10855786|FG006|STARTED|Phase I||4
9753035|NCT00331344|10855787|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
9753036|NCT00331344|10855788|FG008|STARTED|Phase I||0
9753037|NCT00331344|10855780|FG000|COMPLETED|Phase I||3
9753038|NCT00331344|10855781|FG001|COMPLETED|Phase I||3
9753039|NCT00331344|10855782|FG002|COMPLETED|Phase I||3
9753040|NCT00331344|10855783|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
9753041|NCT00331344|10855784|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
9753042|NCT00331344|10855785|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
9753043|NCT00331344|10855786|FG006|COMPLETED|Phase I||4
9753044|NCT00331344|10855787|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
9753045|NCT00331344|10855788|FG008|COMPLETED|Phase I||0
9753046|NCT00331344|10855780|FG000|NOT COMPLETED|Phase I||0
9753047|NCT00331344|10855781|FG001|NOT COMPLETED|Phase I||0
9753048|NCT00331344|10855782|FG002|NOT COMPLETED|Phase I||0
9753049|NCT00331344|10855783|FG003|NOT COMPLETED|Phase I||1
9753050|NCT00331344|10855784|FG004|NOT COMPLETED|Phase I||2
9753051|NCT00331344|10855785|FG005|NOT COMPLETED|Phase I||2
9753052|NCT00331344|10855786|FG006|NOT COMPLETED|Phase I||0
9753053|NCT00331344|10855787|FG007|NOT COMPLETED|Phase I||1
9753054|NCT00331344|10855788|FG008|NOT COMPLETED|Phase I||0
9753055|NCT00331344|10855780|FG000|STARTED|Phase II||0
9753056|NCT00331344|10855781|FG001|STARTED|Phase II||0
9753057|NCT00331344|10855782|FG002|STARTED|Phase II||0
9753058|NCT00331344|10855783|FG003|STARTED|Phase II||0
9753059|NCT00331344|10855784|FG004|STARTED|Phase II||0
9853986|NCT00890721|10966980|FG001|NOT COMPLETED|Overall Study||1
9853987|NCT00890825|10966988|FG000|STARTED|Overall Study||44
9853988|NCT00890825|10966989|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
9853989|NCT00890825|10966988|FG000|COMPLETED|Overall Study||30
9853990|NCT00890825|10966989|FG001|COMPLETED|Overall Study||29
9853991|NCT00890825|10966988|FG000|NOT COMPLETED|Overall Study||14
9853992|NCT00890825|10966989|FG001|NOT COMPLETED|Overall Study||14
9853993|NCT00890916|10966995|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
9853994|NCT00890916|10966995|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
9853995|NCT00890916|10966995|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
9853996|NCT00890916|10966995|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
9853997|NCT00890916|10966995|FG000|STARTED|"Rehab - NP Off"||10
9853998|NCT00890916|10966995|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
9853999|NCT00890916|10966995|FG000|COMPLETED|"Rehab - NP Off"||10
9854000|NCT00890916|10966995|FG000|NOT COMPLETED|"Rehab - NP Off"||0
9854001|NCT00890929|10966999|FG000|STARTED|Overall Study||45
9854002|NCT00890929|10966999|FG000|Consented & Enrolled|Overall Study||45
9854003|NCT00890929|10966999|FG000|Initiated Treatment|Overall Study||43
9854004|NCT00890929|10966999|FG000|COMPLETED|Overall Study||39
9854005|NCT00890929|10966999|FG000|NOT COMPLETED|Overall Study||6
9854006|NCT00890981|10967005|FG000|STARTED|Overall Study||39
9854007|NCT00890981|10967006|FG001|STARTED|Overall Study||40
9854008|NCT00890981|10967005|FG000|COMPLETED|Overall Study||39
9854009|NCT00890981|10967006|FG001|COMPLETED|Overall Study||40
9854010|NCT00890981|10967005|FG000|NOT COMPLETED|Overall Study||0
9854011|NCT00890981|10967006|FG001|NOT COMPLETED|Overall Study||0
9854012|NCT00891020|10967015|FG000|STARTED|24 Week Treatment Period||163
9854013|NCT00891020|10967016|FG001|STARTED|24 Week Treatment Period||363
9854014|NCT00891020|10967017|FG002|STARTED|24 Week Treatment Period||360
9854015|NCT00891020|10967015|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163
9854016|NCT00891020|10967016|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362
9854017|NCT00891020|10967017|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358
9854018|NCT00891020|10967015|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
9854019|NCT00891020|10967016|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
9854020|NCT00891020|10967017|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
9854021|NCT00891020|10967015|FG000|COMPLETED|24 Week Treatment Period||126
9854022|NCT00891020|10967016|FG001|COMPLETED|24 Week Treatment Period||303
9854023|NCT00891020|10967017|FG002|COMPLETED|24 Week Treatment Period||302
9854024|NCT00891020|10967015|FG000|NOT COMPLETED|24 Week Treatment Period||37
9854025|NCT00891020|10967016|FG001|NOT COMPLETED|24 Week Treatment Period||60
9854026|NCT00891020|10967017|FG002|NOT COMPLETED|24 Week Treatment Period||58
9854027|NCT00891020|10967015|FG000|STARTED|Long-term Extension Period||55
9753060|NCT00331344|10855785|FG005|STARTED|Phase II||0
9753061|NCT00331344|10855786|FG006|STARTED|Phase II||0
9753062|NCT00331344|10855787|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
9753063|NCT00331344|10855788|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
9753064|NCT00331344|10855780|FG000|COMPLETED|Phase II||0
9753065|NCT00331344|10855781|FG001|COMPLETED|Phase II||0
9753066|NCT00331344|10855782|FG002|COMPLETED|Phase II||0
9753067|NCT00331344|10855783|FG003|COMPLETED|Phase II||0
9753068|NCT00331344|10855784|FG004|COMPLETED|Phase II||0
9753069|NCT00331344|10855785|FG005|COMPLETED|Phase II||0
9753070|NCT00331344|10855786|FG006|COMPLETED|Phase II||0
9753071|NCT00331344|10855787|FG007|COMPLETED|Phase II||6
9753072|NCT00331344|10855788|FG008|COMPLETED|Phase II||48
9753073|NCT00331344|10855780|FG000|NOT COMPLETED|Phase II||0
9753074|NCT00331344|10855781|FG001|NOT COMPLETED|Phase II||0
9753075|NCT00331344|10855782|FG002|NOT COMPLETED|Phase II||0
9753076|NCT00331344|10855783|FG003|NOT COMPLETED|Phase II||0
9753077|NCT00331344|10855784|FG004|NOT COMPLETED|Phase II||0
9753078|NCT00331344|10855785|FG005|NOT COMPLETED|Phase II||0
9753079|NCT00331344|10855786|FG006|NOT COMPLETED|Phase II||0
9753080|NCT00331344|10855787|FG007|NOT COMPLETED|Phase II||0
9753081|NCT00331344|10855788|FG008|NOT COMPLETED|Phase II||4
9753082|NCT00331409|10855801|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
9753083|NCT00331409|10855801|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
9753084|NCT00331409|10855801|FG000|NOT COMPLETED|Overall Study||4
9753085|NCT00331422|10855805|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
9753086|NCT00331422|10855805|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
9753087|NCT00331422|10855805|FG000|NOT COMPLETED|Overall Study||5
9753088|NCT00331552|10855812|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
9753089|NCT00331552|10855813|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
9753090|NCT00331552|10855812|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
9753091|NCT00331552|10855813|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
9753092|NCT00331552|10855812|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
9753093|NCT00331552|10855813|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
9753094|NCT00331552|10855812|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
9753095|NCT00331552|10855813|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
9753096|NCT00331552|10855812|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
9753097|NCT00331552|10855813|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
9753098|NCT00331552|10855812|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
9753099|NCT00331552|10855813|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
9753100|NCT00331552|10855812|FG000|STARTED|Period 3: Phase II||24
9753101|NCT00331552|10855813|FG001|STARTED|Period 3: Phase II||0
9753102|NCT00331552|10855812|FG000|COMPLETED|Period 3: Phase II||22
9753103|NCT00331552|10855813|FG001|COMPLETED|Period 3: Phase II||0
9753104|NCT00331552|10855812|FG000|NOT COMPLETED|Period 3: Phase II||2
9753105|NCT00331552|10855813|FG001|NOT COMPLETED|Period 3: Phase II||0
9753106|NCT00331630|10855824|FG000|STARTED|Treatment on Study||30
9753107|NCT00331630|10855824|FG000|Completed 1st Cycle|Treatment on Study||30
9753108|NCT00331630|10855824|FG000|Completed 4 Cycles|Treatment on Study||30
9753109|NCT00331630|10855824|FG000|COMPLETED|Treatment on Study||30
9753110|NCT00331630|10855824|FG000|NOT COMPLETED|Treatment on Study||0
9753111|NCT00331630|10855824|FG000|STARTED|Evaluated for and Completed SOC Surgery||30
9753112|NCT00331630|10855824|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28
9753113|NCT00331630|10855824|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
9753114|NCT00331630|10855824|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
9753115|NCT00331630|10855824|FG000|COMPLETED|Follow up for 5 Years||0
9753116|NCT00331630|10855824|FG000|NOT COMPLETED|Follow up for 5 Years||29
9753117|NCT00331682|10855828|FG000|STARTED|Overall Study||10
9753118|NCT00331682|10855828|FG000|COMPLETED|Overall Study||9
9753119|NCT00331682|10855828|FG000|NOT COMPLETED|Overall Study||1
9753120|NCT00331760|10855834|FG000|STARTED|Overall Study||58
9753121|NCT00331760|10855835|FG001|STARTED|Overall Study||48
9753122|NCT00331760|10855834|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
9753123|NCT00331760|10855835|FG001|COMPLETED|Overall Study||40
9753124|NCT00331760|10855834|FG000|NOT COMPLETED|Overall Study||15
9753125|NCT00331760|10855835|FG001|NOT COMPLETED|Overall Study||8
9753126|NCT00331799|10855842|FG000|STARTED|Overall Study||18
9753127|NCT00331799|10855842|FG000|COMPLETED|Overall Study||15
9753128|NCT00331799|10855842|FG000|NOT COMPLETED|Overall Study||3
9753129|NCT00331864|10855848|FG000|STARTED|Overall Study||513
9753130|NCT00331864|10855849|FG001|STARTED|Overall Study||18
9753131|NCT00331864|10855848|FG000|COMPLETED|Overall Study||455
9753132|NCT00331864|10855849|FG001|COMPLETED|Overall Study||14
9753133|NCT00331864|10855848|FG000|NOT COMPLETED|Overall Study||58
9753134|NCT00331864|10855849|FG001|NOT COMPLETED|Overall Study||4
9753135|NCT00332163|10855857|FG000|STARTED|Overall Study||48
9753136|NCT00332163|10855858|FG001|STARTED|Overall Study||47
9753137|NCT00332163|10855857|FG000|Received Treatment|Overall Study||48
9753138|NCT00332163|10855858|FG001|Received Treatment|Overall Study||47
9753139|NCT00332163|10855857|FG000|COMPLETED|Overall Study||48
9753140|NCT00332163|10855858|FG001|COMPLETED|Overall Study||47
9753141|NCT00332163|10855857|FG000|NOT COMPLETED|Overall Study||0
9753142|NCT00332163|10855858|FG001|NOT COMPLETED|Overall Study||0
9753143|NCT00332189|10855864|FG000|STARTED|Overall Study||111
9753144|NCT00332189|10855864|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
9753145|NCT00332189|10855864|FG000|NOT COMPLETED|Overall Study||21
9753146|NCT00332202|10855871|FG000|STARTED|Overall Study||504
9753147|NCT00332202|10855872|FG001|STARTED|Overall Study||254
9753148|NCT00332202|10855871|FG000|Received At Least One Dose of Study Drug|Overall Study||493
9753149|NCT00332202|10855872|FG001|Received At Least One Dose of Study Drug|Overall Study||249
9753150|NCT00332202|10855871|FG000|COMPLETED|Overall Study||263
9753151|NCT00332202|10855872|FG001|COMPLETED|Overall Study||129
9753152|NCT00332202|10855871|FG000|NOT COMPLETED|Overall Study||241
9753153|NCT00332202|10855872|FG001|NOT COMPLETED|Overall Study||125
9753154|NCT00332241|10855889|FG000|STARTED|Overall Study||51
9753155|NCT00332241|10855890|FG001|STARTED|Overall Study||47
9753156|NCT00332241|10855889|FG000|COMPLETED|Overall Study||36
9753157|NCT00332241|10855890|FG001|COMPLETED|Overall Study||39
9753158|NCT00332241|10855889|FG000|NOT COMPLETED|Overall Study||15
9753159|NCT00332241|10855890|FG001|NOT COMPLETED|Overall Study||8
9753160|NCT00332332|10855896|FG000|STARTED|Overall Study||246
9753161|NCT00332332|10855896|FG000|Received Study Medication|Overall Study||230
9753162|NCT00332332|10855896|FG000|COMPLETED|Overall Study||178
9753163|NCT00332332|10855896|FG000|NOT COMPLETED|Overall Study||68
9753164|NCT00332462|10855900|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34
9753165|NCT00332462|10855900|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34
9753166|NCT00332462|10855900|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29
9753167|NCT00332462|10855900|FG000|COMPLETED|Overall Study||18
9753168|NCT00332462|10855900|FG000|NOT COMPLETED|Overall Study||16
9753169|NCT00332488|10855910|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
9753170|NCT00332488|10855911|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
9753171|NCT00332488|10855912|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
9753172|NCT00332488|10855910|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
9753173|NCT00332488|10855911|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
9753174|NCT00332488|10855912|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
9753175|NCT00332488|10855910|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
9753176|NCT00332488|10855911|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
9753177|NCT00332488|10855912|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
9753178|NCT00332488|10855910|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
9753179|NCT00332488|10855911|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
9753180|NCT00332488|10855912|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
9753181|NCT00332488|10855910|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
9753182|NCT00332488|10855911|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
9753183|NCT00332488|10855912|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
9753184|NCT00332488|10855910|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
9753185|NCT00332488|10855911|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
9753186|NCT00332488|10855912|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
9753187|NCT00332579|10855924|FG000|STARTED|Overall Study||12
9753188|NCT00332579|10855925|FG001|STARTED|Overall Study||13
9753189|NCT00332579|10855924|FG000|COMPLETED|Overall Study||11
9753190|NCT00332579|10855925|FG001|COMPLETED|Overall Study||12
9753191|NCT00332579|10855924|FG000|NOT COMPLETED|Overall Study||1
9753192|NCT00332579|10855925|FG001|NOT COMPLETED|Overall Study||1
9753193|NCT00332605|10855934|FG000|STARTED|Overall Study||14
9753194|NCT00332605|10855935|FG001|STARTED|Overall Study||14
9753195|NCT00332605|10855936|FG002|STARTED|Overall Study||17
9753196|NCT00332605|10855934|FG000|COMPLETED|Overall Study||12
9753197|NCT00332605|10855935|FG001|COMPLETED|Overall Study||12
9753198|NCT00332605|10855936|FG002|COMPLETED|Overall Study||9
9753199|NCT00332605|10855934|FG000|NOT COMPLETED|Overall Study||2
9753200|NCT00332605|10855935|FG001|NOT COMPLETED|Overall Study||2
9753201|NCT00332605|10855936|FG002|NOT COMPLETED|Overall Study||8
9753202|NCT00332644|10855950|FG000|STARTED|Overall Study||262
9753203|NCT00332644|10855951|FG001|STARTED|Overall Study||260
9753204|NCT00332644|10855952|FG002|STARTED|Overall Study||267
9753205|NCT00332644|10855953|FG003|STARTED|Overall Study||264
9753206|NCT00332644|10855954|FG004|STARTED|Overall Study||262
9753207|NCT00332644|10855955|FG005|STARTED|Overall Study||189
9753208|NCT00332644|10855950|FG000|COMPLETED|Overall Study||250
9753209|NCT00332644|10855951|FG001|COMPLETED|Overall Study||238
9753210|NCT00332644|10855952|FG002|COMPLETED|Overall Study||258
9753211|NCT00332644|10855953|FG003|COMPLETED|Overall Study||244
9753212|NCT00332644|10855954|FG004|COMPLETED|Overall Study||250
9753213|NCT00332644|10855955|FG005|COMPLETED|Overall Study||174
9753214|NCT00332644|10855950|FG000|NOT COMPLETED|Overall Study||12
9753215|NCT00332644|10855951|FG001|NOT COMPLETED|Overall Study||22
9753216|NCT00332644|10855952|FG002|NOT COMPLETED|Overall Study||9
9753217|NCT00332644|10855953|FG003|NOT COMPLETED|Overall Study||20
9753218|NCT00332644|10855954|FG004|NOT COMPLETED|Overall Study||12
9753219|NCT00332644|10855955|FG005|NOT COMPLETED|Overall Study||15
9753220|NCT00332696|10855971|FG000|STARTED|Overall Study||32
9753221|NCT00332696|10855972|FG001|STARTED|Overall Study||32
9753222|NCT00332696|10855971|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
9753223|NCT00332696|10855972|FG001|Completed Day 14 Visit|Overall Study||15
9753224|NCT00332696|10855971|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2
9753225|NCT00332696|10855972|FG001|COMPLETED|Overall Study||2
9753226|NCT00332696|10855971|FG000|NOT COMPLETED|Overall Study||30
9753227|NCT00332696|10855972|FG001|NOT COMPLETED|Overall Study||30
9753228|NCT00332709|10855980|FG000|STARTED|Overall Study||40
9753229|NCT00332709|10855981|FG001|STARTED|Overall Study||41
9753230|NCT00332709|10855980|FG000|COMPLETED|Overall Study||24
9753231|NCT00332709|10855981|FG001|COMPLETED|Overall Study||21
9753232|NCT00332709|10855980|FG000|NOT COMPLETED|Overall Study||16
9753233|NCT00332709|10855981|FG001|NOT COMPLETED|Overall Study||20
9753234|NCT00332722|10855989|FG000|STARTED|Overall Study||60
9753235|NCT00332722|10855990|FG001|STARTED|Overall Study||60
9753236|NCT00332722|10855989|FG000|COMPLETED|Overall Study||60
9753237|NCT00332722|10855990|FG001|COMPLETED|Overall Study||60
9753238|NCT00332722|10855989|FG000|NOT COMPLETED|Overall Study||0
9753239|NCT00332722|10855990|FG001|NOT COMPLETED|Overall Study||0
9753240|NCT00332839|10855998|FG000|STARTED|Core (Months 0 - 12)||47
9753241|NCT00332839|10855999|FG001|STARTED|Core (Months 0 - 12)||46
9753242|NCT00332839|10855998|FG000|Safety Set|Core (Months 0 - 12)||47
9753243|NCT00332839|10855999|FG001|Safety Set|Core (Months 0 - 12)||46
9753244|NCT00332839|10855998|FG000|COMPLETED|Core (Months 0 - 12)||37
9753245|NCT00332839|10855999|FG001|COMPLETED|Core (Months 0 - 12)||28
9753246|NCT00332839|10855998|FG000|NOT COMPLETED|Core (Months 0 - 12)||10
9753247|NCT00332839|10855999|FG001|NOT COMPLETED|Core (Months 0 - 12)||18
9753248|NCT00332839|10855998|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
9753249|NCT00332839|10855999|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
9753250|NCT00332839|10855998|FG000|COMPLETED|Follow-up (Months 12 - 60)||29
9753251|NCT00332839|10855999|FG001|COMPLETED|Follow-up (Months 12 - 60)||31
9753252|NCT00332839|10855998|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4
9753253|NCT00332839|10855999|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3
9753254|NCT00333138|10856008|FG000|STARTED|Core Study (6 Months)||93
9753255|NCT00333138|10856009|FG001|STARTED|Core Study (6 Months)||94
9753256|NCT00333138|10856010|FG002|STARTED|Core Study (6 Months)||94
9753257|NCT00333138|10856008|FG000|COMPLETED|Core Study (6 Months)||86
9753258|NCT00333138|10856009|FG001|COMPLETED|Core Study (6 Months)||88
9753259|NCT00333138|10856010|FG002|COMPLETED|Core Study (6 Months)||82
9753260|NCT00333138|10856008|FG000|NOT COMPLETED|Core Study (6 Months)||7
9753261|NCT00333138|10856009|FG001|NOT COMPLETED|Core Study (6 Months)||6
9753262|NCT00333138|10856010|FG002|NOT COMPLETED|Core Study (6 Months)||12
9753263|NCT00333138|10856008|FG000|STARTED|Extension Study (Month6 to End of Study)||83
9753264|NCT00333138|10856009|FG001|STARTED|Extension Study (Month6 to End of Study)||87
9753265|NCT00333138|10856010|FG002|STARTED|Extension Study (Month6 to End of Study)||80
9753266|NCT00333138|10856008|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40
9753267|NCT00333138|10856009|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45
9753268|NCT00333138|10856010|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37
9753269|NCT00333138|10856008|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
9753270|NCT00333138|10856009|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
9753271|NCT00333138|10856010|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
9753272|NCT00333177|10856024|FG000|STARTED|Overall Study||12
9753273|NCT00333177|10856025|FG001|STARTED|Overall Study||17
9753274|NCT00333177|10856026|FG002|STARTED|Overall Study||17
9753275|NCT00333177|10856027|FG003|STARTED|Overall Study||14
9753276|NCT00333177|10856024|FG000|Received Intervention|Overall Study||12
9753277|NCT00333177|10856025|FG001|Received Intervention|Overall Study||16
9753278|NCT00333177|10856026|FG002|Received Intervention|Overall Study||16
9753279|NCT00333177|10856027|FG003|Received Intervention|Overall Study||12
9753280|NCT00333177|10856024|FG000|COMPLETED|Overall Study||12
9753281|NCT00333177|10856025|FG001|COMPLETED|Overall Study||16
9753282|NCT00333177|10856026|FG002|COMPLETED|Overall Study||16
9753283|NCT00333177|10856027|FG003|COMPLETED|Overall Study||12
9753284|NCT00333177|10856024|FG000|NOT COMPLETED|Overall Study||0
9753285|NCT00333177|10856025|FG001|NOT COMPLETED|Overall Study||1
9753286|NCT00333177|10856026|FG002|NOT COMPLETED|Overall Study||1
9753287|NCT00333177|10856027|FG003|NOT COMPLETED|Overall Study||2
9753288|NCT00333359|10856041|FG000|STARTED|Overall Study||199
9753289|NCT00333359|10856042|FG001|STARTED|Overall Study||382
9753290|NCT00333359|10856041|FG000|COMPLETED|Overall Study||126
9753291|NCT00333359|10856042|FG001|COMPLETED|Overall Study||260
9753292|NCT00333359|10856041|FG000|NOT COMPLETED|Overall Study||73
9753293|NCT00333359|10856042|FG001|NOT COMPLETED|Overall Study||122
9753294|NCT00333437|10856050|FG000|STARTED|Overall Study||7
9753295|NCT00333437|10856050|FG000|COMPLETED|Overall Study||7
9753296|NCT00333437|10856050|FG000|NOT COMPLETED|Overall Study||0
9753297|NCT00333606|10856057|FG000|STARTED|Overall Study||30
9753298|NCT00333606|10856058|FG001|STARTED|Overall Study||30
9753299|NCT00333606|10856057|FG000|COMPLETED|Overall Study||30
9753300|NCT00333606|10856058|FG001|COMPLETED|Overall Study||30
9753301|NCT00333606|10856057|FG000|NOT COMPLETED|Overall Study||0
9753302|NCT00333606|10856058|FG001|NOT COMPLETED|Overall Study||0
9753303|NCT00333619|10856068|FG000|STARTED|Overall Study||110
9753304|NCT00333619|10856069|FG001|STARTED|Overall Study||109
9753305|NCT00333619|10856068|FG000|Post-treatment|Overall Study||109
9753306|NCT00333619|10856069|FG001|Post-treatment|Overall Study||109
9753307|NCT00333619|10856068|FG000|3-month Follow-up|Overall Study||101
9753308|NCT00333619|10856069|FG001|3-month Follow-up|Overall Study||105
9753309|NCT00333619|10856068|FG000|COMPLETED|Overall Study||89
9753310|NCT00333619|10856069|FG001|COMPLETED|Overall Study||99
9753311|NCT00333619|10856068|FG000|NOT COMPLETED|Overall Study||21
9753312|NCT00333619|10856069|FG001|NOT COMPLETED|Overall Study||10
9753313|NCT00333710|10856080|FG000|STARTED|Overall Study||19
9753314|NCT00333710|10856081|FG001|STARTED|Overall Study||18
9753315|NCT00333710|10856082|FG002|STARTED|Overall Study||16
9753316|NCT00333710|10856080|FG000|COMPLETED|Overall Study||8
9753317|NCT00333710|10856081|FG001|COMPLETED|Overall Study||14
9753318|NCT00333710|10856082|FG002|COMPLETED|Overall Study||15
9753319|NCT00333710|10856080|FG000|NOT COMPLETED|Overall Study||11
9753320|NCT00333710|10856081|FG001|NOT COMPLETED|Overall Study||4
9753321|NCT00333710|10856082|FG002|NOT COMPLETED|Overall Study||1
9753322|NCT00333775|10856093|FG000|STARTED|Overall Study||241
9753323|NCT00333775|10856094|FG001|STARTED|Overall Study||248
9753324|NCT00333775|10856095|FG002|STARTED|Overall Study||247
9753325|NCT00333775|10856093|FG000|Received Treatment|Overall Study||238
9753326|NCT00333775|10856094|FG001|Received Treatment|Overall Study||247
9753327|NCT00333775|10856095|FG002|Received Treatment|Overall Study||245
9753328|NCT00333775|10856093|FG000|COMPLETED|Overall Study||0
9753329|NCT00333775|10856094|FG001|COMPLETED|Overall Study||0
9753330|NCT00333775|10856095|FG002|COMPLETED|Overall Study||0
9753331|NCT00333775|10856093|FG000|NOT COMPLETED|Overall Study||241
9753332|NCT00333775|10856094|FG001|NOT COMPLETED|Overall Study||248
9753333|NCT00333775|10856095|FG002|NOT COMPLETED|Overall Study||247
9753334|NCT00333788|10856103|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
9753335|NCT00333788|10856103|FG000|COMPLETED|Overall Study||71
9753336|NCT00333788|10856103|FG000|NOT COMPLETED|Overall Study||162
9753337|NCT00333801|10856109|FG000|STARTED|Overall Study||43
9753338|NCT00333801|10856110|FG001|STARTED|Overall Study||42
9753339|NCT00333801|10856109|FG000|COMPLETED|Overall Study||35
9753340|NCT00333801|10856110|FG001|COMPLETED|Overall Study||36
9753341|NCT00333801|10856109|FG000|NOT COMPLETED|Overall Study||8
9753342|NCT00333801|10856110|FG001|NOT COMPLETED|Overall Study||6
9753343|NCT00333814|10856119|FG000|STARTED|Overall Study||76
9753344|NCT00333814|10856120|FG001|STARTED|Overall Study||77
9753345|NCT00333814|10856121|FG002|STARTED|Overall Study||76
9753346|NCT00333814|10856119|FG000|COMPLETED|Overall Study||73
9753347|NCT00333814|10856120|FG001|COMPLETED|Overall Study||73
9753348|NCT00333814|10856121|FG002|COMPLETED|Overall Study||71
9753349|NCT00333814|10856119|FG000|NOT COMPLETED|Overall Study||3
9753350|NCT00333814|10856120|FG001|NOT COMPLETED|Overall Study||4
9753351|NCT00333814|10856121|FG002|NOT COMPLETED|Overall Study||5
9753352|NCT00333840|10856131|FG000|STARTED|First-line Treatment Period||553
9753353|NCT00333840|10856132|FG001|STARTED|First-line Treatment Period||553
9753354|NCT00333840|10856133|FG002|STARTED|First-line Treatment Period||0
9753355|NCT00333840|10856134|FG003|STARTED|First-line Treatment Period||0
9753356|NCT00333840|10856131|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551
9753357|NCT00333840|10856132|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533
9753358|NCT00333840|10856133|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0
9753359|NCT00333840|10856134|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0
9753360|NCT00333840|10856131|FG000|COMPLETED|First-line Treatment Period||267
9753361|NCT00333840|10856132|FG001|COMPLETED|First-line Treatment Period||7
9753362|NCT00333840|10856133|FG002|COMPLETED|First-line Treatment Period||0
9753363|NCT00333840|10856134|FG003|COMPLETED|First-line Treatment Period||0
9753364|NCT00333840|10856131|FG000|NOT COMPLETED|First-line Treatment Period||286
9753365|NCT00333840|10856132|FG001|NOT COMPLETED|First-line Treatment Period||546
9753366|NCT00333840|10856133|FG002|NOT COMPLETED|First-line Treatment Period||0
9753367|NCT00333840|10856134|FG003|NOT COMPLETED|First-line Treatment Period||0
9753368|NCT00333840|10856131|FG000|STARTED|Second-line Treatment Period||0
9753369|NCT00333840|10856132|FG001|STARTED|Second-line Treatment Period||0
9753370|NCT00333840|10856133|FG002|STARTED|Second-line Treatment Period||14
9753371|NCT00333840|10856134|FG003|STARTED|Second-line Treatment Period||363
9753372|NCT00333840|10856131|FG000|COMPLETED|Second-line Treatment Period||0
9753373|NCT00333840|10856132|FG001|COMPLETED|Second-line Treatment Period||0
9753374|NCT00333840|10856133|FG002|COMPLETED|Second-line Treatment Period||0
9854028|NCT00891020|10967016|FG001|STARTED|Long-term Extension Period||196
9854029|NCT00891020|10967017|FG002|STARTED|Long-term Extension Period||193
9854030|NCT00891020|10967015|FG000|COMPLETED|Long-term Extension Period||49
9854031|NCT00891020|10967016|FG001|COMPLETED|Long-term Extension Period||172
9854032|NCT00891020|10967017|FG002|COMPLETED|Long-term Extension Period||170
9854033|NCT00891020|10967015|FG000|NOT COMPLETED|Long-term Extension Period||6
9854034|NCT00891020|10967016|FG001|NOT COMPLETED|Long-term Extension Period||24
9854035|NCT00891020|10967017|FG002|NOT COMPLETED|Long-term Extension Period||23
9854036|NCT00891046|10967032|FG000|STARTED|Overall Study||33
9854037|NCT00891046|10967033|FG001|STARTED|Overall Study||63
9854038|NCT00891046|10967034|FG002|STARTED|Overall Study||40
9854039|NCT00891046|10967035|FG003|STARTED|Overall Study||11
9854040|NCT00891046|10967036|FG004|STARTED|Overall Study||123
9854041|NCT00891046|10967032|FG000|COMPLETED|Overall Study||21
9854042|NCT00891046|10967033|FG001|COMPLETED|Overall Study||54
9854043|NCT00891046|10967034|FG002|COMPLETED|Overall Study||17
9854044|NCT00891046|10967035|FG003|COMPLETED|Overall Study||8
9854045|NCT00891046|10967036|FG004|COMPLETED|Overall Study||84
9854046|NCT00891046|10967032|FG000|NOT COMPLETED|Overall Study||12
9854047|NCT00891046|10967033|FG001|NOT COMPLETED|Overall Study||9
9854048|NCT00891046|10967034|FG002|NOT COMPLETED|Overall Study||23
9854049|NCT00891046|10967035|FG003|NOT COMPLETED|Overall Study||3
9854050|NCT00891046|10967036|FG004|NOT COMPLETED|Overall Study||39
9854051|NCT00891176|10967067|FG000|STARTED|At 3 Years of Age||144
9854052|NCT00891176|10967068|FG001|STARTED|At 3 Years of Age||147
9753375|NCT00333840|10856134|FG003|COMPLETED|Second-line Treatment Period||175
9753376|NCT00333840|10856131|FG000|NOT COMPLETED|Second-line Treatment Period||0
9753377|NCT00333840|10856132|FG001|NOT COMPLETED|Second-line Treatment Period||0
9753378|NCT00333840|10856133|FG002|NOT COMPLETED|Second-line Treatment Period||14
9753379|NCT00333840|10856134|FG003|NOT COMPLETED|Second-line Treatment Period||188
9753380|NCT00333866|10856152|FG000|STARTED|Overall Study||189
9753381|NCT00333866|10856153|FG001|STARTED|Overall Study||187
9753382|NCT00333866|10856154|FG002|STARTED|Overall Study||184
9753383|NCT00333866|10856155|FG003|STARTED|Overall Study||187
9753384|NCT00333866|10856152|FG000|TREATED|Overall Study||184
9753385|NCT00333866|10856153|FG001|TREATED|Overall Study||184
9753386|NCT00333866|10856154|FG002|TREATED|Overall Study||182
9753387|NCT00333866|10856155|FG003|TREATED|Overall Study||186
9753388|NCT00333866|10856152|FG000|COMPLETED|Overall Study||141
9753389|NCT00333866|10856153|FG001|COMPLETED|Overall Study||123
9753390|NCT00333866|10856154|FG002|COMPLETED|Overall Study||133
9753391|NCT00333866|10856155|FG003|COMPLETED|Overall Study||121
9854053|NCT00891176|10967069|FG002|STARTED|At 3 Years of Age||149
9854054|NCT00891176|10967070|FG003|STARTED|At 3 Years of Age||141
9854055|NCT00891176|10967067|FG000|COMPLETED|At 3 Years of Age||144
9854056|NCT00891176|10967068|FG001|COMPLETED|At 3 Years of Age||147
9854057|NCT00891176|10967069|FG002|COMPLETED|At 3 Years of Age||149
9854058|NCT00891176|10967070|FG003|COMPLETED|At 3 Years of Age||141
9854059|NCT00891176|10967067|FG000|NOT COMPLETED|At 3 Years of Age||0
9854060|NCT00891176|10967068|FG001|NOT COMPLETED|At 3 Years of Age||0
9753392|NCT00333866|10856152|FG000|NOT COMPLETED|Overall Study||48
9753393|NCT00333866|10856153|FG001|NOT COMPLETED|Overall Study||64
9753394|NCT00333866|10856154|FG002|NOT COMPLETED|Overall Study||51
9753395|NCT00333866|10856155|FG003|NOT COMPLETED|Overall Study||66
9753396|NCT00333879|10856165|FG000|STARTED|Overall Study||4
9753397|NCT00333879|10856165|FG000|COMPLETED|Overall Study||4
9753398|NCT00333879|10856165|FG000|NOT COMPLETED|Overall Study||0
9753399|NCT00333970|10856171|FG000|STARTED|Overall Study||50
9753400|NCT00333970|10856172|FG001|STARTED|Overall Study||25
9753401|NCT00333970|10856171|FG000|COMPLETED|Overall Study||37
9753402|NCT00333970|10856172|FG001|COMPLETED|Overall Study||18
9753403|NCT00333970|10856171|FG000|NOT COMPLETED|Overall Study||13
9753404|NCT00333970|10856172|FG001|NOT COMPLETED|Overall Study||7
9753405|NCT00333983|10856181|FG000|STARTED|Overall Study||20
9753406|NCT00333983|10856182|FG001|STARTED|Overall Study||21
9854061|NCT00891176|10967069|FG002|NOT COMPLETED|At 3 Years of Age||0
9753407|NCT00333983|10856183|FG002|STARTED|Overall Study||21
9753408|NCT00333983|10856181|FG000|COMPLETED|Overall Study||17
9753409|NCT00333983|10856182|FG001|COMPLETED|Overall Study||16
9753410|NCT00333983|10856183|FG002|COMPLETED|Overall Study||19
9753411|NCT00333983|10856181|FG000|NOT COMPLETED|Overall Study||3
9753412|NCT00333983|10856182|FG001|NOT COMPLETED|Overall Study||5
9753413|NCT00333983|10856183|FG002|NOT COMPLETED|Overall Study||2
9753414|NCT00334061|10856191|FG000|STARTED|Overall Study|June 2006|125
9753415|NCT00334061|10856191|FG000|COMPLETED|Overall Study|November 2007|125
9753416|NCT00334061|10856191|FG000|NOT COMPLETED|Overall Study||0
9753417|NCT00334074|10856195|FG000|STARTED|Overall Study||30
9753418|NCT00334074|10856195|FG000|COMPLETED|Overall Study||30
9753419|NCT00334074|10856195|FG000|NOT COMPLETED|Overall Study||0
9753420|NCT00334113|10856202|FG000|STARTED|Overall Study||32
9753421|NCT00334113|10856203|FG001|STARTED|Overall Study||34
9753422|NCT00334113|10856202|FG000|COMPLETED|Overall Study||30
9753423|NCT00334113|10856203|FG001|COMPLETED|Overall Study||31
9753424|NCT00334113|10856202|FG000|NOT COMPLETED|Overall Study||2
9753425|NCT00334113|10856203|FG001|NOT COMPLETED|Overall Study||3
9753426|NCT00334204|10856209|FG000|STARTED|Overall Study||58
9753427|NCT00334204|10856209|FG000|COMPLETED|Overall Study||56
9753428|NCT00334204|10856209|FG000|NOT COMPLETED|Overall Study||2
9753429|NCT00334282|10856216|FG000|STARTED|Overall Study||290
9753430|NCT00334282|10856217|FG001|STARTED|Overall Study||145
9753431|NCT00334282|10856216|FG000|COMPLETED|Overall Study||68
9753432|NCT00334282|10856217|FG001|COMPLETED|Overall Study||37
9753433|NCT00334282|10856216|FG000|NOT COMPLETED|Overall Study||222
9753434|NCT00334282|10856217|FG001|NOT COMPLETED|Overall Study||108
9753435|NCT00334295|10856227|FG000|STARTED|Overall Study||35
9753436|NCT00334295|10856227|FG000|COMPLETED|Overall Study||30
9753437|NCT00334295|10856227|FG000|NOT COMPLETED|Overall Study||5
9753438|NCT00334542|10856231|FG000|STARTED|Overall Study||50
9753439|NCT00334542|10856231|FG000|COMPLETED|Overall Study||45
9753440|NCT00334542|10856231|FG000|NOT COMPLETED|Overall Study||5
9753441|NCT00334633|10856239|FG000|STARTED|Overall Study||197
9753442|NCT00334633|10856240|FG001|STARTED|Overall Study||200
9753443|NCT00334633|10856241|FG002|STARTED|Overall Study||196
9753444|NCT00334633|10856239|FG000|COMPLETED|Overall Study||117
9753445|NCT00334633|10856240|FG001|COMPLETED|Overall Study||118
9753446|NCT00334633|10856241|FG002|COMPLETED|Overall Study||114
9753447|NCT00334633|10856239|FG000|NOT COMPLETED|Overall Study||80
9753448|NCT00334633|10856240|FG001|NOT COMPLETED|Overall Study||82
9753449|NCT00334633|10856241|FG002|NOT COMPLETED|Overall Study||82
9753450|NCT00334737|10856255|FG000|STARTED|Hospital Phase||34
9753451|NCT00334737|10856256|FG001|STARTED|Hospital Phase||34
9753452|NCT00334737|10856257|FG002|STARTED|Hospital Phase||34
9753453|NCT00334737|10856255|FG000|COMPLETED|Hospital Phase||32
9753454|NCT00334737|10856256|FG001|COMPLETED|Hospital Phase||32
9753455|NCT00334737|10856257|FG002|COMPLETED|Hospital Phase||30
9854062|NCT00891176|10967070|FG003|NOT COMPLETED|At 3 Years of Age||0
9753456|NCT00334737|10856255|FG000|NOT COMPLETED|Hospital Phase||2
9753457|NCT00334737|10856256|FG001|NOT COMPLETED|Hospital Phase||2
9753458|NCT00334737|10856257|FG002|NOT COMPLETED|Hospital Phase||4
9753459|NCT00334737|10856255|FG000|STARTED|Follow up Phase||32
9753460|NCT00334737|10856256|FG001|STARTED|Follow up Phase||32
9753461|NCT00334737|10856257|FG002|STARTED|Follow up Phase||30
9753462|NCT00334737|10856255|FG000|COMPLETED|Follow up Phase||27
9753463|NCT00334737|10856256|FG001|COMPLETED|Follow up Phase||29
9753464|NCT00334737|10856257|FG002|COMPLETED|Follow up Phase||24
9753465|NCT00334737|10856255|FG000|NOT COMPLETED|Follow up Phase||5
9753466|NCT00334737|10856256|FG001|NOT COMPLETED|Follow up Phase||3
9753467|NCT00334737|10856257|FG002|NOT COMPLETED|Follow up Phase||6
9753468|NCT00334802|10856267|FG000|STARTED|Overall Study||6
9753469|NCT00334802|10856268|FG001|STARTED|Overall Study||56
9753470|NCT00334802|10856267|FG000|COMPLETED|Overall Study||0
9753471|NCT00334802|10856268|FG001|COMPLETED|Overall Study||16
9753472|NCT00334802|10856267|FG000|NOT COMPLETED|Overall Study||6
9753473|NCT00334802|10856268|FG001|NOT COMPLETED|Overall Study||40
9753474|NCT00334893|10856279|FG000|STARTED|Overall Study||37
9753475|NCT00334893|10856280|FG001|STARTED|Overall Study||37
9753476|NCT00334893|10856279|FG000|COMPLETED|Overall Study||36
9753477|NCT00334893|10856280|FG001|COMPLETED|Overall Study||37
9753478|NCT00334893|10856279|FG000|NOT COMPLETED|Overall Study||1
9753479|NCT00334893|10856280|FG001|NOT COMPLETED|Overall Study||0
9753480|NCT00334958|10856290|FG000|STARTED|Overall Study||176
9753481|NCT00334958|10856291|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
9753482|NCT00334958|10856290|FG000|COMPLETED|Overall Study||139
9753483|NCT00334958|10856291|FG001|COMPLETED|Overall Study||156
9753484|NCT00334958|10856290|FG000|NOT COMPLETED|Overall Study||37
9753485|NCT00334958|10856291|FG001|NOT COMPLETED|Overall Study||24
9753486|NCT00335140|10856297|FG000|STARTED|Overall Study||26
9753487|NCT00335140|10856297|FG000|Eligible|Overall Study||25
9753488|NCT00335140|10856297|FG000|Treated|Overall Study||25
9753489|NCT00335140|10856297|FG000|COMPLETED|Overall Study||25
9753490|NCT00335140|10856297|FG000|NOT COMPLETED|Overall Study||1
9753491|NCT00335153|10856301|FG000|STARTED|Nasojejunal (NJ) Test Period||354
9753492|NCT00335153|10856301|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324
9753493|NCT00335153|10856301|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
9753494|NCT00335153|10856301|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324
9753495|NCT00335153|10856301|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
9753496|NCT00335153|10856301|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
9753497|NCT00335257|10856308|FG000|STARTED|Overall Study||15542
9753498|NCT00335257|10856309|FG001|STARTED|Overall Study||9377
9753499|NCT00335257|10856310|FG002|STARTED|Overall Study||60190
9753500|NCT00335257|10856308|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
9753501|NCT00335257|10856309|FG001|COMPLETED|Overall Study||9377
9753502|NCT00335257|10856310|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
9753503|NCT00335257|10856308|FG000|NOT COMPLETED|Overall Study||0
9854063|NCT00891176|10967067|FG000|STARTED|At 4 Years of Age||140
9854064|NCT00891176|10967068|FG001|STARTED|At 4 Years of Age||142
9854065|NCT00891176|10967069|FG002|STARTED|At 4 Years of Age||142
9753504|NCT00335257|10856309|FG001|NOT COMPLETED|Overall Study||0
9753505|NCT00335257|10856310|FG002|NOT COMPLETED|Overall Study||0
9753506|NCT00335283|10856326|FG000|STARTED|Overall Study||36
9753507|NCT00335283|10856327|FG001|STARTED|Overall Study||39
9753508|NCT00335283|10856326|FG000|COMPLETED|Overall Study||30
9753509|NCT00335283|10856327|FG001|COMPLETED|Overall Study||34
9753510|NCT00335283|10856326|FG000|NOT COMPLETED|Overall Study||6
9753511|NCT00335283|10856327|FG001|NOT COMPLETED|Overall Study||5
9753512|NCT00335322|10856336|FG000|STARTED|Overall Study||115
9753513|NCT00335322|10856337|FG001|STARTED|Overall Study||107
9753514|NCT00335322|10856338|FG002|STARTED|Overall Study||105
9753515|NCT00335322|10856336|FG000|COMPLETED|Overall Study||114
9753516|NCT00335322|10856337|FG001|COMPLETED|Overall Study||105
9753517|NCT00335322|10856338|FG002|COMPLETED|Overall Study||103
9753518|NCT00335322|10856336|FG000|NOT COMPLETED|Overall Study||1
9753519|NCT00335322|10856337|FG001|NOT COMPLETED|Overall Study||2
9753520|NCT00335322|10856338|FG002|NOT COMPLETED|Overall Study||2
9753521|NCT00335452|10856353|FG000|STARTED|Overall Study|Randomized|6312
9753522|NCT00335452|10856354|FG001|STARTED|Overall Study|Randomized|6254
9753523|NCT00335452|10856355|FG002|STARTED|Overall Study|Randomized|6267
9753524|NCT00335452|10856356|FG003|STARTED|Overall Study|Randomized|6253
9753525|NCT00335452|10856353|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271
9753526|NCT00335452|10856354|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218
9753527|NCT00335452|10856355|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228
9753528|NCT00335452|10856356|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217
9753529|NCT00335452|10856353|FG000|TREATED WITH ASA|Overall Study||6302
9753530|NCT00335452|10856354|FG001|TREATED WITH ASA|Overall Study||6251
9753531|NCT00335452|10856355|FG002|TREATED WITH ASA|Overall Study||6261
9753532|NCT00335452|10856356|FG003|TREATED WITH ASA|Overall Study||6247
9753533|NCT00335452|10856353|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
9753534|NCT00335452|10856354|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
9753535|NCT00335452|10856355|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
9753536|NCT00335452|10856356|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
9753537|NCT00335452|10856353|FG000|NOT COMPLETED|Overall Study||158
9753538|NCT00335452|10856354|FG001|NOT COMPLETED|Overall Study||147
9753539|NCT00335452|10856355|FG002|NOT COMPLETED|Overall Study||159
9753540|NCT00335452|10856356|FG003|NOT COMPLETED|Overall Study||131
9753541|NCT00335478|10856371|FG000|STARTED|Overall Study||54
9753542|NCT00335478|10856371|FG000|COMPLETED|Overall Study||30
9854066|NCT00891176|10967070|FG003|STARTED|At 4 Years of Age||137
9753543|NCT00335478|10856371|FG000|NOT COMPLETED|Overall Study||24
9753544|NCT00335504|10856379|FG000|STARTED|Overall Study||22
9753545|NCT00335504|10856380|FG001|STARTED|Overall Study||21
9753546|NCT00335504|10856381|FG002|STARTED|Overall Study||20
9753547|NCT00335504|10856382|FG003|STARTED|Overall Study||22
9753548|NCT00335504|10856379|FG000|COMPLETED|Overall Study||22
9753549|NCT00335504|10856380|FG001|COMPLETED|Overall Study||21
9753550|NCT00335504|10856381|FG002|COMPLETED|Overall Study||20
9753551|NCT00335504|10856382|FG003|COMPLETED|Overall Study||22
9854067|NCT00891176|10967067|FG000|COMPLETED|At 4 Years of Age||140
9854068|NCT00891176|10967068|FG001|COMPLETED|At 4 Years of Age||142
9854069|NCT00891176|10967069|FG002|COMPLETED|At 4 Years of Age||142
9753552|NCT00335504|10856379|FG000|NOT COMPLETED|Overall Study||0
9753553|NCT00335504|10856380|FG001|NOT COMPLETED|Overall Study||0
9753554|NCT00335504|10856381|FG002|NOT COMPLETED|Overall Study||0
9753555|NCT00335504|10856382|FG003|NOT COMPLETED|Overall Study||0
9753556|NCT00335517|10856392|FG000|STARTED|Overall Study||100
9753557|NCT00335517|10856392|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
9753558|NCT00335517|10856392|FG000|NOT COMPLETED|Overall Study||2
9753559|NCT00335556|10856402|FG000|STARTED|Overall Study||68
9753560|NCT00335556|10856403|FG001|STARTED|Overall Study||98
9753561|NCT00335556|10856404|FG002|STARTED|Overall Study||7
9753562|NCT00335556|10856405|FG003|STARTED|Overall Study||10
9753563|NCT00335556|10856406|FG004|STARTED|Overall Study||78
9753564|NCT00335556|10856407|FG005|STARTED|Overall Study||30
9753565|NCT00335556|10856402|FG000|COMPLETED|Overall Study||66
9753566|NCT00335556|10856403|FG001|COMPLETED|Overall Study||64
9753567|NCT00335556|10856404|FG002|COMPLETED|Overall Study||2
9753568|NCT00335556|10856405|FG003|COMPLETED|Overall Study||5
9753569|NCT00335556|10856406|FG004|COMPLETED|Overall Study||77
9753570|NCT00335556|10856407|FG005|COMPLETED|Overall Study||29
9753571|NCT00335556|10856402|FG000|NOT COMPLETED|Overall Study||2
9753572|NCT00335556|10856403|FG001|NOT COMPLETED|Overall Study||34
9753573|NCT00335556|10856404|FG002|NOT COMPLETED|Overall Study||5
9753574|NCT00335556|10856405|FG003|NOT COMPLETED|Overall Study||5
9753575|NCT00335556|10856406|FG004|NOT COMPLETED|Overall Study||1
9753576|NCT00335556|10856407|FG005|NOT COMPLETED|Overall Study||1
9753577|NCT00335725|10856428|FG000|STARTED|Overall Study||75
9753578|NCT00335725|10856429|FG001|STARTED|Overall Study||76
9753579|NCT00335725|10856428|FG000|COMPLETED|Overall Study||71
9753580|NCT00335725|10856429|FG001|COMPLETED|Overall Study||71
9753581|NCT00335725|10856428|FG000|NOT COMPLETED|Overall Study||4
9753582|NCT00335725|10856429|FG001|NOT COMPLETED|Overall Study||5
9753583|NCT00335738|10856438|FG000|STARTED|Overall Study||108
9753584|NCT00335738|10856439|FG001|STARTED|Overall Study||223
9753585|NCT00335738|10856438|FG000|COMPLETED|Overall Study||97
9753586|NCT00335738|10856439|FG001|COMPLETED|Overall Study||219
9753587|NCT00335738|10856438|FG000|NOT COMPLETED|Overall Study||11
9753588|NCT00335738|10856439|FG001|NOT COMPLETED|Overall Study||4
9753589|NCT00335764|10856451|FG000|STARTED|Overall Study||17
9753590|NCT00335764|10856452|FG001|STARTED|Overall Study||13
9753591|NCT00335764|10856453|FG002|STARTED|Overall Study||24
9753592|NCT00335764|10856454|FG003|STARTED|Overall Study||19
9753593|NCT00335764|10856455|FG004|STARTED|Overall Study||19
9753594|NCT00335764|10856451|FG000|COMPLETED|Overall Study||16
9753595|NCT00335764|10856452|FG001|COMPLETED|Overall Study||13
9753596|NCT00335764|10856453|FG002|COMPLETED|Overall Study||24
9753597|NCT00335764|10856454|FG003|COMPLETED|Overall Study||19
9753598|NCT00335764|10856455|FG004|COMPLETED|Overall Study||18
9753599|NCT00335764|10856451|FG000|NOT COMPLETED|Overall Study||1
9753600|NCT00335764|10856452|FG001|NOT COMPLETED|Overall Study||0
9753601|NCT00335764|10856453|FG002|NOT COMPLETED|Overall Study||0
9753602|NCT00335764|10856454|FG003|NOT COMPLETED|Overall Study||0
9753603|NCT00335764|10856455|FG004|NOT COMPLETED|Overall Study||1
9753604|NCT00335829|10856491|FG000|STARTED|Overall Study||26
9753605|NCT00335829|10856491|FG000|Received Bevacizumab|Overall Study||26
9753606|NCT00335829|10856491|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
9753607|NCT00335829|10856491|FG000|COMPLETED|Overall Study||23
9753608|NCT00335829|10856491|FG000|NOT COMPLETED|Overall Study||3
9753609|NCT00335959|10856495|FG000|STARTED|Overall Study||7
9753610|NCT00335959|10856495|FG000|Eligible|Overall Study||6
9753611|NCT00335959|10856495|FG000|Eligible and Began Protocol Therapy|Overall Study||6
9753612|NCT00335959|10856495|FG000|COMPLETED|Overall Study||4
9753613|NCT00335959|10856495|FG000|NOT COMPLETED|Overall Study||3
9753614|NCT00335972|10856502|FG000|STARTED|Overall Study||71
9753615|NCT00335972|10856503|FG001|STARTED|Overall Study||71
9753616|NCT00335972|10856502|FG000|COMPLETED|Overall Study||71
9753617|NCT00335972|10856503|FG001|COMPLETED|Overall Study||68
9753618|NCT00335972|10856502|FG000|NOT COMPLETED|Overall Study||0
9753619|NCT00335972|10856503|FG001|NOT COMPLETED|Overall Study||3
9753620|NCT00336024|10856511|FG000|STARTED|Overall Study||46
9753621|NCT00336024|10856512|FG001|STARTED|Overall Study||45
9753622|NCT00336024|10856511|FG000|COMPLETED|Overall Study||26
9753623|NCT00336024|10856512|FG001|COMPLETED|Overall Study||26
9753624|NCT00336024|10856511|FG000|NOT COMPLETED|Overall Study||20
9753625|NCT00336024|10856512|FG001|NOT COMPLETED|Overall Study||19
9753626|NCT00336232|10856518|FG000|STARTED|Baseline (200mcg Daily)||59
9753627|NCT00336232|10856518|FG000|COMPLETED|Baseline (200mcg Daily)||42
9753628|NCT00336232|10856518|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17
9753629|NCT00336232|10856518|FG000|STARTED|Low Vitamin K (10mcg Daily)||42
9753630|NCT00336232|10856518|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42
9753631|NCT00336232|10856518|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
9753632|NCT00336232|10856518|FG000|STARTED|High Vitamin K (500mcg Daily)||42
9753633|NCT00336232|10856518|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42
9753634|NCT00336232|10856518|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
9753635|NCT00336284|10856524|FG000|STARTED|Overall Study||977
9753636|NCT00336284|10856525|FG001|STARTED|Overall Study||473
9753637|NCT00336284|10856524|FG000|COMPLETED|Overall Study||741
9753638|NCT00336284|10856525|FG001|COMPLETED|Overall Study||322
9753639|NCT00336284|10856524|FG000|NOT COMPLETED|Overall Study||236
9753640|NCT00336284|10856525|FG001|NOT COMPLETED|Overall Study||151
9753641|NCT00336323|10856536|FG000|STARTED|Overall Study||19
9753642|NCT00336323|10856537|FG001|STARTED|Overall Study||22
9753643|NCT00336323|10856538|FG002|STARTED|Overall Study||24
9753644|NCT00336323|10856539|FG003|STARTED|Overall Study||22
9753645|NCT00336323|10856540|FG004|STARTED|Overall Study||22
9753646|NCT00336323|10856536|FG000|3 Week Visit|Overall Study||18
9753647|NCT00336323|10856537|FG001|3 Week Visit|Overall Study||21
9753648|NCT00336323|10856538|FG002|3 Week Visit|Overall Study||24
9753649|NCT00336323|10856539|FG003|3 Week Visit|Overall Study||22
9753650|NCT00336323|10856540|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
9753651|NCT00336323|10856536|FG000|6 Week Visit|Overall Study||18
9753652|NCT00336323|10856537|FG001|6 Week Visit|Overall Study||22
9753653|NCT00336323|10856538|FG002|6 Week Visit|Overall Study||24
9753654|NCT00336323|10856539|FG003|6 Week Visit|Overall Study||22
9753655|NCT00336323|10856540|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
9753656|NCT00336323|10856536|FG000|9 Week Visit|Overall Study||18
9753657|NCT00336323|10856537|FG001|9 Week Visit|Overall Study||21
9753658|NCT00336323|10856538|FG002|9 Week Visit|Overall Study||23
9753659|NCT00336323|10856539|FG003|9 Week Visit|Overall Study||21
9753660|NCT00336323|10856540|FG004|9 Week Visit|Overall Study||19
9753661|NCT00336323|10856536|FG000|12 Week Visit|Overall Study||19
9753662|NCT00336323|10856537|FG001|12 Week Visit|Overall Study||21
9753663|NCT00336323|10856538|FG002|12 Week Visit|Overall Study||24
9753664|NCT00336323|10856539|FG003|12 Week Visit|Overall Study||22
9753665|NCT00336323|10856540|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20
9753666|NCT00336323|10856536|FG000|18 Week Visit|Overall Study||19
9753667|NCT00336323|10856537|FG001|18 Week Visit|Overall Study||22
9753668|NCT00336323|10856538|FG002|18 Week Visit|Overall Study||23
9753669|NCT00336323|10856539|FG003|18 Week Visit|Overall Study||21
9753670|NCT00336323|10856540|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18
9753671|NCT00336323|10856536|FG000|24 Week Visit|Overall Study||18
9753672|NCT00336323|10856537|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20
9753673|NCT00336323|10856538|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22
9753674|NCT00336323|10856539|FG003|24 Week Visit|Overall Study||22
9753675|NCT00336323|10856540|FG004|24 Week Visit|Overall Study||19
9753676|NCT00336323|10856536|FG000|COMPLETED|Overall Study||19
9753677|NCT00336323|10856537|FG001|COMPLETED|Overall Study||21
9753678|NCT00336323|10856538|FG002|COMPLETED|Overall Study||23
9753679|NCT00336323|10856539|FG003|COMPLETED|Overall Study||22
9753680|NCT00336323|10856540|FG004|COMPLETED|Overall Study||19
9753681|NCT00336323|10856536|FG000|NOT COMPLETED|Overall Study||0
9753682|NCT00336323|10856537|FG001|NOT COMPLETED|Overall Study||1
9753683|NCT00336323|10856538|FG002|NOT COMPLETED|Overall Study||1
9753684|NCT00336323|10856539|FG003|NOT COMPLETED|Overall Study||0
9753685|NCT00336323|10856540|FG004|NOT COMPLETED|Overall Study||3
9753686|NCT00336479|10856560|FG000|STARTED|Overall Study||75
9753687|NCT00336479|10856561|FG001|STARTED|Overall Study||79
9753688|NCT00336479|10856562|FG002|STARTED|Overall Study||79
9753689|NCT00336479|10856563|FG003|STARTED|Overall Study||17
9753690|NCT00336479|10856560|FG000|COMPLETED|Overall Study||38
9753691|NCT00336479|10856561|FG001|COMPLETED|Overall Study||54
9753692|NCT00336479|10856562|FG002|COMPLETED|Overall Study||53
9753693|NCT00336479|10856563|FG003|COMPLETED|Overall Study||13
9753694|NCT00336479|10856560|FG000|NOT COMPLETED|Overall Study||37
9753695|NCT00336479|10856561|FG001|NOT COMPLETED|Overall Study||25
9753696|NCT00336479|10856562|FG002|NOT COMPLETED|Overall Study||26
9753697|NCT00336479|10856563|FG003|NOT COMPLETED|Overall Study||4
9753698|NCT00336492|10856577|FG000|STARTED|Overall Study||15
9753699|NCT00336492|10856578|FG001|STARTED|Overall Study||22
9753700|NCT00336492|10856579|FG002|STARTED|Overall Study||23
9753701|NCT00336492|10856577|FG000|COMPLETED|Overall Study||0
9753702|NCT00336492|10856578|FG001|COMPLETED|Overall Study||18
9753703|NCT00336492|10856579|FG002|COMPLETED|Overall Study||12
9753704|NCT00336492|10856577|FG000|NOT COMPLETED|Overall Study||15
9753705|NCT00336492|10856578|FG001|NOT COMPLETED|Overall Study||4
9753706|NCT00336492|10856579|FG002|NOT COMPLETED|Overall Study||11
9753707|NCT00336505|10856589|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291
9753708|NCT00336505|10856590|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291
9753709|NCT00336505|10856589|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
9753710|NCT00336505|10856590|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
9753711|NCT00336505|10856589|FG000|NOT COMPLETED|Overall Study||37
9753712|NCT00336505|10856590|FG001|NOT COMPLETED|Overall Study||27
9753713|NCT00336544|10856598|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261
9753714|NCT00336544|10856599|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260
9753715|NCT00336544|10856598|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
9753716|NCT00336544|10856599|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
9753717|NCT00336544|10856598|FG000|NOT COMPLETED|Overall Study||19
9753718|NCT00336544|10856599|FG001|NOT COMPLETED|Overall Study||22
9753719|NCT00336583|10856605|FG000|STARTED|Overall Study||27
9753720|NCT00336583|10856605|FG000|COMPLETED|Overall Study||25
9753721|NCT00336583|10856605|FG000|NOT COMPLETED|Overall Study||2
9753722|NCT00336700|10856609|FG000|STARTED|Overall Study||25
9753723|NCT00336700|10856609|FG000|COMPLETED|Overall Study||25
9753724|NCT00336700|10856609|FG000|NOT COMPLETED|Overall Study||0
9753725|NCT00336817|10856615|FG000|STARTED|Overall Study||15
9753726|NCT00336817|10856616|FG001|STARTED|Overall Study||15
9753727|NCT00336817|10856615|FG000|COMPLETED|Overall Study||14
9753728|NCT00336817|10856616|FG001|COMPLETED|Overall Study||13
9753729|NCT00336817|10856615|FG000|NOT COMPLETED|Overall Study||1
9753730|NCT00336817|10856616|FG001|NOT COMPLETED|Overall Study||2
9753731|NCT00336856|10856624|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35
9753732|NCT00336856|10856624|FG000|COMPLETED|Overall Study||31
9753733|NCT00336856|10856624|FG000|NOT COMPLETED|Overall Study||4
9753734|NCT00336895|10856628|FG000|STARTED|Overall Study||30
9753735|NCT00336895|10856628|FG000|COMPLETED|Overall Study||26
9753736|NCT00336895|10856628|FG000|NOT COMPLETED|Overall Study||4
9753737|NCT00337077|10856635|FG000|STARTED|Overall Study||43
9753738|NCT00337077|10856636|FG001|STARTED|Overall Study||53
9753739|NCT00337077|10856637|FG002|STARTED|Overall Study||25
9753740|NCT00337077|10856635|FG000|Treated|Overall Study||42
9753741|NCT00337077|10856636|FG001|Treated|Overall Study||52
9753742|NCT00337077|10856637|FG002|Treated|Overall Study||25
9753743|NCT00337077|10856635|FG000|Toxicity Assessed|Overall Study||42
9753744|NCT00337077|10856636|FG001|Toxicity Assessed|Overall Study||51
9753745|NCT00337077|10856637|FG002|Toxicity Assessed|Overall Study||25
9753746|NCT00337077|10856635|FG000|Eligible and Treated|Overall Study||41
9753747|NCT00337077|10856636|FG001|Eligible and Treated|Overall Study||51
9753748|NCT00337077|10856637|FG002|Eligible and Treated|Overall Study||24
9753749|NCT00337077|10856635|FG000|Patients With Measurable Disease|Overall Study||26
9753750|NCT00337077|10856636|FG001|Patients With Measurable Disease|Overall Study||38
9753751|NCT00337077|10856637|FG002|Patients With Measurable Disease|Overall Study||13
9753752|NCT00337077|10856635|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
9753753|NCT00337077|10856636|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
9753754|NCT00337077|10856637|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
9753755|NCT00337077|10856635|FG000|NOT COMPLETED|Overall Study||43
9753756|NCT00337077|10856636|FG001|NOT COMPLETED|Overall Study||53
9753757|NCT00337077|10856637|FG002|NOT COMPLETED|Overall Study||25
9753758|NCT00337103|10856645|FG000|STARTED|Overall Study||554
9753759|NCT00337103|10856646|FG001|STARTED|Overall Study||548
9753760|NCT00337103|10856645|FG000|Treated (Safety Population)|Overall Study||544
9753761|NCT00337103|10856646|FG001|Treated (Safety Population)|Overall Study||546
9753762|NCT00337103|10856645|FG000|COMPLETED|Overall Study||0
9753763|NCT00337103|10856646|FG001|COMPLETED|Overall Study||0
9753764|NCT00337103|10856645|FG000|NOT COMPLETED|Overall Study||554
9753765|NCT00337103|10856646|FG001|NOT COMPLETED|Overall Study||548
9753766|NCT00337129|10856653|FG000|STARTED|Overall Study||40
9753767|NCT00337129|10856653|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
9753768|NCT00337129|10856653|FG000|NOT COMPLETED|Overall Study||40
9753769|NCT00337168|10856657|FG000|STARTED|Overall Study||37
9753770|NCT00337168|10856657|FG000|Eligible|Overall Study||37
9753771|NCT00337168|10856657|FG000|Eligible and Treated|Overall Study||36
9753772|NCT00337168|10856657|FG000|COMPLETED|Overall Study||29
9753773|NCT00337168|10856657|FG000|NOT COMPLETED|Overall Study||8
9753774|NCT00337181|10856664|FG000|STARTED|Overall Study||49
9753775|NCT00337181|10856665|FG001|STARTED|Overall Study||65
9753776|NCT00337181|10856664|FG000|COMPLETED|Overall Study||49
9753777|NCT00337181|10856665|FG001|COMPLETED|Overall Study||65
9753778|NCT00337181|10856664|FG000|NOT COMPLETED|Overall Study||0
9753779|NCT00337181|10856665|FG001|NOT COMPLETED|Overall Study||0
9753780|NCT00337194|10856673|FG000|STARTED|Overall Study||23
9753781|NCT00337194|10856674|FG001|STARTED|Overall Study||7
9753782|NCT00337194|10856673|FG000|COMPLETED|Overall Study||11
9753783|NCT00337194|10856674|FG001|COMPLETED|Overall Study||3
9753784|NCT00337194|10856673|FG000|NOT COMPLETED|Overall Study||12
9753785|NCT00337194|10856674|FG001|NOT COMPLETED|Overall Study||4
9829001|NCT00758498|10939622|FG002|NOT COMPLETED|Overall Study||5
9829002|NCT00758524|10939636|FG000|STARTED|Core Period (Week 0 to Week 8)||92
9829003|NCT00758524|10939637|FG001|STARTED|Core Period (Week 0 to Week 8)||88
9829004|NCT00758524|10939638|FG002|STARTED|Core Period (Week 0 to Week 8)||86
9829005|NCT00758524|10939639|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
9829006|NCT00758524|10939640|FG004|STARTED|Core Period (Week 0 to Week 8)||84
9829007|NCT00758524|10939641|FG005|STARTED|Core Period (Week 0 to Week 8)||77
9829008|NCT00758524|10939642|FG006|STARTED|Core Period (Week 0 to Week 8)||0
9829009|NCT00758524|10939643|FG007|STARTED|Core Period (Week 0 to Week 8)||0
9829010|NCT00758524|10939644|FG008|STARTED|Core Period (Week 0 to Week 8)||0
9829011|NCT00758524|10939645|FG009|STARTED|Core Period (Week 0 to Week 8)||0
9753786|NCT00337207|10856682|FG000|STARTED|Overall Study||55
9753787|NCT00337207|10856682|FG000|COMPLETED|Overall Study||52
9753788|NCT00337207|10856682|FG000|NOT COMPLETED|Overall Study||3
9753789|NCT00337272|10856689|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
9753790|NCT00337272|10856690|FG001|STARTED|Screening Period (Pre-randomization)||0
9753791|NCT00337272|10856689|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
9753792|NCT00337272|10856690|FG001|COMPLETED|Screening Period (Pre-randomization)||0
9753793|NCT00337272|10856689|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6
9753794|NCT00337272|10856690|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0
9753795|NCT00337272|10856689|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
9753796|NCT00337272|10856690|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
9753797|NCT00337272|10856689|FG000|Randomization|Treatment Period||7
9753798|NCT00337272|10856690|FG001|Randomization|Treatment Period||9
9753799|NCT00337272|10856689|FG000|COMPLETED|Treatment Period||6
9753800|NCT00337272|10856690|FG001|COMPLETED|Treatment Period||7
9753801|NCT00337272|10856689|FG000|NOT COMPLETED|Treatment Period||1
9753802|NCT00337272|10856690|FG001|NOT COMPLETED|Treatment Period||2
9753803|NCT00337272|10856689|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
9753804|NCT00337272|10856690|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
9753805|NCT00337272|10856689|FG000|COMPLETED|Withdrawal Period||6
9753806|NCT00337272|10856690|FG001|COMPLETED|Withdrawal Period||6
9753807|NCT00337272|10856689|FG000|NOT COMPLETED|Withdrawal Period||0
9753808|NCT00337272|10856690|FG001|NOT COMPLETED|Withdrawal Period||1
9753809|NCT00337285|10856696|FG000|STARTED|Overall Study||349
9753810|NCT00337285|10856696|FG000|COMPLETED|Overall Study||191
9753811|NCT00337285|10856696|FG000|NOT COMPLETED|Overall Study||158
9753812|NCT00337350|10856702|FG000|STARTED|Overall Study||9
9753813|NCT00337350|10856703|FG001|STARTED|Overall Study||11
9753814|NCT00337350|10856702|FG000|COMPLETED|Overall Study||8
9753815|NCT00337350|10856703|FG001|COMPLETED|Overall Study||10
9753816|NCT00337350|10856702|FG000|NOT COMPLETED|Overall Study||1
9753817|NCT00337350|10856703|FG001|NOT COMPLETED|Overall Study||1
9753818|NCT00337428|10856711|FG000|STARTED|Overall Study||419
9753819|NCT00337428|10856712|FG001|STARTED|Overall Study||424
9753820|NCT00337428|10856711|FG000|COMPLETED|Overall Study||415
9753821|NCT00337428|10856712|FG001|COMPLETED|Overall Study||421
9753822|NCT00337428|10856711|FG000|NOT COMPLETED|Overall Study||4
9753823|NCT00337428|10856712|FG001|NOT COMPLETED|Overall Study||3
9753824|NCT00337467|10856718|FG000|STARTED|Overall Study||61
9753825|NCT00337467|10856718|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
9753826|NCT00337467|10856718|FG000|COMPLETED|Overall Study||51
9753827|NCT00337467|10856718|FG000|NOT COMPLETED|Overall Study||10
9753828|NCT00337571|10856729|FG000|STARTED|Overall Study||52
9753829|NCT00337571|10856730|FG001|STARTED|Overall Study||53
9753830|NCT00337571|10856731|FG002|STARTED|Overall Study||59
9753831|NCT00337571|10856732|FG003|STARTED|Overall Study||54
9753832|NCT00337571|10856729|FG000|COMPLETED|Overall Study||38
9753833|NCT00337571|10856730|FG001|COMPLETED|Overall Study||44
9753834|NCT00337571|10856731|FG002|COMPLETED|Overall Study||49
9753835|NCT00337571|10856732|FG003|COMPLETED|Overall Study||47
9753836|NCT00337571|10856729|FG000|NOT COMPLETED|Overall Study||14
9753837|NCT00337571|10856730|FG001|NOT COMPLETED|Overall Study||9
9753838|NCT00337571|10856731|FG002|NOT COMPLETED|Overall Study||10
9753839|NCT00337571|10856732|FG003|NOT COMPLETED|Overall Study||7
9753840|NCT00337610|10856744|FG000|STARTED|Overall Study||96
9753841|NCT00337610|10856745|FG001|STARTED|Overall Study||94
9753842|NCT00337610|10856744|FG000|Completed Week 18|Overall Study||89
9753843|NCT00337610|10856745|FG001|Completed Week 18|Overall Study||82
9753844|NCT00337610|10856744|FG000|COMPLETED|Overall Study||79
9753845|NCT00337610|10856745|FG001|COMPLETED|Overall Study||80
9753846|NCT00337610|10856744|FG000|NOT COMPLETED|Overall Study||17
9753847|NCT00337610|10856745|FG001|NOT COMPLETED|Overall Study||14
9753848|NCT00337662|10856754|FG000|STARTED|Study Period II||0
9753849|NCT00337662|10856755|FG001|STARTED|Study Period II||0
9753850|NCT00337662|10856756|FG002|STARTED|Study Period II||0
9753851|NCT00337662|10856757|FG003|STARTED|Study Period II||628
9753852|NCT00337662|10856754|FG000|COMPLETED|Study Period II||0
9753853|NCT00337662|10856755|FG001|COMPLETED|Study Period II||0
9753854|NCT00337662|10856756|FG002|COMPLETED|Study Period II||0
9753855|NCT00337662|10856757|FG003|COMPLETED|Study Period II||522
9753856|NCT00337662|10856754|FG000|NOT COMPLETED|Study Period II||0
9753857|NCT00337662|10856755|FG001|NOT COMPLETED|Study Period II||0
9753858|NCT00337662|10856756|FG002|NOT COMPLETED|Study Period II||0
9753859|NCT00337662|10856757|FG003|NOT COMPLETED|Study Period II||106
9753860|NCT00337662|10856754|FG000|STARTED|Study Period III||186
9753861|NCT00337662|10856755|FG001|STARTED|Study Period III||192
9753862|NCT00337662|10856756|FG002|STARTED|Study Period III||144
9753863|NCT00337662|10856757|FG003|STARTED|Study Period III||0
9753864|NCT00337662|10856754|FG000|COMPLETED|Study Period III||126
9753865|NCT00337662|10856755|FG001|COMPLETED|Study Period III||134
9753866|NCT00337662|10856756|FG002|COMPLETED|Study Period III||100
9753867|NCT00337662|10856757|FG003|COMPLETED|Study Period III||0
9753868|NCT00337662|10856754|FG000|NOT COMPLETED|Study Period III||60
9753869|NCT00337662|10856755|FG001|NOT COMPLETED|Study Period III||58
9753870|NCT00337662|10856756|FG002|NOT COMPLETED|Study Period III||44
9753871|NCT00337662|10856757|FG003|NOT COMPLETED|Study Period III||0
9753872|NCT00337727|10856770|FG000|STARTED|Overall Study||430
9753873|NCT00337727|10856771|FG001|STARTED|Overall Study||418
9753874|NCT00337727|10856770|FG000|COMPLETED|Overall Study||412
10092339|NCT02336438|11220778|FG000|COMPLETED|Overall Study||10
10092340|NCT02336438|11220778|FG000|NOT COMPLETED|Overall Study||1
10092341|NCT02336451|11220787|FG000|STARTED|Overall Study||42
9753875|NCT00337727|10856771|FG001|COMPLETED|Overall Study||406
9753876|NCT00337727|10856770|FG000|NOT COMPLETED|Overall Study||18
9753877|NCT00337727|10856771|FG001|NOT COMPLETED|Overall Study||12
9753878|NCT00337779|10856779|FG000|STARTED|Overall Study||586
9753879|NCT00337779|10856780|FG001|STARTED|Overall Study||569
9753880|NCT00337779|10856779|FG000|COMPLETED|Overall Study||534
9753881|NCT00337779|10856780|FG001|COMPLETED|Overall Study||490
9753882|NCT00337779|10856779|FG000|NOT COMPLETED|Overall Study||52
9854070|NCT00891176|10967070|FG003|COMPLETED|At 4 Years of Age||137
9854071|NCT00891176|10967067|FG000|NOT COMPLETED|At 4 Years of Age||0
9854072|NCT00891176|10967068|FG001|NOT COMPLETED|At 4 Years of Age||0
9854073|NCT00891176|10967069|FG002|NOT COMPLETED|At 4 Years of Age||0
9854074|NCT00891176|10967070|FG003|NOT COMPLETED|At 4 Years of Age||0
9854075|NCT00891176|10967067|FG000|STARTED|At 6 Years of Age||131
9854076|NCT00891176|10967068|FG001|STARTED|At 6 Years of Age||138
9854077|NCT00891176|10967069|FG002|STARTED|At 6 Years of Age||135
9854078|NCT00891176|10967070|FG003|STARTED|At 6 Years of Age||135
9854079|NCT00891176|10967067|FG000|COMPLETED|At 6 Years of Age||131
9854080|NCT00891176|10967068|FG001|COMPLETED|At 6 Years of Age||138
9854081|NCT00891176|10967069|FG002|COMPLETED|At 6 Years of Age||135
9854082|NCT00891176|10967070|FG003|COMPLETED|At 6 Years of Age||135
9854083|NCT00891176|10967067|FG000|NOT COMPLETED|At 6 Years of Age||0
9854084|NCT00891176|10967068|FG001|NOT COMPLETED|At 6 Years of Age||0
9854085|NCT00891176|10967069|FG002|NOT COMPLETED|At 6 Years of Age||0
9854086|NCT00891176|10967070|FG003|NOT COMPLETED|At 6 Years of Age||0
9854087|NCT00891202|10967088|FG000|STARTED|PAP (Up To Week 39)||20
9854088|NCT00891202|10967089|FG001|STARTED|PAP (Up To Week 39)||20
9854089|NCT00891202|10967090|FG002|STARTED|PAP (Up To Week 39)||0
9854090|NCT00891202|10967091|FG003|STARTED|PAP (Up To Week 39)||0
9854091|NCT00891202|10967088|FG000|COMPLETED|PAP (Up To Week 39)||19
9854092|NCT00891202|10967089|FG001|COMPLETED|PAP (Up To Week 39)||20
9854093|NCT00891202|10967090|FG002|COMPLETED|PAP (Up To Week 39)||0
9854094|NCT00891202|10967091|FG003|COMPLETED|PAP (Up To Week 39)||0
9854095|NCT00891202|10967088|FG000|NOT COMPLETED|PAP (Up To Week 39)||1
9753883|NCT00337779|10856780|FG001|NOT COMPLETED|Overall Study||79
9753884|NCT00337818|10856789|FG000|STARTED|Overall Study||458
9753885|NCT00337818|10856790|FG001|STARTED|Overall Study||154
9753886|NCT00337818|10856791|FG002|STARTED|Overall Study||158
9753887|NCT00337818|10856789|FG000|COMPLETED|Overall Study||169
9753888|NCT00337818|10856790|FG001|COMPLETED|Overall Study||63
9753889|NCT00337818|10856791|FG002|COMPLETED|Overall Study||51
9753890|NCT00337818|10856789|FG000|NOT COMPLETED|Overall Study||289
9753891|NCT00337818|10856790|FG001|NOT COMPLETED|Overall Study||91
9753892|NCT00337818|10856791|FG002|NOT COMPLETED|Overall Study||107
9753893|NCT00337935|10856801|FG000|STARTED|Overall Study||39
9753894|NCT00337935|10856802|FG001|STARTED|Overall Study||118
9753895|NCT00337935|10856801|FG000|COMPLETED|Overall Study||29
9753896|NCT00337935|10856802|FG001|COMPLETED|Overall Study||91
9753897|NCT00337935|10856801|FG000|NOT COMPLETED|Overall Study||10
9753898|NCT00337935|10856802|FG001|NOT COMPLETED|Overall Study||27
9753899|NCT00337987|10856809|FG000|STARTED|Overall Study||49
9753900|NCT00337987|10856809|FG000|COMPLETED|Overall Study||49
9753901|NCT00337987|10856809|FG000|NOT COMPLETED|Overall Study||0
9753902|NCT00338039|10856813|FG000|STARTED|Overall Study||69
9753903|NCT00338039|10856813|FG000|COMPLETED|Overall Study||69
9753904|NCT00338039|10856813|FG000|NOT COMPLETED|Overall Study||0
9753905|NCT00338286|10856819|FG000|STARTED|Overall Study||1048
9753906|NCT00338286|10856820|FG001|STARTED|Overall Study||1050
9753907|NCT00338286|10856819|FG000|COMPLETED|Overall Study||815
9753908|NCT00338286|10856820|FG001|COMPLETED|Overall Study||837
9753909|NCT00338286|10856819|FG000|NOT COMPLETED|Overall Study||233
9753910|NCT00338286|10856820|FG001|NOT COMPLETED|Overall Study||213
9753911|NCT00338598|10856828|FG000|STARTED|Overall Study||10
9753912|NCT00338598|10856829|FG001|STARTED|Overall Study||10
9753913|NCT00338598|10856828|FG000|COMPLETED|Overall Study||10
9753914|NCT00338598|10856829|FG001|COMPLETED|Overall Study||8
9753915|NCT00338598|10856828|FG000|NOT COMPLETED|Overall Study||0
9753916|NCT00338598|10856829|FG001|NOT COMPLETED|Overall Study||2
9753917|NCT00338728|10856835|FG000|STARTED|Overall Study||59
9753918|NCT00338728|10856835|FG000|COMPLETED|Overall Study||45
9753919|NCT00338728|10856835|FG000|NOT COMPLETED|Overall Study||14
9753920|NCT00338741|10856841|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
9753921|NCT00338741|10856842|FG001|STARTED|Overall Study||2
9753922|NCT00338741|10856841|FG000|COMPLETED|Overall Study||32
9854096|NCT00891202|10967089|FG001|NOT COMPLETED|PAP (Up To Week 39)||0
9854097|NCT00891202|10967090|FG002|NOT COMPLETED|PAP (Up To Week 39)||0
9854098|NCT00891202|10967091|FG003|NOT COMPLETED|PAP (Up To Week 39)||0
9854099|NCT00891202|10967088|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0
9854100|NCT00891202|10967089|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0
9854101|NCT00891202|10967090|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19
10092342|NCT02336451|11220788|FG001|STARTED|Overall Study||40
10092343|NCT02336451|11220789|FG002|STARTED|Overall Study||12
10092344|NCT02336451|11220790|FG003|STARTED|Overall Study||44
9753923|NCT00338741|10856842|FG001|COMPLETED|Overall Study||2
9753924|NCT00338741|10856841|FG000|NOT COMPLETED|Overall Study||2
9753925|NCT00338741|10856842|FG001|NOT COMPLETED|Overall Study||0
9753926|NCT00338806|10856850|FG000|STARTED|Acute Phase||2
9753927|NCT00338806|10856851|FG001|STARTED|Acute Phase||5
9753928|NCT00338806|10856850|FG000|COMPLETED|Acute Phase||2
9753929|NCT00338806|10856851|FG001|COMPLETED|Acute Phase||4
9753930|NCT00338806|10856850|FG000|NOT COMPLETED|Acute Phase||0
9753931|NCT00338806|10856851|FG001|NOT COMPLETED|Acute Phase||1
9753932|NCT00338806|10856850|FG000|STARTED|Follow-up||2
9753933|NCT00338806|10856851|FG001|STARTED|Follow-up||4
9753934|NCT00338806|10856850|FG000|COMPLETED|Follow-up||1
9753935|NCT00338806|10856851|FG001|COMPLETED|Follow-up||1
9753936|NCT00338806|10856850|FG000|NOT COMPLETED|Follow-up||1
9753937|NCT00338806|10856851|FG001|NOT COMPLETED|Follow-up||3
9753938|NCT00338884|10856859|FG000|STARTED|Overall Study||120
9753939|NCT00338884|10856859|FG000|Received Treatment|Overall Study||119
9753940|NCT00338884|10856859|FG000|COMPLETED|Overall Study||42
9753941|NCT00338884|10856859|FG000|NOT COMPLETED|Overall Study||78
9753942|NCT00338949|10856865|FG000|STARTED|Subject Screening||36
9753943|NCT00338949|10856866|FG001|STARTED|Subject Screening||41
9753944|NCT00338949|10856865|FG000|COMPLETED|Subject Screening||25
9753945|NCT00338949|10856866|FG001|COMPLETED|Subject Screening||30
9753946|NCT00338949|10856865|FG000|NOT COMPLETED|Subject Screening||11
9753947|NCT00338949|10856866|FG001|NOT COMPLETED|Subject Screening||11
9753948|NCT00338949|10856865|FG000|STARTED|Randomization||25
9753949|NCT00338949|10856866|FG001|STARTED|Randomization||30
9753950|NCT00338949|10856865|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
9753951|NCT00338949|10856866|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25
9753952|NCT00338949|10856865|FG000|NOT COMPLETED|Randomization||1
9753953|NCT00338949|10856866|FG001|NOT COMPLETED|Randomization||5
9753954|NCT00338962|10856876|FG000|STARTED|Overall Study||22
9753955|NCT00338962|10856877|FG001|STARTED|Overall Study||20
9753956|NCT00338962|10856878|FG002|STARTED|Overall Study||22
9753957|NCT00338962|10856879|FG003|STARTED|Overall Study||24
9753958|NCT00338962|10856876|FG000|COMPLETED|Overall Study||14
9753959|NCT00338962|10856877|FG001|COMPLETED|Overall Study||16
9753960|NCT00338962|10856878|FG002|COMPLETED|Overall Study||16
9753961|NCT00338962|10856879|FG003|COMPLETED|Overall Study||21
9753962|NCT00338962|10856876|FG000|NOT COMPLETED|Overall Study||8
9753963|NCT00338962|10856877|FG001|NOT COMPLETED|Overall Study||4
9753964|NCT00338962|10856878|FG002|NOT COMPLETED|Overall Study||6
9753965|NCT00338962|10856879|FG003|NOT COMPLETED|Overall Study||3
9753966|NCT00338988|10856889|FG000|STARTED|Overall Study||44
9753967|NCT00338988|10856889|FG000|COMPLETED|Overall Study||43
9753968|NCT00338988|10856889|FG000|NOT COMPLETED|Overall Study||1
9753969|NCT00339040|10856896|FG000|STARTED|Stage I||96
9753970|NCT00339040|10856897|FG001|STARTED|Stage I||30
9753971|NCT00339040|10856896|FG000|Vaccination 1 at Week 0|Stage I||96
9753972|NCT00339040|10856897|FG001|Vaccination 1 at Week 0|Stage I||30
9753973|NCT00339040|10856896|FG000|Vaccination 2 at Week 8|Stage I||95
9753974|NCT00339040|10856897|FG001|Vaccination 2 at Week 8|Stage I||30
9753975|NCT00339040|10856896|FG000|Vaccination 3 at Week 24|Stage I||94
9753976|NCT00339040|10856897|FG001|Vaccination 3 at Week 24|Stage I||30
9753977|NCT00339040|10856896|FG000|COMPLETED|Stage I||94
9753978|NCT00339040|10856897|FG001|COMPLETED|Stage I||29
9753979|NCT00339040|10856896|FG000|NOT COMPLETED|Stage I||2
9753980|NCT00339040|10856897|FG001|NOT COMPLETED|Stage I||1
9753981|NCT00339040|10856896|FG000|STARTED|Stage II||94
9753982|NCT00339040|10856897|FG001|STARTED|Stage II||29
9753983|NCT00339040|10856896|FG000|Vaccination 4 at Week 96|Stage II||84
9753984|NCT00339040|10856897|FG001|Vaccination 4 at Week 96|Stage II||29
9753985|NCT00339040|10856896|FG000|Vaccination 5 at Week 104|Stage II||0
9753986|NCT00339040|10856897|FG001|Vaccination 5 at Week 104|Stage II||28
9753987|NCT00339040|10856896|FG000|Vaccination 6 at Week 120|Stage II||0
9753988|NCT00339040|10856897|FG001|Vaccination 6 at Week 120|Stage II||27
9753989|NCT00339040|10856896|FG000|COMPLETED|Stage II||84
9753990|NCT00339040|10856897|FG001|COMPLETED|Stage II||27
9753991|NCT00339040|10856896|FG000|NOT COMPLETED|Stage II||10
9753992|NCT00339040|10856897|FG001|NOT COMPLETED|Stage II||2
9753993|NCT00339079|10856907|FG000|STARTED|Overall Study||53
9753994|NCT00339079|10856908|FG001|STARTED|Overall Study||44
9753995|NCT00339079|10856909|FG002|STARTED|Overall Study||45
9753996|NCT00339079|10856910|FG003|STARTED|Overall Study||53
9753997|NCT00339079|10856907|FG000|COMPLETED|Overall Study||20
9753998|NCT00339079|10856908|FG001|COMPLETED|Overall Study||21
9753999|NCT00339079|10856909|FG002|COMPLETED|Overall Study||27
9754000|NCT00339079|10856910|FG003|COMPLETED|Overall Study||29
9754001|NCT00339079|10856907|FG000|NOT COMPLETED|Overall Study||33
9754002|NCT00339079|10856908|FG001|NOT COMPLETED|Overall Study||23
9754003|NCT00339079|10856909|FG002|NOT COMPLETED|Overall Study||18
9754004|NCT00339079|10856910|FG003|NOT COMPLETED|Overall Study||24
9754005|NCT00339144|10856927|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9
9754006|NCT00339144|10856928|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3
9754007|NCT00339144|10856929|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4
9754008|NCT00339144|10856927|FG000|COMPLETED|Overall Study||0
9754009|NCT00339144|10856928|FG001|COMPLETED|Overall Study||0
9754010|NCT00339144|10856929|FG002|COMPLETED|Overall Study||0
9754011|NCT00339144|10856927|FG000|NOT COMPLETED|Overall Study||9
9754012|NCT00339144|10856928|FG001|NOT COMPLETED|Overall Study||3
9754013|NCT00339144|10856929|FG002|NOT COMPLETED|Overall Study||4
9754014|NCT00339183|10856940|FG000|STARTED|Overall Study||591
9754015|NCT00339183|10856941|FG001|STARTED|Overall Study||595
9754016|NCT00339183|10856940|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
9754017|NCT00339183|10856941|FG001|Received Study Drug|Overall Study||593
9754018|NCT00339183|10856940|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
9754019|NCT00339183|10856941|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
9754020|NCT00339183|10856940|FG000|NOT COMPLETED|Overall Study||121
9754021|NCT00339183|10856941|FG001|NOT COMPLETED|Overall Study||105
9754022|NCT00339833|10856953|FG000|STARTED|Overall Study||28
9754023|NCT00339833|10856954|FG001|STARTED|Overall Study||26
9754024|NCT00339833|10856953|FG000|COMPLETED|Overall Study||22
9754025|NCT00339833|10856954|FG001|COMPLETED|Overall Study||18
9754026|NCT00339833|10856953|FG000|NOT COMPLETED|Overall Study||6
9754027|NCT00339833|10856954|FG001|NOT COMPLETED|Overall Study||8
9754028|NCT00340379|10856962|FG000|STARTED|Overall Study||35
9754029|NCT00340379|10856963|FG001|STARTED|Overall Study||37
9754030|NCT00340379|10856962|FG000|COMPLETED|Overall Study||27
9754031|NCT00340379|10856963|FG001|COMPLETED|Overall Study||28
9754032|NCT00340379|10856962|FG000|NOT COMPLETED|Overall Study||8
9754033|NCT00340379|10856963|FG001|NOT COMPLETED|Overall Study||9
9754034|NCT00340678|10856973|FG000|STARTED|Overall Study||46
9754035|NCT00340678|10856974|FG001|STARTED|Overall Study||46
9754036|NCT00340678|10856975|FG002|STARTED|Overall Study||39
9754037|NCT00340678|10856976|FG003|STARTED|Overall Study||39
9754038|NCT00340678|10856973|FG000|COMPLETED|Overall Study||45
9754039|NCT00340678|10856974|FG001|COMPLETED|Overall Study||46
9754040|NCT00340678|10856975|FG002|COMPLETED|Overall Study||39
9754041|NCT00340678|10856976|FG003|COMPLETED|Overall Study||39
9754042|NCT00340678|10856973|FG000|NOT COMPLETED|Overall Study||1
9754043|NCT00340678|10856974|FG001|NOT COMPLETED|Overall Study||0
9754044|NCT00340678|10856975|FG002|NOT COMPLETED|Overall Study||0
9754045|NCT00340678|10856976|FG003|NOT COMPLETED|Overall Study||0
9754046|NCT00340704|10856993|FG000|STARTED|PK Study||10
9754047|NCT00340704|10856994|FG001|STARTED|PK Study||10
10092345|NCT02336451|11220791|FG004|STARTED|Overall Study||18
10092346|NCT02336451|11220787|FG000|COMPLETED|Overall Study||0
10092347|NCT02336451|11220788|FG001|COMPLETED|Overall Study||0
10092348|NCT02336451|11220789|FG002|COMPLETED|Overall Study||0
10092349|NCT02336451|11220790|FG003|COMPLETED|Overall Study||0
10092350|NCT02336451|11220791|FG004|COMPLETED|Overall Study||0
9754048|NCT00340704|10856995|FG002|STARTED|PK Study||11
9754049|NCT00340704|10856996|FG003|STARTED|PK Study||0
9754050|NCT00340704|10856997|FG004|STARTED|PK Study||0
9754051|NCT00340704|10856998|FG005|STARTED|PK Study||0
9754052|NCT00340704|10856999|FG006|STARTED|PK Study||0
9754053|NCT00340704|10857000|FG007|STARTED|PK Study||0
9754054|NCT00340704|10857001|FG008|STARTED|PK Study||0
9754055|NCT00340704|10856993|FG000|COMPLETED|PK Study||10
9754056|NCT00340704|10856994|FG001|COMPLETED|PK Study||9
9754057|NCT00340704|10856995|FG002|COMPLETED|PK Study||10
9754058|NCT00340704|10856996|FG003|COMPLETED|PK Study||0
9754059|NCT00340704|10856997|FG004|COMPLETED|PK Study||0
9754060|NCT00340704|10856998|FG005|COMPLETED|PK Study||0
9754061|NCT00340704|10856999|FG006|COMPLETED|PK Study||0
9754062|NCT00340704|10857000|FG007|COMPLETED|PK Study||0
10092351|NCT02336451|11220787|FG000|NOT COMPLETED|Overall Study||42
10092352|NCT02336451|11220788|FG001|NOT COMPLETED|Overall Study||40
10201761|NCT03440918|11329165|FG000|COMPLETED|Overall Study||133
10201762|NCT03440918|11329166|FG001|COMPLETED|Overall Study||122
9754063|NCT00340704|10857001|FG008|COMPLETED|PK Study||0
9754064|NCT00340704|10856993|FG000|NOT COMPLETED|PK Study||0
9754065|NCT00340704|10856994|FG001|NOT COMPLETED|PK Study||1
9754066|NCT00340704|10856995|FG002|NOT COMPLETED|PK Study||1
9754067|NCT00340704|10856996|FG003|NOT COMPLETED|PK Study||0
9754068|NCT00340704|10856997|FG004|NOT COMPLETED|PK Study||0
9754069|NCT00340704|10856998|FG005|NOT COMPLETED|PK Study||0
9754070|NCT00340704|10856999|FG006|NOT COMPLETED|PK Study||0
9754071|NCT00340704|10857000|FG007|NOT COMPLETED|PK Study||0
9754072|NCT00340704|10857001|FG008|NOT COMPLETED|PK Study||0
9754073|NCT00340704|10856993|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0
9754074|NCT00340704|10856994|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0
9754075|NCT00340704|10856995|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0
9754076|NCT00340704|10856996|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29
9754077|NCT00340704|10856997|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21
9754078|NCT00340704|10856998|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37
9754079|NCT00340704|10856999|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54
9754080|NCT00340704|10857000|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13
9754081|NCT00340704|10857001|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29
10201763|NCT03440918|11329165|FG000|NOT COMPLETED|Overall Study||0
9754082|NCT00340704|10856993|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
9754083|NCT00340704|10856994|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
9754084|NCT00340704|10856995|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
9754085|NCT00340704|10856996|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
10092353|NCT02336451|11220789|FG002|NOT COMPLETED|Overall Study||12
9754086|NCT00340704|10856997|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
10092354|NCT02336451|11220790|FG003|NOT COMPLETED|Overall Study||44
10201764|NCT03440918|11329166|FG001|NOT COMPLETED|Overall Study||16
9754087|NCT00340704|10856998|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
9754088|NCT00340704|10856999|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
9754089|NCT00340704|10857000|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
9754090|NCT00340704|10857001|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
9754091|NCT00340704|10856993|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
9754092|NCT00340704|10856994|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
9754093|NCT00340704|10856995|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
9754094|NCT00340704|10856996|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
9754095|NCT00340704|10856997|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
9754096|NCT00340704|10856998|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
9754097|NCT00340704|10856999|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
9754098|NCT00340704|10857000|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
9754099|NCT00340704|10857001|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
9754100|NCT00340704|10856993|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
9754101|NCT00340704|10856994|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
9754102|NCT00340704|10856995|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
9754103|NCT00340704|10856996|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
9754104|NCT00340704|10856997|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
9754105|NCT00340704|10856998|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
9754106|NCT00340704|10856999|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
9754107|NCT00340704|10857000|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
9754108|NCT00340704|10857001|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
9754109|NCT00340834|10857032|FG000|STARTED|Core Phase of Study||426
9754110|NCT00340834|10857033|FG001|STARTED|Core Phase of Study||431
9754111|NCT00340834|10857034|FG002|STARTED|Core Phase of Study||435
9754112|NCT00340834|10857035|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
9754113|NCT00340834|10857036|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
9754114|NCT00340834|10857032|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
9754115|NCT00340834|10857033|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
9754116|NCT00340834|10857034|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
9754117|NCT00340834|10857035|FG003|COMPLETED|Core Phase of Study||0
9754118|NCT00340834|10857036|FG004|COMPLETED|Core Phase of Study||0
9754119|NCT00340834|10857032|FG000|NOT COMPLETED|Core Phase of Study||57
9754120|NCT00340834|10857033|FG001|NOT COMPLETED|Core Phase of Study||33
9754121|NCT00340834|10857034|FG002|NOT COMPLETED|Core Phase of Study||49
9754122|NCT00340834|10857035|FG003|NOT COMPLETED|Core Phase of Study||0
9754123|NCT00340834|10857036|FG004|NOT COMPLETED|Core Phase of Study||0
9754124|NCT00340834|10857032|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
9754125|NCT00340834|10857033|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
9754126|NCT00340834|10857034|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
9754127|NCT00340834|10857035|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
9754128|NCT00340834|10857036|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
9754129|NCT00340834|10857032|FG000|Received Study Drug|Extension Phase of Study||330
9754130|NCT00340834|10857033|FG001|Received Study Drug|Extension Phase of Study||356
9754131|NCT00340834|10857034|FG002|Received Study Drug|Extension Phase of Study||0
9754132|NCT00340834|10857035|FG003|Received Study Drug|Extension Phase of Study||174
9754133|NCT00340834|10857036|FG004|Received Study Drug|Extension Phase of Study||167
9754134|NCT00340834|10857032|FG000|COMPLETED|Extension Phase of Study||245
9754135|NCT00340834|10857033|FG001|COMPLETED|Extension Phase of Study||281
9754136|NCT00340834|10857034|FG002|COMPLETED|Extension Phase of Study||0
9754137|NCT00340834|10857035|FG003|COMPLETED|Extension Phase of Study||123
9754138|NCT00340834|10857036|FG004|COMPLETED|Extension Phase of Study||123
9754139|NCT00340834|10857032|FG000|NOT COMPLETED|Extension Phase of Study||85
9754140|NCT00340834|10857033|FG001|NOT COMPLETED|Extension Phase of Study||76
9754141|NCT00340834|10857034|FG002|NOT COMPLETED|Extension Phase of Study||0
9754142|NCT00340834|10857035|FG003|NOT COMPLETED|Extension Phase of Study||53
9754143|NCT00340834|10857036|FG004|NOT COMPLETED|Extension Phase of Study||44
9754144|NCT00342355|10857050|FG000|STARTED|Overall Study||444
9754145|NCT00342355|10857051|FG001|STARTED|Overall Study||440
9754146|NCT00342355|10857052|FG002|STARTED|Overall Study||444
9754147|NCT00342355|10857053|FG003|STARTED|Overall Study||443
9754148|NCT00342355|10857050|FG000|COMPLETED|Overall Study||444
9754149|NCT00342355|10857051|FG001|COMPLETED|Overall Study||440
9754150|NCT00342355|10857052|FG002|COMPLETED|Overall Study||444
9754151|NCT00342355|10857053|FG003|COMPLETED|Overall Study||443
9754152|NCT00342355|10857050|FG000|NOT COMPLETED|Overall Study||0
9754153|NCT00342355|10857051|FG001|NOT COMPLETED|Overall Study||0
9754154|NCT00342355|10857052|FG002|NOT COMPLETED|Overall Study||0
9754155|NCT00342355|10857053|FG003|NOT COMPLETED|Overall Study||0
9754156|NCT00342563|10857067|FG000|STARTED|Overall Study||41
9754157|NCT00342563|10857068|FG001|STARTED|Overall Study||27
9754158|NCT00342563|10857069|FG002|STARTED|Overall Study||40
9754159|NCT00342563|10857070|FG003|STARTED|Overall Study||28
9754160|NCT00342563|10857067|FG000|COMPLETED|Overall Study||35
9754161|NCT00342563|10857068|FG001|COMPLETED|Overall Study||19
9754162|NCT00342563|10857069|FG002|COMPLETED|Overall Study||26
9754163|NCT00342563|10857070|FG003|COMPLETED|Overall Study||22
9754164|NCT00342563|10857067|FG000|NOT COMPLETED|Overall Study||6
9754165|NCT00342563|10857068|FG001|NOT COMPLETED|Overall Study||8
9754166|NCT00342563|10857069|FG002|NOT COMPLETED|Overall Study||14
9754167|NCT00342563|10857070|FG003|NOT COMPLETED|Overall Study||6
9754168|NCT00342628|10857085|FG000|STARTED|Overall Study||100
9754169|NCT00342628|10857086|FG001|STARTED|Overall Study||101
9754170|NCT00342628|10857087|FG002|STARTED|Overall Study||100
9754171|NCT00342628|10857085|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
9754172|NCT00342628|10857086|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
9754173|NCT00342628|10857087|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
9754174|NCT00342628|10857085|FG000|NOT COMPLETED|Overall Study||20
9754175|NCT00342628|10857086|FG001|NOT COMPLETED|Overall Study||21
9754176|NCT00342628|10857087|FG002|NOT COMPLETED|Overall Study||19
9754177|NCT00343044|10857095|FG000|STARTED|Overall Study||40
9754178|NCT00343044|10857095|FG000|COMPLETED|Overall Study||40
9754179|NCT00343044|10857095|FG000|NOT COMPLETED|Overall Study||0
9754180|NCT00343083|10857099|FG000|STARTED|Overall Study||43
9754181|NCT00343083|10857099|FG000|COMPLETED|Overall Study||22
9754182|NCT00343083|10857099|FG000|NOT COMPLETED|Overall Study||21
9754183|NCT00343252|10857106|FG000|STARTED|All Randomized Participants||361
9754184|NCT00343252|10857107|FG001|STARTED|All Randomized Participants||351
9754185|NCT00343252|10857106|FG000|COMPLETED|All Randomized Participants||259
9754186|NCT00343252|10857107|FG001|COMPLETED|All Randomized Participants||269
9754187|NCT00343252|10857106|FG000|NOT COMPLETED|All Randomized Participants||102
9754188|NCT00343252|10857107|FG001|NOT COMPLETED|All Randomized Participants||82
9754189|NCT00343252|10857106|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
9754190|NCT00343252|10857107|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
9754191|NCT00343252|10857106|FG000|COMPLETED|6 Months (All Treated Participants)||304
9754192|NCT00343252|10857107|FG001|COMPLETED|6 Months (All Treated Participants)||306
9754193|NCT00343252|10857106|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56
9754194|NCT00343252|10857107|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44
9754195|NCT00343252|10857106|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
9754196|NCT00343252|10857107|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
9754197|NCT00343252|10857106|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
9754198|NCT00343252|10857107|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
9754199|NCT00343252|10857106|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86
9754200|NCT00343252|10857107|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69
9754201|NCT00343252|10857106|FG000|STARTED|18 Months (All Treated Participants)||360
9754202|NCT00343252|10857107|FG001|STARTED|18 Months (All Treated Participants)||350
9754203|NCT00343252|10857106|FG000|COMPLETED|18 Months (All Treated Participants)||259
9754204|NCT00343252|10857107|FG001|COMPLETED|18 Months (All Treated Participants)||269
9754205|NCT00343252|10857106|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101
9754206|NCT00343252|10857107|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81
9754207|NCT00343291|10857115|FG000|STARTED|Overall Study||60
9754208|NCT00343291|10857116|FG001|STARTED|Overall Study||61
9754209|NCT00343291|10857115|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
9754210|NCT00343291|10857116|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
9754211|NCT00343291|10857115|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
9754212|NCT00343291|10857116|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
9754213|NCT00343291|10857115|FG000|NOT COMPLETED|Overall Study||57
9754214|NCT00343291|10857116|FG001|NOT COMPLETED|Overall Study||56
9754215|NCT00343382|10857125|FG000|STARTED|Overall Study||64
9754216|NCT00343382|10857126|FG001|STARTED|Overall Study||65
9754217|NCT00343382|10857127|FG002|STARTED|Overall Study||66
9754218|NCT00343382|10857125|FG000|COMPLETED|Overall Study||60
9754219|NCT00343382|10857126|FG001|COMPLETED|Overall Study||51
9754220|NCT00343382|10857127|FG002|COMPLETED|Overall Study||49
9754221|NCT00343382|10857125|FG000|NOT COMPLETED|Overall Study||4
9754222|NCT00343382|10857126|FG001|NOT COMPLETED|Overall Study||14
9754223|NCT00343382|10857127|FG002|NOT COMPLETED|Overall Study||17
9754224|NCT00343460|10857141|FG000|STARTED|Cycle 1||475
9754225|NCT00343460|10857142|FG001|STARTED|Cycle 1||481
9754226|NCT00343460|10857143|FG002|STARTED|Cycle 1||472
9754227|NCT00343460|10857141|FG000|COMPLETED|Cycle 1||453
9754228|NCT00343460|10857142|FG001|COMPLETED|Cycle 1||459
9754229|NCT00343460|10857143|FG002|COMPLETED|Cycle 1||454
9754230|NCT00343460|10857141|FG000|NOT COMPLETED|Cycle 1||22
9754231|NCT00343460|10857142|FG001|NOT COMPLETED|Cycle 1||22
9754232|NCT00343460|10857143|FG002|NOT COMPLETED|Cycle 1||18
9754233|NCT00343460|10857141|FG000|STARTED|Cycle 2 - 4||584
9754234|NCT00343460|10857142|FG001|STARTED|Cycle 2 - 4||565
9754235|NCT00343460|10857143|FG002|STARTED|Cycle 2 - 4||0
9754236|NCT00343460|10857141|FG000|COMPLETED|Cycle 2 - 4||528
9754237|NCT00343460|10857142|FG001|COMPLETED|Cycle 2 - 4||515
9754238|NCT00343460|10857143|FG002|COMPLETED|Cycle 2 - 4||0
9754239|NCT00343460|10857141|FG000|NOT COMPLETED|Cycle 2 - 4||56
9754240|NCT00343460|10857142|FG001|NOT COMPLETED|Cycle 2 - 4||50
9754241|NCT00343460|10857143|FG002|NOT COMPLETED|Cycle 2 - 4||0
9754242|NCT00343512|10857161|FG000|STARTED|Overall Study||34
9754243|NCT00343512|10857161|FG000|COMPLETED|Overall Study||32
9754244|NCT00343512|10857161|FG000|NOT COMPLETED|Overall Study||2
9754245|NCT00343564|10857177|FG000|STARTED|Overall Study||6
9754246|NCT00343564|10857178|FG001|STARTED|Overall Study||7
9754247|NCT00343564|10857179|FG002|STARTED|Overall Study||3
9754248|NCT00343564|10857180|FG003|STARTED|Overall Study||7
9754249|NCT00343564|10857181|FG004|STARTED|Overall Study||10
9754250|NCT00343564|10857182|FG005|STARTED|Overall Study||9
9754251|NCT00343564|10857183|FG006|STARTED|Overall Study||4
9754252|NCT00343564|10857184|FG007|STARTED|Overall Study||3
9754253|NCT00343564|10857185|FG008|STARTED|Overall Study||3
9754254|NCT00343564|10857186|FG009|STARTED|Overall Study||8
9754255|NCT00343564|10857187|FG010|STARTED|Overall Study||8
9754256|NCT00343564|10857177|FG000|COMPLETED|Overall Study||6
9754257|NCT00343564|10857178|FG001|COMPLETED|Overall Study||7
9754258|NCT00343564|10857179|FG002|COMPLETED|Overall Study||3
9754259|NCT00343564|10857180|FG003|COMPLETED|Overall Study||7
9754260|NCT00343564|10857181|FG004|COMPLETED|Overall Study||10
9754261|NCT00343564|10857182|FG005|COMPLETED|Overall Study||9
9754262|NCT00343564|10857183|FG006|COMPLETED|Overall Study||4
9754263|NCT00343564|10857184|FG007|COMPLETED|Overall Study||3
9754264|NCT00343564|10857185|FG008|COMPLETED|Overall Study||3
9754265|NCT00343564|10857186|FG009|COMPLETED|Overall Study||8
9754266|NCT00343564|10857187|FG010|COMPLETED|Overall Study||8
9754267|NCT00343564|10857177|FG000|NOT COMPLETED|Overall Study||0
9754268|NCT00343564|10857178|FG001|NOT COMPLETED|Overall Study||0
9754269|NCT00343564|10857179|FG002|NOT COMPLETED|Overall Study||0
9754270|NCT00343564|10857180|FG003|NOT COMPLETED|Overall Study||0
9754271|NCT00343564|10857181|FG004|NOT COMPLETED|Overall Study||0
9754272|NCT00343564|10857182|FG005|NOT COMPLETED|Overall Study||0
9754273|NCT00343564|10857183|FG006|NOT COMPLETED|Overall Study||0
9754274|NCT00343564|10857184|FG007|NOT COMPLETED|Overall Study||0
9754275|NCT00343564|10857185|FG008|NOT COMPLETED|Overall Study||0
9754276|NCT00343564|10857186|FG009|NOT COMPLETED|Overall Study||0
9754277|NCT00343564|10857187|FG010|NOT COMPLETED|Overall Study||0
9754278|NCT00343642|10857285|FG000|STARTED|Overall Study||19
9754279|NCT00343642|10857286|FG001|STARTED|Overall Study||19
9754280|NCT00343642|10857287|FG002|STARTED|Overall Study||16
9754281|NCT00343642|10857285|FG000|Upto 3 Months Complete or Flare|Overall Study||2
9754282|NCT00343642|10857286|FG001|Upto 3 Months Complete or Flare|Overall Study||0
9754283|NCT00343642|10857287|FG002|Upto 3 Months Complete or Flare|Overall Study||1
9754284|NCT00343642|10857285|FG000|3-6 Months Complete or Flare|Overall Study||4
9754285|NCT00343642|10857286|FG001|3-6 Months Complete or Flare|Overall Study||2
9754286|NCT00343642|10857287|FG002|3-6 Months Complete or Flare|Overall Study||2
9754287|NCT00343642|10857285|FG000|COMPLETED|Overall Study||10
9754288|NCT00343642|10857286|FG001|COMPLETED|Overall Study||11
9754289|NCT00343642|10857287|FG002|COMPLETED|Overall Study||9
9754290|NCT00343642|10857285|FG000|NOT COMPLETED|Overall Study||9
9754291|NCT00343642|10857286|FG001|NOT COMPLETED|Overall Study||8
9754292|NCT00343642|10857287|FG002|NOT COMPLETED|Overall Study||7
9754293|NCT00343785|10857298|FG000|STARTED|Overall Study||21
9754294|NCT00343785|10857298|FG000|COMPLETED|Overall Study||21
9754295|NCT00343785|10857298|FG000|NOT COMPLETED|Overall Study||0
9754296|NCT00343863|10857305|FG000|STARTED|Overall Study||7
9754297|NCT00343863|10857306|FG001|STARTED|Overall Study||34
9754298|NCT00343863|10857305|FG000|COMPLETED|Overall Study||7
9754299|NCT00343863|10857306|FG001|COMPLETED|Overall Study||34
9754300|NCT00343863|10857305|FG000|NOT COMPLETED|Overall Study||0
9754301|NCT00343863|10857306|FG001|NOT COMPLETED|Overall Study||0
9754302|NCT00343889|10857316|FG000|STARTED|Overall Study||190
9754303|NCT00343889|10857317|FG001|STARTED|Overall Study||189
9754304|NCT00343889|10857316|FG000|COMPLETED|Overall Study||187
9754305|NCT00343889|10857317|FG001|COMPLETED|Overall Study||188
9754306|NCT00343889|10857316|FG000|NOT COMPLETED|Overall Study||3
9754307|NCT00343889|10857317|FG001|NOT COMPLETED|Overall Study||1
9754308|NCT00343915|10857325|FG000|STARTED|Primary Study||258
9754309|NCT00343915|10857326|FG001|STARTED|Primary Study||126
9754310|NCT00343915|10857325|FG000|COMPLETED|Primary Study||254
9754311|NCT00343915|10857326|FG001|COMPLETED|Primary Study||123
9754312|NCT00343915|10857325|FG000|NOT COMPLETED|Primary Study||4
9754313|NCT00343915|10857326|FG001|NOT COMPLETED|Primary Study||3
9754314|NCT00343915|10857325|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
9754315|NCT00343915|10857326|FG001|STARTED|Month 30 Follow-up||88
9754316|NCT00343915|10857325|FG000|COMPLETED|Month 30 Follow-up||179
9754317|NCT00343915|10857326|FG001|COMPLETED|Month 30 Follow-up||88
9754318|NCT00343915|10857325|FG000|NOT COMPLETED|Month 30 Follow-up||0
9754319|NCT00343915|10857326|FG001|NOT COMPLETED|Month 30 Follow-up||0
9754320|NCT00343915|10857325|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
9754321|NCT00343915|10857326|FG001|STARTED|Month 42 Follow-up||84
9754322|NCT00343915|10857325|FG000|COMPLETED|Month 42 Follow-up||174
9754323|NCT00343915|10857326|FG001|COMPLETED|Month 42 Follow-up||84
9754324|NCT00343915|10857325|FG000|NOT COMPLETED|Month 42 Follow-up||0
9754325|NCT00343915|10857326|FG001|NOT COMPLETED|Month 42 Follow-up||0
9754326|NCT00343915|10857325|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
9754327|NCT00343915|10857326|FG001|STARTED|Month 54 Follow-up||79
9754328|NCT00343915|10857325|FG000|COMPLETED|Month 54 Follow-up||166
9754329|NCT00343915|10857326|FG001|COMPLETED|Month 54 Follow-up||79
9754330|NCT00343915|10857325|FG000|NOT COMPLETED|Month 54 Follow-up||0
9754331|NCT00343915|10857326|FG001|NOT COMPLETED|Month 54 Follow-up||0
9754332|NCT00343915|10857325|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
9754333|NCT00343915|10857326|FG001|STARTED|Month 66 Follow-up||76
9754334|NCT00343915|10857325|FG000|COMPLETED|Month 66 Follow-up||158
9754335|NCT00343915|10857326|FG001|COMPLETED|Month 66 Follow-up||76
9754336|NCT00343915|10857325|FG000|NOT COMPLETED|Month 66 Follow-up||0
9854102|NCT00891202|10967091|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20
9854103|NCT00891202|10967088|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
9854104|NCT00891202|10967089|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
9754337|NCT00343915|10857326|FG001|NOT COMPLETED|Month 66 Follow-up||0
9754338|NCT00344032|10857337|FG000|STARTED|Overall Study||176
9754339|NCT00344032|10857338|FG001|STARTED|Overall Study||178
9754340|NCT00344032|10857337|FG000|COMPLETED|Overall Study||162
9754341|NCT00344032|10857338|FG001|COMPLETED|Overall Study||168
9754342|NCT00344032|10857337|FG000|NOT COMPLETED|Overall Study||14
9754343|NCT00344032|10857338|FG001|NOT COMPLETED|Overall Study||10
9754344|NCT00344175|10857346|FG000|STARTED|Overall Study||121
9754345|NCT00344175|10857347|FG001|STARTED|Overall Study||57
9754346|NCT00344175|10857346|FG000|COMPLETED|Overall Study||109
9754347|NCT00344175|10857347|FG001|COMPLETED|Overall Study||47
9754348|NCT00344175|10857346|FG000|NOT COMPLETED|Overall Study||12
9754349|NCT00344175|10857347|FG001|NOT COMPLETED|Overall Study||10
9754350|NCT00344305|10857355|FG000|STARTED|Overall Study||100
9754351|NCT00344305|10857356|FG001|STARTED|Overall Study||100
9754352|NCT00344305|10857355|FG000|COMPLETED|Overall Study||98
9754353|NCT00344305|10857356|FG001|COMPLETED|Overall Study||99
9754354|NCT00344305|10857355|FG000|NOT COMPLETED|Overall Study||2
9754355|NCT00344305|10857356|FG001|NOT COMPLETED|Overall Study||1
9754356|NCT00344318|10857367|FG000|STARTED|Overall Study||300
9754357|NCT00344318|10857368|FG001|STARTED|Overall Study||303
9754358|NCT00344318|10857369|FG002|STARTED|Overall Study||100
9754359|NCT00344318|10857370|FG003|STARTED|Overall Study||103
9754360|NCT00344318|10857367|FG000|COMPLETED|Overall Study||296
9754361|NCT00344318|10857368|FG001|COMPLETED|Overall Study||298
9754362|NCT00344318|10857369|FG002|COMPLETED|Overall Study||99
9754363|NCT00344318|10857370|FG003|COMPLETED|Overall Study||100
9754364|NCT00344318|10857367|FG000|NOT COMPLETED|Overall Study||4
9754365|NCT00344318|10857368|FG001|NOT COMPLETED|Overall Study||5
9754366|NCT00344318|10857369|FG002|NOT COMPLETED|Overall Study||1
9754367|NCT00344318|10857370|FG003|NOT COMPLETED|Overall Study||3
9754368|NCT00344370|10857384|FG000|STARTED|Overall Study||143
9754369|NCT00344370|10857385|FG001|STARTED|Overall Study||71
9754370|NCT00344370|10857384|FG000|COMPLETED|Overall Study||128
9754371|NCT00344370|10857385|FG001|COMPLETED|Overall Study||68
9754372|NCT00344370|10857384|FG000|NOT COMPLETED|Overall Study||15
9754373|NCT00344370|10857385|FG001|NOT COMPLETED|Overall Study||3
9754374|NCT00344448|10857393|FG000|STARTED|Screening|No randomization during the screening phase|6
9754375|NCT00344448|10857394|FG001|STARTED|Screening||4
9754376|NCT00344448|10857393|FG000|COMPLETED|Screening||6
9754377|NCT00344448|10857394|FG001|COMPLETED|Screening||3
9754378|NCT00344448|10857393|FG000|NOT COMPLETED|Screening||0
9754379|NCT00344448|10857394|FG001|NOT COMPLETED|Screening||1
9754380|NCT00344448|10857393|FG000|STARTED|Double Blind, Placebo Controlled||6
9754381|NCT00344448|10857394|FG001|STARTED|Double Blind, Placebo Controlled||3
9754382|NCT00344448|10857393|FG000|COMPLETED|Double Blind, Placebo Controlled||4
9754383|NCT00344448|10857394|FG001|COMPLETED|Double Blind, Placebo Controlled||3
9754384|NCT00344448|10857393|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2
9754385|NCT00344448|10857394|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0
9754386|NCT00344448|10857393|FG000|STARTED|Open Label||4
9754387|NCT00344448|10857394|FG001|STARTED|Open Label||3
9754388|NCT00344448|10857393|FG000|COMPLETED|Open Label||2
9754389|NCT00344448|10857394|FG001|COMPLETED|Open Label||2
9754390|NCT00344448|10857393|FG000|NOT COMPLETED|Open Label||2
9754391|NCT00344448|10857394|FG001|NOT COMPLETED|Open Label||1
9754392|NCT00344461|10857400|FG000|STARTED|Overall Study||54
9754393|NCT00344461|10857400|FG000|COMPLETED|Overall Study||33
9754394|NCT00344461|10857400|FG000|NOT COMPLETED|Overall Study||21
9754395|NCT00344500|10857407|FG000|STARTED|Overall Study||48
9754396|NCT00344500|10857408|FG001|STARTED|Overall Study||60
9754397|NCT00344500|10857409|FG002|STARTED|Overall Study||14
9754398|NCT00344500|10857407|FG000|COMPLETED|Overall Study||25
9754399|NCT00344500|10857408|FG001|COMPLETED|Overall Study||25
9754400|NCT00344500|10857409|FG002|COMPLETED|Overall Study||12
9754401|NCT00344500|10857407|FG000|NOT COMPLETED|Overall Study||23
9754402|NCT00344500|10857408|FG001|NOT COMPLETED|Overall Study||35
9754403|NCT00344500|10857409|FG002|NOT COMPLETED|Overall Study||2
9754404|NCT00344682|10857418|FG000|STARTED|Overall Study||16
9754405|NCT00344682|10857419|FG001|STARTED|Overall Study||15
9754406|NCT00344682|10857418|FG000|COMPLETED|Overall Study||12
9754407|NCT00344682|10857419|FG001|COMPLETED|Overall Study||14
9754408|NCT00344682|10857418|FG000|NOT COMPLETED|Overall Study||4
9754409|NCT00344682|10857419|FG001|NOT COMPLETED|Overall Study||1
9754410|NCT00344773|10857425|FG000|STARTED|Overall Study||46
9754411|NCT00344773|10857425|FG000|COMPLETED|Overall Study||25
9754412|NCT00344773|10857425|FG000|NOT COMPLETED|Overall Study||21
9754413|NCT00344968|10857432|FG000|STARTED|Overall Study||185
9754414|NCT00344968|10857433|FG001|STARTED|Overall Study||376
9754415|NCT00344968|10857434|FG002|STARTED|Overall Study||395
9854105|NCT00891202|10967090|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
9854106|NCT00891202|10967091|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
9854107|NCT00891202|10967088|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
9854108|NCT00891202|10967089|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
9854109|NCT00891202|10967090|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
9854110|NCT00891202|10967091|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
9854111|NCT00891228|10967102|FG000|STARTED|Overall Study||32
9854112|NCT00891228|10967103|FG001|STARTED|Overall Study||33
9854113|NCT00891228|10967104|FG002|STARTED|Overall Study||34
9854114|NCT00891228|10967102|FG000|COMPLETED|Overall Study||21
9854115|NCT00891228|10967103|FG001|COMPLETED|Overall Study||20
9854116|NCT00891228|10967104|FG002|COMPLETED|Overall Study||19
9854117|NCT00891228|10967102|FG000|NOT COMPLETED|Overall Study||11
9854118|NCT00891228|10967103|FG001|NOT COMPLETED|Overall Study||13
9854119|NCT00891228|10967104|FG002|NOT COMPLETED|Overall Study||15
9854120|NCT00891293|10967112|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
9854121|NCT00891293|10967112|FG000|COMPLETED|Overall Study||9
9854122|NCT00891293|10967112|FG000|NOT COMPLETED|Overall Study||84
9854123|NCT00891319|10967118|FG000|STARTED|Overall Study||40
9854124|NCT00891319|10967119|FG001|STARTED|Overall Study||40
9854125|NCT00891319|10967118|FG000|COMPLETED|Overall Study||32
9854126|NCT00891319|10967119|FG001|COMPLETED|Overall Study||40
9854127|NCT00891319|10967118|FG000|NOT COMPLETED|Overall Study||8
9854128|NCT00891319|10967119|FG001|NOT COMPLETED|Overall Study||0
9854129|NCT00891371|10967125|FG000|STARTED|Pre-assignment||42
9854130|NCT00891371|10967125|FG000|COMPLETED|Pre-assignment||36
9854131|NCT00891371|10967125|FG000|NOT COMPLETED|Pre-assignment||6
9854132|NCT00891371|10967125|FG000|STARTED|Treatment||36
9854133|NCT00891371|10967125|FG000|COMPLETED|Treatment||27
9854134|NCT00891371|10967125|FG000|NOT COMPLETED|Treatment||9
9854135|NCT00891436|10967131|FG000|STARTED|Overall Study||10
9854136|NCT00891436|10967132|FG001|STARTED|Overall Study||10
9854137|NCT00891436|10967131|FG000|COMPLETED|Overall Study||10
9854138|NCT00891436|10967132|FG001|COMPLETED|Overall Study||10
9854139|NCT00891436|10967131|FG000|NOT COMPLETED|Overall Study||0
9854140|NCT00891436|10967132|FG001|NOT COMPLETED|Overall Study||0
9854141|NCT00891462|10967141|FG000|STARTED|Overall Study||186
9854142|NCT00891462|10967142|FG001|STARTED|Overall Study||185
9854143|NCT00891462|10967143|FG002|STARTED|Overall Study||190
9854144|NCT00891462|10967141|FG000|COMPLETED|Overall Study||149
9854145|NCT00891462|10967142|FG001|COMPLETED|Overall Study||152
9854146|NCT00891462|10967143|FG002|COMPLETED|Overall Study||166
9854147|NCT00891462|10967141|FG000|NOT COMPLETED|Overall Study||37
9854148|NCT00891462|10967142|FG001|NOT COMPLETED|Overall Study||33
9854149|NCT00891462|10967143|FG002|NOT COMPLETED|Overall Study||24
9854150|NCT00891527|10967153|FG000|STARTED|Overall Study||50
9854151|NCT00891527|10967153|FG000|COMPLETED|Overall Study||48
9854152|NCT00891527|10967153|FG000|NOT COMPLETED|Overall Study||2
10092355|NCT02336451|11220791|FG004|NOT COMPLETED|Overall Study||18
10092356|NCT02336555|11220807|FG000|STARTED|Treatment Period 1 (28 Days)||18
10092357|NCT02336555|11220808|FG001|STARTED|Treatment Period 1 (28 Days)||17
10092358|NCT02336555|11220807|FG000|COMPLETED|Treatment Period 1 (28 Days)||16
10092359|NCT02336555|11220808|FG001|COMPLETED|Treatment Period 1 (28 Days)||16
9754416|NCT00344968|10857432|FG000|COMPLETED|Overall Study||126
9854153|NCT00891618|10967158|FG000|STARTED|Overall Study||21
9854154|NCT00891618|10967158|FG000|COMPLETED|Overall Study||20
9854155|NCT00891618|10967158|FG000|NOT COMPLETED|Overall Study||1
9854156|NCT00891657|10967164|FG000|STARTED|Overall Study||9
9854157|NCT00891657|10967165|FG001|STARTED|Overall Study||6
9854158|NCT00891657|10967164|FG000|COMPLETED|Overall Study||8
9854159|NCT00891657|10967165|FG001|COMPLETED|Overall Study||5
9854160|NCT00891657|10967164|FG000|NOT COMPLETED|Overall Study||1
9854161|NCT00891657|10967165|FG001|NOT COMPLETED|Overall Study||1
9854162|NCT00891735|10967175|FG000|STARTED|Overall Study||275
9854163|NCT00891735|10967176|FG001|STARTED|Overall Study||274
9854164|NCT00891735|10967177|FG002|STARTED|Overall Study||275
9854165|NCT00891735|10967178|FG003|STARTED|Overall Study||273
9854166|NCT00891735|10967175|FG000|COMPLETED|Overall Study||258
10092360|NCT02336555|11220807|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2
10092361|NCT02336555|11220808|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10092362|NCT02336555|11220807|FG000|STARTED|Treatment Period 2 (28 Days)||16
9754417|NCT00344968|10857433|FG001|COMPLETED|Overall Study||274
9754418|NCT00344968|10857434|FG002|COMPLETED|Overall Study||279
9754419|NCT00344968|10857432|FG000|NOT COMPLETED|Overall Study||59
9754420|NCT00344968|10857433|FG001|NOT COMPLETED|Overall Study||102
9754421|NCT00344968|10857434|FG002|NOT COMPLETED|Overall Study||116
9754422|NCT00345033|10857445|FG000|STARTED|Overall Study||20
9754423|NCT00345033|10857446|FG001|STARTED|Overall Study||18
9754424|NCT00345033|10857445|FG000|COMPLETED|Overall Study||16
9754425|NCT00345033|10857446|FG001|COMPLETED|Overall Study||14
9754426|NCT00345033|10857445|FG000|NOT COMPLETED|Overall Study||4
9754427|NCT00345033|10857446|FG001|NOT COMPLETED|Overall Study||4
9854167|NCT00891735|10967176|FG001|COMPLETED|Overall Study||258
9854168|NCT00891735|10967177|FG002|COMPLETED|Overall Study||263
9854169|NCT00891735|10967178|FG003|COMPLETED|Overall Study||258
9854170|NCT00891735|10967175|FG000|NOT COMPLETED|Overall Study||17
9754428|NCT00345046|10857455|FG000|STARTED|Overall Study||18
9854171|NCT00891735|10967176|FG001|NOT COMPLETED|Overall Study||16
9754429|NCT00345046|10857456|FG001|STARTED|Overall Study||22
9754430|NCT00345046|10857457|FG002|STARTED|Overall Study||16
9754431|NCT00345046|10857455|FG000|COMPLETED|Overall Study||17
9754432|NCT00345046|10857456|FG001|COMPLETED|Overall Study||21
9754433|NCT00345046|10857457|FG002|COMPLETED|Overall Study||14
9754434|NCT00345046|10857455|FG000|NOT COMPLETED|Overall Study||1
9754435|NCT00345046|10857456|FG001|NOT COMPLETED|Overall Study||1
9754436|NCT00345046|10857457|FG002|NOT COMPLETED|Overall Study||2
9754437|NCT00345176|10857469|FG000|STARTED|Overall Study||1012
9754438|NCT00345176|10857470|FG001|STARTED|Overall Study||1044
9754439|NCT00345176|10857471|FG002|STARTED|Overall Study||1068
9754440|NCT00345176|10857472|FG003|STARTED|Overall Study||1079
9754441|NCT00345176|10857469|FG000|COMPLETED|Overall Study||1007
9754442|NCT00345176|10857470|FG001|COMPLETED|Overall Study||1038
9754443|NCT00345176|10857471|FG002|COMPLETED|Overall Study||1062
9754444|NCT00345176|10857472|FG003|COMPLETED|Overall Study||1069
9754445|NCT00345176|10857469|FG000|NOT COMPLETED|Overall Study||5
9754446|NCT00345176|10857470|FG001|NOT COMPLETED|Overall Study||6
9754447|NCT00345176|10857471|FG002|NOT COMPLETED|Overall Study||6
9754448|NCT00345176|10857472|FG003|NOT COMPLETED|Overall Study||10
10092363|NCT02336555|11220808|FG001|STARTED|Treatment Period 2 (28 Days)||16
10092364|NCT02336555|11220807|FG000|COMPLETED|Treatment Period 2 (28 Days)||16
10092365|NCT02336555|11220808|FG001|COMPLETED|Treatment Period 2 (28 Days)||15
10092366|NCT02336555|11220807|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10092367|NCT02336555|11220808|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
10092368|NCT02336594|11220818|FG000|STARTED|Overall Study||3
10092369|NCT02336594|11220819|FG001|STARTED|Overall Study||4
10092370|NCT02336594|11220820|FG002|STARTED|Overall Study||4
10092371|NCT02336594|11220821|FG003|STARTED|Overall Study||4
10092372|NCT02336594|11220818|FG000|COMPLETED|Overall Study||3
10092373|NCT02336594|11220819|FG001|COMPLETED|Overall Study||4
9754449|NCT00345254|10857486|FG000|STARTED|Overall Study||30
9754450|NCT00345254|10857487|FG001|STARTED|Overall Study||30
9754451|NCT00345254|10857486|FG000|COMPLETED|Overall Study||30
9754452|NCT00345254|10857487|FG001|COMPLETED|Overall Study||30
9754453|NCT00345254|10857486|FG000|NOT COMPLETED|Overall Study||0
9754454|NCT00345254|10857487|FG001|NOT COMPLETED|Overall Study||0
9754455|NCT00345293|10857493|FG000|STARTED|Overall Study||10
9754456|NCT00345293|10857494|FG001|STARTED|Overall Study||3
9754457|NCT00345293|10857493|FG000|COMPLETED|Overall Study||8
9754458|NCT00345293|10857494|FG001|COMPLETED|Overall Study||3
9754459|NCT00345293|10857493|FG000|NOT COMPLETED|Overall Study||2
9754460|NCT00345293|10857494|FG001|NOT COMPLETED|Overall Study||0
9754461|NCT00345332|10857502|FG000|STARTED|Overall Study||11
9754462|NCT00345332|10857503|FG001|STARTED|Overall Study||20
9754463|NCT00345332|10857502|FG000|COMPLETED|Overall Study||11
9754464|NCT00345332|10857503|FG001|COMPLETED|Overall Study||20
9754465|NCT00345332|10857502|FG000|NOT COMPLETED|Overall Study||0
9754466|NCT00345332|10857503|FG001|NOT COMPLETED|Overall Study||0
9754467|NCT00345371|10857511|FG000|STARTED|Overall Study||69
9754468|NCT00345371|10857512|FG001|STARTED|Overall Study||71
9754469|NCT00345371|10857511|FG000|COMPLETED|Overall Study||39
9754470|NCT00345371|10857512|FG001|COMPLETED|Overall Study||38
9754471|NCT00345371|10857511|FG000|NOT COMPLETED|Overall Study||30
9754472|NCT00345371|10857512|FG001|NOT COMPLETED|Overall Study||33
9754473|NCT00345384|10857520|FG000|STARTED|Overall Study||19
9754474|NCT00345384|10857521|FG001|STARTED|Overall Study||19
9754475|NCT00345384|10857520|FG000|COMPLETED|Overall Study||19
9754476|NCT00345384|10857521|FG001|COMPLETED|Overall Study||19
9754477|NCT00345384|10857520|FG000|NOT COMPLETED|Overall Study||0
9754478|NCT00345384|10857521|FG001|NOT COMPLETED|Overall Study||0
9754479|NCT00345397|10857529|FG000|STARTED|Overall Study||7
9754480|NCT00345397|10857529|FG000|COMPLETED|Overall Study||6
9754481|NCT00345397|10857529|FG000|NOT COMPLETED|Overall Study||1
9754482|NCT00345540|10857534|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
9754483|NCT00345540|10857534|FG000|COMPLETED|Overall Study||15
9754484|NCT00345540|10857534|FG000|NOT COMPLETED|Overall Study||1
9754485|NCT00345579|10857540|FG000|STARTED|Overall Study||3278
9754486|NCT00345579|10857541|FG001|STARTED|Overall Study||1113
9754487|NCT00345579|10857540|FG000|COMPLETED|Overall Study||3114
9754488|NCT00345579|10857541|FG001|COMPLETED|Overall Study||1048
9754489|NCT00345579|10857540|FG000|NOT COMPLETED|Overall Study||164
9754490|NCT00345579|10857541|FG001|NOT COMPLETED|Overall Study||65
9754491|NCT00345592|10857550|FG000|STARTED|Overall Study||199
9754492|NCT00345592|10857551|FG001|STARTED|Overall Study||197
9754493|NCT00345592|10857550|FG000|COMPLETED|Overall Study||174
9754494|NCT00345592|10857551|FG001|COMPLETED|Overall Study||173
9754495|NCT00345592|10857550|FG000|NOT COMPLETED|Overall Study||25
9754496|NCT00345592|10857551|FG001|NOT COMPLETED|Overall Study||24
9754497|NCT00345605|10857557|FG000|STARTED|Initial Washout||6
9754498|NCT00345605|10857558|FG001|STARTED|Initial Washout||6
10092374|NCT02336594|11220820|FG002|COMPLETED|Overall Study||4
10092375|NCT02336594|11220821|FG003|COMPLETED|Overall Study||4
9754499|NCT00345605|10857557|FG000|COMPLETED|Initial Washout||6
9754500|NCT00345605|10857558|FG001|COMPLETED|Initial Washout||6
9754501|NCT00345605|10857557|FG000|NOT COMPLETED|Initial Washout||0
9754502|NCT00345605|10857558|FG001|NOT COMPLETED|Initial Washout||0
9754503|NCT00345605|10857557|FG000|STARTED|Arm 1||6
9754504|NCT00345605|10857558|FG001|STARTED|Arm 1||6
9754505|NCT00345605|10857557|FG000|COMPLETED|Arm 1||6
9754506|NCT00345605|10857558|FG001|COMPLETED|Arm 1||5
9754507|NCT00345605|10857557|FG000|NOT COMPLETED|Arm 1||0
9754508|NCT00345605|10857558|FG001|NOT COMPLETED|Arm 1||1
9754509|NCT00345605|10857557|FG000|STARTED|Interval||6
9754510|NCT00345605|10857558|FG001|STARTED|Interval||6
9754511|NCT00345605|10857557|FG000|COMPLETED|Interval||6
9754512|NCT00345605|10857558|FG001|COMPLETED|Interval||6
9754513|NCT00345605|10857557|FG000|NOT COMPLETED|Interval||0
9754514|NCT00345605|10857558|FG001|NOT COMPLETED|Interval||0
9754515|NCT00345605|10857557|FG000|STARTED|Crossover Wash-out||6
9754516|NCT00345605|10857558|FG001|STARTED|Crossover Wash-out||6
9754517|NCT00345605|10857557|FG000|COMPLETED|Crossover Wash-out||6
9854172|NCT00891735|10967177|FG002|NOT COMPLETED|Overall Study||12
9854173|NCT00891735|10967178|FG003|NOT COMPLETED|Overall Study||15
9854174|NCT00891774|10967188|FG000|STARTED|Overall Study||172
9854175|NCT00891774|10967188|FG000|COMPLETED|Overall Study||158
9854176|NCT00891774|10967188|FG000|NOT COMPLETED|Overall Study||14
9854177|NCT00891813|10967192|FG000|STARTED|Overall Study||100
9854178|NCT00891813|10967192|FG000|COMPLETED|Overall Study||88
10092376|NCT02336594|11220818|FG000|NOT COMPLETED|Overall Study||0
10092377|NCT02336594|11220819|FG001|NOT COMPLETED|Overall Study||0
10092378|NCT02336594|11220820|FG002|NOT COMPLETED|Overall Study||0
9754518|NCT00345605|10857558|FG001|COMPLETED|Crossover Wash-out||6
9754519|NCT00345605|10857557|FG000|NOT COMPLETED|Crossover Wash-out||0
9754520|NCT00345605|10857558|FG001|NOT COMPLETED|Crossover Wash-out||0
9754521|NCT00345605|10857557|FG000|STARTED|Arm 2, Opposite Treatment||6
9754522|NCT00345605|10857558|FG001|STARTED|Arm 2, Opposite Treatment||6
9754523|NCT00345605|10857557|FG000|COMPLETED|Arm 2, Opposite Treatment||5
9754524|NCT00345605|10857558|FG001|COMPLETED|Arm 2, Opposite Treatment||6
9754525|NCT00345605|10857557|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1
9754526|NCT00345605|10857558|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0
9754527|NCT00345631|10857569|FG000|STARTED|Overall Study||87
9754528|NCT00345631|10857570|FG001|STARTED|Overall Study||267
9754529|NCT00345631|10857571|FG002|STARTED|Overall Study||134
9754530|NCT00345631|10857569|FG000|COMPLETED|Overall Study||83
9754531|NCT00345631|10857570|FG001|COMPLETED|Overall Study||259
9754532|NCT00345631|10857571|FG002|COMPLETED|Overall Study||128
9754533|NCT00345631|10857569|FG000|NOT COMPLETED|Overall Study||4
9754534|NCT00345631|10857570|FG001|NOT COMPLETED|Overall Study||8
9754535|NCT00345631|10857571|FG002|NOT COMPLETED|Overall Study||6
9754536|NCT00345683|10857583|FG000|STARTED|Overall Study||3010
9754537|NCT00345683|10857584|FG001|STARTED|Overall Study||1010
9754538|NCT00345683|10857583|FG000|COMPLETED|Overall Study||2985
9754539|NCT00345683|10857584|FG001|COMPLETED|Overall Study||1001
9754540|NCT00345683|10857583|FG000|NOT COMPLETED|Overall Study||25
9754541|NCT00345683|10857584|FG001|NOT COMPLETED|Overall Study||9
9754542|NCT00345839|10857592|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948
9854179|NCT00891813|10967192|FG000|NOT COMPLETED|Overall Study||12
9854180|NCT00891839|10967196|FG000|STARTED|Overall Study||45
9854181|NCT00891839|10967196|FG000|COMPLETED|Overall Study|completed treatment|38
9854182|NCT00891839|10967196|FG000|NOT COMPLETED|Overall Study||7
9854183|NCT00891878|10967202|FG000|STARTED|Overall Study||6
9854184|NCT00891878|10967203|FG001|STARTED|Overall Study||6
9854185|NCT00891878|10967202|FG000|COMPLETED|Overall Study||6
9854186|NCT00891878|10967203|FG001|COMPLETED|Overall Study||6
9854187|NCT00891878|10967202|FG000|NOT COMPLETED|Overall Study||0
9854188|NCT00891878|10967203|FG001|NOT COMPLETED|Overall Study||0
9854189|NCT00891930|10967209|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76
9854190|NCT00891930|10967209|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74
9854191|NCT00891930|10967209|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36
9854192|NCT00891930|10967209|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
9854193|NCT00891930|10967209|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36
9854194|NCT00891930|10967209|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5
9854195|NCT00891930|10967209|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
9854196|NCT00891982|10967219|FG000|STARTED|Overall Study||30
9854197|NCT00891982|10967220|FG001|STARTED|Overall Study||31
9854198|NCT00891982|10967219|FG000|COMPLETED|Overall Study||28
9854199|NCT00891982|10967220|FG001|COMPLETED|Overall Study||30
9854200|NCT00891982|10967219|FG000|NOT COMPLETED|Overall Study||2
9854201|NCT00891982|10967220|FG001|NOT COMPLETED|Overall Study||1
9854202|NCT00891995|10967228|FG000|STARTED|Overall Study||50
9854203|NCT00891995|10967229|FG001|STARTED|Overall Study||21
9854204|NCT00891995|10967228|FG000|COMPLETED|Overall Study||50
9854205|NCT00891995|10967229|FG001|COMPLETED|Overall Study||21
9854206|NCT00891995|10967228|FG000|NOT COMPLETED|Overall Study||0
9854207|NCT00891995|10967229|FG001|NOT COMPLETED|Overall Study||0
9854208|NCT00892008|10967235|FG000|STARTED|Overall Study||2278
9854209|NCT00892008|10967235|FG000|COMPLETED|Overall Study||1713
9854210|NCT00892008|10967235|FG000|NOT COMPLETED|Overall Study||565
9854211|NCT00892047|10967241|FG000|STARTED|Overall Study||91
9854212|NCT00892047|10967242|FG001|STARTED|Overall Study||90
9854213|NCT00892047|10967241|FG000|COMPLETED|Overall Study||87
9854214|NCT00892047|10967242|FG001|COMPLETED|Overall Study||83
9854215|NCT00892047|10967241|FG000|NOT COMPLETED|Overall Study||4
9854216|NCT00892047|10967242|FG001|NOT COMPLETED|Overall Study||7
9854217|NCT00892099|10967253|FG000|STARTED|Overall Study||36
9754543|NCT00345839|10857593|FG001|STARTED|Overall Study|Randomized to placebo|1935
9754544|NCT00345839|10857592|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
9854218|NCT00892099|10967254|FG001|STARTED|Overall Study||33
9854219|NCT00892099|10967255|FG002|STARTED|Overall Study||36
9854220|NCT00892099|10967253|FG000|COMPLETED|Overall Study||31
9854221|NCT00892099|10967254|FG001|COMPLETED|Overall Study||32
9854222|NCT00892099|10967255|FG002|COMPLETED|Overall Study||29
9854223|NCT00892099|10967253|FG000|NOT COMPLETED|Overall Study||5
9854224|NCT00892099|10967254|FG001|NOT COMPLETED|Overall Study||1
9754545|NCT00345839|10857593|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
9754546|NCT00345839|10857592|FG000|NOT COMPLETED|Overall Study||149
9754547|NCT00345839|10857593|FG001|NOT COMPLETED|Overall Study||159
9754548|NCT00345865|10857604|FG000|STARTED|Overall Study||171
9754549|NCT00345865|10857605|FG001|STARTED|Overall Study||149
9754550|NCT00345865|10857606|FG002|STARTED|Overall Study||2
9754551|NCT00345865|10857607|FG003|STARTED|Overall Study||5
9754552|NCT00345865|10857608|FG004|STARTED|Overall Study||146
9754553|NCT00345865|10857604|FG000|COMPLETED|Overall Study||171
9754554|NCT00345865|10857605|FG001|COMPLETED|Overall Study||149
9754555|NCT00345865|10857606|FG002|COMPLETED|Overall Study||2
9754556|NCT00345865|10857607|FG003|COMPLETED|Overall Study||5
9754557|NCT00345865|10857608|FG004|COMPLETED|Overall Study||146
10201765|NCT03440944|11329174|FG000|STARTED|Overall Study||9
10201766|NCT03440944|11329175|FG001|STARTED|Overall Study||9
10201767|NCT03440944|11329174|FG000|COMPLETED|Overall Study||8
9754558|NCT00345865|10857604|FG000|NOT COMPLETED|Overall Study||0
9754559|NCT00345865|10857605|FG001|NOT COMPLETED|Overall Study||0
9754560|NCT00345865|10857606|FG002|NOT COMPLETED|Overall Study||0
9754561|NCT00345865|10857607|FG003|NOT COMPLETED|Overall Study||0
9754562|NCT00345865|10857608|FG004|NOT COMPLETED|Overall Study||0
9754563|NCT00345878|10857622|FG000|STARTED|Overall Study||135
9754564|NCT00345878|10857623|FG001|STARTED|Overall Study||136
9754565|NCT00345878|10857622|FG000|COMPLETED|Overall Study||131
9754566|NCT00345878|10857623|FG001|COMPLETED|Overall Study||135
9754567|NCT00345878|10857622|FG000|NOT COMPLETED|Overall Study||4
9754568|NCT00345878|10857623|FG001|NOT COMPLETED|Overall Study||1
9754569|NCT00345969|10857631|FG000|STARTED|Overall Study||12
9754570|NCT00345969|10857632|FG001|STARTED|Overall Study||13
9754571|NCT00345969|10857631|FG000|COMPLETED|Overall Study||11
9754572|NCT00345969|10857632|FG001|COMPLETED|Overall Study||11
9754573|NCT00345969|10857631|FG000|NOT COMPLETED|Overall Study||1
9754574|NCT00345969|10857632|FG001|NOT COMPLETED|Overall Study||2
9754575|NCT00346034|10857638|FG000|STARTED|Overall Study||357
9754576|NCT00346034|10857638|FG000|COMPLETED|Overall Study||300
9754577|NCT00346034|10857638|FG000|NOT COMPLETED|Overall Study||57
9754578|NCT00346073|10857644|FG000|STARTED|Overall Study||1522
9754579|NCT00346073|10857645|FG001|STARTED|Overall Study||762
9754580|NCT00346073|10857644|FG000|COMPLETED|Overall Study||1481
9754581|NCT00346073|10857645|FG001|COMPLETED|Overall Study||738
9754582|NCT00346073|10857644|FG000|NOT COMPLETED|Overall Study||41
9754583|NCT00346073|10857645|FG001|NOT COMPLETED|Overall Study||24
9754584|NCT00346151|10857651|FG000|STARTED|Overall Study||5
9754585|NCT00346151|10857651|FG000|COMPLETED|Overall Study||2
9754586|NCT00346151|10857651|FG000|NOT COMPLETED|Overall Study||3
9754587|NCT00346216|10857658|FG000|STARTED|Overall Study||8072
9754588|NCT00346216|10857659|FG001|STARTED|Overall Study||8040
9754589|NCT00346216|10857660|FG002|STARTED|Overall Study||7969
9754590|NCT00346216|10857658|FG000|COMPLETED|Overall Study||5664
9754591|NCT00346216|10857659|FG001|COMPLETED|Overall Study||5580
9754592|NCT00346216|10857660|FG002|COMPLETED|Overall Study||5621
9754593|NCT00346216|10857658|FG000|NOT COMPLETED|Overall Study||2408
9754594|NCT00346216|10857659|FG001|NOT COMPLETED|Overall Study||2460
9754595|NCT00346216|10857660|FG002|NOT COMPLETED|Overall Study||2348
9754596|NCT00346268|10857670|FG000|STARTED|Overall Study||52
9754597|NCT00346268|10857671|FG001|STARTED|Overall Study||53
9754598|NCT00346268|10857670|FG000|COMPLETED|Overall Study||50
9754599|NCT00346268|10857671|FG001|COMPLETED|Overall Study||50
9854225|NCT00892099|10967255|FG002|NOT COMPLETED|Overall Study||7
9854226|NCT00892151|10967263|FG000|STARTED|Overall Study||51
9854227|NCT00892151|10967263|FG000|COMPLETED|Overall Study||50
9854228|NCT00892151|10967263|FG000|NOT COMPLETED|Overall Study||1
10201768|NCT03440944|11329175|FG001|COMPLETED|Overall Study||8
9754600|NCT00346268|10857670|FG000|NOT COMPLETED|Overall Study||2
9754601|NCT00346268|10857671|FG001|NOT COMPLETED|Overall Study||3
9754602|NCT00346333|10857679|FG000|STARTED|Overall Study||121
9754603|NCT00346333|10857680|FG001|STARTED|Overall Study||119
9754604|NCT00346333|10857679|FG000|COMPLETED|Overall Study||116
9754605|NCT00346333|10857680|FG001|COMPLETED|Overall Study||111
9754606|NCT00346333|10857679|FG000|NOT COMPLETED|Overall Study||5
9754607|NCT00346333|10857680|FG001|NOT COMPLETED|Overall Study||8
9754608|NCT00346398|10857690|FG000|STARTED|Overall Study||25
9754609|NCT00346398|10857691|FG001|STARTED|Overall Study||26
9754610|NCT00346398|10857690|FG000|COMPLETED|Overall Study||22
10201769|NCT03440944|11329174|FG000|NOT COMPLETED|Overall Study||1
9754611|NCT00346398|10857691|FG001|COMPLETED|Overall Study||24
9754612|NCT00346398|10857690|FG000|NOT COMPLETED|Overall Study||3
9754613|NCT00346398|10857691|FG001|NOT COMPLETED|Overall Study||2
9754614|NCT00346476|10857697|FG000|STARTED|Overall Study||1250
9754615|NCT00346476|10857697|FG000|COMPLETED|Overall Study||1250
9754616|NCT00346476|10857697|FG000|NOT COMPLETED|Overall Study||0
9754617|NCT00346632|10857703|FG000|STARTED|Overall Study||3
9754618|NCT00346632|10857704|FG001|STARTED|Overall Study||3
9754619|NCT00346632|10857705|FG002|STARTED|Overall Study||6
9754620|NCT00346632|10857706|FG003|STARTED|Overall Study||3
9854229|NCT00892177|10967270|FG000|STARTED|Phase I: Dose Level 0||3
9854230|NCT00892177|10967271|FG001|STARTED|Phase I: Dose Level 0||0
9854231|NCT00892177|10967272|FG002|STARTED|Phase I: Dose Level 0||0
9754621|NCT00346632|10857707|FG004|STARTED|Overall Study||4
9754622|NCT00346632|10857708|FG005|STARTED|Overall Study||2
9754623|NCT00346632|10857709|FG006|STARTED|Overall Study||5
9754624|NCT00346632|10857710|FG007|STARTED|Overall Study||4
9754625|NCT00346632|10857711|FG008|STARTED|Overall Study||4
9754626|NCT00346632|10857712|FG009|STARTED|Overall Study||3
9754627|NCT00346632|10857703|FG000|COMPLETED|Overall Study||0
9754628|NCT00346632|10857704|FG001|COMPLETED|Overall Study||0
9754629|NCT00346632|10857705|FG002|COMPLETED|Overall Study||0
9754630|NCT00346632|10857706|FG003|COMPLETED|Overall Study||0
9754631|NCT00346632|10857707|FG004|COMPLETED|Overall Study||0
9754632|NCT00346632|10857708|FG005|COMPLETED|Overall Study||0
9754633|NCT00346632|10857709|FG006|COMPLETED|Overall Study||0
9754634|NCT00346632|10857710|FG007|COMPLETED|Overall Study||0
9754635|NCT00346632|10857711|FG008|COMPLETED|Overall Study||0
9754636|NCT00346632|10857712|FG009|COMPLETED|Overall Study||0
9754637|NCT00346632|10857703|FG000|NOT COMPLETED|Overall Study||3
9754638|NCT00346632|10857704|FG001|NOT COMPLETED|Overall Study||3
9754639|NCT00346632|10857705|FG002|NOT COMPLETED|Overall Study||6
9754640|NCT00346632|10857706|FG003|NOT COMPLETED|Overall Study||3
9754641|NCT00346632|10857707|FG004|NOT COMPLETED|Overall Study||4
9754642|NCT00346632|10857708|FG005|NOT COMPLETED|Overall Study||2
9754643|NCT00346632|10857709|FG006|NOT COMPLETED|Overall Study||5
9754644|NCT00346632|10857710|FG007|NOT COMPLETED|Overall Study||4
9754645|NCT00346632|10857711|FG008|NOT COMPLETED|Overall Study||4
9754646|NCT00346632|10857712|FG009|NOT COMPLETED|Overall Study||3
9754647|NCT00346697|10857776|FG000|STARTED|Overall Study||24
9754648|NCT00346697|10857777|FG001|STARTED|Overall Study||24
9754649|NCT00346697|10857776|FG000|COMPLETED|Overall Study||24
9754650|NCT00346697|10857777|FG001|COMPLETED|Overall Study||23
9754651|NCT00346697|10857776|FG000|NOT COMPLETED|Overall Study||0
9754652|NCT00346697|10857777|FG001|NOT COMPLETED|Overall Study||1
9754653|NCT00346775|10857785|FG000|STARTED|Period 1: Intervention Period 1||49
9754654|NCT00346775|10857786|FG001|STARTED|Period 1: Intervention Period 1||48
9754655|NCT00346775|10857785|FG000|COMPLETED|Period 1: Intervention Period 1||44
9754656|NCT00346775|10857786|FG001|COMPLETED|Period 1: Intervention Period 1||45
9754657|NCT00346775|10857785|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5
9754658|NCT00346775|10857786|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3
9754659|NCT00346775|10857785|FG000|STARTED|Period 2: Washout Period (7 Days)||44
9754660|NCT00346775|10857786|FG001|STARTED|Period 2: Washout Period (7 Days)||45
9754661|NCT00346775|10857785|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44
9754662|NCT00346775|10857786|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45
9754663|NCT00346775|10857785|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
9754664|NCT00346775|10857786|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
9754665|NCT00346775|10857785|FG000|STARTED|Period 3: Intervention Period 2||44
9754666|NCT00346775|10857786|FG001|STARTED|Period 3: Intervention Period 2||45
9754667|NCT00346775|10857785|FG000|COMPLETED|Period 3: Intervention Period 2||44
9754668|NCT00346775|10857786|FG001|COMPLETED|Period 3: Intervention Period 2||45
9754669|NCT00346775|10857785|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
9754670|NCT00346775|10857786|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
9754671|NCT00346905|10857796|FG000|STARTED|Overall Study||16
9754672|NCT00346905|10857796|FG000|COMPLETED|Overall Study||12
9754673|NCT00346905|10857796|FG000|NOT COMPLETED|Overall Study||4
9754674|NCT00347009|10857800|FG000|STARTED|Overall Study||155
9754675|NCT00347009|10857800|FG000|COMPLETED|Overall Study||128
9754676|NCT00347009|10857800|FG000|NOT COMPLETED|Overall Study||27
9754677|NCT00347022|10857806|FG000|STARTED|Overall Study||74
9754678|NCT00347022|10857807|FG001|STARTED|Overall Study||71
9754679|NCT00347022|10857806|FG000|COMPLETED|Overall Study||62
9754680|NCT00347022|10857807|FG001|COMPLETED|Overall Study||66
9754681|NCT00347022|10857806|FG000|NOT COMPLETED|Overall Study||12
9754682|NCT00347022|10857807|FG001|NOT COMPLETED|Overall Study||5
9754683|NCT00347269|10857815|FG000|STARTED|Overall Study||503
9754684|NCT00347269|10857816|FG001|STARTED|Overall Study||501
9754685|NCT00347269|10857815|FG000|COMPLETED|Overall Study||409
9754686|NCT00347269|10857816|FG001|COMPLETED|Overall Study||395
9754687|NCT00347269|10857815|FG000|NOT COMPLETED|Overall Study||94
9754688|NCT00347269|10857816|FG001|NOT COMPLETED|Overall Study||106
9754689|NCT00347308|10857822|FG000|STARTED|Overall Study||40
9754690|NCT00347308|10857822|FG000|COMPLETED|Overall Study||40
9754691|NCT00347308|10857822|FG000|NOT COMPLETED|Overall Study||0
9754692|NCT00347360|10857841|FG000|STARTED|Overall Study||44
9754693|NCT00347360|10857842|FG001|STARTED|Overall Study||43
9754694|NCT00347360|10857843|FG002|STARTED|Overall Study||43
9754695|NCT00347360|10857844|FG003|STARTED|Overall Study||43
9754696|NCT00347360|10857845|FG004|STARTED|Overall Study||44
9754697|NCT00347360|10857846|FG005|STARTED|Overall Study||44
9754698|NCT00347360|10857847|FG006|STARTED|Overall Study||44
9754699|NCT00347360|10857848|FG007|STARTED|Overall Study||43
9754700|NCT00347360|10857849|FG008|STARTED|Overall Study||44
9754701|NCT00347360|10857850|FG009|STARTED|Overall Study||44
9754702|NCT00347360|10857851|FG010|STARTED|Overall Study||44
9754703|NCT00347360|10857852|FG011|STARTED|Overall Study||43
9754704|NCT00347360|10857853|FG012|STARTED|Overall Study||44
9754705|NCT00347360|10857854|FG013|STARTED|Overall Study||44
9754706|NCT00347360|10857855|FG014|STARTED|Overall Study||43
9754707|NCT00347360|10857841|FG000|COMPLETED|Overall Study||39
9754708|NCT00347360|10857842|FG001|COMPLETED|Overall Study||35
9754709|NCT00347360|10857843|FG002|COMPLETED|Overall Study||37
9754710|NCT00347360|10857844|FG003|COMPLETED|Overall Study||30
9754711|NCT00347360|10857845|FG004|COMPLETED|Overall Study||39
9754712|NCT00347360|10857846|FG005|COMPLETED|Overall Study||36
9754713|NCT00347360|10857847|FG006|COMPLETED|Overall Study||37
9754714|NCT00347360|10857848|FG007|COMPLETED|Overall Study||40
9754715|NCT00347360|10857849|FG008|COMPLETED|Overall Study||38
9754716|NCT00347360|10857850|FG009|COMPLETED|Overall Study||35
9754717|NCT00347360|10857851|FG010|COMPLETED|Overall Study||39
9754718|NCT00347360|10857852|FG011|COMPLETED|Overall Study||37
9754719|NCT00347360|10857853|FG012|COMPLETED|Overall Study||34
9754720|NCT00347360|10857854|FG013|COMPLETED|Overall Study||36
9754721|NCT00347360|10857855|FG014|COMPLETED|Overall Study||39
9754722|NCT00347360|10857841|FG000|NOT COMPLETED|Overall Study||5
9754723|NCT00347360|10857842|FG001|NOT COMPLETED|Overall Study||8
9754724|NCT00347360|10857843|FG002|NOT COMPLETED|Overall Study||6
9754725|NCT00347360|10857844|FG003|NOT COMPLETED|Overall Study||13
9754726|NCT00347360|10857845|FG004|NOT COMPLETED|Overall Study||5
9754727|NCT00347360|10857846|FG005|NOT COMPLETED|Overall Study||8
9754728|NCT00347360|10857847|FG006|NOT COMPLETED|Overall Study||7
9754729|NCT00347360|10857848|FG007|NOT COMPLETED|Overall Study||3
9754730|NCT00347360|10857849|FG008|NOT COMPLETED|Overall Study||6
9754731|NCT00347360|10857850|FG009|NOT COMPLETED|Overall Study||9
9754732|NCT00347360|10857851|FG010|NOT COMPLETED|Overall Study||5
9754733|NCT00347360|10857852|FG011|NOT COMPLETED|Overall Study||6
9754734|NCT00347360|10857853|FG012|NOT COMPLETED|Overall Study||10
9754735|NCT00347360|10857854|FG013|NOT COMPLETED|Overall Study||8
9754736|NCT00347360|10857855|FG014|NOT COMPLETED|Overall Study||4
9754737|NCT00347438|10857887|FG000|STARTED|Overall Study||18
9754738|NCT00347438|10857887|FG000|COMPLETED|Overall Study||16
9754739|NCT00347438|10857887|FG000|NOT COMPLETED|Overall Study||2
9754740|NCT00347776|10857894|FG000|STARTED|1.5 Month Follow-up||484
9754741|NCT00347776|10857895|FG001|STARTED|1.5 Month Follow-up||483
9754742|NCT00347776|10857896|FG002|STARTED|1.5 Month Follow-up||485
9754743|NCT00347776|10857894|FG000|COMPLETED|1.5 Month Follow-up||470
9754744|NCT00347776|10857895|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
9754745|NCT00347776|10857896|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
9754746|NCT00347776|10857894|FG000|NOT COMPLETED|1.5 Month Follow-up||14
9754747|NCT00347776|10857895|FG001|NOT COMPLETED|1.5 Month Follow-up||8
10092379|NCT02336594|11220821|FG003|NOT COMPLETED|Overall Study||0
10092380|NCT02336607|11220838|FG000|STARTED|Overall Study||85
10092381|NCT02336607|11220839|FG001|STARTED|Overall Study||85
10092382|NCT02336607|11220840|FG002|STARTED|Overall Study||92
9754748|NCT00347776|10857896|FG002|NOT COMPLETED|1.5 Month Follow-up||12
9754749|NCT00347776|10857894|FG000|STARTED|6 Month Follow-up||470
9754750|NCT00347776|10857895|FG001|STARTED|6 Month Follow-up||475
9754751|NCT00347776|10857896|FG002|STARTED|6 Month Follow-up||473
9754752|NCT00347776|10857894|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
9754753|NCT00347776|10857895|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
9754754|NCT00347776|10857896|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
9754755|NCT00347776|10857894|FG000|NOT COMPLETED|6 Month Follow-up||22
9754756|NCT00347776|10857895|FG001|NOT COMPLETED|6 Month Follow-up||13
9754757|NCT00347776|10857896|FG002|NOT COMPLETED|6 Month Follow-up||18
9754758|NCT00347776|10857894|FG000|STARTED|12 Month Follow-up||448
9754759|NCT00347776|10857895|FG001|STARTED|12 Month Follow-up||462
9754760|NCT00347776|10857896|FG002|STARTED|12 Month Follow-up||455
9754761|NCT00347776|10857894|FG000|COMPLETED|12 Month Follow-up||425
9754762|NCT00347776|10857895|FG001|COMPLETED|12 Month Follow-up||446
9754763|NCT00347776|10857896|FG002|COMPLETED|12 Month Follow-up||436
9754764|NCT00347776|10857894|FG000|NOT COMPLETED|12 Month Follow-up||23
9754765|NCT00347776|10857895|FG001|NOT COMPLETED|12 Month Follow-up||16
9754766|NCT00347776|10857896|FG002|NOT COMPLETED|12 Month Follow-up||19
9754767|NCT00347919|10857907|FG000|STARTED|Overall Study|Safety Population|73
9754768|NCT00347919|10857908|FG001|STARTED|Overall Study|Safety Population|76
9754769|NCT00347919|10857909|FG002|STARTED|Overall Study|Safety Population|40
9754770|NCT00347919|10857907|FG000|COMPLETED|Overall Study||2
9754771|NCT00347919|10857908|FG001|COMPLETED|Overall Study||0
9754772|NCT00347919|10857909|FG002|COMPLETED|Overall Study||2
9754773|NCT00347919|10857907|FG000|NOT COMPLETED|Overall Study||71
9754774|NCT00347919|10857908|FG001|NOT COMPLETED|Overall Study||76
9754775|NCT00347919|10857909|FG002|NOT COMPLETED|Overall Study||38
9754776|NCT00347932|10857921|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
9754777|NCT00347932|10857922|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
9754778|NCT00347932|10857921|FG000|COMPLETED|Overall Study||444
9754779|NCT00347932|10857922|FG001|COMPLETED|Overall Study||430
9754780|NCT00347932|10857921|FG000|NOT COMPLETED|Overall Study||31
9754781|NCT00347932|10857922|FG001|NOT COMPLETED|Overall Study||52
9829012|NCT00758524|10939646|FG010|STARTED|Core Period (Week 0 to Week 8)||0
9829013|NCT00758524|10939647|FG011|STARTED|Core Period (Week 0 to Week 8)||0
9829014|NCT00758524|10939648|FG012|STARTED|Core Period (Week 0 to Week 8)||0
9829015|NCT00758524|10939649|FG013|STARTED|Core Period (Week 0 to Week 8)||0
9829016|NCT00758524|10939650|FG014|STARTED|Core Period (Week 0 to Week 8)||0
10092383|NCT02336607|11220841|FG003|STARTED|Overall Study||267
10092384|NCT02336607|11220838|FG000|Patients Included in ITT Population|Overall Study||84
9754782|NCT00347958|10857928|FG000|STARTED|Overall Study||544
9754783|NCT00347958|10857928|FG000|COMPLETED|Overall Study||540
9754784|NCT00347958|10857928|FG000|NOT COMPLETED|Overall Study||4
9754785|NCT00348140|10857935|FG000|STARTED|Overall Study||487
9754786|NCT00348140|10857936|FG001|STARTED|Overall Study||490
9754787|NCT00348140|10857937|FG002|STARTED|Overall Study||491
9754788|NCT00348140|10857935|FG000|COMPLETED|Overall Study||361
9754789|NCT00348140|10857936|FG001|COMPLETED|Overall Study||351
9754790|NCT00348140|10857937|FG002|COMPLETED|Overall Study||328
9754791|NCT00348140|10857935|FG000|NOT COMPLETED|Overall Study||126
9754792|NCT00348140|10857936|FG001|NOT COMPLETED|Overall Study||139
9754793|NCT00348140|10857937|FG002|NOT COMPLETED|Overall Study||163
9754794|NCT00348205|10857946|FG000|STARTED|Overall Study||80
9754795|NCT00348205|10857946|FG000|COMPLETED|Overall Study||78
9754796|NCT00348205|10857946|FG000|NOT COMPLETED|Overall Study||2
9754797|NCT00348283|10857952|FG000|STARTED|Induction||0
9754798|NCT00348283|10857953|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
9754799|NCT00348283|10857952|FG000|COMPLETED|Induction||0
9754800|NCT00348283|10857953|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
9754801|NCT00348283|10857952|FG000|NOT COMPLETED|Induction||0
9754802|NCT00348283|10857953|FG001|NOT COMPLETED|Induction||6
9754803|NCT00348283|10857952|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
9754804|NCT00348283|10857953|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
9754805|NCT00348283|10857952|FG000|COMPLETED|Double Blind||60
9754806|NCT00348283|10857953|FG001|COMPLETED|Double Blind||54
9754807|NCT00348283|10857952|FG000|NOT COMPLETED|Double Blind||5
9754808|NCT00348283|10857953|FG001|NOT COMPLETED|Double Blind||10
9754809|NCT00348283|10857952|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
9754810|NCT00348283|10857953|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
9754811|NCT00348283|10857952|FG000|COMPLETED|Open Label||0
9754812|NCT00348283|10857953|FG001|COMPLETED|Open Label||66
9754813|NCT00348283|10857952|FG000|NOT COMPLETED|Open Label||0
9754814|NCT00348283|10857953|FG001|NOT COMPLETED|Open Label||34
9754815|NCT00348309|10857962|FG000|STARTED|Overall Study||496
9754816|NCT00348309|10857963|FG001|STARTED|Overall Study||494
9754817|NCT00348309|10857964|FG002|STARTED|Overall Study||489
9754818|NCT00348309|10857962|FG000|COMPLETED|Overall Study||362
9754819|NCT00348309|10857963|FG001|COMPLETED|Overall Study||396
9754820|NCT00348309|10857964|FG002|COMPLETED|Overall Study||346
9754821|NCT00348309|10857962|FG000|NOT COMPLETED|Overall Study||134
9754822|NCT00348309|10857963|FG001|NOT COMPLETED|Overall Study||98
9754823|NCT00348309|10857964|FG002|NOT COMPLETED|Overall Study||143
9754824|NCT00348348|10857975|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
9754825|NCT00348348|10857976|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
9754826|NCT00348348|10857975|FG000|COMPLETED|Overall Study||554
9754827|NCT00348348|10857976|FG001|COMPLETED|Overall Study||555
9754828|NCT00348348|10857975|FG000|NOT COMPLETED|Overall Study||25
9754829|NCT00348348|10857976|FG001|NOT COMPLETED|Overall Study||27
9754830|NCT00348374|10857984|FG000|STARTED|Overall Study||88
9754831|NCT00348374|10857985|FG001|STARTED|Overall Study||103
9754832|NCT00348374|10857984|FG000|Received Study Treatment|Overall Study||88
9754833|NCT00348374|10857985|FG001|Received Study Treatment|Overall Study||96
9754834|NCT00348374|10857984|FG000|COMPLETED|Overall Study||69
9754835|NCT00348374|10857985|FG001|COMPLETED|Overall Study||71
9754836|NCT00348374|10857984|FG000|NOT COMPLETED|Overall Study||19
9754837|NCT00348374|10857985|FG001|NOT COMPLETED|Overall Study||32
9754838|NCT00348595|10857994|FG000|STARTED|Overall Study||26
9754839|NCT00348595|10857995|FG001|STARTED|Overall Study||34
9754840|NCT00348595|10857994|FG000|COMPLETED|Overall Study||21
9754841|NCT00348595|10857995|FG001|COMPLETED|Overall Study||26
9754842|NCT00348595|10857994|FG000|NOT COMPLETED|Overall Study||5
9754843|NCT00348595|10857995|FG001|NOT COMPLETED|Overall Study||8
9754844|NCT00348673|10858009|FG000|STARTED|Stage 1||6
9754845|NCT00348673|10858010|FG001|STARTED|Stage 1||6
9754846|NCT00348673|10858011|FG002|STARTED|Stage 1||7
9754847|NCT00348673|10858012|FG003|STARTED|Stage 1||6
9754848|NCT00348673|10858013|FG004|STARTED|Stage 1||4
9754849|NCT00348673|10858014|FG005|STARTED|Stage 1||0
9754850|NCT00348673|10858015|FG006|STARTED|Stage 1||0
9754851|NCT00348673|10858016|FG007|STARTED|Stage 1||0
9754852|NCT00348673|10858017|FG008|STARTED|Stage 1||0
9754853|NCT00348673|10858009|FG000|Treated|Stage 1||6
9754854|NCT00348673|10858010|FG001|Treated|Stage 1||6
9754855|NCT00348673|10858011|FG002|Treated|Stage 1||6
9754856|NCT00348673|10858012|FG003|Treated|Stage 1||6
9754857|NCT00348673|10858013|FG004|Treated|Stage 1||4
9754858|NCT00348673|10858014|FG005|Treated|Stage 1||0
9754859|NCT00348673|10858015|FG006|Treated|Stage 1||0
9754860|NCT00348673|10858016|FG007|Treated|Stage 1||0
9754861|NCT00348673|10858017|FG008|Treated|Stage 1||0
9754862|NCT00348673|10858009|FG000|COMPLETED|Stage 1||6
9754863|NCT00348673|10858010|FG001|COMPLETED|Stage 1||6
9754864|NCT00348673|10858011|FG002|COMPLETED|Stage 1||6
9754865|NCT00348673|10858012|FG003|COMPLETED|Stage 1||6
9754866|NCT00348673|10858013|FG004|COMPLETED|Stage 1||4
9754867|NCT00348673|10858014|FG005|COMPLETED|Stage 1||0
9754868|NCT00348673|10858015|FG006|COMPLETED|Stage 1||0
9754869|NCT00348673|10858016|FG007|COMPLETED|Stage 1||0
9754870|NCT00348673|10858017|FG008|COMPLETED|Stage 1||0
9754871|NCT00348673|10858009|FG000|NOT COMPLETED|Stage 1||0
9754872|NCT00348673|10858010|FG001|NOT COMPLETED|Stage 1||0
9754873|NCT00348673|10858011|FG002|NOT COMPLETED|Stage 1||1
10092385|NCT02336607|11220839|FG001|Patients Included in ITT Population|Overall Study||84
10092386|NCT02336607|11220840|FG002|Patients Included in ITT Population|Overall Study||91
10092387|NCT02336607|11220841|FG003|Patients Included in ITT Population|Overall Study||222
9754874|NCT00348673|10858012|FG003|NOT COMPLETED|Stage 1||0
9754875|NCT00348673|10858013|FG004|NOT COMPLETED|Stage 1||0
9754876|NCT00348673|10858014|FG005|NOT COMPLETED|Stage 1||0
9754877|NCT00348673|10858015|FG006|NOT COMPLETED|Stage 1||0
9754878|NCT00348673|10858016|FG007|NOT COMPLETED|Stage 1||0
9754879|NCT00348673|10858017|FG008|NOT COMPLETED|Stage 1||0
9754880|NCT00348673|10858009|FG000|STARTED|Stage 2||0
9754881|NCT00348673|10858010|FG001|STARTED|Stage 2||0
9754882|NCT00348673|10858011|FG002|STARTED|Stage 2||0
9754883|NCT00348673|10858012|FG003|STARTED|Stage 2||0
9754884|NCT00348673|10858013|FG004|STARTED|Stage 2||0
9754885|NCT00348673|10858014|FG005|STARTED|Stage 2||6
9754886|NCT00348673|10858015|FG006|STARTED|Stage 2||6
9754887|NCT00348673|10858016|FG007|STARTED|Stage 2||6
9754888|NCT00348673|10858017|FG008|STARTED|Stage 2||2
9754889|NCT00348673|10858009|FG000|COMPLETED|Stage 2||0
9754890|NCT00348673|10858010|FG001|COMPLETED|Stage 2||0
9754891|NCT00348673|10858011|FG002|COMPLETED|Stage 2||0
9754892|NCT00348673|10858012|FG003|COMPLETED|Stage 2||0
9754893|NCT00348673|10858013|FG004|COMPLETED|Stage 2||0
9754894|NCT00348673|10858014|FG005|COMPLETED|Stage 2||6
9754895|NCT00348673|10858015|FG006|COMPLETED|Stage 2||6
9754896|NCT00348673|10858016|FG007|COMPLETED|Stage 2||6
10092388|NCT02336607|11220838|FG000|Patients Included in PP Population|Overall Study||78
10092389|NCT02336607|11220839|FG001|Patients Included in PP Population|Overall Study||75
10092390|NCT02336607|11220840|FG002|Patients Included in PP Population|Overall Study||75
10092391|NCT02336607|11220841|FG003|Patients Included in PP Population|Overall Study||162
10092392|NCT02336607|11220838|FG000|Patients Included in Safety Population|Overall Study||85
10092393|NCT02336607|11220839|FG001|Patients Included in Safety Population|Overall Study||85
9754897|NCT00348673|10858017|FG008|COMPLETED|Stage 2||2
9754898|NCT00348673|10858009|FG000|NOT COMPLETED|Stage 2||0
9754899|NCT00348673|10858010|FG001|NOT COMPLETED|Stage 2||0
9754900|NCT00348673|10858011|FG002|NOT COMPLETED|Stage 2||0
9754901|NCT00348673|10858012|FG003|NOT COMPLETED|Stage 2||0
9754902|NCT00348673|10858013|FG004|NOT COMPLETED|Stage 2||0
10092394|NCT02336607|11220840|FG002|Patients Included in Safety Population|Overall Study||92
10092395|NCT02336607|11220841|FG003|Patients Included in Safety Population|Overall Study||260
10092396|NCT02336607|11220838|FG000|COMPLETED|Overall Study||81
10092397|NCT02336607|11220839|FG001|COMPLETED|Overall Study||75
10092398|NCT02336607|11220840|FG002|COMPLETED|Overall Study||86
10092399|NCT02336607|11220841|FG003|COMPLETED|Overall Study||180
9754903|NCT00348673|10858014|FG005|NOT COMPLETED|Stage 2||0
9754904|NCT00348673|10858015|FG006|NOT COMPLETED|Stage 2||0
9754905|NCT00348673|10858016|FG007|NOT COMPLETED|Stage 2||0
9754906|NCT00348673|10858017|FG008|NOT COMPLETED|Stage 2||0
9754907|NCT00348686|10858035|FG000|STARTED|Overall Study||315
9754908|NCT00348686|10858035|FG000|COMPLETED|Overall Study||249
9754909|NCT00348686|10858035|FG000|NOT COMPLETED|Overall Study||66
9754910|NCT00348790|10858039|FG000|STARTED|Began Treatment||25
9754911|NCT00348790|10858039|FG000|COMPLETED|Began Treatment||25
9754912|NCT00348790|10858039|FG000|NOT COMPLETED|Began Treatment||0
9754913|NCT00348790|10858039|FG000|STARTED|Completed Treatment||25
9754914|NCT00348790|10858039|FG000|COMPLETED|Completed Treatment||0
9754915|NCT00348790|10858039|FG000|NOT COMPLETED|Completed Treatment||25
9754916|NCT00348816|10858044|FG000|STARTED|Overall Study||20
9754917|NCT00348816|10858044|FG000|COMPLETED|Overall Study||19
9754918|NCT00348816|10858044|FG000|NOT COMPLETED|Overall Study||1
9754919|NCT00348881|10858052|FG000|STARTED|Overall Study||1424
9754920|NCT00348881|10858053|FG001|STARTED|Overall Study||709
9754921|NCT00348881|10858052|FG000|COMPLETED|Overall Study||1407
9754922|NCT00348881|10858053|FG001|COMPLETED|Overall Study||697
9754923|NCT00348881|10858052|FG000|NOT COMPLETED|Overall Study||17
9754924|NCT00348881|10858053|FG001|NOT COMPLETED|Overall Study||12
9754925|NCT00348933|10858063|FG000|STARTED|Overall Study||90
9754926|NCT00348933|10858063|FG000|COMPLETED|Overall Study||65
9754927|NCT00348933|10858063|FG000|NOT COMPLETED|Overall Study||25
9754928|NCT00348946|10858070|FG000|STARTED|Overall Study||46
9754929|NCT00348946|10858071|FG001|STARTED|Overall Study||47
9754930|NCT00348946|10858070|FG000|COMPLETED|Overall Study||35
10092400|NCT02336607|11220838|FG000|NOT COMPLETED|Overall Study||4
10092401|NCT02336607|11220839|FG001|NOT COMPLETED|Overall Study||10
10092402|NCT02336607|11220840|FG002|NOT COMPLETED|Overall Study||6
10092403|NCT02336607|11220841|FG003|NOT COMPLETED|Overall Study||87
10092404|NCT02336737|11220851|FG000|STARTED|Overall Study||160
9754931|NCT00348946|10858071|FG001|COMPLETED|Overall Study||35
9754932|NCT00348946|10858070|FG000|NOT COMPLETED|Overall Study||11
10092405|NCT02336737|11220851|FG000|COMPLETED|Overall Study||147
9754933|NCT00348946|10858071|FG001|NOT COMPLETED|Overall Study||12
9754934|NCT00349336|10858081|FG000|STARTED|Overall Study||32
9754935|NCT00349336|10858082|FG001|STARTED|Overall Study||32
9754936|NCT00349336|10858081|FG000|COMPLETED|Overall Study||19
9754937|NCT00349336|10858082|FG001|COMPLETED|Overall Study||18
9754938|NCT00349336|10858081|FG000|NOT COMPLETED|Overall Study||13
9754939|NCT00349336|10858082|FG001|NOT COMPLETED|Overall Study||14
9754940|NCT00349349|10858091|FG000|STARTED|Overall Study||95
9754941|NCT00349349|10858092|FG001|STARTED|Overall Study||112
9754942|NCT00349349|10858093|FG002|STARTED|Overall Study||16
9754943|NCT00349349|10858091|FG000|COMPLETED|Overall Study||42
10092406|NCT02336737|11220851|FG000|NOT COMPLETED|Overall Study||13
10092407|NCT02336815|11220858|FG000|STARTED|Overall Study||79
10092408|NCT02336815|11220859|FG001|STARTED|Overall Study||123
10092409|NCT02336815|11220858|FG000|COMPLETED|Overall Study||0
10092410|NCT02336815|11220859|FG001|COMPLETED|Overall Study||0
10092411|NCT02336815|11220858|FG000|NOT COMPLETED|Overall Study||79
10092412|NCT02336815|11220859|FG001|NOT COMPLETED|Overall Study||123
10092413|NCT02336958|11220869|FG000|STARTED|Overall Study||20
10092414|NCT02336958|11220870|FG001|STARTED|Overall Study||20
10092415|NCT02336958|11220869|FG000|COMPLETED|Overall Study||20
10092416|NCT02336958|11220870|FG001|COMPLETED|Overall Study||20
10092417|NCT02336958|11220869|FG000|NOT COMPLETED|Overall Study||0
10092418|NCT02336958|11220870|FG001|NOT COMPLETED|Overall Study||0
10092419|NCT02337062|11220878|FG000|STARTED|Overall Study||572
10092420|NCT02337062|11220879|FG001|STARTED|Overall Study||575
10092421|NCT02337062|11220878|FG000|COMPLETED|Overall Study||555
10092422|NCT02337062|11220879|FG001|COMPLETED|Overall Study||556
10092423|NCT02337062|11220878|FG000|NOT COMPLETED|Overall Study||17
10092424|NCT02337062|11220879|FG001|NOT COMPLETED|Overall Study||19
10092425|NCT02337218|11220889|FG000|STARTED|Overall Study||17
10092426|NCT02337218|11220890|FG001|STARTED|Overall Study||11
9754944|NCT00349349|10858092|FG001|COMPLETED|Overall Study||50
9754945|NCT00349349|10858093|FG002|COMPLETED|Overall Study||10
9754946|NCT00349349|10858091|FG000|NOT COMPLETED|Overall Study||53
9754947|NCT00349349|10858092|FG001|NOT COMPLETED|Overall Study||62
9754948|NCT00349349|10858093|FG002|NOT COMPLETED|Overall Study||6
9754949|NCT00349388|10858105|FG000|STARTED|Overall Study|no patients enrolled|0
9754950|NCT00349388|10858106|FG001|STARTED|Overall Study||1
9754951|NCT00349388|10858105|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
9754952|NCT00349388|10858106|FG001|COMPLETED|Overall Study||1
9754953|NCT00349388|10858105|FG000|NOT COMPLETED|Overall Study||0
9754954|NCT00349388|10858106|FG001|NOT COMPLETED|Overall Study||0
9754955|NCT00349622|10858114|FG000|STARTED|Overall Study||340
9754956|NCT00349622|10858115|FG001|STARTED|Overall Study||173
9754957|NCT00349622|10858114|FG000|COMPLETED|Overall Study||162
9754958|NCT00349622|10858115|FG001|COMPLETED|Overall Study||77
9754959|NCT00349622|10858114|FG000|NOT COMPLETED|Overall Study||178
9754960|NCT00349622|10858115|FG001|NOT COMPLETED|Overall Study||96
9754961|NCT00349713|10858124|FG000|STARTED|Overall Study||20
9754962|NCT00349713|10858125|FG001|STARTED|Overall Study||20
9754963|NCT00349713|10858126|FG002|STARTED|Overall Study||20
9754964|NCT00349713|10858124|FG000|COMPLETED|Overall Study||20
9754965|NCT00349713|10858125|FG001|COMPLETED|Overall Study||20
9754966|NCT00349713|10858126|FG002|COMPLETED|Overall Study||20
9754967|NCT00349713|10858124|FG000|NOT COMPLETED|Overall Study||0
9754968|NCT00349713|10858125|FG001|NOT COMPLETED|Overall Study||0
9754969|NCT00349713|10858126|FG002|NOT COMPLETED|Overall Study||0
9754970|NCT00349752|10858136|FG000|STARTED|Overall Study||87
9754971|NCT00349752|10858137|FG001|STARTED|Overall Study||87
9754972|NCT00349752|10858136|FG000|COMPLETED|Overall Study||28
9754973|NCT00349752|10858137|FG001|COMPLETED|Overall Study||23
9754974|NCT00349752|10858136|FG000|NOT COMPLETED|Overall Study||59
9754975|NCT00349752|10858137|FG001|NOT COMPLETED|Overall Study||64
9754976|NCT00349778|10858143|FG000|STARTED|Overall Study||102
9754977|NCT00349778|10858143|FG000|COMPLETED|Overall Study||102
9754978|NCT00349778|10858143|FG000|NOT COMPLETED|Overall Study||0
9754979|NCT00349908|10858149|FG000|STARTED|Overall Study||10
9754980|NCT00349908|10858150|FG001|STARTED|Overall Study||10
9754981|NCT00349908|10858149|FG000|COMPLETED|Overall Study||10
9754982|NCT00349908|10858150|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
9754983|NCT00349908|10858149|FG000|NOT COMPLETED|Overall Study||0
9754984|NCT00349908|10858150|FG001|NOT COMPLETED|Overall Study||4
9754985|NCT00349921|10858161|FG000|STARTED|First Spinal Injection||10
9754986|NCT00349921|10858162|FG001|STARTED|First Spinal Injection||10
9754987|NCT00349921|10858163|FG002|STARTED|First Spinal Injection||1
9754988|NCT00349921|10858164|FG003|STARTED|First Spinal Injection||1
9754989|NCT00349921|10858161|FG000|COMPLETED|First Spinal Injection||9
9754990|NCT00349921|10858162|FG001|COMPLETED|First Spinal Injection||10
9754991|NCT00349921|10858163|FG002|COMPLETED|First Spinal Injection||0
9754992|NCT00349921|10858164|FG003|COMPLETED|First Spinal Injection||1
9754993|NCT00349921|10858161|FG000|NOT COMPLETED|First Spinal Injection||1
9754994|NCT00349921|10858162|FG001|NOT COMPLETED|First Spinal Injection||0
9754995|NCT00349921|10858163|FG002|NOT COMPLETED|First Spinal Injection||1
9754996|NCT00349921|10858164|FG003|NOT COMPLETED|First Spinal Injection||0
9754997|NCT00349921|10858161|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
9754998|NCT00349921|10858162|FG001|STARTED|Second Spinal Injection||10
9754999|NCT00349921|10858163|FG002|STARTED|Second Spinal Injection||0
9755000|NCT00349921|10858164|FG003|STARTED|Second Spinal Injection||1
9755001|NCT00349921|10858161|FG000|COMPLETED|Second Spinal Injection||9
9755002|NCT00349921|10858162|FG001|COMPLETED|Second Spinal Injection||10
9755003|NCT00349921|10858163|FG002|COMPLETED|Second Spinal Injection||0
9755004|NCT00349921|10858164|FG003|COMPLETED|Second Spinal Injection||1
10092427|NCT02337218|11220889|FG000|COMPLETED|Overall Study||17
9755005|NCT00349921|10858161|FG000|NOT COMPLETED|Second Spinal Injection||0
9755006|NCT00349921|10858162|FG001|NOT COMPLETED|Second Spinal Injection||0
9755007|NCT00349921|10858163|FG002|NOT COMPLETED|Second Spinal Injection||0
10092428|NCT02337218|11220890|FG001|COMPLETED|Overall Study||11
10092429|NCT02337218|11220889|FG000|NOT COMPLETED|Overall Study||0
9755008|NCT00349921|10858164|FG003|NOT COMPLETED|Second Spinal Injection||0
9755009|NCT00349973|10858175|FG000|STARTED|Overall Study||12
9755010|NCT00349973|10858176|FG001|STARTED|Overall Study||8
9755011|NCT00349973|10858175|FG000|COMPLETED|Overall Study||8
9755012|NCT00349973|10858176|FG001|COMPLETED|Overall Study||5
9755013|NCT00349973|10858175|FG000|NOT COMPLETED|Overall Study||4
9755014|NCT00349973|10858176|FG001|NOT COMPLETED|Overall Study||3
9755015|NCT00350025|10858184|FG000|STARTED|Overall Study||11
9755016|NCT00350025|10858185|FG001|STARTED|Overall Study||30
9755017|NCT00350025|10858184|FG000|COMPLETED|Overall Study||11
9755018|NCT00350025|10858185|FG001|COMPLETED|Overall Study||28
9755019|NCT00350025|10858184|FG000|NOT COMPLETED|Overall Study||0
9755020|NCT00350025|10858185|FG001|NOT COMPLETED|Overall Study||2
9755021|NCT00350142|10858191|FG000|STARTED|Overall Study||20
9755022|NCT00350142|10858191|FG000|COMPLETED|Overall Study||20
9755023|NCT00350142|10858191|FG000|NOT COMPLETED|Overall Study||0
9755024|NCT00350207|10858199|FG000|STARTED|Overall Study||128
9755025|NCT00350207|10858200|FG001|STARTED|Overall Study||134
9755026|NCT00350207|10858201|FG002|STARTED|Overall Study||126
9755027|NCT00350207|10858199|FG000|COMPLETED|Overall Study||120
9755028|NCT00350207|10858200|FG001|COMPLETED|Overall Study||128
9755029|NCT00350207|10858201|FG002|COMPLETED|Overall Study||119
9755030|NCT00350207|10858199|FG000|NOT COMPLETED|Overall Study||8
9755031|NCT00350207|10858200|FG001|NOT COMPLETED|Overall Study||6
9755032|NCT00350207|10858201|FG002|NOT COMPLETED|Overall Study||7
9755033|NCT00350220|10858211|FG000|STARTED|Overall Study||30
9755034|NCT00350220|10858212|FG001|STARTED|Overall Study||30
9755035|NCT00350220|10858211|FG000|COMPLETED|Overall Study||30
9755036|NCT00350220|10858212|FG001|COMPLETED|Overall Study||30
9755037|NCT00350220|10858211|FG000|NOT COMPLETED|Overall Study||0
9755038|NCT00350220|10858212|FG001|NOT COMPLETED|Overall Study||0
9755039|NCT00350272|10858220|FG000|STARTED|Blinded 12 Week Treatment||39
9755040|NCT00350272|10858221|FG001|STARTED|Blinded 12 Week Treatment||37
9755041|NCT00350272|10858220|FG000|COMPLETED|Blinded 12 Week Treatment||30
9755042|NCT00350272|10858221|FG001|COMPLETED|Blinded 12 Week Treatment||35
9755043|NCT00350272|10858220|FG000|NOT COMPLETED|Blinded 12 Week Treatment||9
9755044|NCT00350272|10858221|FG001|NOT COMPLETED|Blinded 12 Week Treatment||2
9755045|NCT00350272|10858220|FG000|STARTED|Open-Label 84 Week Treatment||30
9755046|NCT00350272|10858221|FG001|STARTED|Open-Label 84 Week Treatment||35
9755047|NCT00350272|10858220|FG000|COMPLETED|Open-Label 84 Week Treatment||21
9755048|NCT00350272|10858221|FG001|COMPLETED|Open-Label 84 Week Treatment||27
9755049|NCT00350272|10858220|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9
9755050|NCT00350272|10858221|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8
9755051|NCT00350298|10858231|FG000|STARTED|Overall Study||101
9755052|NCT00350298|10858232|FG001|STARTED|Overall Study||99
9755053|NCT00350298|10858231|FG000|COMPLETED|Overall Study||92
9755054|NCT00350298|10858232|FG001|COMPLETED|Overall Study||86
9854232|NCT00892177|10967273|FG003|STARTED|Phase I: Dose Level 0||0
9854233|NCT00892177|10967274|FG004|STARTED|Phase I: Dose Level 0||0
9854234|NCT00892177|10967275|FG005|STARTED|Phase I: Dose Level 0||0
9854235|NCT00892177|10967270|FG000|COMPLETED|Phase I: Dose Level 0||3
9854236|NCT00892177|10967271|FG001|COMPLETED|Phase I: Dose Level 0||0
9854237|NCT00892177|10967272|FG002|COMPLETED|Phase I: Dose Level 0||0
9755055|NCT00350298|10858231|FG000|NOT COMPLETED|Overall Study||9
9755056|NCT00350298|10858232|FG001|NOT COMPLETED|Overall Study||13
9755057|NCT00350337|10858242|FG000|STARTED|Overall Study||22
9755058|NCT00350337|10858243|FG001|STARTED|Overall Study||22
9755059|NCT00350337|10858244|FG002|STARTED|Overall Study||21
9755060|NCT00350337|10858245|FG003|STARTED|Overall Study||21
9755061|NCT00350337|10858242|FG000|COMPLETED|Overall Study||17
9755062|NCT00350337|10858243|FG001|COMPLETED|Overall Study||19
9755063|NCT00350337|10858244|FG002|COMPLETED|Overall Study||18
9755064|NCT00350337|10858245|FG003|COMPLETED|Overall Study||21
9755065|NCT00350337|10858242|FG000|NOT COMPLETED|Overall Study||5
9755066|NCT00350337|10858243|FG001|NOT COMPLETED|Overall Study||3
9755067|NCT00350337|10858244|FG002|NOT COMPLETED|Overall Study||3
9755068|NCT00350337|10858245|FG003|NOT COMPLETED|Overall Study||0
9755069|NCT00350363|10858256|FG000|STARTED|Overall Study||60
9755070|NCT00350363|10858256|FG000|COMPLETED|Overall Study||60
9755071|NCT00350363|10858256|FG000|NOT COMPLETED|Overall Study||0
9755072|NCT00350402|10858262|FG000|STARTED|Overall Study||21
9755073|NCT00350402|10858263|FG001|STARTED|Overall Study||21
9755074|NCT00350402|10858262|FG000|COMPLETED|Overall Study||20
9755075|NCT00350402|10858263|FG001|COMPLETED|Overall Study||20
9755076|NCT00350402|10858262|FG000|NOT COMPLETED|Overall Study||1
9755077|NCT00350402|10858263|FG001|NOT COMPLETED|Overall Study||1
9755078|NCT00350519|10858277|FG000|STARTED|Overall Study||18
9755079|NCT00350519|10858278|FG001|STARTED|Overall Study||19
9755080|NCT00350519|10858277|FG000|COMPLETED|Overall Study||14
9755081|NCT00350519|10858278|FG001|COMPLETED|Overall Study||13
9755082|NCT00350519|10858277|FG000|NOT COMPLETED|Overall Study||4
9755083|NCT00350519|10858278|FG001|NOT COMPLETED|Overall Study||6
9755084|NCT00350532|10858286|FG000|STARTED|Overall Study||24
9755085|NCT00350532|10858287|FG001|STARTED|Overall Study||19
9755086|NCT00350532|10858286|FG000|COMPLETED|Overall Study||24
9755087|NCT00350532|10858287|FG001|COMPLETED|Overall Study||19
9755088|NCT00350532|10858286|FG000|NOT COMPLETED|Overall Study||0
9755089|NCT00350532|10858287|FG001|NOT COMPLETED|Overall Study||0
9755090|NCT00350545|10858293|FG000|STARTED|Overall Study||37
9755091|NCT00350545|10858293|FG000|COMPLETED|Overall Study||35
9755092|NCT00350545|10858293|FG000|NOT COMPLETED|Overall Study||2
9755093|NCT00350636|10858299|FG000|STARTED|Overall Study||389
9755094|NCT00350636|10858300|FG001|STARTED|Overall Study||400
9755095|NCT00350636|10858299|FG000|COMPLETED|Overall Study||346
9755096|NCT00350636|10858300|FG001|COMPLETED|Overall Study||355
9755097|NCT00350636|10858299|FG000|NOT COMPLETED|Overall Study||43
9755098|NCT00350636|10858300|FG001|NOT COMPLETED|Overall Study||45
9755099|NCT00350727|10858309|FG000|STARTED|Phase I: Dose Escalation||34
9755100|NCT00350727|10858310|FG001|STARTED|Phase I: Dose Escalation||0
9755101|NCT00350727|10858311|FG002|STARTED|Phase I: Dose Escalation||0
9755102|NCT00350727|10858309|FG000|COMPLETED|Phase I: Dose Escalation||0
9755103|NCT00350727|10858310|FG001|COMPLETED|Phase I: Dose Escalation||0
9755104|NCT00350727|10858311|FG002|COMPLETED|Phase I: Dose Escalation||0
9755105|NCT00350727|10858309|FG000|NOT COMPLETED|Phase I: Dose Escalation||34
9755106|NCT00350727|10858310|FG001|NOT COMPLETED|Phase I: Dose Escalation||0
9755107|NCT00350727|10858311|FG002|NOT COMPLETED|Phase I: Dose Escalation||0
9755108|NCT00350727|10858309|FG000|STARTED|Phase II||0
9755109|NCT00350727|10858310|FG001|STARTED|Phase II||19
9755110|NCT00350727|10858311|FG002|STARTED|Phase II||22
9755111|NCT00350727|10858309|FG000|COMPLETED|Phase II||0
9755112|NCT00350727|10858310|FG001|COMPLETED|Phase II||0
9755113|NCT00350727|10858311|FG002|COMPLETED|Phase II||0
9755114|NCT00350727|10858309|FG000|NOT COMPLETED|Phase II||0
9755115|NCT00350727|10858310|FG001|NOT COMPLETED|Phase II||19
9755116|NCT00350727|10858311|FG002|NOT COMPLETED|Phase II||22
9755117|NCT00350779|10858332|FG000|STARTED|Overall Study||170
9755118|NCT00350779|10858333|FG001|STARTED|Overall Study||92
9755119|NCT00350779|10858332|FG000|COMPLETED|Overall Study||148
9755120|NCT00350779|10858333|FG001|COMPLETED|Overall Study||71
9755121|NCT00350779|10858332|FG000|NOT COMPLETED|Overall Study||22
9755122|NCT00350779|10858333|FG001|NOT COMPLETED|Overall Study||21
9755123|NCT00350792|10858341|FG000|STARTED|Overall Study||62
9755124|NCT00350792|10858341|FG000|COMPLETED|Overall Study||29
9755125|NCT00350792|10858341|FG000|NOT COMPLETED|Overall Study||33
9755126|NCT00350870|10858349|FG000|STARTED|Overall Study||27
9755127|NCT00350870|10858350|FG001|STARTED|Overall Study||28
9755128|NCT00350870|10858351|FG002|STARTED|Overall Study||22
9755129|NCT00350870|10858352|FG003|STARTED|Overall Study||22
9755130|NCT00350870|10858349|FG000|Had at Least 1 Day of Med|Overall Study||19
9755131|NCT00350870|10858350|FG001|Had at Least 1 Day of Med|Overall Study||24
9755132|NCT00350870|10858351|FG002|Had at Least 1 Day of Med|Overall Study||18
9755133|NCT00350870|10858352|FG003|Had at Least 1 Day of Med|Overall Study||19
9755134|NCT00350870|10858349|FG000|COMPLETED|Overall Study||5
9755135|NCT00350870|10858350|FG001|COMPLETED|Overall Study||11
9755136|NCT00350870|10858351|FG002|COMPLETED|Overall Study||6
9755137|NCT00350870|10858352|FG003|COMPLETED|Overall Study||7
9755138|NCT00350870|10858349|FG000|NOT COMPLETED|Overall Study||22
10092430|NCT02337218|11220890|FG001|NOT COMPLETED|Overall Study||0
10092431|NCT02337361|11220898|FG000|STARTED|Baseline Assessment||99
10092432|NCT02337361|11220899|FG001|STARTED|Baseline Assessment||86
10092433|NCT02337361|11220898|FG000|COMPLETED|Baseline Assessment||99
10092434|NCT02337361|11220899|FG001|COMPLETED|Baseline Assessment||86
10092435|NCT02337361|11220898|FG000|NOT COMPLETED|Baseline Assessment||0
10092436|NCT02337361|11220899|FG001|NOT COMPLETED|Baseline Assessment||0
10092437|NCT02337361|11220898|FG000|STARTED|3-month Follow-up||99
10092438|NCT02337361|11220899|FG001|STARTED|3-month Follow-up||86
10092439|NCT02337361|11220898|FG000|COMPLETED|3-month Follow-up||80
10092440|NCT02337361|11220899|FG001|COMPLETED|3-month Follow-up||72
10092441|NCT02337361|11220898|FG000|NOT COMPLETED|3-month Follow-up||19
10092442|NCT02337361|11220899|FG001|NOT COMPLETED|3-month Follow-up||14
10092443|NCT02337361|11220898|FG000|STARTED|6-month Follow-up||80
10092444|NCT02337361|11220899|FG001|STARTED|6-month Follow-up||72
10092445|NCT02337361|11220898|FG000|COMPLETED|6-month Follow-up||78
10092446|NCT02337361|11220899|FG001|COMPLETED|6-month Follow-up||68
10092447|NCT02337361|11220898|FG000|NOT COMPLETED|6-month Follow-up||2
10092448|NCT02337361|11220899|FG001|NOT COMPLETED|6-month Follow-up||4
10092449|NCT02337387|11220910|FG000|STARTED|Overall Study||14
10092450|NCT02337387|11220911|FG001|STARTED|Overall Study||8
10092451|NCT02337387|11220912|FG002|STARTED|Overall Study||3
10092452|NCT02337387|11220913|FG003|STARTED|Overall Study||3
10092453|NCT02337387|11220910|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
10092454|NCT02337387|11220911|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10092455|NCT02337387|11220912|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9755139|NCT00350870|10858350|FG001|NOT COMPLETED|Overall Study||17
9755140|NCT00350870|10858351|FG002|NOT COMPLETED|Overall Study||16
9755141|NCT00350870|10858352|FG003|NOT COMPLETED|Overall Study||15
9755142|NCT00351000|10858362|FG000|STARTED|Overall Study||24
9755143|NCT00351000|10858362|FG000|COMPLETED|Overall Study||21
9755144|NCT00351000|10858362|FG000|NOT COMPLETED|Overall Study||3
9755145|NCT00351039|10858369|FG000|STARTED|Overall Study||8
9755146|NCT00351039|10858369|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
9755147|NCT00351039|10858369|FG000|NOT COMPLETED|Overall Study||0
9755148|NCT00351273|10858377|FG000|STARTED|Overall Study||15
9755149|NCT00351273|10858378|FG001|STARTED|Overall Study||12
9755150|NCT00351273|10858379|FG002|STARTED|Overall Study||15
9755151|NCT00351273|10858377|FG000|COMPLETED|Overall Study||14
9755152|NCT00351273|10858378|FG001|COMPLETED|Overall Study||10
9755153|NCT00351273|10858379|FG002|COMPLETED|Overall Study||10
9755154|NCT00351273|10858377|FG000|NOT COMPLETED|Overall Study||1
10092456|NCT02337387|11220913|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10092457|NCT02337387|11220910|FG000|COMPLETED|Overall Study||0
10092458|NCT02337387|11220911|FG001|COMPLETED|Overall Study||0
10092459|NCT02337387|11220912|FG002|COMPLETED|Overall Study||0
10092460|NCT02337387|11220913|FG003|COMPLETED|Overall Study||0
10092461|NCT02337387|11220910|FG000|NOT COMPLETED|Overall Study||14
10092462|NCT02337387|11220911|FG001|NOT COMPLETED|Overall Study||8
9755155|NCT00351273|10858378|FG001|NOT COMPLETED|Overall Study||2
9755156|NCT00351273|10858379|FG002|NOT COMPLETED|Overall Study||5
9755157|NCT00351299|10858394|FG000|STARTED|Overall Study||25
9755158|NCT00351299|10858395|FG001|STARTED|Overall Study||28
9755159|NCT00351299|10858394|FG000|COMPLETED|Overall Study||25
9755160|NCT00351299|10858395|FG001|COMPLETED|Overall Study||28
9755161|NCT00351299|10858394|FG000|NOT COMPLETED|Overall Study||0
9755162|NCT00351299|10858395|FG001|NOT COMPLETED|Overall Study||0
9755163|NCT00351351|10858407|FG000|STARTED|Overall Study||34
9755164|NCT00351351|10858408|FG001|STARTED|Overall Study||36
9755165|NCT00351351|10858407|FG000|COMPLETED|Overall Study||25
9755166|NCT00351351|10858408|FG001|COMPLETED|Overall Study||32
9755167|NCT00351351|10858407|FG000|NOT COMPLETED|Overall Study||9
9755168|NCT00351351|10858408|FG001|NOT COMPLETED|Overall Study||4
9755169|NCT00351377|10858414|FG000|STARTED|Overall Study||111
9755170|NCT00351377|10858414|FG000|COMPLETED|Overall Study||104
9755171|NCT00351377|10858414|FG000|NOT COMPLETED|Overall Study||7
9755172|NCT00351416|10858420|FG000|STARTED|Overall Study||6
9755173|NCT00351416|10858421|FG001|STARTED|Overall Study||9
9755174|NCT00351416|10858420|FG000|COMPLETED|Overall Study||6
9755175|NCT00351416|10858421|FG001|COMPLETED|Overall Study||9
9755176|NCT00351416|10858420|FG000|NOT COMPLETED|Overall Study||0
9755177|NCT00351416|10858421|FG001|NOT COMPLETED|Overall Study||0
9755178|NCT00351468|10858427|FG000|STARTED|Overall Study||302
9755179|NCT00351468|10858427|FG000|Subjects From TRA100773A|Overall Study||51
9755180|NCT00351468|10858427|FG000|Subjects From TRA100773B|Overall Study||61
9755181|NCT00351468|10858427|FG000|Subjects From TRA102537 Raise|Overall Study||146
9755182|NCT00351468|10858427|FG000|Subjects From TRA108057 Repeat|Overall Study||43
9755183|NCT00351468|10858427|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
9755184|NCT00351468|10858427|FG000|COMPLETED|Overall Study||135
9755185|NCT00351468|10858427|FG000|NOT COMPLETED|Overall Study||167
9755186|NCT00351533|10858434|FG000|STARTED|Overall Study||41
9755187|NCT00351533|10858435|FG001|STARTED|Overall Study||49
9755188|NCT00351533|10858434|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
9755189|NCT00351533|10858435|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
9755190|NCT00351533|10858434|FG000|NOT COMPLETED|Overall Study||2
9755191|NCT00351533|10858435|FG001|NOT COMPLETED|Overall Study||5
9755192|NCT00351611|10858443|FG000|STARTED|Overall Study||89
9755193|NCT00351611|10858444|FG001|STARTED|Overall Study||98
9755194|NCT00351611|10858443|FG000|Treated|Overall Study||89
9755195|NCT00351611|10858444|FG001|Treated|Overall Study||98
9755196|NCT00351611|10858443|FG000|COMPLETED|Overall Study||75
9755197|NCT00351611|10858444|FG001|COMPLETED|Overall Study||88
9755198|NCT00351611|10858443|FG000|NOT COMPLETED|Overall Study||14
9755199|NCT00351611|10858444|FG001|NOT COMPLETED|Overall Study||10
9755200|NCT00351741|10858452|FG000|STARTED|Overall Study||31
9755201|NCT00351741|10858453|FG001|STARTED|Overall Study||31
9755202|NCT00351741|10858452|FG000|COMPLETED|Overall Study||31
9755203|NCT00351741|10858453|FG001|COMPLETED|Overall Study||31
9755204|NCT00351741|10858452|FG000|NOT COMPLETED|Overall Study||0
9755205|NCT00351741|10858453|FG001|NOT COMPLETED|Overall Study||0
9755206|NCT00351819|10858461|FG000|STARTED|Overall Study||43
9755207|NCT00351819|10858462|FG001|STARTED|Overall Study||41
9755208|NCT00351819|10858461|FG000|COMPLETED|Overall Study||36
9755209|NCT00351819|10858462|FG001|COMPLETED|Overall Study||29
9755210|NCT00351819|10858461|FG000|NOT COMPLETED|Overall Study||7
9755211|NCT00351819|10858462|FG001|NOT COMPLETED|Overall Study||12
9755212|NCT00351936|10858468|FG000|STARTED|Overall Study||15
9755213|NCT00351936|10858468|FG000|COMPLETED|Overall Study||15
9755214|NCT00351936|10858468|FG000|NOT COMPLETED|Overall Study||0
9755215|NCT00352001|10858473|FG000|STARTED|Overall Study||37
9755216|NCT00352001|10858473|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
9755217|NCT00352001|10858473|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
9755218|NCT00352001|10858473|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
9755219|NCT00352001|10858473|FG000|COMPLETED|Overall Study||37
9755220|NCT00352001|10858473|FG000|NOT COMPLETED|Overall Study||0
9755221|NCT00352053|10858479|FG000|STARTED|Double-Blind Phase (Through Week 48)||45
10092463|NCT02337387|11220912|FG002|NOT COMPLETED|Overall Study||3
10092464|NCT02337387|11220913|FG003|NOT COMPLETED|Overall Study||3
10092465|NCT02337465|11220923|FG000|STARTED|Overall Study||30
10092466|NCT02337465|11220923|FG000|COMPLETED|Overall Study||30
10092467|NCT02337465|11220923|FG000|NOT COMPLETED|Overall Study||0
10092468|NCT02337478|11220927|FG000|STARTED|Overall Study||5
10092469|NCT02337478|11220927|FG000|COMPLETED|Overall Study||0
10092470|NCT02337478|11220927|FG000|NOT COMPLETED|Overall Study||5
10092471|NCT02337491|11220933|FG000|STARTED|Overall Study||50
10092472|NCT02337491|11220934|FG001|STARTED|Overall Study||30
10092473|NCT02337491|11220933|FG000|COMPLETED|Overall Study||0
9755222|NCT00352053|10858480|FG001|STARTED|Double-Blind Phase (Through Week 48)||42
9755223|NCT00352053|10858479|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27
9829017|NCT00758524|10939651|FG015|STARTED|Core Period (Week 0 to Week 8)||0
9755224|NCT00352053|10858480|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
9755225|NCT00352053|10858479|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
9755226|NCT00352053|10858480|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
9755227|NCT00352053|10858479|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
9755228|NCT00352053|10858480|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
9755229|NCT00352053|10858479|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12
9755230|NCT00352053|10858480|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19
9755231|NCT00352053|10858479|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
9755232|NCT00352053|10858480|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
9755233|NCT00352053|10858479|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
9755234|NCT00352053|10858480|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
9755235|NCT00352053|10858479|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4
9755236|NCT00352053|10858480|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9
9755237|NCT00352053|10858479|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
9755238|NCT00352053|10858480|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
9755239|NCT00352053|10858479|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
9755240|NCT00352053|10858480|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
9755241|NCT00352053|10858479|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0
9755242|NCT00352053|10858480|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2
9755243|NCT00352053|10858479|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
9755244|NCT00352053|10858480|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
9755245|NCT00352105|10858494|FG000|STARTED|Overall Study||60
9755246|NCT00352105|10858494|FG000|COMPLETED|Overall Study||20
9755247|NCT00352105|10858494|FG000|NOT COMPLETED|Overall Study||40
9755248|NCT00352365|10858498|FG000|STARTED|Induction Therapy||41
9755249|NCT00352365|10858498|FG000|Eligible|Induction Therapy||38
9755250|NCT00352365|10858498|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37
9755251|NCT00352365|10858498|FG000|COMPLETED|Induction Therapy||14
9755252|NCT00352365|10858498|FG000|NOT COMPLETED|Induction Therapy||27
9755253|NCT00352365|10858498|FG000|STARTED|Maintenance Therapy||12
9755254|NCT00352365|10858498|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8
9755255|NCT00352365|10858498|FG000|COMPLETED|Maintenance Therapy||0
9755256|NCT00352365|10858498|FG000|NOT COMPLETED|Maintenance Therapy||12
9755257|NCT00352417|10858508|FG000|STARTED|Overall Study||24
9755258|NCT00352417|10858509|FG001|STARTED|Overall Study||26
9755259|NCT00352417|10858508|FG000|COMPLETED|Overall Study||19
9755260|NCT00352417|10858509|FG001|COMPLETED|Overall Study||21
9755261|NCT00352417|10858508|FG000|NOT COMPLETED|Overall Study||5
9755262|NCT00352417|10858509|FG001|NOT COMPLETED|Overall Study||5
9755263|NCT00352612|10858517|FG000|STARTED|Overall Study||100
9755264|NCT00352612|10858518|FG001|STARTED|Overall Study||100
9755265|NCT00352612|10858517|FG000|COMPLETED|Overall Study||100
9755266|NCT00352612|10858518|FG001|COMPLETED|Overall Study||100
9755267|NCT00352612|10858517|FG000|NOT COMPLETED|Overall Study||0
9755268|NCT00352612|10858518|FG001|NOT COMPLETED|Overall Study||0
9755269|NCT00352664|10858526|FG000|STARTED|Overall Study||27
9755270|NCT00352664|10858527|FG001|STARTED|Overall Study||0
9755271|NCT00352664|10858526|FG000|COMPLETED|Overall Study||20
9755272|NCT00352664|10858527|FG001|COMPLETED|Overall Study||0
9755273|NCT00352664|10858526|FG000|NOT COMPLETED|Overall Study||7
9755274|NCT00352664|10858527|FG001|NOT COMPLETED|Overall Study||0
9755275|NCT00352690|10858535|FG000|STARTED|Overall Study||10
9755276|NCT00352690|10858536|FG001|STARTED|Overall Study||0
9755277|NCT00352690|10858535|FG000|COMPLETED|Overall Study||8
9755278|NCT00352690|10858536|FG001|COMPLETED|Overall Study||0
9755279|NCT00352690|10858535|FG000|NOT COMPLETED|Overall Study||2
9755280|NCT00352690|10858536|FG001|NOT COMPLETED|Overall Study||0
9755281|NCT00352755|10858542|FG000|STARTED|Overall Study||18
9755282|NCT00352755|10858542|FG000|COMPLETED|Overall Study||16
9755283|NCT00352755|10858542|FG000|NOT COMPLETED|Overall Study||2
9755284|NCT00352781|10858546|FG000|STARTED|Overall Study||1767
9755285|NCT00352781|10858546|FG000|COMPLETED|Overall Study||884
9755286|NCT00352781|10858546|FG000|NOT COMPLETED|Overall Study||883
9755287|NCT00352794|10858550|FG000|STARTED|Overall Study||40
9755288|NCT00352794|10858550|FG000|COMPLETED|Overall Study||40
9755289|NCT00352794|10858550|FG000|NOT COMPLETED|Overall Study||0
9755290|NCT00352846|10858556|FG000|STARTED|Overall Study||37
9755291|NCT00352846|10858557|FG001|STARTED|Overall Study||37
9755292|NCT00352846|10858556|FG000|COMPLETED|Overall Study||29
9755293|NCT00352846|10858557|FG001|COMPLETED|Overall Study||24
9755294|NCT00352846|10858556|FG000|NOT COMPLETED|Overall Study||8
9755295|NCT00352846|10858557|FG001|NOT COMPLETED|Overall Study||13
9755296|NCT00352885|10858565|FG000|STARTED|Overall Study||9
9755297|NCT00352885|10858566|FG001|STARTED|Overall Study||11
9755298|NCT00352885|10858565|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
9755299|NCT00352885|10858566|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
9755300|NCT00352885|10858565|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
9755301|NCT00352885|10858566|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
9755302|NCT00352885|10858565|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
9755303|NCT00352885|10858566|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
9755304|NCT00352885|10858565|FG000|COMPLETED|Overall Study||3
9755305|NCT00352885|10858566|FG001|COMPLETED|Overall Study||4
9755306|NCT00352885|10858565|FG000|NOT COMPLETED|Overall Study||6
9755307|NCT00352885|10858566|FG001|NOT COMPLETED|Overall Study||7
9755308|NCT00352911|10858574|FG000|STARTED|150mg Twice Daily (14 Days)||16
9755309|NCT00352911|10858575|FG001|STARTED|150mg Twice Daily (14 Days)||3
9755310|NCT00352911|10858574|FG000|COMPLETED|150mg Twice Daily (14 Days)||16
9755311|NCT00352911|10858575|FG001|COMPLETED|150mg Twice Daily (14 Days)||3
9854238|NCT00892177|10967273|FG003|COMPLETED|Phase I: Dose Level 0||0
9854239|NCT00892177|10967274|FG004|COMPLETED|Phase I: Dose Level 0||0
9854240|NCT00892177|10967275|FG005|COMPLETED|Phase I: Dose Level 0||0
9854241|NCT00892177|10967270|FG000|NOT COMPLETED|Phase I: Dose Level 0||0
9854242|NCT00892177|10967271|FG001|NOT COMPLETED|Phase I: Dose Level 0||0
9854243|NCT00892177|10967272|FG002|NOT COMPLETED|Phase I: Dose Level 0||0
9854244|NCT00892177|10967273|FG003|NOT COMPLETED|Phase I: Dose Level 0||0
9854245|NCT00892177|10967274|FG004|NOT COMPLETED|Phase I: Dose Level 0||0
9854246|NCT00892177|10967275|FG005|NOT COMPLETED|Phase I: Dose Level 0||0
9854247|NCT00892177|10967270|FG000|STARTED|Phase I: Dose Level 1||0
9854248|NCT00892177|10967271|FG001|STARTED|Phase I: Dose Level 1||4
9854249|NCT00892177|10967272|FG002|STARTED|Phase I: Dose Level 1||0
9854250|NCT00892177|10967273|FG003|STARTED|Phase I: Dose Level 1||0
9854251|NCT00892177|10967274|FG004|STARTED|Phase I: Dose Level 1||0
9854252|NCT00892177|10967275|FG005|STARTED|Phase I: Dose Level 1||0
9854253|NCT00892177|10967270|FG000|COMPLETED|Phase I: Dose Level 1||0
9854254|NCT00892177|10967271|FG001|COMPLETED|Phase I: Dose Level 1||4
9854255|NCT00892177|10967272|FG002|COMPLETED|Phase I: Dose Level 1||0
9854256|NCT00892177|10967273|FG003|COMPLETED|Phase I: Dose Level 1||0
9854257|NCT00892177|10967274|FG004|COMPLETED|Phase I: Dose Level 1||0
9854258|NCT00892177|10967275|FG005|COMPLETED|Phase I: Dose Level 1||0
9854259|NCT00892177|10967270|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
9854260|NCT00892177|10967271|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
9854261|NCT00892177|10967272|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
9854262|NCT00892177|10967273|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
9854263|NCT00892177|10967274|FG004|NOT COMPLETED|Phase I: Dose Level 1||0
9854264|NCT00892177|10967275|FG005|NOT COMPLETED|Phase I: Dose Level 1||0
9854265|NCT00892177|10967270|FG000|STARTED|Phase I: Dose Level 2||0
9854266|NCT00892177|10967271|FG001|STARTED|Phase I: Dose Level 2||0
9854267|NCT00892177|10967272|FG002|STARTED|Phase I: Dose Level 2||3
9854268|NCT00892177|10967273|FG003|STARTED|Phase I: Dose Level 2||0
9854269|NCT00892177|10967274|FG004|STARTED|Phase I: Dose Level 2||0
9854270|NCT00892177|10967275|FG005|STARTED|Phase I: Dose Level 2||0
9854271|NCT00892177|10967270|FG000|COMPLETED|Phase I: Dose Level 2||0
9854272|NCT00892177|10967271|FG001|COMPLETED|Phase I: Dose Level 2||0
9854273|NCT00892177|10967272|FG002|COMPLETED|Phase I: Dose Level 2||3
9854274|NCT00892177|10967273|FG003|COMPLETED|Phase I: Dose Level 2||0
9854275|NCT00892177|10967274|FG004|COMPLETED|Phase I: Dose Level 2||0
9854276|NCT00892177|10967275|FG005|COMPLETED|Phase I: Dose Level 2||0
9854277|NCT00892177|10967270|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
9854278|NCT00892177|10967271|FG001|NOT COMPLETED|Phase I: Dose Level 2||0
9854279|NCT00892177|10967272|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
9854280|NCT00892177|10967273|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
9854281|NCT00892177|10967274|FG004|NOT COMPLETED|Phase I: Dose Level 2||0
9854282|NCT00892177|10967275|FG005|NOT COMPLETED|Phase I: Dose Level 2||0
9854283|NCT00892177|10967270|FG000|STARTED|Phase I: Dose Level 3||0
9854284|NCT00892177|10967271|FG001|STARTED|Phase I: Dose Level 3||0
9854285|NCT00892177|10967272|FG002|STARTED|Phase I: Dose Level 3||0
9854286|NCT00892177|10967273|FG003|STARTED|Phase I: Dose Level 3||6
9854287|NCT00892177|10967274|FG004|STARTED|Phase I: Dose Level 3||0
9854288|NCT00892177|10967275|FG005|STARTED|Phase I: Dose Level 3||0
9854289|NCT00892177|10967270|FG000|COMPLETED|Phase I: Dose Level 3||0
9854290|NCT00892177|10967271|FG001|COMPLETED|Phase I: Dose Level 3||0
9854291|NCT00892177|10967272|FG002|COMPLETED|Phase I: Dose Level 3||0
9854292|NCT00892177|10967273|FG003|COMPLETED|Phase I: Dose Level 3||6
9854293|NCT00892177|10967274|FG004|COMPLETED|Phase I: Dose Level 3||0
9854294|NCT00892177|10967275|FG005|COMPLETED|Phase I: Dose Level 3||0
9854295|NCT00892177|10967270|FG000|NOT COMPLETED|Phase I: Dose Level 3||0
9854296|NCT00892177|10967271|FG001|NOT COMPLETED|Phase I: Dose Level 3||0
9854297|NCT00892177|10967272|FG002|NOT COMPLETED|Phase I: Dose Level 3||0
9854298|NCT00892177|10967273|FG003|NOT COMPLETED|Phase I: Dose Level 3||0
9854299|NCT00892177|10967274|FG004|NOT COMPLETED|Phase I: Dose Level 3||0
9854300|NCT00892177|10967275|FG005|NOT COMPLETED|Phase I: Dose Level 3||0
9854301|NCT00892177|10967270|FG000|STARTED|Phase II||0
9854302|NCT00892177|10967271|FG001|STARTED|Phase II||0
9854303|NCT00892177|10967272|FG002|STARTED|Phase II||0
9854304|NCT00892177|10967273|FG003|STARTED|Phase II||0
9854305|NCT00892177|10967274|FG004|STARTED|Phase II||88
9854306|NCT00892177|10967275|FG005|STARTED|Phase II||40
9854307|NCT00892177|10967270|FG000|COMPLETED|Phase II||0
9854308|NCT00892177|10967271|FG001|COMPLETED|Phase II||0
9854309|NCT00892177|10967272|FG002|COMPLETED|Phase II||0
9854310|NCT00892177|10967273|FG003|COMPLETED|Phase II||0
9854311|NCT00892177|10967274|FG004|COMPLETED|Phase II||83
9854312|NCT00892177|10967275|FG005|COMPLETED|Phase II||38
9755312|NCT00352911|10858574|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0
9755313|NCT00352911|10858575|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0
9755314|NCT00352911|10858574|FG000|STARTED|300mg Twice Daily (14 Days)||16
9755315|NCT00352911|10858575|FG001|STARTED|300mg Twice Daily (14 Days)||3
9755316|NCT00352911|10858574|FG000|COMPLETED|300mg Twice Daily (14 Days)||15
9755317|NCT00352911|10858575|FG001|COMPLETED|300mg Twice Daily (14 Days)||3
9755318|NCT00352911|10858574|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1
9755319|NCT00352911|10858575|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0
9755320|NCT00352976|10858581|FG000|STARTED|Overall Study||83
9755321|NCT00352976|10858581|FG000|COMPLETED|Overall Study||83
9755322|NCT00352976|10858581|FG000|NOT COMPLETED|Overall Study||0
9755323|NCT00353119|10858588|FG000|STARTED|First Intervention Day 0 to Week 12||5
9755324|NCT00353119|10858589|FG001|STARTED|First Intervention Day 0 to Week 12||10
9755325|NCT00353119|10858588|FG000|COMPLETED|First Intervention Day 0 to Week 12||5
9755326|NCT00353119|10858589|FG001|COMPLETED|First Intervention Day 0 to Week 12||10
9755327|NCT00353119|10858588|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0
9755328|NCT00353119|10858589|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0
9755329|NCT00353119|10858588|FG000|STARTED|Second Intervention Week 12 to Week 28||5
9755330|NCT00353119|10858589|FG001|STARTED|Second Intervention Week 12 to Week 28||10
9755331|NCT00353119|10858588|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5
9755332|NCT00353119|10858589|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10
9755333|NCT00353119|10858588|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
9755334|NCT00353119|10858589|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
9755335|NCT00353262|10858598|FG000|STARTED|Overall Study||36
9854313|NCT00892177|10967270|FG000|NOT COMPLETED|Phase II||0
9854314|NCT00892177|10967271|FG001|NOT COMPLETED|Phase II||0
9854315|NCT00892177|10967272|FG002|NOT COMPLETED|Phase II||0
9755336|NCT00353262|10858598|FG000|COMPLETED|Overall Study||7
9755337|NCT00353262|10858598|FG000|NOT COMPLETED|Overall Study||29
9755338|NCT00353301|10858602|FG000|STARTED|Overall Study||25
9755339|NCT00353301|10858602|FG000|COMPLETED|Overall Study||25
9755340|NCT00353301|10858602|FG000|NOT COMPLETED|Overall Study||0
9755341|NCT00353366|10858606|FG000|STARTED|Overall Study||1439
9755342|NCT00353366|10858606|FG000|COMPLETED|Overall Study||1296
9755343|NCT00353366|10858606|FG000|NOT COMPLETED|Overall Study||143
9755344|NCT00353418|10858612|FG000|STARTED|Overall Study||138
9755345|NCT00353418|10858613|FG001|STARTED|Overall Study||277
9755346|NCT00353418|10858612|FG000|COMPLETED|Overall Study||55
9755347|NCT00353418|10858613|FG001|COMPLETED|Overall Study||119
9755348|NCT00353418|10858612|FG000|NOT COMPLETED|Overall Study||83
9755349|NCT00353418|10858613|FG001|NOT COMPLETED|Overall Study||158
9755350|NCT00353431|10858621|FG000|STARTED|Overall Study||63
9755351|NCT00353431|10858622|FG001|STARTED|Overall Study||67
9755352|NCT00353431|10858621|FG000|COMPLETED|Overall Study||63
9755353|NCT00353431|10858622|FG001|COMPLETED|Overall Study||67
9755354|NCT00353431|10858621|FG000|NOT COMPLETED|Overall Study||0
9755355|NCT00353431|10858622|FG001|NOT COMPLETED|Overall Study||0
9755356|NCT00353496|10858630|FG000|STARTED|Overall Study||101
9755357|NCT00353496|10858631|FG001|STARTED|Overall Study||103
9755358|NCT00353496|10858630|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
9755359|NCT00353496|10858631|FG001|COMPLETED|Overall Study||86
9755360|NCT00353496|10858630|FG000|NOT COMPLETED|Overall Study||16
9755361|NCT00353496|10858631|FG001|NOT COMPLETED|Overall Study||17
9755362|NCT00353522|10858640|FG000|STARTED|Overall Study||89
9755363|NCT00353522|10858641|FG001|STARTED|Overall Study||46
9854316|NCT00892177|10967273|FG003|NOT COMPLETED|Phase II||0
9854317|NCT00892177|10967274|FG004|NOT COMPLETED|Phase II||5
9854318|NCT00892177|10967275|FG005|NOT COMPLETED|Phase II||2
9854319|NCT00892281|10967292|FG000|STARTED|Overall Study||1197
9854320|NCT00892281|10967293|FG001|STARTED|Overall Study||224
9854321|NCT00892281|10967292|FG000|COMPLETED|Overall Study||930
9854322|NCT00892281|10967293|FG001|COMPLETED|Overall Study||187
9854323|NCT00892281|10967292|FG000|NOT COMPLETED|Overall Study||267
9854324|NCT00892281|10967293|FG001|NOT COMPLETED|Overall Study||37
9854325|NCT00892437|10967301|FG000|STARTED|Randomized Phase||56
9854326|NCT00892437|10967302|FG001|STARTED|Randomized Phase||29
9854327|NCT00892437|10967301|FG000|Randomized and Treated|Randomized Phase||50
9854328|NCT00892437|10967302|FG001|Randomized and Treated|Randomized Phase||29
9854329|NCT00892437|10967301|FG000|COMPLETED|Randomized Phase||45
9854330|NCT00892437|10967302|FG001|COMPLETED|Randomized Phase||24
9854331|NCT00892437|10967301|FG000|NOT COMPLETED|Randomized Phase||11
9854332|NCT00892437|10967302|FG001|NOT COMPLETED|Randomized Phase||5
9854333|NCT00892437|10967301|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
9854334|NCT00892437|10967302|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
9854335|NCT00892437|10967301|FG000|COMPLETED|Open-Label Extension Phase||32
9854336|NCT00892437|10967302|FG001|COMPLETED|Open-Label Extension Phase||15
9854337|NCT00892437|10967301|FG000|NOT COMPLETED|Open-Label Extension Phase||12
9854338|NCT00892437|10967302|FG001|NOT COMPLETED|Open-Label Extension Phase||4
9854339|NCT00892606|10967311|FG000|STARTED|Overall Study||38
9854340|NCT00892606|10967312|FG001|STARTED|Overall Study||37
9854341|NCT00892606|10967311|FG000|COMPLETED|Overall Study||33
9755364|NCT00353522|10858640|FG000|COMPLETED|Overall Study||74
9854342|NCT00892606|10967312|FG001|COMPLETED|Overall Study||33
9854343|NCT00892606|10967311|FG000|NOT COMPLETED|Overall Study||5
9854344|NCT00892606|10967312|FG001|NOT COMPLETED|Overall Study||4
9755365|NCT00353522|10858641|FG001|COMPLETED|Overall Study||37
9755366|NCT00353522|10858640|FG000|NOT COMPLETED|Overall Study||15
9755367|NCT00353522|10858641|FG001|NOT COMPLETED|Overall Study||9
9755368|NCT00353652|10858649|FG000|STARTED|First Intervention - 3 Months||15
9755369|NCT00353652|10858650|FG001|STARTED|First Intervention - 3 Months||15
9755370|NCT00353652|10858651|FG002|STARTED|First Intervention - 3 Months||6
9755371|NCT00353652|10858652|FG003|STARTED|First Intervention - 3 Months||7
9755372|NCT00353652|10858653|FG004|STARTED|First Intervention - 3 Months||3
9755373|NCT00353652|10858654|FG005|STARTED|First Intervention - 3 Months||0
9755374|NCT00353652|10858655|FG006|STARTED|First Intervention - 3 Months||1
9755375|NCT00353652|10858656|FG007|STARTED|First Intervention - 3 Months||0
9755376|NCT00353652|10858649|FG000|COMPLETED|First Intervention - 3 Months||12
9755377|NCT00353652|10858650|FG001|COMPLETED|First Intervention - 3 Months||11
9755378|NCT00353652|10858651|FG002|COMPLETED|First Intervention - 3 Months||6
9755379|NCT00353652|10858652|FG003|COMPLETED|First Intervention - 3 Months||7
9755380|NCT00353652|10858653|FG004|COMPLETED|First Intervention - 3 Months||3
9755381|NCT00353652|10858654|FG005|COMPLETED|First Intervention - 3 Months||0
9755382|NCT00353652|10858655|FG006|COMPLETED|First Intervention - 3 Months||1
9755383|NCT00353652|10858656|FG007|COMPLETED|First Intervention - 3 Months||0
9755384|NCT00353652|10858649|FG000|NOT COMPLETED|First Intervention - 3 Months||3
9755385|NCT00353652|10858650|FG001|NOT COMPLETED|First Intervention - 3 Months||4
9755386|NCT00353652|10858651|FG002|NOT COMPLETED|First Intervention - 3 Months||0
9755387|NCT00353652|10858652|FG003|NOT COMPLETED|First Intervention - 3 Months||0
9755388|NCT00353652|10858653|FG004|NOT COMPLETED|First Intervention - 3 Months||0
9755389|NCT00353652|10858654|FG005|NOT COMPLETED|First Intervention - 3 Months||0
9755390|NCT00353652|10858655|FG006|NOT COMPLETED|First Intervention - 3 Months||0
9755391|NCT00353652|10858656|FG007|NOT COMPLETED|First Intervention - 3 Months||0
9755392|NCT00353652|10858649|FG000|STARTED|Second Intervention - 3 Months||12
9755393|NCT00353652|10858650|FG001|STARTED|Second Intervention - 3 Months||11
9755394|NCT00353652|10858651|FG002|STARTED|Second Intervention - 3 Months||6
9755395|NCT00353652|10858652|FG003|STARTED|Second Intervention - 3 Months||7
9755396|NCT00353652|10858653|FG004|STARTED|Second Intervention - 3 Months||3
9755397|NCT00353652|10858654|FG005|STARTED|Second Intervention - 3 Months||0
9755398|NCT00353652|10858655|FG006|STARTED|Second Intervention - 3 Months||1
9755399|NCT00353652|10858656|FG007|STARTED|Second Intervention - 3 Months||0
9755400|NCT00353652|10858649|FG000|COMPLETED|Second Intervention - 3 Months||12
9755401|NCT00353652|10858650|FG001|COMPLETED|Second Intervention - 3 Months||11
9755402|NCT00353652|10858651|FG002|COMPLETED|Second Intervention - 3 Months||6
9755403|NCT00353652|10858652|FG003|COMPLETED|Second Intervention - 3 Months||7
9755404|NCT00353652|10858653|FG004|COMPLETED|Second Intervention - 3 Months||3
9755405|NCT00353652|10858654|FG005|COMPLETED|Second Intervention - 3 Months||0
9755406|NCT00353652|10858655|FG006|COMPLETED|Second Intervention - 3 Months||1
9755407|NCT00353652|10858656|FG007|COMPLETED|Second Intervention - 3 Months||0
9755408|NCT00353652|10858649|FG000|NOT COMPLETED|Second Intervention - 3 Months||0
9755409|NCT00353652|10858650|FG001|NOT COMPLETED|Second Intervention - 3 Months||0
9755410|NCT00353652|10858651|FG002|NOT COMPLETED|Second Intervention - 3 Months||0
9755411|NCT00353652|10858652|FG003|NOT COMPLETED|Second Intervention - 3 Months||0
9755412|NCT00353652|10858653|FG004|NOT COMPLETED|Second Intervention - 3 Months||0
9755413|NCT00353652|10858654|FG005|NOT COMPLETED|Second Intervention - 3 Months||0
9755414|NCT00353652|10858655|FG006|NOT COMPLETED|Second Intervention - 3 Months||0
9755415|NCT00353652|10858656|FG007|NOT COMPLETED|Second Intervention - 3 Months||0
9755416|NCT00353652|10858649|FG000|STARTED|Third Intervention - 3 Months||0
9755417|NCT00353652|10858650|FG001|STARTED|Third Intervention - 3 Months||0
9755418|NCT00353652|10858651|FG002|STARTED|Third Intervention - 3 Months||6
9755419|NCT00353652|10858652|FG003|STARTED|Third Intervention - 3 Months||7
9755420|NCT00353652|10858653|FG004|STARTED|Third Intervention - 3 Months||3
9755421|NCT00353652|10858654|FG005|STARTED|Third Intervention - 3 Months||0
9755422|NCT00353652|10858655|FG006|STARTED|Third Intervention - 3 Months||1
9755423|NCT00353652|10858656|FG007|STARTED|Third Intervention - 3 Months||0
9755424|NCT00353652|10858649|FG000|COMPLETED|Third Intervention - 3 Months||0
9755425|NCT00353652|10858650|FG001|COMPLETED|Third Intervention - 3 Months||0
9755426|NCT00353652|10858651|FG002|COMPLETED|Third Intervention - 3 Months||6
9755427|NCT00353652|10858652|FG003|COMPLETED|Third Intervention - 3 Months||6
9755428|NCT00353652|10858653|FG004|COMPLETED|Third Intervention - 3 Months||3
9755429|NCT00353652|10858654|FG005|COMPLETED|Third Intervention - 3 Months||0
9755430|NCT00353652|10858655|FG006|COMPLETED|Third Intervention - 3 Months||1
9755431|NCT00353652|10858656|FG007|COMPLETED|Third Intervention - 3 Months||0
9755432|NCT00353652|10858649|FG000|NOT COMPLETED|Third Intervention - 3 Months||0
9755433|NCT00353652|10858650|FG001|NOT COMPLETED|Third Intervention - 3 Months||0
9755434|NCT00353652|10858651|FG002|NOT COMPLETED|Third Intervention - 3 Months||0
9755435|NCT00353652|10858652|FG003|NOT COMPLETED|Third Intervention - 3 Months||1
9755436|NCT00353652|10858653|FG004|NOT COMPLETED|Third Intervention - 3 Months||0
9755437|NCT00353652|10858654|FG005|NOT COMPLETED|Third Intervention - 3 Months||0
9755438|NCT00353652|10858655|FG006|NOT COMPLETED|Third Intervention - 3 Months||0
9755439|NCT00353652|10858656|FG007|NOT COMPLETED|Third Intervention - 3 Months||0
9755440|NCT00353704|10858673|FG000|STARTED|Overall Study||25
9755441|NCT00353704|10858674|FG001|STARTED|Overall Study||25
9755442|NCT00353704|10858673|FG000|COMPLETED|Overall Study||22
9755443|NCT00353704|10858674|FG001|COMPLETED|Overall Study||24
9755444|NCT00353704|10858673|FG000|NOT COMPLETED|Overall Study||3
9755445|NCT00353704|10858674|FG001|NOT COMPLETED|Overall Study||1
9755446|NCT00353795|10858680|FG000|STARTED|Overall Study||179
9755447|NCT00353795|10858680|FG000|COMPLETED|Overall Study||179
9755448|NCT00353795|10858680|FG000|NOT COMPLETED|Overall Study||0
9755449|NCT00353834|10858686|FG000|STARTED|Overall Study||26
9755450|NCT00353834|10858687|FG001|STARTED|Overall Study||27
9755451|NCT00353834|10858686|FG000|COMPLETED|Overall Study||26
9755452|NCT00353834|10858687|FG001|COMPLETED|Overall Study||27
9755453|NCT00353834|10858686|FG000|NOT COMPLETED|Overall Study||0
9755454|NCT00353834|10858687|FG001|NOT COMPLETED|Overall Study||0
9755455|NCT00353873|10858695|FG000|STARTED|Overall Study||153
9755456|NCT00353873|10858696|FG001|STARTED|Overall Study||150
9755457|NCT00353873|10858695|FG000|COMPLETED|Overall Study||147
9755458|NCT00353873|10858696|FG001|COMPLETED|Overall Study||147
9755459|NCT00353873|10858695|FG000|NOT COMPLETED|Overall Study||6
9755460|NCT00353873|10858696|FG001|NOT COMPLETED|Overall Study||3
9755461|NCT00353977|10858702|FG000|STARTED|Overall Study||38
9755462|NCT00353977|10858702|FG000|COMPLETED|Overall Study||38
9755463|NCT00353977|10858702|FG000|NOT COMPLETED|Overall Study||0
9755464|NCT00354029|10858708|FG000|STARTED|Overall Study||43
9755465|NCT00354029|10858709|FG001|STARTED|Overall Study||40
9755466|NCT00354029|10858708|FG000|COMPLETED|Overall Study||39
9755467|NCT00354029|10858709|FG001|COMPLETED|Overall Study||38
9755468|NCT00354029|10858708|FG000|NOT COMPLETED|Overall Study||4
9755469|NCT00354029|10858709|FG001|NOT COMPLETED|Overall Study||2
9755470|NCT00354107|10858715|FG000|STARTED|Overall Study||5
9755471|NCT00354107|10858715|FG000|COMPLETED|Overall Study||0
9755472|NCT00354107|10858715|FG000|NOT COMPLETED|Overall Study||5
9755473|NCT00354159|10858721|FG000|STARTED|Randomized Study Period||202
9755474|NCT00354159|10858722|FG001|STARTED|Randomized Study Period||198
9755475|NCT00354159|10858721|FG000|COMPLETED|Randomized Study Period||180
9755476|NCT00354159|10858722|FG001|COMPLETED|Randomized Study Period||176
9755477|NCT00354159|10858721|FG000|NOT COMPLETED|Randomized Study Period||22
9755478|NCT00354159|10858722|FG001|NOT COMPLETED|Randomized Study Period||22
9755479|NCT00354159|10858721|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
9755480|NCT00354159|10858722|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
9755481|NCT00354159|10858721|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
9755482|NCT00354159|10858722|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
9755483|NCT00354159|10858721|FG000|NOT COMPLETED|Long-term Follow-up||180
9755484|NCT00354159|10858722|FG001|NOT COMPLETED|Long-term Follow-up||176
9755485|NCT00354172|10858735|FG000|STARTED|Overall Study||16
9755486|NCT00354172|10858735|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
9755487|NCT00354172|10858735|FG000|NOT COMPLETED|Overall Study||1
9755488|NCT00354224|10858739|FG000|STARTED|Overall Study||10
9755489|NCT00354224|10858739|FG000|COMPLETED|Overall Study||10
9755490|NCT00354224|10858739|FG000|NOT COMPLETED|Overall Study||0
9755491|NCT00354341|10858745|FG000|STARTED|Overall Study||88
9755492|NCT00354341|10858746|FG001|STARTED|Overall Study||82
9755493|NCT00354341|10858745|FG000|COMPLETED|Overall Study||85
9755494|NCT00354341|10858746|FG001|COMPLETED|Overall Study||75
9755495|NCT00354341|10858745|FG000|NOT COMPLETED|Overall Study||3
9755496|NCT00354341|10858746|FG001|NOT COMPLETED|Overall Study||7
9755497|NCT00354432|10858756|FG000|STARTED|Overall Study||30
9755498|NCT00354432|10858757|FG001|STARTED|Overall Study||30
9755499|NCT00354432|10858758|FG002|STARTED|Overall Study||30
9755500|NCT00354432|10858759|FG003|STARTED|Overall Study||30
9755501|NCT00354432|10858756|FG000|COMPLETED|Overall Study||24
9755502|NCT00354432|10858757|FG001|COMPLETED|Overall Study||22
9755503|NCT00354432|10858758|FG002|COMPLETED|Overall Study||20
9755504|NCT00354432|10858759|FG003|COMPLETED|Overall Study||20
9755505|NCT00354432|10858756|FG000|NOT COMPLETED|Overall Study||6
9755506|NCT00354432|10858757|FG001|NOT COMPLETED|Overall Study||8
9755507|NCT00354432|10858758|FG002|NOT COMPLETED|Overall Study||10
9755508|NCT00354432|10858759|FG003|NOT COMPLETED|Overall Study||10
9755509|NCT00354484|10858771|FG000|STARTED|Overall Study||142
9755510|NCT00354484|10858772|FG001|STARTED|Overall Study||147
9755511|NCT00354484|10858771|FG000|COMPLETED|Overall Study||138
9755512|NCT00354484|10858772|FG001|COMPLETED|Overall Study||144
9755513|NCT00354484|10858771|FG000|NOT COMPLETED|Overall Study||4
9755514|NCT00354484|10858772|FG001|NOT COMPLETED|Overall Study||3
9755515|NCT00354601|10858778|FG000|STARTED|Overall Study||2
9755516|NCT00354601|10858778|FG000|COMPLETED|Overall Study||0
9755517|NCT00354601|10858778|FG000|NOT COMPLETED|Overall Study||2
9755518|NCT00354614|10858782|FG000|STARTED|Overall Study||81
9755519|NCT00354614|10858782|FG000|COMPLETED|Overall Study||53
9755520|NCT00354614|10858782|FG000|NOT COMPLETED|Overall Study||28
9755521|NCT00354640|10858786|FG000|STARTED|Overall Study||11
9755522|NCT00354640|10858786|FG000|COMPLETED|Overall Study||11
9755523|NCT00354640|10858786|FG000|NOT COMPLETED|Overall Study||0
9755524|NCT00354679|10858790|FG000|STARTED|Overall Study||34
9755525|NCT00354679|10858790|FG000|COMPLETED|Overall Study||33
9755526|NCT00354679|10858790|FG000|NOT COMPLETED|Overall Study||1
9755527|NCT00354744|10858794|FG000|STARTED|Overall Study||109
9755528|NCT00354744|10858794|FG000|COMPLETED|Overall Study||67
9755529|NCT00354744|10858794|FG000|NOT COMPLETED|Overall Study||42
9755530|NCT00354770|10858802|FG000|STARTED|Overall Study||25
9755531|NCT00354770|10858803|FG001|STARTED|Overall Study||25
9755532|NCT00354770|10858802|FG000|COMPLETED|Overall Study||22
9755533|NCT00354770|10858803|FG001|COMPLETED|Overall Study||22
9755534|NCT00354770|10858802|FG000|NOT COMPLETED|Overall Study||3
9755535|NCT00354770|10858803|FG001|NOT COMPLETED|Overall Study||3
9755536|NCT00354887|10858809|FG000|STARTED|Overall Study||30
9755537|NCT00354887|10858809|FG000|COMPLETED|Overall Study||29
9755538|NCT00354887|10858809|FG000|NOT COMPLETED|Overall Study||1
9755539|NCT00354913|10858813|FG000|STARTED|Overall Study||21
9755540|NCT00354913|10858813|FG000|COMPLETED|Overall Study||21
9755541|NCT00354913|10858813|FG000|NOT COMPLETED|Overall Study||0
9829018|NCT00758524|10939652|FG016|STARTED|Core Period (Week 0 to Week 8)||0
9829019|NCT00758524|10939636|FG000|Treated|Core Period (Week 0 to Week 8)||92
9829020|NCT00758524|10939637|FG001|Treated|Core Period (Week 0 to Week 8)||87
9829021|NCT00758524|10939638|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
9829022|NCT00758524|10939639|FG003|Treated|Core Period (Week 0 to Week 8)||97
9829023|NCT00758524|10939640|FG004|Treated|Core Period (Week 0 to Week 8)||84
9829024|NCT00758524|10939641|FG005|Treated|Core Period (Week 0 to Week 8)||76
9829025|NCT00758524|10939642|FG006|Treated|Core Period (Week 0 to Week 8)||0
9829026|NCT00758524|10939643|FG007|Treated|Core Period (Week 0 to Week 8)||0
9829027|NCT00758524|10939644|FG008|Treated|Core Period (Week 0 to Week 8)||0
9829028|NCT00758524|10939645|FG009|Treated|Core Period (Week 0 to Week 8)||0
9829029|NCT00758524|10939646|FG010|Treated|Core Period (Week 0 to Week 8)||0
9829030|NCT00758524|10939647|FG011|Treated|Core Period (Week 0 to Week 8)||0
9829031|NCT00758524|10939648|FG012|Treated|Core Period (Week 0 to Week 8)||0
9829032|NCT00758524|10939649|FG013|Treated|Core Period (Week 0 to Week 8)||0
9829033|NCT00758524|10939650|FG014|Treated|Core Period (Week 0 to Week 8)||0
9829034|NCT00758524|10939651|FG015|Treated|Core Period (Week 0 to Week 8)||0
9829035|NCT00758524|10939652|FG016|Treated|Core Period (Week 0 to Week 8)||0
9829036|NCT00758524|10939636|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84
9829037|NCT00758524|10939637|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81
9829038|NCT00758524|10939638|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77
9829039|NCT00758524|10939639|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90
9829040|NCT00758524|10939640|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75
9829041|NCT00758524|10939641|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67
9829042|NCT00758524|10939642|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0
9829043|NCT00758524|10939643|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0
9829044|NCT00758524|10939644|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0
9829045|NCT00758524|10939645|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0
9829046|NCT00758524|10939646|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0
9829047|NCT00758524|10939647|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0
9829048|NCT00758524|10939648|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0
9829049|NCT00758524|10939649|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0
9829050|NCT00758524|10939650|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0
9829051|NCT00758524|10939651|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0
9829052|NCT00758524|10939652|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0
9829053|NCT00758524|10939636|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
9829054|NCT00758524|10939637|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
9829055|NCT00758524|10939638|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
9829056|NCT00758524|10939639|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
9829057|NCT00758524|10939640|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
9829058|NCT00758524|10939641|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
9829059|NCT00758524|10939642|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829060|NCT00758524|10939643|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829061|NCT00758524|10939644|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829062|NCT00758524|10939645|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829063|NCT00758524|10939646|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829064|NCT00758524|10939647|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829065|NCT00758524|10939648|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829066|NCT00758524|10939649|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829067|NCT00758524|10939650|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829068|NCT00758524|10939651|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829069|NCT00758524|10939652|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
9829070|NCT00758524|10939636|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0
9829071|NCT00758524|10939637|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0
9829072|NCT00758524|10939638|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0
9829073|NCT00758524|10939639|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0
9829074|NCT00758524|10939640|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0
9829075|NCT00758524|10939641|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0
9829076|NCT00758524|10939642|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46
9829077|NCT00758524|10939643|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38
9829078|NCT00758524|10939644|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44
9829079|NCT00758524|10939645|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
9829080|NCT00758524|10939646|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41
9829081|NCT00758524|10939647|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
9829082|NCT00758524|10939648|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45
9829083|NCT00758524|10939649|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45
9755542|NCT00354978|10858817|FG000|STARTED|Overall Study||43
9755543|NCT00354978|10858817|FG000|COMPLETED|Overall Study||43
9755544|NCT00354978|10858817|FG000|NOT COMPLETED|Overall Study||0
9755545|NCT00355030|10858823|FG000|STARTED|Study Period 1 Treatment||46
9755546|NCT00355030|10858824|FG001|STARTED|Study Period 1 Treatment||45
9755547|NCT00355030|10858823|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
9755548|NCT00355030|10858824|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
9755549|NCT00355030|10858823|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
9755550|NCT00355030|10858824|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
9755551|NCT00355030|10858823|FG000|NOT COMPLETED|Study Period 1 Treatment||45
9755552|NCT00355030|10858824|FG001|NOT COMPLETED|Study Period 1 Treatment||44
9755553|NCT00355030|10858823|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
9755554|NCT00355030|10858824|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
9755555|NCT00355030|10858823|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19
9755556|NCT00355030|10858824|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17
9755557|NCT00355030|10858823|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
9755558|NCT00355030|10858824|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
9755559|NCT00355056|10858832|FG000|STARTED|Randomization Period||107
9755560|NCT00355056|10858833|FG001|STARTED|Randomization Period||123
9755561|NCT00355056|10858832|FG000|COMPLETED|Randomization Period||103
9755562|NCT00355056|10858833|FG001|COMPLETED|Randomization Period||117
9755563|NCT00355056|10858832|FG000|NOT COMPLETED|Randomization Period||4
9755564|NCT00355056|10858833|FG001|NOT COMPLETED|Randomization Period||6
9755565|NCT00355056|10858832|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
9755566|NCT00355056|10858833|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
9755567|NCT00355056|10858832|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0
9755568|NCT00355056|10858833|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84
9755569|NCT00355056|10858832|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
9755570|NCT00355056|10858833|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
9755571|NCT00355082|10858849|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
9755572|NCT00355082|10858850|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
9755573|NCT00355082|10858851|FG002|STARTED|Double-Blind (DB) Treatment Phase||0
9755574|NCT00355082|10858849|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94
9755575|NCT00355082|10858850|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79
9755576|NCT00355082|10858851|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0
9755577|NCT00355082|10858849|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
9755578|NCT00355082|10858850|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
9755579|NCT00355082|10858851|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
9755580|NCT00355082|10858849|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
9755581|NCT00355082|10858850|FG001|STARTED|Continuation Phase||0
9755582|NCT00355082|10858851|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
9755583|NCT00355082|10858849|FG000|COMPLETED|Continuation Phase||160
9755584|NCT00355082|10858850|FG001|COMPLETED|Continuation Phase||0
9755585|NCT00355082|10858851|FG002|COMPLETED|Continuation Phase||8
9755586|NCT00355082|10858849|FG000|NOT COMPLETED|Continuation Phase||24
9755587|NCT00355082|10858850|FG001|NOT COMPLETED|Continuation Phase||0
9755588|NCT00355082|10858851|FG002|NOT COMPLETED|Continuation Phase||3
9755589|NCT00355121|10858865|FG000|STARTED|Overall Study||353
9755590|NCT00355121|10858866|FG001|STARTED|Overall Study||353
9755591|NCT00355121|10858867|FG002|STARTED|Overall Study||175
9755592|NCT00355121|10858865|FG000|COMPLETED|Overall Study||332
9755593|NCT00355121|10858866|FG001|COMPLETED|Overall Study||324
9755594|NCT00355121|10858867|FG002|COMPLETED|Overall Study||170
9755595|NCT00355121|10858865|FG000|NOT COMPLETED|Overall Study||21
9755596|NCT00355121|10858866|FG001|NOT COMPLETED|Overall Study||29
9755597|NCT00355121|10858867|FG002|NOT COMPLETED|Overall Study||5
9755598|NCT00355134|10858883|FG000|STARTED|Core Phase||370
9755599|NCT00355134|10858884|FG001|STARTED|Core Phase||358
9755600|NCT00355134|10858885|FG002|STARTED|Core Phase||355
9755601|NCT00355134|10858886|FG003|STARTED|Core Phase||0
9755602|NCT00355134|10858887|FG004|STARTED|Core Phase||0
9755603|NCT00355134|10858883|FG000|COMPLETED|Core Phase||251
9755604|NCT00355134|10858884|FG001|COMPLETED|Core Phase||272
9755605|NCT00355134|10858885|FG002|COMPLETED|Core Phase||255
9755606|NCT00355134|10858886|FG003|COMPLETED|Core Phase||0
9755607|NCT00355134|10858887|FG004|COMPLETED|Core Phase||0
9755608|NCT00355134|10858883|FG000|NOT COMPLETED|Core Phase||119
9755609|NCT00355134|10858884|FG001|NOT COMPLETED|Core Phase||86
9755610|NCT00355134|10858885|FG002|NOT COMPLETED|Core Phase||100
9755611|NCT00355134|10858886|FG003|NOT COMPLETED|Core Phase||0
9755612|NCT00355134|10858887|FG004|NOT COMPLETED|Core Phase||0
9755613|NCT00355134|10858883|FG000|STARTED|Extension Phase||203
9755614|NCT00355134|10858884|FG001|STARTED|Extension Phase||217
9755615|NCT00355134|10858885|FG002|STARTED|Extension Phase||0
9755616|NCT00355134|10858886|FG003|STARTED|Extension Phase||105
9755617|NCT00355134|10858887|FG004|STARTED|Extension Phase||107
9755618|NCT00355134|10858883|FG000|COMPLETED|Extension Phase||172
9755619|NCT00355134|10858884|FG001|COMPLETED|Extension Phase||180
9755620|NCT00355134|10858885|FG002|COMPLETED|Extension Phase||0
9755621|NCT00355134|10858886|FG003|COMPLETED|Extension Phase||89
9755622|NCT00355134|10858887|FG004|COMPLETED|Extension Phase||88
9755623|NCT00355134|10858883|FG000|NOT COMPLETED|Extension Phase||31
9755624|NCT00355134|10858884|FG001|NOT COMPLETED|Extension Phase||37
9755625|NCT00355134|10858885|FG002|NOT COMPLETED|Extension Phase||0
9755626|NCT00355134|10858886|FG003|NOT COMPLETED|Extension Phase||16
9755627|NCT00355134|10858887|FG004|NOT COMPLETED|Extension Phase||19
9755628|NCT00355147|10858899|FG000|STARTED|Overall Study||87
9755629|NCT00355147|10858900|FG001|STARTED|Overall Study||87
9755630|NCT00355147|10858899|FG000|COMPLETED|Overall Study||69
9755631|NCT00355147|10858900|FG001|COMPLETED|Overall Study||67
9755632|NCT00355147|10858899|FG000|NOT COMPLETED|Overall Study||18
9755633|NCT00355147|10858900|FG001|NOT COMPLETED|Overall Study||20
9755634|NCT00355199|10858912|FG000|STARTED|Overall Study||120
9755635|NCT00355199|10858913|FG001|STARTED|Overall Study||126
9755636|NCT00355199|10858912|FG000|COMPLETED|Overall Study||113
9755637|NCT00355199|10858913|FG001|COMPLETED|Overall Study||122
9755638|NCT00355199|10858912|FG000|NOT COMPLETED|Overall Study||7
9755639|NCT00355199|10858913|FG001|NOT COMPLETED|Overall Study||4
9755640|NCT00355264|10858919|FG000|STARTED|Part 1 (2 Weeks)||12
9755641|NCT00355264|10858919|FG000|COMPLETED|Part 1 (2 Weeks)||12
9755642|NCT00355264|10858919|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0
9755643|NCT00355264|10858919|FG000|STARTED|Part 2 (8 Weeks)||12
9755644|NCT00355264|10858919|FG000|COMPLETED|Part 2 (8 Weeks)||12
9755645|NCT00355264|10858919|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
9755646|NCT00355264|10858919|FG000|STARTED|Part 3 (7 Weeks of Extension)||2
9755647|NCT00355264|10858919|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2
9755648|NCT00355264|10858919|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
9755649|NCT00355264|10858919|FG000|STARTED|Extension (Variable Duration)||12
9755650|NCT00355264|10858919|FG000|COMPLETED|Extension (Variable Duration)||10
9755651|NCT00355264|10858919|FG000|NOT COMPLETED|Extension (Variable Duration)||2
9755652|NCT00355342|10858930|FG000|STARTED|Overall Study||94
9755653|NCT00355342|10858931|FG001|STARTED|Overall Study||92
9755654|NCT00355342|10858930|FG000|COMPLETED|Overall Study||55
9755655|NCT00355342|10858931|FG001|COMPLETED|Overall Study||56
9755656|NCT00355342|10858930|FG000|NOT COMPLETED|Overall Study||39
9755657|NCT00355342|10858931|FG001|NOT COMPLETED|Overall Study||36
9755658|NCT00355368|10858939|FG000|STARTED|Overall Study||210
9755659|NCT00355368|10858940|FG001|STARTED|Overall Study||210
9755660|NCT00355368|10858939|FG000|COMPLETED|Overall Study||200
9755661|NCT00355368|10858940|FG001|COMPLETED|Overall Study||201
9755662|NCT00355368|10858939|FG000|NOT COMPLETED|Overall Study||10
9755663|NCT00355368|10858940|FG001|NOT COMPLETED|Overall Study||9
9755664|NCT00355394|10858948|FG000|STARTED|Overall Study||15
9755665|NCT00355394|10858949|FG001|STARTED|Overall Study||16
9755666|NCT00355394|10858948|FG000|COMPLETED|Overall Study||15
9755667|NCT00355394|10858949|FG001|COMPLETED|Overall Study||16
9755668|NCT00355394|10858948|FG000|NOT COMPLETED|Overall Study||0
9755669|NCT00355394|10858949|FG001|NOT COMPLETED|Overall Study||0
9755670|NCT00355472|10858957|FG000|STARTED|Overall Study||16
9755671|NCT00355472|10858957|FG000|COMPLETED|Overall Study||15
9755672|NCT00355472|10858957|FG000|NOT COMPLETED|Overall Study||1
9755673|NCT00355615|10858973|FG000|STARTED|Randomized Double Blind Period||42
9755674|NCT00355615|10858974|FG001|STARTED|Randomized Double Blind Period||44
9755675|NCT00355615|10858975|FG002|STARTED|Randomized Double Blind Period||45
9755676|NCT00355615|10858976|FG003|STARTED|Randomized Double Blind Period||46
9755677|NCT00355615|10858977|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
9755678|NCT00355615|10858973|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
9755679|NCT00355615|10858974|FG001|COMPLETED|Randomized Double Blind Period||44
9755680|NCT00355615|10858975|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
9755681|NCT00355615|10858976|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
9755682|NCT00355615|10858977|FG004|COMPLETED|Randomized Double Blind Period||0
9755683|NCT00355615|10858973|FG000|NOT COMPLETED|Randomized Double Blind Period||1
9755684|NCT00355615|10858974|FG001|NOT COMPLETED|Randomized Double Blind Period||0
9755685|NCT00355615|10858975|FG002|NOT COMPLETED|Randomized Double Blind Period||1
9755686|NCT00355615|10858976|FG003|NOT COMPLETED|Randomized Double Blind Period||1
9755687|NCT00355615|10858977|FG004|NOT COMPLETED|Randomized Double Blind Period||0
9755688|NCT00355615|10858973|FG000|STARTED|40-week Rosuvastatin Open Label Period||0
9755689|NCT00355615|10858974|FG001|STARTED|40-week Rosuvastatin Open Label Period||0
9755690|NCT00355615|10858975|FG002|STARTED|40-week Rosuvastatin Open Label Period||0
9755691|NCT00355615|10858976|FG003|STARTED|40-week Rosuvastatin Open Label Period||0
9755692|NCT00355615|10858977|FG004|STARTED|40-week Rosuvastatin Open Label Period||173
9755693|NCT00355615|10858973|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0
9755694|NCT00355615|10858974|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0
9755695|NCT00355615|10858975|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0
9755696|NCT00355615|10858976|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0
9755697|NCT00355615|10858977|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164
9755698|NCT00355615|10858973|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
9755699|NCT00355615|10858974|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
9755700|NCT00355615|10858975|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
9755701|NCT00355615|10858976|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
9755702|NCT00355615|10858977|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
9755703|NCT00355706|10858990|FG000|STARTED|Overall Study||50
9755704|NCT00355706|10858991|FG001|STARTED|Overall Study||50
9755705|NCT00355706|10858990|FG000|COMPLETED|Overall Study||50
9755706|NCT00355706|10858991|FG001|COMPLETED|Overall Study||50
9755707|NCT00355706|10858990|FG000|NOT COMPLETED|Overall Study||0
9755708|NCT00355706|10858991|FG001|NOT COMPLETED|Overall Study||0
9755709|NCT00355784|10859002|FG000|STARTED|Overall Study||9
9755710|NCT00355784|10859003|FG001|STARTED|Overall Study||8
9755711|NCT00355784|10859004|FG002|STARTED|Overall Study||7
9755712|NCT00355784|10859002|FG000|COMPLETED|Overall Study||9
9755713|NCT00355784|10859003|FG001|COMPLETED|Overall Study||8
9755714|NCT00355784|10859004|FG002|COMPLETED|Overall Study||5
9755715|NCT00355784|10859002|FG000|NOT COMPLETED|Overall Study||0
9854345|NCT00892697|10967318|FG000|STARTED|Overall Study||15
9854346|NCT00892697|10967318|FG000|COMPLETED|Overall Study||15
9854347|NCT00892697|10967318|FG000|NOT COMPLETED|Overall Study||0
9854348|NCT00892710|10967326|FG000|STARTED|Overall Study||48
9854349|NCT00892710|10967327|FG001|STARTED|Overall Study||59
9854350|NCT00892710|10967328|FG002|STARTED|Overall Study||55
9755716|NCT00355784|10859003|FG001|NOT COMPLETED|Overall Study||0
9755717|NCT00355784|10859004|FG002|NOT COMPLETED|Overall Study||2
9755718|NCT00355797|10859016|FG000|STARTED|Overall Study||741
9755719|NCT00355797|10859017|FG001|STARTED|Overall Study||369
9755720|NCT00355797|10859018|FG002|STARTED|Overall Study||381
9755721|NCT00355797|10859016|FG000|COMPLETED|Overall Study||501
9755722|NCT00355797|10859017|FG001|COMPLETED|Overall Study||221
9755723|NCT00355797|10859018|FG002|COMPLETED|Overall Study||239
9755724|NCT00355797|10859016|FG000|NOT COMPLETED|Overall Study||240
9755725|NCT00355797|10859017|FG001|NOT COMPLETED|Overall Study||148
9755726|NCT00355797|10859018|FG002|NOT COMPLETED|Overall Study||142
9755727|NCT00355914|10859028|FG000|STARTED|Overall Study||60
9755728|NCT00355914|10859029|FG001|STARTED|Overall Study||60
9755729|NCT00355914|10859028|FG000|COMPLETED|Overall Study||60
9755730|NCT00355914|10859029|FG001|COMPLETED|Overall Study||60
9755731|NCT00355914|10859028|FG000|NOT COMPLETED|Overall Study||0
9755732|NCT00355914|10859029|FG001|NOT COMPLETED|Overall Study||0
9755733|NCT00356031|10859037|FG000|STARTED|Overall Study||20
9755734|NCT00356031|10859037|FG000|COMPLETED|Overall Study||20
9755735|NCT00356031|10859037|FG000|NOT COMPLETED|Overall Study||0
9755736|NCT00356057|10859046|FG000|STARTED|Overall Study||58
9755737|NCT00356057|10859047|FG001|STARTED|Overall Study||61
9755738|NCT00356057|10859048|FG002|STARTED|Overall Study||34
9755739|NCT00356057|10859046|FG000|IMPLANTED|Overall Study||49
9755740|NCT00356057|10859047|FG001|IMPLANTED|Overall Study||52
9755741|NCT00356057|10859048|FG002|IMPLANTED|Overall Study||25
9755742|NCT00356057|10859046|FG000|COMPLETED|Overall Study||45
9755743|NCT00356057|10859047|FG001|COMPLETED|Overall Study||47
9755744|NCT00356057|10859048|FG002|COMPLETED|Overall Study||22
9755745|NCT00356057|10859046|FG000|NOT COMPLETED|Overall Study||13
9755746|NCT00356057|10859047|FG001|NOT COMPLETED|Overall Study||14
9755747|NCT00356057|10859048|FG002|NOT COMPLETED|Overall Study||12
9755748|NCT00356122|10859060|FG000|STARTED|TREATMENT||53
9755749|NCT00356122|10859060|FG000|COMPLETED|TREATMENT||8
9755750|NCT00356122|10859060|FG000|NOT COMPLETED|TREATMENT||45
9755751|NCT00356122|10859060|FG000|STARTED|FOLLOW-UP||53
9755752|NCT00356122|10859060|FG000|COMPLETED|FOLLOW-UP||12
9755753|NCT00356122|10859060|FG000|NOT COMPLETED|FOLLOW-UP||41
9755754|NCT00356135|10859067|FG000|STARTED|Overall Study||47
9755755|NCT00356135|10859068|FG001|STARTED|Overall Study||48
9755756|NCT00356135|10859069|FG002|STARTED|Overall Study||44
9755757|NCT00356135|10859067|FG000|COMPLETED|Overall Study||43
9755758|NCT00356135|10859068|FG001|COMPLETED|Overall Study||46
9755759|NCT00356135|10859069|FG002|COMPLETED|Overall Study||39
9755760|NCT00356135|10859067|FG000|NOT COMPLETED|Overall Study||4
9755761|NCT00356135|10859068|FG001|NOT COMPLETED|Overall Study||2
9755762|NCT00356135|10859069|FG002|NOT COMPLETED|Overall Study||5
9755763|NCT00356148|10859081|FG000|STARTED|Overall Study||189
9755764|NCT00356148|10859082|FG001|STARTED|Overall Study||183
9755765|NCT00356148|10859081|FG000|COMPLETED|Overall Study||187
9755766|NCT00356148|10859082|FG001|COMPLETED|Overall Study||182
9755767|NCT00356148|10859081|FG000|NOT COMPLETED|Overall Study||2
9755768|NCT00356148|10859082|FG001|NOT COMPLETED|Overall Study||1
9755769|NCT00356200|10859091|FG000|STARTED|Cohort 1: 10 ug/ml||5
9755770|NCT00356200|10859092|FG001|STARTED|Cohort 1: 10 ug/ml||0
9755771|NCT00356200|10859091|FG000|COMPLETED|Cohort 1: 10 ug/ml||4
9755772|NCT00356200|10859092|FG001|COMPLETED|Cohort 1: 10 ug/ml||0
9755773|NCT00356200|10859091|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1
9755774|NCT00356200|10859092|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0
9755775|NCT00356200|10859091|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
9755776|NCT00356200|10859092|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
9755777|NCT00356200|10859091|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
9755778|NCT00356200|10859092|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
9755779|NCT00356200|10859091|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
9854351|NCT00892710|10967326|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
9854352|NCT00892710|10967327|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
9755780|NCT00356200|10859092|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
9755781|NCT00356265|10859107|FG000|STARTED|Overall Study||7
9755782|NCT00356265|10859108|FG001|STARTED|Overall Study||2
9755783|NCT00356265|10859109|FG002|STARTED|Overall Study||6
9755784|NCT00356265|10859107|FG000|COMPLETED|Overall Study||7
9755785|NCT00356265|10859108|FG001|COMPLETED|Overall Study||2
9755786|NCT00356265|10859109|FG002|COMPLETED|Overall Study||5
9755787|NCT00356265|10859107|FG000|NOT COMPLETED|Overall Study||0
9755788|NCT00356265|10859108|FG001|NOT COMPLETED|Overall Study||0
9755789|NCT00356265|10859109|FG002|NOT COMPLETED|Overall Study||1
9755790|NCT00356278|10859121|FG000|STARTED|Overall Study||53
9755791|NCT00356278|10859122|FG001|STARTED|Overall Study||50
9755792|NCT00356278|10859123|FG002|STARTED|Overall Study||53
9755793|NCT00356278|10859121|FG000|COMPLETED|Overall Study||28
9755794|NCT00356278|10859122|FG001|COMPLETED|Overall Study||35
9755795|NCT00356278|10859123|FG002|COMPLETED|Overall Study||34
9755796|NCT00356278|10859121|FG000|NOT COMPLETED|Overall Study||25
9755797|NCT00356278|10859122|FG001|NOT COMPLETED|Overall Study||15
9755798|NCT00356278|10859123|FG002|NOT COMPLETED|Overall Study||19
9755799|NCT00356304|10859133|FG000|STARTED|Overall Study||26
9755800|NCT00356304|10859134|FG001|STARTED|Overall Study||24
9755801|NCT00356304|10859133|FG000|COMPLETED|Overall Study||24
9755802|NCT00356304|10859134|FG001|COMPLETED|Overall Study||20
9755803|NCT00356304|10859133|FG000|NOT COMPLETED|Overall Study||2
9755804|NCT00356304|10859134|FG001|NOT COMPLETED|Overall Study||4
9755805|NCT00356369|10859142|FG000|STARTED|Active Phase||374
9755806|NCT00356369|10859143|FG001|STARTED|Active Phase||126
9755807|NCT00356369|10859142|FG000|COMPLETED|Active Phase||372
9755808|NCT00356369|10859143|FG001|COMPLETED|Active Phase||125
9755809|NCT00356369|10859142|FG000|NOT COMPLETED|Active Phase||2
9755810|NCT00356369|10859143|FG001|NOT COMPLETED|Active Phase||1
9755811|NCT00356369|10859142|FG000|STARTED|Year 1||364
9755812|NCT00356369|10859143|FG001|STARTED|Year 1||121
9755813|NCT00356369|10859142|FG000|COMPLETED|Year 1||364
9755814|NCT00356369|10859143|FG001|COMPLETED|Year 1||121
9755815|NCT00356369|10859142|FG000|NOT COMPLETED|Year 1||0
9755816|NCT00356369|10859143|FG001|NOT COMPLETED|Year 1||0
9755817|NCT00356369|10859142|FG000|STARTED|Year 2||354
9755818|NCT00356369|10859143|FG001|STARTED|Year 2||117
9755819|NCT00356369|10859142|FG000|COMPLETED|Year 2||354
9755820|NCT00356369|10859143|FG001|COMPLETED|Year 2||117
9755821|NCT00356369|10859142|FG000|NOT COMPLETED|Year 2||0
9755822|NCT00356369|10859143|FG001|NOT COMPLETED|Year 2||0
9755823|NCT00356369|10859142|FG000|STARTED|Year 3||344
9755824|NCT00356369|10859143|FG001|STARTED|Year 3||116
9755825|NCT00356369|10859142|FG000|COMPLETED|Year 3||344
9755826|NCT00356369|10859143|FG001|COMPLETED|Year 3||116
9755827|NCT00356369|10859142|FG000|NOT COMPLETED|Year 3||0
9755828|NCT00356369|10859143|FG001|NOT COMPLETED|Year 3||0
9755829|NCT00356369|10859142|FG000|STARTED|Year 4||317
9755830|NCT00356369|10859143|FG001|STARTED|Year 4||109
9755831|NCT00356369|10859142|FG000|COMPLETED|Year 4||317
9755832|NCT00356369|10859143|FG001|COMPLETED|Year 4||109
9755833|NCT00356369|10859142|FG000|NOT COMPLETED|Year 4||0
9755834|NCT00356369|10859143|FG001|NOT COMPLETED|Year 4||0
9755835|NCT00356369|10859142|FG000|STARTED|Year 5||299
9755836|NCT00356369|10859143|FG001|STARTED|Year 5||105
9755837|NCT00356369|10859142|FG000|COMPLETED|Year 5||299
9755838|NCT00356369|10859143|FG001|COMPLETED|Year 5||105
9755839|NCT00356369|10859142|FG000|NOT COMPLETED|Year 5||0
9755840|NCT00356369|10859143|FG001|NOT COMPLETED|Year 5||0
9755841|NCT00356408|10859153|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
9755842|NCT00356408|10859153|FG000|COMPLETED|Overall Study||43
9755843|NCT00356408|10859153|FG000|NOT COMPLETED|Overall Study||60
9755844|NCT00356434|10859166|FG000|STARTED|Overall Study||4
9755845|NCT00356434|10859167|FG001|STARTED|Overall Study||7
9755846|NCT00356434|10859166|FG000|COMPLETED|Overall Study||4
9755847|NCT00356434|10859167|FG001|COMPLETED|Overall Study||7
9755848|NCT00356434|10859166|FG000|NOT COMPLETED|Overall Study||0
9755849|NCT00356434|10859167|FG001|NOT COMPLETED|Overall Study||0
9755850|NCT00356525|10859178|FG000|STARTED|Overall Study||14
9755851|NCT00356525|10859179|FG001|STARTED|Overall Study||11
9755852|NCT00356525|10859180|FG002|STARTED|Overall Study||7
9755853|NCT00356525|10859181|FG003|STARTED|Overall Study||9
9755854|NCT00356525|10859178|FG000|COMPLETED|Overall Study||0
9755855|NCT00356525|10859179|FG001|COMPLETED|Overall Study||0
9755856|NCT00356525|10859180|FG002|COMPLETED|Overall Study||0
9755857|NCT00356525|10859181|FG003|COMPLETED|Overall Study||0
9755858|NCT00356525|10859178|FG000|NOT COMPLETED|Overall Study||14
9755859|NCT00356525|10859179|FG001|NOT COMPLETED|Overall Study||11
9755860|NCT00356525|10859180|FG002|NOT COMPLETED|Overall Study||7
9755861|NCT00356525|10859181|FG003|NOT COMPLETED|Overall Study||9
9755862|NCT00356590|10859191|FG000|STARTED|Overall Study||468
9755863|NCT00356590|10859191|FG000|COMPLETED|Overall Study||194
9755864|NCT00356590|10859191|FG000|NOT COMPLETED|Overall Study||274
9755865|NCT00356603|10859197|FG000|STARTED|Overall Study||39
9755866|NCT00356603|10859198|FG001|STARTED|Overall Study||36
9755867|NCT00356603|10859197|FG000|COMPLETED|Overall Study||33
9755868|NCT00356603|10859198|FG001|COMPLETED|Overall Study||33
9755869|NCT00356603|10859197|FG000|NOT COMPLETED|Overall Study||6
9755870|NCT00356603|10859198|FG001|NOT COMPLETED|Overall Study||3
9755871|NCT00356759|10859208|FG000|STARTED|Overall Study||126
9755872|NCT00356759|10859209|FG001|STARTED|Overall Study||124
9755873|NCT00356759|10859208|FG000|COMPLETED|Overall Study||112
9755874|NCT00356759|10859209|FG001|COMPLETED|Overall Study||114
9755875|NCT00356759|10859208|FG000|NOT COMPLETED|Overall Study||14
9755876|NCT00356759|10859209|FG001|NOT COMPLETED|Overall Study||10
9755877|NCT00356811|10859215|FG000|STARTED|Overall Study||57
9755878|NCT00356811|10859215|FG000|COMPLETED|Overall Study||8
9755879|NCT00356811|10859215|FG000|NOT COMPLETED|Overall Study||49
9755880|NCT00356863|10859222|FG000|STARTED|Overall Study||504
9755881|NCT00356863|10859223|FG001|STARTED|Overall Study||520
9755882|NCT00356863|10859222|FG000|COMPLETED|Overall Study||412
9755883|NCT00356863|10859223|FG001|COMPLETED|Overall Study||445
9755884|NCT00356863|10859222|FG000|NOT COMPLETED|Overall Study||92
9755885|NCT00356863|10859223|FG001|NOT COMPLETED|Overall Study||75
9755886|NCT00356889|10859233|FG000|STARTED|Overall Study||56
9755887|NCT00356889|10859233|FG000|COMPLETED|Overall Study||53
9755888|NCT00356889|10859233|FG000|NOT COMPLETED|Overall Study||3
9755889|NCT00356915|10859241|FG000|STARTED|Overall Study||593
9755890|NCT00356915|10859242|FG001|STARTED|Overall Study||590
9755891|NCT00356915|10859243|FG002|STARTED|Overall Study||198
9755892|NCT00356915|10859241|FG000|COMPLETED|Overall Study||517
9755893|NCT00356915|10859242|FG001|COMPLETED|Overall Study||496
9755894|NCT00356915|10859243|FG002|COMPLETED|Overall Study||156
9755895|NCT00356915|10859241|FG000|NOT COMPLETED|Overall Study||76
9755896|NCT00356915|10859242|FG001|NOT COMPLETED|Overall Study||94
9755897|NCT00356915|10859243|FG002|NOT COMPLETED|Overall Study||42
9755898|NCT00356993|10859257|FG000|STARTED|Overall Study||6009
9755899|NCT00356993|10859257|FG000|COMPLETED|Overall Study||2088
9755900|NCT00356993|10859257|FG000|NOT COMPLETED|Overall Study||3921
9755901|NCT00357006|10859264|FG000|STARTED|Overall Study||62
9755902|NCT00357006|10859265|FG001|STARTED|Overall Study||56
9755903|NCT00357006|10859266|FG002|STARTED|Overall Study||62
9755904|NCT00357006|10859264|FG000|COMPLETED|Overall Study||60
9755905|NCT00357006|10859265|FG001|COMPLETED|Overall Study||51
9755906|NCT00357006|10859266|FG002|COMPLETED|Overall Study||59
9755907|NCT00357006|10859264|FG000|NOT COMPLETED|Overall Study||2
9755908|NCT00357006|10859265|FG001|NOT COMPLETED|Overall Study||5
9755909|NCT00357006|10859266|FG002|NOT COMPLETED|Overall Study||3
9755910|NCT00357032|10859274|FG000|STARTED|Overall Study||12
9755911|NCT00357032|10859274|FG000|COMPLETED|Overall Study||12
9755912|NCT00357032|10859274|FG000|NOT COMPLETED|Overall Study||0
9755913|NCT00357097|10859280|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
9755914|NCT00357097|10859281|FG001|STARTED|Overall Study||67
9755915|NCT00357097|10859280|FG000|COMPLETED|Overall Study||145
9755916|NCT00357097|10859281|FG001|COMPLETED|Overall Study||38
9755917|NCT00357097|10859280|FG000|NOT COMPLETED|Overall Study||54
9755918|NCT00357097|10859281|FG001|NOT COMPLETED|Overall Study||29
9755919|NCT00357110|10859289|FG000|STARTED|Overall Study||6
9755920|NCT00357110|10859290|FG001|STARTED|Overall Study||7
9755921|NCT00357110|10859289|FG000|COMPLETED|Overall Study||1
9755922|NCT00357110|10859290|FG001|COMPLETED|Overall Study||2
9755923|NCT00357110|10859289|FG000|NOT COMPLETED|Overall Study||5
9755924|NCT00357110|10859290|FG001|NOT COMPLETED|Overall Study||5
9755925|NCT00357162|10859296|FG000|STARTED|Overall Study||21
9755926|NCT00357162|10859296|FG000|COMPLETED|Overall Study||21
9755927|NCT00357162|10859296|FG000|NOT COMPLETED|Overall Study||0
9755928|NCT00357214|10859304|FG000|STARTED|Overall Study||43
9755929|NCT00357214|10859305|FG001|STARTED|Overall Study||43
9755930|NCT00357214|10859306|FG002|STARTED|Overall Study||42
9755931|NCT00357214|10859307|FG003|STARTED|Overall Study||43
9755932|NCT00357214|10859304|FG000|COMPLETED|Overall Study||39
9755933|NCT00357214|10859305|FG001|COMPLETED|Overall Study||39
9755934|NCT00357214|10859306|FG002|COMPLETED|Overall Study||42
9755935|NCT00357214|10859307|FG003|COMPLETED|Overall Study||42
9755936|NCT00357214|10859304|FG000|NOT COMPLETED|Overall Study||4
9755937|NCT00357214|10859305|FG001|NOT COMPLETED|Overall Study||4
9755938|NCT00357214|10859306|FG002|NOT COMPLETED|Overall Study||0
9755939|NCT00357214|10859307|FG003|NOT COMPLETED|Overall Study||1
9755940|NCT00357331|10859319|FG000|STARTED|Overall Study||42
9755941|NCT00357331|10859320|FG001|STARTED|Overall Study||41
9755942|NCT00357331|10859319|FG000|COMPLETED|Overall Study||42
9755943|NCT00357331|10859320|FG001|COMPLETED|Overall Study||41
9755944|NCT00357331|10859319|FG000|NOT COMPLETED|Overall Study||0
9755945|NCT00357331|10859320|FG001|NOT COMPLETED|Overall Study||0
9755946|NCT00357370|10859329|FG000|STARTED|Cohort 1||4
9755947|NCT00357370|10859330|FG001|STARTED|Cohort 1||0
9755948|NCT00357370|10859331|FG002|STARTED|Cohort 1||0
9755949|NCT00357370|10859329|FG000|COMPLETED|Cohort 1||4
9755950|NCT00357370|10859330|FG001|COMPLETED|Cohort 1||0
9755951|NCT00357370|10859331|FG002|COMPLETED|Cohort 1||0
9755952|NCT00357370|10859329|FG000|NOT COMPLETED|Cohort 1||0
9755953|NCT00357370|10859330|FG001|NOT COMPLETED|Cohort 1||0
9755954|NCT00357370|10859331|FG002|NOT COMPLETED|Cohort 1||0
9755955|NCT00357370|10859329|FG000|STARTED|Cohort 2||24
9755956|NCT00357370|10859330|FG001|STARTED|Cohort 2||23
9755957|NCT00357370|10859331|FG002|STARTED|Cohort 2||24
9755958|NCT00357370|10859329|FG000|COMPLETED|Cohort 2||22
9755959|NCT00357370|10859330|FG001|COMPLETED|Cohort 2||16
9755960|NCT00357370|10859331|FG002|COMPLETED|Cohort 2||22
9755961|NCT00357370|10859329|FG000|NOT COMPLETED|Cohort 2||2
9755962|NCT00357370|10859330|FG001|NOT COMPLETED|Cohort 2||7
9755963|NCT00357370|10859331|FG002|NOT COMPLETED|Cohort 2||2
9755964|NCT00357396|10859341|FG000|STARTED|Overall Study||6
9755965|NCT00357396|10859342|FG001|STARTED|Overall Study||4
9755966|NCT00357396|10859341|FG000|COMPLETED|Overall Study||5
9755967|NCT00357396|10859342|FG001|COMPLETED|Overall Study||4
9755968|NCT00357396|10859341|FG000|NOT COMPLETED|Overall Study||1
9755969|NCT00357396|10859342|FG001|NOT COMPLETED|Overall Study||0
9755970|NCT00357500|10859347|FG000|STARTED|Overall Study||101
9755971|NCT00357500|10859347|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
9755972|NCT00357500|10859347|FG000|COMPLETED|Overall Study||24
9755973|NCT00357500|10859347|FG000|NOT COMPLETED|Overall Study||77
9755974|NCT00357552|10859351|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
9755975|NCT00357552|10859351|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
9755976|NCT00357552|10859351|FG000|NOT COMPLETED|Screening||84
9755977|NCT00357552|10859351|FG000|STARTED|Weeks 0 to 24||123
9755978|NCT00357552|10859351|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
9755979|NCT00357552|10859351|FG000|NOT COMPLETED|Weeks 0 to 24||1
9755980|NCT00357552|10859351|FG000|STARTED|Weeks 24 to 104||122
9755981|NCT00357552|10859351|FG000|COMPLETED|Weeks 24 to 104||117
9755982|NCT00357552|10859351|FG000|NOT COMPLETED|Weeks 24 to 104||5
9755983|NCT00357656|10859361|FG000|STARTED|Overall Study||31
9755984|NCT00357656|10859362|FG001|STARTED|Overall Study||32
9755985|NCT00357656|10859361|FG000|COMPLETED|Overall Study||31
9755986|NCT00357656|10859362|FG001|COMPLETED|Overall Study||29
9755987|NCT00357656|10859361|FG000|NOT COMPLETED|Overall Study||0
9755988|NCT00357656|10859362|FG001|NOT COMPLETED|Overall Study||3
9755989|NCT00357734|10859380|FG000|STARTED|Overall Study||14
9755990|NCT00357734|10859380|FG000|Patients Received 250 mg of ZD1839|Overall Study||13
9755991|NCT00357734|10859380|FG000|Patient Received 500 mg of ZD1839|Overall Study||1
9755992|NCT00357734|10859380|FG000|COMPLETED|Overall Study||10
9755993|NCT00357734|10859380|FG000|NOT COMPLETED|Overall Study||4
9755994|NCT00357760|10859386|FG000|STARTED|Overall Study||59
9755995|NCT00357760|10859387|FG001|STARTED|Overall Study||35
9755996|NCT00357760|10859386|FG000|Patients Who Started Treatment|Overall Study||57
9755997|NCT00357760|10859387|FG001|Patients Who Started Treatment|Overall Study||34
9755998|NCT00357760|10859386|FG000|Eligible and Treated Patients|Overall Study||57
9755999|NCT00357760|10859387|FG001|Eligible and Treated Patients|Overall Study||32
9756000|NCT00357760|10859386|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
9756001|NCT00357760|10859387|FG001|Patients Who Undergo Dose Escalation|Overall Study||16
9756002|NCT00357760|10859386|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
9756003|NCT00357760|10859387|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
9756004|NCT00357760|10859386|FG000|NOT COMPLETED|Overall Study||59
9756005|NCT00357760|10859387|FG001|NOT COMPLETED|Overall Study||35
9756006|NCT00357877|10859395|FG000|STARTED|Overall Study||493
9756007|NCT00357877|10859396|FG001|STARTED|Overall Study||490
9756008|NCT00357877|10859395|FG000|COMPLETED|Overall Study||467
9756009|NCT00357877|10859396|FG001|COMPLETED|Overall Study||460
9756010|NCT00357877|10859395|FG000|NOT COMPLETED|Overall Study||26
9756011|NCT00357877|10859396|FG001|NOT COMPLETED|Overall Study||30
9756012|NCT00357903|10859406|FG000|STARTED|Overall Study||581
9756013|NCT00357903|10859407|FG001|STARTED|Overall Study||58
9756014|NCT00357903|10859406|FG000|COMPLETED|Overall Study||218
9756015|NCT00357903|10859407|FG001|COMPLETED|Overall Study||15
9756016|NCT00357903|10859406|FG000|NOT COMPLETED|Overall Study||363
9756017|NCT00357903|10859407|FG001|NOT COMPLETED|Overall Study||43
9756018|NCT00357955|10859416|FG000|STARTED|Overall Study||64
9756019|NCT00357955|10859417|FG001|STARTED|Overall Study||54
9756020|NCT00357955|10859416|FG000|COMPLETED|Overall Study||58
9756021|NCT00357955|10859417|FG001|COMPLETED|Overall Study||51
9756022|NCT00357955|10859416|FG000|NOT COMPLETED|Overall Study||6
9756023|NCT00357955|10859417|FG001|NOT COMPLETED|Overall Study||3
9756024|NCT00357968|10859425|FG000|STARTED|First Maintenance Dose Phase||102
9756025|NCT00357968|10859426|FG001|STARTED|First Maintenance Dose Phase||99
9756026|NCT00357968|10859425|FG000|Received Loading Dose|First Maintenance Dose Phase||102
9756027|NCT00357968|10859426|FG001|Received Loading Dose|First Maintenance Dose Phase||99
9756028|NCT00357968|10859425|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
9756029|NCT00357968|10859426|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
9756030|NCT00357968|10859425|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55
9756031|NCT00357968|10859426|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55
9756032|NCT00357968|10859425|FG000|COMPLETED|First Maintenance Dose Phase||54
9756033|NCT00357968|10859426|FG001|COMPLETED|First Maintenance Dose Phase||55
9756034|NCT00357968|10859425|FG000|NOT COMPLETED|First Maintenance Dose Phase||48
9756035|NCT00357968|10859426|FG001|NOT COMPLETED|First Maintenance Dose Phase||44
9756036|NCT00357968|10859425|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
9756037|NCT00357968|10859426|FG001|STARTED|Crossover Maintenance Dose Phase||55
9756038|NCT00357968|10859425|FG000|COMPLETED|Crossover Maintenance Dose Phase||54
9756039|NCT00357968|10859426|FG001|COMPLETED|Crossover Maintenance Dose Phase||55
9756040|NCT00357968|10859425|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0
9756041|NCT00357968|10859426|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0
9756042|NCT00357994|10859449|FG000|STARTED|Overall Study||37
9756043|NCT00357994|10859450|FG001|STARTED|Overall Study||34
9756044|NCT00357994|10859449|FG000|COMPLETED|Overall Study||35
9756045|NCT00357994|10859450|FG001|COMPLETED|Overall Study||31
9756046|NCT00357994|10859449|FG000|NOT COMPLETED|Overall Study||2
9756047|NCT00357994|10859450|FG001|NOT COMPLETED|Overall Study||3
9756048|NCT00358007|10859456|FG000|STARTED|Overall Study||30
9756049|NCT00358007|10859456|FG000|COMPLETED|Overall Study||28
9756050|NCT00358007|10859456|FG000|NOT COMPLETED|Overall Study||2
9756051|NCT00358150|10859460|FG000|STARTED|Overall Study||26
9756052|NCT00358150|10859460|FG000|COMPLETED|Overall Study||19
9756053|NCT00358150|10859460|FG000|NOT COMPLETED|Overall Study||7
9756054|NCT00358215|10859469|FG000|STARTED|Overall Study||1142
9756055|NCT00358215|10859470|FG001|STARTED|Overall Study||1136
9756056|NCT00358215|10859469|FG000|Received Investigational Product|Overall Study||1140
9756057|NCT00358215|10859470|FG001|Received Investigational Product|Overall Study||1133
9756058|NCT00358215|10859469|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463
9756059|NCT00358215|10859470|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484
9756060|NCT00358215|10859469|FG000|NOT COMPLETED|Overall Study||679
9756061|NCT00358215|10859470|FG001|NOT COMPLETED|Overall Study||652
9756062|NCT00358332|10859480|FG000|STARTED|Overall Study||15
9756063|NCT00358332|10859481|FG001|STARTED|Overall Study||30
9756064|NCT00358332|10859482|FG002|STARTED|Overall Study||30
9756065|NCT00358332|10859483|FG003|STARTED|Overall Study||25
9756066|NCT00358332|10859480|FG000|COMPLETED|Overall Study||15
9756067|NCT00358332|10859481|FG001|COMPLETED|Overall Study||27
9756068|NCT00358332|10859482|FG002|COMPLETED|Overall Study||29
9756069|NCT00358332|10859483|FG003|COMPLETED|Overall Study||25
9756070|NCT00358332|10859480|FG000|NOT COMPLETED|Overall Study||0
9756071|NCT00358332|10859481|FG001|NOT COMPLETED|Overall Study||3
9756072|NCT00358332|10859482|FG002|NOT COMPLETED|Overall Study||1
9756073|NCT00358332|10859483|FG003|NOT COMPLETED|Overall Study||0
9756074|NCT00358436|10859495|FG000|STARTED|Overall Study||600
9756075|NCT00358436|10859496|FG001|STARTED|Overall Study||204
9756076|NCT00358436|10859495|FG000|COMPLETED|Overall Study||446
9756077|NCT00358436|10859496|FG001|COMPLETED|Overall Study||118
9756078|NCT00358436|10859495|FG000|NOT COMPLETED|Overall Study||154
9756079|NCT00358436|10859496|FG001|NOT COMPLETED|Overall Study||86
9756080|NCT00358449|10859507|FG000|STARTED|Overall Study||19
9756081|NCT00358449|10859508|FG001|STARTED|Overall Study||20
9756082|NCT00358449|10859509|FG002|STARTED|Overall Study||20
9756083|NCT00358449|10859507|FG000|COMPLETED|Overall Study||15
9756084|NCT00358449|10859508|FG001|COMPLETED|Overall Study||19
9756085|NCT00358449|10859509|FG002|COMPLETED|Overall Study||18
9756086|NCT00358449|10859507|FG000|NOT COMPLETED|Overall Study||4
9756087|NCT00358449|10859508|FG001|NOT COMPLETED|Overall Study||1
9756088|NCT00358449|10859509|FG002|NOT COMPLETED|Overall Study||2
9756089|NCT00358462|10859521|FG000|STARTED|Overall Study||304
9756090|NCT00358462|10859522|FG001|STARTED|Overall Study||302
9756091|NCT00358462|10859521|FG000|COMPLETED|Overall Study||245
9756092|NCT00358462|10859522|FG001|COMPLETED|Overall Study||238
9756093|NCT00358462|10859521|FG000|NOT COMPLETED|Overall Study||59
9756094|NCT00358462|10859522|FG001|NOT COMPLETED|Overall Study||64
9756095|NCT00358501|10859540|FG000|STARTED|Overall Study||102
9756096|NCT00358501|10859541|FG001|STARTED|Overall Study||32
9756097|NCT00358501|10859540|FG000|COMPLETED|Overall Study||102
9756098|NCT00358501|10859541|FG001|COMPLETED|Overall Study||32
9756099|NCT00358501|10859540|FG000|NOT COMPLETED|Overall Study||0
9756100|NCT00358501|10859541|FG001|NOT COMPLETED|Overall Study||0
9756101|NCT00358579|10859550|FG000|STARTED|Overall Study||353
9756102|NCT00358579|10859551|FG001|STARTED|Overall Study||374
9756103|NCT00358579|10859550|FG000|COMPLETED|Overall Study||353
9756104|NCT00358579|10859551|FG001|COMPLETED|Overall Study||374
9756105|NCT00358579|10859550|FG000|NOT COMPLETED|Overall Study||0
9756106|NCT00358579|10859551|FG001|NOT COMPLETED|Overall Study||0
9756107|NCT00358644|10859557|FG000|STARTED|Overall Study||55
9756108|NCT00358644|10859557|FG000|COMPLETED|Overall Study||5
9756109|NCT00358644|10859557|FG000|NOT COMPLETED|Overall Study||50
9756110|NCT00358657|10859561|FG000|STARTED|Overall Study||14
9756111|NCT00358657|10859561|FG000|COMPLETED|Overall Study||14
9756112|NCT00358657|10859561|FG000|NOT COMPLETED|Overall Study||0
9756113|NCT00358670|10859567|FG000|STARTED|Overall Study||222
9756114|NCT00358670|10859568|FG001|STARTED|Overall Study||219
9756115|NCT00358670|10859567|FG000|COMPLETED|Overall Study||0
9756116|NCT00358670|10859568|FG001|COMPLETED|Overall Study||0
9756117|NCT00358670|10859567|FG000|NOT COMPLETED|Overall Study||222
9756118|NCT00358670|10859568|FG001|NOT COMPLETED|Overall Study||219
9756119|NCT00358735|10859576|FG000|STARTED|Overall Study||204
9756120|NCT00358735|10859577|FG001|STARTED|Overall Study||207
9756121|NCT00358735|10859576|FG000|Completed Safety|Overall Study||198
9756122|NCT00358735|10859577|FG001|Completed Safety|Overall Study||194
9756123|NCT00358735|10859576|FG000|Not Completed Safety|Overall Study||6
9756124|NCT00358735|10859577|FG001|Not Completed Safety|Overall Study||13
9756125|NCT00358735|10859576|FG000|COMPLETED|Overall Study|Efficacy|196
9756126|NCT00358735|10859577|FG001|COMPLETED|Overall Study|Efficacy|190
9756127|NCT00358735|10859576|FG000|NOT COMPLETED|Overall Study||8
9756128|NCT00358735|10859577|FG001|NOT COMPLETED|Overall Study||17
9756129|NCT00358826|10859587|FG000|STARTED|Core Study||49
9756130|NCT00358826|10859588|FG001|STARTED|Core Study||46
9756131|NCT00358826|10859589|FG002|STARTED|Core Study||44
9756132|NCT00358826|10859590|FG003|STARTED|Core Study||52
9756133|NCT00358826|10859591|FG004|STARTED|Core Study||0
9756134|NCT00358826|10859592|FG005|STARTED|Core Study||0
9756135|NCT00358826|10859593|FG006|STARTED|Core Study||0
9756136|NCT00358826|10859594|FG007|STARTED|Core Study||0
9756137|NCT00358826|10859587|FG000|COMPLETED|Core Study||46
9756138|NCT00358826|10859588|FG001|COMPLETED|Core Study||41
9756139|NCT00358826|10859589|FG002|COMPLETED|Core Study||42
9756140|NCT00358826|10859590|FG003|COMPLETED|Core Study||50
9756141|NCT00358826|10859591|FG004|COMPLETED|Core Study||0
9756142|NCT00358826|10859592|FG005|COMPLETED|Core Study||0
9756143|NCT00358826|10859593|FG006|COMPLETED|Core Study||0
9756144|NCT00358826|10859594|FG007|COMPLETED|Core Study||0
9756145|NCT00358826|10859587|FG000|NOT COMPLETED|Core Study||3
9756146|NCT00358826|10859588|FG001|NOT COMPLETED|Core Study||5
9756147|NCT00358826|10859589|FG002|NOT COMPLETED|Core Study||2
9756148|NCT00358826|10859590|FG003|NOT COMPLETED|Core Study||2
9756149|NCT00358826|10859591|FG004|NOT COMPLETED|Core Study||0
9756150|NCT00358826|10859592|FG005|NOT COMPLETED|Core Study||0
9756151|NCT00358826|10859593|FG006|NOT COMPLETED|Core Study||0
9756152|NCT00358826|10859594|FG007|NOT COMPLETED|Core Study||0
9756153|NCT00358826|10859587|FG000|STARTED|MDCT Substudy||0
9756154|NCT00358826|10859588|FG001|STARTED|MDCT Substudy||0
9756155|NCT00358826|10859589|FG002|STARTED|MDCT Substudy||0
9756156|NCT00358826|10859590|FG003|STARTED|MDCT Substudy||0
9756157|NCT00358826|10859591|FG004|STARTED|MDCT Substudy||25
9756158|NCT00358826|10859592|FG005|STARTED|MDCT Substudy||22
9756159|NCT00358826|10859593|FG006|STARTED|MDCT Substudy||19
9756160|NCT00358826|10859594|FG007|STARTED|MDCT Substudy||27
9756161|NCT00358826|10859587|FG000|COMPLETED|MDCT Substudy||0
9756162|NCT00358826|10859588|FG001|COMPLETED|MDCT Substudy||0
9756163|NCT00358826|10859589|FG002|COMPLETED|MDCT Substudy||0
9756164|NCT00358826|10859590|FG003|COMPLETED|MDCT Substudy||0
9756165|NCT00358826|10859591|FG004|COMPLETED|MDCT Substudy||24
9756166|NCT00358826|10859592|FG005|COMPLETED|MDCT Substudy||20
9756167|NCT00358826|10859593|FG006|COMPLETED|MDCT Substudy||19
9756168|NCT00358826|10859594|FG007|COMPLETED|MDCT Substudy||27
9756169|NCT00358826|10859587|FG000|NOT COMPLETED|MDCT Substudy||0
9756170|NCT00358826|10859588|FG001|NOT COMPLETED|MDCT Substudy||0
9756171|NCT00358826|10859589|FG002|NOT COMPLETED|MDCT Substudy||0
9756172|NCT00358826|10859590|FG003|NOT COMPLETED|MDCT Substudy||0
9756173|NCT00358826|10859591|FG004|NOT COMPLETED|MDCT Substudy||1
9756174|NCT00358826|10859592|FG005|NOT COMPLETED|MDCT Substudy||2
9756175|NCT00358826|10859593|FG006|NOT COMPLETED|MDCT Substudy||0
9756176|NCT00358826|10859594|FG007|NOT COMPLETED|MDCT Substudy||0
9756177|NCT00358917|10859610|FG000|STARTED|Overall Study||300
9756178|NCT00358917|10859611|FG001|STARTED|Overall Study||299
9756179|NCT00358917|10859610|FG000|COMPLETED|Overall Study||234
9756180|NCT00358917|10859611|FG001|COMPLETED|Overall Study||230
9756181|NCT00358917|10859610|FG000|NOT COMPLETED|Overall Study||66
9756182|NCT00358917|10859611|FG001|NOT COMPLETED|Overall Study||69
9756183|NCT00358956|10859619|FG000|STARTED|Overall Study||19
9756184|NCT00358956|10859619|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
9756185|NCT00358956|10859619|FG000|NOT COMPLETED|Overall Study||8
9756186|NCT00359021|10859625|FG000|STARTED|Overall Study||256
9756187|NCT00359021|10859626|FG001|STARTED|Overall Study||247
9756188|NCT00359021|10859625|FG000|COMPLETED|Overall Study||175
9756189|NCT00359021|10859626|FG001|COMPLETED|Overall Study||195
9756190|NCT00359021|10859625|FG000|NOT COMPLETED|Overall Study||81
9756191|NCT00359021|10859626|FG001|NOT COMPLETED|Overall Study||52
9756192|NCT00359073|10859636|FG000|STARTED|Overall Study||12
9756193|NCT00359073|10859637|FG001|STARTED|Overall Study||13
9756194|NCT00359073|10859636|FG000|COMPLETED|Overall Study||8
9756195|NCT00359073|10859637|FG001|COMPLETED|Overall Study||11
9756196|NCT00359073|10859636|FG000|NOT COMPLETED|Overall Study||4
9756197|NCT00359073|10859637|FG001|NOT COMPLETED|Overall Study||2
9756198|NCT00359203|10859647|FG000|STARTED|Overall Study||39
9756199|NCT00359203|10859648|FG001|STARTED|Overall Study||38
9756200|NCT00359203|10859647|FG000|COMPLETED|Overall Study||39
9756201|NCT00359203|10859648|FG001|COMPLETED|Overall Study||38
9756202|NCT00359203|10859647|FG000|NOT COMPLETED|Overall Study||0
9756203|NCT00359203|10859648|FG001|NOT COMPLETED|Overall Study||0
9756204|NCT00359281|10859663|FG000|STARTED|Overall Study||16
9756205|NCT00359281|10859664|FG001|STARTED|Overall Study||15
9756206|NCT00359281|10859665|FG002|STARTED|Overall Study||10
9756207|NCT00359281|10859666|FG003|STARTED|Overall Study||10
9756208|NCT00359281|10859667|FG004|STARTED|Overall Study||10
9756209|NCT00359281|10859668|FG005|STARTED|Overall Study||15
9756210|NCT00359281|10859669|FG006|STARTED|Overall Study||18
9756211|NCT00359281|10859670|FG007|STARTED|Overall Study||15
9756212|NCT00359281|10859671|FG008|STARTED|Overall Study||20
9756213|NCT00359281|10859663|FG000|COMPLETED|Overall Study||15
9756214|NCT00359281|10859664|FG001|COMPLETED|Overall Study||15
9756215|NCT00359281|10859665|FG002|COMPLETED|Overall Study||10
9756216|NCT00359281|10859666|FG003|COMPLETED|Overall Study||10
9756217|NCT00359281|10859667|FG004|COMPLETED|Overall Study||10
9756218|NCT00359281|10859668|FG005|COMPLETED|Overall Study||15
9756219|NCT00359281|10859669|FG006|COMPLETED|Overall Study||16
9756220|NCT00359281|10859670|FG007|COMPLETED|Overall Study||15
9756221|NCT00359281|10859671|FG008|COMPLETED|Overall Study||20
9756222|NCT00359281|10859663|FG000|NOT COMPLETED|Overall Study||1
9756223|NCT00359281|10859664|FG001|NOT COMPLETED|Overall Study||0
9756224|NCT00359281|10859665|FG002|NOT COMPLETED|Overall Study||0
9756225|NCT00359281|10859666|FG003|NOT COMPLETED|Overall Study||0
9756226|NCT00359281|10859667|FG004|NOT COMPLETED|Overall Study||0
9756227|NCT00359281|10859668|FG005|NOT COMPLETED|Overall Study||0
9756228|NCT00359281|10859669|FG006|NOT COMPLETED|Overall Study||2
9756229|NCT00359281|10859670|FG007|NOT COMPLETED|Overall Study||0
9756230|NCT00359281|10859671|FG008|NOT COMPLETED|Overall Study||0
9756231|NCT00359294|10859703|FG000|STARTED|Overall Study||1
9756232|NCT00359294|10859704|FG001|STARTED|Overall Study||1
9756233|NCT00359294|10859705|FG002|STARTED|Overall Study||3
9756234|NCT00359294|10859706|FG003|STARTED|Overall Study||4
9756235|NCT00359294|10859707|FG004|STARTED|Overall Study||3
9756236|NCT00359294|10859703|FG000|COMPLETED|Overall Study||0
9756237|NCT00359294|10859704|FG001|COMPLETED|Overall Study||0
9756238|NCT00359294|10859705|FG002|COMPLETED|Overall Study||0
9756239|NCT00359294|10859706|FG003|COMPLETED|Overall Study||0
9756240|NCT00359294|10859707|FG004|COMPLETED|Overall Study||0
9756241|NCT00359294|10859703|FG000|NOT COMPLETED|Overall Study||1
9756242|NCT00359294|10859704|FG001|NOT COMPLETED|Overall Study||1
9756243|NCT00359294|10859705|FG002|NOT COMPLETED|Overall Study||3
9756244|NCT00359294|10859706|FG003|NOT COMPLETED|Overall Study||4
9756245|NCT00359294|10859707|FG004|NOT COMPLETED|Overall Study||3
9756246|NCT00359424|10859717|FG000|STARTED|Overall Study||434
9756247|NCT00359424|10859718|FG001|STARTED|Overall Study||222
9756248|NCT00359424|10859717|FG000|90 Day Follow up|Overall Study||343
9756249|NCT00359424|10859718|FG001|90 Day Follow up|Overall Study||172
9756250|NCT00359424|10859717|FG000|180 Day Follow up|Overall Study||325
9756251|NCT00359424|10859718|FG001|180 Day Follow up|Overall Study||167
9756252|NCT00359424|10859717|FG000|270 Day Follow up|Overall Study||313
9756253|NCT00359424|10859718|FG001|270 Day Follow up|Overall Study||159
9756254|NCT00359424|10859717|FG000|COMPLETED|Overall Study||304
9756255|NCT00359424|10859718|FG001|COMPLETED|Overall Study||155
9756256|NCT00359424|10859717|FG000|NOT COMPLETED|Overall Study||130
9756257|NCT00359424|10859718|FG001|NOT COMPLETED|Overall Study||67
9756258|NCT00359619|10859731|FG000|STARTED|Overall Study||88
9756259|NCT00359619|10859732|FG001|STARTED|Overall Study||50
9756260|NCT00359619|10859733|FG002|STARTED|Overall Study||49
9756261|NCT00359619|10859734|FG003|STARTED|Overall Study||48
9756262|NCT00359619|10859735|FG004|STARTED|Overall Study||48
9756263|NCT00359619|10859736|FG005|STARTED|Overall Study||50
9756264|NCT00359619|10859737|FG006|STARTED|Overall Study||50
9756265|NCT00359619|10859731|FG000|COMPLETED|Overall Study||80
9756266|NCT00359619|10859732|FG001|COMPLETED|Overall Study||45
9756267|NCT00359619|10859733|FG002|COMPLETED|Overall Study||42
9756268|NCT00359619|10859734|FG003|COMPLETED|Overall Study||45
9756269|NCT00359619|10859735|FG004|COMPLETED|Overall Study||45
9756270|NCT00359619|10859736|FG005|COMPLETED|Overall Study||45
9756271|NCT00359619|10859737|FG006|COMPLETED|Overall Study||46
9756272|NCT00359619|10859731|FG000|NOT COMPLETED|Overall Study||8
9756273|NCT00359619|10859732|FG001|NOT COMPLETED|Overall Study||5
9756274|NCT00359619|10859733|FG002|NOT COMPLETED|Overall Study||7
9756275|NCT00359619|10859734|FG003|NOT COMPLETED|Overall Study||3
9756276|NCT00359619|10859735|FG004|NOT COMPLETED|Overall Study||3
9756277|NCT00359619|10859736|FG005|NOT COMPLETED|Overall Study||5
9756278|NCT00359619|10859737|FG006|NOT COMPLETED|Overall Study||4
9756279|NCT00359632|10859755|FG000|STARTED|Overall Study||24
9756280|NCT00359632|10859756|FG001|STARTED|Overall Study||9
9756281|NCT00359632|10859755|FG000|COMPLETED|Overall Study||20
9756282|NCT00359632|10859756|FG001|COMPLETED|Overall Study||9
9756283|NCT00359632|10859755|FG000|NOT COMPLETED|Overall Study||4
9756284|NCT00359632|10859756|FG001|NOT COMPLETED|Overall Study||0
9756285|NCT00359736|10859764|FG000|STARTED|Overall Study||14
9756286|NCT00359736|10859765|FG001|STARTED|Overall Study||15
9756287|NCT00359736|10859764|FG000|COMPLETED|Overall Study||14
9756288|NCT00359736|10859765|FG001|COMPLETED|Overall Study||15
9756289|NCT00359736|10859764|FG000|NOT COMPLETED|Overall Study||0
9756290|NCT00359736|10859765|FG001|NOT COMPLETED|Overall Study||0
9756291|NCT00359762|10859775|FG000|STARTED|Period II||514
9756292|NCT00359762|10859776|FG001|STARTED|Period II||0
9756293|NCT00359762|10859777|FG002|STARTED|Period II||0
9756294|NCT00359762|10859778|FG003|STARTED|Period II||0
9756295|NCT00359762|10859779|FG004|STARTED|Period II||515
9756296|NCT00359762|10859775|FG000|Intent to Treat (ITT) Safety Population|Period II||508
9756297|NCT00359762|10859776|FG001|Intent to Treat (ITT) Safety Population|Period II||0
9756298|NCT00359762|10859777|FG002|Intent to Treat (ITT) Safety Population|Period II||0
9756299|NCT00359762|10859778|FG003|Intent to Treat (ITT) Safety Population|Period II||0
9756300|NCT00359762|10859779|FG004|Intent to Treat (ITT) Safety Population|Period II||511
9756301|NCT00359762|10859775|FG000|ITT Efficacy Population|Period II||487
9756302|NCT00359762|10859776|FG001|ITT Efficacy Population|Period II||0
9756303|NCT00359762|10859777|FG002|ITT Efficacy Population|Period II||0
9756304|NCT00359762|10859778|FG003|ITT Efficacy Population|Period II||0
9756305|NCT00359762|10859779|FG004|ITT Efficacy Population|Period II||490
9756306|NCT00359762|10859775|FG000|Met Primary Endpoint|Period II||262
9756307|NCT00359762|10859776|FG001|Met Primary Endpoint|Period II||0
9756308|NCT00359762|10859777|FG002|Met Primary Endpoint|Period II||0
9756309|NCT00359762|10859778|FG003|Met Primary Endpoint|Period II||0
9756310|NCT00359762|10859779|FG004|Met Primary Endpoint|Period II||203
9756311|NCT00359762|10859775|FG000|Without Treatment Failure|Period II||124
9756312|NCT00359762|10859776|FG001|Without Treatment Failure|Period II||0
9756313|NCT00359762|10859777|FG002|Without Treatment Failure|Period II||0
9756314|NCT00359762|10859778|FG003|Without Treatment Failure|Period II||0
9756315|NCT00359762|10859779|FG004|Without Treatment Failure|Period II||138
9756316|NCT00359762|10859775|FG000|COMPLETED|Period II||386
9756317|NCT00359762|10859776|FG001|COMPLETED|Period II||0
9756318|NCT00359762|10859777|FG002|COMPLETED|Period II||0
9756319|NCT00359762|10859778|FG003|COMPLETED|Period II||0
9756320|NCT00359762|10859779|FG004|COMPLETED|Period II||341
9756321|NCT00359762|10859775|FG000|NOT COMPLETED|Period II||128
9756322|NCT00359762|10859776|FG001|NOT COMPLETED|Period II||0
9756323|NCT00359762|10859777|FG002|NOT COMPLETED|Period II||0
9756324|NCT00359762|10859778|FG003|NOT COMPLETED|Period II||0
9756325|NCT00359762|10859779|FG004|NOT COMPLETED|Period II||174
9756326|NCT00359762|10859775|FG000|STARTED|Period III||0
9756327|NCT00359762|10859776|FG001|STARTED|Period III||77
9756328|NCT00359762|10859777|FG002|STARTED|Period III||77
9756329|NCT00359762|10859778|FG003|STARTED|Period III||166
9756330|NCT00359762|10859779|FG004|STARTED|Period III||0
9756331|NCT00359762|10859775|FG000|Extension ITT Safety Population|Period III||0
9756332|NCT00359762|10859776|FG001|Extension ITT Safety Population|Period III||74
9756333|NCT00359762|10859777|FG002|Extension ITT Safety Population|Period III||76
9756334|NCT00359762|10859778|FG003|Extension ITT Safety Population|Period III||166
9756335|NCT00359762|10859779|FG004|Extension ITT Safety Population|Period III||0
9756336|NCT00359762|10859775|FG000|Extension ITT Efficacy Population|Period III||0
9756337|NCT00359762|10859776|FG001|Extension ITT Efficacy Population|Period III||73
9756338|NCT00359762|10859777|FG002|Extension ITT Efficacy Population|Period III||75
9756339|NCT00359762|10859778|FG003|Extension ITT Efficacy Population|Period III||164
9756340|NCT00359762|10859779|FG004|Extension ITT Efficacy Population|Period III||0
9756341|NCT00359762|10859775|FG000|COMPLETED|Period III||0
9756342|NCT00359762|10859776|FG001|COMPLETED|Period III||48
9756343|NCT00359762|10859777|FG002|COMPLETED|Period III||47
9756344|NCT00359762|10859778|FG003|COMPLETED|Period III||101
9756345|NCT00359762|10859779|FG004|COMPLETED|Period III||0
9756346|NCT00359762|10859775|FG000|NOT COMPLETED|Period III||0
9854353|NCT00892710|10967328|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
9854354|NCT00892710|10967326|FG000|NOT COMPLETED|Overall Study||48
9854355|NCT00892710|10967327|FG001|NOT COMPLETED|Overall Study||59
9854356|NCT00892710|10967328|FG002|NOT COMPLETED|Overall Study||55
9854357|NCT00892723|10967339|FG000|STARTED|Overall Study||21
9854358|NCT00892723|10967340|FG001|STARTED|Overall Study||19
9854359|NCT00892723|10967341|FG002|STARTED|Overall Study||19
9854360|NCT00892723|10967339|FG000|COMPLETED|Overall Study||19
9854361|NCT00892723|10967340|FG001|COMPLETED|Overall Study||15
9854362|NCT00892723|10967341|FG002|COMPLETED|Overall Study||17
9854363|NCT00892723|10967339|FG000|NOT COMPLETED|Overall Study||2
9854364|NCT00892723|10967340|FG001|NOT COMPLETED|Overall Study||4
9854365|NCT00892723|10967341|FG002|NOT COMPLETED|Overall Study||2
9854366|NCT00892775|10967384|FG000|STARTED|Overall Study||332
9854367|NCT00892775|10967385|FG001|STARTED|Overall Study||166
9854368|NCT00892775|10967384|FG000|COMPLETED|Overall Study||327
9854369|NCT00892775|10967385|FG001|COMPLETED|Overall Study||165
9854370|NCT00892775|10967384|FG000|NOT COMPLETED|Overall Study||5
9854371|NCT00892775|10967385|FG001|NOT COMPLETED|Overall Study||1
9854372|NCT00892957|10967393|FG000|STARTED|Intraoperative Day 0||70
9854373|NCT00892957|10967394|FG001|STARTED|Intraoperative Day 0||70
9854374|NCT00892957|10967393|FG000|COMPLETED|Intraoperative Day 0||70
9854375|NCT00892957|10967394|FG001|COMPLETED|Intraoperative Day 0||70
9854376|NCT00892957|10967393|FG000|NOT COMPLETED|Intraoperative Day 0||0
9854377|NCT00892957|10967394|FG001|NOT COMPLETED|Intraoperative Day 0||0
9854378|NCT00892957|10967393|FG000|STARTED|Postoperative Day 1 Assessment||70
9854379|NCT00892957|10967394|FG001|STARTED|Postoperative Day 1 Assessment||70
9854380|NCT00892957|10967393|FG000|COMPLETED|Postoperative Day 1 Assessment||70
9854381|NCT00892957|10967394|FG001|COMPLETED|Postoperative Day 1 Assessment||70
9854382|NCT00892957|10967393|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0
9854383|NCT00892957|10967394|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0
9854384|NCT00892957|10967393|FG000|STARTED|Between Postoperative Day 1 and Day 14||70
9854385|NCT00892957|10967394|FG001|STARTED|Between Postoperative Day 1 and Day 14||70
9854386|NCT00892957|10967393|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70
9854387|NCT00892957|10967394|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66
9854388|NCT00892957|10967393|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
9854389|NCT00892957|10967394|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
9854390|NCT00892957|10967393|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
9854391|NCT00892957|10967394|FG001|STARTED|Postoperative Day 14 Assessment||66
9854392|NCT00892957|10967393|FG000|COMPLETED|Postoperative Day 14 Assessment||68
9854393|NCT00892957|10967394|FG001|COMPLETED|Postoperative Day 14 Assessment||66
9854394|NCT00892957|10967393|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0
9854395|NCT00892957|10967394|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0
9756347|NCT00359762|10859776|FG001|NOT COMPLETED|Period III||29
9756348|NCT00359762|10859777|FG002|NOT COMPLETED|Period III||30
9756349|NCT00359762|10859778|FG003|NOT COMPLETED|Period III||65
9756350|NCT00359762|10859779|FG004|NOT COMPLETED|Period III||0
9756351|NCT00359762|10859775|FG000|STARTED|Period I||0
9756352|NCT00359762|10859776|FG001|STARTED|Period I||0
9756353|NCT00359762|10859777|FG002|STARTED|Period I||0
9756354|NCT00359762|10859778|FG003|STARTED|Period I||0
9756355|NCT00359762|10859779|FG004|STARTED|Period I||0
9756356|NCT00359762|10859775|FG000|COMPLETED|Period I||0
9756357|NCT00359762|10859776|FG001|COMPLETED|Period I||0
9756358|NCT00359762|10859777|FG002|COMPLETED|Period I||0
9756359|NCT00359762|10859778|FG003|COMPLETED|Period I||0
9756360|NCT00359762|10859779|FG004|COMPLETED|Period I||0
9756361|NCT00359762|10859775|FG000|NOT COMPLETED|Period I||0
9756362|NCT00359762|10859776|FG001|NOT COMPLETED|Period I||0
9756363|NCT00359762|10859777|FG002|NOT COMPLETED|Period I||0
9756364|NCT00359762|10859778|FG003|NOT COMPLETED|Period I||0
9756365|NCT00359762|10859779|FG004|NOT COMPLETED|Period I||0
9756366|NCT00359788|10859795|FG000|STARTED|Overall Study||173
9756367|NCT00359788|10859796|FG001|STARTED|Overall Study||176
9756368|NCT00359788|10859795|FG000|COMPLETED|Overall Study||150
9756369|NCT00359788|10859796|FG001|COMPLETED|Overall Study||159
9756370|NCT00359788|10859795|FG000|NOT COMPLETED|Overall Study||23
9756371|NCT00359788|10859796|FG001|NOT COMPLETED|Overall Study||17
9756372|NCT00359801|10859804|FG000|STARTED|Overall Study||987
9756373|NCT00359801|10859805|FG001|STARTED|Overall Study||989
9756374|NCT00359801|10859804|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
9756375|NCT00359801|10859805|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
9756376|NCT00359801|10859804|FG000|NOT COMPLETED|Overall Study||305
9756377|NCT00359801|10859805|FG001|NOT COMPLETED|Overall Study||220
9756378|NCT00359944|10859814|FG000|STARTED|Overall Study||50
9756379|NCT00359944|10859815|FG001|STARTED|Overall Study||47
9756380|NCT00359944|10859816|FG002|STARTED|Overall Study||57
9756381|NCT00359944|10859814|FG000|COMPLETED|Overall Study||34
9756382|NCT00359944|10859815|FG001|COMPLETED|Overall Study||28
9756383|NCT00359944|10859816|FG002|COMPLETED|Overall Study||38
9756384|NCT00359944|10859814|FG000|NOT COMPLETED|Overall Study||16
9756385|NCT00359944|10859815|FG001|NOT COMPLETED|Overall Study||19
9756386|NCT00359944|10859816|FG002|NOT COMPLETED|Overall Study||19
9756387|NCT00359983|10859827|FG000|STARTED|Year 1 Persistence Follow-up||138
9756388|NCT00359983|10859828|FG001|STARTED|Year 1 Persistence Follow-up||70
9756389|NCT00359983|10859829|FG002|STARTED|Year 1 Persistence Follow-up||62
9756390|NCT00359983|10859827|FG000|COMPLETED|Year 1 Persistence Follow-up||138
9756391|NCT00359983|10859828|FG001|COMPLETED|Year 1 Persistence Follow-up||70
9756392|NCT00359983|10859829|FG002|COMPLETED|Year 1 Persistence Follow-up||62
9756393|NCT00359983|10859827|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0
9756394|NCT00359983|10859828|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0
9756395|NCT00359983|10859829|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0
9756396|NCT00359983|10859827|FG000|STARTED|Year 3 Persistence Follow-up||103
9756397|NCT00359983|10859828|FG001|STARTED|Year 3 Persistence Follow-up||47
9756398|NCT00359983|10859829|FG002|STARTED|Year 3 Persistence Follow-up||51
9756399|NCT00359983|10859827|FG000|COMPLETED|Year 3 Persistence Follow-up||103
9756400|NCT00359983|10859828|FG001|COMPLETED|Year 3 Persistence Follow-up||47
9756401|NCT00359983|10859829|FG002|COMPLETED|Year 3 Persistence Follow-up||51
9756402|NCT00359983|10859827|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0
9756403|NCT00359983|10859828|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0
9756404|NCT00359983|10859829|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0
9756405|NCT00359983|10859827|FG000|STARTED|Year 5 Persistence Follow-up||95
9756406|NCT00359983|10859828|FG001|STARTED|Year 5 Persistence Follow-up||44
9756407|NCT00359983|10859829|FG002|STARTED|Year 5 Persistence Follow-up||42
9756408|NCT00359983|10859827|FG000|COMPLETED|Year 5 Persistence Follow-up||95
9756409|NCT00359983|10859828|FG001|COMPLETED|Year 5 Persistence Follow-up||44
9756410|NCT00359983|10859829|FG002|COMPLETED|Year 5 Persistence Follow-up||42
9756411|NCT00359983|10859827|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0
9756412|NCT00359983|10859828|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0
9756413|NCT00359983|10859829|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0
9756414|NCT00360009|10859840|FG000|STARTED|Overall Study||10
9756415|NCT00360009|10859841|FG001|STARTED|Overall Study||26
9756416|NCT00360009|10859842|FG002|STARTED|Overall Study||26
9756417|NCT00360009|10859840|FG000|COMPLETED|Overall Study||10
9756418|NCT00360009|10859841|FG001|COMPLETED|Overall Study||22
9756419|NCT00360009|10859842|FG002|COMPLETED|Overall Study||23
9756420|NCT00360009|10859840|FG000|NOT COMPLETED|Overall Study||0
9756421|NCT00360009|10859841|FG001|NOT COMPLETED|Overall Study||4
9756422|NCT00360009|10859842|FG002|NOT COMPLETED|Overall Study||3
9756423|NCT00360126|10859850|FG000|STARTED|Overall Study||11
9756424|NCT00360126|10859850|FG000|COMPLETED|Overall Study||11
9756425|NCT00360126|10859850|FG000|NOT COMPLETED|Overall Study||0
9756426|NCT00360230|10859861|FG000|STARTED|Overall Study||90
9756427|NCT00360230|10859862|FG001|STARTED|Overall Study||90
9756428|NCT00360230|10859863|FG002|STARTED|Overall Study||45
9953025|NCT01425203|11071888|FG002|COMPLETED|Treatment Phase||0
9953026|NCT01425203|11071886|FG000|NOT COMPLETED|Treatment Phase||27
9756429|NCT00360230|10859864|FG003|STARTED|Overall Study||90
9756430|NCT00360230|10859865|FG004|STARTED|Overall Study||90
9756431|NCT00360230|10859866|FG005|STARTED|Overall Study||90
9756432|NCT00360230|10859867|FG006|STARTED|Overall Study||45
9756433|NCT00360230|10859861|FG000|COMPLETED|Overall Study||84
9756434|NCT00360230|10859862|FG001|COMPLETED|Overall Study||87
9756435|NCT00360230|10859863|FG002|COMPLETED|Overall Study||42
9756436|NCT00360230|10859864|FG003|COMPLETED|Overall Study||88
9756437|NCT00360230|10859865|FG004|COMPLETED|Overall Study||85
9756438|NCT00360230|10859866|FG005|COMPLETED|Overall Study||86
9756439|NCT00360230|10859867|FG006|COMPLETED|Overall Study||43
9756440|NCT00360230|10859861|FG000|NOT COMPLETED|Overall Study||6
9756441|NCT00360230|10859862|FG001|NOT COMPLETED|Overall Study||3
9756442|NCT00360230|10859863|FG002|NOT COMPLETED|Overall Study||3
9756443|NCT00360230|10859864|FG003|NOT COMPLETED|Overall Study||2
9756444|NCT00360230|10859865|FG004|NOT COMPLETED|Overall Study||5
9756445|NCT00360230|10859866|FG005|NOT COMPLETED|Overall Study||4
9756446|NCT00360230|10859867|FG006|NOT COMPLETED|Overall Study||2
9756447|NCT00360243|10859889|FG000|STARTED|Overall Study||337
9756448|NCT00360243|10859890|FG001|STARTED|Overall Study||363
9756449|NCT00360243|10859891|FG002|STARTED|Overall Study||336
9756450|NCT00360243|10859892|FG003|STARTED|Overall Study||349
9756451|NCT00360243|10859889|FG000|COMPLETED|Overall Study||235
9756452|NCT00360243|10859890|FG001|COMPLETED|Overall Study||243
9756453|NCT00360243|10859891|FG002|COMPLETED|Overall Study||180
9756454|NCT00360243|10859892|FG003|COMPLETED|Overall Study||224
9756455|NCT00360243|10859889|FG000|NOT COMPLETED|Overall Study||102
9756456|NCT00360243|10859890|FG001|NOT COMPLETED|Overall Study||120
9756457|NCT00360243|10859891|FG002|NOT COMPLETED|Overall Study||156
9756458|NCT00360243|10859892|FG003|NOT COMPLETED|Overall Study||125
9756459|NCT00360269|10859904|FG000|STARTED|Overall Study||19
9756460|NCT00360269|10859905|FG001|STARTED|Overall Study||19
9756461|NCT00360269|10859904|FG000|COMPLETED|Overall Study||9
9756462|NCT00360269|10859905|FG001|COMPLETED|Overall Study||7
9756463|NCT00360269|10859904|FG000|NOT COMPLETED|Overall Study||10
9756464|NCT00360269|10859905|FG001|NOT COMPLETED|Overall Study||12
9756465|NCT00360282|10859911|FG000|STARTED|First Intervention||6
9756466|NCT00360282|10859912|FG001|STARTED|First Intervention||8
9854396|NCT00892957|10967393|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
9854397|NCT00892957|10967394|FG001|STARTED|Postoperative Day 30 Assessment||66
9854398|NCT00892957|10967393|FG000|COMPLETED|Postoperative Day 30 Assessment||70
9854399|NCT00892957|10967394|FG001|COMPLETED|Postoperative Day 30 Assessment||66
9854400|NCT00892957|10967393|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0
9854401|NCT00892957|10967394|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0
9854402|NCT00893074|10967414|FG000|STARTED|Overall Study||24
9854403|NCT00893074|10967414|FG000|COMPLETED|Overall Study||13
9854404|NCT00893074|10967414|FG000|NOT COMPLETED|Overall Study||11
9854405|NCT00893113|10967431|FG000|STARTED|Overall Study||36
9854406|NCT00893113|10967432|FG001|STARTED|Overall Study||38
9854407|NCT00893113|10967431|FG000|COMPLETED|Overall Study||23
9854408|NCT00893113|10967432|FG001|COMPLETED|Overall Study||22
9854409|NCT00893113|10967431|FG000|NOT COMPLETED|Overall Study||13
9854410|NCT00893113|10967432|FG001|NOT COMPLETED|Overall Study||16
9854411|NCT00893152|10967440|FG000|STARTED|Overall Study||47
9854412|NCT00893152|10967441|FG001|STARTED|Overall Study||36
9854413|NCT00893152|10967440|FG000|COMPLETED|Overall Study||47
9854414|NCT00893152|10967441|FG001|COMPLETED|Overall Study||36
9854415|NCT00893152|10967440|FG000|NOT COMPLETED|Overall Study||0
9854416|NCT00893152|10967441|FG001|NOT COMPLETED|Overall Study||0
9854417|NCT00893464|10967455|FG000|STARTED|Overall Study||1
9854418|NCT00893464|10967456|FG001|STARTED|Overall Study||1
9854419|NCT00893464|10967457|FG002|STARTED|Overall Study||1
9854420|NCT00893464|10967458|FG003|STARTED|Overall Study||1
9854421|NCT00893464|10967459|FG004|STARTED|Overall Study||4
9854422|NCT00893464|10967460|FG005|STARTED|Overall Study||7
9854423|NCT00893464|10967461|FG006|STARTED|Overall Study||10
9854424|NCT00893464|10967462|FG007|STARTED|Overall Study||5
9854425|NCT00893464|10967455|FG000|COMPLETED|Overall Study||1
9854426|NCT00893464|10967456|FG001|COMPLETED|Overall Study||1
9854427|NCT00893464|10967457|FG002|COMPLETED|Overall Study||1
9854428|NCT00893464|10967458|FG003|COMPLETED|Overall Study||1
9854429|NCT00893464|10967459|FG004|COMPLETED|Overall Study||4
9854430|NCT00893464|10967460|FG005|COMPLETED|Overall Study||7
9854431|NCT00893464|10967461|FG006|COMPLETED|Overall Study||8
9854432|NCT00893464|10967462|FG007|COMPLETED|Overall Study||3
9854433|NCT00893464|10967455|FG000|NOT COMPLETED|Overall Study||0
9854434|NCT00893464|10967456|FG001|NOT COMPLETED|Overall Study||0
9854435|NCT00893464|10967457|FG002|NOT COMPLETED|Overall Study||0
9854436|NCT00893464|10967458|FG003|NOT COMPLETED|Overall Study||0
9854437|NCT00893464|10967459|FG004|NOT COMPLETED|Overall Study||0
9854438|NCT00893464|10967460|FG005|NOT COMPLETED|Overall Study||0
9854439|NCT00893464|10967461|FG006|NOT COMPLETED|Overall Study||2
9854440|NCT00893464|10967462|FG007|NOT COMPLETED|Overall Study||2
9854441|NCT00893737|10967485|FG000|STARTED|Overall Study||147
9854442|NCT00893737|10967485|FG000|COMPLETED|Overall Study||135
9854443|NCT00893737|10967485|FG000|NOT COMPLETED|Overall Study||12
9854444|NCT00893763|10967491|FG000|STARTED|Overall Study||157
9854445|NCT00893763|10967492|FG001|STARTED|Overall Study||157
9854446|NCT00893763|10967491|FG000|COMPLETED|Overall Study||47
9756467|NCT00360282|10859913|FG002|STARTED|First Intervention||7
9756468|NCT00360282|10859914|FG003|STARTED|First Intervention||6
9756469|NCT00360282|10859911|FG000|COMPLETED|First Intervention||6
9756470|NCT00360282|10859912|FG001|COMPLETED|First Intervention||8
9756471|NCT00360282|10859913|FG002|COMPLETED|First Intervention||7
9756472|NCT00360282|10859914|FG003|COMPLETED|First Intervention||6
9756473|NCT00360282|10859911|FG000|NOT COMPLETED|First Intervention||0
9756474|NCT00360282|10859912|FG001|NOT COMPLETED|First Intervention||0
9756475|NCT00360282|10859913|FG002|NOT COMPLETED|First Intervention||0
9756476|NCT00360282|10859914|FG003|NOT COMPLETED|First Intervention||0
9756477|NCT00360282|10859911|FG000|STARTED|Washout 1-3 Weeks||6
9756478|NCT00360282|10859912|FG001|STARTED|Washout 1-3 Weeks||8
9756479|NCT00360282|10859913|FG002|STARTED|Washout 1-3 Weeks||7
9756480|NCT00360282|10859914|FG003|STARTED|Washout 1-3 Weeks||6
9756481|NCT00360282|10859911|FG000|COMPLETED|Washout 1-3 Weeks||6
9756482|NCT00360282|10859912|FG001|COMPLETED|Washout 1-3 Weeks||8
9756483|NCT00360282|10859913|FG002|COMPLETED|Washout 1-3 Weeks||6
9756484|NCT00360282|10859914|FG003|COMPLETED|Washout 1-3 Weeks||6
9756485|NCT00360282|10859911|FG000|NOT COMPLETED|Washout 1-3 Weeks||0
9756486|NCT00360282|10859912|FG001|NOT COMPLETED|Washout 1-3 Weeks||0
9756487|NCT00360282|10859913|FG002|NOT COMPLETED|Washout 1-3 Weeks||1
9756488|NCT00360282|10859914|FG003|NOT COMPLETED|Washout 1-3 Weeks||0
9756489|NCT00360282|10859911|FG000|STARTED|Second Intervention||6
9756490|NCT00360282|10859912|FG001|STARTED|Second Intervention||8
9756491|NCT00360282|10859913|FG002|STARTED|Second Intervention||6
9756492|NCT00360282|10859914|FG003|STARTED|Second Intervention||6
9756493|NCT00360282|10859911|FG000|COMPLETED|Second Intervention||6
9756494|NCT00360282|10859912|FG001|COMPLETED|Second Intervention||7
9756495|NCT00360282|10859913|FG002|COMPLETED|Second Intervention||6
9756496|NCT00360282|10859914|FG003|COMPLETED|Second Intervention||6
9756497|NCT00360282|10859911|FG000|NOT COMPLETED|Second Intervention||0
9756498|NCT00360282|10859912|FG001|NOT COMPLETED|Second Intervention||1
9756499|NCT00360282|10859913|FG002|NOT COMPLETED|Second Intervention||0
9756500|NCT00360282|10859914|FG003|NOT COMPLETED|Second Intervention||0
9756501|NCT00360308|10859925|FG000|STARTED|Overall Study||247
9756502|NCT00360308|10859926|FG001|STARTED|Overall Study||234
9756503|NCT00360308|10859927|FG002|STARTED|Overall Study||242
9756504|NCT00360308|10859925|FG000|COMPLETED|Overall Study||171
9756505|NCT00360308|10859926|FG001|COMPLETED|Overall Study||155
9756506|NCT00360308|10859927|FG002|COMPLETED|Overall Study||154
9756507|NCT00360308|10859925|FG000|NOT COMPLETED|Overall Study||76
9756508|NCT00360308|10859926|FG001|NOT COMPLETED|Overall Study||79
9756509|NCT00360308|10859927|FG002|NOT COMPLETED|Overall Study||88
9756510|NCT00360334|10859941|FG000|STARTED|Overall Study||118
9756511|NCT00360334|10859942|FG001|STARTED|Overall Study||117
10201770|NCT03440944|11329175|FG001|NOT COMPLETED|Overall Study||1
10201771|NCT03441178|11329182|FG000|STARTED|Overall Study||36
10201772|NCT03441178|11329183|FG001|STARTED|Overall Study||44
10201773|NCT03441178|11329184|FG002|STARTED|Overall Study||21
10201774|NCT03441178|11329182|FG000|COMPLETED|Overall Study||36
9756512|NCT00360334|10859941|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
9756513|NCT00360334|10859942|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
9756514|NCT00360334|10859941|FG000|COMPLETED|Overall Study||99
9756515|NCT00360334|10859942|FG001|COMPLETED|Overall Study||104
9756516|NCT00360334|10859941|FG000|NOT COMPLETED|Overall Study||19
9756517|NCT00360334|10859942|FG001|NOT COMPLETED|Overall Study||13
9756518|NCT00360360|10859948|FG000|STARTED|Overall Study||60
9756519|NCT00360360|10859948|FG000|COMPLETED|Overall Study||54
9756520|NCT00360360|10859948|FG000|NOT COMPLETED|Overall Study||6
9756521|NCT00360399|10859955|FG000|STARTED|Overall Study||114
9756522|NCT00360399|10859956|FG001|STARTED|Overall Study||115
9756523|NCT00360399|10859957|FG002|STARTED|Overall Study||115
9756524|NCT00360399|10859955|FG000|Had Post-randomization Assessment|Overall Study||105
9756525|NCT00360399|10859956|FG001|Had Post-randomization Assessment|Overall Study||106
9756526|NCT00360399|10859957|FG002|Had Post-randomization Assessment|Overall Study||105
9756527|NCT00360399|10859955|FG000|COMPLETED|Overall Study||86
9756528|NCT00360399|10859956|FG001|COMPLETED|Overall Study||79
9756529|NCT00360399|10859957|FG002|COMPLETED|Overall Study||69
9756530|NCT00360399|10859955|FG000|NOT COMPLETED|Overall Study||28
9756531|NCT00360399|10859956|FG001|NOT COMPLETED|Overall Study||36
9756532|NCT00360399|10859957|FG002|NOT COMPLETED|Overall Study||46
9756533|NCT00360412|10859967|FG000|STARTED|Overall Study||333
9756534|NCT00360412|10859968|FG001|STARTED|Overall Study||664
9756535|NCT00360412|10859967|FG000|COMPLETED|Overall Study||0
9756536|NCT00360412|10859968|FG001|COMPLETED|Overall Study||2
9756537|NCT00360412|10859967|FG000|NOT COMPLETED|Overall Study||333
9756538|NCT00360412|10859968|FG001|NOT COMPLETED|Overall Study||662
9756539|NCT00360490|10859976|FG000|STARTED|Overall Study||82
9756540|NCT00360490|10859977|FG001|STARTED|Overall Study||83
9756541|NCT00360490|10859976|FG000|COMPLETED|Overall Study||73
9756542|NCT00360490|10859977|FG001|COMPLETED|Overall Study||72
9756543|NCT00360490|10859976|FG000|NOT COMPLETED|Overall Study||9
9756544|NCT00360490|10859977|FG001|NOT COMPLETED|Overall Study||11
9829084|NCT00758524|10939650|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39
9829085|NCT00758524|10939651|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36
9829086|NCT00758524|10939652|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66
9829087|NCT00758524|10939636|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
9829088|NCT00758524|10939637|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
9829089|NCT00758524|10939638|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
9829090|NCT00758524|10939639|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
9829091|NCT00758524|10939640|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
9829092|NCT00758524|10939641|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
9829093|NCT00758524|10939642|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
9829094|NCT00758524|10939643|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
9832516|NCT00773422|10943285|FG002|STARTED|Overall Study||10
10201775|NCT03441178|11329183|FG001|COMPLETED|Overall Study||43
9756545|NCT00360529|10859986|FG000|STARTED|Overall Study||295
9756546|NCT00360529|10859987|FG001|STARTED|Overall Study||295
9756547|NCT00360529|10859988|FG002|STARTED|Overall Study||290
9756548|NCT00360529|10859986|FG000|COMPLETED|Overall Study||234
9756549|NCT00360529|10859987|FG001|COMPLETED|Overall Study||230
9756550|NCT00360529|10859988|FG002|COMPLETED|Overall Study||199
9756551|NCT00360529|10859986|FG000|NOT COMPLETED|Overall Study||61
9756552|NCT00360529|10859987|FG001|NOT COMPLETED|Overall Study||65
9756553|NCT00360529|10859988|FG002|NOT COMPLETED|Overall Study||91
9756554|NCT00360555|10860000|FG000|STARTED|Overall Study||396
9756555|NCT00360555|10860001|FG001|STARTED|Overall Study||393
9756556|NCT00360555|10860002|FG002|STARTED|Overall Study||396
9756557|NCT00360555|10860003|FG003|STARTED|Overall Study||399
9756558|NCT00360555|10860000|FG000|COMPLETED|Overall Study||274
9756559|NCT00360555|10860001|FG001|COMPLETED|Overall Study||259
9756560|NCT00360555|10860002|FG002|COMPLETED|Overall Study||251
9756561|NCT00360555|10860003|FG003|COMPLETED|Overall Study||287
9756562|NCT00360555|10860000|FG000|NOT COMPLETED|Overall Study||122
9756563|NCT00360555|10860001|FG001|NOT COMPLETED|Overall Study||134
9756564|NCT00360555|10860002|FG002|NOT COMPLETED|Overall Study||145
9756565|NCT00360555|10860003|FG003|NOT COMPLETED|Overall Study||112
9756566|NCT00360568|10860015|FG000|STARTED|Overall Study||33
9756567|NCT00360568|10860016|FG001|STARTED|Overall Study||29
9756568|NCT00360568|10860015|FG000|COMPLETED|Overall Study||31
9756569|NCT00360568|10860016|FG001|COMPLETED|Overall Study||24
9756570|NCT00360568|10860015|FG000|NOT COMPLETED|Overall Study||2
9756571|NCT00360568|10860016|FG001|NOT COMPLETED|Overall Study||5
9756572|NCT00360672|10860024|FG000|STARTED|Overall Study||27
9756573|NCT00360672|10860024|FG000|COMPLETED|Overall Study||27
9756574|NCT00360672|10860024|FG000|NOT COMPLETED|Overall Study||0
9756575|NCT00360685|10860030|FG000|STARTED|Overall Study||47
9756576|NCT00360685|10860031|FG001|STARTED|Overall Study||42
9756577|NCT00360685|10860030|FG000|COMPLETED|Overall Study||47
9756578|NCT00360685|10860031|FG001|COMPLETED|Overall Study||42
9756579|NCT00360685|10860030|FG000|NOT COMPLETED|Overall Study||0
9756580|NCT00360685|10860031|FG001|NOT COMPLETED|Overall Study||0
9756581|NCT00360698|10860040|FG000|STARTED|Run-In||0
9756582|NCT00360698|10860041|FG001|STARTED|Run-In||135
9756583|NCT00360698|10860040|FG000|COMPLETED|Run-In||0
9756584|NCT00360698|10860041|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
9756585|NCT00360698|10860040|FG000|NOT COMPLETED|Run-In||0
9756586|NCT00360698|10860041|FG001|NOT COMPLETED|Run-In||10
9756587|NCT00360698|10860040|FG000|STARTED|Treatment Period||49
9756588|NCT00360698|10860041|FG001|STARTED|Treatment Period||57
9756589|NCT00360698|10860040|FG000|COMPLETED|Treatment Period||48
9756590|NCT00360698|10860041|FG001|COMPLETED|Treatment Period||56
9756591|NCT00360698|10860040|FG000|NOT COMPLETED|Treatment Period||1
9756592|NCT00360698|10860041|FG001|NOT COMPLETED|Treatment Period||1
9756593|NCT00360724|10860049|FG000|STARTED|Overall Study||33
9756594|NCT00360724|10860050|FG001|STARTED|Overall Study||32
9756595|NCT00360724|10860049|FG000|COMPLETED|Overall Study||29
9756596|NCT00360724|10860050|FG001|COMPLETED|Overall Study||28
9756597|NCT00360724|10860049|FG000|NOT COMPLETED|Overall Study||4
9756598|NCT00360724|10860050|FG001|NOT COMPLETED|Overall Study||4
9756599|NCT00360828|10860059|FG000|STARTED|Overall Study||10
9756600|NCT00360828|10860059|FG000|COMPLETED|Overall Study||9
9756601|NCT00360828|10860059|FG000|NOT COMPLETED|Overall Study||1
9756602|NCT00360971|10860065|FG000|STARTED|Overall Study||10
9756603|NCT00360971|10860066|FG001|STARTED|Overall Study||11
9756604|NCT00360971|10860065|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
9756605|NCT00360971|10860066|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
9756606|NCT00360971|10860065|FG000|NOT COMPLETED|Overall Study||0
9756607|NCT00360971|10860066|FG001|NOT COMPLETED|Overall Study||0
9756608|NCT00361140|10860075|FG000|STARTED|Overall Study||40
9756609|NCT00361140|10860076|FG001|STARTED|Overall Study||29
9756610|NCT00361140|10860077|FG002|STARTED|Overall Study||3
9756611|NCT00361140|10860075|FG000|COMPLETED|Overall Study||40
9756612|NCT00361140|10860076|FG001|COMPLETED|Overall Study||29
9756613|NCT00361140|10860077|FG002|COMPLETED|Overall Study||3
9756614|NCT00361140|10860075|FG000|NOT COMPLETED|Overall Study||0
9756615|NCT00361140|10860076|FG001|NOT COMPLETED|Overall Study||0
9756616|NCT00361140|10860077|FG002|NOT COMPLETED|Overall Study||0
9756617|NCT00361218|10860085|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
9756618|NCT00361218|10860085|FG000|Completed Baseline Assessment|Overall Study||47
9756619|NCT00361218|10860085|FG000|COMPLETED|Overall Study||30
9756620|NCT00361218|10860085|FG000|NOT COMPLETED|Overall Study||23
9756621|NCT00361231|10860089|FG000|STARTED|Overall Study||35
9756622|NCT00361231|10860089|FG000|COMPLETED|Overall Study||1
9756623|NCT00361231|10860089|FG000|NOT COMPLETED|Overall Study||34
9756624|NCT00361257|10860095|FG000|STARTED|Step 1: Minocycline vs. Placebo||52
9756625|NCT00361257|10860096|FG001|STARTED|Step 1: Minocycline vs. Placebo||55
9756626|NCT00361257|10860095|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40
9756627|NCT00361257|10860096|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43
9756628|NCT00361257|10860095|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
9756629|NCT00361257|10860096|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
9756630|NCT00361257|10860095|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
9829095|NCT00758524|10939644|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
9756631|NCT00361257|10860096|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
9756632|NCT00361257|10860095|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13
9756633|NCT00361257|10860096|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19
9756634|NCT00361257|10860095|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
9756635|NCT00361257|10860096|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
9756636|NCT00361270|10860108|FG000|STARTED|Overall Study||49
9756637|NCT00361270|10860109|FG001|STARTED|Overall Study||39
9756638|NCT00361270|10860110|FG002|STARTED|Overall Study||35
9756639|NCT00361270|10860111|FG003|STARTED|Overall Study||38
9756640|NCT00361270|10860108|FG000|COMPLETED|Overall Study||25
9756641|NCT00361270|10860109|FG001|COMPLETED|Overall Study||25
9756642|NCT00361270|10860110|FG002|COMPLETED|Overall Study||25
9756643|NCT00361270|10860111|FG003|COMPLETED|Overall Study||25
9756644|NCT00361270|10860108|FG000|NOT COMPLETED|Overall Study||24
9756645|NCT00361270|10860109|FG001|NOT COMPLETED|Overall Study||14
9756646|NCT00361270|10860110|FG002|NOT COMPLETED|Overall Study||10
9756647|NCT00361270|10860111|FG003|NOT COMPLETED|Overall Study||13
9756648|NCT00361283|10860128|FG000|STARTED|Overall Study||108
9756649|NCT00361283|10860128|FG000|COMPLETED|Overall Study||81
9756650|NCT00361283|10860128|FG000|NOT COMPLETED|Overall Study||27
9756651|NCT00361296|10860132|FG000|STARTED|Overall Study||5
9756652|NCT00361296|10860132|FG000|COMPLETED|Overall Study||2
9756653|NCT00361296|10860132|FG000|NOT COMPLETED|Overall Study||3
9756654|NCT00361335|10860141|FG000|STARTED|IV Period: Baseline to E0||129
9756655|NCT00361335|10860142|FG001|STARTED|IV Period: Baseline to E0||128
9756656|NCT00361335|10860143|FG002|STARTED|IV Period: Baseline to E0||128
9756657|NCT00361335|10860144|FG003|STARTED|IV Period: Baseline to E0||129
9756658|NCT00361335|10860145|FG004|STARTED|IV Period: Baseline to E0||129
9756659|NCT00361335|10860146|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
9756660|NCT00361335|10860147|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
9756661|NCT00361335|10860141|FG000|COMPLETED|IV Period: Baseline to E0||109
9756662|NCT00361335|10860142|FG001|COMPLETED|IV Period: Baseline to E0||99
9756663|NCT00361335|10860143|FG002|COMPLETED|IV Period: Baseline to E0||107
9756664|NCT00361335|10860144|FG003|COMPLETED|IV Period: Baseline to E0||102
9756665|NCT00361335|10860145|FG004|COMPLETED|IV Period: Baseline to E0||105
9756666|NCT00361335|10860146|FG005|COMPLETED|IV Period: Baseline to E0||0
9756667|NCT00361335|10860147|FG006|COMPLETED|IV Period: Baseline to E0||0
9756668|NCT00361335|10860141|FG000|NOT COMPLETED|IV Period: Baseline to E0||20
9756669|NCT00361335|10860142|FG001|NOT COMPLETED|IV Period: Baseline to E0||29
9756670|NCT00361335|10860143|FG002|NOT COMPLETED|IV Period: Baseline to E0||21
9756671|NCT00361335|10860144|FG003|NOT COMPLETED|IV Period: Baseline to E0||27
9756672|NCT00361335|10860145|FG004|NOT COMPLETED|IV Period: Baseline to E0||24
9756673|NCT00361335|10860146|FG005|NOT COMPLETED|IV Period: Baseline to E0||0
9756674|NCT00361335|10860147|FG006|NOT COMPLETED|IV Period: Baseline to E0||0
9756675|NCT00361335|10860141|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
9756676|NCT00361335|10860142|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
9756677|NCT00361335|10860143|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
9756678|NCT00361335|10860144|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
9756679|NCT00361335|10860145|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
9756680|NCT00361335|10860146|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
9756681|NCT00361335|10860147|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
9756682|NCT00361335|10860141|FG000|COMPLETED|SC Period: Week E0 to Week E24||80
9756683|NCT00361335|10860142|FG001|COMPLETED|SC Period: Week E0 to Week E24||56
9756684|NCT00361335|10860143|FG002|COMPLETED|SC Period: Week E0 to Week E24||99
9756685|NCT00361335|10860144|FG003|COMPLETED|SC Period: Week E0 to Week E24||59
9756686|NCT00361335|10860145|FG004|COMPLETED|SC Period: Week E0 to Week E24||3
9756687|NCT00361335|10860146|FG005|COMPLETED|SC Period: Week E0 to Week E24||23
9756688|NCT00361335|10860147|FG006|COMPLETED|SC Period: Week E0 to Week E24||164
9756689|NCT00361335|10860141|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2
9756690|NCT00361335|10860142|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3
9756691|NCT00361335|10860143|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5
9756692|NCT00361335|10860144|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4
9756693|NCT00361335|10860145|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0
9756694|NCT00361335|10860146|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1
9756695|NCT00361335|10860147|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9
9756696|NCT00361374|10860166|FG000|STARTED|Overall Study||66
9756697|NCT00361374|10860167|FG001|STARTED|Overall Study||65
9756698|NCT00361374|10860168|FG002|STARTED|Overall Study||65
9756699|NCT00361374|10860166|FG000|COMPLETED|Overall Study||51
9756700|NCT00361374|10860167|FG001|COMPLETED|Overall Study||50
9756701|NCT00361374|10860168|FG002|COMPLETED|Overall Study||53
9756702|NCT00361374|10860166|FG000|NOT COMPLETED|Overall Study||15
9756703|NCT00361374|10860167|FG001|NOT COMPLETED|Overall Study||15
9756704|NCT00361374|10860168|FG002|NOT COMPLETED|Overall Study||12
9756705|NCT00361439|10860178|FG000|STARTED|Overall Study||8
9756706|NCT00361439|10860179|FG001|STARTED|Overall Study||9
9756707|NCT00361439|10860178|FG000|COMPLETED|Overall Study||8
9756708|NCT00361439|10860179|FG001|COMPLETED|Overall Study||9
9756709|NCT00361439|10860178|FG000|NOT COMPLETED|Overall Study||0
9756710|NCT00361439|10860179|FG001|NOT COMPLETED|Overall Study||0
9756711|NCT00361504|10860187|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
9756712|NCT00361504|10860188|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
9756713|NCT00361504|10860187|FG000|COMPLETED|Overall Study||413
9756714|NCT00361504|10860188|FG001|COMPLETED|Overall Study||78
9756715|NCT00361504|10860187|FG000|NOT COMPLETED|Overall Study||481
9756716|NCT00361504|10860188|FG001|NOT COMPLETED|Overall Study||145
9756717|NCT00361569|10860198|FG000|STARTED|Overall Study||150
9756718|NCT00361569|10860199|FG001|STARTED|Overall Study||161
9756719|NCT00361569|10860200|FG002|STARTED|Overall Study||155
9756720|NCT00361569|10860201|FG003|STARTED|Overall Study||156
9756721|NCT00361569|10860198|FG000|COMPLETED|Overall Study||138
9756722|NCT00361569|10860199|FG001|COMPLETED|Overall Study||150
9756723|NCT00361569|10860200|FG002|COMPLETED|Overall Study||137
9756724|NCT00361569|10860201|FG003|COMPLETED|Overall Study||135
9756725|NCT00361569|10860198|FG000|NOT COMPLETED|Overall Study||12
9756726|NCT00361569|10860199|FG001|NOT COMPLETED|Overall Study||11
9756727|NCT00361569|10860200|FG002|NOT COMPLETED|Overall Study||18
9756728|NCT00361569|10860201|FG003|NOT COMPLETED|Overall Study||21
9756729|NCT00361595|10860211|FG000|STARTED|Overall Study||35
9756730|NCT00361595|10860211|FG000|COMPLETED|Overall Study||35
9756731|NCT00361595|10860211|FG000|NOT COMPLETED|Overall Study||0
9756732|NCT00361634|10860215|FG000|STARTED|Overall Study||14
9756733|NCT00361634|10860215|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
9756734|NCT00361634|10860215|FG000|COMPLETED|Overall Study||12
9756735|NCT00361634|10860215|FG000|NOT COMPLETED|Overall Study||2
9756736|NCT00361712|10860221|FG000|STARTED|Overall Study||20
9756737|NCT00361712|10860222|FG001|STARTED|Overall Study||21
9756738|NCT00361712|10860221|FG000|COMPLETED|Overall Study||20
9756739|NCT00361712|10860222|FG001|COMPLETED|Overall Study||21
9756740|NCT00361712|10860221|FG000|NOT COMPLETED|Overall Study||0
9756741|NCT00361712|10860222|FG001|NOT COMPLETED|Overall Study||0
9756742|NCT00361842|10860230|FG000|STARTED|Overall Study||28
9756743|NCT00361842|10860231|FG001|STARTED|Overall Study||35
9756744|NCT00361842|10860230|FG000|COMPLETED|Overall Study||1
9756745|NCT00361842|10860231|FG001|COMPLETED|Overall Study||1
9756746|NCT00361842|10860230|FG000|NOT COMPLETED|Overall Study||27
9756747|NCT00361842|10860231|FG001|NOT COMPLETED|Overall Study||34
9756748|NCT00361972|10860241|FG000|STARTED|Overall Study||8
9756749|NCT00361972|10860242|FG001|STARTED|Overall Study||9
9756750|NCT00361972|10860241|FG000|COMPLETED|Overall Study||8
9756751|NCT00361972|10860242|FG001|COMPLETED|Overall Study||9
9756752|NCT00361972|10860241|FG000|NOT COMPLETED|Overall Study||0
9756753|NCT00361972|10860242|FG001|NOT COMPLETED|Overall Study||0
9756754|NCT00362115|10860256|FG000|STARTED|Overall Study||65
9756755|NCT00362115|10860257|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
9756756|NCT00362115|10860258|FG002|STARTED|Overall Study||64
9756757|NCT00362115|10860259|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
9756758|NCT00362115|10860260|FG004|STARTED|Overall Study||64
9756759|NCT00362115|10860261|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
9756760|NCT00362115|10860262|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
9756761|NCT00362115|10860256|FG000|COMPLETED|Overall Study||63
9756762|NCT00362115|10860257|FG001|COMPLETED|Overall Study||59
9756763|NCT00362115|10860258|FG002|COMPLETED|Overall Study||57
9756764|NCT00362115|10860259|FG003|COMPLETED|Overall Study||59
9756765|NCT00362115|10860260|FG004|COMPLETED|Overall Study||57
9756766|NCT00362115|10860261|FG005|COMPLETED|Overall Study||57
9756767|NCT00362115|10860262|FG006|COMPLETED|Overall Study||52
9756768|NCT00362115|10860256|FG000|NOT COMPLETED|Overall Study||2
9756769|NCT00362115|10860257|FG001|NOT COMPLETED|Overall Study||6
9756770|NCT00362115|10860258|FG002|NOT COMPLETED|Overall Study||7
9756771|NCT00362115|10860259|FG003|NOT COMPLETED|Overall Study||4
9756772|NCT00362115|10860260|FG004|NOT COMPLETED|Overall Study||7
9756773|NCT00362115|10860261|FG005|NOT COMPLETED|Overall Study||7
9756774|NCT00362115|10860262|FG006|NOT COMPLETED|Overall Study||12
9756775|NCT00362128|10860278|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
9756776|NCT00362128|10860278|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
9756777|NCT00362128|10860278|FG000|NOT COMPLETED|Overall Study||0
9756778|NCT00362180|10860291|FG000|STARTED|Treated Period||4
9756779|NCT00362180|10860292|FG001|STARTED|Treated Period||2
9756780|NCT00362180|10860293|FG002|STARTED|Treated Period||1
9756781|NCT00362180|10860294|FG003|STARTED|Treated Period||0
9756782|NCT00362180|10860295|FG004|STARTED|Treated Period||11
9756783|NCT00362180|10860296|FG005|STARTED|Treated Period||10
9756784|NCT00362180|10860297|FG006|STARTED|Treated Period||6
9756785|NCT00362180|10860298|FG007|STARTED|Treated Period||3
9756786|NCT00362180|10860299|FG008|STARTED|Treated Period||1
9756787|NCT00362180|10860291|FG000|COMPLETED|Treated Period||3
9756788|NCT00362180|10860292|FG001|COMPLETED|Treated Period||2
9756789|NCT00362180|10860293|FG002|COMPLETED|Treated Period||1
9756790|NCT00362180|10860294|FG003|COMPLETED|Treated Period||0
9756791|NCT00362180|10860295|FG004|COMPLETED|Treated Period||11
9756792|NCT00362180|10860296|FG005|COMPLETED|Treated Period||9
9756793|NCT00362180|10860297|FG006|COMPLETED|Treated Period||6
9756794|NCT00362180|10860298|FG007|COMPLETED|Treated Period||2
9756795|NCT00362180|10860299|FG008|COMPLETED|Treated Period||1
9756796|NCT00362180|10860291|FG000|NOT COMPLETED|Treated Period||1
9756797|NCT00362180|10860292|FG001|NOT COMPLETED|Treated Period||0
9756798|NCT00362180|10860293|FG002|NOT COMPLETED|Treated Period||0
9756799|NCT00362180|10860294|FG003|NOT COMPLETED|Treated Period||0
9756800|NCT00362180|10860295|FG004|NOT COMPLETED|Treated Period||0
9756801|NCT00362180|10860296|FG005|NOT COMPLETED|Treated Period||1
9756802|NCT00362180|10860297|FG006|NOT COMPLETED|Treated Period||0
9756803|NCT00362180|10860298|FG007|NOT COMPLETED|Treated Period||1
9756804|NCT00362180|10860299|FG008|NOT COMPLETED|Treated Period||0
9756805|NCT00362180|10860291|FG000|STARTED|20 Week Safety Follow-up||3
9756806|NCT00362180|10860292|FG001|STARTED|20 Week Safety Follow-up||2
9756807|NCT00362180|10860293|FG002|STARTED|20 Week Safety Follow-up||1
9756808|NCT00362180|10860294|FG003|STARTED|20 Week Safety Follow-up||0
9756809|NCT00362180|10860295|FG004|STARTED|20 Week Safety Follow-up||11
9756810|NCT00362180|10860296|FG005|STARTED|20 Week Safety Follow-up||9
9756811|NCT00362180|10860297|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
9756812|NCT00362180|10860298|FG007|STARTED|20 Week Safety Follow-up||3
9756813|NCT00362180|10860299|FG008|STARTED|20 Week Safety Follow-up||1
9756814|NCT00362180|10860291|FG000|COMPLETED|20 Week Safety Follow-up||3
9756815|NCT00362180|10860292|FG001|COMPLETED|20 Week Safety Follow-up||2
9756816|NCT00362180|10860293|FG002|COMPLETED|20 Week Safety Follow-up||1
9756817|NCT00362180|10860294|FG003|COMPLETED|20 Week Safety Follow-up||0
9756818|NCT00362180|10860295|FG004|COMPLETED|20 Week Safety Follow-up||11
9756819|NCT00362180|10860296|FG005|COMPLETED|20 Week Safety Follow-up||9
9756820|NCT00362180|10860297|FG006|COMPLETED|20 Week Safety Follow-up||0
9756821|NCT00362180|10860298|FG007|COMPLETED|20 Week Safety Follow-up||3
9756822|NCT00362180|10860299|FG008|COMPLETED|20 Week Safety Follow-up||1
9756823|NCT00362180|10860291|FG000|NOT COMPLETED|20 Week Safety Follow-up||0
9756824|NCT00362180|10860292|FG001|NOT COMPLETED|20 Week Safety Follow-up||0
9756825|NCT00362180|10860293|FG002|NOT COMPLETED|20 Week Safety Follow-up||0
9756826|NCT00362180|10860294|FG003|NOT COMPLETED|20 Week Safety Follow-up||0
9756827|NCT00362180|10860295|FG004|NOT COMPLETED|20 Week Safety Follow-up||0
9756828|NCT00362180|10860296|FG005|NOT COMPLETED|20 Week Safety Follow-up||0
9756829|NCT00362180|10860297|FG006|NOT COMPLETED|20 Week Safety Follow-up||0
9756830|NCT00362180|10860298|FG007|NOT COMPLETED|20 Week Safety Follow-up||0
9756831|NCT00362180|10860299|FG008|NOT COMPLETED|20 Week Safety Follow-up||0
9756832|NCT00362232|10860319|FG000|STARTED|Treatment (12 +/- 2 Days)||1584
9756833|NCT00362232|10860320|FG001|STARTED|Treatment (12 +/- 2 Days)||1564
9756834|NCT00362232|10860319|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
9756835|NCT00362232|10860320|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
9756836|NCT00362232|10860319|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425
9756837|NCT00362232|10860320|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413
9756838|NCT00362232|10860319|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
9756839|NCT00362232|10860320|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
9756840|NCT00362232|10860319|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471
9756841|NCT00362232|10860320|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455
9756842|NCT00362232|10860319|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433
9756843|NCT00362232|10860320|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416
9756844|NCT00362232|10860319|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
9756845|NCT00362232|10860320|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
9756846|NCT00362297|10860328|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16
9756847|NCT00362297|10860329|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15
9756848|NCT00362297|10860328|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
9756849|NCT00362297|10860329|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
9756850|NCT00362297|10860328|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
9756851|NCT00362297|10860329|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
9756852|NCT00362297|10860328|FG000|STARTED|Treatment 2||16
9756853|NCT00362297|10860329|FG001|STARTED|Treatment 2||11
9756854|NCT00362297|10860328|FG000|COMPLETED|Treatment 2||16
9756855|NCT00362297|10860329|FG001|COMPLETED|Treatment 2||11
9756856|NCT00362297|10860328|FG000|NOT COMPLETED|Treatment 2||0
9756857|NCT00362297|10860329|FG001|NOT COMPLETED|Treatment 2||0
9756858|NCT00362336|10860338|FG000|STARTED|Overall Study||243
9756859|NCT00362336|10860339|FG001|STARTED|Overall Study||242
9756860|NCT00362336|10860340|FG002|STARTED|Overall Study||137
9756861|NCT00362336|10860338|FG000|COMPLETED|Overall Study||233
9756862|NCT00362336|10860339|FG001|COMPLETED|Overall Study||235
9756863|NCT00362336|10860340|FG002|COMPLETED|Overall Study||134
9756864|NCT00362336|10860338|FG000|NOT COMPLETED|Overall Study||10
9756865|NCT00362336|10860339|FG001|NOT COMPLETED|Overall Study||7
9756866|NCT00362336|10860340|FG002|NOT COMPLETED|Overall Study||3
9756867|NCT00362375|10860357|FG000|STARTED|Overall Study|Number eligible and randomized|161
9756868|NCT00362375|10860358|FG001|STARTED|Overall Study|Number eligible and randomized|152
9756869|NCT00362375|10860357|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
9756870|NCT00362375|10860358|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
9756871|NCT00362375|10860357|FG000|NOT COMPLETED|Overall Study||40
9756872|NCT00362375|10860358|FG001|NOT COMPLETED|Overall Study||35
9756873|NCT00362414|10860364|FG000|STARTED|Overall Study||15
9756874|NCT00362414|10860364|FG000|COMPLETED|Overall Study||12
9756875|NCT00362414|10860364|FG000|NOT COMPLETED|Overall Study||3
9756876|NCT00362440|10860373|FG000|STARTED|Overall Study||5
9756877|NCT00362440|10860374|FG001|STARTED|Overall Study||4
9756878|NCT00362440|10860373|FG000|COMPLETED|Overall Study||3
9756879|NCT00362440|10860374|FG001|COMPLETED|Overall Study||3
9756880|NCT00362440|10860373|FG000|NOT COMPLETED|Overall Study||2
9756881|NCT00362440|10860374|FG001|NOT COMPLETED|Overall Study||1
9756882|NCT00362453|10860382|FG000|STARTED|Overall Study||20
9756883|NCT00362453|10860383|FG001|STARTED|Overall Study||20
9756884|NCT00362453|10860382|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
9756885|NCT00362453|10860383|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
9756886|NCT00362453|10860382|FG000|NOT COMPLETED|Overall Study||0
9756887|NCT00362453|10860383|FG001|NOT COMPLETED|Overall Study||0
9756888|NCT00362466|10860391|FG000|STARTED|Overall Study||2
9756889|NCT00362466|10860392|FG001|STARTED|Overall Study||1
9756890|NCT00362466|10860391|FG000|COMPLETED|Overall Study||2
9756891|NCT00362466|10860392|FG001|COMPLETED|Overall Study||1
9756892|NCT00362466|10860391|FG000|NOT COMPLETED|Overall Study||0
9756893|NCT00362466|10860392|FG001|NOT COMPLETED|Overall Study||0
9756894|NCT00362609|10860400|FG000|STARTED|Overall Study||19
9756895|NCT00362609|10860401|FG001|STARTED|Overall Study||40
9756896|NCT00362609|10860400|FG000|COMPLETED|Overall Study||19
9756897|NCT00362609|10860401|FG001|COMPLETED|Overall Study||38
9756898|NCT00362609|10860400|FG000|NOT COMPLETED|Overall Study||0
9756899|NCT00362609|10860401|FG001|NOT COMPLETED|Overall Study||2
9756900|NCT00362648|10860411|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
9756901|NCT00362648|10860412|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
9756902|NCT00362648|10860413|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
9756903|NCT00362648|10860414|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
9756904|NCT00362648|10860411|FG000|Vaccinated at Visit 1|Overall Study||2733
9756905|NCT00362648|10860412|FG001|Vaccinated at Visit 1|Overall Study||2735
9756906|NCT00362648|10860413|FG002|Vaccinated at Visit 1|Overall Study||1018
9756907|NCT00362648|10860414|FG003|Vaccinated at Visit 1|Overall Study||1018
9756908|NCT00362648|10860411|FG000|Vaccinated at Visit 2|Overall Study||2657
9756909|NCT00362648|10860412|FG001|Vaccinated at Visit 2|Overall Study||2666
9756910|NCT00362648|10860413|FG002|Vaccinated at Visit 2|Overall Study||1013
9756911|NCT00362648|10860414|FG003|Vaccinated at Visit 2|Overall Study||1009
9756912|NCT00362648|10860411|FG000|Vaccinated at Visit 3|Overall Study||2613
9756913|NCT00362648|10860412|FG001|Vaccinated at Visit 3|Overall Study||2612
9756914|NCT00362648|10860413|FG002|Vaccinated at Visit 3|Overall Study||1009
9756915|NCT00362648|10860414|FG003|Vaccinated at Visit 3|Overall Study||1007
9756916|NCT00362648|10860411|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
9756917|NCT00362648|10860412|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
9756918|NCT00362648|10860413|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
9756919|NCT00362648|10860414|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
9756920|NCT00362648|10860411|FG000|NOT COMPLETED|Overall Study||126
9756921|NCT00362648|10860412|FG001|NOT COMPLETED|Overall Study||134
9756922|NCT00362648|10860413|FG002|NOT COMPLETED|Overall Study||9
9756923|NCT00362648|10860414|FG003|NOT COMPLETED|Overall Study||11
9756924|NCT00362817|10860428|FG000|STARTED|Overall Study||17
9756925|NCT00362817|10860428|FG000|COMPLETED|Overall Study||17
9756926|NCT00362817|10860428|FG000|NOT COMPLETED|Overall Study||0
9756927|NCT00362882|10860435|FG000|STARTED|Overall Study||40
9756928|NCT00362882|10860436|FG001|STARTED|Overall Study||41
9756929|NCT00362882|10860435|FG000|COMPLETED|Overall Study||40
9756930|NCT00362882|10860436|FG001|COMPLETED|Overall Study||41
9756931|NCT00362882|10860435|FG000|NOT COMPLETED|Overall Study||0
9756932|NCT00362882|10860436|FG001|NOT COMPLETED|Overall Study||0
9756933|NCT00363051|10860444|FG000|STARTED|Overall Study||115
9756934|NCT00363051|10860445|FG001|STARTED|Overall Study||45
9756935|NCT00363051|10860444|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
9756936|NCT00363051|10860445|FG001|COMPLETED|Overall Study||23
9756937|NCT00363051|10860444|FG000|NOT COMPLETED|Overall Study||38
9756938|NCT00363051|10860445|FG001|NOT COMPLETED|Overall Study||22
9756939|NCT00363077|10860455|FG000|STARTED|Overall Study||75
9756940|NCT00363077|10860456|FG001|STARTED|Overall Study||75
9756941|NCT00363077|10860455|FG000|COMPLETED|Overall Study||75
9756942|NCT00363077|10860456|FG001|COMPLETED|Overall Study||75
9756943|NCT00363077|10860455|FG000|NOT COMPLETED|Overall Study||0
9756944|NCT00363077|10860456|FG001|NOT COMPLETED|Overall Study||0
9756945|NCT00363129|10860464|FG000|STARTED|Overall Study||96
9756946|NCT00363129|10860465|FG001|STARTED|Overall Study||93
9756947|NCT00363129|10860464|FG000|COMPLETED|Overall Study||67
9756948|NCT00363129|10860465|FG001|COMPLETED|Overall Study||60
9756949|NCT00363129|10860464|FG000|NOT COMPLETED|Overall Study||29
9756950|NCT00363129|10860465|FG001|NOT COMPLETED|Overall Study||33
9756951|NCT00363142|10860473|FG000|STARTED|Overall Study||140
9756952|NCT00363142|10860474|FG001|STARTED|Overall Study||69
9756953|NCT00363142|10860473|FG000|COMPLETED|Overall Study||133
9756954|NCT00363142|10860474|FG001|COMPLETED|Overall Study||66
9756955|NCT00363142|10860473|FG000|NOT COMPLETED|Overall Study||7
9756956|NCT00363142|10860474|FG001|NOT COMPLETED|Overall Study||3
9756957|NCT00363168|10860485|FG000|STARTED|Overall Study||5
9756958|NCT00363168|10860486|FG001|STARTED|Overall Study||2
9756959|NCT00363168|10860485|FG000|COMPLETED|Overall Study||5
9756960|NCT00363168|10860486|FG001|COMPLETED|Overall Study||2
9756961|NCT00363168|10860485|FG000|NOT COMPLETED|Overall Study||0
9756962|NCT00363168|10860486|FG001|NOT COMPLETED|Overall Study||0
9756963|NCT00363246|10860492|FG000|STARTED|Overall Study||766
9756964|NCT00363246|10860492|FG000|COMPLETED|Overall Study||669
9756965|NCT00363246|10860492|FG000|NOT COMPLETED|Overall Study||97
9756966|NCT00363298|10860499|FG000|STARTED|First Study Week||12
9756967|NCT00363298|10860500|FG001|STARTED|First Study Week||12
9756968|NCT00363298|10860499|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
9756969|NCT00363298|10860500|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
9756970|NCT00363298|10860499|FG000|NOT COMPLETED|First Study Week||6
9756971|NCT00363298|10860500|FG001|NOT COMPLETED|First Study Week||5
9756972|NCT00363298|10860499|FG000|STARTED|4-week Study Continuation Phase||6
9756973|NCT00363298|10860500|FG001|STARTED|4-week Study Continuation Phase||7
9756974|NCT00363298|10860499|FG000|COMPLETED|4-week Study Continuation Phase||5
9756975|NCT00363298|10860500|FG001|COMPLETED|4-week Study Continuation Phase||7
9756976|NCT00363298|10860499|FG000|NOT COMPLETED|4-week Study Continuation Phase||1
9756977|NCT00363298|10860500|FG001|NOT COMPLETED|4-week Study Continuation Phase||0
9756978|NCT00363311|10860509|FG000|STARTED|Overall Study||155
9756979|NCT00363311|10860510|FG001|STARTED|Overall Study||147
9756980|NCT00363311|10860509|FG000|COMPLETED|Overall Study||79
9756981|NCT00363311|10860510|FG001|COMPLETED|Overall Study||102
9756982|NCT00363311|10860509|FG000|NOT COMPLETED|Overall Study||76
9756983|NCT00363311|10860510|FG001|NOT COMPLETED|Overall Study||45
9756984|NCT00363415|10860518|FG000|STARTED|Overall Study||453
9756985|NCT00363415|10860519|FG001|STARTED|Overall Study||455
9756986|NCT00363415|10860518|FG000|Received at Least One Dose of Study Drug|Overall Study||433
9756987|NCT00363415|10860519|FG001|Received at Least One Dose of Study Drug|Overall Study||447
9756988|NCT00363415|10860518|FG000|COMPLETED|Overall Study||92
9756989|NCT00363415|10860519|FG001|COMPLETED|Overall Study||206
9756990|NCT00363415|10860518|FG000|NOT COMPLETED|Overall Study||361
9756991|NCT00363415|10860519|FG001|NOT COMPLETED|Overall Study||249
9756992|NCT00363467|10860525|FG000|STARTED|Overall Study||3
9756993|NCT00363467|10860525|FG000|COMPLETED|Overall Study||2
9756994|NCT00363467|10860525|FG000|NOT COMPLETED|Overall Study||1
9756995|NCT00363480|10860529|FG000|STARTED|Overall Study||221
9756996|NCT00363480|10860529|FG000|COMPLETED|Overall Study||204
9756997|NCT00363480|10860529|FG000|NOT COMPLETED|Overall Study||17
9756998|NCT00363545|10860535|FG000|STARTED|Overall Study||636
9756999|NCT00363545|10860536|FG001|STARTED|Overall Study||638
9757000|NCT00363545|10860535|FG000|COMPLETED|Overall Study||592
9757001|NCT00363545|10860536|FG001|COMPLETED|Overall Study||581
9757002|NCT00363545|10860535|FG000|NOT COMPLETED|Overall Study||44
9757003|NCT00363545|10860536|FG001|NOT COMPLETED|Overall Study||57
9757004|NCT00363649|10860544|FG000|STARTED|Overall Study||18
9757005|NCT00363649|10860545|FG001|STARTED|Overall Study||16
9757006|NCT00363649|10860544|FG000|Crossed Over to Arm B|Overall Study||9
9757007|NCT00363649|10860545|FG001|Crossed Over to Arm B|Overall Study||0
9757008|NCT00363649|10860544|FG000|Crossed Over to Arm A|Overall Study||0
9757009|NCT00363649|10860545|FG001|Crossed Over to Arm A|Overall Study||12
9757010|NCT00363649|10860544|FG000|Did Not Cross Over|Overall Study||2
9757011|NCT00363649|10860545|FG001|Did Not Cross Over|Overall Study||3
9757012|NCT00363649|10860544|FG000|COMPLETED|Overall Study||11
9757013|NCT00363649|10860545|FG001|COMPLETED|Overall Study||15
9757014|NCT00363649|10860544|FG000|NOT COMPLETED|Overall Study||7
9757015|NCT00363649|10860545|FG001|NOT COMPLETED|Overall Study||1
9757016|NCT00363675|10860551|FG000|STARTED|Overall Study||3
9757017|NCT00363675|10860551|FG000|Completed Testing|Overall Study||3
9757018|NCT00363675|10860551|FG000|COMPLETED|Overall Study||3
9757019|NCT00363675|10860551|FG000|NOT COMPLETED|Overall Study||0
9757020|NCT00363766|10860558|FG000|STARTED|Overall Study||32
9757021|NCT00363766|10860559|FG001|STARTED|Overall Study||20
9757022|NCT00363766|10860558|FG000|COMPLETED|Overall Study||0
9757023|NCT00363766|10860559|FG001|COMPLETED|Overall Study||0
9757024|NCT00363766|10860558|FG000|NOT COMPLETED|Overall Study||32
9757025|NCT00363766|10860559|FG001|NOT COMPLETED|Overall Study||20
9757026|NCT00363779|10860566|FG000|STARTED|Overall Study||5
9757027|NCT00363779|10860566|FG000|COMPLETED|Overall Study||5
9757028|NCT00363779|10860566|FG000|NOT COMPLETED|Overall Study||0
9757029|NCT00363805|10860573|FG000|STARTED|Overall Study||42
9757030|NCT00363805|10860574|FG001|STARTED|Overall Study||63
9757031|NCT00363805|10860575|FG002|STARTED|Overall Study||73
9757032|NCT00363805|10860573|FG000|COMPLETED|Overall Study||38
9757033|NCT00363805|10860574|FG001|COMPLETED|Overall Study||57
9757034|NCT00363805|10860575|FG002|COMPLETED|Overall Study||70
9757035|NCT00363805|10860573|FG000|NOT COMPLETED|Overall Study||4
9757036|NCT00363805|10860574|FG001|NOT COMPLETED|Overall Study||6
9757037|NCT00363805|10860575|FG002|NOT COMPLETED|Overall Study||3
9757038|NCT00363883|10860583|FG000|STARTED|Overall Study||14
9757039|NCT00363883|10860583|FG000|COMPLETED|Overall Study||14
9757040|NCT00363883|10860583|FG000|NOT COMPLETED|Overall Study||0
9757041|NCT00363896|10860589|FG000|STARTED|Overall Study||627
9757042|NCT00363896|10860590|FG001|STARTED|Overall Study||216
9757043|NCT00363896|10860589|FG000|COMPLETED|Overall Study||538
9757044|NCT00363896|10860590|FG001|COMPLETED|Overall Study||169
9757045|NCT00363896|10860589|FG000|NOT COMPLETED|Overall Study||89
9757046|NCT00363896|10860590|FG001|NOT COMPLETED|Overall Study||47
9757047|NCT00364013|10860601|FG000|STARTED|Overall Study||593
9757048|NCT00364013|10860602|FG001|STARTED|Overall Study||590
9757049|NCT00364013|10860601|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
9757050|NCT00364013|10860602|FG001|Received Study Drug|Overall Study||583
9757051|NCT00364013|10860601|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
9757052|NCT00364013|10860602|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
9757053|NCT00364013|10860601|FG000|NOT COMPLETED|Overall Study||101
9757054|NCT00364013|10860602|FG001|NOT COMPLETED|Overall Study||95
9757055|NCT00364130|10860614|FG000|STARTED|Intervention Period||69
9757056|NCT00364130|10860615|FG001|STARTED|Intervention Period||69
9757057|NCT00364130|10860614|FG000|COMPLETED|Intervention Period||60
9757058|NCT00364130|10860615|FG001|COMPLETED|Intervention Period||61
9757059|NCT00364130|10860614|FG000|NOT COMPLETED|Intervention Period||9
9757060|NCT00364130|10860615|FG001|NOT COMPLETED|Intervention Period||8
9757061|NCT00364130|10860614|FG000|STARTED|Post Intervention Follow-up Period||60
9757062|NCT00364130|10860615|FG001|STARTED|Post Intervention Follow-up Period||61
9757063|NCT00364130|10860614|FG000|COMPLETED|Post Intervention Follow-up Period||55
9757064|NCT00364130|10860615|FG001|COMPLETED|Post Intervention Follow-up Period||50
9757065|NCT00364130|10860614|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5
9757066|NCT00364130|10860615|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11
9757067|NCT00364156|10860625|FG000|STARTED|Overall Study||282
9757068|NCT00364156|10860626|FG001|STARTED|Overall Study||286
9757069|NCT00364156|10860625|FG000|COMPLETED|Overall Study||203
9757070|NCT00364156|10860626|FG001|COMPLETED|Overall Study||205
9757071|NCT00364156|10860625|FG000|NOT COMPLETED|Overall Study||79
9757072|NCT00364156|10860626|FG001|NOT COMPLETED|Overall Study||81
9757073|NCT00364182|10860635|FG000|STARTED|First Intervention||3
9757074|NCT00364182|10860636|FG001|STARTED|First Intervention||22
9757075|NCT00364182|10860637|FG002|STARTED|First Intervention||25
9757076|NCT00364182|10860635|FG000|COMPLETED|First Intervention||0
9757077|NCT00364182|10860636|FG001|COMPLETED|First Intervention||22
9757078|NCT00364182|10860637|FG002|COMPLETED|First Intervention||25
9757079|NCT00364182|10860635|FG000|NOT COMPLETED|First Intervention||3
9757080|NCT00364182|10860636|FG001|NOT COMPLETED|First Intervention||0
9757081|NCT00364182|10860637|FG002|NOT COMPLETED|First Intervention||0
9757082|NCT00364182|10860635|FG000|STARTED|Second Intervention||0
9757083|NCT00364182|10860636|FG001|STARTED|Second Intervention||22
9757084|NCT00364182|10860637|FG002|STARTED|Second Intervention||25
9757085|NCT00364182|10860635|FG000|Randomized|Second Intervention||0
9757086|NCT00364182|10860636|FG001|Randomized|Second Intervention||22
9757087|NCT00364182|10860637|FG002|Randomized|Second Intervention||25
9757088|NCT00364182|10860635|FG000|COMPLETED|Second Intervention||0
9757089|NCT00364182|10860636|FG001|COMPLETED|Second Intervention||20
9757090|NCT00364182|10860637|FG002|COMPLETED|Second Intervention||23
9757091|NCT00364182|10860635|FG000|NOT COMPLETED|Second Intervention||0
9757092|NCT00364182|10860636|FG001|NOT COMPLETED|Second Intervention||2
9757093|NCT00364182|10860637|FG002|NOT COMPLETED|Second Intervention||2
9757094|NCT00364182|10860635|FG000|STARTED|Third Intervention||0
9757095|NCT00364182|10860636|FG001|STARTED|Third Intervention||20
9757096|NCT00364182|10860637|FG002|STARTED|Third Intervention||23
9757097|NCT00364182|10860635|FG000|COMPLETED|Third Intervention||0
9757098|NCT00364182|10860636|FG001|COMPLETED|Third Intervention||19
9757099|NCT00364182|10860637|FG002|COMPLETED|Third Intervention||22
9757100|NCT00364182|10860635|FG000|NOT COMPLETED|Third Intervention||0
9757101|NCT00364182|10860636|FG001|NOT COMPLETED|Third Intervention||1
9757102|NCT00364182|10860637|FG002|NOT COMPLETED|Third Intervention||1
9757103|NCT00364182|10860635|FG000|STARTED|Fourth Intervention||0
9757104|NCT00364182|10860636|FG001|STARTED|Fourth Intervention||19
9757105|NCT00364182|10860637|FG002|STARTED|Fourth Intervention||22
9757106|NCT00364182|10860635|FG000|COMPLETED|Fourth Intervention||0
9757107|NCT00364182|10860636|FG001|COMPLETED|Fourth Intervention||19
9757108|NCT00364182|10860637|FG002|COMPLETED|Fourth Intervention||22
9757109|NCT00364182|10860635|FG000|NOT COMPLETED|Fourth Intervention||0
9757110|NCT00364182|10860636|FG001|NOT COMPLETED|Fourth Intervention||0
9757111|NCT00364182|10860637|FG002|NOT COMPLETED|Fourth Intervention||0
9757112|NCT00364286|10860647|FG000|STARTED|Overall Study||17
9757113|NCT00364286|10860647|FG000|COMPLETED|Overall Study||14
9757114|NCT00364286|10860647|FG000|NOT COMPLETED|Overall Study||3
9757115|NCT00364351|10860653|FG000|STARTED|Overall Study|randomised patients|623
9757116|NCT00364351|10860654|FG001|STARTED|Overall Study|randomised patients|617
9757117|NCT00364351|10860653|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
9757118|NCT00364351|10860654|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
9757119|NCT00364351|10860653|FG000|NOT COMPLETED|Overall Study||592
9757120|NCT00364351|10860654|FG001|NOT COMPLETED|Overall Study||583
9757121|NCT00364377|10860662|FG000|STARTED|Overall Study||11
9757122|NCT00364377|10860663|FG001|STARTED|Overall Study||11
9757123|NCT00364377|10860662|FG000|COMPLETED|Overall Study||11
9757124|NCT00364377|10860663|FG001|COMPLETED|Overall Study||11
9757125|NCT00364377|10860662|FG000|NOT COMPLETED|Overall Study||0
9757126|NCT00364377|10860663|FG001|NOT COMPLETED|Overall Study||0
9757127|NCT00364533|10860674|FG000|STARTED|Overall Study||77
9757128|NCT00364533|10860675|FG001|STARTED|Overall Study||71
9757129|NCT00364533|10860676|FG002|STARTED|Overall Study||75
9757130|NCT00364533|10860677|FG003|STARTED|Overall Study||67
9757131|NCT00364533|10860678|FG004|STARTED|Overall Study||75
9757132|NCT00364533|10860674|FG000|COMPLETED|Overall Study||35
9757133|NCT00364533|10860675|FG001|COMPLETED|Overall Study||31
9757134|NCT00364533|10860676|FG002|COMPLETED|Overall Study||30
9757135|NCT00364533|10860677|FG003|COMPLETED|Overall Study||36
9757136|NCT00364533|10860678|FG004|COMPLETED|Overall Study||24
9757137|NCT00364533|10860674|FG000|NOT COMPLETED|Overall Study||42
9757138|NCT00364533|10860675|FG001|NOT COMPLETED|Overall Study||40
9757139|NCT00364533|10860676|FG002|NOT COMPLETED|Overall Study||45
9757140|NCT00364533|10860677|FG003|NOT COMPLETED|Overall Study||31
9757141|NCT00364533|10860678|FG004|NOT COMPLETED|Overall Study||51
9757142|NCT00364611|10860692|FG000|STARTED|Overall Study||52
9757143|NCT00364611|10860693|FG001|STARTED|Overall Study||21
9757144|NCT00364611|10860692|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
9757145|NCT00364611|10860693|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
9757146|NCT00364611|10860692|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
9757147|NCT00364611|10860693|FG001|COMPLETED|Overall Study||0
9757148|NCT00364611|10860692|FG000|NOT COMPLETED|Overall Study||51
9757149|NCT00364611|10860693|FG001|NOT COMPLETED|Overall Study||21
9757150|NCT00364793|10860703|FG000|STARTED|Overall Study||15
9757151|NCT00364793|10860704|FG001|STARTED|Overall Study||10
9757152|NCT00364793|10860705|FG002|STARTED|Overall Study||4
9757153|NCT00364793|10860706|FG003|STARTED|Overall Study||8
9757154|NCT00364793|10860703|FG000|COMPLETED|Overall Study||7
9757155|NCT00364793|10860704|FG001|COMPLETED|Overall Study||5
9757156|NCT00364793|10860705|FG002|COMPLETED|Overall Study||0
9757157|NCT00364793|10860706|FG003|COMPLETED|Overall Study||5
9757158|NCT00364793|10860703|FG000|NOT COMPLETED|Overall Study||8
9757159|NCT00364793|10860704|FG001|NOT COMPLETED|Overall Study||5
9757160|NCT00364793|10860705|FG002|NOT COMPLETED|Overall Study||4
9757161|NCT00364793|10860706|FG003|NOT COMPLETED|Overall Study||3
9757162|NCT00364819|10860719|FG000|STARTED|Overall Study||6
9757163|NCT00364819|10860719|FG000|COMPLETED|Overall Study||6
9757164|NCT00364819|10860719|FG000|NOT COMPLETED|Overall Study||0
9757165|NCT00364832|10860732|FG000|STARTED|Core Period||16
9757166|NCT00364832|10860733|FG001|STARTED|Core Period||15
9757167|NCT00364832|10860734|FG002|STARTED|Core Period||15
9757168|NCT00364832|10860735|FG003|STARTED|Core Period||16
9757169|NCT00364832|10860736|FG004|STARTED|Core Period||16
9757170|NCT00364832|10860737|FG005|STARTED|Core Period||12
9757171|NCT00364832|10860738|FG006|STARTED|Core Period||16
9757172|NCT00364832|10860739|FG007|STARTED|Core Period||15
9757173|NCT00364832|10860740|FG008|STARTED|Core Period||16
9757174|NCT00364832|10860741|FG009|STARTED|Core Period||0
9757175|NCT00364832|10860742|FG010|STARTED|Core Period||0
9757176|NCT00364832|10860743|FG011|STARTED|Core Period||0
9757177|NCT00364832|10860732|FG000|COMPLETED|Core Period||14
9757178|NCT00364832|10860733|FG001|COMPLETED|Core Period||13
9757179|NCT00364832|10860734|FG002|COMPLETED|Core Period||14
9757180|NCT00364832|10860735|FG003|COMPLETED|Core Period||15
9757181|NCT00364832|10860736|FG004|COMPLETED|Core Period||16
9757182|NCT00364832|10860737|FG005|COMPLETED|Core Period||12
9757183|NCT00364832|10860738|FG006|COMPLETED|Core Period||12
9757184|NCT00364832|10860739|FG007|COMPLETED|Core Period||14
9757185|NCT00364832|10860740|FG008|COMPLETED|Core Period||16
9757186|NCT00364832|10860741|FG009|COMPLETED|Core Period||0
9757187|NCT00364832|10860742|FG010|COMPLETED|Core Period||0
9757188|NCT00364832|10860743|FG011|COMPLETED|Core Period||0
9757189|NCT00364832|10860732|FG000|NOT COMPLETED|Core Period||2
9757190|NCT00364832|10860733|FG001|NOT COMPLETED|Core Period||2
9757191|NCT00364832|10860734|FG002|NOT COMPLETED|Core Period||1
9757192|NCT00364832|10860735|FG003|NOT COMPLETED|Core Period||1
9757193|NCT00364832|10860736|FG004|NOT COMPLETED|Core Period||0
9757194|NCT00364832|10860737|FG005|NOT COMPLETED|Core Period||0
9757195|NCT00364832|10860738|FG006|NOT COMPLETED|Core Period||4
9757196|NCT00364832|10860739|FG007|NOT COMPLETED|Core Period||1
9757197|NCT00364832|10860740|FG008|NOT COMPLETED|Core Period||0
9757198|NCT00364832|10860741|FG009|NOT COMPLETED|Core Period||0
9757199|NCT00364832|10860742|FG010|NOT COMPLETED|Core Period||0
9757200|NCT00364832|10860743|FG011|NOT COMPLETED|Core Period||0
9854447|NCT00893763|10967492|FG001|COMPLETED|Overall Study||47
9854448|NCT00893763|10967491|FG000|NOT COMPLETED|Overall Study||110
9854449|NCT00893763|10967492|FG001|NOT COMPLETED|Overall Study||110
9854450|NCT00893971|10967500|FG000|STARTED|Overall Study||16
9854451|NCT00893971|10967500|FG000|Placebo + GP MDI (PT001)|Overall Study||15
9854452|NCT00893971|10967500|FG000|Placebo + GFF MDI (PT003)|Overall Study||15
9854453|NCT00893971|10967500|FG000|Placebo + FF MDI (PT005)|Overall Study||13
9757201|NCT00364832|10860732|FG000|STARTED|Extension Year 1||0
9757202|NCT00364832|10860733|FG001|STARTED|Extension Year 1||0
9757203|NCT00364832|10860734|FG002|STARTED|Extension Year 1||0
9757204|NCT00364832|10860735|FG003|STARTED|Extension Year 1||0
9757205|NCT00364832|10860736|FG004|STARTED|Extension Year 1||0
9757206|NCT00364832|10860737|FG005|STARTED|Extension Year 1||0
9757207|NCT00364832|10860738|FG006|STARTED|Extension Year 1||0
9757208|NCT00364832|10860739|FG007|STARTED|Extension Year 1||0
9757209|NCT00364832|10860740|FG008|STARTED|Extension Year 1||0
9832517|NCT00773422|10943283|FG000|COMPLETED|Overall Study||11
9832518|NCT00773422|10943284|FG001|COMPLETED|Overall Study||9
9832519|NCT00773422|10943285|FG002|COMPLETED|Overall Study||10
9832520|NCT00773422|10943283|FG000|NOT COMPLETED|Overall Study||0
9832521|NCT00773422|10943284|FG001|NOT COMPLETED|Overall Study||0
9832522|NCT00773422|10943285|FG002|NOT COMPLETED|Overall Study||0
9757210|NCT00364832|10860741|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
9757211|NCT00364832|10860742|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
9757212|NCT00364832|10860743|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
9757213|NCT00364832|10860732|FG000|COMPLETED|Extension Year 1||0
9757214|NCT00364832|10860733|FG001|COMPLETED|Extension Year 1||0
9757215|NCT00364832|10860734|FG002|COMPLETED|Extension Year 1||0
9757216|NCT00364832|10860735|FG003|COMPLETED|Extension Year 1||0
9757217|NCT00364832|10860736|FG004|COMPLETED|Extension Year 1||0
9757218|NCT00364832|10860737|FG005|COMPLETED|Extension Year 1||0
9757219|NCT00364832|10860738|FG006|COMPLETED|Extension Year 1||0
9757220|NCT00364832|10860739|FG007|COMPLETED|Extension Year 1||0
9757221|NCT00364832|10860740|FG008|COMPLETED|Extension Year 1||0
9757222|NCT00364832|10860741|FG009|COMPLETED|Extension Year 1||14
9757223|NCT00364832|10860742|FG010|COMPLETED|Extension Year 1||15
9854454|NCT00893971|10967500|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
9854455|NCT00893971|10967500|FG000|COMPLETED|Overall Study||13
9854456|NCT00893971|10967500|FG000|NOT COMPLETED|Overall Study||3
9854457|NCT00893984|10967513|FG000|STARTED|Overall Study||6
9854458|NCT00893984|10967513|FG000|COMPLETED|Overall Study||0
9854459|NCT00893984|10967513|FG000|NOT COMPLETED|Overall Study||6
9854460|NCT00893997|10967517|FG000|STARTED|Overall Study||10
9854461|NCT00893997|10967517|FG000|COMPLETED|Overall Study||10
9854462|NCT00893997|10967517|FG000|NOT COMPLETED|Overall Study||0
9854463|NCT00894127|10967521|FG000|STARTED|Overall Study||128
9757224|NCT00364832|10860743|FG011|COMPLETED|Extension Year 1||17
9757225|NCT00364832|10860732|FG000|NOT COMPLETED|Extension Year 1||0
9757226|NCT00364832|10860733|FG001|NOT COMPLETED|Extension Year 1||0
9757227|NCT00364832|10860734|FG002|NOT COMPLETED|Extension Year 1||0
9757228|NCT00364832|10860735|FG003|NOT COMPLETED|Extension Year 1||0
9757229|NCT00364832|10860736|FG004|NOT COMPLETED|Extension Year 1||0
9757230|NCT00364832|10860737|FG005|NOT COMPLETED|Extension Year 1||0
9757231|NCT00364832|10860738|FG006|NOT COMPLETED|Extension Year 1||0
9757232|NCT00364832|10860739|FG007|NOT COMPLETED|Extension Year 1||0
9757233|NCT00364832|10860740|FG008|NOT COMPLETED|Extension Year 1||0
9757234|NCT00364832|10860741|FG009|NOT COMPLETED|Extension Year 1||4
9757235|NCT00364832|10860742|FG010|NOT COMPLETED|Extension Year 1||2
9757236|NCT00364832|10860743|FG011|NOT COMPLETED|Extension Year 1||10
9757237|NCT00364832|10860732|FG000|STARTED|Extension Year 2||0
9757238|NCT00364832|10860733|FG001|STARTED|Extension Year 2||0
9757239|NCT00364832|10860734|FG002|STARTED|Extension Year 2||0
9757240|NCT00364832|10860735|FG003|STARTED|Extension Year 2||0
9757241|NCT00364832|10860736|FG004|STARTED|Extension Year 2||0
9757242|NCT00364832|10860737|FG005|STARTED|Extension Year 2||0
9757243|NCT00364832|10860738|FG006|STARTED|Extension Year 2||0
9757244|NCT00364832|10860739|FG007|STARTED|Extension Year 2||0
9757245|NCT00364832|10860740|FG008|STARTED|Extension Year 2||0
9757246|NCT00364832|10860741|FG009|STARTED|Extension Year 2||14
9757247|NCT00364832|10860742|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
9757248|NCT00364832|10860743|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
9757249|NCT00364832|10860732|FG000|COMPLETED|Extension Year 2||0
9757250|NCT00364832|10860733|FG001|COMPLETED|Extension Year 2||0
9757251|NCT00364832|10860734|FG002|COMPLETED|Extension Year 2||0
9757252|NCT00364832|10860735|FG003|COMPLETED|Extension Year 2||0
9757253|NCT00364832|10860736|FG004|COMPLETED|Extension Year 2||0
9757254|NCT00364832|10860737|FG005|COMPLETED|Extension Year 2||0
9757255|NCT00364832|10860738|FG006|COMPLETED|Extension Year 2||0
9757256|NCT00364832|10860739|FG007|COMPLETED|Extension Year 2||0
9757257|NCT00364832|10860740|FG008|COMPLETED|Extension Year 2||0
9757258|NCT00364832|10860741|FG009|COMPLETED|Extension Year 2||9
9757259|NCT00364832|10860742|FG010|COMPLETED|Extension Year 2||9
9757260|NCT00364832|10860743|FG011|COMPLETED|Extension Year 2||11
9757261|NCT00364832|10860732|FG000|NOT COMPLETED|Extension Year 2||0
9757262|NCT00364832|10860733|FG001|NOT COMPLETED|Extension Year 2||0
9757263|NCT00364832|10860734|FG002|NOT COMPLETED|Extension Year 2||0
9757264|NCT00364832|10860735|FG003|NOT COMPLETED|Extension Year 2||0
9757265|NCT00364832|10860736|FG004|NOT COMPLETED|Extension Year 2||0
9757266|NCT00364832|10860737|FG005|NOT COMPLETED|Extension Year 2||0
9757267|NCT00364832|10860738|FG006|NOT COMPLETED|Extension Year 2||0
9757268|NCT00364832|10860739|FG007|NOT COMPLETED|Extension Year 2||0
9757269|NCT00364832|10860740|FG008|NOT COMPLETED|Extension Year 2||0
9757270|NCT00364832|10860741|FG009|NOT COMPLETED|Extension Year 2||5
9757271|NCT00364832|10860742|FG010|NOT COMPLETED|Extension Year 2||5
9757272|NCT00364832|10860743|FG011|NOT COMPLETED|Extension Year 2||3
9757273|NCT00364845|10860762|FG000|STARTED|Overall Study||28
9757274|NCT00364845|10860763|FG001|STARTED|Overall Study||23
9757275|NCT00364845|10860762|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
9757276|NCT00364845|10860763|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
9757277|NCT00364845|10860762|FG000|NOT COMPLETED|Overall Study||11
9757278|NCT00364845|10860763|FG001|NOT COMPLETED|Overall Study||11
9757279|NCT00364858|10860771|FG000|STARTED|Overall Study||33
9757280|NCT00364858|10860772|FG001|STARTED|Overall Study||62
9757281|NCT00364858|10860771|FG000|COMPLETED|Overall Study||26
9757282|NCT00364858|10860772|FG001|COMPLETED|Overall Study||40
9757283|NCT00364858|10860771|FG000|NOT COMPLETED|Overall Study||7
9757284|NCT00364858|10860772|FG001|NOT COMPLETED|Overall Study||22
9757285|NCT00364923|10860779|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
9757286|NCT00364923|10860779|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
9757287|NCT00364923|10860779|FG000|NOT COMPLETED|Treatment With Pralatrexate||4
9757288|NCT00364923|10860779|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
9757289|NCT00364923|10860779|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
9757290|NCT00364923|10860779|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
9757291|NCT00364949|10860785|FG000|STARTED|Overall Study||31
9757292|NCT00364949|10860786|FG001|STARTED|Overall Study||39
9757293|NCT00364949|10860785|FG000|COMPLETED|Overall Study||31
9757294|NCT00364949|10860786|FG001|COMPLETED|Overall Study||39
9757295|NCT00364949|10860785|FG000|NOT COMPLETED|Overall Study||0
9757296|NCT00364949|10860786|FG001|NOT COMPLETED|Overall Study||0
9854464|NCT00894127|10967521|FG000|COMPLETED|Overall Study||128
9854465|NCT00894127|10967521|FG000|NOT COMPLETED|Overall Study||0
9854466|NCT00894166|10967533|FG000|STARTED|Overall Study||132
9757297|NCT00365053|10860792|FG000|STARTED|Overall Study||13
9757298|NCT00365053|10860792|FG000|COMPLETED|Overall Study||13
9757299|NCT00365053|10860792|FG000|NOT COMPLETED|Overall Study||0
9757300|NCT00365105|10860798|FG000|STARTED|Overall Study||129
9757301|NCT00365105|10860799|FG001|STARTED|Overall Study||132
9757302|NCT00365105|10860798|FG000|Eligible|Overall Study||124
9757303|NCT00365105|10860799|FG001|Eligible|Overall Study||124
9757304|NCT00365105|10860798|FG000|Eligible With Adverse Event Data|Overall Study||123
9757305|NCT00365105|10860799|FG001|Eligible With Adverse Event Data|Overall Study||124
9757306|NCT00365105|10860798|FG000|COMPLETED|Overall Study||124
9757307|NCT00365105|10860799|FG001|COMPLETED|Overall Study||124
9757308|NCT00365105|10860798|FG000|NOT COMPLETED|Overall Study||5
9757309|NCT00365105|10860799|FG001|NOT COMPLETED|Overall Study||8
9757310|NCT00365144|10860805|FG000|STARTED|Overall Study||36
9757311|NCT00365144|10860805|FG000|COMPLETED|Overall Study||36
9757312|NCT00365144|10860805|FG000|NOT COMPLETED|Overall Study||0
9757313|NCT00365209|10860810|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23
9757314|NCT00365209|10860810|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21
9757315|NCT00365209|10860810|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
9757316|NCT00365209|10860810|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21
9757317|NCT00365209|10860810|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19
9757318|NCT00365209|10860810|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
9757319|NCT00365261|10860817|FG000|STARTED|Overall Study||23
9757320|NCT00365261|10860818|FG001|STARTED|Overall Study||22
9757321|NCT00365261|10860817|FG000|COMPLETED|Overall Study||20
9757322|NCT00365261|10860818|FG001|COMPLETED|Overall Study||19
9757323|NCT00365261|10860817|FG000|NOT COMPLETED|Overall Study||3
9757324|NCT00365261|10860818|FG001|NOT COMPLETED|Overall Study||3
9757325|NCT00365274|10860826|FG000|STARTED|Overall Study||6
9757326|NCT00365274|10860826|FG000|COMPLETED|Overall Study||6
9757327|NCT00365274|10860826|FG000|NOT COMPLETED|Overall Study||0
9757328|NCT00365300|10860832|FG000|STARTED|Open-label Phase||129
9757329|NCT00365300|10860833|FG001|STARTED|Open-label Phase||0
9757330|NCT00365300|10860832|FG000|COMPLETED|Open-label Phase||107
9757331|NCT00365300|10860833|FG001|COMPLETED|Open-label Phase||0
9757332|NCT00365300|10860832|FG000|NOT COMPLETED|Open-label Phase||22
9757333|NCT00365300|10860833|FG001|NOT COMPLETED|Open-label Phase||0
9757334|NCT00365300|10860832|FG000|STARTED|Double-blind Phase||54
9757335|NCT00365300|10860833|FG001|STARTED|Double-blind Phase||54
9757336|NCT00365300|10860832|FG000|COMPLETED|Double-blind Phase||43
9757337|NCT00365300|10860833|FG001|COMPLETED|Double-blind Phase||45
9757338|NCT00365300|10860832|FG000|NOT COMPLETED|Double-blind Phase||11
9757339|NCT00365300|10860833|FG001|NOT COMPLETED|Double-blind Phase||9
9757340|NCT00365352|10860845|FG000|STARTED|Overall Study||97
9757341|NCT00365352|10860846|FG001|STARTED|Overall Study||115
9757342|NCT00365352|10860847|FG002|STARTED|Overall Study||113
9757343|NCT00365352|10860845|FG000|Safety Population|Overall Study||96
9757344|NCT00365352|10860846|FG001|Safety Population|Overall Study||115
9757345|NCT00365352|10860847|FG002|Safety Population|Overall Study||111
9757346|NCT00365352|10860845|FG000|Modified Intent-to-Treat Population|Overall Study||96
9757347|NCT00365352|10860846|FG001|Modified Intent-to-Treat Population|Overall Study||114
9757348|NCT00365352|10860847|FG002|Modified Intent-to-Treat Population|Overall Study||111
9854467|NCT00894166|10967534|FG001|STARTED|Overall Study||109
9757349|NCT00365352|10860845|FG000|COMPLETED|Overall Study||77
9757350|NCT00365352|10860846|FG001|COMPLETED|Overall Study||104
9757351|NCT00365352|10860847|FG002|COMPLETED|Overall Study||98
9757352|NCT00365352|10860845|FG000|NOT COMPLETED|Overall Study||20
9757353|NCT00365352|10860846|FG001|NOT COMPLETED|Overall Study||11
9757354|NCT00365352|10860847|FG002|NOT COMPLETED|Overall Study||15
9757355|NCT00365365|10860861|FG000|STARTED|Overall Study||78
9757356|NCT00365365|10860862|FG001|STARTED|Overall Study||77
9757357|NCT00365365|10860863|FG002|STARTED|Overall Study||59
9757358|NCT00365365|10860861|FG000|TREATED (SAFETY POPULATION)|Overall Study||78
9757359|NCT00365365|10860862|FG001|TREATED (SAFETY POPULATION)|Overall Study||75
9757360|NCT00365365|10860863|FG002|TREATED (SAFETY POPULATION)|Overall Study||59
9757361|NCT00365365|10860861|FG000|COMPLETED TREATMENT|Overall Study||38
9757362|NCT00365365|10860862|FG001|COMPLETED TREATMENT|Overall Study||36
9757363|NCT00365365|10860863|FG002|COMPLETED TREATMENT|Overall Study||45
9757364|NCT00365365|10860861|FG000|COMPLETED|Overall Study||44
9757365|NCT00365365|10860862|FG001|COMPLETED|Overall Study||41
9757366|NCT00365365|10860863|FG002|COMPLETED|Overall Study||44
9757367|NCT00365365|10860861|FG000|NOT COMPLETED|Overall Study||34
9757368|NCT00365365|10860862|FG001|NOT COMPLETED|Overall Study||36
9757369|NCT00365365|10860863|FG002|NOT COMPLETED|Overall Study||15
9757370|NCT00365378|10860873|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204
9757371|NCT00365378|10860874|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205
9757372|NCT00365378|10860875|FG002|STARTED|Vaccination (Day 1 to Month 7)||0
9757373|NCT00365378|10860873|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
9757374|NCT00365378|10860874|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
9757375|NCT00365378|10860875|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
9757376|NCT00365378|10860873|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993
9757377|NCT00365378|10860874|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038
9757378|NCT00365378|10860875|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0
9757379|NCT00365378|10860873|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
9757380|NCT00365378|10860874|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
9757381|NCT00365378|10860875|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
9757382|NCT00365378|10860873|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993
9757383|NCT00365378|10860874|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038
9757384|NCT00365378|10860875|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0
9757385|NCT00365378|10860873|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835
9757386|NCT00365378|10860874|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836
9757387|NCT00365378|10860875|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0
9757388|NCT00365378|10860873|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
9757389|NCT00365378|10860874|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
9757390|NCT00365378|10860875|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
9757391|NCT00365378|10860873|FG000|STARTED|Extension||0
9757392|NCT00365378|10860874|FG001|STARTED|Extension||0
9757393|NCT00365378|10860875|FG002|STARTED|Extension||400
9757394|NCT00365378|10860873|FG000|COMPLETED|Extension||0
9757395|NCT00365378|10860874|FG001|COMPLETED|Extension||0
9757396|NCT00365378|10860875|FG002|COMPLETED|Extension||203
9757397|NCT00365378|10860873|FG000|NOT COMPLETED|Extension||0
9757398|NCT00365378|10860874|FG001|NOT COMPLETED|Extension||0
9757399|NCT00365378|10860875|FG002|NOT COMPLETED|Extension||197
9757400|NCT00365391|10860882|FG000|STARTED|Overall Study||27
9757401|NCT00365391|10860882|FG000|COMPLETED|Overall Study||27
9757402|NCT00365391|10860882|FG000|NOT COMPLETED|Overall Study||0
9757403|NCT00365417|10860886|FG000|STARTED|Overall Study||45
9757404|NCT00365417|10860886|FG000|COMPLETED|Overall Study||45
9757405|NCT00365417|10860886|FG000|NOT COMPLETED|Overall Study||0
10201776|NCT03441178|11329184|FG002|COMPLETED|Overall Study||20
10201777|NCT03441178|11329182|FG000|NOT COMPLETED|Overall Study||0
10201778|NCT03441178|11329183|FG001|NOT COMPLETED|Overall Study||1
9757406|NCT00365456|10860891|FG000|STARTED|Trial Period I (12 Months)||407
9757407|NCT00365456|10860892|FG001|STARTED|Trial Period I (12 Months)||0
9757408|NCT00365456|10860891|FG000|COMPLETED|Trial Period I (12 Months)||282
9757409|NCT00365456|10860892|FG001|COMPLETED|Trial Period I (12 Months)||0
9757410|NCT00365456|10860891|FG000|NOT COMPLETED|Trial Period I (12 Months)||125
9757411|NCT00365456|10860892|FG001|NOT COMPLETED|Trial Period I (12 Months)||0
9757412|NCT00365456|10860891|FG000|STARTED|Trial Period II (12 Months)||0
9757413|NCT00365456|10860892|FG001|STARTED|Trial Period II (12 Months)||282
9757414|NCT00365456|10860891|FG000|COMPLETED|Trial Period II (12 Months)||0
9757415|NCT00365456|10860892|FG001|COMPLETED|Trial Period II (12 Months)||268
9757416|NCT00365456|10860891|FG000|NOT COMPLETED|Trial Period II (12 Months)||0
9757417|NCT00365456|10860892|FG001|NOT COMPLETED|Trial Period II (12 Months)||14
9757418|NCT00365456|10860891|FG000|STARTED|Trial Period III (12 Months)||136
9757419|NCT00365456|10860892|FG001|STARTED|Trial Period III (12 Months)||132
10201779|NCT03441178|11329184|FG002|NOT COMPLETED|Overall Study||1
10201780|NCT03441269|11329197|FG000|STARTED|Overall Study||75
9757420|NCT00365456|10860891|FG000|COMPLETED|Trial Period III (12 Months)||118
9757421|NCT00365456|10860892|FG001|COMPLETED|Trial Period III (12 Months)||127
9757422|NCT00365456|10860891|FG000|NOT COMPLETED|Trial Period III (12 Months)||18
9757423|NCT00365456|10860892|FG001|NOT COMPLETED|Trial Period III (12 Months)||5
9757424|NCT00365508|10860900|FG000|STARTED|Overall Study||321
9757425|NCT00365508|10860901|FG001|STARTED|Overall Study||321
9757426|NCT00365508|10860900|FG000|COMPLETED|Overall Study||182
9757427|NCT00365508|10860901|FG001|COMPLETED|Overall Study||167
9757428|NCT00365508|10860900|FG000|NOT COMPLETED|Overall Study||139
9757429|NCT00365508|10860901|FG001|NOT COMPLETED|Overall Study||154
9757430|NCT00365547|10860907|FG000|STARTED|Overall Study||46
9757431|NCT00365547|10860907|FG000|COMPLETED|Overall Study||43
9757432|NCT00365547|10860907|FG000|NOT COMPLETED|Overall Study||3
9757433|NCT00365599|10860914|FG000|STARTED|Overall Study||43
9757434|NCT00365599|10860914|FG000|COMPLETED|Overall Study||43
9757435|NCT00365599|10860914|FG000|NOT COMPLETED|Overall Study||0
9757436|NCT00365716|10860923|FG000|STARTED|Base Study (Day 1 to Month 7)||290
9757437|NCT00365716|10860924|FG001|STARTED|Base Study (Day 1 to Month 7)||284
9757438|NCT00365716|10860925|FG002|STARTED|Base Study (Day 1 to Month 7)||292
9757439|NCT00365716|10860926|FG003|STARTED|Base Study (Day 1 to Month 7)||146
9757440|NCT00365716|10860927|FG004|STARTED|Base Study (Day 1 to Month 7)||146
9757441|NCT00365716|10860928|FG005|STARTED|Base Study (Day 1 to Month 7)||0
9757442|NCT00365716|10860929|FG006|STARTED|Base Study (Day 1 to Month 7)||0
9757443|NCT00365716|10860923|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269
10201781|NCT03441269|11329198|FG001|STARTED|Overall Study||75
9757444|NCT00365716|10860924|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260
9757445|NCT00365716|10860925|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271
9757446|NCT00365716|10860926|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136
9757447|NCT00365716|10860927|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139
9757448|NCT00365716|10860928|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0
9757449|NCT00365716|10860929|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0
9757450|NCT00365716|10860923|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
9757451|NCT00365716|10860924|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
9757452|NCT00365716|10860925|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
9757453|NCT00365716|10860926|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
9757454|NCT00365716|10860927|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
9757455|NCT00365716|10860928|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
9757456|NCT00365716|10860929|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
9757457|NCT00365716|10860923|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
9757458|NCT00365716|10860924|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
9757459|NCT00365716|10860925|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
9757460|NCT00365716|10860926|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
9757461|NCT00365716|10860927|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
9757462|NCT00365716|10860928|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
9757463|NCT00365716|10860929|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
9757464|NCT00365716|10860923|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
9757465|NCT00365716|10860924|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
9757466|NCT00365716|10860925|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
9757467|NCT00365716|10860926|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
9757468|NCT00365716|10860927|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
9757469|NCT00365716|10860928|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
9757470|NCT00365716|10860929|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
9757471|NCT00365716|10860923|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
9757472|NCT00365716|10860924|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
9757473|NCT00365716|10860925|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
9757474|NCT00365716|10860926|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
9757475|NCT00365716|10860927|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
9757476|NCT00365716|10860928|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
9757477|NCT00365716|10860929|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
9757478|NCT00365716|10860923|FG000|STARTED|Extension 1||0
9757479|NCT00365716|10860924|FG001|STARTED|Extension 1||0
9757480|NCT00365716|10860925|FG002|STARTED|Extension 1||0
9757481|NCT00365716|10860926|FG003|STARTED|Extension 1||0
9757482|NCT00365716|10860927|FG004|STARTED|Extension 1||0
9757483|NCT00365716|10860928|FG005|STARTED|Extension 1||241
9757484|NCT00365716|10860929|FG006|STARTED|Extension 1||0
9757485|NCT00365716|10860923|FG000|COMPLETED|Extension 1||0
9757486|NCT00365716|10860924|FG001|COMPLETED|Extension 1||0
9757487|NCT00365716|10860925|FG002|COMPLETED|Extension 1||0
9757488|NCT00365716|10860926|FG003|COMPLETED|Extension 1||0
9757489|NCT00365716|10860927|FG004|COMPLETED|Extension 1||0
9757490|NCT00365716|10860928|FG005|COMPLETED|Extension 1||219
9757491|NCT00365716|10860929|FG006|COMPLETED|Extension 1||0
9757492|NCT00365716|10860923|FG000|NOT COMPLETED|Extension 1||0
9757493|NCT00365716|10860924|FG001|NOT COMPLETED|Extension 1||0
9757494|NCT00365716|10860925|FG002|NOT COMPLETED|Extension 1||0
9757495|NCT00365716|10860926|FG003|NOT COMPLETED|Extension 1||0
9757496|NCT00365716|10860927|FG004|NOT COMPLETED|Extension 1||0
9757497|NCT00365716|10860928|FG005|NOT COMPLETED|Extension 1||22
9757498|NCT00365716|10860929|FG006|NOT COMPLETED|Extension 1||0
9757499|NCT00365716|10860923|FG000|STARTED|Extension 2||0
9757500|NCT00365716|10860924|FG001|STARTED|Extension 2||0
9757501|NCT00365716|10860925|FG002|STARTED|Extension 2||0
9757502|NCT00365716|10860926|FG003|STARTED|Extension 2||0
9757503|NCT00365716|10860927|FG004|STARTED|Extension 2||0
9757504|NCT00365716|10860928|FG005|STARTED|Extension 2||0
9757505|NCT00365716|10860929|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
9757506|NCT00365716|10860923|FG000|COMPLETED|Extension 2||0
9757507|NCT00365716|10860924|FG001|COMPLETED|Extension 2||0
9757508|NCT00365716|10860925|FG002|COMPLETED|Extension 2||0
9757509|NCT00365716|10860926|FG003|COMPLETED|Extension 2||0
9757510|NCT00365716|10860927|FG004|COMPLETED|Extension 2||0
9757511|NCT00365716|10860928|FG005|COMPLETED|Extension 2||0
9757512|NCT00365716|10860929|FG006|COMPLETED|Extension 2||7
9757513|NCT00365716|10860923|FG000|NOT COMPLETED|Extension 2||0
9757514|NCT00365716|10860924|FG001|NOT COMPLETED|Extension 2||0
9757515|NCT00365716|10860925|FG002|NOT COMPLETED|Extension 2||0
9757516|NCT00365716|10860926|FG003|NOT COMPLETED|Extension 2||0
9757517|NCT00365716|10860927|FG004|NOT COMPLETED|Extension 2||0
9757518|NCT00365716|10860928|FG005|NOT COMPLETED|Extension 2||0
9757519|NCT00365716|10860929|FG006|NOT COMPLETED|Extension 2||10
9757520|NCT00365768|10860945|FG000|STARTED|Overall Study||24
9757521|NCT00365768|10860946|FG001|STARTED|Overall Study||25
9757522|NCT00365768|10860945|FG000|COMPLETED|Overall Study||24
9757523|NCT00365768|10860946|FG001|COMPLETED|Overall Study||25
9757524|NCT00365768|10860945|FG000|NOT COMPLETED|Overall Study||0
9757525|NCT00365768|10860946|FG001|NOT COMPLETED|Overall Study||0
9757526|NCT00365794|10860952|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
9757527|NCT00365794|10860952|FG000|COMPLETED|Overall Study||20
9757528|NCT00365794|10860952|FG000|NOT COMPLETED|Overall Study||2
9757529|NCT00365846|10860957|FG000|STARTED|Overall Study||29
9757530|NCT00365846|10860957|FG000|COMPLETED|Overall Study||28
9757531|NCT00365846|10860957|FG000|NOT COMPLETED|Overall Study||1
9757532|NCT00365859|10860966|FG000|STARTED|Overall Study||86
9757533|NCT00365859|10860967|FG001|STARTED|Overall Study||70
9757534|NCT00365859|10860968|FG002|STARTED|Overall Study||174
9757535|NCT00365859|10860969|FG003|STARTED|Overall Study||330
9757536|NCT00365859|10860966|FG000|Safety Population|Overall Study||86
9757537|NCT00365859|10860967|FG001|Safety Population|Overall Study||70
9757538|NCT00365859|10860968|FG002|Safety Population|Overall Study||174
9757539|NCT00365859|10860969|FG003|Safety Population|Overall Study||330
9757540|NCT00365859|10860966|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
9757541|NCT00365859|10860967|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
9757542|NCT00365859|10860968|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
9757543|NCT00365859|10860969|FG003|Efficacy Population|Overall Study||322
9757544|NCT00365859|10860966|FG000|COMPLETED|Overall Study||55
9757545|NCT00365859|10860967|FG001|COMPLETED|Overall Study||37
9757546|NCT00365859|10860968|FG002|COMPLETED|Overall Study||107
9757547|NCT00365859|10860969|FG003|COMPLETED|Overall Study||199
9757548|NCT00365859|10860966|FG000|NOT COMPLETED|Overall Study||31
10092474|NCT02337491|11220934|FG001|COMPLETED|Overall Study||0
10092475|NCT02337491|11220933|FG000|NOT COMPLETED|Overall Study||50
10092476|NCT02337491|11220934|FG001|NOT COMPLETED|Overall Study||30
10092477|NCT02337517|11220941|FG000|STARTED|Overall Study||6
10092478|NCT02337517|11220941|FG000|COMPLETED|Overall Study||6
10092479|NCT02337517|11220941|FG000|NOT COMPLETED|Overall Study||0
10092480|NCT02337530|11220948|FG000|STARTED|Overall Study||20
10092481|NCT02337530|11220949|FG001|STARTED|Overall Study||21
10092482|NCT02337530|11220950|FG002|STARTED|Overall Study||21
10092483|NCT02337530|11220948|FG000|COMPLETED|Overall Study||20
10092484|NCT02337530|11220949|FG001|COMPLETED|Overall Study||21
10092485|NCT02337530|11220950|FG002|COMPLETED|Overall Study||21
10092486|NCT02337530|11220948|FG000|NOT COMPLETED|Overall Study||0
10092487|NCT02337530|11220949|FG001|NOT COMPLETED|Overall Study||0
9757549|NCT00365859|10860967|FG001|NOT COMPLETED|Overall Study||33
9757550|NCT00365859|10860968|FG002|NOT COMPLETED|Overall Study||67
9757551|NCT00365859|10860969|FG003|NOT COMPLETED|Overall Study||131
9757552|NCT00365872|10860981|FG000|STARTED|Overall Study||5
9757553|NCT00365872|10860982|FG001|STARTED|Overall Study||6
9757554|NCT00365872|10860983|FG002|STARTED|Overall Study||6
9757555|NCT00365872|10860981|FG000|COMPLETED|Overall Study||5
9757556|NCT00365872|10860982|FG001|COMPLETED|Overall Study||6
9757557|NCT00365872|10860983|FG002|COMPLETED|Overall Study||6
9757558|NCT00365872|10860981|FG000|NOT COMPLETED|Overall Study||0
9757559|NCT00365872|10860982|FG001|NOT COMPLETED|Overall Study||0
9757560|NCT00365872|10860983|FG002|NOT COMPLETED|Overall Study||0
9757561|NCT00365976|10860992|FG000|STARTED|Overall Study||33
9757562|NCT00365976|10860993|FG001|STARTED|Overall Study||25
9757563|NCT00365976|10860992|FG000|COMPLETED|Overall Study||32
9757564|NCT00365976|10860993|FG001|COMPLETED|Overall Study||20
10092488|NCT02337530|11220950|FG002|NOT COMPLETED|Overall Study||0
10092489|NCT02337907|11220964|FG000|STARTED|Overall Study||55
10092490|NCT02337907|11220965|FG001|STARTED|Overall Study||53
10092491|NCT02337907|11220966|FG002|STARTED|Overall Study||55
10092492|NCT02337907|11220967|FG003|STARTED|Overall Study||55
10092493|NCT02337907|11220968|FG004|STARTED|Overall Study||106
9757565|NCT00365976|10860992|FG000|NOT COMPLETED|Overall Study||1
9757566|NCT00365976|10860993|FG001|NOT COMPLETED|Overall Study||5
9757567|NCT00365989|10860999|FG000|STARTED|Overall Study||50
9757568|NCT00365989|10860999|FG000|COMPLETED|Overall Study||48
9757569|NCT00365989|10860999|FG000|NOT COMPLETED|Overall Study||2
9829096|NCT00758524|10939645|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
9829097|NCT00758524|10939646|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
9829098|NCT00758524|10939647|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
9829099|NCT00758524|10939648|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
9829100|NCT00758524|10939649|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
10092494|NCT02337907|11220969|FG005|STARTED|Overall Study||5
10092495|NCT02337907|11220964|FG000|COMPLETED|Overall Study||51
10092496|NCT02337907|11220965|FG001|COMPLETED|Overall Study||49
9829101|NCT00758524|10939650|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
9829102|NCT00758524|10939651|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
9829103|NCT00758524|10939652|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
9829104|NCT00758524|10939636|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829105|NCT00758524|10939637|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829106|NCT00758524|10939638|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829107|NCT00758524|10939639|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829108|NCT00758524|10939640|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10092497|NCT02337907|11220966|FG002|COMPLETED|Overall Study||54
10092498|NCT02337907|11220967|FG003|COMPLETED|Overall Study||51
10092499|NCT02337907|11220968|FG004|COMPLETED|Overall Study||96
10092500|NCT02337907|11220969|FG005|COMPLETED|Overall Study||4
9757570|NCT00366028|10861006|FG000|STARTED|Overall Study||889
9757571|NCT00366028|10861007|FG001|STARTED|Overall Study||735
9757572|NCT00366028|10861006|FG000|COMPLETED|Overall Study||889
9757573|NCT00366028|10861007|FG001|COMPLETED|Overall Study||735
9757574|NCT00366028|10861006|FG000|NOT COMPLETED|Overall Study||0
9757575|NCT00366028|10861007|FG001|NOT COMPLETED|Overall Study||0
9757576|NCT00366106|10861015|FG000|STARTED|Overall Study||32
9757577|NCT00366106|10861015|FG000|COMPLETED|Overall Study||32
9757578|NCT00366106|10861015|FG000|NOT COMPLETED|Overall Study||0
9757579|NCT00366249|10861021|FG000|STARTED|Overall Study||553
9757580|NCT00366249|10861022|FG001|STARTED|Overall Study||508
9757581|NCT00366249|10861021|FG000|COMPLETED|Overall Study||422
9757582|NCT00366249|10861022|FG001|COMPLETED|Overall Study||430
9757583|NCT00366249|10861021|FG000|NOT COMPLETED|Overall Study||131
9757584|NCT00366249|10861022|FG001|NOT COMPLETED|Overall Study||78
9757585|NCT00366275|10861028|FG000|STARTED|Overall Study||64
9757586|NCT00366275|10861028|FG000|COMPLETED|Overall Study||58
9757587|NCT00366275|10861028|FG000|NOT COMPLETED|Overall Study||6
9757588|NCT00366301|10861036|FG000|STARTED|Overall Study||124
9757589|NCT00366301|10861037|FG001|STARTED|Overall Study||126
9757590|NCT00366301|10861038|FG002|STARTED|Overall Study||126
9757591|NCT00366301|10861039|FG003|STARTED|Overall Study||124
9757592|NCT00366301|10861036|FG000|Either 6W or 14W CRP Obtained|Overall Study||120
9757593|NCT00366301|10861037|FG001|Either 6W or 14W CRP Obtained|Overall Study||124
9757594|NCT00366301|10861038|FG002|Either 6W or 14W CRP Obtained|Overall Study||124
9757595|NCT00366301|10861039|FG003|Either 6W or 14W CRP Obtained|Overall Study||119
9757596|NCT00366301|10861036|FG000|COMPLETED|Overall Study||116
9757597|NCT00366301|10861037|FG001|COMPLETED|Overall Study||120
9757598|NCT00366301|10861038|FG002|COMPLETED|Overall Study||122
9757599|NCT00366301|10861039|FG003|COMPLETED|Overall Study||116
9757600|NCT00366301|10861036|FG000|NOT COMPLETED|Overall Study||8
9757601|NCT00366301|10861037|FG001|NOT COMPLETED|Overall Study||6
9757602|NCT00366301|10861038|FG002|NOT COMPLETED|Overall Study||4
9757603|NCT00366301|10861039|FG003|NOT COMPLETED|Overall Study||8
9757604|NCT00366340|10861051|FG000|STARTED|Infant Series||301
9757605|NCT00366340|10861052|FG001|STARTED|Infant Series||303
9757606|NCT00366340|10861051|FG000|Vaccinated Dose 1|Infant Series||300
9757607|NCT00366340|10861052|FG001|Vaccinated Dose 1|Infant Series||303
9757608|NCT00366340|10861051|FG000|Vaccinated Dose 2|Infant Series||296
9757609|NCT00366340|10861052|FG001|Vaccinated Dose 2|Infant Series||297
9757610|NCT00366340|10861051|FG000|Vaccinated Dose 3|Infant Series||294
9757611|NCT00366340|10861052|FG001|Vaccinated Dose 3|Infant Series||293
9757612|NCT00366340|10861051|FG000|COMPLETED|Infant Series||293
9757613|NCT00366340|10861052|FG001|COMPLETED|Infant Series||293
9757614|NCT00366340|10861051|FG000|NOT COMPLETED|Infant Series||8
9757615|NCT00366340|10861052|FG001|NOT COMPLETED|Infant Series||10
9757616|NCT00366340|10861051|FG000|STARTED|After the Infant Series||293
9757617|NCT00366340|10861052|FG001|STARTED|After the Infant Series||293
9757618|NCT00366340|10861051|FG000|COMPLETED|After the Infant Series||290
9757619|NCT00366340|10861052|FG001|COMPLETED|After the Infant Series||287
9757620|NCT00366340|10861051|FG000|NOT COMPLETED|After the Infant Series||3
9757621|NCT00366340|10861052|FG001|NOT COMPLETED|After the Infant Series||6
9757622|NCT00366340|10861051|FG000|STARTED|Toddler Dose||290
9757623|NCT00366340|10861052|FG001|STARTED|Toddler Dose||287
9757624|NCT00366340|10861051|FG000|COMPLETED|Toddler Dose||289
9757625|NCT00366340|10861052|FG001|COMPLETED|Toddler Dose||286
9757626|NCT00366340|10861051|FG000|NOT COMPLETED|Toddler Dose||1
9757627|NCT00366340|10861052|FG001|NOT COMPLETED|Toddler Dose||1
9757628|NCT00366444|10861084|FG000|STARTED|Overall Study||102
9757629|NCT00366444|10861085|FG001|STARTED|Overall Study||99
9757630|NCT00366444|10861084|FG000|COMPLETED|Overall Study||101
9757631|NCT00366444|10861085|FG001|COMPLETED|Overall Study||97
9757632|NCT00366444|10861084|FG000|NOT COMPLETED|Overall Study||1
9757633|NCT00366444|10861085|FG001|NOT COMPLETED|Overall Study||2
9757634|NCT00366457|10861091|FG000|STARTED|Overall Study||32
9757635|NCT00366457|10861091|FG000|COMPLETED|Overall Study||30
9757636|NCT00366457|10861091|FG000|NOT COMPLETED|Overall Study||2
9757637|NCT00366535|10861097|FG000|STARTED|First Phase: 12 Weeks||27
9757638|NCT00366535|10861098|FG001|STARTED|First Phase: 12 Weeks||29
9757639|NCT00366535|10861097|FG000|COMPLETED|First Phase: 12 Weeks||24
9757640|NCT00366535|10861098|FG001|COMPLETED|First Phase: 12 Weeks||21
9757641|NCT00366535|10861097|FG000|NOT COMPLETED|First Phase: 12 Weeks||3
9757642|NCT00366535|10861098|FG001|NOT COMPLETED|First Phase: 12 Weeks||8
9757643|NCT00366535|10861097|FG000|STARTED|Washout Period (at Least a Week)||24
9757644|NCT00366535|10861098|FG001|STARTED|Washout Period (at Least a Week)||21
9757645|NCT00366535|10861097|FG000|COMPLETED|Washout Period (at Least a Week)||24
9757646|NCT00366535|10861098|FG001|COMPLETED|Washout Period (at Least a Week)||21
9757647|NCT00366535|10861097|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0
9757648|NCT00366535|10861098|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0
9757649|NCT00366535|10861097|FG000|STARTED|Second Phase: 12 Weeks||24
9757650|NCT00366535|10861098|FG001|STARTED|Second Phase: 12 Weeks||21
9757651|NCT00366535|10861097|FG000|COMPLETED|Second Phase: 12 Weeks||21
9757652|NCT00366535|10861098|FG001|COMPLETED|Second Phase: 12 Weeks||18
9757653|NCT00366535|10861097|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3
9757654|NCT00366535|10861098|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3
9757655|NCT00366548|10861114|FG000|STARTED|Infant Series||250
9757656|NCT00366548|10861115|FG001|STARTED|Infant Series||250
9757657|NCT00366548|10861114|FG000|Vaccinated Dose 1|Infant Series||250
9757658|NCT00366548|10861115|FG001|Vaccinated Dose 1|Infant Series||250
9757659|NCT00366548|10861114|FG000|Vaccinated Dose 2|Infant Series||246
9757660|NCT00366548|10861115|FG001|Vaccinated Dose 2|Infant Series||249
9757661|NCT00366548|10861114|FG000|Vaccinated Dose 3|Infant Series||246
9757662|NCT00366548|10861115|FG001|Vaccinated Dose 3|Infant Series||247
9757663|NCT00366548|10861114|FG000|COMPLETED|Infant Series||246
9854468|NCT00894166|10967535|FG002|STARTED|Overall Study||112
9854469|NCT00894166|10967536|FG003|STARTED|Overall Study||114
9854470|NCT00894166|10967537|FG004|STARTED|Overall Study||34
9854471|NCT00894166|10967538|FG005|STARTED|Overall Study||36
9854472|NCT00894166|10967539|FG006|STARTED|Overall Study||35
9854473|NCT00894166|10967540|FG007|STARTED|Overall Study||34
9854474|NCT00894166|10967533|FG000|COMPLETED|Overall Study||71
9854475|NCT00894166|10967534|FG001|COMPLETED|Overall Study||46
9854476|NCT00894166|10967535|FG002|COMPLETED|Overall Study||50
9854477|NCT00894166|10967536|FG003|COMPLETED|Overall Study||45
9854478|NCT00894166|10967537|FG004|COMPLETED|Overall Study||10
9854479|NCT00894166|10967538|FG005|COMPLETED|Overall Study||20
9854480|NCT00894166|10967539|FG006|COMPLETED|Overall Study||19
9854481|NCT00894166|10967540|FG007|COMPLETED|Overall Study||0
9854482|NCT00894166|10967533|FG000|NOT COMPLETED|Overall Study||61
9854483|NCT00894166|10967534|FG001|NOT COMPLETED|Overall Study||63
9854484|NCT00894166|10967535|FG002|NOT COMPLETED|Overall Study||62
9854485|NCT00894166|10967536|FG003|NOT COMPLETED|Overall Study||69
9854486|NCT00894166|10967537|FG004|NOT COMPLETED|Overall Study||24
9854487|NCT00894166|10967538|FG005|NOT COMPLETED|Overall Study||16
9854488|NCT00894166|10967539|FG006|NOT COMPLETED|Overall Study||16
9854489|NCT00894166|10967540|FG007|NOT COMPLETED|Overall Study||34
9854490|NCT00894322|10967566|FG000|STARTED|Overall Study||30
9854491|NCT00894322|10967567|FG001|STARTED|Overall Study||23
9854492|NCT00894322|10967568|FG002|STARTED|Overall Study||12
9854493|NCT00894322|10967566|FG000|COMPLETED|Overall Study||29
9854494|NCT00894322|10967567|FG001|COMPLETED|Overall Study||23
9854495|NCT00894322|10967568|FG002|COMPLETED|Overall Study||12
9854496|NCT00894322|10967566|FG000|NOT COMPLETED|Overall Study||1
9854497|NCT00894322|10967567|FG001|NOT COMPLETED|Overall Study||0
9854498|NCT00894322|10967568|FG002|NOT COMPLETED|Overall Study||0
9854499|NCT00894361|10967580|FG000|STARTED|Overall Study||200
9854500|NCT00894361|10967581|FG001|STARTED|Overall Study||200
9854501|NCT00894361|10967580|FG000|COMPLETED|Overall Study||176
9854502|NCT00894361|10967581|FG001|COMPLETED|Overall Study||136
9854503|NCT00894361|10967580|FG000|NOT COMPLETED|Overall Study||24
9854504|NCT00894361|10967581|FG001|NOT COMPLETED|Overall Study||64
9854505|NCT00894387|10967591|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821
9854506|NCT00894387|10967592|FG001|STARTED|Overall Study||818
9854507|NCT00894387|10967591|FG000|Safety Set|Overall Study||808
9854508|NCT00894387|10967592|FG001|Safety Set|Overall Study||810
9854509|NCT00894387|10967591|FG000|Full Analysis Set|Overall Study||808
9854510|NCT00894387|10967592|FG001|Full Analysis Set|Overall Study||807
9854511|NCT00894387|10967591|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717
9854512|NCT00894387|10967592|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707
9854513|NCT00894387|10967591|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654
9854514|NCT00894387|10967592|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640
9854515|NCT00894387|10967591|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
9854516|NCT00894387|10967592|FG001|COMPLETED|Overall Study||643
9854517|NCT00894387|10967591|FG000|NOT COMPLETED|Overall Study||175
9854518|NCT00894387|10967592|FG001|NOT COMPLETED|Overall Study||175
9854519|NCT00894413|10967600|FG000|STARTED|Overall Study||15
9854520|NCT00894413|10967601|FG001|STARTED|Overall Study||25
9854521|NCT00894413|10967600|FG000|COMPLETED|Overall Study||15
9854522|NCT00894413|10967601|FG001|COMPLETED|Overall Study||17
9854523|NCT00894413|10967600|FG000|NOT COMPLETED|Overall Study||0
9854524|NCT00894413|10967601|FG001|NOT COMPLETED|Overall Study||8
9757664|NCT00366548|10861115|FG001|COMPLETED|Infant Series||245
9757665|NCT00366548|10861114|FG000|NOT COMPLETED|Infant Series||4
9757666|NCT00366548|10861115|FG001|NOT COMPLETED|Infant Series||5
9757667|NCT00366548|10861114|FG000|STARTED|After Infant Series||246
9757668|NCT00366548|10861115|FG001|STARTED|After Infant Series||245
9757669|NCT00366548|10861114|FG000|COMPLETED|After Infant Series||240
9757670|NCT00366548|10861115|FG001|COMPLETED|After Infant Series||244
9757671|NCT00366548|10861114|FG000|NOT COMPLETED|After Infant Series||6
9757672|NCT00366548|10861115|FG001|NOT COMPLETED|After Infant Series||1
9757673|NCT00366548|10861114|FG000|STARTED|Toddler Dose||240
9757674|NCT00366548|10861115|FG001|STARTED|Toddler Dose||244
9854525|NCT00894465|10967609|FG000|STARTED|Overall Study||22
9854526|NCT00894465|10967610|FG001|STARTED|Overall Study||22
9854527|NCT00894465|10967609|FG000|COMPLETED|Overall Study||22
9854528|NCT00894465|10967610|FG001|COMPLETED|Overall Study||22
9854529|NCT00894465|10967609|FG000|NOT COMPLETED|Overall Study||0
9854530|NCT00894465|10967610|FG001|NOT COMPLETED|Overall Study||0
9854531|NCT00894504|10967618|FG000|STARTED|Overall Study||71
9854532|NCT00894504|10967618|FG000|COMPLETED|Overall Study||0
9854533|NCT00894504|10967618|FG000|NOT COMPLETED|Overall Study||71
9854534|NCT00894517|10967634|FG000|STARTED|Overall Study||30
9854535|NCT00894517|10967635|FG001|STARTED|Overall Study||31
9854536|NCT00894517|10967634|FG000|COMPLETED|Overall Study||28
9854537|NCT00894517|10967635|FG001|COMPLETED|Overall Study||26
9854538|NCT00894517|10967634|FG000|NOT COMPLETED|Overall Study||2
9854539|NCT00894517|10967635|FG001|NOT COMPLETED|Overall Study||5
9854540|NCT00894543|10967643|FG000|STARTED|Baseline||104
9854541|NCT00894543|10967644|FG001|STARTED|Baseline||101
9757675|NCT00366548|10861114|FG000|COMPLETED|Toddler Dose||240
9757676|NCT00366548|10861115|FG001|COMPLETED|Toddler Dose||244
9757677|NCT00366548|10861114|FG000|NOT COMPLETED|Toddler Dose||0
9757678|NCT00366548|10861115|FG001|NOT COMPLETED|Toddler Dose||0
9757679|NCT00366626|10861141|FG000|STARTED|Overall Study||38
9757680|NCT00366626|10861142|FG001|STARTED|Overall Study||45
9757681|NCT00366626|10861141|FG000|COMPLETED|Overall Study||38
9757682|NCT00366626|10861142|FG001|COMPLETED|Overall Study||45
9757683|NCT00366626|10861141|FG000|NOT COMPLETED|Overall Study||0
9757684|NCT00366626|10861142|FG001|NOT COMPLETED|Overall Study||0
9757685|NCT00366678|10861152|FG000|STARTED|Infant Series||304
9757686|NCT00366678|10861153|FG001|STARTED|Infant Series||309
9757687|NCT00366678|10861154|FG002|STARTED|Infant Series||0
9757688|NCT00366678|10861152|FG000|Vaccinated Dose 1|Infant Series||302
9757689|NCT00366678|10861153|FG001|Vaccinated Dose 1|Infant Series||309
9757690|NCT00366678|10861154|FG002|Vaccinated Dose 1|Infant Series||0
9757691|NCT00366678|10861152|FG000|Vaccinated Dose 2|Infant Series||295
9757692|NCT00366678|10861153|FG001|Vaccinated Dose 2|Infant Series||304
9757693|NCT00366678|10861154|FG002|Vaccinated Dose 2|Infant Series||0
9757694|NCT00366678|10861152|FG000|Vaccinated Dose 3|Infant Series||291
9757695|NCT00366678|10861153|FG001|Vaccinated Dose 3|Infant Series||302
9757696|NCT00366678|10861154|FG002|Vaccinated Dose 3|Infant Series||0
9757697|NCT00366678|10861152|FG000|COMPLETED|Infant Series||290
9757698|NCT00366678|10861153|FG001|COMPLETED|Infant Series||299
9757699|NCT00366678|10861154|FG002|COMPLETED|Infant Series||0
9757700|NCT00366678|10861152|FG000|NOT COMPLETED|Infant Series||14
9757701|NCT00366678|10861153|FG001|NOT COMPLETED|Infant Series||10
9757702|NCT00366678|10861154|FG002|NOT COMPLETED|Infant Series||0
9757703|NCT00366678|10861152|FG000|STARTED|After Infant||290
9757704|NCT00366678|10861153|FG001|STARTED|After Infant||299
9757705|NCT00366678|10861154|FG002|STARTED|After Infant||0
9757706|NCT00366678|10861152|FG000|COMPLETED|After Infant||273
9757707|NCT00366678|10861153|FG001|COMPLETED|After Infant||289
9757708|NCT00366678|10861154|FG002|COMPLETED|After Infant||0
9757709|NCT00366678|10861152|FG000|NOT COMPLETED|After Infant||17
9757710|NCT00366678|10861153|FG001|NOT COMPLETED|After Infant||10
9757711|NCT00366678|10861154|FG002|NOT COMPLETED|After Infant||0
9757712|NCT00366678|10861152|FG000|STARTED|Toddler Dose||273
9757713|NCT00366678|10861153|FG001|STARTED|Toddler Dose||152
9757714|NCT00366678|10861154|FG002|STARTED|Toddler Dose||137
9757715|NCT00366678|10861152|FG000|COMPLETED|Toddler Dose||268
9757716|NCT00366678|10861153|FG001|COMPLETED|Toddler Dose||151
9757717|NCT00366678|10861154|FG002|COMPLETED|Toddler Dose||137
9757718|NCT00366678|10861152|FG000|NOT COMPLETED|Toddler Dose||5
9757719|NCT00366678|10861153|FG001|NOT COMPLETED|Toddler Dose||1
9757720|NCT00366678|10861154|FG002|NOT COMPLETED|Toddler Dose||0
9757721|NCT00366899|10861201|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
9757722|NCT00366899|10861202|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
9757723|NCT00366899|10861201|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
9757724|NCT00366899|10861202|FG001|Vaccinated Dose 1|Infant Series||302
9757725|NCT00366899|10861201|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
9757726|NCT00366899|10861202|FG001|Vaccinated Dose 2|Infant Series||293
9757727|NCT00366899|10861201|FG000|COMPLETED|Infant Series||294
9757728|NCT00366899|10861202|FG001|COMPLETED|Infant Series||291
9757729|NCT00366899|10861201|FG000|NOT COMPLETED|Infant Series||9
9757730|NCT00366899|10861202|FG001|NOT COMPLETED|Infant Series||12
9757731|NCT00366899|10861201|FG000|STARTED|After Infant Series||294
9757732|NCT00366899|10861202|FG001|STARTED|After Infant Series||291
9757733|NCT00366899|10861201|FG000|COMPLETED|After Infant Series||287
9757734|NCT00366899|10861202|FG001|COMPLETED|After Infant Series||282
9757735|NCT00366899|10861201|FG000|NOT COMPLETED|After Infant Series||7
9757736|NCT00366899|10861202|FG001|NOT COMPLETED|After Infant Series||9
9757737|NCT00366899|10861201|FG000|STARTED|Toddler Dose||287
9757738|NCT00366899|10861202|FG001|STARTED|Toddler Dose||282
9757739|NCT00366899|10861201|FG000|COMPLETED|Toddler Dose||285
9757740|NCT00366899|10861202|FG001|COMPLETED|Toddler Dose||281
9757741|NCT00366899|10861201|FG000|NOT COMPLETED|Toddler Dose||2
9757742|NCT00366899|10861202|FG001|NOT COMPLETED|Toddler Dose||1
9757743|NCT00367003|10861234|FG000|STARTED|Overall Study||37
9757744|NCT00367003|10861234|FG000|COMPLETED|Overall Study||28
9757745|NCT00367003|10861234|FG000|NOT COMPLETED|Overall Study||9
9757746|NCT00367016|10861240|FG000|STARTED|Overall Study||3
9757747|NCT00367016|10861241|FG001|STARTED|Overall Study||3
9757748|NCT00367016|10861240|FG000|First Intervention|Overall Study||3
9757749|NCT00367016|10861241|FG001|First Intervention|Overall Study||3
9757750|NCT00367016|10861240|FG000|Second Intervention|Overall Study||3
9757751|NCT00367016|10861241|FG001|Second Intervention|Overall Study||3
9757752|NCT00367016|10861240|FG000|COMPLETED|Overall Study||3
9757753|NCT00367016|10861241|FG001|COMPLETED|Overall Study||3
9757754|NCT00367016|10861240|FG000|NOT COMPLETED|Overall Study||0
9757755|NCT00367016|10861241|FG001|NOT COMPLETED|Overall Study||0
9757756|NCT00367055|10861251|FG000|STARTED|Overall Study||43
9757757|NCT00367055|10861252|FG001|STARTED|Overall Study||41
9757758|NCT00367055|10861251|FG000|COMPLETED|Overall Study||32
9757759|NCT00367055|10861252|FG001|COMPLETED|Overall Study||30
9757760|NCT00367055|10861251|FG000|NOT COMPLETED|Overall Study||11
9757761|NCT00367055|10861252|FG001|NOT COMPLETED|Overall Study||11
9757762|NCT00367133|10861261|FG000|STARTED|2 Years|Number of Eyes|330
9757763|NCT00367133|10861262|FG001|STARTED|2 Years|Number of Eyes|256
9757764|NCT00367133|10861263|FG002|STARTED|2 Years|Number of Eyes|254
9757765|NCT00367133|10861261|FG000|COMPLETED|2 Years||272
9757766|NCT00367133|10861262|FG001|COMPLETED|2 Years||220
9757767|NCT00367133|10861263|FG002|COMPLETED|2 Years||205
9757768|NCT00367133|10861261|FG000|NOT COMPLETED|2 Years||58
9757769|NCT00367133|10861262|FG001|NOT COMPLETED|2 Years||36
9757770|NCT00367133|10861263|FG002|NOT COMPLETED|2 Years||49
9757771|NCT00367133|10861261|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
9757772|NCT00367133|10861262|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
9757773|NCT00367133|10861263|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
9757774|NCT00367133|10861261|FG000|COMPLETED|3 Years||115
9757775|NCT00367133|10861262|FG001|COMPLETED|3 Years||93
9757776|NCT00367133|10861263|FG002|COMPLETED|3 Years||98
9757777|NCT00367133|10861261|FG000|NOT COMPLETED|3 Years||28
9757778|NCT00367133|10861262|FG001|NOT COMPLETED|3 Years||23
9757779|NCT00367133|10861263|FG002|NOT COMPLETED|3 Years||18
9757780|NCT00367237|10861273|FG000|STARTED|Overall Study|Number of subjects randomized|57
9757781|NCT00367237|10861274|FG001|STARTED|Overall Study|Number of subjects randomized|58
9757782|NCT00367237|10861273|FG000|COMPLETED|Overall Study||47
9757783|NCT00367237|10861274|FG001|COMPLETED|Overall Study||47
9757784|NCT00367237|10861273|FG000|NOT COMPLETED|Overall Study||10
9757785|NCT00367237|10861274|FG001|NOT COMPLETED|Overall Study||11
9757786|NCT00367341|10861282|FG000|STARTED|Overall Study||42
9757787|NCT00367341|10861283|FG001|STARTED|Overall Study||40
9757788|NCT00367341|10861282|FG000|COMPLETED|Overall Study||40
9757789|NCT00367341|10861283|FG001|COMPLETED|Overall Study||40
9757790|NCT00367341|10861282|FG000|NOT COMPLETED|Overall Study||2
9757791|NCT00367341|10861283|FG001|NOT COMPLETED|Overall Study||0
9757792|NCT00367380|10861292|FG000|STARTED|Overall Study||6
9757793|NCT00367380|10861293|FG001|STARTED|Overall Study||6
9757794|NCT00367380|10861294|FG002|STARTED|Overall Study||6
9757795|NCT00367380|10861292|FG000|COMPLETED|Overall Study||6
9757796|NCT00367380|10861293|FG001|COMPLETED|Overall Study||6
9757797|NCT00367380|10861294|FG002|COMPLETED|Overall Study||6
9757798|NCT00367380|10861292|FG000|NOT COMPLETED|Overall Study||0
9757799|NCT00367380|10861293|FG001|NOT COMPLETED|Overall Study||0
9757800|NCT00367380|10861294|FG002|NOT COMPLETED|Overall Study||0
9757801|NCT00367432|10861302|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
9757802|NCT00367432|10861303|FG001|STARTED|First Period (16 Weeks)||0
9757803|NCT00367432|10861302|FG000|COMPLETED|First Period (16 Weeks)||275
9757804|NCT00367432|10861303|FG001|COMPLETED|First Period (16 Weeks)||0
9757805|NCT00367432|10861302|FG000|NOT COMPLETED|First Period (16 Weeks)||38
9757806|NCT00367432|10861303|FG001|NOT COMPLETED|First Period (16 Weeks)||0
9757807|NCT00367432|10861302|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
9757808|NCT00367432|10861303|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
9757809|NCT00367432|10861302|FG000|COMPLETED|Second Period (up to 54 Months)||188
9757810|NCT00367432|10861303|FG001|COMPLETED|Second Period (up to 54 Months)||69
9757811|NCT00367432|10861302|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87
9757812|NCT00367432|10861303|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16
9757813|NCT00367458|10861309|FG000|STARTED|First Intervention - 8 Weeks||12
9757814|NCT00367458|10861310|FG001|STARTED|First Intervention - 8 Weeks||12
9757815|NCT00367458|10861309|FG000|COMPLETED|First Intervention - 8 Weeks||10
9757816|NCT00367458|10861310|FG001|COMPLETED|First Intervention - 8 Weeks||12
9757817|NCT00367458|10861309|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
9757818|NCT00367458|10861310|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0
9757819|NCT00367458|10861309|FG000|STARTED|Washout Period - 4-6 Weeks||10
9757820|NCT00367458|10861310|FG001|STARTED|Washout Period - 4-6 Weeks||12
9757821|NCT00367458|10861309|FG000|COMPLETED|Washout Period - 4-6 Weeks||10
9757822|NCT00367458|10861310|FG001|COMPLETED|Washout Period - 4-6 Weeks||12
9757823|NCT00367458|10861309|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0
9757824|NCT00367458|10861310|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0
9757825|NCT00367458|10861309|FG000|STARTED|Second Intervention - 8 Weeks||10
9757826|NCT00367458|10861310|FG001|STARTED|Second Intervention - 8 Weeks||12
9757827|NCT00367458|10861309|FG000|COMPLETED|Second Intervention - 8 Weeks||10
9757828|NCT00367458|10861310|FG001|COMPLETED|Second Intervention - 8 Weeks||12
9757829|NCT00367458|10861309|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
9757830|NCT00367458|10861310|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
9757831|NCT00367484|10861316|FG000|STARTED|Overall Study||460
9757832|NCT00367484|10861316|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
9757833|NCT00367484|10861316|FG000|NOT COMPLETED|Overall Study||17
9757834|NCT00367601|10861320|FG000|STARTED|Overall Study||25
9757835|NCT00367601|10861320|FG000|COMPLETED|Overall Study||25
9757836|NCT00367601|10861320|FG000|NOT COMPLETED|Overall Study||0
9757837|NCT00367640|10861329|FG000|STARTED|Overall Study||157
9757838|NCT00367640|10861330|FG001|STARTED|Overall Study||155
9757839|NCT00367640|10861331|FG002|STARTED|Overall Study||160
9757840|NCT00367640|10861332|FG003|STARTED|Overall Study||156
9757841|NCT00367640|10861329|FG000|COMPLETED|Overall Study||139
9757842|NCT00367640|10861330|FG001|COMPLETED|Overall Study||133
9757843|NCT00367640|10861331|FG002|COMPLETED|Overall Study||141
9757844|NCT00367640|10861332|FG003|COMPLETED|Overall Study||146
9757845|NCT00367640|10861329|FG000|NOT COMPLETED|Overall Study||18
9757846|NCT00367640|10861330|FG001|NOT COMPLETED|Overall Study||22
9757847|NCT00367640|10861331|FG002|NOT COMPLETED|Overall Study||19
9757848|NCT00367640|10861332|FG003|NOT COMPLETED|Overall Study||10
9757849|NCT00367679|10861342|FG000|STARTED|Overall Study||35
9757850|NCT00367679|10861342|FG000|COMPLETED|Overall Study||35
9757851|NCT00367679|10861342|FG000|NOT COMPLETED|Overall Study||0
9757852|NCT00367744|10861350|FG000|STARTED|Overall Study||34
9757853|NCT00367744|10861351|FG001|STARTED|Overall Study||37
9757854|NCT00367744|10861350|FG000|COMPLETED|Overall Study||30
9757855|NCT00367744|10861351|FG001|COMPLETED|Overall Study||32
9757856|NCT00367744|10861350|FG000|NOT COMPLETED|Overall Study||4
9757857|NCT00367744|10861351|FG001|NOT COMPLETED|Overall Study||5
9757858|NCT00367770|10861358|FG000|STARTED|Overall Study||37
9757859|NCT00367770|10861358|FG000|COMPLETED|Overall Study||35
9757860|NCT00367770|10861358|FG000|NOT COMPLETED|Overall Study||2
9757861|NCT00367835|10861364|FG000|STARTED|Overall Study||138
9757862|NCT00367835|10861365|FG001|STARTED|Overall Study||79
9757863|NCT00367835|10861364|FG000|COMPLETED|Overall Study||109
9757864|NCT00367835|10861365|FG001|COMPLETED|Overall Study||48
9757865|NCT00367835|10861364|FG000|NOT COMPLETED|Overall Study||29
9757866|NCT00367835|10861365|FG001|NOT COMPLETED|Overall Study||31
9757867|NCT00367991|10861373|FG000|STARTED|Overall Study||29
9757868|NCT00367991|10861374|FG001|STARTED|Overall Study||15
9757869|NCT00367991|10861373|FG000|COMPLETED|Overall Study||27
9757870|NCT00367991|10861374|FG001|COMPLETED|Overall Study||13
9757871|NCT00367991|10861373|FG000|NOT COMPLETED|Overall Study||2
9757872|NCT00367991|10861374|FG001|NOT COMPLETED|Overall Study||2
9757873|NCT00368069|10861382|FG000|STARTED|Overall Study||79
9757874|NCT00368069|10861383|FG001|STARTED|Overall Study||79
9757875|NCT00368069|10861382|FG000|COMPLETED|Overall Study||71
9757876|NCT00368069|10861383|FG001|COMPLETED|Overall Study||72
9757877|NCT00368069|10861382|FG000|NOT COMPLETED|Overall Study||8
9757878|NCT00368069|10861383|FG001|NOT COMPLETED|Overall Study||7
9757879|NCT00368108|10861392|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
9757880|NCT00368108|10861393|FG001|STARTED|Overall Study||251
9757881|NCT00368108|10861394|FG002|STARTED|Overall Study||250
9757882|NCT00368108|10861392|FG000|COMPLETED|Overall Study||187
9757883|NCT00368108|10861393|FG001|COMPLETED|Overall Study||198
9757884|NCT00368108|10861394|FG002|COMPLETED|Overall Study||182
9757885|NCT00368108|10861392|FG000|NOT COMPLETED|Overall Study||64
9757886|NCT00368108|10861393|FG001|NOT COMPLETED|Overall Study||53
9757887|NCT00368108|10861394|FG002|NOT COMPLETED|Overall Study||68
9757888|NCT00368251|10861405|FG000|STARTED|Overall Study||18
9757889|NCT00368251|10861406|FG001|STARTED|Overall Study||20
9757890|NCT00368251|10861407|FG002|STARTED|Overall Study||18
9757891|NCT00368251|10861405|FG000|COMPLETED|Overall Study||17
9757892|NCT00368251|10861406|FG001|COMPLETED|Overall Study||20
9757893|NCT00368251|10861407|FG002|COMPLETED|Overall Study||17
9757894|NCT00368251|10861405|FG000|NOT COMPLETED|Overall Study||1
9757895|NCT00368251|10861406|FG001|NOT COMPLETED|Overall Study||0
9757896|NCT00368251|10861407|FG002|NOT COMPLETED|Overall Study||1
9757897|NCT00368277|10861417|FG000|STARTED|Overall Study||457
9757898|NCT00368277|10861418|FG001|STARTED|Overall Study||444
9757899|NCT00368277|10861417|FG000|COMPLETED|Overall Study||344
9757900|NCT00368277|10861418|FG001|COMPLETED|Overall Study||336
9757901|NCT00368277|10861417|FG000|NOT COMPLETED|Overall Study||113
9757902|NCT00368277|10861418|FG001|NOT COMPLETED|Overall Study||108
9757903|NCT00368290|10861426|FG000|STARTED|Overall Study||47
9757904|NCT00368290|10861427|FG001|STARTED|Overall Study||47
9757905|NCT00368290|10861426|FG000|COMPLETED|Overall Study||34
9757906|NCT00368290|10861427|FG001|COMPLETED|Overall Study||37
9757907|NCT00368290|10861426|FG000|NOT COMPLETED|Overall Study||13
9757908|NCT00368290|10861427|FG001|NOT COMPLETED|Overall Study||10
9757909|NCT00368316|10861435|FG000|STARTED|Overall Study||1434
9757910|NCT00368316|10861436|FG001|STARTED|Overall Study||1365
9757911|NCT00368316|10861435|FG000|COMPLETED|Overall Study||1392
9757912|NCT00368316|10861436|FG001|COMPLETED|Overall Study||1319
9757913|NCT00368316|10861435|FG000|NOT COMPLETED|Overall Study||42
9757914|NCT00368316|10861436|FG001|NOT COMPLETED|Overall Study||46
9757915|NCT00368355|10861444|FG000|STARTED|Overall Study||18
9757916|NCT00368355|10861445|FG001|STARTED|Overall Study||28
9757917|NCT00368355|10861444|FG000|COMPLETED|Overall Study||7
9757918|NCT00368355|10861445|FG001|COMPLETED|Overall Study||11
9757919|NCT00368355|10861444|FG000|NOT COMPLETED|Overall Study||11
9757920|NCT00368355|10861445|FG001|NOT COMPLETED|Overall Study||17
9757921|NCT00368459|10861453|FG000|STARTED|Overall Study||21
9757922|NCT00368459|10861454|FG001|STARTED|Overall Study||21
9757923|NCT00368459|10861453|FG000|COMPLETED|Overall Study||19
9757924|NCT00368459|10861454|FG001|COMPLETED|Overall Study||20
9757925|NCT00368459|10861453|FG000|NOT COMPLETED|Overall Study||2
9757926|NCT00368459|10861454|FG001|NOT COMPLETED|Overall Study||1
9757927|NCT00368472|10861460|FG000|STARTED|Overall Study||138
9757928|NCT00368472|10861460|FG000|COMPLETED|Overall Study||33
9757929|NCT00368472|10861460|FG000|NOT COMPLETED|Overall Study||105
9757930|NCT00368537|10861466|FG000|STARTED|Randomization||281
9757931|NCT00368537|10861467|FG001|STARTED|Randomization||269
9757932|NCT00368537|10861466|FG000|COMPLETED|Randomization||268
9757933|NCT00368537|10861467|FG001|COMPLETED|Randomization||263
9757934|NCT00368537|10861466|FG000|NOT COMPLETED|Randomization||13
9757935|NCT00368537|10861467|FG001|NOT COMPLETED|Randomization||6
9757936|NCT00368537|10861466|FG000|STARTED|Baseline Participants||268
9757937|NCT00368537|10861467|FG001|STARTED|Baseline Participants||263
9757938|NCT00368537|10861466|FG000|COMPLETED|Baseline Participants||244
9757939|NCT00368537|10861467|FG001|COMPLETED|Baseline Participants||239
9757940|NCT00368537|10861466|FG000|NOT COMPLETED|Baseline Participants||24
9757941|NCT00368537|10861467|FG001|NOT COMPLETED|Baseline Participants||24
9757942|NCT00368550|10861475|FG000|STARTED|Overall Study||63
9757943|NCT00368550|10861476|FG001|STARTED|Overall Study||71
9757944|NCT00368550|10861475|FG000|COMPLETED|Overall Study||35
9757945|NCT00368550|10861476|FG001|COMPLETED|Overall Study||48
9757946|NCT00368550|10861475|FG000|NOT COMPLETED|Overall Study||28
9757947|NCT00368550|10861476|FG001|NOT COMPLETED|Overall Study||23
9757948|NCT00368641|10861484|FG000|STARTED|Overall Study||6
9757949|NCT00368641|10861485|FG001|STARTED|Overall Study||6
9757950|NCT00368641|10861484|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
9757951|NCT00368641|10861485|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
9757952|NCT00368641|10861484|FG000|NOT COMPLETED|Overall Study||6
9757953|NCT00368641|10861485|FG001|NOT COMPLETED|Overall Study||6
9757954|NCT00368745|10861493|FG000|STARTED|Randomized to Double-blind Treatment||57
9757955|NCT00368745|10861494|FG001|STARTED|Randomized to Double-blind Treatment||51
9757956|NCT00368745|10861493|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
9757957|NCT00368745|10861494|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
9757958|NCT00368745|10861493|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1
9757959|NCT00368745|10861494|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
9757960|NCT00368745|10861493|FG000|STARTED|Double-blind Treatment Period||56
9757961|NCT00368745|10861494|FG001|STARTED|Double-blind Treatment Period||50
9757962|NCT00368745|10861493|FG000|COMPLETED|Double-blind Treatment Period||30
9757963|NCT00368745|10861494|FG001|COMPLETED|Double-blind Treatment Period||19
9757964|NCT00368745|10861493|FG000|NOT COMPLETED|Double-blind Treatment Period||26
9757965|NCT00368745|10861494|FG001|NOT COMPLETED|Double-blind Treatment Period||31
9757966|NCT00368849|10861500|FG000|STARTED|Overall Study||10
9757967|NCT00368849|10861501|FG001|STARTED|Overall Study||10
9757968|NCT00368849|10861500|FG000|COMPLETED|Overall Study||10
9757969|NCT00368849|10861501|FG001|COMPLETED|Overall Study||8
9757970|NCT00368849|10861500|FG000|NOT COMPLETED|Overall Study||0
9757971|NCT00368849|10861501|FG001|NOT COMPLETED|Overall Study||2
9757972|NCT00368875|10861508|FG000|STARTED|Overall Study||6
9757973|NCT00368875|10861509|FG001|STARTED|Overall Study||48
9757974|NCT00368875|10861508|FG000|COMPLETED|Overall Study||0
9757975|NCT00368875|10861509|FG001|COMPLETED|Overall Study||0
9757976|NCT00368875|10861508|FG000|NOT COMPLETED|Overall Study||6
9757977|NCT00368875|10861509|FG001|NOT COMPLETED|Overall Study||48
9757978|NCT00368927|10861517|FG000|STARTED|Overall Study||31
9757979|NCT00368927|10861518|FG001|STARTED|Overall Study||30
9757980|NCT00368927|10861517|FG000|COMPLETED|Overall Study||26
9757981|NCT00368927|10861518|FG001|COMPLETED|Overall Study||27
9757982|NCT00368927|10861517|FG000|NOT COMPLETED|Overall Study||5
9757983|NCT00368927|10861518|FG001|NOT COMPLETED|Overall Study||3
9757984|NCT00368940|10861526|FG000|STARTED|Intention-to-Treat||37
9757985|NCT00368940|10861527|FG001|STARTED|Intention-to-Treat||37
9757986|NCT00368940|10861526|FG000|COMPLETED|Intention-to-Treat||37
9757987|NCT00368940|10861527|FG001|COMPLETED|Intention-to-Treat||37
9757988|NCT00368940|10861526|FG000|NOT COMPLETED|Intention-to-Treat||0
9757989|NCT00368940|10861527|FG001|NOT COMPLETED|Intention-to-Treat||0
9757990|NCT00368940|10861526|FG000|STARTED|Completed 12-wk Treatment||37
9757991|NCT00368940|10861527|FG001|STARTED|Completed 12-wk Treatment||37
9757992|NCT00368940|10861526|FG000|COMPLETED|Completed 12-wk Treatment||31
9757993|NCT00368940|10861527|FG001|COMPLETED|Completed 12-wk Treatment||32
9757994|NCT00368940|10861526|FG000|NOT COMPLETED|Completed 12-wk Treatment||6
9757995|NCT00368940|10861527|FG001|NOT COMPLETED|Completed 12-wk Treatment||5
9757996|NCT00368966|10861536|FG000|STARTED|Infant Series||315
9757997|NCT00368966|10861537|FG001|STARTED|Infant Series||304
9757998|NCT00368966|10861536|FG000|Vaccinated Dose 1|Infant Series||314
9757999|NCT00368966|10861537|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
9758000|NCT00368966|10861536|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
9758001|NCT00368966|10861537|FG001|Vaccinated Dose 2|Infant Series||298
9758002|NCT00368966|10861536|FG000|Vaccinated Dose 3|Infant Series||301
9758003|NCT00368966|10861537|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
9758004|NCT00368966|10861536|FG000|COMPLETED|Infant Series||299
9758005|NCT00368966|10861537|FG001|COMPLETED|Infant Series||294
9758006|NCT00368966|10861536|FG000|NOT COMPLETED|Infant Series||16
9758007|NCT00368966|10861537|FG001|NOT COMPLETED|Infant Series||10
9758008|NCT00368966|10861536|FG000|STARTED|After Infant||299
9758009|NCT00368966|10861537|FG001|STARTED|After Infant||294
9758010|NCT00368966|10861536|FG000|COMPLETED|After Infant||293
9758011|NCT00368966|10861537|FG001|COMPLETED|After Infant||289
9758012|NCT00368966|10861536|FG000|NOT COMPLETED|After Infant||6
9758013|NCT00368966|10861537|FG001|NOT COMPLETED|After Infant||5
9758014|NCT00368966|10861536|FG000|STARTED|Toddler Dose||293
9758015|NCT00368966|10861537|FG001|STARTED|Toddler Dose||289
9758016|NCT00368966|10861536|FG000|COMPLETED|Toddler Dose||292
9758017|NCT00368966|10861537|FG001|COMPLETED|Toddler Dose||286
9758018|NCT00368966|10861536|FG000|NOT COMPLETED|Toddler Dose||1
9758019|NCT00368966|10861537|FG001|NOT COMPLETED|Toddler Dose||3
9758020|NCT00368979|10861570|FG000|STARTED|Overall Study||185
9758021|NCT00368979|10861571|FG001|STARTED|Overall Study||193
9758022|NCT00368979|10861570|FG000|COMPLETED|Overall Study||160
9758023|NCT00368979|10861571|FG001|COMPLETED|Overall Study||163
9758024|NCT00368979|10861570|FG000|NOT COMPLETED|Overall Study||25
9758025|NCT00368979|10861571|FG001|NOT COMPLETED|Overall Study||30
9758026|NCT00368992|10861577|FG000|STARTED|Overall Study||110
9758027|NCT00368992|10861577|FG000|COMPLETED|Overall Study||0
9758028|NCT00368992|10861577|FG000|NOT COMPLETED|Overall Study||110
9758029|NCT00369122|10861582|FG000|STARTED|Overall Study||60
9758030|NCT00369122|10861582|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
9758031|NCT00369122|10861582|FG000|NOT COMPLETED|Overall Study||11
9758032|NCT00369161|10861588|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109
9758033|NCT00369161|10861589|FG001|STARTED|Overall Study||119
9758034|NCT00369161|10861588|FG000|Intention to Treat (ITT)|Overall Study||107
9758035|NCT00369161|10861589|FG001|Intention to Treat (ITT)|Overall Study||117
9758036|NCT00369161|10861588|FG000|COMPLETED|Overall Study||82
9758037|NCT00369161|10861589|FG001|COMPLETED|Overall Study||95
9758038|NCT00369161|10861588|FG000|NOT COMPLETED|Overall Study||27
9758039|NCT00369161|10861589|FG001|NOT COMPLETED|Overall Study||24
9758040|NCT00369226|10861597|FG000|STARTED|Phase I (45 Days)||13
9758041|NCT00369226|10861598|FG001|STARTED|Phase I (45 Days)||0
9758042|NCT00369226|10861597|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
9758043|NCT00369226|10861598|FG001|COMPLETED|Phase I (45 Days)||0
9758044|NCT00369226|10861597|FG000|NOT COMPLETED|Phase I (45 Days)||0
9758045|NCT00369226|10861598|FG001|NOT COMPLETED|Phase I (45 Days)||0
9758046|NCT00369226|10861597|FG000|STARTED|Phase II (45 Days)||0
9758047|NCT00369226|10861598|FG001|STARTED|Phase II (45 Days)||32
9758048|NCT00369226|10861597|FG000|COMPLETED|Phase II (45 Days)||0
9758049|NCT00369226|10861598|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
9758050|NCT00369226|10861597|FG000|NOT COMPLETED|Phase II (45 Days)||0
9758051|NCT00369226|10861598|FG001|NOT COMPLETED|Phase II (45 Days)||0
9758052|NCT00369278|10861609|FG000|STARTED|Overall Study||63
9758053|NCT00369278|10861610|FG001|STARTED|Overall Study||65
9758054|NCT00369278|10861609|FG000|COMPLETED|Overall Study||39
9758055|NCT00369278|10861610|FG001|COMPLETED|Overall Study||44
9758056|NCT00369278|10861609|FG000|NOT COMPLETED|Overall Study||24
9758057|NCT00369278|10861610|FG001|NOT COMPLETED|Overall Study||21
9758058|NCT00369343|10861618|FG000|STARTED|Double-blind Phase||256
9758059|NCT00369343|10861619|FG001|STARTED|Double-blind Phase||125
9758060|NCT00369343|10861618|FG000|COMPLETED|Double-blind Phase||212
9758061|NCT00369343|10861619|FG001|COMPLETED|Double-blind Phase||109
9758062|NCT00369343|10861618|FG000|NOT COMPLETED|Double-blind Phase||44
9758063|NCT00369343|10861619|FG001|NOT COMPLETED|Double-blind Phase||16
9758064|NCT00369343|10861618|FG000|STARTED|Open-label Phase||212
9758065|NCT00369343|10861619|FG001|STARTED|Open-label Phase||109
9758066|NCT00369343|10861618|FG000|COMPLETED|Open-label Phase||155
9758067|NCT00369343|10861619|FG001|COMPLETED|Open-label Phase||79
9758068|NCT00369343|10861618|FG000|NOT COMPLETED|Open-label Phase||57
9758069|NCT00369343|10861619|FG001|NOT COMPLETED|Open-label Phase||30
9758070|NCT00369382|10861634|FG000|STARTED|Overall Study||59
9758071|NCT00369382|10861635|FG001|STARTED|Overall Study||57
9758072|NCT00369382|10861634|FG000|Received Treatment|Overall Study||57
9758073|NCT00369382|10861635|FG001|Received Treatment|Overall Study||57
9758074|NCT00369382|10861634|FG000|Completed Assigned Treatment Regimen|Overall Study||48
9758075|NCT00369382|10861635|FG001|Completed Assigned Treatment Regimen|Overall Study||33
9758076|NCT00369382|10861634|FG000|COMPLETED|Overall Study||49
9758077|NCT00369382|10861635|FG001|COMPLETED|Overall Study||54
9758078|NCT00369382|10861634|FG000|NOT COMPLETED|Overall Study||10
9758079|NCT00369382|10861635|FG001|NOT COMPLETED|Overall Study||3
9758080|NCT00369486|10861647|FG000|STARTED|4-Week Visit|Number of eyes|38
9758081|NCT00369486|10861648|FG001|STARTED|4-Week Visit|Number of eyes|21
9758082|NCT00369486|10861649|FG002|STARTED|4-Week Visit|Number of eyes|23
9758083|NCT00369486|10861650|FG003|STARTED|4-Week Visit|Number of eyes|22
9758084|NCT00369486|10861651|FG004|STARTED|4-Week Visit|Number of eyes|25
9758085|NCT00369486|10861647|FG000|COMPLETED|4-Week Visit|Number of eyes|36
9758086|NCT00369486|10861648|FG001|COMPLETED|4-Week Visit|Number of eyes;|19
9758087|NCT00369486|10861649|FG002|COMPLETED|4-Week Visit|Number of eyes|22
9758088|NCT00369486|10861650|FG003|COMPLETED|4-Week Visit|Number of eyes|20
9758089|NCT00369486|10861651|FG004|COMPLETED|4-Week Visit|Number of eyes|24
9758090|NCT00369486|10861647|FG000|NOT COMPLETED|4-Week Visit||2
9758091|NCT00369486|10861648|FG001|NOT COMPLETED|4-Week Visit||2
9758092|NCT00369486|10861649|FG002|NOT COMPLETED|4-Week Visit||1
9758093|NCT00369486|10861650|FG003|NOT COMPLETED|4-Week Visit||2
10092501|NCT02337907|11220964|FG000|NOT COMPLETED|Overall Study||4
10092502|NCT02337907|11220965|FG001|NOT COMPLETED|Overall Study||4
10092503|NCT02337907|11220966|FG002|NOT COMPLETED|Overall Study||1
10092504|NCT02337907|11220967|FG003|NOT COMPLETED|Overall Study||4
9758094|NCT00369486|10861651|FG004|NOT COMPLETED|4-Week Visit||1
9758095|NCT00369486|10861647|FG000|STARTED|8-Week Visit|Number of eyes|38
9758096|NCT00369486|10861648|FG001|STARTED|8-Week Visit|Number of eyes|21
9758097|NCT00369486|10861649|FG002|STARTED|8-Week Visit|Number of eyes|22
9758098|NCT00369486|10861650|FG003|STARTED|8-Week Visit|Number of eyes|22
9758099|NCT00369486|10861651|FG004|STARTED|8-Week Visit|Number of eyes|25
9758100|NCT00369486|10861647|FG000|COMPLETED|8-Week Visit|Number of eyes|38
9758101|NCT00369486|10861648|FG001|COMPLETED|8-Week Visit|Number of eyes|20
10092505|NCT02337907|11220968|FG004|NOT COMPLETED|Overall Study||10
10092506|NCT02337907|11220969|FG005|NOT COMPLETED|Overall Study||1
10092507|NCT02337933|11220986|FG000|STARTED|Overall Study||12
10092508|NCT02337933|11220987|FG001|STARTED|Overall Study||12
10092509|NCT02337933|11220986|FG000|COMPLETED|Overall Study||12
10092510|NCT02337933|11220987|FG001|COMPLETED|Overall Study||12
9758102|NCT00369486|10861649|FG002|COMPLETED|8-Week Visit|Number of eyes|22
9758103|NCT00369486|10861650|FG003|COMPLETED|8-Week Visit|Number of eyes|21
9758104|NCT00369486|10861651|FG004|COMPLETED|8-Week Visit|Number of eyes|24
9758105|NCT00369486|10861647|FG000|NOT COMPLETED|8-Week Visit||0
9758106|NCT00369486|10861648|FG001|NOT COMPLETED|8-Week Visit||1
9758107|NCT00369486|10861649|FG002|NOT COMPLETED|8-Week Visit||0
9758108|NCT00369486|10861650|FG003|NOT COMPLETED|8-Week Visit||1
9758109|NCT00369486|10861651|FG004|NOT COMPLETED|8-Week Visit||1
9758110|NCT00369486|10861647|FG000|STARTED|17-Week Visit|Number of eyes|38
9758111|NCT00369486|10861648|FG001|STARTED|17-Week Visit|Number of eyes|21
9758112|NCT00369486|10861649|FG002|STARTED|17-Week Visit|Number of eyes|23
9758113|NCT00369486|10861650|FG003|STARTED|17-Week Visit|Number of eyes|22
9758114|NCT00369486|10861651|FG004|STARTED|17-Week Visit|Number of eyes|25
9758115|NCT00369486|10861647|FG000|COMPLETED|17-Week Visit|Number of eyes|38
9758116|NCT00369486|10861648|FG001|COMPLETED|17-Week Visit|Number of eyes|21
9758117|NCT00369486|10861649|FG002|COMPLETED|17-Week Visit|Number of eyes|22
9758118|NCT00369486|10861650|FG003|COMPLETED|17-Week Visit|Number of eyes|21
9758119|NCT00369486|10861651|FG004|COMPLETED|17-Week Visit|Number of eyes|24
9758120|NCT00369486|10861647|FG000|NOT COMPLETED|17-Week Visit||0
9758121|NCT00369486|10861648|FG001|NOT COMPLETED|17-Week Visit||0
9758122|NCT00369486|10861649|FG002|NOT COMPLETED|17-Week Visit||1
9758123|NCT00369486|10861650|FG003|NOT COMPLETED|17-Week Visit||1
9758124|NCT00369486|10861651|FG004|NOT COMPLETED|17-Week Visit||1
9758125|NCT00369486|10861647|FG000|STARTED|34-Week Visit|Number of eyes|38
9758126|NCT00369486|10861648|FG001|STARTED|34-Week Visit|Number of eyes|21
9758127|NCT00369486|10861649|FG002|STARTED|34-Week Visit|Number of eyes|23
9758128|NCT00369486|10861650|FG003|STARTED|34-Week Visit|Number of eyes|22
9758129|NCT00369486|10861651|FG004|STARTED|34-Week Visit|Number of eyes that|25
9758130|NCT00369486|10861647|FG000|COMPLETED|34-Week Visit|Number of eyes|38
9758131|NCT00369486|10861648|FG001|COMPLETED|34-Week Visit|Number of eyes|20
9758132|NCT00369486|10861649|FG002|COMPLETED|34-Week Visit|Number of eyes|22
9758133|NCT00369486|10861650|FG003|COMPLETED|34-Week Visit|Number of eyes|19
9758134|NCT00369486|10861651|FG004|COMPLETED|34-Week Visit|Number of eyes|22
9758135|NCT00369486|10861647|FG000|NOT COMPLETED|34-Week Visit||0
9758136|NCT00369486|10861648|FG001|NOT COMPLETED|34-Week Visit||1
9758137|NCT00369486|10861649|FG002|NOT COMPLETED|34-Week Visit||1
9758138|NCT00369486|10861650|FG003|NOT COMPLETED|34-Week Visit||3
9758139|NCT00369486|10861651|FG004|NOT COMPLETED|34-Week Visit||3
9758140|NCT00369512|10861663|FG000|STARTED|Overall Study||15
9758141|NCT00369512|10861663|FG000|COMPLETED|Overall Study||15
9758142|NCT00369512|10861663|FG000|NOT COMPLETED|Overall Study||0
9758143|NCT00369564|10861669|FG000|STARTED|Overall Study||127
9758144|NCT00369564|10861670|FG001|STARTED|Overall Study||123
9758145|NCT00369564|10861669|FG000|COMPLETED|Overall Study||84
9758146|NCT00369564|10861670|FG001|COMPLETED|Overall Study||100
9758147|NCT00369564|10861669|FG000|NOT COMPLETED|Overall Study||43
9758148|NCT00369564|10861670|FG001|NOT COMPLETED|Overall Study||23
9758149|NCT00369577|10861683|FG000|STARTED|Overall Study||43
9758150|NCT00369577|10861684|FG001|STARTED|Overall Study||45
9758151|NCT00369577|10861685|FG002|STARTED|Overall Study||41
9758152|NCT00369577|10861683|FG000|COMPLETED|Overall Study||43
9758153|NCT00369577|10861684|FG001|COMPLETED|Overall Study||45
9758154|NCT00369577|10861685|FG002|COMPLETED|Overall Study||40
9758155|NCT00369577|10861683|FG000|NOT COMPLETED|Overall Study||0
9758156|NCT00369577|10861684|FG001|NOT COMPLETED|Overall Study||0
9758157|NCT00369577|10861685|FG002|NOT COMPLETED|Overall Study||1
9758158|NCT00369590|10861695|FG000|STARTED|Overall Study||16
9758159|NCT00369590|10861696|FG001|STARTED|Overall Study||42
9758160|NCT00369590|10861695|FG000|COMPLETED|Overall Study||16
9758161|NCT00369590|10861696|FG001|COMPLETED|Overall Study||42
9758162|NCT00369590|10861695|FG000|NOT COMPLETED|Overall Study||0
9758163|NCT00369590|10861696|FG001|NOT COMPLETED|Overall Study||0
9758164|NCT00369629|10861701|FG000|STARTED|Treated 2 Cycles/Reached First Response||6
9758165|NCT00369629|10861702|FG001|STARTED|Treated 2 Cycles/Reached First Response||3
9758166|NCT00369629|10861703|FG002|STARTED|Treated 2 Cycles/Reached First Response||5
9758167|NCT00369629|10861704|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
9758168|NCT00369629|10861701|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4
9758169|NCT00369629|10861702|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2
9758170|NCT00369629|10861703|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3
9758171|NCT00369629|10861704|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0
9758172|NCT00369629|10861701|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
9758173|NCT00369629|10861702|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
9758174|NCT00369629|10861703|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
9758175|NCT00369629|10861704|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
10092511|NCT02337933|11220986|FG000|NOT COMPLETED|Overall Study||0
10092512|NCT02337933|11220987|FG001|NOT COMPLETED|Overall Study||0
10092513|NCT02337946|11220993|FG000|STARTED|Protocol Treatment 1 Period||164
10092514|NCT02337946|11220994|FG001|STARTED|Protocol Treatment 1 Period||0
9758176|NCT00369629|10861701|FG000|STARTED|Moved on to 4 More Cycles||4
9758177|NCT00369629|10861702|FG001|STARTED|Moved on to 4 More Cycles||2
9758178|NCT00369629|10861703|FG002|STARTED|Moved on to 4 More Cycles||3
9758179|NCT00369629|10861704|FG003|STARTED|Moved on to 4 More Cycles||0
9758180|NCT00369629|10861701|FG000|COMPLETED|Moved on to 4 More Cycles||4
9758181|NCT00369629|10861702|FG001|COMPLETED|Moved on to 4 More Cycles||2
9758182|NCT00369629|10861703|FG002|COMPLETED|Moved on to 4 More Cycles||2
9758183|NCT00369629|10861704|FG003|COMPLETED|Moved on to 4 More Cycles||0
9758184|NCT00369629|10861701|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0
9758185|NCT00369629|10861702|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0
9758186|NCT00369629|10861703|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1
9758187|NCT00369629|10861704|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0
9758188|NCT00369629|10861701|FG000|STARTED|Completed 4 More Cycles||4
9758189|NCT00369629|10861702|FG001|STARTED|Completed 4 More Cycles||2
9758190|NCT00369629|10861703|FG002|STARTED|Completed 4 More Cycles||2
9758191|NCT00369629|10861704|FG003|STARTED|Completed 4 More Cycles||0
9758192|NCT00369629|10861701|FG000|COMPLETED|Completed 4 More Cycles||0
9758193|NCT00369629|10861702|FG001|COMPLETED|Completed 4 More Cycles||0
9758194|NCT00369629|10861703|FG002|COMPLETED|Completed 4 More Cycles||0
9758195|NCT00369629|10861704|FG003|COMPLETED|Completed 4 More Cycles||0
9758196|NCT00369629|10861701|FG000|NOT COMPLETED|Completed 4 More Cycles||4
9758197|NCT00369629|10861702|FG001|NOT COMPLETED|Completed 4 More Cycles||2
9758198|NCT00369629|10861703|FG002|NOT COMPLETED|Completed 4 More Cycles||2
9758199|NCT00369629|10861704|FG003|NOT COMPLETED|Completed 4 More Cycles||0
9758200|NCT00369629|10861701|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
9758201|NCT00369629|10861702|FG001|STARTED|Follow up for 1 Year||3
9758202|NCT00369629|10861703|FG002|STARTED|Follow up for 1 Year||5
9758203|NCT00369629|10861704|FG003|STARTED|Follow up for 1 Year||0
9758204|NCT00369629|10861701|FG000|COMPLETED|Follow up for 1 Year||4
9758205|NCT00369629|10861702|FG001|COMPLETED|Follow up for 1 Year||1
9758206|NCT00369629|10861703|FG002|COMPLETED|Follow up for 1 Year||2
9758207|NCT00369629|10861704|FG003|COMPLETED|Follow up for 1 Year||0
9758208|NCT00369629|10861701|FG000|NOT COMPLETED|Follow up for 1 Year||2
9758209|NCT00369629|10861702|FG001|NOT COMPLETED|Follow up for 1 Year||2
9758210|NCT00369629|10861703|FG002|NOT COMPLETED|Follow up for 1 Year||3
9758211|NCT00369629|10861704|FG003|NOT COMPLETED|Follow up for 1 Year||0
9758212|NCT00369655|10861714|FG000|STARTED|Overall Study||21
9758213|NCT00369655|10861714|FG000|COMPLETED|Overall Study||19
9758214|NCT00369655|10861714|FG000|NOT COMPLETED|Overall Study||2
9758215|NCT00369668|10861721|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
9758216|NCT00369668|10861722|FG001|STARTED|Overall Study||10
9758217|NCT00369668|10861723|FG002|STARTED|Overall Study||10
9758218|NCT00369668|10861721|FG000|COMPLETED|Overall Study||6
9758219|NCT00369668|10861722|FG001|COMPLETED|Overall Study||5
9758220|NCT00369668|10861723|FG002|COMPLETED|Overall Study||3
9758221|NCT00369668|10861721|FG000|NOT COMPLETED|Overall Study||4
9758222|NCT00369668|10861722|FG001|NOT COMPLETED|Overall Study||5
9758223|NCT00369668|10861723|FG002|NOT COMPLETED|Overall Study||7
9758224|NCT00369681|10861734|FG000|STARTED|Overall Study||50
9758225|NCT00369681|10861734|FG000|COMPLETED|Overall Study||49
9758226|NCT00369681|10861734|FG000|NOT COMPLETED|Overall Study||1
9758227|NCT00369707|10861738|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42
9758228|NCT00369707|10861738|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
9758229|NCT00369707|10861738|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
9758230|NCT00369707|10861738|FG000|STARTED|Induction Part B (2 Cycles)||42
9758231|NCT00369707|10861738|FG000|COMPLETED|Induction Part B (2 Cycles)||35
9758232|NCT00369707|10861738|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7
9758233|NCT00369707|10861738|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35
9758234|NCT00369707|10861738|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27
9758235|NCT00369707|10861738|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
9758236|NCT00369707|10861738|FG000|STARTED|Follow up for 2 Years After Treatment||41
9758237|NCT00369707|10861738|FG000|COMPLETED|Follow up for 2 Years After Treatment||38
9758238|NCT00369707|10861738|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3
9758239|NCT00369746|10861744|FG000|STARTED|Overall Study||138
9758240|NCT00369746|10861745|FG001|STARTED|Overall Study||536
9758241|NCT00369746|10861744|FG000|COMPLETED|Overall Study||138
9758242|NCT00369746|10861745|FG001|COMPLETED|Overall Study||536
9758243|NCT00369746|10861744|FG000|NOT COMPLETED|Overall Study||0
9758244|NCT00369746|10861745|FG001|NOT COMPLETED|Overall Study||0
9758245|NCT00369785|10861753|FG000|STARTED|Overall Study||99
9758246|NCT00369785|10861754|FG001|STARTED|Overall Study||99
9758247|NCT00369785|10861753|FG000|COMPLETED|Overall Study||72
9758248|NCT00369785|10861754|FG001|COMPLETED|Overall Study||74
9758249|NCT00369785|10861753|FG000|NOT COMPLETED|Overall Study||27
9758250|NCT00369785|10861754|FG001|NOT COMPLETED|Overall Study||25
9758251|NCT00369824|10861766|FG000|STARTED|Overall Study||212
9758252|NCT00369824|10861767|FG001|STARTED|Overall Study||214
9758253|NCT00369824|10861768|FG002|STARTED|Overall Study||214
9758254|NCT00369824|10861769|FG003|STARTED|Overall Study||214
9758255|NCT00369824|10861770|FG004|STARTED|Overall Study||214
9758256|NCT00369824|10861771|FG005|STARTED|Overall Study||215
9758257|NCT00369824|10861766|FG000|COMPLETED|Overall Study||197
9758258|NCT00369824|10861767|FG001|COMPLETED|Overall Study||195
9758259|NCT00369824|10861768|FG002|COMPLETED|Overall Study||202
9758260|NCT00369824|10861769|FG003|COMPLETED|Overall Study||199
9758261|NCT00369824|10861770|FG004|COMPLETED|Overall Study||196
9758262|NCT00369824|10861771|FG005|COMPLETED|Overall Study||204
9758263|NCT00369824|10861766|FG000|NOT COMPLETED|Overall Study||15
9758264|NCT00369824|10861767|FG001|NOT COMPLETED|Overall Study||19
9758265|NCT00369824|10861768|FG002|NOT COMPLETED|Overall Study||12
9758266|NCT00369824|10861769|FG003|NOT COMPLETED|Overall Study||15
9758267|NCT00369824|10861770|FG004|NOT COMPLETED|Overall Study||18
9758268|NCT00369824|10861771|FG005|NOT COMPLETED|Overall Study||11
9758269|NCT00369915|10861787|FG000|STARTED|Overall Study||10
9758270|NCT00369915|10861788|FG001|STARTED|Overall Study||7
9758271|NCT00369915|10861787|FG000|COMPLETED|Overall Study||4
9758272|NCT00369915|10861788|FG001|COMPLETED|Overall Study||4
9758273|NCT00369915|10861787|FG000|NOT COMPLETED|Overall Study||6
9758274|NCT00369915|10861788|FG001|NOT COMPLETED|Overall Study||3
9758275|NCT00369928|10861797|FG000|STARTED|Overall Study||85
9758276|NCT00369928|10861798|FG001|STARTED|Overall Study||85
9758277|NCT00369928|10861799|FG002|STARTED|Overall Study||86
9758278|NCT00369928|10861797|FG000|COMPLETED|Overall Study||77
9758279|NCT00369928|10861798|FG001|COMPLETED|Overall Study||69
9758280|NCT00369928|10861799|FG002|COMPLETED|Overall Study||66
9758281|NCT00369928|10861797|FG000|NOT COMPLETED|Overall Study||8
9758282|NCT00369928|10861798|FG001|NOT COMPLETED|Overall Study||16
9758283|NCT00369928|10861799|FG002|NOT COMPLETED|Overall Study||20
9758284|NCT00369941|10861809|FG000|STARTED|Overall Study||282
9758285|NCT00369941|10861810|FG001|STARTED|Overall Study||284
9758286|NCT00369941|10861809|FG000|Treated|Overall Study||281
9758287|NCT00369941|10861810|FG001|Treated|Overall Study||282
9758288|NCT00369941|10861809|FG000|COMPLETED|Overall Study||210
9758289|NCT00369941|10861810|FG001|COMPLETED|Overall Study||184
9758290|NCT00369941|10861809|FG000|NOT COMPLETED|Overall Study||72
9758291|NCT00369941|10861810|FG001|NOT COMPLETED|Overall Study||100
9758292|NCT00369967|10861819|FG000|STARTED|Overall Study||31
9758293|NCT00369967|10861820|FG001|STARTED|Overall Study||17
9758294|NCT00369967|10861819|FG000|COMPLETED|Overall Study||8
9758295|NCT00369967|10861820|FG001|COMPLETED|Overall Study||5
9758296|NCT00369967|10861819|FG000|NOT COMPLETED|Overall Study||23
9758297|NCT00369967|10861820|FG001|NOT COMPLETED|Overall Study||12
9758298|NCT00370032|10861832|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
9758299|NCT00370032|10861833|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
9758300|NCT00370032|10861832|FG000|COMPLETED|Treatment Period 1||24
9758301|NCT00370032|10861833|FG001|COMPLETED|Treatment Period 1||24
9758302|NCT00370032|10861832|FG000|NOT COMPLETED|Treatment Period 1||0
9758303|NCT00370032|10861833|FG001|NOT COMPLETED|Treatment Period 1||1
9758304|NCT00370032|10861832|FG000|STARTED|Washout Period||24
9758305|NCT00370032|10861833|FG001|STARTED|Washout Period||24
9758306|NCT00370032|10861832|FG000|COMPLETED|Washout Period||23
9758307|NCT00370032|10861833|FG001|COMPLETED|Washout Period||22
9758308|NCT00370032|10861832|FG000|NOT COMPLETED|Washout Period||1
9758309|NCT00370032|10861833|FG001|NOT COMPLETED|Washout Period||2
9758310|NCT00370032|10861832|FG000|STARTED|Treatment Period 2||23
9758311|NCT00370032|10861833|FG001|STARTED|Treatment Period 2||22
9758312|NCT00370032|10861832|FG000|COMPLETED|Treatment Period 2||23
9758313|NCT00370032|10861833|FG001|COMPLETED|Treatment Period 2||22
9758314|NCT00370032|10861832|FG000|NOT COMPLETED|Treatment Period 2||0
9758315|NCT00370032|10861833|FG001|NOT COMPLETED|Treatment Period 2||0
9758316|NCT00370032|10861832|FG000|STARTED|Follow-up Period||23
9758317|NCT00370032|10861833|FG001|STARTED|Follow-up Period||22
9758318|NCT00370032|10861832|FG000|COMPLETED|Follow-up Period||22
9758319|NCT00370032|10861833|FG001|COMPLETED|Follow-up Period||22
9758320|NCT00370032|10861832|FG000|NOT COMPLETED|Follow-up Period||1
9758321|NCT00370032|10861833|FG001|NOT COMPLETED|Follow-up Period||0
9758322|NCT00370071|10861848|FG000|STARTED|Overall Study||39
9758323|NCT00370071|10861848|FG000|COMPLETED|Overall Study||37
9758324|NCT00370071|10861848|FG000|NOT COMPLETED|Overall Study||2
9758325|NCT00370149|10861854|FG000|STARTED|Overall Study||165
9758326|NCT00370149|10861855|FG001|STARTED|Overall Study||161
9758327|NCT00370149|10861854|FG000|COMPLETED|Overall Study||146
9758328|NCT00370149|10861855|FG001|COMPLETED|Overall Study||142
9758329|NCT00370149|10861854|FG000|NOT COMPLETED|Overall Study||19
9758330|NCT00370149|10861855|FG001|NOT COMPLETED|Overall Study||19
9758331|NCT00370292|10861866|FG000|STARTED|Overall Study||19
9758332|NCT00370292|10861866|FG000|COMPLETED|Overall Study||6
9758333|NCT00370292|10861866|FG000|NOT COMPLETED|Overall Study||13
9829109|NCT00758524|10939641|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829110|NCT00758524|10939642|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
9829111|NCT00758524|10939643|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
9829112|NCT00758524|10939644|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
9829113|NCT00758524|10939645|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
9829114|NCT00758524|10939646|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
9829115|NCT00758524|10939647|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
9829116|NCT00758524|10939648|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
9829117|NCT00758524|10939649|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
9829118|NCT00758524|10939650|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
9829119|NCT00758524|10939651|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
9829120|NCT00758524|10939652|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
9829121|NCT00758524|10939636|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829122|NCT00758524|10939637|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9758334|NCT04876274|10861879|FG000|STARTED|Overall Study||91
9758335|NCT04876274|10861880|FG001|STARTED|Overall Study||90
9758336|NCT04876274|10861879|FG000|COMPLETED|Overall Study||82
9758337|NCT04876274|10861880|FG001|COMPLETED|Overall Study||78
9758338|NCT04876274|10861879|FG000|NOT COMPLETED|Overall Study||9
9758339|NCT04876274|10861880|FG001|NOT COMPLETED|Overall Study||12
9758355|NCT04150341|10861908|FG000|STARTED|Overall Study||4
9758356|NCT04150341|10861909|FG001|STARTED|Overall Study||4
9758357|NCT04150341|10861910|FG002|STARTED|Overall Study||4
9758358|NCT04150341|10861911|FG003|STARTED|Overall Study||4
9758359|NCT04150341|10861912|FG004|STARTED|Overall Study||4
9758360|NCT04150341|10861913|FG005|STARTED|Overall Study||4
9758361|NCT04150341|10861908|FG000|COMPLETED|Overall Study||4
9758362|NCT04150341|10861909|FG001|COMPLETED|Overall Study||4
9758363|NCT04150341|10861910|FG002|COMPLETED|Overall Study||3
9758364|NCT04150341|10861911|FG003|COMPLETED|Overall Study||4
9758365|NCT04150341|10861912|FG004|COMPLETED|Overall Study||3
9758366|NCT04150341|10861913|FG005|COMPLETED|Overall Study||4
9758367|NCT04150341|10861908|FG000|NOT COMPLETED|Overall Study||0
9758368|NCT04150341|10861909|FG001|NOT COMPLETED|Overall Study||0
9758369|NCT04150341|10861910|FG002|NOT COMPLETED|Overall Study||1
9758370|NCT04150341|10861911|FG003|NOT COMPLETED|Overall Study||0
9758371|NCT04150341|10861912|FG004|NOT COMPLETED|Overall Study||1
9758372|NCT04150341|10861913|FG005|NOT COMPLETED|Overall Study||0
9758373|NCT04115839|10861926|FG000|STARTED|Main Study (Up to 16 Weeks)||36
9758374|NCT04115839|10861927|FG001|STARTED|Main Study (Up to 16 Weeks)||34
9758375|NCT04115839|10861928|FG002|STARTED|Main Study (Up to 16 Weeks)||36
9758376|NCT04115839|10861929|FG003|STARTED|Main Study (Up to 16 Weeks)||0
9758377|NCT04115839|10861930|FG004|STARTED|Main Study (Up to 16 Weeks)||0
9758378|NCT04115839|10861931|FG005|STARTED|Main Study (Up to 16 Weeks)||0
9758379|NCT04115839|10861932|FG006|STARTED|Main Study (Up to 16 Weeks)||0
9758380|NCT04115839|10861926|FG000|COMPLETED|Main Study (Up to 16 Weeks)||18
9758381|NCT04115839|10861927|FG001|COMPLETED|Main Study (Up to 16 Weeks)||20
9758382|NCT04115839|10861928|FG002|COMPLETED|Main Study (Up to 16 Weeks)||18
9758383|NCT04115839|10861929|FG003|COMPLETED|Main Study (Up to 16 Weeks)||0
9758384|NCT04115839|10861930|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
9758385|NCT04115839|10861931|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
9758386|NCT04115839|10861932|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
9758387|NCT04115839|10861926|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
9758388|NCT04115839|10861927|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||14
9758389|NCT04115839|10861928|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
9758390|NCT04115839|10861929|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9758391|NCT04115839|10861930|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9758392|NCT04115839|10861931|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9758393|NCT04115839|10861932|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9758394|NCT04115839|10861926|FG000|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
9758395|NCT04115839|10861927|FG001|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
9758396|NCT04115839|10861928|FG002|STARTED|LTE Phase (After Week 16 to Week 63)|18 participants who completed main study did not enter LTE phase.|0
9758397|NCT04115839|10861929|FG003|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|18
9758398|NCT04115839|10861930|FG004|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|20
9758399|NCT04115839|10861931|FG005|STARTED|LTE Phase (After Week 16 to Week 63)|10 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|10
9758400|NCT04115839|10861932|FG006|STARTED|LTE Phase (After Week 16 to Week 63)|8 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|8
9758401|NCT04115839|10861926|FG000|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758402|NCT04115839|10861927|FG001|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758403|NCT04115839|10861928|FG002|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758404|NCT04115839|10861929|FG003|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758405|NCT04115839|10861930|FG004|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758406|NCT04115839|10861931|FG005|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758407|NCT04115839|10861932|FG006|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758408|NCT04115839|10861926|FG000|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758409|NCT04115839|10861927|FG001|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758410|NCT04115839|10861928|FG002|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
9758411|NCT04115839|10861929|FG003|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||18
9758412|NCT04115839|10861930|FG004|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||20
9758413|NCT04115839|10861931|FG005|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||10
9758414|NCT04115839|10861932|FG006|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||8
9758415|NCT04078126|10861957|FG000|STARTED|Period 1||18
9758416|NCT04078126|10861958|FG001|STARTED|Period 1||17
9758417|NCT04078126|10861957|FG000|COMPLETED|Period 1||18
9758418|NCT04078126|10861958|FG001|COMPLETED|Period 1||17
9758419|NCT04078126|10861957|FG000|NOT COMPLETED|Period 1||0
9758420|NCT04078126|10861958|FG001|NOT COMPLETED|Period 1||0
9758421|NCT04078126|10861957|FG000|STARTED|Washout||18
9758422|NCT04078126|10861958|FG001|STARTED|Washout||17
9758423|NCT04078126|10861957|FG000|COMPLETED|Washout||18
9758424|NCT04078126|10861958|FG001|COMPLETED|Washout||15
9758340|NCT04656691|10861886|FG000|STARTED|Overall Study||139
9758341|NCT04656691|10861886|FG000|COMPLETED|Overall Study||138
9758342|NCT04656691|10861886|FG000|NOT COMPLETED|Overall Study||1
9758343|NCT04615299|10861892|FG000|STARTED|Overall Study||36
9758344|NCT04615299|10861893|FG001|STARTED|Overall Study||36
9758345|NCT04615299|10861892|FG000|COMPLETED|Overall Study||36
9758346|NCT04615299|10861893|FG001|COMPLETED|Overall Study||36
9758347|NCT04615299|10861892|FG000|NOT COMPLETED|Overall Study||0
9758348|NCT04615299|10861893|FG001|NOT COMPLETED|Overall Study||0
9758349|NCT04555096|10861901|FG000|STARTED|Overall Study||9
9758350|NCT04555096|10861902|FG001|STARTED|Overall Study||7
9758351|NCT04555096|10861901|FG000|COMPLETED|Overall Study||4
9758352|NCT04555096|10861902|FG001|COMPLETED|Overall Study||2
9758353|NCT04555096|10861901|FG000|NOT COMPLETED|Overall Study||5
9758354|NCT04555096|10861902|FG001|NOT COMPLETED|Overall Study||5
9758425|NCT04078126|10861957|FG000|NOT COMPLETED|Washout||0
9758426|NCT04078126|10861958|FG001|NOT COMPLETED|Washout||2
9758427|NCT04078126|10861957|FG000|STARTED|Period 2||18
9758428|NCT04078126|10861958|FG001|STARTED|Period 2||15
9758429|NCT04078126|10861957|FG000|COMPLETED|Period 2||17
9758430|NCT04078126|10861958|FG001|COMPLETED|Period 2||14
9854542|NCT00894543|10967643|FG000|COMPLETED|Baseline||104
9854543|NCT00894543|10967644|FG001|COMPLETED|Baseline||101
9854544|NCT00894543|10967643|FG000|NOT COMPLETED|Baseline||0
9854545|NCT00894543|10967644|FG001|NOT COMPLETED|Baseline||0
9854546|NCT00894543|10967643|FG000|STARTED|Baseline to Week 4||104
9854547|NCT00894543|10967644|FG001|STARTED|Baseline to Week 4||101
9854548|NCT00894543|10967643|FG000|COMPLETED|Baseline to Week 4||101
9854549|NCT00894543|10967644|FG001|COMPLETED|Baseline to Week 4||99
9854550|NCT00894543|10967643|FG000|NOT COMPLETED|Baseline to Week 4||3
9854551|NCT00894543|10967644|FG001|NOT COMPLETED|Baseline to Week 4||2
9854552|NCT00894543|10967643|FG000|STARTED|Week 4 to Week 8||101
9854553|NCT00894543|10967644|FG001|STARTED|Week 4 to Week 8||99
9854554|NCT00894543|10967643|FG000|COMPLETED|Week 4 to Week 8||97
9854555|NCT00894543|10967644|FG001|COMPLETED|Week 4 to Week 8||97
9854556|NCT00894543|10967643|FG000|NOT COMPLETED|Week 4 to Week 8||4
9854557|NCT00894543|10967644|FG001|NOT COMPLETED|Week 4 to Week 8||2
9854558|NCT00894647|10967652|FG000|STARTED|Overall Study||121
9854559|NCT00894647|10967653|FG001|STARTED|Overall Study||126
9854560|NCT00894647|10967652|FG000|COMPLETED|Overall Study||111
9854561|NCT00894647|10967653|FG001|COMPLETED|Overall Study||112
9854562|NCT00894647|10967652|FG000|NOT COMPLETED|Overall Study||10
9854563|NCT00894647|10967653|FG001|NOT COMPLETED|Overall Study||14
9854564|NCT00894686|10967659|FG000|STARTED|Overall Study||179
9854565|NCT00894686|10967659|FG000|COMPLETED|Overall Study||123
9854566|NCT00894686|10967659|FG000|NOT COMPLETED|Overall Study||56
9854567|NCT00894699|10967665|FG000|STARTED|Overall Study||21
9854568|NCT00894699|10967666|FG001|STARTED|Overall Study||19
9854569|NCT00894699|10967665|FG000|COMPLETED|Overall Study||21
9854570|NCT00894699|10967666|FG001|COMPLETED|Overall Study||19
9854571|NCT00894699|10967665|FG000|NOT COMPLETED|Overall Study||0
9854572|NCT00894699|10967666|FG001|NOT COMPLETED|Overall Study||0
9953027|NCT01425203|11071887|FG001|NOT COMPLETED|Treatment Phase||37
9953028|NCT01425203|11071888|FG002|NOT COMPLETED|Treatment Phase||0
9953029|NCT01425203|11071886|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
9953030|NCT01425203|11071887|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
9953031|NCT01425203|11071888|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
9953032|NCT01425203|11071886|FG000|COMPLETED|Crossover Phase||0
9953033|NCT01425203|11071887|FG001|COMPLETED|Crossover Phase||0
9953034|NCT01425203|11071888|FG002|COMPLETED|Crossover Phase||21
9953035|NCT01425203|11071886|FG000|NOT COMPLETED|Crossover Phase||0
9953036|NCT01425203|11071887|FG001|NOT COMPLETED|Crossover Phase||0
9953037|NCT01425203|11071888|FG002|NOT COMPLETED|Crossover Phase||6
9953038|NCT01425203|11071886|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
9953039|NCT01425203|11071887|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
9953040|NCT01425203|11071888|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
9953041|NCT01425203|11071886|FG000|COMPLETED|Follow-up Phase||153
9953042|NCT01425203|11071887|FG001|COMPLETED|Follow-up Phase||49
9953043|NCT01425203|11071888|FG002|COMPLETED|Follow-up Phase||27
9953044|NCT01425203|11071886|FG000|NOT COMPLETED|Follow-up Phase||0
9953045|NCT01425203|11071887|FG001|NOT COMPLETED|Follow-up Phase||0
9953046|NCT01425203|11071888|FG002|NOT COMPLETED|Follow-up Phase||0
9953047|NCT01425229|11071896|FG000|STARTED|Bosentan Single Dose||16
9953048|NCT01425229|11071896|FG000|COMPLETED|Bosentan Single Dose||16
9953049|NCT01425229|11071896|FG000|NOT COMPLETED|Bosentan Single Dose||0
9953050|NCT01425229|11071896|FG000|STARTED|Bosentan Steady-state||16
9953051|NCT01425229|11071896|FG000|COMPLETED|Bosentan Steady-state||16
9953052|NCT01425229|11071896|FG000|NOT COMPLETED|Bosentan Steady-state||0
9953053|NCT01425229|11071896|FG000|STARTED|Bosentan During Clarithromycin||16
9953054|NCT01425229|11071896|FG000|COMPLETED|Bosentan During Clarithromycin||16
9953055|NCT01425229|11071896|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0
9758431|NCT04078126|10861957|FG000|NOT COMPLETED|Period 2||1
9758432|NCT04078126|10861958|FG001|NOT COMPLETED|Period 2||1
9758433|NCT03825341|10861966|FG000|STARTED|Overall Study||0
9758434|NCT03825341|10861967|FG001|STARTED|Overall Study||1
9758435|NCT03825341|10861966|FG000|COMPLETED|Overall Study||0
9758436|NCT03825341|10861967|FG001|COMPLETED|Overall Study||0
9758437|NCT03825341|10861966|FG000|NOT COMPLETED|Overall Study||0
9758438|NCT03825341|10861967|FG001|NOT COMPLETED|Overall Study||1
9758439|NCT03751631|10861975|FG000|STARTED|Overall Study||10
9758440|NCT03751631|10861976|FG001|STARTED|Overall Study||11
9758441|NCT03751631|10861977|FG002|STARTED|Overall Study||11
9758442|NCT03751631|10861978|FG003|STARTED|Overall Study||11
9758443|NCT03751631|10861979|FG004|STARTED|Overall Study||10
9758444|NCT03751631|10861980|FG005|STARTED|Overall Study||11
9758445|NCT03751631|10861975|FG000|Received 1st Drug in Sequence|Overall Study||10
9758446|NCT03751631|10861976|FG001|Received 1st Drug in Sequence|Overall Study||11
9758447|NCT03751631|10861977|FG002|Received 1st Drug in Sequence|Overall Study||11
9758448|NCT03751631|10861978|FG003|Received 1st Drug in Sequence|Overall Study||11
9758449|NCT03751631|10861979|FG004|Received 1st Drug in Sequence|Overall Study||10
9758450|NCT03751631|10861980|FG005|Received 1st Drug in Sequence|Overall Study||11
9758451|NCT03751631|10861975|FG000|Received 2nd Drug in Sequence|Overall Study||10
9758452|NCT03751631|10861976|FG001|Received 2nd Drug in Sequence|Overall Study||11
9758453|NCT03751631|10861977|FG002|Received 2nd Drug in Sequence|Overall Study||10
9758454|NCT03751631|10861978|FG003|Received 2nd Drug in Sequence|Overall Study||10
9758455|NCT03751631|10861979|FG004|Received 2nd Drug in Sequence|Overall Study||10
9758456|NCT03751631|10861980|FG005|Received 2nd Drug in Sequence|Overall Study||11
9758457|NCT03751631|10861975|FG000|Received 3rd Drug in Sequence|Overall Study||10
9758458|NCT03751631|10861976|FG001|Received 3rd Drug in Sequence|Overall Study||11
9758459|NCT03751631|10861977|FG002|Received 3rd Drug in Sequence|Overall Study||10
9758460|NCT03751631|10861978|FG003|Received 3rd Drug in Sequence|Overall Study||10
9758461|NCT03751631|10861979|FG004|Received 3rd Drug in Sequence|Overall Study||10
9758462|NCT03751631|10861980|FG005|Received 3rd Drug in Sequence|Overall Study||11
9758463|NCT03751631|10861975|FG000|COMPLETED|Overall Study||10
9758464|NCT03751631|10861976|FG001|COMPLETED|Overall Study||11
9758465|NCT03751631|10861977|FG002|COMPLETED|Overall Study||10
9758466|NCT03751631|10861978|FG003|COMPLETED|Overall Study||10
9758467|NCT03751631|10861979|FG004|COMPLETED|Overall Study||10
9758468|NCT03751631|10861980|FG005|COMPLETED|Overall Study||11
9758469|NCT03751631|10861975|FG000|NOT COMPLETED|Overall Study||0
9758470|NCT03751631|10861976|FG001|NOT COMPLETED|Overall Study||0
9758471|NCT03751631|10861977|FG002|NOT COMPLETED|Overall Study||1
9758472|NCT03751631|10861978|FG003|NOT COMPLETED|Overall Study||1
9758473|NCT03751631|10861979|FG004|NOT COMPLETED|Overall Study||0
9758474|NCT03751631|10861980|FG005|NOT COMPLETED|Overall Study||0
9758475|NCT03751098|10861991|FG000|STARTED|Overall Study||37
9758476|NCT03751098|10861992|FG001|STARTED|Overall Study||33
9758477|NCT03751098|10861991|FG000|COMPLETED|Overall Study||37
9758478|NCT03751098|10861992|FG001|COMPLETED|Overall Study||32
9758479|NCT03751098|10861991|FG000|NOT COMPLETED|Overall Study||0
9758480|NCT03751098|10861992|FG001|NOT COMPLETED|Overall Study||1
9758481|NCT03673345|10862008|FG000|STARTED|Overall Study||5
9758482|NCT03673345|10862009|FG001|STARTED|Overall Study||3
9758483|NCT03673345|10862010|FG002|STARTED|Overall Study||57
9758484|NCT03673345|10862011|FG003|STARTED|Overall Study||12
9758485|NCT03673345|10862012|FG004|STARTED|Overall Study||21
9758486|NCT03673345|10862013|FG005|STARTED|Overall Study||7
9758487|NCT03673345|10862014|FG006|STARTED|Overall Study||20
9758488|NCT03673345|10862015|FG007|STARTED|Overall Study||0
9758489|NCT03673345|10862008|FG000|COMPLETED|Overall Study||3
9758490|NCT03673345|10862009|FG001|COMPLETED|Overall Study||3
9758491|NCT03673345|10862010|FG002|COMPLETED|Overall Study||48
9758492|NCT03673345|10862011|FG003|COMPLETED|Overall Study||7
9758493|NCT03673345|10862012|FG004|COMPLETED|Overall Study||19
9758494|NCT03673345|10862013|FG005|COMPLETED|Overall Study||6
9758495|NCT03673345|10862014|FG006|COMPLETED|Overall Study||20
9758496|NCT03673345|10862015|FG007|COMPLETED|Overall Study||0
9758497|NCT03673345|10862008|FG000|NOT COMPLETED|Overall Study||2
9758498|NCT03673345|10862009|FG001|NOT COMPLETED|Overall Study||0
9758499|NCT03673345|10862010|FG002|NOT COMPLETED|Overall Study||9
9758500|NCT03673345|10862011|FG003|NOT COMPLETED|Overall Study||5
9758501|NCT03673345|10862012|FG004|NOT COMPLETED|Overall Study||2
9758502|NCT03673345|10862013|FG005|NOT COMPLETED|Overall Study||1
9758503|NCT03673345|10862014|FG006|NOT COMPLETED|Overall Study||0
9758504|NCT03673345|10862015|FG007|NOT COMPLETED|Overall Study||0
9758505|NCT03418675|10862035|FG000|STARTED|Overall Study||40
9758506|NCT03418675|10862036|FG001|STARTED|Overall Study||40
9758507|NCT03418675|10862035|FG000|Completed All Baseline Measures|Overall Study||37
9832523|NCT00773461|10943295|FG000|STARTED|Overall Study||70
9832524|NCT00773461|10943296|FG001|STARTED|Overall Study||139
9832525|NCT00773461|10943295|FG000|COMPLETED|Overall Study||65
9832526|NCT00773461|10943296|FG001|COMPLETED|Overall Study||135
9832527|NCT00773461|10943295|FG000|NOT COMPLETED|Overall Study||5
9832528|NCT00773461|10943296|FG001|NOT COMPLETED|Overall Study||4
9832529|NCT00773474|10943303|FG000|STARTED|Overall Study||29
9832530|NCT00773474|10943303|FG000|COMPLETED|Overall Study||29
9832531|NCT00773474|10943303|FG000|NOT COMPLETED|Overall Study||0
9832532|NCT00773513|10943309|FG000|STARTED|Overall Study||1413
9832533|NCT00773513|10943310|FG001|STARTED|Overall Study||1412
9832534|NCT00773513|10943309|FG000|Received Study Treatment|Overall Study||1409
9832535|NCT00773513|10943310|FG001|Received Study Treatment|Overall Study||1409
9832536|NCT00773513|10943309|FG000|COMPLETED|Overall Study||312
9832537|NCT00773513|10943310|FG001|COMPLETED|Overall Study||303
9832538|NCT00773513|10943309|FG000|NOT COMPLETED|Overall Study||1101
9854573|NCT00894738|10967674|FG000|STARTED|Overall Study||25
9854574|NCT00894738|10967675|FG001|STARTED|Overall Study||19
9854575|NCT00894738|10967674|FG000|COMPLETED|Overall Study||25
9854576|NCT00894738|10967675|FG001|COMPLETED|Overall Study||19
9854577|NCT00894738|10967674|FG000|NOT COMPLETED|Overall Study||0
9854578|NCT00894738|10967675|FG001|NOT COMPLETED|Overall Study||0
9854579|NCT00894803|10967683|FG000|STARTED|Overall Study||101
9854580|NCT00894803|10967684|FG001|STARTED|Overall Study||25
9854581|NCT00894803|10967683|FG000|COMPLETED|Overall Study||81
9854582|NCT00894803|10967684|FG001|COMPLETED|Overall Study||20
9854583|NCT00894803|10967683|FG000|NOT COMPLETED|Overall Study||20
9854584|NCT00894803|10967684|FG001|NOT COMPLETED|Overall Study||5
9854585|NCT00894933|10967690|FG000|STARTED|Overall Study||33
9854586|NCT00894933|10967690|FG000|COMPLETED|Overall Study||29
9854587|NCT00894933|10967690|FG000|NOT COMPLETED|Overall Study||4
9854588|NCT00895011|10967697|FG000|STARTED|Overall Study||100
9854589|NCT00895011|10967698|FG001|STARTED|Overall Study||99
9854590|NCT00895011|10967699|FG002|STARTED|Overall Study||99
9854591|NCT00895011|10967697|FG000|COMPLETED|Overall Study||76
9854592|NCT00895011|10967698|FG001|COMPLETED|Overall Study||85
9854593|NCT00895011|10967699|FG002|COMPLETED|Overall Study||91
9854594|NCT00895011|10967697|FG000|NOT COMPLETED|Overall Study||24
9854595|NCT00895011|10967698|FG001|NOT COMPLETED|Overall Study||14
9854596|NCT00895011|10967699|FG002|NOT COMPLETED|Overall Study||8
9854597|NCT00895037|10967711|FG000|STARTED|Overall Study||22
9854598|NCT00895037|10967712|FG001|STARTED|Overall Study||77
9854599|NCT00895037|10967713|FG002|STARTED|Overall Study||2
9854600|NCT00895037|10967711|FG000|COMPLETED|Overall Study||22
9854601|NCT00895037|10967712|FG001|COMPLETED|Overall Study||75
9854602|NCT00895037|10967713|FG002|COMPLETED|Overall Study||1
9854603|NCT00895037|10967711|FG000|NOT COMPLETED|Overall Study||0
9854604|NCT00895037|10967712|FG001|NOT COMPLETED|Overall Study||2
9854605|NCT00895037|10967713|FG002|NOT COMPLETED|Overall Study||1
9854606|NCT00895154|10967723|FG000|STARTED|Overall Study||8
9854607|NCT00895154|10967724|FG001|STARTED|Overall Study||10
9854608|NCT00895154|10967723|FG000|Follow Up|Overall Study||7
9854609|NCT00895154|10967724|FG001|Follow Up|Overall Study||8
9854610|NCT00895154|10967723|FG000|COMPLETED|Overall Study||7
9854611|NCT00895154|10967724|FG001|COMPLETED|Overall Study||8
9854612|NCT00895154|10967723|FG000|NOT COMPLETED|Overall Study||1
9854613|NCT00895154|10967724|FG001|NOT COMPLETED|Overall Study||2
9854614|NCT00895180|10967732|FG000|STARTED|Overall Study||40
9854615|NCT00895180|10967733|FG001|STARTED|Overall Study||40
9854616|NCT00895180|10967732|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
9854617|NCT00895180|10967733|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
9854618|NCT00895180|10967732|FG000|COMPLETED|Overall Study||40
9854619|NCT00895180|10967733|FG001|COMPLETED|Overall Study||40
9854620|NCT00895180|10967732|FG000|NOT COMPLETED|Overall Study||0
9854621|NCT00895180|10967733|FG001|NOT COMPLETED|Overall Study||0
9854622|NCT00895193|10967745|FG000|STARTED|Overall Study||25
9854623|NCT00895193|10967746|FG001|STARTED|Overall Study||25
9854624|NCT00895193|10967747|FG002|STARTED|Overall Study||25
9854625|NCT00895193|10967748|FG003|STARTED|Overall Study||25
9854626|NCT00895193|10967745|FG000|COMPLETED|Overall Study||25
9854627|NCT00895193|10967746|FG001|COMPLETED|Overall Study||25
9854628|NCT00895193|10967747|FG002|COMPLETED|Overall Study||25
9854629|NCT00895193|10967748|FG003|COMPLETED|Overall Study||25
9854630|NCT00895193|10967745|FG000|NOT COMPLETED|Overall Study||0
9854631|NCT00895193|10967746|FG001|NOT COMPLETED|Overall Study||0
9854632|NCT00895193|10967747|FG002|NOT COMPLETED|Overall Study||0
9854633|NCT00895193|10967748|FG003|NOT COMPLETED|Overall Study||0
9854634|NCT00895232|10967761|FG000|STARTED|Overall Study||7
9854635|NCT00895232|10967762|FG001|STARTED|Overall Study||6
9854636|NCT00895232|10967763|FG002|STARTED|Overall Study||8
9854637|NCT00895232|10967761|FG000|COMPLETED|Overall Study||4
9854638|NCT00895232|10967762|FG001|COMPLETED|Overall Study||2
9854639|NCT00895232|10967763|FG002|COMPLETED|Overall Study||3
9854640|NCT00895232|10967761|FG000|NOT COMPLETED|Overall Study||3
9854641|NCT00895232|10967762|FG001|NOT COMPLETED|Overall Study||4
9854642|NCT00895232|10967763|FG002|NOT COMPLETED|Overall Study||5
9854643|NCT00895245|10967771|FG000|STARTED|Overall Study||6
9854644|NCT00895245|10967771|FG000|COMPLETED|Overall Study||0
9854645|NCT00895245|10967771|FG000|NOT COMPLETED|Overall Study||6
9854646|NCT00895310|10967775|FG000|STARTED|Overall Study||30
9854647|NCT00895310|10967775|FG000|COMPLETED|Overall Study||29
9854648|NCT00895310|10967775|FG000|NOT COMPLETED|Overall Study||1
9854649|NCT00895414|10967779|FG000|STARTED|First Intervention (14 Days)||9
9854650|NCT00895414|10967780|FG001|STARTED|First Intervention (14 Days)||10
9854651|NCT00895414|10967779|FG000|COMPLETED|First Intervention (14 Days)||8
9854652|NCT00895414|10967780|FG001|COMPLETED|First Intervention (14 Days)||9
9854653|NCT00895414|10967779|FG000|NOT COMPLETED|First Intervention (14 Days)||1
9854654|NCT00895414|10967780|FG001|NOT COMPLETED|First Intervention (14 Days)||1
9854655|NCT00895414|10967779|FG000|STARTED|Second Intervention (14 Days)||8
9854656|NCT00895414|10967780|FG001|STARTED|Second Intervention (14 Days)||9
9854657|NCT00895414|10967779|FG000|COMPLETED|Second Intervention (14 Days)||8
9854658|NCT00895414|10967780|FG001|COMPLETED|Second Intervention (14 Days)||9
9854659|NCT00895414|10967779|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
9854660|NCT00895414|10967780|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
9854661|NCT00895453|10967789|FG000|STARTED|Overall Study||48
9854662|NCT00895453|10967790|FG001|STARTED|Overall Study||50
9854663|NCT00895453|10967791|FG002|STARTED|Overall Study||46
9854664|NCT00895453|10967789|FG000|COMPLETED|Overall Study||23
9854665|NCT00895453|10967790|FG001|COMPLETED|Overall Study||25
9854666|NCT00895453|10967791|FG002|COMPLETED|Overall Study||23
9854667|NCT00895453|10967789|FG000|NOT COMPLETED|Overall Study||25
9854668|NCT00895453|10967790|FG001|NOT COMPLETED|Overall Study||25
9854669|NCT00895453|10967791|FG002|NOT COMPLETED|Overall Study||23
9854670|NCT00895531|10967801|FG000|STARTED|Overall Study||38
9854671|NCT00895531|10967802|FG001|STARTED|Overall Study||37
9854672|NCT00895531|10967801|FG000|COMPLETED|Overall Study||38
9854673|NCT00895531|10967802|FG001|COMPLETED|Overall Study||37
9854674|NCT00895531|10967801|FG000|NOT COMPLETED|Overall Study||0
9854675|NCT00895531|10967802|FG001|NOT COMPLETED|Overall Study||0
9854676|NCT00895583|10967810|FG000|STARTED|Overall Study||131
9854677|NCT00895583|10967811|FG001|STARTED|Overall Study||123
9854678|NCT00895583|10967810|FG000|COMPLETED|Overall Study||87
9854679|NCT00895583|10967811|FG001|COMPLETED|Overall Study||111
9854680|NCT00895583|10967810|FG000|NOT COMPLETED|Overall Study||44
9854681|NCT00895583|10967811|FG001|NOT COMPLETED|Overall Study||12
9854682|NCT00895622|10967820|FG000|STARTED|Overall Study||65
9854683|NCT00895622|10967821|FG001|STARTED|Overall Study||56
9854684|NCT00895622|10967822|FG002|STARTED|Overall Study||57
9854685|NCT00895622|10967820|FG000|COMPLETED|Overall Study||60
9854686|NCT00895622|10967821|FG001|COMPLETED|Overall Study||52
9854687|NCT00895622|10967822|FG002|COMPLETED|Overall Study||53
9854688|NCT00895622|10967820|FG000|NOT COMPLETED|Overall Study||5
9854689|NCT00895622|10967821|FG001|NOT COMPLETED|Overall Study||4
9854690|NCT00895622|10967822|FG002|NOT COMPLETED|Overall Study||4
9854691|NCT00895661|10967838|FG000|STARTED|Overall Study||40
9854692|NCT00895661|10967838|FG000|COMPLETED|Overall Study||37
9854693|NCT00895661|10967838|FG000|NOT COMPLETED|Overall Study||3
9854694|NCT00895752|10967842|FG000|STARTED|Overall Study||6
9854695|NCT00895752|10967842|FG000|COMPLETED|Overall Study||6
9854696|NCT00895752|10967842|FG000|NOT COMPLETED|Overall Study||0
9854697|NCT00895817|10967850|FG000|STARTED|Overall Study||21
9854698|NCT00895817|10967851|FG001|STARTED|Overall Study||21
9854699|NCT00895817|10967850|FG000|COMPLETED|Overall Study||21
9854700|NCT00895817|10967851|FG001|COMPLETED|Overall Study||21
9854701|NCT00895817|10967850|FG000|NOT COMPLETED|Overall Study||0
9854702|NCT00895817|10967851|FG001|NOT COMPLETED|Overall Study||0
9854703|NCT00895830|10967862|FG000|STARTED|Overall Study||51
9854704|NCT00895830|10967863|FG001|STARTED|Overall Study||50
9854705|NCT00895830|10967864|FG002|STARTED|Overall Study||49
9854706|NCT00895830|10967865|FG003|STARTED|Overall Study||52
9854707|NCT00895830|10967866|FG004|STARTED|Overall Study||55
9854708|NCT00895830|10967862|FG000|COMPLETED|Overall Study||51
9854709|NCT00895830|10967863|FG001|COMPLETED|Overall Study||50
9854710|NCT00895830|10967864|FG002|COMPLETED|Overall Study||49
9854711|NCT00895830|10967865|FG003|COMPLETED|Overall Study||52
9854712|NCT00895830|10967866|FG004|COMPLETED|Overall Study||55
9854713|NCT00895830|10967862|FG000|NOT COMPLETED|Overall Study||0
9854714|NCT00895830|10967863|FG001|NOT COMPLETED|Overall Study||0
9854715|NCT00895830|10967864|FG002|NOT COMPLETED|Overall Study||0
9854716|NCT00895830|10967865|FG003|NOT COMPLETED|Overall Study||0
9854717|NCT00895830|10967866|FG004|NOT COMPLETED|Overall Study||0
9854718|NCT00895843|10967880|FG000|STARTED|Overall Study||60
9854719|NCT00895843|10967881|FG001|STARTED|Overall Study||62
9854720|NCT00895843|10967880|FG000|COMPLETED|Overall Study||48
9854721|NCT00895843|10967881|FG001|COMPLETED|Overall Study||50
9854722|NCT00895843|10967880|FG000|NOT COMPLETED|Overall Study||12
9854723|NCT00895843|10967881|FG001|NOT COMPLETED|Overall Study||12
9854724|NCT00895895|10967892|FG000|STARTED|Period 1||107
9854725|NCT00895895|10967893|FG001|STARTED|Period 1||105
9854726|NCT00895895|10967894|FG002|STARTED|Period 1||104
9854727|NCT00895895|10967895|FG003|STARTED|Period 1||104
9854728|NCT00895895|10967896|FG004|STARTED|Period 1||106
9854729|NCT00895895|10967892|FG000|Randomized But Not Treated|Period 1||1
9854730|NCT00895895|10967893|FG001|Randomized But Not Treated|Period 1||3
9854731|NCT00895895|10967894|FG002|Randomized But Not Treated|Period 1||1
9854732|NCT00895895|10967895|FG003|Randomized But Not Treated|Period 1||1
10092515|NCT02337946|11220995|FG002|STARTED|Protocol Treatment 1 Period||0
9854733|NCT00895895|10967896|FG004|Randomized But Not Treated|Period 1||2
9854734|NCT00895895|10967892|FG000|COMPLETED|Period 1||86
9854735|NCT00895895|10967893|FG001|COMPLETED|Period 1||84
9854736|NCT00895895|10967894|FG002|COMPLETED|Period 1||84
9854737|NCT00895895|10967895|FG003|COMPLETED|Period 1||91
9854738|NCT00895895|10967896|FG004|COMPLETED|Period 1||86
9854739|NCT00895895|10967892|FG000|NOT COMPLETED|Period 1||21
9854740|NCT00895895|10967893|FG001|NOT COMPLETED|Period 1||21
9854741|NCT00895895|10967894|FG002|NOT COMPLETED|Period 1||20
9854742|NCT00895895|10967895|FG003|NOT COMPLETED|Period 1||13
9854743|NCT00895895|10967896|FG004|NOT COMPLETED|Period 1||20
9854744|NCT00895895|10967892|FG000|STARTED|After Period 1, Prior to Period 2||86
9854745|NCT00895895|10967893|FG001|STARTED|After Period 1, Prior to Period 2||84
9854746|NCT00895895|10967894|FG002|STARTED|After Period 1, Prior to Period 2||84
9854747|NCT00895895|10967895|FG003|STARTED|After Period 1, Prior to Period 2||91
9854748|NCT00895895|10967896|FG004|STARTED|After Period 1, Prior to Period 2||86
9854749|NCT00895895|10967892|FG000|COMPLETED|After Period 1, Prior to Period 2||86
9854750|NCT00895895|10967893|FG001|COMPLETED|After Period 1, Prior to Period 2||84
9854751|NCT00895895|10967894|FG002|COMPLETED|After Period 1, Prior to Period 2||82
9854752|NCT00895895|10967895|FG003|COMPLETED|After Period 1, Prior to Period 2||91
9854753|NCT00895895|10967896|FG004|COMPLETED|After Period 1, Prior to Period 2||84
10092516|NCT02337946|11220993|FG000|COMPLETED|Protocol Treatment 1 Period||114
10092517|NCT02337946|11220994|FG001|COMPLETED|Protocol Treatment 1 Period||0
9854754|NCT00895895|10967892|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0
9854755|NCT00895895|10967893|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
9854756|NCT00895895|10967894|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2
9854757|NCT00895895|10967895|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
9854758|NCT00895895|10967896|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2
9854759|NCT00895895|10967892|FG000|STARTED|Period 2||86
9854760|NCT00895895|10967893|FG001|STARTED|Period 2||84
9854761|NCT00895895|10967894|FG002|STARTED|Period 2||82
9854762|NCT00895895|10967895|FG003|STARTED|Period 2||91
9854763|NCT00895895|10967896|FG004|STARTED|Period 2||84
9854764|NCT00895895|10967892|FG000|COMPLETED|Period 2||30
9854765|NCT00895895|10967893|FG001|COMPLETED|Period 2||31
9854766|NCT00895895|10967894|FG002|COMPLETED|Period 2||33
9854767|NCT00895895|10967895|FG003|COMPLETED|Period 2||37
9854768|NCT00895895|10967896|FG004|COMPLETED|Period 2||35
9854769|NCT00895895|10967892|FG000|NOT COMPLETED|Period 2||56
9854770|NCT00895895|10967893|FG001|NOT COMPLETED|Period 2||53
9854771|NCT00895895|10967894|FG002|NOT COMPLETED|Period 2||49
9854772|NCT00895895|10967895|FG003|NOT COMPLETED|Period 2||54
9854773|NCT00895895|10967896|FG004|NOT COMPLETED|Period 2||49
9854774|NCT00895921|10967916|FG000|STARTED|Overall Study||15
9854775|NCT00895921|10967917|FG001|STARTED|Overall Study||15
9854776|NCT00895921|10967916|FG000|COMPLETED|Overall Study||15
9854777|NCT00895921|10967917|FG001|COMPLETED|Overall Study||15
9854778|NCT00895921|10967916|FG000|NOT COMPLETED|Overall Study||0
9854779|NCT00895921|10967917|FG001|NOT COMPLETED|Overall Study||0
9854780|NCT00895934|10967925|FG000|STARTED|Dose Escalation||3
9854781|NCT00895934|10967926|FG001|STARTED|Dose Escalation||3
9854782|NCT00895934|10967927|FG002|STARTED|Dose Escalation||3
9854783|NCT00895934|10967928|FG003|STARTED|Dose Escalation||6
9854784|NCT00895934|10967925|FG000|COMPLETED|Dose Escalation||3
9854785|NCT00895934|10967926|FG001|COMPLETED|Dose Escalation||3
9854786|NCT00895934|10967927|FG002|COMPLETED|Dose Escalation||3
9854787|NCT00895934|10967928|FG003|COMPLETED|Dose Escalation||6
9854788|NCT00895934|10967925|FG000|NOT COMPLETED|Dose Escalation||0
9854789|NCT00895934|10967926|FG001|NOT COMPLETED|Dose Escalation||0
9854790|NCT00895934|10967927|FG002|NOT COMPLETED|Dose Escalation||0
9854791|NCT00895934|10967928|FG003|NOT COMPLETED|Dose Escalation||0
9854792|NCT00895934|10967925|FG000|STARTED|Efficacy of Most Tolerated Dose||0
9854793|NCT00895934|10967926|FG001|STARTED|Efficacy of Most Tolerated Dose||0
9854794|NCT00895934|10967927|FG002|STARTED|Efficacy of Most Tolerated Dose||0
9854795|NCT00895934|10967928|FG003|STARTED|Efficacy of Most Tolerated Dose||37
9854796|NCT00895934|10967925|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0
9854797|NCT00895934|10967926|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0
9854798|NCT00895934|10967927|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0
9854799|NCT00895934|10967928|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37
9854800|NCT00895934|10967925|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
9854801|NCT00895934|10967926|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
9854802|NCT00895934|10967927|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
9854803|NCT00895934|10967928|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
9854804|NCT00895947|10967941|FG000|STARTED|Overall Study||100
9854805|NCT00895947|10967942|FG001|STARTED|Overall Study||100
9854806|NCT00895947|10967941|FG000|COMPLETED|Overall Study||88
9854807|NCT00895947|10967942|FG001|COMPLETED|Overall Study||90
9854808|NCT00895947|10967941|FG000|NOT COMPLETED|Overall Study||12
9854809|NCT00895947|10967942|FG001|NOT COMPLETED|Overall Study||10
9854810|NCT00896012|10967950|FG000|STARTED|Overall Study||29
9854811|NCT00896012|10967951|FG001|STARTED|Overall Study||23
9854812|NCT00896012|10967950|FG000|COMPLETED|Overall Study||18
9854813|NCT00896012|10967951|FG001|COMPLETED|Overall Study||12
9854814|NCT00896012|10967950|FG000|NOT COMPLETED|Overall Study||11
9854815|NCT00896012|10967951|FG001|NOT COMPLETED|Overall Study||11
9854816|NCT00896038|10967959|FG000|STARTED|Overall Study||30
9854817|NCT00896038|10967960|FG001|STARTED|Overall Study||28
9854818|NCT00896038|10967959|FG000|COMPLETED|Overall Study||26
9854819|NCT00896038|10967960|FG001|COMPLETED|Overall Study||27
9854820|NCT00896038|10967959|FG000|NOT COMPLETED|Overall Study||4
9854821|NCT00896038|10967960|FG001|NOT COMPLETED|Overall Study||1
9854822|NCT00896051|10967968|FG000|STARTED|Overall Study||25
9854823|NCT00896051|10967969|FG001|STARTED|Overall Study||25
9854824|NCT00896051|10967968|FG000|COMPLETED|Overall Study||15
9854825|NCT00896051|10967969|FG001|COMPLETED|Overall Study||16
9854826|NCT00896051|10967968|FG000|NOT COMPLETED|Overall Study||10
9854827|NCT00896051|10967969|FG001|NOT COMPLETED|Overall Study||9
9854828|NCT00896064|10967986|FG000|STARTED|Overall Study||22
9854829|NCT00896064|10967987|FG001|STARTED|Overall Study||21
9854830|NCT00896064|10967986|FG000|COMPLETED|Overall Study||22
9854831|NCT00896064|10967987|FG001|COMPLETED|Overall Study||21
9854832|NCT00896064|10967986|FG000|NOT COMPLETED|Overall Study||0
9854833|NCT00896064|10967987|FG001|NOT COMPLETED|Overall Study||0
9854834|NCT00896168|10967995|FG000|STARTED|Overall Study||104
9854835|NCT00896168|10967996|FG001|STARTED|Overall Study||130
10092518|NCT02337946|11220995|FG002|COMPLETED|Protocol Treatment 1 Period||0
10092519|NCT02337946|11220993|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50
9854836|NCT00896168|10967995|FG000|COMPLETED|Overall Study||90
9854837|NCT00896168|10967996|FG001|COMPLETED|Overall Study||111
9854838|NCT00896168|10967995|FG000|NOT COMPLETED|Overall Study||14
9854839|NCT00896168|10967996|FG001|NOT COMPLETED|Overall Study||19
9854840|NCT00896181|10968002|FG000|STARTED|Overall Study||26
9854841|NCT00896181|10968002|FG000|COMPLETED|Overall Study||26
9854842|NCT00896181|10968002|FG000|NOT COMPLETED|Overall Study||0
9854843|NCT00896233|10968006|FG000|STARTED|Overall Study||10
9854844|NCT00896233|10968006|FG000|COMPLETED|Overall Study||9
9854845|NCT00896233|10968006|FG000|NOT COMPLETED|Overall Study||1
9854846|NCT00896298|10968013|FG000|STARTED|Overall Study||13
9854847|NCT00896298|10968014|FG001|STARTED|Overall Study||12
9854848|NCT00896298|10968013|FG000|COMPLETED|Overall Study||10
9854849|NCT00896298|10968014|FG001|COMPLETED|Overall Study||9
9854850|NCT00896298|10968013|FG000|NOT COMPLETED|Overall Study||3
9854851|NCT00896298|10968014|FG001|NOT COMPLETED|Overall Study||3
9854852|NCT00896337|10968020|FG000|STARTED|Overall Study||125
9854853|NCT00896337|10968020|FG000|COMPLETED|Overall Study||100
9854854|NCT00896337|10968020|FG000|NOT COMPLETED|Overall Study||25
9854855|NCT00896363|10968032|FG000|STARTED|Overall Study||31
9854856|NCT00896363|10968033|FG001|STARTED|Overall Study||36
9854857|NCT00896363|10968034|FG002|STARTED|Overall Study||32
9854858|NCT00896363|10968032|FG000|COMPLETED|Overall Study||25
9854859|NCT00896363|10968033|FG001|COMPLETED|Overall Study||25
9854860|NCT00896363|10968034|FG002|COMPLETED|Overall Study||24
9854861|NCT00896363|10968032|FG000|NOT COMPLETED|Overall Study||6
9854862|NCT00896363|10968033|FG001|NOT COMPLETED|Overall Study||11
9854863|NCT00896363|10968034|FG002|NOT COMPLETED|Overall Study||8
9854864|NCT00896441|10968047|FG000|STARTED|Overall Study||17
9854865|NCT00896441|10968048|FG001|STARTED|Overall Study||9
9854866|NCT00896441|10968047|FG000|COMPLETED|Overall Study||15
9854867|NCT00896441|10968048|FG001|COMPLETED|Overall Study||9
9854868|NCT00896441|10968047|FG000|NOT COMPLETED|Overall Study||2
9854869|NCT00896441|10968048|FG001|NOT COMPLETED|Overall Study||0
9854870|NCT00896454|10968053|FG000|STARTED|Overall Study||33
9854871|NCT00896454|10968053|FG000|COMPLETED|Overall Study||0
9854872|NCT00896454|10968053|FG000|NOT COMPLETED|Overall Study||33
9854873|NCT00896480|10968057|FG000|STARTED|Overall Study||24
9854874|NCT00896480|10968057|FG000|COMPLETED|Overall Study||3
9854875|NCT00896480|10968057|FG000|NOT COMPLETED|Overall Study||21
9854876|NCT00896532|10968072|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52
9854877|NCT00896532|10968073|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51
9854878|NCT00896532|10968074|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55
9854879|NCT00896532|10968075|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51
9854880|NCT00896532|10968076|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54
9854881|NCT00896532|10968077|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51
9854882|NCT00896532|10968078|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53
9854883|NCT00896532|10968079|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52
9854884|NCT00896532|10968080|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854885|NCT00896532|10968081|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854886|NCT00896532|10968082|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854887|NCT00896532|10968083|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854888|NCT00896532|10968084|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854889|NCT00896532|10968085|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854890|NCT00896532|10968086|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854891|NCT00896532|10968087|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854892|NCT00896532|10968088|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854893|NCT00896532|10968089|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854894|NCT00896532|10968090|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854895|NCT00896532|10968091|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854896|NCT00896532|10968092|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854897|NCT00896532|10968093|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854898|NCT00896532|10968094|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0
9854899|NCT00896532|10968072|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
9854900|NCT00896532|10968073|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
9854901|NCT00896532|10968074|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
9854902|NCT00896532|10968075|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
9854903|NCT00896532|10968076|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
9854904|NCT00896532|10968077|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
9854905|NCT00896532|10968078|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
9854906|NCT00896532|10968079|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
9854907|NCT00896532|10968080|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854908|NCT00896532|10968081|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854909|NCT00896532|10968082|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854910|NCT00896532|10968083|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854911|NCT00896532|10968084|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854912|NCT00896532|10968085|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854913|NCT00896532|10968086|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854914|NCT00896532|10968087|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854915|NCT00896532|10968088|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854916|NCT00896532|10968089|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854917|NCT00896532|10968090|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854918|NCT00896532|10968091|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854919|NCT00896532|10968092|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854920|NCT00896532|10968093|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854921|NCT00896532|10968094|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
9854922|NCT00896532|10968072|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
9854923|NCT00896532|10968073|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
9854924|NCT00896532|10968074|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
9854925|NCT00896532|10968075|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
9854926|NCT00896532|10968076|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
9854927|NCT00896532|10968077|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
9854928|NCT00896532|10968078|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
9854929|NCT00896532|10968079|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
9854930|NCT00896532|10968080|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854931|NCT00896532|10968081|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854932|NCT00896532|10968082|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854933|NCT00896532|10968083|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854934|NCT00896532|10968084|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854935|NCT00896532|10968085|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854936|NCT00896532|10968086|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854937|NCT00896532|10968087|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854938|NCT00896532|10968088|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854939|NCT00896532|10968089|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854940|NCT00896532|10968090|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854941|NCT00896532|10968091|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854942|NCT00896532|10968092|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854943|NCT00896532|10968093|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854944|NCT00896532|10968094|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
9854945|NCT00896532|10968072|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
9854946|NCT00896532|10968073|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
9854947|NCT00896532|10968074|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
9854948|NCT00896532|10968075|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
9854949|NCT00896532|10968076|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
9854950|NCT00896532|10968077|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
9854951|NCT00896532|10968078|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
9854952|NCT00896532|10968079|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
9854953|NCT00896532|10968080|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854954|NCT00896532|10968081|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854955|NCT00896532|10968082|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854956|NCT00896532|10968083|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854957|NCT00896532|10968084|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854958|NCT00896532|10968085|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854959|NCT00896532|10968086|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854960|NCT00896532|10968087|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854961|NCT00896532|10968088|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854962|NCT00896532|10968089|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854963|NCT00896532|10968090|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854964|NCT00896532|10968091|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854965|NCT00896532|10968092|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854966|NCT00896532|10968093|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854967|NCT00896532|10968094|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854968|NCT00896532|10968072|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
9854969|NCT00896532|10968073|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
9854970|NCT00896532|10968074|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
9854971|NCT00896532|10968075|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
9854972|NCT00896532|10968076|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
9854973|NCT00896532|10968077|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
9854974|NCT00896532|10968078|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
9854975|NCT00896532|10968079|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
9854976|NCT00896532|10968080|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854977|NCT00896532|10968081|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854978|NCT00896532|10968082|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854979|NCT00896532|10968083|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854980|NCT00896532|10968084|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854981|NCT00896532|10968085|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854982|NCT00896532|10968086|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854983|NCT00896532|10968087|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854984|NCT00896532|10968088|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854985|NCT00896532|10968089|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854986|NCT00896532|10968090|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854987|NCT00896532|10968091|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854988|NCT00896532|10968092|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854989|NCT00896532|10968093|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854990|NCT00896532|10968094|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
9854991|NCT00896532|10968072|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0
9854992|NCT00896532|10968073|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0
9854993|NCT00896532|10968074|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0
9854994|NCT00896532|10968075|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0
9854995|NCT00896532|10968076|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0
9854996|NCT00896532|10968077|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0
9854997|NCT00896532|10968078|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0
9854998|NCT00896532|10968079|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0
9854999|NCT00896532|10968080|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18
9855000|NCT00896532|10968081|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18
9855001|NCT00896532|10968082|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20
9855002|NCT00896532|10968083|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21
9855003|NCT00896532|10968084|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93
9855004|NCT00896532|10968085|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90
9855005|NCT00896532|10968086|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0
9855006|NCT00896532|10968087|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0
9855007|NCT00896532|10968088|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0
9855008|NCT00896532|10968089|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0
9855009|NCT00896532|10968090|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0
9855010|NCT00896532|10968091|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0
9855011|NCT00896532|10968092|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0
9855012|NCT00896532|10968093|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0
9855013|NCT00896532|10968094|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0
9855014|NCT00896532|10968072|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855015|NCT00896532|10968073|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855016|NCT00896532|10968074|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855017|NCT00896532|10968075|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855018|NCT00896532|10968076|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855019|NCT00896532|10968077|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855020|NCT00896532|10968078|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855021|NCT00896532|10968079|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855022|NCT00896532|10968080|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18
9855023|NCT00896532|10968081|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
9855024|NCT00896532|10968082|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19
9855025|NCT00896532|10968083|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19
9855026|NCT00896532|10968084|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90
9855027|NCT00896532|10968085|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88
9855028|NCT00896532|10968086|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855029|NCT00896532|10968087|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855030|NCT00896532|10968088|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10201782|NCT03441269|11329199|FG002|STARTED|Overall Study||75
10201783|NCT03441269|11329197|FG000|COMPLETED|Overall Study||75
10201784|NCT03441269|11329198|FG001|COMPLETED|Overall Study||74
10201785|NCT03441269|11329199|FG002|COMPLETED|Overall Study||74
10201786|NCT03441269|11329197|FG000|NOT COMPLETED|Overall Study||0
10201787|NCT03441269|11329198|FG001|NOT COMPLETED|Overall Study||1
10201788|NCT03441269|11329199|FG002|NOT COMPLETED|Overall Study||1
10201789|NCT03441581|11329209|FG000|STARTED|Overall Study||12
10201790|NCT03441581|11329210|FG001|STARTED|Overall Study||12
10201791|NCT03441581|11329209|FG000|COMPLETED|Overall Study||12
10201792|NCT03441581|11329210|FG001|COMPLETED|Overall Study||12
10201793|NCT03441581|11329209|FG000|NOT COMPLETED|Overall Study||0
10201794|NCT03441581|11329210|FG001|NOT COMPLETED|Overall Study||0
10201795|NCT03441594|11329216|FG000|STARTED|Overall Study||56
10201796|NCT03441594|11329216|FG000|COMPLETED|Overall Study||56
10201797|NCT03441594|11329216|FG000|NOT COMPLETED|Overall Study||0
10201798|NCT03441633|11329230|FG000|STARTED|Overall Study||4712
10201799|NCT03441633|11329231|FG001|STARTED|Overall Study||1423
10201800|NCT03441633|11329232|FG002|STARTED|Overall Study||32212
10201801|NCT03441633|11329233|FG003|STARTED|Overall Study||192
10201802|NCT03441633|11329234|FG004|STARTED|Overall Study||2286
10201803|NCT03441633|11329235|FG005|STARTED|Overall Study||363
10201804|NCT03441633|11329236|FG006|STARTED|Overall Study||2855
10201805|NCT03441633|11329237|FG007|STARTED|Overall Study||953
10201806|NCT03441633|11329238|FG008|STARTED|Overall Study||5132
10201807|NCT03441633|11329239|FG009|STARTED|Overall Study||1562
10201808|NCT03441633|11329230|FG000|COMPLETED|Overall Study||4712
10201809|NCT03441633|11329231|FG001|COMPLETED|Overall Study||1423
10201810|NCT03441633|11329232|FG002|COMPLETED|Overall Study||32212
10201811|NCT03441633|11329233|FG003|COMPLETED|Overall Study||192
10201812|NCT03441633|11329234|FG004|COMPLETED|Overall Study||2286
10201813|NCT03441633|11329235|FG005|COMPLETED|Overall Study||363
10201814|NCT03441633|11329236|FG006|COMPLETED|Overall Study||2855
10201815|NCT03441633|11329237|FG007|COMPLETED|Overall Study||953
10201816|NCT03441633|11329238|FG008|COMPLETED|Overall Study||5132
10201817|NCT03441633|11329239|FG009|COMPLETED|Overall Study||1562
10201818|NCT03441633|11329230|FG000|NOT COMPLETED|Overall Study||0
10201819|NCT03441633|11329231|FG001|NOT COMPLETED|Overall Study||0
10201820|NCT03441633|11329232|FG002|NOT COMPLETED|Overall Study||0
10201821|NCT03441633|11329233|FG003|NOT COMPLETED|Overall Study||0
10201822|NCT03441633|11329234|FG004|NOT COMPLETED|Overall Study||0
10201823|NCT03441633|11329235|FG005|NOT COMPLETED|Overall Study||0
10201824|NCT03441633|11329236|FG006|NOT COMPLETED|Overall Study||0
10201825|NCT03441633|11329237|FG007|NOT COMPLETED|Overall Study||0
10201826|NCT03441633|11329238|FG008|NOT COMPLETED|Overall Study||0
10201827|NCT03441633|11329239|FG009|NOT COMPLETED|Overall Study||0
10201828|NCT03441789|11329267|FG000|STARTED|Overall Study||14
10201829|NCT03441789|11329268|FG001|STARTED|Overall Study||14
10201830|NCT03441789|11329267|FG000|COMPLETED|Overall Study||13
10201831|NCT03441789|11329268|FG001|COMPLETED|Overall Study||10
10201832|NCT03441789|11329267|FG000|NOT COMPLETED|Overall Study||1
10201833|NCT03441789|11329268|FG001|NOT COMPLETED|Overall Study||4
10201834|NCT03441984|11329276|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3
9855031|NCT00896532|10968089|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855032|NCT00896532|10968090|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855033|NCT00896532|10968091|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855034|NCT00896532|10968092|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855035|NCT00896532|10968093|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855036|NCT00896532|10968094|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0
9855037|NCT00896532|10968072|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855038|NCT00896532|10968073|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855039|NCT00896532|10968074|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855040|NCT00896532|10968075|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855041|NCT00896532|10968076|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855042|NCT00896532|10968077|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855043|NCT00896532|10968078|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855044|NCT00896532|10968079|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855045|NCT00896532|10968080|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17
9855046|NCT00896532|10968081|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18
9855047|NCT00896532|10968082|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18
9855048|NCT00896532|10968083|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19
9855049|NCT00896532|10968084|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88
9855050|NCT00896532|10968085|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88
9855051|NCT00896532|10968086|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855052|NCT00896532|10968087|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855053|NCT00896532|10968088|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855054|NCT00896532|10968089|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855055|NCT00896532|10968090|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855056|NCT00896532|10968091|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855057|NCT00896532|10968092|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855058|NCT00896532|10968093|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855059|NCT00896532|10968094|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855060|NCT00896532|10968072|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855061|NCT00896532|10968073|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855062|NCT00896532|10968074|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855063|NCT00896532|10968075|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855064|NCT00896532|10968076|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855065|NCT00896532|10968077|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855066|NCT00896532|10968078|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855067|NCT00896532|10968079|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855068|NCT00896532|10968080|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
9855069|NCT00896532|10968081|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855070|NCT00896532|10968082|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
9855071|NCT00896532|10968083|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
9855072|NCT00896532|10968084|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
9855073|NCT00896532|10968085|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
9855074|NCT00896532|10968086|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855075|NCT00896532|10968087|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855076|NCT00896532|10968088|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855077|NCT00896532|10968089|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855078|NCT00896532|10968090|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855079|NCT00896532|10968091|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855080|NCT00896532|10968092|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10201835|NCT03441984|11329277|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3
10201836|NCT03441984|11329278|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3
10201837|NCT03441984|11329279|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3
10201838|NCT03441984|11329280|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3
10201839|NCT03441984|11329281|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3
9855081|NCT00896532|10968093|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855082|NCT00896532|10968094|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
9855083|NCT00896532|10968072|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0
9855084|NCT00896532|10968073|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0
9855085|NCT00896532|10968074|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0
9855086|NCT00896532|10968075|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0
9855087|NCT00896532|10968076|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0
9855088|NCT00896532|10968077|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0
9855089|NCT00896532|10968078|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0
9855090|NCT00896532|10968079|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0
9855091|NCT00896532|10968080|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0
9855092|NCT00896532|10968081|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0
9855093|NCT00896532|10968082|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0
9855094|NCT00896532|10968083|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0
9855095|NCT00896532|10968084|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0
9855096|NCT00896532|10968085|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0
9855097|NCT00896532|10968086|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12
9855098|NCT00896532|10968087|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16
9855099|NCT00896532|10968088|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72
9855100|NCT00896532|10968089|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67
9855101|NCT00896532|10968090|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0
9855102|NCT00896532|10968091|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0
9855103|NCT00896532|10968092|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0
9855104|NCT00896532|10968093|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0
9855105|NCT00896532|10968094|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0
9855106|NCT00896532|10968072|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855107|NCT00896532|10968073|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855108|NCT00896532|10968074|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855109|NCT00896532|10968075|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855110|NCT00896532|10968076|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855111|NCT00896532|10968077|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855112|NCT00896532|10968078|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855113|NCT00896532|10968079|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855114|NCT00896532|10968080|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855115|NCT00896532|10968081|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855116|NCT00896532|10968082|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855117|NCT00896532|10968083|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855118|NCT00896532|10968084|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855119|NCT00896532|10968085|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855120|NCT00896532|10968086|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
9855121|NCT00896532|10968087|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
9855122|NCT00896532|10968088|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
9855123|NCT00896532|10968089|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
9855124|NCT00896532|10968090|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855125|NCT00896532|10968091|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855126|NCT00896532|10968092|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855127|NCT00896532|10968093|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855128|NCT00896532|10968094|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9855129|NCT00896532|10968072|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855130|NCT00896532|10968073|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855131|NCT00896532|10968074|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855132|NCT00896532|10968075|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855133|NCT00896532|10968076|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855134|NCT00896532|10968077|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855135|NCT00896532|10968078|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855136|NCT00896532|10968079|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855137|NCT00896532|10968080|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855138|NCT00896532|10968081|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855139|NCT00896532|10968082|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855140|NCT00896532|10968083|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855141|NCT00896532|10968084|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855142|NCT00896532|10968085|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855143|NCT00896532|10968086|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12
9855144|NCT00896532|10968087|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14
9855145|NCT00896532|10968088|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65
9855146|NCT00896532|10968089|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64
9855147|NCT00896532|10968090|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855148|NCT00896532|10968091|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855149|NCT00896532|10968092|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855150|NCT00896532|10968093|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855151|NCT00896532|10968094|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855152|NCT00896532|10968072|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855153|NCT00896532|10968073|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855154|NCT00896532|10968074|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855155|NCT00896532|10968075|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855156|NCT00896532|10968076|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855157|NCT00896532|10968077|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855158|NCT00896532|10968078|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855159|NCT00896532|10968079|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855160|NCT00896532|10968080|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855161|NCT00896532|10968081|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855162|NCT00896532|10968082|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855163|NCT00896532|10968083|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855164|NCT00896532|10968084|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855165|NCT00896532|10968085|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855166|NCT00896532|10968086|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855167|NCT00896532|10968087|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
9855168|NCT00896532|10968088|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
9855169|NCT00896532|10968089|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
9855170|NCT00896532|10968090|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855171|NCT00896532|10968091|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855172|NCT00896532|10968092|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855173|NCT00896532|10968093|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855174|NCT00896532|10968094|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
9855175|NCT00896532|10968072|FG000|STARTED|Months 48-72: Follow-on Phase||0
9855176|NCT00896532|10968073|FG001|STARTED|Months 48-72: Follow-on Phase||0
9855177|NCT00896532|10968074|FG002|STARTED|Months 48-72: Follow-on Phase||0
9855178|NCT00896532|10968075|FG003|STARTED|Months 48-72: Follow-on Phase||0
9855179|NCT00896532|10968076|FG004|STARTED|Months 48-72: Follow-on Phase||0
9855180|NCT00896532|10968077|FG005|STARTED|Months 48-72: Follow-on Phase||0
9855181|NCT00896532|10968078|FG006|STARTED|Months 48-72: Follow-on Phase||0
9855182|NCT00896532|10968079|FG007|STARTED|Months 48-72: Follow-on Phase||0
9855183|NCT00896532|10968080|FG008|STARTED|Months 48-72: Follow-on Phase||0
9855184|NCT00896532|10968081|FG009|STARTED|Months 48-72: Follow-on Phase||0
9855185|NCT00896532|10968082|FG010|STARTED|Months 48-72: Follow-on Phase||0
9855186|NCT00896532|10968083|FG011|STARTED|Months 48-72: Follow-on Phase||0
9855187|NCT00896532|10968084|FG012|STARTED|Months 48-72: Follow-on Phase||0
9855188|NCT00896532|10968085|FG013|STARTED|Months 48-72: Follow-on Phase||0
9855189|NCT00896532|10968086|FG014|STARTED|Months 48-72: Follow-on Phase||0
9855190|NCT00896532|10968087|FG015|STARTED|Months 48-72: Follow-on Phase||0
9855191|NCT00896532|10968088|FG016|STARTED|Months 48-72: Follow-on Phase||0
9855192|NCT00896532|10968089|FG017|STARTED|Months 48-72: Follow-on Phase||0
9855193|NCT00896532|10968090|FG018|STARTED|Months 48-72: Follow-on Phase||51
9855194|NCT00896532|10968091|FG019|STARTED|Months 48-72: Follow-on Phase||11
9855195|NCT00896532|10968092|FG020|STARTED|Months 48-72: Follow-on Phase||12
9855196|NCT00896532|10968093|FG021|STARTED|Months 48-72: Follow-on Phase||59
9855197|NCT00896532|10968094|FG022|STARTED|Months 48-72: Follow-on Phase||8
9855198|NCT00896532|10968072|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855199|NCT00896532|10968073|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855200|NCT00896532|10968074|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855201|NCT00896532|10968075|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855202|NCT00896532|10968076|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855203|NCT00896532|10968077|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855204|NCT00896532|10968078|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855205|NCT00896532|10968079|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855206|NCT00896532|10968080|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855207|NCT00896532|10968081|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855208|NCT00896532|10968082|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855209|NCT00896532|10968083|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855210|NCT00896532|10968084|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855211|NCT00896532|10968085|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855212|NCT00896532|10968086|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855213|NCT00896532|10968087|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855214|NCT00896532|10968088|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855215|NCT00896532|10968089|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855216|NCT00896532|10968090|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
9855217|NCT00896532|10968091|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
9855218|NCT00896532|10968092|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
9855219|NCT00896532|10968093|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
9855220|NCT00896532|10968094|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
9855221|NCT00896532|10968072|FG000|COMPLETED|Months 48-72: Follow-on Phase||0
10092520|NCT02337946|11220994|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0
10092521|NCT02337946|11220995|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0
9855222|NCT00896532|10968073|FG001|COMPLETED|Months 48-72: Follow-on Phase||0
9855223|NCT00896532|10968074|FG002|COMPLETED|Months 48-72: Follow-on Phase||0
9855224|NCT00896532|10968075|FG003|COMPLETED|Months 48-72: Follow-on Phase||0
9855225|NCT00896532|10968076|FG004|COMPLETED|Months 48-72: Follow-on Phase||0
9855226|NCT00896532|10968077|FG005|COMPLETED|Months 48-72: Follow-on Phase||0
9855227|NCT00896532|10968078|FG006|COMPLETED|Months 48-72: Follow-on Phase||0
9855228|NCT00896532|10968079|FG007|COMPLETED|Months 48-72: Follow-on Phase||0
9855229|NCT00896532|10968080|FG008|COMPLETED|Months 48-72: Follow-on Phase||0
9855230|NCT00896532|10968081|FG009|COMPLETED|Months 48-72: Follow-on Phase||0
9855231|NCT00896532|10968082|FG010|COMPLETED|Months 48-72: Follow-on Phase||0
9855232|NCT00896532|10968083|FG011|COMPLETED|Months 48-72: Follow-on Phase||0
9855233|NCT00896532|10968084|FG012|COMPLETED|Months 48-72: Follow-on Phase||0
9855234|NCT00896532|10968085|FG013|COMPLETED|Months 48-72: Follow-on Phase||0
9855235|NCT00896532|10968086|FG014|COMPLETED|Months 48-72: Follow-on Phase||0
9855236|NCT00896532|10968087|FG015|COMPLETED|Months 48-72: Follow-on Phase||0
9855237|NCT00896532|10968088|FG016|COMPLETED|Months 48-72: Follow-on Phase||0
10092522|NCT02337946|11220993|FG000|STARTED|In-between Period||114
10092523|NCT02337946|11220994|FG001|STARTED|In-between Period||0
10092524|NCT02337946|11220995|FG002|STARTED|In-between Period||0
10092525|NCT02337946|11220993|FG000|COMPLETED|In-between Period||113
10092526|NCT02337946|11220994|FG001|COMPLETED|In-between Period||0
10092527|NCT02337946|11220995|FG002|COMPLETED|In-between Period||0
9855238|NCT00896532|10968089|FG017|COMPLETED|Months 48-72: Follow-on Phase||0
9855239|NCT00896532|10968090|FG018|COMPLETED|Months 48-72: Follow-on Phase||50
9855240|NCT00896532|10968091|FG019|COMPLETED|Months 48-72: Follow-on Phase||11
9855241|NCT00896532|10968092|FG020|COMPLETED|Months 48-72: Follow-on Phase||12
9855242|NCT00896532|10968093|FG021|COMPLETED|Months 48-72: Follow-on Phase||57
9855243|NCT00896532|10968094|FG022|COMPLETED|Months 48-72: Follow-on Phase||8
9855244|NCT00896532|10968072|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855245|NCT00896532|10968073|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855246|NCT00896532|10968074|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855247|NCT00896532|10968075|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855248|NCT00896532|10968076|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855249|NCT00896532|10968077|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855250|NCT00896532|10968078|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855251|NCT00896532|10968079|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855252|NCT00896532|10968080|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855253|NCT00896532|10968081|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855254|NCT00896532|10968082|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855255|NCT00896532|10968083|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855256|NCT00896532|10968084|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855257|NCT00896532|10968085|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855258|NCT00896532|10968086|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855259|NCT00896532|10968087|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855260|NCT00896532|10968088|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855261|NCT00896532|10968089|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855262|NCT00896532|10968090|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1
9855263|NCT00896532|10968091|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855264|NCT00896532|10968092|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855265|NCT00896532|10968093|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2
9855266|NCT00896532|10968094|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0
9855267|NCT00896649|10968141|FG000|STARTED|Overall Study||193
9855268|NCT00896649|10968141|FG000|COMPLETED|Overall Study||188
9855269|NCT00896649|10968141|FG000|NOT COMPLETED|Overall Study||5
9855270|NCT00896779|10968148|FG000|STARTED|Overall Study||8
9855271|NCT00896779|10968149|FG001|STARTED|Overall Study||12
9855272|NCT00896779|10968148|FG000|COMPLETED|Overall Study||8
9855273|NCT00896779|10968149|FG001|COMPLETED|Overall Study||11
9855274|NCT00896779|10968148|FG000|NOT COMPLETED|Overall Study||0
9855275|NCT00896779|10968149|FG001|NOT COMPLETED|Overall Study||1
9855276|NCT00897390|10968155|FG000|STARTED|Overall Study||24
9855277|NCT00897390|10968155|FG000|COMPLETED|Overall Study||18
9855278|NCT00897390|10968155|FG000|NOT COMPLETED|Overall Study||6
9855279|NCT00897676|10968166|FG000|STARTED|Intervention 1(6 Hours)||9
9855280|NCT00897676|10968167|FG001|STARTED|Intervention 1(6 Hours)||7
9855281|NCT00897676|10968166|FG000|COMPLETED|Intervention 1(6 Hours)||9
9855282|NCT00897676|10968167|FG001|COMPLETED|Intervention 1(6 Hours)||7
10092528|NCT02337946|11220993|FG000|NOT COMPLETED|In-between Period||1
10092529|NCT02337946|11220994|FG001|NOT COMPLETED|In-between Period||0
9855283|NCT00897676|10968166|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0
9855284|NCT00897676|10968167|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0
9855285|NCT00897676|10968166|FG000|STARTED|Intervention 2(6 Hours)||9
9855286|NCT00897676|10968167|FG001|STARTED|Intervention 2(6 Hours)||7
9855287|NCT00897676|10968166|FG000|COMPLETED|Intervention 2(6 Hours)||9
9855288|NCT00897676|10968167|FG001|COMPLETED|Intervention 2(6 Hours)||7
9855289|NCT00897676|10968166|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0
9855290|NCT00897676|10968167|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0
9855291|NCT00897715|10968182|FG000|STARTED|Overall Study||8
9855292|NCT00897715|10968183|FG001|STARTED|Overall Study||7
9855293|NCT00897715|10968182|FG000|COMPLETED|Overall Study||6
9855294|NCT00897715|10968183|FG001|COMPLETED|Overall Study||6
10092530|NCT02337946|11220995|FG002|NOT COMPLETED|In-between Period||0
10092531|NCT02337946|11220993|FG000|STARTED|Protocol Treatment 2 Period||0
9855295|NCT00897715|10968182|FG000|NOT COMPLETED|Overall Study||2
9855296|NCT00897715|10968183|FG001|NOT COMPLETED|Overall Study||1
9855297|NCT00897897|10968189|FG000|STARTED|Overall Study||33
9855298|NCT00897897|10968189|FG000|COMPLETED|Overall Study||33
9855299|NCT00897897|10968189|FG000|NOT COMPLETED|Overall Study||0
9855300|NCT00898222|10968193|FG000|STARTED|Overall Study||4
9855301|NCT00898222|10968193|FG000|COMPLETED|Overall Study||4
9855302|NCT00898222|10968193|FG000|NOT COMPLETED|Overall Study||0
9855303|NCT00898443|10968199|FG000|STARTED|Overall Study||10
9855304|NCT00898443|10968200|FG001|STARTED|Overall Study||8
9855305|NCT00898443|10968199|FG000|COMPLETED|Overall Study||9
9855306|NCT00898443|10968200|FG001|COMPLETED|Overall Study||8
9855307|NCT00898443|10968199|FG000|NOT COMPLETED|Overall Study||1
9855308|NCT00898443|10968200|FG001|NOT COMPLETED|Overall Study||0
9855309|NCT00898560|10968206|FG000|STARTED|Overall Study||20
9855310|NCT00898560|10968206|FG000|COMPLETED|Overall Study||19
9855311|NCT00898560|10968206|FG000|NOT COMPLETED|Overall Study||1
9855312|NCT00898807|10968214|FG000|STARTED|Overall Study||94
9855313|NCT00898807|10968215|FG001|STARTED|Overall Study||92
9855314|NCT00898807|10968214|FG000|COMPLETED|Overall Study||86
9855315|NCT00898807|10968215|FG001|COMPLETED|Overall Study||83
9855316|NCT00898807|10968214|FG000|NOT COMPLETED|Overall Study||8
9855317|NCT00898807|10968215|FG001|NOT COMPLETED|Overall Study||9
9855318|NCT00898937|10968224|FG000|STARTED|Overall Study||25
9855319|NCT00898937|10968225|FG001|STARTED|Overall Study||21
9855320|NCT00898937|10968226|FG002|STARTED|Overall Study||9
9855321|NCT00898937|10968224|FG000|COMPLETED|Overall Study||25
9855322|NCT00898937|10968225|FG001|COMPLETED|Overall Study||21
9855323|NCT00898937|10968226|FG002|COMPLETED|Overall Study||9
9855324|NCT00898937|10968224|FG000|NOT COMPLETED|Overall Study||0
9855325|NCT00898937|10968225|FG001|NOT COMPLETED|Overall Study||0
9855326|NCT00898937|10968226|FG002|NOT COMPLETED|Overall Study||0
9855327|NCT00899353|10968234|FG000|STARTED|Overall Study||16
9855328|NCT00899353|10968234|FG000|COMPLETED|Overall Study||11
9855329|NCT00899353|10968234|FG000|NOT COMPLETED|Overall Study||5
9855330|NCT00899392|10968257|FG000|STARTED|Overall Study||68
9855331|NCT00899392|10968258|FG001|STARTED|Overall Study||74
9855332|NCT00899392|10968257|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
9855333|NCT00899392|10968258|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
9855334|NCT00899392|10968257|FG000|NOT COMPLETED|Overall Study||21
9855335|NCT00899392|10968258|FG001|NOT COMPLETED|Overall Study||24
9758508|NCT03418675|10862036|FG001|Completed All Baseline Measures|Overall Study||40
9758509|NCT03418675|10862035|FG000|Completed One-post Randomization Visit|Overall Study||34
9758510|NCT03418675|10862036|FG001|Completed One-post Randomization Visit|Overall Study||35
9855336|NCT00899431|10968267|FG000|STARTED|Overall Study||22
9855337|NCT00899431|10968268|FG001|STARTED|Overall Study||8
9855338|NCT00899431|10968269|FG002|STARTED|Overall Study||9
9855339|NCT00899431|10968267|FG000|COMPLETED|Overall Study||21
9855340|NCT00899431|10968268|FG001|COMPLETED|Overall Study||8
9855341|NCT00899431|10968269|FG002|COMPLETED|Overall Study||9
9855342|NCT00899431|10968267|FG000|NOT COMPLETED|Overall Study||1
9855343|NCT00899431|10968268|FG001|NOT COMPLETED|Overall Study||0
9855344|NCT00899431|10968269|FG002|NOT COMPLETED|Overall Study||0
9855345|NCT00899470|10968280|FG000|STARTED|First Therapy||6
9855346|NCT00899470|10968281|FG001|STARTED|First Therapy||6
9855347|NCT00899470|10968282|FG002|STARTED|First Therapy||6
9855348|NCT00899470|10968283|FG003|STARTED|First Therapy||6
9855349|NCT00899470|10968280|FG000|COMPLETED|First Therapy||6
9855350|NCT00899470|10968281|FG001|COMPLETED|First Therapy||6
9855351|NCT00899470|10968282|FG002|COMPLETED|First Therapy||6
9855352|NCT00899470|10968283|FG003|COMPLETED|First Therapy||6
9855353|NCT00899470|10968280|FG000|NOT COMPLETED|First Therapy||0
9855354|NCT00899470|10968281|FG001|NOT COMPLETED|First Therapy||0
9855355|NCT00899470|10968282|FG002|NOT COMPLETED|First Therapy||0
9855356|NCT00899470|10968283|FG003|NOT COMPLETED|First Therapy||0
9855357|NCT00899470|10968280|FG000|STARTED|First Washout Period||6
9855358|NCT00899470|10968281|FG001|STARTED|First Washout Period||6
9855359|NCT00899470|10968282|FG002|STARTED|First Washout Period||6
9855360|NCT00899470|10968283|FG003|STARTED|First Washout Period||6
9855361|NCT00899470|10968280|FG000|COMPLETED|First Washout Period||6
9855362|NCT00899470|10968281|FG001|COMPLETED|First Washout Period||6
9855363|NCT00899470|10968282|FG002|COMPLETED|First Washout Period||6
9855364|NCT00899470|10968283|FG003|COMPLETED|First Washout Period||6
9758511|NCT03418675|10862035|FG000|COMPLETED|Overall Study||25
9758512|NCT03418675|10862036|FG001|COMPLETED|Overall Study||30
9758513|NCT03418675|10862035|FG000|NOT COMPLETED|Overall Study||15
9758514|NCT03418675|10862036|FG001|NOT COMPLETED|Overall Study||10
9758515|NCT03367910|10862042|FG000|STARTED|Overall Study||1
9758516|NCT03367910|10862042|FG000|COMPLETED|Overall Study||1
9758517|NCT03367910|10862042|FG000|NOT COMPLETED|Overall Study||0
9758518|NCT03329690|10862051|FG000|STARTED|Overall Study||126
9758519|NCT03329690|10862052|FG001|STARTED|Overall Study||55
9758520|NCT03329690|10862053|FG002|STARTED|Overall Study||7
9758521|NCT03329690|10862054|FG003|STARTED|Overall Study||21
9758522|NCT03329690|10862055|FG004|STARTED|Overall Study||24
9855365|NCT00899470|10968280|FG000|NOT COMPLETED|First Washout Period||0
9855366|NCT00899470|10968281|FG001|NOT COMPLETED|First Washout Period||0
9855367|NCT00899470|10968282|FG002|NOT COMPLETED|First Washout Period||0
9855368|NCT00899470|10968283|FG003|NOT COMPLETED|First Washout Period||0
9855369|NCT00899470|10968280|FG000|STARTED|Second Therapy||6
9855370|NCT00899470|10968281|FG001|STARTED|Second Therapy||6
9855371|NCT00899470|10968282|FG002|STARTED|Second Therapy||6
9855372|NCT00899470|10968283|FG003|STARTED|Second Therapy||6
9855373|NCT00899470|10968280|FG000|COMPLETED|Second Therapy||6
9855374|NCT00899470|10968281|FG001|COMPLETED|Second Therapy||6
9855375|NCT00899470|10968282|FG002|COMPLETED|Second Therapy||6
9855376|NCT00899470|10968283|FG003|COMPLETED|Second Therapy||6
9855377|NCT00899470|10968280|FG000|NOT COMPLETED|Second Therapy||0
9855378|NCT00899470|10968281|FG001|NOT COMPLETED|Second Therapy||0
9855379|NCT00899470|10968282|FG002|NOT COMPLETED|Second Therapy||0
9855380|NCT00899470|10968283|FG003|NOT COMPLETED|Second Therapy||0
9855381|NCT00899470|10968280|FG000|STARTED|Second Washout||6
9855382|NCT00899470|10968281|FG001|STARTED|Second Washout||6
9855383|NCT00899470|10968282|FG002|STARTED|Second Washout||6
9855384|NCT00899470|10968283|FG003|STARTED|Second Washout||6
9855385|NCT00899470|10968280|FG000|COMPLETED|Second Washout||6
9855386|NCT00899470|10968281|FG001|COMPLETED|Second Washout||6
9855387|NCT00899470|10968282|FG002|COMPLETED|Second Washout||6
9855388|NCT00899470|10968283|FG003|COMPLETED|Second Washout||6
9855389|NCT00899470|10968280|FG000|NOT COMPLETED|Second Washout||0
9855390|NCT00899470|10968281|FG001|NOT COMPLETED|Second Washout||0
9855391|NCT00899470|10968282|FG002|NOT COMPLETED|Second Washout||0
9855392|NCT00899470|10968283|FG003|NOT COMPLETED|Second Washout||0
9855393|NCT00899470|10968280|FG000|STARTED|Third Therapy||6
9855394|NCT00899470|10968281|FG001|STARTED|Third Therapy||6
9855395|NCT00899470|10968282|FG002|STARTED|Third Therapy||6
9855396|NCT00899470|10968283|FG003|STARTED|Third Therapy||6
9855397|NCT00899470|10968280|FG000|COMPLETED|Third Therapy||6
9855398|NCT00899470|10968281|FG001|COMPLETED|Third Therapy||6
9855399|NCT00899470|10968282|FG002|COMPLETED|Third Therapy||6
9855400|NCT00899470|10968283|FG003|COMPLETED|Third Therapy||6
9855401|NCT00899470|10968280|FG000|NOT COMPLETED|Third Therapy||0
9855402|NCT00899470|10968281|FG001|NOT COMPLETED|Third Therapy||0
9855403|NCT00899470|10968282|FG002|NOT COMPLETED|Third Therapy||0
9855404|NCT00899470|10968283|FG003|NOT COMPLETED|Third Therapy||0
9855405|NCT00899470|10968280|FG000|STARTED|Third Washout||6
9855406|NCT00899470|10968281|FG001|STARTED|Third Washout||6
9855407|NCT00899470|10968282|FG002|STARTED|Third Washout||6
9855408|NCT00899470|10968283|FG003|STARTED|Third Washout||6
9855409|NCT00899470|10968280|FG000|COMPLETED|Third Washout||6
9855410|NCT00899470|10968281|FG001|COMPLETED|Third Washout||6
9855411|NCT00899470|10968282|FG002|COMPLETED|Third Washout||6
9855412|NCT00899470|10968283|FG003|COMPLETED|Third Washout||6
9855413|NCT00899470|10968280|FG000|NOT COMPLETED|Third Washout||0
9855414|NCT00899470|10968281|FG001|NOT COMPLETED|Third Washout||0
9855415|NCT00899470|10968282|FG002|NOT COMPLETED|Third Washout||0
9855416|NCT00899470|10968283|FG003|NOT COMPLETED|Third Washout||0
9855417|NCT00899470|10968280|FG000|STARTED|Fourth Therapy||6
9855418|NCT00899470|10968281|FG001|STARTED|Fourth Therapy||6
9855419|NCT00899470|10968282|FG002|STARTED|Fourth Therapy||6
9855420|NCT00899470|10968283|FG003|STARTED|Fourth Therapy||6
9855421|NCT00899470|10968280|FG000|COMPLETED|Fourth Therapy||6
9855422|NCT00899470|10968281|FG001|COMPLETED|Fourth Therapy||6
9855423|NCT00899470|10968282|FG002|COMPLETED|Fourth Therapy||6
9855424|NCT00899470|10968283|FG003|COMPLETED|Fourth Therapy||6
9855425|NCT00899470|10968280|FG000|NOT COMPLETED|Fourth Therapy||0
9855426|NCT00899470|10968281|FG001|NOT COMPLETED|Fourth Therapy||0
9855427|NCT00899470|10968282|FG002|NOT COMPLETED|Fourth Therapy||0
9855428|NCT00899470|10968283|FG003|NOT COMPLETED|Fourth Therapy||0
9855429|NCT00899548|10968298|FG000|STARTED|Overall Study||182
9855430|NCT00899548|10968298|FG000|COMPLETED|Overall Study||179
9855431|NCT00899548|10968298|FG000|NOT COMPLETED|Overall Study||3
9855432|NCT00899574|10968306|FG000|STARTED|Overall Study||10
9855433|NCT00899574|10968306|FG000|COMPLETED|Overall Study||10
9855434|NCT00899574|10968306|FG000|NOT COMPLETED|Overall Study||0
9855435|NCT00899600|10968312|FG000|STARTED|Overall Study||50
9855436|NCT00899600|10968313|FG001|STARTED|Overall Study||52
9855437|NCT00899600|10968312|FG000|COMPLETED|Overall Study||50
9855438|NCT00899600|10968313|FG001|COMPLETED|Overall Study||52
9855439|NCT00899600|10968312|FG000|NOT COMPLETED|Overall Study||0
9855440|NCT00899600|10968313|FG001|NOT COMPLETED|Overall Study||0
9855441|NCT00899678|10968322|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
9855442|NCT00899678|10968323|FG001|STARTED|Induction Period (Weeks 0 to 6)||37
9855443|NCT00899678|10968324|FG002|STARTED|Induction Period (Weeks 0 to 6)||35
9855444|NCT00899678|10968322|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
9855445|NCT00899678|10968323|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37
9855446|NCT00899678|10968324|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35
9855447|NCT00899678|10968322|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
9855448|NCT00899678|10968323|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
9855449|NCT00899678|10968324|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
9855450|NCT00899678|10968322|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
9855451|NCT00899678|10968323|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37
9855452|NCT00899678|10968324|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35
9855453|NCT00899678|10968322|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
9855454|NCT00899678|10968323|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
9855455|NCT00899678|10968324|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
9855456|NCT00899678|10968322|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
9855457|NCT00899678|10968323|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
9855458|NCT00899678|10968324|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
9855459|NCT00899717|10968334|FG000|STARTED|Overall Study||10
9855460|NCT00899717|10968335|FG001|STARTED|Overall Study||11
9855461|NCT00899717|10968334|FG000|COMPLETED|Overall Study||10
9855462|NCT00899717|10968335|FG001|COMPLETED|Overall Study||11
10092532|NCT02337946|11220994|FG001|STARTED|Protocol Treatment 2 Period||56
10092533|NCT02337946|11220995|FG002|STARTED|Protocol Treatment 2 Period||57
10092534|NCT02337946|11220993|FG000|Safety Population|Protocol Treatment 2 Period||0
10092535|NCT02337946|11220994|FG001|Safety Population|Protocol Treatment 2 Period||56
9855463|NCT00899717|10968334|FG000|NOT COMPLETED|Overall Study||0
9855464|NCT00899717|10968335|FG001|NOT COMPLETED|Overall Study||0
9855465|NCT00899847|10968347|FG000|STARTED|Overall Study||9
9855466|NCT00899847|10968347|FG000|COMPLETED|Overall Study||7
9855467|NCT00899847|10968347|FG000|NOT COMPLETED|Overall Study||2
9855468|NCT00900029|10968358|FG000|STARTED|Overall Study||38
9855469|NCT00900029|10968359|FG001|STARTED|Overall Study||41
9855470|NCT00900029|10968360|FG002|STARTED|Overall Study||41
9855471|NCT00900029|10968361|FG003|STARTED|Overall Study||42
9855472|NCT00900029|10968362|FG004|STARTED|Overall Study||44
9855473|NCT00900029|10968358|FG000|COMPLETED|Overall Study||35
9855474|NCT00900029|10968359|FG001|COMPLETED|Overall Study||37
9855475|NCT00900029|10968360|FG002|COMPLETED|Overall Study||38
9855476|NCT00900029|10968361|FG003|COMPLETED|Overall Study||35
9855477|NCT00900029|10968362|FG004|COMPLETED|Overall Study||38
9855478|NCT00900029|10968358|FG000|NOT COMPLETED|Overall Study||3
9855479|NCT00900029|10968359|FG001|NOT COMPLETED|Overall Study||4
9855480|NCT00900029|10968360|FG002|NOT COMPLETED|Overall Study||3
9855481|NCT00900029|10968361|FG003|NOT COMPLETED|Overall Study||7
9855482|NCT00900029|10968362|FG004|NOT COMPLETED|Overall Study||6
9855483|NCT00900146|10968379|FG000|STARTED|Dose Finding: Period II (4 Months)||93
9855484|NCT00900146|10968380|FG001|STARTED|Dose Finding: Period II (4 Months)||95
9855485|NCT00900146|10968381|FG002|STARTED|Dose Finding: Period II (4 Months)||92
9855486|NCT00900146|10968382|FG003|STARTED|Dose Finding: Period II (4 Months)||92
9855487|NCT00900146|10968383|FG004|STARTED|Dose Finding: Period II (4 Months)||179
9855488|NCT00900146|10968379|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
9855489|NCT00900146|10968380|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
9855490|NCT00900146|10968381|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
9855491|NCT00900146|10968382|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
9855492|NCT00900146|10968383|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
9855493|NCT00900146|10968379|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88
9855494|NCT00900146|10968380|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93
9855495|NCT00900146|10968381|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87
9855496|NCT00900146|10968382|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90
9855497|NCT00900146|10968383|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
9855498|NCT00900146|10968379|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
9855499|NCT00900146|10968380|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
9855500|NCT00900146|10968381|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
9855501|NCT00900146|10968382|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
9855502|NCT00900146|10968383|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
9855503|NCT00900146|10968379|FG000|STARTED|Intermediate: Period III||87
9855504|NCT00900146|10968380|FG001|STARTED|Intermediate: Period III||93
9855505|NCT00900146|10968381|FG002|STARTED|Intermediate: Period III||84
9855506|NCT00900146|10968382|FG003|STARTED|Intermediate: Period III||90
9855507|NCT00900146|10968383|FG004|STARTED|Intermediate: Period III||167
9855508|NCT00900146|10968379|FG000|Safety Set|Intermediate: Period III||86
9855509|NCT00900146|10968380|FG001|Safety Set|Intermediate: Period III||92
9855510|NCT00900146|10968381|FG002|Safety Set|Intermediate: Period III||84
9855511|NCT00900146|10968382|FG003|Safety Set|Intermediate: Period III||90
9855512|NCT00900146|10968383|FG004|Safety Set|Intermediate: Period III||166
9855513|NCT00900146|10968379|FG000|COMPLETED|Intermediate: Period III||0
9855514|NCT00900146|10968380|FG001|COMPLETED|Intermediate: Period III||0
9855515|NCT00900146|10968381|FG002|COMPLETED|Intermediate: Period III||0
9855516|NCT00900146|10968382|FG003|COMPLETED|Intermediate: Period III||0
9855517|NCT00900146|10968383|FG004|COMPLETED|Intermediate: Period III||0
9855518|NCT00900146|10968379|FG000|NOT COMPLETED|Intermediate: Period III||87
9855519|NCT00900146|10968380|FG001|NOT COMPLETED|Intermediate: Period III||93
9855520|NCT00900146|10968381|FG002|NOT COMPLETED|Intermediate: Period III||84
9855521|NCT00900146|10968382|FG003|NOT COMPLETED|Intermediate: Period III||90
9855522|NCT00900146|10968383|FG004|NOT COMPLETED|Intermediate: Period III||167
9855523|NCT00900159|10968397|FG000|STARTED|First Intervention||11
9855524|NCT00900159|10968398|FG001|STARTED|First Intervention||13
9855525|NCT00900159|10968397|FG000|COMPLETED|First Intervention||11
9855526|NCT00900159|10968398|FG001|COMPLETED|First Intervention||13
9855527|NCT00900159|10968397|FG000|NOT COMPLETED|First Intervention||0
9855528|NCT00900159|10968398|FG001|NOT COMPLETED|First Intervention||0
9855529|NCT00900159|10968397|FG000|STARTED|Washout||11
9855530|NCT00900159|10968398|FG001|STARTED|Washout||13
9855531|NCT00900159|10968397|FG000|COMPLETED|Washout||11
9855532|NCT00900159|10968398|FG001|COMPLETED|Washout||13
9855533|NCT00900159|10968397|FG000|NOT COMPLETED|Washout||0
9855534|NCT00900159|10968398|FG001|NOT COMPLETED|Washout||0
9855535|NCT00900159|10968397|FG000|STARTED|Second Intervention||11
9855536|NCT00900159|10968398|FG001|STARTED|Second Intervention||13
9855537|NCT00900159|10968397|FG000|COMPLETED|Second Intervention||10
9855538|NCT00900159|10968398|FG001|COMPLETED|Second Intervention||13
9855539|NCT00900159|10968397|FG000|NOT COMPLETED|Second Intervention||1
9855540|NCT00900159|10968398|FG001|NOT COMPLETED|Second Intervention||0
9855541|NCT00900237|10968406|FG000|STARTED|Overall Study||7
9855542|NCT00900237|10968407|FG001|STARTED|Overall Study||7
9855543|NCT00900237|10968406|FG000|COMPLETED|Overall Study||7
9855544|NCT00900237|10968407|FG001|COMPLETED|Overall Study||7
9855545|NCT00900237|10968406|FG000|NOT COMPLETED|Overall Study||0
9855546|NCT00900237|10968407|FG001|NOT COMPLETED|Overall Study||0
9855547|NCT00900562|10968415|FG000|STARTED|Overall Study||12
9855548|NCT00900562|10968416|FG001|STARTED|Overall Study||7
9855549|NCT00900562|10968415|FG000|COMPLETED|Overall Study||0
9855550|NCT00900562|10968416|FG001|COMPLETED|Overall Study||0
9855551|NCT00900562|10968415|FG000|NOT COMPLETED|Overall Study||12
9855552|NCT00900562|10968416|FG001|NOT COMPLETED|Overall Study||7
9855553|NCT00900601|10968423|FG000|STARTED|Overall Study||9
9855554|NCT00900601|10968423|FG000|COMPLETED|Overall Study||8
9855555|NCT00900601|10968423|FG000|NOT COMPLETED|Overall Study||1
9855556|NCT00900627|10968433|FG000|STARTED|Overall Study||6
9855557|NCT00900627|10968434|FG001|STARTED|Overall Study||2
9855558|NCT00900627|10968435|FG002|STARTED|Overall Study||6
9855559|NCT00900627|10968436|FG003|STARTED|Overall Study||6
9855560|NCT00900627|10968437|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
9855561|NCT00900627|10968438|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
9855562|NCT00900627|10968433|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
9855563|NCT00900627|10968434|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
9855564|NCT00900627|10968435|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
9855565|NCT00900627|10968436|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
9855566|NCT00900627|10968437|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
9855567|NCT00900627|10968438|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
9855568|NCT00900627|10968433|FG000|NOT COMPLETED|Overall Study||6
9855569|NCT00900627|10968434|FG001|NOT COMPLETED|Overall Study||2
9855570|NCT00900627|10968435|FG002|NOT COMPLETED|Overall Study||6
9855571|NCT00900627|10968436|FG003|NOT COMPLETED|Overall Study||6
9855572|NCT00900627|10968437|FG004|NOT COMPLETED|Overall Study||29
9855573|NCT00900627|10968438|FG005|NOT COMPLETED|Overall Study||26
9855574|NCT00900666|10968454|FG000|STARTED|Overall Study||10
9855575|NCT00900666|10968455|FG001|STARTED|Overall Study||9
9855576|NCT00900666|10968454|FG000|COMPLETED|Overall Study||10
9855577|NCT00900666|10968455|FG001|COMPLETED|Overall Study||9
9855578|NCT00900666|10968454|FG000|NOT COMPLETED|Overall Study||0
9855579|NCT00900666|10968455|FG001|NOT COMPLETED|Overall Study||0
9855580|NCT00900731|10968463|FG000|STARTED|Overall Study|Randomized participants|797
9855581|NCT00900731|10968464|FG001|STARTED|Overall Study||801
9855582|NCT00900731|10968463|FG000|Safety Set: Received Study Drug|Overall Study||794
9855583|NCT00900731|10968464|FG001|Safety Set: Received Study Drug|Overall Study||799
9855584|NCT00900731|10968463|FG000|COMPLETED|Overall Study||737
9855585|NCT00900731|10968464|FG001|COMPLETED|Overall Study||740
9855586|NCT00900731|10968463|FG000|NOT COMPLETED|Overall Study||60
9855587|NCT00900731|10968464|FG001|NOT COMPLETED|Overall Study||61
9855588|NCT00900757|10968470|FG000|STARTED|Overall Study||57
9855589|NCT00900757|10968470|FG000|COMPLETED|Overall Study||38
9855590|NCT00900757|10968470|FG000|NOT COMPLETED|Overall Study||19
9855591|NCT00900796|10968474|FG000|STARTED|Phase 1||132
9855592|NCT00900796|10968474|FG000|COMPLETED|Phase 1||121
9855593|NCT00900796|10968474|FG000|NOT COMPLETED|Phase 1||11
9855594|NCT00900796|10968474|FG000|STARTED|Between Phase 1 and Phase 2||121
9855595|NCT00900796|10968474|FG000|COMPLETED|Between Phase 1 and Phase 2||11
9855596|NCT00900796|10968474|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110
9855597|NCT00900796|10968474|FG000|STARTED|Phase 2||11
9855598|NCT00900796|10968474|FG000|COMPLETED|Phase 2||6
9855599|NCT00900796|10968474|FG000|NOT COMPLETED|Phase 2||5
9855600|NCT00900822|10968479|FG000|STARTED|9 Months Histological Evaluation||11
9855601|NCT00900822|10968479|FG000|COMPLETED|9 Months Histological Evaluation||11
9855602|NCT00900822|10968479|FG000|NOT COMPLETED|9 Months Histological Evaluation||0
9855603|NCT00900822|10968479|FG000|STARTED|12 Months Clinical Evaluation||11
9855604|NCT00900822|10968479|FG000|COMPLETED|12 Months Clinical Evaluation||11
9855605|NCT00900822|10968479|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0
9855606|NCT00901017|10968486|FG000|STARTED|Overall Study||14
9855607|NCT00901017|10968486|FG000|COMPLETED|Overall Study||14
9855608|NCT00901017|10968486|FG000|NOT COMPLETED|Overall Study||0
9855609|NCT00901186|10968495|FG000|STARTED|Overall Study||40
9855610|NCT00901186|10968496|FG001|STARTED|Overall Study||43
9855611|NCT00901186|10968495|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
9855612|NCT00901186|10968496|FG001|Safety Set|Overall Study||43
9855613|NCT00901186|10968495|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
9855614|NCT00901186|10968496|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
9855615|NCT00901186|10968495|FG000|COMPLETED|Overall Study||31
9855616|NCT00901186|10968496|FG001|COMPLETED|Overall Study||32
9855617|NCT00901186|10968495|FG000|NOT COMPLETED|Overall Study||9
9855618|NCT00901186|10968496|FG001|NOT COMPLETED|Overall Study||11
9855619|NCT00901199|10968502|FG000|STARTED|Overall Study||22
9855620|NCT00901199|10968502|FG000|COMPLETED|Overall Study||18
9855621|NCT00901199|10968502|FG000|NOT COMPLETED|Overall Study||4
9855622|NCT00901225|10968506|FG000|STARTED|Overall Study||21
9855623|NCT00901225|10968506|FG000|COMPLETED|Overall Study||20
9855624|NCT00901225|10968506|FG000|NOT COMPLETED|Overall Study||1
9855625|NCT00901316|10968512|FG000|STARTED|Overall Study||492
9855626|NCT00901316|10968513|FG001|STARTED|Overall Study||495
9855627|NCT00901316|10968512|FG000|COMPLETED|Overall Study||492
9855628|NCT00901316|10968513|FG001|COMPLETED|Overall Study||495
9855629|NCT00901316|10968512|FG000|NOT COMPLETED|Overall Study||0
9855630|NCT00901316|10968513|FG001|NOT COMPLETED|Overall Study||0
9855631|NCT00901342|10968519|FG000|STARTED|Overall Study||104
9855632|NCT00901342|10968519|FG000|Received at Least 1 Infusion|Overall Study||98
9855633|NCT00901342|10968519|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
9855634|NCT00901342|10968519|FG000|NOT COMPLETED|Overall Study||15
9855635|NCT00901394|10968526|FG000|STARTED|Overall Study||21
9855636|NCT00901394|10968527|FG001|STARTED|Overall Study||20
9855637|NCT00901394|10968528|FG002|STARTED|Overall Study||22
9855638|NCT00901394|10968526|FG000|COMPLETED|Overall Study||20
9855639|NCT00901394|10968527|FG001|COMPLETED|Overall Study||19
9855640|NCT00901394|10968528|FG002|COMPLETED|Overall Study||20
9855641|NCT00901394|10968526|FG000|NOT COMPLETED|Overall Study||1
9855642|NCT00901394|10968527|FG001|NOT COMPLETED|Overall Study||1
9855643|NCT00901394|10968528|FG002|NOT COMPLETED|Overall Study||2
9855644|NCT00901459|10968536|FG000|STARTED|Overall Study||21
10092536|NCT02337946|11220995|FG002|Safety Population|Protocol Treatment 2 Period||54
10092537|NCT02337946|11220993|FG000|COMPLETED|Protocol Treatment 2 Period||0
10092538|NCT02337946|11220994|FG001|COMPLETED|Protocol Treatment 2 Period||5
10092539|NCT02337946|11220995|FG002|COMPLETED|Protocol Treatment 2 Period||7
10092540|NCT02337946|11220993|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0
10092541|NCT02337946|11220994|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51
9855645|NCT00901459|10968536|FG000|COMPLETED|Overall Study||15
9855646|NCT00901459|10968536|FG000|NOT COMPLETED|Overall Study||6
9855647|NCT00901485|10968547|FG000|STARTED|Overall Study||10
9855648|NCT00901485|10968548|FG001|STARTED|Overall Study||13
9855649|NCT00901485|10968547|FG000|COMPLETED|Overall Study||9
9855650|NCT00901485|10968548|FG001|COMPLETED|Overall Study||9
9855651|NCT00901485|10968547|FG000|NOT COMPLETED|Overall Study||1
9855652|NCT00901485|10968548|FG001|NOT COMPLETED|Overall Study||4
9855653|NCT00901576|10968560|FG000|STARTED|First Intervention||6
9855654|NCT00901576|10968561|FG001|STARTED|First Intervention||7
9855655|NCT00901576|10968562|FG002|STARTED|First Intervention||7
9855656|NCT00901576|10968563|FG003|STARTED|First Intervention||6
9855657|NCT00901576|10968564|FG004|STARTED|First Intervention||6
9855658|NCT00901576|10968565|FG005|STARTED|First Intervention||6
9855659|NCT00901576|10968560|FG000|COMPLETED|First Intervention||6
9855660|NCT00901576|10968561|FG001|COMPLETED|First Intervention||7
9855661|NCT00901576|10968562|FG002|COMPLETED|First Intervention||7
9855662|NCT00901576|10968563|FG003|COMPLETED|First Intervention||6
9855663|NCT00901576|10968564|FG004|COMPLETED|First Intervention||6
10092542|NCT02337946|11220995|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50
10092543|NCT02337959|11221004|FG000|STARTED|Overall Study||10
10092544|NCT02337959|11221005|FG001|STARTED|Overall Study||10
9855664|NCT00901576|10968565|FG005|COMPLETED|First Intervention||6
9855665|NCT00901576|10968560|FG000|NOT COMPLETED|First Intervention||0
9855666|NCT00901576|10968561|FG001|NOT COMPLETED|First Intervention||0
9855667|NCT00901576|10968562|FG002|NOT COMPLETED|First Intervention||0
9855668|NCT00901576|10968563|FG003|NOT COMPLETED|First Intervention||0
9855669|NCT00901576|10968564|FG004|NOT COMPLETED|First Intervention||0
9855670|NCT00901576|10968565|FG005|NOT COMPLETED|First Intervention||0
9855671|NCT00901576|10968560|FG000|STARTED|Washout||6
9855672|NCT00901576|10968561|FG001|STARTED|Washout||7
9855673|NCT00901576|10968562|FG002|STARTED|Washout||7
9855674|NCT00901576|10968563|FG003|STARTED|Washout||6
9855675|NCT00901576|10968564|FG004|STARTED|Washout||6
9855676|NCT00901576|10968565|FG005|STARTED|Washout||6
9855677|NCT00901576|10968560|FG000|COMPLETED|Washout||6
9855678|NCT00901576|10968561|FG001|COMPLETED|Washout||7
9855679|NCT00901576|10968562|FG002|COMPLETED|Washout||7
9855680|NCT00901576|10968563|FG003|COMPLETED|Washout||6
9855681|NCT00901576|10968564|FG004|COMPLETED|Washout||6
9855682|NCT00901576|10968565|FG005|COMPLETED|Washout||6
9855683|NCT00901576|10968560|FG000|NOT COMPLETED|Washout||0
9855684|NCT00901576|10968561|FG001|NOT COMPLETED|Washout||0
9855685|NCT00901576|10968562|FG002|NOT COMPLETED|Washout||0
9855686|NCT00901576|10968563|FG003|NOT COMPLETED|Washout||0
9855687|NCT00901576|10968564|FG004|NOT COMPLETED|Washout||0
9855688|NCT00901576|10968565|FG005|NOT COMPLETED|Washout||0
9855689|NCT00901576|10968560|FG000|STARTED|Second Intervention||6
9855690|NCT00901576|10968561|FG001|STARTED|Second Intervention||7
9855691|NCT00901576|10968562|FG002|STARTED|Second Intervention||7
9855692|NCT00901576|10968563|FG003|STARTED|Second Intervention||6
9855693|NCT00901576|10968564|FG004|STARTED|Second Intervention||6
9855694|NCT00901576|10968565|FG005|STARTED|Second Intervention||6
9855695|NCT00901576|10968560|FG000|COMPLETED|Second Intervention||5
10092545|NCT02337959|11221006|FG002|STARTED|Overall Study||7
10092546|NCT02337959|11221004|FG000|COMPLETED|Overall Study||10
9855696|NCT00901576|10968561|FG001|COMPLETED|Second Intervention||7
9855697|NCT00901576|10968562|FG002|COMPLETED|Second Intervention||7
9855698|NCT00901576|10968563|FG003|COMPLETED|Second Intervention||5
9855699|NCT00901576|10968564|FG004|COMPLETED|Second Intervention||6
9855700|NCT00901576|10968565|FG005|COMPLETED|Second Intervention||5
9855701|NCT00901576|10968560|FG000|NOT COMPLETED|Second Intervention||1
9855702|NCT00901576|10968561|FG001|NOT COMPLETED|Second Intervention||0
9855703|NCT00901576|10968562|FG002|NOT COMPLETED|Second Intervention||0
9855704|NCT00901576|10968563|FG003|NOT COMPLETED|Second Intervention||1
9855705|NCT00901576|10968564|FG004|NOT COMPLETED|Second Intervention||0
9855706|NCT00901576|10968565|FG005|NOT COMPLETED|Second Intervention||1
9855707|NCT00901576|10968560|FG000|STARTED|Washout||5
9855708|NCT00901576|10968561|FG001|STARTED|Washout||7
9855709|NCT00901576|10968562|FG002|STARTED|Washout||7
9855710|NCT00901576|10968563|FG003|STARTED|Washout||5
9855711|NCT00901576|10968564|FG004|STARTED|Washout||6
9855712|NCT00901576|10968565|FG005|STARTED|Washout||5
9855713|NCT00901576|10968560|FG000|COMPLETED|Washout||5
9855714|NCT00901576|10968561|FG001|COMPLETED|Washout||7
9855715|NCT00901576|10968562|FG002|COMPLETED|Washout||7
9855716|NCT00901576|10968563|FG003|COMPLETED|Washout||5
9855717|NCT00901576|10968564|FG004|COMPLETED|Washout||6
9855718|NCT00901576|10968565|FG005|COMPLETED|Washout||5
9855719|NCT00901576|10968560|FG000|NOT COMPLETED|Washout||0
9855720|NCT00901576|10968561|FG001|NOT COMPLETED|Washout||0
9855721|NCT00901576|10968562|FG002|NOT COMPLETED|Washout||0
9855722|NCT00901576|10968563|FG003|NOT COMPLETED|Washout||0
9855723|NCT00901576|10968564|FG004|NOT COMPLETED|Washout||0
9855724|NCT00901576|10968565|FG005|NOT COMPLETED|Washout||0
9855725|NCT00901576|10968560|FG000|STARTED|Third Intervention||5
9855726|NCT00901576|10968561|FG001|STARTED|Third Intervention||7
9855727|NCT00901576|10968562|FG002|STARTED|Third Intervention||7
9855728|NCT00901576|10968563|FG003|STARTED|Third Intervention||5
9855729|NCT00901576|10968564|FG004|STARTED|Third Intervention||6
9855730|NCT00901576|10968565|FG005|STARTED|Third Intervention||5
9855731|NCT00901576|10968560|FG000|COMPLETED|Third Intervention||5
9855732|NCT00901576|10968561|FG001|COMPLETED|Third Intervention||7
9855733|NCT00901576|10968562|FG002|COMPLETED|Third Intervention||7
9855734|NCT00901576|10968563|FG003|COMPLETED|Third Intervention||5
9855735|NCT00901576|10968564|FG004|COMPLETED|Third Intervention||6
9855736|NCT00901576|10968565|FG005|COMPLETED|Third Intervention||5
9855737|NCT00901576|10968560|FG000|NOT COMPLETED|Third Intervention||0
9855738|NCT00901576|10968561|FG001|NOT COMPLETED|Third Intervention||0
9855739|NCT00901576|10968562|FG002|NOT COMPLETED|Third Intervention||0
9855740|NCT00901576|10968563|FG003|NOT COMPLETED|Third Intervention||0
9855741|NCT00901576|10968564|FG004|NOT COMPLETED|Third Intervention||0
9855742|NCT00901576|10968565|FG005|NOT COMPLETED|Third Intervention||0
9855743|NCT00901628|10968575|FG000|STARTED|Overall Study||49
9855744|NCT00901628|10968576|FG001|STARTED|Overall Study||52
9855745|NCT00901628|10968575|FG000|COMPLETED|Overall Study||45
9855746|NCT00901628|10968576|FG001|COMPLETED|Overall Study||42
9855747|NCT00901628|10968575|FG000|NOT COMPLETED|Overall Study||4
9855748|NCT00901628|10968576|FG001|NOT COMPLETED|Overall Study||10
9855749|NCT00901901|10968584|FG000|STARTED|Treatment Period||362
9855750|NCT00901901|10968585|FG001|STARTED|Treatment Period||358
9855751|NCT00901901|10968584|FG000|Participants Received Treatment|Treatment Period||362
9855752|NCT00901901|10968585|FG001|Participants Received Treatment|Treatment Period||355
9855753|NCT00901901|10968584|FG000|COMPLETED|Treatment Period||193
9855754|NCT00901901|10968585|FG001|COMPLETED|Treatment Period||181
9855755|NCT00901901|10968584|FG000|NOT COMPLETED|Treatment Period||169
9855756|NCT00901901|10968585|FG001|NOT COMPLETED|Treatment Period||177
9855757|NCT00901901|10968584|FG000|STARTED|Follow-up Period||340
9855758|NCT00901901|10968585|FG001|STARTED|Follow-up Period||341
9855759|NCT00901901|10968584|FG000|COMPLETED|Follow-up Period||0
9855760|NCT00901901|10968585|FG001|COMPLETED|Follow-up Period||0
9855761|NCT00901901|10968584|FG000|NOT COMPLETED|Follow-up Period||340
9855762|NCT00901901|10968585|FG001|NOT COMPLETED|Follow-up Period||341
9855763|NCT00901927|10968593|FG000|STARTED|Overall Study||14
9855764|NCT00901927|10968593|FG000|COMPLETED|Overall Study||8
9855765|NCT00901927|10968593|FG000|NOT COMPLETED|Overall Study||6
9855766|NCT00902018|10968600|FG000|STARTED|Overall Study||7
9855767|NCT00902018|10968601|FG001|STARTED|Overall Study||3
9855768|NCT00902018|10968602|FG002|STARTED|Overall Study||10
9855769|NCT00902018|10968600|FG000|COMPLETED|Overall Study||7
9855770|NCT00902018|10968601|FG001|COMPLETED|Overall Study||3
9855771|NCT00902018|10968602|FG002|COMPLETED|Overall Study||10
9855772|NCT00902018|10968600|FG000|NOT COMPLETED|Overall Study||0
9855773|NCT00902018|10968601|FG001|NOT COMPLETED|Overall Study||0
9855774|NCT00902018|10968602|FG002|NOT COMPLETED|Overall Study||0
9855775|NCT00902161|10968618|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0
9855776|NCT00902161|10968619|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0
9855777|NCT00902161|10968620|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22
9855778|NCT00902161|10968618|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0
9855779|NCT00902161|10968619|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0
9855780|NCT00902161|10968620|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22
9855781|NCT00902161|10968618|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
9855782|NCT00902161|10968619|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
9855783|NCT00902161|10968620|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
9855784|NCT00902161|10968618|FG000|STARTED|Period 1||12
9855785|NCT00902161|10968619|FG001|STARTED|Period 1||10
9855786|NCT00902161|10968620|FG002|STARTED|Period 1||0
9855787|NCT00902161|10968618|FG000|COMPLETED|Period 1||12
9855788|NCT00902161|10968619|FG001|COMPLETED|Period 1||10
9855789|NCT00902161|10968620|FG002|COMPLETED|Period 1||0
9855790|NCT00902161|10968618|FG000|NOT COMPLETED|Period 1||0
9855791|NCT00902161|10968619|FG001|NOT COMPLETED|Period 1||0
9855792|NCT00902161|10968620|FG002|NOT COMPLETED|Period 1||0
9855793|NCT00902161|10968618|FG000|STARTED|Post-clamp Washout||0
9855794|NCT00902161|10968619|FG001|STARTED|Post-clamp Washout||0
9855795|NCT00902161|10968620|FG002|STARTED|Post-clamp Washout||22
9855796|NCT00902161|10968618|FG000|COMPLETED|Post-clamp Washout||0
9855797|NCT00902161|10968619|FG001|COMPLETED|Post-clamp Washout||0
9855798|NCT00902161|10968620|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
9855799|NCT00902161|10968618|FG000|NOT COMPLETED|Post-clamp Washout||0
9855800|NCT00902161|10968619|FG001|NOT COMPLETED|Post-clamp Washout||0
9855801|NCT00902161|10968620|FG002|NOT COMPLETED|Post-clamp Washout||0
9855802|NCT00902161|10968618|FG000|STARTED|Period 2||8
9855803|NCT00902161|10968619|FG001|STARTED|Period 2||9
9855804|NCT00902161|10968620|FG002|STARTED|Period 2||0
9855805|NCT00902161|10968618|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
9855806|NCT00902161|10968619|FG001|COMPLETED|Period 2||9
9855807|NCT00902161|10968620|FG002|COMPLETED|Period 2||0
9855808|NCT00902161|10968618|FG000|NOT COMPLETED|Period 2||0
9855809|NCT00902161|10968619|FG001|NOT COMPLETED|Period 2||0
9855810|NCT00902161|10968620|FG002|NOT COMPLETED|Period 2||0
9855811|NCT00902174|10968632|FG000|STARTED|Overall Study||103
9855812|NCT00902174|10968633|FG001|STARTED|Overall Study||99
9855813|NCT00902174|10968632|FG000|COMPLETED|Overall Study||69
9855814|NCT00902174|10968633|FG001|COMPLETED|Overall Study||81
9855815|NCT00902174|10968632|FG000|NOT COMPLETED|Overall Study||34
9855816|NCT00902174|10968633|FG001|NOT COMPLETED|Overall Study||18
9855817|NCT00902226|10968642|FG000|STARTED|Overall Study||30
9855818|NCT00902226|10968642|FG000|COMPLETED|Overall Study||30
9855819|NCT00902226|10968642|FG000|NOT COMPLETED|Overall Study||0
9855820|NCT00902265|10968646|FG000|STARTED|Overall Study||138
9855821|NCT00902265|10968646|FG000|Participants Who Received Treatment|Overall Study||137
9855822|NCT00902265|10968646|FG000|COMPLETED|Overall Study||132
9855823|NCT00902265|10968646|FG000|NOT COMPLETED|Overall Study||6
9855824|NCT00902278|10968655|FG000|STARTED|Overall Study||54
9855825|NCT00902278|10968656|FG001|STARTED|Overall Study||36
9855826|NCT00902278|10968657|FG002|STARTED|Overall Study||54
9855827|NCT00902278|10968658|FG003|STARTED|Overall Study||12
9855828|NCT00902278|10968659|FG004|STARTED|Overall Study||37
9855829|NCT00902278|10968655|FG000|COMPLETED|Overall Study||50
9855830|NCT00902278|10968656|FG001|COMPLETED|Overall Study||34
9855831|NCT00902278|10968657|FG002|COMPLETED|Overall Study||49
9855832|NCT00902278|10968658|FG003|COMPLETED|Overall Study||12
9855833|NCT00902278|10968659|FG004|COMPLETED|Overall Study||35
9855834|NCT00902278|10968655|FG000|NOT COMPLETED|Overall Study||4
9855835|NCT00902278|10968656|FG001|NOT COMPLETED|Overall Study||2
9855836|NCT00902278|10968657|FG002|NOT COMPLETED|Overall Study||5
9855837|NCT00902278|10968658|FG003|NOT COMPLETED|Overall Study||0
9855838|NCT00902278|10968659|FG004|NOT COMPLETED|Overall Study||2
9855839|NCT00902304|10968674|FG000|STARTED|Overall Study||524
9855840|NCT00902304|10968675|FG001|STARTED|Overall Study||360
9855841|NCT00902304|10968676|FG002|STARTED|Overall Study||678
9855842|NCT00902304|10968674|FG000|COMPLETED|Overall Study||466
9855843|NCT00902304|10968675|FG001|COMPLETED|Overall Study||289
9855844|NCT00902304|10968676|FG002|COMPLETED|Overall Study||568
9855845|NCT00902304|10968674|FG000|NOT COMPLETED|Overall Study||58
9855846|NCT00902304|10968675|FG001|NOT COMPLETED|Overall Study||71
9855847|NCT00902304|10968676|FG002|NOT COMPLETED|Overall Study||110
9855848|NCT00902330|10968687|FG000|STARTED|Overall Study||81
9855849|NCT00902330|10968688|FG001|STARTED|Overall Study||80
9855850|NCT00902330|10968687|FG000|COMPLETED|Overall Study||77
9855851|NCT00902330|10968688|FG001|COMPLETED|Overall Study||75
9855852|NCT00902330|10968687|FG000|NOT COMPLETED|Overall Study||4
9855853|NCT00902330|10968688|FG001|NOT COMPLETED|Overall Study||5
9855854|NCT00902486|10968701|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31
9855855|NCT00902486|10968702|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0
9855856|NCT00902486|10968703|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0
9855857|NCT00902486|10968704|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32
9855858|NCT00902486|10968705|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32
9855859|NCT00902486|10968706|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32
9855860|NCT00902486|10968701|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
9855861|NCT00902486|10968702|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
9855862|NCT00902486|10968703|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
9855863|NCT00902486|10968704|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
9855864|NCT00902486|10968705|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
9855865|NCT00902486|10968706|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
9855866|NCT00902486|10968701|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
9855867|NCT00902486|10968702|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
9855868|NCT00902486|10968703|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
9855869|NCT00902486|10968704|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
9957085|NCT01449370|11076235|FG000|NOT COMPLETED|Overall Study||6
9855870|NCT00902486|10968705|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
9855871|NCT00902486|10968706|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
9855872|NCT00902486|10968701|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
9855873|NCT00902486|10968702|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
9855874|NCT00902486|10968703|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
9855875|NCT00902486|10968704|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
9855876|NCT00902486|10968705|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
9855877|NCT00902486|10968706|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
9855878|NCT00902486|10968701|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
9855879|NCT00902486|10968702|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
9855880|NCT00902486|10968703|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
9855881|NCT00902486|10968704|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
9855882|NCT00902486|10968705|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
9855883|NCT00902486|10968706|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
9855884|NCT00902486|10968701|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0
9855885|NCT00902486|10968702|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14
9855886|NCT00902486|10968703|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15
9855887|NCT00902486|10968704|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29
9855888|NCT00902486|10968705|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30
9855889|NCT00902486|10968706|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27
9855890|NCT00902486|10968701|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0
9855891|NCT00902486|10968702|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14
9855892|NCT00902486|10968703|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13
9855893|NCT00902486|10968704|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27
9855894|NCT00902486|10968705|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29
9855895|NCT00902486|10968706|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24
9855896|NCT00902486|10968701|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
9855897|NCT00902486|10968702|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
9855898|NCT00902486|10968703|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
9855899|NCT00902486|10968704|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
9855900|NCT00902486|10968705|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
9855901|NCT00902486|10968706|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
9855902|NCT00902486|10968701|FG000|STARTED|Follow-up (After Week 24)||0
9855903|NCT00902486|10968702|FG001|STARTED|Follow-up (After Week 24)||14
9855904|NCT00902486|10968703|FG002|STARTED|Follow-up (After Week 24)||13
9855905|NCT00902486|10968704|FG003|STARTED|Follow-up (After Week 24)||27
9855906|NCT00902486|10968705|FG004|STARTED|Follow-up (After Week 24)||29
9855907|NCT00902486|10968706|FG005|STARTED|Follow-up (After Week 24)||24
9855908|NCT00902486|10968701|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0
9855909|NCT00902486|10968702|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14
9855910|NCT00902486|10968703|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15
9855911|NCT00902486|10968704|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29
9855912|NCT00902486|10968705|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30
9855913|NCT00902486|10968706|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27
9855914|NCT00902486|10968701|FG000|COMPLETED|Follow-up (After Week 24)||0
9855915|NCT00902486|10968702|FG001|COMPLETED|Follow-up (After Week 24)||14
9855916|NCT00902486|10968703|FG002|COMPLETED|Follow-up (After Week 24)||13
9855917|NCT00902486|10968704|FG003|COMPLETED|Follow-up (After Week 24)||26
9855918|NCT00902486|10968705|FG004|COMPLETED|Follow-up (After Week 24)||29
9855919|NCT00902486|10968706|FG005|COMPLETED|Follow-up (After Week 24)||24
9855920|NCT00902486|10968701|FG000|NOT COMPLETED|Follow-up (After Week 24)||0
9855921|NCT00902486|10968702|FG001|NOT COMPLETED|Follow-up (After Week 24)||0
9855922|NCT00902486|10968703|FG002|NOT COMPLETED|Follow-up (After Week 24)||0
9855923|NCT00902486|10968704|FG003|NOT COMPLETED|Follow-up (After Week 24)||1
9855924|NCT00902486|10968705|FG004|NOT COMPLETED|Follow-up (After Week 24)||0
9855925|NCT00902486|10968706|FG005|NOT COMPLETED|Follow-up (After Week 24)||0
9855926|NCT00902538|10968739|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
9855927|NCT00902538|10968740|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0
9855928|NCT00902538|10968741|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0
9855929|NCT00902538|10968742|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0
9855930|NCT00902538|10968743|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0
9855931|NCT00902538|10968744|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0
9855932|NCT00902538|10968739|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
9855933|NCT00902538|10968740|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855934|NCT00902538|10968741|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855935|NCT00902538|10968742|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855936|NCT00902538|10968743|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855937|NCT00902538|10968744|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855938|NCT00902538|10968739|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
9855939|NCT00902538|10968740|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855940|NCT00902538|10968741|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855941|NCT00902538|10968742|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855942|NCT00902538|10968743|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9957086|NCT01449370|11076236|FG001|NOT COMPLETED|Overall Study||6
9855943|NCT00902538|10968744|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
9855944|NCT00902538|10968739|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
9855945|NCT00902538|10968740|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269
9855946|NCT00902538|10968741|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270
9855947|NCT00902538|10968742|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0
9855948|NCT00902538|10968743|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0
9855949|NCT00902538|10968744|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0
9855950|NCT00902538|10968739|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260
9855951|NCT00902538|10968740|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263
9855952|NCT00902538|10968741|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262
9855953|NCT00902538|10968742|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0
9855954|NCT00902538|10968743|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0
9855955|NCT00902538|10968744|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0
9855956|NCT00902538|10968739|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
9855957|NCT00902538|10968740|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
9855958|NCT00902538|10968741|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
9855959|NCT00902538|10968742|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
9855960|NCT00902538|10968743|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
9855961|NCT00902538|10968744|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
9855962|NCT00902538|10968739|FG000|STARTED|3-Single-blind, Single Treatment||0
9855963|NCT00902538|10968740|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
9855964|NCT00902538|10968741|FG002|STARTED|3-Single-blind, Single Treatment||0
9855965|NCT00902538|10968742|FG003|STARTED|3-Single-blind, Single Treatment||0
9855966|NCT00902538|10968743|FG004|STARTED|3-Single-blind, Single Treatment||0
9855967|NCT00902538|10968744|FG005|STARTED|3-Single-blind, Single Treatment||0
9855968|NCT00902538|10968739|FG000|COMPLETED|3-Single-blind, Single Treatment||0
9855969|NCT00902538|10968740|FG001|COMPLETED|3-Single-blind, Single Treatment||767
9855970|NCT00902538|10968741|FG002|COMPLETED|3-Single-blind, Single Treatment||0
9855971|NCT00902538|10968742|FG003|COMPLETED|3-Single-blind, Single Treatment||0
9855972|NCT00902538|10968743|FG004|COMPLETED|3-Single-blind, Single Treatment||0
9855973|NCT00902538|10968744|FG005|COMPLETED|3-Single-blind, Single Treatment||0
9855974|NCT00902538|10968739|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0
9855975|NCT00902538|10968740|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15
9855976|NCT00902538|10968741|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0
9855977|NCT00902538|10968742|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0
9855978|NCT00902538|10968743|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0
9855979|NCT00902538|10968744|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0
9855980|NCT00902538|10968739|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0
9855981|NCT00902538|10968740|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0
9855982|NCT00902538|10968741|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0
9855983|NCT00902538|10968742|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
9855984|NCT00902538|10968743|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
9855985|NCT00902538|10968744|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197
9855986|NCT00902538|10968739|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0
9855987|NCT00902538|10968740|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0
9855988|NCT00902538|10968741|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0
9855989|NCT00902538|10968742|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458
9855990|NCT00902538|10968743|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95
9855991|NCT00902538|10968744|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196
9855992|NCT00902538|10968739|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
9855993|NCT00902538|10968740|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
9855994|NCT00902538|10968741|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
9855995|NCT00902538|10968742|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
9855996|NCT00902538|10968743|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
9855997|NCT00902538|10968744|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
9855998|NCT00902564|10968756|FG000|STARTED|Overall Study||30
9855999|NCT00902564|10968756|FG000|COMPLETED|Overall Study||28
9856000|NCT00902564|10968756|FG000|NOT COMPLETED|Overall Study||2
9856001|NCT00902577|10968760|FG000|STARTED|Overall Study||50
9856002|NCT00902577|10968760|FG000|FMISO/PET|Overall Study||38
9856003|NCT00902577|10968760|FG000|DCE MRI|Overall Study||31
9856004|NCT00902577|10968760|FG000|DSE MRI|Overall Study||37
9856005|NCT00902577|10968760|FG000|DWI MRI|Overall Study||39
9856006|NCT00902577|10968760|FG000|COMPLETED|Overall Study||42
9856007|NCT00902577|10968760|FG000|NOT COMPLETED|Overall Study||8
9856008|NCT00902746|10968783|FG000|STARTED|Overall Study||149
9856009|NCT00902746|10968783|FG000|Initiation of Study Drug Administration|Overall Study||148
9856010|NCT00902746|10968783|FG000|Transfer to Step 2|Overall Study||133
9856011|NCT00902746|10968783|FG000|COMPLETED|Overall Study||113
9856012|NCT00902746|10968783|FG000|NOT COMPLETED|Overall Study||36
9856013|NCT00902850|10968789|FG000|STARTED|Overall Study||14
9856014|NCT00902850|10968790|FG001|STARTED|Overall Study||14
9856015|NCT00902850|10968789|FG000|COMPLETED|Overall Study||12
9856016|NCT00902850|10968790|FG001|COMPLETED|Overall Study||12
9856017|NCT00902850|10968789|FG000|NOT COMPLETED|Overall Study||2
9856018|NCT00902850|10968790|FG001|NOT COMPLETED|Overall Study||2
9856019|NCT00903032|10968798|FG000|STARTED|Overall Study||129
9758523|NCT03329690|10862051|FG000|Received Treatment|Overall Study||125
9758524|NCT03329690|10862052|FG001|Received Treatment|Overall Study||55
9758525|NCT03329690|10862053|FG002|Received Treatment|Overall Study||7
9758526|NCT03329690|10862054|FG003|Received Treatment|Overall Study||20
9758527|NCT03329690|10862055|FG004|Received Treatment|Overall Study||24
9758528|NCT03329690|10862051|FG000|COMPLETED|Overall Study||0
9758529|NCT03329690|10862052|FG001|COMPLETED|Overall Study||0
9758530|NCT03329690|10862053|FG002|COMPLETED|Overall Study||0
9758531|NCT03329690|10862054|FG003|COMPLETED|Overall Study||0
9856020|NCT00903032|10968799|FG001|STARTED|Overall Study||124
9856021|NCT00903032|10968798|FG000|COMPLETED|Overall Study||122
9856022|NCT00903032|10968799|FG001|COMPLETED|Overall Study||119
9856023|NCT00903032|10968798|FG000|NOT COMPLETED|Overall Study||7
9856024|NCT00903032|10968799|FG001|NOT COMPLETED|Overall Study||5
9953056|NCT01425268|11071906|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
9953057|NCT01425268|11071907|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
9953058|NCT01425268|11071906|FG000|COMPLETED|Overall Study||98
9953059|NCT01425268|11071907|FG001|COMPLETED|Overall Study||52
9953060|NCT01425268|11071906|FG000|NOT COMPLETED|Overall Study||8
9953061|NCT01425268|11071907|FG001|NOT COMPLETED|Overall Study||0
9953062|NCT01425307|11071915|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
9953063|NCT01425307|11071916|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
9953064|NCT01425307|11071915|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
9953065|NCT01425307|11071916|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
9953066|NCT01425307|11071915|FG000|NOT COMPLETED|Overall Study||19
9953067|NCT01425307|11071916|FG001|NOT COMPLETED|Overall Study||19
9953068|NCT01425359|11071926|FG000|STARTED|Overall Study||476
9953069|NCT01425359|11071927|FG001|STARTED|Overall Study||473
9953070|NCT01425359|11071926|FG000|COMPLETED|Overall Study||457
9953071|NCT01425359|11071927|FG001|COMPLETED|Overall Study||451
9953072|NCT01425359|11071926|FG000|NOT COMPLETED|Overall Study||19
9953073|NCT01425359|11071927|FG001|NOT COMPLETED|Overall Study||22
9953074|NCT01425463|11071936|FG000|STARTED|Overall Study||130
9953075|NCT01425463|11071937|FG001|STARTED|Overall Study||126
9953076|NCT01425463|11071936|FG000|Safety Set|Overall Study||126
9953077|NCT01425463|11071937|FG001|Safety Set|Overall Study||122
9953078|NCT01425463|11071936|FG000|Full Analysis Set|Overall Study||122
9953079|NCT01425463|11071937|FG001|Full Analysis Set|Overall Study||116
9953080|NCT01425463|11071936|FG000|COMPLETED|Overall Study||106
9953081|NCT01425463|11071937|FG001|COMPLETED|Overall Study||102
9953082|NCT01425463|11071936|FG000|NOT COMPLETED|Overall Study||24
9953083|NCT01425463|11071937|FG001|NOT COMPLETED|Overall Study||24
9953084|NCT01425528|11071945|FG000|STARTED|Overall Study||6
9953085|NCT01425528|11071946|FG001|STARTED|Overall Study||6
9953086|NCT01425528|11071945|FG000|COMPLETED|Overall Study||5
9953087|NCT01425528|11071946|FG001|COMPLETED|Overall Study||5
9953088|NCT01425528|11071945|FG000|NOT COMPLETED|Overall Study||1
9953089|NCT01425528|11071946|FG001|NOT COMPLETED|Overall Study||1
9953090|NCT01425281|11071954|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
9953091|NCT01425281|11071955|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
9953092|NCT01425281|11071954|FG000|COMPLETED|At 30-day Clinical Follow-up||334
9953093|NCT01425281|11071955|FG001|COMPLETED|At 30-day Clinical Follow-up||166
9953094|NCT01425281|11071954|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1
9953095|NCT01425281|11071955|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0
9953096|NCT01425281|11071954|FG000|STARTED|At 180-day Clinical Follow-up||334
9953097|NCT01425281|11071955|FG001|STARTED|At 180-day Clinical Follow-up||166
9953098|NCT01425281|11071954|FG000|COMPLETED|At 180-day Clinical Follow-up||331
9953099|NCT01425281|11071955|FG001|COMPLETED|At 180-day Clinical Follow-up||165
9953100|NCT01425281|11071954|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3
9953101|NCT01425281|11071955|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1
9953102|NCT01425281|11071954|FG000|STARTED|At 1-year Clinical Follow-up||331
9953103|NCT01425281|11071955|FG001|STARTED|At 1-year Clinical Follow-up||165
9953104|NCT01425281|11071954|FG000|COMPLETED|At 1-year Clinical Follow-up||329
9953105|NCT01425281|11071955|FG001|COMPLETED|At 1-year Clinical Follow-up||164
9953106|NCT01425281|11071954|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2
9953107|NCT01425281|11071955|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1
9953108|NCT01425281|11071954|FG000|STARTED|At 2-year Clinical Follow-up||329
9953109|NCT01425281|11071955|FG001|STARTED|At 2-year Clinical Follow-up||164
9953110|NCT01425281|11071954|FG000|COMPLETED|At 2-year Clinical Follow-up||323
9953111|NCT01425281|11071955|FG001|COMPLETED|At 2-year Clinical Follow-up||163
9953112|NCT01425281|11071954|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6
9953113|NCT01425281|11071955|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1
9953114|NCT01425281|11071954|FG000|STARTED|At 3-year Clinical Follow-up||323
9953115|NCT01425281|11071955|FG001|STARTED|At 3-year Clinical Follow-up||163
9953116|NCT01425281|11071954|FG000|COMPLETED|At 3-year Clinical Follow-up||318
9953117|NCT01425281|11071955|FG001|COMPLETED|At 3-year Clinical Follow-up||157
9953118|NCT01425281|11071954|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5
9953119|NCT01425281|11071955|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6
9758532|NCT03329690|10862055|FG004|COMPLETED|Overall Study||0
9758533|NCT03329690|10862051|FG000|NOT COMPLETED|Overall Study||126
9856025|NCT00903162|10968805|FG000|STARTED|Overall Study||16
9856026|NCT00903162|10968805|FG000|COMPLETED|Overall Study||12
9856027|NCT00903162|10968805|FG000|NOT COMPLETED|Overall Study||4
9856028|NCT00903175|10968811|FG000|STARTED|Period 1 - First Line||238
9856029|NCT00903175|10968812|FG001|STARTED|Period 1 - First Line||231
9856030|NCT00903175|10968811|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
9856031|NCT00903175|10968812|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
9856032|NCT00903175|10968811|FG000|NOT COMPLETED|Period 1 - First Line||77
9856033|NCT00903175|10968812|FG001|NOT COMPLETED|Period 1 - First Line||89
9856034|NCT00903175|10968811|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
9856035|NCT00903175|10968812|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
9856036|NCT00903175|10968811|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
9856037|NCT00903175|10968812|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
9856038|NCT00903175|10968811|FG000|NOT COMPLETED|Period 2 - Second Line||49
9856039|NCT00903175|10968812|FG001|NOT COMPLETED|Period 2 - Second Line||36
9856040|NCT00903201|10968821|FG000|STARTED|Overall Study||61
9856041|NCT00903201|10968822|FG001|STARTED|Overall Study||44
9856042|NCT00903201|10968823|FG002|STARTED|Overall Study||41
9856043|NCT00903201|10968821|FG000|COMPLETED|Overall Study||56
9856044|NCT00903201|10968822|FG001|COMPLETED|Overall Study||38
9856045|NCT00903201|10968823|FG002|COMPLETED|Overall Study||39
9856046|NCT00903201|10968821|FG000|NOT COMPLETED|Overall Study||5
9856047|NCT00903201|10968822|FG001|NOT COMPLETED|Overall Study||6
9856048|NCT00903201|10968823|FG002|NOT COMPLETED|Overall Study||2
9856049|NCT00903331|10968835|FG000|STARTED|Overall Study||59
9856050|NCT00903331|10968836|FG001|STARTED|Overall Study||119
9856051|NCT00903331|10968835|FG000|COMPLETED|Overall Study||54
9856052|NCT00903331|10968836|FG001|COMPLETED|Overall Study||101
9856053|NCT00903331|10968835|FG000|NOT COMPLETED|Overall Study||5
9856054|NCT00903331|10968836|FG001|NOT COMPLETED|Overall Study||18
9856055|NCT00903344|10968844|FG000|STARTED|Overall Study||12
9856056|NCT00903344|10968845|FG001|STARTED|Overall Study||10
9856057|NCT00903344|10968844|FG000|3 Month Visit|Overall Study||10
9856058|NCT00903344|10968845|FG001|3 Month Visit|Overall Study||10
9856059|NCT00903344|10968844|FG000|6 Month Visit|Overall Study||9
9856060|NCT00903344|10968845|FG001|6 Month Visit|Overall Study||10
9856061|NCT00903344|10968844|FG000|COMPLETED|Overall Study||7
9856062|NCT00903344|10968845|FG001|COMPLETED|Overall Study||7
9856063|NCT00903344|10968844|FG000|NOT COMPLETED|Overall Study||5
9856064|NCT00903344|10968845|FG001|NOT COMPLETED|Overall Study||3
9856065|NCT00903357|10968851|FG000|STARTED|First Intervention||27
9856066|NCT00903357|10968852|FG001|STARTED|First Intervention||27
9856067|NCT00903357|10968851|FG000|COMPLETED|First Intervention||22
9856068|NCT00903357|10968852|FG001|COMPLETED|First Intervention||23
9856069|NCT00903357|10968851|FG000|NOT COMPLETED|First Intervention||5
9856070|NCT00903357|10968852|FG001|NOT COMPLETED|First Intervention||4
9856071|NCT00903357|10968851|FG000|STARTED|Wash Out Period of 2 Weeks||22
9856072|NCT00903357|10968852|FG001|STARTED|Wash Out Period of 2 Weeks||23
9856073|NCT00903357|10968851|FG000|COMPLETED|Wash Out Period of 2 Weeks||22
9856074|NCT00903357|10968852|FG001|COMPLETED|Wash Out Period of 2 Weeks||22
9856075|NCT00903357|10968851|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0
9856076|NCT00903357|10968852|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1
9856077|NCT00903357|10968851|FG000|STARTED|Second Intervention||22
9856078|NCT00903357|10968852|FG001|STARTED|Second Intervention||22
9856079|NCT00903357|10968851|FG000|COMPLETED|Second Intervention||21
9856080|NCT00903357|10968852|FG001|COMPLETED|Second Intervention||22
9856081|NCT00903357|10968851|FG000|NOT COMPLETED|Second Intervention||1
9856082|NCT00903357|10968852|FG001|NOT COMPLETED|Second Intervention||0
9856083|NCT00903370|10968864|FG000|STARTED|Overall Study||127
9856084|NCT00903370|10968865|FG001|STARTED|Overall Study||133
9856085|NCT00903370|10968864|FG000|COMPLETED|Overall Study||99
9856086|NCT00903370|10968865|FG001|COMPLETED|Overall Study||109
9856087|NCT00903370|10968864|FG000|NOT COMPLETED|Overall Study||28
9856088|NCT00903370|10968865|FG001|NOT COMPLETED|Overall Study||24
9856089|NCT00903383|10968875|FG000|STARTED|Overall Study||55
9856090|NCT00903383|10968876|FG001|STARTED|Overall Study||54
9856091|NCT00903383|10968877|FG002|STARTED|Overall Study||50
9856092|NCT00903383|10968878|FG003|STARTED|Overall Study||49
9856093|NCT00903383|10968875|FG000|COMPLETED|Overall Study||48
9856094|NCT00903383|10968876|FG001|COMPLETED|Overall Study||48
9856095|NCT00903383|10968877|FG002|COMPLETED|Overall Study||47
9856096|NCT00903383|10968878|FG003|COMPLETED|Overall Study||44
9856097|NCT00903383|10968875|FG000|NOT COMPLETED|Overall Study||7
9856098|NCT00903383|10968876|FG001|NOT COMPLETED|Overall Study||6
9856099|NCT00903383|10968877|FG002|NOT COMPLETED|Overall Study||3
9856100|NCT00903383|10968878|FG003|NOT COMPLETED|Overall Study||5
9856101|NCT00903409|10968890|FG000|STARTED|Overall Study||88
9856102|NCT00903409|10968891|FG001|STARTED|Overall Study||100
9856103|NCT00903409|10968890|FG000|COMPLETED|Overall Study||62
9856104|NCT00903409|10968891|FG001|COMPLETED|Overall Study||73
9856105|NCT00903409|10968890|FG000|NOT COMPLETED|Overall Study||26
9856106|NCT00903409|10968891|FG001|NOT COMPLETED|Overall Study||27
9856107|NCT00903448|10968899|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20
9856108|NCT00903448|10968900|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20
9856109|NCT00903448|10968899|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
9856110|NCT00903448|10968900|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
9856111|NCT00903448|10968899|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
9856112|NCT00903448|10968900|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
9856113|NCT00903448|10968899|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20
9856114|NCT00903448|10968900|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20
9856115|NCT00903448|10968899|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
9856116|NCT00903448|10968900|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
9856117|NCT00903448|10968899|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
9856118|NCT00903448|10968900|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
9856119|NCT00903448|10968899|FG000|STARTED|Period 3: 5 Days||20
9856120|NCT00903448|10968900|FG001|STARTED|Period 3: 5 Days||20
9856121|NCT00903448|10968899|FG000|COMPLETED|Period 3: 5 Days||20
9856122|NCT00903448|10968900|FG001|COMPLETED|Period 3: 5 Days||20
9856123|NCT00903448|10968899|FG000|NOT COMPLETED|Period 3: 5 Days||0
9856124|NCT00903448|10968900|FG001|NOT COMPLETED|Period 3: 5 Days||0
9856125|NCT00903617|10968910|FG000|STARTED|Overall Study||19
9856126|NCT00903617|10968911|FG001|STARTED|Overall Study||20
9856127|NCT00903617|10968912|FG002|STARTED|Overall Study||20
9856128|NCT00903617|10968913|FG003|STARTED|Overall Study||21
9856129|NCT00903617|10968910|FG000|COMPLETED|Overall Study||16
9856130|NCT00903617|10968911|FG001|COMPLETED|Overall Study||15
9856131|NCT00903617|10968912|FG002|COMPLETED|Overall Study||15
9856132|NCT00903617|10968913|FG003|COMPLETED|Overall Study||20
9856133|NCT00903617|10968910|FG000|NOT COMPLETED|Overall Study||3
9856134|NCT00903617|10968911|FG001|NOT COMPLETED|Overall Study||5
9856135|NCT00903617|10968912|FG002|NOT COMPLETED|Overall Study||5
9856136|NCT00903617|10968913|FG003|NOT COMPLETED|Overall Study||1
9856137|NCT00903630|10968927|FG000|STARTED|Phase l||6
9856138|NCT00903630|10968928|FG001|STARTED|Phase l||5
9856139|NCT00903630|10968929|FG002|STARTED|Phase l||0
9856140|NCT00903630|10968927|FG000|COMPLETED|Phase l||6
9856141|NCT00903630|10968928|FG001|COMPLETED|Phase l||5
9856142|NCT00903630|10968929|FG002|COMPLETED|Phase l||0
9856143|NCT00903630|10968927|FG000|NOT COMPLETED|Phase l||0
9856144|NCT00903630|10968928|FG001|NOT COMPLETED|Phase l||0
9856145|NCT00903630|10968929|FG002|NOT COMPLETED|Phase l||0
9856146|NCT00903630|10968927|FG000|STARTED|Phase 2||6
9856147|NCT00903630|10968928|FG001|STARTED|Phase 2||0
9856148|NCT00903630|10968929|FG002|STARTED|Phase 2||4
9856149|NCT00903630|10968927|FG000|COMPLETED|Phase 2||6
9856150|NCT00903630|10968928|FG001|COMPLETED|Phase 2||0
9856151|NCT00903630|10968929|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
9856152|NCT00903630|10968927|FG000|NOT COMPLETED|Phase 2||0
9856153|NCT00903630|10968928|FG001|NOT COMPLETED|Phase 2||0
9856154|NCT00903630|10968929|FG002|NOT COMPLETED|Phase 2||1
9856155|NCT00903682|10968941|FG000|STARTED|Overall Study||79
9856156|NCT00903682|10968942|FG001|STARTED|Overall Study||78
9856157|NCT00903682|10968941|FG000|COMPLETED|Overall Study||63
9856158|NCT00903682|10968942|FG001|COMPLETED|Overall Study||63
9856159|NCT00903682|10968941|FG000|NOT COMPLETED|Overall Study||16
9856160|NCT00903682|10968942|FG001|NOT COMPLETED|Overall Study||15
9856161|NCT00903695|10968950|FG000|STARTED|Overall Study||8
9856162|NCT00903695|10968951|FG001|STARTED|Overall Study||2
9856163|NCT00903695|10968950|FG000|COMPLETED|Overall Study||6
9856164|NCT00903695|10968951|FG001|COMPLETED|Overall Study||2
9856165|NCT00903695|10968950|FG000|NOT COMPLETED|Overall Study||2
9856166|NCT00903695|10968951|FG001|NOT COMPLETED|Overall Study||0
9856167|NCT00903760|10968961|FG000|STARTED|Overall Study||19
9856168|NCT00903760|10968962|FG001|STARTED|Overall Study||18
9856169|NCT00903760|10968961|FG000|COMPLETED|Overall Study|Completed all 24 courses|0
9856170|NCT00903760|10968962|FG001|COMPLETED|Overall Study|Completed all 24 courses|2
9856171|NCT00903760|10968961|FG000|NOT COMPLETED|Overall Study||19
9856172|NCT00903760|10968962|FG001|NOT COMPLETED|Overall Study||16
9856173|NCT00903786|10968968|FG000|STARTED|Overall Study||21
9856174|NCT00903786|10968968|FG000|COMPLETED|Overall Study||6
9856175|NCT00903786|10968968|FG000|NOT COMPLETED|Overall Study||15
9856176|NCT00903877|10968973|FG000|STARTED|Overall Study||51
9856177|NCT00903877|10968973|FG000|COMPLETED|Overall Study||8
9856178|NCT00903877|10968973|FG000|NOT COMPLETED|Overall Study||43
9856179|NCT00903929|10968977|FG000|STARTED|Overall Study||3
9856180|NCT00903929|10968978|FG001|STARTED|Overall Study||3
9856181|NCT00903929|10968979|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
9856182|NCT00903929|10968980|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
9856183|NCT00903929|10968977|FG000|COMPLETED|Overall Study||3
9856184|NCT00903929|10968978|FG001|COMPLETED|Overall Study||3
9856185|NCT00903929|10968979|FG002|COMPLETED|Overall Study||3
9856186|NCT00903929|10968980|FG003|COMPLETED|Overall Study||6
9856187|NCT00903929|10968977|FG000|NOT COMPLETED|Overall Study||0
9856188|NCT00903929|10968978|FG001|NOT COMPLETED|Overall Study||0
9856189|NCT00903929|10968979|FG002|NOT COMPLETED|Overall Study||1
9856190|NCT00903929|10968980|FG003|NOT COMPLETED|Overall Study||3
9856191|NCT00903968|10968987|FG000|STARTED|Overall Study||3
9856192|NCT00903968|10968988|FG001|STARTED|Overall Study||3
9856193|NCT00903968|10968989|FG002|STARTED|Overall Study||3
9856194|NCT00903968|10968990|FG003|STARTED|Overall Study||3
9856195|NCT00903968|10968991|FG004|STARTED|Overall Study||4
9856196|NCT00903968|10968992|FG005|STARTED|Overall Study||6
9856197|NCT00903968|10968993|FG006|STARTED|Overall Study||3
9856198|NCT00903968|10968994|FG007|STARTED|Overall Study||33
9856199|NCT00903968|10968987|FG000|COMPLETED|Overall Study||0
9856200|NCT00903968|10968988|FG001|COMPLETED|Overall Study||0
9856201|NCT00903968|10968989|FG002|COMPLETED|Overall Study||0
9856202|NCT00903968|10968990|FG003|COMPLETED|Overall Study||0
9856203|NCT00903968|10968991|FG004|COMPLETED|Overall Study||0
9856204|NCT00903968|10968992|FG005|COMPLETED|Overall Study||0
9856205|NCT00903968|10968993|FG006|COMPLETED|Overall Study||0
9856206|NCT00903968|10968994|FG007|COMPLETED|Overall Study||0
9856207|NCT00903968|10968987|FG000|NOT COMPLETED|Overall Study||3
9856208|NCT00903968|10968988|FG001|NOT COMPLETED|Overall Study||3
9856209|NCT00903968|10968989|FG002|NOT COMPLETED|Overall Study||3
9856210|NCT00903968|10968990|FG003|NOT COMPLETED|Overall Study||3
9856211|NCT00903968|10968991|FG004|NOT COMPLETED|Overall Study||4
9856212|NCT00903968|10968992|FG005|NOT COMPLETED|Overall Study||6
10092547|NCT02337959|11221005|FG001|COMPLETED|Overall Study||7
10092548|NCT02337959|11221006|FG002|COMPLETED|Overall Study||7
10092549|NCT02337959|11221004|FG000|NOT COMPLETED|Overall Study||0
10092550|NCT02337959|11221005|FG001|NOT COMPLETED|Overall Study||3
10092551|NCT02337959|11221006|FG002|NOT COMPLETED|Overall Study||0
10092552|NCT02338076|11221014|FG000|STARTED|Overall Study||20
10092553|NCT02338076|11221014|FG000|COMPLETED|Overall Study||20
10092554|NCT02338076|11221014|FG000|NOT COMPLETED|Overall Study||0
10092555|NCT02338154|11221020|FG000|STARTED|Overall Study||516
10092556|NCT02338154|11221020|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516
10092557|NCT02338154|11221020|FG000|INTUITY (Study Valve Cohort)|Overall Study||493
10092558|NCT02338154|11221020|FG000|COMPLETED|Overall Study||373
10092559|NCT02338154|11221020|FG000|NOT COMPLETED|Overall Study||143
10092560|NCT02338193|11221035|FG000|STARTED|Overall Study||20
10092561|NCT02338193|11221036|FG001|STARTED|Overall Study||21
10092562|NCT02338193|11221037|FG002|STARTED|Overall Study||25
10092563|NCT02338193|11221035|FG000|COMPLETED|Overall Study||17
10092564|NCT02338193|11221036|FG001|COMPLETED|Overall Study||17
10092565|NCT02338193|11221037|FG002|COMPLETED|Overall Study||15
10092566|NCT02338193|11221035|FG000|NOT COMPLETED|Overall Study||3
10092567|NCT02338193|11221036|FG001|NOT COMPLETED|Overall Study||4
10092568|NCT02338193|11221037|FG002|NOT COMPLETED|Overall Study||10
10092569|NCT02338336|11221047|FG000|STARTED|Overall Study||26
10092570|NCT02338336|11221048|FG001|STARTED|Overall Study||17
10092571|NCT02338336|11221049|FG002|STARTED|Overall Study||7
10092572|NCT02338336|11221050|FG003|STARTED|Overall Study||4
10092573|NCT02338336|11221047|FG000|COMPLETED|Overall Study||24
10092574|NCT02338336|11221048|FG001|COMPLETED|Overall Study||17
10092575|NCT02338336|11221049|FG002|COMPLETED|Overall Study||7
10092576|NCT02338336|11221050|FG003|COMPLETED|Overall Study||4
10092577|NCT02338336|11221047|FG000|NOT COMPLETED|Overall Study||2
10092578|NCT02338336|11221048|FG001|NOT COMPLETED|Overall Study||0
10092579|NCT02338336|11221049|FG002|NOT COMPLETED|Overall Study||0
10092580|NCT02338336|11221050|FG003|NOT COMPLETED|Overall Study||0
10092581|NCT02338362|11221058|FG000|STARTED|Overall Study||11
10092582|NCT02338362|11221059|FG001|STARTED|Overall Study||11
10092583|NCT02338362|11221058|FG000|COMPLETED|Overall Study||10
10092584|NCT02338362|11221059|FG001|COMPLETED|Overall Study||10
10092585|NCT02338362|11221058|FG000|NOT COMPLETED|Overall Study||1
10092586|NCT02338362|11221059|FG001|NOT COMPLETED|Overall Study||1
10092587|NCT02338492|11221065|FG000|STARTED|Overall Study||81
10092588|NCT02338492|11221065|FG000|Enrolled|Overall Study||81
10092589|NCT02338492|11221065|FG000|Device Implanted|Overall Study||79
10092590|NCT02338492|11221065|FG000|Treatment Failure|Overall Study||2
10092591|NCT02338492|11221065|FG000|COMPLETED|Overall Study||36
10092592|NCT02338492|11221065|FG000|NOT COMPLETED|Overall Study||45
10092593|NCT02338713|11221069|FG000|STARTED|Overall Study||27
10092594|NCT02338713|11221069|FG000|COMPLETED|Overall Study||27
10092595|NCT02338713|11221069|FG000|NOT COMPLETED|Overall Study||0
10092596|NCT02338843|11221077|FG000|STARTED|Overall Study||163
10092597|NCT02338843|11221078|FG001|STARTED|Overall Study||158
10092598|NCT02338843|11221077|FG000|COMPLETED|Overall Study||119
10092599|NCT02338843|11221078|FG001|COMPLETED|Overall Study||100
10092600|NCT02338843|11221077|FG000|NOT COMPLETED|Overall Study||44
10092601|NCT02338843|11221078|FG001|NOT COMPLETED|Overall Study||58
10092602|NCT02338882|11221086|FG000|STARTED|Overall Study||50
10092603|NCT02338882|11221087|FG001|STARTED|Overall Study||50
10092604|NCT02338882|11221086|FG000|COMPLETED|Overall Study||43
10092605|NCT02338882|11221087|FG001|COMPLETED|Overall Study||47
9856213|NCT00903968|10968993|FG006|NOT COMPLETED|Overall Study||3
10092606|NCT02338882|11221086|FG000|NOT COMPLETED|Overall Study||7
10092607|NCT02338882|11221087|FG001|NOT COMPLETED|Overall Study||3
10092608|NCT02338960|11221098|FG000|STARTED|Core Study||306
10092609|NCT02338960|11221099|FG001|STARTED|Core Study||308
10092610|NCT02338960|11221098|FG000|Received Intervention|Core Study||303
10092611|NCT02338960|11221099|FG001|Received Intervention|Core Study||301
10092612|NCT02338960|11221098|FG000|COMPLETED|Core Study||219
10092613|NCT02338960|11221099|FG001|COMPLETED|Core Study||173
10092614|NCT02338960|11221098|FG000|NOT COMPLETED|Core Study||87
10092615|NCT02338960|11221099|FG001|NOT COMPLETED|Core Study||135
10092616|NCT02338960|11221098|FG000|STARTED|Open Label Extension||191
9856214|NCT00903968|10968994|FG007|NOT COMPLETED|Overall Study||33
10092617|NCT02338960|11221099|FG001|STARTED|Open Label Extension||130
10092618|NCT02338960|11221098|FG000|COMPLETED|Open Label Extension||77
10092619|NCT02338960|11221099|FG001|COMPLETED|Open Label Extension||51
10092620|NCT02338960|11221098|FG000|NOT COMPLETED|Open Label Extension||114
10092621|NCT02338960|11221099|FG001|NOT COMPLETED|Open Label Extension||79
10092622|NCT02338973|11221110|FG000|STARTED|Overall Study||4
9856215|NCT00904007|10969017|FG000|STARTED|Overall Study||55
9856216|NCT00904007|10969018|FG001|STARTED|Overall Study||56
9856217|NCT00904007|10969017|FG000|COMPLETED|Overall Study||55
9856218|NCT00904007|10969018|FG001|COMPLETED|Overall Study||56
9856219|NCT00904007|10969017|FG000|NOT COMPLETED|Overall Study||0
9856220|NCT00904007|10969018|FG001|NOT COMPLETED|Overall Study||0
9856221|NCT00904033|10969030|FG000|STARTED|Overall Study||10
9856222|NCT00904033|10969031|FG001|STARTED|Overall Study||10
9856223|NCT00904033|10969032|FG002|STARTED|Overall Study||10
9856224|NCT00904033|10969033|FG003|STARTED|Overall Study||11
9856225|NCT00904033|10969030|FG000|COMPLETED|Overall Study||9
9856226|NCT00904033|10969031|FG001|COMPLETED|Overall Study||9
9856227|NCT00904033|10969032|FG002|COMPLETED|Overall Study||9
9856228|NCT00904033|10969033|FG003|COMPLETED|Overall Study||9
9856229|NCT00904033|10969030|FG000|NOT COMPLETED|Overall Study||1
9856230|NCT00904033|10969031|FG001|NOT COMPLETED|Overall Study||1
9856231|NCT00904033|10969032|FG002|NOT COMPLETED|Overall Study||1
9856232|NCT00904033|10969033|FG003|NOT COMPLETED|Overall Study||2
9856233|NCT00904150|10969046|FG000|STARTED|Saliva Samples (DNA)||285
9856234|NCT00904150|10969047|FG001|STARTED|Saliva Samples (DNA)||300
9856235|NCT00904150|10969046|FG000|COMPLETED|Saliva Samples (DNA)||282
9856236|NCT00904150|10969047|FG001|COMPLETED|Saliva Samples (DNA)||155
9856237|NCT00904150|10969046|FG000|NOT COMPLETED|Saliva Samples (DNA)||3
9856238|NCT00904150|10969047|FG001|NOT COMPLETED|Saliva Samples (DNA)||145
9856239|NCT00904150|10969046|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37
9856240|NCT00904150|10969047|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32
9856241|NCT00904150|10969046|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37
9856242|NCT00904150|10969047|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32
9856243|NCT00904150|10969046|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
9856244|NCT00904150|10969047|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
9856245|NCT00904150|10969046|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34
9856246|NCT00904150|10969047|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30
9856247|NCT00904150|10969046|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34
9856248|NCT00904150|10969047|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30
9856249|NCT00904150|10969046|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
9856250|NCT00904150|10969047|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
9856251|NCT00904215|10969053|FG000|STARTED|Overall Study||1095
9856252|NCT00904215|10969053|FG000|COMPLETED|Overall Study||960
9856253|NCT00904215|10969053|FG000|NOT COMPLETED|Overall Study||135
9856254|NCT00904345|10969057|FG000|STARTED|Overall Study||21
9856255|NCT00904345|10969057|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
9856256|NCT00904345|10969057|FG000|COMPLETED|Overall Study||18
9856257|NCT00904345|10969057|FG000|NOT COMPLETED|Overall Study||3
9856258|NCT00904371|10969061|FG000|STARTED|Overall Study||211
9856259|NCT00904371|10969061|FG000|COMPLETED|Overall Study||202
9856260|NCT00904371|10969061|FG000|NOT COMPLETED|Overall Study||9
9856261|NCT00904488|10969067|FG000|STARTED|Overall Study||5
10092623|NCT02338973|11221110|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2
10092624|NCT02338973|11221110|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
10092625|NCT02338973|11221110|FG000|COMPLETED|Overall Study||4
10092626|NCT02338973|11221110|FG000|NOT COMPLETED|Overall Study||0
10092627|NCT02338999|11221193|FG000|STARTED|First Intervention||39
10092628|NCT02338999|11221194|FG001|STARTED|First Intervention||41
10092629|NCT02338999|11221193|FG000|COMPLETED|First Intervention||36
10092630|NCT02338999|11221194|FG001|COMPLETED|First Intervention||40
10092631|NCT02338999|11221193|FG000|NOT COMPLETED|First Intervention||3
10092632|NCT02338999|11221194|FG001|NOT COMPLETED|First Intervention||1
10092633|NCT02338999|11221193|FG000|STARTED|Washout Period||36
10092634|NCT02338999|11221194|FG001|STARTED|Washout Period||40
10092635|NCT02338999|11221193|FG000|COMPLETED|Washout Period||36
10092636|NCT02338999|11221194|FG001|COMPLETED|Washout Period||38
10092637|NCT02338999|11221193|FG000|NOT COMPLETED|Washout Period||0
10092638|NCT02338999|11221194|FG001|NOT COMPLETED|Washout Period||2
10092639|NCT02338999|11221193|FG000|STARTED|Second Intervention||36
10092640|NCT02338999|11221194|FG001|STARTED|Second Intervention||38
10092641|NCT02338999|11221193|FG000|COMPLETED|Second Intervention||36
10092642|NCT02338999|11221194|FG001|COMPLETED|Second Intervention||36
10092643|NCT02338999|11221193|FG000|NOT COMPLETED|Second Intervention||0
10092644|NCT02338999|11221194|FG001|NOT COMPLETED|Second Intervention||2
10092645|NCT02339038|11221200|FG000|STARTED|Overall Study||600
10092646|NCT02339038|11221200|FG000|COMPLETED|Overall Study||0
10092647|NCT02339038|11221200|FG000|NOT COMPLETED|Overall Study||600
10092648|NCT02339155|11221206|FG000|STARTED|Overall Study||287
10092649|NCT02339155|11221207|FG001|STARTED|Overall Study||286
10092650|NCT02339155|11221206|FG000|Received Study Treatment|Overall Study||286
10092651|NCT02339155|11221207|FG001|Received Study Treatment|Overall Study||280
9856262|NCT00904488|10969068|FG001|STARTED|Overall Study||6
9856263|NCT00904488|10969067|FG000|COMPLETED|Overall Study||5
9856264|NCT00904488|10969068|FG001|COMPLETED|Overall Study||6
9856265|NCT00904488|10969067|FG000|NOT COMPLETED|Overall Study||0
10092652|NCT02339155|11221206|FG000|COMPLETED|Overall Study||272
10092653|NCT02339155|11221207|FG001|COMPLETED|Overall Study||265
10092654|NCT02339155|11221206|FG000|NOT COMPLETED|Overall Study||15
10092655|NCT02339155|11221207|FG001|NOT COMPLETED|Overall Study||21
9856266|NCT00904488|10969068|FG001|NOT COMPLETED|Overall Study||0
9856267|NCT00904618|10969074|FG000|STARTED|Overall Study||48
9856268|NCT00904618|10969074|FG000|COMPLETED|Overall Study||48
9856269|NCT00904618|10969074|FG000|NOT COMPLETED|Overall Study||0
10092656|NCT02339246|11221217|FG000|STARTED|First Intervention (7 Days)||0
10092657|NCT02339246|11221218|FG001|STARTED|First Intervention (7 Days)||0
10092658|NCT02339246|11221219|FG002|STARTED|First Intervention (7 Days)||31
10092659|NCT02339246|11221217|FG000|COMPLETED|First Intervention (7 Days)||0
10092660|NCT02339246|11221218|FG001|COMPLETED|First Intervention (7 Days)||0
10092661|NCT02339246|11221219|FG002|COMPLETED|First Intervention (7 Days)||31
10092662|NCT02339246|11221217|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10092663|NCT02339246|11221218|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10092664|NCT02339246|11221219|FG002|NOT COMPLETED|First Intervention (7 Days)||0
10092665|NCT02339246|11221217|FG000|STARTED|Second Intervention (7 Days)||16
10092666|NCT02339246|11221218|FG001|STARTED|Second Intervention (7 Days)||15
10092667|NCT02339246|11221219|FG002|STARTED|Second Intervention (7 Days)||0
10092668|NCT02339246|11221217|FG000|COMPLETED|Second Intervention (7 Days)||16
10092669|NCT02339246|11221218|FG001|COMPLETED|Second Intervention (7 Days)||15
10092670|NCT02339246|11221219|FG002|COMPLETED|Second Intervention (7 Days)||0
10092671|NCT02339246|11221217|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10092672|NCT02339246|11221218|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10092673|NCT02339246|11221219|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
10092674|NCT02339246|11221217|FG000|STARTED|Third Period (7 Days)||15
10092675|NCT02339246|11221218|FG001|STARTED|Third Period (7 Days)||16
10092676|NCT02339246|11221219|FG002|STARTED|Third Period (7 Days)||0
10092677|NCT02339246|11221217|FG000|COMPLETED|Third Period (7 Days)||15
10092678|NCT02339246|11221218|FG001|COMPLETED|Third Period (7 Days)||16
10092679|NCT02339246|11221219|FG002|COMPLETED|Third Period (7 Days)||0
10092680|NCT02339246|11221217|FG000|NOT COMPLETED|Third Period (7 Days)||0
10092681|NCT02339246|11221218|FG001|NOT COMPLETED|Third Period (7 Days)||0
10092682|NCT02339246|11221219|FG002|NOT COMPLETED|Third Period (7 Days)||0
10092683|NCT02339285|11221230|FG000|STARTED|Overall Study||10
10092684|NCT02339285|11221231|FG001|STARTED|Overall Study||11
10092685|NCT02339285|11221232|FG002|STARTED|Overall Study||11
10092686|NCT02339285|11221230|FG000|Completed Intervention|Overall Study||10
10092687|NCT02339285|11221231|FG001|Completed Intervention|Overall Study||10
10092688|NCT02339285|11221232|FG002|Completed Intervention|Overall Study||10
10092689|NCT02339285|11221230|FG000|2 Week Follow-up|Overall Study||9
10092690|NCT02339285|11221231|FG001|2 Week Follow-up|Overall Study||10
10092691|NCT02339285|11221232|FG002|2 Week Follow-up|Overall Study||10
10092692|NCT02339285|11221230|FG000|4 Week Follow-up Visit|Overall Study||9
10092693|NCT02339285|11221231|FG001|4 Week Follow-up Visit|Overall Study||8
10092694|NCT02339285|11221232|FG002|4 Week Follow-up Visit|Overall Study||9
10092695|NCT02339285|11221230|FG000|COMPLETED|Overall Study||9
10092696|NCT02339285|11221231|FG001|COMPLETED|Overall Study||8
10092697|NCT02339285|11221232|FG002|COMPLETED|Overall Study||9
10092698|NCT02339285|11221230|FG000|NOT COMPLETED|Overall Study||1
10092699|NCT02339285|11221231|FG001|NOT COMPLETED|Overall Study||3
10092700|NCT02339285|11221232|FG002|NOT COMPLETED|Overall Study||2
10092701|NCT02339389|11221240|FG000|STARTED|Overall Study||57
10092702|NCT02339389|11221240|FG000|COMPLETED|Overall Study||41
10092703|NCT02339389|11221240|FG000|NOT COMPLETED|Overall Study||16
10092704|NCT02339415|11221247|FG000|STARTED|First Period||22
10092705|NCT02339415|11221248|FG001|STARTED|First Period||22
10092706|NCT02339415|11221247|FG000|Received at Least One Dose|First Period||21
10092707|NCT02339415|11221248|FG001|Received at Least One Dose|First Period||20
10092708|NCT02339415|11221247|FG000|COMPLETED|First Period||20
10092709|NCT02339415|11221248|FG001|COMPLETED|First Period||20
10092710|NCT02339415|11221247|FG000|NOT COMPLETED|First Period||2
10092711|NCT02339415|11221248|FG001|NOT COMPLETED|First Period||2
10092712|NCT02339415|11221247|FG000|STARTED|Washout||20
10092713|NCT02339415|11221248|FG001|STARTED|Washout||20
10092714|NCT02339415|11221247|FG000|COMPLETED|Washout||20
10092715|NCT02339415|11221248|FG001|COMPLETED|Washout||20
10092716|NCT02339415|11221247|FG000|NOT COMPLETED|Washout||0
10092717|NCT02339415|11221248|FG001|NOT COMPLETED|Washout||0
10092718|NCT02339415|11221247|FG000|STARTED|Second Period||20
10092719|NCT02339415|11221248|FG001|STARTED|Second Period||20
10092720|NCT02339415|11221247|FG000|COMPLETED|Second Period||19
10092721|NCT02339415|11221248|FG001|COMPLETED|Second Period||18
10092722|NCT02339415|11221247|FG000|NOT COMPLETED|Second Period||1
10092723|NCT02339415|11221248|FG001|NOT COMPLETED|Second Period||2
10092724|NCT02339506|11221256|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12
10092725|NCT02339506|11221257|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11
10092726|NCT02339506|11221256|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
10092727|NCT02339506|11221257|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
10092728|NCT02339506|11221256|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
10092729|NCT02339506|11221257|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
10092730|NCT02339506|11221256|FG000|STARTED|Washout (Period 2)||12
10092731|NCT02339506|11221257|FG001|STARTED|Washout (Period 2)||10
10092732|NCT02339506|11221256|FG000|COMPLETED|Washout (Period 2)||10
10092733|NCT02339506|11221257|FG001|COMPLETED|Washout (Period 2)||10
10092734|NCT02339506|11221256|FG000|NOT COMPLETED|Washout (Period 2)||2
10092735|NCT02339506|11221257|FG001|NOT COMPLETED|Washout (Period 2)||0
10092736|NCT02339506|11221256|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10
10092737|NCT02339506|11221257|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10
10092738|NCT02339506|11221256|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
10092739|NCT02339506|11221257|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
10092740|NCT02339506|11221256|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
10092741|NCT02339506|11221257|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
10092742|NCT02339545|11221263|FG000|STARTED|Overall Study||15
9856270|NCT00904670|10969081|FG000|STARTED|Open Label Phase||23
9856271|NCT00904670|10969082|FG001|STARTED|Open Label Phase||22
9856272|NCT00904670|10969081|FG000|COMPLETED|Open Label Phase||17
9856273|NCT00904670|10969082|FG001|COMPLETED|Open Label Phase||22
9856274|NCT00904670|10969081|FG000|NOT COMPLETED|Open Label Phase||6
9856275|NCT00904670|10969082|FG001|NOT COMPLETED|Open Label Phase||0
10092743|NCT02339545|11221263|FG000|COMPLETED|Overall Study||15
10092744|NCT02339545|11221263|FG000|NOT COMPLETED|Overall Study||0
10092745|NCT02339558|11221268|FG000|STARTED|Overall Study||45
10092746|NCT02339558|11221268|FG000|COMPLETED|Overall Study||45
10092747|NCT02339558|11221268|FG000|NOT COMPLETED|Overall Study||0
10092748|NCT02339584|11221274|FG000|STARTED|Overall Study||188
10092749|NCT02339584|11221275|FG001|STARTED|Overall Study||191
10092750|NCT02339584|11221274|FG000|COMPLETED|Overall Study||173
10092751|NCT02339584|11221275|FG001|COMPLETED|Overall Study||176
10092752|NCT02339584|11221274|FG000|NOT COMPLETED|Overall Study||15
10092753|NCT02339584|11221275|FG001|NOT COMPLETED|Overall Study||15
10092754|NCT02339831|11221283|FG000|STARTED|Overall Study||58
10092755|NCT02339831|11221284|FG001|STARTED|Overall Study||52
10092756|NCT02339831|11221283|FG000|Lost to Follow Up|Overall Study||20
10092757|NCT02339831|11221284|FG001|Lost to Follow Up|Overall Study||7
10092758|NCT02339831|11221283|FG000|COMPLETED|Overall Study||38
10092759|NCT02339831|11221284|FG001|COMPLETED|Overall Study||45
10092760|NCT02339831|11221283|FG000|NOT COMPLETED|Overall Study||20
10092761|NCT02339831|11221284|FG001|NOT COMPLETED|Overall Study||7
10092762|NCT02339909|11221293|FG000|STARTED|Overall Study||524
10092763|NCT02339909|11221294|FG001|STARTED|Overall Study||375
10092764|NCT02339909|11221295|FG002|STARTED|Overall Study||375
10092765|NCT02339909|11221293|FG000|COMPLETED|Overall Study||435
10092766|NCT02339909|11221294|FG001|COMPLETED|Overall Study||312
10092767|NCT02339909|11221295|FG002|COMPLETED|Overall Study||304
10092768|NCT02339909|11221293|FG000|NOT COMPLETED|Overall Study||89
10092769|NCT02339909|11221294|FG001|NOT COMPLETED|Overall Study||63
10092770|NCT02339909|11221295|FG002|NOT COMPLETED|Overall Study||71
10092771|NCT02340000|11221305|FG000|STARTED|Time Period 1||90
10092772|NCT02340000|11221306|FG001|STARTED|Time Period 1||89
10092773|NCT02340000|11221305|FG000|COMPLETED|Time Period 1||78
10092774|NCT02340000|11221306|FG001|COMPLETED|Time Period 1||74
10092775|NCT02340000|11221305|FG000|NOT COMPLETED|Time Period 1||12
10092776|NCT02340000|11221306|FG001|NOT COMPLETED|Time Period 1||15
10092777|NCT02340000|11221305|FG000|STARTED|Time Period 2||69
10092778|NCT02340000|11221306|FG001|STARTED|Time Period 2||67
10092779|NCT02340000|11221305|FG000|COMPLETED|Time Period 2||50
10092780|NCT02340000|11221306|FG001|COMPLETED|Time Period 2||52
10092781|NCT02340000|11221305|FG000|NOT COMPLETED|Time Period 2||19
10092782|NCT02340000|11221306|FG001|NOT COMPLETED|Time Period 2||15
10092783|NCT02340078|11221319|FG000|STARTED|Overall Study||62
10092784|NCT02340078|11221319|FG000|COMPLETED|Overall Study||61
10092785|NCT02340078|11221319|FG000|NOT COMPLETED|Overall Study||1
10092786|NCT02340091|11221324|FG000|STARTED|Overall Study|All Study Participants|62
10092787|NCT02340091|11221324|FG000|COMPLETED|Overall Study||60
10092788|NCT02340091|11221324|FG000|NOT COMPLETED|Overall Study||2
10092789|NCT02340104|11221329|FG000|STARTED|Overall Study||8
10092790|NCT02340104|11221329|FG000|COMPLETED|Overall Study||8
10092791|NCT02340104|11221329|FG000|NOT COMPLETED|Overall Study||0
10092792|NCT02340156|11221334|FG000|STARTED|Overall Study||1
10092793|NCT02340156|11221334|FG000|COMPLETED|Overall Study||1
10092794|NCT02340156|11221334|FG000|NOT COMPLETED|Overall Study||0
10092795|NCT02340299|11221340|FG000|STARTED|Overall Study||4
10092796|NCT02340299|11221341|FG001|STARTED|Overall Study||2
10092797|NCT02340299|11221340|FG000|COMPLETED|Overall Study||4
10092798|NCT02340299|11221341|FG001|COMPLETED|Overall Study||2
10092799|NCT02340299|11221340|FG000|NOT COMPLETED|Overall Study||0
10092800|NCT02340299|11221341|FG001|NOT COMPLETED|Overall Study||0
10092801|NCT02340338|11221354|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2
10092802|NCT02340338|11221355|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2
10092803|NCT02340338|11221356|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3
10092804|NCT02340338|11221357|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9
10092805|NCT02340338|11221358|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9
10092806|NCT02340338|11221359|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9
10092807|NCT02340338|11221360|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
10092808|NCT02340338|11221354|FG000|COMPLETED|Overall Study||2
9856276|NCT00904670|10969081|FG000|STARTED|First Intervention Period||17
9856277|NCT00904670|10969082|FG001|STARTED|First Intervention Period||22
10092809|NCT02340338|11221355|FG001|COMPLETED|Overall Study||2
10092810|NCT02340338|11221356|FG002|COMPLETED|Overall Study||3
10092811|NCT02340338|11221357|FG003|COMPLETED|Overall Study||9
10092812|NCT02340338|11221358|FG004|COMPLETED|Overall Study||9
10092813|NCT02340338|11221359|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
10092814|NCT02340338|11221360|FG006|COMPLETED|Overall Study||12
10092815|NCT02340338|11221354|FG000|NOT COMPLETED|Overall Study||0
10092816|NCT02340338|11221355|FG001|NOT COMPLETED|Overall Study||0
10092817|NCT02340338|11221356|FG002|NOT COMPLETED|Overall Study||0
10092818|NCT02340338|11221357|FG003|NOT COMPLETED|Overall Study||0
10092819|NCT02340338|11221358|FG004|NOT COMPLETED|Overall Study||0
10092820|NCT02340338|11221359|FG005|NOT COMPLETED|Overall Study||0
10092821|NCT02340338|11221360|FG006|NOT COMPLETED|Overall Study||0
10092822|NCT02340520|11221376|FG000|STARTED|Overall Study||11
10092823|NCT02340520|11221376|FG000|COMPLETED|Overall Study||8
10092824|NCT02340520|11221376|FG000|NOT COMPLETED|Overall Study||3
10092825|NCT02340663|11221382|FG000|STARTED|Overall Study||35
10092826|NCT02340663|11221383|FG001|STARTED|Overall Study||32
10092827|NCT02340663|11221382|FG000|Clinical Exam, Impressions|Overall Study||35
10092828|NCT02340663|11221383|FG001|Clinical Exam, Impressions|Overall Study||32
10092829|NCT02340663|11221382|FG000|Splint Delivery, Assessments|Overall Study||33
10092830|NCT02340663|11221383|FG001|Splint Delivery, Assessments|Overall Study||31
10092831|NCT02340663|11221382|FG000|1 Week Follow-up, Assessments|Overall Study||33
10092832|NCT02340663|11221383|FG001|1 Week Follow-up, Assessments|Overall Study||31
10092833|NCT02340663|11221382|FG000|4 Month Follow-up, Assessments|Overall Study||30
10092834|NCT02340663|11221383|FG001|4 Month Follow-up, Assessments|Overall Study||31
10092835|NCT02340663|11221382|FG000|COMPLETED|Overall Study||30
10092836|NCT02340663|11221383|FG001|COMPLETED|Overall Study||31
10092837|NCT02340663|11221382|FG000|NOT COMPLETED|Overall Study||5
10092838|NCT02340663|11221383|FG001|NOT COMPLETED|Overall Study||1
10092839|NCT02340715|11221389|FG000|STARTED|Overall Study|158|158
10092840|NCT02340715|11221389|FG000|COMPLETED|Overall Study|158|158
10092841|NCT02340715|11221389|FG000|NOT COMPLETED|Overall Study||0
10092842|NCT02340767|11221402|FG000|STARTED|Overall Study||28
10092843|NCT02340767|11221403|FG001|STARTED|Overall Study||28
10092844|NCT02340767|11221404|FG002|STARTED|Overall Study||29
10092845|NCT02340767|11221405|FG003|STARTED|Overall Study||500
10092846|NCT02340767|11221406|FG004|STARTED|Overall Study||474
10092847|NCT02340767|11221407|FG005|STARTED|Overall Study||526
10092848|NCT02340767|11221408|FG006|STARTED|Overall Study||525
10092849|NCT02340767|11221409|FG007|STARTED|Overall Study||444
10092850|NCT02340767|11221410|FG008|STARTED|Overall Study||531
10092851|NCT02340767|11221402|FG000|COMPLETED|Overall Study||28
10092852|NCT02340767|11221403|FG001|COMPLETED|Overall Study||28
10092853|NCT02340767|11221404|FG002|COMPLETED|Overall Study||29
10092854|NCT02340767|11221405|FG003|COMPLETED|Overall Study||500
10092855|NCT02340767|11221406|FG004|COMPLETED|Overall Study||474
10092856|NCT02340767|11221407|FG005|COMPLETED|Overall Study||526
10092857|NCT02340767|11221408|FG006|COMPLETED|Overall Study||525
10092858|NCT02340767|11221409|FG007|COMPLETED|Overall Study||444
10092859|NCT02340767|11221410|FG008|COMPLETED|Overall Study||531
10092860|NCT02340767|11221402|FG000|NOT COMPLETED|Overall Study||0
10092861|NCT02340767|11221403|FG001|NOT COMPLETED|Overall Study||0
10092862|NCT02340767|11221404|FG002|NOT COMPLETED|Overall Study||0
10092863|NCT02340767|11221405|FG003|NOT COMPLETED|Overall Study||0
10092864|NCT02340767|11221406|FG004|NOT COMPLETED|Overall Study||0
10092865|NCT02340767|11221407|FG005|NOT COMPLETED|Overall Study||0
10092866|NCT02340767|11221408|FG006|NOT COMPLETED|Overall Study||0
10092867|NCT02340767|11221409|FG007|NOT COMPLETED|Overall Study||0
10092868|NCT02340767|11221410|FG008|NOT COMPLETED|Overall Study||0
10112900|NCT02506114|11243784|FG002|STARTED|Overall Study||6
10112901|NCT02506114|11243782|FG000|COMPLETED|Overall Study||5
10112902|NCT02506114|11243783|FG001|COMPLETED|Overall Study||4
10112903|NCT02506114|11243784|FG002|COMPLETED|Overall Study||6
10112904|NCT02506114|11243782|FG000|NOT COMPLETED|Overall Study||0
10112905|NCT02506114|11243783|FG001|NOT COMPLETED|Overall Study||0
10112906|NCT02506114|11243784|FG002|NOT COMPLETED|Overall Study||0
10112907|NCT02506257|11243796|FG000|STARTED|Overall Study||26
10112908|NCT02506257|11243797|FG001|STARTED|Overall Study||28
10112909|NCT02506257|11243798|FG002|STARTED|Overall Study||27
10112910|NCT02506257|11243799|FG003|STARTED|Overall Study||9
10112911|NCT02506257|11243796|FG000|COMPLETED|Overall Study||26
10112912|NCT02506257|11243797|FG001|COMPLETED|Overall Study||26
10112913|NCT02506257|11243798|FG002|COMPLETED|Overall Study||23
10112914|NCT02506257|11243799|FG003|COMPLETED|Overall Study||9
10112915|NCT02506257|11243796|FG000|NOT COMPLETED|Overall Study||0
10112916|NCT02506257|11243797|FG001|NOT COMPLETED|Overall Study||2
10112917|NCT02506257|11243798|FG002|NOT COMPLETED|Overall Study||4
10112918|NCT02506257|11243799|FG003|NOT COMPLETED|Overall Study||0
10112919|NCT02506309|11243811|FG000|STARTED|Overall Study||84
10112920|NCT02506309|11243812|FG001|STARTED|Overall Study||84
10112921|NCT02506309|11243811|FG000|COMPLETED|Overall Study||66
10112922|NCT02506309|11243812|FG001|COMPLETED|Overall Study||64
10112923|NCT02506309|11243811|FG000|NOT COMPLETED|Overall Study||18
10112924|NCT02506309|11243812|FG001|NOT COMPLETED|Overall Study||20
10112925|NCT02506634|11243826|FG000|STARTED|Overall Study||374
10112926|NCT02506634|11243826|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154
10112927|NCT02506634|11243826|FG000|Participants Who Received PPI Treatment|Overall Study||357
10112928|NCT02506634|11243826|FG000|Participants Who Finished GERDQ|Overall Study||342
10112929|NCT02506634|11243826|FG000|COMPLETED|Overall Study||357
10112930|NCT02506634|11243826|FG000|NOT COMPLETED|Overall Study||17
10112931|NCT02506660|11243866|FG000|STARTED|Overall Study||64
10112932|NCT02506660|11243867|FG001|STARTED|Overall Study||64
10112933|NCT02506660|11243866|FG000|COMPLETED|Overall Study||62
10112934|NCT02506660|11243867|FG001|COMPLETED|Overall Study||63
10112935|NCT02506660|11243866|FG000|NOT COMPLETED|Overall Study||2
10112936|NCT02506660|11243867|FG001|NOT COMPLETED|Overall Study||1
10112937|NCT02506673|11243875|FG000|STARTED|Overall Study||13
10112938|NCT02506673|11243876|FG001|STARTED|Overall Study||13
10112939|NCT02506673|11243875|FG000|COMPLETED|Overall Study||13
10112940|NCT02506673|11243876|FG001|COMPLETED|Overall Study||13
10112941|NCT02506673|11243875|FG000|NOT COMPLETED|Overall Study||0
10112942|NCT02506673|11243876|FG001|NOT COMPLETED|Overall Study||0
10112943|NCT02506816|11243882|FG000|STARTED|Overall Study||36
10092869|NCT02340780|11221425|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
10092870|NCT02340780|11221425|FG000|COMPLETED|Overall Study||13
10092871|NCT02340780|11221425|FG000|NOT COMPLETED|Overall Study||1
10092872|NCT02340806|11221431|FG000|STARTED|Overall Study||108
9856278|NCT00904670|10969081|FG000|COMPLETED|First Intervention Period||17
9856279|NCT00904670|10969082|FG001|COMPLETED|First Intervention Period||22
9856280|NCT00904670|10969081|FG000|NOT COMPLETED|First Intervention Period||0
9856281|NCT00904670|10969082|FG001|NOT COMPLETED|First Intervention Period||0
9856282|NCT00904670|10969081|FG000|STARTED|Second Intervention Period||17
9856283|NCT00904670|10969082|FG001|STARTED|Second Intervention Period||22
9856284|NCT00904670|10969081|FG000|COMPLETED|Second Intervention Period||17
9856285|NCT00904670|10969082|FG001|COMPLETED|Second Intervention Period||22
9856286|NCT00904670|10969081|FG000|NOT COMPLETED|Second Intervention Period||0
9856287|NCT00904670|10969082|FG001|NOT COMPLETED|Second Intervention Period||0
9856288|NCT00904722|10969090|FG000|STARTED|Overall Study||30
9856289|NCT00904722|10969090|FG000|COMPLETED|Overall Study||29
9856290|NCT00904722|10969090|FG000|NOT COMPLETED|Overall Study||1
9856291|NCT00904748|10969094|FG000|STARTED|Overall Study||8
9856292|NCT00904748|10969095|FG001|STARTED|Overall Study||8
9856293|NCT00904748|10969096|FG002|STARTED|Overall Study||8
9856294|NCT00904748|10969097|FG003|STARTED|Overall Study||8
9856295|NCT00904748|10969098|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
9856296|NCT00904748|10969099|FG005|STARTED|Overall Study||8
9856297|NCT00904748|10969094|FG000|Received Treatment|Overall Study||8
9856298|NCT00904748|10969095|FG001|Received Treatment|Overall Study||8
9856299|NCT00904748|10969096|FG002|Received Treatment|Overall Study||8
9856300|NCT00904748|10969097|FG003|Received Treatment|Overall Study||8
9856301|NCT00904748|10969098|FG004|Received Treatment|Overall Study||7
9856302|NCT00904748|10969099|FG005|Received Treatment|Overall Study||8
9856303|NCT00904748|10969094|FG000|COMPLETED|Overall Study||7
9856304|NCT00904748|10969095|FG001|COMPLETED|Overall Study||7
9856305|NCT00904748|10969096|FG002|COMPLETED|Overall Study||7
9856306|NCT00904748|10969097|FG003|COMPLETED|Overall Study||6
9856307|NCT00904748|10969098|FG004|COMPLETED|Overall Study||7
9856308|NCT00904748|10969099|FG005|COMPLETED|Overall Study||8
9856309|NCT00904748|10969094|FG000|NOT COMPLETED|Overall Study||1
9856310|NCT00904748|10969095|FG001|NOT COMPLETED|Overall Study||1
9856311|NCT00904748|10969096|FG002|NOT COMPLETED|Overall Study||1
9856312|NCT00904748|10969097|FG003|NOT COMPLETED|Overall Study||2
9856313|NCT00904748|10969098|FG004|NOT COMPLETED|Overall Study||1
9856314|NCT00904748|10969099|FG005|NOT COMPLETED|Overall Study||0
9856315|NCT00904813|10969113|FG000|STARTED|Overall Study||129
9856316|NCT00904813|10969114|FG001|STARTED|Overall Study||128
9856317|NCT00904813|10969115|FG002|STARTED|Overall Study||128
9856318|NCT00904813|10969116|FG003|STARTED|Overall Study||228
9856319|NCT00904813|10969117|FG004|STARTED|Overall Study||227
9856320|NCT00904813|10969113|FG000|COMPLETED|Overall Study||129
9856321|NCT00904813|10969114|FG001|COMPLETED|Overall Study||128
9856322|NCT00904813|10969115|FG002|COMPLETED|Overall Study||128
9856323|NCT00904813|10969116|FG003|COMPLETED|Overall Study||228
9856324|NCT00904813|10969117|FG004|COMPLETED|Overall Study||227
9856325|NCT00904813|10969113|FG000|NOT COMPLETED|Overall Study||0
9856326|NCT00904813|10969114|FG001|NOT COMPLETED|Overall Study||0
9856327|NCT00904813|10969115|FG002|NOT COMPLETED|Overall Study||0
9856328|NCT00904813|10969116|FG003|NOT COMPLETED|Overall Study||0
9856329|NCT00904813|10969117|FG004|NOT COMPLETED|Overall Study||0
9856330|NCT00904826|10969140|FG000|STARTED|Overall Study||14
9856331|NCT00904826|10969140|FG000|COMPLETED|Overall Study||14
9856332|NCT00904826|10969140|FG000|NOT COMPLETED|Overall Study||0
9856333|NCT00904839|10969146|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
9856334|NCT00904839|10969147|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
9856335|NCT00904839|10969148|FG002|STARTED|Overall Study|Randomised|42
9856336|NCT00904839|10969146|FG000|COMPLETED|Overall Study||3
9856337|NCT00904839|10969147|FG001|COMPLETED|Overall Study||64
9856338|NCT00904839|10969148|FG002|COMPLETED|Overall Study||27
9856339|NCT00904839|10969146|FG000|NOT COMPLETED|Overall Study||1
9856340|NCT00904839|10969147|FG001|NOT COMPLETED|Overall Study||18
9856341|NCT00904839|10969148|FG002|NOT COMPLETED|Overall Study||15
9856342|NCT00904917|10969163|FG000|STARTED|Overall Study||7
9856343|NCT00904917|10969164|FG001|STARTED|Overall Study||11
9856344|NCT00904917|10969165|FG002|STARTED|Overall Study||8
9856345|NCT00904917|10969166|FG003|STARTED|Overall Study||8
9856346|NCT00904917|10969163|FG000|COMPLETED|Overall Study||5
9856347|NCT00904917|10969164|FG001|COMPLETED|Overall Study||9
9856348|NCT00904917|10969165|FG002|COMPLETED|Overall Study||6
9856349|NCT00904917|10969166|FG003|COMPLETED|Overall Study||6
9856350|NCT00904917|10969163|FG000|NOT COMPLETED|Overall Study||2
9856351|NCT00904917|10969164|FG001|NOT COMPLETED|Overall Study||2
9856352|NCT00904917|10969165|FG002|NOT COMPLETED|Overall Study||2
9856353|NCT00904917|10969166|FG003|NOT COMPLETED|Overall Study||2
9856354|NCT00904969|10969179|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
9856355|NCT00904969|10969179|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
9856356|NCT00904969|10969179|FG000|NOT COMPLETED|Overall Study||19
9856357|NCT00904982|10969202|FG000|STARTED|Overall Study||68
9856358|NCT00904982|10969203|FG001|STARTED|Overall Study||67
9856359|NCT00904982|10969204|FG002|STARTED|Overall Study||67
9856360|NCT00904982|10969205|FG003|STARTED|Overall Study||68
9856361|NCT00904982|10969202|FG000|COMPLETED|Overall Study||66
9856362|NCT00904982|10969203|FG001|COMPLETED|Overall Study||67
9856363|NCT00904982|10969204|FG002|COMPLETED|Overall Study||67
9856364|NCT00904982|10969205|FG003|COMPLETED|Overall Study||68
9856365|NCT00904982|10969202|FG000|NOT COMPLETED|Overall Study||2
9856366|NCT00904982|10969203|FG001|NOT COMPLETED|Overall Study||0
9856367|NCT00904982|10969204|FG002|NOT COMPLETED|Overall Study||0
9856368|NCT00904982|10969205|FG003|NOT COMPLETED|Overall Study||0
9856369|NCT00904995|10969217|FG000|STARTED|Overall Study||10
9856370|NCT00904995|10969218|FG001|STARTED|Overall Study||11
9856371|NCT00904995|10969217|FG000|COMPLETED|Overall Study||10
9856372|NCT00904995|10969218|FG001|COMPLETED|Overall Study||11
9856373|NCT00904995|10969217|FG000|NOT COMPLETED|Overall Study||0
9856374|NCT00904995|10969218|FG001|NOT COMPLETED|Overall Study||0
9856375|NCT00905021|10969224|FG000|STARTED|Overall Study||4
9856376|NCT00905021|10969224|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2
9856377|NCT00905021|10969224|FG000|NOT COMPLETED|Overall Study||2
9856378|NCT00905034|10969229|FG000|STARTED|Overall Study||37
9856379|NCT00905034|10969229|FG000|COMPLETED|Overall Study||36
9856380|NCT00905034|10969229|FG000|NOT COMPLETED|Overall Study||1
9856381|NCT00905060|10969233|FG000|STARTED|Surgical Resection||70
9856382|NCT00905060|10969233|FG000|COMPLETED|Surgical Resection||46
9856383|NCT00905060|10969233|FG000|NOT COMPLETED|Surgical Resection||24
9856384|NCT00905060|10969233|FG000|STARTED|Vaccination Treatment Period||46
9856385|NCT00905060|10969233|FG000|COMPLETED|Vaccination Treatment Period||46
9856386|NCT00905060|10969233|FG000|NOT COMPLETED|Vaccination Treatment Period||0
9856387|NCT00905125|10969239|FG000|STARTED|Overall Study||46
9856388|NCT00905125|10969240|FG001|STARTED|Overall Study||56
9856389|NCT00905125|10969239|FG000|COMPLETED|Overall Study||42
9856390|NCT00905125|10969240|FG001|COMPLETED|Overall Study||53
9856391|NCT00905125|10969239|FG000|NOT COMPLETED|Overall Study||4
9856392|NCT00905125|10969240|FG001|NOT COMPLETED|Overall Study||3
9856393|NCT00905151|10969246|FG000|STARTED|Overall Study||206
9856394|NCT00905151|10969246|FG000|COMPLETED|Overall Study||200
9856395|NCT00905151|10969246|FG000|NOT COMPLETED|Overall Study||6
9856396|NCT00905255|10969252|FG000|STARTED|Overall Study|Randomized.|33
9856397|NCT00905255|10969253|FG001|STARTED|Overall Study||36
9856398|NCT00905255|10969252|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
9856399|NCT00905255|10969253|FG001|Safety Population|Overall Study||36
9856400|NCT00905255|10969252|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
9856401|NCT00905255|10969253|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36
9856402|NCT00905255|10969252|FG000|COMPLETED|Overall Study||20
9856403|NCT00905255|10969253|FG001|COMPLETED|Overall Study||27
9856404|NCT00905255|10969252|FG000|NOT COMPLETED|Overall Study||13
9856405|NCT00905255|10969253|FG001|NOT COMPLETED|Overall Study||9
9856406|NCT00905268|10969264|FG000|STARTED|Overall Study||57
9856407|NCT00905268|10969265|FG001|STARTED|Overall Study||57
9856408|NCT00905268|10969266|FG002|STARTED|Overall Study||59
9856409|NCT00905268|10969267|FG003|STARTED|Overall Study||59
9856410|NCT00905268|10969264|FG000|COMPLETED|Overall Study||53
9856411|NCT00905268|10969265|FG001|COMPLETED|Overall Study||56
9856412|NCT00905268|10969266|FG002|COMPLETED|Overall Study||59
9856413|NCT00905268|10969267|FG003|COMPLETED|Overall Study||57
9856414|NCT00905268|10969264|FG000|NOT COMPLETED|Overall Study||4
9856415|NCT00905268|10969265|FG001|NOT COMPLETED|Overall Study||1
9856416|NCT00905268|10969266|FG002|NOT COMPLETED|Overall Study||0
9856417|NCT00905268|10969267|FG003|NOT COMPLETED|Overall Study||2
9856418|NCT00905307|10969283|FG000|STARTED|Overall Study||42
9856419|NCT00905307|10969284|FG001|STARTED|Overall Study||89
9856420|NCT00905307|10969285|FG002|STARTED|Overall Study||90
9856421|NCT00905307|10969286|FG003|STARTED|Overall Study||93
9856422|NCT00905307|10969287|FG004|STARTED|Overall Study||50
9856423|NCT00905307|10969288|FG005|STARTED|Overall Study||95
9856424|NCT00905307|10969283|FG000|COMPLETED|Overall Study||20
9856425|NCT00905307|10969284|FG001|COMPLETED|Overall Study||52
9856426|NCT00905307|10969285|FG002|COMPLETED|Overall Study||53
9856427|NCT00905307|10969286|FG003|COMPLETED|Overall Study||56
9856428|NCT00905307|10969287|FG004|COMPLETED|Overall Study||34
9856429|NCT00905307|10969288|FG005|COMPLETED|Overall Study||53
9856430|NCT00905307|10969283|FG000|NOT COMPLETED|Overall Study||22
9856431|NCT00905307|10969284|FG001|NOT COMPLETED|Overall Study||37
9856432|NCT00905307|10969285|FG002|NOT COMPLETED|Overall Study||37
9856433|NCT00905307|10969286|FG003|NOT COMPLETED|Overall Study||37
9856434|NCT00905307|10969287|FG004|NOT COMPLETED|Overall Study||16
9856435|NCT00905307|10969288|FG005|NOT COMPLETED|Overall Study||42
9856436|NCT00905359|10969317|FG000|STARTED|Overall Study||82
9856437|NCT00905359|10969318|FG001|STARTED|Overall Study||81
9856438|NCT00905359|10969317|FG000|12 Months Follow up|Overall Study||68
9856439|NCT00905359|10969318|FG001|12 Months Follow up|Overall Study||72
9856440|NCT00905359|10969317|FG000|24 Months Follow up|Overall Study||58
9856441|NCT00905359|10969318|FG001|24 Months Follow up|Overall Study||65
9856442|NCT00905359|10969317|FG000|COMPLETED|Overall Study||58
9856443|NCT00905359|10969318|FG001|COMPLETED|Overall Study||65
9856444|NCT00905359|10969317|FG000|NOT COMPLETED|Overall Study||24
9856445|NCT00905359|10969318|FG001|NOT COMPLETED|Overall Study||16
9856446|NCT00905424|10969326|FG000|STARTED|Overall Study||89
9856447|NCT00905424|10969327|FG001|STARTED|Overall Study||88
9856448|NCT00905424|10969326|FG000|COMPLETED|Overall Study||78
9856449|NCT00905424|10969327|FG001|COMPLETED|Overall Study||79
9856450|NCT00905424|10969326|FG000|NOT COMPLETED|Overall Study||11
9856451|NCT00905424|10969327|FG001|NOT COMPLETED|Overall Study||9
9856452|NCT00905437|10969337|FG000|STARTED|Overall Study||35
9856453|NCT00905437|10969338|FG001|STARTED|Overall Study||37
9856454|NCT00905437|10969337|FG000|COMPLETED|Overall Study||27
9856455|NCT00905437|10969338|FG001|COMPLETED|Overall Study||27
9856456|NCT00905437|10969337|FG000|NOT COMPLETED|Overall Study||8
9856457|NCT00905437|10969338|FG001|NOT COMPLETED|Overall Study||10
9856458|NCT00905450|10969352|FG000|STARTED|Overall Study||60
9856459|NCT00905450|10969353|FG001|STARTED|Overall Study||28
9856460|NCT00905450|10969354|FG002|STARTED|Overall Study||28
9856461|NCT00905450|10969355|FG003|STARTED|Overall Study||60
9856462|NCT00905450|10969356|FG004|STARTED|Overall Study||59
9856463|NCT00905450|10969357|FG005|STARTED|Overall Study||60
9856464|NCT00905450|10969358|FG006|STARTED|Overall Study||60
9856465|NCT00905450|10969359|FG007|STARTED|Overall Study||60
9856466|NCT00905450|10969352|FG000|COMPLETED|Overall Study||59
9856467|NCT00905450|10969353|FG001|COMPLETED|Overall Study||27
9856468|NCT00905450|10969354|FG002|COMPLETED|Overall Study||28
9856469|NCT00905450|10969355|FG003|COMPLETED|Overall Study||60
9856470|NCT00905450|10969356|FG004|COMPLETED|Overall Study||59
9856471|NCT00905450|10969357|FG005|COMPLETED|Overall Study||58
9856472|NCT00905450|10969358|FG006|COMPLETED|Overall Study||58
9856473|NCT00905450|10969359|FG007|COMPLETED|Overall Study||59
9856474|NCT00905450|10969352|FG000|NOT COMPLETED|Overall Study||1
9856475|NCT00905450|10969353|FG001|NOT COMPLETED|Overall Study||1
9856476|NCT00905450|10969354|FG002|NOT COMPLETED|Overall Study||0
9856477|NCT00905450|10969355|FG003|NOT COMPLETED|Overall Study||0
9856478|NCT00905450|10969356|FG004|NOT COMPLETED|Overall Study||0
9856479|NCT00905450|10969357|FG005|NOT COMPLETED|Overall Study||2
9856480|NCT00905450|10969358|FG006|NOT COMPLETED|Overall Study||2
9856481|NCT00905450|10969359|FG007|NOT COMPLETED|Overall Study||1
9856482|NCT00905489|10969377|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85
9856483|NCT00905489|10969377|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80
9856484|NCT00905489|10969377|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
9856485|NCT00905489|10969377|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
9856486|NCT00905489|10969377|FG000|COMPLETED|Optional Extension Phase (OEP)||39
9856487|NCT00905489|10969377|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1
9856488|NCT00905515|10969389|FG000|STARTED|Overall Study||21
9856489|NCT00905515|10969390|FG001|STARTED|Overall Study||20
9856490|NCT00905515|10969391|FG002|STARTED|Overall Study||22
9856491|NCT00905515|10969389|FG000|COMPLETED|Overall Study||19
9856492|NCT00905515|10969390|FG001|COMPLETED|Overall Study||20
9856493|NCT00905515|10969391|FG002|COMPLETED|Overall Study||20
9856494|NCT00905515|10969389|FG000|NOT COMPLETED|Overall Study||2
9856495|NCT00905515|10969390|FG001|NOT COMPLETED|Overall Study||0
9856496|NCT00905515|10969391|FG002|NOT COMPLETED|Overall Study||2
9856497|NCT00905554|10969401|FG000|STARTED|Overall Study||116
9856498|NCT00905554|10969402|FG001|STARTED|Overall Study||114
9856499|NCT00905554|10969401|FG000|COMPLETED|Overall Study||116
9856500|NCT00905554|10969402|FG001|COMPLETED|Overall Study||114
9856501|NCT00905554|10969401|FG000|NOT COMPLETED|Overall Study||0
9856502|NCT00905554|10969402|FG001|NOT COMPLETED|Overall Study||0
9856503|NCT00905580|10969410|FG000|STARTED|Overall Study||49
9856504|NCT00905580|10969411|FG001|STARTED|Overall Study||50
9856505|NCT00905580|10969410|FG000|COMPLETED|Overall Study||47
9856506|NCT00905580|10969411|FG001|COMPLETED|Overall Study||47
9856507|NCT00905580|10969410|FG000|NOT COMPLETED|Overall Study||2
9856508|NCT00905580|10969411|FG001|NOT COMPLETED|Overall Study||3
9856509|NCT00905632|10969424|FG000|STARTED|Overall Study||8
9856510|NCT00905632|10969425|FG001|STARTED|Overall Study||6
9856511|NCT00905632|10969426|FG002|STARTED|Overall Study||7
9856512|NCT00905632|10969427|FG003|STARTED|Overall Study||6
9856513|NCT00905632|10969428|FG004|STARTED|Overall Study||10
9856514|NCT00905632|10969429|FG005|STARTED|Overall Study||9
9856515|NCT00905632|10969430|FG006|STARTED|Overall Study||11
9856516|NCT00905632|10969424|FG000|COMPLETED|Overall Study||8
9856517|NCT00905632|10969425|FG001|COMPLETED|Overall Study||6
9856518|NCT00905632|10969426|FG002|COMPLETED|Overall Study||7
9856519|NCT00905632|10969427|FG003|COMPLETED|Overall Study||6
9856520|NCT00905632|10969428|FG004|COMPLETED|Overall Study||10
9856521|NCT00905632|10969429|FG005|COMPLETED|Overall Study||8
9856522|NCT00905632|10969430|FG006|COMPLETED|Overall Study||7
9856523|NCT00905632|10969424|FG000|NOT COMPLETED|Overall Study||0
9856524|NCT00905632|10969425|FG001|NOT COMPLETED|Overall Study||0
9856525|NCT00905632|10969426|FG002|NOT COMPLETED|Overall Study||0
9856526|NCT00905632|10969427|FG003|NOT COMPLETED|Overall Study||0
9856527|NCT00905632|10969428|FG004|NOT COMPLETED|Overall Study||0
9856528|NCT00905632|10969429|FG005|NOT COMPLETED|Overall Study||1
9856529|NCT00905632|10969430|FG006|NOT COMPLETED|Overall Study||4
9856530|NCT00905827|10969456|FG000|STARTED|Overall Study||70
9856531|NCT00905827|10969457|FG001|STARTED|Overall Study||69
9856532|NCT00905827|10969458|FG002|STARTED|Overall Study||73
9856533|NCT00905827|10969456|FG000|COMPLETED|Overall Study||70
9856534|NCT00905827|10969457|FG001|COMPLETED|Overall Study||69
9856535|NCT00905827|10969458|FG002|COMPLETED|Overall Study||73
9856536|NCT00905827|10969456|FG000|NOT COMPLETED|Overall Study||0
9856537|NCT00905827|10969457|FG001|NOT COMPLETED|Overall Study||0
9856538|NCT00905827|10969458|FG002|NOT COMPLETED|Overall Study||0
9856539|NCT00905840|10969466|FG000|STARTED|Overall Study||91
9856540|NCT00905840|10969466|FG000|COMPLETED|Overall Study||75
9856541|NCT00905840|10969466|FG000|NOT COMPLETED|Overall Study||16
9856542|NCT00906074|10969475|FG000|STARTED|Overall Study||90
9856543|NCT00906074|10969476|FG001|STARTED|Overall Study||90
9856544|NCT00906074|10969475|FG000|COMPLETED|Overall Study||90
9856545|NCT00906074|10969476|FG001|COMPLETED|Overall Study||90
9856546|NCT00906074|10969475|FG000|NOT COMPLETED|Overall Study||0
9856547|NCT00906074|10969476|FG001|NOT COMPLETED|Overall Study||0
9856548|NCT00906087|10969482|FG000|STARTED|Initial Washout||14
9856549|NCT00906087|10969482|FG000|Completed Screening|Initial Washout||14
9856550|NCT00906087|10969482|FG000|Begin Washout|Initial Washout||13
9856551|NCT00906087|10969482|FG000|Completed Washout and Continue Protocol|Initial Washout||12
9856552|NCT00906087|10969482|FG000|COMPLETED|Initial Washout||12
9856553|NCT00906087|10969482|FG000|NOT COMPLETED|Initial Washout||2
9856554|NCT00906087|10969482|FG000|STARTED|Cosopt Treatment 6 Weeks||12
9856555|NCT00906087|10969482|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12
9856556|NCT00906087|10969482|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
9856557|NCT00906087|10969482|FG000|STARTED|Final Washout Period 4 Weeks||12
9856558|NCT00906087|10969482|FG000|COMPLETED|Final Washout Period 4 Weeks||12
9856559|NCT00906087|10969482|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0
9856560|NCT00906165|10969491|FG000|STARTED|Overall Study||14
9856561|NCT00906165|10969492|FG001|STARTED|Overall Study||14
9856562|NCT00906165|10969491|FG000|COMPLETED|Overall Study||10
9856563|NCT00906165|10969492|FG001|COMPLETED|Overall Study||14
9856564|NCT00906165|10969491|FG000|NOT COMPLETED|Overall Study||4
9856565|NCT00906165|10969492|FG001|NOT COMPLETED|Overall Study||0
9856566|NCT00906178|10969500|FG000|STARTED|Overall Study||183
9856567|NCT00906178|10969501|FG001|STARTED|Overall Study||183
9856568|NCT00906178|10969500|FG000|COMPLETED|Overall Study||168
9856569|NCT00906178|10969501|FG001|COMPLETED|Overall Study||167
9856570|NCT00906178|10969500|FG000|NOT COMPLETED|Overall Study||15
9856571|NCT00906178|10969501|FG001|NOT COMPLETED|Overall Study||16
9856572|NCT00906204|10969509|FG000|STARTED|Primary Endpoint (Early Safety)||45
9856573|NCT00906204|10969510|FG001|STARTED|Primary Endpoint (Early Safety)||52
9856574|NCT00906204|10969509|FG000|COMPLETED|Primary Endpoint (Early Safety)||43
9856575|NCT00906204|10969510|FG001|COMPLETED|Primary Endpoint (Early Safety)||51
9856576|NCT00906204|10969509|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2
9856577|NCT00906204|10969510|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1
9856578|NCT00906204|10969509|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43
9856579|NCT00906204|10969510|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51
9856580|NCT00906204|10969509|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41
9856581|NCT00906204|10969510|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48
9856582|NCT00906204|10969509|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
9856583|NCT00906204|10969510|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
9856584|NCT00906243|10969516|FG000|STARTED|Overall Study||6
9856585|NCT00906243|10969516|FG000|COMPLETED|Overall Study||6
9856586|NCT00906243|10969516|FG000|NOT COMPLETED|Overall Study||0
9856587|NCT00906282|10969520|FG000|STARTED|Preoperative Chemotherapy||46
9856588|NCT00906282|10969520|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
9856589|NCT00906282|10969520|FG000|NOT COMPLETED|Preoperative Chemotherapy||19
9856590|NCT00906282|10969520|FG000|STARTED|Surgical Resection||27
9856591|NCT00906282|10969520|FG000|COMPLETED|Surgical Resection||27
9856592|NCT00906282|10969520|FG000|NOT COMPLETED|Surgical Resection||0
9856593|NCT00906347|10969527|FG000|STARTED|Randomized||176
9856594|NCT00906347|10969528|FG001|STARTED|Randomized||174
9856595|NCT00906347|10969527|FG000|COMPLETED|Randomized||176
9856596|NCT00906347|10969528|FG001|COMPLETED|Randomized||174
9856597|NCT00906347|10969527|FG000|NOT COMPLETED|Randomized||0
9856598|NCT00906347|10969528|FG001|NOT COMPLETED|Randomized||0
9856599|NCT00906347|10969527|FG000|STARTED|Received Study Drug||176
9856600|NCT00906347|10969528|FG001|STARTED|Received Study Drug||174
9856601|NCT00906347|10969527|FG000|COMPLETED|Received Study Drug||136
9856602|NCT00906347|10969528|FG001|COMPLETED|Received Study Drug||143
9856603|NCT00906347|10969527|FG000|NOT COMPLETED|Received Study Drug||40
9856604|NCT00906347|10969528|FG001|NOT COMPLETED|Received Study Drug||31
9856605|NCT00906373|10969536|FG000|STARTED|Overall Study||6
9856606|NCT00906373|10969537|FG001|STARTED|Overall Study||41
9856607|NCT00906373|10969536|FG000|Received Any Amount of Study Drug|Overall Study||6
9856608|NCT00906373|10969537|FG001|Received Any Amount of Study Drug|Overall Study||41
9856609|NCT00906373|10969536|FG000|COMPLETED|Overall Study||6
9856610|NCT00906373|10969537|FG001|COMPLETED|Overall Study||33
9856611|NCT00906373|10969536|FG000|NOT COMPLETED|Overall Study||0
9856612|NCT00906373|10969537|FG001|NOT COMPLETED|Overall Study||8
9856613|NCT00906399|10969547|FG000|STARTED|Year 1||500
9856614|NCT00906399|10969548|FG001|STARTED|Year 1||501
9856615|NCT00906399|10969549|FG002|STARTED|Year 1||515
9856616|NCT00906399|10969550|FG003|STARTED|Year 1||0
9856617|NCT00906399|10969551|FG004|STARTED|Year 1||0
9856618|NCT00906399|10969552|FG005|STARTED|Year 1||0
9856619|NCT00906399|10969553|FG006|STARTED|Year 1||0
9856620|NCT00906399|10969547|FG000|Completed Year 1 Study Treatment|Year 1||456
9856621|NCT00906399|10969548|FG001|Completed Year 1 Study Treatment|Year 1||438
9856622|NCT00906399|10969549|FG002|Completed Year 1 Study Treatment|Year 1||438
9856623|NCT00906399|10969550|FG003|Completed Year 1 Study Treatment|Year 1||0
9856624|NCT00906399|10969551|FG004|Completed Year 1 Study Treatment|Year 1||0
9856625|NCT00906399|10969552|FG005|Completed Year 1 Study Treatment|Year 1||0
9856626|NCT00906399|10969553|FG006|Completed Year 1 Study Treatment|Year 1||0
9856627|NCT00906399|10969547|FG000|COMPLETED|Year 1||456
9856628|NCT00906399|10969548|FG001|COMPLETED|Year 1||438
9856629|NCT00906399|10969549|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
9856630|NCT00906399|10969550|FG003|COMPLETED|Year 1||0
9856631|NCT00906399|10969551|FG004|COMPLETED|Year 1||0
9856632|NCT00906399|10969552|FG005|COMPLETED|Year 1||0
9856633|NCT00906399|10969553|FG006|COMPLETED|Year 1||0
9856634|NCT00906399|10969547|FG000|NOT COMPLETED|Year 1||44
9856635|NCT00906399|10969548|FG001|NOT COMPLETED|Year 1||63
9856636|NCT00906399|10969549|FG002|NOT COMPLETED|Year 1||76
10201840|NCT03441984|11329282|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0
10201841|NCT03441984|11329283|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0
10201842|NCT03441984|11329284|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0
9856637|NCT00906399|10969550|FG003|NOT COMPLETED|Year 1||0
9856638|NCT00906399|10969551|FG004|NOT COMPLETED|Year 1||0
9856639|NCT00906399|10969552|FG005|NOT COMPLETED|Year 1||0
9856640|NCT00906399|10969553|FG006|NOT COMPLETED|Year 1||0
9856641|NCT00906399|10969547|FG000|STARTED|Year 2||0
9856642|NCT00906399|10969548|FG001|STARTED|Year 2||0
9856643|NCT00906399|10969549|FG002|STARTED|Year 2||0
9856644|NCT00906399|10969550|FG003|STARTED|Year 2||228
9856645|NCT00906399|10969551|FG004|STARTED|Year 2||228
9856646|NCT00906399|10969552|FG005|STARTED|Year 2||438
9856647|NCT00906399|10969553|FG006|STARTED|Year 2||438
9856648|NCT00906399|10969547|FG000|Completed Year 2 Study Treatment|Year 2||0
9856649|NCT00906399|10969548|FG001|Completed Year 2 Study Treatment|Year 2||0
9856650|NCT00906399|10969549|FG002|Completed Year 2 Study Treatment|Year 2||0
9856651|NCT00906399|10969550|FG003|Completed Year 2 Study Treatment|Year 2||200
9856652|NCT00906399|10969551|FG004|Completed Year 2 Study Treatment|Year 2||196
9856653|NCT00906399|10969552|FG005|Completed Year 2 Study Treatment|Year 2||391
9856654|NCT00906399|10969553|FG006|Completed Year 2 Study Treatment|Year 2||411
9856655|NCT00906399|10969547|FG000|COMPLETED|Year 2||0
9856656|NCT00906399|10969548|FG001|COMPLETED|Year 2||0
9856657|NCT00906399|10969549|FG002|COMPLETED|Year 2||0
9856658|NCT00906399|10969550|FG003|COMPLETED|Year 2||198
9856659|NCT00906399|10969551|FG004|COMPLETED|Year 2||193
9856660|NCT00906399|10969552|FG005|COMPLETED|Year 2||391
9856661|NCT00906399|10969553|FG006|COMPLETED|Year 2||409
9856662|NCT00906399|10969547|FG000|NOT COMPLETED|Year 2||0
9856663|NCT00906399|10969548|FG001|NOT COMPLETED|Year 2||0
9856664|NCT00906399|10969549|FG002|NOT COMPLETED|Year 2||0
9856665|NCT00906399|10969550|FG003|NOT COMPLETED|Year 2||30
9856666|NCT00906399|10969551|FG004|NOT COMPLETED|Year 2||35
9856667|NCT00906399|10969552|FG005|NOT COMPLETED|Year 2||47
9856668|NCT00906399|10969553|FG006|NOT COMPLETED|Year 2||29
9856669|NCT00906425|10969567|FG000|STARTED|Overall Study||73
9856670|NCT00906425|10969568|FG001|STARTED|Overall Study||72
9856671|NCT00906425|10969567|FG000|6 Months|Overall Study|ITT population|69
9856672|NCT00906425|10969568|FG001|6 Months|Overall Study|ITT population|64
9856673|NCT00906425|10969567|FG000|1 Year|Overall Study|ITT population|67
9856674|NCT00906425|10969568|FG001|1 Year|Overall Study|ITT population|60
9856675|NCT00906425|10969567|FG000|2 Year|Overall Study|ITT population|62
9856676|NCT00906425|10969568|FG001|2 Year|Overall Study|ITT population|58
9856677|NCT00906425|10969567|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
9856678|NCT00906425|10969568|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
9856679|NCT00906425|10969567|FG000|NOT COMPLETED|Overall Study||73
9856680|NCT00906425|10969568|FG001|NOT COMPLETED|Overall Study||72
9856681|NCT00906503|10969574|FG000|STARTED|Overall Study||9
9856682|NCT00906503|10969574|FG000|COMPLETED|Overall Study||9
9856683|NCT00906503|10969574|FG000|NOT COMPLETED|Overall Study||0
9856684|NCT00906698|10969584|FG000|STARTED|Overall Study||3
9856685|NCT00906698|10969585|FG001|STARTED|Overall Study||19
9856686|NCT00906698|10969586|FG002|STARTED|Overall Study||6
9856687|NCT00906698|10969587|FG003|STARTED|Overall Study||4
9856688|NCT00906698|10969588|FG004|STARTED|Overall Study||18
9856689|NCT00906698|10969589|FG005|STARTED|Overall Study||5
9856690|NCT00906698|10969584|FG000|COMPLETED|Overall Study||0
9856691|NCT00906698|10969585|FG001|COMPLETED|Overall Study||0
9856692|NCT00906698|10969586|FG002|COMPLETED|Overall Study||0
9856693|NCT00906698|10969587|FG003|COMPLETED|Overall Study||0
9856694|NCT00906698|10969588|FG004|COMPLETED|Overall Study||0
9856695|NCT00906698|10969589|FG005|COMPLETED|Overall Study||0
9856696|NCT00906698|10969584|FG000|NOT COMPLETED|Overall Study||3
9856697|NCT00906698|10969585|FG001|NOT COMPLETED|Overall Study||19
9856698|NCT00906698|10969586|FG002|NOT COMPLETED|Overall Study||6
9856699|NCT00906698|10969587|FG003|NOT COMPLETED|Overall Study||4
9856700|NCT00906698|10969588|FG004|NOT COMPLETED|Overall Study||18
9856701|NCT00906698|10969589|FG005|NOT COMPLETED|Overall Study||5
9856702|NCT00906776|10969623|FG000|STARTED|Overall Study||11
9856703|NCT00906776|10969624|FG001|STARTED|Overall Study||8
10201843|NCT03441984|11329285|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0
9856704|NCT00906776|10969623|FG000|COMPLETED|Overall Study||11
9856705|NCT00906776|10969624|FG001|COMPLETED|Overall Study||8
9856706|NCT00906776|10969623|FG000|NOT COMPLETED|Overall Study||0
9856707|NCT00906776|10969624|FG001|NOT COMPLETED|Overall Study||0
9856708|NCT00906789|10969630|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
9856709|NCT00906789|10969630|FG000|COMPLETED|Overall Study||15
9856710|NCT00906789|10969630|FG000|NOT COMPLETED|Overall Study||0
9856711|NCT00906945|10969641|FG000|STARTED|Overall Study||3
9856712|NCT00906945|10969642|FG001|STARTED|Overall Study||3
9856713|NCT00906945|10969643|FG002|STARTED|Overall Study||3
9856714|NCT00906945|10969644|FG003|STARTED|Overall Study||7
9856715|NCT00906945|10969645|FG004|STARTED|Overall Study||7
9856716|NCT00906945|10969646|FG005|STARTED|Overall Study||16
9856717|NCT00906945|10969641|FG000|COMPLETED|Overall Study||3
9856718|NCT00906945|10969642|FG001|COMPLETED|Overall Study||3
9856719|NCT00906945|10969643|FG002|COMPLETED|Overall Study||3
9856720|NCT00906945|10969644|FG003|COMPLETED|Overall Study||6
9856721|NCT00906945|10969645|FG004|COMPLETED|Overall Study||6
9856722|NCT00906945|10969646|FG005|COMPLETED|Overall Study||14
9856723|NCT00906945|10969641|FG000|NOT COMPLETED|Overall Study||0
9856724|NCT00906945|10969642|FG001|NOT COMPLETED|Overall Study||0
9856725|NCT00906945|10969643|FG002|NOT COMPLETED|Overall Study||0
9856726|NCT00906945|10969644|FG003|NOT COMPLETED|Overall Study||1
9856727|NCT00906945|10969645|FG004|NOT COMPLETED|Overall Study||1
9856728|NCT00906945|10969646|FG005|NOT COMPLETED|Overall Study||2
9856729|NCT00906958|10969662|FG000|STARTED|Overall Study||10
9856730|NCT00906958|10969663|FG001|STARTED|Overall Study||10
9856731|NCT00906958|10969662|FG000|COMPLETED|Overall Study||10
9856732|NCT00906958|10969663|FG001|COMPLETED|Overall Study||10
9856733|NCT00906958|10969662|FG000|NOT COMPLETED|Overall Study||0
9856734|NCT00906958|10969663|FG001|NOT COMPLETED|Overall Study||0
9856735|NCT00906971|10969673|FG000|STARTED|Overall Study||36
9856736|NCT00906971|10969674|FG001|STARTED|Overall Study||36
9856737|NCT00906971|10969673|FG000|COMPLETED|Overall Study||28
9856738|NCT00906971|10969674|FG001|COMPLETED|Overall Study||33
9856739|NCT00906971|10969673|FG000|NOT COMPLETED|Overall Study||8
9856740|NCT00906971|10969674|FG001|NOT COMPLETED|Overall Study||3
9856741|NCT00907088|10969682|FG000|STARTED|Overall Study||122
9856742|NCT00907088|10969683|FG001|STARTED|Overall Study||129
9856743|NCT00907088|10969682|FG000|COMPLETED|Overall Study||102
9856744|NCT00907088|10969683|FG001|COMPLETED|Overall Study||99
9856745|NCT00907088|10969682|FG000|NOT COMPLETED|Overall Study||20
9856746|NCT00907088|10969683|FG001|NOT COMPLETED|Overall Study||30
9856747|NCT00907101|10969689|FG000|STARTED|Overall Study||30
9856748|NCT00907101|10969689|FG000|COMPLETED|Overall Study||30
9856749|NCT00907101|10969689|FG000|NOT COMPLETED|Overall Study||0
9856750|NCT00907153|10969695|FG000|STARTED|Overall Study||13
9856751|NCT00907153|10969696|FG001|STARTED|Overall Study||15
9856752|NCT00907153|10969695|FG000|COMPLETED|Overall Study||11
9856753|NCT00907153|10969696|FG001|COMPLETED|Overall Study||11
9856754|NCT00907153|10969695|FG000|NOT COMPLETED|Overall Study||2
9856755|NCT00907153|10969696|FG001|NOT COMPLETED|Overall Study||4
9856756|NCT00907257|10969704|FG000|STARTED|Overall Study||123
9856757|NCT00907257|10969705|FG001|STARTED|Overall Study||124
9856758|NCT00907257|10969704|FG000|COMPLETED|Overall Study||110
9856759|NCT00907257|10969705|FG001|COMPLETED|Overall Study||112
9856760|NCT00907257|10969704|FG000|NOT COMPLETED|Overall Study||13
9856761|NCT00907257|10969705|FG001|NOT COMPLETED|Overall Study||12
9856762|NCT00907296|10969721|FG000|STARTED|Overall Study||103
9856763|NCT00907296|10969722|FG001|STARTED|Overall Study||34
9856764|NCT00907296|10969723|FG002|STARTED|Overall Study||34
9856765|NCT00907296|10969724|FG003|STARTED|Overall Study||33
9856766|NCT00907296|10969725|FG004|STARTED|Overall Study||33
9856767|NCT00907296|10969726|FG005|STARTED|Overall Study||33
9856768|NCT00907296|10969727|FG006|STARTED|Overall Study||33
9856769|NCT00907296|10969728|FG007|STARTED|Overall Study||33
9856770|NCT00907296|10969729|FG008|STARTED|Overall Study||31
9856771|NCT00907296|10969730|FG009|STARTED|Overall Study||35
9856772|NCT00907296|10969721|FG000|Received Treatment|Overall Study||100
9856773|NCT00907296|10969722|FG001|Received Treatment|Overall Study||34
9856774|NCT00907296|10969723|FG002|Received Treatment|Overall Study||34
9856775|NCT00907296|10969724|FG003|Received Treatment|Overall Study||32
9856776|NCT00907296|10969725|FG004|Received Treatment|Overall Study||33
9856777|NCT00907296|10969726|FG005|Received Treatment|Overall Study||32
9856778|NCT00907296|10969727|FG006|Received Treatment|Overall Study||31
9856779|NCT00907296|10969728|FG007|Received Treatment|Overall Study||32
9856780|NCT00907296|10969729|FG008|Received Treatment|Overall Study||30
9856781|NCT00907296|10969730|FG009|Received Treatment|Overall Study||35
9856782|NCT00907296|10969721|FG000|COMPLETED|Overall Study||83
9856783|NCT00907296|10969722|FG001|COMPLETED|Overall Study||29
9856784|NCT00907296|10969723|FG002|COMPLETED|Overall Study||32
9856785|NCT00907296|10969724|FG003|COMPLETED|Overall Study||29
9856786|NCT00907296|10969725|FG004|COMPLETED|Overall Study||32
9856787|NCT00907296|10969726|FG005|COMPLETED|Overall Study||24
9856788|NCT00907296|10969727|FG006|COMPLETED|Overall Study||27
9856789|NCT00907296|10969728|FG007|COMPLETED|Overall Study||26
9856790|NCT00907296|10969729|FG008|COMPLETED|Overall Study||27
9856791|NCT00907296|10969730|FG009|COMPLETED|Overall Study||28
9856792|NCT00907296|10969721|FG000|NOT COMPLETED|Overall Study||20
9856793|NCT00907296|10969722|FG001|NOT COMPLETED|Overall Study||5
9856794|NCT00907296|10969723|FG002|NOT COMPLETED|Overall Study||2
9856795|NCT00907296|10969724|FG003|NOT COMPLETED|Overall Study||4
9856796|NCT00907296|10969725|FG004|NOT COMPLETED|Overall Study||1
9856797|NCT00907296|10969726|FG005|NOT COMPLETED|Overall Study||9
9856798|NCT00907296|10969727|FG006|NOT COMPLETED|Overall Study||6
9856799|NCT00907296|10969728|FG007|NOT COMPLETED|Overall Study||7
9856800|NCT00907296|10969729|FG008|NOT COMPLETED|Overall Study||4
9856801|NCT00907296|10969730|FG009|NOT COMPLETED|Overall Study||7
9856802|NCT00907335|10969754|FG000|STARTED|Overall Study||55
9856803|NCT00907335|10969755|FG001|STARTED|Overall Study||55
9856804|NCT00907335|10969754|FG000|COMPLETED|Overall Study||47
9856805|NCT00907335|10969755|FG001|COMPLETED|Overall Study||54
9856806|NCT00907335|10969754|FG000|NOT COMPLETED|Overall Study||8
9856807|NCT00907335|10969755|FG001|NOT COMPLETED|Overall Study||1
9856808|NCT00907374|10969763|FG000|STARTED|Overall Study||14
9856809|NCT00907374|10969764|FG001|STARTED|Overall Study||13
9856810|NCT00907374|10969763|FG000|COMPLETED|Overall Study||12
9856811|NCT00907374|10969764|FG001|COMPLETED|Overall Study||11
9856812|NCT00907374|10969763|FG000|NOT COMPLETED|Overall Study||2
9856813|NCT00907374|10969764|FG001|NOT COMPLETED|Overall Study||2
9856814|NCT00907426|10969773|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215
9856815|NCT00907426|10969774|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60
9856816|NCT00907426|10969775|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93
9856817|NCT00907426|10969773|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
9856818|NCT00907426|10969774|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
9856819|NCT00907426|10969775|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
9856820|NCT00907426|10969773|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
9856821|NCT00907426|10969774|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
9856822|NCT00907426|10969775|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
9856823|NCT00907426|10969773|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195
9856824|NCT00907426|10969774|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55
9856825|NCT00907426|10969775|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84
9856826|NCT00907426|10969773|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
9856827|NCT00907426|10969774|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
9856828|NCT00907426|10969775|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
9856829|NCT00907426|10969773|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
9856830|NCT00907426|10969774|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
9856831|NCT00907426|10969775|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
9856832|NCT00907478|10969785|FG000|STARTED|Overall Study||50
9856833|NCT00907478|10969786|FG001|STARTED|Overall Study||50
9856834|NCT00907478|10969787|FG002|STARTED|Overall Study||69
9856835|NCT00907478|10969785|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
9856836|NCT00907478|10969786|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
9856837|NCT00907478|10969787|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
9856838|NCT00907478|10969785|FG000|NOT COMPLETED|Overall Study||27
9856839|NCT00907478|10969786|FG001|NOT COMPLETED|Overall Study||17
9856840|NCT00907478|10969787|FG002|NOT COMPLETED|Overall Study||22
9856841|NCT00907517|10969802|FG000|STARTED|Overall Study||3
9856842|NCT00907517|10969803|FG001|STARTED|Overall Study||3
9856843|NCT00907517|10969804|FG002|STARTED|Overall Study||6
9856844|NCT00907517|10969805|FG003|STARTED|Overall Study||6
9856845|NCT00907517|10969806|FG004|STARTED|Overall Study||6
9856846|NCT00907517|10969802|FG000|COMPLETED|Overall Study||0
9856847|NCT00907517|10969803|FG001|COMPLETED|Overall Study||0
9856848|NCT00907517|10969804|FG002|COMPLETED|Overall Study||2
9856849|NCT00907517|10969805|FG003|COMPLETED|Overall Study||2
9856850|NCT00907517|10969806|FG004|COMPLETED|Overall Study||1
9856851|NCT00907517|10969802|FG000|NOT COMPLETED|Overall Study||3
9856852|NCT00907517|10969803|FG001|NOT COMPLETED|Overall Study||3
9856853|NCT00907517|10969804|FG002|NOT COMPLETED|Overall Study||4
9856854|NCT00907517|10969805|FG003|NOT COMPLETED|Overall Study||4
9856855|NCT00907517|10969806|FG004|NOT COMPLETED|Overall Study||5
9856856|NCT00907621|10969820|FG000|STARTED|Overall Study||45
9856857|NCT00907621|10969821|FG001|STARTED|Overall Study||45
9856858|NCT00907621|10969820|FG000|COMPLETED|Overall Study||38
9856859|NCT00907621|10969821|FG001|COMPLETED|Overall Study||41
9856860|NCT00907621|10969820|FG000|NOT COMPLETED|Overall Study||7
9856861|NCT00907621|10969821|FG001|NOT COMPLETED|Overall Study||4
9856862|NCT00907738|10969832|FG000|STARTED|Overall Study||13
9856863|NCT00907738|10969833|FG001|STARTED|Overall Study||1
9856864|NCT00907738|10969834|FG002|STARTED|Overall Study||7
9856865|NCT00907738|10969835|FG003|STARTED|Overall Study||4
9856866|NCT00907738|10969836|FG004|STARTED|Overall Study||2
9856867|NCT00907738|10969832|FG000|COMPLETED|Overall Study||0
9856868|NCT00907738|10969833|FG001|COMPLETED|Overall Study||0
9856869|NCT00907738|10969834|FG002|COMPLETED|Overall Study||0
9856870|NCT00907738|10969835|FG003|COMPLETED|Overall Study||0
9856871|NCT00907738|10969836|FG004|COMPLETED|Overall Study||0
9856872|NCT00907738|10969832|FG000|NOT COMPLETED|Overall Study||13
9856873|NCT00907738|10969833|FG001|NOT COMPLETED|Overall Study||1
9856874|NCT00907738|10969834|FG002|NOT COMPLETED|Overall Study||7
9856875|NCT00907738|10969835|FG003|NOT COMPLETED|Overall Study||4
9856876|NCT00907738|10969836|FG004|NOT COMPLETED|Overall Study||2
9856877|NCT00907777|10969854|FG000|STARTED|Overall Study||25
9856878|NCT00907777|10969855|FG001|STARTED|Overall Study||27
9856879|NCT00907777|10969854|FG000|COMPLETED|Overall Study||25
9856880|NCT00907777|10969855|FG001|COMPLETED|Overall Study||26
9856881|NCT00907777|10969854|FG000|NOT COMPLETED|Overall Study||0
9856882|NCT00907777|10969855|FG001|NOT COMPLETED|Overall Study||1
9856883|NCT00907803|10969864|FG000|STARTED|Overall Study||45
9856884|NCT00907803|10969865|FG001|STARTED|Overall Study||46
9856885|NCT00907803|10969866|FG002|STARTED|Overall Study||16
9856886|NCT00907803|10969864|FG000|COMPLETED|Overall Study||42
9856887|NCT00907803|10969865|FG001|COMPLETED|Overall Study||43
9856888|NCT00907803|10969866|FG002|COMPLETED|Overall Study||16
9856889|NCT00907803|10969864|FG000|NOT COMPLETED|Overall Study||3
9856890|NCT00907803|10969865|FG001|NOT COMPLETED|Overall Study||3
9856891|NCT00907803|10969866|FG002|NOT COMPLETED|Overall Study||0
9856892|NCT00907881|10969874|FG000|STARTED|Overall Study||1069
9856893|NCT00907881|10969874|FG000|COMPLETED|Overall Study||984
9856894|NCT00907881|10969874|FG000|NOT COMPLETED|Overall Study||85
9856895|NCT00908011|10969880|FG000|STARTED|Overall Study||23
9856896|NCT00908011|10969881|FG001|STARTED|Overall Study||20
9856897|NCT00908011|10969880|FG000|COMPLETED|Overall Study||21
9856898|NCT00908011|10969881|FG001|COMPLETED|Overall Study||18
9856899|NCT00908011|10969880|FG000|NOT COMPLETED|Overall Study||2
9856900|NCT00908011|10969881|FG001|NOT COMPLETED|Overall Study||2
9856901|NCT00908037|10969894|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5
9856902|NCT00908037|10969895|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5
9856903|NCT00908037|10969896|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5
9856904|NCT00908037|10969897|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856905|NCT00908037|10969898|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856906|NCT00908037|10969899|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856907|NCT00908037|10969900|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856908|NCT00908037|10969901|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856909|NCT00908037|10969902|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856910|NCT00908037|10969903|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856911|NCT00908037|10969904|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856912|NCT00908037|10969905|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0
9856913|NCT00908037|10969894|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
9856914|NCT00908037|10969895|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
9856915|NCT00908037|10969896|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
9856916|NCT00908037|10969897|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856917|NCT00908037|10969898|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856918|NCT00908037|10969899|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856919|NCT00908037|10969900|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856920|NCT00908037|10969901|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856921|NCT00908037|10969902|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856922|NCT00908037|10969903|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856923|NCT00908037|10969904|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856924|NCT00908037|10969905|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856925|NCT00908037|10969894|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856926|NCT00908037|10969895|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856927|NCT00908037|10969896|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856928|NCT00908037|10969897|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856929|NCT00908037|10969898|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856930|NCT00908037|10969899|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856931|NCT00908037|10969900|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856932|NCT00908037|10969901|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856933|NCT00908037|10969902|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856934|NCT00908037|10969903|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856935|NCT00908037|10969904|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856936|NCT00908037|10969905|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
9856937|NCT00908037|10969894|FG000|STARTED|Part 2 (7 Week Randomized Period)||0
9856938|NCT00908037|10969895|FG001|STARTED|Part 2 (7 Week Randomized Period)||0
9856939|NCT00908037|10969896|FG002|STARTED|Part 2 (7 Week Randomized Period)||0
9856940|NCT00908037|10969897|FG003|STARTED|Part 2 (7 Week Randomized Period)||8
9856941|NCT00908037|10969898|FG004|STARTED|Part 2 (7 Week Randomized Period)||16
9856942|NCT00908037|10969899|FG005|STARTED|Part 2 (7 Week Randomized Period)||9
9856943|NCT00908037|10969900|FG006|STARTED|Part 2 (7 Week Randomized Period)||19
9856944|NCT00908037|10969901|FG007|STARTED|Part 2 (7 Week Randomized Period)||5
9856945|NCT00908037|10969902|FG008|STARTED|Part 2 (7 Week Randomized Period)||10
9856946|NCT00908037|10969903|FG009|STARTED|Part 2 (7 Week Randomized Period)||0
9856947|NCT00908037|10969904|FG010|STARTED|Part 2 (7 Week Randomized Period)||0
9856948|NCT00908037|10969905|FG011|STARTED|Part 2 (7 Week Randomized Period)||0
9856949|NCT00908037|10969894|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0
9856950|NCT00908037|10969895|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0
9856951|NCT00908037|10969896|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0
9856952|NCT00908037|10969897|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7
9856953|NCT00908037|10969898|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13
9856954|NCT00908037|10969899|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9
9856955|NCT00908037|10969900|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15
9856956|NCT00908037|10969901|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5
9856957|NCT00908037|10969902|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5
9856958|NCT00908037|10969903|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0
9856959|NCT00908037|10969904|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0
9856960|NCT00908037|10969905|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0
9856961|NCT00908037|10969894|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
9856962|NCT00908037|10969895|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
9856963|NCT00908037|10969896|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
9856964|NCT00908037|10969897|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
9856965|NCT00908037|10969898|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
9856966|NCT00908037|10969899|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
9856967|NCT00908037|10969900|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
9856968|NCT00908037|10969901|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
9856969|NCT00908037|10969902|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
9856970|NCT00908037|10969903|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
9856971|NCT00908037|10969904|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
9856972|NCT00908037|10969905|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10201844|NCT03441984|11329286|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0
10201845|NCT03441984|11329287|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0
10201846|NCT03441984|11329276|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10201847|NCT03441984|11329277|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10201848|NCT03441984|11329278|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10201849|NCT03441984|11329279|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
9856973|NCT00908037|10969894|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856974|NCT00908037|10969895|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856975|NCT00908037|10969896|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856976|NCT00908037|10969897|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856977|NCT00908037|10969898|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856978|NCT00908037|10969899|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856979|NCT00908037|10969900|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856980|NCT00908037|10969901|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856981|NCT00908037|10969902|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
9856982|NCT00908037|10969903|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
9856983|NCT00908037|10969904|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
9856984|NCT00908037|10969905|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
9856985|NCT00908037|10969894|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856986|NCT00908037|10969895|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856987|NCT00908037|10969896|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856988|NCT00908037|10969897|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856989|NCT00908037|10969898|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856990|NCT00908037|10969899|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856991|NCT00908037|10969900|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856992|NCT00908037|10969901|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856993|NCT00908037|10969902|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856994|NCT00908037|10969903|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
9856995|NCT00908037|10969904|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
9856996|NCT00908037|10969905|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
9856997|NCT00908037|10969894|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856998|NCT00908037|10969895|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9856999|NCT00908037|10969896|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9857000|NCT00908037|10969897|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9857001|NCT00908037|10969898|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9857002|NCT00908037|10969899|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9857003|NCT00908037|10969900|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9857004|NCT00908037|10969901|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9857005|NCT00908037|10969902|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9857006|NCT00908037|10969903|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
9857007|NCT00908037|10969904|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
9857008|NCT00908037|10969905|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
9857009|NCT00908076|10969959|FG000|STARTED|Overall Study||27
9857010|NCT00908076|10969960|FG001|STARTED|Overall Study||27
9857011|NCT00908076|10969959|FG000|COMPLETED|Overall Study||26
9857012|NCT00908076|10969960|FG001|COMPLETED|Overall Study||26
9857013|NCT00908076|10969959|FG000|NOT COMPLETED|Overall Study||1
9857014|NCT00908076|10969960|FG001|NOT COMPLETED|Overall Study||1
9857015|NCT00908115|10969966|FG000|STARTED|Overall Study||1258
9857016|NCT00908115|10969966|FG000|COMPLETED|Overall Study||1244
9857017|NCT00908115|10969966|FG000|NOT COMPLETED|Overall Study||14
9857018|NCT00908141|10969972|FG000|STARTED|Overall Study||8
9857019|NCT00908141|10969973|FG001|STARTED|Overall Study||9
9857020|NCT00908141|10969972|FG000|COMPLETED|Overall Study||8
9857021|NCT00908141|10969973|FG001|COMPLETED|Overall Study||8
9857022|NCT00908141|10969972|FG000|NOT COMPLETED|Overall Study||0
9857023|NCT00908141|10969973|FG001|NOT COMPLETED|Overall Study||1
9857024|NCT00908232|10969979|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
9857025|NCT00908232|10969980|FG001|STARTED|Cycle 1 to 4||0
9857026|NCT00908232|10969981|FG002|STARTED|Cycle 1 to 4||0
9857027|NCT00908232|10969982|FG003|STARTED|Cycle 1 to 4||0
9857028|NCT00908232|10969979|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
9857029|NCT00908232|10969980|FG001|COMPLETED|Cycle 1 to 4||0
9857030|NCT00908232|10969981|FG002|COMPLETED|Cycle 1 to 4||0
9857031|NCT00908232|10969982|FG003|COMPLETED|Cycle 1 to 4||0
10201850|NCT03441984|11329280|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10201851|NCT03441984|11329281|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10201852|NCT03441984|11329282|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9857032|NCT00908232|10969979|FG000|NOT COMPLETED|Cycle 1 to 4||28
9857033|NCT00908232|10969980|FG001|NOT COMPLETED|Cycle 1 to 4||0
9857034|NCT00908232|10969981|FG002|NOT COMPLETED|Cycle 1 to 4||0
9857035|NCT00908232|10969982|FG003|NOT COMPLETED|Cycle 1 to 4||0
9857036|NCT00908232|10969979|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
9857037|NCT00908232|10969980|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7
9857038|NCT00908232|10969981|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8
9857039|NCT00908232|10969982|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4
9857040|NCT00908232|10969979|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
9857041|NCT00908232|10969980|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
9857042|NCT00908232|10969981|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
9857043|NCT00908232|10969982|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
9857044|NCT00908232|10969979|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
9857045|NCT00908232|10969980|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
9857046|NCT00908232|10969981|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
9857047|NCT00908232|10969982|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
9857048|NCT00908310|10969988|FG000|STARTED|Overall Study||213
9857049|NCT00908310|10969988|FG000|COMPLETED|Overall Study||153
9857050|NCT00908310|10969988|FG000|NOT COMPLETED|Overall Study||60
9857051|NCT00908349|10969992|FG000|STARTED|Overall Study||214
9857052|NCT00908349|10969992|FG000|COMPLETED|Overall Study||179
9857053|NCT00908349|10969992|FG000|NOT COMPLETED|Overall Study||35
9857054|NCT00908375|10969998|FG000|STARTED|Overall Study||20
9857055|NCT00908375|10969999|FG001|STARTED|Overall Study||19
9857056|NCT00908375|10969998|FG000|COMPLETED|Overall Study||10
9857057|NCT00908375|10969999|FG001|COMPLETED|Overall Study||9
9857058|NCT00908375|10969998|FG000|NOT COMPLETED|Overall Study||10
9857059|NCT00908375|10969999|FG001|NOT COMPLETED|Overall Study||10
9857060|NCT00908388|10970005|FG000|STARTED|Overall Study||50
9857061|NCT00908388|10970005|FG000|COMPLETED|Overall Study||40
9857062|NCT00908388|10970005|FG000|NOT COMPLETED|Overall Study||10
9857063|NCT00908466|10970011|FG000|STARTED|Overall Study||15
9857064|NCT00908466|10970012|FG001|STARTED|Overall Study||15
9857065|NCT00908466|10970011|FG000|COMPLETED|Overall Study||14
9857066|NCT00908466|10970012|FG001|COMPLETED|Overall Study||14
9857067|NCT00908466|10970011|FG000|NOT COMPLETED|Overall Study||1
9857068|NCT00908466|10970012|FG001|NOT COMPLETED|Overall Study||1
9953120|NCT01425281|11071954|FG000|STARTED|At 4-year Clinical Follow-up||318
9953121|NCT01425281|11071955|FG001|STARTED|At 4-year Clinical Follow-up||157
9953122|NCT01425281|11071954|FG000|COMPLETED|At 4-year Clinical Follow-up||288
9953123|NCT01425281|11071955|FG001|COMPLETED|At 4-year Clinical Follow-up||136
9953124|NCT01425281|11071954|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30
9953125|NCT01425281|11071955|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21
9953126|NCT01425281|11071954|FG000|STARTED|At 5-year Clinical Follow-up||288
9953127|NCT01425281|11071955|FG001|STARTED|At 5-year Clinical Follow-up||136
9953128|NCT01425281|11071954|FG000|COMPLETED|At 5-year Clinical Follow-up||256
9953129|NCT01425281|11071955|FG001|COMPLETED|At 5-year Clinical Follow-up||125
9953130|NCT01425281|11071954|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32
9953131|NCT01425281|11071955|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11
9953132|NCT01425632|11071965|FG000|STARTED|Overall Study||161
9953133|NCT01425632|11071966|FG001|STARTED|Overall Study||166
9953134|NCT01425632|11071967|FG002|STARTED|Overall Study||163
9953135|NCT01425632|11071965|FG000|COMPLETED|Overall Study||160
9953136|NCT01425632|11071966|FG001|COMPLETED|Overall Study||165
9953137|NCT01425632|11071967|FG002|COMPLETED|Overall Study||159
9953138|NCT01425632|11071965|FG000|NOT COMPLETED|Overall Study||1
9953139|NCT01425632|11071966|FG001|NOT COMPLETED|Overall Study||1
9953140|NCT01425632|11071967|FG002|NOT COMPLETED|Overall Study||4
9953141|NCT01425723|11071977|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
9953142|NCT01425723|11071978|FG001|STARTED|Overall Study||93
9953143|NCT01425723|11071977|FG000|Weekly Prophylaxis|Overall Study||23
9953144|NCT01425723|11071978|FG001|Weekly Prophylaxis|Overall Study||51
9953145|NCT01425723|11071977|FG000|Individualized Prophylaxis|Overall Study||5
9953146|NCT01425723|11071978|FG001|Individualized Prophylaxis|Overall Study||31
9953147|NCT01425723|11071977|FG000|Personalized Prophylaxis|Overall Study||2
9953148|NCT01425723|11071978|FG001|Personalized Prophylaxis|Overall Study||17
9953149|NCT01425723|11071977|FG000|Episodic|Overall Study||0
9953150|NCT01425723|11071978|FG001|Episodic|Overall Study||15
9953151|NCT01425723|11071977|FG000|Surgery Subgroup|Overall Study||1
9953152|NCT01425723|11071978|FG001|Surgery Subgroup|Overall Study||15
9953153|NCT01425723|11071977|FG000|COMPLETED|Overall Study||23
9953154|NCT01425723|11071978|FG001|COMPLETED|Overall Study||75
9953155|NCT01425723|11071977|FG000|NOT COMPLETED|Overall Study||4
9953156|NCT01425723|11071978|FG001|NOT COMPLETED|Overall Study||18
9953157|NCT01425749|11071995|FG000|STARTED|Overall Study||13
9953158|NCT01425749|11071996|FG001|STARTED|Overall Study||12
9953159|NCT01425749|11071995|FG000|COMPLETED|Overall Study||13
9953160|NCT01425749|11071996|FG001|COMPLETED|Overall Study||11
9953161|NCT01425749|11071995|FG000|NOT COMPLETED|Overall Study||0
9953162|NCT01425749|11071996|FG001|NOT COMPLETED|Overall Study||1
9953163|NCT01425801|11072005|FG000|STARTED|Period 1||9
9953164|NCT01425801|11072006|FG001|STARTED|Period 1||9
9953165|NCT01425801|11072007|FG002|STARTED|Period 1||9
9953166|NCT01425801|11072008|FG003|STARTED|Period 1||12
9953167|NCT01425801|11072009|FG004|STARTED|Period 1||13
9953168|NCT01425801|11072010|FG005|STARTED|Period 1||10
9953169|NCT01425801|11072005|FG000|COMPLETED|Period 1||9
9953170|NCT01425801|11072006|FG001|COMPLETED|Period 1||9
9953171|NCT01425801|11072007|FG002|COMPLETED|Period 1||9
9953172|NCT01425801|11072008|FG003|COMPLETED|Period 1||12
9953173|NCT01425801|11072009|FG004|COMPLETED|Period 1||12
9857069|NCT00908544|10970020|FG000|STARTED|Overall Study||20
9857070|NCT00908544|10970021|FG001|STARTED|Overall Study||22
9857071|NCT00908544|10970020|FG000|COMPLETED|Overall Study||15
9857072|NCT00908544|10970021|FG001|COMPLETED|Overall Study||16
9857073|NCT00908544|10970020|FG000|NOT COMPLETED|Overall Study||5
9857074|NCT00908544|10970021|FG001|NOT COMPLETED|Overall Study||6
9857075|NCT00908583|10970027|FG000|STARTED|Phase 1||20
9857076|NCT00908583|10970027|FG000|COMPLETED|Phase 1||15
9857077|NCT00908583|10970027|FG000|NOT COMPLETED|Phase 1||5
9857078|NCT00908583|10970027|FG000|STARTED|Phase 2||12
9857079|NCT00908583|10970027|FG000|COMPLETED|Phase 2||10
9857080|NCT00908583|10970027|FG000|NOT COMPLETED|Phase 2||2
9857081|NCT00908583|10970027|FG000|STARTED|Phase 3||10
9857082|NCT00908583|10970027|FG000|COMPLETED|Phase 3||8
9857083|NCT00908583|10970027|FG000|NOT COMPLETED|Phase 3||2
9857084|NCT00908583|10970027|FG000|STARTED|Phase 4||5
9857085|NCT00908583|10970027|FG000|COMPLETED|Phase 4||3
9857086|NCT00908583|10970027|FG000|NOT COMPLETED|Phase 4||2
9857087|NCT00908583|10970027|FG000|STARTED|Phase 5||5
9857088|NCT00908583|10970027|FG000|COMPLETED|Phase 5||2
9857089|NCT00908583|10970027|FG000|NOT COMPLETED|Phase 5||3
9857090|NCT00908596|10970049|FG000|STARTED|Overall Study||47
9857091|NCT00908596|10970050|FG001|STARTED|Overall Study||32
9857092|NCT00908596|10970051|FG002|STARTED|Overall Study||193
9857093|NCT00908596|10970052|FG003|STARTED|Overall Study||85
9857094|NCT00908596|10970049|FG000|COMPLETED|Overall Study||0
9857095|NCT00908596|10970050|FG001|COMPLETED|Overall Study||19
9857096|NCT00908596|10970051|FG002|COMPLETED|Overall Study||119
9857097|NCT00908596|10970052|FG003|COMPLETED|Overall Study||48
9857098|NCT00908596|10970049|FG000|NOT COMPLETED|Overall Study||47
9857099|NCT00908596|10970050|FG001|NOT COMPLETED|Overall Study||13
9857100|NCT00908596|10970051|FG002|NOT COMPLETED|Overall Study||74
9857101|NCT00908596|10970052|FG003|NOT COMPLETED|Overall Study||37
9857102|NCT00908791|10970062|FG000|STARTED|Overall Study||24
9857103|NCT00908791|10970062|FG000|COMPLETED|Overall Study||24
9857104|NCT00908791|10970062|FG000|NOT COMPLETED|Overall Study||0
9857105|NCT00908830|10970077|FG000|STARTED|Overall Study||5
9857106|NCT00908830|10970078|FG001|STARTED|Overall Study||5
9857107|NCT00908830|10970077|FG000|COMPLETED|Overall Study||5
9857108|NCT00908830|10970078|FG001|COMPLETED|Overall Study||5
9857109|NCT00908830|10970077|FG000|NOT COMPLETED|Overall Study||0
9857110|NCT00908830|10970078|FG001|NOT COMPLETED|Overall Study||0
9857111|NCT00908882|10970086|FG000|STARTED|Overall Study||89
9857112|NCT00908882|10970087|FG001|STARTED|Overall Study||89
9857113|NCT00908882|10970086|FG000|COMPLETED|Overall Study||61
9857114|NCT00908882|10970087|FG001|COMPLETED|Overall Study||59
9857115|NCT00908882|10970086|FG000|NOT COMPLETED|Overall Study||28
9857116|NCT00908882|10970087|FG001|NOT COMPLETED|Overall Study||30
9857117|NCT00908895|10970095|FG000|STARTED|Overall Study||57
9857118|NCT00908895|10970096|FG001|STARTED|Overall Study||63
9857119|NCT00908895|10970095|FG000|COMPLETED|Overall Study||53
9857120|NCT00908895|10970096|FG001|COMPLETED|Overall Study||57
9857121|NCT00908895|10970095|FG000|NOT COMPLETED|Overall Study||4
9857122|NCT00908895|10970096|FG001|NOT COMPLETED|Overall Study||6
9857123|NCT00908908|10970102|FG000|STARTED|Overall Study||6
9857124|NCT00908908|10970102|FG000|Adverse Event|Overall Study||0
9857125|NCT00908908|10970102|FG000|Withdrawl by Subject|Overall Study||0
9857126|NCT00908908|10970102|FG000|Administrative/Other|Overall Study||0
9857127|NCT00908908|10970102|FG000|Physician Decision|Overall Study||0
9857128|NCT00908908|10970102|FG000|COMPLETED|Overall Study||6
9857129|NCT00908908|10970102|FG000|NOT COMPLETED|Overall Study||0
9857130|NCT00908947|10970106|FG000|STARTED|Overall Study||173
9857131|NCT00908947|10970106|FG000|COMPLETED|Overall Study||83
9857132|NCT00908947|10970106|FG000|NOT COMPLETED|Overall Study||90
9857133|NCT00908960|10970114|FG000|STARTED|Overall Study||24
9857134|NCT00908960|10970115|FG001|STARTED|Overall Study||12
9857135|NCT00908960|10970116|FG002|STARTED|Overall Study||34
9857136|NCT00908960|10970114|FG000|Evaluable|Overall Study||23
9857137|NCT00908960|10970115|FG001|Evaluable|Overall Study||11
9857138|NCT00908960|10970116|FG002|Evaluable|Overall Study||32
10092873|NCT02340806|11221432|FG001|STARTED|Overall Study||112
10092874|NCT02340806|11221431|FG000|COMPLETED|Overall Study||102
10092875|NCT02340806|11221432|FG001|COMPLETED|Overall Study||108
10092876|NCT02340806|11221431|FG000|NOT COMPLETED|Overall Study||6
9857139|NCT00908960|10970114|FG000|COMPLETED|Overall Study||23
9857140|NCT00908960|10970115|FG001|COMPLETED|Overall Study||11
9857141|NCT00908960|10970116|FG002|COMPLETED|Overall Study||32
9857142|NCT00908960|10970114|FG000|NOT COMPLETED|Overall Study||1
9857143|NCT00908960|10970115|FG001|NOT COMPLETED|Overall Study||1
9857144|NCT00908960|10970116|FG002|NOT COMPLETED|Overall Study||2
9857145|NCT00909038|10970124|FG000|STARTED|Overall Study||2411
9857146|NCT00909038|10970124|FG000|COMPLETED|Overall Study||1994
9857147|NCT00909038|10970124|FG000|NOT COMPLETED|Overall Study||417
9857148|NCT00909064|10970128|FG000|STARTED|Overall Study||114
9857149|NCT00909064|10970128|FG000|COMPLETED|Overall Study||114
9857150|NCT00909064|10970128|FG000|NOT COMPLETED|Overall Study||0
9857151|NCT00909090|10970134|FG000|STARTED|Overall Study||53
9857152|NCT00909090|10970135|FG001|STARTED|Overall Study||56
9857153|NCT00909090|10970134|FG000|COMPLETED|Overall Study||36
9857154|NCT00909090|10970135|FG001|COMPLETED|Overall Study||39
9857155|NCT00909090|10970134|FG000|NOT COMPLETED|Overall Study||17
9857156|NCT00909090|10970135|FG001|NOT COMPLETED|Overall Study||17
9857157|NCT00909155|10970147|FG000|STARTED|Overall Study||15
9857158|NCT00909155|10970148|FG001|STARTED|Overall Study||14
9857159|NCT00909155|10970149|FG002|STARTED|Overall Study||21
9857160|NCT00909155|10970147|FG000|COMPLETED|Overall Study||12
9857161|NCT00909155|10970148|FG001|COMPLETED|Overall Study||9
9857162|NCT00909155|10970149|FG002|COMPLETED|Overall Study||14
9857163|NCT00909155|10970147|FG000|NOT COMPLETED|Overall Study||3
9857164|NCT00909155|10970148|FG001|NOT COMPLETED|Overall Study||5
9857165|NCT00909155|10970149|FG002|NOT COMPLETED|Overall Study||7
9857166|NCT00909181|10970163|FG000|STARTED|Overall Study||210
9857167|NCT00909181|10970164|FG001|STARTED|Overall Study||214
9857168|NCT00909181|10970165|FG002|STARTED|Overall Study||202
9857169|NCT00909181|10970163|FG000|COMPLETED|Overall Study||171
9857170|NCT00909181|10970164|FG001|COMPLETED|Overall Study||196
9857171|NCT00909181|10970165|FG002|COMPLETED|Overall Study||169
9857172|NCT00909181|10970163|FG000|NOT COMPLETED|Overall Study||39
9857173|NCT00909181|10970164|FG001|NOT COMPLETED|Overall Study||18
9857174|NCT00909181|10970165|FG002|NOT COMPLETED|Overall Study||33
9857175|NCT00909220|10970175|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41
9857176|NCT00909220|10970176|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36
9857177|NCT00909220|10970175|FG000|Data Entry|Overall Study||41
9857178|NCT00909220|10970176|FG001|Data Entry|Overall Study||36
9857179|NCT00909220|10970175|FG000|Data Analyses|Overall Study||41
9857180|NCT00909220|10970176|FG001|Data Analyses|Overall Study||36
9857181|NCT00909220|10970175|FG000|Submission for Publication|Overall Study||41
9857182|NCT00909220|10970176|FG001|Submission for Publication|Overall Study||36
9857183|NCT00909220|10970175|FG000|COMPLETED|Overall Study||41
9857184|NCT00909220|10970176|FG001|COMPLETED|Overall Study||36
9857185|NCT00909220|10970175|FG000|NOT COMPLETED|Overall Study||0
9857186|NCT00909220|10970176|FG001|NOT COMPLETED|Overall Study||0
9857187|NCT00909324|10970186|FG000|STARTED|Overall Study||72
9857188|NCT00909324|10970187|FG001|STARTED|Overall Study||90
9857189|NCT00909324|10970186|FG000|COMPLETED|Overall Study||72
9857190|NCT00909324|10970187|FG001|COMPLETED|Overall Study||90
9857191|NCT00909324|10970186|FG000|NOT COMPLETED|Overall Study||0
9857192|NCT00909324|10970187|FG001|NOT COMPLETED|Overall Study||0
9857193|NCT00909363|10970196|FG000|STARTED|Overall Study||11
9857194|NCT00909363|10970197|FG001|STARTED|Overall Study||8
9857195|NCT00909363|10970198|FG002|STARTED|Overall Study||5
9857196|NCT00909363|10970196|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
9857197|NCT00909363|10970197|FG001|COMPLETED|Overall Study||8
9857198|NCT00909363|10970198|FG002|COMPLETED|Overall Study||5
9857199|NCT00909363|10970196|FG000|NOT COMPLETED|Overall Study||2
9857200|NCT00909363|10970197|FG001|NOT COMPLETED|Overall Study||0
9857201|NCT00909363|10970198|FG002|NOT COMPLETED|Overall Study||0
9857202|NCT00909428|10970212|FG000|STARTED|Overall Study||18
9857203|NCT00909428|10970213|FG001|STARTED|Overall Study||15
9857204|NCT00909428|10970214|FG002|STARTED|Overall Study||9
9857205|NCT00909428|10970212|FG000|COMPLETED|Overall Study||5
9857206|NCT00909428|10970213|FG001|COMPLETED|Overall Study||5
9857207|NCT00909428|10970214|FG002|COMPLETED|Overall Study||0
9857208|NCT00909428|10970212|FG000|NOT COMPLETED|Overall Study||13
9857209|NCT00909428|10970213|FG001|NOT COMPLETED|Overall Study||10
9857210|NCT00909428|10970214|FG002|NOT COMPLETED|Overall Study||9
9857211|NCT00909480|10970223|FG000|STARTED|Overall Study||228
9857212|NCT00909480|10970224|FG001|STARTED|Overall Study||229
9857213|NCT00909480|10970223|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
9857214|NCT00909480|10970224|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
9857215|NCT00909480|10970223|FG000|COMPLETED|Overall Study||190
9857216|NCT00909480|10970224|FG001|COMPLETED|Overall Study||188
9857217|NCT00909480|10970223|FG000|NOT COMPLETED|Overall Study||38
9857218|NCT00909480|10970224|FG001|NOT COMPLETED|Overall Study||41
9857219|NCT00909532|10970232|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
9857220|NCT00909532|10970233|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
9857221|NCT00909532|10970232|FG000|Completed Treatment Period, Week 24|Overall Study||71
9857222|NCT00909532|10970233|FG001|Completed Treatment Period, Week 24|Overall Study||80
9857223|NCT00909532|10970232|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
9857224|NCT00909532|10970233|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
9857225|NCT00909532|10970232|FG000|NOT COMPLETED|Overall Study||10
9857226|NCT00909532|10970233|FG001|NOT COMPLETED|Overall Study||6
9857227|NCT00909545|10970244|FG000|STARTED|Overall Study||26
9857228|NCT00909545|10970245|FG001|STARTED|Overall Study||23
9857229|NCT00909545|10970246|FG002|STARTED|Overall Study||26
9857230|NCT00909545|10970247|FG003|STARTED|Overall Study||24
9857231|NCT00909545|10970244|FG000|COMPLETED|Overall Study||25
9857232|NCT00909545|10970245|FG001|COMPLETED|Overall Study||22
9857233|NCT00909545|10970246|FG002|COMPLETED|Overall Study||25
9857234|NCT00909545|10970247|FG003|COMPLETED|Overall Study||19
9857235|NCT00909545|10970244|FG000|NOT COMPLETED|Overall Study||1
9857236|NCT00909545|10970245|FG001|NOT COMPLETED|Overall Study||1
9857237|NCT00909545|10970246|FG002|NOT COMPLETED|Overall Study||1
9857238|NCT00909545|10970247|FG003|NOT COMPLETED|Overall Study||5
9857239|NCT00909727|10970260|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
9857240|NCT00909727|10970261|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
9857241|NCT00909727|10970260|FG000|Completed Treatment Period, Week 24|Overall Study||23
9857242|NCT00909727|10970261|FG001|Completed Treatment Period, Week 24|Overall Study||26
9953174|NCT01425801|11072010|FG005|COMPLETED|Period 1||10
9857243|NCT00909727|10970260|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
9857244|NCT00909727|10970261|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
9857245|NCT00909727|10970260|FG000|NOT COMPLETED|Overall Study||4
9857246|NCT00909727|10970261|FG001|NOT COMPLETED|Overall Study||0
9857247|NCT00909779|10970269|FG000|STARTED|Overall Study||421
9857248|NCT00909779|10970270|FG001|STARTED|Overall Study||420
9857249|NCT00909779|10970269|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
9857250|NCT00909779|10970270|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
9857251|NCT00909779|10970269|FG000|NOT COMPLETED|Overall Study||210
9857252|NCT00909779|10970270|FG001|NOT COMPLETED|Overall Study||165
9857253|NCT00909792|10970278|FG000|STARTED|Period 1||130
9857254|NCT00909792|10970279|FG001|STARTED|Period 1||128
9857255|NCT00909792|10970278|FG000|COMPLETED|Period 1||130
9857256|NCT00909792|10970279|FG001|COMPLETED|Period 1||127
9857257|NCT00909792|10970278|FG000|NOT COMPLETED|Period 1||0
9857258|NCT00909792|10970279|FG001|NOT COMPLETED|Period 1||1
9857259|NCT00909792|10970278|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
9857260|NCT00909792|10970279|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
9857261|NCT00909792|10970278|FG000|COMPLETED|Period 2||128
9857262|NCT00909792|10970279|FG001|COMPLETED|Period 2||124
9857263|NCT00909792|10970278|FG000|NOT COMPLETED|Period 2||1
9857264|NCT00909792|10970279|FG001|NOT COMPLETED|Period 2||1
9857265|NCT00909844|10970285|FG000|STARTED|Overall Study||35
9857266|NCT00909844|10970285|FG000|COMPLETED|Overall Study||31
9857267|NCT00909844|10970285|FG000|NOT COMPLETED|Overall Study||4
9857268|NCT00909857|10970292|FG000|STARTED|Overall Study||253
9857269|NCT00909857|10970293|FG001|STARTED|Overall Study||254
9857270|NCT00909857|10970292|FG000|Treated|Overall Study||234
9857271|NCT00909857|10970293|FG001|Treated|Overall Study||230
9857272|NCT00909857|10970292|FG000|COMPLETED|Overall Study||217
9857273|NCT00909857|10970293|FG001|COMPLETED|Overall Study||209
9857274|NCT00909857|10970292|FG000|NOT COMPLETED|Overall Study||36
9857275|NCT00909857|10970293|FG001|NOT COMPLETED|Overall Study||45
9857276|NCT00909870|10970301|FG000|STARTED|Overall Study||274
9857277|NCT00909870|10970302|FG001|STARTED|Overall Study||263
9857278|NCT00909870|10970301|FG000|COMPLETED|Overall Study||251
9857279|NCT00909870|10970302|FG001|COMPLETED|Overall Study||236
9857280|NCT00909870|10970301|FG000|NOT COMPLETED|Overall Study||23
9857281|NCT00909870|10970302|FG001|NOT COMPLETED|Overall Study||27
9857282|NCT00910000|10970315|FG000|STARTED|Overall Study||3
9857283|NCT00910000|10970316|FG001|STARTED|Overall Study||3
9857284|NCT00910000|10970317|FG002|STARTED|Overall Study||3
9857285|NCT00910000|10970318|FG003|STARTED|Overall Study||2
9857286|NCT00910000|10970319|FG004|STARTED|Overall Study||3
9857287|NCT00910000|10970320|FG005|STARTED|Overall Study||1
9857288|NCT00910000|10970315|FG000|COMPLETED|Overall Study||3
9857289|NCT00910000|10970316|FG001|COMPLETED|Overall Study||0
9857290|NCT00910000|10970317|FG002|COMPLETED|Overall Study||0
9857291|NCT00910000|10970318|FG003|COMPLETED|Overall Study||0
9857292|NCT00910000|10970319|FG004|COMPLETED|Overall Study||2
9857293|NCT00910000|10970320|FG005|COMPLETED|Overall Study||0
9857294|NCT00910000|10970315|FG000|NOT COMPLETED|Overall Study||0
9857295|NCT00910000|10970316|FG001|NOT COMPLETED|Overall Study||3
9857296|NCT00910000|10970317|FG002|NOT COMPLETED|Overall Study||3
9857297|NCT00910000|10970318|FG003|NOT COMPLETED|Overall Study||2
9857298|NCT00910000|10970319|FG004|NOT COMPLETED|Overall Study||1
9857299|NCT00910000|10970320|FG005|NOT COMPLETED|Overall Study||1
9857300|NCT00910039|10970330|FG000|STARTED|Overall Study||14
9857301|NCT00910039|10970330|FG000|COMPLETED|Overall Study||13
9857302|NCT00910039|10970330|FG000|NOT COMPLETED|Overall Study||1
9857303|NCT00910091|10970337|FG000|STARTED|Pre-assignment||36
9857304|NCT00910091|10970338|FG001|STARTED|Pre-assignment||37
9857305|NCT00910091|10970337|FG000|COMPLETED|Pre-assignment||36
9857306|NCT00910091|10970338|FG001|COMPLETED|Pre-assignment||35
9857307|NCT00910091|10970337|FG000|NOT COMPLETED|Pre-assignment||0
9857308|NCT00910091|10970338|FG001|NOT COMPLETED|Pre-assignment||2
9857309|NCT00910091|10970337|FG000|STARTED|Treatment and Survival||36
9857310|NCT00910091|10970338|FG001|STARTED|Treatment and Survival||35
9857311|NCT00910091|10970337|FG000|COMPLETED|Treatment and Survival||32
9857312|NCT00910091|10970338|FG001|COMPLETED|Treatment and Survival||31
9857313|NCT00910091|10970337|FG000|NOT COMPLETED|Treatment and Survival||4
9857314|NCT00910091|10970338|FG001|NOT COMPLETED|Treatment and Survival||4
9857315|NCT00910208|10970348|FG000|STARTED|Overall Study||69
9857316|NCT00910208|10970349|FG001|STARTED|Overall Study||72
9857317|NCT00910208|10970350|FG002|STARTED|Overall Study||70
9857318|NCT00910208|10970348|FG000|COMPLETED|Overall Study||67
9857319|NCT00910208|10970349|FG001|COMPLETED|Overall Study||70
9857320|NCT00910208|10970350|FG002|COMPLETED|Overall Study||69
9857321|NCT00910208|10970348|FG000|NOT COMPLETED|Overall Study||2
9857322|NCT00910208|10970349|FG001|NOT COMPLETED|Overall Study||2
9857323|NCT00910208|10970350|FG002|NOT COMPLETED|Overall Study||1
9857324|NCT00910247|10970358|FG000|STARTED|Overall Study||274
9857325|NCT00910247|10970358|FG000|COMPLETED|Overall Study||205
9857326|NCT00910247|10970358|FG000|NOT COMPLETED|Overall Study||69
9857327|NCT00910273|10970364|FG000|STARTED|Overall Study||18
9857328|NCT00910273|10970365|FG001|STARTED|Overall Study||16
9857329|NCT00910273|10970364|FG000|COMPLETED|Overall Study||0
9857330|NCT00910273|10970365|FG001|COMPLETED|Overall Study||3
9857331|NCT00910273|10970364|FG000|NOT COMPLETED|Overall Study||18
9857332|NCT00910273|10970365|FG001|NOT COMPLETED|Overall Study||13
9857333|NCT00910299|10970373|FG000|STARTED|Overall Study||212
9857334|NCT00910299|10970374|FG001|STARTED|Overall Study||211
9857335|NCT00910299|10970373|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210
9857336|NCT00910299|10970374|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
9857337|NCT00910299|10970373|FG000|COMPLETED|Overall Study||136
9857338|NCT00910299|10970374|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
9857339|NCT00910299|10970373|FG000|NOT COMPLETED|Overall Study||76
9857340|NCT00910299|10970374|FG001|NOT COMPLETED|Overall Study||74
9857341|NCT00910429|10970382|FG000|STARTED|Overall Study||155
9857342|NCT00910429|10970383|FG001|STARTED|Overall Study||82
9857343|NCT00910429|10970382|FG000|COMPLETED|Overall Study|Completed treatment|116
9857344|NCT00910429|10970383|FG001|COMPLETED|Overall Study|Completed treatment|61
9857345|NCT00910429|10970382|FG000|NOT COMPLETED|Overall Study||39
9857346|NCT00910429|10970383|FG001|NOT COMPLETED|Overall Study||21
9857347|NCT00910481|10970391|FG000|STARTED|Overall Study||151
9857348|NCT00910481|10970392|FG001|STARTED|Overall Study||150
9857349|NCT00910481|10970391|FG000|COMPLETED|Overall Study||151
9857350|NCT00910481|10970392|FG001|COMPLETED|Overall Study||150
9857351|NCT00910481|10970391|FG000|NOT COMPLETED|Overall Study||0
9857352|NCT00910481|10970392|FG001|NOT COMPLETED|Overall Study||0
9857353|NCT00910520|10970400|FG000|STARTED|Treatment Cycle 1||277
9857354|NCT00910520|10970401|FG001|STARTED|Treatment Cycle 1||271
9857355|NCT00910520|10970400|FG000|COMPLETED|Treatment Cycle 1||257
9857356|NCT00910520|10970401|FG001|COMPLETED|Treatment Cycle 1||247
9857357|NCT00910520|10970400|FG000|NOT COMPLETED|Treatment Cycle 1||20
9857358|NCT00910520|10970401|FG001|NOT COMPLETED|Treatment Cycle 1||24
9857359|NCT00910520|10970400|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
9857360|NCT00910520|10970401|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
9857361|NCT00910520|10970400|FG000|COMPLETED|Treatment Cycle 2||156
9857362|NCT00910520|10970401|FG001|COMPLETED|Treatment Cycle 2||215
9857363|NCT00910520|10970400|FG000|NOT COMPLETED|Treatment Cycle 2||7
9857364|NCT00910520|10970401|FG001|NOT COMPLETED|Treatment Cycle 2||8
9857365|NCT00910624|10970411|FG000|STARTED|Treatment Phase||52
9857366|NCT00910624|10970412|FG001|STARTED|Treatment Phase||85
9857367|NCT00910624|10970413|FG002|STARTED|Treatment Phase||29
9857368|NCT00910624|10970414|FG003|STARTED|Treatment Phase||2
9857369|NCT00910624|10970411|FG000|COMPLETED|Treatment Phase||22
9857370|NCT00910624|10970412|FG001|COMPLETED|Treatment Phase||64
9857371|NCT00910624|10970413|FG002|COMPLETED|Treatment Phase||20
9857372|NCT00910624|10970414|FG003|COMPLETED|Treatment Phase||2
9857373|NCT00910624|10970411|FG000|NOT COMPLETED|Treatment Phase||30
9857374|NCT00910624|10970412|FG001|NOT COMPLETED|Treatment Phase||21
9857375|NCT00910624|10970413|FG002|NOT COMPLETED|Treatment Phase||9
9857376|NCT00910624|10970414|FG003|NOT COMPLETED|Treatment Phase||0
9857377|NCT00910624|10970411|FG000|STARTED|Follow-Up Phase||48
9857378|NCT00910624|10970412|FG001|STARTED|Follow-Up Phase||80
9857379|NCT00910624|10970413|FG002|STARTED|Follow-Up Phase||29
9857380|NCT00910624|10970414|FG003|STARTED|Follow-Up Phase||2
9857381|NCT00910624|10970411|FG000|COMPLETED|Follow-Up Phase||42
9857382|NCT00910624|10970412|FG001|COMPLETED|Follow-Up Phase||76
9857383|NCT00910624|10970413|FG002|COMPLETED|Follow-Up Phase||25
9857384|NCT00910624|10970414|FG003|COMPLETED|Follow-Up Phase||2
9857385|NCT00910624|10970411|FG000|NOT COMPLETED|Follow-Up Phase||6
9857386|NCT00910624|10970412|FG001|NOT COMPLETED|Follow-Up Phase||4
9857387|NCT00910624|10970413|FG002|NOT COMPLETED|Follow-Up Phase||4
9857388|NCT00910624|10970414|FG003|NOT COMPLETED|Follow-Up Phase||0
9857389|NCT00910663|10970424|FG000|STARTED|Period 1||30
9857390|NCT00910663|10970425|FG001|STARTED|Period 1||30
9857391|NCT00910663|10970424|FG000|COMPLETED|Period 1||30
9857392|NCT00910663|10970425|FG001|COMPLETED|Period 1||29
9857393|NCT00910663|10970424|FG000|NOT COMPLETED|Period 1||0
9857394|NCT00910663|10970425|FG001|NOT COMPLETED|Period 1||1
9857395|NCT00910663|10970424|FG000|STARTED|Period 2||30
9857396|NCT00910663|10970425|FG001|STARTED|Period 2||29
9857397|NCT00910663|10970424|FG000|COMPLETED|Period 2||30
9857398|NCT00910663|10970425|FG001|COMPLETED|Period 2||29
9857399|NCT00910663|10970424|FG000|NOT COMPLETED|Period 2||0
9857400|NCT00910663|10970425|FG001|NOT COMPLETED|Period 2||0
9857401|NCT00910689|10970435|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55
9857402|NCT00910689|10970436|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53
9857403|NCT00910689|10970437|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55
9857404|NCT00910689|10970438|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69
9857405|NCT00910689|10970435|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
9857406|NCT00910689|10970436|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
9857407|NCT00910689|10970437|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
9857408|NCT00910689|10970438|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
9857409|NCT00910689|10970435|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
9857410|NCT00910689|10970436|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
9857411|NCT00910689|10970437|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
9857412|NCT00910689|10970438|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
9857413|NCT00910689|10970435|FG000|STARTED|Month 2- 4: Treatment Period||53
9857414|NCT00910689|10970436|FG001|STARTED|Month 2- 4: Treatment Period||52
9857415|NCT00910689|10970437|FG002|STARTED|Month 2- 4: Treatment Period||50
9857416|NCT00910689|10970438|FG003|STARTED|Month 2- 4: Treatment Period||59
9857417|NCT00910689|10970435|FG000|COMPLETED|Month 2- 4: Treatment Period||44
9857418|NCT00910689|10970436|FG001|COMPLETED|Month 2- 4: Treatment Period||42
9857419|NCT00910689|10970437|FG002|COMPLETED|Month 2- 4: Treatment Period||42
9857420|NCT00910689|10970438|FG003|COMPLETED|Month 2- 4: Treatment Period||48
9857421|NCT00910689|10970435|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9
9857422|NCT00910689|10970436|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10
9857423|NCT00910689|10970437|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8
9857424|NCT00910689|10970438|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11
9857425|NCT00910689|10970435|FG000|STARTED|Months 5 - 10: Evaluation Period I||44
9857426|NCT00910689|10970436|FG001|STARTED|Months 5 - 10: Evaluation Period I||42
9857427|NCT00910689|10970437|FG002|STARTED|Months 5 - 10: Evaluation Period I||42
9857428|NCT00910689|10970438|FG003|STARTED|Months 5 - 10: Evaluation Period I||48
9857429|NCT00910689|10970435|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40
9857430|NCT00910689|10970436|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35
9857431|NCT00910689|10970437|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35
9857432|NCT00910689|10970438|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41
9857433|NCT00910689|10970435|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
9857434|NCT00910689|10970436|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
9857435|NCT00910689|10970437|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
9857436|NCT00910689|10970438|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
9857437|NCT00910689|10970435|FG000|STARTED|Months 11- 16: Evaluation Period II||40
9857438|NCT00910689|10970436|FG001|STARTED|Months 11- 16: Evaluation Period II||35
9857439|NCT00910689|10970437|FG002|STARTED|Months 11- 16: Evaluation Period II||35
9857440|NCT00910689|10970438|FG003|STARTED|Months 11- 16: Evaluation Period II||41
9857441|NCT00910689|10970435|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30
9857442|NCT00910689|10970436|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25
9857443|NCT00910689|10970437|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28
9857444|NCT00910689|10970438|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35
9857445|NCT00910689|10970435|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
9857446|NCT00910689|10970436|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
9857447|NCT00910689|10970437|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
9857448|NCT00910689|10970438|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
9857449|NCT00910715|10970451|FG000|STARTED|Overall Study||108
9857450|NCT00910715|10970452|FG001|STARTED|Overall Study||117
9857451|NCT00910715|10970453|FG002|STARTED|Overall Study||81
9857452|NCT00910715|10970451|FG000|COMPLETED|Overall Study||86
9857453|NCT00910715|10970452|FG001|COMPLETED|Overall Study||91
9857454|NCT00910715|10970453|FG002|COMPLETED|Overall Study||81
9857455|NCT00910715|10970451|FG000|NOT COMPLETED|Overall Study||22
10092877|NCT02340806|11221432|FG001|NOT COMPLETED|Overall Study||4
10092878|NCT02340819|11221438|FG000|STARTED|Overall Study||11
10092879|NCT02340819|11221438|FG000|Started Stage 2|Overall Study||11
10092880|NCT02340819|11221438|FG000|Completed Stage 2|Overall Study||9
9857456|NCT00910715|10970452|FG001|NOT COMPLETED|Overall Study||26
9857457|NCT00910715|10970453|FG002|NOT COMPLETED|Overall Study||0
9857458|NCT00910728|10970472|FG000|STARTED|Overall Study||6
9857459|NCT00910728|10970473|FG001|STARTED|Overall Study||3
9857460|NCT00910728|10970474|FG002|STARTED|Overall Study||3
9857461|NCT00910728|10970475|FG003|STARTED|Overall Study||3
9857462|NCT00910728|10970476|FG004|STARTED|Overall Study||6
9857463|NCT00910728|10970477|FG005|STARTED|Overall Study||1
9857464|NCT00910728|10970478|FG006|STARTED|Overall Study||6
9857465|NCT00910728|10970479|FG007|STARTED|Overall Study||4
9857466|NCT00910728|10970480|FG008|STARTED|Overall Study||3
9857467|NCT00910728|10970472|FG000|COMPLETED|Overall Study||0
9857468|NCT00910728|10970473|FG001|COMPLETED|Overall Study||0
9857469|NCT00910728|10970474|FG002|COMPLETED|Overall Study||0
9857470|NCT00910728|10970475|FG003|COMPLETED|Overall Study||0
9857471|NCT00910728|10970476|FG004|COMPLETED|Overall Study||1
9857472|NCT00910728|10970477|FG005|COMPLETED|Overall Study||0
9857473|NCT00910728|10970478|FG006|COMPLETED|Overall Study||0
9857474|NCT00910728|10970479|FG007|COMPLETED|Overall Study||1
9857475|NCT00910728|10970480|FG008|COMPLETED|Overall Study||0
9857476|NCT00910728|10970472|FG000|NOT COMPLETED|Overall Study||6
9857477|NCT00910728|10970473|FG001|NOT COMPLETED|Overall Study||3
9857478|NCT00910728|10970474|FG002|NOT COMPLETED|Overall Study||3
9857479|NCT00910728|10970475|FG003|NOT COMPLETED|Overall Study||3
9857480|NCT00910728|10970476|FG004|NOT COMPLETED|Overall Study||5
9857481|NCT00910728|10970477|FG005|NOT COMPLETED|Overall Study||1
9857482|NCT00910728|10970478|FG006|NOT COMPLETED|Overall Study||6
9857483|NCT00910728|10970479|FG007|NOT COMPLETED|Overall Study||3
9857484|NCT00910728|10970480|FG008|NOT COMPLETED|Overall Study||3
9857485|NCT00910845|10970502|FG000|STARTED|Treatment Cycle 1||280
9857486|NCT00910845|10970503|FG001|STARTED|Treatment Cycle 1||277
9857487|NCT00910845|10970502|FG000|COMPLETED|Treatment Cycle 1||249
9857488|NCT00910845|10970503|FG001|COMPLETED|Treatment Cycle 1||243
9857489|NCT00910845|10970502|FG000|NOT COMPLETED|Treatment Cycle 1||31
9857490|NCT00910845|10970503|FG001|NOT COMPLETED|Treatment Cycle 1||34
9857491|NCT00910845|10970502|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
9857492|NCT00910845|10970503|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
9857493|NCT00910845|10970502|FG000|COMPLETED|Treatment Cycle 2||136
9857494|NCT00910845|10970503|FG001|COMPLETED|Treatment Cycle 2||203
9857495|NCT00910845|10970502|FG000|NOT COMPLETED|Treatment Cycle 2||5
9857496|NCT00910845|10970503|FG001|NOT COMPLETED|Treatment Cycle 2||9
9857497|NCT00910858|10970512|FG000|STARTED|Pharmacokinetic Phase||9
9857498|NCT00910858|10970513|FG001|STARTED|Pharmacokinetic Phase||0
9857499|NCT00910858|10970514|FG002|STARTED|Pharmacokinetic Phase||3
9857500|NCT00910858|10970512|FG000|COMPLETED|Pharmacokinetic Phase||8
9857501|NCT00910858|10970513|FG001|COMPLETED|Pharmacokinetic Phase||0
9857502|NCT00910858|10970514|FG002|COMPLETED|Pharmacokinetic Phase||3
9857503|NCT00910858|10970512|FG000|NOT COMPLETED|Pharmacokinetic Phase||1
9857504|NCT00910858|10970513|FG001|NOT COMPLETED|Pharmacokinetic Phase||0
9857505|NCT00910858|10970514|FG002|NOT COMPLETED|Pharmacokinetic Phase||0
9857506|NCT00910858|10970512|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
9857507|NCT00910858|10970513|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
9857508|NCT00910858|10970514|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
9857509|NCT00910858|10970512|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
9857510|NCT00910858|10970513|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
9857511|NCT00910858|10970514|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
9857512|NCT00910858|10970512|FG000|Pharmacokinetic Population|Monotherapy Phase||17
9857513|NCT00910858|10970513|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
9857514|NCT00910858|10970514|FG002|Pharmacokinetic Population|Monotherapy Phase||7
9857515|NCT00910858|10970512|FG000|COMPLETED|Monotherapy Phase||0
9857516|NCT00910858|10970513|FG001|COMPLETED|Monotherapy Phase||0
9857517|NCT00910858|10970514|FG002|COMPLETED|Monotherapy Phase||0
9857518|NCT00910858|10970512|FG000|NOT COMPLETED|Monotherapy Phase||17
9857519|NCT00910858|10970513|FG001|NOT COMPLETED|Monotherapy Phase||15
9857520|NCT00910858|10970514|FG002|NOT COMPLETED|Monotherapy Phase||7
9857521|NCT00910858|10970512|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
9857522|NCT00910858|10970513|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
9857523|NCT00910858|10970514|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
9857524|NCT00910858|10970512|FG000|COMPLETED|Combined Treatment Phase||0
9857525|NCT00910858|10970513|FG001|COMPLETED|Combined Treatment Phase||0
9857526|NCT00910858|10970514|FG002|COMPLETED|Combined Treatment Phase||0
9857527|NCT00910858|10970512|FG000|NOT COMPLETED|Combined Treatment Phase||9
9857528|NCT00910858|10970513|FG001|NOT COMPLETED|Combined Treatment Phase||10
9857529|NCT00910858|10970514|FG002|NOT COMPLETED|Combined Treatment Phase||4
9857530|NCT00910871|10970530|FG000|STARTED|Overall Study||233
9857531|NCT00910871|10970530|FG000|COMPLETED|Overall Study||179
9857532|NCT00910871|10970530|FG000|NOT COMPLETED|Overall Study||54
9857533|NCT00910910|10970536|FG000|STARTED|Overall Study||225
9857534|NCT00910910|10970537|FG001|STARTED|Overall Study||225
9857535|NCT00910910|10970536|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
9857536|NCT00910910|10970537|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
9857537|NCT00910910|10970536|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
9857538|NCT00910910|10970537|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
9857539|NCT00910910|10970536|FG000|NOT COMPLETED|Overall Study||225
9857540|NCT00910910|10970537|FG001|NOT COMPLETED|Overall Study||224
9857541|NCT00910962|10970546|FG000|STARTED|Overall Study||135
9857542|NCT00910962|10970547|FG001|STARTED|Overall Study||199
9857543|NCT00910962|10970548|FG002|STARTED|Overall Study||192
9857544|NCT00910962|10970546|FG000|COMPLETED|Overall Study||92
9857545|NCT00910962|10970547|FG001|COMPLETED|Overall Study||121
9857546|NCT00910962|10970548|FG002|COMPLETED|Overall Study||116
9857547|NCT00910962|10970546|FG000|NOT COMPLETED|Overall Study||43
9857548|NCT00910962|10970547|FG001|NOT COMPLETED|Overall Study||78
9857549|NCT00910962|10970548|FG002|NOT COMPLETED|Overall Study||76
9857550|NCT00910988|10970562|FG000|STARTED|Overall Study||16
9857551|NCT00910988|10970563|FG001|STARTED|Overall Study||16
9857552|NCT00910988|10970564|FG002|STARTED|Overall Study||8
9857553|NCT00910988|10970565|FG003|STARTED|Overall Study||6
9857554|NCT00910988|10970562|FG000|COMPLETED|Overall Study||14
9857555|NCT00910988|10970563|FG001|COMPLETED|Overall Study||12
9857556|NCT00910988|10970564|FG002|COMPLETED|Overall Study||5
9857557|NCT00910988|10970565|FG003|COMPLETED|Overall Study||6
9857558|NCT00910988|10970562|FG000|NOT COMPLETED|Overall Study||2
9857559|NCT00910988|10970563|FG001|NOT COMPLETED|Overall Study||4
9857560|NCT00910988|10970564|FG002|NOT COMPLETED|Overall Study||3
9857561|NCT00910988|10970565|FG003|NOT COMPLETED|Overall Study||0
9857562|NCT00911144|10970593|FG000|STARTED|Overall Study||335
9857563|NCT00911144|10970594|FG001|STARTED|Overall Study||113
9857564|NCT00911144|10970593|FG000|COMPLETED|Overall Study||319
9857565|NCT00911144|10970594|FG001|COMPLETED|Overall Study||108
9857566|NCT00911144|10970593|FG000|NOT COMPLETED|Overall Study||16
9857567|NCT00911144|10970594|FG001|NOT COMPLETED|Overall Study||5
9857568|NCT00911157|10970602|FG000|STARTED|Overall Study||29
9857569|NCT00911157|10970603|FG001|STARTED|Overall Study||10
9857570|NCT00911157|10970602|FG000|COMPLETED|Overall Study||22
9857571|NCT00911157|10970603|FG001|COMPLETED|Overall Study||8
9857572|NCT00911157|10970602|FG000|NOT COMPLETED|Overall Study||7
9857573|NCT00911157|10970603|FG001|NOT COMPLETED|Overall Study||2
9857574|NCT00911170|10970611|FG000|STARTED|Treatment Period||424
9857575|NCT00911170|10970612|FG001|STARTED|Treatment Period||423
9857576|NCT00911170|10970611|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
9857577|NCT00911170|10970612|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
9857578|NCT00911170|10970611|FG000|Received Bevacizumab|Treatment Period||423
9857579|NCT00911170|10970612|FG001|Received Bevacizumab|Treatment Period||420
9857580|NCT00911170|10970611|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
9857581|NCT00911170|10970612|FG001|Received Investigational Product|Treatment Period||419
9857582|NCT00911170|10970611|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
9857583|NCT00911170|10970612|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
9857584|NCT00911170|10970611|FG000|NOT COMPLETED|Treatment Period||27
9857585|NCT00911170|10970612|FG001|NOT COMPLETED|Treatment Period||37
9857586|NCT00911170|10970611|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
9857587|NCT00911170|10970612|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
9857588|NCT00911170|10970611|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
9857589|NCT00911170|10970612|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
9857590|NCT00911170|10970611|FG000|NOT COMPLETED|Long Term Follow-Up||423
9857591|NCT00911170|10970612|FG001|NOT COMPLETED|Long Term Follow-Up||422
9857592|NCT00911300|10970620|FG000|STARTED|Overall Study||175
9857593|NCT00911300|10970621|FG001|STARTED|Overall Study||174
9857594|NCT00911300|10970620|FG000|COMPLETED|Overall Study||140
9857595|NCT00911300|10970621|FG001|COMPLETED|Overall Study||131
9857596|NCT00911300|10970620|FG000|NOT COMPLETED|Overall Study||35
9857597|NCT00911300|10970621|FG001|NOT COMPLETED|Overall Study||43
9857598|NCT00911326|10970628|FG000|STARTED|Overall Study||101
9857599|NCT00911326|10970628|FG000|COMPLETED|Overall Study||85
9857600|NCT00911326|10970628|FG000|NOT COMPLETED|Overall Study||16
9857601|NCT00911495|10970632|FG000|STARTED|Overall Study||15
9857602|NCT00911495|10970632|FG000|COMPLETED|Overall Study||14
9857603|NCT00911495|10970632|FG000|NOT COMPLETED|Overall Study||1
9857604|NCT00911508|10970638|FG000|STARTED|Overall Study||1108
9857605|NCT00911508|10970639|FG001|STARTED|Overall Study||1096
9857606|NCT00911508|10970638|FG000|COMPLETED|Overall Study||1002
9857607|NCT00911508|10970639|FG001|COMPLETED|Overall Study||966
9857608|NCT00911508|10970638|FG000|NOT COMPLETED|Overall Study||106
9857609|NCT00911508|10970639|FG001|NOT COMPLETED|Overall Study||130
9857610|NCT00911534|10970647|FG000|STARTED|Overall Study|Randomized (treated)|147
9857611|NCT00911534|10970648|FG001|STARTED|Overall Study|Randomized (treated)|153
9857612|NCT00911534|10970647|FG000|COMPLETED|Overall Study||132
9857613|NCT00911534|10970648|FG001|COMPLETED|Overall Study||137
9857614|NCT00911534|10970647|FG000|NOT COMPLETED|Overall Study||15
9857615|NCT00911534|10970648|FG001|NOT COMPLETED|Overall Study||16
9857616|NCT00911586|10970654|FG000|STARTED|Overall Study||15
9857617|NCT00911586|10970654|FG000|COMPLETED|Overall Study||15
9857618|NCT00911586|10970654|FG000|NOT COMPLETED|Overall Study||0
9857619|NCT00911612|10970661|FG000|STARTED|Overall Study||12
9857620|NCT00911612|10970662|FG001|STARTED|Overall Study||12
9857621|NCT00911612|10970661|FG000|COMPLETED|Overall Study||12
9857622|NCT00911612|10970662|FG001|COMPLETED|Overall Study||12
9857623|NCT00911612|10970661|FG000|NOT COMPLETED|Overall Study||0
9857624|NCT00911612|10970662|FG001|NOT COMPLETED|Overall Study||0
9857625|NCT00911625|10970670|FG000|STARTED|Overall Study||57
9857626|NCT00911625|10970671|FG001|STARTED|Overall Study||57
9857627|NCT00911625|10970670|FG000|COMPLETED|Overall Study||50
9857628|NCT00911625|10970671|FG001|COMPLETED|Overall Study||57
9857629|NCT00911625|10970670|FG000|NOT COMPLETED|Overall Study||7
9857630|NCT00911625|10970671|FG001|NOT COMPLETED|Overall Study||0
9857631|NCT00911742|10970679|FG000|STARTED|Treatment Phase I||13
9857632|NCT00911742|10970680|FG001|STARTED|Treatment Phase I||13
9857633|NCT00911742|10970679|FG000|COMPLETED|Treatment Phase I||13
9857634|NCT00911742|10970680|FG001|COMPLETED|Treatment Phase I||13
9857635|NCT00911742|10970679|FG000|NOT COMPLETED|Treatment Phase I||0
9857636|NCT00911742|10970680|FG001|NOT COMPLETED|Treatment Phase I||0
9857637|NCT00911742|10970679|FG000|STARTED|Treatment Phase II||13
9857638|NCT00911742|10970680|FG001|STARTED|Treatment Phase II||13
9857639|NCT00911742|10970679|FG000|COMPLETED|Treatment Phase II||13
9857640|NCT00911742|10970680|FG001|COMPLETED|Treatment Phase II||13
9857641|NCT00911742|10970679|FG000|NOT COMPLETED|Treatment Phase II||0
9857642|NCT00911742|10970680|FG001|NOT COMPLETED|Treatment Phase II||0
9857643|NCT00911768|10970688|FG000|STARTED|Overall Study||50
9857644|NCT00911768|10970689|FG001|STARTED|Overall Study||50
9857645|NCT00911768|10970688|FG000|COMPLETED|Overall Study||44
9857646|NCT00911768|10970689|FG001|COMPLETED|Overall Study||46
9857647|NCT00911768|10970688|FG000|NOT COMPLETED|Overall Study||6
9857648|NCT00911768|10970689|FG001|NOT COMPLETED|Overall Study||4
9857649|NCT00911807|10970698|FG000|STARTED|Overall Study||72
9857650|NCT00911807|10970699|FG001|STARTED|Overall Study||70
9857651|NCT00911807|10970700|FG002|STARTED|Overall Study||75
9857652|NCT00911807|10970698|FG000|COMPLETED|Overall Study||55
9857653|NCT00911807|10970699|FG001|COMPLETED|Overall Study||52
9857654|NCT00911807|10970700|FG002|COMPLETED|Overall Study||52
9857655|NCT00911807|10970698|FG000|NOT COMPLETED|Overall Study||17
9857656|NCT00911807|10970699|FG001|NOT COMPLETED|Overall Study||18
9857657|NCT00911807|10970700|FG002|NOT COMPLETED|Overall Study||23
9857658|NCT00911820|10970710|FG000|STARTED|Overall Study||45
9857659|NCT00911820|10970711|FG001|STARTED|Overall Study||43
9857660|NCT00911820|10970710|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
9857661|NCT00911820|10970711|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
9857662|NCT00911820|10970710|FG000|COMPLETED|Overall Study||0
9857663|NCT00911820|10970711|FG001|COMPLETED|Overall Study||0
9857664|NCT00911820|10970710|FG000|NOT COMPLETED|Overall Study||45
9857665|NCT00911820|10970711|FG001|NOT COMPLETED|Overall Study||43
9857666|NCT00911859|10970720|FG000|STARTED|Treatment Period||12
9857667|NCT00911859|10970721|FG001|STARTED|Treatment Period||54
9857668|NCT00911859|10970722|FG002|STARTED|Treatment Period||52
9857669|NCT00911859|10970720|FG000|Received Treatment|Treatment Period||12
9857670|NCT00911859|10970721|FG001|Received Treatment|Treatment Period||53
9857671|NCT00911859|10970722|FG002|Received Treatment|Treatment Period||52
9857672|NCT00911859|10970720|FG000|COMPLETED|Treatment Period||4
9857673|NCT00911859|10970721|FG001|COMPLETED|Treatment Period||33
9857674|NCT00911859|10970722|FG002|COMPLETED|Treatment Period||27
9857675|NCT00911859|10970720|FG000|NOT COMPLETED|Treatment Period||8
9857676|NCT00911859|10970721|FG001|NOT COMPLETED|Treatment Period||21
9857677|NCT00911859|10970722|FG002|NOT COMPLETED|Treatment Period||25
9857678|NCT00911859|10970720|FG000|STARTED|Maintainance Period||0
9857679|NCT00911859|10970721|FG001|STARTED|Maintainance Period||0
9857680|NCT00911859|10970722|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
9857681|NCT00911859|10970720|FG000|COMPLETED|Maintainance Period||0
9857682|NCT00911859|10970721|FG001|COMPLETED|Maintainance Period||0
9857683|NCT00911859|10970722|FG002|COMPLETED|Maintainance Period||0
9857684|NCT00911859|10970720|FG000|NOT COMPLETED|Maintainance Period||0
9857685|NCT00911859|10970721|FG001|NOT COMPLETED|Maintainance Period||0
9857686|NCT00911859|10970722|FG002|NOT COMPLETED|Maintainance Period||21
9857687|NCT00911859|10970720|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
9857688|NCT00911859|10970721|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
9857689|NCT00911859|10970722|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
9857690|NCT00911859|10970720|FG000|COMPLETED|Follow-up Period||1
9857691|NCT00911859|10970721|FG001|COMPLETED|Follow-up Period||7
9857692|NCT00911859|10970722|FG002|COMPLETED|Follow-up Period||11
9857693|NCT00911859|10970720|FG000|NOT COMPLETED|Follow-up Period||11
9857694|NCT00911859|10970721|FG001|NOT COMPLETED|Follow-up Period||46
9857695|NCT00911859|10970722|FG002|NOT COMPLETED|Follow-up Period||41
9857696|NCT00911898|10970730|FG000|STARTED|Overall Study||20
9857697|NCT00911898|10970730|FG000|COMPLETED|Overall Study||20
9857698|NCT00911898|10970730|FG000|NOT COMPLETED|Overall Study||0
9857699|NCT00911937|10970736|FG000|STARTED|Overall Study||487
9857700|NCT00911937|10970737|FG001|STARTED|Overall Study||476
9857701|NCT00911937|10970736|FG000|Treated|Overall Study||474
9857702|NCT00911937|10970737|FG001|Treated|Overall Study||463
9857703|NCT00911937|10970736|FG000|COMPLETED|Overall Study||400
9857704|NCT00911937|10970737|FG001|COMPLETED|Overall Study||381
9857705|NCT00911937|10970736|FG000|NOT COMPLETED|Overall Study||87
9857706|NCT00911937|10970737|FG001|NOT COMPLETED|Overall Study||95
9857707|NCT00911989|10970743|FG000|STARTED|Overall Study||4
9857708|NCT00911989|10970743|FG000|COMPLETED|Overall Study||3
9857709|NCT00911989|10970743|FG000|NOT COMPLETED|Overall Study||1
9857710|NCT00912002|10970747|FG000|STARTED|Overall Study||6
9857711|NCT00912002|10970747|FG000|COMPLETED|Overall Study||6
9857712|NCT00912002|10970747|FG000|NOT COMPLETED|Overall Study||0
9857713|NCT00912015|10970756|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
9857714|NCT00912015|10970757|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
9857715|NCT00912015|10970758|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
9857716|NCT00912015|10970759|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
9857717|NCT00912015|10970756|FG000|COMPLETED|Overall Study||125
9857718|NCT00912015|10970757|FG001|COMPLETED|Overall Study||62
9857719|NCT00912015|10970758|FG002|COMPLETED|Overall Study||22
9857720|NCT00912015|10970759|FG003|COMPLETED|Overall Study||0
9857721|NCT00912015|10970756|FG000|NOT COMPLETED|Overall Study||16
9857722|NCT00912015|10970757|FG001|NOT COMPLETED|Overall Study||8
9857723|NCT00912015|10970758|FG002|NOT COMPLETED|Overall Study||3
9857724|NCT00912015|10970759|FG003|NOT COMPLETED|Overall Study||2
9857725|NCT00912028|10970772|FG000|STARTED|Overall Study||35
9857726|NCT00912028|10970773|FG001|STARTED|Overall Study||3
9857727|NCT00912028|10970774|FG002|STARTED|Overall Study||13
9857728|NCT00912028|10970775|FG003|STARTED|Overall Study||17
9857729|NCT00912028|10970776|FG004|STARTED|Overall Study||3
9857730|NCT00912028|10970772|FG000|COMPLETED|Overall Study||30
9857731|NCT00912028|10970773|FG001|COMPLETED|Overall Study||0
9857732|NCT00912028|10970774|FG002|COMPLETED|Overall Study||13
9857733|NCT00912028|10970775|FG003|COMPLETED|Overall Study||16
9857734|NCT00912028|10970776|FG004|COMPLETED|Overall Study||0
9857735|NCT00912028|10970772|FG000|NOT COMPLETED|Overall Study||5
9857736|NCT00912028|10970773|FG001|NOT COMPLETED|Overall Study||3
9857737|NCT00912028|10970774|FG002|NOT COMPLETED|Overall Study||0
9857738|NCT00912028|10970775|FG003|NOT COMPLETED|Overall Study||1
9857739|NCT00912028|10970776|FG004|NOT COMPLETED|Overall Study||3
9857740|NCT00912093|10970791|FG000|STARTED|The Controlled Phase||43
9857741|NCT00912093|10970792|FG001|STARTED|The Controlled Phase||45
9857742|NCT00912093|10970793|FG002|STARTED|The Controlled Phase||3
9857743|NCT00912093|10970794|FG003|STARTED|The Controlled Phase||2
9857744|NCT00912093|10970795|FG004|STARTED|The Controlled Phase||5
9857745|NCT00912093|10970791|FG000|COMPLETED|The Controlled Phase||43
9857746|NCT00912093|10970792|FG001|COMPLETED|The Controlled Phase||43
9857747|NCT00912093|10970793|FG002|COMPLETED|The Controlled Phase||3
9857748|NCT00912093|10970794|FG003|COMPLETED|The Controlled Phase||2
9857749|NCT00912093|10970795|FG004|COMPLETED|The Controlled Phase||4
9857750|NCT00912093|10970791|FG000|NOT COMPLETED|The Controlled Phase||0
9857751|NCT00912093|10970792|FG001|NOT COMPLETED|The Controlled Phase||2
9857752|NCT00912093|10970793|FG002|NOT COMPLETED|The Controlled Phase||0
9857753|NCT00912093|10970794|FG003|NOT COMPLETED|The Controlled Phase||0
9857754|NCT00912093|10970795|FG004|NOT COMPLETED|The Controlled Phase||1
9857755|NCT00912093|10970791|FG000|STARTED|The Open Label Extension (OLE) Phase||38
9857756|NCT00912093|10970792|FG001|STARTED|The Open Label Extension (OLE) Phase||35
9857757|NCT00912093|10970793|FG002|STARTED|The Open Label Extension (OLE) Phase||3
9857758|NCT00912093|10970794|FG003|STARTED|The Open Label Extension (OLE) Phase||2
9857759|NCT00912093|10970795|FG004|STARTED|The Open Label Extension (OLE) Phase||4
9857760|NCT00912093|10970791|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38
9857761|NCT00912093|10970792|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35
9857762|NCT00912093|10970793|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3
9857763|NCT00912093|10970794|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2
9857764|NCT00912093|10970795|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4
9857765|NCT00912093|10970791|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
9857766|NCT00912093|10970792|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
9857767|NCT00912093|10970793|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
9857768|NCT00912093|10970794|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
9857769|NCT00912093|10970795|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
9857770|NCT00912197|10970805|FG000|STARTED|Overall Study||15
9857771|NCT00912197|10970806|FG001|STARTED|Overall Study||13
9857772|NCT00912197|10970805|FG000|COMPLETED|Overall Study||12
9857773|NCT00912197|10970806|FG001|COMPLETED|Overall Study||10
9857774|NCT00912197|10970805|FG000|NOT COMPLETED|Overall Study||3
9857775|NCT00912197|10970806|FG001|NOT COMPLETED|Overall Study||3
9857776|NCT00912288|10970816|FG000|STARTED|Overall Study||44
9857777|NCT00912288|10970817|FG001|STARTED|Overall Study||42
9857778|NCT00912288|10970816|FG000|COMPLETED|Overall Study||3
9857779|NCT00912288|10970817|FG001|COMPLETED|Overall Study||2
9857780|NCT00912288|10970816|FG000|NOT COMPLETED|Overall Study||41
9857781|NCT00912288|10970817|FG001|NOT COMPLETED|Overall Study||40
9857782|NCT00912301|10970826|FG000|STARTED|Overall Study||11
9857783|NCT00912301|10970827|FG001|STARTED|Overall Study||12
9857784|NCT00912301|10970828|FG002|STARTED|Overall Study||13
9857785|NCT00912301|10970826|FG000|COMPLETED|Overall Study||11
9857786|NCT00912301|10970827|FG001|COMPLETED|Overall Study||12
9857787|NCT00912301|10970828|FG002|COMPLETED|Overall Study||13
9857788|NCT00912301|10970826|FG000|NOT COMPLETED|Overall Study||0
9857789|NCT00912301|10970827|FG001|NOT COMPLETED|Overall Study||0
9857790|NCT00912301|10970828|FG002|NOT COMPLETED|Overall Study||0
9857791|NCT00912340|10970839|FG000|STARTED|Overall Study||24
9857792|NCT00912340|10970840|FG001|STARTED|Overall Study||30
9857793|NCT00912340|10970841|FG002|STARTED|Overall Study||4
9857794|NCT00912340|10970839|FG000|COMPLETED|Overall Study||22
9857795|NCT00912340|10970840|FG001|COMPLETED|Overall Study||26
9857796|NCT00912340|10970841|FG002|COMPLETED|Overall Study||0
9857797|NCT00912340|10970839|FG000|NOT COMPLETED|Overall Study||2
9857798|NCT00912340|10970840|FG001|NOT COMPLETED|Overall Study||4
9857799|NCT00912340|10970841|FG002|NOT COMPLETED|Overall Study||4
9857800|NCT00912405|10970849|FG000|STARTED|Overall Study||50
9857801|NCT00912405|10970849|FG000|COMPLETED|Overall Study||45
9857802|NCT00912405|10970849|FG000|NOT COMPLETED|Overall Study||5
9857803|NCT00912509|10970855|FG000|STARTED|Overall Study||20
9857804|NCT00912509|10970856|FG001|STARTED|Overall Study||10
9857805|NCT00912509|10970855|FG000|COMPLETED|Overall Study||15
9857806|NCT00912509|10970856|FG001|COMPLETED|Overall Study||7
9857807|NCT00912509|10970855|FG000|NOT COMPLETED|Overall Study||5
9857808|NCT00912509|10970856|FG001|NOT COMPLETED|Overall Study||3
9857809|NCT00912743|10970865|FG000|STARTED|Overall Study||13
9857810|NCT00912743|10970866|FG001|STARTED|Overall Study||20
9857811|NCT00912743|10970865|FG000|COMPLETED|Overall Study||0
9857812|NCT00912743|10970866|FG001|COMPLETED|Overall Study||0
9857813|NCT00912743|10970865|FG000|NOT COMPLETED|Overall Study||13
9857814|NCT00912743|10970866|FG001|NOT COMPLETED|Overall Study||20
9857815|NCT00912782|10970874|FG000|STARTED|Overall Study||27
9857816|NCT00912782|10970875|FG001|STARTED|Overall Study||25
9857817|NCT00912782|10970874|FG000|COMPLETED|Overall Study||24
9857818|NCT00912782|10970875|FG001|COMPLETED|Overall Study||20
9857819|NCT00912782|10970874|FG000|NOT COMPLETED|Overall Study||3
9857820|NCT00912782|10970875|FG001|NOT COMPLETED|Overall Study||5
9857821|NCT00912795|10970883|FG000|STARTED|Overall Study||76
9857822|NCT00912795|10970884|FG001|STARTED|Overall Study||75
9857823|NCT00912795|10970883|FG000|COMPLETED|Overall Study||29
9857824|NCT00912795|10970884|FG001|COMPLETED|Overall Study||17
9857825|NCT00912795|10970883|FG000|NOT COMPLETED|Overall Study||47
9857826|NCT00912795|10970884|FG001|NOT COMPLETED|Overall Study||58
9857827|NCT00912808|10970892|FG000|STARTED|First Intervention (6 Weeks)||11
9857828|NCT00912808|10970893|FG001|STARTED|First Intervention (6 Weeks)||12
9857829|NCT00912808|10970892|FG000|Received Intervention|First Intervention (6 Weeks)||11
9857830|NCT00912808|10970893|FG001|Received Intervention|First Intervention (6 Weeks)||12
9857831|NCT00912808|10970892|FG000|COMPLETED|First Intervention (6 Weeks)||9
9857832|NCT00912808|10970893|FG001|COMPLETED|First Intervention (6 Weeks)||11
9857833|NCT00912808|10970892|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
9857834|NCT00912808|10970893|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
9857835|NCT00912808|10970892|FG000|STARTED|Washout||9
9857836|NCT00912808|10970893|FG001|STARTED|Washout||11
9857837|NCT00912808|10970892|FG000|COMPLETED|Washout||9
9857838|NCT00912808|10970893|FG001|COMPLETED|Washout||10
9857839|NCT00912808|10970892|FG000|NOT COMPLETED|Washout||0
9857840|NCT00912808|10970893|FG001|NOT COMPLETED|Washout||1
9857841|NCT00912808|10970892|FG000|STARTED|Second Intervention (6 Weeks)||9
9857842|NCT00912808|10970893|FG001|STARTED|Second Intervention (6 Weeks)||10
9857843|NCT00912808|10970892|FG000|Received Intervention|Second Intervention (6 Weeks)||9
9857844|NCT00912808|10970893|FG001|Received Intervention|Second Intervention (6 Weeks)||10
9857845|NCT00912808|10970892|FG000|COMPLETED|Second Intervention (6 Weeks)||8
9857846|NCT00912808|10970893|FG001|COMPLETED|Second Intervention (6 Weeks)||9
9857847|NCT00912808|10970892|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1
9857848|NCT00912808|10970893|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1
9857849|NCT00912873|10970902|FG000|STARTED|Overall Study||26
9857850|NCT00912873|10970903|FG001|STARTED|Overall Study||24
9857851|NCT00912873|10970902|FG000|COMPLETED|Overall Study||26
9857852|NCT00912873|10970903|FG001|COMPLETED|Overall Study||24
9857853|NCT00912873|10970902|FG000|NOT COMPLETED|Overall Study||0
9857854|NCT00912873|10970903|FG001|NOT COMPLETED|Overall Study||0
9857855|NCT00912912|10970913|FG000|STARTED|Overall Study||5
9857856|NCT00912912|10970913|FG000|COMPLETED|Overall Study||1
9857857|NCT00912912|10970913|FG000|NOT COMPLETED|Overall Study||4
9857858|NCT00912925|10970919|FG000|STARTED|Overall Study||23
9857859|NCT00912925|10970920|FG001|STARTED|Overall Study||22
9857860|NCT00912925|10970919|FG000|COMPLETED|Overall Study||23
9857861|NCT00912925|10970920|FG001|COMPLETED|Overall Study||22
9857862|NCT00912925|10970919|FG000|NOT COMPLETED|Overall Study||0
9857863|NCT00912925|10970920|FG001|NOT COMPLETED|Overall Study||0
9857864|NCT00912964|10970929|FG000|STARTED|Overall Study||433
9857865|NCT00912964|10970930|FG001|STARTED|Overall Study||433
9857866|NCT00912964|10970931|FG002|STARTED|Overall Study||440
9857867|NCT00912964|10970929|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
9857868|NCT00912964|10970930|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
9857869|NCT00912964|10970931|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
9857870|NCT00912964|10970929|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
9857871|NCT00912964|10970930|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
9857872|NCT00912964|10970931|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
9857873|NCT00912964|10970929|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
9857874|NCT00912964|10970930|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
9857875|NCT00912964|10970931|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
9857876|NCT00912964|10970929|FG000|COMPLETED|Overall Study||367
9857877|NCT00912964|10970930|FG001|COMPLETED|Overall Study||387
9857878|NCT00912964|10970931|FG002|COMPLETED|Overall Study||386
9857879|NCT00912964|10970929|FG000|NOT COMPLETED|Overall Study||66
9857880|NCT00912964|10970930|FG001|NOT COMPLETED|Overall Study||46
9857881|NCT00912964|10970931|FG002|NOT COMPLETED|Overall Study||54
9857882|NCT00912990|10970941|FG000|STARTED|Overall Study||16
9857883|NCT00912990|10970942|FG001|STARTED|Overall Study||18
9857884|NCT00912990|10970941|FG000|COMPLETED|Overall Study||16
9857885|NCT00912990|10970942|FG001|COMPLETED|Overall Study||18
9857886|NCT00912990|10970941|FG000|NOT COMPLETED|Overall Study||0
9857887|NCT00912990|10970942|FG001|NOT COMPLETED|Overall Study||0
9857888|NCT00913003|10970950|FG000|STARTED|Overall Study||11
9857889|NCT00913003|10970951|FG001|STARTED|Overall Study||11
9857890|NCT00913003|10970950|FG000|COMPLETED|Overall Study||11
9857891|NCT00913003|10970951|FG001|COMPLETED|Overall Study||11
9857892|NCT00913003|10970950|FG000|NOT COMPLETED|Overall Study||0
9857893|NCT00913003|10970951|FG001|NOT COMPLETED|Overall Study||0
9857894|NCT00913068|10970959|FG000|STARTED|Overall Study||56
9857895|NCT00913068|10970960|FG001|STARTED|Overall Study||54
9857896|NCT00913068|10970959|FG000|COMPLETED|Overall Study||48
9857897|NCT00913068|10970960|FG001|COMPLETED|Overall Study||46
9857898|NCT00913068|10970959|FG000|NOT COMPLETED|Overall Study||8
9857899|NCT00913068|10970960|FG001|NOT COMPLETED|Overall Study||8
9857900|NCT00913081|10970966|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
9857901|NCT00913081|10970966|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
9857902|NCT00913081|10970966|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
9857903|NCT00913081|10970966|FG000|STARTED|Washout #1 (7 Days)||17
9857904|NCT00913081|10970966|FG000|COMPLETED|Washout #1 (7 Days)||17
9857905|NCT00913081|10970966|FG000|NOT COMPLETED|Washout #1 (7 Days)||0
9857906|NCT00913081|10970966|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
9857907|NCT00913081|10970966|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
9857908|NCT00913081|10970966|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
9857909|NCT00913081|10970966|FG000|STARTED|Washout #2 (7 Days)||17
9857910|NCT00913081|10970966|FG000|COMPLETED|Washout #2 (7 Days)||17
9857911|NCT00913081|10970966|FG000|NOT COMPLETED|Washout #2 (7 Days)||0
9857912|NCT00913081|10970966|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
9857913|NCT00913081|10970966|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
9857914|NCT00913081|10970966|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
9857915|NCT00913081|10970966|FG000|STARTED|Washout #3 (7days)||17
9857916|NCT00913081|10970966|FG000|COMPLETED|Washout #3 (7days)||17
9857917|NCT00913081|10970966|FG000|NOT COMPLETED|Washout #3 (7days)||0
9857918|NCT00913081|10970966|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17
9857919|NCT00913081|10970966|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17
9857920|NCT00913081|10970966|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
9857921|NCT00913133|10970976|FG000|STARTED|Overall Study||516
9857922|NCT00913133|10970976|FG000|COMPLETED|Overall Study||516
9857923|NCT00913133|10970976|FG000|NOT COMPLETED|Overall Study||0
9857924|NCT00913263|10970980|FG000|STARTED|Overall Study||24
9857925|NCT00913263|10970980|FG000|COMPLETED|Overall Study||24
9857926|NCT00913263|10970980|FG000|NOT COMPLETED|Overall Study||0
9857927|NCT00913380|10970990|FG000|STARTED|CT Examination||444
9857928|NCT00913380|10970991|FG001|STARTED|CT Examination||447
9857929|NCT00913380|10970990|FG000|COMPLETED|CT Examination||444
10092881|NCT02340819|11221438|FG000|Started Stage 3|Overall Study||8
10092882|NCT02340819|11221438|FG000|Completed Stage 3|Overall Study||7
10092883|NCT02340819|11221438|FG000|Started Stage 4|Overall Study||7
9857930|NCT00913380|10970991|FG001|COMPLETED|CT Examination||447
9857931|NCT00913380|10970990|FG000|NOT COMPLETED|CT Examination||0
9857932|NCT00913380|10970991|FG001|NOT COMPLETED|CT Examination||0
9857933|NCT00913380|10970990|FG000|STARTED|Clinical Outcomes||444
9857934|NCT00913380|10970991|FG001|STARTED|Clinical Outcomes||447
9857935|NCT00913380|10970990|FG000|COMPLETED|Clinical Outcomes||438
9857936|NCT00913380|10970991|FG001|COMPLETED|Clinical Outcomes||441
9857937|NCT00913380|10970990|FG000|NOT COMPLETED|Clinical Outcomes||6
9857938|NCT00913380|10970991|FG001|NOT COMPLETED|Clinical Outcomes||6
9857939|NCT00913458|10970997|FG000|STARTED|Phase 1||306
9857940|NCT00913458|10970998|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0
9857941|NCT00913458|10970999|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0
9857942|NCT00913458|10971000|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0
9857943|NCT00913458|10971001|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0
9857944|NCT00913458|10971002|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0
9857945|NCT00913458|10971003|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0
9857946|NCT00913458|10970997|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
9857947|NCT00913458|10970998|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
9857948|NCT00913458|10970999|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
9857949|NCT00913458|10971000|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
9857950|NCT00913458|10971001|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
9857951|NCT00913458|10971002|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
9857952|NCT00913458|10971003|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
9857953|NCT00913458|10970997|FG000|NOT COMPLETED|Phase 1||112
9857954|NCT00913458|10970998|FG001|NOT COMPLETED|Phase 1||0
9857955|NCT00913458|10970999|FG002|NOT COMPLETED|Phase 1||0
9857956|NCT00913458|10971000|FG003|NOT COMPLETED|Phase 1||0
9857957|NCT00913458|10971001|FG004|NOT COMPLETED|Phase 1||0
9857958|NCT00913458|10971002|FG005|NOT COMPLETED|Phase 1||0
9857959|NCT00913458|10971003|FG006|NOT COMPLETED|Phase 1||0
9857960|NCT00913458|10970997|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
9857961|NCT00913458|10970998|FG001|STARTED|Phase 2||63
9857962|NCT00913458|10970999|FG002|STARTED|Phase 2||65
9857963|NCT00913458|10971000|FG003|STARTED|Phase 2||65
9857964|NCT00913458|10971001|FG004|STARTED|Phase 2||0
9857965|NCT00913458|10971002|FG005|STARTED|Phase 2||0
9857966|NCT00913458|10971003|FG006|STARTED|Phase 2||0
9857967|NCT00913458|10970997|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
9857968|NCT00913458|10970998|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
9857969|NCT00913458|10970999|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
9857970|NCT00913458|10971000|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
9857971|NCT00913458|10971001|FG004|COMPLETED|Phase 2||0
9857972|NCT00913458|10971002|FG005|COMPLETED|Phase 2||0
9857973|NCT00913458|10971003|FG006|COMPLETED|Phase 2||0
9857974|NCT00913458|10970997|FG000|NOT COMPLETED|Phase 2||0
9857975|NCT00913458|10970998|FG001|NOT COMPLETED|Phase 2||10
9857976|NCT00913458|10970999|FG002|NOT COMPLETED|Phase 2||19
9857977|NCT00913458|10971000|FG003|NOT COMPLETED|Phase 2||33
10092884|NCT02340819|11221438|FG000|Completed Stage 4|Overall Study||7
9857978|NCT00913458|10971001|FG004|NOT COMPLETED|Phase 2||0
9857979|NCT00913458|10971002|FG005|NOT COMPLETED|Phase 2||0
9857980|NCT00913458|10971003|FG006|NOT COMPLETED|Phase 2||0
9857981|NCT00913458|10970997|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
9857982|NCT00913458|10970998|FG001|STARTED|Phase 3||0
9857983|NCT00913458|10970999|FG002|STARTED|Phase 3||0
9857984|NCT00913458|10971000|FG003|STARTED|Phase 3||0
9857985|NCT00913458|10971001|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53
9857986|NCT00913458|10971002|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46
9857987|NCT00913458|10971003|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32
9857988|NCT00913458|10970997|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
9857989|NCT00913458|10970998|FG001|COMPLETED|Phase 3||0
9857990|NCT00913458|10970999|FG002|COMPLETED|Phase 3||0
9857991|NCT00913458|10971000|FG003|COMPLETED|Phase 3||0
9857992|NCT00913458|10971001|FG004|COMPLETED|Phase 3||31
9857993|NCT00913458|10971002|FG005|COMPLETED|Phase 3||28
9857994|NCT00913458|10971003|FG006|COMPLETED|Phase 3||24
9857995|NCT00913458|10970997|FG000|NOT COMPLETED|Phase 3||0
9857996|NCT00913458|10970998|FG001|NOT COMPLETED|Phase 3||0
9857997|NCT00913458|10970999|FG002|NOT COMPLETED|Phase 3||0
9857998|NCT00913458|10971000|FG003|NOT COMPLETED|Phase 3||0
9857999|NCT00913458|10971001|FG004|NOT COMPLETED|Phase 3||22
9858000|NCT00913458|10971002|FG005|NOT COMPLETED|Phase 3||18
9858001|NCT00913458|10971003|FG006|NOT COMPLETED|Phase 3||8
9858002|NCT00913510|10971022|FG000|STARTED|Overall Study||13
9858003|NCT00913510|10971023|FG001|STARTED|Overall Study||7
9858004|NCT00913510|10971022|FG000|COMPLETED|Overall Study||5
9858005|NCT00913510|10971023|FG001|COMPLETED|Overall Study||3
9858006|NCT00913510|10971022|FG000|NOT COMPLETED|Overall Study||8
9858007|NCT00913510|10971023|FG001|NOT COMPLETED|Overall Study||4
9858008|NCT00913523|10971032|FG000|STARTED|Overall Study||162
9858009|NCT00913523|10971033|FG001|STARTED|Overall Study||159
9858010|NCT00913523|10971034|FG002|STARTED|Overall Study||161
9858011|NCT00913523|10971032|FG000|COMPLETED|Overall Study||144
9858012|NCT00913523|10971033|FG001|COMPLETED|Overall Study||143
9858013|NCT00913523|10971034|FG002|COMPLETED|Overall Study||147
9858014|NCT00913523|10971032|FG000|NOT COMPLETED|Overall Study||18
9858015|NCT00913523|10971033|FG001|NOT COMPLETED|Overall Study||16
9858016|NCT00913523|10971034|FG002|NOT COMPLETED|Overall Study||14
9858017|NCT00913627|10971046|FG000|STARTED|Overall Study||29
9858018|NCT00913627|10971047|FG001|STARTED|Overall Study||53
9858019|NCT00913627|10971048|FG002|STARTED|Overall Study||56
9858020|NCT00913627|10971049|FG003|STARTED|Overall Study||58
9858021|NCT00913627|10971046|FG000|COMPLETED|Overall Study||29
9858022|NCT00913627|10971047|FG001|COMPLETED|Overall Study||53
9858023|NCT00913627|10971048|FG002|COMPLETED|Overall Study||56
9858024|NCT00913627|10971049|FG003|COMPLETED|Overall Study||58
9858025|NCT00913627|10971046|FG000|NOT COMPLETED|Overall Study||0
9858026|NCT00913627|10971047|FG001|NOT COMPLETED|Overall Study||0
9858027|NCT00913627|10971048|FG002|NOT COMPLETED|Overall Study||0
9858028|NCT00913627|10971049|FG003|NOT COMPLETED|Overall Study||0
9858029|NCT00913744|10971061|FG000|STARTED|Overall Study||75
9858030|NCT00913744|10971062|FG001|STARTED|Overall Study||25
9858031|NCT00913744|10971061|FG000|COMPLETED|Overall Study||70
9858032|NCT00913744|10971062|FG001|COMPLETED|Overall Study||24
9858033|NCT00913744|10971061|FG000|NOT COMPLETED|Overall Study||5
9858034|NCT00913744|10971062|FG001|NOT COMPLETED|Overall Study||1
9858035|NCT00913770|10971071|FG000|STARTED|Overall Study||104
9858036|NCT00913770|10971072|FG001|STARTED|Overall Study||111
9858037|NCT00913770|10971073|FG002|STARTED|Overall Study||114
9858038|NCT00913770|10971071|FG000|COMPLETED|Overall Study||69
9858039|NCT00913770|10971072|FG001|COMPLETED|Overall Study||82
9858040|NCT00913770|10971073|FG002|COMPLETED|Overall Study||93
9858041|NCT00913770|10971071|FG000|NOT COMPLETED|Overall Study||35
9858042|NCT00913770|10971072|FG001|NOT COMPLETED|Overall Study||29
9858043|NCT00913770|10971073|FG002|NOT COMPLETED|Overall Study||21
9858044|NCT00913835|10971083|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
9858045|NCT00913835|10971084|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
9858046|NCT00913835|10971083|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
9858047|NCT00913835|10971084|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
9858048|NCT00913835|10971083|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
9858049|NCT00913835|10971084|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
9858050|NCT00913835|10971083|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
9858051|NCT00913835|10971084|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
9858052|NCT00913835|10971083|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0
9858053|NCT00913835|10971084|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28
9858054|NCT00913835|10971083|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
9858055|NCT00913835|10971084|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
9858056|NCT00913835|10971083|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
9858057|NCT00913835|10971084|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
9858058|NCT00913835|10971083|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
9858059|NCT00913835|10971084|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
9953175|NCT01425801|11072005|FG000|NOT COMPLETED|Period 1||0
9953176|NCT01425801|11072006|FG001|NOT COMPLETED|Period 1||0
9953177|NCT01425801|11072007|FG002|NOT COMPLETED|Period 1||0
9953178|NCT01425801|11072008|FG003|NOT COMPLETED|Period 1||0
9953179|NCT01425801|11072009|FG004|NOT COMPLETED|Period 1||1
9953180|NCT01425801|11072010|FG005|NOT COMPLETED|Period 1||0
9953181|NCT01425801|11072005|FG000|STARTED|Period 2||9
9953182|NCT01425801|11072006|FG001|STARTED|Period 2||9
9953183|NCT01425801|11072007|FG002|STARTED|Period 2||9
9953184|NCT01425801|11072008|FG003|STARTED|Period 2||12
9953185|NCT01425801|11072009|FG004|STARTED|Period 2||12
9953186|NCT01425801|11072010|FG005|STARTED|Period 2||10
9953187|NCT01425801|11072005|FG000|COMPLETED|Period 2||9
9858060|NCT00913913|10971097|FG000|STARTED|Overall Study||8
9858061|NCT00913913|10971097|FG000|COMPLETED|Overall Study||0
9858062|NCT00913913|10971097|FG000|NOT COMPLETED|Overall Study||8
9858063|NCT00913978|10971103|FG000|STARTED|Overall Study||26
9858064|NCT00913978|10971104|FG001|STARTED|Overall Study||24
9858065|NCT00913978|10971103|FG000|COMPLETED|Overall Study||25
9858066|NCT00913978|10971104|FG001|COMPLETED|Overall Study||21
9858067|NCT00913978|10971103|FG000|NOT COMPLETED|Overall Study||1
9858068|NCT00913978|10971104|FG001|NOT COMPLETED|Overall Study||3
9858069|NCT00914069|10971112|FG000|STARTED|Overall Study||84
9858070|NCT00914069|10971113|FG001|STARTED|Overall Study||88
9858071|NCT00914069|10971112|FG000|COMPLETED|Overall Study||84
9858072|NCT00914069|10971113|FG001|COMPLETED|Overall Study||88
9858073|NCT00914069|10971112|FG000|NOT COMPLETED|Overall Study||0
9858074|NCT00914069|10971113|FG001|NOT COMPLETED|Overall Study||0
9858075|NCT00914186|10971123|FG000|STARTED|Overall Study||31
9858076|NCT00914186|10971124|FG001|STARTED|Overall Study||30
9858077|NCT00914186|10971125|FG002|STARTED|Overall Study||31
9858078|NCT00914186|10971126|FG003|STARTED|Overall Study||30
9858079|NCT00914186|10971123|FG000|COMPLETED|Overall Study||28
9858080|NCT00914186|10971124|FG001|COMPLETED|Overall Study||28
9858081|NCT00914186|10971125|FG002|COMPLETED|Overall Study||29
9858082|NCT00914186|10971126|FG003|COMPLETED|Overall Study||20
9858083|NCT00914186|10971123|FG000|NOT COMPLETED|Overall Study||3
9858084|NCT00914186|10971124|FG001|NOT COMPLETED|Overall Study||2
9858085|NCT00914186|10971125|FG002|NOT COMPLETED|Overall Study||2
9858086|NCT00914186|10971126|FG003|NOT COMPLETED|Overall Study||10
9858087|NCT00914316|10971141|FG000|STARTED|Phase 1||7
9858088|NCT00914316|10971142|FG001|STARTED|Phase 1||6
9858089|NCT00914316|10971143|FG002|STARTED|Phase 1||8
9858090|NCT00914316|10971144|FG003|STARTED|Phase 1||8
9858091|NCT00914316|10971141|FG000|COMPLETED|Phase 1||2
9858092|NCT00914316|10971142|FG001|COMPLETED|Phase 1||4
9858093|NCT00914316|10971143|FG002|COMPLETED|Phase 1||3
9858094|NCT00914316|10971144|FG003|COMPLETED|Phase 1||6
9858095|NCT00914316|10971141|FG000|NOT COMPLETED|Phase 1||5
9858096|NCT00914316|10971142|FG001|NOT COMPLETED|Phase 1||2
9858097|NCT00914316|10971143|FG002|NOT COMPLETED|Phase 1||5
9858098|NCT00914316|10971144|FG003|NOT COMPLETED|Phase 1||2
9858099|NCT00914316|10971141|FG000|STARTED|Phase 2||2
9858100|NCT00914316|10971142|FG001|STARTED|Phase 2||4
9858101|NCT00914316|10971143|FG002|STARTED|Phase 2||3
9858102|NCT00914316|10971144|FG003|STARTED|Phase 2||6
9858103|NCT00914316|10971141|FG000|COMPLETED|Phase 2||1
9858104|NCT00914316|10971142|FG001|COMPLETED|Phase 2||4
9858105|NCT00914316|10971143|FG002|COMPLETED|Phase 2||2
9858106|NCT00914316|10971144|FG003|COMPLETED|Phase 2||6
9858107|NCT00914316|10971141|FG000|NOT COMPLETED|Phase 2||1
9858108|NCT00914316|10971142|FG001|NOT COMPLETED|Phase 2||0
9858109|NCT00914316|10971143|FG002|NOT COMPLETED|Phase 2||1
9858110|NCT00914316|10971144|FG003|NOT COMPLETED|Phase 2||0
9858111|NCT00914459|10971156|FG000|STARTED|Overall Study||18
9858112|NCT00914459|10971157|FG001|STARTED|Overall Study||19
9858113|NCT00914459|10971156|FG000|COMPLETED|Overall Study||17
9858114|NCT00914459|10971157|FG001|COMPLETED|Overall Study||18
9858115|NCT00914459|10971156|FG000|NOT COMPLETED|Overall Study||1
9858116|NCT00914459|10971157|FG001|NOT COMPLETED|Overall Study||1
9858117|NCT00914485|10971165|FG000|STARTED|Overall Study||369
9858118|NCT00914485|10971165|FG000|COMPLETED|Overall Study||369
9858119|NCT00914485|10971165|FG000|NOT COMPLETED|Overall Study||0
9858120|NCT00914589|10971172|FG000|STARTED|Overall Study||128
9858121|NCT00914589|10971173|FG001|STARTED|Overall Study||143
9858122|NCT00914589|10971174|FG002|STARTED|Overall Study||138
9858123|NCT00914589|10971172|FG000|COMPLETED|Overall Study||103
9858124|NCT00914589|10971173|FG001|COMPLETED|Overall Study||127
9858125|NCT00914589|10971174|FG002|COMPLETED|Overall Study||126
9858126|NCT00914589|10971172|FG000|NOT COMPLETED|Overall Study||25
9858127|NCT00914589|10971173|FG001|NOT COMPLETED|Overall Study||16
9858128|NCT00914589|10971174|FG002|NOT COMPLETED|Overall Study||12
9858129|NCT00914628|10971184|FG000|STARTED|Overall Study|Referred to all randomized patient|64
9858130|NCT00914628|10971185|FG001|STARTED|Overall Study|Referred to all randomized patient|28
9858131|NCT00914628|10971184|FG000|COMPLETED|Overall Study|Early termination of the Study|0
9858132|NCT00914628|10971185|FG001|COMPLETED|Overall Study|Early termination of the Study|0
9858133|NCT00914628|10971184|FG000|NOT COMPLETED|Overall Study||64
9858134|NCT00914628|10971185|FG001|NOT COMPLETED|Overall Study||28
9858135|NCT00914732|10971198|FG000|STARTED|Overall Study||165
9858136|NCT00914732|10971199|FG001|STARTED|Overall Study||167
9858137|NCT00914732|10971200|FG002|STARTED|Overall Study||191
9858138|NCT00914732|10971198|FG000|Received Second Vaccination|Overall Study||150
9858139|NCT00914732|10971199|FG001|Received Second Vaccination|Overall Study||157
9858140|NCT00914732|10971200|FG002|Received Second Vaccination|Overall Study||153
9858141|NCT00914732|10971198|FG000|COMPLETED|Overall Study||155
9858142|NCT00914732|10971199|FG001|COMPLETED|Overall Study||160
9858143|NCT00914732|10971200|FG002|COMPLETED|Overall Study||180
9858144|NCT00914732|10971198|FG000|NOT COMPLETED|Overall Study||10
9858145|NCT00914732|10971199|FG001|NOT COMPLETED|Overall Study||7
9858146|NCT00914732|10971200|FG002|NOT COMPLETED|Overall Study||11
9858147|NCT00914810|10971211|FG000|STARTED|Overall Study||20
9858148|NCT00914810|10971212|FG001|STARTED|Overall Study||19
9858149|NCT00914810|10971211|FG000|COMPLETED|Overall Study||18
9858150|NCT00914810|10971212|FG001|COMPLETED|Overall Study||18
9858151|NCT00914810|10971211|FG000|NOT COMPLETED|Overall Study||2
9858152|NCT00914810|10971212|FG001|NOT COMPLETED|Overall Study||1
9858153|NCT00914849|10971220|FG000|STARTED|Overall Study||34
10092885|NCT02340819|11221438|FG000|COMPLETED|Overall Study||7
10092886|NCT02340819|11221438|FG000|NOT COMPLETED|Overall Study||4
10092887|NCT02340949|11221444|FG000|STARTED|Overall Study||115
10092888|NCT02340949|11221445|FG001|STARTED|Overall Study||65
10092889|NCT02340949|11221444|FG000|COMPLETED|Overall Study||99
10092890|NCT02340949|11221445|FG001|COMPLETED|Overall Study||61
10092891|NCT02340949|11221444|FG000|NOT COMPLETED|Overall Study||16
10092892|NCT02340949|11221445|FG001|NOT COMPLETED|Overall Study||4
10092893|NCT02340962|11221453|FG000|STARTED|Overall Study||13
10092894|NCT02340962|11221454|FG001|STARTED|Overall Study||12
10092895|NCT02340962|11221453|FG000|COMPLETED|Overall Study||12
9758534|NCT03329690|10862052|FG001|NOT COMPLETED|Overall Study||55
9758535|NCT03329690|10862053|FG002|NOT COMPLETED|Overall Study||7
9758536|NCT03329690|10862054|FG003|NOT COMPLETED|Overall Study||21
9758537|NCT03329690|10862055|FG004|NOT COMPLETED|Overall Study||24
9758538|NCT03320564|10862073|FG000|STARTED|Overall Study||2
9758539|NCT03320564|10862073|FG000|COMPLETED|Overall Study||1
9758540|NCT03320564|10862073|FG000|NOT COMPLETED|Overall Study||1
9829123|NCT00758524|10939638|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829124|NCT00758524|10939639|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829125|NCT00758524|10939640|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829126|NCT00758524|10939641|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829127|NCT00758524|10939642|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
9829128|NCT00758524|10939643|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829129|NCT00758524|10939644|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
9829130|NCT00758524|10939645|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829131|NCT00758524|10939646|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829132|NCT00758524|10939647|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829133|NCT00758524|10939648|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829134|NCT00758524|10939649|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829135|NCT00758524|10939650|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829136|NCT00758524|10939651|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829137|NCT00758524|10939652|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
9829138|NCT00758550|10939692|FG000|STARTED|Overall Study||30
9829139|NCT00758550|10939693|FG001|STARTED|Overall Study||30
9829140|NCT00758550|10939692|FG000|COMPLETED|Overall Study||30
9829141|NCT00758550|10939693|FG001|COMPLETED|Overall Study||30
9829142|NCT00758550|10939692|FG000|NOT COMPLETED|Overall Study||0
9829143|NCT00758550|10939693|FG001|NOT COMPLETED|Overall Study||0
9829144|NCT00758576|10939699|FG000|STARTED|Overall Study||64
9829145|NCT00758576|10939699|FG000|COMPLETED|Overall Study||63
9829146|NCT00758576|10939699|FG000|NOT COMPLETED|Overall Study||1
9829147|NCT00758589|10939707|FG000|STARTED|Overall Study||95
9829148|NCT00758589|10939708|FG001|STARTED|Overall Study||90
9829149|NCT00758589|10939709|FG002|STARTED|Overall Study||92
9829150|NCT00758589|10939710|FG003|STARTED|Overall Study||91
9829151|NCT00758589|10939707|FG000|COMPLETED|Overall Study||92
9829152|NCT00758589|10939708|FG001|COMPLETED|Overall Study||87
9829153|NCT00758589|10939709|FG002|COMPLETED|Overall Study||86
9829154|NCT00758589|10939710|FG003|COMPLETED|Overall Study||85
9829155|NCT00758589|10939707|FG000|NOT COMPLETED|Overall Study||3
9829156|NCT00758589|10939708|FG001|NOT COMPLETED|Overall Study||3
9829157|NCT00758589|10939709|FG002|NOT COMPLETED|Overall Study||6
9829158|NCT00758589|10939710|FG003|NOT COMPLETED|Overall Study||6
9829159|NCT00758602|10939722|FG000|STARTED|Overall Study||104
9829160|NCT00758602|10939723|FG001|STARTED|Overall Study||106
9829161|NCT00758602|10939722|FG000|COMPLETED|Overall Study||85
9829162|NCT00758602|10939723|FG001|COMPLETED|Overall Study||84
9829163|NCT00758602|10939722|FG000|NOT COMPLETED|Overall Study||19
9829164|NCT00758602|10939723|FG001|NOT COMPLETED|Overall Study||22
9829165|NCT00758667|10939732|FG000|STARTED|Overall Study||9
9829166|NCT00758667|10939733|FG001|STARTED|Overall Study||11
9829167|NCT00758667|10939732|FG000|COMPLETED|Overall Study||9
9829168|NCT00758667|10939733|FG001|COMPLETED|Overall Study||11
9829169|NCT00758667|10939732|FG000|NOT COMPLETED|Overall Study||0
9829170|NCT00758667|10939733|FG001|NOT COMPLETED|Overall Study||0
9829171|NCT00758680|10939740|FG000|STARTED|Overall Study||6
9829172|NCT00758680|10939741|FG001|STARTED|Overall Study||6
9829173|NCT00758680|10939742|FG002|STARTED|Overall Study||6
9829174|NCT00758680|10939743|FG003|STARTED|Overall Study||6
9829175|NCT00758680|10939744|FG004|STARTED|Overall Study||6
9829176|NCT00758680|10939745|FG005|STARTED|Overall Study||6
9829177|NCT00758680|10939746|FG006|STARTED|Overall Study||7
9829178|NCT00758680|10939747|FG007|STARTED|Overall Study||20
9829179|NCT00758680|10939748|FG008|STARTED|Overall Study||20
9829180|NCT00758680|10939749|FG009|STARTED|Overall Study||29
9829181|NCT00758680|10939740|FG000|COMPLETED|Overall Study||6
9829182|NCT00758680|10939741|FG001|COMPLETED|Overall Study||6
9829183|NCT00758680|10939742|FG002|COMPLETED|Overall Study||6
9829184|NCT00758680|10939743|FG003|COMPLETED|Overall Study||6
9829185|NCT00758680|10939744|FG004|COMPLETED|Overall Study||6
9829186|NCT00758680|10939745|FG005|COMPLETED|Overall Study||6
9829187|NCT00758680|10939746|FG006|COMPLETED|Overall Study||6
9829188|NCT00758680|10939747|FG007|COMPLETED|Overall Study||19
9829189|NCT00758680|10939748|FG008|COMPLETED|Overall Study||18
9829190|NCT00758680|10939749|FG009|COMPLETED|Overall Study||28
9858154|NCT00914849|10971221|FG001|STARTED|Overall Study||34
9858155|NCT00914849|10971220|FG000|COMPLETED|Overall Study||33
9858156|NCT00914849|10971221|FG001|COMPLETED|Overall Study||33
9858157|NCT00914849|10971220|FG000|NOT COMPLETED|Overall Study||1
9858158|NCT00914849|10971221|FG001|NOT COMPLETED|Overall Study||1
9858159|NCT00914862|10971232|FG000|STARTED|Overall Study||6
9858160|NCT00914862|10971233|FG001|STARTED|Overall Study||6
9858161|NCT00914862|10971234|FG002|STARTED|Overall Study||8
9858162|NCT00914862|10971235|FG003|STARTED|Overall Study||8
9858163|NCT00914862|10971236|FG004|STARTED|Overall Study||28
9858164|NCT00914862|10971232|FG000|COMPLETED|Overall Study||6
9858165|NCT00914862|10971233|FG001|COMPLETED|Overall Study||6
9858166|NCT00914862|10971234|FG002|COMPLETED|Overall Study||8
9858167|NCT00914862|10971235|FG003|COMPLETED|Overall Study||8
9858168|NCT00914862|10971236|FG004|COMPLETED|Overall Study||28
9858169|NCT00914862|10971232|FG000|NOT COMPLETED|Overall Study||0
9858170|NCT00914862|10971233|FG001|NOT COMPLETED|Overall Study||0
9858171|NCT00914862|10971234|FG002|NOT COMPLETED|Overall Study||0
9858172|NCT00914862|10971235|FG003|NOT COMPLETED|Overall Study||0
9858173|NCT00914862|10971236|FG004|NOT COMPLETED|Overall Study||0
9858174|NCT00914927|10971255|FG000|STARTED|Overall Study||18
9858175|NCT00914927|10971256|FG001|STARTED|Overall Study||16
9858176|NCT00914927|10971257|FG002|STARTED|Overall Study||17
9858177|NCT00914927|10971258|FG003|STARTED|Overall Study||16
9858178|NCT00914927|10971259|FG004|STARTED|Overall Study||21
9858179|NCT00914927|10971260|FG005|STARTED|Overall Study||21
9858180|NCT00914927|10971261|FG006|STARTED|Overall Study||21
9858181|NCT00914927|10971255|FG000|COMPLETED|Overall Study||16
9858182|NCT00914927|10971256|FG001|COMPLETED|Overall Study||14
9858183|NCT00914927|10971257|FG002|COMPLETED|Overall Study||17
9858184|NCT00914927|10971258|FG003|COMPLETED|Overall Study||14
9858185|NCT00914927|10971259|FG004|COMPLETED|Overall Study||19
9858186|NCT00914927|10971260|FG005|COMPLETED|Overall Study||21
9858187|NCT00914927|10971261|FG006|COMPLETED|Overall Study||21
9858188|NCT00914927|10971255|FG000|NOT COMPLETED|Overall Study||2
9858189|NCT00914927|10971256|FG001|NOT COMPLETED|Overall Study||2
9858190|NCT00914927|10971257|FG002|NOT COMPLETED|Overall Study||0
9858191|NCT00914927|10971258|FG003|NOT COMPLETED|Overall Study||2
9858192|NCT00914927|10971259|FG004|NOT COMPLETED|Overall Study||2
9858193|NCT00914927|10971260|FG005|NOT COMPLETED|Overall Study||0
9858194|NCT00914927|10971261|FG006|NOT COMPLETED|Overall Study||0
9858195|NCT00914940|10971286|FG000|STARTED|D0 to D100 Post-transplant||41
9858196|NCT00914940|10971286|FG000|COMPLETED|D0 to D100 Post-transplant||39
9858197|NCT00914940|10971286|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2
9858198|NCT00914940|10971286|FG000|STARTED|D101 to 2 Years Post-transplant||39
9858199|NCT00914940|10971286|FG000|COMPLETED|D101 to 2 Years Post-transplant||31
9858200|NCT00914940|10971286|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8
9858201|NCT00914940|10971286|FG000|STARTED|2 Years to 5 Years Post-transplant||31
9858202|NCT00914940|10971286|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28
9858203|NCT00914940|10971286|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
9858204|NCT00914966|10971290|FG000|STARTED|Step 1: 1500 Units||20
9858205|NCT00914966|10971290|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
9858206|NCT00914966|10971290|FG000|NOT COMPLETED|Step 1: 1500 Units||2
9858207|NCT00914966|10971290|FG000|STARTED|Step 2: 2000 Units||13
9858208|NCT00914966|10971290|FG000|COMPLETED|Step 2: 2000 Units||12
9858209|NCT00914966|10971290|FG000|NOT COMPLETED|Step 2: 2000 Units||1
9858210|NCT00914966|10971290|FG000|STARTED|Step 3: 2500 Units||12
9858211|NCT00914966|10971290|FG000|COMPLETED|Step 3: 2500 Units||12
9858212|NCT00914966|10971290|FG000|NOT COMPLETED|Step 3: 2500 Units||0
9858213|NCT00915005|10971301|FG000|STARTED|Overall Study||105
9858214|NCT00915005|10971302|FG001|STARTED|Overall Study||76
9858215|NCT00915005|10971301|FG000|COMPLETED|Overall Study||92
9858216|NCT00915005|10971302|FG001|COMPLETED|Overall Study||57
9858217|NCT00915005|10971301|FG000|NOT COMPLETED|Overall Study||13
9858218|NCT00915005|10971302|FG001|NOT COMPLETED|Overall Study||19
9858219|NCT00915018|10971310|FG000|STARTED|Overall Study||242
9858220|NCT00915018|10971311|FG001|STARTED|Overall Study||237
9858221|NCT00915018|10971310|FG000|Received Treatment|Overall Study||240
9858222|NCT00915018|10971311|FG001|Received Treatment|Overall Study||234
9858223|NCT00915018|10971310|FG000|COMPLETED|Overall Study||27
9858224|NCT00915018|10971311|FG001|COMPLETED|Overall Study||30
9858225|NCT00915018|10971310|FG000|NOT COMPLETED|Overall Study||215
9858226|NCT00915018|10971311|FG001|NOT COMPLETED|Overall Study||207
9858227|NCT00915031|10971319|FG000|STARTED|Overall Study||714
9858228|NCT00915031|10971320|FG001|STARTED|Overall Study||24
9858229|NCT00915031|10971319|FG000|COMPLETED|Overall Study||714
9858230|NCT00915031|10971320|FG001|COMPLETED|Overall Study||24
9858231|NCT00915031|10971319|FG000|NOT COMPLETED|Overall Study||0
9858232|NCT00915031|10971320|FG001|NOT COMPLETED|Overall Study||0
9858233|NCT00915148|10971325|FG000|STARTED|Overall Study|October 2009|110
9858234|NCT00915148|10971325|FG000|COMPLETED|Overall Study|August 2010|110
9858235|NCT00915148|10971325|FG000|NOT COMPLETED|Overall Study||0
9858236|NCT00915278|10971336|FG000|STARTED|Overall Study||8
9858237|NCT00915278|10971337|FG001|STARTED|Overall Study||5
9858238|NCT00915278|10971338|FG002|STARTED|Overall Study||3
9858239|NCT00915278|10971339|FG003|STARTED|Overall Study||5
9858240|NCT00915278|10971340|FG004|STARTED|Overall Study||3
9858241|NCT00915278|10971341|FG005|STARTED|Overall Study||9
9858242|NCT00915278|10971336|FG000|COMPLETED|Overall Study||3
9858243|NCT00915278|10971337|FG001|COMPLETED|Overall Study||2
9858244|NCT00915278|10971338|FG002|COMPLETED|Overall Study||2
9858245|NCT00915278|10971339|FG003|COMPLETED|Overall Study||2
9858246|NCT00915278|10971340|FG004|COMPLETED|Overall Study||1
9858247|NCT00915278|10971341|FG005|COMPLETED|Overall Study||1
9858248|NCT00915278|10971336|FG000|NOT COMPLETED|Overall Study||5
9858249|NCT00915278|10971337|FG001|NOT COMPLETED|Overall Study||3
9858250|NCT00915278|10971338|FG002|NOT COMPLETED|Overall Study||1
9858251|NCT00915278|10971339|FG003|NOT COMPLETED|Overall Study||3
9858252|NCT00915278|10971340|FG004|NOT COMPLETED|Overall Study||2
9858253|NCT00915278|10971341|FG005|NOT COMPLETED|Overall Study||8
9858254|NCT00915343|10971355|FG000|STARTED|Part A - First Intervention Period||32
9858255|NCT00915343|10971356|FG001|STARTED|Part A - First Intervention Period||32
9858256|NCT00915343|10971357|FG002|STARTED|Part A - First Intervention Period||0
9858257|NCT00915343|10971355|FG000|COMPLETED|Part A - First Intervention Period||32
9858258|NCT00915343|10971356|FG001|COMPLETED|Part A - First Intervention Period||32
9858259|NCT00915343|10971357|FG002|COMPLETED|Part A - First Intervention Period||0
9858260|NCT00915343|10971355|FG000|NOT COMPLETED|Part A - First Intervention Period||0
9858261|NCT00915343|10971356|FG001|NOT COMPLETED|Part A - First Intervention Period||0
9858262|NCT00915343|10971357|FG002|NOT COMPLETED|Part A - First Intervention Period||0
9858263|NCT00915343|10971355|FG000|STARTED|Part A - Second Intervention Period||32
9858264|NCT00915343|10971356|FG001|STARTED|Part A - Second Intervention Period||32
9858265|NCT00915343|10971357|FG002|STARTED|Part A - Second Intervention Period||0
9858266|NCT00915343|10971355|FG000|COMPLETED|Part A - Second Intervention Period||32
9858267|NCT00915343|10971356|FG001|COMPLETED|Part A - Second Intervention Period||32
9858268|NCT00915343|10971357|FG002|COMPLETED|Part A - Second Intervention Period||0
9858269|NCT00915343|10971355|FG000|NOT COMPLETED|Part A - Second Intervention Period||0
9858270|NCT00915343|10971356|FG001|NOT COMPLETED|Part A - Second Intervention Period||0
9858271|NCT00915343|10971357|FG002|NOT COMPLETED|Part A - Second Intervention Period||0
9858272|NCT00915343|10971355|FG000|STARTED|Part B - Open Label Period||0
9858273|NCT00915343|10971356|FG001|STARTED|Part B - Open Label Period||0
9858274|NCT00915343|10971357|FG002|STARTED|Part B - Open Label Period||59
9858275|NCT00915343|10971355|FG000|COMPLETED|Part B - Open Label Period||0
9858276|NCT00915343|10971356|FG001|COMPLETED|Part B - Open Label Period||0
9858277|NCT00915343|10971357|FG002|COMPLETED|Part B - Open Label Period||57
9858278|NCT00915343|10971355|FG000|NOT COMPLETED|Part B - Open Label Period||0
9858279|NCT00915343|10971356|FG001|NOT COMPLETED|Part B - Open Label Period||0
9858280|NCT00915343|10971357|FG002|NOT COMPLETED|Part B - Open Label Period||2
9858281|NCT00915356|10971374|FG000|STARTED|Overall Study||26
9858282|NCT00915356|10971375|FG001|STARTED|Overall Study||45
9858283|NCT00915356|10971376|FG002|STARTED|Overall Study||45
9858284|NCT00915356|10971377|FG003|STARTED|Overall Study||12
9858285|NCT00915356|10971378|FG004|STARTED|Overall Study||43
9858286|NCT00915356|10971374|FG000|COMPLETED|Overall Study||25
9858287|NCT00915356|10971375|FG001|COMPLETED|Overall Study||45
9858288|NCT00915356|10971376|FG002|COMPLETED|Overall Study||45
9858289|NCT00915356|10971377|FG003|COMPLETED|Overall Study||12
9858290|NCT00915356|10971378|FG004|COMPLETED|Overall Study||43
9858291|NCT00915356|10971374|FG000|NOT COMPLETED|Overall Study||1
9858292|NCT00915356|10971375|FG001|NOT COMPLETED|Overall Study||0
9858293|NCT00915356|10971376|FG002|NOT COMPLETED|Overall Study||0
9858294|NCT00915356|10971377|FG003|NOT COMPLETED|Overall Study||0
9858295|NCT00915356|10971378|FG004|NOT COMPLETED|Overall Study||0
9858296|NCT00915473|10971392|FG000|STARTED|Screening||35
9858297|NCT00915473|10971393|FG001|STARTED|Screening||35
9858298|NCT00915473|10971392|FG000|COMPLETED|Screening||34
9858299|NCT00915473|10971393|FG001|COMPLETED|Screening||35
9858300|NCT00915473|10971392|FG000|NOT COMPLETED|Screening||1
9858301|NCT00915473|10971393|FG001|NOT COMPLETED|Screening||0
9858302|NCT00915473|10971392|FG000|STARTED|Injection||34
9858303|NCT00915473|10971393|FG001|STARTED|Injection||35
9858304|NCT00915473|10971392|FG000|COMPLETED|Injection||34
9858305|NCT00915473|10971393|FG001|COMPLETED|Injection||35
9858306|NCT00915473|10971392|FG000|NOT COMPLETED|Injection||0
9858307|NCT00915473|10971393|FG001|NOT COMPLETED|Injection||0
9858308|NCT00915473|10971392|FG000|STARTED|4-week Follow Up||34
9858309|NCT00915473|10971393|FG001|STARTED|4-week Follow Up||35
9858310|NCT00915473|10971392|FG000|COMPLETED|4-week Follow Up||33
9858311|NCT00915473|10971393|FG001|COMPLETED|4-week Follow Up||30
9858312|NCT00915473|10971392|FG000|NOT COMPLETED|4-week Follow Up||1
9858313|NCT00915473|10971393|FG001|NOT COMPLETED|4-week Follow Up||5
9858314|NCT00915499|10971401|FG000|STARTED|Overall Study||33
9858315|NCT00915499|10971402|FG001|STARTED|Overall Study||33
9858316|NCT00915499|10971401|FG000|COMPLETED|Overall Study||29
9858317|NCT00915499|10971402|FG001|COMPLETED|Overall Study||31
9858318|NCT00915499|10971401|FG000|NOT COMPLETED|Overall Study||4
9858319|NCT00915499|10971402|FG001|NOT COMPLETED|Overall Study||2
9858320|NCT00915525|10971410|FG000|STARTED|Overall Study||543
9858321|NCT00915525|10971411|FG001|STARTED|Overall Study||286
9858322|NCT00915525|10971410|FG000|COMPLETED|Overall Study||278
9858323|NCT00915525|10971411|FG001|COMPLETED|Overall Study||151
9858324|NCT00915525|10971410|FG000|NOT COMPLETED|Overall Study||265
9858325|NCT00915525|10971411|FG001|NOT COMPLETED|Overall Study||135
9858326|NCT00915538|10971439|FG000|STARTED|Overall Study||8
9858327|NCT00915538|10971440|FG001|STARTED|Overall Study||8
9858328|NCT00915538|10971439|FG000|COMPLETED|Overall Study||8
9858329|NCT00915538|10971440|FG001|COMPLETED|Overall Study||8
9858330|NCT00915538|10971439|FG000|NOT COMPLETED|Overall Study||0
9858331|NCT00915538|10971440|FG001|NOT COMPLETED|Overall Study||0
9858332|NCT00915551|10971450|FG000|STARTED|Overall Study||142
9858333|NCT00915551|10971451|FG001|STARTED|Overall Study||136
9858334|NCT00915551|10971450|FG000|COMPLETED|Overall Study||142
9858335|NCT00915551|10971451|FG001|COMPLETED|Overall Study||135
9858336|NCT00915551|10971450|FG000|NOT COMPLETED|Overall Study||0
9858337|NCT00915551|10971451|FG001|NOT COMPLETED|Overall Study||1
9858338|NCT00915590|10971459|FG000|STARTED|Overall Study||5
9858339|NCT00915590|10971460|FG001|STARTED|Overall Study||5
9858340|NCT00915590|10971459|FG000|COMPLETED|Overall Study||3
9858341|NCT00915590|10971460|FG001|COMPLETED|Overall Study||4
9858342|NCT00915590|10971459|FG000|NOT COMPLETED|Overall Study||2
9858343|NCT00915590|10971460|FG001|NOT COMPLETED|Overall Study||1
9858344|NCT00915603|10971473|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
9858345|NCT00915603|10971474|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
9858346|NCT00915603|10971473|FG000|COMPLETED|Overall Study||0
9858347|NCT00915603|10971474|FG001|COMPLETED|Overall Study||0
9858348|NCT00915603|10971473|FG000|NOT COMPLETED|Overall Study||56
9858349|NCT00915603|10971474|FG001|NOT COMPLETED|Overall Study||55
9858350|NCT00915655|10971480|FG000|STARTED|Overall Study||12
9858351|NCT00915655|10971480|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
9858352|NCT00915655|10971480|FG000|NOT COMPLETED|Overall Study||0
9858353|NCT00915759|10971484|FG000|STARTED|Overall Study|number of participants|40
9858354|NCT00915759|10971484|FG000|COMPLETED|Overall Study|number of participants|40
9858355|NCT00915759|10971484|FG000|NOT COMPLETED|Overall Study||0
9858356|NCT00915772|10971497|FG000|STARTED|Overall Study||170
9858357|NCT00915772|10971498|FG001|STARTED|Overall Study||225
9858358|NCT00915772|10971499|FG002|STARTED|Overall Study||171
9858359|NCT00915772|10971497|FG000|COMPLETED|Overall Study||134
9858360|NCT00915772|10971498|FG001|COMPLETED|Overall Study||179
9858361|NCT00915772|10971499|FG002|COMPLETED|Overall Study||142
9858362|NCT00915772|10971497|FG000|NOT COMPLETED|Overall Study||36
9858363|NCT00915772|10971498|FG001|NOT COMPLETED|Overall Study||46
9858364|NCT00915772|10971499|FG002|NOT COMPLETED|Overall Study||29
9858365|NCT00915798|10971512|FG000|STARTED|Overall Study||19
9858366|NCT00915798|10971513|FG001|STARTED|Overall Study||21
9858367|NCT00915798|10971514|FG002|STARTED|Overall Study||23
9858368|NCT00915798|10971515|FG003|STARTED|Overall Study||26
9858369|NCT00915798|10971512|FG000|COMPLETED|Overall Study||19
9858370|NCT00915798|10971513|FG001|COMPLETED|Overall Study||21
9858371|NCT00915798|10971514|FG002|COMPLETED|Overall Study||23
9858372|NCT00915798|10971515|FG003|COMPLETED|Overall Study||26
9858373|NCT00915798|10971512|FG000|NOT COMPLETED|Overall Study||0
9858374|NCT00915798|10971513|FG001|NOT COMPLETED|Overall Study||0
9858375|NCT00915798|10971514|FG002|NOT COMPLETED|Overall Study||0
9858376|NCT00915798|10971515|FG003|NOT COMPLETED|Overall Study||0
9858377|NCT00915876|10971537|FG000|STARTED|Overall Study||20
9858378|NCT00915876|10971538|FG001|STARTED|Overall Study||21
9858379|NCT00915876|10971537|FG000|Moving Beyond First Dose|Overall Study||20
9858380|NCT00915876|10971538|FG001|Moving Beyond First Dose|Overall Study||20
9858381|NCT00915876|10971537|FG000|COMPLETED|Overall Study||20
9858382|NCT00915876|10971538|FG001|COMPLETED|Overall Study||20
9858383|NCT00915876|10971537|FG000|NOT COMPLETED|Overall Study||0
9858384|NCT00915876|10971538|FG001|NOT COMPLETED|Overall Study||1
9858385|NCT00915902|10971546|FG000|STARTED|1st Treatment Period||20
9858386|NCT00915902|10971547|FG001|STARTED|1st Treatment Period||22
9858387|NCT00915902|10971546|FG000|COMPLETED|1st Treatment Period||19
9858388|NCT00915902|10971547|FG001|COMPLETED|1st Treatment Period||22
9858389|NCT00915902|10971546|FG000|NOT COMPLETED|1st Treatment Period||1
9858390|NCT00915902|10971547|FG001|NOT COMPLETED|1st Treatment Period||0
9858391|NCT00915902|10971546|FG000|STARTED|Washout (4 Weeks)||19
9858392|NCT00915902|10971547|FG001|STARTED|Washout (4 Weeks)||22
9858393|NCT00915902|10971546|FG000|COMPLETED|Washout (4 Weeks)||19
9858394|NCT00915902|10971547|FG001|COMPLETED|Washout (4 Weeks)||21
9858395|NCT00915902|10971546|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9858396|NCT00915902|10971547|FG001|NOT COMPLETED|Washout (4 Weeks)||1
9858397|NCT00915902|10971546|FG000|STARTED|2nd Treatment Period||19
9858398|NCT00915902|10971547|FG001|STARTED|2nd Treatment Period||21
9858399|NCT00915902|10971546|FG000|COMPLETED|2nd Treatment Period||19
9858400|NCT00915902|10971547|FG001|COMPLETED|2nd Treatment Period||20
9858401|NCT00915902|10971546|FG000|NOT COMPLETED|2nd Treatment Period||0
9858402|NCT00915902|10971547|FG001|NOT COMPLETED|2nd Treatment Period||1
9858403|NCT00915928|10971557|FG000|STARTED|Overall Study||25
9858404|NCT00915928|10971558|FG001|STARTED|Overall Study||22
9858405|NCT00915928|10971557|FG000|COMPLETED|Overall Study||25
9858406|NCT00915928|10971558|FG001|COMPLETED|Overall Study||22
9858407|NCT00915928|10971557|FG000|NOT COMPLETED|Overall Study||0
9858408|NCT00915928|10971558|FG001|NOT COMPLETED|Overall Study||0
9858409|NCT00915954|10971568|FG000|STARTED|Overall Study||10
9858410|NCT00915954|10971569|FG001|STARTED|Overall Study||8
9858411|NCT00915954|10971570|FG002|STARTED|Overall Study||10
9858412|NCT00915954|10971568|FG000|COMPLETED|Overall Study||10
9858413|NCT00915954|10971569|FG001|COMPLETED|Overall Study||8
9858414|NCT00915954|10971570|FG002|COMPLETED|Overall Study||10
9858415|NCT00915954|10971568|FG000|NOT COMPLETED|Overall Study||0
9858416|NCT00915954|10971569|FG001|NOT COMPLETED|Overall Study||0
9858417|NCT00915954|10971570|FG002|NOT COMPLETED|Overall Study||0
9858418|NCT00915967|10971580|FG000|STARTED|Overall Study||98
9858419|NCT00915967|10971581|FG001|STARTED|Overall Study||100
9858420|NCT00915967|10971580|FG000|COMPLETED|Overall Study||97
9858421|NCT00915967|10971581|FG001|COMPLETED|Overall Study||98
9858422|NCT00915967|10971580|FG000|NOT COMPLETED|Overall Study||1
9858423|NCT00915967|10971581|FG001|NOT COMPLETED|Overall Study||2
9858424|NCT00916006|10971589|FG000|STARTED|Overall Study||135
9858425|NCT00916006|10971590|FG001|STARTED|Overall Study||134
9858426|NCT00916006|10971589|FG000|COMPLETED|Overall Study||132
9858427|NCT00916006|10971590|FG001|COMPLETED|Overall Study||127
9858428|NCT00916006|10971589|FG000|NOT COMPLETED|Overall Study||3
9858429|NCT00916006|10971590|FG001|NOT COMPLETED|Overall Study||7
9858430|NCT00916032|10971596|FG000|STARTED|Overall Study||12
9858431|NCT00916032|10971597|FG001|STARTED|Overall Study||11
9858432|NCT00916032|10971596|FG000|COMPLETED|Overall Study||12
9858433|NCT00916032|10971597|FG001|COMPLETED|Overall Study||11
9858434|NCT00916032|10971596|FG000|NOT COMPLETED|Overall Study||0
9858435|NCT00916032|10971597|FG001|NOT COMPLETED|Overall Study||0
9858436|NCT00916058|10971610|FG000|STARTED|Phase 1||3
9858437|NCT00916058|10971611|FG001|STARTED|Phase 1||6
9858438|NCT00916058|10971612|FG002|STARTED|Phase 1||3
9858439|NCT00916058|10971613|FG003|STARTED|Phase 1||3
9858440|NCT00916058|10971614|FG004|STARTED|Phase 1||3
9858441|NCT00916058|10971615|FG005|STARTED|Phase 1||8
9858442|NCT00916058|10971616|FG006|STARTED|Phase 1||0
9858443|NCT00916058|10971610|FG000|COMPLETED|Phase 1||3
9858444|NCT00916058|10971611|FG001|COMPLETED|Phase 1||6
9858445|NCT00916058|10971612|FG002|COMPLETED|Phase 1||3
9858446|NCT00916058|10971613|FG003|COMPLETED|Phase 1||3
9858447|NCT00916058|10971614|FG004|COMPLETED|Phase 1||3
9858448|NCT00916058|10971615|FG005|COMPLETED|Phase 1||7
9858449|NCT00916058|10971616|FG006|COMPLETED|Phase 1||0
9858450|NCT00916058|10971610|FG000|NOT COMPLETED|Phase 1||0
9858451|NCT00916058|10971611|FG001|NOT COMPLETED|Phase 1||0
9858452|NCT00916058|10971612|FG002|NOT COMPLETED|Phase 1||0
9858453|NCT00916058|10971613|FG003|NOT COMPLETED|Phase 1||0
9858454|NCT00916058|10971614|FG004|NOT COMPLETED|Phase 1||0
9858455|NCT00916058|10971615|FG005|NOT COMPLETED|Phase 1||1
9858456|NCT00916058|10971616|FG006|NOT COMPLETED|Phase 1||0
9858457|NCT00916058|10971610|FG000|STARTED|Phase 2||0
9858458|NCT00916058|10971611|FG001|STARTED|Phase 2||0
9858459|NCT00916058|10971612|FG002|STARTED|Phase 2||0
9858460|NCT00916058|10971613|FG003|STARTED|Phase 2||0
9858461|NCT00916058|10971614|FG004|STARTED|Phase 2||0
9858462|NCT00916058|10971615|FG005|STARTED|Phase 2||0
9858463|NCT00916058|10971616|FG006|STARTED|Phase 2||31
9858464|NCT00916058|10971610|FG000|COMPLETED|Phase 2||0
9858465|NCT00916058|10971611|FG001|COMPLETED|Phase 2||0
9858466|NCT00916058|10971612|FG002|COMPLETED|Phase 2||0
9858467|NCT00916058|10971613|FG003|COMPLETED|Phase 2||0
9858468|NCT00916058|10971614|FG004|COMPLETED|Phase 2||0
9858469|NCT00916058|10971615|FG005|COMPLETED|Phase 2||0
9858470|NCT00916058|10971616|FG006|COMPLETED|Phase 2||28
9858471|NCT00916058|10971610|FG000|NOT COMPLETED|Phase 2||0
9858472|NCT00916058|10971611|FG001|NOT COMPLETED|Phase 2||0
9858473|NCT00916058|10971612|FG002|NOT COMPLETED|Phase 2||0
9858474|NCT00916058|10971613|FG003|NOT COMPLETED|Phase 2||0
9858475|NCT00916058|10971614|FG004|NOT COMPLETED|Phase 2||0
9858476|NCT00916058|10971615|FG005|NOT COMPLETED|Phase 2||0
9858477|NCT00916058|10971616|FG006|NOT COMPLETED|Phase 2||3
9858478|NCT00916136|10971636|FG000|STARTED|Overall Study||37
9858479|NCT00916136|10971637|FG001|STARTED|Overall Study||29
9858480|NCT00916136|10971636|FG000|COMPLETED|Overall Study||37
9858481|NCT00916136|10971637|FG001|COMPLETED|Overall Study||29
9858482|NCT00916136|10971636|FG000|NOT COMPLETED|Overall Study||0
9858483|NCT00916136|10971637|FG001|NOT COMPLETED|Overall Study||0
9858484|NCT00916149|10971646|FG000|STARTED|Overall Study||16
9858485|NCT00916149|10971647|FG001|STARTED|Overall Study||10
9858486|NCT00916149|10971648|FG002|STARTED|Overall Study||5
9858487|NCT00916149|10971646|FG000|COMPLETED|Overall Study||12
9858488|NCT00916149|10971647|FG001|COMPLETED|Overall Study||8
9858489|NCT00916149|10971648|FG002|COMPLETED|Overall Study||5
9858490|NCT00916149|10971646|FG000|NOT COMPLETED|Overall Study||4
9858491|NCT00916149|10971647|FG001|NOT COMPLETED|Overall Study||2
9858492|NCT00916149|10971648|FG002|NOT COMPLETED|Overall Study||0
9858493|NCT00916279|10971655|FG000|STARTED|Overall Study||41
9858494|NCT00916279|10971655|FG000|30 Days|Overall Study||41
9858495|NCT00916279|10971655|FG000|6 Months|Overall Study||41
9858496|NCT00916279|10971655|FG000|24 Months|Overall Study||37
9858497|NCT00916279|10971655|FG000|COMPLETED|Overall Study||37
9858498|NCT00916279|10971655|FG000|NOT COMPLETED|Overall Study||4
9858499|NCT00916305|10971664|FG000|STARTED|Overall Study||28
9858500|NCT00916305|10971665|FG001|STARTED|Overall Study||37
9858501|NCT00916305|10971664|FG000|COMPLETED|Overall Study||7
9858502|NCT00916305|10971665|FG001|COMPLETED|Overall Study||9
9858503|NCT00916305|10971664|FG000|NOT COMPLETED|Overall Study||21
9858504|NCT00916305|10971665|FG001|NOT COMPLETED|Overall Study||28
9858505|NCT00916344|10971671|FG000|STARTED|Overall Study||175
9858506|NCT00916344|10971671|FG000|COMPLETED|Overall Study||167
9858507|NCT00916344|10971671|FG000|NOT COMPLETED|Overall Study||8
9858508|NCT00916357|10971675|FG000|STARTED|Period 1||4
9858509|NCT00916357|10971676|FG001|STARTED|Period 1||4
9858510|NCT00916357|10971677|FG002|STARTED|Period 1||4
9858511|NCT00916357|10971678|FG003|STARTED|Period 1||4
9858512|NCT00916357|10971679|FG004|STARTED|Period 1||3
9858513|NCT00916357|10971680|FG005|STARTED|Period 1||4
9858514|NCT00916357|10971675|FG000|Received at Least 1 Dose of Study Drug|Period 1||4
9858515|NCT00916357|10971676|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
9858516|NCT00916357|10971677|FG002|Received at Least 1 Dose of Study Drug|Period 1||4
9858517|NCT00916357|10971678|FG003|Received at Least 1 Dose of Study Drug|Period 1||4
9858518|NCT00916357|10971679|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
9858519|NCT00916357|10971680|FG005|Received at Least 1 Dose of Study Drug|Period 1||4
9858520|NCT00916357|10971675|FG000|COMPLETED|Period 1||3
9858521|NCT00916357|10971676|FG001|COMPLETED|Period 1||4
9858522|NCT00916357|10971677|FG002|COMPLETED|Period 1||4
9858523|NCT00916357|10971678|FG003|COMPLETED|Period 1||4
9858524|NCT00916357|10971679|FG004|COMPLETED|Period 1||3
9858525|NCT00916357|10971680|FG005|COMPLETED|Period 1||4
9858526|NCT00916357|10971675|FG000|NOT COMPLETED|Period 1||1
9858527|NCT00916357|10971676|FG001|NOT COMPLETED|Period 1||0
9858528|NCT00916357|10971677|FG002|NOT COMPLETED|Period 1||0
9858529|NCT00916357|10971678|FG003|NOT COMPLETED|Period 1||0
9858530|NCT00916357|10971679|FG004|NOT COMPLETED|Period 1||0
9858531|NCT00916357|10971680|FG005|NOT COMPLETED|Period 1||0
9858532|NCT00916357|10971675|FG000|STARTED|Washout (3 to 14 Days)||3
9858533|NCT00916357|10971676|FG001|STARTED|Washout (3 to 14 Days)||4
9858534|NCT00916357|10971677|FG002|STARTED|Washout (3 to 14 Days)||4
9858535|NCT00916357|10971678|FG003|STARTED|Washout (3 to 14 Days)||4
9858536|NCT00916357|10971679|FG004|STARTED|Washout (3 to 14 Days)||3
9858537|NCT00916357|10971680|FG005|STARTED|Washout (3 to 14 Days)||4
9858538|NCT00916357|10971675|FG000|COMPLETED|Washout (3 to 14 Days)||3
9858539|NCT00916357|10971676|FG001|COMPLETED|Washout (3 to 14 Days)||4
9858540|NCT00916357|10971677|FG002|COMPLETED|Washout (3 to 14 Days)||4
9858541|NCT00916357|10971678|FG003|COMPLETED|Washout (3 to 14 Days)||4
9858542|NCT00916357|10971679|FG004|COMPLETED|Washout (3 to 14 Days)||3
9858543|NCT00916357|10971680|FG005|COMPLETED|Washout (3 to 14 Days)||4
9858544|NCT00916357|10971675|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
9858545|NCT00916357|10971676|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
9858546|NCT00916357|10971677|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
9858547|NCT00916357|10971678|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
9858548|NCT00916357|10971679|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
9858549|NCT00916357|10971680|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
9858550|NCT00916357|10971675|FG000|STARTED|Period 2||3
9858551|NCT00916357|10971676|FG001|STARTED|Period 2||4
9858552|NCT00916357|10971677|FG002|STARTED|Period 2||4
9858553|NCT00916357|10971678|FG003|STARTED|Period 2||4
9858554|NCT00916357|10971679|FG004|STARTED|Period 2||3
9858555|NCT00916357|10971680|FG005|STARTED|Period 2||4
9858556|NCT00916357|10971675|FG000|COMPLETED|Period 2||3
9858557|NCT00916357|10971676|FG001|COMPLETED|Period 2||4
9858558|NCT00916357|10971677|FG002|COMPLETED|Period 2||4
9858559|NCT00916357|10971678|FG003|COMPLETED|Period 2||3
9858560|NCT00916357|10971679|FG004|COMPLETED|Period 2||3
9858561|NCT00916357|10971680|FG005|COMPLETED|Period 2||4
9858562|NCT00916357|10971675|FG000|NOT COMPLETED|Period 2||0
9858563|NCT00916357|10971676|FG001|NOT COMPLETED|Period 2||0
9858564|NCT00916357|10971677|FG002|NOT COMPLETED|Period 2||0
9858565|NCT00916357|10971678|FG003|NOT COMPLETED|Period 2||1
9858566|NCT00916357|10971679|FG004|NOT COMPLETED|Period 2||0
9858567|NCT00916357|10971680|FG005|NOT COMPLETED|Period 2||0
9858568|NCT00916357|10971675|FG000|STARTED|Washout (3 to 14 Days)||3
9858569|NCT00916357|10971676|FG001|STARTED|Washout (3 to 14 Days)||4
9858570|NCT00916357|10971677|FG002|STARTED|Washout (3 to 14 Days)||4
9858571|NCT00916357|10971678|FG003|STARTED|Washout (3 to 14 Days)||3
9858572|NCT00916357|10971679|FG004|STARTED|Washout (3 to 14 Days)||3
9858573|NCT00916357|10971680|FG005|STARTED|Washout (3 to 14 Days)||4
9858574|NCT00916357|10971675|FG000|COMPLETED|Washout (3 to 14 Days)||3
9858575|NCT00916357|10971676|FG001|COMPLETED|Washout (3 to 14 Days)||4
9858576|NCT00916357|10971677|FG002|COMPLETED|Washout (3 to 14 Days)||4
9858577|NCT00916357|10971678|FG003|COMPLETED|Washout (3 to 14 Days)||3
9858578|NCT00916357|10971679|FG004|COMPLETED|Washout (3 to 14 Days)||3
9858579|NCT00916357|10971680|FG005|COMPLETED|Washout (3 to 14 Days)||4
9858580|NCT00916357|10971675|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
9858581|NCT00916357|10971676|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
9858582|NCT00916357|10971677|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
9858583|NCT00916357|10971678|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
9858584|NCT00916357|10971679|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
9858585|NCT00916357|10971680|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
9858586|NCT00916357|10971675|FG000|STARTED|Period 3||3
9858587|NCT00916357|10971676|FG001|STARTED|Period 3||4
9858588|NCT00916357|10971677|FG002|STARTED|Period 3||4
9858589|NCT00916357|10971678|FG003|STARTED|Period 3||3
9858590|NCT00916357|10971679|FG004|STARTED|Period 3||3
9858591|NCT00916357|10971680|FG005|STARTED|Period 3||4
9858592|NCT00916357|10971675|FG000|COMPLETED|Period 3||3
9858593|NCT00916357|10971676|FG001|COMPLETED|Period 3||4
9858594|NCT00916357|10971677|FG002|COMPLETED|Period 3||4
9858595|NCT00916357|10971678|FG003|COMPLETED|Period 3||3
9858596|NCT00916357|10971679|FG004|COMPLETED|Period 3||3
9858597|NCT00916357|10971680|FG005|COMPLETED|Period 3||4
9858598|NCT00916357|10971675|FG000|NOT COMPLETED|Period 3||0
9858599|NCT00916357|10971676|FG001|NOT COMPLETED|Period 3||0
9858600|NCT00916357|10971677|FG002|NOT COMPLETED|Period 3||0
9858601|NCT00916357|10971678|FG003|NOT COMPLETED|Period 3||0
9858602|NCT00916357|10971679|FG004|NOT COMPLETED|Period 3||0
9858603|NCT00916357|10971680|FG005|NOT COMPLETED|Period 3||0
9858604|NCT00916370|10971691|FG000|STARTED|Overall Study||401
9858605|NCT00916370|10971692|FG001|STARTED|Overall Study||104
9858606|NCT00916370|10971691|FG000|COMPLETED|Overall Study||396
9858607|NCT00916370|10971692|FG001|COMPLETED|Overall Study||102
9858608|NCT00916370|10971691|FG000|NOT COMPLETED|Overall Study||5
9858609|NCT00916370|10971692|FG001|NOT COMPLETED|Overall Study||2
9858610|NCT00916383|10971699|FG000|STARTED|Overall Study||49
9858611|NCT00916383|10971699|FG000|COMPLETED|Overall Study||46
9858612|NCT00916383|10971699|FG000|NOT COMPLETED|Overall Study||3
9858613|NCT00916539|10971709|FG000|STARTED|Overall Study||31
9858614|NCT00916539|10971710|FG001|STARTED|Overall Study||31
9858615|NCT00916539|10971709|FG000|COMPLETED|Overall Study||31
9858616|NCT00916539|10971710|FG001|COMPLETED|Overall Study||31
9858617|NCT00916539|10971709|FG000|NOT COMPLETED|Overall Study||0
9858618|NCT00916539|10971710|FG001|NOT COMPLETED|Overall Study||0
9858619|NCT00916578|10971716|FG000|STARTED|Overall Study||33
9858620|NCT00916578|10971716|FG000|COMPLETED|Overall Study||26
9858621|NCT00916578|10971716|FG000|NOT COMPLETED|Overall Study||7
9858622|NCT00916617|10971724|FG000|STARTED|Overall Study||24
9858623|NCT00916617|10971725|FG001|STARTED|Overall Study||21
9858624|NCT00916617|10971726|FG002|STARTED|Overall Study||10
9858625|NCT00916617|10971727|FG003|STARTED|Overall Study||7
9858626|NCT00916617|10971724|FG000|COMPLETED|Overall Study||1
9858627|NCT00916617|10971725|FG001|COMPLETED|Overall Study||0
9858628|NCT00916617|10971726|FG002|COMPLETED|Overall Study||0
9858629|NCT00916617|10971727|FG003|COMPLETED|Overall Study||0
9858630|NCT00916617|10971724|FG000|NOT COMPLETED|Overall Study||23
9858631|NCT00916617|10971725|FG001|NOT COMPLETED|Overall Study||21
9858632|NCT00916617|10971726|FG002|NOT COMPLETED|Overall Study||10
9858633|NCT00916617|10971727|FG003|NOT COMPLETED|Overall Study||7
9858634|NCT00916643|10971737|FG000|STARTED|Overall Study||113
9858635|NCT00916643|10971737|FG000|COMPLETED|Overall Study||113
9858636|NCT00916643|10971737|FG000|NOT COMPLETED|Overall Study||0
9858637|NCT00916721|10971743|FG000|STARTED|Overall Study||35
9858638|NCT00916721|10971744|FG001|STARTED|Overall Study||39
9858639|NCT00916721|10971743|FG000|COMPLETED|Overall Study||25
9858640|NCT00916721|10971744|FG001|COMPLETED|Overall Study||29
9858641|NCT00916721|10971743|FG000|NOT COMPLETED|Overall Study||10
9858642|NCT00916721|10971744|FG001|NOT COMPLETED|Overall Study||10
9858643|NCT00916929|10971752|FG000|STARTED|Overall Study||80
9858644|NCT00916929|10971753|FG001|STARTED|Overall Study||82
9858645|NCT00916929|10971752|FG000|COMPLETED|Overall Study||70
9858646|NCT00916929|10971753|FG001|COMPLETED|Overall Study||53
9858647|NCT00916929|10971752|FG000|NOT COMPLETED|Overall Study||10
9858648|NCT00916929|10971753|FG001|NOT COMPLETED|Overall Study||29
9858649|NCT00917124|10971763|FG000|STARTED|Overall Study||100
9858650|NCT00917124|10971764|FG001|STARTED|Overall Study||100
9858651|NCT00917124|10971763|FG000|COMPLETED|Overall Study||96
9858652|NCT00917124|10971764|FG001|COMPLETED|Overall Study||94
9858653|NCT00917124|10971763|FG000|NOT COMPLETED|Overall Study||4
9858654|NCT00917124|10971764|FG001|NOT COMPLETED|Overall Study||6
9858655|NCT00917150|10971774|FG000|STARTED|Overall Study||192
9858656|NCT00917150|10971775|FG001|STARTED|Overall Study||198
9858657|NCT00917150|10971776|FG002|STARTED|Overall Study||191
9858658|NCT00917150|10971777|FG003|STARTED|Overall Study||190
9858659|NCT00917150|10971774|FG000|COMPLETED|Overall Study||155
9858660|NCT00917150|10971775|FG001|COMPLETED|Overall Study||161
9858661|NCT00917150|10971776|FG002|COMPLETED|Overall Study||149
9858662|NCT00917150|10971777|FG003|COMPLETED|Overall Study||156
9858663|NCT00917150|10971774|FG000|NOT COMPLETED|Overall Study||37
9858664|NCT00917150|10971775|FG001|NOT COMPLETED|Overall Study||37
9858665|NCT00917150|10971776|FG002|NOT COMPLETED|Overall Study||42
9858666|NCT00917150|10971777|FG003|NOT COMPLETED|Overall Study||34
9858667|NCT00917267|10971789|FG000|STARTED|Overall Study||346
9858668|NCT00917267|10971790|FG001|STARTED|Overall Study||345
9858669|NCT00917267|10971789|FG000|Intent to Treat (ITT)|Overall Study||340
9858670|NCT00917267|10971790|FG001|Intent to Treat (ITT)|Overall Study||338
9858671|NCT00917267|10971789|FG000|COMPLETED|Overall Study||307
9858672|NCT00917267|10971790|FG001|COMPLETED|Overall Study||266
9858673|NCT00917267|10971789|FG000|NOT COMPLETED|Overall Study||39
9858674|NCT00917267|10971790|FG001|NOT COMPLETED|Overall Study||79
9858675|NCT00917384|10971802|FG000|STARTED|Overall Study||238
9858676|NCT00917384|10971803|FG001|STARTED|Overall Study||117
9858677|NCT00917384|10971802|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
9858678|NCT00917384|10971803|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
9858679|NCT00917384|10971802|FG000|COMPLETED|Overall Study||224
9858680|NCT00917384|10971803|FG001|COMPLETED|Overall Study||113
9858681|NCT00917384|10971802|FG000|NOT COMPLETED|Overall Study||14
9858682|NCT00917384|10971803|FG001|NOT COMPLETED|Overall Study||4
9858683|NCT00917462|10971809|FG000|STARTED|Overall Study||35
9858684|NCT00917462|10971809|FG000|COMPLETED|Overall Study||34
9858685|NCT00917462|10971809|FG000|NOT COMPLETED|Overall Study||1
9858686|NCT00917501|10971815|FG000|STARTED|Overall Study||29
9858687|NCT00917501|10971816|FG001|STARTED|Overall Study||26
9858688|NCT00917501|10971815|FG000|COMPLETED|Overall Study||21
9858689|NCT00917501|10971816|FG001|COMPLETED|Overall Study||21
9858690|NCT00917501|10971815|FG000|NOT COMPLETED|Overall Study||8
9858691|NCT00917501|10971816|FG001|NOT COMPLETED|Overall Study||5
9858692|NCT00917553|10971824|FG000|STARTED|Overall Study||17
9858693|NCT00917553|10971825|FG001|STARTED|Overall Study||16
9858694|NCT00917553|10971824|FG000|COMPLETED|Overall Study||15
9858695|NCT00917553|10971825|FG001|COMPLETED|Overall Study||15
9858696|NCT00917553|10971824|FG000|NOT COMPLETED|Overall Study||2
9858697|NCT00917553|10971825|FG001|NOT COMPLETED|Overall Study||1
9858698|NCT00917579|10971831|FG000|STARTED|Period 1: 1st Intervention||39
9858699|NCT00917579|10971832|FG001|STARTED|Period 1: 1st Intervention||37
9858700|NCT00917579|10971831|FG000|COMPLETED|Period 1: 1st Intervention||39
9858701|NCT00917579|10971832|FG001|COMPLETED|Period 1: 1st Intervention||37
9858702|NCT00917579|10971831|FG000|NOT COMPLETED|Period 1: 1st Intervention||0
9858703|NCT00917579|10971832|FG001|NOT COMPLETED|Period 1: 1st Intervention||0
9858704|NCT00917579|10971831|FG000|STARTED|Washout >= 2 Weeks||39
9858705|NCT00917579|10971832|FG001|STARTED|Washout >= 2 Weeks||37
9858706|NCT00917579|10971831|FG000|COMPLETED|Washout >= 2 Weeks||37
9858707|NCT00917579|10971832|FG001|COMPLETED|Washout >= 2 Weeks||37
9858708|NCT00917579|10971831|FG000|NOT COMPLETED|Washout >= 2 Weeks||2
9858709|NCT00917579|10971832|FG001|NOT COMPLETED|Washout >= 2 Weeks||0
9858710|NCT00917579|10971831|FG000|STARTED|Period 2: 2nd Intervention||37
9858711|NCT00917579|10971832|FG001|STARTED|Period 2: 2nd Intervention||37
9858712|NCT00917579|10971831|FG000|COMPLETED|Period 2: 2nd Intervention||37
9858713|NCT00917579|10971832|FG001|COMPLETED|Period 2: 2nd Intervention||37
9858714|NCT00917579|10971831|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0
9858715|NCT00917579|10971832|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0
9858716|NCT00917644|10971838|FG000|STARTED|Period 1: First Intervention||39
9858717|NCT00917644|10971839|FG001|STARTED|Period 1: First Intervention||37
9858718|NCT00917644|10971838|FG000|COMPLETED|Period 1: First Intervention||39
9858719|NCT00917644|10971839|FG001|COMPLETED|Period 1: First Intervention||37
9858720|NCT00917644|10971838|FG000|NOT COMPLETED|Period 1: First Intervention||0
9858721|NCT00917644|10971839|FG001|NOT COMPLETED|Period 1: First Intervention||0
9858722|NCT00917644|10971838|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39
9858723|NCT00917644|10971839|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37
9858724|NCT00917644|10971838|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37
9858725|NCT00917644|10971839|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37
9858726|NCT00917644|10971838|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
9858727|NCT00917644|10971839|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
9858728|NCT00917644|10971838|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
9858729|NCT00917644|10971839|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
9858730|NCT00917644|10971838|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
9858731|NCT00917644|10971839|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
9858732|NCT00917644|10971838|FG000|NOT COMPLETED|Period 2: Second Intervention||1
9858733|NCT00917644|10971839|FG001|NOT COMPLETED|Period 2: Second Intervention||0
9858734|NCT00917735|10971847|FG000|STARTED|Overall Study||538
9858735|NCT00917735|10971848|FG001|STARTED|Overall Study||537
9858736|NCT00917735|10971847|FG000|COMPLETED|Overall Study||463
9858737|NCT00917735|10971848|FG001|COMPLETED|Overall Study||474
9858738|NCT00917735|10971847|FG000|NOT COMPLETED|Overall Study||75
9858739|NCT00917735|10971848|FG001|NOT COMPLETED|Overall Study||63
9858740|NCT00917852|10971854|FG000|STARTED|Overall Study||51
9858741|NCT00917852|10971854|FG000|COMPLETED|Overall Study||45
9858742|NCT00917852|10971854|FG000|NOT COMPLETED|Overall Study||6
9858743|NCT00917865|10971859|FG000|STARTED|Overall Study||11
9858744|NCT00917865|10971859|FG000|COMPLETED|Overall Study||11
9858745|NCT00917865|10971859|FG000|NOT COMPLETED|Overall Study||0
9858746|NCT00918125|10971872|FG000|STARTED|Overall Study||20
9858747|NCT00918125|10971873|FG001|STARTED|Overall Study||39
9858748|NCT00918125|10971872|FG000|COMPLETED|Overall Study||20
9858749|NCT00918125|10971873|FG001|COMPLETED|Overall Study||39
9858750|NCT00918125|10971872|FG000|NOT COMPLETED|Overall Study||0
9858751|NCT00918125|10971873|FG001|NOT COMPLETED|Overall Study||0
9858752|NCT00918138|10971884|FG000|STARTED|Overall Study||46
9858753|NCT00918138|10971885|FG001|STARTED|Overall Study||47
9858754|NCT00918138|10971884|FG000|COMPLETED|Overall Study||44
9858755|NCT00918138|10971885|FG001|COMPLETED|Overall Study||46
9858756|NCT00918138|10971884|FG000|NOT COMPLETED|Overall Study||2
9858757|NCT00918138|10971885|FG001|NOT COMPLETED|Overall Study||1
9858758|NCT00918203|10971893|FG000|STARTED|Treatment With or Without Olaratumab||70
9858759|NCT00918203|10971894|FG001|STARTED|Treatment With or Without Olaratumab||67
9858760|NCT00918203|10971895|FG002|STARTED|Treatment With or Without Olaratumab||0
9858761|NCT00918203|10971893|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
9858762|NCT00918203|10971894|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
9858763|NCT00918203|10971895|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
9858764|NCT00918203|10971893|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53
9858765|NCT00918203|10971894|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47
9858766|NCT00918203|10971895|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0
9858767|NCT00918203|10971893|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
9858768|NCT00918203|10971894|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
9858769|NCT00918203|10971895|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
9858770|NCT00918203|10971893|FG000|COMPLETED|Treatment With or Without Olaratumab||64
9858771|NCT00918203|10971894|FG001|COMPLETED|Treatment With or Without Olaratumab||57
9858772|NCT00918203|10971895|FG002|COMPLETED|Treatment With or Without Olaratumab||0
9858773|NCT00918203|10971893|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6
9858774|NCT00918203|10971894|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10
9858775|NCT00918203|10971895|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0
9858776|NCT00918203|10971893|FG000|STARTED|Crossover to Olaratumab Monotherapy||0
9858777|NCT00918203|10971894|FG001|STARTED|Crossover to Olaratumab Monotherapy||0
9858778|NCT00918203|10971895|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
9858779|NCT00918203|10971893|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0
9858780|NCT00918203|10971894|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0
9858781|NCT00918203|10971895|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18
9858782|NCT00918203|10971893|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
9858783|NCT00918203|10971894|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
9858784|NCT00918203|10971895|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
9858785|NCT00918229|10971907|FG000|STARTED|Overall Study||24
9858786|NCT00918229|10971907|FG000|COMPLETED|Overall Study||24
9858787|NCT00918229|10971907|FG000|NOT COMPLETED|Overall Study||0
9858788|NCT00918255|10971914|FG000|STARTED|Overall Study||51
9858789|NCT00918255|10971915|FG001|STARTED|Overall Study||52
9858790|NCT00918255|10971916|FG002|STARTED|Overall Study||51
9858791|NCT00918255|10971914|FG000|COMPLETED|Overall Study||45
9858792|NCT00918255|10971915|FG001|COMPLETED|Overall Study||52
9858793|NCT00918255|10971916|FG002|COMPLETED|Overall Study||46
9858794|NCT00918255|10971914|FG000|NOT COMPLETED|Overall Study||6
9858795|NCT00918255|10971915|FG001|NOT COMPLETED|Overall Study||0
9858796|NCT00918255|10971916|FG002|NOT COMPLETED|Overall Study||5
9858797|NCT00918281|10971924|FG000|STARTED|Overall Study||70
9858798|NCT00918281|10971924|FG000|COMPLETED|Overall Study||41
9858799|NCT00918281|10971924|FG000|NOT COMPLETED|Overall Study||29
9858800|NCT00918333|10971933|FG000|STARTED|Overall Study||26
9858801|NCT00918333|10971934|FG001|STARTED|Overall Study||98
9858802|NCT00918333|10971933|FG000|COMPLETED|Overall Study||23
9858803|NCT00918333|10971934|FG001|COMPLETED|Overall Study||93
9858804|NCT00918333|10971933|FG000|NOT COMPLETED|Overall Study||3
9858805|NCT00918333|10971934|FG001|NOT COMPLETED|Overall Study||5
9858806|NCT00918346|10971943|FG000|STARTED|First Treatment Period (4 Weeks)||21
9858807|NCT00918346|10971944|FG001|STARTED|First Treatment Period (4 Weeks)||22
9858808|NCT00918346|10971943|FG000|COMPLETED|First Treatment Period (4 Weeks)||21
9858809|NCT00918346|10971944|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
9858810|NCT00918346|10971943|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0
9858811|NCT00918346|10971944|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1
9858812|NCT00918346|10971943|FG000|STARTED|Washout (at Least 4 Weeks)||21
9858813|NCT00918346|10971944|FG001|STARTED|Washout (at Least 4 Weeks)||21
9858814|NCT00918346|10971943|FG000|COMPLETED|Washout (at Least 4 Weeks)||21
9858815|NCT00918346|10971944|FG001|COMPLETED|Washout (at Least 4 Weeks)||21
9858816|NCT00918346|10971943|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0
9858817|NCT00918346|10971944|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0
9858818|NCT00918346|10971943|FG000|STARTED|Second Treatment Period (4 Weeks)||21
9858819|NCT00918346|10971944|FG001|STARTED|Second Treatment Period (4 Weeks)||21
9858820|NCT00918346|10971943|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21
9858821|NCT00918346|10971944|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21
9858822|NCT00918346|10971943|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
9858823|NCT00918346|10971944|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
9858824|NCT00918346|10971943|FG000|STARTED|Post Study Period||21
9858825|NCT00918346|10971944|FG001|STARTED|Post Study Period||21
9858826|NCT00918346|10971943|FG000|COMPLETED|Post Study Period||21
9858827|NCT00918346|10971944|FG001|COMPLETED|Post Study Period||21
9858828|NCT00918346|10971943|FG000|NOT COMPLETED|Post Study Period||0
9858829|NCT00918346|10971944|FG001|NOT COMPLETED|Post Study Period||0
9858830|NCT00918385|10971955|FG000|STARTED|Monotherapy||14
9858831|NCT00918385|10971956|FG001|STARTED|Monotherapy||17
9858832|NCT00918385|10971955|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
9858833|NCT00918385|10971956|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
9858834|NCT00918385|10971955|FG000|NOT COMPLETED|Monotherapy||2
9858835|NCT00918385|10971956|FG001|NOT COMPLETED|Monotherapy||6
9858836|NCT00918385|10971955|FG000|STARTED|Combination Nilutamide and Dasatinib||12
9858837|NCT00918385|10971956|FG001|STARTED|Combination Nilutamide and Dasatinib||11
9858838|NCT00918385|10971955|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6
9858839|NCT00918385|10971956|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3
9858840|NCT00918385|10971955|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
9858841|NCT00918385|10971956|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
9858842|NCT00918567|10971966|FG000|STARTED|Overall Study||29
9858843|NCT00918567|10971967|FG001|STARTED|Overall Study||27
9858844|NCT00918567|10971966|FG000|COMPLETED|Overall Study||24
9858845|NCT00918567|10971967|FG001|COMPLETED|Overall Study||25
9858846|NCT00918567|10971966|FG000|NOT COMPLETED|Overall Study||5
9858847|NCT00918567|10971967|FG001|NOT COMPLETED|Overall Study||2
9858848|NCT00918580|10971973|FG000|STARTED|Up to 6-month Follow-up(FU)||158
9858849|NCT00918580|10971973|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
9858850|NCT00918580|10971973|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
9858851|NCT00918580|10971973|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
9858852|NCT00918580|10971973|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
9858853|NCT00918580|10971973|FG000|STARTED|After 6-month FU to 1-year FU||147
9858854|NCT00918580|10971973|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
9858855|NCT00918580|10971973|FG000|COMPLETED|After 6-month FU to 1-year FU||87
9858856|NCT00918580|10971973|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60
9858857|NCT00918671|10971980|FG000|STARTED|Overall Study||60
9858858|NCT00918671|10971980|FG000|COMPLETED|Overall Study||60
9858859|NCT00918671|10971980|FG000|NOT COMPLETED|Overall Study||0
9858860|NCT00918684|10971984|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106
9858861|NCT00918684|10971984|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90
9858862|NCT00918684|10971984|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
9858863|NCT00918684|10971984|FG000|STARTED|Treatment Phase||90
9858864|NCT00918684|10971984|FG000|COMPLETED|Treatment Phase||65
9858865|NCT00918684|10971984|FG000|NOT COMPLETED|Treatment Phase||25
9858866|NCT00918723|10971988|FG000|STARTED|Overall Study||40
9858867|NCT00918723|10971988|FG000|COMPLETED|Overall Study||40
9858868|NCT00918723|10971988|FG000|NOT COMPLETED|Overall Study||0
9858869|NCT00918736|10971994|FG000|STARTED|Overall Study|October, 2007|50
9858870|NCT00918736|10971994|FG000|COMPLETED|Overall Study|October, 2008|46
9858871|NCT00918736|10971994|FG000|NOT COMPLETED|Overall Study||4
9858872|NCT00918749|10972001|FG000|STARTED|Overall Study||70
9858873|NCT00918749|10972002|FG001|STARTED|Overall Study||66
9858874|NCT00918749|10972003|FG002|STARTED|Overall Study||69
9858875|NCT00918749|10972001|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
9858876|NCT00918749|10972002|FG001|ITT (Intent to Treat) Population|Overall Study||66
9858877|NCT00918749|10972003|FG002|ITT (Intent to Treat) Population|Overall Study||69
9858878|NCT00918749|10972001|FG000|COMPLETED|Overall Study||63
9858879|NCT00918749|10972002|FG001|COMPLETED|Overall Study||63
9858880|NCT00918749|10972003|FG002|COMPLETED|Overall Study||62
9858881|NCT00918749|10972001|FG000|NOT COMPLETED|Overall Study||7
9858882|NCT00918749|10972002|FG001|NOT COMPLETED|Overall Study||3
9858883|NCT00918749|10972003|FG002|NOT COMPLETED|Overall Study||7
9858884|NCT00918866|10972013|FG000|STARTED|Overall Study||16
9858885|NCT00918866|10972014|FG001|STARTED|Overall Study||16
9858886|NCT00918866|10972013|FG000|COMPLETED|Overall Study||16
9858887|NCT00918866|10972014|FG001|COMPLETED|Overall Study||16
9858888|NCT00918866|10972013|FG000|NOT COMPLETED|Overall Study||0
9858889|NCT00918866|10972014|FG001|NOT COMPLETED|Overall Study||0
9858890|NCT00918879|10972022|FG000|STARTED|Overall Study|Randomized and treated|107
9858891|NCT00918879|10972023|FG001|STARTED|Overall Study|Randomized and treated|106
9858892|NCT00918879|10972022|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
9858893|NCT00918879|10972023|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
9858894|NCT00918879|10972022|FG000|NOT COMPLETED|Overall Study||6
9858895|NCT00918879|10972023|FG001|NOT COMPLETED|Overall Study||6
9858896|NCT00918931|10972029|FG000|STARTED|Overall Study||3
9858897|NCT00918931|10972029|FG000|COMPLETED|Overall Study||3
9858898|NCT00918931|10972029|FG000|NOT COMPLETED|Overall Study||0
9858899|NCT00918957|10972035|FG000|STARTED|Overall Study||32
9858900|NCT00918957|10972036|FG001|STARTED|Overall Study||30
9858901|NCT00918957|10972035|FG000|COMPLETED|Overall Study||29
9858902|NCT00918957|10972036|FG001|COMPLETED|Overall Study||30
9858903|NCT00918957|10972035|FG000|NOT COMPLETED|Overall Study||3
9858904|NCT00918957|10972036|FG001|NOT COMPLETED|Overall Study||0
9858905|NCT00919035|10972042|FG000|STARTED|Overall Study||21
9858906|NCT00919035|10972042|FG000|COMPLETED|Overall Study||21
9858907|NCT00919035|10972042|FG000|NOT COMPLETED|Overall Study||0
9858908|NCT00919061|10972046|FG000|STARTED|Overall Study||39
9858909|NCT00919061|10972046|FG000|COMPLETED|Overall Study||37
9858910|NCT00919061|10972046|FG000|NOT COMPLETED|Overall Study||2
9858911|NCT00919100|10972052|FG000|STARTED|Overall Study||40
9858912|NCT00919100|10972053|FG001|STARTED|Overall Study||41
9858913|NCT00919100|10972052|FG000|COMPLETED|Overall Study||40
9858914|NCT00919100|10972053|FG001|COMPLETED|Overall Study||41
9858915|NCT00919100|10972052|FG000|NOT COMPLETED|Overall Study||0
9858916|NCT00919100|10972053|FG001|NOT COMPLETED|Overall Study||0
9858917|NCT00919113|10972061|FG000|STARTED|Overall Study||50
9858918|NCT00919113|10972062|FG001|STARTED|Overall Study||48
9858919|NCT00919113|10972061|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
9858920|NCT00919113|10972062|FG001|Received Uracyst|Overall Study||0
9858921|NCT00919113|10972061|FG000|Received Placebo|Overall Study||0
9858922|NCT00919113|10972062|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
9858923|NCT00919113|10972061|FG000|COMPLETED|Overall Study||41
9858924|NCT00919113|10972062|FG001|COMPLETED|Overall Study||40
9858925|NCT00919113|10972061|FG000|NOT COMPLETED|Overall Study||9
9858926|NCT00919113|10972062|FG001|NOT COMPLETED|Overall Study||8
9858927|NCT00919126|10972071|FG000|STARTED|Overall Study||32
9858928|NCT00919126|10972072|FG001|STARTED|Overall Study||37
9858929|NCT00919126|10972073|FG002|STARTED|Overall Study||33
9858930|NCT00919126|10972071|FG000|COMPLETED|Overall Study||31
9858931|NCT00919126|10972072|FG001|COMPLETED|Overall Study||32
9858932|NCT00919126|10972073|FG002|COMPLETED|Overall Study||32
9858933|NCT00919126|10972071|FG000|NOT COMPLETED|Overall Study||1
9858934|NCT00919126|10972072|FG001|NOT COMPLETED|Overall Study||5
9858935|NCT00919126|10972073|FG002|NOT COMPLETED|Overall Study||1
9858936|NCT00919191|10972082|FG000|STARTED|Overall Study||26
9858937|NCT00919191|10972082|FG000|COMPLETED|Overall Study||26
9858938|NCT00919191|10972082|FG000|NOT COMPLETED|Overall Study||0
9858939|NCT00919503|10972090|FG000|STARTED|Overall Study||84
9858940|NCT00919503|10972091|FG001|STARTED|Overall Study||14
9858941|NCT00919503|10972090|FG000|COMPLETED|Overall Study||84
9858942|NCT00919503|10972091|FG001|COMPLETED|Overall Study||14
9858943|NCT00919503|10972090|FG000|NOT COMPLETED|Overall Study||0
9858944|NCT00919503|10972091|FG001|NOT COMPLETED|Overall Study||0
9858945|NCT00919633|10972101|FG000|STARTED|Overall Study||28
9858946|NCT00919633|10972102|FG001|STARTED|Overall Study||25
9858947|NCT00919633|10972103|FG002|STARTED|Overall Study||27
9858948|NCT00919633|10972104|FG003|STARTED|Overall Study||26
9858949|NCT00919633|10972101|FG000|COMPLETED|Overall Study||6
9858950|NCT00919633|10972102|FG001|COMPLETED|Overall Study||10
9858951|NCT00919633|10972103|FG002|COMPLETED|Overall Study||4
9858952|NCT00919633|10972104|FG003|COMPLETED|Overall Study||5
9858953|NCT00919633|10972101|FG000|NOT COMPLETED|Overall Study||22
9858954|NCT00919633|10972102|FG001|NOT COMPLETED|Overall Study||15
9858955|NCT00919633|10972103|FG002|NOT COMPLETED|Overall Study||23
9858956|NCT00919633|10972104|FG003|NOT COMPLETED|Overall Study||21
9858957|NCT00919711|10972116|FG000|STARTED|Overall Study||435
9858958|NCT00919711|10972117|FG001|STARTED|Overall Study||435
9858959|NCT00919711|10972116|FG000|COMPLETED|Overall Study||402
9858960|NCT00919711|10972117|FG001|COMPLETED|Overall Study||422
9858961|NCT00919711|10972116|FG000|NOT COMPLETED|Overall Study||33
9858962|NCT00919711|10972117|FG001|NOT COMPLETED|Overall Study||13
9858963|NCT00919724|10972125|FG000|STARTED|Overall Study||45
9858964|NCT00919724|10972126|FG001|STARTED|Overall Study||44
9858965|NCT00919724|10972125|FG000|COMPLETED|Overall Study||45
9858966|NCT00919724|10972126|FG001|COMPLETED|Overall Study||44
9858967|NCT00919724|10972125|FG000|NOT COMPLETED|Overall Study||0
9858968|NCT00919724|10972126|FG001|NOT COMPLETED|Overall Study||0
9858969|NCT00919763|10972134|FG000|STARTED|Overall Study||53
9858970|NCT00919763|10972135|FG001|STARTED|Overall Study||49
9858971|NCT00919763|10972134|FG000|COMPLETED|Overall Study||41
9858972|NCT00919763|10972135|FG001|COMPLETED|Overall Study||45
9858973|NCT00919763|10972134|FG000|NOT COMPLETED|Overall Study||12
9858974|NCT00919763|10972135|FG001|NOT COMPLETED|Overall Study||4
9858975|NCT00919802|10972141|FG000|STARTED|First Intervention - (24 Hours)||12
9858976|NCT00919802|10972142|FG001|STARTED|First Intervention - (24 Hours)||13
9858977|NCT00919802|10972141|FG000|COMPLETED|First Intervention - (24 Hours)||12
9858978|NCT00919802|10972142|FG001|COMPLETED|First Intervention - (24 Hours)||13
9858979|NCT00919802|10972141|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0
9858980|NCT00919802|10972142|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0
9858981|NCT00919802|10972141|FG000|STARTED|Second Intervention - (24 Hours)||12
9858982|NCT00919802|10972142|FG001|STARTED|Second Intervention - (24 Hours)||13
9858983|NCT00919802|10972141|FG000|COMPLETED|Second Intervention - (24 Hours)||12
9858984|NCT00919802|10972142|FG001|COMPLETED|Second Intervention - (24 Hours)||13
9858985|NCT00919802|10972141|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0
10092896|NCT02340962|11221454|FG001|COMPLETED|Overall Study||12
10092897|NCT02340962|11221453|FG000|NOT COMPLETED|Overall Study||1
10092898|NCT02340962|11221454|FG001|NOT COMPLETED|Overall Study||0
10092899|NCT02340975|11221466|FG000|STARTED|Overall Study||6
10092900|NCT02340975|11221467|FG001|STARTED|Overall Study||27
10092901|NCT02340975|11221468|FG002|STARTED|Overall Study||24
10092902|NCT02340975|11221469|FG003|STARTED|Overall Study||12
10092903|NCT02340975|11221470|FG004|STARTED|Overall Study||25
10092904|NCT02340975|11221471|FG005|STARTED|Overall Study||19
10092905|NCT02340975|11221466|FG000|COMPLETED|Overall Study||0
10092906|NCT02340975|11221467|FG001|COMPLETED|Overall Study||0
10092907|NCT02340975|11221468|FG002|COMPLETED|Overall Study||0
10092908|NCT02340975|11221469|FG003|COMPLETED|Overall Study||0
10092909|NCT02340975|11221470|FG004|COMPLETED|Overall Study||0
10092910|NCT02340975|11221471|FG005|COMPLETED|Overall Study||0
10092911|NCT02340975|11221466|FG000|NOT COMPLETED|Overall Study||6
10092912|NCT02340975|11221467|FG001|NOT COMPLETED|Overall Study||27
10092913|NCT02340975|11221468|FG002|NOT COMPLETED|Overall Study||24
10092914|NCT02340975|11221469|FG003|NOT COMPLETED|Overall Study||12
10092915|NCT02340975|11221470|FG004|NOT COMPLETED|Overall Study||25
10092916|NCT02340975|11221471|FG005|NOT COMPLETED|Overall Study||19
10092917|NCT02341144|11221488|FG000|STARTED|Overall Study||30
10092918|NCT02341144|11221489|FG001|STARTED|Overall Study||31
10092919|NCT02341144|11221488|FG000|COMPLETED|Overall Study||28
9858986|NCT00919802|10972142|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0
9953188|NCT01425801|11072006|FG001|COMPLETED|Period 2||9
9953189|NCT01425801|11072007|FG002|COMPLETED|Period 2||9
9953190|NCT01425801|11072008|FG003|COMPLETED|Period 2||12
9953191|NCT01425801|11072009|FG004|COMPLETED|Period 2||11
9953192|NCT01425801|11072010|FG005|COMPLETED|Period 2||10
9953193|NCT01425801|11072005|FG000|NOT COMPLETED|Period 2||0
9953194|NCT01425801|11072006|FG001|NOT COMPLETED|Period 2||0
9953195|NCT01425801|11072007|FG002|NOT COMPLETED|Period 2||0
9953196|NCT01425801|11072008|FG003|NOT COMPLETED|Period 2||0
9953197|NCT01425801|11072009|FG004|NOT COMPLETED|Period 2||1
9953198|NCT01425801|11072010|FG005|NOT COMPLETED|Period 2||0
9953199|NCT01425801|11072005|FG000|STARTED|Period 3||9
9953200|NCT01425801|11072006|FG001|STARTED|Period 3||9
9953201|NCT01425801|11072007|FG002|STARTED|Period 3||9
9953202|NCT01425801|11072008|FG003|STARTED|Period 3||12
9953203|NCT01425801|11072009|FG004|STARTED|Period 3||11
9953204|NCT01425801|11072010|FG005|STARTED|Period 3||10
10092920|NCT02341144|11221489|FG001|COMPLETED|Overall Study||30
10092921|NCT02341144|11221488|FG000|NOT COMPLETED|Overall Study||2
10092922|NCT02341144|11221489|FG001|NOT COMPLETED|Overall Study||1
9953205|NCT01425801|11072005|FG000|COMPLETED|Period 3||9
9953206|NCT01425801|11072006|FG001|COMPLETED|Period 3||9
10092923|NCT02341417|11221498|FG000|STARTED|Overall Study||13
10092924|NCT02341417|11221499|FG001|STARTED|Overall Study||14
10092925|NCT02341417|11221500|FG002|STARTED|Overall Study||1
9858987|NCT00919854|10972148|FG000|STARTED|Overall Study||21
9858988|NCT00919854|10972148|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
9858989|NCT00919854|10972148|FG000|NOT COMPLETED|Overall Study||1
9858990|NCT00919867|10972158|FG000|STARTED|First Intervention||7
9858991|NCT00919867|10972159|FG001|STARTED|First Intervention||7
9858992|NCT00919867|10972160|FG002|STARTED|First Intervention||7
9858993|NCT00919867|10972161|FG003|STARTED|First Intervention||7
9858994|NCT00919867|10972162|FG004|STARTED|First Intervention||7
9858995|NCT00919867|10972163|FG005|STARTED|First Intervention||7
9858996|NCT00919867|10972158|FG000|COMPLETED|First Intervention||7
9858997|NCT00919867|10972159|FG001|COMPLETED|First Intervention||7
9858998|NCT00919867|10972160|FG002|COMPLETED|First Intervention||6
9858999|NCT00919867|10972161|FG003|COMPLETED|First Intervention||7
9859000|NCT00919867|10972162|FG004|COMPLETED|First Intervention||7
9859001|NCT00919867|10972163|FG005|COMPLETED|First Intervention||6
9859002|NCT00919867|10972158|FG000|NOT COMPLETED|First Intervention||0
9859003|NCT00919867|10972159|FG001|NOT COMPLETED|First Intervention||0
9859004|NCT00919867|10972160|FG002|NOT COMPLETED|First Intervention||1
9859005|NCT00919867|10972161|FG003|NOT COMPLETED|First Intervention||0
9859006|NCT00919867|10972162|FG004|NOT COMPLETED|First Intervention||0
9859007|NCT00919867|10972163|FG005|NOT COMPLETED|First Intervention||1
9859008|NCT00919867|10972158|FG000|STARTED|Washout||7
9859009|NCT00919867|10972159|FG001|STARTED|Washout||7
9859010|NCT00919867|10972160|FG002|STARTED|Washout||6
9859011|NCT00919867|10972161|FG003|STARTED|Washout||7
9859012|NCT00919867|10972162|FG004|STARTED|Washout||7
9859013|NCT00919867|10972163|FG005|STARTED|Washout||6
9859014|NCT00919867|10972158|FG000|COMPLETED|Washout||7
9859015|NCT00919867|10972159|FG001|COMPLETED|Washout||7
9859016|NCT00919867|10972160|FG002|COMPLETED|Washout||6
9859017|NCT00919867|10972161|FG003|COMPLETED|Washout||7
9859018|NCT00919867|10972162|FG004|COMPLETED|Washout||7
9859019|NCT00919867|10972163|FG005|COMPLETED|Washout||6
9859020|NCT00919867|10972158|FG000|NOT COMPLETED|Washout||0
9859021|NCT00919867|10972159|FG001|NOT COMPLETED|Washout||0
9859022|NCT00919867|10972160|FG002|NOT COMPLETED|Washout||0
9859023|NCT00919867|10972161|FG003|NOT COMPLETED|Washout||0
9859024|NCT00919867|10972162|FG004|NOT COMPLETED|Washout||0
9859025|NCT00919867|10972163|FG005|NOT COMPLETED|Washout||0
9859026|NCT00919867|10972158|FG000|STARTED|Second Intervention||7
9859027|NCT00919867|10972159|FG001|STARTED|Second Intervention||7
9859028|NCT00919867|10972160|FG002|STARTED|Second Intervention||6
9859029|NCT00919867|10972161|FG003|STARTED|Second Intervention||7
9859030|NCT00919867|10972162|FG004|STARTED|Second Intervention||7
9859031|NCT00919867|10972163|FG005|STARTED|Second Intervention||6
9859032|NCT00919867|10972158|FG000|COMPLETED|Second Intervention||7
9859033|NCT00919867|10972159|FG001|COMPLETED|Second Intervention||7
9859034|NCT00919867|10972160|FG002|COMPLETED|Second Intervention||6
9859035|NCT00919867|10972161|FG003|COMPLETED|Second Intervention||7
9859036|NCT00919867|10972162|FG004|COMPLETED|Second Intervention||7
9859037|NCT00919867|10972163|FG005|COMPLETED|Second Intervention||6
9859038|NCT00919867|10972158|FG000|NOT COMPLETED|Second Intervention||0
9859039|NCT00919867|10972159|FG001|NOT COMPLETED|Second Intervention||0
9859040|NCT00919867|10972160|FG002|NOT COMPLETED|Second Intervention||0
9859041|NCT00919867|10972161|FG003|NOT COMPLETED|Second Intervention||0
9859042|NCT00919867|10972162|FG004|NOT COMPLETED|Second Intervention||0
9859043|NCT00919867|10972163|FG005|NOT COMPLETED|Second Intervention||0
9859044|NCT00919867|10972158|FG000|STARTED|Washout||7
9859045|NCT00919867|10972159|FG001|STARTED|Washout||7
9859046|NCT00919867|10972160|FG002|STARTED|Washout||6
9859047|NCT00919867|10972161|FG003|STARTED|Washout||7
9859048|NCT00919867|10972162|FG004|STARTED|Washout||7
9859049|NCT00919867|10972163|FG005|STARTED|Washout||6
9859050|NCT00919867|10972158|FG000|COMPLETED|Washout||7
9859051|NCT00919867|10972159|FG001|COMPLETED|Washout||7
9859052|NCT00919867|10972160|FG002|COMPLETED|Washout||6
9859053|NCT00919867|10972161|FG003|COMPLETED|Washout||7
9859054|NCT00919867|10972162|FG004|COMPLETED|Washout||7
9859055|NCT00919867|10972163|FG005|COMPLETED|Washout||6
9859056|NCT00919867|10972158|FG000|NOT COMPLETED|Washout||0
9859057|NCT00919867|10972159|FG001|NOT COMPLETED|Washout||0
9859058|NCT00919867|10972160|FG002|NOT COMPLETED|Washout||0
9859059|NCT00919867|10972161|FG003|NOT COMPLETED|Washout||0
9859060|NCT00919867|10972162|FG004|NOT COMPLETED|Washout||0
9859061|NCT00919867|10972163|FG005|NOT COMPLETED|Washout||0
9859062|NCT00919867|10972158|FG000|STARTED|Third Intervention||7
9859063|NCT00919867|10972159|FG001|STARTED|Third Intervention||7
9859064|NCT00919867|10972160|FG002|STARTED|Third Intervention||6
9859065|NCT00919867|10972161|FG003|STARTED|Third Intervention||7
9859066|NCT00919867|10972162|FG004|STARTED|Third Intervention||7
9859067|NCT00919867|10972163|FG005|STARTED|Third Intervention||6
9859068|NCT00919867|10972158|FG000|COMPLETED|Third Intervention||7
9859069|NCT00919867|10972159|FG001|COMPLETED|Third Intervention||7
9859070|NCT00919867|10972160|FG002|COMPLETED|Third Intervention||6
9859071|NCT00919867|10972161|FG003|COMPLETED|Third Intervention||7
9859072|NCT00919867|10972162|FG004|COMPLETED|Third Intervention||7
9859073|NCT00919867|10972163|FG005|COMPLETED|Third Intervention||6
9859074|NCT00919867|10972158|FG000|NOT COMPLETED|Third Intervention||0
9859075|NCT00919867|10972159|FG001|NOT COMPLETED|Third Intervention||0
9859076|NCT00919867|10972160|FG002|NOT COMPLETED|Third Intervention||0
9859077|NCT00919867|10972161|FG003|NOT COMPLETED|Third Intervention||0
9859078|NCT00919867|10972162|FG004|NOT COMPLETED|Third Intervention||0
9859079|NCT00919867|10972163|FG005|NOT COMPLETED|Third Intervention||0
9859080|NCT00919932|10972173|FG000|STARTED|Overall Study||4
9859081|NCT00919932|10972174|FG001|STARTED|Overall Study||5
9859082|NCT00919932|10972173|FG000|COMPLETED|Overall Study||4
9859083|NCT00919932|10972174|FG001|COMPLETED|Overall Study||5
9859084|NCT00919932|10972173|FG000|NOT COMPLETED|Overall Study||0
9859085|NCT00919932|10972174|FG001|NOT COMPLETED|Overall Study||0
9859086|NCT00920023|10972180|FG000|STARTED|Overall Study||15
9859087|NCT00920023|10972180|FG000|COMPLETED|Overall Study||15
9859088|NCT00920023|10972180|FG000|NOT COMPLETED|Overall Study||0
9859089|NCT00920075|10972184|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11
9859090|NCT00920075|10972184|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
9859091|NCT00920075|10972184|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
9859092|NCT00920075|10972184|FG000|STARTED|Post Study, 11 Pts Responded||11
9859093|NCT00920075|10972184|FG000|COMPLETED|Post Study, 11 Pts Responded||11
9859094|NCT00920075|10972184|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0
9859095|NCT00920140|10972193|FG000|STARTED|Phase 1 (Dose Escalation)||5
9859096|NCT00920140|10972194|FG001|STARTED|Phase 1 (Dose Escalation)||9
9859097|NCT00920140|10972195|FG002|STARTED|Phase 1 (Dose Escalation)||0
9859098|NCT00920140|10972196|FG003|STARTED|Phase 1 (Dose Escalation)||0
9859099|NCT00920140|10972197|FG004|STARTED|Phase 1 (Dose Escalation)||0
9859100|NCT00920140|10972193|FG000|COMPLETED|Phase 1 (Dose Escalation)||0
9859101|NCT00920140|10972194|FG001|COMPLETED|Phase 1 (Dose Escalation)||0
9859102|NCT00920140|10972195|FG002|COMPLETED|Phase 1 (Dose Escalation)||0
9859103|NCT00920140|10972196|FG003|COMPLETED|Phase 1 (Dose Escalation)||0
9859104|NCT00920140|10972197|FG004|COMPLETED|Phase 1 (Dose Escalation)||0
9859105|NCT00920140|10972193|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5
9859106|NCT00920140|10972194|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9
9859107|NCT00920140|10972195|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0
9859108|NCT00920140|10972196|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0
9859109|NCT00920140|10972197|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0
9859110|NCT00920140|10972193|FG000|STARTED|Phase 2||0
9859111|NCT00920140|10972194|FG001|STARTED|Phase 2||0
9859112|NCT00920140|10972195|FG002|STARTED|Phase 2||50
9859113|NCT00920140|10972196|FG003|STARTED|Phase 2||22
9859114|NCT00920140|10972197|FG004|STARTED|Phase 2||11
9859115|NCT00920140|10972193|FG000|COMPLETED|Phase 2||0
9859116|NCT00920140|10972194|FG001|COMPLETED|Phase 2||0
9859117|NCT00920140|10972195|FG002|COMPLETED|Phase 2||0
9859118|NCT00920140|10972196|FG003|COMPLETED|Phase 2||0
9859119|NCT00920140|10972197|FG004|COMPLETED|Phase 2||0
9859120|NCT00920140|10972193|FG000|NOT COMPLETED|Phase 2||0
9859121|NCT00920140|10972194|FG001|NOT COMPLETED|Phase 2||0
9859122|NCT00920140|10972195|FG002|NOT COMPLETED|Phase 2||50
9859123|NCT00920140|10972196|FG003|NOT COMPLETED|Phase 2||22
9859124|NCT00920140|10972197|FG004|NOT COMPLETED|Phase 2||11
9859125|NCT00920218|10972214|FG000|STARTED|Overall Study||30
9859126|NCT00920218|10972215|FG001|STARTED|Overall Study||29
9859127|NCT00920218|10972216|FG002|STARTED|Overall Study||31
9859128|NCT00920218|10972217|FG003|STARTED|Overall Study||30
9859129|NCT00920218|10972214|FG000|COMPLETED|Overall Study||28
9859130|NCT00920218|10972215|FG001|COMPLETED|Overall Study||24
9859131|NCT00920218|10972216|FG002|COMPLETED|Overall Study||23
9859132|NCT00920218|10972217|FG003|COMPLETED|Overall Study||23
9859133|NCT00920218|10972214|FG000|NOT COMPLETED|Overall Study||2
9859134|NCT00920218|10972215|FG001|NOT COMPLETED|Overall Study||5
9859135|NCT00920218|10972216|FG002|NOT COMPLETED|Overall Study||8
9859136|NCT00920218|10972217|FG003|NOT COMPLETED|Overall Study||7
9859137|NCT00920231|10972233|FG000|STARTED|Overall Study||8
9859138|NCT00920231|10972234|FG001|STARTED|Overall Study||8
9859139|NCT00920231|10972233|FG000|COMPLETED|Overall Study||8
9859140|NCT00920231|10972234|FG001|COMPLETED|Overall Study||8
9859141|NCT00920231|10972233|FG000|NOT COMPLETED|Overall Study||0
9859142|NCT00920231|10972234|FG001|NOT COMPLETED|Overall Study||0
9859143|NCT00920374|10972244|FG000|STARTED|Overall Study||61
9859144|NCT00920374|10972245|FG001|STARTED|Overall Study||57
9859145|NCT00920374|10972244|FG000|COMPLETED|Overall Study||61
9859146|NCT00920374|10972245|FG001|COMPLETED|Overall Study||57
9859147|NCT00920374|10972244|FG000|NOT COMPLETED|Overall Study||0
9859148|NCT00920374|10972245|FG001|NOT COMPLETED|Overall Study||0
9859149|NCT00920426|10972254|FG000|STARTED|ITZ111451||8
9859150|NCT00920426|10972255|FG001|STARTED|ITZ111451||0
9859151|NCT00920426|10972256|FG002|STARTED|ITZ111451||0
9859152|NCT00920426|10972257|FG003|STARTED|ITZ111451||0
9859153|NCT00920426|10972254|FG000|COMPLETED|ITZ111451||7
9859154|NCT00920426|10972255|FG001|COMPLETED|ITZ111451||0
9859155|NCT00920426|10972256|FG002|COMPLETED|ITZ111451||0
9859156|NCT00920426|10972257|FG003|COMPLETED|ITZ111451||0
9859157|NCT00920426|10972254|FG000|NOT COMPLETED|ITZ111451||1
9859158|NCT00920426|10972255|FG001|NOT COMPLETED|ITZ111451||0
9859159|NCT00920426|10972256|FG002|NOT COMPLETED|ITZ111451||0
9859160|NCT00920426|10972257|FG003|NOT COMPLETED|ITZ111451||0
9859161|NCT00920426|10972254|FG000|STARTED|ITZ112929: Randomized Regimen||0
9859162|NCT00920426|10972255|FG001|STARTED|ITZ112929: Randomized Regimen||7
9859163|NCT00920426|10972256|FG002|STARTED|ITZ112929: Randomized Regimen||2
9859164|NCT00920426|10972257|FG003|STARTED|ITZ112929: Randomized Regimen||0
9859165|NCT00920426|10972254|FG000|COMPLETED|ITZ112929: Randomized Regimen||0
9859166|NCT00920426|10972255|FG001|COMPLETED|ITZ112929: Randomized Regimen||7
9859167|NCT00920426|10972256|FG002|COMPLETED|ITZ112929: Randomized Regimen||2
9859168|NCT00920426|10972257|FG003|COMPLETED|ITZ112929: Randomized Regimen||0
9859169|NCT00920426|10972254|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0
9859170|NCT00920426|10972255|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0
9859171|NCT00920426|10972256|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0
9859172|NCT00920426|10972257|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0
9859173|NCT00920426|10972254|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0
9859174|NCT00920426|10972255|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0
9859175|NCT00920426|10972256|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0
9859176|NCT00920426|10972257|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
9859177|NCT00920426|10972254|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
9859178|NCT00920426|10972255|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
9859179|NCT00920426|10972256|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
9859180|NCT00920426|10972257|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
9859181|NCT00920426|10972254|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
9859182|NCT00920426|10972255|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
9859183|NCT00920426|10972256|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
9859184|NCT00920426|10972257|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
9859185|NCT00920439|10972269|FG000|STARTED|Overall Study||25
9859186|NCT00920439|10972269|FG000|COMPLETED|Overall Study||25
9859187|NCT00920439|10972269|FG000|NOT COMPLETED|Overall Study||0
9859188|NCT00920556|10972273|FG000|STARTED|Overall Study||24
9859189|NCT00920556|10972273|FG000|COMPLETED|Overall Study||0
9859190|NCT00920556|10972273|FG000|NOT COMPLETED|Overall Study||24
9859191|NCT00920647|10972285|FG000|STARTED|Overall Study||4
9859192|NCT00920647|10972286|FG001|STARTED|Overall Study||4
9859193|NCT00920647|10972287|FG002|STARTED|Overall Study||4
9859194|NCT00920647|10972288|FG003|STARTED|Overall Study||4
9859195|NCT00920647|10972285|FG000|COMPLETED|Overall Study||4
9859196|NCT00920647|10972286|FG001|COMPLETED|Overall Study||4
9859197|NCT00920647|10972287|FG002|COMPLETED|Overall Study||4
9859198|NCT00920647|10972288|FG003|COMPLETED|Overall Study||4
9859199|NCT00920647|10972285|FG000|NOT COMPLETED|Overall Study||0
9859200|NCT00920647|10972286|FG001|NOT COMPLETED|Overall Study||0
9859201|NCT00920647|10972287|FG002|NOT COMPLETED|Overall Study||0
9859202|NCT00920647|10972288|FG003|NOT COMPLETED|Overall Study||0
9859203|NCT00920686|10972311|FG000|STARTED|Overall Study||82
10092926|NCT02341417|11221498|FG000|COMPLETED|Overall Study||11
10092927|NCT02341417|11221499|FG001|COMPLETED|Overall Study||12
10092928|NCT02341417|11221500|FG002|COMPLETED|Overall Study||0
9859204|NCT00920686|10972312|FG001|STARTED|Overall Study||82
9859205|NCT00920686|10972313|FG002|STARTED|Overall Study||75
9859206|NCT00920686|10972311|FG000|COMPLETED|Overall Study||63
9859207|NCT00920686|10972312|FG001|COMPLETED|Overall Study||60
9859208|NCT00920686|10972313|FG002|COMPLETED|Overall Study||62
9859209|NCT00920686|10972311|FG000|NOT COMPLETED|Overall Study||19
9859210|NCT00920686|10972312|FG001|NOT COMPLETED|Overall Study||22
9859211|NCT00920686|10972313|FG002|NOT COMPLETED|Overall Study||13
9859212|NCT00920699|10972328|FG000|STARTED|Overall Study||29
9859213|NCT00920699|10972329|FG001|STARTED|Overall Study||30
9859214|NCT00920699|10972330|FG002|STARTED|Overall Study||32
9859215|NCT00920699|10972328|FG000|COMPLETED|Overall Study||27
9859216|NCT00920699|10972329|FG001|COMPLETED|Overall Study||29
9859217|NCT00920699|10972330|FG002|COMPLETED|Overall Study||28
9859218|NCT00920699|10972328|FG000|NOT COMPLETED|Overall Study||2
9859219|NCT00920699|10972329|FG001|NOT COMPLETED|Overall Study||1
9859220|NCT00920699|10972330|FG002|NOT COMPLETED|Overall Study||4
9859221|NCT00920790|10972338|FG000|STARTED|Overall Study||27
9859222|NCT00920790|10972338|FG000|COMPLETED|Overall Study||13
9859223|NCT00920790|10972338|FG000|NOT COMPLETED|Overall Study||14
9859224|NCT00920829|10972346|FG000|STARTED|Allocation||38
9859225|NCT00920829|10972347|FG001|STARTED|Allocation||39
9859226|NCT00920829|10972348|FG002|STARTED|Allocation||38
9859227|NCT00920829|10972349|FG003|STARTED|Allocation||37
9859228|NCT00920829|10972346|FG000|COMPLETED|Allocation||35
9859229|NCT00920829|10972347|FG001|COMPLETED|Allocation||38
9859230|NCT00920829|10972348|FG002|COMPLETED|Allocation||38
9859231|NCT00920829|10972349|FG003|COMPLETED|Allocation||35
9859232|NCT00920829|10972346|FG000|NOT COMPLETED|Allocation||3
9859233|NCT00920829|10972347|FG001|NOT COMPLETED|Allocation||1
9859234|NCT00920829|10972348|FG002|NOT COMPLETED|Allocation||0
9859235|NCT00920829|10972349|FG003|NOT COMPLETED|Allocation||2
9859236|NCT00920829|10972346|FG000|STARTED|Available for Analysis||35
9859237|NCT00920829|10972347|FG001|STARTED|Available for Analysis||38
9859238|NCT00920829|10972348|FG002|STARTED|Available for Analysis||38
9859239|NCT00920829|10972349|FG003|STARTED|Available for Analysis||35
9859240|NCT00920829|10972346|FG000|COMPLETED|Available for Analysis||27
9859241|NCT00920829|10972347|FG001|COMPLETED|Available for Analysis||27
9859242|NCT00920829|10972348|FG002|COMPLETED|Available for Analysis||28
9859243|NCT00920829|10972349|FG003|COMPLETED|Available for Analysis||24
9859244|NCT00920829|10972346|FG000|NOT COMPLETED|Available for Analysis||8
9859245|NCT00920829|10972347|FG001|NOT COMPLETED|Available for Analysis||11
10092929|NCT02341417|11221498|FG000|NOT COMPLETED|Overall Study||2
9859246|NCT00920829|10972348|FG002|NOT COMPLETED|Available for Analysis||10
9859247|NCT00920829|10972349|FG003|NOT COMPLETED|Available for Analysis||11
9859248|NCT00920855|10972362|FG000|STARTED|Overall Study||5
9859249|NCT00920855|10972363|FG001|STARTED|Overall Study||4
9859250|NCT00920855|10972364|FG002|STARTED|Overall Study||31
9859251|NCT00920855|10972362|FG000|Safety and Efficacy Populations|Overall Study||5
9859252|NCT00920855|10972363|FG001|Safety and Efficacy Populations|Overall Study||4
9953207|NCT01425801|11072007|FG002|COMPLETED|Period 3||8
9859253|NCT00920855|10972364|FG002|Safety and Efficacy Populations|Overall Study||31
9859254|NCT00920855|10972362|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0
9859255|NCT00920855|10972363|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1
10092930|NCT02341417|11221499|FG001|NOT COMPLETED|Overall Study||2
10092931|NCT02341417|11221500|FG002|NOT COMPLETED|Overall Study||1
10092932|NCT02341456|11221512|FG000|STARTED|Overall Study||7
10092933|NCT02341456|11221513|FG001|STARTED|Overall Study||6
10092934|NCT02341456|11221514|FG002|STARTED|Overall Study||6
9859256|NCT00920855|10972364|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9
9859257|NCT00920855|10972362|FG000|NOT COMPLETED|Overall Study||5
9859258|NCT00920855|10972363|FG001|NOT COMPLETED|Overall Study||3
9859259|NCT00920855|10972364|FG002|NOT COMPLETED|Overall Study||22
9859260|NCT00920907|10972375|FG000|STARTED|Induction Period||37
9859261|NCT00920907|10972376|FG001|STARTED|Induction Period||38
9859262|NCT00920907|10972375|FG000|COMPLETED|Induction Period||15
9859263|NCT00920907|10972376|FG001|COMPLETED|Induction Period||16
9859264|NCT00920907|10972375|FG000|NOT COMPLETED|Induction Period||22
9859265|NCT00920907|10972376|FG001|NOT COMPLETED|Induction Period||22
9859266|NCT00920907|10972375|FG000|STARTED|Maintenance Period||15
9859267|NCT00920907|10972376|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
9859268|NCT00920907|10972375|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
9859269|NCT00920907|10972376|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
9859270|NCT00920907|10972375|FG000|NOT COMPLETED|Maintenance Period||12
9859271|NCT00920907|10972376|FG001|NOT COMPLETED|Maintenance Period||13
9859272|NCT00921024|10972386|FG000|STARTED|Overall Study||85
9859273|NCT00921024|10972387|FG001|STARTED|Overall Study||42
9859274|NCT00921024|10972386|FG000|COMPLETED|Overall Study||81
9859275|NCT00921024|10972387|FG001|COMPLETED|Overall Study||39
9859276|NCT00921024|10972386|FG000|NOT COMPLETED|Overall Study||4
9859277|NCT00921024|10972387|FG001|NOT COMPLETED|Overall Study||3
9859278|NCT00921310|10972395|FG000|STARTED|Overall Study||2
9859279|NCT00921310|10972396|FG001|STARTED|Overall Study||6
9859280|NCT00921310|10972397|FG002|STARTED|Overall Study||4
9859281|NCT00921310|10972395|FG000|COMPLETED|Overall Study||2
9859282|NCT00921310|10972396|FG001|COMPLETED|Overall Study||6
9859283|NCT00921310|10972397|FG002|COMPLETED|Overall Study||4
9859284|NCT00921310|10972395|FG000|NOT COMPLETED|Overall Study||0
9859285|NCT00921310|10972396|FG001|NOT COMPLETED|Overall Study||0
9859286|NCT00921310|10972397|FG002|NOT COMPLETED|Overall Study||0
9859287|NCT00921518|10972411|FG000|STARTED|Overall Study||48
9859288|NCT00921518|10972412|FG001|STARTED|Overall Study||44
9859289|NCT00921518|10972411|FG000|COMPLETED|Overall Study||48
9859290|NCT00921518|10972412|FG001|COMPLETED|Overall Study||44
9859291|NCT00921518|10972411|FG000|NOT COMPLETED|Overall Study||0
9859292|NCT00921518|10972412|FG001|NOT COMPLETED|Overall Study||0
9859293|NCT00921557|10972421|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17
9859294|NCT00921557|10972422|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17
9859295|NCT00921557|10972423|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18
9859296|NCT00921557|10972421|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
9859297|NCT00921557|10972422|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
9859298|NCT00921557|10972423|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
9859299|NCT00921557|10972421|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
9859300|NCT00921557|10972422|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
9859301|NCT00921557|10972423|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
9859302|NCT00921557|10972421|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15
9859303|NCT00921557|10972422|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17
9859304|NCT00921557|10972423|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18
9859305|NCT00921557|10972421|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15
9859306|NCT00921557|10972422|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16
9859307|NCT00921557|10972423|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17
9859308|NCT00921557|10972421|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
9859309|NCT00921557|10972422|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
9859310|NCT00921557|10972423|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
9859311|NCT00921557|10972421|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15
9859312|NCT00921557|10972422|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16
9859313|NCT00921557|10972423|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17
9859314|NCT00921557|10972421|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
9859315|NCT00921557|10972422|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
9859316|NCT00921557|10972423|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
9859317|NCT00921557|10972421|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
9859318|NCT00921557|10972422|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
9859319|NCT00921557|10972423|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
9859320|NCT00921687|10972438|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
9859321|NCT00921687|10972439|FG001|STARTED|Overall Study||363
9859322|NCT00921687|10972438|FG000|COMPLETED|Overall Study||418
9859323|NCT00921687|10972439|FG001|COMPLETED|Overall Study||363
9859324|NCT00921687|10972438|FG000|NOT COMPLETED|Overall Study||0
9859325|NCT00921687|10972439|FG001|NOT COMPLETED|Overall Study||0
9859326|NCT00921843|10972449|FG000|STARTED|Overall Study||10
9859327|NCT00921843|10972450|FG001|STARTED|Overall Study||10
9859328|NCT00921843|10972451|FG002|STARTED|Overall Study||11
9859329|NCT00921843|10972452|FG003|STARTED|Overall Study||30
9859330|NCT00921843|10972449|FG000|COMPLETED|Overall Study||10
9859331|NCT00921843|10972450|FG001|COMPLETED|Overall Study||10
9859332|NCT00921843|10972451|FG002|COMPLETED|Overall Study||11
9859333|NCT00921843|10972452|FG003|COMPLETED|Overall Study||30
9859334|NCT00921843|10972449|FG000|NOT COMPLETED|Overall Study||0
9859335|NCT00921843|10972450|FG001|NOT COMPLETED|Overall Study||0
9859336|NCT00921843|10972451|FG002|NOT COMPLETED|Overall Study||0
9859337|NCT00921843|10972452|FG003|NOT COMPLETED|Overall Study||0
9859338|NCT00921895|10972462|FG000|STARTED|Overall Study||128
9859339|NCT00921895|10972462|FG000|COMPLETED|Overall Study||128
9859340|NCT00921895|10972462|FG000|NOT COMPLETED|Overall Study||0
9859341|NCT00921934|10972467|FG000|STARTED|Overall Study||68
9859342|NCT00921934|10972467|FG000|COMPLETED|Overall Study||68
9859343|NCT00921934|10972467|FG000|NOT COMPLETED|Overall Study||0
9859344|NCT00921947|10972473|FG000|STARTED|Day 0||30
9859345|NCT00921947|10972474|FG001|STARTED|Day 0||30
9859346|NCT00921947|10972473|FG000|COMPLETED|Day 0||30
9859347|NCT00921947|10972474|FG001|COMPLETED|Day 0||30
9859348|NCT00921947|10972473|FG000|NOT COMPLETED|Day 0||0
9859349|NCT00921947|10972474|FG001|NOT COMPLETED|Day 0||0
9859350|NCT00921947|10972473|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
9859351|NCT00921947|10972474|FG001|STARTED|Day 28||30
9859352|NCT00921947|10972473|FG000|COMPLETED|Day 28||28
9859353|NCT00921947|10972474|FG001|COMPLETED|Day 28||30
9859354|NCT00921947|10972473|FG000|NOT COMPLETED|Day 28||0
9859355|NCT00921947|10972474|FG001|NOT COMPLETED|Day 28||0
9859356|NCT00922116|10972480|FG000|STARTED|Overall Study||191
9859357|NCT00922116|10972480|FG000|COMPLETED|Overall Study||176
9859358|NCT00922116|10972480|FG000|NOT COMPLETED|Overall Study||15
9859359|NCT00922194|10972484|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
9859360|NCT00922194|10972484|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
9859361|NCT00922194|10972484|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
9859362|NCT00922194|10972484|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
9859363|NCT00922194|10972484|FG000|COMPLETED|Metformin for 12 Months or More||102
9859364|NCT00922194|10972484|FG000|NOT COMPLETED|Metformin for 12 Months or More||0
9859365|NCT00922207|10972491|FG000|STARTED|Overall Study||91
9859366|NCT00922207|10972492|FG001|STARTED|Overall Study||95
9859367|NCT00922207|10972493|FG002|STARTED|Overall Study||94
9859368|NCT00922207|10972491|FG000|COMPLETED|Overall Study||85
9859369|NCT00922207|10972492|FG001|COMPLETED|Overall Study||88
9859370|NCT00922207|10972493|FG002|COMPLETED|Overall Study||90
9859371|NCT00922207|10972491|FG000|NOT COMPLETED|Overall Study||6
9859372|NCT00922207|10972492|FG001|NOT COMPLETED|Overall Study||7
9859373|NCT00922207|10972493|FG002|NOT COMPLETED|Overall Study||4
9859374|NCT00922233|10972501|FG000|STARTED|Overall Study||72
9859375|NCT00922233|10972501|FG000|COMPLETED|Overall Study||68
9859376|NCT00922233|10972501|FG000|NOT COMPLETED|Overall Study||4
9859377|NCT00922272|10972506|FG000|STARTED|Open-label Phase||92
9859378|NCT00922272|10972507|FG001|STARTED|Open-label Phase||0
9859379|NCT00922272|10972506|FG000|COMPLETED|Open-label Phase||69
9859380|NCT00922272|10972507|FG001|COMPLETED|Open-label Phase||0
9859381|NCT00922272|10972506|FG000|NOT COMPLETED|Open-label Phase||23
9859382|NCT00922272|10972507|FG001|NOT COMPLETED|Open-label Phase||0
9859383|NCT00922272|10972506|FG000|STARTED|Double-blind Phase||34
9859384|NCT00922272|10972507|FG001|STARTED|Double-blind Phase||35
9859385|NCT00922272|10972506|FG000|COMPLETED|Double-blind Phase||27
9859386|NCT00922272|10972507|FG001|COMPLETED|Double-blind Phase||29
9859387|NCT00922272|10972506|FG000|NOT COMPLETED|Double-blind Phase||7
9859388|NCT00922272|10972507|FG001|NOT COMPLETED|Double-blind Phase||6
9859389|NCT00922428|10972515|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
9859390|NCT00922428|10972515|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374
9859391|NCT00922428|10972515|FG000|NOT COMPLETED|Overall Study||15
9859392|NCT00922441|10972528|FG000|STARTED|Overall Study||30
9859393|NCT00922441|10972529|FG001|STARTED|Overall Study||30
9859394|NCT00922441|10972530|FG002|STARTED|Overall Study||32
9859395|NCT00922441|10972528|FG000|COMPLETED|Overall Study||30
9859396|NCT00922441|10972529|FG001|COMPLETED|Overall Study||30
9859397|NCT00922441|10972530|FG002|COMPLETED|Overall Study||29
9859398|NCT00922441|10972528|FG000|NOT COMPLETED|Overall Study||0
9859399|NCT00922441|10972529|FG001|NOT COMPLETED|Overall Study||0
9859400|NCT00922441|10972530|FG002|NOT COMPLETED|Overall Study||3
9859401|NCT00922480|10972540|FG000|STARTED|Main Study||250
9859402|NCT00922480|10972541|FG001|STARTED|Main Study||255
9859403|NCT00922480|10972540|FG000|COMPLETED|Main Study||213
9859404|NCT00922480|10972541|FG001|COMPLETED|Main Study||226
9859405|NCT00922480|10972540|FG000|NOT COMPLETED|Main Study||37
9859406|NCT00922480|10972541|FG001|NOT COMPLETED|Main Study||29
9859407|NCT00922480|10972540|FG000|STARTED|Extension Study||73
9859408|NCT00922480|10972541|FG001|STARTED|Extension Study||85
9859409|NCT00922480|10972540|FG000|COMPLETED|Extension Study||68
9859410|NCT00922480|10972541|FG001|COMPLETED|Extension Study||82
9859411|NCT00922480|10972540|FG000|NOT COMPLETED|Extension Study||5
9859412|NCT00922480|10972541|FG001|NOT COMPLETED|Extension Study||3
9859413|NCT00922623|10972549|FG000|STARTED|Overall Study||93
9859414|NCT00922623|10972549|FG000|COMPLETED|Overall Study||88
9859415|NCT00922623|10972549|FG000|NOT COMPLETED|Overall Study||5
9859416|NCT00922636|10972560|FG000|STARTED|Overall Study||36
9859417|NCT00922636|10972561|FG001|STARTED|Overall Study||78
9859418|NCT00922636|10972562|FG002|STARTED|Overall Study||76
9859419|NCT00922636|10972563|FG003|STARTED|Overall Study||75
9859420|NCT00922636|10972564|FG004|STARTED|Overall Study||75
9859421|NCT00922636|10972560|FG000|Entered Optional Taper Phase|Overall Study||4
9859422|NCT00922636|10972561|FG001|Entered Optional Taper Phase|Overall Study||10
9859423|NCT00922636|10972562|FG002|Entered Optional Taper Phase|Overall Study||15
9859424|NCT00922636|10972563|FG003|Entered Optional Taper Phase|Overall Study||7
9859425|NCT00922636|10972564|FG004|Entered Optional Taper Phase|Overall Study||12
9859426|NCT00922636|10972560|FG000|COMPLETED|Overall Study||29
9859427|NCT00922636|10972561|FG001|COMPLETED|Overall Study||62
9859428|NCT00922636|10972562|FG002|COMPLETED|Overall Study||56
9859429|NCT00922636|10972563|FG003|COMPLETED|Overall Study||58
9859430|NCT00922636|10972564|FG004|COMPLETED|Overall Study||59
9859431|NCT00922636|10972560|FG000|NOT COMPLETED|Overall Study||7
9859432|NCT00922636|10972561|FG001|NOT COMPLETED|Overall Study||16
9859433|NCT00922636|10972562|FG002|NOT COMPLETED|Overall Study||20
9859434|NCT00922636|10972563|FG003|NOT COMPLETED|Overall Study||17
9859435|NCT00922636|10972564|FG004|NOT COMPLETED|Overall Study||16
9859436|NCT00922701|10972581|FG000|STARTED|Overall Study||4
9859437|NCT00922701|10972581|FG000|COMPLETED|Overall Study||4
9859438|NCT00922701|10972581|FG000|NOT COMPLETED|Overall Study||0
9859439|NCT00922766|10972585|FG000|STARTED|Overall Study||617
9859440|NCT00922766|10972585|FG000|COMPLETED|Overall Study||610
9859441|NCT00922766|10972585|FG000|NOT COMPLETED|Overall Study||7
9859442|NCT00922779|10972589|FG000|STARTED|Overall Study||6661
9859443|NCT00922779|10972589|FG000|COMPLETED|Overall Study||4334
9859444|NCT00922779|10972589|FG000|NOT COMPLETED|Overall Study||2327
9859445|NCT00922883|10972593|FG000|STARTED|Overall Study||43
9859446|NCT00922883|10972593|FG000|COMPLETED|Overall Study||43
9859447|NCT00922883|10972593|FG000|NOT COMPLETED|Overall Study||0
9859448|NCT00922935|10972600|FG000|STARTED|Overall Study||10
9859449|NCT00922935|10972601|FG001|STARTED|Overall Study||16
9859450|NCT00922935|10972602|FG002|STARTED|Overall Study||10
9859451|NCT00922935|10972600|FG000|COMPLETED|Overall Study||9
9859452|NCT00922935|10972601|FG001|COMPLETED|Overall Study||11
9859453|NCT00922935|10972602|FG002|COMPLETED|Overall Study||10
9859454|NCT00922935|10972600|FG000|NOT COMPLETED|Overall Study||1
9859455|NCT00922935|10972601|FG001|NOT COMPLETED|Overall Study||5
9859456|NCT00922935|10972602|FG002|NOT COMPLETED|Overall Study||0
9859457|NCT00922974|10972613|FG000|STARTED|Phase II Component||46
9859458|NCT00922974|10972614|FG001|STARTED|Phase II Component||0
9859459|NCT00922974|10972613|FG000|Eligible|Phase II Component||44
9859460|NCT00922974|10972614|FG001|Eligible|Phase II Component||0
9859461|NCT00922974|10972613|FG000|Eligible and Started Treatment|Phase II Component||39
9859462|NCT00922974|10972614|FG001|Eligible and Started Treatment|Phase II Component||0
9859463|NCT00922974|10972613|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34
9859464|NCT00922974|10972614|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0
9859465|NCT00922974|10972613|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
9859466|NCT00922974|10972614|FG001|COMPLETED|Phase II Component||0
9859467|NCT00922974|10972613|FG000|NOT COMPLETED|Phase II Component||7
9859468|NCT00922974|10972614|FG001|NOT COMPLETED|Phase II Component||0
9859469|NCT00922974|10972613|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
9859470|NCT00922974|10972614|FG001|STARTED|Phase III Component||136
9859471|NCT00922974|10972613|FG000|Eligible|Phase III Component||209
9859472|NCT00922974|10972614|FG001|Eligible|Phase III Component||130
9859473|NCT00922974|10972613|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139
9859474|NCT00922974|10972614|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76
9859475|NCT00922974|10972613|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87
9859476|NCT00922974|10972614|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58
9859477|NCT00922974|10972613|FG000|Eligible With Adverse Event Data|Phase III Component||202
9859478|NCT00922974|10972614|FG001|Eligible With Adverse Event Data|Phase III Component||117
9859479|NCT00922974|10972613|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148
9859480|NCT00922974|10972614|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83
9859481|NCT00922974|10972613|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
9859482|NCT00922974|10972614|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
9859483|NCT00922974|10972613|FG000|COMPLETED|Phase III Component||209
9859484|NCT00922974|10972614|FG001|COMPLETED|Phase III Component||130
9859485|NCT00922974|10972613|FG000|NOT COMPLETED|Phase III Component||8
9859486|NCT00922974|10972614|FG001|NOT COMPLETED|Phase III Component||6
9859487|NCT00922987|10972622|FG000|STARTED|Overall Study||281
9859488|NCT00922987|10972622|FG000|COMPLETED|Overall Study||277
9859489|NCT00922987|10972622|FG000|NOT COMPLETED|Overall Study||4
9859490|NCT00923078|10972629|FG000|STARTED|First Intervention (Weeks 1-4)||20
9859491|NCT00923078|10972630|FG001|STARTED|First Intervention (Weeks 1-4)||20
9859492|NCT00923078|10972631|FG002|STARTED|First Intervention (Weeks 1-4)||20
9859493|NCT00923078|10972629|FG000|COMPLETED|First Intervention (Weeks 1-4)||19
9859494|NCT00923078|10972630|FG001|COMPLETED|First Intervention (Weeks 1-4)||19
9859495|NCT00923078|10972631|FG002|COMPLETED|First Intervention (Weeks 1-4)||0
9859496|NCT00923078|10972629|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1
9859497|NCT00923078|10972630|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1
9859498|NCT00923078|10972631|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20
9859499|NCT00923078|10972629|FG000|STARTED|Second Intervention (Weeks 5-8)||19
9859500|NCT00923078|10972630|FG001|STARTED|Second Intervention (Weeks 5-8)||19
9859501|NCT00923078|10972631|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
9859502|NCT00923078|10972629|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19
9859503|NCT00923078|10972630|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19
9859504|NCT00923078|10972631|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0
9859505|NCT00923078|10972629|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
9859506|NCT00923078|10972630|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
9859507|NCT00923078|10972631|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
9859508|NCT00923091|10972646|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335
9859509|NCT00923091|10972647|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336
9859510|NCT00923091|10972648|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336
9859511|NCT00923091|10972649|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336
9859512|NCT00923091|10972650|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336
9859513|NCT00923091|10972651|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337
9859514|NCT00923091|10972652|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337
9859515|NCT00923091|10972653|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336
9859516|NCT00923091|10972654|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0
9859517|NCT00923091|10972655|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0
9859518|NCT00923091|10972656|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0
9859519|NCT00923091|10972657|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0
9859520|NCT00923091|10972658|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0
9859521|NCT00923091|10972646|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
9859522|NCT00923091|10972647|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
9859523|NCT00923091|10972648|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
9859524|NCT00923091|10972649|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
9859525|NCT00923091|10972650|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
9859526|NCT00923091|10972651|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
9859527|NCT00923091|10972652|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
9859528|NCT00923091|10972653|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
9859529|NCT00923091|10972654|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859530|NCT00923091|10972655|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859531|NCT00923091|10972656|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859532|NCT00923091|10972657|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859533|NCT00923091|10972658|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859534|NCT00923091|10972646|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
9859535|NCT00923091|10972647|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
9859536|NCT00923091|10972648|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
9859537|NCT00923091|10972649|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
9859538|NCT00923091|10972650|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
9859539|NCT00923091|10972651|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
9859540|NCT00923091|10972652|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
9859541|NCT00923091|10972653|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
9859542|NCT00923091|10972654|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859543|NCT00923091|10972655|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859544|NCT00923091|10972656|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859545|NCT00923091|10972657|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859546|NCT00923091|10972658|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9859547|NCT00923091|10972646|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
9859548|NCT00923091|10972647|FG001|STARTED|Period III (Single-Blind)||0
9859549|NCT00923091|10972648|FG002|STARTED|Period III (Single-Blind)||0
9859550|NCT00923091|10972649|FG003|STARTED|Period III (Single-Blind)||0
9859551|NCT00923091|10972650|FG004|STARTED|Period III (Single-Blind)||0
9859552|NCT00923091|10972651|FG005|STARTED|Period III (Single-Blind)||0
9859553|NCT00923091|10972652|FG006|STARTED|Period III (Single-Blind)||0
9859554|NCT00923091|10972653|FG007|STARTED|Period III (Single-Blind)||0
9859555|NCT00923091|10972654|FG008|STARTED|Period III (Single-Blind)||0
9859556|NCT00923091|10972655|FG009|STARTED|Period III (Single-Blind)||0
9859557|NCT00923091|10972656|FG010|STARTED|Period III (Single-Blind)||0
9859558|NCT00923091|10972657|FG011|STARTED|Period III (Single-Blind)||0
9859559|NCT00923091|10972658|FG012|STARTED|Period III (Single-Blind)||0
9859560|NCT00923091|10972646|FG000|COMPLETED|Period III (Single-Blind)||2520
9859561|NCT00923091|10972647|FG001|COMPLETED|Period III (Single-Blind)||0
9859562|NCT00923091|10972648|FG002|COMPLETED|Period III (Single-Blind)||0
9859563|NCT00923091|10972649|FG003|COMPLETED|Period III (Single-Blind)||0
9859564|NCT00923091|10972650|FG004|COMPLETED|Period III (Single-Blind)||0
9859565|NCT00923091|10972651|FG005|COMPLETED|Period III (Single-Blind)||0
9859566|NCT00923091|10972652|FG006|COMPLETED|Period III (Single-Blind)||0
9859567|NCT00923091|10972653|FG007|COMPLETED|Period III (Single-Blind)||0
9859568|NCT00923091|10972654|FG008|COMPLETED|Period III (Single-Blind)||0
9859569|NCT00923091|10972655|FG009|COMPLETED|Period III (Single-Blind)||0
9859570|NCT00923091|10972656|FG010|COMPLETED|Period III (Single-Blind)||0
9859571|NCT00923091|10972657|FG011|COMPLETED|Period III (Single-Blind)||0
9859572|NCT00923091|10972658|FG012|COMPLETED|Period III (Single-Blind)||0
9859573|NCT00923091|10972646|FG000|NOT COMPLETED|Period III (Single-Blind)||20
9859574|NCT00923091|10972647|FG001|NOT COMPLETED|Period III (Single-Blind)||0
9859575|NCT00923091|10972648|FG002|NOT COMPLETED|Period III (Single-Blind)||0
9859576|NCT00923091|10972649|FG003|NOT COMPLETED|Period III (Single-Blind)||0
9859577|NCT00923091|10972650|FG004|NOT COMPLETED|Period III (Single-Blind)||0
9859578|NCT00923091|10972651|FG005|NOT COMPLETED|Period III (Single-Blind)||0
9859579|NCT00923091|10972652|FG006|NOT COMPLETED|Period III (Single-Blind)||0
9859580|NCT00923091|10972653|FG007|NOT COMPLETED|Period III (Single-Blind)||0
9859581|NCT00923091|10972654|FG008|NOT COMPLETED|Period III (Single-Blind)||0
9859582|NCT00923091|10972655|FG009|NOT COMPLETED|Period III (Single-Blind)||0
9859583|NCT00923091|10972656|FG010|NOT COMPLETED|Period III (Single-Blind)||0
9859584|NCT00923091|10972657|FG011|NOT COMPLETED|Period III (Single-Blind)||0
9859585|NCT00923091|10972658|FG012|NOT COMPLETED|Period III (Single-Blind)||0
9859586|NCT00923091|10972646|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
9859587|NCT00923091|10972647|FG001|STARTED|Period IV (Double-Blind)||453
9859588|NCT00923091|10972648|FG002|STARTED|Period IV (Double-Blind)||0
9859589|NCT00923091|10972649|FG003|STARTED|Period IV (Double-Blind)||0
9859590|NCT00923091|10972650|FG004|STARTED|Period IV (Double-Blind)||0
9859591|NCT00923091|10972651|FG005|STARTED|Period IV (Double-Blind)||0
9859592|NCT00923091|10972652|FG006|STARTED|Period IV (Double-Blind)||0
9859593|NCT00923091|10972653|FG007|STARTED|Period IV (Double-Blind)||0
9859594|NCT00923091|10972654|FG008|STARTED|Period IV (Double-Blind)||0
9859595|NCT00923091|10972655|FG009|STARTED|Period IV (Double-Blind)||0
9859596|NCT00923091|10972656|FG010|STARTED|Period IV (Double-Blind)||0
9859597|NCT00923091|10972657|FG011|STARTED|Period IV (Double-Blind)||0
9859598|NCT00923091|10972658|FG012|STARTED|Period IV (Double-Blind)||0
9859599|NCT00923091|10972646|FG000|COMPLETED|Period IV (Double-Blind)||226
9859600|NCT00923091|10972647|FG001|COMPLETED|Period IV (Double-Blind)||451
9859601|NCT00923091|10972648|FG002|COMPLETED|Period IV (Double-Blind)||0
9859602|NCT00923091|10972649|FG003|COMPLETED|Period IV (Double-Blind)||0
9859603|NCT00923091|10972650|FG004|COMPLETED|Period IV (Double-Blind)||0
9859604|NCT00923091|10972651|FG005|COMPLETED|Period IV (Double-Blind)||0
9859605|NCT00923091|10972652|FG006|COMPLETED|Period IV (Double-Blind)||0
9859606|NCT00923091|10972653|FG007|COMPLETED|Period IV (Double-Blind)||0
9859607|NCT00923091|10972654|FG008|COMPLETED|Period IV (Double-Blind)||0
9859608|NCT00923091|10972655|FG009|COMPLETED|Period IV (Double-Blind)||0
9859609|NCT00923091|10972656|FG010|COMPLETED|Period IV (Double-Blind)||0
9859610|NCT00923091|10972657|FG011|COMPLETED|Period IV (Double-Blind)||0
9859611|NCT00923091|10972658|FG012|COMPLETED|Period IV (Double-Blind)||0
9859612|NCT00923091|10972646|FG000|NOT COMPLETED|Period IV (Double-Blind)||2
9859613|NCT00923091|10972647|FG001|NOT COMPLETED|Period IV (Double-Blind)||2
9859614|NCT00923091|10972648|FG002|NOT COMPLETED|Period IV (Double-Blind)||0
9859615|NCT00923091|10972649|FG003|NOT COMPLETED|Period IV (Double-Blind)||0
9859616|NCT00923091|10972650|FG004|NOT COMPLETED|Period IV (Double-Blind)||0
9859617|NCT00923091|10972651|FG005|NOT COMPLETED|Period IV (Double-Blind)||0
9859618|NCT00923091|10972652|FG006|NOT COMPLETED|Period IV (Double-Blind)||0
9859619|NCT00923091|10972653|FG007|NOT COMPLETED|Period IV (Double-Blind)||0
9859620|NCT00923091|10972654|FG008|NOT COMPLETED|Period IV (Double-Blind)||0
9859621|NCT00923091|10972655|FG009|NOT COMPLETED|Period IV (Double-Blind)||0
9859622|NCT00923091|10972656|FG010|NOT COMPLETED|Period IV (Double-Blind)||0
9859623|NCT00923091|10972657|FG011|NOT COMPLETED|Period IV (Double-Blind)||0
9859624|NCT00923091|10972658|FG012|NOT COMPLETED|Period IV (Double-Blind)||0
9859625|NCT00923091|10972646|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
9859626|NCT00923091|10972647|FG001|STARTED|Period V (Double -Blind)||0
9859627|NCT00923091|10972648|FG002|STARTED|Period V (Double -Blind)||0
9859628|NCT00923091|10972649|FG003|STARTED|Period V (Double -Blind)||0
9859629|NCT00923091|10972650|FG004|STARTED|Period V (Double -Blind)||0
9859630|NCT00923091|10972651|FG005|STARTED|Period V (Double -Blind)||0
9859631|NCT00923091|10972652|FG006|STARTED|Period V (Double -Blind)||0
9859632|NCT00923091|10972653|FG007|STARTED|Period V (Double -Blind)||0
9859633|NCT00923091|10972654|FG008|STARTED|Period V (Double -Blind)||135
9859634|NCT00923091|10972655|FG009|STARTED|Period V (Double -Blind)||119
9859635|NCT00923091|10972656|FG010|STARTED|Period V (Double -Blind)||194
9859636|NCT00923091|10972657|FG011|STARTED|Period V (Double -Blind)||151
9859637|NCT00923091|10972658|FG012|STARTED|Period V (Double -Blind)||75
9859638|NCT00923091|10972646|FG000|COMPLETED|Period V (Double -Blind)||0
9859639|NCT00923091|10972647|FG001|COMPLETED|Period V (Double -Blind)||0
9859640|NCT00923091|10972648|FG002|COMPLETED|Period V (Double -Blind)||0
9859641|NCT00923091|10972649|FG003|COMPLETED|Period V (Double -Blind)||0
9859642|NCT00923091|10972650|FG004|COMPLETED|Period V (Double -Blind)||0
9859643|NCT00923091|10972651|FG005|COMPLETED|Period V (Double -Blind)||0
9859644|NCT00923091|10972652|FG006|COMPLETED|Period V (Double -Blind)||0
9859645|NCT00923091|10972653|FG007|COMPLETED|Period V (Double -Blind)||0
9859646|NCT00923091|10972654|FG008|COMPLETED|Period V (Double -Blind)||134
9859647|NCT00923091|10972655|FG009|COMPLETED|Period V (Double -Blind)||119
9859648|NCT00923091|10972656|FG010|COMPLETED|Period V (Double -Blind)||193
9859649|NCT00923091|10972657|FG011|COMPLETED|Period V (Double -Blind)||151
9859650|NCT00923091|10972658|FG012|COMPLETED|Period V (Double -Blind)||73
9859651|NCT00923091|10972646|FG000|NOT COMPLETED|Period V (Double -Blind)||0
9859652|NCT00923091|10972647|FG001|NOT COMPLETED|Period V (Double -Blind)||0
9859653|NCT00923091|10972648|FG002|NOT COMPLETED|Period V (Double -Blind)||0
9859654|NCT00923091|10972649|FG003|NOT COMPLETED|Period V (Double -Blind)||0
9859655|NCT00923091|10972650|FG004|NOT COMPLETED|Period V (Double -Blind)||0
9859656|NCT00923091|10972651|FG005|NOT COMPLETED|Period V (Double -Blind)||0
9859657|NCT00923091|10972652|FG006|NOT COMPLETED|Period V (Double -Blind)||0
9859658|NCT00923091|10972653|FG007|NOT COMPLETED|Period V (Double -Blind)||0
9859659|NCT00923091|10972654|FG008|NOT COMPLETED|Period V (Double -Blind)||1
9859660|NCT00923091|10972655|FG009|NOT COMPLETED|Period V (Double -Blind)||0
9859661|NCT00923091|10972656|FG010|NOT COMPLETED|Period V (Double -Blind)||1
9859662|NCT00923091|10972657|FG011|NOT COMPLETED|Period V (Double -Blind)||0
9859663|NCT00923091|10972658|FG012|NOT COMPLETED|Period V (Double -Blind)||2
9859664|NCT00923091|10972646|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
9859665|NCT00923091|10972647|FG001|STARTED|Period VI (Open-Label)||272
9859666|NCT00923091|10972648|FG002|STARTED|Period VI (Open-Label)||480
9859667|NCT00923091|10972649|FG003|STARTED|Period VI (Open-Label)||146
9859668|NCT00923091|10972650|FG004|STARTED|Period VI (Open-Label)||164
9859669|NCT00923091|10972651|FG005|STARTED|Period VI (Open-Label)||0
9859670|NCT00923091|10972652|FG006|STARTED|Period VI (Open-Label)||0
9859671|NCT00923091|10972653|FG007|STARTED|Period VI (Open-Label)||0
9859672|NCT00923091|10972654|FG008|STARTED|Period VI (Open-Label)||0
9859673|NCT00923091|10972655|FG009|STARTED|Period VI (Open-Label)||0
9859674|NCT00923091|10972656|FG010|STARTED|Period VI (Open-Label)||0
9859675|NCT00923091|10972657|FG011|STARTED|Period VI (Open-Label)||0
9859676|NCT00923091|10972658|FG012|STARTED|Period VI (Open-Label)||0
9859677|NCT00923091|10972646|FG000|COMPLETED|Period VI (Open-Label)||1408
9859678|NCT00923091|10972647|FG001|COMPLETED|Period VI (Open-Label)||264
9859679|NCT00923091|10972648|FG002|COMPLETED|Period VI (Open-Label)||467
9859680|NCT00923091|10972649|FG003|COMPLETED|Period VI (Open-Label)||143
9859681|NCT00923091|10972650|FG004|COMPLETED|Period VI (Open-Label)||157
9859682|NCT00923091|10972651|FG005|COMPLETED|Period VI (Open-Label)||0
9859683|NCT00923091|10972652|FG006|COMPLETED|Period VI (Open-Label)||0
9859684|NCT00923091|10972653|FG007|COMPLETED|Period VI (Open-Label)||0
9859685|NCT00923091|10972654|FG008|COMPLETED|Period VI (Open-Label)||0
9859686|NCT00923091|10972655|FG009|COMPLETED|Period VI (Open-Label)||0
9859687|NCT00923091|10972656|FG010|COMPLETED|Period VI (Open-Label)||0
9859688|NCT00923091|10972657|FG011|COMPLETED|Period VI (Open-Label)||0
9859689|NCT00923091|10972658|FG012|COMPLETED|Period VI (Open-Label)||0
9859690|NCT00923091|10972646|FG000|NOT COMPLETED|Period VI (Open-Label)||39
9859691|NCT00923091|10972647|FG001|NOT COMPLETED|Period VI (Open-Label)||8
9859692|NCT00923091|10972648|FG002|NOT COMPLETED|Period VI (Open-Label)||13
9859693|NCT00923091|10972649|FG003|NOT COMPLETED|Period VI (Open-Label)||3
9859694|NCT00923091|10972650|FG004|NOT COMPLETED|Period VI (Open-Label)||7
9859695|NCT00923091|10972651|FG005|NOT COMPLETED|Period VI (Open-Label)||0
9859696|NCT00923091|10972652|FG006|NOT COMPLETED|Period VI (Open-Label)||0
9859697|NCT00923091|10972653|FG007|NOT COMPLETED|Period VI (Open-Label)||0
9859698|NCT00923091|10972654|FG008|NOT COMPLETED|Period VI (Open-Label)||0
9859699|NCT00923091|10972655|FG009|NOT COMPLETED|Period VI (Open-Label)||0
9859700|NCT00923091|10972656|FG010|NOT COMPLETED|Period VI (Open-Label)||0
9859701|NCT00923091|10972657|FG011|NOT COMPLETED|Period VI (Open-Label)||0
9859702|NCT00923091|10972658|FG012|NOT COMPLETED|Period VI (Open-Label)||0
9859703|NCT00923117|10972685|FG000|STARTED|Overall Study||44
9859704|NCT00923117|10972686|FG001|STARTED|Overall Study||43
10092935|NCT02341456|11221512|FG000|COMPLETED|Overall Study||3
10092936|NCT02341456|11221513|FG001|COMPLETED|Overall Study||0
10092937|NCT02341456|11221514|FG002|COMPLETED|Overall Study||2
10092938|NCT02341456|11221512|FG000|NOT COMPLETED|Overall Study||4
10092939|NCT02341456|11221513|FG001|NOT COMPLETED|Overall Study||6
10092940|NCT02341456|11221514|FG002|NOT COMPLETED|Overall Study||4
10092941|NCT02341482|11221522|FG000|STARTED|Overall Study||13
10092942|NCT02341482|11221522|FG000|COMPLETED|Overall Study||12
10092943|NCT02341482|11221522|FG000|NOT COMPLETED|Overall Study||1
10092944|NCT02341599|11221536|FG000|STARTED|Overall Study||8
10092945|NCT02341599|11221537|FG001|STARTED|Overall Study||8
10092946|NCT02341599|11221538|FG002|STARTED|Overall Study||8
10092947|NCT02341599|11221539|FG003|STARTED|Overall Study||8
10092948|NCT02341599|11221540|FG004|STARTED|Overall Study||8
10092949|NCT02341599|11221536|FG000|COMPLETED|Overall Study||8
10092950|NCT02341599|11221537|FG001|COMPLETED|Overall Study||8
10092951|NCT02341599|11221538|FG002|COMPLETED|Overall Study||8
10201853|NCT03441984|11329283|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201854|NCT03441984|11329284|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201855|NCT03441984|11329285|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10092952|NCT02341599|11221539|FG003|COMPLETED|Overall Study||8
10092953|NCT02341599|11221540|FG004|COMPLETED|Overall Study||8
10201856|NCT03441984|11329286|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9859705|NCT00923117|10972685|FG000|COMPLETED|Overall Study||44
9859706|NCT00923117|10972686|FG001|COMPLETED|Overall Study||43
9859707|NCT00923117|10972685|FG000|NOT COMPLETED|Overall Study||0
9859708|NCT00923117|10972686|FG001|NOT COMPLETED|Overall Study||0
9859709|NCT00923130|10972692|FG000|STARTED|Overall Study||30
9859710|NCT00923130|10972692|FG000|COMPLETED|Overall Study||5
9859711|NCT00923130|10972692|FG000|NOT COMPLETED|Overall Study||25
9859712|NCT00923156|10972699|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
9859713|NCT00923156|10972700|FG001|STARTED|Overall Study||42
9859714|NCT00923156|10972701|FG002|STARTED|Overall Study||41
9859715|NCT00923156|10972699|FG000|COMPLETED|Overall Study||40
10092954|NCT02341599|11221536|FG000|NOT COMPLETED|Overall Study||0
10092955|NCT02341599|11221537|FG001|NOT COMPLETED|Overall Study||0
9859716|NCT00923156|10972700|FG001|COMPLETED|Overall Study||38
9859717|NCT00923156|10972701|FG002|COMPLETED|Overall Study||38
9859718|NCT00923156|10972699|FG000|NOT COMPLETED|Overall Study||0
9859719|NCT00923156|10972700|FG001|NOT COMPLETED|Overall Study||4
9859720|NCT00923156|10972701|FG002|NOT COMPLETED|Overall Study||3
9859721|NCT00923195|10972711|FG000|STARTED|Overall Study||2
9859722|NCT00923195|10972712|FG001|STARTED|Overall Study||2
9859723|NCT00923195|10972711|FG000|COMPLETED|Overall Study||2
9859724|NCT00923195|10972712|FG001|COMPLETED|Overall Study||1
9859725|NCT00923195|10972711|FG000|NOT COMPLETED|Overall Study||0
9859726|NCT00923195|10972712|FG001|NOT COMPLETED|Overall Study||1
9859727|NCT00923260|10972720|FG000|STARTED|Overall Study||12
9859728|NCT00923260|10972721|FG001|STARTED|Overall Study||12
9859729|NCT00923260|10972720|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
9859730|NCT00923260|10972721|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
9859731|NCT00923260|10972720|FG000|NOT COMPLETED|Overall Study||1
9859732|NCT00923260|10972721|FG001|NOT COMPLETED|Overall Study||1
9859733|NCT00923273|10972732|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
9859734|NCT00923273|10972733|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
9859735|NCT00923273|10972734|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
9859736|NCT00923273|10972735|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
9859737|NCT00923273|10972736|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
9859738|NCT00923273|10972732|FG000|COMPLETED|Phase I Treatment Period||4
9859739|NCT00923273|10972733|FG001|COMPLETED|Phase I Treatment Period||3
9859740|NCT00923273|10972734|FG002|COMPLETED|Phase I Treatment Period||3
9859741|NCT00923273|10972735|FG003|COMPLETED|Phase I Treatment Period||7
9859742|NCT00923273|10972736|FG004|COMPLETED|Phase I Treatment Period||5
9859743|NCT00923273|10972732|FG000|NOT COMPLETED|Phase I Treatment Period||0
9859744|NCT00923273|10972733|FG001|NOT COMPLETED|Phase I Treatment Period||0
9859745|NCT00923273|10972734|FG002|NOT COMPLETED|Phase I Treatment Period||0
9859746|NCT00923273|10972735|FG003|NOT COMPLETED|Phase I Treatment Period||0
9859747|NCT00923273|10972736|FG004|NOT COMPLETED|Phase I Treatment Period||0
9859748|NCT00923273|10972732|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
9859749|NCT00923273|10972733|FG001|STARTED|Phase II Treatment Period||0
9859750|NCT00923273|10972734|FG002|STARTED|Phase II Treatment Period||0
9859751|NCT00923273|10972735|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
9859752|NCT00923273|10972736|FG004|STARTED|Phase II Treatment Period||0
9859753|NCT00923273|10972732|FG000|COMPLETED|Phase II Treatment Period||0
9859754|NCT00923273|10972733|FG001|COMPLETED|Phase II Treatment Period||0
9859755|NCT00923273|10972734|FG002|COMPLETED|Phase II Treatment Period||0
9859756|NCT00923273|10972735|FG003|COMPLETED|Phase II Treatment Period||20
9859757|NCT00923273|10972736|FG004|COMPLETED|Phase II Treatment Period||0
9859758|NCT00923273|10972732|FG000|NOT COMPLETED|Phase II Treatment Period||0
9859759|NCT00923273|10972733|FG001|NOT COMPLETED|Phase II Treatment Period||0
9859760|NCT00923273|10972734|FG002|NOT COMPLETED|Phase II Treatment Period||0
9859761|NCT00923273|10972735|FG003|NOT COMPLETED|Phase II Treatment Period||7
9859762|NCT00923273|10972736|FG004|NOT COMPLETED|Phase II Treatment Period||0
9859763|NCT00923351|10972756|FG000|STARTED|Overall Study||6
9859764|NCT00923351|10972757|FG001|STARTED|Overall Study||26
9859765|NCT00923351|10972758|FG002|STARTED|Overall Study||12
9859766|NCT00923351|10972756|FG000|COMPLETED|Overall Study||6
9859767|NCT00923351|10972757|FG001|COMPLETED|Overall Study||26
9859768|NCT00923351|10972758|FG002|COMPLETED|Overall Study||0
9859769|NCT00923351|10972756|FG000|NOT COMPLETED|Overall Study||0
9859770|NCT00923351|10972757|FG001|NOT COMPLETED|Overall Study||0
9859771|NCT00923351|10972758|FG002|NOT COMPLETED|Overall Study||12
9859772|NCT00923364|10972764|FG000|STARTED|Overall Study||14
9859773|NCT00923364|10972765|FG001|STARTED|Overall Study||5
9859774|NCT00923364|10972764|FG000|COMPLETED|Overall Study||10
9859775|NCT00923364|10972765|FG001|COMPLETED|Overall Study||5
9859776|NCT00923364|10972764|FG000|NOT COMPLETED|Overall Study||4
9859777|NCT00923364|10972765|FG001|NOT COMPLETED|Overall Study||0
9859778|NCT00923481|10972770|FG000|STARTED|Overall Study||37
9859779|NCT00923481|10972770|FG000|COMPLETED|Overall Study||37
9859780|NCT00923481|10972770|FG000|NOT COMPLETED|Overall Study||0
9859781|NCT00923559|10972776|FG000|STARTED|Overall Study||40
9859782|NCT00923559|10972777|FG001|STARTED|Overall Study||40
9859783|NCT00923559|10972776|FG000|COMPLETED|Overall Study||38
9859784|NCT00923559|10972777|FG001|COMPLETED|Overall Study||37
9859785|NCT00923559|10972776|FG000|NOT COMPLETED|Overall Study||2
9859786|NCT00923559|10972777|FG001|NOT COMPLETED|Overall Study||3
9859787|NCT00923598|10972787|FG000|STARTED|Overall Study||23
9859788|NCT00923598|10972788|FG001|STARTED|Overall Study||22
9859789|NCT00923598|10972787|FG000|COMPLETED|Overall Study||19
9859790|NCT00923598|10972788|FG001|COMPLETED|Overall Study||17
9859791|NCT00923598|10972787|FG000|NOT COMPLETED|Overall Study||4
9859792|NCT00923598|10972788|FG001|NOT COMPLETED|Overall Study||5
9859793|NCT00923845|10972796|FG000|STARTED|Donor Lymphocyte Harvest||13
9859794|NCT00923845|10972797|FG001|STARTED|Donor Lymphocyte Harvest||0
9859795|NCT00923845|10972796|FG000|COMPLETED|Donor Lymphocyte Harvest||13
9859796|NCT00923845|10972797|FG001|COMPLETED|Donor Lymphocyte Harvest||0
9859797|NCT00923845|10972796|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0
9859798|NCT00923845|10972797|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0
9859799|NCT00923845|10972796|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13
9859800|NCT00923845|10972797|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0
9859801|NCT00923845|10972796|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
9859802|NCT00923845|10972797|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
9859803|NCT00923845|10972796|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
9859804|NCT00923845|10972797|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
9859805|NCT00923845|10972796|FG000|STARTED|Induction Therapy||0
9859806|NCT00923845|10972797|FG001|STARTED|Induction Therapy||12
9859807|NCT00923845|10972796|FG000|COMPLETED|Induction Therapy||0
9859808|NCT00923845|10972797|FG001|COMPLETED|Induction Therapy||10
9859809|NCT00923845|10972796|FG000|NOT COMPLETED|Induction Therapy||0
9859810|NCT00923845|10972797|FG001|NOT COMPLETED|Induction Therapy||2
9859811|NCT00923845|10972796|FG000|STARTED|Allogeneic Stem Cell Therapy||0
9859812|NCT00923845|10972797|FG001|STARTED|Allogeneic Stem Cell Therapy||10
9859813|NCT00923845|10972796|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
9859814|NCT00923845|10972797|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
9859815|NCT00923845|10972796|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
9859816|NCT00923845|10972797|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
9859817|NCT00923845|10972796|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0
9859818|NCT00923845|10972797|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10
9859819|NCT00923845|10972796|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
9859820|NCT00923845|10972797|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
9859821|NCT00923910|10972806|FG000|STARTED|Period 1||5
9859822|NCT00923910|10972807|FG001|STARTED|Period 1||5
9859823|NCT00923910|10972806|FG000|COMPLETED|Period 1||5
9859824|NCT00923910|10972807|FG001|COMPLETED|Period 1||5
9859825|NCT00923910|10972806|FG000|NOT COMPLETED|Period 1||0
9859826|NCT00923910|10972807|FG001|NOT COMPLETED|Period 1||0
9859827|NCT00923910|10972806|FG000|STARTED|Period 2||5
9859828|NCT00923910|10972807|FG001|STARTED|Period 2||5
9859829|NCT00923910|10972806|FG000|COMPLETED|Period 2||5
9859830|NCT00923910|10972807|FG001|COMPLETED|Period 2||5
9859831|NCT00923910|10972806|FG000|NOT COMPLETED|Period 2||0
9859832|NCT00923910|10972807|FG001|NOT COMPLETED|Period 2||0
9859833|NCT00923936|10972814|FG000|STARTED|Overall Study||10
9859834|NCT00923936|10972815|FG001|STARTED|Overall Study||6
9859835|NCT00923936|10972814|FG000|COMPLETED|Overall Study||2
9859836|NCT00923936|10972815|FG001|COMPLETED|Overall Study||3
9859837|NCT00923936|10972814|FG000|NOT COMPLETED|Overall Study||8
9859838|NCT00923936|10972815|FG001|NOT COMPLETED|Overall Study||3
9859839|NCT00923949|10972823|FG000|STARTED|Overall Study||1
9859840|NCT00923949|10972823|FG000|COMPLETED|Overall Study||1
9859841|NCT00923949|10972823|FG000|NOT COMPLETED|Overall Study||0
9859842|NCT00923975|10972827|FG000|STARTED|Overall Study||51
9859843|NCT00923975|10972827|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
9859844|NCT00923975|10972827|FG000|NOT COMPLETED|Overall Study||1
9859845|NCT00924001|10972831|FG000|STARTED|Overall Study||1
9859846|NCT00924001|10972831|FG000|COMPLETED|Overall Study||1
9859847|NCT00924001|10972831|FG000|NOT COMPLETED|Overall Study||0
9859848|NCT00924040|10972835|FG000|STARTED|Overall Study||1
9859849|NCT00924040|10972835|FG000|COMPLETED|Overall Study||1
9859850|NCT00924040|10972835|FG000|NOT COMPLETED|Overall Study||0
9859851|NCT00924053|10972843|FG000|STARTED|Overall Study||6
9859852|NCT00924053|10972844|FG001|STARTED|Overall Study||6
9859853|NCT00924053|10972845|FG002|STARTED|Overall Study||6
9859854|NCT00924053|10972846|FG003|STARTED|Overall Study||6
9859855|NCT00924053|10972843|FG000|COMPLETED|Overall Study||6
9859856|NCT00924053|10972844|FG001|COMPLETED|Overall Study||6
9859857|NCT00924053|10972845|FG002|COMPLETED|Overall Study||6
9859858|NCT00924053|10972846|FG003|COMPLETED|Overall Study||6
9859859|NCT00924053|10972843|FG000|NOT COMPLETED|Overall Study||0
9859860|NCT00924053|10972844|FG001|NOT COMPLETED|Overall Study||0
9859861|NCT00924053|10972845|FG002|NOT COMPLETED|Overall Study||0
9859862|NCT00924053|10972846|FG003|NOT COMPLETED|Overall Study||0
9859863|NCT00924066|10972856|FG000|STARTED|Overall Study||41
9859864|NCT00924066|10972856|FG000|COMPLETED|Overall Study||41
9859865|NCT00924066|10972856|FG000|NOT COMPLETED|Overall Study||0
9859866|NCT00924118|10972863|FG000|STARTED|Overall Study||15
9859867|NCT00924118|10972864|FG001|STARTED|Overall Study||15
9859868|NCT00924118|10972863|FG000|COMPLETED|Overall Study||15
9859869|NCT00924118|10972864|FG001|COMPLETED|Overall Study||15
9859870|NCT00924118|10972863|FG000|NOT COMPLETED|Overall Study||0
9859871|NCT00924118|10972864|FG001|NOT COMPLETED|Overall Study||0
9859872|NCT00924209|10972870|FG000|STARTED|Overall Study||7
9859873|NCT00924209|10972870|FG000|COMPLETED|Overall Study||7
9859874|NCT00924209|10972870|FG000|NOT COMPLETED|Overall Study||0
9859875|NCT00924287|10972874|FG000|STARTED|Overall Study||1
9859876|NCT00924287|10972874|FG000|COMPLETED|Overall Study||0
9859877|NCT00924287|10972874|FG000|NOT COMPLETED|Overall Study||1
9859878|NCT00924313|10972878|FG000|STARTED|Overall Study||40
9859879|NCT00924313|10972878|FG000|COMPLETED|Overall Study||39
9859880|NCT00924313|10972878|FG000|NOT COMPLETED|Overall Study||1
9859881|NCT00924352|10972882|FG000|STARTED|Overall Study||12
9859882|NCT00924352|10972883|FG001|STARTED|Overall Study||44
9859883|NCT00924352|10972882|FG000|COMPLETED|Overall Study||12
9859884|NCT00924352|10972883|FG001|COMPLETED|Overall Study||44
9859885|NCT00924352|10972882|FG000|NOT COMPLETED|Overall Study||0
9859886|NCT00924352|10972883|FG001|NOT COMPLETED|Overall Study||0
9859887|NCT00924404|10972892|FG000|STARTED|Overall Study||27
9859888|NCT00924404|10972893|FG001|STARTED|Overall Study||26
9859889|NCT00924404|10972892|FG000|COMPLETED|Overall Study||21
9859890|NCT00924404|10972893|FG001|COMPLETED|Overall Study||22
9859891|NCT00924404|10972892|FG000|NOT COMPLETED|Overall Study||6
9859892|NCT00924404|10972893|FG001|NOT COMPLETED|Overall Study||4
9859893|NCT00924443|10972899|FG000|STARTED|Overall Study||69
9859894|NCT00924443|10972899|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66
9859895|NCT00924443|10972899|FG000|COMPLETED|Overall Study||66
9859896|NCT00924443|10972899|FG000|NOT COMPLETED|Overall Study||3
9859897|NCT00924469|10972905|FG000|STARTED|Overall Study||30
9859898|NCT00924469|10972906|FG001|STARTED|Overall Study||28
9859899|NCT00924469|10972905|FG000|COMPLETED|Overall Study||28
9859900|NCT00924469|10972906|FG001|COMPLETED|Overall Study||26
9859901|NCT00924469|10972905|FG000|NOT COMPLETED|Overall Study||2
9859902|NCT00924469|10972906|FG001|NOT COMPLETED|Overall Study||2
9859903|NCT00924482|10972912|FG000|STARTED|Overall Study||261
9859904|NCT00924482|10972912|FG000|COMPLETED|Overall Study||261
9859905|NCT00924482|10972912|FG000|NOT COMPLETED|Overall Study||0
9859906|NCT00924508|10972917|FG000|STARTED|Overall Study||23
9859907|NCT00924508|10972917|FG000|COMPLETED|Overall Study||20
9859908|NCT00924508|10972917|FG000|NOT COMPLETED|Overall Study||3
9859909|NCT00924560|10972927|FG000|STARTED|Overall Study||458
9859910|NCT00924560|10972928|FG001|STARTED|Overall Study||448
9859911|NCT00924560|10972929|FG002|STARTED|Overall Study||455
9859912|NCT00924560|10972927|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
9859913|NCT00924560|10972928|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
9859914|NCT00924560|10972929|FG002|Received Treatment|Overall Study||0
9859915|NCT00924560|10972927|FG000|COMPLETED|Overall Study||247
9859916|NCT00924560|10972928|FG001|COMPLETED|Overall Study||240
9859917|NCT00924560|10972929|FG002|COMPLETED|Overall Study||372
9859918|NCT00924560|10972927|FG000|NOT COMPLETED|Overall Study||211
9859919|NCT00924560|10972928|FG001|NOT COMPLETED|Overall Study||208
9859920|NCT00924560|10972929|FG002|NOT COMPLETED|Overall Study||83
10092956|NCT02341599|11221538|FG002|NOT COMPLETED|Overall Study||0
10092957|NCT02341599|11221539|FG003|NOT COMPLETED|Overall Study||0
10092958|NCT02341599|11221540|FG004|NOT COMPLETED|Overall Study||0
10092959|NCT02341859|11221555|FG000|STARTED|First Intervention (1 Day)||10
10092960|NCT02341859|11221556|FG001|STARTED|First Intervention (1 Day)||9
10092961|NCT02341859|11221555|FG000|COMPLETED|First Intervention (1 Day)||10
10092962|NCT02341859|11221556|FG001|COMPLETED|First Intervention (1 Day)||9
10092963|NCT02341859|11221555|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10092964|NCT02341859|11221556|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10092965|NCT02341859|11221555|FG000|STARTED|Second Intervention (1 Day)||10
10092966|NCT02341859|11221556|FG001|STARTED|Second Intervention (1 Day)||9
10092967|NCT02341859|11221555|FG000|COMPLETED|Second Intervention (1 Day)||10
10092968|NCT02341859|11221556|FG001|COMPLETED|Second Intervention (1 Day)||9
10092969|NCT02341859|11221555|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10092970|NCT02341859|11221556|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10092971|NCT02342015|11221569|FG000|STARTED|Overall Study||20
10092972|NCT02342015|11221569|FG000|COMPLETED|Overall Study||20
10092973|NCT02342015|11221569|FG000|NOT COMPLETED|Overall Study||0
10092974|NCT02342171|11221575|FG000|STARTED|Overall Study||99
10092975|NCT02342171|11221576|FG001|STARTED|Overall Study||507
10092976|NCT02342171|11221575|FG000|COMPLETED|Overall Study||84
10092977|NCT02342171|11221576|FG001|COMPLETED|Overall Study||418
10092978|NCT02342171|11221575|FG000|NOT COMPLETED|Overall Study||15
10092979|NCT02342171|11221576|FG001|NOT COMPLETED|Overall Study||89
10092980|NCT02342197|11221583|FG000|STARTED|Overall Study||30
10092981|NCT02342197|11221584|FG001|STARTED|Overall Study||30
10092982|NCT02342197|11221583|FG000|COMPLETED|Overall Study||27
10092983|NCT02342197|11221584|FG001|COMPLETED|Overall Study||28
10092984|NCT02342197|11221583|FG000|NOT COMPLETED|Overall Study||3
10092985|NCT02342197|11221584|FG001|NOT COMPLETED|Overall Study||2
10092986|NCT02342223|11221590|FG000|STARTED|Overall Study||20
10092987|NCT02342223|11221590|FG000|COMPLETED|Overall Study||19
10092988|NCT02342223|11221590|FG000|NOT COMPLETED|Overall Study||1
10092989|NCT02342288|11221596|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30
10092990|NCT02342288|11221597|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33
10092991|NCT02342288|11221596|FG000|COMPLETED|Overall Study||25
9859921|NCT00924612|10972939|FG000|STARTED|Overall Study||4
9859922|NCT00924612|10972940|FG001|STARTED|Overall Study||4
9859923|NCT00924612|10972941|FG002|STARTED|Overall Study||4
9859924|NCT00924612|10972942|FG003|STARTED|Overall Study||4
9859925|NCT00924612|10972939|FG000|COMPLETED|Overall Study||4
9859926|NCT00924612|10972940|FG001|COMPLETED|Overall Study||4
9859927|NCT00924612|10972941|FG002|COMPLETED|Overall Study||4
9859928|NCT00924612|10972942|FG003|COMPLETED|Overall Study||4
10092992|NCT02342288|11221597|FG001|COMPLETED|Overall Study||27
10092993|NCT02342288|11221596|FG000|NOT COMPLETED|Overall Study||5
10092994|NCT02342288|11221597|FG001|NOT COMPLETED|Overall Study||6
9859929|NCT00924612|10972939|FG000|NOT COMPLETED|Overall Study||0
9859930|NCT00924612|10972940|FG001|NOT COMPLETED|Overall Study||0
9859931|NCT00924612|10972941|FG002|NOT COMPLETED|Overall Study||0
9859932|NCT00924612|10972942|FG003|NOT COMPLETED|Overall Study||0
9859933|NCT00924638|10972956|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
9859934|NCT00924638|10972957|FG001|STARTED|Overall Study|Randomized to Control Arm|220
9859935|NCT00924638|10972956|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209
9859936|NCT00924638|10972957|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207
9859937|NCT00924638|10972956|FG000|NOT COMPLETED|Overall Study||12
9859938|NCT00924638|10972957|FG001|NOT COMPLETED|Overall Study||13
9859939|NCT00924651|10972965|FG000|STARTED|Overall Study||356
9859940|NCT00924651|10972966|FG001|STARTED|Overall Study||337
9859941|NCT00924651|10972965|FG000|COMPLETED|Overall Study||331
9859942|NCT00924651|10972966|FG001|COMPLETED|Overall Study||312
9859943|NCT00924651|10972965|FG000|NOT COMPLETED|Overall Study||25
9859944|NCT00924651|10972966|FG001|NOT COMPLETED|Overall Study||25
9859945|NCT00924664|10972974|FG000|STARTED|Overall Study||322
9859946|NCT00924664|10972975|FG001|STARTED|Overall Study||527
9859947|NCT00924664|10972974|FG000|Treated|Overall Study||321
9859948|NCT00924664|10972975|FG001|Treated|Overall Study||527
9859949|NCT00924664|10972974|FG000|COMPLETED|Overall Study||0
9859950|NCT00924664|10972975|FG001|COMPLETED|Overall Study||0
9859951|NCT00924664|10972974|FG000|NOT COMPLETED|Overall Study||322
9859952|NCT00924664|10972975|FG001|NOT COMPLETED|Overall Study||527
9859953|NCT00924703|10972981|FG000|STARTED|Overall Study||68
9859954|NCT00924703|10972981|FG000|COMPLETED|Overall Study||46
9859955|NCT00924703|10972981|FG000|NOT COMPLETED|Overall Study||22
9859956|NCT00924729|10972987|FG000|STARTED|Overall Study||25
9859957|NCT00924729|10972988|FG001|STARTED|Overall Study||25
9859958|NCT00924729|10972987|FG000|COMPLETED|Overall Study||23
9859959|NCT00924729|10972988|FG001|COMPLETED|Overall Study||25
9859960|NCT00924729|10972987|FG000|NOT COMPLETED|Overall Study||2
9859961|NCT00924729|10972988|FG001|NOT COMPLETED|Overall Study||0
9859962|NCT00924781|10973000|FG000|STARTED|Overall Study||20
9859963|NCT00924781|10973001|FG001|STARTED|Overall Study||19
9859964|NCT00924781|10973000|FG000|COMPLETED|Overall Study||8
9859965|NCT00924781|10973001|FG001|COMPLETED|Overall Study||9
9859966|NCT00924781|10973000|FG000|NOT COMPLETED|Overall Study||12
9859967|NCT00924781|10973001|FG001|NOT COMPLETED|Overall Study||10
9859968|NCT00924820|10973017|FG000|STARTED|Overall Study||20
9859969|NCT00924820|10973017|FG000|COMPLETED|Overall Study||13
9859970|NCT00924820|10973017|FG000|NOT COMPLETED|Overall Study||7
9859971|NCT00924885|10973023|FG000|STARTED|Overall Study||129
9859972|NCT00924885|10973024|FG001|STARTED|Overall Study||128
9859973|NCT00924885|10973023|FG000|COMPLETED|Overall Study||126
9859974|NCT00924885|10973024|FG001|COMPLETED|Overall Study||124
9859975|NCT00924885|10973023|FG000|NOT COMPLETED|Overall Study||3
9859976|NCT00924885|10973024|FG001|NOT COMPLETED|Overall Study||4
9859977|NCT00924898|10973032|FG000|STARTED|Overall Study||92
9859978|NCT00924898|10973032|FG000|COMPLETED|Overall Study||90
9859979|NCT00924898|10973032|FG000|NOT COMPLETED|Overall Study||2
9859980|NCT00924950|10973041|FG000|STARTED|Overall Study||30
9859981|NCT00924950|10973041|FG000|COMPLETED|Overall Study||28
9859982|NCT00924950|10973041|FG000|NOT COMPLETED|Overall Study||2
9859983|NCT00925002|10973051|FG000|STARTED|Overall Study||38
9859984|NCT00925002|10973052|FG001|STARTED|Overall Study||37
9859985|NCT00925002|10973053|FG002|STARTED|Overall Study||18
9859986|NCT00925002|10973051|FG000|Treated|Overall Study||38
9859987|NCT00925002|10973052|FG001|Treated|Overall Study||37
9859988|NCT00925002|10973053|FG002|Treated|Overall Study||18
9859989|NCT00925002|10973051|FG000|COMPLETED|Overall Study||32
9859990|NCT00925002|10973052|FG001|COMPLETED|Overall Study||28
9859991|NCT00925002|10973053|FG002|COMPLETED|Overall Study||8
9859992|NCT00925002|10973051|FG000|NOT COMPLETED|Overall Study||6
9859993|NCT00925002|10973052|FG001|NOT COMPLETED|Overall Study||9
9859994|NCT00925002|10973053|FG002|NOT COMPLETED|Overall Study||10
9859995|NCT00925015|10973065|FG000|STARTED|Overall Study||8
9859996|NCT00925015|10973066|FG001|STARTED|Overall Study||6
9859997|NCT00925015|10973067|FG002|STARTED|Overall Study||6
9859998|NCT00925015|10973065|FG000|COMPLETED|Overall Study||0
9859999|NCT00925015|10973066|FG001|COMPLETED|Overall Study||0
9860000|NCT00925015|10973067|FG002|COMPLETED|Overall Study||0
9860001|NCT00925015|10973065|FG000|NOT COMPLETED|Overall Study||8
9860002|NCT00925015|10973066|FG001|NOT COMPLETED|Overall Study||6
9860003|NCT00925015|10973067|FG002|NOT COMPLETED|Overall Study||6
9860004|NCT00925054|10973084|FG000|STARTED|Overall Study||7
9860005|NCT00925054|10973085|FG001|STARTED|Overall Study||9
9860006|NCT00925054|10973086|FG002|STARTED|Overall Study||13
9860007|NCT00925054|10973087|FG003|STARTED|Overall Study||1
9860008|NCT00925054|10973088|FG004|STARTED|Overall Study||10
9860009|NCT00925054|10973084|FG000|COMPLETED|Overall Study||7
9860010|NCT00925054|10973085|FG001|COMPLETED|Overall Study||8
9860011|NCT00925054|10973086|FG002|COMPLETED|Overall Study||12
9860012|NCT00925054|10973087|FG003|COMPLETED|Overall Study||0
9860013|NCT00925054|10973088|FG004|COMPLETED|Overall Study||10
9860014|NCT00925054|10973084|FG000|NOT COMPLETED|Overall Study||0
9860015|NCT00925054|10973085|FG001|NOT COMPLETED|Overall Study||1
9860016|NCT00925054|10973086|FG002|NOT COMPLETED|Overall Study||1
9860017|NCT00925054|10973087|FG003|NOT COMPLETED|Overall Study||1
9860018|NCT00925054|10973088|FG004|NOT COMPLETED|Overall Study||0
9860019|NCT00925119|10973101|FG000|STARTED|Overall Study||31
9860020|NCT00925119|10973101|FG000|COMPLETED|Overall Study||19
9860021|NCT00925119|10973101|FG000|NOT COMPLETED|Overall Study||12
9860022|NCT00925132|10973105|FG000|STARTED|Overall Study||5
9860023|NCT00925132|10973106|FG001|STARTED|Overall Study||4
9860024|NCT00925132|10973107|FG002|STARTED|Overall Study||4
9860025|NCT00925132|10973108|FG003|STARTED|Overall Study||4
9860026|NCT00925132|10973109|FG004|STARTED|Overall Study||22
9860027|NCT00925132|10973105|FG000|COMPLETED|Overall Study||3
9860028|NCT00925132|10973106|FG001|COMPLETED|Overall Study||4
9860029|NCT00925132|10973107|FG002|COMPLETED|Overall Study||4
9860030|NCT00925132|10973108|FG003|COMPLETED|Overall Study||4
9860031|NCT00925132|10973109|FG004|COMPLETED|Overall Study||17
9860032|NCT00925132|10973105|FG000|NOT COMPLETED|Overall Study||2
9860033|NCT00925132|10973106|FG001|NOT COMPLETED|Overall Study||0
9860034|NCT00925132|10973107|FG002|NOT COMPLETED|Overall Study||0
9860035|NCT00925132|10973108|FG003|NOT COMPLETED|Overall Study||0
9860036|NCT00925132|10973109|FG004|NOT COMPLETED|Overall Study||5
9860037|NCT00925288|10973117|FG000|STARTED|Overall Study||100
9860038|NCT00925288|10973118|FG001|STARTED|Overall Study||100
9860039|NCT00925288|10973117|FG000|COMPLETED|Overall Study||91
9860040|NCT00925288|10973118|FG001|COMPLETED|Overall Study||93
9860041|NCT00925288|10973117|FG000|NOT COMPLETED|Overall Study||9
9860042|NCT00925288|10973118|FG001|NOT COMPLETED|Overall Study||7
9860043|NCT00925301|10973128|FG000|STARTED|6-Month Double-blind (Stage 1)||34
9860044|NCT00925301|10973129|FG001|STARTED|6-Month Double-blind (Stage 1)||33
9860045|NCT00925301|10973130|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
9860046|NCT00925301|10973131|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
9860047|NCT00925301|10973128|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
9860048|NCT00925301|10973129|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
9860049|NCT00925301|10973130|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
9860050|NCT00925301|10973131|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
9860051|NCT00925301|10973128|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
9860052|NCT00925301|10973129|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
9860053|NCT00925301|10973130|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
9860054|NCT00925301|10973131|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
9860055|NCT00925301|10973128|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
9860056|NCT00925301|10973129|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
9860057|NCT00925301|10973130|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
9860058|NCT00925301|10973131|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
9860059|NCT00925301|10973128|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34
9860060|NCT00925301|10973129|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30
9860061|NCT00925301|10973130|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0
9860062|NCT00925301|10973131|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0
9860063|NCT00925301|10973128|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
9860064|NCT00925301|10973129|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
9860065|NCT00925301|10973130|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
9860066|NCT00925301|10973131|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
9860067|NCT00925301|10973128|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
9860068|NCT00925301|10973129|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
9860069|NCT00925301|10973130|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
9860070|NCT00925301|10973131|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
9860071|NCT00925301|10973128|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0
9860072|NCT00925301|10973129|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0
9860073|NCT00925301|10973130|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47
9860074|NCT00925301|10973131|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0
9860075|NCT00925301|10973128|FG000|COMPLETED|6-Month Open-label (Stage 2)||0
9860076|NCT00925301|10973129|FG001|COMPLETED|6-Month Open-label (Stage 2)||0
9860077|NCT00925301|10973130|FG002|COMPLETED|6-Month Open-label (Stage 2)||60
9860078|NCT00925301|10973131|FG003|COMPLETED|6-Month Open-label (Stage 2)||0
9860079|NCT00925301|10973128|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0
9860080|NCT00925301|10973129|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0
9860081|NCT00925301|10973130|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3
9860082|NCT00925301|10973131|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0
9860083|NCT00925301|10973128|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
9860084|NCT00925301|10973129|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
9860085|NCT00925301|10973130|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
9860086|NCT00925301|10973131|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
9860087|NCT00925301|10973128|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0
9860088|NCT00925301|10973129|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0
9860089|NCT00925301|10973130|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0
9860090|NCT00925301|10973131|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42
9860091|NCT00925301|10973128|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0
9860092|NCT00925301|10973129|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0
9860093|NCT00925301|10973130|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0
9860094|NCT00925301|10973131|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54
9860095|NCT00925301|10973128|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
9953208|NCT01425801|11072008|FG003|COMPLETED|Period 3||12
9860096|NCT00925301|10973129|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
9860097|NCT00925301|10973130|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
9860098|NCT00925301|10973131|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
9860099|NCT00925353|10973142|FG000|STARTED|Overall Study||13
9860100|NCT00925353|10973142|FG000|COMPLETED|Overall Study||10
9860101|NCT00925353|10973142|FG000|NOT COMPLETED|Overall Study||3
9860102|NCT00925522|10973146|FG000|STARTED|Overall Study||20
9860103|NCT00925522|10973146|FG000|COMPLETED|Overall Study||0
9860104|NCT00925522|10973146|FG000|NOT COMPLETED|Overall Study||20
9860105|NCT00925587|10973152|FG000|STARTED|Overall Study||178
9860106|NCT00925587|10973153|FG001|STARTED|Overall Study||180
9860107|NCT00925587|10973152|FG000|COMPLETED|Overall Study||142
9860108|NCT00925587|10973153|FG001|COMPLETED|Overall Study||155
9860109|NCT00925587|10973152|FG000|NOT COMPLETED|Overall Study||36
9860110|NCT00925587|10973153|FG001|NOT COMPLETED|Overall Study||25
9860111|NCT00925600|10973161|FG000|STARTED|Overall Study||386
9860112|NCT00925600|10973162|FG001|STARTED|Overall Study||383
9860113|NCT00925600|10973161|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
9860114|NCT00925600|10973162|FG001|Received Treatment|Overall Study||382
9860115|NCT00925600|10973161|FG000|COMPLETED|Overall Study||354
9860116|NCT00925600|10973162|FG001|COMPLETED|Overall Study||355
9860117|NCT00925600|10973161|FG000|NOT COMPLETED|Overall Study||32
9860118|NCT00925600|10973162|FG001|NOT COMPLETED|Overall Study||28
9953209|NCT01425801|11072009|FG004|COMPLETED|Period 3||11
9953210|NCT01425801|11072010|FG005|COMPLETED|Period 3||10
9953211|NCT01425801|11072005|FG000|NOT COMPLETED|Period 3||0
9953212|NCT01425801|11072006|FG001|NOT COMPLETED|Period 3||0
9953213|NCT01425801|11072007|FG002|NOT COMPLETED|Period 3||1
9953214|NCT01425801|11072008|FG003|NOT COMPLETED|Period 3||0
9953215|NCT01425801|11072009|FG004|NOT COMPLETED|Period 3||0
9953216|NCT01425801|11072010|FG005|NOT COMPLETED|Period 3||0
9953217|NCT01425801|11072005|FG000|STARTED|Period 4||9
9953218|NCT01425801|11072006|FG001|STARTED|Period 4||9
9953219|NCT01425801|11072007|FG002|STARTED|Period 4||8
9953220|NCT01425801|11072008|FG003|STARTED|Period 4||12
9953221|NCT01425801|11072009|FG004|STARTED|Period 4||11
9953222|NCT01425801|11072010|FG005|STARTED|Period 4||10
9953223|NCT01425801|11072005|FG000|COMPLETED|Period 4||9
9953224|NCT01425801|11072006|FG001|COMPLETED|Period 4||9
9953225|NCT01425801|11072007|FG002|COMPLETED|Period 4||7
9953226|NCT01425801|11072008|FG003|COMPLETED|Period 4||12
9953227|NCT01425801|11072009|FG004|COMPLETED|Period 4||11
9953228|NCT01425801|11072010|FG005|COMPLETED|Period 4||10
9953229|NCT01425801|11072005|FG000|NOT COMPLETED|Period 4||0
9953230|NCT01425801|11072006|FG001|NOT COMPLETED|Period 4||0
9953231|NCT01425801|11072007|FG002|NOT COMPLETED|Period 4||1
9953232|NCT01425801|11072008|FG003|NOT COMPLETED|Period 4||0
9953233|NCT01425801|11072009|FG004|NOT COMPLETED|Period 4||0
9953234|NCT01425801|11072010|FG005|NOT COMPLETED|Period 4||0
9953235|NCT01425801|11072005|FG000|STARTED|Period 5||9
9953236|NCT01425801|11072006|FG001|STARTED|Period 5||9
9953237|NCT01425801|11072007|FG002|STARTED|Period 5||7
9953238|NCT01425801|11072008|FG003|STARTED|Period 5||12
9953239|NCT01425801|11072009|FG004|STARTED|Period 5||11
9953240|NCT01425801|11072010|FG005|STARTED|Period 5||10
9953241|NCT01425801|11072005|FG000|COMPLETED|Period 5||9
9953242|NCT01425801|11072006|FG001|COMPLETED|Period 5||9
9953243|NCT01425801|11072007|FG002|COMPLETED|Period 5||7
9953244|NCT01425801|11072008|FG003|COMPLETED|Period 5||12
9953245|NCT01425801|11072009|FG004|COMPLETED|Period 5||11
9953246|NCT01425801|11072010|FG005|COMPLETED|Period 5||10
9953247|NCT01425801|11072005|FG000|NOT COMPLETED|Period 5||0
9953248|NCT01425801|11072006|FG001|NOT COMPLETED|Period 5||0
9953249|NCT01425801|11072007|FG002|NOT COMPLETED|Period 5||0
9953250|NCT01425801|11072008|FG003|NOT COMPLETED|Period 5||0
9953251|NCT01425801|11072009|FG004|NOT COMPLETED|Period 5||0
9953252|NCT01425801|11072010|FG005|NOT COMPLETED|Period 5||0
9953253|NCT01425801|11072005|FG000|STARTED|Period 6||9
9953254|NCT01425801|11072006|FG001|STARTED|Period 6||9
9953255|NCT01425801|11072007|FG002|STARTED|Period 6||7
9953256|NCT01425801|11072008|FG003|STARTED|Period 6||12
9953257|NCT01425801|11072009|FG004|STARTED|Period 6||11
9953258|NCT01425801|11072010|FG005|STARTED|Period 6||10
9953259|NCT01425801|11072005|FG000|COMPLETED|Period 6||9
9953260|NCT01425801|11072006|FG001|COMPLETED|Period 6||9
9953261|NCT01425801|11072007|FG002|COMPLETED|Period 6||7
9953262|NCT01425801|11072008|FG003|COMPLETED|Period 6||12
9953263|NCT01425801|11072009|FG004|COMPLETED|Period 6||11
9953264|NCT01425801|11072010|FG005|COMPLETED|Period 6||10
9953265|NCT01425801|11072005|FG000|NOT COMPLETED|Period 6||0
9953266|NCT01425801|11072006|FG001|NOT COMPLETED|Period 6||0
9953267|NCT01425801|11072007|FG002|NOT COMPLETED|Period 6||0
9953268|NCT01425801|11072008|FG003|NOT COMPLETED|Period 6||0
9953269|NCT01425801|11072009|FG004|NOT COMPLETED|Period 6||0
9953270|NCT01425801|11072010|FG005|NOT COMPLETED|Period 6||0
9953271|NCT01425814|11072024|FG000|STARTED|Period 1||12
9953272|NCT01425814|11072025|FG001|STARTED|Period 1||11
9953273|NCT01425814|11072026|FG002|STARTED|Period 1||12
9953274|NCT01425814|11072027|FG003|STARTED|Period 1||10
9953275|NCT01425814|11072028|FG004|STARTED|Period 1||12
9953276|NCT01425814|11072029|FG005|STARTED|Period 1||13
9953277|NCT01425814|11072024|FG000|COMPLETED|Period 1||12
9953278|NCT01425814|11072025|FG001|COMPLETED|Period 1||10
9953279|NCT01425814|11072026|FG002|COMPLETED|Period 1||12
9953280|NCT01425814|11072027|FG003|COMPLETED|Period 1||10
9953281|NCT01425814|11072028|FG004|COMPLETED|Period 1||12
9860119|NCT00925704|10973178|FG000|STARTED|First Intervention||6
9860120|NCT00925704|10973179|FG001|STARTED|First Intervention||7
9860121|NCT00925704|10973180|FG002|STARTED|First Intervention||7
9860122|NCT00925704|10973181|FG003|STARTED|First Intervention||7
9860123|NCT00925704|10973182|FG004|STARTED|First Intervention||7
9860124|NCT00925704|10973183|FG005|STARTED|First Intervention||7
9860125|NCT00925704|10973178|FG000|COMPLETED|First Intervention||6
9860126|NCT00925704|10973179|FG001|COMPLETED|First Intervention||7
9860127|NCT00925704|10973180|FG002|COMPLETED|First Intervention||7
9860128|NCT00925704|10973181|FG003|COMPLETED|First Intervention||6
9860129|NCT00925704|10973182|FG004|COMPLETED|First Intervention||6
9860130|NCT00925704|10973183|FG005|COMPLETED|First Intervention||7
9860131|NCT00925704|10973178|FG000|NOT COMPLETED|First Intervention||0
9860132|NCT00925704|10973179|FG001|NOT COMPLETED|First Intervention||0
9860133|NCT00925704|10973180|FG002|NOT COMPLETED|First Intervention||0
9860134|NCT00925704|10973181|FG003|NOT COMPLETED|First Intervention||1
9860135|NCT00925704|10973182|FG004|NOT COMPLETED|First Intervention||1
9860136|NCT00925704|10973183|FG005|NOT COMPLETED|First Intervention||0
9860137|NCT00925704|10973178|FG000|STARTED|Washout||6
9860138|NCT00925704|10973179|FG001|STARTED|Washout||7
9860139|NCT00925704|10973180|FG002|STARTED|Washout||7
9860140|NCT00925704|10973181|FG003|STARTED|Washout||6
9860141|NCT00925704|10973182|FG004|STARTED|Washout||6
9860142|NCT00925704|10973183|FG005|STARTED|Washout||7
9860143|NCT00925704|10973178|FG000|COMPLETED|Washout||6
9860144|NCT00925704|10973179|FG001|COMPLETED|Washout||7
9860145|NCT00925704|10973180|FG002|COMPLETED|Washout||7
9860146|NCT00925704|10973181|FG003|COMPLETED|Washout||6
9860147|NCT00925704|10973182|FG004|COMPLETED|Washout||6
9860148|NCT00925704|10973183|FG005|COMPLETED|Washout||7
9860149|NCT00925704|10973178|FG000|NOT COMPLETED|Washout||0
9860150|NCT00925704|10973179|FG001|NOT COMPLETED|Washout||0
9860151|NCT00925704|10973180|FG002|NOT COMPLETED|Washout||0
9860152|NCT00925704|10973181|FG003|NOT COMPLETED|Washout||0
9860153|NCT00925704|10973182|FG004|NOT COMPLETED|Washout||0
9860154|NCT00925704|10973183|FG005|NOT COMPLETED|Washout||0
9860155|NCT00925704|10973178|FG000|STARTED|Second Intervention||6
9860156|NCT00925704|10973179|FG001|STARTED|Second Intervention||7
9860157|NCT00925704|10973180|FG002|STARTED|Second Intervention||7
9860158|NCT00925704|10973181|FG003|STARTED|Second Intervention||6
9860159|NCT00925704|10973182|FG004|STARTED|Second Intervention||6
9860160|NCT00925704|10973183|FG005|STARTED|Second Intervention||7
9860161|NCT00925704|10973178|FG000|COMPLETED|Second Intervention||5
9860162|NCT00925704|10973179|FG001|COMPLETED|Second Intervention||7
9860163|NCT00925704|10973180|FG002|COMPLETED|Second Intervention||7
9860164|NCT00925704|10973181|FG003|COMPLETED|Second Intervention||6
9860165|NCT00925704|10973182|FG004|COMPLETED|Second Intervention||5
9860166|NCT00925704|10973183|FG005|COMPLETED|Second Intervention||7
9860167|NCT00925704|10973178|FG000|NOT COMPLETED|Second Intervention||1
9860168|NCT00925704|10973179|FG001|NOT COMPLETED|Second Intervention||0
9860169|NCT00925704|10973180|FG002|NOT COMPLETED|Second Intervention||0
9860170|NCT00925704|10973181|FG003|NOT COMPLETED|Second Intervention||0
9860171|NCT00925704|10973182|FG004|NOT COMPLETED|Second Intervention||1
9860172|NCT00925704|10973183|FG005|NOT COMPLETED|Second Intervention||0
9860173|NCT00925704|10973178|FG000|STARTED|Washout||5
9860174|NCT00925704|10973179|FG001|STARTED|Washout||7
9860175|NCT00925704|10973180|FG002|STARTED|Washout||7
9860176|NCT00925704|10973181|FG003|STARTED|Washout||6
10092995|NCT02342314|11221605|FG000|STARTED|Part A||6
10092996|NCT02342314|11221606|FG001|STARTED|Part A||3
10092997|NCT02342314|11221607|FG002|STARTED|Part A||3
10092998|NCT02342314|11221608|FG003|STARTED|Part A||3
10092999|NCT02342314|11221609|FG004|STARTED|Part A||6
10093000|NCT02342314|11221610|FG005|STARTED|Part A||3
10093001|NCT02342314|11221611|FG006|STARTED|Part A||0
10093002|NCT02342314|11221612|FG007|STARTED|Part A||0
10093003|NCT02342314|11221613|FG008|STARTED|Part A||0
10093004|NCT02342314|11221614|FG009|STARTED|Part A||0
10093005|NCT02342314|11221615|FG010|STARTED|Part A||0
10093006|NCT02342314|11221616|FG011|STARTED|Part A||0
10093007|NCT02342314|11221617|FG012|STARTED|Part A||0
10093008|NCT02342314|11221618|FG013|STARTED|Part A||0
10093009|NCT02342314|11221619|FG014|STARTED|Part A||0
10093010|NCT02342314|11221620|FG015|STARTED|Part A||0
10093011|NCT02342314|11221621|FG016|STARTED|Part A||0
9860177|NCT00925704|10973182|FG004|STARTED|Washout||5
9860178|NCT00925704|10973183|FG005|STARTED|Washout||7
9860179|NCT00925704|10973178|FG000|COMPLETED|Washout||5
9860180|NCT00925704|10973179|FG001|COMPLETED|Washout||7
9860181|NCT00925704|10973180|FG002|COMPLETED|Washout||7
10093012|NCT02342314|11221605|FG000|COMPLETED|Part A||6
10093013|NCT02342314|11221606|FG001|COMPLETED|Part A||3
10093014|NCT02342314|11221607|FG002|COMPLETED|Part A||3
9860182|NCT00925704|10973181|FG003|COMPLETED|Washout||6
9860183|NCT00925704|10973182|FG004|COMPLETED|Washout||5
9860184|NCT00925704|10973183|FG005|COMPLETED|Washout||7
9860185|NCT00925704|10973178|FG000|NOT COMPLETED|Washout||0
9860186|NCT00925704|10973179|FG001|NOT COMPLETED|Washout||0
9860187|NCT00925704|10973180|FG002|NOT COMPLETED|Washout||0
9860188|NCT00925704|10973181|FG003|NOT COMPLETED|Washout||0
9860189|NCT00925704|10973182|FG004|NOT COMPLETED|Washout||0
9860190|NCT00925704|10973183|FG005|NOT COMPLETED|Washout||0
9860191|NCT00925704|10973178|FG000|STARTED|Third Intervention||5
9860192|NCT00925704|10973179|FG001|STARTED|Third Intervention||7
9860193|NCT00925704|10973180|FG002|STARTED|Third Intervention||7
10093015|NCT02342314|11221608|FG003|COMPLETED|Part A||3
10093016|NCT02342314|11221609|FG004|COMPLETED|Part A||6
10093017|NCT02342314|11221610|FG005|COMPLETED|Part A||3
9860194|NCT00925704|10973181|FG003|STARTED|Third Intervention||6
9860195|NCT00925704|10973182|FG004|STARTED|Third Intervention||5
9860196|NCT00925704|10973183|FG005|STARTED|Third Intervention||7
9860197|NCT00925704|10973178|FG000|COMPLETED|Third Intervention||5
9860198|NCT00925704|10973179|FG001|COMPLETED|Third Intervention||7
9860199|NCT00925704|10973180|FG002|COMPLETED|Third Intervention||7
9860200|NCT00925704|10973181|FG003|COMPLETED|Third Intervention||6
9860201|NCT00925704|10973182|FG004|COMPLETED|Third Intervention||5
9860202|NCT00925704|10973183|FG005|COMPLETED|Third Intervention||6
9860203|NCT00925704|10973178|FG000|NOT COMPLETED|Third Intervention||0
9860204|NCT00925704|10973179|FG001|NOT COMPLETED|Third Intervention||0
9860205|NCT00925704|10973180|FG002|NOT COMPLETED|Third Intervention||0
9860206|NCT00925704|10973181|FG003|NOT COMPLETED|Third Intervention||0
9860207|NCT00925704|10973182|FG004|NOT COMPLETED|Third Intervention||0
9860208|NCT00925704|10973183|FG005|NOT COMPLETED|Third Intervention||1
9860209|NCT00925756|10973194|FG000|STARTED|Overall Study||32
9860210|NCT00925756|10973194|FG000|COMPLETED|Overall Study||32
9860211|NCT00925756|10973194|FG000|NOT COMPLETED|Overall Study||0
9860212|NCT00925769|10973198|FG000|STARTED|Overall Study||6
9860213|NCT00925769|10973199|FG001|STARTED|Overall Study||6
9860214|NCT00925769|10973200|FG002|STARTED|Overall Study||6
9860215|NCT00925769|10973201|FG003|STARTED|Overall Study||6
9860216|NCT00925769|10973202|FG004|STARTED|Overall Study||3
9860217|NCT00925769|10973203|FG005|STARTED|Overall Study||3
9860218|NCT00925769|10973198|FG000|COMPLETED|Overall Study||0
9860219|NCT00925769|10973199|FG001|COMPLETED|Overall Study||0
9860220|NCT00925769|10973200|FG002|COMPLETED|Overall Study||0
9860221|NCT00925769|10973201|FG003|COMPLETED|Overall Study||0
9860222|NCT00925769|10973202|FG004|COMPLETED|Overall Study||0
9860223|NCT00925769|10973203|FG005|COMPLETED|Overall Study||0
9860224|NCT00925769|10973198|FG000|NOT COMPLETED|Overall Study||6
9860225|NCT00925769|10973199|FG001|NOT COMPLETED|Overall Study||6
10093018|NCT02342314|11221611|FG006|COMPLETED|Part A||0
10093019|NCT02342314|11221612|FG007|COMPLETED|Part A||0
10093020|NCT02342314|11221613|FG008|COMPLETED|Part A||0
10093021|NCT02342314|11221614|FG009|COMPLETED|Part A||0
10093022|NCT02342314|11221615|FG010|COMPLETED|Part A||0
10093023|NCT02342314|11221616|FG011|COMPLETED|Part A||0
10093024|NCT02342314|11221617|FG012|COMPLETED|Part A||0
10093025|NCT02342314|11221618|FG013|COMPLETED|Part A||0
10093026|NCT02342314|11221619|FG014|COMPLETED|Part A||0
10093027|NCT02342314|11221620|FG015|COMPLETED|Part A||0
10093028|NCT02342314|11221621|FG016|COMPLETED|Part A||0
10093029|NCT02342314|11221605|FG000|NOT COMPLETED|Part A||0
10093030|NCT02342314|11221606|FG001|NOT COMPLETED|Part A||0
10093031|NCT02342314|11221607|FG002|NOT COMPLETED|Part A||0
10093032|NCT02342314|11221608|FG003|NOT COMPLETED|Part A||0
10093033|NCT02342314|11221609|FG004|NOT COMPLETED|Part A||0
10093034|NCT02342314|11221610|FG005|NOT COMPLETED|Part A||0
10093035|NCT02342314|11221611|FG006|NOT COMPLETED|Part A||0
10093036|NCT02342314|11221612|FG007|NOT COMPLETED|Part A||0
10093037|NCT02342314|11221613|FG008|NOT COMPLETED|Part A||0
10093038|NCT02342314|11221614|FG009|NOT COMPLETED|Part A||0
10093039|NCT02342314|11221615|FG010|NOT COMPLETED|Part A||0
10093040|NCT02342314|11221616|FG011|NOT COMPLETED|Part A||0
10093041|NCT02342314|11221617|FG012|NOT COMPLETED|Part A||0
10093042|NCT02342314|11221618|FG013|NOT COMPLETED|Part A||0
10093043|NCT02342314|11221619|FG014|NOT COMPLETED|Part A||0
10093044|NCT02342314|11221620|FG015|NOT COMPLETED|Part A||0
10093045|NCT02342314|11221621|FG016|NOT COMPLETED|Part A||0
10093046|NCT02342314|11221605|FG000|STARTED|Part B|Participants received placebo in Part A.|0
10093047|NCT02342314|11221606|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0
10093048|NCT02342314|11221607|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0
10093049|NCT02342314|11221608|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0
10093050|NCT02342314|11221609|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0
10093051|NCT02342314|11221610|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0
10093052|NCT02342314|11221611|FG006|STARTED|Part B|Participants received placebo in Part B.|11
10093053|NCT02342314|11221612|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3
10093054|NCT02342314|11221613|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3
10093055|NCT02342314|11221614|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3
10093056|NCT02342314|11221615|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3
10093057|NCT02342314|11221616|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3
10093058|NCT02342314|11221617|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3
9860226|NCT00925769|10973200|FG002|NOT COMPLETED|Overall Study||6
9860227|NCT00925769|10973201|FG003|NOT COMPLETED|Overall Study||6
9860228|NCT00925769|10973202|FG004|NOT COMPLETED|Overall Study||3
9860229|NCT00925769|10973203|FG005|NOT COMPLETED|Overall Study||3
9860230|NCT00925782|10973219|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12
9860231|NCT00925782|10973220|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12
9860232|NCT00925782|10973219|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12
9860233|NCT00925782|10973220|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12
9860234|NCT00925782|10973219|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
9860235|NCT00925782|10973220|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
9860236|NCT00925782|10973219|FG000|STARTED|Study Period (Day -3 to Day 0)||12
10093059|NCT02342314|11221618|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3
10093060|NCT02342314|11221619|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3
10093061|NCT02342314|11221620|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3
9860237|NCT00925782|10973220|FG001|STARTED|Study Period (Day -3 to Day 0)||12
9860238|NCT00925782|10973219|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12
9860239|NCT00925782|10973220|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12
9860240|NCT00925782|10973219|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
9860241|NCT00925782|10973220|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
9860242|NCT00925782|10973219|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
9860243|NCT00925782|10973220|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
9860244|NCT00925782|10973219|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
9860245|NCT00925782|10973220|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
9860246|NCT00925782|10973219|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
9860247|NCT00925782|10973220|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
9860248|NCT00925899|10973229|FG000|STARTED|Part 1||34
9860249|NCT00925899|10973230|FG001|STARTED|Part 1||38
9860250|NCT00925899|10973229|FG000|COMPLETED|Part 1||23
9860251|NCT00925899|10973230|FG001|COMPLETED|Part 1||27
9860252|NCT00925899|10973229|FG000|NOT COMPLETED|Part 1||11
9860253|NCT00925899|10973230|FG001|NOT COMPLETED|Part 1||11
9860254|NCT00925899|10973229|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
9860255|NCT00925899|10973230|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
9860256|NCT00925899|10973229|FG000|COMPLETED|Part 2||9
9860257|NCT00925899|10973230|FG001|COMPLETED|Part 2||9
9860258|NCT00925899|10973229|FG000|NOT COMPLETED|Part 2||6
9860259|NCT00925899|10973230|FG001|NOT COMPLETED|Part 2||12
9860260|NCT00925938|10973240|FG000|STARTED|Overall Study||9
9860261|NCT00925938|10973241|FG001|STARTED|Overall Study||25
9860262|NCT00925938|10973242|FG002|STARTED|Overall Study||17
9860263|NCT00925938|10973240|FG000|COMPLETED|Overall Study||9
9860264|NCT00925938|10973241|FG001|COMPLETED|Overall Study||25
9860265|NCT00925938|10973242|FG002|COMPLETED|Overall Study||17
9860266|NCT00925938|10973240|FG000|NOT COMPLETED|Overall Study||0
9860267|NCT00925938|10973241|FG001|NOT COMPLETED|Overall Study||0
9860268|NCT00925938|10973242|FG002|NOT COMPLETED|Overall Study||0
9860269|NCT00925990|10973252|FG000|STARTED|Overall Study||35
9860270|NCT00925990|10973253|FG001|STARTED|Overall Study||35
9860271|NCT00925990|10973252|FG000|COMPLETED|Overall Study||30
9860272|NCT00925990|10973253|FG001|COMPLETED|Overall Study||24
9860273|NCT00925990|10973252|FG000|NOT COMPLETED|Overall Study||5
9860274|NCT00925990|10973253|FG001|NOT COMPLETED|Overall Study||11
9860275|NCT00926003|10973262|FG000|STARTED|Baseline||53
9860276|NCT00926003|10973263|FG001|STARTED|Baseline||54
9860277|NCT00926003|10973264|FG002|STARTED|Baseline||52
9860278|NCT00926003|10973262|FG000|COMPLETED|Baseline||53
9860279|NCT00926003|10973263|FG001|COMPLETED|Baseline||54
9860280|NCT00926003|10973264|FG002|COMPLETED|Baseline||52
9860281|NCT00926003|10973262|FG000|NOT COMPLETED|Baseline||0
9860282|NCT00926003|10973263|FG001|NOT COMPLETED|Baseline||0
9860283|NCT00926003|10973264|FG002|NOT COMPLETED|Baseline||0
9860284|NCT00926003|10973262|FG000|STARTED|Post-Training Evaluation||53
9860285|NCT00926003|10973263|FG001|STARTED|Post-Training Evaluation||54
9860286|NCT00926003|10973264|FG002|STARTED|Post-Training Evaluation||52
9860287|NCT00926003|10973262|FG000|COMPLETED|Post-Training Evaluation||52
9860288|NCT00926003|10973263|FG001|COMPLETED|Post-Training Evaluation||54
9860289|NCT00926003|10973264|FG002|COMPLETED|Post-Training Evaluation||52
9860290|NCT00926003|10973262|FG000|NOT COMPLETED|Post-Training Evaluation||1
9860291|NCT00926003|10973263|FG001|NOT COMPLETED|Post-Training Evaluation||0
9860292|NCT00926003|10973264|FG002|NOT COMPLETED|Post-Training Evaluation||0
9860293|NCT00926003|10973262|FG000|STARTED|Post-Training 3-month Follow-up||52
9860294|NCT00926003|10973263|FG001|STARTED|Post-Training 3-month Follow-up||54
9860295|NCT00926003|10973264|FG002|STARTED|Post-Training 3-month Follow-up||52
9860296|NCT00926003|10973262|FG000|COMPLETED|Post-Training 3-month Follow-up||51
9860297|NCT00926003|10973263|FG001|COMPLETED|Post-Training 3-month Follow-up||54
9860298|NCT00926003|10973264|FG002|COMPLETED|Post-Training 3-month Follow-up||52
9860299|NCT00926003|10973262|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1
9860300|NCT00926003|10973263|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0
9860301|NCT00926003|10973264|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0
9860302|NCT00926029|10973275|FG000|STARTED|Overall Study||34
9860303|NCT00926029|10973276|FG001|STARTED|Overall Study||34
9860304|NCT00926029|10973277|FG002|STARTED|Overall Study||34
9860305|NCT00926029|10973275|FG000|COMPLETED|Overall Study||32
9860306|NCT00926029|10973276|FG001|COMPLETED|Overall Study||33
9860307|NCT00926029|10973277|FG002|COMPLETED|Overall Study||33
9860308|NCT00926029|10973275|FG000|NOT COMPLETED|Overall Study||2
9860309|NCT00926029|10973276|FG001|NOT COMPLETED|Overall Study||1
9860310|NCT00926029|10973277|FG002|NOT COMPLETED|Overall Study||1
9860311|NCT00926185|10973291|FG000|STARTED|Overall Study||57
9860312|NCT00926185|10973292|FG001|STARTED|Overall Study||57
9860313|NCT00926185|10973293|FG002|STARTED|Overall Study||58
9860314|NCT00926185|10973294|FG003|STARTED|Overall Study||58
9860315|NCT00926185|10973291|FG000|COMPLETED|Overall Study||54
9860316|NCT00926185|10973292|FG001|COMPLETED|Overall Study||51
9860317|NCT00926185|10973293|FG002|COMPLETED|Overall Study||48
9860318|NCT00926185|10973294|FG003|COMPLETED|Overall Study||48
9860319|NCT00926185|10973291|FG000|NOT COMPLETED|Overall Study||3
9860320|NCT00926185|10973292|FG001|NOT COMPLETED|Overall Study||6
9860321|NCT00926185|10973293|FG002|NOT COMPLETED|Overall Study||10
9860322|NCT00926185|10973294|FG003|NOT COMPLETED|Overall Study||10
9860323|NCT00926211|10973304|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
9860324|NCT00926211|10973304|FG000|COMPLETED|Overall Study||35
9860325|NCT00926211|10973304|FG000|NOT COMPLETED|Overall Study||1
9860326|NCT00926237|10973309|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
9860327|NCT00926237|10973310|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
9860328|NCT00926237|10973309|FG000|COMPLETED|Overall Study||17
9860329|NCT00926237|10973310|FG001|COMPLETED|Overall Study||19
9860330|NCT00926237|10973309|FG000|NOT COMPLETED|Overall Study||2
9860331|NCT00926237|10973310|FG001|NOT COMPLETED|Overall Study||1
9860332|NCT00926263|10973322|FG000|STARTED|Overall Study||16
9860333|NCT00926263|10973323|FG001|STARTED|Overall Study||12
9860334|NCT00926263|10973322|FG000|COMPLETED|Overall Study||16
9860335|NCT00926263|10973323|FG001|COMPLETED|Overall Study||12
9860336|NCT00926263|10973322|FG000|NOT COMPLETED|Overall Study||0
9860337|NCT00926263|10973323|FG001|NOT COMPLETED|Overall Study||0
9860338|NCT00926289|10973332|FG000|STARTED|Overall Study|Number of treated patients|294
9860339|NCT00926289|10973333|FG001|STARTED|Overall Study|Number of treated patients|594
9860340|NCT00926289|10973332|FG000|COMPLETED|Overall Study||269
9860341|NCT00926289|10973333|FG001|COMPLETED|Overall Study||558
9860342|NCT00926289|10973332|FG000|NOT COMPLETED|Overall Study||25
9860343|NCT00926289|10973333|FG001|NOT COMPLETED|Overall Study||36
9860344|NCT00926328|10973341|FG000|STARTED|Overall Study||60
9860345|NCT00926328|10973342|FG001|STARTED|Overall Study||60
9860346|NCT00926328|10973341|FG000|COMPLETED|Overall Study||48
9860347|NCT00926328|10973342|FG001|COMPLETED|Overall Study||46
9860348|NCT00926328|10973341|FG000|NOT COMPLETED|Overall Study||12
9860349|NCT00926328|10973342|FG001|NOT COMPLETED|Overall Study||14
9860350|NCT00926367|10973350|FG000|STARTED|Overall Study||25
9860351|NCT00926367|10973351|FG001|STARTED|Overall Study||27
9860352|NCT00926367|10973350|FG000|COMPLETED|Overall Study||23
9860353|NCT00926367|10973351|FG001|COMPLETED|Overall Study||24
9860354|NCT00926367|10973350|FG000|NOT COMPLETED|Overall Study||2
9860355|NCT00926367|10973351|FG001|NOT COMPLETED|Overall Study||3
9860356|NCT00926380|10973362|FG000|STARTED|Year 1||33
9860357|NCT00926380|10973363|FG001|STARTED|Year 1||31
9860358|NCT00926380|10973364|FG002|STARTED|Year 1||30
9860359|NCT00926380|10973362|FG000|COMPLETED|Year 1||33
9860360|NCT00926380|10973363|FG001|COMPLETED|Year 1||30
9860361|NCT00926380|10973364|FG002|COMPLETED|Year 1||29
9860362|NCT00926380|10973362|FG000|NOT COMPLETED|Year 1||0
9860363|NCT00926380|10973363|FG001|NOT COMPLETED|Year 1||1
9860364|NCT00926380|10973364|FG002|NOT COMPLETED|Year 1||1
9860365|NCT00926380|10973362|FG000|STARTED|Year 2||33
9860366|NCT00926380|10973363|FG001|STARTED|Year 2||30
9860367|NCT00926380|10973364|FG002|STARTED|Year 2||29
9860368|NCT00926380|10973362|FG000|COMPLETED|Year 2||31
9860369|NCT00926380|10973363|FG001|COMPLETED|Year 2||28
9860370|NCT00926380|10973364|FG002|COMPLETED|Year 2||24
9860371|NCT00926380|10973362|FG000|NOT COMPLETED|Year 2||2
9860372|NCT00926380|10973363|FG001|NOT COMPLETED|Year 2||2
9860373|NCT00926380|10973364|FG002|NOT COMPLETED|Year 2||5
9860374|NCT00926393|10973374|FG000|STARTED|Overall Study||69
9860375|NCT00926393|10973375|FG001|STARTED|Overall Study||70
9860376|NCT00926393|10973374|FG000|COMPLETED|Overall Study||67
9860377|NCT00926393|10973375|FG001|COMPLETED|Overall Study||67
9860378|NCT00926393|10973374|FG000|NOT COMPLETED|Overall Study||2
9860379|NCT00926393|10973375|FG001|NOT COMPLETED|Overall Study||3
9860380|NCT00926497|10973383|FG000|STARTED|Overall Study||60
9860381|NCT00926497|10973384|FG001|STARTED|Overall Study||61
9860382|NCT00926497|10973383|FG000|COMPLETED|Overall Study||60
9860383|NCT00926497|10973384|FG001|COMPLETED|Overall Study||61
9860384|NCT00926497|10973383|FG000|NOT COMPLETED|Overall Study||0
9860385|NCT00926497|10973384|FG001|NOT COMPLETED|Overall Study||0
9860386|NCT00926536|10973392|FG000|STARTED|Overall Study||44
9860387|NCT00926536|10973393|FG001|STARTED|Overall Study||43
9860388|NCT00926536|10973392|FG000|COMPLETED|Overall Study||43
9860389|NCT00926536|10973393|FG001|COMPLETED|Overall Study||41
9860390|NCT00926536|10973392|FG000|NOT COMPLETED|Overall Study||1
9860391|NCT00926536|10973393|FG001|NOT COMPLETED|Overall Study||2
9860392|NCT00926588|10973401|FG000|STARTED|Overall Study||124
9860393|NCT00926588|10973402|FG001|STARTED|Overall Study||126
9860394|NCT00926588|10973401|FG000|COMPLETED|Overall Study||116
9860395|NCT00926588|10973402|FG001|COMPLETED|Overall Study||122
9860396|NCT00926588|10973401|FG000|NOT COMPLETED|Overall Study||8
9860397|NCT00926588|10973402|FG001|NOT COMPLETED|Overall Study||4
9860398|NCT00926783|10973410|FG000|STARTED|Overall Study||42
9860399|NCT00926783|10973411|FG001|STARTED|Overall Study||41
9860400|NCT00926783|10973410|FG000|COMPLETED|Overall Study||39
9860401|NCT00926783|10973411|FG001|COMPLETED|Overall Study||38
9860402|NCT00926783|10973410|FG000|NOT COMPLETED|Overall Study||3
9860403|NCT00926783|10973411|FG001|NOT COMPLETED|Overall Study||3
9860404|NCT00926796|10973419|FG000|STARTED|Overall Study|Number randomized|309
9860405|NCT00926796|10973420|FG001|STARTED|Overall Study|Number randomized|305
9860406|NCT00926796|10973419|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
9860407|NCT00926796|10973420|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
9860408|NCT00926796|10973419|FG000|NOT COMPLETED|Overall Study||107
9860409|NCT00926796|10973420|FG001|NOT COMPLETED|Overall Study||106
9860410|NCT00926848|10973430|FG000|STARTED|Overall Study||34
9860411|NCT00926848|10973431|FG001|STARTED|Overall Study||34
9860412|NCT00926848|10973430|FG000|COMPLETED|Overall Study||34
9860413|NCT00926848|10973431|FG001|COMPLETED|Overall Study||34
9860414|NCT00926848|10973430|FG000|NOT COMPLETED|Overall Study||0
9860415|NCT00926848|10973431|FG001|NOT COMPLETED|Overall Study||0
9860416|NCT00926887|10973449|FG000|STARTED|Overall Study||54
9860417|NCT00926887|10973450|FG001|STARTED|Overall Study||50
9860418|NCT00926887|10973449|FG000|COMPLETED|Overall Study||54
9860419|NCT00926887|10973450|FG001|COMPLETED|Overall Study||50
9860420|NCT00926887|10973449|FG000|NOT COMPLETED|Overall Study||0
9860421|NCT00926887|10973450|FG001|NOT COMPLETED|Overall Study||0
9860422|NCT00926952|10973456|FG000|STARTED|Overall Study||20
9860423|NCT00926952|10973456|FG000|COMPLETED|Overall Study||20
9860424|NCT00926952|10973456|FG000|NOT COMPLETED|Overall Study||0
9860425|NCT00927069|10973462|FG000|STARTED|Week 0 to Week 12||50
9860426|NCT00927069|10973463|FG001|STARTED|Week 0 to Week 12||35
9860427|NCT00927069|10973464|FG002|STARTED|Week 0 to Week 12||0
9860428|NCT00927069|10973465|FG003|STARTED|Week 0 to Week 12||0
9860429|NCT00927069|10973462|FG000|COMPLETED|Week 0 to Week 12||49
9860430|NCT00927069|10973463|FG001|COMPLETED|Week 0 to Week 12||34
9860431|NCT00927069|10973464|FG002|COMPLETED|Week 0 to Week 12||0
9860432|NCT00927069|10973465|FG003|COMPLETED|Week 0 to Week 12||0
9860433|NCT00927069|10973462|FG000|NOT COMPLETED|Week 0 to Week 12||1
9860434|NCT00927069|10973463|FG001|NOT COMPLETED|Week 0 to Week 12||1
9860435|NCT00927069|10973464|FG002|NOT COMPLETED|Week 0 to Week 12||0
9860436|NCT00927069|10973465|FG003|NOT COMPLETED|Week 0 to Week 12||0
9860437|NCT00927069|10973462|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
9860438|NCT00927069|10973463|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
9860439|NCT00927069|10973464|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
9860440|NCT00927069|10973465|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
9860441|NCT00927069|10973462|FG000|COMPLETED|Week 12 to Week 24||16
9860442|NCT00927069|10973463|FG001|COMPLETED|Week 12 to Week 24||11
9860443|NCT00927069|10973464|FG002|COMPLETED|Week 12 to Week 24||28
9860444|NCT00927069|10973465|FG003|COMPLETED|Week 12 to Week 24||20
9860445|NCT00927069|10973462|FG000|NOT COMPLETED|Week 12 to Week 24||2
9860446|NCT00927069|10973463|FG001|NOT COMPLETED|Week 12 to Week 24||0
9860447|NCT00927069|10973464|FG002|NOT COMPLETED|Week 12 to Week 24||3
9860448|NCT00927069|10973465|FG003|NOT COMPLETED|Week 12 to Week 24||3
9860449|NCT00927082|10973479|FG000|STARTED|Overall Study||91
9860450|NCT00927082|10973480|FG001|STARTED|Overall Study||87
9860451|NCT00927082|10973481|FG002|STARTED|Overall Study||108
9860452|NCT00927082|10973482|FG003|STARTED|Overall Study||97
9860453|NCT00927082|10973479|FG000|COMPLETED|Overall Study||79
9860454|NCT00927082|10973480|FG001|COMPLETED|Overall Study||77
9860455|NCT00927082|10973481|FG002|COMPLETED|Overall Study||86
9860456|NCT00927082|10973482|FG003|COMPLETED|Overall Study||78
9860457|NCT00927082|10973479|FG000|NOT COMPLETED|Overall Study||12
9860458|NCT00927082|10973480|FG001|NOT COMPLETED|Overall Study||10
9860459|NCT00927082|10973481|FG002|NOT COMPLETED|Overall Study||22
9860460|NCT00927082|10973482|FG003|NOT COMPLETED|Overall Study||19
9860461|NCT00927095|10973499|FG000|STARTED|Overall Study||22
9860462|NCT00927095|10973500|FG001|STARTED|Overall Study||21
9860463|NCT00927095|10973501|FG002|STARTED|Overall Study||24
9860464|NCT00927095|10973499|FG000|COMPLETED|Overall Study||16
9860465|NCT00927095|10973500|FG001|COMPLETED|Overall Study||17
9860466|NCT00927095|10973501|FG002|COMPLETED|Overall Study||22
9860467|NCT00927095|10973499|FG000|NOT COMPLETED|Overall Study||6
9860468|NCT00927095|10973500|FG001|NOT COMPLETED|Overall Study||4
9860469|NCT00927095|10973501|FG002|NOT COMPLETED|Overall Study||2
9860470|NCT00927160|10973511|FG000|STARTED|Overall Study||173
9860471|NCT00927160|10973512|FG001|STARTED|Overall Study||173
9860472|NCT00927160|10973511|FG000|COMPLETED|Overall Study||173
9860473|NCT00927160|10973512|FG001|COMPLETED|Overall Study||173
9860474|NCT00927160|10973511|FG000|NOT COMPLETED|Overall Study||0
9860475|NCT00927160|10973512|FG001|NOT COMPLETED|Overall Study||0
9860476|NCT00927186|10973520|FG000|STARTED|12 Months Primary Study||34
9860477|NCT00927186|10973521|FG001|STARTED|12 Months Primary Study||35
9860478|NCT00927186|10973520|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
9860479|NCT00927186|10973521|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
9860480|NCT00927186|10973520|FG000|COMPLETED|12 Months Primary Study||27
9860481|NCT00927186|10973521|FG001|COMPLETED|12 Months Primary Study||31
9860482|NCT00927186|10973520|FG000|NOT COMPLETED|12 Months Primary Study||7
9860483|NCT00927186|10973521|FG001|NOT COMPLETED|12 Months Primary Study||4
9860484|NCT00927186|10973520|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
9860485|NCT00927186|10973521|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
9860486|NCT00927186|10973520|FG000|COMPLETED|12 - 24 Months Extension Treatment||10
9860487|NCT00927186|10973521|FG001|COMPLETED|12 - 24 Months Extension Treatment||11
9860488|NCT00927186|10973520|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0
9860489|NCT00927186|10973521|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0
9860490|NCT00927251|10973530|FG000|STARTED|Overall Study||90
9860491|NCT00927251|10973530|FG000|COMPLETED|Overall Study||82
9860492|NCT00927251|10973530|FG000|NOT COMPLETED|Overall Study||8
9860493|NCT00927264|10973536|FG000|STARTED|Overall Study||165
9860494|NCT00927264|10973537|FG001|STARTED|Overall Study||165
9860495|NCT00927264|10973536|FG000|COMPLETED|Overall Study||109
9860496|NCT00927264|10973537|FG001|COMPLETED|Overall Study||140
9860497|NCT00927264|10973536|FG000|NOT COMPLETED|Overall Study||56
9860498|NCT00927264|10973537|FG001|NOT COMPLETED|Overall Study||25
9860499|NCT00927355|10973547|FG000|STARTED|Overall Study||5
9860500|NCT00927355|10973548|FG001|STARTED|Overall Study||5
9860501|NCT00927355|10973547|FG000|COMPLETED|Overall Study||4
9860502|NCT00927355|10973548|FG001|COMPLETED|Overall Study||4
9860503|NCT00927355|10973547|FG000|NOT COMPLETED|Overall Study||1
9860504|NCT00927355|10973548|FG001|NOT COMPLETED|Overall Study||1
9860505|NCT00927368|10973569|FG000|STARTED|Overall Study||153
9860506|NCT00927368|10973570|FG001|STARTED|Overall Study||157
9860507|NCT00927368|10973571|FG002|STARTED|Overall Study||143
9860508|NCT00927368|10973569|FG000|COMPLETED|Overall Study||147
9860509|NCT00927368|10973570|FG001|COMPLETED|Overall Study||152
9860510|NCT00927368|10973571|FG002|COMPLETED|Overall Study||138
9860511|NCT00927368|10973569|FG000|NOT COMPLETED|Overall Study||6
9860512|NCT00927368|10973570|FG001|NOT COMPLETED|Overall Study||5
9860513|NCT00927368|10973571|FG002|NOT COMPLETED|Overall Study||5
9860514|NCT00927394|10973581|FG000|STARTED|Overall Study||575
9860515|NCT00927394|10973582|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
9860516|NCT00927394|10973581|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
9860517|NCT00927394|10973582|FG001|Cohort 1 (Randomized)|Overall Study||165
9860518|NCT00927394|10973581|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
9860519|NCT00927394|10973582|FG001|Cohort 2 (Randomized)|Overall Study||403
9860520|NCT00927394|10973581|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
9860521|NCT00927394|10973582|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
9860522|NCT00927394|10973581|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
9860523|NCT00927394|10973582|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
9860524|NCT00927394|10973581|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
9860525|NCT00927394|10973582|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
9860526|NCT00927394|10973581|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
9860527|NCT00927394|10973582|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
9860528|NCT00927394|10973581|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
9860529|NCT00927394|10973582|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
9860530|NCT00927394|10973581|FG000|COMPLETED|Overall Study||498
9860531|NCT00927394|10973582|FG001|COMPLETED|Overall Study||483
9860532|NCT00927394|10973581|FG000|NOT COMPLETED|Overall Study||77
9860533|NCT00927394|10973582|FG001|NOT COMPLETED|Overall Study||85
9860534|NCT00927472|10973591|FG000|STARTED|Overall Study||126
9860535|NCT00927472|10973592|FG001|STARTED|Overall Study||128
9860536|NCT00927472|10973591|FG000|COMPLETED|Overall Study||115
9860537|NCT00927472|10973592|FG001|COMPLETED|Overall Study||106
9860538|NCT00927472|10973591|FG000|NOT COMPLETED|Overall Study||11
9860539|NCT00927472|10973592|FG001|NOT COMPLETED|Overall Study||22
9860540|NCT00927485|10973600|FG000|STARTED|Overall Study||21
9860541|NCT00927485|10973601|FG001|STARTED|Overall Study||23
9860542|NCT00927485|10973600|FG000|COMPLETED|Overall Study||15
9860543|NCT00927485|10973601|FG001|COMPLETED|Overall Study||19
9860544|NCT00927485|10973600|FG000|NOT COMPLETED|Overall Study||6
9860545|NCT00927485|10973601|FG001|NOT COMPLETED|Overall Study||4
9860546|NCT00927563|10973607|FG000|STARTED|Overall Study||24
9860547|NCT00927563|10973607|FG000|COMPLETED|Overall Study||22
9860548|NCT00927563|10973607|FG000|NOT COMPLETED|Overall Study||2
9860549|NCT00927576|10973613|FG000|STARTED|Overall Study||237
9860550|NCT00927576|10973614|FG001|STARTED|Overall Study||28
9860551|NCT00927576|10973613|FG000|Cognitive Testing|Overall Study||237
9860552|NCT00927576|10973614|FG001|Cognitive Testing|Overall Study||28
9860553|NCT00927576|10973613|FG000|COMPLETED|Overall Study||237
9860554|NCT00927576|10973614|FG001|COMPLETED|Overall Study||28
9860555|NCT00927576|10973613|FG000|NOT COMPLETED|Overall Study||0
9860556|NCT00927576|10973614|FG001|NOT COMPLETED|Overall Study||0
9860557|NCT00927589|10973619|FG000|STARTED|Overall Study||59
9860558|NCT00927589|10973619|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
9860559|NCT00927589|10973619|FG000|NOT COMPLETED|Overall Study||16
9860560|NCT00927758|10973623|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
9860561|NCT00927758|10973624|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
9860562|NCT00927758|10973625|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
10093062|NCT02342314|11221621|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6
10093063|NCT02342314|11221605|FG000|COMPLETED|Part B||0
10093064|NCT02342314|11221606|FG001|COMPLETED|Part B||0
10093065|NCT02342314|11221607|FG002|COMPLETED|Part B||0
10093066|NCT02342314|11221608|FG003|COMPLETED|Part B||0
10093067|NCT02342314|11221609|FG004|COMPLETED|Part B||0
10093068|NCT02342314|11221610|FG005|COMPLETED|Part B||0
10093069|NCT02342314|11221611|FG006|COMPLETED|Part B||11
9860563|NCT00927758|10973626|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
9860564|NCT00927758|10973627|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
9860565|NCT00927758|10973628|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
9860566|NCT00927758|10973623|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
10093070|NCT02342314|11221612|FG007|COMPLETED|Part B||3
10093071|NCT02342314|11221613|FG008|COMPLETED|Part B||3
10093072|NCT02342314|11221614|FG009|COMPLETED|Part B||3
10093073|NCT02342314|11221615|FG010|COMPLETED|Part B||3
9860567|NCT00927758|10973624|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
9860568|NCT00927758|10973625|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
9860569|NCT00927758|10973626|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
9860570|NCT00927758|10973627|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
9860571|NCT00927758|10973628|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
9860572|NCT00927758|10973623|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
9860573|NCT00927758|10973624|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
9860574|NCT00927758|10973625|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
9860575|NCT00927758|10973626|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
9860576|NCT00927758|10973627|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
9860577|NCT00927758|10973628|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
9860578|NCT00927758|10973623|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
9860579|NCT00927758|10973624|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
9860580|NCT00927758|10973625|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
9860581|NCT00927758|10973626|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
9860582|NCT00927758|10973627|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
9860583|NCT00927758|10973628|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
9860584|NCT00927758|10973623|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
9860585|NCT00927758|10973624|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
9860586|NCT00927758|10973625|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
9860587|NCT00927758|10973626|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
9860588|NCT00927758|10973627|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
9860589|NCT00927758|10973628|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
9860590|NCT00927758|10973623|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
9860591|NCT00927758|10973624|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
9860592|NCT00927758|10973625|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
9860593|NCT00927758|10973626|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
9860594|NCT00927758|10973627|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
9860595|NCT00927758|10973628|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
9860596|NCT00927758|10973623|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
9860597|NCT00927758|10973624|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
9860598|NCT00927758|10973625|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
9860599|NCT00927758|10973626|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
9860600|NCT00927758|10973627|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
9860601|NCT00927758|10973628|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
9860602|NCT00927758|10973623|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
9860603|NCT00927758|10973624|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
9860604|NCT00927758|10973625|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
9860605|NCT00927758|10973626|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
9860606|NCT00927758|10973627|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
9860607|NCT00927758|10973628|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
9860608|NCT00927758|10973623|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
9860609|NCT00927758|10973624|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
9860610|NCT00927758|10973625|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
9860611|NCT00927758|10973626|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
9860612|NCT00927758|10973627|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
9860613|NCT00927758|10973628|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
9860614|NCT00927758|10973623|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
9860615|NCT00927758|10973624|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
9860616|NCT00927758|10973625|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
9860617|NCT00927758|10973626|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
9860618|NCT00927758|10973627|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
9860619|NCT00927758|10973628|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
9860620|NCT00927758|10973623|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
9860621|NCT00927758|10973624|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
9860622|NCT00927758|10973625|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
9860623|NCT00927758|10973626|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
9860624|NCT00927758|10973627|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
9860625|NCT00927758|10973628|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
9860626|NCT00927784|10973638|FG000|STARTED|Overall Study||8
9860627|NCT00927784|10973639|FG001|STARTED|Overall Study||2
9860628|NCT00927784|10973638|FG000|COMPLETED|Overall Study||6
9860629|NCT00927784|10973639|FG001|COMPLETED|Overall Study||2
9860630|NCT00927784|10973638|FG000|NOT COMPLETED|Overall Study||2
9860631|NCT00927784|10973639|FG001|NOT COMPLETED|Overall Study||0
9860632|NCT00927810|10973649|FG000|STARTED|Overall Study||75
9860633|NCT00927810|10973650|FG001|STARTED|Overall Study||181
9860634|NCT00927810|10973651|FG002|STARTED|Overall Study||25
9860635|NCT00927810|10973652|FG003|STARTED|Overall Study||60
9860636|NCT00927810|10973649|FG000|COMPLETED|Overall Study||75
9860637|NCT00927810|10973650|FG001|COMPLETED|Overall Study||173
9860638|NCT00927810|10973651|FG002|COMPLETED|Overall Study||24
9860639|NCT00927810|10973652|FG003|COMPLETED|Overall Study||58
9860640|NCT00927810|10973649|FG000|NOT COMPLETED|Overall Study||0
9860641|NCT00927810|10973650|FG001|NOT COMPLETED|Overall Study||8
9860642|NCT00927810|10973651|FG002|NOT COMPLETED|Overall Study||1
9860643|NCT00927810|10973652|FG003|NOT COMPLETED|Overall Study||2
9860644|NCT00927823|10973670|FG000|STARTED|Lead-In Period||3
9860645|NCT00927823|10973671|FG001|STARTED|Lead-In Period||3
9860646|NCT00927823|10973672|FG002|STARTED|Lead-In Period||26
9860647|NCT00927823|10973673|FG003|STARTED|Lead-In Period||5
9860648|NCT00927823|10973670|FG000|COMPLETED|Lead-In Period||3
9860649|NCT00927823|10973671|FG001|COMPLETED|Lead-In Period||3
9860650|NCT00927823|10973672|FG002|COMPLETED|Lead-In Period||26
9860651|NCT00927823|10973673|FG003|COMPLETED|Lead-In Period||5
9860652|NCT00927823|10973670|FG000|NOT COMPLETED|Lead-In Period||0
9860653|NCT00927823|10973671|FG001|NOT COMPLETED|Lead-In Period||0
9860654|NCT00927823|10973672|FG002|NOT COMPLETED|Lead-In Period||0
9860655|NCT00927823|10973673|FG003|NOT COMPLETED|Lead-In Period||0
9860656|NCT00927823|10973670|FG000|STARTED|Continuous Dosing Period||3
9860657|NCT00927823|10973671|FG001|STARTED|Continuous Dosing Period||3
9860658|NCT00927823|10973672|FG002|STARTED|Continuous Dosing Period||26
9860659|NCT00927823|10973673|FG003|STARTED|Continuous Dosing Period||5
9860660|NCT00927823|10973670|FG000|Treated|Continuous Dosing Period||3
9860661|NCT00927823|10973671|FG001|Treated|Continuous Dosing Period||3
9860662|NCT00927823|10973672|FG002|Treated|Continuous Dosing Period||23
9860663|NCT00927823|10973673|FG003|Treated|Continuous Dosing Period||5
9860664|NCT00927823|10973670|FG000|COMPLETED|Continuous Dosing Period||0
9860665|NCT00927823|10973671|FG001|COMPLETED|Continuous Dosing Period||0
9860666|NCT00927823|10973672|FG002|COMPLETED|Continuous Dosing Period||0
9860667|NCT00927823|10973673|FG003|COMPLETED|Continuous Dosing Period||0
9860668|NCT00927823|10973670|FG000|NOT COMPLETED|Continuous Dosing Period||3
9860669|NCT00927823|10973671|FG001|NOT COMPLETED|Continuous Dosing Period||3
9860670|NCT00927823|10973672|FG002|NOT COMPLETED|Continuous Dosing Period||26
9860671|NCT00927823|10973673|FG003|NOT COMPLETED|Continuous Dosing Period||5
9860672|NCT00927849|10973693|FG000|STARTED|Overall Study||21
9860673|NCT00927849|10973694|FG001|STARTED|Overall Study||21
9860674|NCT00927849|10973695|FG002|STARTED|Overall Study||21
9860675|NCT00927849|10973693|FG000|COMPLETED|Overall Study||21
9860676|NCT00927849|10973694|FG001|COMPLETED|Overall Study||21
9860677|NCT00927849|10973695|FG002|COMPLETED|Overall Study||21
9860678|NCT00927849|10973693|FG000|NOT COMPLETED|Overall Study||0
9860679|NCT00927849|10973694|FG001|NOT COMPLETED|Overall Study||0
9860680|NCT00927849|10973695|FG002|NOT COMPLETED|Overall Study||0
10093074|NCT02342314|11221616|FG011|COMPLETED|Part B||3
10093075|NCT02342314|11221617|FG012|COMPLETED|Part B||3
9860681|NCT00927862|10973705|FG000|STARTED|Overall Study||504
9860682|NCT00927862|10973706|FG001|STARTED|Overall Study||1911
9860683|NCT00927862|10973705|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
9860684|NCT00927862|10973706|FG001|COMPLETED|Overall Study||1866
9860685|NCT00927862|10973705|FG000|NOT COMPLETED|Overall Study||27
9860686|NCT00927862|10973706|FG001|NOT COMPLETED|Overall Study||45
9860687|NCT00927888|10973716|FG000|STARTED|Overall Study||29
9860688|NCT00927888|10973717|FG001|STARTED|Overall Study||27
9860689|NCT00927888|10973716|FG000|COMPLETED|Overall Study||29
9860690|NCT00927888|10973717|FG001|COMPLETED|Overall Study||27
9860691|NCT00927888|10973716|FG000|NOT COMPLETED|Overall Study||0
9860692|NCT00927888|10973717|FG001|NOT COMPLETED|Overall Study||0
9860693|NCT00927901|10973725|FG000|STARTED|Treatment Period 1||7
9860694|NCT00927901|10973726|FG001|STARTED|Treatment Period 1||7
9860695|NCT00927901|10973727|FG002|STARTED|Treatment Period 1||7
9860696|NCT00927901|10973728|FG003|STARTED|Treatment Period 1||9
9860697|NCT00927901|10973725|FG000|COMPLETED|Treatment Period 1||7
9860698|NCT00927901|10973726|FG001|COMPLETED|Treatment Period 1||7
9860699|NCT00927901|10973727|FG002|COMPLETED|Treatment Period 1||6
9860700|NCT00927901|10973728|FG003|COMPLETED|Treatment Period 1||9
9860701|NCT00927901|10973725|FG000|NOT COMPLETED|Treatment Period 1||0
9860702|NCT00927901|10973726|FG001|NOT COMPLETED|Treatment Period 1||0
9860703|NCT00927901|10973727|FG002|NOT COMPLETED|Treatment Period 1||1
9860704|NCT00927901|10973728|FG003|NOT COMPLETED|Treatment Period 1||0
9860705|NCT00927901|10973725|FG000|STARTED|Treatment Period 2||7
9860706|NCT00927901|10973726|FG001|STARTED|Treatment Period 2||7
9860707|NCT00927901|10973727|FG002|STARTED|Treatment Period 2||6
9860708|NCT00927901|10973728|FG003|STARTED|Treatment Period 2||9
9860709|NCT00927901|10973725|FG000|COMPLETED|Treatment Period 2||7
9860710|NCT00927901|10973726|FG001|COMPLETED|Treatment Period 2||7
9860711|NCT00927901|10973727|FG002|COMPLETED|Treatment Period 2||6
9860712|NCT00927901|10973728|FG003|COMPLETED|Treatment Period 2||9
9860713|NCT00927901|10973725|FG000|NOT COMPLETED|Treatment Period 2||0
9860714|NCT00927901|10973726|FG001|NOT COMPLETED|Treatment Period 2||0
9860715|NCT00927901|10973727|FG002|NOT COMPLETED|Treatment Period 2||0
10093076|NCT02342314|11221618|FG013|COMPLETED|Part B||3
9860716|NCT00927901|10973728|FG003|NOT COMPLETED|Treatment Period 2||0
9860717|NCT00927901|10973725|FG000|STARTED|Treatment Period 3||7
9860718|NCT00927901|10973726|FG001|STARTED|Treatment Period 3||7
9860719|NCT00927901|10973727|FG002|STARTED|Treatment Period 3||6
9860720|NCT00927901|10973728|FG003|STARTED|Treatment Period 3||9
9860721|NCT00927901|10973725|FG000|COMPLETED|Treatment Period 3||7
9860722|NCT00927901|10973726|FG001|COMPLETED|Treatment Period 3||7
9860723|NCT00927901|10973727|FG002|COMPLETED|Treatment Period 3||6
9860724|NCT00927901|10973728|FG003|COMPLETED|Treatment Period 3||9
9860725|NCT00927901|10973725|FG000|NOT COMPLETED|Treatment Period 3||0
9860726|NCT00927901|10973726|FG001|NOT COMPLETED|Treatment Period 3||0
9860727|NCT00927901|10973727|FG002|NOT COMPLETED|Treatment Period 3||0
9860728|NCT00927901|10973728|FG003|NOT COMPLETED|Treatment Period 3||0
9860729|NCT00927901|10973725|FG000|STARTED|Treatment Period 4||7
10093077|NCT02342314|11221619|FG014|COMPLETED|Part B||3
9860730|NCT00927901|10973726|FG001|STARTED|Treatment Period 4||7
9860731|NCT00927901|10973727|FG002|STARTED|Treatment Period 4||6
9860732|NCT00927901|10973728|FG003|STARTED|Treatment Period 4||9
9860733|NCT00927901|10973725|FG000|COMPLETED|Treatment Period 4||7
9860734|NCT00927901|10973726|FG001|COMPLETED|Treatment Period 4||7
9860735|NCT00927901|10973727|FG002|COMPLETED|Treatment Period 4||5
9860736|NCT00927901|10973728|FG003|COMPLETED|Treatment Period 4||8
9860737|NCT00927901|10973725|FG000|NOT COMPLETED|Treatment Period 4||0
9860738|NCT00927901|10973726|FG001|NOT COMPLETED|Treatment Period 4||0
9860739|NCT00927901|10973727|FG002|NOT COMPLETED|Treatment Period 4||1
9860740|NCT00927901|10973728|FG003|NOT COMPLETED|Treatment Period 4||1
9860741|NCT00927927|10973756|FG000|STARTED|Overall Study||3
9860742|NCT00927927|10973757|FG001|STARTED|Overall Study||3
9860743|NCT00927927|10973758|FG002|STARTED|Overall Study||3
9860744|NCT00927927|10973759|FG003|STARTED|Overall Study||3
9860745|NCT00927927|10973760|FG004|STARTED|Overall Study||3
9860746|NCT00927927|10973761|FG005|STARTED|Overall Study||3
9860747|NCT00927927|10973762|FG006|STARTED|Overall Study||3
9860748|NCT00927927|10973763|FG007|STARTED|Overall Study||3
9860749|NCT00927927|10973764|FG008|STARTED|Overall Study||8
9860750|NCT00927927|10973765|FG009|STARTED|Overall Study||3
9860751|NCT00927927|10973766|FG010|STARTED|Overall Study||5
9860752|NCT00927927|10973767|FG011|STARTED|Overall Study||6
9860753|NCT00927927|10973768|FG012|STARTED|Overall Study||5
9860754|NCT00927927|10973769|FG013|STARTED|Overall Study||5
9860755|NCT00927927|10973770|FG014|STARTED|Overall Study||9
9860756|NCT00927927|10973756|FG000|Exposed|Overall Study||3
9860757|NCT00927927|10973757|FG001|Exposed|Overall Study||3
9860758|NCT00927927|10973758|FG002|Exposed|Overall Study||3
9860759|NCT00927927|10973759|FG003|Exposed|Overall Study||3
9860760|NCT00927927|10973760|FG004|Exposed|Overall Study||3
9860761|NCT00927927|10973761|FG005|Exposed|Overall Study||3
9860762|NCT00927927|10973762|FG006|Exposed|Overall Study||3
9860763|NCT00927927|10973763|FG007|Exposed|Overall Study||3
9860764|NCT00927927|10973764|FG008|Exposed|Overall Study||8
9860765|NCT00927927|10973765|FG009|Exposed|Overall Study||3
9860766|NCT00927927|10973766|FG010|Exposed|Overall Study||5
9860767|NCT00927927|10973767|FG011|Exposed|Overall Study||5
9860768|NCT00927927|10973768|FG012|Exposed|Overall Study||5
9860769|NCT00927927|10973769|FG013|Exposed|Overall Study||5
9860770|NCT00927927|10973770|FG014|Exposed|Overall Study||9
9860771|NCT00927927|10973756|FG000|COMPLETED|Overall Study||3
9860772|NCT00927927|10973757|FG001|COMPLETED|Overall Study||3
9860773|NCT00927927|10973758|FG002|COMPLETED|Overall Study||3
9860774|NCT00927927|10973759|FG003|COMPLETED|Overall Study||3
9860775|NCT00927927|10973760|FG004|COMPLETED|Overall Study||3
9860776|NCT00927927|10973761|FG005|COMPLETED|Overall Study||3
9860777|NCT00927927|10973762|FG006|COMPLETED|Overall Study||3
9860778|NCT00927927|10973763|FG007|COMPLETED|Overall Study||1
9860779|NCT00927927|10973764|FG008|COMPLETED|Overall Study||8
9860780|NCT00927927|10973765|FG009|COMPLETED|Overall Study||3
9860781|NCT00927927|10973766|FG010|COMPLETED|Overall Study||5
9860782|NCT00927927|10973767|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
9860783|NCT00927927|10973768|FG012|COMPLETED|Overall Study||5
9860784|NCT00927927|10973769|FG013|COMPLETED|Overall Study||5
9860785|NCT00927927|10973770|FG014|COMPLETED|Overall Study||9
9860786|NCT00927927|10973756|FG000|NOT COMPLETED|Overall Study||0
9860787|NCT00927927|10973757|FG001|NOT COMPLETED|Overall Study||0
9860788|NCT00927927|10973758|FG002|NOT COMPLETED|Overall Study||0
9860789|NCT00927927|10973759|FG003|NOT COMPLETED|Overall Study||0
9860790|NCT00927927|10973760|FG004|NOT COMPLETED|Overall Study||0
9860791|NCT00927927|10973761|FG005|NOT COMPLETED|Overall Study||0
9860792|NCT00927927|10973762|FG006|NOT COMPLETED|Overall Study||0
9860793|NCT00927927|10973763|FG007|NOT COMPLETED|Overall Study||2
9860794|NCT00927927|10973764|FG008|NOT COMPLETED|Overall Study||0
9860795|NCT00927927|10973765|FG009|NOT COMPLETED|Overall Study||0
9860796|NCT00927927|10973766|FG010|NOT COMPLETED|Overall Study||0
9860797|NCT00927927|10973767|FG011|NOT COMPLETED|Overall Study||2
9860798|NCT00927927|10973768|FG012|NOT COMPLETED|Overall Study||0
9860799|NCT00927927|10973769|FG013|NOT COMPLETED|Overall Study||0
9860800|NCT00927927|10973770|FG014|NOT COMPLETED|Overall Study||0
9860801|NCT00927940|10973802|FG000|STARTED|Overall Study||100
9860802|NCT00927940|10973802|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
9860803|NCT00927940|10973802|FG000|NOT COMPLETED|Overall Study||1
9860804|NCT00927992|10973807|FG000|STARTED|Overall Study||11
9860805|NCT00927992|10973807|FG000|COMPLETED|Overall Study||11
9860806|NCT00927992|10973807|FG000|NOT COMPLETED|Overall Study||0
9860807|NCT00928018|10973813|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
9860808|NCT00928018|10973814|FG001|STARTED|Overall Study||73
9860809|NCT00928018|10973813|FG000|COMPLETED|Overall Study||65
9860810|NCT00928018|10973814|FG001|COMPLETED|Overall Study||73
9860811|NCT00928018|10973813|FG000|NOT COMPLETED|Overall Study||1
9860812|NCT00928018|10973814|FG001|NOT COMPLETED|Overall Study||0
9860813|NCT00928057|10973826|FG000|STARTED|Overall Study||84
9860814|NCT00928057|10973827|FG001|STARTED|Overall Study||89
9860815|NCT00928057|10973826|FG000|COMPLETED|Overall Study||82
9860816|NCT00928057|10973827|FG001|COMPLETED|Overall Study||85
9860817|NCT00928057|10973826|FG000|NOT COMPLETED|Overall Study||2
9860818|NCT00928057|10973827|FG001|NOT COMPLETED|Overall Study||4
9860819|NCT00928070|10973845|FG000|STARTED|Overall Study||283
9860820|NCT00928070|10973846|FG001|STARTED|Overall Study||283
9860821|NCT00928070|10973845|FG000|Treated|Overall Study||281
9860822|NCT00928070|10973846|FG001|Treated|Overall Study||281
9860823|NCT00928070|10973845|FG000|COMPLETED|Overall Study||220
9860824|NCT00928070|10973846|FG001|COMPLETED|Overall Study||226
9860825|NCT00928070|10973845|FG000|NOT COMPLETED|Overall Study||63
9860826|NCT00928070|10973846|FG001|NOT COMPLETED|Overall Study||57
9860827|NCT00928083|10973855|FG000|STARTED|Overall Study||10
9860828|NCT00928083|10973856|FG001|STARTED|Overall Study||8
9860829|NCT00928083|10973857|FG002|STARTED|Overall Study||8
9860830|NCT00928083|10973858|FG003|STARTED|Overall Study||6
9860831|NCT00928083|10973859|FG004|STARTED|Overall Study||7
9860832|NCT00928083|10973860|FG005|STARTED|Overall Study||6
9860833|NCT00928083|10973861|FG006|STARTED|Overall Study||6
9860834|NCT00928083|10973862|FG007|STARTED|Overall Study||6
9860835|NCT00928083|10973863|FG008|STARTED|Overall Study||6
9860836|NCT00928083|10973855|FG000|COMPLETED|Overall Study||6
9860837|NCT00928083|10973856|FG001|COMPLETED|Overall Study||8
9860838|NCT00928083|10973857|FG002|COMPLETED|Overall Study||8
9860839|NCT00928083|10973858|FG003|COMPLETED|Overall Study||5
10093078|NCT02342314|11221620|FG015|COMPLETED|Part B||3
10093079|NCT02342314|11221621|FG016|COMPLETED|Part B||6
10093080|NCT02342314|11221605|FG000|NOT COMPLETED|Part B||0
10093081|NCT02342314|11221606|FG001|NOT COMPLETED|Part B||0
10093082|NCT02342314|11221607|FG002|NOT COMPLETED|Part B||0
10093083|NCT02342314|11221608|FG003|NOT COMPLETED|Part B||0
10093084|NCT02342314|11221609|FG004|NOT COMPLETED|Part B||0
10093085|NCT02342314|11221610|FG005|NOT COMPLETED|Part B||0
10093086|NCT02342314|11221611|FG006|NOT COMPLETED|Part B||0
10093087|NCT02342314|11221612|FG007|NOT COMPLETED|Part B||0
10093088|NCT02342314|11221613|FG008|NOT COMPLETED|Part B||0
10093089|NCT02342314|11221614|FG009|NOT COMPLETED|Part B||0
10093090|NCT02342314|11221615|FG010|NOT COMPLETED|Part B||0
10093091|NCT02342314|11221616|FG011|NOT COMPLETED|Part B||0
10093092|NCT02342314|11221617|FG012|NOT COMPLETED|Part B||0
10093093|NCT02342314|11221618|FG013|NOT COMPLETED|Part B||0
10093094|NCT02342314|11221619|FG014|NOT COMPLETED|Part B||0
10093095|NCT02342314|11221620|FG015|NOT COMPLETED|Part B||0
10093096|NCT02342314|11221621|FG016|NOT COMPLETED|Part B||0
10093097|NCT02342327|11221694|FG000|STARTED|Overall Study||60
10093098|NCT02342327|11221695|FG001|STARTED|Overall Study||62
10093099|NCT02342327|11221694|FG000|Completed Quit Day Visit|Overall Study||54
10093100|NCT02342327|11221695|FG001|Completed Quit Day Visit|Overall Study||53
10093101|NCT02342327|11221694|FG000|COMPLETED|Overall Study||39
10093102|NCT02342327|11221695|FG001|COMPLETED|Overall Study||40
10093103|NCT02342327|11221694|FG000|NOT COMPLETED|Overall Study||21
10093104|NCT02342327|11221695|FG001|NOT COMPLETED|Overall Study||22
10093105|NCT02342379|11221701|FG000|STARTED|Overall Study||35
10093106|NCT02342379|11221701|FG000|COMPLETED|Overall Study||35
10093107|NCT02342379|11221701|FG000|NOT COMPLETED|Overall Study||0
10093108|NCT02342418|11221707|FG000|STARTED|Overall Study||9
10093109|NCT02342418|11221708|FG001|STARTED|Overall Study||10
10093110|NCT02342418|11221707|FG000|COMPLETED|Overall Study||9
10093111|NCT02342418|11221708|FG001|COMPLETED|Overall Study||9
10093112|NCT02342418|11221707|FG000|NOT COMPLETED|Overall Study||0
10093113|NCT02342418|11221708|FG001|NOT COMPLETED|Overall Study||1
10093114|NCT02342535|11221714|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
10093115|NCT02342535|11221714|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
10093116|NCT02342535|11221714|FG000|NOT COMPLETED|Overall Study||0
10093117|NCT02342548|11221721|FG000|STARTED|Overall Study||51
10093118|NCT02342548|11221722|FG001|STARTED|Overall Study||71
10093119|NCT02342548|11221723|FG002|STARTED|Overall Study||66
10093120|NCT02342548|11221721|FG000|COMPLETED|Overall Study||17
10093121|NCT02342548|11221722|FG001|COMPLETED|Overall Study||9
10093122|NCT02342548|11221723|FG002|COMPLETED|Overall Study||23
10093123|NCT02342548|11221721|FG000|NOT COMPLETED|Overall Study||34
10093124|NCT02342548|11221722|FG001|NOT COMPLETED|Overall Study||62
10093125|NCT02342548|11221723|FG002|NOT COMPLETED|Overall Study||43
10093126|NCT02342561|11221731|FG000|STARTED|Overall Study||20
10093127|NCT02342561|11221731|FG000|COMPLETED|Overall Study||20
10093128|NCT02342561|11221731|FG000|NOT COMPLETED|Overall Study||0
10093129|NCT02342639|11221741|FG000|STARTED|Overall Study||19
10093130|NCT02342639|11221742|FG001|STARTED|Overall Study||19
10093131|NCT02342639|11221741|FG000|COMPLETED|Overall Study||17
10093132|NCT02342639|11221742|FG001|COMPLETED|Overall Study||14
10093133|NCT02342639|11221741|FG000|NOT COMPLETED|Overall Study||2
10093134|NCT02342639|11221742|FG001|NOT COMPLETED|Overall Study||5
10093135|NCT02342678|11221752|FG000|STARTED|Overall Study||28
10093136|NCT02342678|11221753|FG001|STARTED|Overall Study||28
10093137|NCT02342678|11221752|FG000|COMPLETED|Overall Study||27
10093138|NCT02342678|11221753|FG001|COMPLETED|Overall Study||23
10093139|NCT02342678|11221752|FG000|NOT COMPLETED|Overall Study||1
10093140|NCT02342678|11221753|FG001|NOT COMPLETED|Overall Study||5
10093141|NCT02342704|11221761|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
10093142|NCT02342704|11221762|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
10093143|NCT02342704|11221761|FG000|COMPLETED|Overall Study||1
9860840|NCT00928083|10973859|FG004|COMPLETED|Overall Study||6
9860841|NCT00928083|10973860|FG005|COMPLETED|Overall Study||6
9860842|NCT00928083|10973861|FG006|COMPLETED|Overall Study||6
9860843|NCT00928083|10973862|FG007|COMPLETED|Overall Study||6
9860844|NCT00928083|10973863|FG008|COMPLETED|Overall Study||6
9860845|NCT00928083|10973855|FG000|NOT COMPLETED|Overall Study||4
9860846|NCT00928083|10973856|FG001|NOT COMPLETED|Overall Study||0
9860847|NCT00928083|10973857|FG002|NOT COMPLETED|Overall Study||0
9860848|NCT00928083|10973858|FG003|NOT COMPLETED|Overall Study||1
9860849|NCT00928083|10973859|FG004|NOT COMPLETED|Overall Study||1
9860850|NCT00928083|10973860|FG005|NOT COMPLETED|Overall Study||0
9860851|NCT00928083|10973861|FG006|NOT COMPLETED|Overall Study||0
9860852|NCT00928083|10973862|FG007|NOT COMPLETED|Overall Study||0
9860853|NCT00928083|10973863|FG008|NOT COMPLETED|Overall Study||0
9860854|NCT00928135|10973914|FG000|STARTED|Overall Study||30
9860855|NCT00928135|10973915|FG001|STARTED|Overall Study||30
9860856|NCT00928135|10973914|FG000|COMPLETED|Overall Study||29
9860857|NCT00928135|10973915|FG001|COMPLETED|Overall Study||30
9860858|NCT00928135|10973914|FG000|NOT COMPLETED|Overall Study||1
9860859|NCT00928135|10973915|FG001|NOT COMPLETED|Overall Study||0
9860860|NCT00928174|10973921|FG000|STARTED|Overall Study||27
9860861|NCT00928174|10973921|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22
9860862|NCT00928174|10973921|FG000|NOT COMPLETED|Overall Study||5
9860863|NCT00928187|10973928|FG000|STARTED|Overall Study||152
9860864|NCT00928187|10973929|FG001|STARTED|Overall Study||147
9860865|NCT00928187|10973930|FG002|STARTED|Overall Study||155
9860866|NCT00928187|10973928|FG000|Analysed|Overall Study||152
9860867|NCT00928187|10973929|FG001|Analysed|Overall Study||145
9860868|NCT00928187|10973930|FG002|Analysed|Overall Study||154
9860869|NCT00928187|10973928|FG000|COMPLETED|Overall Study||150
9860870|NCT00928187|10973929|FG001|COMPLETED|Overall Study||141
9860871|NCT00928187|10973930|FG002|COMPLETED|Overall Study||150
9860872|NCT00928187|10973928|FG000|NOT COMPLETED|Overall Study||2
9860873|NCT00928187|10973929|FG001|NOT COMPLETED|Overall Study||6
9860874|NCT00928187|10973930|FG002|NOT COMPLETED|Overall Study||5
9860875|NCT00928200|10973938|FG000|STARTED|Overall Study||1
9860876|NCT00928200|10973938|FG000|COMPLETED|Overall Study||1
9860877|NCT00928200|10973938|FG000|NOT COMPLETED|Overall Study||0
10093144|NCT02342704|11221762|FG001|COMPLETED|Overall Study||3
10093145|NCT02342704|11221761|FG000|NOT COMPLETED|Overall Study||53
10093146|NCT02342704|11221762|FG001|NOT COMPLETED|Overall Study||51
10093147|NCT02342743|11221768|FG000|STARTED|Baseline Period||73
10093148|NCT02342743|11221768|FG000|COMPLETED|Baseline Period||58
10093149|NCT02342743|11221768|FG000|NOT COMPLETED|Baseline Period||15
9860878|NCT00928252|10973942|FG000|STARTED|Overall Study||45
9860879|NCT00928252|10973942|FG000|COMPLETED|Overall Study||42
9860880|NCT00928252|10973942|FG000|NOT COMPLETED|Overall Study||3
9860881|NCT00928304|10973948|FG000|STARTED|Overall Study||39
9860882|NCT00928304|10973949|FG001|STARTED|Overall Study||70
9860883|NCT00928304|10973948|FG000|COMPLETED|Overall Study||39
9860884|NCT00928304|10973949|FG001|COMPLETED|Overall Study||70
9860885|NCT00928304|10973948|FG000|NOT COMPLETED|Overall Study||0
9860886|NCT00928304|10973949|FG001|NOT COMPLETED|Overall Study||0
9860887|NCT00928395|10973961|FG000|STARTED|Overall Study||50
9860888|NCT00928395|10973961|FG000|COMPLETED|Overall Study||29
9860889|NCT00928395|10973961|FG000|NOT COMPLETED|Overall Study||21
9860890|NCT00928408|10973965|FG000|STARTED|Overall Study|Number Enrolled|305
9860891|NCT00928408|10973965|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
9860892|NCT00928408|10973965|FG000|COMPLETED|Overall Study||282
9860893|NCT00928408|10973965|FG000|NOT COMPLETED|Overall Study||23
9860894|NCT00928421|10973969|FG000|STARTED|Overall Study||16
9860895|NCT00928421|10973969|FG000|Treated With Study Drug|Overall Study||16
9860896|NCT00928421|10973969|FG000|COMPLETED|Overall Study||16
9860897|NCT00928421|10973969|FG000|NOT COMPLETED|Overall Study||0
9860898|NCT00928434|10973976|FG000|STARTED|Overall Study|Full Analysis Set Patients|175
9860899|NCT00928434|10973977|FG001|STARTED|Overall Study|Full Analysis Set Patients|50
9860900|NCT00928434|10973978|FG002|STARTED|Overall Study|Full Analysis Set Patients|178
9860901|NCT00928434|10973976|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
9860902|NCT00928434|10973977|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
9860903|NCT00928434|10973978|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
9860904|NCT00928434|10973976|FG000|COMPLETED|Overall Study||131
9860905|NCT00928434|10973977|FG001|COMPLETED|Overall Study||36
9860906|NCT00928434|10973978|FG002|COMPLETED|Overall Study||134
9860907|NCT00928434|10973976|FG000|NOT COMPLETED|Overall Study||44
9860908|NCT00928434|10973977|FG001|NOT COMPLETED|Overall Study||14
9860909|NCT00928434|10973978|FG002|NOT COMPLETED|Overall Study||44
9860910|NCT00928486|10973994|FG000|STARTED|Overall Study||25
10113439|NCT02509117|11244195|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
9860911|NCT00928486|10973994|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
9860912|NCT00928486|10973994|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
9860913|NCT00928486|10973994|FG000|NOT COMPLETED|Overall Study||10
9860914|NCT00928512|10974003|FG000|STARTED|Overall Study||41
9860915|NCT00928512|10974004|FG001|STARTED|Overall Study||43
9860916|NCT00928512|10974005|FG002|STARTED|Overall Study||49
9860917|NCT00928512|10974006|FG003|STARTED|Overall Study||54
9860918|NCT00928512|10974007|FG004|STARTED|Overall Study||50
9860919|NCT00928512|10974003|FG000|Discontinued Prior to Week 16|Overall Study||3
9860920|NCT00928512|10974004|FG001|Discontinued Prior to Week 16|Overall Study||0
9860921|NCT00928512|10974005|FG002|Discontinued Prior to Week 16|Overall Study||2
9860922|NCT00928512|10974006|FG003|Discontinued Prior to Week 16|Overall Study||6
9860923|NCT00928512|10974007|FG004|Discontinued Prior to Week 16|Overall Study||5
9860924|NCT00928512|10974003|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
9860925|NCT00928512|10974004|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
9860926|NCT00928512|10974005|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
9860927|NCT00928512|10974006|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
9860928|NCT00928512|10974007|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
9860929|NCT00928512|10974003|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37
9860930|NCT00928512|10974004|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20
9860931|NCT00928512|10974005|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23
9860932|NCT00928512|10974006|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18
9860933|NCT00928512|10974007|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0
9860934|NCT00928512|10974003|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
9860935|NCT00928512|10974004|FG001|New Groups After Reassignment|Overall Study||115
9860936|NCT00928512|10974005|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
9860937|NCT00928512|10974006|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
9860938|NCT00928512|10974007|FG004|New Groups After Reassignment|Overall Study||0
9860939|NCT00928512|10974003|FG000|Completed Week 16|Overall Study||38
9860940|NCT00928512|10974004|FG001|Completed Week 16|Overall Study||43
9860941|NCT00928512|10974005|FG002|Completed Week 16|Overall Study||47
9860942|NCT00928512|10974006|FG003|Completed Week 16|Overall Study||48
9860943|NCT00928512|10974007|FG004|Completed Week 16|Overall Study||45
9860944|NCT00928512|10974003|FG000|Entered/Continued to Week 20 (All)|Overall Study||37
9860945|NCT00928512|10974004|FG001|Entered/Continued to Week 20 (All)|Overall Study||43
9860946|NCT00928512|10974005|FG002|Entered/Continued to Week 20 (All)|Overall Study||46
9860947|NCT00928512|10974006|FG003|Entered/Continued to Week 20 (All)|Overall Study||45
9860948|NCT00928512|10974007|FG004|Entered/Continued to Week 20 (All)|Overall Study||45
9860949|NCT00928512|10974003|FG000|COMPLETED|Overall Study||31
9860950|NCT00928512|10974004|FG001|COMPLETED|Overall Study||37
9860951|NCT00928512|10974005|FG002|COMPLETED|Overall Study||38
9860952|NCT00928512|10974006|FG003|COMPLETED|Overall Study||33
9860953|NCT00928512|10974007|FG004|COMPLETED|Overall Study||35
9860954|NCT00928512|10974003|FG000|NOT COMPLETED|Overall Study||10
9860955|NCT00928512|10974004|FG001|NOT COMPLETED|Overall Study||6
9860956|NCT00928512|10974005|FG002|NOT COMPLETED|Overall Study||11
9860957|NCT00928512|10974006|FG003|NOT COMPLETED|Overall Study||21
9860958|NCT00928512|10974007|FG004|NOT COMPLETED|Overall Study||15
9860959|NCT00928564|10974025|FG000|STARTED|Overall Study||28
9860960|NCT00928564|10974026|FG001|STARTED|Overall Study||12
9860961|NCT00928564|10974025|FG000|COMPLETED|Overall Study||22
9860962|NCT00928564|10974026|FG001|COMPLETED|Overall Study||12
9860963|NCT00928564|10974025|FG000|NOT COMPLETED|Overall Study||6
9860964|NCT00928564|10974026|FG001|NOT COMPLETED|Overall Study||0
9860965|NCT00928642|10974032|FG000|STARTED|Overall Study||8
9860966|NCT00928642|10974032|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
9860967|NCT00928642|10974032|FG000|NOT COMPLETED|Overall Study||0
9860968|NCT00928668|10974039|FG000|STARTED|Overall Study||7
9860969|NCT00928668|10974040|FG001|STARTED|Overall Study||7
9860970|NCT00928668|10974041|FG002|STARTED|Overall Study||7
9860971|NCT00928668|10974042|FG003|STARTED|Overall Study||4
9860972|NCT00928668|10974043|FG004|STARTED|Overall Study||6
9860973|NCT00928668|10974039|FG000|COMPLETED|Overall Study||6
9860974|NCT00928668|10974040|FG001|COMPLETED|Overall Study||6
9860975|NCT00928668|10974041|FG002|COMPLETED|Overall Study||6
9860976|NCT00928668|10974042|FG003|COMPLETED|Overall Study||3
9860977|NCT00928668|10974043|FG004|COMPLETED|Overall Study||5
10093150|NCT02342743|11221768|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
10093151|NCT02342743|11221768|FG000|COMPLETED|Treatment Period||47
10093152|NCT02342743|11221768|FG000|NOT COMPLETED|Treatment Period||11
10093153|NCT02342886|11221777|FG000|STARTED|Overall Study||65
10093154|NCT02342886|11221778|FG001|STARTED|Overall Study||71
10093155|NCT02342886|11221779|FG002|STARTED|Overall Study||67
10093156|NCT02342886|11221780|FG003|STARTED|Overall Study||68
10093157|NCT02342886|11221781|FG004|STARTED|Overall Study||13
10093158|NCT02342886|11221777|FG000|Completed Month 12 Follow-Up|Overall Study||43
10093159|NCT02342886|11221778|FG001|Completed Month 12 Follow-Up|Overall Study||52
10093160|NCT02342886|11221779|FG002|Completed Month 12 Follow-Up|Overall Study||49
10093161|NCT02342886|11221780|FG003|Completed Month 12 Follow-Up|Overall Study||57
10093162|NCT02342886|11221781|FG004|Completed Month 12 Follow-Up|Overall Study||10
10093163|NCT02342886|11221777|FG000|Completed Month 24 Follow-Up|Overall Study||40
10093164|NCT02342886|11221778|FG001|Completed Month 24 Follow-Up|Overall Study||47
10093165|NCT02342886|11221779|FG002|Completed Month 24 Follow-Up|Overall Study||46
9860978|NCT00928668|10974039|FG000|NOT COMPLETED|Overall Study||1
9860979|NCT00928668|10974040|FG001|NOT COMPLETED|Overall Study||1
9860980|NCT00928668|10974041|FG002|NOT COMPLETED|Overall Study||1
9860981|NCT00928668|10974042|FG003|NOT COMPLETED|Overall Study||1
9860982|NCT00928668|10974043|FG004|NOT COMPLETED|Overall Study||1
9860983|NCT00928694|10974060|FG000|STARTED|First Intervention||7
9860984|NCT00928694|10974061|FG001|STARTED|First Intervention||7
9860985|NCT00928694|10974060|FG000|COMPLETED|First Intervention||7
9860986|NCT00928694|10974061|FG001|COMPLETED|First Intervention||7
9860987|NCT00928694|10974060|FG000|NOT COMPLETED|First Intervention||0
9860988|NCT00928694|10974061|FG001|NOT COMPLETED|First Intervention||0
9860989|NCT00928694|10974060|FG000|STARTED|Second Intervention||7
9860990|NCT00928694|10974061|FG001|STARTED|Second Intervention||7
9860991|NCT00928694|10974060|FG000|COMPLETED|Second Intervention||7
9860992|NCT00928694|10974061|FG001|COMPLETED|Second Intervention||7
9860993|NCT00928694|10974060|FG000|NOT COMPLETED|Second Intervention||0
9860994|NCT00928694|10974061|FG001|NOT COMPLETED|Second Intervention||0
9860995|NCT00928707|10974069|FG000|STARTED|Overall Study||23
9860996|NCT00928707|10974070|FG001|STARTED|Overall Study||22
9860997|NCT00928707|10974069|FG000|COMPLETED|Overall Study||22
9860998|NCT00928707|10974070|FG001|COMPLETED|Overall Study||22
9860999|NCT00928707|10974069|FG000|NOT COMPLETED|Overall Study||1
9861000|NCT00928707|10974070|FG001|NOT COMPLETED|Overall Study||0
9861001|NCT00928720|10974079|FG000|STARTED|Overall Study||19
9861002|NCT00928720|10974080|FG001|STARTED|Overall Study||20
9861003|NCT00928720|10974081|FG002|STARTED|Overall Study||18
9861004|NCT00928720|10974079|FG000|COMPLETED|Overall Study||17
9861005|NCT00928720|10974080|FG001|COMPLETED|Overall Study||14
9861006|NCT00928720|10974081|FG002|COMPLETED|Overall Study||15
9861007|NCT00928720|10974079|FG000|NOT COMPLETED|Overall Study||2
9861008|NCT00928720|10974080|FG001|NOT COMPLETED|Overall Study||6
9861009|NCT00928720|10974081|FG002|NOT COMPLETED|Overall Study||3
9861010|NCT00928746|10974092|FG000|STARTED|Overall Study||142
9861011|NCT00928746|10974092|FG000|COMPLETED|Overall Study||136
9861012|NCT00928746|10974092|FG000|NOT COMPLETED|Overall Study||6
9861013|NCT00928772|10974101|FG000|STARTED|Overall Study||39
9861014|NCT00928772|10974102|FG001|STARTED|Overall Study||38
9861015|NCT00928772|10974103|FG002|STARTED|Overall Study||38
9861016|NCT00928772|10974101|FG000|COMPLETED|Overall Study||39
9861017|NCT00928772|10974102|FG001|COMPLETED|Overall Study||38
10093166|NCT02342886|11221780|FG003|Completed Month 24 Follow-Up|Overall Study||53
10093167|NCT02342886|11221781|FG004|Completed Month 24 Follow-Up|Overall Study||10
10093168|NCT02342886|11221777|FG000|COMPLETED|Overall Study||57
9861018|NCT00928772|10974103|FG002|COMPLETED|Overall Study||38
9861019|NCT00928772|10974101|FG000|NOT COMPLETED|Overall Study||0
9861020|NCT00928772|10974102|FG001|NOT COMPLETED|Overall Study||0
9861021|NCT00928772|10974103|FG002|NOT COMPLETED|Overall Study||0
9861022|NCT00928889|10974113|FG000|STARTED|Overall Study||80
9861023|NCT00928889|10974114|FG001|STARTED|Overall Study||80
9861024|NCT00928889|10974113|FG000|COMPLETED|Overall Study||75
9861025|NCT00928889|10974114|FG001|COMPLETED|Overall Study||78
9861026|NCT00928889|10974113|FG000|NOT COMPLETED|Overall Study||5
9861027|NCT00928889|10974114|FG001|NOT COMPLETED|Overall Study||2
9861028|NCT00928954|10974120|FG000|STARTED|Overall Study||4
9861029|NCT00928954|10974121|FG001|STARTED|Overall Study||6
9861030|NCT00928954|10974120|FG000|COMPLETED|Overall Study||4
9861031|NCT00928954|10974121|FG001|COMPLETED|Overall Study||6
9861032|NCT00928954|10974120|FG000|NOT COMPLETED|Overall Study||0
9861033|NCT00928954|10974121|FG001|NOT COMPLETED|Overall Study||0
9861034|NCT00929071|10974127|FG000|STARTED|Overall Study||10
9861035|NCT00929071|10974127|FG000|COMPLETED|Overall Study||10
9861036|NCT00929071|10974127|FG000|NOT COMPLETED|Overall Study||0
9861037|NCT00929110|10974137|FG000|STARTED|Overall Study||529
9861038|NCT00929110|10974138|FG001|STARTED|Overall Study||269
9861039|NCT00929110|10974139|FG002|STARTED|Overall Study||268
9861040|NCT00929110|10974137|FG000|COMPLETED|Overall Study||411
9861041|NCT00929110|10974138|FG001|COMPLETED|Overall Study||193
9861042|NCT00929110|10974139|FG002|COMPLETED|Overall Study||206
9861043|NCT00929110|10974137|FG000|NOT COMPLETED|Overall Study||118
9861044|NCT00929110|10974138|FG001|NOT COMPLETED|Overall Study||76
9861045|NCT00929110|10974139|FG002|NOT COMPLETED|Overall Study||62
9861046|NCT00929162|10974149|FG000|STARTED|Overall Study||59
9861047|NCT00929162|10974150|FG001|STARTED|Overall Study||61
9861048|NCT00929162|10974149|FG000|Patients Who Received Treatment|Overall Study||58
9861049|NCT00929162|10974150|FG001|Patients Who Received Treatment|Overall Study||58
9861050|NCT00929162|10974149|FG000|COMPLETED|Overall Study||11
9861051|NCT00929162|10974150|FG001|COMPLETED|Overall Study||19
9861052|NCT00929162|10974149|FG000|NOT COMPLETED|Overall Study||48
9861053|NCT00929162|10974150|FG001|NOT COMPLETED|Overall Study||42
9861054|NCT00929201|10974156|FG000|STARTED|Period 1||30
9861055|NCT00929201|10974157|FG001|STARTED|Period 1||31
9861056|NCT00929201|10974156|FG000|COMPLETED|Period 1||30
9861057|NCT00929201|10974157|FG001|COMPLETED|Period 1||30
9861058|NCT00929201|10974156|FG000|NOT COMPLETED|Period 1||0
9861059|NCT00929201|10974157|FG001|NOT COMPLETED|Period 1||1
9861060|NCT00929201|10974156|FG000|STARTED|7-day Washout||30
9861061|NCT00929201|10974157|FG001|STARTED|7-day Washout||30
9861062|NCT00929201|10974156|FG000|COMPLETED|7-day Washout||30
9861063|NCT00929201|10974157|FG001|COMPLETED|7-day Washout||30
9861064|NCT00929201|10974156|FG000|NOT COMPLETED|7-day Washout||0
9861065|NCT00929201|10974157|FG001|NOT COMPLETED|7-day Washout||0
9861066|NCT00929201|10974156|FG000|STARTED|Period 2||30
9861067|NCT00929201|10974157|FG001|STARTED|Period 2||30
9861068|NCT00929201|10974156|FG000|COMPLETED|Period 2||30
9861069|NCT00929201|10974157|FG001|COMPLETED|Period 2||30
9861070|NCT00929201|10974156|FG000|NOT COMPLETED|Period 2||0
9861071|NCT00929201|10974157|FG001|NOT COMPLETED|Period 2||0
9861072|NCT00929240|10974164|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
9861073|NCT00929240|10974165|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
9861074|NCT00929240|10974166|FG002|STARTED|Initial Treatment Phase||0
9861075|NCT00929240|10974164|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
9861076|NCT00929240|10974165|FG001|COMPLETED|Initial Treatment Phase||0
9861077|NCT00929240|10974166|FG002|COMPLETED|Initial Treatment Phase||0
9861078|NCT00929240|10974164|FG000|NOT COMPLETED|Initial Treatment Phase||99
9861079|NCT00929240|10974165|FG001|NOT COMPLETED|Initial Treatment Phase||0
9861080|NCT00929240|10974166|FG002|NOT COMPLETED|Initial Treatment Phase||0
9861081|NCT00929240|10974164|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
9861082|NCT00929240|10974165|FG001|STARTED|Maintenance Phase||94
9861083|NCT00929240|10974166|FG002|STARTED|Maintenance Phase||91
9861084|NCT00929240|10974164|FG000|COMPLETED|Maintenance Phase||0
9861085|NCT00929240|10974165|FG001|COMPLETED|Maintenance Phase||0
9861086|NCT00929240|10974166|FG002|COMPLETED|Maintenance Phase||0
9861087|NCT00929240|10974164|FG000|NOT COMPLETED|Maintenance Phase||0
9861088|NCT00929240|10974165|FG001|NOT COMPLETED|Maintenance Phase||94
9861089|NCT00929240|10974166|FG002|NOT COMPLETED|Maintenance Phase||91
9861090|NCT00929305|10974177|FG000|STARTED|Overall Study||43
9861091|NCT00929305|10974178|FG001|STARTED|Overall Study||43
9861092|NCT00929305|10974177|FG000|COMPLETED|Overall Study||43
9861093|NCT00929305|10974178|FG001|COMPLETED|Overall Study||43
9861094|NCT00929305|10974177|FG000|NOT COMPLETED|Overall Study||0
9861095|NCT00929305|10974178|FG001|NOT COMPLETED|Overall Study||0
9861096|NCT00929331|10974187|FG000|STARTED|Overall Study||55
9861097|NCT00929331|10974188|FG001|STARTED|Overall Study||55
9861098|NCT00929331|10974187|FG000|COMPLETED|Overall Study||55
9861099|NCT00929331|10974188|FG001|COMPLETED|Overall Study||55
9861100|NCT00929331|10974187|FG000|NOT COMPLETED|Overall Study||0
9861101|NCT00929331|10974188|FG001|NOT COMPLETED|Overall Study||0
9861102|NCT00929344|10974197|FG000|STARTED|Overall Study||50
9861103|NCT00929344|10974198|FG001|STARTED|Overall Study||50
9861104|NCT00929344|10974199|FG002|STARTED|Overall Study||50
9861105|NCT00929344|10974197|FG000|COMPLETED|Overall Study||28
9861106|NCT00929344|10974198|FG001|COMPLETED|Overall Study||37
9861107|NCT00929344|10974199|FG002|COMPLETED|Overall Study||29
9861108|NCT00929344|10974197|FG000|NOT COMPLETED|Overall Study||22
9861109|NCT00929344|10974198|FG001|NOT COMPLETED|Overall Study||13
9861110|NCT00929344|10974199|FG002|NOT COMPLETED|Overall Study||21
9861111|NCT00929357|10974209|FG000|STARTED|Overall Study||92
9861112|NCT00929357|10974210|FG001|STARTED|Overall Study||64
9861113|NCT00929357|10974209|FG000|COMPLETED|Overall Study||92
9861114|NCT00929357|10974210|FG001|COMPLETED|Overall Study||64
9861115|NCT00929357|10974209|FG000|NOT COMPLETED|Overall Study||0
9861116|NCT00929357|10974210|FG001|NOT COMPLETED|Overall Study||0
9861117|NCT00929383|10974216|FG000|STARTED|Overall Study||82
9861118|NCT00929383|10974216|FG000|COMPLETED|Overall Study||67
9861119|NCT00929383|10974216|FG000|NOT COMPLETED|Overall Study||15
9861120|NCT00929500|10974222|FG000|STARTED|Overall Study||8
9861121|NCT00929500|10974223|FG001|STARTED|Overall Study||4
9861122|NCT00929500|10974222|FG000|COMPLETED|Overall Study||4
9861123|NCT00929500|10974223|FG001|COMPLETED|Overall Study||4
9861124|NCT00929500|10974222|FG000|NOT COMPLETED|Overall Study||4
9861125|NCT00929500|10974223|FG001|NOT COMPLETED|Overall Study||0
9861126|NCT00929526|10974231|FG000|STARTED|Overall Study||375
9861127|NCT00929526|10974232|FG001|STARTED|Overall Study||377
9861128|NCT00929526|10974231|FG000|COMPLETED|Overall Study||358
9861129|NCT00929526|10974232|FG001|COMPLETED|Overall Study||348
9861130|NCT00929526|10974231|FG000|NOT COMPLETED|Overall Study||17
9861131|NCT00929526|10974232|FG001|NOT COMPLETED|Overall Study||29
9861132|NCT00929578|10974238|FG000|STARTED|Overall Study||15
9861133|NCT00929578|10974238|FG000|COMPLETED|Overall Study||15
9861134|NCT00929578|10974238|FG000|NOT COMPLETED|Overall Study||0
9861135|NCT00929643|10974247|FG000|STARTED|Overall Study||203
9861136|NCT00929643|10974247|FG000|COMPLETED|Overall Study||201
9861137|NCT00929643|10974247|FG000|NOT COMPLETED|Overall Study||2
9861138|NCT00929656|10974253|FG000|STARTED|Overall Study||13
9861139|NCT00929656|10974254|FG001|STARTED|Overall Study||9
9861140|NCT00929656|10974253|FG000|COMPLETED|Overall Study||13
9861141|NCT00929656|10974254|FG001|COMPLETED|Overall Study||8
9861142|NCT00929656|10974253|FG000|NOT COMPLETED|Overall Study||0
9861143|NCT00929656|10974254|FG001|NOT COMPLETED|Overall Study||1
9861144|NCT00929669|10974260|FG000|STARTED|Overall Study||2
9861145|NCT00929669|10974260|FG000|COMPLETED|Overall Study||1
9861146|NCT00929669|10974260|FG000|NOT COMPLETED|Overall Study||1
9861147|NCT00929695|10974266|FG000|STARTED|Overall Study||81
9861148|NCT00929695|10974267|FG001|STARTED|Overall Study||83
9861149|NCT00929695|10974266|FG000|COMPLETED|Overall Study||73
9861150|NCT00929695|10974267|FG001|COMPLETED|Overall Study||77
9861151|NCT00929695|10974266|FG000|NOT COMPLETED|Overall Study||8
9861152|NCT00929695|10974267|FG001|NOT COMPLETED|Overall Study||6
9861153|NCT00929708|10974283|FG000|STARTED|Overall Study||65
9861154|NCT00929708|10974284|FG001|STARTED|Overall Study||69
9861155|NCT00929708|10974285|FG002|STARTED|Overall Study||65
9861156|NCT00929708|10974286|FG003|STARTED|Overall Study||67
9861157|NCT00929708|10974287|FG004|STARTED|Overall Study||63
9861158|NCT00929708|10974283|FG000|COMPLETED|Overall Study||61
9861159|NCT00929708|10974284|FG001|COMPLETED|Overall Study||66
9861160|NCT00929708|10974285|FG002|COMPLETED|Overall Study||62
9861161|NCT00929708|10974286|FG003|COMPLETED|Overall Study||61
9861162|NCT00929708|10974287|FG004|COMPLETED|Overall Study||57
9861163|NCT00929708|10974283|FG000|NOT COMPLETED|Overall Study||4
9861164|NCT00929708|10974284|FG001|NOT COMPLETED|Overall Study||3
9861165|NCT00929708|10974285|FG002|NOT COMPLETED|Overall Study||3
9861166|NCT00929708|10974286|FG003|NOT COMPLETED|Overall Study||6
9861167|NCT00929708|10974287|FG004|NOT COMPLETED|Overall Study||6
9861168|NCT00929734|10974301|FG000|STARTED|Overall Study||49
9861169|NCT00929734|10974302|FG001|STARTED|Overall Study||50
9861170|NCT00929734|10974301|FG000|COMPLETED|Overall Study||47
9861171|NCT00929734|10974302|FG001|COMPLETED|Overall Study||47
9861172|NCT00929734|10974301|FG000|NOT COMPLETED|Overall Study||2
9861173|NCT00929734|10974302|FG001|NOT COMPLETED|Overall Study||3
9861174|NCT00929773|10974310|FG000|STARTED|Overall Study||50
9861175|NCT00929773|10974311|FG001|STARTED|Overall Study||50
9861176|NCT00929773|10974310|FG000|COMPLETED|Overall Study||50
9861177|NCT00929773|10974311|FG001|COMPLETED|Overall Study||50
9861178|NCT00929773|10974310|FG000|NOT COMPLETED|Overall Study||0
9861179|NCT00929773|10974311|FG001|NOT COMPLETED|Overall Study||0
9861180|NCT00929838|10974322|FG000|STARTED|Overall Study||63
9861181|NCT00929838|10974323|FG001|STARTED|Overall Study||65
9861182|NCT00929838|10974324|FG002|STARTED|Overall Study||63
9861183|NCT00929838|10974325|FG003|STARTED|Overall Study||64
9861184|NCT00929838|10974322|FG000|COMPLETED|Overall Study||53
9861185|NCT00929838|10974323|FG001|COMPLETED|Overall Study||56
9861186|NCT00929838|10974324|FG002|COMPLETED|Overall Study||53
9861187|NCT00929838|10974325|FG003|COMPLETED|Overall Study||55
9861188|NCT00929838|10974322|FG000|NOT COMPLETED|Overall Study||10
9861189|NCT00929838|10974323|FG001|NOT COMPLETED|Overall Study||9
9861190|NCT00929838|10974324|FG002|NOT COMPLETED|Overall Study||10
9861191|NCT00929838|10974325|FG003|NOT COMPLETED|Overall Study||9
9861192|NCT00929864|10974337|FG000|STARTED|Overall Study||318
9861193|NCT00929864|10974338|FG001|STARTED|Overall Study||328
9861194|NCT00929864|10974337|FG000|COMPLETED|Overall Study||252
9861195|NCT00929864|10974338|FG001|COMPLETED|Overall Study||245
9861196|NCT00929864|10974337|FG000|NOT COMPLETED|Overall Study||66
9861197|NCT00929864|10974338|FG001|NOT COMPLETED|Overall Study||83
10093169|NCT02342886|11221778|FG001|COMPLETED|Overall Study||63
10093170|NCT02342886|11221779|FG002|COMPLETED|Overall Study||52
10093171|NCT02342886|11221780|FG003|COMPLETED|Overall Study||59
10093172|NCT02342886|11221781|FG004|COMPLETED|Overall Study||10
10093173|NCT02342886|11221777|FG000|NOT COMPLETED|Overall Study||8
10093174|NCT02342886|11221778|FG001|NOT COMPLETED|Overall Study||8
10093175|NCT02342886|11221779|FG002|NOT COMPLETED|Overall Study||15
10093176|NCT02342886|11221780|FG003|NOT COMPLETED|Overall Study||9
10093177|NCT02342886|11221781|FG004|NOT COMPLETED|Overall Study||3
10093178|NCT02343003|11221795|FG000|STARTED|Overall Study||76
10093179|NCT02343003|11221796|FG001|STARTED|Overall Study||75
10093180|NCT02343003|11221795|FG000|COMPLETED|Overall Study||58
10093181|NCT02343003|11221796|FG001|COMPLETED|Overall Study||68
10093182|NCT02343003|11221795|FG000|NOT COMPLETED|Overall Study||18
10093183|NCT02343003|11221796|FG001|NOT COMPLETED|Overall Study||7
10093184|NCT02343081|11221804|FG000|STARTED|First Intervention (Day 3)||8
10093185|NCT02343081|11221805|FG001|STARTED|First Intervention (Day 3)||8
10093186|NCT02343081|11221804|FG000|Received Intervention|First Intervention (Day 3)||8
10093187|NCT02343081|11221805|FG001|Received Intervention|First Intervention (Day 3)||8
10093188|NCT02343081|11221804|FG000|COMPLETED|First Intervention (Day 3)||8
10093189|NCT02343081|11221805|FG001|COMPLETED|First Intervention (Day 3)||8
10093190|NCT02343081|11221804|FG000|NOT COMPLETED|First Intervention (Day 3)||0
10093191|NCT02343081|11221805|FG001|NOT COMPLETED|First Intervention (Day 3)||0
9953282|NCT01425814|11072029|FG005|COMPLETED|Period 1||13
9953283|NCT01425814|11072024|FG000|NOT COMPLETED|Period 1||0
9953284|NCT01425814|11072025|FG001|NOT COMPLETED|Period 1||1
9953285|NCT01425814|11072026|FG002|NOT COMPLETED|Period 1||0
9953286|NCT01425814|11072027|FG003|NOT COMPLETED|Period 1||0
9953287|NCT01425814|11072028|FG004|NOT COMPLETED|Period 1||0
9953288|NCT01425814|11072029|FG005|NOT COMPLETED|Period 1||0
9953289|NCT01425814|11072024|FG000|STARTED|Period 2||12
9953290|NCT01425814|11072025|FG001|STARTED|Period 2||10
9953291|NCT01425814|11072026|FG002|STARTED|Period 2||12
9953292|NCT01425814|11072027|FG003|STARTED|Period 2||10
9953293|NCT01425814|11072028|FG004|STARTED|Period 2||12
9953294|NCT01425814|11072029|FG005|STARTED|Period 2||13
9953295|NCT01425814|11072024|FG000|COMPLETED|Period 2||12
9953296|NCT01425814|11072025|FG001|COMPLETED|Period 2||9
9953297|NCT01425814|11072026|FG002|COMPLETED|Period 2||12
9953298|NCT01425814|11072027|FG003|COMPLETED|Period 2||10
9953299|NCT01425814|11072028|FG004|COMPLETED|Period 2||12
9953300|NCT01425814|11072029|FG005|COMPLETED|Period 2||13
9953301|NCT01425814|11072024|FG000|NOT COMPLETED|Period 2||0
9953302|NCT01425814|11072025|FG001|NOT COMPLETED|Period 2||1
9953303|NCT01425814|11072026|FG002|NOT COMPLETED|Period 2||0
9953304|NCT01425814|11072027|FG003|NOT COMPLETED|Period 2||0
9953305|NCT01425814|11072028|FG004|NOT COMPLETED|Period 2||0
9953306|NCT01425814|11072029|FG005|NOT COMPLETED|Period 2||0
9953307|NCT01425814|11072024|FG000|STARTED|Period 3||12
9953308|NCT01425814|11072025|FG001|STARTED|Period 3||9
9861198|NCT00929981|10974344|FG000|STARTED|Overall Study||80
9861199|NCT00929981|10974344|FG000|COMPLETED|Overall Study||80
9861200|NCT00929981|10974344|FG000|NOT COMPLETED|Overall Study||0
9861201|NCT00929994|10974348|FG000|STARTED|Overall Study||20
9861202|NCT00929994|10974348|FG000|COMPLETED|Overall Study||14
9861203|NCT00929994|10974348|FG000|NOT COMPLETED|Overall Study||6
9861204|NCT00930046|10974357|FG000|STARTED|Overall Study||8
9861205|NCT00930046|10974358|FG001|STARTED|Overall Study||7
9861206|NCT00930046|10974357|FG000|COMPLETED|Overall Study||7
9861207|NCT00930046|10974358|FG001|COMPLETED|Overall Study||5
9861208|NCT00930046|10974357|FG000|NOT COMPLETED|Overall Study||1
9861209|NCT00930046|10974358|FG001|NOT COMPLETED|Overall Study||2
9861210|NCT00930059|10974366|FG000|STARTED|Overall Study||100
9861211|NCT00930059|10974367|FG001|STARTED|Overall Study||91
9861212|NCT00930059|10974366|FG000|COMPLETED|Overall Study||92
9861213|NCT00930059|10974367|FG001|COMPLETED|Overall Study||79
9861214|NCT00930059|10974366|FG000|NOT COMPLETED|Overall Study||8
9861215|NCT00930059|10974367|FG001|NOT COMPLETED|Overall Study||12
9861216|NCT00930176|10974373|FG000|STARTED|Overall Study||16
9861217|NCT00930176|10974373|FG000|COMPLETED|Overall Study||15
9861218|NCT00930176|10974373|FG000|NOT COMPLETED|Overall Study||1
9861219|NCT00930293|10974379|FG000|STARTED|Overall Study||24
9861220|NCT00930293|10974380|FG001|STARTED|Overall Study||26
9861221|NCT00930293|10974379|FG000|COMPLETED|Overall Study||17
9861222|NCT00930293|10974380|FG001|COMPLETED|Overall Study||19
9861223|NCT00930293|10974379|FG000|NOT COMPLETED|Overall Study||7
9861224|NCT00930293|10974380|FG001|NOT COMPLETED|Overall Study||7
9861225|NCT00930553|10974386|FG000|STARTED|Overall Study||1314
9861226|NCT00930553|10974386|FG000|Participants Entered From CAMMS223|Overall Study||141
9861227|NCT00930553|10974386|FG000|Participants Entered From CAMMS323|Overall Study||488
9861228|NCT00930553|10974386|FG000|Participants Entered From CAMMS324|Overall Study||685
9861229|NCT00930553|10974386|FG000|COMPLETED|Overall Study||1091
9861230|NCT00930553|10974386|FG000|NOT COMPLETED|Overall Study||223
9861231|NCT00930644|10974408|FG000|STARTED|Overall Study||88
9861232|NCT00930644|10974408|FG000|COMPLETED|Overall Study||65
9861233|NCT00930644|10974408|FG000|NOT COMPLETED|Overall Study||23
9861234|NCT00930761|10974417|FG000|STARTED|Overall Study||50
9861235|NCT00930761|10974418|FG001|STARTED|Overall Study||51
9861236|NCT00930761|10974417|FG000|COMPLETED|Overall Study||46
9861237|NCT00930761|10974418|FG001|COMPLETED|Overall Study||48
9861238|NCT00930761|10974417|FG000|NOT COMPLETED|Overall Study||4
9861239|NCT00930761|10974418|FG001|NOT COMPLETED|Overall Study||3
9861240|NCT00930774|10974428|FG000|STARTED|Overall Study||25
9861241|NCT00930774|10974429|FG001|STARTED|Overall Study||25
9861242|NCT00930774|10974430|FG002|STARTED|Overall Study||24
9861243|NCT00930774|10974431|FG003|STARTED|Overall Study||25
9861244|NCT00930774|10974428|FG000|COMPLETED|Overall Study||24
9861245|NCT00930774|10974429|FG001|COMPLETED|Overall Study||16
9861246|NCT00930774|10974430|FG002|COMPLETED|Overall Study||22
9861247|NCT00930774|10974431|FG003|COMPLETED|Overall Study||25
9861248|NCT00930774|10974428|FG000|NOT COMPLETED|Overall Study||1
9861249|NCT00930774|10974429|FG001|NOT COMPLETED|Overall Study||9
9861250|NCT00930774|10974430|FG002|NOT COMPLETED|Overall Study||2
9861251|NCT00930774|10974431|FG003|NOT COMPLETED|Overall Study||0
9861252|NCT00930813|10974444|FG000|STARTED|Overall Study||49
9861253|NCT00930813|10974445|FG001|STARTED|Overall Study||52
9861254|NCT00930813|10974444|FG000|COMPLETED|Overall Study||41
9861255|NCT00930813|10974445|FG001|COMPLETED|Overall Study||38
9861256|NCT00930813|10974444|FG000|NOT COMPLETED|Overall Study||8
9861257|NCT00930813|10974445|FG001|NOT COMPLETED|Overall Study||14
9861258|NCT00930930|10974455|FG000|STARTED|Overall Study||96
9861259|NCT00930930|10974456|FG001|STARTED|Overall Study||49
9861260|NCT00930930|10974455|FG000|COMPLETED|Overall Study||75
9861261|NCT00930930|10974456|FG001|COMPLETED|Overall Study||40
9861262|NCT00930930|10974455|FG000|NOT COMPLETED|Overall Study||21
9861263|NCT00930930|10974456|FG001|NOT COMPLETED|Overall Study||9
9861264|NCT00930969|10974462|FG000|STARTED|Overall Study||175
9861265|NCT00930969|10974462|FG000|COMPLETED|Overall Study||137
9861266|NCT00930969|10974462|FG000|NOT COMPLETED|Overall Study||38
9861267|NCT00930982|10974468|FG000|STARTED|Overall Study||60
9861268|NCT00930982|10974469|FG001|STARTED|Overall Study||64
9861269|NCT00930982|10974468|FG000|COMPLETED|Overall Study||39
9861270|NCT00930982|10974469|FG001|COMPLETED|Overall Study||35
9861271|NCT00930982|10974468|FG000|NOT COMPLETED|Overall Study||21
9861272|NCT00930982|10974469|FG001|NOT COMPLETED|Overall Study||29
9861273|NCT00931164|10974475|FG000|STARTED|Overall Study||6
9861274|NCT00931164|10974475|FG000|COMPLETED|Overall Study||6
9861275|NCT00931164|10974475|FG000|NOT COMPLETED|Overall Study||0
9861276|NCT00931242|10974481|FG000|STARTED|Overall Study||10
9861277|NCT00931242|10974482|FG001|STARTED|Overall Study||2
9861278|NCT00931242|10974481|FG000|COMPLETED|Overall Study||5
9861279|NCT00931242|10974482|FG001|COMPLETED|Overall Study||0
9861280|NCT00931242|10974481|FG000|NOT COMPLETED|Overall Study||5
9861281|NCT00931242|10974482|FG001|NOT COMPLETED|Overall Study||2
9861282|NCT00931268|10974486|FG000|STARTED|Overall Study||10
9861283|NCT00931268|10974486|FG000|COMPLETED|Overall Study||4
9861284|NCT00931268|10974486|FG000|NOT COMPLETED|Overall Study||6
9861285|NCT00931307|10974490|FG000|STARTED|Overall Study||22
9861286|NCT00931307|10974490|FG000|COMPLETED|Overall Study||9
9861287|NCT00931307|10974490|FG000|NOT COMPLETED|Overall Study||13
9861288|NCT00931359|10974496|FG000|STARTED|Overall Study||39
9861289|NCT00931359|10974497|FG001|STARTED|Overall Study||81
9861290|NCT00931359|10974496|FG000|COMPLETED|Overall Study||33
9861291|NCT00931359|10974497|FG001|COMPLETED|Overall Study||68
9861292|NCT00931359|10974496|FG000|NOT COMPLETED|Overall Study||6
9861293|NCT00931359|10974497|FG001|NOT COMPLETED|Overall Study||13
9861294|NCT00931385|10974503|FG000|STARTED|Overall Study||25
9861295|NCT00931385|10974504|FG001|STARTED|Overall Study||23
9861296|NCT00931385|10974505|FG002|STARTED|Overall Study||25
9861297|NCT00931385|10974506|FG003|STARTED|Overall Study||26
9861298|NCT00931385|10974503|FG000|COMPLETED|Overall Study||23
9861299|NCT00931385|10974504|FG001|COMPLETED|Overall Study||21
9861300|NCT00931385|10974505|FG002|COMPLETED|Overall Study||24
9861301|NCT00931385|10974506|FG003|COMPLETED|Overall Study||21
9861302|NCT00931385|10974503|FG000|NOT COMPLETED|Overall Study||2
9861303|NCT00931385|10974504|FG001|NOT COMPLETED|Overall Study||2
9861304|NCT00931385|10974505|FG002|NOT COMPLETED|Overall Study||1
9861305|NCT00931385|10974506|FG003|NOT COMPLETED|Overall Study||5
9861306|NCT00931411|10974522|FG000|STARTED|First Intervention - 42 Days||35
9861307|NCT00931411|10974523|FG001|STARTED|First Intervention - 42 Days||38
9861308|NCT00931411|10974522|FG000|COMPLETED|First Intervention - 42 Days||31
9861309|NCT00931411|10974523|FG001|COMPLETED|First Intervention - 42 Days||35
9861310|NCT00931411|10974522|FG000|NOT COMPLETED|First Intervention - 42 Days||4
9861311|NCT00931411|10974523|FG001|NOT COMPLETED|First Intervention - 42 Days||3
9861312|NCT00931411|10974522|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31
9861313|NCT00931411|10974523|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35
9861314|NCT00931411|10974522|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
9861315|NCT00931411|10974523|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
9861316|NCT00931411|10974522|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
9861317|NCT00931411|10974523|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
9861318|NCT00931463|10974535|FG000|STARTED|Overall Study||271
9861319|NCT00931463|10974536|FG001|STARTED|Overall Study||270
9861320|NCT00931463|10974535|FG000|COMPLETED|Overall Study||254
9861321|NCT00931463|10974536|FG001|COMPLETED|Overall Study||265
9861322|NCT00931463|10974535|FG000|NOT COMPLETED|Overall Study||17
9861323|NCT00931463|10974536|FG001|NOT COMPLETED|Overall Study||5
9861324|NCT00931489|10974547|FG000|STARTED|Overall Study||40
9861325|NCT00931489|10974548|FG001|STARTED|Overall Study||40
9861326|NCT00931489|10974549|FG002|STARTED|Overall Study||5
9861327|NCT00931489|10974550|FG003|STARTED|Overall Study||39
9861328|NCT00931489|10974551|FG004|STARTED|Overall Study||7
9861329|NCT00931489|10974547|FG000|COMPLETED|Overall Study||40
9861330|NCT00931489|10974548|FG001|COMPLETED|Overall Study||40
9861331|NCT00931489|10974549|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
9861332|NCT00931489|10974550|FG003|COMPLETED|Overall Study||39
9861333|NCT00931489|10974551|FG004|COMPLETED|Overall Study||7
9861334|NCT00931489|10974547|FG000|NOT COMPLETED|Overall Study||0
9861335|NCT00931489|10974548|FG001|NOT COMPLETED|Overall Study||0
9861336|NCT00931489|10974549|FG002|NOT COMPLETED|Overall Study||0
9861337|NCT00931489|10974550|FG003|NOT COMPLETED|Overall Study||0
9861338|NCT00931489|10974551|FG004|NOT COMPLETED|Overall Study||0
9861339|NCT00931515|10974564|FG000|STARTED|Overall Study||15
9861340|NCT00931515|10974565|FG001|STARTED|Overall Study||15
9861341|NCT00931515|10974564|FG000|COMPLETED|Overall Study||13
9861342|NCT00931515|10974565|FG001|COMPLETED|Overall Study||10
9861343|NCT00931515|10974564|FG000|NOT COMPLETED|Overall Study||2
9861344|NCT00931515|10974565|FG001|NOT COMPLETED|Overall Study||5
9861345|NCT00931528|10974573|FG000|STARTED|Overall Study||121
9861346|NCT00931528|10974574|FG001|STARTED|Overall Study||121
9861347|NCT00931528|10974573|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
9861348|NCT00931528|10974574|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
9861349|NCT00931528|10974573|FG000|NOT COMPLETED|Overall Study||41
9861350|NCT00931528|10974574|FG001|NOT COMPLETED|Overall Study||60
9861351|NCT00931632|10974583|FG000|STARTED|Overall Study|Randomized|229
9861352|NCT00931632|10974584|FG001|STARTED|Overall Study|Randomized|222
9953309|NCT01425814|11072026|FG002|STARTED|Period 3||12
9861353|NCT00931632|10974583|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
9861354|NCT00931632|10974584|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
9861355|NCT00931632|10974583|FG000|NOT COMPLETED|Overall Study||21
9861356|NCT00931632|10974584|FG001|NOT COMPLETED|Overall Study||18
9861357|NCT00931710|10974592|FG000|STARTED|Overall Study||241
9861358|NCT00931710|10974593|FG001|STARTED|Overall Study||247
9861359|NCT00931710|10974592|FG000|COMPLETED|Overall Study||207
9861360|NCT00931710|10974593|FG001|COMPLETED|Overall Study||209
9861361|NCT00931710|10974592|FG000|NOT COMPLETED|Overall Study||34
9861362|NCT00931710|10974593|FG001|NOT COMPLETED|Overall Study||38
9861363|NCT00931723|10974601|FG000|STARTED|Overall Study||173
9861364|NCT00931723|10974602|FG001|STARTED|Overall Study||183
9861365|NCT00931723|10974601|FG000|COMPLETED|Overall Study||147
9861366|NCT00931723|10974602|FG001|COMPLETED|Overall Study||144
9861367|NCT00931723|10974601|FG000|NOT COMPLETED|Overall Study||26
9861368|NCT00931723|10974602|FG001|NOT COMPLETED|Overall Study||39
9861369|NCT00931762|10974608|FG000|STARTED|Overall Study||35
9861370|NCT00931762|10974608|FG000|COMPLETED|Overall Study||0
9861371|NCT00931762|10974608|FG000|NOT COMPLETED|Overall Study||35
9861372|NCT00931801|10974615|FG000|STARTED|Overall Study||14
9861373|NCT00931801|10974616|FG001|STARTED|Overall Study||15
9861374|NCT00931801|10974617|FG002|STARTED|Overall Study||14
9861375|NCT00931801|10974615|FG000|COMPLETED|Overall Study||13
9861376|NCT00931801|10974616|FG001|COMPLETED|Overall Study||14
9861377|NCT00931801|10974617|FG002|COMPLETED|Overall Study||10
9861378|NCT00931801|10974615|FG000|NOT COMPLETED|Overall Study||1
9861379|NCT00931801|10974616|FG001|NOT COMPLETED|Overall Study||1
9861380|NCT00931801|10974617|FG002|NOT COMPLETED|Overall Study||4
9861381|NCT00931879|10974631|FG000|STARTED|Overall Study||22
9861382|NCT00931879|10974632|FG001|STARTED|Overall Study||22
9861383|NCT00931879|10974631|FG000|COMPLETED|Overall Study||19
9861384|NCT00931879|10974632|FG001|COMPLETED|Overall Study||19
9861385|NCT00931879|10974631|FG000|NOT COMPLETED|Overall Study||3
9861386|NCT00931879|10974632|FG001|NOT COMPLETED|Overall Study||3
9861387|NCT00931892|10974641|FG000|STARTED|Completed Gluten Challenge||10
9861388|NCT00931892|10974642|FG001|STARTED|Completed Gluten Challenge||10
9861389|NCT00931892|10974641|FG000|COMPLETED|Completed Gluten Challenge||10
9861390|NCT00931892|10974642|FG001|COMPLETED|Completed Gluten Challenge||10
9861391|NCT00931892|10974641|FG000|NOT COMPLETED|Completed Gluten Challenge||0
9861392|NCT00931892|10974642|FG001|NOT COMPLETED|Completed Gluten Challenge||0
9861393|NCT00931892|10974641|FG000|STARTED|Completed Endoscopies||10
9861394|NCT00931892|10974642|FG001|STARTED|Completed Endoscopies||10
9861395|NCT00931892|10974641|FG000|First Endoscopy|Completed Endoscopies||10
9861396|NCT00931892|10974642|FG001|First Endoscopy|Completed Endoscopies||10
9861397|NCT00931892|10974641|FG000|Second Endoscopy|Completed Endoscopies||10
9861398|NCT00931892|10974642|FG001|Second Endoscopy|Completed Endoscopies||10
9861399|NCT00931892|10974641|FG000|Third Endoscopy|Completed Endoscopies||10
9861400|NCT00931892|10974642|FG001|Third Endoscopy|Completed Endoscopies||9
9861401|NCT00931892|10974641|FG000|COMPLETED|Completed Endoscopies||10
9861402|NCT00931892|10974642|FG001|COMPLETED|Completed Endoscopies||9
9861403|NCT00931892|10974641|FG000|NOT COMPLETED|Completed Endoscopies||0
9861404|NCT00931892|10974642|FG001|NOT COMPLETED|Completed Endoscopies||1
9861405|NCT00931918|10974690|FG000|STARTED|Overall Study||103
9861406|NCT00931918|10974691|FG001|STARTED|Overall Study||103
9861407|NCT00931918|10974690|FG000|Safety Population: Received Study Drug|Overall Study||100
9861408|NCT00931918|10974691|FG001|Safety Population: Received Study Drug|Overall Study||101
9861409|NCT00931918|10974690|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
9861410|NCT00931918|10974691|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
9861411|NCT00931918|10974690|FG000|NOT COMPLETED|Overall Study||17
9861412|NCT00931918|10974691|FG001|NOT COMPLETED|Overall Study||17
9861413|NCT00931944|10974697|FG000|STARTED|Overall Study||74
9861414|NCT00931944|10974697|FG000|COMPLETED|Overall Study||19
9861415|NCT00931944|10974697|FG000|NOT COMPLETED|Overall Study||55
9861416|NCT00931996|10974701|FG000|STARTED|Overall Study||12
9861417|NCT00931996|10974701|FG000|COMPLETED|Overall Study||5
9861418|NCT00931996|10974701|FG000|NOT COMPLETED|Overall Study||7
9861419|NCT00932022|10974707|FG000|STARTED|Overall Study||64
9861420|NCT00932022|10974708|FG001|STARTED|Overall Study||63
9861421|NCT00932022|10974707|FG000|COMPLETED|Overall Study||59
9861422|NCT00932022|10974708|FG001|COMPLETED|Overall Study||59
9861423|NCT00932022|10974707|FG000|NOT COMPLETED|Overall Study||5
10093192|NCT02343081|11221804|FG000|STARTED|Washout (10 Hours)||8
10093193|NCT02343081|11221805|FG001|STARTED|Washout (10 Hours)||8
10093194|NCT02343081|11221804|FG000|COMPLETED|Washout (10 Hours)||8
10093195|NCT02343081|11221805|FG001|COMPLETED|Washout (10 Hours)||8
9861424|NCT00932022|10974708|FG001|NOT COMPLETED|Overall Study||4
9861425|NCT00932035|10974716|FG000|STARTED|Overall Study||18
10093196|NCT02343081|11221804|FG000|NOT COMPLETED|Washout (10 Hours)||0
9861426|NCT00932035|10974717|FG001|STARTED|Overall Study||21
9861427|NCT00932035|10974716|FG000|COMPLETED|Overall Study||18
9861428|NCT00932035|10974717|FG001|COMPLETED|Overall Study||21
9861429|NCT00932035|10974716|FG000|NOT COMPLETED|Overall Study||0
9861430|NCT00932035|10974717|FG001|NOT COMPLETED|Overall Study||0
9861431|NCT00932113|10974725|FG000|STARTED|Overall Study||15
9861432|NCT00932113|10974726|FG001|STARTED|Overall Study||15
9861433|NCT00932113|10974725|FG000|COMPLETED|Overall Study||14
9861434|NCT00932113|10974726|FG001|COMPLETED|Overall Study||15
9861435|NCT00932113|10974725|FG000|NOT COMPLETED|Overall Study||1
9861436|NCT00932113|10974726|FG001|NOT COMPLETED|Overall Study||0
9861437|NCT00932126|10974732|FG000|STARTED|Overall Study||3
9861438|NCT00932126|10974733|FG001|STARTED|Overall Study||3
9861439|NCT00932126|10974734|FG002|STARTED|Overall Study||3
9861440|NCT00932126|10974735|FG003|STARTED|Overall Study||3
9861441|NCT00932126|10974736|FG004|STARTED|Overall Study||5
9861442|NCT00932126|10974737|FG005|STARTED|Overall Study||3
9861443|NCT00932126|10974738|FG006|STARTED|Overall Study||5
9861444|NCT00932126|10974739|FG007|STARTED|Overall Study||10
9861445|NCT00932126|10974732|FG000|COMPLETED|Overall Study||0
9861446|NCT00932126|10974733|FG001|COMPLETED|Overall Study||0
9861447|NCT00932126|10974734|FG002|COMPLETED|Overall Study||0
9861448|NCT00932126|10974735|FG003|COMPLETED|Overall Study||0
9861449|NCT00932126|10974736|FG004|COMPLETED|Overall Study||0
9861450|NCT00932126|10974737|FG005|COMPLETED|Overall Study||0
9861451|NCT00932126|10974738|FG006|COMPLETED|Overall Study||0
9861452|NCT00932126|10974739|FG007|COMPLETED|Overall Study||0
9861453|NCT00932126|10974732|FG000|NOT COMPLETED|Overall Study||3
9861454|NCT00932126|10974733|FG001|NOT COMPLETED|Overall Study||3
9861455|NCT00932126|10974734|FG002|NOT COMPLETED|Overall Study||3
9861456|NCT00932126|10974735|FG003|NOT COMPLETED|Overall Study||3
9861457|NCT00932126|10974736|FG004|NOT COMPLETED|Overall Study||5
9861458|NCT00932126|10974737|FG005|NOT COMPLETED|Overall Study||3
9861459|NCT00932126|10974738|FG006|NOT COMPLETED|Overall Study||5
9861460|NCT00932126|10974739|FG007|NOT COMPLETED|Overall Study||10
9861461|NCT00932165|10974759|FG000|STARTED|Overall Study||451
9861462|NCT00932165|10974759|FG000|COMPLETED|Overall Study||450
9861463|NCT00932165|10974759|FG000|NOT COMPLETED|Overall Study||1
9861464|NCT00932282|10974766|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
9861465|NCT00932282|10974767|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
9861466|NCT00932282|10974766|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
9861467|NCT00932282|10974767|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
9861468|NCT00932282|10974766|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
9861469|NCT00932282|10974767|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
9861470|NCT00932282|10974766|FG000|STARTED|Modified OIT Rush Desensitization Phase||6
9861471|NCT00932282|10974767|FG001|STARTED|Modified OIT Rush Desensitization Phase||5
9861472|NCT00932282|10974766|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6
9861473|NCT00932282|10974767|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5
9861474|NCT00932282|10974766|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
9861475|NCT00932282|10974767|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
9861476|NCT00932282|10974766|FG000|STARTED|Biweekly OIT Buildup Phase||6
9861477|NCT00932282|10974767|FG001|STARTED|Biweekly OIT Buildup Phase||5
9861478|NCT00932282|10974766|FG000|COMPLETED|Biweekly OIT Buildup Phase||5
9861479|NCT00932282|10974767|FG001|COMPLETED|Biweekly OIT Buildup Phase||4
9861480|NCT00932282|10974766|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1
9861481|NCT00932282|10974767|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1
9861482|NCT00932282|10974766|FG000|STARTED|OIT Maintenance Phase||5
9861483|NCT00932282|10974767|FG001|STARTED|OIT Maintenance Phase||4
9861484|NCT00932282|10974766|FG000|COMPLETED|OIT Maintenance Phase||4
9861485|NCT00932282|10974767|FG001|COMPLETED|OIT Maintenance Phase||2
9861486|NCT00932282|10974766|FG000|NOT COMPLETED|OIT Maintenance Phase||1
9861487|NCT00932282|10974767|FG001|NOT COMPLETED|OIT Maintenance Phase||2
9861488|NCT00932321|10974775|FG000|STARTED|Overall Study||751
9861489|NCT00932321|10974776|FG001|STARTED|Overall Study||187
9861490|NCT00932321|10974775|FG000|MITT Population|Overall Study||705
9861491|NCT00932321|10974776|FG001|MITT Population|Overall Study||181
9861492|NCT00932321|10974775|FG000|COMPLETED|Overall Study||580
9861493|NCT00932321|10974776|FG001|COMPLETED|Overall Study||141
9861494|NCT00932321|10974775|FG000|NOT COMPLETED|Overall Study||171
9861495|NCT00932321|10974776|FG001|NOT COMPLETED|Overall Study||46
9861496|NCT00932360|10974782|FG000|STARTED|1: Visit 1/Week1||10
9861497|NCT00932360|10974783|FG001|STARTED|1: Visit 1/Week1||6
9861498|NCT00932360|10974784|FG002|STARTED|1: Visit 1/Week1||3
9861499|NCT00932360|10974785|FG003|STARTED|1: Visit 1/Week1||13
9861500|NCT00932360|10974786|FG004|STARTED|1: Visit 1/Week1||4
9861501|NCT00932360|10974787|FG005|STARTED|1: Visit 1/Week1||7
9861502|NCT00932360|10974782|FG000|COMPLETED|1: Visit 1/Week1||10
9861503|NCT00932360|10974783|FG001|COMPLETED|1: Visit 1/Week1||6
9861504|NCT00932360|10974784|FG002|COMPLETED|1: Visit 1/Week1||3
9861505|NCT00932360|10974785|FG003|COMPLETED|1: Visit 1/Week1||13
9861506|NCT00932360|10974786|FG004|COMPLETED|1: Visit 1/Week1||4
9861507|NCT00932360|10974787|FG005|COMPLETED|1: Visit 1/Week1||7
9861508|NCT00932360|10974782|FG000|NOT COMPLETED|1: Visit 1/Week1||0
9861509|NCT00932360|10974783|FG001|NOT COMPLETED|1: Visit 1/Week1||0
9861510|NCT00932360|10974784|FG002|NOT COMPLETED|1: Visit 1/Week1||0
9861511|NCT00932360|10974785|FG003|NOT COMPLETED|1: Visit 1/Week1||0
9861512|NCT00932360|10974786|FG004|NOT COMPLETED|1: Visit 1/Week1||0
9861513|NCT00932360|10974787|FG005|NOT COMPLETED|1: Visit 1/Week1||0
9861514|NCT00932360|10974782|FG000|STARTED|Washout (One Week)||10
9861515|NCT00932360|10974783|FG001|STARTED|Washout (One Week)||6
9861516|NCT00932360|10974784|FG002|STARTED|Washout (One Week)||3
9861517|NCT00932360|10974785|FG003|STARTED|Washout (One Week)||13
9861518|NCT00932360|10974786|FG004|STARTED|Washout (One Week)||4
9861519|NCT00932360|10974787|FG005|STARTED|Washout (One Week)||7
9861520|NCT00932360|10974782|FG000|COMPLETED|Washout (One Week)||10
9861521|NCT00932360|10974783|FG001|COMPLETED|Washout (One Week)||6
9861522|NCT00932360|10974784|FG002|COMPLETED|Washout (One Week)||3
9861523|NCT00932360|10974785|FG003|COMPLETED|Washout (One Week)||13
9861524|NCT00932360|10974786|FG004|COMPLETED|Washout (One Week)||2
9861525|NCT00932360|10974787|FG005|COMPLETED|Washout (One Week)||7
9861526|NCT00932360|10974782|FG000|NOT COMPLETED|Washout (One Week)||0
9861527|NCT00932360|10974783|FG001|NOT COMPLETED|Washout (One Week)||0
9861528|NCT00932360|10974784|FG002|NOT COMPLETED|Washout (One Week)||0
9861529|NCT00932360|10974785|FG003|NOT COMPLETED|Washout (One Week)||0
9861530|NCT00932360|10974786|FG004|NOT COMPLETED|Washout (One Week)||2
9861531|NCT00932360|10974787|FG005|NOT COMPLETED|Washout (One Week)||0
9861532|NCT00932360|10974782|FG000|STARTED|Visit 2/Week 2||10
9861533|NCT00932360|10974783|FG001|STARTED|Visit 2/Week 2||6
9861534|NCT00932360|10974784|FG002|STARTED|Visit 2/Week 2||3
9861535|NCT00932360|10974785|FG003|STARTED|Visit 2/Week 2||13
9861536|NCT00932360|10974786|FG004|STARTED|Visit 2/Week 2||2
9861537|NCT00932360|10974787|FG005|STARTED|Visit 2/Week 2||7
9861538|NCT00932360|10974782|FG000|COMPLETED|Visit 2/Week 2||10
9861539|NCT00932360|10974783|FG001|COMPLETED|Visit 2/Week 2||6
9861540|NCT00932360|10974784|FG002|COMPLETED|Visit 2/Week 2||3
9861541|NCT00932360|10974785|FG003|COMPLETED|Visit 2/Week 2||13
9861542|NCT00932360|10974786|FG004|COMPLETED|Visit 2/Week 2||2
9861543|NCT00932360|10974787|FG005|COMPLETED|Visit 2/Week 2||7
9861544|NCT00932360|10974782|FG000|NOT COMPLETED|Visit 2/Week 2||0
9861545|NCT00932360|10974783|FG001|NOT COMPLETED|Visit 2/Week 2||0
9861546|NCT00932360|10974784|FG002|NOT COMPLETED|Visit 2/Week 2||0
9861547|NCT00932360|10974785|FG003|NOT COMPLETED|Visit 2/Week 2||0
9861548|NCT00932360|10974786|FG004|NOT COMPLETED|Visit 2/Week 2||0
9861549|NCT00932360|10974787|FG005|NOT COMPLETED|Visit 2/Week 2||0
9861550|NCT00932360|10974782|FG000|STARTED|Washout (One Week)||10
9861551|NCT00932360|10974783|FG001|STARTED|Washout (One Week)||6
9861552|NCT00932360|10974784|FG002|STARTED|Washout (One Week)||3
9861553|NCT00932360|10974785|FG003|STARTED|Washout (One Week)||13
9861554|NCT00932360|10974786|FG004|STARTED|Washout (One Week)||2
9861555|NCT00932360|10974787|FG005|STARTED|Washout (One Week)||7
9861556|NCT00932360|10974782|FG000|COMPLETED|Washout (One Week)||10
9861557|NCT00932360|10974783|FG001|COMPLETED|Washout (One Week)||6
9861558|NCT00932360|10974784|FG002|COMPLETED|Washout (One Week)||3
9861559|NCT00932360|10974785|FG003|COMPLETED|Washout (One Week)||13
9861560|NCT00932360|10974786|FG004|COMPLETED|Washout (One Week)||2
9861561|NCT00932360|10974787|FG005|COMPLETED|Washout (One Week)||7
9861562|NCT00932360|10974782|FG000|NOT COMPLETED|Washout (One Week)||0
9861563|NCT00932360|10974783|FG001|NOT COMPLETED|Washout (One Week)||0
9861564|NCT00932360|10974784|FG002|NOT COMPLETED|Washout (One Week)||0
9861565|NCT00932360|10974785|FG003|NOT COMPLETED|Washout (One Week)||0
9861566|NCT00932360|10974786|FG004|NOT COMPLETED|Washout (One Week)||0
9861567|NCT00932360|10974787|FG005|NOT COMPLETED|Washout (One Week)||0
9861568|NCT00932360|10974782|FG000|STARTED|Visit 3/Week 3||10
9861569|NCT00932360|10974783|FG001|STARTED|Visit 3/Week 3||6
9861570|NCT00932360|10974784|FG002|STARTED|Visit 3/Week 3||3
9861571|NCT00932360|10974785|FG003|STARTED|Visit 3/Week 3||13
9861572|NCT00932360|10974786|FG004|STARTED|Visit 3/Week 3||2
9861573|NCT00932360|10974787|FG005|STARTED|Visit 3/Week 3||7
9861574|NCT00932360|10974782|FG000|COMPLETED|Visit 3/Week 3||10
9861575|NCT00932360|10974783|FG001|COMPLETED|Visit 3/Week 3||6
9861576|NCT00932360|10974784|FG002|COMPLETED|Visit 3/Week 3||3
9861577|NCT00932360|10974785|FG003|COMPLETED|Visit 3/Week 3||13
9861578|NCT00932360|10974786|FG004|COMPLETED|Visit 3/Week 3||2
9861579|NCT00932360|10974787|FG005|COMPLETED|Visit 3/Week 3||7
9861580|NCT00932360|10974782|FG000|NOT COMPLETED|Visit 3/Week 3||0
9861581|NCT00932360|10974783|FG001|NOT COMPLETED|Visit 3/Week 3||0
9861582|NCT00932360|10974784|FG002|NOT COMPLETED|Visit 3/Week 3||0
9861583|NCT00932360|10974785|FG003|NOT COMPLETED|Visit 3/Week 3||0
9861584|NCT00932360|10974786|FG004|NOT COMPLETED|Visit 3/Week 3||0
9861585|NCT00932360|10974787|FG005|NOT COMPLETED|Visit 3/Week 3||0
9861586|NCT00932373|10974812|FG000|STARTED|Overall Study||3
9861587|NCT00932373|10974813|FG001|STARTED|Overall Study||1
10093197|NCT02343081|11221805|FG001|NOT COMPLETED|Washout (10 Hours)||0
10093198|NCT02343081|11221804|FG000|STARTED|Second Intervention (Day 4)||8
10093199|NCT02343081|11221805|FG001|STARTED|Second Intervention (Day 4)||8
10093200|NCT02343081|11221804|FG000|Received Intervention|Second Intervention (Day 4)||8
10093201|NCT02343081|11221805|FG001|Received Intervention|Second Intervention (Day 4)||8
10093202|NCT02343081|11221804|FG000|COMPLETED|Second Intervention (Day 4)||8
10093203|NCT02343081|11221805|FG001|COMPLETED|Second Intervention (Day 4)||8
10093204|NCT02343081|11221804|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
10093205|NCT02343081|11221805|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
10093206|NCT02343276|11221813|FG000|STARTED|Overall Study||164
10093207|NCT02343276|11221814|FG001|STARTED|Overall Study||164
9861588|NCT00932373|10974814|FG002|STARTED|Overall Study||1
9861589|NCT00932373|10974815|FG003|STARTED|Overall Study||1
9861590|NCT00932373|10974816|FG004|STARTED|Overall Study||15
9861591|NCT00932373|10974817|FG005|STARTED|Overall Study||3
9861592|NCT00932373|10974818|FG006|STARTED|Overall Study||3
9861593|NCT00932373|10974819|FG007|STARTED|Overall Study||3
9861594|NCT00932373|10974820|FG008|STARTED|Overall Study||3
9861595|NCT00932373|10974821|FG009|STARTED|Overall Study||16
9861596|NCT00932373|10974822|FG010|STARTED|Overall Study||3
9861597|NCT00932373|10974812|FG000|COMPLETED|Overall Study||0
9861598|NCT00932373|10974813|FG001|COMPLETED|Overall Study||0
9861599|NCT00932373|10974814|FG002|COMPLETED|Overall Study||0
9861600|NCT00932373|10974815|FG003|COMPLETED|Overall Study||1
9861601|NCT00932373|10974816|FG004|COMPLETED|Overall Study||1
9861602|NCT00932373|10974817|FG005|COMPLETED|Overall Study||0
9861603|NCT00932373|10974818|FG006|COMPLETED|Overall Study||2
9861604|NCT00932373|10974819|FG007|COMPLETED|Overall Study||0
9861605|NCT00932373|10974820|FG008|COMPLETED|Overall Study||1
9861606|NCT00932373|10974821|FG009|COMPLETED|Overall Study||3
9861607|NCT00932373|10974822|FG010|COMPLETED|Overall Study||0
9861608|NCT00932373|10974812|FG000|NOT COMPLETED|Overall Study||3
9861609|NCT00932373|10974813|FG001|NOT COMPLETED|Overall Study||1
9861610|NCT00932373|10974814|FG002|NOT COMPLETED|Overall Study||1
9861611|NCT00932373|10974815|FG003|NOT COMPLETED|Overall Study||0
9861612|NCT00932373|10974816|FG004|NOT COMPLETED|Overall Study||14
9861613|NCT00932373|10974817|FG005|NOT COMPLETED|Overall Study||3
9861614|NCT00932373|10974818|FG006|NOT COMPLETED|Overall Study||1
9861615|NCT00932373|10974819|FG007|NOT COMPLETED|Overall Study||3
9861616|NCT00932373|10974820|FG008|NOT COMPLETED|Overall Study||2
9861617|NCT00932373|10974821|FG009|NOT COMPLETED|Overall Study||13
9861618|NCT00932373|10974822|FG010|NOT COMPLETED|Overall Study||3
9861619|NCT00932399|10974856|FG000|STARTED|Overall Study||759
9861620|NCT00932399|10974857|FG001|STARTED|Overall Study||3790
9861621|NCT00932399|10974856|FG000|COMPLETED|Overall Study||759
9861622|NCT00932399|10974857|FG001|COMPLETED|Overall Study||3790
9861623|NCT00932399|10974856|FG000|NOT COMPLETED|Overall Study||0
9861624|NCT00932399|10974857|FG001|NOT COMPLETED|Overall Study||0
9861625|NCT00932425|10974865|FG000|STARTED|Overall Study||20
9861626|NCT00932425|10974866|FG001|STARTED|Overall Study||20
9861627|NCT00932425|10974865|FG000|COMPLETED|Overall Study||20
9861628|NCT00932425|10974866|FG001|COMPLETED|Overall Study||18
9861629|NCT00932425|10974865|FG000|NOT COMPLETED|Overall Study||0
9861630|NCT00932425|10974866|FG001|NOT COMPLETED|Overall Study||2
9861631|NCT00932438|10974874|FG000|STARTED|Overall Study||40
9861632|NCT00932438|10974875|FG001|STARTED|Overall Study||30
9861633|NCT00932438|10974874|FG000|COMPLETED|Overall Study||39
9861634|NCT00932438|10974875|FG001|COMPLETED|Overall Study||30
9861635|NCT00932438|10974874|FG000|NOT COMPLETED|Overall Study||1
9861636|NCT00932438|10974875|FG001|NOT COMPLETED|Overall Study||0
9861637|NCT00932451|10974883|FG000|STARTED|Overall Study||1066
9861638|NCT00932451|10974883|FG000|COMPLETED|Overall Study||244
9861639|NCT00932451|10974883|FG000|NOT COMPLETED|Overall Study||822
9861640|NCT00932477|10974891|FG000|STARTED|Treatment 1||7
9861641|NCT00932477|10974892|FG001|STARTED|Treatment 1||8
9861642|NCT00932477|10974893|FG002|STARTED|Treatment 1||9
9861643|NCT00932477|10974894|FG003|STARTED|Treatment 1||7
9861644|NCT00932477|10974895|FG004|STARTED|Treatment 1||8
9861645|NCT00932477|10974896|FG005|STARTED|Treatment 1||8
9861646|NCT00932477|10974891|FG000|COMPLETED|Treatment 1||7
9861647|NCT00932477|10974892|FG001|COMPLETED|Treatment 1||8
9861648|NCT00932477|10974893|FG002|COMPLETED|Treatment 1||9
9861649|NCT00932477|10974894|FG003|COMPLETED|Treatment 1||7
9861650|NCT00932477|10974895|FG004|COMPLETED|Treatment 1||8
9861651|NCT00932477|10974896|FG005|COMPLETED|Treatment 1||8
9861652|NCT00932477|10974891|FG000|NOT COMPLETED|Treatment 1||0
9861653|NCT00932477|10974892|FG001|NOT COMPLETED|Treatment 1||0
9861654|NCT00932477|10974893|FG002|NOT COMPLETED|Treatment 1||0
9861655|NCT00932477|10974894|FG003|NOT COMPLETED|Treatment 1||0
9861656|NCT00932477|10974895|FG004|NOT COMPLETED|Treatment 1||0
9861657|NCT00932477|10974896|FG005|NOT COMPLETED|Treatment 1||0
9861658|NCT00932477|10974891|FG000|STARTED|Treatment 2||7
9861659|NCT00932477|10974892|FG001|STARTED|Treatment 2||8
9861660|NCT00932477|10974893|FG002|STARTED|Treatment 2||9
9861661|NCT00932477|10974894|FG003|STARTED|Treatment 2||7
9861662|NCT00932477|10974895|FG004|STARTED|Treatment 2||8
9861663|NCT00932477|10974896|FG005|STARTED|Treatment 2||8
9861664|NCT00932477|10974891|FG000|COMPLETED|Treatment 2||7
9861665|NCT00932477|10974892|FG001|COMPLETED|Treatment 2||8
9861666|NCT00932477|10974893|FG002|COMPLETED|Treatment 2||9
9861667|NCT00932477|10974894|FG003|COMPLETED|Treatment 2||7
9861668|NCT00932477|10974895|FG004|COMPLETED|Treatment 2||8
9861669|NCT00932477|10974896|FG005|COMPLETED|Treatment 2||8
9861670|NCT00932477|10974891|FG000|NOT COMPLETED|Treatment 2||0
9861671|NCT00932477|10974892|FG001|NOT COMPLETED|Treatment 2||0
9861672|NCT00932477|10974893|FG002|NOT COMPLETED|Treatment 2||0
9861673|NCT00932477|10974894|FG003|NOT COMPLETED|Treatment 2||0
9861674|NCT00932477|10974895|FG004|NOT COMPLETED|Treatment 2||0
9861675|NCT00932477|10974896|FG005|NOT COMPLETED|Treatment 2||0
9861676|NCT00932477|10974891|FG000|STARTED|Treatment 3||7
9861677|NCT00932477|10974892|FG001|STARTED|Treatment 3||8
9861678|NCT00932477|10974893|FG002|STARTED|Treatment 3||9
9861679|NCT00932477|10974894|FG003|STARTED|Treatment 3||7
9861680|NCT00932477|10974895|FG004|STARTED|Treatment 3||8
9861681|NCT00932477|10974896|FG005|STARTED|Treatment 3||8
9861682|NCT00932477|10974891|FG000|COMPLETED|Treatment 3||7
9861683|NCT00932477|10974892|FG001|COMPLETED|Treatment 3||8
9861684|NCT00932477|10974893|FG002|COMPLETED|Treatment 3||9
9861685|NCT00932477|10974894|FG003|COMPLETED|Treatment 3||7
9861686|NCT00932477|10974895|FG004|COMPLETED|Treatment 3||8
9861687|NCT00932477|10974896|FG005|COMPLETED|Treatment 3||8
9861688|NCT00932477|10974891|FG000|NOT COMPLETED|Treatment 3||0
9861689|NCT00932477|10974892|FG001|NOT COMPLETED|Treatment 3||0
9861690|NCT00932477|10974893|FG002|NOT COMPLETED|Treatment 3||0
9861691|NCT00932477|10974894|FG003|NOT COMPLETED|Treatment 3||0
9861692|NCT00932477|10974895|FG004|NOT COMPLETED|Treatment 3||0
9861693|NCT00932477|10974896|FG005|NOT COMPLETED|Treatment 3||0
9861694|NCT00932620|10974906|FG000|STARTED|Overall Study||50
9861695|NCT00932620|10974907|FG001|STARTED|Overall Study||50
9861696|NCT00932620|10974906|FG000|COMPLETED|Overall Study||50
9861697|NCT00932620|10974907|FG001|COMPLETED|Overall Study||50
9861698|NCT00932620|10974906|FG000|NOT COMPLETED|Overall Study||0
9861699|NCT00932620|10974907|FG001|NOT COMPLETED|Overall Study||0
9861700|NCT00932646|10974915|FG000|STARTED|Overall Study||25
9861701|NCT00932646|10974916|FG001|STARTED|Overall Study||25
9861702|NCT00932646|10974917|FG002|STARTED|Overall Study||25
9861703|NCT00932646|10974918|FG003|STARTED|Overall Study||25
9861704|NCT00932646|10974915|FG000|COMPLETED|Overall Study||20
9861705|NCT00932646|10974916|FG001|COMPLETED|Overall Study||22
9861706|NCT00932646|10974917|FG002|COMPLETED|Overall Study||21
9861707|NCT00932646|10974918|FG003|COMPLETED|Overall Study||24
9861708|NCT00932646|10974915|FG000|NOT COMPLETED|Overall Study||5
9861709|NCT00932646|10974916|FG001|NOT COMPLETED|Overall Study||3
9861710|NCT00932646|10974917|FG002|NOT COMPLETED|Overall Study||4
9861711|NCT00932646|10974918|FG003|NOT COMPLETED|Overall Study||1
9861712|NCT00932659|10974932|FG000|STARTED|Overall Study||8
9861713|NCT00932659|10974932|FG000|COMPLETED|Overall Study||8
9861714|NCT00932659|10974932|FG000|NOT COMPLETED|Overall Study||0
9861715|NCT00932698|10974947|FG000|STARTED|Part 1 (Dose Escalation)||3
9861716|NCT00932698|10974948|FG001|STARTED|Part 1 (Dose Escalation)||3
9861717|NCT00932698|10974949|FG002|STARTED|Part 1 (Dose Escalation)||3
9861718|NCT00932698|10974950|FG003|STARTED|Part 1 (Dose Escalation)||3
9861719|NCT00932698|10974951|FG004|STARTED|Part 1 (Dose Escalation)||3
9861720|NCT00932698|10974952|FG005|STARTED|Part 1 (Dose Escalation)||7
9861721|NCT00932698|10974953|FG006|STARTED|Part 1 (Dose Escalation)||4
9861722|NCT00932698|10974954|FG007|STARTED|Part 1 (Dose Escalation)||0
9861723|NCT00932698|10974955|FG008|STARTED|Part 1 (Dose Escalation)||0
9861724|NCT00932698|10974956|FG009|STARTED|Part 1 (Dose Escalation)||0
9861725|NCT00932698|10974957|FG010|STARTED|Part 1 (Dose Escalation)||0
9861726|NCT00932698|10974947|FG000|COMPLETED|Part 1 (Dose Escalation)||0
9861727|NCT00932698|10974948|FG001|COMPLETED|Part 1 (Dose Escalation)||0
9861728|NCT00932698|10974949|FG002|COMPLETED|Part 1 (Dose Escalation)||0
9861729|NCT00932698|10974950|FG003|COMPLETED|Part 1 (Dose Escalation)||0
9861730|NCT00932698|10974951|FG004|COMPLETED|Part 1 (Dose Escalation)||0
9861731|NCT00932698|10974952|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
9861732|NCT00932698|10974953|FG006|COMPLETED|Part 1 (Dose Escalation)||0
9861733|NCT00932698|10974954|FG007|COMPLETED|Part 1 (Dose Escalation)||0
9861734|NCT00932698|10974955|FG008|COMPLETED|Part 1 (Dose Escalation)||0
9861735|NCT00932698|10974956|FG009|COMPLETED|Part 1 (Dose Escalation)||0
10093208|NCT02343276|11221813|FG000|COMPLETED|Overall Study||164
10093209|NCT02343276|11221814|FG001|COMPLETED|Overall Study||164
9861736|NCT00932698|10974957|FG010|COMPLETED|Part 1 (Dose Escalation)||0
9861737|NCT00932698|10974947|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3
9861738|NCT00932698|10974948|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3
9861739|NCT00932698|10974949|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3
9861740|NCT00932698|10974950|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3
9861741|NCT00932698|10974951|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3
9861742|NCT00932698|10974952|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7
9861743|NCT00932698|10974953|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4
9861744|NCT00932698|10974954|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0
9861745|NCT00932698|10974955|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0
9861746|NCT00932698|10974956|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0
9861747|NCT00932698|10974957|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0
9861748|NCT00932698|10974947|FG000|STARTED|Part 2 (Dose Expansion)||0
9861749|NCT00932698|10974948|FG001|STARTED|Part 2 (Dose Expansion)||0
9861750|NCT00932698|10974949|FG002|STARTED|Part 2 (Dose Expansion)||0
9861751|NCT00932698|10974950|FG003|STARTED|Part 2 (Dose Expansion)||0
9861752|NCT00932698|10974951|FG004|STARTED|Part 2 (Dose Expansion)||0
9861753|NCT00932698|10974952|FG005|STARTED|Part 2 (Dose Expansion)||0
9861754|NCT00932698|10974953|FG006|STARTED|Part 2 (Dose Expansion)||0
9861755|NCT00932698|10974954|FG007|STARTED|Part 2 (Dose Expansion)||20
9861756|NCT00932698|10974955|FG008|STARTED|Part 2 (Dose Expansion)||12
9861757|NCT00932698|10974956|FG009|STARTED|Part 2 (Dose Expansion)||6
9861758|NCT00932698|10974957|FG010|STARTED|Part 2 (Dose Expansion)||2
9861759|NCT00932698|10974947|FG000|COMPLETED|Part 2 (Dose Expansion)||0
9861760|NCT00932698|10974948|FG001|COMPLETED|Part 2 (Dose Expansion)||0
9861761|NCT00932698|10974949|FG002|COMPLETED|Part 2 (Dose Expansion)||0
9861762|NCT00932698|10974950|FG003|COMPLETED|Part 2 (Dose Expansion)||0
9861763|NCT00932698|10974951|FG004|COMPLETED|Part 2 (Dose Expansion)||0
9861764|NCT00932698|10974952|FG005|COMPLETED|Part 2 (Dose Expansion)||0
9861765|NCT00932698|10974953|FG006|COMPLETED|Part 2 (Dose Expansion)||0
9861766|NCT00932698|10974954|FG007|COMPLETED|Part 2 (Dose Expansion)||0
10093210|NCT02343276|11221813|FG000|NOT COMPLETED|Overall Study||0
9861767|NCT00932698|10974955|FG008|COMPLETED|Part 2 (Dose Expansion)||0
9861768|NCT00932698|10974956|FG009|COMPLETED|Part 2 (Dose Expansion)||0
9861769|NCT00932698|10974957|FG010|COMPLETED|Part 2 (Dose Expansion)||0
9861770|NCT00932698|10974947|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0
9861771|NCT00932698|10974948|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0
9861772|NCT00932698|10974949|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0
9861773|NCT00932698|10974950|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0
9861774|NCT00932698|10974951|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0
9861775|NCT00932698|10974952|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0
9861776|NCT00932698|10974953|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0
9861777|NCT00932698|10974954|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20
9861778|NCT00932698|10974955|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12
9861779|NCT00932698|10974956|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6
9861780|NCT00932698|10974957|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2
9861781|NCT00932828|10974983|FG000|STARTED|Overall Study||37
9861782|NCT00932828|10974983|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
9861783|NCT00932828|10974983|FG000|NOT COMPLETED|Overall Study||5
9861784|NCT00932893|10974989|FG000|STARTED|Overall Study||173
9861785|NCT00932893|10974990|FG001|STARTED|Overall Study||174
9861786|NCT00932893|10974989|FG000|Treated|Overall Study||172
10093211|NCT02343276|11221814|FG001|NOT COMPLETED|Overall Study||0
10093212|NCT02343380|11221822|FG000|STARTED|Overall Study|Morning test (first week)|10
10093213|NCT02343380|11221823|FG001|STARTED|Overall Study|Evening test (first week)|10
10093214|NCT02343380|11221822|FG000|COMPLETED|Overall Study|Evening test (second week)|10
10093215|NCT02343380|11221823|FG001|COMPLETED|Overall Study|Morning test (second week)|10
10093216|NCT02343380|11221822|FG000|NOT COMPLETED|Overall Study||0
10093217|NCT02343380|11221823|FG001|NOT COMPLETED|Overall Study||0
10093218|NCT02343406|11221844|FG000|STARTED|Overall Study||88
10093219|NCT02343406|11221845|FG001|STARTED|Overall Study||86
10093220|NCT02343406|11221846|FG002|STARTED|Overall Study||60
10093221|NCT02343406|11221847|FG003|STARTED|Overall Study||26
10093222|NCT02343406|11221848|FG004|STARTED|Overall Study||6
10093223|NCT02343406|11221844|FG000|COMPLETED|Overall Study||0
10093224|NCT02343406|11221845|FG001|COMPLETED|Overall Study||0
10093225|NCT02343406|11221846|FG002|COMPLETED|Overall Study||2
10093226|NCT02343406|11221847|FG003|COMPLETED|Overall Study||0
10093227|NCT02343406|11221848|FG004|COMPLETED|Overall Study||1
10093228|NCT02343406|11221844|FG000|NOT COMPLETED|Overall Study||88
10093229|NCT02343406|11221845|FG001|NOT COMPLETED|Overall Study||86
10093230|NCT02343406|11221846|FG002|NOT COMPLETED|Overall Study||58
10093231|NCT02343406|11221847|FG003|NOT COMPLETED|Overall Study||26
10093232|NCT02343406|11221848|FG004|NOT COMPLETED|Overall Study||5
10093233|NCT02343458|11221863|FG000|STARTED|Overall Study||555
10093234|NCT02343458|11221864|FG001|STARTED|Overall Study||483
10093235|NCT02343458|11221865|FG002|STARTED|Overall Study||480
10093236|NCT02343458|11221866|FG003|STARTED|Overall Study||238
10093237|NCT02343458|11221863|FG000|COMPLETED|Overall Study||494
10093238|NCT02343458|11221864|FG001|COMPLETED|Overall Study||417
10093239|NCT02343458|11221865|FG002|COMPLETED|Overall Study||417
10093240|NCT02343458|11221866|FG003|COMPLETED|Overall Study||200
10093241|NCT02343458|11221863|FG000|NOT COMPLETED|Overall Study||61
10093242|NCT02343458|11221864|FG001|NOT COMPLETED|Overall Study||66
10093243|NCT02343458|11221865|FG002|NOT COMPLETED|Overall Study||63
10093244|NCT02343458|11221866|FG003|NOT COMPLETED|Overall Study||38
10093245|NCT02343575|11221878|FG000|STARTED|Overall Study||1
10093246|NCT02343575|11221879|FG001|STARTED|Overall Study||2
10093247|NCT02343575|11221878|FG000|COMPLETED|Overall Study||1
10093248|NCT02343575|11221879|FG001|COMPLETED|Overall Study||2
10093249|NCT02343575|11221878|FG000|NOT COMPLETED|Overall Study||0
10093250|NCT02343575|11221879|FG001|NOT COMPLETED|Overall Study||0
10093251|NCT02343627|11221887|FG000|STARTED|Overall Study||35
10093252|NCT02343627|11221888|FG001|STARTED|Overall Study||12
10093253|NCT02343627|11221887|FG000|COMPLETED|Overall Study||23
10093254|NCT02343627|11221888|FG001|COMPLETED|Overall Study||11
10093255|NCT02343627|11221887|FG000|NOT COMPLETED|Overall Study||12
10093256|NCT02343627|11221888|FG001|NOT COMPLETED|Overall Study||1
10093257|NCT02343939|11221903|FG000|STARTED|Overall Study||3
10093258|NCT02343939|11221904|FG001|STARTED|Overall Study||50
10093259|NCT02343939|11221905|FG002|STARTED|Overall Study||5
10093260|NCT02343939|11221906|FG003|STARTED|Overall Study||6
10093261|NCT02343939|11221907|FG004|STARTED|Overall Study||8
10093262|NCT02343939|11221908|FG005|STARTED|Overall Study||17
10093263|NCT02343939|11221909|FG006|STARTED|Overall Study||15
10093264|NCT02343939|11221910|FG007|STARTED|Overall Study||37
10093265|NCT02343939|11221911|FG008|STARTED|Overall Study||7
10093266|NCT02343939|11221903|FG000|COMPLETED|Overall Study||0
10093267|NCT02343939|11221904|FG001|COMPLETED|Overall Study||2
10093268|NCT02343939|11221905|FG002|COMPLETED|Overall Study||0
10093269|NCT02343939|11221906|FG003|COMPLETED|Overall Study||0
9861787|NCT00932893|10974990|FG001|Treated|Overall Study||171
9861788|NCT00932893|10974989|FG000|COMPLETED|Overall Study||40
10093270|NCT02343939|11221907|FG004|COMPLETED|Overall Study||0
10093271|NCT02343939|11221908|FG005|COMPLETED|Overall Study||0
10093272|NCT02343939|11221909|FG006|COMPLETED|Overall Study||0
10093273|NCT02343939|11221910|FG007|COMPLETED|Overall Study||0
10093274|NCT02343939|11221911|FG008|COMPLETED|Overall Study||0
10093275|NCT02343939|11221903|FG000|NOT COMPLETED|Overall Study||3
10093276|NCT02343939|11221904|FG001|NOT COMPLETED|Overall Study||48
9861789|NCT00932893|10974990|FG001|COMPLETED|Overall Study||4
10093277|NCT02343939|11221905|FG002|NOT COMPLETED|Overall Study||5
10093278|NCT02343939|11221906|FG003|NOT COMPLETED|Overall Study||6
10093279|NCT02343939|11221907|FG004|NOT COMPLETED|Overall Study||8
10093280|NCT02343939|11221908|FG005|NOT COMPLETED|Overall Study||17
10093281|NCT02343939|11221909|FG006|NOT COMPLETED|Overall Study||15
10093282|NCT02343939|11221910|FG007|NOT COMPLETED|Overall Study||37
10093283|NCT02343939|11221911|FG008|NOT COMPLETED|Overall Study||7
10093284|NCT02344004|11221947|FG000|STARTED|Overall Study||224
10093285|NCT02344004|11221948|FG001|STARTED|Overall Study||112
9861790|NCT00932893|10974989|FG000|NOT COMPLETED|Overall Study||133
9861791|NCT00932893|10974990|FG001|NOT COMPLETED|Overall Study||170
9861792|NCT00933166|10974997|FG000|STARTED|Overall Study||169
9861793|NCT00933166|10974997|FG000|COMPLETED|Overall Study||151
9861794|NCT00933166|10974997|FG000|NOT COMPLETED|Overall Study||18
9861795|NCT00933244|10975004|FG000|STARTED|Overall Study||79
9861796|NCT00933244|10975005|FG001|STARTED|Overall Study||75
9861797|NCT00933244|10975006|FG002|STARTED|Overall Study||76
9861798|NCT00933244|10975004|FG000|COMPLETED|Overall Study||74
9861799|NCT00933244|10975005|FG001|COMPLETED|Overall Study||74
9861800|NCT00933244|10975006|FG002|COMPLETED|Overall Study||73
9861801|NCT00933244|10975004|FG000|NOT COMPLETED|Overall Study||5
9861802|NCT00933244|10975005|FG001|NOT COMPLETED|Overall Study||1
9861803|NCT00933244|10975006|FG002|NOT COMPLETED|Overall Study||3
9861804|NCT00933270|10975014|FG000|STARTED|Overall Study|ITT population|264
9861805|NCT00933270|10975014|FG000|COMPLETED|Overall Study||177
9861806|NCT00933270|10975014|FG000|NOT COMPLETED|Overall Study||87
9861807|NCT00933335|10975021|FG000|STARTED|Overall Study||2
9861808|NCT00933335|10975022|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
9861809|NCT00933335|10975021|FG000|COMPLETED|Overall Study||0
9861810|NCT00933335|10975022|FG001|COMPLETED|Overall Study||20
9861811|NCT00933335|10975021|FG000|NOT COMPLETED|Overall Study||2
9861812|NCT00933335|10975022|FG001|NOT COMPLETED|Overall Study||16
9861813|NCT00933491|10975036|FG000|STARTED|Overall Study||14
9861814|NCT00933491|10975037|FG001|STARTED|Overall Study||18
9861815|NCT00933491|10975036|FG000|COMPLETED|Overall Study||14
9861816|NCT00933491|10975037|FG001|COMPLETED|Overall Study||18
9861817|NCT00933491|10975036|FG000|NOT COMPLETED|Overall Study||0
9861818|NCT00933491|10975037|FG001|NOT COMPLETED|Overall Study||0
9861819|NCT00933543|10975045|FG000|STARTED|Overall Study||54
9861820|NCT00933543|10975046|FG001|STARTED|Overall Study||53
9861821|NCT00933543|10975045|FG000|COMPLETED|Overall Study||51
9861822|NCT00933543|10975046|FG001|COMPLETED|Overall Study||46
9861823|NCT00933543|10975045|FG000|NOT COMPLETED|Overall Study||3
9861824|NCT00933543|10975046|FG001|NOT COMPLETED|Overall Study||7
9861825|NCT00933608|10975054|FG000|STARTED|Overall Study||7
9861826|NCT00933608|10975055|FG001|STARTED|Overall Study||10
9861827|NCT00933608|10975054|FG000|COMPLETED|Overall Study||2
9861828|NCT00933608|10975055|FG001|COMPLETED|Overall Study||8
9861829|NCT00933608|10975054|FG000|NOT COMPLETED|Overall Study||5
9861830|NCT00933608|10975055|FG001|NOT COMPLETED|Overall Study||2
9861831|NCT00933686|10975063|FG000|STARTED|Overall Study||55
9861832|NCT00933686|10975064|FG001|STARTED|Overall Study||58
9861833|NCT00933686|10975063|FG000|COMPLETED|Overall Study||45
9861834|NCT00933686|10975064|FG001|COMPLETED|Overall Study||47
9861835|NCT00933686|10975063|FG000|NOT COMPLETED|Overall Study||10
10093286|NCT02344004|11221947|FG000|COMPLETED|Overall Study||163
10093287|NCT02344004|11221948|FG001|COMPLETED|Overall Study||98
10093288|NCT02344004|11221947|FG000|NOT COMPLETED|Overall Study||61
10093289|NCT02344004|11221948|FG001|NOT COMPLETED|Overall Study||14
10093290|NCT02344173|11221955|FG000|STARTED|Enrollment||2035
10093291|NCT02344173|11221955|FG000|COMPLETED|Enrollment||2035
10093292|NCT02344173|11221955|FG000|NOT COMPLETED|Enrollment||0
10093293|NCT02344173|11221955|FG000|STARTED|Procedure||2035
10093294|NCT02344173|11221955|FG000|COMPLETED|Procedure||2028
10093295|NCT02344173|11221955|FG000|NOT COMPLETED|Procedure||7
10093296|NCT02344173|11221955|FG000|STARTED|12-month Visit||2028
10093297|NCT02344173|11221955|FG000|COMPLETED|12-month Visit||1932
10093298|NCT02344173|11221955|FG000|NOT COMPLETED|12-month Visit||96
10093299|NCT02344225|11221964|FG000|STARTED|Overall Study||6
10093300|NCT02344225|11221965|FG001|STARTED|Overall Study||3
10093301|NCT02344225|11221966|FG002|STARTED|Overall Study||5
10093302|NCT02344225|11221964|FG000|COMPLETED|Overall Study||6
10093303|NCT02344225|11221965|FG001|COMPLETED|Overall Study||3
10093304|NCT02344225|11221966|FG002|COMPLETED|Overall Study||5
10093305|NCT02344225|11221964|FG000|NOT COMPLETED|Overall Study||0
10093306|NCT02344225|11221965|FG001|NOT COMPLETED|Overall Study||0
10093307|NCT02344225|11221966|FG002|NOT COMPLETED|Overall Study||0
10093308|NCT02344238|11221977|FG000|STARTED|Overall Study||20
10093309|NCT02344238|11221978|FG001|STARTED|Overall Study||20
10093310|NCT02344238|11221979|FG002|STARTED|Overall Study||20
10093311|NCT02344238|11221977|FG000|COMPLETED|Overall Study||20
10093312|NCT02344238|11221978|FG001|COMPLETED|Overall Study||20
10093313|NCT02344238|11221979|FG002|COMPLETED|Overall Study||20
10093314|NCT02344238|11221977|FG000|NOT COMPLETED|Overall Study||0
10093315|NCT02344238|11221978|FG001|NOT COMPLETED|Overall Study||0
10093316|NCT02344238|11221979|FG002|NOT COMPLETED|Overall Study||0
10093317|NCT02344251|11221990|FG000|STARTED|Overall Study||20
9861836|NCT00933686|10975064|FG001|NOT COMPLETED|Overall Study||11
9861837|NCT00933933|10975075|FG000|STARTED|General Population From 16 to 89 Years||6164
9861838|NCT00933933|10975076|FG001|STARTED|General Population From 16 to 89 Years||1287
9861839|NCT00933933|10975077|FG002|STARTED|General Population From 16 to 89 Years||1206
10093318|NCT02344251|11221991|FG001|STARTED|Overall Study||20
10093319|NCT02344251|11221990|FG000|COMPLETED|Overall Study||20
10093320|NCT02344251|11221991|FG001|COMPLETED|Overall Study||20
10093321|NCT02344251|11221990|FG000|NOT COMPLETED|Overall Study||0
10093322|NCT02344251|11221991|FG001|NOT COMPLETED|Overall Study||0
9861840|NCT00933933|10975075|FG000|COMPLETED|General Population From 16 to 89 Years||6164
9861841|NCT00933933|10975076|FG001|COMPLETED|General Population From 16 to 89 Years||1267
9861842|NCT00933933|10975077|FG002|COMPLETED|General Population From 16 to 89 Years||1206
10093323|NCT02344316|11222001|FG000|STARTED|Overall Study||13
9861843|NCT00933933|10975075|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0
9861844|NCT00933933|10975076|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20
9861845|NCT00933933|10975077|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0
9861846|NCT00933933|10975075|FG000|STARTED|Pregnant Females Between 16-44 Years||448
9861847|NCT00933933|10975076|FG001|STARTED|Pregnant Females Between 16-44 Years||67
9861848|NCT00933933|10975077|FG002|STARTED|Pregnant Females Between 16-44 Years||203
9861849|NCT00933933|10975075|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448
9861850|NCT00933933|10975076|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65
9861851|NCT00933933|10975077|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203
9861852|NCT00933933|10975075|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
9861853|NCT00933933|10975076|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
9861854|NCT00933933|10975077|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
9861855|NCT00933933|10975075|FG000|STARTED|Pediatric From 2 to 21 Years||588
9861856|NCT00933933|10975076|FG001|STARTED|Pediatric From 2 to 21 Years||64
9861857|NCT00933933|10975077|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
9861858|NCT00933933|10975075|FG000|COMPLETED|Pediatric From 2 to 21 Years||588
9861859|NCT00933933|10975076|FG001|COMPLETED|Pediatric From 2 to 21 Years||64
9861860|NCT00933933|10975077|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
9861861|NCT00933933|10975075|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0
10093324|NCT02344316|11222002|FG001|STARTED|Overall Study||13
10093325|NCT02344316|11222001|FG000|COMPLETED|Overall Study||12
10093326|NCT02344316|11222002|FG001|COMPLETED|Overall Study||11
10093327|NCT02344316|11222001|FG000|NOT COMPLETED|Overall Study||1
10093328|NCT02344316|11222002|FG001|NOT COMPLETED|Overall Study||2
10093329|NCT02344342|11222015|FG000|STARTED|Overall Study||13
10093330|NCT02344342|11222016|FG001|STARTED|Overall Study||11
10093331|NCT02344342|11222017|FG002|STARTED|Overall Study||14
10093332|NCT02344342|11222018|FG003|STARTED|Overall Study||13
10093333|NCT02344342|11222015|FG000|COMPLETED|Overall Study||2
10093334|NCT02344342|11222016|FG001|COMPLETED|Overall Study||2
10093335|NCT02344342|11222017|FG002|COMPLETED|Overall Study||0
10093336|NCT02344342|11222018|FG003|COMPLETED|Overall Study||3
10093337|NCT02344342|11222015|FG000|NOT COMPLETED|Overall Study||11
10093338|NCT02344342|11222016|FG001|NOT COMPLETED|Overall Study||9
10093339|NCT02344342|11222017|FG002|NOT COMPLETED|Overall Study||14
10093340|NCT02344342|11222018|FG003|NOT COMPLETED|Overall Study||10
10093341|NCT02344407|11222035|FG000|STARTED|Overall Study||500
10093342|NCT02344407|11222036|FG001|STARTED|Overall Study||500
10093343|NCT02344407|11222037|FG002|STARTED|Overall Study||500
10093344|NCT02344407|11222035|FG000|COMPLETED|Overall Study||492
10093345|NCT02344407|11222036|FG001|COMPLETED|Overall Study||491
10093346|NCT02344407|11222037|FG002|COMPLETED|Overall Study||494
10093347|NCT02344407|11222035|FG000|NOT COMPLETED|Overall Study||8
10093348|NCT02344407|11222036|FG001|NOT COMPLETED|Overall Study||9
10093349|NCT02344407|11222037|FG002|NOT COMPLETED|Overall Study||6
10093350|NCT02344576|11222049|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
10093351|NCT02344576|11222050|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
10093352|NCT02344576|11222051|FG002|STARTED|Enrollment||111
10093353|NCT02344576|11222052|FG003|STARTED|Enrollment||71
10093354|NCT02344576|11222049|FG000|Agreed to Survey Data Collection|Enrollment||135
10093355|NCT02344576|11222050|FG001|Agreed to Survey Data Collection|Enrollment||113
10093356|NCT02344576|11222051|FG002|Agreed to Survey Data Collection|Enrollment||111
10093357|NCT02344576|11222052|FG003|Agreed to Survey Data Collection|Enrollment||71
10093358|NCT02344576|11222049|FG000|COMPLETED|Enrollment||135
10093359|NCT02344576|11222050|FG001|COMPLETED|Enrollment||113
10093360|NCT02344576|11222051|FG002|COMPLETED|Enrollment||111
10093361|NCT02344576|11222052|FG003|COMPLETED|Enrollment||71
10093362|NCT02344576|11222049|FG000|NOT COMPLETED|Enrollment||7
10093363|NCT02344576|11222050|FG001|NOT COMPLETED|Enrollment||8
10093364|NCT02344576|11222051|FG002|NOT COMPLETED|Enrollment||0
10093365|NCT02344576|11222052|FG003|NOT COMPLETED|Enrollment||0
10093366|NCT02344576|11222049|FG000|STARTED|1-Month Follow-Up||135
10093367|NCT02344576|11222050|FG001|STARTED|1-Month Follow-Up||113
10093368|NCT02344576|11222051|FG002|STARTED|1-Month Follow-Up||111
10093369|NCT02344576|11222052|FG003|STARTED|1-Month Follow-Up||71
10093370|NCT02344576|11222049|FG000|Completed 1-Month Survey|1-Month Follow-Up||104
10093371|NCT02344576|11222050|FG001|Completed 1-Month Survey|1-Month Follow-Up||79
10093372|NCT02344576|11222051|FG002|Completed 1-Month Survey|1-Month Follow-Up||89
10093373|NCT02344576|11222052|FG003|Completed 1-Month Survey|1-Month Follow-Up||53
10093374|NCT02344576|11222049|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
10113440|NCT02509117|11244196|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
9861862|NCT00933933|10975076|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0
9861863|NCT00933933|10975077|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0
9861864|NCT00934024|10975095|FG000|STARTED|Overall Study||10
9861865|NCT00934024|10975096|FG001|STARTED|Overall Study||11
9861866|NCT00934024|10975095|FG000|COMPLETED|Overall Study||10
9861867|NCT00934024|10975096|FG001|COMPLETED|Overall Study||6
9861868|NCT00934024|10975095|FG000|NOT COMPLETED|Overall Study||0
9861869|NCT00934024|10975096|FG001|NOT COMPLETED|Overall Study||5
9861870|NCT00934050|10975107|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12
9861871|NCT00934050|10975108|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12
9861872|NCT00934050|10975109|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12
9861873|NCT00934050|10975110|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14
9861874|NCT00934050|10975111|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0
9861875|NCT00934050|10975112|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0
9861876|NCT00934050|10975107|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861877|NCT00934050|10975108|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861878|NCT00934050|10975109|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861879|NCT00934050|10975110|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861880|NCT00934050|10975111|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861881|NCT00934050|10975112|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861882|NCT00934050|10975107|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
9861883|NCT00934050|10975108|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
9861884|NCT00934050|10975109|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
9861885|NCT00934050|10975110|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
9861886|NCT00934050|10975111|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861887|NCT00934050|10975112|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
9861888|NCT00934050|10975107|FG000|STARTED|Enrolled After 15 Dec 2009||0
9861889|NCT00934050|10975108|FG001|STARTED|Enrolled After 15 Dec 2009||0
9861890|NCT00934050|10975109|FG002|STARTED|Enrolled After 15 Dec 2009||0
9861891|NCT00934050|10975110|FG003|STARTED|Enrolled After 15 Dec 2009||0
9861892|NCT00934050|10975111|FG004|STARTED|Enrolled After 15 Dec 2009||26
9861893|NCT00934050|10975112|FG005|STARTED|Enrolled After 15 Dec 2009||27
9861894|NCT00934050|10975107|FG000|COMPLETED|Enrolled After 15 Dec 2009||0
9861895|NCT00934050|10975108|FG001|COMPLETED|Enrolled After 15 Dec 2009||0
9861896|NCT00934050|10975109|FG002|COMPLETED|Enrolled After 15 Dec 2009||0
9861897|NCT00934050|10975110|FG003|COMPLETED|Enrolled After 15 Dec 2009||0
9861898|NCT00934050|10975111|FG004|COMPLETED|Enrolled After 15 Dec 2009||19
9861899|NCT00934050|10975112|FG005|COMPLETED|Enrolled After 15 Dec 2009||23
9861900|NCT00934050|10975107|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0
9861901|NCT00934050|10975108|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0
9861902|NCT00934050|10975109|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0
9861903|NCT00934050|10975110|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0
9861904|NCT00934050|10975111|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7
9861905|NCT00934050|10975112|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4
9861906|NCT00934089|10975124|FG000|STARTED|First Intervention Period (14 Days)||15
9861907|NCT00934089|10975125|FG001|STARTED|First Intervention Period (14 Days)||16
9861908|NCT00934089|10975124|FG000|Treated|First Intervention Period (14 Days)||14
9861909|NCT00934089|10975125|FG001|Treated|First Intervention Period (14 Days)||16
9861910|NCT00934089|10975124|FG000|COMPLETED|First Intervention Period (14 Days)||13
9861911|NCT00934089|10975125|FG001|COMPLETED|First Intervention Period (14 Days)||16
9861912|NCT00934089|10975124|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2
9861913|NCT00934089|10975125|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0
9861914|NCT00934089|10975124|FG000|STARTED|Washout Period (28 Days)||13
9861915|NCT00934089|10975125|FG001|STARTED|Washout Period (28 Days)||16
9861916|NCT00934089|10975124|FG000|COMPLETED|Washout Period (28 Days)||13
9861917|NCT00934089|10975125|FG001|COMPLETED|Washout Period (28 Days)||16
9861918|NCT00934089|10975124|FG000|NOT COMPLETED|Washout Period (28 Days)||0
9861919|NCT00934089|10975125|FG001|NOT COMPLETED|Washout Period (28 Days)||0
9861920|NCT00934089|10975124|FG000|STARTED|Second Intervention Period (14 Days)||13
9861921|NCT00934089|10975125|FG001|STARTED|Second Intervention Period (14 Days)||16
9861922|NCT00934089|10975124|FG000|COMPLETED|Second Intervention Period (14 Days)||13
9861923|NCT00934089|10975125|FG001|COMPLETED|Second Intervention Period (14 Days)||16
9861924|NCT00934089|10975124|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0
9861925|NCT00934089|10975125|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0
9861926|NCT00934102|10975131|FG000|STARTED|Period 1, One Night of Wear||16
9861927|NCT00934102|10975132|FG001|STARTED|Period 1, One Night of Wear||15
9861928|NCT00934102|10975133|FG002|STARTED|Period 1, One Night of Wear||15
9861929|NCT00934102|10975131|FG000|COMPLETED|Period 1, One Night of Wear||15
9861930|NCT00934102|10975132|FG001|COMPLETED|Period 1, One Night of Wear||15
9861931|NCT00934102|10975133|FG002|COMPLETED|Period 1, One Night of Wear||15
9861932|NCT00934102|10975131|FG000|NOT COMPLETED|Period 1, One Night of Wear||1
9861933|NCT00934102|10975132|FG001|NOT COMPLETED|Period 1, One Night of Wear||0
9861934|NCT00934102|10975133|FG002|NOT COMPLETED|Period 1, One Night of Wear||0
9861935|NCT00934102|10975131|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15
9861936|NCT00934102|10975132|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15
9861937|NCT00934102|10975133|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15
9861938|NCT00934102|10975131|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
9861939|NCT00934102|10975132|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
9861940|NCT00934102|10975133|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
9861941|NCT00934102|10975131|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
9861942|NCT00934102|10975132|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
9861943|NCT00934102|10975133|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
9861944|NCT00934128|10975143|FG000|STARTED|First Intervention (2 Hours)||15
9861945|NCT00934128|10975144|FG001|STARTED|First Intervention (2 Hours)||15
9861946|NCT00934128|10975143|FG000|COMPLETED|First Intervention (2 Hours)||10
9861947|NCT00934128|10975144|FG001|COMPLETED|First Intervention (2 Hours)||13
9861948|NCT00934128|10975143|FG000|NOT COMPLETED|First Intervention (2 Hours)||5
9861949|NCT00934128|10975144|FG001|NOT COMPLETED|First Intervention (2 Hours)||2
9861950|NCT00934128|10975143|FG000|STARTED|Washout Period (1 Hour)||10
9861951|NCT00934128|10975144|FG001|STARTED|Washout Period (1 Hour)||13
9861952|NCT00934128|10975143|FG000|COMPLETED|Washout Period (1 Hour)||3
9861953|NCT00934128|10975144|FG001|COMPLETED|Washout Period (1 Hour)||8
9861954|NCT00934128|10975143|FG000|NOT COMPLETED|Washout Period (1 Hour)||7
9861955|NCT00934128|10975144|FG001|NOT COMPLETED|Washout Period (1 Hour)||5
9861956|NCT00934128|10975143|FG000|STARTED|Second Intervention (2 Hours)||3
9861957|NCT00934128|10975144|FG001|STARTED|Second Intervention (2 Hours)||8
9861958|NCT00934128|10975143|FG000|COMPLETED|Second Intervention (2 Hours)||3
9861959|NCT00934128|10975144|FG001|COMPLETED|Second Intervention (2 Hours)||5
9861960|NCT00934128|10975143|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
9861961|NCT00934128|10975144|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3
9861962|NCT00934141|10975154|FG000|STARTED|Overall Study||49
9861963|NCT00934141|10975155|FG001|STARTED|Overall Study||50
9861964|NCT00934141|10975156|FG002|STARTED|Overall Study||48
9861965|NCT00934141|10975157|FG003|STARTED|Overall Study||54
9861966|NCT00934141|10975154|FG000|COMPLETED|Overall Study||45
9861967|NCT00934141|10975155|FG001|COMPLETED|Overall Study||47
9861968|NCT00934141|10975156|FG002|COMPLETED|Overall Study||48
9861969|NCT00934141|10975157|FG003|COMPLETED|Overall Study||51
9861970|NCT00934141|10975154|FG000|NOT COMPLETED|Overall Study||4
9861971|NCT00934141|10975155|FG001|NOT COMPLETED|Overall Study||3
9861972|NCT00934141|10975156|FG002|NOT COMPLETED|Overall Study||0
9861973|NCT00934141|10975157|FG003|NOT COMPLETED|Overall Study||3
9861974|NCT00934362|10975171|FG000|STARTED|Overall Study||8
9861975|NCT00934362|10975172|FG001|STARTED|Overall Study||8
10093375|NCT02344576|11222050|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
10093376|NCT02344576|11222051|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
10093377|NCT02344576|11222052|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
10093378|NCT02344576|11222049|FG000|NOT COMPLETED|1-Month Follow-Up||18
10093379|NCT02344576|11222050|FG001|NOT COMPLETED|1-Month Follow-Up||27
10093380|NCT02344576|11222051|FG002|NOT COMPLETED|1-Month Follow-Up||19
10093381|NCT02344576|11222052|FG003|NOT COMPLETED|1-Month Follow-Up||13
10093382|NCT02344576|11222049|FG000|STARTED|6-Month Follow-Up||117
10093383|NCT02344576|11222050|FG001|STARTED|6-Month Follow-Up||86
10093384|NCT02344576|11222051|FG002|STARTED|6-Month Follow-Up||92
10093385|NCT02344576|11222052|FG003|STARTED|6-Month Follow-Up||58
10093386|NCT02344576|11222049|FG000|Completed 6-Month Survey|6-Month Follow-Up||98
10093387|NCT02344576|11222050|FG001|Completed 6-Month Survey|6-Month Follow-Up||67
10093388|NCT02344576|11222051|FG002|Completed 6-Month Survey|6-Month Follow-Up||78
10093389|NCT02344576|11222052|FG003|Completed 6-Month Survey|6-Month Follow-Up||50
10093390|NCT02344576|11222049|FG000|COMPLETED|6-Month Follow-Up||98
10093391|NCT02344576|11222050|FG001|COMPLETED|6-Month Follow-Up||67
10093392|NCT02344576|11222051|FG002|COMPLETED|6-Month Follow-Up||78
10093393|NCT02344576|11222052|FG003|COMPLETED|6-Month Follow-Up||50
10093394|NCT02344576|11222049|FG000|NOT COMPLETED|6-Month Follow-Up||19
10093395|NCT02344576|11222050|FG001|NOT COMPLETED|6-Month Follow-Up||19
10093396|NCT02344576|11222051|FG002|NOT COMPLETED|6-Month Follow-Up||14
10093397|NCT02344576|11222052|FG003|NOT COMPLETED|6-Month Follow-Up||8
10093398|NCT02344576|11222049|FG000|STARTED|12-Month Medical Record Follow-Up||98
10093399|NCT02344576|11222050|FG001|STARTED|12-Month Medical Record Follow-Up||67
10093400|NCT02344576|11222051|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
10093401|NCT02344576|11222052|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
10093402|NCT02344576|11222049|FG000|COMPLETED|12-Month Medical Record Follow-Up||98
10093403|NCT02344576|11222050|FG001|COMPLETED|12-Month Medical Record Follow-Up||67
10093404|NCT02344576|11222051|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
10093405|NCT02344576|11222052|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
10093406|NCT02344576|11222049|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10093407|NCT02344576|11222050|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10093408|NCT02344576|11222051|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10093409|NCT02344576|11222052|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10093410|NCT02344628|11222066|FG000|STARTED|Overall Study||291
10093411|NCT02344628|11222067|FG001|STARTED|Overall Study||292
10093412|NCT02344628|11222066|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
10093413|NCT02344628|11222067|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
10093414|NCT02344628|11222066|FG000|NOT COMPLETED|Overall Study||91
10093415|NCT02344628|11222067|FG001|NOT COMPLETED|Overall Study||86
10093416|NCT02344745|11222075|FG000|STARTED|Overall Study||40
10093417|NCT02344745|11222076|FG001|STARTED|Overall Study||40
10093418|NCT02344745|11222075|FG000|COMPLETED|Overall Study||38
10093419|NCT02344745|11222076|FG001|COMPLETED|Overall Study||40
10093420|NCT02344745|11222075|FG000|NOT COMPLETED|Overall Study||2
10093421|NCT02344745|11222076|FG001|NOT COMPLETED|Overall Study||0
9861976|NCT00934362|10975171|FG000|COMPLETED|Overall Study||7
9861977|NCT00934362|10975172|FG001|COMPLETED|Overall Study||8
9861978|NCT00934362|10975171|FG000|NOT COMPLETED|Overall Study||1
9861979|NCT00934362|10975172|FG001|NOT COMPLETED|Overall Study||0
9861980|NCT00934375|10975180|FG000|STARTED|Overall Study||68
9861981|NCT00934375|10975181|FG001|STARTED|Overall Study||77
9861982|NCT00934375|10975180|FG000|COMPLETED|Overall Study||55
9861983|NCT00934375|10975181|FG001|COMPLETED|Overall Study||55
9861984|NCT00934375|10975180|FG000|NOT COMPLETED|Overall Study||13
9861985|NCT00934375|10975181|FG001|NOT COMPLETED|Overall Study||22
9861986|NCT00934440|10975187|FG000|STARTED|Overall Study||11
9861987|NCT00934440|10975187|FG000|COMPLETED|Overall Study||10
9861988|NCT00934440|10975187|FG000|NOT COMPLETED|Overall Study||1
9861989|NCT00934544|10975194|FG000|STARTED|Primary Endpoint Analysis (Interim)||146
9861990|NCT00934544|10975195|FG001|STARTED|Primary Endpoint Analysis (Interim)||73
9861991|NCT00934544|10975196|FG002|STARTED|Primary Endpoint Analysis (Interim)||0
9861992|NCT00934544|10975194|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91
10093422|NCT02345031|11222084|FG000|STARTED|Overall Study||38
10093423|NCT02345031|11222085|FG001|STARTED|Overall Study||40
10093424|NCT02345031|11222084|FG000|COMPLETED|Overall Study||37
10093425|NCT02345031|11222085|FG001|COMPLETED|Overall Study||39
10093426|NCT02345031|11222084|FG000|NOT COMPLETED|Overall Study||1
9861993|NCT00934544|10975195|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31
9861994|NCT00934544|10975196|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0
9861995|NCT00934544|10975194|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
9861996|NCT00934544|10975195|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
9861997|NCT00934544|10975196|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
9861998|NCT00934544|10975194|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146
9861999|NCT00934544|10975195|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28
9862000|NCT00934544|10975196|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45
9862001|NCT00934544|10975194|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
9862002|NCT00934544|10975195|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
9862003|NCT00934544|10975196|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
9862004|NCT00934544|10975194|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
9862005|NCT00934544|10975195|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
9862006|NCT00934544|10975196|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
9862007|NCT00934544|10975194|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
9862008|NCT00934544|10975195|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
9862009|NCT00934544|10975196|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
9862010|NCT00934544|10975194|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39
9862011|NCT00934544|10975195|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0
9862012|NCT00934544|10975196|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11
9862013|NCT00934544|10975194|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
9862014|NCT00934544|10975195|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
9862015|NCT00934544|10975196|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
9862016|NCT00934596|10975215|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
9862017|NCT00934596|10975216|FG001|STARTED|Overall Study||10
9862018|NCT00934596|10975215|FG000|COMPLETED|Overall Study||10
10093427|NCT02345031|11222085|FG001|NOT COMPLETED|Overall Study||1
10093428|NCT02345161|11222095|FG000|STARTED|Overall Study||911
10093429|NCT02345161|11222096|FG001|STARTED|Overall Study||899
10093430|NCT02345161|11222095|FG000|COMPLETED|Overall Study||866
10093431|NCT02345161|11222096|FG001|COMPLETED|Overall Study||842
10093432|NCT02345161|11222095|FG000|NOT COMPLETED|Overall Study||45
10093433|NCT02345161|11222096|FG001|NOT COMPLETED|Overall Study||57
10093434|NCT02345226|11222109|FG000|STARTED|Double-Blind Phase||440
10093435|NCT02345226|11222110|FG001|STARTED|Double-Blind Phase||441
10093436|NCT02345226|11222109|FG000|COMPLETED|Double-Blind Phase||371
10093437|NCT02345226|11222110|FG001|COMPLETED|Double-Blind Phase||370
10093438|NCT02345226|11222109|FG000|NOT COMPLETED|Double-Blind Phase||69
10093439|NCT02345226|11222110|FG001|NOT COMPLETED|Double-Blind Phase||71
10093440|NCT02345226|11222109|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
10093441|NCT02345226|11222110|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
10093442|NCT02345226|11222109|FG000|COMPLETED|Open-Label Extension Phase||25
10093443|NCT02345226|11222110|FG001|COMPLETED|Open-Label Extension Phase||20
10093444|NCT02345226|11222109|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10093445|NCT02345226|11222110|FG001|NOT COMPLETED|Open-Label Extension Phase||1
10093446|NCT02345252|11222120|FG000|STARTED|Double-Blind Phase||316
10093447|NCT02345252|11222121|FG001|STARTED|Double-Blind Phase||316
10093448|NCT02345252|11222120|FG000|COMPLETED|Double-Blind Phase||276
10093449|NCT02345252|11222121|FG001|COMPLETED|Double-Blind Phase||267
10093450|NCT02345252|11222120|FG000|NOT COMPLETED|Double-Blind Phase||40
10093451|NCT02345252|11222121|FG001|NOT COMPLETED|Double-Blind Phase||49
10093452|NCT02345252|11222120|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
10093453|NCT02345252|11222121|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
10093454|NCT02345252|11222120|FG000|COMPLETED|Open-Label Extension Phase||19
10093455|NCT02345252|11222121|FG001|COMPLETED|Open-Label Extension Phase||17
10093456|NCT02345252|11222120|FG000|NOT COMPLETED|Open-Label Extension Phase||0
9862019|NCT00934596|10975216|FG001|COMPLETED|Overall Study||10
9862020|NCT00934596|10975215|FG000|NOT COMPLETED|Overall Study||0
9862021|NCT00934596|10975216|FG001|NOT COMPLETED|Overall Study||0
9862022|NCT00934622|10975226|FG000|STARTED|Overall Study||76
9862023|NCT00934622|10975226|FG000|COMPLETED|Overall Study||68
9862024|NCT00934622|10975226|FG000|NOT COMPLETED|Overall Study||8
9862025|NCT00934635|10975239|FG000|STARTED|Overall Study||0
9862026|NCT00934635|10975240|FG001|STARTED|Overall Study||1
9862027|NCT00934635|10975241|FG002|STARTED|Overall Study||0
9862028|NCT00934635|10975242|FG003|STARTED|Overall Study||0
9862029|NCT00934635|10975243|FG004|STARTED|Overall Study||0
9862030|NCT00934635|10975244|FG005|STARTED|Overall Study||0
9862031|NCT00934635|10975245|FG006|STARTED|Overall Study||0
9862032|NCT00934635|10975246|FG007|STARTED|Overall Study||0
9862033|NCT00934635|10975247|FG008|STARTED|Overall Study||1
9862034|NCT00934635|10975239|FG000|COMPLETED|Overall Study||0
9862035|NCT00934635|10975240|FG001|COMPLETED|Overall Study||1
9862036|NCT00934635|10975241|FG002|COMPLETED|Overall Study||0
9862037|NCT00934635|10975242|FG003|COMPLETED|Overall Study||0
9862038|NCT00934635|10975243|FG004|COMPLETED|Overall Study||0
9862039|NCT00934635|10975244|FG005|COMPLETED|Overall Study||0
9862040|NCT00934635|10975245|FG006|COMPLETED|Overall Study||0
9862041|NCT00934635|10975246|FG007|COMPLETED|Overall Study||0
9862042|NCT00934635|10975247|FG008|COMPLETED|Overall Study||1
9862043|NCT00934635|10975239|FG000|NOT COMPLETED|Overall Study||0
9862044|NCT00934635|10975240|FG001|NOT COMPLETED|Overall Study||0
9862045|NCT00934635|10975241|FG002|NOT COMPLETED|Overall Study||0
9862046|NCT00934635|10975242|FG003|NOT COMPLETED|Overall Study||0
9862047|NCT00934635|10975243|FG004|NOT COMPLETED|Overall Study||0
9862048|NCT00934635|10975244|FG005|NOT COMPLETED|Overall Study||0
9862049|NCT00934635|10975245|FG006|NOT COMPLETED|Overall Study||0
9862050|NCT00934635|10975246|FG007|NOT COMPLETED|Overall Study||0
9862051|NCT00934635|10975247|FG008|NOT COMPLETED|Overall Study||0
9862052|NCT00934648|10975267|FG000|STARTED|Overall Study||15
9862053|NCT00934648|10975267|FG000|COMPLETED|Overall Study||6
9862054|NCT00934648|10975267|FG000|NOT COMPLETED|Overall Study||9
9862055|NCT00934661|10975273|FG000|STARTED|Overall Study||20
9862056|NCT00934661|10975274|FG001|STARTED|Overall Study||20
9862057|NCT00934661|10975273|FG000|COMPLETED|Overall Study||19
9862058|NCT00934661|10975274|FG001|COMPLETED|Overall Study||20
9862059|NCT00934661|10975273|FG000|NOT COMPLETED|Overall Study||1
9862060|NCT00934661|10975274|FG001|NOT COMPLETED|Overall Study||0
9862061|NCT00934843|10975282|FG000|STARTED|Overall Study||37
9862062|NCT00934843|10975283|FG001|STARTED|Overall Study||40
9862063|NCT00934843|10975282|FG000|COMPLETED|Overall Study||37
9862064|NCT00934843|10975283|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
9862065|NCT00934843|10975282|FG000|NOT COMPLETED|Overall Study||0
9862066|NCT00934843|10975283|FG001|NOT COMPLETED|Overall Study||1
9862067|NCT00934856|10975295|FG000|STARTED|Feasibility Part||6
9862068|NCT00934856|10975296|FG001|STARTED|Feasibility Part||6
9862069|NCT00934856|10975297|FG002|STARTED|Feasibility Part||3
9862070|NCT00934856|10975298|FG003|STARTED|Feasibility Part||6
9862071|NCT00934856|10975299|FG004|STARTED|Feasibility Part||12
9862072|NCT00934856|10975300|FG005|STARTED|Feasibility Part||9
9862073|NCT00934856|10975295|FG000|COMPLETED|Feasibility Part||1
9862074|NCT00934856|10975296|FG001|COMPLETED|Feasibility Part||1
9862075|NCT00934856|10975297|FG002|COMPLETED|Feasibility Part||0
9862076|NCT00934856|10975298|FG003|COMPLETED|Feasibility Part||1
9862077|NCT00934856|10975299|FG004|COMPLETED|Feasibility Part||12
9862078|NCT00934856|10975300|FG005|COMPLETED|Feasibility Part||6
9862079|NCT00934856|10975295|FG000|NOT COMPLETED|Feasibility Part||5
9862080|NCT00934856|10975296|FG001|NOT COMPLETED|Feasibility Part||5
9862081|NCT00934856|10975297|FG002|NOT COMPLETED|Feasibility Part||3
9862082|NCT00934856|10975298|FG003|NOT COMPLETED|Feasibility Part||5
9862083|NCT00934856|10975299|FG004|NOT COMPLETED|Feasibility Part||0
9862084|NCT00934856|10975300|FG005|NOT COMPLETED|Feasibility Part||3
9862085|NCT00934856|10975295|FG000|STARTED|Extension Part||0
9862086|NCT00934856|10975296|FG001|STARTED|Extension Part||0
9862087|NCT00934856|10975297|FG002|STARTED|Extension Part||0
9862088|NCT00934856|10975298|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4
9862089|NCT00934856|10975299|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28
9862090|NCT00934856|10975300|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24
9862091|NCT00934856|10975295|FG000|COMPLETED|Extension Part||0
9862092|NCT00934856|10975296|FG001|COMPLETED|Extension Part||0
9862093|NCT00934856|10975297|FG002|COMPLETED|Extension Part||0
9862094|NCT00934856|10975298|FG003|COMPLETED|Extension Part||2
9862095|NCT00934856|10975299|FG004|COMPLETED|Extension Part||24
9862096|NCT00934856|10975300|FG005|COMPLETED|Extension Part||19
9862097|NCT00934856|10975295|FG000|NOT COMPLETED|Extension Part||0
9862098|NCT00934856|10975296|FG001|NOT COMPLETED|Extension Part||0
9862099|NCT00934856|10975297|FG002|NOT COMPLETED|Extension Part||0
9862100|NCT00934856|10975298|FG003|NOT COMPLETED|Extension Part||2
9862101|NCT00934856|10975299|FG004|NOT COMPLETED|Extension Part||4
9862102|NCT00934856|10975300|FG005|NOT COMPLETED|Extension Part||5
9862103|NCT00934934|10975334|FG000|STARTED|Overall Study||30
9862104|NCT00934934|10975335|FG001|STARTED|Overall Study||31
9862105|NCT00934934|10975334|FG000|COMPLETED|Overall Study||29
9862106|NCT00934934|10975335|FG001|COMPLETED|Overall Study||31
9862107|NCT00934934|10975334|FG000|NOT COMPLETED|Overall Study||1
9862108|NCT00934934|10975335|FG001|NOT COMPLETED|Overall Study||0
9862109|NCT00934947|10975346|FG000|STARTED|Overall Study||23
9862110|NCT00934947|10975347|FG001|STARTED|Overall Study||22
9862111|NCT00934947|10975346|FG000|COMPLETED|Overall Study||23
9862112|NCT00934947|10975347|FG001|COMPLETED|Overall Study||20
9862113|NCT00934947|10975346|FG000|NOT COMPLETED|Overall Study||0
9862114|NCT00934947|10975347|FG001|NOT COMPLETED|Overall Study||2
9862115|NCT00935012|10975355|FG000|STARTED|Overall Study||31
9862116|NCT00935012|10975355|FG000|COMPLETED|Overall Study||2
9862117|NCT00935012|10975355|FG000|NOT COMPLETED|Overall Study||29
9862118|NCT00935064|10975361|FG000|STARTED|Overall Study||30
9862119|NCT00935064|10975362|FG001|STARTED|Overall Study||30
9862120|NCT00935064|10975361|FG000|COMPLETED|Overall Study||30
9862121|NCT00935064|10975362|FG001|COMPLETED|Overall Study||30
9862122|NCT00935064|10975361|FG000|NOT COMPLETED|Overall Study||0
9862123|NCT00935064|10975362|FG001|NOT COMPLETED|Overall Study||0
9862124|NCT00935220|10975368|FG000|STARTED|Overall Study||41
9862125|NCT00935220|10975368|FG000|COMPLETED|Overall Study||39
9862126|NCT00935220|10975368|FG000|NOT COMPLETED|Overall Study||2
9862127|NCT00935259|10975372|FG000|STARTED|Period 1||16
9862128|NCT00935259|10975373|FG001|STARTED|Period 1||15
9862129|NCT00935259|10975372|FG000|COMPLETED|Period 1||15
9862130|NCT00935259|10975373|FG001|COMPLETED|Period 1||14
9862131|NCT00935259|10975372|FG000|NOT COMPLETED|Period 1||1
9862132|NCT00935259|10975373|FG001|NOT COMPLETED|Period 1||1
9862133|NCT00935259|10975372|FG000|STARTED|Period 2||15
9862134|NCT00935259|10975373|FG001|STARTED|Period 2||14
9862135|NCT00935259|10975372|FG000|COMPLETED|Period 2||15
9862136|NCT00935259|10975373|FG001|COMPLETED|Period 2||14
9862137|NCT00935259|10975372|FG000|NOT COMPLETED|Period 2||0
9862138|NCT00935259|10975373|FG001|NOT COMPLETED|Period 2||0
9862139|NCT00935272|10975383|FG000|STARTED|Overall Study||135
9862140|NCT00935272|10975384|FG001|STARTED|Overall Study||45
10093457|NCT02345252|11222121|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10093458|NCT02345330|11222129|FG000|STARTED|Overall Study||4
10093459|NCT02345330|11222129|FG000|COMPLETED|Overall Study||1
10093460|NCT02345330|11222129|FG000|NOT COMPLETED|Overall Study||3
10093461|NCT02345434|11222135|FG000|STARTED|Overall Study||763
10093462|NCT02345434|11222136|FG001|STARTED|Overall Study||762
10093463|NCT02345434|11222135|FG000|COMPLETED|Overall Study||758
10093464|NCT02345434|11222136|FG001|COMPLETED|Overall Study||760
10093465|NCT02345434|11222135|FG000|NOT COMPLETED|Overall Study||5
10093466|NCT02345434|11222136|FG001|NOT COMPLETED|Overall Study||2
10093467|NCT02345486|11222144|FG000|STARTED|Overall Study||454
10093468|NCT02345486|11222145|FG001|STARTED|Overall Study||520
10093469|NCT02345486|11222144|FG000|COMPLETED|Overall Study||454
10093470|NCT02345486|11222145|FG001|COMPLETED|Overall Study||520
10093471|NCT02345486|11222144|FG000|NOT COMPLETED|Overall Study||0
10093472|NCT02345486|11222145|FG001|NOT COMPLETED|Overall Study||0
10093473|NCT02345512|11222151|FG000|STARTED|Overall Study||11
10093474|NCT02345512|11222151|FG000|COMPLETED|Overall Study||9
10093475|NCT02345512|11222151|FG000|NOT COMPLETED|Overall Study||2
10093476|NCT02345642|11222162|FG000|STARTED|Overall Study||10
10093477|NCT02345642|11222163|FG001|STARTED|Overall Study||10
10093478|NCT02345642|11222162|FG000|COMPLETED|Overall Study||10
10093479|NCT02345642|11222163|FG001|COMPLETED|Overall Study||10
10093480|NCT02345642|11222162|FG000|NOT COMPLETED|Overall Study||0
10093481|NCT02345642|11222163|FG001|NOT COMPLETED|Overall Study||0
10093482|NCT02345720|11222169|FG000|STARTED|Overall Study||20
10093483|NCT02345720|11222169|FG000|COMPLETED|Overall Study||20
10093484|NCT02345720|11222169|FG000|NOT COMPLETED|Overall Study||0
10093485|NCT02345811|11222173|FG000|STARTED|First Intervention||17
10093486|NCT02345811|11222174|FG001|STARTED|First Intervention||17
10093487|NCT02345811|11222173|FG000|COMPLETED|First Intervention||16
10093488|NCT02345811|11222174|FG001|COMPLETED|First Intervention||16
10093489|NCT02345811|11222173|FG000|NOT COMPLETED|First Intervention||1
10093490|NCT02345811|11222174|FG001|NOT COMPLETED|First Intervention||1
10093491|NCT02345811|11222173|FG000|STARTED|Second Intervention||16
10093492|NCT02345811|11222174|FG001|STARTED|Second Intervention||16
10093493|NCT02345811|11222173|FG000|COMPLETED|Second Intervention||16
10093494|NCT02345811|11222174|FG001|COMPLETED|Second Intervention||16
10093495|NCT02345811|11222173|FG000|NOT COMPLETED|Second Intervention||0
10093496|NCT02345811|11222174|FG001|NOT COMPLETED|Second Intervention||0
10093497|NCT02345889|11222186|FG000|STARTED|Overall Study||316
10093498|NCT02345889|11222187|FG001|STARTED|Overall Study||316
10093499|NCT02345889|11222188|FG002|STARTED|Overall Study||315
10093500|NCT02345889|11222189|FG003|STARTED|Overall Study||315
9862141|NCT00935272|10975383|FG000|COMPLETED|Overall Study||116
9862142|NCT00935272|10975384|FG001|COMPLETED|Overall Study||39
9862143|NCT00935272|10975383|FG000|NOT COMPLETED|Overall Study||19
9862144|NCT00935272|10975384|FG001|NOT COMPLETED|Overall Study||6
9862145|NCT00935311|10975394|FG000|STARTED|Overall Study||43
9862146|NCT00935311|10975395|FG001|STARTED|Overall Study||39
9862147|NCT00935311|10975396|FG002|STARTED|Overall Study||40
9862148|NCT00935311|10975394|FG000|COMPLETED|Overall Study||43
9862149|NCT00935311|10975395|FG001|COMPLETED|Overall Study||39
9862150|NCT00935311|10975396|FG002|COMPLETED|Overall Study||40
9862151|NCT00935311|10975394|FG000|NOT COMPLETED|Overall Study||0
9862152|NCT00935311|10975395|FG001|NOT COMPLETED|Overall Study||0
9862153|NCT00935311|10975396|FG002|NOT COMPLETED|Overall Study||0
9862154|NCT00935428|10975404|FG000|STARTED|Overall Study||231
10093501|NCT02345889|11222186|FG000|COMPLETED|Overall Study||295
10093502|NCT02345889|11222187|FG001|COMPLETED|Overall Study||299
10093503|NCT02345889|11222188|FG002|COMPLETED|Overall Study||295
10093504|NCT02345889|11222189|FG003|COMPLETED|Overall Study||299
9862155|NCT00935428|10975404|FG000|COMPLETED|Overall Study||231
9862156|NCT00935428|10975404|FG000|NOT COMPLETED|Overall Study||0
9862157|NCT00935493|10975417|FG000|STARTED|Overall Study||41
9862158|NCT00935493|10975418|FG001|STARTED|Overall Study||41
9862159|NCT00935493|10975419|FG002|STARTED|Overall Study||41
9862160|NCT00935493|10975417|FG000|COMPLETED|Overall Study||40
9862161|NCT00935493|10975418|FG001|COMPLETED|Overall Study||39
9862162|NCT00935493|10975419|FG002|COMPLETED|Overall Study||40
9862163|NCT00935493|10975417|FG000|NOT COMPLETED|Overall Study||1
9862164|NCT00935493|10975418|FG001|NOT COMPLETED|Overall Study||2
9862165|NCT00935493|10975419|FG002|NOT COMPLETED|Overall Study||1
9862166|NCT00935532|10975429|FG000|STARTED|Overall Study||215
9862167|NCT00935532|10975430|FG001|STARTED|Overall Study||212
9862168|NCT00935532|10975429|FG000|COMPLETED|Overall Study||193
9862169|NCT00935532|10975430|FG001|COMPLETED|Overall Study||201
9862170|NCT00935532|10975429|FG000|NOT COMPLETED|Overall Study||22
9862171|NCT00935532|10975430|FG001|NOT COMPLETED|Overall Study||11
9862172|NCT00935584|10975438|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
9862173|NCT00935584|10975439|FG001|STARTED|Overall Study||23
9862174|NCT00935584|10975438|FG000|COMPLETED|Overall Study||77
9862175|NCT00935584|10975439|FG001|COMPLETED|Overall Study||19
9862176|NCT00935584|10975438|FG000|NOT COMPLETED|Overall Study||49
9862177|NCT00935584|10975439|FG001|NOT COMPLETED|Overall Study||4
9862178|NCT00935701|10975443|FG000|STARTED|Overall Study||10
9862179|NCT00935701|10975443|FG000|Transition Acupressure to Acupuncture|Overall Study||9
9862180|NCT00935701|10975443|FG000|COMPLETED|Overall Study||9
9862181|NCT00935701|10975443|FG000|NOT COMPLETED|Overall Study||1
9862182|NCT00935766|10975450|FG000|STARTED|Overall Study||42
9862183|NCT00935766|10975451|FG001|STARTED|Overall Study||34
9862184|NCT00935766|10975450|FG000|COMPLETED|Overall Study||35
9862185|NCT00935766|10975451|FG001|COMPLETED|Overall Study||27
9862186|NCT00935766|10975450|FG000|NOT COMPLETED|Overall Study||7
9862187|NCT00935766|10975451|FG001|NOT COMPLETED|Overall Study||7
9862188|NCT00935792|10975460|FG000|STARTED|Overall Study||7
9862189|NCT00935792|10975461|FG001|STARTED|Overall Study||9
9862190|NCT00935792|10975462|FG002|STARTED|Overall Study||12
9862191|NCT00935792|10975460|FG000|COMPLETED|Overall Study||6
9862192|NCT00935792|10975461|FG001|COMPLETED|Overall Study||6
9862193|NCT00935792|10975462|FG002|COMPLETED|Overall Study||12
9862194|NCT00935792|10975460|FG000|NOT COMPLETED|Overall Study||1
9862195|NCT00935792|10975461|FG001|NOT COMPLETED|Overall Study||3
9862196|NCT00935792|10975462|FG002|NOT COMPLETED|Overall Study||0
9862197|NCT00935818|10975474|FG000|STARTED|Overall Study||249
9862198|NCT00935818|10975475|FG001|STARTED|Overall Study||257
9862199|NCT00935818|10975474|FG000|End of Medication Phase|Overall Study||182
9862200|NCT00935818|10975475|FG001|End of Medication Phase|Overall Study||184
9862201|NCT00935818|10975474|FG000|COMPLETED|Overall Study||158
9862202|NCT00935818|10975475|FG001|COMPLETED|Overall Study||157
9862203|NCT00935818|10975474|FG000|NOT COMPLETED|Overall Study||91
9862204|NCT00935818|10975475|FG001|NOT COMPLETED|Overall Study||100
9862205|NCT00935857|10975483|FG000|STARTED|Overall Study||14
9862206|NCT00935857|10975484|FG001|STARTED|Overall Study||16
9862207|NCT00935857|10975483|FG000|COMPLETED|Overall Study||14
9862208|NCT00935857|10975484|FG001|COMPLETED|Overall Study||16
9862209|NCT00935857|10975483|FG000|NOT COMPLETED|Overall Study||0
9862210|NCT00935857|10975484|FG001|NOT COMPLETED|Overall Study||0
9862211|NCT00935883|10975492|FG000|STARTED|Treatment Period||20
9862212|NCT00935883|10975493|FG001|STARTED|Treatment Period||40
9862213|NCT00935883|10975492|FG000|COMPLETED|Treatment Period||19
9862214|NCT00935883|10975493|FG001|COMPLETED|Treatment Period||38
9862215|NCT00935883|10975492|FG000|NOT COMPLETED|Treatment Period||1
9862216|NCT00935883|10975493|FG001|NOT COMPLETED|Treatment Period||2
9862217|NCT00935883|10975492|FG000|STARTED|Follow-Up Period||19
9862218|NCT00935883|10975493|FG001|STARTED|Follow-Up Period||38
9862219|NCT00935883|10975492|FG000|COMPLETED|Follow-Up Period||19
9862220|NCT00935883|10975493|FG001|COMPLETED|Follow-Up Period||38
9862221|NCT00935883|10975492|FG000|NOT COMPLETED|Follow-Up Period||0
9862222|NCT00935883|10975493|FG001|NOT COMPLETED|Follow-Up Period||0
9862223|NCT00936065|10975502|FG000|STARTED|Overall Study||21
9862224|NCT00936065|10975503|FG001|STARTED|Overall Study||20
9862225|NCT00936065|10975504|FG002|STARTED|Overall Study||19
9862226|NCT00936065|10975502|FG000|Received Treatment|Overall Study||21
9862227|NCT00936065|10975503|FG001|Received Treatment|Overall Study||20
9862228|NCT00936065|10975504|FG002|Received Treatment|Overall Study||18
9862229|NCT00936065|10975502|FG000|Study Assessments Performed|Overall Study||21
9862230|NCT00936065|10975503|FG001|Study Assessments Performed|Overall Study||19
9862231|NCT00936065|10975504|FG002|Study Assessments Performed|Overall Study||18
9862232|NCT00936065|10975502|FG000|COMPLETED|Overall Study||17
9862233|NCT00936065|10975503|FG001|COMPLETED|Overall Study||16
9862234|NCT00936065|10975504|FG002|COMPLETED|Overall Study||12
9862235|NCT00936065|10975502|FG000|NOT COMPLETED|Overall Study||4
9862236|NCT00936065|10975503|FG001|NOT COMPLETED|Overall Study||4
9862237|NCT00936065|10975504|FG002|NOT COMPLETED|Overall Study||7
9953310|NCT01425814|11072027|FG003|STARTED|Period 3||10
9953311|NCT01425814|11072028|FG004|STARTED|Period 3||12
9953312|NCT01425814|11072029|FG005|STARTED|Period 3||13
9953313|NCT01425814|11072024|FG000|COMPLETED|Period 3||12
9953314|NCT01425814|11072025|FG001|COMPLETED|Period 3||9
9953315|NCT01425814|11072026|FG002|COMPLETED|Period 3||12
9953316|NCT01425814|11072027|FG003|COMPLETED|Period 3||10
9953317|NCT01425814|11072028|FG004|COMPLETED|Period 3||12
9862238|NCT00936117|10975512|FG000|STARTED|Overall Study||20
9862239|NCT00936117|10975512|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10
9862240|NCT00936117|10975512|FG000|NOT COMPLETED|Overall Study||10
9862241|NCT00936208|10975519|FG000|STARTED|Overall Study||1499
9862242|NCT00936208|10975520|FG001|STARTED|Overall Study||1596
9862243|NCT00936208|10975519|FG000|COMPLETED|Overall Study||1462
9862244|NCT00936208|10975520|FG001|COMPLETED|Overall Study||1574
9862245|NCT00936208|10975519|FG000|NOT COMPLETED|Overall Study||37
9862246|NCT00936208|10975520|FG001|NOT COMPLETED|Overall Study||22
9862247|NCT00936221|10975528|FG000|STARTED|Overall Study||45
9862248|NCT00936221|10975529|FG001|STARTED|Overall Study||46
9862249|NCT00936221|10975528|FG000|Received Treatment|Overall Study||44
9862250|NCT00936221|10975529|FG001|Received Treatment|Overall Study||45
9862251|NCT00936221|10975528|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
9862252|NCT00936221|10975529|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
10093505|NCT02345889|11222186|FG000|NOT COMPLETED|Overall Study||21
10093506|NCT02345889|11222187|FG001|NOT COMPLETED|Overall Study||17
10093507|NCT02345889|11222188|FG002|NOT COMPLETED|Overall Study||20
10093508|NCT02345889|11222189|FG003|NOT COMPLETED|Overall Study||16
10093509|NCT02346136|11222201|FG000|STARTED|Overall Study||93
10093510|NCT02346136|11222202|FG001|STARTED|Overall Study||87
10093511|NCT02346136|11222201|FG000|COMPLETED|Overall Study||71
10093512|NCT02346136|11222202|FG001|COMPLETED|Overall Study||64
10093513|NCT02346136|11222201|FG000|NOT COMPLETED|Overall Study||22
10093514|NCT02346136|11222202|FG001|NOT COMPLETED|Overall Study||23
10093515|NCT02346240|11222212|FG000|STARTED|Initial Period (Baseline to Week 16)||57
10093516|NCT02346240|11222213|FG001|STARTED|Initial Period (Baseline to Week 16)||170
10093517|NCT02346240|11222214|FG002|STARTED|Initial Period (Baseline to Week 16)||165
10093518|NCT02346240|11222215|FG003|STARTED|Initial Period (Baseline to Week 16)||167
10093519|NCT02346240|11222216|FG004|STARTED|Initial Period (Baseline to Week 16)||0
10093520|NCT02346240|11222217|FG005|STARTED|Initial Period (Baseline to Week 16)||0
10093521|NCT02346240|11222218|FG006|STARTED|Initial Period (Baseline to Week 16)||0
10093522|NCT02346240|11222219|FG007|STARTED|Initial Period (Baseline to Week 16)||0
10093523|NCT02346240|11222220|FG008|STARTED|Initial Period (Baseline to Week 16)||0
10093524|NCT02346240|11222221|FG009|STARTED|Initial Period (Baseline to Week 16)||0
10093525|NCT02346240|11222222|FG010|STARTED|Initial Period (Baseline to Week 16)||0
10093526|NCT02346240|11222223|FG011|STARTED|Initial Period (Baseline to Week 16)||0
10093527|NCT02346240|11222224|FG012|STARTED|Initial Period (Baseline to Week 16)||0
10093528|NCT02346240|11222225|FG013|STARTED|Initial Period (Baseline to Week 16)||0
10093529|NCT02346240|11222226|FG014|STARTED|Initial Period (Baseline to Week 16)||0
10093530|NCT02346240|11222227|FG015|STARTED|Initial Period (Baseline to Week 16)||0
10093531|NCT02346240|11222228|FG016|STARTED|Initial Period (Baseline to Week 16)||0
10093532|NCT02346240|11222229|FG017|STARTED|Initial Period (Baseline to Week 16)||0
10093533|NCT02346240|11222230|FG018|STARTED|Initial Period (Baseline to Week 16)||0
10093534|NCT02346240|11222231|FG019|STARTED|Initial Period (Baseline to Week 16)||0
10093535|NCT02346240|11222232|FG020|STARTED|Initial Period (Baseline to Week 16)||0
10093536|NCT02346240|11222233|FG021|STARTED|Initial Period (Baseline to Week 16)||0
10093537|NCT02346240|11222234|FG022|STARTED|Initial Period (Baseline to Week 16)||0
10093538|NCT02346240|11222235|FG023|STARTED|Initial Period (Baseline to Week 16)||0
10093539|NCT02346240|11222212|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55
10093540|NCT02346240|11222213|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159
10093541|NCT02346240|11222214|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159
10093542|NCT02346240|11222215|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162
10093543|NCT02346240|11222216|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093544|NCT02346240|11222217|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093545|NCT02346240|11222218|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093546|NCT02346240|11222219|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093547|NCT02346240|11222220|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093548|NCT02346240|11222221|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093549|NCT02346240|11222222|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093550|NCT02346240|11222223|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093551|NCT02346240|11222224|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093552|NCT02346240|11222225|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093553|NCT02346240|11222226|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093554|NCT02346240|11222227|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093555|NCT02346240|11222228|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093556|NCT02346240|11222229|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093557|NCT02346240|11222230|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093558|NCT02346240|11222231|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093559|NCT02346240|11222232|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093560|NCT02346240|11222233|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0
10201857|NCT03441984|11329287|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201858|NCT03441984|11329276|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201859|NCT03441984|11329277|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9862253|NCT00936221|10975528|FG000|NOT COMPLETED|Overall Study||1
9862254|NCT00936221|10975529|FG001|NOT COMPLETED|Overall Study||1
9862255|NCT00936299|10975537|FG000|STARTED|Overall Study||53
9862256|NCT00936299|10975538|FG001|STARTED|Overall Study||52
9862257|NCT00936299|10975537|FG000|COMPLETED|Overall Study||40
9862258|NCT00936299|10975538|FG001|COMPLETED|Overall Study||40
9862259|NCT00936299|10975537|FG000|NOT COMPLETED|Overall Study||13
9862260|NCT00936299|10975538|FG001|NOT COMPLETED|Overall Study||12
9862261|NCT00936351|10975548|FG000|STARTED|Overall Study||18
9862262|NCT00936351|10975549|FG001|STARTED|Overall Study||16
9862263|NCT00936351|10975548|FG000|COMPLETED|Overall Study||15
9862264|NCT00936351|10975549|FG001|COMPLETED|Overall Study||14
9862265|NCT00936351|10975548|FG000|NOT COMPLETED|Overall Study||3
9862266|NCT00936351|10975549|FG001|NOT COMPLETED|Overall Study||2
9862267|NCT00936377|10975558|FG000|STARTED|Overall Study||8
9862268|NCT00936377|10975559|FG001|STARTED|Overall Study||8
9862269|NCT00936377|10975560|FG002|STARTED|Overall Study||8
9862270|NCT00936377|10975558|FG000|COMPLETED|Overall Study||8
9862271|NCT00936377|10975559|FG001|COMPLETED|Overall Study||8
9862272|NCT00936377|10975560|FG002|COMPLETED|Overall Study||8
9862273|NCT00936377|10975558|FG000|NOT COMPLETED|Overall Study||0
9862274|NCT00936377|10975559|FG001|NOT COMPLETED|Overall Study||0
9862275|NCT00936377|10975560|FG002|NOT COMPLETED|Overall Study||0
9862276|NCT00936455|10975570|FG000|STARTED|Overall Study||37
9862277|NCT00936455|10975571|FG001|STARTED|Overall Study||38
9862278|NCT00936455|10975570|FG000|COMPLETED|Overall Study||37
9862279|NCT00936455|10975571|FG001|COMPLETED|Overall Study||38
9862280|NCT00936455|10975570|FG000|NOT COMPLETED|Overall Study||0
9862281|NCT00936455|10975571|FG001|NOT COMPLETED|Overall Study||0
9862282|NCT00936481|10975585|FG000|STARTED|Overall Study||17
9862283|NCT00936481|10975586|FG001|STARTED|Overall Study||17
9862284|NCT00936481|10975585|FG000|COMPLETED|Overall Study||17
9862285|NCT00936481|10975586|FG001|COMPLETED|Overall Study||17
9862286|NCT00936481|10975585|FG000|NOT COMPLETED|Overall Study||0
9862287|NCT00936481|10975586|FG001|NOT COMPLETED|Overall Study||0
9862288|NCT00936611|10975592|FG000|STARTED|Overall Study||39
9862289|NCT00936611|10975592|FG000|Treated|Overall Study||36
9862290|NCT00936611|10975592|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
9862291|NCT00936611|10975592|FG000|COMPLETED|Overall Study||0
9862292|NCT00936611|10975592|FG000|NOT COMPLETED|Overall Study||39
9862293|NCT00936663|10975598|FG000|STARTED|Overall Study||1
9862294|NCT00936663|10975599|FG001|STARTED|Overall Study||2
9862295|NCT00936663|10975598|FG000|COMPLETED|Overall Study||1
9862296|NCT00936663|10975599|FG001|COMPLETED|Overall Study||2
9862297|NCT00936663|10975598|FG000|NOT COMPLETED|Overall Study||0
9862298|NCT00936663|10975599|FG001|NOT COMPLETED|Overall Study||0
9862299|NCT00936702|10975605|FG000|STARTED|Overall Study||46
9862300|NCT00936702|10975605|FG000|COMPLETED|Overall Study||0
9862301|NCT00936702|10975605|FG000|NOT COMPLETED|Overall Study||46
9862302|NCT00936715|10975609|FG000|STARTED|Overall Study||24
9862303|NCT00936715|10975609|FG000|COMPLETED|Overall Study||18
9862304|NCT00936715|10975609|FG000|NOT COMPLETED|Overall Study||6
9862305|NCT00936741|10975613|FG000|STARTED|Overall Study||30
9862306|NCT00936741|10975613|FG000|COMPLETED|Overall Study||21
9862307|NCT00936741|10975613|FG000|NOT COMPLETED|Overall Study||9
9862308|NCT00936858|10975617|FG000|STARTED|Overall Study||50
9862309|NCT00936858|10975617|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10
9862310|NCT00936858|10975617|FG000|COMPLETED|Overall Study||0
9862311|NCT00936858|10975617|FG000|NOT COMPLETED|Overall Study||50
9862312|NCT00936884|10975624|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
9862313|NCT00936884|10975625|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
9862314|NCT00936884|10975626|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
9862315|NCT00936884|10975624|FG000|COMPLETED|Double-blind||13
9862316|NCT00936884|10975625|FG001|COMPLETED|Double-blind||18
9862317|NCT00936884|10975626|FG002|COMPLETED|Double-blind||0
9862318|NCT00936884|10975624|FG000|NOT COMPLETED|Double-blind||12
9862319|NCT00936884|10975625|FG001|NOT COMPLETED|Double-blind||7
9862320|NCT00936884|10975626|FG002|NOT COMPLETED|Double-blind||0
9862321|NCT00936884|10975624|FG000|STARTED|Open-label||0
9862322|NCT00936884|10975625|FG001|STARTED|Open-label||0
9862323|NCT00936884|10975626|FG002|STARTED|Open-label||31
9862324|NCT00936884|10975624|FG000|COMPLETED|Open-label||0
9862325|NCT00936884|10975625|FG001|COMPLETED|Open-label||0
9862326|NCT00936884|10975626|FG002|COMPLETED|Open-label||12
9862327|NCT00936884|10975624|FG000|NOT COMPLETED|Open-label||0
9862328|NCT00936884|10975625|FG001|NOT COMPLETED|Open-label||0
9862329|NCT00936884|10975626|FG002|NOT COMPLETED|Open-label||19
9862330|NCT00936897|10975635|FG000|STARTED|Overall Study|Randomized|417
9862331|NCT00936897|10975636|FG001|STARTED|Overall Study|Randomized|416
9862332|NCT00936897|10975635|FG000|COMPLETED|Overall Study||398
9862333|NCT00936897|10975636|FG001|COMPLETED|Overall Study||356
9862334|NCT00936897|10975635|FG000|NOT COMPLETED|Overall Study||19
9862335|NCT00936897|10975636|FG001|NOT COMPLETED|Overall Study||60
9862336|NCT00936910|10975642|FG000|STARTED|Overall Study||13
9862337|NCT00936910|10975642|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
9862338|NCT00936910|10975642|FG000|NOT COMPLETED|Overall Study||3
9862339|NCT00936975|10975647|FG000|STARTED|Overall Study||18
9862340|NCT00936975|10975647|FG000|COMPLETED|Overall Study||12
9862341|NCT00936975|10975647|FG000|NOT COMPLETED|Overall Study||6
9862342|NCT00937040|10975654|FG000|STARTED|Overall Study||179
9862343|NCT00937040|10975655|FG001|STARTED|Overall Study||178
9862344|NCT00937040|10975654|FG000|COMPLETED|Overall Study||138
9862345|NCT00937040|10975655|FG001|COMPLETED|Overall Study||141
9862346|NCT00937040|10975654|FG000|NOT COMPLETED|Overall Study||41
9862347|NCT00937040|10975655|FG001|NOT COMPLETED|Overall Study||37
9862348|NCT00937105|10975663|FG000|STARTED|Overall Study||109
9862349|NCT00937105|10975664|FG001|STARTED|Overall Study||109
9862350|NCT00937105|10975663|FG000|COMPLETED|Overall Study||69
9862351|NCT00937105|10975664|FG001|COMPLETED|Overall Study||70
9862352|NCT00937105|10975663|FG000|NOT COMPLETED|Overall Study||40
9862353|NCT00937105|10975664|FG001|NOT COMPLETED|Overall Study||39
9862354|NCT00937118|10975679|FG000|STARTED|Overall Study||41
9862355|NCT00937118|10975679|FG000|COMPLETED|Overall Study||41
9862356|NCT00937118|10975679|FG000|NOT COMPLETED|Overall Study||0
9862357|NCT00937157|10975686|FG000|STARTED|Overall Study||12
9862358|NCT00937157|10975686|FG000|COMPLETED|Overall Study||8
9862359|NCT00937157|10975686|FG000|NOT COMPLETED|Overall Study||4
9862360|NCT00937235|10975692|FG000|STARTED|Overall Study||72
9862361|NCT00937235|10975693|FG001|STARTED|Overall Study||70
9862362|NCT00937235|10975692|FG000|COMPLETED|Overall Study||72
9862363|NCT00937235|10975693|FG001|COMPLETED|Overall Study||70
9862364|NCT00937235|10975692|FG000|NOT COMPLETED|Overall Study||0
9862365|NCT00937235|10975693|FG001|NOT COMPLETED|Overall Study||0
9862366|NCT00937326|10975704|FG000|STARTED|Overall Study||46
9862367|NCT00937326|10975705|FG001|STARTED|Overall Study||45
10093561|NCT02346240|11222234|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093562|NCT02346240|11222235|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0
10093563|NCT02346240|11222212|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
10093564|NCT02346240|11222213|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
10093565|NCT02346240|11222214|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
10093566|NCT02346240|11222215|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
10093567|NCT02346240|11222216|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093568|NCT02346240|11222217|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093569|NCT02346240|11222218|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093570|NCT02346240|11222219|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093571|NCT02346240|11222220|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093572|NCT02346240|11222221|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093573|NCT02346240|11222222|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10201860|NCT03441984|11329278|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201861|NCT03441984|11329279|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201862|NCT03441984|11329280|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201863|NCT03441984|11329281|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201864|NCT03441984|11329282|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201865|NCT03441984|11329283|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201866|NCT03441984|11329284|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201867|NCT03441984|11329285|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201868|NCT03441984|11329286|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201869|NCT03441984|11329287|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10201870|NCT03441984|11329276|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201871|NCT03441984|11329277|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201872|NCT03441984|11329278|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201873|NCT03441984|11329279|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201874|NCT03441984|11329280|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201875|NCT03441984|11329281|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201876|NCT03441984|11329282|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201877|NCT03441984|11329283|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201878|NCT03441984|11329284|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201879|NCT03441984|11329285|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201880|NCT03441984|11329286|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201881|NCT03441984|11329287|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201882|NCT03441984|11329276|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201883|NCT03441984|11329277|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201884|NCT03441984|11329278|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201885|NCT03441984|11329279|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201886|NCT03441984|11329280|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201887|NCT03441984|11329281|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10201888|NCT03441984|11329282|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201889|NCT03441984|11329283|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201890|NCT03441984|11329284|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201891|NCT03441984|11329285|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9862368|NCT00937326|10975706|FG002|STARTED|Overall Study||46
9862369|NCT00937326|10975707|FG003|STARTED|Overall Study||45
9862370|NCT00937326|10975708|FG004|STARTED|Overall Study||45
9862371|NCT00937326|10975704|FG000|COMPLETED|Overall Study||43
9862372|NCT00937326|10975705|FG001|COMPLETED|Overall Study||38
9862373|NCT00937326|10975706|FG002|COMPLETED|Overall Study||42
9862374|NCT00937326|10975707|FG003|COMPLETED|Overall Study||40
9862375|NCT00937326|10975708|FG004|COMPLETED|Overall Study||40
9862376|NCT00937326|10975704|FG000|NOT COMPLETED|Overall Study||3
9862377|NCT00937326|10975705|FG001|NOT COMPLETED|Overall Study||7
9862378|NCT00937326|10975706|FG002|NOT COMPLETED|Overall Study||4
9862379|NCT00937326|10975707|FG003|NOT COMPLETED|Overall Study||5
9862380|NCT00937326|10975708|FG004|NOT COMPLETED|Overall Study||5
9862381|NCT00937378|10975727|FG000|STARTED|Overall Study||167
9862382|NCT00937378|10975728|FG001|STARTED|Overall Study||159
9862383|NCT00937378|10975727|FG000|COMPLETED|Overall Study||149
9862384|NCT00937378|10975728|FG001|COMPLETED|Overall Study||141
9862385|NCT00937378|10975727|FG000|NOT COMPLETED|Overall Study||18
9862386|NCT00937378|10975728|FG001|NOT COMPLETED|Overall Study||18
9862387|NCT00937391|10975736|FG000|STARTED|Stage 1||20
9862388|NCT00937391|10975736|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
9862389|NCT00937391|10975736|FG000|COMPLETED|Stage 1||20
9862390|NCT00937391|10975736|FG000|NOT COMPLETED|Stage 1||0
9862391|NCT00937391|10975736|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
9862392|NCT00937391|10975736|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
9862393|NCT00937391|10975736|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
9862394|NCT00937391|10975736|FG000|NOT COMPLETED|Stage 2||1
9862395|NCT00937404|10975753|FG000|STARTED|Overall Study||25
9862396|NCT00937404|10975753|FG000|COMPLETED|Overall Study||23
9862397|NCT00937404|10975753|FG000|NOT COMPLETED|Overall Study||2
9862398|NCT00937495|10975757|FG000|STARTED|Overall Study||16
9862399|NCT00937495|10975757|FG000|COMPLETED|Overall Study||14
9862400|NCT00937495|10975757|FG000|NOT COMPLETED|Overall Study||2
9862401|NCT00937521|10975769|FG000|STARTED|Overall Study - Prior to Booster Dose||188
9862402|NCT00937521|10975770|FG001|STARTED|Overall Study - Prior to Booster Dose||190
9862403|NCT00937521|10975771|FG002|STARTED|Overall Study - Prior to Booster Dose||192
9862404|NCT00937521|10975772|FG003|STARTED|Overall Study - Prior to Booster Dose||188
9862405|NCT00937521|10975773|FG004|STARTED|Overall Study - Prior to Booster Dose||191
9862406|NCT00937521|10975774|FG005|STARTED|Overall Study - Prior to Booster Dose||188
9862407|NCT00937521|10975775|FG006|STARTED|Overall Study - Prior to Booster Dose||186
9862408|NCT00937521|10975776|FG007|STARTED|Overall Study - Prior to Booster Dose||184
9862409|NCT00937521|10975769|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
9862410|NCT00937521|10975770|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
10093574|NCT02346240|11222223|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093575|NCT02346240|11222224|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093576|NCT02346240|11222225|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093577|NCT02346240|11222226|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093578|NCT02346240|11222227|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093579|NCT02346240|11222228|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093580|NCT02346240|11222229|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093581|NCT02346240|11222230|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093582|NCT02346240|11222231|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093583|NCT02346240|11222232|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093584|NCT02346240|11222233|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093585|NCT02346240|11222234|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093586|NCT02346240|11222235|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10093587|NCT02346240|11222212|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55
10093588|NCT02346240|11222213|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159
10093589|NCT02346240|11222214|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159
10093590|NCT02346240|11222215|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160
10093591|NCT02346240|11222216|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0
10093592|NCT02346240|11222217|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0
10093593|NCT02346240|11222218|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0
10093594|NCT02346240|11222219|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0
10093595|NCT02346240|11222220|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0
10093596|NCT02346240|11222221|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0
10093597|NCT02346240|11222222|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0
10093598|NCT02346240|11222223|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0
10093599|NCT02346240|11222224|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0
10093600|NCT02346240|11222225|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0
10093601|NCT02346240|11222226|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0
10093602|NCT02346240|11222227|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0
10093603|NCT02346240|11222228|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0
10093604|NCT02346240|11222229|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0
10093605|NCT02346240|11222230|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0
10093606|NCT02346240|11222231|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0
10093607|NCT02346240|11222232|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0
9862411|NCT00937521|10975771|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
9862412|NCT00937521|10975772|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
9862413|NCT00937521|10975773|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
9862414|NCT00937521|10975774|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
9862415|NCT00937521|10975775|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
9862416|NCT00937521|10975776|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
9862417|NCT00937521|10975769|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185
9862418|NCT00937521|10975770|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185
9862419|NCT00937521|10975771|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186
9862420|NCT00937521|10975772|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187
9862421|NCT00937521|10975773|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188
9862422|NCT00937521|10975774|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187
9862423|NCT00937521|10975775|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181
9862424|NCT00937521|10975776|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183
9862425|NCT00937521|10975769|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
9862426|NCT00937521|10975770|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
9862427|NCT00937521|10975771|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
9862428|NCT00937521|10975772|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
9862429|NCT00937521|10975773|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
10093608|NCT02346240|11222233|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0
10093609|NCT02346240|11222234|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0
10093610|NCT02346240|11222235|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0
10093611|NCT02346240|11222212|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
10093612|NCT02346240|11222213|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
10093613|NCT02346240|11222214|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
10093614|NCT02346240|11222215|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
10093615|NCT02346240|11222216|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093616|NCT02346240|11222217|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093617|NCT02346240|11222218|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093618|NCT02346240|11222219|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093619|NCT02346240|11222220|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093620|NCT02346240|11222221|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093621|NCT02346240|11222222|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093622|NCT02346240|11222223|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093623|NCT02346240|11222224|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093624|NCT02346240|11222225|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093625|NCT02346240|11222226|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093626|NCT02346240|11222227|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093627|NCT02346240|11222228|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093628|NCT02346240|11222229|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093629|NCT02346240|11222230|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093630|NCT02346240|11222231|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093631|NCT02346240|11222232|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093632|NCT02346240|11222233|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093633|NCT02346240|11222234|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093634|NCT02346240|11222235|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10093635|NCT02346240|11222212|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093636|NCT02346240|11222213|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093637|NCT02346240|11222214|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093638|NCT02346240|11222215|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093639|NCT02346240|11222216|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2
10093640|NCT02346240|11222217|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24
10093641|NCT02346240|11222218|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50
10093642|NCT02346240|11222219|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22
10093643|NCT02346240|11222220|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44
10093644|NCT02346240|11222221|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44
10093645|NCT02346240|11222222|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25
10093646|NCT02346240|11222223|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50
10093647|NCT02346240|11222224|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49
10093648|NCT02346240|11222225|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53
10093649|NCT02346240|11222226|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85
10093650|NCT02346240|11222227|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49
10093651|NCT02346240|11222228|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36
10093652|NCT02346240|11222229|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093653|NCT02346240|11222230|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093654|NCT02346240|11222231|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093655|NCT02346240|11222232|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093656|NCT02346240|11222233|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093657|NCT02346240|11222234|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093658|NCT02346240|11222235|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0
10093659|NCT02346240|11222212|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093660|NCT02346240|11222213|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093661|NCT02346240|11222214|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093662|NCT02346240|11222215|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
9862430|NCT00937521|10975774|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
9862431|NCT00937521|10975775|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
9862432|NCT00937521|10975776|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
9862433|NCT00937521|10975769|FG000|STARTED|Booster Phase||155
9862434|NCT00937521|10975770|FG001|STARTED|Booster Phase||163
9862435|NCT00937521|10975771|FG002|STARTED|Booster Phase||169
9862436|NCT00937521|10975772|FG003|STARTED|Booster Phase||170
9862437|NCT00937521|10975773|FG004|STARTED|Booster Phase||168
9862438|NCT00937521|10975774|FG005|STARTED|Booster Phase||165
9862439|NCT00937521|10975775|FG006|STARTED|Booster Phase||165
9862440|NCT00937521|10975776|FG007|STARTED|Booster Phase||161
9862441|NCT00937521|10975769|FG000|Premature Withdrawal|Booster Phase||3
9862442|NCT00937521|10975770|FG001|Premature Withdrawal|Booster Phase||2
9862443|NCT00937521|10975771|FG002|Premature Withdrawal|Booster Phase||5
9862444|NCT00937521|10975772|FG003|Premature Withdrawal|Booster Phase||3
9862445|NCT00937521|10975773|FG004|Premature Withdrawal|Booster Phase||5
9862446|NCT00937521|10975774|FG005|Premature Withdrawal|Booster Phase||5
9862447|NCT00937521|10975775|FG006|Premature Withdrawal|Booster Phase||5
9862448|NCT00937521|10975776|FG007|Premature Withdrawal|Booster Phase||2
9862449|NCT00937521|10975769|FG000|COMPLETED|Booster Phase||152
9862450|NCT00937521|10975770|FG001|COMPLETED|Booster Phase||161
9862451|NCT00937521|10975771|FG002|COMPLETED|Booster Phase||164
9862452|NCT00937521|10975772|FG003|COMPLETED|Booster Phase||167
10093663|NCT02346240|11222216|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
10093664|NCT02346240|11222217|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
10093665|NCT02346240|11222218|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
10093666|NCT02346240|11222219|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
10093667|NCT02346240|11222220|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
10093668|NCT02346240|11222221|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
10093669|NCT02346240|11222222|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
10093670|NCT02346240|11222223|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
10093671|NCT02346240|11222224|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
10093672|NCT02346240|11222225|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
10093673|NCT02346240|11222226|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
10093674|NCT02346240|11222227|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
10093675|NCT02346240|11222228|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
10093676|NCT02346240|11222229|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093677|NCT02346240|11222230|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093678|NCT02346240|11222231|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093679|NCT02346240|11222232|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093680|NCT02346240|11222233|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093681|NCT02346240|11222234|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093682|NCT02346240|11222235|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10093683|NCT02346240|11222212|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093684|NCT02346240|11222213|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093685|NCT02346240|11222214|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093686|NCT02346240|11222215|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093687|NCT02346240|11222216|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
10093688|NCT02346240|11222217|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
10093689|NCT02346240|11222218|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
10093690|NCT02346240|11222219|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
10093691|NCT02346240|11222220|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
10093692|NCT02346240|11222221|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
10093693|NCT02346240|11222222|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
10093694|NCT02346240|11222223|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
10093695|NCT02346240|11222224|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
10093696|NCT02346240|11222225|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
10093697|NCT02346240|11222226|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
10093698|NCT02346240|11222227|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
10093699|NCT02346240|11222228|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
10239819|NCT01780636|11371554|FG000|COMPLETED|Overall Study||7
9862453|NCT00937521|10975773|FG004|COMPLETED|Booster Phase||163
9862454|NCT00937521|10975774|FG005|COMPLETED|Booster Phase||160
9862455|NCT00937521|10975775|FG006|COMPLETED|Booster Phase||160
9862456|NCT00937521|10975776|FG007|COMPLETED|Booster Phase||159
9862457|NCT00937521|10975769|FG000|NOT COMPLETED|Booster Phase||3
9862458|NCT00937521|10975770|FG001|NOT COMPLETED|Booster Phase||2
9862459|NCT00937521|10975771|FG002|NOT COMPLETED|Booster Phase||5
9862460|NCT00937521|10975772|FG003|NOT COMPLETED|Booster Phase||3
9862461|NCT00937521|10975773|FG004|NOT COMPLETED|Booster Phase||5
9862462|NCT00937521|10975774|FG005|NOT COMPLETED|Booster Phase||5
9862463|NCT00937521|10975775|FG006|NOT COMPLETED|Booster Phase||5
9862464|NCT00937521|10975776|FG007|NOT COMPLETED|Booster Phase||2
9862465|NCT00937547|10975812|FG000|STARTED|Overall Study||96
9862466|NCT00937547|10975813|FG001|STARTED|Overall Study||84
9862467|NCT00937547|10975814|FG002|STARTED|Overall Study||149
9862468|NCT00937547|10975812|FG000|Histological Samples|Overall Study||95
9862469|NCT00937547|10975813|FG001|Histological Samples|Overall Study||78
9862470|NCT00937547|10975814|FG002|Histological Samples|Overall Study||142
9862471|NCT00937547|10975812|FG000|COMPLETED|Overall Study||95
9862472|NCT00937547|10975813|FG001|COMPLETED|Overall Study||78
9862473|NCT00937547|10975814|FG002|COMPLETED|Overall Study||142
9862474|NCT00937547|10975812|FG000|NOT COMPLETED|Overall Study||1
9862475|NCT00937547|10975813|FG001|NOT COMPLETED|Overall Study||6
9862476|NCT00937547|10975814|FG002|NOT COMPLETED|Overall Study||7
9862477|NCT00937560|10975822|FG000|STARTED|Initial Treatment||189
9862478|NCT00937560|10975822|FG000|Received Treatment|Initial Treatment||189
9862479|NCT00937560|10975822|FG000|COMPLETED|Initial Treatment||168
9862480|NCT00937560|10975822|FG000|NOT COMPLETED|Initial Treatment||21
9862481|NCT00937560|10975822|FG000|STARTED|Maintenance Treatment||168
9862482|NCT00937560|10975822|FG000|COMPLETED|Maintenance Treatment||150
9862483|NCT00937560|10975822|FG000|NOT COMPLETED|Maintenance Treatment||18
9862484|NCT00937768|10975828|FG000|STARTED|Overall Study||8
9862485|NCT00937768|10975829|FG001|STARTED|Overall Study||8
9862486|NCT00937768|10975828|FG000|COMPLETED|Overall Study||0
9862487|NCT00937768|10975829|FG001|COMPLETED|Overall Study||0
9862488|NCT00937768|10975828|FG000|NOT COMPLETED|Overall Study||8
9862489|NCT00937768|10975829|FG001|NOT COMPLETED|Overall Study||8
9862490|NCT00937794|10975835|FG000|STARTED|Overall Study||33
9862491|NCT00937794|10975835|FG000|COMPLETED|Overall Study||33
9862492|NCT00937794|10975835|FG000|NOT COMPLETED|Overall Study||0
9862493|NCT00937833|10975841|FG000|STARTED|Overall Study||73
9862494|NCT00937833|10975842|FG001|STARTED|Overall Study||77
9862495|NCT00937833|10975841|FG000|COMPLETED|Overall Study||58
9862496|NCT00937833|10975842|FG001|COMPLETED|Overall Study||60
9862497|NCT00937833|10975841|FG000|NOT COMPLETED|Overall Study||15
9862498|NCT00937833|10975842|FG001|NOT COMPLETED|Overall Study||17
9862499|NCT00937859|10975850|FG000|STARTED|Overall Study||148
9862500|NCT00937859|10975851|FG001|STARTED|Overall Study||153
9862501|NCT00937859|10975850|FG000|COMPLETED|Overall Study||129
9862502|NCT00937859|10975851|FG001|COMPLETED|Overall Study||134
9862503|NCT00937859|10975850|FG000|NOT COMPLETED|Overall Study||19
9862504|NCT00937859|10975851|FG001|NOT COMPLETED|Overall Study||19
9862505|NCT00937950|10975857|FG000|STARTED|Overall Study||2003
9862506|NCT00937950|10975857|FG000|COMPLETED|Overall Study||1787
9862507|NCT00937950|10975857|FG000|NOT COMPLETED|Overall Study||216
9862508|NCT00938015|10975861|FG000|STARTED|Overall Study||303
9862509|NCT00938015|10975861|FG000|COMPLETED|Overall Study||156
9862510|NCT00938015|10975861|FG000|NOT COMPLETED|Overall Study||147
9862511|NCT00938041|10975865|FG000|STARTED|Overall Study||32
9862512|NCT00938041|10975865|FG000|COMPLETED|Overall Study||5
9862513|NCT00938041|10975865|FG000|NOT COMPLETED|Overall Study||27
9862514|NCT00938314|10975873|FG000|STARTED|Cohort 1||24
9862515|NCT00938314|10975874|FG001|STARTED|Cohort 1||0
9862516|NCT00938314|10975875|FG002|STARTED|Cohort 1||0
9862517|NCT00938314|10975876|FG003|STARTED|Cohort 1||8
9862518|NCT00938314|10975873|FG000|COMPLETED|Cohort 1||22
9862519|NCT00938314|10975874|FG001|COMPLETED|Cohort 1||0
9862520|NCT00938314|10975875|FG002|COMPLETED|Cohort 1||0
9862521|NCT00938314|10975876|FG003|COMPLETED|Cohort 1||6
9862522|NCT00938314|10975873|FG000|NOT COMPLETED|Cohort 1||2
9862523|NCT00938314|10975874|FG001|NOT COMPLETED|Cohort 1||0
9862524|NCT00938314|10975875|FG002|NOT COMPLETED|Cohort 1||0
9862525|NCT00938314|10975876|FG003|NOT COMPLETED|Cohort 1||2
9862526|NCT00938314|10975873|FG000|STARTED|Cohort 2||0
9862527|NCT00938314|10975874|FG001|STARTED|Cohort 2||24
9862528|NCT00938314|10975875|FG002|STARTED|Cohort 2||0
9862529|NCT00938314|10975876|FG003|STARTED|Cohort 2||8
9862530|NCT00938314|10975873|FG000|COMPLETED|Cohort 2||0
9862531|NCT00938314|10975874|FG001|COMPLETED|Cohort 2||18
9862532|NCT00938314|10975875|FG002|COMPLETED|Cohort 2||0
9862533|NCT00938314|10975876|FG003|COMPLETED|Cohort 2||6
9862534|NCT00938314|10975873|FG000|NOT COMPLETED|Cohort 2||0
9862535|NCT00938314|10975874|FG001|NOT COMPLETED|Cohort 2||6
9862536|NCT00938314|10975875|FG002|NOT COMPLETED|Cohort 2||0
9862537|NCT00938314|10975876|FG003|NOT COMPLETED|Cohort 2||2
9862538|NCT00938314|10975873|FG000|STARTED|Cohort 3||0
9862539|NCT00938314|10975874|FG001|STARTED|Cohort 3||0
9862540|NCT00938314|10975875|FG002|STARTED|Cohort 3||24
9862541|NCT00938314|10975876|FG003|STARTED|Cohort 3||8
9862542|NCT00938314|10975873|FG000|COMPLETED|Cohort 3||0
9862543|NCT00938314|10975874|FG001|COMPLETED|Cohort 3||0
9862544|NCT00938314|10975875|FG002|COMPLETED|Cohort 3||20
9862545|NCT00938314|10975876|FG003|COMPLETED|Cohort 3||7
9862546|NCT00938314|10975873|FG000|NOT COMPLETED|Cohort 3||0
9862547|NCT00938314|10975874|FG001|NOT COMPLETED|Cohort 3||0
9862548|NCT00938314|10975875|FG002|NOT COMPLETED|Cohort 3||4
9862549|NCT00938314|10975876|FG003|NOT COMPLETED|Cohort 3||1
9862550|NCT00938327|10975886|FG000|STARTED|Overall Study||332
9862551|NCT00938327|10975886|FG000|COMPLETED|Overall Study||272
9862552|NCT00938327|10975886|FG000|NOT COMPLETED|Overall Study||60
9862553|NCT00938340|10975890|FG000|STARTED|Overall Study||20
9862554|NCT00938340|10975890|FG000|Received Whole Walnut Intervention|Overall Study||16
9862555|NCT00938340|10975890|FG000|Received Walnut Nutmeat Intervention|Overall Study||19
9862556|NCT00938340|10975890|FG000|Received Walnut Skins Intervention|Overall Study||15
9862557|NCT00938340|10975890|FG000|Received Walnut Oil Intervention|Overall Study||15
9862558|NCT00938340|10975890|FG000|COMPLETED|Overall Study||15
9862559|NCT00938340|10975890|FG000|NOT COMPLETED|Overall Study||5
9862560|NCT00938366|10975938|FG000|STARTED|Overall Study||9
9862561|NCT00938366|10975939|FG001|STARTED|Overall Study||9
9862562|NCT00938366|10975938|FG000|COMPLETED|Overall Study||8
9862563|NCT00938366|10975939|FG001|COMPLETED|Overall Study||9
9862564|NCT00938366|10975938|FG000|NOT COMPLETED|Overall Study||1
9862565|NCT00938366|10975939|FG001|NOT COMPLETED|Overall Study||0
9862566|NCT00938392|10975947|FG000|STARTED|Overall Study||362
9862567|NCT00938392|10975948|FG001|STARTED|Overall Study||362
9862568|NCT00938392|10975947|FG000|COMPLETED|Overall Study||360
9862569|NCT00938392|10975948|FG001|COMPLETED|Overall Study||358
9862570|NCT00938392|10975947|FG000|NOT COMPLETED|Overall Study||2
9862571|NCT00938392|10975948|FG001|NOT COMPLETED|Overall Study||4
9862572|NCT00938431|10975957|FG000|STARTED|Overall Study||15
9862573|NCT00938431|10975958|FG001|STARTED|Overall Study||23
9862574|NCT00938431|10975959|FG002|STARTED|Overall Study||9
9862575|NCT00938431|10975957|FG000|COMPLETED|Overall Study||9
9862576|NCT00938431|10975958|FG001|COMPLETED|Overall Study||14
9862577|NCT00938431|10975959|FG002|COMPLETED|Overall Study||1
9862578|NCT00938431|10975957|FG000|NOT COMPLETED|Overall Study||6
9862579|NCT00938431|10975958|FG001|NOT COMPLETED|Overall Study||9
9862580|NCT00938431|10975959|FG002|NOT COMPLETED|Overall Study||8
9862581|NCT00938457|10975971|FG000|STARTED|Overall Study||3
9862582|NCT00938457|10975971|FG000|COMPLETED|Overall Study||3
9862583|NCT00938457|10975971|FG000|NOT COMPLETED|Overall Study||0
9862584|NCT00938470|10975977|FG000|STARTED|Overall Study||34
9862585|NCT00938470|10975978|FG001|STARTED|Overall Study||28
9862586|NCT00938470|10975977|FG000|COMPLETED|Overall Study||27
9862587|NCT00938470|10975978|FG001|COMPLETED|Overall Study||25
9862588|NCT00938470|10975977|FG000|NOT COMPLETED|Overall Study||7
9862589|NCT00938470|10975978|FG001|NOT COMPLETED|Overall Study||3
9862590|NCT00938548|10975986|FG000|STARTED|Overall Study||35
9862591|NCT00938548|10975987|FG001|STARTED|Overall Study||35
9862592|NCT00938548|10975986|FG000|COMPLETED|Overall Study||35
9862593|NCT00938548|10975987|FG001|COMPLETED|Overall Study||35
9862594|NCT00938548|10975986|FG000|NOT COMPLETED|Overall Study||0
9862595|NCT00938548|10975987|FG001|NOT COMPLETED|Overall Study||0
9862596|NCT00938639|10975995|FG000|STARTED|Overall Study||120
9862597|NCT00938639|10975996|FG001|STARTED|Overall Study||120
9862598|NCT00938639|10975995|FG000|COMPLETED|Overall Study||117
9862599|NCT00938639|10975996|FG001|COMPLETED|Overall Study||116
9862600|NCT00938639|10975995|FG000|NOT COMPLETED|Overall Study||3
9862601|NCT00938639|10975996|FG001|NOT COMPLETED|Overall Study||4
9862602|NCT00938704|10976008|FG000|STARTED|Overall Study||33
9862603|NCT00938704|10976009|FG001|STARTED|Overall Study||37
9862604|NCT00938704|10976008|FG000|COMPLETED|Overall Study||33
9862605|NCT00938704|10976009|FG001|COMPLETED|Overall Study||37
9862606|NCT00938704|10976008|FG000|NOT COMPLETED|Overall Study||0
9862607|NCT00938704|10976009|FG001|NOT COMPLETED|Overall Study||0
9862608|NCT00938717|10976017|FG000|STARTED|Overall Study||403
9862609|NCT00938717|10976018|FG001|STARTED|Overall Study||402
9862610|NCT00938717|10976017|FG000|COMPLETED|Overall Study||305
9862611|NCT00938717|10976018|FG001|COMPLETED|Overall Study||294
9862612|NCT00938717|10976017|FG000|NOT COMPLETED|Overall Study||98
9862613|NCT00938717|10976018|FG001|NOT COMPLETED|Overall Study||108
9862614|NCT00938782|10976026|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32
9862615|NCT00938782|10976027|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
9862616|NCT00938782|10976026|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32
9862617|NCT00938782|10976027|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35
9862618|NCT00938782|10976026|FG000|NOT COMPLETED|Overall Study||0
9862619|NCT00938782|10976027|FG001|NOT COMPLETED|Overall Study||0
9862620|NCT00938860|10976035|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
9862621|NCT00938860|10976036|FG001|STARTED|Overall Study||42
9862622|NCT00938860|10976035|FG000|Efficacy Population|Overall Study||40
9862623|NCT00938860|10976036|FG001|Efficacy Population|Overall Study||41
9862624|NCT00938860|10976035|FG000|COMPLETED|Overall Study||25
9862625|NCT00938860|10976036|FG001|COMPLETED|Overall Study||25
9862626|NCT00938860|10976035|FG000|NOT COMPLETED|Overall Study||25
9862627|NCT00938860|10976036|FG001|NOT COMPLETED|Overall Study||17
9862628|NCT00938886|10976044|FG000|STARTED|Overall Study||75
9862629|NCT00938886|10976045|FG001|STARTED|Overall Study||75
9862630|NCT00938886|10976044|FG000|Attended 1 Counseling Session|Overall Study||70
9862631|NCT00938886|10976045|FG001|Attended 1 Counseling Session|Overall Study||70
9862632|NCT00938886|10976044|FG000|COMPLETED|Overall Study||68
9862633|NCT00938886|10976045|FG001|COMPLETED|Overall Study||65
9862634|NCT00938886|10976044|FG000|NOT COMPLETED|Overall Study||7
9862635|NCT00938886|10976045|FG001|NOT COMPLETED|Overall Study||10
9862636|NCT00938964|10976053|FG000|STARTED|Overall Study||241
9862637|NCT00938964|10976054|FG001|STARTED|Overall Study||237
9862638|NCT00938964|10976053|FG000|COMPLETED|Overall Study||211
9862639|NCT00938964|10976054|FG001|COMPLETED|Overall Study||209
9862640|NCT00938964|10976053|FG000|NOT COMPLETED|Overall Study||30
9862641|NCT00938964|10976054|FG001|NOT COMPLETED|Overall Study||28
9862642|NCT00939003|10976062|FG000|STARTED|Double-blind Treatment Period||97
9862643|NCT00939003|10976063|FG001|STARTED|Double-blind Treatment Period||95
9862644|NCT00939003|10976062|FG000|COMPLETED|Double-blind Treatment Period||95
9862645|NCT00939003|10976063|FG001|COMPLETED|Double-blind Treatment Period||91
9862646|NCT00939003|10976062|FG000|NOT COMPLETED|Double-blind Treatment Period||2
9862647|NCT00939003|10976063|FG001|NOT COMPLETED|Double-blind Treatment Period||4
9862648|NCT00939003|10976062|FG000|STARTED|Open-label Treatment Period||95
9862649|NCT00939003|10976063|FG001|STARTED|Open-label Treatment Period||91
9862650|NCT00939003|10976062|FG000|COMPLETED|Open-label Treatment Period||66
9862651|NCT00939003|10976063|FG001|COMPLETED|Open-label Treatment Period||62
9862652|NCT00939003|10976062|FG000|NOT COMPLETED|Open-label Treatment Period||29
9862653|NCT00939003|10976063|FG001|NOT COMPLETED|Open-label Treatment Period||29
9862654|NCT00939029|10976074|FG000|STARTED|Overall Study||25
9862655|NCT00939029|10976075|FG001|STARTED|Overall Study||27
9862656|NCT00939029|10976074|FG000|COMPLETED|Overall Study||19
9862657|NCT00939029|10976075|FG001|COMPLETED|Overall Study||15
9862658|NCT00939029|10976074|FG000|NOT COMPLETED|Overall Study||6
9862659|NCT00939029|10976075|FG001|NOT COMPLETED|Overall Study||12
9862660|NCT00939055|10976083|FG000|STARTED|Overall Study||73
9862661|NCT00939055|10976084|FG001|STARTED|Overall Study||39
9862662|NCT00939055|10976083|FG000|COMPLETED|Overall Study||69
9862663|NCT00939055|10976084|FG001|COMPLETED|Overall Study||39
9862664|NCT00939055|10976083|FG000|NOT COMPLETED|Overall Study||4
9862665|NCT00939055|10976084|FG001|NOT COMPLETED|Overall Study||0
9862666|NCT00939094|10976093|FG000|STARTED|Overall Study||42
9862667|NCT00939094|10976094|FG001|STARTED|Overall Study||45
9862668|NCT00939094|10976093|FG000|COMPLETED|Overall Study||28
9862669|NCT00939094|10976094|FG001|COMPLETED|Overall Study||35
9862670|NCT00939094|10976093|FG000|NOT COMPLETED|Overall Study||14
9862671|NCT00939094|10976094|FG001|NOT COMPLETED|Overall Study||10
9862672|NCT00939107|10976102|FG000|STARTED|Overall Study||175
9862673|NCT00939107|10976103|FG001|STARTED|Overall Study||175
9862674|NCT00939107|10976102|FG000|12 Months Follow-up|Overall Study||161
9862675|NCT00939107|10976103|FG001|12 Months Follow-up|Overall Study||163
9862676|NCT00939107|10976102|FG000|COMPLETED|Overall Study||161
9862677|NCT00939107|10976103|FG001|COMPLETED|Overall Study||163
9862678|NCT00939107|10976102|FG000|NOT COMPLETED|Overall Study||14
9862679|NCT00939107|10976103|FG001|NOT COMPLETED|Overall Study||12
9862680|NCT00939120|10976111|FG000|STARTED|Overall Study||23
9862681|NCT00939120|10976112|FG001|STARTED|Overall Study||23
9862682|NCT00939120|10976111|FG000|COMPLETED|Overall Study||15
9862683|NCT00939120|10976112|FG001|COMPLETED|Overall Study||18
9862684|NCT00939120|10976111|FG000|NOT COMPLETED|Overall Study||8
9862685|NCT00939120|10976112|FG001|NOT COMPLETED|Overall Study||5
9862686|NCT00939159|10976118|FG000|STARTED|Overall Study||13
9862687|NCT00939159|10976118|FG000|COMPLETED|Overall Study||13
9862688|NCT00939159|10976118|FG000|NOT COMPLETED|Overall Study||0
9862689|NCT00939185|10976122|FG000|STARTED|Overall Study||400
9862690|NCT00939185|10976122|FG000|Received Treatment|Overall Study||390
9862691|NCT00939185|10976122|FG000|COMPLETED|Overall Study||375
9862692|NCT00939185|10976122|FG000|NOT COMPLETED|Overall Study||25
9862693|NCT00939198|10976126|FG000|STARTED|Overall Study||87
9862694|NCT00939198|10976126|FG000|COMPLETED|Overall Study||87
9862695|NCT00939198|10976126|FG000|NOT COMPLETED|Overall Study||0
9862696|NCT00939211|10976131|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
9862697|NCT00939211|10976131|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
9862698|NCT00939211|10976131|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
9862699|NCT00939211|10976131|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28
9862700|NCT00939211|10976131|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
9862701|NCT00939211|10976131|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
9862702|NCT00939211|10976131|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
9862703|NCT00939211|10976131|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
9862704|NCT00939211|10976131|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
9862705|NCT00939211|10976131|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28
9862706|NCT00939211|10976131|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
9862707|NCT00939211|10976131|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
9862708|NCT00939211|10976131|FG000|STARTED|Placebo||28
9862709|NCT00939211|10976131|FG000|COMPLETED|Placebo||28
9862710|NCT00939211|10976131|FG000|NOT COMPLETED|Placebo||0
9862711|NCT00939341|10976143|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
9862712|NCT00939341|10976143|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
9862713|NCT00939341|10976143|FG000|NOT COMPLETED|Overall Study||66
9862714|NCT00939367|10976147|FG000|STARTED|First Intervention||15
9862715|NCT00939367|10976148|FG001|STARTED|First Intervention||15
9862716|NCT00939367|10976147|FG000|COMPLETED|First Intervention||15
9862717|NCT00939367|10976148|FG001|COMPLETED|First Intervention||15
9862718|NCT00939367|10976147|FG000|NOT COMPLETED|First Intervention||0
9862719|NCT00939367|10976148|FG001|NOT COMPLETED|First Intervention||0
9862720|NCT00939367|10976147|FG000|STARTED|Second Intervention||15
9862721|NCT00939367|10976148|FG001|STARTED|Second Intervention||15
9862722|NCT00939367|10976147|FG000|COMPLETED|Second Intervention||15
9862723|NCT00939367|10976148|FG001|COMPLETED|Second Intervention||15
9862724|NCT00939367|10976147|FG000|NOT COMPLETED|Second Intervention||0
9862725|NCT00939367|10976148|FG001|NOT COMPLETED|Second Intervention||0
9862726|NCT00939393|10976156|FG000|STARTED|Overall Study||37
9862727|NCT00939393|10976157|FG001|STARTED|Overall Study||35
9862728|NCT00939393|10976156|FG000|COMPLETED|Overall Study||33
9862729|NCT00939393|10976157|FG001|COMPLETED|Overall Study||35
9862730|NCT00939393|10976156|FG000|NOT COMPLETED|Overall Study||4
9862731|NCT00939393|10976157|FG001|NOT COMPLETED|Overall Study||0
9862732|NCT00939471|10976165|FG000|STARTED|Overall Study||44
9862733|NCT00939471|10976165|FG000|COMPLETED|Overall Study||33
9862734|NCT00939471|10976165|FG000|NOT COMPLETED|Overall Study||11
9862735|NCT00939484|10976172|FG000|STARTED|Overall Study||8
9862736|NCT00939484|10976173|FG001|STARTED|Overall Study||20
9862737|NCT00939484|10976174|FG002|STARTED|Overall Study||3
9862738|NCT00939484|10976172|FG000|COMPLETED|Overall Study||0
9862739|NCT00939484|10976173|FG001|COMPLETED|Overall Study||0
9862740|NCT00939484|10976174|FG002|COMPLETED|Overall Study||0
9862741|NCT00939484|10976172|FG000|NOT COMPLETED|Overall Study||8
9862742|NCT00939484|10976173|FG001|NOT COMPLETED|Overall Study||20
9862743|NCT00939484|10976174|FG002|NOT COMPLETED|Overall Study||3
9862744|NCT00939510|10976184|FG000|STARTED|Overall Study||32
9862745|NCT00939510|10976184|FG000|COMPLETED|Overall Study||31
9862746|NCT00939510|10976184|FG000|NOT COMPLETED|Overall Study||1
9862747|NCT00939523|10976188|FG000|STARTED|Overall Study||9
9862748|NCT00939523|10976188|FG000|COMPLETED|Overall Study||6
9862749|NCT00939523|10976188|FG000|NOT COMPLETED|Overall Study||3
9862750|NCT00939536|10976194|FG000|STARTED|First Intervention||12
9862751|NCT00939536|10976195|FG001|STARTED|First Intervention||12
9862752|NCT00939536|10976194|FG000|COMPLETED|First Intervention||12
9862753|NCT00939536|10976195|FG001|COMPLETED|First Intervention||12
9862754|NCT00939536|10976194|FG000|NOT COMPLETED|First Intervention||0
9862755|NCT00939536|10976195|FG001|NOT COMPLETED|First Intervention||0
9862756|NCT00939536|10976194|FG000|STARTED|Second Intervention||12
9862757|NCT00939536|10976195|FG001|STARTED|Second Intervention||12
9862758|NCT00939536|10976194|FG000|COMPLETED|Second Intervention||12
9862759|NCT00939536|10976195|FG001|COMPLETED|Second Intervention||12
9862760|NCT00939536|10976194|FG000|NOT COMPLETED|Second Intervention||0
9862761|NCT00939536|10976195|FG001|NOT COMPLETED|Second Intervention||0
9862762|NCT00939562|10976201|FG000|STARTED|Period 1||12
9862763|NCT00939562|10976202|FG001|STARTED|Period 1||12
9862764|NCT00939562|10976201|FG000|COMPLETED|Period 1||12
9862765|NCT00939562|10976202|FG001|COMPLETED|Period 1||12
9862766|NCT00939562|10976201|FG000|NOT COMPLETED|Period 1||0
9862767|NCT00939562|10976202|FG001|NOT COMPLETED|Period 1||0
9862768|NCT00939562|10976201|FG000|STARTED|Period 2||12
9862769|NCT00939562|10976202|FG001|STARTED|Period 2||12
10093700|NCT02346240|11222229|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093701|NCT02346240|11222230|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093702|NCT02346240|11222231|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093703|NCT02346240|11222232|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093704|NCT02346240|11222233|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093705|NCT02346240|11222234|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093706|NCT02346240|11222235|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10093707|NCT02346240|11222212|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093708|NCT02346240|11222213|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093709|NCT02346240|11222214|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093710|NCT02346240|11222215|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093711|NCT02346240|11222216|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10093712|NCT02346240|11222217|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
10093713|NCT02346240|11222218|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
10093714|NCT02346240|11222219|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
10093715|NCT02346240|11222220|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
10093716|NCT02346240|11222221|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
10093717|NCT02346240|11222222|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
10093718|NCT02346240|11222223|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
10093719|NCT02346240|11222224|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
10093720|NCT02346240|11222225|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
10093721|NCT02346240|11222226|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
10093722|NCT02346240|11222227|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
10113441|NCT02509117|11244197|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
9862770|NCT00939562|10976201|FG000|COMPLETED|Period 2||12
9862771|NCT00939562|10976202|FG001|COMPLETED|Period 2||12
9862772|NCT00939562|10976201|FG000|NOT COMPLETED|Period 2||0
9862773|NCT00939562|10976202|FG001|NOT COMPLETED|Period 2||0
9862774|NCT00939627|10976210|FG000|STARTED|Overall Study||27
9862775|NCT00939627|10976211|FG001|STARTED|Overall Study||28
9862776|NCT00939627|10976212|FG002|STARTED|Overall Study||0
9862777|NCT00939627|10976210|FG000|COMPLETED|Overall Study||0
9862778|NCT00939627|10976211|FG001|COMPLETED|Overall Study||0
9862779|NCT00939627|10976212|FG002|COMPLETED|Overall Study||0
9862780|NCT00939627|10976210|FG000|NOT COMPLETED|Overall Study||27
9862781|NCT00939627|10976211|FG001|NOT COMPLETED|Overall Study||28
9862782|NCT00939627|10976212|FG002|NOT COMPLETED|Overall Study||0
9862783|NCT00939640|10976218|FG000|STARTED|Overall Study||14
9862784|NCT00939640|10976218|FG000|COMPLETED|Overall Study||13
9862785|NCT00939640|10976218|FG000|NOT COMPLETED|Overall Study||1
9862786|NCT00939653|10976227|FG000|STARTED|Treatment Course 1||6
9862787|NCT00939653|10976227|FG000|COMPLETED|Treatment Course 1||6
9862788|NCT00939653|10976227|FG000|NOT COMPLETED|Treatment Course 1||0
9862789|NCT00939653|10976227|FG000|STARTED|Treatment Course 2||2
9862790|NCT00939653|10976227|FG000|COMPLETED|Treatment Course 2||2
9862791|NCT00939653|10976227|FG000|NOT COMPLETED|Treatment Course 2||0
9862792|NCT00939653|10976227|FG000|STARTED|Treatment Course 3||0
9862793|NCT00939653|10976227|FG000|COMPLETED|Treatment Course 3||0
9862794|NCT00939653|10976227|FG000|NOT COMPLETED|Treatment Course 3||0
9862795|NCT00939653|10976227|FG000|STARTED|Treatment Course 4||0
9862796|NCT00939653|10976227|FG000|COMPLETED|Treatment Course 4||0
9862797|NCT00939653|10976227|FG000|NOT COMPLETED|Treatment Course 4||0
9862798|NCT00939692|10976234|FG000|STARTED|Period 1 - First Intervention - 5 Days||13
9862799|NCT00939692|10976235|FG001|STARTED|Period 1 - First Intervention - 5 Days||13
9862800|NCT00939692|10976234|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12
9862801|NCT00939692|10976235|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13
9862802|NCT00939692|10976234|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
9862803|NCT00939692|10976235|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
9862804|NCT00939692|10976234|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12
9862805|NCT00939692|10976235|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13
9862806|NCT00939692|10976234|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12
9862807|NCT00939692|10976235|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12
9862808|NCT00939692|10976234|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
9862809|NCT00939692|10976235|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
9862810|NCT00939705|10976243|FG000|STARTED|Period 1 - First Intervention - 5 Days||9
9862811|NCT00939705|10976244|FG001|STARTED|Period 1 - First Intervention - 5 Days||9
9862812|NCT00939705|10976243|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9
9862813|NCT00939705|10976244|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9
9862814|NCT00939705|10976243|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
9862815|NCT00939705|10976244|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
9862816|NCT00939705|10976243|FG000|STARTED|Period 2 - Washout Period - 21 Days||9
9862817|NCT00939705|10976244|FG001|STARTED|Period 2 - Washout Period - 21 Days||9
9862818|NCT00939705|10976243|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9
9862819|NCT00939705|10976244|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9
9862820|NCT00939705|10976243|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
9862821|NCT00939705|10976244|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
9862822|NCT00939705|10976243|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9
9862823|NCT00939705|10976244|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9
9862824|NCT00939705|10976243|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9
9862825|NCT00939705|10976244|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9
9862826|NCT00939705|10976243|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
9862827|NCT00939705|10976244|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
9862828|NCT00939731|10976250|FG000|STARTED|First Intervention Period||12
9862829|NCT00939731|10976251|FG001|STARTED|First Intervention Period||12
9862830|NCT00939731|10976250|FG000|COMPLETED|First Intervention Period||12
9862831|NCT00939731|10976251|FG001|COMPLETED|First Intervention Period||12
9862832|NCT00939731|10976250|FG000|NOT COMPLETED|First Intervention Period||0
9862833|NCT00939731|10976251|FG001|NOT COMPLETED|First Intervention Period||0
9862834|NCT00939731|10976250|FG000|STARTED|Washout Period (at Least 14 Days)||12
9862835|NCT00939731|10976251|FG001|STARTED|Washout Period (at Least 14 Days)||12
9862836|NCT00939731|10976250|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
9862837|NCT00939731|10976251|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
9862838|NCT00939731|10976250|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9862839|NCT00939731|10976251|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9862840|NCT00939731|10976250|FG000|STARTED|Second Intervention Period||12
9862841|NCT00939731|10976251|FG001|STARTED|Second Intervention Period||12
9862842|NCT00939731|10976250|FG000|COMPLETED|Second Intervention Period||12
9862843|NCT00939731|10976251|FG001|COMPLETED|Second Intervention Period||12
9862844|NCT00939731|10976250|FG000|NOT COMPLETED|Second Intervention Period||0
9862845|NCT00939731|10976251|FG001|NOT COMPLETED|Second Intervention Period||0
9862846|NCT00939770|10976265|FG000|STARTED|Overall Study||6
9862847|NCT00939770|10976266|FG001|STARTED|Overall Study||8
9862848|NCT00939770|10976267|FG002|STARTED|Overall Study||23
9862849|NCT00939770|10976268|FG003|STARTED|Overall Study||12
9862850|NCT00939770|10976269|FG004|STARTED|Overall Study||38
9862851|NCT00939770|10976270|FG005|STARTED|Overall Study||11
9862852|NCT00939770|10976271|FG006|STARTED|Overall Study||14
9862853|NCT00939770|10976272|FG007|STARTED|Overall Study||10
9862854|NCT00939770|10976265|FG000|COMPLETED|Overall Study||1
9862855|NCT00939770|10976266|FG001|COMPLETED|Overall Study||0
9862856|NCT00939770|10976267|FG002|COMPLETED|Overall Study||3
9862857|NCT00939770|10976268|FG003|COMPLETED|Overall Study||1
9862858|NCT00939770|10976269|FG004|COMPLETED|Overall Study||1
9862859|NCT00939770|10976270|FG005|COMPLETED|Overall Study||0
9862860|NCT00939770|10976271|FG006|COMPLETED|Overall Study||0
9862861|NCT00939770|10976272|FG007|COMPLETED|Overall Study||0
9862862|NCT00939770|10976265|FG000|NOT COMPLETED|Overall Study||5
9862863|NCT00939770|10976266|FG001|NOT COMPLETED|Overall Study||8
9862864|NCT00939770|10976267|FG002|NOT COMPLETED|Overall Study||20
9862865|NCT00939770|10976268|FG003|NOT COMPLETED|Overall Study||11
9862866|NCT00939770|10976269|FG004|NOT COMPLETED|Overall Study||37
9862867|NCT00939770|10976270|FG005|NOT COMPLETED|Overall Study||11
9862868|NCT00939770|10976271|FG006|NOT COMPLETED|Overall Study||14
9862869|NCT00939770|10976272|FG007|NOT COMPLETED|Overall Study||10
9862870|NCT00939783|10976303|FG000|STARTED|Overall Study||649
9862871|NCT00939783|10976303|FG000|Treated|Overall Study||648
9862872|NCT00939783|10976303|FG000|COMPLETED|Overall Study||0
9862873|NCT00939783|10976303|FG000|NOT COMPLETED|Overall Study||649
9862874|NCT00939796|10976307|FG000|STARTED|Overall Study||16
9862875|NCT00939796|10976307|FG000|COMPLETED|Overall Study||16
9862876|NCT00939796|10976307|FG000|NOT COMPLETED|Overall Study||0
9862877|NCT00939809|10976311|FG000|STARTED|Overall Study||31
9862878|NCT00939809|10976311|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
9862879|NCT00939809|10976311|FG000|NOT COMPLETED|Overall Study||3
9862880|NCT00939822|10976317|FG000|STARTED|Overall Study||44
9862881|NCT00939822|10976318|FG001|STARTED|Overall Study||44
9862882|NCT00939822|10976317|FG000|COMPLETED|Overall Study||42
9862883|NCT00939822|10976318|FG001|COMPLETED|Overall Study||41
9862884|NCT00939822|10976317|FG000|NOT COMPLETED|Overall Study||2
9862885|NCT00939822|10976318|FG001|NOT COMPLETED|Overall Study||3
9862886|NCT00939874|10976324|FG000|STARTED|Overall Study||52
9862887|NCT00939874|10976324|FG000|Completed Week 48|Overall Study||37
9862888|NCT00939874|10976324|FG000|COMPLETED|Overall Study||32
9862889|NCT00939874|10976324|FG000|NOT COMPLETED|Overall Study||20
9862890|NCT00939900|10976330|FG000|STARTED|Overall Study||55
9862891|NCT00939900|10976331|FG001|STARTED|Overall Study||55
9862892|NCT00939900|10976330|FG000|COMPLETED|Overall Study||53
9862893|NCT00939900|10976331|FG001|COMPLETED|Overall Study||48
9862894|NCT00939900|10976330|FG000|NOT COMPLETED|Overall Study||2
9862895|NCT00939900|10976331|FG001|NOT COMPLETED|Overall Study||7
9862896|NCT00939952|10976337|FG000|STARTED|Overall Study||7
9862897|NCT00939952|10976337|FG000|COMPLETED|Overall Study||7
9862898|NCT00939952|10976337|FG000|NOT COMPLETED|Overall Study||0
9862899|NCT00939991|10976343|FG000|STARTED|Overall Study||9
9862900|NCT00939991|10976344|FG001|STARTED|Overall Study||39
9862901|NCT00939991|10976343|FG000|COMPLETED|Overall Study||9
9862902|NCT00939991|10976344|FG001|COMPLETED|Overall Study||39
9862903|NCT00939991|10976343|FG000|NOT COMPLETED|Overall Study||0
9862904|NCT00939991|10976344|FG001|NOT COMPLETED|Overall Study||0
9862905|NCT00940017|10976350|FG000|STARTED|Overall Study||24
9862906|NCT00940017|10976350|FG000|Subjects Treated|Overall Study||21
9862907|NCT00940017|10976350|FG000|COMPLETED|Overall Study||20
9862908|NCT00940017|10976350|FG000|NOT COMPLETED|Overall Study||4
9862909|NCT00940108|10976358|FG000|STARTED|Overall Study||82
9862910|NCT00940108|10976359|FG001|STARTED|Overall Study||80
9862911|NCT00940108|10976360|FG002|STARTED|Overall Study||103
9862912|NCT00940108|10976361|FG003|STARTED|Overall Study||104
9862913|NCT00940108|10976358|FG000|COMPLETED|Overall Study||77
9862914|NCT00940108|10976359|FG001|COMPLETED|Overall Study||71
9862915|NCT00940108|10976360|FG002|COMPLETED|Overall Study||100
9862916|NCT00940108|10976361|FG003|COMPLETED|Overall Study||99
9862917|NCT00940108|10976358|FG000|NOT COMPLETED|Overall Study||5
9862918|NCT00940108|10976359|FG001|NOT COMPLETED|Overall Study||9
9862919|NCT00940108|10976360|FG002|NOT COMPLETED|Overall Study||3
9862920|NCT00940108|10976361|FG003|NOT COMPLETED|Overall Study||5
9862921|NCT00940290|10976375|FG000|STARTED|Overall Study||54
9862922|NCT00940290|10976376|FG001|STARTED|Overall Study||53
9862923|NCT00940290|10976377|FG002|STARTED|Overall Study||55
9862924|NCT00940290|10976378|FG003|STARTED|Overall Study||54
9862925|NCT00940290|10976375|FG000|COMPLETED|Overall Study||54
9862926|NCT00940290|10976376|FG001|COMPLETED|Overall Study||53
9862927|NCT00940290|10976377|FG002|COMPLETED|Overall Study||55
9862928|NCT00940290|10976378|FG003|COMPLETED|Overall Study||54
9862929|NCT00940290|10976375|FG000|NOT COMPLETED|Overall Study||0
9862930|NCT00940290|10976376|FG001|NOT COMPLETED|Overall Study||0
9862931|NCT00940290|10976377|FG002|NOT COMPLETED|Overall Study||0
9862932|NCT00940290|10976378|FG003|NOT COMPLETED|Overall Study||0
9862933|NCT00940316|10976391|FG000|STARTED|Reached First Response at 8 Weeks||13
9862934|NCT00940316|10976392|FG001|STARTED|Reached First Response at 8 Weeks||13
9862935|NCT00940316|10976393|FG002|STARTED|Reached First Response at 8 Weeks||2
9862936|NCT00940316|10976391|FG000|COMPLETED|Reached First Response at 8 Weeks||10
9862937|NCT00940316|10976392|FG001|COMPLETED|Reached First Response at 8 Weeks||9
9862938|NCT00940316|10976393|FG002|COMPLETED|Reached First Response at 8 Weeks||2
9862939|NCT00940316|10976391|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3
9862940|NCT00940316|10976392|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4
9862941|NCT00940316|10976393|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0
9862942|NCT00940316|10976391|FG000|STARTED|Moved on to be Treated Cycle 5||10
9862943|NCT00940316|10976392|FG001|STARTED|Moved on to be Treated Cycle 5||9
9862944|NCT00940316|10976393|FG002|STARTED|Moved on to be Treated Cycle 5||2
9862945|NCT00940316|10976391|FG000|COMPLETED|Moved on to be Treated Cycle 5||8
9862946|NCT00940316|10976392|FG001|COMPLETED|Moved on to be Treated Cycle 5||9
9862947|NCT00940316|10976393|FG002|COMPLETED|Moved on to be Treated Cycle 5||2
9862948|NCT00940316|10976391|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2
9862949|NCT00940316|10976392|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0
9862950|NCT00940316|10976393|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0
9862951|NCT00940316|10976391|FG000|STARTED|Treated After Cycle 5||8
9862952|NCT00940316|10976392|FG001|STARTED|Treated After Cycle 5||9
9862953|NCT00940316|10976393|FG002|STARTED|Treated After Cycle 5||2
9862954|NCT00940316|10976391|FG000|COMPLETED|Treated After Cycle 5||8
9862955|NCT00940316|10976392|FG001|COMPLETED|Treated After Cycle 5||8
9862956|NCT00940316|10976393|FG002|COMPLETED|Treated After Cycle 5||1
9862957|NCT00940316|10976391|FG000|NOT COMPLETED|Treated After Cycle 5||0
9862958|NCT00940316|10976392|FG001|NOT COMPLETED|Treated After Cycle 5||1
9862959|NCT00940316|10976393|FG002|NOT COMPLETED|Treated After Cycle 5||1
9862960|NCT00940316|10976391|FG000|STARTED|Crossed Over to Arm A After Progression||0
9862961|NCT00940316|10976392|FG001|STARTED|Crossed Over to Arm A After Progression||3
9862962|NCT00940316|10976393|FG002|STARTED|Crossed Over to Arm A After Progression||0
9862963|NCT00940316|10976391|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0
9862964|NCT00940316|10976392|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3
9862965|NCT00940316|10976393|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0
9862966|NCT00940316|10976391|FG000|COMPLETED|Crossed Over to Arm A After Progression||0
9862967|NCT00940316|10976392|FG001|COMPLETED|Crossed Over to Arm A After Progression||3
9862968|NCT00940316|10976393|FG002|COMPLETED|Crossed Over to Arm A After Progression||0
9862969|NCT00940316|10976391|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0
9862970|NCT00940316|10976392|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0
9862971|NCT00940316|10976393|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0
9862972|NCT00940316|10976391|FG000|STARTED|Follow up Every 3 Months||13
9862973|NCT00940316|10976392|FG001|STARTED|Follow up Every 3 Months||13
9862974|NCT00940316|10976393|FG002|STARTED|Follow up Every 3 Months||2
9862975|NCT00940316|10976391|FG000|COMPLETED|Follow up Every 3 Months||13
9862976|NCT00940316|10976392|FG001|COMPLETED|Follow up Every 3 Months||13
9862977|NCT00940316|10976393|FG002|COMPLETED|Follow up Every 3 Months||2
9862978|NCT00940316|10976391|FG000|NOT COMPLETED|Follow up Every 3 Months||0
9862979|NCT00940316|10976392|FG001|NOT COMPLETED|Follow up Every 3 Months||0
9862980|NCT00940316|10976393|FG002|NOT COMPLETED|Follow up Every 3 Months||0
9862981|NCT00940342|10976412|FG000|STARTED|Overall Study||50
9862982|NCT00940342|10976413|FG001|STARTED|Overall Study||40
9862983|NCT00940342|10976414|FG002|STARTED|Overall Study||40
9862984|NCT00940342|10976412|FG000|COMPLETED|Overall Study||50
9862985|NCT00940342|10976413|FG001|COMPLETED|Overall Study||38
9862986|NCT00940342|10976414|FG002|COMPLETED|Overall Study||39
9862987|NCT00940342|10976412|FG000|NOT COMPLETED|Overall Study||0
9862988|NCT00940342|10976413|FG001|NOT COMPLETED|Overall Study||2
9862989|NCT00940342|10976414|FG002|NOT COMPLETED|Overall Study||1
9862990|NCT00940446|10976424|FG000|STARTED|Overall Study||30
9862991|NCT00940446|10976425|FG001|STARTED|Overall Study||30
9862992|NCT00940446|10976424|FG000|COMPLETED|Overall Study||30
9862993|NCT00940446|10976425|FG001|COMPLETED|Overall Study||30
9862994|NCT00940446|10976424|FG000|NOT COMPLETED|Overall Study||0
9862995|NCT00940446|10976425|FG001|NOT COMPLETED|Overall Study||0
9862996|NCT00940485|10976435|FG000|STARTED|Overall Study||97
9862997|NCT00940485|10976436|FG001|STARTED|Overall Study||100
9862998|NCT00940485|10976435|FG000|COMPLETED|Overall Study||82
9862999|NCT00940485|10976436|FG001|COMPLETED|Overall Study||93
9863000|NCT00940485|10976435|FG000|NOT COMPLETED|Overall Study||15
9863001|NCT00940485|10976436|FG001|NOT COMPLETED|Overall Study||7
9863002|NCT00940537|10976444|FG000|STARTED|Overall Study||5
9863003|NCT00940537|10976445|FG001|STARTED|Overall Study||9
9863004|NCT00940537|10976444|FG000|COMPLETED|Overall Study||5
9863005|NCT00940537|10976445|FG001|COMPLETED|Overall Study||9
9863006|NCT00940537|10976444|FG000|NOT COMPLETED|Overall Study||0
9863007|NCT00940537|10976445|FG001|NOT COMPLETED|Overall Study||0
9863008|NCT00940576|10976452|FG000|STARTED|Overall Study||8
9863009|NCT00940576|10976453|FG001|STARTED|Overall Study||9
9863010|NCT00940576|10976452|FG000|COMPLETED|Overall Study||8
9863011|NCT00940576|10976453|FG001|COMPLETED|Overall Study||9
9863012|NCT00940576|10976452|FG000|NOT COMPLETED|Overall Study||0
9863013|NCT00940576|10976453|FG001|NOT COMPLETED|Overall Study||0
9863014|NCT00940589|10976462|FG000|STARTED|Overall Study||39
9863015|NCT00940589|10976463|FG001|STARTED|Overall Study||34
9863016|NCT00940589|10976462|FG000|COMPLETED|Overall Study||31
9863017|NCT00940589|10976463|FG001|COMPLETED|Overall Study||29
9863018|NCT00940589|10976462|FG000|NOT COMPLETED|Overall Study||8
9863019|NCT00940589|10976463|FG001|NOT COMPLETED|Overall Study||5
9863020|NCT00940602|10976471|FG000|STARTED|Overall Study||149
9863021|NCT00940602|10976472|FG001|STARTED|Overall Study||76
9863022|NCT00940602|10976471|FG000|Safety Analysis Set|Overall Study||148
9863023|NCT00940602|10976472|FG001|Safety Analysis Set|Overall Study||76
9863024|NCT00940602|10976471|FG000|Full Analysis Set|Overall Study||149
9863025|NCT00940602|10976472|FG001|Full Analysis Set|Overall Study||76
9863026|NCT00940602|10976471|FG000|Treated|Overall Study||148
9863027|NCT00940602|10976472|FG001|Treated|Overall Study||76
9863028|NCT00940602|10976471|FG000|Untreated|Overall Study||1
9863029|NCT00940602|10976472|FG001|Untreated|Overall Study||0
9863030|NCT00940602|10976471|FG000|COMPLETED|Overall Study||0
9863031|NCT00940602|10976472|FG001|COMPLETED|Overall Study||0
9863032|NCT00940602|10976471|FG000|NOT COMPLETED|Overall Study||149
9863033|NCT00940602|10976472|FG001|NOT COMPLETED|Overall Study||76
9863034|NCT00940771|10976479|FG000|STARTED|Pre-Entry||10
9863035|NCT00940771|10976479|FG000|COMPLETED|Pre-Entry||10
9863036|NCT00940771|10976479|FG000|NOT COMPLETED|Pre-Entry||0
9863037|NCT00940771|10976479|FG000|STARTED|4 Weeks||10
9863038|NCT00940771|10976479|FG000|COMPLETED|4 Weeks||10
9863039|NCT00940771|10976479|FG000|NOT COMPLETED|4 Weeks||0
9863040|NCT00940771|10976479|FG000|STARTED|12 Weeks||10
9863041|NCT00940771|10976479|FG000|COMPLETED|12 Weeks||10
9863042|NCT00940771|10976479|FG000|NOT COMPLETED|12 Weeks||0
9863043|NCT00940771|10976479|FG000|STARTED|24 Weeks||10
9863044|NCT00940771|10976479|FG000|COMPLETED|24 Weeks||10
9863045|NCT00940771|10976479|FG000|NOT COMPLETED|24 Weeks||0
9863046|NCT00940823|10976485|FG000|STARTED|Overall Study||124
9863047|NCT00940823|10976486|FG001|STARTED|Overall Study||114
9863048|NCT00940823|10976485|FG000|COMPLETED|Overall Study||89
9863049|NCT00940823|10976486|FG001|COMPLETED|Overall Study||82
9863050|NCT00940823|10976485|FG000|NOT COMPLETED|Overall Study||35
9863051|NCT00940823|10976486|FG001|NOT COMPLETED|Overall Study||32
9863052|NCT00940875|10976496|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
9863053|NCT00940875|10976497|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
9863054|NCT00940875|10976496|FG000|COMPLETED|Treatment Phase||5
9863055|NCT00940875|10976497|FG001|COMPLETED|Treatment Phase||4
9863056|NCT00940875|10976496|FG000|NOT COMPLETED|Treatment Phase||26
9863057|NCT00940875|10976497|FG001|NOT COMPLETED|Treatment Phase||19
9863058|NCT00940875|10976496|FG000|STARTED|Post-Study Treatment||0
9863059|NCT00940875|10976497|FG001|STARTED|Post-Study Treatment||4
9863060|NCT00940875|10976496|FG000|COMPLETED|Post-Study Treatment||0
9863061|NCT00940875|10976497|FG001|COMPLETED|Post-Study Treatment||1
9863062|NCT00940875|10976496|FG000|NOT COMPLETED|Post-Study Treatment||0
9863063|NCT00940875|10976497|FG001|NOT COMPLETED|Post-Study Treatment||3
9863064|NCT00940888|10976504|FG000|STARTED|Overall Study|Total number of subjects consented|1701
9863065|NCT00940888|10976504|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
9863066|NCT00940888|10976504|FG000|NOT COMPLETED|Overall Study||835
9863067|NCT00940901|10976510|FG000|STARTED|Weeks 1-8 (Phase 1)||6
9863068|NCT00940901|10976511|FG001|STARTED|Weeks 1-8 (Phase 1)||7
9863069|NCT00940901|10976510|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6
9863070|NCT00940901|10976511|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7
9863071|NCT00940901|10976510|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
9863072|NCT00940901|10976511|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
9863073|NCT00940901|10976510|FG000|STARTED|Week 9-16 (Phase 2)||6
9863074|NCT00940901|10976511|FG001|STARTED|Week 9-16 (Phase 2)||7
9863075|NCT00940901|10976510|FG000|COMPLETED|Week 9-16 (Phase 2)||4
9863076|NCT00940901|10976511|FG001|COMPLETED|Week 9-16 (Phase 2)||4
9863077|NCT00940901|10976510|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2
9863078|NCT00940901|10976511|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3
9863079|NCT00940927|10976519|FG000|STARTED|Overall Study||81
9863080|NCT00940927|10976519|FG000|COMPLETED|Overall Study||81
9863081|NCT00940927|10976519|FG000|NOT COMPLETED|Overall Study||0
9863082|NCT00940992|10976526|FG000|STARTED|Overall Study||32
9863083|NCT00940992|10976527|FG001|STARTED|Overall Study||30
9863084|NCT00940992|10976528|FG002|STARTED|Overall Study||30
9863085|NCT00940992|10976526|FG000|COMPLETED|Overall Study||28
9863086|NCT00940992|10976527|FG001|COMPLETED|Overall Study||28
9863087|NCT00940992|10976528|FG002|COMPLETED|Overall Study||28
9863088|NCT00940992|10976526|FG000|NOT COMPLETED|Overall Study||4
9863089|NCT00940992|10976527|FG001|NOT COMPLETED|Overall Study||2
9863090|NCT00940992|10976528|FG002|NOT COMPLETED|Overall Study||2
9863091|NCT00941005|10976538|FG000|STARTED|Overall Study||61
9863092|NCT00941005|10976539|FG001|STARTED|Overall Study||61
9863093|NCT00941005|10976538|FG000|COMPLETED|Overall Study||61
9863094|NCT00941005|10976539|FG001|COMPLETED|Overall Study||61
9863095|NCT00941005|10976538|FG000|NOT COMPLETED|Overall Study||0
9863096|NCT00941005|10976539|FG001|NOT COMPLETED|Overall Study||0
9863097|NCT00941031|10976551|FG000|STARTED|Induction Period||66
9863098|NCT00941031|10976552|FG001|STARTED|Induction Period||138
9863099|NCT00941031|10976553|FG002|STARTED|Induction Period||133
9863100|NCT00941031|10976554|FG003|STARTED|Induction Period||67
9863101|NCT00941031|10976555|FG004|STARTED|Induction Period||0
9863102|NCT00941031|10976556|FG005|STARTED|Induction Period||0
9863103|NCT00941031|10976557|FG006|STARTED|Induction Period||0
9863104|NCT00941031|10976551|FG000|COMPLETED|Induction Period||61
9863105|NCT00941031|10976552|FG001|COMPLETED|Induction Period||134
9863106|NCT00941031|10976553|FG002|COMPLETED|Induction Period||127
9863107|NCT00941031|10976554|FG003|COMPLETED|Induction Period||58
9863108|NCT00941031|10976555|FG004|COMPLETED|Induction Period||0
10093723|NCT02346240|11222228|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
10093724|NCT02346240|11222229|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093725|NCT02346240|11222230|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093726|NCT02346240|11222231|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
9863109|NCT00941031|10976556|FG005|COMPLETED|Induction Period||0
9863110|NCT00941031|10976557|FG006|COMPLETED|Induction Period||0
9863111|NCT00941031|10976551|FG000|NOT COMPLETED|Induction Period||5
9863112|NCT00941031|10976552|FG001|NOT COMPLETED|Induction Period||4
9863113|NCT00941031|10976553|FG002|NOT COMPLETED|Induction Period||6
9863114|NCT00941031|10976554|FG003|NOT COMPLETED|Induction Period||9
9863115|NCT00941031|10976555|FG004|NOT COMPLETED|Induction Period||0
9863116|NCT00941031|10976556|FG005|NOT COMPLETED|Induction Period||0
9863117|NCT00941031|10976557|FG006|NOT COMPLETED|Induction Period||0
9863118|NCT00941031|10976551|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
9863119|NCT00941031|10976552|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
9863120|NCT00941031|10976553|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
9863121|NCT00941031|10976554|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
10093727|NCT02346240|11222232|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093728|NCT02346240|11222233|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093729|NCT02346240|11222234|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093730|NCT02346240|11222235|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093731|NCT02346240|11222212|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093732|NCT02346240|11222213|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093733|NCT02346240|11222214|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093734|NCT02346240|11222215|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093735|NCT02346240|11222216|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093736|NCT02346240|11222217|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10093737|NCT02346240|11222218|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
9863122|NCT00941031|10976555|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
9863123|NCT00941031|10976556|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
9863124|NCT00941031|10976557|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
9863125|NCT00941031|10976551|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
9863126|NCT00941031|10976552|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
9863127|NCT00941031|10976553|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
9863128|NCT00941031|10976554|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
9863129|NCT00941031|10976555|FG004|COMPLETED|Maintenance Period||56
9863130|NCT00941031|10976556|FG005|COMPLETED|Maintenance Period||61
9863131|NCT00941031|10976557|FG006|COMPLETED|Maintenance Period||204
9863132|NCT00941031|10976551|FG000|NOT COMPLETED|Maintenance Period||0
9863133|NCT00941031|10976552|FG001|NOT COMPLETED|Maintenance Period||0
9863134|NCT00941031|10976553|FG002|NOT COMPLETED|Maintenance Period||0
9863135|NCT00941031|10976554|FG003|NOT COMPLETED|Maintenance Period||0
9863136|NCT00941031|10976555|FG004|NOT COMPLETED|Maintenance Period||9
9863137|NCT00941031|10976556|FG005|NOT COMPLETED|Maintenance Period||6
9863138|NCT00941031|10976557|FG006|NOT COMPLETED|Maintenance Period||43
9863139|NCT00941070|10976576|FG000|STARTED|Overall Study||26
9863140|NCT00941070|10976576|FG000|COMPLETED|Overall Study||25
9863141|NCT00941070|10976576|FG000|NOT COMPLETED|Overall Study||1
10093738|NCT02346240|11222219|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10093739|NCT02346240|11222220|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
10093740|NCT02346240|11222221|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10093741|NCT02346240|11222222|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10093742|NCT02346240|11222223|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10093743|NCT02346240|11222224|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093744|NCT02346240|11222225|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
10093745|NCT02346240|11222226|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
10093746|NCT02346240|11222227|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
10093747|NCT02346240|11222228|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10093748|NCT02346240|11222229|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093749|NCT02346240|11222230|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093750|NCT02346240|11222231|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093751|NCT02346240|11222232|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093752|NCT02346240|11222233|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093753|NCT02346240|11222234|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093754|NCT02346240|11222235|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10093755|NCT02346240|11222212|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093756|NCT02346240|11222213|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093757|NCT02346240|11222214|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093758|NCT02346240|11222215|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093759|NCT02346240|11222216|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093760|NCT02346240|11222217|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093761|NCT02346240|11222218|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093762|NCT02346240|11222219|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093763|NCT02346240|11222220|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093764|NCT02346240|11222221|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093765|NCT02346240|11222222|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093766|NCT02346240|11222223|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093767|NCT02346240|11222224|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093768|NCT02346240|11222225|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093769|NCT02346240|11222226|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093770|NCT02346240|11222227|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0
10239820|NCT01780636|11371554|FG000|NOT COMPLETED|Overall Study||0
9863142|NCT00941304|10976587|FG000|STARTED|Overall Study||31
10093771|NCT02346240|11222228|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0
10093772|NCT02346240|11222229|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34
10093773|NCT02346240|11222230|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122
10093774|NCT02346240|11222231|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41
10093775|NCT02346240|11222232|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48
10093776|NCT02346240|11222233|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177
9863143|NCT00941304|10976588|FG001|STARTED|Overall Study||30
9863144|NCT00941304|10976589|FG002|STARTED|Overall Study||31
9863145|NCT00941304|10976590|FG003|STARTED|Overall Study||30
9863146|NCT00941304|10976591|FG004|STARTED|Overall Study||31
9863147|NCT00941304|10976587|FG000|COMPLETED|Overall Study||30
9863148|NCT00941304|10976588|FG001|COMPLETED|Overall Study||30
9863149|NCT00941304|10976589|FG002|COMPLETED|Overall Study||31
9863150|NCT00941304|10976590|FG003|COMPLETED|Overall Study||30
9863151|NCT00941304|10976591|FG004|COMPLETED|Overall Study||31
9863152|NCT00941304|10976587|FG000|NOT COMPLETED|Overall Study||1
9863153|NCT00941304|10976588|FG001|NOT COMPLETED|Overall Study||0
9863154|NCT00941304|10976589|FG002|NOT COMPLETED|Overall Study||0
9863155|NCT00941304|10976590|FG003|NOT COMPLETED|Overall Study||0
9863156|NCT00941304|10976591|FG004|NOT COMPLETED|Overall Study||0
9863157|NCT00941330|10976605|FG000|STARTED|Overall Study||15
9863158|NCT00941330|10976606|FG001|STARTED|Overall Study||11
10093777|NCT02346240|11222234|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34
10093778|NCT02346240|11222235|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16
10093779|NCT02346240|11222212|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093780|NCT02346240|11222213|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093781|NCT02346240|11222214|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093782|NCT02346240|11222215|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093783|NCT02346240|11222216|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093784|NCT02346240|11222217|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093785|NCT02346240|11222218|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093786|NCT02346240|11222219|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093787|NCT02346240|11222220|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093788|NCT02346240|11222221|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093789|NCT02346240|11222222|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093790|NCT02346240|11222223|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093791|NCT02346240|11222224|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093792|NCT02346240|11222225|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093793|NCT02346240|11222226|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093794|NCT02346240|11222227|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093795|NCT02346240|11222228|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093796|NCT02346240|11222229|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
10093797|NCT02346240|11222230|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
10093798|NCT02346240|11222231|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
10093799|NCT02346240|11222232|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
10093800|NCT02346240|11222233|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
10093801|NCT02346240|11222234|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
10093802|NCT02346240|11222235|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
10093803|NCT02346240|11222212|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093804|NCT02346240|11222213|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093805|NCT02346240|11222214|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093806|NCT02346240|11222215|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093807|NCT02346240|11222216|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093808|NCT02346240|11222217|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093809|NCT02346240|11222218|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093810|NCT02346240|11222219|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093811|NCT02346240|11222220|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093812|NCT02346240|11222221|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093813|NCT02346240|11222222|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093814|NCT02346240|11222223|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093815|NCT02346240|11222224|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093816|NCT02346240|11222225|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093817|NCT02346240|11222226|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093818|NCT02346240|11222227|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093819|NCT02346240|11222228|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10093820|NCT02346240|11222229|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
10093821|NCT02346240|11222230|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
10093822|NCT02346240|11222231|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
10093823|NCT02346240|11222232|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
10093824|NCT02346240|11222233|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
9863159|NCT00941330|10976605|FG000|COMPLETED|Overall Study||14
9863160|NCT00941330|10976606|FG001|COMPLETED|Overall Study||9
9863161|NCT00941330|10976605|FG000|NOT COMPLETED|Overall Study||1
9863162|NCT00941330|10976606|FG001|NOT COMPLETED|Overall Study||2
9863163|NCT00941603|10976618|FG000|STARTED|Overall Study||104
10093825|NCT02346240|11222234|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
10093826|NCT02346240|11222235|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
10093827|NCT02346370|11222260|FG000|STARTED|Overall Study||8
9863164|NCT00941603|10976619|FG001|STARTED|Overall Study||105
9863165|NCT00941603|10976620|FG002|STARTED|Overall Study||104
9863166|NCT00941603|10976621|FG003|STARTED|Overall Study||104
9863167|NCT00941603|10976622|FG004|STARTED|Overall Study||105
9863168|NCT00941603|10976623|FG005|STARTED|Overall Study||97
9863169|NCT00941603|10976618|FG000|COMPLETED|Overall Study||93
9863170|NCT00941603|10976619|FG001|COMPLETED|Overall Study||89
9863171|NCT00941603|10976620|FG002|COMPLETED|Overall Study||99
9863172|NCT00941603|10976621|FG003|COMPLETED|Overall Study||100
9863173|NCT00941603|10976622|FG004|COMPLETED|Overall Study||101
9863174|NCT00941603|10976623|FG005|COMPLETED|Overall Study||94
9863175|NCT00941603|10976618|FG000|NOT COMPLETED|Overall Study||11
9863176|NCT00941603|10976619|FG001|NOT COMPLETED|Overall Study||16
9863177|NCT00941603|10976620|FG002|NOT COMPLETED|Overall Study||5
9863178|NCT00941603|10976621|FG003|NOT COMPLETED|Overall Study||4
9863179|NCT00941603|10976622|FG004|NOT COMPLETED|Overall Study||4
9863180|NCT00941603|10976623|FG005|NOT COMPLETED|Overall Study||3
9863181|NCT00941655|10976639|FG000|STARTED|Overall Study||8
9863182|NCT00941655|10976640|FG001|STARTED|Overall Study||7
9863183|NCT00941655|10976639|FG000|COMPLETED|Overall Study||3
9863184|NCT00941655|10976640|FG001|COMPLETED|Overall Study||2
9863185|NCT00941655|10976639|FG000|NOT COMPLETED|Overall Study||5
9863186|NCT00941655|10976640|FG001|NOT COMPLETED|Overall Study||5
9863187|NCT00941668|10976649|FG000|STARTED|Overall Study||24
9863188|NCT00941668|10976650|FG001|STARTED|Overall Study||25
9863189|NCT00941668|10976649|FG000|COMPLETED|Overall Study||0
9863190|NCT00941668|10976650|FG001|COMPLETED|Overall Study||0
9863191|NCT00941668|10976649|FG000|NOT COMPLETED|Overall Study||24
9863192|NCT00941668|10976650|FG001|NOT COMPLETED|Overall Study||25
9863193|NCT00941681|10976659|FG000|STARTED|Overall Study||12
9863194|NCT00941681|10976660|FG001|STARTED|Overall Study||11
9863195|NCT00941681|10976661|FG002|STARTED|Overall Study||12
9863196|NCT00941681|10976659|FG000|COMPLETED|Overall Study||12
9863197|NCT00941681|10976660|FG001|COMPLETED|Overall Study||10
9863198|NCT00941681|10976661|FG002|COMPLETED|Overall Study||12
9863199|NCT00941681|10976659|FG000|NOT COMPLETED|Overall Study||0
9863200|NCT00941681|10976660|FG001|NOT COMPLETED|Overall Study||1
9863201|NCT00941681|10976661|FG002|NOT COMPLETED|Overall Study||0
9863202|NCT00941720|10976669|FG000|STARTED|Overall Study||71
9863203|NCT00941720|10976669|FG000|COMPLETED|Overall Study||57
9863204|NCT00941720|10976669|FG000|NOT COMPLETED|Overall Study||14
9863205|NCT00941733|10976675|FG000|STARTED|Overall Study||239
9863206|NCT00941733|10976676|FG001|STARTED|Overall Study||119
9863207|NCT00941733|10976675|FG000|COMPLETED|Overall Study|1 year follow-up|165
9863208|NCT00941733|10976676|FG001|COMPLETED|Overall Study|1 year follow-up|91
9863209|NCT00941733|10976675|FG000|NOT COMPLETED|Overall Study||74
9863210|NCT00941733|10976676|FG001|NOT COMPLETED|Overall Study||28
9863211|NCT00941798|10976684|FG000|STARTED|Overall Study||755
9863212|NCT00941798|10976685|FG001|STARTED|Overall Study||763
9863213|NCT00941798|10976684|FG000|Full Analysis Set|Overall Study||749
9863214|NCT00941798|10976685|FG001|Full Analysis Set|Overall Study||759
9863215|NCT00941798|10976684|FG000|COMPLETED|Overall Study||561
10093828|NCT02346370|11222261|FG001|STARTED|Overall Study||4
10093829|NCT02346370|11222262|FG002|STARTED|Overall Study||4
10093830|NCT02346370|11222260|FG000|COMPLETED|Overall Study||0
10093831|NCT02346370|11222261|FG001|COMPLETED|Overall Study||0
10093832|NCT02346370|11222262|FG002|COMPLETED|Overall Study||0
10093833|NCT02346370|11222260|FG000|NOT COMPLETED|Overall Study||8
10093834|NCT02346370|11222261|FG001|NOT COMPLETED|Overall Study||4
10093835|NCT02346370|11222262|FG002|NOT COMPLETED|Overall Study||4
10093836|NCT02346383|11222272|FG000|STARTED|Overall Study||40
10093837|NCT02346383|11222272|FG000|COMPLETED|Overall Study||40
10093838|NCT02346383|11222272|FG000|NOT COMPLETED|Overall Study||0
10093839|NCT02346461|11222282|FG000|STARTED|Overall Study||6
10093840|NCT02346461|11222283|FG001|STARTED|Overall Study||6
10093841|NCT02346461|11222282|FG000|COMPLETED|Overall Study||6
10093842|NCT02346461|11222283|FG001|COMPLETED|Overall Study||6
10093843|NCT02346461|11222282|FG000|NOT COMPLETED|Overall Study||0
10093844|NCT02346461|11222283|FG001|NOT COMPLETED|Overall Study||0
10093845|NCT02346643|11222290|FG000|STARTED|Overall Study||41
10093846|NCT02346643|11222290|FG000|Received Trial System|Overall Study||29
10093847|NCT02346643|11222290|FG000|Received Permanent System|Overall Study||31
10093848|NCT02346643|11222290|FG000|COMPLETED|Overall Study||6
10093849|NCT02346643|11222290|FG000|NOT COMPLETED|Overall Study||35
10093850|NCT02346708|11222296|FG000|STARTED|Overall Study||24
10093851|NCT02346708|11222297|FG001|STARTED|Overall Study||25
10093852|NCT02346708|11222296|FG000|COMPLETED|Overall Study||22
10093853|NCT02346708|11222297|FG001|COMPLETED|Overall Study||24
9863216|NCT00941798|10976685|FG001|COMPLETED|Overall Study||578
9863217|NCT00941798|10976684|FG000|NOT COMPLETED|Overall Study||194
9863218|NCT00941798|10976685|FG001|NOT COMPLETED|Overall Study||185
9863219|NCT00941863|10976696|FG000|STARTED|Until Primary Completion Date (PCD)||7
9863220|NCT00941863|10976697|FG001|STARTED|Until Primary Completion Date (PCD)||3
9863221|NCT00941863|10976698|FG002|STARTED|Until Primary Completion Date (PCD)||12
9863222|NCT00941863|10976699|FG003|STARTED|Until Primary Completion Date (PCD)||17
9863223|NCT00941863|10976700|FG004|STARTED|Until Primary Completion Date (PCD)||119
9863224|NCT00941863|10976696|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
9863225|NCT00941863|10976697|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
9863226|NCT00941863|10976698|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
9863227|NCT00941863|10976699|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
9863228|NCT00941863|10976700|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
10093854|NCT02346708|11222296|FG000|NOT COMPLETED|Overall Study||2
9863229|NCT00941863|10976696|FG000|COMPLETED|Until Primary Completion Date (PCD)||0
9863230|NCT00941863|10976697|FG001|COMPLETED|Until Primary Completion Date (PCD)||0
10093855|NCT02346708|11222297|FG001|NOT COMPLETED|Overall Study||1
10093856|NCT02346721|11222304|FG000|STARTED|Overall Study||111
9863231|NCT00941863|10976698|FG002|COMPLETED|Until Primary Completion Date (PCD)||0
9863232|NCT00941863|10976699|FG003|COMPLETED|Until Primary Completion Date (PCD)||0
9863233|NCT00941863|10976700|FG004|COMPLETED|Until Primary Completion Date (PCD)||25
10093857|NCT02346721|11222304|FG000|COMPLETED|Overall Study||107
10093858|NCT02346721|11222304|FG000|NOT COMPLETED|Overall Study||4
10093859|NCT02346903|11222310|FG000|STARTED|Overall Study||99
10093860|NCT02346903|11222310|FG000|COMPLETED|Overall Study||99
10093861|NCT02346903|11222310|FG000|NOT COMPLETED|Overall Study||0
10093862|NCT02346916|11222314|FG000|STARTED|Overall Study||20
10093863|NCT02346916|11222314|FG000|COMPLETED|Overall Study||20
10093864|NCT02346916|11222314|FG000|NOT COMPLETED|Overall Study||0
10093865|NCT02347072|11222318|FG000|STARTED|Overall Study||80
10093866|NCT02347072|11222318|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75
10093867|NCT02347072|11222318|FG000|Placebo MDI|Overall Study||72
10093868|NCT02347072|11222318|FG000|Spiriva Respimat 5 µg|Overall Study||73
10093869|NCT02347072|11222318|FG000|COMPLETED|Overall Study||62
10093870|NCT02347072|11222318|FG000|NOT COMPLETED|Overall Study||18
10093871|NCT02347085|11222326|FG000|STARTED|Overall Study||43
10093872|NCT02347085|11222326|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40
10093873|NCT02347085|11222326|FG000|Placebo MDI|Overall Study||40
10093874|NCT02347085|11222326|FG000|COMPLETED|Overall Study||33
10093875|NCT02347085|11222326|FG000|NOT COMPLETED|Overall Study||10
10093876|NCT02347098|11222334|FG000|STARTED|Overall Study||63
10093877|NCT02347098|11222335|FG001|STARTED|Overall Study||66
10093878|NCT02347098|11222334|FG000|COMPLETED|Overall Study||56
10093879|NCT02347098|11222335|FG001|COMPLETED|Overall Study||58
10093880|NCT02347098|11222334|FG000|NOT COMPLETED|Overall Study||7
10093881|NCT02347098|11222335|FG001|NOT COMPLETED|Overall Study||8
10093882|NCT02347124|11222343|FG000|STARTED|Overall Study||360
10093883|NCT02347124|11222344|FG001|STARTED|Overall Study||358
10093884|NCT02347124|11222343|FG000|2 Month Follow-up|Overall Study||298
10093885|NCT02347124|11222344|FG001|2 Month Follow-up|Overall Study||275
10093886|NCT02347124|11222343|FG000|COMPLETED|Overall Study||267
10093887|NCT02347124|11222344|FG001|COMPLETED|Overall Study||259
10093888|NCT02347124|11222343|FG000|NOT COMPLETED|Overall Study||93
10093889|NCT02347124|11222344|FG001|NOT COMPLETED|Overall Study||99
10093890|NCT02347176|11222354|FG000|STARTED|Overall Study||51
10093891|NCT02347176|11222355|FG001|STARTED|Overall Study||50
10093892|NCT02347176|11222356|FG002|STARTED|Overall Study||51
10093893|NCT02347176|11222357|FG003|STARTED|Overall Study||52
10093894|NCT02347176|11222354|FG000|COMPLETED|Overall Study||39
10093895|NCT02347176|11222355|FG001|COMPLETED|Overall Study||40
10093896|NCT02347176|11222356|FG002|COMPLETED|Overall Study||43
10093897|NCT02347176|11222357|FG003|COMPLETED|Overall Study||48
10093898|NCT02347176|11222354|FG000|NOT COMPLETED|Overall Study||12
10093899|NCT02347176|11222355|FG001|NOT COMPLETED|Overall Study||10
10093900|NCT02347176|11222356|FG002|NOT COMPLETED|Overall Study||8
10093901|NCT02347176|11222357|FG003|NOT COMPLETED|Overall Study||4
10093902|NCT02347189|11222367|FG000|STARTED|Overall Study||39
10093903|NCT02347189|11222367|FG000|Catheterized|Overall Study||39
10093904|NCT02347189|11222367|FG000|Implanted|Overall Study||30
10093905|NCT02347189|11222367|FG000|Implanted > 24 Hours|Overall Study||30
10093906|NCT02347189|11222367|FG000|COMPLETED|Overall Study||28
10093907|NCT02347189|11222367|FG000|NOT COMPLETED|Overall Study||11
10093908|NCT02347332|11222384|FG000|STARTED|Overall Study||230
10093909|NCT02347332|11222385|FG001|STARTED|Overall Study||229
10093910|NCT02347332|11222384|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
10093911|NCT02347332|11222385|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
10093912|NCT02347332|11222384|FG000|NOT COMPLETED|Overall Study||230
10093913|NCT02347332|11222385|FG001|NOT COMPLETED|Overall Study||229
10093914|NCT02347345|11222394|FG000|STARTED|Overall Study||10
10093915|NCT02347345|11222395|FG001|STARTED|Overall Study||12
10093916|NCT02347345|11222396|FG002|STARTED|Overall Study||12
10093917|NCT02347345|11222394|FG000|COMPLETED|Overall Study||10
10093918|NCT02347345|11222395|FG001|COMPLETED|Overall Study||12
10093919|NCT02347345|11222396|FG002|COMPLETED|Overall Study||12
10093920|NCT02347345|11222394|FG000|NOT COMPLETED|Overall Study||0
10093921|NCT02347345|11222395|FG001|NOT COMPLETED|Overall Study||0
10093922|NCT02347345|11222396|FG002|NOT COMPLETED|Overall Study||0
10093923|NCT02347410|11222407|FG000|STARTED|Overall Study||102
10093924|NCT02347410|11222407|FG000|COMPLETED|Overall Study||98
10093925|NCT02347410|11222407|FG000|NOT COMPLETED|Overall Study||4
10093926|NCT02347488|11222417|FG000|STARTED|Overall Study||30
10093927|NCT02347488|11222417|FG000|COMPLETED|Overall Study||30
10093928|NCT02347488|11222417|FG000|NOT COMPLETED|Overall Study||0
10093929|NCT02347605|11222429|FG000|STARTED|Overall Study||10
10093930|NCT02347605|11222430|FG001|STARTED|Overall Study||10
10093931|NCT02347605|11222431|FG002|STARTED|Overall Study||8
10093932|NCT02347605|11222432|FG003|STARTED|Overall Study||10
10093933|NCT02347605|11222433|FG004|STARTED|Overall Study||9
10093934|NCT02347605|11222434|FG005|STARTED|Overall Study||9
10093935|NCT02347605|11222429|FG000|Completed Lab 1|Overall Study||10
10093936|NCT02347605|11222430|FG001|Completed Lab 1|Overall Study||10
10093937|NCT02347605|11222431|FG002|Completed Lab 1|Overall Study||8
10093938|NCT02347605|11222432|FG003|Completed Lab 1|Overall Study||10
10093939|NCT02347605|11222433|FG004|Completed Lab 1|Overall Study||8
10093940|NCT02347605|11222434|FG005|Completed Lab 1|Overall Study||9
10093941|NCT02347605|11222429|FG000|Completed Lab 2|Overall Study||7
9863234|NCT00941863|10976696|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7
9863235|NCT00941863|10976697|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3
9863236|NCT00941863|10976698|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12
9863237|NCT00941863|10976699|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17
9863238|NCT00941863|10976700|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94
9863239|NCT00941863|10976696|FG000|STARTED|Continued After PCD||0
9863240|NCT00941863|10976697|FG001|STARTED|Continued After PCD||0
9863241|NCT00941863|10976698|FG002|STARTED|Continued After PCD||0
9863242|NCT00941863|10976699|FG003|STARTED|Continued After PCD||0
9863243|NCT00941863|10976700|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
9863244|NCT00941863|10976696|FG000|COMPLETED|Continued After PCD||0
9863245|NCT00941863|10976697|FG001|COMPLETED|Continued After PCD||0
9863246|NCT00941863|10976698|FG002|COMPLETED|Continued After PCD||0
9863247|NCT00941863|10976699|FG003|COMPLETED|Continued After PCD||0
9863248|NCT00941863|10976700|FG004|COMPLETED|Continued After PCD||6
9863249|NCT00941863|10976696|FG000|NOT COMPLETED|Continued After PCD||0
9863250|NCT00941863|10976697|FG001|NOT COMPLETED|Continued After PCD||0
9863251|NCT00941863|10976698|FG002|NOT COMPLETED|Continued After PCD||0
9863252|NCT00941863|10976699|FG003|NOT COMPLETED|Continued After PCD||0
9863253|NCT00941863|10976700|FG004|NOT COMPLETED|Continued After PCD||19
9863254|NCT00941889|10976718|FG000|STARTED|Overall Study||17
9863255|NCT00941889|10976719|FG001|STARTED|Overall Study||15
9863256|NCT00941889|10976718|FG000|COMPLETED|Overall Study||5
9863257|NCT00941889|10976719|FG001|COMPLETED|Overall Study||3
9863258|NCT00941889|10976718|FG000|NOT COMPLETED|Overall Study||12
9863259|NCT00941889|10976719|FG001|NOT COMPLETED|Overall Study||12
9863260|NCT00941993|10976725|FG000|STARTED|Overall Study||109
9863261|NCT00941993|10976725|FG000|COMPLETED|Overall Study||109
9863262|NCT00941993|10976725|FG000|NOT COMPLETED|Overall Study||0
9863263|NCT00942084|10976730|FG000|STARTED|Overall Study||32
9863264|NCT00942084|10976730|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
9863265|NCT00942084|10976730|FG000|NOT COMPLETED|Overall Study||2
9863266|NCT00942149|10976734|FG000|STARTED|Overall Study||20
9863267|NCT00942149|10976734|FG000|COMPLETED|Overall Study||20
9863268|NCT00942149|10976734|FG000|NOT COMPLETED|Overall Study||0
9863269|NCT00942162|10976741|FG000|STARTED|Overall Study||71
9863270|NCT00942162|10976742|FG001|STARTED|Overall Study||50
9863271|NCT00942162|10976743|FG002|STARTED|Overall Study||2
9863272|NCT00942162|10976741|FG000|COMPLETED|Overall Study||1
9863273|NCT00942162|10976742|FG001|COMPLETED|Overall Study||0
9863274|NCT00942162|10976743|FG002|COMPLETED|Overall Study||0
9863275|NCT00942162|10976741|FG000|NOT COMPLETED|Overall Study||70
9863276|NCT00942162|10976742|FG001|NOT COMPLETED|Overall Study||50
9863277|NCT00942162|10976743|FG002|NOT COMPLETED|Overall Study||2
9863278|NCT00942175|10976757|FG000|STARTED|Overall Study||40
9863279|NCT00942175|10976758|FG001|STARTED|Overall Study||40
9863280|NCT00942175|10976759|FG002|STARTED|Overall Study||40
9863281|NCT00942175|10976760|FG003|STARTED|Overall Study||40
9863282|NCT00942175|10976757|FG000|COMPLETED|Overall Study||38
10093942|NCT02347605|11222430|FG001|Completed Lab 2|Overall Study||7
10093943|NCT02347605|11222431|FG002|Completed Lab 2|Overall Study||7
10093944|NCT02347605|11222432|FG003|Completed Lab 2|Overall Study||7
10093945|NCT02347605|11222433|FG004|Completed Lab 2|Overall Study||6
10093946|NCT02347605|11222434|FG005|Completed Lab 2|Overall Study||8
10093947|NCT02347605|11222429|FG000|COMPLETED|Overall Study||7
10093948|NCT02347605|11222430|FG001|COMPLETED|Overall Study||7
10093949|NCT02347605|11222431|FG002|COMPLETED|Overall Study||7
10093950|NCT02347605|11222432|FG003|COMPLETED|Overall Study||6
10093951|NCT02347605|11222433|FG004|COMPLETED|Overall Study||6
10093952|NCT02347605|11222434|FG005|COMPLETED|Overall Study||7
10093953|NCT02347605|11222429|FG000|NOT COMPLETED|Overall Study||3
10093954|NCT02347605|11222430|FG001|NOT COMPLETED|Overall Study||3
10093955|NCT02347605|11222431|FG002|NOT COMPLETED|Overall Study||1
10093956|NCT02347605|11222432|FG003|NOT COMPLETED|Overall Study||4
10093957|NCT02347605|11222433|FG004|NOT COMPLETED|Overall Study||3
10093958|NCT02347605|11222434|FG005|NOT COMPLETED|Overall Study||2
10093959|NCT02347631|11222444|FG000|STARTED|Washout 1 (1 Month)||61
10093960|NCT02347631|11222445|FG001|STARTED|Washout 1 (1 Month)||57
10093961|NCT02347631|11222444|FG000|COMPLETED|Washout 1 (1 Month)||61
10093962|NCT02347631|11222445|FG001|COMPLETED|Washout 1 (1 Month)||57
9863283|NCT00942175|10976758|FG001|COMPLETED|Overall Study||36
10093963|NCT02347631|11222444|FG000|NOT COMPLETED|Washout 1 (1 Month)||0
10093964|NCT02347631|11222445|FG001|NOT COMPLETED|Washout 1 (1 Month)||0
9863284|NCT00942175|10976759|FG002|COMPLETED|Overall Study||38
9863285|NCT00942175|10976760|FG003|COMPLETED|Overall Study||38
9863286|NCT00942175|10976757|FG000|NOT COMPLETED|Overall Study||2
9863287|NCT00942175|10976758|FG001|NOT COMPLETED|Overall Study||4
9863288|NCT00942175|10976759|FG002|NOT COMPLETED|Overall Study||2
9863289|NCT00942175|10976760|FG003|NOT COMPLETED|Overall Study||2
9863290|NCT00942188|10976782|FG000|STARTED|Overall Study||26
9863291|NCT00942188|10976783|FG001|STARTED|Overall Study||26
9863292|NCT00942188|10976784|FG002|STARTED|Overall Study||27
9863293|NCT00942188|10976785|FG003|STARTED|Overall Study||27
9863294|NCT00942188|10976782|FG000|COMPLETED|Overall Study||22
9863295|NCT00942188|10976783|FG001|COMPLETED|Overall Study||16
9863296|NCT00942188|10976784|FG002|COMPLETED|Overall Study||18
10093965|NCT02347631|11222444|FG000|STARTED|First Intervention (2 Months)||61
10093966|NCT02347631|11222445|FG001|STARTED|First Intervention (2 Months)||57
10093967|NCT02347631|11222444|FG000|COMPLETED|First Intervention (2 Months)||54
9863297|NCT00942188|10976785|FG003|COMPLETED|Overall Study||23
9863298|NCT00942188|10976782|FG000|NOT COMPLETED|Overall Study||4
9863299|NCT00942188|10976783|FG001|NOT COMPLETED|Overall Study||10
9863300|NCT00942188|10976784|FG002|NOT COMPLETED|Overall Study||9
9863301|NCT00942188|10976785|FG003|NOT COMPLETED|Overall Study||4
9863302|NCT00942266|10976797|FG000|STARTED|Overall Study||43
9863303|NCT00942266|10976798|FG001|STARTED|Overall Study||15
9863304|NCT00942266|10976797|FG000|COMPLETED|Overall Study||0
9863305|NCT00942266|10976798|FG001|COMPLETED|Overall Study||0
9863306|NCT00942266|10976797|FG000|NOT COMPLETED|Overall Study||43
9863307|NCT00942266|10976798|FG001|NOT COMPLETED|Overall Study||15
9863308|NCT00942305|10976814|FG000|STARTED|Overall Study||30
9863309|NCT00942305|10976815|FG001|STARTED|Overall Study||10
9863310|NCT00942305|10976816|FG002|STARTED|Overall Study||29
9863311|NCT00942305|10976817|FG003|STARTED|Overall Study||10
9863312|NCT00942305|10976818|FG004|STARTED|Overall Study||39
9863313|NCT00942305|10976819|FG005|STARTED|Overall Study||14
9863314|NCT00942305|10976820|FG006|STARTED|Overall Study||30
9863315|NCT00942305|10976821|FG007|STARTED|Overall Study||10
9863316|NCT00942305|10976822|FG008|STARTED|Overall Study||50
9863317|NCT00942305|10976823|FG009|STARTED|Overall Study||17
9863318|NCT00942305|10976814|FG000|COMPLETED|Overall Study||7
9863319|NCT00942305|10976815|FG001|COMPLETED|Overall Study||5
9863320|NCT00942305|10976816|FG002|COMPLETED|Overall Study||14
10093968|NCT02347631|11222445|FG001|COMPLETED|First Intervention (2 Months)||51
10093969|NCT02347631|11222444|FG000|NOT COMPLETED|First Intervention (2 Months)||7
10093970|NCT02347631|11222445|FG001|NOT COMPLETED|First Intervention (2 Months)||6
10093971|NCT02347631|11222444|FG000|STARTED|Washout 2 (1 Month)||54
10093972|NCT02347631|11222445|FG001|STARTED|Washout 2 (1 Month)||51
10093973|NCT02347631|11222444|FG000|COMPLETED|Washout 2 (1 Month)||52
10093974|NCT02347631|11222445|FG001|COMPLETED|Washout 2 (1 Month)||48
10093975|NCT02347631|11222444|FG000|NOT COMPLETED|Washout 2 (1 Month)||2
10093976|NCT02347631|11222445|FG001|NOT COMPLETED|Washout 2 (1 Month)||3
10093977|NCT02347631|11222444|FG000|STARTED|Second Intervention (2 Months)||52
10093978|NCT02347631|11222445|FG001|STARTED|Second Intervention (2 Months)||48
10093979|NCT02347631|11222444|FG000|COMPLETED|Second Intervention (2 Months)||39
10093980|NCT02347631|11222445|FG001|COMPLETED|Second Intervention (2 Months)||44
10093981|NCT02347631|11222444|FG000|NOT COMPLETED|Second Intervention (2 Months)||13
10093982|NCT02347631|11222445|FG001|NOT COMPLETED|Second Intervention (2 Months)||4
10093983|NCT02347657|11222455|FG000|STARTED|Overall Study||259
10093984|NCT02347657|11222456|FG001|STARTED|Overall Study||251
10093985|NCT02347657|11222455|FG000|Treated|Overall Study||258
10093986|NCT02347657|11222456|FG001|Treated|Overall Study||251
10093987|NCT02347657|11222455|FG000|COMPLETED|Overall Study||241
10093988|NCT02347657|11222456|FG001|COMPLETED|Overall Study||236
10093989|NCT02347657|11222455|FG000|NOT COMPLETED|Overall Study||18
10093990|NCT02347657|11222456|FG001|NOT COMPLETED|Overall Study||15
10093991|NCT02347761|11222466|FG000|STARTED|All Collected||218
10093992|NCT02347761|11222467|FG001|STARTED|All Collected||217
10093993|NCT02347761|11222468|FG002|STARTED|All Collected||218
10093994|NCT02347761|11222466|FG000|COMPLETED|All Collected||201
10093995|NCT02347761|11222467|FG001|COMPLETED|All Collected||203
10093996|NCT02347761|11222468|FG002|COMPLETED|All Collected||191
10093997|NCT02347761|11222466|FG000|NOT COMPLETED|All Collected||17
10093998|NCT02347761|11222467|FG001|NOT COMPLETED|All Collected||14
10093999|NCT02347761|11222468|FG002|NOT COMPLETED|All Collected||27
10094000|NCT02347761|11222466|FG000|STARTED|On Study Treatment||218
10094001|NCT02347761|11222467|FG001|STARTED|On Study Treatment||217
10094002|NCT02347761|11222468|FG002|STARTED|On Study Treatment||218
10094003|NCT02347761|11222466|FG000|COMPLETED|On Study Treatment||191
10094004|NCT02347761|11222467|FG001|COMPLETED|On Study Treatment||194
10094005|NCT02347761|11222468|FG002|COMPLETED|On Study Treatment||176
10094006|NCT02347761|11222466|FG000|NOT COMPLETED|On Study Treatment||27
10094007|NCT02347761|11222467|FG001|NOT COMPLETED|On Study Treatment||23
10094008|NCT02347761|11222468|FG002|NOT COMPLETED|On Study Treatment||42
10094009|NCT02347774|11222479|FG000|STARTED|Study Participation||214
10094010|NCT02347774|11222480|FG001|STARTED|Study Participation||214
10094011|NCT02347774|11222481|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
10094012|NCT02347774|11222479|FG000|COMPLETED|Study Participation||199
10094013|NCT02347774|11222480|FG001|COMPLETED|Study Participation||193
10094014|NCT02347774|11222481|FG002|COMPLETED|Study Participation||188
10094015|NCT02347774|11222479|FG000|NOT COMPLETED|Study Participation||15
10094016|NCT02347774|11222480|FG001|NOT COMPLETED|Study Participation||21
10094017|NCT02347774|11222481|FG002|NOT COMPLETED|Study Participation||25
10094018|NCT02347774|11222479|FG000|STARTED|On Study Treatment||214
10094019|NCT02347774|11222480|FG001|STARTED|On Study Treatment||214
10094020|NCT02347774|11222481|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
9863321|NCT00942305|10976817|FG003|COMPLETED|Overall Study||4
9863322|NCT00942305|10976818|FG004|COMPLETED|Overall Study||14
9863323|NCT00942305|10976819|FG005|COMPLETED|Overall Study||9
9863324|NCT00942305|10976820|FG006|COMPLETED|Overall Study||6
10094021|NCT02347774|11222479|FG000|COMPLETED|On Study Treatment||190
10094022|NCT02347774|11222480|FG001|COMPLETED|On Study Treatment||183
9863325|NCT00942305|10976821|FG007|COMPLETED|Overall Study||5
10094023|NCT02347774|11222481|FG002|COMPLETED|On Study Treatment||177
10094024|NCT02347774|11222479|FG000|NOT COMPLETED|On Study Treatment||24
10094025|NCT02347774|11222480|FG001|NOT COMPLETED|On Study Treatment||31
10094026|NCT02347774|11222481|FG002|NOT COMPLETED|On Study Treatment||36
9863326|NCT00942305|10976822|FG008|COMPLETED|Overall Study||25
9863327|NCT00942305|10976823|FG009|COMPLETED|Overall Study||7
9863328|NCT00942305|10976814|FG000|NOT COMPLETED|Overall Study||23
9863329|NCT00942305|10976815|FG001|NOT COMPLETED|Overall Study||5
9863330|NCT00942305|10976816|FG002|NOT COMPLETED|Overall Study||15
9863331|NCT00942305|10976817|FG003|NOT COMPLETED|Overall Study||6
10094027|NCT02347787|11222491|FG000|STARTED|6 Month Follow-Up||288
10094028|NCT02347787|11222492|FG001|STARTED|6 Month Follow-Up||304
10094029|NCT02347787|11222491|FG000|COMPLETED|6 Month Follow-Up||222
10094030|NCT02347787|11222492|FG001|COMPLETED|6 Month Follow-Up||248
10094031|NCT02347787|11222491|FG000|NOT COMPLETED|6 Month Follow-Up||66
10094032|NCT02347787|11222492|FG001|NOT COMPLETED|6 Month Follow-Up||56
10094033|NCT02347787|11222491|FG000|STARTED|9 Month Follow-Up||288
10094034|NCT02347787|11222492|FG001|STARTED|9 Month Follow-Up||304
10094035|NCT02347787|11222491|FG000|COMPLETED|9 Month Follow-Up||227
10094036|NCT02347787|11222492|FG001|COMPLETED|9 Month Follow-Up||233
10094037|NCT02347787|11222491|FG000|NOT COMPLETED|9 Month Follow-Up||61
10094038|NCT02347787|11222492|FG001|NOT COMPLETED|9 Month Follow-Up||71
10094039|NCT02347813|11222505|FG000|STARTED|First Intervention, 24 Weeks||6
10094040|NCT02347813|11222506|FG001|STARTED|First Intervention, 24 Weeks||6
10094041|NCT02347813|11222505|FG000|COMPLETED|First Intervention, 24 Weeks||4
10094042|NCT02347813|11222506|FG001|COMPLETED|First Intervention, 24 Weeks||4
10094043|NCT02347813|11222505|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2
10094044|NCT02347813|11222506|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2
10094045|NCT02347813|11222505|FG000|STARTED|Second Intervention, 24 Weeks||4
10094046|NCT02347813|11222506|FG001|STARTED|Second Intervention, 24 Weeks||4
10094047|NCT02347813|11222505|FG000|COMPLETED|Second Intervention, 24 Weeks||4
10094048|NCT02347813|11222506|FG001|COMPLETED|Second Intervention, 24 Weeks||4
10094049|NCT02347813|11222505|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0
10094050|NCT02347813|11222506|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0
10094051|NCT02348008|11222514|FG000|STARTED|Overall Study||3
10094052|NCT02348008|11222515|FG001|STARTED|Overall Study||10
10094053|NCT02348008|11222516|FG002|STARTED|Overall Study||48
10094054|NCT02348008|11222514|FG000|COMPLETED|Overall Study||0
10094055|NCT02348008|11222515|FG001|COMPLETED|Overall Study||0
10094056|NCT02348008|11222516|FG002|COMPLETED|Overall Study||29
10094057|NCT02348008|11222514|FG000|NOT COMPLETED|Overall Study||3
10094058|NCT02348008|11222515|FG001|NOT COMPLETED|Overall Study||10
10094059|NCT02348008|11222516|FG002|NOT COMPLETED|Overall Study||19
10094060|NCT02348385|11222524|FG000|STARTED|Overall Study||24
10094061|NCT02348385|11222525|FG001|STARTED|Overall Study||25
10094062|NCT02348385|11222524|FG000|COMPLETED|Overall Study||24
10094063|NCT02348385|11222525|FG001|COMPLETED|Overall Study||25
10094064|NCT02348385|11222524|FG000|NOT COMPLETED|Overall Study||0
10094065|NCT02348385|11222525|FG001|NOT COMPLETED|Overall Study||0
10094066|NCT02348489|11222535|FG000|STARTED|Overall Study||408
10094067|NCT02348489|11222536|FG001|STARTED|Overall Study||407
10094068|NCT02348489|11222535|FG000|COMPLETED|Overall Study||55
10094069|NCT02348489|11222536|FG001|COMPLETED|Overall Study||40
10094070|NCT02348489|11222535|FG000|NOT COMPLETED|Overall Study||353
10094071|NCT02348489|11222536|FG001|NOT COMPLETED|Overall Study||367
10094072|NCT02348593|11222548|FG000|STARTED|Overall Study||59
10094073|NCT02348593|11222549|FG001|STARTED|Overall Study||59
10094074|NCT02348593|11222550|FG002|STARTED|Overall Study||59
10094075|NCT02348593|11222551|FG003|STARTED|Overall Study||59
10094076|NCT02348593|11222548|FG000|COMPLETED|Overall Study||49
10094077|NCT02348593|11222549|FG001|COMPLETED|Overall Study||51
10094078|NCT02348593|11222550|FG002|COMPLETED|Overall Study||43
10094079|NCT02348593|11222551|FG003|COMPLETED|Overall Study||52
10094080|NCT02348593|11222548|FG000|NOT COMPLETED|Overall Study||10
10094081|NCT02348593|11222549|FG001|NOT COMPLETED|Overall Study||8
10094082|NCT02348593|11222550|FG002|NOT COMPLETED|Overall Study||16
10094083|NCT02348593|11222551|FG003|NOT COMPLETED|Overall Study||7
10094084|NCT02348606|11222566|FG000|STARTED|Overall Study||58
10094085|NCT02348606|11222567|FG001|STARTED|Overall Study||62
10094086|NCT02348606|11222568|FG002|STARTED|Overall Study||117
10094087|NCT02348606|11222569|FG003|STARTED|Overall Study||118
10094088|NCT02348606|11222570|FG004|STARTED|Overall Study||119
10094089|NCT02348606|11222566|FG000|COMPLETED|Overall Study||49
10094090|NCT02348606|11222567|FG001|COMPLETED|Overall Study||54
10094091|NCT02348606|11222568|FG002|COMPLETED|Overall Study||106
10094092|NCT02348606|11222569|FG003|COMPLETED|Overall Study||94
10094093|NCT02348606|11222570|FG004|COMPLETED|Overall Study||101
10094094|NCT02348606|11222566|FG000|NOT COMPLETED|Overall Study||9
10094095|NCT02348606|11222567|FG001|NOT COMPLETED|Overall Study||8
10094096|NCT02348606|11222568|FG002|NOT COMPLETED|Overall Study||11
10094097|NCT02348606|11222569|FG003|NOT COMPLETED|Overall Study||24
10094098|NCT02348606|11222570|FG004|NOT COMPLETED|Overall Study||18
10094099|NCT02348619|11222582|FG000|STARTED|Titration Phase||174
9863332|NCT00942305|10976818|FG004|NOT COMPLETED|Overall Study||25
10094100|NCT02348619|11222583|FG001|STARTED|Titration Phase||0
10094101|NCT02348619|11222582|FG000|COMPLETED|Titration Phase||157
10094102|NCT02348619|11222583|FG001|COMPLETED|Titration Phase||0
10094103|NCT02348619|11222582|FG000|NOT COMPLETED|Titration Phase||17
10094104|NCT02348619|11222583|FG001|NOT COMPLETED|Titration Phase||0
10094105|NCT02348619|11222582|FG000|STARTED|Stable-Dose Phase||157
10094106|NCT02348619|11222583|FG001|STARTED|Stable-Dose Phase||0
10094107|NCT02348619|11222582|FG000|COMPLETED|Stable-Dose Phase||124
10094108|NCT02348619|11222583|FG001|COMPLETED|Stable-Dose Phase||0
10094109|NCT02348619|11222582|FG000|NOT COMPLETED|Stable-Dose Phase||33
10094110|NCT02348619|11222583|FG001|NOT COMPLETED|Stable-Dose Phase||0
9863333|NCT00942305|10976819|FG005|NOT COMPLETED|Overall Study||5
9863334|NCT00942305|10976820|FG006|NOT COMPLETED|Overall Study||24
9863335|NCT00942305|10976821|FG007|NOT COMPLETED|Overall Study||5
9863336|NCT00942305|10976822|FG008|NOT COMPLETED|Overall Study||25
9863337|NCT00942305|10976823|FG009|NOT COMPLETED|Overall Study||10
9863338|NCT00942357|10976847|FG000|STARTED|Overall Study||407
9863339|NCT00942357|10976848|FG001|STARTED|Overall Study||406
9863340|NCT00942357|10976847|FG000|COMPLETED|Overall Study||370
9863341|NCT00942357|10976848|FG001|COMPLETED|Overall Study||366
9863342|NCT00942357|10976847|FG000|NOT COMPLETED|Overall Study||37
9863343|NCT00942357|10976848|FG001|NOT COMPLETED|Overall Study||40
9863344|NCT00942422|10976854|FG000|STARTED|Overall Study||8
9863345|NCT00942422|10976854|FG000|COMPLETED|Overall Study||5
9863346|NCT00942422|10976854|FG000|NOT COMPLETED|Overall Study||3
9863347|NCT00942448|10976862|FG000|STARTED|Overall Study||77
9863348|NCT00942448|10976863|FG001|STARTED|Overall Study||76
9863349|NCT00942448|10976864|FG002|STARTED|Overall Study||78
9863350|NCT00942448|10976865|FG003|STARTED|Overall Study||75
9863351|NCT00942448|10976862|FG000|COMPLETED|Overall Study||77
9863352|NCT00942448|10976863|FG001|COMPLETED|Overall Study||76
9863353|NCT00942448|10976864|FG002|COMPLETED|Overall Study||78
9863354|NCT00942448|10976865|FG003|COMPLETED|Overall Study||75
9863355|NCT00942448|10976862|FG000|NOT COMPLETED|Overall Study||0
9863356|NCT00942448|10976863|FG001|NOT COMPLETED|Overall Study||0
9863357|NCT00942448|10976864|FG002|NOT COMPLETED|Overall Study||0
9863358|NCT00942448|10976865|FG003|NOT COMPLETED|Overall Study||0
9863359|NCT00942578|10976882|FG000|STARTED|Dose Escalation Phase||3
9863360|NCT00942578|10976883|FG001|STARTED|Dose Escalation Phase||3
9863361|NCT00942578|10976884|FG002|STARTED|Dose Escalation Phase||3
9863362|NCT00942578|10976882|FG000|COMPLETED|Dose Escalation Phase||3
9863363|NCT00942578|10976883|FG001|COMPLETED|Dose Escalation Phase||3
9863364|NCT00942578|10976884|FG002|COMPLETED|Dose Escalation Phase||3
9863365|NCT00942578|10976882|FG000|NOT COMPLETED|Dose Escalation Phase||0
9863366|NCT00942578|10976883|FG001|NOT COMPLETED|Dose Escalation Phase||0
9863367|NCT00942578|10976884|FG002|NOT COMPLETED|Dose Escalation Phase||0
9863368|NCT00942578|10976882|FG000|STARTED|Expansion Phase||11
9863369|NCT00942578|10976883|FG001|STARTED|Expansion Phase||0
9863370|NCT00942578|10976884|FG002|STARTED|Expansion Phase||43
9863371|NCT00942578|10976882|FG000|COMPLETED|Expansion Phase||11
9863372|NCT00942578|10976883|FG001|COMPLETED|Expansion Phase||0
9863373|NCT00942578|10976884|FG002|COMPLETED|Expansion Phase||43
9863374|NCT00942578|10976882|FG000|NOT COMPLETED|Expansion Phase||0
9863375|NCT00942578|10976883|FG001|NOT COMPLETED|Expansion Phase||0
9863376|NCT00942578|10976884|FG002|NOT COMPLETED|Expansion Phase||0
9863377|NCT00942604|10976899|FG000|STARTED|Overall Study||100
9863378|NCT00942604|10976900|FG001|STARTED|Overall Study||103
9863379|NCT00942604|10976899|FG000|COMPLETED|Overall Study||98
9863380|NCT00942604|10976900|FG001|COMPLETED|Overall Study||99
9863381|NCT00942604|10976899|FG000|NOT COMPLETED|Overall Study||2
9863382|NCT00942604|10976900|FG001|NOT COMPLETED|Overall Study||4
9863383|NCT00942708|10976906|FG000|STARTED|Overall Study||6
9863384|NCT00942708|10976906|FG000|COMPLETED|Overall Study||5
9863385|NCT00942708|10976906|FG000|NOT COMPLETED|Overall Study||1
9863386|NCT00942734|10976911|FG000|STARTED|Overall Study||43
9863387|NCT00942734|10976911|FG000|COMPLETED|Overall Study||35
9863388|NCT00942734|10976911|FG000|NOT COMPLETED|Overall Study||8
9863389|NCT00942786|10976915|FG000|STARTED|Overall Study||297
9863390|NCT00942786|10976915|FG000|COMPLETED|Overall Study|date of last follow-up|297
9863391|NCT00942786|10976915|FG000|NOT COMPLETED|Overall Study||0
9863392|NCT00942825|10976924|FG000|STARTED|Overall Study||97
9863393|NCT00942825|10976925|FG001|STARTED|Overall Study||98
9863394|NCT00942825|10976924|FG000|COMPLETED|Overall Study||97
9863395|NCT00942825|10976925|FG001|COMPLETED|Overall Study||98
9863396|NCT00942825|10976924|FG000|NOT COMPLETED|Overall Study||0
9863397|NCT00942825|10976925|FG001|NOT COMPLETED|Overall Study||0
9863398|NCT00942851|10976933|FG000|STARTED|Overall Study||12
9863399|NCT00942851|10976934|FG001|STARTED|Overall Study||12
9863400|NCT00942851|10976933|FG000|COMPLETED|Overall Study||12
9863401|NCT00942851|10976934|FG001|COMPLETED|Overall Study||11
9863402|NCT00942851|10976933|FG000|NOT COMPLETED|Overall Study||0
9863403|NCT00942851|10976934|FG001|NOT COMPLETED|Overall Study||1
9863404|NCT00942890|10976946|FG000|STARTED|Overall Study||21
9863405|NCT00942890|10976947|FG001|STARTED|Overall Study||23
9863406|NCT00942890|10976946|FG000|COMPLETED|Overall Study||21
9863407|NCT00942890|10976947|FG001|COMPLETED|Overall Study||23
9863408|NCT00942890|10976946|FG000|NOT COMPLETED|Overall Study||0
9863409|NCT00942890|10976947|FG001|NOT COMPLETED|Overall Study||0
9863410|NCT00942903|10976954|FG000|STARTED|Overall Study||20
9863411|NCT00942903|10976954|FG000|COMPLETED|Overall Study||20
9863412|NCT00942903|10976954|FG000|NOT COMPLETED|Overall Study||0
9863413|NCT00942968|10976958|FG000|STARTED|Overall Study||338
9863414|NCT00942968|10976958|FG000|Treated|Overall Study||334
9863415|NCT00942968|10976958|FG000|COMPLETED|Overall Study||109
9863416|NCT00942968|10976958|FG000|NOT COMPLETED|Overall Study||229
9863417|NCT00942994|10976964|FG000|STARTED|Overall Study||203
9863418|NCT00942994|10976965|FG001|STARTED|Overall Study||209
9863419|NCT00942994|10976964|FG000|COMPLETED|Overall Study||187
9863420|NCT00942994|10976965|FG001|COMPLETED|Overall Study||190
9863421|NCT00942994|10976964|FG000|NOT COMPLETED|Overall Study||16
9863422|NCT00942994|10976965|FG001|NOT COMPLETED|Overall Study||19
9863423|NCT00943072|10976973|FG000|STARTED|Overall Study||115
9863424|NCT00943072|10976974|FG001|STARTED|Overall Study||74
9863425|NCT00943072|10976973|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114
9863426|NCT00943072|10976974|FG001|Participants Received Treatment|Overall Study||74
9863427|NCT00943072|10976973|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
9863428|NCT00943072|10976974|FG001|Full Analysis Set (FAS) Population|Overall Study||73
9863429|NCT00943072|10976973|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
9863430|NCT00943072|10976974|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
9863431|NCT00943072|10976973|FG000|NOT COMPLETED|Overall Study||5
9863432|NCT00943072|10976974|FG001|NOT COMPLETED|Overall Study||14
9863433|NCT00943098|10976984|FG000|STARTED|Overall Study||70
9863434|NCT00943098|10976985|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
9863435|NCT00943098|10976984|FG000|COMPLETED|Overall Study||70
9863436|NCT00943098|10976985|FG001|COMPLETED|Overall Study||72
9863437|NCT00943098|10976984|FG000|NOT COMPLETED|Overall Study||0
9863438|NCT00943098|10976985|FG001|NOT COMPLETED|Overall Study||0
9863439|NCT00943111|10976993|FG000|STARTED|52-Weeks Primary Analysis Period||106
9863440|NCT00943111|10976994|FG001|STARTED|52-Weeks Primary Analysis Period||54
9863441|NCT00943111|10976995|FG002|STARTED|52-Weeks Primary Analysis Period||0
9863442|NCT00943111|10976993|FG000|Treated|52-Weeks Primary Analysis Period||106
9863443|NCT00943111|10976994|FG001|Treated|52-Weeks Primary Analysis Period||53
9863444|NCT00943111|10976995|FG002|Treated|52-Weeks Primary Analysis Period||0
9863445|NCT00943111|10976993|FG000|COMPLETED|52-Weeks Primary Analysis Period||104
9863446|NCT00943111|10976994|FG001|COMPLETED|52-Weeks Primary Analysis Period||52
9863447|NCT00943111|10976995|FG002|COMPLETED|52-Weeks Primary Analysis Period||0
9863448|NCT00943111|10976993|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2
9863449|NCT00943111|10976994|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2
9863450|NCT00943111|10976995|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0
9863451|NCT00943111|10976993|FG000|STARTED|5 Years Long-term Treatment Period||0
9863452|NCT00943111|10976994|FG001|STARTED|5 Years Long-term Treatment Period||0
9863453|NCT00943111|10976995|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
9863454|NCT00943111|10976993|FG000|COMPLETED|5 Years Long-term Treatment Period||0
9863455|NCT00943111|10976994|FG001|COMPLETED|5 Years Long-term Treatment Period||0
9863456|NCT00943111|10976995|FG002|COMPLETED|5 Years Long-term Treatment Period||77
9863457|NCT00943111|10976993|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0
9863458|NCT00943111|10976994|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0
9863459|NCT00943111|10976995|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75
9863460|NCT00943124|10977002|FG000|STARTED|Period 1||110
9863461|NCT00943124|10977003|FG001|STARTED|Period 1||110
9863462|NCT00943124|10977002|FG000|COMPLETED|Period 1||108
9863463|NCT00943124|10977003|FG001|COMPLETED|Period 1||108
9863464|NCT00943124|10977002|FG000|NOT COMPLETED|Period 1||2
9863465|NCT00943124|10977003|FG001|NOT COMPLETED|Period 1||2
9863466|NCT00943124|10977002|FG000|STARTED|Period 2||108
9863467|NCT00943124|10977003|FG001|STARTED|Period 2||108
9863468|NCT00943124|10977002|FG000|COMPLETED|Period 2||108
9863469|NCT00943124|10977003|FG001|COMPLETED|Period 2||108
9863470|NCT00943124|10977002|FG000|NOT COMPLETED|Period 2||0
9863471|NCT00943124|10977003|FG001|NOT COMPLETED|Period 2||0
9863472|NCT00943150|10977011|FG000|STARTED|Overall Study||10
9863473|NCT00943150|10977012|FG001|STARTED|Overall Study||10
9863474|NCT00943150|10977011|FG000|COMPLETED|Overall Study||10
9863475|NCT00943150|10977012|FG001|COMPLETED|Overall Study||10
9863476|NCT00943150|10977011|FG000|NOT COMPLETED|Overall Study||0
9863477|NCT00943150|10977012|FG001|NOT COMPLETED|Overall Study||0
9863478|NCT00943202|10977026|FG000|STARTED|Overall Study||133
9863479|NCT00943202|10977027|FG001|STARTED|Overall Study||133
9863480|NCT00943202|10977028|FG002|STARTED|Overall Study||133
9863481|NCT00943202|10977029|FG003|STARTED|Overall Study||132
9863482|NCT00943202|10977026|FG000|COMPLETED|Overall Study||132
9863483|NCT00943202|10977027|FG001|COMPLETED|Overall Study||131
9863484|NCT00943202|10977028|FG002|COMPLETED|Overall Study||133
9863485|NCT00943202|10977029|FG003|COMPLETED|Overall Study||131
9863486|NCT00943202|10977026|FG000|NOT COMPLETED|Overall Study||1
9863487|NCT00943202|10977027|FG001|NOT COMPLETED|Overall Study||2
9863488|NCT00943202|10977028|FG002|NOT COMPLETED|Overall Study||0
9863489|NCT00943202|10977029|FG003|NOT COMPLETED|Overall Study||1
9863490|NCT00943306|10977040|FG000|STARTED|Overall Study||19
9863491|NCT00943306|10977040|FG000|COMPLETED|Overall Study||16
9863492|NCT00943306|10977040|FG000|NOT COMPLETED|Overall Study||3
9863493|NCT00943319|10977044|FG000|STARTED|Overall Study||50
9863494|NCT00943319|10977044|FG000|COMPLETED|Overall Study||49
9863495|NCT00943319|10977044|FG000|NOT COMPLETED|Overall Study||1
9863496|NCT00943384|10977048|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
9863497|NCT00943384|10977048|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
9863498|NCT00943384|10977048|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
9863499|NCT00943384|10977048|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
9863500|NCT00943384|10977048|FG000|NOT COMPLETED|Overall Study||49
9863501|NCT00943436|10977054|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10
9863502|NCT00943436|10977055|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10
9863503|NCT00943436|10977054|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10
9863504|NCT00943436|10977055|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10
9863505|NCT00943436|10977054|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
9863506|NCT00943436|10977055|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
9863507|NCT00943436|10977054|FG000|STARTED|Rest Session: 45 Minutes of Reading||10
9863508|NCT00943436|10977055|FG001|STARTED|Rest Session: 45 Minutes of Reading||10
9863509|NCT00943436|10977054|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10
9863510|NCT00943436|10977055|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10
9863511|NCT00943436|10977054|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
9863512|NCT00943436|10977055|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
9863513|NCT00943488|10977063|FG000|STARTED|Overall Study||204
9863514|NCT00943488|10977064|FG001|STARTED|Overall Study||204
9863515|NCT00943488|10977063|FG000|COMPLETED|Overall Study||203
9863516|NCT00943488|10977064|FG001|COMPLETED|Overall Study||202
9863517|NCT00943488|10977063|FG000|NOT COMPLETED|Overall Study||1
9863518|NCT00943488|10977064|FG001|NOT COMPLETED|Overall Study||2
9863519|NCT00943579|10977072|FG000|STARTED|Overall Study||21
9863520|NCT00943579|10977073|FG001|STARTED|Overall Study||20
9863521|NCT00943579|10977072|FG000|COMPLETED|Overall Study||15
9863522|NCT00943579|10977073|FG001|COMPLETED|Overall Study||15
9863523|NCT00943579|10977072|FG000|NOT COMPLETED|Overall Study||6
9863524|NCT00943579|10977073|FG001|NOT COMPLETED|Overall Study||5
9863525|NCT00943592|10977082|FG000|STARTED|Overall Study||82
9863526|NCT00943592|10977082|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
9863527|NCT00943592|10977082|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
9863528|NCT00943592|10977082|FG000|NOT COMPLETED|Overall Study||3
9863529|NCT00943631|10977088|FG000|STARTED|Overall Study||202
9863530|NCT00943631|10977089|FG001|STARTED|Overall Study||204
9863531|NCT00943631|10977088|FG000|COMPLETED|Overall Study||198
9863532|NCT00943631|10977089|FG001|COMPLETED|Overall Study||202
9863533|NCT00943631|10977088|FG000|NOT COMPLETED|Overall Study||4
9863534|NCT00943631|10977089|FG001|NOT COMPLETED|Overall Study||2
9863535|NCT00943670|10977095|FG000|STARTED|Single-agent Trastuzumab Emtansine||51
9863536|NCT00943670|10977095|FG000|Treated|Single-agent Trastuzumab Emtansine||51
9863537|NCT00943670|10977095|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
9863538|NCT00943670|10977095|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
9863539|NCT00943670|10977095|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
9863540|NCT00943670|10977095|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
9863541|NCT00943670|10977095|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
9863542|NCT00943735|10977110|FG000|STARTED|Overall Study||774
9863543|NCT00943735|10977110|FG000|Per Protocol Population|Overall Study||500
9863544|NCT00943735|10977110|FG000|COMPLETED|Overall Study||742
9863545|NCT00943735|10977110|FG000|NOT COMPLETED|Overall Study||32
9863546|NCT00943761|10977116|FG000|STARTED|Overall Study||21
9863547|NCT00943761|10977117|FG001|STARTED|Overall Study||24
9863548|NCT00943761|10977116|FG000|COMPLETED|Overall Study||17
9863549|NCT00943761|10977117|FG001|COMPLETED|Overall Study||23
9863550|NCT00943761|10977116|FG000|NOT COMPLETED|Overall Study||4
9863551|NCT00943761|10977117|FG001|NOT COMPLETED|Overall Study||1
9863552|NCT00943787|10977123|FG000|STARTED|Overall Study||41
9863553|NCT00943787|10977123|FG000|COMPLETED|Overall Study||34
9863554|NCT00943787|10977123|FG000|NOT COMPLETED|Overall Study||7
9863555|NCT00943800|10977127|FG000|STARTED|Overall Study||87
9863556|NCT00943800|10977127|FG000|COMPLETED|Overall Study||87
9863557|NCT00943800|10977127|FG000|NOT COMPLETED|Overall Study||0
9863558|NCT00943826|10977133|FG000|STARTED|Concurrent Phase||458
9863559|NCT00943826|10977134|FG001|STARTED|Concurrent Phase||463
9863560|NCT00943826|10977133|FG000|Treated|Concurrent Phase||452
9863561|NCT00943826|10977134|FG001|Treated|Concurrent Phase||459
9863562|NCT00943826|10977133|FG000|COMPLETED|Concurrent Phase||397
9863563|NCT00943826|10977134|FG001|COMPLETED|Concurrent Phase||421
9863564|NCT00943826|10977133|FG000|NOT COMPLETED|Concurrent Phase||61
9863565|NCT00943826|10977134|FG001|NOT COMPLETED|Concurrent Phase||42
9863566|NCT00943826|10977133|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
9863567|NCT00943826|10977134|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
9863568|NCT00943826|10977133|FG000|COMPLETED|Maintenance Phase||353
9863569|NCT00943826|10977134|FG001|COMPLETED|Maintenance Phase||331
9863570|NCT00943826|10977133|FG000|NOT COMPLETED|Maintenance Phase||43
9863571|NCT00943826|10977134|FG001|NOT COMPLETED|Maintenance Phase||39
9863572|NCT00943826|10977133|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
9863573|NCT00943826|10977134|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
9863574|NCT00943826|10977133|FG000|COMPLETED|Monotherapy Phase||204
9863575|NCT00943826|10977134|FG001|COMPLETED|Monotherapy Phase||143
9863576|NCT00943826|10977133|FG000|NOT COMPLETED|Monotherapy Phase||65
9863577|NCT00943826|10977134|FG001|NOT COMPLETED|Monotherapy Phase||16
9863578|NCT00943826|10977133|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
9953318|NCT01425814|11072029|FG005|COMPLETED|Period 3||12
9863579|NCT00943826|10977134|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
9863580|NCT00943826|10977133|FG000|COMPLETED|After Primary Overall Survival Analysis||0
9863581|NCT00943826|10977134|FG001|COMPLETED|After Primary Overall Survival Analysis||0
9863582|NCT00943826|10977133|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27
9863583|NCT00943826|10977134|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20
9863584|NCT00943878|10977145|FG000|STARTED|Overall Study||202
9863585|NCT00943878|10977146|FG001|STARTED|Overall Study||200
9863586|NCT00943878|10977147|FG002|STARTED|Overall Study||203
9863587|NCT00943878|10977148|FG003|STARTED|Overall Study||200
9863588|NCT00943878|10977145|FG000|COMPLETED|Overall Study||200
9863589|NCT00943878|10977146|FG001|COMPLETED|Overall Study||198
9863590|NCT00943878|10977147|FG002|COMPLETED|Overall Study||197
9863591|NCT00943878|10977148|FG003|COMPLETED|Overall Study||198
9863592|NCT00943878|10977145|FG000|NOT COMPLETED|Overall Study||2
9863593|NCT00943878|10977146|FG001|NOT COMPLETED|Overall Study||2
9863594|NCT00943878|10977147|FG002|NOT COMPLETED|Overall Study||6
9863595|NCT00943878|10977148|FG003|NOT COMPLETED|Overall Study||2
9863596|NCT00943904|10977158|FG000|STARTED|Overall Study||31
9863597|NCT00943904|10977158|FG000|COMPLETED|Overall Study||31
9863598|NCT00943904|10977158|FG000|NOT COMPLETED|Overall Study||0
9863599|NCT00943917|10977177|FG000|STARTED|Stage I||51
9863600|NCT00943917|10977178|FG001|STARTED|Stage I||51
9863601|NCT00943917|10977179|FG002|STARTED|Stage I||53
9863602|NCT00943917|10977180|FG003|STARTED|Stage I||0
9863603|NCT00943917|10977181|FG004|STARTED|Stage I||0
9863604|NCT00943917|10977182|FG005|STARTED|Stage I||0
9863605|NCT00943917|10977183|FG006|STARTED|Stage I||0
9863606|NCT00943917|10977184|FG007|STARTED|Stage I||0
9863607|NCT00943917|10977185|FG008|STARTED|Stage I||0
9863608|NCT00943917|10977186|FG009|STARTED|Stage I||0
9863609|NCT00943917|10977187|FG010|STARTED|Stage I||0
9863610|NCT00943917|10977188|FG011|STARTED|Stage I||0
9863611|NCT00943917|10977189|FG012|STARTED|Stage I||0
9863612|NCT00943917|10977190|FG013|STARTED|Stage I||0
9863613|NCT00943917|10977191|FG014|STARTED|Stage I||0
9863614|NCT00943917|10977177|FG000|COMPLETED|Stage I||47
9863615|NCT00943917|10977178|FG001|COMPLETED|Stage I||48
9863616|NCT00943917|10977179|FG002|COMPLETED|Stage I||47
9863617|NCT00943917|10977180|FG003|COMPLETED|Stage I||0
9863618|NCT00943917|10977181|FG004|COMPLETED|Stage I||0
9863619|NCT00943917|10977182|FG005|COMPLETED|Stage I||0
9863620|NCT00943917|10977183|FG006|COMPLETED|Stage I||0
9863621|NCT00943917|10977184|FG007|COMPLETED|Stage I||0
9863622|NCT00943917|10977185|FG008|COMPLETED|Stage I||0
9863623|NCT00943917|10977186|FG009|COMPLETED|Stage I||0
9863624|NCT00943917|10977187|FG010|COMPLETED|Stage I||0
9863625|NCT00943917|10977188|FG011|COMPLETED|Stage I||0
9863626|NCT00943917|10977189|FG012|COMPLETED|Stage I||0
9863627|NCT00943917|10977190|FG013|COMPLETED|Stage I||0
9863628|NCT00943917|10977191|FG014|COMPLETED|Stage I||0
9863629|NCT00943917|10977177|FG000|NOT COMPLETED|Stage I||4
9863630|NCT00943917|10977178|FG001|NOT COMPLETED|Stage I||3
9863631|NCT00943917|10977179|FG002|NOT COMPLETED|Stage I||6
9863632|NCT00943917|10977180|FG003|NOT COMPLETED|Stage I||0
9863633|NCT00943917|10977181|FG004|NOT COMPLETED|Stage I||0
9863634|NCT00943917|10977182|FG005|NOT COMPLETED|Stage I||0
9863635|NCT00943917|10977183|FG006|NOT COMPLETED|Stage I||0
9863636|NCT00943917|10977184|FG007|NOT COMPLETED|Stage I||0
9863637|NCT00943917|10977185|FG008|NOT COMPLETED|Stage I||0
9863638|NCT00943917|10977186|FG009|NOT COMPLETED|Stage I||0
9863639|NCT00943917|10977187|FG010|NOT COMPLETED|Stage I||0
9863640|NCT00943917|10977188|FG011|NOT COMPLETED|Stage I||0
9863641|NCT00943917|10977189|FG012|NOT COMPLETED|Stage I||0
9863642|NCT00943917|10977190|FG013|NOT COMPLETED|Stage I||0
9863643|NCT00943917|10977191|FG014|NOT COMPLETED|Stage I||0
9863644|NCT00943917|10977177|FG000|STARTED|Stage II||0
9863645|NCT00943917|10977178|FG001|STARTED|Stage II||0
9863646|NCT00943917|10977179|FG002|STARTED|Stage II||0
9863647|NCT00943917|10977180|FG003|STARTED|Stage II||20
9863648|NCT00943917|10977181|FG004|STARTED|Stage II||21
9863649|NCT00943917|10977182|FG005|STARTED|Stage II||23
9863650|NCT00943917|10977183|FG006|STARTED|Stage II||23
9863651|NCT00943917|10977184|FG007|STARTED|Stage II||23
9863652|NCT00943917|10977185|FG008|STARTED|Stage II||21
9863653|NCT00943917|10977186|FG009|STARTED|Stage II||0
9863654|NCT00943917|10977187|FG010|STARTED|Stage II||0
9863655|NCT00943917|10977188|FG011|STARTED|Stage II||0
9863656|NCT00943917|10977189|FG012|STARTED|Stage II||0
9863657|NCT00943917|10977190|FG013|STARTED|Stage II||0
9863658|NCT00943917|10977191|FG014|STARTED|Stage II||0
9863659|NCT00943917|10977177|FG000|COMPLETED|Stage II||0
9863660|NCT00943917|10977178|FG001|COMPLETED|Stage II||0
9863661|NCT00943917|10977179|FG002|COMPLETED|Stage II||0
9863662|NCT00943917|10977180|FG003|COMPLETED|Stage II||20
9863663|NCT00943917|10977181|FG004|COMPLETED|Stage II||21
9863664|NCT00943917|10977182|FG005|COMPLETED|Stage II||20
9863665|NCT00943917|10977183|FG006|COMPLETED|Stage II||20
9863666|NCT00943917|10977184|FG007|COMPLETED|Stage II||23
9863667|NCT00943917|10977185|FG008|COMPLETED|Stage II||20
9863668|NCT00943917|10977186|FG009|COMPLETED|Stage II||0
9863669|NCT00943917|10977187|FG010|COMPLETED|Stage II||0
9863670|NCT00943917|10977188|FG011|COMPLETED|Stage II||0
9863671|NCT00943917|10977189|FG012|COMPLETED|Stage II||0
9863672|NCT00943917|10977190|FG013|COMPLETED|Stage II||0
9863673|NCT00943917|10977191|FG014|COMPLETED|Stage II||0
9863674|NCT00943917|10977177|FG000|NOT COMPLETED|Stage II||0
10094111|NCT02348619|11222582|FG000|STARTED|Double-Blind Withdrawal Phase||62
10094112|NCT02348619|11222583|FG001|STARTED|Double-Blind Withdrawal Phase||62
10094113|NCT02348619|11222582|FG000|COMPLETED|Double-Blind Withdrawal Phase||60
10094114|NCT02348619|11222583|FG001|COMPLETED|Double-Blind Withdrawal Phase||62
10094115|NCT02348619|11222582|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2
10094116|NCT02348619|11222583|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0
9863675|NCT00943917|10977178|FG001|NOT COMPLETED|Stage II||0
9863676|NCT00943917|10977179|FG002|NOT COMPLETED|Stage II||0
9863677|NCT00943917|10977180|FG003|NOT COMPLETED|Stage II||0
9863678|NCT00943917|10977181|FG004|NOT COMPLETED|Stage II||0
9863679|NCT00943917|10977182|FG005|NOT COMPLETED|Stage II||3
9863680|NCT00943917|10977183|FG006|NOT COMPLETED|Stage II||3
9863681|NCT00943917|10977184|FG007|NOT COMPLETED|Stage II||0
9863682|NCT00943917|10977185|FG008|NOT COMPLETED|Stage II||1
9863683|NCT00943917|10977186|FG009|NOT COMPLETED|Stage II||0
9863684|NCT00943917|10977187|FG010|NOT COMPLETED|Stage II||0
9863685|NCT00943917|10977188|FG011|NOT COMPLETED|Stage II||0
9863686|NCT00943917|10977189|FG012|NOT COMPLETED|Stage II||0
9863687|NCT00943917|10977190|FG013|NOT COMPLETED|Stage II||0
9863688|NCT00943917|10977191|FG014|NOT COMPLETED|Stage II||0
9863689|NCT00943917|10977177|FG000|STARTED|Stage II Continuation||0
9863690|NCT00943917|10977178|FG001|STARTED|Stage II Continuation||0
9863691|NCT00943917|10977179|FG002|STARTED|Stage II Continuation||0
9863692|NCT00943917|10977180|FG003|STARTED|Stage II Continuation||0
9863693|NCT00943917|10977181|FG004|STARTED|Stage II Continuation||0
9863694|NCT00943917|10977182|FG005|STARTED|Stage II Continuation||0
9863695|NCT00943917|10977183|FG006|STARTED|Stage II Continuation||0
9863696|NCT00943917|10977184|FG007|STARTED|Stage II Continuation||0
9863697|NCT00943917|10977185|FG008|STARTED|Stage II Continuation||0
9863698|NCT00943917|10977186|FG009|STARTED|Stage II Continuation||15
9863699|NCT00943917|10977187|FG010|STARTED|Stage II Continuation||15
9863700|NCT00943917|10977188|FG011|STARTED|Stage II Continuation||13
9863701|NCT00943917|10977189|FG012|STARTED|Stage II Continuation||16
9863702|NCT00943917|10977190|FG013|STARTED|Stage II Continuation||15
9863703|NCT00943917|10977191|FG014|STARTED|Stage II Continuation||12
9863704|NCT00943917|10977177|FG000|COMPLETED|Stage II Continuation||0
9863705|NCT00943917|10977178|FG001|COMPLETED|Stage II Continuation||0
9863706|NCT00943917|10977179|FG002|COMPLETED|Stage II Continuation||0
9863707|NCT00943917|10977180|FG003|COMPLETED|Stage II Continuation||0
9863708|NCT00943917|10977181|FG004|COMPLETED|Stage II Continuation||0
9863709|NCT00943917|10977182|FG005|COMPLETED|Stage II Continuation||0
9863710|NCT00943917|10977183|FG006|COMPLETED|Stage II Continuation||0
9863711|NCT00943917|10977184|FG007|COMPLETED|Stage II Continuation||0
9863712|NCT00943917|10977185|FG008|COMPLETED|Stage II Continuation||0
9863713|NCT00943917|10977186|FG009|COMPLETED|Stage II Continuation||14
9863714|NCT00943917|10977187|FG010|COMPLETED|Stage II Continuation||15
9863715|NCT00943917|10977188|FG011|COMPLETED|Stage II Continuation||11
9863716|NCT00943917|10977189|FG012|COMPLETED|Stage II Continuation||13
9863717|NCT00943917|10977190|FG013|COMPLETED|Stage II Continuation||12
9863718|NCT00943917|10977191|FG014|COMPLETED|Stage II Continuation||8
9863719|NCT00943917|10977177|FG000|NOT COMPLETED|Stage II Continuation||0
9863720|NCT00943917|10977178|FG001|NOT COMPLETED|Stage II Continuation||0
9863721|NCT00943917|10977179|FG002|NOT COMPLETED|Stage II Continuation||0
9863722|NCT00943917|10977180|FG003|NOT COMPLETED|Stage II Continuation||0
9863723|NCT00943917|10977181|FG004|NOT COMPLETED|Stage II Continuation||0
9863724|NCT00943917|10977182|FG005|NOT COMPLETED|Stage II Continuation||0
9863725|NCT00943917|10977183|FG006|NOT COMPLETED|Stage II Continuation||0
9863726|NCT00943917|10977184|FG007|NOT COMPLETED|Stage II Continuation||0
9863727|NCT00943917|10977185|FG008|NOT COMPLETED|Stage II Continuation||0
10094117|NCT02348632|11222589|FG000|STARTED|Open-label Period||643
9863728|NCT00943917|10977186|FG009|NOT COMPLETED|Stage II Continuation||1
9863729|NCT00943917|10977187|FG010|NOT COMPLETED|Stage II Continuation||0
9863730|NCT00943917|10977188|FG011|NOT COMPLETED|Stage II Continuation||2
9863731|NCT00943917|10977189|FG012|NOT COMPLETED|Stage II Continuation||3
9863732|NCT00943917|10977190|FG013|NOT COMPLETED|Stage II Continuation||3
9863733|NCT00943917|10977191|FG014|NOT COMPLETED|Stage II Continuation||4
9863734|NCT00944021|10977229|FG000|STARTED|Overall Study||15
9863735|NCT00944021|10977230|FG001|STARTED|Overall Study||15
9863736|NCT00944021|10977231|FG002|STARTED|Overall Study||15
10094118|NCT02348632|11222590|FG001|STARTED|Open-label Period||0
10094119|NCT02348632|11222589|FG000|COMPLETED|Open-label Period||458
10094120|NCT02348632|11222590|FG001|COMPLETED|Open-label Period||0
9863737|NCT00944021|10977232|FG003|STARTED|Overall Study||16
9863738|NCT00944021|10977233|FG004|STARTED|Overall Study||8
9863739|NCT00944021|10977229|FG000|COMPLETED|Overall Study||14
9863740|NCT00944021|10977230|FG001|COMPLETED|Overall Study||15
9863741|NCT00944021|10977231|FG002|COMPLETED|Overall Study||15
9863742|NCT00944021|10977232|FG003|COMPLETED|Overall Study||16
9863743|NCT00944021|10977233|FG004|COMPLETED|Overall Study||8
9863744|NCT00944021|10977229|FG000|NOT COMPLETED|Overall Study||1
9863745|NCT00944021|10977230|FG001|NOT COMPLETED|Overall Study||0
9863746|NCT00944021|10977231|FG002|NOT COMPLETED|Overall Study||0
9863747|NCT00944021|10977232|FG003|NOT COMPLETED|Overall Study||0
9863748|NCT00944021|10977233|FG004|NOT COMPLETED|Overall Study||0
9863749|NCT00944034|10977257|FG000|STARTED|Overall Study||188
9863750|NCT00944034|10977258|FG001|STARTED|Overall Study||157
9863751|NCT00944034|10977259|FG002|STARTED|Overall Study||152
9863752|NCT00944034|10977260|FG003|STARTED|Overall Study||174
9863753|NCT00944034|10977261|FG004|STARTED|Overall Study||164
9863754|NCT00944034|10977262|FG005|STARTED|Overall Study||143
9863755|NCT00944034|10977263|FG006|STARTED|Overall Study||106
9863756|NCT00944034|10977264|FG007|STARTED|Overall Study||78
9863757|NCT00944034|10977265|FG008|STARTED|Overall Study||73
9863758|NCT00944034|10977266|FG009|STARTED|Overall Study||246
9863759|NCT00944034|10977267|FG010|STARTED|Overall Study||51
9863760|NCT00944034|10977268|FG011|STARTED|Overall Study||56
9863761|NCT00944034|10977257|FG000|COMPLETED|Overall Study||183
9863762|NCT00944034|10977258|FG001|COMPLETED|Overall Study||150
9863763|NCT00944034|10977259|FG002|COMPLETED|Overall Study||143
9863764|NCT00944034|10977260|FG003|COMPLETED|Overall Study||170
9863765|NCT00944034|10977261|FG004|COMPLETED|Overall Study||150
9863766|NCT00944034|10977262|FG005|COMPLETED|Overall Study||123
9863767|NCT00944034|10977263|FG006|COMPLETED|Overall Study||102
9863768|NCT00944034|10977264|FG007|COMPLETED|Overall Study||73
9863769|NCT00944034|10977265|FG008|COMPLETED|Overall Study||63
9863770|NCT00944034|10977266|FG009|COMPLETED|Overall Study||236
9863771|NCT00944034|10977267|FG010|COMPLETED|Overall Study||50
9863772|NCT00944034|10977268|FG011|COMPLETED|Overall Study||52
9863773|NCT00944034|10977257|FG000|NOT COMPLETED|Overall Study||5
9863774|NCT00944034|10977258|FG001|NOT COMPLETED|Overall Study||7
9863775|NCT00944034|10977259|FG002|NOT COMPLETED|Overall Study||9
9863776|NCT00944034|10977260|FG003|NOT COMPLETED|Overall Study||4
9863777|NCT00944034|10977261|FG004|NOT COMPLETED|Overall Study||14
9863778|NCT00944034|10977262|FG005|NOT COMPLETED|Overall Study||20
9863779|NCT00944034|10977263|FG006|NOT COMPLETED|Overall Study||4
9863780|NCT00944034|10977264|FG007|NOT COMPLETED|Overall Study||5
9863781|NCT00944034|10977265|FG008|NOT COMPLETED|Overall Study||10
9863782|NCT00944034|10977266|FG009|NOT COMPLETED|Overall Study||10
9863783|NCT00944034|10977267|FG010|NOT COMPLETED|Overall Study||1
9863784|NCT00944034|10977268|FG011|NOT COMPLETED|Overall Study||4
9863785|NCT00944047|10977311|FG000|STARTED|Overall Study||32
9863786|NCT00944047|10977311|FG000|COMPLETED|Overall Study||27
9863787|NCT00944047|10977311|FG000|NOT COMPLETED|Overall Study||5
9863788|NCT00944073|10977317|FG000|STARTED|Overall Study||292
9863789|NCT00944073|10977318|FG001|STARTED|Overall Study||291
9863790|NCT00944073|10977317|FG000|COMPLETED|Overall Study||287
9863791|NCT00944073|10977318|FG001|COMPLETED|Overall Study||287
9863792|NCT00944073|10977317|FG000|NOT COMPLETED|Overall Study||5
9863793|NCT00944073|10977318|FG001|NOT COMPLETED|Overall Study||4
9863794|NCT00944125|10977324|FG000|STARTED|Baseline to 3 Months||19
9863795|NCT00944125|10977325|FG001|STARTED|Baseline to 3 Months||22
9863796|NCT00944125|10977324|FG000|COMPLETED|Baseline to 3 Months||19
9863797|NCT00944125|10977325|FG001|COMPLETED|Baseline to 3 Months||22
9863798|NCT00944125|10977324|FG000|NOT COMPLETED|Baseline to 3 Months||0
9863799|NCT00944125|10977325|FG001|NOT COMPLETED|Baseline to 3 Months||0
9863800|NCT00944125|10977324|FG000|STARTED|3 to 6 Months||19
9863801|NCT00944125|10977325|FG001|STARTED|3 to 6 Months||22
9863802|NCT00944125|10977324|FG000|COMPLETED|3 to 6 Months||19
9863803|NCT00944125|10977325|FG001|COMPLETED|3 to 6 Months||20
9863804|NCT00944125|10977324|FG000|NOT COMPLETED|3 to 6 Months||0
9863805|NCT00944125|10977325|FG001|NOT COMPLETED|3 to 6 Months||2
9863806|NCT00944125|10977324|FG000|STARTED|6 Months to Study Completion||19
9863807|NCT00944125|10977325|FG001|STARTED|6 Months to Study Completion||20
9863808|NCT00944125|10977324|FG000|COMPLETED|6 Months to Study Completion||19
9863809|NCT00944125|10977325|FG001|COMPLETED|6 Months to Study Completion||18
9863810|NCT00944125|10977324|FG000|NOT COMPLETED|6 Months to Study Completion||0
9863811|NCT00944125|10977325|FG001|NOT COMPLETED|6 Months to Study Completion||2
9863812|NCT00944450|10977331|FG000|STARTED|Period 1||6
9863813|NCT00944450|10977332|FG001|STARTED|Period 1||6
9863814|NCT00944450|10977331|FG000|COMPLETED|Period 1||6
9863815|NCT00944450|10977332|FG001|COMPLETED|Period 1||6
9863816|NCT00944450|10977331|FG000|NOT COMPLETED|Period 1||0
9863817|NCT00944450|10977332|FG001|NOT COMPLETED|Period 1||0
9863818|NCT00944450|10977331|FG000|STARTED|Period 2||6
9863819|NCT00944450|10977332|FG001|STARTED|Period 2||6
9863820|NCT00944450|10977331|FG000|COMPLETED|Period 2||6
9863821|NCT00944450|10977332|FG001|COMPLETED|Period 2||6
9863822|NCT00944450|10977331|FG000|NOT COMPLETED|Period 2||0
9863823|NCT00944450|10977332|FG001|NOT COMPLETED|Period 2||0
9863824|NCT00944554|10977340|FG000|STARTED|Overall Study||50
9863825|NCT00944554|10977341|FG001|STARTED|Overall Study||54
9863826|NCT00944554|10977340|FG000|COMPLETED|Overall Study||22
9863827|NCT00944554|10977341|FG001|COMPLETED|Overall Study||25
9863828|NCT00944554|10977340|FG000|NOT COMPLETED|Overall Study||28
9863829|NCT00944554|10977341|FG001|NOT COMPLETED|Overall Study||29
9863830|NCT00944645|10977347|FG000|STARTED|Period 1||94
9863831|NCT00944645|10977348|FG001|STARTED|Period 1||94
9863832|NCT00944645|10977347|FG000|COMPLETED|Period 1||94
9863833|NCT00944645|10977348|FG001|COMPLETED|Period 1||94
9863834|NCT00944645|10977347|FG000|NOT COMPLETED|Period 1||0
9863835|NCT00944645|10977348|FG001|NOT COMPLETED|Period 1||0
9863836|NCT00944645|10977347|FG000|STARTED|Period 2||94
9863837|NCT00944645|10977348|FG001|STARTED|Period 2||94
9863838|NCT00944645|10977347|FG000|COMPLETED|Period 2||86
9863839|NCT00944645|10977348|FG001|COMPLETED|Period 2||85
9863840|NCT00944645|10977347|FG000|NOT COMPLETED|Period 2||8
9863841|NCT00944645|10977348|FG001|NOT COMPLETED|Period 2||9
9863842|NCT00944658|10977356|FG000|STARTED|Treatment 12 Weeks||19
9863843|NCT00944658|10977357|FG001|STARTED|Treatment 12 Weeks||19
9863844|NCT00944658|10977356|FG000|COMPLETED|Treatment 12 Weeks||19
9863845|NCT00944658|10977357|FG001|COMPLETED|Treatment 12 Weeks||17
9863846|NCT00944658|10977356|FG000|NOT COMPLETED|Treatment 12 Weeks||0
9863847|NCT00944658|10977357|FG001|NOT COMPLETED|Treatment 12 Weeks||2
9863848|NCT00944658|10977356|FG000|STARTED|Follow up 4 Weeks||19
9863849|NCT00944658|10977357|FG001|STARTED|Follow up 4 Weeks||17
9863850|NCT00944658|10977356|FG000|COMPLETED|Follow up 4 Weeks||19
9863851|NCT00944658|10977357|FG001|COMPLETED|Follow up 4 Weeks||17
9863852|NCT00944658|10977356|FG000|NOT COMPLETED|Follow up 4 Weeks||0
9863853|NCT00944658|10977357|FG001|NOT COMPLETED|Follow up 4 Weeks||0
9863854|NCT00944671|10977369|FG000|STARTED|Period I||4
9863855|NCT00944671|10977370|FG001|STARTED|Period I||4
9863856|NCT00944671|10977371|FG002|STARTED|Period I||4
9863857|NCT00944671|10977372|FG003|STARTED|Period I||4
9863858|NCT00944671|10977373|FG004|STARTED|Period I||4
9863859|NCT00944671|10977374|FG005|STARTED|Period I||4
9863860|NCT00944671|10977369|FG000|COMPLETED|Period I||4
9863861|NCT00944671|10977370|FG001|COMPLETED|Period I||4
9863862|NCT00944671|10977371|FG002|COMPLETED|Period I||4
9863863|NCT00944671|10977372|FG003|COMPLETED|Period I||4
9863864|NCT00944671|10977373|FG004|COMPLETED|Period I||4
9863865|NCT00944671|10977374|FG005|COMPLETED|Period I||4
9863866|NCT00944671|10977369|FG000|NOT COMPLETED|Period I||0
9863867|NCT00944671|10977370|FG001|NOT COMPLETED|Period I||0
9863868|NCT00944671|10977371|FG002|NOT COMPLETED|Period I||0
9863869|NCT00944671|10977372|FG003|NOT COMPLETED|Period I||0
10094121|NCT02348632|11222589|FG000|NOT COMPLETED|Open-label Period||185
10094122|NCT02348632|11222590|FG001|NOT COMPLETED|Open-label Period||0
9863870|NCT00944671|10977373|FG004|NOT COMPLETED|Period I||0
9863871|NCT00944671|10977374|FG005|NOT COMPLETED|Period I||0
9863872|NCT00944671|10977369|FG000|STARTED|Period II||4
9863873|NCT00944671|10977370|FG001|STARTED|Period II||4
9863874|NCT00944671|10977371|FG002|STARTED|Period II||4
9863875|NCT00944671|10977372|FG003|STARTED|Period II||4
9863876|NCT00944671|10977373|FG004|STARTED|Period II||4
9863877|NCT00944671|10977374|FG005|STARTED|Period II||4
9863878|NCT00944671|10977369|FG000|COMPLETED|Period II||4
9863879|NCT00944671|10977370|FG001|COMPLETED|Period II||4
9863880|NCT00944671|10977371|FG002|COMPLETED|Period II||4
9863881|NCT00944671|10977372|FG003|COMPLETED|Period II||4
9863882|NCT00944671|10977373|FG004|COMPLETED|Period II||4
9863883|NCT00944671|10977374|FG005|COMPLETED|Period II||4
9863884|NCT00944671|10977369|FG000|NOT COMPLETED|Period II||0
9863885|NCT00944671|10977370|FG001|NOT COMPLETED|Period II||0
9863886|NCT00944671|10977371|FG002|NOT COMPLETED|Period II||0
9863887|NCT00944671|10977372|FG003|NOT COMPLETED|Period II||0
9863888|NCT00944671|10977373|FG004|NOT COMPLETED|Period II||0
9863889|NCT00944671|10977374|FG005|NOT COMPLETED|Period II||0
9863890|NCT00944671|10977369|FG000|STARTED|Period III||4
9863891|NCT00944671|10977370|FG001|STARTED|Period III||4
9863892|NCT00944671|10977371|FG002|STARTED|Period III||4
9863893|NCT00944671|10977372|FG003|STARTED|Period III||4
9863894|NCT00944671|10977373|FG004|STARTED|Period III||4
9863895|NCT00944671|10977374|FG005|STARTED|Period III||4
9863896|NCT00944671|10977369|FG000|COMPLETED|Period III||4
9863897|NCT00944671|10977370|FG001|COMPLETED|Period III||4
9863898|NCT00944671|10977371|FG002|COMPLETED|Period III||4
9863899|NCT00944671|10977372|FG003|COMPLETED|Period III||4
9863900|NCT00944671|10977373|FG004|COMPLETED|Period III||4
9863901|NCT00944671|10977374|FG005|COMPLETED|Period III||4
9863902|NCT00944671|10977369|FG000|NOT COMPLETED|Period III||0
9863903|NCT00944671|10977370|FG001|NOT COMPLETED|Period III||0
9863904|NCT00944671|10977371|FG002|NOT COMPLETED|Period III||0
9863905|NCT00944671|10977372|FG003|NOT COMPLETED|Period III||0
9863906|NCT00944671|10977373|FG004|NOT COMPLETED|Period III||0
9863907|NCT00944671|10977374|FG005|NOT COMPLETED|Period III||0
9863908|NCT00944697|10977384|FG000|STARTED|Overall Study||50
9863909|NCT00944697|10977385|FG001|STARTED|Overall Study||48
10094123|NCT02348632|11222589|FG000|STARTED|Randomized Withdrawal Period||140
9863910|NCT00944697|10977384|FG000|COMPLETED|Overall Study||48
9863911|NCT00944697|10977385|FG001|COMPLETED|Overall Study||43
9863912|NCT00944697|10977384|FG000|NOT COMPLETED|Overall Study||2
9863913|NCT00944697|10977385|FG001|NOT COMPLETED|Overall Study||5
9863914|NCT00944710|10977393|FG000|STARTED|10-week Primary Outcome||40
9863915|NCT00944710|10977394|FG001|STARTED|10-week Primary Outcome||33
9863916|NCT00944710|10977393|FG000|COMPLETED|10-week Primary Outcome||40
9863917|NCT00944710|10977394|FG001|COMPLETED|10-week Primary Outcome||33
9863918|NCT00944710|10977393|FG000|NOT COMPLETED|10-week Primary Outcome||0
9863919|NCT00944710|10977394|FG001|NOT COMPLETED|10-week Primary Outcome||0
9863920|NCT00944710|10977393|FG000|STARTED|12-week Visit (Off-treatment)||40
9863921|NCT00944710|10977394|FG001|STARTED|12-week Visit (Off-treatment)||33
9863922|NCT00944710|10977393|FG000|COMPLETED|12-week Visit (Off-treatment)||40
9863923|NCT00944710|10977394|FG001|COMPLETED|12-week Visit (Off-treatment)||33
9863924|NCT00944710|10977393|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0
9863925|NCT00944710|10977394|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0
9863926|NCT00944710|10977393|FG000|STARTED|Additional Post 10-week Primary Outcome||40
9863927|NCT00944710|10977394|FG001|STARTED|Additional Post 10-week Primary Outcome||33
9863928|NCT00944710|10977393|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
9863929|NCT00944710|10977394|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
9863930|NCT00944710|10977393|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23
9863931|NCT00944710|10977394|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22
9863932|NCT00944710|10977393|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
9863933|NCT00944710|10977394|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
9863934|NCT00944749|10977400|FG000|STARTED|Overall Study||23
9863935|NCT00944749|10977400|FG000|COMPLETED|Overall Study||22
9863936|NCT00944749|10977400|FG000|NOT COMPLETED|Overall Study||1
9863937|NCT00945061|10977406|FG000|STARTED|Overall Study||12
9863938|NCT00945061|10977407|FG001|STARTED|Overall Study||1
9863939|NCT00945061|10977406|FG000|COMPLETED|Overall Study||12
9863940|NCT00945061|10977407|FG001|COMPLETED|Overall Study||1
9863941|NCT00945061|10977406|FG000|NOT COMPLETED|Overall Study||0
9863942|NCT00945061|10977407|FG001|NOT COMPLETED|Overall Study||0
9863943|NCT00945100|10977424|FG000|STARTED|10-week Primary Outcome||83
9863944|NCT00945100|10977425|FG001|STARTED|10-week Primary Outcome||86
9863945|NCT00945100|10977424|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
9863946|NCT00945100|10977425|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
9863947|NCT00945100|10977424|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
9863948|NCT00945100|10977425|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
9863949|NCT00945100|10977424|FG000|COMPLETED|10-week Primary Outcome||82
9863950|NCT00945100|10977425|FG001|COMPLETED|10-week Primary Outcome||83
9863951|NCT00945100|10977424|FG000|NOT COMPLETED|10-week Primary Outcome||1
9863952|NCT00945100|10977425|FG001|NOT COMPLETED|10-week Primary Outcome||3
9863953|NCT00945100|10977424|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
9863954|NCT00945100|10977425|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
9863955|NCT00945100|10977424|FG000|COMPLETED|Post-10 Week Primary Outcome||51
9863956|NCT00945100|10977425|FG001|COMPLETED|Post-10 Week Primary Outcome||56
9863957|NCT00945100|10977424|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4
9863958|NCT00945100|10977425|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7
9863959|NCT00945139|10977431|FG000|STARTED|Overall Study||46
9863960|NCT00945139|10977431|FG000|COMPLETED|Overall Study||46
9863961|NCT00945139|10977431|FG000|NOT COMPLETED|Overall Study||0
9863962|NCT00945191|10977436|FG000|STARTED|Overall Study||24
9863963|NCT00945191|10977436|FG000|COMPLETED|Overall Study||0
9863964|NCT00945191|10977436|FG000|NOT COMPLETED|Overall Study||24
9863965|NCT00945243|10977440|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
9863966|NCT00945243|10977440|FG000|COMPLETED|Overall Study||8
9863967|NCT00945243|10977440|FG000|NOT COMPLETED|Overall Study||3
9863968|NCT00945256|10977449|FG000|STARTED|Overall Study||13
9863969|NCT00945256|10977450|FG001|STARTED|Overall Study||10
9863970|NCT00945256|10977451|FG002|STARTED|Overall Study||15
9863971|NCT00945256|10977452|FG003|STARTED|Overall Study||16
9863972|NCT00945256|10977453|FG004|STARTED|Overall Study||8
9863973|NCT00945256|10977449|FG000|COMPLETED|Overall Study||9
9863974|NCT00945256|10977450|FG001|COMPLETED|Overall Study||8
9863975|NCT00945256|10977451|FG002|COMPLETED|Overall Study||7
9863976|NCT00945256|10977452|FG003|COMPLETED|Overall Study||7
9863977|NCT00945256|10977453|FG004|COMPLETED|Overall Study||7
9863978|NCT00945256|10977449|FG000|NOT COMPLETED|Overall Study||4
9863979|NCT00945256|10977450|FG001|NOT COMPLETED|Overall Study||2
9863980|NCT00945256|10977451|FG002|NOT COMPLETED|Overall Study||8
9863981|NCT00945256|10977452|FG003|NOT COMPLETED|Overall Study||9
9863982|NCT00945256|10977453|FG004|NOT COMPLETED|Overall Study||1
9863983|NCT00945282|10977467|FG000|STARTED|Overall Study||6
9863984|NCT00945282|10977468|FG001|STARTED|Overall Study||2
9863985|NCT00945282|10977467|FG000|COMPLETED|Overall Study||6
9863986|NCT00945282|10977468|FG001|COMPLETED|Overall Study||2
9863987|NCT00945282|10977467|FG000|NOT COMPLETED|Overall Study||0
9863988|NCT00945282|10977468|FG001|NOT COMPLETED|Overall Study||0
9863989|NCT00945295|10977484|FG000|STARTED|Overall Study||15
9863990|NCT00945295|10977485|FG001|STARTED|Overall Study||16
9863991|NCT00945295|10977484|FG000|COMPLETED|Overall Study||15
9863992|NCT00945295|10977485|FG001|COMPLETED|Overall Study||14
9863993|NCT00945295|10977484|FG000|NOT COMPLETED|Overall Study||0
9863994|NCT00945295|10977485|FG001|NOT COMPLETED|Overall Study||2
9863995|NCT00945321|10977491|FG000|STARTED|Period 1||7
9863996|NCT00945321|10977492|FG001|STARTED|Period 1||7
9863997|NCT00945321|10977493|FG002|STARTED|Period 1||7
9863998|NCT00945321|10977494|FG003|STARTED|Period 1||7
9863999|NCT00945321|10977495|FG004|STARTED|Period 1||7
9864000|NCT00945321|10977496|FG005|STARTED|Period 1||7
9864001|NCT00945321|10977491|FG000|COMPLETED|Period 1||7
9864002|NCT00945321|10977492|FG001|COMPLETED|Period 1||7
9864003|NCT00945321|10977493|FG002|COMPLETED|Period 1||7
9864004|NCT00945321|10977494|FG003|COMPLETED|Period 1||7
9864005|NCT00945321|10977495|FG004|COMPLETED|Period 1||6
9864006|NCT00945321|10977496|FG005|COMPLETED|Period 1||7
9864007|NCT00945321|10977491|FG000|NOT COMPLETED|Period 1||0
9864008|NCT00945321|10977492|FG001|NOT COMPLETED|Period 1||0
9864009|NCT00945321|10977493|FG002|NOT COMPLETED|Period 1||0
9864010|NCT00945321|10977494|FG003|NOT COMPLETED|Period 1||0
9864011|NCT00945321|10977495|FG004|NOT COMPLETED|Period 1||1
9864012|NCT00945321|10977496|FG005|NOT COMPLETED|Period 1||0
9864013|NCT00945321|10977491|FG000|STARTED|Period 2||7
9864014|NCT00945321|10977492|FG001|STARTED|Period 2||7
9864015|NCT00945321|10977493|FG002|STARTED|Period 2||7
9864016|NCT00945321|10977494|FG003|STARTED|Period 2||7
9864017|NCT00945321|10977495|FG004|STARTED|Period 2||6
9864018|NCT00945321|10977496|FG005|STARTED|Period 2||7
9864019|NCT00945321|10977491|FG000|COMPLETED|Period 2||7
9864020|NCT00945321|10977492|FG001|COMPLETED|Period 2||7
9864021|NCT00945321|10977493|FG002|COMPLETED|Period 2||7
9864022|NCT00945321|10977494|FG003|COMPLETED|Period 2||7
9864023|NCT00945321|10977495|FG004|COMPLETED|Period 2||6
9864024|NCT00945321|10977496|FG005|COMPLETED|Period 2||7
9864025|NCT00945321|10977491|FG000|NOT COMPLETED|Period 2||0
9864026|NCT00945321|10977492|FG001|NOT COMPLETED|Period 2||0
9864027|NCT00945321|10977493|FG002|NOT COMPLETED|Period 2||0
9864028|NCT00945321|10977494|FG003|NOT COMPLETED|Period 2||0
9864029|NCT00945321|10977495|FG004|NOT COMPLETED|Period 2||0
9864030|NCT00945321|10977496|FG005|NOT COMPLETED|Period 2||0
9864031|NCT00945321|10977491|FG000|STARTED|Period 3||7
9864032|NCT00945321|10977492|FG001|STARTED|Period 3||7
9864033|NCT00945321|10977493|FG002|STARTED|Period 3||7
9864034|NCT00945321|10977494|FG003|STARTED|Period 3||7
9864035|NCT00945321|10977495|FG004|STARTED|Period 3||6
9864036|NCT00945321|10977496|FG005|STARTED|Period 3||7
9864037|NCT00945321|10977491|FG000|COMPLETED|Period 3||7
9864038|NCT00945321|10977492|FG001|COMPLETED|Period 3||7
9864039|NCT00945321|10977493|FG002|COMPLETED|Period 3||7
9864040|NCT00945321|10977494|FG003|COMPLETED|Period 3||7
9864041|NCT00945321|10977495|FG004|COMPLETED|Period 3||6
9864042|NCT00945321|10977496|FG005|COMPLETED|Period 3||7
9864043|NCT00945321|10977491|FG000|NOT COMPLETED|Period 3||0
9864044|NCT00945321|10977492|FG001|NOT COMPLETED|Period 3||0
9864045|NCT00945321|10977493|FG002|NOT COMPLETED|Period 3||0
9864046|NCT00945321|10977494|FG003|NOT COMPLETED|Period 3||0
9864047|NCT00945321|10977495|FG004|NOT COMPLETED|Period 3||0
9864048|NCT00945321|10977496|FG005|NOT COMPLETED|Period 3||0
9864049|NCT00945321|10977491|FG000|STARTED|Period 4||7
9864050|NCT00945321|10977492|FG001|STARTED|Period 4||7
10094124|NCT02348632|11222590|FG001|STARTED|Randomized Withdrawal Period||142
10094125|NCT02348632|11222589|FG000|COMPLETED|Randomized Withdrawal Period||137
10094126|NCT02348632|11222590|FG001|COMPLETED|Randomized Withdrawal Period||141
10094127|NCT02348632|11222589|FG000|NOT COMPLETED|Randomized Withdrawal Period||3
10094128|NCT02348632|11222590|FG001|NOT COMPLETED|Randomized Withdrawal Period||1
10094129|NCT02348658|11222596|FG000|STARTED|Period 1 (7 Days)||6
10094130|NCT02348658|11222597|FG001|STARTED|Period 1 (7 Days)||6
10094131|NCT02348658|11222596|FG000|COMPLETED|Period 1 (7 Days)||6
10094132|NCT02348658|11222597|FG001|COMPLETED|Period 1 (7 Days)||6
10094133|NCT02348658|11222596|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10094134|NCT02348658|11222597|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10094135|NCT02348658|11222596|FG000|STARTED|Washout Period (22 Days)||6
10094136|NCT02348658|11222597|FG001|STARTED|Washout Period (22 Days)||6
10094137|NCT02348658|11222596|FG000|COMPLETED|Washout Period (22 Days)||6
10094138|NCT02348658|11222597|FG001|COMPLETED|Washout Period (22 Days)||6
10094139|NCT02348658|11222596|FG000|NOT COMPLETED|Washout Period (22 Days)||0
9864051|NCT00945321|10977493|FG002|STARTED|Period 4||7
9864052|NCT00945321|10977494|FG003|STARTED|Period 4||7
9864053|NCT00945321|10977495|FG004|STARTED|Period 4||6
9864054|NCT00945321|10977496|FG005|STARTED|Period 4||7
9864055|NCT00945321|10977491|FG000|COMPLETED|Period 4||7
9864056|NCT00945321|10977492|FG001|COMPLETED|Period 4||7
9864057|NCT00945321|10977493|FG002|COMPLETED|Period 4||7
9864058|NCT00945321|10977494|FG003|COMPLETED|Period 4||7
9864059|NCT00945321|10977495|FG004|COMPLETED|Period 4||6
9864060|NCT00945321|10977496|FG005|COMPLETED|Period 4||6
9864061|NCT00945321|10977491|FG000|NOT COMPLETED|Period 4||0
9864062|NCT00945321|10977492|FG001|NOT COMPLETED|Period 4||0
9864063|NCT00945321|10977493|FG002|NOT COMPLETED|Period 4||0
9864064|NCT00945321|10977494|FG003|NOT COMPLETED|Period 4||0
9864065|NCT00945321|10977495|FG004|NOT COMPLETED|Period 4||0
9864066|NCT00945321|10977496|FG005|NOT COMPLETED|Period 4||1
9864067|NCT00945334|10977516|FG000|STARTED|Overall Study||19
9864068|NCT00945334|10977517|FG001|STARTED|Overall Study||18
9864069|NCT00945334|10977516|FG000|COMPLETED|Overall Study||16
9864070|NCT00945334|10977517|FG001|COMPLETED|Overall Study||15
10094140|NCT02348658|11222597|FG001|NOT COMPLETED|Washout Period (22 Days)||0
10094141|NCT02348658|11222596|FG000|STARTED|Period 2 (7 Days)||6
10094142|NCT02348658|11222597|FG001|STARTED|Period 2 (7 Days)||6
10094143|NCT02348658|11222596|FG000|COMPLETED|Period 2 (7 Days)||6
10094144|NCT02348658|11222597|FG001|COMPLETED|Period 2 (7 Days)||6
10094145|NCT02348658|11222596|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10094146|NCT02348658|11222597|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10094147|NCT02348684|11222603|FG000|STARTED|Overall Study||20
9864071|NCT00945334|10977516|FG000|NOT COMPLETED|Overall Study||3
10094148|NCT02348684|11222603|FG000|COMPLETED|Overall Study||20
10094149|NCT02348684|11222603|FG000|NOT COMPLETED|Overall Study||0
10094150|NCT02348723|11222609|FG000|STARTED|Overall Study||338
9864072|NCT00945334|10977517|FG001|NOT COMPLETED|Overall Study||3
9864073|NCT00945477|10977523|FG000|STARTED|Overall Study||11
9864074|NCT00945477|10977523|FG000|COMPLETED|Overall Study||5
9864075|NCT00945477|10977523|FG000|NOT COMPLETED|Overall Study||6
9864076|NCT00945555|10977528|FG000|STARTED|Overall Study||264
9864077|NCT00945555|10977528|FG000|COMPLETED|Overall Study||236
9864078|NCT00945555|10977528|FG000|NOT COMPLETED|Overall Study||28
9864079|NCT00945594|10977534|FG000|STARTED|Overall Study||50
9864080|NCT00945594|10977535|FG001|STARTED|Overall Study||50
9864081|NCT00945594|10977534|FG000|COMPLETED|Overall Study||50
9864082|NCT00945594|10977535|FG001|COMPLETED|Overall Study||50
9864083|NCT00945594|10977534|FG000|NOT COMPLETED|Overall Study||0
9864084|NCT00945594|10977535|FG001|NOT COMPLETED|Overall Study||0
9864085|NCT00945659|10977546|FG000|STARTED|Overall Study||39
9864086|NCT00945659|10977547|FG001|STARTED|Overall Study||40
9864087|NCT00945659|10977548|FG002|STARTED|Overall Study||37
9864088|NCT00945659|10977546|FG000|Baseline|Overall Study||39
9864089|NCT00945659|10977547|FG001|Baseline|Overall Study||40
9864090|NCT00945659|10977548|FG002|Baseline|Overall Study||37
9864091|NCT00945659|10977546|FG000|3-Months|Overall Study||38
9864092|NCT00945659|10977547|FG001|3-Months|Overall Study||39
9864093|NCT00945659|10977548|FG002|3-Months|Overall Study||35
9864094|NCT00945659|10977546|FG000|6-Months|Overall Study||31
9864095|NCT00945659|10977547|FG001|6-Months|Overall Study||29
9864096|NCT00945659|10977548|FG002|6-Months|Overall Study||25
9864097|NCT00945659|10977546|FG000|9-Months|Overall Study||32
9864098|NCT00945659|10977547|FG001|9-Months|Overall Study||20
9864099|NCT00945659|10977548|FG002|9-Months|Overall Study||20
9864100|NCT00945659|10977546|FG000|12-Months|Overall Study||32
9864101|NCT00945659|10977547|FG001|12-Months|Overall Study||20
9864102|NCT00945659|10977548|FG002|12-Months|Overall Study||20
9864103|NCT00945659|10977546|FG000|COMPLETED|Overall Study||32
9864104|NCT00945659|10977547|FG001|COMPLETED|Overall Study||20
9864105|NCT00945659|10977548|FG002|COMPLETED|Overall Study||20
9864106|NCT00945659|10977546|FG000|NOT COMPLETED|Overall Study||7
9864107|NCT00945659|10977547|FG001|NOT COMPLETED|Overall Study||20
9864108|NCT00945659|10977548|FG002|NOT COMPLETED|Overall Study||17
9864109|NCT00945750|10977562|FG000|STARTED|Period I||5
9864110|NCT00945750|10977563|FG001|STARTED|Period I||5
9864111|NCT00945750|10977564|FG002|STARTED|Period I||5
9864112|NCT00945750|10977565|FG003|STARTED|Period I||5
9864113|NCT00945750|10977566|FG004|STARTED|Period I||5
9864114|NCT00945750|10977567|FG005|STARTED|Period I||5
9864115|NCT00945750|10977562|FG000|COMPLETED|Period I||5
9864116|NCT00945750|10977563|FG001|COMPLETED|Period I||5
9864117|NCT00945750|10977564|FG002|COMPLETED|Period I||5
9864118|NCT00945750|10977565|FG003|COMPLETED|Period I||5
9864119|NCT00945750|10977566|FG004|COMPLETED|Period I||5
9864120|NCT00945750|10977567|FG005|COMPLETED|Period I||5
9864121|NCT00945750|10977562|FG000|NOT COMPLETED|Period I||0
9864122|NCT00945750|10977563|FG001|NOT COMPLETED|Period I||0
9864123|NCT00945750|10977564|FG002|NOT COMPLETED|Period I||0
9864124|NCT00945750|10977565|FG003|NOT COMPLETED|Period I||0
9864125|NCT00945750|10977566|FG004|NOT COMPLETED|Period I||0
9864126|NCT00945750|10977567|FG005|NOT COMPLETED|Period I||0
9864127|NCT00945750|10977562|FG000|STARTED|Period II||5
9864128|NCT00945750|10977563|FG001|STARTED|Period II||5
9864129|NCT00945750|10977564|FG002|STARTED|Period II||5
9864130|NCT00945750|10977565|FG003|STARTED|Period II||5
9864131|NCT00945750|10977566|FG004|STARTED|Period II||5
9864132|NCT00945750|10977567|FG005|STARTED|Period II||5
9864133|NCT00945750|10977562|FG000|COMPLETED|Period II||5
9864134|NCT00945750|10977563|FG001|COMPLETED|Period II||5
9864135|NCT00945750|10977564|FG002|COMPLETED|Period II||5
9864136|NCT00945750|10977565|FG003|COMPLETED|Period II||5
9864137|NCT00945750|10977566|FG004|COMPLETED|Period II||5
9864138|NCT00945750|10977567|FG005|COMPLETED|Period II||5
9864139|NCT00945750|10977562|FG000|NOT COMPLETED|Period II||0
9864140|NCT00945750|10977563|FG001|NOT COMPLETED|Period II||0
9864141|NCT00945750|10977564|FG002|NOT COMPLETED|Period II||0
9864142|NCT00945750|10977565|FG003|NOT COMPLETED|Period II||0
9864143|NCT00945750|10977566|FG004|NOT COMPLETED|Period II||0
9864144|NCT00945750|10977567|FG005|NOT COMPLETED|Period II||0
9864145|NCT00945750|10977562|FG000|STARTED|Period III||5
9864146|NCT00945750|10977563|FG001|STARTED|Period III||5
9864147|NCT00945750|10977564|FG002|STARTED|Period III||5
9864148|NCT00945750|10977565|FG003|STARTED|Period III||5
9864149|NCT00945750|10977566|FG004|STARTED|Period III||5
9864150|NCT00945750|10977567|FG005|STARTED|Period III||5
9864151|NCT00945750|10977562|FG000|COMPLETED|Period III||5
9864152|NCT00945750|10977563|FG001|COMPLETED|Period III||5
9864153|NCT00945750|10977564|FG002|COMPLETED|Period III||5
9864154|NCT00945750|10977565|FG003|COMPLETED|Period III||5
9864155|NCT00945750|10977566|FG004|COMPLETED|Period III||5
9864156|NCT00945750|10977567|FG005|COMPLETED|Period III||5
10094151|NCT02348723|11222610|FG001|STARTED|Overall Study||338
10094152|NCT02348723|11222609|FG000|COMPLETED|Overall Study||310
10094153|NCT02348723|11222610|FG001|COMPLETED|Overall Study||312
9864157|NCT00945750|10977562|FG000|NOT COMPLETED|Period III||0
9864158|NCT00945750|10977563|FG001|NOT COMPLETED|Period III||0
9864159|NCT00945750|10977564|FG002|NOT COMPLETED|Period III||0
9864160|NCT00945750|10977565|FG003|NOT COMPLETED|Period III||0
9864161|NCT00945750|10977566|FG004|NOT COMPLETED|Period III||0
9864162|NCT00945750|10977567|FG005|NOT COMPLETED|Period III||0
9864163|NCT00945815|10977575|FG000|STARTED|Overall Study||35
9864164|NCT00945815|10977575|FG000|Eligible|Overall Study||32
9864165|NCT00945815|10977575|FG000|Eligible and Began Protocol Therapy|Overall Study||31
9864166|NCT00945815|10977575|FG000|COMPLETED|Overall Study||27
9864167|NCT00945815|10977575|FG000|NOT COMPLETED|Overall Study||8
9864168|NCT00945854|10977581|FG000|STARTED|Overall Study||30
9864169|NCT00945854|10977582|FG001|STARTED|Overall Study||30
9864170|NCT00945854|10977581|FG000|COMPLETED|Overall Study||28
9864171|NCT00945854|10977582|FG001|COMPLETED|Overall Study||26
9864172|NCT00945854|10977581|FG000|NOT COMPLETED|Overall Study||2
9864173|NCT00945854|10977582|FG001|NOT COMPLETED|Overall Study||4
9864174|NCT00945893|10977590|FG000|STARTED|Overall Study||60
9864175|NCT00945893|10977591|FG001|STARTED|Overall Study||240
9864176|NCT00945893|10977590|FG000|Day 15 Post Dose 1|Overall Study||60
9864177|NCT00945893|10977591|FG001|Day 15 Post Dose 1|Overall Study||238
9864178|NCT00945893|10977590|FG000|Day 15 Post Dose 2|Overall Study||54
9864179|NCT00945893|10977591|FG001|Day 15 Post Dose 2|Overall Study||226
9864180|NCT00945893|10977590|FG000|COMPLETED|Overall Study||57
9864181|NCT00945893|10977591|FG001|COMPLETED|Overall Study||230
10094154|NCT02348723|11222609|FG000|NOT COMPLETED|Overall Study||28
9864182|NCT00945893|10977590|FG000|NOT COMPLETED|Overall Study||3
9864183|NCT00945893|10977591|FG001|NOT COMPLETED|Overall Study||10
9864184|NCT00945906|10977601|FG000|STARTED|Overall Study||61
9864185|NCT00945906|10977601|FG000|COMPLETED|Overall Study||54
9864186|NCT00945906|10977601|FG000|NOT COMPLETED|Overall Study||7
9864187|NCT00945945|10977607|FG000|STARTED|Overall Study||207
9864188|NCT00945945|10977608|FG001|STARTED|Overall Study||217
9864189|NCT00945945|10977607|FG000|COMPLETED|Overall Study||171
9864190|NCT00945945|10977608|FG001|COMPLETED|Overall Study||162
9864191|NCT00945945|10977607|FG000|NOT COMPLETED|Overall Study||36
9864192|NCT00945945|10977608|FG001|NOT COMPLETED|Overall Study||55
9864193|NCT00945958|10977614|FG000|STARTED|Overall Study||161
9864194|NCT00945958|10977614|FG000|COMPLETED|Overall Study||149
9864195|NCT00945958|10977614|FG000|NOT COMPLETED|Overall Study||12
9864196|NCT00946023|10977619|FG000|STARTED|Overall Study||83
9864197|NCT00946023|10977619|FG000|COMPLETED|Overall Study||83
9864198|NCT00946023|10977619|FG000|NOT COMPLETED|Overall Study||0
9953319|NCT01425814|11072024|FG000|NOT COMPLETED|Period 3||0
9953320|NCT01425814|11072025|FG001|NOT COMPLETED|Period 3||0
9953321|NCT01425814|11072026|FG002|NOT COMPLETED|Period 3||0
9953322|NCT01425814|11072027|FG003|NOT COMPLETED|Period 3||0
9953323|NCT01425814|11072028|FG004|NOT COMPLETED|Period 3||0
9953324|NCT01425814|11072029|FG005|NOT COMPLETED|Period 3||1
10094155|NCT02348723|11222610|FG001|NOT COMPLETED|Overall Study||26
10094156|NCT02348775|11222618|FG000|STARTED|Overall Study||8
10094157|NCT02348775|11222619|FG001|STARTED|Overall Study||8
10094158|NCT02348775|11222618|FG000|COMPLETED|Overall Study||8
10094159|NCT02348775|11222619|FG001|COMPLETED|Overall Study||8
10094160|NCT02348775|11222618|FG000|NOT COMPLETED|Overall Study||0
10094161|NCT02348775|11222619|FG001|NOT COMPLETED|Overall Study||0
10094162|NCT02348840|11222629|FG000|STARTED|Overall Study||23
10094163|NCT02348840|11222630|FG001|STARTED|Overall Study||21
9953325|NCT01425814|11072024|FG000|STARTED|Period 4||12
9953326|NCT01425814|11072025|FG001|STARTED|Period 4||9
9953327|NCT01425814|11072026|FG002|STARTED|Period 4||12
9953328|NCT01425814|11072027|FG003|STARTED|Period 4||10
9953329|NCT01425814|11072028|FG004|STARTED|Period 4||12
9953330|NCT01425814|11072029|FG005|STARTED|Period 4||12
9953331|NCT01425814|11072024|FG000|COMPLETED|Period 4||11
9953332|NCT01425814|11072025|FG001|COMPLETED|Period 4||9
9953333|NCT01425814|11072026|FG002|COMPLETED|Period 4||11
9953334|NCT01425814|11072027|FG003|COMPLETED|Period 4||10
9953335|NCT01425814|11072028|FG004|COMPLETED|Period 4||12
9953336|NCT01425814|11072029|FG005|COMPLETED|Period 4||12
9953337|NCT01425814|11072024|FG000|NOT COMPLETED|Period 4||1
9953338|NCT01425814|11072025|FG001|NOT COMPLETED|Period 4||0
9953339|NCT01425814|11072026|FG002|NOT COMPLETED|Period 4||1
9953340|NCT01425814|11072027|FG003|NOT COMPLETED|Period 4||0
9953341|NCT01425814|11072028|FG004|NOT COMPLETED|Period 4||0
9953342|NCT01425814|11072029|FG005|NOT COMPLETED|Period 4||0
9953343|NCT01425814|11072024|FG000|STARTED|Period 5||11
9953344|NCT01425814|11072025|FG001|STARTED|Period 5||9
9953345|NCT01425814|11072026|FG002|STARTED|Period 5||11
9953346|NCT01425814|11072027|FG003|STARTED|Period 5||10
9953347|NCT01425814|11072028|FG004|STARTED|Period 5||12
9953348|NCT01425814|11072029|FG005|STARTED|Period 5||12
9953349|NCT01425814|11072024|FG000|COMPLETED|Period 5||11
9953350|NCT01425814|11072025|FG001|COMPLETED|Period 5||9
9953351|NCT01425814|11072026|FG002|COMPLETED|Period 5||10
9953352|NCT01425814|11072027|FG003|COMPLETED|Period 5||10
9953353|NCT01425814|11072028|FG004|COMPLETED|Period 5||12
9953354|NCT01425814|11072029|FG005|COMPLETED|Period 5||11
9953355|NCT01425814|11072024|FG000|NOT COMPLETED|Period 5||0
9953356|NCT01425814|11072025|FG001|NOT COMPLETED|Period 5||0
9953357|NCT01425814|11072026|FG002|NOT COMPLETED|Period 5||1
9953358|NCT01425814|11072027|FG003|NOT COMPLETED|Period 5||0
9953359|NCT01425814|11072028|FG004|NOT COMPLETED|Period 5||0
9953360|NCT01425814|11072029|FG005|NOT COMPLETED|Period 5||1
9953361|NCT01425853|11072045|FG000|STARTED|Overall Study||304
9953362|NCT01425853|11072046|FG001|STARTED|Overall Study||302
9953363|NCT01425853|11072045|FG000|Safety Population|Overall Study||304
9953364|NCT01425853|11072046|FG001|Safety Population|Overall Study||299
9953365|NCT01425853|11072045|FG000|Per Protocol (PP)|Overall Study||264
9953366|NCT01425853|11072046|FG001|Per Protocol (PP)|Overall Study||258
10094164|NCT02348840|11222631|FG002|STARTED|Overall Study||425
10094165|NCT02348840|11222632|FG003|STARTED|Overall Study||374
9953367|NCT01425853|11072045|FG000|COMPLETED|Overall Study||240
9953368|NCT01425853|11072046|FG001|COMPLETED|Overall Study||225
9953369|NCT01425853|11072045|FG000|NOT COMPLETED|Overall Study||64
9953370|NCT01425853|11072046|FG001|NOT COMPLETED|Overall Study||77
9953371|NCT01425879|11072053|FG000|STARTED|Overall Study||8
9953372|NCT01425879|11072053|FG000|COMPLETED|Overall Study||8
9953373|NCT01425879|11072053|FG000|NOT COMPLETED|Overall Study||0
9953374|NCT01426009|11072057|FG000|STARTED|Period 1-First Intervention (7 Days)||139
9953375|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
9953376|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
9953377|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
9953378|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
9953379|NCT01426009|11072057|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
9953380|NCT01426009|11072057|FG000|Placebo|Period 1-First Intervention (7 Days)||24
9953381|NCT01426009|11072057|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137
9953382|NCT01426009|11072057|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
10094166|NCT02348840|11222629|FG000|COMPLETED|Overall Study||21
9864199|NCT00946088|10977625|FG000|STARTED|Overall Study||4
9864200|NCT00946088|10977626|FG001|STARTED|Overall Study||3
9864201|NCT00946088|10977625|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
9864202|NCT00946088|10977626|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
9864203|NCT00946088|10977625|FG000|NOT COMPLETED|Overall Study||0
9864204|NCT00946088|10977626|FG001|NOT COMPLETED|Overall Study||1
9864205|NCT00946101|10977636|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
9864206|NCT00946101|10977637|FG001|STARTED|Overall Study||65
9864207|NCT00946101|10977636|FG000|Day 15 Post Dose 1|Overall Study||260
9864208|NCT00946101|10977637|FG001|Day 15 Post Dose 1|Overall Study||64
9864209|NCT00946101|10977636|FG000|Day 15 Post Dose 2|Overall Study||254
9864210|NCT00946101|10977637|FG001|Day 15 Post Dose 2|Overall Study||63
9864211|NCT00946101|10977636|FG000|COMPLETED|Overall Study||257
9864212|NCT00946101|10977637|FG001|COMPLETED|Overall Study||63
9864213|NCT00946101|10977636|FG000|NOT COMPLETED|Overall Study||4
9864214|NCT00946101|10977637|FG001|NOT COMPLETED|Overall Study||2
9864215|NCT00946114|10977649|FG000|STARTED|Overall Study||20
9864216|NCT00946114|10977650|FG001|STARTED|Overall Study||12
9864217|NCT00946114|10977649|FG000|COMPLETED|Overall Study||12
9864218|NCT00946114|10977650|FG001|COMPLETED|Overall Study||10
9864219|NCT00946114|10977649|FG000|NOT COMPLETED|Overall Study||8
9864220|NCT00946114|10977650|FG001|NOT COMPLETED|Overall Study||2
9864221|NCT00946153|10977661|FG000|STARTED|Phase 1||6
9864222|NCT00946153|10977662|FG001|STARTED|Phase 1||3
9864223|NCT00946153|10977663|FG002|STARTED|Phase 1||6
9864224|NCT00946153|10977664|FG003|STARTED|Phase 1||5
9864225|NCT00946153|10977665|FG004|STARTED|Phase 1||0
9864226|NCT00946153|10977661|FG000|COMPLETED|Phase 1||6
9864227|NCT00946153|10977662|FG001|COMPLETED|Phase 1||3
9864228|NCT00946153|10977663|FG002|COMPLETED|Phase 1||6
9864229|NCT00946153|10977664|FG003|COMPLETED|Phase 1||5
9864230|NCT00946153|10977665|FG004|COMPLETED|Phase 1||0
9864231|NCT00946153|10977661|FG000|NOT COMPLETED|Phase 1||0
9864232|NCT00946153|10977662|FG001|NOT COMPLETED|Phase 1||0
9864233|NCT00946153|10977663|FG002|NOT COMPLETED|Phase 1||0
9864234|NCT00946153|10977664|FG003|NOT COMPLETED|Phase 1||0
9864235|NCT00946153|10977665|FG004|NOT COMPLETED|Phase 1||0
9864236|NCT00946153|10977661|FG000|STARTED|Phase 2||0
10094167|NCT02348840|11222630|FG001|COMPLETED|Overall Study||20
10094168|NCT02348840|11222631|FG002|COMPLETED|Overall Study||425
10094169|NCT02348840|11222632|FG003|COMPLETED|Overall Study||374
10094170|NCT02348840|11222629|FG000|NOT COMPLETED|Overall Study||2
9864237|NCT00946153|10977662|FG001|STARTED|Phase 2||0
9864238|NCT00946153|10977663|FG002|STARTED|Phase 2||0
9864239|NCT00946153|10977664|FG003|STARTED|Phase 2||0
9864240|NCT00946153|10977665|FG004|STARTED|Phase 2||46
9864241|NCT00946153|10977661|FG000|COMPLETED|Phase 2||0
9864242|NCT00946153|10977662|FG001|COMPLETED|Phase 2||0
9864243|NCT00946153|10977663|FG002|COMPLETED|Phase 2||0
9864244|NCT00946153|10977664|FG003|COMPLETED|Phase 2||0
9864245|NCT00946153|10977665|FG004|COMPLETED|Phase 2||33
9864246|NCT00946153|10977661|FG000|NOT COMPLETED|Phase 2||0
9864247|NCT00946153|10977662|FG001|NOT COMPLETED|Phase 2||0
9864248|NCT00946153|10977663|FG002|NOT COMPLETED|Phase 2||0
9864249|NCT00946153|10977664|FG003|NOT COMPLETED|Phase 2||0
9864250|NCT00946153|10977665|FG004|NOT COMPLETED|Phase 2||13
9864251|NCT00946192|10977685|FG000|STARTED|Overall Study||43
9864252|NCT00946192|10977686|FG001|STARTED|Overall Study||40
9864253|NCT00946192|10977687|FG002|STARTED|Overall Study||38
9864254|NCT00946192|10977685|FG000|COMPLETED|Overall Study||25
9864255|NCT00946192|10977686|FG001|COMPLETED|Overall Study||22
9864256|NCT00946192|10977687|FG002|COMPLETED|Overall Study||26
9864257|NCT00946192|10977685|FG000|NOT COMPLETED|Overall Study||18
9864258|NCT00946192|10977686|FG001|NOT COMPLETED|Overall Study||18
9864259|NCT00946192|10977687|FG002|NOT COMPLETED|Overall Study||12
9864260|NCT00946270|10977698|FG000|STARTED|Overall Study||21
9864261|NCT00946270|10977699|FG001|STARTED|Overall Study||20
9864262|NCT00946270|10977700|FG002|STARTED|Overall Study||29
9864263|NCT00946270|10977698|FG000|COMPLETED|Overall Study||21
9864264|NCT00946270|10977699|FG001|COMPLETED|Overall Study||20
9864265|NCT00946270|10977700|FG002|COMPLETED|Overall Study||29
9864266|NCT00946270|10977698|FG000|NOT COMPLETED|Overall Study||0
9864267|NCT00946270|10977699|FG001|NOT COMPLETED|Overall Study||0
9864268|NCT00946270|10977700|FG002|NOT COMPLETED|Overall Study||0
9864269|NCT00946296|10977710|FG000|STARTED|Overall Study||21
9864270|NCT00946296|10977711|FG001|STARTED|Overall Study||15
9864271|NCT00946296|10977710|FG000|COMPLETED|Overall Study||18
9864272|NCT00946296|10977711|FG001|COMPLETED|Overall Study||15
9864273|NCT00946296|10977710|FG000|NOT COMPLETED|Overall Study||3
9864274|NCT00946296|10977711|FG001|NOT COMPLETED|Overall Study||0
9864275|NCT00946309|10977719|FG000|STARTED|Overall Study||22
9864276|NCT00946309|10977720|FG001|STARTED|Overall Study||23
10094171|NCT02348840|11222630|FG001|NOT COMPLETED|Overall Study||1
10094172|NCT02348840|11222631|FG002|NOT COMPLETED|Overall Study||0
9864277|NCT00946309|10977719|FG000|COMPLETED|Overall Study||21
9864278|NCT00946309|10977720|FG001|COMPLETED|Overall Study||19
9864279|NCT00946309|10977719|FG000|NOT COMPLETED|Overall Study||1
9864280|NCT00946309|10977720|FG001|NOT COMPLETED|Overall Study||4
9864281|NCT00946322|10977727|FG000|STARTED|Pre-treatment||12
9864282|NCT00946322|10977727|FG000|COMPLETED|Pre-treatment||11
9864283|NCT00946322|10977727|FG000|NOT COMPLETED|Pre-treatment||1
9864284|NCT00946322|10977727|FG000|STARTED|Post-treatment||11
9864285|NCT00946322|10977727|FG000|COMPLETED|Post-treatment||9
9864286|NCT00946322|10977727|FG000|NOT COMPLETED|Post-treatment||2
10094173|NCT02348840|11222632|FG003|NOT COMPLETED|Overall Study||0
9758541|NCT03235817|10862080|FG000|STARTED|Overall Study||13
9758542|NCT03235817|10862081|FG001|STARTED|Overall Study||13
9758543|NCT03235817|10862082|FG002|STARTED|Overall Study||13
9758544|NCT03235817|10862080|FG000|COMPLETED|Overall Study||10
9758545|NCT03235817|10862081|FG001|COMPLETED|Overall Study||12
9758546|NCT03235817|10862082|FG002|COMPLETED|Overall Study||11
9864287|NCT00946348|10977733|FG000|STARTED|Overall Study||6
9864288|NCT00946348|10977734|FG001|STARTED|Overall Study||6
9864289|NCT00946348|10977733|FG000|COMPLETED|Overall Study||6
9864290|NCT00946348|10977734|FG001|COMPLETED|Overall Study||6
9864291|NCT00946348|10977733|FG000|NOT COMPLETED|Overall Study||0
9864292|NCT00946348|10977734|FG001|NOT COMPLETED|Overall Study||0
9864293|NCT00946478|10977742|FG000|STARTED|Overall Study||20
9864294|NCT00946478|10977743|FG001|STARTED|Overall Study||20
9864295|NCT00946478|10977742|FG000|COMPLETED|Overall Study||20
9864296|NCT00946478|10977743|FG001|COMPLETED|Overall Study||20
9864297|NCT00946478|10977742|FG000|NOT COMPLETED|Overall Study||0
9864298|NCT00946478|10977743|FG001|NOT COMPLETED|Overall Study||0
9864299|NCT00946530|10977753|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
9864300|NCT00946530|10977754|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
9864301|NCT00946530|10977755|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
9864302|NCT00946530|10977756|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
9864303|NCT00946530|10977753|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
9864304|NCT00946530|10977754|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
9864305|NCT00946530|10977755|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
9864306|NCT00946530|10977756|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
9864307|NCT00946530|10977753|FG000|NOT COMPLETED|Overall Study||1
9864308|NCT00946530|10977754|FG001|NOT COMPLETED|Overall Study||4
9864309|NCT00946530|10977755|FG002|NOT COMPLETED|Overall Study||1
9864310|NCT00946530|10977756|FG003|NOT COMPLETED|Overall Study||4
9864311|NCT00946647|10977775|FG000|STARTED|Phase 1 Part||6
9864312|NCT00946647|10977776|FG001|STARTED|Phase 1 Part||18
9864313|NCT00946647|10977777|FG002|STARTED|Phase 1 Part||7
9864314|NCT00946647|10977778|FG003|STARTED|Phase 1 Part||0
9864315|NCT00946647|10977779|FG004|STARTED|Phase 1 Part||0
9864316|NCT00946647|10977775|FG000|COMPLETED|Phase 1 Part||0
9864317|NCT00946647|10977776|FG001|COMPLETED|Phase 1 Part||0
9864318|NCT00946647|10977777|FG002|COMPLETED|Phase 1 Part||0
9864319|NCT00946647|10977778|FG003|COMPLETED|Phase 1 Part||0
9864320|NCT00946647|10977779|FG004|COMPLETED|Phase 1 Part||0
9864321|NCT00946647|10977775|FG000|NOT COMPLETED|Phase 1 Part||6
9864322|NCT00946647|10977776|FG001|NOT COMPLETED|Phase 1 Part||18
9864323|NCT00946647|10977777|FG002|NOT COMPLETED|Phase 1 Part||7
9864324|NCT00946647|10977778|FG003|NOT COMPLETED|Phase 1 Part||0
9864325|NCT00946647|10977779|FG004|NOT COMPLETED|Phase 1 Part||0
9864326|NCT00946647|10977775|FG000|STARTED|Phase ll Part||0
9864327|NCT00946647|10977776|FG001|STARTED|Phase ll Part||0
9864328|NCT00946647|10977777|FG002|STARTED|Phase ll Part||0
9864329|NCT00946647|10977778|FG003|STARTED|Phase ll Part||40
9864330|NCT00946647|10977779|FG004|STARTED|Phase ll Part||42
9864331|NCT00946647|10977775|FG000|Safety Set|Phase ll Part||0
9864332|NCT00946647|10977776|FG001|Safety Set|Phase ll Part||0
9864333|NCT00946647|10977777|FG002|Safety Set|Phase ll Part||0
9864334|NCT00946647|10977778|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
9864335|NCT00946647|10977779|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
9864336|NCT00946647|10977775|FG000|COMPLETED|Phase ll Part||0
9864337|NCT00946647|10977776|FG001|COMPLETED|Phase ll Part||0
9864338|NCT00946647|10977777|FG002|COMPLETED|Phase ll Part||0
9864339|NCT00946647|10977778|FG003|COMPLETED|Phase ll Part||0
9864340|NCT00946647|10977779|FG004|COMPLETED|Phase ll Part||0
9864341|NCT00946647|10977775|FG000|NOT COMPLETED|Phase ll Part||0
9864342|NCT00946647|10977776|FG001|NOT COMPLETED|Phase ll Part||0
9864343|NCT00946647|10977777|FG002|NOT COMPLETED|Phase ll Part||0
9864344|NCT00946647|10977778|FG003|NOT COMPLETED|Phase ll Part||40
9864345|NCT00946647|10977779|FG004|NOT COMPLETED|Phase ll Part||42
10113442|NCT02509117|11244198|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
9758547|NCT03235817|10862080|FG000|NOT COMPLETED|Overall Study||3
9758548|NCT03235817|10862081|FG001|NOT COMPLETED|Overall Study||1
9758549|NCT03235817|10862082|FG002|NOT COMPLETED|Overall Study||2
9758550|NCT03165955|10862091|FG000|STARTED|Screening/Baseline||31
9758551|NCT03165955|10862091|FG000|COMPLETED|Screening/Baseline||28
9758552|NCT03165955|10862091|FG000|NOT COMPLETED|Screening/Baseline||3
9758553|NCT03165955|10862091|FG000|STARTED|Treatment||28
9758554|NCT03165955|10862091|FG000|COMPLETED|Treatment||20
9758555|NCT03165955|10862091|FG000|NOT COMPLETED|Treatment||8
9758556|NCT03133793|10862099|FG000|STARTED|Overall Study||39
9758557|NCT03133793|10862100|FG001|STARTED|Overall Study||39
9758558|NCT03133793|10862101|FG002|STARTED|Overall Study||37
9758559|NCT03133793|10862102|FG003|STARTED|Overall Study||38
9758560|NCT03133793|10862099|FG000|COMPLETED|Overall Study||38
9758561|NCT03133793|10862100|FG001|COMPLETED|Overall Study||35
9758562|NCT03133793|10862101|FG002|COMPLETED|Overall Study||33
9864346|NCT00946712|10977794|FG000|STARTED|Overall Study||671
9864347|NCT00946712|10977795|FG001|STARTED|Overall Study||662
9864348|NCT00946712|10977794|FG000|COMPLETED|Overall Study||124
9864349|NCT00946712|10977795|FG001|COMPLETED|Overall Study||0
9864350|NCT00946712|10977794|FG000|NOT COMPLETED|Overall Study||547
10094174|NCT02348918|11222651|FG000|STARTED|Overall Study||39
9864351|NCT00946712|10977795|FG001|NOT COMPLETED|Overall Study||662
9864352|NCT00946881|10977802|FG000|STARTED|First Treatment||30
9864353|NCT00946881|10977802|FG000|COMPLETED|First Treatment||28
9864354|NCT00946881|10977802|FG000|NOT COMPLETED|First Treatment||2
9864355|NCT00946881|10977802|FG000|STARTED|Retreatment||8
9864356|NCT00946881|10977802|FG000|COMPLETED|Retreatment||7
9864357|NCT00946881|10977802|FG000|NOT COMPLETED|Retreatment||1
9864358|NCT00946920|10977829|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565
9864359|NCT00946920|10977830|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
9864360|NCT00946920|10977829|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
9864361|NCT00946920|10977830|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
9864362|NCT00946920|10977829|FG000|COMPLETED|Overall Study||455
9864363|NCT00946920|10977830|FG001|COMPLETED|Overall Study||239
9864364|NCT00946920|10977829|FG000|NOT COMPLETED|Overall Study||110
9864365|NCT00946920|10977830|FG001|NOT COMPLETED|Overall Study||44
10094175|NCT02348918|11222652|FG001|STARTED|Overall Study||33
10094176|NCT02348918|11222653|FG002|STARTED|Overall Study||42
10094177|NCT02348918|11222654|FG003|STARTED|Overall Study||24
10094178|NCT02348918|11222655|FG004|STARTED|Overall Study||19
10094179|NCT02348918|11222656|FG005|STARTED|Overall Study||17
10094180|NCT02348918|11222657|FG006|STARTED|Overall Study||13
10094181|NCT02348918|11222658|FG007|STARTED|Overall Study||16
10094182|NCT02348918|11222659|FG008|STARTED|Overall Study||15
10094183|NCT02348918|11222651|FG000|COMPLETED|Overall Study||39
10094184|NCT02348918|11222652|FG001|COMPLETED|Overall Study||33
10094185|NCT02348918|11222653|FG002|COMPLETED|Overall Study||42
10094186|NCT02348918|11222654|FG003|COMPLETED|Overall Study||24
10094187|NCT02348918|11222655|FG004|COMPLETED|Overall Study||19
10094188|NCT02348918|11222656|FG005|COMPLETED|Overall Study||17
10094189|NCT02348918|11222657|FG006|COMPLETED|Overall Study||13
10094190|NCT02348918|11222658|FG007|COMPLETED|Overall Study||16
10094191|NCT02348918|11222659|FG008|COMPLETED|Overall Study||15
10094192|NCT02348918|11222651|FG000|NOT COMPLETED|Overall Study||0
10094193|NCT02348918|11222652|FG001|NOT COMPLETED|Overall Study||0
10094194|NCT02348918|11222653|FG002|NOT COMPLETED|Overall Study||0
9864366|NCT00946998|10977838|FG000|STARTED|Overall Study||102
9864367|NCT00946998|10977839|FG001|STARTED|Overall Study||99
9864368|NCT00946998|10977838|FG000|Received Treatment as Randomized|Overall Study||102
9864369|NCT00946998|10977839|FG001|Received Treatment as Randomized|Overall Study||99
9864370|NCT00946998|10977838|FG000|COMPLETED|Overall Study||97
9864371|NCT00946998|10977839|FG001|COMPLETED|Overall Study||96
9864372|NCT00946998|10977838|FG000|NOT COMPLETED|Overall Study||5
9864373|NCT00946998|10977839|FG001|NOT COMPLETED|Overall Study||3
9864374|NCT00947115|10977848|FG000|STARTED|Overall Study||159
9864375|NCT00947115|10977849|FG001|STARTED|Overall Study||194
9864376|NCT00947115|10977850|FG002|STARTED|Overall Study||171
9864377|NCT00947115|10977848|FG000|COMPLETED|Overall Study||142
9864378|NCT00947115|10977849|FG001|COMPLETED|Overall Study||172
9864379|NCT00947115|10977850|FG002|COMPLETED|Overall Study||156
9864380|NCT00947115|10977848|FG000|NOT COMPLETED|Overall Study||17
9864381|NCT00947115|10977849|FG001|NOT COMPLETED|Overall Study||22
9864382|NCT00947115|10977850|FG002|NOT COMPLETED|Overall Study||15
9864383|NCT00947154|10977858|FG000|STARTED|Overall Study||12
9864384|NCT00947154|10977858|FG000|COMPLETED|Overall Study||11
9864385|NCT00947154|10977858|FG000|NOT COMPLETED|Overall Study||1
9864386|NCT00947167|10977863|FG000|STARTED|Pertuzumab Alone||4
9864387|NCT00947167|10977863|FG000|COMPLETED|Pertuzumab Alone||4
9864388|NCT00947167|10977863|FG000|NOT COMPLETED|Pertuzumab Alone||0
9864389|NCT00947167|10977863|FG000|STARTED|Erlotinib Added to Pertuzumab||3
9864390|NCT00947167|10977863|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3
9864391|NCT00947167|10977863|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
9864392|NCT00947193|10977867|FG000|STARTED|Overall Study||3
9864393|NCT00947193|10977868|FG001|STARTED|Overall Study||10
9864394|NCT00947193|10977867|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9864395|NCT00947193|10977868|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
9864396|NCT00947193|10977867|FG000|COMPLETED|Overall Study||0
9864397|NCT00947193|10977868|FG001|COMPLETED|Overall Study||10
9864398|NCT00947193|10977867|FG000|NOT COMPLETED|Overall Study||3
9864399|NCT00947193|10977868|FG001|NOT COMPLETED|Overall Study||0
9864400|NCT00947219|10977876|FG000|STARTED|Overall Study||28
9864401|NCT00947219|10977877|FG001|STARTED|Overall Study||25
9864402|NCT00947219|10977878|FG002|STARTED|Overall Study||26
9864403|NCT00947219|10977876|FG000|COMPLETED|Overall Study||22
10094195|NCT02348918|11222654|FG003|NOT COMPLETED|Overall Study||0
10094196|NCT02348918|11222655|FG004|NOT COMPLETED|Overall Study||0
9864404|NCT00947219|10977877|FG001|COMPLETED|Overall Study||21
9864405|NCT00947219|10977878|FG002|COMPLETED|Overall Study||22
9864406|NCT00947219|10977876|FG000|NOT COMPLETED|Overall Study||6
9864407|NCT00947219|10977877|FG001|NOT COMPLETED|Overall Study||4
9864408|NCT00947219|10977878|FG002|NOT COMPLETED|Overall Study||4
10094197|NCT02348918|11222656|FG005|NOT COMPLETED|Overall Study||0
10094198|NCT02348918|11222657|FG006|NOT COMPLETED|Overall Study||0
10094199|NCT02348918|11222658|FG007|NOT COMPLETED|Overall Study||0
9864409|NCT00947271|10977890|FG000|STARTED|3 Months Post Intervention||254
9864410|NCT00947271|10977891|FG001|STARTED|3 Months Post Intervention||252
9864411|NCT00947271|10977892|FG002|STARTED|3 Months Post Intervention||254
9864412|NCT00947271|10977893|FG003|STARTED|3 Months Post Intervention||250
9864413|NCT00947271|10977890|FG000|COMPLETED|3 Months Post Intervention||202
9864414|NCT00947271|10977891|FG001|COMPLETED|3 Months Post Intervention||204
9864415|NCT00947271|10977892|FG002|COMPLETED|3 Months Post Intervention||218
9864416|NCT00947271|10977893|FG003|COMPLETED|3 Months Post Intervention||206
9864417|NCT00947271|10977890|FG000|NOT COMPLETED|3 Months Post Intervention||52
9864418|NCT00947271|10977891|FG001|NOT COMPLETED|3 Months Post Intervention||48
9864419|NCT00947271|10977892|FG002|NOT COMPLETED|3 Months Post Intervention||36
9864420|NCT00947271|10977893|FG003|NOT COMPLETED|3 Months Post Intervention||44
9864421|NCT00947271|10977890|FG000|STARTED|6 Months Post Intervention||254
9864422|NCT00947271|10977891|FG001|STARTED|6 Months Post Intervention||252
9864423|NCT00947271|10977892|FG002|STARTED|6 Months Post Intervention||254
9864424|NCT00947271|10977893|FG003|STARTED|6 Months Post Intervention||250
9864425|NCT00947271|10977890|FG000|COMPLETED|6 Months Post Intervention||199
9864426|NCT00947271|10977891|FG001|COMPLETED|6 Months Post Intervention||199
9864427|NCT00947271|10977892|FG002|COMPLETED|6 Months Post Intervention||196
9864428|NCT00947271|10977893|FG003|COMPLETED|6 Months Post Intervention||196
9864429|NCT00947271|10977890|FG000|NOT COMPLETED|6 Months Post Intervention||55
9864430|NCT00947271|10977891|FG001|NOT COMPLETED|6 Months Post Intervention||53
9864431|NCT00947271|10977892|FG002|NOT COMPLETED|6 Months Post Intervention||58
9864432|NCT00947271|10977893|FG003|NOT COMPLETED|6 Months Post Intervention||54
9864433|NCT00947271|10977890|FG000|STARTED|9 Months Post Intervention||254
9864434|NCT00947271|10977891|FG001|STARTED|9 Months Post Intervention||252
9864435|NCT00947271|10977892|FG002|STARTED|9 Months Post Intervention||254
9864436|NCT00947271|10977893|FG003|STARTED|9 Months Post Intervention||250
9864437|NCT00947271|10977890|FG000|COMPLETED|9 Months Post Intervention||184
9864438|NCT00947271|10977891|FG001|COMPLETED|9 Months Post Intervention||192
9864439|NCT00947271|10977892|FG002|COMPLETED|9 Months Post Intervention||193
9864440|NCT00947271|10977893|FG003|COMPLETED|9 Months Post Intervention||191
9864441|NCT00947271|10977890|FG000|NOT COMPLETED|9 Months Post Intervention||70
9864442|NCT00947271|10977891|FG001|NOT COMPLETED|9 Months Post Intervention||60
9864443|NCT00947271|10977892|FG002|NOT COMPLETED|9 Months Post Intervention||61
9864444|NCT00947271|10977893|FG003|NOT COMPLETED|9 Months Post Intervention||59
9864445|NCT00947271|10977890|FG000|STARTED|12 Months Post Intervention||254
9864446|NCT00947271|10977891|FG001|STARTED|12 Months Post Intervention||252
9864447|NCT00947271|10977892|FG002|STARTED|12 Months Post Intervention||254
9864448|NCT00947271|10977893|FG003|STARTED|12 Months Post Intervention||250
9864449|NCT00947271|10977890|FG000|COMPLETED|12 Months Post Intervention||183
9864450|NCT00947271|10977891|FG001|COMPLETED|12 Months Post Intervention||192
9864451|NCT00947271|10977892|FG002|COMPLETED|12 Months Post Intervention||195
9864452|NCT00947271|10977893|FG003|COMPLETED|12 Months Post Intervention||188
9864453|NCT00947271|10977890|FG000|NOT COMPLETED|12 Months Post Intervention||71
9864454|NCT00947271|10977891|FG001|NOT COMPLETED|12 Months Post Intervention||60
9864455|NCT00947271|10977892|FG002|NOT COMPLETED|12 Months Post Intervention||59
9864456|NCT00947271|10977893|FG003|NOT COMPLETED|12 Months Post Intervention||62
9864457|NCT00947297|10977903|FG000|STARTED|Overall Study||60
9864458|NCT00947297|10977903|FG000|COMPLETED|Overall Study||53
9864459|NCT00947297|10977903|FG000|NOT COMPLETED|Overall Study||7
9864460|NCT00947310|10977911|FG000|STARTED|Overall Study||514
9864461|NCT00947310|10977912|FG001|STARTED|Overall Study||500
9864462|NCT00947310|10977913|FG002|STARTED|Overall Study||486
9864463|NCT00947310|10977911|FG000|COMPLETED|Overall Study||514
9864464|NCT00947310|10977912|FG001|COMPLETED|Overall Study||500
9864465|NCT00947310|10977913|FG002|COMPLETED|Overall Study||486
9864466|NCT00947310|10977911|FG000|NOT COMPLETED|Overall Study||0
9864467|NCT00947310|10977912|FG001|NOT COMPLETED|Overall Study||0
9864468|NCT00947310|10977913|FG002|NOT COMPLETED|Overall Study||0
9864469|NCT00947349|10977925|FG000|STARTED|Triple Treatment Combination Period||4
9864470|NCT00947349|10977926|FG001|STARTED|Triple Treatment Combination Period||6
10094200|NCT02348918|11222659|FG008|NOT COMPLETED|Overall Study||0
9864471|NCT00947349|10977927|FG002|STARTED|Triple Treatment Combination Period||6
9864472|NCT00947349|10977928|FG003|STARTED|Triple Treatment Combination Period||6
9864473|NCT00947349|10977925|FG000|COMPLETED|Triple Treatment Combination Period||4
9864474|NCT00947349|10977926|FG001|COMPLETED|Triple Treatment Combination Period||5
9864475|NCT00947349|10977927|FG002|COMPLETED|Triple Treatment Combination Period||6
9864476|NCT00947349|10977928|FG003|COMPLETED|Triple Treatment Combination Period||6
9864477|NCT00947349|10977925|FG000|NOT COMPLETED|Triple Treatment Combination Period||0
9864478|NCT00947349|10977926|FG001|NOT COMPLETED|Triple Treatment Combination Period||1
9864479|NCT00947349|10977927|FG002|NOT COMPLETED|Triple Treatment Combination Period||0
9864480|NCT00947349|10977928|FG003|NOT COMPLETED|Triple Treatment Combination Period||0
9864481|NCT00947349|10977925|FG000|STARTED|Overall Study Standard of Care||4
9864482|NCT00947349|10977926|FG001|STARTED|Overall Study Standard of Care||5
9864483|NCT00947349|10977927|FG002|STARTED|Overall Study Standard of Care||6
9864484|NCT00947349|10977928|FG003|STARTED|Overall Study Standard of Care||6
9864485|NCT00947349|10977925|FG000|COMPLETED|Overall Study Standard of Care||4
9864486|NCT00947349|10977926|FG001|COMPLETED|Overall Study Standard of Care||5
9864487|NCT00947349|10977927|FG002|COMPLETED|Overall Study Standard of Care||4
9864488|NCT00947349|10977928|FG003|COMPLETED|Overall Study Standard of Care||4
9864489|NCT00947349|10977925|FG000|NOT COMPLETED|Overall Study Standard of Care||0
9864490|NCT00947349|10977926|FG001|NOT COMPLETED|Overall Study Standard of Care||0
9864491|NCT00947349|10977927|FG002|NOT COMPLETED|Overall Study Standard of Care||2
9864492|NCT00947349|10977928|FG003|NOT COMPLETED|Overall Study Standard of Care||2
9864493|NCT00947427|10977958|FG000|STARTED|Overall Study||22
9864494|NCT00947427|10977959|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
9864495|NCT00947427|10977958|FG000|COMPLETED|Overall Study||21
9864496|NCT00947427|10977959|FG001|COMPLETED|Overall Study||45
9864497|NCT00947427|10977958|FG000|NOT COMPLETED|Overall Study||1
9864498|NCT00947427|10977959|FG001|NOT COMPLETED|Overall Study||4
9864499|NCT00947505|10977967|FG000|STARTED|Overall Study||33
9864500|NCT00947505|10977968|FG001|STARTED|Overall Study||16
9864501|NCT00947505|10977967|FG000|COMPLETED|Overall Study||24
9864502|NCT00947505|10977968|FG001|COMPLETED|Overall Study||14
9864503|NCT00947505|10977967|FG000|NOT COMPLETED|Overall Study||9
9864504|NCT00947505|10977968|FG001|NOT COMPLETED|Overall Study||2
9864505|NCT00947531|10977976|FG000|STARTED|Overall Study||121
9864506|NCT00947531|10977977|FG001|STARTED|Overall Study||121
9864507|NCT00947531|10977976|FG000|COMPLETED|Overall Study||107
9864508|NCT00947531|10977977|FG001|COMPLETED|Overall Study||110
9864509|NCT00947531|10977976|FG000|NOT COMPLETED|Overall Study||14
9864510|NCT00947531|10977977|FG001|NOT COMPLETED|Overall Study||11
9864511|NCT00947544|10977983|FG000|STARTED|Switch-Over Period (2 Weeks)||11
9864512|NCT00947544|10977984|FG001|STARTED|Switch-Over Period (2 Weeks)||0
9864513|NCT00947544|10977983|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11
9864514|NCT00947544|10977984|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0
9864515|NCT00947544|10977983|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
9864516|NCT00947544|10977984|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
9864517|NCT00947544|10977983|FG000|STARTED|Safety-Extension Period (12 Months)||11
9864518|NCT00947544|10977984|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
9864519|NCT00947544|10977983|FG000|COMPLETED|Safety-Extension Period (12 Months)||10
9864520|NCT00947544|10977984|FG001|COMPLETED|Safety-Extension Period (12 Months)||6
9864521|NCT00947544|10977983|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1
9864522|NCT00947544|10977984|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0
9864523|NCT00947661|10977996|FG000|STARTED|Overall Study||289
9864524|NCT00947661|10977997|FG001|STARTED|Overall Study||289
9864525|NCT00947661|10977996|FG000|COMPLETED|Overall Study||276
9864526|NCT00947661|10977997|FG001|COMPLETED|Overall Study||274
9864527|NCT00947661|10977996|FG000|NOT COMPLETED|Overall Study||13
9864528|NCT00947661|10977997|FG001|NOT COMPLETED|Overall Study||15
9864529|NCT00947752|10978005|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
9864530|NCT00947752|10978006|FG001|STARTED|7-Day Run-in Treatment Period||0
9864531|NCT00947752|10978005|FG000|COMPLETED|7-Day Run-in Treatment Period||147
9864532|NCT00947752|10978006|FG001|COMPLETED|7-Day Run-in Treatment Period||0
9864533|NCT00947752|10978005|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0
9864534|NCT00947752|10978006|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0
9864535|NCT00947752|10978005|FG000|STARTED|1st 14-day Treatment Period||76
9864536|NCT00947752|10978006|FG001|STARTED|1st 14-day Treatment Period||71
9864537|NCT00947752|10978005|FG000|COMPLETED|1st 14-day Treatment Period||76
9864538|NCT00947752|10978006|FG001|COMPLETED|1st 14-day Treatment Period||71
9864539|NCT00947752|10978005|FG000|NOT COMPLETED|1st 14-day Treatment Period||0
9864540|NCT00947752|10978006|FG001|NOT COMPLETED|1st 14-day Treatment Period||0
9864541|NCT00947752|10978005|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71
9864542|NCT00947752|10978006|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76
9864543|NCT00947752|10978005|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
9864544|NCT00947752|10978006|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
9864545|NCT00947752|10978005|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
9864546|NCT00947752|10978006|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
9864547|NCT00947765|10978014|FG000|STARTED|Overall Study||30
9864548|NCT00947765|10978015|FG001|STARTED|Overall Study||30
9864549|NCT00947765|10978014|FG000|COMPLETED|Overall Study||30
9864550|NCT00947765|10978015|FG001|COMPLETED|Overall Study||30
9864551|NCT00947765|10978014|FG000|NOT COMPLETED|Overall Study||0
9864552|NCT00947765|10978015|FG001|NOT COMPLETED|Overall Study||0
9864553|NCT00947856|10978023|FG000|STARTED|Treatment Period||78
9864554|NCT00947856|10978024|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
9864555|NCT00947856|10978023|FG000|COMPLETED|Treatment Period||0
9864556|NCT00947856|10978024|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
9864557|NCT00947856|10978023|FG000|NOT COMPLETED|Treatment Period||78
9864558|NCT00947856|10978024|FG001|NOT COMPLETED|Treatment Period||32
9864559|NCT00947856|10978023|FG000|STARTED|Follow-up Period||78
9864560|NCT00947856|10978024|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
9864561|NCT00947856|10978023|FG000|COMPLETED|Follow-up Period||27
9864562|NCT00947856|10978024|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
9864563|NCT00947856|10978023|FG000|NOT COMPLETED|Follow-up Period||51
9864564|NCT00947856|10978024|FG001|NOT COMPLETED|Follow-up Period||23
9864565|NCT00947882|10978043|FG000|STARTED|Overall Study|Started: Randomised.|100
9864566|NCT00947882|10978044|FG001|STARTED|Overall Study||101
9864567|NCT00947882|10978045|FG002|STARTED|Overall Study||101
9864568|NCT00947882|10978046|FG003|STARTED|Overall Study||102
9864569|NCT00947882|10978043|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
9864570|NCT00947882|10978044|FG001|Full Analysis Set (FAS)|Overall Study||101
9864571|NCT00947882|10978045|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
9864572|NCT00947882|10978046|FG003|Full Analysis Set (FAS)|Overall Study||102
9864573|NCT00947882|10978043|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
9864574|NCT00947882|10978044|FG001|Actual Treatment|Overall Study||101
9864575|NCT00947882|10978045|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
9864576|NCT00947882|10978046|FG003|Actual Treatment|Overall Study||105
9864577|NCT00947882|10978043|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
9864578|NCT00947882|10978044|FG001|Safety Analysis Set|Overall Study||101
9864579|NCT00947882|10978045|FG002|Safety Analysis Set|Overall Study||100
9864580|NCT00947882|10978046|FG003|Safety Analysis Set|Overall Study||105
9864581|NCT00947882|10978043|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
9864582|NCT00947882|10978044|FG001|Visit 12, Month 6|Overall Study||91
9864583|NCT00947882|10978045|FG002|Visit 12, Month 6|Overall Study||90
9864584|NCT00947882|10978046|FG003|Visit 12, Month 6|Overall Study||95
9864585|NCT00947882|10978043|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
9864586|NCT00947882|10978044|FG001|COMPLETED|Overall Study||24
9864587|NCT00947882|10978045|FG002|COMPLETED|Overall Study||22
9864588|NCT00947882|10978046|FG003|COMPLETED|Overall Study||20
9864589|NCT00947882|10978043|FG000|NOT COMPLETED|Overall Study||74
9864590|NCT00947882|10978044|FG001|NOT COMPLETED|Overall Study||77
9864591|NCT00947882|10978045|FG002|NOT COMPLETED|Overall Study||79
9864592|NCT00947882|10978046|FG003|NOT COMPLETED|Overall Study||82
9864593|NCT00948025|10978059|FG000|STARTED|Phase 1 (Pilot Phase)||14
9864594|NCT00948025|10978060|FG001|STARTED|Phase 1 (Pilot Phase)||9
9864595|NCT00948025|10978059|FG000|COMPLETED|Phase 1 (Pilot Phase)||5
9864596|NCT00948025|10978060|FG001|COMPLETED|Phase 1 (Pilot Phase)||6
9864597|NCT00948025|10978059|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9
9864598|NCT00948025|10978060|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3
9864599|NCT00948025|10978059|FG000|STARTED|Phase 2 (Comparative Phase)||0
9864600|NCT00948025|10978060|FG001|STARTED|Phase 2 (Comparative Phase)||0
9864601|NCT00948025|10978059|FG000|COMPLETED|Phase 2 (Comparative Phase)||0
9864602|NCT00948025|10978060|FG001|COMPLETED|Phase 2 (Comparative Phase)||0
9864603|NCT00948025|10978059|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0
9864604|NCT00948025|10978060|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0
9864605|NCT00948064|10978070|FG000|STARTED|Phase I||31
9864606|NCT00948064|10978071|FG001|STARTED|Phase I||0
9864607|NCT00948064|10978072|FG002|STARTED|Phase I||0
9864608|NCT00948064|10978070|FG000|COMPLETED|Phase I||30
9864609|NCT00948064|10978071|FG001|COMPLETED|Phase I||0
9864610|NCT00948064|10978072|FG002|COMPLETED|Phase I||0
9864611|NCT00948064|10978070|FG000|NOT COMPLETED|Phase I||1
9864612|NCT00948064|10978071|FG001|NOT COMPLETED|Phase I||0
9864613|NCT00948064|10978072|FG002|NOT COMPLETED|Phase I||0
9864614|NCT00948064|10978070|FG000|STARTED|Phase II||0
9864615|NCT00948064|10978071|FG001|STARTED|Phase II||52
9864616|NCT00948064|10978072|FG002|STARTED|Phase II||27
9864617|NCT00948064|10978070|FG000|COMPLETED|Phase II||0
9864618|NCT00948064|10978071|FG001|COMPLETED|Phase II||51
9864619|NCT00948064|10978072|FG002|COMPLETED|Phase II||26
9864620|NCT00948064|10978070|FG000|NOT COMPLETED|Phase II||0
9864621|NCT00948064|10978071|FG001|NOT COMPLETED|Phase II||1
9864622|NCT00948064|10978072|FG002|NOT COMPLETED|Phase II||1
9864623|NCT00948090|10978084|FG000|STARTED|Overall Study||65
9864624|NCT00948090|10978085|FG001|STARTED|Overall Study||1
9864625|NCT00948090|10978086|FG002|STARTED|Overall Study||123
9864626|NCT00948090|10978087|FG003|STARTED|Overall Study||18
9864627|NCT00948090|10978084|FG000|COMPLETED|Overall Study||22
9864628|NCT00948090|10978085|FG001|COMPLETED|Overall Study||0
9864629|NCT00948090|10978086|FG002|COMPLETED|Overall Study||67
9864630|NCT00948090|10978087|FG003|COMPLETED|Overall Study||7
9864631|NCT00948090|10978084|FG000|NOT COMPLETED|Overall Study||43
9864632|NCT00948090|10978085|FG001|NOT COMPLETED|Overall Study||1
9864633|NCT00948090|10978086|FG002|NOT COMPLETED|Overall Study||56
9864634|NCT00948090|10978087|FG003|NOT COMPLETED|Overall Study||11
9864635|NCT00948155|10978096|FG000|STARTED|First Intervention 21 Days||14
9864636|NCT00948155|10978097|FG001|STARTED|First Intervention 21 Days||15
9864637|NCT00948155|10978096|FG000|COMPLETED|First Intervention 21 Days||12
9864638|NCT00948155|10978097|FG001|COMPLETED|First Intervention 21 Days||13
9864639|NCT00948155|10978096|FG000|NOT COMPLETED|First Intervention 21 Days||2
9864640|NCT00948155|10978097|FG001|NOT COMPLETED|First Intervention 21 Days||2
9864641|NCT00948155|10978096|FG000|STARTED|Washout 14 Days||12
9864642|NCT00948155|10978097|FG001|STARTED|Washout 14 Days||13
9864643|NCT00948155|10978096|FG000|COMPLETED|Washout 14 Days||11
9864644|NCT00948155|10978097|FG001|COMPLETED|Washout 14 Days||11
9864645|NCT00948155|10978096|FG000|NOT COMPLETED|Washout 14 Days||1
9864646|NCT00948155|10978097|FG001|NOT COMPLETED|Washout 14 Days||2
9864647|NCT00948155|10978096|FG000|STARTED|Second Intervention 21 Days||11
9864648|NCT00948155|10978097|FG001|STARTED|Second Intervention 21 Days||11
9864649|NCT00948155|10978096|FG000|COMPLETED|Second Intervention 21 Days||9
9864650|NCT00948155|10978097|FG001|COMPLETED|Second Intervention 21 Days||8
9864651|NCT00948155|10978096|FG000|NOT COMPLETED|Second Intervention 21 Days||2
9864652|NCT00948155|10978097|FG001|NOT COMPLETED|Second Intervention 21 Days||3
9864653|NCT00948246|10978105|FG000|STARTED|Overall Study||110
9864654|NCT00948246|10978105|FG000|COMPLETED|Overall Study||86
9864655|NCT00948246|10978105|FG000|NOT COMPLETED|Overall Study||24
9864656|NCT00948298|10978111|FG000|STARTED|Overall Study||65
9864657|NCT00948298|10978112|FG001|STARTED|Overall Study||65
9864658|NCT00948298|10978111|FG000|COMPLETED|Overall Study||55
9864659|NCT00948298|10978112|FG001|COMPLETED|Overall Study||60
9864660|NCT00948298|10978111|FG000|NOT COMPLETED|Overall Study||10
9864661|NCT00948298|10978112|FG001|NOT COMPLETED|Overall Study||5
9864662|NCT00948389|10978123|FG000|STARTED|Overall Study||6
9864663|NCT00948389|10978124|FG001|STARTED|Overall Study||3
9864664|NCT00948389|10978125|FG002|STARTED|Overall Study||7
9864665|NCT00948389|10978126|FG003|STARTED|Overall Study||9
9864666|NCT00948389|10978127|FG004|STARTED|Overall Study||1
9864667|NCT00948389|10978123|FG000|COMPLETED|Overall Study||0
9864668|NCT00948389|10978124|FG001|COMPLETED|Overall Study||0
9864669|NCT00948389|10978125|FG002|COMPLETED|Overall Study||0
9864670|NCT00948389|10978126|FG003|COMPLETED|Overall Study||0
9864671|NCT00948389|10978127|FG004|COMPLETED|Overall Study||0
9864672|NCT00948389|10978123|FG000|NOT COMPLETED|Overall Study||6
9864673|NCT00948389|10978124|FG001|NOT COMPLETED|Overall Study||3
9864674|NCT00948389|10978125|FG002|NOT COMPLETED|Overall Study||7
9864675|NCT00948389|10978126|FG003|NOT COMPLETED|Overall Study||9
9864676|NCT00948389|10978127|FG004|NOT COMPLETED|Overall Study||1
9864677|NCT00948428|10978144|FG000|STARTED|Overall Study||185
9864678|NCT00948428|10978145|FG001|STARTED|Overall Study||185
9864679|NCT00948428|10978146|FG002|STARTED|Overall Study||92
9864680|NCT00948428|10978144|FG000|COMPLETED|Overall Study||167
9864681|NCT00948428|10978145|FG001|COMPLETED|Overall Study||167
9864682|NCT00948428|10978146|FG002|COMPLETED|Overall Study||84
9864683|NCT00948428|10978144|FG000|NOT COMPLETED|Overall Study||18
9864684|NCT00948428|10978145|FG001|NOT COMPLETED|Overall Study||18
9864685|NCT00948428|10978146|FG002|NOT COMPLETED|Overall Study||8
9864686|NCT00948441|10978156|FG000|STARTED|Overall Study||8
9864687|NCT00948441|10978157|FG001|STARTED|Overall Study||8
9864688|NCT00948441|10978156|FG000|COMPLETED|Overall Study||7
9864689|NCT00948441|10978157|FG001|COMPLETED|Overall Study||4
9864690|NCT00948441|10978156|FG000|NOT COMPLETED|Overall Study||1
9864691|NCT00948441|10978157|FG001|NOT COMPLETED|Overall Study||4
9864692|NCT00948506|10978167|FG000|STARTED|Overall Study||11
9864693|NCT00948506|10978168|FG001|STARTED|Overall Study||9
9864694|NCT00948506|10978167|FG000|COMPLETED|Overall Study||8
9864695|NCT00948506|10978168|FG001|COMPLETED|Overall Study||8
9864696|NCT00948506|10978167|FG000|NOT COMPLETED|Overall Study||3
9864697|NCT00948506|10978168|FG001|NOT COMPLETED|Overall Study||1
9864698|NCT00948610|10978179|FG000|STARTED|Overall Study||10
9864699|NCT00948610|10978180|FG001|STARTED|Overall Study||10
9864700|NCT00948610|10978179|FG000|COMPLETED|Overall Study||9
9864701|NCT00948610|10978180|FG001|COMPLETED|Overall Study||9
9864702|NCT00948610|10978179|FG000|NOT COMPLETED|Overall Study||1
9864703|NCT00948610|10978180|FG001|NOT COMPLETED|Overall Study||1
9864704|NCT00948675|10978188|FG000|STARTED|Overall Study||182
9864705|NCT00948675|10978189|FG001|STARTED|Overall Study||179
9864706|NCT00948675|10978188|FG000|Received Any Amount of Study Drug|Overall Study||171
9864707|NCT00948675|10978189|FG001|Received Any Amount of Study Drug|Overall Study||166
9864708|NCT00948675|10978188|FG000|COMPLETED|Overall Study||181
9864709|NCT00948675|10978189|FG001|COMPLETED|Overall Study||179
9864710|NCT00948675|10978188|FG000|NOT COMPLETED|Overall Study||1
9864711|NCT00948675|10978189|FG001|NOT COMPLETED|Overall Study||0
9864712|NCT00948688|10978195|FG000|STARTED|Period 1: 200 mg Vorinostat||4
9864713|NCT00948688|10978196|FG001|STARTED|Period 1: 200 mg Vorinostat||0
9864714|NCT00948688|10978195|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2
9864715|NCT00948688|10978196|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0
9864716|NCT00948688|10978195|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
9864717|NCT00948688|10978196|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
9864718|NCT00948688|10978195|FG000|STARTED|Period 2: 100 mg Vorinostat||0
9864719|NCT00948688|10978196|FG001|STARTED|Period 2: 100 mg Vorinostat||6
9864720|NCT00948688|10978195|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0
9864721|NCT00948688|10978196|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5
9864722|NCT00948688|10978195|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
9864723|NCT00948688|10978196|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
9864724|NCT00948766|10978205|FG000|STARTED|Core Study||356
9864725|NCT00948766|10978206|FG001|STARTED|Core Study||360
9864726|NCT00948766|10978205|FG000|Exposed to Study Medication|Core Study||355
9864727|NCT00948766|10978206|FG001|Exposed to Study Medication|Core Study||359
9864728|NCT00948766|10978205|FG000|COMPLETED|Core Study||229
9864729|NCT00948766|10978206|FG001|COMPLETED|Core Study||234
9864730|NCT00948766|10978205|FG000|NOT COMPLETED|Core Study||127
9864731|NCT00948766|10978206|FG001|NOT COMPLETED|Core Study||126
9864732|NCT00948766|10978205|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
9864733|NCT00948766|10978206|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0
9864734|NCT00948766|10978205|FG000|Exposed to Study Medication|Extension Study||396
9864735|NCT00948766|10978206|FG001|Exposed to Study Medication|Extension Study||0
9864736|NCT00948766|10978205|FG000|COMPLETED|Extension Study||306
9864737|NCT00948766|10978206|FG001|COMPLETED|Extension Study||0
9864738|NCT00948766|10978205|FG000|NOT COMPLETED|Extension Study||91
9864739|NCT00948766|10978206|FG001|NOT COMPLETED|Extension Study||0
9864740|NCT00948792|10978213|FG000|STARTED|Overall Study||21
9864741|NCT00948792|10978213|FG000|COMPLETED|Overall Study||21
9864742|NCT00948792|10978213|FG000|NOT COMPLETED|Overall Study||0
9864743|NCT00948818|10978221|FG000|STARTED|Overall Study||397
9864744|NCT00948818|10978222|FG001|STARTED|Overall Study||406
9864745|NCT00948818|10978221|FG000|COMPLETED|Overall Study||335
9864746|NCT00948818|10978222|FG001|COMPLETED|Overall Study||312
9864747|NCT00948818|10978221|FG000|NOT COMPLETED|Overall Study||62
9864748|NCT00948818|10978222|FG001|NOT COMPLETED|Overall Study||94
9864749|NCT00948857|10978233|FG000|STARTED|Overall Study||3
9864750|NCT00948857|10978234|FG001|STARTED|Overall Study||2
9864751|NCT00948857|10978233|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
9864752|NCT00948857|10978234|FG001|COMPLETED|Overall Study||2
9864753|NCT00948857|10978233|FG000|NOT COMPLETED|Overall Study||1
9864754|NCT00948857|10978234|FG001|NOT COMPLETED|Overall Study||0
9864755|NCT00948896|10978248|FG000|STARTED|Randomization to 24 Months of Age||98
9864756|NCT00948896|10978249|FG001|STARTED|Randomization to 24 Months of Age||98
9864757|NCT00948896|10978250|FG002|STARTED|Randomization to 24 Months of Age||99
9864758|NCT00948896|10978251|FG003|STARTED|Randomization to 24 Months of Age||98
9864759|NCT00948896|10978252|FG004|STARTED|Randomization to 24 Months of Age||46
9864760|NCT00948896|10978253|FG005|STARTED|Randomization to 24 Months of Age||46
9864761|NCT00948896|10978254|FG006|STARTED|Randomization to 24 Months of Age||47
9864762|NCT00948896|10978255|FG007|STARTED|Randomization to 24 Months of Age||47
9864763|NCT00948896|10978248|FG000|COMPLETED|Randomization to 24 Months of Age||90
9864764|NCT00948896|10978249|FG001|COMPLETED|Randomization to 24 Months of Age||85
9864765|NCT00948896|10978250|FG002|COMPLETED|Randomization to 24 Months of Age||90
9864766|NCT00948896|10978251|FG003|COMPLETED|Randomization to 24 Months of Age||87
9864767|NCT00948896|10978252|FG004|COMPLETED|Randomization to 24 Months of Age||44
9864768|NCT00948896|10978253|FG005|COMPLETED|Randomization to 24 Months of Age||42
9864769|NCT00948896|10978254|FG006|COMPLETED|Randomization to 24 Months of Age||43
9864770|NCT00948896|10978255|FG007|COMPLETED|Randomization to 24 Months of Age||45
9864771|NCT00948896|10978248|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8
9864772|NCT00948896|10978249|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13
9864773|NCT00948896|10978250|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9
9864774|NCT00948896|10978251|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11
9864775|NCT00948896|10978252|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2
9864776|NCT00948896|10978253|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4
9864777|NCT00948896|10978254|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4
9864778|NCT00948896|10978255|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2
9864779|NCT00948896|10978248|FG000|STARTED|24 Months of Age to 36 Months of Age||90
9864780|NCT00948896|10978249|FG001|STARTED|24 Months of Age to 36 Months of Age||85
9864781|NCT00948896|10978250|FG002|STARTED|24 Months of Age to 36 Months of Age||90
9864782|NCT00948896|10978251|FG003|STARTED|24 Months of Age to 36 Months of Age||87
9864783|NCT00948896|10978252|FG004|STARTED|24 Months of Age to 36 Months of Age||44
9864784|NCT00948896|10978253|FG005|STARTED|24 Months of Age to 36 Months of Age||42
9864785|NCT00948896|10978254|FG006|STARTED|24 Months of Age to 36 Months of Age||43
9864786|NCT00948896|10978255|FG007|STARTED|24 Months of Age to 36 Months of Age||45
9864787|NCT00948896|10978248|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87
9864788|NCT00948896|10978249|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83
9864789|NCT00948896|10978250|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85
9864790|NCT00948896|10978251|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85
9864791|NCT00948896|10978252|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43
9864792|NCT00948896|10978253|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40
9864793|NCT00948896|10978254|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43
9864794|NCT00948896|10978255|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45
9864795|NCT00948896|10978248|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
9864796|NCT00948896|10978249|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
9864797|NCT00948896|10978250|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
9864798|NCT00948896|10978251|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
9864799|NCT00948896|10978252|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
9864800|NCT00948896|10978253|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
9864801|NCT00948896|10978254|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
9864802|NCT00948896|10978255|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
9864803|NCT00948922|10978280|FG000|STARTED|Overall Study||34
9864804|NCT00948922|10978281|FG001|STARTED|Overall Study||51
9864805|NCT00948922|10978282|FG002|STARTED|Overall Study||39
9864806|NCT00948922|10978280|FG000|COMPLETED|Overall Study||26
9864807|NCT00948922|10978281|FG001|COMPLETED|Overall Study||37
9864808|NCT00948922|10978282|FG002|COMPLETED|Overall Study||38
9864809|NCT00948922|10978280|FG000|NOT COMPLETED|Overall Study||8
9864810|NCT00948922|10978281|FG001|NOT COMPLETED|Overall Study||14
9864811|NCT00948922|10978282|FG002|NOT COMPLETED|Overall Study||1
9864812|NCT00948935|10978294|FG000|STARTED|Overall Study||35
9864813|NCT00948935|10978294|FG000|COMPLETED|Overall Study||35
9864814|NCT00948935|10978294|FG000|NOT COMPLETED|Overall Study||0
9864815|NCT00948974|10978300|FG000|STARTED|Overall Study||40
9864816|NCT00948974|10978301|FG001|STARTED|Overall Study||48
9864817|NCT00948974|10978300|FG000|COMPLETED|Overall Study||17
9864818|NCT00948974|10978301|FG001|COMPLETED|Overall Study||28
9864819|NCT00948974|10978300|FG000|NOT COMPLETED|Overall Study||23
9864820|NCT00948974|10978301|FG001|NOT COMPLETED|Overall Study||20
9864821|NCT00949078|10978309|FG000|STARTED|Overall Study||5
9864822|NCT00949078|10978310|FG001|STARTED|Overall Study||9
9864823|NCT00949078|10978309|FG000|COMPLETED|Overall Study||5
9864824|NCT00949078|10978310|FG001|COMPLETED|Overall Study||9
9864825|NCT00949078|10978309|FG000|NOT COMPLETED|Overall Study||0
9864826|NCT00949078|10978310|FG001|NOT COMPLETED|Overall Study||0
9864827|NCT00949117|10978318|FG000|STARTED|Overall Study||4
9864828|NCT00949117|10978319|FG001|STARTED|Overall Study||5
9864829|NCT00949117|10978318|FG000|COMPLETED|Overall Study||1
9864830|NCT00949117|10978319|FG001|COMPLETED|Overall Study||0
9864831|NCT00949117|10978318|FG000|NOT COMPLETED|Overall Study||3
9864832|NCT00949117|10978319|FG001|NOT COMPLETED|Overall Study||5
9864833|NCT00949234|10978327|FG000|STARTED|Overall Study||267
9864834|NCT00949234|10978327|FG000|COMPLETED|Overall Study||225
9864835|NCT00949234|10978327|FG000|NOT COMPLETED|Overall Study||42
9864836|NCT00949325|10978331|FG000|STARTED|Overall Study||3
10094201|NCT02349048|11222681|FG000|STARTED|Overall Study||59
10094202|NCT02349048|11222682|FG001|STARTED|Overall Study||9
10094203|NCT02349048|11222681|FG000|COMPLETED|Overall Study||54
10094204|NCT02349048|11222682|FG001|COMPLETED|Overall Study||9
10094205|NCT02349048|11222681|FG000|NOT COMPLETED|Overall Study||5
10094206|NCT02349048|11222682|FG001|NOT COMPLETED|Overall Study||0
10094207|NCT02349061|11222690|FG000|STARTED|Main Study: PCP (Up to Week 24)||42
10094208|NCT02349061|11222691|FG001|STARTED|Main Study: PCP (Up to Week 24)||60
10094209|NCT02349061|11222692|FG002|STARTED|Main Study: PCP (Up to Week 24)||0
10094210|NCT02349061|11222690|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33
10094211|NCT02349061|11222691|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56
10094212|NCT02349061|11222692|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0
10094213|NCT02349061|11222690|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
10094214|NCT02349061|11222691|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
10094215|NCT02349061|11222692|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
10094216|NCT02349061|11222690|FG000|STARTED|Main Study: Week 24 to 56||0
10094217|NCT02349061|11222691|FG001|STARTED|Main Study: Week 24 to 56||56
10094218|NCT02349061|11222692|FG002|STARTED|Main Study: Week 24 to 56||33
10094219|NCT02349061|11222690|FG000|COMPLETED|Main Study: Week 24 to 56||0
10094220|NCT02349061|11222691|FG001|COMPLETED|Main Study: Week 24 to 56||53
10094221|NCT02349061|11222692|FG002|COMPLETED|Main Study: Week 24 to 56||30
10094222|NCT02349061|11222690|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0
10094223|NCT02349061|11222691|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3
10094224|NCT02349061|11222692|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3
10094225|NCT02349061|11222690|FG000|STARTED|Study Extension (Week 56 to Week 120)||0
10094226|NCT02349061|11222691|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
10094227|NCT02349061|11222692|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
10094228|NCT02349061|11222690|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0
10094229|NCT02349061|11222691|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24
10094230|NCT02349061|11222692|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14
10094231|NCT02349061|11222690|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
10094232|NCT02349061|11222691|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
10094233|NCT02349061|11222692|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
10094234|NCT02349152|11222704|FG000|STARTED|Overall Study||60
10094235|NCT02349152|11222705|FG001|STARTED|Overall Study||56
10094236|NCT02349152|11222704|FG000|COMPLETED|Overall Study||54
10094237|NCT02349152|11222705|FG001|COMPLETED|Overall Study||52
10094238|NCT02349152|11222704|FG000|NOT COMPLETED|Overall Study||6
10094239|NCT02349152|11222705|FG001|NOT COMPLETED|Overall Study||4
10094240|NCT02349178|11222711|FG000|STARTED|Overall Study||6
10094241|NCT02349178|11222711|FG000|COMPLETED|Overall Study||6
10094242|NCT02349178|11222711|FG000|NOT COMPLETED|Overall Study||0
10094243|NCT02349295|11222718|FG000|STARTED|Double Blind Treatment (Week 0-24)||123
10094244|NCT02349295|11222719|FG001|STARTED|Double Blind Treatment (Week 0-24)||122
10094245|NCT02349295|11222720|FG002|STARTED|Double Blind Treatment (Week 0-24)||118
10094246|NCT02349295|11222721|FG003|STARTED|Double Blind Treatment (Week 0-24)||0
10094247|NCT02349295|11222722|FG004|STARTED|Double Blind Treatment (Week 0-24)||0
10094248|NCT02349295|11222723|FG005|STARTED|Double Blind Treatment (Week 0-24)||0
10094249|NCT02349295|11222724|FG006|STARTED|Double Blind Treatment (Week 0-24)||0
10094250|NCT02349295|11222725|FG007|STARTED|Double Blind Treatment (Week 0-24)||0
10094251|NCT02349295|11222726|FG008|STARTED|Double Blind Treatment (Week 0-24)||0
10094252|NCT02349295|11222727|FG009|STARTED|Double Blind Treatment (Week 0-24)||0
10094253|NCT02349295|11222728|FG010|STARTED|Double Blind Treatment (Week 0-24)||0
9864837|NCT00949325|10978332|FG001|STARTED|Overall Study||18
9864838|NCT00949325|10978333|FG002|STARTED|Overall Study||3
9864839|NCT00949325|10978331|FG000|COMPLETED|Overall Study||3
9864840|NCT00949325|10978332|FG001|COMPLETED|Overall Study||16
9864841|NCT00949325|10978333|FG002|COMPLETED|Overall Study||3
10094254|NCT02349295|11222729|FG011|STARTED|Double Blind Treatment (Week 0-24)||0
10094255|NCT02349295|11222730|FG012|STARTED|Double Blind Treatment (Week 0-24)||0
10094256|NCT02349295|11222731|FG013|STARTED|Double Blind Treatment (Week 0-24)||0
10094257|NCT02349295|11222718|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
10239821|NCT00479167|11371558|FG000|STARTED|Overall Study||1
9864842|NCT00949325|10978331|FG000|NOT COMPLETED|Overall Study||0
9864843|NCT00949325|10978332|FG001|NOT COMPLETED|Overall Study||2
9864844|NCT00949325|10978333|FG002|NOT COMPLETED|Overall Study||0
9864845|NCT00949533|10978351|FG000|STARTED|Overall Study||19
9864846|NCT00949533|10978352|FG001|STARTED|Overall Study||18
9864847|NCT00949533|10978351|FG000|COMPLETED|Overall Study||19
9864848|NCT00949533|10978352|FG001|COMPLETED|Overall Study||17
9864849|NCT00949533|10978351|FG000|NOT COMPLETED|Overall Study||0
9864850|NCT00949533|10978352|FG001|NOT COMPLETED|Overall Study||1
9864851|NCT00949650|10978360|FG000|STARTED|Overall Study|Treated patients.|230
10094258|NCT02349295|11222719|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
10094259|NCT02349295|11222720|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
9864852|NCT00949650|10978361|FG001|STARTED|Overall Study|Treated patients.|115
9864853|NCT00949650|10978360|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
9864854|NCT00949650|10978361|FG001|COMPLETED|Overall Study||0
9864855|NCT00949650|10978360|FG000|NOT COMPLETED|Overall Study||230
9864856|NCT00949650|10978361|FG001|NOT COMPLETED|Overall Study||115
9864857|NCT00949702|10978371|FG000|STARTED|Overall Study||132
9864858|NCT00949702|10978371|FG000|COMPLETED|Overall Study||84
9864859|NCT00949702|10978371|FG000|NOT COMPLETED|Overall Study||48
9864860|NCT00949715|10978377|FG000|STARTED|Overall Study||32
9864861|NCT00949715|10978378|FG001|STARTED|Overall Study||33
9864862|NCT00949715|10978377|FG000|COMPLETED|Overall Study||28
9864863|NCT00949715|10978378|FG001|COMPLETED|Overall Study||33
9864864|NCT00949715|10978377|FG000|NOT COMPLETED|Overall Study||4
9864865|NCT00949715|10978378|FG001|NOT COMPLETED|Overall Study||0
9864866|NCT00949884|10978386|FG000|STARTED|Overall Study||420
9864867|NCT00949884|10978387|FG001|STARTED|Overall Study||52
9864868|NCT00949884|10978388|FG002|STARTED|Overall Study||469
9864869|NCT00949884|10978386|FG000|COMPLETED|Overall Study||370
9864870|NCT00949884|10978387|FG001|COMPLETED|Overall Study||37
9864871|NCT00949884|10978388|FG002|COMPLETED|Overall Study||411
9864872|NCT00949884|10978386|FG000|NOT COMPLETED|Overall Study||50
9864873|NCT00949884|10978387|FG001|NOT COMPLETED|Overall Study||15
9864874|NCT00949884|10978388|FG002|NOT COMPLETED|Overall Study||58
9864875|NCT00949910|10978397|FG000|STARTED|Overall Study||6586
9864876|NCT00949910|10978397|FG000|COMPLETED|Overall Study||10
9864877|NCT00949910|10978397|FG000|NOT COMPLETED|Overall Study||6576
9864878|NCT00949975|10978405|FG000|STARTED|Overall Study||212
9864879|NCT00949975|10978406|FG001|STARTED|Overall Study||206
9864880|NCT00949975|10978407|FG002|STARTED|Overall Study||202
9864881|NCT00949975|10978408|FG003|STARTED|Overall Study||218
9864882|NCT00949975|10978405|FG000|COMPLETED|Overall Study||185
9864883|NCT00949975|10978406|FG001|COMPLETED|Overall Study||177
9864884|NCT00949975|10978407|FG002|COMPLETED|Overall Study||183
9864885|NCT00949975|10978408|FG003|COMPLETED|Overall Study||190
9864886|NCT00949975|10978405|FG000|NOT COMPLETED|Overall Study||27
9864887|NCT00949975|10978406|FG001|NOT COMPLETED|Overall Study||29
9864888|NCT00949975|10978407|FG002|NOT COMPLETED|Overall Study||19
9864889|NCT00949975|10978408|FG003|NOT COMPLETED|Overall Study||28
9864890|NCT00950170|10978418|FG000|STARTED|Overall Study||23
9864891|NCT00950170|10978418|FG000|COMPLETED|Overall Study||19
9864892|NCT00950170|10978418|FG000|NOT COMPLETED|Overall Study||4
9864893|NCT00950235|10978442|FG000|STARTED|Overall Study||60
9864894|NCT00950235|10978443|FG001|STARTED|Overall Study||58
9864895|NCT00950235|10978442|FG000|COMPLETED|Overall Study||58
9864896|NCT00950235|10978443|FG001|COMPLETED|Overall Study||54
9864897|NCT00950235|10978442|FG000|NOT COMPLETED|Overall Study||2
9864898|NCT00950235|10978443|FG001|NOT COMPLETED|Overall Study||4
9864899|NCT00950248|10978451|FG000|STARTED|Year 1: Baseline||85
9864900|NCT00950248|10978452|FG001|STARTED|Year 1: Baseline||0
9864901|NCT00950248|10978453|FG002|STARTED|Year 1: Baseline||0
9864902|NCT00950248|10978451|FG000|COMPLETED|Year 1: Baseline||77
9864903|NCT00950248|10978452|FG001|COMPLETED|Year 1: Baseline||0
9864904|NCT00950248|10978453|FG002|COMPLETED|Year 1: Baseline||0
9864905|NCT00950248|10978451|FG000|NOT COMPLETED|Year 1: Baseline||8
9864906|NCT00950248|10978452|FG001|NOT COMPLETED|Year 1: Baseline||0
9864907|NCT00950248|10978453|FG002|NOT COMPLETED|Year 1: Baseline||0
9864908|NCT00950248|10978451|FG000|STARTED|Year 2&3 Treatment Randomization||0
9864909|NCT00950248|10978452|FG001|STARTED|Year 2&3 Treatment Randomization||39
9864910|NCT00950248|10978453|FG002|STARTED|Year 2&3 Treatment Randomization||38
9864911|NCT00950248|10978451|FG000|COMPLETED|Year 2&3 Treatment Randomization||0
9864912|NCT00950248|10978452|FG001|COMPLETED|Year 2&3 Treatment Randomization||33
9864913|NCT00950248|10978453|FG002|COMPLETED|Year 2&3 Treatment Randomization||33
9864914|NCT00950248|10978451|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0
9864915|NCT00950248|10978452|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6
9864916|NCT00950248|10978453|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5
9864917|NCT00950300|10978462|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
9864918|NCT00950300|10978463|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
9864919|NCT00950300|10978462|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
9864920|NCT00950300|10978463|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
9864921|NCT00950300|10978462|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
9864922|NCT00950300|10978463|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
9864923|NCT00950300|10978462|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
9864924|NCT00950300|10978463|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
9864925|NCT00950300|10978462|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
10094260|NCT02349295|11222721|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094261|NCT02349295|11222722|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094262|NCT02349295|11222723|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
9864926|NCT00950300|10978463|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
9864927|NCT00950300|10978462|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
9864928|NCT00950300|10978463|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
9864929|NCT00950300|10978462|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
9864930|NCT00950300|10978463|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
9864931|NCT00950300|10978462|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
9864932|NCT00950300|10978463|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
9864933|NCT00950300|10978462|FG000|NOT COMPLETED|TFFU Period||100
9864934|NCT00950300|10978463|FG001|NOT COMPLETED|TFFU Period||107
9864935|NCT00950300|10978462|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
9864936|NCT00950300|10978463|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
9864937|NCT00950300|10978462|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
9864938|NCT00950300|10978463|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
9864939|NCT00950300|10978462|FG000|NOT COMPLETED|SFU Period||78
9864940|NCT00950300|10978463|FG001|NOT COMPLETED|SFU Period||78
9864941|NCT00950352|10978472|FG000|STARTED|Overall Study||72
9864942|NCT00950352|10978473|FG001|STARTED|Overall Study||32
9864943|NCT00950352|10978472|FG000|COMPLETED|Overall Study||30
9864944|NCT00950352|10978473|FG001|COMPLETED|Overall Study||21
9864945|NCT00950352|10978472|FG000|NOT COMPLETED|Overall Study||42
9864946|NCT00950352|10978473|FG001|NOT COMPLETED|Overall Study||11
9864947|NCT00950365|10978481|FG000|STARTED|Overall Study||27
9864948|NCT00950365|10978482|FG001|STARTED|Overall Study||52
9864949|NCT00950365|10978481|FG000|COMPLETED|Overall Study||25
9864950|NCT00950365|10978482|FG001|COMPLETED|Overall Study||50
9864951|NCT00950365|10978481|FG000|NOT COMPLETED|Overall Study||2
9864952|NCT00950365|10978482|FG001|NOT COMPLETED|Overall Study||2
9864953|NCT00950599|10978496|FG000|STARTED|Double-Blind Treatment Period||55
9864954|NCT00950599|10978497|FG001|STARTED|Double-Blind Treatment Period||47
9864955|NCT00950599|10978498|FG002|STARTED|Double-Blind Treatment Period||63
9864956|NCT00950599|10978499|FG003|STARTED|Double-Blind Treatment Period||54
9864957|NCT00950599|10978500|FG004|STARTED|Double-Blind Treatment Period||52
9864958|NCT00950599|10978501|FG005|STARTED|Double-Blind Treatment Period||67
9864959|NCT00950599|10978502|FG006|STARTED|Double-Blind Treatment Period||44
9864960|NCT00950599|10978503|FG007|STARTED|Double-Blind Treatment Period||41
9864961|NCT00950599|10978504|FG008|STARTED|Double-Blind Treatment Period||0
9864962|NCT00950599|10978505|FG009|STARTED|Double-Blind Treatment Period||0
9864963|NCT00950599|10978496|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
9864964|NCT00950599|10978497|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
9864965|NCT00950599|10978498|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
9864966|NCT00950599|10978499|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
9864967|NCT00950599|10978500|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
9864968|NCT00950599|10978501|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
9864969|NCT00950599|10978502|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
10094263|NCT02349295|11222724|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094264|NCT02349295|11222725|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094265|NCT02349295|11222726|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094266|NCT02349295|11222727|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094267|NCT02349295|11222728|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094268|NCT02349295|11222729|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094269|NCT02349295|11222730|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094270|NCT02349295|11222731|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10094271|NCT02349295|11222718|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109
10094272|NCT02349295|11222719|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111
10094273|NCT02349295|11222720|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94
10094274|NCT02349295|11222721|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094275|NCT02349295|11222722|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094276|NCT02349295|11222723|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094277|NCT02349295|11222724|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094278|NCT02349295|11222725|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094279|NCT02349295|11222726|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094280|NCT02349295|11222727|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094281|NCT02349295|11222728|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094282|NCT02349295|11222729|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094283|NCT02349295|11222730|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0
9864970|NCT00950599|10978503|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
9864971|NCT00950599|10978504|FG008|COMPLETED|Double-Blind Treatment Period||0
9864972|NCT00950599|10978505|FG009|COMPLETED|Double-Blind Treatment Period||0
9864973|NCT00950599|10978496|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
9864974|NCT00950599|10978497|FG001|NOT COMPLETED|Double-Blind Treatment Period||10
9864975|NCT00950599|10978498|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
9864976|NCT00950599|10978499|FG003|NOT COMPLETED|Double-Blind Treatment Period||11
9864977|NCT00950599|10978500|FG004|NOT COMPLETED|Double-Blind Treatment Period||7
9864978|NCT00950599|10978501|FG005|NOT COMPLETED|Double-Blind Treatment Period||12
9864979|NCT00950599|10978502|FG006|NOT COMPLETED|Double-Blind Treatment Period||0
9864980|NCT00950599|10978503|FG007|NOT COMPLETED|Double-Blind Treatment Period||6
9864981|NCT00950599|10978504|FG008|NOT COMPLETED|Double-Blind Treatment Period||0
9864982|NCT00950599|10978505|FG009|NOT COMPLETED|Double-Blind Treatment Period||0
9864983|NCT00950599|10978496|FG000|STARTED|Follow-Up Period||0
9864984|NCT00950599|10978497|FG001|STARTED|Follow-Up Period||0
9864985|NCT00950599|10978498|FG002|STARTED|Follow-Up Period||0
9864986|NCT00950599|10978499|FG003|STARTED|Follow-Up Period||0
9864987|NCT00950599|10978500|FG004|STARTED|Follow-Up Period||0
9864988|NCT00950599|10978501|FG005|STARTED|Follow-Up Period||0
9864989|NCT00950599|10978502|FG006|STARTED|Follow-Up Period||0
9864990|NCT00950599|10978503|FG007|STARTED|Follow-Up Period||0
9864991|NCT00950599|10978504|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
9864992|NCT00950599|10978505|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
9864993|NCT00950599|10978496|FG000|COMPLETED|Follow-Up Period||0
9864994|NCT00950599|10978497|FG001|COMPLETED|Follow-Up Period||0
9864995|NCT00950599|10978498|FG002|COMPLETED|Follow-Up Period||0
9864996|NCT00950599|10978499|FG003|COMPLETED|Follow-Up Period||0
9864997|NCT00950599|10978500|FG004|COMPLETED|Follow-Up Period||0
9864998|NCT00950599|10978501|FG005|COMPLETED|Follow-Up Period||0
9864999|NCT00950599|10978502|FG006|COMPLETED|Follow-Up Period||0
9865000|NCT00950599|10978503|FG007|COMPLETED|Follow-Up Period||0
9865001|NCT00950599|10978504|FG008|COMPLETED|Follow-Up Period||296
9865002|NCT00950599|10978505|FG009|COMPLETED|Follow-Up Period||78
9865003|NCT00950599|10978496|FG000|NOT COMPLETED|Follow-Up Period||0
9865004|NCT00950599|10978497|FG001|NOT COMPLETED|Follow-Up Period||0
9865005|NCT00950599|10978498|FG002|NOT COMPLETED|Follow-Up Period||0
9865006|NCT00950599|10978499|FG003|NOT COMPLETED|Follow-Up Period||0
9865007|NCT00950599|10978500|FG004|NOT COMPLETED|Follow-Up Period||0
9865008|NCT00950599|10978501|FG005|NOT COMPLETED|Follow-Up Period||0
9865009|NCT00950599|10978502|FG006|NOT COMPLETED|Follow-Up Period||0
9865010|NCT00950599|10978503|FG007|NOT COMPLETED|Follow-Up Period||0
9865011|NCT00950599|10978504|FG008|NOT COMPLETED|Follow-Up Period||13
9865012|NCT00950599|10978505|FG009|NOT COMPLETED|Follow-Up Period||2
9865013|NCT00950612|10978530|FG000|STARTED|Overall Study||40
9865014|NCT00950612|10978531|FG001|STARTED|Overall Study||20
9865015|NCT00950612|10978530|FG000|COMPLETED|Overall Study||40
9865016|NCT00950612|10978531|FG001|COMPLETED|Overall Study||20
9865017|NCT00950612|10978530|FG000|NOT COMPLETED|Overall Study||0
9865018|NCT00950612|10978531|FG001|NOT COMPLETED|Overall Study||0
9865019|NCT00950651|10978539|FG000|STARTED|Overall Study||215
9865020|NCT00950651|10978540|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216
9865021|NCT00950651|10978539|FG000|COMPLETED|Overall Study||184
9865022|NCT00950651|10978540|FG001|COMPLETED|Overall Study||181
9865023|NCT00950651|10978539|FG000|NOT COMPLETED|Overall Study||31
9865024|NCT00950651|10978540|FG001|NOT COMPLETED|Overall Study||35
9865025|NCT00950664|10978548|FG000|STARTED|First Intervention||49
9865026|NCT00950664|10978549|FG001|STARTED|First Intervention||53
9865027|NCT00950664|10978548|FG000|COMPLETED|First Intervention||46
9865028|NCT00950664|10978549|FG001|COMPLETED|First Intervention||48
9865029|NCT00950664|10978548|FG000|NOT COMPLETED|First Intervention||3
10094284|NCT02349295|11222731|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0
10094285|NCT02349295|11222718|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
10094286|NCT02349295|11222719|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
10094287|NCT02349295|11222720|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
10094288|NCT02349295|11222721|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094289|NCT02349295|11222722|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094290|NCT02349295|11222723|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094291|NCT02349295|11222724|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
9865030|NCT00950664|10978549|FG001|NOT COMPLETED|First Intervention||5
9865031|NCT00950664|10978548|FG000|STARTED|Washout Period of 4 Weeks||46
9865032|NCT00950664|10978549|FG001|STARTED|Washout Period of 4 Weeks||48
9865033|NCT00950664|10978548|FG000|COMPLETED|Washout Period of 4 Weeks||46
9865034|NCT00950664|10978549|FG001|COMPLETED|Washout Period of 4 Weeks||48
9865035|NCT00950664|10978548|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
9865036|NCT00950664|10978549|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0
9865037|NCT00950664|10978548|FG000|STARTED|Second Intervention||46
9865038|NCT00950664|10978549|FG001|STARTED|Second Intervention||48
9865039|NCT00950664|10978548|FG000|COMPLETED|Second Intervention||0
9865040|NCT00950664|10978549|FG001|COMPLETED|Second Intervention||0
10094292|NCT02349295|11222725|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
9865041|NCT00950664|10978548|FG000|NOT COMPLETED|Second Intervention||46
9865042|NCT00950664|10978549|FG001|NOT COMPLETED|Second Intervention||48
9865043|NCT00950729|10978555|FG000|STARTED|Driving With Running Shoes|March 2007|48
9865044|NCT00950729|10978555|FG000|COMPLETED|Driving With Running Shoes|June 2007|48
9865045|NCT00950729|10978555|FG000|NOT COMPLETED|Driving With Running Shoes||0
9865046|NCT00950729|10978555|FG000|STARTED|Driving With Plaster Cast||48
9865047|NCT00950729|10978555|FG000|COMPLETED|Driving With Plaster Cast||48
9865048|NCT00950729|10978555|FG000|NOT COMPLETED|Driving With Plaster Cast||0
9865049|NCT00950729|10978555|FG000|STARTED|Driving With Aircast||48
9865050|NCT00950729|10978555|FG000|COMPLETED|Driving With Aircast||48
9865051|NCT00950729|10978555|FG000|NOT COMPLETED|Driving With Aircast||0
9865052|NCT00950742|10978561|FG000|STARTED|Overall Study|entered and treated|16
9865053|NCT00950742|10978562|FG001|STARTED|Overall Study|entered and treated|2
9865054|NCT00950742|10978561|FG000|COMPLETED|Overall Study||0
9865055|NCT00950742|10978562|FG001|COMPLETED|Overall Study||0
9865056|NCT00950742|10978561|FG000|NOT COMPLETED|Overall Study||16
9865057|NCT00950742|10978562|FG001|NOT COMPLETED|Overall Study||2
9865058|NCT00950755|10978572|FG000|STARTED|Dosimetric and Therapeutic Treatment||41
9865059|NCT00950755|10978572|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
9865060|NCT00950755|10978572|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
9865061|NCT00950755|10978572|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
9865062|NCT00950755|10978572|FG000|COMPLETED|Long-Term Follow-Up||9
9865063|NCT00950755|10978572|FG000|NOT COMPLETED|Long-Term Follow-Up||9
9865064|NCT00950807|10978576|FG000|STARTED|Treatment Period 1||59
9865065|NCT00950807|10978577|FG001|STARTED|Treatment Period 1||13
9865066|NCT00950807|10978578|FG002|STARTED|Treatment Period 1||14
9865067|NCT00950807|10978579|FG003|STARTED|Treatment Period 1||12
9865068|NCT00950807|10978580|FG004|STARTED|Treatment Period 1||13
9865069|NCT00950807|10978581|FG005|STARTED|Treatment Period 1||13
9865070|NCT00950807|10978582|FG006|STARTED|Treatment Period 1||12
9865071|NCT00950807|10978583|FG007|STARTED|Treatment Period 1||14
9865072|NCT00950807|10978584|FG008|STARTED|Treatment Period 1||13
9865073|NCT00950807|10978585|FG009|STARTED|Treatment Period 1||13
9865074|NCT00950807|10978576|FG000|COMPLETED|Treatment Period 1||56
9865075|NCT00950807|10978577|FG001|COMPLETED|Treatment Period 1||13
9865076|NCT00950807|10978578|FG002|COMPLETED|Treatment Period 1||13
9865077|NCT00950807|10978579|FG003|COMPLETED|Treatment Period 1||12
9865078|NCT00950807|10978580|FG004|COMPLETED|Treatment Period 1||12
9865079|NCT00950807|10978581|FG005|COMPLETED|Treatment Period 1||11
9865080|NCT00950807|10978582|FG006|COMPLETED|Treatment Period 1||12
9865081|NCT00950807|10978583|FG007|COMPLETED|Treatment Period 1||14
9865082|NCT00950807|10978584|FG008|COMPLETED|Treatment Period 1||12
9865083|NCT00950807|10978585|FG009|COMPLETED|Treatment Period 1||13
9865084|NCT00950807|10978576|FG000|NOT COMPLETED|Treatment Period 1||3
9865085|NCT00950807|10978577|FG001|NOT COMPLETED|Treatment Period 1||0
9865086|NCT00950807|10978578|FG002|NOT COMPLETED|Treatment Period 1||1
9865087|NCT00950807|10978579|FG003|NOT COMPLETED|Treatment Period 1||0
9865088|NCT00950807|10978580|FG004|NOT COMPLETED|Treatment Period 1||1
9865089|NCT00950807|10978581|FG005|NOT COMPLETED|Treatment Period 1||2
9865090|NCT00950807|10978582|FG006|NOT COMPLETED|Treatment Period 1||0
9865091|NCT00950807|10978583|FG007|NOT COMPLETED|Treatment Period 1||0
9865092|NCT00950807|10978584|FG008|NOT COMPLETED|Treatment Period 1||1
9865093|NCT00950807|10978585|FG009|NOT COMPLETED|Treatment Period 1||0
9865094|NCT00950807|10978576|FG000|STARTED|Washout Period 1||56
9865095|NCT00950807|10978577|FG001|STARTED|Washout Period 1||13
9865096|NCT00950807|10978578|FG002|STARTED|Washout Period 1||13
9865097|NCT00950807|10978579|FG003|STARTED|Washout Period 1||12
9865098|NCT00950807|10978580|FG004|STARTED|Washout Period 1||12
9865099|NCT00950807|10978581|FG005|STARTED|Washout Period 1||11
9865100|NCT00950807|10978582|FG006|STARTED|Washout Period 1||12
9865101|NCT00950807|10978583|FG007|STARTED|Washout Period 1||14
9865102|NCT00950807|10978584|FG008|STARTED|Washout Period 1||12
9865103|NCT00950807|10978585|FG009|STARTED|Washout Period 1||13
9865104|NCT00950807|10978576|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
9865105|NCT00950807|10978577|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
9865106|NCT00950807|10978578|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
9865107|NCT00950807|10978579|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
9865108|NCT00950807|10978580|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
9865109|NCT00950807|10978581|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
9865110|NCT00950807|10978582|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
9865111|NCT00950807|10978583|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
9865112|NCT00950807|10978584|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
9865113|NCT00950807|10978585|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
9865114|NCT00950807|10978576|FG000|NOT COMPLETED|Washout Period 1||5
9865115|NCT00950807|10978577|FG001|NOT COMPLETED|Washout Period 1||0
9865116|NCT00950807|10978578|FG002|NOT COMPLETED|Washout Period 1||0
9865117|NCT00950807|10978579|FG003|NOT COMPLETED|Washout Period 1||1
9865118|NCT00950807|10978580|FG004|NOT COMPLETED|Washout Period 1||1
9865119|NCT00950807|10978581|FG005|NOT COMPLETED|Washout Period 1||0
9865120|NCT00950807|10978582|FG006|NOT COMPLETED|Washout Period 1||2
9865121|NCT00950807|10978583|FG007|NOT COMPLETED|Washout Period 1||1
9865122|NCT00950807|10978584|FG008|NOT COMPLETED|Washout Period 1||1
9865123|NCT00950807|10978585|FG009|NOT COMPLETED|Washout Period 1||0
9865124|NCT00950807|10978576|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
9865125|NCT00950807|10978577|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
9865126|NCT00950807|10978578|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
9865127|NCT00950807|10978579|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
9865128|NCT00950807|10978580|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
9865129|NCT00950807|10978581|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
9865130|NCT00950807|10978582|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
9865131|NCT00950807|10978583|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
9865132|NCT00950807|10978584|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
9865133|NCT00950807|10978585|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
9865134|NCT00950807|10978576|FG000|COMPLETED|Treatment Period 2||51
9865135|NCT00950807|10978577|FG001|COMPLETED|Treatment Period 2||12
9865136|NCT00950807|10978578|FG002|COMPLETED|Treatment Period 2||10
9865137|NCT00950807|10978579|FG003|COMPLETED|Treatment Period 2||12
9865138|NCT00950807|10978580|FG004|COMPLETED|Treatment Period 2||13
9865139|NCT00950807|10978581|FG005|COMPLETED|Treatment Period 2||9
9865140|NCT00950807|10978582|FG006|COMPLETED|Treatment Period 2||9
9865141|NCT00950807|10978583|FG007|COMPLETED|Treatment Period 2||10
9865142|NCT00950807|10978584|FG008|COMPLETED|Treatment Period 2||11
9865143|NCT00950807|10978585|FG009|COMPLETED|Treatment Period 2||11
9865144|NCT00950807|10978576|FG000|NOT COMPLETED|Treatment Period 2||2
9865145|NCT00950807|10978577|FG001|NOT COMPLETED|Treatment Period 2||1
9865146|NCT00950807|10978578|FG002|NOT COMPLETED|Treatment Period 2||0
9865147|NCT00950807|10978579|FG003|NOT COMPLETED|Treatment Period 2||1
9865148|NCT00950807|10978580|FG004|NOT COMPLETED|Treatment Period 2||0
9865149|NCT00950807|10978581|FG005|NOT COMPLETED|Treatment Period 2||1
9865150|NCT00950807|10978582|FG006|NOT COMPLETED|Treatment Period 2||1
9865151|NCT00950807|10978583|FG007|NOT COMPLETED|Treatment Period 2||3
9865152|NCT00950807|10978584|FG008|NOT COMPLETED|Treatment Period 2||0
9865153|NCT00950807|10978585|FG009|NOT COMPLETED|Treatment Period 2||0
9865154|NCT00950807|10978576|FG000|STARTED|Washout Period 2||51
9865155|NCT00950807|10978577|FG001|STARTED|Washout Period 2||12
9865156|NCT00950807|10978578|FG002|STARTED|Washout Period 2||10
9865157|NCT00950807|10978579|FG003|STARTED|Washout Period 2||12
9865158|NCT00950807|10978580|FG004|STARTED|Washout Period 2||13
9865159|NCT00950807|10978581|FG005|STARTED|Washout Period 2||9
9865160|NCT00950807|10978582|FG006|STARTED|Washout Period 2||9
9865161|NCT00950807|10978583|FG007|STARTED|Washout Period 2||10
9865162|NCT00950807|10978584|FG008|STARTED|Washout Period 2||11
9865163|NCT00950807|10978585|FG009|STARTED|Washout Period 2||11
9865164|NCT00950807|10978576|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
9865165|NCT00950807|10978577|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
9865166|NCT00950807|10978578|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
9865167|NCT00950807|10978579|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
9865168|NCT00950807|10978580|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
9865169|NCT00950807|10978581|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
10094293|NCT02349295|11222726|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094294|NCT02349295|11222727|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094295|NCT02349295|11222728|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094296|NCT02349295|11222729|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094297|NCT02349295|11222730|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094298|NCT02349295|11222731|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10094299|NCT02349295|11222718|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0
10094300|NCT02349295|11222719|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0
10094301|NCT02349295|11222720|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0
10094302|NCT02349295|11222721|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
10094303|NCT02349295|11222722|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
10094304|NCT02349295|11222723|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
10094305|NCT02349295|11222724|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
10094306|NCT02349295|11222725|FG007|STARTED|IR (Week 16-24)||0
10094307|NCT02349295|11222726|FG008|STARTED|IR (Week 16-24)||0
10094308|NCT02349295|11222727|FG009|STARTED|IR (Week 16-24)||0
10094309|NCT02349295|11222728|FG010|STARTED|IR (Week 16-24)||0
10094310|NCT02349295|11222729|FG011|STARTED|IR (Week 16-24)||0
10094311|NCT02349295|11222730|FG012|STARTED|IR (Week 16-24)||0
10094312|NCT02349295|11222731|FG013|STARTED|IR (Week 16-24)||0
10094313|NCT02349295|11222718|FG000|COMPLETED|IR (Week 16-24)||0
10094314|NCT02349295|11222719|FG001|COMPLETED|IR (Week 16-24)||0
10094315|NCT02349295|11222720|FG002|COMPLETED|IR (Week 16-24)||0
10094316|NCT02349295|11222721|FG003|COMPLETED|IR (Week 16-24)||16
10094317|NCT02349295|11222722|FG004|COMPLETED|IR (Week 16-24)||15
9865170|NCT00950807|10978582|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
9865171|NCT00950807|10978583|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
9865172|NCT00950807|10978584|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
9865173|NCT00950807|10978585|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
9865174|NCT00950807|10978576|FG000|NOT COMPLETED|Washout Period 2||4
9865175|NCT00950807|10978577|FG001|NOT COMPLETED|Washout Period 2||1
9865176|NCT00950807|10978578|FG002|NOT COMPLETED|Washout Period 2||0
9865177|NCT00950807|10978579|FG003|NOT COMPLETED|Washout Period 2||1
9865178|NCT00950807|10978580|FG004|NOT COMPLETED|Washout Period 2||1
9865179|NCT00950807|10978581|FG005|NOT COMPLETED|Washout Period 2||0
9865180|NCT00950807|10978582|FG006|NOT COMPLETED|Washout Period 2||1
9865181|NCT00950807|10978583|FG007|NOT COMPLETED|Washout Period 2||1
9865182|NCT00950807|10978584|FG008|NOT COMPLETED|Washout Period 2||0
9865183|NCT00950807|10978585|FG009|NOT COMPLETED|Washout Period 2||0
9865184|NCT00950807|10978576|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
9865185|NCT00950807|10978577|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
9865186|NCT00950807|10978578|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
9865187|NCT00950807|10978579|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
9865188|NCT00950807|10978580|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
9865189|NCT00950807|10978581|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
9865190|NCT00950807|10978582|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
9865191|NCT00950807|10978583|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
9865192|NCT00950807|10978584|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
9865193|NCT00950807|10978585|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
9865194|NCT00950807|10978576|FG000|COMPLETED|Treatment Period 3||45
9865195|NCT00950807|10978577|FG001|COMPLETED|Treatment Period 3||9
9865196|NCT00950807|10978578|FG002|COMPLETED|Treatment Period 3||10
9865197|NCT00950807|10978579|FG003|COMPLETED|Treatment Period 3||11
9865198|NCT00950807|10978580|FG004|COMPLETED|Treatment Period 3||12
9865199|NCT00950807|10978581|FG005|COMPLETED|Treatment Period 3||9
9865200|NCT00950807|10978582|FG006|COMPLETED|Treatment Period 3||11
9865201|NCT00950807|10978583|FG007|COMPLETED|Treatment Period 3||9
9865202|NCT00950807|10978584|FG008|COMPLETED|Treatment Period 3||9
9865203|NCT00950807|10978585|FG009|COMPLETED|Treatment Period 3||10
9865204|NCT00950807|10978576|FG000|NOT COMPLETED|Treatment Period 3||1
9865205|NCT00950807|10978577|FG001|NOT COMPLETED|Treatment Period 3||0
9865206|NCT00950807|10978578|FG002|NOT COMPLETED|Treatment Period 3||0
9865207|NCT00950807|10978579|FG003|NOT COMPLETED|Treatment Period 3||0
9865208|NCT00950807|10978580|FG004|NOT COMPLETED|Treatment Period 3||0
9865209|NCT00950807|10978581|FG005|NOT COMPLETED|Treatment Period 3||0
9865210|NCT00950807|10978582|FG006|NOT COMPLETED|Treatment Period 3||1
9865211|NCT00950807|10978583|FG007|NOT COMPLETED|Treatment Period 3||1
9865212|NCT00950807|10978584|FG008|NOT COMPLETED|Treatment Period 3||0
9865213|NCT00950807|10978585|FG009|NOT COMPLETED|Treatment Period 3||1
9865214|NCT00950833|10978610|FG000|STARTED|Overall Study||112
9865215|NCT00950833|10978611|FG001|STARTED|Overall Study||108
9865216|NCT00950833|10978612|FG002|STARTED|Overall Study||223
9865217|NCT00950833|10978610|FG000|COMPLETED|Overall Study||112
9865218|NCT00950833|10978611|FG001|COMPLETED|Overall Study||108
9865219|NCT00950833|10978612|FG002|COMPLETED|Overall Study||223
9865220|NCT00950833|10978610|FG000|NOT COMPLETED|Overall Study||0
9865221|NCT00950833|10978611|FG001|NOT COMPLETED|Overall Study||0
9865222|NCT00950833|10978612|FG002|NOT COMPLETED|Overall Study||0
9865223|NCT00950859|10978624|FG000|STARTED|Overall Study||27
9865224|NCT00950859|10978625|FG001|STARTED|Overall Study||24
9865225|NCT00950859|10978624|FG000|COMPLETED|Overall Study||11
9865226|NCT00950859|10978625|FG001|COMPLETED|Overall Study||14
9865227|NCT00950859|10978624|FG000|NOT COMPLETED|Overall Study||16
9865228|NCT00950859|10978625|FG001|NOT COMPLETED|Overall Study||10
9865229|NCT00950872|10978631|FG000|STARTED|Overall Study||29
9865230|NCT00950872|10978631|FG000|COMPLETED|Overall Study||26
9865231|NCT00950872|10978631|FG000|NOT COMPLETED|Overall Study||3
9865232|NCT00950911|10978637|FG000|STARTED|Overall Study||17
9865233|NCT00950911|10978638|FG001|STARTED|Overall Study||18
9865234|NCT00950911|10978637|FG000|COMPLETED|Overall Study||5
9865235|NCT00950911|10978638|FG001|COMPLETED|Overall Study||3
9865236|NCT00950911|10978637|FG000|NOT COMPLETED|Overall Study||12
9865237|NCT00950911|10978638|FG001|NOT COMPLETED|Overall Study||15
10094318|NCT02349295|11222723|FG005|COMPLETED|IR (Week 16-24)||16
10094319|NCT02349295|11222724|FG006|COMPLETED|IR (Week 16-24)||16
10094320|NCT02349295|11222725|FG007|COMPLETED|IR (Week 16-24)||0
9865238|NCT00950950|10978646|FG000|STARTED|Overall Study||12
9865239|NCT00950950|10978647|FG001|STARTED|Overall Study||12
9865240|NCT00950950|10978646|FG000|COMPLETED|Overall Study||11
9865241|NCT00950950|10978647|FG001|COMPLETED|Overall Study||11
9865242|NCT00950950|10978646|FG000|NOT COMPLETED|Overall Study||1
9865243|NCT00950950|10978647|FG001|NOT COMPLETED|Overall Study||1
9865244|NCT00950963|10978656|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
9865245|NCT00950963|10978657|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
9865246|NCT00950963|10978656|FG000|COMPLETED|Overall Study||352
9865247|NCT00950963|10978657|FG001|COMPLETED|Overall Study||357
9865248|NCT00950963|10978656|FG000|NOT COMPLETED|Overall Study||29
9865249|NCT00950963|10978657|FG001|NOT COMPLETED|Overall Study||24
9865250|NCT00951015|10978667|FG000|STARTED|Randomization Phase 96 Week||53
9865251|NCT00951015|10978668|FG001|STARTED|Randomization Phase 96 Week||51
9865252|NCT00951015|10978669|FG002|STARTED|Randomization Phase 96 Week||51
9865253|NCT00951015|10978670|FG003|STARTED|Randomization Phase 96 Week||50
9865254|NCT00951015|10978671|FG004|STARTED|Randomization Phase 96 Week||0
9865255|NCT00951015|10978667|FG000|COMPLETED|Randomization Phase 96 Week||48
9865256|NCT00951015|10978668|FG001|COMPLETED|Randomization Phase 96 Week||44
9865257|NCT00951015|10978669|FG002|COMPLETED|Randomization Phase 96 Week||46
9865258|NCT00951015|10978670|FG003|COMPLETED|Randomization Phase 96 Week||40
9865259|NCT00951015|10978671|FG004|COMPLETED|Randomization Phase 96 Week||0
9865260|NCT00951015|10978667|FG000|NOT COMPLETED|Randomization Phase 96 Week||5
9865261|NCT00951015|10978668|FG001|NOT COMPLETED|Randomization Phase 96 Week||7
9865262|NCT00951015|10978669|FG002|NOT COMPLETED|Randomization Phase 96 Week||5
9865263|NCT00951015|10978670|FG003|NOT COMPLETED|Randomization Phase 96 Week||10
9865264|NCT00951015|10978671|FG004|NOT COMPLETED|Randomization Phase 96 Week||0
9865265|NCT00951015|10978667|FG000|STARTED|Open-label Phase||0
9865266|NCT00951015|10978668|FG001|STARTED|Open-label Phase||0
9865267|NCT00951015|10978669|FG002|STARTED|Open-label Phase||0
9865268|NCT00951015|10978670|FG003|STARTED|Open-label Phase||0
9865269|NCT00951015|10978671|FG004|STARTED|Open-label Phase||138
9865270|NCT00951015|10978667|FG000|COMPLETED|Open-label Phase||0
9865271|NCT00951015|10978668|FG001|COMPLETED|Open-label Phase||0
9865272|NCT00951015|10978669|FG002|COMPLETED|Open-label Phase||0
9865273|NCT00951015|10978670|FG003|COMPLETED|Open-label Phase||0
9865274|NCT00951015|10978671|FG004|COMPLETED|Open-label Phase||88
9865275|NCT00951015|10978667|FG000|NOT COMPLETED|Open-label Phase||0
9865276|NCT00951015|10978668|FG001|NOT COMPLETED|Open-label Phase||0
9865277|NCT00951015|10978669|FG002|NOT COMPLETED|Open-label Phase||0
9865278|NCT00951015|10978670|FG003|NOT COMPLETED|Open-label Phase||0
9865279|NCT00951015|10978671|FG004|NOT COMPLETED|Open-label Phase||50
9865280|NCT00951041|10978696|FG000|STARTED|Overall Study||64
9865281|NCT00951041|10978697|FG001|STARTED|Overall Study||66
9865282|NCT00951041|10978696|FG000|COMPLETED|Overall Study||59
9865283|NCT00951041|10978697|FG001|COMPLETED|Overall Study||65
9865284|NCT00951041|10978696|FG000|NOT COMPLETED|Overall Study||5
9865285|NCT00951041|10978697|FG001|NOT COMPLETED|Overall Study||1
9865286|NCT00951080|10978706|FG000|STARTED|Overall Study||64
9865287|NCT00951080|10978707|FG001|STARTED|Overall Study||68
9865288|NCT00951080|10978706|FG000|COMPLETED|Overall Study||38
9865289|NCT00951080|10978707|FG001|COMPLETED|Overall Study||41
9865290|NCT00951080|10978706|FG000|NOT COMPLETED|Overall Study||26
9865291|NCT00951080|10978707|FG001|NOT COMPLETED|Overall Study||27
9865292|NCT00951093|10978713|FG000|STARTED|Before GBP||53
9865293|NCT00951093|10978713|FG000|COMPLETED|Before GBP||53
10094321|NCT02349295|11222726|FG008|COMPLETED|IR (Week 16-24)||0
10094322|NCT02349295|11222727|FG009|COMPLETED|IR (Week 16-24)||0
10094323|NCT02349295|11222728|FG010|COMPLETED|IR (Week 16-24)||0
10094324|NCT02349295|11222729|FG011|COMPLETED|IR (Week 16-24)||0
9865294|NCT00951093|10978713|FG000|NOT COMPLETED|Before GBP||0
9865295|NCT00951093|10978713|FG000|STARTED|6 Months After GBP||53
9865296|NCT00951093|10978713|FG000|COMPLETED|6 Months After GBP||53
9865297|NCT00951093|10978713|FG000|NOT COMPLETED|6 Months After GBP||0
9865298|NCT00951171|10978721|FG000|STARTED|Overall Study||40
9865299|NCT00951171|10978722|FG001|STARTED|Overall Study||55
9865300|NCT00951171|10978721|FG000|Pregnancy|Overall Study||1
9865301|NCT00951171|10978722|FG001|Pregnancy|Overall Study||7
9865302|NCT00951171|10978721|FG000|COMPLETED|Overall Study||38
9865303|NCT00951171|10978722|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
9865304|NCT00951171|10978721|FG000|NOT COMPLETED|Overall Study||2
9865305|NCT00951171|10978722|FG001|NOT COMPLETED|Overall Study||0
9865306|NCT00951275|10978728|FG000|STARTED|Overall Study||105
9865307|NCT00951275|10978728|FG000|COMPLETED|Overall Study||92
9865308|NCT00951275|10978728|FG000|NOT COMPLETED|Overall Study||13
9865309|NCT00951379|10978734|FG000|STARTED|Overall Study||27
9865310|NCT00951379|10978735|FG001|STARTED|Overall Study||25
9865311|NCT00951379|10978734|FG000|COMPLETED|Overall Study||21
9865312|NCT00951379|10978735|FG001|COMPLETED|Overall Study||23
10094325|NCT02349295|11222730|FG012|COMPLETED|IR (Week 16-24)||0
9865313|NCT00951379|10978734|FG000|NOT COMPLETED|Overall Study||6
9865314|NCT00951379|10978735|FG001|NOT COMPLETED|Overall Study||2
9865315|NCT00951483|10978751|FG000|STARTED|Overall Study||47
9865316|NCT00951483|10978752|FG001|STARTED|Overall Study||44
9865317|NCT00951483|10978751|FG000|COMPLETED|Overall Study||28
9865318|NCT00951483|10978752|FG001|COMPLETED|Overall Study||44
9865319|NCT00951483|10978751|FG000|NOT COMPLETED|Overall Study||19
9865320|NCT00951483|10978752|FG001|NOT COMPLETED|Overall Study||0
9865321|NCT00951496|10978763|FG000|STARTED|Overall Study||521
9865322|NCT00951496|10978764|FG001|STARTED|Overall Study||518
9865323|NCT00951496|10978765|FG002|STARTED|Overall Study||521
9865324|NCT00951496|10978763|FG000|COMPLETED|Overall Study||511
9865325|NCT00951496|10978764|FG001|COMPLETED|Overall Study||510
9865326|NCT00951496|10978765|FG002|COMPLETED|Overall Study||508
9865327|NCT00951496|10978763|FG000|NOT COMPLETED|Overall Study||10
9865328|NCT00951496|10978764|FG001|NOT COMPLETED|Overall Study||8
9865329|NCT00951496|10978765|FG002|NOT COMPLETED|Overall Study||13
9865330|NCT00951509|10978776|FG000|STARTED|Overall Study||31
9865331|NCT00951509|10978776|FG000|Driving Condition 1|Overall Study||29
9865332|NCT00951509|10978776|FG000|Driving Condition 2|Overall Study||29
9865333|NCT00951509|10978776|FG000|Driving Condition 3|Overall Study||25
9865334|NCT00951509|10978776|FG000|Driving Condition 4|Overall Study||28
9865335|NCT00951509|10978776|FG000|Driving Condition 5|Overall Study||30
9865336|NCT00951509|10978776|FG000|COMPLETED|Overall Study||29
9865337|NCT00951509|10978776|FG000|NOT COMPLETED|Overall Study||2
9865338|NCT00951561|10978784|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
9865339|NCT00951561|10978785|FG001|STARTED|Overall Study||29
9865340|NCT00951561|10978786|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
9865341|NCT00951561|10978787|FG003|STARTED|Overall Study||27
9865342|NCT00951561|10978784|FG000|COMPLETED|Overall Study||25
9865343|NCT00951561|10978785|FG001|COMPLETED|Overall Study||29
9865344|NCT00951561|10978786|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18
9865345|NCT00951561|10978787|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26
9865346|NCT00951561|10978784|FG000|NOT COMPLETED|Overall Study||0
9865347|NCT00951561|10978785|FG001|NOT COMPLETED|Overall Study||0
9865348|NCT00951561|10978786|FG002|NOT COMPLETED|Overall Study||3
9865349|NCT00951561|10978787|FG003|NOT COMPLETED|Overall Study||1
9865350|NCT00951665|10978798|FG000|STARTED|Phase 1b||29
9865351|NCT00951665|10978799|FG001|STARTED|Phase 1b||10
9865352|NCT00951665|10978800|FG002|STARTED|Phase 1b||21
9865353|NCT00951665|10978801|FG003|STARTED|Phase 1b||3
9865354|NCT00951665|10978802|FG004|STARTED|Phase 1b||0
9865355|NCT00951665|10978803|FG005|STARTED|Phase 1b||0
9865356|NCT00951665|10978798|FG000|Started Treatment|Phase 1b||26
9865357|NCT00951665|10978799|FG001|Started Treatment|Phase 1b||10
9865358|NCT00951665|10978800|FG002|Started Treatment|Phase 1b||21
9865359|NCT00951665|10978801|FG003|Started Treatment|Phase 1b||3
9865360|NCT00951665|10978802|FG004|Started Treatment|Phase 1b||0
9865361|NCT00951665|10978803|FG005|Started Treatment|Phase 1b||0
9865362|NCT00951665|10978798|FG000|COMPLETED|Phase 1b||7
9865363|NCT00951665|10978799|FG001|COMPLETED|Phase 1b||6
9865364|NCT00951665|10978800|FG002|COMPLETED|Phase 1b||4
9865365|NCT00951665|10978801|FG003|COMPLETED|Phase 1b||2
9865366|NCT00951665|10978802|FG004|COMPLETED|Phase 1b||0
9865367|NCT00951665|10978803|FG005|COMPLETED|Phase 1b||0
9865368|NCT00951665|10978798|FG000|NOT COMPLETED|Phase 1b||22
9865369|NCT00951665|10978799|FG001|NOT COMPLETED|Phase 1b||4
9865370|NCT00951665|10978800|FG002|NOT COMPLETED|Phase 1b||17
9865371|NCT00951665|10978801|FG003|NOT COMPLETED|Phase 1b||1
9865372|NCT00951665|10978802|FG004|NOT COMPLETED|Phase 1b||0
9865373|NCT00951665|10978803|FG005|NOT COMPLETED|Phase 1b||0
9865374|NCT00951665|10978798|FG000|STARTED|Phase 2a||0
9865375|NCT00951665|10978799|FG001|STARTED|Phase 2a||0
9865376|NCT00951665|10978800|FG002|STARTED|Phase 2a||0
9865377|NCT00951665|10978801|FG003|STARTED|Phase 2a||0
9865378|NCT00951665|10978802|FG004|STARTED|Phase 2a||22
9865379|NCT00951665|10978803|FG005|STARTED|Phase 2a||22
9865380|NCT00951665|10978798|FG000|COMPLETED|Phase 2a||0
9865381|NCT00951665|10978799|FG001|COMPLETED|Phase 2a||0
9865382|NCT00951665|10978800|FG002|COMPLETED|Phase 2a||0
9865383|NCT00951665|10978801|FG003|COMPLETED|Phase 2a||0
9865384|NCT00951665|10978802|FG004|COMPLETED|Phase 2a||10
9865385|NCT00951665|10978803|FG005|COMPLETED|Phase 2a||15
9865386|NCT00951665|10978798|FG000|NOT COMPLETED|Phase 2a||0
9865387|NCT00951665|10978799|FG001|NOT COMPLETED|Phase 2a||0
9865388|NCT00951665|10978800|FG002|NOT COMPLETED|Phase 2a||0
9865389|NCT00951665|10978801|FG003|NOT COMPLETED|Phase 2a||0
9865390|NCT00951665|10978802|FG004|NOT COMPLETED|Phase 2a||12
9865391|NCT00951665|10978803|FG005|NOT COMPLETED|Phase 2a||7
9865392|NCT00951808|10978837|FG000|STARTED|Overall Study||4
9865393|NCT00951808|10978838|FG001|STARTED|Overall Study||6
9865394|NCT00951808|10978839|FG002|STARTED|Overall Study||227
9865395|NCT00951808|10978837|FG000|COMPLETED|Overall Study||4
9865396|NCT00951808|10978838|FG001|COMPLETED|Overall Study||6
9865397|NCT00951808|10978839|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
9865398|NCT00951808|10978837|FG000|NOT COMPLETED|Overall Study||0
9865399|NCT00951808|10978838|FG001|NOT COMPLETED|Overall Study||0
9865400|NCT00951808|10978839|FG002|NOT COMPLETED|Overall Study||4
9953383|NCT01426009|11072057|FG000|STARTED|Washout 1||137
9953384|NCT01426009|11072057|FG000|COMPLETED|Washout 1||135
9953385|NCT01426009|11072057|FG000|NOT COMPLETED|Washout 1||2
9953386|NCT01426009|11072057|FG000|STARTED|Period 2-Second Intervention (7 Days)||135
9865401|NCT00951821|10978847|FG000|STARTED|Overall Study||16
9865402|NCT00951821|10978848|FG001|STARTED|Overall Study||8
9865403|NCT00951821|10978847|FG000|COMPLETED|Overall Study||16
9865404|NCT00951821|10978848|FG001|COMPLETED|Overall Study||8
9865405|NCT00951821|10978847|FG000|NOT COMPLETED|Overall Study||0
9865406|NCT00951821|10978848|FG001|NOT COMPLETED|Overall Study||0
9865407|NCT00951899|10978856|FG000|STARTED|Overall Study||19
9865408|NCT00951899|10978857|FG001|STARTED|Overall Study||19
9865409|NCT00951899|10978856|FG000|COMPLETED|Overall Study||19
9865410|NCT00951899|10978857|FG001|COMPLETED|Overall Study||19
9865411|NCT00951899|10978856|FG000|NOT COMPLETED|Overall Study||0
9865412|NCT00951899|10978857|FG001|NOT COMPLETED|Overall Study||0
9865413|NCT00951912|10978866|FG000|STARTED|Overall Study||54
9865414|NCT00951912|10978867|FG001|STARTED|Overall Study||55
9865415|NCT00951912|10978868|FG002|STARTED|Overall Study||56
9865416|NCT00951912|10978866|FG000|COMPLETED|Overall Study||47
9865417|NCT00951912|10978867|FG001|COMPLETED|Overall Study||50
9865418|NCT00951912|10978868|FG002|COMPLETED|Overall Study||54
9865419|NCT00951912|10978866|FG000|NOT COMPLETED|Overall Study||7
9865420|NCT00951912|10978867|FG001|NOT COMPLETED|Overall Study||5
9865421|NCT00951912|10978868|FG002|NOT COMPLETED|Overall Study||2
9865422|NCT00952068|10978876|FG000|STARTED|Overall Study||47
9865423|NCT00952068|10978876|FG000|COMPLETED|Overall Study||40
9865424|NCT00952068|10978876|FG000|NOT COMPLETED|Overall Study||7
9865425|NCT00952081|10978880|FG000|STARTED|Overall Study||22
9865426|NCT00952081|10978880|FG000|COMPLETED|Overall Study||22
9865427|NCT00952081|10978880|FG000|NOT COMPLETED|Overall Study||0
9865428|NCT00952120|10978887|FG000|STARTED|Overall Study||52
9865429|NCT00952120|10978888|FG001|STARTED|Overall Study||47
9865430|NCT00952120|10978889|FG002|STARTED|Overall Study||5
9865431|NCT00952120|10978887|FG000|COMPLETED|Overall Study||52
9865432|NCT00952120|10978888|FG001|COMPLETED|Overall Study||47
9865433|NCT00952120|10978889|FG002|COMPLETED|Overall Study||5
9865434|NCT00952120|10978887|FG000|NOT COMPLETED|Overall Study||0
9865435|NCT00952120|10978888|FG001|NOT COMPLETED|Overall Study||0
9865436|NCT00952120|10978889|FG002|NOT COMPLETED|Overall Study||0
9865437|NCT00952133|10978897|FG000|STARTED|Overall Study||59
9865438|NCT00952133|10978898|FG001|STARTED|Overall Study||59
9865439|NCT00952133|10978897|FG000|COMPLETED|Overall Study||59
9865440|NCT00952133|10978898|FG001|COMPLETED|Overall Study||59
9865441|NCT00952133|10978897|FG000|NOT COMPLETED|Overall Study||0
10094326|NCT02349295|11222731|FG013|COMPLETED|IR (Week 16-24)||0
10094327|NCT02349295|11222718|FG000|NOT COMPLETED|IR (Week 16-24)||0
10094328|NCT02349295|11222719|FG001|NOT COMPLETED|IR (Week 16-24)||0
10094329|NCT02349295|11222720|FG002|NOT COMPLETED|IR (Week 16-24)||0
10094330|NCT02349295|11222721|FG003|NOT COMPLETED|IR (Week 16-24)||1
10094331|NCT02349295|11222722|FG004|NOT COMPLETED|IR (Week 16-24)||0
10094332|NCT02349295|11222723|FG005|NOT COMPLETED|IR (Week 16-24)||0
10094333|NCT02349295|11222724|FG006|NOT COMPLETED|IR (Week 16-24)||0
10094334|NCT02349295|11222725|FG007|NOT COMPLETED|IR (Week 16-24)||0
10094335|NCT02349295|11222726|FG008|NOT COMPLETED|IR (Week 16-24)||0
10094336|NCT02349295|11222727|FG009|NOT COMPLETED|IR (Week 16-24)||0
10094337|NCT02349295|11222728|FG010|NOT COMPLETED|IR (Week 16-24)||0
10094338|NCT02349295|11222729|FG011|NOT COMPLETED|IR (Week 16-24)||0
10094339|NCT02349295|11222730|FG012|NOT COMPLETED|IR (Week 16-24)||0
10094340|NCT02349295|11222731|FG013|NOT COMPLETED|IR (Week 16-24)||0
10094341|NCT02349295|11222718|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0
10094342|NCT02349295|11222719|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0
10094343|NCT02349295|11222720|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0
10094344|NCT02349295|11222721|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10094345|NCT02349295|11222722|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10094346|NCT02349295|11222723|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10094347|NCT02349295|11222724|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10094348|NCT02349295|11222725|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
10094349|NCT02349295|11222726|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
10094350|NCT02349295|11222727|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
10094351|NCT02349295|11222728|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
10094352|NCT02349295|11222729|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0
10094353|NCT02349295|11222730|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0
10094354|NCT02349295|11222731|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0
10239822|NCT00479167|11371558|FG000|COMPLETED|Overall Study||0
9865442|NCT00952133|10978898|FG001|NOT COMPLETED|Overall Study||0
9865443|NCT00952211|10978908|FG000|STARTED|Overall Study||3
9865444|NCT00952211|10978909|FG001|STARTED|Overall Study||0
9865445|NCT00952211|10978908|FG000|COMPLETED|Overall Study||3
9865446|NCT00952211|10978909|FG001|COMPLETED|Overall Study||0
9865447|NCT00952211|10978908|FG000|NOT COMPLETED|Overall Study||0
9865448|NCT00952211|10978909|FG001|NOT COMPLETED|Overall Study||0
9865449|NCT00952276|10978920|FG000|STARTED|Overall Study||127
9865450|NCT00952276|10978921|FG001|STARTED|Overall Study||115
9865451|NCT00952276|10978922|FG002|STARTED|Overall Study||122
9865452|NCT00952276|10978923|FG003|STARTED|Overall Study||121
9865453|NCT00952276|10978924|FG004|STARTED|Overall Study||63
9865454|NCT00952276|10978920|FG000|COMPLETED|Overall Study||126
9865455|NCT00952276|10978921|FG001|COMPLETED|Overall Study||115
9865456|NCT00952276|10978922|FG002|COMPLETED|Overall Study||122
9865457|NCT00952276|10978923|FG003|COMPLETED|Overall Study||120
9865458|NCT00952276|10978924|FG004|COMPLETED|Overall Study||63
9865459|NCT00952276|10978920|FG000|NOT COMPLETED|Overall Study||1
9865460|NCT00952276|10978921|FG001|NOT COMPLETED|Overall Study||0
9865461|NCT00952276|10978922|FG002|NOT COMPLETED|Overall Study||0
9865462|NCT00952276|10978923|FG003|NOT COMPLETED|Overall Study||1
9865463|NCT00952276|10978924|FG004|NOT COMPLETED|Overall Study||0
9865464|NCT00952289|10978938|FG000|STARTED|All Participants||155
9865465|NCT00952289|10978939|FG001|STARTED|All Participants||154
9865466|NCT00952289|10978938|FG000|Safety Population|All Participants||155
9865467|NCT00952289|10978939|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
9865468|NCT00952289|10978938|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
9865469|NCT00952289|10978939|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
9865470|NCT00952289|10978938|FG000|NOT COMPLETED|All Participants||21
9865471|NCT00952289|10978939|FG001|NOT COMPLETED|All Participants||40
9865472|NCT00952289|10978938|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0
9865473|NCT00952289|10978939|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111
9865474|NCT00952289|10978938|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
9865475|NCT00952289|10978939|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
9865476|NCT00952289|10978938|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
9865477|NCT00952289|10978939|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
9865478|NCT00952315|10978948|FG000|STARTED|Overall Study||90
9865479|NCT00952315|10978949|FG001|STARTED|Overall Study||90
9865480|NCT00952315|10978950|FG002|STARTED|Overall Study||90
9865481|NCT00952315|10978948|FG000|COMPLETED|Overall Study||64
9865482|NCT00952315|10978949|FG001|COMPLETED|Overall Study||66
9865483|NCT00952315|10978950|FG002|COMPLETED|Overall Study||71
9865484|NCT00952315|10978948|FG000|NOT COMPLETED|Overall Study||26
9865485|NCT00952315|10978949|FG001|NOT COMPLETED|Overall Study||24
9865486|NCT00952315|10978950|FG002|NOT COMPLETED|Overall Study||19
9865487|NCT00952341|10978963|FG000|STARTED|Cycle 1||209
9865488|NCT00952341|10978964|FG001|STARTED|Cycle 1||212
10094355|NCT02349295|11222718|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094356|NCT02349295|11222719|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094357|NCT02349295|11222720|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094358|NCT02349295|11222721|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094359|NCT02349295|11222722|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094360|NCT02349295|11222723|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094361|NCT02349295|11222724|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094362|NCT02349295|11222725|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55
10094363|NCT02349295|11222726|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70
10094364|NCT02349295|11222727|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20
10094365|NCT02349295|11222728|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23
10094366|NCT02349295|11222729|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094367|NCT02349295|11222730|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094368|NCT02349295|11222731|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094369|NCT02349295|11222718|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094370|NCT02349295|11222719|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094371|NCT02349295|11222720|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094372|NCT02349295|11222721|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094373|NCT02349295|11222722|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094374|NCT02349295|11222723|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094375|NCT02349295|11222724|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094376|NCT02349295|11222725|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
10094377|NCT02349295|11222726|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
10094378|NCT02349295|11222727|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
10094379|NCT02349295|11222728|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
10094380|NCT02349295|11222729|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094381|NCT02349295|11222730|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094382|NCT02349295|11222731|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10094383|NCT02349295|11222718|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10094384|NCT02349295|11222719|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10094385|NCT02349295|11222720|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10094386|NCT02349295|11222721|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10094387|NCT02349295|11222722|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10239823|NCT00479167|11371558|FG000|NOT COMPLETED|Overall Study||1
9865489|NCT00952341|10978963|FG000|COMPLETED|Cycle 1||189
9865490|NCT00952341|10978964|FG001|COMPLETED|Cycle 1||199
9865491|NCT00952341|10978963|FG000|NOT COMPLETED|Cycle 1||20
9865492|NCT00952341|10978964|FG001|NOT COMPLETED|Cycle 1||13
9865493|NCT00952341|10978963|FG000|STARTED|Cycle 2||110
9865494|NCT00952341|10978964|FG001|STARTED|Cycle 2||130
9865495|NCT00952341|10978963|FG000|COMPLETED|Cycle 2||101
9865496|NCT00952341|10978964|FG001|COMPLETED|Cycle 2||118
9865497|NCT00952341|10978963|FG000|NOT COMPLETED|Cycle 2||9
9865498|NCT00952341|10978964|FG001|NOT COMPLETED|Cycle 2||12
9865499|NCT00952367|10978970|FG000|STARTED|Overall Study||3641
9865500|NCT00952367|10978970|FG000|COMPLETED|Overall Study||3635
9865501|NCT00952367|10978970|FG000|NOT COMPLETED|Overall Study||6
9865502|NCT00952380|10978979|FG000|STARTED|Overall Study||1
9865503|NCT00952380|10978980|FG001|STARTED|Overall Study||2
9865504|NCT00952380|10978981|FG002|STARTED|Overall Study||8
9865505|NCT00952380|10978982|FG003|STARTED|Overall Study||7
9865506|NCT00952380|10978983|FG004|STARTED|Overall Study||20
9865507|NCT00952380|10978979|FG000|COMPLETED|Overall Study||1
9865508|NCT00952380|10978980|FG001|COMPLETED|Overall Study||1
9865509|NCT00952380|10978981|FG002|COMPLETED|Overall Study||6
9865510|NCT00952380|10978982|FG003|COMPLETED|Overall Study||4
9865511|NCT00952380|10978983|FG004|COMPLETED|Overall Study||14
9865512|NCT00952380|10978979|FG000|NOT COMPLETED|Overall Study||0
9865513|NCT00952380|10978980|FG001|NOT COMPLETED|Overall Study||1
9865514|NCT00952380|10978981|FG002|NOT COMPLETED|Overall Study||2
9865515|NCT00952380|10978982|FG003|NOT COMPLETED|Overall Study||3
9865516|NCT00952380|10978983|FG004|NOT COMPLETED|Overall Study||6
9865517|NCT00952393|10979000|FG000|STARTED|Overall Study|10|10
9865518|NCT00952393|10979000|FG000|COMPLETED|Overall Study||10
9865519|NCT00952393|10979000|FG000|NOT COMPLETED|Overall Study||0
9865520|NCT00952419|10979007|FG000|STARTED|Overall Study||215
9865521|NCT00952419|10979008|FG001|STARTED|Overall Study||208
9865522|NCT00952419|10979009|FG002|STARTED|Overall Study||51
9865523|NCT00952419|10979007|FG000|COMPLETED|Overall Study||209
9865524|NCT00952419|10979008|FG001|COMPLETED|Overall Study||198
9865525|NCT00952419|10979009|FG002|COMPLETED|Overall Study||51
9865526|NCT00952419|10979007|FG000|NOT COMPLETED|Overall Study||6
9865527|NCT00952419|10979008|FG001|NOT COMPLETED|Overall Study||10
9865528|NCT00952419|10979009|FG002|NOT COMPLETED|Overall Study||0
9865529|NCT00952484|10979020|FG000|STARTED|Overall Study||6
9865530|NCT00952484|10979021|FG001|STARTED|Overall Study||7
9865531|NCT00952484|10979022|FG002|STARTED|Overall Study||16
9865532|NCT00952484|10979020|FG000|COMPLETED|Overall Study||6
9865533|NCT00952484|10979021|FG001|COMPLETED|Overall Study||6
9865534|NCT00952484|10979022|FG002|COMPLETED|Overall Study||16
9865535|NCT00952484|10979020|FG000|NOT COMPLETED|Overall Study||0
9865536|NCT00952484|10979021|FG001|NOT COMPLETED|Overall Study||1
9865537|NCT00952484|10979022|FG002|NOT COMPLETED|Overall Study||0
9865538|NCT00952523|10979031|FG000|STARTED|Overall Study||162
9865539|NCT00952523|10979031|FG000|COMPLETED|Overall Study||155
9865540|NCT00952523|10979031|FG000|NOT COMPLETED|Overall Study||7
9865541|NCT00952588|10979039|FG000|STARTED|Overall Study||48
9865542|NCT00952588|10979040|FG001|STARTED|Overall Study||26
9865543|NCT00952588|10979039|FG000|COMPLETED|Overall Study||12
9865544|NCT00952588|10979040|FG001|COMPLETED|Overall Study||2
9865545|NCT00952588|10979039|FG000|NOT COMPLETED|Overall Study||36
9865546|NCT00952588|10979040|FG001|NOT COMPLETED|Overall Study||24
9865547|NCT00952614|10979046|FG000|STARTED|Overall Study||30
9865548|NCT00952614|10979046|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
10094388|NCT02349295|11222723|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10094389|NCT02349295|11222724|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10094390|NCT02349295|11222725|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10094391|NCT02349295|11222726|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10094392|NCT02349295|11222727|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10094393|NCT02349295|11222728|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10094394|NCT02349295|11222729|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
9865549|NCT00952614|10979046|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
9865550|NCT00952614|10979046|FG000|NOT COMPLETED|Overall Study||7
9865551|NCT00952653|10979051|FG000|STARTED|Period 1: MDZ Alone||28
9865552|NCT00952653|10979051|FG000|COMPLETED|Period 1: MDZ Alone||28
9865553|NCT00952653|10979051|FG000|NOT COMPLETED|Period 1: MDZ Alone||0
9865554|NCT00952653|10979051|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28
9865555|NCT00952653|10979051|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
9865556|NCT00952653|10979051|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
9865557|NCT00952705|10979061|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
9865558|NCT00952705|10979062|FG001|STARTED|Overall Study||300
9865559|NCT00952705|10979063|FG002|STARTED|Overall Study||298
9865560|NCT00952705|10979061|FG000|COMPLETED|Overall Study||1169
9865561|NCT00952705|10979062|FG001|COMPLETED|Overall Study||290
9865562|NCT00952705|10979063|FG002|COMPLETED|Overall Study||288
9865563|NCT00952705|10979061|FG000|NOT COMPLETED|Overall Study||33
9865564|NCT00952705|10979062|FG001|NOT COMPLETED|Overall Study||10
9865565|NCT00952705|10979063|FG002|NOT COMPLETED|Overall Study||10
9865566|NCT00952718|10979077|FG000|STARTED|Overall Study||19
9865567|NCT00952718|10979078|FG001|STARTED|Overall Study||19
9865568|NCT00952718|10979077|FG000|COMPLETED|Overall Study||13
9865569|NCT00952718|10979078|FG001|COMPLETED|Overall Study||13
9865570|NCT00952718|10979077|FG000|NOT COMPLETED|Overall Study||6
9865571|NCT00952718|10979078|FG001|NOT COMPLETED|Overall Study||6
9865572|NCT00952731|10979088|FG000|STARTED|Overall Study||13
9865573|NCT00952731|10979089|FG001|STARTED|Overall Study||14
9865574|NCT00952731|10979088|FG000|Randomization|Overall Study||13
9865575|NCT00952731|10979089|FG001|Randomization|Overall Study||14
9865576|NCT00952731|10979088|FG000|Treatment & Pre-Surgery|Overall Study||12
9865577|NCT00952731|10979089|FG001|Treatment & Pre-Surgery|Overall Study||14
9865578|NCT00952731|10979088|FG000|Surgery|Overall Study||12
9865579|NCT00952731|10979089|FG001|Surgery|Overall Study||14
9865580|NCT00952731|10979088|FG000|Follow-up|Overall Study||12
9865581|NCT00952731|10979089|FG001|Follow-up|Overall Study||14
9865582|NCT00952731|10979088|FG000|COMPLETED|Overall Study||12
9865583|NCT00952731|10979089|FG001|COMPLETED|Overall Study||14
9865584|NCT00952731|10979088|FG000|NOT COMPLETED|Overall Study||1
9865585|NCT00952731|10979089|FG001|NOT COMPLETED|Overall Study||0
9865586|NCT00952822|10979095|FG000|STARTED|1st Pharmacokinetic Evaluation||9
9865587|NCT00952822|10979096|FG001|STARTED|1st Pharmacokinetic Evaluation||18
9865588|NCT00952822|10979097|FG002|STARTED|1st Pharmacokinetic Evaluation||11
9865589|NCT00952822|10979098|FG003|STARTED|1st Pharmacokinetic Evaluation||4
9865590|NCT00952822|10979095|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9
9865591|NCT00952822|10979096|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17
9865592|NCT00952822|10979097|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11
9865593|NCT00952822|10979098|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4
9865594|NCT00952822|10979095|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
9865595|NCT00952822|10979096|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
9865596|NCT00952822|10979097|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
9865597|NCT00952822|10979098|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
9865598|NCT00952822|10979095|FG000|STARTED|2nd Pharmacokinetic Evaluation||9
9865599|NCT00952822|10979096|FG001|STARTED|2nd Pharmacokinetic Evaluation||17
9865600|NCT00952822|10979097|FG002|STARTED|2nd Pharmacokinetic Evaluation||11
9865601|NCT00952822|10979098|FG003|STARTED|2nd Pharmacokinetic Evaluation||4
9865602|NCT00952822|10979095|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9
9865603|NCT00952822|10979096|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17
9865604|NCT00952822|10979097|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10
9865605|NCT00952822|10979098|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4
9865606|NCT00952822|10979095|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
9865607|NCT00952822|10979096|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
9865608|NCT00952822|10979097|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
9865609|NCT00952822|10979098|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
9865610|NCT00952848|10979109|FG000|STARTED|Overall Study||18
9865611|NCT00952848|10979109|FG000|COMPLETED|Overall Study||14
9865612|NCT00952848|10979109|FG000|NOT COMPLETED|Overall Study||4
9865613|NCT00953017|10979117|FG000|STARTED|Overall Study||106
9865614|NCT00953017|10979118|FG001|STARTED|Overall Study||107
9865615|NCT00953017|10979119|FG002|STARTED|Overall Study||106
9865616|NCT00953017|10979120|FG003|STARTED|Overall Study||106
9865617|NCT00953017|10979117|FG000|COMPLETED|Overall Study||101
9865618|NCT00953017|10979118|FG001|COMPLETED|Overall Study||101
9865619|NCT00953017|10979119|FG002|COMPLETED|Overall Study||100
9865620|NCT00953017|10979120|FG003|COMPLETED|Overall Study||101
9865621|NCT00953017|10979117|FG000|NOT COMPLETED|Overall Study||5
9865622|NCT00953017|10979118|FG001|NOT COMPLETED|Overall Study||6
9865623|NCT00953017|10979119|FG002|NOT COMPLETED|Overall Study||6
9865624|NCT00953017|10979120|FG003|NOT COMPLETED|Overall Study||5
9865625|NCT00953043|10979132|FG000|STARTED|Overall Study||30
9865626|NCT00953043|10979133|FG001|STARTED|Overall Study||30
9865627|NCT00953043|10979132|FG000|COMPLETED|Overall Study||26
9865628|NCT00953043|10979133|FG001|COMPLETED|Overall Study||28
9865629|NCT00953043|10979132|FG000|NOT COMPLETED|Overall Study||4
9865630|NCT00953043|10979133|FG001|NOT COMPLETED|Overall Study||2
9865631|NCT00953056|10979145|FG000|STARTED|Overall Study||24
9865632|NCT00953056|10979146|FG001|STARTED|Overall Study||24
9865633|NCT00953056|10979147|FG002|STARTED|Overall Study||24
9865634|NCT00953056|10979148|FG003|STARTED|Overall Study||24
9865635|NCT00953056|10979149|FG004|STARTED|Overall Study||24
9865636|NCT00953056|10979150|FG005|STARTED|Overall Study||24
9865637|NCT00953056|10979145|FG000|COMPLETED|Overall Study||24
9865638|NCT00953056|10979146|FG001|COMPLETED|Overall Study||24
9865639|NCT00953056|10979147|FG002|COMPLETED|Overall Study||24
9865640|NCT00953056|10979148|FG003|COMPLETED|Overall Study||24
9865641|NCT00953056|10979149|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
9865642|NCT00953056|10979150|FG005|COMPLETED|Overall Study||20
9865643|NCT00953056|10979145|FG000|NOT COMPLETED|Overall Study||0
9865644|NCT00953056|10979146|FG001|NOT COMPLETED|Overall Study||0
9865645|NCT00953056|10979147|FG002|NOT COMPLETED|Overall Study||0
9865646|NCT00953056|10979148|FG003|NOT COMPLETED|Overall Study||0
9865647|NCT00953056|10979149|FG004|NOT COMPLETED|Overall Study||2
9865648|NCT00953056|10979150|FG005|NOT COMPLETED|Overall Study||4
9865649|NCT00953121|10979169|FG000|STARTED|Overall Study||40
9865650|NCT00953121|10979170|FG001|STARTED|Overall Study||39
9865651|NCT00953121|10979171|FG002|STARTED|Overall Study||25
9865652|NCT00953121|10979169|FG000|COMPLETED|Overall Study||40
9865653|NCT00953121|10979170|FG001|COMPLETED|Overall Study||39
9865654|NCT00953121|10979171|FG002|COMPLETED|Overall Study||25
9865655|NCT00953121|10979169|FG000|NOT COMPLETED|Overall Study||0
9865656|NCT00953121|10979170|FG001|NOT COMPLETED|Overall Study||0
9865657|NCT00953121|10979171|FG002|NOT COMPLETED|Overall Study||0
9865658|NCT00953147|10979182|FG000|STARTED|Overall Study||298
9865659|NCT00953147|10979183|FG001|STARTED|Overall Study||505
9865660|NCT00953147|10979184|FG002|STARTED|Overall Study||307
9865661|NCT00953147|10979182|FG000|COMPLETED|Overall Study||261
9865662|NCT00953147|10979183|FG001|COMPLETED|Overall Study||439
9865663|NCT00953147|10979184|FG002|COMPLETED|Overall Study||265
9865664|NCT00953147|10979182|FG000|NOT COMPLETED|Overall Study||37
9865665|NCT00953147|10979183|FG001|NOT COMPLETED|Overall Study||66
9865666|NCT00953147|10979184|FG002|NOT COMPLETED|Overall Study||42
9865667|NCT00953160|10979192|FG000|STARTED|Overall Study||76
9865668|NCT00953160|10979192|FG000|COMPLETED|Overall Study||49
9865669|NCT00953160|10979192|FG000|NOT COMPLETED|Overall Study||27
9865670|NCT00953173|10979196|FG000|STARTED|Overall Study||671
9865671|NCT00953173|10979196|FG000|COMPLETED|Overall Study||389
9865672|NCT00953173|10979196|FG000|NOT COMPLETED|Overall Study||282
9865673|NCT00953199|10979202|FG000|STARTED|Overall Study||254
9865674|NCT00953199|10979203|FG001|STARTED|Overall Study||252
9865675|NCT00953199|10979202|FG000|COMPLETED|Overall Study||254
9865676|NCT00953199|10979203|FG001|COMPLETED|Overall Study||252
9865677|NCT00953199|10979202|FG000|NOT COMPLETED|Overall Study||0
9865678|NCT00953199|10979203|FG001|NOT COMPLETED|Overall Study||0
9865679|NCT00953212|10979215|FG000|STARTED|Overall Study||76
9865680|NCT00953212|10979216|FG001|STARTED|Overall Study||74
9865681|NCT00953212|10979217|FG002|STARTED|Overall Study||78
9865682|NCT00953212|10979218|FG003|STARTED|Overall Study||76
9865683|NCT00953212|10979215|FG000|COMPLETED|Overall Study||76
10094395|NCT02349295|11222730|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
10094396|NCT02349295|11222731|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
10094397|NCT02349295|11222718|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094398|NCT02349295|11222719|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094399|NCT02349295|11222720|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094400|NCT02349295|11222721|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094401|NCT02349295|11222722|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
9865684|NCT00953212|10979216|FG001|COMPLETED|Overall Study||74
9865685|NCT00953212|10979217|FG002|COMPLETED|Overall Study||78
9865686|NCT00953212|10979218|FG003|COMPLETED|Overall Study||76
9865687|NCT00953212|10979215|FG000|NOT COMPLETED|Overall Study||0
9865688|NCT00953212|10979216|FG001|NOT COMPLETED|Overall Study||0
9865689|NCT00953212|10979217|FG002|NOT COMPLETED|Overall Study||0
9865690|NCT00953212|10979218|FG003|NOT COMPLETED|Overall Study||0
9865691|NCT00953225|10979234|FG000|STARTED|Overall Study||46
9865692|NCT00953225|10979235|FG001|STARTED|Overall Study||37
9865693|NCT00953225|10979234|FG000|COMPLETED|Overall Study||44
9865694|NCT00953225|10979235|FG001|COMPLETED|Overall Study||37
9865695|NCT00953225|10979234|FG000|NOT COMPLETED|Overall Study||2
9865696|NCT00953225|10979235|FG001|NOT COMPLETED|Overall Study||0
9865697|NCT00953290|10979241|FG000|STARTED|Overall Study||4
9865698|NCT00953290|10979241|FG000|COMPLETED|Overall Study||4
9865699|NCT00953290|10979241|FG000|NOT COMPLETED|Overall Study||0
9865700|NCT00953407|10979253|FG000|STARTED|Overall Study||26
9865701|NCT00953407|10979254|FG001|STARTED|Overall Study||25
9865702|NCT00953407|10979255|FG002|STARTED|Overall Study||26
9865703|NCT00953407|10979256|FG003|STARTED|Overall Study||25
9865704|NCT00953407|10979257|FG004|STARTED|Overall Study||24
9865705|NCT00953407|10979253|FG000|COMPLETED|Overall Study||25
9865706|NCT00953407|10979254|FG001|COMPLETED|Overall Study||24
9865707|NCT00953407|10979255|FG002|COMPLETED|Overall Study||25
9865708|NCT00953407|10979256|FG003|COMPLETED|Overall Study||23
9865709|NCT00953407|10979257|FG004|COMPLETED|Overall Study||23
9865710|NCT00953407|10979253|FG000|NOT COMPLETED|Overall Study||1
9865711|NCT00953407|10979254|FG001|NOT COMPLETED|Overall Study||1
9865712|NCT00953407|10979255|FG002|NOT COMPLETED|Overall Study||1
9865713|NCT00953407|10979256|FG003|NOT COMPLETED|Overall Study||2
9865714|NCT00953407|10979257|FG004|NOT COMPLETED|Overall Study||1
9865715|NCT00953524|10979273|FG000|STARTED|Overall Study||249
9865716|NCT00953524|10979274|FG001|STARTED|Overall Study||254
9865717|NCT00953524|10979275|FG002|STARTED|Overall Study||247
9865718|NCT00953524|10979276|FG003|STARTED|Overall Study||99
9865719|NCT00953524|10979273|FG000|COMPLETED|Overall Study||227
9865720|NCT00953524|10979274|FG001|COMPLETED|Overall Study||239
9865721|NCT00953524|10979275|FG002|COMPLETED|Overall Study||233
9865722|NCT00953524|10979276|FG003|COMPLETED|Overall Study||91
9865723|NCT00953524|10979273|FG000|NOT COMPLETED|Overall Study||22
9865724|NCT00953524|10979274|FG001|NOT COMPLETED|Overall Study||15
9865725|NCT00953524|10979275|FG002|NOT COMPLETED|Overall Study||14
9865726|NCT00953524|10979276|FG003|NOT COMPLETED|Overall Study||8
9865727|NCT00953576|10979288|FG000|STARTED|Overall Study||6
9865728|NCT00953576|10979289|FG001|STARTED|Overall Study||5
9865729|NCT00953576|10979288|FG000|DLT Evaluable|Overall Study||3
9865730|NCT00953576|10979289|FG001|DLT Evaluable|Overall Study||5
9865731|NCT00953576|10979288|FG000|Treated|Overall Study||4
9865732|NCT00953576|10979289|FG001|Treated|Overall Study||5
9865733|NCT00953576|10979288|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4
9865734|NCT00953576|10979289|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3
9865735|NCT00953576|10979288|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
9865736|NCT00953576|10979289|FG001|COMPLETED|Overall Study||4
9865737|NCT00953576|10979288|FG000|NOT COMPLETED|Overall Study||2
9865738|NCT00953576|10979289|FG001|NOT COMPLETED|Overall Study||1
9865739|NCT00953654|10979301|FG000|STARTED|Overall Study||10
9865740|NCT00953654|10979302|FG001|STARTED|Overall Study||10
9865741|NCT00953654|10979303|FG002|STARTED|Overall Study||10
9865742|NCT00953654|10979301|FG000|COMPLETED|Overall Study||10
9865743|NCT00953654|10979302|FG001|COMPLETED|Overall Study||10
9865744|NCT00953654|10979303|FG002|COMPLETED|Overall Study||10
9865745|NCT00953654|10979301|FG000|NOT COMPLETED|Overall Study||0
9865746|NCT00953654|10979302|FG001|NOT COMPLETED|Overall Study||0
9865747|NCT00953654|10979303|FG002|NOT COMPLETED|Overall Study||0
9865748|NCT00953667|10979311|FG000|STARTED|Overall Study||400
9865749|NCT00953667|10979311|FG000|COMPLETED|Overall Study||277
9865750|NCT00953667|10979311|FG000|NOT COMPLETED|Overall Study||123
9865751|NCT00953706|10979317|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
9865752|NCT00953706|10979318|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
9865753|NCT00953706|10979319|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0
9865754|NCT00953706|10979320|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0
9865755|NCT00953706|10979317|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
9865756|NCT00953706|10979318|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
9865757|NCT00953706|10979319|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
9865758|NCT00953706|10979320|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
9865759|NCT00953706|10979317|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
9865760|NCT00953706|10979318|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
9865761|NCT00953706|10979319|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
9865762|NCT00953706|10979320|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
9865763|NCT00953706|10979317|FG000|STARTED|Part B (96-Week Open-Label Extension)||0
9865764|NCT00953706|10979318|FG001|STARTED|Part B (96-Week Open-Label Extension)||0
9865765|NCT00953706|10979319|FG002|STARTED|Part B (96-Week Open-Label Extension)||5
9865766|NCT00953706|10979320|FG003|STARTED|Part B (96-Week Open-Label Extension)||33
9865767|NCT00953706|10979317|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0
9865768|NCT00953706|10979318|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0
9865769|NCT00953706|10979319|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0
9865770|NCT00953706|10979320|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0
9865771|NCT00953706|10979317|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
9865772|NCT00953706|10979318|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
9865773|NCT00953706|10979319|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
9865774|NCT00953706|10979320|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
9865775|NCT00953719|10979332|FG000|STARTED|Overall Study||169
9865776|NCT00953719|10979333|FG001|STARTED|Overall Study||74
9865777|NCT00953719|10979332|FG000|COMPLETED|Overall Study||150
9865778|NCT00953719|10979333|FG001|COMPLETED|Overall Study||69
9865779|NCT00953719|10979332|FG000|NOT COMPLETED|Overall Study||19
9865780|NCT00953719|10979333|FG001|NOT COMPLETED|Overall Study||5
9865781|NCT00953745|10979341|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
9865782|NCT00953745|10979342|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
9865783|NCT00953745|10979341|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
9865784|NCT00953745|10979342|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
9865785|NCT00953745|10979341|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
9865786|NCT00953745|10979342|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
9865787|NCT00953745|10979341|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
9865788|NCT00953745|10979342|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
9865789|NCT00953745|10979341|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
9865790|NCT00953745|10979342|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
9865791|NCT00953745|10979341|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
9865792|NCT00953745|10979342|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
9865793|NCT00953745|10979341|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
9865794|NCT00953745|10979342|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
9865795|NCT00953745|10979341|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
9865796|NCT00953745|10979342|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
9865797|NCT00953745|10979341|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
9865798|NCT00953745|10979342|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
9865799|NCT00953849|10979354|FG000|STARTED|Overall Study||6
9865800|NCT00953849|10979355|FG001|STARTED|Overall Study||6
9865801|NCT00953849|10979356|FG002|STARTED|Overall Study||4
9865802|NCT00953849|10979357|FG003|STARTED|Overall Study||5
9865803|NCT00953849|10979354|FG000|COMPLETED|Overall Study||6
9865804|NCT00953849|10979355|FG001|COMPLETED|Overall Study||6
9865805|NCT00953849|10979356|FG002|COMPLETED|Overall Study||4
9865806|NCT00953849|10979357|FG003|COMPLETED|Overall Study||5
9865807|NCT00953849|10979354|FG000|NOT COMPLETED|Overall Study||0
9865808|NCT00953849|10979355|FG001|NOT COMPLETED|Overall Study||0
9865809|NCT00953849|10979356|FG002|NOT COMPLETED|Overall Study||0
9865810|NCT00953849|10979357|FG003|NOT COMPLETED|Overall Study||0
9865811|NCT00953862|10979371|FG000|STARTED|Overall Study||18
9865812|NCT00953862|10979371|FG000|COMPLETED|Overall Study||12
9865813|NCT00953862|10979371|FG000|NOT COMPLETED|Overall Study||6
9865814|NCT00953927|10979379|FG000|STARTED|Overall Study||1399
9865815|NCT00953927|10979380|FG001|STARTED|Overall Study||1398
9865816|NCT00953927|10979379|FG000|COMPLETED|Overall Study||1294
9865817|NCT00953927|10979380|FG001|COMPLETED|Overall Study||1303
9865818|NCT00953927|10979379|FG000|NOT COMPLETED|Overall Study||105
9865819|NCT00953927|10979380|FG001|NOT COMPLETED|Overall Study||95
9865820|NCT00954109|10979386|FG000|STARTED|Overall Study||11
9865821|NCT00954109|10979386|FG000|COMPLETED|Overall Study||11
9865822|NCT00954109|10979386|FG000|NOT COMPLETED|Overall Study||0
9865823|NCT00954122|10979390|FG000|STARTED|Overall Study||35
9865824|NCT00954122|10979390|FG000|COMPLETED|Overall Study||28
9865825|NCT00954122|10979390|FG000|NOT COMPLETED|Overall Study||7
9865826|NCT00954174|10979399|FG000|STARTED|Overall Study||268
9865827|NCT00954174|10979400|FG001|STARTED|Overall Study||268
9865828|NCT00954174|10979401|FG002|STARTED|Overall Study||51
9865829|NCT00954174|10979402|FG003|STARTED|Overall Study||50
9865830|NCT00954174|10979399|FG000|COMPLETED|Overall Study||142
9865831|NCT00954174|10979400|FG001|COMPLETED|Overall Study||145
9865832|NCT00954174|10979401|FG002|COMPLETED|Overall Study||27
9865833|NCT00954174|10979402|FG003|COMPLETED|Overall Study||25
9865834|NCT00954174|10979399|FG000|NOT COMPLETED|Overall Study||126
9865835|NCT00954174|10979400|FG001|NOT COMPLETED|Overall Study||123
9865836|NCT00954174|10979401|FG002|NOT COMPLETED|Overall Study||24
9865837|NCT00954174|10979402|FG003|NOT COMPLETED|Overall Study||25
9865838|NCT00954356|10979417|FG000|STARTED|Overall Study||41
9865839|NCT00954356|10979418|FG001|STARTED|Overall Study||20
9865840|NCT00954356|10979417|FG000|COMPLETED|Overall Study||41
9865841|NCT00954356|10979418|FG001|COMPLETED|Overall Study||20
9865842|NCT00954356|10979417|FG000|NOT COMPLETED|Overall Study||0
9865843|NCT00954356|10979418|FG001|NOT COMPLETED|Overall Study||0
9865844|NCT00954421|10979424|FG000|STARTED|Screening||16
9865845|NCT00954421|10979424|FG000|COMPLETED|Screening||13
9865846|NCT00954421|10979424|FG000|NOT COMPLETED|Screening||3
9865847|NCT00954421|10979424|FG000|STARTED|Baseline||13
9865848|NCT00954421|10979424|FG000|COMPLETED|Baseline||13
9865849|NCT00954421|10979424|FG000|NOT COMPLETED|Baseline||0
9865850|NCT00954421|10979424|FG000|STARTED|6 Months of DBS||13
10094402|NCT02349295|11222723|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094403|NCT02349295|11222724|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094404|NCT02349295|11222725|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094405|NCT02349295|11222726|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094406|NCT02349295|11222727|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094407|NCT02349295|11222728|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094408|NCT02349295|11222729|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
10094409|NCT02349295|11222730|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
10094410|NCT02349295|11222731|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
10094411|NCT02349295|11222718|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094412|NCT02349295|11222719|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094413|NCT02349295|11222720|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094414|NCT02349295|11222721|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094415|NCT02349295|11222722|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094416|NCT02349295|11222723|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094417|NCT02349295|11222724|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094418|NCT02349295|11222725|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094419|NCT02349295|11222726|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094420|NCT02349295|11222727|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094421|NCT02349295|11222728|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10094422|NCT02349295|11222729|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
10094423|NCT02349295|11222730|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
10094424|NCT02349295|11222731|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
10094425|NCT02349360|11222758|FG000|STARTED|Overall Study||21
10094426|NCT02349360|11222759|FG001|STARTED|Overall Study||21
10094427|NCT02349360|11222758|FG000|COMPLETED|Overall Study||21
10094428|NCT02349360|11222759|FG001|COMPLETED|Overall Study||20
10094429|NCT02349360|11222758|FG000|NOT COMPLETED|Overall Study||0
10094430|NCT02349360|11222759|FG001|NOT COMPLETED|Overall Study||1
10094431|NCT02349412|11222767|FG000|STARTED|Overall Study||202
10094432|NCT02349412|11222768|FG001|STARTED|Overall Study||203
10094433|NCT02349412|11222767|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92
10094434|NCT02349412|11222768|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101
10094435|NCT02349412|11222767|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68
10094436|NCT02349412|11222768|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80
10094437|NCT02349412|11222767|FG000|COMPLETED|Overall Study||195
10094438|NCT02349412|11222768|FG001|COMPLETED|Overall Study||196
10094439|NCT02349412|11222767|FG000|NOT COMPLETED|Overall Study||7
10094440|NCT02349412|11222768|FG001|NOT COMPLETED|Overall Study||7
10094441|NCT02349425|11222778|FG000|STARTED|Period 1||15
10094442|NCT02349425|11222779|FG001|STARTED|Period 1||14
10094443|NCT02349425|11222780|FG002|STARTED|Period 1||15
9865851|NCT00954421|10979424|FG000|COMPLETED|6 Months of DBS||12
9865852|NCT00954421|10979424|FG000|NOT COMPLETED|6 Months of DBS||1
9865853|NCT00954421|10979424|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
9865854|NCT00954421|10979424|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12
9865855|NCT00954421|10979424|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
10094444|NCT02349425|11222781|FG003|STARTED|Period 1||15
10094445|NCT02349425|11222778|FG000|COMPLETED|Period 1||14
9865856|NCT00954421|10979424|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12
9865857|NCT00954421|10979424|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
9865858|NCT00954421|10979424|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
9865859|NCT00954421|10979424|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12
10094446|NCT02349425|11222779|FG001|COMPLETED|Period 1||13
10094447|NCT02349425|11222780|FG002|COMPLETED|Period 1||15
10094448|NCT02349425|11222781|FG003|COMPLETED|Period 1||15
9865860|NCT00954421|10979424|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12
9865861|NCT00954421|10979424|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
9865862|NCT00954421|10979424|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12
9865863|NCT00954421|10979424|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11
9865864|NCT00954421|10979424|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
9865865|NCT00954447|10979432|FG000|STARTED|Overall Study||630
9865866|NCT00954447|10979433|FG001|STARTED|Overall Study||631
9865867|NCT00954447|10979432|FG000|COMPLETED|Overall Study||520
9865868|NCT00954447|10979433|FG001|COMPLETED|Overall Study||543
9865869|NCT00954447|10979432|FG000|NOT COMPLETED|Overall Study||110
9865870|NCT00954447|10979433|FG001|NOT COMPLETED|Overall Study||88
9865871|NCT00954512|10979445|FG000|STARTED|Overall Study||2
9865872|NCT00954512|10979446|FG001|STARTED|Overall Study||3
9865873|NCT00954512|10979447|FG002|STARTED|Overall Study||0
9865874|NCT00954512|10979448|FG003|STARTED|Overall Study||2
9865875|NCT00954512|10979449|FG004|STARTED|Overall Study||4
9865876|NCT00954512|10979450|FG005|STARTED|Overall Study||4
9865877|NCT00954512|10979445|FG000|COMPLETED|Overall Study||0
9865878|NCT00954512|10979446|FG001|COMPLETED|Overall Study||0
9865879|NCT00954512|10979447|FG002|COMPLETED|Overall Study||0
9865880|NCT00954512|10979448|FG003|COMPLETED|Overall Study||0
9865881|NCT00954512|10979449|FG004|COMPLETED|Overall Study||0
9865882|NCT00954512|10979450|FG005|COMPLETED|Overall Study||0
9865883|NCT00954512|10979445|FG000|NOT COMPLETED|Overall Study||2
9865884|NCT00954512|10979446|FG001|NOT COMPLETED|Overall Study||3
9865885|NCT00954512|10979447|FG002|NOT COMPLETED|Overall Study||0
9865886|NCT00954512|10979448|FG003|NOT COMPLETED|Overall Study||2
9865887|NCT00954512|10979449|FG004|NOT COMPLETED|Overall Study||4
9865888|NCT00954512|10979450|FG005|NOT COMPLETED|Overall Study||4
9865889|NCT00954538|10979465|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3
9865890|NCT00954538|10979466|FG001|STARTED|Part I||0
9865891|NCT00954538|10979467|FG002|STARTED|Part I||0
9865892|NCT00954538|10979468|FG003|STARTED|Part I||0
9865893|NCT00954538|10979469|FG004|STARTED|Part I||0
9865894|NCT00954538|10979470|FG005|STARTED|Part I||0
9865895|NCT00954538|10979465|FG000|COMPLETED|Part I||3
9865896|NCT00954538|10979466|FG001|COMPLETED|Part I||0
9865897|NCT00954538|10979467|FG002|COMPLETED|Part I||0
9865898|NCT00954538|10979468|FG003|COMPLETED|Part I||0
9865899|NCT00954538|10979469|FG004|COMPLETED|Part I||0
9865900|NCT00954538|10979470|FG005|COMPLETED|Part I||0
9865901|NCT00954538|10979465|FG000|NOT COMPLETED|Part I||0
9865902|NCT00954538|10979466|FG001|NOT COMPLETED|Part I||0
9865903|NCT00954538|10979467|FG002|NOT COMPLETED|Part I||0
9865904|NCT00954538|10979468|FG003|NOT COMPLETED|Part I||0
9865905|NCT00954538|10979469|FG004|NOT COMPLETED|Part I||0
9865906|NCT00954538|10979470|FG005|NOT COMPLETED|Part I||0
9865907|NCT00954538|10979465|FG000|STARTED|Part II||0
9865908|NCT00954538|10979466|FG001|STARTED|Part II|This subject did not participate in Part I or III|1
9865909|NCT00954538|10979467|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3
9865910|NCT00954538|10979468|FG003|STARTED|Part II||0
9865911|NCT00954538|10979469|FG004|STARTED|Part II||0
9865912|NCT00954538|10979470|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
9865913|NCT00954538|10979465|FG000|COMPLETED|Part II||0
9865914|NCT00954538|10979466|FG001|COMPLETED|Part II||1
9865915|NCT00954538|10979467|FG002|COMPLETED|Part II||3
9865916|NCT00954538|10979468|FG003|COMPLETED|Part II||0
9865917|NCT00954538|10979469|FG004|COMPLETED|Part II||0
9865918|NCT00954538|10979470|FG005|COMPLETED|Part II||2
9865919|NCT00954538|10979465|FG000|NOT COMPLETED|Part II||0
9865920|NCT00954538|10979466|FG001|NOT COMPLETED|Part II||0
9865921|NCT00954538|10979467|FG002|NOT COMPLETED|Part II||0
9865922|NCT00954538|10979468|FG003|NOT COMPLETED|Part II||0
9865923|NCT00954538|10979469|FG004|NOT COMPLETED|Part II||0
9865924|NCT00954538|10979470|FG005|NOT COMPLETED|Part II||0
9865925|NCT00954538|10979465|FG000|STARTED|Part III||0
9865926|NCT00954538|10979466|FG001|STARTED|Part III||0
9865927|NCT00954538|10979467|FG002|STARTED|Part III||0
9865928|NCT00954538|10979468|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4
9865929|NCT00954538|10979469|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6
9865930|NCT00954538|10979470|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
9865931|NCT00954538|10979465|FG000|COMPLETED|Part III||0
9865932|NCT00954538|10979466|FG001|COMPLETED|Part III||0
9865933|NCT00954538|10979467|FG002|COMPLETED|Part III||0
9865934|NCT00954538|10979468|FG003|COMPLETED|Part III||4
9865935|NCT00954538|10979469|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
9865936|NCT00954538|10979470|FG005|COMPLETED|Part III||2
9865937|NCT00954538|10979465|FG000|NOT COMPLETED|Part III||0
9865938|NCT00954538|10979466|FG001|NOT COMPLETED|Part III||0
9865939|NCT00954538|10979467|FG002|NOT COMPLETED|Part III||0
9865940|NCT00954538|10979468|FG003|NOT COMPLETED|Part III||0
9865941|NCT00954538|10979469|FG004|NOT COMPLETED|Part III||1
9865942|NCT00954538|10979470|FG005|NOT COMPLETED|Part III||0
9865943|NCT00954681|10979479|FG000|STARTED|Overall Study||15
9865944|NCT00954681|10979479|FG000|COMPLETED|Overall Study||10
9865945|NCT00954681|10979479|FG000|NOT COMPLETED|Overall Study||5
9865946|NCT00954707|10979483|FG000|STARTED|Overall Study||2509
9865947|NCT00954707|10979483|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
9865948|NCT00954707|10979483|FG000|NOT COMPLETED|Overall Study||167
9865949|NCT00954733|10979487|FG000|STARTED|Overall Study||40
9865950|NCT00954733|10979487|FG000|COMPLETED|Overall Study||39
9865951|NCT00954733|10979487|FG000|NOT COMPLETED|Overall Study||1
9865952|NCT00954824|10979491|FG000|STARTED|Overall Study||100
9865953|NCT00954824|10979491|FG000|COMPLETED|Overall Study||50
9865954|NCT00954824|10979491|FG000|NOT COMPLETED|Overall Study||50
9865955|NCT00954941|10979497|FG000|STARTED|Overall Study||50
9865956|NCT00954941|10979498|FG001|STARTED|Overall Study||48
9865957|NCT00954941|10979497|FG000|COMPLETED|Overall Study||42
9865958|NCT00954941|10979498|FG001|COMPLETED|Overall Study||41
9865959|NCT00954941|10979497|FG000|NOT COMPLETED|Overall Study||8
9865960|NCT00954941|10979498|FG001|NOT COMPLETED|Overall Study||7
9865961|NCT00954993|10979504|FG000|STARTED|Period 1||3
9865962|NCT00954993|10979504|FG000|COMPLETED|Period 1||3
9865963|NCT00954993|10979504|FG000|NOT COMPLETED|Period 1||0
9865964|NCT00954993|10979504|FG000|STARTED|Washout||3
9865965|NCT00954993|10979504|FG000|COMPLETED|Washout||3
9865966|NCT00954993|10979504|FG000|NOT COMPLETED|Washout||0
9865967|NCT00954993|10979504|FG000|STARTED|Period 2||3
9865968|NCT00954993|10979504|FG000|COMPLETED|Period 2||3
9865969|NCT00954993|10979504|FG000|NOT COMPLETED|Period 2||0
9865970|NCT00955032|10979512|FG000|STARTED|Overall Study||16
9865971|NCT00955032|10979513|FG001|STARTED|Overall Study||8
9865972|NCT00955032|10979512|FG000|COMPLETED|Overall Study||16
9865973|NCT00955032|10979513|FG001|COMPLETED|Overall Study||8
9865974|NCT00955032|10979512|FG000|NOT COMPLETED|Overall Study||0
9865975|NCT00955032|10979513|FG001|NOT COMPLETED|Overall Study||0
9865976|NCT00955110|10979528|FG000|STARTED|Qualification Phase||78
9865977|NCT00955110|10979528|FG000|COMPLETED|Qualification Phase||54
9865978|NCT00955110|10979528|FG000|NOT COMPLETED|Qualification Phase||24
9865979|NCT00955110|10979528|FG000|STARTED|Treatment Phase||41
9865980|NCT00955110|10979528|FG000|Placebo|Treatment Phase||38
9865981|NCT00955110|10979528|FG000|Oxymorphone ER 15 mg|Treatment Phase||37
9865982|NCT00955110|10979528|FG000|Oxymorphone ER 30 mg|Treatment Phase||38
9865983|NCT00955110|10979528|FG000|Oxycodone CR 30 mg|Treatment Phase||40
9865984|NCT00955110|10979528|FG000|Oxycodone CR 60 mg|Treatment Phase||40
9865985|NCT00955110|10979528|FG000|COMPLETED|Treatment Phase||35
9865986|NCT00955110|10979528|FG000|NOT COMPLETED|Treatment Phase||6
9865987|NCT00955201|10979544|FG000|STARTED|Overall Study||12
9865988|NCT00955201|10979545|FG001|STARTED|Overall Study||11
9865989|NCT00955201|10979546|FG002|STARTED|Overall Study||11
9865990|NCT00955201|10979547|FG003|STARTED|Overall Study||11
9865991|NCT00955201|10979544|FG000|COMPLETED|Overall Study||8
9865992|NCT00955201|10979545|FG001|COMPLETED|Overall Study||11
9865993|NCT00955201|10979546|FG002|COMPLETED|Overall Study||10
9865994|NCT00955201|10979547|FG003|COMPLETED|Overall Study||7
9865995|NCT00955201|10979544|FG000|NOT COMPLETED|Overall Study||4
9865996|NCT00955201|10979545|FG001|NOT COMPLETED|Overall Study||0
9865997|NCT00955201|10979546|FG002|NOT COMPLETED|Overall Study||1
9865998|NCT00955201|10979547|FG003|NOT COMPLETED|Overall Study||4
9865999|NCT00955253|10979566|FG000|STARTED|First Intervention (Day 2)||7
9866000|NCT00955253|10979567|FG001|STARTED|First Intervention (Day 2)||6
9866001|NCT00955253|10979566|FG000|COMPLETED|First Intervention (Day 2)||7
9866002|NCT00955253|10979567|FG001|COMPLETED|First Intervention (Day 2)||6
9866003|NCT00955253|10979566|FG000|NOT COMPLETED|First Intervention (Day 2)||0
9866004|NCT00955253|10979567|FG001|NOT COMPLETED|First Intervention (Day 2)||0
9866005|NCT00955253|10979566|FG000|STARTED|Second Intervention (Day 4)||7
9866006|NCT00955253|10979567|FG001|STARTED|Second Intervention (Day 4)||6
9866007|NCT00955253|10979566|FG000|COMPLETED|Second Intervention (Day 4)||7
9866008|NCT00955253|10979567|FG001|COMPLETED|Second Intervention (Day 4)||6
9866009|NCT00955253|10979566|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
9866010|NCT00955253|10979567|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
9866011|NCT00955266|10979574|FG000|STARTED|Overall Study||4
9866012|NCT00955266|10979575|FG001|STARTED|Overall Study||4
9866013|NCT00955266|10979574|FG000|COMPLETED|Overall Study||4
9866014|NCT00955266|10979575|FG001|COMPLETED|Overall Study||4
9866015|NCT00955266|10979574|FG000|NOT COMPLETED|Overall Study||0
9866016|NCT00955266|10979575|FG001|NOT COMPLETED|Overall Study||0
9866017|NCT00955279|10979584|FG000|STARTED|Overall Study||58
9866018|NCT00955279|10979585|FG001|STARTED|Overall Study||55
9866019|NCT00955279|10979586|FG002|STARTED|Overall Study||60
9866020|NCT00955279|10979584|FG000|COMPLETED|Overall Study||55
9866021|NCT00955279|10979585|FG001|COMPLETED|Overall Study||51
9866022|NCT00955279|10979586|FG002|COMPLETED|Overall Study||52
9866023|NCT00955279|10979584|FG000|NOT COMPLETED|Overall Study||3
9866024|NCT00955279|10979585|FG001|NOT COMPLETED|Overall Study||4
9866025|NCT00955279|10979586|FG002|NOT COMPLETED|Overall Study||8
9866026|NCT00955305|10979596|FG000|STARTED|Overall Study||88
9866027|NCT00955305|10979597|FG001|STARTED|Overall Study||87
9866028|NCT00955305|10979596|FG000|Treated|Overall Study||83
9866029|NCT00955305|10979597|FG001|Treated|Overall Study||82
9866030|NCT00955305|10979596|FG000|Eligible and Treated|Overall Study||78
9866031|NCT00955305|10979597|FG001|Eligible and Treated|Overall Study||75
9866032|NCT00955305|10979596|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
9866033|NCT00955305|10979597|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
9866034|NCT00955305|10979596|FG000|NOT COMPLETED|Overall Study||88
9866035|NCT00955305|10979597|FG001|NOT COMPLETED|Overall Study||87
9866036|NCT00955357|10979605|FG000|STARTED|Titration Phase||96
9866037|NCT00955357|10979606|FG001|STARTED|Titration Phase||360
9866038|NCT00955357|10979605|FG000|COMPLETED|Titration Phase||80
9866039|NCT00955357|10979606|FG001|COMPLETED|Titration Phase||294
9866040|NCT00955357|10979605|FG000|NOT COMPLETED|Titration Phase||16
9866041|NCT00955357|10979606|FG001|NOT COMPLETED|Titration Phase||66
9866042|NCT00955357|10979605|FG000|STARTED|Maintenance Phase||80
9866043|NCT00955357|10979606|FG001|STARTED|Maintenance Phase||294
9866044|NCT00955357|10979605|FG000|COMPLETED|Maintenance Phase||68
9866045|NCT00955357|10979606|FG001|COMPLETED|Maintenance Phase||249
9866046|NCT00955357|10979605|FG000|NOT COMPLETED|Maintenance Phase||12
9866047|NCT00955357|10979606|FG001|NOT COMPLETED|Maintenance Phase||45
9866048|NCT00955409|10979622|FG000|STARTED|Overall Study|Started=Randomized|21
9866049|NCT00955409|10979623|FG001|STARTED|Overall Study|Started=Randomized|6
9866050|NCT00955409|10979624|FG002|STARTED|Overall Study|Started=Randomized|41
9866051|NCT00955409|10979625|FG003|STARTED|Overall Study|Started=Randomized.|25
9866052|NCT00955409|10979626|FG004|STARTED|Overall Study|Started=Randomized|5
9866053|NCT00955409|10979627|FG005|STARTED|Overall Study|Started=Randomized|9
9866054|NCT00955409|10979628|FG006|STARTED|Overall Study|Started=Randomized|27
9866055|NCT00955409|10979629|FG007|STARTED|Overall Study|Started=Randomized|6
9866056|NCT00955409|10979630|FG008|STARTED|Overall Study|Started=Randomized|16
9866057|NCT00955409|10979631|FG009|STARTED|Overall Study|Started=Randomized|4
9866058|NCT00955409|10979622|FG000|Treated|Overall Study||21
9866059|NCT00955409|10979623|FG001|Treated|Overall Study||6
9866060|NCT00955409|10979624|FG002|Treated|Overall Study||41
9866061|NCT00955409|10979625|FG003|Treated|Overall Study||24
9866062|NCT00955409|10979626|FG004|Treated|Overall Study||5
9866063|NCT00955409|10979627|FG005|Treated|Overall Study||9
9866064|NCT00955409|10979628|FG006|Treated|Overall Study||27
9866065|NCT00955409|10979629|FG007|Treated|Overall Study||6
9866066|NCT00955409|10979630|FG008|Treated|Overall Study||16
9866067|NCT00955409|10979631|FG009|Treated|Overall Study||4
9866068|NCT00955409|10979622|FG000|Completed Treatment|Overall Study||12
9866069|NCT00955409|10979623|FG001|Completed Treatment|Overall Study||5
9866070|NCT00955409|10979624|FG002|Completed Treatment|Overall Study||15
10094449|NCT02349425|11222778|FG000|NOT COMPLETED|Period 1||1
10094450|NCT02349425|11222779|FG001|NOT COMPLETED|Period 1||1
10094451|NCT02349425|11222780|FG002|NOT COMPLETED|Period 1||0
10094452|NCT02349425|11222781|FG003|NOT COMPLETED|Period 1||0
10094453|NCT02349425|11222778|FG000|STARTED|Period 2||14
10094454|NCT02349425|11222779|FG001|STARTED|Period 2||13
10094455|NCT02349425|11222780|FG002|STARTED|Period 2||15
10094456|NCT02349425|11222781|FG003|STARTED|Period 2||15
10094457|NCT02349425|11222778|FG000|COMPLETED|Period 2||14
10094458|NCT02349425|11222779|FG001|COMPLETED|Period 2||12
10094459|NCT02349425|11222780|FG002|COMPLETED|Period 2||14
10094460|NCT02349425|11222781|FG003|COMPLETED|Period 2||15
10094461|NCT02349425|11222778|FG000|NOT COMPLETED|Period 2||0
10094462|NCT02349425|11222779|FG001|NOT COMPLETED|Period 2||1
10094463|NCT02349425|11222780|FG002|NOT COMPLETED|Period 2||1
10094464|NCT02349425|11222781|FG003|NOT COMPLETED|Period 2||0
10094465|NCT02349438|11222819|FG000|STARTED|Period 1||11
10094466|NCT02349438|11222820|FG001|STARTED|Period 1||10
10094467|NCT02349438|11222819|FG000|COMPLETED|Period 1||11
10094468|NCT02349438|11222820|FG001|COMPLETED|Period 1||10
10094469|NCT02349438|11222819|FG000|NOT COMPLETED|Period 1||0
10094470|NCT02349438|11222820|FG001|NOT COMPLETED|Period 1||0
10094471|NCT02349438|11222819|FG000|STARTED|Period 2||11
10094472|NCT02349438|11222820|FG001|STARTED|Period 2||10
10094473|NCT02349438|11222819|FG000|COMPLETED|Period 2||11
10094474|NCT02349438|11222820|FG001|COMPLETED|Period 2||10
10094475|NCT02349438|11222819|FG000|NOT COMPLETED|Period 2||0
10094476|NCT02349438|11222820|FG001|NOT COMPLETED|Period 2||0
10094477|NCT02349451|11222830|FG000|STARTED|Overall Study||24
10094478|NCT02349451|11222831|FG001|STARTED|Overall Study||72
10094479|NCT02349451|11222832|FG002|STARTED|Overall Study||71
10094480|NCT02349451|11222833|FG003|STARTED|Overall Study||73
10094481|NCT02349451|11222830|FG000|COMPLETED|Overall Study||24
10094482|NCT02349451|11222831|FG001|COMPLETED|Overall Study||71
10094483|NCT02349451|11222832|FG002|COMPLETED|Overall Study||69
10094484|NCT02349451|11222833|FG003|COMPLETED|Overall Study||72
10094485|NCT02349451|11222830|FG000|NOT COMPLETED|Overall Study||0
10094486|NCT02349451|11222831|FG001|NOT COMPLETED|Overall Study||1
10094487|NCT02349451|11222832|FG002|NOT COMPLETED|Overall Study||2
10094488|NCT02349451|11222833|FG003|NOT COMPLETED|Overall Study||1
10094489|NCT02349477|11222848|FG000|STARTED|Overall Study||44
10094490|NCT02349477|11222849|FG001|STARTED|Overall Study||46
9866071|NCT00955409|10979625|FG003|Completed Treatment|Overall Study||17
9866072|NCT00955409|10979626|FG004|Completed Treatment|Overall Study||3
9866073|NCT00955409|10979627|FG005|Completed Treatment|Overall Study||7
9866074|NCT00955409|10979628|FG006|Completed Treatment|Overall Study||4
9866075|NCT00955409|10979629|FG007|Completed Treatment|Overall Study||3
9866076|NCT00955409|10979630|FG008|Completed Treatment|Overall Study||2
9866077|NCT00955409|10979631|FG009|Completed Treatment|Overall Study||4
9866078|NCT00955409|10979622|FG000|COMPLETED|Overall Study|Completed study|11
10094491|NCT02349477|11222848|FG000|COMPLETED|Overall Study||31
10094492|NCT02349477|11222849|FG001|COMPLETED|Overall Study||28
10094493|NCT02349477|11222848|FG000|NOT COMPLETED|Overall Study||13
10094494|NCT02349477|11222849|FG001|NOT COMPLETED|Overall Study||18
10094495|NCT02349542|11222859|FG000|STARTED|Overall Study||20
10094496|NCT02349542|11222859|FG000|COMPLETED|Overall Study||15
10094497|NCT02349542|11222859|FG000|NOT COMPLETED|Overall Study||5
10094498|NCT02349633|11222877|FG000|STARTED|Overall Study||4
10094499|NCT02349633|11222878|FG001|STARTED|Overall Study||3
10094500|NCT02349633|11222879|FG002|STARTED|Overall Study||4
10094501|NCT02349633|11222880|FG003|STARTED|Overall Study||4
10094502|NCT02349633|11222881|FG004|STARTED|Overall Study||3
9866079|NCT00955409|10979623|FG001|COMPLETED|Overall Study|Completed study|5
9866080|NCT00955409|10979624|FG002|COMPLETED|Overall Study|Completed study|15
9866081|NCT00955409|10979625|FG003|COMPLETED|Overall Study|Completed study|17
9866082|NCT00955409|10979626|FG004|COMPLETED|Overall Study|Completed study|3
9866083|NCT00955409|10979627|FG005|COMPLETED|Overall Study|Completed study|6
9866084|NCT00955409|10979628|FG006|COMPLETED|Overall Study|Completed study|3
9866085|NCT00955409|10979629|FG007|COMPLETED|Overall Study|Completed study|2
9866086|NCT00955409|10979630|FG008|COMPLETED|Overall Study|Completed study|2
9866087|NCT00955409|10979631|FG009|COMPLETED|Overall Study|Completed study|3
9866088|NCT00955409|10979622|FG000|NOT COMPLETED|Overall Study||10
9866089|NCT00955409|10979623|FG001|NOT COMPLETED|Overall Study||1
9866090|NCT00955409|10979624|FG002|NOT COMPLETED|Overall Study||26
9866091|NCT00955409|10979625|FG003|NOT COMPLETED|Overall Study||8
9866092|NCT00955409|10979626|FG004|NOT COMPLETED|Overall Study||2
9866093|NCT00955409|10979627|FG005|NOT COMPLETED|Overall Study||3
9866094|NCT00955409|10979628|FG006|NOT COMPLETED|Overall Study||24
9866095|NCT00955409|10979629|FG007|NOT COMPLETED|Overall Study||4
9866096|NCT00955409|10979630|FG008|NOT COMPLETED|Overall Study||14
9866097|NCT00955409|10979631|FG009|NOT COMPLETED|Overall Study||1
9866098|NCT00955474|10979659|FG000|STARTED|Overall Study||12
9866099|NCT00955474|10979660|FG001|STARTED|Overall Study||13
9866100|NCT00955474|10979659|FG000|COMPLETED|Overall Study||5
9866101|NCT00955474|10979660|FG001|COMPLETED|Overall Study||8
9866102|NCT00955474|10979659|FG000|NOT COMPLETED|Overall Study||7
9866103|NCT00955474|10979660|FG001|NOT COMPLETED|Overall Study||5
9866104|NCT00955487|10979670|FG000|STARTED|Overall Study||10
9866105|NCT00955487|10979671|FG001|STARTED|Overall Study||9
9866106|NCT00955487|10979672|FG002|STARTED|Overall Study||17
9866107|NCT00955487|10979673|FG003|STARTED|Overall Study||21
9866108|NCT00955487|10979674|FG004|STARTED|Overall Study||32
9866109|NCT00955487|10979675|FG005|STARTED|Overall Study||35
9866110|NCT00955487|10979670|FG000|COMPLETED|Overall Study||10
9866111|NCT00955487|10979671|FG001|COMPLETED|Overall Study||9
9866112|NCT00955487|10979672|FG002|COMPLETED|Overall Study||17
9866113|NCT00955487|10979673|FG003|COMPLETED|Overall Study||21
9866114|NCT00955487|10979674|FG004|COMPLETED|Overall Study||32
9866115|NCT00955487|10979675|FG005|COMPLETED|Overall Study||35
9866116|NCT00955487|10979670|FG000|NOT COMPLETED|Overall Study||0
9866117|NCT00955487|10979671|FG001|NOT COMPLETED|Overall Study||0
9866118|NCT00955487|10979672|FG002|NOT COMPLETED|Overall Study||0
9866119|NCT00955487|10979673|FG003|NOT COMPLETED|Overall Study||0
9866120|NCT00955487|10979674|FG004|NOT COMPLETED|Overall Study||0
9866121|NCT00955487|10979675|FG005|NOT COMPLETED|Overall Study||0
9866122|NCT00955513|10979690|FG000|STARTED|Overall Study||80
9866123|NCT00955513|10979691|FG001|STARTED|Overall Study||80
9866124|NCT00955513|10979692|FG002|STARTED|Overall Study||82
9866125|NCT00955513|10979690|FG000|COMPLETED|Overall Study||79
9866126|NCT00955513|10979691|FG001|COMPLETED|Overall Study||78
9866127|NCT00955513|10979692|FG002|COMPLETED|Overall Study||79
9866128|NCT00955513|10979690|FG000|NOT COMPLETED|Overall Study||1
9866129|NCT00955513|10979691|FG001|NOT COMPLETED|Overall Study||2
9866130|NCT00955513|10979692|FG002|NOT COMPLETED|Overall Study||3
9866131|NCT00955617|10979700|FG000|STARTED|First MRA (Between Day0 and Day21)||10
9866132|NCT00955617|10979701|FG001|STARTED|First MRA (Between Day0 and Day21)||10
9866133|NCT00955617|10979700|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10
9866134|NCT00955617|10979701|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10
9866135|NCT00955617|10979700|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
9866136|NCT00955617|10979701|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
9866137|NCT00955617|10979700|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10
9866138|NCT00955617|10979701|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10
9866139|NCT00955617|10979700|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
9866140|NCT00955617|10979701|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
10094503|NCT02349633|11222882|FG005|STARTED|Overall Study||4
10094504|NCT02349633|11222883|FG006|STARTED|Overall Study||4
10094505|NCT02349633|11222884|FG007|STARTED|Overall Study||29
10094506|NCT02349633|11222885|FG008|STARTED|Overall Study||5
10094507|NCT02349633|11222886|FG009|STARTED|Overall Study||5
10094508|NCT02349633|11222887|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
10094509|NCT02349633|11222888|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
9866141|NCT00955617|10979700|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
9866142|NCT00955617|10979701|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
9866143|NCT00955682|10979709|FG000|STARTED|Year 2 Period||253
9866144|NCT00955682|10979710|FG001|STARTED|Year 2 Period||42
9866145|NCT00955682|10979709|FG000|COMPLETED|Year 2 Period||253
9866146|NCT00955682|10979710|FG001|COMPLETED|Year 2 Period||42
9866147|NCT00955682|10979709|FG000|NOT COMPLETED|Year 2 Period||0
9866148|NCT00955682|10979710|FG001|NOT COMPLETED|Year 2 Period||0
9866149|NCT00955682|10979709|FG000|STARTED|Year 3 Period||273
9866150|NCT00955682|10979710|FG001|STARTED|Year 3 Period||47
9866151|NCT00955682|10979709|FG000|COMPLETED|Year 3 Period||273
9866152|NCT00955682|10979710|FG001|COMPLETED|Year 3 Period||47
9866153|NCT00955682|10979709|FG000|NOT COMPLETED|Year 3 Period||0
9866154|NCT00955682|10979710|FG001|NOT COMPLETED|Year 3 Period||0
9866155|NCT00955682|10979709|FG000|STARTED|Year 4 Period||246
9866156|NCT00955682|10979710|FG001|STARTED|Year 4 Period||48
9866157|NCT00955682|10979709|FG000|COMPLETED|Year 4 Period||246
9866158|NCT00955682|10979710|FG001|COMPLETED|Year 4 Period||48
9866159|NCT00955682|10979709|FG000|NOT COMPLETED|Year 4 Period||0
9866160|NCT00955682|10979710|FG001|NOT COMPLETED|Year 4 Period||0
9866161|NCT00955682|10979709|FG000|STARTED|Booster Period (Month 48- 49)||245
9866162|NCT00955682|10979710|FG001|STARTED|Booster Period (Month 48- 49)||48
9866163|NCT00955682|10979709|FG000|COMPLETED|Booster Period (Month 48- 49)||244
9866164|NCT00955682|10979710|FG001|COMPLETED|Booster Period (Month 48- 49)||47
9866165|NCT00955682|10979709|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1
9866166|NCT00955682|10979710|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1
9866167|NCT00955682|10979709|FG000|STARTED|Year 5 Period||239
9866168|NCT00955682|10979710|FG001|STARTED|Year 5 Period||47
9866169|NCT00955682|10979709|FG000|COMPLETED|Year 5 Period||239
9866170|NCT00955682|10979710|FG001|COMPLETED|Year 5 Period||47
9866171|NCT00955682|10979709|FG000|NOT COMPLETED|Year 5 Period||0
9866172|NCT00955682|10979710|FG001|NOT COMPLETED|Year 5 Period||0
9866173|NCT00955708|10979724|FG000|STARTED|Overall Study||1308
9866174|NCT00955708|10979724|FG000|COMPLETED|Overall Study||250
9866175|NCT00955708|10979724|FG000|NOT COMPLETED|Overall Study||1058
9866176|NCT00955721|10979730|FG000|STARTED|Overall Study||9
9866177|NCT00955721|10979731|FG001|STARTED|Overall Study||0
9866178|NCT00955721|10979730|FG000|COMPLETED|Overall Study||6
9866179|NCT00955721|10979731|FG001|COMPLETED|Overall Study||0
9866180|NCT00955721|10979730|FG000|NOT COMPLETED|Overall Study||3
9866181|NCT00955721|10979731|FG001|NOT COMPLETED|Overall Study||0
9866182|NCT00955747|10979740|FG000|STARTED|Overall Study||253
9866183|NCT00955747|10979741|FG001|STARTED|Overall Study||241
9866184|NCT00955747|10979740|FG000|COMPLETED|Overall Study||184
9866185|NCT00955747|10979741|FG001|COMPLETED|Overall Study||172
9866186|NCT00955747|10979740|FG000|NOT COMPLETED|Overall Study||69
9866187|NCT00955747|10979741|FG001|NOT COMPLETED|Overall Study||69
9866188|NCT00955825|10979749|FG000|STARTED|Overall Study||233
9866189|NCT00955825|10979750|FG001|STARTED|Overall Study||240
9866190|NCT00955825|10979749|FG000|COMPLETED|Overall Study||207
9866191|NCT00955825|10979750|FG001|COMPLETED|Overall Study||223
9866192|NCT00955825|10979749|FG000|NOT COMPLETED|Overall Study||26
9866193|NCT00955825|10979750|FG001|NOT COMPLETED|Overall Study||17
9866194|NCT00955877|10979759|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
9866195|NCT00955877|10979760|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
9866196|NCT00955877|10979761|FG002|STARTED|Overall Study||7
10094510|NCT02349633|11222889|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
10094511|NCT02349633|11222890|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
10094512|NCT02349633|11222877|FG000|COMPLETED|Overall Study||4
10094513|NCT02349633|11222878|FG001|COMPLETED|Overall Study||2
10094514|NCT02349633|11222879|FG002|COMPLETED|Overall Study||4
10094515|NCT02349633|11222880|FG003|COMPLETED|Overall Study||2
10094516|NCT02349633|11222881|FG004|COMPLETED|Overall Study||1
10094517|NCT02349633|11222882|FG005|COMPLETED|Overall Study||3
10094518|NCT02349633|11222883|FG006|COMPLETED|Overall Study||3
10094519|NCT02349633|11222884|FG007|COMPLETED|Overall Study||13
10094520|NCT02349633|11222885|FG008|COMPLETED|Overall Study||3
10094521|NCT02349633|11222886|FG009|COMPLETED|Overall Study||0
10094522|NCT02349633|11222887|FG010|COMPLETED|Overall Study||0
10094523|NCT02349633|11222888|FG011|COMPLETED|Overall Study||0
10094524|NCT02349633|11222889|FG012|COMPLETED|Overall Study||0
10094525|NCT02349633|11222890|FG013|COMPLETED|Overall Study||0
10094526|NCT02349633|11222877|FG000|NOT COMPLETED|Overall Study||0
10094527|NCT02349633|11222878|FG001|NOT COMPLETED|Overall Study||1
10094528|NCT02349633|11222879|FG002|NOT COMPLETED|Overall Study||0
10094529|NCT02349633|11222880|FG003|NOT COMPLETED|Overall Study||2
10094530|NCT02349633|11222881|FG004|NOT COMPLETED|Overall Study||2
10094531|NCT02349633|11222882|FG005|NOT COMPLETED|Overall Study||1
10094532|NCT02349633|11222883|FG006|NOT COMPLETED|Overall Study||1
10094533|NCT02349633|11222884|FG007|NOT COMPLETED|Overall Study||16
10094534|NCT02349633|11222885|FG008|NOT COMPLETED|Overall Study||2
10094535|NCT02349633|11222886|FG009|NOT COMPLETED|Overall Study||5
10094536|NCT02349633|11222887|FG010|NOT COMPLETED|Overall Study||0
10094537|NCT02349633|11222888|FG011|NOT COMPLETED|Overall Study||0
10094538|NCT02349633|11222889|FG012|NOT COMPLETED|Overall Study||0
10094539|NCT02349633|11222890|FG013|NOT COMPLETED|Overall Study||0
10094540|NCT02349646|11222951|FG000|STARTED|Overall Study||33
10094541|NCT02349646|11222951|FG000|Received Trial System|Overall Study||24
9866197|NCT00955877|10979759|FG000|COMPLETED|Overall Study||6
9866198|NCT00955877|10979760|FG001|COMPLETED|Overall Study||0
9866199|NCT00955877|10979761|FG002|COMPLETED|Overall Study||7
9866200|NCT00955877|10979759|FG000|NOT COMPLETED|Overall Study||0
9866201|NCT00955877|10979760|FG001|NOT COMPLETED|Overall Study||0
9866202|NCT00955877|10979761|FG002|NOT COMPLETED|Overall Study||0
9866203|NCT00955903|10979772|FG000|STARTED|Overall Study||55
9866204|NCT00955903|10979773|FG001|STARTED|Overall Study||54
9866205|NCT00955903|10979774|FG002|STARTED|Overall Study||55
9866206|NCT00955903|10979772|FG000|COMPLETED|Overall Study||49
9866207|NCT00955903|10979773|FG001|COMPLETED|Overall Study||51
10094542|NCT02349646|11222951|FG000|Receive Permanent System|Overall Study||27
10094543|NCT02349646|11222951|FG000|COMPLETED|Overall Study||16
10094544|NCT02349646|11222951|FG000|NOT COMPLETED|Overall Study||17
10094545|NCT02349685|11222958|FG000|STARTED|Overall Study||89
10094546|NCT02349685|11222959|FG001|STARTED|Overall Study||89
10094547|NCT02349685|11222960|FG002|STARTED|Overall Study||41
10094548|NCT02349685|11222958|FG000|COMPLETED|Overall Study||84
9866208|NCT00955903|10979774|FG002|COMPLETED|Overall Study||48
9866209|NCT00955903|10979772|FG000|NOT COMPLETED|Overall Study||6
9866210|NCT00955903|10979773|FG001|NOT COMPLETED|Overall Study||3
9866211|NCT00955903|10979774|FG002|NOT COMPLETED|Overall Study||7
9866212|NCT00955916|10979782|FG000|STARTED|Overall Study||38
9866213|NCT00955916|10979782|FG000|COMPLETED|Overall Study||38
9866214|NCT00955916|10979782|FG000|NOT COMPLETED|Overall Study||0
9866215|NCT00955955|10979789|FG000|STARTED|Overall Study||19
9866216|NCT00955955|10979790|FG001|STARTED|Overall Study||28
9866217|NCT00955955|10979791|FG002|STARTED|Overall Study||28
9866218|NCT00955955|10979789|FG000|COMPLETED|Overall Study||17
9866219|NCT00955955|10979790|FG001|COMPLETED|Overall Study||28
9866220|NCT00955955|10979791|FG002|COMPLETED|Overall Study||28
9866221|NCT00955955|10979789|FG000|NOT COMPLETED|Overall Study||2
9866222|NCT00955955|10979790|FG001|NOT COMPLETED|Overall Study||0
9866223|NCT00955955|10979791|FG002|NOT COMPLETED|Overall Study||0
9866224|NCT00955968|10979807|FG000|STARTED|Overall Study||828
9866225|NCT00955968|10979808|FG001|STARTED|Overall Study||825
9866226|NCT00955968|10979807|FG000|COMPLETED|Overall Study||691
9866227|NCT00955968|10979808|FG001|COMPLETED|Overall Study||699
9866228|NCT00955968|10979807|FG000|NOT COMPLETED|Overall Study||137
9866229|NCT00955968|10979808|FG001|NOT COMPLETED|Overall Study||126
9866230|NCT00956020|10979817|FG000|STARTED|Overall Study||4
9866231|NCT00956020|10979817|FG000|COMPLETED|Overall Study||4
9866232|NCT00956020|10979817|FG000|NOT COMPLETED|Overall Study||0
9866233|NCT00956085|10979830|FG000|STARTED|Overall Study||12
9866234|NCT00956085|10979830|FG000|COMPLETED|Overall Study||12
9866235|NCT00956085|10979830|FG000|NOT COMPLETED|Overall Study||0
9866236|NCT00956254|10979834|FG000|STARTED|Overall Study||18
9866237|NCT00956254|10979834|FG000|COMPLETED|Overall Study||18
9866238|NCT00956254|10979834|FG000|NOT COMPLETED|Overall Study||0
9866239|NCT00956293|10979842|FG000|STARTED|Main Period (Pre-randomization)||0
9866240|NCT00956293|10979843|FG001|STARTED|Main Period (Pre-randomization)||0
9866241|NCT00956293|10979844|FG002|STARTED|Main Period (Pre-randomization)||207
9866242|NCT00956293|10979842|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0
10094549|NCT02349685|11222959|FG001|COMPLETED|Overall Study||87
10094550|NCT02349685|11222960|FG002|COMPLETED|Overall Study||37
10094551|NCT02349685|11222958|FG000|NOT COMPLETED|Overall Study||5
10094552|NCT02349685|11222959|FG001|NOT COMPLETED|Overall Study||2
10094553|NCT02349685|11222960|FG002|NOT COMPLETED|Overall Study||4
10094554|NCT02349711|11222970|FG000|STARTED|Overall Study||87
10094555|NCT02349711|11222971|FG001|STARTED|Overall Study||86
10094556|NCT02349711|11222970|FG000|COMPLETED|Overall Study||84
10094557|NCT02349711|11222971|FG001|COMPLETED|Overall Study||84
10094558|NCT02349711|11222970|FG000|NOT COMPLETED|Overall Study||3
10094559|NCT02349711|11222971|FG001|NOT COMPLETED|Overall Study||2
10094560|NCT02349789|11222977|FG000|STARTED|Overall Study||11
10094561|NCT02349789|11222977|FG000|COMPLETED|Overall Study||9
10094562|NCT02349789|11222977|FG000|NOT COMPLETED|Overall Study||2
10094563|NCT02350127|11222983|FG000|STARTED|4-Month Assessment||44
10094564|NCT02350127|11222984|FG001|STARTED|4-Month Assessment||44
10094565|NCT02350127|11222983|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
10094566|NCT02350127|11222984|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
10094567|NCT02350127|11222983|FG000|COMPLETED|4-Month Assessment||33
10094568|NCT02350127|11222984|FG001|COMPLETED|4-Month Assessment||35
10094569|NCT02350127|11222983|FG000|NOT COMPLETED|4-Month Assessment||11
10094570|NCT02350127|11222984|FG001|NOT COMPLETED|4-Month Assessment||9
10094571|NCT02350127|11222983|FG000|STARTED|8-Month Assessment||33
10094572|NCT02350127|11222984|FG001|STARTED|8-Month Assessment||35
10094573|NCT02350127|11222983|FG000|COMPLETED|8-Month Assessment||27
10094574|NCT02350127|11222984|FG001|COMPLETED|8-Month Assessment||26
10094575|NCT02350127|11222983|FG000|NOT COMPLETED|8-Month Assessment||6
10094576|NCT02350127|11222984|FG001|NOT COMPLETED|8-Month Assessment||9
10094577|NCT02350309|11222997|FG000|STARTED|Treatment Period 1 (2 Days)||12
10094578|NCT02350309|11222998|FG001|STARTED|Treatment Period 1 (2 Days)||11
10094579|NCT02350309|11222999|FG002|STARTED|Treatment Period 1 (2 Days)||11
10094580|NCT02350309|11223000|FG003|STARTED|Treatment Period 1 (2 Days)||11
10094581|NCT02350309|11223001|FG004|STARTED|Treatment Period 1 (2 Days)||12
10094582|NCT02350309|11223002|FG005|STARTED|Treatment Period 1 (2 Days)||12
10094583|NCT02350309|11222997|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
10094584|NCT02350309|11222998|FG001|COMPLETED|Treatment Period 1 (2 Days)||11
10094585|NCT02350309|11222999|FG002|COMPLETED|Treatment Period 1 (2 Days)||10
10094586|NCT02350309|11223000|FG003|COMPLETED|Treatment Period 1 (2 Days)||11
10094587|NCT02350309|11223001|FG004|COMPLETED|Treatment Period 1 (2 Days)||12
9866243|NCT00956293|10979843|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0
9866244|NCT00956293|10979844|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203
9866245|NCT00956293|10979842|FG000|COMPLETED|Main Period (Pre-randomization)||0
9866246|NCT00956293|10979843|FG001|COMPLETED|Main Period (Pre-randomization)||0
10094588|NCT02350309|11223002|FG005|COMPLETED|Treatment Period 1 (2 Days)||12
10094589|NCT02350309|11222997|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10094590|NCT02350309|11222998|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10094591|NCT02350309|11222999|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1
10094592|NCT02350309|11223000|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10094593|NCT02350309|11223001|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10094594|NCT02350309|11223002|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10094595|NCT02350309|11222997|FG000|STARTED|Washout Period 1 (12-16 Days)||12
9866247|NCT00956293|10979844|FG002|COMPLETED|Main Period (Pre-randomization)||77
9866248|NCT00956293|10979842|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0
9866249|NCT00956293|10979843|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0
9866250|NCT00956293|10979844|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130
9866251|NCT00956293|10979842|FG000|STARTED|Main Period (Randomization)||24
9866252|NCT00956293|10979843|FG001|STARTED|Main Period (Randomization)||53
9866253|NCT00956293|10979844|FG002|STARTED|Main Period (Randomization)||0
9866254|NCT00956293|10979842|FG000|Full Analysis Set|Main Period (Randomization)||24
9866255|NCT00956293|10979843|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
9866256|NCT00956293|10979844|FG002|Full Analysis Set|Main Period (Randomization)||0
9866257|NCT00956293|10979842|FG000|Randomized Safety Set|Main Period (Randomization)||24
9866258|NCT00956293|10979843|FG001|Randomized Safety Set|Main Period (Randomization)||51
9866259|NCT00956293|10979844|FG002|Randomized Safety Set|Main Period (Randomization)||0
9866260|NCT00956293|10979842|FG000|COMPLETED|Main Period (Randomization)||23
9866261|NCT00956293|10979843|FG001|COMPLETED|Main Period (Randomization)||26
9866262|NCT00956293|10979844|FG002|COMPLETED|Main Period (Randomization)||0
9866263|NCT00956293|10979842|FG000|NOT COMPLETED|Main Period (Randomization)||1
9866264|NCT00956293|10979843|FG001|NOT COMPLETED|Main Period (Randomization)||27
9866265|NCT00956293|10979844|FG002|NOT COMPLETED|Main Period (Randomization)||0
9866266|NCT00956293|10979842|FG000|STARTED|Follow-up Period||20
9866267|NCT00956293|10979843|FG001|STARTED|Follow-up Period||32
9866268|NCT00956293|10979844|FG002|STARTED|Follow-up Period||0
9866269|NCT00956293|10979842|FG000|COMPLETED|Follow-up Period||0
9866270|NCT00956293|10979843|FG001|COMPLETED|Follow-up Period||0
9866271|NCT00956293|10979844|FG002|COMPLETED|Follow-up Period||0
9866272|NCT00956293|10979842|FG000|NOT COMPLETED|Follow-up Period||20
9866273|NCT00956293|10979843|FG001|NOT COMPLETED|Follow-up Period||32
9866274|NCT00956293|10979844|FG002|NOT COMPLETED|Follow-up Period||0
9866275|NCT00956540|10979854|FG000|STARTED|Overall Study||54
9866276|NCT00956540|10979855|FG001|STARTED|Overall Study||50
9866277|NCT00956540|10979856|FG002|STARTED|Overall Study||46
9866278|NCT00956540|10979857|FG003|STARTED|Overall Study||45
9866279|NCT00956540|10979854|FG000|COMPLETED|Overall Study||51
9866280|NCT00956540|10979855|FG001|COMPLETED|Overall Study||46
9866281|NCT00956540|10979856|FG002|COMPLETED|Overall Study||43
9866282|NCT00956540|10979857|FG003|COMPLETED|Overall Study||41
9866283|NCT00956540|10979854|FG000|NOT COMPLETED|Overall Study||3
9866284|NCT00956540|10979855|FG001|NOT COMPLETED|Overall Study||4
9866285|NCT00956540|10979856|FG002|NOT COMPLETED|Overall Study||3
9866286|NCT00956540|10979857|FG003|NOT COMPLETED|Overall Study||4
9866287|NCT00956592|10979869|FG000|STARTED|Overall Study||150
9866288|NCT00956592|10979870|FG001|STARTED|Overall Study||150
9866289|NCT00956592|10979869|FG000|COMPLETED|Overall Study||149
9866290|NCT00956592|10979870|FG001|COMPLETED|Overall Study||147
9866291|NCT00956592|10979869|FG000|NOT COMPLETED|Overall Study||1
9866292|NCT00956592|10979870|FG001|NOT COMPLETED|Overall Study||3
9866293|NCT00956631|10979878|FG000|STARTED|Overall Study||78
9866294|NCT00956631|10979878|FG000|COMPLETED|Overall Study||62
9866295|NCT00956631|10979878|FG000|NOT COMPLETED|Overall Study||16
9866296|NCT00956657|10979886|FG000|STARTED|Overall Study||18
9866297|NCT00956657|10979887|FG001|STARTED|Overall Study||13
9866298|NCT00956657|10979886|FG000|COMPLETED|Overall Study||18
9866299|NCT00956657|10979887|FG001|COMPLETED|Overall Study||13
9866300|NCT00956657|10979886|FG000|NOT COMPLETED|Overall Study||0
9866301|NCT00956657|10979887|FG001|NOT COMPLETED|Overall Study||0
9866302|NCT00956709|10979895|FG000|STARTED|Overall Study||16
9866303|NCT00956709|10979896|FG001|STARTED|Overall Study||19
9866304|NCT00956709|10979895|FG000|COMPLETED|Overall Study||16
9866305|NCT00956709|10979896|FG001|COMPLETED|Overall Study||19
9866306|NCT00956709|10979895|FG000|NOT COMPLETED|Overall Study||0
9866307|NCT00956709|10979896|FG001|NOT COMPLETED|Overall Study||0
9866308|NCT00956761|10979902|FG000|STARTED|Overall Study||63
9866309|NCT00956761|10979902|FG000|COMPLETED|Overall Study||63
9866310|NCT00956761|10979902|FG000|NOT COMPLETED|Overall Study||0
9866311|NCT00956813|10979909|FG000|STARTED|Flaxseed and Placebo||105
9866312|NCT00956813|10979910|FG001|STARTED|Flaxseed and Placebo||105
10094596|NCT02350309|11222998|FG001|STARTED|Washout Period 1 (12-16 Days)||11
10094597|NCT02350309|11222999|FG002|STARTED|Washout Period 1 (12-16 Days)||10
9866313|NCT00956813|10979909|FG000|COMPLETED|Flaxseed and Placebo||97
9866314|NCT00956813|10979910|FG001|COMPLETED|Flaxseed and Placebo||100
9866315|NCT00956813|10979909|FG000|NOT COMPLETED|Flaxseed and Placebo||8
9866316|NCT00956813|10979910|FG001|NOT COMPLETED|Flaxseed and Placebo||5
9866317|NCT00956813|10979909|FG000|STARTED|Continuation Phase||80
9866318|NCT00956813|10979910|FG001|STARTED|Continuation Phase||0
9866319|NCT00956813|10979909|FG000|COMPLETED|Continuation Phase||80
9866320|NCT00956813|10979910|FG001|COMPLETED|Continuation Phase||0
9866321|NCT00956813|10979909|FG000|NOT COMPLETED|Continuation Phase||0
9866322|NCT00956813|10979910|FG001|NOT COMPLETED|Continuation Phase||0
9866323|NCT00956839|10979920|FG000|STARTED|Overall Study||14
9866324|NCT00956839|10979921|FG001|STARTED|Overall Study||13
9866325|NCT00956839|10979922|FG002|STARTED|Overall Study||13
9866326|NCT00956839|10979920|FG000|COMPLETED|Overall Study||11
9866327|NCT00956839|10979921|FG001|COMPLETED|Overall Study||13
9866328|NCT00956839|10979922|FG002|COMPLETED|Overall Study||10
9866329|NCT00956839|10979920|FG000|NOT COMPLETED|Overall Study||3
9866330|NCT00956839|10979921|FG001|NOT COMPLETED|Overall Study||0
9866331|NCT00956839|10979922|FG002|NOT COMPLETED|Overall Study||3
9866332|NCT00956930|10979932|FG000|STARTED|Overall Study||24
9866333|NCT00956930|10979933|FG001|STARTED|Overall Study||21
9866334|NCT00956930|10979932|FG000|COMPLETED|Overall Study||24
9866335|NCT00956930|10979933|FG001|COMPLETED|Overall Study||21
9866336|NCT00956930|10979932|FG000|NOT COMPLETED|Overall Study||0
9866337|NCT00956930|10979933|FG001|NOT COMPLETED|Overall Study||0
9866338|NCT00956943|10979943|FG000|STARTED|Overall Study||43
9866339|NCT00956943|10979944|FG001|STARTED|Overall Study||44
9866340|NCT00956943|10979943|FG000|Baseline|Overall Study||43
9866341|NCT00956943|10979944|FG001|Baseline|Overall Study||44
9866342|NCT00956943|10979943|FG000|COMPLETED|Overall Study||34
9866343|NCT00956943|10979944|FG001|COMPLETED|Overall Study||34
9866344|NCT00956943|10979943|FG000|NOT COMPLETED|Overall Study||9
9866345|NCT00956943|10979944|FG001|NOT COMPLETED|Overall Study||10
9866346|NCT00957008|10979954|FG000|STARTED|Overall Study||49
9866347|NCT00957008|10979955|FG001|STARTED|Overall Study||49
9866348|NCT00957008|10979956|FG002|STARTED|Overall Study||49
9866349|NCT00957008|10979957|FG003|STARTED|Overall Study||50
9866350|NCT00957008|10979954|FG000|COMPLETED|Overall Study||28
9866351|NCT00957008|10979955|FG001|COMPLETED|Overall Study||37
9866352|NCT00957008|10979956|FG002|COMPLETED|Overall Study||32
9866353|NCT00957008|10979957|FG003|COMPLETED|Overall Study||26
9866354|NCT00957008|10979954|FG000|NOT COMPLETED|Overall Study||21
9866355|NCT00957008|10979955|FG001|NOT COMPLETED|Overall Study||12
9866356|NCT00957008|10979956|FG002|NOT COMPLETED|Overall Study||17
9866357|NCT00957008|10979957|FG003|NOT COMPLETED|Overall Study||24
9953387|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
9953388|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
9953389|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
9953390|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
9953391|NCT01426009|11072057|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
9953392|NCT01426009|11072057|FG000|Placebo|Period 2-Second Intervention (7 Days)||21
9953393|NCT01426009|11072057|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130
9953394|NCT01426009|11072057|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
9953395|NCT01426009|11072057|FG000|STARTED|Washout 2||130
9953396|NCT01426009|11072057|FG000|COMPLETED|Washout 2||129
9953397|NCT01426009|11072057|FG000|NOT COMPLETED|Washout 2||1
9953398|NCT01426009|11072057|FG000|STARTED|Period 3-Third Intervention (7 Days)||129
9953399|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
9953400|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
9953401|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
9953402|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
9953403|NCT01426009|11072057|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
9953404|NCT01426009|11072057|FG000|Placebo|Period 3-Third Intervention (7 Days)||22
9953405|NCT01426009|11072057|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129
9953406|NCT01426009|11072057|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
9953407|NCT01426009|11072057|FG000|STARTED|Washout 3||129
9953408|NCT01426009|11072057|FG000|COMPLETED|Washout 3||128
9953409|NCT01426009|11072057|FG000|NOT COMPLETED|Washout 3||1
9953410|NCT01426009|11072057|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128
9953411|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
9953412|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
9953413|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
9953414|NCT01426009|11072057|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
9953415|NCT01426009|11072057|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
9953416|NCT01426009|11072057|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
9953417|NCT01426009|11072057|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10
9953418|NCT01426009|11072057|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
9953419|NCT01426009|11072057|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
9953420|NCT01426009|11072057|FG000|STARTED|Washout 4||127
9953421|NCT01426009|11072057|FG000|COMPLETED|Washout 4||126
9953422|NCT01426009|11072057|FG000|NOT COMPLETED|Washout 4||1
9953423|NCT01426191|11072073|FG000|STARTED|Overall Study||2032
9953424|NCT01426191|11072073|FG000|COMPLETED|Overall Study||2032
9953425|NCT01426191|11072073|FG000|NOT COMPLETED|Overall Study||0
9953426|NCT01426217|11072079|FG000|STARTED|Overall Study||314
9953427|NCT01426217|11072080|FG001|STARTED|Overall Study||280
9953428|NCT01426217|11072079|FG000|COMPLETED|Overall Study||306
9953429|NCT01426217|11072080|FG001|COMPLETED|Overall Study||266
9953430|NCT01426217|11072079|FG000|NOT COMPLETED|Overall Study||8
9953431|NCT01426217|11072080|FG001|NOT COMPLETED|Overall Study||14
9953432|NCT01426230|11072088|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
9953433|NCT01426230|11072089|FG001|STARTED|Overall Study||111
9953434|NCT01426230|11072088|FG000|COMPLETED|Overall Study||55
9953435|NCT01426230|11072089|FG001|COMPLETED|Overall Study||84
9953436|NCT01426230|11072088|FG000|NOT COMPLETED|Overall Study||31
9953437|NCT01426230|11072089|FG001|NOT COMPLETED|Overall Study||27
9953438|NCT01426269|11072094|FG000|STARTED|Period 1: 12 Weeks||235
9953439|NCT01426269|11072095|FG001|STARTED|Period 1: 12 Weeks||0
9953440|NCT01426269|11072096|FG002|STARTED|Period 1: 12 Weeks||0
9953441|NCT01426269|11072094|FG000|COMPLETED|Period 1: 12 Weeks||180
9953442|NCT01426269|11072095|FG001|COMPLETED|Period 1: 12 Weeks||0
9953443|NCT01426269|11072096|FG002|COMPLETED|Period 1: 12 Weeks||0
9866358|NCT00957021|10979971|FG000|STARTED|Overall Study||354
9866359|NCT00957021|10979971|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
9866360|NCT00957021|10979971|FG000|NOT COMPLETED|Overall Study||117
9866361|NCT00957047|10979980|FG000|STARTED|PART I||100
9866362|NCT00957047|10979981|FG001|STARTED|PART I||96
9866363|NCT00957047|10979982|FG002|STARTED|PART I||101
9866364|NCT00957047|10979983|FG003|STARTED|PART I||98
9866365|NCT00957047|10979984|FG004|STARTED|PART I||0
9866366|NCT00957047|10979980|FG000|Randomized/Safety Population|PART I||100
9866367|NCT00957047|10979981|FG001|Randomized/Safety Population|PART I||96
9866368|NCT00957047|10979982|FG002|Randomized/Safety Population|PART I||101
9866369|NCT00957047|10979983|FG003|Randomized/Safety Population|PART I||98
9866370|NCT00957047|10979984|FG004|Randomized/Safety Population|PART I||0
9866371|NCT00957047|10979980|FG000|Intention-to-treat (ITT) Population|PART I||100
9866372|NCT00957047|10979981|FG001|Intention-to-treat (ITT) Population|PART I||96
9866373|NCT00957047|10979982|FG002|Intention-to-treat (ITT) Population|PART I||100
9866374|NCT00957047|10979983|FG003|Intention-to-treat (ITT) Population|PART I||97
9866375|NCT00957047|10979984|FG004|Intention-to-treat (ITT) Population|PART I||0
9866376|NCT00957047|10979980|FG000|Per-Protocol Population|PART I||81
9866377|NCT00957047|10979981|FG001|Per-Protocol Population|PART I||70
9866378|NCT00957047|10979982|FG002|Per-Protocol Population|PART I||75
9866379|NCT00957047|10979983|FG003|Per-Protocol Population|PART I||54
9866380|NCT00957047|10979984|FG004|Per-Protocol Population|PART I||0
9866381|NCT00957047|10979980|FG000|COMPLETED|PART I||94
9866382|NCT00957047|10979981|FG001|COMPLETED|PART I||83
9866383|NCT00957047|10979982|FG002|COMPLETED|PART I||80
9866384|NCT00957047|10979983|FG003|COMPLETED|PART I||68
9866385|NCT00957047|10979984|FG004|COMPLETED|PART I||0
9866386|NCT00957047|10979980|FG000|NOT COMPLETED|PART I||6
9866387|NCT00957047|10979981|FG001|NOT COMPLETED|PART I||13
9866388|NCT00957047|10979982|FG002|NOT COMPLETED|PART I||21
9866389|NCT00957047|10979983|FG003|NOT COMPLETED|PART I||30
9866390|NCT00957047|10979984|FG004|NOT COMPLETED|PART I||0
9866391|NCT00957047|10979980|FG000|STARTED|PART II||0
9866392|NCT00957047|10979981|FG001|STARTED|PART II||0
9866393|NCT00957047|10979982|FG002|STARTED|PART II||0
9866394|NCT00957047|10979983|FG003|STARTED|PART II||0
9866395|NCT00957047|10979984|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
9866396|NCT00957047|10979980|FG000|Terminated Prematurely|PART II||0
9866397|NCT00957047|10979981|FG001|Terminated Prematurely|PART II||0
9866398|NCT00957047|10979982|FG002|Terminated Prematurely|PART II||0
9866399|NCT00957047|10979983|FG003|Terminated Prematurely|PART II||0
9866400|NCT00957047|10979984|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
9866401|NCT00957047|10979980|FG000|COMPLETED|PART II||0
9866402|NCT00957047|10979981|FG001|COMPLETED|PART II||0
9866403|NCT00957047|10979982|FG002|COMPLETED|PART II||0
9866404|NCT00957047|10979983|FG003|COMPLETED|PART II||0
9866405|NCT00957047|10979984|FG004|COMPLETED|PART II||223
9866406|NCT00957047|10979980|FG000|NOT COMPLETED|PART II||0
9866407|NCT00957047|10979981|FG001|NOT COMPLETED|PART II||0
9866408|NCT00957047|10979982|FG002|NOT COMPLETED|PART II||0
9866409|NCT00957047|10979983|FG003|NOT COMPLETED|PART II||0
9866410|NCT00957047|10979984|FG004|NOT COMPLETED|PART II||102
9866411|NCT00957229|10980004|FG000|STARTED|Study Start||15
9866412|NCT00957229|10980005|FG001|STARTED|Study Start||26
9866413|NCT00957229|10980004|FG000|COMPLETED|Study Start||14
9866414|NCT00957229|10980005|FG001|COMPLETED|Study Start||23
9866415|NCT00957229|10980004|FG000|NOT COMPLETED|Study Start||1
9866416|NCT00957229|10980005|FG001|NOT COMPLETED|Study Start||3
9866417|NCT00957229|10980004|FG000|STARTED|Reallocated to or Continued Vismodegib||14
9866418|NCT00957229|10980005|FG001|STARTED|Reallocated to or Continued Vismodegib||23
9866419|NCT00957229|10980004|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11
9866420|NCT00957229|10980005|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21
9866421|NCT00957229|10980004|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
9866422|NCT00957229|10980005|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
9866423|NCT00957242|10980013|FG000|STARTED|Overall Study||73
9866424|NCT00957242|10980014|FG001|STARTED|Overall Study||72
9866425|NCT00957242|10980013|FG000|COMPLETED|Overall Study||73
9866426|NCT00957242|10980014|FG001|COMPLETED|Overall Study||72
9866427|NCT00957242|10980013|FG000|NOT COMPLETED|Overall Study||0
9866428|NCT00957242|10980014|FG001|NOT COMPLETED|Overall Study||0
10094598|NCT02350309|11223000|FG003|STARTED|Washout Period 1 (12-16 Days)||11
10094599|NCT02350309|11223001|FG004|STARTED|Washout Period 1 (12-16 Days)||12
10094600|NCT02350309|11223002|FG005|STARTED|Washout Period 1 (12-16 Days)||12
10094601|NCT02350309|11222997|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12
10094602|NCT02350309|11222998|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11
10094603|NCT02350309|11222999|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10
10094604|NCT02350309|11223000|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11
10094605|NCT02350309|11223001|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12
10094606|NCT02350309|11223002|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12
9866429|NCT00957268|10980027|FG000|STARTED|Overall Study||5
9866430|NCT00957268|10980028|FG001|STARTED|Overall Study||4
9866431|NCT00957268|10980029|FG002|STARTED|Overall Study||8
9866432|NCT00957268|10980030|FG003|STARTED|Overall Study||7
9866433|NCT00957268|10980031|FG004|STARTED|Overall Study||22
9866434|NCT00957268|10980027|FG000|COMPLETED|Overall Study||5
9866435|NCT00957268|10980028|FG001|COMPLETED|Overall Study||4
10094607|NCT02350309|11222997|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
9866436|NCT00957268|10980029|FG002|COMPLETED|Overall Study||7
9866437|NCT00957268|10980030|FG003|COMPLETED|Overall Study||7
9866438|NCT00957268|10980031|FG004|COMPLETED|Overall Study||22
9866439|NCT00957268|10980027|FG000|NOT COMPLETED|Overall Study||0
9866440|NCT00957268|10980028|FG001|NOT COMPLETED|Overall Study||0
9866441|NCT00957268|10980029|FG002|NOT COMPLETED|Overall Study||1
9866442|NCT00957268|10980030|FG003|NOT COMPLETED|Overall Study||0
9866443|NCT00957268|10980031|FG004|NOT COMPLETED|Overall Study||0
9866444|NCT00957333|10980043|FG000|STARTED|Overall Study||44
9866445|NCT00957333|10980043|FG000|COMPLETED|Overall Study||44
9866446|NCT00957333|10980043|FG000|NOT COMPLETED|Overall Study||0
9866447|NCT00957359|10980049|FG000|STARTED|Overall Study||14
9866448|NCT00957359|10980050|FG001|STARTED|Overall Study||15
9866449|NCT00957359|10980049|FG000|COMPLETED|Overall Study||14
9866450|NCT00957359|10980050|FG001|COMPLETED|Overall Study||15
9866451|NCT00957359|10980049|FG000|NOT COMPLETED|Overall Study||0
9866452|NCT00957359|10980050|FG001|NOT COMPLETED|Overall Study||0
9866453|NCT00957372|10980059|FG000|STARTED|PART I||80
9866454|NCT00957372|10980060|FG001|STARTED|PART I||85
9866455|NCT00957372|10980061|FG002|STARTED|PART I||88
9866456|NCT00957372|10980062|FG003|STARTED|PART I||0
9866457|NCT00957372|10980059|FG000|Safety Population|PART I||80
9866458|NCT00957372|10980060|FG001|Safety Population|PART I||85
9866459|NCT00957372|10980061|FG002|Safety Population|PART I||87
9866460|NCT00957372|10980062|FG003|Safety Population|PART I||0
9866461|NCT00957372|10980059|FG000|Intention-to-Treat Population|PART I||77
9866462|NCT00957372|10980060|FG001|Intention-to-Treat Population|PART I||84
9866463|NCT00957372|10980061|FG002|Intention-to-Treat Population|PART I||84
9866464|NCT00957372|10980062|FG003|Intention-to-Treat Population|PART I||0
9866465|NCT00957372|10980059|FG000|Per-Protocol Population|PART I||35
9866466|NCT00957372|10980060|FG001|Per-Protocol Population|PART I||47
9866467|NCT00957372|10980061|FG002|Per-Protocol Population|PART I||51
9866468|NCT00957372|10980062|FG003|Per-Protocol Population|PART I||0
9866469|NCT00957372|10980059|FG000|Randomized But Not Treated|PART I||0
9866470|NCT00957372|10980060|FG001|Randomized But Not Treated|PART I||0
9866471|NCT00957372|10980061|FG002|Randomized But Not Treated|PART I||1
10094608|NCT02350309|11222998|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10094609|NCT02350309|11222999|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10094610|NCT02350309|11223000|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10094611|NCT02350309|11223001|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10094612|NCT02350309|11223002|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10094613|NCT02350309|11222997|FG000|STARTED|Treatment Period 2 (2 Days)||12
10094614|NCT02350309|11222998|FG001|STARTED|Treatment Period 2 (2 Days)||11
10094615|NCT02350309|11222999|FG002|STARTED|Treatment Period 2 (2 Days)||10
10094616|NCT02350309|11223000|FG003|STARTED|Treatment Period 2 (2 Days)||11
10094617|NCT02350309|11223001|FG004|STARTED|Treatment Period 2 (2 Days)||12
10094618|NCT02350309|11223002|FG005|STARTED|Treatment Period 2 (2 Days)||12
10094619|NCT02350309|11222997|FG000|COMPLETED|Treatment Period 2 (2 Days)||12
10094620|NCT02350309|11222998|FG001|COMPLETED|Treatment Period 2 (2 Days)||11
10094621|NCT02350309|11222999|FG002|COMPLETED|Treatment Period 2 (2 Days)||10
10094622|NCT02350309|11223000|FG003|COMPLETED|Treatment Period 2 (2 Days)||11
10094623|NCT02350309|11223001|FG004|COMPLETED|Treatment Period 2 (2 Days)||12
10094624|NCT02350309|11223002|FG005|COMPLETED|Treatment Period 2 (2 Days)||12
10094625|NCT02350309|11222997|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10094626|NCT02350309|11222998|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10094627|NCT02350309|11222999|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10094628|NCT02350309|11223000|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10094629|NCT02350309|11223001|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10094630|NCT02350309|11223002|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10094631|NCT02350309|11222997|FG000|STARTED|Washout Period 2 (12-16 Days)||12
10094632|NCT02350309|11222998|FG001|STARTED|Washout Period 2 (12-16 Days)||11
10094633|NCT02350309|11222999|FG002|STARTED|Washout Period 2 (12-16 Days)||10
10094634|NCT02350309|11223000|FG003|STARTED|Washout Period 2 (12-16 Days)||11
10094635|NCT02350309|11223001|FG004|STARTED|Washout Period 2 (12-16 Days)||12
10094636|NCT02350309|11223002|FG005|STARTED|Washout Period 2 (12-16 Days)||12
10094637|NCT02350309|11222997|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12
10094638|NCT02350309|11222998|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11
10094639|NCT02350309|11222999|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10
10094640|NCT02350309|11223000|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11
10094641|NCT02350309|11223001|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12
10094642|NCT02350309|11223002|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12
10094643|NCT02350309|11222997|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10094644|NCT02350309|11222998|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10094645|NCT02350309|11222999|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10094646|NCT02350309|11223000|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10094647|NCT02350309|11223001|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
9866472|NCT00957372|10980062|FG003|Randomized But Not Treated|PART I||0
9866473|NCT00957372|10980059|FG000|COMPLETED|PART I||80
9866474|NCT00957372|10980060|FG001|COMPLETED|PART I||85
9866475|NCT00957372|10980061|FG002|COMPLETED|PART I||87
9866476|NCT00957372|10980062|FG003|COMPLETED|PART I||0
9866477|NCT00957372|10980059|FG000|NOT COMPLETED|PART I||0
10094648|NCT02350309|11223002|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10094649|NCT02350309|11222997|FG000|STARTED|Treatment Period 3 (2 Days)||12
10094650|NCT02350309|11222998|FG001|STARTED|Treatment Period 3 (2 Days)||11
9866478|NCT00957372|10980060|FG001|NOT COMPLETED|PART I||0
9866479|NCT00957372|10980061|FG002|NOT COMPLETED|PART I||1
9866480|NCT00957372|10980062|FG003|NOT COMPLETED|PART I||0
9866481|NCT00957372|10980059|FG000|STARTED|PART II||0
9866482|NCT00957372|10980060|FG001|STARTED|PART II||0
9866483|NCT00957372|10980061|FG002|STARTED|PART II||0
9866484|NCT00957372|10980062|FG003|STARTED|PART II||194
9866485|NCT00957372|10980059|FG000|Safety Population|PART II||0
9866486|NCT00957372|10980060|FG001|Safety Population|PART II||0
9866487|NCT00957372|10980061|FG002|Safety Population|PART II||0
9866488|NCT00957372|10980062|FG003|Safety Population|PART II||194
9866489|NCT00957372|10980059|FG000|Intention-to-treat (ITT) Population|PART II||0
9866490|NCT00957372|10980060|FG001|Intention-to-treat (ITT) Population|PART II||0
9866491|NCT00957372|10980061|FG002|Intention-to-treat (ITT) Population|PART II||0
9866492|NCT00957372|10980062|FG003|Intention-to-treat (ITT) Population|PART II||191
9866493|NCT00957372|10980059|FG000|Per-Protocol Population|PART II||0
10094651|NCT02350309|11222999|FG002|STARTED|Treatment Period 3 (2 Days)||10
10094652|NCT02350309|11223000|FG003|STARTED|Treatment Period 3 (2 Days)||11
10094653|NCT02350309|11223001|FG004|STARTED|Treatment Period 3 (2 Days)||12
10094654|NCT02350309|11223002|FG005|STARTED|Treatment Period 3 (2 Days)||12
10094655|NCT02350309|11222997|FG000|COMPLETED|Treatment Period 3 (2 Days)||12
10094656|NCT02350309|11222998|FG001|COMPLETED|Treatment Period 3 (2 Days)||11
10094657|NCT02350309|11222999|FG002|COMPLETED|Treatment Period 3 (2 Days)||10
10094658|NCT02350309|11223000|FG003|COMPLETED|Treatment Period 3 (2 Days)||11
10094659|NCT02350309|11223001|FG004|COMPLETED|Treatment Period 3 (2 Days)||12
10094660|NCT02350309|11223002|FG005|COMPLETED|Treatment Period 3 (2 Days)||12
10094661|NCT02350309|11222997|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10094662|NCT02350309|11222998|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10094663|NCT02350309|11222999|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10094664|NCT02350309|11223000|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10094665|NCT02350309|11223001|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10094666|NCT02350309|11223002|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10094667|NCT02350309|11222997|FG000|STARTED|Washout Period 3 (12-16 Days)||12
10094668|NCT02350309|11222998|FG001|STARTED|Washout Period 3 (12-16 Days)||11
10094669|NCT02350309|11222999|FG002|STARTED|Washout Period 3 (12-16 Days)||10
10094670|NCT02350309|11223000|FG003|STARTED|Washout Period 3 (12-16 Days)||11
10094671|NCT02350309|11223001|FG004|STARTED|Washout Period 3 (12-16 Days)||12
10094672|NCT02350309|11223002|FG005|STARTED|Washout Period 3 (12-16 Days)||12
10094673|NCT02350309|11222997|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12
10094674|NCT02350309|11222998|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11
10094675|NCT02350309|11222999|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10
10094676|NCT02350309|11223000|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11
10094677|NCT02350309|11223001|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12
10094678|NCT02350309|11223002|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12
10094679|NCT02350309|11222997|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10094680|NCT02350309|11222998|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10094681|NCT02350309|11222999|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10094682|NCT02350309|11223000|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10094683|NCT02350309|11223001|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10094684|NCT02350309|11223002|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10094685|NCT02350309|11222997|FG000|STARTED|Treatment Period 4 (2 Days)||12
10094686|NCT02350309|11222998|FG001|STARTED|Treatment Period 4 (2 Days)||11
10094687|NCT02350309|11222999|FG002|STARTED|Treatment Period 4 (2 Days)||10
10094688|NCT02350309|11223000|FG003|STARTED|Treatment Period 4 (2 Days)||11
10094689|NCT02350309|11223001|FG004|STARTED|Treatment Period 4 (2 Days)||12
10094690|NCT02350309|11223002|FG005|STARTED|Treatment Period 4 (2 Days)||12
10094691|NCT02350309|11222997|FG000|COMPLETED|Treatment Period 4 (2 Days)||12
10094692|NCT02350309|11222998|FG001|COMPLETED|Treatment Period 4 (2 Days)||11
10094693|NCT02350309|11222999|FG002|COMPLETED|Treatment Period 4 (2 Days)||10
10094694|NCT02350309|11223000|FG003|COMPLETED|Treatment Period 4 (2 Days)||11
10094695|NCT02350309|11223001|FG004|COMPLETED|Treatment Period 4 (2 Days)||12
10094696|NCT02350309|11223002|FG005|COMPLETED|Treatment Period 4 (2 Days)||11
10094697|NCT02350309|11222997|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10094698|NCT02350309|11222998|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10094699|NCT02350309|11222999|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10094700|NCT02350309|11223000|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10094701|NCT02350309|11223001|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10094702|NCT02350309|11223002|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1
10094703|NCT02350478|11223019|FG000|STARTED|Overall Study||25
10094704|NCT02350478|11223020|FG001|STARTED|Overall Study||24
10094705|NCT02350478|11223019|FG000|COMPLETED|Overall Study||20
10094706|NCT02350478|11223020|FG001|COMPLETED|Overall Study||23
10094707|NCT02350478|11223019|FG000|NOT COMPLETED|Overall Study||5
10094708|NCT02350478|11223020|FG001|NOT COMPLETED|Overall Study||1
10094709|NCT02350569|11223026|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16
10094710|NCT02350569|11223026|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
10094711|NCT02350569|11223026|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
9866494|NCT00957372|10980060|FG001|Per-Protocol Population|PART II||0
9866495|NCT00957372|10980061|FG002|Per-Protocol Population|PART II||0
9866496|NCT00957372|10980062|FG003|Per-Protocol Population|PART II||108
9866497|NCT00957372|10980059|FG000|COMPLETED|PART II||0
10113443|NCT02509117|11244199|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
9866498|NCT00957372|10980060|FG001|COMPLETED|PART II||0
9866499|NCT00957372|10980061|FG002|COMPLETED|PART II||0
9866500|NCT00957372|10980062|FG003|COMPLETED|PART II||150
9866501|NCT00957372|10980059|FG000|NOT COMPLETED|PART II||0
9866502|NCT00957372|10980060|FG001|NOT COMPLETED|PART II||0
9866503|NCT00957372|10980061|FG002|NOT COMPLETED|PART II||0
9866504|NCT00957372|10980062|FG003|NOT COMPLETED|PART II||44
9866505|NCT00957424|10980078|FG000|STARTED|Overall Study||67
9866506|NCT00957424|10980078|FG000|Follow-up #1|Overall Study||59
9866507|NCT00957424|10980078|FG000|Follow-up #2|Overall Study||50
9866508|NCT00957424|10980078|FG000|COMPLETED|Overall Study||44
9866509|NCT00957424|10980078|FG000|NOT COMPLETED|Overall Study||23
9866510|NCT00957528|10980085|FG000|STARTED|Overall Study||8
9866511|NCT00957528|10980086|FG001|STARTED|Overall Study||9
9866512|NCT00957528|10980087|FG002|STARTED|Overall Study||9
9866513|NCT00957528|10980085|FG000|COMPLETED|Overall Study||8
9866514|NCT00957528|10980086|FG001|COMPLETED|Overall Study||8
9866515|NCT00957528|10980087|FG002|COMPLETED|Overall Study||8
9866516|NCT00957528|10980085|FG000|NOT COMPLETED|Overall Study||0
9866517|NCT00957528|10980086|FG001|NOT COMPLETED|Overall Study||1
9866518|NCT00957528|10980087|FG002|NOT COMPLETED|Overall Study||1
9866519|NCT00957580|10980098|FG000|STARTED|Overall Study||33
9866520|NCT00957580|10980099|FG001|STARTED|Overall Study||33
9866521|NCT00957580|10980100|FG002|STARTED|Overall Study||15
9866522|NCT00957580|10980098|FG000|Treated|Overall Study||33
10094712|NCT02350569|11223026|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
10094713|NCT02350569|11223026|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
10094714|NCT02350569|11223026|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
10094715|NCT02350647|11223034|FG000|STARTED|Overall Study||32
10094716|NCT02350647|11223035|FG001|STARTED|Overall Study||32
10094717|NCT02350647|11223034|FG000|COMPLETED|Overall Study||26
10094718|NCT02350647|11223035|FG001|COMPLETED|Overall Study||26
10094719|NCT02350647|11223034|FG000|NOT COMPLETED|Overall Study||6
10094720|NCT02350647|11223035|FG001|NOT COMPLETED|Overall Study||6
10094721|NCT02350660|11223043|FG000|STARTED|Overall Study||7
10094722|NCT02350660|11223044|FG001|STARTED|Overall Study||17
10094723|NCT02350660|11223043|FG000|COMPLETED|Overall Study||7
10094724|NCT02350660|11223044|FG001|COMPLETED|Overall Study||17
10094725|NCT02350660|11223043|FG000|NOT COMPLETED|Overall Study||0
10094726|NCT02350660|11223044|FG001|NOT COMPLETED|Overall Study||0
10094727|NCT02350816|11223054|FG000|STARTED|Overall Study||7
10094728|NCT02350816|11223055|FG001|STARTED|Overall Study||6
10094729|NCT02350816|11223056|FG002|STARTED|Overall Study||2
10094730|NCT02350816|11223057|FG003|STARTED|Overall Study||2
10094731|NCT02350816|11223054|FG000|COMPLETED|Overall Study||7
10094732|NCT02350816|11223055|FG001|COMPLETED|Overall Study||6
10094733|NCT02350816|11223056|FG002|COMPLETED|Overall Study||2
10094734|NCT02350816|11223057|FG003|COMPLETED|Overall Study||2
10094735|NCT02350816|11223054|FG000|NOT COMPLETED|Overall Study||0
10094736|NCT02350816|11223055|FG001|NOT COMPLETED|Overall Study||0
10094737|NCT02350816|11223056|FG002|NOT COMPLETED|Overall Study||0
10094738|NCT02350816|11223057|FG003|NOT COMPLETED|Overall Study||0
10094739|NCT02350881|11223067|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64
10094740|NCT02350881|11223067|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
10094741|NCT02350881|11223067|FG000|NOT COMPLETED|Overall Study||0
10094742|NCT02350998|11223092|FG000|STARTED|Overall Study||33
10094743|NCT02350998|11223092|FG000|COMPLETED|Overall Study||33
10094744|NCT02350998|11223092|FG000|NOT COMPLETED|Overall Study||0
10094745|NCT02351037|11223101|FG000|STARTED|Overall Study||7
10094746|NCT02351037|11223102|FG001|STARTED|Overall Study||21
10094747|NCT02351037|11223103|FG002|STARTED|Overall Study||8
10094748|NCT02351037|11223101|FG000|COMPLETED|Overall Study||7
10094749|NCT02351037|11223102|FG001|COMPLETED|Overall Study||21
10094750|NCT02351037|11223103|FG002|COMPLETED|Overall Study||8
10094751|NCT02351037|11223101|FG000|NOT COMPLETED|Overall Study||0
10094752|NCT02351037|11223102|FG001|NOT COMPLETED|Overall Study||0
10094753|NCT02351037|11223103|FG002|NOT COMPLETED|Overall Study||0
10094754|NCT02351115|11223116|FG000|STARTED|Overall Study||1
10094755|NCT02351115|11223117|FG001|STARTED|Overall Study||1
10094756|NCT02351115|11223118|FG002|STARTED|Overall Study||1
10094757|NCT02351115|11223119|FG003|STARTED|Overall Study||1
10094758|NCT02351115|11223120|FG004|STARTED|Overall Study||1
10094759|NCT02351115|11223116|FG000|COMPLETED|Overall Study||1
10094760|NCT02351115|11223117|FG001|COMPLETED|Overall Study||1
10094761|NCT02351115|11223118|FG002|COMPLETED|Overall Study||1
10094762|NCT02351115|11223119|FG003|COMPLETED|Overall Study||1
10094763|NCT02351115|11223120|FG004|COMPLETED|Overall Study||1
10094764|NCT02351115|11223116|FG000|NOT COMPLETED|Overall Study||0
10094765|NCT02351115|11223117|FG001|NOT COMPLETED|Overall Study||0
10094766|NCT02351115|11223118|FG002|NOT COMPLETED|Overall Study||0
9866523|NCT00957580|10980099|FG001|Treated|Overall Study||32
9866524|NCT00957580|10980100|FG002|Treated|Overall Study||15
9866525|NCT00957580|10980098|FG000|COMPLETED|Overall Study||33
10094767|NCT02351115|11223119|FG003|NOT COMPLETED|Overall Study||0
9866526|NCT00957580|10980099|FG001|COMPLETED|Overall Study||31
9866527|NCT00957580|10980100|FG002|COMPLETED|Overall Study||15
9866528|NCT00957580|10980098|FG000|NOT COMPLETED|Overall Study||0
9866529|NCT00957580|10980099|FG001|NOT COMPLETED|Overall Study||2
10094768|NCT02351115|11223120|FG004|NOT COMPLETED|Overall Study||0
10094769|NCT02351167|11223136|FG000|STARTED|Overall Study||275
10094770|NCT02351167|11223137|FG001|STARTED|Overall Study||274
10094771|NCT02351167|11223138|FG002|STARTED|Overall Study||273
9866530|NCT00957580|10980100|FG002|NOT COMPLETED|Overall Study||0
9866531|NCT00957593|10980123|FG000|STARTED|Overall Study||127
9866532|NCT00957593|10980124|FG001|STARTED|Overall Study||125
9866533|NCT00957593|10980123|FG000|COMPLETED|Overall Study||127
9866534|NCT00957593|10980124|FG001|COMPLETED|Overall Study||125
9866535|NCT00957593|10980123|FG000|NOT COMPLETED|Overall Study||0
9866536|NCT00957593|10980124|FG001|NOT COMPLETED|Overall Study||0
9866537|NCT00957658|10980132|FG000|STARTED|Overall Study||234
9866538|NCT00957658|10980132|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
9866539|NCT00957658|10980132|FG000|NOT COMPLETED|Overall Study||65
9866540|NCT00957671|10980138|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15
9866541|NCT00957671|10980138|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
9866542|NCT00957671|10980138|FG000|NOT COMPLETED|Overall Study||0
9866543|NCT00957684|10980147|FG000|STARTED|PART I||102
9866544|NCT00957684|10980148|FG001|STARTED|PART I||98
9866545|NCT00957684|10980149|FG002|STARTED|PART I||100
9866546|NCT00957684|10980150|FG003|STARTED|PART I||102
9866547|NCT00957684|10980151|FG004|STARTED|PART I||0
9866548|NCT00957684|10980147|FG000|Randomised (Safety Population)|PART I||102
9866549|NCT00957684|10980148|FG001|Randomised (Safety Population)|PART I||98
10094772|NCT02351167|11223136|FG000|COMPLETED|Overall Study||256
10094773|NCT02351167|11223137|FG001|COMPLETED|Overall Study||256
10094774|NCT02351167|11223138|FG002|COMPLETED|Overall Study||252
10094775|NCT02351167|11223136|FG000|NOT COMPLETED|Overall Study||19
10094776|NCT02351167|11223137|FG001|NOT COMPLETED|Overall Study||18
10094777|NCT02351167|11223138|FG002|NOT COMPLETED|Overall Study||21
10094778|NCT02351258|11223147|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094779|NCT02351258|11223148|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094780|NCT02351258|11223147|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094781|NCT02351258|11223148|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094782|NCT02351258|11223147|FG000|NOT COMPLETED|Intervention 1 (12 Months)||
10094783|NCT02351258|11223148|FG001|NOT COMPLETED|Intervention 1 (12 Months)||
10094784|NCT02351258|11223147|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094785|NCT02351258|11223148|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094786|NCT02351258|11223147|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094787|NCT02351258|11223148|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094788|NCT02351258|11223147|FG000|NOT COMPLETED|Washout (2-3 Months)||
10094789|NCT02351258|11223148|FG001|NOT COMPLETED|Washout (2-3 Months)||
10094790|NCT02351258|11223147|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094791|NCT02351258|11223148|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094792|NCT02351258|11223147|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094793|NCT02351258|11223148|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10094794|NCT02351258|11223147|FG000|NOT COMPLETED|Intervention 2 (12 Months)||
10094795|NCT02351258|11223148|FG001|NOT COMPLETED|Intervention 2 (12 Months)||
10094796|NCT02351271|11223155|FG000|STARTED|Overall Study||68
10094797|NCT02351271|11223156|FG001|STARTED|Overall Study||62
10094798|NCT02351271|11223155|FG000|COMPLETED|Overall Study||68
10094799|NCT02351271|11223156|FG001|COMPLETED|Overall Study||62
10094800|NCT02351271|11223155|FG000|NOT COMPLETED|Overall Study||0
10094801|NCT02351271|11223156|FG001|NOT COMPLETED|Overall Study||0
10094802|NCT02351349|11223166|FG000|STARTED|Overall Study||6
10094803|NCT02351349|11223167|FG001|STARTED|Overall Study||8
10094804|NCT02351349|11223166|FG000|COMPLETED|Overall Study||4
10094805|NCT02351349|11223167|FG001|COMPLETED|Overall Study||5
10094806|NCT02351349|11223166|FG000|NOT COMPLETED|Overall Study||2
10094807|NCT02351349|11223167|FG001|NOT COMPLETED|Overall Study||3
10094808|NCT02351505|11223178|FG000|STARTED|Overall Study||1
10094809|NCT02351505|11223178|FG000|COMPLETED|Overall Study||1
10094810|NCT02351505|11223178|FG000|NOT COMPLETED|Overall Study||0
10094811|NCT02351700|11223185|FG000|STARTED|Overall Study||28
10094812|NCT02351700|11223186|FG001|STARTED|Overall Study||34
10094813|NCT02351700|11223185|FG000|COMPLETED|Overall Study||28
10094814|NCT02351700|11223186|FG001|COMPLETED|Overall Study||34
10094815|NCT02351700|11223185|FG000|NOT COMPLETED|Overall Study||0
9866550|NCT00957684|10980149|FG002|Randomised (Safety Population)|PART I||100
9866551|NCT00957684|10980150|FG003|Randomised (Safety Population)|PART I||102
9866552|NCT00957684|10980151|FG004|Randomised (Safety Population)|PART I||0
9866553|NCT00957684|10980147|FG000|Intention-to-treat (ITT) Population|PART I||98
9866554|NCT00957684|10980148|FG001|Intention-to-treat (ITT) Population|PART I||98
9866555|NCT00957684|10980149|FG002|Intention-to-treat (ITT) Population|PART I||99
10094816|NCT02351700|11223186|FG001|NOT COMPLETED|Overall Study||0
10094817|NCT02351739|11223196|FG000|STARTED|Overall Study||38
10094818|NCT02351739|11223197|FG001|STARTED|Overall Study||40
10094819|NCT02351739|11223196|FG000|Enrolled|Overall Study||38
10094820|NCT02351739|11223197|FG001|Enrolled|Overall Study||40
9866556|NCT00957684|10980150|FG003|Intention-to-treat (ITT) Population|PART I||102
9866557|NCT00957684|10980151|FG004|Intention-to-treat (ITT) Population|PART I||0
9866558|NCT00957684|10980147|FG000|Per-protocol (PP)Population|PART I||72
9866559|NCT00957684|10980148|FG001|Per-protocol (PP)Population|PART I||86
9866560|NCT00957684|10980149|FG002|Per-protocol (PP)Population|PART I||94
9866561|NCT00957684|10980150|FG003|Per-protocol (PP)Population|PART I||91
9866562|NCT00957684|10980151|FG004|Per-protocol (PP)Population|PART I||0
9866563|NCT00957684|10980147|FG000|COMPLETED|PART I||71
9866564|NCT00957684|10980148|FG001|COMPLETED|PART I||85
9866565|NCT00957684|10980149|FG002|COMPLETED|PART I||90
9866566|NCT00957684|10980150|FG003|COMPLETED|PART I||84
9866567|NCT00957684|10980151|FG004|COMPLETED|PART I||0
9866568|NCT00957684|10980147|FG000|NOT COMPLETED|PART I||31
9866569|NCT00957684|10980148|FG001|NOT COMPLETED|PART I||13
9866570|NCT00957684|10980149|FG002|NOT COMPLETED|PART I||10
9866571|NCT00957684|10980150|FG003|NOT COMPLETED|PART I||18
9866572|NCT00957684|10980151|FG004|NOT COMPLETED|PART I||0
9866573|NCT00957684|10980147|FG000|STARTED|PART II||0
9866574|NCT00957684|10980148|FG001|STARTED|PART II||0
9866575|NCT00957684|10980149|FG002|STARTED|PART II||0
9866576|NCT00957684|10980150|FG003|STARTED|PART II||0
9866577|NCT00957684|10980151|FG004|STARTED|PART II||314
9866578|NCT00957684|10980147|FG000|Patients Entered Part II|PART II||0
9866579|NCT00957684|10980148|FG001|Patients Entered Part II|PART II||0
9866580|NCT00957684|10980149|FG002|Patients Entered Part II|PART II||0
9866581|NCT00957684|10980150|FG003|Patients Entered Part II|PART II||0
9866582|NCT00957684|10980151|FG004|Patients Entered Part II|PART II||314
9866583|NCT00957684|10980147|FG000|COMPLETED|PART II||0
9866584|NCT00957684|10980148|FG001|COMPLETED|PART II||0
9866585|NCT00957684|10980149|FG002|COMPLETED|PART II||0
9866586|NCT00957684|10980150|FG003|COMPLETED|PART II||0
9866587|NCT00957684|10980151|FG004|COMPLETED|PART II||239
9866588|NCT00957684|10980147|FG000|NOT COMPLETED|PART II||0
9866589|NCT00957684|10980148|FG001|NOT COMPLETED|PART II||0
9866590|NCT00957684|10980149|FG002|NOT COMPLETED|PART II||0
9866591|NCT00957684|10980150|FG003|NOT COMPLETED|PART II||0
9866592|NCT00957684|10980151|FG004|NOT COMPLETED|PART II||75
9866593|NCT00957723|10980161|FG000|STARTED|Overall Study||411
9866594|NCT00957723|10980161|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
9866595|NCT00957723|10980161|FG000|NOT COMPLETED|Overall Study||113
9866596|NCT00957801|10980171|FG000|STARTED|Overall Study||7
9866597|NCT00957801|10980172|FG001|STARTED|Overall Study||7
9866598|NCT00957801|10980173|FG002|STARTED|Overall Study||7
9866599|NCT00957801|10980174|FG003|STARTED|Overall Study||8
9866600|NCT00957801|10980171|FG000|COMPLETED|Overall Study||7
9866601|NCT00957801|10980172|FG001|COMPLETED|Overall Study||7
9866602|NCT00957801|10980173|FG002|COMPLETED|Overall Study||7
9866603|NCT00957801|10980174|FG003|COMPLETED|Overall Study||7
9866604|NCT00957801|10980171|FG000|NOT COMPLETED|Overall Study||0
9866605|NCT00957801|10980172|FG001|NOT COMPLETED|Overall Study||0
9866606|NCT00957801|10980173|FG002|NOT COMPLETED|Overall Study||0
9866607|NCT00957801|10980174|FG003|NOT COMPLETED|Overall Study||1
9866608|NCT00957853|10980187|FG000|STARTED|Overall Study||4
9866609|NCT00957853|10980188|FG001|STARTED|Overall Study||6
9866610|NCT00957853|10980189|FG002|STARTED|Overall Study||5
9866611|NCT00957853|10980187|FG000|Randomization|Overall Study||4
9866612|NCT00957853|10980188|FG001|Randomization|Overall Study||6
9866613|NCT00957853|10980189|FG002|Randomization|Overall Study||5
9866614|NCT00957853|10980187|FG000|Neoadjuvant Tx Completion|Overall Study||3
9866615|NCT00957853|10980188|FG001|Neoadjuvant Tx Completion|Overall Study||6
9866616|NCT00957853|10980189|FG002|Neoadjuvant Tx Completion|Overall Study||5
9866617|NCT00957853|10980187|FG000|COMPLETED|Overall Study||3
9866618|NCT00957853|10980188|FG001|COMPLETED|Overall Study||6
9866619|NCT00957853|10980189|FG002|COMPLETED|Overall Study||5
9866620|NCT00957853|10980187|FG000|NOT COMPLETED|Overall Study||1
9866621|NCT00957853|10980188|FG001|NOT COMPLETED|Overall Study||0
9866622|NCT00957853|10980189|FG002|NOT COMPLETED|Overall Study||0
9866623|NCT00957905|10980199|FG000|STARTED|Part A||7
9866624|NCT00957905|10980200|FG001|STARTED|Part A||0
9866625|NCT00957905|10980199|FG000|COMPLETED|Part A||7
9866626|NCT00957905|10980200|FG001|COMPLETED|Part A||0
9866627|NCT00957905|10980199|FG000|NOT COMPLETED|Part A||0
9866628|NCT00957905|10980200|FG001|NOT COMPLETED|Part A||0
9866629|NCT00957905|10980199|FG000|STARTED|Part B||0
9866630|NCT00957905|10980200|FG001|STARTED|Part B||29
9866631|NCT00957905|10980199|FG000|COMPLETED|Part B||0
9866632|NCT00957905|10980200|FG001|COMPLETED|Part B||25
9866633|NCT00957905|10980199|FG000|NOT COMPLETED|Part B||0
9866634|NCT00957905|10980200|FG001|NOT COMPLETED|Part B||4
9866635|NCT00957931|10980206|FG000|STARTED|Overall Study||6
9866636|NCT00957931|10980206|FG000|COMPLETED|Overall Study||2
9866637|NCT00957931|10980206|FG000|NOT COMPLETED|Overall Study||4
9866638|NCT00957944|10980212|FG000|STARTED|First Intervention- 24 Hours||20
9866639|NCT00957944|10980213|FG001|STARTED|First Intervention- 24 Hours||20
9866640|NCT00957944|10980212|FG000|COMPLETED|First Intervention- 24 Hours||20
9866641|NCT00957944|10980213|FG001|COMPLETED|First Intervention- 24 Hours||19
9866642|NCT00957944|10980212|FG000|NOT COMPLETED|First Intervention- 24 Hours||0
9866643|NCT00957944|10980213|FG001|NOT COMPLETED|First Intervention- 24 Hours||1
9866644|NCT00957944|10980212|FG000|STARTED|Washout Period of at Least 5 Days||20
9866645|NCT00957944|10980213|FG001|STARTED|Washout Period of at Least 5 Days||19
9866646|NCT00957944|10980212|FG000|COMPLETED|Washout Period of at Least 5 Days||20
9866647|NCT00957944|10980213|FG001|COMPLETED|Washout Period of at Least 5 Days||19
9866648|NCT00957944|10980212|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0
9866649|NCT00957944|10980213|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0
9866650|NCT00957944|10980212|FG000|STARTED|Second Intervention- 24 Hours||20
9866651|NCT00957944|10980213|FG001|STARTED|Second Intervention- 24 Hours||19
9866652|NCT00957944|10980212|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
9866653|NCT00957944|10980213|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
9866654|NCT00957944|10980212|FG000|COMPLETED|Second Intervention- 24 Hours||20
9866655|NCT00957944|10980213|FG001|COMPLETED|Second Intervention- 24 Hours||19
9866656|NCT00957944|10980212|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0
9866657|NCT00957944|10980213|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0
9866658|NCT00957996|10980221|FG000|STARTED|Overall Study||117
9866659|NCT00957996|10980222|FG001|STARTED|Overall Study||117
9866660|NCT00957996|10980221|FG000|COMPLETED|Overall Study||91
9866661|NCT00957996|10980222|FG001|COMPLETED|Overall Study||89
9866662|NCT00957996|10980221|FG000|NOT COMPLETED|Overall Study||26
9866663|NCT00957996|10980222|FG001|NOT COMPLETED|Overall Study||28
10094821|NCT02351739|11223196|FG000|Received Study Medication|Overall Study||35
10094822|NCT02351739|11223197|FG001|Received Study Medication|Overall Study||40
10094823|NCT02351739|11223196|FG000|Discontinued Study|Overall Study||38
10094824|NCT02351739|11223197|FG001|Discontinued Study|Overall Study||40
10094825|NCT02351739|11223196|FG000|COMPLETED|Overall Study||0
10094826|NCT02351739|11223197|FG001|COMPLETED|Overall Study||0
10094827|NCT02351739|11223196|FG000|NOT COMPLETED|Overall Study||38
10201892|NCT03441984|11329286|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201893|NCT03441984|11329287|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201894|NCT03441984|11329276|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201895|NCT03441984|11329277|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201896|NCT03441984|11329278|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201897|NCT03441984|11329279|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201898|NCT03441984|11329280|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201899|NCT03441984|11329281|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201900|NCT03441984|11329282|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201901|NCT03441984|11329283|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201902|NCT03441984|11329284|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201903|NCT03441984|11329285|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201904|NCT03441984|11329286|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201905|NCT03441984|11329287|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10201906|NCT03441984|11329276|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10201907|NCT03441984|11329277|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10201908|NCT03441984|11329278|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10201909|NCT03441984|11329279|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10201910|NCT03441984|11329280|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10201911|NCT03441984|11329281|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10201912|NCT03441984|11329282|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10201913|NCT03441984|11329283|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10201914|NCT03441984|11329284|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10201915|NCT03441984|11329285|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10201916|NCT03441984|11329286|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10201917|NCT03441984|11329287|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10201918|NCT03441984|11329276|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10201919|NCT03441984|11329277|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10201920|NCT03441984|11329278|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
10201921|NCT03441984|11329279|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10201922|NCT03441984|11329280|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10201923|NCT03441984|11329281|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10201924|NCT03441984|11329282|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201925|NCT03441984|11329283|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201926|NCT03441984|11329284|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201927|NCT03441984|11329285|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201928|NCT03441984|11329286|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201929|NCT03441984|11329287|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201930|NCT03441984|11329276|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201931|NCT03441984|11329277|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201932|NCT03441984|11329278|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
10201933|NCT03441984|11329279|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9866664|NCT00958009|10980230|FG000|STARTED|Overall Study||109
9866665|NCT00958009|10980230|FG000|COMPLETED|Overall Study||107
9866666|NCT00958009|10980230|FG000|NOT COMPLETED|Overall Study||2
9866667|NCT00958035|10980236|FG000|STARTED|Overall Study||46
9866668|NCT00958035|10980237|FG001|STARTED|Overall Study||43
9866669|NCT00958035|10980236|FG000|COMPLETED|Overall Study||43
9866670|NCT00958035|10980237|FG001|COMPLETED|Overall Study||39
9866671|NCT00958035|10980236|FG000|NOT COMPLETED|Overall Study||3
9866672|NCT00958035|10980237|FG001|NOT COMPLETED|Overall Study||4
10094828|NCT02351739|11223197|FG001|NOT COMPLETED|Overall Study||40
10094829|NCT02351817|11223203|FG000|STARTED|Baseline Period||5
10201934|NCT03441984|11329280|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201935|NCT03441984|11329281|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9866673|NCT00958074|10980245|FG000|STARTED|Overall Study||4
9866674|NCT00958074|10980246|FG001|STARTED|Overall Study||7
9866675|NCT00958074|10980245|FG000|COMPLETED|Overall Study||4
9866676|NCT00958074|10980246|FG001|COMPLETED|Overall Study||6
9866677|NCT00958074|10980245|FG000|NOT COMPLETED|Overall Study||0
9866678|NCT00958074|10980246|FG001|NOT COMPLETED|Overall Study||1
9866679|NCT00958126|10980260|FG000|STARTED|Overall Study||49
9866680|NCT00958126|10980261|FG001|STARTED|Overall Study||205
9866681|NCT00958126|10980262|FG002|STARTED|Overall Study||201
9866682|NCT00958126|10980263|FG003|STARTED|Overall Study||203
9866683|NCT00958126|10980264|FG004|STARTED|Overall Study||50
9866684|NCT00958126|10980265|FG005|STARTED|Overall Study||203
9866685|NCT00958126|10980266|FG006|STARTED|Overall Study||200
10094830|NCT02351817|11223204|FG001|STARTED|Baseline Period||5
10094831|NCT02351817|11223203|FG000|COMPLETED|Baseline Period||5
10094832|NCT02351817|11223204|FG001|COMPLETED|Baseline Period||5
10094833|NCT02351817|11223203|FG000|NOT COMPLETED|Baseline Period||0
10094834|NCT02351817|11223204|FG001|NOT COMPLETED|Baseline Period||0
9866686|NCT00958126|10980267|FG007|STARTED|Overall Study||202
9866687|NCT00958126|10980260|FG000|COMPLETED|Overall Study||48
9866688|NCT00958126|10980261|FG001|COMPLETED|Overall Study||196
9866689|NCT00958126|10980262|FG002|COMPLETED|Overall Study||191
9866690|NCT00958126|10980263|FG003|COMPLETED|Overall Study||192
9866691|NCT00958126|10980264|FG004|COMPLETED|Overall Study||50
9866692|NCT00958126|10980265|FG005|COMPLETED|Overall Study||202
9866693|NCT00958126|10980266|FG006|COMPLETED|Overall Study||199
9866694|NCT00958126|10980267|FG007|COMPLETED|Overall Study||202
9866695|NCT00958126|10980260|FG000|NOT COMPLETED|Overall Study||1
9866696|NCT00958126|10980261|FG001|NOT COMPLETED|Overall Study||9
9866697|NCT00958126|10980262|FG002|NOT COMPLETED|Overall Study||10
9866698|NCT00958126|10980263|FG003|NOT COMPLETED|Overall Study||11
9866699|NCT00958126|10980264|FG004|NOT COMPLETED|Overall Study||0
9866700|NCT00958126|10980265|FG005|NOT COMPLETED|Overall Study||1
9866701|NCT00958126|10980266|FG006|NOT COMPLETED|Overall Study||1
9866702|NCT00958126|10980267|FG007|NOT COMPLETED|Overall Study||0
9866703|NCT00958165|10980289|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
9866704|NCT00958165|10980289|FG000|Treated|Overall Study||72
9866705|NCT00958165|10980289|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
9866706|NCT00958165|10980289|FG000|NOT COMPLETED|Overall Study||14
9866707|NCT00958191|10980293|FG000|STARTED|Overall Study||221
9866708|NCT00958191|10980293|FG000|COMPLETED|Overall Study||110
9866709|NCT00958191|10980293|FG000|NOT COMPLETED|Overall Study||111
9866710|NCT00958217|10980301|FG000|STARTED|Overall Study||61
9866711|NCT00958217|10980302|FG001|STARTED|Overall Study||62
9866712|NCT00958217|10980301|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
9866713|NCT00958217|10980302|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
9866714|NCT00958217|10980301|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
9866715|NCT00958217|10980302|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
9866716|NCT00958217|10980301|FG000|NOT COMPLETED|Overall Study||24
9866717|NCT00958217|10980302|FG001|NOT COMPLETED|Overall Study||25
9866718|NCT00958243|10980315|FG000|STARTED|Overall Study||26
9866719|NCT00958243|10980316|FG001|STARTED|Overall Study||105
9866720|NCT00958243|10980317|FG002|STARTED|Overall Study||96
9866721|NCT00958243|10980318|FG003|STARTED|Overall Study||28
9866722|NCT00958243|10980319|FG004|STARTED|Overall Study||109
9866723|NCT00958243|10980320|FG005|STARTED|Overall Study||109
9866724|NCT00958243|10980315|FG000|COMPLETED|Overall Study||24
9866725|NCT00958243|10980316|FG001|COMPLETED|Overall Study||99
9866726|NCT00958243|10980317|FG002|COMPLETED|Overall Study||82
9866727|NCT00958243|10980318|FG003|COMPLETED|Overall Study||25
9866728|NCT00958243|10980319|FG004|COMPLETED|Overall Study||100
9866729|NCT00958243|10980320|FG005|COMPLETED|Overall Study||99
9866730|NCT00958243|10980315|FG000|NOT COMPLETED|Overall Study||2
9866731|NCT00958243|10980316|FG001|NOT COMPLETED|Overall Study||6
9866732|NCT00958243|10980317|FG002|NOT COMPLETED|Overall Study||14
9866733|NCT00958243|10980318|FG003|NOT COMPLETED|Overall Study||3
9866734|NCT00958243|10980319|FG004|NOT COMPLETED|Overall Study||9
9866735|NCT00958243|10980320|FG005|NOT COMPLETED|Overall Study||10
9866736|NCT00958256|10980340|FG000|STARTED|Overall Study||21
9866737|NCT00958256|10980340|FG000|COMPLETED|Overall Study||18
9866738|NCT00958256|10980340|FG000|NOT COMPLETED|Overall Study||3
9866739|NCT00958282|10980346|FG000|STARTED|Overall Study||22
9866740|NCT00958282|10980347|FG001|STARTED|Overall Study||21
9866741|NCT00958282|10980346|FG000|COMPLETED|Overall Study||12
9866742|NCT00958282|10980347|FG001|COMPLETED|Overall Study||15
9866743|NCT00958282|10980346|FG000|NOT COMPLETED|Overall Study||10
9866744|NCT00958282|10980347|FG001|NOT COMPLETED|Overall Study||6
9866745|NCT00958308|10980356|FG000|STARTED|Overall Study||84
9866746|NCT00958308|10980357|FG001|STARTED|Overall Study||85
9866747|NCT00958308|10980358|FG002|STARTED|Overall Study||86
9866748|NCT00958308|10980356|FG000|COMPLETED|Overall Study||84
9866749|NCT00958308|10980357|FG001|COMPLETED|Overall Study||85
9866750|NCT00958308|10980358|FG002|COMPLETED|Overall Study||86
9866751|NCT00958308|10980356|FG000|NOT COMPLETED|Overall Study||0
10094835|NCT02351817|11223203|FG000|STARTED|Period 1||5
10094836|NCT02351817|11223204|FG001|STARTED|Period 1||5
10094837|NCT02351817|11223203|FG000|COMPLETED|Period 1||4
10094838|NCT02351817|11223204|FG001|COMPLETED|Period 1||2
9866752|NCT00958308|10980357|FG001|NOT COMPLETED|Overall Study||0
9866753|NCT00958308|10980358|FG002|NOT COMPLETED|Overall Study||0
9866754|NCT00958334|10980369|FG000|STARTED|Overall Study||22
9866755|NCT00958334|10980370|FG001|STARTED|Overall Study||22
9866756|NCT00958334|10980371|FG002|STARTED|Overall Study||21
9866757|NCT00958334|10980369|FG000|COMPLETED|Overall Study||8
9866758|NCT00958334|10980370|FG001|COMPLETED|Overall Study||5
9866759|NCT00958334|10980371|FG002|COMPLETED|Overall Study||8
9866760|NCT00958334|10980369|FG000|NOT COMPLETED|Overall Study||14
9866761|NCT00958334|10980370|FG001|NOT COMPLETED|Overall Study||17
9866762|NCT00958334|10980371|FG002|NOT COMPLETED|Overall Study||13
9866763|NCT00958360|10980381|FG000|STARTED|Overall Study||163
9866764|NCT00958360|10980382|FG001|STARTED|Overall Study||160
9866765|NCT00958360|10980381|FG000|COMPLETED|Overall Study||152
9866766|NCT00958360|10980382|FG001|COMPLETED|Overall Study||150
9866767|NCT00958360|10980381|FG000|NOT COMPLETED|Overall Study||11
9866768|NCT00958360|10980382|FG001|NOT COMPLETED|Overall Study||10
9866769|NCT00958412|10980388|FG000|STARTED|Overall Study||18
9866770|NCT00958412|10980388|FG000|COMPLETED|Overall Study||0
9866771|NCT00958412|10980388|FG000|NOT COMPLETED|Overall Study||18
9866772|NCT00958438|10980395|FG000|STARTED|Overall Study||82
9866773|NCT00958438|10980396|FG001|STARTED|Overall Study||82
9866774|NCT00958438|10980397|FG002|STARTED|Overall Study||84
9866775|NCT00958438|10980395|FG000|COMPLETED|Overall Study||72
9866776|NCT00958438|10980396|FG001|COMPLETED|Overall Study||72
9866777|NCT00958438|10980397|FG002|COMPLETED|Overall Study||78
9866778|NCT00958438|10980395|FG000|NOT COMPLETED|Overall Study||10
9866779|NCT00958438|10980396|FG001|NOT COMPLETED|Overall Study||10
9866780|NCT00958438|10980397|FG002|NOT COMPLETED|Overall Study||6
10094839|NCT02351817|11223203|FG000|NOT COMPLETED|Period 1||1
10094840|NCT02351817|11223204|FG001|NOT COMPLETED|Period 1||3
10094841|NCT02351817|11223203|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
10094842|NCT02351817|11223204|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
10094843|NCT02351817|11223203|FG000|COMPLETED|Period 2||4
10094844|NCT02351817|11223204|FG001|COMPLETED|Period 2||3
10094845|NCT02351817|11223203|FG000|NOT COMPLETED|Period 2||1
10094846|NCT02351817|11223204|FG001|NOT COMPLETED|Period 2||2
10094847|NCT02351934|11223213|FG000|STARTED|Allocation||62
10094848|NCT02351934|11223214|FG001|STARTED|Allocation||61
10094849|NCT02351934|11223213|FG000|Received Allocation|Allocation||56
10094850|NCT02351934|11223214|FG001|Received Allocation|Allocation||61
10094851|NCT02351934|11223213|FG000|COMPLETED|Allocation||56
10094852|NCT02351934|11223214|FG001|COMPLETED|Allocation||61
10094853|NCT02351934|11223213|FG000|NOT COMPLETED|Allocation||6
10094854|NCT02351934|11223214|FG001|NOT COMPLETED|Allocation||0
10094855|NCT02351934|11223213|FG000|STARTED|Follow-Up||56
10094856|NCT02351934|11223214|FG001|STARTED|Follow-Up||61
10094857|NCT02351934|11223213|FG000|COMPLETED|Follow-Up||44
10094858|NCT02351934|11223214|FG001|COMPLETED|Follow-Up||51
10094859|NCT02351934|11223213|FG000|NOT COMPLETED|Follow-Up||12
10094860|NCT02351934|11223214|FG001|NOT COMPLETED|Follow-Up||10
10094861|NCT02351960|11223222|FG000|STARTED|Overall Study||208
10094862|NCT02351960|11223223|FG001|STARTED|Overall Study||88
10094863|NCT02351960|11223222|FG000|COMPLETED|Overall Study||197
10094864|NCT02351960|11223223|FG001|COMPLETED|Overall Study||76
10094865|NCT02351960|11223222|FG000|NOT COMPLETED|Overall Study||11
10094866|NCT02351960|11223223|FG001|NOT COMPLETED|Overall Study||12
10094867|NCT02352259|11223230|FG000|STARTED|Overall Study||23
10094868|NCT02352259|11223230|FG000|COMPLETED|Overall Study||23
10094869|NCT02352259|11223230|FG000|NOT COMPLETED|Overall Study||0
10094870|NCT02352298|11223234|FG000|STARTED|Overall Study||52
10094871|NCT02352298|11223234|FG000|COMPLETED|Overall Study||52
10094872|NCT02352298|11223234|FG000|NOT COMPLETED|Overall Study||0
10094873|NCT02352363|11223241|FG000|STARTED|Overall Study||278
10094874|NCT02352363|11223242|FG001|STARTED|Overall Study||130
10094875|NCT02352363|11223241|FG000|COMPLETED|Overall Study||271
10094876|NCT02352363|11223242|FG001|COMPLETED|Overall Study||127
10094877|NCT02352363|11223241|FG000|NOT COMPLETED|Overall Study||7
10094878|NCT02352363|11223242|FG001|NOT COMPLETED|Overall Study||3
10094879|NCT02352493|11223266|FG000|STARTED|Overall Study||8
10094880|NCT02352493|11223267|FG001|STARTED|Overall Study||3
10094881|NCT02352493|11223268|FG002|STARTED|Overall Study||3
10094882|NCT02352493|11223269|FG003|STARTED|Overall Study||3
10094883|NCT02352493|11223270|FG004|STARTED|Overall Study||3
10094884|NCT02352493|11223271|FG005|STARTED|Overall Study||3
10094885|NCT02352493|11223272|FG006|STARTED|Overall Study||3
10094886|NCT02352493|11223273|FG007|STARTED|Overall Study||3
10094887|NCT02352493|11223274|FG008|STARTED|Overall Study||3
10094888|NCT02352493|11223275|FG009|STARTED|Overall Study||6
10094889|NCT02352493|11223276|FG010|STARTED|Overall Study||3
10094890|NCT02352493|11223277|FG011|STARTED|Overall Study||3
9866781|NCT00958477|10980409|FG000|STARTED|Overall Study||8
9866782|NCT00958477|10980410|FG001|STARTED|Overall Study||6
9866783|NCT00958477|10980411|FG002|STARTED|Overall Study||6
9866784|NCT00958477|10980412|FG003|STARTED|Overall Study||6
9866785|NCT00958477|10980409|FG000|COMPLETED|Overall Study||8
9866786|NCT00958477|10980410|FG001|COMPLETED|Overall Study||6
9866787|NCT00958477|10980411|FG002|COMPLETED|Overall Study||6
10094891|NCT02352493|11223278|FG012|STARTED|Overall Study||3
10094892|NCT02352493|11223279|FG013|STARTED|Overall Study||3
10094893|NCT02352493|11223280|FG014|STARTED|Overall Study||3
10094894|NCT02352493|11223281|FG015|STARTED|Overall Study||3
10094895|NCT02352493|11223282|FG016|STARTED|Overall Study||3
9866788|NCT00958477|10980412|FG003|COMPLETED|Overall Study||6
9866789|NCT00958477|10980409|FG000|NOT COMPLETED|Overall Study||0
9866790|NCT00958477|10980410|FG001|NOT COMPLETED|Overall Study||0
9866791|NCT00958477|10980411|FG002|NOT COMPLETED|Overall Study||0
9866792|NCT00958477|10980412|FG003|NOT COMPLETED|Overall Study||0
9866793|NCT00958568|10980428|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892
9866794|NCT00958568|10980429|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0
9866795|NCT00958568|10980430|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0
10094896|NCT02352493|11223283|FG017|STARTED|Overall Study||3
10094897|NCT02352493|11223266|FG000|COMPLETED|Overall Study||8
10094898|NCT02352493|11223267|FG001|COMPLETED|Overall Study||3
10094899|NCT02352493|11223268|FG002|COMPLETED|Overall Study||3
10094900|NCT02352493|11223269|FG003|COMPLETED|Overall Study||3
10094901|NCT02352493|11223270|FG004|COMPLETED|Overall Study||3
10094902|NCT02352493|11223271|FG005|COMPLETED|Overall Study||3
10094903|NCT02352493|11223272|FG006|COMPLETED|Overall Study||2
10094904|NCT02352493|11223273|FG007|COMPLETED|Overall Study||3
10094905|NCT02352493|11223274|FG008|COMPLETED|Overall Study||1
10094906|NCT02352493|11223275|FG009|COMPLETED|Overall Study||5
10094907|NCT02352493|11223276|FG010|COMPLETED|Overall Study||3
10094908|NCT02352493|11223277|FG011|COMPLETED|Overall Study||3
10094909|NCT02352493|11223278|FG012|COMPLETED|Overall Study||2
10094910|NCT02352493|11223279|FG013|COMPLETED|Overall Study||1
10094911|NCT02352493|11223280|FG014|COMPLETED|Overall Study||2
10094912|NCT02352493|11223281|FG015|COMPLETED|Overall Study||3
10094913|NCT02352493|11223282|FG016|COMPLETED|Overall Study||3
10094914|NCT02352493|11223283|FG017|COMPLETED|Overall Study||3
10094915|NCT02352493|11223266|FG000|NOT COMPLETED|Overall Study||0
10094916|NCT02352493|11223267|FG001|NOT COMPLETED|Overall Study||0
10094917|NCT02352493|11223268|FG002|NOT COMPLETED|Overall Study||0
10094918|NCT02352493|11223269|FG003|NOT COMPLETED|Overall Study||0
10094919|NCT02352493|11223270|FG004|NOT COMPLETED|Overall Study||0
10094920|NCT02352493|11223271|FG005|NOT COMPLETED|Overall Study||0
10094921|NCT02352493|11223272|FG006|NOT COMPLETED|Overall Study||1
10094922|NCT02352493|11223273|FG007|NOT COMPLETED|Overall Study||0
10094923|NCT02352493|11223274|FG008|NOT COMPLETED|Overall Study||2
10094924|NCT02352493|11223275|FG009|NOT COMPLETED|Overall Study||1
10094925|NCT02352493|11223276|FG010|NOT COMPLETED|Overall Study||0
10094926|NCT02352493|11223277|FG011|NOT COMPLETED|Overall Study||0
10094927|NCT02352493|11223278|FG012|NOT COMPLETED|Overall Study||1
10094928|NCT02352493|11223279|FG013|NOT COMPLETED|Overall Study||2
10094929|NCT02352493|11223280|FG014|NOT COMPLETED|Overall Study||1
10094930|NCT02352493|11223281|FG015|NOT COMPLETED|Overall Study||0
10094931|NCT02352493|11223282|FG016|NOT COMPLETED|Overall Study||0
10094932|NCT02352493|11223283|FG017|NOT COMPLETED|Overall Study||0
10094933|NCT02352779|11223341|FG000|STARTED|Overall Study||37
10094934|NCT02352779|11223342|FG001|STARTED|Overall Study||36
10094935|NCT02352779|11223343|FG002|STARTED|Overall Study||35
10094936|NCT02352779|11223341|FG000|COMPLETED|Overall Study||29
10094937|NCT02352779|11223342|FG001|COMPLETED|Overall Study||35
10094938|NCT02352779|11223343|FG002|COMPLETED|Overall Study||33
10094939|NCT02352779|11223341|FG000|NOT COMPLETED|Overall Study||8
10094940|NCT02352779|11223342|FG001|NOT COMPLETED|Overall Study||1
10094941|NCT02352779|11223343|FG002|NOT COMPLETED|Overall Study||2
10094942|NCT02352831|11223353|FG000|STARTED|Overall Study||6
10094943|NCT02352831|11223354|FG001|STARTED|Overall Study||10
10094944|NCT02352831|11223353|FG000|COMPLETED|Overall Study||6
10094945|NCT02352831|11223354|FG001|COMPLETED|Overall Study||10
10094946|NCT02352831|11223353|FG000|NOT COMPLETED|Overall Study||0
10094947|NCT02352831|11223354|FG001|NOT COMPLETED|Overall Study||0
10094948|NCT02352844|11223362|FG000|STARTED|Overall Study||12
10094949|NCT02352844|11223362|FG000|COMPLETED|Overall Study||12
10094950|NCT02352844|11223362|FG000|NOT COMPLETED|Overall Study||0
10094951|NCT02352922|11223368|FG000|STARTED|Overall Study||32
10094952|NCT02352922|11223369|FG001|STARTED|Overall Study||32
10094953|NCT02352922|11223368|FG000|COMPLETED|Overall Study|completed POD14 Survey|28
10094954|NCT02352922|11223369|FG001|COMPLETED|Overall Study|Completed POD14 survey|28
10094955|NCT02352922|11223368|FG000|NOT COMPLETED|Overall Study||4
10094956|NCT02352922|11223369|FG001|NOT COMPLETED|Overall Study||4
10094957|NCT02352974|11223375|FG000|STARTED|Main Study||12
10094958|NCT02352974|11223375|FG000|COMPLETED|Main Study||12
10094959|NCT02352974|11223375|FG000|NOT COMPLETED|Main Study||0
10094960|NCT02352974|11223375|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
10094961|NCT02352974|11223375|FG000|COMPLETED|Extension||3
10094962|NCT02352974|11223375|FG000|NOT COMPLETED|Extension||0
10094963|NCT02353091|11223381|FG000|STARTED|Overall Study||13
10094964|NCT02353091|11223382|FG001|STARTED|Overall Study||13
10094965|NCT02353091|11223381|FG000|COMPLETED|Overall Study||13
9866796|NCT00958568|10980431|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0
10094966|NCT02353091|11223382|FG001|COMPLETED|Overall Study||13
9866797|NCT00958568|10980428|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
10094967|NCT02353091|11223381|FG000|NOT COMPLETED|Overall Study||0
10094968|NCT02353091|11223382|FG001|NOT COMPLETED|Overall Study||0
9866798|NCT00958568|10980429|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
9866799|NCT00958568|10980430|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
10094969|NCT02353169|11223401|FG000|STARTED|Overall Study||15
10094970|NCT02353169|11223402|FG001|STARTED|Overall Study||18
10094971|NCT02353169|11223403|FG002|STARTED|Overall Study||16
10094972|NCT02353169|11223404|FG003|STARTED|Overall Study||15
10094973|NCT02353169|11223401|FG000|COMPLETED|Overall Study||12
10094974|NCT02353169|11223402|FG001|COMPLETED|Overall Study||12
9866800|NCT00958568|10980431|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
9866801|NCT00958568|10980428|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
9866802|NCT00958568|10980429|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
9866803|NCT00958568|10980430|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
9866804|NCT00958568|10980431|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
9866805|NCT00958568|10980428|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866806|NCT00958568|10980429|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
9866807|NCT00958568|10980430|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866808|NCT00958568|10980431|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866809|NCT00958568|10980428|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866810|NCT00958568|10980429|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
9866811|NCT00958568|10980430|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866812|NCT00958568|10980431|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866813|NCT00958568|10980428|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866814|NCT00958568|10980429|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
9866815|NCT00958568|10980430|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866816|NCT00958568|10980431|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
9866817|NCT00958568|10980428|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
9866818|NCT00958568|10980429|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
9866819|NCT00958568|10980430|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
9866820|NCT00958568|10980431|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
9866821|NCT00958568|10980428|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
9866822|NCT00958568|10980429|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
9866823|NCT00958568|10980430|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
9866824|NCT00958568|10980431|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
9866825|NCT00958568|10980428|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
9866826|NCT00958568|10980429|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
9866827|NCT00958568|10980430|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
9866828|NCT00958568|10980431|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
9866829|NCT00958581|10980445|FG000|STARTED|Overall Study||61
9866830|NCT00958581|10980446|FG001|STARTED|Overall Study||61
9866831|NCT00958581|10980447|FG002|STARTED|Overall Study||55
9866832|NCT00958581|10980445|FG000|COMPLETED|Overall Study||61
9866833|NCT00958581|10980446|FG001|COMPLETED|Overall Study||61
9866834|NCT00958581|10980447|FG002|COMPLETED|Overall Study||55
9866835|NCT00958581|10980445|FG000|NOT COMPLETED|Overall Study||0
9866836|NCT00958581|10980446|FG001|NOT COMPLETED|Overall Study||0
9866837|NCT00958581|10980447|FG002|NOT COMPLETED|Overall Study||0
9866838|NCT00958711|10980460|FG000|STARTED|Overall Study||42
10094975|NCT02353169|11223403|FG002|COMPLETED|Overall Study||12
10094976|NCT02353169|11223404|FG003|COMPLETED|Overall Study||12
10094977|NCT02353169|11223401|FG000|NOT COMPLETED|Overall Study||3
10094978|NCT02353169|11223402|FG001|NOT COMPLETED|Overall Study||6
10094979|NCT02353169|11223403|FG002|NOT COMPLETED|Overall Study||4
10094980|NCT02353169|11223404|FG003|NOT COMPLETED|Overall Study||3
10094981|NCT02353299|11223414|FG000|STARTED|First Intervention (1 Night)||13
10094982|NCT02353299|11223415|FG001|STARTED|First Intervention (1 Night)||13
10094983|NCT02353299|11223416|FG002|STARTED|First Intervention (1 Night)||13
10094984|NCT02353299|11223417|FG003|STARTED|First Intervention (1 Night)||13
10094985|NCT02353299|11223414|FG000|COMPLETED|First Intervention (1 Night)||13
10094986|NCT02353299|11223415|FG001|COMPLETED|First Intervention (1 Night)||13
10094987|NCT02353299|11223416|FG002|COMPLETED|First Intervention (1 Night)||13
10094988|NCT02353299|11223417|FG003|COMPLETED|First Intervention (1 Night)||13
10094989|NCT02353299|11223414|FG000|NOT COMPLETED|First Intervention (1 Night)||0
10094990|NCT02353299|11223415|FG001|NOT COMPLETED|First Intervention (1 Night)||0
10094991|NCT02353299|11223416|FG002|NOT COMPLETED|First Intervention (1 Night)||0
10094992|NCT02353299|11223417|FG003|NOT COMPLETED|First Intervention (1 Night)||0
10094993|NCT02353299|11223414|FG000|STARTED|Second Intervention (1 Night)||13
10094994|NCT02353299|11223415|FG001|STARTED|Second Intervention (1 Night)||13
10094995|NCT02353299|11223416|FG002|STARTED|Second Intervention (1 Night)||13
10094996|NCT02353299|11223417|FG003|STARTED|Second Intervention (1 Night)||13
10094997|NCT02353299|11223414|FG000|COMPLETED|Second Intervention (1 Night)||13
10094998|NCT02353299|11223415|FG001|COMPLETED|Second Intervention (1 Night)||13
10094999|NCT02353299|11223416|FG002|COMPLETED|Second Intervention (1 Night)||13
10095000|NCT02353299|11223417|FG003|COMPLETED|Second Intervention (1 Night)||13
10095001|NCT02353299|11223414|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
10095002|NCT02353299|11223415|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
10095003|NCT02353299|11223416|FG002|NOT COMPLETED|Second Intervention (1 Night)||0
10095004|NCT02353299|11223417|FG003|NOT COMPLETED|Second Intervention (1 Night)||0
10095005|NCT02353299|11223414|FG000|STARTED|Third Intervention (1 Night)||13
10095006|NCT02353299|11223415|FG001|STARTED|Third Intervention (1 Night)||13
10095007|NCT02353299|11223416|FG002|STARTED|Third Intervention (1 Night)||13
9866839|NCT00958711|10980461|FG001|STARTED|Overall Study||48
9866840|NCT00958711|10980460|FG000|COMPLETED|Overall Study||29
9866841|NCT00958711|10980461|FG001|COMPLETED|Overall Study||27
10095008|NCT02353299|11223417|FG003|STARTED|Third Intervention (1 Night)||13
10095009|NCT02353299|11223414|FG000|COMPLETED|Third Intervention (1 Night)||13
10095010|NCT02353299|11223415|FG001|COMPLETED|Third Intervention (1 Night)||13
10095011|NCT02353299|11223416|FG002|COMPLETED|Third Intervention (1 Night)||13
9866842|NCT00958711|10980460|FG000|NOT COMPLETED|Overall Study||13
9866843|NCT00958711|10980461|FG001|NOT COMPLETED|Overall Study||21
9866844|NCT00958724|10980467|FG000|STARTED|Overall Study||6
9866845|NCT00958724|10980467|FG000|COMPLETED|Overall Study||0
9866846|NCT00958724|10980467|FG000|NOT COMPLETED|Overall Study||6
9866847|NCT00958776|10980473|FG000|STARTED|Overall Study||137
9866848|NCT00958776|10980474|FG001|STARTED|Overall Study||268
9866849|NCT00958776|10980473|FG000|COMPLETED|Overall Study||121
9866850|NCT00958776|10980474|FG001|COMPLETED|Overall Study||239
9866851|NCT00958776|10980473|FG000|NOT COMPLETED|Overall Study||16
9866852|NCT00958776|10980474|FG001|NOT COMPLETED|Overall Study||29
9866853|NCT00958789|10980481|FG000|STARTED|Overall Study||180
9866854|NCT00958789|10980481|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
9866855|NCT00958789|10980481|FG000|NOT COMPLETED|Overall Study||50
9866856|NCT00958828|10980490|FG000|STARTED|Period 1, 1 Week of Wear||89
9866857|NCT00958828|10980491|FG001|STARTED|Period 1, 1 Week of Wear||89
9866858|NCT00958828|10980490|FG000|COMPLETED|Period 1, 1 Week of Wear||89
9866859|NCT00958828|10980491|FG001|COMPLETED|Period 1, 1 Week of Wear||88
9866860|NCT00958828|10980490|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
9866861|NCT00958828|10980491|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1
9866862|NCT00958828|10980490|FG000|STARTED|Period 2, 1 Week of Wear||89
9866863|NCT00958828|10980491|FG001|STARTED|Period 2, 1 Week of Wear||88
9866864|NCT00958828|10980490|FG000|COMPLETED|Period 2, 1 Week of Wear||89
9866865|NCT00958828|10980491|FG001|COMPLETED|Period 2, 1 Week of Wear||87
9866866|NCT00958828|10980490|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0
9866867|NCT00958828|10980491|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
9866868|NCT00958841|10980497|FG000|STARTED|Overall Study||118
9866869|NCT00958841|10980497|FG000|Completed Month 6 (M6)|Overall Study||90
9866870|NCT00958841|10980497|FG000|Entered in Extension|Overall Study||63
9866871|NCT00958841|10980497|FG000|COMPLETED|Overall Study|Completed = Completed extension|22
9866872|NCT00958841|10980497|FG000|NOT COMPLETED|Overall Study||96
9866873|NCT00958880|10980513|FG000|STARTED|Overall Study||20
9866874|NCT00958880|10980514|FG001|STARTED|Overall Study||20
9866875|NCT00958880|10980513|FG000|COMPLETED|Overall Study||18
9866876|NCT00958880|10980514|FG001|COMPLETED|Overall Study||18
9866877|NCT00958880|10980513|FG000|NOT COMPLETED|Overall Study||2
9866878|NCT00958880|10980514|FG001|NOT COMPLETED|Overall Study||2
10095012|NCT02353299|11223417|FG003|COMPLETED|Third Intervention (1 Night)||13
10095013|NCT02353299|11223414|FG000|NOT COMPLETED|Third Intervention (1 Night)||0
10095014|NCT02353299|11223415|FG001|NOT COMPLETED|Third Intervention (1 Night)||0
10095015|NCT02353299|11223416|FG002|NOT COMPLETED|Third Intervention (1 Night)||0
10095016|NCT02353299|11223417|FG003|NOT COMPLETED|Third Intervention (1 Night)||0
10095017|NCT02353299|11223414|FG000|STARTED|Fourth Intervention (1 Night)||13
10095018|NCT02353299|11223415|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
10095019|NCT02353299|11223416|FG002|STARTED|Fourth Intervention (1 Night)||13
10095020|NCT02353299|11223417|FG003|STARTED|Fourth Intervention (1 Night)||13
10095021|NCT02353299|11223414|FG000|COMPLETED|Fourth Intervention (1 Night)||13
10095022|NCT02353299|11223415|FG001|COMPLETED|Fourth Intervention (1 Night)||12
10095023|NCT02353299|11223416|FG002|COMPLETED|Fourth Intervention (1 Night)||13
10095024|NCT02353299|11223417|FG003|COMPLETED|Fourth Intervention (1 Night)||13
10095025|NCT02353299|11223414|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0
10095026|NCT02353299|11223415|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0
10095027|NCT02353299|11223416|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0
10095028|NCT02353299|11223417|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0
10095029|NCT02353442|11223437|FG000|STARTED|Overall Study||28
10095030|NCT02353442|11223438|FG001|STARTED|Overall Study||31
10095031|NCT02353442|11223437|FG000|COMPLETED|Overall Study||25
10095032|NCT02353442|11223438|FG001|COMPLETED|Overall Study||27
10095033|NCT02353442|11223437|FG000|NOT COMPLETED|Overall Study||3
10095034|NCT02353442|11223438|FG001|NOT COMPLETED|Overall Study||4
10095035|NCT02353754|11223446|FG000|STARTED|Overall Study||12
10095036|NCT02353754|11223447|FG001|STARTED|Overall Study||0
10095037|NCT02353754|11223446|FG000|COMPLETED|Overall Study||10
10095038|NCT02353754|11223447|FG001|COMPLETED|Overall Study||0
10095039|NCT02353754|11223446|FG000|NOT COMPLETED|Overall Study||2
10095040|NCT02353754|11223447|FG001|NOT COMPLETED|Overall Study||0
10095041|NCT02353780|11223456|FG000|STARTED|Overall Study||3
10095042|NCT02353780|11223457|FG001|STARTED|Overall Study||3
10095043|NCT02353780|11223458|FG002|STARTED|Overall Study||3
10095044|NCT02353780|11223456|FG000|COMPLETED|Overall Study||3
10095045|NCT02353780|11223457|FG001|COMPLETED|Overall Study||3
9866879|NCT00958919|10980520|FG000|STARTED|First Intervention||7
9866880|NCT00958919|10980521|FG001|STARTED|First Intervention||7
9866881|NCT00958919|10980520|FG000|COMPLETED|First Intervention||7
9866882|NCT00958919|10980521|FG001|COMPLETED|First Intervention||7
9866883|NCT00958919|10980520|FG000|NOT COMPLETED|First Intervention||0
9866884|NCT00958919|10980521|FG001|NOT COMPLETED|First Intervention||0
9866885|NCT00958919|10980520|FG000|STARTED|Second Intervention||7
10095046|NCT02353780|11223458|FG002|COMPLETED|Overall Study||3
10095047|NCT02353780|11223456|FG000|NOT COMPLETED|Overall Study||0
10095048|NCT02353780|11223457|FG001|NOT COMPLETED|Overall Study||0
10095049|NCT02353780|11223458|FG002|NOT COMPLETED|Overall Study||0
10095050|NCT02353806|11223466|FG000|STARTED|Overall Study||16
10095051|NCT02353806|11223466|FG000|COMPLETED|Overall Study||6
10095052|NCT02353806|11223466|FG000|NOT COMPLETED|Overall Study||10
9866886|NCT00958919|10980521|FG001|STARTED|Second Intervention||7
9866887|NCT00958919|10980520|FG000|COMPLETED|Second Intervention||7
9866888|NCT00958919|10980521|FG001|COMPLETED|Second Intervention||7
9866889|NCT00958919|10980520|FG000|NOT COMPLETED|Second Intervention||0
9866890|NCT00958919|10980521|FG001|NOT COMPLETED|Second Intervention||0
9866891|NCT00959049|10980540|FG000|STARTED|Overall Study||231
9866892|NCT00959049|10980541|FG001|STARTED|Overall Study||254
9866893|NCT00959049|10980542|FG002|STARTED|Overall Study||254
9866894|NCT00959049|10980543|FG003|STARTED|Overall Study||228
9866895|NCT00959049|10980544|FG004|STARTED|Overall Study||257
9866896|NCT00959049|10980545|FG005|STARTED|Overall Study||250
9866897|NCT00959049|10980540|FG000|COMPLETED|Overall Study||213
9866898|NCT00959049|10980541|FG001|COMPLETED|Overall Study||247
9866899|NCT00959049|10980542|FG002|COMPLETED|Overall Study||253
9866900|NCT00959049|10980543|FG003|COMPLETED|Overall Study||217
9866901|NCT00959049|10980544|FG004|COMPLETED|Overall Study||248
9866902|NCT00959049|10980545|FG005|COMPLETED|Overall Study||249
9866903|NCT00959049|10980540|FG000|NOT COMPLETED|Overall Study||18
10095053|NCT02353871|11223474|FG000|STARTED|Overall Study|Randomised.|125
10095054|NCT02353871|11223475|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
10095055|NCT02353871|11223474|FG000|COMPLETED|Overall Study||122
10095056|NCT02353871|11223475|FG001|COMPLETED|Overall Study||51
10095057|NCT02353871|11223474|FG000|NOT COMPLETED|Overall Study||3
10095058|NCT02353871|11223475|FG001|NOT COMPLETED|Overall Study||9
10095059|NCT02354092|11223483|FG000|STARTED|Overall Study||7
10095060|NCT02354092|11223484|FG001|STARTED|Overall Study||7
10095061|NCT02354092|11223483|FG000|COMPLETED|Overall Study||7
10095062|NCT02354092|11223484|FG001|COMPLETED|Overall Study||7
10095063|NCT02354092|11223483|FG000|NOT COMPLETED|Overall Study||0
10095064|NCT02354092|11223484|FG001|NOT COMPLETED|Overall Study||0
10095065|NCT02354144|11223492|FG000|STARTED|Overall Study||127
10095066|NCT02354144|11223493|FG001|STARTED|Overall Study||128
10095067|NCT02354144|11223492|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
10095068|NCT02354144|11223493|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
10095069|NCT02354144|11223492|FG000|NOT COMPLETED|Overall Study||79
10095070|NCT02354144|11223493|FG001|NOT COMPLETED|Overall Study||77
10095071|NCT02354222|11223501|FG000|STARTED|Overall Study||77
10095072|NCT02354222|11223502|FG001|STARTED|Overall Study||77
10095073|NCT02354222|11223501|FG000|COMPLETED|Overall Study||73
10095074|NCT02354222|11223502|FG001|COMPLETED|Overall Study||66
10095075|NCT02354222|11223501|FG000|NOT COMPLETED|Overall Study||4
10095076|NCT02354222|11223502|FG001|NOT COMPLETED|Overall Study||11
10095077|NCT02354235|11223510|FG000|STARTED|Overall Study||70
10095078|NCT02354235|11223511|FG001|STARTED|Overall Study||68
10095079|NCT02354235|11223510|FG000|COMPLETED|Overall Study||67
10095080|NCT02354235|11223511|FG001|COMPLETED|Overall Study||61
10095081|NCT02354235|11223510|FG000|NOT COMPLETED|Overall Study||3
10095082|NCT02354235|11223511|FG001|NOT COMPLETED|Overall Study||7
10095083|NCT02354339|11223519|FG000|STARTED|Overall Study||12
10095084|NCT02354339|11223520|FG001|STARTED|Overall Study||12
10095085|NCT02354339|11223519|FG000|COMPLETED|Overall Study||12
10095086|NCT02354339|11223520|FG001|COMPLETED|Overall Study||12
10095087|NCT02354339|11223519|FG000|NOT COMPLETED|Overall Study||0
10095088|NCT02354339|11223520|FG001|NOT COMPLETED|Overall Study||0
10095089|NCT02354352|11223528|FG000|STARTED|Overall Study||26
10095090|NCT02354352|11223529|FG001|STARTED|Overall Study||26
10095091|NCT02354352|11223528|FG000|2 Weeks|Overall Study||26
10095092|NCT02354352|11223529|FG001|2 Weeks|Overall Study||25
10095093|NCT02354352|11223528|FG000|1 Month|Overall Study||24
10095094|NCT02354352|11223529|FG001|1 Month|Overall Study||23
10095095|NCT02354352|11223528|FG000|2 Months|Overall Study||24
10095096|NCT02354352|11223529|FG001|2 Months|Overall Study||22
10095097|NCT02354352|11223528|FG000|3 Months|Overall Study||25
10095098|NCT02354352|11223529|FG001|3 Months|Overall Study||23
10095099|NCT02354352|11223528|FG000|6 Months|Overall Study||25
10095100|NCT02354352|11223529|FG001|6 Months|Overall Study||23
10095101|NCT02354352|11223528|FG000|9 Months|Overall Study||25
10095102|NCT02354352|11223529|FG001|9 Months|Overall Study||23
10095103|NCT02354352|11223528|FG000|COMPLETED|Overall Study||23
10095104|NCT02354352|11223529|FG001|COMPLETED|Overall Study||23
10095105|NCT02354352|11223528|FG000|NOT COMPLETED|Overall Study||3
10095106|NCT02354352|11223529|FG001|NOT COMPLETED|Overall Study||3
10095107|NCT02354378|11223537|FG000|STARTED|Overall Study||64
10095108|NCT02354378|11223538|FG001|STARTED|Overall Study||20
10095109|NCT02354378|11223537|FG000|COMPLETED|Overall Study||30
10095110|NCT02354378|11223538|FG001|COMPLETED|Overall Study||16
10095111|NCT02354378|11223537|FG000|NOT COMPLETED|Overall Study||34
10095112|NCT02354378|11223538|FG001|NOT COMPLETED|Overall Study||4
9866904|NCT00959049|10980541|FG001|NOT COMPLETED|Overall Study||7
9866905|NCT00959049|10980542|FG002|NOT COMPLETED|Overall Study||1
9866906|NCT00959049|10980543|FG003|NOT COMPLETED|Overall Study||11
9866907|NCT00959049|10980544|FG004|NOT COMPLETED|Overall Study||9
9866908|NCT00959049|10980545|FG005|NOT COMPLETED|Overall Study||1
9866909|NCT00959166|10980572|FG000|STARTED|Overall Study||24
9866910|NCT00959166|10980573|FG001|STARTED|Overall Study||57
10095113|NCT02354417|11223544|FG000|STARTED|Overall Study||3
10095114|NCT02354417|11223544|FG000|COMPLETED|Overall Study||2
10095115|NCT02354417|11223544|FG000|NOT COMPLETED|Overall Study||1
10095116|NCT02354443|11223548|FG000|STARTED|Overall Study||1
9866911|NCT00959166|10980572|FG000|COMPLETED|Overall Study||24
9866912|NCT00959166|10980573|FG001|COMPLETED|Overall Study||57
10095117|NCT02354443|11223548|FG000|COMPLETED|Overall Study||1
9866913|NCT00959166|10980572|FG000|NOT COMPLETED|Overall Study||0
9866914|NCT00959166|10980573|FG001|NOT COMPLETED|Overall Study||0
9866915|NCT00959192|10980583|FG000|STARTED|Overall Study||6
9866916|NCT00959192|10980584|FG001|STARTED|Overall Study||9
9866917|NCT00959192|10980585|FG002|STARTED|Overall Study||9
9866918|NCT00959192|10980586|FG003|STARTED|Overall Study||8
9866919|NCT00959192|10980583|FG000|COMPLETED|Overall Study||4
9866920|NCT00959192|10980584|FG001|COMPLETED|Overall Study||8
9866921|NCT00959192|10980585|FG002|COMPLETED|Overall Study||6
9866922|NCT00959192|10980586|FG003|COMPLETED|Overall Study||7
9866923|NCT00959192|10980583|FG000|NOT COMPLETED|Overall Study||2
9866924|NCT00959192|10980584|FG001|NOT COMPLETED|Overall Study||1
9866925|NCT00959192|10980585|FG002|NOT COMPLETED|Overall Study||3
9866926|NCT00959192|10980586|FG003|NOT COMPLETED|Overall Study||1
9866927|NCT00959374|10980597|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
9866928|NCT00959374|10980597|FG000|COMPLETED|Overall Study||218
9866929|NCT00959374|10980597|FG000|NOT COMPLETED|Overall Study||23
9866930|NCT00959647|10980605|FG000|STARTED|Overall Study||19
9866931|NCT00959647|10980605|FG000|COMPLETED|Overall Study||0
9866932|NCT00959647|10980605|FG000|NOT COMPLETED|Overall Study||19
9866933|NCT00959660|10980613|FG000|STARTED|Overall Study||26
9866934|NCT00959660|10980614|FG001|STARTED|Overall Study||24
9866935|NCT00959660|10980615|FG002|STARTED|Overall Study||25
9866936|NCT00959660|10980616|FG003|STARTED|Overall Study||25
9866937|NCT00959660|10980613|FG000|COMPLETED|Overall Study||24
9866938|NCT00959660|10980614|FG001|COMPLETED|Overall Study||24
9866939|NCT00959660|10980615|FG002|COMPLETED|Overall Study||22
9866940|NCT00959660|10980616|FG003|COMPLETED|Overall Study||22
10095118|NCT02354443|11223548|FG000|NOT COMPLETED|Overall Study||0
10095119|NCT02354482|11223552|FG000|STARTED|Patient Communication and Care||2158
10095120|NCT02354482|11223552|FG000|COMPLETED|Patient Communication and Care||2158
10095121|NCT02354482|11223552|FG000|NOT COMPLETED|Patient Communication and Care||0
10095122|NCT02354482|11223552|FG000|STARTED|Home-Based Trust and Plain Language||1979
10095123|NCT02354482|11223552|FG000|COMPLETED|Home-Based Trust and Plain Language||1979
10095124|NCT02354482|11223552|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0
10095125|NCT02354482|11223552|FG000|STARTED|Hospital-Based Trust and Plain Language||2090
10095126|NCT02354482|11223552|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090
10095127|NCT02354482|11223552|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
10095128|NCT02354482|11223552|FG000|STARTED|Patient/Family Caregiver Assessment||3093
10095129|NCT02354482|11223552|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093
10095130|NCT02354482|11223552|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0
10095131|NCT02354482|11223552|FG000|STARTED|Assessment and Teach Back||508
10095132|NCT02354482|11223552|FG000|COMPLETED|Assessment and Teach Back||508
10095133|NCT02354482|11223552|FG000|NOT COMPLETED|Assessment and Teach Back||0
10095134|NCT02354482|11223552|FG000|STARTED|Reference||2042
10095135|NCT02354482|11223552|FG000|COMPLETED|Reference||2042
10095136|NCT02354482|11223552|FG000|NOT COMPLETED|Reference||0
10095137|NCT02354508|11223569|FG000|STARTED|Period 1: Core Phase||41
10095138|NCT02354508|11223570|FG001|STARTED|Period 1: Core Phase||29
10095139|NCT02354508|11223571|FG002|STARTED|Period 1: Core Phase||53
10095140|NCT02354508|11223569|FG000|COMPLETED|Period 1: Core Phase||39
10095141|NCT02354508|11223570|FG001|COMPLETED|Period 1: Core Phase||27
10095142|NCT02354508|11223571|FG002|COMPLETED|Period 1: Core Phase||47
10095143|NCT02354508|11223569|FG000|NOT COMPLETED|Period 1: Core Phase||2
10095144|NCT02354508|11223570|FG001|NOT COMPLETED|Period 1: Core Phase||2
10095145|NCT02354508|11223571|FG002|NOT COMPLETED|Period 1: Core Phase||6
10095146|NCT02354508|11223569|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
10095147|NCT02354508|11223570|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
10095148|NCT02354508|11223571|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
10095149|NCT02354508|11223569|FG000|COMPLETED|Period 2: Extension Phase||20
10095150|NCT02354508|11223570|FG001|COMPLETED|Period 2: Extension Phase||19
10095151|NCT02354508|11223571|FG002|COMPLETED|Period 2: Extension Phase||36
10095152|NCT02354508|11223569|FG000|NOT COMPLETED|Period 2: Extension Phase||6
10095153|NCT02354508|11223570|FG001|NOT COMPLETED|Period 2: Extension Phase||4
10095154|NCT02354508|11223571|FG002|NOT COMPLETED|Period 2: Extension Phase||3
10095155|NCT02354508|11223569|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26
10095156|NCT02354508|11223570|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23
10095157|NCT02354508|11223571|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39
10095158|NCT02354508|11223569|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
10095159|NCT02354508|11223570|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
10095160|NCT02354508|11223571|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
10095161|NCT02354508|11223569|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
9866941|NCT00959660|10980613|FG000|NOT COMPLETED|Overall Study||2
9866942|NCT00959660|10980614|FG001|NOT COMPLETED|Overall Study||0
9866943|NCT00959660|10980615|FG002|NOT COMPLETED|Overall Study||3
9866944|NCT00959660|10980616|FG003|NOT COMPLETED|Overall Study||3
9866945|NCT00959699|10980628|FG000|STARTED|Treatment Period||34
9866946|NCT00959699|10980629|FG001|STARTED|Treatment Period||65
9866947|NCT00959699|10980628|FG000|Treated|Treatment Period||34
9866948|NCT00959699|10980629|FG001|Treated|Treatment Period||64
9866949|NCT00959699|10980628|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
9866950|NCT00959699|10980629|FG001|COMPLETED|Treatment Period||40
9866951|NCT00959699|10980628|FG000|NOT COMPLETED|Treatment Period||23
9866952|NCT00959699|10980629|FG001|NOT COMPLETED|Treatment Period||25
9866953|NCT00959699|10980628|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
9866954|NCT00959699|10980629|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
9866955|NCT00959699|10980628|FG000|COMPLETED|Follow-up Period||27
9866956|NCT00959699|10980629|FG001|COMPLETED|Follow-up Period||56
9866957|NCT00959699|10980628|FG000|NOT COMPLETED|Follow-up Period||6
9866958|NCT00959699|10980629|FG001|NOT COMPLETED|Follow-up Period||6
9866959|NCT00959751|10980638|FG000|STARTED|Overall Study||97
9866960|NCT00959751|10980639|FG001|STARTED|Overall Study||98
9866961|NCT00959751|10980638|FG000|COMPLETED|Overall Study||88
9866962|NCT00959751|10980639|FG001|COMPLETED|Overall Study||86
9866963|NCT00959751|10980638|FG000|NOT COMPLETED|Overall Study||9
9866964|NCT00959751|10980639|FG001|NOT COMPLETED|Overall Study||12
9866965|NCT00959764|10980648|FG000|STARTED|Overall Study||271
9866966|NCT00959764|10980649|FG001|STARTED|Overall Study||185
9866967|NCT00959764|10980650|FG002|STARTED|Overall Study||109
9866968|NCT00959764|10980648|FG000|COMPLETED|Overall Study||176
9866969|NCT00959764|10980649|FG001|COMPLETED|Overall Study||128
9866970|NCT00959764|10980650|FG002|COMPLETED|Overall Study||73
9866971|NCT00959764|10980648|FG000|NOT COMPLETED|Overall Study||95
9866972|NCT00959764|10980649|FG001|NOT COMPLETED|Overall Study||57
9866973|NCT00959764|10980650|FG002|NOT COMPLETED|Overall Study||36
9866974|NCT00959842|10980661|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15
9866975|NCT00959842|10980661|FG000|COMPLETED|Overall Study||15
9866976|NCT00959842|10980661|FG000|NOT COMPLETED|Overall Study||0
9866977|NCT00959894|10980665|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
9866978|NCT00959894|10980665|FG000|COMPLETED|Overall Study||63
9866979|NCT00959894|10980665|FG000|NOT COMPLETED|Overall Study||16
9866980|NCT00959907|10980672|FG000|STARTED|Overall Study||30
9866981|NCT00959907|10980673|FG001|STARTED|Overall Study||29
9866982|NCT00959907|10980672|FG000|COMPLETED|Overall Study||27
9866983|NCT00959907|10980673|FG001|COMPLETED|Overall Study||28
9866984|NCT00959907|10980672|FG000|NOT COMPLETED|Overall Study||3
9866985|NCT00959907|10980673|FG001|NOT COMPLETED|Overall Study||1
9866986|NCT00959920|10980681|FG000|STARTED|Overall Study||72
9866987|NCT00959920|10980682|FG001|STARTED|Overall Study||67
9866988|NCT00959920|10980681|FG000|COMPLETED|Overall Study||72
9866989|NCT00959920|10980682|FG001|COMPLETED|Overall Study||66
9866990|NCT00959920|10980681|FG000|NOT COMPLETED|Overall Study||0
10095162|NCT02354508|11223570|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
10095163|NCT02354508|11223571|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
10095164|NCT02354508|11223569|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
10095165|NCT02354508|11223570|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
10095166|NCT02354508|11223571|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
10095167|NCT02354534|11223624|FG000|STARTED|Overall Study||3
10095168|NCT02354534|11223625|FG001|STARTED|Overall Study||9
10095169|NCT02354534|11223626|FG002|STARTED|Overall Study||10
10095170|NCT02354534|11223627|FG003|STARTED|Overall Study||8
10095171|NCT02354534|11223624|FG000|COMPLETED|Overall Study||3
10095172|NCT02354534|11223625|FG001|COMPLETED|Overall Study||9
10095173|NCT02354534|11223626|FG002|COMPLETED|Overall Study||9
10095174|NCT02354534|11223627|FG003|COMPLETED|Overall Study||8
10095175|NCT02354534|11223624|FG000|NOT COMPLETED|Overall Study||0
10095176|NCT02354534|11223625|FG001|NOT COMPLETED|Overall Study||0
10095177|NCT02354534|11223626|FG002|NOT COMPLETED|Overall Study||1
10095178|NCT02354534|11223627|FG003|NOT COMPLETED|Overall Study||0
10095179|NCT02354586|11223637|FG000|STARTED|Overall Study||463
10095180|NCT02354586|11223637|FG000|Ongoing in Study|Overall Study||21
10095181|NCT02354586|11223637|FG000|COMPLETED|Overall Study||122
10095182|NCT02354586|11223637|FG000|NOT COMPLETED|Overall Study||341
10095183|NCT02354599|11223647|FG000|STARTED|Overall Study||6
10095184|NCT02354599|11223648|FG001|STARTED|Overall Study||6
10095185|NCT02354599|11223649|FG002|STARTED|Overall Study||6
10095186|NCT02354599|11223650|FG003|STARTED|Overall Study||6
10095187|NCT02354599|11223651|FG004|STARTED|Overall Study||2
10095188|NCT02354599|11223652|FG005|STARTED|Overall Study||6
10095189|NCT02354599|11223647|FG000|COMPLETED|Overall Study||5
10095190|NCT02354599|11223648|FG001|COMPLETED|Overall Study||5
10095191|NCT02354599|11223649|FG002|COMPLETED|Overall Study||6
10095192|NCT02354599|11223650|FG003|COMPLETED|Overall Study||6
10095193|NCT02354599|11223651|FG004|COMPLETED|Overall Study||2
9866991|NCT00959920|10980682|FG001|NOT COMPLETED|Overall Study||1
10095194|NCT02354599|11223652|FG005|COMPLETED|Overall Study||5
10095195|NCT02354599|11223647|FG000|NOT COMPLETED|Overall Study||1
10095196|NCT02354599|11223648|FG001|NOT COMPLETED|Overall Study||1
10095197|NCT02354599|11223649|FG002|NOT COMPLETED|Overall Study||0
10095198|NCT02354599|11223650|FG003|NOT COMPLETED|Overall Study||0
9866992|NCT00959946|10980698|FG000|STARTED|Overall Study||2
9866993|NCT00959946|10980699|FG001|STARTED|Overall Study||4
9866994|NCT00959946|10980700|FG002|STARTED|Overall Study||4
9866995|NCT00959946|10980701|FG003|STARTED|Overall Study||5
9866996|NCT00959946|10980702|FG004|STARTED|Overall Study||4
9866997|NCT00959946|10980703|FG005|STARTED|Overall Study||9
9866998|NCT00959946|10980704|FG006|STARTED|Overall Study||2
9866999|NCT00959946|10980705|FG007|STARTED|Overall Study||2
9867000|NCT00959946|10980698|FG000|COMPLETED|Overall Study||0
9867001|NCT00959946|10980699|FG001|COMPLETED|Overall Study||0
9867002|NCT00959946|10980700|FG002|COMPLETED|Overall Study||0
9867003|NCT00959946|10980701|FG003|COMPLETED|Overall Study||0
9867004|NCT00959946|10980702|FG004|COMPLETED|Overall Study||0
9867005|NCT00959946|10980703|FG005|COMPLETED|Overall Study||0
9867006|NCT00959946|10980704|FG006|COMPLETED|Overall Study||0
10095199|NCT02354599|11223651|FG004|NOT COMPLETED|Overall Study||0
10095200|NCT02354599|11223652|FG005|NOT COMPLETED|Overall Study||1
10095201|NCT02354690|11223672|FG000|STARTED|Overall Study||13
10095202|NCT02354690|11223672|FG000|COMPLETED|Overall Study||12
10095203|NCT02354690|11223672|FG000|NOT COMPLETED|Overall Study||1
10095204|NCT02354781|11223676|FG000|STARTED|Overall Study||3
10095205|NCT02354781|11223676|FG000|COMPLETED|Overall Study||3
10095206|NCT02354781|11223676|FG000|NOT COMPLETED|Overall Study||0
10095207|NCT02354833|11223683|FG000|STARTED|Overall Study||38
10095208|NCT02354833|11223684|FG001|STARTED|Overall Study||43
10095209|NCT02354833|11223683|FG000|COMPLETED|Overall Study||38
10095210|NCT02354833|11223684|FG001|COMPLETED|Overall Study||43
10095211|NCT02354833|11223683|FG000|NOT COMPLETED|Overall Study||0
10095212|NCT02354833|11223684|FG001|NOT COMPLETED|Overall Study||0
10095213|NCT02354859|11223694|FG000|STARTED|Overall Study||60
10095214|NCT02354859|11223695|FG001|STARTED|Overall Study||59
10095215|NCT02354859|11223694|FG000|COMPLETED|Overall Study||60
10095216|NCT02354859|11223695|FG001|COMPLETED|Overall Study||57
10095217|NCT02354859|11223694|FG000|NOT COMPLETED|Overall Study||0
10095218|NCT02354859|11223695|FG001|NOT COMPLETED|Overall Study||2
10095219|NCT02354924|11223703|FG000|STARTED|Overall Study||40
10095220|NCT02354924|11223704|FG001|STARTED|Overall Study||20
10095221|NCT02354924|11223703|FG000|COMPLETED|Overall Study||40
10095222|NCT02354924|11223704|FG001|COMPLETED|Overall Study||20
10095223|NCT02354924|11223703|FG000|NOT COMPLETED|Overall Study||0
10095224|NCT02354924|11223704|FG001|NOT COMPLETED|Overall Study||0
10095225|NCT02354976|11223715|FG000|STARTED|Overall Study||25
10095226|NCT02354976|11223716|FG001|STARTED|Overall Study||27
10095227|NCT02354976|11223717|FG002|STARTED|Overall Study||26
10095228|NCT02354976|11223715|FG000|COMPLETED|Overall Study||23
10095229|NCT02354976|11223716|FG001|COMPLETED|Overall Study||26
10095230|NCT02354976|11223717|FG002|COMPLETED|Overall Study||23
10095231|NCT02354976|11223715|FG000|NOT COMPLETED|Overall Study||2
10095232|NCT02354976|11223716|FG001|NOT COMPLETED|Overall Study||1
10095233|NCT02354976|11223717|FG002|NOT COMPLETED|Overall Study||3
10095234|NCT02355028|11223727|FG000|STARTED|Overall Study||47
10095235|NCT02355028|11223728|FG001|STARTED|Overall Study||46
10095236|NCT02355028|11223727|FG000|Treated|Overall Study||46
10095237|NCT02355028|11223728|FG001|Treated|Overall Study||45
10095238|NCT02355028|11223727|FG000|COMPLETED|Overall Study||36
10095239|NCT02355028|11223728|FG001|COMPLETED|Overall Study||41
10095240|NCT02355028|11223727|FG000|NOT COMPLETED|Overall Study||11
10095241|NCT02355028|11223728|FG001|NOT COMPLETED|Overall Study||5
10095242|NCT02355067|11223741|FG000|STARTED|Overall Study||20
10095243|NCT02355067|11223742|FG001|STARTED|Overall Study||20
10095244|NCT02355067|11223741|FG000|COMPLETED|Overall Study||12
10095245|NCT02355067|11223742|FG001|COMPLETED|Overall Study||12
10095246|NCT02355067|11223741|FG000|NOT COMPLETED|Overall Study||8
10095247|NCT02355067|11223742|FG001|NOT COMPLETED|Overall Study||8
10095248|NCT02355158|11223748|FG000|STARTED|Overall Study||197
10095249|NCT02355158|11223748|FG000|COMPLETED|Overall Study||47
10095250|NCT02355158|11223748|FG000|NOT COMPLETED|Overall Study||150
10095251|NCT02355210|11223758|FG000|STARTED|Overall Study||19
10095252|NCT02355210|11223759|FG001|STARTED|Overall Study||18
10095253|NCT02355210|11223760|FG002|STARTED|Overall Study||16
10095254|NCT02355210|11223761|FG003|STARTED|Overall Study||17
10095255|NCT02355210|11223762|FG004|STARTED|Overall Study||19
10095256|NCT02355210|11223763|FG005|STARTED|Overall Study||18
10095257|NCT02355210|11223758|FG000|COMPLETED|Overall Study||19
10095258|NCT02355210|11223759|FG001|COMPLETED|Overall Study||18
10095259|NCT02355210|11223760|FG002|COMPLETED|Overall Study||16
10095260|NCT02355210|11223761|FG003|COMPLETED|Overall Study||17
10095261|NCT02355210|11223762|FG004|COMPLETED|Overall Study||19
10095262|NCT02355210|11223763|FG005|COMPLETED|Overall Study||18
10095263|NCT02355210|11223758|FG000|NOT COMPLETED|Overall Study||0
10095264|NCT02355210|11223759|FG001|NOT COMPLETED|Overall Study||0
10095265|NCT02355210|11223760|FG002|NOT COMPLETED|Overall Study||0
10095266|NCT02355210|11223761|FG003|NOT COMPLETED|Overall Study||0
10095267|NCT02355210|11223762|FG004|NOT COMPLETED|Overall Study||0
10095268|NCT02355210|11223763|FG005|NOT COMPLETED|Overall Study||0
10095269|NCT02355275|11223777|FG000|STARTED|Overall Study||22
10095270|NCT02355275|11223777|FG000|COMPLETED|Overall Study||14
10095271|NCT02355275|11223777|FG000|NOT COMPLETED|Overall Study||8
10095272|NCT02355665|11223783|FG000|STARTED|Overall Study||601
10095273|NCT02355665|11223784|FG001|STARTED|Overall Study||597
10095274|NCT02355665|11223783|FG000|COMPLETED|Overall Study||352
9867007|NCT00959946|10980705|FG007|COMPLETED|Overall Study||0
9867008|NCT00959946|10980698|FG000|NOT COMPLETED|Overall Study||2
9867009|NCT00959946|10980699|FG001|NOT COMPLETED|Overall Study||4
10095275|NCT02355665|11223784|FG001|COMPLETED|Overall Study||365
10095276|NCT02355665|11223783|FG000|NOT COMPLETED|Overall Study||249
10095277|NCT02355665|11223784|FG001|NOT COMPLETED|Overall Study||232
10095278|NCT02355691|11223792|FG000|STARTED|Overall Study||7
9867010|NCT00959946|10980700|FG002|NOT COMPLETED|Overall Study||4
9867011|NCT00959946|10980701|FG003|NOT COMPLETED|Overall Study||5
9867012|NCT00959946|10980702|FG004|NOT COMPLETED|Overall Study||4
9867013|NCT00959946|10980703|FG005|NOT COMPLETED|Overall Study||9
9867014|NCT00959946|10980704|FG006|NOT COMPLETED|Overall Study||2
9867015|NCT00959946|10980705|FG007|NOT COMPLETED|Overall Study||2
10095279|NCT02355691|11223793|FG001|STARTED|Overall Study||9
10095280|NCT02355691|11223792|FG000|1st Postop Visit|Overall Study||7
10095281|NCT02355691|11223793|FG001|1st Postop Visit|Overall Study||9
10095282|NCT02355691|11223792|FG000|2nd Postop Visit|Overall Study||7
10095283|NCT02355691|11223793|FG001|2nd Postop Visit|Overall Study||9
10095284|NCT02355691|11223792|FG000|COMPLETED|Overall Study||0
10095285|NCT02355691|11223793|FG001|COMPLETED|Overall Study||0
10095286|NCT02355691|11223792|FG000|NOT COMPLETED|Overall Study||7
10095287|NCT02355691|11223793|FG001|NOT COMPLETED|Overall Study||9
10095288|NCT02355743|11223799|FG000|STARTED|Overall Study||8
10095289|NCT02355743|11223799|FG000|COMPLETED|Overall Study||6
10095290|NCT02355743|11223799|FG000|NOT COMPLETED|Overall Study||2
10095291|NCT02355821|11223805|FG000|STARTED|Overall Study||57
10095292|NCT02355821|11223806|FG001|STARTED|Overall Study||57
10095293|NCT02355821|11223805|FG000|COMPLETED|Overall Study||57
10095294|NCT02355821|11223806|FG001|COMPLETED|Overall Study||57
10095295|NCT02355821|11223805|FG000|NOT COMPLETED|Overall Study||0
10095296|NCT02355821|11223806|FG001|NOT COMPLETED|Overall Study||0
10095297|NCT02355886|11223814|FG000|STARTED|Overall Study||13
10095298|NCT02355886|11223815|FG001|STARTED|Overall Study||12
10095299|NCT02355886|11223814|FG000|COMPLETED|Overall Study||13
10095300|NCT02355886|11223815|FG001|COMPLETED|Overall Study||12
10095301|NCT02355886|11223814|FG000|NOT COMPLETED|Overall Study||0
10095302|NCT02355886|11223815|FG001|NOT COMPLETED|Overall Study||0
10095303|NCT02355977|11223824|FG000|STARTED|Overall Study||21
10095304|NCT02355977|11223825|FG001|STARTED|Overall Study||26
10095305|NCT02355977|11223826|FG002|STARTED|Overall Study||23
10095306|NCT02355977|11223824|FG000|COMPLETED|Overall Study||21
10095307|NCT02355977|11223825|FG001|COMPLETED|Overall Study||26
10095308|NCT02355977|11223826|FG002|COMPLETED|Overall Study||23
10095309|NCT02355977|11223824|FG000|NOT COMPLETED|Overall Study||0
10095310|NCT02355977|11223825|FG001|NOT COMPLETED|Overall Study||0
10095311|NCT02355977|11223826|FG002|NOT COMPLETED|Overall Study||0
10095312|NCT02356003|11223834|FG000|STARTED|Overall Study||10
10095313|NCT02356003|11223834|FG000|COMPLETED|Overall Study||10
10095314|NCT02356003|11223834|FG000|NOT COMPLETED|Overall Study||0
10095315|NCT02356107|11223839|FG000|STARTED|Overall Study||15
10095316|NCT02356107|11223839|FG000|COMPLETED|Overall Study||12
10095317|NCT02356107|11223839|FG000|NOT COMPLETED|Overall Study||3
10095318|NCT02356198|11223845|FG000|STARTED|Overall Study||104
10095319|NCT02356198|11223846|FG001|STARTED|Overall Study||105
10095320|NCT02356198|11223845|FG000|COMPLETED|Overall Study||102
10095321|NCT02356198|11223846|FG001|COMPLETED|Overall Study||98
10095322|NCT02356198|11223845|FG000|NOT COMPLETED|Overall Study||2
10095323|NCT02356198|11223846|FG001|NOT COMPLETED|Overall Study||7
10095324|NCT02356211|11223854|FG000|STARTED|Overall Study||57
10095325|NCT02356211|11223855|FG001|STARTED|Overall Study||52
10095326|NCT02356211|11223854|FG000|COMPLETED|Overall Study||54
10095327|NCT02356211|11223855|FG001|COMPLETED|Overall Study||42
10095328|NCT02356211|11223854|FG000|NOT COMPLETED|Overall Study||3
10095329|NCT02356211|11223855|FG001|NOT COMPLETED|Overall Study||10
10095330|NCT02356471|11223861|FG000|STARTED|Overall Study||34
10095331|NCT02356471|11223861|FG000|COMPLETED|Overall Study||28
10095332|NCT02356471|11223861|FG000|NOT COMPLETED|Overall Study||6
9867016|NCT00959985|10980732|FG000|STARTED|Overall Study||8
9867017|NCT00959985|10980733|FG001|STARTED|Overall Study||7
9867018|NCT00959985|10980734|FG002|STARTED|Overall Study||4
10095333|NCT02356484|11223865|FG000|STARTED|Overall Study||138
10095334|NCT02356484|11223865|FG000|COMPLETED|Overall Study||138
10095335|NCT02356484|11223865|FG000|NOT COMPLETED|Overall Study||0
10095336|NCT02356562|11223871|FG000|STARTED|Overall Study||22
10095337|NCT02356562|11223872|FG001|STARTED|Overall Study||7
10095338|NCT02356562|11223871|FG000|COMPLETED|Overall Study||20
10095339|NCT02356562|11223872|FG001|COMPLETED|Overall Study||6
10095340|NCT02356562|11223871|FG000|NOT COMPLETED|Overall Study||2
10095341|NCT02356562|11223872|FG001|NOT COMPLETED|Overall Study||1
10095342|NCT02356588|11223881|FG000|STARTED|Overall Study||107
10095343|NCT02356588|11223882|FG001|STARTED|Overall Study||54
10095344|NCT02356588|11223881|FG000|COMPLETED|Overall Study||102
10095345|NCT02356588|11223882|FG001|COMPLETED|Overall Study||41
10095346|NCT02356588|11223881|FG000|NOT COMPLETED|Overall Study||5
10095347|NCT02356588|11223882|FG001|NOT COMPLETED|Overall Study||13
10095348|NCT02356692|11223888|FG000|STARTED|Overall Study||60
10095349|NCT02356692|11223889|FG001|STARTED|Overall Study||60
10095350|NCT02356692|11223888|FG000|COMPLETED|Overall Study||60
10095351|NCT02356692|11223889|FG001|COMPLETED|Overall Study||60
10095352|NCT02356692|11223888|FG000|NOT COMPLETED|Overall Study||0
9867019|NCT00959985|10980735|FG003|STARTED|Overall Study||4
9867020|NCT00959985|10980732|FG000|COMPLETED|Overall Study||8
10095353|NCT02356692|11223889|FG001|NOT COMPLETED|Overall Study||0
10095354|NCT02356783|11223899|FG000|STARTED|Overall Study||16
10095355|NCT02356783|11223900|FG001|STARTED|Overall Study||17
10095356|NCT02356783|11223899|FG000|COMPLETED|Overall Study||15
10095357|NCT02356783|11223900|FG001|COMPLETED|Overall Study||14
10095358|NCT02356783|11223899|FG000|NOT COMPLETED|Overall Study||1
10095359|NCT02356783|11223900|FG001|NOT COMPLETED|Overall Study||3
10095360|NCT02356887|11223906|FG000|STARTED|Overall Study||12
9867021|NCT00959985|10980733|FG001|COMPLETED|Overall Study||7
9867022|NCT00959985|10980734|FG002|COMPLETED|Overall Study||4
9867023|NCT00959985|10980735|FG003|COMPLETED|Overall Study||4
9867024|NCT00959985|10980732|FG000|NOT COMPLETED|Overall Study||0
9867025|NCT00959985|10980733|FG001|NOT COMPLETED|Overall Study||0
9867026|NCT00959985|10980734|FG002|NOT COMPLETED|Overall Study||0
10095361|NCT02356887|11223906|FG000|COMPLETED|Overall Study||10
10095362|NCT02356887|11223906|FG000|NOT COMPLETED|Overall Study||2
10095363|NCT02356900|11223918|FG000|STARTED|Overall Study||11
10095364|NCT02356900|11223919|FG001|STARTED|Overall Study||10
10095365|NCT02356900|11223918|FG000|COMPLETED|Overall Study||11
10095366|NCT02356900|11223919|FG001|COMPLETED|Overall Study||10
10095367|NCT02356900|11223918|FG000|NOT COMPLETED|Overall Study||0
10095368|NCT02356900|11223919|FG001|NOT COMPLETED|Overall Study||0
10095369|NCT02357043|11223925|FG000|STARTED|Overall Study||368
10095370|NCT02357043|11223925|FG000|COMPLETED|Overall Study||368
10095371|NCT02357043|11223925|FG000|NOT COMPLETED|Overall Study||0
10112944|NCT02506816|11243882|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
10112945|NCT02506816|11243882|FG000|COMPLETED|Overall Study||33
10112946|NCT02506816|11243882|FG000|NOT COMPLETED|Overall Study||3
10112947|NCT02506868|11243888|FG000|STARTED|Main Period of Study (24 Weeks)||98
10112948|NCT02506868|11243889|FG001|STARTED|Main Period of Study (24 Weeks)||98
10112949|NCT02506868|11243888|FG000|mITT Population|Main Period of Study (24 Weeks)||98
10112950|NCT02506868|11243889|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
10112951|NCT02506868|11243888|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86
10112952|NCT02506868|11243889|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90
10112953|NCT02506868|11243888|FG000|COMPLETED|Main Period of Study (24 Weeks)||86
10112954|NCT02506868|11243889|FG001|COMPLETED|Main Period of Study (24 Weeks)||90
10112955|NCT02506868|11243888|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12
10112956|NCT02506868|11243889|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8
10112957|NCT02506868|11243888|FG000|STARTED|Additional Period of Study (Until 52W)||86
10112958|NCT02506868|11243889|FG001|STARTED|Additional Period of Study (Until 52W)||90
10112959|NCT02506868|11243888|FG000|COMPLETED|Additional Period of Study (Until 52W)||83
10112960|NCT02506868|11243889|FG001|COMPLETED|Additional Period of Study (Until 52W)||85
10112961|NCT02506868|11243888|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3
10112962|NCT02506868|11243889|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5
10112963|NCT02506881|11243903|FG000|STARTED|First Intervention (Day 1)||13
10112964|NCT02506881|11243904|FG001|STARTED|First Intervention (Day 1)||12
10112965|NCT02506881|11243905|FG002|STARTED|First Intervention (Day 1)||25
10112966|NCT02506881|11243906|FG003|STARTED|First Intervention (Day 1)||24
10112967|NCT02506881|11243903|FG000|COMPLETED|First Intervention (Day 1)||12
10112968|NCT02506881|11243904|FG001|COMPLETED|First Intervention (Day 1)||12
10112969|NCT02506881|11243905|FG002|COMPLETED|First Intervention (Day 1)||12
10112970|NCT02506881|11243906|FG003|COMPLETED|First Intervention (Day 1)||12
10112971|NCT02506881|11243903|FG000|NOT COMPLETED|First Intervention (Day 1)||1
10112972|NCT02506881|11243904|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10112973|NCT02506881|11243905|FG002|NOT COMPLETED|First Intervention (Day 1)||13
10112974|NCT02506881|11243906|FG003|NOT COMPLETED|First Intervention (Day 1)||12
10112975|NCT02506881|11243903|FG000|STARTED|Washout (at Least 25 Days)||12
10112976|NCT02506881|11243904|FG001|STARTED|Washout (at Least 25 Days)||12
10112977|NCT02506881|11243905|FG002|STARTED|Washout (at Least 25 Days)||12
10112978|NCT02506881|11243906|FG003|STARTED|Washout (at Least 25 Days)||12
10112979|NCT02506881|11243903|FG000|COMPLETED|Washout (at Least 25 Days)||12
10112980|NCT02506881|11243904|FG001|COMPLETED|Washout (at Least 25 Days)||12
10112981|NCT02506881|11243905|FG002|COMPLETED|Washout (at Least 25 Days)||12
10112982|NCT02506881|11243906|FG003|COMPLETED|Washout (at Least 25 Days)||12
10112983|NCT02506881|11243903|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0
10112984|NCT02506881|11243904|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0
9867027|NCT00959985|10980735|FG003|NOT COMPLETED|Overall Study||0
9867028|NCT00960011|10980747|FG000|STARTED|Overall Study||33
9867029|NCT00960011|10980748|FG001|STARTED|Overall Study||25
9867030|NCT00960011|10980747|FG000|COMPLETED|Overall Study||22
9867031|NCT00960011|10980748|FG001|COMPLETED|Overall Study||23
9867032|NCT00960011|10980747|FG000|NOT COMPLETED|Overall Study||11
9867033|NCT00960011|10980748|FG001|NOT COMPLETED|Overall Study||2
9867034|NCT00960063|10980791|FG000|STARTED|Overall Study||1
9867035|NCT00960063|10980792|FG001|STARTED|Overall Study||0
9867036|NCT00960063|10980793|FG002|STARTED|Overall Study||3
9867037|NCT00960063|10980791|FG000|COMPLETED|Overall Study||0
9867038|NCT00960063|10980792|FG001|COMPLETED|Overall Study||0
9867039|NCT00960063|10980793|FG002|COMPLETED|Overall Study||0
9867040|NCT00960063|10980791|FG000|NOT COMPLETED|Overall Study||1
9867041|NCT00960063|10980792|FG001|NOT COMPLETED|Overall Study||0
9867042|NCT00960063|10980793|FG002|NOT COMPLETED|Overall Study||3
9867043|NCT00960076|10980803|FG000|STARTED|Overall Study|Randomized and treated|138
10112985|NCT02506881|11243905|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0
10112986|NCT02506881|11243906|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0
10112987|NCT02506881|11243903|FG000|STARTED|Second Intervention (Day 1)||12
10112988|NCT02506881|11243904|FG001|STARTED|Second Intervention (Day 1)||12
9867044|NCT00960076|10980804|FG001|STARTED|Overall Study|Randomized and treated|144
9867045|NCT00960076|10980803|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
9867046|NCT00960076|10980804|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
9867047|NCT00960076|10980803|FG000|NOT COMPLETED|Overall Study||8
9867048|NCT00960076|10980804|FG001|NOT COMPLETED|Overall Study||25
10095372|NCT02357134|11223933|FG000|STARTED|Overall Study||11
10095373|NCT02357134|11223934|FG001|STARTED|Overall Study||11
10095374|NCT02357134|11223935|FG002|STARTED|Overall Study||12
10095375|NCT02357134|11223936|FG003|STARTED|Overall Study||11
10095376|NCT02357134|11223933|FG000|COMPLETED|Overall Study||10
10095377|NCT02357134|11223934|FG001|COMPLETED|Overall Study||11
10095378|NCT02357134|11223935|FG002|COMPLETED|Overall Study||12
10095379|NCT02357134|11223936|FG003|COMPLETED|Overall Study||11
10095380|NCT02357134|11223933|FG000|NOT COMPLETED|Overall Study||1
10095381|NCT02357134|11223934|FG001|NOT COMPLETED|Overall Study||0
10095382|NCT02357134|11223935|FG002|NOT COMPLETED|Overall Study||0
10095383|NCT02357134|11223936|FG003|NOT COMPLETED|Overall Study||0
10095384|NCT02357147|11223948|FG000|STARTED|Combination Treatment Phase||52
10095385|NCT02357147|11223949|FG001|STARTED|Combination Treatment Phase||56
10095386|NCT02357147|11223948|FG000|Treated|Combination Treatment Phase||52
10095387|NCT02357147|11223949|FG001|Treated|Combination Treatment Phase||54
10095388|NCT02357147|11223948|FG000|COMPLETED|Combination Treatment Phase||26
10095389|NCT02357147|11223949|FG001|COMPLETED|Combination Treatment Phase||29
10095390|NCT02357147|11223948|FG000|NOT COMPLETED|Combination Treatment Phase||26
10095391|NCT02357147|11223949|FG001|NOT COMPLETED|Combination Treatment Phase||27
10095392|NCT02357147|11223948|FG000|STARTED|Maintenance Treatment Phase||26
10095393|NCT02357147|11223949|FG001|STARTED|Maintenance Treatment Phase||29
10095394|NCT02357147|11223948|FG000|Treated|Maintenance Treatment Phase||25
10095395|NCT02357147|11223949|FG001|Treated|Maintenance Treatment Phase||29
10095396|NCT02357147|11223948|FG000|COMPLETED|Maintenance Treatment Phase||0
10095397|NCT02357147|11223949|FG001|COMPLETED|Maintenance Treatment Phase||0
10095398|NCT02357147|11223948|FG000|NOT COMPLETED|Maintenance Treatment Phase||26
10095399|NCT02357147|11223949|FG001|NOT COMPLETED|Maintenance Treatment Phase||29
10095400|NCT02357173|11223962|FG000|STARTED|Overall Study||25
10095401|NCT02357173|11223963|FG001|STARTED|Overall Study||21
10095402|NCT02357173|11223964|FG002|STARTED|Overall Study||22
10095403|NCT02357173|11223962|FG000|COMPLETED|Overall Study||19
10095404|NCT02357173|11223963|FG001|COMPLETED|Overall Study||15
10095405|NCT02357173|11223964|FG002|COMPLETED|Overall Study||16
10095406|NCT02357173|11223962|FG000|NOT COMPLETED|Overall Study||6
10095407|NCT02357173|11223963|FG001|NOT COMPLETED|Overall Study||6
10095408|NCT02357173|11223964|FG002|NOT COMPLETED|Overall Study||6
10095409|NCT02357264|11223974|FG000|STARTED|Overall Study||56
10095410|NCT02357264|11223975|FG001|STARTED|Overall Study||130
10095411|NCT02357264|11223974|FG000|COMPLETED|Overall Study||56
10095412|NCT02357264|11223975|FG001|COMPLETED|Overall Study||130
10095413|NCT02357264|11223974|FG000|NOT COMPLETED|Overall Study||0
10095414|NCT02357264|11223975|FG001|NOT COMPLETED|Overall Study||0
10095415|NCT02357290|11223981|FG000|STARTED|Overall Study||40
10095416|NCT02357290|11223981|FG000|Exposed|Overall Study||26
10095417|NCT02357290|11223981|FG000|COMPLETED|Overall Study||14
10095418|NCT02357290|11223981|FG000|NOT COMPLETED|Overall Study||26
10095419|NCT02357342|11223987|FG000|STARTED|First 6 Months||20
10095420|NCT02357342|11223988|FG001|STARTED|First 6 Months||20
10095421|NCT02357342|11223987|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
10095422|NCT02357342|11223988|FG001|COMPLETED|First 6 Months||20
10095423|NCT02357342|11223987|FG000|NOT COMPLETED|First 6 Months||2
10095424|NCT02357342|11223988|FG001|NOT COMPLETED|First 6 Months||0
10095425|NCT02357342|11223987|FG000|STARTED|Extension Study||4
10095426|NCT02357342|11223988|FG001|STARTED|Extension Study||9
10095427|NCT02357342|11223987|FG000|COMPLETED|Extension Study||4
10095428|NCT02357342|11223988|FG001|COMPLETED|Extension Study||9
10095429|NCT02357342|11223987|FG000|NOT COMPLETED|Extension Study||0
10095430|NCT02357342|11223988|FG001|NOT COMPLETED|Extension Study||0
10095431|NCT02357368|11223998|FG000|STARTED|Overall Study||19
10095432|NCT02357368|11223999|FG001|STARTED|Overall Study||18
10095433|NCT02357368|11224000|FG002|STARTED|Overall Study||14
10095434|NCT02357368|11224001|FG003|STARTED|Overall Study||8
10095435|NCT02357368|11223998|FG000|COMPLETED|Overall Study||13
10095436|NCT02357368|11223999|FG001|COMPLETED|Overall Study||15
9867049|NCT00960115|10980812|FG000|STARTED|Overall Study||114
9867050|NCT00960115|10980813|FG001|STARTED|Overall Study||58
10095437|NCT02357368|11224000|FG002|COMPLETED|Overall Study||13
10095438|NCT02357368|11224001|FG003|COMPLETED|Overall Study||5
10095439|NCT02357368|11223998|FG000|NOT COMPLETED|Overall Study||6
10095440|NCT02357368|11223999|FG001|NOT COMPLETED|Overall Study||3
10095441|NCT02357368|11224000|FG002|NOT COMPLETED|Overall Study||1
10095442|NCT02357368|11224001|FG003|NOT COMPLETED|Overall Study||3
10095443|NCT02357394|11224013|FG000|STARTED|Overall Study||4
9867051|NCT00960115|10980812|FG000|COMPLETED|Overall Study||95
9867052|NCT00960115|10980813|FG001|COMPLETED|Overall Study||43
10095444|NCT02357394|11224014|FG001|STARTED|Overall Study||3
10095445|NCT02357394|11224013|FG000|COMPLETED|Overall Study||4
10095446|NCT02357394|11224014|FG001|COMPLETED|Overall Study||3
10095447|NCT02357394|11224013|FG000|NOT COMPLETED|Overall Study||0
10095448|NCT02357394|11224014|FG001|NOT COMPLETED|Overall Study||0
10095449|NCT02357420|11224024|FG000|STARTED|Overall Study||104
10095450|NCT02357420|11224025|FG001|STARTED|Overall Study||98
10095451|NCT02357420|11224026|FG002|STARTED|Overall Study||109
10095452|NCT02357420|11224027|FG003|STARTED|Overall Study||82
10095453|NCT02357420|11224024|FG000|Full Analysis Set (FAS)|Overall Study||104
10095454|NCT02357420|11224025|FG001|Full Analysis Set (FAS)|Overall Study||98
9867053|NCT00960115|10980812|FG000|NOT COMPLETED|Overall Study||19
9867054|NCT00960115|10980813|FG001|NOT COMPLETED|Overall Study||15
9867055|NCT00960193|10980819|FG000|STARTED|Colchicine Alone||24
9867056|NCT00960193|10980819|FG000|COMPLETED|Colchicine Alone||24
10095455|NCT02357420|11224026|FG002|Full Analysis Set (FAS)|Overall Study||109
10095456|NCT02357420|11224027|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
10095457|NCT02357420|11224024|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
10095458|NCT02357420|11224025|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
10095459|NCT02357420|11224026|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
10095460|NCT02357420|11224027|FG003|COMPLETED|Overall Study||63
10095461|NCT02357420|11224024|FG000|NOT COMPLETED|Overall Study||12
10095462|NCT02357420|11224025|FG001|NOT COMPLETED|Overall Study||12
10095463|NCT02357420|11224026|FG002|NOT COMPLETED|Overall Study||16
10095464|NCT02357420|11224027|FG003|NOT COMPLETED|Overall Study||19
10095465|NCT02357459|11224040|FG000|STARTED|Overall Study||161
10095466|NCT02357459|11224041|FG001|STARTED|Overall Study||163
10095467|NCT02357459|11224042|FG002|STARTED|Overall Study||162
10095468|NCT02357459|11224040|FG000|COMPLETED|Overall Study||144
10095469|NCT02357459|11224041|FG001|COMPLETED|Overall Study||149
10095470|NCT02357459|11224042|FG002|COMPLETED|Overall Study||150
10095471|NCT02357459|11224040|FG000|NOT COMPLETED|Overall Study||17
10095472|NCT02357459|11224041|FG001|NOT COMPLETED|Overall Study||14
10095473|NCT02357459|11224042|FG002|NOT COMPLETED|Overall Study||12
10095474|NCT02357485|11224053|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
10095475|NCT02357485|11224053|FG000|COMPLETED|Overall Study||6
10095476|NCT02357485|11224053|FG000|NOT COMPLETED|Overall Study||0
10095477|NCT02357576|11224060|FG000|STARTED|Treatment Period||12
10095478|NCT02357576|11224061|FG001|STARTED|Treatment Period||9
10095479|NCT02357576|11224060|FG000|COMPLETED|Treatment Period||12
10095480|NCT02357576|11224061|FG001|COMPLETED|Treatment Period||7
10095481|NCT02357576|11224060|FG000|NOT COMPLETED|Treatment Period||0
10095482|NCT02357576|11224061|FG001|NOT COMPLETED|Treatment Period||2
10095483|NCT02357576|11224060|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
10095484|NCT02357576|11224061|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7
10095485|NCT02357576|11224060|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6
10095486|NCT02357576|11224061|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2
10095487|NCT02357576|11224060|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
10095488|NCT02357576|11224061|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
10095489|NCT02357706|11224067|FG000|STARTED|Overall Study||10
10095490|NCT02357706|11224068|FG001|STARTED|Overall Study||10
10095491|NCT02357706|11224067|FG000|COMPLETED|Overall Study||10
10095492|NCT02357706|11224068|FG001|COMPLETED|Overall Study||10
10095493|NCT02357706|11224067|FG000|NOT COMPLETED|Overall Study||0
10095494|NCT02357706|11224068|FG001|NOT COMPLETED|Overall Study||0
10095495|NCT02357758|11224080|FG000|STARTED|Overall Study||25
10095496|NCT02357758|11224081|FG001|STARTED|Overall Study||20
10095497|NCT02357758|11224082|FG002|STARTED|Overall Study||12
10095498|NCT02357758|11224080|FG000|COMPLETED|Overall Study||9
10095499|NCT02357758|11224081|FG001|COMPLETED|Overall Study||20
10095500|NCT02357758|11224082|FG002|COMPLETED|Overall Study||5
10095501|NCT02357758|11224080|FG000|NOT COMPLETED|Overall Study||16
10095502|NCT02357758|11224081|FG001|NOT COMPLETED|Overall Study||0
10095503|NCT02357758|11224082|FG002|NOT COMPLETED|Overall Study||7
10095504|NCT02357836|11224090|FG000|STARTED|Overall Study||13
10095505|NCT02357836|11224090|FG000|COMPLETED|Overall Study||13
10095506|NCT02357836|11224090|FG000|NOT COMPLETED|Overall Study||0
10095507|NCT02357901|11224098|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
10095508|NCT02357901|11224099|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
10095509|NCT02357901|11224100|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
10095510|NCT02357901|11224101|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
10095511|NCT02357901|11224098|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504
10095512|NCT02357901|11224099|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10095513|NCT02357901|11224100|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10095514|NCT02357901|11224101|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10095515|NCT02357901|11224098|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
10095516|NCT02357901|11224099|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10095517|NCT02357901|11224100|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10095518|NCT02357901|11224101|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10095519|NCT02357901|11224098|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0
10095520|NCT02357901|11224099|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203
10095521|NCT02357901|11224100|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201
10095522|NCT02357901|11224101|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100
10095523|NCT02357901|11224098|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
10095524|NCT02357901|11224099|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
10095525|NCT02357901|11224100|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
9867057|NCT00960193|10980819|FG000|NOT COMPLETED|Colchicine Alone||0
9867058|NCT00960193|10980819|FG000|STARTED|14 Day Washout Period||24
9867059|NCT00960193|10980819|FG000|COMPLETED|14 Day Washout Period||23
9867060|NCT00960193|10980819|FG000|NOT COMPLETED|14 Day Washout Period||1
9867061|NCT00960193|10980819|FG000|STARTED|Seville Orange Juice Alone||23
9867062|NCT00960193|10980819|FG000|COMPLETED|Seville Orange Juice Alone||23
9867063|NCT00960193|10980819|FG000|NOT COMPLETED|Seville Orange Juice Alone||0
9867064|NCT00960193|10980819|FG000|STARTED|Colchicine With Seville Orange Juice||23
9867065|NCT00960193|10980819|FG000|COMPLETED|Colchicine With Seville Orange Juice||23
9867066|NCT00960193|10980819|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0
9867067|NCT00960206|10980829|FG000|STARTED|Overall Study||190
9867068|NCT00960206|10980830|FG001|STARTED|Overall Study||185
9867069|NCT00960206|10980831|FG002|STARTED|Overall Study||89
9867070|NCT00960206|10980829|FG000|COMPLETED|Overall Study||150
9867071|NCT00960206|10980830|FG001|COMPLETED|Overall Study||158
9867072|NCT00960206|10980831|FG002|COMPLETED|Overall Study||77
9867073|NCT00960206|10980829|FG000|NOT COMPLETED|Overall Study||40
9867074|NCT00960206|10980830|FG001|NOT COMPLETED|Overall Study||27
9867075|NCT00960206|10980831|FG002|NOT COMPLETED|Overall Study||12
9867076|NCT00960323|10980840|FG000|STARTED|Colchicine Alone||24
9867077|NCT00960323|10980840|FG000|COMPLETED|Colchicine Alone||24
9867078|NCT00960323|10980840|FG000|NOT COMPLETED|Colchicine Alone||0
9867079|NCT00960323|10980840|FG000|STARTED|14 Day Washout Period||24
9867080|NCT00960323|10980840|FG000|COMPLETED|14 Day Washout Period||24
9867081|NCT00960323|10980840|FG000|NOT COMPLETED|14 Day Washout Period||0
9867082|NCT00960323|10980840|FG000|STARTED|Atorvastatin Alone||24
9867083|NCT00960323|10980840|FG000|COMPLETED|Atorvastatin Alone||23
9867084|NCT00960323|10980840|FG000|NOT COMPLETED|Atorvastatin Alone||1
9867085|NCT00960323|10980840|FG000|STARTED|Colchicine and Atorvastatin||23
9867086|NCT00960323|10980840|FG000|COMPLETED|Colchicine and Atorvastatin||23
9867087|NCT00960323|10980840|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0
9867088|NCT00960375|10980850|FG000|STARTED|Overall Study||92
9867089|NCT00960375|10980851|FG001|STARTED|Overall Study||87
9867090|NCT00960375|10980850|FG000|COMPLETED|Overall Study||72
9867091|NCT00960375|10980851|FG001|COMPLETED|Overall Study||65
9867092|NCT00960375|10980850|FG000|NOT COMPLETED|Overall Study||20
9867093|NCT00960375|10980851|FG001|NOT COMPLETED|Overall Study||22
9867094|NCT00960440|10980861|FG000|STARTED|Overall Study||133
9867095|NCT00960440|10980862|FG001|STARTED|Overall Study||134
9867096|NCT00960440|10980863|FG002|STARTED|Overall Study||66
9867097|NCT00960440|10980864|FG003|STARTED|Overall Study||66
9867098|NCT00960440|10980861|FG000|COMPLETED|Overall Study||107
9867099|NCT00960440|10980862|FG001|COMPLETED|Overall Study||103
9867100|NCT00960440|10980863|FG002|COMPLETED|Overall Study||53
9867101|NCT00960440|10980864|FG003|COMPLETED|Overall Study||48
9867102|NCT00960440|10980861|FG000|NOT COMPLETED|Overall Study||26
9867103|NCT00960440|10980862|FG001|NOT COMPLETED|Overall Study||31
9867104|NCT00960440|10980863|FG002|NOT COMPLETED|Overall Study||13
9867105|NCT00960440|10980864|FG003|NOT COMPLETED|Overall Study||18
9867106|NCT00960505|10980879|FG000|STARTED|Overall Study||34
9867107|NCT00960505|10980880|FG001|STARTED|Overall Study||35
9867108|NCT00960505|10980881|FG002|STARTED|Overall Study||31
9867109|NCT00960505|10980879|FG000|COMPLETED|Overall Study||21
9867110|NCT00960505|10980880|FG001|COMPLETED|Overall Study||25
9867111|NCT00960505|10980881|FG002|COMPLETED|Overall Study||23
9867112|NCT00960505|10980879|FG000|NOT COMPLETED|Overall Study||13
9867113|NCT00960505|10980880|FG001|NOT COMPLETED|Overall Study||10
9867114|NCT00960505|10980881|FG002|NOT COMPLETED|Overall Study||8
9867115|NCT00960531|10980899|FG000|STARTED|Overall Study|Started=Randomized|21
9867116|NCT00960531|10980900|FG001|STARTED|Overall Study|Started=Randomized|6
9867117|NCT00960531|10980901|FG002|STARTED|Overall Study|Started=Randomized|41
9867118|NCT00960531|10980902|FG003|STARTED|Overall Study|Started=Randomized.|25
9867119|NCT00960531|10980903|FG004|STARTED|Overall Study|Started=Randomized|5
9867120|NCT00960531|10980904|FG005|STARTED|Overall Study|Started=Randomized|9
9867121|NCT00960531|10980905|FG006|STARTED|Overall Study|Started=Randomized|27
9867122|NCT00960531|10980906|FG007|STARTED|Overall Study|Started=Randomized|6
9867123|NCT00960531|10980907|FG008|STARTED|Overall Study|Started=Randomized|16
9867124|NCT00960531|10980908|FG009|STARTED|Overall Study|Started=Randomized|4
9867125|NCT00960531|10980899|FG000|Treated|Overall Study||21
9867126|NCT00960531|10980900|FG001|Treated|Overall Study||6
9867127|NCT00960531|10980901|FG002|Treated|Overall Study||41
9867128|NCT00960531|10980902|FG003|Treated|Overall Study||24
9867129|NCT00960531|10980903|FG004|Treated|Overall Study||5
9867130|NCT00960531|10980904|FG005|Treated|Overall Study||9
9867131|NCT00960531|10980905|FG006|Treated|Overall Study||27
9867132|NCT00960531|10980906|FG007|Treated|Overall Study||6
9867133|NCT00960531|10980907|FG008|Treated|Overall Study||16
9867134|NCT00960531|10980908|FG009|Treated|Overall Study||4
9867135|NCT00960531|10980899|FG000|Completed Treatment|Overall Study||12
9867136|NCT00960531|10980900|FG001|Completed Treatment|Overall Study||5
9867137|NCT00960531|10980901|FG002|Completed Treatment|Overall Study||15
9867138|NCT00960531|10980902|FG003|Completed Treatment|Overall Study||17
9867139|NCT00960531|10980903|FG004|Completed Treatment|Overall Study||3
9867140|NCT00960531|10980904|FG005|Completed Treatment|Overall Study||7
9867141|NCT00960531|10980905|FG006|Completed Treatment|Overall Study||4
9867142|NCT00960531|10980906|FG007|Completed Treatment|Overall Study||3
9867143|NCT00960531|10980907|FG008|Completed Treatment|Overall Study||2
9867144|NCT00960531|10980908|FG009|Completed Treatment|Overall Study||4
9867145|NCT00960531|10980899|FG000|COMPLETED|Overall Study|Completed study|11
9867146|NCT00960531|10980900|FG001|COMPLETED|Overall Study|Completed study|5
9867147|NCT00960531|10980901|FG002|COMPLETED|Overall Study|Completed study|15
9867148|NCT00960531|10980902|FG003|COMPLETED|Overall Study|Completed study|17
9867149|NCT00960531|10980903|FG004|COMPLETED|Overall Study|Completed study|3
9867150|NCT00960531|10980904|FG005|COMPLETED|Overall Study|Completed study|6
9867151|NCT00960531|10980905|FG006|COMPLETED|Overall Study|Completed study|3
9867152|NCT00960531|10980906|FG007|COMPLETED|Overall Study|Completed study|2
9867153|NCT00960531|10980907|FG008|COMPLETED|Overall Study|Completed study|2
9867154|NCT00960531|10980908|FG009|COMPLETED|Overall Study|Completed study|3
9867155|NCT00960531|10980899|FG000|NOT COMPLETED|Overall Study||10
9867156|NCT00960531|10980900|FG001|NOT COMPLETED|Overall Study||1
9867157|NCT00960531|10980901|FG002|NOT COMPLETED|Overall Study||26
9867158|NCT00960531|10980902|FG003|NOT COMPLETED|Overall Study||8
9867159|NCT00960531|10980903|FG004|NOT COMPLETED|Overall Study||2
9867160|NCT00960531|10980904|FG005|NOT COMPLETED|Overall Study||3
9867161|NCT00960531|10980905|FG006|NOT COMPLETED|Overall Study||24
9867162|NCT00960531|10980906|FG007|NOT COMPLETED|Overall Study||4
9867163|NCT00960531|10980907|FG008|NOT COMPLETED|Overall Study||14
9867164|NCT00960531|10980908|FG009|NOT COMPLETED|Overall Study||1
9867165|NCT00960570|10980934|FG000|STARTED|Efavirenz Alone||30
9867166|NCT00960570|10980934|FG000|COMPLETED|Efavirenz Alone||30
9867167|NCT00960570|10980934|FG000|NOT COMPLETED|Efavirenz Alone||0
9867168|NCT00960570|10980934|FG000|STARTED|21 Day Washout Period||30
9867169|NCT00960570|10980934|FG000|COMPLETED|21 Day Washout Period||28
9867170|NCT00960570|10980934|FG000|NOT COMPLETED|21 Day Washout Period||2
9867171|NCT00960570|10980934|FG000|STARTED|Fenofibric Acid Alone||28
9867172|NCT00960570|10980934|FG000|COMPLETED|Fenofibric Acid Alone||28
9867173|NCT00960570|10980934|FG000|NOT COMPLETED|Fenofibric Acid Alone||0
9867174|NCT00960570|10980934|FG000|STARTED|1 Day Period Between Dosing||28
9867175|NCT00960570|10980934|FG000|COMPLETED|1 Day Period Between Dosing||25
9867176|NCT00960570|10980934|FG000|NOT COMPLETED|1 Day Period Between Dosing||3
9867177|NCT00960570|10980934|FG000|STARTED|Efavirenz and Fenofibric Acid||25
9867178|NCT00960570|10980934|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25
9867179|NCT00960570|10980934|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
9867180|NCT00960622|10980943|FG000|STARTED|Overall Study||10
9867181|NCT00960622|10980944|FG001|STARTED|Overall Study||10
9867182|NCT00960622|10980943|FG000|COMPLETED|Overall Study||10
9867183|NCT00960622|10980944|FG001|COMPLETED|Overall Study||7
9867184|NCT00960622|10980943|FG000|NOT COMPLETED|Overall Study||0
9867185|NCT00960622|10980944|FG001|NOT COMPLETED|Overall Study||3
9867186|NCT00960661|10980952|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036
9867187|NCT00960661|10980953|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0
9867188|NCT00960661|10980954|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0
9867189|NCT00960661|10980952|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
9867190|NCT00960661|10980953|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
9867191|NCT00960661|10980954|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
9867192|NCT00960661|10980952|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
9867193|NCT00960661|10980953|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
9867194|NCT00960661|10980954|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
9867195|NCT00960661|10980952|FG000|STARTED|Interventional Phase||0
9867196|NCT00960661|10980953|FG001|STARTED|Interventional Phase||316
9867197|NCT00960661|10980954|FG002|STARTED|Interventional Phase||321
9867198|NCT00960661|10980952|FG000|Intent to Treat Population|Interventional Phase||0
9867199|NCT00960661|10980953|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
9867200|NCT00960661|10980954|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
9867201|NCT00960661|10980952|FG000|Per Protocol Population|Interventional Phase||0
9867202|NCT00960661|10980953|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
9867203|NCT00960661|10980954|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
9867204|NCT00960661|10980952|FG000|COMPLETED|Interventional Phase||0
9867205|NCT00960661|10980953|FG001|COMPLETED|Interventional Phase||264
9867206|NCT00960661|10980954|FG002|COMPLETED|Interventional Phase||275
9867207|NCT00960661|10980952|FG000|NOT COMPLETED|Interventional Phase||0
9867208|NCT00960661|10980953|FG001|NOT COMPLETED|Interventional Phase||52
9867209|NCT00960661|10980954|FG002|NOT COMPLETED|Interventional Phase||46
9867210|NCT00960687|10980960|FG000|STARTED|First Intervention||27
9867211|NCT00960687|10980961|FG001|STARTED|First Intervention||27
9867212|NCT00960687|10980960|FG000|COMPLETED|First Intervention||27
9867213|NCT00960687|10980961|FG001|COMPLETED|First Intervention||27
9867214|NCT00960687|10980960|FG000|NOT COMPLETED|First Intervention||0
9867215|NCT00960687|10980961|FG001|NOT COMPLETED|First Intervention||0
9867216|NCT00960687|10980960|FG000|STARTED|Washout Period of 7 Days||27
9867217|NCT00960687|10980961|FG001|STARTED|Washout Period of 7 Days||27
9867218|NCT00960687|10980960|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
9867219|NCT00960687|10980961|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
9867220|NCT00960687|10980960|FG000|NOT COMPLETED|Washout Period of 7 Days||4
9867221|NCT00960687|10980961|FG001|NOT COMPLETED|Washout Period of 7 Days||3
9867222|NCT00960687|10980960|FG000|STARTED|Second Intervention||23
9867223|NCT00960687|10980961|FG001|STARTED|Second Intervention||24
9867224|NCT00960687|10980960|FG000|COMPLETED|Second Intervention||23
9867225|NCT00960687|10980961|FG001|COMPLETED|Second Intervention||24
9867226|NCT00960687|10980960|FG000|NOT COMPLETED|Second Intervention||0
9867227|NCT00960687|10980961|FG001|NOT COMPLETED|Second Intervention||0
9867228|NCT00960778|10980969|FG000|STARTED|Overall Study||17
9867229|NCT00960778|10980970|FG001|STARTED|Overall Study||16
9867230|NCT00960778|10980969|FG000|COMPLETED|Overall Study||8
9867231|NCT00960778|10980970|FG001|COMPLETED|Overall Study||13
9867232|NCT00960778|10980969|FG000|NOT COMPLETED|Overall Study||9
9867233|NCT00960778|10980970|FG001|NOT COMPLETED|Overall Study||3
9867234|NCT00960804|10980979|FG000|STARTED|Overall Study||7
9867235|NCT00960804|10980980|FG001|STARTED|Overall Study||4
9867236|NCT00960804|10980981|FG002|STARTED|Overall Study||10
9867237|NCT00960804|10980979|FG000|COMPLETED|Overall Study||0
9867238|NCT00960804|10980980|FG001|COMPLETED|Overall Study||0
9867239|NCT00960804|10980981|FG002|COMPLETED|Overall Study||0
9867240|NCT00960804|10980979|FG000|NOT COMPLETED|Overall Study||7
9867241|NCT00960804|10980980|FG001|NOT COMPLETED|Overall Study||4
9867242|NCT00960804|10980981|FG002|NOT COMPLETED|Overall Study||10
9867243|NCT00960843|10980991|FG000|STARTED|Overall Study||25
9867244|NCT00960843|10980992|FG001|STARTED|Overall Study||26
9867245|NCT00960843|10980991|FG000|COMPLETED|Overall Study||23
9867246|NCT00960843|10980992|FG001|COMPLETED|Overall Study||21
9867247|NCT00960843|10980991|FG000|NOT COMPLETED|Overall Study||2
9867248|NCT00960843|10980992|FG001|NOT COMPLETED|Overall Study||5
9867249|NCT00960856|10980998|FG000|STARTED|Period I||10
9867250|NCT00960856|10980999|FG001|STARTED|Period I||9
9867251|NCT00960856|10981000|FG002|STARTED|Period I||9
9867252|NCT00960856|10981001|FG003|STARTED|Period I||9
9867253|NCT00960856|10980998|FG000|COMPLETED|Period I||10
9867254|NCT00960856|10980999|FG001|COMPLETED|Period I||9
9867255|NCT00960856|10981000|FG002|COMPLETED|Period I||9
9867256|NCT00960856|10981001|FG003|COMPLETED|Period I||9
9867257|NCT00960856|10980998|FG000|NOT COMPLETED|Period I||0
9867258|NCT00960856|10980999|FG001|NOT COMPLETED|Period I||0
9867259|NCT00960856|10981000|FG002|NOT COMPLETED|Period I||0
9867260|NCT00960856|10981001|FG003|NOT COMPLETED|Period I||0
9867261|NCT00960856|10980998|FG000|STARTED|Washout Period of 7 Days||10
9867262|NCT00960856|10980999|FG001|STARTED|Washout Period of 7 Days||9
9867263|NCT00960856|10981000|FG002|STARTED|Washout Period of 7 Days||9
9867264|NCT00960856|10981001|FG003|STARTED|Washout Period of 7 Days||9
9867265|NCT00960856|10980998|FG000|COMPLETED|Washout Period of 7 Days||10
9867266|NCT00960856|10980999|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7
9867267|NCT00960856|10981000|FG002|COMPLETED|Washout Period of 7 Days||9
9867268|NCT00960856|10981001|FG003|COMPLETED|Washout Period of 7 Days||9
9867269|NCT00960856|10980998|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9867270|NCT00960856|10980999|FG001|NOT COMPLETED|Washout Period of 7 Days||2
9867271|NCT00960856|10981000|FG002|NOT COMPLETED|Washout Period of 7 Days||0
9867272|NCT00960856|10981001|FG003|NOT COMPLETED|Washout Period of 7 Days||0
9867273|NCT00960856|10980998|FG000|STARTED|Period II||10
9867274|NCT00960856|10980999|FG001|STARTED|Period II||7
9867275|NCT00960856|10981000|FG002|STARTED|Period II||9
9867276|NCT00960856|10981001|FG003|STARTED|Period II||9
9867277|NCT00960856|10980998|FG000|COMPLETED|Period II||10
9867278|NCT00960856|10980999|FG001|COMPLETED|Period II||7
9867279|NCT00960856|10981000|FG002|COMPLETED|Period II||9
9867280|NCT00960856|10981001|FG003|COMPLETED|Period II||9
9867281|NCT00960856|10980998|FG000|NOT COMPLETED|Period II||0
9867282|NCT00960856|10980999|FG001|NOT COMPLETED|Period II||0
9867283|NCT00960856|10981000|FG002|NOT COMPLETED|Period II||0
9867284|NCT00960856|10981001|FG003|NOT COMPLETED|Period II||0
9867285|NCT00960856|10980998|FG000|STARTED|Washout Period of 7 Days||10
9867286|NCT00960856|10980999|FG001|STARTED|Washout Period of 7 Days||7
9867287|NCT00960856|10981000|FG002|STARTED|Washout Period of 7 Days||9
9867288|NCT00960856|10981001|FG003|STARTED|Washout Period of 7 Days||9
9867289|NCT00960856|10980998|FG000|COMPLETED|Washout Period of 7 Days||10
9867290|NCT00960856|10980999|FG001|COMPLETED|Washout Period of 7 Days||7
9867291|NCT00960856|10981000|FG002|COMPLETED|Washout Period of 7 Days||9
9867292|NCT00960856|10981001|FG003|COMPLETED|Washout Period of 7 Days||9
9867293|NCT00960856|10980998|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9867294|NCT00960856|10980999|FG001|NOT COMPLETED|Washout Period of 7 Days||0
9867295|NCT00960856|10981000|FG002|NOT COMPLETED|Washout Period of 7 Days||0
9867296|NCT00960856|10981001|FG003|NOT COMPLETED|Washout Period of 7 Days||0
9867297|NCT00960856|10980998|FG000|STARTED|Period III||10
9867298|NCT00960856|10980999|FG001|STARTED|Period III||7
9867299|NCT00960856|10981000|FG002|STARTED|Period III||9
9867300|NCT00960856|10981001|FG003|STARTED|Period III||9
9867301|NCT00960856|10980998|FG000|COMPLETED|Period III||10
9867302|NCT00960856|10980999|FG001|COMPLETED|Period III||7
9867303|NCT00960856|10981000|FG002|COMPLETED|Period III||9
9867304|NCT00960856|10981001|FG003|COMPLETED|Period III||9
9867305|NCT00960856|10980998|FG000|NOT COMPLETED|Period III||0
9867306|NCT00960856|10980999|FG001|NOT COMPLETED|Period III||0
9867307|NCT00960856|10981000|FG002|NOT COMPLETED|Period III||0
9867308|NCT00960856|10981001|FG003|NOT COMPLETED|Period III||0
9867309|NCT00960856|10980998|FG000|STARTED|Washout Period of 7 Days||10
9867310|NCT00960856|10980999|FG001|STARTED|Washout Period of 7 Days||7
9867311|NCT00960856|10981000|FG002|STARTED|Washout Period of 7 Days||9
9867312|NCT00960856|10981001|FG003|STARTED|Washout Period of 7 Days||9
9867313|NCT00960856|10980998|FG000|COMPLETED|Washout Period of 7 Days||10
9867314|NCT00960856|10980999|FG001|COMPLETED|Washout Period of 7 Days||7
9867315|NCT00960856|10981000|FG002|COMPLETED|Washout Period of 7 Days||8
9867316|NCT00960856|10981001|FG003|COMPLETED|Washout Period of 7 Days||9
9867317|NCT00960856|10980998|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9867318|NCT00960856|10980999|FG001|NOT COMPLETED|Washout Period of 7 Days||0
9867319|NCT00960856|10981000|FG002|NOT COMPLETED|Washout Period of 7 Days||1
9867320|NCT00960856|10981001|FG003|NOT COMPLETED|Washout Period of 7 Days||0
9867321|NCT00960856|10980998|FG000|STARTED|Period IV||10
9867322|NCT00960856|10980999|FG001|STARTED|Period IV||7
9867323|NCT00960856|10981000|FG002|STARTED|Period IV||8
9867324|NCT00960856|10981001|FG003|STARTED|Period IV||9
9867325|NCT00960856|10980998|FG000|COMPLETED|Period IV||10
9867326|NCT00960856|10980999|FG001|COMPLETED|Period IV||7
9867327|NCT00960856|10981000|FG002|COMPLETED|Period IV||8
9867328|NCT00960856|10981001|FG003|COMPLETED|Period IV||9
9867329|NCT00960856|10980998|FG000|NOT COMPLETED|Period IV||0
9867330|NCT00960856|10980999|FG001|NOT COMPLETED|Period IV||0
9867331|NCT00960856|10981000|FG002|NOT COMPLETED|Period IV||0
9867332|NCT00960856|10981001|FG003|NOT COMPLETED|Period IV||0
9867333|NCT00960869|10981013|FG000|STARTED|Overall Study||259
9867334|NCT00960869|10981014|FG001|STARTED|Overall Study||260
9867335|NCT00960869|10981013|FG000|Intent-to-Treat Population (ITT)|Overall Study||259
9867336|NCT00960869|10981014|FG001|Intent-to-Treat Population (ITT)|Overall Study||260
9867337|NCT00960869|10981013|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
9867338|NCT00960869|10981014|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
9867339|NCT00960869|10981013|FG000|COMPLETED|Overall Study||206
9867340|NCT00960869|10981014|FG001|COMPLETED|Overall Study||198
9867341|NCT00960869|10981013|FG000|NOT COMPLETED|Overall Study||53
9867342|NCT00960869|10981014|FG001|NOT COMPLETED|Overall Study||62
9867343|NCT00960934|10981026|FG000|STARTED|Overall Study||64
9867344|NCT00960934|10981027|FG001|STARTED|Overall Study||63
9867345|NCT00960934|10981028|FG002|STARTED|Overall Study||64
9867346|NCT00960934|10981029|FG003|STARTED|Overall Study||64
9867347|NCT00960934|10981030|FG004|STARTED|Overall Study||64
9867348|NCT00960934|10981031|FG005|STARTED|Overall Study||64
9867349|NCT00960934|10981026|FG000|Number Treated|Overall Study||64
9867350|NCT00960934|10981027|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62
9867351|NCT00960934|10981028|FG002|Number Treated|Overall Study||64
9867352|NCT00960934|10981029|FG003|Number Treated|Overall Study||64
9867353|NCT00960934|10981030|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63
9867354|NCT00960934|10981031|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63
9867355|NCT00960934|10981026|FG000|COMPLETED|Overall Study||0
9867356|NCT00960934|10981027|FG001|COMPLETED|Overall Study||0
9867357|NCT00960934|10981028|FG002|COMPLETED|Overall Study||0
9867358|NCT00960934|10981029|FG003|COMPLETED|Overall Study||0
9867359|NCT00960934|10981030|FG004|COMPLETED|Overall Study||0
9867360|NCT00960934|10981031|FG005|COMPLETED|Overall Study||0
9867361|NCT00960934|10981026|FG000|NOT COMPLETED|Overall Study||64
9867362|NCT00960934|10981027|FG001|NOT COMPLETED|Overall Study||63
9867363|NCT00960934|10981028|FG002|NOT COMPLETED|Overall Study||64
9867364|NCT00960934|10981029|FG003|NOT COMPLETED|Overall Study||64
9867365|NCT00960934|10981030|FG004|NOT COMPLETED|Overall Study||64
9867366|NCT00960934|10981031|FG005|NOT COMPLETED|Overall Study||64
9867367|NCT00960986|10981049|FG000|STARTED|Period 1 (Screening and Washout)||59
9867368|NCT00960986|10981050|FG001|STARTED|Period 1 (Screening and Washout)||63
9867369|NCT00960986|10981051|FG002|STARTED|Period 1 (Screening and Washout)||63
9867370|NCT00960986|10981052|FG003|STARTED|Period 1 (Screening and Washout)||64
9867371|NCT00960986|10981049|FG000|COMPLETED|Period 1 (Screening and Washout)||56
9867372|NCT00960986|10981050|FG001|COMPLETED|Period 1 (Screening and Washout)||59
9867373|NCT00960986|10981051|FG002|COMPLETED|Period 1 (Screening and Washout)||59
9867374|NCT00960986|10981052|FG003|COMPLETED|Period 1 (Screening and Washout)||61
9867375|NCT00960986|10981049|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3
9867376|NCT00960986|10981050|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4
9867377|NCT00960986|10981051|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4
9867378|NCT00960986|10981052|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3
9867379|NCT00960986|10981049|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56
9867380|NCT00960986|10981050|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59
9867381|NCT00960986|10981051|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59
9867382|NCT00960986|10981052|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61
9867383|NCT00960986|10981049|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
9867384|NCT00960986|10981050|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
9867385|NCT00960986|10981051|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
9867386|NCT00960986|10981052|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
9867387|NCT00960986|10981049|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
9867388|NCT00960986|10981050|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
9867389|NCT00960986|10981051|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
9867390|NCT00960986|10981052|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
9867391|NCT00960986|10981049|FG000|STARTED|Period 3 (7-week Therapy Period)||56
9867392|NCT00960986|10981050|FG001|STARTED|Period 3 (7-week Therapy Period)||59
9867393|NCT00960986|10981051|FG002|STARTED|Period 3 (7-week Therapy Period)||59
9867394|NCT00960986|10981052|FG003|STARTED|Period 3 (7-week Therapy Period)||61
9867395|NCT00960986|10981049|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26
9867396|NCT00960986|10981050|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36
9867397|NCT00960986|10981051|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39
9867398|NCT00960986|10981052|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36
9867399|NCT00960986|10981049|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
9867400|NCT00960986|10981050|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
9867401|NCT00960986|10981051|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
9867402|NCT00960986|10981052|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
9867403|NCT00960999|10981064|FG000|STARTED|Overall Study||47
9867404|NCT00960999|10981065|FG001|STARTED|Overall Study||47
9867405|NCT00960999|10981064|FG000|Eligible|Overall Study||39
9867406|NCT00960999|10981065|FG001|Eligible|Overall Study||45
9867407|NCT00960999|10981064|FG000|Started Protocol Treatment|Overall Study||39
9867408|NCT00960999|10981065|FG001|Started Protocol Treatment|Overall Study||45
9867409|NCT00960999|10981064|FG000|Primary Endpoint Population|Overall Study||38
9867410|NCT00960999|10981065|FG001|Primary Endpoint Population|Overall Study||38
9867411|NCT00960999|10981064|FG000|Peak SUV at 8 Weeks|Overall Study||3
9867412|NCT00960999|10981065|FG001|Peak SUV at 8 Weeks|Overall Study||11
9867413|NCT00960999|10981064|FG000|Peak SUV at 1 Year|Overall Study||4
9867414|NCT00960999|10981065|FG001|Peak SUV at 1 Year|Overall Study||7
9867415|NCT00960999|10981064|FG000|Normalized SUV at 8 Weeks|Overall Study||3
9867416|NCT00960999|10981065|FG001|Normalized SUV at 8 Weeks|Overall Study||9
9867417|NCT00960999|10981064|FG000|Normalized SUV at 1 Year|Overall Study||4
9867418|NCT00960999|10981065|FG001|Normalized SUV at 1 Year|Overall Study||7
9867419|NCT00960999|10981064|FG000|FEV1 by Best Response|Overall Study||26
9867420|NCT00960999|10981065|FG001|FEV1 by Best Response|Overall Study||33
9867421|NCT00960999|10981064|FG000|DLCO by Best Response|Overall Study||23
9867422|NCT00960999|10981065|FG001|DLCO by Best Response|Overall Study||28
9867423|NCT00960999|10981064|FG000|COMPLETED|Overall Study||39
9867424|NCT00960999|10981065|FG001|COMPLETED|Overall Study||45
9867425|NCT00960999|10981064|FG000|NOT COMPLETED|Overall Study||8
9867426|NCT00960999|10981065|FG001|NOT COMPLETED|Overall Study||2
9867427|NCT00961051|10981073|FG000|STARTED|Overall Study||177
9867428|NCT00961051|10981074|FG001|STARTED|Overall Study||93
9867429|NCT00961051|10981073|FG000|COMPLETED|Overall Study||165
9867430|NCT00961051|10981074|FG001|COMPLETED|Overall Study||79
9867431|NCT00961051|10981073|FG000|NOT COMPLETED|Overall Study||12
9867432|NCT00961051|10981074|FG001|NOT COMPLETED|Overall Study||14
9867433|NCT00961116|10981080|FG000|STARTED|First Intervention||27
9867434|NCT00961116|10981081|FG001|STARTED|First Intervention||27
9867435|NCT00961116|10981080|FG000|COMPLETED|First Intervention||27
9867436|NCT00961116|10981081|FG001|COMPLETED|First Intervention||27
9867437|NCT00961116|10981080|FG000|NOT COMPLETED|First Intervention||0
9867438|NCT00961116|10981081|FG001|NOT COMPLETED|First Intervention||0
9867439|NCT00961116|10981080|FG000|STARTED|Washout Period of 7 Days||27
9867440|NCT00961116|10981081|FG001|STARTED|Washout Period of 7 Days||27
9867441|NCT00961116|10981080|FG000|COMPLETED|Washout Period of 7 Days||25
9867442|NCT00961116|10981081|FG001|COMPLETED|Washout Period of 7 Days||24
10095526|NCT02357901|11224101|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
10095527|NCT02357901|11224098|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
10095528|NCT02357901|11224099|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
10095529|NCT02357901|11224100|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
9867443|NCT00961116|10981080|FG000|NOT COMPLETED|Washout Period of 7 Days||2
9867444|NCT00961116|10981081|FG001|NOT COMPLETED|Washout Period of 7 Days||3
9867445|NCT00961116|10981080|FG000|STARTED|Second Intervention||25
9867446|NCT00961116|10981081|FG001|STARTED|Second Intervention||24
9867447|NCT00961116|10981080|FG000|COMPLETED|Second Intervention||25
9867448|NCT00961116|10981081|FG001|COMPLETED|Second Intervention||24
9867449|NCT00961116|10981080|FG000|NOT COMPLETED|Second Intervention||0
9867450|NCT00961116|10981081|FG001|NOT COMPLETED|Second Intervention||0
9867451|NCT00961181|10981088|FG000|STARTED|Overall Study||81
9867452|NCT00961181|10981088|FG000|COMPLETED|Overall Study||76
9867453|NCT00961181|10981088|FG000|NOT COMPLETED|Overall Study||5
9867454|NCT00961220|10981092|FG000|STARTED|Overall Study||17
9867455|NCT00961220|10981092|FG000|COMPLETED|Overall Study||10
9867456|NCT00961220|10981092|FG000|NOT COMPLETED|Overall Study||7
9867457|NCT00961233|10981100|FG000|STARTED|Overall Study||13
9867458|NCT00961233|10981101|FG001|STARTED|Overall Study||12
9867459|NCT00961233|10981100|FG000|COMPLETED|Overall Study||11
9867460|NCT00961233|10981101|FG001|COMPLETED|Overall Study||11
9867461|NCT00961233|10981100|FG000|NOT COMPLETED|Overall Study||2
9867462|NCT00961233|10981101|FG001|NOT COMPLETED|Overall Study||1
9867463|NCT00961259|10981109|FG000|STARTED|First Intervention||18
9867464|NCT00961259|10981110|FG001|STARTED|First Intervention||18
9867465|NCT00961259|10981111|FG002|STARTED|First Intervention||18
9867466|NCT00961259|10981109|FG000|COMPLETED|First Intervention||18
9867467|NCT00961259|10981110|FG001|COMPLETED|First Intervention||18
9867468|NCT00961259|10981111|FG002|COMPLETED|First Intervention||18
9867469|NCT00961259|10981109|FG000|NOT COMPLETED|First Intervention||0
9867470|NCT00961259|10981110|FG001|NOT COMPLETED|First Intervention||0
9867471|NCT00961259|10981111|FG002|NOT COMPLETED|First Intervention||0
9867472|NCT00961259|10981109|FG000|STARTED|Washout Period of 7 Days||18
9867473|NCT00961259|10981110|FG001|STARTED|Washout Period of 7 Days||18
9867474|NCT00961259|10981111|FG002|STARTED|Washout Period of 7 Days||18
9867475|NCT00961259|10981109|FG000|COMPLETED|Washout Period of 7 Days||18
9867476|NCT00961259|10981110|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
9867477|NCT00961259|10981111|FG002|COMPLETED|Washout Period of 7 Days||18
9867478|NCT00961259|10981109|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9867479|NCT00961259|10981110|FG001|NOT COMPLETED|Washout Period of 7 Days||1
9867480|NCT00961259|10981111|FG002|NOT COMPLETED|Washout Period of 7 Days||0
9867481|NCT00961259|10981109|FG000|STARTED|Second Intervention||18
9867482|NCT00961259|10981110|FG001|STARTED|Second Intervention||17
9867483|NCT00961259|10981111|FG002|STARTED|Second Intervention||18
9867484|NCT00961259|10981109|FG000|COMPLETED|Second Intervention||18
9867485|NCT00961259|10981110|FG001|COMPLETED|Second Intervention||17
9867486|NCT00961259|10981111|FG002|COMPLETED|Second Intervention||18
9867487|NCT00961259|10981109|FG000|NOT COMPLETED|Second Intervention||0
9867488|NCT00961259|10981110|FG001|NOT COMPLETED|Second Intervention||0
9867489|NCT00961259|10981111|FG002|NOT COMPLETED|Second Intervention||0
9867490|NCT00961259|10981109|FG000|STARTED|Washout Period of 7 Days||18
9867491|NCT00961259|10981110|FG001|STARTED|Washout Period of 7 Days||17
9867492|NCT00961259|10981111|FG002|STARTED|Washout Period of 7 Days||18
9867493|NCT00961259|10981109|FG000|COMPLETED|Washout Period of 7 Days||18
9867494|NCT00961259|10981110|FG001|COMPLETED|Washout Period of 7 Days||17
9867495|NCT00961259|10981111|FG002|COMPLETED|Washout Period of 7 Days||18
9867496|NCT00961259|10981109|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9867497|NCT00961259|10981110|FG001|NOT COMPLETED|Washout Period of 7 Days||0
9867498|NCT00961259|10981111|FG002|NOT COMPLETED|Washout Period of 7 Days||0
9867499|NCT00961259|10981109|FG000|STARTED|Third Intervention||18
9867500|NCT00961259|10981110|FG001|STARTED|Third Intervention||17
9867501|NCT00961259|10981111|FG002|STARTED|Third Intervention||18
9867502|NCT00961259|10981109|FG000|COMPLETED|Third Intervention||18
9867503|NCT00961259|10981110|FG001|COMPLETED|Third Intervention||17
9867504|NCT00961259|10981111|FG002|COMPLETED|Third Intervention||18
9867505|NCT00961259|10981109|FG000|NOT COMPLETED|Third Intervention||0
9867506|NCT00961259|10981110|FG001|NOT COMPLETED|Third Intervention||0
9867507|NCT00961259|10981111|FG002|NOT COMPLETED|Third Intervention||0
9867508|NCT00961298|10981120|FG000|STARTED|Two Week Placebo Run in||15
9867509|NCT00961298|10981120|FG000|COMPLETED|Two Week Placebo Run in||14
9867510|NCT00961298|10981120|FG000|NOT COMPLETED|Two Week Placebo Run in||1
9867511|NCT00961298|10981120|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14
9867512|NCT00961298|10981120|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
9867513|NCT00961298|10981120|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
9867514|NCT00961311|10981124|FG000|STARTED|Overall Study||51
9867515|NCT00961311|10981124|FG000|COMPLETED|Overall Study||51
9867516|NCT00961311|10981124|FG000|NOT COMPLETED|Overall Study||0
9867517|NCT00961350|10981130|FG000|STARTED|Overall Study||265
9867518|NCT00961350|10981131|FG001|STARTED|Overall Study||265
9867519|NCT00961350|10981130|FG000|Intent-to-Treat Population (ITT)|Overall Study||265
9867520|NCT00961350|10981131|FG001|Intent-to-Treat Population (ITT)|Overall Study||265
9867521|NCT00961350|10981130|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
9867522|NCT00961350|10981131|FG001|Safety Population|Overall Study||265
9867523|NCT00961350|10981130|FG000|COMPLETED|Overall Study||218
9867524|NCT00961350|10981131|FG001|COMPLETED|Overall Study||198
9867525|NCT00961350|10981130|FG000|NOT COMPLETED|Overall Study||47
9867526|NCT00961350|10981131|FG001|NOT COMPLETED|Overall Study||67
9867527|NCT00961402|10981139|FG000|STARTED|Overall Study||64
9867528|NCT00961402|10981140|FG001|STARTED|Overall Study||66
9867529|NCT00961402|10981139|FG000|Randomized|Overall Study||64
9867530|NCT00961402|10981140|FG001|Randomized|Overall Study||66
9867531|NCT00961402|10981139|FG000|COMPLETED|Overall Study||63
9867532|NCT00961402|10981140|FG001|COMPLETED|Overall Study||61
9867533|NCT00961402|10981139|FG000|NOT COMPLETED|Overall Study||1
9867534|NCT00961402|10981140|FG001|NOT COMPLETED|Overall Study||5
9867535|NCT00961415|10981148|FG000|STARTED|Induction Treatment Phase||376
9867536|NCT00961415|10981149|FG001|STARTED|Induction Treatment Phase||0
9867537|NCT00961415|10981150|FG002|STARTED|Induction Treatment Phase||0
9867538|NCT00961415|10981148|FG000|COMPLETED|Induction Treatment Phase||253
9867539|NCT00961415|10981149|FG001|COMPLETED|Induction Treatment Phase||0
9867540|NCT00961415|10981150|FG002|COMPLETED|Induction Treatment Phase||0
9867541|NCT00961415|10981148|FG000|NOT COMPLETED|Induction Treatment Phase||123
9867542|NCT00961415|10981149|FG001|NOT COMPLETED|Induction Treatment Phase||0
9867543|NCT00961415|10981150|FG002|NOT COMPLETED|Induction Treatment Phase||0
9867544|NCT00961415|10981148|FG000|STARTED|Maintenance Treatment Phase||0
9867545|NCT00961415|10981149|FG001|STARTED|Maintenance Treatment Phase||125
9867546|NCT00961415|10981150|FG002|STARTED|Maintenance Treatment Phase||128
9867547|NCT00961415|10981148|FG000|COMPLETED|Maintenance Treatment Phase||0
9867548|NCT00961415|10981149|FG001|COMPLETED|Maintenance Treatment Phase||77
9867549|NCT00961415|10981150|FG002|COMPLETED|Maintenance Treatment Phase||83
9867550|NCT00961415|10981148|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
9867551|NCT00961415|10981149|FG001|NOT COMPLETED|Maintenance Treatment Phase||48
9867552|NCT00961415|10981150|FG002|NOT COMPLETED|Maintenance Treatment Phase||45
9867553|NCT00961441|10981166|FG000|STARTED|Overall Study||12
9867554|NCT00961441|10981167|FG001|STARTED|Overall Study||13
9867555|NCT00961441|10981166|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12
9867556|NCT00961441|10981167|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
9867557|NCT00961441|10981166|FG000|COMPLETED|Overall Study||12
9867558|NCT00961441|10981167|FG001|COMPLETED|Overall Study||13
9867559|NCT00961441|10981166|FG000|NOT COMPLETED|Overall Study||0
9867560|NCT00961441|10981167|FG001|NOT COMPLETED|Overall Study||0
9867561|NCT00961532|10981173|FG000|STARTED|Overall Study||14
9867562|NCT00961532|10981173|FG000|COMPLETED|Overall Study||14
9867563|NCT00961532|10981173|FG000|NOT COMPLETED|Overall Study||0
9867564|NCT00961571|10981177|FG000|STARTED|Overall Study||50
9867565|NCT00961571|10981177|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
9867566|NCT00961571|10981177|FG000|NOT COMPLETED|Overall Study||39
9953444|NCT01426269|11072094|FG000|NOT COMPLETED|Period 1: 12 Weeks||55
9953445|NCT01426269|11072095|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
9953446|NCT01426269|11072096|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
9953447|NCT01426269|11072094|FG000|STARTED|Eligibility for Period 2, Randomization||180
9953448|NCT01426269|11072095|FG001|STARTED|Eligibility for Period 2, Randomization||0
9953449|NCT01426269|11072096|FG002|STARTED|Eligibility for Period 2, Randomization||0
9953450|NCT01426269|11072094|FG000|COMPLETED|Eligibility for Period 2, Randomization||130
9953451|NCT01426269|11072095|FG001|COMPLETED|Eligibility for Period 2, Randomization||0
9953452|NCT01426269|11072096|FG002|COMPLETED|Eligibility for Period 2, Randomization||0
9953453|NCT01426269|11072094|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50
9953454|NCT01426269|11072095|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0
9953455|NCT01426269|11072096|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0
9953456|NCT01426269|11072094|FG000|STARTED|Period 2: 40 Weeks||0
9953457|NCT01426269|11072095|FG001|STARTED|Period 2: 40 Weeks||65
9953458|NCT01426269|11072096|FG002|STARTED|Period 2: 40 Weeks||65
9953459|NCT01426269|11072094|FG000|COMPLETED|Period 2: 40 Weeks||0
9953460|NCT01426269|11072095|FG001|COMPLETED|Period 2: 40 Weeks||27
9953461|NCT01426269|11072096|FG002|COMPLETED|Period 2: 40 Weeks||18
9953462|NCT01426269|11072094|FG000|NOT COMPLETED|Period 2: 40 Weeks||0
9953463|NCT01426269|11072095|FG001|NOT COMPLETED|Period 2: 40 Weeks||38
9953464|NCT01426269|11072096|FG002|NOT COMPLETED|Period 2: 40 Weeks||47
9953465|NCT01426347|11072109|FG000|STARTED|Overall Study||41
9953466|NCT01426347|11072110|FG001|STARTED|Overall Study||42
9953467|NCT01426347|11072109|FG000|COMPLETED|Overall Study||34
9953468|NCT01426347|11072110|FG001|COMPLETED|Overall Study||39
9953469|NCT01426347|11072109|FG000|NOT COMPLETED|Overall Study||7
9953470|NCT01426347|11072110|FG001|NOT COMPLETED|Overall Study||3
9953471|NCT01426360|11072118|FG000|STARTED|Overall Study||38
9953472|NCT01426360|11072119|FG001|STARTED|Overall Study||41
9953473|NCT01426360|11072118|FG000|COMPLETED|Overall Study||38
9953474|NCT01426360|11072119|FG001|COMPLETED|Overall Study||41
9953475|NCT01426360|11072118|FG000|NOT COMPLETED|Overall Study||0
9953476|NCT01426360|11072119|FG001|NOT COMPLETED|Overall Study||0
9953477|NCT01426373|11072125|FG000|STARTED|Overall Study||165
9953478|NCT01426373|11072125|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
9953479|NCT01426373|11072125|FG000|NOT COMPLETED|Overall Study||34
9953480|NCT01426386|11072137|FG000|STARTED|Overall Study||42
9953481|NCT01426386|11072138|FG001|STARTED|Overall Study||45
9953482|NCT01426386|11072139|FG002|STARTED|Overall Study||44
9953483|NCT01426386|11072140|FG003|STARTED|Overall Study||44
9953484|NCT01426386|11072141|FG004|STARTED|Overall Study||47
9953485|NCT01426386|11072142|FG005|STARTED|Overall Study||43
9953486|NCT01426386|11072137|FG000|COMPLETED|Overall Study||39
9953487|NCT01426386|11072138|FG001|COMPLETED|Overall Study||39
9953488|NCT01426386|11072139|FG002|COMPLETED|Overall Study||42
9953489|NCT01426386|11072140|FG003|COMPLETED|Overall Study||44
9953490|NCT01426386|11072141|FG004|COMPLETED|Overall Study||43
9953491|NCT01426386|11072142|FG005|COMPLETED|Overall Study||42
9953492|NCT01426386|11072137|FG000|NOT COMPLETED|Overall Study||3
9953493|NCT01426386|11072138|FG001|NOT COMPLETED|Overall Study||6
9953494|NCT01426386|11072139|FG002|NOT COMPLETED|Overall Study||2
9953495|NCT01426386|11072140|FG003|NOT COMPLETED|Overall Study||0
9953496|NCT01426386|11072141|FG004|NOT COMPLETED|Overall Study||4
9953497|NCT01426386|11072142|FG005|NOT COMPLETED|Overall Study||1
9953498|NCT01426412|11072165|FG000|STARTED|Overall Study||6
9953499|NCT01426412|11072166|FG001|STARTED|Overall Study||6
9953500|NCT01426412|11072167|FG002|STARTED|Overall Study||6
9953501|NCT01426412|11072168|FG003|STARTED|Overall Study||6
9953502|NCT01426412|11072169|FG004|STARTED|Overall Study||6
9953503|NCT01426412|11072170|FG005|STARTED|Overall Study||6
9953504|NCT01426412|11072171|FG006|STARTED|Overall Study||6
9953505|NCT01426412|11072172|FG007|STARTED|Overall Study||10
9953506|NCT01426412|11072173|FG008|STARTED|Overall Study||17
9953507|NCT01426412|11072165|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9953508|NCT01426412|11072166|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9953509|NCT01426412|11072167|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9953510|NCT01426412|11072168|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9953511|NCT01426412|11072169|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
9953512|NCT01426412|11072170|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
9953513|NCT01426412|11072171|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
9953514|NCT01426412|11072172|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10
9953515|NCT01426412|11072173|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17
9953516|NCT01426412|11072165|FG000|COMPLETED|Overall Study||5
9953517|NCT01426412|11072166|FG001|COMPLETED|Overall Study||6
9953518|NCT01426412|11072167|FG002|COMPLETED|Overall Study||6
9953519|NCT01426412|11072168|FG003|COMPLETED|Overall Study||6
9953520|NCT01426412|11072169|FG004|COMPLETED|Overall Study||5
9953521|NCT01426412|11072170|FG005|COMPLETED|Overall Study||6
9953522|NCT01426412|11072171|FG006|COMPLETED|Overall Study||6
9953523|NCT01426412|11072172|FG007|COMPLETED|Overall Study||7
9953524|NCT01426412|11072173|FG008|COMPLETED|Overall Study||16
9953525|NCT01426412|11072165|FG000|NOT COMPLETED|Overall Study||1
9953526|NCT01426412|11072166|FG001|NOT COMPLETED|Overall Study||0
9953527|NCT01426412|11072167|FG002|NOT COMPLETED|Overall Study||0
9867567|NCT00961636|10981184|FG000|STARTED|Overall Study||463
9867568|NCT00961636|10981185|FG001|STARTED|Overall Study||456
9867569|NCT00961636|10981186|FG002|STARTED|Overall Study||233
9867570|NCT00961636|10981184|FG000|COMPLETED|Overall Study||356
9867571|NCT00961636|10981185|FG001|COMPLETED|Overall Study||325
9867572|NCT00961636|10981186|FG002|COMPLETED|Overall Study||201
9867573|NCT00961636|10981184|FG000|NOT COMPLETED|Overall Study||107
9867574|NCT00961636|10981185|FG001|NOT COMPLETED|Overall Study||131
9867575|NCT00961636|10981186|FG002|NOT COMPLETED|Overall Study||32
9867576|NCT00961649|10981198|FG000|STARTED|Overall Study||41
9867577|NCT00961649|10981199|FG001|STARTED|Overall Study||44
9867578|NCT00961649|10981200|FG002|STARTED|Overall Study||44
9867579|NCT00961649|10981201|FG003|STARTED|Overall Study||41
9867580|NCT00961649|10981198|FG000|COMPLETED|Overall Study||32
9867581|NCT00961649|10981199|FG001|COMPLETED|Overall Study||40
9867582|NCT00961649|10981200|FG002|COMPLETED|Overall Study||39
9867583|NCT00961649|10981201|FG003|COMPLETED|Overall Study||37
9867584|NCT00961649|10981198|FG000|NOT COMPLETED|Overall Study||9
9867585|NCT00961649|10981199|FG001|NOT COMPLETED|Overall Study||4
9867586|NCT00961649|10981200|FG002|NOT COMPLETED|Overall Study||5
9867587|NCT00961649|10981201|FG003|NOT COMPLETED|Overall Study||4
9867588|NCT00961662|10981214|FG000|STARTED|Overall Study||57
9867589|NCT00961662|10981215|FG001|STARTED|Overall Study||51
9867590|NCT00961662|10981216|FG002|STARTED|Overall Study||53
9867591|NCT00961662|10981214|FG000|COMPLETED|Overall Study||35
9867592|NCT00961662|10981215|FG001|COMPLETED|Overall Study||32
9867593|NCT00961662|10981216|FG002|COMPLETED|Overall Study||34
9867594|NCT00961662|10981214|FG000|NOT COMPLETED|Overall Study||22
9867595|NCT00961662|10981215|FG001|NOT COMPLETED|Overall Study||19
9867596|NCT00961662|10981216|FG002|NOT COMPLETED|Overall Study||19
9867597|NCT00961896|10981227|FG000|STARTED|Overall Study||8
9867598|NCT00961896|10981228|FG001|STARTED|Overall Study||3
9867599|NCT00961896|10981229|FG002|STARTED|Overall Study||7
9867600|NCT00961896|10981227|FG000|COMPLETED|Overall Study||8
9867601|NCT00961896|10981228|FG001|COMPLETED|Overall Study||3
9867602|NCT00961896|10981229|FG002|COMPLETED|Overall Study||6
9867603|NCT00961896|10981227|FG000|NOT COMPLETED|Overall Study||0
9867604|NCT00961896|10981228|FG001|NOT COMPLETED|Overall Study||0
9867605|NCT00961896|10981229|FG002|NOT COMPLETED|Overall Study||1
9867606|NCT00961961|10981244|FG000|STARTED|Phase I||177
9867607|NCT00961961|10981245|FG001|STARTED|Phase I||0
9867608|NCT00961961|10981246|FG002|STARTED|Phase I||0
9867609|NCT00961961|10981247|FG003|STARTED|Phase I||0
9867610|NCT00961961|10981244|FG000|COMPLETED|Phase I||51
9867611|NCT00961961|10981245|FG001|COMPLETED|Phase I||0
9867612|NCT00961961|10981246|FG002|COMPLETED|Phase I||0
9867613|NCT00961961|10981247|FG003|COMPLETED|Phase I||0
9867614|NCT00961961|10981244|FG000|NOT COMPLETED|Phase I||126
9867615|NCT00961961|10981245|FG001|NOT COMPLETED|Phase I||0
9867616|NCT00961961|10981246|FG002|NOT COMPLETED|Phase I||0
9867617|NCT00961961|10981247|FG003|NOT COMPLETED|Phase I||0
9867618|NCT00961961|10981244|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
9867619|NCT00961961|10981245|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
9867620|NCT00961961|10981246|FG002|STARTED|Phase II||29
9867621|NCT00961961|10981247|FG003|STARTED|Phase II||22
9867622|NCT00961961|10981244|FG000|COMPLETED|Phase II||0
9867623|NCT00961961|10981245|FG001|COMPLETED|Phase II||0
9867624|NCT00961961|10981246|FG002|COMPLETED|Phase II||17
9867625|NCT00961961|10981247|FG003|COMPLETED|Phase II||14
9867626|NCT00961961|10981244|FG000|NOT COMPLETED|Phase II||0
9867627|NCT00961961|10981245|FG001|NOT COMPLETED|Phase II||0
9867628|NCT00961961|10981246|FG002|NOT COMPLETED|Phase II||12
9867629|NCT00961961|10981247|FG003|NOT COMPLETED|Phase II||8
9867630|NCT00962000|10981267|FG000|STARTED|Period 1 - 1 Week||21
9867631|NCT00962000|10981268|FG001|STARTED|Period 1 - 1 Week||21
9867632|NCT00962000|10981267|FG000|COMPLETED|Period 1 - 1 Week||21
9867633|NCT00962000|10981268|FG001|COMPLETED|Period 1 - 1 Week||21
9867634|NCT00962000|10981267|FG000|NOT COMPLETED|Period 1 - 1 Week||0
9867635|NCT00962000|10981268|FG001|NOT COMPLETED|Period 1 - 1 Week||0
9867636|NCT00962000|10981267|FG000|STARTED|Period 2 - 1 Week||21
9867637|NCT00962000|10981268|FG001|STARTED|Period 2 - 1 Week||21
9867638|NCT00962000|10981267|FG000|COMPLETED|Period 2 - 1 Week||21
9867639|NCT00962000|10981268|FG001|COMPLETED|Period 2 - 1 Week||21
9867640|NCT00962000|10981267|FG000|NOT COMPLETED|Period 2 - 1 Week||0
9867641|NCT00962000|10981268|FG001|NOT COMPLETED|Period 2 - 1 Week||0
9867642|NCT00962000|10981267|FG000|STARTED|Period 3 - 1 Week||21
9867643|NCT00962000|10981268|FG001|STARTED|Period 3 - 1 Week||21
9867644|NCT00962000|10981267|FG000|COMPLETED|Period 3 - 1 Week||21
9867645|NCT00962000|10981268|FG001|COMPLETED|Period 3 - 1 Week||21
9867646|NCT00962000|10981267|FG000|NOT COMPLETED|Period 3 - 1 Week||0
9867647|NCT00962000|10981268|FG001|NOT COMPLETED|Period 3 - 1 Week||0
9867648|NCT00962000|10981267|FG000|STARTED|Period 4 - 1 Week||21
9867649|NCT00962000|10981268|FG001|STARTED|Period 4 - 1 Week||21
9867650|NCT00962000|10981267|FG000|COMPLETED|Period 4 - 1 Week||21
9867651|NCT00962000|10981268|FG001|COMPLETED|Period 4 - 1 Week||21
9867652|NCT00962000|10981267|FG000|NOT COMPLETED|Period 4 - 1 Week||0
9867653|NCT00962000|10981268|FG001|NOT COMPLETED|Period 4 - 1 Week||0
9867654|NCT00962013|10981274|FG000|STARTED|Overall Study||120
9867655|NCT00962013|10981274|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
9867656|NCT00962013|10981274|FG000|NOT COMPLETED|Overall Study||68
9867657|NCT00962039|10981280|FG000|STARTED|Overall Study||40
9867658|NCT00962039|10981281|FG001|STARTED|Overall Study||41
9867659|NCT00962039|10981280|FG000|COMPLETED|Overall Study||35
9867660|NCT00962039|10981281|FG001|COMPLETED|Overall Study||37
9867661|NCT00962039|10981280|FG000|NOT COMPLETED|Overall Study||5
9867662|NCT00962039|10981281|FG001|NOT COMPLETED|Overall Study||4
9867663|NCT00962065|10981290|FG000|STARTED|Overall Study||12
9867664|NCT00962065|10981291|FG001|STARTED|Overall Study||12
9867665|NCT00962065|10981292|FG002|STARTED|Overall Study||12
9867666|NCT00962065|10981290|FG000|COMPLETED|Overall Study||12
9867667|NCT00962065|10981291|FG001|COMPLETED|Overall Study||12
9867668|NCT00962065|10981292|FG002|COMPLETED|Overall Study||12
9867669|NCT00962065|10981290|FG000|NOT COMPLETED|Overall Study||0
9867670|NCT00962065|10981291|FG001|NOT COMPLETED|Overall Study||0
9867671|NCT00962065|10981292|FG002|NOT COMPLETED|Overall Study||0
9867672|NCT00962078|10981302|FG000|STARTED|Overall Study||35
9867673|NCT00962078|10981303|FG001|STARTED|Overall Study||36
9867674|NCT00962078|10981302|FG000|COMPLETED|Overall Study||30
9867675|NCT00962078|10981303|FG001|COMPLETED|Overall Study||30
9867676|NCT00962078|10981302|FG000|NOT COMPLETED|Overall Study||5
9867677|NCT00962078|10981303|FG001|NOT COMPLETED|Overall Study||6
9867678|NCT00962091|10981316|FG000|STARTED|Overall Study||4
9867679|NCT00962091|10981317|FG001|STARTED|Overall Study||9
9867680|NCT00962091|10981318|FG002|STARTED|Overall Study||10
9867681|NCT00962091|10981319|FG003|STARTED|Overall Study||3
9867682|NCT00962091|10981320|FG004|STARTED|Overall Study||3
9867683|NCT00962091|10981321|FG005|STARTED|Overall Study||12
9867684|NCT00962091|10981322|FG006|STARTED|Overall Study||12
9867685|NCT00962091|10981316|FG000|COMPLETED|Overall Study||3
9867686|NCT00962091|10981317|FG001|COMPLETED|Overall Study||7
9867687|NCT00962091|10981318|FG002|COMPLETED|Overall Study||9
9867688|NCT00962091|10981319|FG003|COMPLETED|Overall Study||2
9867689|NCT00962091|10981320|FG004|COMPLETED|Overall Study||3
9867690|NCT00962091|10981321|FG005|COMPLETED|Overall Study||11
9867691|NCT00962091|10981322|FG006|COMPLETED|Overall Study||11
9867692|NCT00962091|10981316|FG000|NOT COMPLETED|Overall Study||1
9867693|NCT00962091|10981317|FG001|NOT COMPLETED|Overall Study||2
9867694|NCT00962091|10981318|FG002|NOT COMPLETED|Overall Study||1
9867695|NCT00962091|10981319|FG003|NOT COMPLETED|Overall Study||1
9867696|NCT00962091|10981320|FG004|NOT COMPLETED|Overall Study||0
9867697|NCT00962091|10981321|FG005|NOT COMPLETED|Overall Study||1
9867698|NCT00962091|10981322|FG006|NOT COMPLETED|Overall Study||1
9867699|NCT00962104|10981348|FG000|STARTED|Overall Study||195
9867700|NCT00962104|10981349|FG001|STARTED|Overall Study||196
9867701|NCT00962104|10981348|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
9867702|NCT00962104|10981349|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
9867703|NCT00962104|10981348|FG000|COMPLETED|Overall Study||155
9867704|NCT00962104|10981349|FG001|COMPLETED|Overall Study||171
9867705|NCT00962104|10981348|FG000|NOT COMPLETED|Overall Study||40
9867706|NCT00962104|10981349|FG001|NOT COMPLETED|Overall Study||25
9867707|NCT00962208|10981357|FG000|STARTED|Overall Study||51
9867708|NCT00962208|10981358|FG001|STARTED|Overall Study||51
9867709|NCT00962208|10981357|FG000|COMPLETED|Overall Study||37
9867710|NCT00962208|10981358|FG001|COMPLETED|Overall Study||41
9867711|NCT00962208|10981357|FG000|NOT COMPLETED|Overall Study||14
9867712|NCT00962208|10981358|FG001|NOT COMPLETED|Overall Study||10
9867713|NCT00962247|10981364|FG000|STARTED|Usual Sedentary||61
9867714|NCT00962247|10981364|FG000|COMPLETED|Usual Sedentary||61
9867715|NCT00962247|10981364|FG000|NOT COMPLETED|Usual Sedentary||0
9867716|NCT00962247|10981364|FG000|STARTED|25% Reduction of Sedentary Activity||61
9867717|NCT00962247|10981364|FG000|COMPLETED|25% Reduction of Sedentary Activity||56
9867718|NCT00962247|10981364|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5
9867719|NCT00962247|10981364|FG000|STARTED|50% Reduction of Sedentary Activity||56
9867720|NCT00962247|10981364|FG000|COMPLETED|50% Reduction of Sedentary Activity||56
9867721|NCT00962247|10981364|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0
9867722|NCT00962390|10981374|FG000|STARTED|Overall Study||29
9867723|NCT00962390|10981375|FG001|STARTED|Overall Study||29
9867724|NCT00962390|10981376|FG002|STARTED|Overall Study||29
9867725|NCT00962390|10981377|FG003|STARTED|Overall Study||29
9867726|NCT00962390|10981374|FG000|COMPLETED|Overall Study||25
9867727|NCT00962390|10981375|FG001|COMPLETED|Overall Study||26
9867728|NCT00962390|10981376|FG002|COMPLETED|Overall Study||25
9867729|NCT00962390|10981377|FG003|COMPLETED|Overall Study||28
9867730|NCT00962390|10981374|FG000|NOT COMPLETED|Overall Study||4
9867731|NCT00962390|10981375|FG001|NOT COMPLETED|Overall Study||3
9867732|NCT00962390|10981376|FG002|NOT COMPLETED|Overall Study||4
9867733|NCT00962390|10981377|FG003|NOT COMPLETED|Overall Study||1
9867734|NCT00962585|10981391|FG000|STARTED|Overall Study||43
9867735|NCT00962585|10981392|FG001|STARTED|Overall Study||42
9867736|NCT00962585|10981393|FG002|STARTED|Overall Study||42
9867737|NCT00962585|10981394|FG003|STARTED|Overall Study||42
9867738|NCT00962585|10981391|FG000|COMPLETED|Overall Study||37
9867739|NCT00962585|10981392|FG001|COMPLETED|Overall Study||40
9867740|NCT00962585|10981393|FG002|COMPLETED|Overall Study||39
9867741|NCT00962585|10981394|FG003|COMPLETED|Overall Study||42
9867742|NCT00962585|10981391|FG000|NOT COMPLETED|Overall Study||6
9867743|NCT00962585|10981392|FG001|NOT COMPLETED|Overall Study||2
9867744|NCT00962585|10981393|FG002|NOT COMPLETED|Overall Study||3
9867745|NCT00962585|10981394|FG003|NOT COMPLETED|Overall Study||0
9867746|NCT00962598|10981408|FG000|STARTED|Overall Study||7
9867747|NCT00962598|10981409|FG001|STARTED|Overall Study||9
9867748|NCT00962598|10981408|FG000|COMPLETED|Overall Study||7
9867749|NCT00962598|10981409|FG001|COMPLETED|Overall Study||9
9867750|NCT00962598|10981408|FG000|NOT COMPLETED|Overall Study||0
9867751|NCT00962598|10981409|FG001|NOT COMPLETED|Overall Study||0
9867752|NCT00962650|10981415|FG000|STARTED|Overall Study||10
9867753|NCT00962650|10981415|FG000|COMPLETED|Overall Study||8
9867754|NCT00962650|10981415|FG000|NOT COMPLETED|Overall Study||2
9953528|NCT01426412|11072168|FG003|NOT COMPLETED|Overall Study||0
9953529|NCT01426412|11072169|FG004|NOT COMPLETED|Overall Study||1
9953530|NCT01426412|11072170|FG005|NOT COMPLETED|Overall Study||0
9953531|NCT01426412|11072171|FG006|NOT COMPLETED|Overall Study||0
9953532|NCT01426412|11072172|FG007|NOT COMPLETED|Overall Study||3
9953533|NCT01426412|11072173|FG008|NOT COMPLETED|Overall Study||1
9953534|NCT01426425|11072204|FG000|STARTED|Overall Study||572
9953535|NCT01426425|11072204|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
9953536|NCT01426425|11072204|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
9953537|NCT01426425|11072204|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
9953538|NCT01426425|11072204|FG000|NOT COMPLETED|Overall Study||175
9953539|NCT01426438|11072211|FG000|STARTED|Overall Study||50
9953540|NCT01426438|11072212|FG001|STARTED|Overall Study||49
9953541|NCT01426438|11072211|FG000|COMPLETED|Overall Study||35
9953542|NCT01426438|11072212|FG001|COMPLETED|Overall Study||39
9953543|NCT01426438|11072211|FG000|NOT COMPLETED|Overall Study||15
9953544|NCT01426438|11072212|FG001|NOT COMPLETED|Overall Study||10
9953545|NCT01426581|11072220|FG000|STARTED|Overall Study||62
9953546|NCT01426581|11072221|FG001|STARTED|Overall Study||58
9953547|NCT01426581|11072220|FG000|COMPLETED|Overall Study||62
9953548|NCT01426581|11072221|FG001|COMPLETED|Overall Study||58
9953549|NCT01426581|11072220|FG000|NOT COMPLETED|Overall Study||0
9953550|NCT01426581|11072221|FG001|NOT COMPLETED|Overall Study||0
9953551|NCT01426763|11072231|FG000|STARTED|Overall Study||6
9953552|NCT01426763|11072232|FG001|STARTED|Overall Study||6
9953553|NCT01426763|11072231|FG000|COMPLETED|Overall Study||6
9953554|NCT01426763|11072232|FG001|COMPLETED|Overall Study||6
9953555|NCT01426763|11072231|FG000|NOT COMPLETED|Overall Study||0
9953556|NCT01426763|11072232|FG001|NOT COMPLETED|Overall Study||0
9953557|NCT01426789|11072242|FG000|STARTED|Part 1||68
9953558|NCT01426789|11072243|FG001|STARTED|Part 1||32
9953559|NCT01426789|11072244|FG002|STARTED|Part 1||0
9953560|NCT01426789|11072245|FG003|STARTED|Part 1||0
9953561|NCT01426789|11072246|FG004|STARTED|Part 1||0
9953562|NCT01426789|11072247|FG005|STARTED|Part 1||0
9953563|NCT01426789|11072242|FG000|COMPLETED|Part 1||62
9953564|NCT01426789|11072243|FG001|COMPLETED|Part 1||28
9953565|NCT01426789|11072244|FG002|COMPLETED|Part 1||0
9953566|NCT01426789|11072245|FG003|COMPLETED|Part 1||0
9953567|NCT01426789|11072246|FG004|COMPLETED|Part 1||0
9953568|NCT01426789|11072247|FG005|COMPLETED|Part 1||0
9953569|NCT01426789|11072242|FG000|NOT COMPLETED|Part 1||6
9953570|NCT01426789|11072243|FG001|NOT COMPLETED|Part 1||4
9953571|NCT01426789|11072244|FG002|NOT COMPLETED|Part 1||0
9953572|NCT01426789|11072245|FG003|NOT COMPLETED|Part 1||0
9953573|NCT01426789|11072246|FG004|NOT COMPLETED|Part 1||0
9953574|NCT01426789|11072247|FG005|NOT COMPLETED|Part 1||0
9953575|NCT01426789|11072242|FG000|STARTED|Part 2||0
9953576|NCT01426789|11072243|FG001|STARTED|Part 2||0
9953577|NCT01426789|11072244|FG002|STARTED|Part 2||49
9953578|NCT01426789|11072245|FG003|STARTED|Part 2||13
9953579|NCT01426789|11072246|FG004|STARTED|Part 2||27
9953580|NCT01426789|11072247|FG005|STARTED|Part 2||1
9953581|NCT01426789|11072242|FG000|COMPLETED|Part 2||0
9953582|NCT01426789|11072243|FG001|COMPLETED|Part 2||0
9953583|NCT01426789|11072244|FG002|COMPLETED|Part 2||34
9953584|NCT01426789|11072245|FG003|COMPLETED|Part 2||12
9953585|NCT01426789|11072246|FG004|COMPLETED|Part 2||19
9953586|NCT01426789|11072247|FG005|COMPLETED|Part 2||1
9953587|NCT01426789|11072242|FG000|NOT COMPLETED|Part 2||0
9953588|NCT01426789|11072243|FG001|NOT COMPLETED|Part 2||0
9953589|NCT01426789|11072244|FG002|NOT COMPLETED|Part 2||15
9953590|NCT01426789|11072245|FG003|NOT COMPLETED|Part 2||1
9953591|NCT01426789|11072246|FG004|NOT COMPLETED|Part 2||8
9953592|NCT01426789|11072247|FG005|NOT COMPLETED|Part 2||0
9953593|NCT01426828|11072257|FG000|STARTED|Overall Study Evaluations||22
9953594|NCT01426828|11072258|FG001|STARTED|Overall Study Evaluations||18
9953595|NCT01426828|11072257|FG000|COMPLETED|Overall Study Evaluations||17
9953596|NCT01426828|11072258|FG001|COMPLETED|Overall Study Evaluations||15
9953597|NCT01426828|11072257|FG000|NOT COMPLETED|Overall Study Evaluations||5
9953598|NCT01426828|11072258|FG001|NOT COMPLETED|Overall Study Evaluations||3
9953599|NCT01426828|11072257|FG000|STARTED|Immune Response Analysis||17
9953600|NCT01426828|11072258|FG001|STARTED|Immune Response Analysis||15
9953601|NCT01426828|11072257|FG000|COMPLETED|Immune Response Analysis||8
9953602|NCT01426828|11072258|FG001|COMPLETED|Immune Response Analysis||8
9953603|NCT01426828|11072257|FG000|NOT COMPLETED|Immune Response Analysis||9
9953604|NCT01426828|11072258|FG001|NOT COMPLETED|Immune Response Analysis||7
9953605|NCT01426854|11072266|FG000|STARTED|Overall Study||131
9867755|NCT00962741|10981419|FG000|STARTED|Overall Study||127
9867756|NCT00962741|10981419|FG000|COMPLETED|Overall Study||119
9867757|NCT00962741|10981419|FG000|NOT COMPLETED|Overall Study||8
9867758|NCT00962754|10981425|FG000|STARTED|Overall Study||86
9867759|NCT00962754|10981426|FG001|STARTED|Overall Study||84
9867760|NCT00962754|10981425|FG000|COMPLETED|Overall Study||86
9867761|NCT00962754|10981426|FG001|COMPLETED|Overall Study||84
9867762|NCT00962754|10981425|FG000|NOT COMPLETED|Overall Study||0
9867763|NCT00962754|10981426|FG001|NOT COMPLETED|Overall Study||0
9867764|NCT00962780|10981438|FG000|STARTED|Overall Study||151
9867765|NCT00962780|10981439|FG001|STARTED|Overall Study||152
9867766|NCT00962780|10981438|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150
9867767|NCT00962780|10981439|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151
9867768|NCT00962780|10981438|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145
9867769|NCT00962780|10981439|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145
9867770|NCT00962780|10981438|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144
9867771|NCT00962780|10981439|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142
9867772|NCT00962780|10981438|FG000|Vaccinated 23vPS Dose|Overall Study||143
9867773|NCT00962780|10981439|FG001|Vaccinated 23vPS Dose|Overall Study||139
9867774|NCT00962780|10981438|FG000|COMPLETED|Overall Study||141
9867775|NCT00962780|10981439|FG001|COMPLETED|Overall Study||138
9867776|NCT00962780|10981438|FG000|NOT COMPLETED|Overall Study||10
9867777|NCT00962780|10981439|FG001|NOT COMPLETED|Overall Study||14
9867778|NCT00962871|10981455|FG000|STARTED|Overall Study||6
9867779|NCT00962871|10981456|FG001|STARTED|Overall Study||6
9867780|NCT00962871|10981457|FG002|STARTED|Overall Study||12
9867781|NCT00962871|10981458|FG003|STARTED|Overall Study||6
9867782|NCT00962871|10981455|FG000|COMPLETED|Overall Study||6
9867783|NCT00962871|10981456|FG001|COMPLETED|Overall Study||6
9867784|NCT00962871|10981457|FG002|COMPLETED|Overall Study||12
9867785|NCT00962871|10981458|FG003|COMPLETED|Overall Study||6
9867786|NCT00962871|10981455|FG000|NOT COMPLETED|Overall Study||0
9867787|NCT00962871|10981456|FG001|NOT COMPLETED|Overall Study||0
9867788|NCT00962871|10981457|FG002|NOT COMPLETED|Overall Study||0
9867789|NCT00962871|10981458|FG003|NOT COMPLETED|Overall Study||0
9867790|NCT00962949|10981470|FG000|STARTED|Overall Study||13
9867791|NCT00962949|10981471|FG001|STARTED|Overall Study||15
9867792|NCT00962949|10981470|FG000|COMPLETED|Overall Study||13
9867793|NCT00962949|10981471|FG001|COMPLETED|Overall Study||15
9867794|NCT00962949|10981470|FG000|NOT COMPLETED|Overall Study||0
9867795|NCT00962949|10981471|FG001|NOT COMPLETED|Overall Study||0
9867796|NCT00963105|10981480|FG000|STARTED|Overall Study||34
9867797|NCT00963105|10981481|FG001|STARTED|Overall Study||35
9867798|NCT00963105|10981482|FG002|STARTED|Overall Study||35
9867799|NCT00963105|10981480|FG000|Received Treatment|Overall Study||34
9867800|NCT00963105|10981481|FG001|Received Treatment|Overall Study||34
9867801|NCT00963105|10981482|FG002|Received Treatment|Overall Study||35
9867802|NCT00963105|10981480|FG000|COMPLETED|Overall Study||34
9867803|NCT00963105|10981481|FG001|COMPLETED|Overall Study||35
9867804|NCT00963105|10981482|FG002|COMPLETED|Overall Study||35
9867805|NCT00963105|10981480|FG000|NOT COMPLETED|Overall Study||0
9867806|NCT00963105|10981481|FG001|NOT COMPLETED|Overall Study||0
9867807|NCT00963105|10981482|FG002|NOT COMPLETED|Overall Study||0
9867808|NCT00963157|10981495|FG000|STARTED|Overall Study||156
9867809|NCT00963157|10981496|FG001|STARTED|Overall Study||163
9867810|NCT00963157|10981497|FG002|STARTED|Overall Study||160
9867811|NCT00963157|10981498|FG003|STARTED|Overall Study||157
9867812|NCT00963157|10981499|FG004|STARTED|Overall Study||153
9867813|NCT00963157|10981495|FG000|COMPLETED|Overall Study||151
9867814|NCT00963157|10981496|FG001|COMPLETED|Overall Study||159
9867815|NCT00963157|10981497|FG002|COMPLETED|Overall Study||155
9867816|NCT00963157|10981498|FG003|COMPLETED|Overall Study||150
9867817|NCT00963157|10981499|FG004|COMPLETED|Overall Study||151
9867818|NCT00963157|10981495|FG000|NOT COMPLETED|Overall Study||5
9867819|NCT00963157|10981496|FG001|NOT COMPLETED|Overall Study||4
9867820|NCT00963157|10981497|FG002|NOT COMPLETED|Overall Study||5
9867821|NCT00963157|10981498|FG003|NOT COMPLETED|Overall Study||7
9867822|NCT00963157|10981499|FG004|NOT COMPLETED|Overall Study||2
9867823|NCT00963235|10981511|FG000|STARTED|Overall Study||331
9867824|NCT00963235|10981511|FG000|Vaccinated Dose 1|Overall Study||329
9867825|NCT00963235|10981511|FG000|Vaccinated Dose 2|Overall Study||300
9867826|NCT00963235|10981511|FG000|Vaccinated Dose 3|Overall Study||279
9867827|NCT00963235|10981511|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277
9867828|NCT00963235|10981511|FG000|COMPLETED|Overall Study||271
9867829|NCT00963235|10981511|FG000|NOT COMPLETED|Overall Study||60
9867830|NCT00963430|10981520|FG000|STARTED|Overall Study||60
9867831|NCT00963430|10981521|FG001|STARTED|Overall Study||60
9867832|NCT00963430|10981520|FG000|COMPLETED|Overall Study||59
9867833|NCT00963430|10981521|FG001|COMPLETED|Overall Study||57
9867834|NCT00963430|10981520|FG000|NOT COMPLETED|Overall Study||1
9867835|NCT00963430|10981521|FG001|NOT COMPLETED|Overall Study||3
9867836|NCT00963482|10981529|FG000|STARTED|Overall Study||53
9867837|NCT00963482|10981530|FG001|STARTED|Overall Study||50
9867838|NCT00963482|10981529|FG000|COMPLETED|Overall Study||25
9867839|NCT00963482|10981530|FG001|COMPLETED|Overall Study||33
9867840|NCT00963482|10981529|FG000|NOT COMPLETED|Overall Study||28
9867841|NCT00963482|10981530|FG001|NOT COMPLETED|Overall Study||17
9867842|NCT00963508|10981538|FG000|STARTED|Overall Study||206
9867843|NCT00963508|10981539|FG001|STARTED|Overall Study||197
9867844|NCT00963508|10981538|FG000|COMPLETED|Overall Study||196
9867845|NCT00963508|10981539|FG001|COMPLETED|Overall Study||169
9867846|NCT00963508|10981538|FG000|NOT COMPLETED|Overall Study||10
9867847|NCT00963508|10981539|FG001|NOT COMPLETED|Overall Study||28
9867848|NCT00963547|10981549|FG000|STARTED|Overall Study||4
9867849|NCT00963547|10981550|FG001|STARTED|Overall Study||11
9867850|NCT00963547|10981551|FG002|STARTED|Overall Study||12
9867851|NCT00963547|10981552|FG003|STARTED|Overall Study||6
9867852|NCT00963547|10981553|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
9867853|NCT00963547|10981554|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
9867854|NCT00963547|10981555|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
9867855|NCT00963547|10981549|FG000|Treated|Overall Study||3
9867856|NCT00963547|10981550|FG001|Treated|Overall Study||11
9867857|NCT00963547|10981551|FG002|Treated|Overall Study||11
9867858|NCT00963547|10981552|FG003|Treated|Overall Study||6
9867859|NCT00963547|10981553|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
9867860|NCT00963547|10981554|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
9867861|NCT00963547|10981555|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
9867862|NCT00963547|10981549|FG000|COMPLETED|Overall Study||0
9867863|NCT00963547|10981550|FG001|COMPLETED|Overall Study||0
9867864|NCT00963547|10981551|FG002|COMPLETED|Overall Study||0
9867865|NCT00963547|10981552|FG003|COMPLETED|Overall Study||0
9867866|NCT00963547|10981553|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
9867867|NCT00963547|10981554|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
9867868|NCT00963547|10981555|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
9867869|NCT00963547|10981549|FG000|NOT COMPLETED|Overall Study||4
9867870|NCT00963547|10981550|FG001|NOT COMPLETED|Overall Study||11
9867871|NCT00963547|10981551|FG002|NOT COMPLETED|Overall Study||12
9867872|NCT00963547|10981552|FG003|NOT COMPLETED|Overall Study||6
9867873|NCT00963547|10981553|FG004|NOT COMPLETED|Overall Study||0
9867874|NCT00963547|10981554|FG005|NOT COMPLETED|Overall Study||0
9867875|NCT00963547|10981555|FG006|NOT COMPLETED|Overall Study||0
9867876|NCT00963560|10981571|FG000|STARTED|Overall Study||47
9867877|NCT00963560|10981572|FG001|STARTED|Overall Study||44
9867878|NCT00963560|10981573|FG002|STARTED|Overall Study||41
9867879|NCT00963560|10981571|FG000|COMPLETED|Overall Study||44
9867880|NCT00963560|10981572|FG001|COMPLETED|Overall Study||41
9867881|NCT00963560|10981573|FG002|COMPLETED|Overall Study||41
9867882|NCT00963560|10981571|FG000|NOT COMPLETED|Overall Study||3
9867883|NCT00963560|10981572|FG001|NOT COMPLETED|Overall Study||3
9867884|NCT00963560|10981573|FG002|NOT COMPLETED|Overall Study||0
9867885|NCT00963638|10981583|FG000|STARTED|Overall Study||20
9867886|NCT00963638|10981584|FG001|STARTED|Overall Study||20
9867887|NCT00963638|10981583|FG000|COMPLETED|Overall Study||20
9867888|NCT00963638|10981584|FG001|COMPLETED|Overall Study||20
9867889|NCT00963638|10981583|FG000|NOT COMPLETED|Overall Study||0
10095530|NCT02357901|11224101|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
10095531|NCT02357901|11224098|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0
10095532|NCT02357901|11224099|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125
10095533|NCT02357901|11224100|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129
9867890|NCT00963638|10981584|FG001|NOT COMPLETED|Overall Study||0
9867891|NCT00963677|10981592|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35
9867892|NCT00963677|10981593|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
9867893|NCT00963677|10981592|FG000|COMPLETED|Overall Study||35
9867894|NCT00963677|10981593|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
9867895|NCT00963677|10981592|FG000|NOT COMPLETED|Overall Study||0
9867896|NCT00963677|10981593|FG001|NOT COMPLETED|Overall Study||2
9867897|NCT00963807|10981599|FG000|STARTED|Overall Study||26
9867898|NCT00963807|10981599|FG000|Completed Baseline Imaging|Overall Study||11
9867899|NCT00963807|10981599|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9
9867900|NCT00963807|10981599|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
9867901|NCT00963807|10981599|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
9867902|NCT00963807|10981599|FG000|COMPLETED|Overall Study||8
9867903|NCT00963807|10981599|FG000|NOT COMPLETED|Overall Study||18
9867904|NCT00963820|10981605|FG000|STARTED|Dose Escalation Phase||3
9867905|NCT00963820|10981606|FG001|STARTED|Dose Escalation Phase||3
9867906|NCT00963820|10981607|FG002|STARTED|Dose Escalation Phase||3
9867907|NCT00963820|10981608|FG003|STARTED|Dose Escalation Phase||3
9867908|NCT00963820|10981609|FG004|STARTED|Dose Escalation Phase||4
9867909|NCT00963820|10981610|FG005|STARTED|Dose Escalation Phase||3
9867910|NCT00963820|10981611|FG006|STARTED|Dose Escalation Phase||8
9867911|NCT00963820|10981612|FG007|STARTED|Dose Escalation Phase||5
9867912|NCT00963820|10981613|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
9867913|NCT00963820|10981614|FG009|STARTED|Dose Escalation Phase||0
10095534|NCT02357901|11224101|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34
10095535|NCT02357901|11224098|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
10095536|NCT02357901|11224099|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
10095537|NCT02357901|11224100|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
10095538|NCT02357901|11224101|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
10095539|NCT02357940|11224111|FG000|STARTED|Overall Study||9
10095540|NCT02357940|11224112|FG001|STARTED|Overall Study||32
10095541|NCT02357940|11224111|FG000|COMPLETED|Overall Study||9
10095542|NCT02357940|11224112|FG001|COMPLETED|Overall Study||30
10095543|NCT02357940|11224111|FG000|NOT COMPLETED|Overall Study||0
10095544|NCT02357940|11224112|FG001|NOT COMPLETED|Overall Study||2
9867914|NCT00963820|10981615|FG010|STARTED|Dose Escalation Phase||0
9867915|NCT00963820|10981616|FG011|STARTED|Dose Escalation Phase||0
9867916|NCT00963820|10981605|FG000|COMPLETED|Dose Escalation Phase||0
9867917|NCT00963820|10981606|FG001|COMPLETED|Dose Escalation Phase||0
9867918|NCT00963820|10981607|FG002|COMPLETED|Dose Escalation Phase||0
9867919|NCT00963820|10981608|FG003|COMPLETED|Dose Escalation Phase||0
9867920|NCT00963820|10981609|FG004|COMPLETED|Dose Escalation Phase||0
9867921|NCT00963820|10981610|FG005|COMPLETED|Dose Escalation Phase||0
9867922|NCT00963820|10981611|FG006|COMPLETED|Dose Escalation Phase||0
9867923|NCT00963820|10981612|FG007|COMPLETED|Dose Escalation Phase||0
9867924|NCT00963820|10981613|FG008|COMPLETED|Dose Escalation Phase||0
9867925|NCT00963820|10981614|FG009|COMPLETED|Dose Escalation Phase||0
9867926|NCT00963820|10981615|FG010|COMPLETED|Dose Escalation Phase||0
9867927|NCT00963820|10981616|FG011|COMPLETED|Dose Escalation Phase||0
9867928|NCT00963820|10981605|FG000|NOT COMPLETED|Dose Escalation Phase||3
9867929|NCT00963820|10981606|FG001|NOT COMPLETED|Dose Escalation Phase||3
9867930|NCT00963820|10981607|FG002|NOT COMPLETED|Dose Escalation Phase||3
9867931|NCT00963820|10981608|FG003|NOT COMPLETED|Dose Escalation Phase||3
9867932|NCT00963820|10981609|FG004|NOT COMPLETED|Dose Escalation Phase||4
9867933|NCT00963820|10981610|FG005|NOT COMPLETED|Dose Escalation Phase||3
9867934|NCT00963820|10981611|FG006|NOT COMPLETED|Dose Escalation Phase||8
9867935|NCT00963820|10981612|FG007|NOT COMPLETED|Dose Escalation Phase||5
9867936|NCT00963820|10981613|FG008|NOT COMPLETED|Dose Escalation Phase||0
9867937|NCT00963820|10981614|FG009|NOT COMPLETED|Dose Escalation Phase||0
9867938|NCT00963820|10981615|FG010|NOT COMPLETED|Dose Escalation Phase||0
9867939|NCT00963820|10981616|FG011|NOT COMPLETED|Dose Escalation Phase||0
9867940|NCT00963820|10981605|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
9867941|NCT00963820|10981606|FG001|STARTED|Expansion Phase||0
9867942|NCT00963820|10981607|FG002|STARTED|Expansion Phase||0
9867943|NCT00963820|10981608|FG003|STARTED|Expansion Phase||0
9867944|NCT00963820|10981609|FG004|STARTED|Expansion Phase||0
9867945|NCT00963820|10981610|FG005|STARTED|Expansion Phase||0
9867946|NCT00963820|10981611|FG006|STARTED|Expansion Phase||0
9867947|NCT00963820|10981612|FG007|STARTED|Expansion Phase||0
9867948|NCT00963820|10981613|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
9867949|NCT00963820|10981614|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
9867950|NCT00963820|10981615|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
9867951|NCT00963820|10981616|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
9867952|NCT00963820|10981605|FG000|COMPLETED|Expansion Phase||0
9867953|NCT00963820|10981606|FG001|COMPLETED|Expansion Phase||0
9867954|NCT00963820|10981607|FG002|COMPLETED|Expansion Phase||0
9867955|NCT00963820|10981608|FG003|COMPLETED|Expansion Phase||0
9867956|NCT00963820|10981609|FG004|COMPLETED|Expansion Phase||0
9867957|NCT00963820|10981610|FG005|COMPLETED|Expansion Phase||0
9867958|NCT00963820|10981611|FG006|COMPLETED|Expansion Phase||0
9867959|NCT00963820|10981612|FG007|COMPLETED|Expansion Phase||0
9867960|NCT00963820|10981613|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
9867961|NCT00963820|10981614|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
9867962|NCT00963820|10981615|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
9867963|NCT00963820|10981616|FG011|COMPLETED|Expansion Phase||0
9867964|NCT00963820|10981605|FG000|NOT COMPLETED|Expansion Phase||0
9867965|NCT00963820|10981606|FG001|NOT COMPLETED|Expansion Phase||0
9867966|NCT00963820|10981607|FG002|NOT COMPLETED|Expansion Phase||0
9867967|NCT00963820|10981608|FG003|NOT COMPLETED|Expansion Phase||0
9867968|NCT00963820|10981609|FG004|NOT COMPLETED|Expansion Phase||0
9867969|NCT00963820|10981610|FG005|NOT COMPLETED|Expansion Phase||0
9867970|NCT00963820|10981611|FG006|NOT COMPLETED|Expansion Phase||0
9867971|NCT00963820|10981612|FG007|NOT COMPLETED|Expansion Phase||0
9867972|NCT00963820|10981613|FG008|NOT COMPLETED|Expansion Phase||10
9867973|NCT00963820|10981614|FG009|NOT COMPLETED|Expansion Phase||9
9867974|NCT00963820|10981615|FG010|NOT COMPLETED|Expansion Phase||5
9867975|NCT00963820|10981616|FG011|NOT COMPLETED|Expansion Phase||4
9867976|NCT00963859|10981633|FG000|STARTED|Overall Study||11
9867977|NCT00963859|10981633|FG000|COMPLETED|Overall Study||11
9867978|NCT00963859|10981633|FG000|NOT COMPLETED|Overall Study||0
9867979|NCT00963872|10981639|FG000|STARTED|Overall Study||25
9867980|NCT00963872|10981640|FG001|STARTED|Overall Study||6
9867981|NCT00963872|10981639|FG000|COMPLETED|Overall Study||24
9867982|NCT00963872|10981640|FG001|COMPLETED|Overall Study||5
9867983|NCT00963872|10981639|FG000|NOT COMPLETED|Overall Study||1
9867984|NCT00963872|10981640|FG001|NOT COMPLETED|Overall Study||1
9867985|NCT00963911|10981646|FG000|STARTED|Overall Study||1674
9867986|NCT00963911|10981646|FG000|COMPLETED|Overall Study||1674
9867987|NCT00963911|10981646|FG000|NOT COMPLETED|Overall Study||0
9867988|NCT00963924|10981652|FG000|STARTED|Overall Study||18
9867989|NCT00963924|10981653|FG001|STARTED|Overall Study||18
9867990|NCT00963924|10981652|FG000|COMPLETED|Overall Study||17
9867991|NCT00963924|10981653|FG001|COMPLETED|Overall Study||15
9867992|NCT00963924|10981652|FG000|NOT COMPLETED|Overall Study||1
9867993|NCT00963924|10981653|FG001|NOT COMPLETED|Overall Study||3
9867994|NCT00963937|10981664|FG000|STARTED|Overall Study||89
9867995|NCT00963937|10981665|FG001|STARTED|Overall Study||44
9867996|NCT00963937|10981666|FG002|STARTED|Overall Study||45
9867997|NCT00963937|10981664|FG000|COMPLETED|Overall Study||70
9867998|NCT00963937|10981665|FG001|COMPLETED|Overall Study||33
9867999|NCT00963937|10981666|FG002|COMPLETED|Overall Study||41
9868000|NCT00963937|10981664|FG000|NOT COMPLETED|Overall Study||19
9868001|NCT00963937|10981665|FG001|NOT COMPLETED|Overall Study||11
9868002|NCT00963937|10981666|FG002|NOT COMPLETED|Overall Study||4
9868003|NCT00963989|10981677|FG000|STARTED|Overall Study||146
9868004|NCT00963989|10981677|FG000|COMPLETED|Overall Study||127
9868005|NCT00963989|10981677|FG000|NOT COMPLETED|Overall Study||19
9868006|NCT00964028|10981683|FG000|STARTED|Overall Study||25
9868007|NCT00964028|10981684|FG001|STARTED|Overall Study||25
9868008|NCT00964028|10981683|FG000|COMPLETED|Overall Study||25
9868009|NCT00964028|10981684|FG001|COMPLETED|Overall Study||24
9868010|NCT00964028|10981683|FG000|NOT COMPLETED|Overall Study||0
9868011|NCT00964028|10981684|FG001|NOT COMPLETED|Overall Study||1
9868012|NCT00964119|10981690|FG000|STARTED|Overall Study||15
9868013|NCT00964119|10981690|FG000|COMPLETED|Overall Study||15
9868014|NCT00964119|10981690|FG000|NOT COMPLETED|Overall Study||0
9868015|NCT00964158|10981697|FG000|STARTED|Overall Study||53
9868016|NCT00964158|10981698|FG001|STARTED|Overall Study||57
9868017|NCT00964158|10981699|FG002|STARTED|Overall Study||100
9868018|NCT00964158|10981697|FG000|COMPLETED|Overall Study||53
9868019|NCT00964158|10981698|FG001|COMPLETED|Overall Study||56
9868020|NCT00964158|10981699|FG002|COMPLETED|Overall Study||92
9868021|NCT00964158|10981697|FG000|NOT COMPLETED|Overall Study||0
9868022|NCT00964158|10981698|FG001|NOT COMPLETED|Overall Study||1
9868023|NCT00964158|10981699|FG002|NOT COMPLETED|Overall Study||8
9868024|NCT00964223|10981710|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28
9868025|NCT00964223|10981710|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
9868026|NCT00964223|10981710|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
9868027|NCT00964223|10981710|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28
9868028|NCT00964223|10981710|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
9868029|NCT00964223|10981710|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
9868030|NCT00964353|10981717|FG000|STARTED|Overall Study||181
9868031|NCT00964353|10981718|FG001|STARTED|Overall Study||178
9868032|NCT00964353|10981717|FG000|COMPLETED|Overall Study||181
9868033|NCT00964353|10981718|FG001|COMPLETED|Overall Study||178
9868034|NCT00964353|10981717|FG000|NOT COMPLETED|Overall Study||0
9868035|NCT00964353|10981718|FG001|NOT COMPLETED|Overall Study||0
9868036|NCT00964366|10981726|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
9868037|NCT00964366|10981727|FG001|STARTED|Overall Study||25
9868038|NCT00964366|10981726|FG000|COMPLETED|Overall Study||27
9868039|NCT00964366|10981727|FG001|COMPLETED|Overall Study||24
9868040|NCT00964366|10981726|FG000|NOT COMPLETED|Overall Study||1
9868041|NCT00964366|10981727|FG001|NOT COMPLETED|Overall Study||1
9868042|NCT00964392|10981735|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
9868043|NCT00964392|10981736|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
9868044|NCT00964392|10981735|FG000|COMPLETED|Overall Study||72
9868045|NCT00964392|10981736|FG001|COMPLETED|Overall Study||92
9868046|NCT00964392|10981735|FG000|NOT COMPLETED|Overall Study||53
9868047|NCT00964392|10981736|FG001|NOT COMPLETED|Overall Study||190
9868048|NCT00964431|10981746|FG000|STARTED|Overall Study||50
9868049|NCT00964431|10981747|FG001|STARTED|Overall Study||51
9868050|NCT00964431|10981748|FG002|STARTED|Overall Study||51
9868051|NCT00964431|10981749|FG003|STARTED|Overall Study||51
9868052|NCT00964431|10981746|FG000|COMPLETED|Overall Study||50
9868053|NCT00964431|10981747|FG001|COMPLETED|Overall Study||51
9868054|NCT00964431|10981748|FG002|COMPLETED|Overall Study||51
9868055|NCT00964431|10981749|FG003|COMPLETED|Overall Study||51
9868056|NCT00964431|10981746|FG000|NOT COMPLETED|Overall Study||0
9868057|NCT00964431|10981747|FG001|NOT COMPLETED|Overall Study||0
9868058|NCT00964431|10981748|FG002|NOT COMPLETED|Overall Study||0
9868059|NCT00964431|10981749|FG003|NOT COMPLETED|Overall Study||0
9868060|NCT00964444|10981759|FG000|STARTED|Overall Study||10
9868061|NCT00964444|10981759|FG000|COMPLETED|Overall Study||10
9868062|NCT00964444|10981759|FG000|NOT COMPLETED|Overall Study||0
9868063|NCT00964496|10981765|FG000|STARTED|Overall Study||28
9868064|NCT00964496|10981766|FG001|STARTED|Overall Study||27
9868065|NCT00964496|10981765|FG000|COMPLETED|Overall Study||26
9868066|NCT00964496|10981766|FG001|COMPLETED|Overall Study||26
9868067|NCT00964496|10981765|FG000|NOT COMPLETED|Overall Study||2
9868068|NCT00964496|10981766|FG001|NOT COMPLETED|Overall Study||1
9868069|NCT00964548|10981774|FG000|STARTED|Overall Study||5
9868070|NCT00964548|10981775|FG001|STARTED|Overall Study||5
9868071|NCT00964548|10981774|FG000|COMPLETED|Overall Study||5
9868072|NCT00964548|10981775|FG001|COMPLETED|Overall Study||5
9868073|NCT00964548|10981774|FG000|NOT COMPLETED|Overall Study||0
9868074|NCT00964548|10981775|FG001|NOT COMPLETED|Overall Study||0
9868075|NCT00964678|10981781|FG000|STARTED|Overall Study||10
9868076|NCT00964678|10981781|FG000|COMPLETED|Overall Study||6
9868077|NCT00964678|10981781|FG000|NOT COMPLETED|Overall Study||4
9868078|NCT00964743|10981786|FG000|STARTED|Overall Study||2
9868079|NCT00964743|10981786|FG000|COMPLETED|Overall Study||0
9868080|NCT00964743|10981786|FG000|NOT COMPLETED|Overall Study||2
9868081|NCT00964782|10981792|FG000|STARTED|Overall Study||8
9868082|NCT00964782|10981793|FG001|STARTED|Overall Study||8
9868083|NCT00964782|10981792|FG000|COMPLETED|Overall Study||7
9868084|NCT00964782|10981793|FG001|COMPLETED|Overall Study||8
9868085|NCT00964782|10981792|FG000|NOT COMPLETED|Overall Study||1
9868086|NCT00964782|10981793|FG001|NOT COMPLETED|Overall Study||0
9868087|NCT00964795|10981801|FG000|STARTED|Overall Study|randomized|323
9868088|NCT00964795|10981801|FG000|Number of Participants Treated|Overall Study||320
9868089|NCT00964795|10981801|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
9868090|NCT00964795|10981801|FG000|NOT COMPLETED|Overall Study||307
9868091|NCT00964860|10981808|FG000|STARTED|Overall Study||30
9868092|NCT00964860|10981809|FG001|STARTED|Overall Study||30
9868093|NCT00964860|10981808|FG000|COMPLETED|Overall Study||30
9868094|NCT00964860|10981809|FG001|COMPLETED|Overall Study||29
9868095|NCT00964860|10981808|FG000|NOT COMPLETED|Overall Study||0
9868096|NCT00964860|10981809|FG001|NOT COMPLETED|Overall Study||1
9868097|NCT00964886|10981819|FG000|STARTED|Overall Study||38
9868098|NCT00964886|10981820|FG001|STARTED|Overall Study||34
9868099|NCT00964886|10981821|FG002|STARTED|Overall Study||37
9868100|NCT00964886|10981822|FG003|STARTED|Overall Study||33
9868101|NCT00964886|10981819|FG000|COMPLETED|Overall Study||27
9868102|NCT00964886|10981820|FG001|COMPLETED|Overall Study||27
9868103|NCT00964886|10981821|FG002|COMPLETED|Overall Study||21
9868104|NCT00964886|10981822|FG003|COMPLETED|Overall Study||24
9868105|NCT00964886|10981819|FG000|NOT COMPLETED|Overall Study||11
9868106|NCT00964886|10981820|FG001|NOT COMPLETED|Overall Study||7
9868107|NCT00964886|10981821|FG002|NOT COMPLETED|Overall Study||16
9868108|NCT00964886|10981822|FG003|NOT COMPLETED|Overall Study||9
9868109|NCT00965081|10981838|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
9868110|NCT00965081|10981839|FG001|STARTED|Overall Study||153
9868111|NCT00965081|10981838|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
9868112|NCT00965081|10981839|FG001|COMPLETED|Overall Study||110
9868113|NCT00965081|10981838|FG000|NOT COMPLETED|Overall Study||34
9868114|NCT00965081|10981839|FG001|NOT COMPLETED|Overall Study||43
9868115|NCT00965094|10981848|FG000|STARTED|Overall Study||19
9868116|NCT00965094|10981849|FG001|STARTED|Overall Study||17
9868117|NCT00965094|10981848|FG000|COMPLETED|Overall Study||14
9868118|NCT00965094|10981849|FG001|COMPLETED|Overall Study||16
9868119|NCT00965094|10981848|FG000|NOT COMPLETED|Overall Study||5
9868120|NCT00965094|10981849|FG001|NOT COMPLETED|Overall Study||1
9868121|NCT00965185|10981858|FG000|STARTED|Overall Study||19
9868122|NCT00965185|10981859|FG001|STARTED|Overall Study||21
9868123|NCT00965185|10981858|FG000|1 Month Visit|Overall Study||18
9868124|NCT00965185|10981859|FG001|1 Month Visit|Overall Study||21
9868125|NCT00965185|10981858|FG000|3 Month Visit|Overall Study||18
9868126|NCT00965185|10981859|FG001|3 Month Visit|Overall Study||21
10095545|NCT02357979|11224120|FG000|STARTED|Overall Study||60
10095546|NCT02357979|11224121|FG001|STARTED|Overall Study||60
10095547|NCT02357979|11224120|FG000|COMPLETED|Overall Study||55
10095548|NCT02357979|11224121|FG001|COMPLETED|Overall Study||55
10095549|NCT02357979|11224120|FG000|NOT COMPLETED|Overall Study||5
10095550|NCT02357979|11224121|FG001|NOT COMPLETED|Overall Study||5
10095551|NCT02358044|11224129|FG000|STARTED|Overall Study||129
10095552|NCT02358044|11224130|FG001|STARTED|Overall Study||128
10095553|NCT02358044|11224129|FG000|Treated|Overall Study||129
9868127|NCT00965185|10981858|FG000|6 Month Visit|Overall Study||18
9868128|NCT00965185|10981859|FG001|6 Month Visit|Overall Study||21
9868129|NCT00965185|10981858|FG000|9 Month Visit|Overall Study||18
9868130|NCT00965185|10981859|FG001|9 Month Visit|Overall Study||21
9868131|NCT00965185|10981858|FG000|COMPLETED|Overall Study||17
9868132|NCT00965185|10981859|FG001|COMPLETED|Overall Study||20
9868133|NCT00965185|10981858|FG000|NOT COMPLETED|Overall Study||2
9868134|NCT00965185|10981859|FG001|NOT COMPLETED|Overall Study||1
9868135|NCT00965237|10981867|FG000|STARTED|Period 1, One Week of Wear||8
9868136|NCT00965237|10981868|FG001|STARTED|Period 1, One Week of Wear||8
9868137|NCT00965237|10981867|FG000|COMPLETED|Period 1, One Week of Wear||8
9868138|NCT00965237|10981868|FG001|COMPLETED|Period 1, One Week of Wear||8
9868139|NCT00965237|10981867|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
9868140|NCT00965237|10981868|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
9868141|NCT00965237|10981867|FG000|STARTED|Period 2, One Week of Wear||8
9868142|NCT00965237|10981868|FG001|STARTED|Period 2, One Week of Wear||8
9868143|NCT00965237|10981867|FG000|COMPLETED|Period 2, One Week of Wear||8
9868144|NCT00965237|10981868|FG001|COMPLETED|Period 2, One Week of Wear||8
9868145|NCT00965237|10981867|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
9868146|NCT00965237|10981868|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
9868147|NCT00965250|10981876|FG000|STARTED|Overall Study||37
9868148|NCT00965250|10981877|FG001|STARTED|Overall Study||12
9868149|NCT00965250|10981876|FG000|COMPLETED|Overall Study||37
10095554|NCT02358044|11224130|FG001|Treated|Overall Study||126
9868150|NCT00965250|10981877|FG001|COMPLETED|Overall Study||12
9868151|NCT00965250|10981876|FG000|NOT COMPLETED|Overall Study||0
9868152|NCT00965250|10981877|FG001|NOT COMPLETED|Overall Study||0
9868153|NCT00965263|10981885|FG000|STARTED|Overall Study||6
9868154|NCT00965263|10981886|FG001|STARTED|Overall Study||9
9868155|NCT00965263|10981885|FG000|COMPLETED|Overall Study||4
9868156|NCT00965263|10981886|FG001|COMPLETED|Overall Study||6
9868157|NCT00965263|10981885|FG000|NOT COMPLETED|Overall Study||2
10095555|NCT02358044|11224129|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
10095556|NCT02358044|11224130|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
9868158|NCT00965263|10981886|FG001|NOT COMPLETED|Overall Study||3
9868159|NCT00965341|10981912|FG000|STARTED|Overall Study||19
9868160|NCT00965341|10981913|FG001|STARTED|Overall Study||24
9868161|NCT00965341|10981912|FG000|COMPLETED|Overall Study||13
9868162|NCT00965341|10981913|FG001|COMPLETED|Overall Study||16
9868163|NCT00965341|10981912|FG000|NOT COMPLETED|Overall Study||6
9868164|NCT00965341|10981913|FG001|NOT COMPLETED|Overall Study||8
9868165|NCT00965419|10981919|FG000|STARTED|Open Label Treatment for Responders||267
9868166|NCT00965419|10981919|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
9868167|NCT00965419|10981919|FG000|COMPLETED|Open Label Treatment for Responders||20
9868168|NCT00965419|10981919|FG000|NOT COMPLETED|Open Label Treatment for Responders||247
9868169|NCT00965419|10981919|FG000|STARTED|Follow-up Phase||80
9868170|NCT00965419|10981919|FG000|COMPLETED|Follow-up Phase||18
9868171|NCT00965419|10981919|FG000|NOT COMPLETED|Follow-up Phase||62
9868172|NCT00965458|10981926|FG000|STARTED|Overall Study||33
9868173|NCT00965458|10981927|FG001|STARTED|Overall Study||16
9868174|NCT00965458|10981926|FG000|COMPLETED|Overall Study||31
9868175|NCT00965458|10981927|FG001|COMPLETED|Overall Study||12
9868176|NCT00965458|10981926|FG000|NOT COMPLETED|Overall Study||2
9868177|NCT00965458|10981927|FG001|NOT COMPLETED|Overall Study||4
9868178|NCT00965484|10981935|FG000|STARTED|Overall Study||136
9868179|NCT00965484|10981935|FG000|COMPLETED|Overall Study||134
9868180|NCT00965484|10981935|FG000|NOT COMPLETED|Overall Study||2
9868181|NCT00965497|10981939|FG000|STARTED|Overall Study||14
9868182|NCT00965497|10981939|FG000|COMPLETED|Overall Study||13
9868183|NCT00965497|10981939|FG000|NOT COMPLETED|Overall Study||1
9868184|NCT00965523|10981943|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
9868185|NCT00965523|10981943|FG000|COMPLETED|Study 221||74
9868186|NCT00965523|10981943|FG000|NOT COMPLETED|Study 221||7
9868187|NCT00965523|10981943|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
9868188|NCT00965523|10981943|FG000|COMPLETED|Study 224||0
9868189|NCT00965523|10981943|FG000|NOT COMPLETED|Study 224||6
9868190|NCT00965562|10981950|FG000|STARTED|Overall Study||16
9868191|NCT00965562|10981951|FG001|STARTED|Overall Study||17
9868192|NCT00965562|10981952|FG002|STARTED|Overall Study||16
9868193|NCT00965562|10981950|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
9868194|NCT00965562|10981951|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
9868195|NCT00965562|10981952|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
9868196|NCT00965562|10981950|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
9868197|NCT00965562|10981951|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
9868198|NCT00965562|10981952|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
9868199|NCT00965562|10981950|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
9868200|NCT00965562|10981951|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
9868201|NCT00965562|10981952|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
9868202|NCT00965562|10981950|FG000|NOT COMPLETED|Overall Study||3
9868203|NCT00965562|10981951|FG001|NOT COMPLETED|Overall Study||4
9868204|NCT00965562|10981952|FG002|NOT COMPLETED|Overall Study||3
9868205|NCT00965575|10981963|FG000|STARTED|Overall Study|cross over, total enrolled 11|6
9868206|NCT00965575|10981964|FG001|STARTED|Overall Study|cross over, total enrolled 11|5
9868207|NCT00965575|10981963|FG000|COMPLETED|Overall Study||5
9868208|NCT00965575|10981964|FG001|COMPLETED|Overall Study||5
9868209|NCT00965575|10981963|FG000|NOT COMPLETED|Overall Study||1
9868210|NCT00965575|10981964|FG001|NOT COMPLETED|Overall Study||0
9868211|NCT00965718|10981972|FG000|STARTED|Overall Study||20
9868212|NCT00965718|10981972|FG000|COMPLETED|Overall Study||16
9868213|NCT00965718|10981972|FG000|NOT COMPLETED|Overall Study||4
9868214|NCT00965731|10981978|FG000|STARTED|Overall Study||7
9868215|NCT00965731|10981979|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
9868216|NCT00965731|10981978|FG000|COMPLETED|Overall Study||0
9868217|NCT00965731|10981979|FG001|COMPLETED|Overall Study||0
9868218|NCT00965731|10981978|FG000|NOT COMPLETED|Overall Study||7
9868219|NCT00965731|10981979|FG001|NOT COMPLETED|Overall Study||20
9868220|NCT00965848|10981990|FG000|STARTED|Overall Study||107
9868221|NCT00965848|10981991|FG001|STARTED|Overall Study||34
9868222|NCT00965848|10981992|FG002|STARTED|Overall Study||127
9868223|NCT00965848|10981990|FG000|COMPLETED|Overall Study||78
9868224|NCT00965848|10981991|FG001|COMPLETED|Overall Study||32
9868225|NCT00965848|10981992|FG002|COMPLETED|Overall Study||117
9868226|NCT00965848|10981990|FG000|NOT COMPLETED|Overall Study||29
9868227|NCT00965848|10981991|FG001|NOT COMPLETED|Overall Study||2
9868228|NCT00965848|10981992|FG002|NOT COMPLETED|Overall Study||10
9868229|NCT00966186|10982002|FG000|STARTED|Overall Study||60
9868230|NCT00966186|10982003|FG001|STARTED|Overall Study||60
9868231|NCT00966186|10982002|FG000|COMPLETED|Overall Study||60
9868232|NCT00966186|10982003|FG001|COMPLETED|Overall Study||60
9868233|NCT00966186|10982002|FG000|NOT COMPLETED|Overall Study||0
9868234|NCT00966186|10982003|FG001|NOT COMPLETED|Overall Study||0
9868235|NCT00966238|10982015|FG000|STARTED|Overall Study||20
9868236|NCT00966238|10982016|FG001|STARTED|Overall Study||20
9868237|NCT00966238|10982017|FG002|STARTED|Overall Study||20
9868238|NCT00966238|10982018|FG003|STARTED|Overall Study||20
9868239|NCT00966238|10982019|FG004|STARTED|Overall Study||20
9868240|NCT00966238|10982020|FG005|STARTED|Overall Study||20
9868241|NCT00966238|10982015|FG000|COMPLETED|Overall Study||20
9868242|NCT00966238|10982016|FG001|COMPLETED|Overall Study||20
9868243|NCT00966238|10982017|FG002|COMPLETED|Overall Study||20
9868244|NCT00966238|10982018|FG003|COMPLETED|Overall Study||20
9868245|NCT00966238|10982019|FG004|COMPLETED|Overall Study||20
9868246|NCT00966238|10982020|FG005|COMPLETED|Overall Study||20
9868247|NCT00966238|10982015|FG000|NOT COMPLETED|Overall Study||0
9868248|NCT00966238|10982016|FG001|NOT COMPLETED|Overall Study||0
9868249|NCT00966238|10982017|FG002|NOT COMPLETED|Overall Study||0
9868250|NCT00966238|10982018|FG003|NOT COMPLETED|Overall Study||0
9868251|NCT00966238|10982019|FG004|NOT COMPLETED|Overall Study||0
9868252|NCT00966238|10982020|FG005|NOT COMPLETED|Overall Study||0
9868253|NCT00966264|10982036|FG000|STARTED|Overall Study||119
9868254|NCT00966264|10982037|FG001|STARTED|Overall Study||117
9868255|NCT00966264|10982036|FG000|COMPLETED|Overall Study|5 years results|115
9868256|NCT00966264|10982037|FG001|COMPLETED|Overall Study|5 years results|114
9868257|NCT00966264|10982036|FG000|NOT COMPLETED|Overall Study||4
9868258|NCT00966264|10982037|FG001|NOT COMPLETED|Overall Study||3
9868259|NCT00966277|10982045|FG000|STARTED|Overall Study||38
9868260|NCT00966277|10982046|FG001|STARTED|Overall Study||37
9868261|NCT00966277|10982045|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
9868262|NCT00966277|10982046|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
9868263|NCT00966277|10982045|FG000|NOT COMPLETED|Overall Study||4
9868264|NCT00966277|10982046|FG001|NOT COMPLETED|Overall Study||4
9868265|NCT00966355|10982055|FG000|STARTED|Overall Study||344
9868266|NCT00966355|10982056|FG001|STARTED|Overall Study||345
9868267|NCT00966355|10982057|FG002|STARTED|Overall Study||345
9868268|NCT00966355|10982055|FG000|COMPLETED|Overall Study||260
9868269|NCT00966355|10982056|FG001|COMPLETED|Overall Study||259
9868270|NCT00966355|10982057|FG002|COMPLETED|Overall Study||261
9868271|NCT00966355|10982055|FG000|NOT COMPLETED|Overall Study||84
9868272|NCT00966355|10982056|FG001|NOT COMPLETED|Overall Study||86
9868273|NCT00966355|10982057|FG002|NOT COMPLETED|Overall Study||84
9868274|NCT00966433|10982068|FG000|STARTED|Overall Study||11
9868275|NCT00966433|10982069|FG001|STARTED|Overall Study||11
9868276|NCT00966433|10982070|FG002|STARTED|Overall Study||11
9868277|NCT00966433|10982068|FG000|COMPLETED|Overall Study||10
9868278|NCT00966433|10982069|FG001|COMPLETED|Overall Study||10
9868279|NCT00966433|10982070|FG002|COMPLETED|Overall Study||11
9868280|NCT00966433|10982068|FG000|NOT COMPLETED|Overall Study||1
9868281|NCT00966433|10982069|FG001|NOT COMPLETED|Overall Study||1
9868282|NCT00966433|10982070|FG002|NOT COMPLETED|Overall Study||0
9868283|NCT00966446|10982083|FG000|STARTED|Overall Study||76
9868284|NCT00966446|10982084|FG001|STARTED|Overall Study||74
9868285|NCT00966446|10982085|FG002|STARTED|Overall Study||73
9868286|NCT00966446|10982083|FG000|COMPLETED|Overall Study||48
9868287|NCT00966446|10982084|FG001|COMPLETED|Overall Study||49
9868288|NCT00966446|10982085|FG002|COMPLETED|Overall Study||52
9868289|NCT00966446|10982083|FG000|NOT COMPLETED|Overall Study||28
9868290|NCT00966446|10982084|FG001|NOT COMPLETED|Overall Study||25
9868291|NCT00966446|10982085|FG002|NOT COMPLETED|Overall Study||21
9868292|NCT00966550|10982095|FG000|STARTED|Overall Study||13
9868293|NCT00966550|10982096|FG001|STARTED|Overall Study||12
9868294|NCT00966550|10982095|FG000|COMPLETED|Overall Study||13
9868295|NCT00966550|10982096|FG001|COMPLETED|Overall Study||12
9868296|NCT00966550|10982095|FG000|NOT COMPLETED|Overall Study||0
9868297|NCT00966550|10982096|FG001|NOT COMPLETED|Overall Study||0
9868298|NCT00966641|10982102|FG000|STARTED|First Intervention||17
9868299|NCT00966641|10982103|FG001|STARTED|First Intervention||17
9868300|NCT00966641|10982102|FG000|COMPLETED|First Intervention||17
9868301|NCT00966641|10982103|FG001|COMPLETED|First Intervention||17
9868302|NCT00966641|10982102|FG000|NOT COMPLETED|First Intervention||0
9868303|NCT00966641|10982103|FG001|NOT COMPLETED|First Intervention||0
9868304|NCT00966641|10982102|FG000|STARTED|Second Intervention||17
9868305|NCT00966641|10982103|FG001|STARTED|Second Intervention||17
9868306|NCT00966641|10982102|FG000|COMPLETED|Second Intervention||17
9868307|NCT00966641|10982103|FG001|COMPLETED|Second Intervention||17
9868308|NCT00966641|10982102|FG000|NOT COMPLETED|Second Intervention||0
9868309|NCT00966641|10982103|FG001|NOT COMPLETED|Second Intervention||0
9868310|NCT00966693|10982113|FG000|STARTED|Overall Study||3
9868311|NCT00966693|10982114|FG001|STARTED|Overall Study||3
9868312|NCT00966693|10982115|FG002|STARTED|Overall Study||9
9868313|NCT00966693|10982116|FG003|STARTED|Overall Study||49
9868314|NCT00966693|10982113|FG000|Phase 1 Completed|Overall Study||2
9868315|NCT00966693|10982114|FG001|Phase 1 Completed|Overall Study||3
9868316|NCT00966693|10982115|FG002|Phase 1 Completed|Overall Study||6
9868317|NCT00966693|10982116|FG003|Phase 1 Completed|Overall Study||0
9868318|NCT00966693|10982113|FG000|Phase 2 Completed|Overall Study||0
9868319|NCT00966693|10982114|FG001|Phase 2 Completed|Overall Study||0
9868320|NCT00966693|10982115|FG002|Phase 2 Completed|Overall Study||0
9868321|NCT00966693|10982116|FG003|Phase 2 Completed|Overall Study||46
9868322|NCT00966693|10982113|FG000|COMPLETED|Overall Study||2
9868323|NCT00966693|10982114|FG001|COMPLETED|Overall Study||3
9868324|NCT00966693|10982115|FG002|COMPLETED|Overall Study||6
9868325|NCT00966693|10982116|FG003|COMPLETED|Overall Study||26
9868326|NCT00966693|10982113|FG000|NOT COMPLETED|Overall Study||1
9868327|NCT00966693|10982114|FG001|NOT COMPLETED|Overall Study||0
9868328|NCT00966693|10982115|FG002|NOT COMPLETED|Overall Study||3
9868329|NCT00966693|10982116|FG003|NOT COMPLETED|Overall Study||23
9868330|NCT00966719|10982128|FG000|STARTED|Overall Study||50
9868331|NCT00966719|10982129|FG001|STARTED|Overall Study||49
9868332|NCT00966719|10982128|FG000|COMPLETED|Overall Study||44
9868333|NCT00966719|10982129|FG001|COMPLETED|Overall Study||38
9868334|NCT00966719|10982128|FG000|NOT COMPLETED|Overall Study||6
9868335|NCT00966719|10982129|FG001|NOT COMPLETED|Overall Study||11
9868336|NCT00966823|10982135|FG000|STARTED|Overall Study||3
9868337|NCT00966823|10982135|FG000|COMPLETED|Overall Study||2
9868338|NCT00966823|10982135|FG000|NOT COMPLETED|Overall Study||1
9868339|NCT00966849|10982142|FG000|STARTED|Overall Study||3660
9868340|NCT00966849|10982143|FG001|STARTED|Overall Study||3976
9868341|NCT00966849|10982144|FG002|STARTED|Overall Study||3169
9868342|NCT00966849|10982142|FG000|COMPLETED|Overall Study||2119
9868343|NCT00966849|10982143|FG001|COMPLETED|Overall Study||2498
9868344|NCT00966849|10982144|FG002|COMPLETED|Overall Study||1876
9868345|NCT00966849|10982142|FG000|NOT COMPLETED|Overall Study||1541
9868346|NCT00966849|10982143|FG001|NOT COMPLETED|Overall Study||1478
9868347|NCT00966849|10982144|FG002|NOT COMPLETED|Overall Study||1293
9868348|NCT00966875|10982161|FG000|STARTED|Part A||54
9868349|NCT00966875|10982162|FG001|STARTED|Part A||40
9868350|NCT00966875|10982163|FG002|STARTED|Part A||35
9868351|NCT00966875|10982164|FG003|STARTED|Part A||37
9868352|NCT00966875|10982165|FG004|STARTED|Part A||57
9868353|NCT00966875|10982166|FG005|STARTED|Part A||37
9868354|NCT00966875|10982167|FG006|STARTED|Part A||64
9868355|NCT00966875|10982168|FG007|STARTED|Part A||65
9868356|NCT00966875|10982169|FG008|STARTED|Part A||59
9868357|NCT00966875|10982161|FG000|Received ≥1 Doses of Study Drug|Part A||54
9868358|NCT00966875|10982162|FG001|Received ≥1 Doses of Study Drug|Part A||40
9868359|NCT00966875|10982163|FG002|Received ≥1 Doses of Study Drug|Part A||35
9868360|NCT00966875|10982164|FG003|Received ≥1 Doses of Study Drug|Part A||37
9868361|NCT00966875|10982165|FG004|Received ≥1 Doses of Study Drug|Part A||57
9868362|NCT00966875|10982166|FG005|Received ≥1 Doses of Study Drug|Part A||37
9868363|NCT00966875|10982167|FG006|Received ≥1 Doses of Study Drug|Part A||64
9868364|NCT00966875|10982168|FG007|Received ≥1 Doses of Study Drug|Part A||65
9868365|NCT00966875|10982169|FG008|Received ≥1 Doses of Study Drug|Part A||59
9868366|NCT00966875|10982161|FG000|COMPLETED|Part A||48
9868367|NCT00966875|10982162|FG001|COMPLETED|Part A||36
9868368|NCT00966875|10982163|FG002|COMPLETED|Part A||33
9868369|NCT00966875|10982164|FG003|COMPLETED|Part A||34
9868370|NCT00966875|10982165|FG004|COMPLETED|Part A||52
9868371|NCT00966875|10982166|FG005|COMPLETED|Part A||33
9868372|NCT00966875|10982167|FG006|COMPLETED|Part A||52
9868373|NCT00966875|10982168|FG007|COMPLETED|Part A||58
9868374|NCT00966875|10982169|FG008|COMPLETED|Part A||51
9868375|NCT00966875|10982161|FG000|NOT COMPLETED|Part A||6
9868376|NCT00966875|10982162|FG001|NOT COMPLETED|Part A||4
9868377|NCT00966875|10982163|FG002|NOT COMPLETED|Part A||2
9868378|NCT00966875|10982164|FG003|NOT COMPLETED|Part A||3
9868379|NCT00966875|10982165|FG004|NOT COMPLETED|Part A||5
9868380|NCT00966875|10982166|FG005|NOT COMPLETED|Part A||4
9868381|NCT00966875|10982167|FG006|NOT COMPLETED|Part A||12
9868382|NCT00966875|10982168|FG007|NOT COMPLETED|Part A||7
9868383|NCT00966875|10982169|FG008|NOT COMPLETED|Part A||8
9868384|NCT00966875|10982161|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
9868385|NCT00966875|10982162|FG001|STARTED|Part B||36
9868386|NCT00966875|10982163|FG002|STARTED|Part B||33
9868387|NCT00966875|10982164|FG003|STARTED|Part B||34
9868388|NCT00966875|10982165|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
9868389|NCT00966875|10982166|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
9868390|NCT00966875|10982167|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
9868391|NCT00966875|10982168|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
9868392|NCT00966875|10982169|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
9868393|NCT00966875|10982161|FG000|COMPLETED|Part B||41
9868394|NCT00966875|10982162|FG001|COMPLETED|Part B||33
9868395|NCT00966875|10982163|FG002|COMPLETED|Part B||27
9868396|NCT00966875|10982164|FG003|COMPLETED|Part B||31
9868397|NCT00966875|10982165|FG004|COMPLETED|Part B||44
9868398|NCT00966875|10982166|FG005|COMPLETED|Part B||26
9868399|NCT00966875|10982167|FG006|COMPLETED|Part B||29
9868400|NCT00966875|10982168|FG007|COMPLETED|Part B||38
9868401|NCT00966875|10982169|FG008|COMPLETED|Part B||32
9868402|NCT00966875|10982161|FG000|NOT COMPLETED|Part B||5
9868403|NCT00966875|10982162|FG001|NOT COMPLETED|Part B||3
9868404|NCT00966875|10982163|FG002|NOT COMPLETED|Part B||6
9868405|NCT00966875|10982164|FG003|NOT COMPLETED|Part B||3
9868406|NCT00966875|10982165|FG004|NOT COMPLETED|Part B||7
9868407|NCT00966875|10982166|FG005|NOT COMPLETED|Part B||6
9868408|NCT00966875|10982167|FG006|NOT COMPLETED|Part B||22
9868409|NCT00966875|10982168|FG007|NOT COMPLETED|Part B||19
9868410|NCT00966875|10982169|FG008|NOT COMPLETED|Part B||18
9868411|NCT00966940|10982244|FG000|STARTED|Period 1, First 6 Weeks||28
9868412|NCT00966940|10982245|FG001|STARTED|Period 1, First 6 Weeks||23
9868413|NCT00966940|10982244|FG000|COMPLETED|Period 1, First 6 Weeks||25
9868414|NCT00966940|10982245|FG001|COMPLETED|Period 1, First 6 Weeks||23
9868415|NCT00966940|10982244|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3
9868416|NCT00966940|10982245|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0
9868417|NCT00966940|10982244|FG000|STARTED|Period 2, Second 6 Weeks||25
9868418|NCT00966940|10982245|FG001|STARTED|Period 2, Second 6 Weeks||23
9868419|NCT00966940|10982244|FG000|COMPLETED|Period 2, Second 6 Weeks||25
9868420|NCT00966940|10982245|FG001|COMPLETED|Period 2, Second 6 Weeks||23
9868421|NCT00966940|10982244|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
9868422|NCT00966940|10982245|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
9868423|NCT00967005|10982253|FG000|STARTED|Overall Study||13
9868424|NCT00967005|10982254|FG001|STARTED|Overall Study||15
9868425|NCT00967005|10982253|FG000|Treatment Completion|Overall Study||10
9868426|NCT00967005|10982254|FG001|Treatment Completion|Overall Study||10
9868427|NCT00967005|10982253|FG000|COMPLETED|Overall Study||6
9868428|NCT00967005|10982254|FG001|COMPLETED|Overall Study||5
9868429|NCT00967005|10982253|FG000|NOT COMPLETED|Overall Study||7
9868430|NCT00967005|10982254|FG001|NOT COMPLETED|Overall Study||10
9868431|NCT00967018|10982260|FG000|STARTED|Overall Study||77
9868432|NCT00967018|10982260|FG000|COMPLETED|Overall Study||56
9868433|NCT00967018|10982260|FG000|NOT COMPLETED|Overall Study||21
9868434|NCT00967044|10982264|FG000|STARTED|Overall Study||30
9868435|NCT00967044|10982264|FG000|COMPLETED|Overall Study||30
9868436|NCT00967044|10982264|FG000|NOT COMPLETED|Overall Study||0
9868437|NCT00967226|10982270|FG000|STARTED|Overall Study||11
9868438|NCT00967226|10982271|FG001|STARTED|Overall Study||8
9868439|NCT00967226|10982270|FG000|COMPLETED|Overall Study||9
9868440|NCT00967226|10982271|FG001|COMPLETED|Overall Study||2
9868441|NCT00967226|10982270|FG000|NOT COMPLETED|Overall Study||2
9868442|NCT00967226|10982271|FG001|NOT COMPLETED|Overall Study||6
9868443|NCT00967330|10982303|FG000|STARTED|Overall Study||122
9868444|NCT00967330|10982304|FG001|STARTED|Overall Study||60
9868445|NCT00967330|10982303|FG000|COMPLETED|Overall Study||0
9868446|NCT00967330|10982304|FG001|COMPLETED|Overall Study||0
9868447|NCT00967330|10982303|FG000|NOT COMPLETED|Overall Study||122
9868448|NCT00967330|10982304|FG001|NOT COMPLETED|Overall Study||60
9868449|NCT00967343|10982310|FG000|STARTED|Overall Study||40
9868450|NCT00967343|10982310|FG000|COMPLETED|Overall Study||2
9868451|NCT00967343|10982310|FG000|NOT COMPLETED|Overall Study||38
9868452|NCT00967369|10982316|FG000|STARTED|Overall Study||10
9868453|NCT00967369|10982317|FG001|STARTED|Overall Study||10
9868454|NCT00967369|10982316|FG000|Relapsed|Overall Study||4
9868455|NCT00967369|10982317|FG001|Relapsed|Overall Study||7
9868456|NCT00967369|10982316|FG000|Refractory|Overall Study||6
9868457|NCT00967369|10982317|FG001|Refractory|Overall Study||3
9868458|NCT00967369|10982316|FG000|COMPLETED|Overall Study||10
9868459|NCT00967369|10982317|FG001|COMPLETED|Overall Study||10
9868460|NCT00967369|10982316|FG000|NOT COMPLETED|Overall Study||0
9868461|NCT00967369|10982317|FG001|NOT COMPLETED|Overall Study||0
9868462|NCT00967473|10982323|FG000|STARTED|Overall Study||15
9868463|NCT00967473|10982323|FG000|COMPLETED|Overall Study||15
9868464|NCT00967473|10982323|FG000|NOT COMPLETED|Overall Study||0
9868465|NCT00967486|10982329|FG000|STARTED|Overall Study||98
9868466|NCT00967486|10982330|FG001|STARTED|Overall Study||102
9868467|NCT00967486|10982329|FG000|COMPLETED|Overall Study||98
9868468|NCT00967486|10982330|FG001|COMPLETED|Overall Study||102
9868469|NCT00967486|10982329|FG000|NOT COMPLETED|Overall Study||0
9868470|NCT00967486|10982330|FG001|NOT COMPLETED|Overall Study||0
9868471|NCT00967499|10982338|FG000|STARTED|Overall Study||111
9868472|NCT00967499|10982339|FG001|STARTED|Overall Study||109
9868473|NCT00967499|10982338|FG000|Treated (Full Analysis Set)|Overall Study||48
9868474|NCT00967499|10982339|FG001|Treated (Full Analysis Set)|Overall Study||50
9868475|NCT00967499|10982338|FG000|COMPLETED|Overall Study||46
9868476|NCT00967499|10982339|FG001|COMPLETED|Overall Study||49
9868477|NCT00967499|10982338|FG000|NOT COMPLETED|Overall Study||65
9868478|NCT00967499|10982339|FG001|NOT COMPLETED|Overall Study||60
9953606|NCT01426854|11072267|FG001|STARTED|Overall Study||129
9953607|NCT01426854|11072266|FG000|COMPLETED|Overall Study||119
9953608|NCT01426854|11072267|FG001|COMPLETED|Overall Study||98
9953609|NCT01426854|11072266|FG000|NOT COMPLETED|Overall Study||12
9953610|NCT01426854|11072267|FG001|NOT COMPLETED|Overall Study||31
9956979|NCT01448824|11076140|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
9956980|NCT01448824|11076141|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
9956981|NCT01448824|11076142|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
9956982|NCT01448824|11076143|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
9956983|NCT01448824|11076144|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
9956984|NCT01448824|11076145|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
9956985|NCT01448824|11076146|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
9956986|NCT01448824|11076147|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
10095557|NCT02358044|11224129|FG000|NOT COMPLETED|Overall Study||2
10095558|NCT02358044|11224130|FG001|NOT COMPLETED|Overall Study||7
9956987|NCT01448824|11076140|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
9956988|NCT01448824|11076141|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
9956989|NCT01448824|11076142|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
9956990|NCT01448824|11076143|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
9956991|NCT01448824|11076144|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10095559|NCT02358135|11224138|FG000|STARTED|Overall Study||150
9956992|NCT01448824|11076145|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
9956993|NCT01448824|11076146|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
9956994|NCT01448824|11076147|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
9956995|NCT01448824|11076140|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10095560|NCT02358135|11224139|FG001|STARTED|Overall Study||150
10095561|NCT02358135|11224138|FG000|Randomized|Overall Study||148
9868479|NCT00967551|10982347|FG000|STARTED|Overall Study||68
9868480|NCT00967551|10982348|FG001|STARTED|Overall Study||75
9868481|NCT00967551|10982347|FG000|COMPLETED|Overall Study||68
9868482|NCT00967551|10982348|FG001|COMPLETED|Overall Study||75
9868483|NCT00967551|10982347|FG000|NOT COMPLETED|Overall Study||0
9868484|NCT00967551|10982348|FG001|NOT COMPLETED|Overall Study||0
9868485|NCT00967616|10982356|FG000|STARTED|Overall Study||50
9868486|NCT00967616|10982357|FG001|STARTED|Overall Study||50
9868487|NCT00967616|10982356|FG000|COMPLETED|Overall Study||0
9868488|NCT00967616|10982357|FG001|COMPLETED|Overall Study||0
9868489|NCT00967616|10982356|FG000|NOT COMPLETED|Overall Study||50
9868490|NCT00967616|10982357|FG001|NOT COMPLETED|Overall Study||50
9868491|NCT00967668|10982366|FG000|STARTED|Overall Study||162
9868492|NCT00967668|10982367|FG001|STARTED|Overall Study||160
9868493|NCT00967668|10982368|FG002|STARTED|Overall Study||159
9868494|NCT00967668|10982366|FG000|3-mo Assessment|Overall Study||131
9868495|NCT00967668|10982367|FG001|3-mo Assessment|Overall Study||127
9868496|NCT00967668|10982368|FG002|3-mo Assessment|Overall Study||115
9868497|NCT00967668|10982366|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120
9868498|NCT00967668|10982367|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122
9868499|NCT00967668|10982368|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119
9868500|NCT00967668|10982366|FG000|18-mo Assessment|Overall Study||95
9868501|NCT00967668|10982367|FG001|18-mo Assessment|Overall Study||102
9868502|NCT00967668|10982368|FG002|18-mo Assessment|Overall Study||92
9868503|NCT00967668|10982366|FG000|COMPLETED|Overall Study||91
9868504|NCT00967668|10982367|FG001|COMPLETED|Overall Study||104
9868505|NCT00967668|10982368|FG002|COMPLETED|Overall Study||90
9868506|NCT00967668|10982366|FG000|NOT COMPLETED|Overall Study||71
9868507|NCT00967668|10982367|FG001|NOT COMPLETED|Overall Study||56
9868508|NCT00967668|10982368|FG002|NOT COMPLETED|Overall Study||69
9868509|NCT00967694|10982379|FG000|STARTED|Overall Study||26
9868510|NCT00967694|10982379|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
9868511|NCT00967694|10982379|FG000|NOT COMPLETED|Overall Study||6
9868512|NCT00967798|10982385|FG000|STARTED|Overall Study||17
9868513|NCT00967798|10982386|FG001|STARTED|Overall Study||16
9868514|NCT00967798|10982385|FG000|COMPLETED|Overall Study||8
9868515|NCT00967798|10982386|FG001|COMPLETED|Overall Study||13
9868516|NCT00967798|10982385|FG000|NOT COMPLETED|Overall Study||9
9868517|NCT00967798|10982386|FG001|NOT COMPLETED|Overall Study||3
9868518|NCT00967941|10982395|FG000|STARTED|Overall Study||67
9868519|NCT00967941|10982396|FG001|STARTED|Overall Study||54
9868520|NCT00967941|10982397|FG002|STARTED|Overall Study||60
9868521|NCT00967941|10982395|FG000|COMPLETED|Overall Study||62
9868522|NCT00967941|10982396|FG001|COMPLETED|Overall Study||51
9868523|NCT00967941|10982397|FG002|COMPLETED|Overall Study||56
9868524|NCT00967941|10982395|FG000|NOT COMPLETED|Overall Study||5
9868525|NCT00967941|10982396|FG001|NOT COMPLETED|Overall Study||3
9868526|NCT00967941|10982397|FG002|NOT COMPLETED|Overall Study||4
9868527|NCT00967993|10982405|FG000|STARTED|Overall Study||22
9868528|NCT00967993|10982405|FG000|COMPLETED|Overall Study||18
9868529|NCT00967993|10982405|FG000|NOT COMPLETED|Overall Study||4
9868530|NCT00968019|10982409|FG000|STARTED|Overall Study||318
9868531|NCT00968019|10982409|FG000|COMPLETED|Overall Study||303
9868532|NCT00968019|10982409|FG000|NOT COMPLETED|Overall Study||15
9868533|NCT00968032|10982413|FG000|STARTED|Overall Study||63
9868534|NCT00968032|10982413|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
9868535|NCT00968032|10982413|FG000|NOT COMPLETED|Overall Study||2
9868536|NCT00968071|10982417|FG000|STARTED|Overall Study||71
9868537|NCT00968071|10982417|FG000|COMPLETED|Overall Study||71
9868538|NCT00968071|10982417|FG000|NOT COMPLETED|Overall Study||0
9868539|NCT00968227|10982421|FG000|STARTED|Overall Study||56
9868540|NCT00968227|10982421|FG000|COMPLETED|Overall Study||56
9868541|NCT00968227|10982421|FG000|NOT COMPLETED|Overall Study||0
9868542|NCT00968253|10982428|FG000|STARTED|Overall Study||3
9868543|NCT00968253|10982429|FG001|STARTED|Overall Study||9
9868544|NCT00968253|10982430|FG002|STARTED|Overall Study||12
9868545|NCT00968253|10982428|FG000|COMPLETED|Overall Study||3
9868546|NCT00968253|10982429|FG001|COMPLETED|Overall Study||6
9868547|NCT00968253|10982430|FG002|COMPLETED|Overall Study||5
9868548|NCT00968253|10982428|FG000|NOT COMPLETED|Overall Study||0
9868549|NCT00968253|10982429|FG001|NOT COMPLETED|Overall Study||3
9868550|NCT00968253|10982430|FG002|NOT COMPLETED|Overall Study||7
9868551|NCT00968344|10982441|FG000|STARTED|Overall Study|Includes screen fails|20
9868552|NCT00968344|10982442|FG001|STARTED|Overall Study|Includes screen fails|20
9868553|NCT00968344|10982441|FG000|COMPLETED|Overall Study||10
9868554|NCT00968344|10982442|FG001|COMPLETED|Overall Study||9
9868555|NCT00968344|10982441|FG000|NOT COMPLETED|Overall Study||10
10095562|NCT02358135|11224139|FG001|Randomized|Overall Study||148
9868556|NCT00968344|10982442|FG001|NOT COMPLETED|Overall Study||11
9868557|NCT00968526|10982450|FG000|STARTED|Overall Study||138
9868558|NCT00968526|10982451|FG001|STARTED|Overall Study||102
9868559|NCT00968526|10982450|FG000|COMPLETED|Overall Study||135
9868560|NCT00968526|10982451|FG001|COMPLETED|Overall Study||102
9868561|NCT00968526|10982450|FG000|NOT COMPLETED|Overall Study||3
9868562|NCT00968526|10982451|FG001|NOT COMPLETED|Overall Study||0
10095563|NCT02358135|11224138|FG000|COMPLETED|Overall Study||135
9868563|NCT00968539|10982468|FG000|STARTED|Overall Study||64
9868564|NCT00968539|10982469|FG001|STARTED|Overall Study||66
9868565|NCT00968539|10982468|FG000|COMPLETED|Overall Study||63
10095564|NCT02358135|11224139|FG001|COMPLETED|Overall Study||131
10095565|NCT02358135|11224138|FG000|NOT COMPLETED|Overall Study||15
10095566|NCT02358135|11224139|FG001|NOT COMPLETED|Overall Study||19
9868566|NCT00968539|10982469|FG001|COMPLETED|Overall Study||66
9868567|NCT00968539|10982468|FG000|NOT COMPLETED|Overall Study||1
9868568|NCT00968539|10982469|FG001|NOT COMPLETED|Overall Study||0
9868569|NCT00968617|10982476|FG000|STARTED|Overall Study||7
9868570|NCT00968617|10982476|FG000|COMPLETED|Overall Study||1
9868571|NCT00968617|10982476|FG000|NOT COMPLETED|Overall Study||6
9868572|NCT00968669|10982484|FG000|STARTED|Overall Study||82
9868573|NCT00968669|10982485|FG001|STARTED|Overall Study||81
9868574|NCT00968669|10982486|FG002|STARTED|Overall Study||83
10095567|NCT02358343|11224150|FG000|STARTED|Screening Intervention|90 completed engagement interview|92
10095568|NCT02358343|11224151|FG001|STARTED|Screening Intervention|89 completed control visit|92
10095569|NCT02358343|11224152|FG002|STARTED|Screening Intervention||0
9868575|NCT00968669|10982487|FG003|STARTED|Overall Study||81
9868576|NCT00968669|10982484|FG000|COMPLETED|Overall Study||64
9868577|NCT00968669|10982485|FG001|COMPLETED|Overall Study||63
9868578|NCT00968669|10982486|FG002|COMPLETED|Overall Study||72
9868579|NCT00968669|10982487|FG003|COMPLETED|Overall Study||72
9868580|NCT00968669|10982484|FG000|NOT COMPLETED|Overall Study||18
9868581|NCT00968669|10982485|FG001|NOT COMPLETED|Overall Study||18
9868582|NCT00968669|10982486|FG002|NOT COMPLETED|Overall Study||11
9868583|NCT00968669|10982487|FG003|NOT COMPLETED|Overall Study||9
9868584|NCT00968708|10982499|FG000|STARTED|Overall Study||2679
9868585|NCT00968708|10982500|FG001|STARTED|Overall Study||2701
9868586|NCT00968708|10982499|FG000|Treated|Overall Study||2676
9868587|NCT00968708|10982500|FG001|Treated|Overall Study||2698
9868588|NCT00968708|10982499|FG000|COMPLETED|Overall Study||2361
9868589|NCT00968708|10982500|FG001|COMPLETED|Overall Study||2403
9868590|NCT00968708|10982499|FG000|NOT COMPLETED|Overall Study||318
9868591|NCT00968708|10982500|FG001|NOT COMPLETED|Overall Study||298
9868592|NCT00968799|10982506|FG000|STARTED|Overall Study||6
9868593|NCT00968799|10982506|FG000|COMPLETED|Overall Study||4
9868594|NCT00968799|10982506|FG000|NOT COMPLETED|Overall Study||2
9868595|NCT00968812|10982513|FG000|STARTED|Overall Study||483
9868596|NCT00968812|10982514|FG001|STARTED|Overall Study||485
9868597|NCT00968812|10982515|FG002|STARTED|Overall Study||482
9868598|NCT00968812|10982513|FG000|COMPLETED|Overall Study||343
9868599|NCT00968812|10982514|FG001|COMPLETED|Overall Study||323
9868600|NCT00968812|10982515|FG002|COMPLETED|Overall Study||314
9868601|NCT00968812|10982513|FG000|NOT COMPLETED|Overall Study||140
9868602|NCT00968812|10982514|FG001|NOT COMPLETED|Overall Study||162
9868603|NCT00968812|10982515|FG002|NOT COMPLETED|Overall Study||168
9868604|NCT00968838|10982528|FG000|STARTED|Overall Study||50
9868605|NCT00968838|10982529|FG001|STARTED|Overall Study||58
9868606|NCT00968838|10982528|FG000|COMPLETED|Overall Study||50
9868607|NCT00968838|10982529|FG001|COMPLETED|Overall Study||58
9868608|NCT00968838|10982528|FG000|NOT COMPLETED|Overall Study||0
9868609|NCT00968838|10982529|FG001|NOT COMPLETED|Overall Study||0
9868610|NCT00968890|10982537|FG000|STARTED|Overall Study||84
9868611|NCT00968890|10982538|FG001|STARTED|Overall Study||84
9868612|NCT00968890|10982537|FG000|COMPLETED|Overall Study||84
9868613|NCT00968890|10982538|FG001|COMPLETED|Overall Study||84
9868614|NCT00968890|10982537|FG000|NOT COMPLETED|Overall Study||0
9868615|NCT00968890|10982538|FG001|NOT COMPLETED|Overall Study||0
9868616|NCT00968968|10982546|FG000|STARTED|Overall Study||20
9868617|NCT00968968|10982547|FG001|STARTED|Overall Study||17
9868618|NCT00968968|10982546|FG000|COMPLETED|Overall Study||4
9868619|NCT00968968|10982547|FG001|COMPLETED|Overall Study||3
9868620|NCT00968968|10982546|FG000|NOT COMPLETED|Overall Study||16
9868621|NCT00968968|10982547|FG001|NOT COMPLETED|Overall Study||14
9868622|NCT00968981|10982557|FG000|STARTED|Overall Study||23
9868623|NCT00968981|10982558|FG001|STARTED|Overall Study||22
9868624|NCT00968981|10982559|FG002|STARTED|Overall Study||22
9868625|NCT00968981|10982557|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
10095570|NCT02358343|11224153|FG003|STARTED|Screening Intervention||0
10095571|NCT02358343|11224154|FG004|STARTED|Screening Intervention||0
10095572|NCT02358343|11224150|FG000|COMPLETED|Screening Intervention||86
9868626|NCT00968981|10982558|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
9868627|NCT00968981|10982559|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
9868628|NCT00968981|10982557|FG000|COMPLETED|Overall Study||1
9868629|NCT00968981|10982558|FG001|COMPLETED|Overall Study||0
9868630|NCT00968981|10982559|FG002|COMPLETED|Overall Study||0
9868631|NCT00968981|10982557|FG000|NOT COMPLETED|Overall Study||22
9868632|NCT00968981|10982558|FG001|NOT COMPLETED|Overall Study||22
9868633|NCT00968981|10982559|FG002|NOT COMPLETED|Overall Study||22
9868634|NCT00969124|10982568|FG000|STARTED|Overall Study||328
9868635|NCT00969124|10982568|FG000|COMPLETED|Overall Study||298
9868636|NCT00969124|10982568|FG000|NOT COMPLETED|Overall Study||30
9868637|NCT00969150|10982575|FG000|STARTED|Overall Study||182
10095573|NCT02358343|11224151|FG001|COMPLETED|Screening Intervention||84
9868638|NCT00969150|10982576|FG001|STARTED|Overall Study||175
9868639|NCT00969150|10982575|FG000|COMPLETED|Overall Study||149
10095574|NCT02358343|11224152|FG002|COMPLETED|Screening Intervention||0
10095575|NCT02358343|11224153|FG003|COMPLETED|Screening Intervention||0
10095576|NCT02358343|11224154|FG004|COMPLETED|Screening Intervention||0
9868640|NCT00969150|10982576|FG001|COMPLETED|Overall Study||135
9868641|NCT00969150|10982575|FG000|NOT COMPLETED|Overall Study||33
9868642|NCT00969150|10982576|FG001|NOT COMPLETED|Overall Study||40
9868643|NCT00969228|10982584|FG000|STARTED|Overall Study||508
9868644|NCT00969228|10982585|FG001|STARTED|Overall Study||176
9868645|NCT00969228|10982584|FG000|COMPLETED|Overall Study||465
9868646|NCT00969228|10982585|FG001|COMPLETED|Overall Study||162
9868647|NCT00969228|10982584|FG000|NOT COMPLETED|Overall Study||43
9868648|NCT00969228|10982585|FG001|NOT COMPLETED|Overall Study||14
9868649|NCT00969280|10982593|FG000|STARTED|Overall Study||21
9868650|NCT00969280|10982594|FG001|STARTED|Overall Study||21
9868651|NCT00969280|10982593|FG000|COMPLETED|Overall Study||19
9868652|NCT00969280|10982594|FG001|COMPLETED|Overall Study||18
9868653|NCT00969280|10982593|FG000|NOT COMPLETED|Overall Study||2
9868654|NCT00969280|10982594|FG001|NOT COMPLETED|Overall Study||3
9868655|NCT00969332|10982600|FG000|STARTED|Overall Study||62
9868656|NCT00969332|10982600|FG000|COMPLETED|Overall Study||51
9868657|NCT00969332|10982600|FG000|NOT COMPLETED|Overall Study||11
9868658|NCT00969436|10982608|FG000|STARTED|Overall Study||180
9868659|NCT00969436|10982609|FG001|STARTED|Overall Study||180
9868660|NCT00969436|10982610|FG002|STARTED|Overall Study||90
9868661|NCT00969436|10982608|FG000|COMPLETED|Overall Study||155
9868662|NCT00969436|10982609|FG001|COMPLETED|Overall Study||159
9868663|NCT00969436|10982610|FG002|COMPLETED|Overall Study||79
9868664|NCT00969436|10982608|FG000|NOT COMPLETED|Overall Study||25
9868665|NCT00969436|10982609|FG001|NOT COMPLETED|Overall Study||21
9868666|NCT00969436|10982610|FG002|NOT COMPLETED|Overall Study||11
9868667|NCT00969501|10982618|FG000|STARTED|Overall Study||32
9868668|NCT00969501|10982618|FG000|COMPLETED|Overall Study||27
9868669|NCT00969501|10982618|FG000|NOT COMPLETED|Overall Study||5
9868670|NCT00969540|10982624|FG000|STARTED|Overall Study||4
9868671|NCT00969540|10982625|FG001|STARTED|Overall Study||4
9868672|NCT00969540|10982624|FG000|COMPLETED|Overall Study||3
9868673|NCT00969540|10982625|FG001|COMPLETED|Overall Study||3
9868674|NCT00969540|10982624|FG000|NOT COMPLETED|Overall Study||1
9868675|NCT00969540|10982625|FG001|NOT COMPLETED|Overall Study||1
9868676|NCT00969553|10982652|FG000|STARTED|Overall Study||3
9868677|NCT00969553|10982653|FG001|STARTED|Overall Study||3
9868678|NCT00969553|10982654|FG002|STARTED|Overall Study||6
9868679|NCT00969553|10982655|FG003|STARTED|Overall Study||17
9868680|NCT00969553|10982656|FG004|STARTED|Overall Study||3
9868681|NCT00969553|10982657|FG005|STARTED|Overall Study||4
9868682|NCT00969553|10982658|FG006|STARTED|Overall Study||4
9868683|NCT00969553|10982659|FG007|STARTED|Overall Study||16
9868684|NCT00969553|10982660|FG008|STARTED|Overall Study||3
9868685|NCT00969553|10982652|FG000|COMPLETED|Overall Study||0
9868686|NCT00969553|10982653|FG001|COMPLETED|Overall Study||0
9868687|NCT00969553|10982654|FG002|COMPLETED|Overall Study||0
9868688|NCT00969553|10982655|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
9868689|NCT00969553|10982656|FG004|COMPLETED|Overall Study||0
9868690|NCT00969553|10982657|FG005|COMPLETED|Overall Study||0
9868691|NCT00969553|10982658|FG006|COMPLETED|Overall Study||0
9868692|NCT00969553|10982659|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
9868693|NCT00969553|10982660|FG008|COMPLETED|Overall Study||0
9868694|NCT00969553|10982652|FG000|NOT COMPLETED|Overall Study||3
9868695|NCT00969553|10982653|FG001|NOT COMPLETED|Overall Study||3
9868696|NCT00969553|10982654|FG002|NOT COMPLETED|Overall Study||6
9868697|NCT00969553|10982655|FG003|NOT COMPLETED|Overall Study||16
9868698|NCT00969553|10982656|FG004|NOT COMPLETED|Overall Study||3
9868699|NCT00969553|10982657|FG005|NOT COMPLETED|Overall Study||4
9868700|NCT00969553|10982658|FG006|NOT COMPLETED|Overall Study||4
9868701|NCT00969553|10982659|FG007|NOT COMPLETED|Overall Study||14
9868702|NCT00969553|10982660|FG008|NOT COMPLETED|Overall Study||3
9868703|NCT00969618|10982688|FG000|STARTED|Overall Study||211
9868704|NCT00969618|10982688|FG000|COMPLETED|Overall Study||133
9868705|NCT00969618|10982688|FG000|NOT COMPLETED|Overall Study||78
9868706|NCT00969709|10982696|FG000|STARTED|Overall Study||176
9868707|NCT00969709|10982697|FG001|STARTED|Overall Study||178
9868708|NCT00969709|10982698|FG002|STARTED|Overall Study||179
9868709|NCT00969709|10982699|FG003|STARTED|Overall Study||180
9868710|NCT00969709|10982696|FG000|COMPLETED|Overall Study||138
9868711|NCT00969709|10982697|FG001|COMPLETED|Overall Study||130
9868712|NCT00969709|10982698|FG002|COMPLETED|Overall Study||121
9868713|NCT00969709|10982699|FG003|COMPLETED|Overall Study||117
9868714|NCT00969709|10982696|FG000|NOT COMPLETED|Overall Study||38
9868715|NCT00969709|10982697|FG001|NOT COMPLETED|Overall Study||48
10095577|NCT02358343|11224150|FG000|NOT COMPLETED|Screening Intervention||6
10095578|NCT02358343|11224151|FG001|NOT COMPLETED|Screening Intervention||8
9868716|NCT00969709|10982698|FG002|NOT COMPLETED|Overall Study||58
9868717|NCT00969709|10982699|FG003|NOT COMPLETED|Overall Study||63
9868718|NCT00969761|10982725|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3
9868719|NCT00969761|10982726|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3
10095579|NCT02358343|11224152|FG002|NOT COMPLETED|Screening Intervention||0
9868720|NCT00969761|10982727|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12
9868721|NCT00969761|10982728|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6
9868722|NCT00969761|10982729|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3
9868723|NCT00969761|10982730|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3
9868724|NCT00969761|10982731|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3
9868725|NCT00969761|10982732|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6
10095580|NCT02358343|11224153|FG003|NOT COMPLETED|Screening Intervention||0
10095581|NCT02358343|11224154|FG004|NOT COMPLETED|Screening Intervention||0
9868726|NCT00969761|10982733|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13
9868727|NCT00969761|10982734|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3
9868728|NCT00969761|10982735|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3
9868729|NCT00969761|10982736|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3
9868730|NCT00969761|10982725|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
9868731|NCT00969761|10982726|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
9868732|NCT00969761|10982727|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
9868733|NCT00969761|10982728|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
9868734|NCT00969761|10982729|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
9868735|NCT00969761|10982730|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
9868736|NCT00969761|10982731|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
9868737|NCT00969761|10982732|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
9868738|NCT00969761|10982733|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
9868739|NCT00969761|10982734|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
9868740|NCT00969761|10982735|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
9868741|NCT00969761|10982736|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
9868742|NCT00969761|10982725|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
9868743|NCT00969761|10982726|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
9868744|NCT00969761|10982727|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
9868745|NCT00969761|10982728|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
9868746|NCT00969761|10982729|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
9868747|NCT00969761|10982730|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
9868748|NCT00969761|10982731|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
9868749|NCT00969761|10982732|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
9868750|NCT00969761|10982733|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
9868751|NCT00969761|10982734|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
9868752|NCT00969761|10982735|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
9868753|NCT00969761|10982736|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
9868754|NCT00969761|10982725|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2
9868755|NCT00969761|10982726|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3
9868756|NCT00969761|10982727|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10
9868757|NCT00969761|10982728|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5
9868758|NCT00969761|10982729|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3
9868759|NCT00969761|10982730|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3
9868760|NCT00969761|10982731|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3
9868761|NCT00969761|10982732|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6
9868762|NCT00969761|10982733|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11
9868763|NCT00969761|10982734|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2
9868764|NCT00969761|10982735|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3
9868765|NCT00969761|10982736|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3
9868766|NCT00969761|10982725|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868767|NCT00969761|10982726|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868768|NCT00969761|10982727|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868769|NCT00969761|10982728|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868770|NCT00969761|10982729|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868771|NCT00969761|10982730|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868772|NCT00969761|10982731|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868773|NCT00969761|10982732|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868774|NCT00969761|10982733|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868775|NCT00969761|10982734|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868776|NCT00969761|10982735|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868777|NCT00969761|10982736|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
9868778|NCT00969761|10982725|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
9868779|NCT00969761|10982726|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
9868780|NCT00969761|10982727|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
9868781|NCT00969761|10982728|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
9868782|NCT00969761|10982729|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
9868783|NCT00969761|10982730|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
9868784|NCT00969761|10982731|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
9868785|NCT00969761|10982732|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
9868786|NCT00969761|10982733|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
9868787|NCT00969761|10982734|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
9868788|NCT00969761|10982735|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
9868789|NCT00969761|10982736|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
9868790|NCT00969878|10982764|FG000|STARTED|Overall Study||148
9868791|NCT00969878|10982765|FG001|STARTED|Overall Study||152
9868792|NCT00969878|10982764|FG000|COMPLETED|Overall Study||118
9868793|NCT00969878|10982765|FG001|COMPLETED|Overall Study||126
9868794|NCT00969878|10982764|FG000|NOT COMPLETED|Overall Study||30
9868795|NCT00969878|10982765|FG001|NOT COMPLETED|Overall Study||26
9868796|NCT00970073|10982776|FG000|STARTED|Overall Study||10
10112989|NCT02506881|11243905|FG002|STARTED|Second Intervention (Day 1)||12
9868797|NCT00970073|10982777|FG001|STARTED|Overall Study||10
9868798|NCT00970073|10982778|FG002|STARTED|Overall Study||10
9868799|NCT00970073|10982776|FG000|COMPLETED|Overall Study||10
9868800|NCT00970073|10982777|FG001|COMPLETED|Overall Study||10
9868801|NCT00970073|10982778|FG002|COMPLETED|Overall Study||10
9868802|NCT00970073|10982776|FG000|NOT COMPLETED|Overall Study||0
9868803|NCT00970073|10982777|FG001|NOT COMPLETED|Overall Study||0
9868804|NCT00970073|10982778|FG002|NOT COMPLETED|Overall Study||0
9868805|NCT00970203|10982788|FG000|STARTED|Overall Study||7
9868806|NCT00970203|10982789|FG001|STARTED|Overall Study||6
9868807|NCT00970203|10982788|FG000|COMPLETED|Overall Study||7
9868808|NCT00970203|10982789|FG001|COMPLETED|Overall Study||6
9868809|NCT00970203|10982788|FG000|NOT COMPLETED|Overall Study||0
9868810|NCT00970203|10982789|FG001|NOT COMPLETED|Overall Study||0
9868811|NCT00970216|10982795|FG000|STARTED|Overall Study||160
9868812|NCT00970216|10982795|FG000|COMPLETED|Overall Study||80
9868813|NCT00970216|10982795|FG000|NOT COMPLETED|Overall Study||80
9868814|NCT00970268|10982801|FG000|STARTED|Overall Study||139
9868815|NCT00970268|10982802|FG001|STARTED|Overall Study||152
9868816|NCT00970268|10982801|FG000|COMPLETED|Overall Study||96
9868817|NCT00970268|10982802|FG001|COMPLETED|Overall Study||103
9868818|NCT00970268|10982801|FG000|NOT COMPLETED|Overall Study||43
9868819|NCT00970268|10982802|FG001|NOT COMPLETED|Overall Study||49
9868820|NCT00970281|10982816|FG000|STARTED|Overall Study||46
9868821|NCT00970281|10982817|FG001|STARTED|Overall Study||45
9868822|NCT00970281|10982816|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
9868823|NCT00970281|10982817|FG001|Full Analysis Set|Overall Study||45
9868824|NCT00970281|10982816|FG000|COMPLETED|Overall Study||44
9868825|NCT00970281|10982817|FG001|COMPLETED|Overall Study||29
9868826|NCT00970281|10982816|FG000|NOT COMPLETED|Overall Study||2
9868827|NCT00970281|10982817|FG001|NOT COMPLETED|Overall Study||16
9868828|NCT00970294|10982823|FG000|STARTED|Overall Study||11
9868829|NCT00970294|10982823|FG000|COMPLETED|Overall Study||6
9868830|NCT00970294|10982823|FG000|NOT COMPLETED|Overall Study||5
9868831|NCT00970307|10982830|FG000|STARTED|Overall Study||141
9868832|NCT00970307|10982831|FG001|STARTED|Overall Study||139
9868833|NCT00970307|10982832|FG002|STARTED|Overall Study||141
9868834|NCT00970307|10982830|FG000|COMPLETED|Overall Study||138
9868835|NCT00970307|10982831|FG001|COMPLETED|Overall Study||136
9868836|NCT00970307|10982832|FG002|COMPLETED|Overall Study||139
9868837|NCT00970307|10982830|FG000|NOT COMPLETED|Overall Study||3
9868838|NCT00970307|10982831|FG001|NOT COMPLETED|Overall Study||3
9868839|NCT00970307|10982832|FG002|NOT COMPLETED|Overall Study||2
9868840|NCT00970320|10982845|FG000|STARTED|Overall Study||25
9868841|NCT00970320|10982846|FG001|STARTED|Overall Study||24
9868842|NCT00970320|10982847|FG002|STARTED|Overall Study||48
9868843|NCT00970320|10982848|FG003|STARTED|Overall Study||50
9868844|NCT00970320|10982849|FG004|STARTED|Overall Study||1571
9868845|NCT00970320|10982845|FG000|COMPLETED|Overall Study||25
9868846|NCT00970320|10982846|FG001|COMPLETED|Overall Study||13
9868847|NCT00970320|10982847|FG002|COMPLETED|Overall Study||35
9868848|NCT00970320|10982848|FG003|COMPLETED|Overall Study||36
9868849|NCT00970320|10982849|FG004|COMPLETED|Overall Study||1031
9868850|NCT00970320|10982845|FG000|NOT COMPLETED|Overall Study||0
9868851|NCT00970320|10982846|FG001|NOT COMPLETED|Overall Study||11
9868852|NCT00970320|10982847|FG002|NOT COMPLETED|Overall Study||13
9868853|NCT00970320|10982848|FG003|NOT COMPLETED|Overall Study||14
9868854|NCT00970320|10982849|FG004|NOT COMPLETED|Overall Study||540
9868855|NCT00970359|10982861|FG000|STARTED|Overall Study||24
9868856|NCT00970359|10982861|FG000|COMPLETED|Overall Study||20
9868857|NCT00970359|10982861|FG000|NOT COMPLETED|Overall Study||4
9868858|NCT00970489|10982867|FG000|STARTED|Overall Study||758
9868859|NCT00970489|10982868|FG001|STARTED|Overall Study||758
9868860|NCT00970489|10982867|FG000|COMPLETED|Overall Study||704
9868861|NCT00970489|10982868|FG001|COMPLETED|Overall Study||717
9868862|NCT00970489|10982867|FG000|NOT COMPLETED|Overall Study||54
9868863|NCT00970489|10982868|FG001|NOT COMPLETED|Overall Study||41
9868864|NCT00970502|10982874|FG000|STARTED|Overall Study||15
9868865|NCT00970502|10982874|FG000|COMPLETED|Overall Study||14
9868866|NCT00970502|10982874|FG000|NOT COMPLETED|Overall Study||1
9868867|NCT00970593|10982889|FG000|STARTED|Overall Study||11
9868868|NCT00970593|10982890|FG001|STARTED|Overall Study||15
9868869|NCT00970593|10982891|FG002|STARTED|Overall Study||13
9868870|NCT00970593|10982892|FG003|STARTED|Overall Study||12
9868871|NCT00970593|10982893|FG004|STARTED|Overall Study||20
9868872|NCT00970593|10982894|FG005|STARTED|Overall Study||5
9868873|NCT00970593|10982895|FG006|STARTED|Overall Study||16
9868874|NCT00970593|10982889|FG000|COMPLETED|Overall Study||10
9868875|NCT00970593|10982890|FG001|COMPLETED|Overall Study||14
9868876|NCT00970593|10982891|FG002|COMPLETED|Overall Study||7
9868877|NCT00970593|10982892|FG003|COMPLETED|Overall Study||12
9868878|NCT00970593|10982893|FG004|COMPLETED|Overall Study||20
9868879|NCT00970593|10982894|FG005|COMPLETED|Overall Study||5
9868880|NCT00970593|10982895|FG006|COMPLETED|Overall Study||14
9868881|NCT00970593|10982889|FG000|NOT COMPLETED|Overall Study||1
9868882|NCT00970593|10982890|FG001|NOT COMPLETED|Overall Study||1
9868883|NCT00970593|10982891|FG002|NOT COMPLETED|Overall Study||6
9868884|NCT00970593|10982892|FG003|NOT COMPLETED|Overall Study||0
9868885|NCT00970593|10982893|FG004|NOT COMPLETED|Overall Study||0
9868886|NCT00970593|10982894|FG005|NOT COMPLETED|Overall Study||0
9868887|NCT00970593|10982895|FG006|NOT COMPLETED|Overall Study||2
9868888|NCT00970632|10982918|FG000|STARTED|Overall Study||172
9868889|NCT00970632|10982919|FG001|STARTED|Overall Study||171
9868890|NCT00970632|10982920|FG002|STARTED|Overall Study||168
9868891|NCT00970632|10982918|FG000|COMPLETED|Overall Study||148
9868892|NCT00970632|10982919|FG001|COMPLETED|Overall Study||156
9868893|NCT00970632|10982920|FG002|COMPLETED|Overall Study||150
9868894|NCT00970632|10982918|FG000|NOT COMPLETED|Overall Study||24
9868895|NCT00970632|10982919|FG001|NOT COMPLETED|Overall Study||15
9868896|NCT00970632|10982920|FG002|NOT COMPLETED|Overall Study||18
9868897|NCT00970684|10982928|FG000|STARTED|Overall Study||13
9868898|NCT00970684|10982928|FG000|COMPLETED|Overall Study||3
9868899|NCT00970684|10982928|FG000|NOT COMPLETED|Overall Study||10
9868900|NCT00970814|10982934|FG000|STARTED|Overall Study||66
9868901|NCT00970814|10982935|FG001|STARTED|Overall Study||64
9868902|NCT00970814|10982934|FG000|COMPLETED|Overall Study||58
9868903|NCT00970814|10982935|FG001|COMPLETED|Overall Study||50
9868904|NCT00970814|10982934|FG000|NOT COMPLETED|Overall Study||8
9868905|NCT00970814|10982935|FG001|NOT COMPLETED|Overall Study||14
9868906|NCT00970853|10982943|FG000|STARTED|Overall Study||89
9868907|NCT00970853|10982944|FG001|STARTED|Overall Study||98
9868908|NCT00970853|10982943|FG000|COMPLETED|Overall Study||89
9868909|NCT00970853|10982944|FG001|COMPLETED|Overall Study||98
9868910|NCT00970853|10982943|FG000|NOT COMPLETED|Overall Study||0
9868911|NCT00970853|10982944|FG001|NOT COMPLETED|Overall Study||0
9868912|NCT00970944|10982952|FG000|STARTED|Overall Study||87
9868913|NCT00970944|10982953|FG001|STARTED|Overall Study||97
9868914|NCT00970944|10982952|FG000|COMPLETED|Overall Study||86
9868915|NCT00970944|10982953|FG001|COMPLETED|Overall Study||95
9868916|NCT00970944|10982952|FG000|NOT COMPLETED|Overall Study||1
9868917|NCT00970944|10982953|FG001|NOT COMPLETED|Overall Study||2
9868918|NCT00971048|10982964|FG000|STARTED|Overall Study||30
9868919|NCT00971048|10982965|FG001|STARTED|Overall Study||33
9868920|NCT00971048|10982966|FG002|STARTED|Overall Study||12
9868921|NCT00971048|10982967|FG003|STARTED|Overall Study||13
9868922|NCT00971048|10982964|FG000|COMPLETED|Overall Study||29
9868923|NCT00971048|10982965|FG001|COMPLETED|Overall Study||31
9868924|NCT00971048|10982966|FG002|COMPLETED|Overall Study||11
9868925|NCT00971048|10982967|FG003|COMPLETED|Overall Study||11
9868926|NCT00971048|10982964|FG000|NOT COMPLETED|Overall Study||1
9868927|NCT00971048|10982965|FG001|NOT COMPLETED|Overall Study||2
9868928|NCT00971048|10982966|FG002|NOT COMPLETED|Overall Study||1
9868929|NCT00971048|10982967|FG003|NOT COMPLETED|Overall Study||2
9868930|NCT00971178|10982982|FG000|STARTED|Overall Study||35
9868931|NCT00971178|10982983|FG001|STARTED|Overall Study||35
9868932|NCT00971178|10982984|FG002|STARTED|Overall Study||35
9868933|NCT00971178|10982982|FG000|COMPLETED|Overall Study||33
9868934|NCT00971178|10982983|FG001|COMPLETED|Overall Study||33
9868935|NCT00971178|10982984|FG002|COMPLETED|Overall Study||33
9868936|NCT00971178|10982982|FG000|NOT COMPLETED|Overall Study||2
9868937|NCT00971178|10982983|FG001|NOT COMPLETED|Overall Study||2
9868938|NCT00971178|10982984|FG002|NOT COMPLETED|Overall Study||2
9868939|NCT00971204|10982992|FG000|STARTED|Overall Study|100 enrolled participants|100
9868940|NCT00971204|10982992|FG000|Treated|Overall Study||86
9868941|NCT00971204|10982992|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
9868942|NCT00971204|10982992|FG000|NOT COMPLETED|Overall Study||24
9868943|NCT00971243|10983001|FG000|STARTED|Double Blind Period||87
9868944|NCT00971243|10983002|FG001|STARTED|Double Blind Period||93
9868945|NCT00971243|10983003|FG002|STARTED|Double Blind Period||91
9868946|NCT00971243|10983004|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
9868947|NCT00971243|10983005|FG004|STARTED|Double Blind Period||88
9868948|NCT00971243|10983001|FG000|COMPLETED|Double Blind Period||68
9868949|NCT00971243|10983002|FG001|COMPLETED|Double Blind Period||82
9868950|NCT00971243|10983003|FG002|COMPLETED|Double Blind Period||72
9868951|NCT00971243|10983004|FG003|COMPLETED|Double Blind Period||74
9868952|NCT00971243|10983005|FG004|COMPLETED|Double Blind Period||70
9868953|NCT00971243|10983001|FG000|NOT COMPLETED|Double Blind Period||19
9868954|NCT00971243|10983002|FG001|NOT COMPLETED|Double Blind Period||11
9868955|NCT00971243|10983003|FG002|NOT COMPLETED|Double Blind Period||19
9868956|NCT00971243|10983004|FG003|NOT COMPLETED|Double Blind Period||14
9868957|NCT00971243|10983005|FG004|NOT COMPLETED|Double Blind Period||18
9868958|NCT00971243|10983001|FG000|STARTED|Open-label Period||68
9868959|NCT00971243|10983002|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
9868960|NCT00971243|10983003|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
9868961|NCT00971243|10983004|FG003|STARTED|Open-label Period||74
9868962|NCT00971243|10983005|FG004|STARTED|Open-label Period||70
9868963|NCT00971243|10983001|FG000|COMPLETED|Open-label Period||60
9868964|NCT00971243|10983002|FG001|COMPLETED|Open-label Period||71
9868965|NCT00971243|10983003|FG002|COMPLETED|Open-label Period||66
9868966|NCT00971243|10983004|FG003|COMPLETED|Open-label Period||64
9868967|NCT00971243|10983005|FG004|COMPLETED|Open-label Period||64
9868968|NCT00971243|10983001|FG000|NOT COMPLETED|Open-label Period||8
9868969|NCT00971243|10983002|FG001|NOT COMPLETED|Open-label Period||10
9868970|NCT00971243|10983003|FG002|NOT COMPLETED|Open-label Period||5
9868971|NCT00971243|10983004|FG003|NOT COMPLETED|Open-label Period||10
9868972|NCT00971243|10983005|FG004|NOT COMPLETED|Open-label Period||6
9868973|NCT00971282|10983017|FG000|STARTED|Overall Study||30
9868974|NCT00971282|10983017|FG000|COMPLETED|Overall Study||30
9868975|NCT00971282|10983017|FG000|NOT COMPLETED|Overall Study||0
9868976|NCT00971295|10983023|FG000|STARTED|Overall Study||10
9868977|NCT00971295|10983024|FG001|STARTED|Overall Study||10
9868978|NCT00971295|10983023|FG000|COMPLETED|Overall Study||10
9868979|NCT00971295|10983024|FG001|COMPLETED|Overall Study||9
9868980|NCT00971295|10983023|FG000|NOT COMPLETED|Overall Study||0
9868981|NCT00971295|10983024|FG001|NOT COMPLETED|Overall Study||1
9868982|NCT00971321|10983032|FG000|STARTED|Up to Day 42||104
9868983|NCT00971321|10983033|FG001|STARTED|Up to Day 42||53
9868984|NCT00971321|10983032|FG000|COMPLETED|Up to Day 42||104
9868985|NCT00971321|10983033|FG001|COMPLETED|Up to Day 42||53
9868986|NCT00971321|10983032|FG000|NOT COMPLETED|Up to Day 42||0
9868987|NCT00971321|10983033|FG001|NOT COMPLETED|Up to Day 42||0
9868988|NCT00971321|10983032|FG000|STARTED|Up to Month 7||104
9868989|NCT00971321|10983033|FG001|STARTED|Up to Month 7||53
9868990|NCT00971321|10983032|FG000|COMPLETED|Up to Month 7||100
9868991|NCT00971321|10983033|FG001|COMPLETED|Up to Month 7||51
9868992|NCT00971321|10983032|FG000|NOT COMPLETED|Up to Month 7||4
9868993|NCT00971321|10983033|FG001|NOT COMPLETED|Up to Month 7||2
9868994|NCT00971321|10983032|FG000|STARTED|Up to Month 11-12||104
9868995|NCT00971321|10983033|FG001|STARTED|Up to Month 11-12||53
9868996|NCT00971321|10983032|FG000|COMPLETED|Up to Month 11-12||99
9868997|NCT00971321|10983033|FG001|COMPLETED|Up to Month 11-12||50
9868998|NCT00971321|10983032|FG000|NOT COMPLETED|Up to Month 11-12||5
9868999|NCT00971321|10983033|FG001|NOT COMPLETED|Up to Month 11-12||3
9869000|NCT00971425|10983041|FG000|STARTED|Overall Study||72
9869001|NCT00971425|10983042|FG001|STARTED|Overall Study||73
9869002|NCT00971425|10983041|FG000|COMPLETED|Overall Study||71
9869003|NCT00971425|10983042|FG001|COMPLETED|Overall Study||71
9869004|NCT00971425|10983041|FG000|NOT COMPLETED|Overall Study||1
9869005|NCT00971425|10983042|FG001|NOT COMPLETED|Overall Study||2
9869006|NCT00971620|10983050|FG000|STARTED|Overall Study||9
9869007|NCT00971620|10983051|FG001|STARTED|Overall Study||9
9869008|NCT00971620|10983050|FG000|COMPLETED|Overall Study||9
9869009|NCT00971620|10983051|FG001|COMPLETED|Overall Study||9
9869010|NCT00971620|10983050|FG000|NOT COMPLETED|Overall Study||0
9869011|NCT00971620|10983051|FG001|NOT COMPLETED|Overall Study||0
9869012|NCT00971633|10983057|FG000|STARTED|Period 1||2
9869013|NCT00971633|10983058|FG001|STARTED|Period 1||2
9869014|NCT00971633|10983059|FG002|STARTED|Period 1||2
9869015|NCT00971633|10983060|FG003|STARTED|Period 1||2
9869016|NCT00971633|10983061|FG004|STARTED|Period 1||2
9869017|NCT00971633|10983062|FG005|STARTED|Period 1||2
9869018|NCT00971633|10983057|FG000|COMPLETED|Period 1||2
9869019|NCT00971633|10983058|FG001|COMPLETED|Period 1||2
9869020|NCT00971633|10983059|FG002|COMPLETED|Period 1||2
9869021|NCT00971633|10983060|FG003|COMPLETED|Period 1||2
9869022|NCT00971633|10983061|FG004|COMPLETED|Period 1||2
9869023|NCT00971633|10983062|FG005|COMPLETED|Period 1||2
9869024|NCT00971633|10983057|FG000|NOT COMPLETED|Period 1||0
9869025|NCT00971633|10983058|FG001|NOT COMPLETED|Period 1||0
9869026|NCT00971633|10983059|FG002|NOT COMPLETED|Period 1||0
9869027|NCT00971633|10983060|FG003|NOT COMPLETED|Period 1||0
9869028|NCT00971633|10983061|FG004|NOT COMPLETED|Period 1||0
9869029|NCT00971633|10983062|FG005|NOT COMPLETED|Period 1||0
9869030|NCT00971633|10983057|FG000|STARTED|Period 2||2
9869031|NCT00971633|10983058|FG001|STARTED|Period 2||2
9869032|NCT00971633|10983059|FG002|STARTED|Period 2||2
9869033|NCT00971633|10983060|FG003|STARTED|Period 2||2
9869034|NCT00971633|10983061|FG004|STARTED|Period 2||2
9869035|NCT00971633|10983062|FG005|STARTED|Period 2||2
9869036|NCT00971633|10983057|FG000|COMPLETED|Period 2||2
9869037|NCT00971633|10983058|FG001|COMPLETED|Period 2||2
9869038|NCT00971633|10983059|FG002|COMPLETED|Period 2||2
9869039|NCT00971633|10983060|FG003|COMPLETED|Period 2||2
9869040|NCT00971633|10983061|FG004|COMPLETED|Period 2||2
9869041|NCT00971633|10983062|FG005|COMPLETED|Period 2||2
9869042|NCT00971633|10983057|FG000|NOT COMPLETED|Period 2||0
9869043|NCT00971633|10983058|FG001|NOT COMPLETED|Period 2||0
9869044|NCT00971633|10983059|FG002|NOT COMPLETED|Period 2||0
9869045|NCT00971633|10983060|FG003|NOT COMPLETED|Period 2||0
9869046|NCT00971633|10983061|FG004|NOT COMPLETED|Period 2||0
9869047|NCT00971633|10983062|FG005|NOT COMPLETED|Period 2||0
9869048|NCT00971633|10983057|FG000|STARTED|Period 3||2
9869049|NCT00971633|10983058|FG001|STARTED|Period 3||2
9869050|NCT00971633|10983059|FG002|STARTED|Period 3||2
9869051|NCT00971633|10983060|FG003|STARTED|Period 3||2
9869052|NCT00971633|10983061|FG004|STARTED|Period 3||2
9869053|NCT00971633|10983062|FG005|STARTED|Period 3||2
9869054|NCT00971633|10983057|FG000|COMPLETED|Period 3||2
9869055|NCT00971633|10983058|FG001|COMPLETED|Period 3||2
9869056|NCT00971633|10983059|FG002|COMPLETED|Period 3||2
9869057|NCT00971633|10983060|FG003|COMPLETED|Period 3||2
9869058|NCT00971633|10983061|FG004|COMPLETED|Period 3||2
9869059|NCT00971633|10983062|FG005|COMPLETED|Period 3||2
9869060|NCT00971633|10983057|FG000|NOT COMPLETED|Period 3||0
9869061|NCT00971633|10983058|FG001|NOT COMPLETED|Period 3||0
9869062|NCT00971633|10983059|FG002|NOT COMPLETED|Period 3||0
9869063|NCT00971633|10983060|FG003|NOT COMPLETED|Period 3||0
9869064|NCT00971633|10983061|FG004|NOT COMPLETED|Period 3||0
9869065|NCT00971633|10983062|FG005|NOT COMPLETED|Period 3||0
9869066|NCT00971737|10983072|FG000|STARTED|Overall Study||30
9869067|NCT00971737|10983073|FG001|STARTED|Overall Study||30
9869068|NCT00971737|10983072|FG000|COMPLETED|Overall Study||30
9869069|NCT00971737|10983073|FG001|COMPLETED|Overall Study||30
9869070|NCT00971737|10983072|FG000|NOT COMPLETED|Overall Study||0
9869071|NCT00971737|10983073|FG001|NOT COMPLETED|Overall Study||0
9869072|NCT00971750|10983079|FG000|STARTED|Overall Study||253
9869073|NCT00971750|10983079|FG000|COMPLETED|Overall Study||253
9869074|NCT00971750|10983079|FG000|NOT COMPLETED|Overall Study||0
9869075|NCT00971789|10983085|FG000|STARTED|Overall Study||18
9869076|NCT00971789|10983085|FG000|COMPLETED|Overall Study||18
9869077|NCT00971789|10983085|FG000|NOT COMPLETED|Overall Study||0
9869078|NCT00971841|10983089|FG000|STARTED|Overall Study||1
9869079|NCT00971841|10983089|FG000|COMPLETED|Overall Study||1
9869080|NCT00971841|10983089|FG000|NOT COMPLETED|Overall Study||0
9869081|NCT00971932|10983093|FG000|STARTED|Overall Study|Number of participants treated.|33
9869082|NCT00971932|10983093|FG000|COMPLETED|Overall Study||26
9869083|NCT00971932|10983093|FG000|NOT COMPLETED|Overall Study||7
9869084|NCT00971945|10983097|FG000|STARTED|Overall Study||6
9869085|NCT00971945|10983097|FG000|COMPLETED|Overall Study||0
9869086|NCT00971945|10983097|FG000|NOT COMPLETED|Overall Study||6
9869087|NCT00971997|10983101|FG000|STARTED|Overall Study||135
9869088|NCT00971997|10983101|FG000|COMPLETED|Overall Study||116
9869089|NCT00971997|10983101|FG000|NOT COMPLETED|Overall Study||19
9869090|NCT00972088|10983108|FG000|STARTED|Overall Study||26
9869091|NCT00972088|10983108|FG000|COMPLETED|Overall Study||26
9869092|NCT00972088|10983108|FG000|NOT COMPLETED|Overall Study||0
9869093|NCT00972153|10983115|FG000|STARTED|Overall Study||12
9869094|NCT00972153|10983116|FG001|STARTED|Overall Study||12
9869095|NCT00972153|10983117|FG002|STARTED|Overall Study||12
9869096|NCT00972153|10983115|FG000|COMPLETED|Overall Study||12
9869097|NCT00972153|10983116|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
9869098|NCT00972153|10983117|FG002|COMPLETED|Overall Study||12
9869099|NCT00972153|10983115|FG000|NOT COMPLETED|Overall Study||0
9869100|NCT00972153|10983116|FG001|NOT COMPLETED|Overall Study||1
9869101|NCT00972153|10983117|FG002|NOT COMPLETED|Overall Study||0
9869102|NCT00972205|10983125|FG000|STARTED|Overall Study||12
9869103|NCT00972205|10983125|FG000|COMPLETED|Overall Study||12
9869104|NCT00972205|10983125|FG000|NOT COMPLETED|Overall Study||0
9869105|NCT00972244|10983134|FG000|STARTED|Overall Study||59
9869106|NCT00972244|10983135|FG001|STARTED|Overall Study||56
9869107|NCT00972244|10983136|FG002|STARTED|Overall Study||58
9869108|NCT00972244|10983137|FG003|STARTED|Overall Study||52
9869109|NCT00972244|10983138|FG004|STARTED|Overall Study||54
9869110|NCT00972244|10983134|FG000|COMPLETED|Overall Study||54
9869111|NCT00972244|10983135|FG001|COMPLETED|Overall Study||51
9869112|NCT00972244|10983136|FG002|COMPLETED|Overall Study||56
9869113|NCT00972244|10983137|FG003|COMPLETED|Overall Study||52
9869114|NCT00972244|10983138|FG004|COMPLETED|Overall Study||45
9869115|NCT00972244|10983134|FG000|NOT COMPLETED|Overall Study||5
9869116|NCT00972244|10983135|FG001|NOT COMPLETED|Overall Study||5
9869117|NCT00972244|10983136|FG002|NOT COMPLETED|Overall Study||2
9869118|NCT00972244|10983137|FG003|NOT COMPLETED|Overall Study||0
9869119|NCT00972244|10983138|FG004|NOT COMPLETED|Overall Study||9
9869120|NCT00972283|10983152|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
9869121|NCT00972283|10983153|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
9869122|NCT00972283|10983152|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
9869123|NCT00972283|10983153|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
9869124|NCT00972283|10983152|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
9869125|NCT00972283|10983153|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
9869126|NCT00972283|10983152|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
9869127|NCT00972283|10983153|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
9869128|NCT00972283|10983152|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
9869129|NCT00972283|10983153|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
9869130|NCT00972283|10983152|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
9869131|NCT00972283|10983153|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
9869132|NCT00972283|10983152|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
9869133|NCT00972283|10983153|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
10095582|NCT02358343|11224150|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
10112990|NCT02506881|11243906|FG003|STARTED|Second Intervention (Day 1)||12
9869134|NCT00972283|10983152|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
9869135|NCT00972283|10983153|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
9869136|NCT00972322|10983161|FG000|STARTED|Overall Study||28
9869137|NCT00972322|10983162|FG001|STARTED|Overall Study||28
9869138|NCT00972322|10983161|FG000|COMPLETED|Overall Study||25
9869139|NCT00972322|10983162|FG001|COMPLETED|Overall Study||25
9869140|NCT00972322|10983161|FG000|NOT COMPLETED|Overall Study||3
9869141|NCT00972322|10983162|FG001|NOT COMPLETED|Overall Study||3
9869142|NCT00972335|10983168|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
9869143|NCT00972335|10983168|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
9869144|NCT00972335|10983168|FG000|NOT COMPLETED|Overall Study||17
9869145|NCT00972374|10983175|FG000|STARTED|Overall Study||15
9869146|NCT00972374|10983176|FG001|STARTED|Overall Study||15
9869147|NCT00972374|10983177|FG002|STARTED|Overall Study||14
9869148|NCT00972374|10983175|FG000|COMPLETED|Overall Study||13
9869149|NCT00972374|10983176|FG001|COMPLETED|Overall Study||15
9869150|NCT00972374|10983177|FG002|COMPLETED|Overall Study||13
9869151|NCT00972374|10983175|FG000|NOT COMPLETED|Overall Study||2
9869152|NCT00972374|10983176|FG001|NOT COMPLETED|Overall Study||0
9869153|NCT00972374|10983177|FG002|NOT COMPLETED|Overall Study||1
9869154|NCT00972439|10983187|FG000|STARTED|Overall Study||17
9869155|NCT00972439|10983188|FG001|STARTED|Overall Study||16
9869156|NCT00972439|10983187|FG000|COMPLETED|Overall Study||17
9869157|NCT00972439|10983188|FG001|COMPLETED|Overall Study||16
9869158|NCT00972439|10983187|FG000|NOT COMPLETED|Overall Study||0
9869159|NCT00972439|10983188|FG001|NOT COMPLETED|Overall Study||0
9869160|NCT00972504|10983194|FG000|STARTED|Overall Study||54
9869161|NCT00972504|10983194|FG000|COMPLETED|Overall Study||51
9869162|NCT00972504|10983194|FG000|NOT COMPLETED|Overall Study||3
9869163|NCT00972517|10983204|FG000|STARTED|Overall Study||31
9869164|NCT00972517|10983205|FG001|STARTED|Overall Study||31
9869165|NCT00972517|10983206|FG002|STARTED|Overall Study||60
9869166|NCT00972517|10983207|FG003|STARTED|Overall Study||30
9869167|NCT00972517|10983208|FG004|STARTED|Overall Study||34
9869168|NCT00972517|10983209|FG005|STARTED|Overall Study||58
9869169|NCT00972517|10983204|FG000|COMPLETED|Overall Study||31
9869170|NCT00972517|10983205|FG001|COMPLETED|Overall Study||30
9869171|NCT00972517|10983206|FG002|COMPLETED|Overall Study||60
9869172|NCT00972517|10983207|FG003|COMPLETED|Overall Study||27
9869173|NCT00972517|10983208|FG004|COMPLETED|Overall Study||33
9869174|NCT00972517|10983209|FG005|COMPLETED|Overall Study||58
9869175|NCT00972517|10983204|FG000|NOT COMPLETED|Overall Study||0
9869176|NCT00972517|10983205|FG001|NOT COMPLETED|Overall Study||1
9869177|NCT00972517|10983206|FG002|NOT COMPLETED|Overall Study||0
9869178|NCT00972517|10983207|FG003|NOT COMPLETED|Overall Study||3
9869179|NCT00972517|10983208|FG004|NOT COMPLETED|Overall Study||1
9869180|NCT00972517|10983209|FG005|NOT COMPLETED|Overall Study||0
9869181|NCT00972530|10983231|FG000|STARTED|Overall Study||44
9869182|NCT00972530|10983232|FG001|STARTED|Overall Study||46
9869183|NCT00972530|10983231|FG000|COMPLETED|Overall Study||44
9869184|NCT00972530|10983232|FG001|COMPLETED|Overall Study||46
9869185|NCT00972530|10983231|FG000|NOT COMPLETED|Overall Study||0
9869186|NCT00972530|10983232|FG001|NOT COMPLETED|Overall Study||0
9869187|NCT00972543|10983240|FG000|STARTED|Overall Study||5
9869188|NCT00972543|10983241|FG001|STARTED|Overall Study||1
9869189|NCT00972543|10983240|FG000|COMPLETED|Overall Study||0
9869190|NCT00972543|10983241|FG001|COMPLETED|Overall Study||0
9869191|NCT00972543|10983240|FG000|NOT COMPLETED|Overall Study||5
9869192|NCT00972543|10983241|FG001|NOT COMPLETED|Overall Study||1
9869193|NCT00972595|10983247|FG000|STARTED|Period 1||23
9869194|NCT00972595|10983248|FG001|STARTED|Period 1||22
9869195|NCT00972595|10983247|FG000|COMPLETED|Period 1||22
9869196|NCT00972595|10983248|FG001|COMPLETED|Period 1||22
9869197|NCT00972595|10983247|FG000|NOT COMPLETED|Period 1||1
9869198|NCT00972595|10983248|FG001|NOT COMPLETED|Period 1||0
9869199|NCT00972595|10983247|FG000|STARTED|Period 2||22
9869200|NCT00972595|10983248|FG001|STARTED|Period 2||22
9869201|NCT00972595|10983247|FG000|COMPLETED|Period 2||22
9869202|NCT00972595|10983248|FG001|COMPLETED|Period 2||22
9869203|NCT00972595|10983247|FG000|NOT COMPLETED|Period 2||0
9869204|NCT00972595|10983248|FG001|NOT COMPLETED|Period 2||0
9869205|NCT00972621|10983256|FG000|STARTED|Overall Study||200
9869206|NCT00972621|10983257|FG001|STARTED|Overall Study||200
9869207|NCT00972621|10983256|FG000|COMPLETED|Overall Study||200
9869208|NCT00972621|10983257|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
9869209|NCT00972621|10983256|FG000|NOT COMPLETED|Overall Study||0
9869210|NCT00972621|10983257|FG001|NOT COMPLETED|Overall Study||1
9869211|NCT00972725|10983265|FG000|STARTED|Overall Study||13
9869212|NCT00972725|10983266|FG001|STARTED|Overall Study||15
9869213|NCT00972725|10983265|FG000|COMPLETED|Overall Study||13
9869214|NCT00972725|10983266|FG001|COMPLETED|Overall Study||15
9869215|NCT00972725|10983265|FG000|NOT COMPLETED|Overall Study||0
9869216|NCT00972725|10983266|FG001|NOT COMPLETED|Overall Study||0
9869217|NCT00972777|10983274|FG000|STARTED|Overall Study||231
9869218|NCT00972777|10983275|FG001|STARTED|Overall Study||243
9869219|NCT00972777|10983274|FG000|COMPLETED|Overall Study||217
9869220|NCT00972777|10983275|FG001|COMPLETED|Overall Study||229
9869221|NCT00972777|10983274|FG000|NOT COMPLETED|Overall Study||14
9869222|NCT00972777|10983275|FG001|NOT COMPLETED|Overall Study||14
9869223|NCT00972816|10983289|FG000|STARTED|Overall Study||173
9869224|NCT00972816|10983290|FG001|STARTED|Overall Study||169
9869225|NCT00972816|10983291|FG002|STARTED|Overall Study||169
9869226|NCT00972816|10983292|FG003|STARTED|Overall Study||169
9869227|NCT00972816|10983293|FG004|STARTED|Overall Study||169
9869228|NCT00972816|10983294|FG005|STARTED|Overall Study||169
9869229|NCT00972816|10983295|FG006|STARTED|Overall Study||169
9869230|NCT00972816|10983296|FG007|STARTED|Overall Study||170
9869231|NCT00972816|10983289|FG000|COMPLETED|Overall Study||156
9869232|NCT00972816|10983290|FG001|COMPLETED|Overall Study||158
9869233|NCT00972816|10983291|FG002|COMPLETED|Overall Study||160
9869234|NCT00972816|10983292|FG003|COMPLETED|Overall Study||161
9869235|NCT00972816|10983293|FG004|COMPLETED|Overall Study||157
9869236|NCT00972816|10983294|FG005|COMPLETED|Overall Study||158
9869237|NCT00972816|10983295|FG006|COMPLETED|Overall Study||159
9869238|NCT00972816|10983296|FG007|COMPLETED|Overall Study||161
9869239|NCT00972816|10983289|FG000|NOT COMPLETED|Overall Study||17
9869240|NCT00972816|10983290|FG001|NOT COMPLETED|Overall Study||11
9869241|NCT00972816|10983291|FG002|NOT COMPLETED|Overall Study||9
9869242|NCT00972816|10983292|FG003|NOT COMPLETED|Overall Study||8
9869243|NCT00972816|10983293|FG004|NOT COMPLETED|Overall Study||12
9869244|NCT00972816|10983294|FG005|NOT COMPLETED|Overall Study||11
9869245|NCT00972816|10983295|FG006|NOT COMPLETED|Overall Study||10
9869246|NCT00972816|10983296|FG007|NOT COMPLETED|Overall Study||9
9869247|NCT00972959|10983314|FG000|STARTED|Overall Study||17
9869248|NCT00972959|10983314|FG000|COMPLETED|Overall Study||17
9869249|NCT00972959|10983314|FG000|NOT COMPLETED|Overall Study||0
9869250|NCT00973102|10983320|FG000|STARTED|Overall Study||24
9869251|NCT00973102|10983321|FG001|STARTED|Overall Study||26
9869252|NCT00973102|10983320|FG000|COMPLETED|Overall Study||23
9869253|NCT00973102|10983321|FG001|COMPLETED|Overall Study||25
9869254|NCT00973102|10983320|FG000|NOT COMPLETED|Overall Study||1
9869255|NCT00973102|10983321|FG001|NOT COMPLETED|Overall Study||1
9869256|NCT00973349|10983343|FG000|STARTED|Overall Study||170
9869257|NCT00973349|10983344|FG001|STARTED|Overall Study||168
9869258|NCT00973349|10983345|FG002|STARTED|Overall Study||171
9869259|NCT00973349|10983346|FG003|STARTED|Overall Study||168
9869260|NCT00973349|10983347|FG004|STARTED|Overall Study||170
9869261|NCT00973349|10983348|FG005|STARTED|Overall Study||169
9869262|NCT00973349|10983349|FG006|STARTED|Overall Study||174
9869263|NCT00973349|10983350|FG007|STARTED|Overall Study||169
9869264|NCT00973349|10983351|FG008|STARTED|Overall Study||171
9869265|NCT00973349|10983352|FG009|STARTED|Overall Study||169
9869266|NCT00973349|10983353|FG010|STARTED|Overall Study||174
9869267|NCT00973349|10983354|FG011|STARTED|Overall Study||169
9869268|NCT00973349|10983355|FG012|STARTED|Overall Study||169
9869269|NCT00973349|10983356|FG013|STARTED|Overall Study||171
9869270|NCT00973349|10983357|FG014|STARTED|Overall Study||170
9869271|NCT00973349|10983358|FG015|STARTED|Overall Study||167
9869272|NCT00973349|10983343|FG000|COMPLETED|Overall Study||166
9869273|NCT00973349|10983344|FG001|COMPLETED|Overall Study||165
9869274|NCT00973349|10983345|FG002|COMPLETED|Overall Study||166
9869275|NCT00973349|10983346|FG003|COMPLETED|Overall Study||163
9869276|NCT00973349|10983347|FG004|COMPLETED|Overall Study||165
9869277|NCT00973349|10983348|FG005|COMPLETED|Overall Study||165
9869278|NCT00973349|10983349|FG006|COMPLETED|Overall Study||172
9869279|NCT00973349|10983350|FG007|COMPLETED|Overall Study||166
9869280|NCT00973349|10983351|FG008|COMPLETED|Overall Study||167
9869281|NCT00973349|10983352|FG009|COMPLETED|Overall Study||163
9869282|NCT00973349|10983353|FG010|COMPLETED|Overall Study||174
9869283|NCT00973349|10983354|FG011|COMPLETED|Overall Study||167
9869284|NCT00973349|10983355|FG012|COMPLETED|Overall Study||168
9869285|NCT00973349|10983356|FG013|COMPLETED|Overall Study||171
9869286|NCT00973349|10983357|FG014|COMPLETED|Overall Study||168
9869287|NCT00973349|10983358|FG015|COMPLETED|Overall Study||165
9869288|NCT00973349|10983343|FG000|NOT COMPLETED|Overall Study||4
9869289|NCT00973349|10983344|FG001|NOT COMPLETED|Overall Study||3
9869290|NCT00973349|10983345|FG002|NOT COMPLETED|Overall Study||5
9869291|NCT00973349|10983346|FG003|NOT COMPLETED|Overall Study||5
9869292|NCT00973349|10983347|FG004|NOT COMPLETED|Overall Study||5
9869293|NCT00973349|10983348|FG005|NOT COMPLETED|Overall Study||4
9869294|NCT00973349|10983349|FG006|NOT COMPLETED|Overall Study||2
9869295|NCT00973349|10983350|FG007|NOT COMPLETED|Overall Study||3
9869296|NCT00973349|10983351|FG008|NOT COMPLETED|Overall Study||4
9869297|NCT00973349|10983352|FG009|NOT COMPLETED|Overall Study||6
9869298|NCT00973349|10983353|FG010|NOT COMPLETED|Overall Study||0
9869299|NCT00973349|10983354|FG011|NOT COMPLETED|Overall Study||2
9869300|NCT00973349|10983355|FG012|NOT COMPLETED|Overall Study||1
10095583|NCT02358343|11224151|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
10095584|NCT02358343|11224152|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
10095585|NCT02358343|11224153|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
10095586|NCT02358343|11224154|FG004|STARTED|Comparative Efficacy Trial / Observation||20
10095587|NCT02358343|11224150|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0
10095588|NCT02358343|11224151|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0
10095589|NCT02358343|11224152|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55
10095590|NCT02358343|11224153|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58
10095591|NCT02358343|11224154|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18
10095592|NCT02358343|11224150|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
10095593|NCT02358343|11224151|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
10095594|NCT02358343|11224152|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
10095595|NCT02358343|11224153|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
10095596|NCT02358343|11224154|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
10095597|NCT02358369|11224168|FG000|STARTED|Pre-Randomization Washout Period||156
10095598|NCT02358369|11224169|FG001|STARTED|Pre-Randomization Washout Period||0
10095599|NCT02358369|11224170|FG002|STARTED|Pre-Randomization Washout Period||0
10095600|NCT02358369|11224171|FG003|STARTED|Pre-Randomization Washout Period||0
10095601|NCT02358369|11224172|FG004|STARTED|Pre-Randomization Washout Period||0
10095602|NCT02358369|11224168|FG000|COMPLETED|Pre-Randomization Washout Period||121
9869301|NCT00973349|10983356|FG013|NOT COMPLETED|Overall Study||0
9869302|NCT00973349|10983357|FG014|NOT COMPLETED|Overall Study||2
9869303|NCT00973349|10983358|FG015|NOT COMPLETED|Overall Study||2
9869304|NCT00973362|10983386|FG000|STARTED|Baseline Evaluation||11644
9869305|NCT00973362|10983387|FG001|STARTED|Baseline Evaluation||1252
9869306|NCT00973362|10983386|FG000|Evaluable for Analysis|Baseline Evaluation||10871
9869307|NCT00973362|10983387|FG001|Evaluable for Analysis|Baseline Evaluation||958
9869308|NCT00973362|10983386|FG000|Conclusive Disease Status|Baseline Evaluation||819
9869309|NCT00973362|10983387|FG001|Conclusive Disease Status|Baseline Evaluation||939
9869310|NCT00973362|10983386|FG000|COMPLETED|Baseline Evaluation||10871
9869311|NCT00973362|10983387|FG001|COMPLETED|Baseline Evaluation||1029
10095603|NCT02358369|11224169|FG001|COMPLETED|Pre-Randomization Washout Period||0
9869312|NCT00973362|10983386|FG000|NOT COMPLETED|Baseline Evaluation||773
9869313|NCT00973362|10983387|FG001|NOT COMPLETED|Baseline Evaluation||223
9869314|NCT00973362|10983386|FG000|STARTED|3-Year Follow-up||10871
9869315|NCT00973362|10983387|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
9869316|NCT00973362|10983386|FG000|COMPLETED|3-Year Follow-up||10854
9869317|NCT00973362|10983387|FG001|COMPLETED|3-Year Follow-up||0
9869318|NCT00973362|10983386|FG000|NOT COMPLETED|3-Year Follow-up||17
9869319|NCT00973362|10983387|FG001|NOT COMPLETED|3-Year Follow-up||0
9869320|NCT00973479|10983398|FG000|STARTED|Overall Study||197
9869321|NCT00973479|10983399|FG001|STARTED|Overall Study||395
9869322|NCT00973479|10983398|FG000|COMPLETED|Overall Study||160
9869323|NCT00973479|10983399|FG001|COMPLETED|Overall Study||326
9869324|NCT00973479|10983398|FG000|NOT COMPLETED|Overall Study||37
9869325|NCT00973479|10983399|FG001|NOT COMPLETED|Overall Study||69
9869326|NCT00973622|10983409|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
9869327|NCT00973622|10983410|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
9869328|NCT00973622|10983409|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16
9869329|NCT00973622|10983410|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14
9869330|NCT00973622|10983409|FG000|NOT COMPLETED|Overall Study||31
9869331|NCT00973622|10983410|FG001|NOT COMPLETED|Overall Study||5
9869332|NCT00973674|10983418|FG000|STARTED|Overall Study||24
9869333|NCT00973674|10983419|FG001|STARTED|Overall Study||26
9869334|NCT00973674|10983418|FG000|COMPLETED|Overall Study||22
9869335|NCT00973674|10983419|FG001|COMPLETED|Overall Study||26
9869336|NCT00973674|10983418|FG000|NOT COMPLETED|Overall Study||2
9869337|NCT00973674|10983419|FG001|NOT COMPLETED|Overall Study||0
9869338|NCT00973700|10983431|FG000|STARTED|Overall Study||56
9869339|NCT00973700|10983432|FG001|STARTED|Overall Study||56
9869340|NCT00973700|10983433|FG002|STARTED|Overall Study||168
9869341|NCT00973700|10983434|FG003|STARTED|Overall Study||336
9869342|NCT00973700|10983435|FG004|STARTED|Overall Study||168
9869343|NCT00973700|10983431|FG000|COMPLETED|Overall Study||49
9869344|NCT00973700|10983432|FG001|COMPLETED|Overall Study||54
9869345|NCT00973700|10983433|FG002|COMPLETED|Overall Study||158
9869346|NCT00973700|10983434|FG003|COMPLETED|Overall Study||318
9869347|NCT00973700|10983435|FG004|COMPLETED|Overall Study||158
9869348|NCT00973700|10983431|FG000|NOT COMPLETED|Overall Study||7
9869349|NCT00973700|10983432|FG001|NOT COMPLETED|Overall Study||2
9869350|NCT00973700|10983433|FG002|NOT COMPLETED|Overall Study||10
9869351|NCT00973700|10983434|FG003|NOT COMPLETED|Overall Study||18
9869352|NCT00973700|10983435|FG004|NOT COMPLETED|Overall Study||10
9869353|NCT00973739|10983462|FG000|STARTED|Overall Study||21
9869354|NCT00973739|10983462|FG000|COMPLETED|Overall Study||17
9869355|NCT00973739|10983462|FG000|NOT COMPLETED|Overall Study||4
9869356|NCT00973752|10983466|FG000|STARTED|Overall Study||30
9869357|NCT00973752|10983466|FG000|COMPLETED|Overall Study||30
9869358|NCT00973752|10983466|FG000|NOT COMPLETED|Overall Study||0
9869359|NCT00973765|10983472|FG000|STARTED|Overall Study|96|96
9869360|NCT00973765|10983473|FG001|STARTED|Overall Study|116|116
9869361|NCT00973765|10983472|FG000|COMPLETED|Overall Study|88|88
9869362|NCT00973765|10983473|FG001|COMPLETED|Overall Study|102|102
9869363|NCT00973765|10983472|FG000|NOT COMPLETED|Overall Study||8
9869364|NCT00973765|10983473|FG001|NOT COMPLETED|Overall Study||14
9953611|NCT01426867|11072276|FG000|STARTED|Overall Study||33
9953612|NCT01426867|11072277|FG001|STARTED|Overall Study||34
9953613|NCT01426867|11072278|FG002|STARTED|Overall Study||34
9953614|NCT01426867|11072276|FG000|COMPLETED|Overall Study||33
9953615|NCT01426867|11072277|FG001|COMPLETED|Overall Study||34
9953616|NCT01426867|11072278|FG002|COMPLETED|Overall Study||34
9953617|NCT01426867|11072276|FG000|NOT COMPLETED|Overall Study||0
9953618|NCT01426867|11072277|FG001|NOT COMPLETED|Overall Study||0
9953619|NCT01426867|11072278|FG002|NOT COMPLETED|Overall Study||0
9953620|NCT01426958|11072286|FG000|STARTED|Overall Study||24
9953621|NCT01426958|11072286|FG000|COMPLETED|Overall Study||22
9953622|NCT01426958|11072286|FG000|NOT COMPLETED|Overall Study||2
9953623|NCT01427296|11072296|FG000|STARTED|Overall Study||1041
9953624|NCT01427296|11072297|FG001|STARTED|Overall Study||1051
9953625|NCT01427296|11072296|FG000|COMPLETED|Overall Study||1041
9953626|NCT01427296|11072297|FG001|COMPLETED|Overall Study||1051
9953627|NCT01427296|11072296|FG000|NOT COMPLETED|Overall Study||0
9953628|NCT01427296|11072297|FG001|NOT COMPLETED|Overall Study||0
9953629|NCT01427309|11072307|FG000|STARTED|Overall Study||7253
9953630|NCT01427309|11072308|FG001|STARTED|Overall Study||7244
9953631|NCT01427309|11072309|FG002|STARTED|Overall Study||8737
9953632|NCT01427309|11072310|FG003|STARTED|Overall Study||8749
9953633|NCT01427309|11072307|FG000|COMPLETED|Overall Study||6881
9953634|NCT01427309|11072308|FG001|COMPLETED|Overall Study||6837
9953635|NCT01427309|11072309|FG002|COMPLETED|Overall Study||8376
9953636|NCT01427309|11072310|FG003|COMPLETED|Overall Study||8373
9953637|NCT01427309|11072307|FG000|NOT COMPLETED|Overall Study||372
9953638|NCT01427309|11072308|FG001|NOT COMPLETED|Overall Study||407
9953639|NCT01427309|11072309|FG002|NOT COMPLETED|Overall Study||361
9953640|NCT01427309|11072310|FG003|NOT COMPLETED|Overall Study||376
9953641|NCT01427504|11072326|FG000|STARTED|Overall Study||4
9953642|NCT01427504|11072327|FG001|STARTED|Overall Study||3
9953643|NCT01427504|11072328|FG002|STARTED|Overall Study||4
9953644|NCT01427504|11072329|FG003|STARTED|Overall Study||6
9953645|NCT01427504|11072330|FG004|STARTED|Overall Study||3
9953646|NCT01427504|11072331|FG005|STARTED|Overall Study||6
9953647|NCT01427504|11072326|FG000|Received Boceprevir|Overall Study||4
9869365|NCT00973921|10983479|FG000|STARTED|Overall Study||40
9869366|NCT00973921|10983479|FG000|COMPLETED|Overall Study||31
9869367|NCT00973921|10983479|FG000|NOT COMPLETED|Overall Study||9
9869368|NCT00973973|10983485|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
9869369|NCT00973973|10983486|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
9869370|NCT00973973|10983485|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
9869371|NCT00973973|10983486|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
9869372|NCT00973973|10983485|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
9869373|NCT00973973|10983486|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
9869374|NCT00973973|10983485|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
9869375|NCT00973973|10983486|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
9869376|NCT00973973|10983485|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
9869377|NCT00973973|10983486|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
9869378|NCT00973973|10983485|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
9869379|NCT00973973|10983486|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
9869380|NCT00973973|10983485|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
9869381|NCT00973973|10983486|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
9869382|NCT00974051|10983492|FG000|STARTED|Overall Study||6
9869383|NCT00974051|10983493|FG001|STARTED|Overall Study||4
9869384|NCT00974051|10983494|FG002|STARTED|Overall Study||6
9869385|NCT00974051|10983492|FG000|COMPLETED|Overall Study||6
9869386|NCT00974051|10983493|FG001|COMPLETED|Overall Study||4
10095604|NCT02358369|11224170|FG002|COMPLETED|Pre-Randomization Washout Period||0
9869387|NCT00974051|10983494|FG002|COMPLETED|Overall Study||6
9869388|NCT00974051|10983492|FG000|NOT COMPLETED|Overall Study||0
9869389|NCT00974051|10983493|FG001|NOT COMPLETED|Overall Study||0
9869390|NCT00974051|10983494|FG002|NOT COMPLETED|Overall Study||0
9869391|NCT00974090|10983505|FG000|STARTED|Period 1: Double Blind Period||98
9869392|NCT00974090|10983506|FG001|STARTED|Period 1: Double Blind Period||96
9869393|NCT00974090|10983505|FG000|COMPLETED|Period 1: Double Blind Period||95
9869394|NCT00974090|10983506|FG001|COMPLETED|Period 1: Double Blind Period||95
9869395|NCT00974090|10983505|FG000|NOT COMPLETED|Period 1: Double Blind Period||3
9869396|NCT00974090|10983506|FG001|NOT COMPLETED|Period 1: Double Blind Period||1
9869397|NCT00974090|10983505|FG000|STARTED|Period 2: Open-label Period||95
9869398|NCT00974090|10983506|FG001|STARTED|Period 2: Open-label Period||95
9869399|NCT00974090|10983505|FG000|COMPLETED|Period 2: Open-label Period||87
9869400|NCT00974090|10983506|FG001|COMPLETED|Period 2: Open-label Period||85
9869401|NCT00974090|10983505|FG000|NOT COMPLETED|Period 2: Open-label Period||8
9869402|NCT00974090|10983506|FG001|NOT COMPLETED|Period 2: Open-label Period||10
9869403|NCT00974142|10983516|FG000|STARTED|Overall Study||8
9869404|NCT00974142|10983517|FG001|STARTED|Overall Study||9
9869405|NCT00974142|10983516|FG000|COMPLETED|Overall Study||8
9869406|NCT00974142|10983517|FG001|COMPLETED|Overall Study||9
9869407|NCT00974142|10983516|FG000|NOT COMPLETED|Overall Study||0
9869408|NCT00974142|10983517|FG001|NOT COMPLETED|Overall Study||0
9869409|NCT00974220|10983525|FG000|STARTED|Treatment Period 1||9
9869410|NCT00974220|10983526|FG001|STARTED|Treatment Period 1||7
9869411|NCT00974220|10983525|FG000|COMPLETED|Treatment Period 1||7
9869412|NCT00974220|10983526|FG001|COMPLETED|Treatment Period 1||5
9869413|NCT00974220|10983525|FG000|NOT COMPLETED|Treatment Period 1||2
9869414|NCT00974220|10983526|FG001|NOT COMPLETED|Treatment Period 1||2
9869415|NCT00974220|10983525|FG000|STARTED|Treatment Period 2||7
9869416|NCT00974220|10983526|FG001|STARTED|Treatment Period 2||5
9869417|NCT00974220|10983525|FG000|COMPLETED|Treatment Period 2||7
9869418|NCT00974220|10983526|FG001|COMPLETED|Treatment Period 2||5
9869419|NCT00974220|10983525|FG000|NOT COMPLETED|Treatment Period 2||0
9869420|NCT00974220|10983526|FG001|NOT COMPLETED|Treatment Period 2||0
9869421|NCT00974233|10983532|FG000|STARTED|Induction Chemoimmunotherapy||34
9869422|NCT00974233|10983532|FG000|COMPLETED|Induction Chemoimmunotherapy||19
9869423|NCT00974233|10983532|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15
9869424|NCT00974233|10983532|FG000|STARTED|Maintenance Lenalidomide||19
9869425|NCT00974233|10983532|FG000|COMPLETED|Maintenance Lenalidomide||6
9869426|NCT00974233|10983532|FG000|NOT COMPLETED|Maintenance Lenalidomide||13
9869427|NCT00974246|10983544|FG000|STARTED|Overall Study||27
9869428|NCT00974246|10983544|FG000|COMPLETED|Overall Study||27
9869429|NCT00974246|10983544|FG000|NOT COMPLETED|Overall Study||0
9869430|NCT00974259|10983551|FG000|STARTED|Overall Study||59
9869431|NCT00974259|10983552|FG001|STARTED|Overall Study||63
9869432|NCT00974259|10983551|FG000|COMPLETED|Overall Study||57
9869433|NCT00974259|10983552|FG001|COMPLETED|Overall Study||62
9869434|NCT00974259|10983551|FG000|NOT COMPLETED|Overall Study||2
9869435|NCT00974259|10983552|FG001|NOT COMPLETED|Overall Study||1
9869436|NCT00974311|10983560|FG000|STARTED|DB Phase (up to 24 Months)||800
9869437|NCT00974311|10983561|FG001|STARTED|DB Phase (up to 24 Months)||399
9869438|NCT00974311|10983560|FG000|COMPLETED|DB Phase (up to 24 Months)||109
9869439|NCT00974311|10983561|FG001|COMPLETED|DB Phase (up to 24 Months)||50
9869440|NCT00974311|10983560|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691
9869441|NCT00974311|10983561|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349
9869442|NCT00974311|10983560|FG000|STARTED|OLE Phase (up to 77 Months)||109
9869443|NCT00974311|10983561|FG001|STARTED|OLE Phase (up to 77 Months)||50
9869444|NCT00974311|10983560|FG000|COMPLETED|OLE Phase (up to 77 Months)||0
10095605|NCT02358369|11224171|FG003|COMPLETED|Pre-Randomization Washout Period||0
9869445|NCT00974311|10983561|FG001|COMPLETED|OLE Phase (up to 77 Months)||0
9869446|NCT00974311|10983560|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109
9869447|NCT00974311|10983561|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50
9869448|NCT00974350|10983573|FG000|STARTED|Overall Study||45
9869449|NCT00974350|10983574|FG001|STARTED|Overall Study||47
9869450|NCT00974350|10983575|FG002|STARTED|Overall Study||32
9869451|NCT00974350|10983573|FG000|COMPLETED|Overall Study||42
9869452|NCT00974350|10983574|FG001|COMPLETED|Overall Study||47
9869453|NCT00974350|10983575|FG002|COMPLETED|Overall Study||31
9869454|NCT00974350|10983573|FG000|NOT COMPLETED|Overall Study||3
9869455|NCT00974350|10983574|FG001|NOT COMPLETED|Overall Study||0
9869456|NCT00974350|10983575|FG002|NOT COMPLETED|Overall Study||1
9869457|NCT00974363|10983586|FG000|STARTED|Overall Study||521
9869458|NCT00974363|10983587|FG001|STARTED|Overall Study||168
9869459|NCT00974363|10983586|FG000|COMPLETED|Overall Study||521
9869460|NCT00974363|10983587|FG001|COMPLETED|Overall Study||168
9869461|NCT00974363|10983586|FG000|NOT COMPLETED|Overall Study||0
9869462|NCT00974363|10983587|FG001|NOT COMPLETED|Overall Study||0
9869463|NCT00974376|10983595|FG000|STARTED|Overall Study||75
9869464|NCT00974376|10983596|FG001|STARTED|Overall Study||75
9869465|NCT00974376|10983595|FG000|COMPLETED|Overall Study||41
9869466|NCT00974376|10983596|FG001|COMPLETED|Overall Study||42
9869467|NCT00974376|10983595|FG000|NOT COMPLETED|Overall Study||34
9869468|NCT00974376|10983596|FG001|NOT COMPLETED|Overall Study||33
9869469|NCT00974480|10983605|FG000|STARTED|Overall Study||40
9869470|NCT00974480|10983606|FG001|STARTED|Overall Study||40
9869471|NCT00974480|10983607|FG002|STARTED|Overall Study||40
9869472|NCT00974480|10983605|FG000|COMPLETED|Overall Study||29
9869473|NCT00974480|10983606|FG001|COMPLETED|Overall Study||33
9869474|NCT00974480|10983607|FG002|COMPLETED|Overall Study||30
9869475|NCT00974480|10983605|FG000|NOT COMPLETED|Overall Study||11
9869476|NCT00974480|10983606|FG001|NOT COMPLETED|Overall Study||7
9869477|NCT00974480|10983607|FG002|NOT COMPLETED|Overall Study||10
9869478|NCT00974493|10983623|FG000|STARTED|Overall Study||527
9869479|NCT00974493|10983624|FG001|STARTED|Overall Study||527
9869480|NCT00974493|10983623|FG000|COMPLETED|Overall Study||509
9869481|NCT00974493|10983624|FG001|COMPLETED|Overall Study||506
9869482|NCT00974493|10983623|FG000|NOT COMPLETED|Overall Study||18
9869483|NCT00974493|10983624|FG001|NOT COMPLETED|Overall Study||21
9869484|NCT00974675|10983634|FG000|STARTED|Overall Study||8
9869485|NCT00974675|10983635|FG001|STARTED|Overall Study||8
9869486|NCT00974675|10983636|FG002|STARTED|Overall Study||3
9869487|NCT00974675|10983637|FG003|STARTED|Overall Study||4
9869488|NCT00974675|10983634|FG000|COMPLETED|Overall Study||6
9869489|NCT00974675|10983635|FG001|COMPLETED|Overall Study||7
9869490|NCT00974675|10983636|FG002|COMPLETED|Overall Study||1
9869491|NCT00974675|10983637|FG003|COMPLETED|Overall Study||2
9869492|NCT00974675|10983634|FG000|NOT COMPLETED|Overall Study||2
9869493|NCT00974675|10983635|FG001|NOT COMPLETED|Overall Study||1
9869494|NCT00974675|10983636|FG002|NOT COMPLETED|Overall Study||2
9869495|NCT00974675|10983637|FG003|NOT COMPLETED|Overall Study||2
9869496|NCT00974818|10983649|FG000|STARTED|Overall Study||25
9869497|NCT00974818|10983650|FG001|STARTED|Overall Study||25
9869498|NCT00974818|10983649|FG000|COMPLETED|Overall Study||25
9869499|NCT00974818|10983650|FG001|COMPLETED|Overall Study||25
9869500|NCT00974818|10983649|FG000|NOT COMPLETED|Overall Study||0
9869501|NCT00974818|10983650|FG001|NOT COMPLETED|Overall Study||0
9869502|NCT00974974|10983658|FG000|STARTED|IR CD-LD Dose Adjustment||0
9869503|NCT00974974|10983659|FG001|STARTED|IR CD-LD Dose Adjustment||471
9869504|NCT00974974|10983658|FG000|COMPLETED|IR CD-LD Dose Adjustment||0
9869505|NCT00974974|10983659|FG001|COMPLETED|IR CD-LD Dose Adjustment||450
9869506|NCT00974974|10983658|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0
9869507|NCT00974974|10983659|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21
9869508|NCT00974974|10983658|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
9869509|NCT00974974|10983659|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
9869510|NCT00974974|10983658|FG000|COMPLETED|IPX066 Dose Conversion||393
9869511|NCT00974974|10983659|FG001|COMPLETED|IPX066 Dose Conversion||0
9869512|NCT00974974|10983658|FG000|NOT COMPLETED|IPX066 Dose Conversion||57
9869513|NCT00974974|10983659|FG001|NOT COMPLETED|IPX066 Dose Conversion||0
9869514|NCT00974974|10983658|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
9869515|NCT00974974|10983659|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
9869516|NCT00974974|10983658|FG000|COMPLETED|Maintenance - Double Blind Treatment||186
9869517|NCT00974974|10983659|FG001|COMPLETED|Maintenance - Double Blind Treatment||182
9869518|NCT00974974|10983658|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15
9869519|NCT00974974|10983659|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10
9869520|NCT00975000|10983667|FG000|STARTED|Overall Study||57
9869521|NCT00975000|10983668|FG001|STARTED|Overall Study||57
9869522|NCT00975000|10983667|FG000|Completed Titration Phase|Overall Study||54
9869523|NCT00975000|10983668|FG001|Completed Titration Phase|Overall Study||55
9869524|NCT00975000|10983667|FG000|Completed Efficacy Assessment Phase|Overall Study||54
9869525|NCT00975000|10983668|FG001|Completed Efficacy Assessment Phase|Overall Study||54
9869526|NCT00975000|10983667|FG000|Completed Maintenance Phase|Overall Study||52
9869527|NCT00975000|10983668|FG001|Completed Maintenance Phase|Overall Study||52
9869528|NCT00975000|10983667|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
9869529|NCT00975000|10983668|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
9869530|NCT00975000|10983667|FG000|NOT COMPLETED|Overall Study||5
9869531|NCT00975000|10983668|FG001|NOT COMPLETED|Overall Study||5
9869532|NCT00975130|10983674|FG000|STARTED|Study Part 1||3366
9869533|NCT00975130|10983675|FG001|STARTED|Study Part 1||0
9869534|NCT00975130|10983676|FG002|STARTED|Study Part 1||0
9869535|NCT00975130|10983674|FG000|COMPLETED|Study Part 1||3086
9869536|NCT00975130|10983675|FG001|COMPLETED|Study Part 1||0
9869537|NCT00975130|10983676|FG002|COMPLETED|Study Part 1||0
9869538|NCT00975130|10983674|FG000|NOT COMPLETED|Study Part 1||280
9869539|NCT00975130|10983675|FG001|NOT COMPLETED|Study Part 1||0
9869540|NCT00975130|10983676|FG002|NOT COMPLETED|Study Part 1||0
9869541|NCT00975130|10983674|FG000|STARTED|Study Part 2||0
9869542|NCT00975130|10983675|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
9869543|NCT00975130|10983676|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
9869544|NCT00975130|10983674|FG000|COMPLETED|Study Part 2||0
9869545|NCT00975130|10983675|FG001|COMPLETED|Study Part 2||212
9869546|NCT00975130|10983676|FG002|COMPLETED|Study Part 2||238
9869547|NCT00975130|10983674|FG000|NOT COMPLETED|Study Part 2||0
9869548|NCT00975130|10983675|FG001|NOT COMPLETED|Study Part 2||38
9869549|NCT00975130|10983676|FG002|NOT COMPLETED|Study Part 2||17
9869550|NCT00975143|10983691|FG000|STARTED|Overall Study||464
9869551|NCT00975143|10983692|FG001|STARTED|Overall Study||461
9869552|NCT00975143|10983691|FG000|Completed Treatment (Week 20)|Overall Study||403
9869553|NCT00975143|10983692|FG001|Completed Treatment (Week 20)|Overall Study||410
9869554|NCT00975143|10983691|FG000|COMPLETED|Overall Study||394
9869555|NCT00975143|10983692|FG001|COMPLETED|Overall Study||401
9869556|NCT00975143|10983691|FG000|NOT COMPLETED|Overall Study||70
9869557|NCT00975143|10983692|FG001|NOT COMPLETED|Overall Study||60
9869558|NCT00975156|10983700|FG000|STARTED|Overall Study||11
9869559|NCT00975156|10983701|FG001|STARTED|Overall Study||10
9869560|NCT00975156|10983700|FG000|COMPLETED|Overall Study||11
9869561|NCT00975156|10983701|FG001|COMPLETED|Overall Study||9
9869562|NCT00975156|10983700|FG000|NOT COMPLETED|Overall Study||0
9869563|NCT00975156|10983701|FG001|NOT COMPLETED|Overall Study||1
9869564|NCT00975195|10983713|FG000|STARTED|Overall Study||1244
9869565|NCT00975195|10983714|FG001|STARTED|Overall Study||1244
9869566|NCT00975195|10983713|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
9869567|NCT00975195|10983714|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
9869568|NCT00975195|10983713|FG000|NOT COMPLETED|Overall Study||228
9869569|NCT00975195|10983714|FG001|NOT COMPLETED|Overall Study||233
9869570|NCT00975221|10983722|FG000|STARTED|Titration Phase (Weeks 1-12)||34
9869571|NCT00975221|10983723|FG001|STARTED|Titration Phase (Weeks 1-12)||33
9869572|NCT00975221|10983722|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34
9869573|NCT00975221|10983723|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33
9869574|NCT00975221|10983722|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31
9869575|NCT00975221|10983723|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29
9869576|NCT00975221|10983722|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
9869577|NCT00975221|10983723|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
9869578|NCT00975221|10983722|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
9869579|NCT00975221|10983723|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
9869580|NCT00975221|10983722|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
9869581|NCT00975221|10983723|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
9869582|NCT00975221|10983722|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
9869583|NCT00975221|10983723|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
9869584|NCT00975221|10983722|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
9869585|NCT00975221|10983723|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28
10095606|NCT02358369|11224172|FG004|COMPLETED|Pre-Randomization Washout Period||0
10095607|NCT02358369|11224168|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35
10095608|NCT02358369|11224169|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
10095609|NCT02358369|11224170|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
10095610|NCT02358369|11224171|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
10095611|NCT02358369|11224172|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
10095612|NCT02358369|11224168|FG000|STARTED|Treatment Period A/B||0
10095613|NCT02358369|11224169|FG001|STARTED|Treatment Period A/B||40
10095614|NCT02358369|11224170|FG002|STARTED|Treatment Period A/B||40
10095615|NCT02358369|11224171|FG003|STARTED|Treatment Period A/B||41
10095616|NCT02358369|11224172|FG004|STARTED|Treatment Period A/B||0
10095617|NCT02358369|11224168|FG000|COMPLETED|Treatment Period A/B||0
10095618|NCT02358369|11224169|FG001|COMPLETED|Treatment Period A/B||38
10095619|NCT02358369|11224170|FG002|COMPLETED|Treatment Period A/B||38
10095620|NCT02358369|11224171|FG003|COMPLETED|Treatment Period A/B||37
10095621|NCT02358369|11224172|FG004|COMPLETED|Treatment Period A/B||0
10095622|NCT02358369|11224168|FG000|NOT COMPLETED|Treatment Period A/B||0
10095623|NCT02358369|11224169|FG001|NOT COMPLETED|Treatment Period A/B||2
10095624|NCT02358369|11224170|FG002|NOT COMPLETED|Treatment Period A/B||2
10095625|NCT02358369|11224171|FG003|NOT COMPLETED|Treatment Period A/B||4
10095626|NCT02358369|11224172|FG004|NOT COMPLETED|Treatment Period A/B||0
10095627|NCT02358369|11224168|FG000|STARTED|Treatment Period C||0
10095628|NCT02358369|11224169|FG001|STARTED|Treatment Period C||0
10095629|NCT02358369|11224170|FG002|STARTED|Treatment Period C||0
10095630|NCT02358369|11224171|FG003|STARTED|Treatment Period C||0
10095631|NCT02358369|11224172|FG004|STARTED|Treatment Period C||113
9869586|NCT00975221|10983722|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
9869587|NCT00975221|10983723|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
9869588|NCT00975221|10983722|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
9869589|NCT00975221|10983723|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
9869590|NCT00975286|10983733|FG000|STARTED|Overall Study|Randomized.|223
9869591|NCT00975286|10983734|FG001|STARTED|Overall Study||223
9869592|NCT00975286|10983733|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
9869593|NCT00975286|10983734|FG001|Safety Population|Overall Study||223
9869594|NCT00975286|10983733|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
9869595|NCT00975286|10983734|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223
9869596|NCT00975286|10983733|FG000|COMPLETED|Overall Study||211
9869597|NCT00975286|10983734|FG001|COMPLETED|Overall Study||194
9869598|NCT00975286|10983733|FG000|NOT COMPLETED|Overall Study||12
9869599|NCT00975286|10983734|FG001|NOT COMPLETED|Overall Study||29
9869600|NCT00975416|10983742|FG000|STARTED|Overall Study||14
9869601|NCT00975416|10983743|FG001|STARTED|Overall Study||16
9869602|NCT00975416|10983742|FG000|COMPLETED|Overall Study||11
9869603|NCT00975416|10983743|FG001|COMPLETED|Overall Study||11
9869604|NCT00975416|10983742|FG000|NOT COMPLETED|Overall Study||3
9869605|NCT00975416|10983743|FG001|NOT COMPLETED|Overall Study||5
9869606|NCT00975481|10983750|FG000|STARTED|First Intervention Period||6
9869607|NCT00975481|10983751|FG001|STARTED|First Intervention Period||6
9869608|NCT00975481|10983752|FG002|STARTED|First Intervention Period||6
9869609|NCT00975481|10983753|FG003|STARTED|First Intervention Period||6
9869610|NCT00975481|10983754|FG004|STARTED|First Intervention Period||6
9869611|NCT00975481|10983755|FG005|STARTED|First Intervention Period||6
9869612|NCT00975481|10983750|FG000|COMPLETED|First Intervention Period||6
9869613|NCT00975481|10983751|FG001|COMPLETED|First Intervention Period||6
9869614|NCT00975481|10983752|FG002|COMPLETED|First Intervention Period||6
9869615|NCT00975481|10983753|FG003|COMPLETED|First Intervention Period||6
9869616|NCT00975481|10983754|FG004|COMPLETED|First Intervention Period||6
9869617|NCT00975481|10983755|FG005|COMPLETED|First Intervention Period||6
9869618|NCT00975481|10983750|FG000|NOT COMPLETED|First Intervention Period||0
9869619|NCT00975481|10983751|FG001|NOT COMPLETED|First Intervention Period||0
9869620|NCT00975481|10983752|FG002|NOT COMPLETED|First Intervention Period||0
9869621|NCT00975481|10983753|FG003|NOT COMPLETED|First Intervention Period||0
9869622|NCT00975481|10983754|FG004|NOT COMPLETED|First Intervention Period||0
9869623|NCT00975481|10983755|FG005|NOT COMPLETED|First Intervention Period||0
9869624|NCT00975481|10983750|FG000|STARTED|Washout Period (at Least 7 Days)||6
9869625|NCT00975481|10983751|FG001|STARTED|Washout Period (at Least 7 Days)||6
9869626|NCT00975481|10983752|FG002|STARTED|Washout Period (at Least 7 Days)||6
9869627|NCT00975481|10983753|FG003|STARTED|Washout Period (at Least 7 Days)||6
9869628|NCT00975481|10983754|FG004|STARTED|Washout Period (at Least 7 Days)||6
9869629|NCT00975481|10983755|FG005|STARTED|Washout Period (at Least 7 Days)||6
9869630|NCT00975481|10983750|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
9869631|NCT00975481|10983751|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
9869632|NCT00975481|10983752|FG002|COMPLETED|Washout Period (at Least 7 Days)||6
9869633|NCT00975481|10983753|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
9869634|NCT00975481|10983754|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
9869635|NCT00975481|10983755|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
9869636|NCT00975481|10983750|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869637|NCT00975481|10983751|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869638|NCT00975481|10983752|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869639|NCT00975481|10983753|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869640|NCT00975481|10983754|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869641|NCT00975481|10983755|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869642|NCT00975481|10983750|FG000|STARTED|Second Intervention Period||6
9869643|NCT00975481|10983751|FG001|STARTED|Second Intervention Period||6
9869644|NCT00975481|10983752|FG002|STARTED|Second Intervention Period||6
9869645|NCT00975481|10983753|FG003|STARTED|Second Intervention Period||6
9869646|NCT00975481|10983754|FG004|STARTED|Second Intervention Period||6
9869647|NCT00975481|10983755|FG005|STARTED|Second Intervention Period||6
9869648|NCT00975481|10983750|FG000|COMPLETED|Second Intervention Period||4
9869649|NCT00975481|10983751|FG001|COMPLETED|Second Intervention Period||5
9869650|NCT00975481|10983752|FG002|COMPLETED|Second Intervention Period||5
9869651|NCT00975481|10983753|FG003|COMPLETED|Second Intervention Period||6
9869652|NCT00975481|10983754|FG004|COMPLETED|Second Intervention Period||6
9869653|NCT00975481|10983755|FG005|COMPLETED|Second Intervention Period||6
9869654|NCT00975481|10983750|FG000|NOT COMPLETED|Second Intervention Period||2
9869655|NCT00975481|10983751|FG001|NOT COMPLETED|Second Intervention Period||1
9869656|NCT00975481|10983752|FG002|NOT COMPLETED|Second Intervention Period||1
9869657|NCT00975481|10983753|FG003|NOT COMPLETED|Second Intervention Period||0
9869658|NCT00975481|10983754|FG004|NOT COMPLETED|Second Intervention Period||0
9869659|NCT00975481|10983755|FG005|NOT COMPLETED|Second Intervention Period||0
9869660|NCT00975481|10983750|FG000|STARTED|Washout Period (at Least 7 Days)||4
9869661|NCT00975481|10983751|FG001|STARTED|Washout Period (at Least 7 Days)||5
9869662|NCT00975481|10983752|FG002|STARTED|Washout Period (at Least 7 Days)||5
9869663|NCT00975481|10983753|FG003|STARTED|Washout Period (at Least 7 Days)||6
9869664|NCT00975481|10983754|FG004|STARTED|Washout Period (at Least 7 Days)||6
9869665|NCT00975481|10983755|FG005|STARTED|Washout Period (at Least 7 Days)||6
9869666|NCT00975481|10983750|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
9869667|NCT00975481|10983751|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
9869668|NCT00975481|10983752|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
9869669|NCT00975481|10983753|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
9869670|NCT00975481|10983754|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
9869671|NCT00975481|10983755|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
9869672|NCT00975481|10983750|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869673|NCT00975481|10983751|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869674|NCT00975481|10983752|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869675|NCT00975481|10983753|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869676|NCT00975481|10983754|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869677|NCT00975481|10983755|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869678|NCT00975481|10983750|FG000|STARTED|Third Intervention Period||4
9869679|NCT00975481|10983751|FG001|STARTED|Third Intervention Period||5
9869680|NCT00975481|10983752|FG002|STARTED|Third Intervention Period||5
9869681|NCT00975481|10983753|FG003|STARTED|Third Intervention Period||6
9869682|NCT00975481|10983754|FG004|STARTED|Third Intervention Period||6
9869683|NCT00975481|10983755|FG005|STARTED|Third Intervention Period||6
9869684|NCT00975481|10983750|FG000|COMPLETED|Third Intervention Period||4
9869685|NCT00975481|10983751|FG001|COMPLETED|Third Intervention Period||5
9869686|NCT00975481|10983752|FG002|COMPLETED|Third Intervention Period||5
9869687|NCT00975481|10983753|FG003|COMPLETED|Third Intervention Period||6
9869688|NCT00975481|10983754|FG004|COMPLETED|Third Intervention Period||6
9869689|NCT00975481|10983755|FG005|COMPLETED|Third Intervention Period||6
9869690|NCT00975481|10983750|FG000|NOT COMPLETED|Third Intervention Period||0
9869691|NCT00975481|10983751|FG001|NOT COMPLETED|Third Intervention Period||0
9869692|NCT00975481|10983752|FG002|NOT COMPLETED|Third Intervention Period||0
9869693|NCT00975481|10983753|FG003|NOT COMPLETED|Third Intervention Period||0
9869694|NCT00975481|10983754|FG004|NOT COMPLETED|Third Intervention Period||0
9869695|NCT00975481|10983755|FG005|NOT COMPLETED|Third Intervention Period||0
9869696|NCT00975481|10983750|FG000|STARTED|Washout Period (at Least 7 Days)||4
9869697|NCT00975481|10983751|FG001|STARTED|Washout Period (at Least 7 Days)||5
9869698|NCT00975481|10983752|FG002|STARTED|Washout Period (at Least 7 Days)||5
9869699|NCT00975481|10983753|FG003|STARTED|Washout Period (at Least 7 Days)||6
9869700|NCT00975481|10983754|FG004|STARTED|Washout Period (at Least 7 Days)||6
9869701|NCT00975481|10983755|FG005|STARTED|Washout Period (at Least 7 Days)||6
9869702|NCT00975481|10983750|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
9869703|NCT00975481|10983751|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
9869704|NCT00975481|10983752|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
9869705|NCT00975481|10983753|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
9869706|NCT00975481|10983754|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
9869707|NCT00975481|10983755|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
9869708|NCT00975481|10983750|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869709|NCT00975481|10983751|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869710|NCT00975481|10983752|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869711|NCT00975481|10983753|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869712|NCT00975481|10983754|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869713|NCT00975481|10983755|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869714|NCT00975481|10983750|FG000|STARTED|Fourth Intervention Period||4
10095632|NCT02358369|11224168|FG000|COMPLETED|Treatment Period C||0
10095633|NCT02358369|11224169|FG001|COMPLETED|Treatment Period C||0
10095634|NCT02358369|11224170|FG002|COMPLETED|Treatment Period C||0
10095635|NCT02358369|11224171|FG003|COMPLETED|Treatment Period C||0
10095636|NCT02358369|11224172|FG004|COMPLETED|Treatment Period C||106
10095637|NCT02358369|11224168|FG000|NOT COMPLETED|Treatment Period C||0
10095638|NCT02358369|11224169|FG001|NOT COMPLETED|Treatment Period C||0
10095639|NCT02358369|11224170|FG002|NOT COMPLETED|Treatment Period C||0
9869715|NCT00975481|10983751|FG001|STARTED|Fourth Intervention Period||5
9869716|NCT00975481|10983752|FG002|STARTED|Fourth Intervention Period||5
9869717|NCT00975481|10983753|FG003|STARTED|Fourth Intervention Period||6
9869718|NCT00975481|10983754|FG004|STARTED|Fourth Intervention Period||6
9869719|NCT00975481|10983755|FG005|STARTED|Fourth Intervention Period||6
9869720|NCT00975481|10983750|FG000|COMPLETED|Fourth Intervention Period||4
9869721|NCT00975481|10983751|FG001|COMPLETED|Fourth Intervention Period||5
9869722|NCT00975481|10983752|FG002|COMPLETED|Fourth Intervention Period||4
9869723|NCT00975481|10983753|FG003|COMPLETED|Fourth Intervention Period||5
9869724|NCT00975481|10983754|FG004|COMPLETED|Fourth Intervention Period||6
10095640|NCT02358369|11224171|FG003|NOT COMPLETED|Treatment Period C||0
10095641|NCT02358369|11224172|FG004|NOT COMPLETED|Treatment Period C||7
10095642|NCT02358473|11224182|FG000|STARTED|Overall Study||13
10095643|NCT02358473|11224182|FG000|COMPLETED|Overall Study||0
10095644|NCT02358473|11224182|FG000|NOT COMPLETED|Overall Study||13
10095645|NCT02358603|11224188|FG000|STARTED|Overall Study||40
10095646|NCT02358603|11224189|FG001|STARTED|Overall Study||8
10095647|NCT02358603|11224188|FG000|COMPLETED|Overall Study||40
10095648|NCT02358603|11224189|FG001|COMPLETED|Overall Study||8
10095649|NCT02358603|11224188|FG000|NOT COMPLETED|Overall Study||0
10095650|NCT02358603|11224189|FG001|NOT COMPLETED|Overall Study||0
10095651|NCT02358668|11224198|FG000|STARTED|Overall Study||24
10095652|NCT02358668|11224199|FG001|STARTED|Overall Study||24
10095653|NCT02358668|11224200|FG002|STARTED|Overall Study||12
9869725|NCT00975481|10983755|FG005|COMPLETED|Fourth Intervention Period||6
9869726|NCT00975481|10983750|FG000|NOT COMPLETED|Fourth Intervention Period||0
9869727|NCT00975481|10983751|FG001|NOT COMPLETED|Fourth Intervention Period||0
9869728|NCT00975481|10983752|FG002|NOT COMPLETED|Fourth Intervention Period||1
9869729|NCT00975481|10983753|FG003|NOT COMPLETED|Fourth Intervention Period||1
9869730|NCT00975481|10983754|FG004|NOT COMPLETED|Fourth Intervention Period||0
9869731|NCT00975481|10983755|FG005|NOT COMPLETED|Fourth Intervention Period||0
9869732|NCT00975481|10983750|FG000|STARTED|Washout Period (at Least 7 Days)||4
9869733|NCT00975481|10983751|FG001|STARTED|Washout Period (at Least 7 Days)||5
9869734|NCT00975481|10983752|FG002|STARTED|Washout Period (at Least 7 Days)||4
9869735|NCT00975481|10983753|FG003|STARTED|Washout Period (at Least 7 Days)||5
9869736|NCT00975481|10983754|FG004|STARTED|Washout Period (at Least 7 Days)||6
9869737|NCT00975481|10983755|FG005|STARTED|Washout Period (at Least 7 Days)||6
9869738|NCT00975481|10983750|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
9869739|NCT00975481|10983751|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
9869740|NCT00975481|10983752|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
9869741|NCT00975481|10983753|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
9869742|NCT00975481|10983754|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
9869743|NCT00975481|10983755|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
9869744|NCT00975481|10983750|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869745|NCT00975481|10983751|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869746|NCT00975481|10983752|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869747|NCT00975481|10983753|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869748|NCT00975481|10983754|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869749|NCT00975481|10983755|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869750|NCT00975481|10983750|FG000|STARTED|Fifth Intervention Period||4
9869751|NCT00975481|10983751|FG001|STARTED|Fifth Intervention Period||5
9869752|NCT00975481|10983752|FG002|STARTED|Fifth Intervention Period||4
9869753|NCT00975481|10983753|FG003|STARTED|Fifth Intervention Period||5
9869754|NCT00975481|10983754|FG004|STARTED|Fifth Intervention Period||6
9869755|NCT00975481|10983755|FG005|STARTED|Fifth Intervention Period||6
9869756|NCT00975481|10983750|FG000|COMPLETED|Fifth Intervention Period||4
9869757|NCT00975481|10983751|FG001|COMPLETED|Fifth Intervention Period||5
9869758|NCT00975481|10983752|FG002|COMPLETED|Fifth Intervention Period||4
9869759|NCT00975481|10983753|FG003|COMPLETED|Fifth Intervention Period||5
9869760|NCT00975481|10983754|FG004|COMPLETED|Fifth Intervention Period||5
9869761|NCT00975481|10983755|FG005|COMPLETED|Fifth Intervention Period||6
9869762|NCT00975481|10983750|FG000|NOT COMPLETED|Fifth Intervention Period||0
9869763|NCT00975481|10983751|FG001|NOT COMPLETED|Fifth Intervention Period||0
9869764|NCT00975481|10983752|FG002|NOT COMPLETED|Fifth Intervention Period||0
9869765|NCT00975481|10983753|FG003|NOT COMPLETED|Fifth Intervention Period||0
9869766|NCT00975481|10983754|FG004|NOT COMPLETED|Fifth Intervention Period||1
9869767|NCT00975481|10983755|FG005|NOT COMPLETED|Fifth Intervention Period||0
9869768|NCT00975481|10983750|FG000|STARTED|Washout Period (at Least 7 Days)||4
9869769|NCT00975481|10983751|FG001|STARTED|Washout Period (at Least 7 Days)||5
9869770|NCT00975481|10983752|FG002|STARTED|Washout Period (at Least 7 Days)||4
9869771|NCT00975481|10983753|FG003|STARTED|Washout Period (at Least 7 Days)||5
9869772|NCT00975481|10983754|FG004|STARTED|Washout Period (at Least 7 Days)||5
9869773|NCT00975481|10983755|FG005|STARTED|Washout Period (at Least 7 Days)||6
9869774|NCT00975481|10983750|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
9869775|NCT00975481|10983751|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
9869776|NCT00975481|10983752|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
9869777|NCT00975481|10983753|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
9869778|NCT00975481|10983754|FG004|COMPLETED|Washout Period (at Least 7 Days)||5
9869779|NCT00975481|10983755|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
9869780|NCT00975481|10983750|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869781|NCT00975481|10983751|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869782|NCT00975481|10983752|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869783|NCT00975481|10983753|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869784|NCT00975481|10983754|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869785|NCT00975481|10983755|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9869786|NCT00975481|10983750|FG000|STARTED|Sixth Intervention Period||4
9869787|NCT00975481|10983751|FG001|STARTED|Sixth Intervention Period||5
9869788|NCT00975481|10983752|FG002|STARTED|Sixth Intervention Period||4
9869789|NCT00975481|10983753|FG003|STARTED|Sixth Intervention Period||5
9869790|NCT00975481|10983754|FG004|STARTED|Sixth Intervention Period||5
9869791|NCT00975481|10983755|FG005|STARTED|Sixth Intervention Period||6
9869792|NCT00975481|10983750|FG000|COMPLETED|Sixth Intervention Period||4
9869793|NCT00975481|10983751|FG001|COMPLETED|Sixth Intervention Period||5
9869794|NCT00975481|10983752|FG002|COMPLETED|Sixth Intervention Period||4
9869795|NCT00975481|10983753|FG003|COMPLETED|Sixth Intervention Period||5
9869796|NCT00975481|10983754|FG004|COMPLETED|Sixth Intervention Period||5
9869797|NCT00975481|10983755|FG005|COMPLETED|Sixth Intervention Period||6
9869798|NCT00975481|10983750|FG000|NOT COMPLETED|Sixth Intervention Period||0
9869799|NCT00975481|10983751|FG001|NOT COMPLETED|Sixth Intervention Period||0
9869800|NCT00975481|10983752|FG002|NOT COMPLETED|Sixth Intervention Period||0
9869801|NCT00975481|10983753|FG003|NOT COMPLETED|Sixth Intervention Period||0
9869802|NCT00975481|10983754|FG004|NOT COMPLETED|Sixth Intervention Period||0
9869803|NCT00975481|10983755|FG005|NOT COMPLETED|Sixth Intervention Period||0
9869804|NCT00975507|10983775|FG000|STARTED|Overall Study||323
9869805|NCT00975507|10983776|FG001|STARTED|Overall Study||157
9869806|NCT00975507|10983775|FG000|Vaccinated at Visit 1|Overall Study||323
9869807|NCT00975507|10983776|FG001|Vaccinated at Visit 1|Overall Study||157
9869808|NCT00975507|10983775|FG000|Vaccinated at Visit 2|Overall Study||310
9869809|NCT00975507|10983776|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
9869810|NCT00975507|10983775|FG000|COMPLETED|Overall Study||303
9869811|NCT00975507|10983776|FG001|COMPLETED|Overall Study||153
9869812|NCT00975507|10983775|FG000|NOT COMPLETED|Overall Study||20
9869813|NCT00975507|10983776|FG001|NOT COMPLETED|Overall Study||4
9869814|NCT00975585|10983786|FG000|STARTED|Overall Study||184
9869815|NCT00975585|10983787|FG001|STARTED|Overall Study||195
9869816|NCT00975585|10983786|FG000|COMPLETED|Overall Study||177
9869817|NCT00975585|10983787|FG001|COMPLETED|Overall Study||183
9869818|NCT00975585|10983786|FG000|NOT COMPLETED|Overall Study||7
9869819|NCT00975585|10983787|FG001|NOT COMPLETED|Overall Study||12
9869820|NCT00975637|10983800|FG000|STARTED|Overall Study||40
9869821|NCT00975637|10983801|FG001|STARTED|Overall Study||39
9869822|NCT00975637|10983802|FG002|STARTED|Overall Study||42
9869823|NCT00975637|10983803|FG003|STARTED|Overall Study||38
9869824|NCT00975637|10983804|FG004|STARTED|Overall Study||39
9869825|NCT00975637|10983800|FG000|COMPLETED|Overall Study||37
9869826|NCT00975637|10983801|FG001|COMPLETED|Overall Study||38
9869827|NCT00975637|10983802|FG002|COMPLETED|Overall Study||40
9869828|NCT00975637|10983803|FG003|COMPLETED|Overall Study||32
9869829|NCT00975637|10983804|FG004|COMPLETED|Overall Study||37
9869830|NCT00975637|10983800|FG000|NOT COMPLETED|Overall Study||3
9869831|NCT00975637|10983801|FG001|NOT COMPLETED|Overall Study||1
9869832|NCT00975637|10983802|FG002|NOT COMPLETED|Overall Study||2
9869833|NCT00975637|10983803|FG003|NOT COMPLETED|Overall Study||6
9869834|NCT00975637|10983804|FG004|NOT COMPLETED|Overall Study||2
9869835|NCT00975650|10983816|FG000|STARTED|Period 1||13
9869836|NCT00975650|10983817|FG001|STARTED|Period 1||16
9869837|NCT00975650|10983818|FG002|STARTED|Period 1||14
9869838|NCT00975650|10983819|FG003|STARTED|Period 1||14
9869839|NCT00975650|10983816|FG000|COMPLETED|Period 1||13
9869840|NCT00975650|10983817|FG001|COMPLETED|Period 1||16
9869841|NCT00975650|10983818|FG002|COMPLETED|Period 1||14
9869842|NCT00975650|10983819|FG003|COMPLETED|Period 1||14
9869843|NCT00975650|10983816|FG000|NOT COMPLETED|Period 1||0
9869844|NCT00975650|10983817|FG001|NOT COMPLETED|Period 1||0
9869845|NCT00975650|10983818|FG002|NOT COMPLETED|Period 1||0
9869846|NCT00975650|10983819|FG003|NOT COMPLETED|Period 1||0
9869847|NCT00975650|10983816|FG000|STARTED|Period 2||13
9869848|NCT00975650|10983817|FG001|STARTED|Period 2||16
9869849|NCT00975650|10983818|FG002|STARTED|Period 2||14
9869850|NCT00975650|10983819|FG003|STARTED|Period 2||14
9869851|NCT00975650|10983816|FG000|COMPLETED|Period 2||12
9869852|NCT00975650|10983817|FG001|COMPLETED|Period 2||14
9869853|NCT00975650|10983818|FG002|COMPLETED|Period 2||14
9869854|NCT00975650|10983819|FG003|COMPLETED|Period 2||14
9869855|NCT00975650|10983816|FG000|NOT COMPLETED|Period 2||1
9869856|NCT00975650|10983817|FG001|NOT COMPLETED|Period 2||2
9869857|NCT00975650|10983818|FG002|NOT COMPLETED|Period 2||0
9869858|NCT00975650|10983819|FG003|NOT COMPLETED|Period 2||0
9869859|NCT00975650|10983816|FG000|STARTED|Period 3||12
9869860|NCT00975650|10983817|FG001|STARTED|Period 3||14
9869861|NCT00975650|10983818|FG002|STARTED|Period 3||14
9869862|NCT00975650|10983819|FG003|STARTED|Period 3||14
9869863|NCT00975650|10983816|FG000|COMPLETED|Period 3||12
9869864|NCT00975650|10983817|FG001|COMPLETED|Period 3||14
9869865|NCT00975650|10983818|FG002|COMPLETED|Period 3||14
9869866|NCT00975650|10983819|FG003|COMPLETED|Period 3||14
9869867|NCT00975650|10983816|FG000|NOT COMPLETED|Period 3||0
9869868|NCT00975650|10983817|FG001|NOT COMPLETED|Period 3||0
9869869|NCT00975650|10983818|FG002|NOT COMPLETED|Period 3||0
9869870|NCT00975650|10983819|FG003|NOT COMPLETED|Period 3||0
9869871|NCT00975650|10983816|FG000|STARTED|Period 4||12
9869872|NCT00975650|10983817|FG001|STARTED|Period 4||14
9869873|NCT00975650|10983818|FG002|STARTED|Period 4||14
9869874|NCT00975650|10983819|FG003|STARTED|Period 4||14
9869875|NCT00975650|10983816|FG000|COMPLETED|Period 4||12
9869876|NCT00975650|10983817|FG001|COMPLETED|Period 4||14
9869877|NCT00975650|10983818|FG002|COMPLETED|Period 4||14
9869878|NCT00975650|10983819|FG003|COMPLETED|Period 4||14
9869879|NCT00975650|10983816|FG000|NOT COMPLETED|Period 4||0
9869880|NCT00975650|10983817|FG001|NOT COMPLETED|Period 4||0
9869881|NCT00975650|10983818|FG002|NOT COMPLETED|Period 4||0
9869882|NCT00975650|10983819|FG003|NOT COMPLETED|Period 4||0
9869883|NCT00975676|10983831|FG000|STARTED|Overall Study||32
9869884|NCT00975676|10983832|FG001|STARTED|Overall Study||91
9869885|NCT00975676|10983831|FG000|COMPLETED|Overall Study||26
9869886|NCT00975676|10983832|FG001|COMPLETED|Overall Study||83
9869887|NCT00975676|10983831|FG000|NOT COMPLETED|Overall Study||6
9869888|NCT00975676|10983832|FG001|NOT COMPLETED|Overall Study||8
9869889|NCT00975689|10983845|FG000|STARTED|Overall Study||17
9869890|NCT00975689|10983846|FG001|STARTED|Overall Study||18
9869891|NCT00975689|10983845|FG000|COMPLETED|Overall Study||15
9869892|NCT00975689|10983846|FG001|COMPLETED|Overall Study||15
9869893|NCT00975689|10983845|FG000|NOT COMPLETED|Overall Study||2
9869894|NCT00975689|10983846|FG001|NOT COMPLETED|Overall Study||3
9869895|NCT00975715|10983854|FG000|STARTED|Titration Period||48
9869896|NCT00975715|10983855|FG001|STARTED|Titration Period||51
9869897|NCT00975715|10983854|FG000|COMPLETED|Titration Period||41
9869898|NCT00975715|10983855|FG001|COMPLETED|Titration Period||51
9869899|NCT00975715|10983854|FG000|NOT COMPLETED|Titration Period||7
9869900|NCT00975715|10983855|FG001|NOT COMPLETED|Titration Period||0
9869901|NCT00975715|10983854|FG000|STARTED|Maintenance Period||41
9869902|NCT00975715|10983855|FG001|STARTED|Maintenance Period||51
9869903|NCT00975715|10983854|FG000|COMPLETED|Maintenance Period||39
9869904|NCT00975715|10983855|FG001|COMPLETED|Maintenance Period||50
9869905|NCT00975715|10983854|FG000|NOT COMPLETED|Maintenance Period||2
9869906|NCT00975715|10983855|FG001|NOT COMPLETED|Maintenance Period||1
9869907|NCT00975780|10983863|FG000|STARTED|Allocation||400
9869908|NCT00975780|10983864|FG001|STARTED|Allocation||434
9869909|NCT00975780|10983863|FG000|COMPLETED|Allocation||400
9869910|NCT00975780|10983864|FG001|COMPLETED|Allocation||434
9869911|NCT00975780|10983863|FG000|NOT COMPLETED|Allocation||0
9869912|NCT00975780|10983864|FG001|NOT COMPLETED|Allocation||0
9869913|NCT00975780|10983863|FG000|STARTED|Follow Up||400
9869914|NCT00975780|10983864|FG001|STARTED|Follow Up||434
9869915|NCT00975780|10983863|FG000|COMPLETED|Follow Up||298
9869916|NCT00975780|10983864|FG001|COMPLETED|Follow Up||277
9869917|NCT00975780|10983863|FG000|NOT COMPLETED|Follow Up||102
9869918|NCT00975780|10983864|FG001|NOT COMPLETED|Follow Up||157
9869919|NCT00975806|10983873|FG000|STARTED|Overall Study||5
9869920|NCT00975806|10983874|FG001|STARTED|Overall Study||7
9869921|NCT00975806|10983875|FG002|STARTED|Overall Study||4
9869922|NCT00975806|10983873|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0
9869923|NCT00975806|10983874|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0
9869924|NCT00975806|10983875|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0
9869925|NCT00975806|10983873|FG000|NOT COMPLETED|Overall Study||5
9869926|NCT00975806|10983874|FG001|NOT COMPLETED|Overall Study||7
9869927|NCT00975806|10983875|FG002|NOT COMPLETED|Overall Study||4
9869928|NCT00975884|10983887|FG000|STARTED|Overall Study||184
9869929|NCT00975884|10983888|FG001|STARTED|Overall Study||122
9869930|NCT00975884|10983887|FG000|COMPLETED|Overall Study||168
9869931|NCT00975884|10983888|FG001|COMPLETED|Overall Study||107
9869932|NCT00975884|10983887|FG000|NOT COMPLETED|Overall Study||16
9869933|NCT00975884|10983888|FG001|NOT COMPLETED|Overall Study||15
9869934|NCT00975923|10983906|FG000|STARTED|Overall Study||30
9869935|NCT00975923|10983907|FG001|STARTED|Overall Study||30
9869936|NCT00975923|10983906|FG000|COMPLETED|Overall Study||30
9869937|NCT00975923|10983907|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
9869938|NCT00975923|10983906|FG000|NOT COMPLETED|Overall Study||0
9869939|NCT00975923|10983907|FG001|NOT COMPLETED|Overall Study||1
9869940|NCT00975975|10983914|FG000|STARTED|Overall Study||17
9869941|NCT00975975|10983914|FG000|COMPLETED|Overall Study||11
9869942|NCT00975975|10983914|FG000|NOT COMPLETED|Overall Study||6
9869943|NCT00976027|10983920|FG000|STARTED|Overall Study||6108
9869944|NCT00976027|10983921|FG001|STARTED|Overall Study||3050
9869945|NCT00976027|10983920|FG000|COMPLETED|Overall Study||5697
9869946|NCT00976027|10983921|FG001|COMPLETED|Overall Study||2835
9869947|NCT00976027|10983920|FG000|NOT COMPLETED|Overall Study||411
9869948|NCT00976027|10983921|FG001|NOT COMPLETED|Overall Study||215
9869949|NCT00976183|10983927|FG000|STARTED|Overall Study||18
9869950|NCT00976183|10983927|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
9869951|NCT00976183|10983927|FG000|NOT COMPLETED|Overall Study||0
9869952|NCT00976209|10983933|FG000|STARTED|Treatment Period 1||165
9869953|NCT00976209|10983934|FG001|STARTED|Treatment Period 1||166
9869954|NCT00976209|10983933|FG000|COMPLETED|Treatment Period 1||162
9869955|NCT00976209|10983934|FG001|COMPLETED|Treatment Period 1||165
9869956|NCT00976209|10983933|FG000|NOT COMPLETED|Treatment Period 1||3
9869957|NCT00976209|10983934|FG001|NOT COMPLETED|Treatment Period 1||1
9869958|NCT00976209|10983933|FG000|STARTED|Wash-out Period||162
9869959|NCT00976209|10983934|FG001|STARTED|Wash-out Period||165
9869960|NCT00976209|10983933|FG000|COMPLETED|Wash-out Period||158
9869961|NCT00976209|10983934|FG001|COMPLETED|Wash-out Period||163
9869962|NCT00976209|10983933|FG000|NOT COMPLETED|Wash-out Period||4
9869963|NCT00976209|10983934|FG001|NOT COMPLETED|Wash-out Period||2
9869964|NCT00976209|10983933|FG000|STARTED|Treatment Period 2||158
9869965|NCT00976209|10983934|FG001|STARTED|Treatment Period 2||163
9869966|NCT00976209|10983933|FG000|COMPLETED|Treatment Period 2||158
9869967|NCT00976209|10983934|FG001|COMPLETED|Treatment Period 2||161
9869968|NCT00976209|10983933|FG000|NOT COMPLETED|Treatment Period 2||0
9869969|NCT00976209|10983934|FG001|NOT COMPLETED|Treatment Period 2||2
9869970|NCT00976248|10983939|FG000|STARTED|Overall Study||33
9869971|NCT00976248|10983939|FG000|COMPLETED|Overall Study||33
9869972|NCT00976248|10983939|FG000|NOT COMPLETED|Overall Study||0
9869973|NCT00976274|10983946|FG000|STARTED|Overall Study||31
9869974|NCT00976274|10983947|FG001|STARTED|Overall Study||29
9869975|NCT00976274|10983946|FG000|COMPLETED|Overall Study||24
9869976|NCT00976274|10983947|FG001|COMPLETED|Overall Study||21
9869977|NCT00976274|10983946|FG000|NOT COMPLETED|Overall Study||7
9869978|NCT00976274|10983947|FG001|NOT COMPLETED|Overall Study||8
9869979|NCT00976352|10983955|FG000|STARTED|Overall Study||3
9869980|NCT00976352|10983956|FG001|STARTED|Overall Study||10
9869981|NCT00976352|10983955|FG000|COMPLETED|Overall Study||3
9869982|NCT00976352|10983956|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
9869983|NCT00976352|10983955|FG000|NOT COMPLETED|Overall Study||0
9869984|NCT00976352|10983956|FG001|NOT COMPLETED|Overall Study||4
9869985|NCT00976391|10983968|FG000|STARTED|Treatment Period (52 Weeks)||285
9869986|NCT00976391|10983969|FG001|STARTED|Treatment Period (52 Weeks)||281
9869987|NCT00976391|10983968|FG000|COMPLETED|Treatment Period (52 Weeks)||243
9869988|NCT00976391|10983969|FG001|COMPLETED|Treatment Period (52 Weeks)||242
9869989|NCT00976391|10983968|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42
9869990|NCT00976391|10983969|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39
9869991|NCT00976391|10983968|FG000|STARTED|Follow-up Period (8 Weeks)||285
9869992|NCT00976391|10983969|FG001|STARTED|Follow-up Period (8 Weeks)||281
9869993|NCT00976391|10983968|FG000|COMPLETED|Follow-up Period (8 Weeks)||256
9869994|NCT00976391|10983969|FG001|COMPLETED|Follow-up Period (8 Weeks)||247
9869995|NCT00976391|10983968|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29
9869996|NCT00976391|10983969|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34
9869997|NCT00976404|10983977|FG000|STARTED|Overall Study||14
9869998|NCT00976404|10983978|FG001|STARTED|Overall Study||14
9869999|NCT00976404|10983977|FG000|COMPLETED|Overall Study||14
9870000|NCT00976404|10983978|FG001|COMPLETED|Overall Study||14
9870001|NCT00976404|10983977|FG000|NOT COMPLETED|Overall Study||0
9870002|NCT00976404|10983978|FG001|NOT COMPLETED|Overall Study||0
9870003|NCT00976456|10983988|FG000|STARTED|Overall Study||135
9870004|NCT00976456|10983989|FG001|STARTED|Overall Study||136
9870005|NCT00976456|10983988|FG000|COMPLETED|Overall Study||92
9870006|NCT00976456|10983989|FG001|COMPLETED|Overall Study||98
9870007|NCT00976456|10983988|FG000|NOT COMPLETED|Overall Study||43
9870008|NCT00976456|10983989|FG001|NOT COMPLETED|Overall Study||38
9870009|NCT00976482|10983995|FG000|STARTED|Overall Study||1745
9870010|NCT00976482|10983995|FG000|Eligible for Last Follow up|Overall Study||1487
9870011|NCT00976482|10983995|FG000|COMPLETED|Overall Study||1486
9870012|NCT00976482|10983995|FG000|NOT COMPLETED|Overall Study||259
9870013|NCT00976495|10984002|FG000|STARTED|Overall Study||25
9870014|NCT00976495|10984003|FG001|STARTED|Overall Study||24
9870015|NCT00976495|10984004|FG002|STARTED|Overall Study||26
9870016|NCT00976495|10984002|FG000|COMPLETED|Overall Study||25
9870017|NCT00976495|10984003|FG001|COMPLETED|Overall Study||23
9870018|NCT00976495|10984004|FG002|COMPLETED|Overall Study||26
9870019|NCT00976495|10984002|FG000|NOT COMPLETED|Overall Study||0
9870020|NCT00976495|10984003|FG001|NOT COMPLETED|Overall Study||1
9870021|NCT00976495|10984004|FG002|NOT COMPLETED|Overall Study||0
9870022|NCT00976508|10984014|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
9870023|NCT00976508|10984015|FG001|STARTED|Overall Study||6
9870024|NCT00976508|10984014|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
9870025|NCT00976508|10984015|FG001|COMPLETED|Overall Study||0
9870026|NCT00976508|10984014|FG000|NOT COMPLETED|Overall Study||14
9870027|NCT00976508|10984015|FG001|NOT COMPLETED|Overall Study||6
9870028|NCT00976521|10984028|FG000|STARTED|Overall Study||118
9870029|NCT00976521|10984029|FG001|STARTED|Overall Study||111
9870030|NCT00976521|10984030|FG002|STARTED|Overall Study||111
9870031|NCT00976521|10984031|FG003|STARTED|Overall Study||112
9870032|NCT00976521|10984028|FG000|COMPLETED|Overall Study||109
9870033|NCT00976521|10984029|FG001|COMPLETED|Overall Study||99
9870034|NCT00976521|10984030|FG002|COMPLETED|Overall Study||102
9870035|NCT00976521|10984031|FG003|COMPLETED|Overall Study||93
9870036|NCT00976521|10984028|FG000|NOT COMPLETED|Overall Study||9
9870037|NCT00976521|10984029|FG001|NOT COMPLETED|Overall Study||12
9870038|NCT00976521|10984030|FG002|NOT COMPLETED|Overall Study||9
9870039|NCT00976521|10984031|FG003|NOT COMPLETED|Overall Study||19
9870040|NCT00976560|10984044|FG000|STARTED|Overall Study||64
9870041|NCT00976560|10984045|FG001|STARTED|Overall Study||64
9870042|NCT00976560|10984044|FG000|COMPLETED|Overall Study||50
9870043|NCT00976560|10984045|FG001|COMPLETED|Overall Study||51
9870044|NCT00976560|10984044|FG000|NOT COMPLETED|Overall Study||14
9870045|NCT00976560|10984045|FG001|NOT COMPLETED|Overall Study||13
9870046|NCT00976573|10984053|FG000|STARTED|Overall Study||75
9870047|NCT00976573|10984054|FG001|STARTED|Overall Study||74
9870048|NCT00976573|10984053|FG000|COMPLETED|Overall Study||71
9870049|NCT00976573|10984054|FG001|COMPLETED|Overall Study||71
9870050|NCT00976573|10984053|FG000|NOT COMPLETED|Overall Study||4
9870051|NCT00976573|10984054|FG001|NOT COMPLETED|Overall Study||3
9870052|NCT00976599|10984062|FG000|STARTED|Overall Study||15
10095654|NCT02358668|11224198|FG000|COMPLETED|Overall Study||22
10095655|NCT02358668|11224199|FG001|COMPLETED|Overall Study||23
10095656|NCT02358668|11224200|FG002|COMPLETED|Overall Study||12
10095657|NCT02358668|11224198|FG000|NOT COMPLETED|Overall Study||2
10095658|NCT02358668|11224199|FG001|NOT COMPLETED|Overall Study||1
10095659|NCT02358668|11224200|FG002|NOT COMPLETED|Overall Study||0
9870053|NCT00976599|10984063|FG001|STARTED|Overall Study||14
9870054|NCT00976599|10984062|FG000|COMPLETED|Overall Study||15
9870055|NCT00976599|10984063|FG001|COMPLETED|Overall Study||14
9870056|NCT00976599|10984062|FG000|NOT COMPLETED|Overall Study||0
9870057|NCT00976599|10984063|FG001|NOT COMPLETED|Overall Study||0
9870058|NCT00976664|10984071|FG000|STARTED|Overall Study||25
9870059|NCT00976664|10984072|FG001|STARTED|Overall Study||25
9870060|NCT00976664|10984071|FG000|COMPLETED|Overall Study||22
9870061|NCT00976664|10984072|FG001|COMPLETED|Overall Study||24
9870062|NCT00976664|10984071|FG000|NOT COMPLETED|Overall Study||3
9870063|NCT00976664|10984072|FG001|NOT COMPLETED|Overall Study||1
9870064|NCT00976677|10984080|FG000|STARTED|Overall Study||5
10095660|NCT02358863|11224208|FG000|STARTED|Overall Study||13
10095661|NCT02358863|11224208|FG000|COMPLETED|Overall Study||10
10095662|NCT02358863|11224208|FG000|NOT COMPLETED|Overall Study||3
10095663|NCT02358876|11224212|FG000|STARTED|Overall Study||32
9870065|NCT00976677|10984081|FG001|STARTED|Overall Study||5
9870066|NCT00976677|10984080|FG000|COMPLETED|Overall Study||0
9870067|NCT00976677|10984081|FG001|COMPLETED|Overall Study||0
9870068|NCT00976677|10984080|FG000|NOT COMPLETED|Overall Study||5
9870069|NCT00976677|10984081|FG001|NOT COMPLETED|Overall Study||5
9870070|NCT00976703|10984089|FG000|STARTED|Overall Study||99
9870071|NCT00976703|10984090|FG001|STARTED|Overall Study||98
9870072|NCT00976703|10984089|FG000|COMPLETED|Overall Study||96
9870073|NCT00976703|10984090|FG001|COMPLETED|Overall Study||95
9870074|NCT00976703|10984089|FG000|NOT COMPLETED|Overall Study||3
9870075|NCT00976703|10984090|FG001|NOT COMPLETED|Overall Study||3
9870076|NCT00976716|10984096|FG000|STARTED|Overall Study||80
9870077|NCT00976716|10984096|FG000|COMPLETED|Overall Study||79
9870078|NCT00976716|10984096|FG000|NOT COMPLETED|Overall Study||1
9870079|NCT00976820|10984105|FG000|STARTED|Overall Study||67
9870080|NCT00976820|10984106|FG001|STARTED|Overall Study||128
9870081|NCT00976820|10984107|FG002|STARTED|Overall Study||64
9870082|NCT00976820|10984108|FG003|STARTED|Overall Study||63
9870083|NCT00976820|10984105|FG000|COMPLETED|Overall Study||59
9870084|NCT00976820|10984106|FG001|COMPLETED|Overall Study||108
9870085|NCT00976820|10984107|FG002|COMPLETED|Overall Study||60
9870086|NCT00976820|10984108|FG003|COMPLETED|Overall Study||56
9870087|NCT00976820|10984105|FG000|NOT COMPLETED|Overall Study||8
9870088|NCT00976820|10984106|FG001|NOT COMPLETED|Overall Study||20
9870089|NCT00976820|10984107|FG002|NOT COMPLETED|Overall Study||4
9870090|NCT00976820|10984108|FG003|NOT COMPLETED|Overall Study||7
9870091|NCT00976898|10984159|FG000|STARTED|Overall Study||83
9870092|NCT00976898|10984159|FG000|COMPLETED|Overall Study||78
9870093|NCT00976898|10984159|FG000|NOT COMPLETED|Overall Study||5
9870094|NCT00976937|10984165|FG000|STARTED|Overall Study|Randomized|158
9870095|NCT00976937|10984166|FG001|STARTED|Overall Study||161
9870096|NCT00976937|10984165|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
9870097|NCT00976937|10984166|FG001|Treated/Safety Population|Overall Study||161
9870098|NCT00976937|10984165|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
9870099|NCT00976937|10984166|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161
9870100|NCT00976937|10984165|FG000|COMPLETED|Overall Study||142
9870101|NCT00976937|10984166|FG001|COMPLETED|Overall Study||150
9870102|NCT00976937|10984165|FG000|NOT COMPLETED|Overall Study||16
9870103|NCT00976937|10984166|FG001|NOT COMPLETED|Overall Study||11
9870104|NCT00976950|10984172|FG000|STARTED|Overall Study||42
9870105|NCT00976950|10984172|FG000|COMPLETED|Overall Study||36
9870106|NCT00976950|10984172|FG000|NOT COMPLETED|Overall Study||6
9870107|NCT00976989|10984179|FG000|STARTED|Overall Study||73
9870108|NCT00976989|10984180|FG001|STARTED|Overall Study||75
9870109|NCT00976989|10984181|FG002|STARTED|Overall Study||77
9870110|NCT00976989|10984179|FG000|COMPLETED|Overall Study||60
9870111|NCT00976989|10984180|FG001|COMPLETED|Overall Study||63
9870112|NCT00976989|10984181|FG002|COMPLETED|Overall Study||60
9870113|NCT00976989|10984179|FG000|NOT COMPLETED|Overall Study||13
9870114|NCT00976989|10984180|FG001|NOT COMPLETED|Overall Study||12
10095664|NCT02358876|11224212|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
10095665|NCT02358876|11224212|FG000|NOT COMPLETED|Overall Study||2
10095666|NCT02358889|11224219|FG000|STARTED|Overall Study||30
10095667|NCT02358889|11224220|FG001|STARTED|Overall Study||30
10095668|NCT02358889|11224221|FG002|STARTED|Overall Study||28
10095669|NCT02358889|11224219|FG000|COMPLETED|Overall Study||30
10095670|NCT02358889|11224220|FG001|COMPLETED|Overall Study||28
10095671|NCT02358889|11224221|FG002|COMPLETED|Overall Study||27
10095672|NCT02358889|11224219|FG000|NOT COMPLETED|Overall Study||0
9870115|NCT00976989|10984181|FG002|NOT COMPLETED|Overall Study||17
9870116|NCT00977080|10984193|FG000|STARTED|Overall Study||62
9870117|NCT00977080|10984194|FG001|STARTED|Overall Study||64
9870118|NCT00977080|10984195|FG002|STARTED|Overall Study||72
9870119|NCT00977080|10984196|FG003|STARTED|Overall Study||70
9870120|NCT00977080|10984193|FG000|COMPLETED|Overall Study||50
9870121|NCT00977080|10984194|FG001|COMPLETED|Overall Study||44
9870122|NCT00977080|10984195|FG002|COMPLETED|Overall Study||56
9870123|NCT00977080|10984196|FG003|COMPLETED|Overall Study||53
9870124|NCT00977080|10984193|FG000|NOT COMPLETED|Overall Study||12
9870125|NCT00977080|10984194|FG001|NOT COMPLETED|Overall Study||20
9870126|NCT00977080|10984195|FG002|NOT COMPLETED|Overall Study||16
9870127|NCT00977080|10984196|FG003|NOT COMPLETED|Overall Study||17
9870128|NCT00977106|10984208|FG000|STARTED|Overall Study||47
9870129|NCT00977106|10984209|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
9870130|NCT00977106|10984208|FG000|COMPLETED|Overall Study||37
9870131|NCT00977106|10984209|FG001|COMPLETED|Overall Study||45
9870132|NCT00977106|10984208|FG000|NOT COMPLETED|Overall Study||10
9870133|NCT00977106|10984209|FG001|NOT COMPLETED|Overall Study||11
9870134|NCT00977171|10984217|FG000|STARTED|Overall Study||3
9870135|NCT00977171|10984217|FG000|COMPLETED|Overall Study||3
9870136|NCT00977171|10984217|FG000|NOT COMPLETED|Overall Study||0
9870137|NCT00977184|10984223|FG000|STARTED|Overall Study||13
9870138|NCT00977184|10984224|FG001|STARTED|Overall Study||13
10095673|NCT02358889|11224220|FG001|NOT COMPLETED|Overall Study||2
10095674|NCT02358889|11224221|FG002|NOT COMPLETED|Overall Study||1
10095675|NCT02359006|11224231|FG000|STARTED|Overall Study||14
9870139|NCT00977184|10984223|FG000|COMPLETED|Overall Study||13
9870140|NCT00977184|10984224|FG001|COMPLETED|Overall Study||13
9870141|NCT00977184|10984223|FG000|NOT COMPLETED|Overall Study||0
9870142|NCT00977184|10984224|FG001|NOT COMPLETED|Overall Study||0
9870143|NCT00977197|10984239|FG000|STARTED|Overall Study||41
9870144|NCT00977197|10984240|FG001|STARTED|Overall Study||44
9870145|NCT00977197|10984239|FG000|COMPLETED|Overall Study||32
9870146|NCT00977197|10984240|FG001|COMPLETED|Overall Study||35
9870147|NCT00977197|10984239|FG000|NOT COMPLETED|Overall Study||9
9870148|NCT00977197|10984240|FG001|NOT COMPLETED|Overall Study||9
9870149|NCT00977314|10984248|FG000|STARTED|Overall Study||30
9870150|NCT00977314|10984249|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
9870151|NCT00977314|10984248|FG000|COMPLETED|Overall Study||28
9870152|NCT00977314|10984249|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
9870153|NCT00977314|10984248|FG000|NOT COMPLETED|Overall Study||2
9870154|NCT00977314|10984249|FG001|NOT COMPLETED|Overall Study||0
9870155|NCT00977379|10984257|FG000|STARTED|Overall Study|Randomized|12
9870156|NCT00977379|10984258|FG001|STARTED|Overall Study|Randomized|12
9870157|NCT00977379|10984257|FG000|Treated|Overall Study||12
9870158|NCT00977379|10984258|FG001|Treated|Overall Study||11
9870159|NCT00977379|10984257|FG000|COMPLETED|Overall Study||0
9870160|NCT00977379|10984258|FG001|COMPLETED|Overall Study||0
9870161|NCT00977379|10984257|FG000|NOT COMPLETED|Overall Study||12
9870162|NCT00977379|10984258|FG001|NOT COMPLETED|Overall Study||12
9870163|NCT00977431|10984269|FG000|STARTED|Overall Study||7
10095676|NCT02359006|11224232|FG001|STARTED|Overall Study||13
10095677|NCT02359006|11224231|FG000|COMPLETED|Overall Study||10
9870164|NCT00977431|10984270|FG001|STARTED|Overall Study||6
9870165|NCT00977431|10984271|FG002|STARTED|Overall Study||7
9870166|NCT00977431|10984272|FG003|STARTED|Overall Study||3
9870167|NCT00977431|10984273|FG004|STARTED|Overall Study||13
9870168|NCT00977431|10984269|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1
9870169|NCT00977431|10984270|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0
9870170|NCT00977431|10984271|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4
9870171|NCT00977431|10984272|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0
9870172|NCT00977431|10984273|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3
9870173|NCT00977431|10984269|FG000|COMPLETED|Overall Study||0
9870174|NCT00977431|10984270|FG001|COMPLETED|Overall Study||0
9870175|NCT00977431|10984271|FG002|COMPLETED|Overall Study||0
9870176|NCT00977431|10984272|FG003|COMPLETED|Overall Study||0
9870177|NCT00977431|10984273|FG004|COMPLETED|Overall Study||0
9870178|NCT00977431|10984269|FG000|NOT COMPLETED|Overall Study||7
9870179|NCT00977431|10984270|FG001|NOT COMPLETED|Overall Study||6
9870180|NCT00977431|10984271|FG002|NOT COMPLETED|Overall Study||7
9870181|NCT00977431|10984272|FG003|NOT COMPLETED|Overall Study||3
9870182|NCT00977431|10984273|FG004|NOT COMPLETED|Overall Study||13
9870183|NCT00977470|10984291|FG000|STARTED|Overall Study||38
9870184|NCT00977470|10984292|FG001|STARTED|Overall Study||38
9870185|NCT00977470|10984291|FG000|COMPLETED|Overall Study||0
9870186|NCT00977470|10984292|FG001|COMPLETED|Overall Study||0
9870187|NCT00977470|10984291|FG000|NOT COMPLETED|Overall Study||38
9870188|NCT00977470|10984292|FG001|NOT COMPLETED|Overall Study||38
9870189|NCT00977548|10984298|FG000|STARTED|Overall Study||39
9870190|NCT00977548|10984298|FG000|COMPLETED|Overall Study||26
9870191|NCT00977548|10984298|FG000|NOT COMPLETED|Overall Study||13
9870192|NCT00977561|10984304|FG000|STARTED|Overall Study||5
9870193|NCT00977561|10984305|FG001|STARTED|Overall Study||4
9870194|NCT00977561|10984304|FG000|COMPLETED|Overall Study||0
9870195|NCT00977561|10984305|FG001|COMPLETED|Overall Study||0
9870196|NCT00977561|10984304|FG000|NOT COMPLETED|Overall Study||5
9870197|NCT00977561|10984305|FG001|NOT COMPLETED|Overall Study||4
9870198|NCT00977613|10984313|FG000|STARTED|Overall Study||50
9870199|NCT00977613|10984313|FG000|COMPLETED|Overall Study||34
9870200|NCT00977613|10984313|FG000|NOT COMPLETED|Overall Study||16
9870201|NCT00977665|10984319|FG000|STARTED|Overall Study||84
9870202|NCT00977665|10984320|FG001|STARTED|Overall Study||90
9870203|NCT00977665|10984319|FG000|COMPLETED|Overall Study||63
9870204|NCT00977665|10984320|FG001|COMPLETED|Overall Study||75
9870205|NCT00977665|10984319|FG000|NOT COMPLETED|Overall Study||21
9870206|NCT00977665|10984320|FG001|NOT COMPLETED|Overall Study||15
9870207|NCT00977704|10984326|FG000|STARTED|Overall Study||20
9870208|NCT00977704|10984326|FG000|COMPLETED|Overall Study||20
9870209|NCT00977704|10984326|FG000|NOT COMPLETED|Overall Study||0
9870210|NCT00977769|10984333|FG000|STARTED|Overall Study||25
9870211|NCT00977769|10984334|FG001|STARTED|Overall Study||26
9870212|NCT00977769|10984335|FG002|STARTED|Overall Study||25
9870213|NCT00977769|10984333|FG000|COMPLETED|Overall Study||25
9870214|NCT00977769|10984334|FG001|COMPLETED|Overall Study||26
9870215|NCT00977769|10984335|FG002|COMPLETED|Overall Study||25
9870216|NCT00977769|10984333|FG000|NOT COMPLETED|Overall Study||0
9870217|NCT00977769|10984334|FG001|NOT COMPLETED|Overall Study||0
9870218|NCT00977769|10984335|FG002|NOT COMPLETED|Overall Study||0
9870219|NCT00977808|10984343|FG000|STARTED|Overall Study||12
9870220|NCT00977808|10984343|FG000|Completion of Open-Loop Admission|Overall Study||12
9870221|NCT00977808|10984343|FG000|Completion of Closed-Loop Admission|Overall Study||11
9870222|NCT00977808|10984343|FG000|COMPLETED|Overall Study||11
9870223|NCT00977808|10984343|FG000|NOT COMPLETED|Overall Study||1
9870224|NCT00977938|10984352|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020
9870225|NCT00977938|10984353|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941
9870226|NCT00977938|10984354|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842
10095678|NCT02359006|11224232|FG001|COMPLETED|Overall Study||10
9870227|NCT00977938|10984355|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845
9870228|NCT00977938|10984352|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
9870229|NCT00977938|10984353|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
9870230|NCT00977938|10984354|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
9870231|NCT00977938|10984355|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
9870232|NCT00977938|10984352|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
9870233|NCT00977938|10984353|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
9870234|NCT00977938|10984354|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
9870235|NCT00977938|10984355|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
9870236|NCT00977938|10984352|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783
9870237|NCT00977938|10984353|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716
9870238|NCT00977938|10984354|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796
9870239|NCT00977938|10984355|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784
9870240|NCT00977938|10984352|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
9870241|NCT00977938|10984353|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
9870242|NCT00977938|10984354|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784
9870243|NCT00977938|10984355|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781
9870244|NCT00977938|10984352|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
9870245|NCT00977938|10984353|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
9870246|NCT00977938|10984354|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
9870247|NCT00977938|10984355|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
9870248|NCT00978029|10984370|FG000|STARTED|Overall Study||65
9870249|NCT00978029|10984371|FG001|STARTED|Overall Study||66
9870250|NCT00978029|10984372|FG002|STARTED|Overall Study||65
9870251|NCT00978029|10984370|FG000|COMPLETED|Overall Study||64
9870252|NCT00978029|10984371|FG001|COMPLETED|Overall Study||63
9870253|NCT00978029|10984372|FG002|COMPLETED|Overall Study||59
9870254|NCT00978029|10984370|FG000|NOT COMPLETED|Overall Study||1
9870255|NCT00978029|10984371|FG001|NOT COMPLETED|Overall Study||3
9870256|NCT00978029|10984372|FG002|NOT COMPLETED|Overall Study||6
9870257|NCT00978042|10984382|FG000|STARTED|Initial Treatment Period||235
9870258|NCT00978042|10984383|FG001|STARTED|Initial Treatment Period||47
9870259|NCT00978042|10984382|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235
9870260|NCT00978042|10984383|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35
9870261|NCT00978042|10984382|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
9870262|NCT00978042|10984383|FG001|COMPLETED|Initial Treatment Period||32
9870263|NCT00978042|10984382|FG000|NOT COMPLETED|Initial Treatment Period||61
9870264|NCT00978042|10984383|FG001|NOT COMPLETED|Initial Treatment Period||15
9870265|NCT00978042|10984382|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
9870266|NCT00978042|10984383|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
9870267|NCT00978042|10984382|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
9870268|NCT00978042|10984383|FG001|COMPLETED|Received Repeat Treatment||23
9870269|NCT00978042|10984382|FG000|NOT COMPLETED|Received Repeat Treatment||43
9870270|NCT00978042|10984383|FG001|NOT COMPLETED|Received Repeat Treatment||3
9870271|NCT00978068|10984391|FG000|STARTED|Overall Study||87
9870272|NCT00978068|10984392|FG001|STARTED|Overall Study||89
9870273|NCT00978068|10984391|FG000|Initiated Study Drugs|Overall Study||84
9870274|NCT00978068|10984392|FG001|Initiated Study Drugs|Overall Study||86
9870275|NCT00978068|10984391|FG000|COMPLETED|Overall Study||83
9870276|NCT00978068|10984392|FG001|COMPLETED|Overall Study||80
9870277|NCT00978068|10984391|FG000|NOT COMPLETED|Overall Study||4
9870278|NCT00978068|10984392|FG001|NOT COMPLETED|Overall Study||9
9870279|NCT00978120|10984406|FG000|STARTED|Overall Study||110
9870280|NCT00978120|10984407|FG001|STARTED|Overall Study||107
9870281|NCT00978120|10984408|FG002|STARTED|Overall Study||87
9870282|NCT00978120|10984409|FG003|STARTED|Overall Study||86
9870283|NCT00978120|10984406|FG000|COMPLETED|Overall Study||108
9870284|NCT00978120|10984407|FG001|COMPLETED|Overall Study||107
9870285|NCT00978120|10984408|FG002|COMPLETED|Overall Study||84
9870286|NCT00978120|10984409|FG003|COMPLETED|Overall Study||84
9870287|NCT00978120|10984406|FG000|NOT COMPLETED|Overall Study||2
9870288|NCT00978120|10984407|FG001|NOT COMPLETED|Overall Study||0
9870289|NCT00978120|10984408|FG002|NOT COMPLETED|Overall Study||3
9870290|NCT00978120|10984409|FG003|NOT COMPLETED|Overall Study||2
9870291|NCT00978250|10984427|FG000|STARTED|Overall Study||25
9870292|NCT00978250|10984428|FG001|STARTED|Overall Study||30
9870293|NCT00978250|10984429|FG002|STARTED|Overall Study||18
9870294|NCT00978250|10984430|FG003|STARTED|Overall Study||22
9870295|NCT00978250|10984427|FG000|COMPLETED|Overall Study||25
9870296|NCT00978250|10984428|FG001|COMPLETED|Overall Study||29
9870297|NCT00978250|10984429|FG002|COMPLETED|Overall Study||18
9870298|NCT00978250|10984430|FG003|COMPLETED|Overall Study||21
9870299|NCT00978250|10984427|FG000|NOT COMPLETED|Overall Study||0
9870300|NCT00978250|10984428|FG001|NOT COMPLETED|Overall Study||1
9870301|NCT00978250|10984429|FG002|NOT COMPLETED|Overall Study||0
9870302|NCT00978250|10984430|FG003|NOT COMPLETED|Overall Study||1
9870303|NCT00978341|10984442|FG000|STARTED|First Intervention||8
9870304|NCT00978341|10984443|FG001|STARTED|First Intervention||7
9870305|NCT00978341|10984442|FG000|COMPLETED|First Intervention||8
9870306|NCT00978341|10984443|FG001|COMPLETED|First Intervention||7
9870307|NCT00978341|10984442|FG000|NOT COMPLETED|First Intervention||0
9870308|NCT00978341|10984443|FG001|NOT COMPLETED|First Intervention||0
10095679|NCT02359006|11224231|FG000|NOT COMPLETED|Overall Study||4
10095680|NCT02359006|11224232|FG001|NOT COMPLETED|Overall Study||3
10095681|NCT02359019|11224240|FG000|STARTED|Overall Study||45
10095682|NCT02359019|11224240|FG000|COMPLETED|Overall Study||45
10095683|NCT02359019|11224240|FG000|NOT COMPLETED|Overall Study||0
10095684|NCT02359045|11224246|FG000|STARTED|Overall Study||40
10095685|NCT02359045|11224247|FG001|STARTED|Overall Study||42
10095686|NCT02359045|11224246|FG000|COMPLETED|Overall Study||36
10095687|NCT02359045|11224247|FG001|COMPLETED|Overall Study||39
9870309|NCT00978341|10984442|FG000|STARTED|Washout Period of 2 Weeks||8
9870310|NCT00978341|10984443|FG001|STARTED|Washout Period of 2 Weeks||7
9870311|NCT00978341|10984442|FG000|COMPLETED|Washout Period of 2 Weeks||7
9870312|NCT00978341|10984443|FG001|COMPLETED|Washout Period of 2 Weeks||7
9870313|NCT00978341|10984442|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1
9870314|NCT00978341|10984443|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9870315|NCT00978341|10984442|FG000|STARTED|Second Intervention||7
9870316|NCT00978341|10984443|FG001|STARTED|Second Intervention||7
9870317|NCT00978341|10984442|FG000|COMPLETED|Second Intervention||7
9870318|NCT00978341|10984443|FG001|COMPLETED|Second Intervention||7
9870319|NCT00978341|10984442|FG000|NOT COMPLETED|Second Intervention||0
9870320|NCT00978341|10984443|FG001|NOT COMPLETED|Second Intervention||0
9870321|NCT00978380|10984450|FG000|STARTED|Overall Study||63
9870322|NCT00978380|10984450|FG000|COMPLETED|Overall Study||44
9870323|NCT00978380|10984450|FG000|NOT COMPLETED|Overall Study||19
9870324|NCT00978432|10984458|FG000|STARTED|Overall Study||10
9870325|NCT00978432|10984459|FG001|STARTED|Overall Study||5
9870326|NCT00978432|10984460|FG002|STARTED|Overall Study||18
9870327|NCT00978432|10984458|FG000|COMPLETED|Overall Study||7
9870328|NCT00978432|10984459|FG001|COMPLETED|Overall Study||4
9870329|NCT00978432|10984460|FG002|COMPLETED|Overall Study||13
9870330|NCT00978432|10984458|FG000|NOT COMPLETED|Overall Study||3
9870331|NCT00978432|10984459|FG001|NOT COMPLETED|Overall Study||1
9870332|NCT00978432|10984460|FG002|NOT COMPLETED|Overall Study||5
9870333|NCT00978445|10984468|FG000|STARTED|Overall Study||12
9870334|NCT00978445|10984469|FG001|STARTED|Overall Study||13
9870335|NCT00978445|10984468|FG000|COMPLETED|Overall Study||10
9870336|NCT00978445|10984469|FG001|COMPLETED|Overall Study||12
9870337|NCT00978445|10984468|FG000|NOT COMPLETED|Overall Study||2
9870338|NCT00978445|10984469|FG001|NOT COMPLETED|Overall Study||1
9870339|NCT00978562|10984476|FG000|STARTED|Overall Study||7
9870340|NCT00978562|10984476|FG000|COMPLETED|Overall Study||7
9870341|NCT00978562|10984476|FG000|NOT COMPLETED|Overall Study||0
9870342|NCT00978627|10984483|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
9870343|NCT00978627|10984484|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
9870344|NCT00978627|10984483|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
9870345|NCT00978627|10984484|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
9870346|NCT00978627|10984483|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
9870347|NCT00978627|10984484|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
9870348|NCT00978627|10984483|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
9870349|NCT00978627|10984484|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
9870350|NCT00978627|10984483|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
9870351|NCT00978627|10984484|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
9870352|NCT00978627|10984483|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
9870353|NCT00978627|10984484|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
9870354|NCT00978627|10984483|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
9870355|NCT00978627|10984484|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
9870356|NCT00978731|10984494|FG000|STARTED|Overall Study||22
9870357|NCT00978731|10984495|FG001|STARTED|Overall Study||15
9870358|NCT00978731|10984496|FG002|STARTED|Overall Study||5
9870359|NCT00978731|10984497|FG003|STARTED|Overall Study||4
9870360|NCT00978731|10984494|FG000|COMPLETED|Overall Study||0
9870361|NCT00978731|10984495|FG001|COMPLETED|Overall Study||0
9870362|NCT00978731|10984496|FG002|COMPLETED|Overall Study||0
9870363|NCT00978731|10984497|FG003|COMPLETED|Overall Study||0
9870364|NCT00978731|10984494|FG000|NOT COMPLETED|Overall Study||22
9870365|NCT00978731|10984495|FG001|NOT COMPLETED|Overall Study||15
9870366|NCT00978731|10984496|FG002|NOT COMPLETED|Overall Study||5
9870367|NCT00978731|10984497|FG003|NOT COMPLETED|Overall Study||4
9870368|NCT00978757|10984513|FG000|STARTED|Overall Study|June 2001|22
9870369|NCT00978757|10984514|FG001|STARTED|Overall Study|June 2001|20
9870370|NCT00978757|10984513|FG000|COMPLETED|Overall Study|June 2008|21
9870371|NCT00978757|10984514|FG001|COMPLETED|Overall Study|June 2008|17
9870372|NCT00978757|10984513|FG000|NOT COMPLETED|Overall Study||1
9870373|NCT00978757|10984514|FG001|NOT COMPLETED|Overall Study||3
9870374|NCT00979017|10984520|FG000|STARTED|Overall Study||41
9870375|NCT00979017|10984520|FG000|COMPLETED|Overall Study||41
10095688|NCT02359045|11224246|FG000|NOT COMPLETED|Overall Study||4
10095689|NCT02359045|11224247|FG001|NOT COMPLETED|Overall Study||3
10095690|NCT02359058|11224266|FG000|STARTED|Overall Study||6
10095691|NCT02359058|11224267|FG001|STARTED|Overall Study||6
10095692|NCT02359058|11224268|FG002|STARTED|Overall Study||6
9870376|NCT00979017|10984520|FG000|NOT COMPLETED|Overall Study||0
9870377|NCT00979069|10984526|FG000|STARTED|Overall Study||10
9870378|NCT00979069|10984527|FG001|STARTED|Overall Study||10
9870379|NCT00979069|10984526|FG000|COMPLETED|Overall Study||10
9870380|NCT00979069|10984527|FG001|COMPLETED|Overall Study||8
9870381|NCT00979069|10984526|FG000|NOT COMPLETED|Overall Study||0
9870382|NCT00979069|10984527|FG001|NOT COMPLETED|Overall Study||2
9870383|NCT00979121|10984535|FG000|STARTED|Overall Study||379
9870384|NCT00979121|10984536|FG001|STARTED|Overall Study||366
9870385|NCT00979121|10984535|FG000|COMPLETED|Overall Study||379
9870386|NCT00979121|10984536|FG001|COMPLETED|Overall Study||366
9870387|NCT00979121|10984535|FG000|NOT COMPLETED|Overall Study||0
9870388|NCT00979121|10984536|FG001|NOT COMPLETED|Overall Study||0
9870389|NCT00979134|10984551|FG000|STARTED|Overall Study||43
9870390|NCT00979134|10984552|FG001|STARTED|Overall Study||6
9870391|NCT00979134|10984553|FG002|STARTED|Overall Study||45
9870392|NCT00979134|10984551|FG000|COMPLETED|Overall Study|At DCO|10
9870393|NCT00979134|10984552|FG001|COMPLETED|Overall Study|At DCO|0
9870394|NCT00979134|10984553|FG002|COMPLETED|Overall Study|At DCO|5
9870395|NCT00979134|10984551|FG000|NOT COMPLETED|Overall Study||33
9870396|NCT00979134|10984552|FG001|NOT COMPLETED|Overall Study||6
9870397|NCT00979134|10984553|FG002|NOT COMPLETED|Overall Study||40
9870398|NCT00979199|10984566|FG000|STARTED|Overall Study||697
9870399|NCT00979199|10984566|FG000|COMPLETED|Overall Study||475
9870400|NCT00979199|10984566|FG000|NOT COMPLETED|Overall Study||222
9870401|NCT00979303|10984572|FG000|STARTED|Overall Study||37
9870402|NCT00979303|10984573|FG001|STARTED|Overall Study||37
9870403|NCT00979303|10984572|FG000|COMPLETED|Overall Study||37
9870404|NCT00979303|10984573|FG001|COMPLETED|Overall Study||37
9870405|NCT00979303|10984572|FG000|NOT COMPLETED|Overall Study||0
9870406|NCT00979303|10984573|FG001|NOT COMPLETED|Overall Study||0
9953648|NCT01427504|11072327|FG001|Received Boceprevir|Overall Study||3
9953649|NCT01427504|11072328|FG002|Received Boceprevir|Overall Study||3
9953650|NCT01427504|11072329|FG003|Received Boceprevir|Overall Study||5
9953651|NCT01427504|11072330|FG004|Received Boceprevir|Overall Study||2
9953652|NCT01427504|11072331|FG005|Received Boceprevir|Overall Study||4
9953653|NCT01427504|11072326|FG000|Received Etravirine|Overall Study||4
9953654|NCT01427504|11072327|FG001|Received Etravirine|Overall Study||2
9953655|NCT01427504|11072328|FG002|Received Etravirine|Overall Study||4
9953656|NCT01427504|11072329|FG003|Received Etravirine|Overall Study||6
9953657|NCT01427504|11072330|FG004|Received Etravirine|Overall Study||2
9953658|NCT01427504|11072331|FG005|Received Etravirine|Overall Study||4
9953659|NCT01427504|11072326|FG000|Received Combination|Overall Study||4
9953660|NCT01427504|11072327|FG001|Received Combination|Overall Study||3
9953661|NCT01427504|11072328|FG002|Received Combination|Overall Study||3
9953662|NCT01427504|11072329|FG003|Received Combination|Overall Study||6
9953663|NCT01427504|11072330|FG004|Received Combination|Overall Study||3
9953664|NCT01427504|11072331|FG005|Received Combination|Overall Study||6
9953665|NCT01427504|11072326|FG000|COMPLETED|Overall Study||4
9953666|NCT01427504|11072327|FG001|COMPLETED|Overall Study||2
9953667|NCT01427504|11072328|FG002|COMPLETED|Overall Study||3
9953668|NCT01427504|11072329|FG003|COMPLETED|Overall Study||5
9953669|NCT01427504|11072330|FG004|COMPLETED|Overall Study||2
9953670|NCT01427504|11072331|FG005|COMPLETED|Overall Study||4
9953671|NCT01427504|11072326|FG000|NOT COMPLETED|Overall Study||0
9953672|NCT01427504|11072327|FG001|NOT COMPLETED|Overall Study||1
9953673|NCT01427504|11072328|FG002|NOT COMPLETED|Overall Study||1
9953674|NCT01427504|11072329|FG003|NOT COMPLETED|Overall Study||1
9953675|NCT01427504|11072330|FG004|NOT COMPLETED|Overall Study||1
9953676|NCT01427504|11072331|FG005|NOT COMPLETED|Overall Study||2
9953677|NCT01427517|11072351|FG000|STARTED|Overall Study||3
9953678|NCT01427517|11072352|FG001|STARTED|Overall Study||3
9953679|NCT01427517|11072353|FG002|STARTED|Overall Study||3
9953680|NCT01427517|11072351|FG000|COMPLETED|Overall Study||3
9953681|NCT01427517|11072352|FG001|COMPLETED|Overall Study||3
9953682|NCT01427517|11072353|FG002|COMPLETED|Overall Study||3
9953683|NCT01427517|11072351|FG000|NOT COMPLETED|Overall Study||0
9953684|NCT01427517|11072352|FG001|NOT COMPLETED|Overall Study||0
9953685|NCT01427517|11072353|FG002|NOT COMPLETED|Overall Study||0
9953686|NCT01427595|11072361|FG000|STARTED|Overall Study||25
9953687|NCT01427595|11072361|FG000|COMPLETED|Overall Study||12
9953688|NCT01427595|11072361|FG000|NOT COMPLETED|Overall Study||13
9953689|NCT01427608|11072367|FG000|STARTED|Overall Study||64
9953690|NCT01427608|11072368|FG001|STARTED|Overall Study||62
9953691|NCT01427608|11072367|FG000|COMPLETED|Overall Study||43
9953692|NCT01427608|11072368|FG001|COMPLETED|Overall Study||24
9953693|NCT01427608|11072367|FG000|NOT COMPLETED|Overall Study||21
9953694|NCT01427608|11072368|FG001|NOT COMPLETED|Overall Study||38
9953695|NCT01427738|11072378|FG000|STARTED|Overall Study||110
9953696|NCT01427738|11072379|FG001|STARTED|Overall Study||111
9953697|NCT01427738|11072378|FG000|COMPLETED|Overall Study||91
9953698|NCT01427738|11072379|FG001|COMPLETED|Overall Study||90
9953699|NCT01427738|11072378|FG000|NOT COMPLETED|Overall Study||19
9953700|NCT01427738|11072379|FG001|NOT COMPLETED|Overall Study||21
9953701|NCT01427751|11072387|FG000|STARTED|Overall Study||154
9953702|NCT01427751|11072388|FG001|STARTED|Overall Study||153
9953703|NCT01427751|11072387|FG000|COMPLETED|Overall Study||112
9953704|NCT01427751|11072388|FG001|COMPLETED|Overall Study||139
9953705|NCT01427751|11072387|FG000|NOT COMPLETED|Overall Study||42
9953706|NCT01427751|11072388|FG001|NOT COMPLETED|Overall Study||14
9953707|NCT01427803|11072396|FG000|STARTED|Overall Study||526
9953708|NCT01427803|11072397|FG001|STARTED|Overall Study||252
9953709|NCT01427803|11072396|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525
9953710|NCT01427803|11072397|FG001|Purchased Product|Overall Study||252
9953711|NCT01427803|11072396|FG000|Baseline Assessment|Overall Study||516
9870407|NCT00979407|10984581|FG000|STARTED|Overall Study||167
9870408|NCT00979407|10984582|FG001|STARTED|Overall Study||167
9870409|NCT00979407|10984581|FG000|COMPLETED|Overall Study||161
9870410|NCT00979407|10984582|FG001|COMPLETED|Overall Study||160
9870411|NCT00979407|10984581|FG000|NOT COMPLETED|Overall Study||6
9870412|NCT00979407|10984582|FG001|NOT COMPLETED|Overall Study||7
9870413|NCT00979420|10984594|FG000|STARTED|Overall Study||178
9870414|NCT00979420|10984595|FG001|STARTED|Overall Study||57
9870415|NCT00979420|10984596|FG002|STARTED|Overall Study||60
9870416|NCT00979420|10984597|FG003|STARTED|Overall Study||61
9870417|NCT00979420|10984594|FG000|COMPLETED|Overall Study||171
9870418|NCT00979420|10984595|FG001|COMPLETED|Overall Study||57
9870419|NCT00979420|10984596|FG002|COMPLETED|Overall Study||59
9870420|NCT00979420|10984597|FG003|COMPLETED|Overall Study||59
9870421|NCT00979420|10984594|FG000|NOT COMPLETED|Overall Study||7
9870422|NCT00979420|10984595|FG001|NOT COMPLETED|Overall Study||0
9870423|NCT00979420|10984596|FG002|NOT COMPLETED|Overall Study||1
9870424|NCT00979420|10984597|FG003|NOT COMPLETED|Overall Study||2
9870425|NCT00979459|10984605|FG000|STARTED|First Intervention||6
9870426|NCT00979459|10984606|FG001|STARTED|First Intervention||6
9870427|NCT00979459|10984605|FG000|COMPLETED|First Intervention||6
9870428|NCT00979459|10984606|FG001|COMPLETED|First Intervention||6
9870429|NCT00979459|10984605|FG000|NOT COMPLETED|First Intervention||0
9870430|NCT00979459|10984606|FG001|NOT COMPLETED|First Intervention||0
9870431|NCT00979459|10984605|FG000|STARTED|7-day Washout Period||6
9870432|NCT00979459|10984606|FG001|STARTED|7-day Washout Period||6
9870433|NCT00979459|10984605|FG000|COMPLETED|7-day Washout Period||6
9870434|NCT00979459|10984606|FG001|COMPLETED|7-day Washout Period||6
9870435|NCT00979459|10984605|FG000|NOT COMPLETED|7-day Washout Period||0
9870436|NCT00979459|10984606|FG001|NOT COMPLETED|7-day Washout Period||0
9870437|NCT00979459|10984605|FG000|STARTED|Second Intervention||6
9870438|NCT00979459|10984606|FG001|STARTED|Second Intervention||6
9870439|NCT00979459|10984605|FG000|COMPLETED|Second Intervention||6
9870440|NCT00979459|10984606|FG001|COMPLETED|Second Intervention||6
9870441|NCT00979459|10984605|FG000|NOT COMPLETED|Second Intervention||0
9870442|NCT00979459|10984606|FG001|NOT COMPLETED|Second Intervention||0
9870443|NCT00979576|10984617|FG000|STARTED|Combination Treatment Phase||3
9870444|NCT00979576|10984618|FG001|STARTED|Combination Treatment Phase||6
9870445|NCT00979576|10984619|FG002|STARTED|Combination Treatment Phase||9
9870446|NCT00979576|10984617|FG000|COMPLETED|Combination Treatment Phase||0
9870447|NCT00979576|10984618|FG001|COMPLETED|Combination Treatment Phase||0
9870448|NCT00979576|10984619|FG002|COMPLETED|Combination Treatment Phase||0
9870449|NCT00979576|10984617|FG000|NOT COMPLETED|Combination Treatment Phase||3
9870450|NCT00979576|10984618|FG001|NOT COMPLETED|Combination Treatment Phase||6
9870451|NCT00979576|10984619|FG002|NOT COMPLETED|Combination Treatment Phase||9
9870452|NCT00979576|10984617|FG000|STARTED|Combination Followed by Monotherapy||0
9870453|NCT00979576|10984618|FG001|STARTED|Combination Followed by Monotherapy||2
9870454|NCT00979576|10984619|FG002|STARTED|Combination Followed by Monotherapy||1
9870455|NCT00979576|10984617|FG000|COMPLETED|Combination Followed by Monotherapy||0
9870456|NCT00979576|10984618|FG001|COMPLETED|Combination Followed by Monotherapy||0
9870457|NCT00979576|10984619|FG002|COMPLETED|Combination Followed by Monotherapy||0
9870458|NCT00979576|10984617|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0
9870459|NCT00979576|10984618|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2
9870460|NCT00979576|10984619|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1
9870461|NCT00979602|10984630|FG000|STARTED|Overall Study||2025
9870462|NCT00979602|10984631|FG001|STARTED|Overall Study||2023
9870463|NCT00979602|10984630|FG000|COMPLETED|Overall Study||1880
9870464|NCT00979602|10984631|FG001|COMPLETED|Overall Study||1890
9870465|NCT00979602|10984630|FG000|NOT COMPLETED|Overall Study||145
9870466|NCT00979602|10984631|FG001|NOT COMPLETED|Overall Study||133
9870467|NCT00979615|10984651|FG000|STARTED|Overall Study||63
9870468|NCT00979615|10984652|FG001|STARTED|Overall Study||66
9870469|NCT00979615|10984651|FG000|COMPLETED|Overall Study||57
9870470|NCT00979615|10984652|FG001|COMPLETED|Overall Study||58
9870471|NCT00979615|10984651|FG000|NOT COMPLETED|Overall Study||6
9870472|NCT00979615|10984652|FG001|NOT COMPLETED|Overall Study||8
9870473|NCT00979628|10984661|FG000|STARTED|Overall Study||153
9870474|NCT00979628|10984662|FG001|STARTED|Overall Study||142
9870475|NCT00979628|10984663|FG002|STARTED|Overall Study||80
9870476|NCT00979628|10984661|FG000|COMPLETED|Overall Study||144
9870477|NCT00979628|10984662|FG001|COMPLETED|Overall Study||133
9870478|NCT00979628|10984663|FG002|COMPLETED|Overall Study||74
9870479|NCT00979628|10984661|FG000|NOT COMPLETED|Overall Study||9
9870480|NCT00979628|10984662|FG001|NOT COMPLETED|Overall Study||9
9870481|NCT00979628|10984663|FG002|NOT COMPLETED|Overall Study||6
9870482|NCT00979654|10984674|FG000|STARTED|Overall Study||103
9870483|NCT00979654|10984674|FG000|COMPLETED|Overall Study||67
9870484|NCT00979654|10984674|FG000|NOT COMPLETED|Overall Study||36
9870485|NCT00979732|10984680|FG000|STARTED|Overall Study||15
9870486|NCT00979732|10984681|FG001|STARTED|Overall Study||18
9870487|NCT00979732|10984680|FG000|COMPLETED|Overall Study||12
9870488|NCT00979732|10984681|FG001|COMPLETED|Overall Study||17
9870489|NCT00979732|10984680|FG000|NOT COMPLETED|Overall Study||3
9870490|NCT00979732|10984681|FG001|NOT COMPLETED|Overall Study||1
9870491|NCT00979745|10984689|FG000|STARTED|Overall Study||38
9870492|NCT00979745|10984690|FG001|STARTED|Overall Study||36
9870493|NCT00979745|10984689|FG000|COMPLETED|Overall Study||34
9870494|NCT00979745|10984690|FG001|COMPLETED|Overall Study||34
9870495|NCT00979745|10984689|FG000|NOT COMPLETED|Overall Study||4
9870496|NCT00979745|10984690|FG001|NOT COMPLETED|Overall Study||2
9870497|NCT00979875|10984696|FG000|STARTED|Intervention 1||2
9870498|NCT00979875|10984697|FG001|STARTED|Intervention 1||2
9870499|NCT00979875|10984698|FG002|STARTED|Intervention 1||3
9870500|NCT00979875|10984699|FG003|STARTED|Intervention 1||2
9870501|NCT00979875|10984700|FG004|STARTED|Intervention 1||3
9870502|NCT00979875|10984701|FG005|STARTED|Intervention 1||2
9870503|NCT00979875|10984696|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2
9870504|NCT00979875|10984697|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2
9870505|NCT00979875|10984698|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3
9870506|NCT00979875|10984699|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2
9870507|NCT00979875|10984700|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3
9870508|NCT00979875|10984701|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2
9870509|NCT00979875|10984696|FG000|COMPLETED|Intervention 1||2
9870510|NCT00979875|10984697|FG001|COMPLETED|Intervention 1||2
9870511|NCT00979875|10984698|FG002|COMPLETED|Intervention 1||3
9870512|NCT00979875|10984699|FG003|COMPLETED|Intervention 1||2
9870513|NCT00979875|10984700|FG004|COMPLETED|Intervention 1||3
9870514|NCT00979875|10984701|FG005|COMPLETED|Intervention 1||2
9870515|NCT00979875|10984696|FG000|NOT COMPLETED|Intervention 1||0
9870516|NCT00979875|10984697|FG001|NOT COMPLETED|Intervention 1||0
9870517|NCT00979875|10984698|FG002|NOT COMPLETED|Intervention 1||0
9870518|NCT00979875|10984699|FG003|NOT COMPLETED|Intervention 1||0
9870519|NCT00979875|10984700|FG004|NOT COMPLETED|Intervention 1||0
9870520|NCT00979875|10984701|FG005|NOT COMPLETED|Intervention 1||0
9870521|NCT00979875|10984696|FG000|STARTED|Washout 1 (3 to 14 Days)||2
9870522|NCT00979875|10984697|FG001|STARTED|Washout 1 (3 to 14 Days)||2
9870523|NCT00979875|10984698|FG002|STARTED|Washout 1 (3 to 14 Days)||3
9870524|NCT00979875|10984699|FG003|STARTED|Washout 1 (3 to 14 Days)||2
9870525|NCT00979875|10984700|FG004|STARTED|Washout 1 (3 to 14 Days)||3
9870526|NCT00979875|10984701|FG005|STARTED|Washout 1 (3 to 14 Days)||2
9870527|NCT00979875|10984696|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2
9870528|NCT00979875|10984697|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2
9870529|NCT00979875|10984698|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
9870530|NCT00979875|10984699|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2
9870531|NCT00979875|10984700|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3
9870532|NCT00979875|10984701|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2
9870533|NCT00979875|10984696|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9870534|NCT00979875|10984697|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9870535|NCT00979875|10984698|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9870536|NCT00979875|10984699|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9870537|NCT00979875|10984700|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9870538|NCT00979875|10984701|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9870539|NCT00979875|10984696|FG000|STARTED|Intervention 2||2
9870540|NCT00979875|10984697|FG001|STARTED|Intervention 2||2
9870541|NCT00979875|10984698|FG002|STARTED|Intervention 2||3
9870542|NCT00979875|10984699|FG003|STARTED|Intervention 2||2
9870543|NCT00979875|10984700|FG004|STARTED|Intervention 2||3
9870544|NCT00979875|10984701|FG005|STARTED|Intervention 2||2
9870545|NCT00979875|10984696|FG000|COMPLETED|Intervention 2||2
9870546|NCT00979875|10984697|FG001|COMPLETED|Intervention 2||2
9870547|NCT00979875|10984698|FG002|COMPLETED|Intervention 2||3
9870548|NCT00979875|10984699|FG003|COMPLETED|Intervention 2||2
9870549|NCT00979875|10984700|FG004|COMPLETED|Intervention 2||3
9870550|NCT00979875|10984701|FG005|COMPLETED|Intervention 2||2
9870551|NCT00979875|10984696|FG000|NOT COMPLETED|Intervention 2||0
9870552|NCT00979875|10984697|FG001|NOT COMPLETED|Intervention 2||0
9870553|NCT00979875|10984698|FG002|NOT COMPLETED|Intervention 2||0
9870554|NCT00979875|10984699|FG003|NOT COMPLETED|Intervention 2||0
9870555|NCT00979875|10984700|FG004|NOT COMPLETED|Intervention 2||0
9870556|NCT00979875|10984701|FG005|NOT COMPLETED|Intervention 2||0
9870557|NCT00979875|10984696|FG000|STARTED|Washout 2 (3 to 14 Days)||2
9870558|NCT00979875|10984697|FG001|STARTED|Washout 2 (3 to 14 Days)||2
9870559|NCT00979875|10984698|FG002|STARTED|Washout 2 (3 to 14 Days)||3
9870560|NCT00979875|10984699|FG003|STARTED|Washout 2 (3 to 14 Days)||2
9870561|NCT00979875|10984700|FG004|STARTED|Washout 2 (3 to 14 Days)||3
9870562|NCT00979875|10984701|FG005|STARTED|Washout 2 (3 to 14 Days)||2
9870563|NCT00979875|10984696|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2
9870564|NCT00979875|10984697|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2
9870565|NCT00979875|10984698|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
9870566|NCT00979875|10984699|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2
9870567|NCT00979875|10984700|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3
9870568|NCT00979875|10984701|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2
9870569|NCT00979875|10984696|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9870570|NCT00979875|10984697|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9870571|NCT00979875|10984698|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9870572|NCT00979875|10984699|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9870573|NCT00979875|10984700|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9870574|NCT00979875|10984701|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9870575|NCT00979875|10984696|FG000|STARTED|Intervention 3||2
9870576|NCT00979875|10984697|FG001|STARTED|Intervention 3||2
9870577|NCT00979875|10984698|FG002|STARTED|Intervention 3||3
9870578|NCT00979875|10984699|FG003|STARTED|Intervention 3||2
9870579|NCT00979875|10984700|FG004|STARTED|Intervention 3||3
9870580|NCT00979875|10984701|FG005|STARTED|Intervention 3||2
9870581|NCT00979875|10984696|FG000|COMPLETED|Intervention 3||2
9870582|NCT00979875|10984697|FG001|COMPLETED|Intervention 3||2
9870583|NCT00979875|10984698|FG002|COMPLETED|Intervention 3||3
9870584|NCT00979875|10984699|FG003|COMPLETED|Intervention 3||2
9870585|NCT00979875|10984700|FG004|COMPLETED|Intervention 3||3
9870586|NCT00979875|10984701|FG005|COMPLETED|Intervention 3||2
9870587|NCT00979875|10984696|FG000|NOT COMPLETED|Intervention 3||0
9870588|NCT00979875|10984697|FG001|NOT COMPLETED|Intervention 3||0
9870589|NCT00979875|10984698|FG002|NOT COMPLETED|Intervention 3||0
9870590|NCT00979875|10984699|FG003|NOT COMPLETED|Intervention 3||0
9870591|NCT00979875|10984700|FG004|NOT COMPLETED|Intervention 3||0
9870592|NCT00979875|10984701|FG005|NOT COMPLETED|Intervention 3||0
9870593|NCT00979940|10984717|FG000|STARTED|Overall Study||32
9870594|NCT00979940|10984718|FG001|STARTED|Overall Study||28
9870595|NCT00979940|10984717|FG000|COMPLETED|Overall Study||32
9870596|NCT00979940|10984718|FG001|COMPLETED|Overall Study||28
9870597|NCT00979940|10984717|FG000|NOT COMPLETED|Overall Study||0
9870598|NCT00979940|10984718|FG001|NOT COMPLETED|Overall Study||0
9870599|NCT00979953|10984728|FG000|STARTED|Overall Study||101
9870600|NCT00979953|10984729|FG001|STARTED|Overall Study||99
9870601|NCT00979953|10984730|FG002|STARTED|Overall Study||104
9870602|NCT00979953|10984731|FG003|STARTED|Overall Study||104
9870603|NCT00979953|10984728|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
9870604|NCT00979953|10984729|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99
9870605|NCT00979953|10984730|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
9870606|NCT00979953|10984731|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104
10095693|NCT02359058|11224266|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10095694|NCT02359058|11224267|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10095695|NCT02359058|11224268|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10095696|NCT02359058|11224266|FG000|COMPLETED|Overall Study||6
10095697|NCT02359058|11224267|FG001|COMPLETED|Overall Study||6
10095698|NCT02359058|11224268|FG002|COMPLETED|Overall Study||6
9870607|NCT00979953|10984728|FG000|COMPLETED|Overall Study||93
9870608|NCT00979953|10984729|FG001|COMPLETED|Overall Study||94
9870609|NCT00979953|10984730|FG002|COMPLETED|Overall Study||82
9870610|NCT00979953|10984731|FG003|COMPLETED|Overall Study||97
9870611|NCT00979953|10984728|FG000|NOT COMPLETED|Overall Study||8
9870612|NCT00979953|10984729|FG001|NOT COMPLETED|Overall Study||5
9870613|NCT00979953|10984730|FG002|NOT COMPLETED|Overall Study||22
9870614|NCT00979953|10984731|FG003|NOT COMPLETED|Overall Study||7
9870615|NCT00979992|10984741|FG000|STARTED|Overall Study||35
9870616|NCT00979992|10984741|FG000|COMPLETED|Overall Study||30
9870617|NCT00979992|10984741|FG000|NOT COMPLETED|Overall Study||5
9870618|NCT00980005|10984747|FG000|STARTED|Overall Study||1055
9870619|NCT00980005|10984748|FG001|STARTED|Overall Study||1061
9870620|NCT00980005|10984747|FG000|COMPLETED|Overall Study||1008
10095699|NCT02359058|11224266|FG000|NOT COMPLETED|Overall Study||0
10095700|NCT02359058|11224267|FG001|NOT COMPLETED|Overall Study||0
10095701|NCT02359058|11224268|FG002|NOT COMPLETED|Overall Study||0
9870621|NCT00980005|10984748|FG001|COMPLETED|Overall Study||998
9870622|NCT00980005|10984747|FG000|NOT COMPLETED|Overall Study||47
9870623|NCT00980005|10984748|FG001|NOT COMPLETED|Overall Study||63
9870624|NCT00980018|10984758|FG000|STARTED|Overall Study||52
9870625|NCT00980018|10984758|FG000|COMPLETED|Overall Study||40
9870626|NCT00980018|10984758|FG000|NOT COMPLETED|Overall Study||12
9870627|NCT00980044|10984765|FG000|STARTED|Overall Study||17
9870628|NCT00980044|10984766|FG001|STARTED|Overall Study||19
9870629|NCT00980044|10984767|FG002|STARTED|Overall Study||17
9870630|NCT00980044|10984765|FG000|COMPLETED|Overall Study||12
9870631|NCT00980044|10984766|FG001|COMPLETED|Overall Study||12
9870632|NCT00980044|10984767|FG002|COMPLETED|Overall Study||12
9870633|NCT00980044|10984765|FG000|NOT COMPLETED|Overall Study||5
9870634|NCT00980044|10984766|FG001|NOT COMPLETED|Overall Study||7
9870635|NCT00980044|10984767|FG002|NOT COMPLETED|Overall Study||5
9870636|NCT00980057|10984780|FG000|STARTED|Overall Study||318
9870637|NCT00980057|10984781|FG001|STARTED|Overall Study||160
9870638|NCT00980057|10984780|FG000|COMPLETED|Overall Study||299
9870639|NCT00980057|10984781|FG001|COMPLETED|Overall Study||155
9870640|NCT00980057|10984780|FG000|NOT COMPLETED|Overall Study||19
9870641|NCT00980057|10984781|FG001|NOT COMPLETED|Overall Study||5
9870642|NCT00980148|10984790|FG000|STARTED|Overall Study||284
9870643|NCT00980148|10984791|FG001|STARTED|Overall Study||283
9870644|NCT00980148|10984790|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
9870645|NCT00980148|10984791|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
9870646|NCT00980148|10984790|FG000|NOT COMPLETED|Overall Study||129
9870647|NCT00980148|10984791|FG001|NOT COMPLETED|Overall Study||128
9870648|NCT00980174|10984799|FG000|STARTED|Overall Study||121
9870649|NCT00980174|10984800|FG001|STARTED|Overall Study||121
9870650|NCT00980174|10984799|FG000|COMPLETED|Overall Study||117
10095702|NCT02359110|11224279|FG000|STARTED|Overall Study||55
10095703|NCT02359110|11224280|FG001|STARTED|Overall Study||54
10095704|NCT02359110|11224279|FG000|COMPLETED|Overall Study||55
10095705|NCT02359110|11224280|FG001|COMPLETED|Overall Study||54
10095706|NCT02359110|11224279|FG000|NOT COMPLETED|Overall Study||0
9870651|NCT00980174|10984800|FG001|COMPLETED|Overall Study||111
9870652|NCT00980174|10984799|FG000|NOT COMPLETED|Overall Study||4
9870653|NCT00980174|10984800|FG001|NOT COMPLETED|Overall Study||10
9870654|NCT00980200|10984806|FG000|STARTED|7-day Treatment Period 1||15
9870655|NCT00980200|10984807|FG001|STARTED|7-day Treatment Period 1||14
9870656|NCT00980200|10984808|FG002|STARTED|7-day Treatment Period 1||15
9870657|NCT00980200|10984809|FG003|STARTED|7-day Treatment Period 1||16
10095707|NCT02359110|11224280|FG001|NOT COMPLETED|Overall Study||0
10095708|NCT02359305|11224288|FG000|STARTED|Overall Study||34
10095709|NCT02359305|11224289|FG001|STARTED|Overall Study||34
10095710|NCT02359305|11224288|FG000|COMPLETED|Overall Study||34
10095711|NCT02359305|11224289|FG001|COMPLETED|Overall Study||34
10095712|NCT02359305|11224288|FG000|NOT COMPLETED|Overall Study||0
10095713|NCT02359305|11224289|FG001|NOT COMPLETED|Overall Study||0
10095714|NCT02359435|11224297|FG000|STARTED|Overall Study||220
10095715|NCT02359435|11224298|FG001|STARTED|Overall Study||220
10095716|NCT02359435|11224297|FG000|COMPLETED|Overall Study||216
10095717|NCT02359435|11224298|FG001|COMPLETED|Overall Study||216
10095718|NCT02359435|11224297|FG000|NOT COMPLETED|Overall Study||4
10095719|NCT02359435|11224298|FG001|NOT COMPLETED|Overall Study||4
10095720|NCT02359552|11224306|FG000|STARTED|Overall Study||25
10095721|NCT02359552|11224307|FG001|STARTED|Overall Study||25
10095722|NCT02359552|11224306|FG000|COMPLETED|Overall Study||22
10095723|NCT02359552|11224307|FG001|COMPLETED|Overall Study||21
10095724|NCT02359552|11224306|FG000|NOT COMPLETED|Overall Study||3
10095725|NCT02359552|11224307|FG001|NOT COMPLETED|Overall Study||4
10095726|NCT02359851|11224313|FG000|STARTED|Overall Study||5
10095727|NCT02359851|11224313|FG000|COMPLETED|Overall Study||3
10095728|NCT02359851|11224313|FG000|NOT COMPLETED|Overall Study||2
10095729|NCT02359877|11224321|FG000|STARTED|Overall Study||34
10095730|NCT02359877|11224322|FG001|STARTED|Overall Study||6
10095731|NCT02359877|11224323|FG002|STARTED|Overall Study||6
10095732|NCT02359877|11224324|FG003|STARTED|Overall Study||14
10095733|NCT02359877|11224321|FG000|COMPLETED|Overall Study||33
10095734|NCT02359877|11224322|FG001|COMPLETED|Overall Study||6
10095735|NCT02359877|11224323|FG002|COMPLETED|Overall Study||6
10095736|NCT02359877|11224324|FG003|COMPLETED|Overall Study||11
10095737|NCT02359877|11224321|FG000|NOT COMPLETED|Overall Study||1
10095738|NCT02359877|11224322|FG001|NOT COMPLETED|Overall Study||0
10095739|NCT02359877|11224323|FG002|NOT COMPLETED|Overall Study||0
10095740|NCT02359877|11224324|FG003|NOT COMPLETED|Overall Study||3
10095741|NCT02359890|11224352|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
10095742|NCT02359890|11224352|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
10095743|NCT02359890|11224352|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
10095744|NCT02359890|11224352|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
9870658|NCT00980200|10984810|FG004|STARTED|7-day Treatment Period 1||15
9870659|NCT00980200|10984806|FG000|COMPLETED|7-day Treatment Period 1||15
9870660|NCT00980200|10984807|FG001|COMPLETED|7-day Treatment Period 1||13
9870661|NCT00980200|10984808|FG002|COMPLETED|7-day Treatment Period 1||15
9870662|NCT00980200|10984809|FG003|COMPLETED|7-day Treatment Period 1||16
9870663|NCT00980200|10984810|FG004|COMPLETED|7-day Treatment Period 1||15
9870664|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Treatment Period 1||0
9870665|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Treatment Period 1||1
9870666|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Treatment Period 1||0
9870667|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Treatment Period 1||0
9870668|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Treatment Period 1||0
9870669|NCT00980200|10984806|FG000|STARTED|7-day Washout Period 1||15
9870670|NCT00980200|10984807|FG001|STARTED|7-day Washout Period 1||13
9870671|NCT00980200|10984808|FG002|STARTED|7-day Washout Period 1||15
9870672|NCT00980200|10984809|FG003|STARTED|7-day Washout Period 1||16
9870673|NCT00980200|10984810|FG004|STARTED|7-day Washout Period 1||15
9870674|NCT00980200|10984806|FG000|COMPLETED|7-day Washout Period 1||15
9870675|NCT00980200|10984807|FG001|COMPLETED|7-day Washout Period 1||13
9870676|NCT00980200|10984808|FG002|COMPLETED|7-day Washout Period 1||15
9870677|NCT00980200|10984809|FG003|COMPLETED|7-day Washout Period 1||16
9870678|NCT00980200|10984810|FG004|COMPLETED|7-day Washout Period 1||15
9870679|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Washout Period 1||0
9870680|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Washout Period 1||0
9870681|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Washout Period 1||0
9870682|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Washout Period 1||0
9870683|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Washout Period 1||0
9870684|NCT00980200|10984806|FG000|STARTED|7-day Treatment Period 2||15
10095745|NCT02359890|11224352|FG000|COMPLETED|Overall Study||155
10095746|NCT02359890|11224352|FG000|NOT COMPLETED|Overall Study||10
10095747|NCT02359903|11224358|FG000|STARTED|Overall Study||45
10095748|NCT02359903|11224359|FG001|STARTED|Overall Study||45
10095749|NCT02359903|11224358|FG000|COMPLETED|Overall Study||45
10095750|NCT02359903|11224359|FG001|COMPLETED|Overall Study||43
10095751|NCT02359903|11224358|FG000|NOT COMPLETED|Overall Study||0
10095752|NCT02359903|11224359|FG001|NOT COMPLETED|Overall Study||2
10095753|NCT02359916|11224372|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10095754|NCT02359916|11224373|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10095755|NCT02359916|11224374|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10112991|NCT02506881|11243903|FG000|COMPLETED|Second Intervention (Day 1)||12
9870685|NCT00980200|10984807|FG001|STARTED|7-day Treatment Period 2||13
9870686|NCT00980200|10984808|FG002|STARTED|7-day Treatment Period 2||15
9870687|NCT00980200|10984809|FG003|STARTED|7-day Treatment Period 2||16
9870688|NCT00980200|10984810|FG004|STARTED|7-day Treatment Period 2||15
9870689|NCT00980200|10984806|FG000|COMPLETED|7-day Treatment Period 2||15
9870690|NCT00980200|10984807|FG001|COMPLETED|7-day Treatment Period 2||13
9870691|NCT00980200|10984808|FG002|COMPLETED|7-day Treatment Period 2||15
9870692|NCT00980200|10984809|FG003|COMPLETED|7-day Treatment Period 2||16
9870693|NCT00980200|10984810|FG004|COMPLETED|7-day Treatment Period 2||15
9870694|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Treatment Period 2||0
9870695|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Treatment Period 2||0
9870696|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Treatment Period 2||0
9870697|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Treatment Period 2||0
9870698|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Treatment Period 2||0
9870699|NCT00980200|10984806|FG000|STARTED|7-day Washout Period 2||15
9870700|NCT00980200|10984807|FG001|STARTED|7-day Washout Period 2||13
9870701|NCT00980200|10984808|FG002|STARTED|7-day Washout Period 2||15
9870702|NCT00980200|10984809|FG003|STARTED|7-day Washout Period 2||16
9870703|NCT00980200|10984810|FG004|STARTED|7-day Washout Period 2||15
9870704|NCT00980200|10984806|FG000|COMPLETED|7-day Washout Period 2||15
9870705|NCT00980200|10984807|FG001|COMPLETED|7-day Washout Period 2||13
9870706|NCT00980200|10984808|FG002|COMPLETED|7-day Washout Period 2||15
9870707|NCT00980200|10984809|FG003|COMPLETED|7-day Washout Period 2||16
9870708|NCT00980200|10984810|FG004|COMPLETED|7-day Washout Period 2||15
9870709|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Washout Period 2||0
9870710|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Washout Period 2||0
9870711|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Washout Period 2||0
9870712|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Washout Period 2||0
9870713|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Washout Period 2||0
9870714|NCT00980200|10984806|FG000|STARTED|7-day Treatment Period 3||15
9870715|NCT00980200|10984807|FG001|STARTED|7-day Treatment Period 3||13
9870716|NCT00980200|10984808|FG002|STARTED|7-day Treatment Period 3||15
9870717|NCT00980200|10984809|FG003|STARTED|7-day Treatment Period 3||16
9870718|NCT00980200|10984810|FG004|STARTED|7-day Treatment Period 3||15
9870719|NCT00980200|10984806|FG000|COMPLETED|7-day Treatment Period 3||15
9870720|NCT00980200|10984807|FG001|COMPLETED|7-day Treatment Period 3||12
9870721|NCT00980200|10984808|FG002|COMPLETED|7-day Treatment Period 3||15
9870722|NCT00980200|10984809|FG003|COMPLETED|7-day Treatment Period 3||16
9870723|NCT00980200|10984810|FG004|COMPLETED|7-day Treatment Period 3||14
9870724|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Treatment Period 3||0
9870725|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Treatment Period 3||1
9870726|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Treatment Period 3||0
9870727|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Treatment Period 3||0
9870728|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Treatment Period 3||1
9870729|NCT00980200|10984806|FG000|STARTED|7-day Washout Period 3||15
9870730|NCT00980200|10984807|FG001|STARTED|7-day Washout Period 3||12
9870731|NCT00980200|10984808|FG002|STARTED|7-day Washout Period 3||15
9870732|NCT00980200|10984809|FG003|STARTED|7-day Washout Period 3||16
9870733|NCT00980200|10984810|FG004|STARTED|7-day Washout Period 3||14
9870734|NCT00980200|10984806|FG000|COMPLETED|7-day Washout Period 3||15
9870735|NCT00980200|10984807|FG001|COMPLETED|7-day Washout Period 3||12
9870736|NCT00980200|10984808|FG002|COMPLETED|7-day Washout Period 3||15
9870737|NCT00980200|10984809|FG003|COMPLETED|7-day Washout Period 3||16
9870738|NCT00980200|10984810|FG004|COMPLETED|7-day Washout Period 3||14
9870739|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Washout Period 3||0
9870740|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Washout Period 3||0
9870741|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Washout Period 3||0
9870742|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Washout Period 3||0
9870743|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Washout Period 3||0
9870744|NCT00980200|10984806|FG000|STARTED|7-day Treatment Period 4||15
9870745|NCT00980200|10984807|FG001|STARTED|7-day Treatment Period 4||12
9870746|NCT00980200|10984808|FG002|STARTED|7-day Treatment Period 4||15
9870747|NCT00980200|10984809|FG003|STARTED|7-day Treatment Period 4||16
9870748|NCT00980200|10984810|FG004|STARTED|7-day Treatment Period 4||14
9870749|NCT00980200|10984806|FG000|COMPLETED|7-day Treatment Period 4||15
9870750|NCT00980200|10984807|FG001|COMPLETED|7-day Treatment Period 4||12
9870751|NCT00980200|10984808|FG002|COMPLETED|7-day Treatment Period 4||15
9870752|NCT00980200|10984809|FG003|COMPLETED|7-day Treatment Period 4||16
9870753|NCT00980200|10984810|FG004|COMPLETED|7-day Treatment Period 4||14
9870754|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Treatment Period 4||0
9758563|NCT03133793|10862102|FG003|COMPLETED|Overall Study||33
9758564|NCT03133793|10862099|FG000|NOT COMPLETED|Overall Study||1
9758565|NCT03133793|10862100|FG001|NOT COMPLETED|Overall Study||4
9758566|NCT03133793|10862101|FG002|NOT COMPLETED|Overall Study||4
9758567|NCT03133793|10862102|FG003|NOT COMPLETED|Overall Study||5
9758568|NCT03103542|10862116|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16
9758569|NCT03103542|10862116|FG000|COMPLETED|Overall Study||9
9758570|NCT03103542|10862116|FG000|NOT COMPLETED|Overall Study||7
9758571|NCT03086317|10862123|FG000|STARTED|Overall Study||10
9758572|NCT03086317|10862124|FG001|STARTED|Overall Study||8
9758573|NCT03086317|10862123|FG000|COMPLETED|Overall Study||10
9758574|NCT03086317|10862124|FG001|COMPLETED|Overall Study||8
9758575|NCT03086317|10862123|FG000|NOT COMPLETED|Overall Study||0
9758576|NCT03086317|10862124|FG001|NOT COMPLETED|Overall Study||0
9758577|NCT02676765|10862132|FG000|STARTED|Overall Study||10
9758578|NCT02676765|10862133|FG001|STARTED|Overall Study||10
9758579|NCT02676765|10862132|FG000|COMPLETED|Overall Study||10
9758580|NCT02676765|10862133|FG001|COMPLETED|Overall Study||9
9758581|NCT02676765|10862132|FG000|NOT COMPLETED|Overall Study||0
9758582|NCT02676765|10862133|FG001|NOT COMPLETED|Overall Study||1
9758583|NCT02539563|10862141|FG000|STARTED|Overall Study||45
9758584|NCT02539563|10862142|FG001|STARTED|Overall Study||56
9758585|NCT02539563|10862141|FG000|COMPLETED|Overall Study||39
9758586|NCT02539563|10862142|FG001|COMPLETED|Overall Study||42
9870755|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Treatment Period 4||0
9870756|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Treatment Period 4||0
9870757|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Treatment Period 4||0
9870758|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Treatment Period 4||0
9870759|NCT00980200|10984806|FG000|STARTED|7-day Washout Period 4||15
9870760|NCT00980200|10984807|FG001|STARTED|7-day Washout Period 4||12
9870761|NCT00980200|10984808|FG002|STARTED|7-day Washout Period 4||15
9870762|NCT00980200|10984809|FG003|STARTED|7-day Washout Period 4||16
9870763|NCT00980200|10984810|FG004|STARTED|7-day Washout Period 4||14
9870764|NCT00980200|10984806|FG000|COMPLETED|7-day Washout Period 4||15
9870765|NCT00980200|10984807|FG001|COMPLETED|7-day Washout Period 4||12
9870766|NCT00980200|10984808|FG002|COMPLETED|7-day Washout Period 4||15
9870767|NCT00980200|10984809|FG003|COMPLETED|7-day Washout Period 4||16
9870768|NCT00980200|10984810|FG004|COMPLETED|7-day Washout Period 4||14
9870769|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Washout Period 4||0
9870770|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Washout Period 4||0
9870771|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Washout Period 4||0
9870772|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Washout Period 4||0
9870773|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Washout Period 4||0
9870774|NCT00980200|10984806|FG000|STARTED|7-day Treatment Period 5||15
9870775|NCT00980200|10984807|FG001|STARTED|7-day Treatment Period 5||12
9870776|NCT00980200|10984808|FG002|STARTED|7-day Treatment Period 5||15
9870777|NCT00980200|10984809|FG003|STARTED|7-day Treatment Period 5||16
9870778|NCT00980200|10984810|FG004|STARTED|7-day Treatment Period 5||14
9870779|NCT00980200|10984806|FG000|COMPLETED|7-day Treatment Period 5||15
9870780|NCT00980200|10984807|FG001|COMPLETED|7-day Treatment Period 5||12
9870781|NCT00980200|10984808|FG002|COMPLETED|7-day Treatment Period 5||15
9870782|NCT00980200|10984809|FG003|COMPLETED|7-day Treatment Period 5||16
9870783|NCT00980200|10984810|FG004|COMPLETED|7-day Treatment Period 5||14
9870784|NCT00980200|10984806|FG000|NOT COMPLETED|7-day Treatment Period 5||0
9870785|NCT00980200|10984807|FG001|NOT COMPLETED|7-day Treatment Period 5||0
9870786|NCT00980200|10984808|FG002|NOT COMPLETED|7-day Treatment Period 5||0
9870787|NCT00980200|10984809|FG003|NOT COMPLETED|7-day Treatment Period 5||0
9870788|NCT00980200|10984810|FG004|NOT COMPLETED|7-day Treatment Period 5||0
9870789|NCT00980278|10984824|FG000|STARTED|Overall Study||13
9870790|NCT00980278|10984825|FG001|STARTED|Overall Study||13
9870791|NCT00980278|10984824|FG000|COMPLETED|Overall Study||11
9870792|NCT00980278|10984825|FG001|COMPLETED|Overall Study||13
9870793|NCT00980278|10984824|FG000|NOT COMPLETED|Overall Study||2
9870794|NCT00980278|10984825|FG001|NOT COMPLETED|Overall Study||0
9870795|NCT00980330|10984838|FG000|STARTED|Overall Study||66
9870796|NCT00980330|10984839|FG001|STARTED|Overall Study||65
9870797|NCT00980330|10984840|FG002|STARTED|Overall Study||66
9870798|NCT00980330|10984841|FG003|STARTED|Overall Study||66
9870799|NCT00980330|10984842|FG004|STARTED|Overall Study||68
9870800|NCT00980330|10984843|FG005|STARTED|Overall Study||65
9870801|NCT00980330|10984844|FG006|STARTED|Overall Study||66
9870802|NCT00980330|10984838|FG000|COMPLETED|Overall Study||61
9870803|NCT00980330|10984839|FG001|COMPLETED|Overall Study||60
9870804|NCT00980330|10984840|FG002|COMPLETED|Overall Study||58
9870805|NCT00980330|10984841|FG003|COMPLETED|Overall Study||61
9870806|NCT00980330|10984842|FG004|COMPLETED|Overall Study||63
9870807|NCT00980330|10984843|FG005|COMPLETED|Overall Study||61
9870808|NCT00980330|10984844|FG006|COMPLETED|Overall Study||59
9870809|NCT00980330|10984838|FG000|NOT COMPLETED|Overall Study||5
9870810|NCT00980330|10984839|FG001|NOT COMPLETED|Overall Study||5
9870811|NCT00980330|10984840|FG002|NOT COMPLETED|Overall Study||8
9870812|NCT00980330|10984841|FG003|NOT COMPLETED|Overall Study||5
9870813|NCT00980330|10984842|FG004|NOT COMPLETED|Overall Study||5
9758587|NCT02539563|10862141|FG000|NOT COMPLETED|Overall Study||6
9758588|NCT02539563|10862142|FG001|NOT COMPLETED|Overall Study||14
9758589|NCT02422446|10862150|FG000|STARTED|Overall Study||1
9758590|NCT02422446|10862151|FG001|STARTED|Overall Study||1
9758591|NCT02422446|10862150|FG000|COMPLETED|Overall Study||1
9758592|NCT02422446|10862151|FG001|COMPLETED|Overall Study||1
9758593|NCT02422446|10862150|FG000|NOT COMPLETED|Overall Study||0
9758594|NCT02422446|10862151|FG001|NOT COMPLETED|Overall Study||0
9758595|NCT02362451|10862159|FG000|STARTED|Overall Study||6
9758596|NCT02362451|10862160|FG001|STARTED|Overall Study||1
9758597|NCT02362451|10862159|FG000|COMPLETED|Overall Study||2
9758598|NCT02362451|10862160|FG001|COMPLETED|Overall Study||0
9758599|NCT02362451|10862159|FG000|NOT COMPLETED|Overall Study||4
9758600|NCT02362451|10862160|FG001|NOT COMPLETED|Overall Study||1
9758601|NCT02282020|10862168|FG000|STARTED|Overall Study||178
9758602|NCT02282020|10862169|FG001|STARTED|Overall Study||88
9758603|NCT02282020|10862168|FG000|Received Treatment|Overall Study||178
9758604|NCT02282020|10862169|FG001|Received Treatment|Overall Study||76
9758605|NCT02282020|10862168|FG000|COMPLETED|Overall Study||43
9758606|NCT02282020|10862169|FG001|COMPLETED|Overall Study||1
9870814|NCT00980330|10984843|FG005|NOT COMPLETED|Overall Study||4
9870815|NCT00980330|10984844|FG006|NOT COMPLETED|Overall Study||7
9870816|NCT00980343|10984863|FG000|STARTED|Overall Study||21
9870817|NCT00980343|10984864|FG001|STARTED|Overall Study||23
9870818|NCT00980343|10984863|FG000|COMPLETED|Overall Study||20
9870819|NCT00980343|10984864|FG001|COMPLETED|Overall Study||20
9758607|NCT02282020|10862168|FG000|NOT COMPLETED|Overall Study||135
9758608|NCT02282020|10862169|FG001|NOT COMPLETED|Overall Study||87
9870820|NCT00980343|10984863|FG000|NOT COMPLETED|Overall Study||1
9870821|NCT00980343|10984864|FG001|NOT COMPLETED|Overall Study||3
9870822|NCT00980395|10984871|FG000|STARTED|Overall Study||24
9870823|NCT00980395|10984871|FG000|COMPLETED|Overall Study||24
9870824|NCT00980395|10984871|FG000|NOT COMPLETED|Overall Study||0
9870825|NCT00980590|10984877|FG000|STARTED|Overall Study||50
9870826|NCT00980590|10984878|FG001|STARTED|Overall Study||50
9870827|NCT00980590|10984877|FG000|COMPLETED|Overall Study||50
9870828|NCT00980590|10984878|FG001|COMPLETED|Overall Study||50
9870829|NCT00980590|10984877|FG000|NOT COMPLETED|Overall Study||0
9870830|NCT00980590|10984878|FG001|NOT COMPLETED|Overall Study||0
9870831|NCT00980642|10984886|FG000|STARTED|Overall Study||36
9870832|NCT00980642|10984887|FG001|STARTED|Overall Study||20
9870833|NCT00980642|10984886|FG000|COMPLETED|Overall Study||36
9870834|NCT00980642|10984887|FG001|COMPLETED|Overall Study||20
9870835|NCT00980642|10984886|FG000|NOT COMPLETED|Overall Study||0
9870836|NCT00980642|10984887|FG001|NOT COMPLETED|Overall Study||0
9870837|NCT00980655|10984896|FG000|STARTED|Overall Study||61
9870838|NCT00980655|10984897|FG001|STARTED|Overall Study||190
9870839|NCT00980655|10984896|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59
9870840|NCT00980655|10984897|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188
9870841|NCT00980655|10984896|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55
9870842|NCT00980655|10984897|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176
9870843|NCT00980655|10984896|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54
9870844|NCT00980655|10984897|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167
9870845|NCT00980655|10984896|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46
9870846|NCT00980655|10984897|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146
9870847|NCT00980655|10984896|FG000|Vaccinated 23vPS Dose|Overall Study||45
9870848|NCT00980655|10984897|FG001|Vaccinated 23vPS Dose|Overall Study||140
9870849|NCT00980655|10984896|FG000|COMPLETED|Overall Study||45
9870850|NCT00980655|10984897|FG001|COMPLETED|Overall Study||139
9870851|NCT00980655|10984896|FG000|NOT COMPLETED|Overall Study||16
9870852|NCT00980655|10984897|FG001|NOT COMPLETED|Overall Study||51
9870853|NCT00980681|10984908|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
9870854|NCT00980681|10984908|FG000|COMPLETED|TOF MRA||10
9870855|NCT00980681|10984908|FG000|NOT COMPLETED|TOF MRA||0
9870856|NCT00980681|10984908|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
9870857|NCT00980681|10984908|FG000|COMPLETED|Dotarem MRA||10
9870858|NCT00980681|10984908|FG000|NOT COMPLETED|Dotarem MRA||0
9870859|NCT00980746|10984920|FG000|STARTED|Overall Study||85
9870860|NCT00980746|10984921|FG001|STARTED|Overall Study||89
9870861|NCT00980746|10984922|FG002|STARTED|Overall Study||95
9870862|NCT00980746|10984923|FG003|STARTED|Overall Study||100
9870863|NCT00980746|10984924|FG004|STARTED|Overall Study||92
9870864|NCT00980746|10984925|FG005|STARTED|Overall Study||96
9870865|NCT00980746|10984920|FG000|Randomized|Overall Study||85
9870866|NCT00980746|10984921|FG001|Randomized|Overall Study||89
9870867|NCT00980746|10984922|FG002|Randomized|Overall Study||95
9870868|NCT00980746|10984923|FG003|Randomized|Overall Study||100
9870869|NCT00980746|10984924|FG004|Randomized|Overall Study||92
9870870|NCT00980746|10984925|FG005|Randomized|Overall Study||96
9870871|NCT00980746|10984920|FG000|Safety Population|Overall Study||85
9870872|NCT00980746|10984921|FG001|Safety Population|Overall Study||89
9870873|NCT00980746|10984922|FG002|Safety Population|Overall Study||95
9870874|NCT00980746|10984923|FG003|Safety Population|Overall Study||100
9870875|NCT00980746|10984924|FG004|Safety Population|Overall Study||92
9870876|NCT00980746|10984925|FG005|Safety Population|Overall Study||96
9870877|NCT00980746|10984920|FG000|Per-protocol|Overall Study||55
9870878|NCT00980746|10984921|FG001|Per-protocol|Overall Study||66
9870879|NCT00980746|10984922|FG002|Per-protocol|Overall Study||73
9870880|NCT00980746|10984923|FG003|Per-protocol|Overall Study||62
9870881|NCT00980746|10984924|FG004|Per-protocol|Overall Study||73
9870882|NCT00980746|10984925|FG005|Per-protocol|Overall Study||74
9870883|NCT00980746|10984920|FG000|COMPLETED|Overall Study||58
9870884|NCT00980746|10984921|FG001|COMPLETED|Overall Study||67
9870885|NCT00980746|10984922|FG002|COMPLETED|Overall Study||75
9870886|NCT00980746|10984923|FG003|COMPLETED|Overall Study||64
9870887|NCT00980746|10984924|FG004|COMPLETED|Overall Study||75
9870888|NCT00980746|10984925|FG005|COMPLETED|Overall Study||78
9870889|NCT00980746|10984920|FG000|NOT COMPLETED|Overall Study||27
9870890|NCT00980746|10984921|FG001|NOT COMPLETED|Overall Study||22
9870891|NCT00980746|10984922|FG002|NOT COMPLETED|Overall Study||20
9870892|NCT00980746|10984923|FG003|NOT COMPLETED|Overall Study||36
9870893|NCT00980746|10984924|FG004|NOT COMPLETED|Overall Study||17
9870894|NCT00980746|10984925|FG005|NOT COMPLETED|Overall Study||18
9870895|NCT00980785|10984941|FG000|STARTED|Overall Study||6
9870896|NCT00980785|10984942|FG001|STARTED|Overall Study||8
9870897|NCT00980785|10984941|FG000|COMPLETED|Overall Study||6
9870898|NCT00980785|10984942|FG001|COMPLETED|Overall Study||8
9870899|NCT00980785|10984941|FG000|NOT COMPLETED|Overall Study||0
9870900|NCT00980785|10984942|FG001|NOT COMPLETED|Overall Study||0
9870901|NCT00980798|10984950|FG000|STARTED|Overall Study||149
9870902|NCT00980798|10984951|FG001|STARTED|Overall Study||139
9870903|NCT00980798|10984950|FG000|COMPLETED|Overall Study||116
9870904|NCT00980798|10984951|FG001|COMPLETED|Overall Study||84
9870905|NCT00980798|10984950|FG000|NOT COMPLETED|Overall Study||33
9870906|NCT00980798|10984951|FG001|NOT COMPLETED|Overall Study||55
9870907|NCT00980980|10984960|FG000|STARTED|Overall Study||16
9870908|NCT00980980|10984961|FG001|STARTED|Overall Study||14
9870909|NCT00980980|10984962|FG002|STARTED|Overall Study||13
9870910|NCT00980980|10984960|FG000|COMPLETED|Overall Study||16
9870911|NCT00980980|10984961|FG001|COMPLETED|Overall Study||13
9870912|NCT00980980|10984962|FG002|COMPLETED|Overall Study||13
9870913|NCT00980980|10984960|FG000|NOT COMPLETED|Overall Study||0
9870914|NCT00980980|10984961|FG001|NOT COMPLETED|Overall Study||1
9870915|NCT00980980|10984962|FG002|NOT COMPLETED|Overall Study||0
9870916|NCT00981019|10984973|FG000|STARTED|Overall Study||778
9870917|NCT00981019|10984973|FG000|COMPLETED|Overall Study||301
9870918|NCT00981019|10984973|FG000|NOT COMPLETED|Overall Study||477
9870919|NCT00981045|10984979|FG000|STARTED|Overall Study||1290
9870920|NCT00981045|10984980|FG001|STARTED|Overall Study||1294
9870921|NCT00981045|10984979|FG000|COMPLETED|Overall Study||1276
9870922|NCT00981045|10984980|FG001|COMPLETED|Overall Study||1285
9870923|NCT00981045|10984979|FG000|NOT COMPLETED|Overall Study||14
9870924|NCT00981045|10984980|FG001|NOT COMPLETED|Overall Study||9
9870925|NCT00981084|10984988|FG000|STARTED|First Intervention (One Day)||16
9870926|NCT00981084|10984989|FG001|STARTED|First Intervention (One Day)||17
9870927|NCT00981084|10984988|FG000|COMPLETED|First Intervention (One Day)||16
9870928|NCT00981084|10984989|FG001|COMPLETED|First Intervention (One Day)||17
9870929|NCT00981084|10984988|FG000|NOT COMPLETED|First Intervention (One Day)||0
9870930|NCT00981084|10984989|FG001|NOT COMPLETED|First Intervention (One Day)||0
9870931|NCT00981084|10984988|FG000|STARTED|Washout Period (7 Days)||16
9870932|NCT00981084|10984989|FG001|STARTED|Washout Period (7 Days)||17
9870933|NCT00981084|10984988|FG000|COMPLETED|Washout Period (7 Days)||16
9870934|NCT00981084|10984989|FG001|COMPLETED|Washout Period (7 Days)||17
9870935|NCT00981084|10984988|FG000|NOT COMPLETED|Washout Period (7 Days)||0
9870936|NCT00981084|10984989|FG001|NOT COMPLETED|Washout Period (7 Days)||0
9870937|NCT00981084|10984988|FG000|STARTED|Second Intervention (One Day)||16
9870938|NCT00981084|10984989|FG001|STARTED|Second Intervention (One Day)||17
9870939|NCT00981084|10984988|FG000|COMPLETED|Second Intervention (One Day)||16
9870940|NCT00981084|10984989|FG001|COMPLETED|Second Intervention (One Day)||17
9870941|NCT00981084|10984988|FG000|NOT COMPLETED|Second Intervention (One Day)||0
9870942|NCT00981084|10984989|FG001|NOT COMPLETED|Second Intervention (One Day)||0
9870943|NCT00981084|10984988|FG000|STARTED|Post Intervention (Data Analysis)||16
9870944|NCT00981084|10984989|FG001|STARTED|Post Intervention (Data Analysis)||17
9870945|NCT00981084|10984988|FG000|COMPLETED|Post Intervention (Data Analysis)||14
9870946|NCT00981084|10984989|FG001|COMPLETED|Post Intervention (Data Analysis)||16
9870947|NCT00981084|10984988|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2
9870948|NCT00981084|10984989|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1
9870949|NCT00981149|10984999|FG000|STARTED|Overall Study||12
9870950|NCT00981149|10985000|FG001|STARTED|Overall Study||12
9870951|NCT00981149|10984999|FG000|COMPLETED|Overall Study||10
9870952|NCT00981149|10985000|FG001|COMPLETED|Overall Study||9
9870953|NCT00981149|10984999|FG000|NOT COMPLETED|Overall Study||2
9870954|NCT00981149|10985000|FG001|NOT COMPLETED|Overall Study||3
9870955|NCT00981175|10985009|FG000|STARTED|Primary Dose Vaccination||101
9870956|NCT00981175|10985010|FG001|STARTED|Primary Dose Vaccination||101
9870957|NCT00981175|10985009|FG000|COMPLETED|Primary Dose Vaccination||98
9870958|NCT00981175|10985010|FG001|COMPLETED|Primary Dose Vaccination||99
9870959|NCT00981175|10985009|FG000|NOT COMPLETED|Primary Dose Vaccination||3
9870960|NCT00981175|10985010|FG001|NOT COMPLETED|Primary Dose Vaccination||2
9870961|NCT00981175|10985009|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
9870962|NCT00981175|10985010|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
9870963|NCT00981175|10985009|FG000|COMPLETED|Booster Dose Vaccination||53
9870964|NCT00981175|10985010|FG001|COMPLETED|Booster Dose Vaccination||40
9870965|NCT00981175|10985009|FG000|NOT COMPLETED|Booster Dose Vaccination||2
9870966|NCT00981175|10985010|FG001|NOT COMPLETED|Booster Dose Vaccination||3
9870967|NCT00981214|10985023|FG000|STARTED|Overall Study||19
9870968|NCT00981214|10985023|FG000|COMPLETED|Overall Study||19
9870969|NCT00981214|10985023|FG000|NOT COMPLETED|Overall Study||0
9870970|NCT00981227|10985033|FG000|STARTED|Overall Study||102
9870971|NCT00981227|10985034|FG001|STARTED|Overall Study||94
9870972|NCT00981227|10985035|FG002|STARTED|Overall Study||94
9870973|NCT00981227|10985036|FG003|STARTED|Overall Study||94
9870974|NCT00981227|10985037|FG004|STARTED|Overall Study||90
9870975|NCT00981227|10985038|FG005|STARTED|Overall Study||93
9870976|NCT00981227|10985033|FG000|Randomized|Overall Study||102
9870977|NCT00981227|10985034|FG001|Randomized|Overall Study||94
9870978|NCT00981227|10985035|FG002|Randomized|Overall Study||94
9870979|NCT00981227|10985036|FG003|Randomized|Overall Study||94
9870980|NCT00981227|10985037|FG004|Randomized|Overall Study||90
9870981|NCT00981227|10985038|FG005|Randomized|Overall Study||93
9870982|NCT00981227|10985033|FG000|Safety Population|Overall Study||102
9870983|NCT00981227|10985034|FG001|Safety Population|Overall Study||94
9870984|NCT00981227|10985035|FG002|Safety Population|Overall Study||94
9870985|NCT00981227|10985036|FG003|Safety Population|Overall Study||94
9870986|NCT00981227|10985037|FG004|Safety Population|Overall Study||90
10095756|NCT02359916|11224375|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10095757|NCT02359916|11224376|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10095758|NCT02359916|11224377|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10095759|NCT02359916|11224378|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10112992|NCT02506881|11243904|FG001|COMPLETED|Second Intervention (Day 1)||12
9870987|NCT00981227|10985038|FG005|Safety Population|Overall Study||93
9870988|NCT00981227|10985033|FG000|Per-Protocol|Overall Study||69
10095760|NCT02359916|11224372|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10095761|NCT02359916|11224373|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
9870989|NCT00981227|10985034|FG001|Per-Protocol|Overall Study||72
9870990|NCT00981227|10985035|FG002|Per-Protocol|Overall Study||67
9870991|NCT00981227|10985036|FG003|Per-Protocol|Overall Study||68
9870992|NCT00981227|10985037|FG004|Per-Protocol|Overall Study||50
9870993|NCT00981227|10985038|FG005|Per-Protocol|Overall Study||70
9870994|NCT00981227|10985033|FG000|COMPLETED|Overall Study||80
9870995|NCT00981227|10985034|FG001|COMPLETED|Overall Study||75
9870996|NCT00981227|10985035|FG002|COMPLETED|Overall Study||73
9870997|NCT00981227|10985036|FG003|COMPLETED|Overall Study||73
9870998|NCT00981227|10985037|FG004|COMPLETED|Overall Study||60
9870999|NCT00981227|10985038|FG005|COMPLETED|Overall Study||75
9871000|NCT00981227|10985033|FG000|NOT COMPLETED|Overall Study||22
9871001|NCT00981227|10985034|FG001|NOT COMPLETED|Overall Study||19
9871002|NCT00981227|10985035|FG002|NOT COMPLETED|Overall Study||21
9871003|NCT00981227|10985036|FG003|NOT COMPLETED|Overall Study||21
9871004|NCT00981227|10985037|FG004|NOT COMPLETED|Overall Study||30
9871005|NCT00981227|10985038|FG005|NOT COMPLETED|Overall Study||18
9871006|NCT00981253|10985058|FG000|STARTED|Overall Study||76
9871007|NCT00981253|10985059|FG001|STARTED|Overall Study||75
9871008|NCT00981253|10985058|FG000|COMPLETED|Overall Study||73
9871009|NCT00981253|10985059|FG001|COMPLETED|Overall Study||72
9871010|NCT00981253|10985058|FG000|NOT COMPLETED|Overall Study||3
9871011|NCT00981253|10985059|FG001|NOT COMPLETED|Overall Study||3
9871012|NCT00981292|10985072|FG000|STARTED|Day 1||7
10095762|NCT02359916|11224374|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10095763|NCT02359916|11224375|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10095764|NCT02359916|11224376|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10095765|NCT02359916|11224377|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10095766|NCT02359916|11224378|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
9871013|NCT00981292|10985073|FG001|STARTED|Day 1||4
9871014|NCT00981292|10985074|FG002|STARTED|Day 1||6
9871015|NCT00981292|10985075|FG003|STARTED|Day 1||4
9871016|NCT00981292|10985076|FG004|STARTED|Day 1||4
9871017|NCT00981292|10985077|FG005|STARTED|Day 1||7
9871018|NCT00981292|10985072|FG000|COMPLETED|Day 1||6
9871019|NCT00981292|10985073|FG001|COMPLETED|Day 1||4
9871020|NCT00981292|10985074|FG002|COMPLETED|Day 1||6
9871021|NCT00981292|10985075|FG003|COMPLETED|Day 1||4
9871022|NCT00981292|10985076|FG004|COMPLETED|Day 1||4
9871023|NCT00981292|10985077|FG005|COMPLETED|Day 1||5
9871024|NCT00981292|10985072|FG000|NOT COMPLETED|Day 1||1
9871025|NCT00981292|10985073|FG001|NOT COMPLETED|Day 1||0
9871026|NCT00981292|10985074|FG002|NOT COMPLETED|Day 1||0
9871027|NCT00981292|10985075|FG003|NOT COMPLETED|Day 1||0
9871028|NCT00981292|10985076|FG004|NOT COMPLETED|Day 1||0
9871029|NCT00981292|10985077|FG005|NOT COMPLETED|Day 1||2
9871030|NCT00981292|10985072|FG000|STARTED|Day 2||6
9871031|NCT00981292|10985073|FG001|STARTED|Day 2||4
9871032|NCT00981292|10985074|FG002|STARTED|Day 2||6
9871033|NCT00981292|10985075|FG003|STARTED|Day 2||4
9871034|NCT00981292|10985076|FG004|STARTED|Day 2||4
9871035|NCT00981292|10985077|FG005|STARTED|Day 2||5
9871036|NCT00981292|10985072|FG000|COMPLETED|Day 2||4
9871037|NCT00981292|10985073|FG001|COMPLETED|Day 2||4
9871038|NCT00981292|10985074|FG002|COMPLETED|Day 2||6
9871039|NCT00981292|10985075|FG003|COMPLETED|Day 2||4
9871040|NCT00981292|10985076|FG004|COMPLETED|Day 2||4
9871041|NCT00981292|10985077|FG005|COMPLETED|Day 2||5
9871042|NCT00981292|10985072|FG000|NOT COMPLETED|Day 2||2
9871043|NCT00981292|10985073|FG001|NOT COMPLETED|Day 2||0
9871044|NCT00981292|10985074|FG002|NOT COMPLETED|Day 2||0
9871045|NCT00981292|10985075|FG003|NOT COMPLETED|Day 2||0
9871046|NCT00981292|10985076|FG004|NOT COMPLETED|Day 2||0
9871047|NCT00981292|10985077|FG005|NOT COMPLETED|Day 2||0
9871048|NCT00981292|10985072|FG000|STARTED|Day 3||4
9871049|NCT00981292|10985073|FG001|STARTED|Day 3||4
9871050|NCT00981292|10985074|FG002|STARTED|Day 3||6
9871051|NCT00981292|10985075|FG003|STARTED|Day 3||4
9871052|NCT00981292|10985076|FG004|STARTED|Day 3||4
9871053|NCT00981292|10985077|FG005|STARTED|Day 3||5
9871054|NCT00981292|10985072|FG000|COMPLETED|Day 3||4
9871055|NCT00981292|10985073|FG001|COMPLETED|Day 3||4
9871056|NCT00981292|10985074|FG002|COMPLETED|Day 3||6
9871057|NCT00981292|10985075|FG003|COMPLETED|Day 3||4
9871058|NCT00981292|10985076|FG004|COMPLETED|Day 3||4
9871059|NCT00981292|10985077|FG005|COMPLETED|Day 3||4
9871060|NCT00981292|10985072|FG000|NOT COMPLETED|Day 3||0
9871061|NCT00981292|10985073|FG001|NOT COMPLETED|Day 3||0
9871062|NCT00981292|10985074|FG002|NOT COMPLETED|Day 3||0
9871063|NCT00981292|10985075|FG003|NOT COMPLETED|Day 3||0
9871064|NCT00981292|10985076|FG004|NOT COMPLETED|Day 3||0
9871065|NCT00981292|10985077|FG005|NOT COMPLETED|Day 3||1
9871066|NCT00981305|10985091|FG000|STARTED|Overall Study||69
9871067|NCT00981305|10985092|FG001|STARTED|Overall Study||67
9871068|NCT00981305|10985091|FG000|COMPLETED|Overall Study||50
9871069|NCT00981305|10985092|FG001|COMPLETED|Overall Study||57
9871070|NCT00981305|10985091|FG000|NOT COMPLETED|Overall Study||19
9871071|NCT00981305|10985092|FG001|NOT COMPLETED|Overall Study||10
9871072|NCT00981409|10985100|FG000|STARTED|Overall Study||30
9871073|NCT00981409|10985101|FG001|STARTED|Overall Study||11
9871074|NCT00981409|10985100|FG000|COMPLETED|Overall Study||24
9871075|NCT00981409|10985101|FG001|COMPLETED|Overall Study||10
9871076|NCT00981409|10985100|FG000|NOT COMPLETED|Overall Study||6
9871077|NCT00981409|10985101|FG001|NOT COMPLETED|Overall Study||1
9871078|NCT00981435|10985110|FG000|STARTED|Overall Study||31
9871079|NCT00981435|10985111|FG001|STARTED|Overall Study||29
9871080|NCT00981435|10985112|FG002|STARTED|Overall Study||37
9871081|NCT00981435|10985110|FG000|COMPLETED|Overall Study||31
9871082|NCT00981435|10985111|FG001|COMPLETED|Overall Study||29
9871083|NCT00981435|10985112|FG002|COMPLETED|Overall Study||37
9871084|NCT00981435|10985110|FG000|NOT COMPLETED|Overall Study||0
9871085|NCT00981435|10985111|FG001|NOT COMPLETED|Overall Study||0
9871086|NCT00981435|10985112|FG002|NOT COMPLETED|Overall Study||0
9871087|NCT00981461|10985122|FG000|STARTED|Overall Study||48
9871088|NCT00981461|10985123|FG001|STARTED|Overall Study||24
9871089|NCT00981461|10985122|FG000|COMPLETED|Overall Study||43
9871090|NCT00981461|10985123|FG001|COMPLETED|Overall Study||22
9871091|NCT00981461|10985122|FG000|NOT COMPLETED|Overall Study||5
10095767|NCT02359916|11224372|FG000|NOT COMPLETED|Overall Study||
10095768|NCT02359916|11224373|FG001|NOT COMPLETED|Overall Study||
10095769|NCT02359916|11224374|FG002|NOT COMPLETED|Overall Study||
10095770|NCT02359916|11224375|FG003|NOT COMPLETED|Overall Study||
10095771|NCT02359916|11224376|FG004|NOT COMPLETED|Overall Study||
10095772|NCT02359916|11224377|FG005|NOT COMPLETED|Overall Study||
9871092|NCT00981461|10985123|FG001|NOT COMPLETED|Overall Study||2
9871093|NCT00981474|10985131|FG000|STARTED|Overall Study||228
9871094|NCT00981474|10985132|FG001|STARTED|Overall Study||232
9871095|NCT00981474|10985131|FG000|COMPLETED|Overall Study||228
9871096|NCT00981474|10985132|FG001|COMPLETED|Overall Study||232
9871097|NCT00981474|10985131|FG000|NOT COMPLETED|Overall Study||0
9871098|NCT00981474|10985132|FG001|NOT COMPLETED|Overall Study||0
9871099|NCT00981526|10985142|FG000|STARTED|Overall Study||26
9871100|NCT00981526|10985143|FG001|STARTED|Overall Study||28
10095773|NCT02359916|11224378|FG006|NOT COMPLETED|Overall Study||
10095774|NCT02359955|11224395|FG000|STARTED|Overall Study||10
10095775|NCT02359955|11224396|FG001|STARTED|Overall Study||10
10095776|NCT02359955|11224395|FG000|COMPLETED|Overall Study||10
10095777|NCT02359955|11224396|FG001|COMPLETED|Overall Study||10
10095778|NCT02359955|11224395|FG000|NOT COMPLETED|Overall Study||0
10095779|NCT02359955|11224396|FG001|NOT COMPLETED|Overall Study||0
10095780|NCT02360085|11224412|FG000|STARTED|Overall Study||65
10095781|NCT02360085|11224412|FG000|COMPLETED|Overall Study||49
10095782|NCT02360085|11224412|FG000|NOT COMPLETED|Overall Study||16
10095783|NCT02360098|11224425|FG000|STARTED|Overall Study||36
10095784|NCT02360098|11224425|FG000|COMPLETED|Overall Study||29
10095785|NCT02360098|11224425|FG000|NOT COMPLETED|Overall Study||7
10095786|NCT02360124|11224433|FG000|STARTED|Overall Study||108
10095787|NCT02360124|11224434|FG001|STARTED|Overall Study||107
10095788|NCT02360124|11224435|FG002|STARTED|Overall Study||108
10095789|NCT02360124|11224433|FG000|COMPLETED|Overall Study||80
10095790|NCT02360124|11224434|FG001|COMPLETED|Overall Study||95
10095791|NCT02360124|11224435|FG002|COMPLETED|Overall Study||82
10095792|NCT02360124|11224433|FG000|NOT COMPLETED|Overall Study||28
10095793|NCT02360124|11224434|FG001|NOT COMPLETED|Overall Study||12
10095794|NCT02360124|11224435|FG002|NOT COMPLETED|Overall Study||26
10095795|NCT02360215|11224447|FG000|STARTED|Overall Study||257
10095796|NCT02360215|11224448|FG001|STARTED|Overall Study||261
10095797|NCT02360215|11224447|FG000|All Randomized Participants|Overall Study||257
10095798|NCT02360215|11224448|FG001|All Randomized Participants|Overall Study||261
10095799|NCT02360215|11224447|FG000|Started Protocol Treatment|Overall Study||232
10095800|NCT02360215|11224448|FG001|Started Protocol Treatment|Overall Study||223
10095801|NCT02360215|11224447|FG000|MDASI-BT Symptom Score|Overall Study||249
10095802|NCT02360215|11224448|FG001|MDASI-BT Symptom Score|Overall Study||251
10095803|NCT02360215|11224447|FG000|MDASI-BT Intererence Score|Overall Study||248
10095804|NCT02360215|11224448|FG001|MDASI-BT Intererence Score|Overall Study||251
10095805|NCT02360215|11224447|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249
10095806|NCT02360215|11224448|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251
10095807|NCT02360215|11224447|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249
10095808|NCT02360215|11224448|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251
10095809|NCT02360215|11224447|FG000|HVLT-R Total Recall|Overall Study||256
10095810|NCT02360215|11224448|FG001|HVLT-R Total Recall|Overall Study||259
10095811|NCT02360215|11224447|FG000|HVLT-R Delayed Recall|Overall Study||256
10095812|NCT02360215|11224448|FG001|HVLT-R Delayed Recall|Overall Study||259
10095813|NCT02360215|11224447|FG000|HVLT-R Recognition|Overall Study||255
10095814|NCT02360215|11224448|FG001|HVLT-R Recognition|Overall Study||259
10095815|NCT02360215|11224447|FG000|Trail Making Test (TMT) Part A|Overall Study||256
10095816|NCT02360215|11224448|FG001|Trail Making Test (TMT) Part A|Overall Study||260
10095817|NCT02360215|11224447|FG000|TMT Part B|Overall Study||250
10095818|NCT02360215|11224448|FG001|TMT Part B|Overall Study||257
10095819|NCT02360215|11224447|FG000|Controlled Oral Word Association (COWA)|Overall Study||257
10095820|NCT02360215|11224448|FG001|Controlled Oral Word Association (COWA)|Overall Study||261
10095821|NCT02360215|11224447|FG000|Clinical Trial Battery Composite Score|Overall Study||255
10095822|NCT02360215|11224448|FG001|Clinical Trial Battery Composite Score|Overall Study||259
10095823|NCT02360215|11224447|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142
10095824|NCT02360215|11224448|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125
10095825|NCT02360215|11224447|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110
9871101|NCT00981526|10985142|FG000|COMPLETED|Overall Study||22
9871102|NCT00981526|10985143|FG001|COMPLETED|Overall Study||22
9871103|NCT00981526|10985142|FG000|NOT COMPLETED|Overall Study||4
9871104|NCT00981526|10985143|FG001|NOT COMPLETED|Overall Study||6
9871105|NCT00981578|10985151|FG000|STARTED|Overall Study||17
9871106|NCT00981578|10985151|FG000|COMPLETED|Overall Study||14
9871107|NCT00981578|10985151|FG000|NOT COMPLETED|Overall Study||3
9871108|NCT00981630|10985159|FG000|STARTED|Overall Study||32
9871109|NCT00981630|10985160|FG001|STARTED|Overall Study||32
9871110|NCT00981630|10985161|FG002|STARTED|Overall Study||32
9871111|NCT00981630|10985162|FG003|STARTED|Overall Study||32
9871112|NCT00981630|10985159|FG000|COMPLETED|Overall Study||32
9871113|NCT00981630|10985160|FG001|COMPLETED|Overall Study||32
9871114|NCT00981630|10985161|FG002|COMPLETED|Overall Study||32
9871115|NCT00981630|10985162|FG003|COMPLETED|Overall Study||32
9871116|NCT00981630|10985159|FG000|NOT COMPLETED|Overall Study||0
9871117|NCT00981630|10985160|FG001|NOT COMPLETED|Overall Study||0
9871118|NCT00981630|10985161|FG002|NOT COMPLETED|Overall Study||0
9871119|NCT00981630|10985162|FG003|NOT COMPLETED|Overall Study||0
9871120|NCT00981669|10985174|FG000|STARTED|Overall Study||40
9871121|NCT00981669|10985175|FG001|STARTED|Overall Study||40
9871122|NCT00981669|10985174|FG000|COMPLETED|Overall Study||39
9871123|NCT00981669|10985175|FG001|COMPLETED|Overall Study||40
9871124|NCT00981669|10985174|FG000|NOT COMPLETED|Overall Study||1
9871125|NCT00981669|10985175|FG001|NOT COMPLETED|Overall Study||0
9871126|NCT00981682|10985181|FG000|STARTED|Overall Study||376
9871127|NCT00981682|10985181|FG000|COMPLETED|Overall Study||234
9871128|NCT00981682|10985181|FG000|NOT COMPLETED|Overall Study||142
10095826|NCT02360215|11224448|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96
10095827|NCT02360215|11224447|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79
10095828|NCT02360215|11224448|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70
10095829|NCT02360215|11224447|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56
10095830|NCT02360215|11224448|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45
10095831|NCT02360215|11224447|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139
10095832|NCT02360215|11224448|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123
10095833|NCT02360215|11224447|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104
10095834|NCT02360215|11224448|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193
10095835|NCT02360215|11224447|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76
10095836|NCT02360215|11224448|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69
10095837|NCT02360215|11224447|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57
9871129|NCT00981747|10985185|FG000|STARTED|Losartan||12
9871130|NCT00981747|10985185|FG000|Started Losartan|Losartan||12
9871131|NCT00981747|10985185|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
9871132|NCT00981747|10985185|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
9871133|NCT00981747|10985185|FG000|NOT COMPLETED|Losartan||2
9871134|NCT00981747|10985185|FG000|STARTED|Placebo Oral Tablet||10
9871135|NCT00981747|10985185|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10
9871136|NCT00981747|10985185|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
9871137|NCT00981747|10985185|FG000|COMPLETED|Placebo Oral Tablet||9
9871138|NCT00981747|10985185|FG000|NOT COMPLETED|Placebo Oral Tablet||1
9871139|NCT00981747|10985185|FG000|STARTED|Sildenafil||9
9871140|NCT00981747|10985185|FG000|Started Sildenafil|Sildenafil||9
9871141|NCT00981747|10985185|FG000|Completed Sildenafil|Sildenafil||9
9871142|NCT00981747|10985185|FG000|COMPLETED|Sildenafil||9
9871143|NCT00981747|10985185|FG000|NOT COMPLETED|Sildenafil||0
9871144|NCT00981747|10985185|FG000|STARTED|Sildenafil and Losartan||9
9871145|NCT00981747|10985185|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9
9871146|NCT00981747|10985185|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
9871147|NCT00981747|10985185|FG000|COMPLETED|Sildenafil and Losartan||9
9871148|NCT00981747|10985185|FG000|NOT COMPLETED|Sildenafil and Losartan||0
9871149|NCT00981799|10985199|FG000|STARTED|Overall Study||6
9871150|NCT00981799|10985200|FG001|STARTED|Overall Study||7
9871151|NCT00981799|10985201|FG002|STARTED|Overall Study||10
9871152|NCT00981799|10985202|FG003|STARTED|Overall Study||0
9871153|NCT00981799|10985199|FG000|COMPLETED|Overall Study||5
9871154|NCT00981799|10985200|FG001|COMPLETED|Overall Study||6
9871155|NCT00981799|10985201|FG002|COMPLETED|Overall Study||10
9871156|NCT00981799|10985202|FG003|COMPLETED|Overall Study||0
9871157|NCT00981799|10985199|FG000|NOT COMPLETED|Overall Study||1
9871158|NCT00981799|10985200|FG001|NOT COMPLETED|Overall Study||1
9871159|NCT00981799|10985201|FG002|NOT COMPLETED|Overall Study||0
9871160|NCT00981799|10985202|FG003|NOT COMPLETED|Overall Study||0
9871161|NCT00981812|10985213|FG000|STARTED|Overall Study||20
9871162|NCT00981812|10985213|FG000|COMPLETED|Overall Study||20
9871163|NCT00981812|10985213|FG000|NOT COMPLETED|Overall Study||0
9871164|NCT00981825|10985219|FG000|STARTED|First Intervention||11
9871165|NCT00981825|10985220|FG001|STARTED|First Intervention||11
9871166|NCT00981825|10985219|FG000|COMPLETED|First Intervention||11
10095838|NCT02360215|11224448|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48
9871167|NCT00981825|10985220|FG001|COMPLETED|First Intervention||11
9871168|NCT00981825|10985219|FG000|NOT COMPLETED|First Intervention||0
9871169|NCT00981825|10985220|FG001|NOT COMPLETED|First Intervention||0
9871170|NCT00981825|10985219|FG000|STARTED|Washout After 1st Intervention||11
9871171|NCT00981825|10985220|FG001|STARTED|Washout After 1st Intervention||11
9871172|NCT00981825|10985219|FG000|COMPLETED|Washout After 1st Intervention||11
10095839|NCT02360215|11224447|FG000|COMPLETED|Overall Study||257
10095840|NCT02360215|11224448|FG001|COMPLETED|Overall Study||261
9871173|NCT00981825|10985220|FG001|COMPLETED|Washout After 1st Intervention||11
9871174|NCT00981825|10985219|FG000|NOT COMPLETED|Washout After 1st Intervention||0
9871175|NCT00981825|10985220|FG001|NOT COMPLETED|Washout After 1st Intervention||0
9871176|NCT00981825|10985219|FG000|STARTED|Second Intervention||11
9871177|NCT00981825|10985220|FG001|STARTED|Second Intervention||11
9871178|NCT00981825|10985219|FG000|COMPLETED|Second Intervention||11
9871179|NCT00981825|10985220|FG001|COMPLETED|Second Intervention||11
9871180|NCT00981825|10985219|FG000|NOT COMPLETED|Second Intervention||0
9871181|NCT00981825|10985220|FG001|NOT COMPLETED|Second Intervention||0
10095841|NCT02360215|11224447|FG000|NOT COMPLETED|Overall Study||0
10095842|NCT02360215|11224448|FG001|NOT COMPLETED|Overall Study||0
10095843|NCT02360228|11224458|FG000|STARTED|Overall Study||9
10095844|NCT02360228|11224459|FG001|STARTED|Overall Study||8
10095845|NCT02360228|11224460|FG002|STARTED|Overall Study||8
10095846|NCT02360228|11224458|FG000|COMPLETED|Overall Study||8
10095847|NCT02360228|11224459|FG001|COMPLETED|Overall Study||7
10095848|NCT02360228|11224460|FG002|COMPLETED|Overall Study||7
10095849|NCT02360228|11224458|FG000|NOT COMPLETED|Overall Study||1
10095850|NCT02360228|11224459|FG001|NOT COMPLETED|Overall Study||1
10095851|NCT02360228|11224460|FG002|NOT COMPLETED|Overall Study||1
10095852|NCT02360293|11224470|FG000|STARTED|Overall Study||178
9871182|NCT00982007|10985230|FG000|STARTED|Overall Study||250
9871183|NCT00982007|10985231|FG001|STARTED|Overall Study||257
9871184|NCT00982007|10985232|FG002|STARTED|Overall Study||253
9871185|NCT00982007|10985233|FG003|STARTED|Overall Study||251
9871186|NCT00982007|10985230|FG000|COMPLETED|Overall Study||246
9871187|NCT00982007|10985231|FG001|COMPLETED|Overall Study||253
9871188|NCT00982007|10985232|FG002|COMPLETED|Overall Study||253
9871189|NCT00982007|10985233|FG003|COMPLETED|Overall Study||245
9871190|NCT00982007|10985230|FG000|NOT COMPLETED|Overall Study||4
9871191|NCT00982007|10985231|FG001|NOT COMPLETED|Overall Study||4
9871192|NCT00982007|10985232|FG002|NOT COMPLETED|Overall Study||0
9871193|NCT00982007|10985233|FG003|NOT COMPLETED|Overall Study||6
9871194|NCT00982020|10985245|FG000|STARTED|Overall Study||102
9871195|NCT00982020|10985246|FG001|STARTED|Overall Study||101
9871196|NCT00982020|10985245|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102
9871197|NCT00982020|10985246|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
9871198|NCT00982020|10985245|FG000|COMPLETED|Overall Study||45
9871199|NCT00982020|10985246|FG001|COMPLETED|Overall Study||37
9871200|NCT00982020|10985245|FG000|NOT COMPLETED|Overall Study||57
9871201|NCT00982020|10985246|FG001|NOT COMPLETED|Overall Study||64
9871202|NCT00982033|10985259|FG000|STARTED|Overall Study||25
9871203|NCT00982033|10985260|FG001|STARTED|Overall Study||27
9871204|NCT00982033|10985259|FG000|COMPLETED|Overall Study||25
9871205|NCT00982033|10985260|FG001|COMPLETED|Overall Study||27
9871206|NCT00982033|10985259|FG000|NOT COMPLETED|Overall Study||0
9871207|NCT00982033|10985260|FG001|NOT COMPLETED|Overall Study||0
9871208|NCT00982072|10985268|FG000|STARTED|Overall Study||25
9871209|NCT00982072|10985269|FG001|STARTED|Overall Study||27
9871210|NCT00982072|10985268|FG000|COMPLETED|Overall Study||25
9871211|NCT00982072|10985269|FG001|COMPLETED|Overall Study||25
9871212|NCT00982072|10985268|FG000|NOT COMPLETED|Overall Study||0
9871213|NCT00982072|10985269|FG001|NOT COMPLETED|Overall Study||2
9871214|NCT00982137|10985279|FG000|STARTED|Overall Study||36
9871215|NCT00982137|10985280|FG001|STARTED|Overall Study||36
9871216|NCT00982137|10985281|FG002|STARTED|Overall Study||18
9871217|NCT00982137|10985282|FG003|STARTED|Overall Study||18
9871218|NCT00982137|10985279|FG000|COMPLETED|Overall Study||36
9871219|NCT00982137|10985280|FG001|COMPLETED|Overall Study||35
9871220|NCT00982137|10985281|FG002|COMPLETED|Overall Study||18
9871221|NCT00982137|10985282|FG003|COMPLETED|Overall Study||17
9871222|NCT00982137|10985279|FG000|NOT COMPLETED|Overall Study||0
9871223|NCT00982137|10985280|FG001|NOT COMPLETED|Overall Study||1
9871224|NCT00982137|10985281|FG002|NOT COMPLETED|Overall Study||0
9871225|NCT00982137|10985282|FG003|NOT COMPLETED|Overall Study||1
9871226|NCT00982189|10985303|FG000|STARTED|Overall Study||10
9871227|NCT00982189|10985304|FG001|STARTED|Overall Study||9
9871228|NCT00982189|10985305|FG002|STARTED|Overall Study||9
9871229|NCT00982189|10985306|FG003|STARTED|Overall Study||9
9871230|NCT00982189|10985303|FG000|COMPLETED|Overall Study||10
9871231|NCT00982189|10985304|FG001|COMPLETED|Overall Study||9
9871232|NCT00982189|10985305|FG002|COMPLETED|Overall Study||9
9871233|NCT00982189|10985306|FG003|COMPLETED|Overall Study||9
9871234|NCT00982189|10985303|FG000|NOT COMPLETED|Overall Study||0
9871235|NCT00982189|10985304|FG001|NOT COMPLETED|Overall Study||0
9871236|NCT00982189|10985305|FG002|NOT COMPLETED|Overall Study||0
9871237|NCT00982189|10985306|FG003|NOT COMPLETED|Overall Study||0
9871238|NCT00982228|10985320|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
9871239|NCT00982228|10985321|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
9871240|NCT00982228|10985320|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
9871241|NCT00982228|10985321|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
9871242|NCT00982228|10985320|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
9871243|NCT00982228|10985321|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
9871244|NCT00982228|10985320|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
9871245|NCT00982228|10985321|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
9871246|NCT00982228|10985320|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
9871247|NCT00982228|10985321|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
9871248|NCT00982228|10985320|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
9871249|NCT00982228|10985321|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
10095853|NCT02360293|11224471|FG001|STARTED|Overall Study||179
9871250|NCT00982228|10985320|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
9871251|NCT00982228|10985321|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
9871252|NCT00982228|10985320|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
9871253|NCT00982228|10985321|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
9871254|NCT00982280|10985327|FG000|STARTED|Observation Period||82
9871255|NCT00982280|10985327|FG000|COMPLETED|Observation Period||63
9871256|NCT00982280|10985327|FG000|NOT COMPLETED|Observation Period||19
9871257|NCT00982280|10985327|FG000|STARTED|Titration and Optimal Dose Period||63
9871258|NCT00982280|10985327|FG000|COMPLETED|Titration and Optimal Dose Period||55
9871259|NCT00982280|10985327|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8
9871260|NCT00982280|10985327|FG000|STARTED|Maintenance Period||55
9871261|NCT00982280|10985327|FG000|COMPLETED|Maintenance Period||54
9871262|NCT00982280|10985327|FG000|NOT COMPLETED|Maintenance Period||1
9871263|NCT00982319|10985334|FG000|STARTED|Overall Study||17
9871264|NCT00982319|10985335|FG001|STARTED|Overall Study||17
9871265|NCT00982319|10985334|FG000|COMPLETED|Overall Study||15
9871266|NCT00982319|10985335|FG001|COMPLETED|Overall Study||15
9871267|NCT00982319|10985334|FG000|NOT COMPLETED|Overall Study||2
9871268|NCT00982319|10985335|FG001|NOT COMPLETED|Overall Study||2
9871269|NCT00982345|10985341|FG000|STARTED|Overall Study||20
9871270|NCT00982345|10985341|FG000|COMPLETED|Overall Study||18
9871271|NCT00982345|10985341|FG000|NOT COMPLETED|Overall Study||2
9871272|NCT00982397|10985347|FG000|STARTED|Phase I||236
9871273|NCT00982397|10985348|FG001|STARTED|Phase I||0
9871274|NCT00982397|10985347|FG000|COMPLETED|Phase I||236
9871275|NCT00982397|10985348|FG001|COMPLETED|Phase I||0
9871276|NCT00982397|10985347|FG000|NOT COMPLETED|Phase I||0
9871277|NCT00982397|10985348|FG001|NOT COMPLETED|Phase I||0
9871278|NCT00982397|10985347|FG000|STARTED|Phase II/Overall Study||2019
9871279|NCT00982397|10985348|FG001|STARTED|Phase II/Overall Study||751
9871280|NCT00982397|10985347|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
9871281|NCT00982397|10985348|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
9871282|NCT00982397|10985347|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
9871283|NCT00982397|10985348|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
9871284|NCT00982397|10985347|FG000|COMPLETED|Phase II/Overall Study||2019
9871285|NCT00982397|10985348|FG001|COMPLETED|Phase II/Overall Study||751
9871286|NCT00982397|10985347|FG000|NOT COMPLETED|Phase II/Overall Study||0
9871287|NCT00982397|10985348|FG001|NOT COMPLETED|Phase II/Overall Study||0
10095854|NCT02360293|11224470|FG000|6month f/u Survey|Overall Study||110
10095855|NCT02360293|11224471|FG001|6month f/u Survey|Overall Study||105
10095856|NCT02360293|11224470|FG000|6month Physical Activity|Overall Study||122
10095857|NCT02360293|11224471|FG001|6month Physical Activity|Overall Study||108
10095858|NCT02360293|11224470|FG000|12month f/u Survey|Overall Study||102
10095859|NCT02360293|11224471|FG001|12month f/u Survey|Overall Study||83
9871288|NCT00982410|10985359|FG000|STARTED|3-month Follow-up Assessment||65
9871289|NCT00982410|10985360|FG001|STARTED|3-month Follow-up Assessment||66
9871290|NCT00982410|10985359|FG000|COMPLETED|3-month Follow-up Assessment||56
9871291|NCT00982410|10985360|FG001|COMPLETED|3-month Follow-up Assessment||53
9871292|NCT00982410|10985359|FG000|NOT COMPLETED|3-month Follow-up Assessment||9
9871293|NCT00982410|10985360|FG001|NOT COMPLETED|3-month Follow-up Assessment||13
9871294|NCT00982410|10985359|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
10095860|NCT02360293|11224470|FG000|12month Physical Activity|Overall Study||68
10095861|NCT02360293|11224471|FG001|12month Physical Activity|Overall Study||59
10095862|NCT02360293|11224470|FG000|COMPLETED|Overall Study||102
10095863|NCT02360293|11224471|FG001|COMPLETED|Overall Study||83
10095864|NCT02360293|11224470|FG000|NOT COMPLETED|Overall Study||76
10095865|NCT02360293|11224471|FG001|NOT COMPLETED|Overall Study||96
10095866|NCT02360319|11224479|FG000|STARTED|Overall Study||255
10095867|NCT02360319|11224480|FG001|STARTED|Overall Study||234
10095868|NCT02360319|11224479|FG000|COMPLETED|Overall Study||167
10095869|NCT02360319|11224480|FG001|COMPLETED|Overall Study||173
10095870|NCT02360319|11224479|FG000|NOT COMPLETED|Overall Study||88
10095871|NCT02360319|11224480|FG001|NOT COMPLETED|Overall Study||61
10095872|NCT02360371|11224488|FG000|STARTED|Overall Study||13
10095873|NCT02360371|11224489|FG001|STARTED|Overall Study||84
10095874|NCT02360371|11224488|FG000|Placebo (Oral)|Overall Study||13
10095875|NCT02360371|11224489|FG001|Placebo (Oral)|Overall Study||69
10095876|NCT02360371|11224488|FG000|Hydromorphone (Oral) 2mg|Overall Study||13
10095877|NCT02360371|11224489|FG001|Hydromorphone (Oral) 2mg|Overall Study||69
9871295|NCT00982410|10985360|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
10095878|NCT02360371|11224488|FG000|Hydromorphone (Oral) 4mg|Overall Study||13
10095879|NCT02360371|11224489|FG001|Hydromorphone (Oral) 4mg|Overall Study||69
10095880|NCT02360371|11224488|FG000|Hydromorphone (Oral) 8mg|Overall Study||13
10095881|NCT02360371|11224489|FG001|Hydromorphone (Oral) 8mg|Overall Study||69
10095882|NCT02360371|11224488|FG000|COMPLETED|Overall Study||13
10095883|NCT02360371|11224489|FG001|COMPLETED|Overall Study||69
10095884|NCT02360371|11224488|FG000|NOT COMPLETED|Overall Study||0
10095885|NCT02360371|11224489|FG001|NOT COMPLETED|Overall Study||15
10095886|NCT02360397|11224499|FG000|STARTED|Overall Study||6
9871296|NCT00982410|10985359|FG000|COMPLETED|6-month Follow-up Assessment||59
9871297|NCT00982410|10985360|FG001|COMPLETED|6-month Follow-up Assessment||53
9871298|NCT00982410|10985359|FG000|NOT COMPLETED|6-month Follow-up Assessment||6
9871299|NCT00982410|10985360|FG001|NOT COMPLETED|6-month Follow-up Assessment||11
9957087|NCT01449370|11076237|FG002|NOT COMPLETED|Overall Study||8
9871300|NCT00982410|10985359|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
9871301|NCT00982410|10985360|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
9871302|NCT00982410|10985359|FG000|COMPLETED|12-month Follow-up Assessment||56
9871303|NCT00982410|10985360|FG001|COMPLETED|12-month Follow-up Assessment||55
9871304|NCT00982410|10985359|FG000|NOT COMPLETED|12-month Follow-up Assessment||9
9871305|NCT00982410|10985360|FG001|NOT COMPLETED|12-month Follow-up Assessment||9
9871306|NCT00982423|10985369|FG000|STARTED|Overall Study||13
9871307|NCT00982423|10985370|FG001|STARTED|Overall Study||19
9871308|NCT00982423|10985369|FG000|COMPLETED|Overall Study||13
9871309|NCT00982423|10985370|FG001|COMPLETED|Overall Study||19
9871310|NCT00982423|10985369|FG000|NOT COMPLETED|Overall Study||0
9871311|NCT00982423|10985370|FG001|NOT COMPLETED|Overall Study||0
9871312|NCT00982488|10985382|FG000|STARTED|Overall Study|Received treatment|185
9871313|NCT00982488|10985383|FG001|STARTED|Overall Study|Received treatment|14
9871314|NCT00982488|10985384|FG002|STARTED|Overall Study|Received treatment|34
9871315|NCT00982488|10985385|FG003|STARTED|Overall Study|Received treatment|3
9871316|NCT00982488|10985386|FG004|STARTED|Overall Study|Received treatment|1
9871317|NCT00982488|10985382|FG000|COMPLETED|Overall Study|Still receiving treatment|0
9871318|NCT00982488|10985383|FG001|COMPLETED|Overall Study|Still receiving treatment|0
9871319|NCT00982488|10985384|FG002|COMPLETED|Overall Study|Still receiving treatment|0
9871320|NCT00982488|10985385|FG003|COMPLETED|Overall Study|Still receiving treatment|0
9871321|NCT00982488|10985386|FG004|COMPLETED|Overall Study|Still receiving treatment|0
9871322|NCT00982488|10985382|FG000|NOT COMPLETED|Overall Study||185
9871323|NCT00982488|10985383|FG001|NOT COMPLETED|Overall Study||14
9871324|NCT00982488|10985384|FG002|NOT COMPLETED|Overall Study||34
9871325|NCT00982488|10985385|FG003|NOT COMPLETED|Overall Study||3
9871326|NCT00982488|10985386|FG004|NOT COMPLETED|Overall Study||1
9871327|NCT00982553|10985398|FG000|STARTED|Phase1||14
9871328|NCT00982553|10985398|FG000|COMPLETED|Phase1||14
9871329|NCT00982553|10985398|FG000|NOT COMPLETED|Phase1||0
9871330|NCT00982553|10985398|FG000|STARTED|Phase2||14
9871331|NCT00982553|10985398|FG000|COMPLETED|Phase2||14
9871332|NCT00982553|10985398|FG000|NOT COMPLETED|Phase2||0
9871333|NCT00982553|10985398|FG000|STARTED|Phase3||14
9871334|NCT00982553|10985398|FG000|COMPLETED|Phase3||14
9871335|NCT00982553|10985398|FG000|NOT COMPLETED|Phase3||0
9871336|NCT00982592|10985409|FG000|STARTED|Overall Study||64
9871337|NCT00982592|10985410|FG001|STARTED|Overall Study||60
9871338|NCT00982592|10985409|FG000|Treatment Received|Overall Study||63
9871339|NCT00982592|10985410|FG001|Treatment Received|Overall Study||52
9871340|NCT00982592|10985409|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
9871341|NCT00982592|10985410|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
9871342|NCT00982592|10985409|FG000|NOT COMPLETED|Overall Study||31
9871343|NCT00982592|10985410|FG001|NOT COMPLETED|Overall Study||33
9871344|NCT00982644|10985418|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
9871345|NCT00982644|10985419|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
9871346|NCT00982644|10985418|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
9871347|NCT00982644|10985419|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
9871348|NCT00982644|10985418|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
9871349|NCT00982644|10985419|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
9871350|NCT00982644|10985418|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
9871351|NCT00982644|10985419|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
9871352|NCT00982644|10985418|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
9871353|NCT00982644|10985419|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
9871354|NCT00982644|10985418|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
9871355|NCT00982644|10985419|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
9871356|NCT00982644|10985418|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
9871357|NCT00982644|10985419|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
9871358|NCT00982644|10985418|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
9871359|NCT00982644|10985419|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
9871360|NCT00982657|10985429|FG000|STARTED|Overall Study||12
9871361|NCT00982657|10985430|FG001|STARTED|Overall Study||3
9871362|NCT00982657|10985431|FG002|STARTED|Overall Study||3
9871363|NCT00982657|10985432|FG003|STARTED|Overall Study||16
9871364|NCT00982657|10985429|FG000|COMPLETED|Overall Study||11
9871365|NCT00982657|10985430|FG001|COMPLETED|Overall Study||3
9871366|NCT00982657|10985431|FG002|COMPLETED|Overall Study||1
9871367|NCT00982657|10985432|FG003|COMPLETED|Overall Study||7
9871368|NCT00982657|10985429|FG000|NOT COMPLETED|Overall Study||1
9871369|NCT00982657|10985430|FG001|NOT COMPLETED|Overall Study||0
9871370|NCT00982657|10985431|FG002|NOT COMPLETED|Overall Study||2
9871371|NCT00982657|10985432|FG003|NOT COMPLETED|Overall Study||9
9871372|NCT00982735|10985452|FG000|STARTED|Overall Study||987
9871373|NCT00982735|10985452|FG000|COMPLETED|Overall Study||757
9871374|NCT00982735|10985452|FG000|NOT COMPLETED|Overall Study||230
9871375|NCT00982865|10985460|FG000|STARTED|Overall Study||49
9871376|NCT00982865|10985461|FG001|STARTED|Overall Study||82
9871377|NCT00982865|10985462|FG002|STARTED|Overall Study||15
9871378|NCT00982865|10985463|FG003|STARTED|Overall Study||34
9871379|NCT00982865|10985460|FG000|COMPLETED|Overall Study||49
9871380|NCT00982865|10985461|FG001|COMPLETED|Overall Study||82
9871381|NCT00982865|10985462|FG002|COMPLETED|Overall Study||15
9871382|NCT00982865|10985463|FG003|COMPLETED|Overall Study||34
9871383|NCT00982865|10985460|FG000|NOT COMPLETED|Overall Study||0
9871384|NCT00982865|10985461|FG001|NOT COMPLETED|Overall Study||0
9871385|NCT00982865|10985462|FG002|NOT COMPLETED|Overall Study||0
9871386|NCT00982865|10985463|FG003|NOT COMPLETED|Overall Study||0
9871387|NCT00982878|10985510|FG000|STARTED|Overall Study||13
9871388|NCT00982878|10985510|FG000|COMPLETED|Overall Study||12
9871389|NCT00982878|10985510|FG000|NOT COMPLETED|Overall Study||1
9871390|NCT00982930|10985514|FG000|STARTED|Overall Study||55
9871391|NCT00982930|10985514|FG000|COMPLETED|Overall Study||51
9871392|NCT00982930|10985514|FG000|NOT COMPLETED|Overall Study||4
9871393|NCT00983073|10985518|FG000|STARTED|Observation Period||224
9871394|NCT00983073|10985518|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
9871395|NCT00983073|10985518|FG000|NOT COMPLETED|Observation Period||24
9871396|NCT00983073|10985518|FG000|STARTED|Titration and Optimal Dose Period||200
9871397|NCT00983073|10985518|FG000|COMPLETED|Titration and Optimal Dose Period||160
9871398|NCT00983073|10985518|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40
9871399|NCT00983073|10985518|FG000|STARTED|Maintenance Period||160
9871400|NCT00983073|10985518|FG000|COMPLETED|Maintenance Period||144
9871401|NCT00983073|10985518|FG000|NOT COMPLETED|Maintenance Period||16
9871402|NCT00983216|10985523|FG000|STARTED|Colchicine Alone||24
9871403|NCT00983216|10985523|FG000|COMPLETED|Colchicine Alone||24
9871404|NCT00983216|10985523|FG000|NOT COMPLETED|Colchicine Alone||0
9871405|NCT00983216|10985523|FG000|STARTED|14 Day Washout Period||24
9871406|NCT00983216|10985523|FG000|COMPLETED|14 Day Washout Period||24
9871407|NCT00983216|10985523|FG000|NOT COMPLETED|14 Day Washout Period||0
9871408|NCT00983216|10985523|FG000|STARTED|Ketoconazole Alone||24
9871409|NCT00983216|10985523|FG000|COMPLETED|Ketoconazole Alone||24
9871410|NCT00983216|10985523|FG000|NOT COMPLETED|Ketoconazole Alone||0
9871411|NCT00983216|10985523|FG000|STARTED|Colchicine With Ketoconazole||24
9871412|NCT00983216|10985523|FG000|COMPLETED|Colchicine With Ketoconazole||24
9871413|NCT00983216|10985523|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0
9871414|NCT00983242|10985530|FG000|STARTED|Colchicine Alone||24
9871415|NCT00983242|10985530|FG000|COMPLETED|Colchicine Alone||24
9871416|NCT00983242|10985530|FG000|NOT COMPLETED|Colchicine Alone||0
9871417|NCT00983242|10985530|FG000|STARTED|14 Day Washout Period||24
9871418|NCT00983242|10985530|FG000|COMPLETED|14 Day Washout Period||24
9871419|NCT00983242|10985530|FG000|NOT COMPLETED|14 Day Washout Period||0
9871420|NCT00983242|10985530|FG000|STARTED|Verapamil HCl ER Alone||24
9871421|NCT00983242|10985530|FG000|COMPLETED|Verapamil HCl ER Alone||24
9871422|NCT00983242|10985530|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0
9871423|NCT00983242|10985530|FG000|STARTED|Colchicine With Verapamil HCl ER||24
9871424|NCT00983242|10985530|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24
10095887|NCT02360397|11224499|FG000|COMPLETED|Overall Study||2
10095888|NCT02360397|11224499|FG000|NOT COMPLETED|Overall Study||4
10095889|NCT02360475|11224508|FG000|STARTED|Overall Study||126
10095890|NCT02360475|11224509|FG001|STARTED|Overall Study||124
9758609|NCT02271230|10862179|FG000|STARTED|Overall Study||6463
9758610|NCT02271230|10862180|FG001|STARTED|Overall Study||6464
9758611|NCT02271230|10862181|FG002|STARTED|Overall Study||6470
9758612|NCT02271230|10862182|FG003|STARTED|Overall Study||6474
9758613|NCT02271230|10862179|FG000|COMPLETED|Overall Study||6463
9758614|NCT02271230|10862180|FG001|COMPLETED|Overall Study||6464
9758615|NCT02271230|10862181|FG002|COMPLETED|Overall Study||6470
9758616|NCT02271230|10862182|FG003|COMPLETED|Overall Study||6474
9758617|NCT02271230|10862179|FG000|NOT COMPLETED|Overall Study||0
9758618|NCT02271230|10862180|FG001|NOT COMPLETED|Overall Study||0
9758619|NCT02271230|10862181|FG002|NOT COMPLETED|Overall Study||0
9758620|NCT02271230|10862182|FG003|NOT COMPLETED|Overall Study||0
9758621|NCT02180724|10862194|FG000|STARTED|Overall Study||92
9758622|NCT02180724|10862195|FG001|STARTED|Overall Study||14
9758623|NCT02180724|10862194|FG000|Enrolled|Overall Study||92
9758624|NCT02180724|10862195|FG001|Enrolled|Overall Study||14
9758625|NCT02180724|10862194|FG000|Received Study Medication|Overall Study||92
9758626|NCT02180724|10862195|FG001|Received Study Medication|Overall Study||14
9758627|NCT02180724|10862194|FG000|Discontinued Study|Overall Study||14
9758628|NCT02180724|10862195|FG001|Discontinued Study|Overall Study||3
9758629|NCT02180724|10862194|FG000|Discontinued Treatment|Overall Study||23
9758630|NCT02180724|10862195|FG001|Discontinued Treatment|Overall Study||7
9758631|NCT02180724|10862194|FG000|COMPLETED|Overall Study||0
9758632|NCT02180724|10862195|FG001|COMPLETED|Overall Study||0
9758633|NCT02180724|10862194|FG000|NOT COMPLETED|Overall Study||92
9758634|NCT02180724|10862195|FG001|NOT COMPLETED|Overall Study||14
9758635|NCT02038777|10862209|FG000|STARTED|Overall Study||3
9758636|NCT02038777|10862210|FG001|STARTED|Overall Study||5
9758637|NCT02038777|10862211|FG002|STARTED|Overall Study||6
9758638|NCT02038777|10862212|FG003|STARTED|Overall Study||6
9758639|NCT02038777|10862213|FG004|STARTED|Overall Study||6
9758640|NCT02038777|10862214|FG005|STARTED|Overall Study||6
9758641|NCT02038777|10862215|FG006|STARTED|Overall Study||1
9758642|NCT02038777|10862216|FG007|STARTED|Overall Study||15
9758643|NCT02038777|10862209|FG000|Treated (Safety Set)|Overall Study||3
9871425|NCT00983242|10985530|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
9871426|NCT00983281|10985539|FG000|STARTED|Overall Study||805
9871427|NCT00983281|10985540|FG001|STARTED|Overall Study||909
9871428|NCT00983281|10985539|FG000|COMPLETED|Overall Study||805
10095891|NCT02360475|11224510|FG002|STARTED|Overall Study||125
9871429|NCT00983281|10985540|FG001|COMPLETED|Overall Study||909
9871430|NCT00983281|10985539|FG000|NOT COMPLETED|Overall Study||0
9871431|NCT00983281|10985540|FG001|NOT COMPLETED|Overall Study||0
9871432|NCT00983294|10985546|FG000|STARTED|Colchicine Alone||24
9871433|NCT00983294|10985546|FG000|COMPLETED|Colchicine Alone||24
9871434|NCT00983294|10985546|FG000|NOT COMPLETED|Colchicine Alone||0
9871435|NCT00983294|10985546|FG000|STARTED|14 Day Washout Period||24
9871436|NCT00983294|10985546|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
9871437|NCT00983294|10985546|FG000|NOT COMPLETED|14 Day Washout Period||2
9871438|NCT00983294|10985546|FG000|STARTED|Azithromycin Alone||22
9871439|NCT00983294|10985546|FG000|COMPLETED|Azithromycin Alone||22
9871440|NCT00983294|10985546|FG000|NOT COMPLETED|Azithromycin Alone||0
9871441|NCT00983294|10985546|FG000|STARTED|Colchicine With Azithromycin||22
9871442|NCT00983294|10985546|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
9871443|NCT00983294|10985546|FG000|NOT COMPLETED|Colchicine With Azithromycin||1
9871444|NCT00983307|10985553|FG000|STARTED|Overall Study||17
9871445|NCT00983307|10985553|FG000|COMPLETED|Overall Study||17
9871446|NCT00983307|10985553|FG000|NOT COMPLETED|Overall Study||0
9871447|NCT00983346|10985557|FG000|STARTED|Overall Study||17
9871448|NCT00983346|10985557|FG000|COMPLETED|Overall Study||17
9871449|NCT00983346|10985557|FG000|NOT COMPLETED|Overall Study||0
9871450|NCT00983359|10985561|FG000|STARTED|Overall Study||40
9871451|NCT00983359|10985561|FG000|Not Eligible for Analysis|Overall Study||1
9871452|NCT00983359|10985561|FG000|COMPLETED|Overall Study||39
9871453|NCT00983359|10985561|FG000|NOT COMPLETED|Overall Study||1
9871454|NCT00983372|10985565|FG000|STARTED|Colchicine Alone||24
9871455|NCT00983372|10985565|FG000|COMPLETED|Colchicine Alone||24
9871456|NCT00983372|10985565|FG000|NOT COMPLETED|Colchicine Alone||0
9871457|NCT00983372|10985565|FG000|STARTED|14 Day Washout Period||24
9871458|NCT00983372|10985565|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
9871459|NCT00983372|10985565|FG000|NOT COMPLETED|14 Day Washout Period||1
9871460|NCT00983372|10985565|FG000|STARTED|Diltiazem ER Alone||23
9871461|NCT00983372|10985565|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
9871462|NCT00983372|10985565|FG000|NOT COMPLETED|Diltiazem ER Alone||3
9871463|NCT00983372|10985565|FG000|STARTED|Colchicine With Diltiazem ER||20
9871464|NCT00983372|10985565|FG000|COMPLETED|Colchicine With Diltiazem ER||20
10201936|NCT03441984|11329282|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201937|NCT03441984|11329283|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201938|NCT03441984|11329284|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201939|NCT03441984|11329285|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9871465|NCT00983372|10985565|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0
9871466|NCT00983385|10985572|FG000|STARTED|Observation Period||208
9871467|NCT00983385|10985572|FG000|COMPLETED|Observation Period||176
9871468|NCT00983385|10985572|FG000|NOT COMPLETED|Observation Period||32
9871469|NCT00983385|10985572|FG000|STARTED|Titration and Optimal Dose Period||176
9871470|NCT00983385|10985572|FG000|COMPLETED|Titration and Optimal Dose Period||140
9871471|NCT00983385|10985572|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36
9871472|NCT00983385|10985572|FG000|STARTED|Maintenance Period||140
9871473|NCT00983385|10985572|FG000|COMPLETED|Maintenance Period||117
9871474|NCT00983385|10985572|FG000|NOT COMPLETED|Maintenance Period||23
9871475|NCT00983476|10985594|FG000|STARTED|Overall Study||95
9871476|NCT00983476|10985595|FG001|STARTED|Overall Study||93
9871477|NCT00983476|10985596|FG002|STARTED|Overall Study||88
9871478|NCT00983476|10985594|FG000|6 Month Follow up Assessment|Overall Study||71
9871479|NCT00983476|10985595|FG001|6 Month Follow up Assessment|Overall Study||62
9871480|NCT00983476|10985596|FG002|6 Month Follow up Assessment|Overall Study||74
9871481|NCT00983476|10985594|FG000|COMPLETED|Overall Study||78
9871482|NCT00983476|10985595|FG001|COMPLETED|Overall Study||71
9871483|NCT00983476|10985596|FG002|COMPLETED|Overall Study||88
10095892|NCT02360475|11224511|FG003|STARTED|Overall Study||125
10095893|NCT02360475|11224508|FG000|COMPLETED|Overall Study||122
10095894|NCT02360475|11224509|FG001|COMPLETED|Overall Study||111
10095895|NCT02360475|11224510|FG002|COMPLETED|Overall Study||117
10095896|NCT02360475|11224511|FG003|COMPLETED|Overall Study||120
10095897|NCT02360475|11224508|FG000|NOT COMPLETED|Overall Study||4
10095898|NCT02360475|11224509|FG001|NOT COMPLETED|Overall Study||13
10095899|NCT02360475|11224510|FG002|NOT COMPLETED|Overall Study||8
10095900|NCT02360475|11224511|FG003|NOT COMPLETED|Overall Study||5
10095901|NCT02360488|11224523|FG000|STARTED|Overall Study||62
10095902|NCT02360488|11224524|FG001|STARTED|Overall Study||62
10095903|NCT02360488|11224523|FG000|COMPLETED|Overall Study||59
10095904|NCT02360488|11224524|FG001|COMPLETED|Overall Study||55
10095905|NCT02360488|11224523|FG000|NOT COMPLETED|Overall Study||3
10095906|NCT02360488|11224524|FG001|NOT COMPLETED|Overall Study||7
10095907|NCT02360605|11224532|FG000|STARTED|Overall Study||311
10095908|NCT02360605|11224533|FG001|STARTED|Overall Study||309
10095909|NCT02360605|11224532|FG000|COMPLETED|Overall Study||300
10095910|NCT02360605|11224533|FG001|COMPLETED|Overall Study||291
10095911|NCT02360605|11224532|FG000|NOT COMPLETED|Overall Study||11
10095912|NCT02360605|11224533|FG001|NOT COMPLETED|Overall Study||18
10095913|NCT02360631|11224543|FG000|STARTED|Overall Study||300
10095914|NCT02360631|11224544|FG001|STARTED|Overall Study||200
10095915|NCT02360631|11224543|FG000|Week 12|Overall Study||249
10095916|NCT02360631|11224544|FG001|Week 12|Overall Study||165
10095917|NCT02360631|11224543|FG000|COMPLETED|Overall Study||267
9871484|NCT00983476|10985594|FG000|NOT COMPLETED|Overall Study||17
9871485|NCT00983476|10985595|FG001|NOT COMPLETED|Overall Study||22
9871486|NCT00983476|10985596|FG002|NOT COMPLETED|Overall Study||0
9871487|NCT00983489|10985613|FG000|STARTED|Overall Study||511
9871488|NCT00983489|10985614|FG001|STARTED|Overall Study||453
9871489|NCT00983489|10985615|FG002|STARTED|Overall Study||447
9871490|NCT00983489|10985613|FG000|COMPLETED|Overall Study||326
9871491|NCT00983489|10985614|FG001|COMPLETED|Overall Study||168
9871492|NCT00983489|10985615|FG002|COMPLETED|Overall Study||135
9871493|NCT00983489|10985613|FG000|NOT COMPLETED|Overall Study||185
9871494|NCT00983489|10985614|FG001|NOT COMPLETED|Overall Study||285
9871495|NCT00983489|10985615|FG002|NOT COMPLETED|Overall Study||312
9871496|NCT00983515|10985623|FG000|STARTED|Colchicine Alone||24
9871497|NCT00983515|10985623|FG000|COMPLETED|Colchicine Alone||24
9871498|NCT00983515|10985623|FG000|NOT COMPLETED|Colchicine Alone||0
9871499|NCT00983515|10985623|FG000|STARTED|14 Day Washout Period||24
9871500|NCT00983515|10985623|FG000|COMPLETED|14 Day Washout Period||24
9871501|NCT00983515|10985623|FG000|NOT COMPLETED|14 Day Washout Period||0
9871502|NCT00983515|10985623|FG000|STARTED|Ritonavir Alone||24
9871503|NCT00983515|10985623|FG000|COMPLETED|Ritonavir Alone||18
9871504|NCT00983515|10985623|FG000|NOT COMPLETED|Ritonavir Alone||6
9871505|NCT00983515|10985623|FG000|STARTED|Colchicine With Ritonavir||18
9871506|NCT00983515|10985623|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
9871507|NCT00983515|10985623|FG000|NOT COMPLETED|Colchicine With Ritonavir||1
9871508|NCT00983528|10985630|FG000|STARTED|Overall Study||6
9871509|NCT00983528|10985630|FG000|COMPLETED|Overall Study||0
9871510|NCT00983528|10985630|FG000|NOT COMPLETED|Overall Study||6
9871511|NCT00983541|10985634|FG000|STARTED|Overall Study||1
9871512|NCT00983541|10985634|FG000|COMPLETED|Overall Study||1
9871513|NCT00983541|10985634|FG000|NOT COMPLETED|Overall Study||0
9871514|NCT00983580|10985640|FG000|STARTED|Overall Study||54
9871515|NCT00983580|10985641|FG001|STARTED|Overall Study||53
9871516|NCT00983580|10985640|FG000|COMPLETED|Overall Study||49
9871517|NCT00983580|10985641|FG001|COMPLETED|Overall Study||49
9871518|NCT00983580|10985640|FG000|NOT COMPLETED|Overall Study||5
9871519|NCT00983580|10985641|FG001|NOT COMPLETED|Overall Study||4
9871520|NCT00983619|10985660|FG000|STARTED|Overall Study||3
9871521|NCT00983619|10985661|FG001|STARTED|Overall Study||4
9871522|NCT00983619|10985662|FG002|STARTED|Overall Study||3
9871523|NCT00983619|10985663|FG003|STARTED|Overall Study||6
9871524|NCT00983619|10985664|FG004|STARTED|Overall Study||3
9871525|NCT00983619|10985665|FG005|STARTED|Overall Study||76
9871526|NCT00983619|10985666|FG006|STARTED|Overall Study||3
9871527|NCT00983619|10985667|FG007|STARTED|Overall Study||3
9871528|NCT00983619|10985668|FG008|STARTED|Overall Study||1
9871529|NCT00983619|10985669|FG009|STARTED|Overall Study||3
9871530|NCT00983619|10985670|FG010|STARTED|Overall Study||17
9871531|NCT00983619|10985671|FG011|STARTED|Overall Study||14
9871532|NCT00983619|10985660|FG000|COMPLETED|Overall Study||0
10095918|NCT02360631|11224544|FG001|COMPLETED|Overall Study||174
10095919|NCT02360631|11224543|FG000|NOT COMPLETED|Overall Study||33
10095920|NCT02360631|11224544|FG001|NOT COMPLETED|Overall Study||26
10095921|NCT02360774|11224552|FG000|STARTED|Overall Study||15
10095922|NCT02360774|11224553|FG001|STARTED|Overall Study||15
10095923|NCT02360774|11224552|FG000|COMPLETED|Overall Study||12
10095924|NCT02360774|11224553|FG001|COMPLETED|Overall Study||13
10095925|NCT02360774|11224552|FG000|NOT COMPLETED|Overall Study||3
10095926|NCT02360774|11224553|FG001|NOT COMPLETED|Overall Study||2
10095927|NCT02360995|11224564|FG000|STARTED|Overall Study||43
10095928|NCT02360995|11224565|FG001|STARTED|Overall Study||43
10095929|NCT02360995|11224566|FG002|STARTED|Overall Study||43
10095930|NCT02360995|11224564|FG000|COMPLETED|Overall Study||41
10095931|NCT02360995|11224565|FG001|COMPLETED|Overall Study||42
10095932|NCT02360995|11224566|FG002|COMPLETED|Overall Study||41
10095933|NCT02360995|11224564|FG000|NOT COMPLETED|Overall Study||2
10095934|NCT02360995|11224565|FG001|NOT COMPLETED|Overall Study||1
10095935|NCT02360995|11224566|FG002|NOT COMPLETED|Overall Study||2
10095936|NCT02361216|11224576|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552
10095937|NCT02361216|11224577|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177
10095938|NCT02361216|11224576|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
10095939|NCT02361216|11224577|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
10095940|NCT02361216|11224576|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
10095941|NCT02361216|11224577|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
10095942|NCT02361216|11224576|FG000|STARTED|12-month Follow-up||541
10095943|NCT02361216|11224577|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
10201940|NCT03441984|11329286|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10201941|NCT03441984|11329287|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9871533|NCT00983619|10985661|FG001|COMPLETED|Overall Study||0
9871534|NCT00983619|10985662|FG002|COMPLETED|Overall Study||0
9871535|NCT00983619|10985663|FG003|COMPLETED|Overall Study||1
9871536|NCT00983619|10985664|FG004|COMPLETED|Overall Study||0
9871537|NCT00983619|10985665|FG005|COMPLETED|Overall Study||9
9871538|NCT00983619|10985666|FG006|COMPLETED|Overall Study||0
9871539|NCT00983619|10985667|FG007|COMPLETED|Overall Study||1
9871540|NCT00983619|10985668|FG008|COMPLETED|Overall Study||0
10095944|NCT02361216|11224576|FG000|COMPLETED|12-month Follow-up||489
10095945|NCT02361216|11224577|FG001|COMPLETED|12-month Follow-up||130
10095946|NCT02361216|11224576|FG000|NOT COMPLETED|12-month Follow-up||52
9871541|NCT00983619|10985669|FG009|COMPLETED|Overall Study||0
9871542|NCT00983619|10985670|FG010|COMPLETED|Overall Study||6
9871543|NCT00983619|10985671|FG011|COMPLETED|Overall Study||3
9871544|NCT00983619|10985660|FG000|NOT COMPLETED|Overall Study||3
9871545|NCT00983619|10985661|FG001|NOT COMPLETED|Overall Study||4
9871546|NCT00983619|10985662|FG002|NOT COMPLETED|Overall Study||3
9871547|NCT00983619|10985663|FG003|NOT COMPLETED|Overall Study||5
9871548|NCT00983619|10985664|FG004|NOT COMPLETED|Overall Study||3
9871549|NCT00983619|10985665|FG005|NOT COMPLETED|Overall Study||67
9871550|NCT00983619|10985666|FG006|NOT COMPLETED|Overall Study||3
9871551|NCT00983619|10985667|FG007|NOT COMPLETED|Overall Study||2
9871552|NCT00983619|10985668|FG008|NOT COMPLETED|Overall Study||1
9871553|NCT00983619|10985669|FG009|NOT COMPLETED|Overall Study||3
9871554|NCT00983619|10985670|FG010|NOT COMPLETED|Overall Study||11
9871555|NCT00983619|10985671|FG011|NOT COMPLETED|Overall Study||11
9871556|NCT00983749|10985719|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13
9871557|NCT00983749|10985720|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10
9871558|NCT00983749|10985719|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
9871559|NCT00983749|10985720|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
9871560|NCT00983749|10985719|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
9871561|NCT00983749|10985720|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
9871562|NCT00983749|10985719|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
9871563|NCT00983749|10985720|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
9871564|NCT00983749|10985719|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
9871565|NCT00983749|10985720|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
9871566|NCT00983749|10985719|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
9871567|NCT00983749|10985720|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
9871568|NCT00983801|10985726|FG000|STARTED|Overall Study|Participants who received treatment.|52
9871569|NCT00983801|10985726|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52
9871570|NCT00983801|10985726|FG000|NOT COMPLETED|Overall Study||0
9871571|NCT00983827|10985730|FG000|STARTED|Overall Study||8
9871572|NCT00983827|10985730|FG000|COMPLETED|Overall Study||7
9871573|NCT00983827|10985730|FG000|NOT COMPLETED|Overall Study||1
9871574|NCT00983853|10985740|FG000|STARTED|Overall Study||7
9871575|NCT00983853|10985741|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7
9871576|NCT00983853|10985742|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17
9871577|NCT00983853|10985743|FG003|STARTED|Overall Study||8
9871578|NCT00983853|10985744|FG004|STARTED|Overall Study||15
9871579|NCT00983853|10985745|FG005|STARTED|Overall Study||8
9871580|NCT00983853|10985740|FG000|COMPLETED|Overall Study||6
9871581|NCT00983853|10985741|FG001|COMPLETED|Overall Study||5
9871582|NCT00983853|10985742|FG002|COMPLETED|Overall Study||14
9871583|NCT00983853|10985743|FG003|COMPLETED|Overall Study||6
9871584|NCT00983853|10985744|FG004|COMPLETED|Overall Study||12
9871585|NCT00983853|10985745|FG005|COMPLETED|Overall Study||7
9871586|NCT00983853|10985740|FG000|NOT COMPLETED|Overall Study||1
9871587|NCT00983853|10985741|FG001|NOT COMPLETED|Overall Study||2
9871588|NCT00983853|10985742|FG002|NOT COMPLETED|Overall Study||3
9871589|NCT00983853|10985743|FG003|NOT COMPLETED|Overall Study||2
9871590|NCT00983853|10985744|FG004|NOT COMPLETED|Overall Study||3
9871591|NCT00983853|10985745|FG005|NOT COMPLETED|Overall Study||1
9871592|NCT00983892|10985763|FG000|STARTED|Overall Study||66
9871593|NCT00983892|10985764|FG001|STARTED|Overall Study||68
9871594|NCT00983892|10985763|FG000|COMPLETED|Overall Study||56
9871595|NCT00983892|10985764|FG001|COMPLETED|Overall Study||56
9871596|NCT00983892|10985763|FG000|NOT COMPLETED|Overall Study||10
9871597|NCT00983892|10985764|FG001|NOT COMPLETED|Overall Study||12
9953712|NCT01427803|11072397|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
9953713|NCT01427803|11072396|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
9953714|NCT01427803|11072397|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
9953715|NCT01427803|11072396|FG000|COMPLETED|Overall Study||463
9953716|NCT01427803|11072397|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
10095947|NCT02361216|11224577|FG001|NOT COMPLETED|12-month Follow-up||27
10095948|NCT02361307|11224588|FG000|STARTED|Overall Study||18
9953717|NCT01427803|11072396|FG000|NOT COMPLETED|Overall Study||63
9953718|NCT01427803|11072397|FG001|NOT COMPLETED|Overall Study||26
9953719|NCT01427881|11072401|FG000|STARTED|Overall Study||43
9953720|NCT01427881|11072401|FG000|COMPLETED|Overall Study||43
9953721|NCT01427881|11072401|FG000|NOT COMPLETED|Overall Study||0
9953722|NCT01427907|11072407|FG000|STARTED|Overall Study|Randomized|20
9953723|NCT01427907|11072408|FG001|STARTED|Overall Study|Randomized|18
9953724|NCT01427907|11072407|FG000|COMPLETED|Overall Study|Completed study|17
9953725|NCT01427907|11072408|FG001|COMPLETED|Overall Study|Completed study|14
9953726|NCT01427907|11072407|FG000|NOT COMPLETED|Overall Study||3
9953727|NCT01427907|11072408|FG001|NOT COMPLETED|Overall Study||4
9953728|NCT01427920|11072416|FG000|STARTED|Overall Study||174
9953729|NCT01427920|11072417|FG001|STARTED|Overall Study||174
9953730|NCT01427920|11072416|FG000|Exposed|Overall Study||174
10095949|NCT02361307|11224589|FG001|STARTED|Overall Study||18
9953731|NCT01427920|11072417|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
9953732|NCT01427920|11072416|FG000|COMPLETED|Overall Study||165
9871598|NCT00983905|10985770|FG000|STARTED|Theophylline Alone||30
9871599|NCT00983905|10985770|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
9871600|NCT00983905|10985770|FG000|NOT COMPLETED|Theophylline Alone||1
9871601|NCT00983905|10985770|FG000|STARTED|4 Day Washout Period||29
9871602|NCT00983905|10985770|FG000|COMPLETED|4 Day Washout Period||29
9871603|NCT00983905|10985770|FG000|NOT COMPLETED|4 Day Washout Period||0
9871604|NCT00983905|10985770|FG000|STARTED|Colchicine Alone||29
9871605|NCT00983905|10985770|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
9871606|NCT00983905|10985770|FG000|NOT COMPLETED|Colchicine Alone||2
9871607|NCT00983905|10985770|FG000|STARTED|Theophylline With Colchicine||27
9871608|NCT00983905|10985770|FG000|COMPLETED|Theophylline With Colchicine||27
9871609|NCT00983905|10985770|FG000|NOT COMPLETED|Theophylline With Colchicine||0
9871610|NCT00983918|10985781|FG000|STARTED|Overall Study||20
9871611|NCT00983918|10985782|FG001|STARTED|Overall Study||20
9871612|NCT00983918|10985783|FG002|STARTED|Overall Study||20
9871613|NCT00983918|10985784|FG003|STARTED|Overall Study||20
9871614|NCT00983918|10985781|FG000|COMPLETED|Overall Study||20
9871615|NCT00983918|10985782|FG001|COMPLETED|Overall Study||18
9871616|NCT00983918|10985783|FG002|COMPLETED|Overall Study||18
9871617|NCT00983918|10985784|FG003|COMPLETED|Overall Study||18
9871618|NCT00983918|10985781|FG000|NOT COMPLETED|Overall Study||0
9871619|NCT00983918|10985782|FG001|NOT COMPLETED|Overall Study||2
9871620|NCT00983918|10985783|FG002|NOT COMPLETED|Overall Study||2
9871621|NCT00983918|10985784|FG003|NOT COMPLETED|Overall Study||2
9871622|NCT00983931|10985794|FG000|STARTED|Colchicine Alone||24
9871623|NCT00983931|10985794|FG000|COMPLETED|Colchicine Alone||24
9871624|NCT00983931|10985794|FG000|NOT COMPLETED|Colchicine Alone||0
9871625|NCT00983931|10985794|FG000|STARTED|14 Day Washout Period||24
9871626|NCT00983931|10985794|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
9871627|NCT00983931|10985794|FG000|NOT COMPLETED|14 Day Washout Period||1
9871628|NCT00983931|10985794|FG000|STARTED|Colchicine With Cyclosporine||23
9871629|NCT00983931|10985794|FG000|COMPLETED|Colchicine With Cyclosporine||23
9871630|NCT00983931|10985794|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0
9871631|NCT00983957|10985800|FG000|STARTED|Overall Study||20
9871632|NCT00983957|10985800|FG000|Treatment A|Overall Study||20
9871633|NCT00983957|10985800|FG000|Treatment B|Overall Study||20
9871634|NCT00983957|10985800|FG000|Treatment C|Overall Study||18
9871635|NCT00983957|10985800|FG000|COMPLETED|Overall Study||18
9871636|NCT00983957|10985800|FG000|NOT COMPLETED|Overall Study||2
9871637|NCT00983983|10985813|FG000|STARTED|Overall Study||8
9871638|NCT00983983|10985814|FG001|STARTED|Overall Study||9
9871639|NCT00983983|10985815|FG002|STARTED|Overall Study||7
9871640|NCT00983983|10985813|FG000|COMPLETED|Overall Study||6
9871641|NCT00983983|10985814|FG001|COMPLETED|Overall Study||8
9871642|NCT00983983|10985815|FG002|COMPLETED|Overall Study||6
9871643|NCT00983983|10985813|FG000|NOT COMPLETED|Overall Study||2
9871644|NCT00983983|10985814|FG001|NOT COMPLETED|Overall Study||1
9871645|NCT00983983|10985815|FG002|NOT COMPLETED|Overall Study||1
9871646|NCT00984009|10985824|FG000|STARTED|Colchicine Alone||22
9871647|NCT00984009|10985824|FG000|COMPLETED|Colchicine Alone||22
9871648|NCT00984009|10985824|FG000|NOT COMPLETED|Colchicine Alone||0
9871649|NCT00984009|10985824|FG000|STARTED|14 Day Washout Period||22
9871650|NCT00984009|10985824|FG000|COMPLETED|14 Day Washout Period||22
9871651|NCT00984009|10985824|FG000|NOT COMPLETED|14 Day Washout Period||0
9871652|NCT00984009|10985824|FG000|STARTED|Grapefruit Juice Alone||22
9871653|NCT00984009|10985824|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
9871654|NCT00984009|10985824|FG000|NOT COMPLETED|Grapefruit Juice Alone||1
9871655|NCT00984009|10985824|FG000|STARTED|Colchicine With Grapefruit Juice||21
9871656|NCT00984009|10985824|FG000|COMPLETED|Colchicine With Grapefruit Juice||21
9871657|NCT00984009|10985824|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0
9871658|NCT00984022|10985833|FG000|STARTED|Overall Study||43
9871659|NCT00984022|10985834|FG001|STARTED|Overall Study||49
9871660|NCT00984022|10985833|FG000|COMPLETED|Overall Study||33
9871661|NCT00984022|10985834|FG001|COMPLETED|Overall Study||35
9871662|NCT00984022|10985833|FG000|NOT COMPLETED|Overall Study||10
9871663|NCT00984022|10985834|FG001|NOT COMPLETED|Overall Study||14
9871664|NCT00984061|10985840|FG000|STARTED|Colchicine Alone||24
9871665|NCT00984061|10985840|FG000|COMPLETED|Colchicine Alone||24
9871666|NCT00984061|10985840|FG000|NOT COMPLETED|Colchicine Alone||0
9871667|NCT00984061|10985840|FG000|STARTED|21 Day Washout Period||24
9871668|NCT00984061|10985840|FG000|COMPLETED|21 Day Washout Period||24
9871669|NCT00984061|10985840|FG000|NOT COMPLETED|21 Day Washout Period||0
9871670|NCT00984061|10985840|FG000|STARTED|Clarithromycin Alone||24
9871671|NCT00984061|10985840|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
9871672|NCT00984061|10985840|FG000|NOT COMPLETED|Clarithromycin Alone||1
9871673|NCT00984061|10985840|FG000|STARTED|Colchicine With Clarithromycin||23
9871674|NCT00984061|10985840|FG000|COMPLETED|Colchicine With Clarithromycin||23
9871675|NCT00984061|10985840|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0
9871676|NCT00984126|10985851|FG000|STARTED|Overall Study||27
9871677|NCT00984126|10985852|FG001|STARTED|Overall Study||28
9871678|NCT00984126|10985853|FG002|STARTED|Overall Study||23
9871679|NCT00984126|10985854|FG003|STARTED|Overall Study||135
9871680|NCT00984126|10985851|FG000|COMPLETED|Overall Study||20
9871681|NCT00984126|10985852|FG001|COMPLETED|Overall Study||20
9871682|NCT00984126|10985853|FG002|COMPLETED|Overall Study||16
10095950|NCT02361307|11224588|FG000|COMPLETED|Overall Study||18
10095951|NCT02361307|11224589|FG001|COMPLETED|Overall Study||17
10095952|NCT02361307|11224588|FG000|NOT COMPLETED|Overall Study||0
10095953|NCT02361307|11224589|FG001|NOT COMPLETED|Overall Study||1
10095954|NCT02361476|11224597|FG000|STARTED|Overall Study||191
10095955|NCT02361476|11224598|FG001|STARTED|Overall Study||188
10095956|NCT02361476|11224597|FG000|COMPLETED|Overall Study||191
10095957|NCT02361476|11224598|FG001|COMPLETED|Overall Study||188
10095958|NCT02361476|11224597|FG000|NOT COMPLETED|Overall Study||0
9871683|NCT00984126|10985854|FG003|COMPLETED|Overall Study||76
9871684|NCT00984126|10985851|FG000|NOT COMPLETED|Overall Study||7
9871685|NCT00984126|10985852|FG001|NOT COMPLETED|Overall Study||8
9871686|NCT00984126|10985853|FG002|NOT COMPLETED|Overall Study||7
9871687|NCT00984126|10985854|FG003|NOT COMPLETED|Overall Study||59
9871688|NCT00984139|10985873|FG000|STARTED|Overall Study||306
9871689|NCT00984139|10985873|FG000|COMPLETED|Overall Study||306
9871690|NCT00984139|10985873|FG000|NOT COMPLETED|Overall Study||0
9871691|NCT00984165|10985881|FG000|STARTED|Overall Study||9
9871692|NCT00984165|10985882|FG001|STARTED|Overall Study||1
9871693|NCT00984165|10985883|FG002|STARTED|Overall Study||4
9871694|NCT00984165|10985884|FG003|STARTED|Overall Study||4
9871695|NCT00984165|10985881|FG000|COMPLETED|Overall Study||2
9871696|NCT00984165|10985882|FG001|COMPLETED|Overall Study||0
9871697|NCT00984165|10985883|FG002|COMPLETED|Overall Study||4
9871698|NCT00984165|10985884|FG003|COMPLETED|Overall Study||0
9871699|NCT00984165|10985881|FG000|NOT COMPLETED|Overall Study||7
9871700|NCT00984165|10985882|FG001|NOT COMPLETED|Overall Study||1
9871701|NCT00984165|10985883|FG002|NOT COMPLETED|Overall Study||0
9871702|NCT00984165|10985884|FG003|NOT COMPLETED|Overall Study||4
9871703|NCT00984204|10985895|FG000|STARTED|Overall Study||188
9871704|NCT00984204|10985895|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
9871705|NCT00984204|10985895|FG000|NOT COMPLETED|Overall Study||15
9871706|NCT00984256|10985901|FG000|STARTED|Overall Study||6
9871707|NCT00984256|10985902|FG001|STARTED|Overall Study||30
9871708|NCT00984256|10985901|FG000|COMPLETED|Overall Study||6
9871709|NCT00984256|10985902|FG001|COMPLETED|Overall Study||29
9871710|NCT00984256|10985901|FG000|NOT COMPLETED|Overall Study||0
9871711|NCT00984256|10985902|FG001|NOT COMPLETED|Overall Study||1
9871712|NCT00984282|10985919|FG000|STARTED|Double Blind Treatment||207
9871713|NCT00984282|10985920|FG001|STARTED|Double Blind Treatment||210
9871714|NCT00984282|10985919|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
9871715|NCT00984282|10985920|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
9871716|NCT00984282|10985919|FG000|COMPLETED|Double Blind Treatment||103
9871717|NCT00984282|10985920|FG001|COMPLETED|Double Blind Treatment||172
9871718|NCT00984282|10985919|FG000|NOT COMPLETED|Double Blind Treatment||104
9871719|NCT00984282|10985920|FG001|NOT COMPLETED|Double Blind Treatment||38
9871720|NCT00984282|10985919|FG000|STARTED|Open-label Treatment||86
9871721|NCT00984282|10985920|FG001|STARTED|Open-label Treatment||161
9871722|NCT00984282|10985919|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
9871723|NCT00984282|10985920|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
9871724|NCT00984282|10985919|FG000|COMPLETED|Open-label Treatment||0
9871725|NCT00984282|10985920|FG001|COMPLETED|Open-label Treatment||0
9871726|NCT00984282|10985919|FG000|NOT COMPLETED|Open-label Treatment||86
9871727|NCT00984282|10985920|FG001|NOT COMPLETED|Open-label Treatment||161
9871728|NCT00984282|10985919|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
9871729|NCT00984282|10985920|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
9871730|NCT00984282|10985919|FG000|COMPLETED|Long Term Follow-up||3
9871731|NCT00984282|10985920|FG001|COMPLETED|Long Term Follow-up||4
9871732|NCT00984282|10985919|FG000|NOT COMPLETED|Long Term Follow-up||69
9871733|NCT00984282|10985920|FG001|NOT COMPLETED|Long Term Follow-up||120
9871734|NCT00984295|10985931|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
9871735|NCT00984295|10985932|FG001|STARTED|Overall Study||485
9871736|NCT00984295|10985933|FG002|STARTED|Overall Study||479
9871737|NCT00984295|10985931|FG000|Visit 1|Overall Study||949
10095959|NCT02361476|11224598|FG001|NOT COMPLETED|Overall Study||0
10095960|NCT02361736|11224606|FG000|STARTED|Overall Study||60
10095961|NCT02361736|11224607|FG001|STARTED|Overall Study||60
10095962|NCT02361736|11224606|FG000|COMPLETED|Overall Study||59
10095963|NCT02361736|11224607|FG001|COMPLETED|Overall Study||59
10095964|NCT02361736|11224606|FG000|NOT COMPLETED|Overall Study||1
10095965|NCT02361736|11224607|FG001|NOT COMPLETED|Overall Study||1
10095966|NCT02361762|11224615|FG000|STARTED|Overall Study||35
10095967|NCT02361762|11224616|FG001|STARTED|Overall Study||35
10095968|NCT02361762|11224615|FG000|COMPLETED|Overall Study||35
10095969|NCT02361762|11224616|FG001|COMPLETED|Overall Study||33
10095970|NCT02361762|11224615|FG000|NOT COMPLETED|Overall Study||0
10095971|NCT02361762|11224616|FG001|NOT COMPLETED|Overall Study||2
10095972|NCT02362048|11224624|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
10095973|NCT02362048|11224625|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
10095974|NCT02362048|11224624|FG000|Enrolled|Overall Study||37
10095975|NCT02362048|11224625|FG001|Enrolled|Overall Study||40
10095976|NCT02362048|11224624|FG000|Received Study Medication|Overall Study||35
9871738|NCT00984295|10985932|FG001|Visit 1|Overall Study||485
9871739|NCT00984295|10985933|FG002|Visit 1|Overall Study||479
9871740|NCT00984295|10985931|FG000|Visit 2|Overall Study||909
9871741|NCT00984295|10985932|FG001|Visit 2|Overall Study||468
9871742|NCT00984295|10985933|FG002|Visit 2|Overall Study||453
9871743|NCT00984295|10985931|FG000|COMPLETED|Overall Study||884
9871744|NCT00984295|10985932|FG001|COMPLETED|Overall Study||453
9871745|NCT00984295|10985933|FG002|COMPLETED|Overall Study||442
9871746|NCT00984295|10985931|FG000|NOT COMPLETED|Overall Study||65
9871747|NCT00984295|10985932|FG001|NOT COMPLETED|Overall Study||32
9871748|NCT00984295|10985933|FG002|NOT COMPLETED|Overall Study||37
9871749|NCT00984308|10985943|FG000|STARTED|Overall Study||110
9871750|NCT00984308|10985944|FG001|STARTED|Overall Study||115
9871751|NCT00984308|10985943|FG000|COMPLETED|Overall Study||92
9871752|NCT00984308|10985944|FG001|COMPLETED|Overall Study||109
9871753|NCT00984308|10985943|FG000|NOT COMPLETED|Overall Study||18
10095977|NCT02362048|11224625|FG001|Received Study Medication|Overall Study||38
10095978|NCT02362048|11224624|FG000|Discontinued Study|Overall Study||37
10095979|NCT02362048|11224625|FG001|Discontinued Study|Overall Study||40
10095980|NCT02362048|11224624|FG000|COMPLETED|Overall Study||0
10095981|NCT02362048|11224625|FG001|COMPLETED|Overall Study||0
10095982|NCT02362048|11224624|FG000|NOT COMPLETED|Overall Study||37
10095983|NCT02362048|11224625|FG001|NOT COMPLETED|Overall Study||40
10095984|NCT02362191|11224631|FG000|STARTED|Overall Study||5
10095985|NCT02362191|11224631|FG000|COMPLETED|Overall Study||3
10095986|NCT02362191|11224631|FG000|NOT COMPLETED|Overall Study||2
10095987|NCT02362269|11224637|FG000|STARTED|Overall Study||83
10095988|NCT02362269|11224638|FG001|STARTED|Overall Study||86
10095989|NCT02362269|11224637|FG000|COMPLETED|Overall Study||82
10095990|NCT02362269|11224638|FG001|COMPLETED|Overall Study||80
10095991|NCT02362269|11224637|FG000|NOT COMPLETED|Overall Study||1
10095992|NCT02362269|11224638|FG001|NOT COMPLETED|Overall Study||6
10095993|NCT02362282|11224646|FG000|STARTED|Overall Study||5
10095994|NCT02362282|11224647|FG001|STARTED|Overall Study||7
10095995|NCT02362282|11224646|FG000|COMPLETED|Overall Study||4
10095996|NCT02362282|11224647|FG001|COMPLETED|Overall Study||7
10095997|NCT02362282|11224646|FG000|NOT COMPLETED|Overall Study||1
10095998|NCT02362282|11224647|FG001|NOT COMPLETED|Overall Study||0
10095999|NCT02362321|11224655|FG000|STARTED|Overall Study||10
10096000|NCT02362321|11224656|FG001|STARTED|Overall Study||10
10096001|NCT02362321|11224655|FG000|COMPLETED|Overall Study||6
10096002|NCT02362321|11224656|FG001|COMPLETED|Overall Study||10
10096003|NCT02362321|11224655|FG000|NOT COMPLETED|Overall Study||4
10096004|NCT02362321|11224656|FG001|NOT COMPLETED|Overall Study||0
10096005|NCT02362360|11224662|FG000|STARTED|Period 1||26
10096006|NCT02362360|11224663|FG001|STARTED|Period 1||26
10096007|NCT02362360|11224662|FG000|COMPLETED|Period 1||23
10096008|NCT02362360|11224663|FG001|COMPLETED|Period 1||25
10096009|NCT02362360|11224662|FG000|NOT COMPLETED|Period 1||3
10096010|NCT02362360|11224663|FG001|NOT COMPLETED|Period 1||1
10096011|NCT02362360|11224662|FG000|STARTED|Period 2||23
10096012|NCT02362360|11224663|FG001|STARTED|Period 2||25
10096013|NCT02362360|11224662|FG000|COMPLETED|Period 2||23
10096014|NCT02362360|11224663|FG001|COMPLETED|Period 2||25
10096015|NCT02362360|11224662|FG000|NOT COMPLETED|Period 2||0
10096016|NCT02362360|11224663|FG001|NOT COMPLETED|Period 2||0
10096017|NCT02362373|11224669|FG000|STARTED|Overall Study||20
10096018|NCT02362373|11224669|FG000|COMPLETED|Overall Study||20
10096019|NCT02362373|11224669|FG000|NOT COMPLETED|Overall Study||0
10096020|NCT02362412|11224673|FG000|STARTED|Treatment Period II||9
10096021|NCT02362412|11224674|FG001|STARTED|Treatment Period II||11
10096022|NCT02362412|11224673|FG000|TREATED|Treatment Period II||9
10096023|NCT02362412|11224674|FG001|TREATED|Treatment Period II||11
10096024|NCT02362412|11224673|FG000|COMPLETED|Treatment Period II||9
10096025|NCT02362412|11224674|FG001|COMPLETED|Treatment Period II||11
10096026|NCT02362412|11224673|FG000|NOT COMPLETED|Treatment Period II||0
10096027|NCT02362412|11224674|FG001|NOT COMPLETED|Treatment Period II||0
9871754|NCT00984308|10985944|FG001|NOT COMPLETED|Overall Study||6
9871755|NCT00984334|10985955|FG000|STARTED|Overall Study||8
9871756|NCT00984334|10985956|FG001|STARTED|Overall Study||8
9871757|NCT00984334|10985957|FG002|STARTED|Overall Study||8
9871758|NCT00984334|10985958|FG003|STARTED|Overall Study||8
9871759|NCT00984334|10985959|FG004|STARTED|Overall Study||8
10096028|NCT02362412|11224673|FG000|STARTED|Treatment Period III||9
10096029|NCT02362412|11224674|FG001|STARTED|Treatment Period III||11
10096030|NCT02362412|11224673|FG000|TREATED|Treatment Period III||9
10096031|NCT02362412|11224674|FG001|TREATED|Treatment Period III||11
10096032|NCT02362412|11224673|FG000|COMPLETED|Treatment Period III||9
10096033|NCT02362412|11224674|FG001|COMPLETED|Treatment Period III||10
10096034|NCT02362412|11224673|FG000|NOT COMPLETED|Treatment Period III||0
10096035|NCT02362412|11224674|FG001|NOT COMPLETED|Treatment Period III||1
10096036|NCT02362425|11224690|FG000|STARTED|Phase 1 (up to 6 Months)||53
10096037|NCT02362425|11224691|FG001|STARTED|Phase 1 (up to 6 Months)||10
10096038|NCT02362425|11224692|FG002|STARTED|Phase 1 (up to 6 Months)||0
10096039|NCT02362425|11224693|FG003|STARTED|Phase 1 (up to 6 Months)||0
10096040|NCT02362425|11224690|FG000|COMPLETED|Phase 1 (up to 6 Months)||37
10096041|NCT02362425|11224691|FG001|COMPLETED|Phase 1 (up to 6 Months)||10
10096042|NCT02362425|11224692|FG002|COMPLETED|Phase 1 (up to 6 Months)||0
10096043|NCT02362425|11224693|FG003|COMPLETED|Phase 1 (up to 6 Months)||0
10096044|NCT02362425|11224690|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16
10096045|NCT02362425|11224691|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0
10096046|NCT02362425|11224692|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0
9871760|NCT00984334|10985955|FG000|COMPLETED|Overall Study||7
9871761|NCT00984334|10985956|FG001|COMPLETED|Overall Study||7
9871762|NCT00984334|10985957|FG002|COMPLETED|Overall Study||8
9871763|NCT00984334|10985958|FG003|COMPLETED|Overall Study||7
9871764|NCT00984334|10985959|FG004|COMPLETED|Overall Study||7
9871765|NCT00984334|10985955|FG000|NOT COMPLETED|Overall Study||1
9871766|NCT00984334|10985956|FG001|NOT COMPLETED|Overall Study||1
9871767|NCT00984334|10985957|FG002|NOT COMPLETED|Overall Study||0
9871768|NCT00984334|10985958|FG003|NOT COMPLETED|Overall Study||1
9871769|NCT00984334|10985959|FG004|NOT COMPLETED|Overall Study||1
9871770|NCT00984542|10985971|FG000|STARTED|Overall Study||50
9871771|NCT00984542|10985971|FG000|COMPLETED|Overall Study||9
9871772|NCT00984542|10985971|FG000|NOT COMPLETED|Overall Study||41
9871773|NCT00984568|10985978|FG000|STARTED|Overall Study||15
9871774|NCT00984568|10985979|FG001|STARTED|Overall Study||13
9871775|NCT00984568|10985978|FG000|COMPLETED|Overall Study||7
9871776|NCT00984568|10985979|FG001|COMPLETED|Overall Study||7
9871777|NCT00984568|10985978|FG000|NOT COMPLETED|Overall Study||8
9871778|NCT00984568|10985979|FG001|NOT COMPLETED|Overall Study||6
9871779|NCT00984594|10985987|FG000|STARTED|Overall Study||2
9871780|NCT00984594|10985988|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
9871781|NCT00984594|10985987|FG000|COMPLETED|Overall Study||1
9871782|NCT00984594|10985988|FG001|COMPLETED|Overall Study||1
9871783|NCT00984594|10985987|FG000|NOT COMPLETED|Overall Study||1
9871784|NCT00984594|10985988|FG001|NOT COMPLETED|Overall Study||1
9871785|NCT00984620|10985998|FG000|STARTED|Overall Study||81
9871786|NCT00984620|10985999|FG001|STARTED|Overall Study||79
9871787|NCT00984620|10985998|FG000|COMPLETED|Overall Study||75
9871788|NCT00984620|10985999|FG001|COMPLETED|Overall Study||67
9871789|NCT00984620|10985998|FG000|NOT COMPLETED|Overall Study||6
9871790|NCT00984620|10985999|FG001|NOT COMPLETED|Overall Study||12
9871791|NCT00984659|10986011|FG000|STARTED|2-week Run-in Period||418
9871792|NCT00984659|10986012|FG001|STARTED|2-week Run-in Period||0
9871793|NCT00984659|10986013|FG002|STARTED|2-week Run-in Period||0
9871794|NCT00984659|10986014|FG003|STARTED|2-week Run-in Period||0
9871795|NCT00984659|10986011|FG000|COMPLETED|2-week Run-in Period||366
9871796|NCT00984659|10986012|FG001|COMPLETED|2-week Run-in Period||0
9871797|NCT00984659|10986013|FG002|COMPLETED|2-week Run-in Period||0
9871798|NCT00984659|10986014|FG003|COMPLETED|2-week Run-in Period||0
9871799|NCT00984659|10986011|FG000|NOT COMPLETED|2-week Run-in Period||52
9871800|NCT00984659|10986012|FG001|NOT COMPLETED|2-week Run-in Period||0
9871801|NCT00984659|10986013|FG002|NOT COMPLETED|2-week Run-in Period||0
9871802|NCT00984659|10986014|FG003|NOT COMPLETED|2-week Run-in Period||0
9871803|NCT00984659|10986011|FG000|STARTED|6-week Double-blind Treatment Period||0
9871804|NCT00984659|10986012|FG001|STARTED|6-week Double-blind Treatment Period||75
9871805|NCT00984659|10986013|FG002|STARTED|6-week Double-blind Treatment Period||152
9871806|NCT00984659|10986014|FG003|STARTED|6-week Double-blind Treatment Period||139
9871807|NCT00984659|10986011|FG000|COMPLETED|6-week Double-blind Treatment Period||0
9871808|NCT00984659|10986012|FG001|COMPLETED|6-week Double-blind Treatment Period||69
9871809|NCT00984659|10986013|FG002|COMPLETED|6-week Double-blind Treatment Period||141
9871810|NCT00984659|10986014|FG003|COMPLETED|6-week Double-blind Treatment Period||126
9871811|NCT00984659|10986011|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0
9871812|NCT00984659|10986012|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6
9871813|NCT00984659|10986013|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11
9871814|NCT00984659|10986014|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13
9871815|NCT00984698|10986023|FG000|STARTED|Overall Study||21
9871816|NCT00984698|10986024|FG001|STARTED|Overall Study||22
9871817|NCT00984698|10986023|FG000|COMPLETED|Overall Study||18
9871818|NCT00984698|10986024|FG001|COMPLETED|Overall Study||14
9871819|NCT00984698|10986023|FG000|NOT COMPLETED|Overall Study||3
9871820|NCT00984698|10986024|FG001|NOT COMPLETED|Overall Study||8
9871821|NCT00984815|10986030|FG000|STARTED|Overall Study||86
10096047|NCT02362425|11224693|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0
10096048|NCT02362425|11224690|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0
10096049|NCT02362425|11224691|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0
10096050|NCT02362425|11224692|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16
10096051|NCT02362425|11224693|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17
10096052|NCT02362425|11224690|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
9871822|NCT00984815|10986030|FG000|COMPLETED|Overall Study||56
9871823|NCT00984815|10986030|FG000|NOT COMPLETED|Overall Study||30
9871824|NCT00984867|10986036|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
9871825|NCT00984867|10986037|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
9871826|NCT00984867|10986036|FG000|COMPLETED|Overall Study||203
9871827|NCT00984867|10986037|FG001|COMPLETED|Overall Study||208
9871828|NCT00984867|10986036|FG000|NOT COMPLETED|Overall Study||23
9871829|NCT00984867|10986037|FG001|NOT COMPLETED|Overall Study||17
9871830|NCT00985010|10986047|FG000|STARTED|Overall Study||4
9871831|NCT00985010|10986048|FG001|STARTED|Overall Study||5
9871832|NCT00985010|10986047|FG000|COMPLETED|Overall Study||4
9871833|NCT00985010|10986048|FG001|COMPLETED|Overall Study||5
9871834|NCT00985010|10986047|FG000|NOT COMPLETED|Overall Study||0
9871835|NCT00985010|10986048|FG001|NOT COMPLETED|Overall Study||0
9871836|NCT00985088|10986062|FG000|STARTED|Overall Study||222
9871837|NCT00985088|10986063|FG001|STARTED|Overall Study||114
9871838|NCT00985088|10986064|FG002|STARTED|Overall Study||112
9871839|NCT00985088|10986065|FG003|STARTED|Overall Study||221
9871840|NCT00985088|10986066|FG004|STARTED|Overall Study||223
9871841|NCT00985088|10986067|FG005|STARTED|Overall Study||115
9871842|NCT00985088|10986068|FG006|STARTED|Overall Study||111
9871843|NCT00985088|10986069|FG007|STARTED|Overall Study||222
9871844|NCT00985088|10986062|FG000|COMPLETED|Overall Study||211
9871845|NCT00985088|10986063|FG001|COMPLETED|Overall Study||112
9871846|NCT00985088|10986064|FG002|COMPLETED|Overall Study||108
9871847|NCT00985088|10986065|FG003|COMPLETED|Overall Study||214
9871848|NCT00985088|10986066|FG004|COMPLETED|Overall Study||214
9871849|NCT00985088|10986067|FG005|COMPLETED|Overall Study||108
9871850|NCT00985088|10986068|FG006|COMPLETED|Overall Study||107
9871851|NCT00985088|10986069|FG007|COMPLETED|Overall Study||216
9871852|NCT00985088|10986062|FG000|NOT COMPLETED|Overall Study||11
9871853|NCT00985088|10986063|FG001|NOT COMPLETED|Overall Study||2
9871854|NCT00985088|10986064|FG002|NOT COMPLETED|Overall Study||4
9871855|NCT00985088|10986065|FG003|NOT COMPLETED|Overall Study||7
9871856|NCT00985088|10986066|FG004|NOT COMPLETED|Overall Study||9
9871857|NCT00985088|10986067|FG005|NOT COMPLETED|Overall Study||7
9871858|NCT00985088|10986068|FG006|NOT COMPLETED|Overall Study||4
9871859|NCT00985088|10986069|FG007|NOT COMPLETED|Overall Study||6
9871860|NCT00985114|10986099|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34
9871861|NCT00985114|10986100|FG001|STARTED|Overall Study||39
9871862|NCT00985114|10986099|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0
9871863|NCT00985114|10986100|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
9871864|NCT00985114|10986099|FG000|COMPLETED|Overall Study||33
9871865|NCT00985114|10986100|FG001|COMPLETED|Overall Study||37
9871866|NCT00985114|10986099|FG000|NOT COMPLETED|Overall Study||1
9871867|NCT00985114|10986100|FG001|NOT COMPLETED|Overall Study||2
9871868|NCT00985140|10986106|FG000|STARTED|Overall Study||15
9871869|NCT00985140|10986106|FG000|COMPLETED|Overall Study||15
9871870|NCT00985140|10986106|FG000|NOT COMPLETED|Overall Study||0
9871871|NCT00985153|10986114|FG000|STARTED|Overall Study||985
9871872|NCT00985153|10986115|FG001|STARTED|Overall Study||968
9871873|NCT00985153|10986116|FG002|STARTED|Overall Study||962
9871874|NCT00985153|10986117|FG003|STARTED|Overall Study||1012
9871875|NCT00985153|10986114|FG000|Vaccinated at Visit 1|Overall Study||985
9871876|NCT00985153|10986115|FG001|Vaccinated at Visit 1|Overall Study||968
9871877|NCT00985153|10986116|FG002|Vaccinated at Visit 1|Overall Study||962
9871878|NCT00985153|10986117|FG003|Vaccinated at Visit 1|Overall Study||1012
9871879|NCT00985153|10986114|FG000|COMPLETED|Overall Study||950
9871880|NCT00985153|10986115|FG001|COMPLETED|Overall Study||924
9871881|NCT00985153|10986116|FG002|COMPLETED|Overall Study||918
9871882|NCT00985153|10986117|FG003|COMPLETED|Overall Study||965
9871883|NCT00985153|10986114|FG000|NOT COMPLETED|Overall Study||35
9871884|NCT00985153|10986115|FG001|NOT COMPLETED|Overall Study||44
9871885|NCT00985153|10986116|FG002|NOT COMPLETED|Overall Study||44
9871886|NCT00985153|10986117|FG003|NOT COMPLETED|Overall Study||47
10096053|NCT02362425|11224691|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
10096054|NCT02362425|11224692|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
10096055|NCT02362425|11224693|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
10096056|NCT02362425|11224690|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
10096057|NCT02362425|11224691|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
10096058|NCT02362425|11224692|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
10096059|NCT02362425|11224693|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
10096060|NCT02362594|11224706|FG000|STARTED|Overall Study||514
10096061|NCT02362594|11224707|FG001|STARTED|Overall Study||505
10096062|NCT02362594|11224706|FG000|Treated|Overall Study||509
10096063|NCT02362594|11224707|FG001|Treated|Overall Study||502
10096064|NCT02362594|11224706|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41
10096065|NCT02362594|11224707|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21
10096066|NCT02362594|11224706|FG000|COMPLETED|Overall Study||264
10096067|NCT02362594|11224707|FG001|COMPLETED|Overall Study||280
10096068|NCT02362594|11224706|FG000|NOT COMPLETED|Overall Study||250
9871887|NCT00985166|10986130|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
9871888|NCT00985166|10986131|FG001|STARTED|Overall Study||205
9871889|NCT00985166|10986132|FG002|STARTED|Overall Study||195
9871890|NCT00985166|10986130|FG000|Vaccinated at Visit 1|Overall Study||399
9871891|NCT00985166|10986131|FG001|Vaccinated at Visit 1|Overall Study||205
10096069|NCT02362594|11224707|FG001|NOT COMPLETED|Overall Study||225
10096070|NCT02362646|11224715|FG000|STARTED|Overall Study||106
10096071|NCT02362646|11224716|FG001|STARTED|Overall Study||53
10096072|NCT02362646|11224715|FG000|COMPLETED|Overall Study||68
10096073|NCT02362646|11224716|FG001|COMPLETED|Overall Study||29
10096074|NCT02362646|11224715|FG000|NOT COMPLETED|Overall Study||38
10096075|NCT02362646|11224716|FG001|NOT COMPLETED|Overall Study||24
10096076|NCT02362672|11224726|FG000|STARTED|Titration Phase||1189
10096077|NCT02362672|11224727|FG001|STARTED|Titration Phase||0
10096078|NCT02362672|11224728|FG002|STARTED|Titration Phase||0
10096079|NCT02362672|11224726|FG000|COMPLETED|Titration Phase||610
10096080|NCT02362672|11224727|FG001|COMPLETED|Titration Phase||0
10096081|NCT02362672|11224728|FG002|COMPLETED|Titration Phase||0
10096082|NCT02362672|11224726|FG000|NOT COMPLETED|Titration Phase||579
10096083|NCT02362672|11224727|FG001|NOT COMPLETED|Titration Phase||0
10096084|NCT02362672|11224728|FG002|NOT COMPLETED|Titration Phase||0
10096085|NCT02362672|11224726|FG000|STARTED|Double-blind Maintenance Phase||0
9871892|NCT00985166|10986132|FG002|Vaccinated at Visit 1|Overall Study||195
9871893|NCT00985166|10986130|FG000|COMPLETED|Overall Study||392
9871894|NCT00985166|10986131|FG001|COMPLETED|Overall Study||201
9871895|NCT00985166|10986132|FG002|COMPLETED|Overall Study||188
9871896|NCT00985166|10986130|FG000|NOT COMPLETED|Overall Study||9
9871897|NCT00985166|10986131|FG001|NOT COMPLETED|Overall Study||4
9871898|NCT00985166|10986132|FG002|NOT COMPLETED|Overall Study||7
9871899|NCT00985192|10986142|FG000|STARTED|Overall Study||49
9871900|NCT00985192|10986142|FG000|COMPLETED|Overall Study||45
9871901|NCT00985192|10986142|FG000|NOT COMPLETED|Overall Study||4
9871902|NCT00985231|10986148|FG000|STARTED|Overall Study||133
9871903|NCT00985231|10986149|FG001|STARTED|Overall Study||132
9871904|NCT00985231|10986148|FG000|COMPLETED|Overall Study||130
9871905|NCT00985231|10986149|FG001|COMPLETED|Overall Study||129
9871906|NCT00985231|10986148|FG000|NOT COMPLETED|Overall Study||3
9871907|NCT00985231|10986149|FG001|NOT COMPLETED|Overall Study||3
9871908|NCT00985257|10986155|FG000|STARTED|Overall Study||123
9871909|NCT00985257|10986155|FG000|COMPLETED|Overall Study||123
9871910|NCT00985257|10986155|FG000|NOT COMPLETED|Overall Study||0
9871911|NCT00985426|10986161|FG000|STARTED|Overall Study||258
9871912|NCT00985426|10986162|FG001|STARTED|Overall Study||263
9871913|NCT00985426|10986161|FG000|COMPLETED|Overall Study||215
9871914|NCT00985426|10986162|FG001|COMPLETED|Overall Study||219
9871915|NCT00985426|10986161|FG000|NOT COMPLETED|Overall Study||43
9871916|NCT00985426|10986162|FG001|NOT COMPLETED|Overall Study||44
9871917|NCT00985439|10986172|FG000|STARTED|Overall Study||49
9871918|NCT00985439|10986173|FG001|STARTED|Overall Study||51
9871919|NCT00985439|10986174|FG002|STARTED|Overall Study||51
9871920|NCT00985439|10986175|FG003|STARTED|Overall Study||51
9871921|NCT00985439|10986172|FG000|COMPLETED|Overall Study||49
9871922|NCT00985439|10986173|FG001|COMPLETED|Overall Study||51
9871923|NCT00985439|10986174|FG002|COMPLETED|Overall Study||50
9871924|NCT00985439|10986175|FG003|COMPLETED|Overall Study||51
9871925|NCT00985439|10986172|FG000|NOT COMPLETED|Overall Study||0
9871926|NCT00985439|10986173|FG001|NOT COMPLETED|Overall Study||0
9871927|NCT00985439|10986174|FG002|NOT COMPLETED|Overall Study||1
9871928|NCT00985439|10986175|FG003|NOT COMPLETED|Overall Study||0
9871929|NCT00985465|10986187|FG000|STARTED|Overall Study||141
9871930|NCT00985465|10986188|FG001|STARTED|Overall Study||69
9871931|NCT00985465|10986187|FG000|COMPLETED|Overall Study||140
9871932|NCT00985465|10986188|FG001|COMPLETED|Overall Study||66
9871933|NCT00985465|10986187|FG000|NOT COMPLETED|Overall Study||1
9871934|NCT00985465|10986188|FG001|NOT COMPLETED|Overall Study||3
9871935|NCT00985491|10986195|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
9871936|NCT00985491|10986195|FG000|Received Device|Overall Study||43
9871937|NCT00985491|10986195|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
9871938|NCT00985491|10986195|FG000|NOT COMPLETED|Overall Study||19
9871939|NCT00985504|10986202|FG000|STARTED|Acute Treatment Period||244
9871940|NCT00985504|10986203|FG001|STARTED|Acute Treatment Period||239
9871941|NCT00985504|10986202|FG000|COMPLETED|Acute Treatment Period||229
9871942|NCT00985504|10986203|FG001|COMPLETED|Acute Treatment Period||227
9871943|NCT00985504|10986202|FG000|NOT COMPLETED|Acute Treatment Period||15
9871944|NCT00985504|10986203|FG001|NOT COMPLETED|Acute Treatment Period||12
9871945|NCT00985504|10986202|FG000|STARTED|Optimization Period||229
9871946|NCT00985504|10986203|FG001|STARTED|Optimization Period||227
9871947|NCT00985504|10986202|FG000|COMPLETED|Optimization Period||203
9871948|NCT00985504|10986203|FG001|COMPLETED|Optimization Period||204
9871949|NCT00985504|10986202|FG000|NOT COMPLETED|Optimization Period||26
9871950|NCT00985504|10986203|FG001|NOT COMPLETED|Optimization Period||23
9871951|NCT00985517|10986213|FG000|STARTED|Overall Study||3
9871952|NCT00985517|10986214|FG001|STARTED|Overall Study||3
9871953|NCT00985517|10986215|FG002|STARTED|Overall Study||24
9871954|NCT00985517|10986216|FG003|STARTED|Overall Study||27
9871955|NCT00985517|10986213|FG000|COMPLETED|Overall Study||3
9871956|NCT00985517|10986214|FG001|COMPLETED|Overall Study||3
9871957|NCT00985517|10986215|FG002|COMPLETED|Overall Study||23
9871958|NCT00985517|10986216|FG003|COMPLETED|Overall Study||24
9871959|NCT00985517|10986213|FG000|NOT COMPLETED|Overall Study||0
9871960|NCT00985517|10986214|FG001|NOT COMPLETED|Overall Study||0
9871961|NCT00985517|10986215|FG002|NOT COMPLETED|Overall Study||1
9871962|NCT00985517|10986216|FG003|NOT COMPLETED|Overall Study||3
9871963|NCT00985543|10986227|FG000|STARTED|Overall Study||22
9871964|NCT00985543|10986227|FG000|COMPLETED|Overall Study||22
9871965|NCT00985543|10986227|FG000|NOT COMPLETED|Overall Study||0
9871966|NCT00985621|10986237|FG000|STARTED|Overall Study||142
9871967|NCT00985621|10986238|FG001|STARTED|Overall Study||161
9871968|NCT00985621|10986239|FG002|STARTED|Overall Study||152
9871969|NCT00985621|10986240|FG003|STARTED|Overall Study||159
9871970|NCT00985621|10986237|FG000|Treated|Overall Study||141
9871971|NCT00985621|10986238|FG001|Treated|Overall Study||161
9871972|NCT00985621|10986239|FG002|Treated|Overall Study||150
9871973|NCT00985621|10986240|FG003|Treated|Overall Study||158
9871974|NCT00985621|10986237|FG000|COMPLETED|Overall Study||28
9871975|NCT00985621|10986238|FG001|COMPLETED|Overall Study||30
9871976|NCT00985621|10986239|FG002|COMPLETED|Overall Study||29
9871977|NCT00985621|10986240|FG003|COMPLETED|Overall Study||22
9871978|NCT00985621|10986237|FG000|NOT COMPLETED|Overall Study||114
9871979|NCT00985621|10986238|FG001|NOT COMPLETED|Overall Study||131
9871980|NCT00985621|10986239|FG002|NOT COMPLETED|Overall Study||123
9871981|NCT00985621|10986240|FG003|NOT COMPLETED|Overall Study||137
9871982|NCT00985673|10986258|FG000|STARTED|Overall Study||102
9871983|NCT00985673|10986259|FG001|STARTED|Overall Study||104
9871984|NCT00985673|10986260|FG002|STARTED|Overall Study||102
9871985|NCT00985673|10986261|FG003|STARTED|Overall Study||100
9871986|NCT00985673|10986262|FG004|STARTED|Overall Study||101
9871987|NCT00985673|10986263|FG005|STARTED|Overall Study||102
9871988|NCT00985673|10986258|FG000|COMPLETED|Overall Study||95
9871989|NCT00985673|10986259|FG001|COMPLETED|Overall Study||93
9871990|NCT00985673|10986260|FG002|COMPLETED|Overall Study||90
9871991|NCT00985673|10986261|FG003|COMPLETED|Overall Study||88
9871992|NCT00985673|10986262|FG004|COMPLETED|Overall Study||93
9871993|NCT00985673|10986263|FG005|COMPLETED|Overall Study||96
9871994|NCT00985673|10986258|FG000|NOT COMPLETED|Overall Study||7
9871995|NCT00985673|10986259|FG001|NOT COMPLETED|Overall Study||11
9871996|NCT00985673|10986260|FG002|NOT COMPLETED|Overall Study||12
9871997|NCT00985673|10986261|FG003|NOT COMPLETED|Overall Study||12
9871998|NCT00985673|10986262|FG004|NOT COMPLETED|Overall Study||8
9871999|NCT00985673|10986263|FG005|NOT COMPLETED|Overall Study||6
9872000|NCT00985686|10986282|FG000|STARTED|Overall Study||18
9872001|NCT00985686|10986283|FG001|STARTED|Overall Study||16
9872002|NCT00985686|10986284|FG002|STARTED|Overall Study||13
9872003|NCT00985686|10986285|FG003|STARTED|Overall Study||16
9872004|NCT00985686|10986282|FG000|Visit 1: Baseline Data Collection|Overall Study||18
9872005|NCT00985686|10986283|FG001|Visit 1: Baseline Data Collection|Overall Study||15
9872006|NCT00985686|10986284|FG002|Visit 1: Baseline Data Collection|Overall Study||13
9872007|NCT00985686|10986285|FG003|Visit 1: Baseline Data Collection|Overall Study||16
9872008|NCT00985686|10986282|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18
9872009|NCT00985686|10986283|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15
9872010|NCT00985686|10986284|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13
9872011|NCT00985686|10986285|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16
9872012|NCT00985686|10986282|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17
9872013|NCT00985686|10986283|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15
9872014|NCT00985686|10986284|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13
9872015|NCT00985686|10986285|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16
9872016|NCT00985686|10986282|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17
9872017|NCT00985686|10986283|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15
9872018|NCT00985686|10986284|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13
9872019|NCT00985686|10986285|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14
9872020|NCT00985686|10986282|FG000|COMPLETED|Overall Study||17
9872021|NCT00985686|10986283|FG001|COMPLETED|Overall Study||15
9872022|NCT00985686|10986284|FG002|COMPLETED|Overall Study||13
9872023|NCT00985686|10986285|FG003|COMPLETED|Overall Study||14
9872024|NCT00985686|10986282|FG000|NOT COMPLETED|Overall Study||1
9872025|NCT00985686|10986283|FG001|NOT COMPLETED|Overall Study||1
9872026|NCT00985686|10986284|FG002|NOT COMPLETED|Overall Study||0
9872027|NCT00985686|10986285|FG003|NOT COMPLETED|Overall Study||2
9872028|NCT00985712|10986295|FG000|STARTED|Overall Study||133
9872029|NCT00985712|10986296|FG001|STARTED|Overall Study||130
9872030|NCT00985712|10986295|FG000|Received at Least One Dose of Study Drug|Overall Study||131
9872031|NCT00985712|10986296|FG001|Received at Least One Dose of Study Drug|Overall Study||130
9872032|NCT00985712|10986295|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
9872033|NCT00985712|10986296|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
9872034|NCT00985712|10986295|FG000|COMPLETED|Overall Study||127
9872035|NCT00985712|10986296|FG001|COMPLETED|Overall Study||123
9872036|NCT00985712|10986295|FG000|NOT COMPLETED|Overall Study||6
9872037|NCT00985712|10986296|FG001|NOT COMPLETED|Overall Study||7
9872038|NCT00985725|10986304|FG000|STARTED|Overall Study||71
9872039|NCT00985725|10986305|FG001|STARTED|Overall Study||72
9872040|NCT00985725|10986304|FG000|COMPLETED|Overall Study||60
9872041|NCT00985725|10986305|FG001|COMPLETED|Overall Study||59
9872042|NCT00985725|10986304|FG000|NOT COMPLETED|Overall Study||11
9872043|NCT00985725|10986305|FG001|NOT COMPLETED|Overall Study||13
9872044|NCT00985751|10986316|FG000|STARTED|Overall Study||51
9872045|NCT00985751|10986317|FG001|STARTED|Overall Study||52
9872046|NCT00985751|10986318|FG002|STARTED|Overall Study||52
9872047|NCT00985751|10986319|FG003|STARTED|Overall Study||51
9872048|NCT00985751|10986320|FG004|STARTED|Overall Study||51
9872049|NCT00985751|10986316|FG000|COMPLETED|Overall Study||51
9872050|NCT00985751|10986317|FG001|COMPLETED|Overall Study||52
9872051|NCT00985751|10986318|FG002|COMPLETED|Overall Study||52
9872052|NCT00985751|10986319|FG003|COMPLETED|Overall Study||51
9872053|NCT00985751|10986320|FG004|COMPLETED|Overall Study||50
9872054|NCT00985751|10986316|FG000|NOT COMPLETED|Overall Study||0
9872055|NCT00985751|10986317|FG001|NOT COMPLETED|Overall Study||0
9872056|NCT00985751|10986318|FG002|NOT COMPLETED|Overall Study||0
9872057|NCT00985751|10986319|FG003|NOT COMPLETED|Overall Study||0
9872058|NCT00985751|10986320|FG004|NOT COMPLETED|Overall Study||1
9872059|NCT00985790|10986337|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
9872060|NCT00985790|10986338|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
9872061|NCT00985790|10986337|FG000|COMPLETED|Overall Study||291
9872062|NCT00985790|10986338|FG001|COMPLETED|Overall Study||293
9872063|NCT00985790|10986337|FG000|NOT COMPLETED|Overall Study||7
9872064|NCT00985790|10986338|FG001|NOT COMPLETED|Overall Study||8
9872065|NCT00985829|10986349|FG000|STARTED|Overall Study||28
10096086|NCT02362672|11224727|FG001|STARTED|Double-blind Maintenance Phase||309
10096087|NCT02362672|11224728|FG002|STARTED|Double-blind Maintenance Phase||301
10096088|NCT02362672|11224726|FG000|COMPLETED|Double-blind Maintenance Phase||0
9872066|NCT00985829|10986349|FG000|COMPLETED|Overall Study||28
9872067|NCT00985829|10986349|FG000|NOT COMPLETED|Overall Study||0
9872068|NCT00985907|10986354|FG000|STARTED|Overall Study||13
9872069|NCT00985907|10986354|FG000|COMPLETED|Overall Study||0
9872070|NCT00985907|10986354|FG000|NOT COMPLETED|Overall Study||13
9872071|NCT00985946|10986358|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
9872072|NCT00985946|10986358|FG000|COMPLETED|Overall Study||8
9872073|NCT00985946|10986358|FG000|NOT COMPLETED|Overall Study||7
9872074|NCT00985959|10986365|FG000|STARTED|Overall Study|Number of participants treated|6
9872075|NCT00985959|10986366|FG001|STARTED|Overall Study|Number of participants treated|6
9872076|NCT00985959|10986367|FG002|STARTED|Overall Study|Number of participants treated|87
10096089|NCT02362672|11224727|FG001|COMPLETED|Double-blind Maintenance Phase||249
10096090|NCT02362672|11224728|FG002|COMPLETED|Double-blind Maintenance Phase||242
10096091|NCT02362672|11224726|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
10096092|NCT02362672|11224727|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60
10096093|NCT02362672|11224728|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59
10096094|NCT02362724|11224739|FG000|STARTED|Overall Study||59
10096095|NCT02362724|11224740|FG001|STARTED|Overall Study||30
10096096|NCT02362724|11224739|FG000|COMPLETED|Overall Study||53
10096097|NCT02362724|11224740|FG001|COMPLETED|Overall Study||29
10096098|NCT02362724|11224739|FG000|NOT COMPLETED|Overall Study||6
10096099|NCT02362724|11224740|FG001|NOT COMPLETED|Overall Study||1
10096100|NCT02362789|11224748|FG000|STARTED|Run-in Phase (Week 0 to 16)||130
10096101|NCT02362789|11224749|FG001|STARTED|Run-in Phase (Week 0 to 16)||0
10096102|NCT02362789|11224750|FG002|STARTED|Run-in Phase (Week 0 to 16)||0
10096103|NCT02362789|11224748|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128
10096104|NCT02362789|11224749|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0
10096105|NCT02362789|11224750|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0
10096106|NCT02362789|11224748|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
10096107|NCT02362789|11224749|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
10096108|NCT02362789|11224750|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
10096109|NCT02362789|11224748|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
10096110|NCT02362789|11224749|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
10096111|NCT02362789|11224750|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
10096112|NCT02362789|11224748|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
10096113|NCT02362789|11224749|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
10096114|NCT02362789|11224750|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
10096115|NCT02362789|11224748|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
10096116|NCT02362789|11224749|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
10096117|NCT02362789|11224750|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
10096118|NCT02363270|11224759|FG000|STARTED|Overall Study||24
10096119|NCT02363270|11224760|FG001|STARTED|Overall Study||24
10096120|NCT02363270|11224759|FG000|COMPLETED|Overall Study||24
10096121|NCT02363270|11224760|FG001|COMPLETED|Overall Study||24
10096122|NCT02363270|11224759|FG000|NOT COMPLETED|Overall Study||0
10096123|NCT02363270|11224760|FG001|NOT COMPLETED|Overall Study||0
10096124|NCT02363283|11224766|FG000|STARTED|Overall Study||37
10096125|NCT02363283|11224766|FG000|COMPLETED|Overall Study||35
10096126|NCT02363283|11224766|FG000|NOT COMPLETED|Overall Study||2
10096127|NCT02363322|11224772|FG000|STARTED|Overall Study||36
10096128|NCT02363322|11224773|FG001|STARTED|Overall Study||36
10096129|NCT02363322|11224772|FG000|COMPLETED|Overall Study||35
10096130|NCT02363322|11224773|FG001|COMPLETED|Overall Study||36
10096131|NCT02363322|11224772|FG000|NOT COMPLETED|Overall Study||1
10096132|NCT02363322|11224773|FG001|NOT COMPLETED|Overall Study||0
10096133|NCT02363439|11224779|FG000|STARTED|Overall Study||5
10096134|NCT02363439|11224779|FG000|COMPLETED|Overall Study||1
9872077|NCT00985959|10986365|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3
9872078|NCT00985959|10986366|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3
9872079|NCT00985959|10986367|FG002|COMPLETED|Overall Study||28
9872080|NCT00985959|10986365|FG000|NOT COMPLETED|Overall Study||3
10096135|NCT02363439|11224779|FG000|NOT COMPLETED|Overall Study||4
10096136|NCT02363478|11224783|FG000|STARTED|Overall Study||30
10096137|NCT02363478|11224783|FG000|COMPLETED|Overall Study||22
10096138|NCT02363478|11224783|FG000|NOT COMPLETED|Overall Study||8
10096139|NCT02363621|11224790|FG000|STARTED|Overall Study||51
10096140|NCT02363621|11224791|FG001|STARTED|Overall Study||50
10096141|NCT02363621|11224790|FG000|COMPLETED|Overall Study||50
10096142|NCT02363621|11224791|FG001|COMPLETED|Overall Study||50
10096143|NCT02363621|11224790|FG000|NOT COMPLETED|Overall Study||1
10096144|NCT02363621|11224791|FG001|NOT COMPLETED|Overall Study||0
10096145|NCT02363686|11224797|FG000|STARTED|Overall Study||248
10096146|NCT02363686|11224797|FG000|COMPLETED|Overall Study||213
9872081|NCT00985959|10986366|FG001|NOT COMPLETED|Overall Study||3
9872082|NCT00985959|10986367|FG002|NOT COMPLETED|Overall Study||59
9872083|NCT00985985|10986385|FG000|STARTED|Overall Study||241
9872084|NCT00985985|10986386|FG001|STARTED|Overall Study||242
9872085|NCT00985985|10986387|FG002|STARTED|Overall Study||120
9872086|NCT00985985|10986388|FG003|STARTED|Overall Study||120
9872087|NCT00985985|10986385|FG000|Safety Population|Overall Study||241
9872088|NCT00985985|10986386|FG001|Safety Population|Overall Study||242
9872089|NCT00985985|10986387|FG002|Safety Population|Overall Study||119
9872090|NCT00985985|10986388|FG003|Safety Population|Overall Study||118
9872091|NCT00985985|10986385|FG000|Full Analysis Set (FAS) Population|Overall Study||241
9872092|NCT00985985|10986386|FG001|Full Analysis Set (FAS) Population|Overall Study||242
9872093|NCT00985985|10986387|FG002|Full Analysis Set (FAS) Population|Overall Study||120
9872094|NCT00985985|10986388|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
9872095|NCT00985985|10986385|FG000|COMPLETED|Overall Study||217
9872096|NCT00985985|10986386|FG001|COMPLETED|Overall Study||218
9872097|NCT00985985|10986387|FG002|COMPLETED|Overall Study||109
9872098|NCT00985985|10986388|FG003|COMPLETED|Overall Study||107
9872099|NCT00985985|10986385|FG000|NOT COMPLETED|Overall Study||24
9872100|NCT00985985|10986386|FG001|NOT COMPLETED|Overall Study||24
9872101|NCT00985985|10986387|FG002|NOT COMPLETED|Overall Study||11
9872102|NCT00985985|10986388|FG003|NOT COMPLETED|Overall Study||13
10096147|NCT02363686|11224797|FG000|NOT COMPLETED|Overall Study||35
10096148|NCT02363738|11224803|FG000|STARTED|Overall Study||29
10096149|NCT02363738|11224804|FG001|STARTED|Overall Study||31
10096150|NCT02363738|11224803|FG000|COMPLETED|Overall Study||21
10096151|NCT02363738|11224804|FG001|COMPLETED|Overall Study||26
10096152|NCT02363738|11224803|FG000|NOT COMPLETED|Overall Study||8
10096153|NCT02363738|11224804|FG001|NOT COMPLETED|Overall Study||5
10096154|NCT02363803|11224812|FG000|STARTED|Period 1||17
10096155|NCT02363803|11224813|FG001|STARTED|Period 1||17
10096156|NCT02363803|11224812|FG000|COMPLETED|Period 1||17
10096157|NCT02363803|11224813|FG001|COMPLETED|Period 1||17
10096158|NCT02363803|11224812|FG000|NOT COMPLETED|Period 1||0
10096159|NCT02363803|11224813|FG001|NOT COMPLETED|Period 1||0
10096160|NCT02363803|11224812|FG000|STARTED|Period 2||17
10096161|NCT02363803|11224813|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16
10096162|NCT02363803|11224812|FG000|COMPLETED|Period 2||17
10096163|NCT02363803|11224813|FG001|COMPLETED|Period 2||16
10096164|NCT02363803|11224812|FG000|NOT COMPLETED|Period 2||0
10096165|NCT02363803|11224813|FG001|NOT COMPLETED|Period 2||0
10096166|NCT02363907|11224825|FG000|STARTED|Overall Study||30
10096167|NCT02363907|11224825|FG000|COMPLETED|Overall Study||30
10096168|NCT02363907|11224825|FG000|NOT COMPLETED|Overall Study||0
10096169|NCT02363933|11224829|FG000|STARTED|Overall Study||8
10096170|NCT02363933|11224829|FG000|COMPLETED|Overall Study||2
10096171|NCT02363933|11224829|FG000|NOT COMPLETED|Overall Study||6
10096172|NCT02363946|11224846|FG000|STARTED|Overall Study||4
10096173|NCT02363946|11224847|FG001|STARTED|Overall Study||4
10096174|NCT02363946|11224848|FG002|STARTED|Overall Study||4
10096175|NCT02363946|11224849|FG003|STARTED|Overall Study||4
10096176|NCT02363946|11224850|FG004|STARTED|Overall Study||4
10096177|NCT02363946|11224851|FG005|STARTED|Overall Study||4
10096178|NCT02363946|11224852|FG006|STARTED|Overall Study||4
10096179|NCT02363946|11224853|FG007|STARTED|Overall Study||4
10096180|NCT02363946|11224854|FG008|STARTED|Overall Study||4
10096181|NCT02363946|11224855|FG009|STARTED|Overall Study||18
10096182|NCT02363946|11224856|FG010|STARTED|Overall Study||4
10096183|NCT02363946|11224857|FG011|STARTED|Overall Study||3
10096184|NCT02363946|11224858|FG012|STARTED|Overall Study||4
10096185|NCT02363946|11224846|FG000|COMPLETED|Overall Study||4
10096186|NCT02363946|11224847|FG001|COMPLETED|Overall Study||4
9872103|NCT00986102|10986407|FG000|STARTED|Overall Study|Number of participants who received study medication|53
9872104|NCT00986102|10986408|FG001|STARTED|Overall Study|Number of participants who received study medication|77
9872105|NCT00986102|10986409|FG002|STARTED|Overall Study|Number of participants who received study medication|19
9872106|NCT00986102|10986410|FG003|STARTED|Overall Study|Number of participants who received study medication|67
10096187|NCT02363946|11224848|FG002|COMPLETED|Overall Study||4
10096188|NCT02363946|11224849|FG003|COMPLETED|Overall Study||4
10096189|NCT02363946|11224850|FG004|COMPLETED|Overall Study||4
10096190|NCT02363946|11224851|FG005|COMPLETED|Overall Study||4
10096191|NCT02363946|11224852|FG006|COMPLETED|Overall Study||4
10096192|NCT02363946|11224853|FG007|COMPLETED|Overall Study||3
10096193|NCT02363946|11224854|FG008|COMPLETED|Overall Study||4
10096194|NCT02363946|11224855|FG009|COMPLETED|Overall Study||18
10096195|NCT02363946|11224856|FG010|COMPLETED|Overall Study||4
10096196|NCT02363946|11224857|FG011|COMPLETED|Overall Study||3
10096197|NCT02363946|11224858|FG012|COMPLETED|Overall Study||4
10096198|NCT02363946|11224846|FG000|NOT COMPLETED|Overall Study||0
10096199|NCT02363946|11224847|FG001|NOT COMPLETED|Overall Study||0
10096200|NCT02363946|11224848|FG002|NOT COMPLETED|Overall Study||0
10096201|NCT02363946|11224849|FG003|NOT COMPLETED|Overall Study||0
10096202|NCT02363946|11224850|FG004|NOT COMPLETED|Overall Study||0
10096203|NCT02363946|11224851|FG005|NOT COMPLETED|Overall Study||0
10096204|NCT02363946|11224852|FG006|NOT COMPLETED|Overall Study||0
10096205|NCT02363946|11224853|FG007|NOT COMPLETED|Overall Study||1
10096206|NCT02363946|11224854|FG008|NOT COMPLETED|Overall Study||0
10096207|NCT02363946|11224855|FG009|NOT COMPLETED|Overall Study||0
10096208|NCT02363946|11224856|FG010|NOT COMPLETED|Overall Study||0
10096209|NCT02363946|11224857|FG011|NOT COMPLETED|Overall Study||0
9872107|NCT00986102|10986407|FG000|COMPLETED|Overall Study||52
9872108|NCT00986102|10986408|FG001|COMPLETED|Overall Study||75
9872109|NCT00986102|10986409|FG002|COMPLETED|Overall Study||19
9872110|NCT00986102|10986410|FG003|COMPLETED|Overall Study||66
9872111|NCT00986102|10986407|FG000|NOT COMPLETED|Overall Study||1
9872112|NCT00986102|10986408|FG001|NOT COMPLETED|Overall Study||2
9872113|NCT00986102|10986409|FG002|NOT COMPLETED|Overall Study||0
9872114|NCT00986102|10986410|FG003|NOT COMPLETED|Overall Study||1
9872115|NCT00986154|10986422|FG000|STARTED|Overall Study||4143
10096210|NCT02363946|11224858|FG012|NOT COMPLETED|Overall Study||0
10096211|NCT02363959|11224888|FG000|STARTED|Overall Study||10
10096212|NCT02363959|11224889|FG001|STARTED|Overall Study||10
10096213|NCT02363959|11224888|FG000|COMPLETED|Overall Study||9
10096214|NCT02363959|11224889|FG001|COMPLETED|Overall Study||10
10096215|NCT02363959|11224888|FG000|NOT COMPLETED|Overall Study||1
10096216|NCT02363959|11224889|FG001|NOT COMPLETED|Overall Study||0
10096217|NCT02363972|11224895|FG000|STARTED|Overall Study||103
10096218|NCT02363972|11224895|FG000|COMPLETED|Overall Study||77
10096219|NCT02363972|11224895|FG000|NOT COMPLETED|Overall Study||26
10096220|NCT02364037|11224901|FG000|STARTED|Overall Study||502
10096221|NCT02364037|11224902|FG001|STARTED|Overall Study||506
10096222|NCT02364037|11224901|FG000|COMPLETED|Overall Study||458
10096223|NCT02364037|11224902|FG001|COMPLETED|Overall Study||453
10096224|NCT02364037|11224901|FG000|NOT COMPLETED|Overall Study||44
10096225|NCT02364037|11224902|FG001|NOT COMPLETED|Overall Study||53
10096226|NCT02364076|11224908|FG000|STARTED|Overall Study||45
10096227|NCT02364076|11224908|FG000|COMPLETED|Overall Study||40
10096228|NCT02364076|11224908|FG000|NOT COMPLETED|Overall Study||5
10096229|NCT02364180|11224912|FG000|STARTED|Overall Study||11
10096230|NCT02364180|11224912|FG000|COMPLETED|Overall Study||10
10096231|NCT02364180|11224912|FG000|NOT COMPLETED|Overall Study||1
10096232|NCT02364271|11224918|FG000|STARTED|Overall Study||479
10096233|NCT02364271|11224919|FG001|STARTED|Overall Study||123
10096234|NCT02364271|11224918|FG000|COMPLETED|Overall Study||479
10096235|NCT02364271|11224919|FG001|COMPLETED|Overall Study||123
10096236|NCT02364271|11224918|FG000|NOT COMPLETED|Overall Study||0
10096237|NCT02364271|11224919|FG001|NOT COMPLETED|Overall Study||0
10096238|NCT02364336|11224928|FG000|STARTED|Overall Study||1
10096239|NCT02364336|11224929|FG001|STARTED|Overall Study||12
10096240|NCT02364336|11224928|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1
10096241|NCT02364336|11224929|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12
10096242|NCT02364336|11224928|FG000|End of Peginterferon Treatment|Overall Study||1
10096243|NCT02364336|11224929|FG001|End of Peginterferon Treatment|Overall Study||11
10096244|NCT02364336|11224928|FG000|24 Weeks After End of Peginterferon|Overall Study||1
10096245|NCT02364336|11224929|FG001|24 Weeks After End of Peginterferon|Overall Study||11
10096246|NCT02364336|11224928|FG000|48 Weeks After End of Peginterferon|Overall Study||1
10096247|NCT02364336|11224929|FG001|48 Weeks After End of Peginterferon|Overall Study||10
10096248|NCT02364336|11224928|FG000|COMPLETED|Overall Study||1
10096249|NCT02364336|11224929|FG001|COMPLETED|Overall Study||11
10096250|NCT02364336|11224928|FG000|NOT COMPLETED|Overall Study||0
10096251|NCT02364336|11224929|FG001|NOT COMPLETED|Overall Study||1
10096252|NCT02364388|11224936|FG000|STARTED|Overall Study||217
10096253|NCT02364388|11224936|FG000|Biopsied|Overall Study||209
10096254|NCT02364388|11224936|FG000|Excluded|Overall Study||8
10096255|NCT02364388|11224936|FG000|COMPLETED|Overall Study||209
10096256|NCT02364388|11224936|FG000|NOT COMPLETED|Overall Study||8
10096257|NCT02364570|11224940|FG000|STARTED|Overall Study||1
10096258|NCT02364570|11224941|FG001|STARTED|Overall Study||1
10096259|NCT02364570|11224942|FG002|STARTED|Overall Study||2
10096260|NCT02364570|11224943|FG003|STARTED|Overall Study||1
10096261|NCT02364570|11224944|FG004|STARTED|Overall Study||1
10096262|NCT02364570|11224945|FG005|STARTED|Overall Study||1
10096263|NCT02364570|11224946|FG006|STARTED|Overall Study||2
10096264|NCT02364570|11224947|FG007|STARTED|Overall Study||1
10096265|NCT02364570|11224948|FG008|STARTED|Overall Study||2
10096266|NCT02364570|11224949|FG009|STARTED|Overall Study||1
10096267|NCT02364570|11224950|FG010|STARTED|Overall Study||1
10096268|NCT02364570|11224951|FG011|STARTED|Overall Study||1
9872116|NCT00986154|10986423|FG001|STARTED|Overall Study||4149
9872117|NCT00986154|10986422|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118
9872118|NCT00986154|10986423|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122
10096269|NCT02364570|11224952|FG012|STARTED|Overall Study||1
10096270|NCT02364570|11224953|FG013|STARTED|Overall Study||2
10096271|NCT02364570|11224954|FG014|STARTED|Overall Study||1
10096272|NCT02364570|11224955|FG015|STARTED|Overall Study||1
10096273|NCT02364570|11224940|FG000|COMPLETED|Overall Study||1
10096274|NCT02364570|11224941|FG001|COMPLETED|Overall Study||1
10096275|NCT02364570|11224942|FG002|COMPLETED|Overall Study||2
10096276|NCT02364570|11224943|FG003|COMPLETED|Overall Study||1
10096277|NCT02364570|11224944|FG004|COMPLETED|Overall Study||1
10096278|NCT02364570|11224945|FG005|COMPLETED|Overall Study||1
10096279|NCT02364570|11224946|FG006|COMPLETED|Overall Study||2
10096280|NCT02364570|11224947|FG007|COMPLETED|Overall Study||1
10096281|NCT02364570|11224948|FG008|COMPLETED|Overall Study||2
10096282|NCT02364570|11224949|FG009|COMPLETED|Overall Study||1
10096283|NCT02364570|11224950|FG010|COMPLETED|Overall Study||1
10096284|NCT02364570|11224951|FG011|COMPLETED|Overall Study||1
10096285|NCT02364570|11224952|FG012|COMPLETED|Overall Study||1
10096286|NCT02364570|11224953|FG013|COMPLETED|Overall Study||2
10096287|NCT02364570|11224954|FG014|COMPLETED|Overall Study||1
10096288|NCT02364570|11224955|FG015|COMPLETED|Overall Study||1
10096289|NCT02364570|11224940|FG000|NOT COMPLETED|Overall Study||0
9872119|NCT00986154|10986422|FG000|COMPLETED|Overall Study||3937
9872120|NCT00986154|10986423|FG001|COMPLETED|Overall Study||3955
9872121|NCT00986154|10986422|FG000|NOT COMPLETED|Overall Study||206
9872122|NCT00986154|10986423|FG001|NOT COMPLETED|Overall Study||194
9872123|NCT00986180|10986431|FG000|STARTED|Overall Study||321
9872124|NCT00986180|10986432|FG001|STARTED|Overall Study||324
9872125|NCT00986180|10986431|FG000|COMPLETED|Overall Study||277
9872126|NCT00986180|10986432|FG001|COMPLETED|Overall Study||268
9872127|NCT00986180|10986431|FG000|NOT COMPLETED|Overall Study||44
9872128|NCT00986180|10986432|FG001|NOT COMPLETED|Overall Study||56
9872129|NCT00986232|10986442|FG000|STARTED|Overall Study||387
9872130|NCT00986232|10986443|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
9872131|NCT00986232|10986444|FG002|STARTED|Overall Study||381
9872132|NCT00986232|10986445|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
9872133|NCT00986232|10986442|FG000|Vaccination Visit 1|Overall Study||387
9872134|NCT00986232|10986443|FG001|Vaccination Visit 1|Overall Study||393
9872135|NCT00986232|10986444|FG002|Vaccination Visit 1|Overall Study||381
9872136|NCT00986232|10986445|FG003|Vaccination Visit 1|Overall Study||390
9872137|NCT00986232|10986442|FG000|Vaccination Visit 2|Overall Study||360
9872138|NCT00986232|10986443|FG001|Vaccination Visit 2|Overall Study||365
9872139|NCT00986232|10986444|FG002|Vaccination Visit 2|Overall Study||360
9872140|NCT00986232|10986445|FG003|Vaccination Visit 2|Overall Study||0
9872141|NCT00986232|10986442|FG000|COMPLETED|Overall Study||336
9872142|NCT00986232|10986443|FG001|COMPLETED|Overall Study||343
9872143|NCT00986232|10986444|FG002|COMPLETED|Overall Study||346
9872144|NCT00986232|10986445|FG003|COMPLETED|Overall Study||370
10096290|NCT02364570|11224941|FG001|NOT COMPLETED|Overall Study||0
10096291|NCT02364570|11224942|FG002|NOT COMPLETED|Overall Study||0
10096292|NCT02364570|11224943|FG003|NOT COMPLETED|Overall Study||0
10096293|NCT02364570|11224944|FG004|NOT COMPLETED|Overall Study||0
10096294|NCT02364570|11224945|FG005|NOT COMPLETED|Overall Study||0
10096295|NCT02364570|11224946|FG006|NOT COMPLETED|Overall Study||0
10096296|NCT02364570|11224947|FG007|NOT COMPLETED|Overall Study||0
10096297|NCT02364570|11224948|FG008|NOT COMPLETED|Overall Study||0
10096298|NCT02364570|11224949|FG009|NOT COMPLETED|Overall Study||0
10096299|NCT02364570|11224950|FG010|NOT COMPLETED|Overall Study||0
10096300|NCT02364570|11224951|FG011|NOT COMPLETED|Overall Study||0
10096301|NCT02364570|11224952|FG012|NOT COMPLETED|Overall Study||0
10096302|NCT02364570|11224953|FG013|NOT COMPLETED|Overall Study||0
10096303|NCT02364570|11224954|FG014|NOT COMPLETED|Overall Study||0
10096304|NCT02364570|11224955|FG015|NOT COMPLETED|Overall Study||0
10096305|NCT02364700|11224965|FG000|STARTED|Overall Study||12
10096306|NCT02364700|11224965|FG000|COMPLETED|Overall Study||12
10096307|NCT02364700|11224965|FG000|NOT COMPLETED|Overall Study||0
10096308|NCT02364778|11224971|FG000|STARTED|Overall Study||30
10096309|NCT02364778|11224971|FG000|COMPLETED|Overall Study||30
10096310|NCT02364778|11224971|FG000|NOT COMPLETED|Overall Study||0
10096311|NCT02364947|11224980|FG000|STARTED|Overall Study||248
10096312|NCT02364947|11224981|FG001|STARTED|Overall Study||184
10096313|NCT02364947|11224982|FG002|STARTED|Overall Study||245
10096314|NCT02364947|11224980|FG000|COMPLETED|Overall Study||189
10096315|NCT02364947|11224981|FG001|COMPLETED|Overall Study||139
10096316|NCT02364947|11224982|FG002|COMPLETED|Overall Study||219
10096317|NCT02364947|11224980|FG000|NOT COMPLETED|Overall Study||59
10096318|NCT02364947|11224981|FG001|NOT COMPLETED|Overall Study||45
10096319|NCT02364947|11224982|FG002|NOT COMPLETED|Overall Study||26
10112993|NCT02506881|11243905|FG002|COMPLETED|Second Intervention (Day 1)||12
10112994|NCT02506881|11243906|FG003|COMPLETED|Second Intervention (Day 1)||12
10112995|NCT02506881|11243903|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
10112996|NCT02506881|11243904|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
10112997|NCT02506881|11243905|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
10112998|NCT02506881|11243906|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
10112999|NCT02507011|11243926|FG000|STARTED|First Intervention||1
10113000|NCT02507011|11243927|FG001|STARTED|First Intervention||1
10113001|NCT02507011|11243926|FG000|COMPLETED|First Intervention||1
9872145|NCT00986232|10986442|FG000|NOT COMPLETED|Overall Study||51
9872146|NCT00986232|10986443|FG001|NOT COMPLETED|Overall Study||50
9872147|NCT00986232|10986444|FG002|NOT COMPLETED|Overall Study||35
9872148|NCT00986232|10986445|FG003|NOT COMPLETED|Overall Study||20
9872149|NCT00986245|10986461|FG000|STARTED|First Intervention||41
9872150|NCT00986245|10986462|FG001|STARTED|First Intervention||41
10113002|NCT02507011|11243927|FG001|COMPLETED|First Intervention||1
10113003|NCT02507011|11243926|FG000|NOT COMPLETED|First Intervention||0
10113004|NCT02507011|11243927|FG001|NOT COMPLETED|First Intervention||0
10113005|NCT02507011|11243926|FG000|STARTED|Second Intervention||1
10113006|NCT02507011|11243927|FG001|STARTED|Second Intervention||1
10113007|NCT02507011|11243926|FG000|COMPLETED|Second Intervention||1
10113008|NCT02507011|11243927|FG001|COMPLETED|Second Intervention||1
10113009|NCT02507011|11243926|FG000|NOT COMPLETED|Second Intervention||0
10113010|NCT02507011|11243927|FG001|NOT COMPLETED|Second Intervention||0
10113011|NCT02507219|11243933|FG000|STARTED|Overall Study||5
10113012|NCT02507219|11243934|FG001|STARTED|Overall Study||4
10113013|NCT02507219|11243935|FG002|STARTED|Overall Study||3
10113014|NCT02507219|11243936|FG003|STARTED|Overall Study||3
10113015|NCT02507219|11243937|FG004|STARTED|Overall Study||4
10113016|NCT02507219|11243938|FG005|STARTED|Overall Study||3
10113017|NCT02507219|11243933|FG000|COMPLETED|Overall Study||4
10113018|NCT02507219|11243934|FG001|COMPLETED|Overall Study||4
9872151|NCT00986245|10986461|FG000|COMPLETED|First Intervention||31
9872152|NCT00986245|10986462|FG001|COMPLETED|First Intervention||33
10096320|NCT02364999|11224992|FG000|STARTED|Overall Study||358
10096321|NCT02364999|11224993|FG001|STARTED|Overall Study||361
10096322|NCT02364999|11224992|FG000|Received Treatment|Overall Study||356
10096323|NCT02364999|11224993|FG001|Received Treatment|Overall Study||358
10096324|NCT02364999|11224992|FG000|COMPLETED|Overall Study||193
10096325|NCT02364999|11224993|FG001|COMPLETED|Overall Study||188
9872153|NCT00986245|10986461|FG000|NOT COMPLETED|First Intervention||10
9872154|NCT00986245|10986462|FG001|NOT COMPLETED|First Intervention||8
9872155|NCT00986245|10986461|FG000|STARTED|Second Intervention||31
10096326|NCT02364999|11224992|FG000|NOT COMPLETED|Overall Study||165
10096327|NCT02364999|11224993|FG001|NOT COMPLETED|Overall Study||173
10096328|NCT02365064|11225002|FG000|STARTED|Overall Study||31
9872156|NCT00986245|10986462|FG001|STARTED|Second Intervention||33
9872157|NCT00986245|10986461|FG000|COMPLETED|Second Intervention||29
9872158|NCT00986245|10986462|FG001|COMPLETED|Second Intervention||32
9872159|NCT00986245|10986461|FG000|NOT COMPLETED|Second Intervention||2
9872160|NCT00986245|10986462|FG001|NOT COMPLETED|Second Intervention||1
9872161|NCT00986258|10986473|FG000|STARTED|Observation Period||136
10096329|NCT02365064|11225003|FG001|STARTED|Overall Study||47
10096330|NCT02365064|11225002|FG000|Included in ITT Analysis|Overall Study||29
10096331|NCT02365064|11225003|FG001|Included in ITT Analysis|Overall Study||32
10096332|NCT02365064|11225002|FG000|COMPLETED|Overall Study||21
10096333|NCT02365064|11225003|FG001|COMPLETED|Overall Study||19
10096334|NCT02365064|11225002|FG000|NOT COMPLETED|Overall Study||10
10096335|NCT02365064|11225003|FG001|NOT COMPLETED|Overall Study||28
10096336|NCT02365285|11225013|FG000|STARTED|Overall Study||7
10096337|NCT02365285|11225014|FG001|STARTED|Overall Study||6
10096338|NCT02365285|11225015|FG002|STARTED|Overall Study||7
10096339|NCT02365285|11225016|FG003|STARTED|Overall Study||3
10096340|NCT02365285|11225013|FG000|COMPLETED|Overall Study||7
10096341|NCT02365285|11225014|FG001|COMPLETED|Overall Study||5
10096342|NCT02365285|11225015|FG002|COMPLETED|Overall Study||6
10096343|NCT02365285|11225016|FG003|COMPLETED|Overall Study||1
10096344|NCT02365285|11225013|FG000|NOT COMPLETED|Overall Study||0
10096345|NCT02365285|11225014|FG001|NOT COMPLETED|Overall Study||1
10096346|NCT02365285|11225015|FG002|NOT COMPLETED|Overall Study||1
10096347|NCT02365285|11225016|FG003|NOT COMPLETED|Overall Study||2
10096348|NCT02365298|11225028|FG000|STARTED|Period 1||14
10096349|NCT02365298|11225029|FG001|STARTED|Period 1||14
10096350|NCT02365298|11225028|FG000|COMPLETED|Period 1||14
10096351|NCT02365298|11225029|FG001|COMPLETED|Period 1||14
10096352|NCT02365298|11225028|FG000|NOT COMPLETED|Period 1||0
10096353|NCT02365298|11225029|FG001|NOT COMPLETED|Period 1||0
10096354|NCT02365298|11225028|FG000|STARTED|Period 2||14
10096355|NCT02365298|11225029|FG001|STARTED|Period 2||14
10096356|NCT02365298|11225028|FG000|COMPLETED|Period 2||12
10096357|NCT02365298|11225029|FG001|COMPLETED|Period 2||12
10096358|NCT02365298|11225028|FG000|NOT COMPLETED|Period 2||2
10096359|NCT02365298|11225029|FG001|NOT COMPLETED|Period 2||2
10096360|NCT02365480|11225037|FG000|STARTED|Overall Study||14
10096361|NCT02365480|11225038|FG001|STARTED|Overall Study||4
9872162|NCT00986258|10986473|FG000|COMPLETED|Observation Period||125
9872163|NCT00986258|10986473|FG000|NOT COMPLETED|Observation Period||11
9872164|NCT00986258|10986473|FG000|STARTED|Titration and Optimal Dose Period||125
10096362|NCT02365480|11225037|FG000|COMPLETED|Overall Study||12
10096363|NCT02365480|11225038|FG001|COMPLETED|Overall Study||4
10096364|NCT02365480|11225037|FG000|NOT COMPLETED|Overall Study||2
10096365|NCT02365480|11225038|FG001|NOT COMPLETED|Overall Study||0
10096366|NCT02365506|11225047|FG000|STARTED|Overall Study||4
10096367|NCT02365506|11225048|FG001|STARTED|Overall Study||4
10096368|NCT02365506|11225049|FG002|STARTED|Overall Study||5
10096369|NCT02365506|11225047|FG000|COMPLETED|Overall Study||4
10096370|NCT02365506|11225048|FG001|COMPLETED|Overall Study||4
10096371|NCT02365506|11225049|FG002|COMPLETED|Overall Study||4
10096372|NCT02365506|11225047|FG000|NOT COMPLETED|Overall Study||0
10096373|NCT02365506|11225048|FG001|NOT COMPLETED|Overall Study||0
10096374|NCT02365506|11225049|FG002|NOT COMPLETED|Overall Study||1
10096375|NCT02365519|11225059|FG000|STARTED|Vehicle Run-In||213
9872165|NCT00986258|10986473|FG000|COMPLETED|Titration and Optimal Dose Period||102
10096376|NCT02365519|11225060|FG001|STARTED|Vehicle Run-In||0
10096377|NCT02365519|11225061|FG002|STARTED|Vehicle Run-In||0
10096378|NCT02365519|11225059|FG000|COMPLETED|Vehicle Run-In||134
10096379|NCT02365519|11225060|FG001|COMPLETED|Vehicle Run-In||0
10096380|NCT02365519|11225061|FG002|COMPLETED|Vehicle Run-In||0
10096381|NCT02365519|11225059|FG000|NOT COMPLETED|Vehicle Run-In||79
10096382|NCT02365519|11225060|FG001|NOT COMPLETED|Vehicle Run-In||0
10096383|NCT02365519|11225061|FG002|NOT COMPLETED|Vehicle Run-In||0
10096384|NCT02365519|11225059|FG000|STARTED|Randomized and Treated||0
10096385|NCT02365519|11225060|FG001|STARTED|Randomized and Treated||69
9872166|NCT00986258|10986473|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23
9872167|NCT00986258|10986473|FG000|STARTED|Maintenance Period||102
10096386|NCT02365519|11225061|FG002|STARTED|Randomized and Treated||65
10096387|NCT02365519|11225059|FG000|COMPLETED|Randomized and Treated||0
10096388|NCT02365519|11225060|FG001|COMPLETED|Randomized and Treated||67
10096389|NCT02365519|11225061|FG002|COMPLETED|Randomized and Treated||64
10096390|NCT02365519|11225059|FG000|NOT COMPLETED|Randomized and Treated||0
10096391|NCT02365519|11225060|FG001|NOT COMPLETED|Randomized and Treated||2
10096392|NCT02365519|11225061|FG002|NOT COMPLETED|Randomized and Treated||1
10096393|NCT02365558|11225070|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34
9872168|NCT00986258|10986473|FG000|COMPLETED|Maintenance Period||93
9872169|NCT00986258|10986473|FG000|NOT COMPLETED|Maintenance Period||9
9872170|NCT00986349|10986487|FG000|STARTED|Overall Study|attempted implant procedures|23
9872171|NCT00986349|10986487|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20
9872172|NCT00986349|10986487|FG000|Early Explant|Overall Study||4
9872173|NCT00986349|10986487|FG000|COMPLETED|Overall Study||16
9872174|NCT00986349|10986487|FG000|NOT COMPLETED|Overall Study||7
9872175|NCT00986362|10986502|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
9872176|NCT00986362|10986503|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
9872177|NCT00986362|10986502|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
9872178|NCT00986362|10986503|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
9872179|NCT00986362|10986502|FG000|NOT COMPLETED|Overall Study||2
9872180|NCT00986362|10986503|FG001|NOT COMPLETED|Overall Study||1
9872181|NCT00986401|10986511|FG000|STARTED|Period 1||22
9872182|NCT00986401|10986512|FG001|STARTED|Period 1||22
9872183|NCT00986401|10986511|FG000|COMPLETED|Period 1||22
9872184|NCT00986401|10986512|FG001|COMPLETED|Period 1||21
9872185|NCT00986401|10986511|FG000|NOT COMPLETED|Period 1||0
9872186|NCT00986401|10986512|FG001|NOT COMPLETED|Period 1||1
9872187|NCT00986401|10986511|FG000|STARTED|Period 2||22
9872188|NCT00986401|10986512|FG001|STARTED|Period 2||21
9872189|NCT00986401|10986511|FG000|COMPLETED|Period 2||22
9872190|NCT00986401|10986512|FG001|COMPLETED|Period 2||21
9872191|NCT00986401|10986511|FG000|NOT COMPLETED|Period 2||0
9872192|NCT00986401|10986512|FG001|NOT COMPLETED|Period 2||0
9872193|NCT00986427|10986523|FG000|STARTED|Overall Study||12
9872194|NCT00986427|10986524|FG001|STARTED|Overall Study||12
9872195|NCT00986427|10986523|FG000|COMPLETED|Overall Study||8
9872196|NCT00986427|10986524|FG001|COMPLETED|Overall Study||12
9872197|NCT00986427|10986523|FG000|NOT COMPLETED|Overall Study||4
9872198|NCT00986427|10986524|FG001|NOT COMPLETED|Overall Study||0
9872199|NCT00986440|10986536|FG000|STARTED|Overall Study||41
9872200|NCT00986440|10986537|FG001|STARTED|Overall Study||43
9872201|NCT00986440|10986536|FG000|Randomized, But Not Dosed|Overall Study||0
9872202|NCT00986440|10986537|FG001|Randomized, But Not Dosed|Overall Study||1
9872203|NCT00986440|10986536|FG000|COMPLETED|Overall Study||0
9872204|NCT00986440|10986537|FG001|COMPLETED|Overall Study||0
9872205|NCT00986440|10986536|FG000|NOT COMPLETED|Overall Study||41
9872206|NCT00986440|10986537|FG001|NOT COMPLETED|Overall Study||43
9872207|NCT00986453|10986543|FG000|STARTED|Overall Study||45
9872208|NCT00986453|10986543|FG000|COMPLETED|Overall Study||43
9872209|NCT00986453|10986543|FG000|NOT COMPLETED|Overall Study||2
9872210|NCT00986479|10986551|FG000|STARTED|Period 1||12
9872211|NCT00986479|10986552|FG001|STARTED|Period 1||10
9872212|NCT00986479|10986551|FG000|COMPLETED|Period 1||10
9872213|NCT00986479|10986552|FG001|COMPLETED|Period 1||10
9872214|NCT00986479|10986551|FG000|NOT COMPLETED|Period 1||2
9872215|NCT00986479|10986552|FG001|NOT COMPLETED|Period 1||0
9872216|NCT00986479|10986551|FG000|STARTED|Period 2||10
9872217|NCT00986479|10986552|FG001|STARTED|Period 2||10
9872218|NCT00986479|10986551|FG000|COMPLETED|Period 2||10
9872219|NCT00986479|10986552|FG001|COMPLETED|Period 2||10
9872220|NCT00986479|10986551|FG000|NOT COMPLETED|Period 2||0
9872221|NCT00986479|10986552|FG001|NOT COMPLETED|Period 2||0
9872222|NCT00986544|10986560|FG000|STARTED|Overall Study||53
9872223|NCT00986544|10986561|FG001|STARTED|Overall Study||53
9872224|NCT00986544|10986560|FG000|COMPLETED|Overall Study||53
9872225|NCT00986544|10986561|FG001|COMPLETED|Overall Study||53
9872226|NCT00986544|10986560|FG000|NOT COMPLETED|Overall Study||0
9872227|NCT00986544|10986561|FG001|NOT COMPLETED|Overall Study||0
9872228|NCT00986570|10986568|FG000|STARTED|Overall Study||121
9872229|NCT00986570|10986568|FG000|COMPLETED|Overall Study||114
9872230|NCT00986570|10986568|FG000|NOT COMPLETED|Overall Study||7
9872231|NCT00986583|10986574|FG000|STARTED|Overall Study||38
9872232|NCT00986583|10986575|FG001|STARTED|Overall Study||32
9872233|NCT00986583|10986574|FG000|COMPLETED|Overall Study||38
9872234|NCT00986583|10986575|FG001|COMPLETED|Overall Study||32
9872235|NCT00986583|10986574|FG000|NOT COMPLETED|Overall Study||0
9872236|NCT00986583|10986575|FG001|NOT COMPLETED|Overall Study||0
9872237|NCT00986674|10986585|FG000|STARTED|Overall Study||47
9872238|NCT00986674|10986586|FG001|STARTED|Overall Study||45
9872239|NCT00986674|10986587|FG002|STARTED|Overall Study||48
9872240|NCT00986674|10986585|FG000|Treated|Overall Study||43
9872241|NCT00986674|10986586|FG001|Treated|Overall Study||42
9872242|NCT00986674|10986587|FG002|Treated|Overall Study||47
9872243|NCT00986674|10986585|FG000|Eligible and Treated|Overall Study||39
9872244|NCT00986674|10986586|FG001|Eligible and Treated|Overall Study||41
9872245|NCT00986674|10986587|FG002|Eligible and Treated|Overall Study||47
9872246|NCT00986674|10986585|FG000|COMPLETED|Overall Study||0
9872247|NCT00986674|10986586|FG001|COMPLETED|Overall Study||0
9872248|NCT00986674|10986587|FG002|COMPLETED|Overall Study||0
9872249|NCT00986674|10986585|FG000|NOT COMPLETED|Overall Study||47
9872250|NCT00986674|10986586|FG001|NOT COMPLETED|Overall Study||45
9872251|NCT00986674|10986587|FG002|NOT COMPLETED|Overall Study||48
9872252|NCT00986830|10986595|FG000|STARTED|Overall Study||74
9872253|NCT00986830|10986595|FG000|Treated|Overall Study||69
9872254|NCT00986830|10986595|FG000|COMPLETED|Overall Study||66
9872255|NCT00986830|10986595|FG000|NOT COMPLETED|Overall Study||8
9872256|NCT00986856|10986601|FG000|STARTED|Overall Study||42
9872257|NCT00986856|10986602|FG001|STARTED|Overall Study||16
9872258|NCT00986856|10986601|FG000|COMPLETED|Overall Study||42
9872259|NCT00986856|10986602|FG001|COMPLETED|Overall Study||16
9872260|NCT00986856|10986601|FG000|NOT COMPLETED|Overall Study||0
9872261|NCT00986856|10986602|FG001|NOT COMPLETED|Overall Study||0
9872262|NCT00986921|10986610|FG000|STARTED|Overall Study||25
9872263|NCT00986921|10986611|FG001|STARTED|Overall Study||25
9872264|NCT00986921|10986610|FG000|COMPLETED|Overall Study||24
9872265|NCT00986921|10986611|FG001|COMPLETED|Overall Study||25
9872266|NCT00986921|10986610|FG000|NOT COMPLETED|Overall Study||1
9872267|NCT00986921|10986611|FG001|NOT COMPLETED|Overall Study||0
9872268|NCT00986973|10986620|FG000|STARTED|Overall Study||6
9872269|NCT00986973|10986620|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
9872270|NCT00986973|10986620|FG000|NOT COMPLETED|Overall Study||1
9872271|NCT00986986|10986627|FG000|STARTED|Overall Study||10
9872272|NCT00986986|10986628|FG001|STARTED|Overall Study||10
9872273|NCT00986986|10986627|FG000|COMPLETED|Overall Study||10
9872274|NCT00986986|10986628|FG001|COMPLETED|Overall Study||9
9872275|NCT00986986|10986627|FG000|NOT COMPLETED|Overall Study||0
9872276|NCT00986986|10986628|FG001|NOT COMPLETED|Overall Study||1
9872277|NCT00987337|10986638|FG000|STARTED|Overall Study||96
9872278|NCT00987337|10986639|FG001|STARTED|Overall Study||96
9872279|NCT00987337|10986640|FG002|STARTED|Overall Study||96
9872280|NCT00987337|10986638|FG000|COMPLETED|Overall Study||39
9872281|NCT00987337|10986639|FG001|COMPLETED|Overall Study||41
9872282|NCT00987337|10986640|FG002|COMPLETED|Overall Study||45
9872283|NCT00987337|10986638|FG000|NOT COMPLETED|Overall Study||57
9872284|NCT00987337|10986639|FG001|NOT COMPLETED|Overall Study||55
9872285|NCT00987337|10986640|FG002|NOT COMPLETED|Overall Study||51
9872286|NCT00987389|10986652|FG000|STARTED|Overall Study||176
9872287|NCT00987389|10986653|FG001|STARTED|Overall Study||176
9872288|NCT00987389|10986654|FG002|STARTED|Overall Study||175
9872289|NCT00987389|10986655|FG003|STARTED|Overall Study||177
9872290|NCT00987389|10986652|FG000|COMPLETED|Overall Study||167
9872291|NCT00987389|10986653|FG001|COMPLETED|Overall Study||168
9872292|NCT00987389|10986654|FG002|COMPLETED|Overall Study||167
9872293|NCT00987389|10986655|FG003|COMPLETED|Overall Study||174
9872294|NCT00987389|10986652|FG000|NOT COMPLETED|Overall Study||9
9872295|NCT00987389|10986653|FG001|NOT COMPLETED|Overall Study||8
9872296|NCT00987389|10986654|FG002|NOT COMPLETED|Overall Study||8
9872297|NCT00987389|10986655|FG003|NOT COMPLETED|Overall Study||3
9872298|NCT00987402|10986665|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
9872299|NCT00987402|10986666|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
9872300|NCT00987402|10986665|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
9872301|NCT00987402|10986666|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
9872302|NCT00987402|10986665|FG000|NOT COMPLETED|Overall Study||86
9872303|NCT00987402|10986666|FG001|NOT COMPLETED|Overall Study||98
9872304|NCT00987415|10986674|FG000|STARTED|Overall Study||128
9872305|NCT00987415|10986675|FG001|STARTED|Overall Study||125
9872306|NCT00987415|10986674|FG000|COMPLETED|Overall Study||119
9872307|NCT00987415|10986675|FG001|COMPLETED|Overall Study||116
9872308|NCT00987415|10986674|FG000|NOT COMPLETED|Overall Study||9
9872309|NCT00987415|10986675|FG001|NOT COMPLETED|Overall Study||9
9872310|NCT00987467|10986681|FG000|STARTED|Overall Study||12
9872311|NCT00987467|10986681|FG000|COMPLETED|Overall Study||10
9872312|NCT00987467|10986681|FG000|NOT COMPLETED|Overall Study||2
9872313|NCT00987480|10986686|FG000|STARTED|Overall Study||45
9872314|NCT00987480|10986686|FG000|COMPLETED|Overall Study||45
9872315|NCT00987480|10986686|FG000|NOT COMPLETED|Overall Study||0
9872316|NCT00987558|10986690|FG000|STARTED|Overall Study||13
9872317|NCT00987558|10986691|FG001|STARTED|Overall Study||17
9872318|NCT00987558|10986690|FG000|Simvastatin|Overall Study||13
9872319|NCT00987558|10986691|FG001|Simvastatin|Overall Study||12
9872320|NCT00987558|10986690|FG000|Washout|Overall Study||13
9872321|NCT00987558|10986691|FG001|Washout|Overall Study||12
9872322|NCT00987558|10986690|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
9872323|NCT00987558|10986691|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
9872324|NCT00987558|10986690|FG000|COMPLETED|Overall Study||12
9872325|NCT00987558|10986691|FG001|COMPLETED|Overall Study||12
9872326|NCT00987558|10986690|FG000|NOT COMPLETED|Overall Study||1
9872327|NCT00987558|10986691|FG001|NOT COMPLETED|Overall Study||5
9872328|NCT00987623|10986700|FG000|STARTED|Overall Study||145
9872329|NCT00987623|10986701|FG001|STARTED|Overall Study||154
9872330|NCT00987623|10986700|FG000|COMPLETED|Overall Study||140
9872331|NCT00987623|10986701|FG001|COMPLETED|Overall Study||151
9872332|NCT00987623|10986700|FG000|NOT COMPLETED|Overall Study||5
9872333|NCT00987623|10986701|FG001|NOT COMPLETED|Overall Study||3
9872334|NCT00987727|10986709|FG000|STARTED|Overall Study||41
9872335|NCT00987727|10986710|FG001|STARTED|Overall Study||41
9872336|NCT00987727|10986709|FG000|COMPLETED|Overall Study||36
9872337|NCT00987727|10986710|FG001|COMPLETED|Overall Study||34
9872338|NCT00987727|10986709|FG000|NOT COMPLETED|Overall Study||5
9872339|NCT00987727|10986710|FG001|NOT COMPLETED|Overall Study||7
9872340|NCT00987831|10986719|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
9872341|NCT00987831|10986720|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
9872342|NCT00987831|10986721|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
9872343|NCT00987831|10986719|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
9953733|NCT01427920|11072417|FG001|COMPLETED|Overall Study||157
9872344|NCT00987831|10986720|FG001|COMPLETED|Overall Study|all controls returned for two visits|52
9872345|NCT00987831|10986721|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
9872346|NCT00987831|10986719|FG000|NOT COMPLETED|Overall Study||1
9872347|NCT00987831|10986720|FG001|NOT COMPLETED|Overall Study||3
9872348|NCT00987831|10986721|FG002|NOT COMPLETED|Overall Study||0
9872349|NCT00987935|10986739|FG000|STARTED|Overall Study||4
9872350|NCT00987935|10986740|FG001|STARTED|Overall Study||3
9872351|NCT00987935|10986741|FG002|STARTED|Overall Study||3
9872352|NCT00987935|10986742|FG003|STARTED|Overall Study||3
9872353|NCT00987935|10986743|FG004|STARTED|Overall Study||7
9872354|NCT00987935|10986744|FG005|STARTED|Overall Study||3
9872355|NCT00987935|10986745|FG006|STARTED|Overall Study||16
9872356|NCT00987935|10986746|FG007|STARTED|Overall Study||63
9872357|NCT00987935|10986747|FG008|STARTED|Overall Study||32
9872358|NCT00987935|10986739|FG000|COMPLETED|Overall Study||0
9872359|NCT00987935|10986740|FG001|COMPLETED|Overall Study||0
9872360|NCT00987935|10986741|FG002|COMPLETED|Overall Study||0
9872361|NCT00987935|10986742|FG003|COMPLETED|Overall Study||0
9872362|NCT00987935|10986743|FG004|COMPLETED|Overall Study||0
9872363|NCT00987935|10986744|FG005|COMPLETED|Overall Study||0
9872364|NCT00987935|10986745|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
9872365|NCT00987935|10986746|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
9872366|NCT00987935|10986747|FG008|COMPLETED|Overall Study||0
9872367|NCT00987935|10986739|FG000|NOT COMPLETED|Overall Study||4
9872368|NCT00987935|10986740|FG001|NOT COMPLETED|Overall Study||3
9872369|NCT00987935|10986741|FG002|NOT COMPLETED|Overall Study||3
9872370|NCT00987935|10986742|FG003|NOT COMPLETED|Overall Study||3
9872371|NCT00987935|10986743|FG004|NOT COMPLETED|Overall Study||7
9872372|NCT00987935|10986744|FG005|NOT COMPLETED|Overall Study||3
9872373|NCT00987935|10986745|FG006|NOT COMPLETED|Overall Study||15
9872374|NCT00987935|10986746|FG007|NOT COMPLETED|Overall Study||62
9872375|NCT00987935|10986747|FG008|NOT COMPLETED|Overall Study||32
9872376|NCT00987948|10986773|FG000|STARTED|Overall Study||15
9872377|NCT00987948|10986773|FG000|COMPLETED|Overall Study||12
9872378|NCT00987948|10986773|FG000|NOT COMPLETED|Overall Study||3
9872379|NCT00988000|10986780|FG000|STARTED|Overall Study||49
9872380|NCT00988000|10986781|FG001|STARTED|Overall Study||51
9872381|NCT00988000|10986782|FG002|STARTED|Overall Study||57
9872382|NCT00988000|10986780|FG000|COMPLETED|Overall Study||49
9872383|NCT00988000|10986781|FG001|COMPLETED|Overall Study||51
9872384|NCT00988000|10986782|FG002|COMPLETED|Overall Study||57
9872385|NCT00988000|10986780|FG000|NOT COMPLETED|Overall Study||0
9872386|NCT00988000|10986781|FG001|NOT COMPLETED|Overall Study||0
9872387|NCT00988000|10986782|FG002|NOT COMPLETED|Overall Study||0
9872388|NCT00988013|10986796|FG000|STARTED|Overall Study||3
9872389|NCT00988013|10986797|FG001|STARTED|Overall Study||3
9872390|NCT00988013|10986798|FG002|STARTED|Overall Study||6
9872391|NCT00988013|10986799|FG003|STARTED|Overall Study||2
9872392|NCT00988013|10986796|FG000|COMPLETED|Overall Study||3
9872393|NCT00988013|10986797|FG001|COMPLETED|Overall Study||3
9872394|NCT00988013|10986798|FG002|COMPLETED|Overall Study||6
9872395|NCT00988013|10986799|FG003|COMPLETED|Overall Study||2
9872396|NCT00988013|10986796|FG000|NOT COMPLETED|Overall Study||0
9872397|NCT00988013|10986797|FG001|NOT COMPLETED|Overall Study||0
9872398|NCT00988013|10986798|FG002|NOT COMPLETED|Overall Study||0
9872399|NCT00988013|10986799|FG003|NOT COMPLETED|Overall Study||0
9872400|NCT00988065|10986814|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148
9872401|NCT00988065|10986815|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150
9872402|NCT00988065|10986816|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150
9872403|NCT00988065|10986814|FG000|Received First Randomized Dose|Overall Study||148
9872404|NCT00988065|10986815|FG001|Received First Randomized Dose|Overall Study||150
9872405|NCT00988065|10986816|FG002|Received First Randomized Dose|Overall Study||150
9872406|NCT00988065|10986814|FG000|Received Second Randomized Dose|Overall Study||139
9872407|NCT00988065|10986815|FG001|Received Second Randomized Dose|Overall Study||135
9872408|NCT00988065|10986816|FG002|Received Second Randomized Dose|Overall Study||145
9872409|NCT00988065|10986814|FG000|Received Third Randomized Dose|Overall Study||135
9872410|NCT00988065|10986815|FG001|Received Third Randomized Dose|Overall Study||127
9872411|NCT00988065|10986816|FG002|Received Third Randomized Dose|Overall Study||135
9872412|NCT00988065|10986814|FG000|COMPLETED|Overall Study||135
9872413|NCT00988065|10986815|FG001|COMPLETED|Overall Study||127
9872414|NCT00988065|10986816|FG002|COMPLETED|Overall Study||135
9872415|NCT00988065|10986814|FG000|NOT COMPLETED|Overall Study||13
9872416|NCT00988065|10986815|FG001|NOT COMPLETED|Overall Study||23
9872417|NCT00988065|10986816|FG002|NOT COMPLETED|Overall Study||15
9872418|NCT00988091|10986826|FG000|STARTED|Double-blind Period||298
9872419|NCT00988091|10986827|FG001|STARTED|Double-blind Period||298
9872420|NCT00988091|10986826|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
9872421|NCT00988091|10986827|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
9872422|NCT00988091|10986826|FG000|COMPLETED|Double-blind Period||255
9872423|NCT00988091|10986827|FG001|COMPLETED|Double-blind Period||251
9872424|NCT00988091|10986826|FG000|NOT COMPLETED|Double-blind Period||43
9872425|NCT00988091|10986827|FG001|NOT COMPLETED|Double-blind Period||47
9872426|NCT00988091|10986826|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
9953734|NCT01427920|11072416|FG000|NOT COMPLETED|Overall Study||9
9872427|NCT00988091|10986827|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
9872428|NCT00988091|10986826|FG000|COMPLETED|Open-label Period||208
9872429|NCT00988091|10986827|FG001|COMPLETED|Open-label Period||192
9872430|NCT00988091|10986826|FG000|NOT COMPLETED|Open-label Period||21
9872431|NCT00988091|10986827|FG001|NOT COMPLETED|Open-label Period||33
9872432|NCT00988117|10986834|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
9872433|NCT00988117|10986834|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
9872434|NCT00988117|10986834|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
9872435|NCT00988117|10986834|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
9872436|NCT00988117|10986834|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
9872437|NCT00988117|10986834|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
9872438|NCT00988143|10986842|FG000|STARTED|Overall Study||220
9872439|NCT00988143|10986843|FG001|STARTED|Overall Study||190
9872440|NCT00988143|10986844|FG002|STARTED|Overall Study||190
9872441|NCT00988143|10986842|FG000|COMPLETED|Overall Study||220
9872442|NCT00988143|10986843|FG001|COMPLETED|Overall Study||190
9872443|NCT00988143|10986844|FG002|COMPLETED|Overall Study||190
9872444|NCT00988143|10986842|FG000|NOT COMPLETED|Overall Study||0
9872445|NCT00988143|10986843|FG001|NOT COMPLETED|Overall Study||0
9872446|NCT00988143|10986844|FG002|NOT COMPLETED|Overall Study||0
9872447|NCT00988156|10986854|FG000|STARTED|Overall Study||149
9872448|NCT00988156|10986855|FG001|STARTED|Overall Study||155
9872449|NCT00988156|10986854|FG000|Intention-to-Treat Set (ITT)|Overall Study||129
9872450|NCT00988156|10986855|FG001|Intention-to-Treat Set (ITT)|Overall Study||134
9872451|NCT00988156|10986854|FG000|Per Protocol Set (PP)|Overall Study||101
9872452|NCT00988156|10986855|FG001|Per Protocol Set (PP)|Overall Study||97
9872453|NCT00988156|10986854|FG000|Safety Set|Overall Study||129
9872454|NCT00988156|10986855|FG001|Safety Set|Overall Study||134
9872455|NCT00988156|10986854|FG000|COMPLETED|Overall Study||132
10096394|NCT02365558|11225071|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0
10096395|NCT02365558|11225070|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
10096396|NCT02365558|11225071|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
10096397|NCT02365558|11225070|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33
10096398|NCT02365558|11225071|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0
10096399|NCT02365558|11225070|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
10096400|NCT02365558|11225071|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
10096401|NCT02365558|11225070|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
10096402|NCT02365558|11225071|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
10096403|NCT02365558|11225070|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0
10096404|NCT02365558|11225071|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32
10096405|NCT02365558|11225070|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
10096406|NCT02365558|11225071|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
10096407|NCT02365584|11225082|FG000|STARTED|Overall Study||21
10096408|NCT02365584|11225083|FG001|STARTED|Overall Study||22
10096409|NCT02365584|11225082|FG000|COMPLETED|Overall Study||9
10096410|NCT02365584|11225083|FG001|COMPLETED|Overall Study||8
10096411|NCT02365584|11225082|FG000|NOT COMPLETED|Overall Study||12
10096412|NCT02365584|11225083|FG001|NOT COMPLETED|Overall Study||14
10096413|NCT02365636|11225092|FG000|STARTED|Overall Study||100
10096414|NCT02365636|11225093|FG001|STARTED|Overall Study||100
10096415|NCT02365636|11225094|FG002|STARTED|Overall Study||100
10096416|NCT02365636|11225092|FG000|Safety Population|Overall Study||100
10096417|NCT02365636|11225093|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
10096418|NCT02365636|11225094|FG002|Safety Population|Overall Study||100
10096419|NCT02365636|11225092|FG000|Full Analysis Set|Overall Study||100
10096420|NCT02365636|11225093|FG001|Full Analysis Set|Overall Study||98
10096421|NCT02365636|11225094|FG002|Full Analysis Set|Overall Study||100
10096422|NCT02365636|11225092|FG000|COMPLETED|Overall Study||94
10096423|NCT02365636|11225093|FG001|COMPLETED|Overall Study||93
10096424|NCT02365636|11225094|FG002|COMPLETED|Overall Study||97
10096425|NCT02365636|11225092|FG000|NOT COMPLETED|Overall Study||6
10096426|NCT02365636|11225093|FG001|NOT COMPLETED|Overall Study||7
10096427|NCT02365636|11225094|FG002|NOT COMPLETED|Overall Study||3
10096428|NCT02365714|11225102|FG000|STARTED|Overall Study||2
10096429|NCT02365714|11225102|FG000|COMPLETED|Overall Study||2
10096430|NCT02365714|11225102|FG000|NOT COMPLETED|Overall Study||0
10096431|NCT02365870|11225108|FG000|STARTED|Overall Study||1
10096432|NCT02365870|11225109|FG001|STARTED|Overall Study||3
10096433|NCT02365870|11225108|FG000|COMPLETED|Overall Study||1
10096434|NCT02365870|11225109|FG001|COMPLETED|Overall Study||3
10096435|NCT02365870|11225108|FG000|NOT COMPLETED|Overall Study||0
9872456|NCT00988156|10986855|FG001|COMPLETED|Overall Study||135
10096436|NCT02365870|11225109|FG001|NOT COMPLETED|Overall Study||0
10096437|NCT02365961|11225117|FG000|STARTED|Overall Study||41
10096438|NCT02365961|11225118|FG001|STARTED|Overall Study||43
10096439|NCT02365961|11225117|FG000|COMPLETED|Overall Study||41
10096440|NCT02365961|11225118|FG001|COMPLETED|Overall Study||43
10096441|NCT02365961|11225117|FG000|NOT COMPLETED|Overall Study||0
10096442|NCT02365961|11225118|FG001|NOT COMPLETED|Overall Study||0
10096443|NCT02366091|11225128|FG000|STARTED|Overall Study||24
10096444|NCT02366091|11225129|FG001|STARTED|Overall Study||23
9872457|NCT00988156|10986854|FG000|NOT COMPLETED|Overall Study||17
9872458|NCT00988156|10986855|FG001|NOT COMPLETED|Overall Study||20
9872459|NCT00988169|10986861|FG000|STARTED|Overall Study||6
9872460|NCT00988169|10986861|FG000|COMPLETED|Overall Study||5
9872461|NCT00988169|10986861|FG000|NOT COMPLETED|Overall Study||1
9872462|NCT00988208|10986867|FG000|STARTED|Overall Study||526
9872463|NCT00988208|10986868|FG001|STARTED|Overall Study||533
9872464|NCT00988208|10986867|FG000|Treated|Overall Study||521
9872465|NCT00988208|10986868|FG001|Treated|Overall Study||525
9872466|NCT00988208|10986867|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
9872467|NCT00988208|10986868|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
9872468|NCT00988208|10986867|FG000|NOT COMPLETED|Overall Study||431
9872469|NCT00988208|10986868|FG001|NOT COMPLETED|Overall Study||438
9872470|NCT00988221|10986877|FG000|STARTED|Part I||35
9872471|NCT00988221|10986878|FG001|STARTED|Part I||34
9872472|NCT00988221|10986879|FG002|STARTED|Part I||119
9872473|NCT00988221|10986880|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0
9872474|NCT00988221|10986877|FG000|COMPLETED|Part I||31
9872475|NCT00988221|10986878|FG001|COMPLETED|Part I||24
9872476|NCT00988221|10986879|FG002|COMPLETED|Part I||111
9872477|NCT00988221|10986880|FG003|COMPLETED|Part I||0
9872478|NCT00988221|10986877|FG000|NOT COMPLETED|Part I||4
9872479|NCT00988221|10986878|FG001|NOT COMPLETED|Part I||10
9872480|NCT00988221|10986879|FG002|NOT COMPLETED|Part I||8
9872481|NCT00988221|10986880|FG003|NOT COMPLETED|Part I||0
9872482|NCT00988221|10986877|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
9872483|NCT00988221|10986878|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
9872484|NCT00988221|10986879|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
9872485|NCT00988221|10986880|FG003|STARTED|Part II||84
9872486|NCT00988221|10986877|FG000|COMPLETED|Part II||15
9872487|NCT00988221|10986878|FG001|COMPLETED|Part II||11
9872488|NCT00988221|10986879|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
9872489|NCT00988221|10986880|FG003|COMPLETED|Part II||81
9872490|NCT00988221|10986877|FG000|NOT COMPLETED|Part II||1
9872491|NCT00988221|10986878|FG001|NOT COMPLETED|Part II||0
9872492|NCT00988221|10986879|FG002|NOT COMPLETED|Part II||3
10096445|NCT02366091|11225130|FG002|STARTED|Overall Study||24
10096446|NCT02366091|11225131|FG003|STARTED|Overall Study||23
10096447|NCT02366091|11225128|FG000|COMPLETED|Overall Study||21
10096448|NCT02366091|11225129|FG001|COMPLETED|Overall Study||16
10096449|NCT02366091|11225130|FG002|COMPLETED|Overall Study||21
10096450|NCT02366091|11225131|FG003|COMPLETED|Overall Study||22
10201942|NCT03441984|11329276|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201943|NCT03441984|11329277|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201944|NCT03441984|11329278|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
10201945|NCT03441984|11329279|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
9872493|NCT00988221|10986880|FG003|NOT COMPLETED|Part II||3
9872494|NCT00988221|10986877|FG000|STARTED|Part III||30
10096451|NCT02366091|11225128|FG000|NOT COMPLETED|Overall Study||3
10096452|NCT02366091|11225129|FG001|NOT COMPLETED|Overall Study||7
10096453|NCT02366091|11225130|FG002|NOT COMPLETED|Overall Study||3
10096454|NCT02366091|11225131|FG003|NOT COMPLETED|Overall Study||1
10096455|NCT02366130|11225141|FG000|STARTED|Overall Study||45
10096456|NCT02366130|11225141|FG000|COMPLETED|Overall Study||36
10096457|NCT02366130|11225141|FG000|NOT COMPLETED|Overall Study||9
10096458|NCT02366143|11225148|FG000|STARTED|Overall Study||400
10096459|NCT02366143|11225149|FG001|STARTED|Overall Study||400
10096460|NCT02366143|11225150|FG002|STARTED|Overall Study||402
10096461|NCT02366143|11225148|FG000|COMPLETED|Overall Study||0
10096462|NCT02366143|11225149|FG001|COMPLETED|Overall Study||0
10096463|NCT02366143|11225150|FG002|COMPLETED|Overall Study||0
10096464|NCT02366143|11225148|FG000|NOT COMPLETED|Overall Study||400
10096465|NCT02366143|11225149|FG001|NOT COMPLETED|Overall Study||400
10096466|NCT02366143|11225150|FG002|NOT COMPLETED|Overall Study||402
10096467|NCT02366195|11225162|FG000|STARTED|Overall Study||112
10096468|NCT02366195|11225162|FG000|Received Study Drug|Overall Study||111
10096469|NCT02366195|11225162|FG000|COMPLETED|Overall Study||58
10096470|NCT02366195|11225162|FG000|NOT COMPLETED|Overall Study||54
10096471|NCT02366312|11225168|FG000|STARTED|Overall Study||1
10096472|NCT02366312|11225169|FG001|STARTED|Overall Study||1
10096473|NCT02366312|11225168|FG000|COMPLETED|Overall Study||1
10096474|NCT02366312|11225169|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
10096475|NCT02366312|11225168|FG000|NOT COMPLETED|Overall Study||0
9872495|NCT00988221|10986878|FG001|STARTED|Part III||24
10096476|NCT02366312|11225169|FG001|NOT COMPLETED|Overall Study||1
10096477|NCT02366338|11225178|FG000|STARTED|Overall Study||73
10096478|NCT02366338|11225179|FG001|STARTED|Overall Study||39
10096479|NCT02366338|11225180|FG002|STARTED|Overall Study||36
10096480|NCT02366338|11225178|FG000|COMPLETED|Overall Study||73
10096481|NCT02366338|11225179|FG001|COMPLETED|Overall Study||39
10096482|NCT02366338|11225180|FG002|COMPLETED|Overall Study||36
10096483|NCT02366338|11225178|FG000|NOT COMPLETED|Overall Study||0
10096484|NCT02366338|11225179|FG001|NOT COMPLETED|Overall Study||0
10096485|NCT02366338|11225180|FG002|NOT COMPLETED|Overall Study||0
10096486|NCT02366468|11225190|FG000|STARTED|Overall Study||68
10096487|NCT02366468|11225191|FG001|STARTED|Overall Study||67
10096488|NCT02366468|11225190|FG000|Full Analysis Set (FAS)|Overall Study||67
10096489|NCT02366468|11225191|FG001|Full Analysis Set (FAS)|Overall Study||66
10201946|NCT03441984|11329280|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
9872496|NCT00988221|10986879|FG002|STARTED|Part III||106
9872497|NCT00988221|10986880|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0
9872498|NCT00988221|10986877|FG000|COMPLETED|Part III||29
9872499|NCT00988221|10986878|FG001|COMPLETED|Part III||23
9872500|NCT00988221|10986879|FG002|COMPLETED|Part III||103
9872501|NCT00988221|10986880|FG003|COMPLETED|Part III||0
9872502|NCT00988221|10986877|FG000|NOT COMPLETED|Part III||1
9872503|NCT00988221|10986878|FG001|NOT COMPLETED|Part III||1
9872504|NCT00988221|10986879|FG002|NOT COMPLETED|Part III||3
9872505|NCT00988221|10986880|FG003|NOT COMPLETED|Part III||0
9872506|NCT00988325|10986902|FG000|STARTED|Overall Study||40
9872507|NCT00988325|10986903|FG001|STARTED|Overall Study||20
9872508|NCT00988325|10986904|FG002|STARTED|Overall Study||5
9872509|NCT00988325|10986902|FG000|COMPLETED|Overall Study||40
9872510|NCT00988325|10986903|FG001|COMPLETED|Overall Study||20
9872511|NCT00988325|10986904|FG002|COMPLETED|Overall Study||5
9872512|NCT00988325|10986902|FG000|NOT COMPLETED|Overall Study||0
9872513|NCT00988325|10986903|FG001|NOT COMPLETED|Overall Study||0
9872514|NCT00988325|10986904|FG002|NOT COMPLETED|Overall Study||0
9872515|NCT00988351|10986918|FG000|STARTED|Overall Study||78
9872516|NCT00988351|10986919|FG001|STARTED|Overall Study||78
9872517|NCT00988351|10986918|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78
9872518|NCT00988351|10986919|FG001|CPAP Titration|Overall Study|no titration needed|78
9872519|NCT00988351|10986918|FG000|PAP Setup|Overall Study|CPAP treatment started|70
9872520|NCT00988351|10986919|FG001|PAP Setup|Overall Study|APAP treatment started|78
9872521|NCT00988351|10986918|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
9872522|NCT00988351|10986919|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
10096490|NCT02366468|11225190|FG000|Per Protocol Set (PPS)|Overall Study||62
10096491|NCT02366468|11225191|FG001|Per Protocol Set (PPS)|Overall Study||61
10096492|NCT02366468|11225190|FG000|COMPLETED|Overall Study||62
10096493|NCT02366468|11225191|FG001|COMPLETED|Overall Study||58
10096494|NCT02366468|11225190|FG000|NOT COMPLETED|Overall Study||6
10096495|NCT02366468|11225191|FG001|NOT COMPLETED|Overall Study||9
10096496|NCT02366611|11225199|FG000|STARTED|Overall Study||10
10096497|NCT02366611|11225200|FG001|STARTED|Overall Study||1
10096498|NCT02366611|11225199|FG000|COMPLETED|Overall Study||8
10096499|NCT02366611|11225200|FG001|COMPLETED|Overall Study||1
10096500|NCT02366611|11225199|FG000|NOT COMPLETED|Overall Study||2
10096501|NCT02366611|11225200|FG001|NOT COMPLETED|Overall Study||0
10096502|NCT02366637|11225207|FG000|STARTED|First Intervention Period||7
10096503|NCT02366637|11225208|FG001|STARTED|First Intervention Period||6
10096504|NCT02366637|11225207|FG000|COMPLETED|First Intervention Period||1
10096505|NCT02366637|11225208|FG001|COMPLETED|First Intervention Period||1
10096506|NCT02366637|11225207|FG000|NOT COMPLETED|First Intervention Period||6
10096507|NCT02366637|11225208|FG001|NOT COMPLETED|First Intervention Period||5
10096508|NCT02366637|11225207|FG000|STARTED|Washout Period 28 to 49 Days||1
10096509|NCT02366637|11225208|FG001|STARTED|Washout Period 28 to 49 Days||1
10096510|NCT02366637|11225207|FG000|COMPLETED|Washout Period 28 to 49 Days||1
10096511|NCT02366637|11225208|FG001|COMPLETED|Washout Period 28 to 49 Days||1
10096512|NCT02366637|11225207|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0
10096513|NCT02366637|11225208|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0
10096514|NCT02366637|11225207|FG000|STARTED|Second Intervention Period||1
10096515|NCT02366637|11225208|FG001|STARTED|Second Intervention Period||1
10096516|NCT02366637|11225207|FG000|COMPLETED|Second Intervention Period||0
10096517|NCT02366637|11225208|FG001|COMPLETED|Second Intervention Period||0
10096518|NCT02366637|11225207|FG000|NOT COMPLETED|Second Intervention Period||1
10096519|NCT02366637|11225208|FG001|NOT COMPLETED|Second Intervention Period||1
10096520|NCT02366663|11225216|FG000|STARTED|Overall Study||2
10096521|NCT02366663|11225217|FG001|STARTED|Overall Study||1
10096522|NCT02366663|11225216|FG000|COMPLETED|Overall Study||2
10096523|NCT02366663|11225217|FG001|COMPLETED|Overall Study||1
10096524|NCT02366663|11225216|FG000|NOT COMPLETED|Overall Study||0
10096525|NCT02366663|11225217|FG001|NOT COMPLETED|Overall Study||0
10096526|NCT02366689|11225226|FG000|STARTED|Overall Study||60
10096527|NCT02366689|11225227|FG001|STARTED|Overall Study||58
10096528|NCT02366689|11225228|FG002|STARTED|Overall Study||61
10096529|NCT02366689|11225226|FG000|COMPLETED|Overall Study||56
10096530|NCT02366689|11225227|FG001|COMPLETED|Overall Study||55
10096531|NCT02366689|11225228|FG002|COMPLETED|Overall Study||59
10096532|NCT02366689|11225226|FG000|NOT COMPLETED|Overall Study||4
10096533|NCT02366689|11225227|FG001|NOT COMPLETED|Overall Study||3
10096534|NCT02366689|11225228|FG002|NOT COMPLETED|Overall Study||2
10096535|NCT02366767|11225238|FG000|STARTED|Overall Study||11
10096536|NCT02366767|11225239|FG001|STARTED|Overall Study||10
10096537|NCT02366767|11225238|FG000|COMPLETED|Overall Study||10
10096538|NCT02366767|11225239|FG001|COMPLETED|Overall Study||10
10096539|NCT02366767|11225238|FG000|NOT COMPLETED|Overall Study||1
10096540|NCT02366767|11225239|FG001|NOT COMPLETED|Overall Study||0
10096541|NCT02366845|11225247|FG000|STARTED|Overall Study||25
10096542|NCT02366845|11225248|FG001|STARTED|Overall Study||25
10096543|NCT02366845|11225247|FG000|COMPLETED|Overall Study||25
9872523|NCT00988351|10986918|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
10096544|NCT02366845|11225248|FG001|COMPLETED|Overall Study||25
10096545|NCT02366845|11225247|FG000|NOT COMPLETED|Overall Study||0
10096546|NCT02366845|11225248|FG001|NOT COMPLETED|Overall Study||0
10096547|NCT02366871|11225256|FG000|STARTED|Overall Study||204
10096548|NCT02366871|11225257|FG001|STARTED|Overall Study||196
10096549|NCT02366871|11225256|FG000|COMPLETED|Overall Study||204
9872524|NCT00988351|10986919|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
9872525|NCT00988351|10986918|FG000|COMPLETED|Overall Study||59
9872526|NCT00988351|10986919|FG001|COMPLETED|Overall Study||66
9872527|NCT00988351|10986918|FG000|NOT COMPLETED|Overall Study||19
9872528|NCT00988351|10986919|FG001|NOT COMPLETED|Overall Study||12
9872529|NCT00988429|10986928|FG000|STARTED|Overall Study||226
9872530|NCT00988429|10986929|FG001|STARTED|Overall Study||216
10096550|NCT02366871|11225257|FG001|COMPLETED|Overall Study||196
10096551|NCT02366871|11225256|FG000|NOT COMPLETED|Overall Study||0
10096552|NCT02366871|11225257|FG001|NOT COMPLETED|Overall Study||0
10096553|NCT02366910|11225263|FG000|STARTED|Overall Study||26
10096554|NCT02366910|11225263|FG000|COMPLETED|Overall Study||21
10096555|NCT02366910|11225263|FG000|NOT COMPLETED|Overall Study||5
10096556|NCT02366923|11225269|FG000|STARTED|Overall Study||28
10096557|NCT02366923|11225269|FG000|COMPLETED|Overall Study||22
10096558|NCT02366923|11225269|FG000|NOT COMPLETED|Overall Study||6
10096559|NCT02366936|11225274|FG000|STARTED|Overall Study||32
10096560|NCT02366936|11225274|FG000|COMPLETED|Overall Study||24
10096561|NCT02366936|11225274|FG000|NOT COMPLETED|Overall Study||8
10096562|NCT02367014|11225282|FG000|STARTED|Overall Study||9
10096563|NCT02367014|11225283|FG001|STARTED|Overall Study||9
10096564|NCT02367014|11225284|FG002|STARTED|Overall Study||9
10096565|NCT02367014|11225285|FG003|STARTED|Overall Study||9
10096566|NCT02367014|11225282|FG000|COMPLETED|Overall Study||9
10096567|NCT02367014|11225283|FG001|COMPLETED|Overall Study||9
10096568|NCT02367014|11225284|FG002|COMPLETED|Overall Study||9
10096569|NCT02367014|11225285|FG003|COMPLETED|Overall Study||9
10096570|NCT02367014|11225282|FG000|NOT COMPLETED|Overall Study||0
10096571|NCT02367014|11225283|FG001|NOT COMPLETED|Overall Study||0
10096572|NCT02367014|11225284|FG002|NOT COMPLETED|Overall Study||0
10096573|NCT02367014|11225285|FG003|NOT COMPLETED|Overall Study||0
10096574|NCT02367066|11225299|FG000|STARTED|Overall Study||10
10096575|NCT02367066|11225300|FG001|STARTED|Overall Study||10
10096576|NCT02367066|11225299|FG000|COMPLETED|Overall Study||10
10096577|NCT02367066|11225300|FG001|COMPLETED|Overall Study||10
10096578|NCT02367066|11225299|FG000|NOT COMPLETED|Overall Study||0
10096579|NCT02367066|11225300|FG001|NOT COMPLETED|Overall Study||0
10096580|NCT02367131|11225311|FG000|STARTED|Overall Study|Started are the treated patients|423
10096581|NCT02367131|11225311|FG000|COMPLETED|Overall Study||201
10096582|NCT02367131|11225311|FG000|NOT COMPLETED|Overall Study||222
10096583|NCT02367352|11225315|FG000|STARTED|Overall Study||9
10096584|NCT02367352|11225316|FG001|STARTED|Overall Study||0
10096585|NCT02367352|11225317|FG002|STARTED|Overall Study||0
10096586|NCT02367352|11225315|FG000|COMPLETED|Overall Study||0
10096587|NCT02367352|11225316|FG001|COMPLETED|Overall Study||0
10096588|NCT02367352|11225317|FG002|COMPLETED|Overall Study||0
10096589|NCT02367352|11225315|FG000|NOT COMPLETED|Overall Study||9
10096590|NCT02367352|11225316|FG001|NOT COMPLETED|Overall Study||0
10096591|NCT02367352|11225317|FG002|NOT COMPLETED|Overall Study||0
10096592|NCT02367391|11225325|FG000|STARTED|Overall Study||76
10096593|NCT02367391|11225326|FG001|STARTED|Overall Study||76
10096594|NCT02367391|11225325|FG000|COMPLETED|Overall Study||74
10096595|NCT02367391|11225326|FG001|COMPLETED|Overall Study||76
10096596|NCT02367391|11225325|FG000|NOT COMPLETED|Overall Study||2
10096597|NCT02367391|11225326|FG001|NOT COMPLETED|Overall Study||0
10096598|NCT02367430|11225332|FG000|STARTED|Overall Study||14
10096599|NCT02367430|11225332|FG000|COMPLETED|Overall Study||11
10096600|NCT02367430|11225332|FG000|NOT COMPLETED|Overall Study||3
10096601|NCT02367521|11225338|FG000|STARTED|Overall Study||17
10096602|NCT02367521|11225339|FG001|STARTED|Overall Study||17
10096603|NCT02367521|11225338|FG000|COMPLETED|Overall Study||13
10096604|NCT02367521|11225339|FG001|COMPLETED|Overall Study||17
10096605|NCT02367521|11225338|FG000|NOT COMPLETED|Overall Study||4
10096606|NCT02367521|11225339|FG001|NOT COMPLETED|Overall Study||0
10096607|NCT02367599|11225347|FG000|STARTED|Overall Study||48
10096608|NCT02367599|11225348|FG001|STARTED|Overall Study||48
10096609|NCT02367599|11225347|FG000|COMPLETED|Overall Study||48
10096610|NCT02367599|11225348|FG001|COMPLETED|Overall Study||48
10096611|NCT02367599|11225347|FG000|NOT COMPLETED|Overall Study||0
10096612|NCT02367599|11225348|FG001|NOT COMPLETED|Overall Study||0
10096613|NCT02367716|11225354|FG000|STARTED|Overall Study||121
9872531|NCT00988429|10986930|FG002|STARTED|Overall Study||211
9872532|NCT00988429|10986928|FG000|Safety Population|Overall Study||224
9872533|NCT00988429|10986929|FG001|Safety Population|Overall Study||216
9872534|NCT00988429|10986930|FG002|Safety Population|Overall Study||210
9872535|NCT00988429|10986928|FG000|Intention-to-treat (ITT) Population|Overall Study||220
10096614|NCT02367716|11225354|FG000|COMPLETED|Overall Study||120
10096615|NCT02367716|11225354|FG000|NOT COMPLETED|Overall Study||1
10096616|NCT02367729|11225361|FG000|STARTED|Overall Study||60
10096617|NCT02367729|11225362|FG001|STARTED|Overall Study||55
10096618|NCT02367729|11225361|FG000|COMPLETED|Overall Study||57
10096619|NCT02367729|11225362|FG001|COMPLETED|Overall Study||47
10096620|NCT02367729|11225361|FG000|NOT COMPLETED|Overall Study||3
9953735|NCT01427920|11072417|FG001|NOT COMPLETED|Overall Study||17
10096621|NCT02367729|11225362|FG001|NOT COMPLETED|Overall Study||8
10096622|NCT02367781|11225371|FG000|STARTED|Overall Study||483
10096623|NCT02367781|11225372|FG001|STARTED|Overall Study||240
10096624|NCT02367781|11225371|FG000|COMPLETED|Overall Study||0
10096625|NCT02367781|11225372|FG001|COMPLETED|Overall Study||0
10096626|NCT02367781|11225371|FG000|NOT COMPLETED|Overall Study||483
10096627|NCT02367781|11225372|FG001|NOT COMPLETED|Overall Study||240
10096628|NCT02367820|11225384|FG000|STARTED|Overall Study||638
9872536|NCT00988429|10986929|FG001|Intention-to-treat (ITT) Population|Overall Study||215
9872537|NCT00988429|10986930|FG002|Intention-to-treat (ITT) Population|Overall Study||205
9872538|NCT00988429|10986928|FG000|COMPLETED|Overall Study||189
9872539|NCT00988429|10986929|FG001|COMPLETED|Overall Study||173
9872540|NCT00988429|10986930|FG002|COMPLETED|Overall Study||142
9872541|NCT00988429|10986928|FG000|NOT COMPLETED|Overall Study||37
9872542|NCT00988429|10986929|FG001|NOT COMPLETED|Overall Study||43
10096629|NCT02367820|11225384|FG000|COMPLETED|Overall Study||402
10096630|NCT02367820|11225384|FG000|NOT COMPLETED|Overall Study||236
10096631|NCT02367833|11225397|FG000|STARTED|Overall Study||9
10096632|NCT02367833|11225398|FG001|STARTED|Overall Study||9
10096633|NCT02367833|11225399|FG002|STARTED|Overall Study||8
10096634|NCT02367833|11225397|FG000|COMPLETED|Overall Study||8
10096635|NCT02367833|11225398|FG001|COMPLETED|Overall Study||8
10096636|NCT02367833|11225399|FG002|COMPLETED|Overall Study||8
10096637|NCT02367833|11225397|FG000|NOT COMPLETED|Overall Study||1
10096638|NCT02367833|11225398|FG001|NOT COMPLETED|Overall Study||1
10096639|NCT02367833|11225399|FG002|NOT COMPLETED|Overall Study||0
10096640|NCT02367859|11225407|FG000|STARTED|Overall Study||1
10096641|NCT02367859|11225407|FG000|COMPLETED|Overall Study||1
10096642|NCT02367859|11225407|FG000|NOT COMPLETED|Overall Study||0
10096643|NCT02367872|11225419|FG000|STARTED|Overall Study||6
10096644|NCT02367872|11225420|FG001|STARTED|Overall Study||6
10096645|NCT02367872|11225421|FG002|STARTED|Overall Study||6
10096646|NCT02367872|11225422|FG003|STARTED|Overall Study||6
10096647|NCT02367872|11225423|FG004|STARTED|Overall Study||6
10096648|NCT02367872|11225424|FG005|STARTED|Overall Study||6
10096649|NCT02367872|11225425|FG006|STARTED|Overall Study||6
10096650|NCT02367872|11225426|FG007|STARTED|Overall Study||6
10096651|NCT02367872|11225419|FG000|COMPLETED|Overall Study||6
10096652|NCT02367872|11225420|FG001|COMPLETED|Overall Study||6
10096653|NCT02367872|11225421|FG002|COMPLETED|Overall Study||6
10096654|NCT02367872|11225422|FG003|COMPLETED|Overall Study||6
10096655|NCT02367872|11225423|FG004|COMPLETED|Overall Study||6
10096656|NCT02367872|11225424|FG005|COMPLETED|Overall Study||6
10096657|NCT02367872|11225425|FG006|COMPLETED|Overall Study||6
10096658|NCT02367872|11225426|FG007|COMPLETED|Overall Study||6
10096659|NCT02367872|11225419|FG000|NOT COMPLETED|Overall Study||0
10096660|NCT02367872|11225420|FG001|NOT COMPLETED|Overall Study||0
10096661|NCT02367872|11225421|FG002|NOT COMPLETED|Overall Study||0
10096662|NCT02367872|11225422|FG003|NOT COMPLETED|Overall Study||0
10096663|NCT02367872|11225423|FG004|NOT COMPLETED|Overall Study||0
10096664|NCT02367872|11225424|FG005|NOT COMPLETED|Overall Study||0
10096665|NCT02367872|11225425|FG006|NOT COMPLETED|Overall Study||0
10096666|NCT02367872|11225426|FG007|NOT COMPLETED|Overall Study||0
10096667|NCT02367885|11225456|FG000|STARTED|Overall Study||33
10096668|NCT02367885|11225457|FG001|STARTED|Overall Study||33
10096669|NCT02367885|11225458|FG002|STARTED|Overall Study||33
10096670|NCT02367885|11225456|FG000|COMPLETED|Overall Study||31
10096671|NCT02367885|11225457|FG001|COMPLETED|Overall Study||33
10096672|NCT02367885|11225458|FG002|COMPLETED|Overall Study||33
10096673|NCT02367885|11225456|FG000|NOT COMPLETED|Overall Study||2
10096674|NCT02367885|11225457|FG001|NOT COMPLETED|Overall Study||0
10096675|NCT02367885|11225458|FG002|NOT COMPLETED|Overall Study||0
10096676|NCT02367911|11225471|FG000|STARTED|Overall Study||71
10096677|NCT02367911|11225472|FG001|STARTED|Overall Study||73
10096678|NCT02367911|11225471|FG000|COMPLETED|Overall Study||66
10096679|NCT02367911|11225472|FG001|COMPLETED|Overall Study||69
10096680|NCT02367911|11225471|FG000|NOT COMPLETED|Overall Study||5
10096681|NCT02367911|11225472|FG001|NOT COMPLETED|Overall Study||4
10096682|NCT02368093|11225480|FG000|STARTED|Overall Study||24
10096683|NCT02368093|11225481|FG001|STARTED|Overall Study||24
10096684|NCT02368093|11225480|FG000|COMPLETED|Overall Study||24
10096685|NCT02368093|11225481|FG001|COMPLETED|Overall Study||24
10096686|NCT02368093|11225480|FG000|NOT COMPLETED|Overall Study||0
10096687|NCT02368093|11225481|FG001|NOT COMPLETED|Overall Study||0
10096688|NCT02368210|11225489|FG000|STARTED|Overall Study||75
10096689|NCT02368210|11225490|FG001|STARTED|Overall Study||76
10096690|NCT02368210|11225489|FG000|COMPLETED|Overall Study||74
10096691|NCT02368210|11225490|FG001|COMPLETED|Overall Study||75
10096692|NCT02368210|11225489|FG000|NOT COMPLETED|Overall Study||1
10096693|NCT02368210|11225490|FG001|NOT COMPLETED|Overall Study||1
10096694|NCT02368314|11225498|FG000|STARTED|Overall Study||64
10096695|NCT02368314|11225499|FG001|STARTED|Overall Study||60
10096696|NCT02368314|11225498|FG000|COMPLETED|Overall Study||61
10096697|NCT02368314|11225499|FG001|COMPLETED|Overall Study||57
10096698|NCT02368314|11225498|FG000|NOT COMPLETED|Overall Study||3
9872543|NCT00988429|10986930|FG002|NOT COMPLETED|Overall Study||69
10096699|NCT02368314|11225499|FG001|NOT COMPLETED|Overall Study||3
10096700|NCT02368431|11225507|FG000|STARTED|Overall Study||46
10096701|NCT02368431|11225508|FG001|STARTED|Overall Study||46
10096702|NCT02368431|11225507|FG000|COMPLETED|Overall Study||22
10096703|NCT02368431|11225508|FG001|COMPLETED|Overall Study||27
10096704|NCT02368431|11225507|FG000|NOT COMPLETED|Overall Study||24
10096705|NCT02368431|11225508|FG001|NOT COMPLETED|Overall Study||19
10096706|NCT02368457|11225516|FG000|STARTED|Overall Study||12
10096707|NCT02368457|11225517|FG001|STARTED|Overall Study||12
10096708|NCT02368457|11225516|FG000|COMPLETED|Overall Study||12
10096709|NCT02368457|11225517|FG001|COMPLETED|Overall Study||12
10096710|NCT02368457|11225516|FG000|NOT COMPLETED|Overall Study||0
10096711|NCT02368457|11225517|FG001|NOT COMPLETED|Overall Study||0
10096712|NCT02368691|11225524|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
9872544|NCT00988442|10986941|FG000|STARTED|Overall Study||30
9872545|NCT00988442|10986942|FG001|STARTED|Overall Study||29
9872546|NCT00988442|10986941|FG000|COMPLETED|Overall Study||0
9872547|NCT00988442|10986942|FG001|COMPLETED|Overall Study||1
9872548|NCT00988442|10986941|FG000|NOT COMPLETED|Overall Study||30
9872549|NCT00988442|10986942|FG001|NOT COMPLETED|Overall Study||28
9872550|NCT00988533|10986951|FG000|STARTED|Overall Study||30
9872551|NCT00988533|10986951|FG000|COMPLETED|Overall Study||27
10096713|NCT02368691|11225524|FG000|COMPLETED|Overall Study||0
10096714|NCT02368691|11225524|FG000|NOT COMPLETED|Overall Study||32
10096715|NCT02369068|11225530|FG000|STARTED|1 Month||10
10096716|NCT02369068|11225531|FG001|STARTED|1 Month||11
10096717|NCT02369068|11225530|FG000|COMPLETED|1 Month||9
10096718|NCT02369068|11225531|FG001|COMPLETED|1 Month||10
10096719|NCT02369068|11225530|FG000|NOT COMPLETED|1 Month||1
10096720|NCT02369068|11225531|FG001|NOT COMPLETED|1 Month||1
10096721|NCT02369068|11225530|FG000|STARTED|3 Months||9
10096722|NCT02369068|11225531|FG001|STARTED|3 Months||10
10096723|NCT02369068|11225530|FG000|COMPLETED|3 Months||9
10096724|NCT02369068|11225531|FG001|COMPLETED|3 Months||8
10096725|NCT02369068|11225530|FG000|NOT COMPLETED|3 Months||0
10096726|NCT02369068|11225531|FG001|NOT COMPLETED|3 Months||2
10096727|NCT02369068|11225530|FG000|STARTED|6 Months||9
10096728|NCT02369068|11225531|FG001|STARTED|6 Months||8
10096729|NCT02369068|11225530|FG000|COMPLETED|6 Months||9
10096730|NCT02369068|11225531|FG001|COMPLETED|6 Months||7
10096731|NCT02369068|11225530|FG000|NOT COMPLETED|6 Months||0
10096732|NCT02369068|11225531|FG001|NOT COMPLETED|6 Months||1
10096733|NCT02369159|11225539|FG000|STARTED|Overall Study||114
10096734|NCT02369159|11225540|FG001|STARTED|Overall Study||23
10201947|NCT03441984|11329281|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201948|NCT03441984|11329282|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201949|NCT03441984|11329283|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201950|NCT03441984|11329284|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201951|NCT03441984|11329285|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201952|NCT03441984|11329286|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201953|NCT03441984|11329287|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201954|NCT03441984|11329276|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201955|NCT03441984|11329277|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201956|NCT03441984|11329278|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
10201957|NCT03441984|11329279|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201958|NCT03441984|11329280|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201959|NCT03441984|11329281|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10201960|NCT03441984|11329282|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201961|NCT03441984|11329283|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201962|NCT03441984|11329284|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201963|NCT03441984|11329285|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201964|NCT03441984|11329286|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201965|NCT03441984|11329287|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201966|NCT03441984|11329276|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201967|NCT03441984|11329277|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201968|NCT03441984|11329278|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201969|NCT03441984|11329279|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201970|NCT03441984|11329280|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201971|NCT03441984|11329281|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201972|NCT03441984|11329282|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201973|NCT03441984|11329283|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201974|NCT03441984|11329284|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201975|NCT03441984|11329285|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201976|NCT03441984|11329286|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201977|NCT03441984|11329287|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10201978|NCT03441984|11329276|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10201979|NCT03441984|11329277|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10201980|NCT03441984|11329278|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2
10201981|NCT03441984|11329279|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10201982|NCT03441984|11329280|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3
9872552|NCT00988533|10986951|FG000|NOT COMPLETED|Overall Study||3
9872553|NCT00988559|10986959|FG000|STARTED|Overall Study||10
9872554|NCT00988559|10986960|FG001|STARTED|Overall Study||11
9872555|NCT00988559|10986961|FG002|STARTED|Overall Study||11
9872556|NCT00988559|10986962|FG003|STARTED|Overall Study||7
9872557|NCT00988559|10986959|FG000|COMPLETED|Overall Study||9
9872558|NCT00988559|10986960|FG001|COMPLETED|Overall Study||9
10096735|NCT02369159|11225539|FG000|ITT Population|Overall Study||114
10096736|NCT02369159|11225540|FG001|ITT Population|Overall Study||23
10096737|NCT02369159|11225539|FG000|Safety Population|Overall Study||107
10096738|NCT02369159|11225540|FG001|Safety Population|Overall Study||23
10096739|NCT02369159|11225539|FG000|ITTI Population|Overall Study||81
9872559|NCT00988559|10986961|FG002|COMPLETED|Overall Study||9
9872560|NCT00988559|10986962|FG003|COMPLETED|Overall Study||6
10096740|NCT02369159|11225540|FG001|ITTI Population|Overall Study||16
10096741|NCT02369159|11225539|FG000|E-R Population|Overall Study||80
10096742|NCT02369159|11225540|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
9872561|NCT00988559|10986959|FG000|NOT COMPLETED|Overall Study||1
9872562|NCT00988559|10986960|FG001|NOT COMPLETED|Overall Study||2
9872563|NCT00988559|10986961|FG002|NOT COMPLETED|Overall Study||2
9872564|NCT00988559|10986962|FG003|NOT COMPLETED|Overall Study||1
9872565|NCT00988598|10986974|FG000|STARTED|Overall Study||10
10096743|NCT02369159|11225539|FG000|COMPLETED|Overall Study||106
10096744|NCT02369159|11225540|FG001|COMPLETED|Overall Study||21
10096745|NCT02369159|11225539|FG000|NOT COMPLETED|Overall Study||8
10096746|NCT02369159|11225540|FG001|NOT COMPLETED|Overall Study||2
10096747|NCT02369172|11225557|FG000|STARTED|Overall Study||24
10096748|NCT02369172|11225557|FG000|COMPLETED|Overall Study||24
10096749|NCT02369172|11225557|FG000|NOT COMPLETED|Overall Study||0
10096750|NCT02369211|11225581|FG000|STARTED|Overall Study||43
10096751|NCT02369211|11225582|FG001|STARTED|Overall Study||43
10096752|NCT02369211|11225581|FG000|COMPLETED|Overall Study||43
10096753|NCT02369211|11225582|FG001|COMPLETED|Overall Study||41
10096754|NCT02369211|11225581|FG000|NOT COMPLETED|Overall Study||0
10096755|NCT02369211|11225582|FG001|NOT COMPLETED|Overall Study||2
10096756|NCT02369341|11225590|FG000|STARTED|Overall Study||63
10096757|NCT02369341|11225591|FG001|STARTED|Overall Study||57
10096758|NCT02369341|11225590|FG000|COMPLETED|Overall Study||62
10096759|NCT02369341|11225591|FG001|COMPLETED|Overall Study||57
10096760|NCT02369341|11225590|FG000|NOT COMPLETED|Overall Study||1
10096761|NCT02369341|11225591|FG001|NOT COMPLETED|Overall Study||0
10096762|NCT02369484|11225601|FG000|STARTED|Overall Study||13
10096763|NCT02369484|11225601|FG000|COMPLETED|Overall Study||13
10096764|NCT02369484|11225601|FG000|NOT COMPLETED|Overall Study||0
10096765|NCT02369510|11225608|FG000|STARTED|Overall Study||23
10096766|NCT02369510|11225609|FG001|STARTED|Overall Study||22
10096767|NCT02369510|11225610|FG002|STARTED|Overall Study||23
10096768|NCT02369510|11225608|FG000|COMPLETED|Overall Study||21
10096769|NCT02369510|11225609|FG001|COMPLETED|Overall Study||19
10096770|NCT02369510|11225610|FG002|COMPLETED|Overall Study||17
10096771|NCT02369510|11225608|FG000|NOT COMPLETED|Overall Study||2
10096772|NCT02369510|11225609|FG001|NOT COMPLETED|Overall Study||3
10096773|NCT02369510|11225610|FG002|NOT COMPLETED|Overall Study||6
10096774|NCT02369796|11225623|FG000|STARTED|Overall Study||3
10096775|NCT02369796|11225624|FG001|STARTED|Overall Study||3
10096776|NCT02369796|11225625|FG002|STARTED|Overall Study||3
10096777|NCT02369796|11225626|FG003|STARTED|Overall Study||3
10096778|NCT02369796|11225627|FG004|STARTED|Overall Study||3
10096779|NCT02369796|11225623|FG000|COMPLETED|Overall Study||3
10096780|NCT02369796|11225624|FG001|COMPLETED|Overall Study||3
10096781|NCT02369796|11225625|FG002|COMPLETED|Overall Study||3
10096782|NCT02369796|11225626|FG003|COMPLETED|Overall Study||3
10096783|NCT02369796|11225627|FG004|COMPLETED|Overall Study||3
10096784|NCT02369796|11225623|FG000|NOT COMPLETED|Overall Study||0
10096785|NCT02369796|11225624|FG001|NOT COMPLETED|Overall Study||0
10096786|NCT02369796|11225625|FG002|NOT COMPLETED|Overall Study||0
10096787|NCT02369796|11225626|FG003|NOT COMPLETED|Overall Study||0
10096788|NCT02369796|11225627|FG004|NOT COMPLETED|Overall Study||0
10096789|NCT02369835|11225641|FG000|STARTED|Overall Study||64
10096790|NCT02369835|11225642|FG001|STARTED|Overall Study||68
10096791|NCT02369835|11225641|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
10096792|NCT02369835|11225642|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
10096793|NCT02369835|11225641|FG000|NOT COMPLETED|Overall Study||11
10096794|NCT02369835|11225642|FG001|NOT COMPLETED|Overall Study||13
10096795|NCT02369848|11225648|FG000|STARTED|Overall Study||60
10096796|NCT02369848|11225648|FG000|30 Day Primary Safety Endpoint|Overall Study||58
10096797|NCT02369848|11225648|FG000|12 Month Primary Endpoint|Overall Study||30
10096798|NCT02369848|11225648|FG000|COMPLETED|Overall Study||56
10096799|NCT02369848|11225648|FG000|NOT COMPLETED|Overall Study||4
10096800|NCT02369874|11225655|FG000|STARTED|Overall Study||247
10096801|NCT02369874|11225656|FG001|STARTED|Overall Study||240
10096802|NCT02369874|11225657|FG002|STARTED|Overall Study||249
10096803|NCT02369874|11225655|FG000|Received Treatment|Overall Study||246
10096804|NCT02369874|11225656|FG001|Received Treatment|Overall Study||237
10096805|NCT02369874|11225657|FG002|Received Treatment|Overall Study||240
10096806|NCT02369874|11225655|FG000|COMPLETED|Overall Study||203
10096807|NCT02369874|11225656|FG001|COMPLETED|Overall Study||183
10096808|NCT02369874|11225657|FG002|COMPLETED|Overall Study||188
9872566|NCT00988598|10986975|FG001|STARTED|Overall Study||5
9872567|NCT00988598|10986974|FG000|COMPLETED|Overall Study||8
10096809|NCT02369874|11225655|FG000|NOT COMPLETED|Overall Study||44
10096810|NCT02369874|11225656|FG001|NOT COMPLETED|Overall Study||57
10096811|NCT02369874|11225657|FG002|NOT COMPLETED|Overall Study||61
10096812|NCT02369900|11225667|FG000|STARTED|Overall Study||18
10096813|NCT02369900|11225668|FG001|STARTED|Overall Study||22
10096814|NCT02369900|11225667|FG000|COMPLETED|Overall Study||18
10096815|NCT02369900|11225668|FG001|COMPLETED|Overall Study||22
10096816|NCT02369900|11225667|FG000|NOT COMPLETED|Overall Study||0
10096817|NCT02369900|11225668|FG001|NOT COMPLETED|Overall Study||0
9872568|NCT00988598|10986975|FG001|COMPLETED|Overall Study||5
10096818|NCT02370004|11225674|FG000|STARTED|Overall Study||11
10096819|NCT02370004|11225674|FG000|COMPLETED|Overall Study||10
10096820|NCT02370004|11225674|FG000|NOT COMPLETED|Overall Study||1
10096821|NCT02370043|11225683|FG000|STARTED|Overall Study||3
10096822|NCT02370043|11225684|FG001|STARTED|Overall Study||3
10096823|NCT02370043|11225685|FG002|STARTED|Overall Study||3
10096824|NCT02370043|11225686|FG003|STARTED|Overall Study||3
10096825|NCT02370043|11225687|FG004|STARTED|Overall Study||3
9872569|NCT00988598|10986974|FG000|NOT COMPLETED|Overall Study||2
9872570|NCT00988598|10986975|FG001|NOT COMPLETED|Overall Study||0
9872571|NCT00988637|10986983|FG000|STARTED|Overall Study||70
9872572|NCT00988637|10986984|FG001|STARTED|Overall Study||68
9872573|NCT00988637|10986983|FG000|COMPLETED|Overall Study||67
9872574|NCT00988637|10986984|FG001|COMPLETED|Overall Study||65
9872575|NCT00988637|10986983|FG000|NOT COMPLETED|Overall Study||3
9872576|NCT00988637|10986984|FG001|NOT COMPLETED|Overall Study||3
9872577|NCT00988832|10986990|FG000|STARTED|Overall Study||380
9872578|NCT00988832|10986990|FG000|COMPLETED|Overall Study||380
9872579|NCT00988832|10986990|FG000|NOT COMPLETED|Overall Study||0
9872580|NCT00988858|10986997|FG000|STARTED|Overall Study||55
9872581|NCT00988858|10986997|FG000|COMPLETED|Overall Study||45
9872582|NCT00988858|10986997|FG000|NOT COMPLETED|Overall Study||10
9872583|NCT00988884|10987003|FG000|STARTED|Overall Study||621
9872584|NCT00988884|10987004|FG001|STARTED|Overall Study||620
9872585|NCT00988884|10987003|FG000|COMPLETED|Overall Study||586
9872586|NCT00988884|10987004|FG001|COMPLETED|Overall Study||584
9872587|NCT00988884|10987003|FG000|NOT COMPLETED|Overall Study||35
9872588|NCT00988884|10987004|FG001|NOT COMPLETED|Overall Study||36
9872589|NCT00989014|10987014|FG000|STARTED|Overall Study||31
9872590|NCT00989014|10987015|FG001|STARTED|Overall Study||31
9872591|NCT00989014|10987016|FG002|STARTED|Overall Study||28
9872592|NCT00989014|10987017|FG003|STARTED|Overall Study||32
9872593|NCT00989014|10987014|FG000|COMPLETED|Overall Study||31
9872594|NCT00989014|10987015|FG001|COMPLETED|Overall Study||31
9872595|NCT00989014|10987016|FG002|COMPLETED|Overall Study||28
9872596|NCT00989014|10987017|FG003|COMPLETED|Overall Study||32
9872597|NCT00989014|10987014|FG000|NOT COMPLETED|Overall Study||0
9872598|NCT00989014|10987015|FG001|NOT COMPLETED|Overall Study||0
9872599|NCT00989014|10987016|FG002|NOT COMPLETED|Overall Study||0
9872600|NCT00989014|10987017|FG003|NOT COMPLETED|Overall Study||0
9872601|NCT00989092|10987029|FG000|STARTED|Overall Study||228
9872602|NCT00989092|10987030|FG001|STARTED|Overall Study||59
9872603|NCT00989092|10987029|FG000|Treated With Darbepoetin Alfa|Overall Study||226
9872604|NCT00989092|10987030|FG001|Treated With Darbepoetin Alfa|Overall Study||33
9872605|NCT00989092|10987029|FG000|COMPLETED|Overall Study||138
9872606|NCT00989092|10987030|FG001|COMPLETED|Overall Study||31
9872607|NCT00989092|10987029|FG000|NOT COMPLETED|Overall Study||90
9872608|NCT00989092|10987030|FG001|NOT COMPLETED|Overall Study||28
9872609|NCT00989157|10987039|FG000|STARTED|Overall Study||10
9872610|NCT00989157|10987040|FG001|STARTED|Overall Study||10
9872611|NCT00989157|10987039|FG000|COMPLETED|Overall Study||10
9872612|NCT00989157|10987040|FG001|COMPLETED|Overall Study||10
9872613|NCT00989157|10987039|FG000|NOT COMPLETED|Overall Study||0
9872614|NCT00989157|10987040|FG001|NOT COMPLETED|Overall Study||0
9872615|NCT00989196|10987048|FG000|STARTED|PK Crossover Period||10
10096826|NCT02370043|11225688|FG005|STARTED|Overall Study||4
10096827|NCT02370043|11225683|FG000|COMPLETED|Overall Study||3
10096828|NCT02370043|11225684|FG001|COMPLETED|Overall Study||3
10096829|NCT02370043|11225685|FG002|COMPLETED|Overall Study||3
10096830|NCT02370043|11225686|FG003|COMPLETED|Overall Study||3
10096831|NCT02370043|11225687|FG004|COMPLETED|Overall Study||2
10096832|NCT02370043|11225688|FG005|COMPLETED|Overall Study||3
10096833|NCT02370043|11225683|FG000|NOT COMPLETED|Overall Study||0
10096834|NCT02370043|11225684|FG001|NOT COMPLETED|Overall Study||0
10096835|NCT02370043|11225685|FG002|NOT COMPLETED|Overall Study||0
10096836|NCT02370043|11225686|FG003|NOT COMPLETED|Overall Study||0
10096837|NCT02370043|11225687|FG004|NOT COMPLETED|Overall Study||1
10096838|NCT02370043|11225688|FG005|NOT COMPLETED|Overall Study||1
10096839|NCT02370056|11225718|FG000|STARTED|Overall Study||27
10096840|NCT02370056|11225719|FG001|STARTED|Overall Study||26
10096841|NCT02370056|11225718|FG000|COMPLETED|Overall Study||27
10096842|NCT02370056|11225719|FG001|COMPLETED|Overall Study||26
9872616|NCT00989196|10987049|FG001|STARTED|PK Crossover Period||12
9872617|NCT00989196|10987048|FG000|COMPLETED|PK Crossover Period||10
9872618|NCT00989196|10987049|FG001|COMPLETED|PK Crossover Period||12
9872619|NCT00989196|10987048|FG000|NOT COMPLETED|PK Crossover Period||0
9872620|NCT00989196|10987049|FG001|NOT COMPLETED|PK Crossover Period||0
9872621|NCT00989196|10987048|FG000|STARTED|Treatment Period||10
9872622|NCT00989196|10987049|FG001|STARTED|Treatment Period||12
9872623|NCT00989196|10987048|FG000|COMPLETED|Treatment Period||9
9872624|NCT00989196|10987049|FG001|COMPLETED|Treatment Period||12
9872625|NCT00989196|10987048|FG000|NOT COMPLETED|Treatment Period||1
9872626|NCT00989196|10987049|FG001|NOT COMPLETED|Treatment Period||0
9872627|NCT00989235|10987057|FG000|STARTED|Overall Study||58
9872628|NCT00989235|10987058|FG001|STARTED|Overall Study||50
9872629|NCT00989235|10987057|FG000|Number Rescued to Open-Label Treatment|Overall Study||4
10096843|NCT02370056|11225718|FG000|NOT COMPLETED|Overall Study||0
10096844|NCT02370056|11225719|FG001|NOT COMPLETED|Overall Study||0
10096845|NCT02370095|11225727|FG000|STARTED|Overall Study||10
9872630|NCT00989235|10987058|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
9872631|NCT00989235|10987057|FG000|Number Completing Double-Blind Treatment|Overall Study||51
9872632|NCT00989235|10987058|FG001|Number Completing Double-Blind Treatment|Overall Study||41
9872633|NCT00989235|10987057|FG000|COMPLETED|Overall Study||55
9872634|NCT00989235|10987058|FG001|COMPLETED|Overall Study||44
9872635|NCT00989235|10987057|FG000|NOT COMPLETED|Overall Study||3
9872636|NCT00989235|10987058|FG001|NOT COMPLETED|Overall Study||6
10096846|NCT02370095|11225728|FG001|STARTED|Overall Study||4
10096847|NCT02370095|11225727|FG000|COMPLETED|Overall Study||10
9872637|NCT00989261|10987069|FG000|STARTED|Overall Study||157
9872638|NCT00989261|10987070|FG001|STARTED|Overall Study||176
9872639|NCT00989261|10987069|FG000|COMPLETED|Overall Study||142
9872640|NCT00989261|10987070|FG001|COMPLETED|Overall Study||154
9872641|NCT00989261|10987069|FG000|NOT COMPLETED|Overall Study||15
9872642|NCT00989261|10987070|FG001|NOT COMPLETED|Overall Study||22
9872643|NCT00989287|10987078|FG000|STARTED|Overall Study||65
9872644|NCT00989287|10987079|FG001|STARTED|Overall Study||66
9872645|NCT00989287|10987078|FG000|COMPLETED|Overall Study||64
9872646|NCT00989287|10987079|FG001|COMPLETED|Overall Study||65
10096848|NCT02370095|11225728|FG001|COMPLETED|Overall Study||3
10096849|NCT02370095|11225727|FG000|NOT COMPLETED|Overall Study||0
10096850|NCT02370095|11225728|FG001|NOT COMPLETED|Overall Study||1
10096851|NCT02370121|11225736|FG000|STARTED|Overall Study||12
10096852|NCT02370121|11225737|FG001|STARTED|Overall Study||12
10096853|NCT02370121|11225736|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
10096854|NCT02370121|11225737|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
10096855|NCT02370121|11225736|FG000|NOT COMPLETED|Overall Study||1
10096856|NCT02370121|11225737|FG001|NOT COMPLETED|Overall Study||1
10096857|NCT02370160|11225743|FG000|STARTED|Overall Study||9
10096858|NCT02370160|11225744|FG001|STARTED|Overall Study||6
10096859|NCT02370160|11225745|FG002|STARTED|Overall Study||3
10096860|NCT02370160|11225743|FG000|COMPLETED|Overall Study||6
10096861|NCT02370160|11225744|FG001|COMPLETED|Overall Study||2
10096862|NCT02370160|11225745|FG002|COMPLETED|Overall Study||2
10096863|NCT02370160|11225743|FG000|NOT COMPLETED|Overall Study||3
10096864|NCT02370160|11225744|FG001|NOT COMPLETED|Overall Study||4
10096865|NCT02370160|11225745|FG002|NOT COMPLETED|Overall Study||1
10096866|NCT02370238|11225760|FG000|STARTED|Overall Study||62
10096867|NCT02370238|11225761|FG001|STARTED|Overall Study||61
10096868|NCT02370238|11225760|FG000|ITT Population|Overall Study||62
10096869|NCT02370238|11225761|FG001|ITT Population|Overall Study||61
10096870|NCT02370238|11225760|FG000|Safety Population|Overall Study||61
10096871|NCT02370238|11225761|FG001|Safety Population|Overall Study||60
10096872|NCT02370238|11225760|FG000|Responsable-evaluable Population|Overall Study||57
10096873|NCT02370238|11225761|FG001|Responsable-evaluable Population|Overall Study||54
10096874|NCT02370238|11225760|FG000|COMPLETED|Overall Study||15
10096875|NCT02370238|11225761|FG001|COMPLETED|Overall Study||16
10096876|NCT02370238|11225760|FG000|NOT COMPLETED|Overall Study||47
10096877|NCT02370238|11225761|FG001|NOT COMPLETED|Overall Study||45
10096878|NCT02370251|11225771|FG000|STARTED|Overall Study||63
10096879|NCT02370251|11225771|FG000|COMPLETED|Overall Study||52
10096880|NCT02370251|11225771|FG000|NOT COMPLETED|Overall Study||11
10096881|NCT02370368|11225777|FG000|STARTED|Overall Study||14
10096882|NCT02370368|11225778|FG001|STARTED|Overall Study||13
10096883|NCT02370368|11225777|FG000|COMPLETED|Overall Study||8
10096884|NCT02370368|11225778|FG001|COMPLETED|Overall Study||7
10096885|NCT02370368|11225777|FG000|NOT COMPLETED|Overall Study||6
10096886|NCT02370368|11225778|FG001|NOT COMPLETED|Overall Study||6
10096887|NCT02370394|11225786|FG000|STARTED|Overall Study||28
10096888|NCT02370394|11225787|FG001|STARTED|Overall Study||25
10096889|NCT02370394|11225786|FG000|COMPLETED|Overall Study||26
10096890|NCT02370394|11225787|FG001|COMPLETED|Overall Study||23
10096891|NCT02370394|11225786|FG000|NOT COMPLETED|Overall Study||2
10096892|NCT02370394|11225787|FG001|NOT COMPLETED|Overall Study||2
10096893|NCT02370407|11225796|FG000|STARTED|Overall Study||20
10096894|NCT02370407|11225797|FG001|STARTED|Overall Study||20
10096895|NCT02370407|11225796|FG000|COMPLETED|Overall Study||20
10096896|NCT02370407|11225797|FG001|COMPLETED|Overall Study||20
10096897|NCT02370407|11225796|FG000|NOT COMPLETED|Overall Study||0
10096898|NCT02370407|11225797|FG001|NOT COMPLETED|Overall Study||0
10096899|NCT02370420|11225809|FG000|STARTED|Overall Study||29
10096900|NCT02370420|11225810|FG001|STARTED|Overall Study||27
10096901|NCT02370420|11225809|FG000|COMPLETED|Overall Study||15
10096902|NCT02370420|11225810|FG001|COMPLETED|Overall Study||15
10096903|NCT02370420|11225809|FG000|NOT COMPLETED|Overall Study||14
10096904|NCT02370420|11225810|FG001|NOT COMPLETED|Overall Study||12
10096905|NCT02370498|11225818|FG000|STARTED|Overall Study||296
10096906|NCT02370498|11225819|FG001|STARTED|Overall Study||296
10096907|NCT02370498|11225818|FG000|Treated|Overall Study||294
10096908|NCT02370498|11225819|FG001|Treated|Overall Study||276
9872647|NCT00989287|10987078|FG000|NOT COMPLETED|Overall Study||1
10096909|NCT02370498|11225818|FG000|PD-L1 Positive Participants|Overall Study||196
10096910|NCT02370498|11225819|FG001|PD-L1 Positive Participants|Overall Study||199
10096911|NCT02370498|11225818|FG000|COMPLETED|Overall Study||0
10096912|NCT02370498|11225819|FG001|COMPLETED|Overall Study||0
10096913|NCT02370498|11225818|FG000|NOT COMPLETED|Overall Study||296
10096914|NCT02370498|11225819|FG001|NOT COMPLETED|Overall Study||296
10096915|NCT02370511|11225829|FG000|STARTED|Overall Study||31
10096916|NCT02370511|11225830|FG001|STARTED|Overall Study||30
9872648|NCT00989287|10987079|FG001|NOT COMPLETED|Overall Study||1
10096917|NCT02370511|11225831|FG002|STARTED|Overall Study||30
10096918|NCT02370511|11225829|FG000|COMPLETED|Overall Study||19
10096919|NCT02370511|11225830|FG001|COMPLETED|Overall Study||19
10096920|NCT02370511|11225831|FG002|COMPLETED|Overall Study||29
10096921|NCT02370511|11225829|FG000|NOT COMPLETED|Overall Study||12
10096922|NCT02370511|11225830|FG001|NOT COMPLETED|Overall Study||11
10096923|NCT02370511|11225831|FG002|NOT COMPLETED|Overall Study||1
10096924|NCT02370537|11225842|FG000|STARTED|Part A (Open-label Recruitment)||16
10096925|NCT02370537|11225843|FG001|STARTED|Part A (Open-label Recruitment)||16
10096926|NCT02370537|11225844|FG002|STARTED|Part A (Open-label Recruitment)||283
9872649|NCT00989573|10987101|FG000|STARTED|Overall Study||65
9872650|NCT00989573|10987102|FG001|STARTED|Overall Study||63
9872651|NCT00989573|10987103|FG002|STARTED|Overall Study||63
9872652|NCT00989573|10987101|FG000|COMPLETED|Overall Study||52
10096927|NCT02370537|11225842|FG000|COMPLETED|Part A (Open-label Recruitment)||16
10096928|NCT02370537|11225843|FG001|COMPLETED|Part A (Open-label Recruitment)||15
10096929|NCT02370537|11225844|FG002|COMPLETED|Part A (Open-label Recruitment)||282
10096930|NCT02370537|11225842|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0
10096931|NCT02370537|11225843|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1
10096932|NCT02370537|11225844|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1
10096933|NCT02370537|11225842|FG000|STARTED|Part B||16
10096934|NCT02370537|11225843|FG001|STARTED|Part B||15
10096935|NCT02370537|11225844|FG002|STARTED|Part B||282
10096936|NCT02370537|11225842|FG000|Eligible for Randomisation|Part B||15
10096937|NCT02370537|11225843|FG001|Eligible for Randomisation|Part B||13
10096938|NCT02370537|11225844|FG002|Eligible for Randomisation|Part B||23
10096939|NCT02370537|11225842|FG000|Period 1 Sequence AB|Part B||8
10096940|NCT02370537|11225843|FG001|Period 1 Sequence AB|Part B||6
10096941|NCT02370537|11225844|FG002|Period 1 Sequence AB|Part B||11
10096942|NCT02370537|11225842|FG000|Period 1 Sequence BA|Part B||7
10096943|NCT02370537|11225843|FG001|Period 1 Sequence BA|Part B||7
10096944|NCT02370537|11225844|FG002|Period 1 Sequence BA|Part B||12
10096945|NCT02370537|11225842|FG000|Period 2 Sequence AB|Part B||8
10096946|NCT02370537|11225843|FG001|Period 2 Sequence AB|Part B||5
10096947|NCT02370537|11225844|FG002|Period 2 Sequence AB|Part B||11
10096948|NCT02370537|11225842|FG000|Period 2 Sequence BA|Part B||7
10096949|NCT02370537|11225843|FG001|Period 2 Sequence BA|Part B||7
10096950|NCT02370537|11225844|FG002|Period 2 Sequence BA|Part B||12
10096951|NCT02370537|11225842|FG000|COMPLETED|Part B||15
10096952|NCT02370537|11225843|FG001|COMPLETED|Part B||12
10096953|NCT02370537|11225844|FG002|COMPLETED|Part B||23
10096954|NCT02370537|11225842|FG000|NOT COMPLETED|Part B||1
10096955|NCT02370537|11225843|FG001|NOT COMPLETED|Part B||3
10096956|NCT02370537|11225844|FG002|NOT COMPLETED|Part B||259
10096957|NCT02370602|11225867|FG000|STARTED|Overall Study||1
10096958|NCT02370602|11225868|FG001|STARTED|Overall Study||2
10096959|NCT02370602|11225869|FG002|STARTED|Overall Study||2
10096960|NCT02370602|11225870|FG003|STARTED|Overall Study||3
10096961|NCT02370602|11225871|FG004|STARTED|Overall Study||3
10096962|NCT02370602|11225872|FG005|STARTED|Overall Study||2
10096963|NCT02370602|11225867|FG000|COMPLETED|Overall Study||0
10096964|NCT02370602|11225868|FG001|COMPLETED|Overall Study||2
10096965|NCT02370602|11225869|FG002|COMPLETED|Overall Study||2
10096966|NCT02370602|11225870|FG003|COMPLETED|Overall Study||3
10096967|NCT02370602|11225871|FG004|COMPLETED|Overall Study||3
10096968|NCT02370602|11225872|FG005|COMPLETED|Overall Study||2
10096969|NCT02370602|11225867|FG000|NOT COMPLETED|Overall Study||1
10096970|NCT02370602|11225868|FG001|NOT COMPLETED|Overall Study||0
10096971|NCT02370602|11225869|FG002|NOT COMPLETED|Overall Study||0
10096972|NCT02370602|11225870|FG003|NOT COMPLETED|Overall Study||0
10096973|NCT02370602|11225871|FG004|NOT COMPLETED|Overall Study||0
10096974|NCT02370602|11225872|FG005|NOT COMPLETED|Overall Study||0
10096975|NCT02370615|11225891|FG000|STARTED|Overall Study||16
10096976|NCT02370615|11225892|FG001|STARTED|Overall Study||18
10096977|NCT02370615|11225891|FG000|COMPLETED|Overall Study||15
10096978|NCT02370615|11225892|FG001|COMPLETED|Overall Study||18
10096979|NCT02370615|11225891|FG000|NOT COMPLETED|Overall Study||1
10096980|NCT02370615|11225892|FG001|NOT COMPLETED|Overall Study||0
10096981|NCT02370641|11225907|FG000|STARTED|Overall Study||18
10096982|NCT02370641|11225908|FG001|STARTED|Overall Study||8
10096983|NCT02370641|11225907|FG000|COMPLETED|Overall Study||14
10096984|NCT02370641|11225908|FG001|COMPLETED|Overall Study||6
10096985|NCT02370641|11225907|FG000|NOT COMPLETED|Overall Study||4
10096986|NCT02370641|11225908|FG001|NOT COMPLETED|Overall Study||2
10096987|NCT02370667|11225917|FG000|STARTED|Overall Study||10
10096988|NCT02370667|11225918|FG001|STARTED|Overall Study||11
10096989|NCT02370667|11225919|FG002|STARTED|Overall Study||10
10096990|NCT02370667|11225917|FG000|COMPLETED|Overall Study||10
10096991|NCT02370667|11225918|FG001|COMPLETED|Overall Study||10
10096992|NCT02370667|11225919|FG002|COMPLETED|Overall Study||10
10096993|NCT02370667|11225917|FG000|NOT COMPLETED|Overall Study||0
10096994|NCT02370667|11225918|FG001|NOT COMPLETED|Overall Study||1
10096995|NCT02370667|11225919|FG002|NOT COMPLETED|Overall Study||0
10096996|NCT02370693|11225930|FG000|STARTED|Overall Study||3
10096997|NCT02370693|11225931|FG001|STARTED|Overall Study||4
10096998|NCT02370693|11225930|FG000|COMPLETED|Overall Study||2
10096999|NCT02370693|11225931|FG001|COMPLETED|Overall Study||3
10097000|NCT02370693|11225930|FG000|NOT COMPLETED|Overall Study||1
10097001|NCT02370693|11225931|FG001|NOT COMPLETED|Overall Study||1
10097002|NCT02370784|11225939|FG000|STARTED|Overall Study||10
10097003|NCT02370784|11225940|FG001|STARTED|Overall Study||14
10097004|NCT02370784|11225939|FG000|COMPLETED|Overall Study||10
10097005|NCT02370784|11225940|FG001|COMPLETED|Overall Study||13
10097006|NCT02370784|11225939|FG000|NOT COMPLETED|Overall Study||0
10097007|NCT02370784|11225940|FG001|NOT COMPLETED|Overall Study||1
10097008|NCT02370810|11225950|FG000|STARTED|Overall Study||73
10097009|NCT02370810|11225951|FG001|STARTED|Overall Study||73
10097010|NCT02370810|11225950|FG000|COMPLETED|Overall Study||50
10097011|NCT02370810|11225951|FG001|COMPLETED|Overall Study||54
10097012|NCT02370810|11225950|FG000|NOT COMPLETED|Overall Study||23
9872653|NCT00989573|10987102|FG001|COMPLETED|Overall Study||41
9872654|NCT00989573|10987103|FG002|COMPLETED|Overall Study||55
10097013|NCT02370810|11225951|FG001|NOT COMPLETED|Overall Study||19
9872655|NCT00989573|10987101|FG000|NOT COMPLETED|Overall Study||13
9872656|NCT00989573|10987102|FG001|NOT COMPLETED|Overall Study||22
9872657|NCT00989573|10987103|FG002|NOT COMPLETED|Overall Study||8
9872658|NCT00989586|10987113|FG000|STARTED|Overall Study||18
9872659|NCT00989586|10987114|FG001|STARTED|Overall Study||17
9872660|NCT00989586|10987113|FG000|COMPLETED|Overall Study||18
9872661|NCT00989586|10987114|FG001|COMPLETED|Overall Study||17
9872662|NCT00989586|10987113|FG000|NOT COMPLETED|Overall Study||0
10097014|NCT02370914|11225959|FG000|STARTED|Overall Study||84
10097015|NCT02370914|11225959|FG000|COMPLETED|Overall Study||82
10097016|NCT02370914|11225959|FG000|NOT COMPLETED|Overall Study||2
10097017|NCT02371187|11225965|FG000|STARTED|Overall Study||18
10097018|NCT02371187|11225966|FG001|STARTED|Overall Study||19
10097019|NCT02371187|11225965|FG000|COMPLETED|Overall Study||15
10097020|NCT02371187|11225966|FG001|COMPLETED|Overall Study||15
10097021|NCT02371187|11225965|FG000|NOT COMPLETED|Overall Study||3
10097022|NCT02371187|11225966|FG001|NOT COMPLETED|Overall Study||4
10097023|NCT02371252|11225974|FG000|STARTED|Overall Study||70
10097024|NCT02371252|11225975|FG001|STARTED|Overall Study||70
10097025|NCT02371252|11225974|FG000|COMPLETED|Overall Study||70
10097026|NCT02371252|11225975|FG001|COMPLETED|Overall Study||70
10097027|NCT02371252|11225974|FG000|NOT COMPLETED|Overall Study||0
10097028|NCT02371252|11225975|FG001|NOT COMPLETED|Overall Study||0
10097029|NCT02371356|11225986|FG000|STARTED|Overall Study||1320
10097030|NCT02371356|11225987|FG001|STARTED|Overall Study||7354
10097031|NCT02371356|11225988|FG002|STARTED|Overall Study||2804
10097032|NCT02371356|11225989|FG003|STARTED|Overall Study||7423
10097033|NCT02371356|11225990|FG004|STARTED|Overall Study||72183
10097034|NCT02371356|11225986|FG000|COMPLETED|Overall Study||1320
10097035|NCT02371356|11225987|FG001|COMPLETED|Overall Study||7354
10097036|NCT02371356|11225988|FG002|COMPLETED|Overall Study||2804
10097037|NCT02371356|11225989|FG003|COMPLETED|Overall Study||7423
10097038|NCT02371356|11225990|FG004|COMPLETED|Overall Study||72183
10097039|NCT02371356|11225986|FG000|NOT COMPLETED|Overall Study||0
10097040|NCT02371356|11225987|FG001|NOT COMPLETED|Overall Study||0
10097041|NCT02371356|11225988|FG002|NOT COMPLETED|Overall Study||0
10097042|NCT02371356|11225989|FG003|NOT COMPLETED|Overall Study||0
10097043|NCT02371356|11225990|FG004|NOT COMPLETED|Overall Study||0
10097044|NCT02371395|11226002|FG000|STARTED|Overall Study||1000
10097045|NCT02371395|11226002|FG000|COMPLETED|Overall Study||1000
10097046|NCT02371395|11226002|FG000|NOT COMPLETED|Overall Study||0
10097047|NCT02371616|11226008|FG000|STARTED|Overall Study||150
10097048|NCT02371616|11226009|FG001|STARTED|Overall Study||154
10097049|NCT02371616|11226008|FG000|COMPLETED|Overall Study||146
10097050|NCT02371616|11226009|FG001|COMPLETED|Overall Study||147
10097051|NCT02371616|11226008|FG000|NOT COMPLETED|Overall Study||4
10097052|NCT02371616|11226009|FG001|NOT COMPLETED|Overall Study||7
10097053|NCT02371629|11226017|FG000|STARTED|Overall Study||388
10097054|NCT02371629|11226018|FG001|STARTED|Overall Study||388
10097055|NCT02371629|11226017|FG000|COMPLETED|Overall Study||362
10097056|NCT02371629|11226018|FG001|COMPLETED|Overall Study||363
10097057|NCT02371629|11226017|FG000|NOT COMPLETED|Overall Study||26
10097058|NCT02371629|11226018|FG001|NOT COMPLETED|Overall Study||25
10097059|NCT02371668|11226026|FG000|STARTED|Overall Study||49
10097060|NCT02371668|11226027|FG001|STARTED|Overall Study||42
10097061|NCT02371668|11226026|FG000|COMPLETED|Overall Study||49
10097062|NCT02371668|11226027|FG001|COMPLETED|Overall Study||42
10097063|NCT02371668|11226026|FG000|NOT COMPLETED|Overall Study||0
10097064|NCT02371668|11226027|FG001|NOT COMPLETED|Overall Study||0
10097065|NCT02371746|11226040|FG000|STARTED|Overall Study||7
10097066|NCT02371746|11226041|FG001|STARTED|Overall Study||10
10097067|NCT02371746|11226042|FG002|STARTED|Overall Study||2
10097068|NCT02371746|11226043|FG003|STARTED|Overall Study||2
10097069|NCT02371746|11226044|FG004|STARTED|Overall Study||5
10097070|NCT02371746|11226045|FG005|STARTED|Overall Study||6
10097071|NCT02371746|11226046|FG006|STARTED|Overall Study||9
9872663|NCT00989586|10987114|FG001|NOT COMPLETED|Overall Study||0
9872664|NCT00989612|10987121|FG000|STARTED|Overall Study||100
9872665|NCT00989612|10987121|FG000|COMPLETED|Overall Study||100
9872666|NCT00989612|10987121|FG000|NOT COMPLETED|Overall Study||0
9872667|NCT00989664|10987127|FG000|STARTED|Dosimetric and Therapeutic Treatment||61
9872668|NCT00989664|10987127|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
9872669|NCT00989664|10987127|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
9953736|NCT01427933|11072425|FG000|STARTED|Overall Study||71
10097072|NCT02371746|11226040|FG000|COMPLETED|Overall Study||7
10097073|NCT02371746|11226041|FG001|COMPLETED|Overall Study||10
10097074|NCT02371746|11226042|FG002|COMPLETED|Overall Study||2
10097075|NCT02371746|11226043|FG003|COMPLETED|Overall Study||2
10097076|NCT02371746|11226044|FG004|COMPLETED|Overall Study||5
10097077|NCT02371746|11226045|FG005|COMPLETED|Overall Study||6
10097078|NCT02371746|11226046|FG006|COMPLETED|Overall Study||8
10097079|NCT02371746|11226040|FG000|NOT COMPLETED|Overall Study||0
10097080|NCT02371746|11226041|FG001|NOT COMPLETED|Overall Study||0
10097081|NCT02371746|11226042|FG002|NOT COMPLETED|Overall Study||0
10097082|NCT02371746|11226043|FG003|NOT COMPLETED|Overall Study||0
10097083|NCT02371746|11226044|FG004|NOT COMPLETED|Overall Study||0
10097084|NCT02371746|11226045|FG005|NOT COMPLETED|Overall Study||0
10097085|NCT02371746|11226046|FG006|NOT COMPLETED|Overall Study||1
10097086|NCT02371759|11226070|FG000|STARTED|Overall Study||32
10097087|NCT02371759|11226071|FG001|STARTED|Overall Study||31
10097088|NCT02371759|11226072|FG002|STARTED|Overall Study||33
10097089|NCT02371759|11226073|FG003|STARTED|Overall Study||31
10097090|NCT02371759|11226074|FG004|STARTED|Overall Study||27
9872670|NCT00989664|10987127|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
9872671|NCT00989664|10987127|FG000|COMPLETED|Long-Term Follow-Up||11
9872672|NCT00989664|10987127|FG000|NOT COMPLETED|Long-Term Follow-Up||3
9872673|NCT00989768|10987133|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
9872674|NCT00989768|10987133|FG000|COMPLETED|Overall Study||28
10097091|NCT02371759|11226075|FG005|STARTED|Overall Study||26
10097092|NCT02371759|11226076|FG006|STARTED|Overall Study||25
10097093|NCT02371759|11226077|FG007|STARTED|Overall Study||28
10097094|NCT02371759|11226070|FG000|COMPLETED|Overall Study||29
10097095|NCT02371759|11226071|FG001|COMPLETED|Overall Study||30
10097096|NCT02371759|11226072|FG002|COMPLETED|Overall Study||32
10097097|NCT02371759|11226073|FG003|COMPLETED|Overall Study||31
10097098|NCT02371759|11226074|FG004|COMPLETED|Overall Study||24
10097099|NCT02371759|11226075|FG005|COMPLETED|Overall Study||25
10097100|NCT02371759|11226076|FG006|COMPLETED|Overall Study||25
10097101|NCT02371759|11226077|FG007|COMPLETED|Overall Study||24
10097102|NCT02371759|11226070|FG000|NOT COMPLETED|Overall Study||3
10097103|NCT02371759|11226071|FG001|NOT COMPLETED|Overall Study||1
10097104|NCT02371759|11226072|FG002|NOT COMPLETED|Overall Study||1
10097105|NCT02371759|11226073|FG003|NOT COMPLETED|Overall Study||0
10097106|NCT02371759|11226074|FG004|NOT COMPLETED|Overall Study||3
10097107|NCT02371759|11226075|FG005|NOT COMPLETED|Overall Study||1
10097108|NCT02371759|11226076|FG006|NOT COMPLETED|Overall Study||0
10097109|NCT02371759|11226077|FG007|NOT COMPLETED|Overall Study||4
10097110|NCT02371785|11226095|FG000|STARTED|Overall Study||20
10097111|NCT02371785|11226095|FG000|COMPLETED|Overall Study||20
10097112|NCT02371785|11226095|FG000|NOT COMPLETED|Overall Study||0
10097113|NCT02371850|11226105|FG000|STARTED|Overall Study||10
10097114|NCT02371850|11226105|FG000|COMPLETED|Overall Study||10
10097115|NCT02371850|11226105|FG000|NOT COMPLETED|Overall Study||0
10097116|NCT02371876|11226116|FG000|STARTED|Overall Study||134
10097117|NCT02371876|11226116|FG000|COMPLETED|Overall Study||134
10097118|NCT02371876|11226116|FG000|NOT COMPLETED|Overall Study||0
10113019|NCT02507219|11243935|FG002|COMPLETED|Overall Study||3
10113020|NCT02507219|11243936|FG003|COMPLETED|Overall Study||3
10113021|NCT02507219|11243937|FG004|COMPLETED|Overall Study||3
10113022|NCT02507219|11243938|FG005|COMPLETED|Overall Study||3
10113023|NCT02507219|11243933|FG000|NOT COMPLETED|Overall Study||1
10113024|NCT02507219|11243934|FG001|NOT COMPLETED|Overall Study||0
10113025|NCT02507219|11243935|FG002|NOT COMPLETED|Overall Study||0
10113026|NCT02507219|11243936|FG003|NOT COMPLETED|Overall Study||0
10113027|NCT02507219|11243937|FG004|NOT COMPLETED|Overall Study||1
10113028|NCT02507219|11243938|FG005|NOT COMPLETED|Overall Study||0
10113029|NCT02507297|11243948|FG000|STARTED|Overall Study||16
10113030|NCT02507297|11243949|FG001|STARTED|Overall Study||13
10113031|NCT02507297|11243948|FG000|COMPLETED|Overall Study||15
10113032|NCT02507297|11243949|FG001|COMPLETED|Overall Study||12
10113033|NCT02507297|11243948|FG000|NOT COMPLETED|Overall Study||1
10113034|NCT02507297|11243949|FG001|NOT COMPLETED|Overall Study||1
10113035|NCT02507349|11243957|FG000|STARTED|Overall Study||1232
10113036|NCT02507349|11243958|FG001|STARTED|Overall Study||1211
10113037|NCT02507349|11243957|FG000|COMPLETED|Overall Study||1045
10113038|NCT02507349|11243958|FG001|COMPLETED|Overall Study||1050
10113039|NCT02507349|11243957|FG000|NOT COMPLETED|Overall Study||187
10113040|NCT02507349|11243958|FG001|NOT COMPLETED|Overall Study||161
10113041|NCT02507375|11243966|FG000|STARTED|Overall Study||6
10113042|NCT02507375|11243967|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
10113043|NCT02507375|11243966|FG000|Cycle 1|Overall Study||6
10113044|NCT02507375|11243967|FG001|Cycle 1|Overall Study||9
10113045|NCT02507375|11243966|FG000|Received Pertuzumab|Overall Study||6
10113046|NCT02507375|11243967|FG001|Received Pertuzumab|Overall Study||6
10113047|NCT02507375|11243966|FG000|Cycle 2|Overall Study||5
10113048|NCT02507375|11243967|FG001|Cycle 2|Overall Study||5
10113049|NCT02507375|11243966|FG000|Cycle 3|Overall Study||4
10113050|NCT02507375|11243967|FG001|Cycle 3|Overall Study||5
10113051|NCT02507375|11243966|FG000|Cycle 4|Overall Study||4
10113052|NCT02507375|11243967|FG001|Cycle 4|Overall Study||2
10113053|NCT02507375|11243966|FG000|Cycle 5|Overall Study||3
10113054|NCT02507375|11243967|FG001|Cycle 5|Overall Study||1
10113055|NCT02507375|11243966|FG000|Cycle 6|Overall Study||3
10113056|NCT02507375|11243967|FG001|Cycle 6|Overall Study||1
10113057|NCT02507375|11243966|FG000|Extension Period|Overall Study||2
10113058|NCT02507375|11243967|FG001|Extension Period|Overall Study||1
10113059|NCT02507375|11243966|FG000|COMPLETED|Overall Study||2
10113060|NCT02507375|11243967|FG001|COMPLETED|Overall Study||1
10113061|NCT02507375|11243966|FG000|NOT COMPLETED|Overall Study||4
9872675|NCT00989768|10987133|FG000|NOT COMPLETED|Overall Study||1
10113062|NCT02507375|11243967|FG001|NOT COMPLETED|Overall Study||8
10113063|NCT02507388|11243979|FG000|STARTED|Overall Study||25
10113064|NCT02507388|11243980|FG001|STARTED|Overall Study||25
10113065|NCT02507388|11243979|FG000|COMPLETED|Overall Study||25
10113066|NCT02507388|11243980|FG001|COMPLETED|Overall Study||25
10113067|NCT02507388|11243979|FG000|NOT COMPLETED|Overall Study||0
10113068|NCT02507388|11243980|FG001|NOT COMPLETED|Overall Study||0
10113069|NCT02507752|11243987|FG000|STARTED|Overall Study||72
10113070|NCT02507752|11243987|FG000|COMPLETED|Overall Study||55
10113071|NCT02507752|11243987|FG000|NOT COMPLETED|Overall Study||17
10113072|NCT02508077|11243991|FG000|STARTED|Overall Study||1
10113073|NCT02508077|11243991|FG000|COMPLETED|Overall Study||1
10113074|NCT02508077|11243991|FG000|NOT COMPLETED|Overall Study||0
9872676|NCT00989781|10987143|FG000|STARTED|Ovarian Response to hCG||21
9872677|NCT00989781|10987144|FG001|STARTED|Ovarian Response to hCG||20
9872678|NCT00989781|10987143|FG000|COMPLETED|Ovarian Response to hCG||18
9872679|NCT00989781|10987144|FG001|COMPLETED|Ovarian Response to hCG||18
9872680|NCT00989781|10987143|FG000|NOT COMPLETED|Ovarian Response to hCG||3
9872681|NCT00989781|10987144|FG001|NOT COMPLETED|Ovarian Response to hCG||2
9872682|NCT00989781|10987143|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
9872683|NCT00989781|10987144|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
9872684|NCT00989781|10987143|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
9872685|NCT00989781|10987144|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
9872686|NCT00989781|10987143|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5
9872687|NCT00989781|10987144|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3
9872688|NCT00989833|10987154|FG000|STARTED|Overall Study||21
9872689|NCT00989833|10987155|FG001|STARTED|Overall Study||22
9872690|NCT00989833|10987156|FG002|STARTED|Overall Study||23
9872691|NCT00989833|10987154|FG000|COMPLETED|Overall Study||19
9872692|NCT00989833|10987155|FG001|COMPLETED|Overall Study||19
9872693|NCT00989833|10987156|FG002|COMPLETED|Overall Study||21
9872694|NCT00989833|10987154|FG000|NOT COMPLETED|Overall Study||2
9872695|NCT00989833|10987155|FG001|NOT COMPLETED|Overall Study||3
9872696|NCT00989833|10987156|FG002|NOT COMPLETED|Overall Study||2
9872697|NCT00989911|10987164|FG000|STARTED|Overall Study||10
9872698|NCT00989911|10987164|FG000|COMPLETED|Overall Study||7
9872699|NCT00989911|10987164|FG000|NOT COMPLETED|Overall Study||3
9872700|NCT00989950|10987172|FG000|STARTED|Open Label Dose Optimization||6
9872701|NCT00989950|10987173|FG001|STARTED|Open Label Dose Optimization||9
9872702|NCT00989950|10987174|FG002|STARTED|Open Label Dose Optimization||4
9872703|NCT00989950|10987175|FG003|STARTED|Open Label Dose Optimization||7
9872704|NCT00989950|10987172|FG000|COMPLETED|Open Label Dose Optimization||6
9872705|NCT00989950|10987173|FG001|COMPLETED|Open Label Dose Optimization||9
9872706|NCT00989950|10987174|FG002|COMPLETED|Open Label Dose Optimization||4
9872707|NCT00989950|10987175|FG003|COMPLETED|Open Label Dose Optimization||7
9872708|NCT00989950|10987172|FG000|NOT COMPLETED|Open Label Dose Optimization||0
9872709|NCT00989950|10987173|FG001|NOT COMPLETED|Open Label Dose Optimization||0
9872710|NCT00989950|10987174|FG002|NOT COMPLETED|Open Label Dose Optimization||0
9872711|NCT00989950|10987175|FG003|NOT COMPLETED|Open Label Dose Optimization||0
9872712|NCT00989950|10987172|FG000|STARTED|Randomized Phase||6
9872713|NCT00989950|10987173|FG001|STARTED|Randomized Phase||9
9872714|NCT00989950|10987174|FG002|STARTED|Randomized Phase||4
9872715|NCT00989950|10987175|FG003|STARTED|Randomized Phase||7
9872716|NCT00989950|10987172|FG000|COMPLETED|Randomized Phase||5
9872717|NCT00989950|10987173|FG001|COMPLETED|Randomized Phase||8
9872718|NCT00989950|10987174|FG002|COMPLETED|Randomized Phase||4
9872719|NCT00989950|10987175|FG003|COMPLETED|Randomized Phase||7
9872720|NCT00989950|10987172|FG000|NOT COMPLETED|Randomized Phase||1
9872721|NCT00989950|10987173|FG001|NOT COMPLETED|Randomized Phase||1
9872722|NCT00989950|10987174|FG002|NOT COMPLETED|Randomized Phase||0
9872723|NCT00989950|10987175|FG003|NOT COMPLETED|Randomized Phase||0
9872724|NCT00989963|10987188|FG000|STARTED|Overall Study||12
9872725|NCT00989963|10987189|FG001|STARTED|Overall Study||12
9872726|NCT00989963|10987190|FG002|STARTED|Overall Study||12
9872727|NCT00989963|10987188|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
9872728|NCT00989963|10987189|FG001|Safety Population|Overall Study||12
9872729|NCT00989963|10987190|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
9872730|NCT00989963|10987188|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
9872731|NCT00989963|10987189|FG001|Per-Protocol Population|Overall Study||11
9872732|NCT00989963|10987190|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
9872733|NCT00989963|10987188|FG000|COMPLETED|Overall Study||11
9872734|NCT00989963|10987189|FG001|COMPLETED|Overall Study||11
9872735|NCT00989963|10987190|FG002|COMPLETED|Overall Study||11
9872736|NCT00989963|10987188|FG000|NOT COMPLETED|Overall Study||1
9872737|NCT00989963|10987189|FG001|NOT COMPLETED|Overall Study||1
9872738|NCT00989963|10987190|FG002|NOT COMPLETED|Overall Study||1
9872739|NCT00989989|10987201|FG000|STARTED|Overall Study||132
9872740|NCT00989989|10987202|FG001|STARTED|Overall Study||133
9872741|NCT00989989|10987203|FG002|STARTED|Overall Study||131
9872742|NCT00989989|10987201|FG000|COMPLETED|Overall Study||114
9872743|NCT00989989|10987202|FG001|COMPLETED|Overall Study||123
9872744|NCT00989989|10987203|FG002|COMPLETED|Overall Study||108
9872745|NCT00989989|10987201|FG000|NOT COMPLETED|Overall Study||18
9872746|NCT00989989|10987202|FG001|NOT COMPLETED|Overall Study||10
9872747|NCT00989989|10987203|FG002|NOT COMPLETED|Overall Study||23
9872748|NCT00990093|10987211|FG000|STARTED|Test Period 1 (1-14 Days)||19
9872749|NCT00990093|10987212|FG001|STARTED|Test Period 1 (1-14 Days)||17
9872750|NCT00990093|10987211|FG000|COMPLETED|Test Period 1 (1-14 Days)||15
9872751|NCT00990093|10987212|FG001|COMPLETED|Test Period 1 (1-14 Days)||15
9872752|NCT00990093|10987211|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4
9872753|NCT00990093|10987212|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2
9872754|NCT00990093|10987211|FG000|STARTED|Test Period 2 (15-28 Days)||15
9872755|NCT00990093|10987212|FG001|STARTED|Test Period 2 (15-28 Days)||15
9872756|NCT00990093|10987211|FG000|COMPLETED|Test Period 2 (15-28 Days)||13
9872757|NCT00990093|10987212|FG001|COMPLETED|Test Period 2 (15-28 Days)||14
9872758|NCT00990093|10987211|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2
9872759|NCT00990093|10987212|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1
9872760|NCT00990106|10987220|FG000|STARTED|Overall Study||32
9872761|NCT00990106|10987221|FG001|STARTED|Overall Study||35
9872762|NCT00990106|10987220|FG000|COMPLETED|Overall Study||23
9872763|NCT00990106|10987221|FG001|COMPLETED|Overall Study||23
9872764|NCT00990106|10987220|FG000|NOT COMPLETED|Overall Study||9
9872765|NCT00990106|10987221|FG001|NOT COMPLETED|Overall Study||12
9872766|NCT00990184|10987227|FG000|STARTED|Overall Study||21
9872767|NCT00990184|10987227|FG000|COMPLETED|Overall Study||20
9872768|NCT00990184|10987227|FG000|NOT COMPLETED|Overall Study||1
9872769|NCT00990236|10987235|FG000|STARTED|Overall Study||89
9872770|NCT00990236|10987236|FG001|STARTED|Overall Study||96
9872771|NCT00990236|10987235|FG000|COMPLETED|Overall Study||89
9872772|NCT00990236|10987236|FG001|COMPLETED|Overall Study||96
9872773|NCT00990236|10987235|FG000|NOT COMPLETED|Overall Study||0
9872774|NCT00990236|10987236|FG001|NOT COMPLETED|Overall Study||0
9872775|NCT00990249|10987242|FG000|STARTED|Overall Study||120
9872776|NCT00990249|10987242|FG000|COMPLETED|Overall Study||107
9872777|NCT00990249|10987242|FG000|NOT COMPLETED|Overall Study||13
9872778|NCT00990288|10987248|FG000|STARTED|Overall Study||97
9872779|NCT00990288|10987249|FG001|STARTED|Overall Study||99
9872780|NCT00990288|10987248|FG000|COMPLETED|Overall Study||97
9872781|NCT00990288|10987249|FG001|COMPLETED|Overall Study||99
9872782|NCT00990288|10987248|FG000|NOT COMPLETED|Overall Study||0
9872783|NCT00990288|10987249|FG001|NOT COMPLETED|Overall Study||0
9872784|NCT00990314|10987255|FG000|STARTED|Overall Study||31
9872785|NCT00990314|10987255|FG000|COMPLETED|Overall Study||19
9872786|NCT00990314|10987255|FG000|NOT COMPLETED|Overall Study||12
9872787|NCT00990340|10987261|FG000|STARTED|First 14-day Treatment||27
9872788|NCT00990340|10987262|FG001|STARTED|First 14-day Treatment||25
9872789|NCT00990340|10987261|FG000|COMPLETED|First 14-day Treatment||21
9872790|NCT00990340|10987262|FG001|COMPLETED|First 14-day Treatment||21
9872791|NCT00990340|10987261|FG000|NOT COMPLETED|First 14-day Treatment||6
9872792|NCT00990340|10987262|FG001|NOT COMPLETED|First 14-day Treatment||4
9872793|NCT00990340|10987261|FG000|STARTED|Second 14-day Treatment||21
9872794|NCT00990340|10987262|FG001|STARTED|Second 14-day Treatment||21
9872795|NCT00990340|10987261|FG000|COMPLETED|Second 14-day Treatment||21
9872796|NCT00990340|10987262|FG001|COMPLETED|Second 14-day Treatment||21
9872797|NCT00990340|10987261|FG000|NOT COMPLETED|Second 14-day Treatment||0
9872798|NCT00990340|10987262|FG001|NOT COMPLETED|Second 14-day Treatment||0
9872799|NCT00990509|10987272|FG000|STARTED|Overall Study||5
9872800|NCT00990509|10987273|FG001|STARTED|Overall Study||9
9872801|NCT00990509|10987272|FG000|COMPLETED|Overall Study||5
9872802|NCT00990509|10987273|FG001|COMPLETED|Overall Study||8
9872803|NCT00990509|10987272|FG000|NOT COMPLETED|Overall Study||0
9872804|NCT00990509|10987273|FG001|NOT COMPLETED|Overall Study||1
9872805|NCT00990561|10987281|FG000|STARTED|Period 1||20
9872806|NCT00990561|10987282|FG001|STARTED|Period 1||20
9872807|NCT00990561|10987283|FG002|STARTED|Period 1||0
9872808|NCT00990561|10987284|FG003|STARTED|Period 1||0
9872809|NCT00990561|10987281|FG000|COMPLETED|Period 1||20
9872810|NCT00990561|10987282|FG001|COMPLETED|Period 1||19
9872811|NCT00990561|10987283|FG002|COMPLETED|Period 1||0
9872812|NCT00990561|10987284|FG003|COMPLETED|Period 1||0
9872813|NCT00990561|10987281|FG000|NOT COMPLETED|Period 1||0
9872814|NCT00990561|10987282|FG001|NOT COMPLETED|Period 1||1
9872815|NCT00990561|10987283|FG002|NOT COMPLETED|Period 1||0
9872816|NCT00990561|10987284|FG003|NOT COMPLETED|Period 1||0
9872817|NCT00990561|10987281|FG000|STARTED|Period 2||0
9872818|NCT00990561|10987282|FG001|STARTED|Period 2||0
9872819|NCT00990561|10987283|FG002|STARTED|Period 2||20
9872820|NCT00990561|10987284|FG003|STARTED|Period 2||19
9872821|NCT00990561|10987281|FG000|COMPLETED|Period 2||0
9872822|NCT00990561|10987282|FG001|COMPLETED|Period 2||0
9872823|NCT00990561|10987283|FG002|COMPLETED|Period 2||20
9872824|NCT00990561|10987284|FG003|COMPLETED|Period 2||17
9872825|NCT00990561|10987281|FG000|NOT COMPLETED|Period 2||0
9872826|NCT00990561|10987282|FG001|NOT COMPLETED|Period 2||0
9872827|NCT00990561|10987283|FG002|NOT COMPLETED|Period 2||0
9872828|NCT00990561|10987284|FG003|NOT COMPLETED|Period 2||2
9872829|NCT00990652|10987290|FG000|STARTED|Pre-surgical Bortezomib||10
9872830|NCT00990652|10987290|FG000|COMPLETED|Pre-surgical Bortezomib||9
9872831|NCT00990652|10987290|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1
9872832|NCT00990652|10987290|FG000|STARTED|Surgical Resection||9
9872833|NCT00990652|10987290|FG000|COMPLETED|Surgical Resection||9
9872834|NCT00990652|10987290|FG000|NOT COMPLETED|Surgical Resection||0
9872835|NCT00990652|10987290|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9
9872836|NCT00990652|10987290|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
9872837|NCT00990652|10987290|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
9872838|NCT00990665|10987295|FG000|STARTED|Overall Study||178
9872839|NCT00990665|10987295|FG000|COMPLETED|Overall Study||130
9872840|NCT00990665|10987295|FG000|NOT COMPLETED|Overall Study||48
9872841|NCT00990704|10987303|FG000|STARTED|Overall Study||14
9872842|NCT00990704|10987304|FG001|STARTED|Overall Study||33
9872843|NCT00990704|10987303|FG000|COMPLETED|Overall Study||13
9872844|NCT00990704|10987304|FG001|COMPLETED|Overall Study||31
9872845|NCT00990704|10987303|FG000|NOT COMPLETED|Overall Study||1
9872846|NCT00990704|10987304|FG001|NOT COMPLETED|Overall Study||2
9872847|NCT00990769|10987312|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
9872848|NCT00990769|10987313|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
9872849|NCT00990769|10987312|FG000|COMPLETED|Overall Study||22
9872850|NCT00990769|10987313|FG001|COMPLETED|Overall Study||18
9872851|NCT00990769|10987312|FG000|NOT COMPLETED|Overall Study||0
9872852|NCT00990769|10987313|FG001|NOT COMPLETED|Overall Study||0
9872853|NCT00990782|10987319|FG000|STARTED|Overall Study||93
9872854|NCT00990782|10987319|FG000|COMPLETED|Overall Study||88
9872855|NCT00990782|10987319|FG000|NOT COMPLETED|Overall Study||5
9872856|NCT00990821|10987337|FG000|STARTED|Overall Study||14
9872857|NCT00990821|10987338|FG001|STARTED|Overall Study||16
9872858|NCT00990821|10987339|FG002|STARTED|Overall Study||14
9872859|NCT00990821|10987340|FG003|STARTED|Overall Study||8
9872860|NCT00990821|10987341|FG004|STARTED|Overall Study||17
9872861|NCT00990821|10987342|FG005|STARTED|Overall Study||17
9872862|NCT00990821|10987343|FG006|STARTED|Overall Study||12
9872863|NCT00990821|10987344|FG007|STARTED|Overall Study||14
9872864|NCT00990821|10987345|FG008|STARTED|Overall Study||12
9872865|NCT00990821|10987346|FG009|STARTED|Overall Study||14
9872866|NCT00990821|10987347|FG010|STARTED|Overall Study||12
9872867|NCT00990821|10987348|FG011|STARTED|Overall Study||14
9872868|NCT00990821|10987349|FG012|STARTED|Overall Study||12
9872869|NCT00990821|10987350|FG013|STARTED|Overall Study||12
9872870|NCT00990821|10987337|FG000|COMPLETED|Overall Study||14
9872871|NCT00990821|10987338|FG001|COMPLETED|Overall Study||14
9872872|NCT00990821|10987339|FG002|COMPLETED|Overall Study||14
9872873|NCT00990821|10987340|FG003|COMPLETED|Overall Study||8
9872874|NCT00990821|10987341|FG004|COMPLETED|Overall Study||14
9872875|NCT00990821|10987342|FG005|COMPLETED|Overall Study||14
9872876|NCT00990821|10987343|FG006|COMPLETED|Overall Study||11
9872877|NCT00990821|10987344|FG007|COMPLETED|Overall Study||14
9872878|NCT00990821|10987345|FG008|COMPLETED|Overall Study||12
9872879|NCT00990821|10987346|FG009|COMPLETED|Overall Study||13
9872880|NCT00990821|10987347|FG010|COMPLETED|Overall Study||9
9872881|NCT00990821|10987348|FG011|COMPLETED|Overall Study||9
9872882|NCT00990821|10987349|FG012|COMPLETED|Overall Study||10
9872883|NCT00990821|10987350|FG013|COMPLETED|Overall Study||11
9872884|NCT00990821|10987337|FG000|NOT COMPLETED|Overall Study||0
9872885|NCT00990821|10987338|FG001|NOT COMPLETED|Overall Study||2
9872886|NCT00990821|10987339|FG002|NOT COMPLETED|Overall Study||0
9872887|NCT00990821|10987340|FG003|NOT COMPLETED|Overall Study||0
9872888|NCT00990821|10987341|FG004|NOT COMPLETED|Overall Study||3
9872889|NCT00990821|10987342|FG005|NOT COMPLETED|Overall Study||3
9872890|NCT00990821|10987343|FG006|NOT COMPLETED|Overall Study||1
9872891|NCT00990821|10987344|FG007|NOT COMPLETED|Overall Study||0
9872892|NCT00990821|10987345|FG008|NOT COMPLETED|Overall Study||0
9872893|NCT00990821|10987346|FG009|NOT COMPLETED|Overall Study||1
9872894|NCT00990821|10987347|FG010|NOT COMPLETED|Overall Study||3
9872895|NCT00990821|10987348|FG011|NOT COMPLETED|Overall Study||5
9872896|NCT00990821|10987349|FG012|NOT COMPLETED|Overall Study||2
9872897|NCT00990821|10987350|FG013|NOT COMPLETED|Overall Study||1
9872898|NCT00990938|10987373|FG000|STARTED|Overall Study||3
9872899|NCT00990938|10987374|FG001|STARTED|Overall Study||12
9872900|NCT00990938|10987375|FG002|STARTED|Overall Study||12
9872901|NCT00990938|10987376|FG003|STARTED|Overall Study||12
9872902|NCT00990938|10987377|FG004|STARTED|Overall Study||12
9872903|NCT00990938|10987378|FG005|STARTED|Overall Study||12
9872904|NCT00990938|10987373|FG000|COMPLETED|Overall Study||3
9872905|NCT00990938|10987374|FG001|COMPLETED|Overall Study||12
9872906|NCT00990938|10987375|FG002|COMPLETED|Overall Study||12
9872907|NCT00990938|10987376|FG003|COMPLETED|Overall Study||12
9872908|NCT00990938|10987377|FG004|COMPLETED|Overall Study||12
9872909|NCT00990938|10987378|FG005|COMPLETED|Overall Study||12
9872910|NCT00990938|10987373|FG000|NOT COMPLETED|Overall Study||0
9872911|NCT00990938|10987374|FG001|NOT COMPLETED|Overall Study||0
9872912|NCT00990938|10987375|FG002|NOT COMPLETED|Overall Study||0
9872913|NCT00990938|10987376|FG003|NOT COMPLETED|Overall Study||0
9872914|NCT00990938|10987377|FG004|NOT COMPLETED|Overall Study||0
9872915|NCT00990938|10987378|FG005|NOT COMPLETED|Overall Study||0
9872916|NCT00990964|10987392|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014
9872917|NCT00990964|10987392|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
9872918|NCT00990964|10987392|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
9872919|NCT00990964|10987392|FG000|NOT COMPLETED|Overall Study||212
9872920|NCT00991029|10987399|FG000|STARTED|Overall Study||2432
9872921|NCT00991029|10987400|FG001|STARTED|Overall Study||2449
9872922|NCT00991029|10987399|FG000|COMPLETED|Overall Study||2276
9872923|NCT00991029|10987400|FG001|COMPLETED|Overall Study||2281
9872924|NCT00991029|10987399|FG000|NOT COMPLETED|Overall Study||156
9872925|NCT00991029|10987400|FG001|NOT COMPLETED|Overall Study||168
9872926|NCT00991081|10987408|FG000|STARTED|Phase I, Formative Research||20
9872927|NCT00991081|10987409|FG001|STARTED|Phase I, Formative Research||0
9872928|NCT00991081|10987410|FG002|STARTED|Phase I, Formative Research||0
9872929|NCT00991081|10987408|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
9872930|NCT00991081|10987409|FG001|COMPLETED|Phase I, Formative Research||0
9872931|NCT00991081|10987410|FG002|COMPLETED|Phase I, Formative Research||0
9872932|NCT00991081|10987408|FG000|NOT COMPLETED|Phase I, Formative Research||0
9872933|NCT00991081|10987409|FG001|NOT COMPLETED|Phase I, Formative Research||0
9872934|NCT00991081|10987410|FG002|NOT COMPLETED|Phase I, Formative Research||0
9872935|NCT00991081|10987408|FG000|STARTED|Phase II, Randomized Control Trial||0
9872936|NCT00991081|10987409|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
9872937|NCT00991081|10987410|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
9872938|NCT00991081|10987408|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0
9872939|NCT00991081|10987409|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16
9872940|NCT00991081|10987410|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17
9872941|NCT00991081|10987408|FG000|COMPLETED|Phase II, Randomized Control Trial||0
9872942|NCT00991081|10987409|FG001|COMPLETED|Phase II, Randomized Control Trial||15
9872943|NCT00991081|10987410|FG002|COMPLETED|Phase II, Randomized Control Trial||15
9872944|NCT00991081|10987408|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0
9872945|NCT00991081|10987409|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2
9872946|NCT00991081|10987410|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4
9872947|NCT00991185|10987416|FG000|STARTED|Overall Study||8
9872948|NCT00991185|10987416|FG000|COMPLETED|Overall Study||8
9872949|NCT00991185|10987416|FG000|NOT COMPLETED|Overall Study||0
9872950|NCT00991276|10987426|FG000|STARTED|First Intervention Period||15
9872951|NCT00991276|10987427|FG001|STARTED|First Intervention Period||13
9872952|NCT00991276|10987428|FG002|STARTED|First Intervention Period||14
9872953|NCT00991276|10987429|FG003|STARTED|First Intervention Period||15
9872954|NCT00991276|10987430|FG004|STARTED|First Intervention Period||15
9872955|NCT00991276|10987431|FG005|STARTED|First Intervention Period||13
9872956|NCT00991276|10987426|FG000|COMPLETED|First Intervention Period||15
9872957|NCT00991276|10987427|FG001|COMPLETED|First Intervention Period||10
9872958|NCT00991276|10987428|FG002|COMPLETED|First Intervention Period||14
9872959|NCT00991276|10987429|FG003|COMPLETED|First Intervention Period||11
9872960|NCT00991276|10987430|FG004|COMPLETED|First Intervention Period||11
9872961|NCT00991276|10987431|FG005|COMPLETED|First Intervention Period||12
9872962|NCT00991276|10987426|FG000|NOT COMPLETED|First Intervention Period||0
9872963|NCT00991276|10987427|FG001|NOT COMPLETED|First Intervention Period||3
9872964|NCT00991276|10987428|FG002|NOT COMPLETED|First Intervention Period||0
9872965|NCT00991276|10987429|FG003|NOT COMPLETED|First Intervention Period||4
9872966|NCT00991276|10987430|FG004|NOT COMPLETED|First Intervention Period||4
9872967|NCT00991276|10987431|FG005|NOT COMPLETED|First Intervention Period||1
9872968|NCT00991276|10987426|FG000|STARTED|Placebo Wash-out Period (7 Days)||15
9872969|NCT00991276|10987427|FG001|STARTED|Placebo Wash-out Period (7 Days)||10
9872970|NCT00991276|10987428|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
9872971|NCT00991276|10987429|FG003|STARTED|Placebo Wash-out Period (7 Days)||11
9872972|NCT00991276|10987430|FG004|STARTED|Placebo Wash-out Period (7 Days)||11
9872973|NCT00991276|10987431|FG005|STARTED|Placebo Wash-out Period (7 Days)||12
9872974|NCT00991276|10987426|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15
9872975|NCT00991276|10987427|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10
9872976|NCT00991276|10987428|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
9872977|NCT00991276|10987429|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11
9872978|NCT00991276|10987430|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11
9872979|NCT00991276|10987431|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12
9872980|NCT00991276|10987426|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9872981|NCT00991276|10987427|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9872982|NCT00991276|10987428|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9872983|NCT00991276|10987429|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9872984|NCT00991276|10987430|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9872985|NCT00991276|10987431|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9872986|NCT00991276|10987426|FG000|STARTED|Second Intervention Period||15
9872987|NCT00991276|10987427|FG001|STARTED|Second Intervention Period||10
9872988|NCT00991276|10987428|FG002|STARTED|Second Intervention Period||14
9872989|NCT00991276|10987429|FG003|STARTED|Second Intervention Period||11
9872990|NCT00991276|10987430|FG004|STARTED|Second Intervention Period||11
9872991|NCT00991276|10987431|FG005|STARTED|Second Intervention Period||12
9872992|NCT00991276|10987426|FG000|COMPLETED|Second Intervention Period||14
9872993|NCT00991276|10987427|FG001|COMPLETED|Second Intervention Period||8
9872994|NCT00991276|10987428|FG002|COMPLETED|Second Intervention Period||14
9872995|NCT00991276|10987429|FG003|COMPLETED|Second Intervention Period||9
9872996|NCT00991276|10987430|FG004|COMPLETED|Second Intervention Period||10
9872997|NCT00991276|10987431|FG005|COMPLETED|Second Intervention Period||11
9872998|NCT00991276|10987426|FG000|NOT COMPLETED|Second Intervention Period||1
9872999|NCT00991276|10987427|FG001|NOT COMPLETED|Second Intervention Period||2
9873000|NCT00991276|10987428|FG002|NOT COMPLETED|Second Intervention Period||0
9873001|NCT00991276|10987429|FG003|NOT COMPLETED|Second Intervention Period||2
10097119|NCT02371980|11226124|FG000|STARTED|Open-label Period||1106
10097120|NCT02371980|11226125|FG001|STARTED|Open-label Period||0
10097121|NCT02371980|11226126|FG002|STARTED|Open-label Period||0
10097122|NCT02371980|11226127|FG003|STARTED|Open-label Period||0
10097123|NCT02371980|11226128|FG004|STARTED|Open-label Period||0
10097124|NCT02371980|11226124|FG000|COMPLETED|Open-label Period||580
9873002|NCT00991276|10987430|FG004|NOT COMPLETED|Second Intervention Period||1
10097125|NCT02371980|11226125|FG001|COMPLETED|Open-label Period||0
10097126|NCT02371980|11226126|FG002|COMPLETED|Open-label Period||0
10097127|NCT02371980|11226127|FG003|COMPLETED|Open-label Period||0
10097128|NCT02371980|11226128|FG004|COMPLETED|Open-label Period||0
10097129|NCT02371980|11226124|FG000|NOT COMPLETED|Open-label Period||526
10097130|NCT02371980|11226125|FG001|NOT COMPLETED|Open-label Period||0
9873003|NCT00991276|10987431|FG005|NOT COMPLETED|Second Intervention Period||1
9873004|NCT00991276|10987426|FG000|STARTED|Placebo Wash-out Period (7 Days)||14
9873005|NCT00991276|10987427|FG001|STARTED|Placebo Wash-out Period (7 Days)||8
9873006|NCT00991276|10987428|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
9873007|NCT00991276|10987429|FG003|STARTED|Placebo Wash-out Period (7 Days)||9
9873008|NCT00991276|10987430|FG004|STARTED|Placebo Wash-out Period (7 Days)||10
9873009|NCT00991276|10987431|FG005|STARTED|Placebo Wash-out Period (7 Days)||11
9873010|NCT00991276|10987426|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14
9873011|NCT00991276|10987427|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8
9873012|NCT00991276|10987428|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
9873013|NCT00991276|10987429|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9
9873014|NCT00991276|10987430|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10
9873015|NCT00991276|10987431|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11
9873016|NCT00991276|10987426|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9873017|NCT00991276|10987427|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9873018|NCT00991276|10987428|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9873019|NCT00991276|10987429|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9873020|NCT00991276|10987430|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9873021|NCT00991276|10987431|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
9873022|NCT00991276|10987426|FG000|STARTED|Third Intervention Period||14
9873023|NCT00991276|10987427|FG001|STARTED|Third Intervention Period||8
9873024|NCT00991276|10987428|FG002|STARTED|Third Intervention Period||14
9873025|NCT00991276|10987429|FG003|STARTED|Third Intervention Period||9
10097131|NCT02371980|11226126|FG002|NOT COMPLETED|Open-label Period||0
10097132|NCT02371980|11226127|FG003|NOT COMPLETED|Open-label Period||0
10097133|NCT02371980|11226128|FG004|NOT COMPLETED|Open-label Period||0
9873026|NCT00991276|10987430|FG004|STARTED|Third Intervention Period||10
9873027|NCT00991276|10987431|FG005|STARTED|Third Intervention Period||11
9873028|NCT00991276|10987426|FG000|COMPLETED|Third Intervention Period||13
9873029|NCT00991276|10987427|FG001|COMPLETED|Third Intervention Period||8
9873030|NCT00991276|10987428|FG002|COMPLETED|Third Intervention Period||13
9873031|NCT00991276|10987429|FG003|COMPLETED|Third Intervention Period||8
9873032|NCT00991276|10987430|FG004|COMPLETED|Third Intervention Period||10
9873033|NCT00991276|10987431|FG005|COMPLETED|Third Intervention Period||10
9873034|NCT00991276|10987426|FG000|NOT COMPLETED|Third Intervention Period||1
9873035|NCT00991276|10987427|FG001|NOT COMPLETED|Third Intervention Period||0
9873036|NCT00991276|10987428|FG002|NOT COMPLETED|Third Intervention Period||1
9873037|NCT00991276|10987429|FG003|NOT COMPLETED|Third Intervention Period||1
9873038|NCT00991276|10987430|FG004|NOT COMPLETED|Third Intervention Period||0
9873039|NCT00991276|10987431|FG005|NOT COMPLETED|Third Intervention Period||1
9873040|NCT00991289|10987440|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
9873041|NCT00991289|10987440|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
9873042|NCT00991289|10987440|FG000|COMPLETED|Overall Study|Completed study.|55
9873043|NCT00991289|10987440|FG000|NOT COMPLETED|Overall Study||12
9873044|NCT00991302|10987446|FG000|STARTED|Overall Study||86
9873045|NCT00991302|10987447|FG001|STARTED|Overall Study||86
9873046|NCT00991302|10987446|FG000|COMPLETED|Overall Study||72
9873047|NCT00991302|10987447|FG001|COMPLETED|Overall Study||73
9873048|NCT00991302|10987446|FG000|NOT COMPLETED|Overall Study||14
9873049|NCT00991302|10987447|FG001|NOT COMPLETED|Overall Study||13
9873050|NCT00991341|10987455|FG000|STARTED|Overall Study||742
9873051|NCT00991341|10987456|FG001|STARTED|Overall Study||739
9873052|NCT00991341|10987455|FG000|COMPLETED|Overall Study||538
9873053|NCT00991341|10987456|FG001|COMPLETED|Overall Study||560
9873054|NCT00991341|10987455|FG000|NOT COMPLETED|Overall Study||204
9873055|NCT00991341|10987456|FG001|NOT COMPLETED|Overall Study||179
9873056|NCT00991406|10987462|FG000|STARTED|Overall Study||9
9873057|NCT00991406|10987462|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
9873058|NCT00991406|10987462|FG000|NOT COMPLETED|Overall Study||1
10097134|NCT02371980|11226124|FG000|STARTED|Double-blind Period||0
10097135|NCT02371980|11226125|FG001|STARTED|Double-blind Period||151
10097136|NCT02371980|11226126|FG002|STARTED|Double-blind Period||140
9873059|NCT00991458|10987469|FG000|STARTED|Overall Study||207
9873060|NCT00991458|10987470|FG001|STARTED|Overall Study||209
9873061|NCT00991458|10987471|FG002|STARTED|Overall Study||205
9873062|NCT00991458|10987469|FG000|COMPLETED|Overall Study||187
9873063|NCT00991458|10987470|FG001|COMPLETED|Overall Study||181
9873064|NCT00991458|10987471|FG002|COMPLETED|Overall Study||180
9873065|NCT00991458|10987469|FG000|NOT COMPLETED|Overall Study||20
9873066|NCT00991458|10987470|FG001|NOT COMPLETED|Overall Study||28
9873067|NCT00991458|10987471|FG002|NOT COMPLETED|Overall Study||25
9873068|NCT00991510|10987481|FG000|STARTED|Period I (Days 1-14)||22
9873069|NCT00991510|10987482|FG001|STARTED|Period I (Days 1-14)||21
9873070|NCT00991510|10987481|FG000|COMPLETED|Period I (Days 1-14)||21
9873071|NCT00991510|10987482|FG001|COMPLETED|Period I (Days 1-14)||21
9873072|NCT00991510|10987481|FG000|NOT COMPLETED|Period I (Days 1-14)||1
9873073|NCT00991510|10987482|FG001|NOT COMPLETED|Period I (Days 1-14)||0
9873074|NCT00991510|10987481|FG000|STARTED|Period II (Days 15-28)||21
10097137|NCT02371980|11226127|FG003|STARTED|Double-blind Period||145
9873075|NCT00991510|10987482|FG001|STARTED|Period II (Days 15-28)||21
9873076|NCT00991510|10987481|FG000|COMPLETED|Period II (Days 15-28)||21
9873077|NCT00991510|10987482|FG001|COMPLETED|Period II (Days 15-28)||21
10097138|NCT02371980|11226128|FG004|STARTED|Double-blind Period||144
9873078|NCT00991510|10987481|FG000|NOT COMPLETED|Period II (Days 15-28)||0
9873079|NCT00991510|10987482|FG001|NOT COMPLETED|Period II (Days 15-28)||0
9873080|NCT00991510|10987481|FG000|STARTED|Period III (Days 29-112)||21
9873081|NCT00991510|10987482|FG001|STARTED|Period III (Days 29-112)||21
9873082|NCT00991510|10987481|FG000|COMPLETED|Period III (Days 29-112)||20
9873083|NCT00991510|10987482|FG001|COMPLETED|Period III (Days 29-112)||20
9873084|NCT00991510|10987481|FG000|NOT COMPLETED|Period III (Days 29-112)||1
9873085|NCT00991510|10987482|FG001|NOT COMPLETED|Period III (Days 29-112)||1
9873086|NCT00991809|10987494|FG000|STARTED|Overall Study||12
9873087|NCT00991809|10987495|FG001|STARTED|Overall Study||10
9873088|NCT00991809|10987494|FG000|COMPLETED|Overall Study||8
9873089|NCT00991809|10987495|FG001|COMPLETED|Overall Study||4
9873090|NCT00991809|10987494|FG000|NOT COMPLETED|Overall Study||4
9873091|NCT00991809|10987495|FG001|NOT COMPLETED|Overall Study||6
9873092|NCT00991939|10987505|FG000|STARTED|Overall Study||5
9873093|NCT00991939|10987506|FG001|STARTED|Overall Study||3
9873094|NCT00991939|10987505|FG000|COMPLETED|Overall Study||0
9873095|NCT00991939|10987506|FG001|COMPLETED|Overall Study||1
9873096|NCT00991939|10987505|FG000|NOT COMPLETED|Overall Study||5
9873097|NCT00991939|10987506|FG001|NOT COMPLETED|Overall Study||2
9873098|NCT00991952|10987516|FG000|STARTED|Overall Study||13
9873099|NCT00991952|10987517|FG001|STARTED|Overall Study||6
9873100|NCT00991952|10987516|FG000|COMPLETED|Overall Study||13
9873101|NCT00991952|10987517|FG001|COMPLETED|Overall Study||5
9873102|NCT00991952|10987516|FG000|NOT COMPLETED|Overall Study||0
9873103|NCT00991952|10987517|FG001|NOT COMPLETED|Overall Study||1
9873104|NCT00992017|10987523|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
9873105|NCT00992017|10987523|FG000|Received Both Study Vaccinations|Overall Study||124
9873106|NCT00992017|10987523|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
9873107|NCT00992017|10987523|FG000|COMPLETED|Overall Study||118
9873108|NCT00992017|10987523|FG000|NOT COMPLETED|Overall Study||10
9873109|NCT00992056|10987534|FG000|STARTED|Treatment Period 1 (6 Weeks)||12
9873110|NCT00992056|10987535|FG001|STARTED|Treatment Period 1 (6 Weeks)||12
9873111|NCT00992056|10987534|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
9873112|NCT00992056|10987535|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10
9873113|NCT00992056|10987534|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
9873114|NCT00992056|10987535|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
9873115|NCT00992056|10987534|FG000|STARTED|Washout Period (2 Weeks)||11
9873116|NCT00992056|10987535|FG001|STARTED|Washout Period (2 Weeks)||10
9873117|NCT00992056|10987534|FG000|COMPLETED|Washout Period (2 Weeks)||10
9873118|NCT00992056|10987535|FG001|COMPLETED|Washout Period (2 Weeks)||10
9873119|NCT00992056|10987534|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
9873120|NCT00992056|10987535|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
9873121|NCT00992056|10987534|FG000|STARTED|Treatment Period 2 (6 Weeks)||10
9873122|NCT00992056|10987535|FG001|STARTED|Treatment Period 2 (6 Weeks)||10
9873123|NCT00992056|10987534|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10
9873124|NCT00992056|10987535|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10
9873125|NCT00992056|10987534|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
9873126|NCT00992056|10987535|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
9873127|NCT00992108|10987543|FG000|STARTED|Overall Study||7
9873128|NCT00992108|10987544|FG001|STARTED|Overall Study||10
9873129|NCT00992108|10987543|FG000|COMPLETED|Overall Study||7
9873130|NCT00992108|10987544|FG001|COMPLETED|Overall Study||9
9873131|NCT00992108|10987543|FG000|NOT COMPLETED|Overall Study||0
9873132|NCT00992108|10987544|FG001|NOT COMPLETED|Overall Study||1
9873133|NCT00992186|10987550|FG000|STARTED|Overall Study||46
9873134|NCT00992186|10987550|FG000|COMPLETED|Overall Study||0
9873135|NCT00992186|10987550|FG000|NOT COMPLETED|Overall Study||46
9873136|NCT00992225|10987555|FG000|STARTED|Overall Study||43
9873137|NCT00992225|10987555|FG000|Received at Least One Dose of Study Drug|Overall Study||33
9873138|NCT00992225|10987555|FG000|COMPLETED|Overall Study||33
9873139|NCT00992225|10987555|FG000|NOT COMPLETED|Overall Study||10
9873140|NCT00992264|10987575|FG000|STARTED|Overall Study||116
9873141|NCT00992264|10987576|FG001|STARTED|Overall Study||116
9873142|NCT00992264|10987577|FG002|STARTED|Overall Study||117
9873143|NCT00992264|10987578|FG003|STARTED|Overall Study||117
9873144|NCT00992264|10987579|FG004|STARTED|Overall Study||117
9873145|NCT00992264|10987580|FG005|STARTED|Overall Study||117
9873146|NCT00992264|10987581|FG006|STARTED|Overall Study||116
9873147|NCT00992264|10987582|FG007|STARTED|Overall Study||117
9873148|NCT00992264|10987583|FG008|STARTED|Overall Study||116
9873149|NCT00992264|10987584|FG009|STARTED|Overall Study||116
9873150|NCT00992264|10987585|FG010|STARTED|Overall Study||117
9873151|NCT00992264|10987586|FG011|STARTED|Overall Study||117
9873152|NCT00992264|10987587|FG012|STARTED|Overall Study||116
9873153|NCT00992264|10987588|FG013|STARTED|Overall Study||117
9873154|NCT00992264|10987589|FG014|STARTED|Overall Study||117
9873155|NCT00992264|10987590|FG015|STARTED|Overall Study||116
9873156|NCT00992264|10987575|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
9873157|NCT00992264|10987576|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
9873158|NCT00992264|10987577|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873159|NCT00992264|10987578|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9953737|NCT01427933|11072426|FG001|STARTED|Overall Study||70
9873160|NCT00992264|10987579|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873161|NCT00992264|10987580|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873162|NCT00992264|10987581|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
9873163|NCT00992264|10987582|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873164|NCT00992264|10987583|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
9873165|NCT00992264|10987584|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
9873166|NCT00992264|10987585|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873167|NCT00992264|10987586|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873168|NCT00992264|10987587|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
9873169|NCT00992264|10987588|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873170|NCT00992264|10987589|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
9873171|NCT00992264|10987590|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
9873172|NCT00992264|10987575|FG000|NOT COMPLETED|Overall Study||0
9873173|NCT00992264|10987576|FG001|NOT COMPLETED|Overall Study||0
9873174|NCT00992264|10987577|FG002|NOT COMPLETED|Overall Study||0
9873175|NCT00992264|10987578|FG003|NOT COMPLETED|Overall Study||0
9873176|NCT00992264|10987579|FG004|NOT COMPLETED|Overall Study||0
9873177|NCT00992264|10987580|FG005|NOT COMPLETED|Overall Study||0
9873178|NCT00992264|10987581|FG006|NOT COMPLETED|Overall Study||0
9873179|NCT00992264|10987582|FG007|NOT COMPLETED|Overall Study||0
9873180|NCT00992264|10987583|FG008|NOT COMPLETED|Overall Study||0
9873181|NCT00992264|10987584|FG009|NOT COMPLETED|Overall Study||0
9873182|NCT00992264|10987585|FG010|NOT COMPLETED|Overall Study||0
9873183|NCT00992264|10987586|FG011|NOT COMPLETED|Overall Study||0
9873184|NCT00992264|10987587|FG012|NOT COMPLETED|Overall Study||0
9873185|NCT00992264|10987588|FG013|NOT COMPLETED|Overall Study||0
9873186|NCT00992264|10987589|FG014|NOT COMPLETED|Overall Study||0
9873187|NCT00992264|10987590|FG015|NOT COMPLETED|Overall Study||0
9873188|NCT00992394|10987603|FG000|STARTED|Overall Study||88
9873189|NCT00992394|10987604|FG001|STARTED|Overall Study||86
9873190|NCT00992394|10987603|FG000|Safety Population|Overall Study||87
9873191|NCT00992394|10987604|FG001|Safety Population|Overall Study||84
9873192|NCT00992394|10987603|FG000|mITT Population|Overall Study||86
9873193|NCT00992394|10987604|FG001|mITT Population|Overall Study||84
9873194|NCT00992394|10987603|FG000|COMPLETED|Overall Study||64
9873195|NCT00992394|10987604|FG001|COMPLETED|Overall Study||72
9873196|NCT00992394|10987603|FG000|NOT COMPLETED|Overall Study||24
9873197|NCT00992394|10987604|FG001|NOT COMPLETED|Overall Study||14
9873198|NCT00992407|10987612|FG000|STARTED|Overall Study||37
9873199|NCT00992407|10987613|FG001|STARTED|Overall Study||38
9873200|NCT00992407|10987612|FG000|Treated|Overall Study||20
9873201|NCT00992407|10987613|FG001|Treated|Overall Study||25
9873202|NCT00992407|10987612|FG000|COMPLETED|Overall Study||6
9873203|NCT00992407|10987613|FG001|COMPLETED|Overall Study||14
9873204|NCT00992407|10987612|FG000|NOT COMPLETED|Overall Study||31
9873205|NCT00992407|10987613|FG001|NOT COMPLETED|Overall Study||24
9873206|NCT00992433|10987624|FG000|STARTED|Overall Study||95
9873207|NCT00992433|10987625|FG001|STARTED|Overall Study||97
9873208|NCT00992433|10987624|FG000|COMPLETED|Overall Study||91
9873209|NCT00992433|10987625|FG001|COMPLETED|Overall Study||90
9873210|NCT00992433|10987624|FG000|NOT COMPLETED|Overall Study||4
9873211|NCT00992433|10987625|FG001|NOT COMPLETED|Overall Study||7
9873212|NCT00992446|10987631|FG000|STARTED|Overall Study||27
9873213|NCT00992446|10987631|FG000|COMPLETED|Overall Study||19
9873214|NCT00992446|10987631|FG000|NOT COMPLETED|Overall Study||8
9873215|NCT00992459|10987637|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
9873216|NCT00992459|10987638|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
9873217|NCT00992459|10987637|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
9873218|NCT00992459|10987638|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
9873219|NCT00992459|10987637|FG000|NOT COMPLETED|Overall Study||1
9873220|NCT00992459|10987638|FG001|NOT COMPLETED|Overall Study||1
9873221|NCT00992511|10987648|FG000|STARTED|Overall Study||76
9873222|NCT00992511|10987649|FG001|STARTED|Overall Study||73
9873223|NCT00992511|10987650|FG002|STARTED|Overall Study||76
9873224|NCT00992511|10987651|FG003|STARTED|Overall Study||75
9873225|NCT00992511|10987648|FG000|COMPLETED|Overall Study||74
9873226|NCT00992511|10987649|FG001|COMPLETED|Overall Study||73
9873227|NCT00992511|10987650|FG002|COMPLETED|Overall Study||74
9873228|NCT00992511|10987651|FG003|COMPLETED|Overall Study||70
9873229|NCT00992511|10987648|FG000|NOT COMPLETED|Overall Study||2
9873230|NCT00992511|10987649|FG001|NOT COMPLETED|Overall Study||0
9873231|NCT00992511|10987650|FG002|NOT COMPLETED|Overall Study||2
9873232|NCT00992511|10987651|FG003|NOT COMPLETED|Overall Study||5
9873233|NCT00992589|10987661|FG000|STARTED|Open-Label Phase||344
9873234|NCT00992589|10987662|FG001|STARTED|Open-Label Phase||0
9873235|NCT00992589|10987663|FG002|STARTED|Open-Label Phase||0
9873236|NCT00992589|10987664|FG003|STARTED|Open-Label Phase||0
9873237|NCT00992589|10987661|FG000|COMPLETED|Open-Label Phase||267
9873238|NCT00992589|10987662|FG001|COMPLETED|Open-Label Phase||0
9873239|NCT00992589|10987663|FG002|COMPLETED|Open-Label Phase||0
9873240|NCT00992589|10987664|FG003|COMPLETED|Open-Label Phase||0
9873241|NCT00992589|10987661|FG000|NOT COMPLETED|Open-Label Phase||77
9873242|NCT00992589|10987662|FG001|NOT COMPLETED|Open-Label Phase||0
9873243|NCT00992589|10987663|FG002|NOT COMPLETED|Open-Label Phase||0
9873244|NCT00992589|10987664|FG003|NOT COMPLETED|Open-Label Phase||0
9873245|NCT00992589|10987661|FG000|STARTED|Double-Blind Phase||0
9873246|NCT00992589|10987662|FG001|STARTED|Double-Blind Phase||89
9873247|NCT00992589|10987663|FG002|STARTED|Double-Blind Phase||90
9873248|NCT00992589|10987664|FG003|STARTED|Double-Blind Phase||88
9873249|NCT00992589|10987661|FG000|COMPLETED|Double-Blind Phase||0
9873250|NCT00992589|10987662|FG001|COMPLETED|Double-Blind Phase||76
9873251|NCT00992589|10987663|FG002|COMPLETED|Double-Blind Phase||77
9873252|NCT00992589|10987664|FG003|COMPLETED|Double-Blind Phase||78
9873253|NCT00992589|10987661|FG000|NOT COMPLETED|Double-Blind Phase||0
9873254|NCT00992589|10987662|FG001|NOT COMPLETED|Double-Blind Phase||13
9873255|NCT00992589|10987663|FG002|NOT COMPLETED|Double-Blind Phase||13
9873256|NCT00992589|10987664|FG003|NOT COMPLETED|Double-Blind Phase||10
9873257|NCT00992602|10987682|FG000|STARTED|Overall Study||3
9873258|NCT00992602|10987682|FG000|COMPLETED|Overall Study||0
9873259|NCT00992602|10987682|FG000|NOT COMPLETED|Overall Study||3
9873260|NCT00992719|10987689|FG000|STARTED|Overall Study||28
9873261|NCT00992719|10987690|FG001|STARTED|Overall Study||28
9873262|NCT00992719|10987691|FG002|STARTED|Overall Study||28
9873263|NCT00992719|10987689|FG000|COMPLETED|Overall Study||27
9873264|NCT00992719|10987690|FG001|COMPLETED|Overall Study||27
9873265|NCT00992719|10987691|FG002|COMPLETED|Overall Study||28
9873266|NCT00992719|10987689|FG000|NOT COMPLETED|Overall Study||1
9873267|NCT00992719|10987690|FG001|NOT COMPLETED|Overall Study||1
9873268|NCT00992719|10987691|FG002|NOT COMPLETED|Overall Study||0
9873269|NCT00992784|10987702|FG000|STARTED|Overall Study||180
9873270|NCT00992784|10987703|FG001|STARTED|Overall Study||104
9873271|NCT00992784|10987704|FG002|STARTED|Overall Study||86
9873272|NCT00992784|10987702|FG000|COMPLETED|Overall Study||177
9873273|NCT00992784|10987703|FG001|COMPLETED|Overall Study||102
9873274|NCT00992784|10987704|FG002|COMPLETED|Overall Study||85
9873275|NCT00992784|10987702|FG000|NOT COMPLETED|Overall Study||3
9873276|NCT00992784|10987703|FG001|NOT COMPLETED|Overall Study||2
9873277|NCT00992784|10987704|FG002|NOT COMPLETED|Overall Study||1
9873278|NCT00992836|10987712|FG000|STARTED|Overall Study||155
9873279|NCT00992836|10987712|FG000|Received Both Study Vaccinations|Overall Study||150
9873280|NCT00992836|10987712|FG000|COMPLETED|Overall Study||150
9873281|NCT00992836|10987712|FG000|NOT COMPLETED|Overall Study||5
9873282|NCT00992927|10987724|FG000|STARTED|Overall Study||32
9873283|NCT00992927|10987725|FG001|STARTED|Overall Study||22
9873284|NCT00992927|10987724|FG000|COMPLETED|Overall Study||32
9873285|NCT00992927|10987725|FG001|COMPLETED|Overall Study||22
9873286|NCT00992927|10987724|FG000|NOT COMPLETED|Overall Study||0
9873287|NCT00992927|10987725|FG001|NOT COMPLETED|Overall Study||0
9873288|NCT00992992|10987731|FG000|STARTED|Overall Study||25
9873289|NCT00992992|10987731|FG000|COMPLETED|Overall Study||0
9873290|NCT00992992|10987731|FG000|NOT COMPLETED|Overall Study||25
9873291|NCT00993031|10987737|FG000|STARTED|Overall Study||195
9873292|NCT00993031|10987738|FG001|STARTED|Overall Study||194
9873293|NCT00993031|10987737|FG000|Delivered|Overall Study||187
9873294|NCT00993031|10987738|FG001|Delivered|Overall Study||190
9873295|NCT00993031|10987737|FG000|COMPLETED|Overall Study||173
9873296|NCT00993031|10987738|FG001|COMPLETED|Overall Study||175
9873297|NCT00993031|10987737|FG000|NOT COMPLETED|Overall Study||22
9873298|NCT00993031|10987738|FG001|NOT COMPLETED|Overall Study||19
9873299|NCT00993044|10987748|FG000|STARTED|Irinotecan 30 mg||6
9873300|NCT00993044|10987748|FG000|COMPLETED|Irinotecan 30 mg||6
9873301|NCT00993044|10987748|FG000|NOT COMPLETED|Irinotecan 30 mg||0
9873302|NCT00993044|10987748|FG000|STARTED|Irinotecan 50 mg||7
9873303|NCT00993044|10987748|FG000|COMPLETED|Irinotecan 50 mg||6
9873304|NCT00993044|10987748|FG000|NOT COMPLETED|Irinotecan 50 mg||1
9873305|NCT00993148|10987753|FG000|STARTED|Overall Study||25
9873306|NCT00993148|10987753|FG000|COMPLETED|Overall Study||22
9873307|NCT00993148|10987753|FG000|NOT COMPLETED|Overall Study||3
9873308|NCT00993187|10987759|FG000|STARTED|Overall Study||147
9873309|NCT00993187|10987760|FG001|STARTED|Overall Study||145
9873310|NCT00993187|10987759|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146
9873311|NCT00993187|10987760|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144
9873312|NCT00993187|10987759|FG000|COMPLETED|Overall Study||121
9873313|NCT00993187|10987760|FG001|COMPLETED|Overall Study||108
9873314|NCT00993187|10987759|FG000|NOT COMPLETED|Overall Study||26
9873315|NCT00993187|10987760|FG001|NOT COMPLETED|Overall Study||37
9873316|NCT00993200|10987768|FG000|STARTED|Overall Study||13
9873317|NCT00993200|10987769|FG001|STARTED|Overall Study||13
9873318|NCT00993200|10987768|FG000|COMPLETED|Overall Study||13
9873319|NCT00993200|10987769|FG001|COMPLETED|Overall Study||13
9873320|NCT00993200|10987768|FG000|NOT COMPLETED|Overall Study||0
9873321|NCT00993200|10987769|FG001|NOT COMPLETED|Overall Study||0
9873322|NCT00993226|10987780|FG000|STARTED|Overall Study||61
9873323|NCT00993226|10987781|FG001|STARTED|Overall Study||27
9873324|NCT00993226|10987782|FG002|STARTED|Overall Study||27
9873325|NCT00993226|10987780|FG000|COMPLETED|Overall Study||60
9873326|NCT00993226|10987781|FG001|COMPLETED|Overall Study||26
9873327|NCT00993226|10987782|FG002|COMPLETED|Overall Study||27
9873328|NCT00993226|10987780|FG000|NOT COMPLETED|Overall Study||1
9873329|NCT00993226|10987781|FG001|NOT COMPLETED|Overall Study||1
9873330|NCT00993226|10987782|FG002|NOT COMPLETED|Overall Study||0
9873331|NCT00993265|10987792|FG000|STARTED|Overall Study||20
9873332|NCT00993265|10987793|FG001|STARTED|Overall Study||19
9873333|NCT00993265|10987792|FG000|COMPLETED|Overall Study||16
9873334|NCT00993265|10987793|FG001|COMPLETED|Overall Study||19
9873335|NCT00993265|10987792|FG000|NOT COMPLETED|Overall Study||4
9873336|NCT00993265|10987793|FG001|NOT COMPLETED|Overall Study||0
9873337|NCT00993291|10987799|FG000|STARTED|Overall Study||20
9873338|NCT00993291|10987799|FG000|COMPLETED|Overall Study||19
9873339|NCT00993291|10987799|FG000|NOT COMPLETED|Overall Study||1
9873340|NCT00993317|10987805|FG000|STARTED|Overall Study||42
9873341|NCT00993317|10987806|FG001|STARTED|Overall Study||85
9873342|NCT00993317|10987805|FG000|COMPLETED|Overall Study||21
9873343|NCT00993317|10987806|FG001|COMPLETED|Overall Study||60
9873344|NCT00993317|10987805|FG000|NOT COMPLETED|Overall Study||21
9873345|NCT00993317|10987806|FG001|NOT COMPLETED|Overall Study||25
9873346|NCT00993421|10987819|FG000|STARTED|Overall Study||49
9873347|NCT00993421|10987820|FG001|STARTED|Overall Study||49
9873348|NCT00993421|10987821|FG002|STARTED|Overall Study||48
9873349|NCT00993421|10987822|FG003|STARTED|Overall Study||49
9873350|NCT00993421|10987823|FG004|STARTED|Overall Study||52
9873351|NCT00993421|10987824|FG005|STARTED|Overall Study||50
9873352|NCT00993421|10987825|FG006|STARTED|Overall Study||46
9873353|NCT00993421|10987819|FG000|COMPLETED|Overall Study||5
9873354|NCT00993421|10987820|FG001|COMPLETED|Overall Study||4
9873355|NCT00993421|10987821|FG002|COMPLETED|Overall Study||5
9873356|NCT00993421|10987822|FG003|COMPLETED|Overall Study||4
9873357|NCT00993421|10987823|FG004|COMPLETED|Overall Study||6
9873358|NCT00993421|10987824|FG005|COMPLETED|Overall Study||4
9873359|NCT00993421|10987825|FG006|COMPLETED|Overall Study||4
9873360|NCT00993421|10987819|FG000|NOT COMPLETED|Overall Study||44
9873361|NCT00993421|10987820|FG001|NOT COMPLETED|Overall Study||45
9873362|NCT00993421|10987821|FG002|NOT COMPLETED|Overall Study||43
9873363|NCT00993421|10987822|FG003|NOT COMPLETED|Overall Study||45
9873364|NCT00993421|10987823|FG004|NOT COMPLETED|Overall Study||46
9873365|NCT00993421|10987824|FG005|NOT COMPLETED|Overall Study||46
9873366|NCT00993421|10987825|FG006|NOT COMPLETED|Overall Study||42
9873367|NCT00993473|10987843|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
9873368|NCT00993473|10987844|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
9873369|NCT00993473|10987843|FG000|COMPLETED|Overall Study||57
9873370|NCT00993473|10987844|FG001|COMPLETED|Overall Study||54
9873371|NCT00993473|10987843|FG000|NOT COMPLETED|Overall Study||4
9873372|NCT00993473|10987844|FG001|NOT COMPLETED|Overall Study||10
9873373|NCT00993499|10987856|FG000|STARTED|Run-in Period (8 Days)||13
9873374|NCT00993499|10987857|FG001|STARTED|Run-in Period (8 Days)||12
9873375|NCT00993499|10987858|FG002|STARTED|Run-in Period (8 Days)||10
9873376|NCT00993499|10987859|FG003|STARTED|Run-in Period (8 Days)||3
9873377|NCT00993499|10987860|FG004|STARTED|Run-in Period (8 Days)||3
9873378|NCT00993499|10987861|FG005|STARTED|Run-in Period (8 Days)||3
9873379|NCT00993499|10987856|FG000|COMPLETED|Run-in Period (8 Days)||12
9873380|NCT00993499|10987857|FG001|COMPLETED|Run-in Period (8 Days)||9
9873381|NCT00993499|10987858|FG002|COMPLETED|Run-in Period (8 Days)||9
9873382|NCT00993499|10987859|FG003|COMPLETED|Run-in Period (8 Days)||3
9873383|NCT00993499|10987860|FG004|COMPLETED|Run-in Period (8 Days)||3
9873384|NCT00993499|10987861|FG005|COMPLETED|Run-in Period (8 Days)||3
9873385|NCT00993499|10987856|FG000|NOT COMPLETED|Run-in Period (8 Days)||1
9873386|NCT00993499|10987857|FG001|NOT COMPLETED|Run-in Period (8 Days)||3
9873387|NCT00993499|10987858|FG002|NOT COMPLETED|Run-in Period (8 Days)||1
9873388|NCT00993499|10987859|FG003|NOT COMPLETED|Run-in Period (8 Days)||0
9873389|NCT00993499|10987860|FG004|NOT COMPLETED|Run-in Period (8 Days)||0
9873390|NCT00993499|10987861|FG005|NOT COMPLETED|Run-in Period (8 Days)||0
9873391|NCT00993499|10987856|FG000|STARTED|Discontinued Before Starting Course 3||12
9873392|NCT00993499|10987857|FG001|STARTED|Discontinued Before Starting Course 3||9
9873393|NCT00993499|10987858|FG002|STARTED|Discontinued Before Starting Course 3||9
9873394|NCT00993499|10987859|FG003|STARTED|Discontinued Before Starting Course 3||3
9873395|NCT00993499|10987860|FG004|STARTED|Discontinued Before Starting Course 3||3
9873396|NCT00993499|10987861|FG005|STARTED|Discontinued Before Starting Course 3||3
9873397|NCT00993499|10987856|FG000|COMPLETED|Discontinued Before Starting Course 3||8
9873398|NCT00993499|10987857|FG001|COMPLETED|Discontinued Before Starting Course 3||5
9873399|NCT00993499|10987858|FG002|COMPLETED|Discontinued Before Starting Course 3||6
9873400|NCT00993499|10987859|FG003|COMPLETED|Discontinued Before Starting Course 3||2
9873401|NCT00993499|10987860|FG004|COMPLETED|Discontinued Before Starting Course 3||3
9873402|NCT00993499|10987861|FG005|COMPLETED|Discontinued Before Starting Course 3||3
9873403|NCT00993499|10987856|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4
9873404|NCT00993499|10987857|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4
9873405|NCT00993499|10987858|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3
9873406|NCT00993499|10987859|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1
9873407|NCT00993499|10987860|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0
9873408|NCT00993499|10987861|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0
9873409|NCT00993499|10987856|FG000|STARTED|Discontinued After Starting Course 3||12
9873410|NCT00993499|10987857|FG001|STARTED|Discontinued After Starting Course 3||9
9873411|NCT00993499|10987858|FG002|STARTED|Discontinued After Starting Course 3||9
9873412|NCT00993499|10987859|FG003|STARTED|Discontinued After Starting Course 3||3
9873413|NCT00993499|10987860|FG004|STARTED|Discontinued After Starting Course 3||3
9873414|NCT00993499|10987861|FG005|STARTED|Discontinued After Starting Course 3||3
9873415|NCT00993499|10987856|FG000|COMPLETED|Discontinued After Starting Course 3||4
9873416|NCT00993499|10987857|FG001|COMPLETED|Discontinued After Starting Course 3||4
9873417|NCT00993499|10987858|FG002|COMPLETED|Discontinued After Starting Course 3||3
9873418|NCT00993499|10987859|FG003|COMPLETED|Discontinued After Starting Course 3||1
9873419|NCT00993499|10987860|FG004|COMPLETED|Discontinued After Starting Course 3||0
9873420|NCT00993499|10987861|FG005|COMPLETED|Discontinued After Starting Course 3||0
9873421|NCT00993499|10987856|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8
9758644|NCT02038777|10862210|FG001|Treated (Safety Set)|Overall Study||4
9758645|NCT02038777|10862211|FG002|Treated (Safety Set)|Overall Study||6
9758646|NCT02038777|10862212|FG003|Treated (Safety Set)|Overall Study||6
9758647|NCT02038777|10862213|FG004|Treated (Safety Set)|Overall Study||6
9758648|NCT02038777|10862214|FG005|Treated (Safety Set)|Overall Study||6
9758649|NCT02038777|10862215|FG006|Treated (Safety Set)|Overall Study||1
9873422|NCT00993499|10987857|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5
9873423|NCT00993499|10987858|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6
9873424|NCT00993499|10987859|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2
9873425|NCT00993499|10987860|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3
9873426|NCT00993499|10987861|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3
9873427|NCT00993616|10987875|FG000|STARTED|Overall Study||29
9873428|NCT00993616|10987875|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
9873429|NCT00993616|10987875|FG000|NOT COMPLETED|Overall Study||2
9873430|NCT00993655|10987888|FG000|STARTED|Overall Study||101
9873431|NCT00993655|10987889|FG001|STARTED|Overall Study||72
9873432|NCT00993655|10987890|FG002|STARTED|Overall Study||102
9873433|NCT00993655|10987888|FG000|COMPLETED|Overall Study||101
9873434|NCT00993655|10987889|FG001|COMPLETED|Overall Study||72
9873435|NCT00993655|10987890|FG002|COMPLETED|Overall Study||102
9873436|NCT00993655|10987888|FG000|NOT COMPLETED|Overall Study||0
9873437|NCT00993655|10987889|FG001|NOT COMPLETED|Overall Study||0
9873438|NCT00993655|10987890|FG002|NOT COMPLETED|Overall Study||0
9873439|NCT00993668|10987903|FG000|STARTED|Single-Blind Period||114
9873440|NCT00993668|10987904|FG001|STARTED|Single-Blind Period||110
9873441|NCT00993668|10987903|FG000|COMPLETED|Single-Blind Period||110
9873442|NCT00993668|10987904|FG001|COMPLETED|Single-Blind Period||107
9873443|NCT00993668|10987903|FG000|NOT COMPLETED|Single-Blind Period||4
9873444|NCT00993668|10987904|FG001|NOT COMPLETED|Single-Blind Period||3
9873445|NCT00993668|10987903|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
9873446|NCT00993668|10987904|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
9873447|NCT00993668|10987903|FG000|COMPLETED|Open-Label Period||86
9873448|NCT00993668|10987904|FG001|COMPLETED|Open-Label Period||91
9873449|NCT00993668|10987903|FG000|NOT COMPLETED|Open-Label Period||23
9873450|NCT00993668|10987904|FG001|NOT COMPLETED|Open-Label Period||15
9873451|NCT00993798|10987914|FG000|STARTED|Overall Study||53
9873452|NCT00993798|10987915|FG001|STARTED|Overall Study||25
9873453|NCT00993798|10987916|FG002|STARTED|Overall Study||29
9873454|NCT00993798|10987917|FG003|STARTED|Overall Study||0
9873455|NCT00993798|10987918|FG004|STARTED|Overall Study||0
9873456|NCT00993798|10987914|FG000|COMPLETED|Overall Study||53
9873457|NCT00993798|10987915|FG001|COMPLETED|Overall Study||25
9873458|NCT00993798|10987916|FG002|COMPLETED|Overall Study||29
9873459|NCT00993798|10987917|FG003|COMPLETED|Overall Study||0
9873460|NCT00993798|10987918|FG004|COMPLETED|Overall Study||0
9873461|NCT00993798|10987914|FG000|NOT COMPLETED|Overall Study||0
9873462|NCT00993798|10987915|FG001|NOT COMPLETED|Overall Study||0
9873463|NCT00993798|10987916|FG002|NOT COMPLETED|Overall Study||0
9873464|NCT00993798|10987917|FG003|NOT COMPLETED|Overall Study||0
9873465|NCT00993798|10987918|FG004|NOT COMPLETED|Overall Study||0
9873466|NCT00993824|10987928|FG000|STARTED|Overall Study||11
9873467|NCT00993824|10987929|FG001|STARTED|Overall Study||10
9873468|NCT00993824|10987928|FG000|COMPLETED|Overall Study||11
9873469|NCT00993824|10987929|FG001|COMPLETED|Overall Study||10
9873470|NCT00993824|10987928|FG000|NOT COMPLETED|Overall Study||0
9873471|NCT00993824|10987929|FG001|NOT COMPLETED|Overall Study||0
9873472|NCT00993915|10987937|FG000|STARTED|Overall Study||687
9873473|NCT00993915|10987937|FG000|COMPLETED|Overall Study||678
9873474|NCT00993915|10987937|FG000|NOT COMPLETED|Overall Study||9
9873475|NCT00993928|10987943|FG000|STARTED|Overall Study||48
9873476|NCT00993928|10987944|FG001|STARTED|Overall Study||45
9873477|NCT00993928|10987943|FG000|COMPLETED|Overall Study||43
9873478|NCT00993928|10987944|FG001|COMPLETED|Overall Study||38
9873479|NCT00993928|10987943|FG000|NOT COMPLETED|Overall Study||5
9873480|NCT00993928|10987944|FG001|NOT COMPLETED|Overall Study||7
9873481|NCT00993954|10987956|FG000|STARTED|Overall Study||145
9873482|NCT00993954|10987957|FG001|STARTED|Overall Study||123
9873483|NCT00993954|10987956|FG000|COMPLETED|Overall Study||124
9873484|NCT00993954|10987957|FG001|COMPLETED|Overall Study||121
9758650|NCT02038777|10862216|FG007|Treated (Safety Set)|Overall Study||15
9758651|NCT02038777|10862209|FG000|COMPLETED|Overall Study||2
9758652|NCT02038777|10862210|FG001|COMPLETED|Overall Study||1
9758653|NCT02038777|10862211|FG002|COMPLETED|Overall Study||3
9758654|NCT02038777|10862212|FG003|COMPLETED|Overall Study||2
9758655|NCT02038777|10862213|FG004|COMPLETED|Overall Study||3
9873485|NCT00993954|10987956|FG000|NOT COMPLETED|Overall Study||21
9873486|NCT00993954|10987957|FG001|NOT COMPLETED|Overall Study||2
9873487|NCT00993967|10987963|FG000|STARTED|Overall Study||200
9873488|NCT00993967|10987963|FG000|COMPLETED|Overall Study||139
9873489|NCT00993967|10987963|FG000|NOT COMPLETED|Overall Study||61
9873490|NCT00994110|10987969|FG000|STARTED|Overall Study||217
9873491|NCT00994110|10987970|FG001|STARTED|Overall Study||222
9873492|NCT00994110|10987969|FG000|COMPLETED|Overall Study||152
9873493|NCT00994110|10987970|FG001|COMPLETED|Overall Study||148
9873494|NCT00994110|10987969|FG000|NOT COMPLETED|Overall Study||65
9873495|NCT00994110|10987970|FG001|NOT COMPLETED|Overall Study||74
9873496|NCT00994123|10987979|FG000|STARTED|Overall Study||33
9873497|NCT00994123|10987980|FG001|STARTED|Overall Study||85
9873498|NCT00994123|10987981|FG002|STARTED|Overall Study||44
9873499|NCT00994123|10987979|FG000|COMPLETED|Overall Study||33
9873500|NCT00994123|10987980|FG001|COMPLETED|Overall Study||85
9873501|NCT00994123|10987981|FG002|COMPLETED|Overall Study||44
9873502|NCT00994123|10987979|FG000|NOT COMPLETED|Overall Study||0
9873503|NCT00994123|10987980|FG001|NOT COMPLETED|Overall Study||0
9873504|NCT00994123|10987981|FG002|NOT COMPLETED|Overall Study||0
9873505|NCT00994175|10988000|FG000|STARTED|First Intervention||6
9873506|NCT00994175|10988001|FG001|STARTED|First Intervention||9
9873507|NCT00994175|10988000|FG000|COMPLETED|First Intervention||4
9873508|NCT00994175|10988001|FG001|COMPLETED|First Intervention||8
9873509|NCT00994175|10988000|FG000|NOT COMPLETED|First Intervention||2
9873510|NCT00994175|10988001|FG001|NOT COMPLETED|First Intervention||1
9873511|NCT00994175|10988000|FG000|STARTED|Second Intervention||4
9873512|NCT00994175|10988001|FG001|STARTED|Second Intervention||8
9873513|NCT00994175|10988000|FG000|COMPLETED|Second Intervention||4
9873514|NCT00994175|10988001|FG001|COMPLETED|Second Intervention||8
9873515|NCT00994175|10988000|FG000|NOT COMPLETED|Second Intervention||0
9873516|NCT00994175|10988001|FG001|NOT COMPLETED|Second Intervention||0
9953738|NCT01427933|11072425|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69
9953739|NCT01427933|11072426|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
9953740|NCT01427933|11072425|FG000|COMPLETED|Overall Study||63
9953741|NCT01427933|11072426|FG001|COMPLETED|Overall Study||57
9953742|NCT01427933|11072425|FG000|NOT COMPLETED|Overall Study||8
9953743|NCT01427933|11072426|FG001|NOT COMPLETED|Overall Study||13
9953744|NCT01427972|11072445|FG000|STARTED|Treatment Period 1 (21 Days)||3
9953745|NCT01427972|11072446|FG001|STARTED|Treatment Period 1 (21 Days)||4
9953746|NCT01427972|11072447|FG002|STARTED|Treatment Period 1 (21 Days)||4
9953747|NCT01427972|11072448|FG003|STARTED|Treatment Period 1 (21 Days)||3
9953748|NCT01427972|11072449|FG004|STARTED|Treatment Period 1 (21 Days)||4
9953749|NCT01427972|11072450|FG005|STARTED|Treatment Period 1 (21 Days)||3
9953750|NCT01427972|11072451|FG006|STARTED|Treatment Period 1 (21 Days)||3
9953751|NCT01427972|11072452|FG007|STARTED|Treatment Period 1 (21 Days)||5
9953752|NCT01427972|11072453|FG008|STARTED|Treatment Period 1 (21 Days)||3
9953753|NCT01427972|11072454|FG009|STARTED|Treatment Period 1 (21 Days)||3
9953754|NCT01427972|11072455|FG010|STARTED|Treatment Period 1 (21 Days)||3
9953755|NCT01427972|11072456|FG011|STARTED|Treatment Period 1 (21 Days)||4
9953756|NCT01427972|11072445|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
9953757|NCT01427972|11072446|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
9953758|NCT01427972|11072447|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
9953759|NCT01427972|11072448|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
9953760|NCT01427972|11072449|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
9953761|NCT01427972|11072450|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
9953762|NCT01427972|11072451|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
9953763|NCT01427972|11072452|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
9953764|NCT01427972|11072453|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
9953765|NCT01427972|11072454|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
9953766|NCT01427972|11072455|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
9953767|NCT01427972|11072456|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
9953768|NCT01427972|11072445|FG000|COMPLETED|Treatment Period 1 (21 Days)||3
9953769|NCT01427972|11072446|FG001|COMPLETED|Treatment Period 1 (21 Days)||4
9953770|NCT01427972|11072447|FG002|COMPLETED|Treatment Period 1 (21 Days)||4
9953771|NCT01427972|11072448|FG003|COMPLETED|Treatment Period 1 (21 Days)||3
9953772|NCT01427972|11072449|FG004|COMPLETED|Treatment Period 1 (21 Days)||4
9953773|NCT01427972|11072450|FG005|COMPLETED|Treatment Period 1 (21 Days)||3
9953774|NCT01427972|11072451|FG006|COMPLETED|Treatment Period 1 (21 Days)||3
9953775|NCT01427972|11072452|FG007|COMPLETED|Treatment Period 1 (21 Days)||4
9953776|NCT01427972|11072453|FG008|COMPLETED|Treatment Period 1 (21 Days)||3
9953777|NCT01427972|11072454|FG009|COMPLETED|Treatment Period 1 (21 Days)||3
9953778|NCT01427972|11072455|FG010|COMPLETED|Treatment Period 1 (21 Days)||3
9953779|NCT01427972|11072456|FG011|COMPLETED|Treatment Period 1 (21 Days)||4
9953780|NCT01427972|11072445|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953781|NCT01427972|11072446|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953782|NCT01427972|11072447|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953783|NCT01427972|11072448|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953784|NCT01427972|11072449|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953785|NCT01427972|11072450|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9873517|NCT00994214|10988011|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19
9873518|NCT00994214|10988012|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19
9873519|NCT00994214|10988013|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18
9873520|NCT00994214|10988014|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20
9873521|NCT00994214|10988011|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5
9873522|NCT00994214|10988012|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6
9873523|NCT00994214|10988013|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5
9873524|NCT00994214|10988014|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5
9873525|NCT00994214|10988011|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
9873526|NCT00994214|10988012|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
9873527|NCT00994214|10988013|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
9873528|NCT00994214|10988014|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
9873529|NCT00994214|10988011|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
9873530|NCT00994214|10988012|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
9873531|NCT00994214|10988013|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
9873532|NCT00994214|10988014|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
9873533|NCT00994214|10988011|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
9873534|NCT00994214|10988012|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
9873535|NCT00994214|10988013|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
9873536|NCT00994214|10988014|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
9873537|NCT00994214|10988011|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
9873538|NCT00994214|10988012|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
9873539|NCT00994214|10988013|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
9873540|NCT00994214|10988014|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
9873541|NCT00994214|10988011|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
9873542|NCT00994214|10988012|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
9873543|NCT00994214|10988013|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
9873544|NCT00994214|10988014|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
9873545|NCT00994214|10988011|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
9873546|NCT00994214|10988012|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
9873547|NCT00994214|10988013|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
9873548|NCT00994214|10988014|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
9873549|NCT00994214|10988011|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0
9873550|NCT00994214|10988012|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0
9873551|NCT00994214|10988013|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0
9873552|NCT00994214|10988014|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0
9873553|NCT00994214|10988011|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
9873554|NCT00994214|10988012|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
9873555|NCT00994214|10988013|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
9873556|NCT00994214|10988014|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
9873557|NCT00994240|10988044|FG000|STARTED|Overall Study||41
9873558|NCT00994240|10988045|FG001|STARTED|Overall Study||44
9873559|NCT00994240|10988044|FG000|COMPLETED|Overall Study||35
9873560|NCT00994240|10988045|FG001|COMPLETED|Overall Study||39
9873561|NCT00994240|10988044|FG000|NOT COMPLETED|Overall Study||6
9873562|NCT00994240|10988045|FG001|NOT COMPLETED|Overall Study||5
9873563|NCT00994279|10988053|FG000|STARTED|Overall Study||22
9873564|NCT00994279|10988054|FG001|STARTED|Overall Study||18
9873565|NCT00994279|10988053|FG000|COMPLETED|Overall Study||18
9873566|NCT00994279|10988054|FG001|COMPLETED|Overall Study||13
9873567|NCT00994279|10988053|FG000|NOT COMPLETED|Overall Study||4
9873568|NCT00994279|10988054|FG001|NOT COMPLETED|Overall Study||5
9873569|NCT00994318|10988063|FG000|STARTED|Overall Study||155
9873570|NCT00994318|10988064|FG001|STARTED|Overall Study||154
9873571|NCT00994318|10988065|FG002|STARTED|Overall Study||317
9873572|NCT00994318|10988063|FG000|COMPLETED|Overall Study||133
9873573|NCT00994318|10988064|FG001|COMPLETED|Overall Study||136
9873574|NCT00994318|10988065|FG002|COMPLETED|Overall Study||250
9873575|NCT00994318|10988063|FG000|NOT COMPLETED|Overall Study||22
9873576|NCT00994318|10988064|FG001|NOT COMPLETED|Overall Study||18
9873577|NCT00994318|10988065|FG002|NOT COMPLETED|Overall Study||67
9873578|NCT00994422|10988075|FG000|STARTED|Overall Study||192
9873579|NCT00994422|10988076|FG001|STARTED|Overall Study||55
9873580|NCT00994422|10988075|FG000|COMPLETED|Overall Study||185
9873581|NCT00994422|10988076|FG001|COMPLETED|Overall Study||54
9873582|NCT00994422|10988075|FG000|NOT COMPLETED|Overall Study||7
9873583|NCT00994422|10988076|FG001|NOT COMPLETED|Overall Study||1
9873584|NCT00994448|10988086|FG000|STARTED|Overall Study||12
9873585|NCT00994448|10988087|FG001|STARTED|Overall Study||7
9873586|NCT00994448|10988086|FG000|COMPLETED|Overall Study||4
9873587|NCT00994448|10988087|FG001|COMPLETED|Overall Study||5
9873588|NCT00994448|10988086|FG000|NOT COMPLETED|Overall Study||8
9873589|NCT00994448|10988087|FG001|NOT COMPLETED|Overall Study||2
9873590|NCT00994461|10988096|FG000|STARTED|Overall Study||76
9873591|NCT00994461|10988097|FG001|STARTED|Overall Study||76
9873592|NCT00994461|10988098|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
9873593|NCT00994461|10988096|FG000|COMPLETED|Overall Study||74
9873594|NCT00994461|10988097|FG001|COMPLETED|Overall Study||75
9873595|NCT00994461|10988098|FG002|COMPLETED|Overall Study||37
9873596|NCT00994461|10988096|FG000|NOT COMPLETED|Overall Study||2
9873597|NCT00994461|10988097|FG001|NOT COMPLETED|Overall Study||1
9873598|NCT00994461|10988098|FG002|NOT COMPLETED|Overall Study||0
9873599|NCT00994604|10988106|FG000|STARTED|Overall Study||51
9873600|NCT00994604|10988106|FG000|COMPLETED|Overall Study||45
9873601|NCT00994604|10988106|FG000|NOT COMPLETED|Overall Study||6
9873602|NCT00994643|10988113|FG000|STARTED|Overall Study||11
9873603|NCT00994643|10988113|FG000|COMPLETED|Overall Study||10
9873604|NCT00994643|10988113|FG000|NOT COMPLETED|Overall Study||1
9873605|NCT00994682|10988119|FG000|STARTED|Double Bilnd||51
9873606|NCT00994682|10988120|FG001|STARTED|Double Bilnd||50
9873607|NCT00994682|10988119|FG000|COMPLETED|Double Bilnd||42
9873608|NCT00994682|10988120|FG001|COMPLETED|Double Bilnd||41
9873609|NCT00994682|10988119|FG000|NOT COMPLETED|Double Bilnd||9
9873610|NCT00994682|10988120|FG001|NOT COMPLETED|Double Bilnd||9
9873611|NCT00994682|10988119|FG000|STARTED|Pioglitazone Open Label||42
9873612|NCT00994682|10988120|FG001|STARTED|Pioglitazone Open Label||41
9873613|NCT00994682|10988119|FG000|COMPLETED|Pioglitazone Open Label||29
9873614|NCT00994682|10988120|FG001|COMPLETED|Pioglitazone Open Label||34
9873615|NCT00994682|10988119|FG000|NOT COMPLETED|Pioglitazone Open Label||13
9873616|NCT00994682|10988120|FG001|NOT COMPLETED|Pioglitazone Open Label||7
9873617|NCT00994760|10988130|FG000|STARTED|Overall Study||131
9873618|NCT00994760|10988130|FG000|COMPLETED|Overall Study||107
9873619|NCT00994760|10988130|FG000|NOT COMPLETED|Overall Study||24
9873620|NCT00994890|10988151|FG000|STARTED|Overall Study||231
9873621|NCT00994890|10988152|FG001|STARTED|Overall Study||222
9873622|NCT00994890|10988153|FG002|STARTED|Overall Study||226
9873623|NCT00994890|10988151|FG000|Treated|Overall Study||230
9873624|NCT00994890|10988152|FG001|Treated|Overall Study||222
9873625|NCT00994890|10988153|FG002|Treated|Overall Study||226
9873626|NCT00994890|10988151|FG000|COMPLETED|Overall Study||0
9873627|NCT00994890|10988152|FG001|COMPLETED|Overall Study||0
9873628|NCT00994890|10988153|FG002|COMPLETED|Overall Study||0
9873629|NCT00994890|10988151|FG000|NOT COMPLETED|Overall Study||231
9873630|NCT00994890|10988152|FG001|NOT COMPLETED|Overall Study||222
9873631|NCT00994890|10988153|FG002|NOT COMPLETED|Overall Study||226
9873632|NCT00994929|10988161|FG000|STARTED|Overall Study||9
9873633|NCT00994929|10988161|FG000|COMPLETED|Overall Study||9
9873634|NCT00994929|10988161|FG000|NOT COMPLETED|Overall Study||0
9873635|NCT00995007|10988168|FG000|STARTED|Overall Study||56
9873636|NCT00995007|10988169|FG001|STARTED|Overall Study||56
9873637|NCT00995007|10988168|FG000|Crossover to Vandetanib|Overall Study||42
9873638|NCT00995007|10988169|FG001|Crossover to Vandetanib|Overall Study||0
9873639|NCT00995007|10988168|FG000|COMPLETED|Overall Study||39
9873640|NCT00995007|10988169|FG001|COMPLETED|Overall Study||54
9873641|NCT00995007|10988168|FG000|NOT COMPLETED|Overall Study||17
9873642|NCT00995007|10988169|FG001|NOT COMPLETED|Overall Study||2
9873643|NCT00995020|10988186|FG000|STARTED|Overall Study||51
9873644|NCT00995020|10988187|FG001|STARTED|Overall Study||52
9873645|NCT00995020|10988186|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
9873646|NCT00995020|10988187|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
9873647|NCT00995020|10988186|FG000|NOT COMPLETED|Overall Study||3
9873648|NCT00995020|10988187|FG001|NOT COMPLETED|Overall Study||7
9873649|NCT00995072|10988197|FG000|STARTED|Overall Study||10
9873650|NCT00995072|10988198|FG001|STARTED|Overall Study||15
9873651|NCT00995072|10988197|FG000|COMPLETED|Overall Study||9
9873652|NCT00995072|10988198|FG001|COMPLETED|Overall Study||12
9873653|NCT00995072|10988197|FG000|NOT COMPLETED|Overall Study||1
9873654|NCT00995072|10988198|FG001|NOT COMPLETED|Overall Study||3
9873655|NCT00995085|10988204|FG000|STARTED|Overall Study||43
9873656|NCT00995085|10988204|FG000|COMPLETED|Overall Study||38
9873657|NCT00995085|10988204|FG000|NOT COMPLETED|Overall Study||5
9873658|NCT00995215|10988208|FG000|STARTED|Overall Study||6
9873659|NCT00995215|10988208|FG000|COMPLETED|Overall Study||6
9873660|NCT00995215|10988208|FG000|NOT COMPLETED|Overall Study||0
9873661|NCT00995345|10988218|FG000|STARTED|Overall Study||81
9873662|NCT00995345|10988219|FG001|STARTED|Overall Study||81
9873663|NCT00995345|10988220|FG002|STARTED|Overall Study||80
9873664|NCT00995345|10988221|FG003|STARTED|Overall Study||81
9873665|NCT00995345|10988222|FG004|STARTED|Overall Study||80
9873666|NCT00995345|10988218|FG000|COMPLETED|Overall Study||70
9873667|NCT00995345|10988219|FG001|COMPLETED|Overall Study||74
9873668|NCT00995345|10988220|FG002|COMPLETED|Overall Study||73
9873669|NCT00995345|10988221|FG003|COMPLETED|Overall Study||76
9873670|NCT00995345|10988222|FG004|COMPLETED|Overall Study||75
9873671|NCT00995345|10988218|FG000|NOT COMPLETED|Overall Study||11
9873672|NCT00995345|10988219|FG001|NOT COMPLETED|Overall Study||7
9873673|NCT00995345|10988220|FG002|NOT COMPLETED|Overall Study||7
9873674|NCT00995345|10988221|FG003|NOT COMPLETED|Overall Study||5
9873675|NCT00995345|10988222|FG004|NOT COMPLETED|Overall Study||5
9873676|NCT00995371|10988236|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21
9873677|NCT00995371|10988237|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17
9873678|NCT00995371|10988236|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
9873679|NCT00995371|10988237|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
9873680|NCT00995371|10988236|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
9873681|NCT00995371|10988237|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
9873682|NCT00995371|10988236|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
9873683|NCT00995371|10988237|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
9873684|NCT00995371|10988236|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
9873685|NCT00995371|10988237|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
9873686|NCT00995371|10988236|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
9873687|NCT00995371|10988237|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
9873688|NCT00995410|10988245|FG000|STARTED|Overall Study||380
9873689|NCT00995410|10988245|FG000|Treated|Overall Study||379
9873690|NCT00995410|10988245|FG000|COMPLETED|Overall Study||292
9873691|NCT00995410|10988245|FG000|NOT COMPLETED|Overall Study||88
9873692|NCT00995436|10988252|FG000|STARTED|Overall Study|25|25
9873693|NCT00995436|10988253|FG001|STARTED|Overall Study||27
9873694|NCT00995436|10988254|FG002|STARTED|Overall Study||26
9873695|NCT00995436|10988252|FG000|COMPLETED|Overall Study||23
9873696|NCT00995436|10988253|FG001|COMPLETED|Overall Study||22
9873697|NCT00995436|10988254|FG002|COMPLETED|Overall Study||26
9873698|NCT00995436|10988252|FG000|NOT COMPLETED|Overall Study||2
9873699|NCT00995436|10988253|FG001|NOT COMPLETED|Overall Study||5
9873700|NCT00995436|10988254|FG002|NOT COMPLETED|Overall Study||0
9873701|NCT00995449|10988266|FG000|STARTED|Overall Study||0
9873702|NCT00995449|10988267|FG001|STARTED|Overall Study||0
9873703|NCT00995449|10988268|FG002|STARTED|Overall Study||7
9873704|NCT00995449|10988269|FG003|STARTED|Overall Study||2
9873705|NCT00995449|10988266|FG000|COMPLETED|Overall Study||0
9873706|NCT00995449|10988267|FG001|COMPLETED|Overall Study||0
9873707|NCT00995449|10988268|FG002|COMPLETED|Overall Study||5
9873708|NCT00995449|10988269|FG003|COMPLETED|Overall Study||2
9873709|NCT00995449|10988266|FG000|NOT COMPLETED|Overall Study||0
9873710|NCT00995449|10988267|FG001|NOT COMPLETED|Overall Study||0
9873711|NCT00995449|10988268|FG002|NOT COMPLETED|Overall Study||2
9873712|NCT00995449|10988269|FG003|NOT COMPLETED|Overall Study||0
9873713|NCT00995475|10988277|FG000|STARTED|First Intervention||9
9873714|NCT00995475|10988278|FG001|STARTED|First Intervention||9
9873715|NCT00995475|10988277|FG000|COMPLETED|First Intervention||9
9873716|NCT00995475|10988278|FG001|COMPLETED|First Intervention||9
9873717|NCT00995475|10988277|FG000|NOT COMPLETED|First Intervention||0
9873718|NCT00995475|10988278|FG001|NOT COMPLETED|First Intervention||0
9873719|NCT00995475|10988277|FG000|STARTED|Wash-out Two Week||9
9758656|NCT02038777|10862214|FG005|COMPLETED|Overall Study||2
9758657|NCT02038777|10862215|FG006|COMPLETED|Overall Study||1
9758658|NCT02038777|10862216|FG007|COMPLETED|Overall Study||5
9758659|NCT02038777|10862209|FG000|NOT COMPLETED|Overall Study||1
9758660|NCT02038777|10862210|FG001|NOT COMPLETED|Overall Study||4
9758661|NCT02038777|10862211|FG002|NOT COMPLETED|Overall Study||3
9873720|NCT00995475|10988278|FG001|STARTED|Wash-out Two Week||9
9873721|NCT00995475|10988277|FG000|COMPLETED|Wash-out Two Week||9
9873722|NCT00995475|10988278|FG001|COMPLETED|Wash-out Two Week||9
9873723|NCT00995475|10988277|FG000|NOT COMPLETED|Wash-out Two Week||0
9873724|NCT00995475|10988278|FG001|NOT COMPLETED|Wash-out Two Week||0
9873725|NCT00995475|10988277|FG000|STARTED|Second Intervention||9
9873726|NCT00995475|10988278|FG001|STARTED|Second Intervention||9
10097139|NCT02371980|11226124|FG000|COMPLETED|Double-blind Period||0
10097140|NCT02371980|11226125|FG001|COMPLETED|Double-blind Period||70
10097141|NCT02371980|11226126|FG002|COMPLETED|Double-blind Period||84
10097142|NCT02371980|11226127|FG003|COMPLETED|Double-blind Period||96
10097143|NCT02371980|11226128|FG004|COMPLETED|Double-blind Period||86
10097144|NCT02371980|11226124|FG000|NOT COMPLETED|Double-blind Period||0
10097145|NCT02371980|11226125|FG001|NOT COMPLETED|Double-blind Period||81
10097146|NCT02371980|11226126|FG002|NOT COMPLETED|Double-blind Period||56
10097147|NCT02371980|11226127|FG003|NOT COMPLETED|Double-blind Period||49
9873727|NCT00995475|10988277|FG000|COMPLETED|Second Intervention||9
9873728|NCT00995475|10988278|FG001|COMPLETED|Second Intervention||9
9873729|NCT00995475|10988277|FG000|NOT COMPLETED|Second Intervention||0
9873730|NCT00995475|10988278|FG001|NOT COMPLETED|Second Intervention||0
9873731|NCT00995488|10988284|FG000|STARTED|Overall Study||16
9873732|NCT00995488|10988284|FG000|COMPLETED|Overall Study||15
9873733|NCT00995488|10988284|FG000|NOT COMPLETED|Overall Study||1
9873734|NCT00995501|10988296|FG000|STARTED|Overall Study||52
9873735|NCT00995501|10988297|FG001|STARTED|Overall Study||51
9873736|NCT00995501|10988298|FG002|STARTED|Overall Study||47
9873737|NCT00995501|10988299|FG003|STARTED|Overall Study||46
9873738|NCT00995501|10988300|FG004|STARTED|Overall Study||46
9873739|NCT00995501|10988301|FG005|STARTED|Overall Study||44
9873740|NCT00995501|10988302|FG006|STARTED|Overall Study||49
9873741|NCT00995501|10988303|FG007|STARTED|Overall Study||46
10097148|NCT02371980|11226128|FG004|NOT COMPLETED|Double-blind Period||58
9758662|NCT02038777|10862212|FG003|NOT COMPLETED|Overall Study||4
9873742|NCT00995501|10988296|FG000|COMPLETED|Overall Study||52
9873743|NCT00995501|10988297|FG001|COMPLETED|Overall Study||51
10097149|NCT02372006|11226142|FG000|STARTED|Overall Study||8
10097150|NCT02372006|11226143|FG001|STARTED|Overall Study||9
9758663|NCT02038777|10862213|FG004|NOT COMPLETED|Overall Study||3
9758664|NCT02038777|10862214|FG005|NOT COMPLETED|Overall Study||4
9758665|NCT02038777|10862215|FG006|NOT COMPLETED|Overall Study||0
9758666|NCT02038777|10862216|FG007|NOT COMPLETED|Overall Study||10
9758667|NCT01996449|10862235|FG000|STARTED|Period 1: First Drug||6
9758668|NCT01996449|10862236|FG001|STARTED|Period 1: First Drug||8
9758669|NCT01996449|10862235|FG000|COMPLETED|Period 1: First Drug||6
9758670|NCT01996449|10862236|FG001|COMPLETED|Period 1: First Drug||8
9758671|NCT01996449|10862235|FG000|NOT COMPLETED|Period 1: First Drug||0
9873744|NCT00995501|10988298|FG002|COMPLETED|Overall Study||47
9873745|NCT00995501|10988299|FG003|COMPLETED|Overall Study||46
9873746|NCT00995501|10988300|FG004|COMPLETED|Overall Study||46
9873747|NCT00995501|10988301|FG005|COMPLETED|Overall Study||44
9873748|NCT00995501|10988302|FG006|COMPLETED|Overall Study||49
9873749|NCT00995501|10988303|FG007|COMPLETED|Overall Study||46
9873750|NCT00995501|10988296|FG000|NOT COMPLETED|Overall Study||0
9873751|NCT00995501|10988297|FG001|NOT COMPLETED|Overall Study||0
9873752|NCT00995501|10988298|FG002|NOT COMPLETED|Overall Study||0
9873753|NCT00995501|10988299|FG003|NOT COMPLETED|Overall Study||0
9873754|NCT00995501|10988300|FG004|NOT COMPLETED|Overall Study||0
9873755|NCT00995501|10988301|FG005|NOT COMPLETED|Overall Study||0
9873756|NCT00995501|10988302|FG006|NOT COMPLETED|Overall Study||0
9873757|NCT00995501|10988303|FG007|NOT COMPLETED|Overall Study||0
9873758|NCT00995553|10988323|FG000|STARTED|Overall Study||40
9873759|NCT00995553|10988324|FG001|STARTED|Overall Study||41
9873760|NCT00995553|10988323|FG000|COMPLETED|Overall Study||38
9873761|NCT00995553|10988324|FG001|COMPLETED|Overall Study||35
9873762|NCT00995553|10988323|FG000|NOT COMPLETED|Overall Study||2
9873763|NCT00995553|10988324|FG001|NOT COMPLETED|Overall Study||6
9873764|NCT00995566|10988330|FG000|STARTED|Overall Study||54
9873765|NCT00995566|10988330|FG000|COMPLETED|Overall Study||0
9873766|NCT00995566|10988330|FG000|NOT COMPLETED|Overall Study||54
9873767|NCT00995670|10988337|FG000|STARTED|Overall Study||26
9873768|NCT00995670|10988338|FG001|STARTED|Overall Study||16
9873769|NCT00995670|10988339|FG002|STARTED|Overall Study||17
9873770|NCT00995670|10988337|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
9873771|NCT00995670|10988338|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
9873772|NCT00995670|10988339|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
9873773|NCT00995670|10988337|FG000|NOT COMPLETED|Overall Study||1
9873774|NCT00995670|10988338|FG001|NOT COMPLETED|Overall Study||0
9873775|NCT00995670|10988339|FG002|NOT COMPLETED|Overall Study||3
9873776|NCT00995709|10988350|FG000|STARTED|Overall Study||39
9873777|NCT00995709|10988351|FG001|STARTED|Overall Study||40
9873778|NCT00995709|10988352|FG002|STARTED|Overall Study||39
9873779|NCT00995709|10988350|FG000|COMPLETED|Overall Study||32
9873780|NCT00995709|10988351|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
9873781|NCT00995709|10988352|FG002|COMPLETED|Overall Study||34
9873782|NCT00995709|10988350|FG000|NOT COMPLETED|Overall Study||7
9873783|NCT00995709|10988351|FG001|NOT COMPLETED|Overall Study||9
9873784|NCT00995709|10988352|FG002|NOT COMPLETED|Overall Study||5
9873785|NCT00995722|10988362|FG000|STARTED|Double Blinded: 16 Weeks||6
9873786|NCT00995722|10988363|FG001|STARTED|Double Blinded: 16 Weeks||5
9873787|NCT00995722|10988362|FG000|COMPLETED|Double Blinded: 16 Weeks||5
9873788|NCT00995722|10988363|FG001|COMPLETED|Double Blinded: 16 Weeks||4
9873789|NCT00995722|10988362|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1
9873790|NCT00995722|10988363|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1
9873791|NCT00995722|10988362|FG000|STARTED|Overall Study: 36 Weeks||5
9873792|NCT00995722|10988363|FG001|STARTED|Overall Study: 36 Weeks||4
9873793|NCT00995722|10988362|FG000|COMPLETED|Overall Study: 36 Weeks||3
9873794|NCT00995722|10988363|FG001|COMPLETED|Overall Study: 36 Weeks||2
9873795|NCT00995722|10988362|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2
9873796|NCT00995722|10988363|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2
9873797|NCT00995761|10988369|FG000|STARTED|Overall Study||48
9873798|NCT00995761|10988369|FG000|COMPLETED|Overall Study||48
9873799|NCT00995761|10988369|FG000|NOT COMPLETED|Overall Study||0
10097151|NCT02372006|11226144|FG002|STARTED|Overall Study||39
10097152|NCT02372006|11226142|FG000|COMPLETED|Overall Study||0
10097153|NCT02372006|11226143|FG001|COMPLETED|Overall Study||0
10097154|NCT02372006|11226144|FG002|COMPLETED|Overall Study||0
10097155|NCT02372006|11226142|FG000|NOT COMPLETED|Overall Study||8
10097156|NCT02372006|11226143|FG001|NOT COMPLETED|Overall Study||9
10097157|NCT02372006|11226144|FG002|NOT COMPLETED|Overall Study||39
10097158|NCT02372058|11226153|FG000|STARTED|Overall Study||103
10097159|NCT02372058|11226153|FG000|COMPLETED|Overall Study||100
10097160|NCT02372058|11226153|FG000|NOT COMPLETED|Overall Study||3
10097161|NCT02372071|11226159|FG000|STARTED|Overall Study||111
10097162|NCT02372071|11226159|FG000|COMPLETED|Overall Study||93
10097163|NCT02372071|11226159|FG000|NOT COMPLETED|Overall Study||18
10097164|NCT02372097|11226166|FG000|STARTED|First Intervention Period (8 Days)||12
10097165|NCT02372097|11226167|FG001|STARTED|First Intervention Period (8 Days)||12
10097166|NCT02372097|11226166|FG000|COMPLETED|First Intervention Period (8 Days)||12
10097167|NCT02372097|11226167|FG001|COMPLETED|First Intervention Period (8 Days)||12
10097168|NCT02372097|11226166|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0
10097169|NCT02372097|11226167|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
10097170|NCT02372097|11226166|FG000|STARTED|Wash Out Period (13 Days)||12
10097171|NCT02372097|11226167|FG001|STARTED|Wash Out Period (13 Days)||12
10097172|NCT02372097|11226166|FG000|COMPLETED|Wash Out Period (13 Days)||12
9873800|NCT00995774|10988375|FG000|STARTED|Training Period 1||7
9873801|NCT00995774|10988376|FG001|STARTED|Training Period 1||5
9873802|NCT00995774|10988375|FG000|COMPLETED|Training Period 1||7
10097173|NCT02372097|11226167|FG001|COMPLETED|Wash Out Period (13 Days)||12
10097174|NCT02372097|11226166|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0
10097175|NCT02372097|11226167|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0
10113075|NCT02508103|11243997|FG000|STARTED|Overall Study||5
9873803|NCT00995774|10988376|FG001|COMPLETED|Training Period 1||5
9873804|NCT00995774|10988375|FG000|NOT COMPLETED|Training Period 1||0
9873805|NCT00995774|10988376|FG001|NOT COMPLETED|Training Period 1||0
9873806|NCT00995774|10988375|FG000|STARTED|Washout Period||7
9873807|NCT00995774|10988376|FG001|STARTED|Washout Period||5
9873808|NCT00995774|10988375|FG000|COMPLETED|Washout Period||7
9873809|NCT00995774|10988376|FG001|COMPLETED|Washout Period||5
9873810|NCT00995774|10988375|FG000|NOT COMPLETED|Washout Period||0
9873811|NCT00995774|10988376|FG001|NOT COMPLETED|Washout Period||0
9873812|NCT00995774|10988375|FG000|STARTED|Training Period 2||7
9873813|NCT00995774|10988376|FG001|STARTED|Training Period 2||5
9873814|NCT00995774|10988375|FG000|COMPLETED|Training Period 2||5
9873815|NCT00995774|10988376|FG001|COMPLETED|Training Period 2||5
9873816|NCT00995774|10988375|FG000|NOT COMPLETED|Training Period 2||2
9873817|NCT00995774|10988376|FG001|NOT COMPLETED|Training Period 2||0
9873818|NCT00995865|10988385|FG000|STARTED|Overall Study||24
9873819|NCT00995865|10988386|FG001|STARTED|Overall Study||24
9873820|NCT00995865|10988387|FG002|STARTED|Overall Study||12
9873821|NCT00995865|10988385|FG000|COMPLETED|Overall Study||22
9873822|NCT00995865|10988386|FG001|COMPLETED|Overall Study||24
9873823|NCT00995865|10988387|FG002|COMPLETED|Overall Study||11
9873824|NCT00995865|10988385|FG000|NOT COMPLETED|Overall Study||2
9873825|NCT00995865|10988386|FG001|NOT COMPLETED|Overall Study||0
9873826|NCT00995865|10988387|FG002|NOT COMPLETED|Overall Study||1
9873827|NCT00995904|10988400|FG000|STARTED|Visit 2 (Randomization)||4
9873828|NCT00995904|10988401|FG001|STARTED|Visit 2 (Randomization)||3
9873829|NCT00995904|10988402|FG002|STARTED|Visit 2 (Randomization)||4
9873830|NCT00995904|10988403|FG003|STARTED|Visit 2 (Randomization)||5
9873831|NCT00995904|10988404|FG004|STARTED|Visit 2 (Randomization)||5
9873832|NCT00995904|10988405|FG005|STARTED|Visit 2 (Randomization)||4
9873833|NCT00995904|10988400|FG000|COMPLETED|Visit 2 (Randomization)||4
9873834|NCT00995904|10988401|FG001|COMPLETED|Visit 2 (Randomization)||3
9873835|NCT00995904|10988402|FG002|COMPLETED|Visit 2 (Randomization)||4
9873836|NCT00995904|10988403|FG003|COMPLETED|Visit 2 (Randomization)||5
9873837|NCT00995904|10988404|FG004|COMPLETED|Visit 2 (Randomization)||5
9873838|NCT00995904|10988405|FG005|COMPLETED|Visit 2 (Randomization)||4
9873839|NCT00995904|10988400|FG000|NOT COMPLETED|Visit 2 (Randomization)||0
9873840|NCT00995904|10988401|FG001|NOT COMPLETED|Visit 2 (Randomization)||0
9873841|NCT00995904|10988402|FG002|NOT COMPLETED|Visit 2 (Randomization)||0
9873842|NCT00995904|10988403|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
9873843|NCT00995904|10988404|FG004|NOT COMPLETED|Visit 2 (Randomization)||0
9873844|NCT00995904|10988405|FG005|NOT COMPLETED|Visit 2 (Randomization)||0
9873845|NCT00995904|10988400|FG000|STARTED|Visit 3||4
9873846|NCT00995904|10988401|FG001|STARTED|Visit 3||3
9873847|NCT00995904|10988402|FG002|STARTED|Visit 3||4
9873848|NCT00995904|10988403|FG003|STARTED|Visit 3||5
9873849|NCT00995904|10988404|FG004|STARTED|Visit 3||5
9873850|NCT00995904|10988405|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
9873851|NCT00995904|10988400|FG000|COMPLETED|Visit 3||4
9873852|NCT00995904|10988401|FG001|COMPLETED|Visit 3||3
9873853|NCT00995904|10988402|FG002|COMPLETED|Visit 3||4
9873854|NCT00995904|10988403|FG003|COMPLETED|Visit 3||5
9873855|NCT00995904|10988404|FG004|COMPLETED|Visit 3||5
9873856|NCT00995904|10988405|FG005|COMPLETED|Visit 3||3
9873857|NCT00995904|10988400|FG000|NOT COMPLETED|Visit 3||0
9873858|NCT00995904|10988401|FG001|NOT COMPLETED|Visit 3||0
9873859|NCT00995904|10988402|FG002|NOT COMPLETED|Visit 3||0
9873860|NCT00995904|10988403|FG003|NOT COMPLETED|Visit 3||0
9873861|NCT00995904|10988404|FG004|NOT COMPLETED|Visit 3||0
9873862|NCT00995904|10988405|FG005|NOT COMPLETED|Visit 3||0
9873863|NCT00995904|10988400|FG000|STARTED|Visit 4||4
9873864|NCT00995904|10988401|FG001|STARTED|Visit 4||3
9873865|NCT00995904|10988402|FG002|STARTED|Visit 4||4
9873866|NCT00995904|10988403|FG003|STARTED|Visit 4||5
9873867|NCT00995904|10988404|FG004|STARTED|Visit 4||5
9873868|NCT00995904|10988405|FG005|STARTED|Visit 4||3
9873869|NCT00995904|10988400|FG000|COMPLETED|Visit 4||4
9873870|NCT00995904|10988401|FG001|COMPLETED|Visit 4||3
9873871|NCT00995904|10988402|FG002|COMPLETED|Visit 4||4
9873872|NCT00995904|10988403|FG003|COMPLETED|Visit 4||5
9873873|NCT00995904|10988404|FG004|COMPLETED|Visit 4||5
9873874|NCT00995904|10988405|FG005|COMPLETED|Visit 4||3
9873875|NCT00995904|10988400|FG000|NOT COMPLETED|Visit 4||0
9873876|NCT00995904|10988401|FG001|NOT COMPLETED|Visit 4||0
9873877|NCT00995904|10988402|FG002|NOT COMPLETED|Visit 4||0
9873878|NCT00995904|10988403|FG003|NOT COMPLETED|Visit 4||0
9873879|NCT00995904|10988404|FG004|NOT COMPLETED|Visit 4||0
9873880|NCT00995904|10988405|FG005|NOT COMPLETED|Visit 4||0
9873881|NCT00995904|10988400|FG000|STARTED|Follow-up Visit (Final Visit)||4
9873882|NCT00995904|10988401|FG001|STARTED|Follow-up Visit (Final Visit)||3
9873883|NCT00995904|10988402|FG002|STARTED|Follow-up Visit (Final Visit)||4
9873884|NCT00995904|10988403|FG003|STARTED|Follow-up Visit (Final Visit)||5
9873885|NCT00995904|10988404|FG004|STARTED|Follow-up Visit (Final Visit)||5
9873886|NCT00995904|10988405|FG005|STARTED|Follow-up Visit (Final Visit)||3
9873887|NCT00995904|10988400|FG000|COMPLETED|Follow-up Visit (Final Visit)||4
9873888|NCT00995904|10988401|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
9873889|NCT00995904|10988402|FG002|COMPLETED|Follow-up Visit (Final Visit)||4
9873890|NCT00995904|10988403|FG003|COMPLETED|Follow-up Visit (Final Visit)||5
9873891|NCT00995904|10988404|FG004|COMPLETED|Follow-up Visit (Final Visit)||5
9873892|NCT00995904|10988405|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
9873893|NCT00995904|10988400|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9957088|NCT01449370|11076238|FG003|NOT COMPLETED|Overall Study||4
9873894|NCT00995904|10988401|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9873895|NCT00995904|10988402|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9873896|NCT00995904|10988403|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9873897|NCT00995904|10988404|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9873898|NCT00995904|10988405|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9873899|NCT00995930|10988418|FG000|STARTED|Overall Study||94
9873900|NCT00995930|10988419|FG001|STARTED|Overall Study||95
9873901|NCT00995930|10988418|FG000|Safety Analysis Set|Overall Study||94
9873902|NCT00995930|10988419|FG001|Safety Analysis Set|Overall Study||95
9873903|NCT00995930|10988418|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
9873904|NCT00995930|10988419|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95
9873905|NCT00995930|10988418|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92
9873906|NCT00995930|10988419|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92
9873907|NCT00995930|10988418|FG000|Imaging Analysis Set|Overall Study||92
9873908|NCT00995930|10988419|FG001|Imaging Analysis Set|Overall Study||92
9873909|NCT00995930|10988418|FG000|COMPLETED|Overall Study||73
9873910|NCT00995930|10988419|FG001|COMPLETED|Overall Study||67
9873911|NCT00995930|10988418|FG000|NOT COMPLETED|Overall Study||21
9873912|NCT00995930|10988419|FG001|NOT COMPLETED|Overall Study||28
9873913|NCT00996034|10988426|FG000|STARTED|Overall Study||14
9873914|NCT00996034|10988426|FG000|COMPLETED|Overall Study||11
9873915|NCT00996034|10988426|FG000|NOT COMPLETED|Overall Study||3
9873916|NCT00996125|10988432|FG000|STARTED|Overall Study||374
9873917|NCT00996125|10988433|FG001|STARTED|Overall Study||376
9873918|NCT00996125|10988432|FG000|COMPLETED|Overall Study||369
9873919|NCT00996125|10988433|FG001|COMPLETED|Overall Study||365
9873920|NCT00996125|10988432|FG000|NOT COMPLETED|Overall Study||5
9873921|NCT00996125|10988433|FG001|NOT COMPLETED|Overall Study||11
9873922|NCT00996164|10988441|FG000|STARTED|Overall Study||543
9873923|NCT00996164|10988442|FG001|STARTED|Overall Study||547
9873924|NCT00996164|10988441|FG000|COMPLETED|Overall Study||408
9873925|NCT00996164|10988442|FG001|COMPLETED|Overall Study||446
9873926|NCT00996164|10988441|FG000|NOT COMPLETED|Overall Study||135
9873927|NCT00996164|10988442|FG001|NOT COMPLETED|Overall Study||101
9873928|NCT00996203|10988448|FG000|STARTED|Overall Study||201
9873929|NCT00996203|10988448|FG000|COMPLETED|Overall Study||194
9873930|NCT00996203|10988448|FG000|NOT COMPLETED|Overall Study||7
9873931|NCT00996216|10988453|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
9873932|NCT00996216|10988453|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
9873933|NCT00996216|10988453|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
9873934|NCT00996216|10988453|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
9873935|NCT00996216|10988453|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
9873936|NCT00996216|10988453|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
9873937|NCT00996281|10988460|FG000|STARTED|Overall Study||418
9873938|NCT00996281|10988461|FG001|STARTED|Overall Study||419
9873939|NCT00996281|10988460|FG000|COMPLETED|Overall Study||287
9873940|NCT00996281|10988461|FG001|COMPLETED|Overall Study||330
9873941|NCT00996281|10988460|FG000|NOT COMPLETED|Overall Study||131
9873942|NCT00996281|10988461|FG001|NOT COMPLETED|Overall Study||89
9873943|NCT00996307|10988471|FG000|STARTED|Overall Study||164
9873944|NCT00996307|10988472|FG001|STARTED|Overall Study||165
9873945|NCT00996307|10988473|FG002|STARTED|Overall Study||160
9873946|NCT00996307|10988474|FG003|STARTED|Overall Study||165
9873947|NCT00996307|10988471|FG000|COMPLETED|Overall Study||144
9873948|NCT00996307|10988472|FG001|COMPLETED|Overall Study||148
9873949|NCT00996307|10988473|FG002|COMPLETED|Overall Study||146
9873950|NCT00996307|10988474|FG003|COMPLETED|Overall Study||144
9873951|NCT00996307|10988471|FG000|NOT COMPLETED|Overall Study||20
9873952|NCT00996307|10988472|FG001|NOT COMPLETED|Overall Study||17
9873953|NCT00996307|10988473|FG002|NOT COMPLETED|Overall Study||14
9873954|NCT00996307|10988474|FG003|NOT COMPLETED|Overall Study||21
9873955|NCT00996346|10988505|FG000|STARTED|Overall Study||6
9873956|NCT00996346|10988506|FG001|STARTED|Overall Study||8
9873957|NCT00996346|10988507|FG002|STARTED|Overall Study||3
9873958|NCT00996346|10988505|FG000|COMPLETED|Overall Study||6
9873959|NCT00996346|10988506|FG001|COMPLETED|Overall Study||8
9873960|NCT00996346|10988507|FG002|COMPLETED|Overall Study||3
9873961|NCT00996346|10988505|FG000|NOT COMPLETED|Overall Study||0
9873962|NCT00996346|10988506|FG001|NOT COMPLETED|Overall Study||0
9873963|NCT00996346|10988507|FG002|NOT COMPLETED|Overall Study||0
9873964|NCT00996372|10988515|FG000|STARTED|Overall Study||468
9873965|NCT00996372|10988516|FG001|STARTED|Overall Study||481
9873966|NCT00996372|10988515|FG000|COMPLETED|Overall Study||365
9873967|NCT00996372|10988516|FG001|COMPLETED|Overall Study||397
9873968|NCT00996372|10988515|FG000|NOT COMPLETED|Overall Study||103
9873969|NCT00996372|10988516|FG001|NOT COMPLETED|Overall Study||84
9873970|NCT00996437|10988526|FG000|STARTED|Overall Study||125
9873971|NCT00996437|10988527|FG001|STARTED|Overall Study||136
9873972|NCT00996437|10988526|FG000|COMPLETED|Overall Study||120
9873973|NCT00996437|10988527|FG001|COMPLETED|Overall Study||129
9873974|NCT00996437|10988526|FG000|NOT COMPLETED|Overall Study||5
9873975|NCT00996437|10988527|FG001|NOT COMPLETED|Overall Study||7
9873976|NCT00996476|10988538|FG000|STARTED|Overall Study||27
9873977|NCT00996476|10988539|FG001|STARTED|Overall Study||26
9873978|NCT00996476|10988540|FG002|STARTED|Overall Study||13
9873979|NCT00996476|10988541|FG003|STARTED|Overall Study||13
9873980|NCT00996476|10988542|FG004|STARTED|Overall Study||13
9873981|NCT00996476|10988538|FG000|COMPLETED|Overall Study||26
9873982|NCT00996476|10988539|FG001|COMPLETED|Overall Study||23
9873983|NCT00996476|10988540|FG002|COMPLETED|Overall Study||12
9873984|NCT00996476|10988541|FG003|COMPLETED|Overall Study||13
9873985|NCT00996476|10988542|FG004|COMPLETED|Overall Study||11
9873986|NCT00996476|10988538|FG000|NOT COMPLETED|Overall Study||1
9873987|NCT00996476|10988539|FG001|NOT COMPLETED|Overall Study||3
9873988|NCT00996476|10988540|FG002|NOT COMPLETED|Overall Study||1
9873989|NCT00996476|10988541|FG003|NOT COMPLETED|Overall Study||0
9873990|NCT00996476|10988542|FG004|NOT COMPLETED|Overall Study||2
9873991|NCT00996489|10988559|FG000|STARTED|Overall Study||459
9873992|NCT00996489|10988559|FG000|COMPLETED|Overall Study||298
9873993|NCT00996489|10988559|FG000|NOT COMPLETED|Overall Study||161
9873994|NCT00996580|10988563|FG000|STARTED|Overall Study||3597
9873995|NCT00996580|10988563|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019
9873996|NCT00996580|10988563|FG000|COMPLETED|Overall Study||2144
9873997|NCT00996580|10988563|FG000|NOT COMPLETED|Overall Study||1453
9873998|NCT00996593|10988570|FG000|STARTED|Dosimetric and Therapeutic Treatment||43
9873999|NCT00996593|10988570|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
9874000|NCT00996593|10988570|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
9874001|NCT00996593|10988570|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
9874002|NCT00996593|10988570|FG000|COMPLETED|Long-Term Follow-Up||6
9874003|NCT00996593|10988570|FG000|NOT COMPLETED|Long-Term Follow-Up||3
9874004|NCT00996606|10988574|FG000|STARTED|Overall Study||58
9874005|NCT00996606|10988574|FG000|COMPLETED|Overall Study||50
9874006|NCT00996606|10988574|FG000|NOT COMPLETED|Overall Study||8
9874007|NCT00996632|10988580|FG000|STARTED|Overall Study||38
9874008|NCT00996632|10988581|FG001|STARTED|Overall Study||56
9874009|NCT00996632|10988580|FG000|COMPLETED|Overall Study||38
9874010|NCT00996632|10988581|FG001|COMPLETED|Overall Study||56
9874011|NCT00996632|10988580|FG000|NOT COMPLETED|Overall Study||0
9874012|NCT00996632|10988581|FG001|NOT COMPLETED|Overall Study||0
9874013|NCT00996658|10988589|FG000|STARTED|Overall Study||92
9874014|NCT00996658|10988590|FG001|STARTED|Overall Study||186
9874015|NCT00996658|10988589|FG000|COMPLETED|Overall Study||76
9874016|NCT00996658|10988590|FG001|COMPLETED|Overall Study||165
9874017|NCT00996658|10988589|FG000|NOT COMPLETED|Overall Study||16
9874018|NCT00996658|10988590|FG001|NOT COMPLETED|Overall Study||21
9874019|NCT00996736|10988598|FG000|STARTED|Overall Study||162
9874020|NCT00996736|10988599|FG001|STARTED|Overall Study||161
9874021|NCT00996736|10988598|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
9874022|NCT00996736|10988599|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
9874023|NCT00996736|10988598|FG000|3-month Visit|Overall Study||146
9874024|NCT00996736|10988599|FG001|3-month Visit|Overall Study||146
9874025|NCT00996736|10988598|FG000|COMPLETED|Overall Study||141
9874026|NCT00996736|10988599|FG001|COMPLETED|Overall Study||143
9874027|NCT00996736|10988598|FG000|NOT COMPLETED|Overall Study||21
9874028|NCT00996736|10988599|FG001|NOT COMPLETED|Overall Study||18
9874029|NCT00996775|10988607|FG000|STARTED|Overall Study||78
9874030|NCT00996775|10988608|FG001|STARTED|Overall Study||89
9874031|NCT00996775|10988607|FG000|COMPLETED|Overall Study||67
9874032|NCT00996775|10988608|FG001|COMPLETED|Overall Study||75
9874033|NCT00996775|10988607|FG000|NOT COMPLETED|Overall Study||11
9874034|NCT00996775|10988608|FG001|NOT COMPLETED|Overall Study||14
9874035|NCT00996801|10988620|FG000|STARTED|Overall Study||88
9874036|NCT00996801|10988621|FG001|STARTED|Overall Study||88
9874037|NCT00996801|10988622|FG002|STARTED|Overall Study||88
9874038|NCT00996801|10988623|FG003|STARTED|Overall Study||87
9874039|NCT00996801|10988624|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
9874040|NCT00996801|10988625|FG005|STARTED|Overall Study||87
9874041|NCT00996801|10988620|FG000|COMPLETED|Overall Study||68
9874042|NCT00996801|10988621|FG001|COMPLETED|Overall Study||72
9874043|NCT00996801|10988622|FG002|COMPLETED|Overall Study||65
9874044|NCT00996801|10988623|FG003|COMPLETED|Overall Study||56
9874045|NCT00996801|10988624|FG004|COMPLETED|Overall Study||0
9874046|NCT00996801|10988625|FG005|COMPLETED|Overall Study||68
9874047|NCT00996801|10988620|FG000|NOT COMPLETED|Overall Study||20
9874048|NCT00996801|10988621|FG001|NOT COMPLETED|Overall Study||16
9874049|NCT00996801|10988622|FG002|NOT COMPLETED|Overall Study||23
9874050|NCT00996801|10988623|FG003|NOT COMPLETED|Overall Study||31
9874051|NCT00996801|10988624|FG004|NOT COMPLETED|Overall Study||88
9874052|NCT00996801|10988625|FG005|NOT COMPLETED|Overall Study||19
9874053|NCT00996840|10988646|FG000|STARTED|Overall Study||20
9874054|NCT00996840|10988647|FG001|STARTED|Overall Study||9
9874055|NCT00996840|10988648|FG002|STARTED|Overall Study||12
9874056|NCT00996840|10988649|FG003|STARTED|Overall Study||18
9874057|NCT00996840|10988650|FG004|STARTED|Overall Study||18
9874058|NCT00996840|10988646|FG000|COMPLETED|Overall Study||19
9874059|NCT00996840|10988647|FG001|COMPLETED|Overall Study||7
9874060|NCT00996840|10988648|FG002|COMPLETED|Overall Study||11
9874061|NCT00996840|10988649|FG003|COMPLETED|Overall Study||17
9874062|NCT00996840|10988650|FG004|COMPLETED|Overall Study||16
9874063|NCT00996840|10988646|FG000|NOT COMPLETED|Overall Study||1
9874064|NCT00996840|10988647|FG001|NOT COMPLETED|Overall Study||2
9874065|NCT00996840|10988648|FG002|NOT COMPLETED|Overall Study||1
9874066|NCT00996840|10988649|FG003|NOT COMPLETED|Overall Study||1
9874067|NCT00996840|10988650|FG004|NOT COMPLETED|Overall Study||2
9874068|NCT00996892|10988666|FG000|STARTED|Dose-Escalation Stage 1||4
9874069|NCT00996892|10988667|FG001|STARTED|Dose-Escalation Stage 1||3
9874070|NCT00996892|10988668|FG002|STARTED|Dose-Escalation Stage 1||3
9874071|NCT00996892|10988669|FG003|STARTED|Dose-Escalation Stage 1||9
9874072|NCT00996892|10988670|FG004|STARTED|Dose-Escalation Stage 1||11
9874073|NCT00996892|10988671|FG005|STARTED|Dose-Escalation Stage 1||10
9874074|NCT00996892|10988672|FG006|STARTED|Dose-Escalation Stage 1||4
9874075|NCT00996892|10988673|FG007|STARTED|Dose-Escalation Stage 1||0
9874076|NCT00996892|10988674|FG008|STARTED|Dose-Escalation Stage 1||0
9874077|NCT00996892|10988675|FG009|STARTED|Dose-Escalation Stage 1||0
9874078|NCT00996892|10988676|FG010|STARTED|Dose-Escalation Stage 1||0
9874079|NCT00996892|10988677|FG011|STARTED|Dose-Escalation Stage 1||0
9874080|NCT00996892|10988678|FG012|STARTED|Dose-Escalation Stage 1||0
9874081|NCT00996892|10988679|FG013|STARTED|Dose-Escalation Stage 1||0
9874082|NCT00996892|10988680|FG014|STARTED|Dose-Escalation Stage 1||0
9874083|NCT00996892|10988681|FG015|STARTED|Dose-Escalation Stage 1||0
9874084|NCT00996892|10988682|FG016|STARTED|Dose-Escalation Stage 1||0
9874085|NCT00996892|10988683|FG017|STARTED|Dose-Escalation Stage 1||0
9874086|NCT00996892|10988684|FG018|STARTED|Dose-Escalation Stage 1||0
9874087|NCT00996892|10988685|FG019|STARTED|Dose-Escalation Stage 1||0
9874088|NCT00996892|10988666|FG000|COMPLETED|Dose-Escalation Stage 1||0
9874089|NCT00996892|10988667|FG001|COMPLETED|Dose-Escalation Stage 1||0
9874090|NCT00996892|10988668|FG002|COMPLETED|Dose-Escalation Stage 1||0
9874091|NCT00996892|10988669|FG003|COMPLETED|Dose-Escalation Stage 1||0
9874092|NCT00996892|10988670|FG004|COMPLETED|Dose-Escalation Stage 1||0
9874093|NCT00996892|10988671|FG005|COMPLETED|Dose-Escalation Stage 1||0
9874094|NCT00996892|10988672|FG006|COMPLETED|Dose-Escalation Stage 1||0
9874095|NCT00996892|10988673|FG007|COMPLETED|Dose-Escalation Stage 1||0
9874096|NCT00996892|10988674|FG008|COMPLETED|Dose-Escalation Stage 1||0
9874097|NCT00996892|10988675|FG009|COMPLETED|Dose-Escalation Stage 1||0
9874098|NCT00996892|10988676|FG010|COMPLETED|Dose-Escalation Stage 1||0
9874099|NCT00996892|10988677|FG011|COMPLETED|Dose-Escalation Stage 1||0
9874100|NCT00996892|10988678|FG012|COMPLETED|Dose-Escalation Stage 1||0
9874101|NCT00996892|10988679|FG013|COMPLETED|Dose-Escalation Stage 1||0
9874102|NCT00996892|10988680|FG014|COMPLETED|Dose-Escalation Stage 1||0
9874103|NCT00996892|10988681|FG015|COMPLETED|Dose-Escalation Stage 1||0
9874104|NCT00996892|10988682|FG016|COMPLETED|Dose-Escalation Stage 1||0
9874105|NCT00996892|10988683|FG017|COMPLETED|Dose-Escalation Stage 1||0
9874106|NCT00996892|10988684|FG018|COMPLETED|Dose-Escalation Stage 1||0
9874107|NCT00996892|10988685|FG019|COMPLETED|Dose-Escalation Stage 1||0
9874108|NCT00996892|10988666|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4
9874109|NCT00996892|10988667|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3
9874110|NCT00996892|10988668|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3
9874111|NCT00996892|10988669|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9
9874112|NCT00996892|10988670|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11
9874113|NCT00996892|10988671|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10
9874114|NCT00996892|10988672|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4
9874115|NCT00996892|10988673|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0
9874116|NCT00996892|10988674|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0
9874117|NCT00996892|10988675|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0
9874118|NCT00996892|10988676|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0
9874119|NCT00996892|10988677|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0
9874120|NCT00996892|10988678|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0
9874121|NCT00996892|10988679|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0
9874122|NCT00996892|10988680|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0
9874123|NCT00996892|10988681|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0
9874124|NCT00996892|10988682|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0
9874125|NCT00996892|10988683|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0
9874126|NCT00996892|10988684|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0
9874127|NCT00996892|10988685|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0
9874128|NCT00996892|10988666|FG000|STARTED|Dose-Escalation Stage 1A||0
9874129|NCT00996892|10988667|FG001|STARTED|Dose-Escalation Stage 1A||0
9874130|NCT00996892|10988668|FG002|STARTED|Dose-Escalation Stage 1A||0
9874131|NCT00996892|10988669|FG003|STARTED|Dose-Escalation Stage 1A||0
9874132|NCT00996892|10988670|FG004|STARTED|Dose-Escalation Stage 1A||0
9874133|NCT00996892|10988671|FG005|STARTED|Dose-Escalation Stage 1A||0
9874134|NCT00996892|10988672|FG006|STARTED|Dose-Escalation Stage 1A||0
9874135|NCT00996892|10988673|FG007|STARTED|Dose-Escalation Stage 1A||3
9874136|NCT00996892|10988674|FG008|STARTED|Dose-Escalation Stage 1A||3
9874137|NCT00996892|10988675|FG009|STARTED|Dose-Escalation Stage 1A||4
9874138|NCT00996892|10988676|FG010|STARTED|Dose-Escalation Stage 1A||7
9874139|NCT00996892|10988677|FG011|STARTED|Dose-Escalation Stage 1A||9
9874140|NCT00996892|10988678|FG012|STARTED|Dose-Escalation Stage 1A||8
9874141|NCT00996892|10988679|FG013|STARTED|Dose-Escalation Stage 1A||5
9874142|NCT00996892|10988680|FG014|STARTED|Dose-Escalation Stage 1A||0
9874143|NCT00996892|10988681|FG015|STARTED|Dose-Escalation Stage 1A||0
9874144|NCT00996892|10988682|FG016|STARTED|Dose-Escalation Stage 1A||0
9874145|NCT00996892|10988683|FG017|STARTED|Dose-Escalation Stage 1A||0
9874146|NCT00996892|10988684|FG018|STARTED|Dose-Escalation Stage 1A||0
9874147|NCT00996892|10988685|FG019|STARTED|Dose-Escalation Stage 1A||0
9874148|NCT00996892|10988666|FG000|COMPLETED|Dose-Escalation Stage 1A||0
9874149|NCT00996892|10988667|FG001|COMPLETED|Dose-Escalation Stage 1A||0
9874150|NCT00996892|10988668|FG002|COMPLETED|Dose-Escalation Stage 1A||0
9874151|NCT00996892|10988669|FG003|COMPLETED|Dose-Escalation Stage 1A||0
9874152|NCT00996892|10988670|FG004|COMPLETED|Dose-Escalation Stage 1A||0
9874153|NCT00996892|10988671|FG005|COMPLETED|Dose-Escalation Stage 1A||0
9874154|NCT00996892|10988672|FG006|COMPLETED|Dose-Escalation Stage 1A||0
9874155|NCT00996892|10988673|FG007|COMPLETED|Dose-Escalation Stage 1A||0
9874156|NCT00996892|10988674|FG008|COMPLETED|Dose-Escalation Stage 1A||0
9874157|NCT00996892|10988675|FG009|COMPLETED|Dose-Escalation Stage 1A||0
9874158|NCT00996892|10988676|FG010|COMPLETED|Dose-Escalation Stage 1A||0
9874159|NCT00996892|10988677|FG011|COMPLETED|Dose-Escalation Stage 1A||0
9874160|NCT00996892|10988678|FG012|COMPLETED|Dose-Escalation Stage 1A||0
9874161|NCT00996892|10988679|FG013|COMPLETED|Dose-Escalation Stage 1A||0
9874162|NCT00996892|10988680|FG014|COMPLETED|Dose-Escalation Stage 1A||0
9874163|NCT00996892|10988681|FG015|COMPLETED|Dose-Escalation Stage 1A||0
9874164|NCT00996892|10988682|FG016|COMPLETED|Dose-Escalation Stage 1A||0
9874165|NCT00996892|10988683|FG017|COMPLETED|Dose-Escalation Stage 1A||0
9874166|NCT00996892|10988684|FG018|COMPLETED|Dose-Escalation Stage 1A||0
9874167|NCT00996892|10988685|FG019|COMPLETED|Dose-Escalation Stage 1A||0
9874168|NCT00996892|10988666|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874169|NCT00996892|10988667|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874170|NCT00996892|10988668|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874171|NCT00996892|10988669|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874172|NCT00996892|10988670|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874173|NCT00996892|10988671|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874174|NCT00996892|10988672|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874175|NCT00996892|10988673|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3
9874176|NCT00996892|10988674|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3
9874177|NCT00996892|10988675|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4
9874178|NCT00996892|10988676|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7
9874179|NCT00996892|10988677|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9
9874180|NCT00996892|10988678|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8
9874181|NCT00996892|10988679|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5
9874182|NCT00996892|10988680|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874183|NCT00996892|10988681|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874184|NCT00996892|10988682|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874185|NCT00996892|10988683|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874186|NCT00996892|10988684|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874187|NCT00996892|10988685|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0
9874188|NCT00996892|10988666|FG000|STARTED|Dose-Escalation Stage 1B||0
9874189|NCT00996892|10988667|FG001|STARTED|Dose-Escalation Stage 1B||0
9874190|NCT00996892|10988668|FG002|STARTED|Dose-Escalation Stage 1B||0
9874191|NCT00996892|10988669|FG003|STARTED|Dose-Escalation Stage 1B||0
9874192|NCT00996892|10988670|FG004|STARTED|Dose-Escalation Stage 1B||0
9874193|NCT00996892|10988671|FG005|STARTED|Dose-Escalation Stage 1B||0
9874194|NCT00996892|10988672|FG006|STARTED|Dose-Escalation Stage 1B||0
9874195|NCT00996892|10988673|FG007|STARTED|Dose-Escalation Stage 1B||0
9874196|NCT00996892|10988674|FG008|STARTED|Dose-Escalation Stage 1B||0
9874197|NCT00996892|10988675|FG009|STARTED|Dose-Escalation Stage 1B||0
9874198|NCT00996892|10988676|FG010|STARTED|Dose-Escalation Stage 1B||0
9874199|NCT00996892|10988677|FG011|STARTED|Dose-Escalation Stage 1B||0
9874200|NCT00996892|10988678|FG012|STARTED|Dose-Escalation Stage 1B||0
9874201|NCT00996892|10988679|FG013|STARTED|Dose-Escalation Stage 1B||0
9874202|NCT00996892|10988680|FG014|STARTED|Dose-Escalation Stage 1B||4
9874203|NCT00996892|10988681|FG015|STARTED|Dose-Escalation Stage 1B||3
9874204|NCT00996892|10988682|FG016|STARTED|Dose-Escalation Stage 1B||3
9874205|NCT00996892|10988683|FG017|STARTED|Dose-Escalation Stage 1B||5
9874206|NCT00996892|10988684|FG018|STARTED|Dose-Escalation Stage 1B||0
9874207|NCT00996892|10988685|FG019|STARTED|Dose-Escalation Stage 1B||0
9874208|NCT00996892|10988666|FG000|COMPLETED|Dose-Escalation Stage 1B||0
9874209|NCT00996892|10988667|FG001|COMPLETED|Dose-Escalation Stage 1B||0
9874210|NCT00996892|10988668|FG002|COMPLETED|Dose-Escalation Stage 1B||0
9874211|NCT00996892|10988669|FG003|COMPLETED|Dose-Escalation Stage 1B||0
9874212|NCT00996892|10988670|FG004|COMPLETED|Dose-Escalation Stage 1B||0
9874213|NCT00996892|10988671|FG005|COMPLETED|Dose-Escalation Stage 1B||0
9874214|NCT00996892|10988672|FG006|COMPLETED|Dose-Escalation Stage 1B||0
9874215|NCT00996892|10988673|FG007|COMPLETED|Dose-Escalation Stage 1B||0
9874216|NCT00996892|10988674|FG008|COMPLETED|Dose-Escalation Stage 1B||0
9874217|NCT00996892|10988675|FG009|COMPLETED|Dose-Escalation Stage 1B||0
9874218|NCT00996892|10988676|FG010|COMPLETED|Dose-Escalation Stage 1B||0
9874219|NCT00996892|10988677|FG011|COMPLETED|Dose-Escalation Stage 1B||0
9874220|NCT00996892|10988678|FG012|COMPLETED|Dose-Escalation Stage 1B||0
9874221|NCT00996892|10988679|FG013|COMPLETED|Dose-Escalation Stage 1B||0
9874222|NCT00996892|10988680|FG014|COMPLETED|Dose-Escalation Stage 1B||0
9874223|NCT00996892|10988681|FG015|COMPLETED|Dose-Escalation Stage 1B||0
9874224|NCT00996892|10988682|FG016|COMPLETED|Dose-Escalation Stage 1B||0
9874225|NCT00996892|10988683|FG017|COMPLETED|Dose-Escalation Stage 1B||0
9874226|NCT00996892|10988684|FG018|COMPLETED|Dose-Escalation Stage 1B||0
9874227|NCT00996892|10988685|FG019|COMPLETED|Dose-Escalation Stage 1B||0
9874228|NCT00996892|10988666|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874229|NCT00996892|10988667|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874230|NCT00996892|10988668|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874231|NCT00996892|10988669|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874232|NCT00996892|10988670|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874233|NCT00996892|10988671|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874234|NCT00996892|10988672|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874235|NCT00996892|10988673|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874236|NCT00996892|10988674|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874237|NCT00996892|10988675|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874238|NCT00996892|10988676|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874239|NCT00996892|10988677|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874240|NCT00996892|10988678|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874241|NCT00996892|10988679|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874242|NCT00996892|10988680|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4
9874243|NCT00996892|10988681|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3
9874244|NCT00996892|10988682|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3
9874245|NCT00996892|10988683|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5
9874246|NCT00996892|10988684|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874247|NCT00996892|10988685|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0
9874248|NCT00996892|10988666|FG000|STARTED|Expansion Stage 2||0
9874249|NCT00996892|10988667|FG001|STARTED|Expansion Stage 2||0
9874250|NCT00996892|10988668|FG002|STARTED|Expansion Stage 2||0
9874251|NCT00996892|10988669|FG003|STARTED|Expansion Stage 2||0
9874252|NCT00996892|10988670|FG004|STARTED|Expansion Stage 2||0
9874253|NCT00996892|10988671|FG005|STARTED|Expansion Stage 2||0
9874254|NCT00996892|10988672|FG006|STARTED|Expansion Stage 2||0
9874255|NCT00996892|10988673|FG007|STARTED|Expansion Stage 2||0
9874256|NCT00996892|10988674|FG008|STARTED|Expansion Stage 2||0
9874257|NCT00996892|10988675|FG009|STARTED|Expansion Stage 2||0
9874258|NCT00996892|10988676|FG010|STARTED|Expansion Stage 2||0
9874259|NCT00996892|10988677|FG011|STARTED|Expansion Stage 2||0
9874260|NCT00996892|10988678|FG012|STARTED|Expansion Stage 2||0
9874261|NCT00996892|10988679|FG013|STARTED|Expansion Stage 2||0
9874262|NCT00996892|10988680|FG014|STARTED|Expansion Stage 2||0
9874263|NCT00996892|10988681|FG015|STARTED|Expansion Stage 2||0
9874264|NCT00996892|10988682|FG016|STARTED|Expansion Stage 2||0
9874265|NCT00996892|10988683|FG017|STARTED|Expansion Stage 2||0
9874266|NCT00996892|10988684|FG018|STARTED|Expansion Stage 2||35
9874267|NCT00996892|10988685|FG019|STARTED|Expansion Stage 2||0
9874268|NCT00996892|10988666|FG000|COMPLETED|Expansion Stage 2||0
9874269|NCT00996892|10988667|FG001|COMPLETED|Expansion Stage 2||0
9874270|NCT00996892|10988668|FG002|COMPLETED|Expansion Stage 2||0
9874271|NCT00996892|10988669|FG003|COMPLETED|Expansion Stage 2||0
9874272|NCT00996892|10988670|FG004|COMPLETED|Expansion Stage 2||0
9874273|NCT00996892|10988671|FG005|COMPLETED|Expansion Stage 2||0
9874274|NCT00996892|10988672|FG006|COMPLETED|Expansion Stage 2||0
9874275|NCT00996892|10988673|FG007|COMPLETED|Expansion Stage 2||0
9874276|NCT00996892|10988674|FG008|COMPLETED|Expansion Stage 2||0
9874277|NCT00996892|10988675|FG009|COMPLETED|Expansion Stage 2||0
9874278|NCT00996892|10988676|FG010|COMPLETED|Expansion Stage 2||0
9874279|NCT00996892|10988677|FG011|COMPLETED|Expansion Stage 2||0
9874280|NCT00996892|10988678|FG012|COMPLETED|Expansion Stage 2||0
9874281|NCT00996892|10988679|FG013|COMPLETED|Expansion Stage 2||0
9874282|NCT00996892|10988680|FG014|COMPLETED|Expansion Stage 2||0
9874283|NCT00996892|10988681|FG015|COMPLETED|Expansion Stage 2||0
9874284|NCT00996892|10988682|FG016|COMPLETED|Expansion Stage 2||0
9874285|NCT00996892|10988683|FG017|COMPLETED|Expansion Stage 2||0
9874286|NCT00996892|10988684|FG018|COMPLETED|Expansion Stage 2||0
9874287|NCT00996892|10988685|FG019|COMPLETED|Expansion Stage 2||0
9874288|NCT00996892|10988666|FG000|NOT COMPLETED|Expansion Stage 2||0
9874289|NCT00996892|10988667|FG001|NOT COMPLETED|Expansion Stage 2||0
9874290|NCT00996892|10988668|FG002|NOT COMPLETED|Expansion Stage 2||0
9874291|NCT00996892|10988669|FG003|NOT COMPLETED|Expansion Stage 2||0
9874292|NCT00996892|10988670|FG004|NOT COMPLETED|Expansion Stage 2||0
9874293|NCT00996892|10988671|FG005|NOT COMPLETED|Expansion Stage 2||0
9874294|NCT00996892|10988672|FG006|NOT COMPLETED|Expansion Stage 2||0
9874295|NCT00996892|10988673|FG007|NOT COMPLETED|Expansion Stage 2||0
9874296|NCT00996892|10988674|FG008|NOT COMPLETED|Expansion Stage 2||0
9874297|NCT00996892|10988675|FG009|NOT COMPLETED|Expansion Stage 2||0
9874298|NCT00996892|10988676|FG010|NOT COMPLETED|Expansion Stage 2||0
9874299|NCT00996892|10988677|FG011|NOT COMPLETED|Expansion Stage 2||0
9874300|NCT00996892|10988678|FG012|NOT COMPLETED|Expansion Stage 2||0
10097176|NCT02372097|11226166|FG000|STARTED|Second Intervention Period (8 Days)||12
10097177|NCT02372097|11226167|FG001|STARTED|Second Intervention Period (8 Days)||12
10097178|NCT02372097|11226166|FG000|COMPLETED|Second Intervention Period (8 Days)||12
10097179|NCT02372097|11226167|FG001|COMPLETED|Second Intervention Period (8 Days)||12
10097180|NCT02372097|11226166|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
10097181|NCT02372097|11226167|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
10097182|NCT02372253|11226175|FG000|STARTED|Overall Study||13
9874301|NCT00996892|10988679|FG013|NOT COMPLETED|Expansion Stage 2||0
9874302|NCT00996892|10988680|FG014|NOT COMPLETED|Expansion Stage 2||0
9874303|NCT00996892|10988681|FG015|NOT COMPLETED|Expansion Stage 2||0
9874304|NCT00996892|10988682|FG016|NOT COMPLETED|Expansion Stage 2||0
9874305|NCT00996892|10988683|FG017|NOT COMPLETED|Expansion Stage 2||0
9874306|NCT00996892|10988684|FG018|NOT COMPLETED|Expansion Stage 2||35
9874307|NCT00996892|10988685|FG019|NOT COMPLETED|Expansion Stage 2||0
9874308|NCT00996892|10988666|FG000|STARTED|Expansion Stage 2A||0
9874309|NCT00996892|10988667|FG001|STARTED|Expansion Stage 2A||0
9874310|NCT00996892|10988668|FG002|STARTED|Expansion Stage 2A||0
9874311|NCT00996892|10988669|FG003|STARTED|Expansion Stage 2A||0
9874312|NCT00996892|10988670|FG004|STARTED|Expansion Stage 2A||0
9874313|NCT00996892|10988671|FG005|STARTED|Expansion Stage 2A||0
9874314|NCT00996892|10988672|FG006|STARTED|Expansion Stage 2A||0
9874315|NCT00996892|10988673|FG007|STARTED|Expansion Stage 2A||0
9874316|NCT00996892|10988674|FG008|STARTED|Expansion Stage 2A||0
9874317|NCT00996892|10988675|FG009|STARTED|Expansion Stage 2A||0
9874318|NCT00996892|10988676|FG010|STARTED|Expansion Stage 2A||0
9874319|NCT00996892|10988677|FG011|STARTED|Expansion Stage 2A||0
9874320|NCT00996892|10988678|FG012|STARTED|Expansion Stage 2A||0
9874321|NCT00996892|10988679|FG013|STARTED|Expansion Stage 2A||0
9874322|NCT00996892|10988680|FG014|STARTED|Expansion Stage 2A||0
9874323|NCT00996892|10988681|FG015|STARTED|Expansion Stage 2A||0
9874324|NCT00996892|10988682|FG016|STARTED|Expansion Stage 2A||0
9874325|NCT00996892|10988683|FG017|STARTED|Expansion Stage 2A||0
9874326|NCT00996892|10988684|FG018|STARTED|Expansion Stage 2A||0
9874327|NCT00996892|10988685|FG019|STARTED|Expansion Stage 2A||45
9874328|NCT00996892|10988666|FG000|COMPLETED|Expansion Stage 2A||0
9874329|NCT00996892|10988667|FG001|COMPLETED|Expansion Stage 2A||0
9874330|NCT00996892|10988668|FG002|COMPLETED|Expansion Stage 2A||0
9874331|NCT00996892|10988669|FG003|COMPLETED|Expansion Stage 2A||0
9874332|NCT00996892|10988670|FG004|COMPLETED|Expansion Stage 2A||0
9874333|NCT00996892|10988671|FG005|COMPLETED|Expansion Stage 2A||0
9874334|NCT00996892|10988672|FG006|COMPLETED|Expansion Stage 2A||0
9874335|NCT00996892|10988673|FG007|COMPLETED|Expansion Stage 2A||0
9874336|NCT00996892|10988674|FG008|COMPLETED|Expansion Stage 2A||0
9874337|NCT00996892|10988675|FG009|COMPLETED|Expansion Stage 2A||0
9874338|NCT00996892|10988676|FG010|COMPLETED|Expansion Stage 2A||0
9874339|NCT00996892|10988677|FG011|COMPLETED|Expansion Stage 2A||0
9874340|NCT00996892|10988678|FG012|COMPLETED|Expansion Stage 2A||0
9874341|NCT00996892|10988679|FG013|COMPLETED|Expansion Stage 2A||0
9874342|NCT00996892|10988680|FG014|COMPLETED|Expansion Stage 2A||0
9874343|NCT00996892|10988681|FG015|COMPLETED|Expansion Stage 2A||0
9874344|NCT00996892|10988682|FG016|COMPLETED|Expansion Stage 2A||0
9874345|NCT00996892|10988683|FG017|COMPLETED|Expansion Stage 2A||0
9874346|NCT00996892|10988684|FG018|COMPLETED|Expansion Stage 2A||0
9874347|NCT00996892|10988685|FG019|COMPLETED|Expansion Stage 2A||0
9874348|NCT00996892|10988666|FG000|NOT COMPLETED|Expansion Stage 2A||0
9874349|NCT00996892|10988667|FG001|NOT COMPLETED|Expansion Stage 2A||0
9874350|NCT00996892|10988668|FG002|NOT COMPLETED|Expansion Stage 2A||0
9874351|NCT00996892|10988669|FG003|NOT COMPLETED|Expansion Stage 2A||0
9874352|NCT00996892|10988670|FG004|NOT COMPLETED|Expansion Stage 2A||0
9874353|NCT00996892|10988671|FG005|NOT COMPLETED|Expansion Stage 2A||0
9874354|NCT00996892|10988672|FG006|NOT COMPLETED|Expansion Stage 2A||0
9874355|NCT00996892|10988673|FG007|NOT COMPLETED|Expansion Stage 2A||0
9874356|NCT00996892|10988674|FG008|NOT COMPLETED|Expansion Stage 2A||0
9874357|NCT00996892|10988675|FG009|NOT COMPLETED|Expansion Stage 2A||0
9874358|NCT00996892|10988676|FG010|NOT COMPLETED|Expansion Stage 2A||0
9874359|NCT00996892|10988677|FG011|NOT COMPLETED|Expansion Stage 2A||0
9874360|NCT00996892|10988678|FG012|NOT COMPLETED|Expansion Stage 2A||0
9874361|NCT00996892|10988679|FG013|NOT COMPLETED|Expansion Stage 2A||0
9874362|NCT00996892|10988680|FG014|NOT COMPLETED|Expansion Stage 2A||0
9874363|NCT00996892|10988681|FG015|NOT COMPLETED|Expansion Stage 2A||0
9874364|NCT00996892|10988682|FG016|NOT COMPLETED|Expansion Stage 2A||0
9874365|NCT00996892|10988683|FG017|NOT COMPLETED|Expansion Stage 2A||0
9874366|NCT00996892|10988684|FG018|NOT COMPLETED|Expansion Stage 2A||0
9874367|NCT00996892|10988685|FG019|NOT COMPLETED|Expansion Stage 2A||45
9874368|NCT00996918|10988751|FG000|STARTED|Overall Study||39
9874369|NCT00996918|10988752|FG001|STARTED|Overall Study||66
9874370|NCT00996918|10988753|FG002|STARTED|Overall Study||37
9874371|NCT00996918|10988754|FG003|STARTED|Overall Study||56
9874372|NCT00996918|10988755|FG004|STARTED|Overall Study||4
9874373|NCT00996918|10988751|FG000|Treated|Overall Study||39
9874374|NCT00996918|10988752|FG001|Treated|Overall Study||66
9874375|NCT00996918|10988753|FG002|Treated|Overall Study||37
9874376|NCT00996918|10988754|FG003|Treated|Overall Study||56
9874377|NCT00996918|10988755|FG004|Treated|Overall Study||4
9874378|NCT00996918|10988751|FG000|COMPLETED|Overall Study||0
9874379|NCT00996918|10988752|FG001|COMPLETED|Overall Study||0
9874380|NCT00996918|10988753|FG002|COMPLETED|Overall Study||0
9874381|NCT00996918|10988754|FG003|COMPLETED|Overall Study||0
9874382|NCT00996918|10988755|FG004|COMPLETED|Overall Study||0
9874383|NCT00996918|10988751|FG000|NOT COMPLETED|Overall Study||39
9874384|NCT00996918|10988752|FG001|NOT COMPLETED|Overall Study||66
9874385|NCT00996918|10988753|FG002|NOT COMPLETED|Overall Study||37
9874386|NCT00996918|10988754|FG003|NOT COMPLETED|Overall Study||56
9874387|NCT00996918|10988755|FG004|NOT COMPLETED|Overall Study||4
9874388|NCT00996931|10988767|FG000|STARTED|Overall Study||6
9874389|NCT00996931|10988767|FG000|COMPLETED|Overall Study||6
9874390|NCT00996931|10988767|FG000|NOT COMPLETED|Overall Study||0
9874391|NCT00996944|10988774|FG000|STARTED|Double-blind Treatment Period||22
9874392|NCT00996944|10988775|FG001|STARTED|Double-blind Treatment Period||12
9874393|NCT00996944|10988774|FG000|COMPLETED|Double-blind Treatment Period||12
9874394|NCT00996944|10988775|FG001|COMPLETED|Double-blind Treatment Period||5
9874395|NCT00996944|10988774|FG000|NOT COMPLETED|Double-blind Treatment Period||10
9874396|NCT00996944|10988775|FG001|NOT COMPLETED|Double-blind Treatment Period||7
9874397|NCT00996944|10988774|FG000|STARTED|Long-term Treatment Period||12
9874398|NCT00996944|10988775|FG001|STARTED|Long-term Treatment Period||5
9874399|NCT00996944|10988774|FG000|COMPLETED|Long-term Treatment Period||0
9874400|NCT00996944|10988775|FG001|COMPLETED|Long-term Treatment Period||0
9874401|NCT00996944|10988774|FG000|NOT COMPLETED|Long-term Treatment Period||12
9874402|NCT00996944|10988775|FG001|NOT COMPLETED|Long-term Treatment Period||5
9874403|NCT00996996|10988783|FG000|STARTED|Overall Study||77
9874404|NCT00996996|10988783|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
9874405|NCT00996996|10988783|FG000|NOT COMPLETED|Overall Study||33
9874406|NCT00997035|10988789|FG000|STARTED|3-week Followup Visit||121
9874407|NCT00997035|10988790|FG001|STARTED|3-week Followup Visit||119
9874408|NCT00997035|10988789|FG000|COMPLETED|3-week Followup Visit||112
9874409|NCT00997035|10988790|FG001|COMPLETED|3-week Followup Visit||113
9874410|NCT00997035|10988789|FG000|NOT COMPLETED|3-week Followup Visit||9
9874411|NCT00997035|10988790|FG001|NOT COMPLETED|3-week Followup Visit||6
9874412|NCT00997035|10988789|FG000|STARTED|3-month Follow-up Visit||112
9874413|NCT00997035|10988790|FG001|STARTED|3-month Follow-up Visit||113
9874414|NCT00997035|10988789|FG000|COMPLETED|3-month Follow-up Visit||100
9874415|NCT00997035|10988790|FG001|COMPLETED|3-month Follow-up Visit||107
9874416|NCT00997035|10988789|FG000|NOT COMPLETED|3-month Follow-up Visit||12
9874417|NCT00997035|10988790|FG001|NOT COMPLETED|3-month Follow-up Visit||6
9874418|NCT00997113|10988808|FG000|STARTED|Overall Study||10
9874419|NCT00997113|10988809|FG001|STARTED|Overall Study||10
9874420|NCT00997113|10988808|FG000|COMPLETED|Overall Study||10
9874421|NCT00997113|10988809|FG001|COMPLETED|Overall Study||10
9874422|NCT00997113|10988808|FG000|NOT COMPLETED|Overall Study||0
9874423|NCT00997113|10988809|FG001|NOT COMPLETED|Overall Study||0
9874424|NCT00997126|10988817|FG000|STARTED|Overall Study||63
9874425|NCT00997126|10988818|FG001|STARTED|Overall Study||63
9874426|NCT00997126|10988817|FG000|COMPLETED|Overall Study||56
9874427|NCT00997126|10988818|FG001|COMPLETED|Overall Study||52
9874428|NCT00997126|10988817|FG000|NOT COMPLETED|Overall Study||7
9874429|NCT00997126|10988818|FG001|NOT COMPLETED|Overall Study||11
9874430|NCT00997139|10988824|FG000|STARTED|Overall Study||216
9874431|NCT00997139|10988824|FG000|Treated for Positive Baseline Culture|Overall Study||30
9874432|NCT00997139|10988824|FG000|COMPLETED|Overall Study||30
9874433|NCT00997139|10988824|FG000|NOT COMPLETED|Overall Study||186
9874434|NCT00997204|10988832|FG000|STARTED|Naive Treatment Phase||25
9874435|NCT00997204|10988833|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
9874436|NCT00997204|10988832|FG000|COMPLETED|Naive Treatment Phase||19
9874437|NCT00997204|10988833|FG001|COMPLETED|Naive Treatment Phase||0
9874438|NCT00997204|10988832|FG000|NOT COMPLETED|Naive Treatment Phase||6
9874439|NCT00997204|10988833|FG001|NOT COMPLETED|Naive Treatment Phase||79
9874440|NCT00997204|10988832|FG000|STARTED|Self-administration Phase||19
9874441|NCT00997204|10988833|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
9874442|NCT00997204|10988832|FG000|COMPLETED|Self-administration Phase||19
9874443|NCT00997204|10988833|FG001|COMPLETED|Self-administration Phase||77
9874444|NCT00997204|10988832|FG000|NOT COMPLETED|Self-administration Phase||0
9874445|NCT00997204|10988833|FG001|NOT COMPLETED|Self-administration Phase||1
9874446|NCT00997243|10988843|FG000|STARTED|Overall Study||7
9874447|NCT00997243|10988843|FG000|COMPLETED|Overall Study||0
9874448|NCT00997243|10988843|FG000|NOT COMPLETED|Overall Study||7
9874449|NCT00997321|10988849|FG000|STARTED|Overall Study||50
9874450|NCT00997321|10988850|FG001|STARTED|Overall Study||50
9874451|NCT00997321|10988849|FG000|COMPLETED|Overall Study||50
9874452|NCT00997321|10988850|FG001|COMPLETED|Overall Study||47
9874453|NCT00997321|10988849|FG000|NOT COMPLETED|Overall Study||0
9874454|NCT00997321|10988850|FG001|NOT COMPLETED|Overall Study||3
9874455|NCT00997334|10988862|FG000|STARTED|Overall Study||60
9874456|NCT00997334|10988862|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
9874457|NCT00997334|10988862|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
9874458|NCT00997334|10988862|FG000|COMPLETED|Overall Study||35
9874459|NCT00997334|10988862|FG000|NOT COMPLETED|Overall Study||25
9874460|NCT00997373|10988868|FG000|STARTED|Overall Study||28
9874461|NCT00997373|10988869|FG001|STARTED|Overall Study||15
9874462|NCT00997373|10988868|FG000|Received Letrozole|Overall Study||23
10097183|NCT02372253|11226176|FG001|STARTED|Overall Study||13
10097184|NCT02372253|11226175|FG000|COMPLETED|Overall Study||11
10097185|NCT02372253|11226176|FG001|COMPLETED|Overall Study||13
10097186|NCT02372253|11226175|FG000|NOT COMPLETED|Overall Study||2
9874463|NCT00997373|10988869|FG001|Received Letrozole|Overall Study||0
9874464|NCT00997373|10988868|FG000|Completed Hysterectomy|Overall Study||17
9874465|NCT00997373|10988869|FG001|Completed Hysterectomy|Overall Study||15
9874466|NCT00997373|10988868|FG000|COMPLETED|Overall Study||13
9874467|NCT00997373|10988869|FG001|COMPLETED|Overall Study||15
9874468|NCT00997373|10988868|FG000|NOT COMPLETED|Overall Study||15
9874469|NCT00997373|10988869|FG001|NOT COMPLETED|Overall Study||0
9874470|NCT00997425|10988875|FG000|STARTED|Overall Study||19
9874471|NCT00997425|10988875|FG000|COMPLETED|Overall Study||19
9874472|NCT00997425|10988875|FG000|NOT COMPLETED|Overall Study||0
9874473|NCT00997438|10988883|FG000|STARTED|Overall Study||21
9874474|NCT00997438|10988884|FG001|STARTED|Overall Study||24
10097187|NCT02372253|11226176|FG001|NOT COMPLETED|Overall Study||0
10097188|NCT02372344|11226184|FG000|STARTED|Period 1 (Visit 2)||14
10097189|NCT02372344|11226185|FG001|STARTED|Period 1 (Visit 2)||14
10097190|NCT02372344|11226186|FG002|STARTED|Period 1 (Visit 2)||14
9874475|NCT00997438|10988885|FG002|STARTED|Overall Study||24
9874476|NCT00997438|10988883|FG000|COMPLETED|Overall Study||16
9874477|NCT00997438|10988884|FG001|COMPLETED|Overall Study||21
9874478|NCT00997438|10988885|FG002|COMPLETED|Overall Study||20
9874479|NCT00997438|10988883|FG000|NOT COMPLETED|Overall Study||5
9874480|NCT00997438|10988884|FG001|NOT COMPLETED|Overall Study||3
9874481|NCT00997438|10988885|FG002|NOT COMPLETED|Overall Study||4
9874482|NCT00997503|10988894|FG000|STARTED|Overall Study||4199
9874483|NCT00997503|10988894|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
9874484|NCT00997503|10988894|FG000|COMPLETED|Overall Study||3926
9874485|NCT00997503|10988894|FG000|NOT COMPLETED|Overall Study||273
9874486|NCT00997516|10988903|FG000|STARTED|Short-term Follow-up (Post Operative)||37
9874487|NCT00997516|10988904|FG001|STARTED|Short-term Follow-up (Post Operative)||38
9874488|NCT00997516|10988903|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37
9874489|NCT00997516|10988904|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38
9874490|NCT00997516|10988903|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
9874491|NCT00997516|10988904|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
9874492|NCT00997516|10988903|FG000|STARTED|Long-term Follow-up (After 6 Months)||37
9874493|NCT00997516|10988904|FG001|STARTED|Long-term Follow-up (After 6 Months)||38
9874494|NCT00997516|10988903|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31
9874495|NCT00997516|10988904|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36
9874496|NCT00997516|10988903|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
9874497|NCT00997516|10988904|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
9874498|NCT00997555|10988912|FG000|STARTED|Overall Study||13
9874499|NCT00997555|10988913|FG001|STARTED|Overall Study||15
9874500|NCT00997555|10988912|FG000|COMPLETED|Overall Study||13
9874501|NCT00997555|10988913|FG001|COMPLETED|Overall Study||15
9874502|NCT00997555|10988912|FG000|NOT COMPLETED|Overall Study||0
9874503|NCT00997555|10988913|FG001|NOT COMPLETED|Overall Study||0
9874504|NCT00997594|10988921|FG000|STARTED|Overall Study||9
9874505|NCT00997594|10988922|FG001|STARTED|Overall Study||9
9874506|NCT00997594|10988921|FG000|Completion of Ablation Procedure|Overall Study||9
9874507|NCT00997594|10988922|FG001|Completion of Ablation Procedure|Overall Study||9
9874508|NCT00997594|10988921|FG000|COMPLETED|Overall Study||9
9874509|NCT00997594|10988922|FG001|COMPLETED|Overall Study||9
9874510|NCT00997594|10988921|FG000|NOT COMPLETED|Overall Study||0
9874511|NCT00997594|10988922|FG001|NOT COMPLETED|Overall Study||0
9874512|NCT00997620|10988930|FG000|STARTED|Overall Study||19
9874513|NCT00997620|10988931|FG001|STARTED|Overall Study||21
9874514|NCT00997620|10988930|FG000|COMPLETED|Overall Study||19
9874515|NCT00997620|10988931|FG001|COMPLETED|Overall Study||21
9874516|NCT00997620|10988930|FG000|NOT COMPLETED|Overall Study||0
9874517|NCT00997620|10988931|FG001|NOT COMPLETED|Overall Study||0
9874518|NCT00997672|10988942|FG000|STARTED|Overall Study||4
9874519|NCT00997672|10988943|FG001|STARTED|Overall Study||5
9874520|NCT00997672|10988942|FG000|COMPLETED|Overall Study||0
9874521|NCT00997672|10988943|FG001|COMPLETED|Overall Study||1
9874522|NCT00997672|10988942|FG000|NOT COMPLETED|Overall Study||4
9874523|NCT00997672|10988943|FG001|NOT COMPLETED|Overall Study||4
9874524|NCT00997893|10988952|FG000|STARTED|Overall Study||14
9874525|NCT00997893|10988953|FG001|STARTED|Overall Study||13
9874526|NCT00997893|10988954|FG002|STARTED|Overall Study||13
9874527|NCT00997893|10988952|FG000|COMPLETED|Overall Study||12
9874528|NCT00997893|10988953|FG001|COMPLETED|Overall Study||12
9874529|NCT00997893|10988954|FG002|COMPLETED|Overall Study||13
9874530|NCT00997893|10988952|FG000|NOT COMPLETED|Overall Study||2
9874531|NCT00997893|10988953|FG001|NOT COMPLETED|Overall Study||1
9874532|NCT00997893|10988954|FG002|NOT COMPLETED|Overall Study||0
9874533|NCT00997932|10988962|FG000|STARTED|Overall Study||29
9874534|NCT00997932|10988962|FG000|COMPLETED|Overall Study||27
9874535|NCT00997932|10988962|FG000|NOT COMPLETED|Overall Study||2
9874536|NCT00997984|10988970|FG000|STARTED|Overall Study||113
9874537|NCT00997984|10988971|FG001|STARTED|Overall Study||113
9874538|NCT00997984|10988972|FG002|STARTED|Overall Study||114
9874539|NCT00997984|10988970|FG000|COMPLETED|Overall Study||76
9874540|NCT00997984|10988971|FG001|COMPLETED|Overall Study||79
9874541|NCT00997984|10988972|FG002|COMPLETED|Overall Study||88
9874542|NCT00997984|10988970|FG000|NOT COMPLETED|Overall Study||37
9874543|NCT00997984|10988971|FG001|NOT COMPLETED|Overall Study||34
9874544|NCT00997984|10988972|FG002|NOT COMPLETED|Overall Study||26
9874545|NCT00998010|10988982|FG000|STARTED|Overall Study||24
9874546|NCT00998010|10988982|FG000|COMPLETED|Overall Study||24
9874547|NCT00998010|10988982|FG000|NOT COMPLETED|Overall Study||0
9874548|NCT00998023|10988988|FG000|STARTED|Overall Study||32
9874549|NCT00998023|10988989|FG001|STARTED|Overall Study||32
9874550|NCT00998023|10988988|FG000|COMPLETED|Overall Study||32
9874551|NCT00998023|10988989|FG001|COMPLETED|Overall Study||32
9874552|NCT00998023|10988988|FG000|NOT COMPLETED|Overall Study||0
9874553|NCT00998023|10988989|FG001|NOT COMPLETED|Overall Study||0
9874554|NCT00998049|10988995|FG000|STARTED|Overall Study||39
9874555|NCT00998049|10988995|FG000|COMPLETED|Overall Study||39
9874556|NCT00998049|10988995|FG000|NOT COMPLETED|Overall Study||0
9874557|NCT00998205|10988999|FG000|STARTED|Overall Study||16
9874558|NCT00998205|10988999|FG000|COMPLETED|Overall Study||16
9874559|NCT00998205|10988999|FG000|NOT COMPLETED|Overall Study||0
9874560|NCT00998296|10989015|FG000|STARTED|Overall Study||6
9874561|NCT00998296|10989016|FG001|STARTED|Overall Study||3
9874562|NCT00998296|10989017|FG002|STARTED|Overall Study||3
9874563|NCT00998296|10989018|FG003|STARTED|Overall Study||3
9874564|NCT00998296|10989019|FG004|STARTED|Overall Study||8
9874565|NCT00998296|10989020|FG005|STARTED|Overall Study||3
9874566|NCT00998296|10989021|FG006|STARTED|Overall Study||7
9874567|NCT00998296|10989022|FG007|STARTED|Overall Study||6
9874568|NCT00998296|10989023|FG008|STARTED|Overall Study||6
9874569|NCT00998296|10989024|FG009|STARTED|Overall Study||18
9874570|NCT00998296|10989025|FG010|STARTED|Overall Study||7
9957089|NCT01449370|11076239|FG004|NOT COMPLETED|Overall Study||3
9874571|NCT00998296|10989015|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
9874572|NCT00998296|10989016|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
9874573|NCT00998296|10989017|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
9874574|NCT00998296|10989018|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
9874575|NCT00998296|10989019|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
9874576|NCT00998296|10989020|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
9874577|NCT00998296|10989021|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
9874578|NCT00998296|10989022|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
9874579|NCT00998296|10989023|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
9874580|NCT00998296|10989024|FG009|COMPLETED|Overall Study||0
9874581|NCT00998296|10989025|FG010|COMPLETED|Overall Study||0
9874582|NCT00998296|10989015|FG000|NOT COMPLETED|Overall Study||0
9874583|NCT00998296|10989016|FG001|NOT COMPLETED|Overall Study||1
9874584|NCT00998296|10989017|FG002|NOT COMPLETED|Overall Study||0
9874585|NCT00998296|10989018|FG003|NOT COMPLETED|Overall Study||0
9874586|NCT00998296|10989019|FG004|NOT COMPLETED|Overall Study||2
9874587|NCT00998296|10989020|FG005|NOT COMPLETED|Overall Study||0
9874588|NCT00998296|10989021|FG006|NOT COMPLETED|Overall Study||1
9874589|NCT00998296|10989022|FG007|NOT COMPLETED|Overall Study||2
9874590|NCT00998296|10989023|FG008|NOT COMPLETED|Overall Study||2
9874591|NCT00998296|10989024|FG009|NOT COMPLETED|Overall Study||18
9874592|NCT00998296|10989025|FG010|NOT COMPLETED|Overall Study||7
9874593|NCT00998309|10989054|FG000|STARTED|Overall Study||502
9874594|NCT00998309|10989054|FG000|COMPLETED|Overall Study||498
9874595|NCT00998309|10989054|FG000|NOT COMPLETED|Overall Study||4
9874596|NCT00998335|10989108|FG000|STARTED|Initial Treatment (Months 0 - 3)||30
9874597|NCT00998335|10989109|FG001|STARTED|Initial Treatment (Months 0 - 3)||0
9874598|NCT00998335|10989108|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30
9874599|NCT00998335|10989109|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0
9874600|NCT00998335|10989108|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
9874601|NCT00998335|10989109|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
9874602|NCT00998335|10989108|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
9874603|NCT00998335|10989109|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
9874604|NCT00998335|10989108|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8
9874605|NCT00998335|10989109|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20
9874606|NCT00998335|10989108|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
9874607|NCT00998335|10989109|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
9874608|NCT00998374|10989123|FG000|STARTED|Overall Study||39
9874609|NCT00998374|10989124|FG001|STARTED|Overall Study||23
9874610|NCT00998374|10989123|FG000|COMPLETED|Overall Study||27
9874611|NCT00998374|10989124|FG001|COMPLETED|Overall Study||12
9874612|NCT00998374|10989123|FG000|NOT COMPLETED|Overall Study||12
9874613|NCT00998374|10989124|FG001|NOT COMPLETED|Overall Study||11
10097191|NCT02372344|11226184|FG000|COMPLETED|Period 1 (Visit 2)||14
10097192|NCT02372344|11226185|FG001|COMPLETED|Period 1 (Visit 2)||14
10097193|NCT02372344|11226186|FG002|COMPLETED|Period 1 (Visit 2)||14
10097194|NCT02372344|11226184|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
10097195|NCT02372344|11226185|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
10097196|NCT02372344|11226186|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
10097197|NCT02372344|11226184|FG000|STARTED|Period 2 (Visit 3)||14
10097198|NCT02372344|11226185|FG001|STARTED|Period 2 (Visit 3)||14
10097199|NCT02372344|11226186|FG002|STARTED|Period 2 (Visit 3)||14
10097200|NCT02372344|11226184|FG000|COMPLETED|Period 2 (Visit 3)||14
10097201|NCT02372344|11226185|FG001|COMPLETED|Period 2 (Visit 3)||14
10097202|NCT02372344|11226186|FG002|COMPLETED|Period 2 (Visit 3)||14
10097203|NCT02372344|11226184|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
10097204|NCT02372344|11226185|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
10097205|NCT02372344|11226186|FG002|NOT COMPLETED|Period 2 (Visit 3)||0
10097206|NCT02372344|11226184|FG000|STARTED|Period 3 (Visit 4)||14
10097207|NCT02372344|11226185|FG001|STARTED|Period 3 (Visit 4)||14
10097208|NCT02372344|11226186|FG002|STARTED|Period 3 (Visit 4)||14
10097209|NCT02372344|11226184|FG000|COMPLETED|Period 3 (Visit 4)||14
10097210|NCT02372344|11226185|FG001|COMPLETED|Period 3 (Visit 4)||14
10097211|NCT02372344|11226186|FG002|COMPLETED|Period 3 (Visit 4)||14
10097212|NCT02372344|11226184|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
10097213|NCT02372344|11226185|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
10097214|NCT02372344|11226186|FG002|NOT COMPLETED|Period 3 (Visit 4)||0
10097215|NCT02372383|11226196|FG000|STARTED|First Intervention (1 Day)||10
10097216|NCT02372383|11226197|FG001|STARTED|First Intervention (1 Day)||11
10097217|NCT02372383|11226198|FG002|STARTED|First Intervention (1 Day)||10
10097218|NCT02372383|11226196|FG000|COMPLETED|First Intervention (1 Day)||10
10097219|NCT02372383|11226197|FG001|COMPLETED|First Intervention (1 Day)||10
10097220|NCT02372383|11226198|FG002|COMPLETED|First Intervention (1 Day)||10
10097221|NCT02372383|11226196|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10097222|NCT02372383|11226197|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10097223|NCT02372383|11226198|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10097224|NCT02372383|11226196|FG000|STARTED|Washout (14 Days)||10
10097225|NCT02372383|11226197|FG001|STARTED|Washout (14 Days)||10
10097226|NCT02372383|11226198|FG002|STARTED|Washout (14 Days)||10
10097227|NCT02372383|11226196|FG000|COMPLETED|Washout (14 Days)||10
9874614|NCT00998400|10989134|FG000|STARTED|Overall Study||50
9874615|NCT00998400|10989135|FG001|STARTED|Overall Study||50
9874616|NCT00998400|10989134|FG000|COMPLETED|Overall Study||48
9874617|NCT00998400|10989135|FG001|COMPLETED|Overall Study||48
9874618|NCT00998400|10989134|FG000|NOT COMPLETED|Overall Study||2
9874619|NCT00998400|10989135|FG001|NOT COMPLETED|Overall Study||2
9874620|NCT00998426|10989142|FG000|STARTED|Overall Study||5
9874621|NCT00998426|10989142|FG000|Blood Glucose Monitoring|Overall Study||5
9874622|NCT00998426|10989142|FG000|COMPLETED|Overall Study||5
9874623|NCT00998426|10989142|FG000|NOT COMPLETED|Overall Study||0
9874624|NCT00998517|10989150|FG000|STARTED|Overall Study||888
9874625|NCT00998517|10989151|FG001|STARTED|Overall Study||906
9874626|NCT00998517|10989152|FG002|STARTED|Overall Study||918
9874627|NCT00998517|10989150|FG000|COMPLETED|Overall Study||888
9874628|NCT00998517|10989151|FG001|COMPLETED|Overall Study||906
9874629|NCT00998517|10989152|FG002|COMPLETED|Overall Study||918
9874630|NCT00998517|10989150|FG000|NOT COMPLETED|Overall Study||0
9874631|NCT00998517|10989151|FG001|NOT COMPLETED|Overall Study||0
9874632|NCT00998517|10989152|FG002|NOT COMPLETED|Overall Study||0
9874633|NCT00998582|10989162|FG000|STARTED|Overall Study||13
9874634|NCT00998582|10989163|FG001|STARTED|Overall Study||14
9874635|NCT00998582|10989162|FG000|COMPLETED|Overall Study||13
9874636|NCT00998582|10989163|FG001|COMPLETED|Overall Study||14
9874637|NCT00998582|10989162|FG000|NOT COMPLETED|Overall Study||0
9874638|NCT00998582|10989163|FG001|NOT COMPLETED|Overall Study||0
9874639|NCT00998660|10989172|FG000|STARTED|Overall Study||100
9874640|NCT00998660|10989172|FG000|Implanted|Overall Study||93
9874641|NCT00998660|10989172|FG000|Month 3 Visit|Overall Study||87
9874642|NCT00998660|10989172|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
9874643|NCT00998660|10989172|FG000|NOT COMPLETED|Overall Study||13
9874644|NCT00998764|10989178|FG000|STARTED|Overall Study||216
9874645|NCT00998764|10989179|FG001|STARTED|Overall Study||276
9874646|NCT00998764|10989178|FG000|Treated|Overall Study||215
9874647|NCT00998764|10989179|FG001|Treated|Overall Study||275
9874648|NCT00998764|10989178|FG000|COMPLETED|Overall Study||0
9874649|NCT00998764|10989179|FG001|COMPLETED|Overall Study||2
9874650|NCT00998764|10989178|FG000|NOT COMPLETED|Overall Study||216
9874651|NCT00998764|10989179|FG001|NOT COMPLETED|Overall Study||274
9874652|NCT00998790|10989187|FG000|STARTED|Overall Study||114
9874653|NCT00998790|10989187|FG000|Participants Who Were Treated|Overall Study||113
9874654|NCT00998790|10989187|FG000|COMPLETED|Overall Study||93
9874655|NCT00998790|10989187|FG000|NOT COMPLETED|Overall Study||21
9874656|NCT00998868|10989191|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
9874657|NCT00998868|10989191|FG000|COMPLETED|Overall Study||51
9874658|NCT00998868|10989191|FG000|NOT COMPLETED|Overall Study||0
9874659|NCT00998881|10989197|FG000|STARTED|Overall Study||104
9874660|NCT00998881|10989198|FG001|STARTED|Overall Study||99
9874661|NCT00998881|10989197|FG000|COMPLETED|Overall Study||96
9874662|NCT00998881|10989198|FG001|COMPLETED|Overall Study||97
9874663|NCT00998881|10989197|FG000|NOT COMPLETED|Overall Study||8
9874664|NCT00998881|10989198|FG001|NOT COMPLETED|Overall Study||2
9874665|NCT00998946|10989204|FG000|STARTED|Overall Study||29
9874666|NCT00998946|10989204|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27
9874667|NCT00998946|10989204|FG000|COMPLETED|Overall Study||20
9874668|NCT00998946|10989204|FG000|NOT COMPLETED|Overall Study||9
9953786|NCT01427972|11072451|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953787|NCT01427972|11072452|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1
9953788|NCT01427972|11072453|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953789|NCT01427972|11072454|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953790|NCT01427972|11072455|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953791|NCT01427972|11072456|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0
9953792|NCT01427972|11072445|FG000|STARTED|Washout (at Least 28 Days)||3
9953793|NCT01427972|11072446|FG001|STARTED|Washout (at Least 28 Days)||4
9953794|NCT01427972|11072447|FG002|STARTED|Washout (at Least 28 Days)||4
9953795|NCT01427972|11072448|FG003|STARTED|Washout (at Least 28 Days)||3
9953796|NCT01427972|11072449|FG004|STARTED|Washout (at Least 28 Days)||4
9953797|NCT01427972|11072450|FG005|STARTED|Washout (at Least 28 Days)||3
9953798|NCT01427972|11072451|FG006|STARTED|Washout (at Least 28 Days)||3
9953799|NCT01427972|11072452|FG007|STARTED|Washout (at Least 28 Days)||4
9953800|NCT01427972|11072453|FG008|STARTED|Washout (at Least 28 Days)||3
9953801|NCT01427972|11072454|FG009|STARTED|Washout (at Least 28 Days)||3
9953802|NCT01427972|11072455|FG010|STARTED|Washout (at Least 28 Days)||3
9953803|NCT01427972|11072456|FG011|STARTED|Washout (at Least 28 Days)||4
9953804|NCT01427972|11072445|FG000|COMPLETED|Washout (at Least 28 Days)||3
9953805|NCT01427972|11072446|FG001|COMPLETED|Washout (at Least 28 Days)||4
9953806|NCT01427972|11072447|FG002|COMPLETED|Washout (at Least 28 Days)||4
9953807|NCT01427972|11072448|FG003|COMPLETED|Washout (at Least 28 Days)||3
9953808|NCT01427972|11072449|FG004|COMPLETED|Washout (at Least 28 Days)||4
9953809|NCT01427972|11072450|FG005|COMPLETED|Washout (at Least 28 Days)||1
9953810|NCT01427972|11072451|FG006|COMPLETED|Washout (at Least 28 Days)||3
9953811|NCT01427972|11072452|FG007|COMPLETED|Washout (at Least 28 Days)||4
9953812|NCT01427972|11072453|FG008|COMPLETED|Washout (at Least 28 Days)||3
9953813|NCT01427972|11072454|FG009|COMPLETED|Washout (at Least 28 Days)||3
9953814|NCT01427972|11072455|FG010|COMPLETED|Washout (at Least 28 Days)||3
9953815|NCT01427972|11072456|FG011|COMPLETED|Washout (at Least 28 Days)||4
9874669|NCT00998985|10989222|FG000|STARTED|Overall Study||5
9874670|NCT00998985|10989223|FG001|STARTED|Overall Study||5
9874671|NCT00998985|10989224|FG002|STARTED|Overall Study||15
9874672|NCT00998985|10989225|FG003|STARTED|Overall Study||5
9874673|NCT00998985|10989226|FG004|STARTED|Overall Study||5
9874674|NCT00998985|10989227|FG005|STARTED|Overall Study||5
9874675|NCT00998985|10989228|FG006|STARTED|Overall Study||5
9874676|NCT00998985|10989229|FG007|STARTED|Overall Study||5
9874677|NCT00998985|10989230|FG008|STARTED|Overall Study||6
9874678|NCT00998985|10989231|FG009|STARTED|Overall Study||5
9874679|NCT00998985|10989232|FG010|STARTED|Overall Study||5
9874680|NCT00998985|10989233|FG011|STARTED|Overall Study||5
9874681|NCT00998985|10989234|FG012|STARTED|Overall Study||5
9874682|NCT00998985|10989235|FG013|STARTED|Overall Study||15
9874683|NCT00998985|10989222|FG000|COMPLETED|Overall Study||5
9874684|NCT00998985|10989223|FG001|COMPLETED|Overall Study||5
9874685|NCT00998985|10989224|FG002|COMPLETED|Overall Study||15
9874686|NCT00998985|10989225|FG003|COMPLETED|Overall Study||5
9874687|NCT00998985|10989226|FG004|COMPLETED|Overall Study||5
9874688|NCT00998985|10989227|FG005|COMPLETED|Overall Study||4
9874689|NCT00998985|10989228|FG006|COMPLETED|Overall Study||5
9874690|NCT00998985|10989229|FG007|COMPLETED|Overall Study||5
9874691|NCT00998985|10989230|FG008|COMPLETED|Overall Study||5
9874692|NCT00998985|10989231|FG009|COMPLETED|Overall Study||5
9874693|NCT00998985|10989232|FG010|COMPLETED|Overall Study||5
9874694|NCT00998985|10989233|FG011|COMPLETED|Overall Study||5
9874695|NCT00998985|10989234|FG012|COMPLETED|Overall Study||5
9874696|NCT00998985|10989235|FG013|COMPLETED|Overall Study||15
9874697|NCT00998985|10989222|FG000|NOT COMPLETED|Overall Study||0
9874698|NCT00998985|10989223|FG001|NOT COMPLETED|Overall Study||0
9874699|NCT00998985|10989224|FG002|NOT COMPLETED|Overall Study||0
9874700|NCT00998985|10989225|FG003|NOT COMPLETED|Overall Study||0
9874701|NCT00998985|10989226|FG004|NOT COMPLETED|Overall Study||0
9874702|NCT00998985|10989227|FG005|NOT COMPLETED|Overall Study||1
9874703|NCT00998985|10989228|FG006|NOT COMPLETED|Overall Study||0
9874704|NCT00998985|10989229|FG007|NOT COMPLETED|Overall Study||0
9874705|NCT00998985|10989230|FG008|NOT COMPLETED|Overall Study||1
9874706|NCT00998985|10989231|FG009|NOT COMPLETED|Overall Study||0
9874707|NCT00998985|10989232|FG010|NOT COMPLETED|Overall Study||0
9874708|NCT00998985|10989233|FG011|NOT COMPLETED|Overall Study||0
9874709|NCT00998985|10989234|FG012|NOT COMPLETED|Overall Study||0
9874710|NCT00998985|10989235|FG013|NOT COMPLETED|Overall Study||0
9874711|NCT00999037|10989282|FG000|STARTED|Overall Study||9
9874712|NCT00999037|10989283|FG001|STARTED|Overall Study|20|9
9874713|NCT00999037|10989282|FG000|COMPLETED|Overall Study||9
9874714|NCT00999037|10989283|FG001|COMPLETED|Overall Study||9
9874715|NCT00999037|10989282|FG000|NOT COMPLETED|Overall Study||0
9874716|NCT00999037|10989283|FG001|NOT COMPLETED|Overall Study||0
9874717|NCT00999102|10989291|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16
9874718|NCT00999102|10989292|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17
9874719|NCT00999102|10989291|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15
9874720|NCT00999102|10989292|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16
9874721|NCT00999102|10989291|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
9874722|NCT00999102|10989292|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
9874723|NCT00999102|10989291|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15
9874724|NCT00999102|10989292|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16
9874725|NCT00999102|10989291|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15
9874726|NCT00999102|10989292|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16
9874727|NCT00999102|10989291|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
9874728|NCT00999102|10989292|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
9874729|NCT00999102|10989291|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15
9874730|NCT00999102|10989292|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16
9874731|NCT00999102|10989291|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
9874732|NCT00999102|10989292|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
9874733|NCT00999102|10989291|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
9874734|NCT00999102|10989292|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
9874735|NCT00999102|10989291|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15
9874736|NCT00999102|10989292|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16
9874737|NCT00999102|10989291|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
9874738|NCT00999102|10989292|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
9874739|NCT00999102|10989291|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
9874740|NCT00999102|10989292|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
9874741|NCT00999141|10989302|FG000|STARTED|Overall Study|Randomized and treated|75
9874742|NCT00999141|10989302|FG000|COMPLETED|Overall Study||75
9874743|NCT00999141|10989302|FG000|NOT COMPLETED|Overall Study||0
9874744|NCT00999167|10989360|FG000|STARTED|Part A: Open Label Safety run-in||15
9874745|NCT00999167|10989361|FG001|STARTED|Part A: Open Label Safety run-in||0
9874746|NCT00999167|10989362|FG002|STARTED|Part A: Open Label Safety run-in||0
9874747|NCT00999167|10989360|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15
9874748|NCT00999167|10989361|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0
9874749|NCT00999167|10989362|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0
9874750|NCT00999167|10989360|FG000|COMPLETED|Part A: Open Label Safety run-in||8
9874751|NCT00999167|10989361|FG001|COMPLETED|Part A: Open Label Safety run-in||0
9874752|NCT00999167|10989362|FG002|COMPLETED|Part A: Open Label Safety run-in||0
9874753|NCT00999167|10989360|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7
9874754|NCT00999167|10989361|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0
9874755|NCT00999167|10989362|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0
9874756|NCT00999167|10989360|FG000|STARTED|Part B: Randomized, Placebo Controlled||0
10097228|NCT02372383|11226197|FG001|COMPLETED|Washout (14 Days)||10
10097229|NCT02372383|11226198|FG002|COMPLETED|Washout (14 Days)||10
10097230|NCT02372383|11226196|FG000|NOT COMPLETED|Washout (14 Days)||0
10097231|NCT02372383|11226197|FG001|NOT COMPLETED|Washout (14 Days)||0
10097232|NCT02372383|11226198|FG002|NOT COMPLETED|Washout (14 Days)||0
9874757|NCT00999167|10989361|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
9874758|NCT00999167|10989362|FG002|STARTED|Part B: Randomized, Placebo Controlled||88
9874759|NCT00999167|10989360|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0
9874760|NCT00999167|10989361|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55
9874761|NCT00999167|10989362|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67
9874762|NCT00999167|10989360|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
9874763|NCT00999167|10989361|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
9874764|NCT00999167|10989362|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
9874765|NCT00999466|10989375|FG000|STARTED|Pilot Part||6
9874766|NCT00999466|10989376|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
9874767|NCT00999466|10989377|FG002|STARTED|Pilot Part||3
9874768|NCT00999466|10989375|FG000|COMPLETED|Pilot Part||6
9874769|NCT00999466|10989376|FG001|COMPLETED|Pilot Part||0
9874770|NCT00999466|10989377|FG002|COMPLETED|Pilot Part||3
9874771|NCT00999466|10989375|FG000|NOT COMPLETED|Pilot Part||0
9874772|NCT00999466|10989376|FG001|NOT COMPLETED|Pilot Part||0
9874773|NCT00999466|10989377|FG002|NOT COMPLETED|Pilot Part||0
9874774|NCT00999466|10989375|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
9874775|NCT00999466|10989376|FG001|STARTED|Main Part||26
9874776|NCT00999466|10989377|FG002|STARTED|Main Part||25
9874777|NCT00999466|10989375|FG000|COMPLETED|Main Part||0
9874778|NCT00999466|10989376|FG001|COMPLETED|Main Part||22
9874779|NCT00999466|10989377|FG002|COMPLETED|Main Part||21
9874780|NCT00999466|10989375|FG000|NOT COMPLETED|Main Part||0
9874781|NCT00999466|10989376|FG001|NOT COMPLETED|Main Part||4
9874782|NCT00999466|10989377|FG002|NOT COMPLETED|Main Part||4
9874783|NCT00999518|10989390|FG000|STARTED|Overall Study||43
9874784|NCT00999518|10989391|FG001|STARTED|Overall Study||42
9874785|NCT00999518|10989392|FG002|STARTED|Overall Study||39
9874786|NCT00999518|10989393|FG003|STARTED|Overall Study||40
9874787|NCT00999518|10989394|FG004|STARTED|Overall Study||41
9874788|NCT00999518|10989390|FG000|Treated|Overall Study||42
9874789|NCT00999518|10989391|FG001|Treated|Overall Study||41
9874790|NCT00999518|10989392|FG002|Treated|Overall Study||37
9874791|NCT00999518|10989393|FG003|Treated|Overall Study||40
9874792|NCT00999518|10989394|FG004|Treated|Overall Study||40
9874793|NCT00999518|10989390|FG000|COMPLETED|Overall Study||19
9874794|NCT00999518|10989391|FG001|COMPLETED|Overall Study||17
9874795|NCT00999518|10989392|FG002|COMPLETED|Overall Study||17
9874796|NCT00999518|10989393|FG003|COMPLETED|Overall Study||18
9874797|NCT00999518|10989394|FG004|COMPLETED|Overall Study||17
9874798|NCT00999518|10989390|FG000|NOT COMPLETED|Overall Study||24
9874799|NCT00999518|10989391|FG001|NOT COMPLETED|Overall Study||25
9874800|NCT00999518|10989392|FG002|NOT COMPLETED|Overall Study||22
9874801|NCT00999518|10989393|FG003|NOT COMPLETED|Overall Study||22
9874802|NCT00999518|10989394|FG004|NOT COMPLETED|Overall Study||24
9874803|NCT00999544|10989410|FG000|STARTED|Overall Study||9
9874804|NCT00999544|10989410|FG000|COMPLETED|Overall Study||8
9874805|NCT00999544|10989410|FG000|NOT COMPLETED|Overall Study||1
9874806|NCT00999596|10989443|FG000|STARTED|Overall Study||107
9874807|NCT00999596|10989443|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
9874808|NCT00999596|10989443|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
9874809|NCT00999596|10989443|FG000|NOT COMPLETED|Overall Study||101
9874810|NCT00999661|10989448|FG000|STARTED|Overall Study||231
9874811|NCT00999661|10989448|FG000|COMPLETED|Overall Study||161
9874812|NCT00999661|10989448|FG000|NOT COMPLETED|Overall Study||70
9874813|NCT00999687|10989452|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
9874814|NCT00999687|10989452|FG000|COMPLETED|First Intervention||30
9874815|NCT00999687|10989452|FG000|NOT COMPLETED|First Intervention||1
9874816|NCT00999687|10989452|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
9874817|NCT00999687|10989452|FG000|COMPLETED|Second Intervention||27
9874818|NCT00999687|10989452|FG000|NOT COMPLETED|Second Intervention||3
9874819|NCT00999713|10989460|FG000|STARTED|Overall Study||26
9874820|NCT00999713|10989461|FG001|STARTED|Overall Study||17
9874821|NCT00999713|10989460|FG000|COMPLETED|Overall Study||24
9874822|NCT00999713|10989461|FG001|COMPLETED|Overall Study||17
9874823|NCT00999713|10989460|FG000|NOT COMPLETED|Overall Study||2
9874824|NCT00999713|10989461|FG001|NOT COMPLETED|Overall Study||0
9874825|NCT00999830|10989469|FG000|STARTED|Overall Study||14
10097233|NCT02372383|11226196|FG000|STARTED|Second Intervention (1 Day)||10
10097234|NCT02372383|11226197|FG001|STARTED|Second Intervention (1 Day)||10
10097235|NCT02372383|11226198|FG002|STARTED|Second Intervention (1 Day)||10
10097236|NCT02372383|11226196|FG000|COMPLETED|Second Intervention (1 Day)||10
10097237|NCT02372383|11226197|FG001|COMPLETED|Second Intervention (1 Day)||10
9874826|NCT00999830|10989470|FG001|STARTED|Overall Study||13
9874827|NCT00999830|10989469|FG000|COMPLETED|Overall Study||14
9874828|NCT00999830|10989470|FG001|COMPLETED|Overall Study||13
9874829|NCT00999830|10989469|FG000|NOT COMPLETED|Overall Study||0
9874830|NCT00999830|10989470|FG001|NOT COMPLETED|Overall Study||0
9874831|NCT00999908|10989476|FG000|STARTED|Treatment Period 1||19
9874832|NCT00999908|10989477|FG001|STARTED|Treatment Period 1||16
9874833|NCT00999908|10989478|FG002|STARTED|Treatment Period 1||19
9874834|NCT00999908|10989476|FG000|COMPLETED|Treatment Period 1||17
9874835|NCT00999908|10989477|FG001|COMPLETED|Treatment Period 1||16
9874836|NCT00999908|10989478|FG002|COMPLETED|Treatment Period 1||19
9874837|NCT00999908|10989476|FG000|NOT COMPLETED|Treatment Period 1||2
9874838|NCT00999908|10989477|FG001|NOT COMPLETED|Treatment Period 1||0
9874839|NCT00999908|10989478|FG002|NOT COMPLETED|Treatment Period 1||0
9874840|NCT00999908|10989476|FG000|STARTED|Treatment Period 2||17
9874841|NCT00999908|10989477|FG001|STARTED|Treatment Period 2||16
9874842|NCT00999908|10989478|FG002|STARTED|Treatment Period 2||19
9874843|NCT00999908|10989476|FG000|COMPLETED|Treatment Period 2||16
9874844|NCT00999908|10989477|FG001|COMPLETED|Treatment Period 2||16
9874845|NCT00999908|10989478|FG002|COMPLETED|Treatment Period 2||19
9874846|NCT00999908|10989476|FG000|NOT COMPLETED|Treatment Period 2||1
9874847|NCT00999908|10989477|FG001|NOT COMPLETED|Treatment Period 2||0
9874848|NCT00999908|10989478|FG002|NOT COMPLETED|Treatment Period 2||0
9874849|NCT00999908|10989476|FG000|STARTED|Treatment Period 3||16
9874850|NCT00999908|10989477|FG001|STARTED|Treatment Period 3||16
9874851|NCT00999908|10989478|FG002|STARTED|Treatment Period 3||19
9874852|NCT00999908|10989476|FG000|COMPLETED|Treatment Period 3||16
9874853|NCT00999908|10989477|FG001|COMPLETED|Treatment Period 3||16
9874854|NCT00999908|10989478|FG002|COMPLETED|Treatment Period 3||19
9874855|NCT00999908|10989476|FG000|NOT COMPLETED|Treatment Period 3||0
9874856|NCT00999908|10989477|FG001|NOT COMPLETED|Treatment Period 3||0
9874857|NCT00999908|10989478|FG002|NOT COMPLETED|Treatment Period 3||0
9874858|NCT00999921|10989488|FG000|STARTED|Overall Study||127
9874859|NCT00999921|10989489|FG001|STARTED|Overall Study||129
9874860|NCT00999921|10989488|FG000|COMPLETED|Overall Study||117
9874861|NCT00999921|10989489|FG001|COMPLETED|Overall Study||110
9874862|NCT00999921|10989488|FG000|NOT COMPLETED|Overall Study||10
9874863|NCT00999921|10989489|FG001|NOT COMPLETED|Overall Study||19
9874864|NCT01000025|10989500|FG000|STARTED|Overall Study||480
9874865|NCT01000025|10989501|FG001|STARTED|Overall Study||240
9874866|NCT01000025|10989500|FG000|COMPLETED|Overall Study||12
9874867|NCT01000025|10989501|FG001|COMPLETED|Overall Study||2
9874868|NCT01000025|10989500|FG000|NOT COMPLETED|Overall Study||468
9874869|NCT01000025|10989501|FG001|NOT COMPLETED|Overall Study||238
9874870|NCT01000051|10989509|FG000|STARTED|Overall Study||42
9874871|NCT01000051|10989510|FG001|STARTED|Overall Study||18
9874872|NCT01000051|10989509|FG000|COMPLETED|Overall Study||39
9874873|NCT01000051|10989510|FG001|COMPLETED|Overall Study||17
9874874|NCT01000051|10989509|FG000|NOT COMPLETED|Overall Study||3
9874875|NCT01000051|10989510|FG001|NOT COMPLETED|Overall Study||1
9874876|NCT01000064|10989516|FG000|STARTED|Overall Study||7
9874877|NCT01000064|10989517|FG001|STARTED|Overall Study||6
9874878|NCT01000064|10989516|FG000|COMPLETED|Overall Study||6
9874879|NCT01000064|10989517|FG001|COMPLETED|Overall Study||5
9874880|NCT01000064|10989516|FG000|NOT COMPLETED|Overall Study||1
9874881|NCT01000064|10989517|FG001|NOT COMPLETED|Overall Study||1
9874882|NCT01000155|10989526|FG000|STARTED|Overall Study||5
9874883|NCT01000155|10989526|FG000|COMPLETED|Overall Study||3
9874884|NCT01000155|10989526|FG000|NOT COMPLETED|Overall Study||2
9874885|NCT01000285|10989532|FG000|STARTED|Overall Study||18
9874886|NCT01000285|10989532|FG000|COMPLETED|Overall Study||18
9874887|NCT01000285|10989532|FG000|NOT COMPLETED|Overall Study||0
9874888|NCT01000311|10989548|FG000|STARTED|Overall Study||258
9874889|NCT01000311|10989549|FG001|STARTED|Overall Study||271
9874890|NCT01000311|10989548|FG000|COMPLETED|Overall Study||213
9874891|NCT01000311|10989549|FG001|COMPLETED|Overall Study||201
9874892|NCT01000311|10989548|FG000|NOT COMPLETED|Overall Study||45
9874893|NCT01000311|10989549|FG001|NOT COMPLETED|Overall Study||70
9874894|NCT01000324|10989555|FG000|STARTED|Year 16||40
9874895|NCT01000324|10989555|FG000|COMPLETED|Year 16||40
9874896|NCT01000324|10989555|FG000|NOT COMPLETED|Year 16||0
9874897|NCT01000324|10989555|FG000|STARTED|Year 17||32
9874898|NCT01000324|10989555|FG000|COMPLETED|Year 17||32
9874899|NCT01000324|10989555|FG000|NOT COMPLETED|Year 17||0
9874900|NCT01000324|10989555|FG000|STARTED|Year 18||29
9874901|NCT01000324|10989555|FG000|COMPLETED|Year 18||29
9874902|NCT01000324|10989555|FG000|NOT COMPLETED|Year 18||0
9874903|NCT01000324|10989555|FG000|STARTED|Year 19||28
9874904|NCT01000324|10989555|FG000|COMPLETED|Year 19||28
9874905|NCT01000324|10989555|FG000|NOT COMPLETED|Year 19||0
9874906|NCT01000324|10989555|FG000|STARTED|Year 20||28
9874907|NCT01000324|10989555|FG000|COMPLETED|Year 20||28
9874908|NCT01000324|10989555|FG000|NOT COMPLETED|Year 20||0
9874909|NCT01000337|10989562|FG000|STARTED|Overall Study||34
9874910|NCT01000337|10989563|FG001|STARTED|Overall Study||33
9874911|NCT01000337|10989562|FG000|COMPLETED|Overall Study||30
9874912|NCT01000337|10989563|FG001|COMPLETED|Overall Study||30
9874913|NCT01000337|10989562|FG000|NOT COMPLETED|Overall Study||4
9874914|NCT01000337|10989563|FG001|NOT COMPLETED|Overall Study||3
9874915|NCT01000376|10989571|FG000|STARTED|Cycle 1 Day 1||6
9874916|NCT01000376|10989572|FG001|STARTED|Cycle 1 Day 1||6
9874917|NCT01000376|10989571|FG000|COMPLETED|Cycle 1 Day 1||4
9874918|NCT01000376|10989572|FG001|COMPLETED|Cycle 1 Day 1||6
9874919|NCT01000376|10989571|FG000|NOT COMPLETED|Cycle 1 Day 1||2
9874920|NCT01000376|10989572|FG001|NOT COMPLETED|Cycle 1 Day 1||0
9874921|NCT01000376|10989571|FG000|STARTED|Cycle 1 Day 15||4
9874922|NCT01000376|10989572|FG001|STARTED|Cycle 1 Day 15||6
9874923|NCT01000376|10989571|FG000|COMPLETED|Cycle 1 Day 15||4
9874924|NCT01000376|10989572|FG001|COMPLETED|Cycle 1 Day 15||6
9874925|NCT01000376|10989571|FG000|NOT COMPLETED|Cycle 1 Day 15||0
9874926|NCT01000376|10989572|FG001|NOT COMPLETED|Cycle 1 Day 15||0
9874927|NCT01000480|10989578|FG000|STARTED|Induction Phase||90
9874928|NCT01000480|10989578|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90
9874929|NCT01000480|10989578|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
9874930|NCT01000480|10989578|FG000|COMPLETED|Induction Phase||83
9874931|NCT01000480|10989578|FG000|NOT COMPLETED|Induction Phase||7
9874932|NCT01000480|10989578|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
9874933|NCT01000480|10989578|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
9874934|NCT01000480|10989578|FG000|COMPLETED|Concurrent Therapy Phase||65
9874935|NCT01000480|10989578|FG000|NOT COMPLETED|Concurrent Therapy Phase||10
9874936|NCT01000480|10989578|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
9874937|NCT01000480|10989578|FG000|COMPLETED|Follow-Up Period||88
9874938|NCT01000480|10989578|FG000|NOT COMPLETED|Follow-Up Period||0
9874939|NCT01000493|10989584|FG000|STARTED|Overall Study||60
9874940|NCT01000493|10989585|FG001|STARTED|Overall Study||69
9874941|NCT01000493|10989584|FG000|COMPLETED|Overall Study||21
9874942|NCT01000493|10989585|FG001|COMPLETED|Overall Study||14
9874943|NCT01000493|10989584|FG000|NOT COMPLETED|Overall Study||39
9874944|NCT01000493|10989585|FG001|NOT COMPLETED|Overall Study||55
9874945|NCT01000506|10989595|FG000|STARTED|Overall Study||155
9874946|NCT01000506|10989596|FG001|STARTED|Overall Study||153
9874947|NCT01000506|10989597|FG002|STARTED|Overall Study||152
9874948|NCT01000506|10989598|FG003|STARTED|Overall Study||156
9874949|NCT01000506|10989595|FG000|COMPLETED|Overall Study||127
9874950|NCT01000506|10989596|FG001|COMPLETED|Overall Study||129
9874951|NCT01000506|10989597|FG002|COMPLETED|Overall Study||131
9874952|NCT01000506|10989598|FG003|COMPLETED|Overall Study||133
9874953|NCT01000506|10989595|FG000|NOT COMPLETED|Overall Study||28
9874954|NCT01000506|10989596|FG001|NOT COMPLETED|Overall Study||24
9874955|NCT01000506|10989597|FG002|NOT COMPLETED|Overall Study||21
9874956|NCT01000506|10989598|FG003|NOT COMPLETED|Overall Study||23
9874957|NCT01000610|10989608|FG000|STARTED|Overall Study||18
9874958|NCT01000610|10989608|FG000|COMPLETED|Overall Study||12
9874959|NCT01000610|10989608|FG000|NOT COMPLETED|Overall Study||6
9874960|NCT01000636|10989612|FG000|STARTED|Overall Study||9
9874961|NCT01000636|10989612|FG000|COMPLETED|Overall Study||7
9874962|NCT01000636|10989612|FG000|NOT COMPLETED|Overall Study||2
9874963|NCT01000649|10989620|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
9874964|NCT01000649|10989621|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
9874965|NCT01000649|10989622|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
9874966|NCT01000649|10989623|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
9874967|NCT01000649|10989620|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
9874968|NCT01000649|10989621|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
9874969|NCT01000649|10989622|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
9874970|NCT01000649|10989623|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
9874971|NCT01000649|10989620|FG000|COMPLETED|Overall Study||5
9874972|NCT01000649|10989621|FG001|COMPLETED|Overall Study||16
9874973|NCT01000649|10989622|FG002|COMPLETED|Overall Study||0
9874974|NCT01000649|10989623|FG003|COMPLETED|Overall Study||15
9874975|NCT01000649|10989620|FG000|NOT COMPLETED|Overall Study||5
9874976|NCT01000649|10989621|FG001|NOT COMPLETED|Overall Study||3
9874977|NCT01000649|10989622|FG002|NOT COMPLETED|Overall Study||2
9874978|NCT01000649|10989623|FG003|NOT COMPLETED|Overall Study||6
9874979|NCT01000662|10989634|FG000|STARTED|Overall Study||206
9874980|NCT01000662|10989635|FG001|STARTED|Overall Study||206
9874981|NCT01000662|10989634|FG000|COMPLETED|Overall Study||202
9874982|NCT01000662|10989635|FG001|COMPLETED|Overall Study||198
9874983|NCT01000662|10989634|FG000|NOT COMPLETED|Overall Study||4
9874984|NCT01000662|10989635|FG001|NOT COMPLETED|Overall Study||8
9874985|NCT01000727|10989645|FG000|STARTED|Overall Study||6522
10097238|NCT02372383|11226198|FG002|COMPLETED|Second Intervention (1 Day)||10
10097239|NCT02372383|11226196|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9874986|NCT01000727|10989646|FG001|STARTED|Overall Study||6504
9874987|NCT01000727|10989645|FG000|COMPLETED|Overall Study||6347
9874988|NCT01000727|10989646|FG001|COMPLETED|Overall Study||6328
9874989|NCT01000727|10989645|FG000|NOT COMPLETED|Overall Study||175
9874990|NCT01000727|10989646|FG001|NOT COMPLETED|Overall Study||176
9874991|NCT01000805|10989656|FG000|STARTED|Overall Study||262
9874992|NCT01000805|10989657|FG001|STARTED|Overall Study||266
9874993|NCT01000805|10989656|FG000|COMPLETED|Overall Study||192
9874994|NCT01000805|10989657|FG001|COMPLETED|Overall Study||204
9874995|NCT01000805|10989656|FG000|NOT COMPLETED|Overall Study||70
9874996|NCT01000805|10989657|FG001|NOT COMPLETED|Overall Study||62
9874997|NCT01000818|10989664|FG000|STARTED|Raltegravir||18
9874998|NCT01000818|10989664|FG000|COMPLETED|Raltegravir||18
9874999|NCT01000818|10989664|FG000|NOT COMPLETED|Raltegravir||0
9875000|NCT01000818|10989664|FG000|STARTED|Famotidine + Raltegravir||18
9875001|NCT01000818|10989664|FG000|COMPLETED|Famotidine + Raltegravir||18
9875002|NCT01000818|10989664|FG000|NOT COMPLETED|Famotidine + Raltegravir||0
9875003|NCT01000818|10989664|FG000|STARTED|Omeprazole + Raltegravir||18
9875004|NCT01000818|10989664|FG000|COMPLETED|Omeprazole + Raltegravir||18
9875005|NCT01000818|10989664|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0
9875006|NCT01000961|10989673|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
9875007|NCT01000961|10989674|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
9875008|NCT01000961|10989673|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
9875009|NCT01000961|10989674|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
9875010|NCT01000961|10989673|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
9875011|NCT01000961|10989674|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
9875012|NCT01000961|10989673|FG000|STARTED|First Intervention (3 Weeks)||21
9875013|NCT01000961|10989674|FG001|STARTED|First Intervention (3 Weeks)||22
9875014|NCT01000961|10989673|FG000|COMPLETED|First Intervention (3 Weeks)||21
9875015|NCT01000961|10989674|FG001|COMPLETED|First Intervention (3 Weeks)||20
9875016|NCT01000961|10989673|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
9875017|NCT01000961|10989674|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
9875018|NCT01000961|10989673|FG000|STARTED|Second Intervention (3 Weeks)||21
9875019|NCT01000961|10989674|FG001|STARTED|Second Intervention (3 Weeks)||20
9875020|NCT01000961|10989673|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
9875021|NCT01000961|10989674|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
9875022|NCT01000961|10989673|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
9875023|NCT01000961|10989674|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9875024|NCT01000974|10989685|FG000|STARTED|Primary Vaccination Phase||2963
9875025|NCT01000974|10989686|FG001|STARTED|Primary Vaccination Phase||520
9875026|NCT01000974|10989687|FG002|STARTED|Primary Vaccination Phase||520
9875027|NCT01000974|10989685|FG000|COMPLETED|Primary Vaccination Phase||2625
9875028|NCT01000974|10989686|FG001|COMPLETED|Primary Vaccination Phase||470
9875029|NCT01000974|10989687|FG002|COMPLETED|Primary Vaccination Phase||457
9875030|NCT01000974|10989685|FG000|NOT COMPLETED|Primary Vaccination Phase||338
9875031|NCT01000974|10989686|FG001|NOT COMPLETED|Primary Vaccination Phase||50
9875032|NCT01000974|10989687|FG002|NOT COMPLETED|Primary Vaccination Phase||63
9875033|NCT01000974|10989685|FG000|STARTED|Booster Vaccination Phase||2337
9875034|NCT01000974|10989686|FG001|STARTED|Booster Vaccination Phase||435
9875035|NCT01000974|10989687|FG002|STARTED|Booster Vaccination Phase||400
9875036|NCT01000974|10989685|FG000|COMPLETED|Booster Vaccination Phase||2270
9875037|NCT01000974|10989686|FG001|COMPLETED|Booster Vaccination Phase||423
9875038|NCT01000974|10989687|FG002|COMPLETED|Booster Vaccination Phase||386
9875039|NCT01000974|10989685|FG000|NOT COMPLETED|Booster Vaccination Phase||67
9875040|NCT01000974|10989686|FG001|NOT COMPLETED|Booster Vaccination Phase||12
9875041|NCT01000974|10989687|FG002|NOT COMPLETED|Booster Vaccination Phase||14
9875042|NCT01000987|10989701|FG000|STARTED|Overall Study||12
9875043|NCT01000987|10989702|FG001|STARTED|Overall Study||15
9875044|NCT01000987|10989703|FG002|STARTED|Overall Study||17
9875045|NCT01000987|10989701|FG000|COMPLETED|Overall Study||12
9875046|NCT01000987|10989702|FG001|COMPLETED|Overall Study||15
9875047|NCT01000987|10989703|FG002|COMPLETED|Overall Study||17
9875048|NCT01000987|10989701|FG000|NOT COMPLETED|Overall Study||0
9875049|NCT01000987|10989702|FG001|NOT COMPLETED|Overall Study||0
9875050|NCT01000987|10989703|FG002|NOT COMPLETED|Overall Study||0
9875051|NCT01001052|10989711|FG000|STARTED|Overall Study||20
9875052|NCT01001052|10989712|FG001|STARTED|Overall Study||18
9875053|NCT01001052|10989711|FG000|COMPLETED|Overall Study||20
9875054|NCT01001052|10989712|FG001|COMPLETED|Overall Study||18
9875055|NCT01001052|10989711|FG000|NOT COMPLETED|Overall Study||0
9875056|NCT01001052|10989712|FG001|NOT COMPLETED|Overall Study||0
9875057|NCT01001078|10989720|FG000|STARTED|Overall Study||50
9875058|NCT01001078|10989721|FG001|STARTED|Overall Study||50
9875059|NCT01001078|10989720|FG000|Received Allocated Intervention|Overall Study||46
9875060|NCT01001078|10989721|FG001|Received Allocated Intervention|Overall Study||46
9875061|NCT01001078|10989720|FG000|Received Crossover|Overall Study||2
9875062|NCT01001078|10989721|FG001|Received Crossover|Overall Study||3
9875063|NCT01001078|10989720|FG000|Intubated|Overall Study||2
9875064|NCT01001078|10989721|FG001|Intubated|Overall Study||1
9875065|NCT01001078|10989720|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
9875066|NCT01001078|10989721|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
9875067|NCT01001078|10989720|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
9875068|NCT01001078|10989721|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
9875069|NCT01001078|10989720|FG000|NOT COMPLETED|Overall Study||0
9875070|NCT01001078|10989721|FG001|NOT COMPLETED|Overall Study||0
9875071|NCT01001104|10989733|FG000|STARTED|Overall Study||35
9875072|NCT01001104|10989734|FG001|STARTED|Overall Study||37
9875073|NCT01001104|10989735|FG002|STARTED|Overall Study||36
9875074|NCT01001104|10989736|FG003|STARTED|Overall Study||37
9875075|NCT01001104|10989733|FG000|COMPLETED|Overall Study||33
9875076|NCT01001104|10989734|FG001|COMPLETED|Overall Study||36
9875077|NCT01001104|10989735|FG002|COMPLETED|Overall Study||35
9875078|NCT01001104|10989736|FG003|COMPLETED|Overall Study||34
9875079|NCT01001104|10989733|FG000|NOT COMPLETED|Overall Study||2
9875080|NCT01001104|10989734|FG001|NOT COMPLETED|Overall Study||1
9875081|NCT01001104|10989735|FG002|NOT COMPLETED|Overall Study||1
9875082|NCT01001104|10989736|FG003|NOT COMPLETED|Overall Study||3
9875083|NCT01001169|10989751|FG000|STARTED|Overall Study||30
9875084|NCT01001169|10989752|FG001|STARTED|Overall Study||30
9875085|NCT01001169|10989751|FG000|COMPLETED|Overall Study||28
9875086|NCT01001169|10989752|FG001|COMPLETED|Overall Study||29
9875087|NCT01001169|10989751|FG000|NOT COMPLETED|Overall Study||2
9875088|NCT01001169|10989752|FG001|NOT COMPLETED|Overall Study||1
9875089|NCT01001195|10989770|FG000|STARTED|Overall Study||39
9875090|NCT01001195|10989771|FG001|STARTED|Overall Study||41
9875091|NCT01001195|10989772|FG002|STARTED|Overall Study||44
9875092|NCT01001195|10989773|FG003|STARTED|Overall Study||41
9875093|NCT01001195|10989770|FG000|COMPLETED|Overall Study||37
9875094|NCT01001195|10989771|FG001|COMPLETED|Overall Study||39
9875095|NCT01001195|10989772|FG002|COMPLETED|Overall Study||44
9875096|NCT01001195|10989773|FG003|COMPLETED|Overall Study||41
9875097|NCT01001195|10989770|FG000|NOT COMPLETED|Overall Study||2
9875098|NCT01001195|10989771|FG001|NOT COMPLETED|Overall Study||2
9875099|NCT01001195|10989772|FG002|NOT COMPLETED|Overall Study||0
9875100|NCT01001195|10989773|FG003|NOT COMPLETED|Overall Study||0
9875101|NCT01001208|10989785|FG000|STARTED|Overall Study||239
9875102|NCT01001208|10989786|FG001|STARTED|Overall Study||239
9875103|NCT01001208|10989785|FG000|COMPLETED|Overall Study||211
9875104|NCT01001208|10989786|FG001|COMPLETED|Overall Study||206
9875105|NCT01001208|10989785|FG000|NOT COMPLETED|Overall Study||28
9875106|NCT01001208|10989786|FG001|NOT COMPLETED|Overall Study||33
9875107|NCT01001221|10989796|FG000|STARTED|Overall Study||5
9875108|NCT01001221|10989797|FG001|STARTED|Overall Study||5
9875109|NCT01001221|10989798|FG002|STARTED|Overall Study||3
9875110|NCT01001221|10989799|FG003|STARTED|Overall Study||6
9875111|NCT01001221|10989800|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
9875112|NCT01001221|10989796|FG000|Treated|Overall Study||5
9875113|NCT01001221|10989797|FG001|Treated|Overall Study||5
9875114|NCT01001221|10989798|FG002|Treated|Overall Study||2
9875115|NCT01001221|10989799|FG003|Treated|Overall Study||6
9875116|NCT01001221|10989800|FG004|Treated|Overall Study||0
9875117|NCT01001221|10989796|FG000|Completed 1st Treatment Cycle|Overall Study||5
9875118|NCT01001221|10989797|FG001|Completed 1st Treatment Cycle|Overall Study||5
9875119|NCT01001221|10989798|FG002|Completed 1st Treatment Cycle|Overall Study||2
9875120|NCT01001221|10989799|FG003|Completed 1st Treatment Cycle|Overall Study||6
9875121|NCT01001221|10989800|FG004|Completed 1st Treatment Cycle|Overall Study||0
9875122|NCT01001221|10989796|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
9875123|NCT01001221|10989797|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
9875124|NCT01001221|10989798|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
9875125|NCT01001221|10989799|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
9875126|NCT01001221|10989800|FG004|COMPLETED|Overall Study||0
9875127|NCT01001221|10989796|FG000|NOT COMPLETED|Overall Study||5
9875128|NCT01001221|10989797|FG001|NOT COMPLETED|Overall Study||5
9875129|NCT01001221|10989798|FG002|NOT COMPLETED|Overall Study||3
9875130|NCT01001221|10989799|FG003|NOT COMPLETED|Overall Study||6
9875131|NCT01001221|10989800|FG004|NOT COMPLETED|Overall Study||0
9875132|NCT01001299|10989811|FG000|STARTED|Overall Study||25
9875133|NCT01001299|10989811|FG000|COMPLETED|Overall Study||0
9875134|NCT01001299|10989811|FG000|NOT COMPLETED|Overall Study||25
9875135|NCT01001325|10989817|FG000|STARTED|Overall Study||234
9875136|NCT01001325|10989818|FG001|STARTED|Overall Study||234
9875137|NCT01001325|10989817|FG000|COMPLETED|Overall Study||216
9875138|NCT01001325|10989818|FG001|COMPLETED|Overall Study||224
9875139|NCT01001325|10989817|FG000|NOT COMPLETED|Overall Study||18
9875140|NCT01001325|10989818|FG001|NOT COMPLETED|Overall Study||10
9875141|NCT01001377|10989826|FG000|STARTED|Overall Study||504
9875142|NCT01001377|10989827|FG001|STARTED|Overall Study||506
9875143|NCT01001377|10989826|FG000|Received Treatment|Overall Study||500
9875144|NCT01001377|10989827|FG001|Received Treatment|Overall Study||499
9875145|NCT01001377|10989826|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78
9875146|NCT01001377|10989827|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85
9875147|NCT01001377|10989826|FG000|NOT COMPLETED|Overall Study||426
9875148|NCT01001377|10989827|FG001|NOT COMPLETED|Overall Study||421
9875149|NCT01001403|10989835|FG000|STARTED|Overall Study||31
9875150|NCT01001403|10989836|FG001|STARTED|Overall Study||31
9875151|NCT01001403|10989835|FG000|COMPLETED|Overall Study||31
9875152|NCT01001403|10989836|FG001|COMPLETED|Overall Study||31
9875153|NCT01001403|10989835|FG000|NOT COMPLETED|Overall Study||0
9875154|NCT01001403|10989836|FG001|NOT COMPLETED|Overall Study||0
9875155|NCT01001429|10989844|FG000|STARTED|Overall Study||39
9875156|NCT01001429|10989845|FG001|STARTED|Overall Study||38
9875157|NCT01001429|10989844|FG000|COMPLETED|Overall Study||39
9875158|NCT01001429|10989845|FG001|COMPLETED|Overall Study||37
9875159|NCT01001429|10989844|FG000|NOT COMPLETED|Overall Study||0
9875160|NCT01001429|10989845|FG001|NOT COMPLETED|Overall Study||1
9875161|NCT01001442|10989883|FG000|STARTED|Overall Study||4
9875162|NCT01001442|10989884|FG001|STARTED|Overall Study||3
9875163|NCT01001442|10989885|FG002|STARTED|Overall Study||4
9875164|NCT01001442|10989886|FG003|STARTED|Overall Study||3
9875165|NCT01001442|10989887|FG004|STARTED|Overall Study||4
9875166|NCT01001442|10989888|FG005|STARTED|Overall Study||3
9875167|NCT01001442|10989889|FG006|STARTED|Overall Study||10
9875168|NCT01001442|10989890|FG007|STARTED|Overall Study||4
9875169|NCT01001442|10989883|FG000|COMPLETED|Overall Study||4
9875170|NCT01001442|10989884|FG001|COMPLETED|Overall Study||3
9875171|NCT01001442|10989885|FG002|COMPLETED|Overall Study||4
9875172|NCT01001442|10989886|FG003|COMPLETED|Overall Study||3
9875173|NCT01001442|10989887|FG004|COMPLETED|Overall Study||2
9875174|NCT01001442|10989888|FG005|COMPLETED|Overall Study||3
9875175|NCT01001442|10989889|FG006|COMPLETED|Overall Study||6
9875176|NCT01001442|10989890|FG007|COMPLETED|Overall Study||2
9875177|NCT01001442|10989883|FG000|NOT COMPLETED|Overall Study||0
9875178|NCT01001442|10989884|FG001|NOT COMPLETED|Overall Study||0
9875179|NCT01001442|10989885|FG002|NOT COMPLETED|Overall Study||0
9875180|NCT01001442|10989886|FG003|NOT COMPLETED|Overall Study||0
9875181|NCT01001442|10989887|FG004|NOT COMPLETED|Overall Study||2
9875182|NCT01001442|10989888|FG005|NOT COMPLETED|Overall Study||0
9875183|NCT01001442|10989889|FG006|NOT COMPLETED|Overall Study||4
9875184|NCT01001442|10989890|FG007|NOT COMPLETED|Overall Study||2
9875185|NCT01001494|10989915|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
9875186|NCT01001494|10989916|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
9875187|NCT01001494|10989917|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
9875188|NCT01001494|10989915|FG000|COMPLETED|Overall Study||253
9875189|NCT01001494|10989916|FG001|COMPLETED|Overall Study||252
9875190|NCT01001494|10989917|FG002|COMPLETED|Overall Study||232
9875191|NCT01001494|10989915|FG000|NOT COMPLETED|Overall Study||24
9875192|NCT01001494|10989916|FG001|NOT COMPLETED|Overall Study||17
9875193|NCT01001494|10989917|FG002|NOT COMPLETED|Overall Study||41
9875194|NCT01001520|10989925|FG000|STARTED|Medication Period 1||22
9875195|NCT01001520|10989926|FG001|STARTED|Medication Period 1||24
9875196|NCT01001520|10989925|FG000|COMPLETED|Medication Period 1||18
9875197|NCT01001520|10989926|FG001|COMPLETED|Medication Period 1||17
9875198|NCT01001520|10989925|FG000|NOT COMPLETED|Medication Period 1||4
9875199|NCT01001520|10989926|FG001|NOT COMPLETED|Medication Period 1||7
9875200|NCT01001520|10989925|FG000|STARTED|Washout Period||18
9875201|NCT01001520|10989926|FG001|STARTED|Washout Period||17
9875202|NCT01001520|10989925|FG000|COMPLETED|Washout Period||16
9875203|NCT01001520|10989926|FG001|COMPLETED|Washout Period||16
9875204|NCT01001520|10989925|FG000|NOT COMPLETED|Washout Period||2
9875205|NCT01001520|10989926|FG001|NOT COMPLETED|Washout Period||1
9875206|NCT01001520|10989925|FG000|STARTED|Medication Period 2||16
9875207|NCT01001520|10989926|FG001|STARTED|Medication Period 2||16
9875208|NCT01001520|10989925|FG000|COMPLETED|Medication Period 2||16
9875209|NCT01001520|10989926|FG001|COMPLETED|Medication Period 2||13
9875210|NCT01001520|10989925|FG000|NOT COMPLETED|Medication Period 2||0
9875211|NCT01001520|10989926|FG001|NOT COMPLETED|Medication Period 2||3
9875212|NCT01001546|10989937|FG000|STARTED|Overall Study||206
9875213|NCT01001546|10989938|FG001|STARTED|Overall Study||207
9875214|NCT01001546|10989937|FG000|COMPLETED|Overall Study||206
9875215|NCT01001546|10989938|FG001|COMPLETED|Overall Study||207
9875216|NCT01001546|10989937|FG000|NOT COMPLETED|Overall Study||0
9875217|NCT01001546|10989938|FG001|NOT COMPLETED|Overall Study||0
9875218|NCT01001559|10989946|FG000|STARTED|Overall Study||95
9875219|NCT01001559|10989947|FG001|STARTED|Overall Study||147
9875220|NCT01001559|10989946|FG000|COMPLETED|Overall Study||95
9875221|NCT01001559|10989947|FG001|COMPLETED|Overall Study||147
9875222|NCT01001559|10989946|FG000|NOT COMPLETED|Overall Study||0
9875223|NCT01001559|10989947|FG001|NOT COMPLETED|Overall Study||0
9875224|NCT01001572|10989955|FG000|STARTED|Single-Blind Valsartan 160 mg||932
9875225|NCT01001572|10989956|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
9875226|NCT01001572|10989957|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
9875227|NCT01001572|10989955|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654
9875228|NCT01001572|10989956|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0
9875229|NCT01001572|10989957|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0
9875230|NCT01001572|10989955|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
9875231|NCT01001572|10989956|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
9875232|NCT01001572|10989957|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
9875233|NCT01001572|10989955|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
9875234|NCT01001572|10989956|FG001|STARTED|Double-Blind Treatment Phase||329
9875235|NCT01001572|10989957|FG002|STARTED|Double-Blind Treatment Phase||325
9875236|NCT01001572|10989955|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
9875237|NCT01001572|10989956|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
9875238|NCT01001572|10989957|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
9875239|NCT01001572|10989955|FG000|COMPLETED|Double-Blind Treatment Phase||0
9875240|NCT01001572|10989956|FG001|COMPLETED|Double-Blind Treatment Phase||319
9875241|NCT01001572|10989957|FG002|COMPLETED|Double-Blind Treatment Phase||306
9875242|NCT01001572|10989955|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
9875243|NCT01001572|10989956|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10
9875244|NCT01001572|10989957|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19
9875245|NCT01001598|10989963|FG000|STARTED|Overall Study||5
9875246|NCT01001598|10989963|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
9875247|NCT01001598|10989963|FG000|NOT COMPLETED|Overall Study||2
9875248|NCT01001702|10989967|FG000|STARTED|Overall Study||85
9875249|NCT01001702|10989967|FG000|COMPLETED|Overall Study||13
9875250|NCT01001702|10989967|FG000|NOT COMPLETED|Overall Study||72
9875251|NCT01001767|10989973|FG000|STARTED|Overall Study||18
9875252|NCT01001767|10989974|FG001|STARTED|Overall Study||17
9875253|NCT01001767|10989973|FG000|COMPLETED|Overall Study||14
9875254|NCT01001767|10989974|FG001|COMPLETED|Overall Study||17
9875255|NCT01001767|10989973|FG000|NOT COMPLETED|Overall Study||4
9875256|NCT01001767|10989974|FG001|NOT COMPLETED|Overall Study||0
9875257|NCT01001806|10989983|FG000|STARTED|Overall Study||42
9875258|NCT01001806|10989984|FG001|STARTED|Overall Study||42
9875259|NCT01001806|10989985|FG002|STARTED|Overall Study||42
9875260|NCT01001806|10989983|FG000|COMPLETED|Overall Study||42
9875261|NCT01001806|10989984|FG001|COMPLETED|Overall Study||41
9875262|NCT01001806|10989985|FG002|COMPLETED|Overall Study||38
9875263|NCT01001806|10989983|FG000|NOT COMPLETED|Overall Study||0
9875264|NCT01001806|10989984|FG001|NOT COMPLETED|Overall Study||1
9875265|NCT01001806|10989985|FG002|NOT COMPLETED|Overall Study||4
9875266|NCT01001832|10989995|FG000|STARTED|Short-term Period||59
9875267|NCT01001832|10989996|FG001|STARTED|Short-term Period||59
9875268|NCT01001832|10989995|FG000|COMPLETED|Short-term Period||57
9875269|NCT01001832|10989996|FG001|COMPLETED|Short-term Period||56
9875270|NCT01001832|10989995|FG000|NOT COMPLETED|Short-term Period||2
9875271|NCT01001832|10989996|FG001|NOT COMPLETED|Short-term Period||3
9875272|NCT01001832|10989995|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
9875273|NCT01001832|10989996|FG001|STARTED|Long-term Period||56
9875274|NCT01001832|10989995|FG000|COMPLETED|Long-term Period||52
9875275|NCT01001832|10989996|FG001|COMPLETED|Long-term Period||51
9875276|NCT01001832|10989995|FG000|NOT COMPLETED|Long-term Period||4
9875277|NCT01001832|10989996|FG001|NOT COMPLETED|Long-term Period||5
9875278|NCT01001832|10989995|FG000|STARTED|Follow-up Period||52
9875279|NCT01001832|10989996|FG001|STARTED|Follow-up Period||51
9875280|NCT01001832|10989995|FG000|COMPLETED|Follow-up Period||34
9875281|NCT01001832|10989996|FG001|COMPLETED|Follow-up Period||30
9875282|NCT01001832|10989995|FG000|NOT COMPLETED|Follow-up Period||18
9875283|NCT01001832|10989996|FG001|NOT COMPLETED|Follow-up Period||21
9875284|NCT01001910|10990005|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28
9875285|NCT01001910|10990005|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22
9875286|NCT01001910|10990005|FG000|NOT COMPLETED|Overall Study||6
9875287|NCT01001975|10990011|FG000|STARTED|Overall Study||5
9875288|NCT01001975|10990012|FG001|STARTED|Overall Study||5
9875289|NCT01001975|10990011|FG000|COMPLETED|Overall Study||5
9875290|NCT01001975|10990012|FG001|COMPLETED|Overall Study||5
9875291|NCT01001975|10990011|FG000|NOT COMPLETED|Overall Study||0
9875292|NCT01001975|10990012|FG001|NOT COMPLETED|Overall Study||0
9875293|NCT01001988|10990018|FG000|STARTED|Overall Study||596
9875294|NCT01001988|10990018|FG000|COMPLETED|Overall Study||479
9875295|NCT01001988|10990018|FG000|NOT COMPLETED|Overall Study||117
9875296|NCT01002105|10990024|FG000|STARTED|Overall Study||32
9875297|NCT01002105|10990025|FG001|STARTED|Overall Study||32
9875298|NCT01002105|10990024|FG000|COMPLETED|Overall Study||13
9875299|NCT01002105|10990025|FG001|COMPLETED|Overall Study||11
9875300|NCT01002105|10990024|FG000|NOT COMPLETED|Overall Study||19
9875301|NCT01002105|10990025|FG001|NOT COMPLETED|Overall Study||21
9875302|NCT01002118|10990034|FG000|STARTED|Overall Study||1
9875303|NCT01002118|10990034|FG000|Randomized Only Patient|Overall Study||1
9875304|NCT01002118|10990034|FG000|COMPLETED|Overall Study||1
9875305|NCT01002118|10990034|FG000|NOT COMPLETED|Overall Study||0
9875306|NCT01002287|10990040|FG000|STARTED|Overall Study||8
9875307|NCT01002287|10990041|FG001|STARTED|Overall Study||3
9875308|NCT01002287|10990040|FG000|COMPLETED|Overall Study||8
9875309|NCT01002287|10990041|FG001|COMPLETED|Overall Study||3
9875310|NCT01002287|10990040|FG000|NOT COMPLETED|Overall Study||0
9875311|NCT01002287|10990041|FG001|NOT COMPLETED|Overall Study||0
9875312|NCT01002339|10990050|FG000|STARTED|Overall Study||44
9875313|NCT01002339|10990051|FG001|STARTED|Overall Study||43
9875314|NCT01002339|10990052|FG002|STARTED|Overall Study||47
9875315|NCT01002339|10990050|FG000|COMPLETED|Overall Study||44
9875316|NCT01002339|10990051|FG001|COMPLETED|Overall Study||42
9875317|NCT01002339|10990052|FG002|COMPLETED|Overall Study||42
9875318|NCT01002339|10990050|FG000|NOT COMPLETED|Overall Study||0
9875319|NCT01002339|10990051|FG001|NOT COMPLETED|Overall Study||1
9875320|NCT01002339|10990052|FG002|NOT COMPLETED|Overall Study||5
9875321|NCT01002456|10990062|FG000|STARTED|Overall Study||98
9875322|NCT01002456|10990063|FG001|STARTED|Overall Study||122
9875323|NCT01002456|10990062|FG000|COMPLETED|Overall Study||98
9875324|NCT01002456|10990063|FG001|COMPLETED|Overall Study||122
9875325|NCT01002456|10990062|FG000|NOT COMPLETED|Overall Study||0
9875326|NCT01002456|10990063|FG001|NOT COMPLETED|Overall Study||0
9875327|NCT01002482|10990073|FG000|STARTED|Overall Study||1351
9875328|NCT01002482|10990074|FG001|STARTED|Overall Study||1333
9875329|NCT01002482|10990073|FG000|COMPLETED|Overall Study||1336
9875330|NCT01002482|10990074|FG001|COMPLETED|Overall Study||1312
9875331|NCT01002482|10990073|FG000|NOT COMPLETED|Overall Study||15
9875332|NCT01002482|10990074|FG001|NOT COMPLETED|Overall Study||21
9875333|NCT01002547|10990083|FG000|STARTED|Overall Study||32
9875334|NCT01002547|10990084|FG001|STARTED|Overall Study||36
9875335|NCT01002547|10990085|FG002|STARTED|Overall Study||37
9875336|NCT01002547|10990083|FG000|COMPLETED|Overall Study||24
9875337|NCT01002547|10990084|FG001|COMPLETED|Overall Study||33
9875338|NCT01002547|10990085|FG002|COMPLETED|Overall Study||29
9875339|NCT01002547|10990083|FG000|NOT COMPLETED|Overall Study||8
9875340|NCT01002547|10990084|FG001|NOT COMPLETED|Overall Study||3
9875341|NCT01002547|10990085|FG002|NOT COMPLETED|Overall Study||8
9875342|NCT01002573|10990095|FG000|STARTED|Overall Study||58
9875343|NCT01002573|10990096|FG001|STARTED|Overall Study||60
9875344|NCT01002573|10990095|FG000|COMPLETED|Overall Study||47
9875345|NCT01002573|10990096|FG001|COMPLETED|Overall Study||53
9875346|NCT01002573|10990095|FG000|NOT COMPLETED|Overall Study||11
9875347|NCT01002573|10990096|FG001|NOT COMPLETED|Overall Study||7
9875348|NCT01002742|10990104|FG000|STARTED|Overall Study||119
9875349|NCT01002742|10990105|FG001|STARTED|Overall Study||117
9875350|NCT01002742|10990104|FG000|COMPLETED|Overall Study||119
9875351|NCT01002742|10990105|FG001|COMPLETED|Overall Study||116
9875352|NCT01002742|10990104|FG000|NOT COMPLETED|Overall Study||0
9875353|NCT01002742|10990105|FG001|NOT COMPLETED|Overall Study||1
9875354|NCT01002755|10990111|FG000|STARTED|Overall Study||36
9875355|NCT01002755|10990111|FG000|COMPLETED|Overall Study||36
9875356|NCT01002755|10990111|FG000|NOT COMPLETED|Overall Study||0
9875357|NCT01002989|10990115|FG000|STARTED|Overall Study||98
9875358|NCT01002989|10990115|FG000|COMPLETED|Overall Study||93
9875359|NCT01002989|10990115|FG000|NOT COMPLETED|Overall Study||5
9875360|NCT01003067|10990121|FG000|STARTED|Overall Study||136
9875361|NCT01003067|10990122|FG001|STARTED|Overall Study||131
9875362|NCT01003067|10990121|FG000|COMPLETED|Overall Study||103
9875363|NCT01003067|10990122|FG001|COMPLETED|Overall Study||107
9875364|NCT01003067|10990121|FG000|NOT COMPLETED|Overall Study||33
9875365|NCT01003067|10990122|FG001|NOT COMPLETED|Overall Study||24
9875366|NCT01003080|10990130|FG000|STARTED|Overall Study||50
9875367|NCT01003080|10990131|FG001|STARTED|Overall Study||61
9875368|NCT01003080|10990130|FG000|COMPLETED|Overall Study||50
9875369|NCT01003080|10990131|FG001|COMPLETED|Overall Study||61
9875370|NCT01003080|10990130|FG000|NOT COMPLETED|Overall Study||0
9875371|NCT01003080|10990131|FG001|NOT COMPLETED|Overall Study||0
9875372|NCT01003106|10990141|FG000|STARTED|Baseline to Month 6||22
9875373|NCT01003106|10990142|FG001|STARTED|Baseline to Month 6||20
9875374|NCT01003106|10990143|FG002|STARTED|Baseline to Month 6||0
9875375|NCT01003106|10990144|FG003|STARTED|Baseline to Month 6||0
9875376|NCT01003106|10990145|FG004|STARTED|Baseline to Month 6||19
9875377|NCT01003106|10990146|FG005|STARTED|Baseline to Month 6||20
9875378|NCT01003106|10990147|FG006|STARTED|Baseline to Month 6||0
9875379|NCT01003106|10990148|FG007|STARTED|Baseline to Month 6||0
9875380|NCT01003106|10990141|FG000|COMPLETED|Baseline to Month 6||22
9875381|NCT01003106|10990142|FG001|COMPLETED|Baseline to Month 6||20
9875382|NCT01003106|10990143|FG002|COMPLETED|Baseline to Month 6||0
9875383|NCT01003106|10990144|FG003|COMPLETED|Baseline to Month 6||0
9875384|NCT01003106|10990145|FG004|COMPLETED|Baseline to Month 6||19
9875385|NCT01003106|10990146|FG005|COMPLETED|Baseline to Month 6||20
9875386|NCT01003106|10990147|FG006|COMPLETED|Baseline to Month 6||0
9875387|NCT01003106|10990148|FG007|COMPLETED|Baseline to Month 6||0
9875388|NCT01003106|10990141|FG000|NOT COMPLETED|Baseline to Month 6||0
9875389|NCT01003106|10990142|FG001|NOT COMPLETED|Baseline to Month 6||0
9875390|NCT01003106|10990143|FG002|NOT COMPLETED|Baseline to Month 6||0
9875391|NCT01003106|10990144|FG003|NOT COMPLETED|Baseline to Month 6||0
9875392|NCT01003106|10990145|FG004|NOT COMPLETED|Baseline to Month 6||0
9875393|NCT01003106|10990146|FG005|NOT COMPLETED|Baseline to Month 6||0
9875394|NCT01003106|10990147|FG006|NOT COMPLETED|Baseline to Month 6||0
9875395|NCT01003106|10990148|FG007|NOT COMPLETED|Baseline to Month 6||0
9875396|NCT01003106|10990141|FG000|STARTED|Month 6-Month 36||0
9875397|NCT01003106|10990142|FG001|STARTED|Month 6-Month 36||0
9875398|NCT01003106|10990143|FG002|STARTED|Month 6-Month 36||19
9875399|NCT01003106|10990144|FG003|STARTED|Month 6-Month 36||20
9875400|NCT01003106|10990145|FG004|STARTED|Month 6-Month 36||0
9875401|NCT01003106|10990146|FG005|STARTED|Month 6-Month 36||0
9875402|NCT01003106|10990147|FG006|STARTED|Month 6-Month 36||20
9875403|NCT01003106|10990148|FG007|STARTED|Month 6-Month 36||18
9875404|NCT01003106|10990141|FG000|COMPLETED|Month 6-Month 36||0
9875405|NCT01003106|10990142|FG001|COMPLETED|Month 6-Month 36||0
9875406|NCT01003106|10990143|FG002|COMPLETED|Month 6-Month 36||18
9875407|NCT01003106|10990144|FG003|COMPLETED|Month 6-Month 36||20
9875408|NCT01003106|10990145|FG004|COMPLETED|Month 6-Month 36||0
9875409|NCT01003106|10990146|FG005|COMPLETED|Month 6-Month 36||0
9875410|NCT01003106|10990147|FG006|COMPLETED|Month 6-Month 36||19
9875411|NCT01003106|10990148|FG007|COMPLETED|Month 6-Month 36||18
9875412|NCT01003106|10990141|FG000|NOT COMPLETED|Month 6-Month 36||0
9875413|NCT01003106|10990142|FG001|NOT COMPLETED|Month 6-Month 36||0
9875414|NCT01003106|10990143|FG002|NOT COMPLETED|Month 6-Month 36||1
9875415|NCT01003106|10990144|FG003|NOT COMPLETED|Month 6-Month 36||0
9875416|NCT01003106|10990145|FG004|NOT COMPLETED|Month 6-Month 36||0
9875417|NCT01003106|10990146|FG005|NOT COMPLETED|Month 6-Month 36||0
9875418|NCT01003106|10990147|FG006|NOT COMPLETED|Month 6-Month 36||1
9875419|NCT01003106|10990148|FG007|NOT COMPLETED|Month 6-Month 36||0
9875420|NCT01003184|10990164|FG000|STARTED|Overall Study||111
9875421|NCT01003184|10990165|FG001|STARTED|Overall Study||111
9875422|NCT01003184|10990164|FG000|Full Analysis Set (FAS)|Overall Study||111
9875423|NCT01003184|10990165|FG001|Full Analysis Set (FAS)|Overall Study||105
9875424|NCT01003184|10990164|FG000|COMPLETED|Overall Study||92
9875425|NCT01003184|10990165|FG001|COMPLETED|Overall Study||99
9875426|NCT01003184|10990164|FG000|NOT COMPLETED|Overall Study||19
9875427|NCT01003184|10990165|FG001|NOT COMPLETED|Overall Study||12
9875428|NCT01003210|10990173|FG000|STARTED|Overall Study||105
9875429|NCT01003210|10990174|FG001|STARTED|Overall Study||105
9875430|NCT01003210|10990173|FG000|COMPLETED|Overall Study||104
9875431|NCT01003210|10990174|FG001|COMPLETED|Overall Study||102
9875432|NCT01003210|10990173|FG000|NOT COMPLETED|Overall Study||1
9875433|NCT01003210|10990174|FG001|NOT COMPLETED|Overall Study||3
9875434|NCT01003249|10990180|FG000|STARTED|First Intervention (4 Weeks)||7
9875435|NCT01003249|10990181|FG001|STARTED|First Intervention (4 Weeks)||5
9875436|NCT01003249|10990180|FG000|Received Intervention|First Intervention (4 Weeks)||7
9875437|NCT01003249|10990181|FG001|Received Intervention|First Intervention (4 Weeks)||5
9875438|NCT01003249|10990180|FG000|COMPLETED|First Intervention (4 Weeks)||5
9875439|NCT01003249|10990181|FG001|COMPLETED|First Intervention (4 Weeks)||3
9875440|NCT01003249|10990180|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
9875441|NCT01003249|10990181|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
9875442|NCT01003249|10990180|FG000|STARTED|Washout (3 Weeks)||4
9875443|NCT01003249|10990181|FG001|STARTED|Washout (3 Weeks)||3
9875444|NCT01003249|10990180|FG000|COMPLETED|Washout (3 Weeks)||4
9875445|NCT01003249|10990181|FG001|COMPLETED|Washout (3 Weeks)||3
9875446|NCT01003249|10990180|FG000|NOT COMPLETED|Washout (3 Weeks)||0
9875447|NCT01003249|10990181|FG001|NOT COMPLETED|Washout (3 Weeks)||0
9875448|NCT01003249|10990180|FG000|STARTED|Second Intervention (4 Weeks)||4
9875449|NCT01003249|10990181|FG001|STARTED|Second Intervention (4 Weeks)||3
9875450|NCT01003249|10990180|FG000|COMPLETED|Second Intervention (4 Weeks)||3
9875451|NCT01003249|10990181|FG001|COMPLETED|Second Intervention (4 Weeks)||2
9875452|NCT01003249|10990180|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
9875453|NCT01003249|10990181|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
9875454|NCT01003275|10990193|FG000|STARTED|Overall Study||11
9875455|NCT01003275|10990194|FG001|STARTED|Overall Study||11
9875456|NCT01003275|10990193|FG000|COMPLETED|Overall Study||10
9875457|NCT01003275|10990194|FG001|COMPLETED|Overall Study||11
9875458|NCT01003275|10990193|FG000|NOT COMPLETED|Overall Study||1
9875459|NCT01003275|10990194|FG001|NOT COMPLETED|Overall Study||0
9875460|NCT01003288|10990202|FG000|STARTED|Overall Study||255
9875461|NCT01003288|10990202|FG000|COMPLETED|Overall Study||255
9875462|NCT01003288|10990202|FG000|NOT COMPLETED|Overall Study||0
10097240|NCT02372383|11226197|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10097241|NCT02372383|11226198|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10097242|NCT02372396|11226210|FG000|STARTED|Overall Study||17
10097243|NCT02372396|11226211|FG001|STARTED|Overall Study||20
10097244|NCT02372396|11226210|FG000|Began Intervention|Overall Study||14
10097245|NCT02372396|11226211|FG001|Began Intervention|Overall Study||14
10097246|NCT02372396|11226210|FG000|COMPLETED|Overall Study||10
10097247|NCT02372396|11226211|FG001|COMPLETED|Overall Study||11
10097248|NCT02372396|11226210|FG000|NOT COMPLETED|Overall Study||7
10097249|NCT02372396|11226211|FG001|NOT COMPLETED|Overall Study||9
10097250|NCT02372682|11226219|FG000|STARTED|Overall Study||78
10097251|NCT02372682|11226220|FG001|STARTED|Overall Study||93
10097252|NCT02372682|11226219|FG000|COMPLETED|Overall Study||70
10097253|NCT02372682|11226220|FG001|COMPLETED|Overall Study||79
10097254|NCT02372682|11226219|FG000|NOT COMPLETED|Overall Study||8
10097255|NCT02372682|11226220|FG001|NOT COMPLETED|Overall Study||14
10097256|NCT02372799|11226236|FG000|STARTED|Treatment Period||186
10097257|NCT02372799|11226237|FG001|STARTED|Treatment Period||187
10097258|NCT02372799|11226238|FG002|STARTED|Treatment Period||97
10097259|NCT02372799|11226236|FG000|COMPLETED|Treatment Period||152
10097260|NCT02372799|11226237|FG001|COMPLETED|Treatment Period||155
10097261|NCT02372799|11226238|FG002|COMPLETED|Treatment Period||82
10097262|NCT02372799|11226236|FG000|NOT COMPLETED|Treatment Period||34
10097263|NCT02372799|11226237|FG001|NOT COMPLETED|Treatment Period||32
10097264|NCT02372799|11226238|FG002|NOT COMPLETED|Treatment Period||15
10097265|NCT02372799|11226236|FG000|STARTED|Down-taper Period||152
10097266|NCT02372799|11226237|FG001|STARTED|Down-taper Period||159
10097267|NCT02372799|11226238|FG002|STARTED|Down-taper Period||82
10097268|NCT02372799|11226236|FG000|COMPLETED|Down-taper Period||151
10097269|NCT02372799|11226237|FG001|COMPLETED|Down-taper Period||157
10097270|NCT02372799|11226238|FG002|COMPLETED|Down-taper Period||80
9875463|NCT01003301|10990209|FG000|STARTED|Overall Study||10
9875464|NCT01003301|10990210|FG001|STARTED|Overall Study||9
9875465|NCT01003301|10990209|FG000|COMPLETED|Overall Study||10
9875466|NCT01003301|10990210|FG001|COMPLETED|Overall Study||9
9875467|NCT01003301|10990209|FG000|NOT COMPLETED|Overall Study||0
9875468|NCT01003301|10990210|FG001|NOT COMPLETED|Overall Study||0
9875469|NCT01003418|10990218|FG000|STARTED|Overall Study||5
9875470|NCT01003418|10990219|FG001|STARTED|Overall Study||3
9875471|NCT01003418|10990218|FG000|COMPLETED|Overall Study||5
9875472|NCT01003418|10990219|FG001|COMPLETED|Overall Study||3
9875473|NCT01003418|10990218|FG000|NOT COMPLETED|Overall Study||0
9875474|NCT01003418|10990219|FG001|NOT COMPLETED|Overall Study||0
9875475|NCT01003639|10990227|FG000|STARTED|Overall Study||86
9875476|NCT01003639|10990228|FG001|STARTED|Overall Study||79
9875477|NCT01003639|10990227|FG000|COMPLETED|Overall Study||69
10097271|NCT02372799|11226236|FG000|NOT COMPLETED|Down-taper Period||1
9875478|NCT01003639|10990228|FG001|COMPLETED|Overall Study||57
9875479|NCT01003639|10990227|FG000|NOT COMPLETED|Overall Study||17
9875480|NCT01003639|10990228|FG001|NOT COMPLETED|Overall Study||22
9875481|NCT01003769|10990234|FG000|STARTED|Overall Study||5
9875482|NCT01003769|10990234|FG000|COMPLETED|Overall Study||5
9875483|NCT01003769|10990234|FG000|NOT COMPLETED|Overall Study||0
9875484|NCT01003886|10990238|FG000|STARTED|Overall Study||989
9875485|NCT01003886|10990238|FG000|COMPLETED|Overall Study||759
9875486|NCT01003886|10990238|FG000|NOT COMPLETED|Overall Study||230
9875487|NCT01003899|10990242|FG000|STARTED|Overall Study|enrolled|47
9875488|NCT01003899|10990242|FG000|COMPLETED|Overall Study||0
9875489|NCT01003899|10990242|FG000|NOT COMPLETED|Overall Study||47
9875490|NCT01003938|10990246|FG000|STARTED|Overall Study||6
9875491|NCT01003938|10990246|FG000|COMPLETED|Overall Study||6
9875492|NCT01003938|10990246|FG000|NOT COMPLETED|Overall Study||0
9875493|NCT01003990|10990253|FG000|STARTED|Overall Study||459
9875494|NCT01003990|10990254|FG001|STARTED|Overall Study||154
9875495|NCT01003990|10990255|FG002|STARTED|Overall Study||96
9875496|NCT01003990|10990253|FG000|COMPLETED|Overall Study||367
9875497|NCT01003990|10990254|FG001|COMPLETED|Overall Study||103
9875498|NCT01003990|10990255|FG002|COMPLETED|Overall Study||53
9875499|NCT01003990|10990253|FG000|NOT COMPLETED|Overall Study||92
9875500|NCT01003990|10990254|FG001|NOT COMPLETED|Overall Study||51
9875501|NCT01003990|10990255|FG002|NOT COMPLETED|Overall Study||43
9875502|NCT01004003|10990272|FG000|STARTED|Overall Study||6
9875503|NCT01004003|10990273|FG001|STARTED|Overall Study||3
9875504|NCT01004003|10990274|FG002|STARTED|Overall Study||4
9875505|NCT01004003|10990275|FG003|STARTED|Overall Study||3
9875506|NCT01004003|10990276|FG004|STARTED|Overall Study||4
9875507|NCT01004003|10990277|FG005|STARTED|Overall Study||4
9875508|NCT01004003|10990278|FG006|STARTED|Overall Study||8
9875509|NCT01004003|10990279|FG007|STARTED|Overall Study||62
9875510|NCT01004003|10990280|FG008|STARTED|Overall Study||31
9875511|NCT01004003|10990272|FG000|COMPLETED|Overall Study||0
9875512|NCT01004003|10990273|FG001|COMPLETED|Overall Study||0
9875513|NCT01004003|10990274|FG002|COMPLETED|Overall Study||0
9875514|NCT01004003|10990275|FG003|COMPLETED|Overall Study||0
9875515|NCT01004003|10990276|FG004|COMPLETED|Overall Study||0
9875516|NCT01004003|10990277|FG005|COMPLETED|Overall Study||0
9875517|NCT01004003|10990278|FG006|COMPLETED|Overall Study||0
9875518|NCT01004003|10990279|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
9875519|NCT01004003|10990280|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
9875520|NCT01004003|10990272|FG000|NOT COMPLETED|Overall Study||6
9875521|NCT01004003|10990273|FG001|NOT COMPLETED|Overall Study||3
9875522|NCT01004003|10990274|FG002|NOT COMPLETED|Overall Study||4
9875523|NCT01004003|10990275|FG003|NOT COMPLETED|Overall Study||3
9875524|NCT01004003|10990276|FG004|NOT COMPLETED|Overall Study||4
9875525|NCT01004003|10990277|FG005|NOT COMPLETED|Overall Study||4
9875526|NCT01004003|10990278|FG006|NOT COMPLETED|Overall Study||8
9875527|NCT01004003|10990279|FG007|NOT COMPLETED|Overall Study||60
9875528|NCT01004003|10990280|FG008|NOT COMPLETED|Overall Study||30
9875529|NCT01004042|10990304|FG000|STARTED|Overall Study||25
9875530|NCT01004042|10990305|FG001|STARTED|Overall Study||25
9875531|NCT01004042|10990304|FG000|COMPLETED|Overall Study||21
9875532|NCT01004042|10990305|FG001|COMPLETED|Overall Study||25
9875533|NCT01004042|10990304|FG000|NOT COMPLETED|Overall Study||4
9875534|NCT01004042|10990305|FG001|NOT COMPLETED|Overall Study||0
9875535|NCT01004107|10990313|FG000|STARTED|Overall Study||76
9875536|NCT01004107|10990314|FG001|STARTED|Overall Study||25
9875537|NCT01004107|10990313|FG000|COMPLETED|Overall Study||75
9875538|NCT01004107|10990314|FG001|COMPLETED|Overall Study||23
9875539|NCT01004107|10990313|FG000|NOT COMPLETED|Overall Study||1
9875540|NCT01004107|10990314|FG001|NOT COMPLETED|Overall Study||2
9875541|NCT01004146|10990341|FG000|STARTED|Overall Study||25
10097272|NCT02372799|11226237|FG001|NOT COMPLETED|Down-taper Period||2
10097273|NCT02372799|11226238|FG002|NOT COMPLETED|Down-taper Period||2
10097274|NCT02373098|11226248|FG000|STARTED|Overall Study||66
10097275|NCT02373098|11226249|FG001|STARTED|Overall Study||60
10097276|NCT02373098|11226248|FG000|COMPLETED|Overall Study||54
10097277|NCT02373098|11226249|FG001|COMPLETED|Overall Study||60
10097278|NCT02373098|11226248|FG000|NOT COMPLETED|Overall Study||12
10097279|NCT02373098|11226249|FG001|NOT COMPLETED|Overall Study||0
10097280|NCT02373124|11226261|FG000|STARTED|Overall Study||4
10097281|NCT02373124|11226261|FG000|COMPLETED|Overall Study||3
10097282|NCT02373124|11226261|FG000|NOT COMPLETED|Overall Study||1
10097283|NCT02373137|11226267|FG000|STARTED|Overall Study||19
10097284|NCT02373137|11226268|FG001|STARTED|Overall Study||19
9875542|NCT01004146|10990342|FG001|STARTED|Overall Study||25
9875543|NCT01004146|10990341|FG000|Have Incentive Spirometry Data|Overall Study||21
9875544|NCT01004146|10990342|FG001|Have Incentive Spirometry Data|Overall Study||20
9875545|NCT01004146|10990341|FG000|COMPLETED|Overall Study||21
9875546|NCT01004146|10990342|FG001|COMPLETED|Overall Study||20
9875547|NCT01004146|10990341|FG000|NOT COMPLETED|Overall Study||4
10097285|NCT02373137|11226267|FG000|3-Month Follow-Up|Overall Study||19
10097286|NCT02373137|11226268|FG001|3-Month Follow-Up|Overall Study||19
10097287|NCT02373137|11226267|FG000|6-Month Follow-Up|Overall Study||19
10097288|NCT02373137|11226268|FG001|6-Month Follow-Up|Overall Study||18
10097289|NCT02373137|11226267|FG000|12-Month Follow-Up|Overall Study||19
10097290|NCT02373137|11226268|FG001|12-Month Follow-Up|Overall Study||19
10097291|NCT02373137|11226267|FG000|COMPLETED|Overall Study||18
10097292|NCT02373137|11226268|FG001|COMPLETED|Overall Study||18
9875548|NCT01004146|10990342|FG001|NOT COMPLETED|Overall Study||5
9875549|NCT01004159|10990348|FG000|STARTED|Overall Study||20
9875550|NCT01004159|10990348|FG000|COMPLETED|Overall Study||0
9875551|NCT01004159|10990348|FG000|NOT COMPLETED|Overall Study||20
9875552|NCT01004172|10990352|FG000|STARTED|Overall Study||38
9875553|NCT01004172|10990352|FG000|COMPLETED|Overall Study||0
9875554|NCT01004172|10990352|FG000|NOT COMPLETED|Overall Study||38
9875555|NCT01004185|10990359|FG000|STARTED|Overall Study||19
9875556|NCT01004185|10990360|FG001|STARTED|Overall Study||20
9875557|NCT01004185|10990359|FG000|COMPLETED|Overall Study||10
9875558|NCT01004185|10990360|FG001|COMPLETED|Overall Study||11
9875559|NCT01004185|10990359|FG000|NOT COMPLETED|Overall Study||9
9875560|NCT01004185|10990360|FG001|NOT COMPLETED|Overall Study||9
9875561|NCT01004250|10990366|FG000|STARTED|Induction Therapy Period||109
9875562|NCT01004250|10990366|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109
9875563|NCT01004250|10990366|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
9875564|NCT01004250|10990366|FG000|COMPLETED|Induction Therapy Period||94
9875565|NCT01004250|10990366|FG000|NOT COMPLETED|Induction Therapy Period||15
9875566|NCT01004250|10990366|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
9875567|NCT01004250|10990366|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
9875568|NCT01004250|10990366|FG000|COMPLETED|Maintenance Therapy Period||46
9875569|NCT01004250|10990366|FG000|NOT COMPLETED|Maintenance Therapy Period||26
9875570|NCT01004250|10990366|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
9875571|NCT01004250|10990366|FG000|COMPLETED|Follow-Up (FU) Period||100
9875572|NCT01004250|10990366|FG000|NOT COMPLETED|Follow-Up (FU) Period||1
9875573|NCT01004354|10990374|FG000|STARTED|Overall Study||12
9875574|NCT01004354|10990374|FG000|COMPLETED|Overall Study||12
9875575|NCT01004354|10990374|FG000|NOT COMPLETED|Overall Study||0
9875576|NCT01004393|10990378|FG000|STARTED|Overall Study||12
9875577|NCT01004393|10990378|FG000|COMPLETED|Overall Study||12
9875578|NCT01004393|10990378|FG000|NOT COMPLETED|Overall Study||0
9953816|NCT01427972|11072445|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0
9953817|NCT01427972|11072446|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0
9953818|NCT01427972|11072447|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0
9953819|NCT01427972|11072448|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0
9953820|NCT01427972|11072449|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0
9953821|NCT01427972|11072450|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2
9953822|NCT01427972|11072451|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0
9953823|NCT01427972|11072452|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0
9953824|NCT01427972|11072453|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0
9953825|NCT01427972|11072454|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0
9953826|NCT01427972|11072455|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0
9953827|NCT01427972|11072456|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0
9953828|NCT01427972|11072445|FG000|STARTED|Treatment Period 2 (21 Days)||3
9953829|NCT01427972|11072446|FG001|STARTED|Treatment Period 2 (21 Days)||4
9953830|NCT01427972|11072447|FG002|STARTED|Treatment Period 2 (21 Days)||4
9953831|NCT01427972|11072448|FG003|STARTED|Treatment Period 2 (21 Days)||3
9953832|NCT01427972|11072449|FG004|STARTED|Treatment Period 2 (21 Days)||4
9953833|NCT01427972|11072450|FG005|STARTED|Treatment Period 2 (21 Days)||1
9953834|NCT01427972|11072451|FG006|STARTED|Treatment Period 2 (21 Days)||3
9953835|NCT01427972|11072452|FG007|STARTED|Treatment Period 2 (21 Days)||4
9953836|NCT01427972|11072453|FG008|STARTED|Treatment Period 2 (21 Days)||3
9953837|NCT01427972|11072454|FG009|STARTED|Treatment Period 2 (21 Days)||3
9953838|NCT01427972|11072455|FG010|STARTED|Treatment Period 2 (21 Days)||3
9953839|NCT01427972|11072456|FG011|STARTED|Treatment Period 2 (21 Days)||4
9953840|NCT01427972|11072445|FG000|COMPLETED|Treatment Period 2 (21 Days)||3
9953841|NCT01427972|11072446|FG001|COMPLETED|Treatment Period 2 (21 Days)||3
9953842|NCT01427972|11072447|FG002|COMPLETED|Treatment Period 2 (21 Days)||4
9953843|NCT01427972|11072448|FG003|COMPLETED|Treatment Period 2 (21 Days)||3
9953844|NCT01427972|11072449|FG004|COMPLETED|Treatment Period 2 (21 Days)||4
9953845|NCT01427972|11072450|FG005|COMPLETED|Treatment Period 2 (21 Days)||1
9953846|NCT01427972|11072451|FG006|COMPLETED|Treatment Period 2 (21 Days)||3
9953847|NCT01427972|11072452|FG007|COMPLETED|Treatment Period 2 (21 Days)||4
9953848|NCT01427972|11072453|FG008|COMPLETED|Treatment Period 2 (21 Days)||3
9953849|NCT01427972|11072454|FG009|COMPLETED|Treatment Period 2 (21 Days)||3
9953850|NCT01427972|11072455|FG010|COMPLETED|Treatment Period 2 (21 Days)||3
9953851|NCT01427972|11072456|FG011|COMPLETED|Treatment Period 2 (21 Days)||4
9953852|NCT01427972|11072445|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953853|NCT01427972|11072446|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1
9953854|NCT01427972|11072447|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953855|NCT01427972|11072448|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953856|NCT01427972|11072449|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953857|NCT01427972|11072450|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953858|NCT01427972|11072451|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953859|NCT01427972|11072452|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953860|NCT01427972|11072453|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953861|NCT01427972|11072454|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953862|NCT01427972|11072455|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9875579|NCT01004406|10990384|FG000|STARTED|Overall Study||21
9875580|NCT01004406|10990385|FG001|STARTED|Overall Study||10
9875581|NCT01004406|10990384|FG000|COMPLETED|Overall Study||18
9875582|NCT01004406|10990385|FG001|COMPLETED|Overall Study||10
9875583|NCT01004406|10990384|FG000|NOT COMPLETED|Overall Study||3
9875584|NCT01004406|10990385|FG001|NOT COMPLETED|Overall Study||0
9875585|NCT01004432|10990391|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433
9875586|NCT01004432|10990392|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0
9875587|NCT01004432|10990393|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0
9875588|NCT01004432|10990394|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0
9875589|NCT01004432|10990395|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0
9875590|NCT01004432|10990391|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
9875591|NCT01004432|10990392|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875592|NCT01004432|10990393|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875593|NCT01004432|10990394|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875594|NCT01004432|10990395|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875595|NCT01004432|10990391|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
9875596|NCT01004432|10990392|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875597|NCT01004432|10990393|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875598|NCT01004432|10990394|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875599|NCT01004432|10990395|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
9875600|NCT01004432|10990391|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
9875601|NCT01004432|10990392|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
9875602|NCT01004432|10990393|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
9875603|NCT01004432|10990394|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
9875604|NCT01004432|10990395|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
9875605|NCT01004432|10990391|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
9875606|NCT01004432|10990392|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
9875607|NCT01004432|10990393|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
9875608|NCT01004432|10990394|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
9875609|NCT01004432|10990395|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
9875610|NCT01004432|10990391|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
9875611|NCT01004432|10990392|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
9875612|NCT01004432|10990393|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
9875613|NCT01004432|10990394|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
9875614|NCT01004432|10990395|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
9875615|NCT01004432|10990391|FG000|STARTED|OL Study Extension (Week 52 - 76)||0
9875616|NCT01004432|10990392|FG001|STARTED|OL Study Extension (Week 52 - 76)||0
9875617|NCT01004432|10990393|FG002|STARTED|OL Study Extension (Week 52 - 76)||0
9875618|NCT01004432|10990394|FG003|STARTED|OL Study Extension (Week 52 - 76)||0
9875619|NCT01004432|10990395|FG004|STARTED|OL Study Extension (Week 52 - 76)||212
9875620|NCT01004432|10990391|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0
9875621|NCT01004432|10990392|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0
9875622|NCT01004432|10990393|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0
9875623|NCT01004432|10990394|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0
9875624|NCT01004432|10990395|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194
9875625|NCT01004432|10990391|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
9875626|NCT01004432|10990392|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
9875627|NCT01004432|10990393|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
9875628|NCT01004432|10990394|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
9875629|NCT01004432|10990395|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
9875630|NCT01004614|10990413|FG000|STARTED|First Intervention||12
9875631|NCT01004614|10990414|FG001|STARTED|First Intervention||12
9875632|NCT01004614|10990415|FG002|STARTED|First Intervention||12
9875633|NCT01004614|10990416|FG003|STARTED|First Intervention||12
9875634|NCT01004614|10990413|FG000|COMPLETED|First Intervention||12
9875635|NCT01004614|10990414|FG001|COMPLETED|First Intervention||12
9875636|NCT01004614|10990415|FG002|COMPLETED|First Intervention||12
9875637|NCT01004614|10990416|FG003|COMPLETED|First Intervention||12
9875638|NCT01004614|10990413|FG000|NOT COMPLETED|First Intervention||0
9875639|NCT01004614|10990414|FG001|NOT COMPLETED|First Intervention||0
9875640|NCT01004614|10990415|FG002|NOT COMPLETED|First Intervention||0
9875641|NCT01004614|10990416|FG003|NOT COMPLETED|First Intervention||0
9875642|NCT01004614|10990413|FG000|STARTED|Washout||12
9875643|NCT01004614|10990414|FG001|STARTED|Washout||12
9875644|NCT01004614|10990415|FG002|STARTED|Washout||12
9875645|NCT01004614|10990416|FG003|STARTED|Washout||12
9875646|NCT01004614|10990413|FG000|COMPLETED|Washout||12
9875647|NCT01004614|10990414|FG001|COMPLETED|Washout||11
10097293|NCT02373137|11226267|FG000|NOT COMPLETED|Overall Study||1
10097294|NCT02373137|11226268|FG001|NOT COMPLETED|Overall Study||1
9875648|NCT01004614|10990415|FG002|COMPLETED|Washout||12
9875649|NCT01004614|10990416|FG003|COMPLETED|Washout||12
9875650|NCT01004614|10990413|FG000|NOT COMPLETED|Washout||0
9875651|NCT01004614|10990414|FG001|NOT COMPLETED|Washout||1
9875652|NCT01004614|10990415|FG002|NOT COMPLETED|Washout||0
10097295|NCT02373202|11226279|FG000|STARTED|Overall Study||15
10097296|NCT02373202|11226280|FG001|STARTED|Overall Study||15
10097297|NCT02373202|11226281|FG002|STARTED|Overall Study||30
10097298|NCT02373202|11226282|FG003|STARTED|Overall Study||31
9875653|NCT01004614|10990416|FG003|NOT COMPLETED|Washout||0
9875654|NCT01004614|10990413|FG000|STARTED|Second Intervention||12
9875655|NCT01004614|10990414|FG001|STARTED|Second Intervention||11
9875656|NCT01004614|10990415|FG002|STARTED|Second Intervention||12
9875657|NCT01004614|10990416|FG003|STARTED|Second Intervention||12
9875658|NCT01004614|10990413|FG000|COMPLETED|Second Intervention||12
9875659|NCT01004614|10990414|FG001|COMPLETED|Second Intervention||11
9875660|NCT01004614|10990415|FG002|COMPLETED|Second Intervention||12
9875661|NCT01004614|10990416|FG003|COMPLETED|Second Intervention||12
9875662|NCT01004614|10990413|FG000|NOT COMPLETED|Second Intervention||0
9875663|NCT01004614|10990414|FG001|NOT COMPLETED|Second Intervention||0
9875664|NCT01004614|10990415|FG002|NOT COMPLETED|Second Intervention||0
9875665|NCT01004614|10990416|FG003|NOT COMPLETED|Second Intervention||0
9875666|NCT01004705|10990426|FG000|STARTED|Run-In||44
9875667|NCT01004705|10990427|FG001|STARTED|Run-In||0
9875668|NCT01004705|10990428|FG002|STARTED|Run-In||0
9875669|NCT01004705|10990426|FG000|COMPLETED|Run-In||36
9875670|NCT01004705|10990427|FG001|COMPLETED|Run-In||0
9875671|NCT01004705|10990428|FG002|COMPLETED|Run-In||0
9875672|NCT01004705|10990426|FG000|NOT COMPLETED|Run-In||8
9875673|NCT01004705|10990427|FG001|NOT COMPLETED|Run-In||0
9875674|NCT01004705|10990428|FG002|NOT COMPLETED|Run-In||0
9875675|NCT01004705|10990426|FG000|STARTED|Period 1 (12 Weeks)||0
9875676|NCT01004705|10990427|FG001|STARTED|Period 1 (12 Weeks)||18
9875677|NCT01004705|10990428|FG002|STARTED|Period 1 (12 Weeks)||18
9875678|NCT01004705|10990426|FG000|COMPLETED|Period 1 (12 Weeks)||0
9875679|NCT01004705|10990427|FG001|COMPLETED|Period 1 (12 Weeks)||13
9875680|NCT01004705|10990428|FG002|COMPLETED|Period 1 (12 Weeks)||13
9875681|NCT01004705|10990426|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
9875682|NCT01004705|10990427|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5
9875683|NCT01004705|10990428|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5
9875684|NCT01004705|10990426|FG000|STARTED|Washout Period (6 Weeks)||0
9875685|NCT01004705|10990427|FG001|STARTED|Washout Period (6 Weeks)||13
9875686|NCT01004705|10990428|FG002|STARTED|Washout Period (6 Weeks)||13
9875687|NCT01004705|10990426|FG000|COMPLETED|Washout Period (6 Weeks)||0
9875688|NCT01004705|10990427|FG001|COMPLETED|Washout Period (6 Weeks)||13
9875689|NCT01004705|10990428|FG002|COMPLETED|Washout Period (6 Weeks)||13
9875690|NCT01004705|10990426|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0
9875691|NCT01004705|10990427|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0
9875692|NCT01004705|10990428|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0
9875693|NCT01004705|10990426|FG000|STARTED|Period 2 (12 Weeks)||0
9875694|NCT01004705|10990427|FG001|STARTED|Period 2 (12 Weeks)||13
9875695|NCT01004705|10990428|FG002|STARTED|Period 2 (12 Weeks)||13
9875696|NCT01004705|10990426|FG000|COMPLETED|Period 2 (12 Weeks)||0
9875697|NCT01004705|10990427|FG001|COMPLETED|Period 2 (12 Weeks)||13
9875698|NCT01004705|10990428|FG002|COMPLETED|Period 2 (12 Weeks)||9
9875699|NCT01004705|10990426|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
9875700|NCT01004705|10990427|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0
9875701|NCT01004705|10990428|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4
9875702|NCT01004718|10990435|FG000|STARTED|Overall Study||10
9875703|NCT01004718|10990435|FG000|COMPLETED|Overall Study||10
9875704|NCT01004718|10990435|FG000|NOT COMPLETED|Overall Study||0
9875705|NCT01004744|10990440|FG000|STARTED|Overall Study||10
9875706|NCT01004744|10990440|FG000|COMPLETED|Overall Study||10
9875707|NCT01004744|10990440|FG000|NOT COMPLETED|Overall Study||0
9875708|NCT01004770|10990449|FG000|STARTED|Overall Study||10
9875709|NCT01004770|10990450|FG001|STARTED|Overall Study||10
9875710|NCT01004770|10990451|FG002|STARTED|Overall Study||10
9875711|NCT01004770|10990452|FG003|STARTED|Overall Study||10
9875712|NCT01004770|10990453|FG004|STARTED|Overall Study||10
9875713|NCT01004770|10990449|FG000|COMPLETED|Overall Study||10
9875714|NCT01004770|10990450|FG001|COMPLETED|Overall Study||10
9875715|NCT01004770|10990451|FG002|COMPLETED|Overall Study||10
9875716|NCT01004770|10990452|FG003|COMPLETED|Overall Study||10
9875717|NCT01004770|10990453|FG004|COMPLETED|Overall Study||10
9875718|NCT01004770|10990449|FG000|NOT COMPLETED|Overall Study||0
9875719|NCT01004770|10990450|FG001|NOT COMPLETED|Overall Study||0
9875720|NCT01004770|10990451|FG002|NOT COMPLETED|Overall Study||0
9875721|NCT01004770|10990452|FG003|NOT COMPLETED|Overall Study||0
9875722|NCT01004770|10990453|FG004|NOT COMPLETED|Overall Study||0
9875723|NCT01004822|10990473|FG000|STARTED|Overall Study||3
9875724|NCT01004822|10990474|FG001|STARTED|Overall Study||3
9875725|NCT01004822|10990475|FG002|STARTED|Overall Study||4
9875726|NCT01004822|10990476|FG003|STARTED|Overall Study||4
9875727|NCT01004822|10990477|FG004|STARTED|Overall Study||4
9875728|NCT01004822|10990478|FG005|STARTED|Overall Study||4
9875729|NCT01004822|10990479|FG006|STARTED|Overall Study||4
9875730|NCT01004822|10990480|FG007|STARTED|Overall Study||5
9875731|NCT01004822|10990473|FG000|Treated|Overall Study||3
9875732|NCT01004822|10990474|FG001|Treated|Overall Study||3
9875733|NCT01004822|10990475|FG002|Treated|Overall Study||3
9875734|NCT01004822|10990476|FG003|Treated|Overall Study||4
9875735|NCT01004822|10990477|FG004|Treated|Overall Study||4
9875736|NCT01004822|10990478|FG005|Treated|Overall Study||4
9875737|NCT01004822|10990479|FG006|Treated|Overall Study||4
9875738|NCT01004822|10990480|FG007|Treated|Overall Study||5
9875739|NCT01004822|10990473|FG000|COMPLETED|Overall Study||0
9875740|NCT01004822|10990474|FG001|COMPLETED|Overall Study||0
9875741|NCT01004822|10990475|FG002|COMPLETED|Overall Study||0
9875742|NCT01004822|10990476|FG003|COMPLETED|Overall Study||0
9875743|NCT01004822|10990477|FG004|COMPLETED|Overall Study||0
9875744|NCT01004822|10990478|FG005|COMPLETED|Overall Study||0
9875745|NCT01004822|10990479|FG006|COMPLETED|Overall Study||0
9875746|NCT01004822|10990480|FG007|COMPLETED|Overall Study||0
9875747|NCT01004822|10990473|FG000|NOT COMPLETED|Overall Study||3
9875748|NCT01004822|10990474|FG001|NOT COMPLETED|Overall Study||3
9875749|NCT01004822|10990475|FG002|NOT COMPLETED|Overall Study||4
9875750|NCT01004822|10990476|FG003|NOT COMPLETED|Overall Study||4
9875751|NCT01004822|10990477|FG004|NOT COMPLETED|Overall Study||4
9875752|NCT01004822|10990478|FG005|NOT COMPLETED|Overall Study||4
9875753|NCT01004822|10990479|FG006|NOT COMPLETED|Overall Study||4
9875754|NCT01004822|10990480|FG007|NOT COMPLETED|Overall Study||5
9875755|NCT01004848|10990502|FG000|STARTED|Overall Study||210
9875756|NCT01004848|10990503|FG001|STARTED|Overall Study||192
9875757|NCT01004848|10990502|FG000|COMPLETED|Overall Study||155
9875758|NCT01004848|10990503|FG001|COMPLETED|Overall Study||147
9875759|NCT01004848|10990502|FG000|NOT COMPLETED|Overall Study||55
9875760|NCT01004848|10990503|FG001|NOT COMPLETED|Overall Study||45
9875761|NCT01004939|10990511|FG000|STARTED|Overall Study||120
9875762|NCT01004939|10990511|FG000|COMPLETED|Overall Study||120
9875763|NCT01004939|10990511|FG000|NOT COMPLETED|Overall Study||0
9875764|NCT01004991|10990517|FG000|STARTED|Overall Study||12
9875765|NCT01004991|10990517|FG000|COMPLETED|Overall Study||12
9875766|NCT01004991|10990517|FG000|NOT COMPLETED|Overall Study||0
9875767|NCT01005251|10990526|FG000|STARTED|Overall Study||134
9875768|NCT01005251|10990527|FG001|STARTED|Overall Study||125
9875769|NCT01005251|10990528|FG002|STARTED|Overall Study||136
9875770|NCT01005251|10990529|FG003|STARTED|Overall Study||126
9875771|NCT01005251|10990530|FG004|STARTED|Overall Study||140
9875772|NCT01005251|10990526|FG000|COMPLETED|Overall Study||121
9875773|NCT01005251|10990527|FG001|COMPLETED|Overall Study||109
9875774|NCT01005251|10990528|FG002|COMPLETED|Overall Study||114
9875775|NCT01005251|10990529|FG003|COMPLETED|Overall Study||114
9875776|NCT01005251|10990530|FG004|COMPLETED|Overall Study||122
9875777|NCT01005251|10990526|FG000|NOT COMPLETED|Overall Study||13
9875778|NCT01005251|10990527|FG001|NOT COMPLETED|Overall Study||16
9875779|NCT01005251|10990528|FG002|NOT COMPLETED|Overall Study||22
9875780|NCT01005251|10990529|FG003|NOT COMPLETED|Overall Study||12
9875781|NCT01005251|10990530|FG004|NOT COMPLETED|Overall Study||18
9875782|NCT01005290|10990542|FG000|STARTED|Run-In||52
9875783|NCT01005290|10990543|FG001|STARTED|Run-In||0
9875784|NCT01005290|10990544|FG002|STARTED|Run-In||0
9875785|NCT01005290|10990542|FG000|COMPLETED|Run-In||38
9875786|NCT01005290|10990543|FG001|COMPLETED|Run-In||0
9875787|NCT01005290|10990544|FG002|COMPLETED|Run-In||0
9875788|NCT01005290|10990542|FG000|NOT COMPLETED|Run-In||14
9875789|NCT01005290|10990543|FG001|NOT COMPLETED|Run-In||0
9875790|NCT01005290|10990544|FG002|NOT COMPLETED|Run-In||0
9875791|NCT01005290|10990542|FG000|STARTED|Period 1 (5 Weeks)||0
9875792|NCT01005290|10990543|FG001|STARTED|Period 1 (5 Weeks)||20
9875793|NCT01005290|10990544|FG002|STARTED|Period 1 (5 Weeks)||18
9875794|NCT01005290|10990542|FG000|COMPLETED|Period 1 (5 Weeks)||0
9875795|NCT01005290|10990543|FG001|COMPLETED|Period 1 (5 Weeks)||13
9875796|NCT01005290|10990544|FG002|COMPLETED|Period 1 (5 Weeks)||9
9875797|NCT01005290|10990542|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0
9875798|NCT01005290|10990543|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7
9875799|NCT01005290|10990544|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9
9875800|NCT01005290|10990542|FG000|STARTED|Washout Period (2 Weeks)||0
9875801|NCT01005290|10990543|FG001|STARTED|Washout Period (2 Weeks)||13
9875802|NCT01005290|10990544|FG002|STARTED|Washout Period (2 Weeks)||9
9875803|NCT01005290|10990542|FG000|COMPLETED|Washout Period (2 Weeks)||0
9875804|NCT01005290|10990543|FG001|COMPLETED|Washout Period (2 Weeks)||13
9875805|NCT01005290|10990544|FG002|COMPLETED|Washout Period (2 Weeks)||9
9875806|NCT01005290|10990542|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
9875807|NCT01005290|10990543|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
9875808|NCT01005290|10990544|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
9875809|NCT01005290|10990542|FG000|STARTED|Period 2 (5 Weeks)||0
9875810|NCT01005290|10990543|FG001|STARTED|Period 2 (5 Weeks)||13
9875811|NCT01005290|10990544|FG002|STARTED|Period 2 (5 Weeks)||9
9875812|NCT01005290|10990542|FG000|COMPLETED|Period 2 (5 Weeks)||0
9875813|NCT01005290|10990543|FG001|COMPLETED|Period 2 (5 Weeks)||13
9875814|NCT01005290|10990544|FG002|COMPLETED|Period 2 (5 Weeks)||7
9875815|NCT01005290|10990542|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0
9875816|NCT01005290|10990543|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0
9875817|NCT01005290|10990544|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2
9875818|NCT01005316|10990554|FG000|STARTED|Overall Study||50
9875819|NCT01005316|10990555|FG001|STARTED|Overall Study||97
9875820|NCT01005316|10990556|FG002|STARTED|Overall Study||16
9875821|NCT01005316|10990557|FG003|STARTED|Overall Study||127
9875822|NCT01005316|10990554|FG000|COMPLETED|Overall Study||0
9875823|NCT01005316|10990555|FG001|COMPLETED|Overall Study||21
9875824|NCT01005316|10990556|FG002|COMPLETED|Overall Study||5
9875825|NCT01005316|10990557|FG003|COMPLETED|Overall Study||19
9875826|NCT01005316|10990554|FG000|NOT COMPLETED|Overall Study||50
9875827|NCT01005316|10990555|FG001|NOT COMPLETED|Overall Study||76
9875828|NCT01005316|10990556|FG002|NOT COMPLETED|Overall Study||11
9875829|NCT01005316|10990557|FG003|NOT COMPLETED|Overall Study||108
9875830|NCT01005329|10990568|FG000|STARTED|Overall Study||34
9875831|NCT01005329|10990568|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
9875832|NCT01005329|10990568|FG000|NOT COMPLETED|Overall Study||4
9875833|NCT01005355|10990576|FG000|STARTED|Overall Study||3
9875834|NCT01005355|10990577|FG001|STARTED|Overall Study||6
9875835|NCT01005355|10990578|FG002|STARTED|Overall Study||6
9875836|NCT01005355|10990576|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9875837|NCT01005355|10990577|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9875838|NCT01005355|10990578|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9875839|NCT01005355|10990576|FG000|COMPLETED|Overall Study||3
9875840|NCT01005355|10990577|FG001|COMPLETED|Overall Study||6
9875841|NCT01005355|10990578|FG002|COMPLETED|Overall Study||6
9875842|NCT01005355|10990576|FG000|NOT COMPLETED|Overall Study||0
9875843|NCT01005355|10990577|FG001|NOT COMPLETED|Overall Study||0
9875844|NCT01005355|10990578|FG002|NOT COMPLETED|Overall Study||0
9875845|NCT01005407|10990591|FG000|STARTED|Overall Study||1969
9875846|NCT01005407|10990592|FG001|STARTED|Overall Study||483
9875847|NCT01005407|10990591|FG000|COMPLETED|Overall Study||1818
9875848|NCT01005407|10990592|FG001|COMPLETED|Overall Study||451
9875849|NCT01005407|10990591|FG000|NOT COMPLETED|Overall Study||151
9875850|NCT01005407|10990592|FG001|NOT COMPLETED|Overall Study||32
9875851|NCT01005459|10990600|FG000|STARTED|Overall Study||23
9875852|NCT01005459|10990601|FG001|STARTED|Overall Study||23
9875853|NCT01005459|10990600|FG000|COMPLETED|Overall Study||23
9875854|NCT01005459|10990601|FG001|COMPLETED|Overall Study||23
9875855|NCT01005459|10990600|FG000|NOT COMPLETED|Overall Study||0
9875856|NCT01005459|10990601|FG001|NOT COMPLETED|Overall Study||0
9875857|NCT01005576|10990607|FG000|STARTED|Overall Study||21
9875858|NCT01005576|10990607|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
9875859|NCT01005576|10990607|FG000|NOT COMPLETED|Overall Study||0
9875860|NCT01005602|10990613|FG000|STARTED|Overall Study||66
9875861|NCT01005602|10990614|FG001|STARTED|Overall Study||66
9875862|NCT01005602|10990613|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
9875863|NCT01005602|10990614|FG001|COMPLETED|Overall Study||66
9875864|NCT01005602|10990613|FG000|NOT COMPLETED|Overall Study||1
9875865|NCT01005602|10990614|FG001|NOT COMPLETED|Overall Study||0
9875866|NCT01005680|10990629|FG000|STARTED|Overall Study||126
9875867|NCT01005680|10990630|FG001|STARTED|Overall Study||130
9875868|NCT01005680|10990629|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125
9875869|NCT01005680|10990630|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
9875870|NCT01005680|10990629|FG000|COMPLETED|Overall Study||120
9875871|NCT01005680|10990630|FG001|COMPLETED|Overall Study||119
9875872|NCT01005680|10990629|FG000|NOT COMPLETED|Overall Study||6
9875873|NCT01005680|10990630|FG001|NOT COMPLETED|Overall Study||11
9875874|NCT01005706|10990639|FG000|STARTED|Overall Study||23
9875875|NCT01005706|10990640|FG001|STARTED|Overall Study||17
9875876|NCT01005706|10990639|FG000|COMPLETED|Overall Study||23
9875877|NCT01005706|10990640|FG001|COMPLETED|Overall Study||17
9875878|NCT01005706|10990639|FG000|NOT COMPLETED|Overall Study||0
9875879|NCT01005706|10990640|FG001|NOT COMPLETED|Overall Study||0
9875880|NCT01005719|10990646|FG000|STARTED|Period 1||10
9875881|NCT01005719|10990647|FG001|STARTED|Period 1||10
9875882|NCT01005719|10990648|FG002|STARTED|Period 1||10
9875883|NCT01005719|10990649|FG003|STARTED|Period 1||11
9875884|NCT01005719|10990650|FG004|STARTED|Period 1||11
9875885|NCT01005719|10990651|FG005|STARTED|Period 1||11
9875886|NCT01005719|10990646|FG000|COMPLETED|Period 1||10
9875887|NCT01005719|10990647|FG001|COMPLETED|Period 1||10
9875888|NCT01005719|10990648|FG002|COMPLETED|Period 1||10
9875889|NCT01005719|10990649|FG003|COMPLETED|Period 1||10
9875890|NCT01005719|10990650|FG004|COMPLETED|Period 1||11
9875891|NCT01005719|10990651|FG005|COMPLETED|Period 1||10
9875892|NCT01005719|10990646|FG000|NOT COMPLETED|Period 1||0
9875893|NCT01005719|10990647|FG001|NOT COMPLETED|Period 1||0
9875894|NCT01005719|10990648|FG002|NOT COMPLETED|Period 1||0
9875895|NCT01005719|10990649|FG003|NOT COMPLETED|Period 1||1
9875896|NCT01005719|10990650|FG004|NOT COMPLETED|Period 1||0
9875897|NCT01005719|10990651|FG005|NOT COMPLETED|Period 1||1
9875898|NCT01005719|10990646|FG000|STARTED|Period 2||10
9875899|NCT01005719|10990647|FG001|STARTED|Period 2||10
9875900|NCT01005719|10990648|FG002|STARTED|Period 2||10
9875901|NCT01005719|10990649|FG003|STARTED|Period 2||10
9875902|NCT01005719|10990650|FG004|STARTED|Period 2||11
9875903|NCT01005719|10990651|FG005|STARTED|Period 2||10
9875904|NCT01005719|10990646|FG000|COMPLETED|Period 2||10
9875905|NCT01005719|10990647|FG001|COMPLETED|Period 2||10
9875906|NCT01005719|10990648|FG002|COMPLETED|Period 2||10
9875907|NCT01005719|10990649|FG003|COMPLETED|Period 2||10
9875908|NCT01005719|10990650|FG004|COMPLETED|Period 2||10
9875909|NCT01005719|10990651|FG005|COMPLETED|Period 2||9
9875910|NCT01005719|10990646|FG000|NOT COMPLETED|Period 2||0
9875911|NCT01005719|10990647|FG001|NOT COMPLETED|Period 2||0
9875912|NCT01005719|10990648|FG002|NOT COMPLETED|Period 2||0
9875913|NCT01005719|10990649|FG003|NOT COMPLETED|Period 2||0
9875914|NCT01005719|10990650|FG004|NOT COMPLETED|Period 2||1
9875915|NCT01005719|10990651|FG005|NOT COMPLETED|Period 2||1
9875916|NCT01005719|10990646|FG000|STARTED|Period 3||10
9875917|NCT01005719|10990647|FG001|STARTED|Period 3||10
9875918|NCT01005719|10990648|FG002|STARTED|Period 3||10
9875919|NCT01005719|10990649|FG003|STARTED|Period 3||10
9875920|NCT01005719|10990650|FG004|STARTED|Period 3||10
9875921|NCT01005719|10990651|FG005|STARTED|Period 3||9
9875922|NCT01005719|10990646|FG000|COMPLETED|Period 3||10
9875923|NCT01005719|10990647|FG001|COMPLETED|Period 3||10
9875924|NCT01005719|10990648|FG002|COMPLETED|Period 3||10
9875925|NCT01005719|10990649|FG003|COMPLETED|Period 3||10
9875926|NCT01005719|10990650|FG004|COMPLETED|Period 3||10
9875927|NCT01005719|10990651|FG005|COMPLETED|Period 3||9
9875928|NCT01005719|10990646|FG000|NOT COMPLETED|Period 3||0
9875929|NCT01005719|10990647|FG001|NOT COMPLETED|Period 3||0
9875930|NCT01005719|10990648|FG002|NOT COMPLETED|Period 3||0
9875931|NCT01005719|10990649|FG003|NOT COMPLETED|Period 3||0
9875932|NCT01005719|10990650|FG004|NOT COMPLETED|Period 3||0
9875933|NCT01005719|10990651|FG005|NOT COMPLETED|Period 3||0
9875934|NCT01005732|10990660|FG000|STARTED|Overall Study||54
9875935|NCT01005732|10990660|FG000|COMPLETED|Overall Study||43
9875936|NCT01005732|10990660|FG000|NOT COMPLETED|Overall Study||11
9875937|NCT01005810|10990670|FG000|STARTED|Overall Study||58
9875938|NCT01005810|10990671|FG001|STARTED|Overall Study||58
9875939|NCT01005810|10990670|FG000|COMPLETED|Overall Study||37
9875940|NCT01005810|10990671|FG001|COMPLETED|Overall Study||33
9875941|NCT01005810|10990670|FG000|NOT COMPLETED|Overall Study||21
9875942|NCT01005810|10990671|FG001|NOT COMPLETED|Overall Study||25
9875943|NCT01005875|10990677|FG000|STARTED|Overall Study||5
9875944|NCT01005875|10990677|FG000|COMPLETED|Overall Study||2
9875945|NCT01005875|10990677|FG000|NOT COMPLETED|Overall Study||3
9875946|NCT01005888|10990685|FG000|STARTED|First Intervention||12
9875947|NCT01005888|10990686|FG001|STARTED|First Intervention||12
9875948|NCT01005888|10990685|FG000|COMPLETED|First Intervention||11
9875949|NCT01005888|10990686|FG001|COMPLETED|First Intervention||11
9875950|NCT01005888|10990685|FG000|NOT COMPLETED|First Intervention||1
9875951|NCT01005888|10990686|FG001|NOT COMPLETED|First Intervention||1
9875952|NCT01005888|10990685|FG000|STARTED|Second Intervention||11
9875953|NCT01005888|10990686|FG001|STARTED|Second Intervention||11
9875954|NCT01005888|10990685|FG000|COMPLETED|Second Intervention||10
9875955|NCT01005888|10990686|FG001|COMPLETED|Second Intervention||10
9875956|NCT01005888|10990685|FG000|NOT COMPLETED|Second Intervention||1
9875957|NCT01005888|10990686|FG001|NOT COMPLETED|Second Intervention||1
9875958|NCT01005901|10990694|FG000|STARTED|Overall Study||552
9875959|NCT01005901|10990695|FG001|STARTED|Overall Study||270
9875960|NCT01005901|10990694|FG000|Safety Population|Overall Study||550
9875961|NCT01005901|10990695|FG001|Safety Population|Overall Study||267
9875962|NCT01005901|10990694|FG000|Full Analysis Set|Overall Study||534
9875963|NCT01005901|10990695|FG001|Full Analysis Set|Overall Study||260
9875964|NCT01005901|10990694|FG000|COMPLETED|Overall Study||450
9875965|NCT01005901|10990695|FG001|COMPLETED|Overall Study||212
9875966|NCT01005901|10990694|FG000|NOT COMPLETED|Overall Study||102
9875967|NCT01005901|10990695|FG001|NOT COMPLETED|Overall Study||58
9875968|NCT01005966|10990701|FG000|STARTED|Treatment Period 1 (14 Days)||13
9875969|NCT01005966|10990702|FG001|STARTED|Treatment Period 1 (14 Days)||13
9875970|NCT01005966|10990703|FG002|STARTED|Treatment Period 1 (14 Days)||13
9875971|NCT01005966|10990704|FG003|STARTED|Treatment Period 1 (14 Days)||13
9875972|NCT01005966|10990705|FG004|STARTED|Treatment Period 1 (14 Days)||13
9875973|NCT01005966|10990701|FG000|COMPLETED|Treatment Period 1 (14 Days)||11
9875974|NCT01005966|10990702|FG001|COMPLETED|Treatment Period 1 (14 Days)||13
9875975|NCT01005966|10990703|FG002|COMPLETED|Treatment Period 1 (14 Days)||12
9875976|NCT01005966|10990704|FG003|COMPLETED|Treatment Period 1 (14 Days)||13
9875977|NCT01005966|10990705|FG004|COMPLETED|Treatment Period 1 (14 Days)||13
9875978|NCT01005966|10990701|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
9875979|NCT01005966|10990702|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
9875980|NCT01005966|10990703|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10097299|NCT02373202|11226279|FG000|COMPLETED|Overall Study||13
10097300|NCT02373202|11226280|FG001|COMPLETED|Overall Study||9
10097301|NCT02373202|11226281|FG002|COMPLETED|Overall Study||27
10097302|NCT02373202|11226282|FG003|COMPLETED|Overall Study||30
9875981|NCT01005966|10990704|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0
9875982|NCT01005966|10990705|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
9875983|NCT01005966|10990701|FG000|STARTED|Washout Period 1 (4 Days)||11
9875984|NCT01005966|10990702|FG001|STARTED|Washout Period 1 (4 Days)||13
9875985|NCT01005966|10990703|FG002|STARTED|Washout Period 1 (4 Days)||12
9875986|NCT01005966|10990704|FG003|STARTED|Washout Period 1 (4 Days)||13
9875987|NCT01005966|10990705|FG004|STARTED|Washout Period 1 (4 Days)||13
9875988|NCT01005966|10990701|FG000|COMPLETED|Washout Period 1 (4 Days)||11
10097303|NCT02373202|11226279|FG000|NOT COMPLETED|Overall Study||2
10097304|NCT02373202|11226280|FG001|NOT COMPLETED|Overall Study||6
10097305|NCT02373202|11226281|FG002|NOT COMPLETED|Overall Study||3
9875989|NCT01005966|10990702|FG001|COMPLETED|Washout Period 1 (4 Days)||13
9875990|NCT01005966|10990703|FG002|COMPLETED|Washout Period 1 (4 Days)||12
9875991|NCT01005966|10990704|FG003|COMPLETED|Washout Period 1 (4 Days)||12
9875992|NCT01005966|10990705|FG004|COMPLETED|Washout Period 1 (4 Days)||13
10097306|NCT02373202|11226282|FG003|NOT COMPLETED|Overall Study||1
10097307|NCT02373371|11226294|FG000|STARTED|Overall Study||13
10097308|NCT02373371|11226295|FG001|STARTED|Overall Study||13
9875993|NCT01005966|10990701|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0
9875994|NCT01005966|10990702|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0
9875995|NCT01005966|10990703|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0
10097309|NCT02373371|11226294|FG000|COMPLETED|Overall Study||13
10097310|NCT02373371|11226295|FG001|COMPLETED|Overall Study||13
10097311|NCT02373371|11226294|FG000|NOT COMPLETED|Overall Study||0
10097312|NCT02373371|11226295|FG001|NOT COMPLETED|Overall Study||0
9875996|NCT01005966|10990704|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1
9875997|NCT01005966|10990705|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0
9875998|NCT01005966|10990701|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
9875999|NCT01005966|10990702|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
9876000|NCT01005966|10990703|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
9876001|NCT01005966|10990704|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
9876002|NCT01005966|10990705|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
9876003|NCT01005966|10990701|FG000|COMPLETED|Treatment Period 2 (14 Days)||13
9876004|NCT01005966|10990702|FG001|COMPLETED|Treatment Period 2 (14 Days)||12
9876005|NCT01005966|10990703|FG002|COMPLETED|Treatment Period 2 (14 Days)||10
9876006|NCT01005966|10990704|FG003|COMPLETED|Treatment Period 2 (14 Days)||11
9876007|NCT01005966|10990705|FG004|COMPLETED|Treatment Period 2 (14 Days)||11
9876008|NCT01005966|10990701|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
9876009|NCT01005966|10990702|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
9876010|NCT01005966|10990703|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
9876011|NCT01005966|10990704|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
9876012|NCT01005966|10990705|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
9876013|NCT01005966|10990701|FG000|STARTED|Washout Period 2 (4 Days)||13
9876014|NCT01005966|10990702|FG001|STARTED|Washout Period 2 (4 Days)||12
9876015|NCT01005966|10990703|FG002|STARTED|Washout Period 2 (4 Days)||10
9876016|NCT01005966|10990704|FG003|STARTED|Washout Period 2 (4 Days)||11
9876017|NCT01005966|10990705|FG004|STARTED|Washout Period 2 (4 Days)||11
9876018|NCT01005966|10990701|FG000|COMPLETED|Washout Period 2 (4 Days)||13
9876019|NCT01005966|10990702|FG001|COMPLETED|Washout Period 2 (4 Days)||12
9876020|NCT01005966|10990703|FG002|COMPLETED|Washout Period 2 (4 Days)||10
9876021|NCT01005966|10990704|FG003|COMPLETED|Washout Period 2 (4 Days)||11
9876022|NCT01005966|10990705|FG004|COMPLETED|Washout Period 2 (4 Days)||11
9876023|NCT01005966|10990701|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0
9876024|NCT01005966|10990702|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0
9876025|NCT01005966|10990703|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0
9876026|NCT01005966|10990704|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0
9876027|NCT01005966|10990705|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0
9876028|NCT01005966|10990701|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
9876029|NCT01005966|10990702|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
9876030|NCT01005966|10990703|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
9876031|NCT01005966|10990704|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
9876032|NCT01005966|10990705|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
9876033|NCT01005966|10990701|FG000|COMPLETED|Treatment Period 3 (14 Days)||12
9876034|NCT01005966|10990702|FG001|COMPLETED|Treatment Period 3 (14 Days)||7
9876035|NCT01005966|10990703|FG002|COMPLETED|Treatment Period 3 (14 Days)||12
9876036|NCT01005966|10990704|FG003|COMPLETED|Treatment Period 3 (14 Days)||13
9876037|NCT01005966|10990705|FG004|COMPLETED|Treatment Period 3 (14 Days)||11
10097313|NCT02373813|11226304|FG000|STARTED|Run-In Period||371
10097314|NCT02373813|11226305|FG001|STARTED|Run-In Period||0
10097315|NCT02373813|11226306|FG002|STARTED|Run-In Period||0
10097316|NCT02373813|11226307|FG003|STARTED|Run-In Period||0
10097317|NCT02373813|11226304|FG000|Treated|Run-In Period||368
10097318|NCT02373813|11226305|FG001|Treated|Run-In Period||0
9876038|NCT01005966|10990701|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
9876039|NCT01005966|10990702|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
9876040|NCT01005966|10990703|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0
9876041|NCT01005966|10990704|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
9876042|NCT01005966|10990705|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1
9876043|NCT01005966|10990701|FG000|STARTED|Washout Period 3 ( 4 Days)||12
9876044|NCT01005966|10990702|FG001|STARTED|Washout Period 3 ( 4 Days)||7
9876045|NCT01005966|10990703|FG002|STARTED|Washout Period 3 ( 4 Days)||12
9876046|NCT01005966|10990704|FG003|STARTED|Washout Period 3 ( 4 Days)||13
9876047|NCT01005966|10990705|FG004|STARTED|Washout Period 3 ( 4 Days)||11
9876048|NCT01005966|10990701|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12
9876049|NCT01005966|10990702|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7
9876050|NCT01005966|10990703|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12
9876051|NCT01005966|10990704|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13
9876052|NCT01005966|10990705|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11
9876053|NCT01005966|10990701|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
10097319|NCT02373813|11226306|FG002|Treated|Run-In Period||0
10097320|NCT02373813|11226307|FG003|Treated|Run-In Period||0
10097321|NCT02373813|11226304|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
10097322|NCT02373813|11226305|FG001|COMPLETED|Run-In Period||0
10097323|NCT02373813|11226306|FG002|COMPLETED|Run-In Period||0
10201983|NCT03441984|11329281|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10201984|NCT03441984|11329282|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0
9876054|NCT01005966|10990702|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
9876055|NCT01005966|10990703|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
9876056|NCT01005966|10990704|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
9876057|NCT01005966|10990705|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
9876058|NCT01005966|10990701|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
9876059|NCT01005966|10990702|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
9876060|NCT01005966|10990703|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
9876061|NCT01005966|10990704|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
9876062|NCT01005966|10990705|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
9876063|NCT01005966|10990701|FG000|COMPLETED|Treatment Period 4 (14 Days)||10
9876064|NCT01005966|10990702|FG001|COMPLETED|Treatment Period 4 (14 Days)||10
9876065|NCT01005966|10990703|FG002|COMPLETED|Treatment Period 4 (14 Days)||11
9876066|NCT01005966|10990704|FG003|COMPLETED|Treatment Period 4 (14 Days)||10
9876067|NCT01005966|10990705|FG004|COMPLETED|Treatment Period 4 (14 Days)||12
9876068|NCT01005966|10990701|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0
9876069|NCT01005966|10990702|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1
9876070|NCT01005966|10990703|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0
9876071|NCT01005966|10990704|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0
9876072|NCT01005966|10990705|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1
9876073|NCT01005966|10990701|FG000|STARTED|Washout Period 4 (4 Days)||10
9876074|NCT01005966|10990702|FG001|STARTED|Washout Period 4 (4 Days)||10
9876075|NCT01005966|10990703|FG002|STARTED|Washout Period 4 (4 Days)||11
9876076|NCT01005966|10990704|FG003|STARTED|Washout Period 4 (4 Days)||10
9876077|NCT01005966|10990705|FG004|STARTED|Washout Period 4 (4 Days)||12
9876078|NCT01005966|10990701|FG000|COMPLETED|Washout Period 4 (4 Days)||10
9876079|NCT01005966|10990702|FG001|COMPLETED|Washout Period 4 (4 Days)||10
9876080|NCT01005966|10990703|FG002|COMPLETED|Washout Period 4 (4 Days)||11
9876081|NCT01005966|10990704|FG003|COMPLETED|Washout Period 4 (4 Days)||10
9876082|NCT01005966|10990705|FG004|COMPLETED|Washout Period 4 (4 Days)||12
9876083|NCT01005966|10990701|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0
9876084|NCT01005966|10990702|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0
9876085|NCT01005966|10990703|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0
9876086|NCT01005966|10990704|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0
9876087|NCT01005966|10990705|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0
9876088|NCT01005966|10990701|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
9876089|NCT01005966|10990702|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
9876090|NCT01005966|10990703|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
9876091|NCT01005966|10990704|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
9876092|NCT01005966|10990705|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
9876093|NCT01005966|10990701|FG000|COMPLETED|Treatment Period 5 (14 Days)||9
9876094|NCT01005966|10990702|FG001|COMPLETED|Treatment Period 5 (14 Days)||12
9876095|NCT01005966|10990703|FG002|COMPLETED|Treatment Period 5 (14 Days)||11
9876096|NCT01005966|10990704|FG003|COMPLETED|Treatment Period 5 (14 Days)||11
9876097|NCT01005966|10990705|FG004|COMPLETED|Treatment Period 5 (14 Days)||10
9876098|NCT01005966|10990701|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0
9876099|NCT01005966|10990702|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0
9876100|NCT01005966|10990703|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0
9876101|NCT01005966|10990704|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0
9876102|NCT01005966|10990705|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0
9876103|NCT01006122|10990722|FG000|STARTED|First Double-blind Intervention Period||47
9876104|NCT01006122|10990723|FG001|STARTED|First Double-blind Intervention Period||48
9876105|NCT01006122|10990722|FG000|COMPLETED|First Double-blind Intervention Period||31
9876106|NCT01006122|10990723|FG001|COMPLETED|First Double-blind Intervention Period||31
9876107|NCT01006122|10990722|FG000|NOT COMPLETED|First Double-blind Intervention Period||16
9876108|NCT01006122|10990723|FG001|NOT COMPLETED|First Double-blind Intervention Period||17
9876109|NCT01006122|10990722|FG000|STARTED|Wash-out Period (at Least 7 Days)||31
9876110|NCT01006122|10990723|FG001|STARTED|Wash-out Period (at Least 7 Days)||31
9876111|NCT01006122|10990722|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31
9876112|NCT01006122|10990723|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31
9876113|NCT01006122|10990722|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
9876114|NCT01006122|10990723|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
9876115|NCT01006122|10990722|FG000|STARTED|Second Double-blind Intervention Period||31
9876116|NCT01006122|10990723|FG001|STARTED|Second Double-blind Intervention Period||31
9876117|NCT01006122|10990722|FG000|COMPLETED|Second Double-blind Intervention Period||29
9876118|NCT01006122|10990723|FG001|COMPLETED|Second Double-blind Intervention Period||24
9876119|NCT01006122|10990722|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
9876120|NCT01006122|10990723|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7
9876121|NCT01006135|10990729|FG000|STARTED|Overall Study||4852
9876122|NCT01006135|10990729|FG000|COMPLETED|Overall Study||4712
9876123|NCT01006135|10990729|FG000|NOT COMPLETED|Overall Study||140
9876124|NCT01006252|10990735|FG000|STARTED|Overall Study||168
9876125|NCT01006252|10990736|FG001|STARTED|Overall Study||168
9876126|NCT01006252|10990735|FG000|Received Treatment|Overall Study||164
9876127|NCT01006252|10990736|FG001|Received Treatment|Overall Study||161
9876128|NCT01006252|10990735|FG000|COMPLETED|Overall Study||168
9876129|NCT01006252|10990736|FG001|COMPLETED|Overall Study||168
9876130|NCT01006252|10990735|FG000|NOT COMPLETED|Overall Study||0
9876131|NCT01006252|10990736|FG001|NOT COMPLETED|Overall Study||0
9876132|NCT01006291|10990749|FG000|STARTED|Overall Study||229
9876133|NCT01006291|10990750|FG001|STARTED|Overall Study||228
9876134|NCT01006291|10990751|FG002|STARTED|Overall Study||230
9876135|NCT01006291|10990749|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
9876136|NCT01006291|10990750|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226
9876137|NCT01006291|10990751|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
9876138|NCT01006291|10990749|FG000|COMPLETED|Overall Study||203
9876139|NCT01006291|10990750|FG001|COMPLETED|Overall Study||204
9876140|NCT01006291|10990751|FG002|COMPLETED|Overall Study||203
9876141|NCT01006291|10990749|FG000|NOT COMPLETED|Overall Study||26
9876142|NCT01006291|10990750|FG001|NOT COMPLETED|Overall Study||24
9876143|NCT01006291|10990751|FG002|NOT COMPLETED|Overall Study||27
9876144|NCT01006356|10990759|FG000|STARTED|Overall Study||141
9876145|NCT01006356|10990759|FG000|COMPLETED|Overall Study||99
9876146|NCT01006356|10990759|FG000|NOT COMPLETED|Overall Study||42
9876147|NCT01006369|10990765|FG000|STARTED|Overall Study||13
9876148|NCT01006369|10990766|FG001|STARTED|Overall Study||25
9876149|NCT01006369|10990765|FG000|COMPLETED|Overall Study||1
9876150|NCT01006369|10990766|FG001|COMPLETED|Overall Study||0
9876151|NCT01006369|10990765|FG000|NOT COMPLETED|Overall Study||12
9876152|NCT01006369|10990766|FG001|NOT COMPLETED|Overall Study||25
9876153|NCT01006538|10990773|FG000|STARTED|Overall Study||244
9876154|NCT01006538|10990774|FG001|STARTED|Overall Study||119
9876155|NCT01006538|10990773|FG000|COMPLETED|Overall Study||233
9876156|NCT01006538|10990774|FG001|COMPLETED|Overall Study||115
9876157|NCT01006538|10990773|FG000|NOT COMPLETED|Overall Study||11
9876158|NCT01006538|10990774|FG001|NOT COMPLETED|Overall Study||4
9876159|NCT01006590|10990782|FG000|STARTED|Overall Study|Randomised and treated|147
9876160|NCT01006590|10990783|FG001|STARTED|Overall Study|Randomised and treated|139
10097324|NCT02373813|11226307|FG003|COMPLETED|Run-In Period||0
10097325|NCT02373813|11226304|FG000|NOT COMPLETED|Run-In Period||116
10097326|NCT02373813|11226305|FG001|NOT COMPLETED|Run-In Period||0
10097327|NCT02373813|11226306|FG002|NOT COMPLETED|Run-In Period||0
10097328|NCT02373813|11226307|FG003|NOT COMPLETED|Run-In Period||0
10097329|NCT02373813|11226304|FG000|STARTED|Double-Blind Treatment Period||0
10097330|NCT02373813|11226305|FG001|STARTED|Double-Blind Treatment Period||101
10097331|NCT02373813|11226306|FG002|STARTED|Double-Blind Treatment Period||101
10097332|NCT02373813|11226307|FG003|STARTED|Double-Blind Treatment Period||51
10097333|NCT02373813|11226304|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0
10097334|NCT02373813|11226305|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101
10097335|NCT02373813|11226306|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100
10097336|NCT02373813|11226307|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51
10097337|NCT02373813|11226304|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0
10097338|NCT02373813|11226305|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52
10097339|NCT02373813|11226306|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36
10097340|NCT02373813|11226307|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15
10097341|NCT02373813|11226304|FG000|COMPLETED|Double-Blind Treatment Period||0
10097342|NCT02373813|11226305|FG001|COMPLETED|Double-Blind Treatment Period||88
10097343|NCT02373813|11226306|FG002|COMPLETED|Double-Blind Treatment Period||92
10201985|NCT03441984|11329283|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10201986|NCT03441984|11329284|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10201987|NCT03441984|11329285|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10201988|NCT03441984|11329286|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10201989|NCT03441984|11329287|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10201990|NCT03441984|11329276|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10201991|NCT03441984|11329277|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10201992|NCT03441984|11329278|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
10201993|NCT03441984|11329279|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
9876161|NCT01006590|10990782|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
9876162|NCT01006590|10990783|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
9876163|NCT01006590|10990782|FG000|NOT COMPLETED|Overall Study||28
9876164|NCT01006590|10990783|FG001|NOT COMPLETED|Overall Study||32
9876165|NCT01006603|10990791|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360
9876166|NCT01006603|10990792|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360
9876167|NCT01006603|10990791|FG000|COMPLETED|Overall Study||289
9876168|NCT01006603|10990792|FG001|COMPLETED|Overall Study||285
10097344|NCT02373813|11226307|FG003|COMPLETED|Double-Blind Treatment Period||47
10097345|NCT02373813|11226304|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10097346|NCT02373813|11226305|FG001|NOT COMPLETED|Double-Blind Treatment Period||13
10097347|NCT02373813|11226306|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
9876169|NCT01006603|10990791|FG000|NOT COMPLETED|Overall Study||71
9876170|NCT01006603|10990792|FG001|NOT COMPLETED|Overall Study||75
9876171|NCT01006616|10990802|FG000|STARTED|Period 1 (6 Months)||152
9876172|NCT01006616|10990803|FG001|STARTED|Period 1 (6 Months)||156
9876173|NCT01006616|10990804|FG002|STARTED|Period 1 (6 Months)||153
9876174|NCT01006616|10990805|FG003|STARTED|Period 1 (6 Months)||155
9876175|NCT01006616|10990802|FG000|Treated|Period 1 (6 Months)||152
9876176|NCT01006616|10990803|FG001|Treated|Period 1 (6 Months)||156
9876177|NCT01006616|10990804|FG002|Treated|Period 1 (6 Months)||152
9876178|NCT01006616|10990805|FG003|Treated|Period 1 (6 Months)||154
9876179|NCT01006616|10990802|FG000|COMPLETED|Period 1 (6 Months)||126
9876180|NCT01006616|10990803|FG001|COMPLETED|Period 1 (6 Months)||102
9876181|NCT01006616|10990804|FG002|COMPLETED|Period 1 (6 Months)||102
9876182|NCT01006616|10990805|FG003|COMPLETED|Period 1 (6 Months)||128
9876183|NCT01006616|10990802|FG000|NOT COMPLETED|Period 1 (6 Months)||26
9876184|NCT01006616|10990803|FG001|NOT COMPLETED|Period 1 (6 Months)||54
9876185|NCT01006616|10990804|FG002|NOT COMPLETED|Period 1 (6 Months)||51
9876186|NCT01006616|10990805|FG003|NOT COMPLETED|Period 1 (6 Months)||27
9876187|NCT01006616|10990802|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
9876188|NCT01006616|10990803|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
9876189|NCT01006616|10990804|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
9876190|NCT01006616|10990805|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
9876191|NCT01006616|10990802|FG000|Treated|Period 2 (18 Months)||75
9876192|NCT01006616|10990803|FG001|Treated|Period 2 (18 Months)||63
9876193|NCT01006616|10990804|FG002|Treated|Period 2 (18 Months)||55
9876194|NCT01006616|10990805|FG003|Treated|Period 2 (18 Months)||82
9876195|NCT01006616|10990802|FG000|COMPLETED|Period 2 (18 Months)||0
9876196|NCT01006616|10990803|FG001|COMPLETED|Period 2 (18 Months)||0
9876197|NCT01006616|10990804|FG002|COMPLETED|Period 2 (18 Months)||0
9876198|NCT01006616|10990805|FG003|COMPLETED|Period 2 (18 Months)||0
9876199|NCT01006616|10990802|FG000|NOT COMPLETED|Period 2 (18 Months)||75
9876200|NCT01006616|10990803|FG001|NOT COMPLETED|Period 2 (18 Months)||63
9876201|NCT01006616|10990804|FG002|NOT COMPLETED|Period 2 (18 Months)||55
9876202|NCT01006616|10990805|FG003|NOT COMPLETED|Period 2 (18 Months)||82
9876203|NCT01006629|10990815|FG000|STARTED|Overall Study||100
9876204|NCT01006629|10990815|FG000|COMPLETED|Overall Study||94
9876205|NCT01006629|10990815|FG000|NOT COMPLETED|Overall Study||6
9876206|NCT01006655|10990821|FG000|STARTED|First Intervention||11
9876207|NCT01006655|10990822|FG001|STARTED|First Intervention||10
9876208|NCT01006655|10990821|FG000|COMPLETED|First Intervention||11
9876209|NCT01006655|10990822|FG001|COMPLETED|First Intervention||10
9876210|NCT01006655|10990821|FG000|NOT COMPLETED|First Intervention||0
9876211|NCT01006655|10990822|FG001|NOT COMPLETED|First Intervention||0
9876212|NCT01006655|10990821|FG000|STARTED|Washout Period of 2 Weeks||11
9876213|NCT01006655|10990822|FG001|STARTED|Washout Period of 2 Weeks||10
9876214|NCT01006655|10990821|FG000|COMPLETED|Washout Period of 2 Weeks||11
9876215|NCT01006655|10990822|FG001|COMPLETED|Washout Period of 2 Weeks||10
9876216|NCT01006655|10990821|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9876217|NCT01006655|10990822|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9876218|NCT01006655|10990821|FG000|STARTED|Second Intervention||11
9876219|NCT01006655|10990822|FG001|STARTED|Second Intervention||10
9876220|NCT01006655|10990821|FG000|COMPLETED|Second Intervention||11
9876221|NCT01006655|10990822|FG001|COMPLETED|Second Intervention||10
9876222|NCT01006655|10990821|FG000|NOT COMPLETED|Second Intervention||0
9876223|NCT01006655|10990822|FG001|NOT COMPLETED|Second Intervention||0
9876224|NCT01006707|10990828|FG000|STARTED|Study Session 1||15
9876225|NCT01006707|10990829|FG001|STARTED|Study Session 1||0
9876226|NCT01006707|10990830|FG002|STARTED|Study Session 1||0
9876227|NCT01006707|10990828|FG000|COMPLETED|Study Session 1||10
9876228|NCT01006707|10990829|FG001|COMPLETED|Study Session 1||0
9876229|NCT01006707|10990830|FG002|COMPLETED|Study Session 1||0
9876230|NCT01006707|10990828|FG000|NOT COMPLETED|Study Session 1||5
9876231|NCT01006707|10990829|FG001|NOT COMPLETED|Study Session 1||0
9876232|NCT01006707|10990830|FG002|NOT COMPLETED|Study Session 1||0
9876233|NCT01006707|10990828|FG000|STARTED|Study Session 2||0
9876234|NCT01006707|10990829|FG001|STARTED|Study Session 2||4
9876235|NCT01006707|10990830|FG002|STARTED|Study Session 2||6
9876236|NCT01006707|10990828|FG000|COMPLETED|Study Session 2||0
9876237|NCT01006707|10990829|FG001|COMPLETED|Study Session 2||4
9876238|NCT01006707|10990830|FG002|COMPLETED|Study Session 2||6
9876239|NCT01006707|10990828|FG000|NOT COMPLETED|Study Session 2||0
9876240|NCT01006707|10990829|FG001|NOT COMPLETED|Study Session 2||0
9876241|NCT01006707|10990830|FG002|NOT COMPLETED|Study Session 2||0
9876242|NCT01006707|10990828|FG000|STARTED|Study Session 3||0
9876243|NCT01006707|10990829|FG001|STARTED|Study Session 3||4
9876244|NCT01006707|10990830|FG002|STARTED|Study Session 3||6
9876245|NCT01006707|10990828|FG000|COMPLETED|Study Session 3||0
9876246|NCT01006707|10990829|FG001|COMPLETED|Study Session 3||4
9876247|NCT01006707|10990830|FG002|COMPLETED|Study Session 3||6
9876248|NCT01006707|10990828|FG000|NOT COMPLETED|Study Session 3||0
9876249|NCT01006707|10990829|FG001|NOT COMPLETED|Study Session 3||0
9876250|NCT01006707|10990830|FG002|NOT COMPLETED|Study Session 3||0
9876251|NCT01006889|10990838|FG000|STARTED|Overall Study||20
9876252|NCT01006889|10990838|FG000|COMPLETED|Overall Study||17
9876253|NCT01006889|10990838|FG000|NOT COMPLETED|Overall Study||3
9876254|NCT01006967|10990845|FG000|STARTED|Overall Study||253
9876255|NCT01006967|10990846|FG001|STARTED|Overall Study||253
9876256|NCT01006967|10990845|FG000|Received Treatment|Overall Study||245
9876257|NCT01006967|10990846|FG001|Received Treatment|Overall Study||245
9876258|NCT01006967|10990845|FG000|3 Month Follow-up|Overall Study||212
9876259|NCT01006967|10990846|FG001|3 Month Follow-up|Overall Study||210
9876260|NCT01006967|10990845|FG000|COMPLETED|Overall Study||187
9876261|NCT01006967|10990846|FG001|COMPLETED|Overall Study||190
9876262|NCT01006967|10990845|FG000|NOT COMPLETED|Overall Study||66
9876263|NCT01006967|10990846|FG001|NOT COMPLETED|Overall Study||63
9876264|NCT01006980|10990856|FG000|STARTED|Vemurafenib and Dacarbazine||337
9876265|NCT01006980|10990857|FG001|STARTED|Vemurafenib and Dacarbazine||338
9876266|NCT01006980|10990856|FG000|Treated|Vemurafenib and Dacarbazine||336
9876267|NCT01006980|10990857|FG001|Treated|Vemurafenib and Dacarbazine||293
9876268|NCT01006980|10990856|FG000|COMPLETED|Vemurafenib and Dacarbazine||0
9876269|NCT01006980|10990857|FG001|COMPLETED|Vemurafenib and Dacarbazine||0
9876270|NCT01006980|10990856|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337
9876271|NCT01006980|10990857|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338
9876272|NCT01006980|10990856|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0
9876273|NCT01006980|10990857|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
9876274|NCT01006980|10990856|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
9876275|NCT01006980|10990857|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
9876276|NCT01006980|10990856|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
9876277|NCT01006980|10990857|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
9876278|NCT01007032|10990868|FG000|STARTED|Overall Study||4
9876279|NCT01007032|10990869|FG001|STARTED|Overall Study||7
9876280|NCT01007032|10990870|FG002|STARTED|Overall Study||3
9876281|NCT01007032|10990871|FG003|STARTED|Overall Study||7
9876282|NCT01007032|10990868|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
9876283|NCT01007032|10990869|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
9876284|NCT01007032|10990870|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9876285|NCT01007032|10990871|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
9876286|NCT01007032|10990868|FG000|COMPLETED|Overall Study||4
9876287|NCT01007032|10990869|FG001|COMPLETED|Overall Study||6
9876288|NCT01007032|10990870|FG002|COMPLETED|Overall Study||2
9876289|NCT01007032|10990871|FG003|COMPLETED|Overall Study||6
9876290|NCT01007032|10990868|FG000|NOT COMPLETED|Overall Study||0
9876291|NCT01007032|10990869|FG001|NOT COMPLETED|Overall Study||1
9876292|NCT01007032|10990870|FG002|NOT COMPLETED|Overall Study||1
9876293|NCT01007032|10990871|FG003|NOT COMPLETED|Overall Study||1
9876294|NCT01007071|10990888|FG000|STARTED|Overall Study||6
9876295|NCT01007071|10990889|FG001|STARTED|Overall Study||5
9876296|NCT01007071|10990888|FG000|COMPLETED|Overall Study||6
9876297|NCT01007071|10990889|FG001|COMPLETED|Overall Study||5
9876298|NCT01007071|10990888|FG000|NOT COMPLETED|Overall Study||0
9876299|NCT01007071|10990889|FG001|NOT COMPLETED|Overall Study||0
10097348|NCT02373813|11226307|FG003|NOT COMPLETED|Double-Blind Treatment Period||4
10097349|NCT02373852|11226318|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
10097350|NCT02373852|11226318|FG000|COMPLETED|Overall Study||11
10097351|NCT02373852|11226318|FG000|NOT COMPLETED|Overall Study||1
10097352|NCT02374060|11226325|FG000|STARTED|Overall Study||65
9876300|NCT01007110|10990898|FG000|STARTED|Allocation||32
9876301|NCT01007110|10990899|FG001|STARTED|Allocation||35
9876302|NCT01007110|10990898|FG000|COMPLETED|Allocation||25
9876303|NCT01007110|10990899|FG001|COMPLETED|Allocation||27
9876304|NCT01007110|10990898|FG000|NOT COMPLETED|Allocation||7
9876305|NCT01007110|10990899|FG001|NOT COMPLETED|Allocation||8
9876306|NCT01007110|10990898|FG000|STARTED|Follow-Up at 24 Weeks||25
9876307|NCT01007110|10990899|FG001|STARTED|Follow-Up at 24 Weeks||27
9876308|NCT01007110|10990898|FG000|COMPLETED|Follow-Up at 24 Weeks||25
9876309|NCT01007110|10990899|FG001|COMPLETED|Follow-Up at 24 Weeks||23
9876310|NCT01007110|10990898|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0
9876311|NCT01007110|10990899|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4
9876312|NCT01007110|10990898|FG000|STARTED|Follow-Up at 32 Weeks||25
9876313|NCT01007110|10990899|FG001|STARTED|Follow-Up at 32 Weeks||23
9876314|NCT01007110|10990898|FG000|COMPLETED|Follow-Up at 32 Weeks||24
9876315|NCT01007110|10990899|FG001|COMPLETED|Follow-Up at 32 Weeks||22
9876316|NCT01007110|10990898|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1
9876317|NCT01007110|10990899|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1
9876318|NCT01007110|10990898|FG000|STARTED|Follow-Up at 36 Weeks||24
9876319|NCT01007110|10990899|FG001|STARTED|Follow-Up at 36 Weeks||22
9876320|NCT01007110|10990898|FG000|COMPLETED|Follow-Up at 36 Weeks||24
9876321|NCT01007110|10990899|FG001|COMPLETED|Follow-Up at 36 Weeks||20
9876322|NCT01007110|10990898|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0
9876323|NCT01007110|10990899|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2
9876324|NCT01007110|10990898|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24
9876325|NCT01007110|10990899|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20
9876326|NCT01007110|10990898|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
9876327|NCT01007110|10990899|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
9876328|NCT01007110|10990898|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
9876329|NCT01007110|10990899|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
9876330|NCT01007123|10990910|FG000|STARTED|Overall Study||48
9876331|NCT01007123|10990911|FG001|STARTED|Overall Study||47
9876332|NCT01007123|10990912|FG002|STARTED|Overall Study||48
9876333|NCT01007123|10990913|FG003|STARTED|Overall Study||47
9876334|NCT01007123|10990910|FG000|COMPLETED|Overall Study||42
10097353|NCT02374060|11226326|FG001|STARTED|Overall Study||63
9876335|NCT01007123|10990911|FG001|COMPLETED|Overall Study||41
9876336|NCT01007123|10990912|FG002|COMPLETED|Overall Study||37
9876337|NCT01007123|10990913|FG003|COMPLETED|Overall Study||41
9876338|NCT01007123|10990910|FG000|NOT COMPLETED|Overall Study||6
9876339|NCT01007123|10990911|FG001|NOT COMPLETED|Overall Study||6
9876340|NCT01007123|10990912|FG002|NOT COMPLETED|Overall Study||11
9876341|NCT01007123|10990913|FG003|NOT COMPLETED|Overall Study||6
9876342|NCT01007136|10990929|FG000|STARTED|Overall Study||19
9876343|NCT01007136|10990930|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
9876344|NCT01007136|10990931|FG002|STARTED|Overall Study||15
9876345|NCT01007136|10990932|FG003|STARTED|Overall Study||6
9876346|NCT01007136|10990933|FG004|STARTED|Overall Study||4
9876347|NCT01007136|10990929|FG000|COMPLETED|Overall Study||15
9876348|NCT01007136|10990930|FG001|COMPLETED|Overall Study||13
9876349|NCT01007136|10990931|FG002|COMPLETED|Overall Study||15
9876350|NCT01007136|10990932|FG003|COMPLETED|Overall Study||6
9876351|NCT01007136|10990933|FG004|COMPLETED|Overall Study||4
9876352|NCT01007136|10990929|FG000|NOT COMPLETED|Overall Study||4
9876353|NCT01007136|10990930|FG001|NOT COMPLETED|Overall Study||4
9876354|NCT01007136|10990931|FG002|NOT COMPLETED|Overall Study||0
9876355|NCT01007136|10990932|FG003|NOT COMPLETED|Overall Study||0
9876356|NCT01007136|10990933|FG004|NOT COMPLETED|Overall Study||0
9876357|NCT01007149|10990946|FG000|STARTED|Overall Study||20
9876358|NCT01007149|10990947|FG001|STARTED|Overall Study||21
9876359|NCT01007149|10990946|FG000|COMPLETED|Overall Study||20
9876360|NCT01007149|10990947|FG001|COMPLETED|Overall Study||20
9876361|NCT01007149|10990946|FG000|NOT COMPLETED|Overall Study||0
9876362|NCT01007149|10990947|FG001|NOT COMPLETED|Overall Study||1
9876363|NCT01007253|10990953|FG000|STARTED|First Intervention||6
9876364|NCT01007253|10990954|FG001|STARTED|First Intervention||5
9876365|NCT01007253|10990955|FG002|STARTED|First Intervention||5
9876366|NCT01007253|10990956|FG003|STARTED|First Intervention||5
9876367|NCT01007253|10990953|FG000|COMPLETED|First Intervention||6
9876368|NCT01007253|10990954|FG001|COMPLETED|First Intervention||5
9876369|NCT01007253|10990955|FG002|COMPLETED|First Intervention||5
9876370|NCT01007253|10990956|FG003|COMPLETED|First Intervention||5
9876371|NCT01007253|10990953|FG000|NOT COMPLETED|First Intervention||0
9876372|NCT01007253|10990954|FG001|NOT COMPLETED|First Intervention||0
9876373|NCT01007253|10990955|FG002|NOT COMPLETED|First Intervention||0
9876374|NCT01007253|10990956|FG003|NOT COMPLETED|First Intervention||0
9876375|NCT01007253|10990953|FG000|STARTED|Washout Period (2 Weeks) # 1||6
9876376|NCT01007253|10990954|FG001|STARTED|Washout Period (2 Weeks) # 1||5
9876377|NCT01007253|10990955|FG002|STARTED|Washout Period (2 Weeks) # 1||5
9876378|NCT01007253|10990956|FG003|STARTED|Washout Period (2 Weeks) # 1||5
9876379|NCT01007253|10990953|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6
9876380|NCT01007253|10990954|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5
9876381|NCT01007253|10990955|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5
9876382|NCT01007253|10990956|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5
9876383|NCT01007253|10990953|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
9876384|NCT01007253|10990954|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
9876385|NCT01007253|10990955|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
9876386|NCT01007253|10990956|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
9876387|NCT01007253|10990953|FG000|STARTED|Second Intervention||6
9876388|NCT01007253|10990954|FG001|STARTED|Second Intervention||5
9876389|NCT01007253|10990955|FG002|STARTED|Second Intervention||5
9876390|NCT01007253|10990956|FG003|STARTED|Second Intervention||5
9876391|NCT01007253|10990953|FG000|COMPLETED|Second Intervention||6
9876392|NCT01007253|10990954|FG001|COMPLETED|Second Intervention||5
9876393|NCT01007253|10990955|FG002|COMPLETED|Second Intervention||5
9876394|NCT01007253|10990956|FG003|COMPLETED|Second Intervention||5
9876395|NCT01007253|10990953|FG000|NOT COMPLETED|Second Intervention||0
9876396|NCT01007253|10990954|FG001|NOT COMPLETED|Second Intervention||0
9876397|NCT01007253|10990955|FG002|NOT COMPLETED|Second Intervention||0
9876398|NCT01007253|10990956|FG003|NOT COMPLETED|Second Intervention||0
9876399|NCT01007253|10990953|FG000|STARTED|Washout Period (2 Weeks) # 2||6
9876400|NCT01007253|10990954|FG001|STARTED|Washout Period (2 Weeks) # 2||5
9876401|NCT01007253|10990955|FG002|STARTED|Washout Period (2 Weeks) # 2||5
9876402|NCT01007253|10990956|FG003|STARTED|Washout Period (2 Weeks) # 2||5
9876403|NCT01007253|10990953|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6
9876404|NCT01007253|10990954|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5
9876405|NCT01007253|10990955|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5
9876406|NCT01007253|10990956|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5
9876407|NCT01007253|10990953|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
9876408|NCT01007253|10990954|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
9876409|NCT01007253|10990955|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
9876410|NCT01007253|10990956|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
9876411|NCT01007253|10990953|FG000|STARTED|Third Intervention||6
9876412|NCT01007253|10990954|FG001|STARTED|Third Intervention||5
9876413|NCT01007253|10990955|FG002|STARTED|Third Intervention||5
9876414|NCT01007253|10990956|FG003|STARTED|Third Intervention||5
9876415|NCT01007253|10990953|FG000|COMPLETED|Third Intervention||6
9876416|NCT01007253|10990954|FG001|COMPLETED|Third Intervention||5
9876417|NCT01007253|10990955|FG002|COMPLETED|Third Intervention||5
9876418|NCT01007253|10990956|FG003|COMPLETED|Third Intervention||5
9876419|NCT01007253|10990953|FG000|NOT COMPLETED|Third Intervention||0
9876420|NCT01007253|10990954|FG001|NOT COMPLETED|Third Intervention||0
9876421|NCT01007253|10990955|FG002|NOT COMPLETED|Third Intervention||0
9876422|NCT01007253|10990956|FG003|NOT COMPLETED|Third Intervention||0
9876423|NCT01007253|10990953|FG000|STARTED|Washout Period (2 Weeks) # 3||6
9876424|NCT01007253|10990954|FG001|STARTED|Washout Period (2 Weeks) # 3||5
9876425|NCT01007253|10990955|FG002|STARTED|Washout Period (2 Weeks) # 3||5
9876426|NCT01007253|10990956|FG003|STARTED|Washout Period (2 Weeks) # 3||5
9876427|NCT01007253|10990953|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5
9876428|NCT01007253|10990954|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5
9876429|NCT01007253|10990955|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5
9876430|NCT01007253|10990956|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5
9876431|NCT01007253|10990953|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
9876432|NCT01007253|10990954|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
9876433|NCT01007253|10990955|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
9876434|NCT01007253|10990956|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
9876435|NCT01007253|10990953|FG000|STARTED|Fourth Intervention||5
9876436|NCT01007253|10990954|FG001|STARTED|Fourth Intervention||5
9876437|NCT01007253|10990955|FG002|STARTED|Fourth Intervention||5
9876438|NCT01007253|10990956|FG003|STARTED|Fourth Intervention||5
9876439|NCT01007253|10990953|FG000|COMPLETED|Fourth Intervention||5
9876440|NCT01007253|10990954|FG001|COMPLETED|Fourth Intervention||5
9876441|NCT01007253|10990955|FG002|COMPLETED|Fourth Intervention||5
9876442|NCT01007253|10990956|FG003|COMPLETED|Fourth Intervention||5
9876443|NCT01007253|10990953|FG000|NOT COMPLETED|Fourth Intervention||0
9876444|NCT01007253|10990954|FG001|NOT COMPLETED|Fourth Intervention||0
9876445|NCT01007253|10990955|FG002|NOT COMPLETED|Fourth Intervention||0
9876446|NCT01007253|10990956|FG003|NOT COMPLETED|Fourth Intervention||0
9876447|NCT01007396|10990966|FG000|STARTED|Overall Study||322
9876448|NCT01007396|10990966|FG000|COMPLETED|Overall Study||275
9876449|NCT01007396|10990966|FG000|NOT COMPLETED|Overall Study||47
9876450|NCT01007435|10990974|FG000|STARTED|Overall Study||289
9876451|NCT01007435|10990975|FG001|STARTED|Overall Study||290
9876452|NCT01007435|10990976|FG002|STARTED|Overall Study||291
9876453|NCT01007435|10990977|FG003|STARTED|Overall Study||292
9876454|NCT01007435|10990974|FG000|COMPLETED|Overall Study||226
9876455|NCT01007435|10990975|FG001|COMPLETED|Overall Study||231
9876456|NCT01007435|10990976|FG002|COMPLETED|Overall Study||227
9876457|NCT01007435|10990977|FG003|COMPLETED|Overall Study||236
9876458|NCT01007435|10990974|FG000|NOT COMPLETED|Overall Study||63
9876459|NCT01007435|10990975|FG001|NOT COMPLETED|Overall Study||59
9876460|NCT01007435|10990976|FG002|NOT COMPLETED|Overall Study||64
9876461|NCT01007435|10990977|FG003|NOT COMPLETED|Overall Study||56
9876462|NCT01007448|10990989|FG000|STARTED|Overall Study||30
9876463|NCT01007448|10990990|FG001|STARTED|Overall Study||29
9876464|NCT01007448|10990989|FG000|Full Analysis Population|Overall Study||30
9876465|NCT01007448|10990990|FG001|Full Analysis Population|Overall Study||29
9876466|NCT01007448|10990989|FG000|Safety Population|Overall Study||30
9876467|NCT01007448|10990990|FG001|Safety Population|Overall Study||29
9876468|NCT01007448|10990989|FG000|COMPLETED|Overall Study||20
9876469|NCT01007448|10990990|FG001|COMPLETED|Overall Study||20
9876470|NCT01007448|10990989|FG000|NOT COMPLETED|Overall Study||10
9876471|NCT01007448|10990990|FG001|NOT COMPLETED|Overall Study||9
9876472|NCT01007526|10990996|FG000|STARTED|Overall Study||31
9876473|NCT01007526|10990996|FG000|COMPLETED|Overall Study||31
9876474|NCT01007526|10990996|FG000|NOT COMPLETED|Overall Study||0
9876475|NCT01007552|10991000|FG000|STARTED|Overall Study||50
9876476|NCT01007552|10991000|FG000|COMPLETED|Overall Study||49
9876477|NCT01007552|10991000|FG000|NOT COMPLETED|Overall Study||1
9876478|NCT01007591|10991006|FG000|STARTED|Overall Study||27
9876479|NCT01007591|10991007|FG001|STARTED|Overall Study||13
9876480|NCT01007591|10991006|FG000|COMPLETED|Overall Study||26
9876481|NCT01007591|10991007|FG001|COMPLETED|Overall Study||12
9876482|NCT01007591|10991006|FG000|NOT COMPLETED|Overall Study||1
9876483|NCT01007591|10991007|FG001|NOT COMPLETED|Overall Study||1
9876484|NCT01007643|10991015|FG000|STARTED|Overall Study||8
9876485|NCT01007643|10991016|FG001|STARTED|Overall Study||14
10097354|NCT02374060|11226327|FG002|STARTED|Overall Study||64
10097355|NCT02374060|11226325|FG000|COMPLETED|Overall Study||63
10097356|NCT02374060|11226326|FG001|COMPLETED|Overall Study||62
9876486|NCT01007643|10991015|FG000|COMPLETED|Overall Study||8
9876487|NCT01007643|10991016|FG001|COMPLETED|Overall Study||14
9876488|NCT01007643|10991015|FG000|NOT COMPLETED|Overall Study||0
9876489|NCT01007643|10991016|FG001|NOT COMPLETED|Overall Study||0
10097357|NCT02374060|11226327|FG002|COMPLETED|Overall Study||61
9876490|NCT01007656|10991022|FG000|STARTED|Overall Study||31
9876491|NCT01007656|10991022|FG000|COMPLETED|Overall Study||31
9876492|NCT01007656|10991022|FG000|NOT COMPLETED|Overall Study||0
9876493|NCT01007812|10991026|FG000|STARTED|Period 1, One Week||25
9876494|NCT01007812|10991027|FG001|STARTED|Period 1, One Week||25
9876495|NCT01007812|10991026|FG000|COMPLETED|Period 1, One Week||24
9876496|NCT01007812|10991027|FG001|COMPLETED|Period 1, One Week||24
9876497|NCT01007812|10991026|FG000|NOT COMPLETED|Period 1, One Week||1
9876498|NCT01007812|10991027|FG001|NOT COMPLETED|Period 1, One Week||1
9876499|NCT01007812|10991026|FG000|STARTED|Period 2, One Week||24
9876500|NCT01007812|10991027|FG001|STARTED|Period 2, One Week||24
9876501|NCT01007812|10991026|FG000|COMPLETED|Period 2, One Week||24
9876502|NCT01007812|10991027|FG001|COMPLETED|Period 2, One Week||24
9876503|NCT01007812|10991026|FG000|NOT COMPLETED|Period 2, One Week||0
9876504|NCT01007812|10991027|FG001|NOT COMPLETED|Period 2, One Week||0
10097358|NCT02374060|11226325|FG000|NOT COMPLETED|Overall Study||2
9876505|NCT01007838|10991037|FG000|STARTED|Overall Study||12
9876506|NCT01007838|10991038|FG001|STARTED|Overall Study||11
9876507|NCT01007838|10991039|FG002|STARTED|Overall Study||5
9876508|NCT01007838|10991040|FG003|STARTED|Overall Study||4
9876509|NCT01007838|10991037|FG000|COMPLETED|Overall Study||9
9876510|NCT01007838|10991038|FG001|COMPLETED|Overall Study||11
9876511|NCT01007838|10991039|FG002|COMPLETED|Overall Study||5
9876512|NCT01007838|10991040|FG003|COMPLETED|Overall Study||4
9876513|NCT01007838|10991037|FG000|NOT COMPLETED|Overall Study||3
9876514|NCT01007838|10991038|FG001|NOT COMPLETED|Overall Study||0
9876515|NCT01007838|10991039|FG002|NOT COMPLETED|Overall Study||0
9876516|NCT01007838|10991040|FG003|NOT COMPLETED|Overall Study||0
9876517|NCT01007916|10991050|FG000|STARTED|Period 1, 4 Weeks of Wear||23
9876518|NCT01007916|10991051|FG001|STARTED|Period 1, 4 Weeks of Wear||26
9876519|NCT01007916|10991050|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22
9876520|NCT01007916|10991051|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26
9876521|NCT01007916|10991050|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
9876522|NCT01007916|10991051|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
9876523|NCT01007916|10991050|FG000|STARTED|Period 2, 4 Weeks of Wear||22
9876524|NCT01007916|10991051|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
9876525|NCT01007916|10991050|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21
9876526|NCT01007916|10991051|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25
9876527|NCT01007916|10991050|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
9876528|NCT01007916|10991051|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
9876529|NCT01007942|10991059|FG000|STARTED|Overall Study||284
9876530|NCT01007942|10991060|FG001|STARTED|Overall Study||285
9876531|NCT01007942|10991059|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
9876532|NCT01007942|10991060|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
9876533|NCT01007942|10991059|FG000|NOT COMPLETED|Overall Study||281
9876534|NCT01007942|10991060|FG001|NOT COMPLETED|Overall Study||278
9876535|NCT01007994|10991072|FG000|STARTED|Overall Study||17
9876536|NCT01007994|10991073|FG001|STARTED|Overall Study||16
9876537|NCT01007994|10991072|FG000|COMPLETED|Overall Study||15
9876538|NCT01007994|10991073|FG001|COMPLETED|Overall Study||14
9876539|NCT01007994|10991072|FG000|NOT COMPLETED|Overall Study||2
9876540|NCT01007994|10991073|FG001|NOT COMPLETED|Overall Study||2
10097359|NCT02374060|11226326|FG001|NOT COMPLETED|Overall Study||1
10097360|NCT02374060|11226327|FG002|NOT COMPLETED|Overall Study||3
10097361|NCT02374099|11226337|FG000|STARTED|Overall Study||48
10097362|NCT02374099|11226338|FG001|STARTED|Overall Study||49
10097363|NCT02374099|11226337|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46
10097364|NCT02374099|11226338|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48
10097365|NCT02374099|11226337|FG000|COMPLETED|Overall Study||0
10097366|NCT02374099|11226338|FG001|COMPLETED|Overall Study||0
10097367|NCT02374099|11226337|FG000|NOT COMPLETED|Overall Study||48
10097368|NCT02374099|11226338|FG001|NOT COMPLETED|Overall Study||49
10097369|NCT02374138|11226346|FG000|STARTED|Six Month Follow Up||110
10097370|NCT02374138|11226347|FG001|STARTED|Six Month Follow Up||107
10097371|NCT02374138|11226346|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
10097372|NCT02374138|11226347|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
10097373|NCT02374138|11226346|FG000|NOT COMPLETED|Six Month Follow Up||8
10097374|NCT02374138|11226347|FG001|NOT COMPLETED|Six Month Follow Up||14
10097375|NCT02374138|11226346|FG000|STARTED|Twelve Month FollowUp||110
10097376|NCT02374138|11226347|FG001|STARTED|Twelve Month FollowUp||107
10097377|NCT02374138|11226346|FG000|COMPLETED|Twelve Month FollowUp||101
10097378|NCT02374138|11226347|FG001|COMPLETED|Twelve Month FollowUp||95
10097379|NCT02374138|11226346|FG000|NOT COMPLETED|Twelve Month FollowUp||9
10097380|NCT02374138|11226347|FG001|NOT COMPLETED|Twelve Month FollowUp||12
10097381|NCT02374164|11226357|FG000|STARTED|Treatment Period 1||12
10097382|NCT02374164|11226358|FG001|STARTED|Treatment Period 1||12
10097383|NCT02374164|11226359|FG002|STARTED|Treatment Period 1||12
10097384|NCT02374164|11226357|FG000|COMPLETED|Treatment Period 1||12
9876541|NCT01008059|10991079|FG000|STARTED|Control Sequential Alfentanil||6
9876542|NCT01008059|10991080|FG001|STARTED|Control Sequential Alfentanil||0
9876543|NCT01008059|10991081|FG002|STARTED|Control Sequential Alfentanil||0
9876544|NCT01008059|10991082|FG003|STARTED|Control Sequential Alfentanil||0
9876545|NCT01008059|10991083|FG004|STARTED|Control Sequential Alfentanil||0
9876546|NCT01008059|10991084|FG005|STARTED|Control Sequential Alfentanil||0
9876547|NCT01008059|10991085|FG006|STARTED|Control Sequential Alfentanil||0
9876548|NCT01008059|10991086|FG007|STARTED|Control Sequential Alfentanil||0
9876549|NCT01008059|10991079|FG000|COMPLETED|Control Sequential Alfentanil||6
9876550|NCT01008059|10991080|FG001|COMPLETED|Control Sequential Alfentanil||0
9876551|NCT01008059|10991081|FG002|COMPLETED|Control Sequential Alfentanil||0
9876552|NCT01008059|10991082|FG003|COMPLETED|Control Sequential Alfentanil||0
9876553|NCT01008059|10991083|FG004|COMPLETED|Control Sequential Alfentanil||0
9876554|NCT01008059|10991084|FG005|COMPLETED|Control Sequential Alfentanil||0
10097385|NCT02374164|11226358|FG001|COMPLETED|Treatment Period 1||12
10097386|NCT02374164|11226359|FG002|COMPLETED|Treatment Period 1||12
10097387|NCT02374164|11226357|FG000|NOT COMPLETED|Treatment Period 1||0
10097388|NCT02374164|11226358|FG001|NOT COMPLETED|Treatment Period 1||0
10097389|NCT02374164|11226359|FG002|NOT COMPLETED|Treatment Period 1||0
10097390|NCT02374164|11226357|FG000|STARTED|Treatment Period 2||12
10097391|NCT02374164|11226358|FG001|STARTED|Treatment Period 2||12
9876555|NCT01008059|10991085|FG006|COMPLETED|Control Sequential Alfentanil||0
9876556|NCT01008059|10991086|FG007|COMPLETED|Control Sequential Alfentanil||0
9876557|NCT01008059|10991079|FG000|NOT COMPLETED|Control Sequential Alfentanil||0
9876558|NCT01008059|10991080|FG001|NOT COMPLETED|Control Sequential Alfentanil||0
9876559|NCT01008059|10991081|FG002|NOT COMPLETED|Control Sequential Alfentanil||0
9876560|NCT01008059|10991082|FG003|NOT COMPLETED|Control Sequential Alfentanil||0
9876561|NCT01008059|10991083|FG004|NOT COMPLETED|Control Sequential Alfentanil||0
9876562|NCT01008059|10991084|FG005|NOT COMPLETED|Control Sequential Alfentanil||0
9876563|NCT01008059|10991085|FG006|NOT COMPLETED|Control Sequential Alfentanil||0
9876564|NCT01008059|10991086|FG007|NOT COMPLETED|Control Sequential Alfentanil||0
9876565|NCT01008059|10991079|FG000|STARTED|Rifampin Sequential Alfentanil||0
9876566|NCT01008059|10991080|FG001|STARTED|Rifampin Sequential Alfentanil||6
9876567|NCT01008059|10991081|FG002|STARTED|Rifampin Sequential Alfentanil||0
9876568|NCT01008059|10991082|FG003|STARTED|Rifampin Sequential Alfentanil||0
9876569|NCT01008059|10991083|FG004|STARTED|Rifampin Sequential Alfentanil||0
9876570|NCT01008059|10991084|FG005|STARTED|Rifampin Sequential Alfentanil||0
9876571|NCT01008059|10991085|FG006|STARTED|Rifampin Sequential Alfentanil||0
9876572|NCT01008059|10991086|FG007|STARTED|Rifampin Sequential Alfentanil||0
9876573|NCT01008059|10991079|FG000|COMPLETED|Rifampin Sequential Alfentanil||0
9876574|NCT01008059|10991080|FG001|COMPLETED|Rifampin Sequential Alfentanil||6
9876575|NCT01008059|10991081|FG002|COMPLETED|Rifampin Sequential Alfentanil||0
9876576|NCT01008059|10991082|FG003|COMPLETED|Rifampin Sequential Alfentanil||0
9876577|NCT01008059|10991083|FG004|COMPLETED|Rifampin Sequential Alfentanil||0
9876578|NCT01008059|10991084|FG005|COMPLETED|Rifampin Sequential Alfentanil||0
9876579|NCT01008059|10991085|FG006|COMPLETED|Rifampin Sequential Alfentanil||0
9876580|NCT01008059|10991086|FG007|COMPLETED|Rifampin Sequential Alfentanil||0
9876581|NCT01008059|10991079|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876582|NCT01008059|10991080|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876583|NCT01008059|10991081|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876584|NCT01008059|10991082|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876585|NCT01008059|10991083|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876586|NCT01008059|10991084|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876587|NCT01008059|10991085|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876588|NCT01008059|10991086|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0
9876589|NCT01008059|10991079|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0
9876590|NCT01008059|10991080|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0
9876591|NCT01008059|10991081|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6
9876592|NCT01008059|10991082|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0
9876593|NCT01008059|10991083|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0
9876594|NCT01008059|10991084|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0
9876595|NCT01008059|10991085|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0
9876596|NCT01008059|10991086|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0
9876597|NCT01008059|10991079|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876598|NCT01008059|10991080|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876599|NCT01008059|10991081|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
9876600|NCT01008059|10991082|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876601|NCT01008059|10991083|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876602|NCT01008059|10991084|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876603|NCT01008059|10991085|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876604|NCT01008059|10991086|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876605|NCT01008059|10991079|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876606|NCT01008059|10991080|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876607|NCT01008059|10991081|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876608|NCT01008059|10991082|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876609|NCT01008059|10991083|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876610|NCT01008059|10991084|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876611|NCT01008059|10991085|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876612|NCT01008059|10991086|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
9876613|NCT01008059|10991079|FG000|STARTED|Ketoconazole Sequential Alfentanil||0
9876614|NCT01008059|10991080|FG001|STARTED|Ketoconazole Sequential Alfentanil||0
9876615|NCT01008059|10991081|FG002|STARTED|Ketoconazole Sequential Alfentanil||0
9876616|NCT01008059|10991082|FG003|STARTED|Ketoconazole Sequential Alfentanil||6
9876617|NCT01008059|10991083|FG004|STARTED|Ketoconazole Sequential Alfentanil||0
9876618|NCT01008059|10991084|FG005|STARTED|Ketoconazole Sequential Alfentanil||0
9876619|NCT01008059|10991085|FG006|STARTED|Ketoconazole Sequential Alfentanil||0
9876620|NCT01008059|10991086|FG007|STARTED|Ketoconazole Sequential Alfentanil||0
9876621|NCT01008059|10991079|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0
9876622|NCT01008059|10991080|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0
9876623|NCT01008059|10991081|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0
9876624|NCT01008059|10991082|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6
9876625|NCT01008059|10991083|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0
9876626|NCT01008059|10991084|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0
9876627|NCT01008059|10991085|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0
9876628|NCT01008059|10991086|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0
9876629|NCT01008059|10991079|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876630|NCT01008059|10991080|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876631|NCT01008059|10991081|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876632|NCT01008059|10991082|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876633|NCT01008059|10991083|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876634|NCT01008059|10991084|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876635|NCT01008059|10991085|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876636|NCT01008059|10991086|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
9876637|NCT01008059|10991079|FG000|STARTED|Control Simultaneous Alfentanil||0
9876638|NCT01008059|10991080|FG001|STARTED|Control Simultaneous Alfentanil||0
9876639|NCT01008059|10991081|FG002|STARTED|Control Simultaneous Alfentanil||0
9876640|NCT01008059|10991082|FG003|STARTED|Control Simultaneous Alfentanil||0
9876641|NCT01008059|10991083|FG004|STARTED|Control Simultaneous Alfentanil||6
9876642|NCT01008059|10991084|FG005|STARTED|Control Simultaneous Alfentanil||0
9876643|NCT01008059|10991085|FG006|STARTED|Control Simultaneous Alfentanil||0
9876644|NCT01008059|10991086|FG007|STARTED|Control Simultaneous Alfentanil||0
9876645|NCT01008059|10991079|FG000|COMPLETED|Control Simultaneous Alfentanil||0
9876646|NCT01008059|10991080|FG001|COMPLETED|Control Simultaneous Alfentanil||0
9876647|NCT01008059|10991081|FG002|COMPLETED|Control Simultaneous Alfentanil||0
9876648|NCT01008059|10991082|FG003|COMPLETED|Control Simultaneous Alfentanil||0
9876649|NCT01008059|10991083|FG004|COMPLETED|Control Simultaneous Alfentanil||6
9876650|NCT01008059|10991084|FG005|COMPLETED|Control Simultaneous Alfentanil||0
9876651|NCT01008059|10991085|FG006|COMPLETED|Control Simultaneous Alfentanil||0
9876652|NCT01008059|10991086|FG007|COMPLETED|Control Simultaneous Alfentanil||0
9876653|NCT01008059|10991079|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876654|NCT01008059|10991080|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876655|NCT01008059|10991081|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876656|NCT01008059|10991082|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876657|NCT01008059|10991083|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876658|NCT01008059|10991084|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876659|NCT01008059|10991085|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876660|NCT01008059|10991086|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0
9876661|NCT01008059|10991079|FG000|STARTED|Rifampin Simultaneous Alfentanil||0
9876662|NCT01008059|10991080|FG001|STARTED|Rifampin Simultaneous Alfentanil||0
9876663|NCT01008059|10991081|FG002|STARTED|Rifampin Simultaneous Alfentanil||0
9876664|NCT01008059|10991082|FG003|STARTED|Rifampin Simultaneous Alfentanil||0
9876665|NCT01008059|10991083|FG004|STARTED|Rifampin Simultaneous Alfentanil||0
9876666|NCT01008059|10991084|FG005|STARTED|Rifampin Simultaneous Alfentanil||6
9876667|NCT01008059|10991085|FG006|STARTED|Rifampin Simultaneous Alfentanil||0
9876668|NCT01008059|10991086|FG007|STARTED|Rifampin Simultaneous Alfentanil||0
9876669|NCT01008059|10991079|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0
9876670|NCT01008059|10991080|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0
9876671|NCT01008059|10991081|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0
9876672|NCT01008059|10991082|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0
9876673|NCT01008059|10991083|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0
9876674|NCT01008059|10991084|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6
9876675|NCT01008059|10991085|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0
9876676|NCT01008059|10991086|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0
9876677|NCT01008059|10991079|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876678|NCT01008059|10991080|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876679|NCT01008059|10991081|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876680|NCT01008059|10991082|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876681|NCT01008059|10991083|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876682|NCT01008059|10991084|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876683|NCT01008059|10991085|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876684|NCT01008059|10991086|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
9876685|NCT01008059|10991079|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
9876686|NCT01008059|10991080|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
9876687|NCT01008059|10991081|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
9876688|NCT01008059|10991082|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
9876689|NCT01008059|10991083|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
9876690|NCT01008059|10991084|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
9876691|NCT01008059|10991085|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
9876692|NCT01008059|10991086|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
9876693|NCT01008059|10991079|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876694|NCT01008059|10991080|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876695|NCT01008059|10991081|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876696|NCT01008059|10991082|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876697|NCT01008059|10991083|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876698|NCT01008059|10991084|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876699|NCT01008059|10991085|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
9876700|NCT01008059|10991086|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876701|NCT01008059|10991079|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876702|NCT01008059|10991080|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9968901|NCT01523756|11089408|FG000|NOT COMPLETED|Baseline Period||0
9968902|NCT01523756|11089409|FG001|NOT COMPLETED|Baseline Period||1
9968903|NCT01523756|11089408|FG000|STARTED|Test Period 1||11
9876703|NCT01008059|10991081|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876704|NCT01008059|10991082|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876705|NCT01008059|10991083|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876706|NCT01008059|10991084|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876707|NCT01008059|10991085|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876708|NCT01008059|10991086|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
9876709|NCT01008059|10991079|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0
9876710|NCT01008059|10991080|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0
9876711|NCT01008059|10991081|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0
9876712|NCT01008059|10991082|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0
9876713|NCT01008059|10991083|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0
9876714|NCT01008059|10991084|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0
9876715|NCT01008059|10991085|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0
9876716|NCT01008059|10991086|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6
9876717|NCT01008059|10991079|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876718|NCT01008059|10991080|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876719|NCT01008059|10991081|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876720|NCT01008059|10991082|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876721|NCT01008059|10991083|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876722|NCT01008059|10991084|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876723|NCT01008059|10991085|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876724|NCT01008059|10991086|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
9876725|NCT01008059|10991079|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876726|NCT01008059|10991080|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876727|NCT01008059|10991081|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876728|NCT01008059|10991082|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876729|NCT01008059|10991083|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876730|NCT01008059|10991084|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876731|NCT01008059|10991085|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876732|NCT01008059|10991086|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
9876733|NCT01008150|10991101|FG000|STARTED|Overall Study||43
9876734|NCT01008150|10991102|FG001|STARTED|Overall Study||43
9876735|NCT01008150|10991103|FG002|STARTED|Overall Study||43
9876736|NCT01008150|10991104|FG003|STARTED|Overall Study||12
9876737|NCT01008150|10991101|FG000|COMPLETED|Overall Study||42
9876738|NCT01008150|10991102|FG001|COMPLETED|Overall Study||42
9876739|NCT01008150|10991103|FG002|COMPLETED|Overall Study||42
9876740|NCT01008150|10991104|FG003|COMPLETED|Overall Study||12
9876741|NCT01008150|10991101|FG000|NOT COMPLETED|Overall Study||1
9876742|NCT01008150|10991102|FG001|NOT COMPLETED|Overall Study||1
9876743|NCT01008150|10991103|FG002|NOT COMPLETED|Overall Study||1
9876744|NCT01008150|10991104|FG003|NOT COMPLETED|Overall Study||0
9876745|NCT01008280|10991117|FG000|STARTED|Overall Study||88
9876746|NCT01008280|10991118|FG001|STARTED|Overall Study||92
9876747|NCT01008280|10991117|FG000|COMPLETED|Overall Study||67
9876748|NCT01008280|10991118|FG001|COMPLETED|Overall Study||73
9876749|NCT01008280|10991117|FG000|NOT COMPLETED|Overall Study||21
9876750|NCT01008280|10991118|FG001|NOT COMPLETED|Overall Study||19
9876751|NCT01008319|10991126|FG000|STARTED|Overall Study||60
9876752|NCT01008319|10991127|FG001|STARTED|Overall Study||60
9876753|NCT01008319|10991126|FG000|COMPLETED|Overall Study||60
9876754|NCT01008319|10991127|FG001|COMPLETED|Overall Study||60
9876755|NCT01008319|10991126|FG000|NOT COMPLETED|Overall Study||0
9876756|NCT01008319|10991127|FG001|NOT COMPLETED|Overall Study||0
9876757|NCT01008410|10991139|FG000|STARTED|Overall Study||133
9876758|NCT01008410|10991140|FG001|STARTED|Overall Study||132
9876759|NCT01008410|10991139|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133
9876760|NCT01008410|10991140|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
9876761|NCT01008410|10991139|FG000|COMPLETED|Overall Study||108
9876762|NCT01008410|10991140|FG001|COMPLETED|Overall Study||116
9876763|NCT01008410|10991139|FG000|NOT COMPLETED|Overall Study||25
9876764|NCT01008410|10991140|FG001|NOT COMPLETED|Overall Study||16
9876765|NCT01008423|10991148|FG000|STARTED|Overall Study||134
9876766|NCT01008423|10991149|FG001|STARTED|Overall Study||147
9876767|NCT01008423|10991148|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134
9876768|NCT01008423|10991149|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
9876769|NCT01008423|10991148|FG000|COMPLETED|Overall Study||115
9876770|NCT01008423|10991149|FG001|COMPLETED|Overall Study||125
9876771|NCT01008423|10991148|FG000|NOT COMPLETED|Overall Study||19
9876772|NCT01008423|10991149|FG001|NOT COMPLETED|Overall Study||22
9876773|NCT01008449|10991157|FG000|STARTED|Overall Study||200
9876774|NCT01008449|10991158|FG001|STARTED|Overall Study||198
9876775|NCT01008449|10991157|FG000|COMPLETED|Overall Study||171
9876776|NCT01008449|10991158|FG001|COMPLETED|Overall Study||179
9876777|NCT01008449|10991157|FG000|NOT COMPLETED|Overall Study||29
9876778|NCT01008449|10991158|FG001|NOT COMPLETED|Overall Study||19
9876779|NCT01008462|10991164|FG000|STARTED|Overall Study||16
9876780|NCT01008462|10991164|FG000|COMPLETED|Overall Study||16
9876781|NCT01008462|10991164|FG000|NOT COMPLETED|Overall Study||0
9876782|NCT01008475|10991175|FG000|STARTED|Overall Study||3
9876783|NCT01008475|10991176|FG001|STARTED|Overall Study||3
9876784|NCT01008475|10991177|FG002|STARTED|Overall Study||7
9876785|NCT01008475|10991178|FG003|STARTED|Overall Study||3
9876786|NCT01008475|10991179|FG004|STARTED|Overall Study||72
9876787|NCT01008475|10991180|FG005|STARTED|Overall Study||73
9876788|NCT01008475|10991181|FG006|STARTED|Overall Study||71
9876789|NCT01008475|10991175|FG000|Safety Analysis Set|Overall Study||3
9876790|NCT01008475|10991176|FG001|Safety Analysis Set|Overall Study||3
9876791|NCT01008475|10991177|FG002|Safety Analysis Set|Overall Study||7
9876792|NCT01008475|10991178|FG003|Safety Analysis Set|Overall Study||3
9876793|NCT01008475|10991179|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
9876794|NCT01008475|10991180|FG005|Safety Analysis Set|Overall Study||72
9876795|NCT01008475|10991181|FG006|Safety Analysis Set|Overall Study||69
9876796|NCT01008475|10991175|FG000|COMPLETED|Overall Study||3
9876797|NCT01008475|10991176|FG001|COMPLETED|Overall Study||3
9876798|NCT01008475|10991177|FG002|COMPLETED|Overall Study||7
9876799|NCT01008475|10991178|FG003|COMPLETED|Overall Study||3
9876800|NCT01008475|10991179|FG004|COMPLETED|Overall Study||67
9876801|NCT01008475|10991180|FG005|COMPLETED|Overall Study||67
9876802|NCT01008475|10991181|FG006|COMPLETED|Overall Study||67
9876803|NCT01008475|10991175|FG000|NOT COMPLETED|Overall Study||0
9876804|NCT01008475|10991176|FG001|NOT COMPLETED|Overall Study||0
9876805|NCT01008475|10991177|FG002|NOT COMPLETED|Overall Study||0
9876806|NCT01008475|10991178|FG003|NOT COMPLETED|Overall Study||0
9876807|NCT01008475|10991179|FG004|NOT COMPLETED|Overall Study||5
9876808|NCT01008475|10991180|FG005|NOT COMPLETED|Overall Study||6
9876809|NCT01008475|10991181|FG006|NOT COMPLETED|Overall Study||4
9876810|NCT01008553|10991197|FG000|STARTED|Period 1 (Titration Period)||258
9876811|NCT01008553|10991198|FG001|STARTED|Period 1 (Titration Period)||0
9876812|NCT01008553|10991199|FG002|STARTED|Period 1 (Titration Period)||0
9876813|NCT01008553|10991197|FG000|COMPLETED|Period 1 (Titration Period)||163
9876814|NCT01008553|10991198|FG001|COMPLETED|Period 1 (Titration Period)||0
9876815|NCT01008553|10991199|FG002|COMPLETED|Period 1 (Titration Period)||0
9876816|NCT01008553|10991197|FG000|NOT COMPLETED|Period 1 (Titration Period)||95
10097392|NCT02374164|11226359|FG002|STARTED|Treatment Period 2||12
10097393|NCT02374164|11226357|FG000|COMPLETED|Treatment Period 2||12
10097394|NCT02374164|11226358|FG001|COMPLETED|Treatment Period 2||12
10097395|NCT02374164|11226359|FG002|COMPLETED|Treatment Period 2||12
10097396|NCT02374164|11226357|FG000|NOT COMPLETED|Treatment Period 2||0
10097397|NCT02374164|11226358|FG001|NOT COMPLETED|Treatment Period 2||0
10097398|NCT02374164|11226359|FG002|NOT COMPLETED|Treatment Period 2||0
9876817|NCT01008553|10991198|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
9876818|NCT01008553|10991199|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
9876819|NCT01008553|10991197|FG000|STARTED|Period 2 (Double-Blind Period)||0
9876820|NCT01008553|10991198|FG001|STARTED|Period 2 (Double-Blind Period)||84
9876821|NCT01008553|10991199|FG002|STARTED|Period 2 (Double-Blind Period)||79
9876822|NCT01008553|10991197|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
9876823|NCT01008553|10991198|FG001|COMPLETED|Period 2 (Double-Blind Period)||47
9876824|NCT01008553|10991199|FG002|COMPLETED|Period 2 (Double-Blind Period)||28
9876825|NCT01008553|10991197|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
9876826|NCT01008553|10991198|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37
9876827|NCT01008553|10991199|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51
9876828|NCT01008605|10991208|FG000|STARTED|Overall Study||48
9876829|NCT01008605|10991208|FG000|COMPLETED|Overall Study||48
9876830|NCT01008605|10991208|FG000|NOT COMPLETED|Overall Study||0
9876831|NCT01008618|10991220|FG000|STARTED|Period 1 (Titration Period)||218
9876832|NCT01008618|10991221|FG001|STARTED|Period 1 (Titration Period)||0
9876833|NCT01008618|10991222|FG002|STARTED|Period 1 (Titration Period)||0
9876834|NCT01008618|10991220|FG000|COMPLETED|Period 1 (Titration Period)||150
9876835|NCT01008618|10991221|FG001|COMPLETED|Period 1 (Titration Period)||0
9876836|NCT01008618|10991222|FG002|COMPLETED|Period 1 (Titration Period)||0
9876837|NCT01008618|10991220|FG000|NOT COMPLETED|Period 1 (Titration Period)||68
9876838|NCT01008618|10991221|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
9876839|NCT01008618|10991222|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
9876840|NCT01008618|10991220|FG000|STARTED|Period 2 (Double-Blind Period)||0
9876841|NCT01008618|10991221|FG001|STARTED|Period 2 (Double-Blind Period)||73
9876842|NCT01008618|10991222|FG002|STARTED|Period 2 (Double-Blind Period)||77
9876843|NCT01008618|10991220|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
9876844|NCT01008618|10991221|FG001|COMPLETED|Period 2 (Double-Blind Period)||37
9876845|NCT01008618|10991222|FG002|COMPLETED|Period 2 (Double-Blind Period)||39
9876846|NCT01008618|10991220|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
9876847|NCT01008618|10991221|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36
9876848|NCT01008618|10991222|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38
9876849|NCT01008696|10991233|FG000|STARTED|Overall Study||108
9876850|NCT01008696|10991234|FG001|STARTED|Overall Study||109
9876851|NCT01008696|10991233|FG000|COMPLETED|Overall Study||91
9876852|NCT01008696|10991234|FG001|COMPLETED|Overall Study||92
9876853|NCT01008696|10991233|FG000|NOT COMPLETED|Overall Study||17
9876854|NCT01008696|10991234|FG001|NOT COMPLETED|Overall Study||17
9876855|NCT01008722|10991243|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
9876856|NCT01008722|10991244|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
9876857|NCT01008722|10991243|FG000|COMPLETED|Overall Study||36
9876858|NCT01008722|10991244|FG001|COMPLETED|Overall Study||71
9876859|NCT01008722|10991243|FG000|NOT COMPLETED|Overall Study||0
10097399|NCT02374164|11226357|FG000|STARTED|Treatment Period 3||12
10113076|NCT02508103|11243998|FG001|STARTED|Overall Study||5
9876860|NCT01008722|10991244|FG001|NOT COMPLETED|Overall Study||0
9876861|NCT01008748|10991250|FG000|STARTED|Overall Study||200
9876862|NCT01008748|10991250|FG000|Baseline|Overall Study||188
9876863|NCT01008748|10991250|FG000|Week 0|Overall Study||182
9876864|NCT01008748|10991250|FG000|Week 3|Overall Study||168
9876865|NCT01008748|10991250|FG000|Week 26|Overall Study||119
9876866|NCT01008748|10991250|FG000|COMPLETED|Overall Study||119
9876867|NCT01008748|10991250|FG000|NOT COMPLETED|Overall Study||81
9876868|NCT01008904|10991254|FG000|STARTED|Overall Study||29
9876869|NCT01008904|10991254|FG000|COMPLETED|Overall Study||25
9876870|NCT01008904|10991254|FG000|NOT COMPLETED|Overall Study||4
9876871|NCT01008943|10991258|FG000|STARTED|Overall Study||16
9876872|NCT01008943|10991258|FG000|COMPLETED|Overall Study||15
9876873|NCT01008943|10991258|FG000|NOT COMPLETED|Overall Study||1
9876874|NCT01008969|10991262|FG000|STARTED|Overall Study||10
9876875|NCT01008969|10991262|FG000|COMPLETED|Overall Study||10
9876876|NCT01008969|10991262|FG000|NOT COMPLETED|Overall Study||0
9876877|NCT01008995|10991268|FG000|STARTED|Controlled Period||162
9876878|NCT01008995|10991269|FG001|STARTED|Controlled Period||160
9876879|NCT01008995|10991270|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9876880|NCT01008995|10991271|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9876881|NCT01008995|10991268|FG000|COMPLETED|Controlled Period||159
9876882|NCT01008995|10991269|FG001|COMPLETED|Controlled Period||157
9876883|NCT01008995|10991270|FG002|COMPLETED|Controlled Period||0
9876884|NCT01008995|10991271|FG003|COMPLETED|Controlled Period||0
9876885|NCT01008995|10991268|FG000|NOT COMPLETED|Controlled Period||3
9876886|NCT01008995|10991269|FG001|NOT COMPLETED|Controlled Period||3
9876887|NCT01008995|10991270|FG002|NOT COMPLETED|Controlled Period||0
9876888|NCT01008995|10991271|FG003|NOT COMPLETED|Controlled Period||0
9876889|NCT01008995|10991268|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9876890|NCT01008995|10991269|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9876891|NCT01008995|10991270|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
9876892|NCT01008995|10991271|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
9876893|NCT01008995|10991268|FG000|COMPLETED|After Controlled Period||0
9876894|NCT01008995|10991269|FG001|COMPLETED|After Controlled Period||0
9876895|NCT01008995|10991270|FG002|COMPLETED|After Controlled Period||156
9876896|NCT01008995|10991271|FG003|COMPLETED|After Controlled Period||156
9876897|NCT01008995|10991268|FG000|NOT COMPLETED|After Controlled Period||0
9876898|NCT01008995|10991269|FG001|NOT COMPLETED|After Controlled Period||0
9876899|NCT01008995|10991270|FG002|NOT COMPLETED|After Controlled Period||2
9876900|NCT01008995|10991271|FG003|NOT COMPLETED|After Controlled Period||1
9876901|NCT01009034|10991279|FG000|STARTED|Overall Study||14
9876902|NCT01009034|10991279|FG000|COMPLETED|Overall Study||10
9876903|NCT01009034|10991279|FG000|NOT COMPLETED|Overall Study||4
9876904|NCT01009047|10991285|FG000|STARTED|Overall Study||113
9876905|NCT01009047|10991286|FG001|STARTED|Overall Study||115
9876906|NCT01009047|10991285|FG000|COMPLETED|Overall Study||85
9876907|NCT01009047|10991286|FG001|COMPLETED|Overall Study||89
9876908|NCT01009047|10991285|FG000|NOT COMPLETED|Overall Study||28
9876909|NCT01009047|10991286|FG001|NOT COMPLETED|Overall Study||26
9876910|NCT01009060|10991294|FG000|STARTED|Overall Study||25
9876911|NCT01009060|10991295|FG001|STARTED|Overall Study||25
9876912|NCT01009060|10991294|FG000|COMPLETED|Overall Study||21
9876913|NCT01009060|10991295|FG001|COMPLETED|Overall Study||20
9876914|NCT01009060|10991294|FG000|NOT COMPLETED|Overall Study||4
9876915|NCT01009060|10991295|FG001|NOT COMPLETED|Overall Study||5
9876916|NCT01009086|10991308|FG000|STARTED|Overall Study||206
9876917|NCT01009086|10991309|FG001|STARTED|Overall Study||205
9876918|NCT01009086|10991310|FG002|STARTED|Overall Study||204
9876919|NCT01009086|10991308|FG000|COMPLETED|Overall Study||162
9876920|NCT01009086|10991309|FG001|COMPLETED|Overall Study||158
9876921|NCT01009086|10991310|FG002|COMPLETED|Overall Study||170
9876922|NCT01009086|10991308|FG000|NOT COMPLETED|Overall Study||44
9876923|NCT01009086|10991309|FG001|NOT COMPLETED|Overall Study||47
9876924|NCT01009086|10991310|FG002|NOT COMPLETED|Overall Study||34
9876925|NCT01009099|10991325|FG000|STARTED|Overall Study||58
9876926|NCT01009099|10991326|FG001|STARTED|Overall Study||61
9876927|NCT01009099|10991325|FG000|COMPLETED|Overall Study||53
9876928|NCT01009099|10991326|FG001|COMPLETED|Overall Study||57
9876929|NCT01009099|10991325|FG000|NOT COMPLETED|Overall Study||5
9876930|NCT01009099|10991326|FG001|NOT COMPLETED|Overall Study||4
9876931|NCT01009138|10991334|FG000|STARTED|Overall Study||106
9876932|NCT01009138|10991335|FG001|STARTED|Overall Study||108
9876933|NCT01009138|10991334|FG000|COMPLETED|Overall Study||93
9876934|NCT01009138|10991335|FG001|COMPLETED|Overall Study||88
9876935|NCT01009138|10991334|FG000|NOT COMPLETED|Overall Study||13
9876936|NCT01009138|10991335|FG001|NOT COMPLETED|Overall Study||20
9876937|NCT01009203|10991341|FG000|STARTED|Overall Study||13
9876938|NCT01009203|10991341|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
9876939|NCT01009203|10991341|FG000|COMPLETED|Overall Study||6
9876940|NCT01009203|10991341|FG000|NOT COMPLETED|Overall Study||7
9876941|NCT01009281|10991345|FG000|STARTED|Overall Study||7
9876942|NCT01009281|10991345|FG000|COMPLETED|Overall Study||0
9876943|NCT01009281|10991345|FG000|NOT COMPLETED|Overall Study||7
9876944|NCT01009333|10991349|FG000|STARTED|Week 1||2
9876945|NCT01009333|10991350|FG001|STARTED|Week 1||3
9876946|NCT01009333|10991351|FG002|STARTED|Week 1||2
9876947|NCT01009333|10991352|FG003|STARTED|Week 1||2
9876948|NCT01009333|10991353|FG004|STARTED|Week 1||2
9876949|NCT01009333|10991354|FG005|STARTED|Week 1||2
9876950|NCT01009333|10991349|FG000|COMPLETED|Week 1||2
9876951|NCT01009333|10991350|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
9876952|NCT01009333|10991351|FG002|COMPLETED|Week 1||2
9876953|NCT01009333|10991352|FG003|COMPLETED|Week 1||2
9876954|NCT01009333|10991353|FG004|COMPLETED|Week 1||2
9876955|NCT01009333|10991354|FG005|COMPLETED|Week 1||2
9876956|NCT01009333|10991349|FG000|NOT COMPLETED|Week 1||0
9876957|NCT01009333|10991350|FG001|NOT COMPLETED|Week 1||0
9876958|NCT01009333|10991351|FG002|NOT COMPLETED|Week 1||0
9876959|NCT01009333|10991352|FG003|NOT COMPLETED|Week 1||0
9876960|NCT01009333|10991353|FG004|NOT COMPLETED|Week 1||0
9876961|NCT01009333|10991354|FG005|NOT COMPLETED|Week 1||0
9876962|NCT01009333|10991349|FG000|STARTED|Week 2||2
9876963|NCT01009333|10991350|FG001|STARTED|Week 2||2
9876964|NCT01009333|10991351|FG002|STARTED|Week 2||2
9876965|NCT01009333|10991352|FG003|STARTED|Week 2||2
9876966|NCT01009333|10991353|FG004|STARTED|Week 2||2
9876967|NCT01009333|10991354|FG005|STARTED|Week 2||2
9876968|NCT01009333|10991349|FG000|COMPLETED|Week 2||2
9876969|NCT01009333|10991350|FG001|COMPLETED|Week 2||2
9876970|NCT01009333|10991351|FG002|COMPLETED|Week 2||2
9876971|NCT01009333|10991352|FG003|COMPLETED|Week 2||2
9876972|NCT01009333|10991353|FG004|COMPLETED|Week 2||2
9876973|NCT01009333|10991354|FG005|COMPLETED|Week 2||2
9876974|NCT01009333|10991349|FG000|NOT COMPLETED|Week 2||0
9876975|NCT01009333|10991350|FG001|NOT COMPLETED|Week 2||0
9876976|NCT01009333|10991351|FG002|NOT COMPLETED|Week 2||0
9876977|NCT01009333|10991352|FG003|NOT COMPLETED|Week 2||0
9876978|NCT01009333|10991353|FG004|NOT COMPLETED|Week 2||0
9876979|NCT01009333|10991354|FG005|NOT COMPLETED|Week 2||0
9876980|NCT01009333|10991349|FG000|STARTED|Week 3||2
9876981|NCT01009333|10991350|FG001|STARTED|Week 3||2
9876982|NCT01009333|10991351|FG002|STARTED|Week 3||2
9876983|NCT01009333|10991352|FG003|STARTED|Week 3||2
9876984|NCT01009333|10991353|FG004|STARTED|Week 3||2
9876985|NCT01009333|10991354|FG005|STARTED|Week 3||2
9876986|NCT01009333|10991349|FG000|COMPLETED|Week 3||2
9876987|NCT01009333|10991350|FG001|COMPLETED|Week 3||2
9876988|NCT01009333|10991351|FG002|COMPLETED|Week 3||2
9876989|NCT01009333|10991352|FG003|COMPLETED|Week 3||2
9876990|NCT01009333|10991353|FG004|COMPLETED|Week 3||2
9876991|NCT01009333|10991354|FG005|COMPLETED|Week 3||2
9876992|NCT01009333|10991349|FG000|NOT COMPLETED|Week 3||0
9876993|NCT01009333|10991350|FG001|NOT COMPLETED|Week 3||0
9876994|NCT01009333|10991351|FG002|NOT COMPLETED|Week 3||0
9876995|NCT01009333|10991352|FG003|NOT COMPLETED|Week 3||0
9876996|NCT01009333|10991353|FG004|NOT COMPLETED|Week 3||0
9876997|NCT01009333|10991354|FG005|NOT COMPLETED|Week 3||0
9876998|NCT01009346|10991362|FG000|STARTED|Overall Study||9
10097400|NCT02374164|11226358|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
10097401|NCT02374164|11226359|FG002|STARTED|Treatment Period 3||12
10097402|NCT02374164|11226357|FG000|COMPLETED|Treatment Period 3||12
10097403|NCT02374164|11226358|FG001|COMPLETED|Treatment Period 3||11
10097404|NCT02374164|11226359|FG002|COMPLETED|Treatment Period 3||12
10097405|NCT02374164|11226357|FG000|NOT COMPLETED|Treatment Period 3||0
10097406|NCT02374164|11226358|FG001|NOT COMPLETED|Treatment Period 3||0
10097407|NCT02374164|11226359|FG002|NOT COMPLETED|Treatment Period 3||0
10097408|NCT02374255|11226371|FG000|STARTED|Overall Study||155
10097409|NCT02374255|11226372|FG001|STARTED|Overall Study||110
10097410|NCT02374255|11226373|FG002|STARTED|Overall Study||11
10097411|NCT02374255|11226374|FG003|STARTED|Overall Study||11
10097412|NCT02374255|11226371|FG000|COMPLETED|Overall Study||153
10097413|NCT02374255|11226372|FG001|COMPLETED|Overall Study||110
10097414|NCT02374255|11226373|FG002|COMPLETED|Overall Study||11
10097415|NCT02374255|11226374|FG003|COMPLETED|Overall Study||11
10097416|NCT02374255|11226371|FG000|NOT COMPLETED|Overall Study||2
10097417|NCT02374255|11226372|FG001|NOT COMPLETED|Overall Study||0
10097418|NCT02374255|11226373|FG002|NOT COMPLETED|Overall Study||0
10097419|NCT02374255|11226374|FG003|NOT COMPLETED|Overall Study||0
10097420|NCT02374307|11226392|FG000|STARTED|3-months Follow-up||77
10097421|NCT02374307|11226393|FG001|STARTED|3-months Follow-up||78
10097422|NCT02374307|11226392|FG000|COMPLETED|3-months Follow-up||69
10097423|NCT02374307|11226393|FG001|COMPLETED|3-months Follow-up||69
10097424|NCT02374307|11226392|FG000|NOT COMPLETED|3-months Follow-up||8
10097425|NCT02374307|11226393|FG001|NOT COMPLETED|3-months Follow-up||9
9876999|NCT01009346|10991362|FG000|COMPLETED|Overall Study||5
9877000|NCT01009346|10991362|FG000|NOT COMPLETED|Overall Study||4
9877001|NCT01009463|10991371|FG000|STARTED|4-week, Open-label Run-In Period||2071
9877002|NCT01009463|10991372|FG001|STARTED|4-week, Open-label Run-In Period||0
9877003|NCT01009463|10991373|FG002|STARTED|4-week, Open-label Run-In Period||0
9877004|NCT01009463|10991374|FG003|STARTED|4-week, Open-label Run-In Period||0
9877005|NCT01009463|10991375|FG004|STARTED|4-week, Open-label Run-In Period||0
9877006|NCT01009463|10991371|FG000|COMPLETED|4-week, Open-label Run-In Period||1622
9877007|NCT01009463|10991372|FG001|COMPLETED|4-week, Open-label Run-In Period||0
9877008|NCT01009463|10991373|FG002|COMPLETED|4-week, Open-label Run-In Period||0
9877009|NCT01009463|10991374|FG003|COMPLETED|4-week, Open-label Run-In Period||0
10097426|NCT02374307|11226392|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
10113077|NCT02508103|11243997|FG000|COMPLETED|Overall Study||5
9877010|NCT01009463|10991375|FG004|COMPLETED|4-week, Open-label Run-In Period||0
9877011|NCT01009463|10991371|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449
9877012|NCT01009463|10991372|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
9877013|NCT01009463|10991373|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
9877014|NCT01009463|10991374|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
9877015|NCT01009463|10991375|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
9877016|NCT01009463|10991371|FG000|STARTED|52-week, Double-blind Treatment Period||0
9877017|NCT01009463|10991372|FG001|STARTED|52-week, Double-blind Treatment Period||409
9877018|NCT01009463|10991373|FG002|STARTED|52-week, Double-blind Treatment Period||408
9877019|NCT01009463|10991374|FG003|STARTED|52-week, Double-blind Treatment Period||403
9877020|NCT01009463|10991375|FG004|STARTED|52-week, Double-blind Treatment Period||402
9877021|NCT01009463|10991371|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
9877022|NCT01009463|10991372|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
9877023|NCT01009463|10991373|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
9877024|NCT01009463|10991374|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
9877025|NCT01009463|10991375|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
9877026|NCT01009463|10991371|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
9877027|NCT01009463|10991372|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
9877028|NCT01009463|10991373|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
9877029|NCT01009463|10991374|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
9877030|NCT01009463|10991375|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
9877031|NCT01009463|10991371|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
9877032|NCT01009463|10991372|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115
9877033|NCT01009463|10991373|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93
9877034|NCT01009463|10991374|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91
9877035|NCT01009463|10991375|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101
9877036|NCT01009515|10991386|FG000|STARTED|Overall Study||19
9877037|NCT01009515|10991386|FG000|COMPLETED|Overall Study||16
9877038|NCT01009515|10991386|FG000|NOT COMPLETED|Overall Study||3
9877039|NCT01009554|10991392|FG000|STARTED|Overall Study||48
9877040|NCT01009554|10991393|FG001|STARTED|Overall Study||48
9877041|NCT01009554|10991392|FG000|COMPLETED|Overall Study||46
9877042|NCT01009554|10991393|FG001|COMPLETED|Overall Study||41
9877043|NCT01009554|10991392|FG000|NOT COMPLETED|Overall Study||2
9877044|NCT01009554|10991393|FG001|NOT COMPLETED|Overall Study||7
9877045|NCT01009580|10991401|FG000|STARTED|Overall Study||224
9877046|NCT01009580|10991402|FG001|STARTED|Overall Study||223
9877047|NCT01009580|10991401|FG000|Exposed|Overall Study||224
9877048|NCT01009580|10991402|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
9877049|NCT01009580|10991401|FG000|COMPLETED|Overall Study||197
9877050|NCT01009580|10991402|FG001|COMPLETED|Overall Study||188
9877051|NCT01009580|10991401|FG000|NOT COMPLETED|Overall Study||27
9877052|NCT01009580|10991402|FG001|NOT COMPLETED|Overall Study||35
9877053|NCT01009619|10991410|FG000|STARTED|Overall Study||40
9877054|NCT01009619|10991411|FG001|STARTED|Overall Study||43
9877055|NCT01009619|10991410|FG000|COMPLETED|Overall Study||40
9877056|NCT01009619|10991411|FG001|COMPLETED|Overall Study||43
9877057|NCT01009619|10991410|FG000|NOT COMPLETED|Overall Study||0
9877058|NCT01009619|10991411|FG001|NOT COMPLETED|Overall Study||0
9877059|NCT01009645|10991421|FG000|STARTED|Overall Study||31
9877060|NCT01009645|10991422|FG001|STARTED|Overall Study||31
9877061|NCT01009645|10991423|FG002|STARTED|Overall Study||32
9877062|NCT01009645|10991424|FG003|STARTED|Overall Study||31
9877063|NCT01009645|10991421|FG000|COMPLETED|Overall Study||29
9877064|NCT01009645|10991422|FG001|COMPLETED|Overall Study||23
9877065|NCT01009645|10991423|FG002|COMPLETED|Overall Study||28
9877066|NCT01009645|10991424|FG003|COMPLETED|Overall Study||26
9877067|NCT01009645|10991421|FG000|NOT COMPLETED|Overall Study||2
9877068|NCT01009645|10991422|FG001|NOT COMPLETED|Overall Study||8
10097427|NCT02374307|11226393|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
10097428|NCT02374307|11226392|FG000|COMPLETED|6-months Follow-up||71
10097429|NCT02374307|11226393|FG001|COMPLETED|6-months Follow-up||64
10097430|NCT02374307|11226392|FG000|NOT COMPLETED|6-months Follow-up||3
10097431|NCT02374307|11226393|FG001|NOT COMPLETED|6-months Follow-up||6
10097432|NCT02374346|11226399|FG000|STARTED|Overall Study||494
10097433|NCT02374346|11226399|FG000|COMPLETED|Overall Study||446
10097434|NCT02374346|11226399|FG000|NOT COMPLETED|Overall Study||48
10097435|NCT02374398|11226409|FG000|STARTED|Overall Study||31
10097436|NCT02374398|11226410|FG001|STARTED|Overall Study||32
10097437|NCT02374398|11226411|FG002|STARTED|Overall Study||32
10097438|NCT02374398|11226412|FG003|STARTED|Overall Study||32
10097439|NCT02374398|11226409|FG000|COMPLETED|Overall Study||29
10097440|NCT02374398|11226410|FG001|COMPLETED|Overall Study||31
10097441|NCT02374398|11226411|FG002|COMPLETED|Overall Study||29
9877069|NCT01009645|10991423|FG002|NOT COMPLETED|Overall Study||4
9877070|NCT01009645|10991424|FG003|NOT COMPLETED|Overall Study||5
9953863|NCT01427972|11072456|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9953864|NCT01428024|11072468|FG000|STARTED|Overall Study||30
9953865|NCT01428024|11072469|FG001|STARTED|Overall Study||30
9953866|NCT01428024|11072468|FG000|COMPLETED|Overall Study||29
9953867|NCT01428024|11072469|FG001|COMPLETED|Overall Study||29
9953868|NCT01428024|11072468|FG000|NOT COMPLETED|Overall Study||1
9953869|NCT01428024|11072469|FG001|NOT COMPLETED|Overall Study||1
9953870|NCT01428063|11072489|FG000|STARTED|Overall Study||99
9953871|NCT01428063|11072490|FG001|STARTED|Overall Study||122
9953872|NCT01428063|11072491|FG002|STARTED|Overall Study||6
9953873|NCT01428063|11072489|FG000|COMPLETED|Overall Study||89
9953874|NCT01428063|11072490|FG001|COMPLETED|Overall Study||112
9953875|NCT01428063|11072491|FG002|COMPLETED|Overall Study||5
9953876|NCT01428063|11072489|FG000|NOT COMPLETED|Overall Study||10
9953877|NCT01428063|11072490|FG001|NOT COMPLETED|Overall Study||10
9953878|NCT01428063|11072491|FG002|NOT COMPLETED|Overall Study||1
9953879|NCT01428076|11072512|FG000|STARTED|Overall Study||9
9953880|NCT01428076|11072513|FG001|STARTED|Overall Study||12
9953881|NCT01428076|11072512|FG000|COMPLETED|Overall Study||9
9953882|NCT01428076|11072513|FG001|COMPLETED|Overall Study||11
9953883|NCT01428076|11072512|FG000|NOT COMPLETED|Overall Study||0
9953884|NCT01428076|11072513|FG001|NOT COMPLETED|Overall Study||1
9953885|NCT01428115|11072521|FG000|STARTED|Overall Study||83
9953886|NCT01428115|11072521|FG000|COMPLETED|Overall Study||62
9953887|NCT01428115|11072521|FG000|NOT COMPLETED|Overall Study||21
9953888|NCT01428128|11072526|FG000|STARTED|Overall Study||50
9953889|NCT01428128|11072526|FG000|COMPLETED|Overall Study||33
9953890|NCT01428128|11072526|FG000|NOT COMPLETED|Overall Study||17
9953891|NCT01428193|11072531|FG000|STARTED|Overall Study||4
9953892|NCT01428193|11072531|FG000|COMPLETED|Overall Study||2
9953893|NCT01428193|11072531|FG000|NOT COMPLETED|Overall Study||2
9953894|NCT01428219|11072535|FG000|STARTED|Overall Study||25
9953895|NCT01428219|11072535|FG000|COMPLETED|Overall Study||22
9953896|NCT01428219|11072535|FG000|NOT COMPLETED|Overall Study||3
9953897|NCT01428245|11072539|FG000|STARTED|Overall Study||1
9953898|NCT01428245|11072539|FG000|COMPLETED|Overall Study||1
9953899|NCT01428245|11072539|FG000|NOT COMPLETED|Overall Study||0
9953900|NCT01428258|11072545|FG000|STARTED|Intervention 1||17
9953901|NCT01428258|11072546|FG001|STARTED|Intervention 1||15
9953902|NCT01428258|11072545|FG000|COMPLETED|Intervention 1||15
9953903|NCT01428258|11072546|FG001|COMPLETED|Intervention 1||15
9953904|NCT01428258|11072545|FG000|NOT COMPLETED|Intervention 1||2
9953905|NCT01428258|11072546|FG001|NOT COMPLETED|Intervention 1||0
9953906|NCT01428258|11072545|FG000|STARTED|Intervention 2||15
9953907|NCT01428258|11072546|FG001|STARTED|Intervention 2||15
9953908|NCT01428258|11072545|FG000|COMPLETED|Intervention 2||15
9953909|NCT01428258|11072546|FG001|COMPLETED|Intervention 2||15
9953910|NCT01428258|11072545|FG000|NOT COMPLETED|Intervention 2||0
9953911|NCT01428258|11072546|FG001|NOT COMPLETED|Intervention 2||0
9953912|NCT01428336|11072562|FG000|STARTED|Overall Study||10
9953913|NCT01428336|11072563|FG001|STARTED|Overall Study||12
9953914|NCT01428336|11072562|FG000|COMPLETED|Overall Study||10
9953915|NCT01428336|11072563|FG001|COMPLETED|Overall Study||12
9953916|NCT01428336|11072562|FG000|NOT COMPLETED|Overall Study||0
9953917|NCT01428336|11072563|FG001|NOT COMPLETED|Overall Study||0
9953918|NCT01428453|11072574|FG000|STARTED|Overall Study||62
9953919|NCT01428453|11072575|FG001|STARTED|Overall Study||61
9953920|NCT01428453|11072574|FG000|COMPLETED|Overall Study||56
9953921|NCT01428453|11072575|FG001|COMPLETED|Overall Study||52
9953922|NCT01428453|11072574|FG000|NOT COMPLETED|Overall Study||6
9953923|NCT01428453|11072575|FG001|NOT COMPLETED|Overall Study||9
9953924|NCT01428583|11072583|FG000|STARTED|Overall Study||395
9953925|NCT01428583|11072583|FG000|COMPLETED|Overall Study||158
9953926|NCT01428583|11072583|FG000|NOT COMPLETED|Overall Study||237
9953927|NCT01428661|11072590|FG000|STARTED|Double-Masked Phase||254
9953928|NCT01428661|11072591|FG001|STARTED|Double-Masked Phase||253
9953929|NCT01428661|11072592|FG002|STARTED|Double-Masked Phase|Does not apply.|0
9953930|NCT01428661|11072590|FG000|COMPLETED|Double-Masked Phase||197
9953931|NCT01428661|11072591|FG001|COMPLETED|Double-Masked Phase||204
9953932|NCT01428661|11072592|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0
9968904|NCT01523756|11089409|FG001|STARTED|Test Period 1||8
9758672|NCT01996449|10862236|FG001|NOT COMPLETED|Period 1: First Drug||0
9758673|NCT01996449|10862235|FG000|STARTED|Period 2: Second Drug||6
9758674|NCT01996449|10862236|FG001|STARTED|Period 2: Second Drug||8
9758675|NCT01996449|10862235|FG000|COMPLETED|Period 2: Second Drug||6
9953933|NCT01428661|11072590|FG000|NOT COMPLETED|Double-Masked Phase||57
9953934|NCT01428661|11072591|FG001|NOT COMPLETED|Double-Masked Phase||49
9953935|NCT01428661|11072592|FG002|NOT COMPLETED|Double-Masked Phase||0
9953936|NCT01428661|11072590|FG000|STARTED|Open Label Extension|Does not apply.|0
9953937|NCT01428661|11072591|FG001|STARTED|Open Label Extension|Does not apply.|0
9953938|NCT01428661|11072592|FG002|STARTED|Open Label Extension||339
9953939|NCT01428661|11072590|FG000|COMPLETED|Open Label Extension|Does not apply.|0
9953940|NCT01428661|11072591|FG001|COMPLETED|Open Label Extension|Does not apply.|0
9953941|NCT01428661|11072592|FG002|COMPLETED|Open Label Extension||19
9953942|NCT01428661|11072590|FG000|NOT COMPLETED|Open Label Extension||0
9953943|NCT01428661|11072591|FG001|NOT COMPLETED|Open Label Extension||0
9953944|NCT01428661|11072592|FG002|NOT COMPLETED|Open Label Extension||320
9953945|NCT01428713|11072600|FG000|STARTED|Overall Study||9
9877071|NCT01009762|10991436|FG000|STARTED|Overall Study||1
9877072|NCT01009762|10991437|FG001|STARTED|Overall Study||10
9877073|NCT01009762|10991436|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
9877074|NCT01009762|10991437|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
9877075|NCT01009762|10991436|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
9877076|NCT01009762|10991437|FG001|COMPLETED|Overall Study|10 participants received vaccine|10
9877077|NCT01009762|10991436|FG000|NOT COMPLETED|Overall Study||0
9877078|NCT01009762|10991437|FG001|NOT COMPLETED|Overall Study||0
9877079|NCT01009814|10991450|FG000|STARTED|Overall Study||10
9877080|NCT01009814|10991451|FG001|STARTED|Overall Study||10
9877081|NCT01009814|10991452|FG002|STARTED|Overall Study||10
9877082|NCT01009814|10991453|FG003|STARTED|Overall Study||10
9877083|NCT01009814|10991454|FG004|STARTED|Overall Study||10
9877084|NCT01009814|10991450|FG000|COMPLETED|Overall Study||9
9877085|NCT01009814|10991451|FG001|COMPLETED|Overall Study||9
9877086|NCT01009814|10991452|FG002|COMPLETED|Overall Study||10
9877087|NCT01009814|10991453|FG003|COMPLETED|Overall Study||10
9877088|NCT01009814|10991454|FG004|COMPLETED|Overall Study||10
9877089|NCT01009814|10991450|FG000|NOT COMPLETED|Overall Study||1
9877090|NCT01009814|10991451|FG001|NOT COMPLETED|Overall Study||1
9877091|NCT01009814|10991452|FG002|NOT COMPLETED|Overall Study||0
9877092|NCT01009814|10991453|FG003|NOT COMPLETED|Overall Study||0
9877093|NCT01009814|10991454|FG004|NOT COMPLETED|Overall Study||0
9877094|NCT01009840|10991470|FG000|STARTED|Overall Study||30
9877095|NCT01009840|10991470|FG000|COMPLETED|Overall Study||16
9877096|NCT01009840|10991470|FG000|NOT COMPLETED|Overall Study||14
9877097|NCT01009918|10991477|FG000|STARTED|Overall Study||158
9877098|NCT01009918|10991478|FG001|STARTED|Overall Study||156
9877099|NCT01009918|10991479|FG002|STARTED|Overall Study||154
9877100|NCT01009918|10991477|FG000|COMPLETED|Overall Study||134
9877101|NCT01009918|10991478|FG001|COMPLETED|Overall Study||132
9877102|NCT01009918|10991479|FG002|COMPLETED|Overall Study||124
9877103|NCT01009918|10991477|FG000|NOT COMPLETED|Overall Study||24
9877104|NCT01009918|10991478|FG001|NOT COMPLETED|Overall Study||24
9877105|NCT01009918|10991479|FG002|NOT COMPLETED|Overall Study||30
9877106|NCT01009983|10991487|FG000|STARTED|Overall Study||14
9877107|NCT01009983|10991487|FG000|COMPLETED|Overall Study||13
9877108|NCT01009983|10991487|FG000|NOT COMPLETED|Overall Study||1
9877109|NCT01010009|10991494|FG000|STARTED|Overall Study||8
9877110|NCT01010009|10991495|FG001|STARTED|Overall Study||8
9877111|NCT01010009|10991496|FG002|STARTED|Overall Study||8
9877112|NCT01010009|10991494|FG000|COMPLETED|Overall Study||8
9877113|NCT01010009|10991495|FG001|COMPLETED|Overall Study||8
9877114|NCT01010009|10991496|FG002|COMPLETED|Overall Study||8
9877115|NCT01010009|10991494|FG000|NOT COMPLETED|Overall Study||0
9877116|NCT01010009|10991495|FG001|NOT COMPLETED|Overall Study||0
9877117|NCT01010009|10991496|FG002|NOT COMPLETED|Overall Study||0
9877118|NCT01010061|10991506|FG000|STARTED|Overall Study||238
9877119|NCT01010061|10991507|FG001|STARTED|Overall Study||118
9877120|NCT01010061|10991506|FG000|Received Study Drug|Overall Study||236
9877121|NCT01010061|10991507|FG001|Received Study Drug|Overall Study||116
9877122|NCT01010061|10991506|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190
9877123|NCT01010061|10991507|FG001|COMPLETED|Overall Study||78
9877124|NCT01010061|10991506|FG000|NOT COMPLETED|Overall Study||48
9877125|NCT01010061|10991507|FG001|NOT COMPLETED|Overall Study||40
9877126|NCT01010126|10991521|FG000|STARTED|Overall Study||27
9877127|NCT01010126|10991522|FG001|STARTED|Overall Study||58
9877128|NCT01010126|10991523|FG002|STARTED|Overall Study||28
9877129|NCT01010126|10991524|FG003|STARTED|Overall Study||57
9877130|NCT01010126|10991525|FG004|STARTED|Overall Study||58
9877131|NCT01010126|10991526|FG005|STARTED|Overall Study||24
9877132|NCT01010126|10991521|FG000|COMPLETED|Overall Study||26
9877133|NCT01010126|10991522|FG001|COMPLETED|Overall Study||58
9877134|NCT01010126|10991523|FG002|COMPLETED|Overall Study||27
9877135|NCT01010126|10991524|FG003|COMPLETED|Overall Study||57
9877136|NCT01010126|10991525|FG004|COMPLETED|Overall Study||55
9877137|NCT01010126|10991526|FG005|COMPLETED|Overall Study||24
9877138|NCT01010126|10991521|FG000|NOT COMPLETED|Overall Study||1
9877139|NCT01010126|10991522|FG001|NOT COMPLETED|Overall Study||0
9877140|NCT01010126|10991523|FG002|NOT COMPLETED|Overall Study||1
9877141|NCT01010126|10991524|FG003|NOT COMPLETED|Overall Study||0
9877142|NCT01010126|10991525|FG004|NOT COMPLETED|Overall Study||3
9877143|NCT01010126|10991526|FG005|NOT COMPLETED|Overall Study||0
9877144|NCT01010204|10991542|FG000|STARTED|Overall Study||31
9877145|NCT01010204|10991543|FG001|STARTED|Overall Study||29
9877146|NCT01010204|10991542|FG000|COMPLETED|Overall Study||24
9877147|NCT01010204|10991543|FG001|COMPLETED|Overall Study||20
9877148|NCT01010204|10991542|FG000|NOT COMPLETED|Overall Study||7
9877149|NCT01010204|10991543|FG001|NOT COMPLETED|Overall Study||9
9877150|NCT01010217|10991554|FG000|STARTED|Overall Study||89
9877151|NCT01010217|10991555|FG001|STARTED|Overall Study||56
9877152|NCT01010217|10991556|FG002|STARTED|Overall Study||22
9877153|NCT01010217|10991557|FG003|STARTED|Overall Study||6
9877154|NCT01010217|10991558|FG004|STARTED|Overall Study||3
9877155|NCT01010217|10991554|FG000|COMPLETED|Overall Study||84
9877156|NCT01010217|10991555|FG001|COMPLETED|Overall Study||51
9877157|NCT01010217|10991556|FG002|COMPLETED|Overall Study||21
9877158|NCT01010217|10991557|FG003|COMPLETED|Overall Study||0
9877159|NCT01010217|10991558|FG004|COMPLETED|Overall Study||0
9877160|NCT01010217|10991554|FG000|NOT COMPLETED|Overall Study||5
9877161|NCT01010217|10991555|FG001|NOT COMPLETED|Overall Study||5
9877162|NCT01010217|10991556|FG002|NOT COMPLETED|Overall Study||1
9877163|NCT01010217|10991557|FG003|NOT COMPLETED|Overall Study||6
9877164|NCT01010217|10991558|FG004|NOT COMPLETED|Overall Study||3
9877165|NCT01010230|10991572|FG000|STARTED|Overall Study||32
9877166|NCT01010230|10991573|FG001|STARTED|Overall Study||33
9877167|NCT01010230|10991572|FG000|COMPLETED|Overall Study||22
9877168|NCT01010230|10991573|FG001|COMPLETED|Overall Study||26
9877169|NCT01010230|10991572|FG000|NOT COMPLETED|Overall Study||10
9877170|NCT01010230|10991573|FG001|NOT COMPLETED|Overall Study||7
9877171|NCT01010282|10991582|FG000|STARTED|Overall Study||97
9877172|NCT01010282|10991583|FG001|STARTED|Overall Study||95
9877173|NCT01010282|10991584|FG002|STARTED|Overall Study||96
9877174|NCT01010282|10991582|FG000|COMPLETED|Overall Study||91
9877175|NCT01010282|10991583|FG001|COMPLETED|Overall Study||88
9877176|NCT01010282|10991584|FG002|COMPLETED|Overall Study||77
9877177|NCT01010282|10991582|FG000|NOT COMPLETED|Overall Study||6
9877178|NCT01010282|10991583|FG001|NOT COMPLETED|Overall Study||7
9877179|NCT01010282|10991584|FG002|NOT COMPLETED|Overall Study||19
9877180|NCT01010399|10991592|FG000|STARTED|Overall Study||36
9877181|NCT01010399|10991592|FG000|COMPLETED|Overall Study||31
9877182|NCT01010399|10991592|FG000|NOT COMPLETED|Overall Study||5
9877183|NCT01010477|10991598|FG000|STARTED|Overall Study||27
9877184|NCT01010477|10991599|FG001|STARTED|Overall Study||25
9877185|NCT01010477|10991598|FG000|COMPLETED|Overall Study||21
9877186|NCT01010477|10991599|FG001|COMPLETED|Overall Study||22
9877187|NCT01010477|10991598|FG000|NOT COMPLETED|Overall Study||6
9877188|NCT01010477|10991599|FG001|NOT COMPLETED|Overall Study||3
9877189|NCT01010503|10991605|FG000|STARTED|Overall Study||32
9877190|NCT01010503|10991605|FG000|COMPLETED|Overall Study||30
10097442|NCT02374398|11226412|FG003|COMPLETED|Overall Study||32
10097443|NCT02374398|11226409|FG000|NOT COMPLETED|Overall Study||2
10097444|NCT02374398|11226410|FG001|NOT COMPLETED|Overall Study||1
10097445|NCT02374398|11226411|FG002|NOT COMPLETED|Overall Study||3
10097446|NCT02374398|11226412|FG003|NOT COMPLETED|Overall Study||0
10097447|NCT02374463|11226425|FG000|STARTED|Overall Study||15
10097448|NCT02374463|11226426|FG001|STARTED|Overall Study||12
10097449|NCT02374463|11226425|FG000|COMPLETED|Overall Study||12
10097450|NCT02374463|11226426|FG001|COMPLETED|Overall Study||9
10097451|NCT02374463|11226425|FG000|NOT COMPLETED|Overall Study||3
10097452|NCT02374463|11226426|FG001|NOT COMPLETED|Overall Study||3
10097453|NCT02374593|11226435|FG000|STARTED|Overall Study||24
10097454|NCT02374593|11226436|FG001|STARTED|Overall Study||44
10097455|NCT02374593|11226435|FG000|COMPLETED|Overall Study||22
10097456|NCT02374593|11226436|FG001|COMPLETED|Overall Study||44
10097457|NCT02374593|11226435|FG000|NOT COMPLETED|Overall Study||2
10097458|NCT02374593|11226436|FG001|NOT COMPLETED|Overall Study||0
10097459|NCT02374671|11226449|FG000|STARTED|Observation (Deferred Implantation)||0
10097460|NCT02374671|11226450|FG001|STARTED|Observation (Deferred Implantation)||0
10097461|NCT02374671|11226451|FG002|STARTED|Observation (Deferred Implantation)||31
10097462|NCT02374671|11226449|FG000|COMPLETED|Observation (Deferred Implantation)||0
10097463|NCT02374671|11226450|FG001|COMPLETED|Observation (Deferred Implantation)||0
10097464|NCT02374671|11226451|FG002|COMPLETED|Observation (Deferred Implantation)||26
10097465|NCT02374671|11226449|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0
10097466|NCT02374671|11226450|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0
10097467|NCT02374671|11226451|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5
10097468|NCT02374671|11226449|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
10097469|NCT02374671|11226450|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
10097470|NCT02374671|11226451|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
10097471|NCT02374671|11226449|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281
10097472|NCT02374671|11226450|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27
10097473|NCT02374671|11226451|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
10097474|NCT02374671|11226449|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
10097475|NCT02374671|11226450|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
10097476|NCT02374671|11226451|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
10097477|NCT02374918|11226461|FG000|STARTED|Overall Study||17
10097478|NCT02374918|11226462|FG001|STARTED|Overall Study||18
10097479|NCT02374918|11226463|FG002|STARTED|Overall Study||22
10097480|NCT02374918|11226464|FG003|STARTED|Overall Study||20
10097481|NCT02374918|11226461|FG000|COMPLETED|Overall Study||14
10097482|NCT02374918|11226462|FG001|COMPLETED|Overall Study||17
10097483|NCT02374918|11226463|FG002|COMPLETED|Overall Study||18
10097484|NCT02374918|11226464|FG003|COMPLETED|Overall Study||18
10097485|NCT02374918|11226461|FG000|NOT COMPLETED|Overall Study||3
10097486|NCT02374918|11226462|FG001|NOT COMPLETED|Overall Study||1
10097487|NCT02374918|11226463|FG002|NOT COMPLETED|Overall Study||4
9877191|NCT01010503|10991605|FG000|NOT COMPLETED|Overall Study||2
9877192|NCT01010555|10991609|FG000|STARTED|First Four Weeks of Wear||11
10097488|NCT02374918|11226464|FG003|NOT COMPLETED|Overall Study||2
9877193|NCT01010555|10991610|FG001|STARTED|First Four Weeks of Wear||10
9877194|NCT01010555|10991609|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
9953946|NCT01428713|11072601|FG001|STARTED|Overall Study||8
9953947|NCT01428713|11072600|FG000|COMPLETED|Overall Study||6
10097489|NCT02374957|11226474|FG000|STARTED|Overall Study||11
10097490|NCT02374957|11226475|FG001|STARTED|Overall Study||9
9877195|NCT01010555|10991610|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
9877196|NCT01010555|10991609|FG000|NOT COMPLETED|First Four Weeks of Wear||0
9877197|NCT01010555|10991610|FG001|NOT COMPLETED|First Four Weeks of Wear||0
9877198|NCT01010555|10991609|FG000|STARTED|Second Four Weeks of Wear||10
9877199|NCT01010555|10991610|FG001|STARTED|Second Four Weeks of Wear||9
9877200|NCT01010555|10991609|FG000|COMPLETED|Second Four Weeks of Wear||10
9877201|NCT01010555|10991610|FG001|COMPLETED|Second Four Weeks of Wear||9
9877202|NCT01010555|10991609|FG000|NOT COMPLETED|Second Four Weeks of Wear||0
9877203|NCT01010555|10991610|FG001|NOT COMPLETED|Second Four Weeks of Wear||0
9877204|NCT01010568|10991620|FG000|STARTED|Overall Study||10
9877205|NCT01010568|10991620|FG000|COMPLETED|Overall Study||5
9877206|NCT01010568|10991620|FG000|NOT COMPLETED|Overall Study||5
9877207|NCT01010633|10991627|FG000|STARTED|Overall Study||203
9877208|NCT01010633|10991628|FG001|STARTED|Overall Study||203
9877209|NCT01010633|10991627|FG000|COMPLETED|Overall Study||199
9877210|NCT01010633|10991628|FG001|COMPLETED|Overall Study||198
9877211|NCT01010633|10991627|FG000|NOT COMPLETED|Overall Study||4
9877212|NCT01010633|10991628|FG001|NOT COMPLETED|Overall Study||5
9877213|NCT01010750|10991640|FG000|STARTED|First Intervention||3
9877214|NCT01010750|10991641|FG001|STARTED|First Intervention||4
9877215|NCT01010750|10991642|FG002|STARTED|First Intervention||3
9877216|NCT01010750|10991643|FG003|STARTED|First Intervention||3
9877217|NCT01010750|10991644|FG004|STARTED|First Intervention||2
9877218|NCT01010750|10991645|FG005|STARTED|First Intervention||3
9877219|NCT01010750|10991640|FG000|COMPLETED|First Intervention||3
9877220|NCT01010750|10991641|FG001|COMPLETED|First Intervention||4
9877221|NCT01010750|10991642|FG002|COMPLETED|First Intervention||3
9877222|NCT01010750|10991643|FG003|COMPLETED|First Intervention||3
9877223|NCT01010750|10991644|FG004|COMPLETED|First Intervention||2
9877224|NCT01010750|10991645|FG005|COMPLETED|First Intervention||3
9877225|NCT01010750|10991640|FG000|NOT COMPLETED|First Intervention||0
9877226|NCT01010750|10991641|FG001|NOT COMPLETED|First Intervention||0
9877227|NCT01010750|10991642|FG002|NOT COMPLETED|First Intervention||0
9877228|NCT01010750|10991643|FG003|NOT COMPLETED|First Intervention||0
9877229|NCT01010750|10991644|FG004|NOT COMPLETED|First Intervention||0
9877230|NCT01010750|10991645|FG005|NOT COMPLETED|First Intervention||0
9877231|NCT01010750|10991640|FG000|STARTED|Second Intervention||3
9877232|NCT01010750|10991641|FG001|STARTED|Second Intervention||4
9877233|NCT01010750|10991642|FG002|STARTED|Second Intervention||3
9877234|NCT01010750|10991643|FG003|STARTED|Second Intervention||3
9877235|NCT01010750|10991644|FG004|STARTED|Second Intervention||2
9877236|NCT01010750|10991645|FG005|STARTED|Second Intervention||3
9877237|NCT01010750|10991640|FG000|COMPLETED|Second Intervention||3
9877238|NCT01010750|10991641|FG001|COMPLETED|Second Intervention||3
9877239|NCT01010750|10991642|FG002|COMPLETED|Second Intervention||3
9877240|NCT01010750|10991643|FG003|COMPLETED|Second Intervention||3
9877241|NCT01010750|10991644|FG004|COMPLETED|Second Intervention||2
9877242|NCT01010750|10991645|FG005|COMPLETED|Second Intervention||3
9877243|NCT01010750|10991640|FG000|NOT COMPLETED|Second Intervention||0
9877244|NCT01010750|10991641|FG001|NOT COMPLETED|Second Intervention||1
9877245|NCT01010750|10991642|FG002|NOT COMPLETED|Second Intervention||0
9877246|NCT01010750|10991643|FG003|NOT COMPLETED|Second Intervention||0
9877247|NCT01010750|10991644|FG004|NOT COMPLETED|Second Intervention||0
9877248|NCT01010750|10991645|FG005|NOT COMPLETED|Second Intervention||0
9877249|NCT01010750|10991640|FG000|STARTED|Third Intervention||3
9877250|NCT01010750|10991641|FG001|STARTED|Third Intervention||3
9877251|NCT01010750|10991642|FG002|STARTED|Third Intervention||3
9877252|NCT01010750|10991643|FG003|STARTED|Third Intervention||3
9877253|NCT01010750|10991644|FG004|STARTED|Third Intervention||2
9877254|NCT01010750|10991645|FG005|STARTED|Third Intervention||3
9877255|NCT01010750|10991640|FG000|COMPLETED|Third Intervention||3
9877256|NCT01010750|10991641|FG001|COMPLETED|Third Intervention||3
9877257|NCT01010750|10991642|FG002|COMPLETED|Third Intervention||3
9877258|NCT01010750|10991643|FG003|COMPLETED|Third Intervention||3
9877259|NCT01010750|10991644|FG004|COMPLETED|Third Intervention||2
9877260|NCT01010750|10991645|FG005|COMPLETED|Third Intervention||3
9877261|NCT01010750|10991640|FG000|NOT COMPLETED|Third Intervention||0
9877262|NCT01010750|10991641|FG001|NOT COMPLETED|Third Intervention||0
9877263|NCT01010750|10991642|FG002|NOT COMPLETED|Third Intervention||0
10097491|NCT02374957|11226474|FG000|COMPLETED|Overall Study||10
10097492|NCT02374957|11226475|FG001|COMPLETED|Overall Study||9
10097493|NCT02374957|11226474|FG000|NOT COMPLETED|Overall Study||1
10097494|NCT02374957|11226475|FG001|NOT COMPLETED|Overall Study||0
10097495|NCT02375347|11226481|FG000|STARTED|Overall Study||13
10097496|NCT02375347|11226481|FG000|COMPLETED|Overall Study||12
10097497|NCT02375347|11226481|FG000|NOT COMPLETED|Overall Study||1
10097498|NCT02375373|11226485|FG000|STARTED|Overall Study||12
9877264|NCT01010750|10991643|FG003|NOT COMPLETED|Third Intervention||0
9877265|NCT01010750|10991644|FG004|NOT COMPLETED|Third Intervention||0
9877266|NCT01010750|10991645|FG005|NOT COMPLETED|Third Intervention||0
9877267|NCT01010763|10991655|FG000|STARTED|Overall Study||96
10097499|NCT02375373|11226485|FG000|COMPLETED|Overall Study||1
10097500|NCT02375373|11226485|FG000|NOT COMPLETED|Overall Study||11
10097501|NCT02375698|11226491|FG000|STARTED|Overall Study||16
10097502|NCT02375698|11226492|FG001|STARTED|Overall Study||6
9877268|NCT01010763|10991656|FG001|STARTED|Overall Study||84
10097503|NCT02375698|11226491|FG000|COMPLETED|Overall Study||14
9877269|NCT01010763|10991655|FG000|COMPLETED|Overall Study||61
9877270|NCT01010763|10991656|FG001|COMPLETED|Overall Study||54
9877271|NCT01010763|10991655|FG000|NOT COMPLETED|Overall Study||35
9877272|NCT01010763|10991656|FG001|NOT COMPLETED|Overall Study||30
9877273|NCT01010776|10991662|FG000|STARTED|Main Phase||223
9877274|NCT01010776|10991662|FG000|Treated|Main Phase||218
9877275|NCT01010776|10991662|FG000|COMPLETED|Main Phase||174
9877276|NCT01010776|10991662|FG000|NOT COMPLETED|Main Phase||49
9877277|NCT01010776|10991662|FG000|STARTED|In-Between Main Phase & Extension Phase||174
9877278|NCT01010776|10991662|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159
9877279|NCT01010776|10991662|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
9877280|NCT01010776|10991662|FG000|STARTED|Extension Phase||159
9877281|NCT01010776|10991662|FG000|COMPLETED|Extension Phase||156
9877282|NCT01010776|10991662|FG000|NOT COMPLETED|Extension Phase||3
9877283|NCT01010854|10991677|FG000|STARTED|Overall Study||6
9877284|NCT01010854|10991677|FG000|COMPLETED|Overall Study||6
9877285|NCT01010854|10991677|FG000|NOT COMPLETED|Overall Study||0
9877286|NCT01010867|10991681|FG000|STARTED|Overall Study||31
9877287|NCT01010867|10991681|FG000|COMPLETED|Overall Study||30
9877288|NCT01010867|10991681|FG000|NOT COMPLETED|Overall Study||1
9877289|NCT01010906|10991691|FG000|STARTED|Overall Study||10
9877290|NCT01010906|10991692|FG001|STARTED|Overall Study||10
9877291|NCT01010906|10991693|FG002|STARTED|Overall Study||10
9877292|NCT01010906|10991694|FG003|STARTED|Overall Study||10
9877293|NCT01010906|10991695|FG004|STARTED|Overall Study||10
9877294|NCT01010906|10991696|FG005|STARTED|Overall Study||10
9877295|NCT01010906|10991691|FG000|COMPLETED|Overall Study||10
9877296|NCT01010906|10991692|FG001|COMPLETED|Overall Study||10
9877297|NCT01010906|10991693|FG002|COMPLETED|Overall Study||10
9877298|NCT01010906|10991694|FG003|COMPLETED|Overall Study||10
9877299|NCT01010906|10991695|FG004|COMPLETED|Overall Study||10
9877300|NCT01010906|10991696|FG005|COMPLETED|Overall Study||10
9877301|NCT01010906|10991691|FG000|NOT COMPLETED|Overall Study||0
9877302|NCT01010906|10991692|FG001|NOT COMPLETED|Overall Study||0
9877303|NCT01010906|10991693|FG002|NOT COMPLETED|Overall Study||0
9877304|NCT01010906|10991694|FG003|NOT COMPLETED|Overall Study||0
9877305|NCT01010906|10991695|FG004|NOT COMPLETED|Overall Study||0
9877306|NCT01010906|10991696|FG005|NOT COMPLETED|Overall Study||0
9877307|NCT01010932|10991710|FG000|STARTED|Overall Study||222
9877308|NCT01010932|10991710|FG000|COMPLETED|Overall Study||200
9877309|NCT01010932|10991710|FG000|NOT COMPLETED|Overall Study||22
9877310|NCT01010971|10991721|FG000|STARTED|Overall Study||225
9877311|NCT01010971|10991722|FG001|STARTED|Overall Study||226
9877312|NCT01010971|10991723|FG002|STARTED|Overall Study||220
9877313|NCT01010971|10991721|FG000|COMPLETED|Overall Study||222
9877314|NCT01010971|10991722|FG001|COMPLETED|Overall Study||218
9877315|NCT01010971|10991723|FG002|COMPLETED|Overall Study||207
9877316|NCT01010971|10991721|FG000|NOT COMPLETED|Overall Study||3
9877317|NCT01010971|10991722|FG001|NOT COMPLETED|Overall Study||8
9877318|NCT01010971|10991723|FG002|NOT COMPLETED|Overall Study||13
9877319|NCT01010984|10991731|FG000|STARTED|Overall Study||20
9877320|NCT01010984|10991731|FG000|COMPLETED|Overall Study||20
9877321|NCT01010984|10991731|FG000|NOT COMPLETED|Overall Study||0
9877322|NCT01011049|10991740|FG000|STARTED|Overall Study||507
9877323|NCT01011049|10991741|FG001|STARTED|Overall Study||252
9877324|NCT01011049|10991742|FG002|STARTED|Overall Study||243
9877325|NCT01011049|10991743|FG003|STARTED|Overall Study||246
9877326|NCT01011049|10991740|FG000|COMPLETED|Overall Study||506
9877327|NCT01011049|10991741|FG001|COMPLETED|Overall Study||250
9877328|NCT01011049|10991742|FG002|COMPLETED|Overall Study||239
9877329|NCT01011049|10991743|FG003|COMPLETED|Overall Study||246
9877330|NCT01011049|10991740|FG000|NOT COMPLETED|Overall Study||1
9877331|NCT01011049|10991741|FG001|NOT COMPLETED|Overall Study||2
9877332|NCT01011049|10991742|FG002|NOT COMPLETED|Overall Study||4
9877333|NCT01011049|10991743|FG003|NOT COMPLETED|Overall Study||0
9877334|NCT01011075|10991753|FG000|STARTED|Overall Study||34
9877335|NCT01011075|10991753|FG000|COMPLETED|Overall Study||34
9877336|NCT01011075|10991753|FG000|NOT COMPLETED|Overall Study||0
9877337|NCT01011153|10991760|FG000|STARTED|Overall Study||54
9877338|NCT01011153|10991761|FG001|STARTED|Overall Study||75
9877339|NCT01011153|10991762|FG002|STARTED|Overall Study||54
9877340|NCT01011153|10991760|FG000|COMPLETED|Overall Study||46
9877341|NCT01011153|10991761|FG001|COMPLETED|Overall Study||64
9877342|NCT01011153|10991762|FG002|COMPLETED|Overall Study||45
9877343|NCT01011153|10991760|FG000|NOT COMPLETED|Overall Study||8
9877344|NCT01011153|10991761|FG001|NOT COMPLETED|Overall Study||11
9877345|NCT01011153|10991762|FG002|NOT COMPLETED|Overall Study||9
9877346|NCT01011179|10991780|FG000|STARTED|Overall Study||24
9877347|NCT01011179|10991781|FG001|STARTED|Overall Study||22
9877348|NCT01011179|10991780|FG000|COMPLETED|Overall Study||20
9877349|NCT01011179|10991781|FG001|COMPLETED|Overall Study||20
9877350|NCT01011179|10991780|FG000|NOT COMPLETED|Overall Study||4
9877351|NCT01011179|10991781|FG001|NOT COMPLETED|Overall Study||2
9877352|NCT01011218|10991793|FG000|STARTED|Overall Study||9
9877353|NCT01011218|10991794|FG001|STARTED|Overall Study||9
9877354|NCT01011218|10991795|FG002|STARTED|Overall Study||26
9877355|NCT01011218|10991796|FG003|STARTED|Overall Study||26
9877356|NCT01011218|10991793|FG000|COMPLETED|Overall Study||9
9877357|NCT01011218|10991794|FG001|COMPLETED|Overall Study||9
9877358|NCT01011218|10991795|FG002|COMPLETED|Overall Study||26
9877359|NCT01011218|10991796|FG003|COMPLETED|Overall Study||26
9877360|NCT01011218|10991793|FG000|NOT COMPLETED|Overall Study||0
9877361|NCT01011218|10991794|FG001|NOT COMPLETED|Overall Study||0
9877362|NCT01011218|10991795|FG002|NOT COMPLETED|Overall Study||0
9877363|NCT01011218|10991796|FG003|NOT COMPLETED|Overall Study||0
9877364|NCT01011283|10991808|FG000|STARTED|Overall Study||13
9877365|NCT01011283|10991809|FG001|STARTED|Overall Study||13
9877366|NCT01011283|10991808|FG000|COMPLETED|Overall Study||2
9877367|NCT01011283|10991809|FG001|COMPLETED|Overall Study||2
9877368|NCT01011283|10991808|FG000|NOT COMPLETED|Overall Study||11
9877369|NCT01011283|10991809|FG001|NOT COMPLETED|Overall Study||11
9877370|NCT01011309|10991818|FG000|STARTED|Overall Study||14
9877371|NCT01011309|10991819|FG001|STARTED|Overall Study||10
9877372|NCT01011309|10991820|FG002|STARTED|Overall Study||21
9877373|NCT01011309|10991818|FG000|COMPLETED|Overall Study||12
9877374|NCT01011309|10991819|FG001|COMPLETED|Overall Study||7
9877375|NCT01011309|10991820|FG002|COMPLETED|Overall Study||16
9877376|NCT01011309|10991818|FG000|NOT COMPLETED|Overall Study||2
9877377|NCT01011309|10991819|FG001|NOT COMPLETED|Overall Study||3
9877378|NCT01011309|10991820|FG002|NOT COMPLETED|Overall Study||5
9968905|NCT01523756|11089408|FG000|COMPLETED|Test Period 1||10
9968906|NCT01523756|11089409|FG001|COMPLETED|Test Period 1||8
9968907|NCT01523756|11089408|FG000|NOT COMPLETED|Test Period 1||1
9968908|NCT01523756|11089409|FG001|NOT COMPLETED|Test Period 1||0
9968909|NCT01523756|11089408|FG000|STARTED|Test Period 2||10
9968910|NCT01523756|11089409|FG001|STARTED|Test Period 2||8
9968911|NCT01523756|11089408|FG000|COMPLETED|Test Period 2||10
9968912|NCT01523756|11089409|FG001|COMPLETED|Test Period 2||7
9968913|NCT01523756|11089408|FG000|NOT COMPLETED|Test Period 2||0
9968914|NCT01523756|11089409|FG001|NOT COMPLETED|Test Period 2||1
9968915|NCT01523782|11089420|FG000|STARTED|Overall Study||3
9968916|NCT01523782|11089421|FG001|STARTED|Overall Study||13
9968917|NCT01523782|11089422|FG002|STARTED|Overall Study||14
9968918|NCT01523782|11089420|FG000|COMPLETED|Overall Study||2
9968919|NCT01523782|11089421|FG001|COMPLETED|Overall Study||13
9968920|NCT01523782|11089422|FG002|COMPLETED|Overall Study||9
9968921|NCT01523782|11089420|FG000|NOT COMPLETED|Overall Study||1
9968922|NCT01523782|11089421|FG001|NOT COMPLETED|Overall Study||0
9968923|NCT01523782|11089422|FG002|NOT COMPLETED|Overall Study||5
10017476|NCT01816906|11140379|FG000|NOT COMPLETED|12 Months||4
10017477|NCT01816906|11140380|FG001|NOT COMPLETED|12 Months||5
10017478|NCT01816945|11140389|FG000|STARTED|Overall Study||23
10017479|NCT01816945|11140390|FG001|STARTED|Overall Study||24
10017480|NCT01816945|11140389|FG000|COMPLETED|Overall Study||21
10017481|NCT01816945|11140390|FG001|COMPLETED|Overall Study||19
10017482|NCT01816945|11140389|FG000|NOT COMPLETED|Overall Study||2
10017483|NCT01816945|11140390|FG001|NOT COMPLETED|Overall Study||5
10017484|NCT01816984|11140396|FG000|STARTED|Overall Study||12
10017485|NCT01816984|11140396|FG000|COMPLETED|Overall Study||11
10017486|NCT01816984|11140396|FG000|NOT COMPLETED|Overall Study||1
10017487|NCT01817075|11140402|FG000|STARTED|Overall Study||88
10017488|NCT01817075|11140403|FG001|STARTED|Overall Study||89
10017489|NCT01817075|11140402|FG000|COMPLETED|Overall Study||41
10017490|NCT01817075|11140403|FG001|COMPLETED|Overall Study||54
10017491|NCT01817075|11140402|FG000|NOT COMPLETED|Overall Study||47
10017492|NCT01817075|11140403|FG001|NOT COMPLETED|Overall Study||35
10017493|NCT01817374|11140409|FG000|STARTED|Overall Study||6
10017494|NCT01817374|11140409|FG000|COMPLETED|Overall Study||6
10017495|NCT01817374|11140409|FG000|NOT COMPLETED|Overall Study||0
10017496|NCT01817491|11140417|FG000|STARTED|Overall Study||32
10017497|NCT01817491|11140418|FG001|STARTED|Overall Study||28
10017498|NCT01817491|11140417|FG000|COMPLETED|Overall Study||28
10017499|NCT01817491|11140418|FG001|COMPLETED|Overall Study||28
10017500|NCT01817491|11140417|FG000|NOT COMPLETED|Overall Study||4
10017501|NCT01817491|11140418|FG001|NOT COMPLETED|Overall Study||0
10017502|NCT01817530|11140433|FG000|STARTED|Overall Study||65
10017503|NCT01817530|11140434|FG001|STARTED|Overall Study||65
10017504|NCT01817530|11140435|FG002|STARTED|Overall Study||64
10017505|NCT01817530|11140436|FG003|STARTED|Overall Study||65
10017506|NCT01817530|11140437|FG004|STARTED|Overall Study||78
10017507|NCT01817530|11140438|FG005|STARTED|Overall Study||77
10017508|NCT01817530|11140439|FG006|STARTED|Overall Study||76
10017509|NCT01817530|11140440|FG007|STARTED|Overall Study||77
10017510|NCT01817530|11140433|FG000|COMPLETED|Overall Study||50
10017511|NCT01817530|11140434|FG001|COMPLETED|Overall Study||52
10017512|NCT01817530|11140435|FG002|COMPLETED|Overall Study||53
10017513|NCT01817530|11140436|FG003|COMPLETED|Overall Study||52
10017514|NCT01817530|11140437|FG004|COMPLETED|Overall Study||67
10017515|NCT01817530|11140438|FG005|COMPLETED|Overall Study||58
10017516|NCT01817530|11140439|FG006|COMPLETED|Overall Study||53
10017517|NCT01817530|11140440|FG007|COMPLETED|Overall Study||53
10017518|NCT01817530|11140433|FG000|NOT COMPLETED|Overall Study||15
10017519|NCT01817530|11140434|FG001|NOT COMPLETED|Overall Study||13
10017520|NCT01817530|11140435|FG002|NOT COMPLETED|Overall Study||11
10017521|NCT01817530|11140436|FG003|NOT COMPLETED|Overall Study||13
10017522|NCT01817530|11140437|FG004|NOT COMPLETED|Overall Study||11
10017523|NCT01817530|11140438|FG005|NOT COMPLETED|Overall Study||19
10017524|NCT01817530|11140439|FG006|NOT COMPLETED|Overall Study||23
10017525|NCT01817530|11140440|FG007|NOT COMPLETED|Overall Study||24
10017526|NCT01817582|11140461|FG000|STARTED|Overall Study||33
10017527|NCT01817582|11140462|FG001|STARTED|Overall Study||36
10017528|NCT01817582|11140463|FG002|STARTED|Overall Study||33
10017529|NCT01817582|11140461|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
10017530|NCT01817582|11140462|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
10017531|NCT01817582|11140463|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33
10017532|NCT01817582|11140461|FG000|COMPLETED|Overall Study||31
9968924|NCT01523808|11089434|FG000|STARTED|Overall Study||3
9968925|NCT01523808|11089435|FG001|STARTED|Overall Study||3
9968926|NCT01523808|11089436|FG002|STARTED|Overall Study||3
9968927|NCT01523808|11089437|FG003|STARTED|Overall Study||3
9968928|NCT01523808|11089434|FG000|COMPLETED|Overall Study||0
9968929|NCT01523808|11089435|FG001|COMPLETED|Overall Study||3
9968930|NCT01523808|11089436|FG002|COMPLETED|Overall Study||1
9968931|NCT01523808|11089437|FG003|COMPLETED|Overall Study||0
9968932|NCT01523808|11089434|FG000|NOT COMPLETED|Overall Study||3
9968933|NCT01523808|11089435|FG001|NOT COMPLETED|Overall Study||0
9968934|NCT01523808|11089436|FG002|NOT COMPLETED|Overall Study||2
9968935|NCT01523808|11089437|FG003|NOT COMPLETED|Overall Study||3
9968936|NCT01523821|11089459|FG000|STARTED|Overall Study||8
9968937|NCT01523821|11089460|FG001|STARTED|Overall Study||6
9968938|NCT01523821|11089461|FG002|STARTED|Overall Study||6
9968939|NCT01523821|11089459|FG000|COMPLETED|Overall Study||8
9968940|NCT01523821|11089460|FG001|COMPLETED|Overall Study||6
9968941|NCT01523821|11089461|FG002|COMPLETED|Overall Study||6
9968942|NCT01523821|11089459|FG000|NOT COMPLETED|Overall Study||0
9968943|NCT01523821|11089460|FG001|NOT COMPLETED|Overall Study||0
9968944|NCT01523821|11089461|FG002|NOT COMPLETED|Overall Study||0
9968945|NCT01523834|11089469|FG000|STARTED|Overall Study|Started Induction Phase|35
9968946|NCT01523834|11089469|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7
9968947|NCT01523834|11089469|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6
9968948|NCT01523834|11089469|FG000|COMPLETED|Overall Study||4
9968949|NCT01523834|11089469|FG000|NOT COMPLETED|Overall Study||31
9968950|NCT01523873|11089474|FG000|STARTED|Overall Study||35921
9968951|NCT01523873|11089474|FG000|Administered With Dotarem|Overall Study||35474
9968952|NCT01523873|11089474|FG000|COMPLETED|Overall Study||35499
9968953|NCT01523873|11089474|FG000|NOT COMPLETED|Overall Study||422
10097504|NCT02375698|11226492|FG001|COMPLETED|Overall Study||4
10097505|NCT02375698|11226491|FG000|NOT COMPLETED|Overall Study||2
10097506|NCT02375698|11226492|FG001|NOT COMPLETED|Overall Study||2
10097507|NCT02375724|11226500|FG000|STARTED|Overall Study||135
10097508|NCT02375724|11226501|FG001|STARTED|Overall Study||134
10097509|NCT02375724|11226500|FG000|COMPLETED|Overall Study||129
10097510|NCT02375724|11226501|FG001|COMPLETED|Overall Study||128
10097511|NCT02375724|11226500|FG000|NOT COMPLETED|Overall Study||6
10097512|NCT02375724|11226501|FG001|NOT COMPLETED|Overall Study||6
10097513|NCT02375971|11226510|FG000|STARTED|Treatment (Day 1 - Baseline)||74
10097514|NCT02375971|11226511|FG001|STARTED|Treatment (Day 1 - Baseline)||77
10097515|NCT02375971|11226512|FG002|STARTED|Treatment (Day 1 - Baseline)||74
10097516|NCT02375971|11226510|FG000|Safety Set|Treatment (Day 1 - Baseline)||73
10097517|NCT02375971|11226511|FG001|Safety Set|Treatment (Day 1 - Baseline)||76
10097518|NCT02375971|11226512|FG002|Safety Set|Treatment (Day 1 - Baseline)||69
10097519|NCT02375971|11226510|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19
10097520|NCT02375971|11226511|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26
10097521|NCT02375971|11226512|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51
10097522|NCT02375971|11226510|FG000|PK Set|Treatment (Day 1 - Baseline)||49
10097523|NCT02375971|11226511|FG001|PK Set|Treatment (Day 1 - Baseline)||46
10097524|NCT02375971|11226512|FG002|PK Set|Treatment (Day 1 - Baseline)||0
10097525|NCT02375971|11226510|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73
10097526|NCT02375971|11226511|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76
10097527|NCT02375971|11226512|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69
10097528|NCT02375971|11226510|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
10097529|NCT02375971|11226511|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
10097530|NCT02375971|11226512|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
9968954|NCT01523886|11089482|FG000|STARTED|Overall Study||25
9968955|NCT01523886|11089483|FG001|STARTED|Overall Study||24
9968956|NCT01523886|11089482|FG000|COMPLETED|Overall Study||25
9968957|NCT01523886|11089483|FG001|COMPLETED|Overall Study||23
9968958|NCT01523886|11089482|FG000|NOT COMPLETED|Overall Study||0
9968959|NCT01523886|11089483|FG001|NOT COMPLETED|Overall Study||1
9968960|NCT01523899|11089491|FG000|STARTED|Overall Study||126
9968961|NCT01523899|11089492|FG001|STARTED|Overall Study||126
9968962|NCT01523899|11089491|FG000|COMPLETED|Overall Study||126
9968963|NCT01523899|11089492|FG001|COMPLETED|Overall Study||126
9968964|NCT01523899|11089491|FG000|NOT COMPLETED|Overall Study||0
9968965|NCT01523899|11089492|FG001|NOT COMPLETED|Overall Study||0
9968966|NCT01523964|11089503|FG000|STARTED|Overall Study||31
9968967|NCT01523964|11089504|FG001|STARTED|Overall Study||30
9968968|NCT01523964|11089505|FG002|STARTED|Overall Study||16
9968969|NCT01523964|11089506|FG003|STARTED|Overall Study||15
9968970|NCT01523964|11089503|FG000|COMPLETED|Overall Study||31
9968971|NCT01523964|11089504|FG001|COMPLETED|Overall Study||30
9968972|NCT01523964|11089505|FG002|COMPLETED|Overall Study||16
9968973|NCT01523964|11089506|FG003|COMPLETED|Overall Study||15
9968974|NCT01523964|11089503|FG000|NOT COMPLETED|Overall Study||0
9968975|NCT01523964|11089504|FG001|NOT COMPLETED|Overall Study||0
9968976|NCT01523964|11089505|FG002|NOT COMPLETED|Overall Study||0
9968977|NCT01523964|11089506|FG003|NOT COMPLETED|Overall Study||0
9968978|NCT01524133|11089519|FG000|STARTED|Treatment Phase||71
9968979|NCT01524133|11089520|FG001|STARTED|Treatment Phase||69
9968980|NCT01524133|11089521|FG002|STARTED|Treatment Phase||67
9968981|NCT01524133|11089519|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
9968982|NCT01524133|11089520|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
9968983|NCT01524133|11089521|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31
9968984|NCT01524133|11089519|FG000|NOT COMPLETED|Treatment Phase||19
9968985|NCT01524133|11089520|FG001|NOT COMPLETED|Treatment Phase||32
9968986|NCT01524133|11089521|FG002|NOT COMPLETED|Treatment Phase||36
9968987|NCT01524133|11089519|FG000|STARTED|Overall Study 52 Weeks||71
9968988|NCT01524133|11089520|FG001|STARTED|Overall Study 52 Weeks||69
9968989|NCT01524133|11089521|FG002|STARTED|Overall Study 52 Weeks||67
9968990|NCT01524133|11089519|FG000|COMPLETED|Overall Study 52 Weeks||50
9968991|NCT01524133|11089520|FG001|COMPLETED|Overall Study 52 Weeks||49
9968992|NCT01524133|11089521|FG002|COMPLETED|Overall Study 52 Weeks||40
9968993|NCT01524133|11089519|FG000|NOT COMPLETED|Overall Study 52 Weeks||21
9968994|NCT01524133|11089520|FG001|NOT COMPLETED|Overall Study 52 Weeks||20
9968995|NCT01524133|11089521|FG002|NOT COMPLETED|Overall Study 52 Weeks||27
9968996|NCT01524198|11089531|FG000|STARTED|Overall Study||471
9968997|NCT01524198|11089532|FG001|STARTED|Overall Study||474
9968998|NCT01524198|11089531|FG000|COMPLETED|Overall Study||448
9968999|NCT01524198|11089532|FG001|COMPLETED|Overall Study||458
9969000|NCT01524198|11089531|FG000|NOT COMPLETED|Overall Study||23
9969001|NCT01524198|11089532|FG001|NOT COMPLETED|Overall Study||16
9969002|NCT01524224|11089546|FG000|STARTED|Overall Study||4
9969003|NCT01524224|11089547|FG001|STARTED|Overall Study||3
9969004|NCT01524224|11089548|FG002|STARTED|Overall Study||3
9969005|NCT01524224|11089549|FG003|STARTED|Overall Study||3
9969006|NCT01524224|11089550|FG004|STARTED|Overall Study||4
9969007|NCT01524224|11089551|FG005|STARTED|Overall Study||3
9969008|NCT01524224|11089552|FG006|STARTED|Overall Study||3
9969009|NCT01524224|11089553|FG007|STARTED|Overall Study||6
9969010|NCT01524224|11089546|FG000|Received at Least One Dose of Study Drug|Overall Study||4
9969011|NCT01524224|11089547|FG001|Received at Least One Dose of Study Drug|Overall Study||3
9969012|NCT01524224|11089548|FG002|Received at Least One Dose of Study Drug|Overall Study||3
9969013|NCT01524224|11089549|FG003|Received at Least One Dose of Study Drug|Overall Study||3
9969014|NCT01524224|11089550|FG004|Received at Least One Dose of Study Drug|Overall Study||4
9969015|NCT01524224|11089551|FG005|Received at Least One Dose of Study Drug|Overall Study||3
9969016|NCT01524224|11089552|FG006|Received at Least One Dose of Study Drug|Overall Study||3
9969017|NCT01524224|11089553|FG007|Received at Least One Dose of Study Drug|Overall Study||6
9969018|NCT01524224|11089546|FG000|COMPLETED|Overall Study||1
9969019|NCT01524224|11089547|FG001|COMPLETED|Overall Study||2
9969020|NCT01524224|11089548|FG002|COMPLETED|Overall Study||1
10097531|NCT02375971|11226510|FG000|STARTED|Follow-Up Phase (up to Day 169)||73
10097532|NCT02375971|11226511|FG001|STARTED|Follow-Up Phase (up to Day 169)||76
10097533|NCT02375971|11226512|FG002|STARTED|Follow-Up Phase (up to Day 169)||69
10097534|NCT02375971|11226510|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66
10097535|NCT02375971|11226511|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71
10097536|NCT02375971|11226512|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64
10097537|NCT02375971|11226510|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
9969021|NCT01524224|11089549|FG003|COMPLETED|Overall Study||1
9969022|NCT01524224|11089550|FG004|COMPLETED|Overall Study||0
9969023|NCT01524224|11089551|FG005|COMPLETED|Overall Study||1
9969024|NCT01524224|11089552|FG006|COMPLETED|Overall Study||0
9969025|NCT01524224|11089553|FG007|COMPLETED|Overall Study||0
9969026|NCT01524224|11089546|FG000|NOT COMPLETED|Overall Study||3
9969027|NCT01524224|11089547|FG001|NOT COMPLETED|Overall Study||1
9969028|NCT01524224|11089548|FG002|NOT COMPLETED|Overall Study||2
9969029|NCT01524224|11089549|FG003|NOT COMPLETED|Overall Study||2
9969030|NCT01524224|11089550|FG004|NOT COMPLETED|Overall Study||4
9969031|NCT01524224|11089551|FG005|NOT COMPLETED|Overall Study||2
9969032|NCT01524224|11089552|FG006|NOT COMPLETED|Overall Study||3
9969033|NCT01524224|11089553|FG007|NOT COMPLETED|Overall Study||6
9969034|NCT01524289|11089573|FG000|STARTED|Overall Study||204
9969035|NCT01524289|11089574|FG001|STARTED|Overall Study||102
9969036|NCT01524289|11089573|FG000|Treated|Overall Study||203
9969037|NCT01524289|11089574|FG001|Treated|Overall Study||102
9969038|NCT01524289|11089573|FG000|COMPLETED|Overall Study||174
9969039|NCT01524289|11089574|FG001|COMPLETED|Overall Study||88
9969040|NCT01524289|11089573|FG000|NOT COMPLETED|Overall Study||30
9969041|NCT01524289|11089574|FG001|NOT COMPLETED|Overall Study||14
9969042|NCT01524302|11089584|FG000|STARTED|Overall Study||6
9969043|NCT01524302|11089585|FG001|STARTED|Overall Study||6
9969044|NCT01524302|11089584|FG000|COMPLETED|Overall Study||6
9969045|NCT01524302|11089585|FG001|COMPLETED|Overall Study||6
9969046|NCT01524302|11089584|FG000|NOT COMPLETED|Overall Study||0
9969047|NCT01524302|11089585|FG001|NOT COMPLETED|Overall Study||0
9969048|NCT01524627|11089597|FG000|STARTED|Overall Study||22
9969049|NCT01524627|11089598|FG001|STARTED|Overall Study||21
9969050|NCT01524627|11089597|FG000|COMPLETED|Overall Study||21
9969051|NCT01524627|11089598|FG001|COMPLETED|Overall Study||19
9969052|NCT01524627|11089597|FG000|NOT COMPLETED|Overall Study||1
9969053|NCT01524627|11089598|FG001|NOT COMPLETED|Overall Study||2
9969054|NCT01524679|11089606|FG000|STARTED|Overall Study||112
9969055|NCT01524679|11089607|FG001|STARTED|Overall Study||58
9969056|NCT01524679|11089606|FG000|COMPLETED|Overall Study||89
9969057|NCT01524679|11089607|FG001|COMPLETED|Overall Study||49
9969058|NCT01524679|11089606|FG000|NOT COMPLETED|Overall Study||23
9969059|NCT01524679|11089607|FG001|NOT COMPLETED|Overall Study||9
9969060|NCT01524692|11089613|FG000|STARTED|Overall Study||35
9969061|NCT01524692|11089613|FG000|COMPLETED|Overall Study||32
9969062|NCT01524692|11089613|FG000|NOT COMPLETED|Overall Study||3
9969063|NCT01524770|11089618|FG000|STARTED|First Intervention||26
9969064|NCT01524770|11089619|FG001|STARTED|First Intervention||24
9969065|NCT01524770|11089618|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26
9969066|NCT01524770|11089619|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24
9969067|NCT01524770|11089618|FG000|COMPLETED|First Intervention||23
9969068|NCT01524770|11089619|FG001|COMPLETED|First Intervention||23
9969069|NCT01524770|11089618|FG000|NOT COMPLETED|First Intervention||3
9969070|NCT01524770|11089619|FG001|NOT COMPLETED|First Intervention||1
9969071|NCT01524770|11089618|FG000|STARTED|Washout Period of at Least 28 Days||23
9969072|NCT01524770|11089619|FG001|STARTED|Washout Period of at Least 28 Days||23
9969073|NCT01524770|11089618|FG000|COMPLETED|Washout Period of at Least 28 Days||23
9969074|NCT01524770|11089619|FG001|COMPLETED|Washout Period of at Least 28 Days||23
9969075|NCT01524770|11089618|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
9969076|NCT01524770|11089619|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
9969077|NCT01524770|11089618|FG000|STARTED|Second Intervention||23
9969078|NCT01524770|11089619|FG001|STARTED|Second Intervention||23
9969079|NCT01524770|11089618|FG000|COMPLETED|Second Intervention||23
9969080|NCT01524770|11089619|FG001|COMPLETED|Second Intervention||23
9969081|NCT01524770|11089618|FG000|NOT COMPLETED|Second Intervention||0
9969082|NCT01524770|11089619|FG001|NOT COMPLETED|Second Intervention||0
9969083|NCT01524783|11089627|FG000|STARTED|Blinded Period||205
9969084|NCT01524783|11089628|FG001|STARTED|Blinded Period||97
9969085|NCT01524783|11089629|FG002|STARTED|Blinded Period||0
9969086|NCT01524783|11089627|FG000|COMPLETED|Blinded Period||26
9969087|NCT01524783|11089628|FG001|COMPLETED|Blinded Period||6
9969088|NCT01524783|11089629|FG002|COMPLETED|Blinded Period||0
9969089|NCT01524783|11089627|FG000|NOT COMPLETED|Blinded Period||179
9969090|NCT01524783|11089628|FG001|NOT COMPLETED|Blinded Period||91
9969091|NCT01524783|11089629|FG002|NOT COMPLETED|Blinded Period||0
9969092|NCT01524783|11089627|FG000|STARTED|Open-label Period||26
9969093|NCT01524783|11089628|FG001|STARTED|Open-label Period||0
9969094|NCT01524783|11089629|FG002|STARTED|Open-label Period||6
9969095|NCT01524783|11089627|FG000|COMPLETED|Open-label Period||0
9969096|NCT01524783|11089628|FG001|COMPLETED|Open-label Period||0
9969097|NCT01524783|11089629|FG002|COMPLETED|Open-label Period||0
9969098|NCT01524783|11089627|FG000|NOT COMPLETED|Open-label Period||26
9969099|NCT01524783|11089628|FG001|NOT COMPLETED|Open-label Period||0
9969100|NCT01524783|11089629|FG002|NOT COMPLETED|Open-label Period||6
9969101|NCT01524796|11089641|FG000|STARTED|Overall Study||128
9969102|NCT01524796|11089641|FG000|COMPLETED|Overall Study||100
9969103|NCT01524796|11089641|FG000|NOT COMPLETED|Overall Study||28
9969104|NCT01524887|11089648|FG000|STARTED|Overall Study||85
9969105|NCT01524887|11089649|FG001|STARTED|Overall Study||90
9969106|NCT01524887|11089650|FG002|STARTED|Overall Study||86
9969107|NCT01524887|11089648|FG000|Received Treatment|Overall Study||83
9969108|NCT01524887|11089649|FG001|Received Treatment|Overall Study||85
9969109|NCT01524887|11089650|FG002|Received Treatment|Overall Study||83
9969110|NCT01524887|11089648|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
9969111|NCT01524887|11089649|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
9969112|NCT01524887|11089650|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
9969113|NCT01524887|11089648|FG000|NOT COMPLETED|Overall Study||85
9969114|NCT01524887|11089649|FG001|NOT COMPLETED|Overall Study||90
9969115|NCT01524887|11089650|FG002|NOT COMPLETED|Overall Study||86
9969116|NCT01524900|11089663|FG000|STARTED|Overall Study||49
10097538|NCT02375971|11226511|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
10097539|NCT02375971|11226512|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
10097540|NCT02375984|11226520|FG000|STARTED|Overall Study||1
10097541|NCT02375984|11226520|FG000|COMPLETED|Overall Study||1
10097542|NCT02375984|11226520|FG000|NOT COMPLETED|Overall Study||0
10097543|NCT02376010|11226526|FG000|STARTED|Overall Study||55
10097544|NCT02376010|11226527|FG001|STARTED|Overall Study||55
10097545|NCT02376010|11226526|FG000|COMPLETED|Overall Study||46
10097546|NCT02376010|11226527|FG001|COMPLETED|Overall Study||51
10097547|NCT02376010|11226526|FG000|NOT COMPLETED|Overall Study||9
10097548|NCT02376010|11226527|FG001|NOT COMPLETED|Overall Study||4
10097549|NCT02376166|11226533|FG000|STARTED|Overall Study||15
10097550|NCT02376166|11226533|FG000|COMPLETED|Overall Study||12
10097551|NCT02376166|11226533|FG000|NOT COMPLETED|Overall Study||3
10097552|NCT02376179|11226537|FG000|STARTED|Overall Study||84
10097553|NCT02376179|11226537|FG000|COMPLETED|Overall Study||84
10097554|NCT02376179|11226537|FG000|NOT COMPLETED|Overall Study||0
10097555|NCT02376257|11226544|FG000|STARTED|Overall Study||13
9969117|NCT01524900|11089664|FG001|STARTED|Overall Study||246
9969118|NCT01524900|11089665|FG002|STARTED|Overall Study||30
9969119|NCT01524900|11089666|FG003|STARTED|Overall Study||22
9969120|NCT01524900|11089667|FG004|STARTED|Overall Study||40
9969121|NCT01524900|11089663|FG000|COMPLETED|Overall Study||43
9969122|NCT01524900|11089664|FG001|COMPLETED|Overall Study||232
9969123|NCT01524900|11089665|FG002|COMPLETED|Overall Study||29
9969124|NCT01524900|11089666|FG003|COMPLETED|Overall Study||21
9969125|NCT01524900|11089667|FG004|COMPLETED|Overall Study||40
9969126|NCT01524900|11089663|FG000|NOT COMPLETED|Overall Study||6
9969127|NCT01524900|11089664|FG001|NOT COMPLETED|Overall Study||14
10097556|NCT02376257|11226545|FG001|STARTED|Overall Study||12
10097557|NCT02376257|11226546|FG002|STARTED|Overall Study||11
10097558|NCT02376257|11226544|FG000|COMPLETED|Overall Study||13
10097559|NCT02376257|11226545|FG001|COMPLETED|Overall Study||12
10097560|NCT02376257|11226546|FG002|COMPLETED|Overall Study||11
10097561|NCT02376257|11226544|FG000|NOT COMPLETED|Overall Study||0
9969128|NCT01524900|11089665|FG002|NOT COMPLETED|Overall Study||1
9969129|NCT01524900|11089666|FG003|NOT COMPLETED|Overall Study||1
9969130|NCT01524900|11089667|FG004|NOT COMPLETED|Overall Study||0
9969131|NCT01524913|11089683|FG000|STARTED|Overall Study||35
9969132|NCT01524913|11089684|FG001|STARTED|Overall Study||36
9969133|NCT01524913|11089685|FG002|STARTED|Overall Study||31
9969134|NCT01524913|11089683|FG000|COMPLETED|Overall Study||31
9969135|NCT01524913|11089684|FG001|COMPLETED|Overall Study||36
9969136|NCT01524913|11089685|FG002|COMPLETED|Overall Study||31
9969137|NCT01524913|11089683|FG000|NOT COMPLETED|Overall Study||4
9969138|NCT01524913|11089684|FG001|NOT COMPLETED|Overall Study||0
9969139|NCT01524913|11089685|FG002|NOT COMPLETED|Overall Study||0
9969140|NCT01524978|11089704|FG000|STARTED|Overall Study||62
9969141|NCT01524978|11089705|FG001|STARTED|Overall Study||4
9969142|NCT01524978|11089706|FG002|STARTED|Overall Study||10
9969143|NCT01524978|11089707|FG003|STARTED|Overall Study||27
9969144|NCT01524978|11089708|FG004|STARTED|Overall Study||9
9969145|NCT01524978|11089709|FG005|STARTED|Overall Study||9
9969146|NCT01524978|11089710|FG006|STARTED|Overall Study||26
9969147|NCT01524978|11089711|FG007|STARTED|Overall Study||12
9969148|NCT01524978|11089712|FG008|STARTED|Overall Study||12
9969149|NCT01524978|11089713|FG009|STARTED|Overall Study||9
9969150|NCT01524978|11089714|FG010|STARTED|Overall Study||28
9969151|NCT01524978|11089704|FG000|COMPLETED|Overall Study||0
9969152|NCT01524978|11089705|FG001|COMPLETED|Overall Study||0
9969153|NCT01524978|11089706|FG002|COMPLETED|Overall Study||0
9969154|NCT01524978|11089707|FG003|COMPLETED|Overall Study||0
9969155|NCT01524978|11089708|FG004|COMPLETED|Overall Study||0
9969156|NCT01524978|11089709|FG005|COMPLETED|Overall Study||0
9969157|NCT01524978|11089710|FG006|COMPLETED|Overall Study||0
9969158|NCT01524978|11089711|FG007|COMPLETED|Overall Study||0
9969159|NCT01524978|11089712|FG008|COMPLETED|Overall Study||0
9969160|NCT01524978|11089713|FG009|COMPLETED|Overall Study||0
9969161|NCT01524978|11089714|FG010|COMPLETED|Overall Study||0
9969162|NCT01524978|11089704|FG000|NOT COMPLETED|Overall Study||62
9969163|NCT01524978|11089705|FG001|NOT COMPLETED|Overall Study||4
9969164|NCT01524978|11089706|FG002|NOT COMPLETED|Overall Study||10
9969165|NCT01524978|11089707|FG003|NOT COMPLETED|Overall Study||27
9969166|NCT01524978|11089708|FG004|NOT COMPLETED|Overall Study||9
9969167|NCT01524978|11089709|FG005|NOT COMPLETED|Overall Study||9
9969168|NCT01524978|11089710|FG006|NOT COMPLETED|Overall Study||26
9969169|NCT01524978|11089711|FG007|NOT COMPLETED|Overall Study||12
9969170|NCT01524978|11089712|FG008|NOT COMPLETED|Overall Study||12
9969171|NCT01524978|11089713|FG009|NOT COMPLETED|Overall Study||9
9969172|NCT01524978|11089714|FG010|NOT COMPLETED|Overall Study||28
9969173|NCT01524991|11089729|FG000|STARTED|Overall Study||36
9969174|NCT01524991|11089729|FG000|COMPLETED|Overall Study||2
9969175|NCT01524991|11089729|FG000|NOT COMPLETED|Overall Study||34
9969176|NCT01525082|11089733|FG000|STARTED|Overall Study||20
9969177|NCT01525082|11089733|FG000|COMPLETED|Overall Study||19
9969178|NCT01525082|11089733|FG000|NOT COMPLETED|Overall Study||1
9969179|NCT01525173|11089742|FG000|STARTED|Overall Study||70
9969180|NCT01525173|11089743|FG001|STARTED|Overall Study||67
9969181|NCT01525173|11089742|FG000|COMPLETED|Overall Study||63
9969182|NCT01525173|11089743|FG001|COMPLETED|Overall Study||62
9969183|NCT01525173|11089742|FG000|NOT COMPLETED|Overall Study||7
9969184|NCT01525173|11089743|FG001|NOT COMPLETED|Overall Study||5
9969185|NCT01525225|11089749|FG000|STARTED|Enrollment||4
9969186|NCT01525225|11089749|FG000|COMPLETED|Enrollment||2
9969187|NCT01525225|11089749|FG000|NOT COMPLETED|Enrollment||2
9969188|NCT01525225|11089749|FG000|STARTED|Treated||2
9969189|NCT01525225|11089749|FG000|COMPLETED|Treated||2
9969190|NCT01525225|11089749|FG000|NOT COMPLETED|Treated||0
9969191|NCT01525238|11089756|FG000|STARTED|Overall Study||8
9969192|NCT01525238|11089757|FG001|STARTED|Overall Study||8
9969193|NCT01525238|11089758|FG002|STARTED|Overall Study||8
9969194|NCT01525238|11089756|FG000|COMPLETED|Overall Study||7
9969195|NCT01525238|11089757|FG001|COMPLETED|Overall Study||8
9969196|NCT01525238|11089758|FG002|COMPLETED|Overall Study||8
9969197|NCT01525238|11089756|FG000|NOT COMPLETED|Overall Study||1
10097562|NCT02376257|11226545|FG001|NOT COMPLETED|Overall Study||0
10097563|NCT02376257|11226546|FG002|NOT COMPLETED|Overall Study||0
10097564|NCT02376283|11226557|FG000|STARTED|Overall Study||27
10097565|NCT02376283|11226558|FG001|STARTED|Overall Study||30
10097566|NCT02376283|11226559|FG002|STARTED|Overall Study||30
10097567|NCT02376283|11226557|FG000|COMPLETED|Overall Study||27
10097568|NCT02376283|11226558|FG001|COMPLETED|Overall Study||30
10097569|NCT02376283|11226559|FG002|COMPLETED|Overall Study||30
10097570|NCT02376283|11226557|FG000|NOT COMPLETED|Overall Study||0
10097571|NCT02376283|11226558|FG001|NOT COMPLETED|Overall Study||0
10097572|NCT02376283|11226559|FG002|NOT COMPLETED|Overall Study||0
9969198|NCT01525238|11089757|FG001|NOT COMPLETED|Overall Study||0
10097573|NCT02376361|11226570|FG000|STARTED|Overall Study||229
10097574|NCT02376361|11226571|FG001|STARTED|Overall Study||207
10097575|NCT02376361|11226570|FG000|COMPLETED|Overall Study||58
10097576|NCT02376361|11226571|FG001|COMPLETED|Overall Study||90
9969199|NCT01525238|11089758|FG002|NOT COMPLETED|Overall Study||0
9969200|NCT01525407|11089768|FG000|STARTED|Overall Study||41
9969201|NCT01525407|11089769|FG001|STARTED|Overall Study||42
9969202|NCT01525407|11089768|FG000|COMPLETED|Overall Study||38
9969203|NCT01525407|11089769|FG001|COMPLETED|Overall Study||38
9969204|NCT01525407|11089768|FG000|NOT COMPLETED|Overall Study||3
9969205|NCT01525407|11089769|FG001|NOT COMPLETED|Overall Study||4
9969206|NCT01525420|11089777|FG000|STARTED|Overall Study||59
9969207|NCT01525420|11089778|FG001|STARTED|Overall Study||62
9969208|NCT01525420|11089777|FG000|COMPLETED|Overall Study||43
9969209|NCT01525420|11089778|FG001|COMPLETED|Overall Study||38
9969210|NCT01525420|11089777|FG000|NOT COMPLETED|Overall Study||16
9969211|NCT01525420|11089778|FG001|NOT COMPLETED|Overall Study||24
9969212|NCT01525550|11089786|FG000|STARTED|Overall Study||61
9969213|NCT01525550|11089787|FG001|STARTED|Overall Study||45
9969214|NCT01525550|11089786|FG000|COMPLETED|Overall Study||0
9969215|NCT01525550|11089787|FG001|COMPLETED|Overall Study||0
9969216|NCT01525550|11089786|FG000|NOT COMPLETED|Overall Study||61
9969217|NCT01525550|11089787|FG001|NOT COMPLETED|Overall Study||45
9969218|NCT01525563|11089793|FG000|STARTED|Overall Study||1000
9969219|NCT01525563|11089793|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
9969220|NCT01525563|11089793|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
9969221|NCT01525563|11089793|FG000|COMPLETED|Overall Study|6 Months Follow-up|788
9969222|NCT01525563|11089793|FG000|NOT COMPLETED|Overall Study||212
9969223|NCT01525589|11089800|FG000|STARTED|Overall Study||56
9969224|NCT01525589|11089801|FG001|STARTED|Overall Study||20
9969225|NCT01525589|11089802|FG002|STARTED|Overall Study||35
9969226|NCT01525589|11089800|FG000|COMPLETED|Overall Study||0
9969227|NCT01525589|11089801|FG001|COMPLETED|Overall Study||0
9969228|NCT01525589|11089802|FG002|COMPLETED|Overall Study||0
9969229|NCT01525589|11089800|FG000|NOT COMPLETED|Overall Study||56
9969230|NCT01525589|11089801|FG001|NOT COMPLETED|Overall Study||20
9969231|NCT01525589|11089802|FG002|NOT COMPLETED|Overall Study||35
9969232|NCT01525602|11089818|FG000|STARTED|Overall Study||9
9969233|NCT01525602|11089819|FG001|STARTED|Overall Study||3
9969234|NCT01525602|11089820|FG002|STARTED|Overall Study||3
9969235|NCT01525602|11089821|FG003|STARTED|Overall Study||6
9969236|NCT01525602|11089822|FG004|STARTED|Overall Study||33
9969237|NCT01525602|11089823|FG005|STARTED|Overall Study||7
9969238|NCT01525602|11089824|FG006|STARTED|Overall Study||6
9969239|NCT01525602|11089825|FG007|STARTED|Overall Study||7
9969240|NCT01525602|11089818|FG000|COMPLETED|Overall Study||0
9969241|NCT01525602|11089819|FG001|COMPLETED|Overall Study||0
9969242|NCT01525602|11089820|FG002|COMPLETED|Overall Study||0
9969243|NCT01525602|11089821|FG003|COMPLETED|Overall Study||0
9969244|NCT01525602|11089822|FG004|COMPLETED|Overall Study||0
9969245|NCT01525602|11089823|FG005|COMPLETED|Overall Study||0
9969246|NCT01525602|11089824|FG006|COMPLETED|Overall Study||0
9969247|NCT01525602|11089825|FG007|COMPLETED|Overall Study||0
9969248|NCT01525602|11089818|FG000|NOT COMPLETED|Overall Study||9
9969249|NCT01525602|11089819|FG001|NOT COMPLETED|Overall Study||3
9969250|NCT01525602|11089820|FG002|NOT COMPLETED|Overall Study||3
9969251|NCT01525602|11089821|FG003|NOT COMPLETED|Overall Study||6
9969252|NCT01525602|11089822|FG004|NOT COMPLETED|Overall Study||33
9969253|NCT01525602|11089823|FG005|NOT COMPLETED|Overall Study||7
9969254|NCT01525602|11089824|FG006|NOT COMPLETED|Overall Study||6
9969255|NCT01525602|11089825|FG007|NOT COMPLETED|Overall Study||7
9969256|NCT01525615|11089853|FG000|STARTED|Overall Study||132
9969257|NCT01525615|11089854|FG001|STARTED|Overall Study||133
9969258|NCT01525615|11089855|FG002|STARTED|Overall Study||139
9969259|NCT01525615|11089853|FG000|COMPLETED|Overall Study||118
9969260|NCT01525615|11089854|FG001|COMPLETED|Overall Study||126
10097577|NCT02376361|11226570|FG000|NOT COMPLETED|Overall Study||171
10097578|NCT02376361|11226571|FG001|NOT COMPLETED|Overall Study||117
10097579|NCT02376530|11226581|FG000|STARTED|Overall Study||196
9969261|NCT01525615|11089855|FG002|COMPLETED|Overall Study||133
9969262|NCT01525615|11089853|FG000|NOT COMPLETED|Overall Study||14
9969263|NCT01525615|11089854|FG001|NOT COMPLETED|Overall Study||7
9969264|NCT01525615|11089855|FG002|NOT COMPLETED|Overall Study||6
9969265|NCT01525628|11089868|FG000|STARTED|Overall Study||16
9969266|NCT01525628|11089869|FG001|STARTED|Overall Study||19
9969267|NCT01525628|11089870|FG002|STARTED|Overall Study||16
9969268|NCT01525628|11089871|FG003|STARTED|Overall Study||14
10097580|NCT02376530|11226582|FG001|STARTED|Overall Study||198
10097581|NCT02376530|11226583|FG002|STARTED|Overall Study||197
10097582|NCT02376530|11226584|FG003|STARTED|Overall Study||197
10097583|NCT02376530|11226581|FG000|COMPLETED|Overall Study||196
10097584|NCT02376530|11226582|FG001|COMPLETED|Overall Study||198
10097585|NCT02376530|11226583|FG002|COMPLETED|Overall Study||197
10097586|NCT02376530|11226584|FG003|COMPLETED|Overall Study||197
10097587|NCT02376530|11226581|FG000|NOT COMPLETED|Overall Study||0
10097588|NCT02376530|11226582|FG001|NOT COMPLETED|Overall Study||0
10097589|NCT02376530|11226583|FG002|NOT COMPLETED|Overall Study||0
10097590|NCT02376530|11226584|FG003|NOT COMPLETED|Overall Study||0
10097591|NCT02376790|11226597|FG000|STARTED|Overall Study||284
10097592|NCT02376790|11226598|FG001|STARTED|Overall Study||284
10097593|NCT02376790|11226599|FG002|STARTED|Overall Study||283
10097594|NCT02376790|11226597|FG000|Received Treatment|Overall Study||282
10097595|NCT02376790|11226598|FG001|Received Treatment|Overall Study||284
10097596|NCT02376790|11226599|FG002|Received Treatment|Overall Study||282
10097597|NCT02376790|11226597|FG000|COMPLETED|Overall Study||224
10097598|NCT02376790|11226598|FG001|COMPLETED|Overall Study||237
9969269|NCT01525628|11089872|FG004|STARTED|Overall Study||7
9969270|NCT01525628|11089868|FG000|COMPLETED|Overall Study||14
9969271|NCT01525628|11089869|FG001|COMPLETED|Overall Study||14
9969272|NCT01525628|11089870|FG002|COMPLETED|Overall Study||11
9969273|NCT01525628|11089871|FG003|COMPLETED|Overall Study||10
9969274|NCT01525628|11089872|FG004|COMPLETED|Overall Study||4
10097599|NCT02376790|11226599|FG002|COMPLETED|Overall Study||230
9969275|NCT01525628|11089868|FG000|NOT COMPLETED|Overall Study||2
9969276|NCT01525628|11089869|FG001|NOT COMPLETED|Overall Study||5
9969277|NCT01525628|11089870|FG002|NOT COMPLETED|Overall Study||5
9969278|NCT01525628|11089871|FG003|NOT COMPLETED|Overall Study||4
9969279|NCT01525628|11089872|FG004|NOT COMPLETED|Overall Study||3
9969280|NCT01525641|11089886|FG000|STARTED|Overall Study||615
9969281|NCT01525641|11089886|FG000|COMPLETED|Overall Study||435
9969282|NCT01525641|11089886|FG000|NOT COMPLETED|Overall Study||180
9969283|NCT01525667|11089893|FG000|STARTED|Overall Study||7
9969284|NCT01525667|11089894|FG001|STARTED|Overall Study||6
9969285|NCT01525667|11089895|FG002|STARTED|Overall Study||7
9969286|NCT01525667|11089893|FG000|COMPLETED|Overall Study||7
9969287|NCT01525667|11089894|FG001|COMPLETED|Overall Study||6
9969288|NCT01525667|11089895|FG002|COMPLETED|Overall Study||7
9969289|NCT01525667|11089893|FG000|NOT COMPLETED|Overall Study||0
9969290|NCT01525667|11089894|FG001|NOT COMPLETED|Overall Study||0
9969291|NCT01525667|11089895|FG002|NOT COMPLETED|Overall Study||0
9969292|NCT01525849|11089907|FG000|STARTED|Overall Study||76
9969293|NCT01525849|11089908|FG001|STARTED|Overall Study||75
9969294|NCT01525849|11089907|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
9969295|NCT01525849|11089908|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
9969296|NCT01525849|11089907|FG000|6-Months|Overall Study||73
9969297|NCT01525849|11089908|FG001|6-Months|Overall Study||60
9969298|NCT01525849|11089907|FG000|COMPLETED|Overall Study||71
9969299|NCT01525849|11089908|FG001|COMPLETED|Overall Study||59
9969300|NCT01525849|11089907|FG000|NOT COMPLETED|Overall Study||5
9969301|NCT01525849|11089908|FG001|NOT COMPLETED|Overall Study||16
9969302|NCT01525862|11089914|FG000|STARTED|Overall Study||21
9969303|NCT01525862|11089914|FG000|COMPLETED|Overall Study||21
9969304|NCT01525862|11089914|FG000|NOT COMPLETED|Overall Study||0
9969305|NCT01525875|11089920|FG000|STARTED|Placebo-controlled Period||22
9969306|NCT01525875|11089921|FG001|STARTED|Placebo-controlled Period||22
9969307|NCT01525875|11089920|FG000|COMPLETED|Placebo-controlled Period||21
9969308|NCT01525875|11089921|FG001|COMPLETED|Placebo-controlled Period||20
9969309|NCT01525875|11089920|FG000|NOT COMPLETED|Placebo-controlled Period||1
9969310|NCT01525875|11089921|FG001|NOT COMPLETED|Placebo-controlled Period||2
9969311|NCT01525875|11089920|FG000|STARTED|Open-label Period||21
9969312|NCT01525875|11089921|FG001|STARTED|Open-label Period||20
9969313|NCT01525875|11089920|FG000|COMPLETED|Open-label Period||21
9969314|NCT01525875|11089921|FG001|COMPLETED|Open-label Period||18
9969315|NCT01525875|11089920|FG000|NOT COMPLETED|Open-label Period||0
9969316|NCT01525875|11089921|FG001|NOT COMPLETED|Open-label Period||2
9969317|NCT01526057|11089930|FG000|STARTED|Overall Study||73
9969318|NCT01526057|11089931|FG001|STARTED|Overall Study||74
9969319|NCT01526057|11089932|FG002|STARTED|Overall Study||73
9969320|NCT01526057|11089930|FG000|COMPLETED|Overall Study||64
9969321|NCT01526057|11089931|FG001|COMPLETED|Overall Study||71
9969322|NCT01526057|11089932|FG002|COMPLETED|Overall Study||67
9969323|NCT01526057|11089930|FG000|NOT COMPLETED|Overall Study||9
9969324|NCT01526057|11089931|FG001|NOT COMPLETED|Overall Study||3
9969325|NCT01526057|11089932|FG002|NOT COMPLETED|Overall Study||6
9969326|NCT01526148|11089942|FG000|STARTED|Overall Study||18
9969327|NCT01526148|11089943|FG001|STARTED|Overall Study||24
9969328|NCT01526148|11089942|FG000|COMPLETED|Overall Study||4
9969329|NCT01526148|11089943|FG001|COMPLETED|Overall Study||11
9969330|NCT01526148|11089942|FG000|NOT COMPLETED|Overall Study||14
9969331|NCT01526148|11089943|FG001|NOT COMPLETED|Overall Study||13
9969332|NCT01526213|11089955|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969333|NCT01526213|11089956|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969334|NCT01526213|11089957|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969335|NCT01526213|11089958|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969336|NCT01526213|11089959|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969337|NCT01526213|11089960|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
9969338|NCT01526213|11089955|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969339|NCT01526213|11089956|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969340|NCT01526213|11089957|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969341|NCT01526213|11089958|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969342|NCT01526213|11089959|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969343|NCT01526213|11089960|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969344|NCT01526213|11089955|FG000|NOT COMPLETED|Period 1 (5 Days)||0
9969345|NCT01526213|11089956|FG001|NOT COMPLETED|Period 1 (5 Days)||0
9969346|NCT01526213|11089957|FG002|NOT COMPLETED|Period 1 (5 Days)||0
9969347|NCT01526213|11089958|FG003|NOT COMPLETED|Period 1 (5 Days)||0
9969348|NCT01526213|11089959|FG004|NOT COMPLETED|Period 1 (5 Days)||0
9969349|NCT01526213|11089960|FG005|NOT COMPLETED|Period 1 (5 Days)||0
9969350|NCT01526213|11089955|FG000|STARTED|Washout 1 (10 Days)||3
9969351|NCT01526213|11089956|FG001|STARTED|Washout 1 (10 Days)||3
9969352|NCT01526213|11089957|FG002|STARTED|Washout 1 (10 Days)||3
9969353|NCT01526213|11089958|FG003|STARTED|Washout 1 (10 Days)||3
9969354|NCT01526213|11089959|FG004|STARTED|Washout 1 (10 Days)||3
9969355|NCT01526213|11089960|FG005|STARTED|Washout 1 (10 Days)||3
9969356|NCT01526213|11089955|FG000|COMPLETED|Washout 1 (10 Days)||3
9969357|NCT01526213|11089956|FG001|COMPLETED|Washout 1 (10 Days)||3
9969358|NCT01526213|11089957|FG002|COMPLETED|Washout 1 (10 Days)||3
9969359|NCT01526213|11089958|FG003|COMPLETED|Washout 1 (10 Days)||3
9969360|NCT01526213|11089959|FG004|COMPLETED|Washout 1 (10 Days)||3
9969361|NCT01526213|11089960|FG005|COMPLETED|Washout 1 (10 Days)||3
9969362|NCT01526213|11089955|FG000|NOT COMPLETED|Washout 1 (10 Days)||0
9969363|NCT01526213|11089956|FG001|NOT COMPLETED|Washout 1 (10 Days)||0
9969364|NCT01526213|11089957|FG002|NOT COMPLETED|Washout 1 (10 Days)||0
9969365|NCT01526213|11089958|FG003|NOT COMPLETED|Washout 1 (10 Days)||0
9969366|NCT01526213|11089959|FG004|NOT COMPLETED|Washout 1 (10 Days)||0
9969367|NCT01526213|11089960|FG005|NOT COMPLETED|Washout 1 (10 Days)||0
9969368|NCT01526213|11089955|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969369|NCT01526213|11089956|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969370|NCT01526213|11089957|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969371|NCT01526213|11089958|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969372|NCT01526213|11089959|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969373|NCT01526213|11089960|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969374|NCT01526213|11089955|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969375|NCT01526213|11089956|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969376|NCT01526213|11089957|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
9969377|NCT01526213|11089958|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
9969378|NCT01526213|11089959|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
9969379|NCT01526213|11089960|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
9969380|NCT01526213|11089955|FG000|NOT COMPLETED|Period 2 (5 Days)||0
9969381|NCT01526213|11089956|FG001|NOT COMPLETED|Period 2 (5 Days)||0
9969382|NCT01526213|11089957|FG002|NOT COMPLETED|Period 2 (5 Days)||0
9969383|NCT01526213|11089958|FG003|NOT COMPLETED|Period 2 (5 Days)||0
9969384|NCT01526213|11089959|FG004|NOT COMPLETED|Period 2 (5 Days)||0
9969385|NCT01526213|11089960|FG005|NOT COMPLETED|Period 2 (5 Days)||0
9969386|NCT01526213|11089955|FG000|STARTED|Washout 2 (10 Days)||3
9969387|NCT01526213|11089956|FG001|STARTED|Washout 2 (10 Days)||3
9969388|NCT01526213|11089957|FG002|STARTED|Washout 2 (10 Days)||3
9969389|NCT01526213|11089958|FG003|STARTED|Washout 2 (10 Days)||3
9969390|NCT01526213|11089959|FG004|STARTED|Washout 2 (10 Days)||3
9969391|NCT01526213|11089960|FG005|STARTED|Washout 2 (10 Days)||3
9969392|NCT01526213|11089955|FG000|COMPLETED|Washout 2 (10 Days)||3
9969393|NCT01526213|11089956|FG001|COMPLETED|Washout 2 (10 Days)||3
9969394|NCT01526213|11089957|FG002|COMPLETED|Washout 2 (10 Days)||3
9969395|NCT01526213|11089958|FG003|COMPLETED|Washout 2 (10 Days)||3
9969396|NCT01526213|11089959|FG004|COMPLETED|Washout 2 (10 Days)||3
9969397|NCT01526213|11089960|FG005|COMPLETED|Washout 2 (10 Days)||3
9969398|NCT01526213|11089955|FG000|NOT COMPLETED|Washout 2 (10 Days)||0
9969399|NCT01526213|11089956|FG001|NOT COMPLETED|Washout 2 (10 Days)||0
9969400|NCT01526213|11089957|FG002|NOT COMPLETED|Washout 2 (10 Days)||0
9969401|NCT01526213|11089958|FG003|NOT COMPLETED|Washout 2 (10 Days)||0
9969402|NCT01526213|11089959|FG004|NOT COMPLETED|Washout 2 (10 Days)||0
9969403|NCT01526213|11089960|FG005|NOT COMPLETED|Washout 2 (10 Days)||0
9969404|NCT01526213|11089955|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969405|NCT01526213|11089956|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969406|NCT01526213|11089957|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969407|NCT01526213|11089958|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969408|NCT01526213|11089959|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969409|NCT01526213|11089960|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
9969410|NCT01526213|11089955|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969411|NCT01526213|11089956|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969412|NCT01526213|11089957|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969413|NCT01526213|11089958|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969414|NCT01526213|11089959|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969415|NCT01526213|11089960|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
9969416|NCT01526213|11089955|FG000|NOT COMPLETED|Period 3 (5 Days)||0
9969417|NCT01526213|11089956|FG001|NOT COMPLETED|Period 3 (5 Days)||0
9969418|NCT01526213|11089957|FG002|NOT COMPLETED|Period 3 (5 Days)||0
9969419|NCT01526213|11089958|FG003|NOT COMPLETED|Period 3 (5 Days)||0
9758676|NCT01996449|10862236|FG001|COMPLETED|Period 2: Second Drug||8
9969420|NCT01526213|11089959|FG004|NOT COMPLETED|Period 3 (5 Days)||0
9969421|NCT01526213|11089960|FG005|NOT COMPLETED|Period 3 (5 Days)||0
9969422|NCT01526343|11089971|FG000|STARTED|Overall Study||47
9969423|NCT01526343|11089971|FG000|COMPLETED|Overall Study||47
9969424|NCT01526343|11089971|FG000|NOT COMPLETED|Overall Study||0
9969425|NCT01526356|11089978|FG000|STARTED|Overall Study||59
9969426|NCT01526356|11089979|FG001|STARTED|Overall Study||63
9969427|NCT01526356|11089980|FG002|STARTED|Overall Study||57
9969428|NCT01526356|11089978|FG000|COMPLETED|Overall Study||51
9969429|NCT01526356|11089979|FG001|COMPLETED|Overall Study||53
9969430|NCT01526356|11089980|FG002|COMPLETED|Overall Study||45
9969431|NCT01526356|11089978|FG000|NOT COMPLETED|Overall Study||8
9969432|NCT01526356|11089979|FG001|NOT COMPLETED|Overall Study||10
9969433|NCT01526356|11089980|FG002|NOT COMPLETED|Overall Study||12
9969434|NCT01526538|11089992|FG000|STARTED|Overall Study||30
9969435|NCT01526538|11089993|FG001|STARTED|Overall Study||22
9969436|NCT01526538|11089992|FG000|COMPLETED|Overall Study||21
9969437|NCT01526538|11089993|FG001|COMPLETED|Overall Study||18
9969438|NCT01526538|11089992|FG000|NOT COMPLETED|Overall Study||9
9969439|NCT01526538|11089993|FG001|NOT COMPLETED|Overall Study||4
9969440|NCT01526551|11090001|FG000|STARTED|Overall Study||935
9969441|NCT01526551|11090001|FG000|COMPLETED|Overall Study||511
9969442|NCT01526551|11090001|FG000|NOT COMPLETED|Overall Study||424
9969443|NCT01526577|11090010|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
9969444|NCT01526577|11090011|FG001|STARTED|Overall Study||12
9969445|NCT01526577|11090012|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
9969446|NCT01526577|11090013|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
9969447|NCT01526577|11090014|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
9969448|NCT01526577|11090010|FG000|COMPLETED|Overall Study||48
9969449|NCT01526577|11090011|FG001|COMPLETED|Overall Study||12
10097600|NCT02376790|11226597|FG000|NOT COMPLETED|Overall Study||60
10097601|NCT02376790|11226598|FG001|NOT COMPLETED|Overall Study||47
10097602|NCT02376790|11226599|FG002|NOT COMPLETED|Overall Study||53
10097603|NCT02376998|11226607|FG000|STARTED|Overall Study||20
10097604|NCT02376998|11226607|FG000|COMPLETED|Overall Study||11
10097605|NCT02376998|11226607|FG000|NOT COMPLETED|Overall Study||9
10097606|NCT02377063|11226611|FG000|STARTED|Overall Study||25
10097607|NCT02377063|11226611|FG000|COMPLETED|Overall Study||20
10097608|NCT02377063|11226611|FG000|NOT COMPLETED|Overall Study||5
10097609|NCT02377349|11226617|FG000|STARTED|Overall Study||341
10097610|NCT02377349|11226618|FG001|STARTED|Overall Study||346
10097611|NCT02377349|11226617|FG000|COMPLETED|Overall Study||325
10097612|NCT02377349|11226618|FG001|COMPLETED|Overall Study||335
10097613|NCT02377349|11226617|FG000|NOT COMPLETED|Overall Study||16
10097614|NCT02377349|11226618|FG001|NOT COMPLETED|Overall Study||11
10097615|NCT02377362|11226646|FG000|STARTED|Part A First Treatment||4
10201994|NCT03441984|11329280|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10201995|NCT03441984|11329281|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10201996|NCT03441984|11329282|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10201997|NCT03441984|11329283|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10201998|NCT03441984|11329284|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10201999|NCT03441984|11329285|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202000|NCT03441984|11329286|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202001|NCT03441984|11329287|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202002|NCT03441984|11329276|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202003|NCT03441984|11329277|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202004|NCT03441984|11329278|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202005|NCT03441984|11329279|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202006|NCT03441984|11329280|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202007|NCT03441984|11329281|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202008|NCT03441984|11329282|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202009|NCT03441984|11329283|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202010|NCT03441984|11329284|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202011|NCT03441984|11329285|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9758677|NCT01996449|10862235|FG000|NOT COMPLETED|Period 2: Second Drug||0
9758678|NCT01996449|10862236|FG001|NOT COMPLETED|Period 2: Second Drug||0
9758679|NCT01927419|10862246|FG000|STARTED|Pre-Treatment Period||95
9758680|NCT01927419|10862247|FG001|STARTED|Pre-Treatment Period||47
9758681|NCT01927419|10862246|FG000|COMPLETED|Pre-Treatment Period||94
10097616|NCT02377362|11226647|FG001|STARTED|Part A First Treatment||4
10097617|NCT02377362|11226648|FG002|STARTED|Part A First Treatment||4
10097618|NCT02377362|11226649|FG003|STARTED|Part A First Treatment||4
10097619|NCT02377362|11226650|FG004|STARTED|Part A First Treatment||4
10097620|NCT02377362|11226651|FG005|STARTED|Part A First Treatment||4
10097621|NCT02377362|11226652|FG006|STARTED|Part A First Treatment||0
10097622|NCT02377362|11226653|FG007|STARTED|Part A First Treatment||0
10097623|NCT02377362|11226654|FG008|STARTED|Part A First Treatment||0
10097624|NCT02377362|11226655|FG009|STARTED|Part A First Treatment||0
10097625|NCT02377362|11226656|FG010|STARTED|Part A First Treatment||0
10097626|NCT02377362|11226657|FG011|STARTED|Part A First Treatment||0
10097627|NCT02377362|11226658|FG012|STARTED|Part A First Treatment||0
9969450|NCT01526577|11090012|FG002|COMPLETED|Overall Study||32
9969451|NCT01526577|11090013|FG003|COMPLETED|Overall Study||8
9969452|NCT01526577|11090014|FG004|COMPLETED|Overall Study||8
9969453|NCT01526577|11090010|FG000|NOT COMPLETED|Overall Study||1
9969454|NCT01526577|11090011|FG001|NOT COMPLETED|Overall Study||0
9969455|NCT01526577|11090012|FG002|NOT COMPLETED|Overall Study||1
9969456|NCT01526577|11090013|FG003|NOT COMPLETED|Overall Study||1
9969457|NCT01526577|11090014|FG004|NOT COMPLETED|Overall Study||2
9969458|NCT01526629|11090022|FG000|STARTED|Overall Study||354
9969459|NCT01526629|11090022|FG000|COMPLETED|Overall Study||308
9969460|NCT01526629|11090022|FG000|NOT COMPLETED|Overall Study||46
9969461|NCT01526733|11090026|FG000|STARTED|Phase 1||12
9969462|NCT01526733|11090027|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
9969463|NCT01526733|11090026|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12
9969464|NCT01526733|11090027|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13
9969465|NCT01526733|11090026|FG000|COMPLETED|Phase 1||10
9969466|NCT01526733|11090027|FG001|COMPLETED|Phase 1||12
9969467|NCT01526733|11090026|FG000|NOT COMPLETED|Phase 1||2
9969468|NCT01526733|11090027|FG001|NOT COMPLETED|Phase 1||1
9969469|NCT01526733|11090026|FG000|STARTED|Washout Period of 5 to 21 Days||10
9969470|NCT01526733|11090027|FG001|STARTED|Washout Period of 5 to 21 Days||12
9969471|NCT01526733|11090026|FG000|COMPLETED|Washout Period of 5 to 21 Days||10
9969472|NCT01526733|11090027|FG001|COMPLETED|Washout Period of 5 to 21 Days||12
9969473|NCT01526733|11090026|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0
9969474|NCT01526733|11090027|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0
9969475|NCT01526733|11090026|FG000|STARTED|Phase 2||10
9969476|NCT01526733|11090027|FG001|STARTED|Phase 2||12
9969477|NCT01526733|11090026|FG000|COMPLETED|Phase 2||10
9969478|NCT01526733|11090027|FG001|COMPLETED|Phase 2||12
9969479|NCT01526733|11090026|FG000|NOT COMPLETED|Phase 2||0
9969480|NCT01526733|11090027|FG001|NOT COMPLETED|Phase 2||0
9969481|NCT01526785|11090034|FG000|STARTED|Overall Study||113
9969482|NCT01526785|11090034|FG000|COMPLETED|Overall Study||100
9969483|NCT01526785|11090034|FG000|NOT COMPLETED|Overall Study||13
9969484|NCT01526889|11090040|FG000|STARTED|Treatment Period||18
9969485|NCT01526889|11090041|FG001|STARTED|Treatment Period||7
9969486|NCT01526889|11090040|FG000|COMPLETED|Treatment Period||16
9969487|NCT01526889|11090041|FG001|COMPLETED|Treatment Period||7
9969488|NCT01526889|11090040|FG000|NOT COMPLETED|Treatment Period||2
9969489|NCT01526889|11090041|FG001|NOT COMPLETED|Treatment Period||0
9969490|NCT01526889|11090040|FG000|STARTED|Treatment Extension Period||5
9969491|NCT01526889|11090041|FG001|STARTED|Treatment Extension Period||0
9969492|NCT01526889|11090040|FG000|COMPLETED|Treatment Extension Period||4
9969493|NCT01526889|11090041|FG001|COMPLETED|Treatment Extension Period||0
9969494|NCT01526889|11090040|FG000|NOT COMPLETED|Treatment Extension Period||1
9969495|NCT01526889|11090041|FG001|NOT COMPLETED|Treatment Extension Period||0
9969496|NCT01526902|11090047|FG000|STARTED|Overall Study||25
9969497|NCT01526902|11090048|FG001|STARTED|Overall Study||24
9969498|NCT01526902|11090047|FG000|COMPLETED|Overall Study||25
9969499|NCT01526902|11090048|FG001|COMPLETED|Overall Study||24
9969500|NCT01526902|11090047|FG000|NOT COMPLETED|Overall Study||0
9969501|NCT01526902|11090048|FG001|NOT COMPLETED|Overall Study||0
9969502|NCT01526928|11090060|FG000|STARTED|Overall Study||38
9969503|NCT01526928|11090061|FG001|STARTED|Overall Study||19
9969504|NCT01526928|11090062|FG002|STARTED|Overall Study||209
9969505|NCT01526928|11090063|FG003|STARTED|Overall Study||245
9969506|NCT01526928|11090064|FG004|STARTED|Overall Study||95
9969507|NCT01526928|11090065|FG005|STARTED|Overall Study||6
9969508|NCT01526928|11090060|FG000|Started Phase 1|Overall Study||38
9969509|NCT01526928|11090061|FG001|Started Phase 1|Overall Study||19
9969510|NCT01526928|11090062|FG002|Started Phase 1|Overall Study||18
9969511|NCT01526928|11090063|FG003|Started Phase 1|Overall Study||17
9969512|NCT01526928|11090064|FG004|Started Phase 1|Overall Study||13
9969513|NCT01526928|11090065|FG005|Started Phase 1|Overall Study||6
9969514|NCT01526928|11090060|FG000|Started Phase 2|Overall Study||0
9969515|NCT01526928|11090061|FG001|Started Phase 2|Overall Study||0
9969516|NCT01526928|11090062|FG002|Started Phase 2|Overall Study||191
9969517|NCT01526928|11090063|FG003|Started Phase 2|Overall Study||228
9969518|NCT01526928|11090064|FG004|Started Phase 2|Overall Study||82
9969519|NCT01526928|11090065|FG005|Started Phase 2|Overall Study||0
9969520|NCT01526928|11090060|FG000|COMPLETED|Overall Study||0
9969521|NCT01526928|11090061|FG001|COMPLETED|Overall Study||0
9969522|NCT01526928|11090062|FG002|COMPLETED|Overall Study||0
9969523|NCT01526928|11090063|FG003|COMPLETED|Overall Study||0
9969524|NCT01526928|11090064|FG004|COMPLETED|Overall Study||0
9969525|NCT01526928|11090065|FG005|COMPLETED|Overall Study||0
9969526|NCT01526928|11090060|FG000|NOT COMPLETED|Overall Study||38
9969527|NCT01526928|11090061|FG001|NOT COMPLETED|Overall Study||19
9969528|NCT01526928|11090062|FG002|NOT COMPLETED|Overall Study||209
9969529|NCT01526928|11090063|FG003|NOT COMPLETED|Overall Study||245
9969530|NCT01526928|11090064|FG004|NOT COMPLETED|Overall Study||95
9969531|NCT01526928|11090065|FG005|NOT COMPLETED|Overall Study||6
9969532|NCT01527006|11090123|FG000|STARTED|Core Study||22
9969533|NCT01527006|11090124|FG001|STARTED|Core Study||28
9969534|NCT01527006|11090123|FG000|COMPLETED|Core Study||20
9969535|NCT01527006|11090124|FG001|COMPLETED|Core Study||22
9969536|NCT01527006|11090123|FG000|NOT COMPLETED|Core Study||2
9969537|NCT01527006|11090124|FG001|NOT COMPLETED|Core Study||6
9969538|NCT01527006|11090123|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
9969539|NCT01527006|11090124|FG001|STARTED|Extension Phase||22
9969540|NCT01527006|11090123|FG000|COMPLETED|Extension Phase||13
9969541|NCT01527006|11090124|FG001|COMPLETED|Extension Phase||14
9969542|NCT01527006|11090123|FG000|NOT COMPLETED|Extension Phase||6
9969543|NCT01527006|11090124|FG001|NOT COMPLETED|Extension Phase||8
9969544|NCT01527045|11090139|FG000|STARTED|Overall Study||30
9969545|NCT01527045|11090140|FG001|STARTED|Overall Study||5
9969546|NCT01527045|11090141|FG002|STARTED|Overall Study||12
9969547|NCT01527045|11090139|FG000|COMPLETED|Overall Study||29
9969548|NCT01527045|11090140|FG001|COMPLETED|Overall Study||5
9969549|NCT01527045|11090141|FG002|COMPLETED|Overall Study||12
9969550|NCT01527045|11090139|FG000|NOT COMPLETED|Overall Study||1
9969551|NCT01527045|11090140|FG001|NOT COMPLETED|Overall Study||0
9969552|NCT01527045|11090141|FG002|NOT COMPLETED|Overall Study||0
9969553|NCT01527110|11090149|FG000|STARTED|Overall Study||21
9969554|NCT01527110|11090149|FG000|COMPLETED|Overall Study||20
9969555|NCT01527110|11090149|FG000|NOT COMPLETED|Overall Study||1
9969556|NCT01527162|11090153|FG000|STARTED|Overall Study||6
9969557|NCT01527162|11090154|FG001|STARTED|Overall Study||5
9969558|NCT01527162|11090153|FG000|COMPLETED|Overall Study||6
9969559|NCT01527162|11090154|FG001|COMPLETED|Overall Study||5
9969560|NCT01527162|11090153|FG000|NOT COMPLETED|Overall Study||0
9969561|NCT01527162|11090154|FG001|NOT COMPLETED|Overall Study||0
9969562|NCT01527357|11090164|FG000|STARTED|Overall Study||482
9969563|NCT01527357|11090165|FG001|STARTED|Overall Study||239
9969564|NCT01527357|11090164|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
9969565|NCT01527357|11090165|FG001|Efficacy Population|Overall Study||239
9969566|NCT01527357|11090164|FG000|COMPLETED|Overall Study||465
9969567|NCT01527357|11090165|FG001|COMPLETED|Overall Study||230
9969568|NCT01527357|11090164|FG000|NOT COMPLETED|Overall Study||17
9969569|NCT01527357|11090165|FG001|NOT COMPLETED|Overall Study||9
9969570|NCT01527370|11090171|FG000|STARTED|Overall Study||250
9969571|NCT01527370|11090171|FG000|COMPLETED|Overall Study||244
9969572|NCT01527370|11090171|FG000|NOT COMPLETED|Overall Study||6
9969573|NCT01527383|11090177|FG000|STARTED|Overall Study||292
9969574|NCT01527383|11090178|FG001|STARTED|Overall Study||62
9969575|NCT01527383|11090177|FG000|Vaccination 1 (Day 1)|Overall Study||291
9969576|NCT01527383|11090178|FG001|Vaccination 1 (Day 1)|Overall Study||62
9969577|NCT01527383|11090177|FG000|Vaccination 2 (~Day 30)|Overall Study||283
9969578|NCT01527383|11090178|FG001|Vaccination 2 (~Day 30)|Overall Study||61
9969579|NCT01527383|11090177|FG000|Vaccination 3 (~Day 60)|Overall Study||278
10097628|NCT02377362|11226646|FG000|COMPLETED|Part A First Treatment||4
10097629|NCT02377362|11226647|FG001|COMPLETED|Part A First Treatment||4
10097630|NCT02377362|11226648|FG002|COMPLETED|Part A First Treatment||4
10097631|NCT02377362|11226649|FG003|COMPLETED|Part A First Treatment||4
10097632|NCT02377362|11226650|FG004|COMPLETED|Part A First Treatment||4
10097633|NCT02377362|11226651|FG005|COMPLETED|Part A First Treatment||4
10097634|NCT02377362|11226652|FG006|COMPLETED|Part A First Treatment||0
10097635|NCT02377362|11226653|FG007|COMPLETED|Part A First Treatment||0
10097636|NCT02377362|11226654|FG008|COMPLETED|Part A First Treatment||0
10097637|NCT02377362|11226655|FG009|COMPLETED|Part A First Treatment||0
10097638|NCT02377362|11226656|FG010|COMPLETED|Part A First Treatment||0
10097639|NCT02377362|11226657|FG011|COMPLETED|Part A First Treatment||0
10097640|NCT02377362|11226658|FG012|COMPLETED|Part A First Treatment||0
10097641|NCT02377362|11226646|FG000|NOT COMPLETED|Part A First Treatment||0
10097642|NCT02377362|11226647|FG001|NOT COMPLETED|Part A First Treatment||0
10097643|NCT02377362|11226648|FG002|NOT COMPLETED|Part A First Treatment||0
10097644|NCT02377362|11226649|FG003|NOT COMPLETED|Part A First Treatment||0
10097645|NCT02377362|11226650|FG004|NOT COMPLETED|Part A First Treatment||0
10097646|NCT02377362|11226651|FG005|NOT COMPLETED|Part A First Treatment||0
10097647|NCT02377362|11226652|FG006|NOT COMPLETED|Part A First Treatment||0
10097648|NCT02377362|11226653|FG007|NOT COMPLETED|Part A First Treatment||0
10097649|NCT02377362|11226654|FG008|NOT COMPLETED|Part A First Treatment||0
10097650|NCT02377362|11226655|FG009|NOT COMPLETED|Part A First Treatment||0
10097651|NCT02377362|11226656|FG010|NOT COMPLETED|Part A First Treatment||0
10097652|NCT02377362|11226657|FG011|NOT COMPLETED|Part A First Treatment||0
10097653|NCT02377362|11226658|FG012|NOT COMPLETED|Part A First Treatment||0
9969580|NCT01527383|11090178|FG001|Vaccination 3 (~Day 60)|Overall Study||58
9969581|NCT01527383|11090177|FG000|Vaccination 4 (~Day 90)|Overall Study||277
9969582|NCT01527383|11090178|FG001|Vaccination 4 (~Day 90)|Overall Study||58
9969583|NCT01527383|11090177|FG000|COMPLETED|Overall Study||277
9969584|NCT01527383|11090178|FG001|COMPLETED|Overall Study||58
9969585|NCT01527383|11090177|FG000|NOT COMPLETED|Overall Study||15
10097654|NCT02377362|11226646|FG000|STARTED|Part A Second Treatment||4
10097655|NCT02377362|11226647|FG001|STARTED|Part A Second Treatment||4
10097656|NCT02377362|11226648|FG002|STARTED|Part A Second Treatment||4
10097657|NCT02377362|11226649|FG003|STARTED|Part A Second Treatment||4
10097658|NCT02377362|11226650|FG004|STARTED|Part A Second Treatment||4
10097659|NCT02377362|11226651|FG005|STARTED|Part A Second Treatment||4
10097660|NCT02377362|11226652|FG006|STARTED|Part A Second Treatment||0
10097661|NCT02377362|11226653|FG007|STARTED|Part A Second Treatment||0
10097662|NCT02377362|11226654|FG008|STARTED|Part A Second Treatment||0
10097663|NCT02377362|11226655|FG009|STARTED|Part A Second Treatment||0
10097664|NCT02377362|11226656|FG010|STARTED|Part A Second Treatment||0
10097665|NCT02377362|11226657|FG011|STARTED|Part A Second Treatment||0
10097666|NCT02377362|11226658|FG012|STARTED|Part A Second Treatment||0
10097667|NCT02377362|11226646|FG000|COMPLETED|Part A Second Treatment||4
10097668|NCT02377362|11226647|FG001|COMPLETED|Part A Second Treatment||4
10097669|NCT02377362|11226648|FG002|COMPLETED|Part A Second Treatment||4
10097670|NCT02377362|11226649|FG003|COMPLETED|Part A Second Treatment||4
9969586|NCT01527383|11090178|FG001|NOT COMPLETED|Overall Study||4
9969587|NCT01527487|11090186|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
9969588|NCT01527487|11090187|FG001|STARTED|Overall Study||22
9969589|NCT01527487|11090186|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
9969590|NCT01527487|11090187|FG001|COMPLETED|Overall Study||15
9969591|NCT01527487|11090186|FG000|NOT COMPLETED|Overall Study||8
9969592|NCT01527487|11090187|FG001|NOT COMPLETED|Overall Study||7
9969593|NCT01527500|11090202|FG000|STARTED|Part A||99
9969594|NCT01527500|11090203|FG001|STARTED|Part A||51
9969595|NCT01527500|11090202|FG000|COMPLETED|Part A||69
9969596|NCT01527500|11090203|FG001|COMPLETED|Part A||38
9969597|NCT01527500|11090202|FG000|NOT COMPLETED|Part A||30
9969598|NCT01527500|11090203|FG001|NOT COMPLETED|Part A||13
9969599|NCT01527500|11090202|FG000|STARTED|Part B||7
9969600|NCT01527500|11090203|FG001|STARTED|Part B||1
9969601|NCT01527500|11090202|FG000|COMPLETED|Part B||6
9969602|NCT01527500|11090203|FG001|COMPLETED|Part B||1
9969603|NCT01527500|11090202|FG000|NOT COMPLETED|Part B||1
9969604|NCT01527500|11090203|FG001|NOT COMPLETED|Part B||0
9969605|NCT01527513|11090221|FG000|STARTED|Double Blind Period (DB) - Part I||40
9969606|NCT01527513|11090222|FG001|STARTED|Double Blind Period (DB) - Part I||83
9969607|NCT01527513|11090221|FG000|Randomized|Double Blind Period (DB) - Part I||40
9969608|NCT01527513|11090222|FG001|Randomized|Double Blind Period (DB) - Part I||83
9969609|NCT01527513|11090221|FG000|Safety Population|Double Blind Period (DB) - Part I||40
9969610|NCT01527513|11090222|FG001|Safety Population|Double Blind Period (DB) - Part I||83
9969611|NCT01527513|11090221|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
9969612|NCT01527513|11090222|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
9969613|NCT01527513|11090221|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
9969614|NCT01527513|11090222|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
9969615|NCT01527513|11090221|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
9969616|NCT01527513|11090222|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
9969617|NCT01527513|11090221|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37
9969618|NCT01527513|11090222|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67
9969619|NCT01527513|11090221|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
9969620|NCT01527513|11090222|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
9969621|NCT01527513|11090221|FG000|COMPLETED|Double Blind Period (DB) - Part I||37
9969622|NCT01527513|11090222|FG001|COMPLETED|Double Blind Period (DB) - Part I||75
9969623|NCT01527513|11090221|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3
9969624|NCT01527513|11090222|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8
9969625|NCT01527513|11090221|FG000|STARTED|Eligible for 1-Year Open Label Period||0
9969626|NCT01527513|11090222|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
9969627|NCT01527513|11090221|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0
9969628|NCT01527513|11090222|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95
9969629|NCT01527513|11090221|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
9969630|NCT01527513|11090222|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
9969631|NCT01527682|11090230|FG000|STARTED|Overall Study||37
9969632|NCT01527682|11090230|FG000|COMPLETED|Overall Study||29
9969633|NCT01527682|11090230|FG000|NOT COMPLETED|Overall Study||8
9969634|NCT01528033|11090236|FG000|STARTED|Primary Endpoint Assessment ITT||273
9969635|NCT01528033|11090237|FG001|STARTED|Primary Endpoint Assessment ITT||266
9969636|NCT01528033|11090236|FG000|COMPLETED|Primary Endpoint Assessment ITT||256
9969637|NCT01528033|11090237|FG001|COMPLETED|Primary Endpoint Assessment ITT||251
9969638|NCT01528033|11090236|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17
9969639|NCT01528033|11090237|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15
9969640|NCT01528033|11090236|FG000|STARTED|Follow Up||256
9969641|NCT01528033|11090237|FG001|STARTED|Follow Up||251
9969642|NCT01528033|11090236|FG000|COMPLETED|Follow Up||210
9969643|NCT01528033|11090237|FG001|COMPLETED|Follow Up||207
9969644|NCT01528033|11090236|FG000|NOT COMPLETED|Follow Up||46
9969645|NCT01528033|11090237|FG001|NOT COMPLETED|Follow Up||44
10097671|NCT02377362|11226650|FG004|COMPLETED|Part A Second Treatment||3
10097672|NCT02377362|11226651|FG005|COMPLETED|Part A Second Treatment||4
10097673|NCT02377362|11226652|FG006|COMPLETED|Part A Second Treatment||0
10097674|NCT02377362|11226653|FG007|COMPLETED|Part A Second Treatment||0
9969646|NCT01528072|11090243|FG000|STARTED|Overall Study||140
9969647|NCT01528072|11090243|FG000|COMPLETED|Overall Study||66
9969648|NCT01528072|11090243|FG000|NOT COMPLETED|Overall Study||74
9969649|NCT01528124|11090254|FG000|STARTED|Overall Study||6
9969650|NCT01528124|11090255|FG001|STARTED|Overall Study||6
9969651|NCT01528124|11090256|FG002|STARTED|Overall Study||6
9969652|NCT01528124|11090257|FG003|STARTED|Overall Study||6
9969653|NCT01528124|11090258|FG004|STARTED|Overall Study||5
9969654|NCT01528124|11090259|FG005|STARTED|Overall Study||6
9969655|NCT01528124|11090260|FG006|STARTED|Overall Study||6
9969656|NCT01528124|11090254|FG000|Received Study Drug|Overall Study||6
9969657|NCT01528124|11090255|FG001|Received Study Drug|Overall Study||6
9969658|NCT01528124|11090256|FG002|Received Study Drug|Overall Study||6
9969659|NCT01528124|11090257|FG003|Received Study Drug|Overall Study||6
9969660|NCT01528124|11090258|FG004|Received Study Drug|Overall Study||5
9969661|NCT01528124|11090259|FG005|Received Study Drug|Overall Study||6
9969662|NCT01528124|11090260|FG006|Received Study Drug|Overall Study||6
9969663|NCT01528124|11090254|FG000|COMPLETED|Overall Study||6
9969664|NCT01528124|11090255|FG001|COMPLETED|Overall Study||6
9969665|NCT01528124|11090256|FG002|COMPLETED|Overall Study||6
9969666|NCT01528124|11090257|FG003|COMPLETED|Overall Study||6
9969667|NCT01528124|11090258|FG004|COMPLETED|Overall Study||5
9969668|NCT01528124|11090259|FG005|COMPLETED|Overall Study||6
9969669|NCT01528124|11090260|FG006|COMPLETED|Overall Study||6
9969670|NCT01528124|11090254|FG000|NOT COMPLETED|Overall Study||0
9969671|NCT01528124|11090255|FG001|NOT COMPLETED|Overall Study||0
9969672|NCT01528124|11090256|FG002|NOT COMPLETED|Overall Study||0
9969673|NCT01528124|11090257|FG003|NOT COMPLETED|Overall Study||0
9969674|NCT01528124|11090258|FG004|NOT COMPLETED|Overall Study||0
10097675|NCT02377362|11226654|FG008|COMPLETED|Part A Second Treatment||0
10097676|NCT02377362|11226655|FG009|COMPLETED|Part A Second Treatment||0
10097677|NCT02377362|11226656|FG010|COMPLETED|Part A Second Treatment||0
10097678|NCT02377362|11226657|FG011|COMPLETED|Part A Second Treatment||0
10097679|NCT02377362|11226658|FG012|COMPLETED|Part A Second Treatment||0
10097680|NCT02377362|11226646|FG000|NOT COMPLETED|Part A Second Treatment||0
10097681|NCT02377362|11226647|FG001|NOT COMPLETED|Part A Second Treatment||0
10097682|NCT02377362|11226648|FG002|NOT COMPLETED|Part A Second Treatment||0
10097683|NCT02377362|11226649|FG003|NOT COMPLETED|Part A Second Treatment||0
10097684|NCT02377362|11226650|FG004|NOT COMPLETED|Part A Second Treatment||1
10097685|NCT02377362|11226651|FG005|NOT COMPLETED|Part A Second Treatment||0
10097686|NCT02377362|11226652|FG006|NOT COMPLETED|Part A Second Treatment||0
10097687|NCT02377362|11226653|FG007|NOT COMPLETED|Part A Second Treatment||0
10097688|NCT02377362|11226654|FG008|NOT COMPLETED|Part A Second Treatment||0
10097689|NCT02377362|11226655|FG009|NOT COMPLETED|Part A Second Treatment||0
10097690|NCT02377362|11226656|FG010|NOT COMPLETED|Part A Second Treatment||0
10097691|NCT02377362|11226657|FG011|NOT COMPLETED|Part A Second Treatment||0
10097692|NCT02377362|11226658|FG012|NOT COMPLETED|Part A Second Treatment||0
10097693|NCT02377362|11226646|FG000|STARTED|Part A Third Treatment||4
10097694|NCT02377362|11226647|FG001|STARTED|Part A Third Treatment||4
10097695|NCT02377362|11226648|FG002|STARTED|Part A Third Treatment||4
10097696|NCT02377362|11226649|FG003|STARTED|Part A Third Treatment||4
10097697|NCT02377362|11226650|FG004|STARTED|Part A Third Treatment||3
10097698|NCT02377362|11226651|FG005|STARTED|Part A Third Treatment||4
10097699|NCT02377362|11226652|FG006|STARTED|Part A Third Treatment||0
10097700|NCT02377362|11226653|FG007|STARTED|Part A Third Treatment||0
10097701|NCT02377362|11226654|FG008|STARTED|Part A Third Treatment||0
10097702|NCT02377362|11226655|FG009|STARTED|Part A Third Treatment||0
10097703|NCT02377362|11226656|FG010|STARTED|Part A Third Treatment||0
10097704|NCT02377362|11226657|FG011|STARTED|Part A Third Treatment||0
10097705|NCT02377362|11226658|FG012|STARTED|Part A Third Treatment||0
10097706|NCT02377362|11226646|FG000|COMPLETED|Part A Third Treatment||4
10097707|NCT02377362|11226647|FG001|COMPLETED|Part A Third Treatment||4
10097708|NCT02377362|11226648|FG002|COMPLETED|Part A Third Treatment||4
10097709|NCT02377362|11226649|FG003|COMPLETED|Part A Third Treatment||0
10097710|NCT02377362|11226650|FG004|COMPLETED|Part A Third Treatment||0
10097711|NCT02377362|11226651|FG005|COMPLETED|Part A Third Treatment||0
10097712|NCT02377362|11226652|FG006|COMPLETED|Part A Third Treatment||0
10097713|NCT02377362|11226653|FG007|COMPLETED|Part A Third Treatment||0
10097714|NCT02377362|11226654|FG008|COMPLETED|Part A Third Treatment||0
10097715|NCT02377362|11226655|FG009|COMPLETED|Part A Third Treatment||0
10097716|NCT02377362|11226656|FG010|COMPLETED|Part A Third Treatment||0
10097717|NCT02377362|11226657|FG011|COMPLETED|Part A Third Treatment||0
10097718|NCT02377362|11226658|FG012|COMPLETED|Part A Third Treatment||0
10097719|NCT02377362|11226646|FG000|NOT COMPLETED|Part A Third Treatment||0
10097720|NCT02377362|11226647|FG001|NOT COMPLETED|Part A Third Treatment||0
10097721|NCT02377362|11226648|FG002|NOT COMPLETED|Part A Third Treatment||0
10097722|NCT02377362|11226649|FG003|NOT COMPLETED|Part A Third Treatment||4
10097723|NCT02377362|11226650|FG004|NOT COMPLETED|Part A Third Treatment||3
10097724|NCT02377362|11226651|FG005|NOT COMPLETED|Part A Third Treatment||4
10097725|NCT02377362|11226652|FG006|NOT COMPLETED|Part A Third Treatment||0
10097726|NCT02377362|11226653|FG007|NOT COMPLETED|Part A Third Treatment||0
10097727|NCT02377362|11226654|FG008|NOT COMPLETED|Part A Third Treatment||0
10097728|NCT02377362|11226655|FG009|NOT COMPLETED|Part A Third Treatment||0
10097729|NCT02377362|11226656|FG010|NOT COMPLETED|Part A Third Treatment||0
10097730|NCT02377362|11226657|FG011|NOT COMPLETED|Part A Third Treatment||0
10097731|NCT02377362|11226658|FG012|NOT COMPLETED|Part A Third Treatment||0
10097732|NCT02377362|11226646|FG000|STARTED|Part B Overall||0
10097733|NCT02377362|11226647|FG001|STARTED|Part B Overall||0
10097734|NCT02377362|11226648|FG002|STARTED|Part B Overall||0
10097735|NCT02377362|11226649|FG003|STARTED|Part B Overall||0
10097736|NCT02377362|11226650|FG004|STARTED|Part B Overall||0
10097737|NCT02377362|11226651|FG005|STARTED|Part B Overall||0
10097738|NCT02377362|11226652|FG006|STARTED|Part B Overall||6
10097739|NCT02377362|11226653|FG007|STARTED|Part B Overall||6
10097740|NCT02377362|11226654|FG008|STARTED|Part B Overall||6
10097741|NCT02377362|11226655|FG009|STARTED|Part B Overall||7
10097742|NCT02377362|11226656|FG010|STARTED|Part B Overall||6
10097743|NCT02377362|11226657|FG011|STARTED|Part B Overall||7
10097744|NCT02377362|11226658|FG012|STARTED|Part B Overall||12
9969675|NCT01528124|11090259|FG005|NOT COMPLETED|Overall Study||0
9969676|NCT01528124|11090260|FG006|NOT COMPLETED|Overall Study||0
9969677|NCT01528150|11090282|FG000|STARTED|Overall Study||466
10097745|NCT02377362|11226646|FG000|COMPLETED|Part B Overall||0
10097746|NCT02377362|11226647|FG001|COMPLETED|Part B Overall||0
10097747|NCT02377362|11226648|FG002|COMPLETED|Part B Overall||0
10097748|NCT02377362|11226649|FG003|COMPLETED|Part B Overall||0
9969678|NCT01528150|11090282|FG000|COMPLETED|Overall Study||422
9969679|NCT01528150|11090282|FG000|NOT COMPLETED|Overall Study||44
9969680|NCT01528215|11090288|FG000|STARTED|Enrollment to 1 Year Follow-up||59
9969681|NCT01528215|11090289|FG001|STARTED|Enrollment to 1 Year Follow-up||61
9969682|NCT01528215|11090288|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55
9969683|NCT01528215|11090289|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60
9969684|NCT01528215|11090288|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
9969685|NCT01528215|11090289|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
9969686|NCT01528215|11090288|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55
9969687|NCT01528215|11090289|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60
9969688|NCT01528215|11090288|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
9969689|NCT01528215|11090289|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
9969690|NCT01528215|11090288|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
9969691|NCT01528215|11090289|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
9969692|NCT01528228|11090297|FG000|STARTED|Overall Study||10
9969693|NCT01528228|11090298|FG001|STARTED|Overall Study||10
9969694|NCT01528228|11090297|FG000|COMPLETED|Overall Study||9
9969695|NCT01528228|11090298|FG001|COMPLETED|Overall Study||9
9969696|NCT01528228|11090297|FG000|NOT COMPLETED|Overall Study||1
9969697|NCT01528228|11090298|FG001|NOT COMPLETED|Overall Study||1
9969698|NCT01528254|11090306|FG000|STARTED|Overall Study||998
9969699|NCT01528254|11090307|FG001|STARTED|Overall Study||1003
9969700|NCT01528254|11090306|FG000|Safety Set|Overall Study||998
9969701|NCT01528254|11090307|FG001|Safety Set|Overall Study||1001
10097749|NCT02377362|11226650|FG004|COMPLETED|Part B Overall||0
10097750|NCT02377362|11226651|FG005|COMPLETED|Part B Overall||0
10097751|NCT02377362|11226652|FG006|COMPLETED|Part B Overall||4
10097752|NCT02377362|11226653|FG007|COMPLETED|Part B Overall||5
10097753|NCT02377362|11226654|FG008|COMPLETED|Part B Overall||6
10097754|NCT02377362|11226655|FG009|COMPLETED|Part B Overall||6
10097755|NCT02377362|11226656|FG010|COMPLETED|Part B Overall||6
10097756|NCT02377362|11226657|FG011|COMPLETED|Part B Overall||6
10097757|NCT02377362|11226658|FG012|COMPLETED|Part B Overall||12
10097758|NCT02377362|11226646|FG000|NOT COMPLETED|Part B Overall||0
10097759|NCT02377362|11226647|FG001|NOT COMPLETED|Part B Overall||0
10097760|NCT02377362|11226648|FG002|NOT COMPLETED|Part B Overall||0
10097761|NCT02377362|11226649|FG003|NOT COMPLETED|Part B Overall||0
10097762|NCT02377362|11226650|FG004|NOT COMPLETED|Part B Overall||0
10097763|NCT02377362|11226651|FG005|NOT COMPLETED|Part B Overall||0
10097764|NCT02377362|11226652|FG006|NOT COMPLETED|Part B Overall||2
10097765|NCT02377362|11226653|FG007|NOT COMPLETED|Part B Overall||1
10097766|NCT02377362|11226654|FG008|NOT COMPLETED|Part B Overall||0
10097767|NCT02377362|11226655|FG009|NOT COMPLETED|Part B Overall||1
10097768|NCT02377362|11226656|FG010|NOT COMPLETED|Part B Overall||0
10097769|NCT02377362|11226657|FG011|NOT COMPLETED|Part B Overall||1
10097770|NCT02377362|11226658|FG012|NOT COMPLETED|Part B Overall||0
10097771|NCT02377427|11226698|FG000|STARTED|Part A (Up to Week 20)||26
10097772|NCT02377427|11226699|FG001|STARTED|Part A (Up to Week 20)||10
10097773|NCT02377427|11226700|FG002|STARTED|Part A (Up to Week 20)||0
10097774|NCT02377427|11226701|FG003|STARTED|Part A (Up to Week 20)||0
10097775|NCT02377427|11226702|FG004|STARTED|Part A (Up to Week 20)||0
10097776|NCT02377427|11226698|FG000|COMPLETED|Part A (Up to Week 20)||22
10097777|NCT02377427|11226699|FG001|COMPLETED|Part A (Up to Week 20)||10
10097778|NCT02377427|11226700|FG002|COMPLETED|Part A (Up to Week 20)||0
10097779|NCT02377427|11226701|FG003|COMPLETED|Part A (Up to Week 20)||0
10097780|NCT02377427|11226702|FG004|COMPLETED|Part A (Up to Week 20)||0
10097781|NCT02377427|11226698|FG000|NOT COMPLETED|Part A (Up to Week 20)||4
10097782|NCT02377427|11226699|FG001|NOT COMPLETED|Part A (Up to Week 20)||0
10097783|NCT02377427|11226700|FG002|NOT COMPLETED|Part A (Up to Week 20)||0
10097784|NCT02377427|11226701|FG003|NOT COMPLETED|Part A (Up to Week 20)||0
10097785|NCT02377427|11226702|FG004|NOT COMPLETED|Part A (Up to Week 20)||0
10097786|NCT02377427|11226698|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0
10097787|NCT02377427|11226699|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0
10097788|NCT02377427|11226700|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
10097789|NCT02377427|11226701|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10
10097790|NCT02377427|11226702|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4
10097791|NCT02377427|11226698|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0
10097792|NCT02377427|11226699|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0
9969702|NCT01528254|11090306|FG000|Full Analysis Set (FAS)|Overall Study||983
9969703|NCT01528254|11090307|FG001|Full Analysis Set (FAS)|Overall Study||989
9969704|NCT01528254|11090306|FG000|Completed Treatment Period 1|Overall Study||458
9969705|NCT01528254|11090307|FG001|Completed Treatment Period 1|Overall Study||273
9969706|NCT01528254|11090306|FG000|Completed Treatment Period 2|Overall Study||244
9969707|NCT01528254|11090307|FG001|Completed Treatment Period 2|Overall Study||399
9969708|NCT01528254|11090306|FG000|Completed Treatment Period 3|Overall Study||109
9969709|NCT01528254|11090307|FG001|Completed Treatment Period 3|Overall Study||115
9969710|NCT01528254|11090306|FG000|COMPLETED|Overall Study||811
9969711|NCT01528254|11090307|FG001|COMPLETED|Overall Study||787
9969712|NCT01528254|11090306|FG000|NOT COMPLETED|Overall Study||187
9969713|NCT01528254|11090307|FG001|NOT COMPLETED|Overall Study||216
9969714|NCT01528319|11090314|FG000|STARTED|Overall Study||24
9969715|NCT01528319|11090314|FG000|12 Weeks After Surgery|Overall Study||24
9969716|NCT01528319|11090314|FG000|COMPLETED|Overall Study||23
9969717|NCT01528319|11090314|FG000|NOT COMPLETED|Overall Study||1
9969718|NCT01528332|11090320|FG000|STARTED|Overall Study||85
9969719|NCT01528332|11090321|FG001|STARTED|Overall Study||86
9969720|NCT01528332|11090320|FG000|COMPLETED|Overall Study||81
9969721|NCT01528332|11090321|FG001|COMPLETED|Overall Study||84
9969722|NCT01528332|11090320|FG000|NOT COMPLETED|Overall Study||4
9969723|NCT01528332|11090321|FG001|NOT COMPLETED|Overall Study||2
9969724|NCT01528345|11090329|FG000|STARTED|Overall Study||47
9969725|NCT01528345|11090330|FG001|STARTED|Overall Study||50
9969726|NCT01528345|11090329|FG000|COMPLETED|Overall Study||0
9969727|NCT01528345|11090330|FG001|COMPLETED|Overall Study||0
10097793|NCT02377427|11226700|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15
10097794|NCT02377427|11226701|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10
10097795|NCT02377427|11226702|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4
10097796|NCT02377427|11226698|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10097797|NCT02377427|11226699|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10097798|NCT02377427|11226700|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
10097799|NCT02377427|11226701|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10097800|NCT02377427|11226702|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10097801|NCT02377466|11226717|FG000|STARTED|Overall Study||13
10097802|NCT02377466|11226718|FG001|STARTED|Overall Study||12
10097803|NCT02377466|11226717|FG000|Treated|Overall Study||13
10097804|NCT02377466|11226718|FG001|Treated|Overall Study||10
10097805|NCT02377466|11226717|FG000|COMPLETED|Overall Study||13
10097806|NCT02377466|11226718|FG001|COMPLETED|Overall Study||10
10097807|NCT02377466|11226717|FG000|NOT COMPLETED|Overall Study||0
10097808|NCT02377466|11226718|FG001|NOT COMPLETED|Overall Study||2
10097809|NCT02377674|11226731|FG000|STARTED|Overall Study||5
10097810|NCT02377674|11226731|FG000|COMPLETED|Overall Study||5
10097811|NCT02377674|11226731|FG000|NOT COMPLETED|Overall Study||0
10097812|NCT02377700|11226735|FG000|STARTED|Overall Study||5
10097813|NCT02377700|11226735|FG000|COMPLETED|Overall Study||5
10097814|NCT02377700|11226735|FG000|NOT COMPLETED|Overall Study||0
10097815|NCT02377752|11226743|FG000|STARTED|Overall Study||7
10097816|NCT02377752|11226744|FG001|STARTED|Overall Study||6
10097817|NCT02377752|11226745|FG002|STARTED|Overall Study||6
10097818|NCT02377752|11226746|FG003|STARTED|Overall Study||6
10097819|NCT02377752|11226743|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10097820|NCT02377752|11226744|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10097821|NCT02377752|11226745|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10097822|NCT02377752|11226746|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10097823|NCT02377752|11226743|FG000|COMPLETED|Overall Study||7
10097824|NCT02377752|11226744|FG001|COMPLETED|Overall Study||6
10097825|NCT02377752|11226745|FG002|COMPLETED|Overall Study||6
10097826|NCT02377752|11226746|FG003|COMPLETED|Overall Study||6
10097827|NCT02377752|11226743|FG000|NOT COMPLETED|Overall Study||0
10097828|NCT02377752|11226744|FG001|NOT COMPLETED|Overall Study||0
10097829|NCT02377752|11226745|FG002|NOT COMPLETED|Overall Study||0
10097830|NCT02377752|11226746|FG003|NOT COMPLETED|Overall Study||0
10097831|NCT02377817|11226761|FG000|STARTED|Overall Study||13
10097832|NCT02377817|11226762|FG001|STARTED|Overall Study||10
10097833|NCT02377817|11226761|FG000|COMPLETED|Overall Study||10
10097834|NCT02377817|11226762|FG001|COMPLETED|Overall Study||10
10097835|NCT02377817|11226761|FG000|NOT COMPLETED|Overall Study||3
10097836|NCT02377817|11226762|FG001|NOT COMPLETED|Overall Study||0
10097837|NCT02377921|11226772|FG000|STARTED|Overall Study||45
10097838|NCT02377921|11226773|FG001|STARTED|Overall Study||44
10097839|NCT02377921|11226772|FG000|COMPLETED|Overall Study||44
10097840|NCT02377921|11226773|FG001|COMPLETED|Overall Study||43
10097841|NCT02377921|11226772|FG000|NOT COMPLETED|Overall Study||1
10097842|NCT02377921|11226773|FG001|NOT COMPLETED|Overall Study||1
10097843|NCT02377947|11226779|FG000|STARTED|Overall Study||50
10097844|NCT02377947|11226779|FG000|COMPLETED|Overall Study||50
10097845|NCT02377947|11226779|FG000|NOT COMPLETED|Overall Study||0
10097846|NCT02377986|11226783|FG000|STARTED|Overall Study||5
10097847|NCT02377986|11226783|FG000|COMPLETED|Overall Study||5
10097848|NCT02377986|11226783|FG000|NOT COMPLETED|Overall Study||0
9969728|NCT01528345|11090329|FG000|NOT COMPLETED|Overall Study||47
9969729|NCT01528345|11090330|FG001|NOT COMPLETED|Overall Study||50
9969730|NCT01528592|11090336|FG000|STARTED|Overall Study||18
9969731|NCT01528592|11090336|FG000|COMPLETED|Overall Study||18
9969732|NCT01528592|11090336|FG000|NOT COMPLETED|Overall Study||0
10097849|NCT02378025|11226789|FG000|STARTED|Overall Study||39
10097850|NCT02378025|11226790|FG001|STARTED|Overall Study||36
10097851|NCT02378025|11226789|FG000|COMPLETED|Overall Study||26
10097852|NCT02378025|11226790|FG001|COMPLETED|Overall Study||15
10097853|NCT02378025|11226789|FG000|NOT COMPLETED|Overall Study||13
10097854|NCT02378025|11226790|FG001|NOT COMPLETED|Overall Study||21
10097855|NCT02378038|11226796|FG000|STARTED|Overall Study||5
9969733|NCT01528605|11090346|FG000|STARTED|Overall Study||28
9969734|NCT01528605|11090347|FG001|STARTED|Overall Study||28
9969735|NCT01528605|11090348|FG002|STARTED|Overall Study||28
9969736|NCT01528605|11090349|FG003|STARTED|Overall Study||28
10097856|NCT02378038|11226796|FG000|COMPLETED|Overall Study||0
10097857|NCT02378038|11226796|FG000|NOT COMPLETED|Overall Study||5
10097858|NCT02378207|11226804|FG000|STARTED|Overall Study||24
10097859|NCT02378207|11226805|FG001|STARTED|Overall Study||24
10097860|NCT02378207|11226806|FG002|STARTED|Overall Study||24
10097861|NCT02378207|11226807|FG003|STARTED|Overall Study||12
10097862|NCT02378207|11226804|FG000|COMPLETED|Overall Study||24
10097863|NCT02378207|11226805|FG001|COMPLETED|Overall Study||21
10097864|NCT02378207|11226806|FG002|COMPLETED|Overall Study||22
10097865|NCT02378207|11226807|FG003|COMPLETED|Overall Study||11
10097866|NCT02378207|11226804|FG000|NOT COMPLETED|Overall Study||0
10097867|NCT02378207|11226805|FG001|NOT COMPLETED|Overall Study||3
10097868|NCT02378207|11226806|FG002|NOT COMPLETED|Overall Study||2
10097869|NCT02378207|11226807|FG003|NOT COMPLETED|Overall Study||1
10097870|NCT02378220|11226819|FG000|STARTED|Overall Study||53
10097871|NCT02378220|11226820|FG001|STARTED|Overall Study||57
10097872|NCT02378220|11226819|FG000|COMPLETED|Overall Study||47
10097873|NCT02378220|11226820|FG001|COMPLETED|Overall Study||56
10097874|NCT02378220|11226819|FG000|NOT COMPLETED|Overall Study||6
10097875|NCT02378220|11226820|FG001|NOT COMPLETED|Overall Study||1
10097876|NCT02378402|11226830|FG000|STARTED|Overall Study||25
10097877|NCT02378402|11226831|FG001|STARTED|Overall Study||25
10097878|NCT02378402|11226832|FG002|STARTED|Overall Study||21
10097879|NCT02378402|11226830|FG000|COMPLETED|Overall Study||25
10097880|NCT02378402|11226831|FG001|COMPLETED|Overall Study||23
10097881|NCT02378402|11226832|FG002|COMPLETED|Overall Study||21
10097882|NCT02378402|11226830|FG000|NOT COMPLETED|Overall Study||0
10097883|NCT02378402|11226831|FG001|NOT COMPLETED|Overall Study||2
10097884|NCT02378402|11226832|FG002|NOT COMPLETED|Overall Study||0
10097885|NCT02378480|11226842|FG000|STARTED|Overall Study||329
10097886|NCT02378480|11226843|FG001|STARTED|Overall Study||326
10097887|NCT02378480|11226842|FG000|COMPLETED|Overall Study||301
10097888|NCT02378480|11226843|FG001|COMPLETED|Overall Study||294
10097889|NCT02378480|11226842|FG000|NOT COMPLETED|Overall Study||28
10097890|NCT02378480|11226843|FG001|NOT COMPLETED|Overall Study||32
10097891|NCT02378506|11226849|FG000|STARTED|Overall Study||188
10097892|NCT02378506|11226849|FG000|Treated|Overall Study||187
10097893|NCT02378506|11226849|FG000|COMPLETED|Overall Study||163
10097894|NCT02378506|11226849|FG000|NOT COMPLETED|Overall Study||25
10097895|NCT02378662|11226855|FG000|STARTED|Overall Study||2
10097896|NCT02378662|11226856|FG001|STARTED|Overall Study||0
10097897|NCT02378662|11226855|FG000|Harvesting|Overall Study||2
10097898|NCT02378662|11226856|FG001|Harvesting|Overall Study||0
10097899|NCT02378662|11226855|FG000|Implantation|Overall Study||2
10097900|NCT02378662|11226856|FG001|Implantation|Overall Study||0
10097901|NCT02378662|11226855|FG000|COMPLETED|Overall Study||0
10097902|NCT02378662|11226856|FG001|COMPLETED|Overall Study||0
10097903|NCT02378662|11226855|FG000|NOT COMPLETED|Overall Study||2
10097904|NCT02378662|11226856|FG001|NOT COMPLETED|Overall Study||0
10097905|NCT02378714|11226866|FG000|STARTED|Overall Study||68
10097906|NCT02378714|11226867|FG001|STARTED|Overall Study||68
10097907|NCT02378714|11226868|FG002|STARTED|Overall Study||81
10097908|NCT02378714|11226869|FG003|STARTED|Overall Study||83
10097909|NCT02378714|11226866|FG000|COMPLETED|Overall Study||39
10097910|NCT02378714|11226867|FG001|COMPLETED|Overall Study||29
10097911|NCT02378714|11226868|FG002|COMPLETED|Overall Study||51
10097912|NCT02378714|11226869|FG003|COMPLETED|Overall Study||51
10097913|NCT02378714|11226866|FG000|NOT COMPLETED|Overall Study||29
10097914|NCT02378714|11226867|FG001|NOT COMPLETED|Overall Study||39
10097915|NCT02378714|11226868|FG002|NOT COMPLETED|Overall Study||30
10097916|NCT02378714|11226869|FG003|NOT COMPLETED|Overall Study||32
10097917|NCT02378753|11226903|FG000|STARTED|Overall Study||4319
10097918|NCT02378753|11226904|FG001|STARTED|Overall Study||4332
10097919|NCT02378753|11226903|FG000|COMPLETED|Overall Study||4101
10097920|NCT02378753|11226904|FG001|COMPLETED|Overall Study||3637
10097921|NCT02378753|11226903|FG000|NOT COMPLETED|Overall Study||218
10097922|NCT02378753|11226904|FG001|NOT COMPLETED|Overall Study||695
10097923|NCT02378844|11226912|FG000|STARTED|Run-in Period||169
10097924|NCT02378844|11226913|FG001|STARTED|Run-in Period||172
10097925|NCT02378844|11226914|FG002|STARTED|Run-in Period||136
10097926|NCT02378844|11226912|FG000|COMPLETED|Run-in Period||165
10097927|NCT02378844|11226913|FG001|COMPLETED|Run-in Period||167
10097928|NCT02378844|11226914|FG002|COMPLETED|Run-in Period||0
10097929|NCT02378844|11226912|FG000|NOT COMPLETED|Run-in Period||4
10097930|NCT02378844|11226913|FG001|NOT COMPLETED|Run-in Period||5
10097931|NCT02378844|11226914|FG002|NOT COMPLETED|Run-in Period||136
10097932|NCT02378844|11226912|FG000|STARTED|Randomized Period (Double Blind)||165
9969737|NCT01528605|11090350|FG004|STARTED|Overall Study||28
9969738|NCT01528605|11090351|FG005|STARTED|Overall Study||28
10097933|NCT02378844|11226913|FG001|STARTED|Randomized Period (Double Blind)||167
10097934|NCT02378844|11226914|FG002|STARTED|Randomized Period (Double Blind)||0
10097935|NCT02378844|11226912|FG000|COMPLETED|Randomized Period (Double Blind)||142
10097936|NCT02378844|11226913|FG001|COMPLETED|Randomized Period (Double Blind)||135
10097937|NCT02378844|11226914|FG002|COMPLETED|Randomized Period (Double Blind)||0
10097938|NCT02378844|11226912|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23
10097939|NCT02378844|11226913|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32
10097940|NCT02378844|11226914|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0
10097941|NCT02378844|11226912|FG000|STARTED|Open Label Period||142
9969739|NCT01528605|11090346|FG000|COMPLETED|Overall Study||26
9969740|NCT01528605|11090347|FG001|COMPLETED|Overall Study||28
9969741|NCT01528605|11090348|FG002|COMPLETED|Overall Study||27
9969742|NCT01528605|11090349|FG003|COMPLETED|Overall Study||27
9969743|NCT01528605|11090350|FG004|COMPLETED|Overall Study||28
9969744|NCT01528605|11090351|FG005|COMPLETED|Overall Study||28
9969745|NCT01528605|11090346|FG000|NOT COMPLETED|Overall Study||2
9969746|NCT01528605|11090347|FG001|NOT COMPLETED|Overall Study||0
9969747|NCT01528605|11090348|FG002|NOT COMPLETED|Overall Study||1
9969748|NCT01528605|11090349|FG003|NOT COMPLETED|Overall Study||1
9969749|NCT01528605|11090350|FG004|NOT COMPLETED|Overall Study||0
9969750|NCT01528605|11090351|FG005|NOT COMPLETED|Overall Study||0
9969751|NCT01528709|11090367|FG000|STARTED|Overall Study||86
9969752|NCT01528709|11090368|FG001|STARTED|Overall Study||87
10097942|NCT02378844|11226913|FG001|STARTED|Open Label Period||135
10097943|NCT02378844|11226914|FG002|STARTED|Open Label Period||0
10097944|NCT02378844|11226912|FG000|COMPLETED|Open Label Period||99
10097945|NCT02378844|11226913|FG001|COMPLETED|Open Label Period||87
10097946|NCT02378844|11226914|FG002|COMPLETED|Open Label Period||0
10097947|NCT02378844|11226912|FG000|NOT COMPLETED|Open Label Period||43
10097948|NCT02378844|11226913|FG001|NOT COMPLETED|Open Label Period||48
10097949|NCT02378844|11226914|FG002|NOT COMPLETED|Open Label Period||0
10097950|NCT02378883|11226924|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121
10097951|NCT02378883|11226924|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
10097952|NCT02378883|11226924|FG000|NOT COMPLETED|Enrollment||9
10097953|NCT02378883|11226924|FG000|STARTED|Discharge||112
10097954|NCT02378883|11226924|FG000|COMPLETED|Discharge||112
10097955|NCT02378883|11226924|FG000|NOT COMPLETED|Discharge||0
10097956|NCT02378883|11226924|FG000|STARTED|30 Day Follow-Up||112
10097957|NCT02378883|11226924|FG000|COMPLETED|30 Day Follow-Up||106
10097958|NCT02378883|11226924|FG000|NOT COMPLETED|30 Day Follow-Up||6
10097959|NCT02378883|11226924|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
10097960|NCT02378883|11226924|FG000|COMPLETED|12 Months Follow-Up||41
10097961|NCT02378883|11226924|FG000|NOT COMPLETED|12 Months Follow-Up||5
10097962|NCT02378935|11226936|FG000|STARTED|Overall Study||34
10097963|NCT02378935|11226937|FG001|STARTED|Overall Study||36
10097964|NCT02378935|11226938|FG002|STARTED|Overall Study||33
10097965|NCT02378935|11226939|FG003|STARTED|Overall Study||31
10097966|NCT02378935|11226940|FG004|STARTED|Overall Study||31
10097967|NCT02378935|11226941|FG005|STARTED|Overall Study||32
10097968|NCT02378935|11226942|FG006|STARTED|Overall Study||8
10097969|NCT02378935|11226936|FG000|COMPLETED|Overall Study||24
10097970|NCT02378935|11226937|FG001|COMPLETED|Overall Study||36
10097971|NCT02378935|11226938|FG002|COMPLETED|Overall Study||30
10097972|NCT02378935|11226939|FG003|COMPLETED|Overall Study||25
10097973|NCT02378935|11226940|FG004|COMPLETED|Overall Study||31
10097974|NCT02378935|11226941|FG005|COMPLETED|Overall Study||32
10097975|NCT02378935|11226942|FG006|COMPLETED|Overall Study||8
10097976|NCT02378935|11226936|FG000|NOT COMPLETED|Overall Study||10
10097977|NCT02378935|11226937|FG001|NOT COMPLETED|Overall Study||0
10097978|NCT02378935|11226938|FG002|NOT COMPLETED|Overall Study||3
10097979|NCT02378935|11226939|FG003|NOT COMPLETED|Overall Study||6
10097980|NCT02378935|11226940|FG004|NOT COMPLETED|Overall Study||0
10097981|NCT02378935|11226941|FG005|NOT COMPLETED|Overall Study||0
10097982|NCT02378935|11226942|FG006|NOT COMPLETED|Overall Study||0
10097983|NCT02378961|11226962|FG000|STARTED|Overall Study||33
10097984|NCT02378961|11226963|FG001|STARTED|Overall Study||30
10097985|NCT02378961|11226964|FG002|STARTED|Overall Study||36
10097986|NCT02378961|11226965|FG003|STARTED|Overall Study||29
10097987|NCT02378961|11226962|FG000|COMPLETED|Overall Study||29
10097988|NCT02378961|11226963|FG001|COMPLETED|Overall Study||28
10097989|NCT02378961|11226964|FG002|COMPLETED|Overall Study||35
10097990|NCT02378961|11226965|FG003|COMPLETED|Overall Study||28
10097991|NCT02378961|11226962|FG000|NOT COMPLETED|Overall Study||4
10097992|NCT02378961|11226963|FG001|NOT COMPLETED|Overall Study||2
10097993|NCT02378961|11226964|FG002|NOT COMPLETED|Overall Study||1
10097994|NCT02378961|11226965|FG003|NOT COMPLETED|Overall Study||1
10097995|NCT02379052|11226977|FG000|STARTED|Overall Study||24
10097996|NCT02379052|11226978|FG001|STARTED|Overall Study||23
10097997|NCT02379052|11226977|FG000|COMPLETED|Overall Study||18
10097998|NCT02379052|11226978|FG001|COMPLETED|Overall Study||18
10097999|NCT02379052|11226977|FG000|NOT COMPLETED|Overall Study||6
10098000|NCT02379052|11226978|FG001|NOT COMPLETED|Overall Study||5
10098001|NCT02379078|11226986|FG000|STARTED|Overall Study||111
10098002|NCT02379078|11226987|FG001|STARTED|Overall Study||114
10098003|NCT02379078|11226986|FG000|COMPLETED|Overall Study||72
10098004|NCT02379078|11226987|FG001|COMPLETED|Overall Study||79
10098005|NCT02379078|11226986|FG000|NOT COMPLETED|Overall Study||39
10098006|NCT02379078|11226987|FG001|NOT COMPLETED|Overall Study||35
10098007|NCT02379091|11226997|FG000|STARTED|Overall Study||27
10098008|NCT02379091|11226998|FG001|STARTED|Overall Study||28
10098009|NCT02379091|11226999|FG002|STARTED|Overall Study||25
9969753|NCT01528709|11090367|FG000|COMPLETED|Overall Study||73
10098010|NCT02379091|11227000|FG003|STARTED|Overall Study||28
10098011|NCT02379091|11226997|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
10098012|NCT02379091|11226998|FG001|Full Analysis Set|Overall Study||28
10098013|NCT02379091|11226999|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
9969754|NCT01528709|11090368|FG001|COMPLETED|Overall Study||72
9969755|NCT01528709|11090367|FG000|NOT COMPLETED|Overall Study||13
9969756|NCT01528709|11090368|FG001|NOT COMPLETED|Overall Study||15
9969757|NCT01528735|11090376|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12
9969758|NCT01528735|11090377|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13
9969759|NCT01528735|11090376|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
9969760|NCT01528735|11090377|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
9969761|NCT01528735|11090376|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
9969762|NCT01528735|11090377|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
9969763|NCT01528735|11090376|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
9969764|NCT01528735|11090377|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
9969765|NCT01528735|11090376|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
9969766|NCT01528735|11090377|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
9969767|NCT01528735|11090376|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
9969768|NCT01528735|11090377|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
9969769|NCT01528787|11090389|FG000|STARTED|Overall Study||22
9969770|NCT01528787|11090390|FG001|STARTED|Overall Study||21
9969771|NCT01528787|11090391|FG002|STARTED|Overall Study||19
9969772|NCT01528787|11090392|FG003|STARTED|Overall Study||23
9969773|NCT01528787|11090389|FG000|COMPLETED|Overall Study||22
9969774|NCT01528787|11090390|FG001|COMPLETED|Overall Study||21
9969775|NCT01528787|11090391|FG002|COMPLETED|Overall Study||18
9969776|NCT01528787|11090392|FG003|COMPLETED|Overall Study||22
9969777|NCT01528787|11090389|FG000|NOT COMPLETED|Overall Study||0
9969778|NCT01528787|11090390|FG001|NOT COMPLETED|Overall Study||0
9969779|NCT01528787|11090391|FG002|NOT COMPLETED|Overall Study||1
10098014|NCT02379091|11227000|FG003|Full Analysis Set|Overall Study||28
10098015|NCT02379091|11226997|FG000|COMPLETED|Overall Study||15
10098016|NCT02379091|11226998|FG001|COMPLETED|Overall Study||18
10098017|NCT02379091|11226999|FG002|COMPLETED|Overall Study||18
10098018|NCT02379091|11227000|FG003|COMPLETED|Overall Study||14
10098019|NCT02379091|11226997|FG000|NOT COMPLETED|Overall Study||12
10098020|NCT02379091|11226998|FG001|NOT COMPLETED|Overall Study||10
10098021|NCT02379091|11226999|FG002|NOT COMPLETED|Overall Study||7
10098022|NCT02379091|11227000|FG003|NOT COMPLETED|Overall Study||14
10098023|NCT02379117|11227014|FG000|STARTED|Overall Study||30
10098024|NCT02379117|11227015|FG001|STARTED|Overall Study||31
10098025|NCT02379117|11227014|FG000|COMPLETED|Overall Study||30
10098026|NCT02379117|11227015|FG001|COMPLETED|Overall Study||31
10098027|NCT02379117|11227014|FG000|NOT COMPLETED|Overall Study||0
10098028|NCT02379117|11227015|FG001|NOT COMPLETED|Overall Study||0
10098029|NCT02379195|11227021|FG000|STARTED|Overall Study||12
10098030|NCT02379195|11227021|FG000|COMPLETED|Overall Study||12
10098031|NCT02379195|11227021|FG000|NOT COMPLETED|Overall Study||0
10098032|NCT02379221|11227025|FG000|STARTED|Overall Study||49
10098033|NCT02379221|11227025|FG000|COMPLETED|Overall Study||48
10098034|NCT02379221|11227025|FG000|NOT COMPLETED|Overall Study||1
10098035|NCT02379273|11227034|FG000|STARTED|Overall Study||35
10098036|NCT02379273|11227034|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35
10098037|NCT02379273|11227034|FG000|NOT COMPLETED|Overall Study||0
10098038|NCT02379442|11227038|FG000|STARTED|Overall Study||1
10098039|NCT02379442|11227038|FG000|COMPLETED|Overall Study||1
10098040|NCT02379442|11227038|FG000|NOT COMPLETED|Overall Study||0
10098041|NCT02379637|11227044|FG000|STARTED|Overall Study||35
10098042|NCT02379637|11227045|FG001|STARTED|Overall Study||35
10098043|NCT02379637|11227044|FG000|COMPLETED|Overall Study||33
10098044|NCT02379637|11227045|FG001|COMPLETED|Overall Study||34
10098045|NCT02379637|11227044|FG000|NOT COMPLETED|Overall Study||2
10098046|NCT02379637|11227045|FG001|NOT COMPLETED|Overall Study||1
10098047|NCT02379728|11227053|FG000|STARTED|Overall Study||84
10098048|NCT02379728|11227054|FG001|STARTED|Overall Study||16
10098049|NCT02379728|11227055|FG002|STARTED|Overall Study||84
10098050|NCT02379728|11227056|FG003|STARTED|Overall Study||16
10098051|NCT02379728|11227053|FG000|COMPLETED|Overall Study||78
10098052|NCT02379728|11227054|FG001|COMPLETED|Overall Study||16
10098053|NCT02379728|11227055|FG002|COMPLETED|Overall Study||74
10098054|NCT02379728|11227056|FG003|COMPLETED|Overall Study||13
10098055|NCT02379728|11227053|FG000|NOT COMPLETED|Overall Study||6
10098056|NCT02379728|11227054|FG001|NOT COMPLETED|Overall Study||0
10098057|NCT02379728|11227055|FG002|NOT COMPLETED|Overall Study||10
10098058|NCT02379728|11227056|FG003|NOT COMPLETED|Overall Study||3
10098059|NCT02379858|11227067|FG000|STARTED|Overall Study||6
10098060|NCT02379858|11227068|FG001|STARTED|Overall Study||4
10098061|NCT02379858|11227067|FG000|COMPLETED|Overall Study||6
10098062|NCT02379858|11227068|FG001|COMPLETED|Overall Study||4
10098063|NCT02379858|11227067|FG000|NOT COMPLETED|Overall Study||0
10098064|NCT02379858|11227068|FG001|NOT COMPLETED|Overall Study||0
10098065|NCT02379923|11227074|FG000|STARTED|Overall Study||163
10098066|NCT02379923|11227074|FG000|COMPLETED|Overall Study||158
10098067|NCT02379923|11227074|FG000|NOT COMPLETED|Overall Study||5
10098068|NCT02380183|11227083|FG000|STARTED|Overall Study||36
10098069|NCT02380183|11227084|FG001|STARTED|Overall Study||34
10098070|NCT02380183|11227083|FG000|COMPLETED|Overall Study||36
9969780|NCT01528787|11090392|FG003|NOT COMPLETED|Overall Study||1
9969781|NCT01528878|11090402|FG000|STARTED|Overall Study||30
9969782|NCT01528878|11090402|FG000|COMPLETED|Overall Study||30
10098071|NCT02380183|11227084|FG001|COMPLETED|Overall Study||34
10098072|NCT02380183|11227083|FG000|NOT COMPLETED|Overall Study||0
10098073|NCT02380183|11227084|FG001|NOT COMPLETED|Overall Study||0
10098074|NCT02380248|11227090|FG000|STARTED|Overall Study||200
10098075|NCT02380248|11227090|FG000|COMPLETED|Overall Study||186
10098076|NCT02380248|11227090|FG000|NOT COMPLETED|Overall Study||14
9969783|NCT01528878|11090402|FG000|NOT COMPLETED|Overall Study||0
9969784|NCT01528891|11090410|FG000|STARTED|Overall Study||200
9969785|NCT01528891|11090411|FG001|STARTED|Overall Study||200
9969786|NCT01528891|11090410|FG000|COMPLETED|Overall Study||200
9969787|NCT01528891|11090411|FG001|COMPLETED|Overall Study||200
9969788|NCT01528891|11090410|FG000|NOT COMPLETED|Overall Study||0
9969789|NCT01528891|11090411|FG001|NOT COMPLETED|Overall Study||0
9969790|NCT01528969|11090421|FG000|STARTED|Overall Study||37
9969791|NCT01528969|11090422|FG001|STARTED|Overall Study||38
9969792|NCT01528969|11090421|FG000|COMPLETED|Overall Study||35
9969793|NCT01528969|11090422|FG001|COMPLETED|Overall Study||38
9969794|NCT01528969|11090421|FG000|NOT COMPLETED|Overall Study||2
9969795|NCT01528969|11090422|FG001|NOT COMPLETED|Overall Study||0
9969796|NCT01529034|11090428|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
9969797|NCT01529034|11090428|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
10098077|NCT02380261|11227095|FG000|STARTED|Overall Study||35
10098078|NCT02380261|11227095|FG000|COMPLETED|Overall Study||35
10098079|NCT02380261|11227095|FG000|NOT COMPLETED|Overall Study||0
10098080|NCT02380287|11227107|FG000|STARTED|Overall Study||1
10098081|NCT02380287|11227108|FG001|STARTED|Overall Study||3
10098082|NCT02380287|11227109|FG002|STARTED|Overall Study||3
10098083|NCT02380287|11227110|FG003|STARTED|Overall Study||3
10098084|NCT02380287|11227111|FG004|STARTED|Overall Study||3
10098085|NCT02380287|11227112|FG005|STARTED|Overall Study||3
10098086|NCT02380287|11227113|FG006|STARTED|Overall Study||3
10098087|NCT02380287|11227114|FG007|STARTED|Overall Study||3
10098088|NCT02380287|11227107|FG000|COMPLETED|Overall Study||1
10098089|NCT02380287|11227108|FG001|COMPLETED|Overall Study||3
10098090|NCT02380287|11227109|FG002|COMPLETED|Overall Study||2
9969798|NCT01529034|11090428|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
9969799|NCT01529034|11090428|FG000|NOT COMPLETED|Overall Study||174
9969800|NCT01529060|11090435|FG000|STARTED|Overall Study||10
9969801|NCT01529060|11090436|FG001|STARTED|Overall Study||10
9969802|NCT01529060|11090435|FG000|COMPLETED|Overall Study||10
9969803|NCT01529060|11090436|FG001|COMPLETED|Overall Study||10
9969804|NCT01529060|11090435|FG000|NOT COMPLETED|Overall Study||0
9969805|NCT01529060|11090436|FG001|NOT COMPLETED|Overall Study||0
9969806|NCT01529112|11090445|FG000|STARTED|Overall Study||89
9969807|NCT01529112|11090446|FG001|STARTED|Overall Study||46
9969808|NCT01529112|11090445|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
9969809|NCT01529112|11090446|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
9969810|NCT01529112|11090445|FG000|NOT COMPLETED|Overall Study||69
9969811|NCT01529112|11090446|FG001|NOT COMPLETED|Overall Study||41
9969812|NCT01529203|11090452|FG000|STARTED|Overall Study||60
9969813|NCT01529203|11090452|FG000|COMPLETED|Overall Study||57
9969814|NCT01529203|11090452|FG000|NOT COMPLETED|Overall Study||3
9969815|NCT01529268|11090458|FG000|STARTED|Overall Study||88
9969816|NCT01529268|11090459|FG001|STARTED|Overall Study||81
9969817|NCT01529268|11090458|FG000|Completed 52-week Biopsy|Overall Study||71
9969818|NCT01529268|11090459|FG001|Completed 52-week Biopsy|Overall Study||75
9969819|NCT01529268|11090458|FG000|COMPLETED|Overall Study||76
9969820|NCT01529268|11090459|FG001|COMPLETED|Overall Study||78
9969821|NCT01529268|11090458|FG000|NOT COMPLETED|Overall Study||12
9969822|NCT01529268|11090459|FG001|NOT COMPLETED|Overall Study||3
9969823|NCT01529346|11090470|FG000|STARTED|Overall Study||55
9969824|NCT01529346|11090471|FG001|STARTED|Overall Study||54
9969825|NCT01529346|11090472|FG002|STARTED|Overall Study||54
9969826|NCT01529346|11090473|FG003|STARTED|Overall Study||36
9969827|NCT01529346|11090474|FG004|STARTED|Overall Study||36
9969828|NCT01529346|11090470|FG000|COMPLETED|Overall Study||53
9969829|NCT01529346|11090471|FG001|COMPLETED|Overall Study||53
9969830|NCT01529346|11090472|FG002|COMPLETED|Overall Study||52
9969831|NCT01529346|11090473|FG003|COMPLETED|Overall Study||36
9969832|NCT01529346|11090474|FG004|COMPLETED|Overall Study||36
9969833|NCT01529346|11090470|FG000|NOT COMPLETED|Overall Study||2
9969834|NCT01529346|11090471|FG001|NOT COMPLETED|Overall Study||1
9969835|NCT01529346|11090472|FG002|NOT COMPLETED|Overall Study||2
9969836|NCT01529346|11090473|FG003|NOT COMPLETED|Overall Study||0
9969837|NCT01529346|11090474|FG004|NOT COMPLETED|Overall Study||0
9969838|NCT01529385|11090489|FG000|STARTED|Overall Study||40
9969839|NCT01529385|11090490|FG001|STARTED|Overall Study||40
9969840|NCT01529385|11090489|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
9969841|NCT01529385|11090490|FG001|Received Intervention|Overall Study||40
9969842|NCT01529385|11090489|FG000|COMPLETED|Overall Study||38
9969843|NCT01529385|11090490|FG001|COMPLETED|Overall Study||39
9969844|NCT01529385|11090489|FG000|NOT COMPLETED|Overall Study||2
9969845|NCT01529385|11090490|FG001|NOT COMPLETED|Overall Study||1
9969846|NCT01529450|11090498|FG000|STARTED|Overall Study||3
9969847|NCT01529450|11090499|FG001|STARTED|Overall Study||8
9969848|NCT01529450|11090498|FG000|COMPLETED|Overall Study||3
10098091|NCT02380287|11227110|FG003|COMPLETED|Overall Study||3
10098092|NCT02380287|11227111|FG004|COMPLETED|Overall Study||3
10098093|NCT02380287|11227112|FG005|COMPLETED|Overall Study||3
9969849|NCT01529450|11090499|FG001|COMPLETED|Overall Study||6
9969850|NCT01529450|11090498|FG000|NOT COMPLETED|Overall Study||0
9969851|NCT01529450|11090499|FG001|NOT COMPLETED|Overall Study||2
9969852|NCT01529502|11090512|FG000|STARTED|Overall Study||2
9969853|NCT01529502|11090513|FG001|STARTED|Overall Study||3
9969854|NCT01529502|11090514|FG002|STARTED|Overall Study||2
9969855|NCT01529502|11090515|FG003|STARTED|Overall Study||3
9969856|NCT01529502|11090516|FG004|STARTED|Overall Study||2
9969857|NCT01529502|11090517|FG005|STARTED|Overall Study||2
9969858|NCT01529502|11090512|FG000|COMPLETED|Overall Study||2
9969859|NCT01529502|11090513|FG001|COMPLETED|Overall Study||3
9969860|NCT01529502|11090514|FG002|COMPLETED|Overall Study||2
9969861|NCT01529502|11090515|FG003|COMPLETED|Overall Study||1
9969862|NCT01529502|11090516|FG004|COMPLETED|Overall Study||2
9969863|NCT01529502|11090517|FG005|COMPLETED|Overall Study||2
9969864|NCT01529502|11090512|FG000|NOT COMPLETED|Overall Study||0
9969865|NCT01529502|11090513|FG001|NOT COMPLETED|Overall Study||0
9969866|NCT01529502|11090514|FG002|NOT COMPLETED|Overall Study||0
9969867|NCT01529502|11090515|FG003|NOT COMPLETED|Overall Study||2
9969868|NCT01529502|11090516|FG004|NOT COMPLETED|Overall Study||0
9969869|NCT01529502|11090517|FG005|NOT COMPLETED|Overall Study||0
9969870|NCT01529515|11090527|FG000|STARTED|TRANSITION PHASE||506
9969871|NCT01529515|11090528|FG001|STARTED|TRANSITION PHASE||0
9969872|NCT01529515|11090529|FG002|STARTED|TRANSITION PHASE||0
9969873|NCT01529515|11090530|FG003|STARTED|TRANSITION PHASE||0
9969874|NCT01529515|11090527|FG000|COMPLETED|TRANSITION PHASE||379
9969875|NCT01529515|11090528|FG001|COMPLETED|TRANSITION PHASE||0
9969876|NCT01529515|11090529|FG002|COMPLETED|TRANSITION PHASE||0
9969877|NCT01529515|11090530|FG003|COMPLETED|TRANSITION PHASE||0
9969878|NCT01529515|11090527|FG000|NOT COMPLETED|TRANSITION PHASE||127
9969879|NCT01529515|11090528|FG001|NOT COMPLETED|TRANSITION PHASE||0
9969880|NCT01529515|11090529|FG002|NOT COMPLETED|TRANSITION PHASE||0
9969881|NCT01529515|11090530|FG003|NOT COMPLETED|TRANSITION PHASE||0
9969882|NCT01529515|11090527|FG000|STARTED|MAINTENANCE PHASE||0
9969883|NCT01529515|11090528|FG001|STARTED|MAINTENANCE PHASE||379
9969884|NCT01529515|11090529|FG002|STARTED|MAINTENANCE PHASE||0
9969885|NCT01529515|11090530|FG003|STARTED|MAINTENANCE PHASE||0
9969886|NCT01529515|11090527|FG000|COMPLETED|MAINTENANCE PHASE||0
9969887|NCT01529515|11090528|FG001|COMPLETED|MAINTENANCE PHASE||305
9969888|NCT01529515|11090529|FG002|COMPLETED|MAINTENANCE PHASE||0
9969889|NCT01529515|11090530|FG003|COMPLETED|MAINTENANCE PHASE||0
9969890|NCT01529515|11090527|FG000|NOT COMPLETED|MAINTENANCE PHASE||0
9969891|NCT01529515|11090528|FG001|NOT COMPLETED|MAINTENANCE PHASE||74
9969892|NCT01529515|11090529|FG002|NOT COMPLETED|MAINTENANCE PHASE||0
9969893|NCT01529515|11090530|FG003|NOT COMPLETED|MAINTENANCE PHASE||0
9969894|NCT01529515|11090527|FG000|STARTED|DOUBLE BLIND PHASE||0
9969895|NCT01529515|11090528|FG001|STARTED|DOUBLE BLIND PHASE||0
9969896|NCT01529515|11090529|FG002|STARTED|DOUBLE BLIND PHASE||145
9969897|NCT01529515|11090530|FG003|STARTED|DOUBLE BLIND PHASE||160
9969898|NCT01529515|11090527|FG000|COMPLETED|DOUBLE BLIND PHASE||0
9969899|NCT01529515|11090528|FG001|COMPLETED|DOUBLE BLIND PHASE||0
9969900|NCT01529515|11090529|FG002|COMPLETED|DOUBLE BLIND PHASE||122
9969901|NCT01529515|11090530|FG003|COMPLETED|DOUBLE BLIND PHASE||148
9969902|NCT01529515|11090527|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0
9969903|NCT01529515|11090528|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0
9969904|NCT01529515|11090529|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23
9969905|NCT01529515|11090530|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12
9969906|NCT01529606|11090539|FG000|STARTED|Overall Study||55
9969907|NCT01529606|11090540|FG001|STARTED|Overall Study||47
9969908|NCT01529606|11090539|FG000|COMPLETED|Overall Study||34
9969909|NCT01529606|11090540|FG001|COMPLETED|Overall Study||29
9969910|NCT01529606|11090539|FG000|NOT COMPLETED|Overall Study||21
9969911|NCT01529606|11090540|FG001|NOT COMPLETED|Overall Study||18
9969912|NCT01529632|11090548|FG000|STARTED|Overall Study||90
9969913|NCT01529632|11090549|FG001|STARTED|Overall Study||103
9969914|NCT01529632|11090548|FG000|COMPLETED|Overall Study||87
9969915|NCT01529632|11090549|FG001|COMPLETED|Overall Study||100
9969916|NCT01529632|11090548|FG000|NOT COMPLETED|Overall Study||3
9969917|NCT01529632|11090549|FG001|NOT COMPLETED|Overall Study||3
9969918|NCT01529645|11090565|FG000|STARTED|Overall Study||42
9969919|NCT01529645|11090566|FG001|STARTED|Overall Study||42
9969920|NCT01529645|11090567|FG002|STARTED|Overall Study||42
9969921|NCT01529645|11090568|FG003|STARTED|Overall Study||42
9969922|NCT01529645|11090569|FG004|STARTED|Overall Study||42
9969923|NCT01529645|11090570|FG005|STARTED|Overall Study||42
9969924|NCT01529645|11090571|FG006|STARTED|Overall Study||42
9969925|NCT01529645|11090572|FG007|STARTED|Overall Study||42
9969926|NCT01529645|11090573|FG008|STARTED|Overall Study||42
9969927|NCT01529645|11090574|FG009|STARTED|Overall Study||42
9969928|NCT01529645|11090565|FG000|COMPLETED|Overall Study||40
9969929|NCT01529645|11090566|FG001|COMPLETED|Overall Study||41
9969930|NCT01529645|11090567|FG002|COMPLETED|Overall Study||40
9969931|NCT01529645|11090568|FG003|COMPLETED|Overall Study||40
9969932|NCT01529645|11090569|FG004|COMPLETED|Overall Study||40
9969933|NCT01529645|11090570|FG005|COMPLETED|Overall Study||41
9969934|NCT01529645|11090571|FG006|COMPLETED|Overall Study||40
9969935|NCT01529645|11090572|FG007|COMPLETED|Overall Study||42
9969936|NCT01529645|11090573|FG008|COMPLETED|Overall Study||41
9969937|NCT01529645|11090574|FG009|COMPLETED|Overall Study||42
9969938|NCT01529645|11090565|FG000|NOT COMPLETED|Overall Study||2
9969939|NCT01529645|11090566|FG001|NOT COMPLETED|Overall Study||1
9969940|NCT01529645|11090567|FG002|NOT COMPLETED|Overall Study||2
9969941|NCT01529645|11090568|FG003|NOT COMPLETED|Overall Study||2
9969942|NCT01529645|11090569|FG004|NOT COMPLETED|Overall Study||2
9969943|NCT01529645|11090570|FG005|NOT COMPLETED|Overall Study||1
9969944|NCT01529645|11090571|FG006|NOT COMPLETED|Overall Study||2
9969945|NCT01529645|11090572|FG007|NOT COMPLETED|Overall Study||0
9969946|NCT01529645|11090573|FG008|NOT COMPLETED|Overall Study||1
9969947|NCT01529645|11090574|FG009|NOT COMPLETED|Overall Study||0
9969948|NCT01529749|11090608|FG000|STARTED|Overall Study||12
9969949|NCT01529749|11090609|FG001|STARTED|Overall Study||12
9969950|NCT01529749|11090610|FG002|STARTED|Overall Study||12
9969951|NCT01529749|11090611|FG003|STARTED|Overall Study||12
9969952|NCT01529749|11090608|FG000|COMPLETED|Overall Study||12
9969953|NCT01529749|11090609|FG001|COMPLETED|Overall Study||10
9969954|NCT01529749|11090610|FG002|COMPLETED|Overall Study||10
9969955|NCT01529749|11090611|FG003|COMPLETED|Overall Study||10
9969956|NCT01529749|11090608|FG000|NOT COMPLETED|Overall Study||0
9969957|NCT01529749|11090609|FG001|NOT COMPLETED|Overall Study||2
9969958|NCT01529749|11090610|FG002|NOT COMPLETED|Overall Study||2
9969959|NCT01529749|11090611|FG003|NOT COMPLETED|Overall Study||2
9969960|NCT01529827|11090621|FG000|STARTED|Overall Study||94
9969961|NCT01529827|11090621|FG000|COMPLETED|Overall Study||94
9969962|NCT01529827|11090621|FG000|NOT COMPLETED|Overall Study||0
9969963|NCT01530178|11090627|FG000|STARTED|Overall Study||2
9969964|NCT01530178|11090628|FG001|STARTED|Overall Study||6
9969965|NCT01530178|11090627|FG000|COMPLETED|Overall Study||2
9969966|NCT01530178|11090628|FG001|COMPLETED|Overall Study||6
9969967|NCT01530178|11090627|FG000|NOT COMPLETED|Overall Study||0
9969968|NCT01530178|11090628|FG001|NOT COMPLETED|Overall Study||0
9969969|NCT01530243|11090642|FG000|STARTED|Overall Study||26
9969970|NCT01530243|11090643|FG001|STARTED|Overall Study||26
9969971|NCT01530243|11090644|FG002|STARTED|Overall Study||26
9969972|NCT01530243|11090645|FG003|STARTED|Overall Study||26
9969973|NCT01530243|11090642|FG000|COMPLETED|Overall Study||24
9969974|NCT01530243|11090643|FG001|COMPLETED|Overall Study||23
9969975|NCT01530243|11090644|FG002|COMPLETED|Overall Study||23
9969976|NCT01530243|11090645|FG003|COMPLETED|Overall Study||24
9969977|NCT01530243|11090642|FG000|NOT COMPLETED|Overall Study||2
9969978|NCT01530243|11090643|FG001|NOT COMPLETED|Overall Study||3
9969979|NCT01530243|11090644|FG002|NOT COMPLETED|Overall Study||3
9969980|NCT01530243|11090645|FG003|NOT COMPLETED|Overall Study||2
10017533|NCT01817582|11140462|FG001|COMPLETED|Overall Study||35
10017534|NCT01817582|11140463|FG002|COMPLETED|Overall Study||33
10017535|NCT01817582|11140461|FG000|NOT COMPLETED|Overall Study||2
10017536|NCT01817582|11140462|FG001|NOT COMPLETED|Overall Study||1
10017537|NCT01817582|11140463|FG002|NOT COMPLETED|Overall Study||0
10017538|NCT01817712|11140473|FG000|STARTED|Overall Study||271
10017539|NCT01817712|11140474|FG001|STARTED|Overall Study||270
10017540|NCT01817712|11140473|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
10017541|NCT01817712|11140474|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
10017542|NCT01817712|11140473|FG000|NOT COMPLETED|Overall Study||21
10017543|NCT01817712|11140474|FG001|NOT COMPLETED|Overall Study||30
10017544|NCT01817725|11140480|FG000|STARTED|Overall Study||20
10017545|NCT01817725|11140480|FG000|COMPLETED|Overall Study||19
10017546|NCT01817725|11140480|FG000|NOT COMPLETED|Overall Study||1
10017547|NCT01817764|11140486|FG000|STARTED|Overall Study||353
10017548|NCT01817764|11140487|FG001|STARTED|Overall Study||353
10017549|NCT01817764|11140486|FG000|COMPLETED|Overall Study||319
10017550|NCT01817764|11140487|FG001|COMPLETED|Overall Study||315
10017551|NCT01817764|11140486|FG000|NOT COMPLETED|Overall Study||34
10017552|NCT01817764|11140487|FG001|NOT COMPLETED|Overall Study||38
10017553|NCT01817777|11140495|FG000|STARTED|Observational Phase (8 Weeks)||36
10017554|NCT01817777|11140496|FG001|STARTED|Observational Phase (8 Weeks)||0
10017555|NCT01817777|11140497|FG002|STARTED|Observational Phase (8 Weeks)||0
10017556|NCT01817777|11140495|FG000|COMPLETED|Observational Phase (8 Weeks)||31
10017557|NCT01817777|11140496|FG001|COMPLETED|Observational Phase (8 Weeks)||0
10017558|NCT01817777|11140497|FG002|COMPLETED|Observational Phase (8 Weeks)||0
10017559|NCT01817777|11140495|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5
10017560|NCT01817777|11140496|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0
10017561|NCT01817777|11140497|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0
10017562|NCT01817777|11140495|FG000|STARTED|Interventional Phase (20 Weeks)||0
10017563|NCT01817777|11140496|FG001|STARTED|Interventional Phase (20 Weeks)||16
10017564|NCT01817777|11140497|FG002|STARTED|Interventional Phase (20 Weeks)||15
10017565|NCT01817777|11140495|FG000|COMPLETED|Interventional Phase (20 Weeks)||0
10017566|NCT01817777|11140496|FG001|COMPLETED|Interventional Phase (20 Weeks)||11
10017567|NCT01817777|11140497|FG002|COMPLETED|Interventional Phase (20 Weeks)||10
10017568|NCT01817777|11140495|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0
10017569|NCT01817777|11140496|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5
10017570|NCT01817777|11140497|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5
10017571|NCT01817790|11140505|FG000|STARTED|Overall Study||314
10017572|NCT01817790|11140506|FG001|STARTED|Overall Study||312
10017573|NCT01817790|11140505|FG000|COMPLETED|Overall Study||310
10017574|NCT01817790|11140506|FG001|COMPLETED|Overall Study||304
10017575|NCT01817790|11140505|FG000|NOT COMPLETED|Overall Study||4
10017576|NCT01817790|11140506|FG001|NOT COMPLETED|Overall Study||8
10017577|NCT01817855|11140518|FG000|STARTED|Overall Study||23
10017578|NCT01817855|11140519|FG001|STARTED|Overall Study||8
10017579|NCT01817855|11140520|FG002|STARTED|Overall Study||11
10017580|NCT01817855|11140521|FG003|STARTED|Overall Study||5
10017581|NCT01817855|11140518|FG000|COMPLETED|Overall Study||23
10017582|NCT01817855|11140519|FG001|COMPLETED|Overall Study||6
10017583|NCT01817855|11140520|FG002|COMPLETED|Overall Study||9
10017584|NCT01817855|11140521|FG003|COMPLETED|Overall Study||5
9969981|NCT01530256|11090656|FG000|STARTED|Overall Study||3
9969982|NCT01530256|11090656|FG000|COMPLETED|Overall Study||1
9969983|NCT01530256|11090656|FG000|NOT COMPLETED|Overall Study||2
9969984|NCT01530334|11090660|FG000|STARTED|Overall Study||61
9969985|NCT01530334|11090660|FG000|COMPLETED|Overall Study||10
9969986|NCT01530334|11090660|FG000|NOT COMPLETED|Overall Study||51
9969987|NCT01530399|11090670|FG000|STARTED|Overall Study||8
9969988|NCT01530399|11090671|FG001|STARTED|Overall Study||10
9969989|NCT01530399|11090672|FG002|STARTED|Overall Study||8
9969990|NCT01530399|11090673|FG003|STARTED|Overall Study||10
9969991|NCT01530399|11090674|FG004|STARTED|Overall Study||6
9969992|NCT01530399|11090675|FG005|STARTED|Overall Study||7
9969993|NCT01530399|11090670|FG000|COMPLETED|Overall Study||7
9969994|NCT01530399|11090671|FG001|COMPLETED|Overall Study||8
9969995|NCT01530399|11090672|FG002|COMPLETED|Overall Study||7
9969996|NCT01530399|11090673|FG003|COMPLETED|Overall Study||10
9969997|NCT01530399|11090674|FG004|COMPLETED|Overall Study||6
9969998|NCT01530399|11090675|FG005|COMPLETED|Overall Study||6
9969999|NCT01530399|11090670|FG000|NOT COMPLETED|Overall Study||1
9970000|NCT01530399|11090671|FG001|NOT COMPLETED|Overall Study||2
9970001|NCT01530399|11090672|FG002|NOT COMPLETED|Overall Study||1
9970002|NCT01530399|11090673|FG003|NOT COMPLETED|Overall Study||0
9970003|NCT01530399|11090674|FG004|NOT COMPLETED|Overall Study||0
9970004|NCT01530399|11090675|FG005|NOT COMPLETED|Overall Study||1
9970005|NCT01530464|11090691|FG000|STARTED|First Intervention (24h)||10
9970006|NCT01530464|11090692|FG001|STARTED|First Intervention (24h)||8
9970007|NCT01530464|11090691|FG000|COMPLETED|First Intervention (24h)||10
9970008|NCT01530464|11090692|FG001|COMPLETED|First Intervention (24h)||8
9970009|NCT01530464|11090691|FG000|NOT COMPLETED|First Intervention (24h)||0
9970010|NCT01530464|11090692|FG001|NOT COMPLETED|First Intervention (24h)||0
9970011|NCT01530464|11090691|FG000|STARTED|Washout (24h)||10
9970012|NCT01530464|11090692|FG001|STARTED|Washout (24h)||8
9970013|NCT01530464|11090691|FG000|COMPLETED|Washout (24h)||10
9970014|NCT01530464|11090692|FG001|COMPLETED|Washout (24h)||8
9970015|NCT01530464|11090691|FG000|NOT COMPLETED|Washout (24h)||0
9970016|NCT01530464|11090692|FG001|NOT COMPLETED|Washout (24h)||0
9970017|NCT01530464|11090691|FG000|STARTED|Second Intervention (24h)||10
9970018|NCT01530464|11090692|FG001|STARTED|Second Intervention (24h)||8
9970019|NCT01530464|11090691|FG000|COMPLETED|Second Intervention (24h)||10
9970020|NCT01530464|11090692|FG001|COMPLETED|Second Intervention (24h)||8
9970021|NCT01530464|11090691|FG000|NOT COMPLETED|Second Intervention (24h)||0
9970022|NCT01530464|11090692|FG001|NOT COMPLETED|Second Intervention (24h)||0
9970023|NCT01530464|11090691|FG000|STARTED|Washout (24h)||10
9970024|NCT01530464|11090692|FG001|STARTED|Washout (24h)||8
9970025|NCT01530464|11090691|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
9970026|NCT01530464|11090692|FG001|COMPLETED|Washout (24h)||8
9970027|NCT01530464|11090691|FG000|NOT COMPLETED|Washout (24h)||1
9970028|NCT01530464|11090692|FG001|NOT COMPLETED|Washout (24h)||0
9970029|NCT01530464|11090691|FG000|STARTED|Third Intervention (24h)||9
9970030|NCT01530464|11090692|FG001|STARTED|Third Intervention (24h)||8
9970031|NCT01530464|11090691|FG000|COMPLETED|Third Intervention (24h)||9
9970032|NCT01530464|11090692|FG001|COMPLETED|Third Intervention (24h)||8
9970033|NCT01530464|11090691|FG000|NOT COMPLETED|Third Intervention (24h)||0
9970034|NCT01530464|11090692|FG001|NOT COMPLETED|Third Intervention (24h)||0
9970035|NCT01530464|11090691|FG000|STARTED|Washout (24h)||9
9970036|NCT01530464|11090692|FG001|STARTED|Washout (24h)||8
9970037|NCT01530464|11090691|FG000|COMPLETED|Washout (24h)||9
9970038|NCT01530464|11090692|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
9970039|NCT01530464|11090691|FG000|NOT COMPLETED|Washout (24h)||0
9970040|NCT01530464|11090692|FG001|NOT COMPLETED|Washout (24h)||1
9970041|NCT01530477|11090706|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
9970042|NCT01530477|11090707|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
9970043|NCT01530477|11090708|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
9970044|NCT01530477|11090706|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
9970045|NCT01530477|11090707|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
9970046|NCT01530477|11090708|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
9970047|NCT01530477|11090706|FG000|NOT COMPLETED|Overall Study||0
9970048|NCT01530477|11090707|FG001|NOT COMPLETED|Overall Study||0
9970049|NCT01530477|11090708|FG002|NOT COMPLETED|Overall Study||0
9970050|NCT01531153|11090717|FG000|STARTED|Overall Study||32
9970051|NCT01531153|11090718|FG001|STARTED|Overall Study||31
9970052|NCT01531153|11090719|FG002|STARTED|Overall Study||30
9970053|NCT01531153|11090717|FG000|COMPLETED|Overall Study||22
9970054|NCT01531153|11090718|FG001|COMPLETED|Overall Study||22
9970055|NCT01531153|11090719|FG002|COMPLETED|Overall Study||15
9970056|NCT01531153|11090717|FG000|NOT COMPLETED|Overall Study||10
9970057|NCT01531153|11090718|FG001|NOT COMPLETED|Overall Study||9
9970058|NCT01531153|11090719|FG002|NOT COMPLETED|Overall Study||15
9970059|NCT01531205|11090730|FG000|STARTED|Overall Study||2
9970060|NCT01531205|11090730|FG000|COMPLETED|Overall Study||1
9970061|NCT01531205|11090730|FG000|NOT COMPLETED|Overall Study||1
9970062|NCT01531335|11090738|FG000|STARTED|Overall Study||40
9970063|NCT01531335|11090739|FG001|STARTED|Overall Study||40
9970064|NCT01531335|11090738|FG000|COMPLETED|Overall Study||40
9970065|NCT01531335|11090739|FG001|COMPLETED|Overall Study||40
9970066|NCT01531335|11090738|FG000|NOT COMPLETED|Overall Study||0
9970067|NCT01531335|11090739|FG001|NOT COMPLETED|Overall Study||0
9970068|NCT01531439|11090747|FG000|STARTED|Overall Study||41
9970069|NCT01531439|11090748|FG001|STARTED|Overall Study||43
9970070|NCT01531439|11090747|FG000|COMPLETED|Overall Study||37
9970071|NCT01531439|11090748|FG001|COMPLETED|Overall Study||42
9970072|NCT01531439|11090747|FG000|NOT COMPLETED|Overall Study||4
9970073|NCT01531439|11090748|FG001|NOT COMPLETED|Overall Study||1
9970074|NCT01531673|11090767|FG000|STARTED|Overall Study||33
9970075|NCT01531673|11090768|FG001|STARTED|Overall Study||8
9970076|NCT01531673|11090769|FG002|STARTED|Overall Study||8
9970077|NCT01531673|11090770|FG003|STARTED|Overall Study||18
9970078|NCT01531673|11090771|FG004|STARTED|Overall Study||8
9970079|NCT01531673|11090772|FG005|STARTED|Overall Study||19
9970080|NCT01531673|11090773|FG006|STARTED|Overall Study||17
9970081|NCT01531673|11090774|FG007|STARTED|Overall Study||9
9970082|NCT01531673|11090775|FG008|STARTED|Overall Study||17
9970083|NCT01531673|11090776|FG009|STARTED|Overall Study||19
9970084|NCT01531673|11090777|FG010|STARTED|Overall Study||16
9970085|NCT01531673|11090778|FG011|STARTED|Overall Study||4
9970086|NCT01531673|11090779|FG012|STARTED|Overall Study||14
9970087|NCT01531673|11090767|FG000|COMPLETED|Overall Study||33
9970088|NCT01531673|11090768|FG001|COMPLETED|Overall Study||7
9970089|NCT01531673|11090769|FG002|COMPLETED|Overall Study||8
9970090|NCT01531673|11090770|FG003|COMPLETED|Overall Study||17
9970091|NCT01531673|11090771|FG004|COMPLETED|Overall Study||7
10098094|NCT02380287|11227113|FG006|COMPLETED|Overall Study||3
9970092|NCT01531673|11090772|FG005|COMPLETED|Overall Study||18
9970093|NCT01531673|11090773|FG006|COMPLETED|Overall Study||17
9970094|NCT01531673|11090774|FG007|COMPLETED|Overall Study||9
9970095|NCT01531673|11090775|FG008|COMPLETED|Overall Study||17
9970096|NCT01531673|11090776|FG009|COMPLETED|Overall Study||18
9970097|NCT01531673|11090777|FG010|COMPLETED|Overall Study||16
9970098|NCT01531673|11090778|FG011|COMPLETED|Overall Study||4
9970099|NCT01531673|11090779|FG012|COMPLETED|Overall Study||14
9970100|NCT01531673|11090767|FG000|NOT COMPLETED|Overall Study||0
9970101|NCT01531673|11090768|FG001|NOT COMPLETED|Overall Study||1
9970102|NCT01531673|11090769|FG002|NOT COMPLETED|Overall Study||0
9970103|NCT01531673|11090770|FG003|NOT COMPLETED|Overall Study||1
9970104|NCT01531673|11090771|FG004|NOT COMPLETED|Overall Study||1
9970105|NCT01531673|11090772|FG005|NOT COMPLETED|Overall Study||1
9970106|NCT01531673|11090773|FG006|NOT COMPLETED|Overall Study||0
9970107|NCT01531673|11090774|FG007|NOT COMPLETED|Overall Study||0
9970108|NCT01531673|11090775|FG008|NOT COMPLETED|Overall Study||0
9970109|NCT01531673|11090776|FG009|NOT COMPLETED|Overall Study||1
9970110|NCT01531673|11090777|FG010|NOT COMPLETED|Overall Study||0
9970111|NCT01531673|11090778|FG011|NOT COMPLETED|Overall Study||0
9970112|NCT01531673|11090779|FG012|NOT COMPLETED|Overall Study||0
9970113|NCT01531725|11090831|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
9970114|NCT01531725|11090831|FG000|COMPLETED|Overall Study||197
9970115|NCT01531725|11090831|FG000|NOT COMPLETED|Overall Study||5
9970116|NCT01531738|11090837|FG000|STARTED|Overall Study||11
9970117|NCT01531738|11090838|FG001|STARTED|Overall Study||11
9970118|NCT01531738|11090837|FG000|COMPLETED|Overall Study||11
9970119|NCT01531738|11090838|FG001|COMPLETED|Overall Study||11
9970120|NCT01531738|11090837|FG000|NOT COMPLETED|Overall Study||0
9970121|NCT01531738|11090838|FG001|NOT COMPLETED|Overall Study||0
9970122|NCT01531803|11090846|FG000|STARTED|Overall Study||1
9970123|NCT01531803|11090847|FG001|STARTED|Overall Study||2
9970124|NCT01531803|11090846|FG000|COMPLETED|Overall Study||1
9970125|NCT01531803|11090847|FG001|COMPLETED|Overall Study||2
9970126|NCT01531803|11090846|FG000|NOT COMPLETED|Overall Study||0
9970127|NCT01531803|11090847|FG001|NOT COMPLETED|Overall Study||0
9970128|NCT01531894|11090853|FG000|STARTED|Overall Study||11
9970129|NCT01531894|11090853|FG000|COMPLETED|Overall Study||2
9970130|NCT01531894|11090853|FG000|NOT COMPLETED|Overall Study||9
9970131|NCT01531959|11090859|FG000|STARTED|Overall Study||68
9970132|NCT01531959|11090860|FG001|STARTED|Overall Study||68
9970133|NCT01531959|11090859|FG000|COMPLETED|Overall Study||66
9970134|NCT01531959|11090860|FG001|COMPLETED|Overall Study||66
9970135|NCT01531959|11090859|FG000|NOT COMPLETED|Overall Study||2
9970136|NCT01531959|11090860|FG001|NOT COMPLETED|Overall Study||2
9970137|NCT01531998|11090866|FG000|STARTED|Overall Study||11
9970138|NCT01531998|11090866|FG000|COMPLETED|Overall Study||8
9970139|NCT01531998|11090866|FG000|NOT COMPLETED|Overall Study||3
9970140|NCT01532089|11090872|FG000|STARTED|Overall Study||45
9970141|NCT01532089|11090873|FG001|STARTED|Overall Study||43
9970142|NCT01532089|11090872|FG000|COMPLETED|Overall Study||45
9970143|NCT01532089|11090873|FG001|COMPLETED|Overall Study||43
9970144|NCT01532089|11090872|FG000|NOT COMPLETED|Overall Study||0
9970145|NCT01532089|11090873|FG001|NOT COMPLETED|Overall Study||0
9970146|NCT01532128|11090884|FG000|STARTED|Overall Study||8
9970147|NCT01532128|11090885|FG001|STARTED|Overall Study||8
9970148|NCT01532128|11090886|FG002|STARTED|Overall Study||8
9970149|NCT01532128|11090884|FG000|COMPLETED|Overall Study||8
9970150|NCT01532128|11090885|FG001|COMPLETED|Overall Study||8
9970151|NCT01532128|11090886|FG002|COMPLETED|Overall Study||8
9970152|NCT01532128|11090884|FG000|NOT COMPLETED|Overall Study||0
9970153|NCT01532128|11090885|FG001|NOT COMPLETED|Overall Study||0
9970154|NCT01532128|11090886|FG002|NOT COMPLETED|Overall Study||0
9970155|NCT01532141|11090898|FG000|STARTED|Overall Study||9
9970156|NCT01532141|11090899|FG001|STARTED|Overall Study||8
9970157|NCT01532141|11090900|FG002|STARTED|Overall Study||8
9970158|NCT01532141|11090898|FG000|Period 1|Overall Study||9
9970159|NCT01532141|11090899|FG001|Period 1|Overall Study||8
9970160|NCT01532141|11090900|FG002|Period 1|Overall Study||8
9970161|NCT01532141|11090898|FG000|Period 2|Overall Study||8
9970162|NCT01532141|11090899|FG001|Period 2|Overall Study||8
9970163|NCT01532141|11090900|FG002|Period 2|Overall Study||8
10098095|NCT02380287|11227114|FG007|COMPLETED|Overall Study||3
10098096|NCT02380287|11227107|FG000|NOT COMPLETED|Overall Study||0
9970164|NCT01532141|11090898|FG000|Period 3|Overall Study||8
9970165|NCT01532141|11090899|FG001|Period 3|Overall Study||8
9970166|NCT01532141|11090900|FG002|Period 3|Overall Study||8
9970167|NCT01532141|11090898|FG000|COMPLETED|Overall Study||8
9970168|NCT01532141|11090899|FG001|COMPLETED|Overall Study||8
9970169|NCT01532141|11090900|FG002|COMPLETED|Overall Study||8
9970170|NCT01532141|11090898|FG000|NOT COMPLETED|Overall Study||1
9970171|NCT01532141|11090899|FG001|NOT COMPLETED|Overall Study||0
9970172|NCT01532141|11090900|FG002|NOT COMPLETED|Overall Study||0
9970173|NCT01532349|11090911|FG000|STARTED|Overall Study||17
9970174|NCT01532349|11090912|FG001|STARTED|Overall Study||17
9970175|NCT01532349|11090911|FG000|COMPLETED|Overall Study||15
9970176|NCT01532349|11090912|FG001|COMPLETED|Overall Study||12
9970177|NCT01532349|11090911|FG000|NOT COMPLETED|Overall Study||2
9970178|NCT01532349|11090912|FG001|NOT COMPLETED|Overall Study||5
9970179|NCT01532388|11090920|FG000|STARTED|3-month Follow-up||101
9970180|NCT01532388|11090921|FG001|STARTED|3-month Follow-up||101
9970181|NCT01532388|11090920|FG000|COMPLETED|3-month Follow-up||33
9970182|NCT01532388|11090921|FG001|COMPLETED|3-month Follow-up||33
9970183|NCT01532388|11090920|FG000|NOT COMPLETED|3-month Follow-up||68
9970184|NCT01532388|11090921|FG001|NOT COMPLETED|3-month Follow-up||68
9970185|NCT01532388|11090920|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
9970186|NCT01532388|11090921|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
9970187|NCT01532388|11090920|FG000|COMPLETED|6-month Follow-up||27
9970188|NCT01532388|11090921|FG001|COMPLETED|6-month Follow-up||35
9970189|NCT01532388|11090920|FG000|NOT COMPLETED|6-month Follow-up||74
9970190|NCT01532388|11090921|FG001|NOT COMPLETED|6-month Follow-up||66
9970191|NCT01532388|11090920|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
9970192|NCT01532388|11090921|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
9970193|NCT01532388|11090920|FG000|COMPLETED|12-month Follow-up||32
9970194|NCT01532388|11090921|FG001|COMPLETED|12-month Follow-up||34
9970195|NCT01532388|11090920|FG000|NOT COMPLETED|12-month Follow-up||69
9970196|NCT01532388|11090921|FG001|NOT COMPLETED|12-month Follow-up||67
9970197|NCT01532414|11090930|FG000|STARTED|Overall Study||92
9970198|NCT01532414|11090931|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
9970199|NCT01532414|11090932|FG002|STARTED|Overall Study||38
9970200|NCT01532414|11090930|FG000|COMPLETED|Overall Study||85
9970201|NCT01532414|11090931|FG001|COMPLETED|Overall Study||19
9970202|NCT01532414|11090932|FG002|COMPLETED|Overall Study||35
9970203|NCT01532414|11090930|FG000|NOT COMPLETED|Overall Study||7
9970204|NCT01532414|11090931|FG001|NOT COMPLETED|Overall Study||2
9970205|NCT01532414|11090932|FG002|NOT COMPLETED|Overall Study||3
9970206|NCT01532453|11090942|FG000|STARTED|Overall Study||81
9970207|NCT01532453|11090943|FG001|STARTED|Overall Study||160
9970208|NCT01532453|11090942|FG000|COMPLETED|Overall Study||54
9970209|NCT01532453|11090943|FG001|COMPLETED|Overall Study||90
9970210|NCT01532453|11090942|FG000|NOT COMPLETED|Overall Study||27
9970211|NCT01532453|11090943|FG001|NOT COMPLETED|Overall Study||70
9970212|NCT01532570|11090953|FG000|STARTED|Overall Study||11
9970213|NCT01532570|11090954|FG001|STARTED|Overall Study||2
9970214|NCT01532570|11090955|FG002|STARTED|Overall Study||1
9970215|NCT01532570|11090956|FG003|STARTED|Overall Study||4
9970216|NCT01532570|11090953|FG000|COMPLETED|Overall Study||10
9970217|NCT01532570|11090954|FG001|COMPLETED|Overall Study||1
9970218|NCT01532570|11090955|FG002|COMPLETED|Overall Study||1
9970219|NCT01532570|11090956|FG003|COMPLETED|Overall Study||4
9970220|NCT01532570|11090953|FG000|NOT COMPLETED|Overall Study||1
9970221|NCT01532570|11090954|FG001|NOT COMPLETED|Overall Study||1
9970222|NCT01532570|11090955|FG002|NOT COMPLETED|Overall Study||0
9970223|NCT01532570|11090956|FG003|NOT COMPLETED|Overall Study||0
9970224|NCT01532648|11090975|FG000|STARTED|Overall Study||255
9970225|NCT01532648|11090976|FG001|STARTED|Overall Study||255
9970226|NCT01532648|11090975|FG000|Safety Population|Overall Study||255
9970227|NCT01532648|11090976|FG001|Safety Population|Overall Study||255
9970228|NCT01532648|11090975|FG000|Intent-To-Treat Population|Overall Study||230
9970229|NCT01532648|11090976|FG001|Intent-To-Treat Population|Overall Study||228
9970230|NCT01532648|11090975|FG000|COMPLETED|Overall Study||219
9970231|NCT01532648|11090976|FG001|COMPLETED|Overall Study||238
9970232|NCT01532648|11090975|FG000|NOT COMPLETED|Overall Study||36
9970233|NCT01532648|11090976|FG001|NOT COMPLETED|Overall Study||17
9970234|NCT01532687|11090984|FG000|STARTED|Overall Study||29
9970235|NCT01532687|11090985|FG001|STARTED|Overall Study||25
9970236|NCT01532687|11090984|FG000|Crossover to Open-label Pazopanib|Overall Study||0
9970237|NCT01532687|11090985|FG001|Crossover to Open-label Pazopanib|Overall Study||14
10017585|NCT01817855|11140518|FG000|NOT COMPLETED|Overall Study||0
10017586|NCT01817855|11140519|FG001|NOT COMPLETED|Overall Study||2
10017587|NCT01817855|11140520|FG002|NOT COMPLETED|Overall Study||2
10017588|NCT01817855|11140521|FG003|NOT COMPLETED|Overall Study||0
9970238|NCT01532687|11090984|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
9970239|NCT01532687|11090985|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
9970240|NCT01532687|11090984|FG000|NOT COMPLETED|Overall Study||14
9970241|NCT01532687|11090985|FG001|NOT COMPLETED|Overall Study||2
9970242|NCT01532700|11090993|FG000|STARTED|Overall Study||28
9970243|NCT01532700|11090993|FG000|COMPLETED|Overall Study||28
9970244|NCT01532700|11090993|FG000|NOT COMPLETED|Overall Study||0
9970245|NCT01532817|11090997|FG000|STARTED|Overall Study||30
9970246|NCT01532817|11090997|FG000|COMPLETED|Overall Study||30
9970247|NCT01532817|11090997|FG000|NOT COMPLETED|Overall Study||0
9970248|NCT01532830|11091001|FG000|STARTED|Overall Study||30
9970249|NCT01532830|11091001|FG000|COMPLETED|Overall Study||26
9970250|NCT01532830|11091001|FG000|NOT COMPLETED|Overall Study||4
9970251|NCT01532869|11091007|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44
9970252|NCT01532869|11091008|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43
9970253|NCT01532869|11091007|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
9970254|NCT01532869|11091008|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
9970255|NCT01532869|11091007|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
9970256|NCT01532869|11091008|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
9970257|NCT01532869|11091007|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44
9970258|NCT01532869|11091008|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43
9970259|NCT01532869|11091007|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
9970260|NCT01532869|11091008|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
9970261|NCT01532869|11091007|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
9970262|NCT01532869|11091008|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
9970263|NCT01532869|11091007|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
9970264|NCT01532869|11091008|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30
9970265|NCT01532869|11091007|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
9970266|NCT01532869|11091008|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
9970267|NCT01532869|11091007|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
9970268|NCT01532869|11091008|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
9970269|NCT01532908|11091021|FG000|STARTED|Overall Study||9
9970270|NCT01532908|11091022|FG001|STARTED|Overall Study||2
9970271|NCT01532908|11091021|FG000|Infused|Overall Study||9
9970272|NCT01532908|11091022|FG001|Infused|Overall Study||2
9970273|NCT01532908|11091021|FG000|Transplanted|Overall Study||8
9970274|NCT01532908|11091022|FG001|Transplanted|Overall Study||2
9970275|NCT01532908|11091021|FG000|COMPLETED|Overall Study||8
9970276|NCT01532908|11091022|FG001|COMPLETED|Overall Study||2
9970277|NCT01532908|11091021|FG000|NOT COMPLETED|Overall Study||1
9970278|NCT01532908|11091022|FG001|NOT COMPLETED|Overall Study||0
9970279|NCT01532921|11091028|FG000|STARTED|Overall Study||85
9970280|NCT01532921|11091028|FG000|Implantation Procedure|Overall Study||76
9970281|NCT01532921|11091028|FG000|Discharge|Overall Study||75
9970282|NCT01532921|11091028|FG000|6 Months Follow Up|Overall Study||68
9970283|NCT01532921|11091028|FG000|COMPLETED|Overall Study||69
9970284|NCT01532921|11091028|FG000|NOT COMPLETED|Overall Study||16
9970285|NCT01532934|11091038|FG000|STARTED|Overall Study||53
9970286|NCT01532934|11091039|FG001|STARTED|Overall Study||52
9970287|NCT01532934|11091038|FG000|COMPLETED|Overall Study||39
9970288|NCT01532934|11091039|FG001|COMPLETED|Overall Study||39
9970289|NCT01532934|11091038|FG000|NOT COMPLETED|Overall Study||14
9970290|NCT01532934|11091039|FG001|NOT COMPLETED|Overall Study||13
9970291|NCT01532973|11091056|FG000|STARTED|Part 1||6
9970292|NCT01532973|11091057|FG001|STARTED|Part 1||6
9970293|NCT01532973|11091058|FG002|STARTED|Part 1||6
9970294|NCT01532973|11091059|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
9970295|NCT01532973|11091060|FG004|STARTED|Part 1||0
9970296|NCT01532973|11091061|FG005|STARTED|Part 1||0
9970297|NCT01532973|11091062|FG006|STARTED|Part 1||0
9970298|NCT01532973|11091063|FG007|STARTED|Part 1||0
9970299|NCT01532973|11091064|FG008|STARTED|Part 1||0
9970300|NCT01532973|11091065|FG009|STARTED|Part 1||0
9970301|NCT01532973|11091056|FG000|COMPLETED|Part 1||6
9970302|NCT01532973|11091057|FG001|COMPLETED|Part 1||6
9970303|NCT01532973|11091058|FG002|COMPLETED|Part 1||6
9970304|NCT01532973|11091059|FG003|COMPLETED|Part 1||0
9970305|NCT01532973|11091060|FG004|COMPLETED|Part 1||0
9970306|NCT01532973|11091061|FG005|COMPLETED|Part 1||0
9970307|NCT01532973|11091062|FG006|COMPLETED|Part 1||0
9970308|NCT01532973|11091063|FG007|COMPLETED|Part 1||0
9970309|NCT01532973|11091064|FG008|COMPLETED|Part 1||0
9970310|NCT01532973|11091065|FG009|COMPLETED|Part 1||0
9970311|NCT01532973|11091056|FG000|NOT COMPLETED|Part 1||0
9970312|NCT01532973|11091057|FG001|NOT COMPLETED|Part 1||0
9970313|NCT01532973|11091058|FG002|NOT COMPLETED|Part 1||0
9970314|NCT01532973|11091059|FG003|NOT COMPLETED|Part 1||0
9970315|NCT01532973|11091060|FG004|NOT COMPLETED|Part 1||0
9970316|NCT01532973|11091061|FG005|NOT COMPLETED|Part 1||0
9970317|NCT01532973|11091062|FG006|NOT COMPLETED|Part 1||0
9970318|NCT01532973|11091063|FG007|NOT COMPLETED|Part 1||0
9970319|NCT01532973|11091064|FG008|NOT COMPLETED|Part 1||0
9970320|NCT01532973|11091065|FG009|NOT COMPLETED|Part 1||0
9970321|NCT01532973|11091056|FG000|STARTED|Part 2||0
9970322|NCT01532973|11091057|FG001|STARTED|Part 2||0
9970323|NCT01532973|11091058|FG002|STARTED|Part 2||0
9970324|NCT01532973|11091059|FG003|STARTED|Part 2||0
9970325|NCT01532973|11091060|FG004|STARTED|Part 2||6
9970326|NCT01532973|11091061|FG005|STARTED|Part 2||6
9970327|NCT01532973|11091062|FG006|STARTED|Part 2||6
9970328|NCT01532973|11091063|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
9970329|NCT01532973|11091064|FG008|STARTED|Part 2||0
9970330|NCT01532973|11091065|FG009|STARTED|Part 2||0
9970331|NCT01532973|11091056|FG000|COMPLETED|Part 2||0
9970332|NCT01532973|11091057|FG001|COMPLETED|Part 2||0
9970333|NCT01532973|11091058|FG002|COMPLETED|Part 2||0
9970334|NCT01532973|11091059|FG003|COMPLETED|Part 2||0
9970335|NCT01532973|11091060|FG004|COMPLETED|Part 2||6
9970336|NCT01532973|11091061|FG005|COMPLETED|Part 2||6
9970337|NCT01532973|11091062|FG006|COMPLETED|Part 2||6
9970338|NCT01532973|11091063|FG007|COMPLETED|Part 2||0
9970339|NCT01532973|11091064|FG008|COMPLETED|Part 2||0
9970340|NCT01532973|11091065|FG009|COMPLETED|Part 2||0
9970341|NCT01532973|11091056|FG000|NOT COMPLETED|Part 2||0
9970342|NCT01532973|11091057|FG001|NOT COMPLETED|Part 2||0
9970343|NCT01532973|11091058|FG002|NOT COMPLETED|Part 2||0
9970344|NCT01532973|11091059|FG003|NOT COMPLETED|Part 2||0
9970345|NCT01532973|11091060|FG004|NOT COMPLETED|Part 2||0
9970346|NCT01532973|11091061|FG005|NOT COMPLETED|Part 2||0
9970347|NCT01532973|11091062|FG006|NOT COMPLETED|Part 2||0
9970348|NCT01532973|11091063|FG007|NOT COMPLETED|Part 2||0
9970349|NCT01532973|11091064|FG008|NOT COMPLETED|Part 2||0
9970350|NCT01532973|11091065|FG009|NOT COMPLETED|Part 2||0
9970351|NCT01532973|11091056|FG000|STARTED|Part 3||0
9970352|NCT01532973|11091057|FG001|STARTED|Part 3||0
9970353|NCT01532973|11091058|FG002|STARTED|Part 3||0
9970354|NCT01532973|11091059|FG003|STARTED|Part 3||0
9970355|NCT01532973|11091060|FG004|STARTED|Part 3||0
9970356|NCT01532973|11091061|FG005|STARTED|Part 3||0
9970357|NCT01532973|11091062|FG006|STARTED|Part 3||0
9970358|NCT01532973|11091063|FG007|STARTED|Part 3||0
9970359|NCT01532973|11091064|FG008|STARTED|Part 3||6
9970360|NCT01532973|11091065|FG009|STARTED|Part 3||6
9970361|NCT01532973|11091056|FG000|COMPLETED|Part 3||0
9970362|NCT01532973|11091057|FG001|COMPLETED|Part 3||0
9970363|NCT01532973|11091058|FG002|COMPLETED|Part 3||0
9970364|NCT01532973|11091059|FG003|COMPLETED|Part 3||0
9970365|NCT01532973|11091060|FG004|COMPLETED|Part 3||0
9970366|NCT01532973|11091061|FG005|COMPLETED|Part 3||0
9970367|NCT01532973|11091062|FG006|COMPLETED|Part 3||0
9970368|NCT01532973|11091063|FG007|COMPLETED|Part 3||0
9970369|NCT01532973|11091064|FG008|COMPLETED|Part 3||6
9970370|NCT01532973|11091065|FG009|COMPLETED|Part 3||6
9970371|NCT01532973|11091056|FG000|NOT COMPLETED|Part 3||0
9970372|NCT01532973|11091057|FG001|NOT COMPLETED|Part 3||0
9970373|NCT01532973|11091058|FG002|NOT COMPLETED|Part 3||0
9970374|NCT01532973|11091059|FG003|NOT COMPLETED|Part 3||0
9970375|NCT01532973|11091060|FG004|NOT COMPLETED|Part 3||0
9970376|NCT01532973|11091061|FG005|NOT COMPLETED|Part 3||0
9970377|NCT01532973|11091062|FG006|NOT COMPLETED|Part 3||0
9970378|NCT01532973|11091063|FG007|NOT COMPLETED|Part 3||0
10098097|NCT02380287|11227108|FG001|NOT COMPLETED|Overall Study||0
10098098|NCT02380287|11227109|FG002|NOT COMPLETED|Overall Study||1
10098099|NCT02380287|11227110|FG003|NOT COMPLETED|Overall Study||0
10098100|NCT02380287|11227111|FG004|NOT COMPLETED|Overall Study||0
10098101|NCT02380287|11227112|FG005|NOT COMPLETED|Overall Study||0
10098102|NCT02380287|11227113|FG006|NOT COMPLETED|Overall Study||0
10098103|NCT02380287|11227114|FG007|NOT COMPLETED|Overall Study||0
10098104|NCT02380612|11227139|FG000|STARTED|Overall Study||30
10098105|NCT02380612|11227139|FG000|COMPLETED|Overall Study||27
10098106|NCT02380612|11227139|FG000|NOT COMPLETED|Overall Study||3
10098107|NCT02380677|11227158|FG000|STARTED|Overall Study||1
10098108|NCT02380677|11227159|FG001|STARTED|Overall Study||1
9970379|NCT01532973|11091064|FG008|NOT COMPLETED|Part 3||0
9970380|NCT01532973|11091065|FG009|NOT COMPLETED|Part 3||0
9970381|NCT01532986|11091091|FG000|STARTED|Overall Study||166
9970382|NCT01532986|11091092|FG001|STARTED|Overall Study||162
10098109|NCT02380677|11227160|FG002|STARTED|Overall Study||3
9970383|NCT01532986|11091091|FG000|COMPLETED|Overall Study||143
9970384|NCT01532986|11091092|FG001|COMPLETED|Overall Study||138
9970385|NCT01532986|11091091|FG000|NOT COMPLETED|Overall Study||23
9970386|NCT01532986|11091092|FG001|NOT COMPLETED|Overall Study||24
9970387|NCT01532999|11091101|FG000|STARTED|Overall Study||96
9970388|NCT01532999|11091102|FG001|STARTED|Overall Study||95
9970389|NCT01532999|11091101|FG000|COMPLETED|Overall Study||65
9970390|NCT01532999|11091102|FG001|COMPLETED|Overall Study||77
9970391|NCT01532999|11091101|FG000|NOT COMPLETED|Overall Study||31
9970392|NCT01532999|11091102|FG001|NOT COMPLETED|Overall Study||18
9970393|NCT01533038|11091110|FG000|STARTED|Overall Study||45
9970394|NCT01533038|11091111|FG001|STARTED|Overall Study||35
9970395|NCT01533038|11091110|FG000|COMPLETED|Overall Study||45
9970396|NCT01533038|11091111|FG001|COMPLETED|Overall Study||34
10098110|NCT02380677|11227161|FG003|STARTED|Overall Study||3
9970397|NCT01533038|11091110|FG000|NOT COMPLETED|Overall Study||0
9970398|NCT01533038|11091111|FG001|NOT COMPLETED|Overall Study||1
9970399|NCT01533077|11091121|FG000|STARTED|Overall Study||5
9970400|NCT01533077|11091122|FG001|STARTED|Overall Study||5
9970401|NCT01533077|11091123|FG002|STARTED|Overall Study||4
9970402|NCT01533077|11091124|FG003|STARTED|Overall Study||4
9970403|NCT01533077|11091121|FG000|BIA 9-1067 50 mg|Overall Study||5
9970404|NCT01533077|11091122|FG001|BIA 9-1067 50 mg|Overall Study||5
9970405|NCT01533077|11091123|FG002|BIA 9-1067 50 mg|Overall Study||4
9970406|NCT01533077|11091124|FG003|BIA 9-1067 50 mg|Overall Study||4
9970407|NCT01533077|11091121|FG000|Sinemet® 100/25|Overall Study||4
9970408|NCT01533077|11091122|FG001|Sinemet® 100/25|Overall Study||5
9970409|NCT01533077|11091123|FG002|Sinemet® 100/25|Overall Study||4
9970410|NCT01533077|11091124|FG003|Sinemet® 100/25|Overall Study||4
9970411|NCT01533077|11091121|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
9970412|NCT01533077|11091122|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
9970413|NCT01533077|11091123|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
9970414|NCT01533077|11091124|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
9970415|NCT01533077|11091121|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
9970416|NCT01533077|11091122|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
9970417|NCT01533077|11091123|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
9970418|NCT01533077|11091124|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
9970419|NCT01533077|11091121|FG000|COMPLETED|Overall Study||4
9970420|NCT01533077|11091122|FG001|COMPLETED|Overall Study||4
9970421|NCT01533077|11091123|FG002|COMPLETED|Overall Study||4
9970422|NCT01533077|11091124|FG003|COMPLETED|Overall Study||4
9970423|NCT01533077|11091121|FG000|NOT COMPLETED|Overall Study||1
9970424|NCT01533077|11091122|FG001|NOT COMPLETED|Overall Study||1
9970425|NCT01533077|11091123|FG002|NOT COMPLETED|Overall Study||0
9970426|NCT01533077|11091124|FG003|NOT COMPLETED|Overall Study||0
9970427|NCT01533116|11091138|FG000|STARTED|Overall Study||14
9970428|NCT01533116|11091139|FG001|STARTED|Overall Study||13
9970429|NCT01533116|11091140|FG002|STARTED|Overall Study||13
9970430|NCT01533116|11091141|FG003|STARTED|Overall Study||12
9970431|NCT01533116|11091138|FG000|COMPLETED|Overall Study||12
9970432|NCT01533116|11091139|FG001|COMPLETED|Overall Study||12
9970433|NCT01533116|11091140|FG002|COMPLETED|Overall Study||12
9970434|NCT01533116|11091141|FG003|COMPLETED|Overall Study||12
9970435|NCT01533116|11091138|FG000|NOT COMPLETED|Overall Study||2
9970436|NCT01533116|11091139|FG001|NOT COMPLETED|Overall Study||1
9970437|NCT01533116|11091140|FG002|NOT COMPLETED|Overall Study||1
9970438|NCT01533116|11091141|FG003|NOT COMPLETED|Overall Study||0
9970439|NCT01533181|11091153|FG000|STARTED|Overall Study||15
9970440|NCT01533181|11091154|FG001|STARTED|Overall Study||29
9970441|NCT01533181|11091153|FG000|COMPLETED|Overall Study||14
9970442|NCT01533181|11091154|FG001|COMPLETED|Overall Study||28
9970443|NCT01533181|11091153|FG000|NOT COMPLETED|Overall Study||1
9970444|NCT01533181|11091154|FG001|NOT COMPLETED|Overall Study||1
9970445|NCT01533207|11091162|FG000|STARTED|Overall Study||20
9970446|NCT01533207|11091163|FG001|STARTED|Overall Study||18
9970447|NCT01533207|11091162|FG000|COMPLETED|Overall Study||20
9970448|NCT01533207|11091163|FG001|COMPLETED|Overall Study||18
9970449|NCT01533207|11091162|FG000|NOT COMPLETED|Overall Study||0
9970450|NCT01533207|11091163|FG001|NOT COMPLETED|Overall Study||0
9970451|NCT01533246|11091169|FG000|STARTED|Overall Study||17
9970452|NCT01533246|11091169|FG000|COMPLETED|Overall Study||15
9970453|NCT01533246|11091169|FG000|NOT COMPLETED|Overall Study||2
9970454|NCT01533259|11091173|FG000|STARTED|Overall Study||48
9970455|NCT01533259|11091173|FG000|COMPLETED|Overall Study||48
9970456|NCT01533259|11091173|FG000|NOT COMPLETED|Overall Study||0
9970457|NCT01533428|11091179|FG000|STARTED|Overall Study||186
9970458|NCT01533428|11091180|FG001|STARTED|Overall Study||183
9970459|NCT01533428|11091179|FG000|COMPLETED|Overall Study||177
9970460|NCT01533428|11091180|FG001|COMPLETED|Overall Study||175
9970461|NCT01533428|11091179|FG000|NOT COMPLETED|Overall Study||9
9970462|NCT01533428|11091180|FG001|NOT COMPLETED|Overall Study||8
9970463|NCT01533493|11091188|FG000|STARTED|Overall Study||12
9970464|NCT01533493|11091189|FG001|STARTED|Overall Study||14
9970465|NCT01533493|11091188|FG000|COMPLETED|Overall Study||7
9970466|NCT01533493|11091189|FG001|COMPLETED|Overall Study||11
9970467|NCT01533493|11091188|FG000|NOT COMPLETED|Overall Study||5
9970468|NCT01533493|11091189|FG001|NOT COMPLETED|Overall Study||3
9970469|NCT01533597|11091197|FG000|STARTED|Overall Study||35
9970470|NCT01533597|11091198|FG001|STARTED|Overall Study||35
9970471|NCT01533597|11091197|FG000|COMPLETED|Overall Study||29
9970472|NCT01533597|11091198|FG001|COMPLETED|Overall Study||25
9970473|NCT01533597|11091197|FG000|NOT COMPLETED|Overall Study||6
9970474|NCT01533597|11091198|FG001|NOT COMPLETED|Overall Study||10
9970475|NCT01533688|11091207|FG000|STARTED|Overall Study||71
9970476|NCT01533688|11091208|FG001|STARTED|Overall Study||70
9970477|NCT01533688|11091209|FG002|STARTED|Overall Study||71
9970478|NCT01533688|11091207|FG000|COMPLETED|Overall Study||63
9970479|NCT01533688|11091208|FG001|COMPLETED|Overall Study||60
9970480|NCT01533688|11091209|FG002|COMPLETED|Overall Study||63
9970481|NCT01533688|11091207|FG000|NOT COMPLETED|Overall Study||8
9970482|NCT01533688|11091208|FG001|NOT COMPLETED|Overall Study||10
9970483|NCT01533688|11091209|FG002|NOT COMPLETED|Overall Study||8
9970484|NCT01533922|11091219|FG000|STARTED|Overall Study||59
9970485|NCT01533922|11091220|FG001|STARTED|Overall Study||59
9970486|NCT01533922|11091221|FG002|STARTED|Overall Study||60
9970487|NCT01533922|11091222|FG003|STARTED|Overall Study||58
9970488|NCT01533922|11091223|FG004|STARTED|Overall Study||59
9970489|NCT01533922|11091219|FG000|Received Placebo|Overall Study||0
9970490|NCT01533922|11091220|FG001|Received Placebo|Overall Study||49
9970491|NCT01533922|11091221|FG002|Received Placebo|Overall Study||57
9970492|NCT01533922|11091222|FG003|Received Placebo|Overall Study||57
9970493|NCT01533922|11091223|FG004|Received Placebo|Overall Study||59
9970494|NCT01533922|11091219|FG000|Received Olo 5|Overall Study||51
9970495|NCT01533922|11091220|FG001|Received Olo 5|Overall Study||52
9970496|NCT01533922|11091221|FG002|Received Olo 5|Overall Study||57
9970497|NCT01533922|11091222|FG003|Received Olo 5|Overall Study||57
9970498|NCT01533922|11091223|FG004|Received Olo 5|Overall Study||0
9970499|NCT01533922|11091219|FG000|Received Tio 5|Overall Study||54
9970500|NCT01533922|11091220|FG001|Received Tio 5|Overall Study||58
9970501|NCT01533922|11091221|FG002|Received Tio 5|Overall Study||59
9970502|NCT01533922|11091222|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
9970503|NCT01533922|11091223|FG004|Received Tio 5|Overall Study||54
9970504|NCT01533922|11091219|FG000|Received Tio+Olo 2.5/5|Overall Study||59
9970505|NCT01533922|11091220|FG001|Received Tio+Olo 2.5/5|Overall Study||0
9970506|NCT01533922|11091221|FG002|Received Tio+Olo 2.5/5|Overall Study||52
9970507|NCT01533922|11091222|FG003|Received Tio+Olo 2.5/5|Overall Study||55
9970508|NCT01533922|11091223|FG004|Received Tio+Olo 2.5/5|Overall Study||56
9970509|NCT01533922|11091219|FG000|Received Tio+Olo 5/5|Overall Study||58
9970510|NCT01533922|11091220|FG001|Received Tio+Olo 5/5|Overall Study||59
9970511|NCT01533922|11091221|FG002|Received Tio+Olo 5/5|Overall Study||0
9970512|NCT01533922|11091222|FG003|Received Tio+Olo 5/5|Overall Study||53
9970513|NCT01533922|11091223|FG004|Received Tio+Olo 5/5|Overall Study||56
9970514|NCT01533922|11091219|FG000|COMPLETED|Overall Study|Completed all treatment arms|49
9970515|NCT01533922|11091220|FG001|COMPLETED|Overall Study|Completed all treatment arms|47
9970516|NCT01533922|11091221|FG002|COMPLETED|Overall Study|Completed all treatment arms|50
9970517|NCT01533922|11091222|FG003|COMPLETED|Overall Study|Completed all treatment arms|53
9970518|NCT01533922|11091223|FG004|COMPLETED|Overall Study|Completed all treatment arms|53
9970519|NCT01533922|11091219|FG000|NOT COMPLETED|Overall Study||10
9970520|NCT01533922|11091220|FG001|NOT COMPLETED|Overall Study||12
9970521|NCT01533922|11091221|FG002|NOT COMPLETED|Overall Study||10
9970522|NCT01533922|11091222|FG003|NOT COMPLETED|Overall Study||5
9970523|NCT01533922|11091223|FG004|NOT COMPLETED|Overall Study||6
9970524|NCT01533935|11091235|FG000|STARTED|Overall Study||58
9970525|NCT01533935|11091236|FG001|STARTED|Overall Study||58
9970526|NCT01533935|11091237|FG002|STARTED|Overall Study||58
9970527|NCT01533935|11091238|FG003|STARTED|Overall Study||59
9970528|NCT01533935|11091239|FG004|STARTED|Overall Study||58
9970529|NCT01533935|11091235|FG000|Received Placebo|Overall Study||0
9970530|NCT01533935|11091236|FG001|Received Placebo|Overall Study||47
9970531|NCT01533935|11091237|FG002|Received Placebo|Overall Study||52
9970532|NCT01533935|11091238|FG003|Received Placebo|Overall Study||57
9970533|NCT01533935|11091239|FG004|Received Placebo|Overall Study||58
9970534|NCT01533935|11091235|FG000|Received Olo 5|Overall Study||52
9970535|NCT01533935|11091236|FG001|Received Olo 5|Overall Study||52
9970536|NCT01533935|11091237|FG002|Received Olo 5|Overall Study||55
9970537|NCT01533935|11091238|FG003|Received Olo 5|Overall Study||59
9970538|NCT01533935|11091239|FG004|Received Olo 5|Overall Study||0
9970539|NCT01533935|11091235|FG000|Received Tio 5|Overall Study||54
9970540|NCT01533935|11091236|FG001|Received Tio 5|Overall Study||54
9970541|NCT01533935|11091237|FG002|Received Tio 5|Overall Study||58
9970542|NCT01533935|11091238|FG003|Received Tio 5|Overall Study||0
9970543|NCT01533935|11091239|FG004|Received Tio 5|Overall Study||52
9970544|NCT01533935|11091235|FG000|Received Tio+Olo 2.5/5|Overall Study||58
9970545|NCT01533935|11091236|FG001|Received Tio+Olo 2.5/5|Overall Study||0
9970546|NCT01533935|11091237|FG002|Received Tio+Olo 2.5/5|Overall Study||49
9970547|NCT01533935|11091238|FG003|Received Tio+Olo 2.5/5|Overall Study||56
9970548|NCT01533935|11091239|FG004|Received Tio+Olo 2.5/5|Overall Study||56
9970549|NCT01533935|11091235|FG000|Received Tio+Olo 5/5|Overall Study||56
9970550|NCT01533935|11091236|FG001|Received Tio+Olo 5/5|Overall Study||58
9970551|NCT01533935|11091237|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
9970552|NCT01533935|11091238|FG003|Received Tio+Olo 5/5|Overall Study||54
9970553|NCT01533935|11091239|FG004|Received Tio+Olo 5/5|Overall Study||55
9970554|NCT01533935|11091235|FG000|COMPLETED|Overall Study|All treatment periods|52
9970555|NCT01533935|11091236|FG001|COMPLETED|Overall Study|All treatment periods|45
9970556|NCT01533935|11091237|FG002|COMPLETED|Overall Study|All treatment periods|50
9970557|NCT01533935|11091238|FG003|COMPLETED|Overall Study|All treatment periods|52
9970558|NCT01533935|11091239|FG004|COMPLETED|Overall Study|All treatment periods|50
9970559|NCT01533935|11091235|FG000|NOT COMPLETED|Overall Study||6
9970560|NCT01533935|11091236|FG001|NOT COMPLETED|Overall Study||13
9970561|NCT01533935|11091237|FG002|NOT COMPLETED|Overall Study||8
9970562|NCT01533935|11091238|FG003|NOT COMPLETED|Overall Study||7
9970563|NCT01533935|11091239|FG004|NOT COMPLETED|Overall Study||8
9970564|NCT01533948|11091251|FG000|STARTED|Overall Study||25
9970565|NCT01533948|11091251|FG000|COMPLETED|Overall Study||25
9970566|NCT01533948|11091251|FG000|NOT COMPLETED|Overall Study||0
9970567|NCT01533974|11091257|FG000|STARTED|Overall Study||224
9970568|NCT01533974|11091258|FG001|STARTED|Overall Study||226
9970569|NCT01533974|11091257|FG000|COMPLETED|Overall Study||173
9970570|NCT01533974|11091258|FG001|COMPLETED|Overall Study||176
9970571|NCT01533974|11091257|FG000|NOT COMPLETED|Overall Study||51
9970572|NCT01533974|11091258|FG001|NOT COMPLETED|Overall Study||50
9970573|NCT01534013|11091266|FG000|STARTED|Overall Study||8
9970574|NCT01534013|11091267|FG001|STARTED|Overall Study||6
9970575|NCT01534013|11091266|FG000|COMPLETED|Overall Study||6
9970576|NCT01534013|11091267|FG001|COMPLETED|Overall Study||6
9970577|NCT01534013|11091266|FG000|NOT COMPLETED|Overall Study||2
9970578|NCT01534013|11091267|FG001|NOT COMPLETED|Overall Study||0
9970579|NCT01534052|11091273|FG000|STARTED|Overall Study||52
9970580|NCT01534052|11091273|FG000|Treatment Received|Overall Study||52
9970581|NCT01534052|11091273|FG000|COMPLETED|Overall Study||52
9970582|NCT01534052|11091273|FG000|NOT COMPLETED|Overall Study||0
9970583|NCT01534078|11091277|FG000|STARTED|Overall Study||34
9970584|NCT01534078|11091277|FG000|COMPLETED|Overall Study||32
9970585|NCT01534078|11091277|FG000|NOT COMPLETED|Overall Study||2
9970586|NCT01534182|11091283|FG000|STARTED|Overall Study||230
9970587|NCT01534182|11091284|FG001|STARTED|Overall Study||68
9970588|NCT01534182|11091283|FG000|Safety Set|Overall Study||230
9970589|NCT01534182|11091284|FG001|Safety Set|Overall Study||64
9970590|NCT01534182|11091283|FG000|Full Analysis Set|Overall Study||229
9970591|NCT01534182|11091284|FG001|Full Analysis Set|Overall Study||62
9970592|NCT01534182|11091283|FG000|COMPLETED|Overall Study||218
9970593|NCT01534182|11091284|FG001|COMPLETED|Overall Study||58
9970594|NCT01534182|11091283|FG000|NOT COMPLETED|Overall Study||12
9970595|NCT01534182|11091284|FG001|NOT COMPLETED|Overall Study||10
9970596|NCT01534195|11091293|FG000|STARTED|Overall Study||5
9970597|NCT01534195|11091294|FG001|STARTED|Overall Study||6
9970598|NCT01534195|11091293|FG000|COMPLETED|Overall Study||4
9970599|NCT01534195|11091294|FG001|COMPLETED|Overall Study||5
9970600|NCT01534195|11091293|FG000|NOT COMPLETED|Overall Study||1
9970601|NCT01534195|11091294|FG001|NOT COMPLETED|Overall Study||1
9970602|NCT01534208|11091302|FG000|STARTED|Overall Study||216
9970603|NCT01534208|11091303|FG001|STARTED|Overall Study||283
9970604|NCT01534208|11091302|FG000|COMPLETED|Overall Study||159
9970605|NCT01534208|11091303|FG001|COMPLETED|Overall Study||234
9970606|NCT01534208|11091302|FG000|NOT COMPLETED|Overall Study||57
9970607|NCT01534208|11091303|FG001|NOT COMPLETED|Overall Study||49
9970608|NCT01534260|11091311|FG000|STARTED|Overall Study||17
9970609|NCT01534260|11091312|FG001|STARTED|Overall Study||20
9970610|NCT01534260|11091311|FG000|COMPLETED|Overall Study||1
9970611|NCT01534260|11091312|FG001|COMPLETED|Overall Study||0
9970612|NCT01534260|11091311|FG000|NOT COMPLETED|Overall Study||16
9970613|NCT01534260|11091312|FG001|NOT COMPLETED|Overall Study||20
9970614|NCT01534273|11091322|FG000|STARTED|Period 1||3
9970615|NCT01534273|11091323|FG001|STARTED|Period 1||6
9970616|NCT01534273|11091324|FG002|STARTED|Period 1||2
9970617|NCT01534273|11091325|FG003|STARTED|Period 1||7
9970618|NCT01534273|11091326|FG004|STARTED|Period 1||3
9970619|NCT01534273|11091327|FG005|STARTED|Period 1||3
9970620|NCT01534273|11091328|FG006|STARTED|Period 1||6
9970621|NCT01534273|11091322|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
9970622|NCT01534273|11091323|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
9970623|NCT01534273|11091324|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
9970624|NCT01534273|11091325|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
9970625|NCT01534273|11091326|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
9970626|NCT01534273|11091327|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
9970627|NCT01534273|11091328|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
9970628|NCT01534273|11091322|FG000|COMPLETED|Period 1||3
9970629|NCT01534273|11091323|FG001|COMPLETED|Period 1||6
9970630|NCT01534273|11091324|FG002|COMPLETED|Period 1||2
9970631|NCT01534273|11091325|FG003|COMPLETED|Period 1||6
9970632|NCT01534273|11091326|FG004|COMPLETED|Period 1||3
9970633|NCT01534273|11091327|FG005|COMPLETED|Period 1||3
9970634|NCT01534273|11091328|FG006|COMPLETED|Period 1||6
9970635|NCT01534273|11091322|FG000|NOT COMPLETED|Period 1||0
9970636|NCT01534273|11091323|FG001|NOT COMPLETED|Period 1||0
9970637|NCT01534273|11091324|FG002|NOT COMPLETED|Period 1||0
9970638|NCT01534273|11091325|FG003|NOT COMPLETED|Period 1||1
9970639|NCT01534273|11091326|FG004|NOT COMPLETED|Period 1||0
9970640|NCT01534273|11091327|FG005|NOT COMPLETED|Period 1||0
9970641|NCT01534273|11091328|FG006|NOT COMPLETED|Period 1||0
9970642|NCT01534273|11091322|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
9970643|NCT01534273|11091323|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
9970644|NCT01534273|11091324|FG002|STARTED|Period 2||2
9970645|NCT01534273|11091325|FG003|STARTED|Period 2||6
9970646|NCT01534273|11091326|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
9970647|NCT01534273|11091327|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
9970648|NCT01534273|11091328|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
9970649|NCT01534273|11091322|FG000|COMPLETED|Period 2||0
9970650|NCT01534273|11091323|FG001|COMPLETED|Period 2||0
9970651|NCT01534273|11091324|FG002|COMPLETED|Period 2||2
9970652|NCT01534273|11091325|FG003|COMPLETED|Period 2||6
9970653|NCT01534273|11091326|FG004|COMPLETED|Period 2||0
9970654|NCT01534273|11091327|FG005|COMPLETED|Period 2||0
9970655|NCT01534273|11091328|FG006|COMPLETED|Period 2||0
9970656|NCT01534273|11091322|FG000|NOT COMPLETED|Period 2||0
9970657|NCT01534273|11091323|FG001|NOT COMPLETED|Period 2||0
9970658|NCT01534273|11091324|FG002|NOT COMPLETED|Period 2||0
9970659|NCT01534273|11091325|FG003|NOT COMPLETED|Period 2||0
9970660|NCT01534273|11091326|FG004|NOT COMPLETED|Period 2||0
9970661|NCT01534273|11091327|FG005|NOT COMPLETED|Period 2||0
9970662|NCT01534273|11091328|FG006|NOT COMPLETED|Period 2||0
9970663|NCT01534351|11091352|FG000|STARTED|Overall Study||1
9970664|NCT01534351|11091353|FG001|STARTED|Overall Study||0
9970665|NCT01534351|11091354|FG002|STARTED|Overall Study||0
9970666|NCT01534351|11091352|FG000|COMPLETED|Overall Study||0
9970667|NCT01534351|11091353|FG001|COMPLETED|Overall Study||0
9970668|NCT01534351|11091354|FG002|COMPLETED|Overall Study||0
9970669|NCT01534351|11091352|FG000|NOT COMPLETED|Overall Study||1
9970670|NCT01534351|11091353|FG001|NOT COMPLETED|Overall Study||0
9970671|NCT01534351|11091354|FG002|NOT COMPLETED|Overall Study||0
9970672|NCT01534416|11091364|FG000|STARTED|Overall Study||68
9970673|NCT01534416|11091365|FG001|STARTED|Overall Study||64
9970674|NCT01534416|11091364|FG000|COMPLETED|Overall Study||68
9970675|NCT01534416|11091365|FG001|COMPLETED|Overall Study||64
9970676|NCT01534416|11091364|FG000|NOT COMPLETED|Overall Study||0
9970677|NCT01534416|11091365|FG001|NOT COMPLETED|Overall Study||0
9970678|NCT01534520|11091383|FG000|STARTED|Overall Study||30
9970679|NCT01534520|11091384|FG001|STARTED|Overall Study||29
9970680|NCT01534520|11091383|FG000|COMPLETED|Overall Study||30
9970681|NCT01534520|11091384|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
9970682|NCT01534520|11091383|FG000|NOT COMPLETED|Overall Study||0
9970683|NCT01534520|11091384|FG001|NOT COMPLETED|Overall Study||1
9970684|NCT01534533|11091398|FG000|STARTED|Overall Study||48
9970685|NCT01534533|11091399|FG001|STARTED|Overall Study||48
9970686|NCT01534533|11091400|FG002|STARTED|Overall Study||48
9970687|NCT01534533|11091401|FG003|STARTED|Overall Study||48
9970688|NCT01534533|11091398|FG000|COMPLETED|Overall Study||40
9970689|NCT01534533|11091399|FG001|COMPLETED|Overall Study||45
9970690|NCT01534533|11091400|FG002|COMPLETED|Overall Study||40
9970691|NCT01534533|11091401|FG003|COMPLETED|Overall Study||44
9970692|NCT01534533|11091398|FG000|NOT COMPLETED|Overall Study||8
9970693|NCT01534533|11091399|FG001|NOT COMPLETED|Overall Study||3
9970694|NCT01534533|11091400|FG002|NOT COMPLETED|Overall Study||8
9970695|NCT01534533|11091401|FG003|NOT COMPLETED|Overall Study||4
9970696|NCT01534637|11091413|FG000|STARTED|Overall Study||22
9970697|NCT01534637|11091413|FG000|COMPLETED|Overall Study||13
9970698|NCT01534637|11091413|FG000|NOT COMPLETED|Overall Study||9
9970699|NCT01534663|11091419|FG000|STARTED|Overall Study||14
9970700|NCT01534663|11091420|FG001|STARTED|Overall Study||17
9970701|NCT01534663|11091419|FG000|COMPLETED|Overall Study||12
9970702|NCT01534663|11091420|FG001|COMPLETED|Overall Study||14
9970703|NCT01534663|11091419|FG000|NOT COMPLETED|Overall Study||2
9970704|NCT01534663|11091420|FG001|NOT COMPLETED|Overall Study||3
9970705|NCT01534689|11091426|FG000|STARTED|Overall Study||105
9970706|NCT01534689|11091426|FG000|COMPLETED|Overall Study||105
9970707|NCT01534689|11091426|FG000|NOT COMPLETED|Overall Study||0
9970708|NCT01534897|11091430|FG000|STARTED|Overall Study||10
9970709|NCT01534897|11091430|FG000|Day 25 Iodine-131 Scan|Overall Study||10
9970710|NCT01534897|11091430|FG000|Day 37 Iodine-131 Treatment|Overall Study||6
9970711|NCT01534897|11091430|FG000|COMPLETED|Overall Study||10
9970712|NCT01534897|11091430|FG000|NOT COMPLETED|Overall Study||0
9970713|NCT01534910|11091437|FG000|STARTED|Overall Study||33
9970714|NCT01534910|11091438|FG001|STARTED|Overall Study||32
9970715|NCT01534910|11091437|FG000|COMPLETED|Overall Study||29
9970716|NCT01534910|11091438|FG001|COMPLETED|Overall Study||28
9970717|NCT01534910|11091437|FG000|NOT COMPLETED|Overall Study||4
9970718|NCT01534910|11091438|FG001|NOT COMPLETED|Overall Study||4
9970719|NCT01534962|11091450|FG000|STARTED|Overall Study||67
9970720|NCT01534962|11091451|FG001|STARTED|Overall Study||60
9970721|NCT01534962|11091452|FG002|STARTED|Overall Study||58
9970722|NCT01534962|11091453|FG003|STARTED|Overall Study||56
9970723|NCT01534962|11091450|FG000|COMPLETED|Overall Study||30
9970724|NCT01534962|11091451|FG001|COMPLETED|Overall Study||34
9970725|NCT01534962|11091452|FG002|COMPLETED|Overall Study||34
9970726|NCT01534962|11091453|FG003|COMPLETED|Overall Study||24
9970727|NCT01534962|11091450|FG000|NOT COMPLETED|Overall Study||37
9970728|NCT01534962|11091451|FG001|NOT COMPLETED|Overall Study||26
9970729|NCT01534962|11091452|FG002|NOT COMPLETED|Overall Study||24
9970730|NCT01534962|11091453|FG003|NOT COMPLETED|Overall Study||32
9970731|NCT01534975|11091467|FG000|STARTED|Overall Study||136
9970732|NCT01534975|11091468|FG001|STARTED|Overall Study||133
9970733|NCT01534975|11091469|FG002|STARTED|Overall Study||160
9970734|NCT01534975|11091470|FG003|STARTED|Overall Study||84
9970735|NCT01534975|11091467|FG000|COMPLETED|Overall Study||136
9970736|NCT01534975|11091468|FG001|COMPLETED|Overall Study||133
9970737|NCT01534975|11091469|FG002|COMPLETED|Overall Study||160
9970738|NCT01534975|11091470|FG003|COMPLETED|Overall Study||84
9970739|NCT01534975|11091467|FG000|NOT COMPLETED|Overall Study||0
9970740|NCT01534975|11091468|FG001|NOT COMPLETED|Overall Study||0
9970741|NCT01534975|11091469|FG002|NOT COMPLETED|Overall Study||0
9970742|NCT01534975|11091470|FG003|NOT COMPLETED|Overall Study||0
9970743|NCT01535001|11091482|FG000|STARTED|Overall Study||50
9970744|NCT01535001|11091483|FG001|STARTED|Overall Study||50
9970745|NCT01535001|11091482|FG000|COMPLETED|Overall Study||47
9970746|NCT01535001|11091483|FG001|COMPLETED|Overall Study||44
9970747|NCT01535001|11091482|FG000|NOT COMPLETED|Overall Study||3
9970748|NCT01535001|11091483|FG001|NOT COMPLETED|Overall Study||6
9970749|NCT01535014|11091493|FG000|STARTED|Overall Study||210
9970750|NCT01535014|11091494|FG001|STARTED|Overall Study||200
9970751|NCT01535014|11091495|FG002|STARTED|Overall Study||50
9970752|NCT01535014|11091496|FG003|STARTED|Overall Study||33
9970753|NCT01535014|11091493|FG000|COMPLETED|Overall Study||208
9970754|NCT01535014|11091494|FG001|COMPLETED|Overall Study||194
9970755|NCT01535014|11091495|FG002|COMPLETED|Overall Study||49
9970756|NCT01535014|11091496|FG003|COMPLETED|Overall Study||33
9970757|NCT01535014|11091493|FG000|NOT COMPLETED|Overall Study||2
9970758|NCT01535014|11091494|FG001|NOT COMPLETED|Overall Study||6
9970759|NCT01535014|11091495|FG002|NOT COMPLETED|Overall Study||1
9970760|NCT01535014|11091496|FG003|NOT COMPLETED|Overall Study||0
9970761|NCT01535040|11091506|FG000|STARTED|Overall Study||65
9970762|NCT01535040|11091507|FG001|STARTED|Overall Study||65
9970763|NCT01535040|11091506|FG000|COMPLETED|Overall Study||35
9970764|NCT01535040|11091507|FG001|COMPLETED|Overall Study||44
9970765|NCT01535040|11091506|FG000|NOT COMPLETED|Overall Study||30
9970766|NCT01535040|11091507|FG001|NOT COMPLETED|Overall Study||21
9970767|NCT01535053|11091515|FG000|STARTED|Overall Study||29
9970768|NCT01535053|11091516|FG001|STARTED|Overall Study||28
9970769|NCT01535053|11091515|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
9970770|NCT01535053|11091516|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
9970771|NCT01535053|11091515|FG000|NOT COMPLETED|Overall Study||1
9970772|NCT01535053|11091516|FG001|NOT COMPLETED|Overall Study||2
9970773|NCT01535118|11091522|FG000|STARTED|Overall Study||2765
9970774|NCT01535118|11091522|FG000|COMPLETED|Overall Study||2765
9970775|NCT01535118|11091522|FG000|NOT COMPLETED|Overall Study||0
9970776|NCT01535222|11091532|FG000|STARTED|Overall Study||3
9970777|NCT01535222|11091533|FG001|STARTED|Overall Study||3
9970778|NCT01535222|11091534|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
9970779|NCT01535222|11091535|FG003|STARTED|Overall Study||6
9970780|NCT01535222|11091536|FG004|STARTED|Overall Study||6
9970781|NCT01535222|11091537|FG005|STARTED|Overall Study||8
9970782|NCT01535222|11091532|FG000|COMPLETED|Overall Study||3
9970783|NCT01535222|11091533|FG001|COMPLETED|Overall Study||3
9970784|NCT01535222|11091534|FG002|COMPLETED|Overall Study||6
9970785|NCT01535222|11091535|FG003|COMPLETED|Overall Study||6
9970786|NCT01535222|11091536|FG004|COMPLETED|Overall Study||6
9970787|NCT01535222|11091537|FG005|COMPLETED|Overall Study||8
9970788|NCT01535222|11091532|FG000|NOT COMPLETED|Overall Study||0
9970789|NCT01535222|11091533|FG001|NOT COMPLETED|Overall Study||0
9970790|NCT01535222|11091534|FG002|NOT COMPLETED|Overall Study||1
9970791|NCT01535222|11091535|FG003|NOT COMPLETED|Overall Study||0
9970792|NCT01535222|11091536|FG004|NOT COMPLETED|Overall Study||0
9970793|NCT01535222|11091537|FG005|NOT COMPLETED|Overall Study||0
9970794|NCT01535235|11091553|FG000|STARTED|Overall Study||16
9970795|NCT01535235|11091554|FG001|STARTED|Overall Study||15
9970796|NCT01535235|11091553|FG000|COMPLETED|Overall Study||15
9970797|NCT01535235|11091554|FG001|COMPLETED|Overall Study||15
9970798|NCT01535235|11091553|FG000|NOT COMPLETED|Overall Study||1
9970799|NCT01535235|11091554|FG001|NOT COMPLETED|Overall Study||0
9970800|NCT01535261|11091560|FG000|STARTED|Overall Study||357
9970801|NCT01535261|11091560|FG000|COMPLETED|Overall Study||307
9970802|NCT01535261|11091560|FG000|NOT COMPLETED|Overall Study||50
9970803|NCT01535287|11091566|FG000|STARTED|Overall Study||70
9970804|NCT01535287|11091567|FG001|STARTED|Overall Study||70
9970805|NCT01535287|11091566|FG000|COMPLETED|Overall Study||65
9970806|NCT01535287|11091567|FG001|COMPLETED|Overall Study||64
9970807|NCT01535287|11091566|FG000|NOT COMPLETED|Overall Study||5
9970808|NCT01535287|11091567|FG001|NOT COMPLETED|Overall Study||6
9970809|NCT01535326|11091576|FG000|STARTED|Overall Study||90
9970810|NCT01535326|11091577|FG001|STARTED|Overall Study||90
9970811|NCT01535326|11091578|FG002|STARTED|Overall Study||90
9970812|NCT01535326|11091576|FG000|COMPLETED|Overall Study||90
9970813|NCT01535326|11091577|FG001|COMPLETED|Overall Study||90
9970814|NCT01535326|11091578|FG002|COMPLETED|Overall Study||90
9970815|NCT01535326|11091576|FG000|NOT COMPLETED|Overall Study||0
9970816|NCT01535326|11091577|FG001|NOT COMPLETED|Overall Study||0
9970817|NCT01535326|11091578|FG002|NOT COMPLETED|Overall Study||0
9970818|NCT01535365|11091591|FG000|STARTED|Overall Study||31
9970819|NCT01535365|11091592|FG001|STARTED|Overall Study||29
9970820|NCT01535365|11091591|FG000|COMPLETED|Overall Study||31
10098111|NCT02380677|11227162|FG004|STARTED|Overall Study||6
9970821|NCT01535365|11091592|FG001|COMPLETED|Overall Study||29
9970822|NCT01535365|11091591|FG000|NOT COMPLETED|Overall Study||0
9970823|NCT01535365|11091592|FG001|NOT COMPLETED|Overall Study||0
9970824|NCT01535443|11091600|FG000|STARTED|Overall Study||35
9970825|NCT01535443|11091600|FG000|COMPLETED|Overall Study||32
9970826|NCT01535443|11091600|FG000|NOT COMPLETED|Overall Study||3
9970827|NCT01535560|11091607|FG000|STARTED|Overall Study||274
9970828|NCT01535560|11091608|FG001|STARTED|Overall Study||275
9970829|NCT01535560|11091607|FG000|COMPLETED|Overall Study||237
9970830|NCT01535560|11091608|FG001|COMPLETED|Overall Study||179
9970831|NCT01535560|11091607|FG000|NOT COMPLETED|Overall Study||37
9970832|NCT01535560|11091608|FG001|NOT COMPLETED|Overall Study||96
9970833|NCT01535573|11091617|FG000|STARTED|Overall Study||21
9970834|NCT01535573|11091618|FG001|STARTED|Overall Study||44
9970835|NCT01535573|11091619|FG002|STARTED|Overall Study||43
9970836|NCT01535573|11091617|FG000|COMPLETED|Overall Study||13
9970837|NCT01535573|11091618|FG001|COMPLETED|Overall Study||23
9970838|NCT01535573|11091619|FG002|COMPLETED|Overall Study||24
9970839|NCT01535573|11091617|FG000|NOT COMPLETED|Overall Study||8
9970840|NCT01535573|11091618|FG001|NOT COMPLETED|Overall Study||21
9970841|NCT01535573|11091619|FG002|NOT COMPLETED|Overall Study||19
9970842|NCT01535599|11091629|FG000|STARTED|Overall Study||347
9970843|NCT01535599|11091630|FG001|STARTED|Overall Study||346
9970844|NCT01535599|11091629|FG000|COMPLETED|Overall Study||297
9970845|NCT01535599|11091630|FG001|COMPLETED|Overall Study||250
9970846|NCT01535599|11091629|FG000|NOT COMPLETED|Overall Study||50
9970847|NCT01535599|11091630|FG001|NOT COMPLETED|Overall Study||96
9970848|NCT01535638|11091636|FG000|STARTED|Treatment 1 (Single Dose)||3
9970849|NCT01535638|11091637|FG001|STARTED|Treatment 1 (Single Dose)||3
9970850|NCT01535638|11091638|FG002|STARTED|Treatment 1 (Single Dose)||3
9970851|NCT01535638|11091639|FG003|STARTED|Treatment 1 (Single Dose)||3
9970852|NCT01535638|11091640|FG004|STARTED|Treatment 1 (Single Dose)||3
9970853|NCT01535638|11091641|FG005|STARTED|Treatment 1 (Single Dose)||3
9970854|NCT01535638|11091636|FG000|COMPLETED|Treatment 1 (Single Dose)||3
9970855|NCT01535638|11091637|FG001|COMPLETED|Treatment 1 (Single Dose)||3
9970856|NCT01535638|11091638|FG002|COMPLETED|Treatment 1 (Single Dose)||3
9970857|NCT01535638|11091639|FG003|COMPLETED|Treatment 1 (Single Dose)||3
9970858|NCT01535638|11091640|FG004|COMPLETED|Treatment 1 (Single Dose)||3
9970859|NCT01535638|11091641|FG005|COMPLETED|Treatment 1 (Single Dose)||2
9970860|NCT01535638|11091636|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0
9970861|NCT01535638|11091637|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0
9970862|NCT01535638|11091638|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0
9970863|NCT01535638|11091639|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0
9970864|NCT01535638|11091640|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0
9970865|NCT01535638|11091641|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1
9970866|NCT01535638|11091636|FG000|STARTED|Treatment 2 (Single Dose)||3
9970867|NCT01535638|11091637|FG001|STARTED|Treatment 2 (Single Dose)||3
9970868|NCT01535638|11091638|FG002|STARTED|Treatment 2 (Single Dose)||3
9970869|NCT01535638|11091639|FG003|STARTED|Treatment 2 (Single Dose)||3
9970870|NCT01535638|11091640|FG004|STARTED|Treatment 2 (Single Dose)||3
9970871|NCT01535638|11091641|FG005|STARTED|Treatment 2 (Single Dose)||2
9970872|NCT01535638|11091636|FG000|COMPLETED|Treatment 2 (Single Dose)||3
9970873|NCT01535638|11091637|FG001|COMPLETED|Treatment 2 (Single Dose)||3
9970874|NCT01535638|11091638|FG002|COMPLETED|Treatment 2 (Single Dose)||3
9970875|NCT01535638|11091639|FG003|COMPLETED|Treatment 2 (Single Dose)||3
9970876|NCT01535638|11091640|FG004|COMPLETED|Treatment 2 (Single Dose)||3
9970877|NCT01535638|11091641|FG005|COMPLETED|Treatment 2 (Single Dose)||2
9970878|NCT01535638|11091636|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0
9970879|NCT01535638|11091637|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0
9970880|NCT01535638|11091638|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0
9970881|NCT01535638|11091639|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0
9970882|NCT01535638|11091640|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0
9970883|NCT01535638|11091641|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0
9970884|NCT01535638|11091636|FG000|STARTED|Treatment 3 (Single Dose)||3
9970885|NCT01535638|11091637|FG001|STARTED|Treatment 3 (Single Dose)||3
9970886|NCT01535638|11091638|FG002|STARTED|Treatment 3 (Single Dose)||3
9970887|NCT01535638|11091639|FG003|STARTED|Treatment 3 (Single Dose)||3
9970888|NCT01535638|11091640|FG004|STARTED|Treatment 3 (Single Dose)||3
9970889|NCT01535638|11091641|FG005|STARTED|Treatment 3 (Single Dose)||2
9970890|NCT01535638|11091636|FG000|COMPLETED|Treatment 3 (Single Dose)||3
9970891|NCT01535638|11091637|FG001|COMPLETED|Treatment 3 (Single Dose)||3
9970892|NCT01535638|11091638|FG002|COMPLETED|Treatment 3 (Single Dose)||3
9970893|NCT01535638|11091639|FG003|COMPLETED|Treatment 3 (Single Dose)||2
9970894|NCT01535638|11091640|FG004|COMPLETED|Treatment 3 (Single Dose)||3
9970895|NCT01535638|11091641|FG005|COMPLETED|Treatment 3 (Single Dose)||2
9970896|NCT01535638|11091636|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0
9970897|NCT01535638|11091637|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0
9970898|NCT01535638|11091638|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0
9970899|NCT01535638|11091639|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1
9970900|NCT01535638|11091640|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0
9970901|NCT01535638|11091641|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0
9970902|NCT01535664|11091650|FG000|STARTED|Overall Study||20
9970903|NCT01535664|11091650|FG000|COMPLETED|Overall Study||20
9970904|NCT01535664|11091650|FG000|NOT COMPLETED|Overall Study||0
9970905|NCT01535729|11091658|FG000|STARTED|Overall Study||465
9970906|NCT01535729|11091658|FG000|Treated|Overall Study||385
9970907|NCT01535729|11091658|FG000|COMPLETED|Overall Study||49
9970908|NCT01535729|11091658|FG000|NOT COMPLETED|Overall Study||416
9970909|NCT01535924|11091668|FG000|STARTED|Overall Study||3
9970910|NCT01535924|11091669|FG001|STARTED|Overall Study||3
9970911|NCT01535924|11091670|FG002|STARTED|Overall Study||3
9970912|NCT01535924|11091671|FG003|STARTED|Overall Study||4
9970913|NCT01535924|11091672|FG004|STARTED|Overall Study||6
9970914|NCT01535924|11091673|FG005|STARTED|Overall Study||7
9970915|NCT01535924|11091668|FG000|COMPLETED|Overall Study||3
9970916|NCT01535924|11091669|FG001|COMPLETED|Overall Study||3
9970917|NCT01535924|11091670|FG002|COMPLETED|Overall Study||3
9970918|NCT01535924|11091671|FG003|COMPLETED|Overall Study||4
9970919|NCT01535924|11091672|FG004|COMPLETED|Overall Study||6
9970920|NCT01535924|11091673|FG005|COMPLETED|Overall Study||7
9970921|NCT01535924|11091668|FG000|NOT COMPLETED|Overall Study||0
9970922|NCT01535924|11091669|FG001|NOT COMPLETED|Overall Study||0
9970923|NCT01535924|11091670|FG002|NOT COMPLETED|Overall Study||0
9970924|NCT01535924|11091671|FG003|NOT COMPLETED|Overall Study||0
9970925|NCT01535924|11091672|FG004|NOT COMPLETED|Overall Study||0
9970926|NCT01535924|11091673|FG005|NOT COMPLETED|Overall Study||0
9970927|NCT01535937|11091690|FG000|STARTED|Overall Study||27
9970928|NCT01535937|11091691|FG001|STARTED|Overall Study||28
9970929|NCT01535937|11091690|FG000|COMPLETED|Overall Study||27
9970930|NCT01535937|11091691|FG001|COMPLETED|Overall Study||28
9970931|NCT01535937|11091690|FG000|NOT COMPLETED|Overall Study||0
9970932|NCT01535937|11091691|FG001|NOT COMPLETED|Overall Study||0
9970933|NCT01535976|11091699|FG000|STARTED|Overall Study||27
9970934|NCT01535976|11091700|FG001|STARTED|Overall Study||27
9970935|NCT01535976|11091699|FG000|COMPLETED|Overall Study||26
9970936|NCT01535976|11091700|FG001|COMPLETED|Overall Study||26
9970937|NCT01535976|11091699|FG000|NOT COMPLETED|Overall Study||1
9970938|NCT01535976|11091700|FG001|NOT COMPLETED|Overall Study||1
9970939|NCT01536067|11091706|FG000|STARTED|Overall Study||3
9970940|NCT01536067|11091706|FG000|COMPLETED|Overall Study||2
9970941|NCT01536067|11091706|FG000|NOT COMPLETED|Overall Study||1
9970942|NCT01536093|11091712|FG000|STARTED|Overall Study||24
9970943|NCT01536093|11091713|FG001|STARTED|Overall Study||24
9970944|NCT01536093|11091712|FG000|COMPLETED|Overall Study||21
9970945|NCT01536093|11091713|FG001|COMPLETED|Overall Study||21
9970946|NCT01536093|11091712|FG000|NOT COMPLETED|Overall Study||3
9970947|NCT01536093|11091713|FG001|NOT COMPLETED|Overall Study||3
9970948|NCT01536119|11091721|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
9970949|NCT01536119|11091722|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
9970950|NCT01536119|11091721|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
9970951|NCT01536119|11091722|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
9970952|NCT01536119|11091721|FG000|NOT COMPLETED|Overall Study||17
9970953|NCT01536119|11091722|FG001|NOT COMPLETED|Overall Study||14
9970954|NCT01536145|11091728|FG000|STARTED|Overall Study||3
9970955|NCT01536145|11091729|FG001|STARTED|Overall Study||4
9970956|NCT01536145|11091730|FG002|STARTED|Overall Study||3
9970957|NCT01536145|11091731|FG003|STARTED|Overall Study||3
9970958|NCT01536145|11091732|FG004|STARTED|Overall Study||4
9970959|NCT01536145|11091733|FG005|STARTED|Overall Study||3
9970960|NCT01536145|11091734|FG006|STARTED|Overall Study||3
9970961|NCT01536145|11091735|FG007|STARTED|Overall Study||4
9970962|NCT01536145|11091736|FG008|STARTED|Overall Study||3
9970963|NCT01536145|11091737|FG009|STARTED|Overall Study||7
9970964|NCT01536145|11091738|FG010|STARTED|Overall Study||10
9970965|NCT01536145|11091728|FG000|COMPLETED|Overall Study||0
9970966|NCT01536145|11091729|FG001|COMPLETED|Overall Study||0
9970967|NCT01536145|11091730|FG002|COMPLETED|Overall Study||1
9970968|NCT01536145|11091731|FG003|COMPLETED|Overall Study||1
9970969|NCT01536145|11091732|FG004|COMPLETED|Overall Study||2
9970970|NCT01536145|11091733|FG005|COMPLETED|Overall Study||0
9970971|NCT01536145|11091734|FG006|COMPLETED|Overall Study||1
9970972|NCT01536145|11091735|FG007|COMPLETED|Overall Study||0
9970973|NCT01536145|11091736|FG008|COMPLETED|Overall Study||0
9970974|NCT01536145|11091737|FG009|COMPLETED|Overall Study||1
9970975|NCT01536145|11091738|FG010|COMPLETED|Overall Study||0
9970976|NCT01536145|11091728|FG000|NOT COMPLETED|Overall Study||3
9970977|NCT01536145|11091729|FG001|NOT COMPLETED|Overall Study||4
9970978|NCT01536145|11091730|FG002|NOT COMPLETED|Overall Study||2
9970979|NCT01536145|11091731|FG003|NOT COMPLETED|Overall Study||2
9970980|NCT01536145|11091732|FG004|NOT COMPLETED|Overall Study||2
9970981|NCT01536145|11091733|FG005|NOT COMPLETED|Overall Study||3
9970982|NCT01536145|11091734|FG006|NOT COMPLETED|Overall Study||2
9970983|NCT01536145|11091735|FG007|NOT COMPLETED|Overall Study||4
9970984|NCT01536145|11091736|FG008|NOT COMPLETED|Overall Study||3
9970985|NCT01536145|11091737|FG009|NOT COMPLETED|Overall Study||6
9970986|NCT01536145|11091738|FG010|NOT COMPLETED|Overall Study||10
9970987|NCT01536171|11091769|FG000|STARTED|Overall Study||22
9970988|NCT01536171|11091769|FG000|COMPLETED|Overall Study||21
9970989|NCT01536171|11091769|FG000|NOT COMPLETED|Overall Study||1
9970990|NCT01536184|11091776|FG000|STARTED|Overall Study||8
9970991|NCT01536184|11091777|FG001|STARTED|Overall Study||4
9970992|NCT01536184|11091776|FG000|COMPLETED|Overall Study||8
9970993|NCT01536184|11091777|FG001|COMPLETED|Overall Study||4
9970994|NCT01536184|11091776|FG000|NOT COMPLETED|Overall Study||0
9970995|NCT01536184|11091777|FG001|NOT COMPLETED|Overall Study||0
9970996|NCT01536197|11091785|FG000|STARTED|Overall Study||23
9970997|NCT01536197|11091786|FG001|STARTED|Overall Study||10
9970998|NCT01536197|11091785|FG000|COMPLETED|Overall Study||23
9970999|NCT01536197|11091786|FG001|COMPLETED|Overall Study||10
9971000|NCT01536197|11091785|FG000|NOT COMPLETED|Overall Study||0
9971001|NCT01536197|11091786|FG001|NOT COMPLETED|Overall Study||0
9971002|NCT01536262|11091795|FG000|STARTED|Overall Study||41
9971003|NCT01536262|11091796|FG001|STARTED|Overall Study||40
9971004|NCT01536262|11091797|FG002|STARTED|Overall Study||41
9971005|NCT01536262|11091795|FG000|COMPLETED|Overall Study||33
9971006|NCT01536262|11091796|FG001|COMPLETED|Overall Study||38
9971007|NCT01536262|11091797|FG002|COMPLETED|Overall Study||39
9971008|NCT01536262|11091795|FG000|NOT COMPLETED|Overall Study||8
9971009|NCT01536262|11091796|FG001|NOT COMPLETED|Overall Study||2
9971010|NCT01536262|11091797|FG002|NOT COMPLETED|Overall Study||2
9971011|NCT01536366|11091808|FG000|STARTED|Overall Study||14
9971012|NCT01536366|11091809|FG001|STARTED|Overall Study||13
9971013|NCT01536366|11091808|FG000|BIA 9-1067 + Repaglinide|Overall Study||14
9971014|NCT01536366|11091809|FG001|BIA 9-1067 + Repaglinide|Overall Study||10
9971015|NCT01536366|11091808|FG000|Repaglinide|Overall Study||14
9971016|NCT01536366|11091809|FG001|Repaglinide|Overall Study||13
9971017|NCT01536366|11091808|FG000|Follow-up|Overall Study||13
9971018|NCT01536366|11091809|FG001|Follow-up|Overall Study||9
9971019|NCT01536366|11091808|FG000|COMPLETED|Overall Study||1
9971020|NCT01536366|11091809|FG001|COMPLETED|Overall Study||9
9971021|NCT01536366|11091808|FG000|NOT COMPLETED|Overall Study||13
9971022|NCT01536366|11091809|FG001|NOT COMPLETED|Overall Study||4
10017589|NCT01817907|11140539|FG000|STARTED|First Intervention||8
10017590|NCT01817907|11140540|FG001|STARTED|First Intervention||7
10017591|NCT01817907|11140539|FG000|COMPLETED|First Intervention||8
10017592|NCT01817907|11140540|FG001|COMPLETED|First Intervention||7
10017593|NCT01817907|11140539|FG000|NOT COMPLETED|First Intervention||0
10017594|NCT01817907|11140540|FG001|NOT COMPLETED|First Intervention||0
10017595|NCT01817907|11140539|FG000|STARTED|Washout Period||8
10017596|NCT01817907|11140540|FG001|STARTED|Washout Period||7
10017597|NCT01817907|11140539|FG000|COMPLETED|Washout Period||8
10017598|NCT01817907|11140540|FG001|COMPLETED|Washout Period||7
10017599|NCT01817907|11140539|FG000|NOT COMPLETED|Washout Period||0
10017600|NCT01817907|11140540|FG001|NOT COMPLETED|Washout Period||0
10017601|NCT01817907|11140539|FG000|STARTED|Second Intervention||8
10017602|NCT01817907|11140540|FG001|STARTED|Second Intervention||7
10017603|NCT01817907|11140539|FG000|COMPLETED|Second Intervention||8
10017604|NCT01817907|11140540|FG001|COMPLETED|Second Intervention||7
10017605|NCT01817907|11140539|FG000|NOT COMPLETED|Second Intervention||0
10017606|NCT01817907|11140540|FG001|NOT COMPLETED|Second Intervention||0
10017607|NCT01817959|11140548|FG000|STARTED|Overall Study||29
10017608|NCT01817959|11140549|FG001|STARTED|Overall Study||19
10017609|NCT01817959|11140548|FG000|COMPLETED|Overall Study||25
10017610|NCT01817959|11140549|FG001|COMPLETED|Overall Study||16
10017611|NCT01817959|11140548|FG000|NOT COMPLETED|Overall Study||4
10017612|NCT01817959|11140549|FG001|NOT COMPLETED|Overall Study||3
10017613|NCT01818063|11140557|FG000|STARTED|Overall Study||5
10017614|NCT01818063|11140558|FG001|STARTED|Overall Study||4
10017615|NCT01818063|11140557|FG000|COMPLETED|Overall Study||5
10017616|NCT01818063|11140558|FG001|COMPLETED|Overall Study||4
10017617|NCT01818063|11140557|FG000|NOT COMPLETED|Overall Study||0
10017618|NCT01818063|11140558|FG001|NOT COMPLETED|Overall Study||0
10017619|NCT01818141|11140566|FG000|STARTED|Overall Study||18
10017620|NCT01818141|11140567|FG001|STARTED|Overall Study||16
10017621|NCT01818141|11140566|FG000|COMPLETED|Overall Study||15
10017622|NCT01818141|11140567|FG001|COMPLETED|Overall Study||13
10017623|NCT01818141|11140566|FG000|NOT COMPLETED|Overall Study||3
10017624|NCT01818141|11140567|FG001|NOT COMPLETED|Overall Study||3
10017625|NCT01818245|11140575|FG000|STARTED|Intervention A||30
10017626|NCT01818245|11140576|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
10017627|NCT01818245|11140575|FG000|Received One Dose of Study Drug|Intervention A||30
10017628|NCT01818245|11140576|FG001|Received One Dose of Study Drug|Intervention A||22
10017629|NCT01818245|11140575|FG000|COMPLETED|Intervention A||30
10017630|NCT01818245|11140576|FG001|COMPLETED|Intervention A||22
10017631|NCT01818245|11140575|FG000|NOT COMPLETED|Intervention A||0
10017632|NCT01818245|11140576|FG001|NOT COMPLETED|Intervention A||0
10017633|NCT01818245|11140575|FG000|STARTED|Washout (16-28 Days)||30
10017634|NCT01818245|11140576|FG001|STARTED|Washout (16-28 Days)||0
10017635|NCT01818245|11140575|FG000|COMPLETED|Washout (16-28 Days)||30
10017636|NCT01818245|11140576|FG001|COMPLETED|Washout (16-28 Days)||0
10017637|NCT01818245|11140575|FG000|NOT COMPLETED|Washout (16-28 Days)||0
10017638|NCT01818245|11140576|FG001|NOT COMPLETED|Washout (16-28 Days)||0
10017639|NCT01818245|11140575|FG000|STARTED|Intervention B||30
10017640|NCT01818245|11140576|FG001|STARTED|Intervention B||0
10017641|NCT01818245|11140575|FG000|COMPLETED|Intervention B||30
10017642|NCT01818245|11140576|FG001|COMPLETED|Intervention B||0
10017643|NCT01818245|11140575|FG000|NOT COMPLETED|Intervention B||0
10017644|NCT01818245|11140576|FG001|NOT COMPLETED|Intervention B||0
10017645|NCT01818245|11140575|FG000|STARTED|Washout (16-28 Days)||30
10017646|NCT01818245|11140576|FG001|STARTED|Washout (16-28 Days)||0
10017647|NCT01818245|11140575|FG000|COMPLETED|Washout (16-28 Days)||30
10017648|NCT01818245|11140576|FG001|COMPLETED|Washout (16-28 Days)||0
10017649|NCT01818245|11140575|FG000|NOT COMPLETED|Washout (16-28 Days)||0
10017650|NCT01818245|11140576|FG001|NOT COMPLETED|Washout (16-28 Days)||0
10017651|NCT01818245|11140575|FG000|STARTED|Intervention C||30
10017652|NCT01818245|11140576|FG001|STARTED|Intervention C||0
10017653|NCT01818245|11140575|FG000|COMPLETED|Intervention C||30
10017654|NCT01818245|11140576|FG001|COMPLETED|Intervention C||0
10017655|NCT01818245|11140575|FG000|NOT COMPLETED|Intervention C||0
10017656|NCT01818245|11140576|FG001|NOT COMPLETED|Intervention C||0
10017657|NCT01818258|11140589|FG000|STARTED|Overall Study||25
10017658|NCT01818258|11140590|FG001|STARTED|Overall Study||27
10017659|NCT01818258|11140589|FG000|COMPLETED|Overall Study||22
10017660|NCT01818258|11140590|FG001|COMPLETED|Overall Study||24
10017661|NCT01818258|11140589|FG000|NOT COMPLETED|Overall Study||3
10017662|NCT01818258|11140590|FG001|NOT COMPLETED|Overall Study||3
10017663|NCT01818284|11140599|FG000|STARTED|Overall Study||11
10017664|NCT01818284|11140600|FG001|STARTED|Overall Study||11
10017665|NCT01818284|11140599|FG000|COMPLETED|Overall Study||7
10017666|NCT01818284|11140600|FG001|COMPLETED|Overall Study||5
10017667|NCT01818284|11140599|FG000|NOT COMPLETED|Overall Study||4
10017668|NCT01818284|11140600|FG001|NOT COMPLETED|Overall Study||6
10017669|NCT01818297|11140607|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32
10017670|NCT01818297|11140608|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30
10017671|NCT01818297|11140607|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32
10017672|NCT01818297|11140608|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30
10017673|NCT01818297|11140607|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32
10017674|NCT01818297|11140608|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29
9971023|NCT01536379|11091817|FG000|STARTED|Overall Study||13
9971024|NCT01536379|11091818|FG001|STARTED|Overall Study||12
9971025|NCT01536379|11091817|FG000|COMPLETED|Overall Study||11
9971026|NCT01536379|11091818|FG001|COMPLETED|Overall Study||9
9971027|NCT01536379|11091817|FG000|NOT COMPLETED|Overall Study||2
9971028|NCT01536379|11091818|FG001|NOT COMPLETED|Overall Study||3
9971029|NCT01536392|11091826|FG000|STARTED|Overall Study||41
9971030|NCT01536392|11091827|FG001|STARTED|Overall Study||34
9971031|NCT01536392|11091826|FG000|COMPLETED|Overall Study||28
9971032|NCT01536392|11091827|FG001|COMPLETED|Overall Study||19
9971033|NCT01536392|11091826|FG000|NOT COMPLETED|Overall Study||13
9971034|NCT01536392|11091827|FG001|NOT COMPLETED|Overall Study||15
9971035|NCT01536405|11091835|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706
9971036|NCT01536405|11091836|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706
9971037|NCT01536405|11091835|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
9971038|NCT01536405|11091836|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
9971039|NCT01536405|11091835|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
9971040|NCT01536405|11091836|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
9971041|NCT01536405|11091835|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
9971042|NCT01536405|11091836|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
9971043|NCT01536405|11091835|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
9971044|NCT01536405|11091836|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
9971045|NCT01536405|11091835|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
9971046|NCT01536405|11091836|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
9971047|NCT01536405|11091835|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
9971048|NCT01536405|11091836|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
9971049|NCT01536405|11091835|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
9971050|NCT01536405|11091836|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
9971051|NCT01536405|11091835|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
9971052|NCT01536405|11091836|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
9971053|NCT01536405|11091835|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
9971054|NCT01536405|11091836|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
9971055|NCT01536405|11091835|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
9971056|NCT01536405|11091836|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
9971057|NCT01536405|11091835|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
9971058|NCT01536405|11091836|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
9971059|NCT01536405|11091835|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
9971060|NCT01536405|11091836|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
9971061|NCT01536405|11091835|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
9971062|NCT01536405|11091836|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
9971063|NCT01536405|11091835|FG000|STARTED|Visit 4 to Extended Study Follow-up||615
9971064|NCT01536405|11091836|FG001|STARTED|Visit 4 to Extended Study Follow-up||618
9971065|NCT01536405|11091835|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595
9971066|NCT01536405|11091836|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595
9971067|NCT01536405|11091835|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
9971068|NCT01536405|11091836|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
9971069|NCT01536418|11091844|FG000|STARTED|Overall Study||127
9971070|NCT01536418|11091845|FG001|STARTED|Overall Study||126
9971071|NCT01536418|11091844|FG000|COMPLETED|Overall Study||58
9971072|NCT01536418|11091845|FG001|COMPLETED|Overall Study||60
9971073|NCT01536418|11091844|FG000|NOT COMPLETED|Overall Study||69
9971074|NCT01536418|11091845|FG001|NOT COMPLETED|Overall Study||66
9971075|NCT01536496|11091854|FG000|STARTED|Overall Study||57
9971076|NCT01536496|11091855|FG001|STARTED|Overall Study||57
9971077|NCT01536496|11091854|FG000|COMPLETED|Overall Study||55
9971078|NCT01536496|11091855|FG001|COMPLETED|Overall Study||56
9971079|NCT01536496|11091854|FG000|NOT COMPLETED|Overall Study||2
9971080|NCT01536496|11091855|FG001|NOT COMPLETED|Overall Study||1
9971081|NCT01536535|11091865|FG000|STARTED|Overall Study||178
9971082|NCT01536535|11091866|FG001|STARTED|Overall Study||250
9971083|NCT01536535|11091865|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
9971084|NCT01536535|11091866|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
9971085|NCT01536535|11091865|FG000|NOT COMPLETED|Overall Study||15
9971086|NCT01536535|11091866|FG001|NOT COMPLETED|Overall Study||13
9971087|NCT01536561|11091873|FG000|STARTED|Dosimetric and Therapeutic Treatment||59
9971088|NCT01536561|11091873|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
9971089|NCT01536561|11091873|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
9971090|NCT01536561|11091873|FG000|STARTED|Long-Term Follow-Up||13
9971091|NCT01536561|11091873|FG000|COMPLETED|Long-Term Follow-Up||13
9971092|NCT01536561|11091873|FG000|NOT COMPLETED|Long-Term Follow-Up||0
9971093|NCT01536574|11091882|FG000|STARTED|Overall Study||162
9971094|NCT01536574|11091883|FG001|STARTED|Overall Study||133
9971095|NCT01536574|11091882|FG000|COMPLETED|Overall Study||156
9971096|NCT01536574|11091883|FG001|COMPLETED|Overall Study||126
9971097|NCT01536574|11091882|FG000|NOT COMPLETED|Overall Study||6
9971098|NCT01536574|11091883|FG001|NOT COMPLETED|Overall Study||7
9971099|NCT01536587|11091889|FG000|STARTED|Overall Study||32
9971100|NCT01536587|11091889|FG000|COMPLETED|Overall Study||30
9971101|NCT01536587|11091889|FG000|NOT COMPLETED|Overall Study||2
9971102|NCT01536704|11091893|FG000|STARTED|Period 1||12
9971103|NCT01536704|11091894|FG001|STARTED|Period 1||12
9971104|NCT01536704|11091895|FG002|STARTED|Period 1||13
9971105|NCT01536704|11091896|FG003|STARTED|Period 1||13
9971106|NCT01536704|11091893|FG000|COMPLETED|Period 1||12
9971107|NCT01536704|11091894|FG001|COMPLETED|Period 1||12
9971108|NCT01536704|11091895|FG002|COMPLETED|Period 1||13
9971109|NCT01536704|11091896|FG003|COMPLETED|Period 1||13
9971110|NCT01536704|11091893|FG000|NOT COMPLETED|Period 1||0
9971111|NCT01536704|11091894|FG001|NOT COMPLETED|Period 1||0
9971112|NCT01536704|11091895|FG002|NOT COMPLETED|Period 1||0
9971113|NCT01536704|11091896|FG003|NOT COMPLETED|Period 1||0
9971114|NCT01536704|11091893|FG000|STARTED|Washout Period 1||12
9971115|NCT01536704|11091894|FG001|STARTED|Washout Period 1||12
9971116|NCT01536704|11091895|FG002|STARTED|Washout Period 1||13
9971117|NCT01536704|11091896|FG003|STARTED|Washout Period 1||13
9971118|NCT01536704|11091893|FG000|COMPLETED|Washout Period 1||11
9971119|NCT01536704|11091894|FG001|COMPLETED|Washout Period 1||10
9971120|NCT01536704|11091895|FG002|COMPLETED|Washout Period 1||13
9971121|NCT01536704|11091896|FG003|COMPLETED|Washout Period 1||13
9971122|NCT01536704|11091893|FG000|NOT COMPLETED|Washout Period 1||1
9971123|NCT01536704|11091894|FG001|NOT COMPLETED|Washout Period 1||2
9971124|NCT01536704|11091895|FG002|NOT COMPLETED|Washout Period 1||0
9971125|NCT01536704|11091896|FG003|NOT COMPLETED|Washout Period 1||0
9971126|NCT01536704|11091893|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
9971127|NCT01536704|11091894|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
9971128|NCT01536704|11091895|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
9971129|NCT01536704|11091896|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
9971130|NCT01536704|11091893|FG000|COMPLETED|Period 2||13
9971131|NCT01536704|11091894|FG001|COMPLETED|Period 2||11
9971132|NCT01536704|11091895|FG002|COMPLETED|Period 2||10
9971133|NCT01536704|11091896|FG003|COMPLETED|Period 2||13
9971134|NCT01536704|11091893|FG000|NOT COMPLETED|Period 2||0
9971135|NCT01536704|11091894|FG001|NOT COMPLETED|Period 2||0
9971136|NCT01536704|11091895|FG002|NOT COMPLETED|Period 2||0
9971137|NCT01536704|11091896|FG003|NOT COMPLETED|Period 2||0
9971138|NCT01536704|11091893|FG000|STARTED|Washout Period 2||13
9971139|NCT01536704|11091894|FG001|STARTED|Washout Period 2||11
9971140|NCT01536704|11091895|FG002|STARTED|Washout Period 2||10
9971141|NCT01536704|11091896|FG003|STARTED|Washout Period 2||13
9971142|NCT01536704|11091893|FG000|COMPLETED|Washout Period 2||12
9971143|NCT01536704|11091894|FG001|COMPLETED|Washout Period 2||11
9971144|NCT01536704|11091895|FG002|COMPLETED|Washout Period 2||10
9971145|NCT01536704|11091896|FG003|COMPLETED|Washout Period 2||12
9971146|NCT01536704|11091893|FG000|NOT COMPLETED|Washout Period 2||1
9971147|NCT01536704|11091894|FG001|NOT COMPLETED|Washout Period 2||0
9971148|NCT01536704|11091895|FG002|NOT COMPLETED|Washout Period 2||0
9971149|NCT01536704|11091896|FG003|NOT COMPLETED|Washout Period 2||1
9971150|NCT01536704|11091893|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
9971151|NCT01536704|11091894|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
9971152|NCT01536704|11091895|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
9971153|NCT01536704|11091896|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
9971154|NCT01536704|11091893|FG000|COMPLETED|Period 3||10
9971155|NCT01536704|11091894|FG001|COMPLETED|Period 3||12
9971156|NCT01536704|11091895|FG002|COMPLETED|Period 3||12
9971157|NCT01536704|11091896|FG003|COMPLETED|Period 3||10
9971158|NCT01536704|11091893|FG000|NOT COMPLETED|Period 3||0
9971159|NCT01536704|11091894|FG001|NOT COMPLETED|Period 3||0
9971160|NCT01536704|11091895|FG002|NOT COMPLETED|Period 3||0
9971161|NCT01536704|11091896|FG003|NOT COMPLETED|Period 3||1
9971162|NCT01536704|11091893|FG000|STARTED|Washout Period 3||10
9971163|NCT01536704|11091894|FG001|STARTED|Washout Period 3||12
9971164|NCT01536704|11091895|FG002|STARTED|Washout Period 3||12
9971165|NCT01536704|11091896|FG003|STARTED|Washout Period 3||10
9971166|NCT01536704|11091893|FG000|COMPLETED|Washout Period 3||10
9971167|NCT01536704|11091894|FG001|COMPLETED|Washout Period 3||12
9971168|NCT01536704|11091895|FG002|COMPLETED|Washout Period 3||11
9971169|NCT01536704|11091896|FG003|COMPLETED|Washout Period 3||10
9971170|NCT01536704|11091893|FG000|NOT COMPLETED|Washout Period 3||0
9971171|NCT01536704|11091894|FG001|NOT COMPLETED|Washout Period 3||0
9971172|NCT01536704|11091895|FG002|NOT COMPLETED|Washout Period 3||1
9971173|NCT01536704|11091896|FG003|NOT COMPLETED|Washout Period 3||0
9971174|NCT01536704|11091893|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
9971175|NCT01536704|11091894|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
9971176|NCT01536704|11091895|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
9971177|NCT01536704|11091896|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
9971178|NCT01536704|11091893|FG000|COMPLETED|Period 4||12
9971179|NCT01536704|11091894|FG001|COMPLETED|Period 4||11
9971180|NCT01536704|11091895|FG002|COMPLETED|Period 4||10
9971181|NCT01536704|11091896|FG003|COMPLETED|Period 4||10
9971182|NCT01536704|11091893|FG000|NOT COMPLETED|Period 4||0
9971183|NCT01536704|11091894|FG001|NOT COMPLETED|Period 4||0
9971184|NCT01536704|11091895|FG002|NOT COMPLETED|Period 4||0
9971185|NCT01536704|11091896|FG003|NOT COMPLETED|Period 4||0
9971186|NCT01536795|11091912|FG000|STARTED|Overall Study||24
9971187|NCT01536795|11091913|FG001|STARTED|Overall Study||24
9971188|NCT01536795|11091912|FG000|COMPLETED|Overall Study||23
9971189|NCT01536795|11091913|FG001|COMPLETED|Overall Study||22
9971190|NCT01536795|11091912|FG000|NOT COMPLETED|Overall Study||1
9971191|NCT01536795|11091913|FG001|NOT COMPLETED|Overall Study||2
9971192|NCT01536860|11091919|FG000|STARTED|First Intervention (1 Day)||4
9971193|NCT01536860|11091920|FG001|STARTED|First Intervention (1 Day)||4
9971194|NCT01536860|11091921|FG002|STARTED|First Intervention (1 Day)||4
9971195|NCT01536860|11091919|FG000|COMPLETED|First Intervention (1 Day)||4
9971196|NCT01536860|11091920|FG001|COMPLETED|First Intervention (1 Day)||4
9971197|NCT01536860|11091921|FG002|COMPLETED|First Intervention (1 Day)||4
9971198|NCT01536860|11091919|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9971199|NCT01536860|11091920|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9971200|NCT01536860|11091921|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9971201|NCT01536860|11091919|FG000|STARTED|Washout Period (3 Days)||4
9971202|NCT01536860|11091920|FG001|STARTED|Washout Period (3 Days)||4
9971203|NCT01536860|11091921|FG002|STARTED|Washout Period (3 Days)||4
9971204|NCT01536860|11091919|FG000|COMPLETED|Washout Period (3 Days)||4
9971205|NCT01536860|11091920|FG001|COMPLETED|Washout Period (3 Days)||4
9971206|NCT01536860|11091921|FG002|COMPLETED|Washout Period (3 Days)||4
9971207|NCT01536860|11091919|FG000|NOT COMPLETED|Washout Period (3 Days)||0
9971208|NCT01536860|11091920|FG001|NOT COMPLETED|Washout Period (3 Days)||0
9971209|NCT01536860|11091921|FG002|NOT COMPLETED|Washout Period (3 Days)||0
9971210|NCT01536860|11091919|FG000|STARTED|Second Intervention (1 Day)||4
9971211|NCT01536860|11091920|FG001|STARTED|Second Intervention (1 Day)||4
9971212|NCT01536860|11091921|FG002|STARTED|Second Intervention (1 Day)||4
9971213|NCT01536860|11091919|FG000|COMPLETED|Second Intervention (1 Day)||4
9971214|NCT01536860|11091920|FG001|COMPLETED|Second Intervention (1 Day)||4
9971215|NCT01536860|11091921|FG002|COMPLETED|Second Intervention (1 Day)||4
9971216|NCT01536860|11091919|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9971217|NCT01536860|11091920|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9971218|NCT01536860|11091921|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
9971219|NCT01536860|11091919|FG000|STARTED|Washout Period (3 Days)||4
9971220|NCT01536860|11091920|FG001|STARTED|Washout Period (3 Days)||4
9971221|NCT01536860|11091921|FG002|STARTED|Washout Period (3 Days)||4
9971222|NCT01536860|11091919|FG000|COMPLETED|Washout Period (3 Days)||3
9971223|NCT01536860|11091920|FG001|COMPLETED|Washout Period (3 Days)||4
9971224|NCT01536860|11091921|FG002|COMPLETED|Washout Period (3 Days)||4
9971225|NCT01536860|11091919|FG000|NOT COMPLETED|Washout Period (3 Days)||1
9971226|NCT01536860|11091920|FG001|NOT COMPLETED|Washout Period (3 Days)||0
9971227|NCT01536860|11091921|FG002|NOT COMPLETED|Washout Period (3 Days)||0
9971228|NCT01536860|11091919|FG000|STARTED|Third Intervention (1 Day)||3
9971229|NCT01536860|11091920|FG001|STARTED|Third Intervention (1 Day)||4
9971230|NCT01536860|11091921|FG002|STARTED|Third Intervention (1 Day)||4
9971231|NCT01536860|11091919|FG000|COMPLETED|Third Intervention (1 Day)||3
9971232|NCT01536860|11091920|FG001|COMPLETED|Third Intervention (1 Day)||4
9971233|NCT01536860|11091921|FG002|COMPLETED|Third Intervention (1 Day)||4
9971234|NCT01536860|11091919|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9971235|NCT01536860|11091920|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9971236|NCT01536860|11091921|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
9971237|NCT01536886|11091933|FG000|STARTED|Overall Study||141
9971238|NCT01536886|11091934|FG001|STARTED|Overall Study||135
9971239|NCT01536886|11091935|FG002|STARTED|Overall Study||49
9971240|NCT01536886|11091936|FG003|STARTED|Overall Study||51
9971241|NCT01536886|11091933|FG000|COMPLETED|Overall Study||136
9971242|NCT01536886|11091934|FG001|COMPLETED|Overall Study||127
9971243|NCT01536886|11091935|FG002|COMPLETED|Overall Study||47
9971244|NCT01536886|11091936|FG003|COMPLETED|Overall Study||48
9971245|NCT01536886|11091933|FG000|NOT COMPLETED|Overall Study||5
9971246|NCT01536886|11091934|FG001|NOT COMPLETED|Overall Study||8
9971247|NCT01536886|11091935|FG002|NOT COMPLETED|Overall Study||2
9971248|NCT01536886|11091936|FG003|NOT COMPLETED|Overall Study||3
9971249|NCT01536938|11091949|FG000|STARTED|Overall Study||100
9971250|NCT01536938|11091950|FG001|STARTED|Overall Study||101
9971251|NCT01536938|11091951|FG002|STARTED|Overall Study||101
9971252|NCT01536938|11091949|FG000|COMPLETED|Overall Study||94
9971253|NCT01536938|11091950|FG001|COMPLETED|Overall Study||94
9971254|NCT01536938|11091951|FG002|COMPLETED|Overall Study||93
9971255|NCT01536938|11091949|FG000|NOT COMPLETED|Overall Study||6
9971256|NCT01536938|11091950|FG001|NOT COMPLETED|Overall Study||7
9971257|NCT01536938|11091951|FG002|NOT COMPLETED|Overall Study||8
9971258|NCT01536951|11091961|FG000|STARTED|First Intervention and Washout Period 1||3
9971259|NCT01536951|11091962|FG001|STARTED|First Intervention and Washout Period 1||3
9971260|NCT01536951|11091963|FG002|STARTED|First Intervention and Washout Period 1||3
9971261|NCT01536951|11091964|FG003|STARTED|First Intervention and Washout Period 1||8
9971262|NCT01536951|11091965|FG004|STARTED|First Intervention and Washout Period 1||9
9971263|NCT01536951|11091966|FG005|STARTED|First Intervention and Washout Period 1||9
9971264|NCT01536951|11091967|FG006|STARTED|First Intervention and Washout Period 1||9
9971265|NCT01536951|11091968|FG007|STARTED|First Intervention and Washout Period 1||9
9971266|NCT01536951|11091969|FG008|STARTED|First Intervention and Washout Period 1||9
9971267|NCT01536951|11091961|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
9971268|NCT01536951|11091962|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
9971269|NCT01536951|11091963|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
9971270|NCT01536951|11091964|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
9971271|NCT01536951|11091965|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
9971272|NCT01536951|11091966|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
9971273|NCT01536951|11091967|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
9971274|NCT01536951|11091968|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
9971275|NCT01536951|11091969|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
9971276|NCT01536951|11091961|FG000|COMPLETED|First Intervention and Washout Period 1||3
9971277|NCT01536951|11091962|FG001|COMPLETED|First Intervention and Washout Period 1||3
9971278|NCT01536951|11091963|FG002|COMPLETED|First Intervention and Washout Period 1||2
9971279|NCT01536951|11091964|FG003|COMPLETED|First Intervention and Washout Period 1||8
9971280|NCT01536951|11091965|FG004|COMPLETED|First Intervention and Washout Period 1||9
9971281|NCT01536951|11091966|FG005|COMPLETED|First Intervention and Washout Period 1||9
9971282|NCT01536951|11091967|FG006|COMPLETED|First Intervention and Washout Period 1||9
9971283|NCT01536951|11091968|FG007|COMPLETED|First Intervention and Washout Period 1||9
9971284|NCT01536951|11091969|FG008|COMPLETED|First Intervention and Washout Period 1||9
9971285|NCT01536951|11091961|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0
9971286|NCT01536951|11091962|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0
9971287|NCT01536951|11091963|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1
9971288|NCT01536951|11091964|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0
9971289|NCT01536951|11091965|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0
9971290|NCT01536951|11091966|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0
9971291|NCT01536951|11091967|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0
9971292|NCT01536951|11091968|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0
9971293|NCT01536951|11091969|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0
9971294|NCT01536951|11091961|FG000|STARTED|Second Intervention and Washout Period 2||3
9971295|NCT01536951|11091962|FG001|STARTED|Second Intervention and Washout Period 2||3
9971296|NCT01536951|11091963|FG002|STARTED|Second Intervention and Washout Period 2||2
9971297|NCT01536951|11091964|FG003|STARTED|Second Intervention and Washout Period 2||8
9971298|NCT01536951|11091965|FG004|STARTED|Second Intervention and Washout Period 2||9
9971299|NCT01536951|11091966|FG005|STARTED|Second Intervention and Washout Period 2||9
9971300|NCT01536951|11091967|FG006|STARTED|Second Intervention and Washout Period 2||9
9971301|NCT01536951|11091968|FG007|STARTED|Second Intervention and Washout Period 2||9
9971302|NCT01536951|11091969|FG008|STARTED|Second Intervention and Washout Period 2||9
9971303|NCT01536951|11091961|FG000|COMPLETED|Second Intervention and Washout Period 2||3
9971304|NCT01536951|11091962|FG001|COMPLETED|Second Intervention and Washout Period 2||3
9971305|NCT01536951|11091963|FG002|COMPLETED|Second Intervention and Washout Period 2||2
10098112|NCT02380677|11227163|FG005|STARTED|Overall Study||6
10098113|NCT02380677|11227164|FG006|STARTED|Overall Study||3
10098114|NCT02380677|11227165|FG007|STARTED|Overall Study||4
10098115|NCT02380677|11227166|FG008|STARTED|Overall Study||4
9971306|NCT01536951|11091964|FG003|COMPLETED|Second Intervention and Washout Period 2||8
9971307|NCT01536951|11091965|FG004|COMPLETED|Second Intervention and Washout Period 2||9
9971308|NCT01536951|11091966|FG005|COMPLETED|Second Intervention and Washout Period 2||9
9971309|NCT01536951|11091967|FG006|COMPLETED|Second Intervention and Washout Period 2||9
9971310|NCT01536951|11091968|FG007|COMPLETED|Second Intervention and Washout Period 2||8
9971311|NCT01536951|11091969|FG008|COMPLETED|Second Intervention and Washout Period 2||9
9971312|NCT01536951|11091961|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971313|NCT01536951|11091962|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971314|NCT01536951|11091963|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971315|NCT01536951|11091964|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971316|NCT01536951|11091965|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971317|NCT01536951|11091966|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971318|NCT01536951|11091967|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971319|NCT01536951|11091968|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1
9971320|NCT01536951|11091969|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0
9971321|NCT01536951|11091961|FG000|STARTED|Third Intervention||3
9971322|NCT01536951|11091962|FG001|STARTED|Third Intervention||3
9971323|NCT01536951|11091963|FG002|STARTED|Third Intervention||2
9971324|NCT01536951|11091964|FG003|STARTED|Third Intervention||8
9971325|NCT01536951|11091965|FG004|STARTED|Third Intervention||9
9971326|NCT01536951|11091966|FG005|STARTED|Third Intervention||9
9971327|NCT01536951|11091967|FG006|STARTED|Third Intervention||9
9971328|NCT01536951|11091968|FG007|STARTED|Third Intervention||8
9971329|NCT01536951|11091969|FG008|STARTED|Third Intervention||9
9971330|NCT01536951|11091961|FG000|COMPLETED|Third Intervention||3
9971331|NCT01536951|11091962|FG001|COMPLETED|Third Intervention||3
9971332|NCT01536951|11091963|FG002|COMPLETED|Third Intervention||2
9971333|NCT01536951|11091964|FG003|COMPLETED|Third Intervention||8
9971334|NCT01536951|11091965|FG004|COMPLETED|Third Intervention||9
9971335|NCT01536951|11091966|FG005|COMPLETED|Third Intervention||9
10098116|NCT02380677|11227167|FG009|STARTED|Overall Study||2
9971336|NCT01536951|11091967|FG006|COMPLETED|Third Intervention||9
9971337|NCT01536951|11091968|FG007|COMPLETED|Third Intervention||8
9971338|NCT01536951|11091969|FG008|COMPLETED|Third Intervention||9
9971339|NCT01536951|11091961|FG000|NOT COMPLETED|Third Intervention||0
9971340|NCT01536951|11091962|FG001|NOT COMPLETED|Third Intervention||0
9971341|NCT01536951|11091963|FG002|NOT COMPLETED|Third Intervention||0
9971342|NCT01536951|11091964|FG003|NOT COMPLETED|Third Intervention||0
9971343|NCT01536951|11091965|FG004|NOT COMPLETED|Third Intervention||0
9971344|NCT01536951|11091966|FG005|NOT COMPLETED|Third Intervention||0
9971345|NCT01536951|11091967|FG006|NOT COMPLETED|Third Intervention||0
9971346|NCT01536951|11091968|FG007|NOT COMPLETED|Third Intervention||0
9971347|NCT01536951|11091969|FG008|NOT COMPLETED|Third Intervention||0
9971348|NCT01537029|11091992|FG000|STARTED|Overall Study||15
9971349|NCT01537029|11091992|FG000|COMPLETED|Overall Study||15
9971350|NCT01537029|11091992|FG000|NOT COMPLETED|Overall Study||0
9971351|NCT01537042|11091998|FG000|STARTED|Overall Study||10
9971352|NCT01537042|11091999|FG001|STARTED|Overall Study||20
9971353|NCT01537042|11091998|FG000|COMPLETED|Overall Study||10
9971354|NCT01537042|11091999|FG001|COMPLETED|Overall Study||15
9971355|NCT01537042|11091998|FG000|NOT COMPLETED|Overall Study||0
9971356|NCT01537042|11091999|FG001|NOT COMPLETED|Overall Study||5
9971357|NCT01537068|11092011|FG000|STARTED|Overall Study||30
9971358|NCT01537068|11092012|FG001|STARTED|Overall Study||29
9971359|NCT01537068|11092011|FG000|COMPLETED|Overall Study||26
9971360|NCT01537068|11092012|FG001|COMPLETED|Overall Study||26
9971361|NCT01537068|11092011|FG000|NOT COMPLETED|Overall Study||4
9971362|NCT01537068|11092012|FG001|NOT COMPLETED|Overall Study||3
9971363|NCT01537081|11092021|FG000|STARTED|Overall Study||1123
9971364|NCT01537081|11092022|FG001|STARTED|Overall Study||1124
9971365|NCT01537081|11092023|FG002|STARTED|Overall Study||563
9971366|NCT01537081|11092021|FG000|Safety Population|Overall Study||1122
9971367|NCT01537081|11092022|FG001|Safety Population|Overall Study||1122
9971368|NCT01537081|11092023|FG002|Safety Population|Overall Study||561
9971369|NCT01537081|11092021|FG000|Modified Intent to Treat Population|Overall Study||1106
9971370|NCT01537081|11092022|FG001|Modified Intent to Treat Population|Overall Study||1109
9971371|NCT01537081|11092023|FG002|Modified Intent to Treat Population|Overall Study||556
9971372|NCT01537081|11092021|FG000|COMPLETED|Overall Study||1084
9971373|NCT01537081|11092022|FG001|COMPLETED|Overall Study||1086
9971374|NCT01537081|11092023|FG002|COMPLETED|Overall Study||547
9971375|NCT01537081|11092021|FG000|NOT COMPLETED|Overall Study||39
9971376|NCT01537081|11092022|FG001|NOT COMPLETED|Overall Study||38
9971377|NCT01537081|11092023|FG002|NOT COMPLETED|Overall Study||16
9971378|NCT01537120|11092032|FG000|STARTED|Enrolled||25
9971379|NCT01537120|11092032|FG000|COMPLETED|Enrolled||25
9971380|NCT01537120|11092032|FG000|NOT COMPLETED|Enrolled||0
9971381|NCT01537120|11092032|FG000|STARTED|8 Weeks Washout||25
9971382|NCT01537120|11092032|FG000|COMPLETED|8 Weeks Washout||24
9971383|NCT01537120|11092032|FG000|NOT COMPLETED|8 Weeks Washout||1
9971384|NCT01537120|11092032|FG000|STARTED|3 Weeks Placebo||24
9971385|NCT01537120|11092032|FG000|COMPLETED|3 Weeks Placebo||23
9971386|NCT01537120|11092032|FG000|NOT COMPLETED|3 Weeks Placebo||1
9971387|NCT01537120|11092032|FG000|STARTED|12 Weeks Vildagliptin||23
9971388|NCT01537120|11092032|FG000|COMPLETED|12 Weeks Vildagliptin||23
9971389|NCT01537120|11092032|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0
9971390|NCT01537133|11092042|FG000|STARTED|Overall Study||28
9971391|NCT01537133|11092043|FG001|STARTED|Overall Study||14
9971392|NCT01537133|11092044|FG002|STARTED|Overall Study||21
9971393|NCT01537133|11092045|FG003|STARTED|Overall Study||21
9971394|NCT01537133|11092042|FG000|COMPLETED|Overall Study||25
9971395|NCT01537133|11092043|FG001|COMPLETED|Overall Study||14
9971396|NCT01537133|11092044|FG002|COMPLETED|Overall Study||21
9971397|NCT01537133|11092045|FG003|COMPLETED|Overall Study||21
9971398|NCT01537133|11092042|FG000|NOT COMPLETED|Overall Study||3
9971399|NCT01537133|11092043|FG001|NOT COMPLETED|Overall Study||0
9971400|NCT01537133|11092044|FG002|NOT COMPLETED|Overall Study||0
9971401|NCT01537133|11092045|FG003|NOT COMPLETED|Overall Study||0
9971402|NCT01537185|11092057|FG000|STARTED|Overall Study||10
9971403|NCT01537185|11092058|FG001|STARTED|Overall Study||12
9971404|NCT01537185|11092059|FG002|STARTED|Overall Study||10
9971405|NCT01537185|11092060|FG003|STARTED|Overall Study||10
10098117|NCT02380677|11227168|FG010|STARTED|Overall Study||4
10098118|NCT02380677|11227169|FG011|STARTED|Overall Study||5
10098119|NCT02380677|11227158|FG000|COMPLETED|Overall Study||0
10098120|NCT02380677|11227159|FG001|COMPLETED|Overall Study||0
10098121|NCT02380677|11227160|FG002|COMPLETED|Overall Study||0
10098122|NCT02380677|11227161|FG003|COMPLETED|Overall Study||0
10098123|NCT02380677|11227162|FG004|COMPLETED|Overall Study||0
9971406|NCT01537185|11092057|FG000|COMPLETED|Overall Study||7
9971407|NCT01537185|11092058|FG001|COMPLETED|Overall Study||6
9971408|NCT01537185|11092059|FG002|COMPLETED|Overall Study||4
9971409|NCT01537185|11092060|FG003|COMPLETED|Overall Study||8
9971410|NCT01537185|11092057|FG000|NOT COMPLETED|Overall Study||3
9971411|NCT01537185|11092058|FG001|NOT COMPLETED|Overall Study||6
9971412|NCT01537185|11092059|FG002|NOT COMPLETED|Overall Study||6
9971413|NCT01537185|11092060|FG003|NOT COMPLETED|Overall Study||2
9971414|NCT01537198|11092072|FG000|STARTED|Overall Study||617
10098124|NCT02380677|11227163|FG005|COMPLETED|Overall Study||0
10098125|NCT02380677|11227164|FG006|COMPLETED|Overall Study||0
9971415|NCT01537198|11092072|FG000|COMPLETED|Overall Study||463
9971416|NCT01537198|11092072|FG000|NOT COMPLETED|Overall Study||154
9971417|NCT01537211|11092078|FG000|STARTED|Overall Study||4
9971418|NCT01537211|11092079|FG001|STARTED|Overall Study||6
9971419|NCT01537211|11092078|FG000|COMPLETED|Overall Study||4
9971420|NCT01537211|11092079|FG001|COMPLETED|Overall Study||5
9971421|NCT01537211|11092078|FG000|NOT COMPLETED|Overall Study||0
9971422|NCT01537211|11092079|FG001|NOT COMPLETED|Overall Study||1
9971423|NCT01537302|11092089|FG000|STARTED|Overall Study||100
9971424|NCT01537302|11092089|FG000|COMPLETED|Overall Study||100
9971425|NCT01537302|11092089|FG000|NOT COMPLETED|Overall Study||0
9971426|NCT01537315|11092095|FG000|STARTED|Overall Study||1
9971427|NCT01537315|11092096|FG001|STARTED|Overall Study||7
9971428|NCT01537315|11092095|FG000|COMPLETED|Overall Study||1
9971429|NCT01537315|11092096|FG001|COMPLETED|Overall Study||7
9971430|NCT01537315|11092095|FG000|NOT COMPLETED|Overall Study||0
9971431|NCT01537315|11092096|FG001|NOT COMPLETED|Overall Study||0
9971432|NCT01537367|11092105|FG000|STARTED|Overall Study||615
9971433|NCT01537367|11092106|FG001|STARTED|Overall Study||610
9971434|NCT01537367|11092107|FG002|STARTED|Overall Study||613
9971435|NCT01537367|11092105|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
9971436|NCT01537367|11092106|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
9971437|NCT01537367|11092107|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
9971438|NCT01537367|11092105|FG000|NOT COMPLETED|Overall Study||0
9971439|NCT01537367|11092106|FG001|NOT COMPLETED|Overall Study||0
9971440|NCT01537367|11092107|FG002|NOT COMPLETED|Overall Study||0
9971441|NCT01537393|11092117|FG000|STARTED|Overall Study||707
9971442|NCT01537393|11092118|FG001|STARTED|Overall Study||698
9971443|NCT01537393|11092117|FG000|COMPLETED|Overall Study||553
9971444|NCT01537393|11092118|FG001|COMPLETED|Overall Study||507
9971445|NCT01537393|11092117|FG000|NOT COMPLETED|Overall Study||154
9971446|NCT01537393|11092118|FG001|NOT COMPLETED|Overall Study||191
9971447|NCT01537419|11092126|FG000|STARTED|Overall Study||63
9971448|NCT01537419|11092127|FG001|STARTED|Overall Study||66
9971449|NCT01537419|11092126|FG000|COMPLETED|Overall Study||52
9971450|NCT01537419|11092127|FG001|COMPLETED|Overall Study||54
9971451|NCT01537419|11092126|FG000|NOT COMPLETED|Overall Study||11
9971452|NCT01537419|11092127|FG001|NOT COMPLETED|Overall Study||12
9971453|NCT01537432|11092135|FG000|STARTED|Overall Study||24
9971454|NCT01537432|11092136|FG001|STARTED|Overall Study||12
9971455|NCT01537432|11092135|FG000|COMPLETED|Overall Study||18
9971456|NCT01537432|11092136|FG001|COMPLETED|Overall Study||10
9971457|NCT01537432|11092135|FG000|NOT COMPLETED|Overall Study||6
9971458|NCT01537432|11092136|FG001|NOT COMPLETED|Overall Study||2
9971459|NCT01537549|11092142|FG000|STARTED|Overall Study||11
9971460|NCT01537549|11092142|FG000|COMPLETED|Overall Study||8
9971461|NCT01537549|11092142|FG000|NOT COMPLETED|Overall Study||3
9971462|NCT01537666|11092152|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
9971463|NCT01537666|11092153|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
9971464|NCT01537666|11092154|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
10098126|NCT02380677|11227165|FG007|COMPLETED|Overall Study||0
10098127|NCT02380677|11227166|FG008|COMPLETED|Overall Study||0
10098128|NCT02380677|11227167|FG009|COMPLETED|Overall Study||0
10098129|NCT02380677|11227168|FG010|COMPLETED|Overall Study||0
9971465|NCT01537666|11092155|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
9971466|NCT01537666|11092152|FG000|COMPLETED|Overall Study||6
9971467|NCT01537666|11092153|FG001|COMPLETED|Overall Study||6
9971468|NCT01537666|11092154|FG002|COMPLETED|Overall Study||6
9971469|NCT01537666|11092155|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
9971470|NCT01537666|11092152|FG000|NOT COMPLETED|Overall Study||0
9971471|NCT01537666|11092153|FG001|NOT COMPLETED|Overall Study||0
9971472|NCT01537666|11092154|FG002|NOT COMPLETED|Overall Study||0
9971473|NCT01537666|11092155|FG003|NOT COMPLETED|Overall Study||0
9971474|NCT01537783|11092177|FG000|STARTED|Overall Study||25
9971475|NCT01537783|11092178|FG001|STARTED|Overall Study||25
9971476|NCT01537783|11092177|FG000|COMPLETED|Overall Study||14
9971477|NCT01537783|11092178|FG001|COMPLETED|Overall Study||23
9971478|NCT01537783|11092177|FG000|NOT COMPLETED|Overall Study||11
9971479|NCT01537783|11092178|FG001|NOT COMPLETED|Overall Study||2
9971480|NCT01537835|11092187|FG000|STARTED|Overall Study||37
9971481|NCT01537835|11092188|FG001|STARTED|Overall Study||37
9971482|NCT01537835|11092189|FG002|STARTED|Overall Study||35
9971483|NCT01537835|11092187|FG000|COMPLETED|Overall Study||37
9971484|NCT01537835|11092188|FG001|COMPLETED|Overall Study||37
9971485|NCT01537835|11092189|FG002|COMPLETED|Overall Study||35
9971486|NCT01537835|11092187|FG000|NOT COMPLETED|Overall Study||0
9971487|NCT01537835|11092188|FG001|NOT COMPLETED|Overall Study||0
9971488|NCT01537835|11092189|FG002|NOT COMPLETED|Overall Study||0
9971489|NCT01537887|11092197|FG000|STARTED|Period 1||12
9971490|NCT01537887|11092198|FG001|STARTED|Period 1||12
9971491|NCT01537887|11092199|FG002|STARTED|Period 1||12
9971492|NCT01537887|11092200|FG003|STARTED|Period 1||12
9971493|NCT01537887|11092201|FG004|STARTED|Period 1||12
9971494|NCT01537887|11092202|FG005|STARTED|Period 1||12
9971495|NCT01537887|11092197|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
9971496|NCT01537887|11092198|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
9971497|NCT01537887|11092199|FG002|Received at Least 1 Dose of Study Drug|Period 1||11
9971498|NCT01537887|11092200|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
9971499|NCT01537887|11092201|FG004|Received at Least 1 Dose of Study Drug|Period 1||12
9971500|NCT01537887|11092202|FG005|Received at Least 1 Dose of Study Drug|Period 1||12
9971501|NCT01537887|11092197|FG000|COMPLETED|Period 1||12
9971502|NCT01537887|11092198|FG001|COMPLETED|Period 1||12
9971503|NCT01537887|11092199|FG002|COMPLETED|Period 1||11
9971504|NCT01537887|11092200|FG003|COMPLETED|Period 1||12
9971505|NCT01537887|11092201|FG004|COMPLETED|Period 1||11
9971506|NCT01537887|11092202|FG005|COMPLETED|Period 1||11
9971507|NCT01537887|11092197|FG000|NOT COMPLETED|Period 1||0
9971508|NCT01537887|11092198|FG001|NOT COMPLETED|Period 1||0
9971509|NCT01537887|11092199|FG002|NOT COMPLETED|Period 1||1
9971510|NCT01537887|11092200|FG003|NOT COMPLETED|Period 1||0
9971511|NCT01537887|11092201|FG004|NOT COMPLETED|Period 1||1
9971512|NCT01537887|11092202|FG005|NOT COMPLETED|Period 1||1
9971513|NCT01537887|11092197|FG000|STARTED|Period 2||12
9971514|NCT01537887|11092198|FG001|STARTED|Period 2||12
9971515|NCT01537887|11092199|FG002|STARTED|Period 2||11
9971516|NCT01537887|11092200|FG003|STARTED|Period 2||12
9971517|NCT01537887|11092201|FG004|STARTED|Period 2||11
9971518|NCT01537887|11092202|FG005|STARTED|Period 2||11
9971519|NCT01537887|11092197|FG000|COMPLETED|Period 2||12
9971520|NCT01537887|11092198|FG001|COMPLETED|Period 2||11
9971521|NCT01537887|11092199|FG002|COMPLETED|Period 2||11
9971522|NCT01537887|11092200|FG003|COMPLETED|Period 2||12
9971523|NCT01537887|11092201|FG004|COMPLETED|Period 2||11
9971524|NCT01537887|11092202|FG005|COMPLETED|Period 2||11
9971525|NCT01537887|11092197|FG000|NOT COMPLETED|Period 2||0
9971526|NCT01537887|11092198|FG001|NOT COMPLETED|Period 2||1
9971527|NCT01537887|11092199|FG002|NOT COMPLETED|Period 2||0
9971528|NCT01537887|11092200|FG003|NOT COMPLETED|Period 2||0
9971529|NCT01537887|11092201|FG004|NOT COMPLETED|Period 2||0
9971530|NCT01537887|11092202|FG005|NOT COMPLETED|Period 2||0
9971531|NCT01537887|11092197|FG000|STARTED|Period 3||12
9971532|NCT01537887|11092198|FG001|STARTED|Period 3||11
9971533|NCT01537887|11092199|FG002|STARTED|Period 3||11
9971534|NCT01537887|11092200|FG003|STARTED|Period 3||12
9971535|NCT01537887|11092201|FG004|STARTED|Period 3||11
9971536|NCT01537887|11092202|FG005|STARTED|Period 3||11
9971537|NCT01537887|11092197|FG000|COMPLETED|Period 3||12
9971538|NCT01537887|11092198|FG001|COMPLETED|Period 3||10
9971539|NCT01537887|11092199|FG002|COMPLETED|Period 3||10
9971540|NCT01537887|11092200|FG003|COMPLETED|Period 3||12
9971541|NCT01537887|11092201|FG004|COMPLETED|Period 3||11
9971542|NCT01537887|11092202|FG005|COMPLETED|Period 3||11
9971543|NCT01537887|11092197|FG000|NOT COMPLETED|Period 3||0
9971544|NCT01537887|11092198|FG001|NOT COMPLETED|Period 3||1
9971545|NCT01537887|11092199|FG002|NOT COMPLETED|Period 3||1
9971546|NCT01537887|11092200|FG003|NOT COMPLETED|Period 3||0
9971547|NCT01537887|11092201|FG004|NOT COMPLETED|Period 3||0
9971548|NCT01537887|11092202|FG005|NOT COMPLETED|Period 3||0
9971549|NCT01537900|11092210|FG000|STARTED|Overall Study||4
9971550|NCT01537900|11092210|FG000|COMPLETED|Overall Study||4
9971551|NCT01537900|11092210|FG000|NOT COMPLETED|Overall Study||0
9971552|NCT01537926|11092216|FG000|STARTED|Overall Study||29
9971553|NCT01537926|11092217|FG001|STARTED|Overall Study||13
9971554|NCT01537926|11092216|FG000|COMPLETED|Overall Study||24
9971555|NCT01537926|11092217|FG001|COMPLETED|Overall Study||11
9971556|NCT01537926|11092216|FG000|NOT COMPLETED|Overall Study||5
9971557|NCT01537926|11092217|FG001|NOT COMPLETED|Overall Study||2
9971558|NCT01538199|11092230|FG000|STARTED|Overall Study||10
9971559|NCT01538199|11092231|FG001|STARTED|Overall Study||11
9971560|NCT01538199|11092232|FG002|STARTED|Overall Study||4
9971561|NCT01538199|11092233|FG003|STARTED|Overall Study||3
9971562|NCT01538199|11092230|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
9971563|NCT01538199|11092231|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
9971564|NCT01538199|11092232|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
9971565|NCT01538199|11092233|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
9971566|NCT01538199|11092230|FG000|NOT COMPLETED|Overall Study||2
9971567|NCT01538199|11092231|FG001|NOT COMPLETED|Overall Study||3
9971568|NCT01538199|11092232|FG002|NOT COMPLETED|Overall Study||1
9971569|NCT01538199|11092233|FG003|NOT COMPLETED|Overall Study||2
9971570|NCT01538472|11092250|FG000|STARTED|Overall Study||40
9971571|NCT01538472|11092250|FG000|COMPLETED|Overall Study||36
9971572|NCT01538472|11092250|FG000|NOT COMPLETED|Overall Study||4
9971573|NCT01538615|11092256|FG000|STARTED|Overall Study||162
9971574|NCT01538615|11092257|FG001|STARTED|Overall Study||158
9971575|NCT01538615|11092256|FG000|COMPLETED|Overall Study||140
9971576|NCT01538615|11092257|FG001|COMPLETED|Overall Study||146
9971577|NCT01538615|11092256|FG000|NOT COMPLETED|Overall Study||22
9971578|NCT01538615|11092257|FG001|NOT COMPLETED|Overall Study||12
9971579|NCT01538628|11092265|FG000|STARTED|Overall Study||149
9971580|NCT01538628|11092266|FG001|STARTED|Overall Study||73
9971581|NCT01538628|11092265|FG000|COMPLETED|Overall Study||148
9971582|NCT01538628|11092266|FG001|COMPLETED|Overall Study||71
9971583|NCT01538628|11092265|FG000|NOT COMPLETED|Overall Study||1
9971584|NCT01538628|11092266|FG001|NOT COMPLETED|Overall Study||2
9971585|NCT01538719|11092275|FG000|STARTED|Overall Study||7
9971586|NCT01538719|11092276|FG001|STARTED|Overall Study||12
9971587|NCT01538719|11092275|FG000|COMPLETED|Overall Study||5
9971588|NCT01538719|11092276|FG001|COMPLETED|Overall Study||12
9971589|NCT01538719|11092275|FG000|NOT COMPLETED|Overall Study||2
9971590|NCT01538719|11092276|FG001|NOT COMPLETED|Overall Study||0
9971591|NCT01538745|11092284|FG000|STARTED|Overall Study||24
9971592|NCT01538745|11092285|FG001|STARTED|Overall Study||21
9971593|NCT01538745|11092284|FG000|COMPLETED|Overall Study||24
9971594|NCT01538745|11092285|FG001|COMPLETED|Overall Study||21
9971595|NCT01538745|11092284|FG000|NOT COMPLETED|Overall Study||0
9971596|NCT01538745|11092285|FG001|NOT COMPLETED|Overall Study||0
9971597|NCT01538862|11092291|FG000|STARTED|Overall Study||7
9971598|NCT01538862|11092291|FG000|COMPLETED|Overall Study||7
9971599|NCT01538862|11092291|FG000|NOT COMPLETED|Overall Study||0
9971600|NCT01539070|11092298|FG000|STARTED|Overall Study||168
9971601|NCT01539070|11092299|FG001|STARTED|Overall Study||138
9971602|NCT01539070|11092298|FG000|COMPLETED|Overall Study||109
9971603|NCT01539070|11092299|FG001|COMPLETED|Overall Study||99
9971604|NCT01539070|11092298|FG000|NOT COMPLETED|Overall Study||59
9971605|NCT01539070|11092299|FG001|NOT COMPLETED|Overall Study||39
9971606|NCT01539083|11092305|FG000|STARTED|Before Randomization (VCD Induction)||256
9971607|NCT01539083|11092306|FG001|STARTED|Before Randomization (VCD Induction)||0
9971608|NCT01539083|11092307|FG002|STARTED|Before Randomization (VCD Induction)||0
9971609|NCT01539083|11092305|FG000|Treated|Before Randomization (VCD Induction)||254
9971610|NCT01539083|11092306|FG001|Treated|Before Randomization (VCD Induction)||0
9971611|NCT01539083|11092307|FG002|Treated|Before Randomization (VCD Induction)||0
9971612|NCT01539083|11092305|FG000|COMPLETED|Before Randomization (VCD Induction)||203
9971613|NCT01539083|11092306|FG001|COMPLETED|Before Randomization (VCD Induction)||0
9971614|NCT01539083|11092307|FG002|COMPLETED|Before Randomization (VCD Induction)||0
9971615|NCT01539083|11092305|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53
9971616|NCT01539083|11092306|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0
9971617|NCT01539083|11092307|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0
9971618|NCT01539083|11092305|FG000|STARTED|After Randomization (TP and VTP)||0
9971619|NCT01539083|11092306|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
9971620|NCT01539083|11092307|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
9971621|NCT01539083|11092305|FG000|Safety Population|After Randomization (TP and VTP)||0
9971622|NCT01539083|11092306|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
9971623|NCT01539083|11092307|FG002|Safety Population|After Randomization (TP and VTP)||103
9971624|NCT01539083|11092305|FG000|COMPLETED|After Randomization (TP and VTP)||0
9971625|NCT01539083|11092306|FG001|COMPLETED|After Randomization (TP and VTP)||79
9971626|NCT01539083|11092307|FG002|COMPLETED|After Randomization (TP and VTP)||80
9971627|NCT01539083|11092305|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0
9971628|NCT01539083|11092306|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21
9971629|NCT01539083|11092307|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23
9971630|NCT01539135|11092316|FG000|STARTED|Overall Study||43
9971631|NCT01539135|11092317|FG001|STARTED|Overall Study||37
9971632|NCT01539135|11092316|FG000|COMPLETED|Overall Study||43
9971633|NCT01539135|11092317|FG001|COMPLETED|Overall Study||37
9971634|NCT01539135|11092316|FG000|NOT COMPLETED|Overall Study||0
9971635|NCT01539135|11092317|FG001|NOT COMPLETED|Overall Study||0
9971636|NCT01539239|11092325|FG000|STARTED|Overall Study||369
9971637|NCT01539239|11092326|FG001|STARTED|Overall Study||187
9971638|NCT01539239|11092325|FG000|COMPLETED|Overall Study||357
9971639|NCT01539239|11092326|FG001|COMPLETED|Overall Study||170
9971640|NCT01539239|11092325|FG000|NOT COMPLETED|Overall Study||12
9971641|NCT01539239|11092326|FG001|NOT COMPLETED|Overall Study||17
9971642|NCT01539291|11092335|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
9971643|NCT01539291|11092336|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
9971644|NCT01539291|11092337|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
9971645|NCT01539291|11092338|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
9971646|NCT01539291|11092335|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
9971647|NCT01539291|11092336|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
9971648|NCT01539291|11092337|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
9971649|NCT01539291|11092338|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
9971650|NCT01539291|11092335|FG000|NOT COMPLETED|Study GS-US-312-0116||25
9971651|NCT01539291|11092336|FG001|NOT COMPLETED|Study GS-US-312-0116||0
9971652|NCT01539291|11092337|FG002|NOT COMPLETED|Study GS-US-312-0116||0
9971653|NCT01539291|11092338|FG003|NOT COMPLETED|Study GS-US-312-0116||0
9971654|NCT01539291|11092335|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
9971655|NCT01539291|11092336|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
9971656|NCT01539291|11092337|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
9971657|NCT01539291|11092338|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
9971658|NCT01539291|11092335|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
10019154|NCT01828073|11142292|FG000|NOT COMPLETED|Overall Study||1
9971659|NCT01539291|11092336|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
9971660|NCT01539291|11092337|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
9971661|NCT01539291|11092338|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
9971662|NCT01539291|11092335|FG000|NOT COMPLETED|Study GS-US-312-0117||41
9971663|NCT01539291|11092336|FG001|NOT COMPLETED|Study GS-US-312-0117||2
9971664|NCT01539291|11092337|FG002|NOT COMPLETED|Study GS-US-312-0117||22
10098130|NCT02380677|11227169|FG011|COMPLETED|Overall Study||0
10098131|NCT02380677|11227158|FG000|NOT COMPLETED|Overall Study||1
10098132|NCT02380677|11227159|FG001|NOT COMPLETED|Overall Study||1
10098133|NCT02380677|11227160|FG002|NOT COMPLETED|Overall Study||3
10098134|NCT02380677|11227161|FG003|NOT COMPLETED|Overall Study||3
9971665|NCT01539291|11092338|FG003|NOT COMPLETED|Study GS-US-312-0117||26
9971666|NCT01539317|11092357|FG000|STARTED|Overall Study||25
9971667|NCT01539317|11092358|FG001|STARTED|Overall Study||25
9971668|NCT01539317|11092357|FG000|COMPLETED|Overall Study||24
9971669|NCT01539317|11092358|FG001|COMPLETED|Overall Study||25
9971670|NCT01539317|11092357|FG000|NOT COMPLETED|Overall Study||1
9971671|NCT01539317|11092358|FG001|NOT COMPLETED|Overall Study||0
9971672|NCT01539512|11092369|FG000|STARTED|Overall Study||110
9971673|NCT01539512|11092370|FG001|STARTED|Overall Study||110
9971674|NCT01539512|11092369|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
9971675|NCT01539512|11092370|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
9971676|NCT01539512|11092369|FG000|NOT COMPLETED|Overall Study||23
9971677|NCT01539512|11092370|FG001|NOT COMPLETED|Overall Study||13
9971678|NCT01539525|11092379|FG000|STARTED|Overall Study||145
9971679|NCT01539525|11092380|FG001|STARTED|Overall Study||143
9971680|NCT01539525|11092381|FG002|STARTED|Overall Study||151
9971681|NCT01539525|11092379|FG000|COMPLETED|Overall Study||125
9971682|NCT01539525|11092380|FG001|COMPLETED|Overall Study||127
9971683|NCT01539525|11092381|FG002|COMPLETED|Overall Study||134
9971684|NCT01539525|11092379|FG000|NOT COMPLETED|Overall Study||20
9971685|NCT01539525|11092380|FG001|NOT COMPLETED|Overall Study||16
9971686|NCT01539525|11092381|FG002|NOT COMPLETED|Overall Study||17
9971687|NCT01539538|11092394|FG000|STARTED|Overall Study||177
9971688|NCT01539538|11092395|FG001|STARTED|Overall Study||180
9971689|NCT01539538|11092394|FG000|COMPLETED|Overall Study||146
9971690|NCT01539538|11092395|FG001|COMPLETED|Overall Study||136
9971691|NCT01539538|11092394|FG000|NOT COMPLETED|Overall Study||31
9971692|NCT01539538|11092395|FG001|NOT COMPLETED|Overall Study||44
9971693|NCT01539642|11092403|FG000|STARTED|Overall Study||114
9971694|NCT01539642|11092404|FG001|STARTED|Overall Study||58
9971695|NCT01539642|11092403|FG000|COMPLETED|Overall Study||78
9971696|NCT01539642|11092404|FG001|COMPLETED|Overall Study||27
9971697|NCT01539642|11092403|FG000|NOT COMPLETED|Overall Study||36
9971698|NCT01539642|11092404|FG001|NOT COMPLETED|Overall Study||31
9971699|NCT01539694|11092410|FG000|STARTED|Overall Study||63
9971700|NCT01539694|11092411|FG001|STARTED|Overall Study||63
9971701|NCT01539694|11092410|FG000|COMPLETED|Overall Study||62
9971702|NCT01539694|11092411|FG001|COMPLETED|Overall Study||62
9971703|NCT01539694|11092410|FG000|NOT COMPLETED|Overall Study||1
9971704|NCT01539694|11092411|FG001|NOT COMPLETED|Overall Study||1
9971705|NCT01539759|11092419|FG000|STARTED|Overall Study||56
9971706|NCT01539759|11092420|FG001|STARTED|Overall Study||56
9971707|NCT01539759|11092419|FG000|Had Successful IUD Placement|Overall Study||34
9971708|NCT01539759|11092420|FG001|Had Successful IUD Placement|Overall Study||53
9971709|NCT01539759|11092419|FG000|IUD Expulsion|Overall Study||1
9971710|NCT01539759|11092420|FG001|IUD Expulsion|Overall Study||4
9971711|NCT01539759|11092419|FG000|IUD Removal|Overall Study||2
9971712|NCT01539759|11092420|FG001|IUD Removal|Overall Study||7
9971713|NCT01539759|11092419|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32
9971714|NCT01539759|11092420|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40
9971715|NCT01539759|11092419|FG000|COMPLETED|Overall Study||50
9971716|NCT01539759|11092420|FG001|COMPLETED|Overall Study||48
9971717|NCT01539759|11092419|FG000|NOT COMPLETED|Overall Study||6
9971718|NCT01539759|11092420|FG001|NOT COMPLETED|Overall Study||8
9971719|NCT01539837|11092429|FG000|STARTED|Overall Study||8
9971720|NCT01539837|11092430|FG001|STARTED|Overall Study||7
9971721|NCT01539837|11092431|FG002|STARTED|Overall Study||7
9971722|NCT01539837|11092429|FG000|COMPLETED|Overall Study||8
10098135|NCT02380677|11227162|FG004|NOT COMPLETED|Overall Study||6
9971723|NCT01539837|11092430|FG001|COMPLETED|Overall Study||6
9971724|NCT01539837|11092431|FG002|COMPLETED|Overall Study||5
9971725|NCT01539837|11092429|FG000|NOT COMPLETED|Overall Study||0
9971726|NCT01539837|11092430|FG001|NOT COMPLETED|Overall Study||1
9971727|NCT01539837|11092431|FG002|NOT COMPLETED|Overall Study||2
9971728|NCT01539980|11092439|FG000|STARTED|Overall Study||30
9971729|NCT01539980|11092439|FG000|COMPLETED|Overall Study||30
9971730|NCT01539980|11092439|FG000|NOT COMPLETED|Overall Study||0
9971731|NCT01540045|11092443|FG000|STARTED|Overall Study||40
9971732|NCT01540045|11092443|FG000|COMPLETED|Overall Study||40
9971733|NCT01540045|11092443|FG000|NOT COMPLETED|Overall Study||0
9971734|NCT01540071|11092468|FG000|STARTED|Overall Study||38
9971735|NCT01540071|11092468|FG000|COMPLETED|Overall Study||38
9971736|NCT01540071|11092468|FG000|NOT COMPLETED|Overall Study||0
9971737|NCT01540162|11092475|FG000|STARTED|Overall Study||30
9971738|NCT01540162|11092476|FG001|STARTED|Overall Study||32
9971739|NCT01540162|11092475|FG000|COMPLETED|Overall Study||30
9971740|NCT01540162|11092476|FG001|COMPLETED|Overall Study||32
9971741|NCT01540162|11092475|FG000|NOT COMPLETED|Overall Study||0
9971742|NCT01540162|11092476|FG001|NOT COMPLETED|Overall Study||0
9971743|NCT01540266|11092488|FG000|STARTED|Overall Study||63
9971744|NCT01540266|11092489|FG001|STARTED|Overall Study||42
9971745|NCT01540266|11092490|FG002|STARTED|Overall Study||60
9971746|NCT01540266|11092491|FG003|STARTED|Overall Study||38
9971747|NCT01540266|11092492|FG004|STARTED|Overall Study||20
9971748|NCT01540266|11092493|FG005|STARTED|Overall Study||19
9971749|NCT01540266|11092488|FG000|COMPLETED|Overall Study||57
9971750|NCT01540266|11092489|FG001|COMPLETED|Overall Study||41
9971751|NCT01540266|11092490|FG002|COMPLETED|Overall Study||59
9971752|NCT01540266|11092491|FG003|COMPLETED|Overall Study||38
9971753|NCT01540266|11092492|FG004|COMPLETED|Overall Study||20
9971754|NCT01540266|11092493|FG005|COMPLETED|Overall Study||19
9971755|NCT01540266|11092488|FG000|NOT COMPLETED|Overall Study||6
9971756|NCT01540266|11092489|FG001|NOT COMPLETED|Overall Study||1
9971757|NCT01540266|11092490|FG002|NOT COMPLETED|Overall Study||1
9971758|NCT01540266|11092491|FG003|NOT COMPLETED|Overall Study||0
9971759|NCT01540266|11092492|FG004|NOT COMPLETED|Overall Study||0
9971760|NCT01540266|11092493|FG005|NOT COMPLETED|Overall Study||0
9971761|NCT01540370|11092507|FG000|STARTED|Overall Study||102
9971762|NCT01540370|11092507|FG000|COMPLETED|Overall Study||100
9971763|NCT01540370|11092507|FG000|NOT COMPLETED|Overall Study||2
9971764|NCT01540409|11092513|FG000|STARTED|Overall Study||6
9971765|NCT01540409|11092514|FG001|STARTED|Overall Study||6
9971766|NCT01540409|11092513|FG000|COMPLETED|Overall Study||6
9971767|NCT01540409|11092514|FG001|COMPLETED|Overall Study||6
9971768|NCT01540409|11092513|FG000|NOT COMPLETED|Overall Study||0
9971769|NCT01540409|11092514|FG001|NOT COMPLETED|Overall Study||0
9971770|NCT01540474|11092527|FG000|STARTED|Vaccination Period||10
9971771|NCT01540474|11092528|FG001|STARTED|Vaccination Period||10
9971772|NCT01540474|11092529|FG002|STARTED|Vaccination Period||10
9971773|NCT01540474|11092530|FG003|STARTED|Vaccination Period||0
9971774|NCT01540474|11092527|FG000|COMPLETED|Vaccination Period||10
9971775|NCT01540474|11092528|FG001|COMPLETED|Vaccination Period||9
9971776|NCT01540474|11092529|FG002|COMPLETED|Vaccination Period||10
9971777|NCT01540474|11092530|FG003|COMPLETED|Vaccination Period||0
9971778|NCT01540474|11092527|FG000|NOT COMPLETED|Vaccination Period||0
9971779|NCT01540474|11092528|FG001|NOT COMPLETED|Vaccination Period||1
9971780|NCT01540474|11092529|FG002|NOT COMPLETED|Vaccination Period||0
9971781|NCT01540474|11092530|FG003|NOT COMPLETED|Vaccination Period||0
9971782|NCT01540474|11092527|FG000|STARTED|Malaria Challenge||10
9971783|NCT01540474|11092528|FG001|STARTED|Malaria Challenge||9
9971784|NCT01540474|11092529|FG002|STARTED|Malaria Challenge||10
9971785|NCT01540474|11092530|FG003|STARTED|Malaria Challenge||6
9971786|NCT01540474|11092527|FG000|COMPLETED|Malaria Challenge||10
9971787|NCT01540474|11092528|FG001|COMPLETED|Malaria Challenge||9
9971788|NCT01540474|11092529|FG002|COMPLETED|Malaria Challenge||10
9971789|NCT01540474|11092530|FG003|COMPLETED|Malaria Challenge||5
9971790|NCT01540474|11092527|FG000|NOT COMPLETED|Malaria Challenge||0
9971791|NCT01540474|11092528|FG001|NOT COMPLETED|Malaria Challenge||0
9971792|NCT01540474|11092529|FG002|NOT COMPLETED|Malaria Challenge||0
9971793|NCT01540474|11092530|FG003|NOT COMPLETED|Malaria Challenge||1
9971794|NCT01540487|11092543|FG000|STARTED|Overall Study||24
9971795|NCT01540487|11092544|FG001|STARTED|Overall Study||24
9971796|NCT01540487|11092543|FG000|COMPLETED|Overall Study||23
9971797|NCT01540487|11092544|FG001|COMPLETED|Overall Study||24
9971798|NCT01540487|11092543|FG000|NOT COMPLETED|Overall Study||1
9971799|NCT01540487|11092544|FG001|NOT COMPLETED|Overall Study||0
9971800|NCT01540513|11092554|FG000|STARTED|Overall Study||12
9971801|NCT01540513|11092554|FG000|COMPLETED|Overall Study||12
9971802|NCT01540513|11092554|FG000|NOT COMPLETED|Overall Study||0
9971803|NCT01540565|11092558|FG000|STARTED|Overall Study||52
9971804|NCT01540565|11092558|FG000|COMPLETED|Overall Study||50
9971805|NCT01540565|11092558|FG000|NOT COMPLETED|Overall Study||2
9971806|NCT01540773|11092562|FG000|STARTED|First Intervention||8
9971807|NCT01540773|11092563|FG001|STARTED|First Intervention||8
9971808|NCT01540773|11092562|FG000|COMPLETED|First Intervention||8
9971809|NCT01540773|11092563|FG001|COMPLETED|First Intervention||8
9971810|NCT01540773|11092562|FG000|NOT COMPLETED|First Intervention||0
9971811|NCT01540773|11092563|FG001|NOT COMPLETED|First Intervention||0
9971812|NCT01540773|11092562|FG000|STARTED|Wash Out Period of 1 Week||8
9971813|NCT01540773|11092563|FG001|STARTED|Wash Out Period of 1 Week||8
9971814|NCT01540773|11092562|FG000|COMPLETED|Wash Out Period of 1 Week||8
9971815|NCT01540773|11092563|FG001|COMPLETED|Wash Out Period of 1 Week||8
9971816|NCT01540773|11092562|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0
9971817|NCT01540773|11092563|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0
9971818|NCT01540773|11092562|FG000|STARTED|Second Intervention||8
9971819|NCT01540773|11092563|FG001|STARTED|Second Intervention||8
9971820|NCT01540773|11092562|FG000|COMPLETED|Second Intervention||8
9971821|NCT01540773|11092563|FG001|COMPLETED|Second Intervention||8
9971822|NCT01540773|11092562|FG000|NOT COMPLETED|Second Intervention||0
9971823|NCT01540773|11092563|FG001|NOT COMPLETED|Second Intervention||0
9971824|NCT01540825|11092582|FG000|STARTED|Overall Study||20
9971825|NCT01540825|11092583|FG001|STARTED|Overall Study||6
9971826|NCT01540825|11092584|FG002|STARTED|Overall Study||6
9971827|NCT01540825|11092585|FG003|STARTED|Overall Study||6
9971828|NCT01540825|11092586|FG004|STARTED|Overall Study||6
9971829|NCT01540825|11092587|FG005|STARTED|Overall Study||6
9971830|NCT01540825|11092588|FG006|STARTED|Overall Study||6
9971831|NCT01540825|11092589|FG007|STARTED|Overall Study||6
9971832|NCT01540825|11092590|FG008|STARTED|Overall Study||6
9971833|NCT01540825|11092591|FG009|STARTED|Overall Study||6
9971834|NCT01540825|11092592|FG010|STARTED|Overall Study||6
9971835|NCT01540825|11092582|FG000|COMPLETED|Overall Study||20
9971836|NCT01540825|11092583|FG001|COMPLETED|Overall Study||6
9971837|NCT01540825|11092584|FG002|COMPLETED|Overall Study||6
9971838|NCT01540825|11092585|FG003|COMPLETED|Overall Study||6
9971839|NCT01540825|11092586|FG004|COMPLETED|Overall Study||6
9971840|NCT01540825|11092587|FG005|COMPLETED|Overall Study||6
9971841|NCT01540825|11092588|FG006|COMPLETED|Overall Study||6
9971842|NCT01540825|11092589|FG007|COMPLETED|Overall Study||6
9971843|NCT01540825|11092590|FG008|COMPLETED|Overall Study||6
9971844|NCT01540825|11092591|FG009|COMPLETED|Overall Study||6
9971845|NCT01540825|11092592|FG010|COMPLETED|Overall Study||6
9971846|NCT01540825|11092582|FG000|NOT COMPLETED|Overall Study||0
9971847|NCT01540825|11092583|FG001|NOT COMPLETED|Overall Study||0
9971848|NCT01540825|11092584|FG002|NOT COMPLETED|Overall Study||0
9971849|NCT01540825|11092585|FG003|NOT COMPLETED|Overall Study||0
9971850|NCT01540825|11092586|FG004|NOT COMPLETED|Overall Study||0
9971851|NCT01540825|11092587|FG005|NOT COMPLETED|Overall Study||0
9971852|NCT01540825|11092588|FG006|NOT COMPLETED|Overall Study||0
9971853|NCT01540825|11092589|FG007|NOT COMPLETED|Overall Study||0
9971854|NCT01540825|11092590|FG008|NOT COMPLETED|Overall Study||0
9971855|NCT01540825|11092591|FG009|NOT COMPLETED|Overall Study||0
9971856|NCT01540825|11092592|FG010|NOT COMPLETED|Overall Study||0
9971857|NCT01540838|11092628|FG000|STARTED|Overall Study||188
9971858|NCT01540838|11092629|FG001|STARTED|Overall Study||187
9971859|NCT01540838|11092628|FG000|COMPLETED|Overall Study||166
9971860|NCT01540838|11092629|FG001|COMPLETED|Overall Study||164
9971861|NCT01540838|11092628|FG000|NOT COMPLETED|Overall Study||22
9971862|NCT01540838|11092629|FG001|NOT COMPLETED|Overall Study||23
9971863|NCT01540851|11092637|FG000|STARTED|Overall Study||154
9971864|NCT01540851|11092638|FG001|STARTED|Overall Study||154
9971865|NCT01540851|11092637|FG000|COMPLETED|Overall Study||133
9971866|NCT01540851|11092638|FG001|COMPLETED|Overall Study||136
9971867|NCT01540851|11092637|FG000|NOT COMPLETED|Overall Study||21
9971868|NCT01540851|11092638|FG001|NOT COMPLETED|Overall Study||18
9971869|NCT01540981|11092648|FG000|STARTED|Overall Study||6
9971870|NCT01540981|11092649|FG001|STARTED|Overall Study||6
9971871|NCT01540981|11092648|FG000|COMPLETED|Overall Study||5
9971872|NCT01540981|11092649|FG001|COMPLETED|Overall Study||6
9971873|NCT01540981|11092648|FG000|NOT COMPLETED|Overall Study||1
9971874|NCT01540981|11092649|FG001|NOT COMPLETED|Overall Study||0
9971875|NCT01541215|11092657|FG000|STARTED|Treatment Period (52 Weeks)||66
9971876|NCT01541215|11092658|FG001|STARTED|Treatment Period (52 Weeks)||69
9971877|NCT01541215|11092657|FG000|Exposed|Treatment Period (52 Weeks)||66
9971878|NCT01541215|11092658|FG001|Exposed|Treatment Period (52 Weeks)||68
9971879|NCT01541215|11092657|FG000|COMPLETED|Treatment Period (52 Weeks)||56
9971880|NCT01541215|11092658|FG001|COMPLETED|Treatment Period (52 Weeks)||53
9971881|NCT01541215|11092657|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10
9971882|NCT01541215|11092658|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16
9971883|NCT01541215|11092657|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
9971884|NCT01541215|11092658|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
9971885|NCT01541215|11092657|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50
9971886|NCT01541215|11092658|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0
9971887|NCT01541215|11092657|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
9971888|NCT01541215|11092658|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
10098136|NCT02380677|11227163|FG005|NOT COMPLETED|Overall Study||6
10098137|NCT02380677|11227164|FG006|NOT COMPLETED|Overall Study||3
10098138|NCT02380677|11227165|FG007|NOT COMPLETED|Overall Study||4
10098139|NCT02380677|11227166|FG008|NOT COMPLETED|Overall Study||4
10098140|NCT02380677|11227167|FG009|NOT COMPLETED|Overall Study||2
10098141|NCT02380677|11227168|FG010|NOT COMPLETED|Overall Study||4
10098142|NCT02380677|11227169|FG011|NOT COMPLETED|Overall Study||5
10098143|NCT02380690|11227199|FG000|STARTED|Overall Study||119
10098144|NCT02380690|11227200|FG001|STARTED|Overall Study||94
9971889|NCT01541215|11092657|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
9971890|NCT01541215|11092658|FG001|STARTED|Follow up 2 (Weeks 105-156)||0
9971891|NCT01541215|11092657|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48
9971892|NCT01541215|11092658|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0
10098145|NCT02380690|11227199|FG000|COMPLETED|Overall Study||85
10098146|NCT02380690|11227200|FG001|COMPLETED|Overall Study||82
9971893|NCT01541215|11092657|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
9971894|NCT01541215|11092658|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
9971895|NCT01541254|11092668|FG000|STARTED|Overall Study||36
9971896|NCT01541254|11092668|FG000|COMPLETED|Overall Study||30
9971897|NCT01541254|11092668|FG000|NOT COMPLETED|Overall Study||6
9971898|NCT01541358|11092672|FG000|STARTED|Overall Study||2
9971899|NCT01541358|11092672|FG000|COMPLETED|Overall Study||2
9971900|NCT01541358|11092672|FG000|NOT COMPLETED|Overall Study||0
9971901|NCT01541371|11092677|FG000|STARTED|Overall Study||403
9971902|NCT01541371|11092677|FG000|Full Analysis Set|Overall Study||394
9971903|NCT01541371|11092677|FG000|COMPLETED|Overall Study||326
9971904|NCT01541371|11092677|FG000|NOT COMPLETED|Overall Study||77
9971905|NCT01541384|11092688|FG000|STARTED|Overall Study||40
9971906|NCT01541384|11092689|FG001|STARTED|Overall Study||40
9971907|NCT01541384|11092690|FG002|STARTED|Overall Study||40
9971908|NCT01541384|11092688|FG000|COMPLETED|Overall Study||40
9971909|NCT01541384|11092689|FG001|COMPLETED|Overall Study||39
9971910|NCT01541384|11092690|FG002|COMPLETED|Overall Study||38
9971911|NCT01541384|11092688|FG000|NOT COMPLETED|Overall Study||0
9971912|NCT01541384|11092689|FG001|NOT COMPLETED|Overall Study||1
9971913|NCT01541384|11092690|FG002|NOT COMPLETED|Overall Study||2
9971914|NCT01541553|11092700|FG000|STARTED|Overall Study||167
9971915|NCT01541553|11092701|FG001|STARTED|Overall Study||162
9971916|NCT01541553|11092700|FG000|COMPLETED|Overall Study||155
10098147|NCT02380690|11227199|FG000|NOT COMPLETED|Overall Study||34
10098148|NCT02380690|11227200|FG001|NOT COMPLETED|Overall Study||12
10098149|NCT02380703|11227208|FG000|STARTED|Overall Study||114
10098150|NCT02380703|11227209|FG001|STARTED|Overall Study||114
9971917|NCT01541553|11092701|FG001|COMPLETED|Overall Study||148
9971918|NCT01541553|11092700|FG000|NOT COMPLETED|Overall Study||12
9971919|NCT01541553|11092701|FG001|NOT COMPLETED|Overall Study||14
9971920|NCT01541644|11092707|FG000|STARTED|Overall Study||27
9971921|NCT01541644|11092707|FG000|COMPLETED|Overall Study||24
9971922|NCT01541644|11092707|FG000|NOT COMPLETED|Overall Study||3
9971923|NCT01541735|11092713|FG000|STARTED|Overall Study||7
9971924|NCT01541735|11092714|FG001|STARTED|Overall Study||7
9971925|NCT01541735|11092713|FG000|COMPLETED|Overall Study||7
9971926|NCT01541735|11092714|FG001|COMPLETED|Overall Study||7
9971927|NCT01541735|11092713|FG000|NOT COMPLETED|Overall Study||0
9971928|NCT01541735|11092714|FG001|NOT COMPLETED|Overall Study||0
9971929|NCT01541748|11092720|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
9971930|NCT01541748|11092720|FG000|COMPLETED|Overall Study||43
9971931|NCT01541748|11092720|FG000|NOT COMPLETED|Overall Study||31
9971932|NCT01541826|11092736|FG000|STARTED|Overall Study||28
9971933|NCT01541826|11092737|FG001|STARTED|Overall Study||28
9971934|NCT01541826|11092738|FG002|STARTED|Overall Study||6
9971935|NCT01541826|11092736|FG000|COMPLETED|Overall Study||24
9971936|NCT01541826|11092737|FG001|COMPLETED|Overall Study||25
9971937|NCT01541826|11092738|FG002|COMPLETED|Overall Study||6
9971938|NCT01541826|11092736|FG000|NOT COMPLETED|Overall Study||4
9971939|NCT01541826|11092737|FG001|NOT COMPLETED|Overall Study||3
9971940|NCT01541826|11092738|FG002|NOT COMPLETED|Overall Study||0
9971941|NCT01541865|11092746|FG000|STARTED|Overall Study||146
9971942|NCT01541865|11092746|FG000|COMPLETED|Overall Study||124
9971943|NCT01541865|11092746|FG000|NOT COMPLETED|Overall Study||22
9971944|NCT01541891|11092752|FG000|STARTED|Overall Study||15
9971945|NCT01541891|11092753|FG001|STARTED|Overall Study||15
9971946|NCT01541891|11092752|FG000|COMPLETED|Overall Study||14
9971947|NCT01541891|11092753|FG001|COMPLETED|Overall Study||14
9971948|NCT01541891|11092752|FG000|NOT COMPLETED|Overall Study||1
9971949|NCT01541891|11092753|FG001|NOT COMPLETED|Overall Study||1
9971950|NCT01541917|11092764|FG000|STARTED|Overall Study||144
9971951|NCT01541917|11092765|FG001|STARTED|Overall Study||145
9971952|NCT01541917|11092764|FG000|COMPLETED|Overall Study||129
9971953|NCT01541917|11092765|FG001|COMPLETED|Overall Study||136
9971954|NCT01541917|11092764|FG000|NOT COMPLETED|Overall Study||15
9971955|NCT01541917|11092765|FG001|NOT COMPLETED|Overall Study||9
9971956|NCT01541930|11092774|FG000|STARTED|Overall Study||21
9971957|NCT01541930|11092774|FG000|COMPLETED|Overall Study||20
9971958|NCT01541930|11092774|FG000|NOT COMPLETED|Overall Study||1
9971959|NCT01541969|11092791|FG000|STARTED|Double-blind (0-12 Weeks)||50
9971960|NCT01541969|11092792|FG001|STARTED|Double-blind (0-12 Weeks)||50
9971961|NCT01541969|11092791|FG000|COMPLETED|Double-blind (0-12 Weeks)||44
9971962|NCT01541969|11092792|FG001|COMPLETED|Double-blind (0-12 Weeks)||48
9971963|NCT01541969|11092791|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6
9971964|NCT01541969|11092792|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2
9971965|NCT01541969|11092791|FG000|STARTED|Open Label Extension (12-36 Weeks)||44
9971966|NCT01541969|11092792|FG001|STARTED|Open Label Extension (12-36 Weeks)||48
9971967|NCT01541969|11092791|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33
9971968|NCT01541969|11092792|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35
9971969|NCT01541969|11092791|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
9971970|NCT01541969|11092792|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
9971971|NCT01542034|11092803|FG000|STARTED|Overall Study||256
9971972|NCT01542034|11092804|FG001|STARTED|Overall Study||250
9971973|NCT01542034|11092803|FG000|Received Treatment|Overall Study||256
9971974|NCT01542034|11092804|FG001|Received Treatment|Overall Study||249
9971975|NCT01542034|11092803|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
9971976|NCT01542034|11092804|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
9971977|NCT01542034|11092803|FG000|NOT COMPLETED|Overall Study||30
9971978|NCT01542034|11092804|FG001|NOT COMPLETED|Overall Study||23
9971979|NCT01542125|11092812|FG000|STARTED|Overall Study||140
9971980|NCT01542125|11092813|FG001|STARTED|Overall Study||141
9971981|NCT01542125|11092812|FG000|COMPLETED|Overall Study||140
9971982|NCT01542125|11092813|FG001|COMPLETED|Overall Study||141
9971983|NCT01542125|11092812|FG000|NOT COMPLETED|Overall Study||0
9971984|NCT01542125|11092813|FG001|NOT COMPLETED|Overall Study||0
9971985|NCT01542229|11092821|FG000|STARTED|Overall Study||68
9971986|NCT01542229|11092822|FG001|STARTED|Overall Study||66
9971987|NCT01542229|11092821|FG000|COMPLETED|Overall Study||45
9971988|NCT01542229|11092822|FG001|COMPLETED|Overall Study||30
9971989|NCT01542229|11092821|FG000|NOT COMPLETED|Overall Study||23
9971990|NCT01542229|11092822|FG001|NOT COMPLETED|Overall Study||36
9971991|NCT01542255|11092829|FG000|STARTED|Overall Study||7
9971992|NCT01542255|11092829|FG000|Analyzed for Time to Progression|Overall Study||7
9971993|NCT01542255|11092829|FG000|COMPLETED|Overall Study||7
9971994|NCT01542255|11092829|FG000|NOT COMPLETED|Overall Study||0
9971995|NCT01542307|11092834|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
9971996|NCT01542307|11092835|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
9971997|NCT01542307|11092834|FG000|COMPLETED|Overall Study||22
9971998|NCT01542307|11092835|FG001|COMPLETED|Overall Study||22
9971999|NCT01542307|11092834|FG000|NOT COMPLETED|Overall Study||0
9972000|NCT01542307|11092835|FG001|NOT COMPLETED|Overall Study||0
9972001|NCT01542372|11092841|FG000|STARTED|Overall Study||11
9972002|NCT01542372|11092842|FG001|STARTED|Overall Study||11
9972003|NCT01542372|11092841|FG000|COMPLETED|Overall Study||11
9972004|NCT01542372|11092842|FG001|COMPLETED|Overall Study||11
9972005|NCT01542372|11092841|FG000|NOT COMPLETED|Overall Study||0
9972006|NCT01542372|11092842|FG001|NOT COMPLETED|Overall Study||0
9972007|NCT01542398|11092849|FG000|STARTED|Overall Study||79
9972008|NCT01542398|11092850|FG001|STARTED|Overall Study||80
9972009|NCT01542398|11092849|FG000|Post-Intervention Assessment|Overall Study||78
9972010|NCT01542398|11092850|FG001|Post-Intervention Assessment|Overall Study||80
9972011|NCT01542398|11092849|FG000|COMPLETED|Overall Study||71
9972012|NCT01542398|11092850|FG001|COMPLETED|Overall Study||67
9972013|NCT01542398|11092849|FG000|NOT COMPLETED|Overall Study||8
9972014|NCT01542398|11092850|FG001|NOT COMPLETED|Overall Study||13
9972015|NCT01542502|11092858|FG000|STARTED|Overall Study||6
9972016|NCT01542502|11092859|FG001|STARTED|Overall Study||6
9972017|NCT01542502|11092858|FG000|COMPLETED|Overall Study||6
9972018|NCT01542502|11092859|FG001|COMPLETED|Overall Study||6
9972019|NCT01542502|11092858|FG000|NOT COMPLETED|Overall Study||0
9972020|NCT01542502|11092859|FG001|NOT COMPLETED|Overall Study||0
9972021|NCT01542528|11092868|FG000|STARTED|Overall Study||61
9972022|NCT01542528|11092869|FG001|STARTED|Overall Study||56
9972023|NCT01542528|11092868|FG000|COMPLETED|Overall Study||49
9972024|NCT01542528|11092869|FG001|COMPLETED|Overall Study||49
9972025|NCT01542528|11092868|FG000|NOT COMPLETED|Overall Study||12
10098151|NCT02380703|11227208|FG000|Month 3|Overall Study||104
10098152|NCT02380703|11227209|FG001|Month 3|Overall Study||109
9972026|NCT01542528|11092869|FG001|NOT COMPLETED|Overall Study||7
9972027|NCT01542541|11092877|FG000|STARTED|Overall Study||38
9972028|NCT01542541|11092878|FG001|STARTED|Overall Study||30
9972029|NCT01542541|11092877|FG000|COMPLETED|Overall Study||30
9972030|NCT01542541|11092878|FG001|COMPLETED|Overall Study||30
9972031|NCT01542541|11092877|FG000|NOT COMPLETED|Overall Study||8
9972032|NCT01542541|11092878|FG001|NOT COMPLETED|Overall Study||0
9972033|NCT01542632|11092890|FG000|STARTED|Overall Study||25
9972034|NCT01542632|11092891|FG001|STARTED|Overall Study||25
9972035|NCT01542632|11092892|FG002|STARTED|Overall Study||24
9972036|NCT01542632|11092893|FG003|STARTED|Overall Study||21
9972037|NCT01542632|11092894|FG004|STARTED|Overall Study||21
9972038|NCT01542632|11092895|FG005|STARTED|Overall Study||24
9972039|NCT01542632|11092890|FG000|COMPLETED|Overall Study||25
9972040|NCT01542632|11092891|FG001|COMPLETED|Overall Study||24
9972041|NCT01542632|11092892|FG002|COMPLETED|Overall Study||23
9972042|NCT01542632|11092893|FG003|COMPLETED|Overall Study||19
9972043|NCT01542632|11092894|FG004|COMPLETED|Overall Study||17
9972044|NCT01542632|11092895|FG005|COMPLETED|Overall Study||24
9972045|NCT01542632|11092890|FG000|NOT COMPLETED|Overall Study||0
9972046|NCT01542632|11092891|FG001|NOT COMPLETED|Overall Study||1
9972047|NCT01542632|11092892|FG002|NOT COMPLETED|Overall Study||1
9972048|NCT01542632|11092893|FG003|NOT COMPLETED|Overall Study||2
9972049|NCT01542632|11092894|FG004|NOT COMPLETED|Overall Study||4
9972050|NCT01542632|11092895|FG005|NOT COMPLETED|Overall Study||0
9972051|NCT01542645|11092916|FG000|STARTED|Overall Study||82
9972052|NCT01542645|11092917|FG001|STARTED|Overall Study||82
9972053|NCT01542645|11092916|FG000|COMPLETED|Overall Study||77
9972054|NCT01542645|11092917|FG001|COMPLETED|Overall Study||79
9972055|NCT01542645|11092916|FG000|NOT COMPLETED|Overall Study||5
9972056|NCT01542645|11092917|FG001|NOT COMPLETED|Overall Study||3
10017675|NCT01818297|11140607|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
10017676|NCT01818297|11140608|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
10017677|NCT01818297|11140607|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
10017678|NCT01818297|11140608|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
10017679|NCT01818297|11140607|FG000|STARTED|Open Label Phase (3-12 Months)||32
10017680|NCT01818297|11140608|FG001|STARTED|Open Label Phase (3-12 Months)||29
10017681|NCT01818297|11140607|FG000|COMPLETED|Open Label Phase (3-12 Months)||14
10017682|NCT01818297|11140608|FG001|COMPLETED|Open Label Phase (3-12 Months)||19
10017683|NCT01818297|11140607|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18
10017684|NCT01818297|11140608|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10
10017685|NCT01818336|11140614|FG000|STARTED|Overall Study||391
10017686|NCT01818336|11140615|FG001|STARTED|Overall Study||59
10017687|NCT01818336|11140614|FG000|COMPLETED|Overall Study||391
10017688|NCT01818336|11140615|FG001|COMPLETED|Overall Study||47
10017689|NCT01818336|11140614|FG000|NOT COMPLETED|Overall Study||0
10017690|NCT01818336|11140615|FG001|NOT COMPLETED|Overall Study||12
10017691|NCT01818414|11140623|FG000|STARTED|Overall Study||14
10017692|NCT01818414|11140624|FG001|STARTED|Overall Study||15
9972057|NCT01542684|11092927|FG000|STARTED|Overall Study||8
9972058|NCT01542684|11092927|FG000|COMPLETED|Overall Study||8
9972059|NCT01542684|11092927|FG000|NOT COMPLETED|Overall Study||0
9972060|NCT01542788|11092933|FG000|STARTED|Overall Study||209
9972061|NCT01542788|11092934|FG001|STARTED|Overall Study||71
9972062|NCT01542788|11092933|FG000|Randomized and Treated|Overall Study||207
9972063|NCT01542788|11092934|FG001|Randomized and Treated|Overall Study||71
9972064|NCT01542788|11092933|FG000|COMPLETED|Overall Study||154
9972065|NCT01542788|11092934|FG001|COMPLETED|Overall Study||0
9972066|NCT01542788|11092933|FG000|NOT COMPLETED|Overall Study||55
9972067|NCT01542788|11092934|FG001|NOT COMPLETED|Overall Study||71
9972068|NCT01542957|11092942|FG000|STARTED|End of Therapy||65
9972069|NCT01542957|11092943|FG001|STARTED|End of Therapy||63
9972070|NCT01542957|11092942|FG000|COMPLETED|End of Therapy||53
9972071|NCT01542957|11092943|FG001|COMPLETED|End of Therapy||53
9972072|NCT01542957|11092942|FG000|NOT COMPLETED|End of Therapy||12
9972073|NCT01542957|11092943|FG001|NOT COMPLETED|End of Therapy||10
9972074|NCT01542957|11092942|FG000|STARTED|3-month Follow-up||53
9972075|NCT01542957|11092943|FG001|STARTED|3-month Follow-up||53
9972076|NCT01542957|11092942|FG000|COMPLETED|3-month Follow-up||50
9972077|NCT01542957|11092943|FG001|COMPLETED|3-month Follow-up||45
9972078|NCT01542957|11092942|FG000|NOT COMPLETED|3-month Follow-up||3
9972079|NCT01542957|11092943|FG001|NOT COMPLETED|3-month Follow-up||8
9972080|NCT01542957|11092942|FG000|STARTED|12-month Follow-up||53
9972081|NCT01542957|11092943|FG001|STARTED|12-month Follow-up||53
9972082|NCT01542957|11092942|FG000|COMPLETED|12-month Follow-up||37
9972083|NCT01542957|11092943|FG001|COMPLETED|12-month Follow-up||40
9972084|NCT01542957|11092942|FG000|NOT COMPLETED|12-month Follow-up||16
9972085|NCT01542957|11092943|FG001|NOT COMPLETED|12-month Follow-up||13
9972086|NCT01543074|11092953|FG000|STARTED|Overall Study||5
9972087|NCT01543074|11092954|FG001|STARTED|Overall Study||7
9972088|NCT01543074|11092955|FG002|STARTED|Overall Study||5
9972089|NCT01543074|11092956|FG003|STARTED|Overall Study||6
9972090|NCT01543074|11092953|FG000|COMPLETED|Overall Study||5
9972091|NCT01543074|11092954|FG001|COMPLETED|Overall Study||7
9972092|NCT01543074|11092955|FG002|COMPLETED|Overall Study||5
9972093|NCT01543074|11092956|FG003|COMPLETED|Overall Study||6
9972094|NCT01543074|11092953|FG000|NOT COMPLETED|Overall Study||0
9972095|NCT01543074|11092954|FG001|NOT COMPLETED|Overall Study||0
9972096|NCT01543074|11092955|FG002|NOT COMPLETED|Overall Study||0
9972097|NCT01543074|11092956|FG003|NOT COMPLETED|Overall Study||0
9972098|NCT01543087|11092976|FG000|STARTED|Stage 1 (48 Months)||70
9972099|NCT01543087|11092977|FG001|STARTED|Stage 1 (48 Months)||103
9972100|NCT01543087|11092978|FG002|STARTED|Stage 1 (48 Months)||277
9972101|NCT01543087|11092979|FG003|STARTED|Stage 1 (48 Months)||116
9972102|NCT01543087|11092980|FG004|STARTED|Stage 1 (48 Months)||86
9972103|NCT01543087|11092981|FG005|STARTED|Stage 1 (48 Months)||46
9972104|NCT01543087|11092976|FG000|Safety Population|Stage 1 (48 Months)||70
9972105|NCT01543087|11092977|FG001|Safety Population|Stage 1 (48 Months)||101
9972106|NCT01543087|11092978|FG002|Safety Population|Stage 1 (48 Months)||277
9972107|NCT01543087|11092979|FG003|Safety Population|Stage 1 (48 Months)||116
9972108|NCT01543087|11092980|FG004|Safety Population|Stage 1 (48 Months)||86
9972109|NCT01543087|11092981|FG005|Safety Population|Stage 1 (48 Months)||46
9972110|NCT01543087|11092976|FG000|COMPLETED|Stage 1 (48 Months)||56
9972111|NCT01543087|11092977|FG001|COMPLETED|Stage 1 (48 Months)||93
9972112|NCT01543087|11092978|FG002|COMPLETED|Stage 1 (48 Months)||237
9972113|NCT01543087|11092979|FG003|COMPLETED|Stage 1 (48 Months)||108
9972114|NCT01543087|11092980|FG004|COMPLETED|Stage 1 (48 Months)||83
9972115|NCT01543087|11092981|FG005|COMPLETED|Stage 1 (48 Months)||46
9972116|NCT01543087|11092976|FG000|NOT COMPLETED|Stage 1 (48 Months)||14
9972117|NCT01543087|11092977|FG001|NOT COMPLETED|Stage 1 (48 Months)||10
9972118|NCT01543087|11092978|FG002|NOT COMPLETED|Stage 1 (48 Months)||40
9972119|NCT01543087|11092979|FG003|NOT COMPLETED|Stage 1 (48 Months)||8
9972120|NCT01543087|11092980|FG004|NOT COMPLETED|Stage 1 (48 Months)||3
9972121|NCT01543087|11092981|FG005|NOT COMPLETED|Stage 1 (48 Months)||0
9972122|NCT01543087|11092976|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
9972123|NCT01543087|11092977|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
9972124|NCT01543087|11092978|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
9972125|NCT01543087|11092979|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
9972126|NCT01543087|11092980|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
9972127|NCT01543087|11092981|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
9972128|NCT01543087|11092976|FG000|Vaccinated|Booster Stage (26 Months)||0
9972129|NCT01543087|11092977|FG001|Vaccinated|Booster Stage (26 Months)||59
9972130|NCT01543087|11092978|FG002|Vaccinated|Booster Stage (26 Months)||92
9972131|NCT01543087|11092979|FG003|Vaccinated|Booster Stage (26 Months)||64
9972132|NCT01543087|11092980|FG004|Vaccinated|Booster Stage (26 Months)||54
9972133|NCT01543087|11092981|FG005|Vaccinated|Booster Stage (26 Months)||32
9972134|NCT01543087|11092976|FG000|COMPLETED|Booster Stage (26 Months)||0
9972135|NCT01543087|11092977|FG001|COMPLETED|Booster Stage (26 Months)||59
9972136|NCT01543087|11092978|FG002|COMPLETED|Booster Stage (26 Months)||91
9972137|NCT01543087|11092979|FG003|COMPLETED|Booster Stage (26 Months)||64
9972138|NCT01543087|11092980|FG004|COMPLETED|Booster Stage (26 Months)||54
9972139|NCT01543087|11092981|FG005|COMPLETED|Booster Stage (26 Months)||32
9972140|NCT01543087|11092976|FG000|NOT COMPLETED|Booster Stage (26 Months)||0
9972141|NCT01543087|11092977|FG001|NOT COMPLETED|Booster Stage (26 Months)||1
9972142|NCT01543087|11092978|FG002|NOT COMPLETED|Booster Stage (26 Months)||1
9972143|NCT01543087|11092979|FG003|NOT COMPLETED|Booster Stage (26 Months)||0
9972144|NCT01543087|11092980|FG004|NOT COMPLETED|Booster Stage (26 Months)||2
9972145|NCT01543087|11092981|FG005|NOT COMPLETED|Booster Stage (26 Months)||0
9972146|NCT01543152|11093022|FG000|STARTED|Overall Study||3
9972147|NCT01543152|11093023|FG001|STARTED|Overall Study||6
9972148|NCT01543152|11093024|FG002|STARTED|Overall Study||11
9972149|NCT01543152|11093025|FG003|STARTED|Overall Study||3
9972150|NCT01543152|11093026|FG004|STARTED|Overall Study||3
9972151|NCT01543152|11093022|FG000|COMPLETED|Overall Study||3
9972152|NCT01543152|11093023|FG001|COMPLETED|Overall Study||4
9972153|NCT01543152|11093024|FG002|COMPLETED|Overall Study||11
9972154|NCT01543152|11093025|FG003|COMPLETED|Overall Study||3
9972155|NCT01543152|11093026|FG004|COMPLETED|Overall Study||3
9972156|NCT01543152|11093022|FG000|NOT COMPLETED|Overall Study||0
9972157|NCT01543152|11093023|FG001|NOT COMPLETED|Overall Study||2
9972158|NCT01543152|11093024|FG002|NOT COMPLETED|Overall Study||0
9972159|NCT01543152|11093025|FG003|NOT COMPLETED|Overall Study||0
9972160|NCT01543152|11093026|FG004|NOT COMPLETED|Overall Study||0
9972161|NCT01543178|11093041|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
9972162|NCT01543178|11093042|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
9972163|NCT01543178|11093043|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
9972164|NCT01543178|11093041|FG000|COMPLETED|Open-label Period||636
9972165|NCT01543178|11093042|FG001|COMPLETED|Open-label Period||0
9972166|NCT01543178|11093043|FG002|COMPLETED|Open-label Period||0
9972167|NCT01543178|11093041|FG000|NOT COMPLETED|Open-label Period||1947
9972168|NCT01543178|11093042|FG001|NOT COMPLETED|Open-label Period||0
9972169|NCT01543178|11093043|FG002|NOT COMPLETED|Open-label Period||0
9972170|NCT01543178|11093041|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
9972171|NCT01543178|11093042|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
9972172|NCT01543178|11093043|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
9972173|NCT01543178|11093041|FG000|COMPLETED|Double-blind Period||0
9972174|NCT01543178|11093042|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
9972175|NCT01543178|11093043|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
9972176|NCT01543178|11093041|FG000|NOT COMPLETED|Double-blind Period||0
9972177|NCT01543178|11093042|FG001|NOT COMPLETED|Double-blind Period||44
9972178|NCT01543178|11093043|FG002|NOT COMPLETED|Double-blind Period||37
9972179|NCT01543204|11093050|FG000|STARTED|Overall Study||64
9972180|NCT01543204|11093050|FG000|COMPLETED|Overall Study||56
9972181|NCT01543204|11093050|FG000|NOT COMPLETED|Overall Study||8
9972182|NCT01543490|11093060|FG000|STARTED|Overall Study||368
9972183|NCT01543490|11093061|FG001|STARTED|Overall Study||190
9972184|NCT01543490|11093060|FG000|COMPLETED|Overall Study||352
9972185|NCT01543490|11093061|FG001|COMPLETED|Overall Study||185
9972186|NCT01543490|11093060|FG000|NOT COMPLETED|Overall Study||16
9972187|NCT01543490|11093061|FG001|NOT COMPLETED|Overall Study||5
9972188|NCT01543503|11093069|FG000|STARTED|Overall Study||426
9972189|NCT01543503|11093070|FG001|STARTED|Overall Study||798
9972190|NCT01543503|11093069|FG000|COMPLETED|Overall Study||350
9972191|NCT01543503|11093070|FG001|COMPLETED|Overall Study||711
9972192|NCT01543503|11093069|FG000|NOT COMPLETED|Overall Study||76
9972193|NCT01543503|11093070|FG001|NOT COMPLETED|Overall Study||87
9972194|NCT01543568|11093076|FG000|STARTED|Overall Study||46
9972195|NCT01543568|11093076|FG000|COMPLETED|Overall Study||45
9972196|NCT01543568|11093076|FG000|NOT COMPLETED|Overall Study||1
9972197|NCT01543581|11093080|FG000|STARTED|Overall Study||1
9972198|NCT01543581|11093081|FG001|STARTED|Overall Study||0
9972199|NCT01543581|11093080|FG000|COMPLETED|Overall Study||1
9972200|NCT01543581|11093081|FG001|COMPLETED|Overall Study||0
9972201|NCT01543581|11093080|FG000|NOT COMPLETED|Overall Study||0
9972202|NCT01543581|11093081|FG001|NOT COMPLETED|Overall Study||0
9972203|NCT01543607|11093087|FG000|STARTED|Overall Study||1
9972204|NCT01543607|11093087|FG000|COMPLETED|Overall Study||1
9972205|NCT01543607|11093087|FG000|NOT COMPLETED|Overall Study||0
9972206|NCT01543685|11093096|FG000|STARTED|Overall Study||93
9972207|NCT01543685|11093097|FG001|STARTED|Overall Study||91
9972208|NCT01543685|11093098|FG002|STARTED|Overall Study||91
9972209|NCT01543685|11093099|FG003|STARTED|Overall Study||93
9972210|NCT01543685|11093100|FG004|STARTED|Overall Study||94
9972211|NCT01543685|11093096|FG000|COMPLETED|Overall Study||90
9972212|NCT01543685|11093097|FG001|COMPLETED|Overall Study||88
9972213|NCT01543685|11093098|FG002|COMPLETED|Overall Study||89
9972214|NCT01543685|11093099|FG003|COMPLETED|Overall Study||93
9972215|NCT01543685|11093100|FG004|COMPLETED|Overall Study||90
9972216|NCT01543685|11093096|FG000|NOT COMPLETED|Overall Study||3
9972217|NCT01543685|11093097|FG001|NOT COMPLETED|Overall Study||3
9972218|NCT01543685|11093098|FG002|NOT COMPLETED|Overall Study||2
9972219|NCT01543685|11093099|FG003|NOT COMPLETED|Overall Study||0
9972220|NCT01543685|11093100|FG004|NOT COMPLETED|Overall Study||4
9972221|NCT01543776|11093114|FG000|STARTED|Overall Study||36
9972222|NCT01543776|11093115|FG001|STARTED|Overall Study||36
9972223|NCT01543776|11093114|FG000|COMPLETED|Overall Study||34
9972224|NCT01543776|11093115|FG001|COMPLETED|Overall Study||34
9972225|NCT01543776|11093114|FG000|NOT COMPLETED|Overall Study||2
9972226|NCT01543776|11093115|FG001|NOT COMPLETED|Overall Study||2
9972227|NCT01543828|11093123|FG000|STARTED|Treatment 1||20
9972228|NCT01543828|11093124|FG001|STARTED|Treatment 1||20
9972229|NCT01543828|11093123|FG000|COMPLETED|Treatment 1||20
9972230|NCT01543828|11093124|FG001|COMPLETED|Treatment 1||20
9972231|NCT01543828|11093123|FG000|NOT COMPLETED|Treatment 1||0
9972232|NCT01543828|11093124|FG001|NOT COMPLETED|Treatment 1||0
9972233|NCT01543828|11093123|FG000|STARTED|Treatment 2||20
9972234|NCT01543828|11093124|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
9972235|NCT01543828|11093123|FG000|COMPLETED|Treatment 2||19
9972236|NCT01543828|11093124|FG001|COMPLETED|Treatment 2||19
9972237|NCT01543828|11093123|FG000|NOT COMPLETED|Treatment 2||1
9972238|NCT01543828|11093124|FG001|NOT COMPLETED|Treatment 2||0
9972239|NCT01543958|11093132|FG000|STARTED|Overall Study||40
9972240|NCT01543958|11093132|FG000|COMPLETED|Overall Study||36
9972241|NCT01543958|11093132|FG000|NOT COMPLETED|Overall Study||4
9972242|NCT01544023|11093136|FG000|STARTED|Overall Study|retrospective|207
9972243|NCT01544023|11093136|FG000|COMPLETED|Overall Study||207
9972244|NCT01544023|11093136|FG000|NOT COMPLETED|Overall Study||0
9972245|NCT01544062|11093142|FG000|STARTED|Overall Study||33
9972246|NCT01544062|11093143|FG001|STARTED|Overall Study||35
9972247|NCT01544062|11093142|FG000|COMPLETED|Overall Study||33
9972248|NCT01544062|11093143|FG001|COMPLETED|Overall Study||35
9972249|NCT01544062|11093142|FG000|NOT COMPLETED|Overall Study||0
9972250|NCT01544062|11093143|FG001|NOT COMPLETED|Overall Study||0
9972251|NCT01544088|11093152|FG000|STARTED|Overall Study||98
9972252|NCT01544088|11093153|FG001|STARTED|Overall Study||100
9972253|NCT01544088|11093152|FG000|COMPLETED|Overall Study||61
9972254|NCT01544088|11093153|FG001|COMPLETED|Overall Study||79
9972255|NCT01544088|11093152|FG000|NOT COMPLETED|Overall Study||37
9972256|NCT01544088|11093153|FG001|NOT COMPLETED|Overall Study||21
9972257|NCT01544114|11093162|FG000|STARTED|Overall Study||4
9972258|NCT01544114|11093163|FG001|STARTED|Overall Study||20
9972259|NCT01544114|11093164|FG002|STARTED|Overall Study||22
9972260|NCT01544114|11093162|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
9972261|NCT01544114|11093163|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
9972262|NCT01544114|11093164|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
9972263|NCT01544114|11093162|FG000|NOT COMPLETED|Overall Study||1
9972264|NCT01544114|11093163|FG001|NOT COMPLETED|Overall Study||4
9972265|NCT01544114|11093164|FG002|NOT COMPLETED|Overall Study||5
9972266|NCT01544153|11093178|FG000|STARTED|Overall Study||1337
9972267|NCT01544153|11093179|FG001|STARTED|Overall Study||1324
9972268|NCT01544153|11093180|FG002|STARTED|Overall Study||1314
9972269|NCT01544153|11093181|FG003|STARTED|Overall Study||1317
9972270|NCT01544153|11093178|FG000|COMPLETED|Overall Study||1337
9972271|NCT01544153|11093179|FG001|COMPLETED|Overall Study||1323
9972272|NCT01544153|11093180|FG002|COMPLETED|Overall Study||1313
9972273|NCT01544153|11093181|FG003|COMPLETED|Overall Study||1317
9972274|NCT01544153|11093178|FG000|NOT COMPLETED|Overall Study||0
9972275|NCT01544153|11093179|FG001|NOT COMPLETED|Overall Study||1
9972276|NCT01544153|11093180|FG002|NOT COMPLETED|Overall Study||1
9972277|NCT01544153|11093181|FG003|NOT COMPLETED|Overall Study||0
9972278|NCT01544166|11093191|FG000|STARTED|Overall Study||44
9972279|NCT01544166|11093191|FG000|COMPLETED|Overall Study||44
9972280|NCT01544166|11093191|FG000|NOT COMPLETED|Overall Study||0
9972281|NCT01544179|11093200|FG000|STARTED|Overall Study||133
9972282|NCT01544179|11093201|FG001|STARTED|Overall Study||132
9972283|NCT01544179|11093200|FG000|Received Treatment|Overall Study||132
9972284|NCT01544179|11093201|FG001|Received Treatment|Overall Study||132
9972285|NCT01544179|11093200|FG000|Did Not Receive Treatment|Overall Study||1
9972286|NCT01544179|11093201|FG001|Did Not Receive Treatment|Overall Study||0
9972287|NCT01544179|11093200|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70
9972288|NCT01544179|11093201|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86
9972289|NCT01544179|11093200|FG000|NOT COMPLETED|Overall Study||63
9972290|NCT01544179|11093201|FG001|NOT COMPLETED|Overall Study||46
9972291|NCT01544309|11093209|FG000|STARTED|Overall Study||524
10098153|NCT02380703|11227208|FG000|Month 6|Overall Study||102
10098154|NCT02380703|11227209|FG001|Month 6|Overall Study||107
10098155|NCT02380703|11227208|FG000|Month 12|Overall Study||99
10098156|NCT02380703|11227209|FG001|Month 12|Overall Study||100
10098157|NCT02380703|11227208|FG000|COMPLETED|Overall Study||78
10098158|NCT02380703|11227209|FG001|COMPLETED|Overall Study||78
10098159|NCT02380703|11227208|FG000|NOT COMPLETED|Overall Study||36
9972292|NCT01544309|11093210|FG001|STARTED|Overall Study||525
9972293|NCT01544309|11093209|FG000|COMPLETED|Overall Study||504
9972294|NCT01544309|11093210|FG001|COMPLETED|Overall Study||514
9972295|NCT01544309|11093209|FG000|NOT COMPLETED|Overall Study||20
9972296|NCT01544309|11093210|FG001|NOT COMPLETED|Overall Study||11
9972297|NCT01544348|11093226|FG000|STARTED|Overall Study||17
9972298|NCT01544348|11093227|FG001|STARTED|Overall Study||6
9972299|NCT01544348|11093228|FG002|STARTED|Overall Study||3
9972300|NCT01544348|11093229|FG003|STARTED|Overall Study||3
9972301|NCT01544348|11093230|FG004|STARTED|Overall Study||16
9972302|NCT01544348|11093231|FG005|STARTED|Overall Study||19
10098160|NCT02380703|11227209|FG001|NOT COMPLETED|Overall Study||36
9972303|NCT01544348|11093232|FG006|STARTED|Overall Study||14
9972304|NCT01544348|11093233|FG007|STARTED|Overall Study||8
9972305|NCT01544348|11093226|FG000|Treated|Overall Study||17
9972306|NCT01544348|11093227|FG001|Treated|Overall Study||6
9972307|NCT01544348|11093228|FG002|Treated|Overall Study||3
9972308|NCT01544348|11093229|FG003|Treated|Overall Study||3
9972309|NCT01544348|11093230|FG004|Treated|Overall Study||15
9972310|NCT01544348|11093231|FG005|Treated|Overall Study||18
9972311|NCT01544348|11093232|FG006|Treated|Overall Study||14
9972312|NCT01544348|11093233|FG007|Treated|Overall Study||8
9972313|NCT01544348|11093226|FG000|COMPLETED|Overall Study||15
9972314|NCT01544348|11093227|FG001|COMPLETED|Overall Study||6
9972315|NCT01544348|11093228|FG002|COMPLETED|Overall Study||3
9972316|NCT01544348|11093229|FG003|COMPLETED|Overall Study||3
9972317|NCT01544348|11093230|FG004|COMPLETED|Overall Study||15
9972318|NCT01544348|11093231|FG005|COMPLETED|Overall Study||16
9972319|NCT01544348|11093232|FG006|COMPLETED|Overall Study||12
9972320|NCT01544348|11093233|FG007|COMPLETED|Overall Study||8
9972321|NCT01544348|11093226|FG000|NOT COMPLETED|Overall Study||2
9972322|NCT01544348|11093227|FG001|NOT COMPLETED|Overall Study||0
9972323|NCT01544348|11093228|FG002|NOT COMPLETED|Overall Study||0
9972324|NCT01544348|11093229|FG003|NOT COMPLETED|Overall Study||0
9972325|NCT01544348|11093230|FG004|NOT COMPLETED|Overall Study||1
9972326|NCT01544348|11093231|FG005|NOT COMPLETED|Overall Study||3
9972327|NCT01544348|11093232|FG006|NOT COMPLETED|Overall Study||2
9972328|NCT01544348|11093233|FG007|NOT COMPLETED|Overall Study||0
9972329|NCT01544361|11093263|FG000|STARTED|Overall Study||8
9972330|NCT01544361|11093264|FG001|STARTED|Overall Study||6
9972331|NCT01544361|11093265|FG002|STARTED|Overall Study||6
9972332|NCT01544361|11093266|FG003|STARTED|Overall Study||6
9972333|NCT01544361|11093267|FG004|STARTED|Overall Study||6
9972334|NCT01544361|11093263|FG000|COMPLETED|Overall Study||8
9972335|NCT01544361|11093264|FG001|COMPLETED|Overall Study||6
9972336|NCT01544361|11093265|FG002|COMPLETED|Overall Study||6
9972337|NCT01544361|11093266|FG003|COMPLETED|Overall Study||6
9972338|NCT01544361|11093267|FG004|COMPLETED|Overall Study||6
9972339|NCT01544361|11093263|FG000|NOT COMPLETED|Overall Study||0
9972340|NCT01544361|11093264|FG001|NOT COMPLETED|Overall Study||0
9972341|NCT01544361|11093265|FG002|NOT COMPLETED|Overall Study||0
9972342|NCT01544361|11093266|FG003|NOT COMPLETED|Overall Study||0
9972343|NCT01544361|11093267|FG004|NOT COMPLETED|Overall Study||0
9972344|NCT01544478|11093279|FG000|STARTED|Overall Study||1030
9972345|NCT01544478|11093279|FG000|Vaccination 1|Overall Study||1030
9972346|NCT01544478|11093279|FG000|Vaccination 2|Overall Study||1026
9972347|NCT01544478|11093279|FG000|Vaccination 3|Overall Study||1019
9972348|NCT01544478|11093279|FG000|COMPLETED|Overall Study||912
9972349|NCT01544478|11093279|FG000|NOT COMPLETED|Overall Study||118
9972350|NCT01544491|11093285|FG000|STARTED|Overall Study||52
9972351|NCT01544491|11093286|FG001|STARTED|Overall Study||54
9972352|NCT01544491|11093285|FG000|COMPLETED|Overall Study||47
9972353|NCT01544491|11093286|FG001|COMPLETED|Overall Study||51
9972354|NCT01544491|11093285|FG000|NOT COMPLETED|Overall Study||5
9972355|NCT01544491|11093286|FG001|NOT COMPLETED|Overall Study||3
9972356|NCT01544582|11093295|FG000|STARTED|Screening/Eligibility||713
9972357|NCT01544582|11093296|FG001|STARTED|Screening/Eligibility||0
9972358|NCT01544582|11093297|FG002|STARTED|Screening/Eligibility||0
9972359|NCT01544582|11093298|FG003|STARTED|Screening/Eligibility||0
9972360|NCT01544582|11093295|FG000|Analysis Population|Screening/Eligibility||679
9972361|NCT01544582|11093296|FG001|Analysis Population|Screening/Eligibility||0
9972362|NCT01544582|11093297|FG002|Analysis Population|Screening/Eligibility||0
9972363|NCT01544582|11093298|FG003|Analysis Population|Screening/Eligibility||0
9972364|NCT01544582|11093295|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
9972365|NCT01544582|11093296|FG001|COMPLETED|Screening/Eligibility||0
9972366|NCT01544582|11093297|FG002|COMPLETED|Screening/Eligibility||0
9972367|NCT01544582|11093298|FG003|COMPLETED|Screening/Eligibility||0
9972368|NCT01544582|11093295|FG000|NOT COMPLETED|Screening/Eligibility||34
9972369|NCT01544582|11093296|FG001|NOT COMPLETED|Screening/Eligibility||0
9972370|NCT01544582|11093297|FG002|NOT COMPLETED|Screening/Eligibility||0
9972371|NCT01544582|11093298|FG003|NOT COMPLETED|Screening/Eligibility||0
9972372|NCT01544582|11093295|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
9972373|NCT01544582|11093296|FG001|STARTED|Analysis Population||298
9972374|NCT01544582|11093297|FG002|STARTED|Analysis Population||307
9972375|NCT01544582|11093298|FG003|STARTED|Analysis Population||74
9972376|NCT01544582|11093295|FG000|COMPLETED|Analysis Population||0
9972377|NCT01544582|11093296|FG001|COMPLETED|Analysis Population||180
9972378|NCT01544582|11093297|FG002|COMPLETED|Analysis Population||205
9972379|NCT01544582|11093298|FG003|COMPLETED|Analysis Population||35
9972380|NCT01544582|11093295|FG000|NOT COMPLETED|Analysis Population||0
9972381|NCT01544582|11093296|FG001|NOT COMPLETED|Analysis Population||118
9972382|NCT01544582|11093297|FG002|NOT COMPLETED|Analysis Population||102
9972383|NCT01544582|11093298|FG003|NOT COMPLETED|Analysis Population||39
9972384|NCT01544595|11093317|FG000|STARTED|Status at Week 68||301
9972385|NCT01544595|11093318|FG001|STARTED|Status at Week 68||363
9972386|NCT01544595|11093319|FG002|STARTED|Status at Week 68||150
9972387|NCT01544595|11093320|FG003|STARTED|Status at Week 68||181
9972388|NCT01544595|11093321|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
9972389|NCT01544595|11093322|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
9972390|NCT01544595|11093317|FG000|COMPLETED|Status at Week 68||262
9972391|NCT01544595|11093318|FG001|COMPLETED|Status at Week 68||346
9972392|NCT01544595|11093319|FG002|COMPLETED|Status at Week 68||87
9972393|NCT01544595|11093320|FG003|COMPLETED|Status at Week 68||130
9972394|NCT01544595|11093321|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
9972395|NCT01544595|11093322|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
9972396|NCT01544595|11093317|FG000|NOT COMPLETED|Status at Week 68||39
9972397|NCT01544595|11093318|FG001|NOT COMPLETED|Status at Week 68||17
9972398|NCT01544595|11093319|FG002|NOT COMPLETED|Status at Week 68||63
9972399|NCT01544595|11093320|FG003|NOT COMPLETED|Status at Week 68||51
9972400|NCT01544595|11093321|FG004|NOT COMPLETED|Status at Week 68||0
9972401|NCT01544595|11093322|FG005|NOT COMPLETED|Status at Week 68||0
9972402|NCT01544595|11093317|FG000|STARTED|Status at Week 156||301
9972403|NCT01544595|11093318|FG001|STARTED|Status at Week 156||363
9972404|NCT01544595|11093319|FG002|STARTED|Status at Week 156||150
9972405|NCT01544595|11093320|FG003|STARTED|Status at Week 156||181
9972406|NCT01544595|11093321|FG004|STARTED|Status at Week 156||98
9972407|NCT01544595|11093322|FG005|STARTED|Status at Week 156||53
9972408|NCT01544595|11093317|FG000|COMPLETED|Status at Week 156||184
9972409|NCT01544595|11093318|FG001|COMPLETED|Status at Week 156||285
9972410|NCT01544595|11093319|FG002|COMPLETED|Status at Week 156||10
9972411|NCT01544595|11093320|FG003|COMPLETED|Status at Week 156||15
9972412|NCT01544595|11093321|FG004|COMPLETED|Status at Week 156||60
9972413|NCT01544595|11093322|FG005|COMPLETED|Status at Week 156||38
9972414|NCT01544595|11093317|FG000|NOT COMPLETED|Status at Week 156||117
9972415|NCT01544595|11093318|FG001|NOT COMPLETED|Status at Week 156||78
9972416|NCT01544595|11093319|FG002|NOT COMPLETED|Status at Week 156||140
9972417|NCT01544595|11093320|FG003|NOT COMPLETED|Status at Week 156||166
9972418|NCT01544595|11093321|FG004|NOT COMPLETED|Status at Week 156||38
9972419|NCT01544595|11093322|FG005|NOT COMPLETED|Status at Week 156||15
9972420|NCT01544920|11093342|FG000|STARTED|Overall Study||368
9972421|NCT01544920|11093343|FG001|STARTED|Overall Study||369
9972422|NCT01544920|11093342|FG000|COMPLETED|Overall Study||349
9972423|NCT01544920|11093343|FG001|COMPLETED|Overall Study||346
9972424|NCT01544920|11093342|FG000|NOT COMPLETED|Overall Study||19
9972425|NCT01544920|11093343|FG001|NOT COMPLETED|Overall Study||23
9972426|NCT01544998|11093351|FG000|STARTED|First Intervention (3 Hours)||26
9972427|NCT01544998|11093352|FG001|STARTED|First Intervention (3 Hours)||15
9972428|NCT01544998|11093351|FG000|COMPLETED|First Intervention (3 Hours)||26
9972429|NCT01544998|11093352|FG001|COMPLETED|First Intervention (3 Hours)||15
9972430|NCT01544998|11093351|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
9972431|NCT01544998|11093352|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
9972432|NCT01544998|11093351|FG000|STARTED|Washout (1 Week)||26
9972433|NCT01544998|11093352|FG001|STARTED|Washout (1 Week)||15
9972434|NCT01544998|11093351|FG000|COMPLETED|Washout (1 Week)||26
9972435|NCT01544998|11093352|FG001|COMPLETED|Washout (1 Week)||15
9972436|NCT01544998|11093351|FG000|NOT COMPLETED|Washout (1 Week)||0
9972437|NCT01544998|11093352|FG001|NOT COMPLETED|Washout (1 Week)||0
9972438|NCT01544998|11093351|FG000|STARTED|Second Intervention (3 Hours)||26
9972439|NCT01544998|11093352|FG001|STARTED|Second Intervention (3 Hours)||15
9972440|NCT01544998|11093351|FG000|COMPLETED|Second Intervention (3 Hours)||26
9972441|NCT01544998|11093352|FG001|COMPLETED|Second Intervention (3 Hours)||15
9972442|NCT01544998|11093351|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
9972443|NCT01544998|11093352|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
9972444|NCT01545076|11093360|FG000|STARTED|IgPro10 Restabilization Period||208
9972445|NCT01545076|11093361|FG001|STARTED|IgPro10 Restabilization Period||0
9972446|NCT01545076|11093362|FG002|STARTED|IgPro10 Restabilization Period||0
9972447|NCT01545076|11093363|FG003|STARTED|IgPro10 Restabilization Period||0
9972448|NCT01545076|11093364|FG004|STARTED|IgPro10 Restabilization Period||0
9972449|NCT01545076|11093360|FG000|COMPLETED|IgPro10 Restabilization Period||172
9972450|NCT01545076|11093361|FG001|COMPLETED|IgPro10 Restabilization Period||0
9972451|NCT01545076|11093362|FG002|COMPLETED|IgPro10 Restabilization Period||0
9972452|NCT01545076|11093363|FG003|COMPLETED|IgPro10 Restabilization Period||0
9972453|NCT01545076|11093364|FG004|COMPLETED|IgPro10 Restabilization Period||0
9972454|NCT01545076|11093360|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36
9972455|NCT01545076|11093361|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0
9972456|NCT01545076|11093362|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0
9972457|NCT01545076|11093363|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0
9972458|NCT01545076|11093364|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0
9972459|NCT01545076|11093360|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0
9972460|NCT01545076|11093361|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58
9972461|NCT01545076|11093362|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57
9972462|NCT01545076|11093363|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57
9972463|NCT01545076|11093364|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0
9972464|NCT01545076|11093360|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
9972465|NCT01545076|11093361|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
9972466|NCT01545076|11093362|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
9972467|NCT01545076|11093363|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
9972468|NCT01545076|11093364|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
9972469|NCT01545076|11093360|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
9972470|NCT01545076|11093361|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
9972471|NCT01545076|11093362|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
9972472|NCT01545076|11093363|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
9972473|NCT01545076|11093364|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
9972474|NCT01545076|11093360|FG000|STARTED|IgPro10 Rescue Period||0
9972475|NCT01545076|11093361|FG001|STARTED|IgPro10 Rescue Period||0
9972476|NCT01545076|11093362|FG002|STARTED|IgPro10 Rescue Period||0
9972477|NCT01545076|11093363|FG003|STARTED|IgPro10 Rescue Period||0
9972478|NCT01545076|11093364|FG004|STARTED|IgPro10 Rescue Period||60
9972479|NCT01545076|11093360|FG000|COMPLETED|IgPro10 Rescue Period||0
9972480|NCT01545076|11093361|FG001|COMPLETED|IgPro10 Rescue Period||0
9972481|NCT01545076|11093362|FG002|COMPLETED|IgPro10 Rescue Period||0
9972482|NCT01545076|11093363|FG003|COMPLETED|IgPro10 Rescue Period||0
9972483|NCT01545076|11093364|FG004|COMPLETED|IgPro10 Rescue Period||60
9972484|NCT01545076|11093360|FG000|NOT COMPLETED|IgPro10 Rescue Period||0
9972485|NCT01545076|11093361|FG001|NOT COMPLETED|IgPro10 Rescue Period||0
9972486|NCT01545076|11093362|FG002|NOT COMPLETED|IgPro10 Rescue Period||0
9972487|NCT01545076|11093363|FG003|NOT COMPLETED|IgPro10 Rescue Period||0
9972488|NCT01545076|11093364|FG004|NOT COMPLETED|IgPro10 Rescue Period||0
9972489|NCT01545141|11093381|FG000|STARTED|Overall Study||2
9972490|NCT01545141|11093382|FG001|STARTED|Overall Study||3
9972491|NCT01545141|11093383|FG002|STARTED|Overall Study||3
9972492|NCT01545141|11093384|FG003|STARTED|Overall Study||7
9972493|NCT01545141|11093381|FG000|COMPLETED|Overall Study||2
9972494|NCT01545141|11093382|FG001|COMPLETED|Overall Study||3
9972495|NCT01545141|11093383|FG002|COMPLETED|Overall Study||3
9972496|NCT01545141|11093384|FG003|COMPLETED|Overall Study||7
9972497|NCT01545141|11093381|FG000|NOT COMPLETED|Overall Study||0
9972498|NCT01545141|11093382|FG001|NOT COMPLETED|Overall Study||0
9972499|NCT01545141|11093383|FG002|NOT COMPLETED|Overall Study||0
9972500|NCT01545141|11093384|FG003|NOT COMPLETED|Overall Study||0
9972501|NCT01545193|11093395|FG000|STARTED|Overall Study||150
9972502|NCT01545193|11093396|FG001|STARTED|Overall Study||150
9972503|NCT01545193|11093395|FG000|COMPLETED|Overall Study||150
9972504|NCT01545193|11093396|FG001|COMPLETED|Overall Study||149
9972505|NCT01545193|11093395|FG000|NOT COMPLETED|Overall Study||0
9972506|NCT01545193|11093396|FG001|NOT COMPLETED|Overall Study||1
9972507|NCT01545232|11093404|FG000|STARTED|Overall Study||338
9972508|NCT01545232|11093405|FG001|STARTED|Overall Study||342
9972509|NCT01545232|11093404|FG000|COMPLETED|Overall Study||338
9972510|NCT01545232|11093405|FG001|COMPLETED|Overall Study||342
9972511|NCT01545232|11093404|FG000|NOT COMPLETED|Overall Study||0
9972512|NCT01545232|11093405|FG001|NOT COMPLETED|Overall Study||0
9972513|NCT01545336|11093415|FG000|STARTED|Overall Study||12
9972514|NCT01545336|11093416|FG001|STARTED|Overall Study||6
9972515|NCT01545336|11093415|FG000|COMPLETED|Overall Study||12
9972516|NCT01545336|11093416|FG001|COMPLETED|Overall Study||6
9972517|NCT01545336|11093415|FG000|NOT COMPLETED|Overall Study||0
9972518|NCT01545336|11093416|FG001|NOT COMPLETED|Overall Study||0
9972519|NCT01545375|11093426|FG000|STARTED|Overall Study||900
9972520|NCT01545375|11093427|FG001|STARTED|Overall Study||903
9972521|NCT01545375|11093426|FG000|COMPLETED|Overall Study||803
9972522|NCT01545375|11093427|FG001|COMPLETED|Overall Study||813
9972523|NCT01545375|11093426|FG000|NOT COMPLETED|Overall Study||97
9972524|NCT01545375|11093427|FG001|NOT COMPLETED|Overall Study||90
9972525|NCT01545388|11093436|FG000|STARTED|Overall Study||138
9972526|NCT01545388|11093437|FG001|STARTED|Overall Study||133
9972527|NCT01545388|11093438|FG002|STARTED|Overall Study||66
9972528|NCT01545388|11093436|FG000|COMPLETED|Overall Study||130
9972529|NCT01545388|11093437|FG001|COMPLETED|Overall Study||122
9972530|NCT01545388|11093438|FG002|COMPLETED|Overall Study||58
9972531|NCT01545388|11093436|FG000|NOT COMPLETED|Overall Study||8
9972532|NCT01545388|11093437|FG001|NOT COMPLETED|Overall Study||11
9972533|NCT01545388|11093438|FG002|NOT COMPLETED|Overall Study||8
9972534|NCT01545583|11093455|FG000|STARTED|Overall Study||12
9972535|NCT01545583|11093456|FG001|STARTED|Overall Study||2
9972536|NCT01545583|11093457|FG002|STARTED|Overall Study||6
9972537|NCT01545583|11093458|FG003|STARTED|Overall Study||6
9972538|NCT01545583|11093459|FG004|STARTED|Overall Study||6
9972539|NCT01545583|11093460|FG005|STARTED|Overall Study||6
9972540|NCT01545583|11093461|FG006|STARTED|Overall Study||6
9972541|NCT01545583|11093462|FG007|STARTED|Overall Study||6
9972542|NCT01545583|11093463|FG008|STARTED|Overall Study||6
9972543|NCT01545583|11093455|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
9972544|NCT01545583|11093456|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
9972545|NCT01545583|11093457|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9972546|NCT01545583|11093458|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9972547|NCT01545583|11093459|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
9972548|NCT01545583|11093460|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
9972549|NCT01545583|11093461|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
9972550|NCT01545583|11093462|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
9972551|NCT01545583|11093463|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
9972552|NCT01545583|11093455|FG000|COMPLETED|Overall Study||12
9972553|NCT01545583|11093456|FG001|COMPLETED|Overall Study||2
9972554|NCT01545583|11093457|FG002|COMPLETED|Overall Study||6
9972555|NCT01545583|11093458|FG003|COMPLETED|Overall Study||6
9972556|NCT01545583|11093459|FG004|COMPLETED|Overall Study||6
9972557|NCT01545583|11093460|FG005|COMPLETED|Overall Study||6
9972558|NCT01545583|11093461|FG006|COMPLETED|Overall Study||6
9972559|NCT01545583|11093462|FG007|COMPLETED|Overall Study||6
9972560|NCT01545583|11093463|FG008|COMPLETED|Overall Study||6
9972561|NCT01545583|11093455|FG000|NOT COMPLETED|Overall Study||0
9972562|NCT01545583|11093456|FG001|NOT COMPLETED|Overall Study||0
9972563|NCT01545583|11093457|FG002|NOT COMPLETED|Overall Study||0
9972564|NCT01545583|11093458|FG003|NOT COMPLETED|Overall Study||0
9972565|NCT01545583|11093459|FG004|NOT COMPLETED|Overall Study||0
9972566|NCT01545583|11093460|FG005|NOT COMPLETED|Overall Study||0
9972567|NCT01545583|11093461|FG006|NOT COMPLETED|Overall Study||0
9972568|NCT01545583|11093462|FG007|NOT COMPLETED|Overall Study||0
9972569|NCT01545583|11093463|FG008|NOT COMPLETED|Overall Study||0
9972570|NCT01545700|11093496|FG000|STARTED|Overall Study||34
9972571|NCT01545700|11093497|FG001|STARTED|Overall Study||33
9972572|NCT01545700|11093498|FG002|STARTED|Overall Study||33
9972573|NCT01545700|11093499|FG003|STARTED|Overall Study||34
9972574|NCT01545700|11093500|FG004|STARTED|Overall Study||33
9972575|NCT01545700|11093501|FG005|STARTED|Overall Study||33
9972576|NCT01545700|11093496|FG000|COMPLETED|Overall Study||33
9972577|NCT01545700|11093497|FG001|COMPLETED|Overall Study||32
9972578|NCT01545700|11093498|FG002|COMPLETED|Overall Study||31
9972579|NCT01545700|11093499|FG003|COMPLETED|Overall Study||34
9972580|NCT01545700|11093500|FG004|COMPLETED|Overall Study||32
9972581|NCT01545700|11093501|FG005|COMPLETED|Overall Study||33
9972582|NCT01545700|11093496|FG000|NOT COMPLETED|Overall Study||1
9972583|NCT01545700|11093497|FG001|NOT COMPLETED|Overall Study||1
9972584|NCT01545700|11093498|FG002|NOT COMPLETED|Overall Study||2
9972585|NCT01545700|11093499|FG003|NOT COMPLETED|Overall Study||0
9972586|NCT01545700|11093500|FG004|NOT COMPLETED|Overall Study||1
9972587|NCT01545700|11093501|FG005|NOT COMPLETED|Overall Study||0
9972588|NCT01545765|11093535|FG000|STARTED|Overall Study||31
9972589|NCT01545765|11093535|FG000|COMPLETED|Overall Study||31
9972590|NCT01545765|11093535|FG000|NOT COMPLETED|Overall Study||0
9972591|NCT01545817|11093542|FG000|STARTED|Pazopanib||74
9972592|NCT01545817|11093543|FG001|STARTED|Pazopanib||0
9972593|NCT01545817|11093542|FG000|COMPLETED|Pazopanib||0
9972594|NCT01545817|11093543|FG001|COMPLETED|Pazopanib||0
9972595|NCT01545817|11093542|FG000|NOT COMPLETED|Pazopanib||74
9972596|NCT01545817|11093543|FG001|NOT COMPLETED|Pazopanib||0
9972597|NCT01545817|11093542|FG000|STARTED|Everolimus||0
9972598|NCT01545817|11093543|FG001|STARTED|Everolimus||38
9972599|NCT01545817|11093542|FG000|COMPLETED|Everolimus||0
9972600|NCT01545817|11093543|FG001|COMPLETED|Everolimus||0
9972601|NCT01545817|11093542|FG000|NOT COMPLETED|Everolimus||0
9972602|NCT01545817|11093543|FG001|NOT COMPLETED|Everolimus||38
9972603|NCT01545843|11093554|FG000|STARTED|Overall Study||19
9972604|NCT01545843|11093555|FG001|STARTED|Overall Study||24
9972605|NCT01545843|11093556|FG002|STARTED|Overall Study||25
9972606|NCT01545843|11093554|FG000|COMPLETED|Overall Study||16
9972607|NCT01545843|11093555|FG001|COMPLETED|Overall Study||17
9972608|NCT01545843|11093556|FG002|COMPLETED|Overall Study||21
9972609|NCT01545843|11093554|FG000|NOT COMPLETED|Overall Study||3
9972610|NCT01545843|11093555|FG001|NOT COMPLETED|Overall Study||7
9972611|NCT01545843|11093556|FG002|NOT COMPLETED|Overall Study||4
9972612|NCT01545934|11093569|FG000|STARTED|Overall Study||132
9972613|NCT01545934|11093570|FG001|STARTED|Overall Study||132
9972614|NCT01545934|11093569|FG000|COMPLETED|Overall Study||127
9972615|NCT01545934|11093570|FG001|COMPLETED|Overall Study||129
9972616|NCT01545934|11093569|FG000|NOT COMPLETED|Overall Study||5
9972617|NCT01545934|11093570|FG001|NOT COMPLETED|Overall Study||3
9972618|NCT01546038|11093583|FG000|STARTED|Overall Study||17
9972619|NCT01546038|11093584|FG001|STARTED|Overall Study||6
9972620|NCT01546038|11093585|FG002|STARTED|Overall Study||4
9972621|NCT01546038|11093586|FG003|STARTED|Overall Study||3
9972622|NCT01546038|11093587|FG004|STARTED|Overall Study||16
9972623|NCT01546038|11093588|FG005|STARTED|Overall Study||6
9972624|NCT01546038|11093589|FG006|STARTED|Overall Study||71
9972625|NCT01546038|11093590|FG007|STARTED|Overall Study||88
9972626|NCT01546038|11093591|FG008|STARTED|Overall Study||44
9972627|NCT01546038|11093583|FG000|Received Treatment|Overall Study||17
9972628|NCT01546038|11093584|FG001|Received Treatment|Overall Study||6
9972629|NCT01546038|11093585|FG002|Received Treatment|Overall Study||4
9972630|NCT01546038|11093586|FG003|Received Treatment|Overall Study||3
9972631|NCT01546038|11093587|FG004|Received Treatment|Overall Study||16
9972632|NCT01546038|11093588|FG005|Received Treatment|Overall Study||6
9972633|NCT01546038|11093589|FG006|Received Treatment|Overall Study||69
9972634|NCT01546038|11093590|FG007|Received Treatment|Overall Study||84
9972635|NCT01546038|11093591|FG008|Received Treatment|Overall Study||41
9972636|NCT01546038|11093583|FG000|COMPLETED|Overall Study||1
9972637|NCT01546038|11093584|FG001|COMPLETED|Overall Study||0
9972638|NCT01546038|11093585|FG002|COMPLETED|Overall Study||0
9972639|NCT01546038|11093586|FG003|COMPLETED|Overall Study||0
9972640|NCT01546038|11093587|FG004|COMPLETED|Overall Study||6
9972641|NCT01546038|11093588|FG005|COMPLETED|Overall Study||2
9972642|NCT01546038|11093589|FG006|COMPLETED|Overall Study||18
9972643|NCT01546038|11093590|FG007|COMPLETED|Overall Study||4
9972644|NCT01546038|11093591|FG008|COMPLETED|Overall Study||1
9972645|NCT01546038|11093583|FG000|NOT COMPLETED|Overall Study||16
9972646|NCT01546038|11093584|FG001|NOT COMPLETED|Overall Study||6
9972647|NCT01546038|11093585|FG002|NOT COMPLETED|Overall Study||4
9972648|NCT01546038|11093586|FG003|NOT COMPLETED|Overall Study||3
9972649|NCT01546038|11093587|FG004|NOT COMPLETED|Overall Study||10
9972650|NCT01546038|11093588|FG005|NOT COMPLETED|Overall Study||4
9972651|NCT01546038|11093589|FG006|NOT COMPLETED|Overall Study||53
9972652|NCT01546038|11093590|FG007|NOT COMPLETED|Overall Study||84
9972653|NCT01546038|11093591|FG008|NOT COMPLETED|Overall Study||43
9972654|NCT01546142|11093643|FG000|STARTED|Overall Study||258
9972655|NCT01546142|11093644|FG001|STARTED|Overall Study||258
9972656|NCT01546142|11093643|FG000|Received Treatment|Overall Study||257
9972657|NCT01546142|11093644|FG001|Received Treatment|Overall Study||257
9972658|NCT01546142|11093643|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
9972659|NCT01546142|11093644|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
9972660|NCT01546142|11093643|FG000|NOT COMPLETED|Overall Study||44
9972661|NCT01546142|11093644|FG001|NOT COMPLETED|Overall Study||34
9972662|NCT01546155|11093650|FG000|STARTED|Overall Study||11
9972663|NCT01546155|11093650|FG000|COMPLETED|Overall Study||8
9972664|NCT01546155|11093650|FG000|NOT COMPLETED|Overall Study||3
9972665|NCT01546168|11093656|FG000|STARTED|Overall Study||55
9972666|NCT01546168|11093657|FG001|STARTED|Overall Study||33
9972667|NCT01546168|11093656|FG000|COMPLETED|Overall Study||51
9972668|NCT01546168|11093657|FG001|COMPLETED|Overall Study||33
9972669|NCT01546168|11093656|FG000|NOT COMPLETED|Overall Study||4
9972670|NCT01546168|11093657|FG001|NOT COMPLETED|Overall Study||0
9972671|NCT01546194|11093665|FG000|STARTED|Overall Study||100
9972672|NCT01546194|11093666|FG001|STARTED|Overall Study||100
9972673|NCT01546194|11093665|FG000|COMPLETED|Overall Study||64
9972674|NCT01546194|11093666|FG001|COMPLETED|Overall Study||65
9972675|NCT01546194|11093665|FG000|NOT COMPLETED|Overall Study||36
9972676|NCT01546194|11093666|FG001|NOT COMPLETED|Overall Study||35
9972677|NCT01546285|11093672|FG000|STARTED|Overall Study||66
9972678|NCT01546285|11093672|FG000|COMPLETED|Overall Study||66
9972679|NCT01546285|11093672|FG000|NOT COMPLETED|Overall Study||0
9972680|NCT01546402|11093680|FG000|STARTED|Overall Study||10
9972681|NCT01546402|11093681|FG001|STARTED|Overall Study||10
9972682|NCT01546402|11093680|FG000|COMPLETED|Overall Study||10
9972683|NCT01546402|11093681|FG001|COMPLETED|Overall Study||10
9972684|NCT01546402|11093680|FG000|NOT COMPLETED|Overall Study||0
9972685|NCT01546402|11093681|FG001|NOT COMPLETED|Overall Study||0
9972686|NCT01546454|11093687|FG000|STARTED|Natural Menstrual Cycle||4
9972687|NCT01546454|11093687|FG000|COMPLETED|Natural Menstrual Cycle||4
9972688|NCT01546454|11093687|FG000|NOT COMPLETED|Natural Menstrual Cycle||0
9972689|NCT01546454|11093687|FG000|STARTED|Oral Contraceptive Cycle||4
9972690|NCT01546454|11093687|FG000|COMPLETED|Oral Contraceptive Cycle||4
9972691|NCT01546454|11093687|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0
9972692|NCT01546454|11093687|FG000|STARTED|Eligard Treatment||4
9972693|NCT01546454|11093687|FG000|COMPLETED|Eligard Treatment||4
9972694|NCT01546454|11093687|FG000|NOT COMPLETED|Eligard Treatment||0
9972695|NCT01546454|11093687|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4
9972696|NCT01546454|11093687|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
9972697|NCT01546454|11093687|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
9972698|NCT01546519|11093697|FG000|STARTED|Overall Study||9
9972699|NCT01546519|11093698|FG001|STARTED|Overall Study||8
9972700|NCT01546519|11093699|FG002|STARTED|Overall Study||8
9972701|NCT01546519|11093700|FG003|STARTED|Overall Study||6
9972702|NCT01546519|11093697|FG000|Safety-Evaluable Participants|Overall Study||9
9972703|NCT01546519|11093698|FG001|Safety-Evaluable Participants|Overall Study||8
9972704|NCT01546519|11093699|FG002|Safety-Evaluable Participants|Overall Study||8
9972705|NCT01546519|11093700|FG003|Safety-Evaluable Participants|Overall Study||6
9972706|NCT01546519|11093697|FG000|COMPLETED|Overall Study||0
9972707|NCT01546519|11093698|FG001|COMPLETED|Overall Study||0
9972708|NCT01546519|11093699|FG002|COMPLETED|Overall Study||0
9972709|NCT01546519|11093700|FG003|COMPLETED|Overall Study||0
9972710|NCT01546519|11093697|FG000|NOT COMPLETED|Overall Study||9
9972711|NCT01546519|11093698|FG001|NOT COMPLETED|Overall Study||8
9972712|NCT01546519|11093699|FG002|NOT COMPLETED|Overall Study||8
9972713|NCT01546519|11093700|FG003|NOT COMPLETED|Overall Study||6
9972714|NCT01546623|11093716|FG000|STARTED|Overall Study||82
9972715|NCT01546623|11093717|FG001|STARTED|Overall Study||80
9972716|NCT01546623|11093716|FG000|Received Study Drug|Overall Study||81
9972717|NCT01546623|11093717|FG001|Received Study Drug|Overall Study||79
9972718|NCT01546623|11093716|FG000|COMPLETED|Overall Study||76
9972719|NCT01546623|11093717|FG001|COMPLETED|Overall Study||74
9972720|NCT01546623|11093716|FG000|NOT COMPLETED|Overall Study||6
9972721|NCT01546623|11093717|FG001|NOT COMPLETED|Overall Study||6
9972722|NCT01546636|11093725|FG000|STARTED|Overall Study||36
9972723|NCT01546636|11093726|FG001|STARTED|Overall Study||34
9972724|NCT01546636|11093725|FG000|COMPLETED|Overall Study||36
9972725|NCT01546636|11093726|FG001|COMPLETED|Overall Study||34
9972726|NCT01546636|11093725|FG000|NOT COMPLETED|Overall Study||0
9972727|NCT01546636|11093726|FG001|NOT COMPLETED|Overall Study||0
9972728|NCT01546649|11093734|FG000|STARTED|Overall Study||83
9972729|NCT01546649|11093735|FG001|STARTED|Overall Study||84
9972730|NCT01546649|11093734|FG000|COMPLETED|Overall Study||75
9972731|NCT01546649|11093735|FG001|COMPLETED|Overall Study||75
9972732|NCT01546649|11093734|FG000|NOT COMPLETED|Overall Study||8
9972733|NCT01546649|11093735|FG001|NOT COMPLETED|Overall Study||9
9972734|NCT01546675|11093743|FG000|STARTED|Overall Study||1
9972735|NCT01546675|11093744|FG001|STARTED|Overall Study||1
9972736|NCT01546675|11093743|FG000|COMPLETED|Overall Study||1
9972737|NCT01546675|11093744|FG001|COMPLETED|Overall Study||1
9972738|NCT01546675|11093743|FG000|NOT COMPLETED|Overall Study||0
9972739|NCT01546675|11093744|FG001|NOT COMPLETED|Overall Study||0
9972740|NCT01546688|11093752|FG000|STARTED|Overall Study||18
9972741|NCT01546688|11093753|FG001|STARTED|Overall Study||33
9972742|NCT01546688|11093752|FG000|COMPLETED|Overall Study||15
9972743|NCT01546688|11093753|FG001|COMPLETED|Overall Study||28
9972744|NCT01546688|11093752|FG000|NOT COMPLETED|Overall Study||3
9972745|NCT01546688|11093753|FG001|NOT COMPLETED|Overall Study||5
9972746|NCT01546857|11093761|FG000|STARTED|Overall Study||14
9972747|NCT01546857|11093762|FG001|STARTED|Overall Study||20
9972748|NCT01546857|11093761|FG000|COMPLETED|Overall Study||12
9972749|NCT01546857|11093762|FG001|COMPLETED|Overall Study||17
9972750|NCT01546857|11093761|FG000|NOT COMPLETED|Overall Study||2
9972751|NCT01546857|11093762|FG001|NOT COMPLETED|Overall Study||3
9972752|NCT01546922|11093769|FG000|STARTED|First Period of 10 Weeks||30
9972753|NCT01546922|11093770|FG001|STARTED|First Period of 10 Weeks||30
9972754|NCT01546922|11093769|FG000|COMPLETED|First Period of 10 Weeks||25
9972755|NCT01546922|11093770|FG001|COMPLETED|First Period of 10 Weeks||28
9972756|NCT01546922|11093769|FG000|NOT COMPLETED|First Period of 10 Weeks||5
9972757|NCT01546922|11093770|FG001|NOT COMPLETED|First Period of 10 Weeks||2
9972758|NCT01546922|11093769|FG000|STARTED|Second Period of 10 Weeks||25
9972759|NCT01546922|11093770|FG001|STARTED|Second Period of 10 Weeks||28
9972760|NCT01546922|11093769|FG000|COMPLETED|Second Period of 10 Weeks||22
9972761|NCT01546922|11093770|FG001|COMPLETED|Second Period of 10 Weeks||25
9972762|NCT01546922|11093769|FG000|NOT COMPLETED|Second Period of 10 Weeks||3
9972763|NCT01546922|11093770|FG001|NOT COMPLETED|Second Period of 10 Weeks||3
9972764|NCT01547000|11093778|FG000|STARTED|Overall Study||18
9972765|NCT01547000|11093779|FG001|STARTED|Overall Study||16
9972766|NCT01547000|11093778|FG000|COMPLETED|Overall Study||18
9972767|NCT01547000|11093779|FG001|COMPLETED|Overall Study||16
9972768|NCT01547000|11093778|FG000|NOT COMPLETED|Overall Study||0
9972769|NCT01547000|11093779|FG001|NOT COMPLETED|Overall Study||0
9972770|NCT01547130|11093787|FG000|STARTED|Overall Study||74
9972771|NCT01547130|11093788|FG001|STARTED|Overall Study||73
9972772|NCT01547130|11093787|FG000|COMPLETED|Overall Study||65
9972773|NCT01547130|11093788|FG001|COMPLETED|Overall Study||68
9972774|NCT01547130|11093787|FG000|NOT COMPLETED|Overall Study||9
9972775|NCT01547130|11093788|FG001|NOT COMPLETED|Overall Study||5
9972776|NCT01547247|11093804|FG000|STARTED|Overall Study||104
9972777|NCT01547247|11093805|FG001|STARTED|Overall Study||104
9972778|NCT01547247|11093804|FG000|COMPLETED|Overall Study||98
9972779|NCT01547247|11093805|FG001|COMPLETED|Overall Study||98
9972780|NCT01547247|11093804|FG000|NOT COMPLETED|Overall Study||6
9972781|NCT01547247|11093805|FG001|NOT COMPLETED|Overall Study||6
9972782|NCT01547286|11093811|FG000|STARTED|Overall Study||7
9972783|NCT01547286|11093811|FG000|COMPLETED|Overall Study||5
9972784|NCT01547286|11093811|FG000|NOT COMPLETED|Overall Study||2
9972785|NCT01547299|11093818|FG000|STARTED|Overall Study||25
9972786|NCT01547299|11093819|FG001|STARTED|Overall Study||27
9972787|NCT01547299|11093818|FG000|COMPLETED|Overall Study||23
9972788|NCT01547299|11093819|FG001|COMPLETED|Overall Study||25
9972789|NCT01547299|11093818|FG000|NOT COMPLETED|Overall Study||2
9972790|NCT01547299|11093819|FG001|NOT COMPLETED|Overall Study||2
9972791|NCT01547390|11093827|FG000|STARTED|Overall Study||27
9972792|NCT01547390|11093828|FG001|STARTED|Overall Study||26
9972793|NCT01547390|11093827|FG000|COMPLETED|Overall Study||14
9972794|NCT01547390|11093828|FG001|COMPLETED|Overall Study||16
9972795|NCT01547390|11093827|FG000|NOT COMPLETED|Overall Study||13
9972796|NCT01547390|11093828|FG001|NOT COMPLETED|Overall Study||10
9972797|NCT01547598|11093836|FG000|STARTED|Overall Study||67
9972798|NCT01547598|11093837|FG001|STARTED|Overall Study||68
9972799|NCT01547598|11093836|FG000|COMPLETED|Overall Study||61
9972800|NCT01547598|11093837|FG001|COMPLETED|Overall Study||63
9972801|NCT01547598|11093836|FG000|NOT COMPLETED|Overall Study||6
9972802|NCT01547598|11093837|FG001|NOT COMPLETED|Overall Study||5
9972803|NCT01547715|11093847|FG000|STARTED|Overall Study||60
9972804|NCT01547715|11093848|FG001|STARTED|Overall Study||60
9972805|NCT01547715|11093849|FG002|STARTED|Overall Study||60
9972806|NCT01547715|11093847|FG000|COMPLETED|Overall Study||60
9972807|NCT01547715|11093848|FG001|COMPLETED|Overall Study||60
9972808|NCT01547715|11093849|FG002|COMPLETED|Overall Study||60
9972809|NCT01547715|11093847|FG000|NOT COMPLETED|Overall Study||0
9972810|NCT01547715|11093848|FG001|NOT COMPLETED|Overall Study||0
9972811|NCT01547715|11093849|FG002|NOT COMPLETED|Overall Study||0
9972812|NCT01547780|11093862|FG000|STARTED|Baseline PET Scan||12
9972813|NCT01547780|11093863|FG001|STARTED|Baseline PET Scan||0
9972814|NCT01547780|11093864|FG002|STARTED|Baseline PET Scan||19
9972815|NCT01547780|11093865|FG003|STARTED|Baseline PET Scan||19
9972816|NCT01547780|11093862|FG000|COMPLETED|Baseline PET Scan||9
9972817|NCT01547780|11093863|FG001|COMPLETED|Baseline PET Scan||0
9972818|NCT01547780|11093864|FG002|COMPLETED|Baseline PET Scan||17
9972819|NCT01547780|11093865|FG003|COMPLETED|Baseline PET Scan||19
9972820|NCT01547780|11093862|FG000|NOT COMPLETED|Baseline PET Scan||3
9972821|NCT01547780|11093863|FG001|NOT COMPLETED|Baseline PET Scan||0
9972822|NCT01547780|11093864|FG002|NOT COMPLETED|Baseline PET Scan||2
9972823|NCT01547780|11093865|FG003|NOT COMPLETED|Baseline PET Scan||0
9972824|NCT01547780|11093862|FG000|STARTED|Repeat PET Scan||0
9972825|NCT01547780|11093863|FG001|STARTED|Repeat PET Scan||4
9972826|NCT01547780|11093864|FG002|STARTED|Repeat PET Scan||0
9972827|NCT01547780|11093865|FG003|STARTED|Repeat PET Scan||0
9972828|NCT01547780|11093862|FG000|COMPLETED|Repeat PET Scan||0
9972829|NCT01547780|11093863|FG001|COMPLETED|Repeat PET Scan||4
9972830|NCT01547780|11093864|FG002|COMPLETED|Repeat PET Scan||0
9972831|NCT01547780|11093865|FG003|COMPLETED|Repeat PET Scan||0
9972832|NCT01547780|11093862|FG000|NOT COMPLETED|Repeat PET Scan||0
9972833|NCT01547780|11093863|FG001|NOT COMPLETED|Repeat PET Scan||0
9972834|NCT01547780|11093864|FG002|NOT COMPLETED|Repeat PET Scan||0
9972835|NCT01547780|11093865|FG003|NOT COMPLETED|Repeat PET Scan||0
9972836|NCT01547806|11093875|FG000|STARTED|Overall Study||49
9972837|NCT01547806|11093875|FG000|COMPLETED|Overall Study||49
9972838|NCT01547806|11093875|FG000|NOT COMPLETED|Overall Study||0
9972839|NCT01548040|11093882|FG000|STARTED|Overall Study||56
9972840|NCT01548040|11093883|FG001|STARTED|Overall Study||55
9972841|NCT01548040|11093882|FG000|COMPLETED|Overall Study||43
9972842|NCT01548040|11093883|FG001|COMPLETED|Overall Study||45
9972843|NCT01548040|11093882|FG000|NOT COMPLETED|Overall Study||13
9972844|NCT01548040|11093883|FG001|NOT COMPLETED|Overall Study||10
9972845|NCT01548287|11093893|FG000|STARTED|Screening||19
9972846|NCT01548287|11093894|FG001|STARTED|Screening||22
9972847|NCT01548287|11093895|FG002|STARTED|Screening||20
9972848|NCT01548287|11093896|FG003|STARTED|Screening||20
9972849|NCT01548287|11093897|FG004|STARTED|Screening||83
9972850|NCT01548287|11093893|FG000|COMPLETED|Screening||19
9972851|NCT01548287|11093894|FG001|COMPLETED|Screening||22
9972852|NCT01548287|11093895|FG002|COMPLETED|Screening||20
9972853|NCT01548287|11093896|FG003|COMPLETED|Screening||20
9972854|NCT01548287|11093897|FG004|COMPLETED|Screening||0
9972855|NCT01548287|11093893|FG000|NOT COMPLETED|Screening||0
9972856|NCT01548287|11093894|FG001|NOT COMPLETED|Screening||0
9972857|NCT01548287|11093895|FG002|NOT COMPLETED|Screening||0
9972858|NCT01548287|11093896|FG003|NOT COMPLETED|Screening||0
9972859|NCT01548287|11093897|FG004|NOT COMPLETED|Screening||83
9972860|NCT01548287|11093893|FG000|STARTED|Randomized Period||19
9972861|NCT01548287|11093894|FG001|STARTED|Randomized Period||22
9972862|NCT01548287|11093895|FG002|STARTED|Randomized Period||20
9972863|NCT01548287|11093896|FG003|STARTED|Randomized Period||20
9972864|NCT01548287|11093897|FG004|STARTED|Randomized Period||0
9972865|NCT01548287|11093893|FG000|COMPLETED|Randomized Period||19
9972866|NCT01548287|11093894|FG001|COMPLETED|Randomized Period||20
9972867|NCT01548287|11093895|FG002|COMPLETED|Randomized Period||13
9972868|NCT01548287|11093896|FG003|COMPLETED|Randomized Period||20
9972869|NCT01548287|11093897|FG004|COMPLETED|Randomized Period||0
9972870|NCT01548287|11093893|FG000|NOT COMPLETED|Randomized Period||0
9972871|NCT01548287|11093894|FG001|NOT COMPLETED|Randomized Period||2
9972872|NCT01548287|11093895|FG002|NOT COMPLETED|Randomized Period||7
9972873|NCT01548287|11093896|FG003|NOT COMPLETED|Randomized Period||0
9972874|NCT01548287|11093897|FG004|NOT COMPLETED|Randomized Period||0
9972875|NCT01548339|11093909|FG000|STARTED|Overall Study||44
9972876|NCT01548339|11093910|FG001|STARTED|Overall Study||42
9972877|NCT01548339|11093909|FG000|COMPLETED|Overall Study||38
9972878|NCT01548339|11093910|FG001|COMPLETED|Overall Study||41
9972879|NCT01548339|11093909|FG000|NOT COMPLETED|Overall Study||6
9972880|NCT01548339|11093910|FG001|NOT COMPLETED|Overall Study||1
9972881|NCT01548404|11093918|FG000|STARTED|Overall Study||54
9972882|NCT01548404|11093919|FG001|STARTED|Overall Study||55
9972883|NCT01548404|11093918|FG000|COMPLETED|Overall Study||24
9972884|NCT01548404|11093919|FG001|COMPLETED|Overall Study||41
9972885|NCT01548404|11093918|FG000|NOT COMPLETED|Overall Study||30
9972886|NCT01548404|11093919|FG001|NOT COMPLETED|Overall Study||14
9972887|NCT01548417|11093928|FG000|STARTED|Overall Study||28
9972888|NCT01548417|11093929|FG001|STARTED|Overall Study||28
9972889|NCT01548417|11093928|FG000|COMPLETED|Overall Study||28
9972890|NCT01548417|11093929|FG001|COMPLETED|Overall Study||26
9972891|NCT01548417|11093928|FG000|NOT COMPLETED|Overall Study||0
9972892|NCT01548417|11093929|FG001|NOT COMPLETED|Overall Study||2
9972893|NCT01548573|11093935|FG000|STARTED|Overall Study||19
9972894|NCT01548573|11093935|FG000|COMPLETED|Overall Study||14
9972895|NCT01548573|11093935|FG000|NOT COMPLETED|Overall Study||5
9972896|NCT01548599|11093942|FG000|STARTED|Overall Study||72
9972897|NCT01548599|11093943|FG001|STARTED|Overall Study||68
9972898|NCT01548599|11093942|FG000|COMPLETED|Overall Study||66
9972899|NCT01548599|11093943|FG001|COMPLETED|Overall Study||66
9972900|NCT01548599|11093942|FG000|NOT COMPLETED|Overall Study||6
9972901|NCT01548599|11093943|FG001|NOT COMPLETED|Overall Study||2
9972902|NCT01548638|11093952|FG000|STARTED|Overall Study||13
9972903|NCT01548638|11093952|FG000|COMPLETED|Overall Study||9
9972904|NCT01548638|11093952|FG000|NOT COMPLETED|Overall Study||4
9972905|NCT01548690|11093961|FG000|STARTED|Overall Study||9
9972906|NCT01548690|11093962|FG001|STARTED|Overall Study||10
9972907|NCT01548690|11093963|FG002|STARTED|Overall Study||13
9972908|NCT01548690|11093964|FG003|STARTED|Overall Study||15
9972909|NCT01548690|11093961|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6
9972910|NCT01548690|11093962|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6
9972911|NCT01548690|11093963|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12
9972912|NCT01548690|11093964|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12
9972913|NCT01548690|11093961|FG000|COMPLETED|Overall Study||9
9972914|NCT01548690|11093962|FG001|COMPLETED|Overall Study||7
9972915|NCT01548690|11093963|FG002|COMPLETED|Overall Study||8
9972916|NCT01548690|11093964|FG003|COMPLETED|Overall Study||10
9972917|NCT01548690|11093961|FG000|NOT COMPLETED|Overall Study||0
9972918|NCT01548690|11093962|FG001|NOT COMPLETED|Overall Study||3
9972919|NCT01548690|11093963|FG002|NOT COMPLETED|Overall Study||5
9972920|NCT01548690|11093964|FG003|NOT COMPLETED|Overall Study||5
9972921|NCT01548742|11093979|FG000|STARTED|Overall Study||58
9972922|NCT01548742|11093980|FG001|STARTED|Overall Study||58
9972923|NCT01548742|11093979|FG000|COMPLETED|Overall Study||45
9972924|NCT01548742|11093980|FG001|COMPLETED|Overall Study||54
9972925|NCT01548742|11093979|FG000|NOT COMPLETED|Overall Study||13
9972926|NCT01548742|11093980|FG001|NOT COMPLETED|Overall Study||4
9972927|NCT01548768|11093992|FG000|STARTED|Overall Study||8
9972928|NCT01548768|11093993|FG001|STARTED|Overall Study||4
9972929|NCT01548768|11093994|FG002|STARTED|Overall Study||16
9972930|NCT01548768|11093995|FG003|STARTED|Overall Study||121
9972931|NCT01548768|11093992|FG000|COMPLETED|Overall Study||7
9972932|NCT01548768|11093993|FG001|COMPLETED|Overall Study||2
9972933|NCT01548768|11093994|FG002|COMPLETED|Overall Study||15
9972934|NCT01548768|11093995|FG003|COMPLETED|Overall Study||117
9972935|NCT01548768|11093992|FG000|NOT COMPLETED|Overall Study||1
9972936|NCT01548768|11093993|FG001|NOT COMPLETED|Overall Study||2
9972937|NCT01548768|11093994|FG002|NOT COMPLETED|Overall Study||1
9972938|NCT01548768|11093995|FG003|NOT COMPLETED|Overall Study||4
9972939|NCT01548833|11094007|FG000|STARTED|Overall Study||39
9972940|NCT01548833|11094007|FG000|COMPLETED|Overall Study||39
9972941|NCT01548833|11094007|FG000|NOT COMPLETED|Overall Study||0
9972942|NCT01548885|11094015|FG000|STARTED|Overall Study||146
9972943|NCT01548885|11094015|FG000|COMPLETED|Overall Study||146
9972944|NCT01548885|11094015|FG000|NOT COMPLETED|Overall Study||0
9972945|NCT01549002|11094021|FG000|STARTED|Overall Study||10
9972946|NCT01549002|11094022|FG001|STARTED|Overall Study||10
9972947|NCT01549002|11094021|FG000|COMPLETED|Overall Study||10
9972948|NCT01549002|11094022|FG001|COMPLETED|Overall Study||6
9972949|NCT01549002|11094021|FG000|NOT COMPLETED|Overall Study||0
9972950|NCT01549002|11094022|FG001|NOT COMPLETED|Overall Study||4
9972951|NCT01549041|11094030|FG000|STARTED|Overall Study||12
9972952|NCT01549041|11094031|FG001|STARTED|Overall Study||18
9972953|NCT01549041|11094030|FG000|COMPLETED|Overall Study||10
9972954|NCT01549041|11094031|FG001|COMPLETED|Overall Study||10
9972955|NCT01549041|11094030|FG000|NOT COMPLETED|Overall Study||2
9972956|NCT01549041|11094031|FG001|NOT COMPLETED|Overall Study||8
9972957|NCT01549223|11094039|FG000|STARTED|Overall Study||30
9972958|NCT01549223|11094040|FG001|STARTED|Overall Study||30
9972959|NCT01549223|11094039|FG000|COMPLETED|Overall Study||30
9972960|NCT01549223|11094040|FG001|COMPLETED|Overall Study||30
9972961|NCT01549223|11094039|FG000|NOT COMPLETED|Overall Study||0
9972962|NCT01549223|11094040|FG001|NOT COMPLETED|Overall Study||0
9972963|NCT01549275|11094048|FG000|STARTED|Overall Study||76
9972964|NCT01549275|11094049|FG001|STARTED|Overall Study||29
9972965|NCT01549275|11094048|FG000|COMPLETED|Overall Study||75
9972966|NCT01549275|11094049|FG001|COMPLETED|Overall Study||29
9972967|NCT01549275|11094048|FG000|NOT COMPLETED|Overall Study||1
9972968|NCT01549275|11094049|FG001|NOT COMPLETED|Overall Study||0
9972969|NCT01549314|11094062|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
9972970|NCT01549314|11094063|FG001|STARTED|Overall Study||26
9972971|NCT01549314|11094064|FG002|STARTED|Overall Study||26
9972972|NCT01549314|11094062|FG000|COMPLETED|Overall Study||23
9972973|NCT01549314|11094063|FG001|COMPLETED|Overall Study||21
9972974|NCT01549314|11094064|FG002|COMPLETED|Overall Study||24
9972975|NCT01549314|11094062|FG000|NOT COMPLETED|Overall Study||4
9972976|NCT01549314|11094063|FG001|NOT COMPLETED|Overall Study||5
9972977|NCT01549314|11094064|FG002|NOT COMPLETED|Overall Study||2
9972978|NCT01549340|11094072|FG000|STARTED|Overall Study|Advised to receive AIT|8790
9972979|NCT01549340|11094072|FG000|Started AIT|Overall Study||3182
9972980|NCT01549340|11094072|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385
9972981|NCT01549340|11094072|FG000|NOT COMPLETED|Overall Study||8405
9972982|NCT01549392|11094083|FG000|STARTED|Overall Study||3
9972983|NCT01549392|11094084|FG001|STARTED|Overall Study||0
10098161|NCT02380742|11227217|FG000|STARTED|Overall Study||28
10098162|NCT02380742|11227218|FG001|STARTED|Overall Study||26
10098163|NCT02380742|11227217|FG000|COMPLETED|Overall Study||27
10098164|NCT02380742|11227218|FG001|COMPLETED|Overall Study||26
10098165|NCT02380742|11227217|FG000|NOT COMPLETED|Overall Study||1
10098166|NCT02380742|11227218|FG001|NOT COMPLETED|Overall Study||0
10098167|NCT02380859|11227226|FG000|STARTED|Overall Study||19
10098168|NCT02380859|11227227|FG001|STARTED|Overall Study||13
10098169|NCT02380859|11227226|FG000|COMPLETED|Overall Study||17
10098170|NCT02380859|11227227|FG001|COMPLETED|Overall Study||13
10098171|NCT02380859|11227226|FG000|NOT COMPLETED|Overall Study||2
10098172|NCT02380859|11227227|FG001|NOT COMPLETED|Overall Study||0
10098173|NCT02381015|11227237|FG000|STARTED|Visit 1 - Enrollment||175
10098174|NCT02381015|11227238|FG001|STARTED|Visit 1 - Enrollment||175
10098175|NCT02381015|11227239|FG002|STARTED|Visit 1 - Enrollment||175
10098176|NCT02381015|11227240|FG003|STARTED|Visit 1 - Enrollment||175
10098177|NCT02381015|11227237|FG000|COMPLETED|Visit 1 - Enrollment||175
10098178|NCT02381015|11227238|FG001|COMPLETED|Visit 1 - Enrollment||173
10098179|NCT02381015|11227239|FG002|COMPLETED|Visit 1 - Enrollment||175
9972984|NCT01549392|11094083|FG000|COMPLETED|Overall Study||2
9972985|NCT01549392|11094084|FG001|COMPLETED|Overall Study||0
9972986|NCT01549392|11094083|FG000|NOT COMPLETED|Overall Study||1
9972987|NCT01549392|11094084|FG001|NOT COMPLETED|Overall Study||0
9972988|NCT01549405|11094092|FG000|STARTED|Overall Study||20
9972989|NCT01549405|11094093|FG001|STARTED|Overall Study||20
9972990|NCT01549405|11094092|FG000|COMPLETED|Overall Study||20
9972991|NCT01549405|11094093|FG001|COMPLETED|Overall Study||20
10098180|NCT02381015|11227240|FG003|COMPLETED|Visit 1 - Enrollment||172
10098181|NCT02381015|11227237|FG000|NOT COMPLETED|Visit 1 - Enrollment||0
10098182|NCT02381015|11227238|FG001|NOT COMPLETED|Visit 1 - Enrollment||2
10098183|NCT02381015|11227239|FG002|NOT COMPLETED|Visit 1 - Enrollment||0
10098184|NCT02381015|11227240|FG003|NOT COMPLETED|Visit 1 - Enrollment||3
9972992|NCT01549405|11094092|FG000|NOT COMPLETED|Overall Study||0
9972993|NCT01549405|11094093|FG001|NOT COMPLETED|Overall Study||0
9972994|NCT01549587|11094103|FG000|STARTED|Overall Study||373
9972995|NCT01549587|11094104|FG001|STARTED|Overall Study||373
9972996|NCT01549587|11094103|FG000|COMPLETED|Overall Study||334
9972997|NCT01549587|11094104|FG001|COMPLETED|Overall Study||336
9972998|NCT01549587|11094103|FG000|NOT COMPLETED|Overall Study||39
9972999|NCT01549587|11094104|FG001|NOT COMPLETED|Overall Study||37
9973000|NCT01549613|11094112|FG000|STARTED|Overall Study||50
9973001|NCT01549613|11094113|FG001|STARTED|Overall Study||50
9973002|NCT01549613|11094112|FG000|COMPLETED|Overall Study||39
9973003|NCT01549613|11094113|FG001|COMPLETED|Overall Study||39
9973004|NCT01549613|11094112|FG000|NOT COMPLETED|Overall Study||11
9973005|NCT01549613|11094113|FG001|NOT COMPLETED|Overall Study||11
9973006|NCT01549652|11094122|FG000|STARTED|Overall Study||27
9973007|NCT01549652|11094123|FG001|STARTED|Overall Study||30
9973008|NCT01549652|11094124|FG002|STARTED|Overall Study||40
9973009|NCT01549652|11094125|FG003|STARTED|Overall Study||36
9973010|NCT01549652|11094122|FG000|COMPLETED|Overall Study||15
9973011|NCT01549652|11094123|FG001|COMPLETED|Overall Study||18
9973012|NCT01549652|11094124|FG002|COMPLETED|Overall Study||23
9973013|NCT01549652|11094125|FG003|COMPLETED|Overall Study||25
9973014|NCT01549652|11094122|FG000|NOT COMPLETED|Overall Study||12
9973015|NCT01549652|11094123|FG001|NOT COMPLETED|Overall Study||12
9973016|NCT01549652|11094124|FG002|NOT COMPLETED|Overall Study||17
9973017|NCT01549652|11094125|FG003|NOT COMPLETED|Overall Study||11
9973018|NCT01549860|11094133|FG000|STARTED|Overall Study||40
9973019|NCT01549860|11094134|FG001|STARTED|Overall Study||41
9973020|NCT01549860|11094133|FG000|COMPLETED|Overall Study||38
9973021|NCT01549860|11094134|FG001|COMPLETED|Overall Study||40
9973022|NCT01549860|11094133|FG000|NOT COMPLETED|Overall Study||2
9973023|NCT01549860|11094134|FG001|NOT COMPLETED|Overall Study||1
9973024|NCT01549873|11094142|FG000|STARTED|Overall Study||15
9973025|NCT01549873|11094143|FG001|STARTED|Overall Study||15
9973026|NCT01549873|11094142|FG000|COMPLETED|Overall Study||15
9973027|NCT01549873|11094143|FG001|COMPLETED|Overall Study||14
9973028|NCT01549873|11094142|FG000|NOT COMPLETED|Overall Study||0
9973029|NCT01549873|11094143|FG001|NOT COMPLETED|Overall Study||1
9973030|NCT01549886|11094151|FG000|STARTED|Overall Study||2
9973031|NCT01549886|11094152|FG001|STARTED|Overall Study||3
9973032|NCT01549886|11094151|FG000|COMPLETED|Overall Study||0
9973033|NCT01549886|11094152|FG001|COMPLETED|Overall Study||0
9973034|NCT01549886|11094151|FG000|NOT COMPLETED|Overall Study||2
9973035|NCT01549886|11094152|FG001|NOT COMPLETED|Overall Study||3
9973036|NCT01549925|11094162|FG000|STARTED|Overall Study||25
9973037|NCT01549925|11094163|FG001|STARTED|Overall Study||25
9973038|NCT01549925|11094162|FG000|COMPLETED|Overall Study||25
9973039|NCT01549925|11094163|FG001|COMPLETED|Overall Study||25
9973040|NCT01549925|11094162|FG000|NOT COMPLETED|Overall Study||0
9973041|NCT01549925|11094163|FG001|NOT COMPLETED|Overall Study||0
10017693|NCT01818414|11140623|FG000|COMPLETED|Overall Study||14
10017694|NCT01818414|11140624|FG001|COMPLETED|Overall Study||15
10017695|NCT01818414|11140623|FG000|NOT COMPLETED|Overall Study||0
10017696|NCT01818414|11140624|FG001|NOT COMPLETED|Overall Study||0
10017697|NCT01818427|11140634|FG000|STARTED|Overall Study||239
10017698|NCT01818427|11140635|FG001|STARTED|Overall Study||284
10017699|NCT01818427|11140634|FG000|COMPLETED|Overall Study||230
10017700|NCT01818427|11140635|FG001|COMPLETED|Overall Study||271
10017701|NCT01818427|11140634|FG000|NOT COMPLETED|Overall Study||9
10017702|NCT01818427|11140635|FG001|NOT COMPLETED|Overall Study||13
10017703|NCT01818492|11140641|FG000|STARTED|Overall Study||45
10017704|NCT01818492|11140641|FG000|COMPLETED|Overall Study||35
10017705|NCT01818492|11140641|FG000|NOT COMPLETED|Overall Study||10
10017706|NCT01818518|11140652|FG000|STARTED|Overall Study||310
10017707|NCT01818518|11140653|FG001|STARTED|Overall Study||263
10017708|NCT01818518|11140654|FG002|STARTED|Overall Study||288
10017709|NCT01818518|11140655|FG003|STARTED|Overall Study||59
10017710|NCT01818518|11140656|FG004|STARTED|Overall Study||38
10017711|NCT01818518|11140657|FG005|STARTED|Overall Study||37
10017712|NCT01818518|11140652|FG000|COMPLETED|Overall Study||310
10017713|NCT01818518|11140653|FG001|COMPLETED|Overall Study||263
10017714|NCT01818518|11140654|FG002|COMPLETED|Overall Study||288
10017715|NCT01818518|11140655|FG003|COMPLETED|Overall Study||59
10017716|NCT01818518|11140656|FG004|COMPLETED|Overall Study||38
10017717|NCT01818518|11140657|FG005|COMPLETED|Overall Study||37
10017718|NCT01818518|11140652|FG000|NOT COMPLETED|Overall Study||0
10017719|NCT01818518|11140653|FG001|NOT COMPLETED|Overall Study||0
10017720|NCT01818518|11140654|FG002|NOT COMPLETED|Overall Study||0
10017721|NCT01818518|11140655|FG003|NOT COMPLETED|Overall Study||0
10017722|NCT01818518|11140656|FG004|NOT COMPLETED|Overall Study||0
10017723|NCT01818518|11140657|FG005|NOT COMPLETED|Overall Study||0
10017724|NCT01818531|11140673|FG000|STARTED|Overall Study||75
10017725|NCT01818531|11140674|FG001|STARTED|Overall Study||75
10017726|NCT01818531|11140673|FG000|COMPLETED|Overall Study||74
10017727|NCT01818531|11140674|FG001|COMPLETED|Overall Study||73
10017728|NCT01818531|11140673|FG000|NOT COMPLETED|Overall Study||1
10017729|NCT01818531|11140674|FG001|NOT COMPLETED|Overall Study||2
10017730|NCT01818596|11140682|FG000|STARTED|Overall Study||246
10017731|NCT01818596|11140683|FG001|STARTED|Overall Study||6
10017732|NCT01818596|11140682|FG000|COMPLETED|Overall Study||215
10017733|NCT01818596|11140683|FG001|COMPLETED|Overall Study||6
10017734|NCT01818596|11140682|FG000|NOT COMPLETED|Overall Study||31
10017735|NCT01818596|11140683|FG001|NOT COMPLETED|Overall Study||0
10017736|NCT01818700|11140690|FG000|STARTED|Overall Study|The No. of enrolled patients|245
10017737|NCT01818700|11140690|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241
9973042|NCT01549951|11094169|FG000|STARTED|Overall Study||50
9973043|NCT01549951|11094169|FG000|Primary Reason Off Study Treatment|Overall Study||50
9973044|NCT01549951|11094169|FG000|COMPLETED|Overall Study||0
9973045|NCT01549951|11094169|FG000|NOT COMPLETED|Overall Study||50
9973046|NCT01549964|11094177|FG000|STARTED|24-Week Treatment Period||132
9973047|NCT01549964|11094178|FG001|STARTED|24-Week Treatment Period||260
9973048|NCT01549964|11094179|FG002|STARTED|24-Week Treatment Period||263
9973049|NCT01549964|11094180|FG003|STARTED|24-Week Treatment Period||261
9973050|NCT01549964|11094177|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
9973051|NCT01549964|11094178|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
9973052|NCT01549964|11094179|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
9973053|NCT01549964|11094180|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
9973054|NCT01549964|11094177|FG000|COMPLETED|24-Week Treatment Period||71
9973055|NCT01549964|11094178|FG001|COMPLETED|24-Week Treatment Period||149
9973056|NCT01549964|11094179|FG002|COMPLETED|24-Week Treatment Period||147
9973057|NCT01549964|11094180|FG003|COMPLETED|24-Week Treatment Period||140
9973058|NCT01549964|11094177|FG000|NOT COMPLETED|24-Week Treatment Period||61
9973059|NCT01549964|11094178|FG001|NOT COMPLETED|24-Week Treatment Period||111
9973060|NCT01549964|11094179|FG002|NOT COMPLETED|24-Week Treatment Period||116
9973061|NCT01549964|11094180|FG003|NOT COMPLETED|24-Week Treatment Period||121
9973062|NCT01549964|11094177|FG000|STARTED|80-Week Extension Period||66
9973063|NCT01549964|11094178|FG001|STARTED|80-Week Extension Period||138
9973064|NCT01549964|11094179|FG002|STARTED|80-Week Extension Period||140
9973065|NCT01549964|11094180|FG003|STARTED|80-Week Extension Period||137
9973066|NCT01549964|11094177|FG000|COMPLETED|80-Week Extension Period||0
9973067|NCT01549964|11094178|FG001|COMPLETED|80-Week Extension Period||0
9973068|NCT01549964|11094179|FG002|COMPLETED|80-Week Extension Period||0
9973069|NCT01549964|11094180|FG003|COMPLETED|80-Week Extension Period||0
9973070|NCT01549964|11094177|FG000|NOT COMPLETED|80-Week Extension Period||66
9973071|NCT01549964|11094178|FG001|NOT COMPLETED|80-Week Extension Period||138
10098185|NCT02381015|11227237|FG000|STARTED|Visit 2 - Results DIsclosure||175
10098186|NCT02381015|11227238|FG001|STARTED|Visit 2 - Results DIsclosure||173
10098187|NCT02381015|11227239|FG002|STARTED|Visit 2 - Results DIsclosure||175
10098188|NCT02381015|11227240|FG003|STARTED|Visit 2 - Results DIsclosure||172
10098189|NCT02381015|11227237|FG000|COMPLETED|Visit 2 - Results DIsclosure||172
10098190|NCT02381015|11227238|FG001|COMPLETED|Visit 2 - Results DIsclosure||168
9973072|NCT01549964|11094179|FG002|NOT COMPLETED|80-Week Extension Period||140
9973073|NCT01549964|11094180|FG003|NOT COMPLETED|80-Week Extension Period||137
9973074|NCT01550224|11094192|FG000|STARTED|Overall Study||3
9973075|NCT01550224|11094193|FG001|STARTED|Overall Study||20
9973076|NCT01550224|11094192|FG000|COMPLETED|Overall Study||3
9973077|NCT01550224|11094193|FG001|COMPLETED|Overall Study||20
9973078|NCT01550224|11094192|FG000|NOT COMPLETED|Overall Study||0
9973079|NCT01550224|11094193|FG001|NOT COMPLETED|Overall Study||0
9973080|NCT01550341|11094201|FG000|STARTED|Overall Study||32
9973081|NCT01550341|11094202|FG001|STARTED|Overall Study||18
9973082|NCT01550341|11094201|FG000|COMPLETED|Overall Study||32
9973083|NCT01550341|11094202|FG001|COMPLETED|Overall Study||18
9973084|NCT01550341|11094201|FG000|NOT COMPLETED|Overall Study||0
9973085|NCT01550341|11094202|FG001|NOT COMPLETED|Overall Study||0
9973086|NCT01550367|11094208|FG000|STARTED|Overall Study||30
9973087|NCT01550367|11094208|FG000|1200 mg/d HCQ|Overall Study||13
9973088|NCT01550367|11094208|FG000|600 mg/d HCQ|Overall Study||17
9973089|NCT01550367|11094208|FG000|COMPLETED|Overall Study||30
9973090|NCT01550367|11094208|FG000|NOT COMPLETED|Overall Study||0
9973091|NCT01550471|11094217|FG000|STARTED|Run-In Period (3 Weeks)||3
9973092|NCT01550471|11094218|FG001|STARTED|Run-In Period (3 Weeks)||4
9973093|NCT01550471|11094219|FG002|STARTED|Run-In Period (3 Weeks)||3
9973094|NCT01550471|11094220|FG003|STARTED|Run-In Period (3 Weeks)||4
9973095|NCT01550471|11094221|FG004|STARTED|Run-In Period (3 Weeks)||4
10098191|NCT02381015|11227239|FG002|COMPLETED|Visit 2 - Results DIsclosure||173
10098192|NCT02381015|11227240|FG003|COMPLETED|Visit 2 - Results DIsclosure||169
10098193|NCT02381015|11227237|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3
10098194|NCT02381015|11227238|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5
10098195|NCT02381015|11227239|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2
10098196|NCT02381015|11227240|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3
10098197|NCT02381015|11227237|FG000|STARTED|Visit 3 - 3 Months Followup||172
9973096|NCT01550471|11094222|FG005|STARTED|Run-In Period (3 Weeks)||4
9973097|NCT01550471|11094217|FG000|COMPLETED|Run-In Period (3 Weeks)||3
10098198|NCT02381015|11227238|FG001|STARTED|Visit 3 - 3 Months Followup||168
10098199|NCT02381015|11227239|FG002|STARTED|Visit 3 - 3 Months Followup||173
10098200|NCT02381015|11227240|FG003|STARTED|Visit 3 - 3 Months Followup||169
10098201|NCT02381015|11227237|FG000|COMPLETED|Visit 3 - 3 Months Followup||172
10098202|NCT02381015|11227238|FG001|COMPLETED|Visit 3 - 3 Months Followup||168
9973098|NCT01550471|11094218|FG001|COMPLETED|Run-In Period (3 Weeks)||4
9973099|NCT01550471|11094219|FG002|COMPLETED|Run-In Period (3 Weeks)||3
9973100|NCT01550471|11094220|FG003|COMPLETED|Run-In Period (3 Weeks)||4
9973101|NCT01550471|11094221|FG004|COMPLETED|Run-In Period (3 Weeks)||4
9973102|NCT01550471|11094222|FG005|COMPLETED|Run-In Period (3 Weeks)||4
9973103|NCT01550471|11094217|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0
9973104|NCT01550471|11094218|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0
9973105|NCT01550471|11094219|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0
9973106|NCT01550471|11094220|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0
9973107|NCT01550471|11094221|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0
9973108|NCT01550471|11094222|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0
9973109|NCT01550471|11094217|FG000|STARTED|First Treatment Period (3 Weeks)||3
9973110|NCT01550471|11094218|FG001|STARTED|First Treatment Period (3 Weeks)||4
9973111|NCT01550471|11094219|FG002|STARTED|First Treatment Period (3 Weeks)||3
9973112|NCT01550471|11094220|FG003|STARTED|First Treatment Period (3 Weeks)||4
9973113|NCT01550471|11094221|FG004|STARTED|First Treatment Period (3 Weeks)||4
9973114|NCT01550471|11094222|FG005|STARTED|First Treatment Period (3 Weeks)||4
9973115|NCT01550471|11094217|FG000|COMPLETED|First Treatment Period (3 Weeks)||3
9973116|NCT01550471|11094218|FG001|COMPLETED|First Treatment Period (3 Weeks)||4
9973117|NCT01550471|11094219|FG002|COMPLETED|First Treatment Period (3 Weeks)||3
9973118|NCT01550471|11094220|FG003|COMPLETED|First Treatment Period (3 Weeks)||4
9973119|NCT01550471|11094221|FG004|COMPLETED|First Treatment Period (3 Weeks)||4
9973120|NCT01550471|11094222|FG005|COMPLETED|First Treatment Period (3 Weeks)||4
9973121|NCT01550471|11094217|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0
9973122|NCT01550471|11094218|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0
9973123|NCT01550471|11094219|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0
9973124|NCT01550471|11094220|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0
9973125|NCT01550471|11094221|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0
9973126|NCT01550471|11094222|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0
9973127|NCT01550471|11094217|FG000|STARTED|First Wash Out Period (3 Weeks)||3
9973128|NCT01550471|11094218|FG001|STARTED|First Wash Out Period (3 Weeks)||4
9973129|NCT01550471|11094219|FG002|STARTED|First Wash Out Period (3 Weeks)||3
9973130|NCT01550471|11094220|FG003|STARTED|First Wash Out Period (3 Weeks)||4
9973131|NCT01550471|11094221|FG004|STARTED|First Wash Out Period (3 Weeks)||4
9973132|NCT01550471|11094222|FG005|STARTED|First Wash Out Period (3 Weeks)||4
9973133|NCT01550471|11094217|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3
9973134|NCT01550471|11094218|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4
9973135|NCT01550471|11094219|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3
9973136|NCT01550471|11094220|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4
9973137|NCT01550471|11094221|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4
9973138|NCT01550471|11094222|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4
9973139|NCT01550471|11094217|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
9973140|NCT01550471|11094218|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
9973141|NCT01550471|11094219|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
9973142|NCT01550471|11094220|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
9973143|NCT01550471|11094221|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
9973144|NCT01550471|11094222|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
9973145|NCT01550471|11094217|FG000|STARTED|Second Treatment Period (3 Weeks)||3
9973146|NCT01550471|11094218|FG001|STARTED|Second Treatment Period (3 Weeks)||4
9973147|NCT01550471|11094219|FG002|STARTED|Second Treatment Period (3 Weeks)||3
9973148|NCT01550471|11094220|FG003|STARTED|Second Treatment Period (3 Weeks)||4
9973149|NCT01550471|11094221|FG004|STARTED|Second Treatment Period (3 Weeks)||4
9973150|NCT01550471|11094222|FG005|STARTED|Second Treatment Period (3 Weeks)||4
9973151|NCT01550471|11094217|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3
9973152|NCT01550471|11094218|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4
9973153|NCT01550471|11094219|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3
10098203|NCT02381015|11227239|FG002|COMPLETED|Visit 3 - 3 Months Followup||173
10098204|NCT02381015|11227240|FG003|COMPLETED|Visit 3 - 3 Months Followup||169
10098205|NCT02381015|11227237|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10098206|NCT02381015|11227238|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10098207|NCT02381015|11227239|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10098208|NCT02381015|11227240|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10098209|NCT02381015|11227237|FG000|STARTED|Year 3 Chart Review||172
10098210|NCT02381015|11227238|FG001|STARTED|Year 3 Chart Review||168
10098211|NCT02381015|11227239|FG002|STARTED|Year 3 Chart Review||173
10098212|NCT02381015|11227240|FG003|STARTED|Year 3 Chart Review||169
10098213|NCT02381015|11227237|FG000|COMPLETED|Year 3 Chart Review||125
10098214|NCT02381015|11227238|FG001|COMPLETED|Year 3 Chart Review||134
10098215|NCT02381015|11227239|FG002|COMPLETED|Year 3 Chart Review||115
10098216|NCT02381015|11227240|FG003|COMPLETED|Year 3 Chart Review||118
10098217|NCT02381015|11227237|FG000|NOT COMPLETED|Year 3 Chart Review||47
10098218|NCT02381015|11227238|FG001|NOT COMPLETED|Year 3 Chart Review||34
10098219|NCT02381015|11227239|FG002|NOT COMPLETED|Year 3 Chart Review||58
10098220|NCT02381015|11227240|FG003|NOT COMPLETED|Year 3 Chart Review||51
10098221|NCT02381288|11227259|FG000|STARTED|Overall Study||5
10098222|NCT02381288|11227260|FG001|STARTED|Overall Study||2
10098223|NCT02381288|11227261|FG002|STARTED|Overall Study||5
10098224|NCT02381288|11227262|FG003|STARTED|Overall Study||5
10098225|NCT02381288|11227259|FG000|COMPLETED|Overall Study||5
10098226|NCT02381288|11227260|FG001|COMPLETED|Overall Study||2
10098227|NCT02381288|11227261|FG002|COMPLETED|Overall Study||5
10098228|NCT02381288|11227262|FG003|COMPLETED|Overall Study||5
9973154|NCT01550471|11094220|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4
9973155|NCT01550471|11094221|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4
9973156|NCT01550471|11094222|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4
9973157|NCT01550471|11094217|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
9973158|NCT01550471|11094218|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
9973159|NCT01550471|11094219|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
10098229|NCT02381288|11227259|FG000|NOT COMPLETED|Overall Study||0
10098230|NCT02381288|11227260|FG001|NOT COMPLETED|Overall Study||0
9973160|NCT01550471|11094220|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
9973161|NCT01550471|11094221|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
9973162|NCT01550471|11094222|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
9973163|NCT01550471|11094217|FG000|STARTED|Second Wash Out Period (3 Weeks)||3
9973164|NCT01550471|11094218|FG001|STARTED|Second Wash Out Period (3 Weeks)||4
9973165|NCT01550471|11094219|FG002|STARTED|Second Wash Out Period (3 Weeks)||3
9973166|NCT01550471|11094220|FG003|STARTED|Second Wash Out Period (3 Weeks)||4
9973167|NCT01550471|11094221|FG004|STARTED|Second Wash Out Period (3 Weeks)||4
9973168|NCT01550471|11094222|FG005|STARTED|Second Wash Out Period (3 Weeks)||4
9973169|NCT01550471|11094217|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3
9973170|NCT01550471|11094218|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4
9973171|NCT01550471|11094219|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3
9973172|NCT01550471|11094220|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4
9973173|NCT01550471|11094221|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4
9973174|NCT01550471|11094222|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3
9973175|NCT01550471|11094217|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
9973176|NCT01550471|11094218|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
9973177|NCT01550471|11094219|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
9973178|NCT01550471|11094220|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
9973179|NCT01550471|11094221|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
9973180|NCT01550471|11094222|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
9973181|NCT01550471|11094217|FG000|STARTED|Third Treatment Period (3 Weeks)||3
9973182|NCT01550471|11094218|FG001|STARTED|Third Treatment Period (3 Weeks)||4
9973183|NCT01550471|11094219|FG002|STARTED|Third Treatment Period (3 Weeks)||3
9973184|NCT01550471|11094220|FG003|STARTED|Third Treatment Period (3 Weeks)||4
9973185|NCT01550471|11094221|FG004|STARTED|Third Treatment Period (3 Weeks)||4
9973186|NCT01550471|11094222|FG005|STARTED|Third Treatment Period (3 Weeks)||3
9973187|NCT01550471|11094217|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3
9973188|NCT01550471|11094218|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4
9973189|NCT01550471|11094219|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3
9973190|NCT01550471|11094220|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4
9973191|NCT01550471|11094221|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4
9973192|NCT01550471|11094222|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3
9973193|NCT01550471|11094217|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
9973194|NCT01550471|11094218|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
9973195|NCT01550471|11094219|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
9973196|NCT01550471|11094220|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
9973197|NCT01550471|11094221|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
9973198|NCT01550471|11094222|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
9973199|NCT01550471|11094217|FG000|STARTED|Third Wash Out Period (3 Weeks)||3
9973200|NCT01550471|11094218|FG001|STARTED|Third Wash Out Period (3 Weeks)||4
9973201|NCT01550471|11094219|FG002|STARTED|Third Wash Out Period (3 Weeks)||3
9973202|NCT01550471|11094220|FG003|STARTED|Third Wash Out Period (3 Weeks)||4
10098231|NCT02381288|11227261|FG002|NOT COMPLETED|Overall Study||0
10098232|NCT02381288|11227262|FG003|NOT COMPLETED|Overall Study||0
10098233|NCT02381392|11227277|FG000|STARTED|Overall Study||11
10098234|NCT02381392|11227278|FG001|STARTED|Overall Study||12
10098235|NCT02381392|11227277|FG000|COMPLETED|Overall Study||11
10098236|NCT02381392|11227278|FG001|COMPLETED|Overall Study||12
10098237|NCT02381392|11227277|FG000|NOT COMPLETED|Overall Study||0
10098238|NCT02381392|11227278|FG001|NOT COMPLETED|Overall Study||0
10098239|NCT02381418|11227284|FG000|STARTED|Overall Study||120
9973203|NCT01550471|11094221|FG004|STARTED|Third Wash Out Period (3 Weeks)||4
9973204|NCT01550471|11094222|FG005|STARTED|Third Wash Out Period (3 Weeks)||3
9973205|NCT01550471|11094217|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3
9973206|NCT01550471|11094218|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4
9973207|NCT01550471|11094219|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3
9973208|NCT01550471|11094220|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4
9973209|NCT01550471|11094221|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4
9973210|NCT01550471|11094222|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3
9973211|NCT01550471|11094217|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
9973212|NCT01550471|11094218|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
9973213|NCT01550471|11094219|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
9973214|NCT01550471|11094220|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
9973215|NCT01550471|11094221|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
9973216|NCT01550471|11094222|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
9973217|NCT01550549|11094231|FG000|STARTED|Overall Study||151
9973218|NCT01550549|11094231|FG000|COMPLETED|Overall Study||151
9973219|NCT01550549|11094231|FG000|NOT COMPLETED|Overall Study||0
9973220|NCT01550705|11094241|FG000|STARTED|Overall Study||11
9973221|NCT01550705|11094241|FG000|COMPLETED|Overall Study||10
9973222|NCT01550705|11094241|FG000|NOT COMPLETED|Overall Study||1
10098240|NCT02381418|11227284|FG000|COMPLETED|Overall Study||120
9973223|NCT01550731|11094247|FG000|STARTED|Overall Study||205
9973224|NCT01550731|11094248|FG001|STARTED|Overall Study||209
9973225|NCT01550731|11094247|FG000|COMPLETED|Overall Study||205
9973226|NCT01550731|11094248|FG001|COMPLETED|Overall Study||209
9973227|NCT01550731|11094247|FG000|NOT COMPLETED|Overall Study||0
9973228|NCT01550731|11094248|FG001|NOT COMPLETED|Overall Study||0
9973229|NCT01550744|11094254|FG000|STARTED|Open-Label||478
10098241|NCT02381418|11227284|FG000|NOT COMPLETED|Overall Study||0
9973230|NCT01550744|11094255|FG001|STARTED|Open-Label||0
9973231|NCT01550744|11094256|FG002|STARTED|Open-Label||0
9973232|NCT01550744|11094254|FG000|COMPLETED|Open-Label||378
9973233|NCT01550744|11094255|FG001|COMPLETED|Open-Label||0
9973234|NCT01550744|11094256|FG002|COMPLETED|Open-Label||0
9973235|NCT01550744|11094254|FG000|NOT COMPLETED|Open-Label||100
9973236|NCT01550744|11094255|FG001|NOT COMPLETED|Open-Label||0
9973237|NCT01550744|11094256|FG002|NOT COMPLETED|Open-Label||0
9973238|NCT01550744|11094254|FG000|STARTED|Double-Blind||0
9973239|NCT01550744|11094255|FG001|STARTED|Double-Blind||76
9973240|NCT01550744|11094256|FG002|STARTED|Double-Blind||302
9973241|NCT01550744|11094254|FG000|COMPLETED|Double-Blind||0
9973242|NCT01550744|11094255|FG001|COMPLETED|Double-Blind||59
9973243|NCT01550744|11094256|FG002|COMPLETED|Double-Blind||235
9973244|NCT01550744|11094254|FG000|NOT COMPLETED|Double-Blind||0
9973245|NCT01550744|11094255|FG001|NOT COMPLETED|Double-Blind||17
9973246|NCT01550744|11094256|FG002|NOT COMPLETED|Double-Blind||67
9973247|NCT01550757|11094267|FG000|STARTED|Overall Study||56
9973248|NCT01550757|11094268|FG001|STARTED|Overall Study||52
9973249|NCT01550757|11094269|FG002|STARTED|Overall Study||130
9973250|NCT01550757|11094270|FG003|STARTED|Overall Study||144
9973251|NCT01550757|11094267|FG000|COMPLETED|Overall Study||33
9973252|NCT01550757|11094268|FG001|COMPLETED|Overall Study||38
9973253|NCT01550757|11094269|FG002|COMPLETED|Overall Study||85
9973254|NCT01550757|11094270|FG003|COMPLETED|Overall Study||90
9973255|NCT01550757|11094267|FG000|NOT COMPLETED|Overall Study||23
9973256|NCT01550757|11094268|FG001|NOT COMPLETED|Overall Study||14
9973257|NCT01550757|11094269|FG002|NOT COMPLETED|Overall Study||45
9973258|NCT01550757|11094270|FG003|NOT COMPLETED|Overall Study||54
9973259|NCT01550809|11094282|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
9973260|NCT01550809|11094283|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
9973261|NCT01550809|11094282|FG000|COMPLETED|Overall Study||6
9973262|NCT01550809|11094283|FG001|COMPLETED|Overall Study||6
9973263|NCT01550809|11094282|FG000|NOT COMPLETED|Overall Study||0
9973264|NCT01550809|11094283|FG001|NOT COMPLETED|Overall Study||0
9973265|NCT01550952|11094289|FG000|STARTED|Overall Study||10
9973266|NCT01550952|11094289|FG000|COMPLETED|Overall Study||10
9973267|NCT01550952|11094289|FG000|NOT COMPLETED|Overall Study||0
9973268|NCT01550965|11094293|FG000|STARTED|Overall Study||463
9973269|NCT01550965|11094293|FG000|COMPLETED|Overall Study||353
9973270|NCT01550965|11094293|FG000|NOT COMPLETED|Overall Study||110
9973271|NCT01551030|11094298|FG000|STARTED|Overall Study||19
9973272|NCT01551030|11094298|FG000|COMPLETED|Overall Study||19
9973273|NCT01551030|11094298|FG000|NOT COMPLETED|Overall Study||0
9973274|NCT01551056|11094304|FG000|STARTED|Overall Study||46
9973275|NCT01551056|11094305|FG001|STARTED|Overall Study||45
9973276|NCT01551056|11094304|FG000|COMPLETED|Overall Study||44
9973277|NCT01551056|11094305|FG001|COMPLETED|Overall Study||45
9973278|NCT01551056|11094304|FG000|NOT COMPLETED|Overall Study||2
9973279|NCT01551056|11094305|FG001|NOT COMPLETED|Overall Study||0
9973280|NCT01551095|11094311|FG000|STARTED|Overall Study||7
9973281|NCT01551095|11094311|FG000|COMPLETED|Overall Study||7
9973282|NCT01551095|11094311|FG000|NOT COMPLETED|Overall Study||0
9973283|NCT01551173|11094317|FG000|STARTED|Overall Study|"Started indicates randomized"|218
9973284|NCT01551173|11094318|FG001|STARTED|Overall Study||218
9973285|NCT01551173|11094317|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
9973286|NCT01551173|11094318|FG001|Full Analysis Set (FAS)|Overall Study||214
9973287|NCT01551173|11094317|FG000|COMPLETED|Overall Study||190
9973288|NCT01551173|11094318|FG001|COMPLETED|Overall Study||186
9973289|NCT01551173|11094317|FG000|NOT COMPLETED|Overall Study||28
9973290|NCT01551173|11094318|FG001|NOT COMPLETED|Overall Study||32
9973291|NCT01551186|11094327|FG000|STARTED|Overall Study||50
9973292|NCT01551186|11094328|FG001|STARTED|Overall Study||53
9973293|NCT01551186|11094327|FG000|COMPLETED|Overall Study||30
9973294|NCT01551186|11094328|FG001|COMPLETED|Overall Study||40
9973295|NCT01551186|11094327|FG000|NOT COMPLETED|Overall Study||20
9973296|NCT01551186|11094328|FG001|NOT COMPLETED|Overall Study||13
9973297|NCT01551199|11094334|FG000|STARTED|Overall Study||7
9973298|NCT01551199|11094334|FG000|COMPLETED|Overall Study||2
9973299|NCT01551199|11094334|FG000|NOT COMPLETED|Overall Study||5
9973300|NCT01551212|11094340|FG000|STARTED|Overall Study||171
9973301|NCT01551212|11094341|FG001|STARTED|Overall Study||168
9973302|NCT01551212|11094340|FG000|Full Anylsis Set (FAS)|Overall Study||169
9973303|NCT01551212|11094341|FG001|Full Anylsis Set (FAS)|Overall Study||164
9973304|NCT01551212|11094340|FG000|Safety Set|Overall Study||169
9973305|NCT01551212|11094341|FG001|Safety Set|Overall Study||164
9973306|NCT01551212|11094340|FG000|Per Protocol Set (PP)|Overall Study||110
9973307|NCT01551212|11094341|FG001|Per Protocol Set (PP)|Overall Study||101
9973308|NCT01551212|11094340|FG000|COMPLETED|Overall Study||166
9973309|NCT01551212|11094341|FG001|COMPLETED|Overall Study||148
9973310|NCT01551212|11094340|FG000|NOT COMPLETED|Overall Study||5
9973311|NCT01551212|11094341|FG001|NOT COMPLETED|Overall Study||20
9973312|NCT01551264|11094349|FG000|STARTED|Overall Study||70
9973313|NCT01551264|11094350|FG001|STARTED|Overall Study||69
9973314|NCT01551264|11094349|FG000|Started Bracing|Overall Study||69
9973315|NCT01551264|11094350|FG001|Started Bracing|Overall Study||67
9973316|NCT01551264|11094349|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44
9973317|NCT01551264|11094350|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55
9973318|NCT01551264|11094349|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38
9973319|NCT01551264|11094350|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41
9973320|NCT01551264|11094349|FG000|NOT COMPLETED|Overall Study||32
9973321|NCT01551264|11094350|FG001|NOT COMPLETED|Overall Study||28
9973322|NCT01551303|11094358|FG000|STARTED|Overall Study||25
9973323|NCT01551303|11094359|FG001|STARTED|Overall Study||22
9973324|NCT01551303|11094358|FG000|COMPLETED|Overall Study||21
9973325|NCT01551303|11094359|FG001|COMPLETED|Overall Study||15
9973326|NCT01551303|11094358|FG000|NOT COMPLETED|Overall Study||4
9973327|NCT01551303|11094359|FG001|NOT COMPLETED|Overall Study||7
9973328|NCT01551355|11094371|FG000|STARTED|Overall Study||622
9973329|NCT01551355|11094372|FG001|STARTED|Overall Study||594
10098242|NCT02381678|11227289|FG000|STARTED|Overall Study||54
10098243|NCT02381678|11227290|FG001|STARTED|Overall Study||139
10098244|NCT02381678|11227291|FG002|STARTED|Overall Study||32
10098245|NCT02381678|11227289|FG000|COMPLETED|Overall Study||54
10098246|NCT02381678|11227290|FG001|COMPLETED|Overall Study||139
10098247|NCT02381678|11227291|FG002|COMPLETED|Overall Study||32
10098248|NCT02381678|11227289|FG000|NOT COMPLETED|Overall Study||0
10098249|NCT02381678|11227290|FG001|NOT COMPLETED|Overall Study||0
10098250|NCT02381678|11227291|FG002|NOT COMPLETED|Overall Study||0
10098251|NCT02381795|11227297|FG000|STARTED|Overall Study||10
10098252|NCT02381795|11227297|FG000|COMPLETED|Overall Study||7
10098253|NCT02381795|11227297|FG000|NOT COMPLETED|Overall Study||3
10113078|NCT02508103|11243998|FG001|COMPLETED|Overall Study||5
10113079|NCT02508103|11243997|FG000|NOT COMPLETED|Overall Study||0
10113080|NCT02508103|11243998|FG001|NOT COMPLETED|Overall Study||0
10113081|NCT02508116|11244006|FG000|STARTED|Overall Study||252
10113082|NCT02508116|11244007|FG001|STARTED|Overall Study||257
10113083|NCT02508116|11244006|FG000|Received Intervention as Randomized|Overall Study||249
10113084|NCT02508116|11244007|FG001|Received Intervention as Randomized|Overall Study||255
10113085|NCT02508116|11244006|FG000|COMPLETED|Overall Study||244
10113086|NCT02508116|11244007|FG001|COMPLETED|Overall Study||250
10113087|NCT02508116|11244006|FG000|NOT COMPLETED|Overall Study||8
10113088|NCT02508116|11244007|FG001|NOT COMPLETED|Overall Study||7
10113089|NCT02508194|11244015|FG000|STARTED|Overall Study||949
10113090|NCT02508194|11244016|FG001|STARTED|Overall Study||951
10113091|NCT02508194|11244015|FG000|COMPLETED|Overall Study||897
10113092|NCT02508194|11244016|FG001|COMPLETED|Overall Study||907
10113093|NCT02508194|11244015|FG000|NOT COMPLETED|Overall Study||52
10113094|NCT02508194|11244016|FG001|NOT COMPLETED|Overall Study||44
10113095|NCT02508207|11244024|FG000|STARTED|Overall Study||7
10113096|NCT02508207|11244025|FG001|STARTED|Overall Study||27
10113097|NCT02508207|11244024|FG000|COMPLETED|Overall Study||7
10113098|NCT02508207|11244025|FG001|COMPLETED|Overall Study||27
10113099|NCT02508207|11244024|FG000|NOT COMPLETED|Overall Study||0
10113100|NCT02508207|11244025|FG001|NOT COMPLETED|Overall Study||0
10113101|NCT02508259|11244033|FG000|STARTED|Overall Study||5
10113102|NCT02508259|11244034|FG001|STARTED|Overall Study||5
10113103|NCT02508259|11244033|FG000|COMPLETED|Overall Study||5
10113104|NCT02508259|11244034|FG001|COMPLETED|Overall Study||5
10113105|NCT02508259|11244033|FG000|NOT COMPLETED|Overall Study||0
10202012|NCT03441984|11329286|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202013|NCT03441984|11329287|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10202014|NCT03441984|11329276|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0
9973330|NCT01551355|11094373|FG002|STARTED|Overall Study||493
9973331|NCT01551355|11094374|FG003|STARTED|Overall Study||435
9973332|NCT01551355|11094375|FG004|STARTED|Overall Study||64
9973333|NCT01551355|11094376|FG005|STARTED|Overall Study||71
9973334|NCT01551355|11094371|FG000|COMPLETED|Overall Study||571
9973335|NCT01551355|11094372|FG001|COMPLETED|Overall Study||545
9973336|NCT01551355|11094373|FG002|COMPLETED|Overall Study||459
9973337|NCT01551355|11094374|FG003|COMPLETED|Overall Study||411
9973338|NCT01551355|11094375|FG004|COMPLETED|Overall Study||55
9973339|NCT01551355|11094376|FG005|COMPLETED|Overall Study||65
9973340|NCT01551355|11094371|FG000|NOT COMPLETED|Overall Study||51
9973341|NCT01551355|11094372|FG001|NOT COMPLETED|Overall Study||49
9973342|NCT01551355|11094373|FG002|NOT COMPLETED|Overall Study||34
9973343|NCT01551355|11094374|FG003|NOT COMPLETED|Overall Study||24
9973344|NCT01551355|11094375|FG004|NOT COMPLETED|Overall Study||9
9973345|NCT01551355|11094376|FG005|NOT COMPLETED|Overall Study||6
9973346|NCT01551420|11094386|FG000|STARTED|In-laboratory (Part A)||39
9973347|NCT01551420|11094387|FG001|STARTED|In-laboratory (Part A)||13
9973348|NCT01551420|11094386|FG000|COMPLETED|In-laboratory (Part A)||33
10113106|NCT02508259|11244034|FG001|NOT COMPLETED|Overall Study||0
10113107|NCT02508389|11244043|FG000|STARTED|Overall Study||73
10113108|NCT02508389|11244044|FG001|STARTED|Overall Study||76
10113109|NCT02508389|11244045|FG002|STARTED|Overall Study||74
10113110|NCT02508389|11244043|FG000|COMPLETED|Overall Study||45
10113111|NCT02508389|11244044|FG001|COMPLETED|Overall Study||45
10113112|NCT02508389|11244045|FG002|COMPLETED|Overall Study||42
10113113|NCT02508389|11244043|FG000|NOT COMPLETED|Overall Study||28
10113114|NCT02508389|11244044|FG001|NOT COMPLETED|Overall Study||31
10113115|NCT02508389|11244045|FG002|NOT COMPLETED|Overall Study||32
10113116|NCT02508428|11244055|FG000|STARTED|Overall Study||114
10113117|NCT02508428|11244056|FG001|STARTED|Overall Study||111
10113118|NCT02508428|11244055|FG000|COMPLETED|Overall Study||62
10113119|NCT02508428|11244056|FG001|COMPLETED|Overall Study||44
10098254|NCT02382016|11227303|FG000|STARTED|Double-blind (DB) Treatment Period||43
9973349|NCT01551420|11094387|FG001|COMPLETED|In-laboratory (Part A)||11
9973350|NCT01551420|11094386|FG000|NOT COMPLETED|In-laboratory (Part A)||6
9973351|NCT01551420|11094387|FG001|NOT COMPLETED|In-laboratory (Part A)||2
9973352|NCT01551420|11094386|FG000|STARTED|Screened for Part B Eligibility||33
9973353|NCT01551420|11094387|FG001|STARTED|Screened for Part B Eligibility||11
9973354|NCT01551420|11094386|FG000|COMPLETED|Screened for Part B Eligibility||24
9973355|NCT01551420|11094387|FG001|COMPLETED|Screened for Part B Eligibility||8
9973356|NCT01551420|11094386|FG000|NOT COMPLETED|Screened for Part B Eligibility||9
9973357|NCT01551420|11094387|FG001|NOT COMPLETED|Screened for Part B Eligibility||3
9973358|NCT01551420|11094386|FG000|STARTED|Home Use (Part B)||24
9973359|NCT01551420|11094387|FG001|STARTED|Home Use (Part B)||8
9973360|NCT01551420|11094386|FG000|COMPLETED|Home Use (Part B)||18
9973361|NCT01551420|11094387|FG001|COMPLETED|Home Use (Part B)||7
9973362|NCT01551420|11094386|FG000|NOT COMPLETED|Home Use (Part B)||6
9973363|NCT01551420|11094387|FG001|NOT COMPLETED|Home Use (Part B)||1
9973364|NCT01551693|11094395|FG000|STARTED|Overall Study||1
9973365|NCT01551693|11094396|FG001|STARTED|Overall Study||2
9973366|NCT01551693|11094395|FG000|COMPLETED|Overall Study||0
9973367|NCT01551693|11094396|FG001|COMPLETED|Overall Study||0
9973368|NCT01551693|11094395|FG000|NOT COMPLETED|Overall Study||1
9973369|NCT01551693|11094396|FG001|NOT COMPLETED|Overall Study||2
9973370|NCT01551745|11094402|FG000|STARTED|Overall Study||5
9973371|NCT01551745|11094402|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
9973372|NCT01551745|11094402|FG000|NOT COMPLETED|Overall Study||3
9973373|NCT01551758|11094408|FG000|STARTED|Overall Study||1403
9973374|NCT01551758|11094409|FG001|STARTED|Overall Study||1396
9973375|NCT01551758|11094408|FG000|COMPLETED|Overall Study||1309
9973376|NCT01551758|11094409|FG001|COMPLETED|Overall Study||1291
9973377|NCT01551758|11094408|FG000|NOT COMPLETED|Overall Study||94
9973378|NCT01551758|11094409|FG001|NOT COMPLETED|Overall Study||105
9973379|NCT01551888|11094419|FG000|STARTED|Period 1||12
9973380|NCT01551888|11094420|FG001|STARTED|Period 1||12
9973381|NCT01551888|11094419|FG000|COMPLETED|Period 1||12
9973382|NCT01551888|11094420|FG001|COMPLETED|Period 1||12
9973383|NCT01551888|11094419|FG000|NOT COMPLETED|Period 1||0
9973384|NCT01551888|11094420|FG001|NOT COMPLETED|Period 1||0
9973385|NCT01551888|11094419|FG000|STARTED|Period 2||12
9973386|NCT01551888|11094420|FG001|STARTED|Period 2||12
9973387|NCT01551888|11094419|FG000|COMPLETED|Period 2||12
9973388|NCT01551888|11094420|FG001|COMPLETED|Period 2||12
9973389|NCT01551888|11094419|FG000|NOT COMPLETED|Period 2||0
9973390|NCT01551888|11094420|FG001|NOT COMPLETED|Period 2||0
10098255|NCT02382016|11227304|FG001|STARTED|Double-blind (DB) Treatment Period||42
10098256|NCT02382016|11227303|FG000|COMPLETED|Double-blind (DB) Treatment Period||39
9973391|NCT01551979|11094428|FG000|STARTED|Overall Study||10
9973392|NCT01551979|11094429|FG001|STARTED|Overall Study||7
9973393|NCT01551979|11094428|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10
9973394|NCT01551979|11094429|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7
9973395|NCT01551979|11094428|FG000|1 Week Post Treatment|Overall Study||10
9973396|NCT01551979|11094429|FG001|1 Week Post Treatment|Overall Study||6
9973397|NCT01551979|11094428|FG000|COMPLETED|Overall Study||8
9973398|NCT01551979|11094429|FG001|COMPLETED|Overall Study||5
9973399|NCT01551979|11094428|FG000|NOT COMPLETED|Overall Study||2
9973400|NCT01551979|11094429|FG001|NOT COMPLETED|Overall Study||2
9973401|NCT01552057|11094437|FG000|STARTED|Overall Study||196
9973402|NCT01552057|11094438|FG001|STARTED|Overall Study||197
9973403|NCT01552057|11094437|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194
9973404|NCT01552057|11094438|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
9973405|NCT01552057|11094437|FG000|COMPLETED|Overall Study||166
9973406|NCT01552057|11094438|FG001|COMPLETED|Overall Study||149
9973407|NCT01552057|11094437|FG000|NOT COMPLETED|Overall Study||30
9973408|NCT01552057|11094438|FG001|NOT COMPLETED|Overall Study||48
9973409|NCT01552213|11094446|FG000|STARTED|Overall Study||50
9973410|NCT01552213|11094447|FG001|STARTED|Overall Study||45
9973411|NCT01552213|11094446|FG000|Analyzed|Overall Study||42
9973412|NCT01552213|11094447|FG001|Analyzed|Overall Study||41
9973413|NCT01552213|11094446|FG000|COMPLETED|Overall Study||37
9973414|NCT01552213|11094447|FG001|COMPLETED|Overall Study||37
9973415|NCT01552213|11094446|FG000|NOT COMPLETED|Overall Study||13
9973416|NCT01552213|11094447|FG001|NOT COMPLETED|Overall Study||8
9973417|NCT01552343|11094455|FG000|STARTED|Overall Study||29
9973418|NCT01552343|11094456|FG001|STARTED|Overall Study||27
9973419|NCT01552343|11094455|FG000|COMPLETED|Overall Study||29
9973420|NCT01552343|11094456|FG001|COMPLETED|Overall Study||27
9973421|NCT01552343|11094455|FG000|NOT COMPLETED|Overall Study||0
9973422|NCT01552343|11094456|FG001|NOT COMPLETED|Overall Study||0
9973423|NCT01552369|11094473|FG000|STARTED|Overall Study||100
9973424|NCT01552369|11094474|FG001|STARTED|Overall Study||105
9973425|NCT01552369|11094473|FG000|One Year|Overall Study||100
9973426|NCT01552369|11094474|FG001|One Year|Overall Study||105
9973427|NCT01552369|11094473|FG000|Final Follow up|Overall Study||92
9973428|NCT01552369|11094474|FG001|Final Follow up|Overall Study||96
9973429|NCT01552369|11094473|FG000|COMPLETED|Overall Study||92
9973430|NCT01552369|11094474|FG001|COMPLETED|Overall Study||96
9973431|NCT01552369|11094473|FG000|NOT COMPLETED|Overall Study||8
9973432|NCT01552369|11094474|FG001|NOT COMPLETED|Overall Study||9
9973433|NCT01552408|11094484|FG000|STARTED|Overall Study||20
9973434|NCT01552408|11094485|FG001|STARTED|Overall Study||20
9973435|NCT01552408|11094484|FG000|COMPLETED|Overall Study||16
9973436|NCT01552408|11094485|FG001|COMPLETED|Overall Study||18
9973437|NCT01552408|11094484|FG000|NOT COMPLETED|Overall Study||4
9973438|NCT01552408|11094485|FG001|NOT COMPLETED|Overall Study||2
9973439|NCT01552603|11094492|FG000|STARTED|Overall Study||14
9973440|NCT01552603|11094492|FG000|COMPLETED|Overall Study||13
9973441|NCT01552603|11094492|FG000|NOT COMPLETED|Overall Study||1
9973442|NCT01552681|11094498|FG000|STARTED|Overall Study||33
9973443|NCT01552681|11094499|FG001|STARTED|Overall Study||19
9973444|NCT01552681|11094498|FG000|COMPLETED|Overall Study||28
9973445|NCT01552681|11094499|FG001|COMPLETED|Overall Study||18
9973446|NCT01552681|11094498|FG000|NOT COMPLETED|Overall Study||5
9973447|NCT01552681|11094499|FG001|NOT COMPLETED|Overall Study||1
9973448|NCT01552694|11094507|FG000|STARTED|Overall Study||18
9973449|NCT01552694|11094508|FG001|STARTED|Overall Study||20
9973450|NCT01552694|11094507|FG000|COMPLETED|Overall Study||18
9973451|NCT01552694|11094508|FG001|COMPLETED|Overall Study||18
9973452|NCT01552694|11094507|FG000|NOT COMPLETED|Overall Study||0
9973453|NCT01552694|11094508|FG001|NOT COMPLETED|Overall Study||2
9973454|NCT01552772|11094514|FG000|STARTED|Overall Study||60
9973455|NCT01552772|11094514|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
9973456|NCT01552772|11094514|FG000|NOT COMPLETED|Overall Study||4
9973457|NCT01552876|11094519|FG000|STARTED|Overall Study||20
9973458|NCT01552876|11094520|FG001|STARTED|Overall Study||20
9973459|NCT01552876|11094519|FG000|COMPLETED|Overall Study||20
9973460|NCT01552876|11094520|FG001|COMPLETED|Overall Study||20
9973461|NCT01552876|11094519|FG000|NOT COMPLETED|Overall Study||0
9973462|NCT01552876|11094520|FG001|NOT COMPLETED|Overall Study||0
9973463|NCT01552889|11094534|FG000|STARTED|Overall Study||101
9973464|NCT01552889|11094535|FG001|STARTED|Overall Study||100
9973465|NCT01552889|11094534|FG000|COMPLETED|Overall Study||90
9973466|NCT01552889|11094535|FG001|COMPLETED|Overall Study||95
9973467|NCT01552889|11094534|FG000|NOT COMPLETED|Overall Study||11
9973468|NCT01552889|11094535|FG001|NOT COMPLETED|Overall Study||5
9973469|NCT01552902|11094546|FG000|STARTED|Overall Study||110
9973470|NCT01552902|11094547|FG001|STARTED|Overall Study||218
9973471|NCT01552902|11094548|FG002|STARTED|Overall Study||219
9973472|NCT01552902|11094546|FG000|COMPLETED|Overall Study||97
9973473|NCT01552902|11094547|FG001|COMPLETED|Overall Study||181
9973474|NCT01552902|11094548|FG002|COMPLETED|Overall Study||186
9973475|NCT01552902|11094546|FG000|NOT COMPLETED|Overall Study||13
9973476|NCT01552902|11094547|FG001|NOT COMPLETED|Overall Study||37
9973477|NCT01552902|11094548|FG002|NOT COMPLETED|Overall Study||33
9973478|NCT01552915|11094559|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
9973479|NCT01552915|11094560|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
9973480|NCT01552915|11094561|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
9973481|NCT01552915|11094559|FG000|COMPLETED|Overall Study||68
9973482|NCT01552915|11094560|FG001|COMPLETED|Overall Study||155
9973483|NCT01552915|11094561|FG002|COMPLETED|Overall Study||157
9973484|NCT01552915|11094559|FG000|NOT COMPLETED|Overall Study||23
9973485|NCT01552915|11094560|FG001|NOT COMPLETED|Overall Study||29
9973486|NCT01552915|11094561|FG002|NOT COMPLETED|Overall Study||27
9973487|NCT01552928|11094573|FG000|STARTED|Period 1||14
9973488|NCT01552928|11094574|FG001|STARTED|Period 1||15
9973489|NCT01552928|11094575|FG002|STARTED|Period 1||15
9973490|NCT01552928|11094576|FG003|STARTED|Period 1||16
9973491|NCT01552928|11094573|FG000|COMPLETED|Period 1||14
9973492|NCT01552928|11094574|FG001|COMPLETED|Period 1||15
9973493|NCT01552928|11094575|FG002|COMPLETED|Period 1||15
9973494|NCT01552928|11094576|FG003|COMPLETED|Period 1||16
9973495|NCT01552928|11094573|FG000|NOT COMPLETED|Period 1||0
9973496|NCT01552928|11094574|FG001|NOT COMPLETED|Period 1||0
9973497|NCT01552928|11094575|FG002|NOT COMPLETED|Period 1||0
9973498|NCT01552928|11094576|FG003|NOT COMPLETED|Period 1||0
9973499|NCT01552928|11094573|FG000|STARTED|Period 2||14
9973500|NCT01552928|11094574|FG001|STARTED|Period 2||15
9973501|NCT01552928|11094575|FG002|STARTED|Period 2||15
9973502|NCT01552928|11094576|FG003|STARTED|Period 2||16
9973503|NCT01552928|11094573|FG000|COMPLETED|Period 2||14
9973504|NCT01552928|11094574|FG001|COMPLETED|Period 2||15
9973505|NCT01552928|11094575|FG002|COMPLETED|Period 2||15
9973506|NCT01552928|11094576|FG003|COMPLETED|Period 2||16
9973507|NCT01552928|11094573|FG000|NOT COMPLETED|Period 2||0
9973508|NCT01552928|11094574|FG001|NOT COMPLETED|Period 2||0
9973509|NCT01552928|11094575|FG002|NOT COMPLETED|Period 2||0
9973510|NCT01552928|11094576|FG003|NOT COMPLETED|Period 2||0
9973511|NCT01552928|11094573|FG000|STARTED|Period 3||14
9973512|NCT01552928|11094574|FG001|STARTED|Period 3||15
9973513|NCT01552928|11094575|FG002|STARTED|Period 3||15
9973514|NCT01552928|11094576|FG003|STARTED|Period 3||16
9973515|NCT01552928|11094573|FG000|COMPLETED|Period 3||14
9973516|NCT01552928|11094574|FG001|COMPLETED|Period 3||15
9973517|NCT01552928|11094575|FG002|COMPLETED|Period 3||14
9973518|NCT01552928|11094576|FG003|COMPLETED|Period 3||16
9973519|NCT01552928|11094573|FG000|NOT COMPLETED|Period 3||0
9973520|NCT01552928|11094574|FG001|NOT COMPLETED|Period 3||0
9973521|NCT01552928|11094575|FG002|NOT COMPLETED|Period 3||1
9973522|NCT01552928|11094576|FG003|NOT COMPLETED|Period 3||0
9973523|NCT01552928|11094573|FG000|STARTED|Period 4||14
9973524|NCT01552928|11094574|FG001|STARTED|Period 4||15
9973525|NCT01552928|11094575|FG002|STARTED|Period 4||14
9973526|NCT01552928|11094576|FG003|STARTED|Period 4||16
9973527|NCT01552928|11094573|FG000|COMPLETED|Period 4||14
9973528|NCT01552928|11094574|FG001|COMPLETED|Period 4||15
9973529|NCT01552928|11094575|FG002|COMPLETED|Period 4||14
9973530|NCT01552928|11094576|FG003|COMPLETED|Period 4||16
9973531|NCT01552928|11094573|FG000|NOT COMPLETED|Period 4||0
9973532|NCT01552928|11094574|FG001|NOT COMPLETED|Period 4||0
9973533|NCT01552928|11094575|FG002|NOT COMPLETED|Period 4||0
9973534|NCT01552928|11094576|FG003|NOT COMPLETED|Period 4||0
9973535|NCT01552954|11094595|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
9973536|NCT01552954|11094596|FG001|STARTED|Overall Study||125
10098257|NCT02382016|11227304|FG001|COMPLETED|Double-blind (DB) Treatment Period||41
10098258|NCT02382016|11227303|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4
10098259|NCT02382016|11227304|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1
10098260|NCT02382016|11227303|FG000|STARTED|Open-label (OL) Treatment Period||80
10098261|NCT02382016|11227304|FG001|STARTED|Open-label (OL) Treatment Period||0
10098262|NCT02382016|11227303|FG000|COMPLETED|Open-label (OL) Treatment Period||71
10098263|NCT02382016|11227304|FG001|COMPLETED|Open-label (OL) Treatment Period||0
10098264|NCT02382016|11227303|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9
10098265|NCT02382016|11227304|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0
10098266|NCT02382016|11227303|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
10098267|NCT02382016|11227304|FG001|STARTED|OL Extension Period||0
10098268|NCT02382016|11227303|FG000|COMPLETED|OL Extension Period||27
10098269|NCT02382016|11227304|FG001|COMPLETED|OL Extension Period||0
10098270|NCT02382016|11227303|FG000|NOT COMPLETED|OL Extension Period||6
9973537|NCT01552954|11094595|FG000|COMPLETED|Overall Study||126
9973538|NCT01552954|11094596|FG001|COMPLETED|Overall Study||119
9973539|NCT01552954|11094595|FG000|NOT COMPLETED|Overall Study||5
9973540|NCT01552954|11094596|FG001|NOT COMPLETED|Overall Study||6
9973541|NCT01553058|11094605|FG000|STARTED|Overall Study||33
9973542|NCT01553058|11094606|FG001|STARTED|Overall Study||31
9973543|NCT01553058|11094607|FG002|STARTED|Overall Study||33
9973544|NCT01553058|11094605|FG000|COMPLETED|Overall Study||32
9973545|NCT01553058|11094606|FG001|COMPLETED|Overall Study||30
9973546|NCT01553058|11094607|FG002|COMPLETED|Overall Study||30
9973547|NCT01553058|11094605|FG000|NOT COMPLETED|Overall Study||1
9973548|NCT01553058|11094606|FG001|NOT COMPLETED|Overall Study||1
9973549|NCT01553058|11094607|FG002|NOT COMPLETED|Overall Study||3
9973550|NCT01553084|11094622|FG000|STARTED|Overall Study||241
9973551|NCT01553084|11094623|FG001|STARTED|Overall Study||421
9973552|NCT01553084|11094624|FG002|STARTED|Overall Study||424
9973553|NCT01553084|11094622|FG000|COMPLETED|Overall Study||226
9973554|NCT01553084|11094623|FG001|COMPLETED|Overall Study||408
9973555|NCT01553084|11094624|FG002|COMPLETED|Overall Study||389
9973556|NCT01553084|11094622|FG000|NOT COMPLETED|Overall Study||15
9973557|NCT01553084|11094623|FG001|NOT COMPLETED|Overall Study||13
9973558|NCT01553084|11094624|FG002|NOT COMPLETED|Overall Study||35
9973559|NCT01553136|11094636|FG000|STARTED|Overall Study||64
9973560|NCT01553136|11094637|FG001|STARTED|Overall Study||67
9973561|NCT01553136|11094636|FG000|Completed Treatment|Overall Study||55
9973562|NCT01553136|11094637|FG001|Completed Treatment|Overall Study||52
9973563|NCT01553136|11094636|FG000|COMPLETED|Overall Study||48
9973564|NCT01553136|11094637|FG001|COMPLETED|Overall Study||45
9973565|NCT01553136|11094636|FG000|NOT COMPLETED|Overall Study||16
9973566|NCT01553136|11094637|FG001|NOT COMPLETED|Overall Study||22
9973567|NCT01553188|11094647|FG000|STARTED|Overall Study||3
9973568|NCT01553188|11094648|FG001|STARTED|Overall Study||6
9973569|NCT01553188|11094649|FG002|STARTED|Overall Study||16
9973570|NCT01553188|11094650|FG003|STARTED|Overall Study||11
9973571|NCT01553188|11094647|FG000|COMPLETED|Overall Study||2
9973572|NCT01553188|11094648|FG001|COMPLETED|Overall Study||5
9973573|NCT01553188|11094649|FG002|COMPLETED|Overall Study||14
9973574|NCT01553188|11094650|FG003|COMPLETED|Overall Study||11
9973575|NCT01553188|11094647|FG000|NOT COMPLETED|Overall Study||1
9973576|NCT01553188|11094648|FG001|NOT COMPLETED|Overall Study||1
9973577|NCT01553188|11094649|FG002|NOT COMPLETED|Overall Study||2
9973578|NCT01553188|11094650|FG003|NOT COMPLETED|Overall Study||0
9973579|NCT01553201|11094665|FG000|STARTED|Overall Study||15
9973580|NCT01553201|11094666|FG001|STARTED|Overall Study||15
9973581|NCT01553201|11094665|FG000|COMPLETED|Overall Study||15
9973582|NCT01553201|11094666|FG001|COMPLETED|Overall Study||15
9973583|NCT01553201|11094665|FG000|NOT COMPLETED|Overall Study||0
9973584|NCT01553201|11094666|FG001|NOT COMPLETED|Overall Study||0
9973585|NCT01553279|11094674|FG000|STARTED|Part 1 (Infant Vaccinations)||142
9973586|NCT01553279|11094675|FG001|STARTED|Part 1 (Infant Vaccinations)||142
9973587|NCT01553279|11094674|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140
9973588|NCT01553279|11094675|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141
9973589|NCT01553279|11094674|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
9973590|NCT01553279|11094675|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
9973591|NCT01553279|11094674|FG000|STARTED|Interim Period||140
9973592|NCT01553279|11094675|FG001|STARTED|Interim Period||141
9973593|NCT01553279|11094674|FG000|COMPLETED|Interim Period||137
9973594|NCT01553279|11094675|FG001|COMPLETED|Interim Period||139
9973595|NCT01553279|11094674|FG000|NOT COMPLETED|Interim Period||3
9973596|NCT01553279|11094675|FG001|NOT COMPLETED|Interim Period||2
9973597|NCT01553279|11094674|FG000|STARTED|Period 2: Toddler Vaccinations||137
9973598|NCT01553279|11094675|FG001|STARTED|Period 2: Toddler Vaccinations||139
9973599|NCT01553279|11094674|FG000|COMPLETED|Period 2: Toddler Vaccinations||134
9973600|NCT01553279|11094675|FG001|COMPLETED|Period 2: Toddler Vaccinations||132
9973601|NCT01553279|11094674|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3
9973602|NCT01553279|11094675|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7
9973603|NCT01553292|11094682|FG000|STARTED|Overall Study||21
9973604|NCT01553292|11094682|FG000|COMPLETED|Overall Study||21
9973605|NCT01553292|11094682|FG000|NOT COMPLETED|Overall Study||0
9973606|NCT01553318|11094690|FG000|STARTED|Overall Study||24
9973607|NCT01553318|11094691|FG001|STARTED|Overall Study||27
9973608|NCT01553318|11094690|FG000|COMPLETED|Overall Study||21
9973609|NCT01553318|11094691|FG001|COMPLETED|Overall Study||25
9973610|NCT01553318|11094690|FG000|NOT COMPLETED|Overall Study||3
9973611|NCT01553318|11094691|FG001|NOT COMPLETED|Overall Study||2
9973612|NCT01553539|11094699|FG000|STARTED|Overall Study||20
9973613|NCT01553539|11094699|FG000|COMPLETED|Overall Study||20
9973614|NCT01553539|11094699|FG000|NOT COMPLETED|Overall Study||0
9973615|NCT01553591|11094706|FG000|STARTED|Overall Study||429
9973616|NCT01553591|11094707|FG001|STARTED|Overall Study||426
9973617|NCT01553591|11094708|FG002|STARTED|Overall Study||427
9973618|NCT01553591|11094706|FG000|Attended Week 12 Visit|Overall Study||341
9973619|NCT01553591|11094707|FG001|Attended Week 12 Visit|Overall Study||330
9973620|NCT01553591|11094708|FG002|Attended Week 12 Visit|Overall Study||342
9973621|NCT01553591|11094706|FG000|Attended Week 26 Visit|Overall Study||289
9973622|NCT01553591|11094707|FG001|Attended Week 26 Visit|Overall Study||291
9973623|NCT01553591|11094708|FG002|Attended Week 26 Visit|Overall Study||290
9973624|NCT01553591|11094706|FG000|COMPLETED|Overall Study||257
9973625|NCT01553591|11094707|FG001|COMPLETED|Overall Study||257
9973626|NCT01553591|11094708|FG002|COMPLETED|Overall Study||269
9973627|NCT01553591|11094706|FG000|NOT COMPLETED|Overall Study||172
9973628|NCT01553591|11094707|FG001|NOT COMPLETED|Overall Study||169
9973629|NCT01553591|11094708|FG002|NOT COMPLETED|Overall Study||158
9973630|NCT01553708|11094718|FG000|STARTED|Overall Study||17
9973631|NCT01553708|11094719|FG001|STARTED|Overall Study||17
9973632|NCT01553708|11094718|FG000|COMPLETED|Overall Study||17
9973633|NCT01553708|11094719|FG001|COMPLETED|Overall Study||17
9973634|NCT01553708|11094718|FG000|NOT COMPLETED|Overall Study||0
9973635|NCT01553708|11094719|FG001|NOT COMPLETED|Overall Study||0
9973636|NCT01553747|11094728|FG000|STARTED|Overall Study||381
9973637|NCT01553747|11094729|FG001|STARTED|Overall Study||383
9973638|NCT01553747|11094730|FG002|STARTED|Overall Study||382
9973639|NCT01553747|11094728|FG000|Attended Week 12 Visit|Overall Study||296
9973640|NCT01553747|11094729|FG001|Attended Week 12 Visit|Overall Study||301
9973641|NCT01553747|11094730|FG002|Attended Week 12 Visit|Overall Study||312
9973642|NCT01553747|11094728|FG000|Attended Week 26 Visit|Overall Study||259
9973643|NCT01553747|11094729|FG001|Attended Week 26 Visit|Overall Study||271
9973644|NCT01553747|11094730|FG002|Attended Week 26 Visit|Overall Study||278
9973645|NCT01553747|11094728|FG000|Participated in Blinded-Placebo Period|Overall Study||246
9973646|NCT01553747|11094729|FG001|Participated in Blinded-Placebo Period|Overall Study||253
9973647|NCT01553747|11094730|FG002|Participated in Blinded-Placebo Period|Overall Study||272
9973648|NCT01553747|11094728|FG000|COMPLETED|Overall Study||250
9973649|NCT01553747|11094729|FG001|COMPLETED|Overall Study||264
9973650|NCT01553747|11094730|FG002|COMPLETED|Overall Study||273
9973651|NCT01553747|11094728|FG000|NOT COMPLETED|Overall Study||131
9973652|NCT01553747|11094729|FG001|NOT COMPLETED|Overall Study||119
9973653|NCT01553747|11094730|FG002|NOT COMPLETED|Overall Study||109
9973654|NCT01553851|11094741|FG000|STARTED|Overall Study||20
9973655|NCT01553851|11094741|FG000|COMPLETED|Overall Study||17
9973656|NCT01553851|11094741|FG000|NOT COMPLETED|Overall Study||3
9973657|NCT01553916|11094745|FG000|STARTED|Overall Study||19
9973658|NCT01553916|11094745|FG000|COMPLETED|Overall Study||16
9973659|NCT01553916|11094745|FG000|NOT COMPLETED|Overall Study||3
9973660|NCT01554176|11094751|FG000|STARTED|Treatment Phase||65
9973661|NCT01554176|11094752|FG001|STARTED|Treatment Phase||64
9973662|NCT01554176|11094753|FG002|STARTED|Treatment Phase||0
9973663|NCT01554176|11094754|FG003|STARTED|Treatment Phase||0
9973664|NCT01554176|11094755|FG004|STARTED|Treatment Phase||0
9973665|NCT01554176|11094751|FG000|Treated|Treatment Phase||64
9973666|NCT01554176|11094752|FG001|Treated|Treatment Phase||64
9973667|NCT01554176|11094753|FG002|Treated|Treatment Phase||0
9973668|NCT01554176|11094754|FG003|Treated|Treatment Phase||0
9973669|NCT01554176|11094755|FG004|Treated|Treatment Phase||0
9973670|NCT01554176|11094751|FG000|COMPLETED|Treatment Phase||57
9973671|NCT01554176|11094752|FG001|COMPLETED|Treatment Phase||59
9973672|NCT01554176|11094753|FG002|COMPLETED|Treatment Phase||0
9973673|NCT01554176|11094754|FG003|COMPLETED|Treatment Phase||0
9973674|NCT01554176|11094755|FG004|COMPLETED|Treatment Phase||0
9973675|NCT01554176|11094751|FG000|NOT COMPLETED|Treatment Phase||8
9973676|NCT01554176|11094752|FG001|NOT COMPLETED|Treatment Phase||5
9973677|NCT01554176|11094753|FG002|NOT COMPLETED|Treatment Phase||0
9973678|NCT01554176|11094754|FG003|NOT COMPLETED|Treatment Phase||0
9973679|NCT01554176|11094755|FG004|NOT COMPLETED|Treatment Phase||0
9973680|NCT01554176|11094751|FG000|STARTED|Run-out Phase||0
9973681|NCT01554176|11094752|FG001|STARTED|Run-out Phase||0
9973682|NCT01554176|11094753|FG002|STARTED|Run-out Phase||29
9973683|NCT01554176|11094754|FG003|STARTED|Run-out Phase||28
9973684|NCT01554176|11094755|FG004|STARTED|Run-out Phase||59
9973685|NCT01554176|11094751|FG000|Treated|Run-out Phase||0
9973686|NCT01554176|11094752|FG001|Treated|Run-out Phase||0
9973687|NCT01554176|11094753|FG002|Treated|Run-out Phase||29
9973688|NCT01554176|11094754|FG003|Treated|Run-out Phase||28
9973689|NCT01554176|11094755|FG004|Treated|Run-out Phase||59
9973690|NCT01554176|11094751|FG000|COMPLETED|Run-out Phase||0
9973691|NCT01554176|11094752|FG001|COMPLETED|Run-out Phase||0
9973692|NCT01554176|11094753|FG002|COMPLETED|Run-out Phase||29
9973693|NCT01554176|11094754|FG003|COMPLETED|Run-out Phase||27
9973694|NCT01554176|11094755|FG004|COMPLETED|Run-out Phase||59
9973695|NCT01554176|11094751|FG000|NOT COMPLETED|Run-out Phase||0
9973696|NCT01554176|11094752|FG001|NOT COMPLETED|Run-out Phase||0
9973697|NCT01554176|11094753|FG002|NOT COMPLETED|Run-out Phase||0
9973698|NCT01554176|11094754|FG003|NOT COMPLETED|Run-out Phase||1
9973699|NCT01554176|11094755|FG004|NOT COMPLETED|Run-out Phase||0
9973700|NCT01554241|11094771|FG000|STARTED|Overall Study||23
9973701|NCT01554241|11094772|FG001|STARTED|Overall Study||20
9973702|NCT01554241|11094773|FG002|STARTED|Overall Study||24
9973703|NCT01554241|11094774|FG003|STARTED|Overall Study||14
9973704|NCT01554241|11094771|FG000|COMPLETED|Overall Study||20
9973705|NCT01554241|11094772|FG001|COMPLETED|Overall Study||19
9973706|NCT01554241|11094773|FG002|COMPLETED|Overall Study||20
9973707|NCT01554241|11094774|FG003|COMPLETED|Overall Study||13
9973708|NCT01554241|11094771|FG000|NOT COMPLETED|Overall Study||3
9973709|NCT01554241|11094772|FG001|NOT COMPLETED|Overall Study||1
9973710|NCT01554241|11094773|FG002|NOT COMPLETED|Overall Study||4
9973711|NCT01554241|11094774|FG003|NOT COMPLETED|Overall Study||1
9973712|NCT01554371|11094787|FG000|STARTED|Overall Study||3
9973713|NCT01554371|11094788|FG001|STARTED|Overall Study||3
9973714|NCT01554371|11094789|FG002|STARTED|Overall Study||38
9973715|NCT01554371|11094787|FG000|COMPLETED|Overall Study||3
9973716|NCT01554371|11094788|FG001|COMPLETED|Overall Study||3
9973717|NCT01554371|11094789|FG002|COMPLETED|Overall Study||38
9973718|NCT01554371|11094787|FG000|NOT COMPLETED|Overall Study||0
9973719|NCT01554371|11094788|FG001|NOT COMPLETED|Overall Study||0
9973720|NCT01554371|11094789|FG002|NOT COMPLETED|Overall Study||0
9973721|NCT01554488|11094802|FG000|STARTED|Overall Study||13
9973722|NCT01554488|11094803|FG001|STARTED|Overall Study||12
9973723|NCT01554488|11094802|FG000|COMPLETED|Overall Study||12
9973724|NCT01554488|11094803|FG001|COMPLETED|Overall Study||9
9973725|NCT01554488|11094802|FG000|NOT COMPLETED|Overall Study||1
9973726|NCT01554488|11094803|FG001|NOT COMPLETED|Overall Study||3
9973727|NCT01554514|11094809|FG000|STARTED|Overall Study||19
9973728|NCT01554514|11094809|FG000|COMPLETED|Overall Study||17
9973729|NCT01554514|11094809|FG000|NOT COMPLETED|Overall Study||2
9973730|NCT01554527|11094816|FG000|STARTED|Overall Study||34
9973731|NCT01554527|11094817|FG001|STARTED|Overall Study||38
9973732|NCT01554527|11094818|FG002|STARTED|Overall Study||33
9973733|NCT01554527|11094816|FG000|Crossed Over to Control|Overall Study||0
9973734|NCT01554527|11094817|FG001|Crossed Over to Control|Overall Study||0
9973735|NCT01554527|11094818|FG002|Crossed Over to Control|Overall Study||2
9973736|NCT01554527|11094816|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
9973737|NCT01554527|11094817|FG001|Had CPAP Titration|Overall Study||38
9973738|NCT01554527|11094818|FG002|Had CPAP Titration|Overall Study||30
9973739|NCT01554527|11094816|FG000|Initiated CPAP Treatment at Home|Overall Study||0
9973740|NCT01554527|11094817|FG001|Initiated CPAP Treatment at Home|Overall Study||38
9973741|NCT01554527|11094818|FG002|Initiated CPAP Treatment at Home|Overall Study||28
9973742|NCT01554527|11094816|FG000|Completed as a Control|Overall Study||33
9973743|NCT01554527|11094817|FG001|Completed as a Control|Overall Study||0
9973744|NCT01554527|11094818|FG002|Completed as a Control|Overall Study||1
9973745|NCT01554527|11094816|FG000|COMPLETED|Overall Study||33
9973746|NCT01554527|11094817|FG001|COMPLETED|Overall Study||38
9973747|NCT01554527|11094818|FG002|COMPLETED|Overall Study||25
9973748|NCT01554527|11094816|FG000|NOT COMPLETED|Overall Study||1
9973749|NCT01554527|11094817|FG001|NOT COMPLETED|Overall Study||0
9973750|NCT01554527|11094818|FG002|NOT COMPLETED|Overall Study||8
9973751|NCT01554579|11094829|FG000|STARTED|Overall Study||86
9973752|NCT01554579|11094830|FG001|STARTED|Overall Study||85
9973753|NCT01554579|11094829|FG000|COMPLETED|Overall Study||76
9973754|NCT01554579|11094830|FG001|COMPLETED|Overall Study||58
9973755|NCT01554579|11094829|FG000|NOT COMPLETED|Overall Study||10
9973756|NCT01554579|11094830|FG001|NOT COMPLETED|Overall Study||27
9973757|NCT01554618|11094839|FG000|STARTED|Randomized Through Start of Treatment||59
9973758|NCT01554618|11094840|FG001|STARTED|Randomized Through Start of Treatment||24
9973759|NCT01554618|11094839|FG000|COMPLETED|Randomized Through Start of Treatment||58
9973760|NCT01554618|11094840|FG001|COMPLETED|Randomized Through Start of Treatment||24
9973761|NCT01554618|11094839|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1
9973762|NCT01554618|11094840|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0
9973763|NCT01554618|11094839|FG000|STARTED|Controlled Assessment Period||58
9973764|NCT01554618|11094840|FG001|STARTED|Controlled Assessment Period||24
9973765|NCT01554618|11094839|FG000|COMPLETED|Controlled Assessment Period||50
9973766|NCT01554618|11094840|FG001|COMPLETED|Controlled Assessment Period||23
9973767|NCT01554618|11094839|FG000|NOT COMPLETED|Controlled Assessment Period||8
9973768|NCT01554618|11094840|FG001|NOT COMPLETED|Controlled Assessment Period||1
9973769|NCT01554618|11094839|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
9973770|NCT01554618|11094840|FG001|STARTED|Open-Label Extension Period||23
9973771|NCT01554618|11094839|FG000|COMPLETED|Open-Label Extension Period||46
9973772|NCT01554618|11094840|FG001|COMPLETED|Open-Label Extension Period||18
9973773|NCT01554618|11094839|FG000|NOT COMPLETED|Open-Label Extension Period||3
9973774|NCT01554618|11094840|FG001|NOT COMPLETED|Open-Label Extension Period||5
9973775|NCT01554683|11094850|FG000|STARTED|Overall Study||2
9973776|NCT01554683|11094851|FG001|STARTED|Overall Study||1
9973777|NCT01554683|11094852|FG002|STARTED|Overall Study||3
9973778|NCT01554683|11094853|FG003|STARTED|Overall Study||2
9973779|NCT01554683|11094854|FG004|STARTED|Overall Study||1
9973780|NCT01554683|11094855|FG005|STARTED|Overall Study||0
9973781|NCT01554683|11094850|FG000|COMPLETED|Overall Study||2
9973782|NCT01554683|11094851|FG001|COMPLETED|Overall Study||1
9973783|NCT01554683|11094852|FG002|COMPLETED|Overall Study||3
9973784|NCT01554683|11094853|FG003|COMPLETED|Overall Study||2
9973785|NCT01554683|11094854|FG004|COMPLETED|Overall Study||1
9973786|NCT01554683|11094855|FG005|COMPLETED|Overall Study||0
9973787|NCT01554683|11094850|FG000|NOT COMPLETED|Overall Study||0
9973788|NCT01554683|11094851|FG001|NOT COMPLETED|Overall Study||0
9973789|NCT01554683|11094852|FG002|NOT COMPLETED|Overall Study||0
9973790|NCT01554683|11094853|FG003|NOT COMPLETED|Overall Study||0
9973791|NCT01554683|11094854|FG004|NOT COMPLETED|Overall Study||0
9973792|NCT01554683|11094855|FG005|NOT COMPLETED|Overall Study||0
9973793|NCT01554891|11094866|FG000|STARTED|Overall Study||105
9973794|NCT01554891|11094867|FG001|STARTED|Overall Study||120
9973795|NCT01554891|11094868|FG002|STARTED|Overall Study||57
9973796|NCT01554891|11094866|FG000|COMPLETED|Overall Study||98
9973797|NCT01554891|11094867|FG001|COMPLETED|Overall Study||115
9973798|NCT01554891|11094868|FG002|COMPLETED|Overall Study||55
9973799|NCT01554891|11094866|FG000|NOT COMPLETED|Overall Study||7
9973800|NCT01554891|11094867|FG001|NOT COMPLETED|Overall Study||5
9973801|NCT01554891|11094868|FG002|NOT COMPLETED|Overall Study||2
9973802|NCT01554904|11094876|FG000|STARTED|Overall Study||18
9973803|NCT01554904|11094876|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18
9973804|NCT01554904|11094876|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
9973805|NCT01554904|11094876|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
9973806|NCT01554904|11094876|FG000|Home Sleep Study 2|Overall Study||14
9973807|NCT01554904|11094876|FG000|COMPLETED|Overall Study||14
9973808|NCT01554904|11094876|FG000|NOT COMPLETED|Overall Study||4
9973809|NCT01554982|11094880|FG000|STARTED|Overall Study||168
9973810|NCT01554982|11094880|FG000|Received Drug|Overall Study||166
9973811|NCT01554982|11094880|FG000|COMPLETED|Overall Study||125
9973812|NCT01554982|11094880|FG000|NOT COMPLETED|Overall Study||43
9973813|NCT01555125|11094887|FG000|STARTED|Induction Period||59
9973814|NCT01555125|11094888|FG001|STARTED|Induction Period||59
9973815|NCT01555125|11094889|FG002|STARTED|Induction Period||0
9973816|NCT01555125|11094890|FG003|STARTED|Induction Period||0
9973817|NCT01555125|11094891|FG004|STARTED|Induction Period||59
9973818|NCT01555125|11094887|FG000|COMPLETED|Induction Period||58
9973819|NCT01555125|11094888|FG001|COMPLETED|Induction Period||56
9973820|NCT01555125|11094889|FG002|COMPLETED|Induction Period||0
9973821|NCT01555125|11094890|FG003|COMPLETED|Induction Period||0
9973822|NCT01555125|11094891|FG004|COMPLETED|Induction Period||56
9973823|NCT01555125|11094887|FG000|NOT COMPLETED|Induction Period||1
9973824|NCT01555125|11094888|FG001|NOT COMPLETED|Induction Period||3
9973825|NCT01555125|11094889|FG002|NOT COMPLETED|Induction Period||0
9973826|NCT01555125|11094890|FG003|NOT COMPLETED|Induction Period||0
9973827|NCT01555125|11094891|FG004|NOT COMPLETED|Induction Period||3
9973828|NCT01555125|11094887|FG000|STARTED|Maintenance Period||58
9973829|NCT01555125|11094888|FG001|STARTED|Maintenance Period||56
10098271|NCT02382016|11227304|FG001|NOT COMPLETED|OL Extension Period||0
10098272|NCT02382133|11227312|FG000|STARTED|Overall Study||43
10098273|NCT02382133|11227312|FG000|COMPLETED|Overall Study||10
10098274|NCT02382133|11227312|FG000|NOT COMPLETED|Overall Study||33
10098275|NCT02382276|11227319|FG000|STARTED|Overall Study||137
10098276|NCT02382276|11227320|FG001|STARTED|Overall Study||94
10098277|NCT02382276|11227321|FG002|STARTED|Overall Study||172
10098278|NCT02382276|11227319|FG000|COMPLETED|Overall Study||126
10098279|NCT02382276|11227320|FG001|COMPLETED|Overall Study||84
9973830|NCT01555125|11094889|FG002|STARTED|Maintenance Period||29
9973831|NCT01555125|11094890|FG003|STARTED|Maintenance Period||27
9973832|NCT01555125|11094891|FG004|STARTED|Maintenance Period||0
9973833|NCT01555125|11094887|FG000|COMPLETED|Maintenance Period||48
9973834|NCT01555125|11094888|FG001|COMPLETED|Maintenance Period||52
9973835|NCT01555125|11094889|FG002|COMPLETED|Maintenance Period||25
9973836|NCT01555125|11094890|FG003|COMPLETED|Maintenance Period||25
9973837|NCT01555125|11094891|FG004|COMPLETED|Maintenance Period||0
9973838|NCT01555125|11094887|FG000|NOT COMPLETED|Maintenance Period||10
9973839|NCT01555125|11094888|FG001|NOT COMPLETED|Maintenance Period||4
9973840|NCT01555125|11094889|FG002|NOT COMPLETED|Maintenance Period||4
9973841|NCT01555125|11094890|FG003|NOT COMPLETED|Maintenance Period||2
9973842|NCT01555125|11094891|FG004|NOT COMPLETED|Maintenance Period||0
9973843|NCT01555125|11094887|FG000|STARTED|Extension||46
9973844|NCT01555125|11094888|FG001|STARTED|Extension||51
9973845|NCT01555125|11094889|FG002|STARTED|Extension||23
9973846|NCT01555125|11094890|FG003|STARTED|Extension||23
10098280|NCT02382276|11227321|FG002|COMPLETED|Overall Study||133
10098281|NCT02382276|11227319|FG000|NOT COMPLETED|Overall Study||11
10098282|NCT02382276|11227320|FG001|NOT COMPLETED|Overall Study||10
9973847|NCT01555125|11094891|FG004|STARTED|Extension||0
9973848|NCT01555125|11094887|FG000|COMPLETED|Extension||1
9973849|NCT01555125|11094888|FG001|COMPLETED|Extension||0
9973850|NCT01555125|11094889|FG002|COMPLETED|Extension||0
9973851|NCT01555125|11094890|FG003|COMPLETED|Extension||1
9973852|NCT01555125|11094891|FG004|COMPLETED|Extension||0
9973853|NCT01555125|11094887|FG000|NOT COMPLETED|Extension||45
9973854|NCT01555125|11094888|FG001|NOT COMPLETED|Extension||51
9973855|NCT01555125|11094889|FG002|NOT COMPLETED|Extension||23
9973856|NCT01555125|11094890|FG003|NOT COMPLETED|Extension||22
9973857|NCT01555125|11094891|FG004|NOT COMPLETED|Extension||0
9973858|NCT01555125|11094887|FG000|STARTED|Follow-Up Period||36
9973859|NCT01555125|11094888|FG001|STARTED|Follow-Up Period||31
9973860|NCT01555125|11094889|FG002|STARTED|Follow-Up Period||19
9973861|NCT01555125|11094890|FG003|STARTED|Follow-Up Period||18
9973862|NCT01555125|11094891|FG004|STARTED|Follow-Up Period||0
9973863|NCT01555125|11094887|FG000|COMPLETED|Follow-Up Period||32
9973864|NCT01555125|11094888|FG001|COMPLETED|Follow-Up Period||30
10098283|NCT02382276|11227321|FG002|NOT COMPLETED|Overall Study||39
10098284|NCT02382640|11227331|FG000|STARTED|Intervention Period 1 (3 Days)||9
10098285|NCT02382640|11227332|FG001|STARTED|Intervention Period 1 (3 Days)||9
10098286|NCT02382640|11227333|FG002|STARTED|Intervention Period 1 (3 Days)||9
10098287|NCT02382640|11227334|FG003|STARTED|Intervention Period 1 (3 Days)||9
10098288|NCT02382640|11227331|FG000|COMPLETED|Intervention Period 1 (3 Days)||9
9973865|NCT01555125|11094889|FG002|COMPLETED|Follow-Up Period||18
9973866|NCT01555125|11094890|FG003|COMPLETED|Follow-Up Period||17
9973867|NCT01555125|11094891|FG004|COMPLETED|Follow-Up Period||0
9973868|NCT01555125|11094887|FG000|NOT COMPLETED|Follow-Up Period||4
9973869|NCT01555125|11094888|FG001|NOT COMPLETED|Follow-Up Period||1
9973870|NCT01555125|11094889|FG002|NOT COMPLETED|Follow-Up Period||1
9973871|NCT01555125|11094890|FG003|NOT COMPLETED|Follow-Up Period||1
9973872|NCT01555125|11094891|FG004|NOT COMPLETED|Follow-Up Period||0
9973873|NCT01555138|11094908|FG000|STARTED|Overall Study||293
9973874|NCT01555138|11094909|FG001|STARTED|Overall Study||288
9973875|NCT01555138|11094908|FG000|COMPLETED|Overall Study||246
9973876|NCT01555138|11094909|FG001|COMPLETED|Overall Study||250
9973877|NCT01555138|11094908|FG000|NOT COMPLETED|Overall Study||47
9973878|NCT01555138|11094909|FG001|NOT COMPLETED|Overall Study||38
9973879|NCT01555151|11094919|FG000|STARTED|Overall Study||188
9973880|NCT01555151|11094920|FG001|STARTED|Overall Study||181
9973881|NCT01555151|11094921|FG002|STARTED|Overall Study||184
9973882|NCT01555151|11094922|FG003|STARTED|Overall Study||186
9973883|NCT01555151|11094919|FG000|Safety Set (SAF)|Overall Study||186
9973884|NCT01555151|11094920|FG001|Safety Set (SAF)|Overall Study||180
9973885|NCT01555151|11094921|FG002|Safety Set (SAF)|Overall Study||183
9973886|NCT01555151|11094922|FG003|Safety Set (SAF)|Overall Study||186
9973887|NCT01555151|11094919|FG000|COMPLETED|Overall Study||175
9973888|NCT01555151|11094920|FG001|COMPLETED|Overall Study||173
9973889|NCT01555151|11094921|FG002|COMPLETED|Overall Study||178
9973890|NCT01555151|11094922|FG003|COMPLETED|Overall Study||176
9973891|NCT01555151|11094919|FG000|NOT COMPLETED|Overall Study||13
9973892|NCT01555151|11094920|FG001|NOT COMPLETED|Overall Study||8
9973893|NCT01555151|11094921|FG002|NOT COMPLETED|Overall Study||6
9973894|NCT01555151|11094922|FG003|NOT COMPLETED|Overall Study||10
9973895|NCT01555164|11094935|FG000|STARTED|Overall Study||222
9973896|NCT01555164|11094936|FG001|STARTED|Overall Study||220
9973897|NCT01555164|11094935|FG000|COMPLETED|Overall Study||182
9973898|NCT01555164|11094936|FG001|COMPLETED|Overall Study||185
9973899|NCT01555164|11094935|FG000|NOT COMPLETED|Overall Study||40
9973900|NCT01555164|11094936|FG001|NOT COMPLETED|Overall Study||35
9973901|NCT01555463|11094944|FG000|STARTED|Treatment||483
9973902|NCT01555463|11094945|FG001|STARTED|Treatment||478
9973903|NCT01555463|11094944|FG000|COMPLETED|Treatment||419
9973904|NCT01555463|11094945|FG001|COMPLETED|Treatment||399
9973905|NCT01555463|11094944|FG000|NOT COMPLETED|Treatment||64
9973906|NCT01555463|11094945|FG001|NOT COMPLETED|Treatment||79
9973907|NCT01555463|11094944|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
10098289|NCT02382640|11227332|FG001|COMPLETED|Intervention Period 1 (3 Days)||9
10098290|NCT02382640|11227333|FG002|COMPLETED|Intervention Period 1 (3 Days)||9
9973908|NCT01555463|11094945|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
9973909|NCT01555463|11094944|FG000|COMPLETED|Follow up||409
9973910|NCT01555463|11094945|FG001|COMPLETED|Follow up||394
9973911|NCT01555463|11094944|FG000|NOT COMPLETED|Follow up||38
9973912|NCT01555463|11094945|FG001|NOT COMPLETED|Follow up||45
9973922|NCT01555567|11094960|FG000|STARTED|12 Week||12
9973923|NCT01555567|11094961|FG001|STARTED|12 Week||13
9973924|NCT01555567|11094962|FG002|STARTED|12 Week||9
9973925|NCT01555567|11094963|FG003|STARTED|12 Week||9
10098291|NCT02382640|11227334|FG003|COMPLETED|Intervention Period 1 (3 Days)||9
9973926|NCT01555567|11094960|FG000|COMPLETED|12 Week||11
9973927|NCT01555567|11094961|FG001|COMPLETED|12 Week||12
9973928|NCT01555567|11094962|FG002|COMPLETED|12 Week||8
9973929|NCT01555567|11094963|FG003|COMPLETED|12 Week||9
9973930|NCT01555567|11094960|FG000|NOT COMPLETED|12 Week||1
9973931|NCT01555567|11094961|FG001|NOT COMPLETED|12 Week||1
9973932|NCT01555567|11094962|FG002|NOT COMPLETED|12 Week||1
9973933|NCT01555567|11094963|FG003|NOT COMPLETED|12 Week||0
9973934|NCT01555567|11094960|FG000|STARTED|Return to Activity||11
9973935|NCT01555567|11094961|FG001|STARTED|Return to Activity||12
9973936|NCT01555567|11094962|FG002|STARTED|Return to Activity||8
9973937|NCT01555567|11094963|FG003|STARTED|Return to Activity||9
9973938|NCT01555567|11094960|FG000|COMPLETED|Return to Activity||10
9973939|NCT01555567|11094961|FG001|COMPLETED|Return to Activity||10
9973940|NCT01555567|11094962|FG002|COMPLETED|Return to Activity||8
9973941|NCT01555567|11094963|FG003|COMPLETED|Return to Activity||8
9973942|NCT01555567|11094960|FG000|NOT COMPLETED|Return to Activity||1
9973943|NCT01555567|11094961|FG001|NOT COMPLETED|Return to Activity||2
9973944|NCT01555567|11094962|FG002|NOT COMPLETED|Return to Activity||0
9973945|NCT01555567|11094963|FG003|NOT COMPLETED|Return to Activity||1
9973946|NCT01555671|11094975|FG000|STARTED|Overall Study||125
9973947|NCT01555671|11094976|FG001|STARTED|Overall Study||125
9973948|NCT01555671|11094975|FG000|COMPLETED|Overall Study||105
9973949|NCT01555671|11094976|FG001|COMPLETED|Overall Study||100
9973950|NCT01555671|11094975|FG000|NOT COMPLETED|Overall Study||20
9973951|NCT01555671|11094976|FG001|NOT COMPLETED|Overall Study||25
9973952|NCT01555697|11094992|FG000|STARTED|Overall Study||10
9973953|NCT01555697|11094993|FG001|STARTED|Overall Study||10
9973954|NCT01555697|11094994|FG002|STARTED|Overall Study||10
9973955|NCT01555697|11094995|FG003|STARTED|Overall Study||10
9973956|NCT01555697|11094996|FG004|STARTED|Overall Study||10
9973957|NCT01555697|11094997|FG005|STARTED|Overall Study||10
9973958|NCT01555697|11094998|FG006|STARTED|Overall Study||10
9973959|NCT01555697|11094999|FG007|STARTED|Overall Study||10
9973960|NCT01555697|11094992|FG000|6 Hours Lab Testing Day 1|Overall Study||10
9973961|NCT01555697|11094993|FG001|6 Hours Lab Testing Day 1|Overall Study||10
9973962|NCT01555697|11094994|FG002|6 Hours Lab Testing Day 1|Overall Study||10
9973963|NCT01555697|11094995|FG003|6 Hours Lab Testing Day 1|Overall Study||10
9973964|NCT01555697|11094996|FG004|6 Hours Lab Testing Day 1|Overall Study||10
9973965|NCT01555697|11094997|FG005|6 Hours Lab Testing Day 1|Overall Study||10
9973966|NCT01555697|11094998|FG006|6 Hours Lab Testing Day 1|Overall Study||10
9973967|NCT01555697|11094999|FG007|6 Hours Lab Testing Day 1|Overall Study||10
9973968|NCT01555697|11094992|FG000|Approx 7 Day Washout|Overall Study||10
9973969|NCT01555697|11094993|FG001|Approx 7 Day Washout|Overall Study||10
9973970|NCT01555697|11094994|FG002|Approx 7 Day Washout|Overall Study||10
9973971|NCT01555697|11094995|FG003|Approx 7 Day Washout|Overall Study||10
9973972|NCT01555697|11094996|FG004|Approx 7 Day Washout|Overall Study||10
9973973|NCT01555697|11094997|FG005|Approx 7 Day Washout|Overall Study||10
9973974|NCT01555697|11094998|FG006|Approx 7 Day Washout|Overall Study||10
9973975|NCT01555697|11094999|FG007|Approx 7 Day Washout|Overall Study||10
9973976|NCT01555697|11094992|FG000|6 Hours Lab Testing Day 2|Overall Study||10
9973977|NCT01555697|11094993|FG001|6 Hours Lab Testing Day 2|Overall Study||10
9973978|NCT01555697|11094994|FG002|6 Hours Lab Testing Day 2|Overall Study||10
9973979|NCT01555697|11094995|FG003|6 Hours Lab Testing Day 2|Overall Study||10
9973980|NCT01555697|11094996|FG004|6 Hours Lab Testing Day 2|Overall Study||10
9973981|NCT01555697|11094997|FG005|6 Hours Lab Testing Day 2|Overall Study||10
9973982|NCT01555697|11094998|FG006|6 Hours Lab Testing Day 2|Overall Study||10
9973983|NCT01555697|11094999|FG007|6 Hours Lab Testing Day 2|Overall Study||10
9973984|NCT01555697|11094992|FG000|COMPLETED|Overall Study||10
9973985|NCT01555697|11094993|FG001|COMPLETED|Overall Study||10
9973986|NCT01555697|11094994|FG002|COMPLETED|Overall Study||10
9973987|NCT01555697|11094995|FG003|COMPLETED|Overall Study||10
9973988|NCT01555697|11094996|FG004|COMPLETED|Overall Study||10
9973989|NCT01555697|11094997|FG005|COMPLETED|Overall Study||10
9973990|NCT01555697|11094998|FG006|COMPLETED|Overall Study||10
9973991|NCT01555697|11094999|FG007|COMPLETED|Overall Study||10
9973992|NCT01555697|11094992|FG000|NOT COMPLETED|Overall Study||0
9973993|NCT01555697|11094993|FG001|NOT COMPLETED|Overall Study||0
9973994|NCT01555697|11094994|FG002|NOT COMPLETED|Overall Study||0
9973995|NCT01555697|11094995|FG003|NOT COMPLETED|Overall Study||0
9973996|NCT01555697|11094996|FG004|NOT COMPLETED|Overall Study||0
9973997|NCT01555697|11094997|FG005|NOT COMPLETED|Overall Study||0
9973998|NCT01555697|11094998|FG006|NOT COMPLETED|Overall Study||0
9973999|NCT01555697|11094999|FG007|NOT COMPLETED|Overall Study||0
9974000|NCT01555762|11095011|FG000|STARTED|Overall Study||402
9974001|NCT01555762|11095011|FG000|Safety Population|Overall Study||383
9974002|NCT01555762|11095011|FG000|Efficacy Population|Overall Study||358
9974003|NCT01555762|11095011|FG000|COMPLETED|Overall Study||128
9974004|NCT01555762|11095011|FG000|NOT COMPLETED|Overall Study||274
9974005|NCT01555931|11095017|FG000|STARTED|Overall Study||17
9974006|NCT01555931|11095018|FG001|STARTED|Overall Study||18
9974007|NCT01555931|11095017|FG000|COMPLETED|Overall Study||15
9974008|NCT01555931|11095018|FG001|COMPLETED|Overall Study||13
9974009|NCT01555931|11095017|FG000|NOT COMPLETED|Overall Study||2
9974010|NCT01555931|11095018|FG001|NOT COMPLETED|Overall Study||5
9974011|NCT01555957|11095026|FG000|STARTED|Overall Study||20
9974012|NCT01555957|11095027|FG001|STARTED|Overall Study||20
9974013|NCT01555957|11095026|FG000|COMPLETED|Overall Study||20
9974014|NCT01555957|11095027|FG001|COMPLETED|Overall Study||20
9974015|NCT01555957|11095026|FG000|NOT COMPLETED|Overall Study||0
9974016|NCT01555957|11095027|FG001|NOT COMPLETED|Overall Study||0
9974017|NCT01555983|11095033|FG000|STARTED|Overall Study||9
9974018|NCT01555983|11095034|FG001|STARTED|Overall Study||7
9974019|NCT01555983|11095035|FG002|STARTED|Overall Study||7
9974020|NCT01555983|11095036|FG003|STARTED|Overall Study||7
9974021|NCT01555983|11095037|FG004|STARTED|Overall Study||5
9974022|NCT01555983|11095038|FG005|STARTED|Overall Study||7
9974023|NCT01555983|11095033|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
9974024|NCT01555983|11095034|FG001|COMPLETED|Overall Study||7
9974025|NCT01555983|11095035|FG002|COMPLETED|Overall Study||7
9974026|NCT01555983|11095036|FG003|COMPLETED|Overall Study||7
9974027|NCT01555983|11095037|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
9974028|NCT01555983|11095038|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
9974029|NCT01555983|11095033|FG000|NOT COMPLETED|Overall Study||1
9974030|NCT01555983|11095034|FG001|NOT COMPLETED|Overall Study||0
9974031|NCT01555983|11095035|FG002|NOT COMPLETED|Overall Study||0
9974032|NCT01555983|11095036|FG003|NOT COMPLETED|Overall Study||0
9974033|NCT01555983|11095037|FG004|NOT COMPLETED|Overall Study||1
9974034|NCT01555983|11095038|FG005|NOT COMPLETED|Overall Study||1
9974035|NCT01556061|11095048|FG000|STARTED|Overall Study||25
9974036|NCT01556061|11095049|FG001|STARTED|Overall Study||25
9974037|NCT01556061|11095048|FG000|COMPLETED|Overall Study||25
9974038|NCT01556061|11095049|FG001|COMPLETED|Overall Study||25
9974039|NCT01556061|11095048|FG000|NOT COMPLETED|Overall Study||0
9974040|NCT01556061|11095049|FG001|NOT COMPLETED|Overall Study||0
9974041|NCT01556100|11095057|FG000|STARTED|Overall Study||40
9974042|NCT01556100|11095057|FG000|COMPLETED|Overall Study||34
9974043|NCT01556100|11095057|FG000|NOT COMPLETED|Overall Study||6
9974044|NCT01556165|11095063|FG000|STARTED|Overall Study||65
9974045|NCT01556165|11095064|FG001|STARTED|Overall Study||65
9974046|NCT01556165|11095063|FG000|COMPLETED|Overall Study||53
9974047|NCT01556165|11095064|FG001|COMPLETED|Overall Study||58
9974048|NCT01556165|11095063|FG000|NOT COMPLETED|Overall Study||12
9974049|NCT01556165|11095064|FG001|NOT COMPLETED|Overall Study||7
9974050|NCT01556204|11095072|FG000|STARTED|Overall Study||35
9974051|NCT01556204|11095073|FG001|STARTED|Overall Study||38
9974052|NCT01556204|11095072|FG000|COMPLETED|Overall Study||35
9974053|NCT01556204|11095073|FG001|COMPLETED|Overall Study||38
9974054|NCT01556204|11095072|FG000|NOT COMPLETED|Overall Study||0
9974055|NCT01556204|11095073|FG001|NOT COMPLETED|Overall Study||0
9974056|NCT01556347|11095079|FG000|STARTED|Induction Immunotherapy||2
9974057|NCT01556347|11095079|FG000|COMPLETED|Induction Immunotherapy||2
9974058|NCT01556347|11095079|FG000|NOT COMPLETED|Induction Immunotherapy||0
9974059|NCT01556347|11095079|FG000|STARTED|Bortezomib Treatment Phase||2
9974060|NCT01556347|11095079|FG000|COMPLETED|Bortezomib Treatment Phase||2
9974061|NCT01556347|11095079|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0
10098292|NCT02382640|11227331|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10098293|NCT02382640|11227332|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10098294|NCT02382640|11227333|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10098295|NCT02382640|11227334|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10098296|NCT02382640|11227331|FG000|STARTED|Washout Period 1 (7 Days)||9
9974062|NCT01556347|11095079|FG000|STARTED|Recovery Phase||2
9974063|NCT01556347|11095079|FG000|COMPLETED|Recovery Phase||2
9974064|NCT01556347|11095079|FG000|NOT COMPLETED|Recovery Phase||0
9974065|NCT01556425|11095111|FG000|STARTED|Overall Study||25
9974066|NCT01556425|11095112|FG001|STARTED|Overall Study||23
9974067|NCT01556425|11095113|FG002|STARTED|Overall Study||18
9974068|NCT01556425|11095114|FG003|STARTED|Overall Study||18
9974069|NCT01556425|11095111|FG000|COMPLETED|Overall Study||25
9974070|NCT01556425|11095112|FG001|COMPLETED|Overall Study||23
9974071|NCT01556425|11095113|FG002|COMPLETED|Overall Study||18
9974072|NCT01556425|11095114|FG003|COMPLETED|Overall Study||18
9974073|NCT01556425|11095111|FG000|NOT COMPLETED|Overall Study||0
9974074|NCT01556425|11095112|FG001|NOT COMPLETED|Overall Study||0
9974075|NCT01556425|11095113|FG002|NOT COMPLETED|Overall Study||0
9974076|NCT01556425|11095114|FG003|NOT COMPLETED|Overall Study||0
9974077|NCT01556438|11095126|FG000|STARTED|Overall Study||4
9974078|NCT01556438|11095127|FG001|STARTED|Overall Study||12
9974079|NCT01556438|11095126|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
9974080|NCT01556438|11095127|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
9974081|NCT01556438|11095126|FG000|Received BTZ IV|Overall Study||4
9974082|NCT01556438|11095127|FG001|Received BTZ IV|Overall Study||4
9974083|NCT01556438|11095126|FG000|Received BTZ SC|Overall Study||0
9974084|NCT01556438|11095127|FG001|Received BTZ SC|Overall Study||8
9974085|NCT01556438|11095126|FG000|COMPLETED|Overall Study||0
9974086|NCT01556438|11095127|FG001|COMPLETED|Overall Study||1
9974087|NCT01556438|11095126|FG000|NOT COMPLETED|Overall Study||4
9974088|NCT01556438|11095127|FG001|NOT COMPLETED|Overall Study||11
9974089|NCT01556451|11095141|FG000|STARTED|Overall Study||180
9974090|NCT01556451|11095141|FG000|COMPLETED|Overall Study||180
9974091|NCT01556451|11095141|FG000|NOT COMPLETED|Overall Study||0
9974092|NCT01556581|11095147|FG000|STARTED|Overall Study||61
9974093|NCT01556581|11095148|FG001|STARTED|Overall Study||58
9974094|NCT01556581|11095147|FG000|COMPLETED|Overall Study||61
9974095|NCT01556581|11095148|FG001|COMPLETED|Overall Study||58
9974096|NCT01556581|11095147|FG000|NOT COMPLETED|Overall Study||0
9974097|NCT01556581|11095148|FG001|NOT COMPLETED|Overall Study||0
9974098|NCT01556594|11095157|FG000|STARTED|Overall Study||10
9974099|NCT01556594|11095158|FG001|STARTED|Overall Study||2
9974100|NCT01556594|11095159|FG002|STARTED|Overall Study||6
9974101|NCT01556594|11095157|FG000|COMPLETED|Overall Study||10
9974102|NCT01556594|11095158|FG001|COMPLETED|Overall Study||2
9974103|NCT01556594|11095159|FG002|COMPLETED|Overall Study||6
9974104|NCT01556594|11095157|FG000|NOT COMPLETED|Overall Study||0
9974105|NCT01556594|11095158|FG001|NOT COMPLETED|Overall Study||0
9974106|NCT01556594|11095159|FG002|NOT COMPLETED|Overall Study||0
9974107|NCT01556633|11095171|FG000|STARTED|Overall Study||10
9974108|NCT01556633|11095172|FG001|STARTED|Overall Study||6
9974109|NCT01556633|11095171|FG000|COMPLETED|Overall Study||10
9974110|NCT01556633|11095172|FG001|COMPLETED|Overall Study||6
9974111|NCT01556633|11095171|FG000|NOT COMPLETED|Overall Study||0
9974112|NCT01556633|11095172|FG001|NOT COMPLETED|Overall Study||0
9974113|NCT01556724|11095183|FG000|STARTED|Overall Study||16
9974114|NCT01556724|11095184|FG001|STARTED|Overall Study||14
9974115|NCT01556724|11095183|FG000|COMPLETED|Overall Study||16
9974116|NCT01556724|11095184|FG001|COMPLETED|Overall Study||14
9974117|NCT01556724|11095183|FG000|NOT COMPLETED|Overall Study||0
9974118|NCT01556724|11095184|FG001|NOT COMPLETED|Overall Study||0
9974119|NCT01556763|11095196|FG000|STARTED|Overall Study||4
9974120|NCT01556763|11095197|FG001|STARTED|Overall Study||9
9974121|NCT01556763|11095198|FG002|STARTED|Overall Study||8
9974122|NCT01556763|11095196|FG000|COMPLETED|Overall Study||4
9974123|NCT01556763|11095197|FG001|COMPLETED|Overall Study||8
9974124|NCT01556763|11095198|FG002|COMPLETED|Overall Study||8
9974125|NCT01556763|11095196|FG000|NOT COMPLETED|Overall Study||0
9974126|NCT01556763|11095197|FG001|NOT COMPLETED|Overall Study||1
9974127|NCT01556763|11095198|FG002|NOT COMPLETED|Overall Study||0
9974128|NCT01556906|11095208|FG000|STARTED|Overall Study||6
9974129|NCT01556906|11095208|FG000|COMPLETED|Overall Study||6
9974130|NCT01556906|11095208|FG000|NOT COMPLETED|Overall Study||0
9974131|NCT01556932|11095212|FG000|STARTED|Baseline First Treatment||13
9974132|NCT01556932|11095213|FG001|STARTED|Baseline First Treatment||9
9974133|NCT01556932|11095212|FG000|Recieved|Baseline First Treatment||13
9974134|NCT01556932|11095213|FG001|Recieved|Baseline First Treatment||9
9974135|NCT01556932|11095212|FG000|COMPLETED|Baseline First Treatment||13
9974136|NCT01556932|11095213|FG001|COMPLETED|Baseline First Treatment||9
9974137|NCT01556932|11095212|FG000|NOT COMPLETED|Baseline First Treatment||0
9974138|NCT01556932|11095213|FG001|NOT COMPLETED|Baseline First Treatment||0
9974139|NCT01556932|11095212|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
9974140|NCT01556932|11095213|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
9974141|NCT01556932|11095212|FG000|Recieved|Time Point 60 Minutes||12
9974142|NCT01556932|11095213|FG001|Recieved|Time Point 60 Minutes||8
9974143|NCT01556932|11095212|FG000|COMPLETED|Time Point 60 Minutes||12
9974144|NCT01556932|11095213|FG001|COMPLETED|Time Point 60 Minutes||8
9974145|NCT01556932|11095212|FG000|NOT COMPLETED|Time Point 60 Minutes||1
9974146|NCT01556932|11095213|FG001|NOT COMPLETED|Time Point 60 Minutes||1
9974147|NCT01556932|11095212|FG000|STARTED|Second Treament||12
9974148|NCT01556932|11095213|FG001|STARTED|Second Treament||8
9974149|NCT01556932|11095212|FG000|Recieved|Second Treament||12
9974150|NCT01556932|11095213|FG001|Recieved|Second Treament||8
9974151|NCT01556932|11095212|FG000|COMPLETED|Second Treament||12
9974152|NCT01556932|11095213|FG001|COMPLETED|Second Treament||8
9974153|NCT01556932|11095212|FG000|NOT COMPLETED|Second Treament||0
9974154|NCT01556932|11095213|FG001|NOT COMPLETED|Second Treament||0
9974155|NCT01556997|11095221|FG000|STARTED|Overall Study||279
9974156|NCT01556997|11095222|FG001|STARTED|Overall Study||280
9974157|NCT01556997|11095223|FG002|STARTED|Overall Study||278
10098297|NCT02382640|11227332|FG001|STARTED|Washout Period 1 (7 Days)||9
10098298|NCT02382640|11227333|FG002|STARTED|Washout Period 1 (7 Days)||9
10098299|NCT02382640|11227334|FG003|STARTED|Washout Period 1 (7 Days)||9
10098300|NCT02382640|11227331|FG000|COMPLETED|Washout Period 1 (7 Days)||9
10098301|NCT02382640|11227332|FG001|COMPLETED|Washout Period 1 (7 Days)||9
10098302|NCT02382640|11227333|FG002|COMPLETED|Washout Period 1 (7 Days)||9
10098303|NCT02382640|11227334|FG003|COMPLETED|Washout Period 1 (7 Days)||9
10098304|NCT02382640|11227331|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10098305|NCT02382640|11227332|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10098306|NCT02382640|11227333|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9974158|NCT01556997|11095221|FG000|COMPLETED|Overall Study||253
9974159|NCT01556997|11095222|FG001|COMPLETED|Overall Study||252
9974160|NCT01556997|11095223|FG002|COMPLETED|Overall Study||246
9974161|NCT01556997|11095221|FG000|NOT COMPLETED|Overall Study||26
9974162|NCT01556997|11095222|FG001|NOT COMPLETED|Overall Study||28
9974163|NCT01556997|11095223|FG002|NOT COMPLETED|Overall Study||32
10017738|NCT01818700|11140690|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
10017739|NCT01818700|11140690|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
10017740|NCT01818700|11140690|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
10017741|NCT01818700|11140690|FG000|NOT COMPLETED|Overall Study||104
10017742|NCT01818726|11140698|FG000|STARTED|Overall Study||10
10017743|NCT01818726|11140699|FG001|STARTED|Overall Study||5
10098307|NCT02382640|11227334|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10098308|NCT02382640|11227331|FG000|STARTED|Intervention Period 2 (3 Days)||9
10017744|NCT01818726|11140698|FG000|COMPLETED|Overall Study||4
10017745|NCT01818726|11140699|FG001|COMPLETED|Overall Study||3
10017746|NCT01818726|11140698|FG000|NOT COMPLETED|Overall Study||6
9974164|NCT01557166|11095233|FG000|STARTED|Overall Study||180
9974165|NCT01557166|11095234|FG001|STARTED|Overall Study||179
9974166|NCT01557166|11095233|FG000|Exposed|Overall Study||176
9974167|NCT01557166|11095234|FG001|Exposed|Overall Study||179
9974168|NCT01557166|11095233|FG000|COMPLETED|Overall Study||134
9974169|NCT01557166|11095234|FG001|COMPLETED|Overall Study||142
9974170|NCT01557166|11095233|FG000|NOT COMPLETED|Overall Study||46
9974171|NCT01557166|11095234|FG001|NOT COMPLETED|Overall Study||37
9974172|NCT01557244|11095245|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
9974173|NCT01557244|11095246|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
9974174|NCT01557244|11095247|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
9974175|NCT01557244|11095248|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
9974176|NCT01557244|11095249|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
9974177|NCT01557244|11095250|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
9974178|NCT01557244|11095251|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
9974179|NCT01557244|11095245|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42
9974180|NCT01557244|11095246|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42
9974181|NCT01557244|11095247|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40
9974182|NCT01557244|11095248|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0
9974183|NCT01557244|11095249|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0
9974184|NCT01557244|11095250|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28
9974185|NCT01557244|11095251|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29
9974186|NCT01557244|11095245|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
9974187|NCT01557244|11095246|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
9974188|NCT01557244|11095247|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
9974189|NCT01557244|11095248|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
9974190|NCT01557244|11095249|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
9974191|NCT01557244|11095250|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
9974192|NCT01557244|11095251|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
9974193|NCT01557244|11095245|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
9974194|NCT01557244|11095246|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
9974195|NCT01557244|11095247|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
9974196|NCT01557244|11095248|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
9974197|NCT01557244|11095249|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
9974198|NCT01557244|11095250|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
9974199|NCT01557244|11095251|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
9974200|NCT01557244|11095245|FG000|STARTED|Safety Extension Phase: 12 Weeks||33
10098309|NCT02382640|11227332|FG001|STARTED|Intervention Period 2 (3 Days)||9
10098310|NCT02382640|11227333|FG002|STARTED|Intervention Period 2 (3 Days)||9
10098311|NCT02382640|11227334|FG003|STARTED|Intervention Period 2 (3 Days)||9
10098312|NCT02382640|11227331|FG000|COMPLETED|Intervention Period 2 (3 Days)||9
10098313|NCT02382640|11227332|FG001|COMPLETED|Intervention Period 2 (3 Days)||9
10098314|NCT02382640|11227333|FG002|COMPLETED|Intervention Period 2 (3 Days)||9
9974201|NCT01557244|11095246|FG001|STARTED|Safety Extension Phase: 12 Weeks||40
9974202|NCT01557244|11095247|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
9974203|NCT01557244|11095248|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
9974204|NCT01557244|11095249|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
9974205|NCT01557244|11095250|FG005|STARTED|Safety Extension Phase: 12 Weeks||21
9974206|NCT01557244|11095251|FG006|STARTED|Safety Extension Phase: 12 Weeks||28
9974207|NCT01557244|11095245|FG000|Treated|Safety Extension Phase: 12 Weeks||30
9974208|NCT01557244|11095246|FG001|Treated|Safety Extension Phase: 12 Weeks||37
9974209|NCT01557244|11095247|FG002|Treated|Safety Extension Phase: 12 Weeks||0
9974210|NCT01557244|11095248|FG003|Treated|Safety Extension Phase: 12 Weeks||16
9974211|NCT01557244|11095249|FG004|Treated|Safety Extension Phase: 12 Weeks||20
9974212|NCT01557244|11095250|FG005|Treated|Safety Extension Phase: 12 Weeks||20
9974213|NCT01557244|11095251|FG006|Treated|Safety Extension Phase: 12 Weeks||28
9974214|NCT01557244|11095245|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30
9974215|NCT01557244|11095246|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36
9974216|NCT01557244|11095247|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0
10098315|NCT02382640|11227334|FG003|COMPLETED|Intervention Period 2 (3 Days)||9
10098316|NCT02382640|11227331|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10098317|NCT02382640|11227332|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10202015|NCT03441984|11329277|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0
10202016|NCT03441984|11329278|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0
10202017|NCT03441984|11329279|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0
10202018|NCT03441984|11329280|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0
10202019|NCT03441984|11329281|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0
10202020|NCT03441984|11329282|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3
10202021|NCT03441984|11329283|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3
10202022|NCT03441984|11329284|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3
10202023|NCT03441984|11329285|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3
9974217|NCT01557244|11095248|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15
9974218|NCT01557244|11095249|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20
9974219|NCT01557244|11095250|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20
10113120|NCT02508428|11244055|FG000|NOT COMPLETED|Overall Study||52
9974220|NCT01557244|11095251|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28
9974221|NCT01557244|11095245|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
9974222|NCT01557244|11095246|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
9974223|NCT01557244|11095247|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
9974224|NCT01557244|11095248|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
9974225|NCT01557244|11095249|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
9974226|NCT01557244|11095250|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
9974227|NCT01557244|11095251|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
9974228|NCT01557283|11095279|FG000|STARTED|Overall Study||140
9974229|NCT01557283|11095279|FG000|COMPLETED|Overall Study||96
9974230|NCT01557283|11095279|FG000|NOT COMPLETED|Overall Study||44
9974231|NCT01557322|11095285|FG000|STARTED|Overall Study||211
9974232|NCT01557322|11095286|FG001|STARTED|Overall Study||1543
9974233|NCT01557322|11095285|FG000|COMPLETED|Overall Study||211
9974234|NCT01557322|11095286|FG001|COMPLETED|Overall Study||1543
9974235|NCT01557322|11095285|FG000|NOT COMPLETED|Overall Study||0
9974236|NCT01557322|11095286|FG001|NOT COMPLETED|Overall Study||0
9974237|NCT01557348|11095294|FG000|STARTED|Overall Study||604
9974238|NCT01557348|11095295|FG001|STARTED|Overall Study||507
9974239|NCT01557348|11095294|FG000|Safety Population|Overall Study||604
9974240|NCT01557348|11095295|FG001|Safety Population|Overall Study||507
9974241|NCT01557348|11095294|FG000|COMPLETED|Overall Study||524
9974242|NCT01557348|11095295|FG001|COMPLETED|Overall Study||417
9974243|NCT01557348|11095294|FG000|NOT COMPLETED|Overall Study||80
9974244|NCT01557348|11095295|FG001|NOT COMPLETED|Overall Study||90
9974245|NCT01557400|11095302|FG000|STARTED|Overall Study||94
9974246|NCT01557400|11095302|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
9974247|NCT01557400|11095302|FG000|COMPLETED|Overall Study||37
9974248|NCT01557400|11095302|FG000|NOT COMPLETED|Overall Study||57
9974249|NCT01557452|11095306|FG000|STARTED|Overall Study||1
9974250|NCT01557452|11095306|FG000|COMPLETED|Overall Study||1
9974251|NCT01557452|11095306|FG000|NOT COMPLETED|Overall Study||0
9974252|NCT01557504|11095313|FG000|STARTED|Overall Study||13
9974253|NCT01557504|11095314|FG001|STARTED|Overall Study||12
9974254|NCT01557504|11095313|FG000|COMPLETED|Overall Study||12
9974255|NCT01557504|11095314|FG001|COMPLETED|Overall Study||12
9974256|NCT01557504|11095313|FG000|NOT COMPLETED|Overall Study||1
9974257|NCT01557504|11095314|FG001|NOT COMPLETED|Overall Study||0
9974258|NCT01557517|11095328|FG000|STARTED|Overall Study||19
9974259|NCT01557517|11095329|FG001|STARTED|Overall Study||21
9974260|NCT01557517|11095328|FG000|COMPLETED|Overall Study||17
9974261|NCT01557517|11095329|FG001|COMPLETED|Overall Study||17
9974262|NCT01557517|11095328|FG000|NOT COMPLETED|Overall Study||2
9974263|NCT01557517|11095329|FG001|NOT COMPLETED|Overall Study||4
9974264|NCT01557569|11095344|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6
9974265|NCT01557569|11095345|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7
9974266|NCT01557569|11095344|FG000|Completed 2-wk Residential Stay|Overall Study||3
9974267|NCT01557569|11095345|FG001|Completed 2-wk Residential Stay|Overall Study||1
9974268|NCT01557569|11095344|FG000|COMPLETED|Overall Study||1
9974269|NCT01557569|11095345|FG001|COMPLETED|Overall Study||0
9974270|NCT01557569|11095344|FG000|NOT COMPLETED|Overall Study||5
9974271|NCT01557569|11095345|FG001|NOT COMPLETED|Overall Study||7
9974272|NCT01557582|11095351|FG000|STARTED|Overall Study||103
9974273|NCT01557582|11095351|FG000|COMPLETED|Overall Study||97
9974274|NCT01557582|11095351|FG000|NOT COMPLETED|Overall Study||6
9974275|NCT01557595|11095355|FG000|STARTED|Overall Study||22
9974276|NCT01557595|11095355|FG000|COMPLETED|Overall Study||14
9974277|NCT01557595|11095355|FG000|NOT COMPLETED|Overall Study||8
9974278|NCT01557699|11095362|FG000|STARTED|Overall Study||20
9974279|NCT01557699|11095363|FG001|STARTED|Overall Study||20
9974280|NCT01557699|11095364|FG002|STARTED|Overall Study||20
9974281|NCT01557699|11095362|FG000|COMPLETED|Overall Study||20
9974282|NCT01557699|11095363|FG001|COMPLETED|Overall Study||20
9974283|NCT01557699|11095364|FG002|COMPLETED|Overall Study||20
9974284|NCT01557699|11095362|FG000|NOT COMPLETED|Overall Study||0
9974285|NCT01557699|11095363|FG001|NOT COMPLETED|Overall Study||0
9974286|NCT01557699|11095364|FG002|NOT COMPLETED|Overall Study||0
9974287|NCT01557790|11095375|FG000|STARTED|Overall Study||5
9974288|NCT01557790|11095375|FG000|COMPLETED|Overall Study||4
9974289|NCT01557790|11095375|FG000|NOT COMPLETED|Overall Study||1
9974290|NCT01557842|11095381|FG000|STARTED|Overall Study||9
9974291|NCT01557842|11095382|FG001|STARTED|Overall Study||6
9974292|NCT01557842|11095381|FG000|COMPLETED|Overall Study||0
9974293|NCT01557842|11095382|FG001|COMPLETED|Overall Study||0
9974294|NCT01557842|11095381|FG000|NOT COMPLETED|Overall Study||9
9974295|NCT01557842|11095382|FG001|NOT COMPLETED|Overall Study||6
9974296|NCT01557868|11095390|FG000|STARTED|Overall Study||103
9974297|NCT01557868|11095391|FG001|STARTED|Overall Study||95
9974298|NCT01557868|11095390|FG000|COMPLETED|Overall Study||76
9974299|NCT01557868|11095391|FG001|COMPLETED|Overall Study||65
9974300|NCT01557868|11095390|FG000|NOT COMPLETED|Overall Study||27
9974301|NCT01557868|11095391|FG001|NOT COMPLETED|Overall Study||30
9974302|NCT01557894|11095399|FG000|STARTED|Overall Study||38
9974303|NCT01557894|11095400|FG001|STARTED|Overall Study||38
9974304|NCT01557894|11095399|FG000|COMPLETED|Overall Study||35
9974305|NCT01557894|11095400|FG001|COMPLETED|Overall Study||33
9974306|NCT01557894|11095399|FG000|NOT COMPLETED|Overall Study||3
9974307|NCT01557894|11095400|FG001|NOT COMPLETED|Overall Study||5
9974308|NCT01557920|11095407|FG000|STARTED|Overall Study||9
9974309|NCT01557920|11095408|FG001|STARTED|Overall Study||9
9974310|NCT01557920|11095407|FG000|COMPLETED|Overall Study||6
9974311|NCT01557920|11095408|FG001|COMPLETED|Overall Study||6
9974312|NCT01557920|11095407|FG000|NOT COMPLETED|Overall Study||3
9974313|NCT01557920|11095408|FG001|NOT COMPLETED|Overall Study||3
9974314|NCT01557946|11095443|FG000|STARTED|Overall Study||20
9974315|NCT01557946|11095444|FG001|STARTED|Overall Study||12
9974316|NCT01557946|11095443|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
9974317|NCT01557946|11095444|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
9974318|NCT01557946|11095443|FG000|NOT COMPLETED|Overall Study||3
9974319|NCT01557946|11095444|FG001|NOT COMPLETED|Overall Study||0
9974320|NCT01557959|11095449|FG000|STARTED|Overall Study||45
9974321|NCT01557959|11095449|FG000|COMPLETED|Overall Study||45
9974322|NCT01557959|11095449|FG000|NOT COMPLETED|Overall Study||0
9974323|NCT01558063|11095461|FG000|STARTED|Overall Study||5
9974324|NCT01558063|11095462|FG001|STARTED|Overall Study||6
9974325|NCT01558063|11095463|FG002|STARTED|Overall Study||8
9974326|NCT01558063|11095464|FG003|STARTED|Overall Study||5
9974327|NCT01558063|11095465|FG004|STARTED|Overall Study||9
9974328|NCT01558063|11095466|FG005|STARTED|Overall Study||5
9974329|NCT01558063|11095461|FG000|COMPLETED|Overall Study||5
9974330|NCT01558063|11095462|FG001|COMPLETED|Overall Study||6
9974331|NCT01558063|11095463|FG002|COMPLETED|Overall Study||8
9974332|NCT01558063|11095464|FG003|COMPLETED|Overall Study||5
9974333|NCT01558063|11095465|FG004|COMPLETED|Overall Study||9
9974334|NCT01558063|11095466|FG005|COMPLETED|Overall Study||5
9974335|NCT01558063|11095461|FG000|NOT COMPLETED|Overall Study||0
9974336|NCT01558063|11095462|FG001|NOT COMPLETED|Overall Study||0
9974337|NCT01558063|11095463|FG002|NOT COMPLETED|Overall Study||0
9974338|NCT01558063|11095464|FG003|NOT COMPLETED|Overall Study||0
9974339|NCT01558063|11095465|FG004|NOT COMPLETED|Overall Study||0
9974340|NCT01558063|11095466|FG005|NOT COMPLETED|Overall Study||0
9974341|NCT01558089|11095475|FG000|STARTED|Overall Study||76
9974342|NCT01558089|11095475|FG000|COMPLETED|Overall Study||63
9974343|NCT01558089|11095475|FG000|NOT COMPLETED|Overall Study||13
9974344|NCT01558128|11095479|FG000|STARTED|Overall Study||1
9974345|NCT01558128|11095479|FG000|COMPLETED|Overall Study||1
9974346|NCT01558128|11095479|FG000|NOT COMPLETED|Overall Study||0
9974347|NCT01558271|11095486|FG000|STARTED|Overall Study||281
9974348|NCT01558271|11095487|FG001|STARTED|Overall Study||70
9974349|NCT01558271|11095488|FG002|STARTED|Overall Study||141
9974350|NCT01558271|11095486|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280
9974351|NCT01558271|11095487|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70
9974352|NCT01558271|11095488|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137
9974353|NCT01558271|11095486|FG000|Completed 26 Weeks|Overall Study||271
9974354|NCT01558271|11095487|FG001|Completed 26 Weeks|Overall Study||63
9974355|NCT01558271|11095488|FG002|Completed 26 Weeks|Overall Study||128
9974356|NCT01558271|11095486|FG000|COMPLETED|Overall Study||263
9974357|NCT01558271|11095487|FG001|COMPLETED|Overall Study||59
9974358|NCT01558271|11095488|FG002|COMPLETED|Overall Study||124
9974359|NCT01558271|11095486|FG000|NOT COMPLETED|Overall Study||18
9974360|NCT01558271|11095487|FG001|NOT COMPLETED|Overall Study||11
9974361|NCT01558271|11095488|FG002|NOT COMPLETED|Overall Study||17
9974362|NCT01558297|11095503|FG000|STARTED|Overall Study||30
9974363|NCT01558297|11095504|FG001|STARTED|Overall Study||29
9974364|NCT01558297|11095505|FG002|STARTED|Overall Study||30
9974365|NCT01558297|11095503|FG000|COMPLETED|Overall Study||28
9974366|NCT01558297|11095504|FG001|COMPLETED|Overall Study||27
9974367|NCT01558297|11095505|FG002|COMPLETED|Overall Study||29
9974368|NCT01558297|11095503|FG000|NOT COMPLETED|Overall Study||2
9974369|NCT01558297|11095504|FG001|NOT COMPLETED|Overall Study||2
9974370|NCT01558297|11095505|FG002|NOT COMPLETED|Overall Study||1
9974371|NCT01558596|11095515|FG000|STARTED|Overall Study||104
10098318|NCT02382640|11227333|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10098319|NCT02382640|11227334|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10098320|NCT02382640|11227331|FG000|STARTED|Washout Period 2 (7 Days)||9
10098321|NCT02382640|11227332|FG001|STARTED|Washout Period 2 (7 Days)||9
10098322|NCT02382640|11227333|FG002|STARTED|Washout Period 2 (7 Days)||9
10098323|NCT02382640|11227334|FG003|STARTED|Washout Period 2 (7 Days)||9
10098324|NCT02382640|11227331|FG000|COMPLETED|Washout Period 2 (7 Days)||9
10098325|NCT02382640|11227332|FG001|COMPLETED|Washout Period 2 (7 Days)||9
9974372|NCT01558596|11095516|FG001|STARTED|Overall Study||101
9974373|NCT01558596|11095515|FG000|COMPLETED|Overall Study||101
9974374|NCT01558596|11095516|FG001|COMPLETED|Overall Study||100
9974375|NCT01558596|11095515|FG000|NOT COMPLETED|Overall Study||3
9974376|NCT01558596|11095516|FG001|NOT COMPLETED|Overall Study||1
9974377|NCT01558635|11095522|FG000|STARTED|Overall Study||17
9974378|NCT01558635|11095522|FG000|Treated|Overall Study||17
9974379|NCT01558635|11095522|FG000|Discharge /1 Month Post-procedure|Overall Study||15
9974380|NCT01558635|11095522|FG000|3 Months Post-procedure|Overall Study||14
9974381|NCT01558635|11095522|FG000|6 Months Post-procedure|Overall Study||14
9974382|NCT01558635|11095522|FG000|COMPLETED|Overall Study||11
9974383|NCT01558635|11095522|FG000|NOT COMPLETED|Overall Study||6
9974384|NCT01558661|11095533|FG000|STARTED|Overall Study||33
9974385|NCT01558661|11095533|FG000|First Stage|Overall Study||18
9974386|NCT01558661|11095533|FG000|Second Stage|Overall Study||15
9974387|NCT01558661|11095533|FG000|COMPLETED|Overall Study||33
9974388|NCT01558661|11095533|FG000|NOT COMPLETED|Overall Study||0
9974389|NCT01558674|11095539|FG000|STARTED|Part 1||11
10098326|NCT02382640|11227333|FG002|COMPLETED|Washout Period 2 (7 Days)||9
9974390|NCT01558674|11095540|FG001|STARTED|Part 1||0
9974391|NCT01558674|11095539|FG000|COMPLETED|Part 1||0
9974392|NCT01558674|11095540|FG001|COMPLETED|Part 1||0
9974393|NCT01558674|11095539|FG000|NOT COMPLETED|Part 1||11
9974394|NCT01558674|11095540|FG001|NOT COMPLETED|Part 1||0
9974395|NCT01558674|11095539|FG000|STARTED|Part 2||0
9974396|NCT01558674|11095540|FG001|STARTED|Part 2||0
9974397|NCT01558674|11095539|FG000|COMPLETED|Part 2||0
9974398|NCT01558674|11095540|FG001|COMPLETED|Part 2||0
9974399|NCT01558674|11095539|FG000|NOT COMPLETED|Part 2||0
9974400|NCT01558674|11095540|FG001|NOT COMPLETED|Part 2||0
10098327|NCT02382640|11227334|FG003|COMPLETED|Washout Period 2 (7 Days)||9
10098328|NCT02382640|11227331|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10098329|NCT02382640|11227332|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10098330|NCT02382640|11227333|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10098331|NCT02382640|11227334|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10098332|NCT02382640|11227331|FG000|STARTED|Intervention Period 3 (3 Days)||9
10098333|NCT02382640|11227332|FG001|STARTED|Intervention Period 3 (3 Days)||9
10098334|NCT02382640|11227333|FG002|STARTED|Intervention Period 3 (3 Days)||9
10098335|NCT02382640|11227334|FG003|STARTED|Intervention Period 3 (3 Days)||9
10098336|NCT02382640|11227331|FG000|COMPLETED|Intervention Period 3 (3 Days)||9
10098337|NCT02382640|11227332|FG001|COMPLETED|Intervention Period 3 (3 Days)||9
10098338|NCT02382640|11227333|FG002|COMPLETED|Intervention Period 3 (3 Days)||9
10098339|NCT02382640|11227334|FG003|COMPLETED|Intervention Period 3 (3 Days)||9
10098340|NCT02382640|11227331|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10098341|NCT02382640|11227332|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10098342|NCT02382640|11227333|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10098343|NCT02382640|11227334|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10098344|NCT02382640|11227331|FG000|STARTED|Washout Period 3 (7 Days)||9
10098345|NCT02382640|11227332|FG001|STARTED|Washout Period 3 (7 Days)||9
10098346|NCT02382640|11227333|FG002|STARTED|Washout Period 3 (7 Days)||9
10098347|NCT02382640|11227334|FG003|STARTED|Washout Period 3 (7 Days)||9
10098348|NCT02382640|11227331|FG000|COMPLETED|Washout Period 3 (7 Days)||9
10098349|NCT02382640|11227332|FG001|COMPLETED|Washout Period 3 (7 Days)||9
10098350|NCT02382640|11227333|FG002|COMPLETED|Washout Period 3 (7 Days)||9
10098351|NCT02382640|11227334|FG003|COMPLETED|Washout Period 3 (7 Days)||9
10098352|NCT02382640|11227331|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10098353|NCT02382640|11227332|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10098354|NCT02382640|11227333|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10098355|NCT02382640|11227334|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10098356|NCT02382640|11227331|FG000|STARTED|Intervention Period 4 (3 Days)||9
10098357|NCT02382640|11227332|FG001|STARTED|Intervention Period 4 (3 Days)||9
10098358|NCT02382640|11227333|FG002|STARTED|Intervention Period 4 (3 Days)||9
10098359|NCT02382640|11227334|FG003|STARTED|Intervention Period 4 (3 Days)||9
10098360|NCT02382640|11227331|FG000|COMPLETED|Intervention Period 4 (3 Days)||8
10098361|NCT02382640|11227332|FG001|COMPLETED|Intervention Period 4 (3 Days)||9
10098362|NCT02382640|11227333|FG002|COMPLETED|Intervention Period 4 (3 Days)||9
10098363|NCT02382640|11227334|FG003|COMPLETED|Intervention Period 4 (3 Days)||9
10098364|NCT02382640|11227331|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1
10098365|NCT02382640|11227332|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10098366|NCT02382640|11227333|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10098367|NCT02382640|11227334|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10098368|NCT02382705|11227344|FG000|STARTED|Overall Study||57
10098369|NCT02382705|11227344|FG000|COMPLETED|Overall Study||33
10098370|NCT02382705|11227344|FG000|NOT COMPLETED|Overall Study||24
10098371|NCT02382744|11227350|FG000|STARTED|Overall Study||40
10098372|NCT02382744|11227351|FG001|STARTED|Overall Study||40
10098373|NCT02382744|11227350|FG000|Allocated|Overall Study||40
10098374|NCT02382744|11227351|FG001|Allocated|Overall Study||40
10098375|NCT02382744|11227350|FG000|Analyzed|Overall Study||40
10098376|NCT02382744|11227351|FG001|Analyzed|Overall Study||40
10098377|NCT02382744|11227350|FG000|COMPLETED|Overall Study||40
10098378|NCT02382744|11227351|FG001|COMPLETED|Overall Study||40
10098379|NCT02382744|11227350|FG000|NOT COMPLETED|Overall Study||0
10098380|NCT02382744|11227351|FG001|NOT COMPLETED|Overall Study||0
10098381|NCT02382796|11227361|FG000|STARTED|Overall Study||7
10098382|NCT02382796|11227361|FG000|COMPLETED|Overall Study||0
9974401|NCT01558700|11095561|FG000|STARTED|Overall Study||19
9974402|NCT01558700|11095562|FG001|STARTED|Overall Study||21
10098383|NCT02382796|11227361|FG000|NOT COMPLETED|Overall Study||7
10098384|NCT02382848|11227365|FG000|STARTED|First Intervention (3 Weeks)||3
10098385|NCT02382848|11227366|FG001|STARTED|First Intervention (3 Weeks)||5
10098386|NCT02382848|11227365|FG000|COMPLETED|First Intervention (3 Weeks)||3
10098387|NCT02382848|11227366|FG001|COMPLETED|First Intervention (3 Weeks)||5
10098388|NCT02382848|11227365|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10098389|NCT02382848|11227366|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10098390|NCT02382848|11227365|FG000|STARTED|Washout (1 Week)||3
10098391|NCT02382848|11227366|FG001|STARTED|Washout (1 Week)||5
10098392|NCT02382848|11227365|FG000|COMPLETED|Washout (1 Week)||3
10098393|NCT02382848|11227366|FG001|COMPLETED|Washout (1 Week)||5
10098394|NCT02382848|11227365|FG000|NOT COMPLETED|Washout (1 Week)||0
10098395|NCT02382848|11227366|FG001|NOT COMPLETED|Washout (1 Week)||0
9974403|NCT01558700|11095561|FG000|COMPLETED|Overall Study||19
9974404|NCT01558700|11095562|FG001|COMPLETED|Overall Study||21
9974405|NCT01558700|11095561|FG000|NOT COMPLETED|Overall Study||0
9974406|NCT01558700|11095562|FG001|NOT COMPLETED|Overall Study||0
9974407|NCT01558739|11095568|FG000|STARTED|Overall Study||48
9974408|NCT01558739|11095568|FG000|COMPLETED|Overall Study||31
9974409|NCT01558739|11095568|FG000|NOT COMPLETED|Overall Study||17
9974410|NCT01558752|11095574|FG000|STARTED|Overall Study||42
9974411|NCT01558752|11095575|FG001|STARTED|Overall Study||46
9974412|NCT01558752|11095574|FG000|COMPLETED|Overall Study||40
9974413|NCT01558752|11095575|FG001|COMPLETED|Overall Study||46
9974414|NCT01558752|11095574|FG000|NOT COMPLETED|Overall Study||2
9974415|NCT01558752|11095575|FG001|NOT COMPLETED|Overall Study||0
9974416|NCT01558791|11095583|FG000|STARTED|Overall Study||607
9974417|NCT01558791|11095584|FG001|STARTED|Overall Study||629
9974418|NCT01558791|11095583|FG000|COMPLETED|Overall Study||607
9974419|NCT01558791|11095584|FG001|COMPLETED|Overall Study||629
9974420|NCT01558791|11095583|FG000|NOT COMPLETED|Overall Study||0
9974421|NCT01558791|11095584|FG001|NOT COMPLETED|Overall Study||0
9974422|NCT01559012|11095594|FG000|STARTED|Overall Study||6
9974423|NCT01559012|11095595|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
9974424|NCT01559012|11095594|FG000|COMPLETED|Overall Study||6
9974425|NCT01559012|11095595|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
9974426|NCT01559012|11095594|FG000|NOT COMPLETED|Overall Study||0
9974427|NCT01559012|11095595|FG001|NOT COMPLETED|Overall Study||1
9974428|NCT01559064|11095619|FG000|STARTED|Overall Study||16
9974429|NCT01559064|11095620|FG001|STARTED|Overall Study||40
9974430|NCT01559064|11095621|FG002|STARTED|Overall Study||59
9974431|NCT01559064|11095619|FG000|COMPLETED|Overall Study||15
9974432|NCT01559064|11095620|FG001|COMPLETED|Overall Study||39
9974433|NCT01559064|11095621|FG002|COMPLETED|Overall Study||57
9974434|NCT01559064|11095619|FG000|NOT COMPLETED|Overall Study||1
9974435|NCT01559064|11095620|FG001|NOT COMPLETED|Overall Study||1
9974436|NCT01559064|11095621|FG002|NOT COMPLETED|Overall Study||2
9974437|NCT01559090|11095632|FG000|STARTED|Stage I||6
9974438|NCT01559090|11095633|FG001|STARTED|Stage I||5
9974439|NCT01559090|11095634|FG002|STARTED|Stage I||6
9974440|NCT01559090|11095632|FG000|COMPLETED|Stage I||4
9974441|NCT01559090|11095633|FG001|COMPLETED|Stage I||3
9974442|NCT01559090|11095634|FG002|COMPLETED|Stage I||3
9974443|NCT01559090|11095632|FG000|NOT COMPLETED|Stage I||2
9974444|NCT01559090|11095633|FG001|NOT COMPLETED|Stage I||2
9974445|NCT01559090|11095634|FG002|NOT COMPLETED|Stage I||3
9974446|NCT01559090|11095632|FG000|STARTED|Stage II||4
9974447|NCT01559090|11095633|FG001|STARTED|Stage II||3
9974448|NCT01559090|11095634|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
9974449|NCT01559090|11095632|FG000|COMPLETED|Stage II||3
9974450|NCT01559090|11095633|FG001|COMPLETED|Stage II||3
9974451|NCT01559090|11095634|FG002|COMPLETED|Stage II||2
9974452|NCT01559090|11095632|FG000|NOT COMPLETED|Stage II||1
9974453|NCT01559090|11095633|FG001|NOT COMPLETED|Stage II||0
9974454|NCT01559090|11095634|FG002|NOT COMPLETED|Stage II||0
9974455|NCT01559116|11095642|FG000|STARTED|Overall Study|Randomised|219
9974456|NCT01559116|11095642|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193
9974457|NCT01559116|11095642|FG000|NOT COMPLETED|Overall Study||26
9974458|NCT01559129|11095661|FG000|STARTED|Treatment Phase||12
9974459|NCT01559129|11095662|FG001|STARTED|Treatment Phase||11
9974460|NCT01559129|11095661|FG000|Received Treatment|Treatment Phase||12
9974461|NCT01559129|11095662|FG001|Received Treatment|Treatment Phase||10
9974462|NCT01559129|11095661|FG000|COMPLETED|Treatment Phase||7
9974463|NCT01559129|11095662|FG001|COMPLETED|Treatment Phase||4
9974464|NCT01559129|11095661|FG000|NOT COMPLETED|Treatment Phase||5
9974465|NCT01559129|11095662|FG001|NOT COMPLETED|Treatment Phase||7
9974466|NCT01559129|11095661|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
9974467|NCT01559129|11095662|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
9974468|NCT01559129|11095661|FG000|COMPLETED|Open-label Extension Period||0
9974469|NCT01559129|11095662|FG001|COMPLETED|Open-label Extension Period||0
9974470|NCT01559129|11095661|FG000|NOT COMPLETED|Open-label Extension Period||6
9974471|NCT01559129|11095662|FG001|NOT COMPLETED|Open-label Extension Period||2
9974472|NCT01559259|11095679|FG000|STARTED|Overall Study||30
9974473|NCT01559259|11095680|FG001|STARTED|Overall Study||90
9974474|NCT01559259|11095681|FG002|STARTED|Overall Study||93
9974475|NCT01559259|11095682|FG003|STARTED|Overall Study||89
9974476|NCT01559259|11095683|FG004|STARTED|Overall Study||92
9974477|NCT01559259|11095679|FG000|COMPLETED|Overall Study||30
9974478|NCT01559259|11095680|FG001|COMPLETED|Overall Study||89
9974479|NCT01559259|11095681|FG002|COMPLETED|Overall Study||92
9974480|NCT01559259|11095682|FG003|COMPLETED|Overall Study||88
9974481|NCT01559259|11095683|FG004|COMPLETED|Overall Study||92
9974482|NCT01559259|11095679|FG000|NOT COMPLETED|Overall Study||0
9974483|NCT01559259|11095680|FG001|NOT COMPLETED|Overall Study||1
9974484|NCT01559259|11095681|FG002|NOT COMPLETED|Overall Study||1
9974485|NCT01559259|11095682|FG003|NOT COMPLETED|Overall Study||1
9974486|NCT01559259|11095683|FG004|NOT COMPLETED|Overall Study||0
9974487|NCT01559311|11095698|FG000|STARTED|Overall Study|Enrollment & Baseline|30
9974488|NCT01559311|11095699|FG001|STARTED|Overall Study|Enrollment & Baseline|34
9974489|NCT01559311|11095700|FG002|STARTED|Overall Study|Enrollment & Baseline|34
9974490|NCT01559311|11095698|FG000|Implant|Overall Study||28
9974491|NCT01559311|11095699|FG001|Implant|Overall Study||34
9974492|NCT01559311|11095700|FG002|Implant|Overall Study||32
9974493|NCT01559311|11095698|FG000|1-Month|Overall Study||27
9974494|NCT01559311|11095699|FG001|1-Month|Overall Study||34
9974495|NCT01559311|11095700|FG002|1-Month|Overall Study||29
9974496|NCT01559311|11095698|FG000|3-Month|Overall Study||27
9974497|NCT01559311|11095699|FG001|3-Month|Overall Study||34
9974498|NCT01559311|11095700|FG002|3-Month|Overall Study||29
9974499|NCT01559311|11095698|FG000|6-Month|Overall Study||27
9974500|NCT01559311|11095699|FG001|6-Month|Overall Study||33
9974501|NCT01559311|11095700|FG002|6-Month|Overall Study||28
9974502|NCT01559311|11095698|FG000|COMPLETED|Overall Study|12-Month|27
9974503|NCT01559311|11095699|FG001|COMPLETED|Overall Study|12-Month|28
9974504|NCT01559311|11095700|FG002|COMPLETED|Overall Study|12-Month|26
9974505|NCT01559311|11095698|FG000|NOT COMPLETED|Overall Study||3
9974506|NCT01559311|11095699|FG001|NOT COMPLETED|Overall Study||6
9974507|NCT01559311|11095700|FG002|NOT COMPLETED|Overall Study||8
9974508|NCT01559389|11095710|FG000|STARTED|Overall Study||69
9974509|NCT01559389|11095711|FG001|STARTED|Overall Study||69
9974510|NCT01559389|11095710|FG000|COMPLETED|Overall Study||49
9974511|NCT01559389|11095711|FG001|COMPLETED|Overall Study||49
9974512|NCT01559389|11095710|FG000|NOT COMPLETED|Overall Study||20
9974513|NCT01559389|11095711|FG001|NOT COMPLETED|Overall Study||20
9974514|NCT01559454|11095723|FG000|STARTED|Overall Study||9
9974515|NCT01559454|11095724|FG001|STARTED|Overall Study||10
9974516|NCT01559454|11095723|FG000|COMPLETED|Overall Study||6
9974517|NCT01559454|11095724|FG001|COMPLETED|Overall Study||4
9974518|NCT01559454|11095723|FG000|NOT COMPLETED|Overall Study||3
9974519|NCT01559454|11095724|FG001|NOT COMPLETED|Overall Study||6
9974520|NCT01559506|11095732|FG000|STARTED|Overall Study||20
9974521|NCT01559506|11095733|FG001|STARTED|Overall Study||21
9974522|NCT01559506|11095732|FG000|COMPLETED|Overall Study||20
9974523|NCT01559506|11095733|FG001|COMPLETED|Overall Study||18
9974524|NCT01559506|11095732|FG000|NOT COMPLETED|Overall Study||0
9974525|NCT01559506|11095733|FG001|NOT COMPLETED|Overall Study||3
9974526|NCT01559649|11095741|FG000|STARTED|Overall Study||269
9974527|NCT01559649|11095742|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
9974528|NCT01559649|11095741|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
9974529|NCT01559649|11095742|FG001|COMPLETED|Overall Study||9
9974530|NCT01559649|11095741|FG000|NOT COMPLETED|Overall Study||19
9974531|NCT01559649|11095742|FG001|NOT COMPLETED|Overall Study||6
9974532|NCT01559675|11095751|FG000|STARTED|Overall Study||58
9974533|NCT01559675|11095752|FG001|STARTED|Overall Study||63
9974534|NCT01559675|11095751|FG000|COMPLETED|Overall Study||43
9974535|NCT01559675|11095752|FG001|COMPLETED|Overall Study||49
9974536|NCT01559675|11095751|FG000|NOT COMPLETED|Overall Study||15
9974537|NCT01559675|11095752|FG001|NOT COMPLETED|Overall Study||14
9974538|NCT01559844|11095758|FG000|STARTED|Overall Study||61
9974539|NCT01559844|11095758|FG000|COMPLETED|Overall Study||36
9974540|NCT01559844|11095758|FG000|NOT COMPLETED|Overall Study||25
9974541|NCT01559857|11095764|FG000|STARTED|Overall Study||19
9974542|NCT01559857|11095765|FG001|STARTED|Overall Study||18
9974543|NCT01559857|11095764|FG000|COMPLETED|Overall Study||19
9974544|NCT01559857|11095765|FG001|COMPLETED|Overall Study||18
9974545|NCT01559857|11095764|FG000|NOT COMPLETED|Overall Study||0
9974546|NCT01559857|11095765|FG001|NOT COMPLETED|Overall Study||0
9974547|NCT01559922|11095775|FG000|STARTED|Overall Study||50
9974548|NCT01559922|11095776|FG001|STARTED|Overall Study||97
9974549|NCT01559922|11095775|FG000|COMPLETED|Overall Study||46
9974550|NCT01559922|11095776|FG001|COMPLETED|Overall Study||87
9974551|NCT01559922|11095775|FG000|NOT COMPLETED|Overall Study||4
9974552|NCT01559922|11095776|FG001|NOT COMPLETED|Overall Study||10
9974553|NCT01559948|11095784|FG000|STARTED|Overall Study||15
9974554|NCT01559948|11095785|FG001|STARTED|Overall Study||15
9974555|NCT01559948|11095784|FG000|COMPLETED|Overall Study||15
9974556|NCT01559948|11095785|FG001|COMPLETED|Overall Study||15
9974557|NCT01559948|11095784|FG000|NOT COMPLETED|Overall Study||0
9974558|NCT01559948|11095785|FG001|NOT COMPLETED|Overall Study||0
9974559|NCT01560143|11095795|FG000|STARTED|Overall Study||12
9974560|NCT01560143|11095795|FG000|COMPLETED|Overall Study||12
9974561|NCT01560143|11095795|FG000|NOT COMPLETED|Overall Study||0
9974562|NCT01560234|11095807|FG000|STARTED|Overall Study||16
9974563|NCT01560234|11095808|FG001|STARTED|Overall Study||4
9974564|NCT01560234|11095809|FG002|STARTED|Overall Study||4
9974565|NCT01560234|11095810|FG003|STARTED|Overall Study||3
9974566|NCT01560234|11095811|FG004|STARTED|Overall Study||4
9974567|NCT01560234|11095812|FG005|STARTED|Overall Study||4
9974568|NCT01560234|11095813|FG006|STARTED|Overall Study||4
9974569|NCT01560234|11095814|FG007|STARTED|Overall Study||8
9974570|NCT01560234|11095807|FG000|COMPLETED|Overall Study||13
9974571|NCT01560234|11095808|FG001|COMPLETED|Overall Study||4
9974572|NCT01560234|11095809|FG002|COMPLETED|Overall Study||3
9974573|NCT01560234|11095810|FG003|COMPLETED|Overall Study||3
9974574|NCT01560234|11095811|FG004|COMPLETED|Overall Study||4
9974575|NCT01560234|11095812|FG005|COMPLETED|Overall Study||2
9974576|NCT01560234|11095813|FG006|COMPLETED|Overall Study||4
9974577|NCT01560234|11095814|FG007|COMPLETED|Overall Study||6
9974578|NCT01560234|11095807|FG000|NOT COMPLETED|Overall Study||3
9974579|NCT01560234|11095808|FG001|NOT COMPLETED|Overall Study||0
9974580|NCT01560234|11095809|FG002|NOT COMPLETED|Overall Study||1
9974581|NCT01560234|11095810|FG003|NOT COMPLETED|Overall Study||0
9974582|NCT01560234|11095811|FG004|NOT COMPLETED|Overall Study||0
9974583|NCT01560234|11095812|FG005|NOT COMPLETED|Overall Study||2
9974584|NCT01560234|11095813|FG006|NOT COMPLETED|Overall Study||0
9974585|NCT01560234|11095814|FG007|NOT COMPLETED|Overall Study||2
9974586|NCT01560260|11095832|FG000|STARTED|Overall Study||20
9974587|NCT01560260|11095832|FG000|COMPLETED|Overall Study||20
9974588|NCT01560260|11095832|FG000|NOT COMPLETED|Overall Study||0
9974589|NCT01560286|11095838|FG000|STARTED|Overall Study||24
9974590|NCT01560286|11095838|FG000|COMPLETED|Overall Study||24
9974591|NCT01560286|11095838|FG000|NOT COMPLETED|Overall Study||0
9974592|NCT01560377|11095842|FG000|STARTED|Overall Study||147
9974593|NCT01560377|11095842|FG000|Eligible for Analysis|Overall Study||139
9974594|NCT01560377|11095842|FG000|COMPLETED|Overall Study||147
9974595|NCT01560377|11095842|FG000|NOT COMPLETED|Overall Study||0
9974596|NCT01560403|11095848|FG000|STARTED|Overall Study||5
9974597|NCT01560403|11095849|FG001|STARTED|Overall Study||9
9974598|NCT01560403|11095848|FG000|COMPLETED|Overall Study||5
9974599|NCT01560403|11095849|FG001|COMPLETED|Overall Study||8
9974600|NCT01560403|11095848|FG000|NOT COMPLETED|Overall Study||0
9974601|NCT01560403|11095849|FG001|NOT COMPLETED|Overall Study||1
9974602|NCT01560416|11095857|FG000|STARTED|Randomized Phase||15
9974603|NCT01560416|11095858|FG001|STARTED|Randomized Phase||35
9974604|NCT01560416|11095857|FG000|COMPLETED|Randomized Phase||8
9974605|NCT01560416|11095858|FG001|COMPLETED|Randomized Phase||35
9974606|NCT01560416|11095857|FG000|NOT COMPLETED|Randomized Phase||7
9974607|NCT01560416|11095858|FG001|NOT COMPLETED|Randomized Phase||0
9974608|NCT01560416|11095857|FG000|STARTED|Crossover Phase||7
9974609|NCT01560416|11095858|FG001|STARTED|Crossover Phase||0
9974610|NCT01560416|11095857|FG000|COMPLETED|Crossover Phase||7
9974611|NCT01560416|11095858|FG001|COMPLETED|Crossover Phase||0
9974612|NCT01560416|11095857|FG000|NOT COMPLETED|Crossover Phase||0
9974613|NCT01560416|11095858|FG001|NOT COMPLETED|Crossover Phase||0
9974614|NCT01560429|11095868|FG000|STARTED|Overall Study||26
9974615|NCT01560429|11095869|FG001|STARTED|Overall Study||26
9974616|NCT01560429|11095868|FG000|COMPLETED|Overall Study||23
9974617|NCT01560429|11095869|FG001|COMPLETED|Overall Study||20
9974618|NCT01560429|11095868|FG000|NOT COMPLETED|Overall Study||3
9974619|NCT01560429|11095869|FG001|NOT COMPLETED|Overall Study||6
9974620|NCT01560624|11095879|FG000|STARTED|Overall Study||346
9974621|NCT01560624|11095880|FG001|STARTED|Overall Study||344
9974622|NCT01560624|11095879|FG000|Clinical Worsening Event|Overall Study||91
9974623|NCT01560624|11095880|FG001|Clinical Worsening Event|Overall Study||133
9974624|NCT01560624|11095879|FG000|Early Discontinuation From Treatment|Overall Study||107
9974625|NCT01560624|11095880|FG001|Early Discontinuation From Treatment|Overall Study||56
9974626|NCT01560624|11095879|FG000|COMPLETED|Overall Study||148
9974627|NCT01560624|11095880|FG001|COMPLETED|Overall Study||155
9974628|NCT01560624|11095879|FG000|NOT COMPLETED|Overall Study||198
9974629|NCT01560624|11095880|FG001|NOT COMPLETED|Overall Study||189
9974630|NCT01560780|11095888|FG000|STARTED|Overall Study||42
9974631|NCT01560780|11095889|FG001|STARTED|Overall Study||42
9974632|NCT01560780|11095888|FG000|Clinical Follow-Up at 12 Months|Overall Study||42
9974633|NCT01560780|11095889|FG001|Clinical Follow-Up at 12 Months|Overall Study||42
9974634|NCT01560780|11095888|FG000|Completed Study Drug for 12 Months|Overall Study||27
9974635|NCT01560780|11095889|FG001|Completed Study Drug for 12 Months|Overall Study||27
9974636|NCT01560780|11095888|FG000|COMPLETED|Overall Study||29
9974637|NCT01560780|11095889|FG001|COMPLETED|Overall Study||30
9974638|NCT01560780|11095888|FG000|NOT COMPLETED|Overall Study||13
9974639|NCT01560780|11095889|FG001|NOT COMPLETED|Overall Study||12
9974640|NCT01560819|11095897|FG000|STARTED|Overall Study||10
9974641|NCT01560819|11095898|FG001|STARTED|Overall Study||10
9974642|NCT01560819|11095897|FG000|COMPLETED|Overall Study||9
9974643|NCT01560819|11095898|FG001|COMPLETED|Overall Study||10
9974644|NCT01560819|11095897|FG000|NOT COMPLETED|Overall Study||1
9974645|NCT01560819|11095898|FG001|NOT COMPLETED|Overall Study||0
9974646|NCT01560871|11095904|FG000|STARTED|Overall Study||9
9974647|NCT01560871|11095905|FG001|STARTED|Overall Study||7
9974648|NCT01560871|11095904|FG000|COMPLETED|Overall Study||3
9974649|NCT01560871|11095905|FG001|COMPLETED|Overall Study||5
9974650|NCT01560871|11095904|FG000|NOT COMPLETED|Overall Study||6
9974651|NCT01560871|11095905|FG001|NOT COMPLETED|Overall Study||2
9974652|NCT01560923|11095914|FG000|STARTED|Overall Study||24
9974653|NCT01560923|11095915|FG001|STARTED|Overall Study||22
9974654|NCT01560923|11095914|FG000|COMPLETED|Overall Study||24
9974655|NCT01560923|11095915|FG001|COMPLETED|Overall Study||22
9974656|NCT01560923|11095914|FG000|NOT COMPLETED|Overall Study||0
9974657|NCT01560923|11095915|FG001|NOT COMPLETED|Overall Study||0
9974658|NCT01560949|11095921|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33
9974659|NCT01560949|11095921|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27
9974660|NCT01560949|11095921|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
9974661|NCT01560949|11095921|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23
9974662|NCT01560949|11095921|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
9974663|NCT01560949|11095921|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
9974664|NCT01560949|11095921|FG000|STARTED|Surgery Phase||18
9974665|NCT01560949|11095921|FG000|COMPLETED|Surgery Phase||15
9974666|NCT01560949|11095921|FG000|NOT COMPLETED|Surgery Phase||3
9974667|NCT01560975|11095929|FG000|STARTED|Overall Study||10
9974668|NCT01560975|11095929|FG000|COMPLETED|Overall Study||10
9974669|NCT01560975|11095929|FG000|NOT COMPLETED|Overall Study||0
9974670|NCT01560988|11095937|FG000|STARTED|First Intervention (Six Weeks)||32
9974671|NCT01560988|11095938|FG001|STARTED|First Intervention (Six Weeks)||30
9974672|NCT01560988|11095937|FG000|COMPLETED|First Intervention (Six Weeks)||22
9974673|NCT01560988|11095938|FG001|COMPLETED|First Intervention (Six Weeks)||26
9974674|NCT01560988|11095937|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10
9974675|NCT01560988|11095938|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4
9974676|NCT01560988|11095937|FG000|STARTED|Washout (Six Weeks)||22
9974677|NCT01560988|11095938|FG001|STARTED|Washout (Six Weeks)||26
9974678|NCT01560988|11095937|FG000|COMPLETED|Washout (Six Weeks)||20
9974679|NCT01560988|11095938|FG001|COMPLETED|Washout (Six Weeks)||24
9974680|NCT01560988|11095937|FG000|NOT COMPLETED|Washout (Six Weeks)||2
9974681|NCT01560988|11095938|FG001|NOT COMPLETED|Washout (Six Weeks)||2
9974682|NCT01560988|11095937|FG000|STARTED|Second Intervention (Six Weeks)||20
9974683|NCT01560988|11095938|FG001|STARTED|Second Intervention (Six Weeks)||24
9974684|NCT01560988|11095937|FG000|COMPLETED|Second Intervention (Six Weeks)||18
9974685|NCT01560988|11095938|FG001|COMPLETED|Second Intervention (Six Weeks)||22
9974686|NCT01560988|11095937|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2
9974687|NCT01560988|11095938|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2
9974688|NCT01561053|11095953|FG000|STARTED|Overall Study||86
9974689|NCT01561053|11095954|FG001|STARTED|Overall Study||92
9974690|NCT01561053|11095955|FG002|STARTED|Overall Study||82
9974691|NCT01561053|11095956|FG003|STARTED|Overall Study||87
9974692|NCT01561053|11095953|FG000|Patients With Baseline MMSE:18-21|Overall Study||47
9974693|NCT01561053|11095954|FG001|Patients With Baseline MMSE:18-21|Overall Study||40
10098396|NCT02382848|11227365|FG000|STARTED|Second Intervention (3 Weeks)||3
10098397|NCT02382848|11227366|FG001|STARTED|Second Intervention (3 Weeks)||5
10098398|NCT02382848|11227365|FG000|COMPLETED|Second Intervention (3 Weeks)||3
10098399|NCT02382848|11227366|FG001|COMPLETED|Second Intervention (3 Weeks)||5
10098400|NCT02382848|11227365|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10098401|NCT02382848|11227366|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10098402|NCT02382913|11227382|FG000|STARTED|Overall Study||27
10098403|NCT02382913|11227383|FG001|STARTED|Overall Study||36
10098404|NCT02382913|11227384|FG002|STARTED|Overall Study||32
10098405|NCT02382913|11227385|FG003|STARTED|Overall Study||27
10098406|NCT02382913|11227386|FG004|STARTED|Overall Study||33
10098407|NCT02382913|11227387|FG005|STARTED|Overall Study||30
10098408|NCT02382913|11227388|FG006|STARTED|Overall Study||37
10098409|NCT02382913|11227389|FG007|STARTED|Overall Study||30
10098410|NCT02382913|11227390|FG008|STARTED|Overall Study||30
10098411|NCT02382913|11227391|FG009|STARTED|Overall Study||33
10098412|NCT02382913|11227382|FG000|COMPLETED|Overall Study||27
10098413|NCT02382913|11227383|FG001|COMPLETED|Overall Study||36
10098414|NCT02382913|11227384|FG002|COMPLETED|Overall Study||32
10098415|NCT02382913|11227385|FG003|COMPLETED|Overall Study||27
10098416|NCT02382913|11227386|FG004|COMPLETED|Overall Study||33
10098417|NCT02382913|11227387|FG005|COMPLETED|Overall Study||30
10098418|NCT02382913|11227388|FG006|COMPLETED|Overall Study||37
10098419|NCT02382913|11227389|FG007|COMPLETED|Overall Study||30
10098420|NCT02382913|11227390|FG008|COMPLETED|Overall Study||30
10098421|NCT02382913|11227391|FG009|COMPLETED|Overall Study||33
10098422|NCT02382913|11227382|FG000|NOT COMPLETED|Overall Study||0
10098423|NCT02382913|11227383|FG001|NOT COMPLETED|Overall Study||0
10098424|NCT02382913|11227384|FG002|NOT COMPLETED|Overall Study||0
10098425|NCT02382913|11227385|FG003|NOT COMPLETED|Overall Study||0
10098426|NCT02382913|11227386|FG004|NOT COMPLETED|Overall Study||0
10098427|NCT02382913|11227387|FG005|NOT COMPLETED|Overall Study||0
10098428|NCT02382913|11227388|FG006|NOT COMPLETED|Overall Study||0
10098429|NCT02382913|11227389|FG007|NOT COMPLETED|Overall Study||0
10098430|NCT02382913|11227390|FG008|NOT COMPLETED|Overall Study||0
10098431|NCT02382913|11227391|FG009|NOT COMPLETED|Overall Study||0
10098432|NCT02382939|11227415|FG000|STARTED|Overall Study||31
10098433|NCT02382939|11227416|FG001|STARTED|Overall Study||61
10098434|NCT02382939|11227415|FG000|Exposed|Overall Study||31
10098435|NCT02382939|11227416|FG001|Exposed|Overall Study||61
10098436|NCT02382939|11227415|FG000|COMPLETED|Overall Study||28
10098437|NCT02382939|11227416|FG001|COMPLETED|Overall Study||58
10098438|NCT02382939|11227415|FG000|NOT COMPLETED|Overall Study||3
10098439|NCT02382939|11227416|FG001|NOT COMPLETED|Overall Study||3
10098440|NCT02382991|11227425|FG000|STARTED|Overall Study||17
10098441|NCT02382991|11227426|FG001|STARTED|Overall Study||18
10098442|NCT02382991|11227425|FG000|COMPLETED|Overall Study||15
10098443|NCT02382991|11227426|FG001|COMPLETED|Overall Study||15
10098444|NCT02382991|11227425|FG000|NOT COMPLETED|Overall Study||2
10098445|NCT02382991|11227426|FG001|NOT COMPLETED|Overall Study||3
10098446|NCT02383017|11227433|FG000|STARTED|Overall Study||15
10098447|NCT02383017|11227434|FG001|STARTED|Overall Study||13
10098448|NCT02383017|11227433|FG000|COMPLETED|Overall Study||10
10098449|NCT02383017|11227434|FG001|COMPLETED|Overall Study||11
10098450|NCT02383017|11227433|FG000|NOT COMPLETED|Overall Study||5
10098451|NCT02383017|11227434|FG001|NOT COMPLETED|Overall Study||2
10098452|NCT02383043|11227443|FG000|STARTED|Overall Study||9
10098453|NCT02383043|11227444|FG001|STARTED|Overall Study||5
10098454|NCT02383043|11227445|FG002|STARTED|Overall Study||4
10098455|NCT02383043|11227443|FG000|COMPLETED|Overall Study||7
9974694|NCT01561053|11095955|FG002|Patients With Baseline MMSE:18-21|Overall Study||47
9974695|NCT01561053|11095956|FG003|Patients With Baseline MMSE:18-21|Overall Study||42
9974696|NCT01561053|11095953|FG000|Patients With Baseline MMSE:22-26|Overall Study||39
9974697|NCT01561053|11095954|FG001|Patients With Baseline MMSE:22-26|Overall Study||52
9974698|NCT01561053|11095955|FG002|Patients With Baseline MMSE:22-26|Overall Study||35
9974699|NCT01561053|11095956|FG003|Patients With Baseline MMSE:22-26|Overall Study||45
10098456|NCT02383043|11227444|FG001|COMPLETED|Overall Study||5
10098457|NCT02383043|11227445|FG002|COMPLETED|Overall Study||4
10098458|NCT02383043|11227443|FG000|NOT COMPLETED|Overall Study||2
10098459|NCT02383043|11227444|FG001|NOT COMPLETED|Overall Study||0
9974700|NCT01561053|11095953|FG000|Randomized Not Treated|Overall Study||8
9974701|NCT01561053|11095954|FG001|Randomized Not Treated|Overall Study||6
9974702|NCT01561053|11095955|FG002|Randomized Not Treated|Overall Study||4
9974703|NCT01561053|11095956|FG003|Randomized Not Treated|Overall Study||7
9974704|NCT01561053|11095953|FG000|Evaluable Subjects|Overall Study||78
9974705|NCT01561053|11095954|FG001|Evaluable Subjects|Overall Study||86
9974706|NCT01561053|11095955|FG002|Evaluable Subjects|Overall Study||78
9974707|NCT01561053|11095956|FG003|Evaluable Subjects|Overall Study||80
9974708|NCT01561053|11095953|FG000|COMPLETED|Overall Study||51
9974709|NCT01561053|11095954|FG001|COMPLETED|Overall Study||56
9974710|NCT01561053|11095955|FG002|COMPLETED|Overall Study||61
9974711|NCT01561053|11095956|FG003|COMPLETED|Overall Study||64
9974712|NCT01561053|11095953|FG000|NOT COMPLETED|Overall Study||35
9974713|NCT01561053|11095954|FG001|NOT COMPLETED|Overall Study||36
9974714|NCT01561053|11095955|FG002|NOT COMPLETED|Overall Study||21
9974715|NCT01561053|11095956|FG003|NOT COMPLETED|Overall Study||23
9974716|NCT01561079|11095967|FG000|STARTED|Overall Study||127
9974717|NCT01561079|11095967|FG000|COMPLETED|Overall Study||49
9974718|NCT01561079|11095967|FG000|NOT COMPLETED|Overall Study||78
9974719|NCT01561300|11096010|FG000|STARTED|Run in on Placebo||15
9974720|NCT01561300|11096011|FG001|STARTED|Run in on Placebo||15
9974721|NCT01561300|11096010|FG000|COMPLETED|Run in on Placebo||14
9974722|NCT01561300|11096011|FG001|COMPLETED|Run in on Placebo||15
9974723|NCT01561300|11096010|FG000|NOT COMPLETED|Run in on Placebo||1
9974724|NCT01561300|11096011|FG001|NOT COMPLETED|Run in on Placebo||0
9974725|NCT01561300|11096010|FG000|STARTED|First Intervention||14
9974726|NCT01561300|11096011|FG001|STARTED|First Intervention||15
9974727|NCT01561300|11096010|FG000|COMPLETED|First Intervention||14
9974728|NCT01561300|11096011|FG001|COMPLETED|First Intervention||15
9974729|NCT01561300|11096010|FG000|NOT COMPLETED|First Intervention||0
9974730|NCT01561300|11096011|FG001|NOT COMPLETED|First Intervention||0
9974731|NCT01561300|11096010|FG000|STARTED|Washout on Placebo||14
9974732|NCT01561300|11096011|FG001|STARTED|Washout on Placebo||15
9974733|NCT01561300|11096010|FG000|COMPLETED|Washout on Placebo||14
9974734|NCT01561300|11096011|FG001|COMPLETED|Washout on Placebo||15
9974735|NCT01561300|11096010|FG000|NOT COMPLETED|Washout on Placebo||0
9974736|NCT01561300|11096011|FG001|NOT COMPLETED|Washout on Placebo||0
9974737|NCT01561300|11096010|FG000|STARTED|Second Intervention||14
9974738|NCT01561300|11096011|FG001|STARTED|Second Intervention||15
9974739|NCT01561300|11096010|FG000|COMPLETED|Second Intervention||14
9974740|NCT01561300|11096011|FG001|COMPLETED|Second Intervention||15
9974741|NCT01561300|11096010|FG000|NOT COMPLETED|Second Intervention||0
9974742|NCT01561300|11096011|FG001|NOT COMPLETED|Second Intervention||0
9974743|NCT01561313|11096020|FG000|STARTED|Overall Study||33
9974744|NCT01561313|11096021|FG001|STARTED|Overall Study||31
9974745|NCT01561313|11096020|FG000|COMPLETED|Overall Study||31
9974746|NCT01561313|11096021|FG001|COMPLETED|Overall Study||31
9974747|NCT01561313|11096020|FG000|NOT COMPLETED|Overall Study||2
9974748|NCT01561313|11096021|FG001|NOT COMPLETED|Overall Study||0
9974749|NCT01561469|11096029|FG000|STARTED|Overall Study||101
9974750|NCT01561469|11096030|FG001|STARTED|Overall Study||87
9974751|NCT01561469|11096029|FG000|COMPLETED|Overall Study||101
9974752|NCT01561469|11096030|FG001|COMPLETED|Overall Study||87
9974753|NCT01561469|11096029|FG000|NOT COMPLETED|Overall Study||0
9974754|NCT01561469|11096030|FG001|NOT COMPLETED|Overall Study||0
9974755|NCT01561560|11096036|FG000|STARTED|First Two Weeks of Wear||60
9974756|NCT01561560|11096037|FG001|STARTED|First Two Weeks of Wear||61
9974757|NCT01561560|11096036|FG000|COMPLETED|First Two Weeks of Wear||60
9974758|NCT01561560|11096037|FG001|COMPLETED|First Two Weeks of Wear||59
9974759|NCT01561560|11096036|FG000|NOT COMPLETED|First Two Weeks of Wear||0
9974760|NCT01561560|11096037|FG001|NOT COMPLETED|First Two Weeks of Wear||2
9974761|NCT01561560|11096036|FG000|STARTED|Second Two Weeks of Wear||60
9974762|NCT01561560|11096037|FG001|STARTED|Second Two Weeks of Wear||59
9974763|NCT01561560|11096036|FG000|COMPLETED|Second Two Weeks of Wear||60
9974764|NCT01561560|11096037|FG001|COMPLETED|Second Two Weeks of Wear||58
9974765|NCT01561560|11096036|FG000|NOT COMPLETED|Second Two Weeks of Wear||0
9974766|NCT01561560|11096037|FG001|NOT COMPLETED|Second Two Weeks of Wear||1
9974767|NCT01561703|11096045|FG000|STARTED|Overall Study||28
9974768|NCT01561703|11096046|FG001|STARTED|Overall Study||30
9974769|NCT01561703|11096045|FG000|COMPLETED|Overall Study||20
9974770|NCT01561703|11096046|FG001|COMPLETED|Overall Study||24
9974771|NCT01561703|11096045|FG000|NOT COMPLETED|Overall Study||8
9974772|NCT01561703|11096046|FG001|NOT COMPLETED|Overall Study||6
9974773|NCT01561716|11096058|FG000|STARTED|Overall Study||5
9974774|NCT01561716|11096059|FG001|STARTED|Overall Study||5
9974775|NCT01561716|11096060|FG002|STARTED|Overall Study||5
9974776|NCT01561716|11096061|FG003|STARTED|Overall Study||5
9974777|NCT01561716|11096062|FG004|STARTED|Overall Study||5
9974778|NCT01561716|11096063|FG005|STARTED|Overall Study||5
9974779|NCT01561716|11096058|FG000|COMPLETED|Overall Study||5
9974780|NCT01561716|11096059|FG001|COMPLETED|Overall Study||5
9974781|NCT01561716|11096060|FG002|COMPLETED|Overall Study||5
9974782|NCT01561716|11096061|FG003|COMPLETED|Overall Study||5
9974783|NCT01561716|11096062|FG004|COMPLETED|Overall Study||5
9974784|NCT01561716|11096063|FG005|COMPLETED|Overall Study||5
9974785|NCT01561716|11096058|FG000|NOT COMPLETED|Overall Study||0
9974786|NCT01561716|11096059|FG001|NOT COMPLETED|Overall Study||0
9974787|NCT01561716|11096060|FG002|NOT COMPLETED|Overall Study||0
9974788|NCT01561716|11096061|FG003|NOT COMPLETED|Overall Study||0
9974789|NCT01561716|11096062|FG004|NOT COMPLETED|Overall Study||0
9974790|NCT01561716|11096063|FG005|NOT COMPLETED|Overall Study||0
9974791|NCT01561755|11096079|FG000|STARTED|Overall Study||6
9974792|NCT01561755|11096080|FG001|STARTED|Overall Study||6
9974793|NCT01561755|11096079|FG000|COMPLETED|Overall Study||6
9974794|NCT01561755|11096080|FG001|COMPLETED|Overall Study||5
9974795|NCT01561755|11096079|FG000|NOT COMPLETED|Overall Study||0
9974796|NCT01561755|11096080|FG001|NOT COMPLETED|Overall Study||1
9974797|NCT01561833|11096086|FG000|STARTED|Overall Study||12
9974798|NCT01561833|11096086|FG000|COMPLETED|Overall Study||12
9974799|NCT01561833|11096086|FG000|NOT COMPLETED|Overall Study||0
9974800|NCT01561898|11096094|FG000|STARTED|Overall Study||7
9974801|NCT01561898|11096095|FG001|STARTED|Overall Study||92
9974802|NCT01561898|11096096|FG002|STARTED|Overall Study||97
9974803|NCT01561898|11096097|FG003|STARTED|Overall Study||32
9974804|NCT01561898|11096094|FG000|COMPLETED|Overall Study||5
9974805|NCT01561898|11096095|FG001|COMPLETED|Overall Study||51
9974806|NCT01561898|11096096|FG002|COMPLETED|Overall Study||53
9974807|NCT01561898|11096097|FG003|COMPLETED|Overall Study||12
9974808|NCT01561898|11096094|FG000|NOT COMPLETED|Overall Study||2
9974809|NCT01561898|11096095|FG001|NOT COMPLETED|Overall Study||41
10098460|NCT02383043|11227445|FG002|NOT COMPLETED|Overall Study||0
10098461|NCT02383056|11227456|FG000|STARTED|Overall Study||7
10098462|NCT02383056|11227457|FG001|STARTED|Overall Study||7
10098463|NCT02383056|11227456|FG000|COMPLETED|Overall Study||6
10098464|NCT02383056|11227457|FG001|COMPLETED|Overall Study||5
10098465|NCT02383056|11227456|FG000|NOT COMPLETED|Overall Study||1
10098466|NCT02383056|11227457|FG001|NOT COMPLETED|Overall Study||2
10098467|NCT02383173|11227465|FG000|STARTED|Overall Study||88
10098468|NCT02383173|11227466|FG001|STARTED|Overall Study||46
10098469|NCT02383173|11227465|FG000|COMPLETED|Overall Study||88
10098470|NCT02383173|11227466|FG001|COMPLETED|Overall Study||44
10098471|NCT02383173|11227465|FG000|NOT COMPLETED|Overall Study||0
10098472|NCT02383173|11227466|FG001|NOT COMPLETED|Overall Study||2
10098473|NCT02383355|11227474|FG000|STARTED|Overall Study||19
10098474|NCT02383355|11227475|FG001|STARTED|Overall Study||21
10098475|NCT02383355|11227474|FG000|COMPLETED|Overall Study||17
10098476|NCT02383355|11227475|FG001|COMPLETED|Overall Study||21
10098477|NCT02383355|11227474|FG000|NOT COMPLETED|Overall Study||2
10098478|NCT02383355|11227475|FG001|NOT COMPLETED|Overall Study||0
10098479|NCT02383420|11227484|FG000|STARTED|Overall Study||10
10098480|NCT02383420|11227485|FG001|STARTED|Overall Study||10
10098481|NCT02383420|11227486|FG002|STARTED|Overall Study||3
10098482|NCT02383420|11227484|FG000|COMPLETED|Overall Study||8
10098483|NCT02383420|11227485|FG001|COMPLETED|Overall Study||10
10098484|NCT02383420|11227486|FG002|COMPLETED|Overall Study||3
10098485|NCT02383420|11227484|FG000|NOT COMPLETED|Overall Study||2
10098486|NCT02383420|11227485|FG001|NOT COMPLETED|Overall Study||0
10098487|NCT02383420|11227486|FG002|NOT COMPLETED|Overall Study||0
10098488|NCT02383472|11227496|FG000|STARTED|Overall Study||23
10098489|NCT02383472|11227497|FG001|STARTED|Overall Study||30
10098490|NCT02383472|11227496|FG000|COMPLETED|Overall Study||22
10098491|NCT02383472|11227497|FG001|COMPLETED|Overall Study||29
10098492|NCT02383472|11227496|FG000|NOT COMPLETED|Overall Study||1
10098493|NCT02383472|11227497|FG001|NOT COMPLETED|Overall Study||1
10098494|NCT02383576|11227507|FG000|STARTED|Overall Study||94
10098495|NCT02383576|11227508|FG001|STARTED|Overall Study||91
10098496|NCT02383576|11227507|FG000|COMPLETED|Overall Study||31
10098497|NCT02383576|11227508|FG001|COMPLETED|Overall Study||46
10098498|NCT02383576|11227507|FG000|NOT COMPLETED|Overall Study||63
10098499|NCT02383576|11227508|FG001|NOT COMPLETED|Overall Study||45
10098500|NCT02383589|11227516|FG000|STARTED|Treatment Period||67
10098501|NCT02383589|11227517|FG001|STARTED|Treatment Period||68
10098502|NCT02383589|11227516|FG000|COMPLETED|Treatment Period||66
10098503|NCT02383589|11227517|FG001|COMPLETED|Treatment Period||58
10098504|NCT02383589|11227516|FG000|NOT COMPLETED|Treatment Period||1
10098505|NCT02383589|11227517|FG001|NOT COMPLETED|Treatment Period||10
10098506|NCT02383589|11227516|FG000|STARTED|Safety Follow-up (SFU)||66
10098507|NCT02383589|11227517|FG001|STARTED|Safety Follow-up (SFU)||58
10098508|NCT02383589|11227516|FG000|COMPLETED|Safety Follow-up (SFU)||59
10098509|NCT02383589|11227517|FG001|COMPLETED|Safety Follow-up (SFU)||53
10098510|NCT02383589|11227516|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7
10098511|NCT02383589|11227517|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5
10098512|NCT02383667|11227525|FG000|STARTED|Overall Study||20
10098513|NCT02383667|11227525|FG000|COMPLETED|Overall Study||20
9974810|NCT01561898|11096096|FG002|NOT COMPLETED|Overall Study||44
9974811|NCT01561898|11096097|FG003|NOT COMPLETED|Overall Study||20
9974812|NCT01561963|11096105|FG000|STARTED|Overall Study||21
9974813|NCT01561963|11096105|FG000|Received Period 1 Treatment|Overall Study||21
9974814|NCT01561963|11096105|FG000|Received Period 2 Treatment|Overall Study||20
9974815|NCT01561963|11096105|FG000|Received Period 3 Treatment|Overall Study||20
9974816|NCT01561963|11096105|FG000|COMPLETED|Overall Study||20
9974817|NCT01561963|11096105|FG000|NOT COMPLETED|Overall Study||1
9974818|NCT01561976|11096120|FG000|STARTED|Period 1||5
9974819|NCT01561976|11096121|FG001|STARTED|Period 1||5
9974820|NCT01561976|11096122|FG002|STARTED|Period 1||5
9974821|NCT01561976|11096123|FG003|STARTED|Period 1||5
9974822|NCT01561976|11096124|FG004|STARTED|Period 1||5
9974823|NCT01561976|11096125|FG005|STARTED|Period 1||5
9974824|NCT01561976|11096120|FG000|COMPLETED|Period 1||5
9974825|NCT01561976|11096121|FG001|COMPLETED|Period 1||5
9974826|NCT01561976|11096122|FG002|COMPLETED|Period 1||4
10098514|NCT02383667|11227525|FG000|NOT COMPLETED|Overall Study||0
10098515|NCT02383706|11227529|FG000|STARTED|Overall Study||108
9974827|NCT01561976|11096123|FG003|COMPLETED|Period 1||5
9974828|NCT01561976|11096124|FG004|COMPLETED|Period 1||5
9974829|NCT01561976|11096125|FG005|COMPLETED|Period 1||5
9974830|NCT01561976|11096120|FG000|NOT COMPLETED|Period 1||0
10098516|NCT02383706|11227529|FG000|COMPLETED|Overall Study||80
10098517|NCT02383706|11227529|FG000|NOT COMPLETED|Overall Study||28
10098518|NCT02383719|11227534|FG000|STARTED|Overall Study||18
10098519|NCT02383719|11227534|FG000|COMPLETED|Overall Study||18
10098520|NCT02383719|11227534|FG000|NOT COMPLETED|Overall Study||0
10098521|NCT02383758|11227540|FG000|STARTED|Overall Study||10
10098522|NCT02383758|11227541|FG001|STARTED|Overall Study||10
10098523|NCT02383758|11227540|FG000|COMPLETED|Overall Study||10
9974831|NCT01561976|11096121|FG001|NOT COMPLETED|Period 1||0
9974832|NCT01561976|11096122|FG002|NOT COMPLETED|Period 1||1
9974833|NCT01561976|11096123|FG003|NOT COMPLETED|Period 1||0
9974834|NCT01561976|11096124|FG004|NOT COMPLETED|Period 1||0
9974835|NCT01561976|11096125|FG005|NOT COMPLETED|Period 1||0
9974836|NCT01561976|11096120|FG000|STARTED|Washout Period 1 (7 Days)||5
9974837|NCT01561976|11096121|FG001|STARTED|Washout Period 1 (7 Days)||5
9974838|NCT01561976|11096122|FG002|STARTED|Washout Period 1 (7 Days)||4
9974839|NCT01561976|11096123|FG003|STARTED|Washout Period 1 (7 Days)||5
9974840|NCT01561976|11096124|FG004|STARTED|Washout Period 1 (7 Days)||5
9974841|NCT01561976|11096125|FG005|STARTED|Washout Period 1 (7 Days)||5
9974842|NCT01561976|11096120|FG000|COMPLETED|Washout Period 1 (7 Days)||5
9974843|NCT01561976|11096121|FG001|COMPLETED|Washout Period 1 (7 Days)||5
9974844|NCT01561976|11096122|FG002|COMPLETED|Washout Period 1 (7 Days)||4
9974845|NCT01561976|11096123|FG003|COMPLETED|Washout Period 1 (7 Days)||4
9974846|NCT01561976|11096124|FG004|COMPLETED|Washout Period 1 (7 Days)||5
9974847|NCT01561976|11096125|FG005|COMPLETED|Washout Period 1 (7 Days)||4
10098524|NCT02383758|11227541|FG001|COMPLETED|Overall Study||8
10098525|NCT02383758|11227540|FG000|NOT COMPLETED|Overall Study||0
10098526|NCT02383758|11227541|FG001|NOT COMPLETED|Overall Study||2
10098527|NCT02383862|11227549|FG000|STARTED|Baseline||151
10098528|NCT02383862|11227550|FG001|STARTED|Baseline||149
10098529|NCT02383862|11227549|FG000|COMPLETED|Baseline||151
10098530|NCT02383862|11227550|FG001|COMPLETED|Baseline||149
10098531|NCT02383862|11227549|FG000|NOT COMPLETED|Baseline||0
10098532|NCT02383862|11227550|FG001|NOT COMPLETED|Baseline||0
10098533|NCT02383862|11227549|FG000|STARTED|3 Month Follow up||151
10098534|NCT02383862|11227550|FG001|STARTED|3 Month Follow up||149
10098535|NCT02383862|11227549|FG000|COMPLETED|3 Month Follow up||128
10098536|NCT02383862|11227550|FG001|COMPLETED|3 Month Follow up||128
10098537|NCT02383862|11227549|FG000|NOT COMPLETED|3 Month Follow up||23
10098538|NCT02383862|11227550|FG001|NOT COMPLETED|3 Month Follow up||21
10098539|NCT02383940|11227565|FG000|STARTED|Overall Study||44
10098540|NCT02383940|11227566|FG001|STARTED|Overall Study||43
10098541|NCT02383940|11227565|FG000|Treated|Overall Study||42
10098542|NCT02383940|11227566|FG001|Treated|Overall Study||43
10098543|NCT02383940|11227565|FG000|COMPLETED|Overall Study||35
10098544|NCT02383940|11227566|FG001|COMPLETED|Overall Study||40
10098545|NCT02383940|11227565|FG000|NOT COMPLETED|Overall Study||9
10098546|NCT02383940|11227566|FG001|NOT COMPLETED|Overall Study||3
10098547|NCT02384044|11227574|FG000|STARTED|Overall Study||15
10098548|NCT02384044|11227575|FG001|STARTED|Overall Study||15
10098549|NCT02384044|11227574|FG000|COMPLETED|Overall Study||15
10098550|NCT02384044|11227575|FG001|COMPLETED|Overall Study||15
10098551|NCT02384044|11227574|FG000|NOT COMPLETED|Overall Study||0
10098552|NCT02384044|11227575|FG001|NOT COMPLETED|Overall Study||0
10098553|NCT02384070|11227584|FG000|STARTED|Overall Study||100
10098554|NCT02384070|11227585|FG001|STARTED|Overall Study||100
10098555|NCT02384070|11227586|FG002|STARTED|Overall Study||100
10098556|NCT02384070|11227584|FG000|COMPLETED|Overall Study||100
10098557|NCT02384070|11227585|FG001|COMPLETED|Overall Study||100
10098558|NCT02384070|11227586|FG002|COMPLETED|Overall Study||100
9974848|NCT01561976|11096120|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9974849|NCT01561976|11096121|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9974850|NCT01561976|11096122|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9974851|NCT01561976|11096123|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
9974852|NCT01561976|11096124|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10098559|NCT02384070|11227584|FG000|NOT COMPLETED|Overall Study||0
10098560|NCT02384070|11227585|FG001|NOT COMPLETED|Overall Study||0
10098561|NCT02384070|11227586|FG002|NOT COMPLETED|Overall Study||0
10098562|NCT02384096|11227596|FG000|STARTED|First Intervention (7 Days)||5
10098563|NCT02384096|11227597|FG001|STARTED|First Intervention (7 Days)||7
10098564|NCT02384096|11227596|FG000|COMPLETED|First Intervention (7 Days)||4
10098565|NCT02384096|11227597|FG001|COMPLETED|First Intervention (7 Days)||7
10098566|NCT02384096|11227596|FG000|NOT COMPLETED|First Intervention (7 Days)||1
10098567|NCT02384096|11227597|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10098568|NCT02384096|11227596|FG000|STARTED|Second Intervention (7 Days)||4
10098569|NCT02384096|11227597|FG001|STARTED|Second Intervention (7 Days)||7
10098570|NCT02384096|11227596|FG000|COMPLETED|Second Intervention (7 Days)||4
10098571|NCT02384096|11227597|FG001|COMPLETED|Second Intervention (7 Days)||6
10098572|NCT02384096|11227596|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10098573|NCT02384096|11227597|FG001|NOT COMPLETED|Second Intervention (7 Days)||1
10098574|NCT02384200|11227604|FG000|STARTED|Overall Study||43
10098575|NCT02384200|11227605|FG001|STARTED|Overall Study||43
10098576|NCT02384200|11227604|FG000|COMPLETED|Overall Study||43
10098577|NCT02384200|11227605|FG001|COMPLETED|Overall Study||43
10098578|NCT02384200|11227604|FG000|NOT COMPLETED|Overall Study||0
10098579|NCT02384200|11227605|FG001|NOT COMPLETED|Overall Study||0
9974853|NCT01561976|11096125|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
9974854|NCT01561976|11096120|FG000|STARTED|Period 2||5
9974855|NCT01561976|11096121|FG001|STARTED|Period 2||5
9974856|NCT01561976|11096122|FG002|STARTED|Period 2||4
9974857|NCT01561976|11096123|FG003|STARTED|Period 2||4
9974858|NCT01561976|11096124|FG004|STARTED|Period 2||5
9974859|NCT01561976|11096125|FG005|STARTED|Period 2||4
9974860|NCT01561976|11096120|FG000|COMPLETED|Period 2||5
9974861|NCT01561976|11096121|FG001|COMPLETED|Period 2||5
9974862|NCT01561976|11096122|FG002|COMPLETED|Period 2||4
9974863|NCT01561976|11096123|FG003|COMPLETED|Period 2||4
9974864|NCT01561976|11096124|FG004|COMPLETED|Period 2||5
9974865|NCT01561976|11096125|FG005|COMPLETED|Period 2||4
9974866|NCT01561976|11096120|FG000|NOT COMPLETED|Period 2||0
9974867|NCT01561976|11096121|FG001|NOT COMPLETED|Period 2||0
9974868|NCT01561976|11096122|FG002|NOT COMPLETED|Period 2||0
9974869|NCT01561976|11096123|FG003|NOT COMPLETED|Period 2||0
9974870|NCT01561976|11096124|FG004|NOT COMPLETED|Period 2||0
9974871|NCT01561976|11096125|FG005|NOT COMPLETED|Period 2||0
9974872|NCT01561976|11096120|FG000|STARTED|Washout Period 2 (7 Days)||5
9974873|NCT01561976|11096121|FG001|STARTED|Washout Period 2 (7 Days)||5
9974874|NCT01561976|11096122|FG002|STARTED|Washout Period 2 (7 Days)||4
9974875|NCT01561976|11096123|FG003|STARTED|Washout Period 2 (7 Days)||4
9974876|NCT01561976|11096124|FG004|STARTED|Washout Period 2 (7 Days)||5
9974877|NCT01561976|11096125|FG005|STARTED|Washout Period 2 (7 Days)||4
9974878|NCT01561976|11096120|FG000|COMPLETED|Washout Period 2 (7 Days)||4
9974879|NCT01561976|11096121|FG001|COMPLETED|Washout Period 2 (7 Days)||5
9974880|NCT01561976|11096122|FG002|COMPLETED|Washout Period 2 (7 Days)||3
9974881|NCT01561976|11096123|FG003|COMPLETED|Washout Period 2 (7 Days)||4
9974882|NCT01561976|11096124|FG004|COMPLETED|Washout Period 2 (7 Days)||5
9974883|NCT01561976|11096125|FG005|COMPLETED|Washout Period 2 (7 Days)||4
9974884|NCT01561976|11096120|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
9974885|NCT01561976|11096121|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9974886|NCT01561976|11096122|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1
9974887|NCT01561976|11096123|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9974888|NCT01561976|11096124|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
9974889|NCT01561976|11096125|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
9974890|NCT01561976|11096120|FG000|STARTED|Period 3||4
9974891|NCT01561976|11096121|FG001|STARTED|Period 3||5
9974892|NCT01561976|11096122|FG002|STARTED|Period 3||3
9974893|NCT01561976|11096123|FG003|STARTED|Period 3||4
9974894|NCT01561976|11096124|FG004|STARTED|Period 3||5
9974895|NCT01561976|11096125|FG005|STARTED|Period 3||4
9974896|NCT01561976|11096120|FG000|COMPLETED|Period 3||4
9974897|NCT01561976|11096121|FG001|COMPLETED|Period 3||5
9974898|NCT01561976|11096122|FG002|COMPLETED|Period 3||3
10098580|NCT02384382|11227611|FG000|STARTED|Overall Study||23
10098581|NCT02384382|11227611|FG000|COMPLETED|Overall Study||0
10098582|NCT02384382|11227611|FG000|NOT COMPLETED|Overall Study||23
10098583|NCT02384395|11227615|FG000|STARTED|Overall Study||40
10098584|NCT02384395|11227615|FG000|Enrolled|Overall Study||40
10098585|NCT02384395|11227615|FG000|Initiated Treatment|Overall Study||37
10098586|NCT02384395|11227615|FG000|Completed Week 24|Overall Study||34
10098587|NCT02384395|11227615|FG000|Completed Week 48|Overall Study||33
10098588|NCT02384395|11227615|FG000|Completed Week 96|Overall Study||30
10098589|NCT02384395|11227615|FG000|COMPLETED|Overall Study||30
10098590|NCT02384395|11227615|FG000|NOT COMPLETED|Overall Study||10
10098591|NCT02384460|11227621|FG000|STARTED|Overall Study||82
9974899|NCT01561976|11096123|FG003|COMPLETED|Period 3||4
9974900|NCT01561976|11096124|FG004|COMPLETED|Period 3||5
9974901|NCT01561976|11096125|FG005|COMPLETED|Period 3||4
9974902|NCT01561976|11096120|FG000|NOT COMPLETED|Period 3||0
9974903|NCT01561976|11096121|FG001|NOT COMPLETED|Period 3||0
9974904|NCT01561976|11096122|FG002|NOT COMPLETED|Period 3||0
9974905|NCT01561976|11096123|FG003|NOT COMPLETED|Period 3||0
9974906|NCT01561976|11096124|FG004|NOT COMPLETED|Period 3||0
9974907|NCT01561976|11096125|FG005|NOT COMPLETED|Period 3||0
9974908|NCT01562028|11096135|FG000|STARTED|Overall Study||37
9974909|NCT01562028|11096136|FG001|STARTED|Overall Study||72
9974910|NCT01562028|11096135|FG000|COMPLETED|Overall Study||34
9974911|NCT01562028|11096136|FG001|COMPLETED|Overall Study||70
9974912|NCT01562028|11096135|FG000|NOT COMPLETED|Overall Study||3
9974913|NCT01562028|11096136|FG001|NOT COMPLETED|Overall Study||2
9974914|NCT01562041|11096142|FG000|STARTED|Overall Study||14
9974915|NCT01562041|11096142|FG000|COMPLETED|Overall Study||14
9974916|NCT01562041|11096142|FG000|NOT COMPLETED|Overall Study||0
9974917|NCT01562132|11096148|FG000|STARTED|Overall Study||3
9974918|NCT01562132|11096149|FG001|STARTED|Overall Study||3
9974919|NCT01562132|11096148|FG000|COMPLETED|Overall Study||3
9974920|NCT01562132|11096149|FG001|COMPLETED|Overall Study||3
9974921|NCT01562132|11096148|FG000|NOT COMPLETED|Overall Study||0
9974922|NCT01562132|11096149|FG001|NOT COMPLETED|Overall Study||0
9974923|NCT01562275|11096168|FG000|STARTED|Stage 1||3
9974924|NCT01562275|11096169|FG001|STARTED|Stage 1||7
9974925|NCT01562275|11096170|FG002|STARTED|Stage 1||3
9974926|NCT01562275|11096171|FG003|STARTED|Stage 1||4
9974927|NCT01562275|11096172|FG004|STARTED|Stage 1||4
9974928|NCT01562275|11096173|FG005|STARTED|Stage 1||4
9974929|NCT01562275|11096174|FG006|STARTED|Stage 1||3
9974930|NCT01562275|11096175|FG007|STARTED|Stage 1||7
9974931|NCT01562275|11096176|FG008|STARTED|Stage 1||3
9974932|NCT01562275|11096177|FG009|STARTED|Stage 1||7
10098592|NCT02384460|11227622|FG001|STARTED|Overall Study||87
10098593|NCT02384460|11227621|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
9974933|NCT01562275|11096178|FG010|STARTED|Stage 1||3
9974934|NCT01562275|11096179|FG011|STARTED|Stage 1||0
9974935|NCT01562275|11096180|FG012|STARTED|Stage 1||0
9974936|NCT01562275|11096168|FG000|COMPLETED|Stage 1||0
9974937|NCT01562275|11096169|FG001|COMPLETED|Stage 1||0
9974938|NCT01562275|11096170|FG002|COMPLETED|Stage 1||0
9974939|NCT01562275|11096171|FG003|COMPLETED|Stage 1||0
9974940|NCT01562275|11096172|FG004|COMPLETED|Stage 1||0
9974941|NCT01562275|11096173|FG005|COMPLETED|Stage 1||0
9974942|NCT01562275|11096174|FG006|COMPLETED|Stage 1||0
9974943|NCT01562275|11096175|FG007|COMPLETED|Stage 1||0
9974944|NCT01562275|11096176|FG008|COMPLETED|Stage 1||0
9974945|NCT01562275|11096177|FG009|COMPLETED|Stage 1||0
9974946|NCT01562275|11096178|FG010|COMPLETED|Stage 1||0
9974947|NCT01562275|11096179|FG011|COMPLETED|Stage 1||0
9974948|NCT01562275|11096180|FG012|COMPLETED|Stage 1||0
9974949|NCT01562275|11096168|FG000|NOT COMPLETED|Stage 1||3
9974950|NCT01562275|11096169|FG001|NOT COMPLETED|Stage 1||7
9974951|NCT01562275|11096170|FG002|NOT COMPLETED|Stage 1||3
9974952|NCT01562275|11096171|FG003|NOT COMPLETED|Stage 1||4
9974953|NCT01562275|11096172|FG004|NOT COMPLETED|Stage 1||4
9974954|NCT01562275|11096173|FG005|NOT COMPLETED|Stage 1||4
9974955|NCT01562275|11096174|FG006|NOT COMPLETED|Stage 1||3
9974956|NCT01562275|11096175|FG007|NOT COMPLETED|Stage 1||7
9974957|NCT01562275|11096176|FG008|NOT COMPLETED|Stage 1||3
9974958|NCT01562275|11096177|FG009|NOT COMPLETED|Stage 1||7
9974959|NCT01562275|11096178|FG010|NOT COMPLETED|Stage 1||3
9974960|NCT01562275|11096179|FG011|NOT COMPLETED|Stage 1||0
9974961|NCT01562275|11096180|FG012|NOT COMPLETED|Stage 1||0
9974962|NCT01562275|11096168|FG000|STARTED|Stage 2||0
9974963|NCT01562275|11096169|FG001|STARTED|Stage 2||0
9974964|NCT01562275|11096170|FG002|STARTED|Stage 2||0
9974965|NCT01562275|11096171|FG003|STARTED|Stage 2||0
9974966|NCT01562275|11096172|FG004|STARTED|Stage 2||0
9974967|NCT01562275|11096173|FG005|STARTED|Stage 2||0
9974968|NCT01562275|11096174|FG006|STARTED|Stage 2||0
9974969|NCT01562275|11096175|FG007|STARTED|Stage 2||0
9974970|NCT01562275|11096176|FG008|STARTED|Stage 2||0
9974971|NCT01562275|11096177|FG009|STARTED|Stage 2||0
9974972|NCT01562275|11096178|FG010|STARTED|Stage 2||0
9974973|NCT01562275|11096179|FG011|STARTED|Stage 2||14
9974974|NCT01562275|11096180|FG012|STARTED|Stage 2||5
9974975|NCT01562275|11096168|FG000|COMPLETED|Stage 2||0
9974976|NCT01562275|11096169|FG001|COMPLETED|Stage 2||0
9974977|NCT01562275|11096170|FG002|COMPLETED|Stage 2||0
9974978|NCT01562275|11096171|FG003|COMPLETED|Stage 2||0
9974979|NCT01562275|11096172|FG004|COMPLETED|Stage 2||0
9974980|NCT01562275|11096173|FG005|COMPLETED|Stage 2||0
9974981|NCT01562275|11096174|FG006|COMPLETED|Stage 2||0
9974982|NCT01562275|11096175|FG007|COMPLETED|Stage 2||0
9974983|NCT01562275|11096176|FG008|COMPLETED|Stage 2||0
10098594|NCT02384460|11227622|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87
10098595|NCT02384460|11227621|FG000|COMPLETED|Overall Study||75
10098596|NCT02384460|11227622|FG001|COMPLETED|Overall Study||80
10098597|NCT02384460|11227621|FG000|NOT COMPLETED|Overall Study||7
10098598|NCT02384460|11227622|FG001|NOT COMPLETED|Overall Study||7
10098599|NCT02384538|11227630|FG000|STARTED|Overall Study||67
10098600|NCT02384538|11227631|FG001|STARTED|Overall Study||64
10098601|NCT02384538|11227630|FG000|COMPLETED|Overall Study||61
10098602|NCT02384538|11227631|FG001|COMPLETED|Overall Study||49
10098603|NCT02384538|11227630|FG000|NOT COMPLETED|Overall Study||6
10098604|NCT02384538|11227631|FG001|NOT COMPLETED|Overall Study||15
10098605|NCT02384941|11227640|FG000|STARTED|Overall Study||268
10098606|NCT02384941|11227641|FG001|STARTED|Overall Study||263
10098607|NCT02384941|11227642|FG002|STARTED|Overall Study||262
10098608|NCT02384941|11227640|FG000|COMPLETED|Overall Study||218
10098609|NCT02384941|11227641|FG001|COMPLETED|Overall Study||228
10098610|NCT02384941|11227642|FG002|COMPLETED|Overall Study||221
10098611|NCT02384941|11227640|FG000|NOT COMPLETED|Overall Study||50
10098612|NCT02384941|11227641|FG001|NOT COMPLETED|Overall Study||35
10098613|NCT02384941|11227642|FG002|NOT COMPLETED|Overall Study||41
10098614|NCT02385084|11227651|FG000|STARTED|Period 1||3
9974984|NCT01562275|11096177|FG009|COMPLETED|Stage 2||0
10098615|NCT02385084|11227652|FG001|STARTED|Period 1||3
10098616|NCT02385084|11227653|FG002|STARTED|Period 1||3
10098617|NCT02385084|11227654|FG003|STARTED|Period 1||3
10098618|NCT02385084|11227655|FG004|STARTED|Period 1||3
9974985|NCT01562275|11096178|FG010|COMPLETED|Stage 2||0
9974986|NCT01562275|11096179|FG011|COMPLETED|Stage 2||0
9974987|NCT01562275|11096180|FG012|COMPLETED|Stage 2||0
9974988|NCT01562275|11096168|FG000|NOT COMPLETED|Stage 2||0
9974989|NCT01562275|11096169|FG001|NOT COMPLETED|Stage 2||0
9974990|NCT01562275|11096170|FG002|NOT COMPLETED|Stage 2||0
9974991|NCT01562275|11096171|FG003|NOT COMPLETED|Stage 2||0
9974992|NCT01562275|11096172|FG004|NOT COMPLETED|Stage 2||0
9974993|NCT01562275|11096173|FG005|NOT COMPLETED|Stage 2||0
9974994|NCT01562275|11096174|FG006|NOT COMPLETED|Stage 2||0
9974995|NCT01562275|11096175|FG007|NOT COMPLETED|Stage 2||0
10098619|NCT02385084|11227656|FG005|STARTED|Period 1||3
9974996|NCT01562275|11096176|FG008|NOT COMPLETED|Stage 2||0
9974997|NCT01562275|11096177|FG009|NOT COMPLETED|Stage 2||0
9974998|NCT01562275|11096178|FG010|NOT COMPLETED|Stage 2||0
9974999|NCT01562275|11096179|FG011|NOT COMPLETED|Stage 2||14
9975000|NCT01562275|11096180|FG012|NOT COMPLETED|Stage 2||5
9975001|NCT01562314|11096212|FG000|STARTED|Overall Study||29
9975002|NCT01562314|11096213|FG001|STARTED|Overall Study||31
9975003|NCT01562314|11096212|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
9975004|NCT01562314|11096213|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31
10098620|NCT02385084|11227651|FG000|Received LY2409021|Period 1||3
9975005|NCT01562314|11096212|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
9975006|NCT01562314|11096213|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
9975007|NCT01562314|11096212|FG000|Per Protocol (PP) Analysis Set|Overall Study||17
9975008|NCT01562314|11096213|FG001|Per Protocol (PP) Analysis Set|Overall Study||27
9975009|NCT01562314|11096212|FG000|COMPLETED|Overall Study||16
9975010|NCT01562314|11096213|FG001|COMPLETED|Overall Study||23
9975011|NCT01562314|11096212|FG000|NOT COMPLETED|Overall Study||13
9975012|NCT01562314|11096213|FG001|NOT COMPLETED|Overall Study||8
9975013|NCT01562327|11096219|FG000|STARTED|Overall Study||50
9975014|NCT01562327|11096219|FG000|COMPLETED|Overall Study||42
9975015|NCT01562327|11096219|FG000|NOT COMPLETED|Overall Study||8
9975016|NCT01562379|11096229|FG000|STARTED|Overall Study||1438
9975017|NCT01562379|11096230|FG001|STARTED|Overall Study||1492
9975018|NCT01562379|11096231|FG002|STARTED|Overall Study||851
9975019|NCT01562379|11096232|FG003|STARTED|Overall Study||843
9975020|NCT01562379|11096233|FG004|STARTED|Overall Study||825
9975021|NCT01562379|11096229|FG000|COMPLETED|Overall Study||1312
9975022|NCT01562379|11096230|FG001|COMPLETED|Overall Study||1395
9975023|NCT01562379|11096231|FG002|COMPLETED|Overall Study||789
9975024|NCT01562379|11096232|FG003|COMPLETED|Overall Study||786
9975025|NCT01562379|11096233|FG004|COMPLETED|Overall Study||785
9975026|NCT01562379|11096229|FG000|NOT COMPLETED|Overall Study||126
9975027|NCT01562379|11096230|FG001|NOT COMPLETED|Overall Study||97
9975028|NCT01562379|11096231|FG002|NOT COMPLETED|Overall Study||62
9975029|NCT01562379|11096232|FG003|NOT COMPLETED|Overall Study||57
9975030|NCT01562379|11096233|FG004|NOT COMPLETED|Overall Study||40
9975031|NCT01562444|11096248|FG000|STARTED|Overall Study||48
9975032|NCT01562444|11096249|FG001|STARTED|Overall Study||51
9975033|NCT01562444|11096250|FG002|STARTED|Overall Study||106
9975034|NCT01562444|11096248|FG000|COMPLETED|Overall Study||43
9975035|NCT01562444|11096249|FG001|COMPLETED|Overall Study||49
9975036|NCT01562444|11096250|FG002|COMPLETED|Overall Study||99
9975037|NCT01562444|11096248|FG000|NOT COMPLETED|Overall Study||5
9975038|NCT01562444|11096249|FG001|NOT COMPLETED|Overall Study||2
9975039|NCT01562444|11096250|FG002|NOT COMPLETED|Overall Study||7
9975040|NCT01562548|11096262|FG000|STARTED|Overall Study||25
9975041|NCT01562548|11096263|FG001|STARTED|Overall Study||15
9975042|NCT01562548|11096264|FG002|STARTED|Overall Study||25
9975043|NCT01562548|11096265|FG003|STARTED|Overall Study||14
9975044|NCT01562548|11096262|FG000|COMPLETED|Overall Study||25
9975045|NCT01562548|11096263|FG001|COMPLETED|Overall Study||15
9975046|NCT01562548|11096264|FG002|COMPLETED|Overall Study||24
9975047|NCT01562548|11096265|FG003|COMPLETED|Overall Study||14
9975048|NCT01562548|11096262|FG000|NOT COMPLETED|Overall Study||0
9975049|NCT01562548|11096263|FG001|NOT COMPLETED|Overall Study||0
9975050|NCT01562548|11096264|FG002|NOT COMPLETED|Overall Study||1
9975051|NCT01562548|11096265|FG003|NOT COMPLETED|Overall Study||0
9975052|NCT01562613|11096277|FG000|STARTED|Overall Study||533
9975053|NCT01562613|11096277|FG000|COMPLETED|Overall Study||529
9975054|NCT01562613|11096277|FG000|NOT COMPLETED|Overall Study||4
9975055|NCT01562678|11096283|FG000|STARTED|Overall Study||14
9975056|NCT01562678|11096284|FG001|STARTED|Overall Study||14
9975057|NCT01562678|11096283|FG000|COMPLETED|Overall Study||8
9975058|NCT01562678|11096284|FG001|COMPLETED|Overall Study||12
9975059|NCT01562678|11096283|FG000|NOT COMPLETED|Overall Study||6
9975060|NCT01562678|11096284|FG001|NOT COMPLETED|Overall Study||2
9975061|NCT01562743|11096290|FG000|STARTED|Overall Study||185
9975062|NCT01562743|11096290|FG000|COMPLETED|Overall Study||133
9975063|NCT01562743|11096290|FG000|NOT COMPLETED|Overall Study||52
9975064|NCT01562756|11096294|FG000|STARTED|Overall Study||6
9975065|NCT01562756|11096294|FG000|COMPLETED|Overall Study||6
9975066|NCT01562756|11096294|FG000|NOT COMPLETED|Overall Study||0
9975067|NCT01562782|11096300|FG000|STARTED|Overall Study||19
9975068|NCT01562782|11096301|FG001|STARTED|Overall Study||20
9975069|NCT01562782|11096300|FG000|COMPLETED|Overall Study||15
9975070|NCT01562782|11096301|FG001|COMPLETED|Overall Study||15
9975071|NCT01562782|11096300|FG000|NOT COMPLETED|Overall Study||4
9975072|NCT01562782|11096301|FG001|NOT COMPLETED|Overall Study||5
9975073|NCT01562873|11096307|FG000|STARTED|Overall Study||21
9975074|NCT01562873|11096308|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
9975075|NCT01562873|11096307|FG000|COMPLETED|Overall Study||0
9975076|NCT01562873|11096308|FG001|COMPLETED|Overall Study||0
9975077|NCT01562873|11096307|FG000|NOT COMPLETED|Overall Study||21
9975078|NCT01562873|11096308|FG001|NOT COMPLETED|Overall Study||0
9975079|NCT01562886|11096312|FG000|STARTED|Overall Study||14
9975080|NCT01562886|11096312|FG000|COMPLETED|Overall Study||13
9975081|NCT01562886|11096312|FG000|NOT COMPLETED|Overall Study||1
9975082|NCT01563003|11096318|FG000|STARTED|Overall Study||16
9975083|NCT01563003|11096319|FG001|STARTED|Overall Study||15
9975084|NCT01563003|11096318|FG000|COMPLETED|Overall Study||16
9975085|NCT01563003|11096319|FG001|COMPLETED|Overall Study||15
9975086|NCT01563003|11096318|FG000|NOT COMPLETED|Overall Study||0
9975087|NCT01563003|11096319|FG001|NOT COMPLETED|Overall Study||0
9975088|NCT01563029|11096330|FG000|STARTED|Overall Study||119
9975089|NCT01563029|11096331|FG001|STARTED|Overall Study||118
9975090|NCT01563029|11096332|FG002|STARTED|Overall Study||120
9975091|NCT01563029|11096333|FG003|STARTED|Overall Study||118
9975092|NCT01563029|11096334|FG004|STARTED|Overall Study||118
9975093|NCT01563029|11096330|FG000|COMPLETED|Overall Study||66
9975094|NCT01563029|11096331|FG001|COMPLETED|Overall Study||94
9975095|NCT01563029|11096332|FG002|COMPLETED|Overall Study||87
9975096|NCT01563029|11096333|FG003|COMPLETED|Overall Study||85
9975097|NCT01563029|11096334|FG004|COMPLETED|Overall Study||89
9975098|NCT01563029|11096330|FG000|NOT COMPLETED|Overall Study||53
9975099|NCT01563029|11096331|FG001|NOT COMPLETED|Overall Study||24
9975100|NCT01563029|11096332|FG002|NOT COMPLETED|Overall Study||33
9975101|NCT01563029|11096333|FG003|NOT COMPLETED|Overall Study||33
9975102|NCT01563029|11096334|FG004|NOT COMPLETED|Overall Study||29
9975103|NCT01563055|11096347|FG000|STARTED|Overall Study||10
9975104|NCT01563055|11096347|FG000|COMPLETED|Overall Study||10
9975105|NCT01563055|11096347|FG000|NOT COMPLETED|Overall Study||0
9975106|NCT01563081|11096356|FG000|STARTED|Overall Study||30
9975107|NCT01563081|11096357|FG001|STARTED|Overall Study||30
9975108|NCT01563081|11096356|FG000|COMPLETED|Overall Study||30
9975109|NCT01563081|11096357|FG001|COMPLETED|Overall Study||30
9975110|NCT01563081|11096356|FG000|NOT COMPLETED|Overall Study||0
9975111|NCT01563081|11096357|FG001|NOT COMPLETED|Overall Study||0
9975112|NCT01563172|11096367|FG000|STARTED|Overall Study||65
9975113|NCT01563172|11096367|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
9975114|NCT01563172|11096367|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
9975115|NCT01563172|11096367|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
9975116|NCT01563172|11096367|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
9975117|NCT01563172|11096367|FG000|Control Dentifrice|Overall Study||60
9975118|NCT01563172|11096367|FG000|COMPLETED|Overall Study||52
9975119|NCT01563172|11096367|FG000|NOT COMPLETED|Overall Study||13
9975120|NCT01563185|11096382|FG000|STARTED|Overall Study||12
9975121|NCT01563185|11096382|FG000|COMPLETED|Overall Study||10
9975122|NCT01563185|11096382|FG000|NOT COMPLETED|Overall Study||2
10098621|NCT02385084|11227652|FG001|Received LY2409021|Period 1||3
10098622|NCT02385084|11227653|FG002|Received LY2409021|Period 1||3
10098623|NCT02385084|11227654|FG003|Received LY2409021|Period 1||3
10098624|NCT02385084|11227655|FG004|Received LY2409021|Period 1||3
10098625|NCT02385084|11227656|FG005|Received LY2409021|Period 1||3
10098626|NCT02385084|11227651|FG000|Washout|Period 1||3
10098627|NCT02385084|11227652|FG001|Washout|Period 1||3
10098628|NCT02385084|11227653|FG002|Washout|Period 1||3
10098629|NCT02385084|11227654|FG003|Washout|Period 1||3
10098630|NCT02385084|11227655|FG004|Washout|Period 1||3
10098631|NCT02385084|11227656|FG005|Washout|Period 1||3
10098632|NCT02385084|11227651|FG000|COMPLETED|Period 1||3
10098633|NCT02385084|11227652|FG001|COMPLETED|Period 1||3
10098634|NCT02385084|11227653|FG002|COMPLETED|Period 1||3
10098635|NCT02385084|11227654|FG003|COMPLETED|Period 1||3
10098636|NCT02385084|11227655|FG004|COMPLETED|Period 1||3
10098637|NCT02385084|11227656|FG005|COMPLETED|Period 1||3
10098638|NCT02385084|11227651|FG000|NOT COMPLETED|Period 1||0
10098639|NCT02385084|11227652|FG001|NOT COMPLETED|Period 1||0
10098640|NCT02385084|11227653|FG002|NOT COMPLETED|Period 1||0
10098641|NCT02385084|11227654|FG003|NOT COMPLETED|Period 1||0
10098642|NCT02385084|11227655|FG004|NOT COMPLETED|Period 1||0
10098643|NCT02385084|11227656|FG005|NOT COMPLETED|Period 1||0
10098644|NCT02385084|11227651|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
10098645|NCT02385084|11227652|FG001|STARTED|Period 2||3
10098646|NCT02385084|11227653|FG002|STARTED|Period 2||3
10098647|NCT02385084|11227654|FG003|STARTED|Period 2||3
10017747|NCT01818726|11140699|FG001|NOT COMPLETED|Overall Study||2
10017748|NCT01818739|11140705|FG000|STARTED|Overall Study||204
10017749|NCT01818739|11140705|FG000|COMPLETED|Overall Study||204
10017750|NCT01818739|11140705|FG000|NOT COMPLETED|Overall Study||0
10017751|NCT01818752|11140712|FG000|STARTED|Overall Study||477
10017752|NCT01818752|11140713|FG001|STARTED|Overall Study||478
10017753|NCT01818752|11140712|FG000|Received Treatment|Overall Study||470
10017754|NCT01818752|11140713|FG001|Received Treatment|Overall Study||474
10017755|NCT01818752|11140712|FG000|COMPLETED|Overall Study|Completed treatment|290
10017756|NCT01818752|11140713|FG001|COMPLETED|Overall Study|Completed treatment|280
10017757|NCT01818752|11140712|FG000|NOT COMPLETED|Overall Study||187
10017758|NCT01818752|11140713|FG001|NOT COMPLETED|Overall Study||198
10017759|NCT01818765|11140719|FG000|STARTED|Overall Study||20
10017760|NCT01818765|11140719|FG000|COMPLETED|Overall Study||18
10017761|NCT01818765|11140719|FG000|NOT COMPLETED|Overall Study||2
10017762|NCT01818804|11140726|FG000|STARTED|Overall Study||73
10017763|NCT01818804|11140727|FG001|STARTED|Overall Study||72
10017764|NCT01818804|11140726|FG000|COMPLETED|Overall Study||68
10017765|NCT01818804|11140727|FG001|COMPLETED|Overall Study||65
10017766|NCT01818804|11140726|FG000|NOT COMPLETED|Overall Study||5
10017767|NCT01818804|11140727|FG001|NOT COMPLETED|Overall Study||7
10017768|NCT01819129|11140735|FG000|STARTED|Overall Study||345
10017769|NCT01819129|11140736|FG001|STARTED|Overall Study||344
10017770|NCT01819129|11140735|FG000|Exposed|Overall Study||341
10017771|NCT01819129|11140736|FG001|Exposed|Overall Study||341
10017772|NCT01819129|11140735|FG000|COMPLETED|Overall Study||301
10017773|NCT01819129|11140736|FG001|COMPLETED|Overall Study||305
10017774|NCT01819129|11140735|FG000|NOT COMPLETED|Overall Study||44
10017775|NCT01819129|11140736|FG001|NOT COMPLETED|Overall Study||39
10017776|NCT01819194|11140742|FG000|STARTED|Overall Study||62
10017777|NCT01819194|11140742|FG000|COMPLETED|Overall Study||60
10017778|NCT01819194|11140742|FG000|NOT COMPLETED|Overall Study||2
10017779|NCT01819233|11140746|FG000|STARTED|Overall Study||38
10017780|NCT01819233|11140746|FG000|COMPLETED|Overall Study||32
10017781|NCT01819233|11140746|FG000|NOT COMPLETED|Overall Study||6
10098648|NCT02385084|11227655|FG004|STARTED|Period 2||3
10098649|NCT02385084|11227656|FG005|STARTED|Period 2||3
10098650|NCT02385084|11227651|FG000|Received LY2409021|Period 2||2
9975123|NCT01563198|11096386|FG000|STARTED|Baseline||49733
9975124|NCT01563198|11096386|FG000|COMPLETED|Baseline||49733
9975125|NCT01563198|11096386|FG000|NOT COMPLETED|Baseline||0
9975126|NCT01563198|11096386|FG000|STARTED|After Training||47979
9975127|NCT01563198|11096386|FG000|COMPLETED|After Training||47979
9975128|NCT01563198|11096386|FG000|NOT COMPLETED|After Training||0
9975129|NCT01563237|11096390|FG000|STARTED|Overall Study||64
9975130|NCT01563237|11096391|FG001|STARTED|Overall Study||5
9975131|NCT01563237|11096390|FG000|COMPLETED|Overall Study||54
9975132|NCT01563237|11096391|FG001|COMPLETED|Overall Study||5
9975133|NCT01563237|11096390|FG000|NOT COMPLETED|Overall Study||10
9975134|NCT01563237|11096391|FG001|NOT COMPLETED|Overall Study||0
9975135|NCT01563354|11096399|FG000|STARTED|Core Phase||41
9975136|NCT01563354|11096400|FG001|STARTED|Core Phase||42
9975137|NCT01563354|11096401|FG002|STARTED|Core Phase||41
9975138|NCT01563354|11096399|FG000|Entered Extension Phase|Core Phase||12
9975139|NCT01563354|11096400|FG001|Entered Extension Phase|Core Phase||14
9975140|NCT01563354|11096401|FG002|Entered Extension Phase|Core Phase||15
9975141|NCT01563354|11096399|FG000|COMPLETED|Core Phase||12
9975142|NCT01563354|11096400|FG001|COMPLETED|Core Phase||14
9975143|NCT01563354|11096401|FG002|COMPLETED|Core Phase||15
9975144|NCT01563354|11096399|FG000|NOT COMPLETED|Core Phase||29
9975145|NCT01563354|11096400|FG001|NOT COMPLETED|Core Phase||28
9975146|NCT01563354|11096401|FG002|NOT COMPLETED|Core Phase||26
9975147|NCT01563354|11096399|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
9975148|NCT01563354|11096400|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
9975149|NCT01563354|11096401|FG002|STARTED|Extension Phase||15
9975150|NCT01563354|11096399|FG000|COMPLETED|Extension Phase||0
9975151|NCT01563354|11096400|FG001|COMPLETED|Extension Phase||0
9975152|NCT01563354|11096401|FG002|COMPLETED|Extension Phase||0
9975153|NCT01563354|11096399|FG000|NOT COMPLETED|Extension Phase||12
9975154|NCT01563354|11096400|FG001|NOT COMPLETED|Extension Phase||14
9975155|NCT01563354|11096401|FG002|NOT COMPLETED|Extension Phase||15
9975156|NCT01563406|11096413|FG000|STARTED|Overall Study|194 hubs|60
9975157|NCT01563406|11096414|FG001|STARTED|Overall Study|102 hubs|30
9975158|NCT01563406|11096415|FG002|STARTED|Overall Study|101 hubs|30
9975159|NCT01563406|11096416|FG003|STARTED|Overall Study|112 hubs|29
9975160|NCT01563406|11096413|FG000|COMPLETED|Overall Study|194 hubs|60
9975161|NCT01563406|11096414|FG001|COMPLETED|Overall Study|102 hubs|30
9975162|NCT01563406|11096415|FG002|COMPLETED|Overall Study|101 hubs|30
9975163|NCT01563406|11096416|FG003|COMPLETED|Overall Study|112 hubs|29
9975164|NCT01563406|11096413|FG000|NOT COMPLETED|Overall Study||0
9975165|NCT01563406|11096414|FG001|NOT COMPLETED|Overall Study||0
9975166|NCT01563406|11096415|FG002|NOT COMPLETED|Overall Study||0
9975167|NCT01563406|11096416|FG003|NOT COMPLETED|Overall Study||0
9975168|NCT01563536|11096432|FG000|STARTED|Overall Study||6
9975169|NCT01563536|11096433|FG001|STARTED|Overall Study||6
9975170|NCT01563536|11096432|FG000|COMPLETED|Overall Study||5
9975171|NCT01563536|11096433|FG001|COMPLETED|Overall Study||4
9975172|NCT01563536|11096432|FG000|NOT COMPLETED|Overall Study||1
9975173|NCT01563536|11096433|FG001|NOT COMPLETED|Overall Study||2
9975174|NCT01563913|11096441|FG000|STARTED|Overall Study||15
9975175|NCT01563913|11096442|FG001|STARTED|Overall Study||15
9975176|NCT01563913|11096441|FG000|COMPLETED|Overall Study||13
9975177|NCT01563913|11096442|FG001|COMPLETED|Overall Study||15
9975178|NCT01563913|11096441|FG000|NOT COMPLETED|Overall Study||2
9975179|NCT01563913|11096442|FG001|NOT COMPLETED|Overall Study||0
9975180|NCT01563978|11096450|FG000|STARTED|Overall Study|Patients who received treatment.|68
9975181|NCT01563978|11096451|FG001|STARTED|Overall Study|Patients who received treatment.|67
9975182|NCT01563978|11096450|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
9975183|NCT01563978|11096451|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
9975184|NCT01563978|11096450|FG000|COMPLETED|Overall Study||64
9975185|NCT01563978|11096451|FG001|COMPLETED|Overall Study||65
9975186|NCT01563978|11096450|FG000|NOT COMPLETED|Overall Study||4
9975187|NCT01563978|11096451|FG001|NOT COMPLETED|Overall Study||2
9975188|NCT01564277|11096459|FG000|STARTED|Overall Study||12
9975189|NCT01564277|11096460|FG001|STARTED|Overall Study||12
9975190|NCT01564277|11096459|FG000|COMPLETED|Overall Study||11
9975191|NCT01564277|11096460|FG001|COMPLETED|Overall Study||11
9975192|NCT01564277|11096459|FG000|NOT COMPLETED|Overall Study||1
9975193|NCT01564277|11096460|FG001|NOT COMPLETED|Overall Study||1
9975194|NCT01564394|11096468|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
9975195|NCT01564394|11096469|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
9975196|NCT01564394|11096468|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
9975197|NCT01564394|11096469|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
9975198|NCT01564394|11096468|FG000|NOT COMPLETED|Overall Study||6
9975199|NCT01564394|11096469|FG001|NOT COMPLETED|Overall Study||10
9975200|NCT01564407|11096480|FG000|STARTED|Overall Study||4
9975201|NCT01564407|11096481|FG001|STARTED|Overall Study||5
9975202|NCT01564407|11096482|FG002|STARTED|Overall Study||4
9975203|NCT01564407|11096483|FG003|STARTED|Overall Study||2
9975204|NCT01564407|11096484|FG004|STARTED|Overall Study||0
9975205|NCT01564407|11096480|FG000|COMPLETED|Overall Study||4
9975206|NCT01564407|11096481|FG001|COMPLETED|Overall Study||3
9975207|NCT01564407|11096482|FG002|COMPLETED|Overall Study||4
9975208|NCT01564407|11096483|FG003|COMPLETED|Overall Study||1
9975209|NCT01564407|11096484|FG004|COMPLETED|Overall Study||0
9975210|NCT01564407|11096480|FG000|NOT COMPLETED|Overall Study||0
9975211|NCT01564407|11096481|FG001|NOT COMPLETED|Overall Study||2
9975212|NCT01564407|11096482|FG002|NOT COMPLETED|Overall Study||0
9975213|NCT01564407|11096483|FG003|NOT COMPLETED|Overall Study||1
9975214|NCT01564407|11096484|FG004|NOT COMPLETED|Overall Study||0
9975215|NCT01564459|11096508|FG000|STARTED|Run-In||12
9975216|NCT01564459|11096509|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
9975217|NCT01564459|11096510|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
9975218|NCT01564459|11096508|FG000|COMPLETED|Run-In||0
9975219|NCT01564459|11096509|FG001|COMPLETED|Run-In||87
9975220|NCT01564459|11096510|FG002|COMPLETED|Run-In||83
9975221|NCT01564459|11096508|FG000|NOT COMPLETED|Run-In||12
9975222|NCT01564459|11096509|FG001|NOT COMPLETED|Run-In||0
9975223|NCT01564459|11096510|FG002|NOT COMPLETED|Run-In||0
9975224|NCT01564459|11096508|FG000|STARTED|Double-blind Treatment||0
9975225|NCT01564459|11096509|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
9975226|NCT01564459|11096510|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
9975227|NCT01564459|11096508|FG000|COMPLETED|Double-blind Treatment||0
9975228|NCT01564459|11096509|FG001|COMPLETED|Double-blind Treatment||87
9975229|NCT01564459|11096510|FG002|COMPLETED|Double-blind Treatment||82
9975230|NCT01564459|11096508|FG000|NOT COMPLETED|Double-blind Treatment||0
9975231|NCT01564459|11096509|FG001|NOT COMPLETED|Double-blind Treatment||0
9975232|NCT01564459|11096510|FG002|NOT COMPLETED|Double-blind Treatment||1
9975233|NCT01564485|11096523|FG000|STARTED|Overall Study||92
9975234|NCT01564485|11096524|FG001|STARTED|Overall Study||101
9975235|NCT01564485|11096523|FG000|COMPLETED|Overall Study||84
9975236|NCT01564485|11096524|FG001|COMPLETED|Overall Study||78
10098651|NCT02385084|11227652|FG001|Received LY2409021|Period 2||3
10098652|NCT02385084|11227653|FG002|Received LY2409021|Period 2||3
10098653|NCT02385084|11227654|FG003|Received LY2409021|Period 2||3
10098654|NCT02385084|11227655|FG004|Received LY2409021|Period 2||3
10098655|NCT02385084|11227656|FG005|Received LY2409021|Period 2||3
10098656|NCT02385084|11227651|FG000|Washout|Period 2||2
10098657|NCT02385084|11227652|FG001|Washout|Period 2||3
10098658|NCT02385084|11227653|FG002|Washout|Period 2||3
10098659|NCT02385084|11227654|FG003|Washout|Period 2||3
10098660|NCT02385084|11227655|FG004|Washout|Period 2||3
10098661|NCT02385084|11227656|FG005|Washout|Period 2||3
10098662|NCT02385084|11227651|FG000|COMPLETED|Period 2||2
10098663|NCT02385084|11227652|FG001|COMPLETED|Period 2||3
10098664|NCT02385084|11227653|FG002|COMPLETED|Period 2||2
10098665|NCT02385084|11227654|FG003|COMPLETED|Period 2||3
10098666|NCT02385084|11227655|FG004|COMPLETED|Period 2||3
10098667|NCT02385084|11227656|FG005|COMPLETED|Period 2||3
10098668|NCT02385084|11227651|FG000|NOT COMPLETED|Period 2||0
10098669|NCT02385084|11227652|FG001|NOT COMPLETED|Period 2||0
10098670|NCT02385084|11227653|FG002|NOT COMPLETED|Period 2||1
10098671|NCT02385084|11227654|FG003|NOT COMPLETED|Period 2||0
10098672|NCT02385084|11227655|FG004|NOT COMPLETED|Period 2||0
10098673|NCT02385084|11227656|FG005|NOT COMPLETED|Period 2||0
10098674|NCT02385084|11227651|FG000|STARTED|Period 3||2
10098675|NCT02385084|11227652|FG001|STARTED|Period 3||3
10098676|NCT02385084|11227653|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
10098677|NCT02385084|11227654|FG003|STARTED|Period 3||3
10098678|NCT02385084|11227655|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
10098679|NCT02385084|11227656|FG005|STARTED|Period 3||3
10098680|NCT02385084|11227651|FG000|Received LY2409021|Period 3||2
10098681|NCT02385084|11227652|FG001|Received LY2409021|Period 3||3
10098682|NCT02385084|11227653|FG002|Received LY2409021|Period 3||1
10098683|NCT02385084|11227654|FG003|Received LY2409021|Period 3||3
10098684|NCT02385084|11227655|FG004|Received LY2409021|Period 3||2
10098685|NCT02385084|11227656|FG005|Received LY2409021|Period 3||3
10098686|NCT02385084|11227651|FG000|Washout|Period 3||2
10098687|NCT02385084|11227652|FG001|Washout|Period 3||3
10098688|NCT02385084|11227653|FG002|Washout|Period 3||1
10098689|NCT02385084|11227654|FG003|Washout|Period 3||3
10098690|NCT02385084|11227655|FG004|Washout|Period 3||2
10098691|NCT02385084|11227656|FG005|Washout|Period 3||3
10098692|NCT02385084|11227651|FG000|COMPLETED|Period 3||2
10098693|NCT02385084|11227652|FG001|COMPLETED|Period 3||3
10098694|NCT02385084|11227653|FG002|COMPLETED|Period 3||1
10098695|NCT02385084|11227654|FG003|COMPLETED|Period 3||3
10098696|NCT02385084|11227655|FG004|COMPLETED|Period 3||2
10098697|NCT02385084|11227656|FG005|COMPLETED|Period 3||3
10098698|NCT02385084|11227651|FG000|NOT COMPLETED|Period 3||0
10098699|NCT02385084|11227652|FG001|NOT COMPLETED|Period 3||0
10098700|NCT02385084|11227653|FG002|NOT COMPLETED|Period 3||0
10098701|NCT02385084|11227654|FG003|NOT COMPLETED|Period 3||0
9975237|NCT01564485|11096523|FG000|NOT COMPLETED|Overall Study||8
9975238|NCT01564485|11096524|FG001|NOT COMPLETED|Overall Study||23
10098702|NCT02385084|11227655|FG004|NOT COMPLETED|Period 3||0
10098703|NCT02385084|11227656|FG005|NOT COMPLETED|Period 3||0
10098704|NCT02385097|11227667|FG000|STARTED|Overall Study||106
10098705|NCT02385097|11227668|FG001|STARTED|Overall Study||105
9975239|NCT01564628|11096530|FG000|STARTED|Overall Study||185
9975240|NCT01564628|11096531|FG001|STARTED|Overall Study||58
9975241|NCT01564628|11096532|FG002|STARTED|Overall Study||63
10098706|NCT02385097|11227667|FG000|COMPLETED|Overall Study||106
10098707|NCT02385097|11227668|FG001|COMPLETED|Overall Study||105
10098708|NCT02385097|11227667|FG000|NOT COMPLETED|Overall Study||0
10098709|NCT02385097|11227668|FG001|NOT COMPLETED|Overall Study||0
9975242|NCT01564628|11096530|FG000|COMPLETED|Overall Study||181
9975243|NCT01564628|11096531|FG001|COMPLETED|Overall Study||56
9975244|NCT01564628|11096532|FG002|COMPLETED|Overall Study||61
9975245|NCT01564628|11096530|FG000|NOT COMPLETED|Overall Study||4
9975246|NCT01564628|11096531|FG001|NOT COMPLETED|Overall Study||2
9975247|NCT01564628|11096532|FG002|NOT COMPLETED|Overall Study||2
9975248|NCT01564654|11096536|FG000|STARTED|Overall Study|106 knees (bilateral)|89
9975249|NCT01564654|11096536|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89
9975250|NCT01564654|11096536|FG000|NOT COMPLETED|Overall Study||0
9975251|NCT01564693|11096543|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
9975252|NCT01564693|11096544|FG001|STARTED|Overall Study||4
9975253|NCT01564693|11096545|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
9975254|NCT01564693|11096543|FG000|COMPLETED|Overall Study||9
9975255|NCT01564693|11096544|FG001|COMPLETED|Overall Study||4
9975256|NCT01564693|11096545|FG002|COMPLETED|Overall Study||2
9975257|NCT01564693|11096543|FG000|NOT COMPLETED|Overall Study||0
9975258|NCT01564693|11096544|FG001|NOT COMPLETED|Overall Study||0
9975259|NCT01564693|11096545|FG002|NOT COMPLETED|Overall Study||0
9975260|NCT01564706|11096553|FG000|STARTED|Overall Study||9
9975261|NCT01564706|11096553|FG000|COMPLETED|Overall Study||9
9975262|NCT01564706|11096553|FG000|NOT COMPLETED|Overall Study||0
9975263|NCT01564758|11096557|FG000|STARTED|Overall Study||99
9975264|NCT01564758|11096557|FG000|COMPLETED|Overall Study||85
9975265|NCT01564758|11096557|FG000|NOT COMPLETED|Overall Study||14
9975266|NCT01564784|11096563|FG000|STARTED|Overall Study|Treated (164 randomized)|164
9975267|NCT01564784|11096564|FG001|STARTED|Overall Study|Treated (162 randomized)|143
9975268|NCT01564784|11096563|FG000|COMPLETED|Overall Study||30
9975269|NCT01564784|11096564|FG001|COMPLETED|Overall Study||10
9975270|NCT01564784|11096563|FG000|NOT COMPLETED|Overall Study||134
9975271|NCT01564784|11096564|FG001|NOT COMPLETED|Overall Study||133
9975272|NCT01564862|11096573|FG000|STARTED|Overall Study||198
9975273|NCT01564862|11096574|FG001|STARTED|Overall Study||210
9975274|NCT01564862|11096575|FG002|STARTED|Overall Study||194
9975275|NCT01564862|11096573|FG000|Received Treatment|Overall Study||196
9975276|NCT01564862|11096574|FG001|Received Treatment|Overall Study||207
9975277|NCT01564862|11096575|FG002|Received Treatment|Overall Study||191
9975278|NCT01564862|11096573|FG000|COMPLETED|Overall Study||168
9975279|NCT01564862|11096574|FG001|COMPLETED|Overall Study||176
9975280|NCT01564862|11096575|FG002|COMPLETED|Overall Study||164
9975281|NCT01564862|11096573|FG000|NOT COMPLETED|Overall Study||30
9975282|NCT01564862|11096574|FG001|NOT COMPLETED|Overall Study||34
9975283|NCT01564862|11096575|FG002|NOT COMPLETED|Overall Study||30
9975284|NCT01564914|11096585|FG000|STARTED|Overall Study||16
9975285|NCT01564914|11096586|FG001|STARTED|Overall Study||6
9975286|NCT01564914|11096585|FG000|COMPLETED|Overall Study||16
9975287|NCT01564914|11096586|FG001|COMPLETED|Overall Study||6
9975288|NCT01564914|11096585|FG000|NOT COMPLETED|Overall Study||0
9975289|NCT01564914|11096586|FG001|NOT COMPLETED|Overall Study||0
9975290|NCT01564953|11096595|FG000|STARTED|Overall Study||143
9975291|NCT01564953|11096595|FG000|COMPLETED|Overall Study||143
9975292|NCT01564953|11096595|FG000|NOT COMPLETED|Overall Study||0
9975293|NCT01565083|11096605|FG000|STARTED|Overall Study||106
9975294|NCT01565083|11096606|FG001|STARTED|Overall Study||107
9975295|NCT01565083|11096605|FG000|COMPLETED|Overall Study||73
9975296|NCT01565083|11096606|FG001|COMPLETED|Overall Study||68
9975297|NCT01565083|11096605|FG000|NOT COMPLETED|Overall Study||33
9975298|NCT01565083|11096606|FG001|NOT COMPLETED|Overall Study||39
9975299|NCT01565148|11096616|FG000|STARTED|Overall Study||47
9975300|NCT01565148|11096617|FG001|STARTED|Overall Study||46
9975301|NCT01565148|11096618|FG002|STARTED|Overall Study||47
9975302|NCT01565148|11096619|FG003|STARTED|Overall Study||45
9975303|NCT01565148|11096616|FG000|COMPLETED|Overall Study||32
9975304|NCT01565148|11096617|FG001|COMPLETED|Overall Study||31
9975305|NCT01565148|11096618|FG002|COMPLETED|Overall Study||40
9975306|NCT01565148|11096619|FG003|COMPLETED|Overall Study||32
9975307|NCT01565148|11096616|FG000|NOT COMPLETED|Overall Study||15
9975308|NCT01565148|11096617|FG001|NOT COMPLETED|Overall Study||15
9975309|NCT01565148|11096618|FG002|NOT COMPLETED|Overall Study||7
9975310|NCT01565148|11096619|FG003|NOT COMPLETED|Overall Study||13
9975311|NCT01565291|11096635|FG000|STARTED|Overall Study||16
9975312|NCT01565291|11096636|FG001|STARTED|Overall Study||16
9975313|NCT01565291|11096635|FG000|COMPLETED|Overall Study||15
9975314|NCT01565291|11096636|FG001|COMPLETED|Overall Study||16
9975315|NCT01565291|11096635|FG000|NOT COMPLETED|Overall Study||1
9975316|NCT01565291|11096636|FG001|NOT COMPLETED|Overall Study||0
9975317|NCT01565330|11096646|FG000|STARTED|Overall Study||5
9975318|NCT01565330|11096647|FG001|STARTED|Overall Study||4
9975319|NCT01565330|11096648|FG002|STARTED|Overall Study||4
9975320|NCT01565330|11096649|FG003|STARTED|Overall Study||7
9975321|NCT01565330|11096646|FG000|COMPLETED|Overall Study||5
9975322|NCT01565330|11096647|FG001|COMPLETED|Overall Study||4
9975323|NCT01565330|11096648|FG002|COMPLETED|Overall Study||4
9975324|NCT01565330|11096649|FG003|COMPLETED|Overall Study||7
9975325|NCT01565330|11096646|FG000|NOT COMPLETED|Overall Study||0
9975326|NCT01565330|11096647|FG001|NOT COMPLETED|Overall Study||0
9975327|NCT01565330|11096648|FG002|NOT COMPLETED|Overall Study||0
9975328|NCT01565330|11096649|FG003|NOT COMPLETED|Overall Study||0
9975329|NCT01565343|11096663|FG000|STARTED|Overall Study||11
9975330|NCT01565343|11096664|FG001|STARTED|Overall Study||4
9975331|NCT01565343|11096665|FG002|STARTED|Overall Study||10
9975332|NCT01565343|11096663|FG000|COMPLETED|Overall Study||10
9975333|NCT01565343|11096664|FG001|COMPLETED|Overall Study||4
9975334|NCT01565343|11096665|FG002|COMPLETED|Overall Study||10
9975335|NCT01565343|11096663|FG000|NOT COMPLETED|Overall Study||1
9975336|NCT01565343|11096664|FG001|NOT COMPLETED|Overall Study||0
9975337|NCT01565343|11096665|FG002|NOT COMPLETED|Overall Study||0
9975338|NCT01565356|11096672|FG000|STARTED|Overall Study||41
9975339|NCT01565356|11096672|FG000|COMPLETED|Overall Study||41
9975340|NCT01565356|11096672|FG000|NOT COMPLETED|Overall Study||0
9975341|NCT01565369|11096676|FG000|STARTED|Overall Study||35
9975342|NCT01565369|11096676|FG000|COMPLETED|Overall Study||35
9975343|NCT01565369|11096676|FG000|NOT COMPLETED|Overall Study||0
9975344|NCT01565382|11096681|FG000|STARTED|Overall Study||40
9975345|NCT01565382|11096682|FG001|STARTED|Overall Study||7
9975346|NCT01565382|11096681|FG000|COMPLETED|Overall Study||40
9975347|NCT01565382|11096682|FG001|COMPLETED|Overall Study||7
9975348|NCT01565382|11096681|FG000|NOT COMPLETED|Overall Study||0
9975349|NCT01565382|11096682|FG001|NOT COMPLETED|Overall Study||0
9975350|NCT01565499|11096687|FG000|STARTED|Overall Study||83
9975351|NCT01565499|11096687|FG000|COMPLETED|Overall Study||75
9975352|NCT01565499|11096687|FG000|NOT COMPLETED|Overall Study||8
9975353|NCT01565538|11096693|FG000|STARTED|Overall Study||61
9975354|NCT01565538|11096694|FG001|STARTED|Overall Study||62
9975355|NCT01565538|11096693|FG000|COMPLETED|Overall Study||61
9975356|NCT01565538|11096694|FG001|COMPLETED|Overall Study||62
9975357|NCT01565538|11096693|FG000|NOT COMPLETED|Overall Study||0
9975358|NCT01565538|11096694|FG001|NOT COMPLETED|Overall Study||0
9975359|NCT01565551|11096702|FG000|STARTED|Overall Study||586
9975360|NCT01565551|11096703|FG001|STARTED|Overall Study||51
9975361|NCT01565551|11096702|FG000|Clinical/Demographics|Overall Study||586
9975362|NCT01565551|11096703|FG001|Clinical/Demographics|Overall Study||51
9975363|NCT01565551|11096702|FG000|Biospecimens/Biomarkers|Overall Study||479
9975364|NCT01565551|11096703|FG001|Biospecimens/Biomarkers|Overall Study||22
9975365|NCT01565551|11096702|FG000|Neuroimaging|Overall Study||233
9975366|NCT01565551|11096703|FG001|Neuroimaging|Overall Study||25
9975367|NCT01565551|11096702|FG000|6-Month Outcomes|Overall Study||412
9975368|NCT01565551|11096703|FG001|6-Month Outcomes|Overall Study||30
9975369|NCT01565551|11096702|FG000|COMPLETED|Overall Study||586
9975370|NCT01565551|11096703|FG001|COMPLETED|Overall Study||51
9975371|NCT01565551|11096702|FG000|NOT COMPLETED|Overall Study||0
9975372|NCT01565551|11096703|FG001|NOT COMPLETED|Overall Study||0
9975373|NCT01565564|11096711|FG000|STARTED|Overall Study||344
9975374|NCT01565564|11096712|FG001|STARTED|Overall Study||362
9975375|NCT01565564|11096711|FG000|COMPLETED|Overall Study||339
9975376|NCT01565564|11096712|FG001|COMPLETED|Overall Study||361
9975377|NCT01565564|11096711|FG000|NOT COMPLETED|Overall Study||5
9975378|NCT01565564|11096712|FG001|NOT COMPLETED|Overall Study||1
9975379|NCT01565616|11096718|FG000|STARTED|Overall Study||22
9975380|NCT01565616|11096718|FG000|First Component: 5 Related Donors|Overall Study||5
9975381|NCT01565616|11096718|FG000|Second Component: Related or Unrelated|Overall Study||17
9975382|NCT01565616|11096718|FG000|COMPLETED|Overall Study||22
9975383|NCT01565616|11096718|FG000|NOT COMPLETED|Overall Study||0
9975384|NCT01565642|11096724|FG000|STARTED|Overall Study||151
9975385|NCT01565642|11096725|FG001|STARTED|Overall Study||151
9975386|NCT01565642|11096724|FG000|COMPLETED|Overall Study||149
9975387|NCT01565642|11096725|FG001|COMPLETED|Overall Study||150
9975388|NCT01565642|11096724|FG000|NOT COMPLETED|Overall Study||2
9975389|NCT01565642|11096725|FG001|NOT COMPLETED|Overall Study||1
9975390|NCT01565668|11096733|FG000|STARTED|Overall Study||38
9975391|NCT01565668|11096734|FG001|STARTED|Overall Study||38
9975392|NCT01565668|11096733|FG000|Completed Treatment Per Protocol|Overall Study||0
9975393|NCT01565668|11096734|FG001|Completed Treatment Per Protocol|Overall Study||0
9975394|NCT01565668|11096733|FG000|Started 30-day Follow-up|Overall Study||37
9975395|NCT01565668|11096734|FG001|Started 30-day Follow-up|Overall Study||37
9975396|NCT01565668|11096733|FG000|Completed 30-day Follow-up|Overall Study||11
9975397|NCT01565668|11096734|FG001|Completed 30-day Follow-up|Overall Study||5
9975398|NCT01565668|11096733|FG000|Started Long-term Follow-up|Overall Study||36
9975399|NCT01565668|11096734|FG001|Started Long-term Follow-up|Overall Study||33
9975400|NCT01565668|11096733|FG000|Completed Long-term Follow-up|Overall Study||0
10098710|NCT02385240|11227677|FG000|STARTED|Overall Study||183
10098711|NCT02385240|11227678|FG001|STARTED|Overall Study||184
10098712|NCT02385240|11227679|FG002|STARTED|Overall Study||185
10098713|NCT02385240|11227677|FG000|COMPLETED|Overall Study||182
9975401|NCT01565668|11096734|FG001|Completed Long-term Follow-up|Overall Study||0
9975402|NCT01565668|11096733|FG000|COMPLETED|Overall Study||0
9975403|NCT01565668|11096734|FG001|COMPLETED|Overall Study||0
9975404|NCT01565668|11096733|FG000|NOT COMPLETED|Overall Study||38
9975405|NCT01565668|11096734|FG001|NOT COMPLETED|Overall Study||38
9975406|NCT01565694|11096740|FG000|STARTED|Dose-Titration Period||76
9975407|NCT01565694|11096740|FG000|COMPLETED|Dose-Titration Period||62
10098714|NCT02385240|11227678|FG001|COMPLETED|Overall Study||178
9975408|NCT01565694|11096740|FG000|NOT COMPLETED|Dose-Titration Period||14
9975409|NCT01565694|11096740|FG000|STARTED|Fixed-Dose Assessment Period||62
9975410|NCT01565694|11096740|FG000|COMPLETED|Fixed-Dose Assessment Period||58
9975411|NCT01565694|11096740|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4
9975412|NCT01565707|11096748|FG000|STARTED|Overall Study||75
9975413|NCT01565707|11096749|FG001|STARTED|Overall Study||73
9975414|NCT01565707|11096750|FG002|STARTED|Overall Study||19
10098715|NCT02385240|11227679|FG002|COMPLETED|Overall Study||184
10098716|NCT02385240|11227677|FG000|NOT COMPLETED|Overall Study||1
9975415|NCT01565707|11096751|FG003|STARTED|Overall Study||22
9975416|NCT01565707|11096748|FG000|Treated|Overall Study||73
9975417|NCT01565707|11096749|FG001|Treated|Overall Study||73
9975418|NCT01565707|11096750|FG002|Treated|Overall Study||19
9975419|NCT01565707|11096751|FG003|Treated|Overall Study||22
9975420|NCT01565707|11096748|FG000|COMPLETED|Overall Study||66
9975421|NCT01565707|11096749|FG001|COMPLETED|Overall Study||65
9975422|NCT01565707|11096750|FG002|COMPLETED|Overall Study||16
9975423|NCT01565707|11096751|FG003|COMPLETED|Overall Study||17
9975424|NCT01565707|11096748|FG000|NOT COMPLETED|Overall Study||9
9975425|NCT01565707|11096749|FG001|NOT COMPLETED|Overall Study||8
9975426|NCT01565707|11096750|FG002|NOT COMPLETED|Overall Study||3
9975427|NCT01565707|11096751|FG003|NOT COMPLETED|Overall Study||5
9975428|NCT01565850|11096770|FG000|STARTED|Overall Study||103
9975429|NCT01565850|11096771|FG001|STARTED|Overall Study||50
9975430|NCT01565850|11096770|FG000|COMPLETED|Overall Study||83
9975431|NCT01565850|11096771|FG001|COMPLETED|Overall Study||42
9975432|NCT01565850|11096770|FG000|NOT COMPLETED|Overall Study||20
10098717|NCT02385240|11227678|FG001|NOT COMPLETED|Overall Study||6
10098718|NCT02385240|11227679|FG002|NOT COMPLETED|Overall Study||1
10098719|NCT02385318|11227690|FG000|STARTED|Overall Study||204
10098720|NCT02385318|11227691|FG001|STARTED|Overall Study||210
10098721|NCT02385318|11227692|FG002|STARTED|Overall Study||105
10098722|NCT02385318|11227690|FG000|COMPLETED|Overall Study||200
10098723|NCT02385318|11227691|FG001|COMPLETED|Overall Study||203
10098724|NCT02385318|11227692|FG002|COMPLETED|Overall Study||99
10098725|NCT02385318|11227690|FG000|NOT COMPLETED|Overall Study||4
10098726|NCT02385318|11227691|FG001|NOT COMPLETED|Overall Study||7
10098727|NCT02385318|11227692|FG002|NOT COMPLETED|Overall Study||6
10098728|NCT02385526|11227703|FG000|STARTED|Overall Study||22
10098729|NCT02385526|11227704|FG001|STARTED|Overall Study||20
10098730|NCT02385526|11227705|FG002|STARTED|Overall Study||20
10098731|NCT02385526|11227703|FG000|COMPLETED|Overall Study||20
10098732|NCT02385526|11227704|FG001|COMPLETED|Overall Study||17
10098733|NCT02385526|11227705|FG002|COMPLETED|Overall Study||20
10098734|NCT02385526|11227703|FG000|NOT COMPLETED|Overall Study||2
10098735|NCT02385526|11227704|FG001|NOT COMPLETED|Overall Study||3
10098736|NCT02385526|11227705|FG002|NOT COMPLETED|Overall Study||0
10098737|NCT02385669|11227713|FG000|STARTED|Overall Study||3
10098738|NCT02385669|11227713|FG000|COMPLETED|Overall Study||1
10098739|NCT02385669|11227713|FG000|NOT COMPLETED|Overall Study||2
10098740|NCT02385708|11227719|FG000|STARTED|Overall Study||81
10098741|NCT02385708|11227720|FG001|STARTED|Overall Study||82
10098742|NCT02385708|11227719|FG000|Intervention Started|Overall Study||81
10098743|NCT02385708|11227720|FG001|Intervention Started|Overall Study||82
10098744|NCT02385708|11227719|FG000|COMPLETED|Overall Study||73
10098745|NCT02385708|11227720|FG001|COMPLETED|Overall Study||67
10098746|NCT02385708|11227719|FG000|NOT COMPLETED|Overall Study||8
10098747|NCT02385708|11227720|FG001|NOT COMPLETED|Overall Study||15
10098748|NCT02385721|11227726|FG000|STARTED|Overall Study||601
10098749|NCT02385721|11227726|FG000|COMPLETED|Overall Study||371
10098750|NCT02385721|11227726|FG000|NOT COMPLETED|Overall Study||230
10098751|NCT02385799|11227732|FG000|STARTED|Overall Study||26
10098752|NCT02385799|11227733|FG001|STARTED|Overall Study||32
10098753|NCT02385799|11227732|FG000|Completed End-of-Treatment Visit|Overall Study||21
10098754|NCT02385799|11227733|FG001|Completed End-of-Treatment Visit|Overall Study||26
10098755|NCT02385799|11227732|FG000|COMPLETED|Overall Study||21
10098756|NCT02385799|11227733|FG001|COMPLETED|Overall Study||24
10098757|NCT02385799|11227732|FG000|NOT COMPLETED|Overall Study||5
10098758|NCT02385799|11227733|FG001|NOT COMPLETED|Overall Study||8
10098759|NCT02386098|11227744|FG000|STARTED|Stage 1 (96 Weeks)||43
10098760|NCT02386098|11227745|FG001|STARTED|Stage 1 (96 Weeks)||43
10098761|NCT02386098|11227746|FG002|STARTED|Stage 1 (96 Weeks)||0
10098762|NCT02386098|11227747|FG003|STARTED|Stage 1 (96 Weeks)||0
10098763|NCT02386098|11227748|FG004|STARTED|Stage 1 (96 Weeks)||0
10098764|NCT02386098|11227744|FG000|COMPLETED|Stage 1 (96 Weeks)||0
10098765|NCT02386098|11227745|FG001|COMPLETED|Stage 1 (96 Weeks)||0
10098766|NCT02386098|11227746|FG002|COMPLETED|Stage 1 (96 Weeks)||0
10098767|NCT02386098|11227747|FG003|COMPLETED|Stage 1 (96 Weeks)||0
10098768|NCT02386098|11227748|FG004|COMPLETED|Stage 1 (96 Weeks)||0
10098769|NCT02386098|11227744|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43
10098770|NCT02386098|11227745|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43
10098771|NCT02386098|11227746|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0
10098772|NCT02386098|11227747|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0
10098773|NCT02386098|11227748|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0
10098774|NCT02386098|11227744|FG000|STARTED|Stage 2 (96 Weeks)||0
9975433|NCT01565850|11096771|FG001|NOT COMPLETED|Overall Study||8
9975434|NCT01565889|11096783|FG000|STARTED|Part A||12
9975435|NCT01565889|11096784|FG001|STARTED|Part A||4
9975436|NCT01565889|11096785|FG002|STARTED|Part A||8
9975437|NCT01565889|11096786|FG003|STARTED|Part A||7
10098775|NCT02386098|11227745|FG001|STARTED|Stage 2 (96 Weeks)||0
10098776|NCT02386098|11227746|FG002|STARTED|Stage 2 (96 Weeks)||0
10098777|NCT02386098|11227747|FG003|STARTED|Stage 2 (96 Weeks)||0
10098778|NCT02386098|11227748|FG004|STARTED|Stage 2 (96 Weeks)||0
10098779|NCT02386098|11227744|FG000|COMPLETED|Stage 2 (96 Weeks)||0
10098780|NCT02386098|11227745|FG001|COMPLETED|Stage 2 (96 Weeks)||0
10098781|NCT02386098|11227746|FG002|COMPLETED|Stage 2 (96 Weeks)||0
10098782|NCT02386098|11227747|FG003|COMPLETED|Stage 2 (96 Weeks)||0
10098783|NCT02386098|11227748|FG004|COMPLETED|Stage 2 (96 Weeks)||0
9975438|NCT01565889|11096787|FG004|STARTED|Part A||7
9975439|NCT01565889|11096788|FG005|STARTED|Part A||0
9975440|NCT01565889|11096783|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
9975441|NCT01565889|11096784|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
9975442|NCT01565889|11096785|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
9975443|NCT01565889|11096786|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
9975444|NCT01565889|11096787|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
9975445|NCT01565889|11096788|FG005|COMPLETED|Part A||0
9975446|NCT01565889|11096783|FG000|NOT COMPLETED|Part A||1
9975447|NCT01565889|11096784|FG001|NOT COMPLETED|Part A||0
9975448|NCT01565889|11096785|FG002|NOT COMPLETED|Part A||0
9975449|NCT01565889|11096786|FG003|NOT COMPLETED|Part A||0
9975450|NCT01565889|11096787|FG004|NOT COMPLETED|Part A||0
9975451|NCT01565889|11096788|FG005|NOT COMPLETED|Part A||0
9975452|NCT01565889|11096783|FG000|STARTED|Part B||0
9975453|NCT01565889|11096784|FG001|STARTED|Part B||0
9975454|NCT01565889|11096785|FG002|STARTED|Part B||0
9975455|NCT01565889|11096786|FG003|STARTED|Part B||0
10098784|NCT02386098|11227744|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0
10098785|NCT02386098|11227745|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0
10098786|NCT02386098|11227746|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0
10098787|NCT02386098|11227747|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0
9975456|NCT01565889|11096787|FG004|STARTED|Part B||0
9975457|NCT01565889|11096788|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
9975458|NCT01565889|11096783|FG000|COMPLETED|Part B||0
9975459|NCT01565889|11096784|FG001|COMPLETED|Part B||0
9975460|NCT01565889|11096785|FG002|COMPLETED|Part B||0
9975461|NCT01565889|11096786|FG003|COMPLETED|Part B||0
9975462|NCT01565889|11096787|FG004|COMPLETED|Part B||0
9975463|NCT01565889|11096788|FG005|COMPLETED|Part B||19
9975464|NCT01565889|11096783|FG000|NOT COMPLETED|Part B||0
9975465|NCT01565889|11096784|FG001|NOT COMPLETED|Part B||0
9975466|NCT01565889|11096785|FG002|NOT COMPLETED|Part B||0
9975467|NCT01565889|11096786|FG003|NOT COMPLETED|Part B||0
9975468|NCT01565889|11096787|FG004|NOT COMPLETED|Part B||0
9975469|NCT01565889|11096788|FG005|NOT COMPLETED|Part B||4
9975470|NCT01565902|11096807|FG000|STARTED|Overall Study||8
9975471|NCT01565902|11096808|FG001|STARTED|Overall Study||8
9975472|NCT01565902|11096809|FG002|STARTED|Overall Study||8
9975473|NCT01565902|11096810|FG003|STARTED|Overall Study||16
9975474|NCT01565902|11096807|FG000|COMPLETED|Overall Study||8
9975475|NCT01565902|11096808|FG001|COMPLETED|Overall Study||8
9975476|NCT01565902|11096809|FG002|COMPLETED|Overall Study||8
9975477|NCT01565902|11096810|FG003|COMPLETED|Overall Study||16
9975478|NCT01565902|11096807|FG000|NOT COMPLETED|Overall Study||0
9975479|NCT01565902|11096808|FG001|NOT COMPLETED|Overall Study||0
9975480|NCT01565902|11096809|FG002|NOT COMPLETED|Overall Study||0
9975481|NCT01565902|11096810|FG003|NOT COMPLETED|Overall Study||0
9975482|NCT01565928|11096823|FG000|STARTED|Overall Study||22
9975483|NCT01565928|11096823|FG000|COMPLETED|Overall Study||0
9975484|NCT01565928|11096823|FG000|NOT COMPLETED|Overall Study||22
9975485|NCT01565941|11096832|FG000|STARTED|Overall Study||360
9975486|NCT01565941|11096833|FG001|STARTED|Overall Study||353
9975487|NCT01565941|11096832|FG000|COMPLETED|Overall Study||349
9975488|NCT01565941|11096833|FG001|COMPLETED|Overall Study||349
9975489|NCT01565941|11096832|FG000|NOT COMPLETED|Overall Study||11
9975490|NCT01565941|11096833|FG001|NOT COMPLETED|Overall Study||4
9975491|NCT01565980|11096843|FG000|STARTED|Overall Study||20
9975492|NCT01565980|11096844|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
9975493|NCT01565980|11096843|FG000|COMPLETED|Overall Study||16
9975494|NCT01565980|11096844|FG001|COMPLETED|Overall Study||16
9975495|NCT01565980|11096843|FG000|NOT COMPLETED|Overall Study||4
9975496|NCT01565980|11096844|FG001|NOT COMPLETED|Overall Study||4
9975497|NCT01565993|11096856|FG000|STARTED|Overall Study||66
9975498|NCT01565993|11096857|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
9975499|NCT01565993|11096856|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
9975500|NCT01565993|11096857|FG001|COMPLETED|Overall Study||39
9975501|NCT01565993|11096856|FG000|NOT COMPLETED|Overall Study||0
9975502|NCT01565993|11096857|FG001|NOT COMPLETED|Overall Study||3
9975503|NCT01566084|11096865|FG000|STARTED|Overall Study||7
9975504|NCT01566084|11096866|FG001|STARTED|Overall Study||10
9975505|NCT01566084|11096865|FG000|COMPLETED|Overall Study||7
9975506|NCT01566084|11096866|FG001|COMPLETED|Overall Study||10
9975507|NCT01566084|11096865|FG000|NOT COMPLETED|Overall Study||0
9975508|NCT01566084|11096866|FG001|NOT COMPLETED|Overall Study||0
9975509|NCT01566162|11096880|FG000|STARTED|Overall Study||191
9975510|NCT01566162|11096880|FG000|COMPLETED|Overall Study||155
9975511|NCT01566162|11096880|FG000|NOT COMPLETED|Overall Study||36
9975512|NCT01566214|11096886|FG000|STARTED|Overall Study||6
9975513|NCT01566214|11096887|FG001|STARTED|Overall Study||6
10098788|NCT02386098|11227748|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0
10098789|NCT02386189|11227762|FG000|STARTED|Overall Study||30
10098790|NCT02386189|11227763|FG001|STARTED|Overall Study||33
9975514|NCT01566214|11096886|FG000|COMPLETED|Overall Study||3
9975515|NCT01566214|11096887|FG001|COMPLETED|Overall Study||6
9975516|NCT01566214|11096886|FG000|NOT COMPLETED|Overall Study||3
9975517|NCT01566214|11096887|FG001|NOT COMPLETED|Overall Study||0
9975518|NCT01566331|11096895|FG000|STARTED|Overall Study||40
9975519|NCT01566331|11096896|FG001|STARTED|Overall Study||40
9975520|NCT01566331|11096895|FG000|COMPLETED|Overall Study||40
9975521|NCT01566331|11096896|FG001|COMPLETED|Overall Study||40
9975522|NCT01566331|11096895|FG000|NOT COMPLETED|Overall Study||0
9975523|NCT01566331|11096896|FG001|NOT COMPLETED|Overall Study||0
9975524|NCT01566409|11096904|FG000|STARTED|Overall Study||49
9975525|NCT01566409|11096905|FG001|STARTED|Overall Study||53
9975526|NCT01566409|11096904|FG000|COMPLETED|Overall Study||47
9975527|NCT01566409|11096905|FG001|COMPLETED|Overall Study||48
9975528|NCT01566409|11096904|FG000|NOT COMPLETED|Overall Study||2
9975529|NCT01566409|11096905|FG001|NOT COMPLETED|Overall Study||5
9975530|NCT01566435|11096911|FG000|STARTED|ACF Induction Therapy||30
9975531|NCT01566435|11096911|FG000|COMPLETED|ACF Induction Therapy||30
9975532|NCT01566435|11096911|FG000|NOT COMPLETED|ACF Induction Therapy||0
9975533|NCT01566435|11096911|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28
9975534|NCT01566435|11096911|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
9975535|NCT01566435|11096911|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
9975536|NCT01566435|11096911|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2
9975537|NCT01566435|11096911|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
9975538|NCT01566435|11096911|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
9975539|NCT01566448|11096919|FG000|STARTED|Overall Study||30
9975540|NCT01566448|11096919|FG000|COMPLETED|Overall Study||30
9975541|NCT01566448|11096919|FG000|NOT COMPLETED|Overall Study||0
9975542|NCT01566461|11096925|FG000|STARTED|IN.PACT SFA I Phase||99
9975543|NCT01566461|11096926|FG001|STARTED|IN.PACT SFA I Phase||51
9975544|NCT01566461|11096925|FG000|COMPLETED|IN.PACT SFA I Phase||88
9975545|NCT01566461|11096926|FG001|COMPLETED|IN.PACT SFA I Phase||49
9975546|NCT01566461|11096925|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
9975547|NCT01566461|11096926|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
9975548|NCT01566461|11096925|FG000|STARTED|IN.PACT SFA II Phase||121
9975549|NCT01566461|11096926|FG001|STARTED|IN.PACT SFA II Phase||60
9975550|NCT01566461|11096925|FG000|COMPLETED|IN.PACT SFA II Phase||109
9975551|NCT01566461|11096926|FG001|COMPLETED|IN.PACT SFA II Phase||55
9975552|NCT01566461|11096925|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
9975553|NCT01566461|11096926|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
9975554|NCT01566500|11096932|FG000|STARTED|Overall Study||140
9975555|NCT01566500|11096932|FG000|COMPLETED|Overall Study||140
9975556|NCT01566500|11096932|FG000|NOT COMPLETED|Overall Study||0
9975557|NCT01566526|11096936|FG000|STARTED|Overall Study||26
9975558|NCT01566526|11096936|FG000|COMPLETED|Overall Study||26
9975559|NCT01566526|11096936|FG000|NOT COMPLETED|Overall Study||0
9975560|NCT01566539|11096948|FG000|STARTED|Main Study Period||101
9975561|NCT01566539|11096949|FG001|STARTED|Main Study Period||100
9975562|NCT01566539|11096950|FG002|STARTED|Main Study Period||104
9975563|NCT01566539|11096951|FG003|STARTED|Main Study Period||0
9975564|NCT01566539|11096952|FG004|STARTED|Main Study Period||40
9975565|NCT01566539|11096953|FG005|STARTED|Main Study Period||43
9975566|NCT01566539|11096954|FG006|STARTED|Main Study Period||30
9975567|NCT01566539|11096955|FG007|STARTED|Main Study Period||30
9975568|NCT01566539|11096956|FG008|STARTED|Main Study Period||1
9975569|NCT01566539|11096948|FG000|COMPLETED|Main Study Period||100
9975570|NCT01566539|11096949|FG001|COMPLETED|Main Study Period||100
9975571|NCT01566539|11096950|FG002|COMPLETED|Main Study Period||104
9975572|NCT01566539|11096951|FG003|COMPLETED|Main Study Period||0
9975573|NCT01566539|11096952|FG004|COMPLETED|Main Study Period||40
9975574|NCT01566539|11096953|FG005|COMPLETED|Main Study Period||40
9975575|NCT01566539|11096954|FG006|COMPLETED|Main Study Period||30
9975576|NCT01566539|11096955|FG007|COMPLETED|Main Study Period||30
9975577|NCT01566539|11096956|FG008|COMPLETED|Main Study Period||1
9975578|NCT01566539|11096948|FG000|NOT COMPLETED|Main Study Period||1
9975579|NCT01566539|11096949|FG001|NOT COMPLETED|Main Study Period||0
9975580|NCT01566539|11096950|FG002|NOT COMPLETED|Main Study Period||0
9975581|NCT01566539|11096951|FG003|NOT COMPLETED|Main Study Period||0
9975582|NCT01566539|11096952|FG004|NOT COMPLETED|Main Study Period||0
9975583|NCT01566539|11096953|FG005|NOT COMPLETED|Main Study Period||3
9975584|NCT01566539|11096954|FG006|NOT COMPLETED|Main Study Period||0
9975585|NCT01566539|11096955|FG007|NOT COMPLETED|Main Study Period||0
9975586|NCT01566539|11096956|FG008|NOT COMPLETED|Main Study Period||0
9975587|NCT01566539|11096948|FG000|STARTED|Within Subject Group||0
9975588|NCT01566539|11096949|FG001|STARTED|Within Subject Group||0
9975589|NCT01566539|11096950|FG002|STARTED|Within Subject Group||0
9975590|NCT01566539|11096951|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
9975591|NCT01566539|11096952|FG004|STARTED|Within Subject Group||0
9975592|NCT01566539|11096953|FG005|STARTED|Within Subject Group||0
9975593|NCT01566539|11096954|FG006|STARTED|Within Subject Group||0
9975594|NCT01566539|11096955|FG007|STARTED|Within Subject Group||0
9975595|NCT01566539|11096956|FG008|STARTED|Within Subject Group||0
9975596|NCT01566539|11096948|FG000|COMPLETED|Within Subject Group||0
9975597|NCT01566539|11096949|FG001|COMPLETED|Within Subject Group||0
9975598|NCT01566539|11096950|FG002|COMPLETED|Within Subject Group||0
10017782|NCT01819272|11140756|FG000|STARTED|Overall Study||41
10017783|NCT01819272|11140757|FG001|STARTED|Overall Study||39
9975599|NCT01566539|11096951|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
9975600|NCT01566539|11096952|FG004|COMPLETED|Within Subject Group||0
9975601|NCT01566539|11096953|FG005|COMPLETED|Within Subject Group||0
9975602|NCT01566539|11096954|FG006|COMPLETED|Within Subject Group||0
9975603|NCT01566539|11096955|FG007|COMPLETED|Within Subject Group||0
9975604|NCT01566539|11096956|FG008|COMPLETED|Within Subject Group||0
9975605|NCT01566539|11096948|FG000|NOT COMPLETED|Within Subject Group||0
9975606|NCT01566539|11096949|FG001|NOT COMPLETED|Within Subject Group||0
9975607|NCT01566539|11096950|FG002|NOT COMPLETED|Within Subject Group||0
9975608|NCT01566539|11096951|FG003|NOT COMPLETED|Within Subject Group||3
9975609|NCT01566539|11096952|FG004|NOT COMPLETED|Within Subject Group||0
9975610|NCT01566539|11096953|FG005|NOT COMPLETED|Within Subject Group||0
9975611|NCT01566539|11096954|FG006|NOT COMPLETED|Within Subject Group||0
9975612|NCT01566539|11096955|FG007|NOT COMPLETED|Within Subject Group||0
9975613|NCT01566539|11096956|FG008|NOT COMPLETED|Within Subject Group||0
9975614|NCT01566604|11096980|FG000|STARTED|Overall Study||306
9975615|NCT01566604|11096981|FG001|STARTED|Overall Study||154
9975616|NCT01566604|11096980|FG000|Safety Set|Overall Study||305
9975617|NCT01566604|11096981|FG001|Safety Set|Overall Study||154
9975618|NCT01566604|11096980|FG000|Full Analysis Set (FAS)|Overall Study||305
9975619|NCT01566604|11096981|FG001|Full Analysis Set (FAS)|Overall Study||154
9975620|NCT01566604|11096980|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134
9975621|NCT01566604|11096981|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58
9975622|NCT01566604|11096980|FG000|COMPLETED|Overall Study||282
9975623|NCT01566604|11096981|FG001|COMPLETED|Overall Study||143
9975624|NCT01566604|11096980|FG000|NOT COMPLETED|Overall Study||24
9975625|NCT01566604|11096981|FG001|NOT COMPLETED|Overall Study||11
9975626|NCT01566630|11096989|FG000|STARTED|Overall Study||2
9975627|NCT01566630|11096990|FG001|STARTED|Overall Study||1
9975628|NCT01566630|11096989|FG000|COMPLETED|Overall Study||2
9975629|NCT01566630|11096990|FG001|COMPLETED|Overall Study||1
9975630|NCT01566630|11096989|FG000|NOT COMPLETED|Overall Study||0
9975631|NCT01566630|11096990|FG001|NOT COMPLETED|Overall Study||0
9975632|NCT01566682|11097002|FG000|STARTED|Overall Study||420
9975633|NCT01566682|11097002|FG000|COMPLETED|Overall Study||374
9975634|NCT01566682|11097002|FG000|NOT COMPLETED|Overall Study||46
9975635|NCT01566721|11097008|FG000|STARTED|Treatment Period||1867
9975636|NCT01566721|11097009|FG001|STARTED|Treatment Period||710
9975637|NCT01566721|11097008|FG000|COMPLETED|Treatment Period||1670
9975638|NCT01566721|11097009|FG001|COMPLETED|Treatment Period||652
9975639|NCT01566721|11097008|FG000|NOT COMPLETED|Treatment Period||197
9975640|NCT01566721|11097009|FG001|NOT COMPLETED|Treatment Period||58
9975641|NCT01566721|11097008|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
9975642|NCT01566721|11097009|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
9975643|NCT01566721|11097008|FG000|COMPLETED|Safety Follow-up||1318
9975644|NCT01566721|11097009|FG001|COMPLETED|Safety Follow-up||501
9975645|NCT01566721|11097008|FG000|NOT COMPLETED|Safety Follow-up||547
9975646|NCT01566721|11097009|FG001|NOT COMPLETED|Safety Follow-up||207
9975647|NCT01566773|11097022|FG000|STARTED|Overall Study||140
9975648|NCT01566773|11097022|FG000|GP MDI 18 µg BID|Overall Study||64
9975649|NCT01566773|11097022|FG000|GP MDI 9 µg BID|Overall Study||64
9975650|NCT01566773|11097022|FG000|GP MDI 4.6 µg BID|Overall Study||62
9975651|NCT01566773|11097022|FG000|GP MDI 2.4 µg BID|Overall Study||64
9975652|NCT01566773|11097022|FG000|GP MDI 1.2 µg BID|Overall Study||57
9975653|NCT01566773|11097022|FG000|GP MDI 0.6 µg BID|Overall Study||59
9975654|NCT01566773|11097022|FG000|Placebo MDI|Overall Study||62
9975655|NCT01566773|11097022|FG000|Spiriva® Handihaler®|Overall Study||62
9975656|NCT01566773|11097022|FG000|COMPLETED|Overall Study||110
9975657|NCT01566773|11097022|FG000|NOT COMPLETED|Overall Study||30
9975658|NCT01566838|11097044|FG000|STARTED|Overall Study||41
9975659|NCT01566838|11097045|FG001|STARTED|Overall Study||42
9975660|NCT01566838|11097044|FG000|COMPLETED|Overall Study||38
9975661|NCT01566838|11097045|FG001|COMPLETED|Overall Study||42
9975662|NCT01566838|11097044|FG000|NOT COMPLETED|Overall Study||3
9975663|NCT01566838|11097045|FG001|NOT COMPLETED|Overall Study||0
9975664|NCT01566981|11097053|FG000|STARTED|Overall Study||58
9975665|NCT01566981|11097054|FG001|STARTED|Overall Study||62
9975666|NCT01566981|11097053|FG000|COMPLETED|Overall Study||53
9975667|NCT01566981|11097054|FG001|COMPLETED|Overall Study||54
9975668|NCT01566981|11097053|FG000|NOT COMPLETED|Overall Study||5
9975669|NCT01566981|11097054|FG001|NOT COMPLETED|Overall Study||8
9975670|NCT01567020|11097066|FG000|STARTED|Overall Study||28
9975671|NCT01567020|11097067|FG001|STARTED|Overall Study||46
9975672|NCT01567020|11097068|FG002|STARTED|Overall Study||20
9975673|NCT01567020|11097069|FG003|STARTED|Overall Study||11
9975674|NCT01567020|11097066|FG000|COMPLETED|Overall Study||21
9975675|NCT01567020|11097067|FG001|COMPLETED|Overall Study||41
9975676|NCT01567020|11097068|FG002|COMPLETED|Overall Study||18
9975677|NCT01567020|11097069|FG003|COMPLETED|Overall Study||10
9975678|NCT01567020|11097066|FG000|NOT COMPLETED|Overall Study||7
9975679|NCT01567020|11097067|FG001|NOT COMPLETED|Overall Study||5
9975680|NCT01567020|11097068|FG002|NOT COMPLETED|Overall Study||2
9975681|NCT01567020|11097069|FG003|NOT COMPLETED|Overall Study||1
9975682|NCT01567085|11097079|FG000|STARTED|Overall Study||80
9975683|NCT01567085|11097079|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
9975684|NCT01567085|11097079|FG000|COMPLETED|Overall Study||60
9975685|NCT01567085|11097079|FG000|NOT COMPLETED|Overall Study||20
9975686|NCT01567150|11097085|FG000|STARTED|Overall Study||21
9975687|NCT01567150|11097086|FG001|STARTED|Overall Study||18
9975688|NCT01567150|11097085|FG000|COMPLETED|Overall Study||19
9975689|NCT01567150|11097086|FG001|COMPLETED|Overall Study||16
9975690|NCT01567150|11097085|FG000|NOT COMPLETED|Overall Study||2
9975691|NCT01567150|11097086|FG001|NOT COMPLETED|Overall Study||2
9975692|NCT01567163|11097092|FG000|STARTED|Overall Study||22
9975693|NCT01567163|11097092|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
9975694|NCT01567163|11097092|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
9975695|NCT01567163|11097092|FG000|COMPLETED|Overall Study||18
9975696|NCT01567163|11097092|FG000|NOT COMPLETED|Overall Study||4
9975697|NCT01567306|11097107|FG000|STARTED|Overall Study||27
9975698|NCT01567306|11097108|FG001|STARTED|Overall Study||25
9975699|NCT01567306|11097109|FG002|STARTED|Overall Study||24
9975700|NCT01567306|11097110|FG003|STARTED|Overall Study||24
9975701|NCT01567306|11097111|FG004|STARTED|Overall Study||25
9975702|NCT01567306|11097112|FG005|STARTED|Overall Study||26
9975703|NCT01567306|11097107|FG000|COMPLETED|Overall Study||24
9975704|NCT01567306|11097108|FG001|COMPLETED|Overall Study||23
9975705|NCT01567306|11097109|FG002|COMPLETED|Overall Study||24
9975706|NCT01567306|11097110|FG003|COMPLETED|Overall Study||19
9975707|NCT01567306|11097111|FG004|COMPLETED|Overall Study||18
9975708|NCT01567306|11097112|FG005|COMPLETED|Overall Study||23
9975709|NCT01567306|11097107|FG000|NOT COMPLETED|Overall Study||3
9975710|NCT01567306|11097108|FG001|NOT COMPLETED|Overall Study||2
9975711|NCT01567306|11097109|FG002|NOT COMPLETED|Overall Study||0
9975712|NCT01567306|11097110|FG003|NOT COMPLETED|Overall Study||5
9975713|NCT01567306|11097111|FG004|NOT COMPLETED|Overall Study||7
9975714|NCT01567306|11097112|FG005|NOT COMPLETED|Overall Study||3
9975715|NCT01567371|11097126|FG000|STARTED|Overall Study||30
9975716|NCT01567371|11097126|FG000|COMPLETED|Overall Study||30
9975717|NCT01567371|11097126|FG000|NOT COMPLETED|Overall Study||0
9975718|NCT01567462|11097132|FG000|STARTED|Overall Study||45
9975719|NCT01567462|11097133|FG001|STARTED|Overall Study||45
9975720|NCT01567462|11097132|FG000|COMPLETED|Overall Study||41
9975721|NCT01567462|11097133|FG001|COMPLETED|Overall Study||38
9975722|NCT01567462|11097132|FG000|NOT COMPLETED|Overall Study||4
9975723|NCT01567462|11097133|FG001|NOT COMPLETED|Overall Study||7
9975724|NCT01567527|11097141|FG000|STARTED|Conversion Phase.||466
9975725|NCT01567527|11097142|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975726|NCT01567527|11097143|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975727|NCT01567527|11097144|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975728|NCT01567527|11097145|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975729|NCT01567527|11097141|FG000|COMPLETED|Conversion Phase.||367
9975730|NCT01567527|11097142|FG001|COMPLETED|Conversion Phase.||0
9975731|NCT01567527|11097143|FG002|COMPLETED|Conversion Phase.||0
9975732|NCT01567527|11097144|FG003|COMPLETED|Conversion Phase.||0
9975733|NCT01567527|11097145|FG004|COMPLETED|Conversion Phase.||0
9975734|NCT01567527|11097141|FG000|NOT COMPLETED|Conversion Phase.||99
9975735|NCT01567527|11097142|FG001|NOT COMPLETED|Conversion Phase.||0
9975736|NCT01567527|11097143|FG002|NOT COMPLETED|Conversion Phase.||0
9975737|NCT01567527|11097144|FG003|NOT COMPLETED|Conversion Phase.||0
9975738|NCT01567527|11097145|FG004|NOT COMPLETED|Conversion Phase.||0
9975739|NCT01567527|11097141|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975740|NCT01567527|11097142|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
9975741|NCT01567527|11097143|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975742|NCT01567527|11097144|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975743|NCT01567527|11097145|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
9975744|NCT01567527|11097141|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975745|NCT01567527|11097142|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
9975746|NCT01567527|11097143|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975747|NCT01567527|11097144|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975748|NCT01567527|11097145|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975749|NCT01567527|11097141|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975750|NCT01567527|11097142|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
9975751|NCT01567527|11097143|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975752|NCT01567527|11097144|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975753|NCT01567527|11097145|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
9975754|NCT01567527|11097141|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
9975755|NCT01567527|11097142|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
9975756|NCT01567527|11097143|FG002|STARTED|IM Depot Stabilization.||425
9975757|NCT01567527|11097144|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
9975758|NCT01567527|11097145|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
9975759|NCT01567527|11097141|FG000|COMPLETED|IM Depot Stabilization.||0
9975760|NCT01567527|11097142|FG001|COMPLETED|IM Depot Stabilization.||0
9975761|NCT01567527|11097143|FG002|COMPLETED|IM Depot Stabilization.||266
9975762|NCT01567527|11097144|FG003|COMPLETED|IM Depot Stabilization.||0
9975763|NCT01567527|11097145|FG004|COMPLETED|IM Depot Stabilization.||0
9975764|NCT01567527|11097141|FG000|NOT COMPLETED|IM Depot Stabilization.||0
9975765|NCT01567527|11097142|FG001|NOT COMPLETED|IM Depot Stabilization.||0
9975766|NCT01567527|11097143|FG002|NOT COMPLETED|IM Depot Stabilization.||159
9975767|NCT01567527|11097144|FG003|NOT COMPLETED|IM Depot Stabilization.||0
9975768|NCT01567527|11097145|FG004|NOT COMPLETED|IM Depot Stabilization.||0
9975769|NCT01567527|11097141|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
9975770|NCT01567527|11097142|FG001|STARTED|Double-blind, Placebo-controlled Phase||0
9975771|NCT01567527|11097143|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
9975772|NCT01567527|11097144|FG003|STARTED|Double-blind, Placebo-controlled Phase||133
9975773|NCT01567527|11097145|FG004|STARTED|Double-blind, Placebo-controlled Phase||133
9975774|NCT01567527|11097141|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
9975775|NCT01567527|11097142|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0
9975776|NCT01567527|11097143|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0
9975777|NCT01567527|11097144|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64
9975778|NCT01567527|11097145|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38
9975779|NCT01567527|11097141|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
9975780|NCT01567527|11097142|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
9975781|NCT01567527|11097143|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
9975782|NCT01567527|11097144|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
9975783|NCT01567527|11097145|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
9975784|NCT01567826|11097156|FG000|STARTED|Overall Study||43
9975785|NCT01567826|11097157|FG001|STARTED|Overall Study||44
9975786|NCT01567826|11097156|FG000|COMPLETED|Overall Study||40
9975787|NCT01567826|11097157|FG001|COMPLETED|Overall Study||42
9975788|NCT01567826|11097156|FG000|NOT COMPLETED|Overall Study||3
9975789|NCT01567826|11097157|FG001|NOT COMPLETED|Overall Study||2
9975790|NCT01567839|11097165|FG000|STARTED|Overall Study||60
9975791|NCT01567839|11097165|FG000|COMPLETED|Overall Study||60
9975792|NCT01567839|11097165|FG000|NOT COMPLETED|Overall Study||0
9975793|NCT01567852|11097175|FG000|STARTED|Overall Study||8
9975794|NCT01567852|11097176|FG001|STARTED|Overall Study||12
9975795|NCT01567852|11097175|FG000|COMPLETED|Overall Study||4
9975796|NCT01567852|11097176|FG001|COMPLETED|Overall Study||5
9975797|NCT01567852|11097175|FG000|NOT COMPLETED|Overall Study||4
9975798|NCT01567852|11097176|FG001|NOT COMPLETED|Overall Study||7
9975799|NCT01567865|11097186|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163
9975800|NCT01567865|11097187|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220
9975801|NCT01567865|11097188|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211
9975802|NCT01567865|11097189|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224
9975803|NCT01567865|11097186|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163
9975804|NCT01567865|11097187|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220
9975805|NCT01567865|11097188|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211
9975806|NCT01567865|11097189|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224
9975807|NCT01567865|11097186|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
9975808|NCT01567865|11097187|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
9975809|NCT01567865|11097188|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
9975810|NCT01567865|11097189|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
9975811|NCT01567865|11097186|FG000|STARTED|Evaluated for Immunogenicity||163
9975812|NCT01567865|11097187|FG001|STARTED|Evaluated for Immunogenicity||220
9975813|NCT01567865|11097188|FG002|STARTED|Evaluated for Immunogenicity||211
9975814|NCT01567865|11097189|FG003|STARTED|Evaluated for Immunogenicity||224
9975815|NCT01567865|11097186|FG000|COMPLETED|Evaluated for Immunogenicity||146
9975816|NCT01567865|11097187|FG001|COMPLETED|Evaluated for Immunogenicity||195
9975817|NCT01567865|11097188|FG002|COMPLETED|Evaluated for Immunogenicity||192
9975818|NCT01567865|11097189|FG003|COMPLETED|Evaluated for Immunogenicity||194
9975819|NCT01567865|11097186|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17
9975820|NCT01567865|11097187|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25
9975821|NCT01567865|11097188|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19
9975822|NCT01567865|11097189|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30
9975823|NCT01567891|11097200|FG000|STARTED|Overall Study||9
9975824|NCT01567891|11097200|FG000|Received T-cell|Overall Study||6
9975825|NCT01567891|11097200|FG000|COMPLETED|Overall Study||6
9975826|NCT01567891|11097200|FG000|NOT COMPLETED|Overall Study||3
9975827|NCT01567943|11097215|FG000|STARTED|Overall Study||40
9975828|NCT01567943|11097216|FG001|STARTED|Overall Study||39
9975829|NCT01567943|11097217|FG002|STARTED|Overall Study||44
9975830|NCT01567943|11097215|FG000|COMPLETED|Overall Study||26
9975831|NCT01567943|11097216|FG001|COMPLETED|Overall Study||29
9975832|NCT01567943|11097217|FG002|COMPLETED|Overall Study||44
9975833|NCT01567943|11097215|FG000|NOT COMPLETED|Overall Study||14
9975834|NCT01567943|11097216|FG001|NOT COMPLETED|Overall Study||10
9975835|NCT01567943|11097217|FG002|NOT COMPLETED|Overall Study||0
9975836|NCT01568008|11097223|FG000|STARTED|Overall Study||933
9975837|NCT01568008|11097223|FG000|COMPLETED|Overall Study||699
9975838|NCT01568008|11097223|FG000|NOT COMPLETED|Overall Study||234
9975839|NCT01568021|11097227|FG000|STARTED|Overall Study||99
9975840|NCT01568021|11097227|FG000|COMPLETED|Overall Study||83
9975841|NCT01568021|11097227|FG000|NOT COMPLETED|Overall Study||16
9975842|NCT01568034|11097231|FG000|STARTED|Overall Study||2
9975843|NCT01568034|11097232|FG001|STARTED|Overall Study||2
9975844|NCT01568034|11097233|FG002|STARTED|Overall Study||3
9975845|NCT01568034|11097234|FG003|STARTED|Overall Study||3
9975846|NCT01568034|11097231|FG000|25 mg BIA 9-1067|Overall Study||2
9975847|NCT01568034|11097232|FG001|25 mg BIA 9-1067|Overall Study||2
9975848|NCT01568034|11097233|FG002|25 mg BIA 9-1067|Overall Study||3
9975849|NCT01568034|11097234|FG003|25 mg BIA 9-1067|Overall Study||3
9975850|NCT01568034|11097231|FG000|50 mg BIA 9-1067|Overall Study||2
9975851|NCT01568034|11097232|FG001|50 mg BIA 9-1067|Overall Study||2
9975852|NCT01568034|11097233|FG002|50 mg BIA 9-1067|Overall Study||3
9975853|NCT01568034|11097234|FG003|50 mg BIA 9-1067|Overall Study||3
9975854|NCT01568034|11097231|FG000|100 mg BIA 9-1067|Overall Study||2
9975855|NCT01568034|11097232|FG001|100 mg BIA 9-1067|Overall Study||2
9975856|NCT01568034|11097233|FG002|100 mg BIA 9-1067|Overall Study||3
9975857|NCT01568034|11097234|FG003|100 mg BIA 9-1067|Overall Study||3
9975858|NCT01568034|11097231|FG000|Placebo|Overall Study||1
9975859|NCT01568034|11097232|FG001|Placebo|Overall Study||2
9975860|NCT01568034|11097233|FG002|Placebo|Overall Study||3
9975861|NCT01568034|11097234|FG003|Placebo|Overall Study||3
9975862|NCT01568034|11097231|FG000|COMPLETED|Overall Study||1
9975863|NCT01568034|11097232|FG001|COMPLETED|Overall Study||2
9975864|NCT01568034|11097233|FG002|COMPLETED|Overall Study||3
9975865|NCT01568034|11097234|FG003|COMPLETED|Overall Study||3
9975866|NCT01568034|11097231|FG000|NOT COMPLETED|Overall Study||1
9975867|NCT01568034|11097232|FG001|NOT COMPLETED|Overall Study||0
9975868|NCT01568034|11097233|FG002|NOT COMPLETED|Overall Study||0
9975869|NCT01568034|11097234|FG003|NOT COMPLETED|Overall Study||0
9975870|NCT01568047|11097248|FG000|STARTED|Overall Study||10
9975871|NCT01568047|11097249|FG001|STARTED|Overall Study||10
9975872|NCT01568047|11097250|FG002|STARTED|Overall Study||10
9975873|NCT01568047|11097251|FG003|STARTED|Overall Study||10
9975874|NCT01568047|11097248|FG000|COMPLETED|Overall Study||9
9975875|NCT01568047|11097249|FG001|COMPLETED|Overall Study||9
9975876|NCT01568047|11097250|FG002|COMPLETED|Overall Study||9
9975877|NCT01568047|11097251|FG003|COMPLETED|Overall Study||9
9975878|NCT01568047|11097248|FG000|NOT COMPLETED|Overall Study||1
9975879|NCT01568047|11097249|FG001|NOT COMPLETED|Overall Study||1
9975880|NCT01568047|11097250|FG002|NOT COMPLETED|Overall Study||1
9975881|NCT01568047|11097251|FG003|NOT COMPLETED|Overall Study||1
9975882|NCT01568073|11097266|FG000|STARTED|Overall Study||121
9975883|NCT01568073|11097267|FG001|STARTED|Overall Study||122
9975884|NCT01568073|11097268|FG002|STARTED|Overall Study||122
9975885|NCT01568073|11097269|FG003|STARTED|Overall Study||119
9975886|NCT01568073|11097270|FG004|STARTED|Overall Study||116
9975887|NCT01568073|11097266|FG000|COMPLETED|Overall Study||110
9975888|NCT01568073|11097267|FG001|COMPLETED|Overall Study||107
9975889|NCT01568073|11097268|FG002|COMPLETED|Overall Study||110
9975890|NCT01568073|11097269|FG003|COMPLETED|Overall Study||108
9975891|NCT01568073|11097270|FG004|COMPLETED|Overall Study||107
9975892|NCT01568073|11097266|FG000|NOT COMPLETED|Overall Study||11
10098791|NCT02386189|11227762|FG000|COMPLETED|Overall Study||26
10098792|NCT02386189|11227763|FG001|COMPLETED|Overall Study||30
10098793|NCT02386189|11227762|FG000|NOT COMPLETED|Overall Study||4
10098794|NCT02386189|11227763|FG001|NOT COMPLETED|Overall Study||3
10098795|NCT02386319|11227771|FG000|STARTED|Overall Study||18
10098796|NCT02386319|11227772|FG001|STARTED|Overall Study||18
10098797|NCT02386319|11227771|FG000|COMPLETED|Overall Study||16
10098798|NCT02386319|11227772|FG001|COMPLETED|Overall Study||17
10098799|NCT02386319|11227771|FG000|NOT COMPLETED|Overall Study||2
10098800|NCT02386319|11227772|FG001|NOT COMPLETED|Overall Study||1
10098801|NCT02386345|11227778|FG000|STARTED|Overall Study||299
10098802|NCT02386345|11227778|FG000|COMPLETED|Overall Study||197
10098803|NCT02386345|11227778|FG000|NOT COMPLETED|Overall Study||102
10098804|NCT02386605|11227784|FG000|STARTED|Overall Study||41
10098805|NCT02386605|11227785|FG001|STARTED|Overall Study||38
10098806|NCT02386605|11227784|FG000|COMPLETED|Overall Study||34
10098807|NCT02386605|11227785|FG001|COMPLETED|Overall Study||28
10098808|NCT02386605|11227784|FG000|NOT COMPLETED|Overall Study||7
9975893|NCT01568073|11097267|FG001|NOT COMPLETED|Overall Study||15
9975894|NCT01568073|11097268|FG002|NOT COMPLETED|Overall Study||12
9975895|NCT01568073|11097269|FG003|NOT COMPLETED|Overall Study||11
9975896|NCT01568073|11097270|FG004|NOT COMPLETED|Overall Study||9
9975897|NCT01568112|11097286|FG000|STARTED|Overall Study||44
9975898|NCT01568112|11097287|FG001|STARTED|Overall Study||44
9975899|NCT01568112|11097288|FG002|STARTED|Overall Study||43
9975900|NCT01568112|11097289|FG003|STARTED|Overall Study||42
9975901|NCT01568112|11097286|FG000|COMPLETED|Overall Study||39
9975902|NCT01568112|11097287|FG001|COMPLETED|Overall Study||36
10098809|NCT02386605|11227785|FG001|NOT COMPLETED|Overall Study||10
10098810|NCT02386995|11227791|FG000|STARTED|Overall Study||30
10098811|NCT02386995|11227791|FG000|COMPLETED|Overall Study||30
10098812|NCT02386995|11227791|FG000|NOT COMPLETED|Overall Study||0
10098813|NCT02387008|11227799|FG000|STARTED|Overall Study||2
10098814|NCT02387008|11227800|FG001|STARTED|Overall Study||0
10098815|NCT02387008|11227801|FG002|STARTED|Overall Study||4
10098816|NCT02387008|11227799|FG000|COMPLETED|Overall Study||2
9975903|NCT01568112|11097288|FG002|COMPLETED|Overall Study||36
9975904|NCT01568112|11097289|FG003|COMPLETED|Overall Study||30
9975905|NCT01568112|11097286|FG000|NOT COMPLETED|Overall Study||5
10098817|NCT02387008|11227800|FG001|COMPLETED|Overall Study||0
10098818|NCT02387008|11227801|FG002|COMPLETED|Overall Study||4
10098819|NCT02387008|11227799|FG000|NOT COMPLETED|Overall Study||0
10098820|NCT02387008|11227800|FG001|NOT COMPLETED|Overall Study||0
9975906|NCT01568112|11097287|FG001|NOT COMPLETED|Overall Study||8
9975907|NCT01568112|11097288|FG002|NOT COMPLETED|Overall Study||7
9975908|NCT01568112|11097289|FG003|NOT COMPLETED|Overall Study||12
9975909|NCT01568255|11097302|FG000|STARTED|Overall Study||5
9975910|NCT01568255|11097303|FG001|STARTED|Overall Study||6
9975911|NCT01568255|11097302|FG000|COMPLETED|Overall Study||5
9975912|NCT01568255|11097303|FG001|COMPLETED|Overall Study||6
9975913|NCT01568255|11097302|FG000|NOT COMPLETED|Overall Study||0
9975914|NCT01568255|11097303|FG001|NOT COMPLETED|Overall Study||0
9975915|NCT01568320|11097309|FG000|STARTED|Overall Study||73
9975916|NCT01568320|11097309|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
9975917|NCT01568320|11097309|FG000|COMPLETED|Overall Study||32
9975918|NCT01568320|11097309|FG000|NOT COMPLETED|Overall Study||41
9975922|NCT01568528|11097320|FG000|STARTED|Overall Study||19
9975923|NCT01568528|11097321|FG001|STARTED|Overall Study||11
9975924|NCT01568528|11097322|FG002|STARTED|Overall Study||9
9975925|NCT01568528|11097320|FG000|COMPLETED|Overall Study||19
9975926|NCT01568528|11097321|FG001|COMPLETED|Overall Study||11
9975927|NCT01568528|11097322|FG002|COMPLETED|Overall Study||9
9975928|NCT01568528|11097320|FG000|NOT COMPLETED|Overall Study||0
9975929|NCT01568528|11097321|FG001|NOT COMPLETED|Overall Study||0
9975930|NCT01568528|11097322|FG002|NOT COMPLETED|Overall Study||0
9975931|NCT01568593|11097332|FG000|STARTED|Overall Study||48
9975932|NCT01568593|11097333|FG001|STARTED|Overall Study||45
9975933|NCT01568593|11097332|FG000|COMPLETED|Overall Study||41
9975934|NCT01568593|11097333|FG001|COMPLETED|Overall Study||42
9975935|NCT01568593|11097332|FG000|NOT COMPLETED|Overall Study||7
9975936|NCT01568593|11097333|FG001|NOT COMPLETED|Overall Study||3
9975937|NCT01568606|11097339|FG000|STARTED|Overall Study||20
9975938|NCT01568606|11097339|FG000|COMPLETED|Overall Study||20
9975939|NCT01568606|11097339|FG000|NOT COMPLETED|Overall Study||0
9975940|NCT01568827|11097345|FG000|STARTED|First Intervention (6 Days)||5
9975941|NCT01568827|11097346|FG001|STARTED|First Intervention (6 Days)||5
9975942|NCT01568827|11097345|FG000|COMPLETED|First Intervention (6 Days)||5
9975943|NCT01568827|11097346|FG001|COMPLETED|First Intervention (6 Days)||5
9975944|NCT01568827|11097345|FG000|NOT COMPLETED|First Intervention (6 Days)||0
9975945|NCT01568827|11097346|FG001|NOT COMPLETED|First Intervention (6 Days)||0
9975946|NCT01568827|11097345|FG000|STARTED|Washout (2 Days)||5
9975947|NCT01568827|11097346|FG001|STARTED|Washout (2 Days)||5
9975948|NCT01568827|11097345|FG000|COMPLETED|Washout (2 Days)||5
9975949|NCT01568827|11097346|FG001|COMPLETED|Washout (2 Days)||5
9975950|NCT01568827|11097345|FG000|NOT COMPLETED|Washout (2 Days)||0
9975951|NCT01568827|11097346|FG001|NOT COMPLETED|Washout (2 Days)||0
9975952|NCT01568827|11097345|FG000|STARTED|Intervention 2 (5 Days)||5
9975953|NCT01568827|11097346|FG001|STARTED|Intervention 2 (5 Days)||5
9975954|NCT01568827|11097345|FG000|COMPLETED|Intervention 2 (5 Days)||5
9975955|NCT01568827|11097346|FG001|COMPLETED|Intervention 2 (5 Days)||5
9975956|NCT01568827|11097345|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
9975957|NCT01568827|11097346|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
9975958|NCT01568866|11097354|FG000|STARTED|Overall Study||465
9975959|NCT01568866|11097355|FG001|STARTED|Overall Study||464
9975960|NCT01568866|11097354|FG000|Received Treatment|Overall Study||456
9975961|NCT01568866|11097355|FG001|Received Treatment|Overall Study||463
9975962|NCT01568866|11097354|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
9975963|NCT01568866|11097355|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
9975964|NCT01568866|11097354|FG000|NOT COMPLETED|Overall Study||438
9975965|NCT01568866|11097355|FG001|NOT COMPLETED|Overall Study||416
9975966|NCT01568892|11097363|FG000|STARTED|Double-blind Phase||14
9975967|NCT01568892|11097364|FG001|STARTED|Double-blind Phase||16
9975968|NCT01568892|11097363|FG000|COMPLETED|Double-blind Phase||14
9975969|NCT01568892|11097364|FG001|COMPLETED|Double-blind Phase||16
9975970|NCT01568892|11097363|FG000|NOT COMPLETED|Double-blind Phase||0
9975971|NCT01568892|11097364|FG001|NOT COMPLETED|Double-blind Phase||0
9975972|NCT01568892|11097363|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
9975973|NCT01568892|11097364|FG001|STARTED|Open-label Phase||16
9975974|NCT01568892|11097363|FG000|COMPLETED|Open-label Phase||7
9975975|NCT01568892|11097364|FG001|COMPLETED|Open-label Phase||13
9975976|NCT01568892|11097363|FG000|NOT COMPLETED|Open-label Phase||6
9975977|NCT01568892|11097364|FG001|NOT COMPLETED|Open-label Phase||3
9975978|NCT01568905|11097374|FG000|STARTED|Overall Study||13
9975979|NCT01568905|11097375|FG001|STARTED|Overall Study||11
9975980|NCT01568905|11097376|FG002|STARTED|Overall Study||12
9975981|NCT01568905|11097374|FG000|COMPLETED|Overall Study||12
9975982|NCT01568905|11097375|FG001|COMPLETED|Overall Study||11
9975983|NCT01568905|11097376|FG002|COMPLETED|Overall Study||12
9975984|NCT01568905|11097374|FG000|NOT COMPLETED|Overall Study||1
9975985|NCT01568905|11097375|FG001|NOT COMPLETED|Overall Study||0
9975986|NCT01568905|11097376|FG002|NOT COMPLETED|Overall Study||0
9975987|NCT01568944|11097386|FG000|STARTED|Overall Study||8
9975988|NCT01568944|11097387|FG001|STARTED|Overall Study||10
9975989|NCT01568944|11097386|FG000|COMPLETED|Overall Study||8
9975990|NCT01568944|11097387|FG001|COMPLETED|Overall Study||10
9975991|NCT01568944|11097386|FG000|NOT COMPLETED|Overall Study||0
9975992|NCT01568944|11097387|FG001|NOT COMPLETED|Overall Study||0
9975993|NCT01569022|11097393|FG000|STARTED|First Intervention||21
9975994|NCT01569022|11097394|FG001|STARTED|First Intervention||21
9975995|NCT01569022|11097393|FG000|COMPLETED|First Intervention||19
9975996|NCT01569022|11097394|FG001|COMPLETED|First Intervention||20
9975997|NCT01569022|11097393|FG000|NOT COMPLETED|First Intervention||2
9975998|NCT01569022|11097394|FG001|NOT COMPLETED|First Intervention||1
9975999|NCT01569022|11097393|FG000|STARTED|Second Intervention||19
9976000|NCT01569022|11097394|FG001|STARTED|Second Intervention||20
9976001|NCT01569022|11097393|FG000|COMPLETED|Second Intervention||17
9976002|NCT01569022|11097394|FG001|COMPLETED|Second Intervention||18
9976003|NCT01569022|11097393|FG000|NOT COMPLETED|Second Intervention||2
9976004|NCT01569022|11097394|FG001|NOT COMPLETED|Second Intervention||2
9976005|NCT01569074|11097407|FG000|STARTED|Overall Study|Patients who received treatment|31
9976006|NCT01569074|11097408|FG001|STARTED|Overall Study|Patients who received treatment|33
9976007|NCT01569074|11097409|FG002|STARTED|Overall Study|Patients who received treatment|33
9976008|NCT01569074|11097410|FG003|STARTED|Overall Study|Patients who received treatment|33
9976009|NCT01569074|11097411|FG004|STARTED|Overall Study|Patients who received treatment|33
9976010|NCT01569074|11097407|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
9976011|NCT01569074|11097408|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
9976012|NCT01569074|11097409|FG002|Randomised But Did Not Receive Treatment|Overall Study||0
9976013|NCT01569074|11097410|FG003|Randomised But Did Not Receive Treatment|Overall Study||0
9976014|NCT01569074|11097411|FG004|Randomised But Did Not Receive Treatment|Overall Study||0
9976015|NCT01569074|11097407|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
9976016|NCT01569074|11097408|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
9976017|NCT01569074|11097409|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
9976018|NCT01569074|11097410|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
9976019|NCT01569074|11097411|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
9976020|NCT01569074|11097407|FG000|NOT COMPLETED|Overall Study||7
9976021|NCT01569074|11097408|FG001|NOT COMPLETED|Overall Study||9
9976022|NCT01569074|11097409|FG002|NOT COMPLETED|Overall Study||12
9976023|NCT01569074|11097410|FG003|NOT COMPLETED|Overall Study||8
9976024|NCT01569074|11097411|FG004|NOT COMPLETED|Overall Study||8
9976025|NCT01569087|11097430|FG000|STARTED|Overall Study||21
9976026|NCT01569087|11097431|FG001|STARTED|Overall Study||20
9976027|NCT01569087|11097432|FG002|STARTED|Overall Study||19
9976028|NCT01569087|11097430|FG000|COMPLETED|Overall Study||20
9976029|NCT01569087|11097431|FG001|COMPLETED|Overall Study||20
9976030|NCT01569087|11097432|FG002|COMPLETED|Overall Study||18
10098821|NCT02387008|11227801|FG002|NOT COMPLETED|Overall Study||0
10098822|NCT02387164|11227811|FG000|STARTED|Overall Study||13
10098823|NCT02387164|11227812|FG001|STARTED|Overall Study||13
10098824|NCT02387164|11227811|FG000|COMPLETED|Overall Study||10
10098825|NCT02387164|11227812|FG001|COMPLETED|Overall Study||11
10098826|NCT02387164|11227811|FG000|NOT COMPLETED|Overall Study||3
10098827|NCT02387164|11227812|FG001|NOT COMPLETED|Overall Study||2
10098828|NCT02387216|11227820|FG000|STARTED|Overall Study||103
10098829|NCT02387216|11227821|FG001|STARTED|Overall Study||49
10098830|NCT02387216|11227820|FG000|COMPLETED|Overall Study||3
10098831|NCT02387216|11227821|FG001|COMPLETED|Overall Study||2
10098832|NCT02387216|11227820|FG000|NOT COMPLETED|Overall Study||100
10098833|NCT02387216|11227821|FG001|NOT COMPLETED|Overall Study||47
10098834|NCT02387268|11227827|FG000|STARTED|Overall Study||10
10098835|NCT02387268|11227827|FG000|COMPLETED|Overall Study||9
10098836|NCT02387268|11227827|FG000|NOT COMPLETED|Overall Study||1
10098837|NCT02387294|11227833|FG000|STARTED|Overall Study||60
10098838|NCT02387294|11227834|FG001|STARTED|Overall Study||60
10098839|NCT02387294|11227833|FG000|COMPLETED|Overall Study||60
10098840|NCT02387294|11227834|FG001|COMPLETED|Overall Study||60
10098841|NCT02387294|11227833|FG000|NOT COMPLETED|Overall Study||0
10098842|NCT02387294|11227834|FG001|NOT COMPLETED|Overall Study||0
10098843|NCT02387359|11227844|FG000|STARTED|Overall Study||354
10098844|NCT02387359|11227845|FG001|STARTED|Overall Study||351
10098845|NCT02387359|11227846|FG002|STARTED|Overall Study||349
10098846|NCT02387359|11227844|FG000|COMPLETED|Overall Study||295
10098847|NCT02387359|11227845|FG001|COMPLETED|Overall Study||309
10098848|NCT02387359|11227846|FG002|COMPLETED|Overall Study||293
10098849|NCT02387359|11227844|FG000|NOT COMPLETED|Overall Study||59
10098850|NCT02387359|11227845|FG001|NOT COMPLETED|Overall Study||42
10098851|NCT02387359|11227846|FG002|NOT COMPLETED|Overall Study||56
9976031|NCT01569087|11097430|FG000|NOT COMPLETED|Overall Study||1
9976032|NCT01569087|11097431|FG001|NOT COMPLETED|Overall Study||0
9976033|NCT01569087|11097432|FG002|NOT COMPLETED|Overall Study||1
9976034|NCT01569126|11097446|FG000|STARTED|Overall Study||8
9976035|NCT01569126|11097447|FG001|STARTED|Overall Study||8
9976036|NCT01569126|11097448|FG002|STARTED|Overall Study||8
9976037|NCT01569126|11097449|FG003|STARTED|Overall Study||8
9976038|NCT01569126|11097450|FG004|STARTED|Overall Study||12
9976039|NCT01569126|11097451|FG005|STARTED|Overall Study||12
9976040|NCT01569126|11097446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9976041|NCT01569126|11097447|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
9976042|NCT01569126|11097448|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
9976043|NCT01569126|11097449|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
9976044|NCT01569126|11097450|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
9976045|NCT01569126|11097451|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12
9976046|NCT01569126|11097446|FG000|COMPLETED|Overall Study||8
9976047|NCT01569126|11097447|FG001|COMPLETED|Overall Study||8
9976048|NCT01569126|11097448|FG002|COMPLETED|Overall Study||8
9976049|NCT01569126|11097449|FG003|COMPLETED|Overall Study||8
9976050|NCT01569126|11097450|FG004|COMPLETED|Overall Study||12
9976051|NCT01569126|11097451|FG005|COMPLETED|Overall Study||12
9976052|NCT01569126|11097446|FG000|NOT COMPLETED|Overall Study||0
9976053|NCT01569126|11097447|FG001|NOT COMPLETED|Overall Study||0
9976054|NCT01569126|11097448|FG002|NOT COMPLETED|Overall Study||0
9976055|NCT01569126|11097449|FG003|NOT COMPLETED|Overall Study||0
9976056|NCT01569126|11097450|FG004|NOT COMPLETED|Overall Study||0
9758682|NCT01927419|10862247|FG001|COMPLETED|Pre-Treatment Period||46
9758683|NCT01927419|10862246|FG000|NOT COMPLETED|Pre-Treatment Period||1
9976057|NCT01569126|11097451|FG005|NOT COMPLETED|Overall Study||0
9976058|NCT01569152|11097472|FG000|STARTED|Phase IIa, Period 1||41
9976059|NCT01569152|11097473|FG001|STARTED|Phase IIa, Period 1||41
9976060|NCT01569152|11097474|FG002|STARTED|Phase IIa, Period 1||0
9976061|NCT01569152|11097472|FG000|COMPLETED|Phase IIa, Period 1||20
9976062|NCT01569152|11097473|FG001|COMPLETED|Phase IIa, Period 1||9
9976063|NCT01569152|11097474|FG002|COMPLETED|Phase IIa, Period 1||0
9976064|NCT01569152|11097472|FG000|NOT COMPLETED|Phase IIa, Period 1||21
9976065|NCT01569152|11097473|FG001|NOT COMPLETED|Phase IIa, Period 1||32
9976066|NCT01569152|11097474|FG002|NOT COMPLETED|Phase IIa, Period 1||0
9976067|NCT01569152|11097472|FG000|STARTED|Safety Extension, Period 3||0
9976068|NCT01569152|11097473|FG001|STARTED|Safety Extension, Period 3||0
9976069|NCT01569152|11097474|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
9976070|NCT01569152|11097472|FG000|COMPLETED|Safety Extension, Period 3||0
9976071|NCT01569152|11097473|FG001|COMPLETED|Safety Extension, Period 3||0
9976072|NCT01569152|11097474|FG002|COMPLETED|Safety Extension, Period 3||0
9976073|NCT01569152|11097472|FG000|NOT COMPLETED|Safety Extension, Period 3||0
9976074|NCT01569152|11097473|FG001|NOT COMPLETED|Safety Extension, Period 3||0
9976075|NCT01569152|11097474|FG002|NOT COMPLETED|Safety Extension, Period 3||55
9976076|NCT01569191|11097483|FG000|STARTED|Overall Study||11
9976077|NCT01569191|11097484|FG001|STARTED|Overall Study||7
9976078|NCT01569191|11097483|FG000|COMPLETED|Overall Study||11
9976079|NCT01569191|11097484|FG001|COMPLETED|Overall Study||7
9976080|NCT01569191|11097483|FG000|NOT COMPLETED|Overall Study||0
10098852|NCT02387372|11227856|FG000|STARTED|Overall Study||27
10098853|NCT02387372|11227857|FG001|STARTED|Overall Study||10
10098854|NCT02387372|11227856|FG000|Treated|Overall Study||26
10098855|NCT02387372|11227857|FG001|Treated|Overall Study||10
10098856|NCT02387372|11227856|FG000|COMPLETED|Overall Study||26
10098857|NCT02387372|11227857|FG001|COMPLETED|Overall Study||10
10098858|NCT02387372|11227856|FG000|NOT COMPLETED|Overall Study||1
10098859|NCT02387372|11227857|FG001|NOT COMPLETED|Overall Study||0
10098860|NCT02387476|11227873|FG000|STARTED|Overall Study||25
10098861|NCT02387476|11227874|FG001|STARTED|Overall Study||22
10098862|NCT02387476|11227873|FG000|COMPLETED|Overall Study||19
10098863|NCT02387476|11227874|FG001|COMPLETED|Overall Study||17
10098864|NCT02387476|11227873|FG000|NOT COMPLETED|Overall Study||6
10098865|NCT02387476|11227874|FG001|NOT COMPLETED|Overall Study||5
10098866|NCT02387502|11227885|FG000|STARTED|Overall Study||40
10098867|NCT02387502|11227886|FG001|STARTED|Overall Study||40
10098868|NCT02387502|11227887|FG002|STARTED|Overall Study||40
10098869|NCT02387502|11227885|FG000|COMPLETED|Overall Study||40
10098870|NCT02387502|11227886|FG001|COMPLETED|Overall Study||40
10098871|NCT02387502|11227887|FG002|COMPLETED|Overall Study||40
10098872|NCT02387502|11227885|FG000|NOT COMPLETED|Overall Study||0
10098873|NCT02387502|11227886|FG001|NOT COMPLETED|Overall Study||0
10098874|NCT02387502|11227887|FG002|NOT COMPLETED|Overall Study||0
10098875|NCT02387554|11227899|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
10098876|NCT02387554|11227900|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
10098877|NCT02387554|11227901|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
9976081|NCT01569191|11097484|FG001|NOT COMPLETED|Overall Study||0
10017784|NCT01819272|11140758|FG002|STARTED|Overall Study||40
10017785|NCT01819272|11140759|FG003|STARTED|Overall Study||40
10017786|NCT01819272|11140760|FG004|STARTED|Overall Study||40
10017787|NCT01819272|11140761|FG005|STARTED|Overall Study||40
10017788|NCT01819272|11140756|FG000|COMPLETED|Overall Study||35
10017789|NCT01819272|11140757|FG001|COMPLETED|Overall Study||36
10017790|NCT01819272|11140758|FG002|COMPLETED|Overall Study||37
10017791|NCT01819272|11140759|FG003|COMPLETED|Overall Study||35
10017792|NCT01819272|11140760|FG004|COMPLETED|Overall Study||36
10017793|NCT01819272|11140761|FG005|COMPLETED|Overall Study||33
10017794|NCT01819272|11140756|FG000|NOT COMPLETED|Overall Study||6
10017795|NCT01819272|11140757|FG001|NOT COMPLETED|Overall Study||3
10017796|NCT01819272|11140758|FG002|NOT COMPLETED|Overall Study||3
10017797|NCT01819272|11140759|FG003|NOT COMPLETED|Overall Study||5
10017798|NCT01819272|11140760|FG004|NOT COMPLETED|Overall Study||4
10098878|NCT02387554|11227902|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
10098879|NCT02387554|11227899|FG000|COMPLETED|Overall Study||7
10017799|NCT01819272|11140761|FG005|NOT COMPLETED|Overall Study||7
10017800|NCT01819311|11140777|FG000|STARTED|Treatment Phase (4 Weeks)||33
10017801|NCT01819311|11140778|FG001|STARTED|Treatment Phase (4 Weeks)||31
10017802|NCT01819311|11140777|FG000|COMPLETED|Treatment Phase (4 Weeks)||31
10017803|NCT01819311|11140778|FG001|COMPLETED|Treatment Phase (4 Weeks)||30
9976082|NCT01569295|11097496|FG000|STARTED|Overall Study||207
9976083|NCT01569295|11097497|FG001|STARTED|Overall Study||209
9976084|NCT01569295|11097496|FG000|Long-Term Follow-up|Overall Study||109
9976085|NCT01569295|11097497|FG001|Long-Term Follow-up|Overall Study||161
9976086|NCT01569295|11097496|FG000|COMPLETED|Overall Study||0
9976087|NCT01569295|11097497|FG001|COMPLETED|Overall Study||0
9976088|NCT01569295|11097496|FG000|NOT COMPLETED|Overall Study||207
9976089|NCT01569295|11097497|FG001|NOT COMPLETED|Overall Study||209
9976090|NCT01569438|11097506|FG000|STARTED|Overall Study||52
9976091|NCT01569438|11097507|FG001|STARTED|Overall Study||55
9976092|NCT01569438|11097506|FG000|Treated|Overall Study||51
9976093|NCT01569438|11097507|FG001|Treated|Overall Study||54
9976094|NCT01569438|11097506|FG000|Titration Set|Overall Study||38
9976095|NCT01569438|11097507|FG001|Titration Set|Overall Study||36
9976096|NCT01569438|11097506|FG000|COMPLETED|Overall Study||45
9976097|NCT01569438|11097507|FG001|COMPLETED|Overall Study||33
9976098|NCT01569438|11097506|FG000|NOT COMPLETED|Overall Study||7
9976099|NCT01569438|11097507|FG001|NOT COMPLETED|Overall Study||22
9976100|NCT01569451|11097515|FG000|STARTED|Overall Study||26
9976101|NCT01569451|11097516|FG001|STARTED|Overall Study||27
9976102|NCT01569451|11097515|FG000|COMPLETED|Overall Study||12
9976103|NCT01569451|11097516|FG001|COMPLETED|Overall Study||14
9976104|NCT01569451|11097515|FG000|NOT COMPLETED|Overall Study||14
9976105|NCT01569451|11097516|FG001|NOT COMPLETED|Overall Study||13
9976106|NCT01569464|11097526|FG000|STARTED|Overall Study||101
9976107|NCT01569464|11097527|FG001|STARTED|Overall Study||49
9976108|NCT01569464|11097526|FG000|COMPLETED|Overall Study||91
9976109|NCT01569464|11097527|FG001|COMPLETED|Overall Study||44
9976110|NCT01569464|11097526|FG000|NOT COMPLETED|Overall Study||10
9976111|NCT01569464|11097527|FG001|NOT COMPLETED|Overall Study||5
9976112|NCT01569529|11097537|FG000|STARTED|Overall Study||2676
9976113|NCT01569529|11097538|FG001|STARTED|Overall Study||394
9976114|NCT01569529|11097537|FG000|COMPLETED|Overall Study||2676
9976115|NCT01569529|11097538|FG001|COMPLETED|Overall Study||394
9976116|NCT01569529|11097537|FG000|NOT COMPLETED|Overall Study||0
9976117|NCT01569529|11097538|FG001|NOT COMPLETED|Overall Study||0
9976118|NCT01569568|11097546|FG000|STARTED|Overall Study||20
9976119|NCT01569568|11097547|FG001|STARTED|Overall Study||29
9976120|NCT01569568|11097546|FG000|COMPLETED|Overall Study||20
9976121|NCT01569568|11097547|FG001|COMPLETED|Overall Study||27
9976122|NCT01569568|11097546|FG000|NOT COMPLETED|Overall Study||0
9976123|NCT01569568|11097547|FG001|NOT COMPLETED|Overall Study||2
9976124|NCT01569594|11097553|FG000|STARTED|Overall Study||230
9976125|NCT01569594|11097553|FG000|COMPLETED|Overall Study||163
9976126|NCT01569594|11097553|FG000|NOT COMPLETED|Overall Study||67
9976127|NCT01569607|11097559|FG000|STARTED|Overall Study||11
9976128|NCT01569607|11097560|FG001|STARTED|Overall Study||11
9976129|NCT01569607|11097559|FG000|COMPLETED|Overall Study||10
9976130|NCT01569607|11097560|FG001|COMPLETED|Overall Study||10
9976131|NCT01569607|11097559|FG000|NOT COMPLETED|Overall Study||1
9976132|NCT01569607|11097560|FG001|NOT COMPLETED|Overall Study||1
9976133|NCT01569737|11097566|FG000|STARTED|Overall Study||98
9976134|NCT01569737|11097566|FG000|COMPLETED|Overall Study||95
9976135|NCT01569737|11097566|FG000|NOT COMPLETED|Overall Study||3
9976136|NCT01569763|11097572|FG000|STARTED|Overall Study||102
9976137|NCT01569763|11097573|FG001|STARTED|Overall Study||51
9976138|NCT01569763|11097572|FG000|Treated|Overall Study||102
9976139|NCT01569763|11097573|FG001|Treated|Overall Study||51
9976140|NCT01569763|11097572|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
9976141|NCT01569763|11097573|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
9976142|NCT01569763|11097572|FG000|NOT COMPLETED|Overall Study||3
9976143|NCT01569763|11097573|FG001|NOT COMPLETED|Overall Study||7
9976144|NCT01569815|11097583|FG000|STARTED|Overall Study||8
9976145|NCT01569815|11097584|FG001|STARTED|Overall Study||8
9976146|NCT01569815|11097585|FG002|STARTED|Overall Study||8
9976147|NCT01569815|11097586|FG003|STARTED|Overall Study||8
9976148|NCT01569815|11097583|FG000|COMPLETED|Overall Study||8
9976149|NCT01569815|11097584|FG001|COMPLETED|Overall Study||8
10098880|NCT02387554|11227900|FG001|COMPLETED|Overall Study||7
10098881|NCT02387554|11227901|FG002|COMPLETED|Overall Study||6
10098882|NCT02387554|11227902|FG003|COMPLETED|Overall Study||6
10098883|NCT02387554|11227899|FG000|NOT COMPLETED|Overall Study||3
10098884|NCT02387554|11227900|FG001|NOT COMPLETED|Overall Study||0
10098885|NCT02387554|11227901|FG002|NOT COMPLETED|Overall Study||2
10098886|NCT02387554|11227902|FG003|NOT COMPLETED|Overall Study||2
9976150|NCT01569815|11097585|FG002|COMPLETED|Overall Study||8
9976151|NCT01569815|11097586|FG003|COMPLETED|Overall Study||8
9976152|NCT01569815|11097583|FG000|NOT COMPLETED|Overall Study||0
9976153|NCT01569815|11097584|FG001|NOT COMPLETED|Overall Study||0
9976154|NCT01569815|11097585|FG002|NOT COMPLETED|Overall Study||0
9976155|NCT01569815|11097586|FG003|NOT COMPLETED|Overall Study||0
9976156|NCT01569828|11097599|FG000|STARTED|Overall Study||6
9976157|NCT01569828|11097600|FG001|STARTED|Overall Study||6
9976158|NCT01569828|11097599|FG000|COMPLETED|Overall Study||6
10098887|NCT02387580|11227918|FG000|STARTED|Overall Study||8
10098888|NCT02387580|11227919|FG001|STARTED|Overall Study||8
9976159|NCT01569828|11097600|FG001|COMPLETED|Overall Study||6
9976160|NCT01569828|11097599|FG000|NOT COMPLETED|Overall Study||0
9976161|NCT01569828|11097600|FG001|NOT COMPLETED|Overall Study||0
9976162|NCT01569841|11097607|FG000|STARTED|Period A (6 Weeks)||12
9976163|NCT01569841|11097608|FG001|STARTED|Period A (6 Weeks)||12
9976164|NCT01569841|11097607|FG000|Exposed|Period A (6 Weeks)||12
9976165|NCT01569841|11097608|FG001|Exposed|Period A (6 Weeks)||12
9976166|NCT01569841|11097607|FG000|COMPLETED|Period A (6 Weeks)||12
9976167|NCT01569841|11097608|FG001|COMPLETED|Period A (6 Weeks)||11
9976168|NCT01569841|11097607|FG000|NOT COMPLETED|Period A (6 Weeks)||0
9976169|NCT01569841|11097608|FG001|NOT COMPLETED|Period A (6 Weeks)||1
9976170|NCT01569841|11097607|FG000|STARTED|Period B (6 Weeks)||12
9976171|NCT01569841|11097608|FG001|STARTED|Period B (6 Weeks)||11
9976172|NCT01569841|11097607|FG000|Exposed|Period B (6 Weeks)||12
9976173|NCT01569841|11097608|FG001|Exposed|Period B (6 Weeks)||11
9976174|NCT01569841|11097607|FG000|COMPLETED|Period B (6 Weeks)||12
9976175|NCT01569841|11097608|FG001|COMPLETED|Period B (6 Weeks)||11
9976176|NCT01569841|11097607|FG000|NOT COMPLETED|Period B (6 Weeks)||0
9976177|NCT01569841|11097608|FG001|NOT COMPLETED|Period B (6 Weeks)||0
9976178|NCT01570036|11097618|FG000|STARTED|Overall Study||136
9976179|NCT01570036|11097619|FG001|STARTED|Overall Study||139
9976180|NCT01570036|11097618|FG000|Primary Vaccine Series Completed|Overall Study||121
9976181|NCT01570036|11097619|FG001|Primary Vaccine Series Completed|Overall Study||132
9976182|NCT01570036|11097618|FG000|Booster Series Completed|Overall Study||40
9976183|NCT01570036|11097619|FG001|Booster Series Completed|Overall Study||30
9976184|NCT01570036|11097618|FG000|COMPLETED|Overall Study||18
9976185|NCT01570036|11097619|FG001|COMPLETED|Overall Study||17
9976186|NCT01570036|11097618|FG000|NOT COMPLETED|Overall Study||118
9976187|NCT01570036|11097619|FG001|NOT COMPLETED|Overall Study||122
9976188|NCT01570192|11097627|FG000|STARTED|Overall Study||13
9976189|NCT01570192|11097628|FG001|STARTED|Overall Study||30
9976190|NCT01570192|11097627|FG000|COMPLETED|Overall Study||6
9976191|NCT01570192|11097628|FG001|COMPLETED|Overall Study||17
9976192|NCT01570192|11097627|FG000|NOT COMPLETED|Overall Study||7
9976193|NCT01570192|11097628|FG001|NOT COMPLETED|Overall Study||13
9976194|NCT01570244|11097639|FG000|STARTED|Microgynon||16
9976195|NCT01570244|11097639|FG000|COMPLETED|Microgynon||16
9976196|NCT01570244|11097639|FG000|NOT COMPLETED|Microgynon||0
9976197|NCT01570244|11097639|FG000|STARTED|Microgynon+Faldaprevir||16
9976198|NCT01570244|11097639|FG000|COMPLETED|Microgynon+Faldaprevir||15
9976199|NCT01570244|11097639|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1
9976200|NCT01570283|11097648|FG000|STARTED|Cohort 1: Dose Level 1||1
9976201|NCT01570283|11097649|FG001|STARTED|Cohort 1: Dose Level 1||3
9976202|NCT01570283|11097650|FG002|STARTED|Cohort 1: Dose Level 1||0
9976203|NCT01570283|11097651|FG003|STARTED|Cohort 1: Dose Level 1||0
9976204|NCT01570283|11097652|FG004|STARTED|Cohort 1: Dose Level 1||0
9976205|NCT01570283|11097653|FG005|STARTED|Cohort 1: Dose Level 1||0
9976206|NCT01570283|11097648|FG000|COMPLETED|Cohort 1: Dose Level 1||1
9976207|NCT01570283|11097649|FG001|COMPLETED|Cohort 1: Dose Level 1||1
10098889|NCT02387580|11227920|FG002|STARTED|Overall Study||8
10098890|NCT02387580|11227921|FG003|STARTED|Overall Study||8
10098891|NCT02387580|11227922|FG004|STARTED|Overall Study||8
10098892|NCT02387580|11227923|FG005|STARTED|Overall Study||8
10098893|NCT02387580|11227918|FG000|COMPLETED|Overall Study||8
10098894|NCT02387580|11227919|FG001|COMPLETED|Overall Study||8
10098895|NCT02387580|11227920|FG002|COMPLETED|Overall Study||8
10098896|NCT02387580|11227921|FG003|COMPLETED|Overall Study||7
10098897|NCT02387580|11227922|FG004|COMPLETED|Overall Study||8
10098898|NCT02387580|11227923|FG005|COMPLETED|Overall Study||8
10098899|NCT02387580|11227918|FG000|NOT COMPLETED|Overall Study||0
10098900|NCT02387580|11227919|FG001|NOT COMPLETED|Overall Study||0
10098901|NCT02387580|11227920|FG002|NOT COMPLETED|Overall Study||0
10098902|NCT02387580|11227921|FG003|NOT COMPLETED|Overall Study||1
10098903|NCT02387580|11227922|FG004|NOT COMPLETED|Overall Study||0
10098904|NCT02387580|11227923|FG005|NOT COMPLETED|Overall Study||0
10098905|NCT02387710|11227939|FG000|STARTED|First Study Night||9
10098906|NCT02387710|11227940|FG001|STARTED|First Study Night||9
10098907|NCT02387710|11227939|FG000|COMPLETED|First Study Night||9
10098908|NCT02387710|11227940|FG001|COMPLETED|First Study Night||9
10098909|NCT02387710|11227939|FG000|NOT COMPLETED|First Study Night||0
10098910|NCT02387710|11227940|FG001|NOT COMPLETED|First Study Night||0
9758684|NCT01927419|10862247|FG001|NOT COMPLETED|Pre-Treatment Period||1
9758685|NCT01927419|10862246|FG000|STARTED|Treatment Period||94
9758686|NCT01927419|10862247|FG001|STARTED|Treatment Period||46
9758687|NCT01927419|10862246|FG000|COMPLETED|Treatment Period||0
9758688|NCT01927419|10862247|FG001|COMPLETED|Treatment Period||0
9758689|NCT01927419|10862246|FG000|NOT COMPLETED|Treatment Period||94
9758690|NCT01927419|10862247|FG001|NOT COMPLETED|Treatment Period||46
9758691|NCT01924533|10862255|FG000|STARTED|Overall Study||263
9758692|NCT01924533|10862256|FG001|STARTED|Overall Study||262
10098911|NCT02387710|11227939|FG000|STARTED|Second Study Night||9
10098912|NCT02387710|11227940|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
10098913|NCT02387710|11227939|FG000|COMPLETED|Second Study Night||9
10098914|NCT02387710|11227940|FG001|COMPLETED|Second Study Night||7
9758693|NCT01924533|10862255|FG000|COMPLETED|Overall Study||74
9976208|NCT01570283|11097650|FG002|COMPLETED|Cohort 1: Dose Level 1||0
9976209|NCT01570283|11097651|FG003|COMPLETED|Cohort 1: Dose Level 1||0
9976210|NCT01570283|11097652|FG004|COMPLETED|Cohort 1: Dose Level 1||0
10098915|NCT02387710|11227939|FG000|NOT COMPLETED|Second Study Night||0
10098916|NCT02387710|11227940|FG001|NOT COMPLETED|Second Study Night||0
10098917|NCT02387749|11227948|FG000|STARTED|Overall Study||10
9976211|NCT01570283|11097653|FG005|COMPLETED|Cohort 1: Dose Level 1||0
9976212|NCT01570283|11097648|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
9976213|NCT01570283|11097649|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2
10098918|NCT02387749|11227948|FG000|COMPLETED|Overall Study||10
10098919|NCT02387749|11227948|FG000|NOT COMPLETED|Overall Study||0
9976214|NCT01570283|11097650|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
9976215|NCT01570283|11097651|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
9976216|NCT01570283|11097652|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0
9976217|NCT01570283|11097653|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0
9976218|NCT01570283|11097648|FG000|STARTED|Cohort 2: Dose Level 2||0
9976219|NCT01570283|11097649|FG001|STARTED|Cohort 2: Dose Level 2||0
9976220|NCT01570283|11097650|FG002|STARTED|Cohort 2: Dose Level 2||2
9976221|NCT01570283|11097651|FG003|STARTED|Cohort 2: Dose Level 2||2
9976222|NCT01570283|11097652|FG004|STARTED|Cohort 2: Dose Level 2||0
9976223|NCT01570283|11097653|FG005|STARTED|Cohort 2: Dose Level 2||0
9976224|NCT01570283|11097648|FG000|COMPLETED|Cohort 2: Dose Level 2||0
9976225|NCT01570283|11097649|FG001|COMPLETED|Cohort 2: Dose Level 2||0
9976226|NCT01570283|11097650|FG002|COMPLETED|Cohort 2: Dose Level 2||1
9976227|NCT01570283|11097651|FG003|COMPLETED|Cohort 2: Dose Level 2||1
9976228|NCT01570283|11097652|FG004|COMPLETED|Cohort 2: Dose Level 2||0
9976229|NCT01570283|11097653|FG005|COMPLETED|Cohort 2: Dose Level 2||0
9976230|NCT01570283|11097648|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
9976231|NCT01570283|11097649|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
9976232|NCT01570283|11097650|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1
9976233|NCT01570283|11097651|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1
10098920|NCT02387762|11227959|FG000|STARTED|Overall Study||16
10098921|NCT02387762|11227960|FG001|STARTED|Overall Study||15
10098922|NCT02387762|11227959|FG000|COMPLETED|Overall Study||15
10098923|NCT02387762|11227960|FG001|COMPLETED|Overall Study||15
10098924|NCT02387762|11227959|FG000|NOT COMPLETED|Overall Study||1
10098925|NCT02387762|11227960|FG001|NOT COMPLETED|Overall Study||0
10098926|NCT02387801|11227968|FG000|STARTED|Induction Dosing Period||6
10098927|NCT02387801|11227969|FG001|STARTED|Induction Dosing Period||6
10098928|NCT02387801|11227968|FG000|COMPLETED|Induction Dosing Period||6
10098929|NCT02387801|11227969|FG001|COMPLETED|Induction Dosing Period||6
10098930|NCT02387801|11227968|FG000|NOT COMPLETED|Induction Dosing Period||0
10098931|NCT02387801|11227969|FG001|NOT COMPLETED|Induction Dosing Period||0
10098932|NCT02387801|11227968|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
10098933|NCT02387801|11227969|FG001|STARTED|Maintenance Dosing Period||12
10098934|NCT02387801|11227968|FG000|COMPLETED|Maintenance Dosing Period||0
10098935|NCT02387801|11227969|FG001|COMPLETED|Maintenance Dosing Period||12
10098936|NCT02387801|11227968|FG000|NOT COMPLETED|Maintenance Dosing Period||0
10098937|NCT02387801|11227969|FG001|NOT COMPLETED|Maintenance Dosing Period||0
10098938|NCT02387801|11227968|FG000|STARTED|Post-Treatment Follow-up||0
10098939|NCT02387801|11227969|FG001|STARTED|Post-Treatment Follow-up||12
10098940|NCT02387801|11227968|FG000|COMPLETED|Post-Treatment Follow-up||0
10098941|NCT02387801|11227969|FG001|COMPLETED|Post-Treatment Follow-up||12
10098942|NCT02387801|11227968|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
10098943|NCT02387801|11227969|FG001|NOT COMPLETED|Post-Treatment Follow-up||0
10098944|NCT02387814|11227981|FG000|STARTED|Overall Study||10
10098945|NCT02387814|11227982|FG001|STARTED|Overall Study||9
10098946|NCT02387814|11227983|FG002|STARTED|Overall Study||10
10098947|NCT02387814|11227984|FG003|STARTED|Overall Study||6
10098948|NCT02387814|11227981|FG000|Received Abemaciclib|Overall Study||10
10098949|NCT02387814|11227982|FG001|Received Abemaciclib|Overall Study||9
10098950|NCT02387814|11227983|FG002|Received Abemaciclib|Overall Study||10
10098951|NCT02387814|11227984|FG003|Received Abemaciclib|Overall Study||6
10098952|NCT02387814|11227981|FG000|COMPLETED|Overall Study||10
9976234|NCT01570283|11097652|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0
9976235|NCT01570283|11097653|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0
9976236|NCT01570283|11097648|FG000|STARTED|Cohort 3: Dose Level 3||0
9976237|NCT01570283|11097649|FG001|STARTED|Cohort 3: Dose Level 3||0
9976238|NCT01570283|11097650|FG002|STARTED|Cohort 3: Dose Level 3||0
9976239|NCT01570283|11097651|FG003|STARTED|Cohort 3: Dose Level 3||0
9976240|NCT01570283|11097652|FG004|STARTED|Cohort 3: Dose Level 3||1
9976241|NCT01570283|11097653|FG005|STARTED|Cohort 3: Dose Level 3||12
9976242|NCT01570283|11097648|FG000|COMPLETED|Cohort 3: Dose Level 3||0
9976243|NCT01570283|11097649|FG001|COMPLETED|Cohort 3: Dose Level 3||0
10098953|NCT02387814|11227982|FG001|COMPLETED|Overall Study||9
10098954|NCT02387814|11227983|FG002|COMPLETED|Overall Study||10
10098955|NCT02387814|11227984|FG003|COMPLETED|Overall Study||6
10098956|NCT02387814|11227981|FG000|NOT COMPLETED|Overall Study||0
10098957|NCT02387814|11227982|FG001|NOT COMPLETED|Overall Study||0
10098958|NCT02387814|11227983|FG002|NOT COMPLETED|Overall Study||0
10098959|NCT02387814|11227984|FG003|NOT COMPLETED|Overall Study||0
10098960|NCT02387840|11228000|FG000|STARTED|Overall Study||4
10098961|NCT02387840|11228001|FG001|STARTED|Overall Study||6
10098962|NCT02387840|11228002|FG002|STARTED|Overall Study||6
10098963|NCT02387840|11228003|FG003|STARTED|Overall Study||8
9976244|NCT01570283|11097650|FG002|COMPLETED|Cohort 3: Dose Level 3||0
9976245|NCT01570283|11097651|FG003|COMPLETED|Cohort 3: Dose Level 3||0
9976246|NCT01570283|11097652|FG004|COMPLETED|Cohort 3: Dose Level 3||1
9976247|NCT01570283|11097653|FG005|COMPLETED|Cohort 3: Dose Level 3||10
9976248|NCT01570283|11097648|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
9976249|NCT01570283|11097649|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
10098964|NCT02387840|11228004|FG004|STARTED|Overall Study||4
10098965|NCT02387840|11228005|FG005|STARTED|Overall Study||6
10098966|NCT02387840|11228000|FG000|COMPLETED|Overall Study||4
10098967|NCT02387840|11228001|FG001|COMPLETED|Overall Study||6
10098968|NCT02387840|11228002|FG002|COMPLETED|Overall Study||6
10098969|NCT02387840|11228003|FG003|COMPLETED|Overall Study||8
9976250|NCT01570283|11097650|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
9976251|NCT01570283|11097651|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
9976252|NCT01570283|11097652|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0
9976253|NCT01570283|11097653|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2
9976254|NCT01570309|11097669|FG000|STARTED|Overall Study||48
9976255|NCT01570309|11097670|FG001|STARTED|Overall Study||48
9976256|NCT01570309|11097669|FG000|COMPLETED|Overall Study||45
9976257|NCT01570309|11097670|FG001|COMPLETED|Overall Study||45
9976258|NCT01570309|11097669|FG000|NOT COMPLETED|Overall Study||3
9976259|NCT01570309|11097670|FG001|NOT COMPLETED|Overall Study||3
9976260|NCT01570348|11097680|FG000|STARTED|Overall Study||2
9976261|NCT01570348|11097680|FG000|COMPLETED|Overall Study||2
9976262|NCT01570348|11097680|FG000|NOT COMPLETED|Overall Study||0
9976263|NCT01570361|11097686|FG000|STARTED|Overall Study||128
9976264|NCT01570361|11097687|FG001|STARTED|Overall Study||127
9976265|NCT01570361|11097686|FG000|Received Study Treatment|Overall Study||102
9976266|NCT01570361|11097687|FG001|Received Study Treatment|Overall Study||123
9976267|NCT01570361|11097686|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
9976268|NCT01570361|11097687|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
9976269|NCT01570361|11097686|FG000|AAD Therapy Only|Overall Study||0
9976270|NCT01570361|11097687|FG001|AAD Therapy Only|Overall Study||108
10098970|NCT02387840|11228004|FG004|COMPLETED|Overall Study||4
10098971|NCT02387840|11228005|FG005|COMPLETED|Overall Study||5
10098972|NCT02387840|11228000|FG000|NOT COMPLETED|Overall Study||0
10098973|NCT02387840|11228001|FG001|NOT COMPLETED|Overall Study||0
10098974|NCT02387840|11228002|FG002|NOT COMPLETED|Overall Study||0
10098975|NCT02387840|11228003|FG003|NOT COMPLETED|Overall Study||0
10098976|NCT02387840|11228004|FG004|NOT COMPLETED|Overall Study||0
10098977|NCT02387840|11228005|FG005|NOT COMPLETED|Overall Study||1
10098978|NCT02387853|11228025|FG000|STARTED|Overall Study||106
10098979|NCT02387853|11228025|FG000|COMPLETED|Overall Study||103
10098980|NCT02387853|11228025|FG000|NOT COMPLETED|Overall Study||3
10098981|NCT02387957|11228032|FG000|STARTED|Overall Study||21
10098982|NCT02387957|11228033|FG001|STARTED|Overall Study||21
10098983|NCT02387957|11228034|FG002|STARTED|Overall Study||21
10098984|NCT02387957|11228032|FG000|COMPLETED|Overall Study|The study was discontinued|0
10098985|NCT02387957|11228033|FG001|COMPLETED|Overall Study|The study was discontinued|0
10098986|NCT02387957|11228034|FG002|COMPLETED|Overall Study|The study was discontinued|1
10098987|NCT02387957|11228032|FG000|NOT COMPLETED|Overall Study||21
10098988|NCT02387957|11228033|FG001|NOT COMPLETED|Overall Study||21
10098989|NCT02387957|11228034|FG002|NOT COMPLETED|Overall Study||20
10098990|NCT02387970|11228044|FG000|STARTED|Overall Study||27
10098991|NCT02387970|11228045|FG001|STARTED|Overall Study||25
10098992|NCT02387970|11228044|FG000|COMPLETED|Overall Study||26
10098993|NCT02387970|11228045|FG001|COMPLETED|Overall Study||23
10098994|NCT02387970|11228044|FG000|NOT COMPLETED|Overall Study||1
10098995|NCT02387970|11228045|FG001|NOT COMPLETED|Overall Study||2
10098996|NCT02387983|11228051|FG000|STARTED|Overall Study||65
10098997|NCT02387983|11228051|FG000|COMPLETED|Overall Study||58
10098998|NCT02387983|11228051|FG000|NOT COMPLETED|Overall Study||7
10098999|NCT02388074|11228055|FG000|STARTED|Overall Study||25
10099000|NCT02388074|11228055|FG000|COMPLETED|Overall Study||22
10099001|NCT02388074|11228055|FG000|NOT COMPLETED|Overall Study||3
10099002|NCT02388165|11228061|FG000|STARTED|Overall Study||1726
10099003|NCT02388165|11228062|FG001|STARTED|Overall Study||1724
10099004|NCT02388165|11228061|FG000|Vaccinated (Safety Population)|Overall Study||1708
10099005|NCT02388165|11228062|FG001|Vaccinated (Safety Population)|Overall Study||1709
10099006|NCT02388165|11228061|FG000|COMPLETED|Overall Study||1599
10099007|NCT02388165|11228062|FG001|COMPLETED|Overall Study||1594
10099008|NCT02388165|11228061|FG000|NOT COMPLETED|Overall Study||127
10099009|NCT02388165|11228062|FG001|NOT COMPLETED|Overall Study||130
10099010|NCT02388191|11228070|FG000|STARTED|Overall Study||59
10099011|NCT02388191|11228071|FG001|STARTED|Overall Study||60
10099012|NCT02388191|11228070|FG000|COMPLETED|Overall Study||58
10099013|NCT02388191|11228071|FG001|COMPLETED|Overall Study||60
10099014|NCT02388191|11228070|FG000|NOT COMPLETED|Overall Study||1
10099015|NCT02388191|11228071|FG001|NOT COMPLETED|Overall Study||0
10099016|NCT02388269|11228081|FG000|STARTED|Overall Study||41
10099017|NCT02388269|11228082|FG001|STARTED|Overall Study||40
10099018|NCT02388269|11228083|FG002|STARTED|Overall Study||10
10202024|NCT03441984|11329286|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3
10202025|NCT03441984|11329287|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3
10202026|NCT03441984|11329276|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202027|NCT03441984|11329277|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202028|NCT03441984|11329278|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202029|NCT03441984|11329279|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202030|NCT03441984|11329280|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0
9976271|NCT01570361|11097686|FG000|COMPLETED|Overall Study||46
9976272|NCT01570361|11097687|FG001|COMPLETED|Overall Study||52
9976273|NCT01570361|11097686|FG000|NOT COMPLETED|Overall Study||82
10099019|NCT02388269|11228081|FG000|Randomised Period|Overall Study||41
10099020|NCT02388269|11228082|FG001|Randomised Period|Overall Study||40
10099021|NCT02388269|11228083|FG002|Randomised Period|Overall Study||0
10099022|NCT02388269|11228081|FG000|Open Label|Overall Study||37
10099023|NCT02388269|11228082|FG001|Open Label|Overall Study||38
10099024|NCT02388269|11228083|FG002|Open Label|Overall Study||0
10099025|NCT02388269|11228081|FG000|COMPLETED|Overall Study||32
10099026|NCT02388269|11228082|FG001|COMPLETED|Overall Study||38
10099027|NCT02388269|11228083|FG002|COMPLETED|Overall Study||0
9976274|NCT01570361|11097687|FG001|NOT COMPLETED|Overall Study||75
9976275|NCT01570387|11097700|FG000|STARTED|Overall Study||6
9976276|NCT01570387|11097701|FG001|STARTED|Overall Study||3
9976277|NCT01570387|11097702|FG002|STARTED|Overall Study||6
9976278|NCT01570387|11097703|FG003|STARTED|Overall Study||12
9976279|NCT01570387|11097700|FG000|Dose Limiting Toxicity|Overall Study||0
9976280|NCT01570387|11097701|FG001|Dose Limiting Toxicity|Overall Study||0
9976281|NCT01570387|11097702|FG002|Dose Limiting Toxicity|Overall Study||6
9976282|NCT01570387|11097703|FG003|Dose Limiting Toxicity|Overall Study||12
9976283|NCT01570387|11097700|FG000|Response to Maximal Tolerated Dose|Overall Study||0
9976284|NCT01570387|11097701|FG001|Response to Maximal Tolerated Dose|Overall Study||0
9976285|NCT01570387|11097702|FG002|Response to Maximal Tolerated Dose|Overall Study||3
9976286|NCT01570387|11097703|FG003|Response to Maximal Tolerated Dose|Overall Study||6
9976287|NCT01570387|11097700|FG000|COMPLETED|Overall Study||5
9976288|NCT01570387|11097701|FG001|COMPLETED|Overall Study||3
10099028|NCT02388269|11228081|FG000|NOT COMPLETED|Overall Study||9
10099029|NCT02388269|11228082|FG001|NOT COMPLETED|Overall Study||2
10099030|NCT02388269|11228083|FG002|NOT COMPLETED|Overall Study||10
10099031|NCT02388295|11228110|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
10099032|NCT02388295|11228111|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
10099033|NCT02388295|11228112|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
10099034|NCT02388295|11228110|FG000|COMPLETED|Dose Escalation Week 1||17
10099035|NCT02388295|11228111|FG001|COMPLETED|Dose Escalation Week 1||16
10099036|NCT02388295|11228112|FG002|COMPLETED|Dose Escalation Week 1||18
10099037|NCT02388295|11228110|FG000|NOT COMPLETED|Dose Escalation Week 1||2
10099038|NCT02388295|11228111|FG001|NOT COMPLETED|Dose Escalation Week 1||3
10099039|NCT02388295|11228112|FG002|NOT COMPLETED|Dose Escalation Week 1||2
10099040|NCT02388295|11228110|FG000|STARTED|Dose Escalation Week 2||17
10099041|NCT02388295|11228111|FG001|STARTED|Dose Escalation Week 2||16
10099042|NCT02388295|11228112|FG002|STARTED|Dose Escalation Week 2||18
10099043|NCT02388295|11228110|FG000|COMPLETED|Dose Escalation Week 2||16
10099044|NCT02388295|11228111|FG001|COMPLETED|Dose Escalation Week 2||14
10099045|NCT02388295|11228112|FG002|COMPLETED|Dose Escalation Week 2||17
10099046|NCT02388295|11228110|FG000|NOT COMPLETED|Dose Escalation Week 2||1
10099047|NCT02388295|11228111|FG001|NOT COMPLETED|Dose Escalation Week 2||2
10099048|NCT02388295|11228112|FG002|NOT COMPLETED|Dose Escalation Week 2||1
10099049|NCT02388295|11228110|FG000|STARTED|Treatment Weeks 3 to 12||16
10099050|NCT02388295|11228111|FG001|STARTED|Treatment Weeks 3 to 12||14
10099051|NCT02388295|11228112|FG002|STARTED|Treatment Weeks 3 to 12||17
10099052|NCT02388295|11228110|FG000|COMPLETED|Treatment Weeks 3 to 12||15
10099053|NCT02388295|11228111|FG001|COMPLETED|Treatment Weeks 3 to 12||13
10099054|NCT02388295|11228112|FG002|COMPLETED|Treatment Weeks 3 to 12||17
10099055|NCT02388295|11228110|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1
10099056|NCT02388295|11228111|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1
10099057|NCT02388295|11228112|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0
10099058|NCT02388321|11228122|FG000|STARTED|Overall Study||11
10099059|NCT02388321|11228123|FG001|STARTED|Overall Study||11
10099060|NCT02388321|11228122|FG000|COMPLETED|Overall Study||11
10099061|NCT02388321|11228123|FG001|COMPLETED|Overall Study||11
10099062|NCT02388321|11228122|FG000|NOT COMPLETED|Overall Study||0
10099063|NCT02388321|11228123|FG001|NOT COMPLETED|Overall Study||0
10099064|NCT02388347|11228134|FG000|STARTED|Overall Study||8
10099065|NCT02388347|11228135|FG001|STARTED|Overall Study||6
10099066|NCT02388347|11228136|FG002|STARTED|Overall Study||6
10099067|NCT02388347|11228137|FG003|STARTED|Overall Study||6
10099068|NCT02388347|11228138|FG004|STARTED|Overall Study||6
10099069|NCT02388347|11228134|FG000|COMPLETED|Overall Study||8
10099070|NCT02388347|11228135|FG001|COMPLETED|Overall Study||6
10099071|NCT02388347|11228136|FG002|COMPLETED|Overall Study||5
10099072|NCT02388347|11228137|FG003|COMPLETED|Overall Study||6
10099073|NCT02388347|11228138|FG004|COMPLETED|Overall Study||6
10099074|NCT02388347|11228134|FG000|NOT COMPLETED|Overall Study||0
10099075|NCT02388347|11228135|FG001|NOT COMPLETED|Overall Study||0
10099076|NCT02388347|11228136|FG002|NOT COMPLETED|Overall Study||1
10099077|NCT02388347|11228137|FG003|NOT COMPLETED|Overall Study||0
10099078|NCT02388347|11228138|FG004|NOT COMPLETED|Overall Study||0
10099079|NCT02388386|11228154|FG000|STARTED|Overall Study||10
10099080|NCT02388386|11228154|FG000|COMPLETED|Overall Study||10
10099081|NCT02388386|11228154|FG000|NOT COMPLETED|Overall Study||0
10099082|NCT02388568|11228164|FG000|STARTED|Overall Study||69
10099083|NCT02388568|11228165|FG001|STARTED|Overall Study||68
10099084|NCT02388568|11228164|FG000|COMPLETED|Overall Study||59
10099085|NCT02388568|11228165|FG001|COMPLETED|Overall Study||53
10099086|NCT02388568|11228164|FG000|NOT COMPLETED|Overall Study||10
10099087|NCT02388568|11228165|FG001|NOT COMPLETED|Overall Study||15
10099088|NCT02388633|11228171|FG000|STARTED|Overall Study||8
10099089|NCT02388633|11228171|FG000|COMPLETED|Overall Study||8
10099090|NCT02388633|11228171|FG000|NOT COMPLETED|Overall Study||0
10099091|NCT02388646|11228178|FG000|STARTED|Overall Study||20
10099092|NCT02388646|11228179|FG001|STARTED|Overall Study||20
10099093|NCT02388646|11228180|FG002|STARTED|Overall Study||20
10099094|NCT02388646|11228178|FG000|COMPLETED|Overall Study||16
10099095|NCT02388646|11228179|FG001|COMPLETED|Overall Study||19
10099096|NCT02388646|11228180|FG002|COMPLETED|Overall Study||14
10099097|NCT02388646|11228178|FG000|NOT COMPLETED|Overall Study||4
10099098|NCT02388646|11228179|FG001|NOT COMPLETED|Overall Study||1
9976289|NCT01570387|11097702|FG002|COMPLETED|Overall Study||6
9976290|NCT01570387|11097703|FG003|COMPLETED|Overall Study||10
9976291|NCT01570387|11097700|FG000|NOT COMPLETED|Overall Study||1
9976292|NCT01570387|11097701|FG001|NOT COMPLETED|Overall Study||0
9976293|NCT01570387|11097702|FG002|NOT COMPLETED|Overall Study||0
9976294|NCT01570387|11097703|FG003|NOT COMPLETED|Overall Study||2
9976295|NCT01570491|11097712|FG000|STARTED|Overall Study||19
9976296|NCT01570491|11097713|FG001|STARTED|Overall Study||19
9976297|NCT01570491|11097712|FG000|COMPLETED|Overall Study||14
9976298|NCT01570491|11097713|FG001|COMPLETED|Overall Study||18
9976299|NCT01570491|11097712|FG000|NOT COMPLETED|Overall Study||5
10099099|NCT02388646|11228180|FG002|NOT COMPLETED|Overall Study||6
10099100|NCT02388724|11228190|FG000|STARTED|Overall Study||244
10099101|NCT02388724|11228191|FG001|STARTED|Overall Study||237
10099102|NCT02388724|11228190|FG000|Safety Set: Randomized But Not Treated|Overall Study||0
10099103|NCT02388724|11228191|FG001|Safety Set: Randomized But Not Treated|Overall Study||2
10099104|NCT02388724|11228190|FG000|COMPLETED|Overall Study||232
10099105|NCT02388724|11228191|FG001|COMPLETED|Overall Study||224
10099106|NCT02388724|11228190|FG000|NOT COMPLETED|Overall Study||12
10099107|NCT02388724|11228191|FG001|NOT COMPLETED|Overall Study||13
10099108|NCT02388737|11228200|FG000|STARTED|Overall Study||235
10099109|NCT02388737|11228201|FG001|STARTED|Overall Study||226
10099110|NCT02388737|11228202|FG002|STARTED|Overall Study||242
10099111|NCT02388737|11228200|FG000|COMPLETED|Overall Study||181
10099112|NCT02388737|11228201|FG001|COMPLETED|Overall Study||166
10099113|NCT02388737|11228202|FG002|COMPLETED|Overall Study||180
10099114|NCT02388737|11228200|FG000|NOT COMPLETED|Overall Study||54
10099115|NCT02388737|11228201|FG001|NOT COMPLETED|Overall Study||60
10099116|NCT02388737|11228202|FG002|NOT COMPLETED|Overall Study||62
10099117|NCT02388763|11228210|FG000|STARTED|Habitual, 10 Days of Wear||32
10099118|NCT02388763|11228211|FG001|STARTED|Habitual, 10 Days of Wear||32
10099119|NCT02388763|11228210|FG000|COMPLETED|Habitual, 10 Days of Wear||31
10099120|NCT02388763|11228211|FG001|COMPLETED|Habitual, 10 Days of Wear||31
10099121|NCT02388763|11228210|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1
10099122|NCT02388763|11228211|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1
10099123|NCT02388763|11228210|FG000|STARTED|Period 1, 10 Days of Wear||31
10099124|NCT02388763|11228211|FG001|STARTED|Period 1, 10 Days of Wear||31
10099125|NCT02388763|11228210|FG000|COMPLETED|Period 1, 10 Days of Wear||30
10099126|NCT02388763|11228211|FG001|COMPLETED|Period 1, 10 Days of Wear||30
10099127|NCT02388763|11228210|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1
10099128|NCT02388763|11228211|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1
10099129|NCT02388763|11228210|FG000|STARTED|Period 2, 10 Days of Wear||30
10099130|NCT02388763|11228211|FG001|STARTED|Period 2, 10 Days of Wear||30
10099131|NCT02388763|11228210|FG000|COMPLETED|Period 2, 10 Days of Wear||30
10099132|NCT02388763|11228211|FG001|COMPLETED|Period 2, 10 Days of Wear||30
10099133|NCT02388763|11228210|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0
10099134|NCT02388763|11228211|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
10099135|NCT02388815|11228220|FG000|STARTED|Overall Study||89
10099136|NCT02388815|11228220|FG000|COMPLETED|Overall Study||85
10099137|NCT02388815|11228220|FG000|NOT COMPLETED|Overall Study||4
10099138|NCT02388880|11228224|FG000|STARTED|Overall Study||3
10099139|NCT02388880|11228224|FG000|COMPLETED|Overall Study||3
10099140|NCT02388880|11228224|FG000|NOT COMPLETED|Overall Study||0
10099141|NCT02388932|11228228|FG000|STARTED|Overall Study||3
10099142|NCT02388932|11228228|FG000|COMPLETED|Overall Study||2
10099143|NCT02388932|11228228|FG000|NOT COMPLETED|Overall Study||1
10099144|NCT02388997|11228235|FG000|STARTED|Overall Study||15
10099145|NCT02388997|11228236|FG001|STARTED|Overall Study||16
10099146|NCT02388997|11228235|FG000|COMPLETED|Overall Study||12
10099147|NCT02388997|11228236|FG001|COMPLETED|Overall Study||10
10099148|NCT02388997|11228235|FG000|NOT COMPLETED|Overall Study||3
10099149|NCT02388997|11228236|FG001|NOT COMPLETED|Overall Study||6
10099150|NCT02389088|11228242|FG000|STARTED|Overall Study - Phase I||9
10099151|NCT02389088|11228242|FG000|COMPLETED|Overall Study - Phase I||9
10099152|NCT02389088|11228242|FG000|NOT COMPLETED|Overall Study - Phase I||0
10099153|NCT02389088|11228242|FG000|STARTED|Phase II - All Study Participants||9
10099154|NCT02389088|11228242|FG000|COMPLETED|Phase II - All Study Participants||9
10099155|NCT02389088|11228242|FG000|NOT COMPLETED|Phase II - All Study Participants||0
10099156|NCT02389101|11228256|FG000|STARTED|Overall Study||21
10099157|NCT02389101|11228256|FG000|COMPLETED|Overall Study||21
10099158|NCT02389101|11228256|FG000|NOT COMPLETED|Overall Study||0
10099159|NCT02389361|11228262|FG000|STARTED|Overall Study||24
9976300|NCT01570491|11097713|FG001|NOT COMPLETED|Overall Study||1
10099160|NCT02389361|11228263|FG001|STARTED|Overall Study||27
10099161|NCT02389361|11228262|FG000|COMPLETED|Overall Study||24
10099162|NCT02389361|11228263|FG001|COMPLETED|Overall Study||27
10099163|NCT02389361|11228262|FG000|NOT COMPLETED|Overall Study||0
10099164|NCT02389361|11228263|FG001|NOT COMPLETED|Overall Study||0
10099165|NCT02389452|11228269|FG000|STARTED|Overall Study||394
10099166|NCT02389452|11228269|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
10099167|NCT02389452|11228269|FG000|COMPLETED|Overall Study||369
10099168|NCT02389452|11228269|FG000|NOT COMPLETED|Overall Study||25
10099169|NCT02389621|11228276|FG000|STARTED|Treatment Period||108
10099170|NCT02389621|11228277|FG001|STARTED|Treatment Period||107
10099171|NCT02389621|11228276|FG000|Received Study Drug|Treatment Period||107
10099172|NCT02389621|11228277|FG001|Received Study Drug|Treatment Period||107
10099173|NCT02389621|11228276|FG000|COMPLETED|Treatment Period||107
9976301|NCT01570686|11097721|FG000|STARTED|Overall Study||296
9976302|NCT01570686|11097722|FG001|STARTED|Overall Study||294
10017804|NCT01819311|11140777|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2
9976303|NCT01570686|11097721|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
9976304|NCT01570686|11097722|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294
9976305|NCT01570686|11097721|FG000|COMPLETED|Overall Study||274
9976306|NCT01570686|11097722|FG001|COMPLETED|Overall Study||278
9976307|NCT01570686|11097721|FG000|NOT COMPLETED|Overall Study||22
9976308|NCT01570686|11097722|FG001|NOT COMPLETED|Overall Study||16
9976309|NCT01570751|11097730|FG000|STARTED|Period A (16 Weeks)||73
9976310|NCT01570751|11097731|FG001|STARTED|Period A (16 Weeks)||72
9976311|NCT01570751|11097730|FG000|Exposed|Period A (16 Weeks)||73
9976312|NCT01570751|11097731|FG001|Exposed|Period A (16 Weeks)||72
9976313|NCT01570751|11097730|FG000|COMPLETED|Period A (16 Weeks)||70
9976314|NCT01570751|11097731|FG001|COMPLETED|Period A (16 Weeks)||67
9976315|NCT01570751|11097730|FG000|NOT COMPLETED|Period A (16 Weeks)||3
9976316|NCT01570751|11097731|FG001|NOT COMPLETED|Period A (16 Weeks)||5
9976317|NCT01570751|11097730|FG000|STARTED|Period B (16 Weeks)||70
9976318|NCT01570751|11097731|FG001|STARTED|Period B (16 Weeks)||67
9976319|NCT01570751|11097730|FG000|Exposed|Period B (16 Weeks)||70
9976320|NCT01570751|11097731|FG001|Exposed|Period B (16 Weeks)||67
9976321|NCT01570751|11097730|FG000|COMPLETED|Period B (16 Weeks)||69
9976322|NCT01570751|11097731|FG001|COMPLETED|Period B (16 Weeks)||66
9976323|NCT01570751|11097730|FG000|NOT COMPLETED|Period B (16 Weeks)||1
9976324|NCT01570751|11097731|FG001|NOT COMPLETED|Period B (16 Weeks)||1
9976325|NCT01570829|11097741|FG000|STARTED|Overall Study||164
9976326|NCT01570829|11097742|FG001|STARTED|Overall Study||167
9976327|NCT01570829|11097741|FG000|COMPLETED|Overall Study||164
9976328|NCT01570829|11097742|FG001|COMPLETED|Overall Study||167
9976329|NCT01570829|11097741|FG000|NOT COMPLETED|Overall Study||0
9976330|NCT01570829|11097742|FG001|NOT COMPLETED|Overall Study||0
9976331|NCT01570868|11097750|FG000|STARTED|Overall Study||43
9976332|NCT01570868|11097751|FG001|STARTED|Overall Study||8
9976333|NCT01570868|11097750|FG000|COMPLETED|Overall Study||0
9976334|NCT01570868|11097751|FG001|COMPLETED|Overall Study||0
9976335|NCT01570868|11097750|FG000|NOT COMPLETED|Overall Study||43
9976336|NCT01570868|11097751|FG001|NOT COMPLETED|Overall Study||8
9976337|NCT01571232|11097763|FG000|STARTED|Overall Study||10
9976338|NCT01571232|11097764|FG001|STARTED|Overall Study||10
9976339|NCT01571232|11097763|FG000|COMPLETED|Overall Study||9
9976340|NCT01571232|11097764|FG001|COMPLETED|Overall Study||9
9976341|NCT01571232|11097763|FG000|NOT COMPLETED|Overall Study||1
9976342|NCT01571232|11097764|FG001|NOT COMPLETED|Overall Study||1
9976343|NCT01571284|11097771|FG000|STARTED|Overall Study||781
10099174|NCT02389621|11228277|FG001|COMPLETED|Treatment Period||106
10099175|NCT02389621|11228276|FG000|NOT COMPLETED|Treatment Period||1
10099176|NCT02389621|11228277|FG001|NOT COMPLETED|Treatment Period||1
10099177|NCT02389621|11228276|FG000|STARTED|Posttreatment Period||107
10099178|NCT02389621|11228277|FG001|STARTED|Posttreatment Period||106
10099179|NCT02389621|11228276|FG000|COMPLETED|Posttreatment Period||98
10099180|NCT02389621|11228277|FG001|COMPLETED|Posttreatment Period||102
10099181|NCT02389621|11228276|FG000|NOT COMPLETED|Posttreatment Period||9
10099182|NCT02389621|11228277|FG001|NOT COMPLETED|Posttreatment Period||4
10099183|NCT02389725|11228289|FG000|STARTED|Overall Study||59
10099184|NCT02389725|11228290|FG001|STARTED|Overall Study||60
10099185|NCT02389725|11228289|FG000|COMPLETED|Overall Study||59
10099186|NCT02389725|11228290|FG001|COMPLETED|Overall Study||60
10099187|NCT02389725|11228289|FG000|NOT COMPLETED|Overall Study||0
10099188|NCT02389725|11228290|FG001|NOT COMPLETED|Overall Study||0
10099189|NCT02389738|11228298|FG000|STARTED|Overall Study||6
10099190|NCT02389738|11228298|FG000|COMPLETED|Overall Study||5
10099191|NCT02389738|11228298|FG000|NOT COMPLETED|Overall Study||1
10099192|NCT02389764|11228302|FG000|STARTED|Overall Study||9
10099193|NCT02389764|11228302|FG000|COMPLETED|Overall Study||0
10099194|NCT02389764|11228302|FG000|NOT COMPLETED|Overall Study||9
10099195|NCT02389816|11228309|FG000|STARTED|Overall Study||164
10099196|NCT02389816|11228310|FG001|STARTED|Overall Study||165
10099197|NCT02389816|11228311|FG002|STARTED|Overall Study||164
10099198|NCT02389816|11228309|FG000|COMPLETED|Overall Study||149
10099199|NCT02389816|11228310|FG001|COMPLETED|Overall Study||152
10099200|NCT02389816|11228311|FG002|COMPLETED|Overall Study||152
10099201|NCT02389816|11228309|FG000|NOT COMPLETED|Overall Study||15
10099202|NCT02389816|11228310|FG001|NOT COMPLETED|Overall Study||13
10099203|NCT02389816|11228311|FG002|NOT COMPLETED|Overall Study||12
10099204|NCT02389829|11228321|FG000|STARTED|Overall Study||64
10099205|NCT02389829|11228322|FG001|STARTED|Overall Study||63
10202031|NCT03441984|11329281|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10099206|NCT02389829|11228321|FG000|COMPLETED|Overall Study||64
10099207|NCT02389829|11228322|FG001|COMPLETED|Overall Study||62
10099208|NCT02389829|11228321|FG000|NOT COMPLETED|Overall Study||0
10099209|NCT02389829|11228322|FG001|NOT COMPLETED|Overall Study||1
10099210|NCT02389881|11228335|FG000|STARTED|Overall Study||6
10099211|NCT02389881|11228336|FG001|STARTED|Overall Study||6
10099212|NCT02389881|11228337|FG002|STARTED|Overall Study||6
9976344|NCT01571284|11097771|FG000|Safety Population|Overall Study||779
9976345|NCT01571284|11097771|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
9976346|NCT01571284|11097771|FG000|NOT COMPLETED|Overall Study||169
9976347|NCT01571362|11097775|FG000|STARTED|Open-Label Conversion + Titration Period||410
9976348|NCT01571362|11097776|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
10017805|NCT01819311|11140778|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1
10099213|NCT02389881|11228338|FG003|STARTED|Overall Study||6
9976349|NCT01571362|11097777|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
9976350|NCT01571362|11097775|FG000|COMPLETED|Open-Label Conversion + Titration Period||281
9976351|NCT01571362|11097776|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
9976352|NCT01571362|11097777|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
9976353|NCT01571362|11097775|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129
9976354|NCT01571362|11097776|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0
9976355|NCT01571362|11097777|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0
9976356|NCT01571362|11097775|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
9976357|NCT01571362|11097776|FG001|STARTED|Double-Blind Treatment Period||134
9976358|NCT01571362|11097777|FG002|STARTED|Double-Blind Treatment Period||146
9976359|NCT01571362|11097775|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
9976360|NCT01571362|11097776|FG001|COMPLETED|Double-Blind Treatment Period||81
9976361|NCT01571362|11097777|FG002|COMPLETED|Double-Blind Treatment Period||107
9976362|NCT01571362|11097775|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
9976363|NCT01571362|11097776|FG001|NOT COMPLETED|Double-Blind Treatment Period||53
9976364|NCT01571362|11097777|FG002|NOT COMPLETED|Double-Blind Treatment Period||39
9976365|NCT01571427|11097787|FG000|STARTED|Overall Study||41
9976366|NCT01571427|11097788|FG001|STARTED|Overall Study||42
9976367|NCT01571427|11097787|FG000|COMPLETED|Overall Study||41
9976368|NCT01571427|11097788|FG001|COMPLETED|Overall Study||42
10099214|NCT02389881|11228339|FG004|STARTED|Overall Study||6
10099215|NCT02389881|11228340|FG005|STARTED|Overall Study||8
10099216|NCT02389881|11228341|FG006|STARTED|Overall Study||2
10099217|NCT02389881|11228335|FG000|COMPLETED|Overall Study||6
10099218|NCT02389881|11228336|FG001|COMPLETED|Overall Study||6
10099219|NCT02389881|11228337|FG002|COMPLETED|Overall Study||6
10099220|NCT02389881|11228338|FG003|COMPLETED|Overall Study||6
10099221|NCT02389881|11228339|FG004|COMPLETED|Overall Study||6
10099222|NCT02389881|11228340|FG005|COMPLETED|Overall Study||8
10099223|NCT02389881|11228341|FG006|COMPLETED|Overall Study||2
10099224|NCT02389881|11228335|FG000|NOT COMPLETED|Overall Study||0
10099225|NCT02389881|11228336|FG001|NOT COMPLETED|Overall Study||0
10099226|NCT02389881|11228337|FG002|NOT COMPLETED|Overall Study||0
10099227|NCT02389881|11228338|FG003|NOT COMPLETED|Overall Study||0
10099228|NCT02389881|11228339|FG004|NOT COMPLETED|Overall Study||0
10099229|NCT02389881|11228340|FG005|NOT COMPLETED|Overall Study||0
10099230|NCT02389881|11228341|FG006|NOT COMPLETED|Overall Study||0
10113121|NCT02508428|11244056|FG001|NOT COMPLETED|Overall Study||67
10113122|NCT02508480|11244064|FG000|STARTED|Overall Study||95
10113123|NCT02508480|11244065|FG001|STARTED|Overall Study||97
10113124|NCT02508480|11244064|FG000|Post-Treatment Assessment|Overall Study||87
10113125|NCT02508480|11244065|FG001|Post-Treatment Assessment|Overall Study||89
10113126|NCT02508480|11244064|FG000|Three Month Follow-up|Overall Study||84
10113127|NCT02508480|11244065|FG001|Three Month Follow-up|Overall Study||86
10113128|NCT02508480|11244064|FG000|Six-Month Follow-Up|Overall Study||84
10113129|NCT02508480|11244065|FG001|Six-Month Follow-Up|Overall Study||86
10113130|NCT02508480|11244064|FG000|COMPLETED|Overall Study||90
10113131|NCT02508480|11244065|FG001|COMPLETED|Overall Study||93
10113132|NCT02508480|11244064|FG000|NOT COMPLETED|Overall Study||5
10113133|NCT02508480|11244065|FG001|NOT COMPLETED|Overall Study||4
10113134|NCT02508636|11244071|FG000|STARTED|Overall Study||11
10113135|NCT02508636|11244071|FG000|COMPLETED|Overall Study||11
10113136|NCT02508636|11244071|FG000|NOT COMPLETED|Overall Study||0
10113137|NCT02508649|11244079|FG000|STARTED|Overall Study||283
10113138|NCT02508649|11244080|FG001|STARTED|Overall Study||197
10113139|NCT02508649|11244081|FG002|STARTED|Overall Study||189
10113140|NCT02508649|11244082|FG003|STARTED|Overall Study||199
10113141|NCT02508649|11244079|FG000|Dosed|Overall Study||266
10113142|NCT02508649|11244080|FG001|Dosed|Overall Study||191
10113143|NCT02508649|11244081|FG002|Dosed|Overall Study||177
10113144|NCT02508649|11244082|FG003|Dosed|Overall Study||194
10113145|NCT02508649|11244079|FG000|COMPLETED|Overall Study||265
10113146|NCT02508649|11244080|FG001|COMPLETED|Overall Study||184
10113147|NCT02508649|11244081|FG002|COMPLETED|Overall Study||174
10113148|NCT02508649|11244082|FG003|COMPLETED|Overall Study||189
10113149|NCT02508649|11244079|FG000|NOT COMPLETED|Overall Study||18
10113150|NCT02508649|11244080|FG001|NOT COMPLETED|Overall Study||13
9976369|NCT01571427|11097787|FG000|NOT COMPLETED|Overall Study||0
9976370|NCT01571427|11097788|FG001|NOT COMPLETED|Overall Study||0
9976371|NCT01571453|11097796|FG000|STARTED|Overall Study||211
9976372|NCT01571453|11097797|FG001|STARTED|Overall Study||226
9976373|NCT01571453|11097796|FG000|COMPLETED|Overall Study||173
9976374|NCT01571453|11097797|FG001|COMPLETED|Overall Study||164
10113151|NCT02508649|11244081|FG002|NOT COMPLETED|Overall Study||15
10113152|NCT02508649|11244082|FG003|NOT COMPLETED|Overall Study||10
10113153|NCT02508701|11244099|FG000|STARTED|Overall Study||9
10113154|NCT02508701|11244100|FG001|STARTED|Overall Study||6
10113155|NCT02508701|11244101|FG002|STARTED|Overall Study||5
10113156|NCT02508701|11244102|FG003|STARTED|Overall Study||4
10113157|NCT02508701|11244099|FG000|COMPLETED|Overall Study||0
10113158|NCT02508701|11244100|FG001|COMPLETED|Overall Study||1
10113159|NCT02508701|11244101|FG002|COMPLETED|Overall Study||0
10113160|NCT02508701|11244102|FG003|COMPLETED|Overall Study||1
10113161|NCT02508701|11244099|FG000|NOT COMPLETED|Overall Study||9
10113162|NCT02508701|11244100|FG001|NOT COMPLETED|Overall Study||5
9976375|NCT01571453|11097796|FG000|NOT COMPLETED|Overall Study||38
9976376|NCT01571453|11097797|FG001|NOT COMPLETED|Overall Study||62
9976377|NCT01571557|11097803|FG000|STARTED|Overall Study||573
9976378|NCT01571557|11097803|FG000|COMPLETED|Overall Study||573
9976379|NCT01571557|11097803|FG000|NOT COMPLETED|Overall Study||0
9976380|NCT01571596|11097810|FG000|STARTED|Overall Study||21
9976381|NCT01571596|11097811|FG001|STARTED|Overall Study||1
9976382|NCT01571596|11097812|FG002|STARTED|Overall Study||1
9976383|NCT01571596|11097810|FG000|COMPLETED|Overall Study||19
9976384|NCT01571596|11097811|FG001|COMPLETED|Overall Study||0
9976385|NCT01571596|11097812|FG002|COMPLETED|Overall Study||0
9976386|NCT01571596|11097810|FG000|NOT COMPLETED|Overall Study||2
10099231|NCT02389894|11228360|FG000|STARTED|Overall Study||133
10099232|NCT02389894|11228361|FG001|STARTED|Overall Study||118
10099233|NCT02389894|11228362|FG002|STARTED|Overall Study||132
10099234|NCT02389894|11228360|FG000|COMPLETED|Overall Study||125
10099235|NCT02389894|11228361|FG001|COMPLETED|Overall Study||108
10099236|NCT02389894|11228362|FG002|COMPLETED|Overall Study||123
10099237|NCT02389894|11228360|FG000|NOT COMPLETED|Overall Study||8
10099238|NCT02389894|11228361|FG001|NOT COMPLETED|Overall Study||10
10099239|NCT02389894|11228362|FG002|NOT COMPLETED|Overall Study||9
10099240|NCT02389959|11228372|FG000|STARTED|Overall Study||20
10099241|NCT02389959|11228373|FG001|STARTED|Overall Study||20
10099242|NCT02389959|11228372|FG000|COMPLETED|Overall Study||18
10099243|NCT02389959|11228373|FG001|COMPLETED|Overall Study||19
10099244|NCT02389959|11228372|FG000|NOT COMPLETED|Overall Study||2
10099245|NCT02389959|11228373|FG001|NOT COMPLETED|Overall Study||1
10099246|NCT02389998|11228381|FG000|STARTED|Overall Study||16
10099247|NCT02389998|11228382|FG001|STARTED|Overall Study||15
10099248|NCT02389998|11228381|FG000|COMPLETED|Overall Study||15
10099249|NCT02389998|11228382|FG001|COMPLETED|Overall Study||15
10099250|NCT02389998|11228381|FG000|NOT COMPLETED|Overall Study||1
10099251|NCT02389998|11228382|FG001|NOT COMPLETED|Overall Study||0
10099252|NCT02390050|11228394|FG000|STARTED|Overall Study||72
10099253|NCT02390050|11228395|FG001|STARTED|Overall Study||72
10099254|NCT02390050|11228396|FG002|STARTED|Overall Study||72
10099255|NCT02390050|11228397|FG003|STARTED|Overall Study||76
10099256|NCT02390050|11228394|FG000|COMPLETED|Overall Study||65
10099257|NCT02390050|11228395|FG001|COMPLETED|Overall Study||67
10099258|NCT02390050|11228396|FG002|COMPLETED|Overall Study||68
10099259|NCT02390050|11228397|FG003|COMPLETED|Overall Study||69
10099260|NCT02390050|11228394|FG000|NOT COMPLETED|Overall Study||7
10099261|NCT02390050|11228395|FG001|NOT COMPLETED|Overall Study||5
10099262|NCT02390050|11228396|FG002|NOT COMPLETED|Overall Study||4
10099263|NCT02390050|11228397|FG003|NOT COMPLETED|Overall Study||7
10099264|NCT02390076|11228410|FG000|STARTED|Overall Study||18
10099265|NCT02390076|11228411|FG001|STARTED|Overall Study||18
10099266|NCT02390076|11228412|FG002|STARTED|Overall Study||15
10099267|NCT02390076|11228410|FG000|COMPLETED|Overall Study||16
10099268|NCT02390076|11228411|FG001|COMPLETED|Overall Study||17
10099269|NCT02390076|11228412|FG002|COMPLETED|Overall Study||11
10099270|NCT02390076|11228410|FG000|NOT COMPLETED|Overall Study||2
10099271|NCT02390076|11228411|FG001|NOT COMPLETED|Overall Study||1
10099272|NCT02390076|11228412|FG002|NOT COMPLETED|Overall Study||4
10099273|NCT02390167|11228420|FG000|STARTED|Overall Study||376
10099274|NCT02390167|11228420|FG000|With Diabetes|Overall Study||333
10099275|NCT02390167|11228420|FG000|Without Diabetes|Overall Study||43
10099276|NCT02390167|11228420|FG000|COMPLETED|Overall Study||375
10099277|NCT02390167|11228420|FG000|NOT COMPLETED|Overall Study||1
10099278|NCT02390219|11228428|FG000|STARTED|Overall Study||46
10099279|NCT02390219|11228428|FG000|COMPLETED|Overall Study||33
10099280|NCT02390219|11228428|FG000|NOT COMPLETED|Overall Study||13
10099281|NCT02390557|11228435|FG000|STARTED|Wave 1||160
10099282|NCT02390557|11228436|FG001|STARTED|Wave 1||156
10099283|NCT02390557|11228437|FG002|STARTED|Wave 1||135
10099284|NCT02390557|11228435|FG000|COMPLETED|Wave 1||160
10099285|NCT02390557|11228436|FG001|COMPLETED|Wave 1||156
9976387|NCT01571596|11097811|FG001|NOT COMPLETED|Overall Study||1
9976388|NCT01571596|11097812|FG002|NOT COMPLETED|Overall Study||1
9976389|NCT01572038|11097822|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436
9976390|NCT01572038|11097822|FG000|Received at Least One Dose of Study Drug|Overall Study||1436
9976391|NCT01572038|11097822|FG000|COMPLETED|Overall Study||445
9976392|NCT01572038|11097822|FG000|NOT COMPLETED|Overall Study||991
9976393|NCT01572298|11097850|FG000|STARTED|Overall Study||14
10099286|NCT02390557|11228437|FG002|COMPLETED|Wave 1||135
10099287|NCT02390557|11228435|FG000|NOT COMPLETED|Wave 1||0
10099288|NCT02390557|11228436|FG001|NOT COMPLETED|Wave 1||0
10099289|NCT02390557|11228437|FG002|NOT COMPLETED|Wave 1||0
10099290|NCT02390557|11228435|FG000|STARTED|Wave 2||160
10099291|NCT02390557|11228436|FG001|STARTED|Wave 2||156
10099292|NCT02390557|11228437|FG002|STARTED|Wave 2||135
10099293|NCT02390557|11228435|FG000|COMPLETED|Wave 2||88
10099294|NCT02390557|11228436|FG001|COMPLETED|Wave 2||115
9976394|NCT01572298|11097851|FG001|STARTED|Overall Study||13
9976395|NCT01572298|11097850|FG000|COMPLETED|Overall Study||12
9976396|NCT01572298|11097851|FG001|COMPLETED|Overall Study||12
10099295|NCT02390557|11228437|FG002|COMPLETED|Wave 2||112
10099296|NCT02390557|11228435|FG000|NOT COMPLETED|Wave 2||72
10099297|NCT02390557|11228436|FG001|NOT COMPLETED|Wave 2||41
10099298|NCT02390557|11228437|FG002|NOT COMPLETED|Wave 2||23
10099299|NCT02390791|11228447|FG000|STARTED|Overall Study||40
10099300|NCT02390791|11228448|FG001|STARTED|Overall Study||45
10099301|NCT02390791|11228447|FG000|COMPLETED|Overall Study||40
10099302|NCT02390791|11228448|FG001|COMPLETED|Overall Study||45
9976397|NCT01572298|11097850|FG000|NOT COMPLETED|Overall Study||2
9976398|NCT01572298|11097851|FG001|NOT COMPLETED|Overall Study||1
9976399|NCT01572389|11097861|FG000|STARTED|Overall Study||136
9976400|NCT01572389|11097862|FG001|STARTED|Overall Study||89
9976401|NCT01572389|11097861|FG000|COMPLETED|Overall Study||90
9976402|NCT01572389|11097862|FG001|COMPLETED|Overall Study||68
9976403|NCT01572389|11097861|FG000|NOT COMPLETED|Overall Study||46
9976404|NCT01572389|11097862|FG001|NOT COMPLETED|Overall Study||21
9976405|NCT01572428|11097870|FG000|STARTED|Overall Study||402
9976406|NCT01572428|11097871|FG001|STARTED|Overall Study||402
9976407|NCT01572428|11097870|FG000|COMPLETED|Overall Study||399
9976408|NCT01572428|11097871|FG001|COMPLETED|Overall Study||401
9976409|NCT01572428|11097870|FG000|NOT COMPLETED|Overall Study||3
9976410|NCT01572428|11097871|FG001|NOT COMPLETED|Overall Study||1
9976411|NCT01572727|11097879|FG000|STARTED|Overall Study||207
9976412|NCT01572727|11097880|FG001|STARTED|Overall Study||209
9976413|NCT01572727|11097879|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
9976414|NCT01572727|11097880|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
9976415|NCT01572727|11097879|FG000|COMPLETED|Overall Study||0
9976416|NCT01572727|11097880|FG001|COMPLETED|Overall Study||0
9976417|NCT01572727|11097879|FG000|NOT COMPLETED|Overall Study||207
9976418|NCT01572727|11097880|FG001|NOT COMPLETED|Overall Study||209
9976419|NCT01572740|11097888|FG000|STARTED|Overall Study||127
9976420|NCT01572740|11097889|FG001|STARTED|Overall Study||130
9976421|NCT01572740|11097888|FG000|COMPLETED|Overall Study||121
9976422|NCT01572740|11097889|FG001|COMPLETED|Overall Study||125
9976423|NCT01572740|11097888|FG000|NOT COMPLETED|Overall Study||6
9976424|NCT01572740|11097889|FG001|NOT COMPLETED|Overall Study||5
9976425|NCT01572792|11097900|FG000|STARTED|Lead-in Study||337
9976426|NCT01572792|11097901|FG001|STARTED|Lead-in Study||338
9976427|NCT01572792|11097902|FG002|STARTED|Lead-in Study||338
9976428|NCT01572792|11097903|FG003|STARTED|Lead-in Study||340
9976429|NCT01572792|11097904|FG004|STARTED|Lead-in Study||339
9976430|NCT01572792|11097900|FG000|COMPLETED|Lead-in Study||236
9976431|NCT01572792|11097901|FG001|COMPLETED|Lead-in Study||272
9976432|NCT01572792|11097902|FG002|COMPLETED|Lead-in Study||276
9976433|NCT01572792|11097903|FG003|COMPLETED|Lead-in Study||268
9976434|NCT01572792|11097904|FG004|COMPLETED|Lead-in Study||270
9976435|NCT01572792|11097900|FG000|NOT COMPLETED|Lead-in Study||101
9976436|NCT01572792|11097901|FG001|NOT COMPLETED|Lead-in Study||66
9976437|NCT01572792|11097902|FG002|NOT COMPLETED|Lead-in Study||62
9976438|NCT01572792|11097903|FG003|NOT COMPLETED|Lead-in Study||72
9976439|NCT01572792|11097904|FG004|NOT COMPLETED|Lead-in Study||69
9976440|NCT01572792|11097900|FG000|STARTED|Extension Study||146
9976441|NCT01572792|11097901|FG001|STARTED|Extension Study||184
9976442|NCT01572792|11097902|FG002|STARTED|Extension Study||205
9976443|NCT01572792|11097903|FG003|STARTED|Extension Study||194
9976444|NCT01572792|11097904|FG004|STARTED|Extension Study||192
9976445|NCT01572792|11097900|FG000|COMPLETED|Extension Study||121
9976446|NCT01572792|11097901|FG001|COMPLETED|Extension Study||155
9976447|NCT01572792|11097902|FG002|COMPLETED|Extension Study||179
9976448|NCT01572792|11097903|FG003|COMPLETED|Extension Study||165
9976449|NCT01572792|11097904|FG004|COMPLETED|Extension Study||160
10099303|NCT02390791|11228447|FG000|NOT COMPLETED|Overall Study||0
10099304|NCT02390791|11228448|FG001|NOT COMPLETED|Overall Study||0
10099305|NCT02390908|11228459|FG000|STARTED|Overall Study||40
10099306|NCT02390908|11228460|FG001|STARTED|Overall Study||22
10099307|NCT02390908|11228461|FG002|STARTED|Overall Study||22
10099308|NCT02390908|11228462|FG003|STARTED|Overall Study||90
10099309|NCT02390908|11228463|FG004|STARTED|Overall Study||120
10099310|NCT02390908|11228459|FG000|COMPLETED|Overall Study||40
10099311|NCT02390908|11228460|FG001|COMPLETED|Overall Study||22
9976450|NCT01572792|11097900|FG000|NOT COMPLETED|Extension Study||25
9976451|NCT01572792|11097901|FG001|NOT COMPLETED|Extension Study||29
9976452|NCT01572792|11097902|FG002|NOT COMPLETED|Extension Study||26
9976453|NCT01572792|11097903|FG003|NOT COMPLETED|Extension Study||29
9976454|NCT01572792|11097904|FG004|NOT COMPLETED|Extension Study||32
9976455|NCT01572844|11097917|FG000|STARTED|Overall Study||3
9976456|NCT01572844|11097918|FG001|STARTED|Overall Study||3
9976457|NCT01572844|11097917|FG000|COMPLETED|Overall Study||2
9976458|NCT01572844|11097918|FG001|COMPLETED|Overall Study||2
9976459|NCT01572844|11097917|FG000|NOT COMPLETED|Overall Study||1
9976460|NCT01572844|11097918|FG001|NOT COMPLETED|Overall Study||1
9976461|NCT01572909|11097929|FG000|STARTED|Overall Study||152
9976462|NCT01572909|11097930|FG001|STARTED|Overall Study||148
9976463|NCT01572909|11097929|FG000|COMPLETED|Overall Study||120
9976464|NCT01572909|11097930|FG001|COMPLETED|Overall Study||123
10099312|NCT02390908|11228461|FG002|COMPLETED|Overall Study||22
10099313|NCT02390908|11228462|FG003|COMPLETED|Overall Study||90
9976465|NCT01572909|11097929|FG000|NOT COMPLETED|Overall Study||32
9976466|NCT01572909|11097930|FG001|NOT COMPLETED|Overall Study||25
9976467|NCT01572922|11097938|FG000|STARTED|Overall Study||142
9976468|NCT01572922|11097938|FG000|COMPLETED|Overall Study||139
9976469|NCT01572922|11097938|FG000|NOT COMPLETED|Overall Study||3
9976470|NCT01572948|11097949|FG000|STARTED|Overall Study||11
9976471|NCT01572948|11097950|FG001|STARTED|Overall Study||16
9976472|NCT01572948|11097949|FG000|COMPLETED|Overall Study||10
9976473|NCT01572948|11097950|FG001|COMPLETED|Overall Study||15
10099314|NCT02390908|11228463|FG004|COMPLETED|Overall Study||120
10099315|NCT02390908|11228459|FG000|NOT COMPLETED|Overall Study||0
10099316|NCT02390908|11228460|FG001|NOT COMPLETED|Overall Study||0
9976474|NCT01572948|11097949|FG000|NOT COMPLETED|Overall Study||1
9976475|NCT01572948|11097950|FG001|NOT COMPLETED|Overall Study||1
9976476|NCT01573000|11097962|FG000|STARTED|Dosimetric and Therapeutic Treatment||42
9976477|NCT01573000|11097963|FG001|STARTED|Dosimetric and Therapeutic Treatment||36
9976478|NCT01573000|11097962|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
9976479|NCT01573000|11097963|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
9976480|NCT01573000|11097962|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
9976481|NCT01573000|11097963|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
9976482|NCT01573000|11097962|FG000|STARTED|Crossover Phase||0
9976483|NCT01573000|11097963|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
9976484|NCT01573000|11097962|FG000|COMPLETED|Crossover Phase||0
9976485|NCT01573000|11097963|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
9976486|NCT01573000|11097962|FG000|NOT COMPLETED|Crossover Phase||0
9976487|NCT01573000|11097963|FG001|NOT COMPLETED|Crossover Phase||18
9976488|NCT01573000|11097962|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
9976489|NCT01573000|11097963|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
9976490|NCT01573000|11097962|FG000|COMPLETED|Long-Term Follow-Up||11
9976491|NCT01573000|11097963|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
9976492|NCT01573000|11097962|FG000|NOT COMPLETED|Long-Term Follow-Up||3
9976493|NCT01573000|11097963|FG001|NOT COMPLETED|Long-Term Follow-Up||1
9976494|NCT01573052|11097975|FG000|STARTED|Overall Study||9
9976495|NCT01573052|11097976|FG001|STARTED|Overall Study||17
9976496|NCT01573052|11097975|FG000|COMPLETED|Overall Study||6
9976497|NCT01573052|11097976|FG001|COMPLETED|Overall Study||11
9976498|NCT01573052|11097975|FG000|NOT COMPLETED|Overall Study||3
9976499|NCT01573052|11097976|FG001|NOT COMPLETED|Overall Study||6
9976500|NCT01573169|11097985|FG000|STARTED|Overall Study||38
9976501|NCT01573169|11097986|FG001|STARTED|Overall Study||35
9976502|NCT01573169|11097985|FG000|COMPLETED|Overall Study||38
9976503|NCT01573169|11097986|FG001|COMPLETED|Overall Study||35
9976504|NCT01573169|11097985|FG000|NOT COMPLETED|Overall Study||0
9976505|NCT01573169|11097986|FG001|NOT COMPLETED|Overall Study||0
9976506|NCT01573260|11097994|FG000|STARTED|Overall Study||18
9976507|NCT01573260|11097995|FG001|STARTED|Overall Study||15
9976508|NCT01573260|11097994|FG000|COMPLETED|Overall Study||18
9976509|NCT01573260|11097995|FG001|COMPLETED|Overall Study||15
10099317|NCT02390908|11228461|FG002|NOT COMPLETED|Overall Study||0
10099318|NCT02390908|11228462|FG003|NOT COMPLETED|Overall Study||0
10099319|NCT02390908|11228463|FG004|NOT COMPLETED|Overall Study||0
10099320|NCT02391038|11228480|FG000|STARTED|Overall Study||3
10099321|NCT02391038|11228481|FG001|STARTED|Overall Study||3
10099322|NCT02391038|11228482|FG002|STARTED|Overall Study||6
9976510|NCT01573260|11097994|FG000|NOT COMPLETED|Overall Study||0
9976511|NCT01573260|11097995|FG001|NOT COMPLETED|Overall Study||0
9976512|NCT01573273|11098007|FG000|STARTED|TSST : Trier Social Stress Task||24
9976513|NCT01573273|11098008|FG001|STARTED|TSST : Trier Social Stress Task||25
9976514|NCT01573273|11098009|FG002|STARTED|TSST : Trier Social Stress Task||0
9976515|NCT01573273|11098010|FG003|STARTED|TSST : Trier Social Stress Task||0
9976516|NCT01573273|11098011|FG004|STARTED|TSST : Trier Social Stress Task||0
9976517|NCT01573273|11098012|FG005|STARTED|TSST : Trier Social Stress Task||0
9976518|NCT01573273|11098013|FG006|STARTED|TSST : Trier Social Stress Task||32
9976519|NCT01573273|11098014|FG007|STARTED|TSST : Trier Social Stress Task||31
9976520|NCT01573273|11098015|FG008|STARTED|TSST : Trier Social Stress Task||0
9976521|NCT01573273|11098016|FG009|STARTED|TSST : Trier Social Stress Task||0
9976522|NCT01573273|11098017|FG010|STARTED|TSST : Trier Social Stress Task||0
9976523|NCT01573273|11098018|FG011|STARTED|TSST : Trier Social Stress Task||0
9976524|NCT01573273|11098007|FG000|COMPLETED|TSST : Trier Social Stress Task||24
9976525|NCT01573273|11098008|FG001|COMPLETED|TSST : Trier Social Stress Task||25
9976526|NCT01573273|11098009|FG002|COMPLETED|TSST : Trier Social Stress Task||0
9976527|NCT01573273|11098010|FG003|COMPLETED|TSST : Trier Social Stress Task||0
9976528|NCT01573273|11098011|FG004|COMPLETED|TSST : Trier Social Stress Task||0
9976529|NCT01573273|11098012|FG005|COMPLETED|TSST : Trier Social Stress Task||0
9976530|NCT01573273|11098013|FG006|COMPLETED|TSST : Trier Social Stress Task||32
9976531|NCT01573273|11098014|FG007|COMPLETED|TSST : Trier Social Stress Task||31
9976532|NCT01573273|11098015|FG008|COMPLETED|TSST : Trier Social Stress Task||0
9976533|NCT01573273|11098016|FG009|COMPLETED|TSST : Trier Social Stress Task||0
9976534|NCT01573273|11098017|FG010|COMPLETED|TSST : Trier Social Stress Task||0
9976535|NCT01573273|11098018|FG011|COMPLETED|TSST : Trier Social Stress Task||0
9976536|NCT01573273|11098007|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976537|NCT01573273|11098008|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976538|NCT01573273|11098009|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976539|NCT01573273|11098010|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976540|NCT01573273|11098011|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976541|NCT01573273|11098012|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976542|NCT01573273|11098013|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0
10099323|NCT02391038|11228480|FG000|COMPLETED|Overall Study||0
10099324|NCT02391038|11228481|FG001|COMPLETED|Overall Study||0
9976543|NCT01573273|11098014|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976544|NCT01573273|11098015|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0
10099325|NCT02391038|11228482|FG002|COMPLETED|Overall Study||0
10099326|NCT02391038|11228480|FG000|NOT COMPLETED|Overall Study||3
10099327|NCT02391038|11228481|FG001|NOT COMPLETED|Overall Study||3
10099328|NCT02391038|11228482|FG002|NOT COMPLETED|Overall Study||6
10099329|NCT02391116|11228491|FG000|STARTED|Treatment||67
10099330|NCT02391116|11228491|FG000|Included in Per Protocol Set|Treatment||40
10099331|NCT02391116|11228491|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
10099332|NCT02391116|11228491|FG000|NOT COMPLETED|Treatment||14
10099333|NCT02391116|11228491|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
10099334|NCT02391116|11228491|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
10099335|NCT02391116|11228491|FG000|NOT COMPLETED|Safety Follow-up||13
10099336|NCT02391116|11228491|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
10099337|NCT02391116|11228491|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
10099338|NCT02391116|11228491|FG000|NOT COMPLETED|Active Follow-up||3
10099339|NCT02391116|11228491|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
10099340|NCT02391116|11228491|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
10099341|NCT02391116|11228491|FG000|NOT COMPLETED|Survival Follow-up||4
10099342|NCT02391311|11228504|FG000|STARTED|Overall Study||21
10099343|NCT02391311|11228505|FG001|STARTED|Overall Study||21
10099344|NCT02391311|11228504|FG000|COMPLETED|Overall Study||18
10099345|NCT02391311|11228505|FG001|COMPLETED|Overall Study||19
10099346|NCT02391311|11228504|FG000|NOT COMPLETED|Overall Study||3
10099347|NCT02391311|11228505|FG001|NOT COMPLETED|Overall Study||2
10099348|NCT02391337|11228513|FG000|STARTED|Baseline||80
10099349|NCT02391337|11228514|FG001|STARTED|Baseline||81
10099350|NCT02391337|11228513|FG000|COMPLETED|Baseline||80
10099351|NCT02391337|11228514|FG001|COMPLETED|Baseline||81
10099352|NCT02391337|11228513|FG000|NOT COMPLETED|Baseline||0
10099353|NCT02391337|11228514|FG001|NOT COMPLETED|Baseline||0
10099354|NCT02391337|11228513|FG000|STARTED|6 Months Follow-up||80
10099355|NCT02391337|11228514|FG001|STARTED|6 Months Follow-up||81
10099356|NCT02391337|11228513|FG000|COMPLETED|6 Months Follow-up||74
10099357|NCT02391337|11228514|FG001|COMPLETED|6 Months Follow-up||76
10099358|NCT02391337|11228513|FG000|NOT COMPLETED|6 Months Follow-up||6
10099359|NCT02391337|11228514|FG001|NOT COMPLETED|6 Months Follow-up||5
10099360|NCT02391337|11228513|FG000|STARTED|12 Months Follow-up||74
10099361|NCT02391337|11228514|FG001|STARTED|12 Months Follow-up||76
10099362|NCT02391337|11228513|FG000|COMPLETED|12 Months Follow-up||72
10099363|NCT02391337|11228514|FG001|COMPLETED|12 Months Follow-up||73
10099364|NCT02391337|11228513|FG000|NOT COMPLETED|12 Months Follow-up||2
10099365|NCT02391337|11228514|FG001|NOT COMPLETED|12 Months Follow-up||3
10099366|NCT02391350|11228522|FG000|STARTED|Overall Study||110
10099367|NCT02391350|11228523|FG001|STARTED|Overall Study||110
10099368|NCT02391350|11228522|FG000|4-week Follow-up|Overall Study||106
10099369|NCT02391350|11228523|FG001|4-week Follow-up|Overall Study||105
10099370|NCT02391350|11228522|FG000|6-month Follow-up|Overall Study||100
10099371|NCT02391350|11228523|FG001|6-month Follow-up|Overall Study||96
10099372|NCT02391350|11228522|FG000|COMPLETED|Overall Study||98
10099373|NCT02391350|11228523|FG001|COMPLETED|Overall Study||93
10099374|NCT02391350|11228522|FG000|NOT COMPLETED|Overall Study||12
10099375|NCT02391350|11228523|FG001|NOT COMPLETED|Overall Study||17
10099376|NCT02391363|11228531|FG000|STARTED|Overall Study||70
10099377|NCT02391363|11228532|FG001|STARTED|Overall Study||64
10099378|NCT02391363|11228531|FG000|COMPLETED|Overall Study||59
10099379|NCT02391363|11228532|FG001|COMPLETED|Overall Study||56
10099380|NCT02391363|11228531|FG000|NOT COMPLETED|Overall Study||11
10099381|NCT02391363|11228532|FG001|NOT COMPLETED|Overall Study||8
10099382|NCT02391545|11228540|FG000|STARTED|Overall Study||27
10099383|NCT02391545|11228541|FG001|STARTED|Overall Study||28
10099384|NCT02391545|11228540|FG000|COMPLETED|Overall Study||1
10099385|NCT02391545|11228541|FG001|COMPLETED|Overall Study||0
10099386|NCT02391545|11228540|FG000|NOT COMPLETED|Overall Study||26
10099387|NCT02391545|11228541|FG001|NOT COMPLETED|Overall Study||28
9976545|NCT01573273|11098016|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976546|NCT01573273|11098017|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976547|NCT01573273|11098018|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0
9976548|NCT01573273|11098007|FG000|STARTED|MRI 1||0
9976549|NCT01573273|11098008|FG001|STARTED|MRI 1||0
9976550|NCT01573273|11098009|FG002|STARTED|MRI 1||19
9976551|NCT01573273|11098010|FG003|STARTED|MRI 1||23
9976552|NCT01573273|11098011|FG004|STARTED|MRI 1||0
9976553|NCT01573273|11098012|FG005|STARTED|MRI 1||0
9976554|NCT01573273|11098013|FG006|STARTED|MRI 1||0
10099388|NCT02391584|11228550|FG000|STARTED|Primary Endpoint (6-weeks)||31
10099389|NCT02391584|11228551|FG001|STARTED|Primary Endpoint (6-weeks)||29
10099390|NCT02391584|11228550|FG000|COMPLETED|Primary Endpoint (6-weeks)||29
10099391|NCT02391584|11228551|FG001|COMPLETED|Primary Endpoint (6-weeks)||27
10099392|NCT02391584|11228550|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2
10099393|NCT02391584|11228551|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2
9976555|NCT01573273|11098014|FG007|STARTED|MRI 1||0
9976556|NCT01573273|11098015|FG008|STARTED|MRI 1||28
9976557|NCT01573273|11098016|FG009|STARTED|MRI 1||29
9976558|NCT01573273|11098017|FG010|STARTED|MRI 1||0
9976559|NCT01573273|11098018|FG011|STARTED|MRI 1||0
9976560|NCT01573273|11098007|FG000|COMPLETED|MRI 1||0
9976561|NCT01573273|11098008|FG001|COMPLETED|MRI 1||0
9976562|NCT01573273|11098009|FG002|COMPLETED|MRI 1||19
9976563|NCT01573273|11098010|FG003|COMPLETED|MRI 1||23
9976564|NCT01573273|11098011|FG004|COMPLETED|MRI 1||0
9976565|NCT01573273|11098012|FG005|COMPLETED|MRI 1||0
9976566|NCT01573273|11098013|FG006|COMPLETED|MRI 1||0
9976567|NCT01573273|11098014|FG007|COMPLETED|MRI 1||0
9976568|NCT01573273|11098015|FG008|COMPLETED|MRI 1||28
9976569|NCT01573273|11098016|FG009|COMPLETED|MRI 1||29
9976570|NCT01573273|11098017|FG010|COMPLETED|MRI 1||0
9976571|NCT01573273|11098018|FG011|COMPLETED|MRI 1||0
9976572|NCT01573273|11098007|FG000|NOT COMPLETED|MRI 1||0
9976573|NCT01573273|11098008|FG001|NOT COMPLETED|MRI 1||0
9976574|NCT01573273|11098009|FG002|NOT COMPLETED|MRI 1||0
9976575|NCT01573273|11098010|FG003|NOT COMPLETED|MRI 1||0
9976576|NCT01573273|11098011|FG004|NOT COMPLETED|MRI 1||0
10099394|NCT02391584|11228550|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
9976577|NCT01573273|11098012|FG005|NOT COMPLETED|MRI 1||0
10099395|NCT02391584|11228551|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
10099396|NCT02391584|11228550|FG000|COMPLETED|3 Month||52
10099397|NCT02391584|11228551|FG001|COMPLETED|3 Month||0
10099398|NCT02391584|11228550|FG000|NOT COMPLETED|3 Month||1
10099399|NCT02391584|11228551|FG001|NOT COMPLETED|3 Month||0
10099400|NCT02391584|11228550|FG000|STARTED|6 Month||52
10099401|NCT02391584|11228551|FG001|STARTED|6 Month||0
10099402|NCT02391584|11228550|FG000|COMPLETED|6 Month||51
10099403|NCT02391584|11228551|FG001|COMPLETED|6 Month||0
10099404|NCT02391584|11228550|FG000|NOT COMPLETED|6 Month||1
10099405|NCT02391584|11228551|FG001|NOT COMPLETED|6 Month||0
10099406|NCT02391584|11228550|FG000|STARTED|12 Month (End of Study)||51
9976578|NCT01573273|11098013|FG006|NOT COMPLETED|MRI 1||0
9976579|NCT01573273|11098014|FG007|NOT COMPLETED|MRI 1||0
9976580|NCT01573273|11098015|FG008|NOT COMPLETED|MRI 1||0
9976581|NCT01573273|11098016|FG009|NOT COMPLETED|MRI 1||0
9976582|NCT01573273|11098017|FG010|NOT COMPLETED|MRI 1||0
9976583|NCT01573273|11098018|FG011|NOT COMPLETED|MRI 1||0
9976584|NCT01573273|11098007|FG000|STARTED|MRI 2||0
9976585|NCT01573273|11098008|FG001|STARTED|MRI 2||0
9976586|NCT01573273|11098009|FG002|STARTED|MRI 2||0
9976587|NCT01573273|11098010|FG003|STARTED|MRI 2||0
9976588|NCT01573273|11098011|FG004|STARTED|MRI 2||23
9976589|NCT01573273|11098012|FG005|STARTED|MRI 2||18
9976590|NCT01573273|11098013|FG006|STARTED|MRI 2||0
9976591|NCT01573273|11098014|FG007|STARTED|MRI 2||0
9976592|NCT01573273|11098015|FG008|STARTED|MRI 2||0
9976593|NCT01573273|11098016|FG009|STARTED|MRI 2||0
9976594|NCT01573273|11098017|FG010|STARTED|MRI 2||27
9976595|NCT01573273|11098018|FG011|STARTED|MRI 2||28
9976596|NCT01573273|11098007|FG000|COMPLETED|MRI 2||0
9976597|NCT01573273|11098008|FG001|COMPLETED|MRI 2||0
9976598|NCT01573273|11098009|FG002|COMPLETED|MRI 2||0
9976599|NCT01573273|11098010|FG003|COMPLETED|MRI 2||0
9976600|NCT01573273|11098011|FG004|COMPLETED|MRI 2||23
9976601|NCT01573273|11098012|FG005|COMPLETED|MRI 2||18
9976602|NCT01573273|11098013|FG006|COMPLETED|MRI 2||0
9976603|NCT01573273|11098014|FG007|COMPLETED|MRI 2||0
9976604|NCT01573273|11098015|FG008|COMPLETED|MRI 2||0
9976605|NCT01573273|11098016|FG009|COMPLETED|MRI 2||0
9976606|NCT01573273|11098017|FG010|COMPLETED|MRI 2||27
9976607|NCT01573273|11098018|FG011|COMPLETED|MRI 2||28
9976608|NCT01573273|11098007|FG000|NOT COMPLETED|MRI 2||0
9976609|NCT01573273|11098008|FG001|NOT COMPLETED|MRI 2||0
9976610|NCT01573273|11098009|FG002|NOT COMPLETED|MRI 2||0
9976611|NCT01573273|11098010|FG003|NOT COMPLETED|MRI 2||0
9976612|NCT01573273|11098011|FG004|NOT COMPLETED|MRI 2||0
9976613|NCT01573273|11098012|FG005|NOT COMPLETED|MRI 2||0
9976614|NCT01573273|11098013|FG006|NOT COMPLETED|MRI 2||0
9976615|NCT01573273|11098014|FG007|NOT COMPLETED|MRI 2||0
9976616|NCT01573273|11098015|FG008|NOT COMPLETED|MRI 2||0
9976617|NCT01573273|11098016|FG009|NOT COMPLETED|MRI 2||0
9976618|NCT01573273|11098017|FG010|NOT COMPLETED|MRI 2||0
9976619|NCT01573273|11098018|FG011|NOT COMPLETED|MRI 2||0
9976620|NCT01573325|11098044|FG000|STARTED|Overall Study||50
9976621|NCT01573325|11098044|FG000|COMPLETED|Overall Study||50
9976622|NCT01573325|11098044|FG000|NOT COMPLETED|Overall Study||0
10099407|NCT02391584|11228551|FG001|STARTED|12 Month (End of Study)||0
10099408|NCT02391584|11228550|FG000|COMPLETED|12 Month (End of Study)||49
10099409|NCT02391584|11228551|FG001|COMPLETED|12 Month (End of Study)||0
10099410|NCT02391584|11228550|FG000|NOT COMPLETED|12 Month (End of Study)||2
10099411|NCT02391584|11228551|FG001|NOT COMPLETED|12 Month (End of Study)||0
9976623|NCT01573442|11098051|FG000|STARTED|Overall Study||113
9976624|NCT01573442|11098052|FG001|STARTED|Overall Study||114
9976625|NCT01573442|11098051|FG000|COMPLETED|Overall Study||104
9976626|NCT01573442|11098052|FG001|COMPLETED|Overall Study||104
9976627|NCT01573442|11098051|FG000|NOT COMPLETED|Overall Study||9
9976628|NCT01573442|11098052|FG001|NOT COMPLETED|Overall Study||10
9976629|NCT01573533|11098058|FG000|STARTED|Overall Study||9
9976630|NCT01573533|11098058|FG000|COMPLETED|Overall Study||9
9976631|NCT01573533|11098058|FG000|NOT COMPLETED|Overall Study||0
9976632|NCT01573572|11098062|FG000|STARTED|Overall Study||131
9976633|NCT01573572|11098062|FG000|COMPLETED|Overall Study||103
9976634|NCT01573572|11098062|FG000|NOT COMPLETED|Overall Study||28
9976635|NCT01573624|11098066|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
9976636|NCT01573624|11098067|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
9976637|NCT01573624|11098068|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
9976638|NCT01573624|11098069|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
9976639|NCT01573624|11098070|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
9976640|NCT01573624|11098071|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
9976641|NCT01573624|11098072|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
9976642|NCT01573624|11098066|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
9976643|NCT01573624|11098067|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
9976644|NCT01573624|11098068|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
9976645|NCT01573624|11098069|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
9976646|NCT01573624|11098070|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
9976647|NCT01573624|11098071|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
9976648|NCT01573624|11098072|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
9976649|NCT01573624|11098066|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
9976650|NCT01573624|11098067|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
9976651|NCT01573624|11098068|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
9976652|NCT01573624|11098069|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
9976653|NCT01573624|11098070|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
9976654|NCT01573624|11098071|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
9976655|NCT01573624|11098072|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
9976656|NCT01573624|11098066|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
9976657|NCT01573624|11098067|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
9976658|NCT01573624|11098068|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
9976659|NCT01573624|11098069|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
9976660|NCT01573624|11098070|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
9976661|NCT01573624|11098071|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
9976662|NCT01573624|11098072|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
9976663|NCT01573624|11098066|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
9976664|NCT01573624|11098067|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
9976665|NCT01573624|11098068|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
9976666|NCT01573624|11098069|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
9976667|NCT01573624|11098070|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
9976668|NCT01573624|11098071|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
9976669|NCT01573624|11098072|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
9976670|NCT01573624|11098066|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
9976671|NCT01573624|11098067|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
9976672|NCT01573624|11098068|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
9976673|NCT01573624|11098069|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
9976674|NCT01573624|11098070|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
9976675|NCT01573624|11098071|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
9976676|NCT01573624|11098072|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
9976677|NCT01573624|11098066|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
9976678|NCT01573624|11098067|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
9976679|NCT01573624|11098068|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
9976680|NCT01573624|11098069|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
9976681|NCT01573624|11098070|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
9976682|NCT01573624|11098071|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
9976683|NCT01573624|11098072|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
9976684|NCT01573624|11098066|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
9976685|NCT01573624|11098067|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
9976686|NCT01573624|11098068|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
9976687|NCT01573624|11098069|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
9976688|NCT01573624|11098070|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
9976689|NCT01573624|11098071|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
9976690|NCT01573624|11098072|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
9976691|NCT01573624|11098066|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
9976692|NCT01573624|11098067|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
9976693|NCT01573624|11098068|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
9976694|NCT01573624|11098069|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
9976695|NCT01573624|11098070|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
9976696|NCT01573624|11098071|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
9976697|NCT01573624|11098072|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
9976698|NCT01573624|11098066|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
9976699|NCT01573624|11098067|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
9976700|NCT01573624|11098068|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
9976701|NCT01573624|11098069|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
9976702|NCT01573624|11098070|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
9976703|NCT01573624|11098071|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
9976704|NCT01573624|11098072|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
9976705|NCT01573624|11098066|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
9976706|NCT01573624|11098067|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
9976707|NCT01573624|11098068|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
9976708|NCT01573624|11098069|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
9976709|NCT01573624|11098070|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
9976710|NCT01573624|11098071|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
9976711|NCT01573624|11098072|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
9976712|NCT01573624|11098066|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
9976713|NCT01573624|11098067|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
9976714|NCT01573624|11098068|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
9976715|NCT01573624|11098069|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
9976716|NCT01573624|11098070|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
9976717|NCT01573624|11098071|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
9976718|NCT01573624|11098072|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
9976719|NCT01573624|11098066|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
9976720|NCT01573624|11098067|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
9976721|NCT01573624|11098068|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
9976722|NCT01573624|11098069|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
9976723|NCT01573624|11098070|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
9976724|NCT01573624|11098071|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
9976725|NCT01573624|11098072|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
9976726|NCT01573624|11098066|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
9976727|NCT01573624|11098067|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
9976728|NCT01573624|11098068|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
9976729|NCT01573624|11098069|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
9976730|NCT01573624|11098070|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
9976731|NCT01573624|11098071|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
9976732|NCT01573624|11098072|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
9976733|NCT01573624|11098066|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
9976734|NCT01573624|11098067|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
9976735|NCT01573624|11098068|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
9976736|NCT01573624|11098069|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
9976737|NCT01573624|11098070|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
9976738|NCT01573624|11098071|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
9976739|NCT01573624|11098072|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
9976740|NCT01573624|11098066|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46
9976741|NCT01573624|11098067|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47
9976742|NCT01573624|11098068|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43
9976743|NCT01573624|11098069|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53
9976744|NCT01573624|11098070|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51
9976745|NCT01573624|11098071|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39
9976746|NCT01573624|11098072|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48
9976747|NCT01573624|11098066|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
9976748|NCT01573624|11098067|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
9976749|NCT01573624|11098068|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
9976750|NCT01573624|11098069|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
9976751|NCT01573624|11098070|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
9976752|NCT01573624|11098071|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
9976753|NCT01573624|11098072|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
9976754|NCT01573624|11098066|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
9976755|NCT01573624|11098067|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
9976756|NCT01573624|11098068|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
9976757|NCT01573624|11098069|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
9976758|NCT01573624|11098070|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
9976759|NCT01573624|11098071|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
9976760|NCT01573624|11098072|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
9976761|NCT01573702|11098094|FG000|STARTED|Overall Study||25
9976762|NCT01573702|11098094|FG000|COMPLETED|Overall Study||25
9976763|NCT01573702|11098094|FG000|NOT COMPLETED|Overall Study||0
9976764|NCT01573767|11098103|FG000|STARTED|Overall Study||115
9976765|NCT01573767|11098104|FG001|STARTED|Overall Study||114
9976766|NCT01573767|11098105|FG002|STARTED|Overall Study||113
9976767|NCT01573767|11098106|FG003|STARTED|Overall Study||114
9976768|NCT01573767|11098103|FG000|COMPLETED|Overall Study||93
9976769|NCT01573767|11098104|FG001|COMPLETED|Overall Study||93
9976770|NCT01573767|11098105|FG002|COMPLETED|Overall Study||99
9976771|NCT01573767|11098106|FG003|COMPLETED|Overall Study||90
9976772|NCT01573767|11098103|FG000|NOT COMPLETED|Overall Study||22
9976773|NCT01573767|11098104|FG001|NOT COMPLETED|Overall Study||21
9976774|NCT01573767|11098105|FG002|NOT COMPLETED|Overall Study||14
9976775|NCT01573767|11098106|FG003|NOT COMPLETED|Overall Study||24
9976776|NCT01573910|11098118|FG000|STARTED|Overall Study||489
9976777|NCT01573910|11098119|FG001|STARTED|Overall Study||493
9976778|NCT01573910|11098118|FG000|COMPLETED|Overall Study||469
9976779|NCT01573910|11098119|FG001|COMPLETED|Overall Study||476
9976780|NCT01573910|11098118|FG000|NOT COMPLETED|Overall Study||20
9976781|NCT01573910|11098119|FG001|NOT COMPLETED|Overall Study||17
9976782|NCT01573949|11098125|FG000|STARTED|Overall Study||7
9976783|NCT01573949|11098125|FG000|COMPLETED|Overall Study||7
9976784|NCT01573949|11098125|FG000|NOT COMPLETED|Overall Study||0
9976785|NCT01574079|11098131|FG000|STARTED|Overall Study||18
9976786|NCT01574079|11098132|FG001|STARTED|Overall Study||15
9976787|NCT01574079|11098131|FG000|COMPLETED|Overall Study||17
9976788|NCT01574079|11098132|FG001|COMPLETED|Overall Study||13
9976789|NCT01574079|11098131|FG000|NOT COMPLETED|Overall Study||1
9976790|NCT01574079|11098132|FG001|NOT COMPLETED|Overall Study||2
10099412|NCT02391701|11228562|FG000|STARTED|Overall Study||367
10099413|NCT02391701|11228563|FG001|STARTED|Overall Study||353
10099414|NCT02391701|11228562|FG000|COMPLETED|Overall Study||346
10099415|NCT02391701|11228563|FG001|COMPLETED|Overall Study||315
10099416|NCT02391701|11228562|FG000|NOT COMPLETED|Overall Study||21
10099417|NCT02391701|11228563|FG001|NOT COMPLETED|Overall Study||38
10099418|NCT02391714|11228571|FG000|STARTED|Overall Study||40
10099419|NCT02391714|11228572|FG001|STARTED|Overall Study||40
10099420|NCT02391714|11228571|FG000|COMPLETED|Overall Study||40
10099421|NCT02391714|11228572|FG001|COMPLETED|Overall Study||40
9976791|NCT01574105|11098140|FG000|STARTED|Overall Study||29
9976792|NCT01574105|11098141|FG001|STARTED|Overall Study||37
9976793|NCT01574105|11098140|FG000|COMPLETED|Overall Study||29
9976794|NCT01574105|11098141|FG001|COMPLETED|Overall Study||37
9976795|NCT01574105|11098140|FG000|NOT COMPLETED|Overall Study||0
9976796|NCT01574105|11098141|FG001|NOT COMPLETED|Overall Study||0
9976797|NCT01574144|11098147|FG000|STARTED|Overall Study||70
9976798|NCT01574144|11098147|FG000|COMPLETED|Overall Study||70
9976799|NCT01574144|11098147|FG000|NOT COMPLETED|Overall Study||0
9976800|NCT01574157|11098154|FG000|STARTED|Overall Study||35
9976801|NCT01574157|11098155|FG001|STARTED|Overall Study||39
9976802|NCT01574157|11098154|FG000|Month 3|Overall Study||31
9976803|NCT01574157|11098155|FG001|Month 3|Overall Study||33
9976804|NCT01574157|11098154|FG000|COMPLETED|Overall Study||31
9976805|NCT01574157|11098155|FG001|COMPLETED|Overall Study||31
9976806|NCT01574157|11098154|FG000|NOT COMPLETED|Overall Study||4
9976807|NCT01574157|11098155|FG001|NOT COMPLETED|Overall Study||8
9976808|NCT01574183|11098167|FG000|STARTED|Overall Study||41
9976809|NCT01574183|11098168|FG001|STARTED|Overall Study||35
9976810|NCT01574183|11098167|FG000|COMPLETED|Overall Study||14
9976811|NCT01574183|11098168|FG001|COMPLETED|Overall Study||17
9976812|NCT01574183|11098167|FG000|NOT COMPLETED|Overall Study||27
9976813|NCT01574183|11098168|FG001|NOT COMPLETED|Overall Study||18
9976814|NCT01574248|11098178|FG000|STARTED|Overall Study||15
9976815|NCT01574248|11098179|FG001|STARTED|Overall Study||18
9976816|NCT01574248|11098178|FG000|COMPLETED|Overall Study||12
9976817|NCT01574248|11098179|FG001|COMPLETED|Overall Study||18
9976818|NCT01574248|11098178|FG000|NOT COMPLETED|Overall Study||3
9976819|NCT01574248|11098179|FG001|NOT COMPLETED|Overall Study||0
9976820|NCT01574287|11098185|FG000|STARTED|Overall Study||4
9976821|NCT01574287|11098185|FG000|COMPLETED|Overall Study||4
9976822|NCT01574287|11098185|FG000|NOT COMPLETED|Overall Study||0
9976823|NCT01574326|11098191|FG000|STARTED|Overall Study||51
9976824|NCT01574326|11098192|FG001|STARTED|Overall Study||50
9976825|NCT01574326|11098191|FG000|Treated|Overall Study||51
9976826|NCT01574326|11098192|FG001|Treated|Overall Study||49
9976827|NCT01574326|11098191|FG000|COMPLETED|Overall Study||35
9976828|NCT01574326|11098192|FG001|COMPLETED|Overall Study||31
9976829|NCT01574326|11098191|FG000|NOT COMPLETED|Overall Study||16
9976830|NCT01574326|11098192|FG001|NOT COMPLETED|Overall Study||19
9976831|NCT01574352|11098205|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
9976832|NCT01574352|11098206|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
9976833|NCT01574352|11098205|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
9976834|NCT01574352|11098206|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
9976835|NCT01574352|11098205|FG000|NOT COMPLETED|Overall Study||7
9976836|NCT01574352|11098206|FG001|NOT COMPLETED|Overall Study||13
9976837|NCT01574612|11098212|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
9976838|NCT01574612|11098212|FG000|COMPLETED|Overall Study||46
9976839|NCT01574612|11098212|FG000|NOT COMPLETED|Overall Study||8
9976840|NCT01574651|11098218|FG000|STARTED|Overall Study||476
9976841|NCT01574651|11098219|FG001|STARTED|Overall Study||458
9976842|NCT01574651|11098218|FG000|Full Analysis Set (FAS)|Overall Study||476
9976843|NCT01574651|11098219|FG001|Full Analysis Set (FAS)|Overall Study||458
9976844|NCT01574651|11098218|FG000|Per Protocol Set (PPS)|Overall Study||373
9976845|NCT01574651|11098219|FG001|Per Protocol Set (PPS)|Overall Study||374
9976846|NCT01574651|11098218|FG000|COMPLETED|Overall Study||415
9976847|NCT01574651|11098219|FG001|COMPLETED|Overall Study||406
9976848|NCT01574651|11098218|FG000|NOT COMPLETED|Overall Study||61
9976849|NCT01574651|11098219|FG001|NOT COMPLETED|Overall Study||52
9976850|NCT01574703|11098229|FG000|STARTED|Overall Study||1192
9976851|NCT01574703|11098230|FG001|STARTED|Overall Study||1166
9976852|NCT01574703|11098231|FG002|STARTED|Overall Study||1116
9976853|NCT01574703|11098232|FG003|STARTED|Overall Study||1121
9976854|NCT01574703|11098229|FG000|COMPLETED|Overall Study||1067
9976855|NCT01574703|11098230|FG001|COMPLETED|Overall Study||1054
9976856|NCT01574703|11098231|FG002|COMPLETED|Overall Study||1011
9976857|NCT01574703|11098232|FG003|COMPLETED|Overall Study||1007
9976858|NCT01574703|11098229|FG000|NOT COMPLETED|Overall Study||125
10099422|NCT02391714|11228571|FG000|NOT COMPLETED|Overall Study||0
9976859|NCT01574703|11098230|FG001|NOT COMPLETED|Overall Study||112
9976860|NCT01574703|11098231|FG002|NOT COMPLETED|Overall Study||105
9976861|NCT01574703|11098232|FG003|NOT COMPLETED|Overall Study||114
9976862|NCT01574716|11098247|FG000|STARTED|Part 1||3
10099423|NCT02391714|11228572|FG001|NOT COMPLETED|Overall Study||0
10099424|NCT02391948|11228585|FG000|STARTED|Baseline||227
10099425|NCT02391948|11228586|FG001|STARTED|Baseline||161
9976863|NCT01574716|11098248|FG001|STARTED|Part 1||4
9976864|NCT01574716|11098249|FG002|STARTED|Part 1||9
9976865|NCT01574716|11098250|FG003|STARTED|Part 1||0
9976866|NCT01574716|11098251|FG004|STARTED|Part 1||0
9976867|NCT01574716|11098247|FG000|COMPLETED|Part 1||0
9976868|NCT01574716|11098248|FG001|COMPLETED|Part 1||0
9976869|NCT01574716|11098249|FG002|COMPLETED|Part 1||0
9976870|NCT01574716|11098250|FG003|COMPLETED|Part 1||0
9976871|NCT01574716|11098251|FG004|COMPLETED|Part 1||0
9976872|NCT01574716|11098247|FG000|NOT COMPLETED|Part 1||3
9976873|NCT01574716|11098248|FG001|NOT COMPLETED|Part 1||4
9976874|NCT01574716|11098249|FG002|NOT COMPLETED|Part 1||9
9976875|NCT01574716|11098250|FG003|NOT COMPLETED|Part 1||0
9976876|NCT01574716|11098251|FG004|NOT COMPLETED|Part 1||0
9976877|NCT01574716|11098247|FG000|STARTED|Part 2||0
9976878|NCT01574716|11098248|FG001|STARTED|Part 2||0
9976879|NCT01574716|11098249|FG002|STARTED|Part 2||0
9976880|NCT01574716|11098250|FG003|STARTED|Part 2||139
9976881|NCT01574716|11098251|FG004|STARTED|Part 2||70
9976882|NCT01574716|11098247|FG000|Treated Participants|Part 2||0
9976883|NCT01574716|11098248|FG001|Treated Participants|Part 2||0
9976884|NCT01574716|11098249|FG002|Treated Participants|Part 2||0
9976885|NCT01574716|11098250|FG003|Treated Participants|Part 2||140
9976886|NCT01574716|11098251|FG004|Treated Participants|Part 2||67
9976887|NCT01574716|11098247|FG000|COMPLETED|Part 2||0
9976888|NCT01574716|11098248|FG001|COMPLETED|Part 2||0
9976889|NCT01574716|11098249|FG002|COMPLETED|Part 2||0
9976890|NCT01574716|11098250|FG003|COMPLETED|Part 2||2
9976891|NCT01574716|11098251|FG004|COMPLETED|Part 2||0
9976892|NCT01574716|11098247|FG000|NOT COMPLETED|Part 2||0
9976893|NCT01574716|11098248|FG001|NOT COMPLETED|Part 2||0
9976894|NCT01574716|11098249|FG002|NOT COMPLETED|Part 2||0
9976895|NCT01574716|11098250|FG003|NOT COMPLETED|Part 2||137
9976896|NCT01574716|11098251|FG004|NOT COMPLETED|Part 2||70
9976897|NCT01574807|11098260|FG000|STARTED|First Appointment||50
9976898|NCT01574807|11098261|FG001|STARTED|First Appointment||50
9976899|NCT01574807|11098260|FG000|COMPLETED|First Appointment||50
9976900|NCT01574807|11098261|FG001|COMPLETED|First Appointment||50
9976901|NCT01574807|11098260|FG000|NOT COMPLETED|First Appointment||0
9976902|NCT01574807|11098261|FG001|NOT COMPLETED|First Appointment||0
9976903|NCT01574807|11098260|FG000|STARTED|Wash Out Period 2 Weeks||50
9976904|NCT01574807|11098261|FG001|STARTED|Wash Out Period 2 Weeks||50
9976905|NCT01574807|11098260|FG000|COMPLETED|Wash Out Period 2 Weeks||50
9976906|NCT01574807|11098261|FG001|COMPLETED|Wash Out Period 2 Weeks||50
9976907|NCT01574807|11098260|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0
9976908|NCT01574807|11098261|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0
9976909|NCT01574807|11098260|FG000|STARTED|Second Appointment||50
9976910|NCT01574807|11098261|FG001|STARTED|Second Appointment||50
9976911|NCT01574807|11098260|FG000|COMPLETED|Second Appointment||50
9976912|NCT01574807|11098261|FG001|COMPLETED|Second Appointment||50
9976913|NCT01574807|11098260|FG000|NOT COMPLETED|Second Appointment||0
9976914|NCT01574807|11098261|FG001|NOT COMPLETED|Second Appointment||0
9976915|NCT01575054|11098268|FG000|STARTED|Overall Study||233
9976916|NCT01575054|11098269|FG001|STARTED|Overall Study||235
9976917|NCT01575054|11098268|FG000|COMPLETED|Overall Study||204
9976918|NCT01575054|11098269|FG001|COMPLETED|Overall Study||209
9976919|NCT01575054|11098268|FG000|NOT COMPLETED|Overall Study||29
9976920|NCT01575054|11098269|FG001|NOT COMPLETED|Overall Study||26
9976921|NCT01575080|11098275|FG000|STARTED|Overall Study||102
9976922|NCT01575080|11098275|FG000|COMPLETED|Overall Study||102
9976923|NCT01575080|11098275|FG000|NOT COMPLETED|Overall Study||0
9976924|NCT01575106|11098279|FG000|STARTED|Overall Study||38
9976925|NCT01575106|11098279|FG000|COMPLETED|Overall Study||24
9976926|NCT01575106|11098279|FG000|NOT COMPLETED|Overall Study||14
9976927|NCT01575197|11098287|FG000|STARTED|Overall Study||152
9976928|NCT01575197|11098288|FG001|STARTED|Overall Study||152
9976929|NCT01575197|11098289|FG002|STARTED|Overall Study||152
9976930|NCT01575197|11098287|FG000|COMPLETED|Overall Study||149
9976931|NCT01575197|11098288|FG001|COMPLETED|Overall Study||143
9976932|NCT01575197|11098289|FG002|COMPLETED|Overall Study||146
9976933|NCT01575197|11098287|FG000|NOT COMPLETED|Overall Study||3
9976934|NCT01575197|11098288|FG001|NOT COMPLETED|Overall Study||9
9976935|NCT01575197|11098289|FG002|NOT COMPLETED|Overall Study||6
9976936|NCT01575275|11098297|FG000|STARTED|Overall Study||8
9976937|NCT01575275|11098297|FG000|COMPLETED|Overall Study||8
9976938|NCT01575275|11098297|FG000|NOT COMPLETED|Overall Study||0
9976939|NCT01575522|11098301|FG000|STARTED|Overall Study||22
9976940|NCT01575522|11098301|FG000|COMPLETED|Overall Study||22
9976941|NCT01575522|11098301|FG000|NOT COMPLETED|Overall Study||0
9976942|NCT01575561|11098308|FG000|STARTED|Overall Study||377
9976943|NCT01575561|11098308|FG000|COMPLETED|Overall Study||338
9976944|NCT01575561|11098308|FG000|NOT COMPLETED|Overall Study||39
9976945|NCT01575756|11098312|FG000|STARTED|Treatment Period 1||11
9976946|NCT01575756|11098313|FG001|STARTED|Treatment Period 1||11
9976947|NCT01575756|11098312|FG000|COMPLETED|Treatment Period 1||11
9976948|NCT01575756|11098313|FG001|COMPLETED|Treatment Period 1||11
9976949|NCT01575756|11098312|FG000|NOT COMPLETED|Treatment Period 1||0
9976950|NCT01575756|11098313|FG001|NOT COMPLETED|Treatment Period 1||0
9976951|NCT01575756|11098312|FG000|STARTED|Treatment Period 2||11
9976952|NCT01575756|11098313|FG001|STARTED|Treatment Period 2||11
9976953|NCT01575756|11098312|FG000|COMPLETED|Treatment Period 2||11
9976954|NCT01575756|11098313|FG001|COMPLETED|Treatment Period 2||11
9976955|NCT01575756|11098312|FG000|NOT COMPLETED|Treatment Period 2||0
9976956|NCT01575756|11098313|FG001|NOT COMPLETED|Treatment Period 2||0
9976957|NCT01575769|11098320|FG000|STARTED|Overall Study||41
9976958|NCT01575769|11098320|FG000|COMPLETED|Overall Study||0
9976959|NCT01575769|11098320|FG000|NOT COMPLETED|Overall Study||41
9976960|NCT01575808|11098328|FG000|STARTED|Overall Study||103
9976961|NCT01575808|11098329|FG001|STARTED|Overall Study||68
9976962|NCT01575808|11098328|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
9976963|NCT01575808|11098329|FG001|COMPLETED|Overall Study||68
9976964|NCT01575808|11098328|FG000|NOT COMPLETED|Overall Study||3
9976965|NCT01575808|11098329|FG001|NOT COMPLETED|Overall Study||0
9976966|NCT01575834|11098339|FG000|STARTED|Overall Study||3591
9976967|NCT01575834|11098340|FG001|STARTED|Overall Study||3589
9976968|NCT01575834|11098339|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
9976969|NCT01575834|11098340|FG001|Received Double-blind Treatment|Overall Study||3575
9976970|NCT01575834|11098339|FG000|Completed Double-blind Period|Overall Study||3205
9976971|NCT01575834|11098340|FG001|Completed Double-blind Period|Overall Study||3185
9976972|NCT01575834|11098339|FG000|Completed 24-month Study Period|Overall Study||3032
9976973|NCT01575834|11098340|FG001|Completed 24-month Study Period|Overall Study||2994
9976974|NCT01575834|11098339|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892
9976975|NCT01575834|11098340|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851
9976976|NCT01575834|11098339|FG000|NOT COMPLETED|Overall Study||699
9976977|NCT01575834|11098340|FG001|NOT COMPLETED|Overall Study||738
9976978|NCT01575873|11098354|FG000|STARTED|Overall Study||145
9976979|NCT01575873|11098355|FG001|STARTED|Overall Study||145
9976980|NCT01575873|11098356|FG002|STARTED|Overall Study||252
9976981|NCT01575873|11098357|FG003|STARTED|Overall Study||253
9976982|NCT01575873|11098354|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140
9976983|NCT01575873|11098355|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
9976984|NCT01575873|11098356|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246
9976985|NCT01575873|11098357|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
9976986|NCT01575873|11098354|FG000|COMPLETED|Overall Study||117
9976987|NCT01575873|11098355|FG001|COMPLETED|Overall Study||109
9976988|NCT01575873|11098356|FG002|COMPLETED|Overall Study||178
9976989|NCT01575873|11098357|FG003|COMPLETED|Overall Study||186
9976990|NCT01575873|11098354|FG000|NOT COMPLETED|Overall Study||28
9976991|NCT01575873|11098355|FG001|NOT COMPLETED|Overall Study||36
9976992|NCT01575873|11098356|FG002|NOT COMPLETED|Overall Study||74
9976993|NCT01575873|11098357|FG003|NOT COMPLETED|Overall Study||67
9976994|NCT01575899|11098368|FG000|STARTED|Overall Study||73
9976995|NCT01575899|11098369|FG001|STARTED|Overall Study||73
9976996|NCT01575899|11098370|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
9976997|NCT01575899|11098368|FG000|COMPLETED|Overall Study||68
9976998|NCT01575899|11098369|FG001|COMPLETED|Overall Study||68
9976999|NCT01575899|11098370|FG002|COMPLETED|Overall Study||60
9977000|NCT01575899|11098368|FG000|NOT COMPLETED|Overall Study||5
9977001|NCT01575899|11098369|FG001|NOT COMPLETED|Overall Study||5
9977002|NCT01575899|11098370|FG002|NOT COMPLETED|Overall Study||2
9977003|NCT01575912|11098383|FG000|STARTED|Overall Study||30
9977004|NCT01575912|11098384|FG001|STARTED|Overall Study||32
9977005|NCT01575912|11098385|FG002|STARTED|Overall Study||30
9977006|NCT01575912|11098383|FG000|COMPLETED|Overall Study||30
9977007|NCT01575912|11098384|FG001|COMPLETED|Overall Study||32
9977008|NCT01575912|11098385|FG002|COMPLETED|Overall Study||30
9977009|NCT01575912|11098383|FG000|NOT COMPLETED|Overall Study||0
9977010|NCT01575912|11098384|FG001|NOT COMPLETED|Overall Study||0
9977011|NCT01575912|11098385|FG002|NOT COMPLETED|Overall Study||0
9977012|NCT01576003|11098396|FG000|STARTED|Overall Study||2
9977013|NCT01576003|11098397|FG001|STARTED|Overall Study||3
9977014|NCT01576003|11098398|FG002|STARTED|Overall Study||4
9977015|NCT01576003|11098396|FG000|COMPLETED|Overall Study||1
9977016|NCT01576003|11098397|FG001|COMPLETED|Overall Study||1
9977017|NCT01576003|11098398|FG002|COMPLETED|Overall Study||4
9977018|NCT01576003|11098396|FG000|NOT COMPLETED|Overall Study||1
9977019|NCT01576003|11098397|FG001|NOT COMPLETED|Overall Study||2
9977020|NCT01576003|11098398|FG002|NOT COMPLETED|Overall Study||0
9977021|NCT01576016|11098408|FG000|STARTED|Lead Safety||920
9977022|NCT01576016|11098409|FG001|STARTED|Lead Safety||0
9977023|NCT01576016|11098408|FG000|COMPLETED|Lead Safety||647
9977024|NCT01576016|11098409|FG001|COMPLETED|Lead Safety||0
9977025|NCT01576016|11098408|FG000|NOT COMPLETED|Lead Safety||273
9977026|NCT01576016|11098409|FG001|NOT COMPLETED|Lead Safety||0
9977027|NCT01576016|11098408|FG000|STARTED|MRI Safety||0
9977028|NCT01576016|11098409|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
9977029|NCT01576016|11098408|FG000|COMPLETED|MRI Safety||0
9977030|NCT01576016|11098409|FG001|COMPLETED|MRI Safety||181
9977031|NCT01576016|11098408|FG000|NOT COMPLETED|MRI Safety||0
9977032|NCT01576016|11098409|FG001|NOT COMPLETED|MRI Safety||74
9977033|NCT01576042|11098419|FG000|STARTED|Overall Study||13
9977034|NCT01576042|11098420|FG001|STARTED|Overall Study||14
9977035|NCT01576042|11098419|FG000|Switched to the Other Arm|Overall Study||5
9977036|NCT01576042|11098420|FG001|Switched to the Other Arm|Overall Study||1
9977037|NCT01576042|11098419|FG000|COMPLETED|Overall Study||11
9977038|NCT01576042|11098420|FG001|COMPLETED|Overall Study||14
9977039|NCT01576042|11098419|FG000|NOT COMPLETED|Overall Study||2
9977040|NCT01576042|11098420|FG001|NOT COMPLETED|Overall Study||0
9977041|NCT01576055|11098428|FG000|STARTED|Overall Study||197
9977042|NCT01576055|11098429|FG001|STARTED|Overall Study||70
9977043|NCT01576055|11098428|FG000|COMPLETED|Overall Study||178
9977044|NCT01576055|11098429|FG001|COMPLETED|Overall Study||64
9977045|NCT01576055|11098428|FG000|NOT COMPLETED|Overall Study||19
9977046|NCT01576055|11098429|FG001|NOT COMPLETED|Overall Study||6
9977047|NCT01576120|11098437|FG000|STARTED|Overall Study||21
9977048|NCT01576120|11098438|FG001|STARTED|Overall Study||19
9977049|NCT01576120|11098437|FG000|COMPLETED|Overall Study||21
9977050|NCT01576120|11098438|FG001|COMPLETED|Overall Study||19
9977051|NCT01576120|11098437|FG000|NOT COMPLETED|Overall Study||0
9977052|NCT01576120|11098438|FG001|NOT COMPLETED|Overall Study||0
9977053|NCT01576146|11098444|FG000|STARTED|Extension Period 1||30
9977054|NCT01576146|11098444|FG000|COMPLETED|Extension Period 1||20
9977055|NCT01576146|11098444|FG000|NOT COMPLETED|Extension Period 1||10
9977056|NCT01576146|11098444|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
9977057|NCT01576146|11098444|FG000|COMPLETED|Extension Period 2||0
9977058|NCT01576146|11098444|FG000|NOT COMPLETED|Extension Period 2||17
9977059|NCT01576159|11098452|FG000|STARTED|Overall Study||12
9977060|NCT01576159|11098453|FG001|STARTED|Overall Study||12
9977061|NCT01576159|11098454|FG002|STARTED|Overall Study||12
9977062|NCT01576159|11098455|FG003|STARTED|Overall Study||12
9977063|NCT01576159|11098452|FG000|COMPLETED|Overall Study||11
9977064|NCT01576159|11098453|FG001|COMPLETED|Overall Study||11
9977065|NCT01576159|11098454|FG002|COMPLETED|Overall Study||11
9977066|NCT01576159|11098455|FG003|COMPLETED|Overall Study||11
9977067|NCT01576159|11098452|FG000|NOT COMPLETED|Overall Study||1
9977068|NCT01576159|11098453|FG001|NOT COMPLETED|Overall Study||1
9977069|NCT01576159|11098454|FG002|NOT COMPLETED|Overall Study||1
9977070|NCT01576159|11098455|FG003|NOT COMPLETED|Overall Study||1
9977071|NCT01576172|11098474|FG000|STARTED|Overall Study||79
9977072|NCT01576172|11098475|FG001|STARTED|Overall Study||80
9977073|NCT01576172|11098474|FG000|COMPLETED|Overall Study||74
9977074|NCT01576172|11098475|FG001|COMPLETED|Overall Study||79
9977075|NCT01576172|11098474|FG000|NOT COMPLETED|Overall Study||5
9977076|NCT01576172|11098475|FG001|NOT COMPLETED|Overall Study||1
9977077|NCT01576276|11098485|FG000|STARTED|Overall Study||22
9977078|NCT01576276|11098486|FG001|STARTED|Overall Study||29
9977079|NCT01576276|11098485|FG000|COMPLETED|Overall Study||14
9977080|NCT01576276|11098486|FG001|COMPLETED|Overall Study||18
9977081|NCT01576276|11098485|FG000|NOT COMPLETED|Overall Study||8
9977082|NCT01576276|11098486|FG001|NOT COMPLETED|Overall Study||11
9977083|NCT01576341|11098493|FG000|STARTED|Overall Study||417
9977084|NCT01576341|11098493|FG000|COMPLETED|Overall Study||324
9977085|NCT01576341|11098493|FG000|NOT COMPLETED|Overall Study||93
9977086|NCT01576367|11098500|FG000|STARTED|Overall Study||17
9977087|NCT01576367|11098500|FG000|COMPLETED|Overall Study||14
9977088|NCT01576367|11098500|FG000|NOT COMPLETED|Overall Study||3
9977089|NCT01576406|11098510|FG000|STARTED|Overall Study||11
9977090|NCT01576406|11098511|FG001|STARTED|Overall Study||15
9977091|NCT01576406|11098512|FG002|STARTED|Overall Study||20
9977092|NCT01576406|11098513|FG003|STARTED|Overall Study||10
9977093|NCT01576406|11098514|FG004|STARTED|Overall Study||16
9977094|NCT01576406|11098515|FG005|STARTED|Overall Study||16
9977095|NCT01576406|11098510|FG000|COMPLETED|Overall Study||5
9977096|NCT01576406|11098511|FG001|COMPLETED|Overall Study||7
9977097|NCT01576406|11098512|FG002|COMPLETED|Overall Study||4
9977098|NCT01576406|11098513|FG003|COMPLETED|Overall Study||1
9977099|NCT01576406|11098514|FG004|COMPLETED|Overall Study||8
9977100|NCT01576406|11098515|FG005|COMPLETED|Overall Study||4
9977101|NCT01576406|11098510|FG000|NOT COMPLETED|Overall Study||6
10099426|NCT02391948|11228587|FG002|STARTED|Baseline||80
10099427|NCT02391948|11228588|FG003|STARTED|Baseline||129
10099428|NCT02391948|11228589|FG004|STARTED|Baseline||111
10099429|NCT02391948|11228585|FG000|COMPLETED|Baseline||227
10099430|NCT02391948|11228586|FG001|COMPLETED|Baseline||161
10099431|NCT02391948|11228587|FG002|COMPLETED|Baseline||80
9977102|NCT01576406|11098511|FG001|NOT COMPLETED|Overall Study||8
9977103|NCT01576406|11098512|FG002|NOT COMPLETED|Overall Study||16
9977104|NCT01576406|11098513|FG003|NOT COMPLETED|Overall Study||9
9977105|NCT01576406|11098514|FG004|NOT COMPLETED|Overall Study||8
9977106|NCT01576406|11098515|FG005|NOT COMPLETED|Overall Study||12
9977107|NCT01576471|11098531|FG000|STARTED|Overall Study||125
9977108|NCT01576471|11098532|FG001|STARTED|Overall Study||125
9977109|NCT01576471|11098531|FG000|COMPLETED|Overall Study||117
9977110|NCT01576471|11098532|FG001|COMPLETED|Overall Study||116
9977111|NCT01576471|11098531|FG000|NOT COMPLETED|Overall Study||8
9977112|NCT01576471|11098532|FG001|NOT COMPLETED|Overall Study||9
9977113|NCT01576484|11098540|FG000|STARTED|Overall Study||12
9977114|NCT01576484|11098541|FG001|STARTED|Overall Study||46
9977115|NCT01576484|11098540|FG000|COMPLETED|Overall Study||7
9977116|NCT01576484|11098541|FG001|COMPLETED|Overall Study||27
9977117|NCT01576484|11098540|FG000|NOT COMPLETED|Overall Study||5
9977118|NCT01576484|11098541|FG001|NOT COMPLETED|Overall Study||19
10017806|NCT01819311|11140777|FG000|STARTED|Follow-up Phase (8 Weeks)||31
10017807|NCT01819311|11140778|FG001|STARTED|Follow-up Phase (8 Weeks)||30
10017808|NCT01819311|11140777|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24
10099432|NCT02391948|11228588|FG003|COMPLETED|Baseline||129
10017809|NCT01819311|11140778|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23
10017810|NCT01819311|11140777|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
10017811|NCT01819311|11140778|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
10099433|NCT02391948|11228589|FG004|COMPLETED|Baseline||111
9977119|NCT01576523|11098555|FG000|STARTED|Dosing Period 1||3
9977120|NCT01576523|11098556|FG001|STARTED|Dosing Period 1||3
9977121|NCT01576523|11098557|FG002|STARTED|Dosing Period 1||3
9977122|NCT01576523|11098558|FG003|STARTED|Dosing Period 1||3
9977123|NCT01576523|11098559|FG004|STARTED|Dosing Period 1||3
9977124|NCT01576523|11098560|FG005|STARTED|Dosing Period 1||3
9977125|NCT01576523|11098555|FG000|COMPLETED|Dosing Period 1||3
9977126|NCT01576523|11098556|FG001|COMPLETED|Dosing Period 1||3
9977127|NCT01576523|11098557|FG002|COMPLETED|Dosing Period 1||3
9977128|NCT01576523|11098558|FG003|COMPLETED|Dosing Period 1||3
9977129|NCT01576523|11098559|FG004|COMPLETED|Dosing Period 1||3
9977130|NCT01576523|11098560|FG005|COMPLETED|Dosing Period 1||3
9977131|NCT01576523|11098555|FG000|NOT COMPLETED|Dosing Period 1||0
9977132|NCT01576523|11098556|FG001|NOT COMPLETED|Dosing Period 1||0
9977133|NCT01576523|11098557|FG002|NOT COMPLETED|Dosing Period 1||0
9977134|NCT01576523|11098558|FG003|NOT COMPLETED|Dosing Period 1||0
9977135|NCT01576523|11098559|FG004|NOT COMPLETED|Dosing Period 1||0
9977136|NCT01576523|11098560|FG005|NOT COMPLETED|Dosing Period 1||0
9977137|NCT01576523|11098555|FG000|STARTED|Dosing Period 2||3
9977138|NCT01576523|11098556|FG001|STARTED|Dosing Period 2||3
9977139|NCT01576523|11098557|FG002|STARTED|Dosing Period 2||3
9977140|NCT01576523|11098558|FG003|STARTED|Dosing Period 2||3
9977141|NCT01576523|11098559|FG004|STARTED|Dosing Period 2||3
9977142|NCT01576523|11098560|FG005|STARTED|Dosing Period 2||3
9977143|NCT01576523|11098555|FG000|COMPLETED|Dosing Period 2||3
9977144|NCT01576523|11098556|FG001|COMPLETED|Dosing Period 2||3
9977145|NCT01576523|11098557|FG002|COMPLETED|Dosing Period 2||3
9977146|NCT01576523|11098558|FG003|COMPLETED|Dosing Period 2||3
9977147|NCT01576523|11098559|FG004|COMPLETED|Dosing Period 2||3
9977148|NCT01576523|11098560|FG005|COMPLETED|Dosing Period 2||3
9977149|NCT01576523|11098555|FG000|NOT COMPLETED|Dosing Period 2||0
9977150|NCT01576523|11098556|FG001|NOT COMPLETED|Dosing Period 2||0
9977151|NCT01576523|11098557|FG002|NOT COMPLETED|Dosing Period 2||0
9977152|NCT01576523|11098558|FG003|NOT COMPLETED|Dosing Period 2||0
9977153|NCT01576523|11098559|FG004|NOT COMPLETED|Dosing Period 2||0
9977154|NCT01576523|11098560|FG005|NOT COMPLETED|Dosing Period 2||0
9977155|NCT01576536|11098569|FG000|STARTED|Overall Study||117
9977156|NCT01576536|11098569|FG000|COMPLETED|Overall Study||117
9977157|NCT01576536|11098569|FG000|NOT COMPLETED|Overall Study||0
9977158|NCT01576588|11098573|FG000|STARTED|Overall Study||25
9977159|NCT01576588|11098573|FG000|COMPLETED|Overall Study||23
9977160|NCT01576588|11098573|FG000|NOT COMPLETED|Overall Study||2
9977161|NCT01576705|11098582|FG000|STARTED|Overall Study||43
9977162|NCT01576705|11098583|FG001|STARTED|Overall Study||45
9977163|NCT01576705|11098584|FG002|STARTED|Overall Study||43
9977164|NCT01576705|11098585|FG003|STARTED|Overall Study||44
9977165|NCT01576705|11098582|FG000|COMPLETED|Overall Study||40
9977166|NCT01576705|11098583|FG001|COMPLETED|Overall Study||37
9977167|NCT01576705|11098584|FG002|COMPLETED|Overall Study||38
9977168|NCT01576705|11098585|FG003|COMPLETED|Overall Study||41
9977169|NCT01576705|11098582|FG000|NOT COMPLETED|Overall Study||3
9977170|NCT01576705|11098583|FG001|NOT COMPLETED|Overall Study||8
9977171|NCT01576705|11098584|FG002|NOT COMPLETED|Overall Study||5
9977172|NCT01576705|11098585|FG003|NOT COMPLETED|Overall Study||3
9977173|NCT01576718|11098601|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889
9977174|NCT01576718|11098602|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9977175|NCT01576718|11098603|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9977176|NCT01576718|11098604|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9977177|NCT01576718|11098605|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9977178|NCT01576718|11098606|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9977179|NCT01576718|11098607|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9977180|NCT01576718|11098601|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
9977181|NCT01576718|11098602|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977182|NCT01576718|11098603|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977183|NCT01576718|11098604|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977184|NCT01576718|11098605|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977185|NCT01576718|11098606|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977186|NCT01576718|11098607|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977187|NCT01576718|11098601|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
9977188|NCT01576718|11098602|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977189|NCT01576718|11098603|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977190|NCT01576718|11098604|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977191|NCT01576718|11098605|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977192|NCT01576718|11098606|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977193|NCT01576718|11098607|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9977194|NCT01576718|11098601|FG000|STARTED|Treatment Period||0
9977195|NCT01576718|11098602|FG001|STARTED|Treatment Period||107
9977196|NCT01576718|11098603|FG002|STARTED|Treatment Period||107
9977197|NCT01576718|11098604|FG003|STARTED|Treatment Period||106
9977198|NCT01576718|11098605|FG004|STARTED|Treatment Period||107
9977199|NCT01576718|11098606|FG005|STARTED|Treatment Period||106
9977200|NCT01576718|11098607|FG006|STARTED|Treatment Period||107
9977201|NCT01576718|11098601|FG000|Safety Population|Treatment Period||0
9977202|NCT01576718|11098602|FG001|Safety Population|Treatment Period||107
9977203|NCT01576718|11098603|FG002|Safety Population|Treatment Period||107
9977204|NCT01576718|11098604|FG003|Safety Population|Treatment Period||106
9977205|NCT01576718|11098605|FG004|Safety Population|Treatment Period||107
9977206|NCT01576718|11098606|FG005|Safety Population|Treatment Period||106
9977207|NCT01576718|11098607|FG006|Safety Population|Treatment Period||106
9977208|NCT01576718|11098601|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0
9977209|NCT01576718|11098602|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107
9977210|NCT01576718|11098603|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106
9977211|NCT01576718|11098604|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102
9977212|NCT01576718|11098605|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107
9977213|NCT01576718|11098606|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105
9977214|NCT01576718|11098607|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103
9977215|NCT01576718|11098601|FG000|COMPLETED|Treatment Period||0
9977216|NCT01576718|11098602|FG001|COMPLETED|Treatment Period||82
9977217|NCT01576718|11098603|FG002|COMPLETED|Treatment Period||87
9977218|NCT01576718|11098604|FG003|COMPLETED|Treatment Period||75
9977219|NCT01576718|11098605|FG004|COMPLETED|Treatment Period||80
9977220|NCT01576718|11098606|FG005|COMPLETED|Treatment Period||58
9977221|NCT01576718|11098607|FG006|COMPLETED|Treatment Period||77
9977222|NCT01576718|11098601|FG000|NOT COMPLETED|Treatment Period||0
9977223|NCT01576718|11098602|FG001|NOT COMPLETED|Treatment Period||25
9977224|NCT01576718|11098603|FG002|NOT COMPLETED|Treatment Period||20
9977225|NCT01576718|11098604|FG003|NOT COMPLETED|Treatment Period||31
9977226|NCT01576718|11098605|FG004|NOT COMPLETED|Treatment Period||27
9977227|NCT01576718|11098606|FG005|NOT COMPLETED|Treatment Period||48
9977228|NCT01576718|11098607|FG006|NOT COMPLETED|Treatment Period||30
9977229|NCT01576783|11098623|FG000|STARTED|Overall Study||189
9977230|NCT01576783|11098624|FG001|STARTED|Overall Study||188
9977231|NCT01576783|11098623|FG000|COMPLETED|Overall Study||169
9977232|NCT01576783|11098624|FG001|COMPLETED|Overall Study||171
9977233|NCT01576783|11098623|FG000|NOT COMPLETED|Overall Study||20
9977234|NCT01576783|11098624|FG001|NOT COMPLETED|Overall Study||17
9977235|NCT01576809|11098630|FG000|STARTED|Overall Study||51
9977236|NCT01576809|11098630|FG000|COMPLETED|Overall Study||51
9977237|NCT01576809|11098630|FG000|NOT COMPLETED|Overall Study||0
9977238|NCT01576874|11098636|FG000|STARTED|Overall Study||72
9977239|NCT01576874|11098637|FG001|STARTED|Overall Study||72
9977240|NCT01576874|11098636|FG000|COMPLETED|Overall Study||72
9977241|NCT01576874|11098637|FG001|COMPLETED|Overall Study||72
9977242|NCT01576874|11098636|FG000|NOT COMPLETED|Overall Study||0
9977243|NCT01576874|11098637|FG001|NOT COMPLETED|Overall Study||0
9977244|NCT01576939|11098643|FG000|STARTED|Overall Study||30
9977245|NCT01576939|11098643|FG000|COMPLETED|Overall Study||30
9977246|NCT01576939|11098643|FG000|NOT COMPLETED|Overall Study||0
9977247|NCT01576952|11098649|FG000|STARTED|Overall Study||180
9977248|NCT01576952|11098650|FG001|STARTED|Overall Study||88
9977249|NCT01576952|11098649|FG000|Safety Population|Overall Study||169
9977250|NCT01576952|11098650|FG001|Safety Population|Overall Study||85
9977251|NCT01576952|11098649|FG000|mITT Population|Overall Study||168
9977252|NCT01576952|11098650|FG001|mITT Population|Overall Study||85
9977253|NCT01576952|11098649|FG000|COMPLETED|Overall Study||139
10099434|NCT02391948|11228585|FG000|NOT COMPLETED|Baseline||0
10099435|NCT02391948|11228586|FG001|NOT COMPLETED|Baseline||0
10099436|NCT02391948|11228587|FG002|NOT COMPLETED|Baseline||0
10099437|NCT02391948|11228588|FG003|NOT COMPLETED|Baseline||0
10099438|NCT02391948|11228589|FG004|NOT COMPLETED|Baseline||0
10099439|NCT02391948|11228585|FG000|STARTED|6-month Assessment||227
10099440|NCT02391948|11228586|FG001|STARTED|6-month Assessment||161
10099441|NCT02391948|11228587|FG002|STARTED|6-month Assessment||80
10099442|NCT02391948|11228588|FG003|STARTED|6-month Assessment||129
9977254|NCT01576952|11098650|FG001|COMPLETED|Overall Study||33
9977255|NCT01576952|11098649|FG000|NOT COMPLETED|Overall Study||41
9977256|NCT01576952|11098650|FG001|NOT COMPLETED|Overall Study||55
9977257|NCT01577108|11098658|FG000|STARTED|Overall Study||54
9977258|NCT01577108|11098659|FG001|STARTED|Overall Study||56
9977259|NCT01577108|11098658|FG000|COMPLETED|Overall Study||49
9977260|NCT01577108|11098659|FG001|COMPLETED|Overall Study||50
9977261|NCT01577108|11098658|FG000|NOT COMPLETED|Overall Study||5
9977262|NCT01577108|11098659|FG001|NOT COMPLETED|Overall Study||6
9977263|NCT01577160|11098665|FG000|STARTED|Overall Study||353
9977264|NCT01577160|11098665|FG000|COMPLETED|Overall Study||255
9977265|NCT01577160|11098665|FG000|NOT COMPLETED|Overall Study||98
9977266|NCT01577186|11098669|FG000|STARTED|Overall Study||480
9977267|NCT01577186|11098669|FG000|COMPLETED|Overall Study||350
9977268|NCT01577186|11098669|FG000|NOT COMPLETED|Overall Study||130
9977269|NCT01577238|11098675|FG000|STARTED|Overall Study||127
9977270|NCT01577238|11098676|FG001|STARTED|Overall Study||123
9977271|NCT01577238|11098675|FG000|COMPLETED|Overall Study||117
9977272|NCT01577238|11098676|FG001|COMPLETED|Overall Study||111
9977273|NCT01577238|11098675|FG000|NOT COMPLETED|Overall Study||10
9977274|NCT01577238|11098676|FG001|NOT COMPLETED|Overall Study||12
9977275|NCT01577329|11098684|FG000|STARTED|Overall Study||19
9977276|NCT01577329|11098685|FG001|STARTED|Overall Study||22
9977277|NCT01577329|11098684|FG000|COMPLETED|Overall Study||16
9977278|NCT01577329|11098685|FG001|COMPLETED|Overall Study||22
9977279|NCT01577329|11098684|FG000|NOT COMPLETED|Overall Study||3
9977280|NCT01577329|11098685|FG001|NOT COMPLETED|Overall Study||0
9977281|NCT01577381|11098695|FG000|STARTED|Overall Study||2
9977282|NCT01577381|11098696|FG001|STARTED|Overall Study||3
10099443|NCT02391948|11228589|FG004|STARTED|6-month Assessment||111
10099444|NCT02391948|11228585|FG000|COMPLETED|6-month Assessment||148
9977283|NCT01577381|11098697|FG002|STARTED|Overall Study||3
9977284|NCT01577381|11098698|FG003|STARTED|Overall Study||2
9977285|NCT01577381|11098695|FG000|COMPLETED|Overall Study||0
9977286|NCT01577381|11098696|FG001|COMPLETED|Overall Study||0
9977287|NCT01577381|11098697|FG002|COMPLETED|Overall Study||0
9977288|NCT01577381|11098698|FG003|COMPLETED|Overall Study||0
9977289|NCT01577381|11098695|FG000|NOT COMPLETED|Overall Study||2
9977290|NCT01577381|11098696|FG001|NOT COMPLETED|Overall Study||3
9977291|NCT01577381|11098697|FG002|NOT COMPLETED|Overall Study||3
9977292|NCT01577381|11098698|FG003|NOT COMPLETED|Overall Study||2
9977293|NCT01577537|11098710|FG000|STARTED|Overall Study||128
9977294|NCT01577537|11098711|FG001|STARTED|Overall Study||123
9977295|NCT01577537|11098710|FG000|COMPLETED|Overall Study||120
9977296|NCT01577537|11098711|FG001|COMPLETED|Overall Study||116
9977297|NCT01577537|11098710|FG000|NOT COMPLETED|Overall Study||8
9977298|NCT01577537|11098711|FG001|NOT COMPLETED|Overall Study||7
9977299|NCT01577706|11098717|FG000|STARTED|First Intervention (1 Day)||3
9977300|NCT01577706|11098718|FG001|STARTED|First Intervention (1 Day)||1
9977301|NCT01577706|11098719|FG002|STARTED|First Intervention (1 Day)||3
9977302|NCT01577706|11098717|FG000|COMPLETED|First Intervention (1 Day)||3
9977303|NCT01577706|11098718|FG001|COMPLETED|First Intervention (1 Day)||1
9977304|NCT01577706|11098719|FG002|COMPLETED|First Intervention (1 Day)||3
9977305|NCT01577706|11098717|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9977306|NCT01577706|11098718|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9977307|NCT01577706|11098719|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9977308|NCT01577706|11098717|FG000|STARTED|Washout (at Least 1 Week)||3
9977309|NCT01577706|11098718|FG001|STARTED|Washout (at Least 1 Week)||1
9977310|NCT01577706|11098719|FG002|STARTED|Washout (at Least 1 Week)||3
9977311|NCT01577706|11098717|FG000|COMPLETED|Washout (at Least 1 Week)||3
9977312|NCT01577706|11098718|FG001|COMPLETED|Washout (at Least 1 Week)||1
9977313|NCT01577706|11098719|FG002|COMPLETED|Washout (at Least 1 Week)||3
9977314|NCT01577706|11098717|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
9977315|NCT01577706|11098718|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
9977316|NCT01577706|11098719|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
9977317|NCT01577706|11098717|FG000|STARTED|Second Intervention (1 Day)||3
9977318|NCT01577706|11098718|FG001|STARTED|Second Intervention (1 Day)||1
9977319|NCT01577706|11098719|FG002|STARTED|Second Intervention (1 Day)||3
9977320|NCT01577706|11098717|FG000|COMPLETED|Second Intervention (1 Day)||3
9977321|NCT01577706|11098718|FG001|COMPLETED|Second Intervention (1 Day)||1
9977322|NCT01577706|11098719|FG002|COMPLETED|Second Intervention (1 Day)||3
9977323|NCT01577706|11098717|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9977324|NCT01577706|11098718|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9977325|NCT01577706|11098719|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
9977326|NCT01577706|11098717|FG000|STARTED|Washout (at Least 1 Week)||3
9977327|NCT01577706|11098718|FG001|STARTED|Washout (at Least 1 Week)||1
9977328|NCT01577706|11098719|FG002|STARTED|Washout (at Least 1 Week)||3
9977329|NCT01577706|11098717|FG000|COMPLETED|Washout (at Least 1 Week)||3
9977330|NCT01577706|11098718|FG001|COMPLETED|Washout (at Least 1 Week)||1
9977331|NCT01577706|11098719|FG002|COMPLETED|Washout (at Least 1 Week)||3
9977332|NCT01577706|11098717|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
9977333|NCT01577706|11098718|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
9977334|NCT01577706|11098719|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
9977335|NCT01577706|11098717|FG000|STARTED|Third Intervention (1 Day)||3
9977336|NCT01577706|11098718|FG001|STARTED|Third Intervention (1 Day)||1
9977337|NCT01577706|11098719|FG002|STARTED|Third Intervention (1 Day)||3
9977338|NCT01577706|11098717|FG000|COMPLETED|Third Intervention (1 Day)||3
9977339|NCT01577706|11098718|FG001|COMPLETED|Third Intervention (1 Day)||1
9977340|NCT01577706|11098719|FG002|COMPLETED|Third Intervention (1 Day)||3
9977341|NCT01577706|11098717|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9977342|NCT01577706|11098718|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9977343|NCT01577706|11098719|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
9977344|NCT01577732|11098727|FG000|STARTED|Overall Study||300
9977345|NCT01577732|11098727|FG000|COMPLETED|Overall Study||300
9977346|NCT01577732|11098727|FG000|NOT COMPLETED|Overall Study||0
9977347|NCT01577745|11098737|FG000|STARTED|Overall Study||3
9977348|NCT01577745|11098738|FG001|STARTED|Overall Study||3
9977349|NCT01577745|11098739|FG002|STARTED|Overall Study||3
9977350|NCT01577745|11098740|FG003|STARTED|Overall Study||6
9977351|NCT01577745|11098741|FG004|STARTED|Overall Study||5
9977352|NCT01577745|11098742|FG005|STARTED|Overall Study||5
9977353|NCT01577745|11098737|FG000|COMPLETED|Overall Study||0
9977354|NCT01577745|11098738|FG001|COMPLETED|Overall Study||0
9977355|NCT01577745|11098739|FG002|COMPLETED|Overall Study||1
9977356|NCT01577745|11098740|FG003|COMPLETED|Overall Study||0
9977357|NCT01577745|11098741|FG004|COMPLETED|Overall Study||0
9977358|NCT01577745|11098742|FG005|COMPLETED|Overall Study||1
9977359|NCT01577745|11098737|FG000|NOT COMPLETED|Overall Study||3
9977360|NCT01577745|11098738|FG001|NOT COMPLETED|Overall Study||3
9977361|NCT01577745|11098739|FG002|NOT COMPLETED|Overall Study||2
9977362|NCT01577745|11098740|FG003|NOT COMPLETED|Overall Study||6
9977363|NCT01577745|11098741|FG004|NOT COMPLETED|Overall Study||5
9977364|NCT01577745|11098742|FG005|NOT COMPLETED|Overall Study||4
9977365|NCT01577758|11098761|FG000|STARTED|Dose Escalation Phase||2
9977366|NCT01577758|11098762|FG001|STARTED|Dose Escalation Phase||2
9977367|NCT01577758|11098763|FG002|STARTED|Dose Escalation Phase||2
9977368|NCT01577758|11098764|FG003|STARTED|Dose Escalation Phase||2
9977369|NCT01577758|11098765|FG004|STARTED|Dose Escalation Phase||6
9977370|NCT01577758|11098766|FG005|STARTED|Dose Escalation Phase||4
9977371|NCT01577758|11098767|FG006|STARTED|Dose Escalation Phase||1
9977372|NCT01577758|11098768|FG007|STARTED|Dose Escalation Phase||0
9977373|NCT01577758|11098761|FG000|COMPLETED|Dose Escalation Phase||0
9977374|NCT01577758|11098762|FG001|COMPLETED|Dose Escalation Phase||0
9977375|NCT01577758|11098763|FG002|COMPLETED|Dose Escalation Phase||0
9977376|NCT01577758|11098764|FG003|COMPLETED|Dose Escalation Phase||0
9977377|NCT01577758|11098765|FG004|COMPLETED|Dose Escalation Phase||0
9977378|NCT01577758|11098766|FG005|COMPLETED|Dose Escalation Phase||0
9977379|NCT01577758|11098767|FG006|COMPLETED|Dose Escalation Phase||0
9977380|NCT01577758|11098768|FG007|COMPLETED|Dose Escalation Phase||0
9977381|NCT01577758|11098761|FG000|NOT COMPLETED|Dose Escalation Phase||2
9977382|NCT01577758|11098762|FG001|NOT COMPLETED|Dose Escalation Phase||2
9977383|NCT01577758|11098763|FG002|NOT COMPLETED|Dose Escalation Phase||2
9977384|NCT01577758|11098764|FG003|NOT COMPLETED|Dose Escalation Phase||2
9977385|NCT01577758|11098765|FG004|NOT COMPLETED|Dose Escalation Phase||6
9977386|NCT01577758|11098766|FG005|NOT COMPLETED|Dose Escalation Phase||4
9977387|NCT01577758|11098767|FG006|NOT COMPLETED|Dose Escalation Phase||1
9977388|NCT01577758|11098768|FG007|NOT COMPLETED|Dose Escalation Phase||0
9977389|NCT01577758|11098761|FG000|STARTED|mCRC Expansion Phase||0
9977390|NCT01577758|11098762|FG001|STARTED|mCRC Expansion Phase||0
9977391|NCT01577758|11098763|FG002|STARTED|mCRC Expansion Phase||0
9977392|NCT01577758|11098764|FG003|STARTED|mCRC Expansion Phase||0
9977393|NCT01577758|11098765|FG004|STARTED|mCRC Expansion Phase||0
9977394|NCT01577758|11098766|FG005|STARTED|mCRC Expansion Phase||0
9977395|NCT01577758|11098767|FG006|STARTED|mCRC Expansion Phase||0
9977396|NCT01577758|11098768|FG007|STARTED|mCRC Expansion Phase||25
9977397|NCT01577758|11098761|FG000|COMPLETED|mCRC Expansion Phase||0
9977398|NCT01577758|11098762|FG001|COMPLETED|mCRC Expansion Phase||0
9977399|NCT01577758|11098763|FG002|COMPLETED|mCRC Expansion Phase||0
9977400|NCT01577758|11098764|FG003|COMPLETED|mCRC Expansion Phase||0
9977401|NCT01577758|11098765|FG004|COMPLETED|mCRC Expansion Phase||0
9977402|NCT01577758|11098766|FG005|COMPLETED|mCRC Expansion Phase||0
9977403|NCT01577758|11098767|FG006|COMPLETED|mCRC Expansion Phase||0
9977404|NCT01577758|11098768|FG007|COMPLETED|mCRC Expansion Phase||0
9977405|NCT01577758|11098761|FG000|NOT COMPLETED|mCRC Expansion Phase||0
9977406|NCT01577758|11098762|FG001|NOT COMPLETED|mCRC Expansion Phase||0
9977407|NCT01577758|11098763|FG002|NOT COMPLETED|mCRC Expansion Phase||0
9977408|NCT01577758|11098764|FG003|NOT COMPLETED|mCRC Expansion Phase||0
9977409|NCT01577758|11098765|FG004|NOT COMPLETED|mCRC Expansion Phase||0
9977410|NCT01577758|11098766|FG005|NOT COMPLETED|mCRC Expansion Phase||0
9977411|NCT01577758|11098767|FG006|NOT COMPLETED|mCRC Expansion Phase||0
9977412|NCT01577758|11098768|FG007|NOT COMPLETED|mCRC Expansion Phase||25
9977413|NCT01577966|11098788|FG000|STARTED|Overall Study||9
9977414|NCT01577966|11098788|FG000|COMPLETED|Overall Study||9
9977415|NCT01577966|11098788|FG000|NOT COMPLETED|Overall Study||0
9977416|NCT01578031|11098796|FG000|STARTED|Overall Study||129
9977417|NCT01578031|11098797|FG001|STARTED|Overall Study||69
9977418|NCT01578031|11098798|FG002|STARTED|Overall Study||12
9977419|NCT01578031|11098799|FG003|STARTED|Overall Study||30
9977420|NCT01578031|11098796|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
9977421|NCT01578031|11098797|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
9977422|NCT01578031|11098798|FG002|COMPLETED|Overall Study|Only baseline data collected|12
9977423|NCT01578031|11098799|FG003|COMPLETED|Overall Study|Only baseline data collected|30
9977424|NCT01578031|11098796|FG000|NOT COMPLETED|Overall Study||62
9977425|NCT01578031|11098797|FG001|NOT COMPLETED|Overall Study||34
9977426|NCT01578031|11098798|FG002|NOT COMPLETED|Overall Study||0
9977427|NCT01578031|11098799|FG003|NOT COMPLETED|Overall Study||0
9977428|NCT01578044|11098809|FG000|STARTED|Overall Study||6
10099445|NCT02391948|11228586|FG001|COMPLETED|6-month Assessment||105
10099446|NCT02391948|11228587|FG002|COMPLETED|6-month Assessment||49
10099447|NCT02391948|11228588|FG003|COMPLETED|6-month Assessment||84
10099448|NCT02391948|11228589|FG004|COMPLETED|6-month Assessment||85
10099449|NCT02391948|11228585|FG000|NOT COMPLETED|6-month Assessment||79
10099450|NCT02391948|11228586|FG001|NOT COMPLETED|6-month Assessment||56
10099451|NCT02391948|11228587|FG002|NOT COMPLETED|6-month Assessment||31
10099452|NCT02391948|11228588|FG003|NOT COMPLETED|6-month Assessment||45
10099453|NCT02391948|11228589|FG004|NOT COMPLETED|6-month Assessment||26
10099454|NCT02391948|11228585|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
10099455|NCT02391948|11228586|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
10099456|NCT02391948|11228587|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
10099457|NCT02391948|11228588|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
10099458|NCT02391948|11228589|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
10099459|NCT02391948|11228585|FG000|COMPLETED|12-month Assessment||217
9977429|NCT01578044|11098810|FG001|STARTED|Overall Study||6
9977430|NCT01578044|11098809|FG000|COMPLETED|Overall Study||6
9977431|NCT01578044|11098810|FG001|COMPLETED|Overall Study||6
9977432|NCT01578044|11098809|FG000|NOT COMPLETED|Overall Study||0
9977433|NCT01578044|11098810|FG001|NOT COMPLETED|Overall Study||0
9977434|NCT01578187|11098816|FG000|STARTED|Label Comprehension Phase||63
9977435|NCT01578187|11098816|FG000|COMPLETED|Label Comprehension Phase||63
9977436|NCT01578187|11098816|FG000|NOT COMPLETED|Label Comprehension Phase||0
9977437|NCT01578187|11098816|FG000|STARTED|Usability Phase||48
9977438|NCT01578187|11098816|FG000|COMPLETED|Usability Phase||47
9977439|NCT01578187|11098816|FG000|NOT COMPLETED|Usability Phase||1
9977440|NCT01578278|11098826|FG000|STARTED|Overall Study||152
9977441|NCT01578278|11098827|FG001|STARTED|Overall Study||152
9977442|NCT01578278|11098828|FG002|STARTED|Overall Study||154
9977443|NCT01578278|11098829|FG003|STARTED|Overall Study||148
9977444|NCT01578278|11098826|FG000|COMPLETED|Overall Study||148
9977445|NCT01578278|11098827|FG001|COMPLETED|Overall Study||150
9977446|NCT01578278|11098828|FG002|COMPLETED|Overall Study||150
9977447|NCT01578278|11098829|FG003|COMPLETED|Overall Study||139
9977448|NCT01578278|11098826|FG000|NOT COMPLETED|Overall Study||4
9977449|NCT01578278|11098827|FG001|NOT COMPLETED|Overall Study||2
9977450|NCT01578278|11098828|FG002|NOT COMPLETED|Overall Study||4
9977451|NCT01578278|11098829|FG003|NOT COMPLETED|Overall Study||9
9977452|NCT01578317|11098841|FG000|STARTED|Overall Study||22
9977453|NCT01578317|11098842|FG001|STARTED|Overall Study||21
9977454|NCT01578317|11098841|FG000|Analysis Population|Overall Study||22
9977455|NCT01578317|11098842|FG001|Analysis Population|Overall Study||20
9977456|NCT01578317|11098841|FG000|COMPLETED|Overall Study||22
9977457|NCT01578317|11098842|FG001|COMPLETED|Overall Study||20
9977458|NCT01578317|11098841|FG000|NOT COMPLETED|Overall Study||0
10099460|NCT02391948|11228586|FG001|COMPLETED|12-month Assessment||147
10099461|NCT02391948|11228587|FG002|COMPLETED|12-month Assessment||73
10099462|NCT02391948|11228588|FG003|COMPLETED|12-month Assessment||116
10099463|NCT02391948|11228589|FG004|COMPLETED|12-month Assessment||103
10099464|NCT02391948|11228585|FG000|NOT COMPLETED|12-month Assessment||8
10099465|NCT02391948|11228586|FG001|NOT COMPLETED|12-month Assessment||9
10099466|NCT02391948|11228587|FG002|NOT COMPLETED|12-month Assessment||4
10099467|NCT02391948|11228588|FG003|NOT COMPLETED|12-month Assessment||9
9977459|NCT01578317|11098842|FG001|NOT COMPLETED|Overall Study||1
9977460|NCT01578330|11098848|FG000|STARTED|Overall Study||42
9977461|NCT01578330|11098848|FG000|Per Protocol Population|Overall Study||35
9977462|NCT01578330|11098848|FG000|COMPLETED|Overall Study||35
9977463|NCT01578330|11098848|FG000|NOT COMPLETED|Overall Study||7
9977464|NCT01578486|11098852|FG000|STARTED|Overall Study||13
9977465|NCT01578486|11098852|FG000|COMPLETED|Overall Study||8
9977466|NCT01578486|11098852|FG000|NOT COMPLETED|Overall Study||5
9977467|NCT01578499|11098858|FG000|STARTED|Overall Study||66
9977468|NCT01578499|11098859|FG001|STARTED|Overall Study||65
9977469|NCT01578499|11098858|FG000|Safety Population: Treated|Overall Study||66
9977470|NCT01578499|11098859|FG001|Safety Population: Treated|Overall Study||62
9977471|NCT01578499|11098858|FG000|Intent to Treat Population: CD30+|Overall Study||64
9977472|NCT01578499|11098859|FG001|Intent to Treat Population: CD30+|Overall Study||64
9977473|NCT01578499|11098858|FG000|COMPLETED|Overall Study||32
9977474|NCT01578499|11098859|FG001|COMPLETED|Overall Study||22
9977475|NCT01578499|11098858|FG000|NOT COMPLETED|Overall Study||34
9977476|NCT01578499|11098859|FG001|NOT COMPLETED|Overall Study||43
9977477|NCT01578551|11098871|FG000|STARTED|Overall Study||19
9977478|NCT01578551|11098872|FG001|STARTED|Overall Study||6
9977479|NCT01578551|11098871|FG000|COMPLETED|Overall Study||18
9977480|NCT01578551|11098872|FG001|COMPLETED|Overall Study||6
9977481|NCT01578551|11098871|FG000|NOT COMPLETED|Overall Study||1
9977482|NCT01578551|11098872|FG001|NOT COMPLETED|Overall Study||0
9977483|NCT01578577|11098882|FG000|STARTED|Overall Study||305
9977484|NCT01578577|11098883|FG001|STARTED|Overall Study||302
9977485|NCT01578577|11098884|FG002|STARTED|Overall Study||313
9977486|NCT01578577|11098882|FG000|COMPLETED|Overall Study||254
9977487|NCT01578577|11098883|FG001|COMPLETED|Overall Study||262
9977488|NCT01578577|11098884|FG002|COMPLETED|Overall Study||278
9977489|NCT01578577|11098882|FG000|NOT COMPLETED|Overall Study||51
9977490|NCT01578577|11098883|FG001|NOT COMPLETED|Overall Study||40
9977491|NCT01578577|11098884|FG002|NOT COMPLETED|Overall Study||35
9977492|NCT01578707|11098904|FG000|STARTED|Overall Study||196
9977493|NCT01578707|11098905|FG001|STARTED|Overall Study||195
9977494|NCT01578707|11098904|FG000|COMPLETED|Overall Study||196
9977495|NCT01578707|11098905|FG001|COMPLETED|Overall Study||195
9977496|NCT01578707|11098904|FG000|NOT COMPLETED|Overall Study||0
9977497|NCT01578707|11098905|FG001|NOT COMPLETED|Overall Study||0
10202032|NCT03441984|11329282|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9977498|NCT01578772|11098911|FG000|STARTED|Overall Study||17
9977499|NCT01578772|11098911|FG000|COMPLETED|Overall Study||17
9977500|NCT01578772|11098911|FG000|NOT COMPLETED|Overall Study||0
9977501|NCT01578850|11098918|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
9977502|NCT01578850|11098919|FG001|STARTED|Period 1||0
10202033|NCT03441984|11329283|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9977503|NCT01578850|11098920|FG002|STARTED|Period 1||0
9977504|NCT01578850|11098918|FG000|COMPLETED|Period 1||452
9977505|NCT01578850|11098919|FG001|COMPLETED|Period 1||0
9977506|NCT01578850|11098920|FG002|COMPLETED|Period 1||0
9977507|NCT01578850|11098918|FG000|NOT COMPLETED|Period 1||37
9977508|NCT01578850|11098919|FG001|NOT COMPLETED|Period 1||0
9977509|NCT01578850|11098920|FG002|NOT COMPLETED|Period 1||0
9977510|NCT01578850|11098918|FG000|STARTED|Period 2||0
9977511|NCT01578850|11098919|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
9977512|NCT01578850|11098920|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176
9977513|NCT01578850|11098918|FG000|COMPLETED|Period 2||0
9977514|NCT01578850|11098919|FG001|COMPLETED|Period 2||154
10202034|NCT03441984|11329284|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10202035|NCT03441984|11329285|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10202036|NCT03441984|11329286|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10202037|NCT03441984|11329287|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9977515|NCT01578850|11098920|FG002|COMPLETED|Period 2||162
9977516|NCT01578850|11098918|FG000|NOT COMPLETED|Period 2||0
9977517|NCT01578850|11098919|FG001|NOT COMPLETED|Period 2||13
9977518|NCT01578850|11098920|FG002|NOT COMPLETED|Period 2||14
9977519|NCT01578902|11098928|FG000|STARTED|Overall Study||84
9977520|NCT01578902|11098928|FG000|COMPLETED|Overall Study||84
9977521|NCT01578902|11098928|FG000|NOT COMPLETED|Overall Study||0
9977522|NCT01578980|11098935|FG000|STARTED|Overall Study||20
9977523|NCT01578980|11098935|FG000|COMPLETED|Overall Study||20
9977524|NCT01578980|11098935|FG000|NOT COMPLETED|Overall Study||0
9977525|NCT01578993|11098939|FG000|STARTED|Overall Study||101
9977526|NCT01578993|11098939|FG000|COMPLETED|Overall Study||101
9977527|NCT01578993|11098939|FG000|NOT COMPLETED|Overall Study||0
9977528|NCT01579006|11098943|FG000|STARTED|Overall Study||184
9977529|NCT01579006|11098943|FG000|COMPLETED|Overall Study||151
9977530|NCT01579006|11098943|FG000|NOT COMPLETED|Overall Study||33
9977531|NCT01579045|11098947|FG000|STARTED|Overall Study||24
9977532|NCT01579045|11098947|FG000|COMPLETED|Overall Study||24
9977533|NCT01579045|11098947|FG000|NOT COMPLETED|Overall Study||0
9977534|NCT01579084|11098969|FG000|STARTED|Overall Study||8
9977535|NCT01579084|11098970|FG001|STARTED|Overall Study||8
9977536|NCT01579084|11098971|FG002|STARTED|Overall Study||8
9977537|NCT01579084|11098972|FG003|STARTED|Overall Study||8
9977538|NCT01579084|11098973|FG004|STARTED|Overall Study||8
9977539|NCT01579084|11098974|FG005|STARTED|Overall Study||8
9977540|NCT01579084|11098975|FG006|STARTED|Overall Study||4
9977541|NCT01579084|11098976|FG007|STARTED|Overall Study||4
9977542|NCT01579084|11098977|FG008|STARTED|Overall Study||4
9977543|NCT01579084|11098978|FG009|STARTED|Overall Study||4
9977544|NCT01579084|11098969|FG000|COMPLETED|Overall Study||8
9977545|NCT01579084|11098970|FG001|COMPLETED|Overall Study||8
9977546|NCT01579084|11098971|FG002|COMPLETED|Overall Study||8
9977547|NCT01579084|11098972|FG003|COMPLETED|Overall Study||8
9977548|NCT01579084|11098973|FG004|COMPLETED|Overall Study||8
9977549|NCT01579084|11098974|FG005|COMPLETED|Overall Study||8
9977550|NCT01579084|11098975|FG006|COMPLETED|Overall Study||4
9977551|NCT01579084|11098976|FG007|COMPLETED|Overall Study||4
9977552|NCT01579084|11098977|FG008|COMPLETED|Overall Study||4
9977553|NCT01579084|11098978|FG009|COMPLETED|Overall Study||4
9977554|NCT01579084|11098969|FG000|NOT COMPLETED|Overall Study||0
9977555|NCT01579084|11098970|FG001|NOT COMPLETED|Overall Study||0
9977556|NCT01579084|11098971|FG002|NOT COMPLETED|Overall Study||0
9977557|NCT01579084|11098972|FG003|NOT COMPLETED|Overall Study||0
9977558|NCT01579084|11098973|FG004|NOT COMPLETED|Overall Study||0
9977559|NCT01579084|11098974|FG005|NOT COMPLETED|Overall Study||0
9977560|NCT01579084|11098975|FG006|NOT COMPLETED|Overall Study||0
9977561|NCT01579084|11098976|FG007|NOT COMPLETED|Overall Study||0
9977562|NCT01579084|11098977|FG008|NOT COMPLETED|Overall Study||0
9977563|NCT01579084|11098978|FG009|NOT COMPLETED|Overall Study||0
9977564|NCT01579162|11098999|FG000|STARTED|Overall Study||16
9977565|NCT01579162|11099000|FG001|STARTED|Overall Study||8
9977566|NCT01579162|11099001|FG002|STARTED|Overall Study||8
9977567|NCT01579162|11099002|FG003|STARTED|Overall Study||8
9977568|NCT01579162|11099003|FG004|STARTED|Overall Study||8
9977569|NCT01579162|11098999|FG000|COMPLETED|Overall Study||16
9977570|NCT01579162|11099000|FG001|COMPLETED|Overall Study||8
9977571|NCT01579162|11099001|FG002|COMPLETED|Overall Study||8
9977572|NCT01579162|11099002|FG003|COMPLETED|Overall Study||8
9977573|NCT01579162|11099003|FG004|COMPLETED|Overall Study||8
9977574|NCT01579162|11098999|FG000|NOT COMPLETED|Overall Study||0
9977575|NCT01579162|11099000|FG001|NOT COMPLETED|Overall Study||0
9977576|NCT01579162|11099001|FG002|NOT COMPLETED|Overall Study||0
9977577|NCT01579162|11099002|FG003|NOT COMPLETED|Overall Study||0
9977578|NCT01579162|11099003|FG004|NOT COMPLETED|Overall Study||0
9977579|NCT01579214|11099018|FG000|STARTED|Overall Study||45
9977580|NCT01579214|11099019|FG001|STARTED|Overall Study||138
9977581|NCT01579214|11099018|FG000|COMPLETED|Overall Study||45
9977582|NCT01579214|11099019|FG001|COMPLETED|Overall Study||138
9977583|NCT01579214|11099018|FG000|NOT COMPLETED|Overall Study||0
9977584|NCT01579214|11099019|FG001|NOT COMPLETED|Overall Study||0
9977585|NCT01579305|11099027|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
9977586|NCT01579305|11099028|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
9977587|NCT01579305|11099027|FG000|Discontinued Before Treatment|Overall Study||0
9977588|NCT01579305|11099028|FG001|Discontinued Before Treatment|Overall Study||1
9977589|NCT01579305|11099027|FG000|Continued After Treatment|Overall Study||139
10202038|NCT03441984|11329276|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9977590|NCT01579305|11099028|FG001|Continued After Treatment|Overall Study||141
9977591|NCT01579305|11099027|FG000|COMPLETED|Overall Study||118
9977592|NCT01579305|11099028|FG001|COMPLETED|Overall Study||115
9977593|NCT01579305|11099027|FG000|NOT COMPLETED|Overall Study||21
9977594|NCT01579305|11099028|FG001|NOT COMPLETED|Overall Study||27
9977595|NCT01579318|11099034|FG000|STARTED|Overall Study||2
9977596|NCT01579318|11099034|FG000|COMPLETED|Overall Study||1
9977597|NCT01579318|11099034|FG000|NOT COMPLETED|Overall Study||1
9977598|NCT01579474|11099044|FG000|STARTED|Overall Study||44
9977599|NCT01579474|11099045|FG001|STARTED|Overall Study||43
9977600|NCT01579474|11099046|FG002|STARTED|Overall Study||29
9977601|NCT01579474|11099047|FG003|STARTED|Overall Study||3
9977602|NCT01579474|11099048|FG004|STARTED|Overall Study||10
9977603|NCT01579474|11099049|FG005|STARTED|Overall Study||2
9977604|NCT01579474|11099044|FG000|COMPLETED|Overall Study||41
9977605|NCT01579474|11099045|FG001|COMPLETED|Overall Study||30
9977606|NCT01579474|11099046|FG002|COMPLETED|Overall Study||27
9977607|NCT01579474|11099047|FG003|COMPLETED|Overall Study||3
9977608|NCT01579474|11099048|FG004|COMPLETED|Overall Study||9
9977609|NCT01579474|11099049|FG005|COMPLETED|Overall Study||1
9977610|NCT01579474|11099044|FG000|NOT COMPLETED|Overall Study||3
9977611|NCT01579474|11099045|FG001|NOT COMPLETED|Overall Study||13
9977612|NCT01579474|11099046|FG002|NOT COMPLETED|Overall Study||2
9977613|NCT01579474|11099047|FG003|NOT COMPLETED|Overall Study||0
9977614|NCT01579474|11099048|FG004|NOT COMPLETED|Overall Study||1
9977615|NCT01579474|11099049|FG005|NOT COMPLETED|Overall Study||1
9977616|NCT01579513|11099064|FG000|STARTED|Primary Hospitalization||91
9977617|NCT01579513|11099065|FG001|STARTED|Primary Hospitalization||99
9977618|NCT01579513|11099064|FG000|COMPLETED|Primary Hospitalization||81
9977619|NCT01579513|11099065|FG001|COMPLETED|Primary Hospitalization||95
9977620|NCT01579513|11099064|FG000|NOT COMPLETED|Primary Hospitalization||10
9977621|NCT01579513|11099065|FG001|NOT COMPLETED|Primary Hospitalization||4
9977622|NCT01579513|11099064|FG000|STARTED|1 Year Neurodevelopmental Follow up||81
9977623|NCT01579513|11099065|FG001|STARTED|1 Year Neurodevelopmental Follow up||95
9977624|NCT01579513|11099064|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61
9977625|NCT01579513|11099065|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68
9977626|NCT01579513|11099064|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
9977627|NCT01579513|11099065|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
9977628|NCT01579565|11099073|FG000|STARTED|Randomized||207
9977629|NCT01579565|11099074|FG001|STARTED|Randomized||209
9977630|NCT01579565|11099073|FG000|COMPLETED|Randomized||202
9977631|NCT01579565|11099074|FG001|COMPLETED|Randomized||204
9977632|NCT01579565|11099073|FG000|NOT COMPLETED|Randomized||5
9977633|NCT01579565|11099074|FG001|NOT COMPLETED|Randomized||5
9977634|NCT01579565|11099073|FG000|STARTED|Treated||202
9977635|NCT01579565|11099074|FG001|STARTED|Treated||204
9977636|NCT01579565|11099073|FG000|COMPLETED|Treated||200
9977637|NCT01579565|11099074|FG001|COMPLETED|Treated||201
9977638|NCT01579565|11099073|FG000|NOT COMPLETED|Treated||2
9977639|NCT01579565|11099074|FG001|NOT COMPLETED|Treated||3
9977640|NCT01579578|11099084|FG000|STARTED|Overall Study||13
9977641|NCT01579578|11099085|FG001|STARTED|Overall Study||12
9977642|NCT01579578|11099084|FG000|Ongoing|Overall Study||3
9977643|NCT01579578|11099085|FG001|Ongoing|Overall Study||0
9977644|NCT01579578|11099084|FG000|COMPLETED|Overall Study||0
9977645|NCT01579578|11099085|FG001|COMPLETED|Overall Study||0
9977646|NCT01579578|11099084|FG000|NOT COMPLETED|Overall Study||13
9977647|NCT01579578|11099085|FG001|NOT COMPLETED|Overall Study||12
9977648|NCT01579669|11099093|FG000|STARTED|Overall Study||170
9977649|NCT01579669|11099094|FG001|STARTED|Overall Study||41
9977650|NCT01579669|11099093|FG000|COMPLETED|Overall Study||134
9977651|NCT01579669|11099094|FG001|COMPLETED|Overall Study||41
9977652|NCT01579669|11099093|FG000|NOT COMPLETED|Overall Study||36
9977653|NCT01579669|11099094|FG001|NOT COMPLETED|Overall Study||0
9977654|NCT01579747|11099102|FG000|STARTED|Overall Study||12
9977655|NCT01579747|11099103|FG001|STARTED|Overall Study||12
9977656|NCT01579747|11099102|FG000|COMPLETED|Overall Study||12
9977657|NCT01579747|11099103|FG001|COMPLETED|Overall Study||12
9977658|NCT01579747|11099102|FG000|NOT COMPLETED|Overall Study||0
9977659|NCT01579747|11099103|FG001|NOT COMPLETED|Overall Study||0
9977660|NCT01579812|11099109|FG000|STARTED|Overall Study||90
9977661|NCT01579812|11099109|FG000|COMPLETED|Overall Study||38
9977662|NCT01579812|11099109|FG000|NOT COMPLETED|Overall Study||52
9977663|NCT01579916|11099118|FG000|STARTED|Overall Study||242
9977664|NCT01579916|11099119|FG001|STARTED|Overall Study||61
9977665|NCT01579916|11099118|FG000|COMPLETED|Overall Study||234
9977666|NCT01579916|11099119|FG001|COMPLETED|Overall Study||59
9977667|NCT01579916|11099118|FG000|NOT COMPLETED|Overall Study||8
9977668|NCT01579916|11099119|FG001|NOT COMPLETED|Overall Study||2
9977669|NCT01580020|11099127|FG000|STARTED|Overall Study||52
9977670|NCT01580020|11099128|FG001|STARTED|Overall Study||40
9977671|NCT01580020|11099129|FG002|STARTED|Overall Study||61
9977672|NCT01580020|11099130|FG003|STARTED|Overall Study||22
9977673|NCT01580020|11099127|FG000|COMPLETED|Overall Study||51
9977674|NCT01580020|11099128|FG001|COMPLETED|Overall Study||33
9977675|NCT01580020|11099129|FG002|COMPLETED|Overall Study||57
9977676|NCT01580020|11099130|FG003|COMPLETED|Overall Study||20
9977677|NCT01580020|11099127|FG000|NOT COMPLETED|Overall Study||1
9977678|NCT01580020|11099128|FG001|NOT COMPLETED|Overall Study||7
9977679|NCT01580020|11099129|FG002|NOT COMPLETED|Overall Study||4
9977680|NCT01580020|11099130|FG003|NOT COMPLETED|Overall Study||2
9977681|NCT01580072|11099143|FG000|STARTED|Overall Study||28
9977682|NCT01580072|11099144|FG001|STARTED|Overall Study||37
9977683|NCT01580072|11099145|FG002|STARTED|Overall Study||0
9977684|NCT01580072|11099143|FG000|COMPLETED|Overall Study||16
9977685|NCT01580072|11099144|FG001|COMPLETED|Overall Study||28
9977686|NCT01580072|11099145|FG002|COMPLETED|Overall Study||0
9977687|NCT01580072|11099143|FG000|NOT COMPLETED|Overall Study||12
9977688|NCT01580072|11099144|FG001|NOT COMPLETED|Overall Study||9
9977689|NCT01580072|11099145|FG002|NOT COMPLETED|Overall Study||0
9977690|NCT01580098|11099155|FG000|STARTED|Overall Study||76
9977691|NCT01580098|11099156|FG001|STARTED|Overall Study||114
9977692|NCT01580098|11099157|FG002|STARTED|Overall Study||3
9977693|NCT01580098|11099155|FG000|COMPLETED|Overall Study||61
9977694|NCT01580098|11099156|FG001|COMPLETED|Overall Study||101
9977695|NCT01580098|11099157|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
9977696|NCT01580098|11099155|FG000|NOT COMPLETED|Overall Study||15
9977697|NCT01580098|11099156|FG001|NOT COMPLETED|Overall Study||13
9977698|NCT01580098|11099157|FG002|NOT COMPLETED|Overall Study||3
9977699|NCT01580293|11099171|FG000|STARTED|Part A_Main Trial||20
9977700|NCT01580293|11099172|FG001|STARTED|Part A_Main Trial||114
9977701|NCT01580293|11099173|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
9977702|NCT01580293|11099171|FG000|COMPLETED|Part A_Main Trial||18
9977703|NCT01580293|11099172|FG001|COMPLETED|Part A_Main Trial||108
9977704|NCT01580293|11099173|FG002|COMPLETED|Part A_Main Trial||0
9977705|NCT01580293|11099171|FG000|NOT COMPLETED|Part A_Main Trial||2
9977706|NCT01580293|11099172|FG001|NOT COMPLETED|Part A_Main Trial||6
9977707|NCT01580293|11099173|FG002|NOT COMPLETED|Part A_Main Trial||0
9977708|NCT01580293|11099171|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
9977709|NCT01580293|11099172|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
9977710|NCT01580293|11099173|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
9977711|NCT01580293|11099171|FG000|COMPLETED|Part A_Extension||14
9977712|NCT01580293|11099172|FG001|COMPLETED|Part A_Extension||95
9977713|NCT01580293|11099173|FG002|COMPLETED|Part A_Extension||0
9977714|NCT01580293|11099171|FG000|NOT COMPLETED|Part A_Extension||0
9977715|NCT01580293|11099172|FG001|NOT COMPLETED|Part A_Extension||12
9977716|NCT01580293|11099173|FG002|NOT COMPLETED|Part A_Extension||0
9977717|NCT01580293|11099171|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
9977718|NCT01580293|11099172|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
9977719|NCT01580293|11099173|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
9977720|NCT01580293|11099171|FG000|COMPLETED|Part B||0
9977721|NCT01580293|11099172|FG001|COMPLETED|Part B||0
9977722|NCT01580293|11099173|FG002|COMPLETED|Part B||17
9977723|NCT01580293|11099171|FG000|NOT COMPLETED|Part B||0
9977724|NCT01580293|11099172|FG001|NOT COMPLETED|Part B||0
9977725|NCT01580293|11099173|FG002|NOT COMPLETED|Part B||2
9977726|NCT01580306|11099204|FG000|STARTED|Overall Study||8
9977727|NCT01580306|11099205|FG001|STARTED|Overall Study||8
9977728|NCT01580306|11099206|FG002|STARTED|Overall Study||8
9977729|NCT01580306|11099207|FG003|STARTED|Overall Study||8
9977730|NCT01580306|11099204|FG000|COMPLETED|Overall Study||8
9977731|NCT01580306|11099205|FG001|COMPLETED|Overall Study||8
9977732|NCT01580306|11099206|FG002|COMPLETED|Overall Study||8
9977733|NCT01580306|11099207|FG003|COMPLETED|Overall Study||8
9977734|NCT01580306|11099204|FG000|NOT COMPLETED|Overall Study||0
9977735|NCT01580306|11099205|FG001|NOT COMPLETED|Overall Study||0
9977736|NCT01580306|11099206|FG002|NOT COMPLETED|Overall Study||0
9977737|NCT01580306|11099207|FG003|NOT COMPLETED|Overall Study||0
9977738|NCT01580410|11099219|FG000|STARTED|Overall Study||68
9977739|NCT01580410|11099220|FG001|STARTED|Overall Study||68
9977740|NCT01580410|11099219|FG000|COMPLETED|Overall Study||57
9977741|NCT01580410|11099220|FG001|COMPLETED|Overall Study||60
9977742|NCT01580410|11099219|FG000|NOT COMPLETED|Overall Study||11
9977743|NCT01580410|11099220|FG001|NOT COMPLETED|Overall Study||8
9977744|NCT01580423|11099226|FG000|STARTED|First Intervention||8
9977745|NCT01580423|11099227|FG001|STARTED|First Intervention||8
9977746|NCT01580423|11099226|FG000|COMPLETED|First Intervention||8
9977747|NCT01580423|11099227|FG001|COMPLETED|First Intervention||8
9977748|NCT01580423|11099226|FG000|NOT COMPLETED|First Intervention||0
9977749|NCT01580423|11099227|FG001|NOT COMPLETED|First Intervention||0
9977750|NCT01580423|11099226|FG000|STARTED|Second Intervention||8
9977751|NCT01580423|11099227|FG001|STARTED|Second Intervention||8
9977752|NCT01580423|11099226|FG000|COMPLETED|Second Intervention||8
9977753|NCT01580423|11099227|FG001|COMPLETED|Second Intervention||8
9977754|NCT01580423|11099226|FG000|NOT COMPLETED|Second Intervention||0
9977755|NCT01580423|11099227|FG001|NOT COMPLETED|Second Intervention||0
9977756|NCT01580488|11099234|FG000|STARTED|Overall Study||24
9977757|NCT01580488|11099234|FG000|COMPLETED|Overall Study||23
9977758|NCT01580488|11099234|FG000|NOT COMPLETED|Overall Study||1
9977759|NCT01580592|11099251|FG000|STARTED|Overall Study||10
9977760|NCT01580592|11099252|FG001|STARTED|Overall Study||9
9977761|NCT01580592|11099253|FG002|STARTED|Overall Study||12
9977762|NCT01580592|11099251|FG000|COMPLETED|Overall Study||10
9977763|NCT01580592|11099252|FG001|COMPLETED|Overall Study||9
9977764|NCT01580592|11099253|FG002|COMPLETED|Overall Study||12
9977765|NCT01580592|11099251|FG000|NOT COMPLETED|Overall Study||0
9977766|NCT01580592|11099252|FG001|NOT COMPLETED|Overall Study||0
9977767|NCT01580592|11099253|FG002|NOT COMPLETED|Overall Study||0
9977768|NCT01580618|11099263|FG000|STARTED|Overall Study||8
9977769|NCT01580618|11099264|FG001|STARTED|Overall Study||12
9977770|NCT01580618|11099263|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
10202039|NCT03441984|11329277|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202040|NCT03441984|11329278|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9977771|NCT01580618|11099264|FG001|COMPLETED|Overall Study||12
9977772|NCT01580618|11099263|FG000|NOT COMPLETED|Overall Study||1
9977773|NCT01580618|11099264|FG001|NOT COMPLETED|Overall Study||0
9977774|NCT01580670|11099270|FG000|STARTED|Induction Period (Week 0 to 14)||14
9977775|NCT01580670|11099270|FG000|COMPLETED|Induction Period (Week 0 to 14)||14
9977776|NCT01580670|11099270|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0
9977777|NCT01580670|11099270|FG000|STARTED|Maintenance Period (Week 14 to 54)||14
9977778|NCT01580670|11099270|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12
9977779|NCT01580670|11099270|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
9977780|NCT01580904|11099276|FG000|STARTED|Overall Study||51
9977781|NCT01580904|11099277|FG001|STARTED|Overall Study||49
9977782|NCT01580904|11099276|FG000|COMPLETED|Overall Study||47
9977783|NCT01580904|11099277|FG001|COMPLETED|Overall Study||42
9977784|NCT01580904|11099276|FG000|NOT COMPLETED|Overall Study||4
9977785|NCT01580904|11099277|FG001|NOT COMPLETED|Overall Study||7
9977786|NCT01580969|11099287|FG000|STARTED|Overall Study||6
9977787|NCT01580969|11099288|FG001|STARTED|Overall Study||3
9977788|NCT01580969|11099289|FG002|STARTED|Overall Study||13
9977789|NCT01580969|11099287|FG000|COMPLETED|Overall Study||3
9977790|NCT01580969|11099288|FG001|COMPLETED|Overall Study||3
9977791|NCT01580969|11099289|FG002|COMPLETED|Overall Study||13
10099468|NCT02391948|11228589|FG004|NOT COMPLETED|12-month Assessment||6
10099469|NCT02391948|11228585|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
10099470|NCT02391948|11228586|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
9977792|NCT01580969|11099287|FG000|NOT COMPLETED|Overall Study||3
9977793|NCT01580969|11099288|FG001|NOT COMPLETED|Overall Study||0
9977794|NCT01580969|11099289|FG002|NOT COMPLETED|Overall Study||0
9977795|NCT01580995|11099299|FG000|STARTED|Overall Study||10
9977796|NCT01580995|11099300|FG001|STARTED|Overall Study||9
9977797|NCT01580995|11099299|FG000|COMPLETED|Overall Study||8
9977798|NCT01580995|11099300|FG001|COMPLETED|Overall Study||7
9977799|NCT01580995|11099299|FG000|NOT COMPLETED|Overall Study||2
9977800|NCT01580995|11099300|FG001|NOT COMPLETED|Overall Study||2
9977801|NCT01581008|11099308|FG000|STARTED|Overall Study||17
9977802|NCT01581008|11099309|FG001|STARTED|Overall Study||13
9977803|NCT01581008|11099308|FG000|COMPLETED|Overall Study||16
9977804|NCT01581008|11099309|FG001|COMPLETED|Overall Study||7
9977805|NCT01581008|11099308|FG000|NOT COMPLETED|Overall Study||1
9977806|NCT01581008|11099309|FG001|NOT COMPLETED|Overall Study||6
9977807|NCT01581021|11099318|FG000|STARTED|Overall Study||29
9977808|NCT01581021|11099319|FG001|STARTED|Overall Study||29
9977809|NCT01581021|11099318|FG000|COMPLETED|Overall Study||19
9977810|NCT01581021|11099319|FG001|COMPLETED|Overall Study||18
9977811|NCT01581021|11099318|FG000|NOT COMPLETED|Overall Study||10
9977812|NCT01581021|11099319|FG001|NOT COMPLETED|Overall Study||11
9977813|NCT01581281|11099328|FG000|STARTED|Overall Study||145
9977814|NCT01581281|11099329|FG001|STARTED|Overall Study||72
9977815|NCT01581281|11099330|FG002|STARTED|Overall Study||144
9977816|NCT01581281|11099328|FG000|COMPLETED|Overall Study||130
9977817|NCT01581281|11099329|FG001|COMPLETED|Overall Study||66
9977818|NCT01581281|11099330|FG002|COMPLETED|Overall Study||132
9977819|NCT01581281|11099328|FG000|NOT COMPLETED|Overall Study||15
9977820|NCT01581281|11099329|FG001|NOT COMPLETED|Overall Study||6
9977821|NCT01581281|11099330|FG002|NOT COMPLETED|Overall Study||12
9977822|NCT01581307|11099339|FG000|STARTED|Overall Study||9
9977823|NCT01581307|11099339|FG000|COMPLETED|Overall Study||8
9977824|NCT01581307|11099339|FG000|NOT COMPLETED|Overall Study||1
9977825|NCT01581437|11099343|FG000|STARTED|Overall Study||78
9977826|NCT01581437|11099343|FG000|COMPLETED|Overall Study||78
9977827|NCT01581437|11099343|FG000|NOT COMPLETED|Overall Study||0
9977828|NCT01581541|11099351|FG000|STARTED|Overall Study||1
9977829|NCT01581541|11099352|FG001|STARTED|Overall Study||1
9977830|NCT01581541|11099353|FG002|STARTED|Overall Study||1
9977831|NCT01581541|11099354|FG003|STARTED|Overall Study||1
9977832|NCT01581541|11099355|FG004|STARTED|Overall Study||2
9977833|NCT01581541|11099356|FG005|STARTED|Overall Study||3
9977834|NCT01581541|11099357|FG006|STARTED|Overall Study||1
9977835|NCT01581541|11099358|FG007|STARTED|Overall Study||2
9977836|NCT01581541|11099359|FG008|STARTED|Overall Study||1
10099471|NCT02391948|11228587|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
9977837|NCT01581541|11099360|FG009|STARTED|Overall Study||3
9977838|NCT01581541|11099361|FG010|STARTED|Overall Study||1
9977839|NCT01581541|11099351|FG000|COMPLETED|Overall Study||1
9977840|NCT01581541|11099352|FG001|COMPLETED|Overall Study||1
9977841|NCT01581541|11099353|FG002|COMPLETED|Overall Study||1
9977842|NCT01581541|11099354|FG003|COMPLETED|Overall Study||1
9977843|NCT01581541|11099355|FG004|COMPLETED|Overall Study||2
9977844|NCT01581541|11099356|FG005|COMPLETED|Overall Study||3
9977845|NCT01581541|11099357|FG006|COMPLETED|Overall Study||1
9977846|NCT01581541|11099358|FG007|COMPLETED|Overall Study||2
9977847|NCT01581541|11099359|FG008|COMPLETED|Overall Study||1
9977848|NCT01581541|11099360|FG009|COMPLETED|Overall Study||3
9977849|NCT01581541|11099361|FG010|COMPLETED|Overall Study||1
9977850|NCT01581541|11099351|FG000|NOT COMPLETED|Overall Study||0
9977851|NCT01581541|11099352|FG001|NOT COMPLETED|Overall Study||0
9977852|NCT01581541|11099353|FG002|NOT COMPLETED|Overall Study||0
9977853|NCT01581541|11099354|FG003|NOT COMPLETED|Overall Study||0
9977854|NCT01581541|11099355|FG004|NOT COMPLETED|Overall Study||0
9977855|NCT01581541|11099356|FG005|NOT COMPLETED|Overall Study||0
9977856|NCT01581541|11099357|FG006|NOT COMPLETED|Overall Study||0
9977857|NCT01581541|11099358|FG007|NOT COMPLETED|Overall Study||0
9977858|NCT01581541|11099359|FG008|NOT COMPLETED|Overall Study||0
10113163|NCT02508701|11244101|FG002|NOT COMPLETED|Overall Study||5
9977859|NCT01581541|11099360|FG009|NOT COMPLETED|Overall Study||0
9977860|NCT01581541|11099361|FG010|NOT COMPLETED|Overall Study||0
9977861|NCT01581593|11099386|FG000|STARTED|Overall Study||45
9977862|NCT01581593|11099386|FG000|COMPLETED|Overall Study||44
9977863|NCT01581593|11099386|FG000|NOT COMPLETED|Overall Study||1
9977864|NCT01581619|11099394|FG000|STARTED|Overall Study||54
9977865|NCT01581619|11099394|FG000|COMPLETED|Overall Study||52
9977866|NCT01581619|11099394|FG000|NOT COMPLETED|Overall Study||2
9977867|NCT01581658|11099404|FG000|STARTED|Overall Study||8
9977868|NCT01581658|11099405|FG001|STARTED|Overall Study||8
9977869|NCT01581658|11099406|FG002|STARTED|Overall Study||8
9977870|NCT01581658|11099407|FG003|STARTED|Overall Study||8
9977871|NCT01581658|11099404|FG000|COMPLETED|Overall Study||8
9977872|NCT01581658|11099405|FG001|COMPLETED|Overall Study||8
9977873|NCT01581658|11099406|FG002|COMPLETED|Overall Study||8
9977874|NCT01581658|11099407|FG003|COMPLETED|Overall Study||8
9977875|NCT01581658|11099404|FG000|NOT COMPLETED|Overall Study||0
9977876|NCT01581658|11099405|FG001|NOT COMPLETED|Overall Study||0
9977877|NCT01581658|11099406|FG002|NOT COMPLETED|Overall Study||0
9977878|NCT01581658|11099407|FG003|NOT COMPLETED|Overall Study||0
9977879|NCT01581684|11099427|FG000|STARTED|Overall Study||14
9977880|NCT01581684|11099428|FG001|STARTED|Overall Study||6
9977881|NCT01581684|11099429|FG002|STARTED|Overall Study||6
9977882|NCT01581684|11099430|FG003|STARTED|Overall Study||6
9977883|NCT01581684|11099431|FG004|STARTED|Overall Study||6
9977884|NCT01581684|11099432|FG005|STARTED|Overall Study||6
9977885|NCT01581684|11099433|FG006|STARTED|Overall Study||6
9977886|NCT01581684|11099434|FG007|STARTED|Overall Study||6
9977887|NCT01581684|11099435|FG008|STARTED|Overall Study||1
9977888|NCT01581684|11099436|FG009|STARTED|Overall Study||5
9977889|NCT01581684|11099427|FG000|COMPLETED|Overall Study||14
9977890|NCT01581684|11099428|FG001|COMPLETED|Overall Study||6
9977891|NCT01581684|11099429|FG002|COMPLETED|Overall Study||6
9977892|NCT01581684|11099430|FG003|COMPLETED|Overall Study||6
9977893|NCT01581684|11099431|FG004|COMPLETED|Overall Study||6
9977894|NCT01581684|11099432|FG005|COMPLETED|Overall Study||6
9977895|NCT01581684|11099433|FG006|COMPLETED|Overall Study||6
9977896|NCT01581684|11099434|FG007|COMPLETED|Overall Study||6
9977897|NCT01581684|11099435|FG008|COMPLETED|Overall Study||0
9977898|NCT01581684|11099436|FG009|COMPLETED|Overall Study||5
9977899|NCT01581684|11099427|FG000|NOT COMPLETED|Overall Study||0
9977900|NCT01581684|11099428|FG001|NOT COMPLETED|Overall Study||0
9977901|NCT01581684|11099429|FG002|NOT COMPLETED|Overall Study||0
9977902|NCT01581684|11099430|FG003|NOT COMPLETED|Overall Study||0
9977903|NCT01581684|11099431|FG004|NOT COMPLETED|Overall Study||0
9977904|NCT01581684|11099432|FG005|NOT COMPLETED|Overall Study||0
9977905|NCT01581684|11099433|FG006|NOT COMPLETED|Overall Study||0
9977906|NCT01581684|11099434|FG007|NOT COMPLETED|Overall Study||0
9977907|NCT01581684|11099435|FG008|NOT COMPLETED|Overall Study||1
9977908|NCT01581684|11099436|FG009|NOT COMPLETED|Overall Study||0
9977909|NCT01581710|11099469|FG000|STARTED|First Intervention (14days)||18
9977910|NCT01581710|11099470|FG001|STARTED|First Intervention (14days)||14
9977911|NCT01581710|11099469|FG000|COMPLETED|First Intervention (14days)||18
9977912|NCT01581710|11099470|FG001|COMPLETED|First Intervention (14days)||14
9977913|NCT01581710|11099469|FG000|NOT COMPLETED|First Intervention (14days)||0
9977914|NCT01581710|11099470|FG001|NOT COMPLETED|First Intervention (14days)||0
9977915|NCT01581710|11099469|FG000|STARTED|Washout Period (14days)||18
9977916|NCT01581710|11099470|FG001|STARTED|Washout Period (14days)||14
9977917|NCT01581710|11099469|FG000|COMPLETED|Washout Period (14days)||18
9977918|NCT01581710|11099470|FG001|COMPLETED|Washout Period (14days)||14
9977919|NCT01581710|11099469|FG000|NOT COMPLETED|Washout Period (14days)||0
9977920|NCT01581710|11099470|FG001|NOT COMPLETED|Washout Period (14days)||0
9977921|NCT01581710|11099469|FG000|STARTED|Second Intervention (14days)||18
9977922|NCT01581710|11099470|FG001|STARTED|Second Intervention (14days)||14
9977923|NCT01581710|11099469|FG000|COMPLETED|Second Intervention (14days)||18
9977924|NCT01581710|11099470|FG001|COMPLETED|Second Intervention (14days)||12
9977925|NCT01581710|11099469|FG000|NOT COMPLETED|Second Intervention (14days)||0
9977926|NCT01581710|11099470|FG001|NOT COMPLETED|Second Intervention (14days)||2
9977927|NCT01581931|11099480|FG000|STARTED|First Period||16
9977928|NCT01581931|11099481|FG001|STARTED|First Period||16
9977929|NCT01581931|11099480|FG000|COMPLETED|First Period||16
9977930|NCT01581931|11099481|FG001|COMPLETED|First Period||16
9977931|NCT01581931|11099480|FG000|NOT COMPLETED|First Period||0
9977932|NCT01581931|11099481|FG001|NOT COMPLETED|First Period||0
9977933|NCT01581931|11099480|FG000|STARTED|Washout||16
9977934|NCT01581931|11099481|FG001|STARTED|Washout||16
9977935|NCT01581931|11099480|FG000|COMPLETED|Washout||16
9977936|NCT01581931|11099481|FG001|COMPLETED|Washout||15
9977937|NCT01581931|11099480|FG000|NOT COMPLETED|Washout||0
9977938|NCT01581931|11099481|FG001|NOT COMPLETED|Washout||1
9977939|NCT01581931|11099480|FG000|STARTED|Second Period||16
9977940|NCT01581931|11099481|FG001|STARTED|Second Period||15
9977941|NCT01581931|11099480|FG000|COMPLETED|Second Period||16
9977942|NCT01581931|11099481|FG001|COMPLETED|Second Period||15
9977943|NCT01581931|11099480|FG000|NOT COMPLETED|Second Period||0
9977944|NCT01581931|11099481|FG001|NOT COMPLETED|Second Period||0
9977945|NCT01581970|11099487|FG000|STARTED|Overall Study||7
9977946|NCT01581970|11099487|FG000|COMPLETED|Overall Study||7
9977947|NCT01581970|11099487|FG000|NOT COMPLETED|Overall Study||0
9977948|NCT01582009|11099491|FG000|STARTED|Overall Study||26
9977949|NCT01582009|11099491|FG000|COMPLETED|Overall Study||24
9977950|NCT01582009|11099491|FG000|NOT COMPLETED|Overall Study||2
9977951|NCT01582061|11099497|FG000|STARTED|Overall Study||49
9977952|NCT01582061|11099498|FG001|STARTED|Overall Study||55
9977953|NCT01582061|11099497|FG000|COMPLETED|Overall Study||21
9977954|NCT01582061|11099498|FG001|COMPLETED|Overall Study||19
9977955|NCT01582061|11099497|FG000|NOT COMPLETED|Overall Study||28
9977956|NCT01582061|11099498|FG001|NOT COMPLETED|Overall Study||36
9977957|NCT01582139|11099516|FG000|STARTED|Overall Study||6
9977958|NCT01582139|11099517|FG001|STARTED|Overall Study||6
9977959|NCT01582139|11099516|FG000|COMPLETED|Overall Study||6
9977960|NCT01582139|11099517|FG001|COMPLETED|Overall Study||6
9977961|NCT01582139|11099516|FG000|NOT COMPLETED|Overall Study||0
9977962|NCT01582139|11099517|FG001|NOT COMPLETED|Overall Study||0
9977963|NCT01582152|11099525|FG000|STARTED|Overall Study||6
9977964|NCT01582152|11099526|FG001|STARTED|Overall Study||6
9977965|NCT01582152|11099525|FG000|COMPLETED|Overall Study||0
9977966|NCT01582152|11099526|FG001|COMPLETED|Overall Study||0
9977967|NCT01582152|11099525|FG000|NOT COMPLETED|Overall Study||6
9977968|NCT01582152|11099526|FG001|NOT COMPLETED|Overall Study||6
9977969|NCT01582178|11099534|FG000|STARTED|Overall Study||106
9977970|NCT01582178|11099535|FG001|STARTED|Overall Study||106
9977971|NCT01582178|11099534|FG000|COMPLETED|Overall Study||100
9977972|NCT01582178|11099535|FG001|COMPLETED|Overall Study||101
9977973|NCT01582178|11099534|FG000|NOT COMPLETED|Overall Study||6
9977974|NCT01582178|11099535|FG001|NOT COMPLETED|Overall Study||5
9977975|NCT01582243|11099541|FG000|STARTED|Overall Study||40
9977976|NCT01582243|11099541|FG000|COMPLETED|Overall Study||37
9977977|NCT01582243|11099541|FG000|NOT COMPLETED|Overall Study||3
9977978|NCT01582282|11099548|FG000|STARTED|Overall Study||15
9977979|NCT01582282|11099549|FG001|STARTED|Overall Study||14
9977980|NCT01582282|11099550|FG002|STARTED|Overall Study||8
9977981|NCT01582282|11099548|FG000|COMPLETED|Overall Study||13
9977982|NCT01582282|11099549|FG001|COMPLETED|Overall Study||12
9977983|NCT01582282|11099550|FG002|COMPLETED|Overall Study||8
9977984|NCT01582282|11099548|FG000|NOT COMPLETED|Overall Study||2
9977985|NCT01582282|11099549|FG001|NOT COMPLETED|Overall Study||2
9977986|NCT01582282|11099550|FG002|NOT COMPLETED|Overall Study||0
9977987|NCT01582308|11099558|FG000|STARTED|Period 1||2
9977988|NCT01582308|11099559|FG001|STARTED|Period 1||2
9977989|NCT01582308|11099560|FG002|STARTED|Period 1||2
9977990|NCT01582308|11099561|FG003|STARTED|Period 1||2
9977991|NCT01582308|11099562|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
9977992|NCT01582308|11099563|FG005|STARTED|Period 1||2
9977993|NCT01582308|11099564|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
9977994|NCT01582308|11099565|FG007|STARTED|Period 1||2
9977995|NCT01582308|11099566|FG008|STARTED|Period 1||2
9977996|NCT01582308|11099567|FG009|STARTED|Period 1||2
9977997|NCT01582308|11099558|FG000|COMPLETED|Period 1||2
9977998|NCT01582308|11099559|FG001|COMPLETED|Period 1||2
9977999|NCT01582308|11099560|FG002|COMPLETED|Period 1||2
9978000|NCT01582308|11099561|FG003|COMPLETED|Period 1||2
9978001|NCT01582308|11099562|FG004|COMPLETED|Period 1||3
9978002|NCT01582308|11099563|FG005|COMPLETED|Period 1||2
9978003|NCT01582308|11099564|FG006|COMPLETED|Period 1||2
9978004|NCT01582308|11099565|FG007|COMPLETED|Period 1||2
9978005|NCT01582308|11099566|FG008|COMPLETED|Period 1||2
9978006|NCT01582308|11099567|FG009|COMPLETED|Period 1||2
9978007|NCT01582308|11099558|FG000|NOT COMPLETED|Period 1||0
9978008|NCT01582308|11099559|FG001|NOT COMPLETED|Period 1||0
9978009|NCT01582308|11099560|FG002|NOT COMPLETED|Period 1||0
9978010|NCT01582308|11099561|FG003|NOT COMPLETED|Period 1||0
9978011|NCT01582308|11099562|FG004|NOT COMPLETED|Period 1||0
9978012|NCT01582308|11099563|FG005|NOT COMPLETED|Period 1||0
9978013|NCT01582308|11099564|FG006|NOT COMPLETED|Period 1||1
9978014|NCT01582308|11099565|FG007|NOT COMPLETED|Period 1||0
9978015|NCT01582308|11099566|FG008|NOT COMPLETED|Period 1||0
9978016|NCT01582308|11099567|FG009|NOT COMPLETED|Period 1||0
9978017|NCT01582308|11099558|FG000|STARTED|10-day Washout Following Period 1||2
9978018|NCT01582308|11099559|FG001|STARTED|10-day Washout Following Period 1||2
9978019|NCT01582308|11099560|FG002|STARTED|10-day Washout Following Period 1||2
9978020|NCT01582308|11099561|FG003|STARTED|10-day Washout Following Period 1||2
9978021|NCT01582308|11099562|FG004|STARTED|10-day Washout Following Period 1||3
9978022|NCT01582308|11099563|FG005|STARTED|10-day Washout Following Period 1||2
9978023|NCT01582308|11099564|FG006|STARTED|10-day Washout Following Period 1||2
9978024|NCT01582308|11099565|FG007|STARTED|10-day Washout Following Period 1||2
9978025|NCT01582308|11099566|FG008|STARTED|10-day Washout Following Period 1||2
9978026|NCT01582308|11099567|FG009|STARTED|10-day Washout Following Period 1||2
9978027|NCT01582308|11099558|FG000|COMPLETED|10-day Washout Following Period 1||2
9978028|NCT01582308|11099559|FG001|COMPLETED|10-day Washout Following Period 1||2
9978029|NCT01582308|11099560|FG002|COMPLETED|10-day Washout Following Period 1||2
9978030|NCT01582308|11099561|FG003|COMPLETED|10-day Washout Following Period 1||2
9978031|NCT01582308|11099562|FG004|COMPLETED|10-day Washout Following Period 1||2
9978032|NCT01582308|11099563|FG005|COMPLETED|10-day Washout Following Period 1||2
9978033|NCT01582308|11099564|FG006|COMPLETED|10-day Washout Following Period 1||2
9978034|NCT01582308|11099565|FG007|COMPLETED|10-day Washout Following Period 1||2
9978035|NCT01582308|11099566|FG008|COMPLETED|10-day Washout Following Period 1||2
9978036|NCT01582308|11099567|FG009|COMPLETED|10-day Washout Following Period 1||2
9978037|NCT01582308|11099558|FG000|NOT COMPLETED|10-day Washout Following Period 1||0
9978038|NCT01582308|11099559|FG001|NOT COMPLETED|10-day Washout Following Period 1||0
9978039|NCT01582308|11099560|FG002|NOT COMPLETED|10-day Washout Following Period 1||0
9978040|NCT01582308|11099561|FG003|NOT COMPLETED|10-day Washout Following Period 1||0
9978041|NCT01582308|11099562|FG004|NOT COMPLETED|10-day Washout Following Period 1||1
9978042|NCT01582308|11099563|FG005|NOT COMPLETED|10-day Washout Following Period 1||0
9978043|NCT01582308|11099564|FG006|NOT COMPLETED|10-day Washout Following Period 1||0
9978044|NCT01582308|11099565|FG007|NOT COMPLETED|10-day Washout Following Period 1||0
9978045|NCT01582308|11099566|FG008|NOT COMPLETED|10-day Washout Following Period 1||0
9978046|NCT01582308|11099567|FG009|NOT COMPLETED|10-day Washout Following Period 1||0
9978047|NCT01582308|11099558|FG000|STARTED|Period 2||2
9978048|NCT01582308|11099559|FG001|STARTED|Period 2||2
9978049|NCT01582308|11099560|FG002|STARTED|Period 2||2
9978050|NCT01582308|11099561|FG003|STARTED|Period 2||2
9978051|NCT01582308|11099562|FG004|STARTED|Period 2||2
9978052|NCT01582308|11099563|FG005|STARTED|Period 2||2
9978053|NCT01582308|11099564|FG006|STARTED|Period 2||2
9978054|NCT01582308|11099565|FG007|STARTED|Period 2||2
9978055|NCT01582308|11099566|FG008|STARTED|Period 2||2
9978056|NCT01582308|11099567|FG009|STARTED|Period 2||2
9978057|NCT01582308|11099558|FG000|COMPLETED|Period 2||2
9978058|NCT01582308|11099559|FG001|COMPLETED|Period 2||2
9978059|NCT01582308|11099560|FG002|COMPLETED|Period 2||2
9978060|NCT01582308|11099561|FG003|COMPLETED|Period 2||2
9978061|NCT01582308|11099562|FG004|COMPLETED|Period 2||2
9978062|NCT01582308|11099563|FG005|COMPLETED|Period 2||2
9978063|NCT01582308|11099564|FG006|COMPLETED|Period 2||2
9978064|NCT01582308|11099565|FG007|COMPLETED|Period 2||2
9978065|NCT01582308|11099566|FG008|COMPLETED|Period 2||2
9978066|NCT01582308|11099567|FG009|COMPLETED|Period 2||2
9978067|NCT01582308|11099558|FG000|NOT COMPLETED|Period 2||0
9978068|NCT01582308|11099559|FG001|NOT COMPLETED|Period 2||0
9978069|NCT01582308|11099560|FG002|NOT COMPLETED|Period 2||0
9978070|NCT01582308|11099561|FG003|NOT COMPLETED|Period 2||0
9978071|NCT01582308|11099562|FG004|NOT COMPLETED|Period 2||0
9978072|NCT01582308|11099563|FG005|NOT COMPLETED|Period 2||0
9978073|NCT01582308|11099564|FG006|NOT COMPLETED|Period 2||0
9978074|NCT01582308|11099565|FG007|NOT COMPLETED|Period 2||0
9978075|NCT01582308|11099566|FG008|NOT COMPLETED|Period 2||0
9978076|NCT01582308|11099567|FG009|NOT COMPLETED|Period 2||0
9978077|NCT01582308|11099558|FG000|STARTED|10-day Washout Following Period 2||2
9978078|NCT01582308|11099559|FG001|STARTED|10-day Washout Following Period 2||2
9978079|NCT01582308|11099560|FG002|STARTED|10-day Washout Following Period 2||2
9978080|NCT01582308|11099561|FG003|STARTED|10-day Washout Following Period 2||2
9978081|NCT01582308|11099562|FG004|STARTED|10-day Washout Following Period 2||2
9978082|NCT01582308|11099563|FG005|STARTED|10-day Washout Following Period 2||2
9978083|NCT01582308|11099564|FG006|STARTED|10-day Washout Following Period 2||2
9978084|NCT01582308|11099565|FG007|STARTED|10-day Washout Following Period 2||2
9978085|NCT01582308|11099566|FG008|STARTED|10-day Washout Following Period 2||2
9978086|NCT01582308|11099567|FG009|STARTED|10-day Washout Following Period 2||2
9978087|NCT01582308|11099558|FG000|COMPLETED|10-day Washout Following Period 2||2
9978088|NCT01582308|11099559|FG001|COMPLETED|10-day Washout Following Period 2||2
9978089|NCT01582308|11099560|FG002|COMPLETED|10-day Washout Following Period 2||2
9978090|NCT01582308|11099561|FG003|COMPLETED|10-day Washout Following Period 2||2
9978091|NCT01582308|11099562|FG004|COMPLETED|10-day Washout Following Period 2||2
9978092|NCT01582308|11099563|FG005|COMPLETED|10-day Washout Following Period 2||2
9978093|NCT01582308|11099564|FG006|COMPLETED|10-day Washout Following Period 2||2
9978094|NCT01582308|11099565|FG007|COMPLETED|10-day Washout Following Period 2||2
9978095|NCT01582308|11099566|FG008|COMPLETED|10-day Washout Following Period 2||2
9978096|NCT01582308|11099567|FG009|COMPLETED|10-day Washout Following Period 2||2
9978097|NCT01582308|11099558|FG000|NOT COMPLETED|10-day Washout Following Period 2||0
9978098|NCT01582308|11099559|FG001|NOT COMPLETED|10-day Washout Following Period 2||0
9978099|NCT01582308|11099560|FG002|NOT COMPLETED|10-day Washout Following Period 2||0
9978100|NCT01582308|11099561|FG003|NOT COMPLETED|10-day Washout Following Period 2||0
9978101|NCT01582308|11099562|FG004|NOT COMPLETED|10-day Washout Following Period 2||0
9978102|NCT01582308|11099563|FG005|NOT COMPLETED|10-day Washout Following Period 2||0
9978103|NCT01582308|11099564|FG006|NOT COMPLETED|10-day Washout Following Period 2||0
9978104|NCT01582308|11099565|FG007|NOT COMPLETED|10-day Washout Following Period 2||0
9978105|NCT01582308|11099566|FG008|NOT COMPLETED|10-day Washout Following Period 2||0
9978106|NCT01582308|11099567|FG009|NOT COMPLETED|10-day Washout Following Period 2||0
9978107|NCT01582308|11099558|FG000|STARTED|Period 3||2
9978108|NCT01582308|11099559|FG001|STARTED|Period 3||2
10099472|NCT02391948|11228588|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
10099473|NCT02391948|11228589|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
10099474|NCT02391948|11228585|FG000|COMPLETED|18-month Assessment||147
10099475|NCT02391948|11228586|FG001|COMPLETED|18-month Assessment||101
10099476|NCT02391948|11228587|FG002|COMPLETED|18-month Assessment||48
10099477|NCT02391948|11228588|FG003|COMPLETED|18-month Assessment||83
10099478|NCT02391948|11228589|FG004|COMPLETED|18-month Assessment||75
10099479|NCT02391948|11228585|FG000|NOT COMPLETED|18-month Assessment||72
10099480|NCT02391948|11228586|FG001|NOT COMPLETED|18-month Assessment||50
10099481|NCT02391948|11228587|FG002|NOT COMPLETED|18-month Assessment||26
10099482|NCT02391948|11228588|FG003|NOT COMPLETED|18-month Assessment||36
9978109|NCT01582308|11099560|FG002|STARTED|Period 3||2
9978110|NCT01582308|11099561|FG003|STARTED|Period 3||2
9978111|NCT01582308|11099562|FG004|STARTED|Period 3||2
9978112|NCT01582308|11099563|FG005|STARTED|Period 3||2
9978113|NCT01582308|11099564|FG006|STARTED|Period 3||2
9978114|NCT01582308|11099565|FG007|STARTED|Period 3||2
9978115|NCT01582308|11099566|FG008|STARTED|Period 3||2
9978116|NCT01582308|11099567|FG009|STARTED|Period 3||2
9978117|NCT01582308|11099558|FG000|COMPLETED|Period 3||2
9978118|NCT01582308|11099559|FG001|COMPLETED|Period 3||2
9978119|NCT01582308|11099560|FG002|COMPLETED|Period 3||2
9978120|NCT01582308|11099561|FG003|COMPLETED|Period 3||2
9978121|NCT01582308|11099562|FG004|COMPLETED|Period 3||2
9978122|NCT01582308|11099563|FG005|COMPLETED|Period 3||2
9978123|NCT01582308|11099564|FG006|COMPLETED|Period 3||2
9978124|NCT01582308|11099565|FG007|COMPLETED|Period 3||2
9978125|NCT01582308|11099566|FG008|COMPLETED|Period 3||2
9978126|NCT01582308|11099567|FG009|COMPLETED|Period 3||2
9978127|NCT01582308|11099558|FG000|NOT COMPLETED|Period 3||0
9978128|NCT01582308|11099559|FG001|NOT COMPLETED|Period 3||0
9978129|NCT01582308|11099560|FG002|NOT COMPLETED|Period 3||0
9978130|NCT01582308|11099561|FG003|NOT COMPLETED|Period 3||0
9978131|NCT01582308|11099562|FG004|NOT COMPLETED|Period 3||0
9978132|NCT01582308|11099563|FG005|NOT COMPLETED|Period 3||0
9978133|NCT01582308|11099564|FG006|NOT COMPLETED|Period 3||0
9978134|NCT01582308|11099565|FG007|NOT COMPLETED|Period 3||0
9978135|NCT01582308|11099566|FG008|NOT COMPLETED|Period 3||0
9978136|NCT01582308|11099567|FG009|NOT COMPLETED|Period 3||0
9978137|NCT01582308|11099558|FG000|STARTED|10-day Washout Following Period 3||2
9978138|NCT01582308|11099559|FG001|STARTED|10-day Washout Following Period 3||2
9978139|NCT01582308|11099560|FG002|STARTED|10-day Washout Following Period 3||2
9978140|NCT01582308|11099561|FG003|STARTED|10-day Washout Following Period 3||2
9978141|NCT01582308|11099562|FG004|STARTED|10-day Washout Following Period 3||2
9978142|NCT01582308|11099563|FG005|STARTED|10-day Washout Following Period 3||2
9978143|NCT01582308|11099564|FG006|STARTED|10-day Washout Following Period 3||2
9978144|NCT01582308|11099565|FG007|STARTED|10-day Washout Following Period 3||2
9978145|NCT01582308|11099566|FG008|STARTED|10-day Washout Following Period 3||2
9978146|NCT01582308|11099567|FG009|STARTED|10-day Washout Following Period 3||2
9978147|NCT01582308|11099558|FG000|COMPLETED|10-day Washout Following Period 3||2
9978148|NCT01582308|11099559|FG001|COMPLETED|10-day Washout Following Period 3||2
9978149|NCT01582308|11099560|FG002|COMPLETED|10-day Washout Following Period 3||2
9978150|NCT01582308|11099561|FG003|COMPLETED|10-day Washout Following Period 3||2
9978151|NCT01582308|11099562|FG004|COMPLETED|10-day Washout Following Period 3||2
9978152|NCT01582308|11099563|FG005|COMPLETED|10-day Washout Following Period 3||2
9978153|NCT01582308|11099564|FG006|COMPLETED|10-day Washout Following Period 3||2
9978154|NCT01582308|11099565|FG007|COMPLETED|10-day Washout Following Period 3||2
9978155|NCT01582308|11099566|FG008|COMPLETED|10-day Washout Following Period 3||2
9978156|NCT01582308|11099567|FG009|COMPLETED|10-day Washout Following Period 3||2
9978157|NCT01582308|11099558|FG000|NOT COMPLETED|10-day Washout Following Period 3||0
9978158|NCT01582308|11099559|FG001|NOT COMPLETED|10-day Washout Following Period 3||0
9978159|NCT01582308|11099560|FG002|NOT COMPLETED|10-day Washout Following Period 3||0
9978160|NCT01582308|11099561|FG003|NOT COMPLETED|10-day Washout Following Period 3||0
9978161|NCT01582308|11099562|FG004|NOT COMPLETED|10-day Washout Following Period 3||0
9978162|NCT01582308|11099563|FG005|NOT COMPLETED|10-day Washout Following Period 3||0
9978163|NCT01582308|11099564|FG006|NOT COMPLETED|10-day Washout Following Period 3||0
9978164|NCT01582308|11099565|FG007|NOT COMPLETED|10-day Washout Following Period 3||0
9978165|NCT01582308|11099566|FG008|NOT COMPLETED|10-day Washout Following Period 3||0
9978166|NCT01582308|11099567|FG009|NOT COMPLETED|10-day Washout Following Period 3||0
9978167|NCT01582308|11099558|FG000|STARTED|Period 4||2
9978168|NCT01582308|11099559|FG001|STARTED|Period 4||2
9978169|NCT01582308|11099560|FG002|STARTED|Period 4||2
9978170|NCT01582308|11099561|FG003|STARTED|Period 4||2
9978171|NCT01582308|11099562|FG004|STARTED|Period 4||2
9978172|NCT01582308|11099563|FG005|STARTED|Period 4||2
9978173|NCT01582308|11099564|FG006|STARTED|Period 4||2
9978174|NCT01582308|11099565|FG007|STARTED|Period 4||2
9978175|NCT01582308|11099566|FG008|STARTED|Period 4||2
9978176|NCT01582308|11099567|FG009|STARTED|Period 4||2
9978177|NCT01582308|11099558|FG000|COMPLETED|Period 4||1
9978178|NCT01582308|11099559|FG001|COMPLETED|Period 4||2
9978179|NCT01582308|11099560|FG002|COMPLETED|Period 4||2
9978180|NCT01582308|11099561|FG003|COMPLETED|Period 4||2
9978181|NCT01582308|11099562|FG004|COMPLETED|Period 4||2
9978182|NCT01582308|11099563|FG005|COMPLETED|Period 4||1
9978183|NCT01582308|11099564|FG006|COMPLETED|Period 4||2
9978184|NCT01582308|11099565|FG007|COMPLETED|Period 4||2
9978185|NCT01582308|11099566|FG008|COMPLETED|Period 4||2
9978186|NCT01582308|11099567|FG009|COMPLETED|Period 4||1
9978187|NCT01582308|11099558|FG000|NOT COMPLETED|Period 4||1
9978188|NCT01582308|11099559|FG001|NOT COMPLETED|Period 4||0
9978189|NCT01582308|11099560|FG002|NOT COMPLETED|Period 4||0
9978190|NCT01582308|11099561|FG003|NOT COMPLETED|Period 4||0
9978191|NCT01582308|11099562|FG004|NOT COMPLETED|Period 4||0
9978192|NCT01582308|11099563|FG005|NOT COMPLETED|Period 4||1
9978193|NCT01582308|11099564|FG006|NOT COMPLETED|Period 4||0
9978194|NCT01582308|11099565|FG007|NOT COMPLETED|Period 4||0
9978195|NCT01582308|11099566|FG008|NOT COMPLETED|Period 4||0
9978196|NCT01582308|11099567|FG009|NOT COMPLETED|Period 4||1
9978197|NCT01582308|11099558|FG000|STARTED|10-day Washout Following Period 4||1
9978198|NCT01582308|11099559|FG001|STARTED|10-day Washout Following Period 4||2
9978199|NCT01582308|11099560|FG002|STARTED|10-day Washout Following Period 4||2
9978200|NCT01582308|11099561|FG003|STARTED|10-day Washout Following Period 4||2
9978201|NCT01582308|11099562|FG004|STARTED|10-day Washout Following Period 4||2
9978202|NCT01582308|11099563|FG005|STARTED|10-day Washout Following Period 4||1
9978203|NCT01582308|11099564|FG006|STARTED|10-day Washout Following Period 4||2
9978204|NCT01582308|11099565|FG007|STARTED|10-day Washout Following Period 4||2
9978205|NCT01582308|11099566|FG008|STARTED|10-day Washout Following Period 4||2
9978206|NCT01582308|11099567|FG009|STARTED|10-day Washout Following Period 4||1
9978207|NCT01582308|11099558|FG000|COMPLETED|10-day Washout Following Period 4||1
9978208|NCT01582308|11099559|FG001|COMPLETED|10-day Washout Following Period 4||2
9978209|NCT01582308|11099560|FG002|COMPLETED|10-day Washout Following Period 4||2
9978210|NCT01582308|11099561|FG003|COMPLETED|10-day Washout Following Period 4||2
9978211|NCT01582308|11099562|FG004|COMPLETED|10-day Washout Following Period 4||2
9978212|NCT01582308|11099563|FG005|COMPLETED|10-day Washout Following Period 4||1
9978213|NCT01582308|11099564|FG006|COMPLETED|10-day Washout Following Period 4||2
9978214|NCT01582308|11099565|FG007|COMPLETED|10-day Washout Following Period 4||2
9978215|NCT01582308|11099566|FG008|COMPLETED|10-day Washout Following Period 4||2
9978216|NCT01582308|11099567|FG009|COMPLETED|10-day Washout Following Period 4||1
9978217|NCT01582308|11099558|FG000|NOT COMPLETED|10-day Washout Following Period 4||0
9978218|NCT01582308|11099559|FG001|NOT COMPLETED|10-day Washout Following Period 4||0
9978219|NCT01582308|11099560|FG002|NOT COMPLETED|10-day Washout Following Period 4||0
9978220|NCT01582308|11099561|FG003|NOT COMPLETED|10-day Washout Following Period 4||0
9978221|NCT01582308|11099562|FG004|NOT COMPLETED|10-day Washout Following Period 4||0
9978222|NCT01582308|11099563|FG005|NOT COMPLETED|10-day Washout Following Period 4||0
9978223|NCT01582308|11099564|FG006|NOT COMPLETED|10-day Washout Following Period 4||0
9978224|NCT01582308|11099565|FG007|NOT COMPLETED|10-day Washout Following Period 4||0
9978225|NCT01582308|11099566|FG008|NOT COMPLETED|10-day Washout Following Period 4||0
9978226|NCT01582308|11099567|FG009|NOT COMPLETED|10-day Washout Following Period 4||0
9978227|NCT01582308|11099558|FG000|STARTED|Period 5||1
9978228|NCT01582308|11099559|FG001|STARTED|Period 5||2
9978229|NCT01582308|11099560|FG002|STARTED|Period 5||2
9978230|NCT01582308|11099561|FG003|STARTED|Period 5||2
9978231|NCT01582308|11099562|FG004|STARTED|Period 5||2
9978232|NCT01582308|11099563|FG005|STARTED|Period 5||1
9978233|NCT01582308|11099564|FG006|STARTED|Period 5||2
9978234|NCT01582308|11099565|FG007|STARTED|Period 5||2
9978235|NCT01582308|11099566|FG008|STARTED|Period 5||2
9978236|NCT01582308|11099567|FG009|STARTED|Period 5||1
9978237|NCT01582308|11099558|FG000|COMPLETED|Period 5||1
9978238|NCT01582308|11099559|FG001|COMPLETED|Period 5||2
9978239|NCT01582308|11099560|FG002|COMPLETED|Period 5||2
9978240|NCT01582308|11099561|FG003|COMPLETED|Period 5||2
9978241|NCT01582308|11099562|FG004|COMPLETED|Period 5||2
9978242|NCT01582308|11099563|FG005|COMPLETED|Period 5||1
9978243|NCT01582308|11099564|FG006|COMPLETED|Period 5||2
9978244|NCT01582308|11099565|FG007|COMPLETED|Period 5||2
10099483|NCT02391948|11228589|FG004|NOT COMPLETED|18-month Assessment||30
10099484|NCT02391948|11228585|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
10099485|NCT02391948|11228586|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
10099486|NCT02391948|11228587|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
9978245|NCT01582308|11099566|FG008|COMPLETED|Period 5||2
9978246|NCT01582308|11099567|FG009|COMPLETED|Period 5||1
9978247|NCT01582308|11099558|FG000|NOT COMPLETED|Period 5||0
9978248|NCT01582308|11099559|FG001|NOT COMPLETED|Period 5||0
9978249|NCT01582308|11099560|FG002|NOT COMPLETED|Period 5||0
9978250|NCT01582308|11099561|FG003|NOT COMPLETED|Period 5||0
9978251|NCT01582308|11099562|FG004|NOT COMPLETED|Period 5||0
9978252|NCT01582308|11099563|FG005|NOT COMPLETED|Period 5||0
9978253|NCT01582308|11099564|FG006|NOT COMPLETED|Period 5||0
9978254|NCT01582308|11099565|FG007|NOT COMPLETED|Period 5||0
9978255|NCT01582308|11099566|FG008|NOT COMPLETED|Period 5||0
9978256|NCT01582308|11099567|FG009|NOT COMPLETED|Period 5||0
9978257|NCT01582451|11099582|FG000|STARTED|Overall Study||307
9978258|NCT01582451|11099583|FG001|STARTED|Overall Study||159
9978259|NCT01582451|11099582|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305
9978260|NCT01582451|11099583|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
9978261|NCT01582451|11099582|FG000|COMPLETED|Overall Study||275
9978262|NCT01582451|11099583|FG001|COMPLETED|Overall Study||139
9978263|NCT01582451|11099582|FG000|NOT COMPLETED|Overall Study||32
9978264|NCT01582451|11099583|FG001|NOT COMPLETED|Overall Study||20
9978265|NCT01582477|11099591|FG000|STARTED|Overall Study||12
9978266|NCT01582477|11099592|FG001|STARTED|Overall Study||12
9978267|NCT01582477|11099591|FG000|COMPLETED|Overall Study||12
9978268|NCT01582477|11099592|FG001|COMPLETED|Overall Study||12
9978269|NCT01582477|11099591|FG000|NOT COMPLETED|Overall Study||0
9978270|NCT01582477|11099592|FG001|NOT COMPLETED|Overall Study||0
9978271|NCT01582490|11099600|FG000|STARTED|Overall Study||9
9978272|NCT01582490|11099601|FG001|STARTED|Overall Study||10
9978273|NCT01582490|11099600|FG000|COMPLETED|Overall Study||8
9978274|NCT01582490|11099601|FG001|COMPLETED|Overall Study||9
9978275|NCT01582490|11099600|FG000|NOT COMPLETED|Overall Study||1
9978276|NCT01582490|11099601|FG001|NOT COMPLETED|Overall Study||1
9978277|NCT01582789|11099609|FG000|STARTED|First Intervention (14 Days)||34
9978278|NCT01582789|11099610|FG001|STARTED|First Intervention (14 Days)||27
9978279|NCT01582789|11099609|FG000|COMPLETED|First Intervention (14 Days)||34
9978280|NCT01582789|11099610|FG001|COMPLETED|First Intervention (14 Days)||27
9978281|NCT01582789|11099609|FG000|NOT COMPLETED|First Intervention (14 Days)||0
9978282|NCT01582789|11099610|FG001|NOT COMPLETED|First Intervention (14 Days)||0
9978283|NCT01582789|11099609|FG000|STARTED|Second Intervention (14 Days)||34
9978284|NCT01582789|11099610|FG001|STARTED|Second Intervention (14 Days)||27
9978285|NCT01582789|11099609|FG000|COMPLETED|Second Intervention (14 Days)||33
9978286|NCT01582789|11099610|FG001|COMPLETED|Second Intervention (14 Days)||27
9978287|NCT01582789|11099609|FG000|NOT COMPLETED|Second Intervention (14 Days)||1
9978288|NCT01582789|11099610|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
9978289|NCT01582854|11099620|FG000|STARTED|Overall Study||248
9978290|NCT01582854|11099621|FG001|STARTED|Overall Study||255
9978291|NCT01582854|11099620|FG000|COMPLETED|Overall Study||212
9978292|NCT01582854|11099621|FG001|COMPLETED|Overall Study||221
9978293|NCT01582854|11099620|FG000|NOT COMPLETED|Overall Study||36
9978294|NCT01582854|11099621|FG001|NOT COMPLETED|Overall Study||34
9978295|NCT01582880|11099627|FG000|STARTED|Overall Study||1
9978296|NCT01582880|11099627|FG000|COMPLETED|Overall Study||1
9978297|NCT01582880|11099627|FG000|NOT COMPLETED|Overall Study||0
9978298|NCT01582945|11099631|FG000|STARTED|Overall Study||14
9978299|NCT01582945|11099631|FG000|COMPLETED|Overall Study||12
9978300|NCT01582945|11099631|FG000|NOT COMPLETED|Overall Study||2
10099487|NCT02391948|11228588|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
10099488|NCT02391948|11228589|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
10099489|NCT02391948|11228585|FG000|COMPLETED|24-month Assessment||135
10202041|NCT03441984|11329279|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202042|NCT03441984|11329280|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202043|NCT03441984|11329281|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202044|NCT03441984|11329282|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202045|NCT03441984|11329283|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202046|NCT03441984|11329284|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202047|NCT03441984|11329285|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202048|NCT03441984|11329286|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202049|NCT03441984|11329287|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10202050|NCT03441984|11329276|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202051|NCT03441984|11329277|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202052|NCT03441984|11329278|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202053|NCT03441984|11329279|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202054|NCT03441984|11329280|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202055|NCT03441984|11329281|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202056|NCT03441984|11329282|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202057|NCT03441984|11329283|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202058|NCT03441984|11329284|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202059|NCT03441984|11329285|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202060|NCT03441984|11329286|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9978301|NCT01582971|11099637|FG000|STARTED|Overall Study||128
9978302|NCT01582971|11099638|FG001|STARTED|Overall Study||128
9978303|NCT01582971|11099637|FG000|COMPLETED|Overall Study||89
9978304|NCT01582971|11099638|FG001|COMPLETED|Overall Study||91
9978305|NCT01582971|11099637|FG000|NOT COMPLETED|Overall Study||39
9978306|NCT01582971|11099638|FG001|NOT COMPLETED|Overall Study||37
9978307|NCT01583101|11099652|FG000|STARTED|Overall Study||1076
9978308|NCT01583101|11099653|FG001|STARTED|Overall Study||1161
9978309|NCT01583101|11099652|FG000|COMPLETED|Overall Study||1076
9978310|NCT01583101|11099653|FG001|COMPLETED|Overall Study||1161
9978311|NCT01583101|11099652|FG000|NOT COMPLETED|Overall Study||0
9978312|NCT01583101|11099653|FG001|NOT COMPLETED|Overall Study||0
9978313|NCT01583166|11099661|FG000|STARTED|Overall Study||45
9978314|NCT01583166|11099662|FG001|STARTED|Overall Study||45
9978315|NCT01583166|11099661|FG000|COMPLETED|Overall Study||41
9978316|NCT01583166|11099662|FG001|COMPLETED|Overall Study||39
9978317|NCT01583166|11099661|FG000|NOT COMPLETED|Overall Study||4
9978318|NCT01583166|11099662|FG001|NOT COMPLETED|Overall Study||6
9978319|NCT01583179|11099670|FG000|STARTED|Overall Study||14
9978320|NCT01583179|11099671|FG001|STARTED|Overall Study||12
9978321|NCT01583179|11099670|FG000|COMPLETED|Overall Study||13
9978322|NCT01583179|11099671|FG001|COMPLETED|Overall Study||10
9978323|NCT01583179|11099670|FG000|NOT COMPLETED|Overall Study||1
9978324|NCT01583179|11099671|FG001|NOT COMPLETED|Overall Study||2
9978325|NCT01583218|11099679|FG000|STARTED|Overall Study||3759
9978326|NCT01583218|11099680|FG001|STARTED|Overall Study||3754
10099490|NCT02391948|11228586|FG001|COMPLETED|24-month Assessment||97
10099491|NCT02391948|11228587|FG002|COMPLETED|24-month Assessment||48
10099492|NCT02391948|11228588|FG003|COMPLETED|24-month Assessment||75
10099493|NCT02391948|11228589|FG004|COMPLETED|24-month Assessment||69
10099494|NCT02391948|11228585|FG000|NOT COMPLETED|24-month Assessment||14
10099495|NCT02391948|11228586|FG001|NOT COMPLETED|24-month Assessment||10
10099496|NCT02391948|11228587|FG002|NOT COMPLETED|24-month Assessment||3
9978327|NCT01583218|11099679|FG000|COMPLETED|Overall Study||3470
9978328|NCT01583218|11099680|FG001|COMPLETED|Overall Study||3471
9978329|NCT01583218|11099679|FG000|NOT COMPLETED|Overall Study||289
9978330|NCT01583218|11099680|FG001|NOT COMPLETED|Overall Study||283
10017812|NCT01819415|11140788|FG000|STARTED|Overall Study||10
10017813|NCT01819415|11140789|FG001|STARTED|Overall Study||10
10017814|NCT01819415|11140790|FG002|STARTED|Overall Study||10
9978331|NCT01583296|11099688|FG000|STARTED|Overall Study||27
9978332|NCT01583296|11099689|FG001|STARTED|Overall Study||26
9978333|NCT01583296|11099688|FG000|COMPLETED|Overall Study||16
9978334|NCT01583296|11099689|FG001|COMPLETED|Overall Study||16
9978335|NCT01583296|11099688|FG000|NOT COMPLETED|Overall Study||11
9978336|NCT01583296|11099689|FG001|NOT COMPLETED|Overall Study||10
9978337|NCT01583374|11099698|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164
9978338|NCT01583374|11099699|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163
9978339|NCT01583374|11099700|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163
9978340|NCT01583374|11099701|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
9978341|NCT01583374|11099702|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
9978342|NCT01583374|11099703|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
9978343|NCT01583374|11099704|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
9978344|NCT01583374|11099705|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
9978345|NCT01583374|11099706|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
9978346|NCT01583374|11099698|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
9978347|NCT01583374|11099699|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
9978348|NCT01583374|11099700|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
9978349|NCT01583374|11099701|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9978350|NCT01583374|11099702|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9978351|NCT01583374|11099703|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9978352|NCT01583374|11099704|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9978353|NCT01583374|11099705|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9978354|NCT01583374|11099706|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9978355|NCT01583374|11099698|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
9978356|NCT01583374|11099699|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
9978357|NCT01583374|11099700|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
9978358|NCT01583374|11099701|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9978359|NCT01583374|11099702|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9978360|NCT01583374|11099703|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9978361|NCT01583374|11099704|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9978362|NCT01583374|11099705|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9978363|NCT01583374|11099706|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9978364|NCT01583374|11099698|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
9978365|NCT01583374|11099699|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
9978366|NCT01583374|11099700|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
9978367|NCT01583374|11099701|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9978368|NCT01583374|11099702|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9978369|NCT01583374|11099703|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9978370|NCT01583374|11099704|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9978371|NCT01583374|11099705|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9978372|NCT01583374|11099706|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9978373|NCT01583374|11099698|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
9978374|NCT01583374|11099699|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
9978375|NCT01583374|11099700|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
9978376|NCT01583374|11099701|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978377|NCT01583374|11099702|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978378|NCT01583374|11099703|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978379|NCT01583374|11099704|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978380|NCT01583374|11099705|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978381|NCT01583374|11099706|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978382|NCT01583374|11099698|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
9978383|NCT01583374|11099699|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
9978384|NCT01583374|11099700|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
9978385|NCT01583374|11099701|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978386|NCT01583374|11099702|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978387|NCT01583374|11099703|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978388|NCT01583374|11099704|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978389|NCT01583374|11099705|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978390|NCT01583374|11099706|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9978391|NCT01583374|11099698|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0
9978392|NCT01583374|11099699|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74
9978393|NCT01583374|11099700|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65
9978394|NCT01583374|11099701|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47
9978395|NCT01583374|11099702|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91
9978396|NCT01583374|11099703|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48
9978397|NCT01583374|11099704|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48
9978398|NCT01583374|11099705|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25
9978399|NCT01583374|11099706|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23
9978400|NCT01583374|11099698|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0
9978401|NCT01583374|11099699|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69
9978402|NCT01583374|11099700|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61
9978403|NCT01583374|11099701|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41
9978404|NCT01583374|11099702|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85
9978405|NCT01583374|11099703|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43
9978406|NCT01583374|11099704|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43
9978407|NCT01583374|11099705|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22
9978408|NCT01583374|11099706|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21
9978409|NCT01583374|11099698|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
9978410|NCT01583374|11099699|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
9978411|NCT01583374|11099700|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
9978412|NCT01583374|11099701|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
9978413|NCT01583374|11099702|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
9978414|NCT01583374|11099703|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
9978415|NCT01583374|11099704|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
9978416|NCT01583374|11099705|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
9978417|NCT01583374|11099706|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
9978418|NCT01583374|11099698|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0
9978419|NCT01583374|11099699|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66
9978420|NCT01583374|11099700|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61
9978421|NCT01583374|11099701|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35
9978422|NCT01583374|11099702|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81
9978423|NCT01583374|11099703|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39
9978424|NCT01583374|11099704|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38
9978425|NCT01583374|11099705|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21
9978426|NCT01583374|11099706|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20
9978427|NCT01583374|11099698|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
9978428|NCT01583374|11099699|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
9978429|NCT01583374|11099700|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
9978430|NCT01583374|11099701|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
9978431|NCT01583374|11099702|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
9978432|NCT01583374|11099703|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
9978433|NCT01583374|11099704|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
9978434|NCT01583374|11099705|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
9978435|NCT01583374|11099706|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
9978436|NCT01583374|11099698|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
9978437|NCT01583374|11099699|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
9978438|NCT01583374|11099700|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
9978439|NCT01583374|11099701|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
9978440|NCT01583374|11099702|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
9978441|NCT01583374|11099703|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
9978442|NCT01583374|11099704|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
9978443|NCT01583374|11099705|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
9978444|NCT01583374|11099706|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
9978445|NCT01583452|11099727|FG000|STARTED|Overall Study||21
9978446|NCT01583452|11099728|FG001|STARTED|Overall Study||20
9978447|NCT01583452|11099727|FG000|COMPLETED|Overall Study||21
9978448|NCT01583452|11099728|FG001|COMPLETED|Overall Study||20
9978449|NCT01583452|11099727|FG000|NOT COMPLETED|Overall Study||0
9978450|NCT01583452|11099728|FG001|NOT COMPLETED|Overall Study||0
9978451|NCT01583530|11099743|FG000|STARTED|Overall Study||19
9978452|NCT01583530|11099744|FG001|STARTED|Overall Study||20
9978453|NCT01583530|11099745|FG002|STARTED|Overall Study||20
9978454|NCT01583530|11099746|FG003|STARTED|Overall Study||19
9978455|NCT01583530|11099747|FG004|STARTED|Overall Study||20
9978456|NCT01583530|11099748|FG005|STARTED|Overall Study||20
9978457|NCT01583530|11099743|FG000|COMPLETED|Overall Study||19
9978458|NCT01583530|11099744|FG001|COMPLETED|Overall Study||17
9978459|NCT01583530|11099745|FG002|COMPLETED|Overall Study||20
9978460|NCT01583530|11099746|FG003|COMPLETED|Overall Study||18
9978461|NCT01583530|11099747|FG004|COMPLETED|Overall Study||15
9978462|NCT01583530|11099748|FG005|COMPLETED|Overall Study||17
9978463|NCT01583530|11099743|FG000|NOT COMPLETED|Overall Study||0
9978464|NCT01583530|11099744|FG001|NOT COMPLETED|Overall Study||3
9978465|NCT01583530|11099745|FG002|NOT COMPLETED|Overall Study||0
9978466|NCT01583530|11099746|FG003|NOT COMPLETED|Overall Study||1
9978467|NCT01583530|11099747|FG004|NOT COMPLETED|Overall Study||5
9978468|NCT01583530|11099748|FG005|NOT COMPLETED|Overall Study||3
9978469|NCT01583543|11099765|FG000|STARTED|Overall Study||12
9978470|NCT01583543|11099765|FG000|COMPLETED|Overall Study||12
9978471|NCT01583543|11099765|FG000|NOT COMPLETED|Overall Study||0
9978472|NCT01583686|11099777|FG000|STARTED|Overall Study||3
9978473|NCT01583686|11099778|FG001|STARTED|Overall Study||3
9758694|NCT01924533|10862256|FG001|COMPLETED|Overall Study||57
9758695|NCT01924533|10862255|FG000|NOT COMPLETED|Overall Study||189
9758696|NCT01924533|10862256|FG001|NOT COMPLETED|Overall Study||205
9758697|NCT01856140|10862264|FG000|STARTED|Overall Study||6
9758698|NCT01856140|10862265|FG001|STARTED|Overall Study||6
9758699|NCT01856140|10862264|FG000|COMPLETED|Overall Study||6
9758700|NCT01856140|10862265|FG001|COMPLETED|Overall Study||6
9758701|NCT01856140|10862264|FG000|NOT COMPLETED|Overall Study||0
9978474|NCT01583686|11099779|FG002|STARTED|Overall Study||3
9978475|NCT01583686|11099780|FG003|STARTED|Overall Study||3
9978476|NCT01583686|11099781|FG004|STARTED|Overall Study||3
9978477|NCT01583686|11099777|FG000|COMPLETED|Overall Study||3
9978478|NCT01583686|11099778|FG001|COMPLETED|Overall Study||3
9978479|NCT01583686|11099779|FG002|COMPLETED|Overall Study||3
9978480|NCT01583686|11099780|FG003|COMPLETED|Overall Study||3
9978481|NCT01583686|11099781|FG004|COMPLETED|Overall Study||3
9978482|NCT01583686|11099777|FG000|NOT COMPLETED|Overall Study||0
9978483|NCT01583686|11099778|FG001|NOT COMPLETED|Overall Study||0
9978484|NCT01583686|11099779|FG002|NOT COMPLETED|Overall Study||0
9978485|NCT01583686|11099780|FG003|NOT COMPLETED|Overall Study||0
9978486|NCT01583686|11099781|FG004|NOT COMPLETED|Overall Study||0
9978487|NCT01583868|11099798|FG000|STARTED|Overall Study||108
9978488|NCT01583868|11099799|FG001|STARTED|Overall Study||108
9978489|NCT01583868|11099798|FG000|COMPLETED|Overall Study||104
9978490|NCT01583868|11099799|FG001|COMPLETED|Overall Study||104
9978491|NCT01583868|11099798|FG000|NOT COMPLETED|Overall Study||4
9978492|NCT01583868|11099799|FG001|NOT COMPLETED|Overall Study||4
9978493|NCT01583894|11099809|FG000|STARTED|Overall Study||828
9978494|NCT01583894|11099809|FG000|COMPLETED|Overall Study||813
9978495|NCT01583894|11099809|FG000|NOT COMPLETED|Overall Study||15
9978496|NCT01583985|11099815|FG000|STARTED|Overall Study||120
9978497|NCT01583985|11099816|FG001|STARTED|Overall Study||120
9978498|NCT01583985|11099815|FG000|Included in Primary Analysis|Overall Study||119
9978499|NCT01583985|11099816|FG001|Included in Primary Analysis|Overall Study||119
9978500|NCT01583985|11099815|FG000|COMPLETED|Overall Study||117
9978501|NCT01583985|11099816|FG001|COMPLETED|Overall Study||117
9978502|NCT01583985|11099815|FG000|NOT COMPLETED|Overall Study||3
9978503|NCT01583985|11099816|FG001|NOT COMPLETED|Overall Study||3
9978504|NCT01584024|11099822|FG000|STARTED|Overall Study||42
9978505|NCT01584024|11099822|FG000|COMPLETED|Overall Study||29
9978506|NCT01584024|11099822|FG000|NOT COMPLETED|Overall Study||13
9978507|NCT01584232|11099829|FG000|STARTED|Overall Study||181
9978508|NCT01584232|11099830|FG001|STARTED|Overall Study||180
9978509|NCT01584232|11099829|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181
9978510|NCT01584232|11099830|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180
9978511|NCT01584232|11099829|FG000|COMPLETED|Overall Study||173
9978512|NCT01584232|11099830|FG001|COMPLETED|Overall Study||177
9978513|NCT01584232|11099829|FG000|NOT COMPLETED|Overall Study||8
9978514|NCT01584232|11099830|FG001|NOT COMPLETED|Overall Study||3
9978515|NCT01584388|11099836|FG000|STARTED|Overall Study||30
9978516|NCT01584388|11099836|FG000|COMPLETED|Overall Study||30
9978517|NCT01584388|11099836|FG000|NOT COMPLETED|Overall Study||0
9978518|NCT01584440|11099856|FG000|STARTED|Stage 1 (5 Weeks)||93
9978519|NCT01584440|11099857|FG001|STARTED|Stage 1 (5 Weeks)||127
9978520|NCT01584440|11099858|FG002|STARTED|Stage 1 (5 Weeks)||0
9978521|NCT01584440|11099859|FG003|STARTED|Stage 1 (5 Weeks)||0
9978522|NCT01584440|11099860|FG004|STARTED|Stage 1 (5 Weeks)||0
9978523|NCT01584440|11099856|FG000|COMPLETED|Stage 1 (5 Weeks)||83
9978524|NCT01584440|11099857|FG001|COMPLETED|Stage 1 (5 Weeks)||119
9978525|NCT01584440|11099858|FG002|COMPLETED|Stage 1 (5 Weeks)||0
9978526|NCT01584440|11099859|FG003|COMPLETED|Stage 1 (5 Weeks)||0
9978527|NCT01584440|11099860|FG004|COMPLETED|Stage 1 (5 Weeks)||0
9978528|NCT01584440|11099856|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10
9978529|NCT01584440|11099857|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8
9978530|NCT01584440|11099858|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0
9978531|NCT01584440|11099859|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0
9978532|NCT01584440|11099860|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0
9978533|NCT01584440|11099856|FG000|STARTED|Stage 2 (5 Weeks)||0
9978534|NCT01584440|11099857|FG001|STARTED|Stage 2 (5 Weeks)||0
9978535|NCT01584440|11099858|FG002|STARTED|Stage 2 (5 Weeks)||83
9978536|NCT01584440|11099859|FG003|STARTED|Stage 2 (5 Weeks)||59
9978537|NCT01584440|11099860|FG004|STARTED|Stage 2 (5 Weeks)||60
9978538|NCT01584440|11099856|FG000|COMPLETED|Stage 2 (5 Weeks)||0
9978539|NCT01584440|11099857|FG001|COMPLETED|Stage 2 (5 Weeks)||0
9978540|NCT01584440|11099858|FG002|COMPLETED|Stage 2 (5 Weeks)||80
9978541|NCT01584440|11099859|FG003|COMPLETED|Stage 2 (5 Weeks)||55
9978542|NCT01584440|11099860|FG004|COMPLETED|Stage 2 (5 Weeks)||59
9978543|NCT01584440|11099856|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0
9978544|NCT01584440|11099857|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0
9978545|NCT01584440|11099858|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3
9978546|NCT01584440|11099859|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4
9978547|NCT01584440|11099860|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1
9978548|NCT01584479|11099877|FG000|STARTED|Overall Study||732
9978549|NCT01584479|11099878|FG001|STARTED|Overall Study||1686
9978550|NCT01584479|11099879|FG002|STARTED|Overall Study||852
9978551|NCT01584479|11099880|FG003|STARTED|Overall Study||1847
9978552|NCT01584479|11099877|FG000|COMPLETED|Overall Study||732
9978553|NCT01584479|11099878|FG001|COMPLETED|Overall Study||1686
9978554|NCT01584479|11099879|FG002|COMPLETED|Overall Study||852
9978555|NCT01584479|11099880|FG003|COMPLETED|Overall Study||1847
9978556|NCT01584479|11099877|FG000|NOT COMPLETED|Overall Study||0
9978557|NCT01584479|11099878|FG001|NOT COMPLETED|Overall Study||0
9978558|NCT01584479|11099879|FG002|NOT COMPLETED|Overall Study||0
9978559|NCT01584479|11099880|FG003|NOT COMPLETED|Overall Study||0
9978560|NCT01584518|11099892|FG000|STARTED|Overall Study||25
9978561|NCT01584518|11099893|FG001|STARTED|Overall Study||25
9978562|NCT01584518|11099892|FG000|COMPLETED|Overall Study||25
9978563|NCT01584518|11099893|FG001|COMPLETED|Overall Study||25
9978564|NCT01584518|11099892|FG000|NOT COMPLETED|Overall Study||0
9978565|NCT01584518|11099893|FG001|NOT COMPLETED|Overall Study||0
9978566|NCT01584544|11099904|FG000|STARTED|Overall Study||3
9978567|NCT01584544|11099905|FG001|STARTED|Overall Study||6
9978568|NCT01584544|11099906|FG002|STARTED|Overall Study||6
9978569|NCT01584544|11099907|FG003|STARTED|Overall Study||3
9978570|NCT01584544|11099908|FG004|STARTED|Overall Study||6
9978571|NCT01584544|11099904|FG000|COMPLETED|Overall Study||3
9978572|NCT01584544|11099905|FG001|COMPLETED|Overall Study||6
9978573|NCT01584544|11099906|FG002|COMPLETED|Overall Study||6
9978574|NCT01584544|11099907|FG003|COMPLETED|Overall Study||3
9978575|NCT01584544|11099908|FG004|COMPLETED|Overall Study||6
9978576|NCT01584544|11099904|FG000|NOT COMPLETED|Overall Study||0
9978577|NCT01584544|11099905|FG001|NOT COMPLETED|Overall Study||0
9978578|NCT01584544|11099906|FG002|NOT COMPLETED|Overall Study||0
9978579|NCT01584544|11099907|FG003|NOT COMPLETED|Overall Study||0
9978580|NCT01584544|11099908|FG004|NOT COMPLETED|Overall Study||0
9978581|NCT01584609|11099922|FG000|STARTED|Overall Study||98
9978582|NCT01584609|11099923|FG001|STARTED|Overall Study||100
9978583|NCT01584609|11099922|FG000|COMPLETED|Overall Study||86
9978584|NCT01584609|11099923|FG001|COMPLETED|Overall Study||96
9978585|NCT01584609|11099922|FG000|NOT COMPLETED|Overall Study||12
9978586|NCT01584609|11099923|FG001|NOT COMPLETED|Overall Study||4
9978587|NCT01584648|11099931|FG000|STARTED|Overall Study||211
9978588|NCT01584648|11099932|FG001|STARTED|Overall Study||212
9978589|NCT01584648|11099931|FG000|Safety Set|Overall Study||209
9978590|NCT01584648|11099932|FG001|Safety Set|Overall Study||211
9978591|NCT01584648|11099931|FG000|Crossover Population|Overall Study||0
9978592|NCT01584648|11099932|FG001|Crossover Population|Overall Study||28
9978593|NCT01584648|11099931|FG000|COMPLETED|Overall Study||0
9978594|NCT01584648|11099932|FG001|COMPLETED|Overall Study||0
9978595|NCT01584648|11099931|FG000|NOT COMPLETED|Overall Study||211
9978596|NCT01584648|11099932|FG001|NOT COMPLETED|Overall Study||212
9978597|NCT01584843|11099945|FG000|STARTED|First Treatment Period||3
9978598|NCT01584843|11099946|FG001|STARTED|First Treatment Period||4
9978599|NCT01584843|11099947|FG002|STARTED|First Treatment Period||3
9978600|NCT01584843|11099948|FG003|STARTED|First Treatment Period||10
9978601|NCT01584843|11099949|FG004|STARTED|First Treatment Period||10
9978602|NCT01584843|11099950|FG005|STARTED|First Treatment Period||11
9978603|NCT01584843|11099945|FG000|COMPLETED|First Treatment Period||3
9978604|NCT01584843|11099946|FG001|COMPLETED|First Treatment Period||4
9978605|NCT01584843|11099947|FG002|COMPLETED|First Treatment Period||2
9978606|NCT01584843|11099948|FG003|COMPLETED|First Treatment Period||10
9978607|NCT01584843|11099949|FG004|COMPLETED|First Treatment Period||10
9978608|NCT01584843|11099950|FG005|COMPLETED|First Treatment Period||9
9978609|NCT01584843|11099945|FG000|NOT COMPLETED|First Treatment Period||0
9978610|NCT01584843|11099946|FG001|NOT COMPLETED|First Treatment Period||0
9978611|NCT01584843|11099947|FG002|NOT COMPLETED|First Treatment Period||1
9978612|NCT01584843|11099948|FG003|NOT COMPLETED|First Treatment Period||0
9978613|NCT01584843|11099949|FG004|NOT COMPLETED|First Treatment Period||0
9978614|NCT01584843|11099950|FG005|NOT COMPLETED|First Treatment Period||2
9978615|NCT01584843|11099945|FG000|STARTED|Second Treatment Period||2
9978616|NCT01584843|11099946|FG001|STARTED|Second Treatment Period||1
9978617|NCT01584843|11099947|FG002|STARTED|Second Treatment Period||2
9978618|NCT01584843|11099948|FG003|STARTED|Second Treatment Period||6
9978619|NCT01584843|11099949|FG004|STARTED|Second Treatment Period||3
9978620|NCT01584843|11099950|FG005|STARTED|Second Treatment Period||1
9978621|NCT01584843|11099945|FG000|COMPLETED|Second Treatment Period||2
9978622|NCT01584843|11099946|FG001|COMPLETED|Second Treatment Period||1
9978623|NCT01584843|11099947|FG002|COMPLETED|Second Treatment Period||2
9978624|NCT01584843|11099948|FG003|COMPLETED|Second Treatment Period||6
9978625|NCT01584843|11099949|FG004|COMPLETED|Second Treatment Period||3
9978626|NCT01584843|11099950|FG005|COMPLETED|Second Treatment Period||0
9978627|NCT01584843|11099945|FG000|NOT COMPLETED|Second Treatment Period||0
9978628|NCT01584843|11099946|FG001|NOT COMPLETED|Second Treatment Period||0
9978629|NCT01584843|11099947|FG002|NOT COMPLETED|Second Treatment Period||0
9978630|NCT01584843|11099948|FG003|NOT COMPLETED|Second Treatment Period||0
9978631|NCT01584843|11099949|FG004|NOT COMPLETED|Second Treatment Period||0
9978632|NCT01584843|11099950|FG005|NOT COMPLETED|Second Treatment Period||1
9978633|NCT01585025|11099969|FG000|STARTED|Overall Study||10
9978634|NCT01585025|11099970|FG001|STARTED|Overall Study||13
9978635|NCT01585025|11099971|FG002|STARTED|Overall Study||12
9978636|NCT01585025|11099969|FG000|COMPLETED|Overall Study||10
9978637|NCT01585025|11099970|FG001|COMPLETED|Overall Study||10
9978638|NCT01585025|11099971|FG002|COMPLETED|Overall Study||8
9978639|NCT01585025|11099969|FG000|NOT COMPLETED|Overall Study||0
9978640|NCT01585025|11099970|FG001|NOT COMPLETED|Overall Study||3
9978641|NCT01585025|11099971|FG002|NOT COMPLETED|Overall Study||4
9978642|NCT01585038|11099981|FG000|STARTED|Overall Study||20
9978643|NCT01585038|11099982|FG001|STARTED|Overall Study||20
9978644|NCT01585038|11099981|FG000|COMPLETED|Overall Study||18
9978645|NCT01585038|11099982|FG001|COMPLETED|Overall Study||18
9978646|NCT01585038|11099981|FG000|NOT COMPLETED|Overall Study||2
9978647|NCT01585038|11099982|FG001|NOT COMPLETED|Overall Study||2
9978648|NCT01585129|11099990|FG000|STARTED|Overall Study||41
9978649|NCT01585129|11099991|FG001|STARTED|Overall Study||39
9978650|NCT01585129|11099990|FG000|COMPLETED|Overall Study||41
9978651|NCT01585129|11099991|FG001|COMPLETED|Overall Study||39
9978652|NCT01585129|11099990|FG000|NOT COMPLETED|Overall Study||0
9978653|NCT01585129|11099991|FG001|NOT COMPLETED|Overall Study||0
9978654|NCT01585155|11099997|FG000|STARTED|Overall Study||21
9978655|NCT01585155|11099997|FG000|COMPLETED|Overall Study||16
9978656|NCT01585155|11099997|FG000|NOT COMPLETED|Overall Study||5
9978657|NCT01585168|11100003|FG000|STARTED|Overall Study||18
9978658|NCT01585168|11100004|FG001|STARTED|Overall Study||18
9978659|NCT01585168|11100005|FG002|STARTED|Overall Study||16
9978660|NCT01585168|11100006|FG003|STARTED|Overall Study||19
9978661|NCT01585168|11100003|FG000|COMPLETED|Overall Study||15
9978662|NCT01585168|11100004|FG001|COMPLETED|Overall Study||17
9978663|NCT01585168|11100005|FG002|COMPLETED|Overall Study||15
9978664|NCT01585168|11100006|FG003|COMPLETED|Overall Study||18
9978665|NCT01585168|11100003|FG000|NOT COMPLETED|Overall Study||3
9978666|NCT01585168|11100004|FG001|NOT COMPLETED|Overall Study||1
9978667|NCT01585168|11100005|FG002|NOT COMPLETED|Overall Study||1
9978668|NCT01585168|11100006|FG003|NOT COMPLETED|Overall Study||1
9978669|NCT01585194|11100014|FG000|STARTED|Overall Study||39
9978670|NCT01585194|11100014|FG000|COMPLETED|Overall Study||35
9978671|NCT01585194|11100014|FG000|NOT COMPLETED|Overall Study||4
9978672|NCT01585207|11100018|FG000|STARTED|Overall Study||4
9978673|NCT01585207|11100018|FG000|COMPLETED|Overall Study||4
9978674|NCT01585207|11100018|FG000|NOT COMPLETED|Overall Study||0
9978675|NCT01585246|11100027|FG000|STARTED|Overall Study||3
9978676|NCT01585246|11100028|FG001|STARTED|Overall Study||4
9978677|NCT01585246|11100029|FG002|STARTED|Overall Study||20
9978678|NCT01585246|11100030|FG003|STARTED|Overall Study||10
9978679|NCT01585246|11100031|FG004|STARTED|Overall Study||11
9978680|NCT01585246|11100027|FG000|COMPLETED|Overall Study||3
9978681|NCT01585246|11100028|FG001|COMPLETED|Overall Study||3
9978682|NCT01585246|11100029|FG002|COMPLETED|Overall Study||16
9978683|NCT01585246|11100030|FG003|COMPLETED|Overall Study||6
9978684|NCT01585246|11100031|FG004|COMPLETED|Overall Study||9
9978685|NCT01585246|11100027|FG000|NOT COMPLETED|Overall Study||0
9978686|NCT01585246|11100028|FG001|NOT COMPLETED|Overall Study||1
9978687|NCT01585246|11100029|FG002|NOT COMPLETED|Overall Study||4
9978688|NCT01585246|11100030|FG003|NOT COMPLETED|Overall Study||4
9978689|NCT01585246|11100031|FG004|NOT COMPLETED|Overall Study||2
9978690|NCT01585272|11100046|FG000|STARTED|Overall Study||121
9978691|NCT01585272|11100046|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
9978692|NCT01585272|11100046|FG000|Exelon Patch 5 cm2|Overall Study||114
9978693|NCT01585272|11100046|FG000|Exelon Patch 10 cm2|Overall Study||96
9978694|NCT01585272|11100046|FG000|COMPLETED|Overall Study||82
9978695|NCT01585272|11100046|FG000|NOT COMPLETED|Overall Study||39
9978696|NCT01585298|11100050|FG000|STARTED|Overall Study||6998
9978697|NCT01585298|11100050|FG000|COMPLETED|Overall Study||6961
9978698|NCT01585298|11100050|FG000|NOT COMPLETED|Overall Study||37
9978699|NCT01585324|11100054|FG000|STARTED|Overall Study||30
9978700|NCT01585324|11100054|FG000|COMPLETED|Overall Study||30
9978701|NCT01585324|11100054|FG000|NOT COMPLETED|Overall Study||0
9978702|NCT01585428|11100062|FG000|STARTED|Overall Study||18
9978703|NCT01585428|11100063|FG001|STARTED|Overall Study||11
9978704|NCT01585428|11100062|FG000|COMPLETED|Overall Study||17
9978705|NCT01585428|11100063|FG001|COMPLETED|Overall Study||11
9978706|NCT01585428|11100062|FG000|NOT COMPLETED|Overall Study||1
9978707|NCT01585428|11100063|FG001|NOT COMPLETED|Overall Study||0
9978708|NCT01585441|11100072|FG000|STARTED|Overall Study||3
9978709|NCT01585441|11100073|FG001|STARTED|Overall Study||3
9978710|NCT01585441|11100072|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
9978711|NCT01585441|11100073|FG001|Month 3|Overall Study||3
9978712|NCT01585441|11100072|FG000|Received Finasteride at Month 3|Overall Study||2
9978713|NCT01585441|11100073|FG001|Received Finasteride at Month 3|Overall Study||2
9978714|NCT01585441|11100072|FG000|Final Study Safety Visit|Overall Study||3
9978715|NCT01585441|11100073|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
9978716|NCT01585441|11100072|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
9978717|NCT01585441|11100073|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
9978718|NCT01585441|11100072|FG000|NOT COMPLETED|Overall Study||0
9978719|NCT01585441|11100073|FG001|NOT COMPLETED|Overall Study||0
9978720|NCT01585558|11100082|FG000|STARTED|Overall Study||62
9978721|NCT01585558|11100083|FG001|STARTED|Overall Study||69
9978722|NCT01585558|11100084|FG002|STARTED|Overall Study||49
9978723|NCT01585558|11100082|FG000|COMPLETED|Overall Study||49
9978724|NCT01585558|11100083|FG001|COMPLETED|Overall Study||57
9978725|NCT01585558|11100084|FG002|COMPLETED|Overall Study||34
9978726|NCT01585558|11100082|FG000|NOT COMPLETED|Overall Study||13
9978727|NCT01585558|11100083|FG001|NOT COMPLETED|Overall Study||12
9978728|NCT01585558|11100084|FG002|NOT COMPLETED|Overall Study||15
9978729|NCT01585584|11100092|FG000|STARTED|Overall Study||10
9978730|NCT01585584|11100092|FG000|COMPLETED|Overall Study||6
9978731|NCT01585584|11100092|FG000|NOT COMPLETED|Overall Study||4
9978732|NCT01585597|11100096|FG000|STARTED|Overall Study||20
9978733|NCT01585597|11100096|FG000|COMPLETED|Overall Study||20
9978734|NCT01585597|11100096|FG000|NOT COMPLETED|Overall Study||0
9978735|NCT01585766|11100106|FG000|STARTED|Overall Study||7
9978736|NCT01585766|11100107|FG001|STARTED|Overall Study||5
9978737|NCT01585766|11100108|FG002|STARTED|Overall Study||3
9978738|NCT01585766|11100109|FG003|STARTED|Overall Study||4
9978739|NCT01585766|11100110|FG004|STARTED|Overall Study||3
9978740|NCT01585766|11100111|FG005|STARTED|Overall Study||6
9978741|NCT01585766|11100106|FG000|COMPLETED|Overall Study||7
9978742|NCT01585766|11100107|FG001|COMPLETED|Overall Study||3
9978743|NCT01585766|11100108|FG002|COMPLETED|Overall Study||1
9978744|NCT01585766|11100109|FG003|COMPLETED|Overall Study||4
9978745|NCT01585766|11100110|FG004|COMPLETED|Overall Study||3
9978746|NCT01585766|11100111|FG005|COMPLETED|Overall Study||6
9978747|NCT01585766|11100106|FG000|NOT COMPLETED|Overall Study||0
9978748|NCT01585766|11100107|FG001|NOT COMPLETED|Overall Study||2
9978749|NCT01585766|11100108|FG002|NOT COMPLETED|Overall Study||2
9978750|NCT01585766|11100109|FG003|NOT COMPLETED|Overall Study||0
9978751|NCT01585766|11100110|FG004|NOT COMPLETED|Overall Study||0
9978752|NCT01585766|11100111|FG005|NOT COMPLETED|Overall Study||0
9978753|NCT01585779|11100134|FG000|STARTED|Overall Study||36
9978754|NCT01585779|11100135|FG001|STARTED|Overall Study||28
9978755|NCT01585779|11100134|FG000|COMPLETED|Overall Study||26
9978756|NCT01585779|11100135|FG001|COMPLETED|Overall Study||21
9978757|NCT01585779|11100134|FG000|NOT COMPLETED|Overall Study||10
9978758|NCT01585779|11100135|FG001|NOT COMPLETED|Overall Study||7
9978759|NCT01585831|11100144|FG000|STARTED|Overall Study||28
9978760|NCT01585831|11100145|FG001|STARTED|Overall Study||20
9978761|NCT01585831|11100144|FG000|COMPLETED|Overall Study||26
9978762|NCT01585831|11100145|FG001|COMPLETED|Overall Study||18
9978763|NCT01585831|11100144|FG000|NOT COMPLETED|Overall Study||2
9978764|NCT01585831|11100145|FG001|NOT COMPLETED|Overall Study||2
9978765|NCT01585961|11100151|FG000|STARTED|Overall Study||511
9978766|NCT01585961|11100151|FG000|Safety|Overall Study|Patients ablated with study catheter|508
9978767|NCT01585961|11100151|FG000|COMPLETED|Overall Study||478
9978768|NCT01585961|11100151|FG000|NOT COMPLETED|Overall Study||33
9978769|NCT01585987|11100157|FG000|STARTED|Randomized||57
9978770|NCT01585987|11100158|FG001|STARTED|Randomized||57
9978771|NCT01585987|11100157|FG000|COMPLETED|Randomized||57
9978772|NCT01585987|11100158|FG001|COMPLETED|Randomized||51
9978773|NCT01585987|11100157|FG000|NOT COMPLETED|Randomized||0
9978774|NCT01585987|11100158|FG001|NOT COMPLETED|Randomized||6
9978775|NCT01585987|11100157|FG000|STARTED|Treated||57
9978776|NCT01585987|11100158|FG001|STARTED|Treated||51
9978777|NCT01585987|11100157|FG000|COMPLETED|Treated||3
9978778|NCT01585987|11100158|FG001|COMPLETED|Treated||2
9978779|NCT01585987|11100157|FG000|NOT COMPLETED|Treated||54
9978780|NCT01585987|11100158|FG001|NOT COMPLETED|Treated||49
9978781|NCT01586026|11100165|FG000|STARTED|Overall Study||350
9978782|NCT01586026|11100166|FG001|STARTED|Overall Study||414
9978783|NCT01586026|11100167|FG002|STARTED|Overall Study||271
9978784|NCT01586026|11100165|FG000|COMPLETED|Overall Study||350
9978785|NCT01586026|11100166|FG001|COMPLETED|Overall Study||414
9978786|NCT01586026|11100167|FG002|COMPLETED|Overall Study||271
9978787|NCT01586026|11100165|FG000|NOT COMPLETED|Overall Study||0
9978788|NCT01586026|11100166|FG001|NOT COMPLETED|Overall Study||0
9978789|NCT01586026|11100167|FG002|NOT COMPLETED|Overall Study||0
9978790|NCT01586039|11100179|FG000|STARTED|Overall Study||8
9978791|NCT01586039|11100180|FG001|STARTED|Overall Study||9
9978792|NCT01586039|11100181|FG002|STARTED|Overall Study||8
9978793|NCT01586039|11100182|FG003|STARTED|Overall Study||8
9978794|NCT01586039|11100179|FG000|COMPLETED|Overall Study||8
9978795|NCT01586039|11100180|FG001|COMPLETED|Overall Study||8
9978796|NCT01586039|11100181|FG002|COMPLETED|Overall Study||8
9978797|NCT01586039|11100182|FG003|COMPLETED|Overall Study||8
9978798|NCT01586039|11100179|FG000|NOT COMPLETED|Overall Study||0
9978799|NCT01586039|11100180|FG001|NOT COMPLETED|Overall Study||1
9978800|NCT01586039|11100181|FG002|NOT COMPLETED|Overall Study||0
9978801|NCT01586039|11100182|FG003|NOT COMPLETED|Overall Study||0
9978802|NCT01586091|11100195|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
9978803|NCT01586091|11100196|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
9978804|NCT01586091|11100197|FG002|STARTED|Overall Study||6
9978805|NCT01586091|11100195|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
9978806|NCT01586091|11100196|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
9978807|NCT01586091|11100197|FG002|COMPLETED|Overall Study||6
9978808|NCT01586091|11100195|FG000|NOT COMPLETED|Overall Study||0
9978809|NCT01586091|11100196|FG001|NOT COMPLETED|Overall Study||0
9978810|NCT01586091|11100197|FG002|NOT COMPLETED|Overall Study||0
9978811|NCT01586156|11100211|FG000|STARTED|Overall Study||10
9978812|NCT01586156|11100212|FG001|STARTED|Overall Study||10
9978813|NCT01586156|11100213|FG002|STARTED|Overall Study||10
9978814|NCT01586156|11100211|FG000|COMPLETED|Overall Study||10
9978815|NCT01586156|11100212|FG001|COMPLETED|Overall Study||9
9978816|NCT01586156|11100213|FG002|COMPLETED|Overall Study||10
9978817|NCT01586156|11100211|FG000|NOT COMPLETED|Overall Study||0
9978818|NCT01586156|11100212|FG001|NOT COMPLETED|Overall Study||1
9978819|NCT01586156|11100213|FG002|NOT COMPLETED|Overall Study||0
9978820|NCT01586195|11100221|FG000|STARTED|Overall Study||31
9978821|NCT01586195|11100221|FG000|COMPLETED|Overall Study||5
9978822|NCT01586195|11100221|FG000|NOT COMPLETED|Overall Study||26
9978823|NCT01586312|11100227|FG000|STARTED|Overall Study||15
9978824|NCT01586312|11100228|FG001|STARTED|Overall Study||15
9978825|NCT01586312|11100227|FG000|COMPLETED|Overall Study||15
9978826|NCT01586312|11100228|FG001|COMPLETED|Overall Study||15
9978827|NCT01586312|11100227|FG000|NOT COMPLETED|Overall Study||0
9978828|NCT01586312|11100228|FG001|NOT COMPLETED|Overall Study||0
9978829|NCT01586338|11100234|FG000|STARTED|Overall Study||237
9978830|NCT01586338|11100234|FG000|COMPLETED|Overall Study||229
9978831|NCT01586338|11100234|FG000|NOT COMPLETED|Overall Study||8
9978832|NCT01586364|11100238|FG000|STARTED|Overall Study||301
9978833|NCT01586364|11100238|FG000|COMPLETED|Overall Study||184
9978834|NCT01586364|11100238|FG000|NOT COMPLETED|Overall Study||117
9978835|NCT01586624|11100250|FG000|STARTED|Overall Study||6
9978836|NCT01586624|11100251|FG001|STARTED|Overall Study||6
9978837|NCT01586624|11100252|FG002|STARTED|Overall Study||6
9978838|NCT01586624|11100253|FG003|STARTED|Overall Study||7
9978839|NCT01586624|11100254|FG004|STARTED|Overall Study||9
9978840|NCT01586624|11100255|FG005|STARTED|Overall Study||8
9978841|NCT01586624|11100256|FG006|STARTED|Overall Study||8
9978842|NCT01586624|11100257|FG007|STARTED|Overall Study||11
9978843|NCT01586624|11100250|FG000|COMPLETED|Overall Study||2
9978844|NCT01586624|11100251|FG001|COMPLETED|Overall Study||2
9978845|NCT01586624|11100252|FG002|COMPLETED|Overall Study||1
9978846|NCT01586624|11100253|FG003|COMPLETED|Overall Study||0
9978847|NCT01586624|11100254|FG004|COMPLETED|Overall Study||1
9978848|NCT01586624|11100255|FG005|COMPLETED|Overall Study||0
9978849|NCT01586624|11100256|FG006|COMPLETED|Overall Study||0
9978850|NCT01586624|11100257|FG007|COMPLETED|Overall Study||1
9978851|NCT01586624|11100250|FG000|NOT COMPLETED|Overall Study||4
9978852|NCT01586624|11100251|FG001|NOT COMPLETED|Overall Study||4
9978853|NCT01586624|11100252|FG002|NOT COMPLETED|Overall Study||5
9978854|NCT01586624|11100253|FG003|NOT COMPLETED|Overall Study||7
9978855|NCT01586624|11100254|FG004|NOT COMPLETED|Overall Study||8
9978856|NCT01586624|11100255|FG005|NOT COMPLETED|Overall Study||8
9978857|NCT01586624|11100256|FG006|NOT COMPLETED|Overall Study||8
9978858|NCT01586624|11100257|FG007|NOT COMPLETED|Overall Study||10
9978859|NCT01586741|11100279|FG000|STARTED|Overall Study||28
9978860|NCT01586741|11100280|FG001|STARTED|Overall Study||29
9978861|NCT01586741|11100281|FG002|STARTED|Overall Study||32
9978862|NCT01586741|11100279|FG000|COMPLETED|Overall Study||27
9978863|NCT01586741|11100280|FG001|COMPLETED|Overall Study||29
9978864|NCT01586741|11100281|FG002|COMPLETED|Overall Study||30
9978865|NCT01586741|11100279|FG000|NOT COMPLETED|Overall Study||1
9978866|NCT01586741|11100280|FG001|NOT COMPLETED|Overall Study||0
9978867|NCT01586741|11100281|FG002|NOT COMPLETED|Overall Study||2
9978868|NCT01586806|11100292|FG000|STARTED|Overall Study||65
9978869|NCT01586806|11100293|FG001|STARTED|Overall Study||65
9978870|NCT01586806|11100294|FG002|STARTED|Overall Study||65
9978871|NCT01586806|11100292|FG000|COMPLETED|Overall Study||62
9978872|NCT01586806|11100293|FG001|COMPLETED|Overall Study||61
9978873|NCT01586806|11100294|FG002|COMPLETED|Overall Study||63
9978874|NCT01586806|11100292|FG000|NOT COMPLETED|Overall Study||3
9978875|NCT01586806|11100293|FG001|NOT COMPLETED|Overall Study||4
9978876|NCT01586806|11100294|FG002|NOT COMPLETED|Overall Study||2
9978877|NCT01586819|11100304|FG000|STARTED|Overall Study||12
9978878|NCT01586819|11100305|FG001|STARTED|Overall Study||14
9978879|NCT01586819|11100304|FG000|COMPLETED|Overall Study||11
9978880|NCT01586819|11100305|FG001|COMPLETED|Overall Study||14
9978881|NCT01586819|11100304|FG000|NOT COMPLETED|Overall Study||1
9978882|NCT01586819|11100305|FG001|NOT COMPLETED|Overall Study||0
9978883|NCT01586871|11100314|FG000|STARTED|Overall Study||560
9978884|NCT01586871|11100315|FG001|STARTED|Overall Study||554
9978885|NCT01586871|11100316|FG002|STARTED|Overall Study||33
9978886|NCT01586871|11100314|FG000|COMPLETED|Overall Study||560
9978887|NCT01586871|11100315|FG001|COMPLETED|Overall Study||554
9978888|NCT01586871|11100316|FG002|COMPLETED|Overall Study||33
9978889|NCT01586871|11100314|FG000|NOT COMPLETED|Overall Study||0
9978890|NCT01586871|11100315|FG001|NOT COMPLETED|Overall Study||0
9978891|NCT01586871|11100316|FG002|NOT COMPLETED|Overall Study||0
9978892|NCT01586897|11100326|FG000|STARTED|Overall Study||26
9978893|NCT01586897|11100327|FG001|STARTED|Overall Study||26
9978894|NCT01586897|11100326|FG000|COMPLETED|Overall Study||26
9978895|NCT01586897|11100327|FG001|COMPLETED|Overall Study||26
9978896|NCT01586897|11100326|FG000|NOT COMPLETED|Overall Study||0
9978897|NCT01586897|11100327|FG001|NOT COMPLETED|Overall Study||0
9978898|NCT01586962|11100335|FG000|STARTED|Overall Study||56
9978899|NCT01586962|11100335|FG000|COMPLETED|Overall Study||56
9978900|NCT01586962|11100335|FG000|NOT COMPLETED|Overall Study||0
9978901|NCT01586975|11100342|FG000|STARTED|Overall Study||15
9978902|NCT01586975|11100343|FG001|STARTED|Overall Study||32
9978903|NCT01586975|11100344|FG002|STARTED|Overall Study||46
9978904|NCT01586975|11100342|FG000|COMPLETED|Overall Study||15
9978905|NCT01586975|11100343|FG001|COMPLETED|Overall Study||32
9978906|NCT01586975|11100344|FG002|COMPLETED|Overall Study||46
9978907|NCT01586975|11100342|FG000|NOT COMPLETED|Overall Study||0
9978908|NCT01586975|11100343|FG001|NOT COMPLETED|Overall Study||0
9978909|NCT01586975|11100344|FG002|NOT COMPLETED|Overall Study||0
9978910|NCT01587001|11100354|FG000|STARTED|Overall Study||14
9978911|NCT01587001|11100355|FG001|STARTED|Overall Study||3
9978912|NCT01587001|11100354|FG000|COMPLETED|Overall Study||8
9978913|NCT01587001|11100355|FG001|COMPLETED|Overall Study||2
9978914|NCT01587001|11100354|FG000|NOT COMPLETED|Overall Study||6
9978915|NCT01587001|11100355|FG001|NOT COMPLETED|Overall Study||1
9978916|NCT01587014|11100362|FG000|STARTED|Overall Study||26
9978917|NCT01587014|11100362|FG000|COMPLETED|Overall Study||24
9978918|NCT01587014|11100362|FG000|NOT COMPLETED|Overall Study||2
9978919|NCT01587027|11100368|FG000|STARTED|First Intervention (1 Day)||8
9978920|NCT01587027|11100369|FG001|STARTED|First Intervention (1 Day)||8
9978921|NCT01587027|11100368|FG000|COMPLETED|First Intervention (1 Day)||8
9978922|NCT01587027|11100369|FG001|COMPLETED|First Intervention (1 Day)||8
9978923|NCT01587027|11100368|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9978924|NCT01587027|11100369|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9978925|NCT01587027|11100368|FG000|STARTED|Washout (1 Day)||8
9978926|NCT01587027|11100369|FG001|STARTED|Washout (1 Day)||8
9978927|NCT01587027|11100368|FG000|COMPLETED|Washout (1 Day)||8
9978928|NCT01587027|11100369|FG001|COMPLETED|Washout (1 Day)||8
9978929|NCT01587027|11100368|FG000|NOT COMPLETED|Washout (1 Day)||0
9978930|NCT01587027|11100369|FG001|NOT COMPLETED|Washout (1 Day)||0
9978931|NCT01587027|11100368|FG000|STARTED|Second Intervention (1 Day)||8
9978932|NCT01587027|11100369|FG001|STARTED|Second Intervention (1 Day)||8
9978933|NCT01587027|11100368|FG000|COMPLETED|Second Intervention (1 Day)||8
9978934|NCT01587027|11100369|FG001|COMPLETED|Second Intervention (1 Day)||8
9978935|NCT01587027|11100368|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9978936|NCT01587027|11100369|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9978937|NCT01587027|11100368|FG000|STARTED|Washout (1 Day)||8
9978938|NCT01587027|11100369|FG001|STARTED|Washout (1 Day)||8
9978939|NCT01587027|11100368|FG000|COMPLETED|Washout (1 Day)||8
9978940|NCT01587027|11100369|FG001|COMPLETED|Washout (1 Day)||8
9978941|NCT01587027|11100368|FG000|NOT COMPLETED|Washout (1 Day)||0
9978942|NCT01587027|11100369|FG001|NOT COMPLETED|Washout (1 Day)||0
9978943|NCT01587027|11100368|FG000|STARTED|Third Intervention (1 Day)||8
9978944|NCT01587027|11100369|FG001|STARTED|Third Intervention (1 Day)||8
9978945|NCT01587027|11100368|FG000|COMPLETED|Third Intervention (1 Day)||8
9978946|NCT01587027|11100369|FG001|COMPLETED|Third Intervention (1 Day)||8
9978947|NCT01587027|11100368|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9978948|NCT01587027|11100369|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9978949|NCT01587027|11100368|FG000|STARTED|Discharge (1 Day)||8
9978950|NCT01587027|11100369|FG001|STARTED|Discharge (1 Day)||8
9978951|NCT01587027|11100368|FG000|COMPLETED|Discharge (1 Day)||8
9978952|NCT01587027|11100369|FG001|COMPLETED|Discharge (1 Day)||8
9978953|NCT01587027|11100368|FG000|NOT COMPLETED|Discharge (1 Day)||0
9978954|NCT01587027|11100369|FG001|NOT COMPLETED|Discharge (1 Day)||0
9978955|NCT01587079|11100375|FG000|STARTED|Overall Study||159
9978956|NCT01587079|11100375|FG000|COMPLETED|Overall Study||120
9978957|NCT01587079|11100375|FG000|NOT COMPLETED|Overall Study||39
9978958|NCT01587105|11100411|FG000|STARTED|Overall Study||150
9978959|NCT01587105|11100412|FG001|STARTED|Overall Study||181
9978960|NCT01587105|11100411|FG000|COMPLETED|Overall Study||144
9978961|NCT01587105|11100412|FG001|COMPLETED|Overall Study||138
9978962|NCT01587105|11100411|FG000|NOT COMPLETED|Overall Study||6
9978963|NCT01587105|11100412|FG001|NOT COMPLETED|Overall Study||43
9978964|NCT01587118|11100418|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
9978965|NCT01587118|11100418|FG000|COMPLETED|Overall Study||11
9978966|NCT01587118|11100418|FG000|NOT COMPLETED|Overall Study||7
9978967|NCT01587274|11100425|FG000|STARTED|Overall Study||108
10099497|NCT02391948|11228588|FG003|NOT COMPLETED|24-month Assessment||9
10099498|NCT02391948|11228589|FG004|NOT COMPLETED|24-month Assessment||10
10099499|NCT02391961|11228606|FG000|STARTED|First Intervention (4 Weeks)||10
10099500|NCT02391961|11228607|FG001|STARTED|First Intervention (4 Weeks)||9
10099501|NCT02391961|11228606|FG000|COMPLETED|First Intervention (4 Weeks)||8
10099502|NCT02391961|11228607|FG001|COMPLETED|First Intervention (4 Weeks)||9
10099503|NCT02391961|11228606|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10099504|NCT02391961|11228607|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10099505|NCT02391961|11228606|FG000|STARTED|Washout (2 Weeks)||8
10099506|NCT02391961|11228607|FG001|STARTED|Washout (2 Weeks)||9
10099507|NCT02391961|11228606|FG000|COMPLETED|Washout (2 Weeks)||7
10099508|NCT02391961|11228607|FG001|COMPLETED|Washout (2 Weeks)||8
10099509|NCT02391961|11228606|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10099510|NCT02391961|11228607|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10099511|NCT02391961|11228606|FG000|STARTED|Second Intervention (4 Weeks)||7
10099512|NCT02391961|11228607|FG001|STARTED|Second Intervention (4 Weeks)||8
10099513|NCT02391961|11228606|FG000|COMPLETED|Second Intervention (4 Weeks)||6
10099514|NCT02391961|11228607|FG001|COMPLETED|Second Intervention (4 Weeks)||7
10099515|NCT02391961|11228606|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10099516|NCT02391961|11228607|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10099517|NCT02391987|11228615|FG000|STARTED|Overall Study||54
10099518|NCT02391987|11228616|FG001|STARTED|Overall Study||58
10099519|NCT02391987|11228615|FG000|COMPLETED|Overall Study||54
10099520|NCT02391987|11228616|FG001|COMPLETED|Overall Study||58
10099521|NCT02391987|11228615|FG000|NOT COMPLETED|Overall Study||0
10099522|NCT02391987|11228616|FG001|NOT COMPLETED|Overall Study||0
10099523|NCT02392000|11228622|FG000|STARTED|Overall Study||38
10099524|NCT02392000|11228622|FG000|COMPLETED|Overall Study||11
10099525|NCT02392000|11228622|FG000|NOT COMPLETED|Overall Study||27
10099526|NCT02392104|11228627|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
9978968|NCT01587274|11100426|FG001|STARTED|Overall Study||108
9978969|NCT01587274|11100427|FG002|STARTED|Overall Study||107
9978970|NCT01587274|11100425|FG000|COMPLETED|Overall Study||104
9978971|NCT01587274|11100426|FG001|COMPLETED|Overall Study||103
9978972|NCT01587274|11100427|FG002|COMPLETED|Overall Study||104
9978973|NCT01587274|11100425|FG000|NOT COMPLETED|Overall Study||4
9978974|NCT01587274|11100426|FG001|NOT COMPLETED|Overall Study||5
9978975|NCT01587274|11100427|FG002|NOT COMPLETED|Overall Study||3
9978976|NCT01587651|11100438|FG000|STARTED|Overall Study||34
9978977|NCT01587651|11100439|FG001|STARTED|Overall Study||41
9978978|NCT01587651|11100440|FG002|STARTED|Overall Study||35
9978979|NCT01587651|11100438|FG000|COMPLETED|Overall Study||34
9978980|NCT01587651|11100439|FG001|COMPLETED|Overall Study||38
9978981|NCT01587651|11100440|FG002|COMPLETED|Overall Study||34
9978982|NCT01587651|11100438|FG000|NOT COMPLETED|Overall Study||0
9978983|NCT01587651|11100439|FG001|NOT COMPLETED|Overall Study||3
9978984|NCT01587651|11100440|FG002|NOT COMPLETED|Overall Study||1
9978985|NCT01587703|11100467|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3
9978986|NCT01587703|11100468|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4
9978987|NCT01587703|11100469|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1
9978988|NCT01587703|11100470|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3
9978989|NCT01587703|11100471|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4
9978990|NCT01587703|11100472|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9
9978991|NCT01587703|11100473|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32
9978992|NCT01587703|11100474|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9
9978993|NCT01587703|11100475|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9978994|NCT01587703|11100476|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9978995|NCT01587703|11100477|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9978996|NCT01587703|11100478|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9978997|NCT01587703|11100479|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9978998|NCT01587703|11100480|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9978999|NCT01587703|11100481|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9979000|NCT01587703|11100482|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9979001|NCT01587703|11100483|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9979002|NCT01587703|11100484|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9979003|NCT01587703|11100485|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0
9979004|NCT01587703|11100467|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979005|NCT01587703|11100468|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979006|NCT01587703|11100469|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979007|NCT01587703|11100470|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979008|NCT01587703|11100471|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979009|NCT01587703|11100472|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
9979010|NCT01587703|11100473|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979011|NCT01587703|11100474|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979012|NCT01587703|11100475|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979013|NCT01587703|11100476|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979014|NCT01587703|11100477|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979015|NCT01587703|11100478|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979016|NCT01587703|11100479|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979017|NCT01587703|11100480|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979018|NCT01587703|11100481|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979019|NCT01587703|11100482|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979020|NCT01587703|11100483|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979021|NCT01587703|11100484|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979022|NCT01587703|11100485|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979023|NCT01587703|11100467|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
9979024|NCT01587703|11100468|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
9979025|NCT01587703|11100469|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
9979026|NCT01587703|11100470|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
9979027|NCT01587703|11100471|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
9979028|NCT01587703|11100472|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
9979029|NCT01587703|11100473|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
9979030|NCT01587703|11100474|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
9979031|NCT01587703|11100475|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979032|NCT01587703|11100476|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979033|NCT01587703|11100477|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979034|NCT01587703|11100478|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979035|NCT01587703|11100479|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979036|NCT01587703|11100480|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979037|NCT01587703|11100481|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979038|NCT01587703|11100482|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979039|NCT01587703|11100483|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979040|NCT01587703|11100484|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979041|NCT01587703|11100485|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
9979042|NCT01587703|11100467|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979043|NCT01587703|11100468|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979044|NCT01587703|11100469|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979045|NCT01587703|11100470|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979046|NCT01587703|11100471|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979047|NCT01587703|11100472|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979048|NCT01587703|11100473|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979049|NCT01587703|11100474|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979050|NCT01587703|11100475|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4
9979051|NCT01587703|11100476|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10
9979052|NCT01587703|11100477|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5
9979053|NCT01587703|11100478|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979054|NCT01587703|11100479|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979055|NCT01587703|11100480|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979056|NCT01587703|11100481|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979057|NCT01587703|11100482|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979058|NCT01587703|11100483|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979059|NCT01587703|11100484|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979060|NCT01587703|11100485|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0
9979061|NCT01587703|11100467|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979062|NCT01587703|11100468|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979063|NCT01587703|11100469|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979064|NCT01587703|11100470|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979065|NCT01587703|11100471|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979066|NCT01587703|11100472|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979067|NCT01587703|11100473|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979068|NCT01587703|11100474|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979069|NCT01587703|11100475|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
9979070|NCT01587703|11100476|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979071|NCT01587703|11100477|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979072|NCT01587703|11100478|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979073|NCT01587703|11100479|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979074|NCT01587703|11100480|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979075|NCT01587703|11100481|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979076|NCT01587703|11100482|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979077|NCT01587703|11100483|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979078|NCT01587703|11100484|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979079|NCT01587703|11100485|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979080|NCT01587703|11100467|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979081|NCT01587703|11100468|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979082|NCT01587703|11100469|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979083|NCT01587703|11100470|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979084|NCT01587703|11100471|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979085|NCT01587703|11100472|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979086|NCT01587703|11100473|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979087|NCT01587703|11100474|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979088|NCT01587703|11100475|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
9979089|NCT01587703|11100476|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
9979090|NCT01587703|11100477|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
9979091|NCT01587703|11100478|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979092|NCT01587703|11100479|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979093|NCT01587703|11100480|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979094|NCT01587703|11100481|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979095|NCT01587703|11100482|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979096|NCT01587703|11100483|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979097|NCT01587703|11100484|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979098|NCT01587703|11100485|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
9979099|NCT01587703|11100467|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979100|NCT01587703|11100468|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979101|NCT01587703|11100469|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979102|NCT01587703|11100470|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979103|NCT01587703|11100471|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979104|NCT01587703|11100472|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979105|NCT01587703|11100473|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979106|NCT01587703|11100474|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979107|NCT01587703|11100475|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979108|NCT01587703|11100476|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979109|NCT01587703|11100477|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979110|NCT01587703|11100478|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979111|NCT01587703|11100479|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979112|NCT01587703|11100480|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979113|NCT01587703|11100481|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979114|NCT01587703|11100482|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979115|NCT01587703|11100483|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979116|NCT01587703|11100484|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
9979117|NCT01587703|11100485|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
9979118|NCT01587703|11100467|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979119|NCT01587703|11100468|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979120|NCT01587703|11100469|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979121|NCT01587703|11100470|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979122|NCT01587703|11100471|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979123|NCT01587703|11100472|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979124|NCT01587703|11100473|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979125|NCT01587703|11100474|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979126|NCT01587703|11100475|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979127|NCT01587703|11100476|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979128|NCT01587703|11100477|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979129|NCT01587703|11100478|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979130|NCT01587703|11100479|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979131|NCT01587703|11100480|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979132|NCT01587703|11100481|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979133|NCT01587703|11100482|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979134|NCT01587703|11100483|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979135|NCT01587703|11100484|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
9979136|NCT01587703|11100485|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
9979137|NCT01587703|11100467|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979138|NCT01587703|11100468|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979139|NCT01587703|11100469|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979140|NCT01587703|11100470|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979141|NCT01587703|11100471|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979142|NCT01587703|11100472|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979143|NCT01587703|11100473|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979144|NCT01587703|11100474|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979145|NCT01587703|11100475|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979146|NCT01587703|11100476|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979147|NCT01587703|11100477|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979148|NCT01587703|11100478|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979149|NCT01587703|11100479|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979150|NCT01587703|11100480|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979151|NCT01587703|11100481|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979152|NCT01587703|11100482|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979153|NCT01587703|11100483|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979154|NCT01587703|11100484|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979155|NCT01587703|11100485|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
9979156|NCT01587703|11100467|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979157|NCT01587703|11100468|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979158|NCT01587703|11100469|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979159|NCT01587703|11100470|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979160|NCT01587703|11100471|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979161|NCT01587703|11100472|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979162|NCT01587703|11100473|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979163|NCT01587703|11100474|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979164|NCT01587703|11100475|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979165|NCT01587703|11100476|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979166|NCT01587703|11100477|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979167|NCT01587703|11100478|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979168|NCT01587703|11100479|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979169|NCT01587703|11100480|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979170|NCT01587703|11100481|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979171|NCT01587703|11100482|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979172|NCT01587703|11100483|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
9979173|NCT01587703|11100484|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
9979174|NCT01587703|11100485|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
9979175|NCT01587703|11100467|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979176|NCT01587703|11100468|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979177|NCT01587703|11100469|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979178|NCT01587703|11100470|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979179|NCT01587703|11100471|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979180|NCT01587703|11100472|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979181|NCT01587703|11100473|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979182|NCT01587703|11100474|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979183|NCT01587703|11100475|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979184|NCT01587703|11100476|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979185|NCT01587703|11100477|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979186|NCT01587703|11100478|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979187|NCT01587703|11100479|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979188|NCT01587703|11100480|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979189|NCT01587703|11100481|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979190|NCT01587703|11100482|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979191|NCT01587703|11100483|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979192|NCT01587703|11100484|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
9979193|NCT01587703|11100485|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
9979194|NCT01587703|11100467|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979195|NCT01587703|11100468|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979196|NCT01587703|11100469|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979197|NCT01587703|11100470|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979198|NCT01587703|11100471|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979199|NCT01587703|11100472|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979200|NCT01587703|11100473|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979201|NCT01587703|11100474|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979202|NCT01587703|11100475|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979203|NCT01587703|11100476|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979204|NCT01587703|11100477|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979205|NCT01587703|11100478|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979206|NCT01587703|11100479|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979207|NCT01587703|11100480|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979208|NCT01587703|11100481|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979209|NCT01587703|11100482|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979210|NCT01587703|11100483|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979211|NCT01587703|11100484|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979212|NCT01587703|11100485|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
9979213|NCT01587703|11100467|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979214|NCT01587703|11100468|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979215|NCT01587703|11100469|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979216|NCT01587703|11100470|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979217|NCT01587703|11100471|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979218|NCT01587703|11100472|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979219|NCT01587703|11100473|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979220|NCT01587703|11100474|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979221|NCT01587703|11100475|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979222|NCT01587703|11100476|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979223|NCT01587703|11100477|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979224|NCT01587703|11100478|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979225|NCT01587703|11100479|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979226|NCT01587703|11100480|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979227|NCT01587703|11100481|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979228|NCT01587703|11100482|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979229|NCT01587703|11100483|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9979230|NCT01587703|11100484|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
9979231|NCT01587703|11100485|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
9979232|NCT01587703|11100467|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979233|NCT01587703|11100468|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979234|NCT01587703|11100469|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979235|NCT01587703|11100470|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979236|NCT01587703|11100471|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979237|NCT01587703|11100472|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979238|NCT01587703|11100473|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979239|NCT01587703|11100474|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979240|NCT01587703|11100475|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979241|NCT01587703|11100476|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979242|NCT01587703|11100477|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979243|NCT01587703|11100478|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979244|NCT01587703|11100479|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979245|NCT01587703|11100480|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979246|NCT01587703|11100481|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979247|NCT01587703|11100482|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979248|NCT01587703|11100483|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979249|NCT01587703|11100484|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
9979250|NCT01587703|11100485|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
9979251|NCT01587703|11100467|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979252|NCT01587703|11100468|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979253|NCT01587703|11100469|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979254|NCT01587703|11100470|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979255|NCT01587703|11100471|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979256|NCT01587703|11100472|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979257|NCT01587703|11100473|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979258|NCT01587703|11100474|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979259|NCT01587703|11100475|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979260|NCT01587703|11100476|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979261|NCT01587703|11100477|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979262|NCT01587703|11100478|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979263|NCT01587703|11100479|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979264|NCT01587703|11100480|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979265|NCT01587703|11100481|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979266|NCT01587703|11100482|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979267|NCT01587703|11100483|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979268|NCT01587703|11100484|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979269|NCT01587703|11100485|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
9979270|NCT01587703|11100467|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979271|NCT01587703|11100468|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979272|NCT01587703|11100469|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979273|NCT01587703|11100470|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979274|NCT01587703|11100471|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979275|NCT01587703|11100472|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979276|NCT01587703|11100473|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979277|NCT01587703|11100474|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979278|NCT01587703|11100475|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979279|NCT01587703|11100476|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979280|NCT01587703|11100477|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979281|NCT01587703|11100478|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979282|NCT01587703|11100479|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979283|NCT01587703|11100480|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979284|NCT01587703|11100481|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979285|NCT01587703|11100482|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979286|NCT01587703|11100483|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
9979287|NCT01587703|11100484|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
9979288|NCT01587703|11100485|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
9979289|NCT01587703|11100467|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979290|NCT01587703|11100468|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979291|NCT01587703|11100469|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979292|NCT01587703|11100470|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979293|NCT01587703|11100471|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979294|NCT01587703|11100472|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979295|NCT01587703|11100473|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979296|NCT01587703|11100474|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979297|NCT01587703|11100475|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979298|NCT01587703|11100476|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979299|NCT01587703|11100477|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979300|NCT01587703|11100478|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979301|NCT01587703|11100479|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979302|NCT01587703|11100480|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979303|NCT01587703|11100481|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979304|NCT01587703|11100482|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979305|NCT01587703|11100483|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979306|NCT01587703|11100484|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979307|NCT01587703|11100485|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979308|NCT01587703|11100467|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979309|NCT01587703|11100468|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979310|NCT01587703|11100469|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979311|NCT01587703|11100470|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979312|NCT01587703|11100471|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979313|NCT01587703|11100472|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979314|NCT01587703|11100473|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979315|NCT01587703|11100474|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979316|NCT01587703|11100475|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979317|NCT01587703|11100476|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979318|NCT01587703|11100477|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979319|NCT01587703|11100478|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979320|NCT01587703|11100479|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979321|NCT01587703|11100480|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979322|NCT01587703|11100481|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979323|NCT01587703|11100482|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979324|NCT01587703|11100483|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
9979325|NCT01587703|11100484|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
9979326|NCT01587703|11100485|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
9979327|NCT01587703|11100467|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979328|NCT01587703|11100468|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979329|NCT01587703|11100469|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979330|NCT01587703|11100470|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979331|NCT01587703|11100471|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979332|NCT01587703|11100472|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979333|NCT01587703|11100473|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979334|NCT01587703|11100474|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979335|NCT01587703|11100475|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979336|NCT01587703|11100476|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979337|NCT01587703|11100477|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979338|NCT01587703|11100478|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12
9979339|NCT01587703|11100479|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14
9979340|NCT01587703|11100480|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23
9979341|NCT01587703|11100481|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19
9979342|NCT01587703|11100482|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21
9979343|NCT01587703|11100483|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13
9979344|NCT01587703|11100484|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979345|NCT01587703|11100485|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0
9979346|NCT01587703|11100467|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979347|NCT01587703|11100468|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979348|NCT01587703|11100469|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979349|NCT01587703|11100470|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979350|NCT01587703|11100471|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979351|NCT01587703|11100472|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979352|NCT01587703|11100473|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979353|NCT01587703|11100474|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979354|NCT01587703|11100475|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979355|NCT01587703|11100476|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979356|NCT01587703|11100477|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979357|NCT01587703|11100478|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979358|NCT01587703|11100479|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979359|NCT01587703|11100480|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
9979360|NCT01587703|11100481|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979361|NCT01587703|11100482|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979362|NCT01587703|11100483|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979363|NCT01587703|11100484|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979364|NCT01587703|11100485|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979365|NCT01587703|11100467|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979366|NCT01587703|11100468|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979367|NCT01587703|11100469|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979368|NCT01587703|11100470|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979369|NCT01587703|11100471|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979370|NCT01587703|11100472|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979371|NCT01587703|11100473|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979372|NCT01587703|11100474|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979373|NCT01587703|11100475|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979374|NCT01587703|11100476|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979375|NCT01587703|11100477|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979376|NCT01587703|11100478|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
9979377|NCT01587703|11100479|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
9979378|NCT01587703|11100480|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
9979379|NCT01587703|11100481|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
9979380|NCT01587703|11100482|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
9979381|NCT01587703|11100483|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
9979382|NCT01587703|11100484|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979383|NCT01587703|11100485|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
9979384|NCT01587885|11100544|FG000|STARTED|Treatment Period 1||26
9979385|NCT01587885|11100545|FG001|STARTED|Treatment Period 1||22
9979386|NCT01587885|11100544|FG000|COMPLETED|Treatment Period 1||26
9979387|NCT01587885|11100545|FG001|COMPLETED|Treatment Period 1||19
9979388|NCT01587885|11100544|FG000|NOT COMPLETED|Treatment Period 1||0
9979389|NCT01587885|11100545|FG001|NOT COMPLETED|Treatment Period 1||3
9979390|NCT01587885|11100544|FG000|STARTED|Treatment Period 2||26
9979391|NCT01587885|11100545|FG001|STARTED|Treatment Period 2||19
9979392|NCT01587885|11100544|FG000|COMPLETED|Treatment Period 2||26
9979393|NCT01587885|11100545|FG001|COMPLETED|Treatment Period 2||19
9979394|NCT01587885|11100544|FG000|NOT COMPLETED|Treatment Period 2||0
9979395|NCT01587885|11100545|FG001|NOT COMPLETED|Treatment Period 2||0
9979396|NCT01587898|11100556|FG000|STARTED|Overall Study||18
9979397|NCT01587898|11100557|FG001|STARTED|Overall Study||17
9979398|NCT01587898|11100558|FG002|STARTED|Overall Study||18
9979399|NCT01587898|11100559|FG003|STARTED|Overall Study||19
9979400|NCT01587898|11100556|FG000|COMPLETED|Overall Study||14
9979401|NCT01587898|11100557|FG001|COMPLETED|Overall Study||12
9979402|NCT01587898|11100558|FG002|COMPLETED|Overall Study||16
9979403|NCT01587898|11100559|FG003|COMPLETED|Overall Study||17
9979404|NCT01587898|11100556|FG000|NOT COMPLETED|Overall Study||4
9979405|NCT01587898|11100557|FG001|NOT COMPLETED|Overall Study||5
9979406|NCT01587898|11100558|FG002|NOT COMPLETED|Overall Study||2
9979407|NCT01587898|11100559|FG003|NOT COMPLETED|Overall Study||2
9979408|NCT01587924|11100576|FG000|STARTED|Overall Study||21
9979409|NCT01587924|11100577|FG001|STARTED|Overall Study||21
9979410|NCT01587924|11100578|FG002|STARTED|Overall Study||21
9979411|NCT01587924|11100579|FG003|STARTED|Overall Study||20
9979412|NCT01587924|11100576|FG000|COMPLETED|Overall Study||17
9979413|NCT01587924|11100577|FG001|COMPLETED|Overall Study||17
9979414|NCT01587924|11100578|FG002|COMPLETED|Overall Study||17
9979415|NCT01587924|11100579|FG003|COMPLETED|Overall Study||19
9979416|NCT01587924|11100576|FG000|NOT COMPLETED|Overall Study||4
9979417|NCT01587924|11100577|FG001|NOT COMPLETED|Overall Study||4
9979418|NCT01587924|11100578|FG002|NOT COMPLETED|Overall Study||4
9979419|NCT01587924|11100579|FG003|NOT COMPLETED|Overall Study||1
9979420|NCT01587950|11100589|FG000|STARTED|Period 1||12
9979421|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
9979422|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
9979423|NCT01587950|11100589|FG000|Received Sterile Water (2 Minutes)|Period 1||2
9979424|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
9979425|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
9979426|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
9979427|NCT01587950|11100589|FG000|Received Sterile Water (10 Minutes)|Period 1||5
9979428|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
9979429|NCT01587950|11100589|FG000|Received Sterile Water (5 Minutes)|Period 1||5
9979430|NCT01587950|11100589|FG000|COMPLETED|Period 1||12
9979431|NCT01587950|11100589|FG000|NOT COMPLETED|Period 1||0
9979432|NCT01587950|11100589|FG000|STARTED|Washout 1||12
9979433|NCT01587950|11100589|FG000|COMPLETED|Washout 1||12
9979434|NCT01587950|11100589|FG000|NOT COMPLETED|Washout 1||0
9979435|NCT01587950|11100589|FG000|STARTED|Period 2||12
9979436|NCT01587950|11100589|FG000|Received Sterile Water (2 Minutes)|Period 2||8
9979437|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
9979438|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
9979439|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
9979440|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
9979441|NCT01587950|11100589|FG000|Received Sterile Water (5 Minutes)|Period 2||2
9979442|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
9979443|NCT01587950|11100589|FG000|Received Sterile Water (10 Minutes)|Period 2||2
9979444|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
9979445|NCT01587950|11100589|FG000|COMPLETED|Period 2||12
9979446|NCT01587950|11100589|FG000|NOT COMPLETED|Period 2||0
9979447|NCT01587950|11100589|FG000|STARTED|Washout 2||12
9979448|NCT01587950|11100589|FG000|COMPLETED|Washout 2||12
9979449|NCT01587950|11100589|FG000|NOT COMPLETED|Washout 2||0
9979450|NCT01587950|11100589|FG000|STARTED|Period 3||12
9979451|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
9979452|NCT01587950|11100589|FG000|Received Sterile Water (10 Minutes)|Period 3||5
9979453|NCT01587950|11100589|FG000|Received Sterile Water (2 Minutes)|Period 3||2
9979454|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
9979455|NCT01587950|11100589|FG000|Received Sterile Water (5 Minutes)|Period 3||5
9979456|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
9979457|NCT01587950|11100589|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
9979458|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
9979459|NCT01587950|11100589|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
9979460|NCT01587950|11100589|FG000|COMPLETED|Period 3||12
9979461|NCT01587950|11100589|FG000|NOT COMPLETED|Period 3||0
9979462|NCT01587989|11100604|FG000|STARTED|12-Week Open-Label Run-In Period||77
9979463|NCT01587989|11100605|FG001|STARTED|12-Week Open-Label Run-In Period||0
9979464|NCT01587989|11100606|FG002|STARTED|12-Week Open-Label Run-In Period||0
9979465|NCT01587989|11100604|FG000|COMPLETED|12-Week Open-Label Run-In Period||65
9979466|NCT01587989|11100605|FG001|COMPLETED|12-Week Open-Label Run-In Period||0
9979467|NCT01587989|11100606|FG002|COMPLETED|12-Week Open-Label Run-In Period||0
9979468|NCT01587989|11100604|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12
9979469|NCT01587989|11100605|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0
9979470|NCT01587989|11100606|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0
9979471|NCT01587989|11100604|FG000|STARTED|Randomized Study Treatment||0
9979472|NCT01587989|11100605|FG001|STARTED|Randomized Study Treatment||32
9979473|NCT01587989|11100606|FG002|STARTED|Randomized Study Treatment||33
9979474|NCT01587989|11100604|FG000|COMPLETED|Randomized Study Treatment||0
9979475|NCT01587989|11100605|FG001|COMPLETED|Randomized Study Treatment||30
9979476|NCT01587989|11100606|FG002|COMPLETED|Randomized Study Treatment||32
9979477|NCT01587989|11100604|FG000|NOT COMPLETED|Randomized Study Treatment||0
9979478|NCT01587989|11100605|FG001|NOT COMPLETED|Randomized Study Treatment||2
9979479|NCT01587989|11100606|FG002|NOT COMPLETED|Randomized Study Treatment||1
9979480|NCT01588106|11100614|FG000|STARTED|Overall Study||78
9979481|NCT01588106|11100615|FG001|STARTED|Overall Study||76
9979482|NCT01588106|11100614|FG000|COMPLETED|Overall Study||73
9979483|NCT01588106|11100615|FG001|COMPLETED|Overall Study||72
9979484|NCT01588106|11100614|FG000|NOT COMPLETED|Overall Study||5
9979485|NCT01588106|11100615|FG001|NOT COMPLETED|Overall Study||4
9979486|NCT01588158|11100623|FG000|STARTED|Overall Study||4
9979487|NCT01588158|11100624|FG001|STARTED|Overall Study||3
9979488|NCT01588158|11100623|FG000|COMPLETED|Overall Study||4
9979489|NCT01588158|11100624|FG001|COMPLETED|Overall Study||3
9979490|NCT01588158|11100623|FG000|NOT COMPLETED|Overall Study||0
9979491|NCT01588158|11100624|FG001|NOT COMPLETED|Overall Study||0
9979492|NCT01588184|11100636|FG000|STARTED|Overall Study||11
9979493|NCT01588184|11100637|FG001|STARTED|Overall Study||41
9979494|NCT01588184|11100638|FG002|STARTED|Overall Study||7
9979495|NCT01588184|11100639|FG003|STARTED|Overall Study||6
10099527|NCT02392104|11228627|FG000|COMPLETED|Overall Study||39
10099528|NCT02392104|11228627|FG000|NOT COMPLETED|Overall Study||11
9979496|NCT01588184|11100640|FG004|STARTED|Overall Study||16
9979497|NCT01588184|11100641|FG005|STARTED|Overall Study||14
9979498|NCT01588184|11100636|FG000|COMPLETED|Overall Study||8
9979499|NCT01588184|11100637|FG001|COMPLETED|Overall Study||28
9979500|NCT01588184|11100638|FG002|COMPLETED|Overall Study||5
9979501|NCT01588184|11100639|FG003|COMPLETED|Overall Study||3
9979502|NCT01588184|11100640|FG004|COMPLETED|Overall Study||14
9979503|NCT01588184|11100641|FG005|COMPLETED|Overall Study||10
9979504|NCT01588184|11100636|FG000|NOT COMPLETED|Overall Study||3
9979505|NCT01588184|11100637|FG001|NOT COMPLETED|Overall Study||13
9979506|NCT01588184|11100638|FG002|NOT COMPLETED|Overall Study||2
10099529|NCT02392195|11228631|FG000|STARTED|Overall Study||10
10099530|NCT02392195|11228631|FG000|COMPLETED|Overall Study||2
10099531|NCT02392195|11228631|FG000|NOT COMPLETED|Overall Study||8
10099532|NCT02392208|11228635|FG000|STARTED|Telavancin Before Hemodialysis||8
10099533|NCT02392208|11228635|FG000|COMPLETED|Telavancin Before Hemodialysis||8
10099534|NCT02392208|11228635|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0
10099535|NCT02392208|11228635|FG000|STARTED|Telavancin After Hemodialysis||8
10099536|NCT02392208|11228635|FG000|COMPLETED|Telavancin After Hemodialysis||8
10099537|NCT02392208|11228635|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0
9979507|NCT01588184|11100639|FG003|NOT COMPLETED|Overall Study||3
9979508|NCT01588184|11100640|FG004|NOT COMPLETED|Overall Study||2
9979509|NCT01588184|11100641|FG005|NOT COMPLETED|Overall Study||4
9979510|NCT01588197|11100657|FG000|STARTED|Overall Study||10
9979511|NCT01588197|11100658|FG001|STARTED|Overall Study||10
9979512|NCT01588197|11100657|FG000|COMPLETED|Overall Study||9
9979513|NCT01588197|11100658|FG001|COMPLETED|Overall Study||9
9979514|NCT01588197|11100657|FG000|NOT COMPLETED|Overall Study||1
9979515|NCT01588197|11100658|FG001|NOT COMPLETED|Overall Study||1
9979516|NCT01588236|11100667|FG000|STARTED|Overall Study||92
9979517|NCT01588236|11100668|FG001|STARTED|Overall Study||94
9979518|NCT01588236|11100669|FG002|STARTED|Overall Study||94
9979519|NCT01588236|11100667|FG000|COMPLETED|Overall Study||76
9979520|NCT01588236|11100668|FG001|COMPLETED|Overall Study||66
9979521|NCT01588236|11100669|FG002|COMPLETED|Overall Study||69
9979522|NCT01588236|11100667|FG000|NOT COMPLETED|Overall Study||16
9979523|NCT01588236|11100668|FG001|NOT COMPLETED|Overall Study||28
9979524|NCT01588236|11100669|FG002|NOT COMPLETED|Overall Study||25
9979525|NCT01588353|11100680|FG000|STARTED|Step1||6
9979526|NCT01588353|11100681|FG001|STARTED|Step1||0
9979527|NCT01588353|11100682|FG002|STARTED|Step1||0
9979528|NCT01588353|11100680|FG000|COMPLETED|Step1||6
9979529|NCT01588353|11100681|FG001|COMPLETED|Step1||0
9979530|NCT01588353|11100682|FG002|COMPLETED|Step1||0
9979531|NCT01588353|11100680|FG000|NOT COMPLETED|Step1||0
9979532|NCT01588353|11100681|FG001|NOT COMPLETED|Step1||0
9979533|NCT01588353|11100682|FG002|NOT COMPLETED|Step1||0
9979534|NCT01588353|11100680|FG000|STARTED|Step2||0
9979535|NCT01588353|11100681|FG001|STARTED|Step2||71
9979536|NCT01588353|11100682|FG002|STARTED|Step2||0
9979537|NCT01588353|11100680|FG000|COMPLETED|Step2||0
9979538|NCT01588353|11100681|FG001|COMPLETED|Step2||70
9979539|NCT01588353|11100682|FG002|COMPLETED|Step2||0
9979540|NCT01588353|11100680|FG000|NOT COMPLETED|Step2||0
9979541|NCT01588353|11100681|FG001|NOT COMPLETED|Step2||1
9979542|NCT01588353|11100682|FG002|NOT COMPLETED|Step2||0
9979543|NCT01588353|11100680|FG000|STARTED|Step3||0
9979544|NCT01588353|11100681|FG001|STARTED|Step3||0
9979545|NCT01588353|11100682|FG002|STARTED|Step3||25
9979546|NCT01588353|11100680|FG000|COMPLETED|Step3||0
9979547|NCT01588353|11100681|FG001|COMPLETED|Step3||0
9979548|NCT01588353|11100682|FG002|COMPLETED|Step3||23
9979549|NCT01588353|11100680|FG000|NOT COMPLETED|Step3||0
9979550|NCT01588353|11100681|FG001|NOT COMPLETED|Step3||0
9979551|NCT01588353|11100682|FG002|NOT COMPLETED|Step3||2
9979552|NCT01588366|11100694|FG000|STARTED|Overall Study||2
9979553|NCT01588366|11100695|FG001|STARTED|Overall Study||7
9979554|NCT01588366|11100696|FG002|STARTED|Overall Study||2
9979555|NCT01588366|11100697|FG003|STARTED|Overall Study||7
9979556|NCT01588366|11100698|FG004|STARTED|Overall Study||3
9979557|NCT01588366|11100699|FG005|STARTED|Overall Study||9
9979558|NCT01588366|11100694|FG000|Received at Least One Dose of Study Drug|Overall Study||2
9979559|NCT01588366|11100695|FG001|Received at Least One Dose of Study Drug|Overall Study||7
9979560|NCT01588366|11100696|FG002|Received at Least One Dose of Study Drug|Overall Study||2
9979561|NCT01588366|11100697|FG003|Received at Least One Dose of Study Drug|Overall Study||7
9979562|NCT01588366|11100698|FG004|Received at Least One Dose of Study Drug|Overall Study||3
9979563|NCT01588366|11100699|FG005|Received at Least One Dose of Study Drug|Overall Study||9
9979564|NCT01588366|11100694|FG000|COMPLETED|Overall Study||2
10099538|NCT02392234|11228646|FG000|STARTED|Treatment Period 1 (8 Weeks)||41
10099539|NCT02392234|11228647|FG001|STARTED|Treatment Period 1 (8 Weeks)||43
9979565|NCT01588366|11100695|FG001|COMPLETED|Overall Study||6
9979566|NCT01588366|11100696|FG002|COMPLETED|Overall Study||2
9979567|NCT01588366|11100697|FG003|COMPLETED|Overall Study||6
9979568|NCT01588366|11100698|FG004|COMPLETED|Overall Study||3
9979569|NCT01588366|11100699|FG005|COMPLETED|Overall Study||7
9979570|NCT01588366|11100694|FG000|NOT COMPLETED|Overall Study||0
9979571|NCT01588366|11100695|FG001|NOT COMPLETED|Overall Study||1
9979572|NCT01588366|11100696|FG002|NOT COMPLETED|Overall Study||0
9979573|NCT01588366|11100697|FG003|NOT COMPLETED|Overall Study||1
9979574|NCT01588366|11100698|FG004|NOT COMPLETED|Overall Study||0
9979575|NCT01588366|11100699|FG005|NOT COMPLETED|Overall Study||2
9979576|NCT01588405|11100715|FG000|STARTED|Overall Study||33
9979577|NCT01588405|11100715|FG000|COMPLETED|Overall Study||31
9979578|NCT01588405|11100715|FG000|NOT COMPLETED|Overall Study||2
9979579|NCT01588418|11100722|FG000|STARTED|Overall Study||11
9979580|NCT01588418|11100723|FG001|STARTED|Overall Study||4
9979581|NCT01588418|11100722|FG000|COMPLETED|Overall Study||11
9979582|NCT01588418|11100723|FG001|COMPLETED|Overall Study||4
9979583|NCT01588418|11100722|FG000|NOT COMPLETED|Overall Study||0
9979584|NCT01588418|11100723|FG001|NOT COMPLETED|Overall Study||0
9979585|NCT01588444|11100731|FG000|STARTED|Overall Study||20
9979586|NCT01588444|11100732|FG001|STARTED|Overall Study||20
9979587|NCT01588444|11100731|FG000|COMPLETED|Overall Study||20
9979588|NCT01588444|11100732|FG001|COMPLETED|Overall Study||20
9979589|NCT01588444|11100731|FG000|NOT COMPLETED|Overall Study||0
9979590|NCT01588444|11100732|FG001|NOT COMPLETED|Overall Study||0
9979591|NCT01588457|11100740|FG000|STARTED|Randomization 1||53
9979592|NCT01588457|11100741|FG001|STARTED|Randomization 1||59
9979593|NCT01588457|11100742|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
9979594|NCT01588457|11100743|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
9979595|NCT01588457|11100740|FG000|COMPLETED|Randomization 1||30
9979596|NCT01588457|11100741|FG001|COMPLETED|Randomization 1||43
9979597|NCT01588457|11100742|FG002|COMPLETED|Randomization 1||0
9979598|NCT01588457|11100743|FG003|COMPLETED|Randomization 1||0
9979599|NCT01588457|11100740|FG000|NOT COMPLETED|Randomization 1||23
9979600|NCT01588457|11100741|FG001|NOT COMPLETED|Randomization 1||16
9979601|NCT01588457|11100742|FG002|NOT COMPLETED|Randomization 1||0
9979602|NCT01588457|11100743|FG003|NOT COMPLETED|Randomization 1||0
9979603|NCT01588457|11100740|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
9979604|NCT01588457|11100741|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
9979605|NCT01588457|11100742|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
9979606|NCT01588457|11100743|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
9979607|NCT01588457|11100740|FG000|COMPLETED|Randomization 2||1
9979608|NCT01588457|11100741|FG001|COMPLETED|Randomization 2||3
9979609|NCT01588457|11100742|FG002|COMPLETED|Randomization 2||12
9979610|NCT01588457|11100743|FG003|COMPLETED|Randomization 2||13
9979611|NCT01588457|11100740|FG000|NOT COMPLETED|Randomization 2||20
9979612|NCT01588457|11100741|FG001|NOT COMPLETED|Randomization 2||28
9979613|NCT01588457|11100742|FG002|NOT COMPLETED|Randomization 2||5
9979614|NCT01588457|11100743|FG003|NOT COMPLETED|Randomization 2||5
9979615|NCT01588470|11100763|FG000|STARTED|Overall Study|First enrolled April 2007|130
9979616|NCT01588470|11100763|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50
9979617|NCT01588470|11100763|FG000|NOT COMPLETED|Overall Study||80
9979618|NCT01588496|11100775|FG000|STARTED|Overall Study||8
9979619|NCT01588496|11100776|FG001|STARTED|Overall Study||17
9979620|NCT01588496|11100777|FG002|STARTED|Overall Study||33
9979621|NCT01588496|11100775|FG000|Received Treatment|Overall Study||8
9979622|NCT01588496|11100776|FG001|Received Treatment|Overall Study||16
9979623|NCT01588496|11100777|FG002|Received Treatment|Overall Study||33
9979624|NCT01588496|11100775|FG000|COMPLETED|Overall Study||8
9979625|NCT01588496|11100776|FG001|COMPLETED|Overall Study||16
9979626|NCT01588496|11100777|FG002|COMPLETED|Overall Study||33
9979627|NCT01588496|11100775|FG000|NOT COMPLETED|Overall Study||0
9979628|NCT01588496|11100776|FG001|NOT COMPLETED|Overall Study||1
9979629|NCT01588496|11100777|FG002|NOT COMPLETED|Overall Study||0
9979630|NCT01588509|11100787|FG000|STARTED|Overall Study||30
9979631|NCT01588509|11100788|FG001|STARTED|Overall Study||30
9979632|NCT01588509|11100787|FG000|Received Treatment|Overall Study||30
9979633|NCT01588509|11100788|FG001|Received Treatment|Overall Study||30
9979634|NCT01588509|11100787|FG000|COMPLETED|Overall Study||29
9979635|NCT01588509|11100788|FG001|COMPLETED|Overall Study||30
9979636|NCT01588509|11100787|FG000|NOT COMPLETED|Overall Study||1
9979637|NCT01588509|11100788|FG001|NOT COMPLETED|Overall Study||0
9979638|NCT01588548|11100800|FG000|STARTED|Overall Study||3
9979639|NCT01588548|11100801|FG001|STARTED|Overall Study||7
9979640|NCT01588548|11100802|FG002|STARTED|Overall Study||6
9979641|NCT01588548|11100803|FG003|STARTED|Overall Study||7
9979642|NCT01588548|11100804|FG004|STARTED|Overall Study||6
9979643|NCT01588548|11100805|FG005|STARTED|Overall Study||6
9979644|NCT01588548|11100800|FG000|Cycle 1 Day 21|Overall Study||3
9979645|NCT01588548|11100801|FG001|Cycle 1 Day 21|Overall Study||5
9979646|NCT01588548|11100802|FG002|Cycle 1 Day 21|Overall Study||2
9979647|NCT01588548|11100803|FG003|Cycle 1 Day 21|Overall Study||5
9979648|NCT01588548|11100804|FG004|Cycle 1 Day 21|Overall Study||3
9979649|NCT01588548|11100805|FG005|Cycle 1 Day 21|Overall Study||3
9979650|NCT01588548|11100800|FG000|COMPLETED|Overall Study||0
9979651|NCT01588548|11100801|FG001|COMPLETED|Overall Study||0
9979652|NCT01588548|11100802|FG002|COMPLETED|Overall Study||0
9979653|NCT01588548|11100803|FG003|COMPLETED|Overall Study||0
9979654|NCT01588548|11100804|FG004|COMPLETED|Overall Study||0
9979655|NCT01588548|11100805|FG005|COMPLETED|Overall Study||0
9979656|NCT01588548|11100800|FG000|NOT COMPLETED|Overall Study||3
9979657|NCT01588548|11100801|FG001|NOT COMPLETED|Overall Study||7
9979658|NCT01588548|11100802|FG002|NOT COMPLETED|Overall Study||6
9979659|NCT01588548|11100803|FG003|NOT COMPLETED|Overall Study||7
9979660|NCT01588548|11100804|FG004|NOT COMPLETED|Overall Study||6
9979661|NCT01588548|11100805|FG005|NOT COMPLETED|Overall Study||6
9979662|NCT01588561|11100819|FG000|STARTED|Overall Study||14
9979663|NCT01588561|11100820|FG001|STARTED|Overall Study||1
9979664|NCT01588561|11100819|FG000|First Injection (Visit 1)|Overall Study||14
9979665|NCT01588561|11100820|FG001|First Injection (Visit 1)|Overall Study||1
9979666|NCT01588561|11100819|FG000|Rest Period|Overall Study||14
9979667|NCT01588561|11100820|FG001|Rest Period|Overall Study||1
9979668|NCT01588561|11100819|FG000|Second Injection (Visit 2)|Overall Study||14
9979669|NCT01588561|11100820|FG001|Second Injection (Visit 2)|Overall Study||1
9979670|NCT01588561|11100819|FG000|COMPLETED|Overall Study||14
9979671|NCT01588561|11100820|FG001|COMPLETED|Overall Study||1
9979672|NCT01588561|11100819|FG000|NOT COMPLETED|Overall Study||0
9979673|NCT01588561|11100820|FG001|NOT COMPLETED|Overall Study||0
9979674|NCT01588821|11100826|FG000|STARTED|Overall Study||37
9979675|NCT01588821|11100826|FG000|COMPLETED|Overall Study||37
9979676|NCT01588821|11100826|FG000|NOT COMPLETED|Overall Study||0
9979677|NCT01588951|11100834|FG000|STARTED|Overall Study||2
9979678|NCT01588951|11100835|FG001|STARTED|Overall Study||2
9979679|NCT01588951|11100836|FG002|STARTED|Overall Study||6
9979680|NCT01588951|11100834|FG000|COMPLETED|Overall Study||2
9979681|NCT01588951|11100835|FG001|COMPLETED|Overall Study||2
9979682|NCT01588951|11100836|FG002|COMPLETED|Overall Study||5
9979683|NCT01588951|11100834|FG000|NOT COMPLETED|Overall Study||0
9979684|NCT01588951|11100835|FG001|NOT COMPLETED|Overall Study||0
9979685|NCT01588951|11100836|FG002|NOT COMPLETED|Overall Study||1
9979686|NCT01588990|11100844|FG000|STARTED|Phase A||128
9979687|NCT01588990|11100844|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
9979688|NCT01588990|11100844|FG000|NOT COMPLETED|Phase A||70
9979689|NCT01588990|11100844|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
9979690|NCT01588990|11100844|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
9979691|NCT01588990|11100844|FG000|NOT COMPLETED|Phase B||16
9979692|NCT01589094|11100852|FG000|STARTED|Overall Study||51
9979693|NCT01589094|11100852|FG000|COMPLETED|Overall Study||49
9979694|NCT01589094|11100852|FG000|NOT COMPLETED|Overall Study||2
9979695|NCT01589185|11100861|FG000|STARTED|Overall Study||6
9979696|NCT01589185|11100862|FG001|STARTED|Overall Study||8
9979697|NCT01589185|11100863|FG002|STARTED|Overall Study||10
9979698|NCT01589185|11100864|FG003|STARTED|Overall Study||8
9979699|NCT01589185|11100865|FG004|STARTED|Overall Study||16
9979700|NCT01589185|11100861|FG000|COMPLETED|Overall Study||4
9979701|NCT01589185|11100862|FG001|COMPLETED|Overall Study||6
9979702|NCT01589185|11100863|FG002|COMPLETED|Overall Study||6
9979703|NCT01589185|11100864|FG003|COMPLETED|Overall Study||5
9979704|NCT01589185|11100865|FG004|COMPLETED|Overall Study||15
9979705|NCT01589185|11100861|FG000|NOT COMPLETED|Overall Study||2
9979706|NCT01589185|11100862|FG001|NOT COMPLETED|Overall Study||2
9979707|NCT01589185|11100863|FG002|NOT COMPLETED|Overall Study||4
9979708|NCT01589185|11100864|FG003|NOT COMPLETED|Overall Study||3
9979709|NCT01589185|11100865|FG004|NOT COMPLETED|Overall Study||1
9979710|NCT01589237|11100882|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
9979711|NCT01589237|11100883|FG001|STARTED|Part A (52 Weeks)||12
9979712|NCT01589237|11100884|FG002|STARTED|Part A (52 Weeks)||10
9979713|NCT01589237|11100885|FG003|STARTED|Part A (52 Weeks)||5
9979714|NCT01589237|11100882|FG000|COMPLETED|Part A (52 Weeks)||9
9979715|NCT01589237|11100883|FG001|COMPLETED|Part A (52 Weeks)||9
9979716|NCT01589237|11100884|FG002|COMPLETED|Part A (52 Weeks)||8
9979717|NCT01589237|11100885|FG003|COMPLETED|Part A (52 Weeks)||5
9979718|NCT01589237|11100882|FG000|NOT COMPLETED|Part A (52 Weeks)||2
9979719|NCT01589237|11100883|FG001|NOT COMPLETED|Part A (52 Weeks)||3
9979720|NCT01589237|11100884|FG002|NOT COMPLETED|Part A (52 Weeks)||2
9979721|NCT01589237|11100885|FG003|NOT COMPLETED|Part A (52 Weeks)||0
9979722|NCT01589237|11100882|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5
9979723|NCT01589237|11100883|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6
9979724|NCT01589237|11100884|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4
9979725|NCT01589237|11100885|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4
9979726|NCT01589237|11100882|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0
9979727|NCT01589237|11100883|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0
9979728|NCT01589237|11100884|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0
9979729|NCT01589237|11100885|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0
9979730|NCT01589237|11100882|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
9979731|NCT01589237|11100883|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
9979732|NCT01589237|11100884|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
9979733|NCT01589237|11100885|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
9979734|NCT01589263|11100901|FG000|STARTED|Overall Study||9
9979735|NCT01589263|11100902|FG001|STARTED|Overall Study||12
9979736|NCT01589263|11100901|FG000|COMPLETED|Overall Study||9
9979737|NCT01589263|11100902|FG001|COMPLETED|Overall Study||12
9979738|NCT01589263|11100901|FG000|NOT COMPLETED|Overall Study||0
9979739|NCT01589263|11100902|FG001|NOT COMPLETED|Overall Study||0
9979740|NCT01589302|11100908|FG000|STARTED|Overall Study||154
9979741|NCT01589302|11100908|FG000|Del17p Patients|Overall Study||76
9979742|NCT01589302|11100908|FG000|Non-Del17p Patients|Overall Study||76
9979743|NCT01589302|11100908|FG000|COMPLETED|Overall Study||152
9979744|NCT01589302|11100908|FG000|NOT COMPLETED|Overall Study||2
9979745|NCT01589315|11100913|FG000|STARTED|Overall Study||17
9979746|NCT01589315|11100913|FG000|COMPLETED|Overall Study||16
9979747|NCT01589315|11100913|FG000|NOT COMPLETED|Overall Study||1
9979748|NCT01589445|11100917|FG000|STARTED|001 (Pioglitazone) -3 Months||77
9979749|NCT01589445|11100917|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
9979750|NCT01589445|11100917|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
9979751|NCT01589445|11100917|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
9979752|NCT01589445|11100917|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
9979753|NCT01589445|11100917|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9
9979754|NCT01589484|11100925|FG000|STARTED|Overall Study||104
9979755|NCT01589484|11100925|FG000|COMPLETED|Overall Study||100
9979756|NCT01589484|11100925|FG000|NOT COMPLETED|Overall Study||4
9979757|NCT01589497|11100934|FG000|STARTED|Overall Study||18
9979758|NCT01589497|11100935|FG001|STARTED|Overall Study||17
9979759|NCT01589497|11100936|FG002|STARTED|Overall Study||16
9979760|NCT01589497|11100937|FG003|STARTED|Overall Study||18
9979761|NCT01589497|11100934|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
9979762|NCT01589497|11100935|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
9979763|NCT01589497|11100936|FG002|COMPLETED|Overall Study||15
9979764|NCT01589497|11100937|FG003|COMPLETED|Overall Study||17
9979765|NCT01589497|11100934|FG000|NOT COMPLETED|Overall Study||1
9979766|NCT01589497|11100935|FG001|NOT COMPLETED|Overall Study||1
9979767|NCT01589497|11100936|FG002|NOT COMPLETED|Overall Study||1
9979768|NCT01589497|11100937|FG003|NOT COMPLETED|Overall Study||1
9979769|NCT01589510|11100952|FG000|STARTED|Overall Study||419
9979770|NCT01589510|11100952|FG000|COMPLETED|Overall Study||386
9979771|NCT01589510|11100952|FG000|NOT COMPLETED|Overall Study||33
9979772|NCT01589601|11100958|FG000|STARTED|Overall Study||75
9979773|NCT01589601|11100959|FG001|STARTED|Overall Study||75
9979774|NCT01589601|11100958|FG000|COMPLETED|Overall Study||28
9979775|NCT01589601|11100959|FG001|COMPLETED|Overall Study||26
9979776|NCT01589601|11100958|FG000|NOT COMPLETED|Overall Study||47
9979777|NCT01589601|11100959|FG001|NOT COMPLETED|Overall Study||49
10017815|NCT01819415|11140791|FG003|STARTED|Overall Study||10
10017816|NCT01819415|11140788|FG000|COMPLETED|Overall Study||7
10017817|NCT01819415|11140789|FG001|COMPLETED|Overall Study||6
10017818|NCT01819415|11140790|FG002|COMPLETED|Overall Study||9
10017819|NCT01819415|11140791|FG003|COMPLETED|Overall Study||8
10017820|NCT01819415|11140788|FG000|NOT COMPLETED|Overall Study||3
10017821|NCT01819415|11140789|FG001|NOT COMPLETED|Overall Study||4
10017822|NCT01819415|11140790|FG002|NOT COMPLETED|Overall Study||1
10017823|NCT01819415|11140791|FG003|NOT COMPLETED|Overall Study||2
10017824|NCT01819506|11140803|FG000|STARTED|Overall Study||51
10017825|NCT01819506|11140804|FG001|STARTED|Overall Study||52
10017826|NCT01819506|11140803|FG000|COMPLETED|Overall Study||43
10017827|NCT01819506|11140804|FG001|COMPLETED|Overall Study||47
10017828|NCT01819506|11140803|FG000|NOT COMPLETED|Overall Study||8
10017829|NCT01819506|11140804|FG001|NOT COMPLETED|Overall Study||5
10017830|NCT01819597|11140810|FG000|STARTED|Overall Study||52
10017831|NCT01819597|11140810|FG000|COMPLETED|Overall Study||52
10017832|NCT01819597|11140810|FG000|NOT COMPLETED|Overall Study||0
10017833|NCT01819727|11140816|FG000|STARTED|Overall Study||131
10017834|NCT01819727|11140817|FG001|STARTED|Overall Study||130
10017835|NCT01819727|11140816|FG000|COMPLETED|Overall Study||111
10017836|NCT01819727|11140817|FG001|COMPLETED|Overall Study||102
10017837|NCT01819727|11140816|FG000|NOT COMPLETED|Overall Study||20
10017838|NCT01819727|11140817|FG001|NOT COMPLETED|Overall Study||28
10017839|NCT01819844|11140823|FG000|STARTED|Overall Study||12
10017840|NCT01819844|11140823|FG000|COMPLETED|Overall Study||12
10017841|NCT01819844|11140823|FG000|NOT COMPLETED|Overall Study||0
10017842|NCT01819883|11140830|FG000|STARTED|Overall Study||20
10017843|NCT01819883|11140831|FG001|STARTED|Overall Study||20
10017844|NCT01819883|11140830|FG000|COMPLETED|Overall Study||16
10017845|NCT01819883|11140831|FG001|COMPLETED|Overall Study||20
10017846|NCT01819883|11140830|FG000|NOT COMPLETED|Overall Study||4
10017847|NCT01819883|11140831|FG001|NOT COMPLETED|Overall Study||0
10017848|NCT01819922|11140836|FG000|STARTED|First Intervention Period (1 Day)||6
10017849|NCT01819922|11140837|FG001|STARTED|First Intervention Period (1 Day)||6
10017850|NCT01819922|11140836|FG000|COMPLETED|First Intervention Period (1 Day)||6
10017851|NCT01819922|11140837|FG001|COMPLETED|First Intervention Period (1 Day)||6
10017852|NCT01819922|11140836|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
10017853|NCT01819922|11140837|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
10017854|NCT01819922|11140836|FG000|STARTED|Washout Period (at Least 7-10 Days)||6
10017855|NCT01819922|11140837|FG001|STARTED|Washout Period (at Least 7-10 Days)||6
10017856|NCT01819922|11140836|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6
10017857|NCT01819922|11140837|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6
10017858|NCT01819922|11140836|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
10017859|NCT01819922|11140837|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
10017860|NCT01819922|11140836|FG000|STARTED|Second Intervention Period (1 Day)||6
10017861|NCT01819922|11140837|FG001|STARTED|Second Intervention Period (1 Day)||6
10017862|NCT01819922|11140836|FG000|COMPLETED|Second Intervention Period (1 Day)||6
10017863|NCT01819922|11140837|FG001|COMPLETED|Second Intervention Period (1 Day)||6
10017864|NCT01819922|11140836|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
10017865|NCT01819922|11140837|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
10017866|NCT01819935|11140845|FG000|STARTED|Overall Study||328
10017867|NCT01819935|11140846|FG001|STARTED|Overall Study||4943
10017868|NCT01819935|11140845|FG000|COMPLETED|Overall Study||328
10017869|NCT01819935|11140846|FG001|COMPLETED|Overall Study||4943
10017870|NCT01819935|11140845|FG000|NOT COMPLETED|Overall Study||0
10017871|NCT01819935|11140846|FG001|NOT COMPLETED|Overall Study||0
10017872|NCT01820260|11140866|FG000|STARTED|Phase 1 (Part 1)||3
10017873|NCT01820260|11140867|FG001|STARTED|Phase 1 (Part 1)||12
10017874|NCT01820260|11140868|FG002|STARTED|Phase 1 (Part 1)||10
10017875|NCT01820260|11140869|FG003|STARTED|Phase 1 (Part 1)||12
10017876|NCT01820260|11140870|FG004|STARTED|Phase 1 (Part 1)||12
10017877|NCT01820260|11140871|FG005|STARTED|Phase 1 (Part 1)||10
10017878|NCT01820260|11140872|FG006|STARTED|Phase 1 (Part 1)||12
10017879|NCT01820260|11140873|FG007|STARTED|Phase 1 (Part 1)||11
10017880|NCT01820260|11140874|FG008|STARTED|Phase 1 (Part 1)||0
10017881|NCT01820260|11140875|FG009|STARTED|Phase 1 (Part 1)||0
10017882|NCT01820260|11140876|FG010|STARTED|Phase 1 (Part 1)||0
9979778|NCT01589653|11100967|FG000|STARTED|Overall Study||76
9979779|NCT01589653|11100968|FG001|STARTED|Overall Study||79
9979780|NCT01589653|11100967|FG000|Exposed|Overall Study||76
9979781|NCT01589653|11100968|FG001|Exposed|Overall Study||78
9979782|NCT01589653|11100967|FG000|COMPLETED|Overall Study||69
9979783|NCT01589653|11100968|FG001|COMPLETED|Overall Study||68
9979784|NCT01589653|11100967|FG000|NOT COMPLETED|Overall Study||7
9979785|NCT01589653|11100968|FG001|NOT COMPLETED|Overall Study||11
9979786|NCT01589770|11100976|FG000|STARTED|Overall Study||67
9979787|NCT01589770|11100977|FG001|STARTED|Overall Study||61
9979788|NCT01589770|11100976|FG000|COMPLETED|Overall Study||59
9979789|NCT01589770|11100977|FG001|COMPLETED|Overall Study||56
9979790|NCT01589770|11100976|FG000|NOT COMPLETED|Overall Study||8
9979791|NCT01589770|11100977|FG001|NOT COMPLETED|Overall Study||5
9979792|NCT01589822|11100986|FG000|STARTED|Overall Study||84
9979793|NCT01589822|11100987|FG001|STARTED|Overall Study||89
9979794|NCT01589822|11100988|FG002|STARTED|Overall Study||41
9979795|NCT01589822|11100986|FG000|COMPLETED|Overall Study||80
9979796|NCT01589822|11100987|FG001|COMPLETED|Overall Study||86
9979797|NCT01589822|11100988|FG002|COMPLETED|Overall Study||40
9979798|NCT01589822|11100986|FG000|NOT COMPLETED|Overall Study||4
9979799|NCT01589822|11100987|FG001|NOT COMPLETED|Overall Study||3
9979800|NCT01589822|11100988|FG002|NOT COMPLETED|Overall Study||1
9979801|NCT01589978|11100998|FG000|STARTED|Overall Study||2681
9979802|NCT01589978|11100998|FG000|COMPLETED|Overall Study||2681
9979803|NCT01589978|11100998|FG000|NOT COMPLETED|Overall Study||0
9979804|NCT01590017|11101003|FG000|STARTED|Overall Study||41
9979805|NCT01590017|11101003|FG000|COMPLETED|Overall Study||37
9979806|NCT01590017|11101003|FG000|NOT COMPLETED|Overall Study||4
9979807|NCT01590082|11101009|FG000|STARTED|Overall Study||11
9979808|NCT01590082|11101010|FG001|STARTED|Overall Study||1
9979809|NCT01590082|11101009|FG000|COMPLETED|Overall Study||9
9979810|NCT01590082|11101010|FG001|COMPLETED|Overall Study||1
9979811|NCT01590082|11101009|FG000|NOT COMPLETED|Overall Study||2
9979812|NCT01590082|11101010|FG001|NOT COMPLETED|Overall Study||0
9979813|NCT01590212|11101019|FG000|STARTED|Overall Study||12
9979814|NCT01590212|11101020|FG001|STARTED|Overall Study||9
9979815|NCT01590212|11101021|FG002|STARTED|Overall Study||14
9979816|NCT01590212|11101019|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
9979817|NCT01590212|11101020|FG001|Baseline (Pre-intervention)|Overall Study||9
9979818|NCT01590212|11101021|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
9979819|NCT01590212|11101019|FG000|Post-intervention|Overall Study|failed contact=3|7
9979820|NCT01590212|11101020|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
9979821|NCT01590212|11101021|FG002|Post-intervention|Overall Study|failed contact=1|10
9979822|NCT01590212|11101019|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
9979823|NCT01590212|11101020|FG001|COMPLETED|Overall Study||5
9979824|NCT01590212|11101021|FG002|COMPLETED|Overall Study||9
9979825|NCT01590212|11101019|FG000|NOT COMPLETED|Overall Study||3
9979826|NCT01590212|11101020|FG001|NOT COMPLETED|Overall Study||4
9979827|NCT01590212|11101021|FG002|NOT COMPLETED|Overall Study||5
9979828|NCT01590238|11101030|FG000|STARTED|Overall Study||15
9979829|NCT01590238|11101030|FG000|COMPLETED|Overall Study||13
9979830|NCT01590238|11101030|FG000|NOT COMPLETED|Overall Study||2
9979831|NCT01590264|11101034|FG000|STARTED|Overall Study||5
9979832|NCT01590264|11101034|FG000|COMPLETED|Overall Study||5
9979833|NCT01590264|11101034|FG000|NOT COMPLETED|Overall Study||0
9979834|NCT01590433|11101040|FG000|STARTED|Overall Study||127
9979835|NCT01590433|11101041|FG001|STARTED|Overall Study||55
9979836|NCT01590433|11101040|FG000|COMPLETED|Overall Study||75
9979837|NCT01590433|11101041|FG001|COMPLETED|Overall Study||33
9979838|NCT01590433|11101040|FG000|NOT COMPLETED|Overall Study||52
9979839|NCT01590433|11101041|FG001|NOT COMPLETED|Overall Study||22
9979840|NCT01590550|11101047|FG000|STARTED|Overall Study||18
9979841|NCT01590550|11101047|FG000|COMPLETED|Overall Study||18
9979842|NCT01590550|11101047|FG000|NOT COMPLETED|Overall Study||0
9979843|NCT01590563|11101052|FG000|STARTED|Overall Study||15
9979844|NCT01590563|11101052|FG000|COMPLETED|Overall Study||14
9979845|NCT01590563|11101052|FG000|NOT COMPLETED|Overall Study||1
9979846|NCT01590758|11101059|FG000|STARTED|Overall Study||85
9979847|NCT01590758|11101060|FG001|STARTED|Overall Study||104
9979848|NCT01590758|11101059|FG000|COMPLETED|Overall Study||80
9979849|NCT01590758|11101060|FG001|COMPLETED|Overall Study||97
9979850|NCT01590758|11101059|FG000|NOT COMPLETED|Overall Study||5
9979851|NCT01590758|11101060|FG001|NOT COMPLETED|Overall Study||7
9979852|NCT01590771|11101068|FG000|STARTED|Overall Study||249
9979853|NCT01590771|11101069|FG001|STARTED|Overall Study||249
9979854|NCT01590771|11101068|FG000|COMPLETED|Overall Study||230
9979855|NCT01590771|11101069|FG001|COMPLETED|Overall Study||210
9979856|NCT01590771|11101068|FG000|NOT COMPLETED|Overall Study||19
9979857|NCT01590771|11101069|FG001|NOT COMPLETED|Overall Study||39
9979858|NCT01590797|11101077|FG000|STARTED|Overall Study||234
9979859|NCT01590797|11101078|FG001|STARTED|Overall Study||233
9979860|NCT01590797|11101077|FG000|COMPLETED|Overall Study||217
9979861|NCT01590797|11101078|FG001|COMPLETED|Overall Study||217
9979862|NCT01590797|11101077|FG000|NOT COMPLETED|Overall Study||17
9979863|NCT01590797|11101078|FG001|NOT COMPLETED|Overall Study||16
9979864|NCT01590810|11101089|FG000|STARTED|Overall Study||8
9979865|NCT01590810|11101090|FG001|STARTED|Overall Study||8
9979866|NCT01590810|11101091|FG002|STARTED|Overall Study||8
9979867|NCT01590810|11101092|FG003|STARTED|Overall Study||8
9979868|NCT01590810|11101093|FG004|STARTED|Overall Study||2
9979869|NCT01590810|11101089|FG000|COMPLETED|Overall Study||8
9979870|NCT01590810|11101090|FG001|COMPLETED|Overall Study||7
9979871|NCT01590810|11101091|FG002|COMPLETED|Overall Study||7
9979872|NCT01590810|11101092|FG003|COMPLETED|Overall Study||8
9979873|NCT01590810|11101093|FG004|COMPLETED|Overall Study||2
9979874|NCT01590810|11101089|FG000|NOT COMPLETED|Overall Study||0
9979875|NCT01590810|11101090|FG001|NOT COMPLETED|Overall Study||1
9979876|NCT01590810|11101091|FG002|NOT COMPLETED|Overall Study||1
9979877|NCT01590810|11101092|FG003|NOT COMPLETED|Overall Study||0
9979878|NCT01590810|11101093|FG004|NOT COMPLETED|Overall Study||0
9979879|NCT01590875|11101128|FG000|STARTED|Overall Study||10
9979880|NCT01590875|11101129|FG001|STARTED|Overall Study||10
9979881|NCT01590875|11101128|FG000|COMPLETED|Overall Study||10
9979882|NCT01590875|11101129|FG001|COMPLETED|Overall Study||10
9979883|NCT01590875|11101128|FG000|NOT COMPLETED|Overall Study||0
9979884|NCT01590875|11101129|FG001|NOT COMPLETED|Overall Study||0
9979885|NCT01590888|11101140|FG000|STARTED|Overall Study||36
9979886|NCT01590888|11101141|FG001|STARTED|Overall Study||38
9979887|NCT01590888|11101142|FG002|STARTED|Overall Study||35
9979888|NCT01590888|11101140|FG000|COMPLETED|Overall Study||32
9979889|NCT01590888|11101141|FG001|COMPLETED|Overall Study||38
9979890|NCT01590888|11101142|FG002|COMPLETED|Overall Study||34
9979891|NCT01590888|11101140|FG000|NOT COMPLETED|Overall Study||4
9979892|NCT01590888|11101141|FG001|NOT COMPLETED|Overall Study||0
9979893|NCT01590888|11101142|FG002|NOT COMPLETED|Overall Study||1
9979894|NCT01590979|11101152|FG000|STARTED|Overall Study||27
9979895|NCT01590979|11101153|FG001|STARTED|Overall Study||27
9979896|NCT01590979|11101152|FG000|COMPLETED|Overall Study||27
9979897|NCT01590979|11101153|FG001|COMPLETED|Overall Study||27
9979898|NCT01590979|11101152|FG000|NOT COMPLETED|Overall Study||0
9979899|NCT01590979|11101153|FG001|NOT COMPLETED|Overall Study||0
9979900|NCT01591005|11101163|FG000|STARTED|Overall Study||53
9979901|NCT01591005|11101164|FG001|STARTED|Overall Study||53
9979902|NCT01591005|11101165|FG002|STARTED|Overall Study||68
9979903|NCT01591005|11101166|FG003|STARTED|Overall Study||68
9979904|NCT01591005|11101163|FG000|COMPLETED|Overall Study||53
9979905|NCT01591005|11101164|FG001|COMPLETED|Overall Study||53
9979906|NCT01591005|11101165|FG002|COMPLETED|Overall Study||68
9979907|NCT01591005|11101166|FG003|COMPLETED|Overall Study||68
9979908|NCT01591005|11101163|FG000|NOT COMPLETED|Overall Study||0
9979909|NCT01591005|11101164|FG001|NOT COMPLETED|Overall Study||0
9979910|NCT01591005|11101165|FG002|NOT COMPLETED|Overall Study||0
9979911|NCT01591005|11101166|FG003|NOT COMPLETED|Overall Study||0
9979912|NCT01591018|11101178|FG000|STARTED|Overall Study||60
9979913|NCT01591018|11101179|FG001|STARTED|Overall Study||60
9979914|NCT01591018|11101178|FG000|COMPLETED|Overall Study||60
9979915|NCT01591018|11101179|FG001|COMPLETED|Overall Study||60
9979916|NCT01591018|11101178|FG000|NOT COMPLETED|Overall Study||0
9979917|NCT01591018|11101179|FG001|NOT COMPLETED|Overall Study||0
9979918|NCT01591044|11101188|FG000|STARTED|Overall Study||101
9979919|NCT01591044|11101189|FG001|STARTED|Overall Study||100
9979920|NCT01591044|11101190|FG002|STARTED|Overall Study||100
9979921|NCT01591044|11101188|FG000|COMPLETED|Overall Study||94
9979922|NCT01591044|11101189|FG001|COMPLETED|Overall Study||91
9979923|NCT01591044|11101190|FG002|COMPLETED|Overall Study||96
9979924|NCT01591044|11101188|FG000|NOT COMPLETED|Overall Study||7
9979925|NCT01591044|11101189|FG001|NOT COMPLETED|Overall Study||9
9979926|NCT01591044|11101190|FG002|NOT COMPLETED|Overall Study||4
9979927|NCT01591161|11101200|FG000|STARTED|Overall Study||245
9979928|NCT01591161|11101201|FG001|STARTED|Overall Study||124
9979929|NCT01591161|11101200|FG000|COMPLETED|Overall Study||174
9979930|NCT01591161|11101201|FG001|COMPLETED|Overall Study||68
9979931|NCT01591161|11101200|FG000|NOT COMPLETED|Overall Study||71
9979932|NCT01591161|11101201|FG001|NOT COMPLETED|Overall Study||56
9979933|NCT01591317|11101210|FG000|STARTED|Overall Study||10
9979934|NCT01591317|11101211|FG001|STARTED|Overall Study||10
9979935|NCT01591317|11101212|FG002|STARTED|Overall Study||10
9979936|NCT01591317|11101210|FG000|COMPLETED|Overall Study||10
9979937|NCT01591317|11101211|FG001|COMPLETED|Overall Study||10
9979938|NCT01591317|11101212|FG002|COMPLETED|Overall Study||10
9979939|NCT01591317|11101210|FG000|NOT COMPLETED|Overall Study||0
9979940|NCT01591317|11101211|FG001|NOT COMPLETED|Overall Study||0
9979941|NCT01591317|11101212|FG002|NOT COMPLETED|Overall Study||0
10099540|NCT02392234|11228648|FG002|STARTED|Treatment Period 1 (8 Weeks)||40
10099541|NCT02392234|11228649|FG003|STARTED|Treatment Period 1 (8 Weeks)||42
10099542|NCT02392234|11228650|FG004|STARTED|Treatment Period 1 (8 Weeks)||41
10099543|NCT02392234|11228651|FG005|STARTED|Treatment Period 1 (8 Weeks)||41
9979942|NCT01591330|11101225|FG000|STARTED|Period 1||8
10099544|NCT02392234|11228646|FG000|Treated|Treatment Period 1 (8 Weeks)||41
10099545|NCT02392234|11228647|FG001|Treated|Treatment Period 1 (8 Weeks)||43
9979943|NCT01591330|11101226|FG001|STARTED|Period 1||9
9979944|NCT01591330|11101227|FG002|STARTED|Period 1||9
9979945|NCT01591330|11101228|FG003|STARTED|Period 1||9
9979946|NCT01591330|11101225|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
9979947|NCT01591330|11101226|FG001|Received at Least 1 Dose of Study Drug|Period 1||9
9979948|NCT01591330|11101227|FG002|Received at Least 1 Dose of Study Drug|Period 1||9
9979949|NCT01591330|11101228|FG003|Received at Least 1 Dose of Study Drug|Period 1||9
9979950|NCT01591330|11101225|FG000|COMPLETED|Period 1||7
9979951|NCT01591330|11101226|FG001|COMPLETED|Period 1||9
9979952|NCT01591330|11101227|FG002|COMPLETED|Period 1||9
9979953|NCT01591330|11101228|FG003|COMPLETED|Period 1||9
9979954|NCT01591330|11101225|FG000|NOT COMPLETED|Period 1||1
10099546|NCT02392234|11228648|FG002|Treated|Treatment Period 1 (8 Weeks)||39
10099547|NCT02392234|11228649|FG003|Treated|Treatment Period 1 (8 Weeks)||42
10099548|NCT02392234|11228650|FG004|Treated|Treatment Period 1 (8 Weeks)||40
10099549|NCT02392234|11228651|FG005|Treated|Treatment Period 1 (8 Weeks)||41
10099550|NCT02392234|11228646|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38
10099551|NCT02392234|11228647|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43
10099552|NCT02392234|11228648|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38
10099553|NCT02392234|11228649|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41
9979955|NCT01591330|11101226|FG001|NOT COMPLETED|Period 1||0
9979956|NCT01591330|11101227|FG002|NOT COMPLETED|Period 1||0
9979957|NCT01591330|11101228|FG003|NOT COMPLETED|Period 1||0
9979958|NCT01591330|11101225|FG000|STARTED|Washout of at Least 3 Days||7
9979959|NCT01591330|11101226|FG001|STARTED|Washout of at Least 3 Days||9
9979960|NCT01591330|11101227|FG002|STARTED|Washout of at Least 3 Days||9
10099554|NCT02392234|11228650|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37
10099555|NCT02392234|11228651|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38
10099556|NCT02392234|11228646|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
10099557|NCT02392234|11228647|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
10099558|NCT02392234|11228648|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
10099559|NCT02392234|11228649|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
10099560|NCT02392234|11228650|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
10099561|NCT02392234|11228651|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
10099562|NCT02392234|11228646|FG000|STARTED|Treatment Period 2 (8 Weeks)||38
10099563|NCT02392234|11228647|FG001|STARTED|Treatment Period 2 (8 Weeks)||43
10099564|NCT02392234|11228648|FG002|STARTED|Treatment Period 2 (8 Weeks)||38
10099565|NCT02392234|11228649|FG003|STARTED|Treatment Period 2 (8 Weeks)||41
10099566|NCT02392234|11228650|FG004|STARTED|Treatment Period 2 (8 Weeks)||37
10099567|NCT02392234|11228651|FG005|STARTED|Treatment Period 2 (8 Weeks)||38
10099568|NCT02392234|11228646|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37
10099569|NCT02392234|11228647|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43
10099570|NCT02392234|11228648|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38
10099571|NCT02392234|11228649|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41
10099572|NCT02392234|11228650|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37
10099573|NCT02392234|11228651|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38
10099574|NCT02392234|11228646|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
10099575|NCT02392234|11228647|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10099576|NCT02392234|11228648|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10099577|NCT02392234|11228649|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10099578|NCT02392234|11228650|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10099579|NCT02392234|11228651|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10099580|NCT02392247|11228662|FG000|STARTED|Overall Study||52
10099581|NCT02392247|11228662|FG000|COMPLETED|Overall Study||50
10099582|NCT02392247|11228662|FG000|NOT COMPLETED|Overall Study||2
10099583|NCT02392286|11228668|FG000|STARTED|Overall Study||7
10099584|NCT02392286|11228669|FG001|STARTED|Overall Study||8
10099585|NCT02392286|11228668|FG000|COMPLETED|Overall Study||4
10099586|NCT02392286|11228669|FG001|COMPLETED|Overall Study||6
10099587|NCT02392286|11228668|FG000|NOT COMPLETED|Overall Study||3
10099588|NCT02392286|11228669|FG001|NOT COMPLETED|Overall Study||2
10099589|NCT02392351|11228677|FG000|STARTED|Overall Study||34
10099590|NCT02392351|11228678|FG001|STARTED|Overall Study||17
10099591|NCT02392351|11228677|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
10099592|NCT02392351|11228678|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
10099593|NCT02392351|11228677|FG000|NOT COMPLETED|Overall Study||34
10099594|NCT02392351|11228678|FG001|NOT COMPLETED|Overall Study||17
10099595|NCT02392403|11228684|FG000|STARTED|Overall Study||45
10099596|NCT02392403|11228684|FG000|COMPLETED|Overall Study||42
10099597|NCT02392403|11228684|FG000|NOT COMPLETED|Overall Study||3
10099598|NCT02392481|11228692|FG000|STARTED|Overall Study||10
10099599|NCT02392481|11228693|FG001|STARTED|Overall Study||12
10099600|NCT02392481|11228694|FG002|STARTED|Overall Study||20
10099601|NCT02392481|11228695|FG003|STARTED|Overall Study||27
10099602|NCT02392481|11228692|FG000|COMPLETED|Overall Study||10
10099603|NCT02392481|11228693|FG001|COMPLETED|Overall Study||12
10099604|NCT02392481|11228694|FG002|COMPLETED|Overall Study||18
10099605|NCT02392481|11228695|FG003|COMPLETED|Overall Study||25
10099606|NCT02392481|11228692|FG000|NOT COMPLETED|Overall Study||0
10099607|NCT02392481|11228693|FG001|NOT COMPLETED|Overall Study||0
10099608|NCT02392481|11228694|FG002|NOT COMPLETED|Overall Study||2
10099609|NCT02392481|11228695|FG003|NOT COMPLETED|Overall Study||2
10099610|NCT02392494|11228708|FG000|STARTED|Overall Study||3
10099611|NCT02392494|11228709|FG001|STARTED|Overall Study||3
10099612|NCT02392494|11228710|FG002|STARTED|Overall Study||3
10099613|NCT02392494|11228711|FG003|STARTED|Overall Study||0
10099614|NCT02392494|11228708|FG000|COMPLETED|Overall Study||3
10099615|NCT02392494|11228709|FG001|COMPLETED|Overall Study||3
10099616|NCT02392494|11228710|FG002|COMPLETED|Overall Study||3
10099617|NCT02392494|11228711|FG003|COMPLETED|Overall Study||0
10099618|NCT02392494|11228708|FG000|NOT COMPLETED|Overall Study||0
10099619|NCT02392494|11228709|FG001|NOT COMPLETED|Overall Study||0
10099620|NCT02392494|11228710|FG002|NOT COMPLETED|Overall Study||0
9979961|NCT01591330|11101228|FG003|STARTED|Washout of at Least 3 Days||9
9979962|NCT01591330|11101225|FG000|COMPLETED|Washout of at Least 3 Days||6
9979963|NCT01591330|11101226|FG001|COMPLETED|Washout of at Least 3 Days||9
9979964|NCT01591330|11101227|FG002|COMPLETED|Washout of at Least 3 Days||9
9979965|NCT01591330|11101228|FG003|COMPLETED|Washout of at Least 3 Days||9
9979966|NCT01591330|11101225|FG000|NOT COMPLETED|Washout of at Least 3 Days||1
9979967|NCT01591330|11101226|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
9979968|NCT01591330|11101227|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
9979969|NCT01591330|11101228|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
9979970|NCT01591330|11101225|FG000|STARTED|Period 2||6
9979971|NCT01591330|11101226|FG001|STARTED|Period 2||9
9979972|NCT01591330|11101227|FG002|STARTED|Period 2||9
9979973|NCT01591330|11101228|FG003|STARTED|Period 2||9
9979974|NCT01591330|11101225|FG000|COMPLETED|Period 2||5
9979975|NCT01591330|11101226|FG001|COMPLETED|Period 2||9
9979976|NCT01591330|11101227|FG002|COMPLETED|Period 2||9
9979977|NCT01591330|11101228|FG003|COMPLETED|Period 2||9
9979978|NCT01591330|11101225|FG000|NOT COMPLETED|Period 2||1
9979979|NCT01591330|11101226|FG001|NOT COMPLETED|Period 2||0
9979980|NCT01591330|11101227|FG002|NOT COMPLETED|Period 2||0
9979981|NCT01591330|11101228|FG003|NOT COMPLETED|Period 2||0
9979982|NCT01591330|11101225|FG000|STARTED|Washout of at Least 3 Days||5
9979983|NCT01591330|11101226|FG001|STARTED|Washout of at Least 3 Days||9
9979984|NCT01591330|11101227|FG002|STARTED|Washout of at Least 3 Days||9
10099621|NCT02392494|11228711|FG003|NOT COMPLETED|Overall Study||0
10099622|NCT02392507|11228719|FG000|STARTED|Induction Regimen||54
10099623|NCT02392507|11228719|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54
10099624|NCT02392507|11228719|FG000|COMPLETED|Induction Regimen||47
10099625|NCT02392507|11228719|FG000|NOT COMPLETED|Induction Regimen||7
9979985|NCT01591330|11101228|FG003|STARTED|Washout of at Least 3 Days||9
9979986|NCT01591330|11101225|FG000|COMPLETED|Washout of at Least 3 Days||5
9979987|NCT01591330|11101226|FG001|COMPLETED|Washout of at Least 3 Days||9
9979988|NCT01591330|11101227|FG002|COMPLETED|Washout of at Least 3 Days||9
9979989|NCT01591330|11101228|FG003|COMPLETED|Washout of at Least 3 Days||9
9979990|NCT01591330|11101225|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
9979991|NCT01591330|11101226|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
9979992|NCT01591330|11101227|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
9979993|NCT01591330|11101228|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
9979994|NCT01591330|11101225|FG000|STARTED|Period 3||5
9979995|NCT01591330|11101226|FG001|STARTED|Period 3||9
9979996|NCT01591330|11101227|FG002|STARTED|Period 3||9
9979997|NCT01591330|11101228|FG003|STARTED|Period 3||9
9979998|NCT01591330|11101225|FG000|COMPLETED|Period 3||5
9979999|NCT01591330|11101226|FG001|COMPLETED|Period 3||9
9980000|NCT01591330|11101227|FG002|COMPLETED|Period 3||9
9980001|NCT01591330|11101228|FG003|COMPLETED|Period 3||9
9980002|NCT01591330|11101225|FG000|NOT COMPLETED|Period 3||0
9980003|NCT01591330|11101226|FG001|NOT COMPLETED|Period 3||0
9980004|NCT01591330|11101227|FG002|NOT COMPLETED|Period 3||0
9980005|NCT01591330|11101228|FG003|NOT COMPLETED|Period 3||0
9980006|NCT01591330|11101225|FG000|STARTED|Washout of at Least 3 Days||5
9980007|NCT01591330|11101226|FG001|STARTED|Washout of at Least 3 Days||9
9980008|NCT01591330|11101227|FG002|STARTED|Washout of at Least 3 Days||9
9980009|NCT01591330|11101228|FG003|STARTED|Washout of at Least 3 Days||9
9980010|NCT01591330|11101225|FG000|COMPLETED|Washout of at Least 3 Days||5
9980011|NCT01591330|11101226|FG001|COMPLETED|Washout of at Least 3 Days||9
9980012|NCT01591330|11101227|FG002|COMPLETED|Washout of at Least 3 Days||9
9980013|NCT01591330|11101228|FG003|COMPLETED|Washout of at Least 3 Days||9
9980014|NCT01591330|11101225|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
9980015|NCT01591330|11101226|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
9980016|NCT01591330|11101227|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
9980017|NCT01591330|11101228|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
9980018|NCT01591330|11101225|FG000|STARTED|Period 4||5
9980019|NCT01591330|11101226|FG001|STARTED|Period 4||9
9980020|NCT01591330|11101227|FG002|STARTED|Period 4||9
9980021|NCT01591330|11101228|FG003|STARTED|Period 4||9
9980022|NCT01591330|11101225|FG000|COMPLETED|Period 4||5
9980023|NCT01591330|11101226|FG001|COMPLETED|Period 4||9
9980024|NCT01591330|11101227|FG002|COMPLETED|Period 4||9
9980025|NCT01591330|11101228|FG003|COMPLETED|Period 4||9
9980026|NCT01591330|11101225|FG000|NOT COMPLETED|Period 4||0
9980027|NCT01591330|11101226|FG001|NOT COMPLETED|Period 4||0
9980028|NCT01591330|11101227|FG002|NOT COMPLETED|Period 4||0
9980029|NCT01591330|11101228|FG003|NOT COMPLETED|Period 4||0
9980030|NCT01591382|11101240|FG000|STARTED|Overall Study||32
9980031|NCT01591382|11101241|FG001|STARTED|Overall Study||32
9980032|NCT01591382|11101240|FG000|COMPLETED|Overall Study||29
9980033|NCT01591382|11101241|FG001|COMPLETED|Overall Study||30
9980034|NCT01591382|11101240|FG000|NOT COMPLETED|Overall Study||3
9980035|NCT01591382|11101241|FG001|NOT COMPLETED|Overall Study||2
9980036|NCT01591408|11101249|FG000|STARTED|Overall Study||36
9980037|NCT01591408|11101250|FG001|STARTED|Overall Study||32
9980038|NCT01591408|11101249|FG000|COMPLETED|Overall Study||24
9980039|NCT01591408|11101250|FG001|COMPLETED|Overall Study||24
9980040|NCT01591408|11101249|FG000|NOT COMPLETED|Overall Study||12
9980041|NCT01591408|11101250|FG001|NOT COMPLETED|Overall Study||8
9980042|NCT01591460|11101256|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
9980043|NCT01591460|11101256|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
9980044|NCT01591460|11101256|FG000|NOT COMPLETED|Overall Study||26
10113164|NCT02508701|11244102|FG003|NOT COMPLETED|Overall Study||3
9980045|NCT01591499|11101268|FG000|STARTED|Baseline Visit||33
9980046|NCT01591499|11101269|FG001|STARTED|Baseline Visit||39
9980047|NCT01591499|11101270|FG002|STARTED|Baseline Visit||31
9980048|NCT01591499|11101271|FG003|STARTED|Baseline Visit||39
9980049|NCT01591499|11101268|FG000|COMPLETED|Baseline Visit||33
9980050|NCT01591499|11101269|FG001|COMPLETED|Baseline Visit||37
9980051|NCT01591499|11101270|FG002|COMPLETED|Baseline Visit||31
9980052|NCT01591499|11101271|FG003|COMPLETED|Baseline Visit||37
9980053|NCT01591499|11101268|FG000|NOT COMPLETED|Baseline Visit||0
9980054|NCT01591499|11101269|FG001|NOT COMPLETED|Baseline Visit||2
9980055|NCT01591499|11101270|FG002|NOT COMPLETED|Baseline Visit||0
9980056|NCT01591499|11101271|FG003|NOT COMPLETED|Baseline Visit||2
9980057|NCT01591499|11101268|FG000|STARTED|First Intervention (up to 24 Days)||33
9980058|NCT01591499|11101269|FG001|STARTED|First Intervention (up to 24 Days)||37
9980059|NCT01591499|11101270|FG002|STARTED|First Intervention (up to 24 Days)||31
9980060|NCT01591499|11101271|FG003|STARTED|First Intervention (up to 24 Days)||37
9980061|NCT01591499|11101268|FG000|COMPLETED|First Intervention (up to 24 Days)||33
9980062|NCT01591499|11101269|FG001|COMPLETED|First Intervention (up to 24 Days)||37
9980063|NCT01591499|11101270|FG002|COMPLETED|First Intervention (up to 24 Days)||31
9980064|NCT01591499|11101271|FG003|COMPLETED|First Intervention (up to 24 Days)||37
9980065|NCT01591499|11101268|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0
9980066|NCT01591499|11101269|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0
9980067|NCT01591499|11101270|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0
9980068|NCT01591499|11101271|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0
9980069|NCT01591499|11101268|FG000|STARTED|Second Intervention (up to 24 Days)||33
9980070|NCT01591499|11101269|FG001|STARTED|Second Intervention (up to 24 Days)||37
9980071|NCT01591499|11101270|FG002|STARTED|Second Intervention (up to 24 Days)||31
9980072|NCT01591499|11101271|FG003|STARTED|Second Intervention (up to 24 Days)||37
9980073|NCT01591499|11101268|FG000|COMPLETED|Second Intervention (up to 24 Days)||27
9980074|NCT01591499|11101269|FG001|COMPLETED|Second Intervention (up to 24 Days)||34
9980075|NCT01591499|11101270|FG002|COMPLETED|Second Intervention (up to 24 Days)||28
9980076|NCT01591499|11101271|FG003|COMPLETED|Second Intervention (up to 24 Days)||34
9980077|NCT01591499|11101268|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6
9980078|NCT01591499|11101269|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3
9980079|NCT01591499|11101270|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3
9980080|NCT01591499|11101271|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3
9980081|NCT01591616|11101295|FG000|STARTED|Overall Study||16
9980082|NCT01591616|11101295|FG000|COMPLETED|Overall Study||15
9980083|NCT01591616|11101295|FG000|NOT COMPLETED|Overall Study||1
9980084|NCT01591655|11101436|FG000|STARTED|Overall Study||240
9980085|NCT01591655|11101437|FG001|STARTED|Overall Study||120
9980086|NCT01591655|11101436|FG000|COMPLETED|Overall Study||168
9980087|NCT01591655|11101437|FG001|COMPLETED|Overall Study||57
9980088|NCT01591655|11101436|FG000|NOT COMPLETED|Overall Study||72
9980089|NCT01591655|11101437|FG001|NOT COMPLETED|Overall Study||63
9980090|NCT01591681|11101443|FG000|STARTED|Overall Study||49
9980091|NCT01591681|11101443|FG000|COMPLETED|Overall Study||45
9980092|NCT01591681|11101443|FG000|NOT COMPLETED|Overall Study||4
9980093|NCT01591733|11101449|FG000|STARTED|Overall Study||48
9980094|NCT01591733|11101449|FG000|COMPLETED|Overall Study||48
9980095|NCT01591733|11101449|FG000|NOT COMPLETED|Overall Study||0
9980096|NCT01591746|11101457|FG000|STARTED|Overall Study||68
9980097|NCT01591746|11101458|FG001|STARTED|Overall Study||63
9980098|NCT01591746|11101457|FG000|COMPLETED|Overall Study||68
9980099|NCT01591746|11101458|FG001|COMPLETED|Overall Study||63
9980100|NCT01591746|11101457|FG000|NOT COMPLETED|Overall Study||0
9980101|NCT01591746|11101458|FG001|NOT COMPLETED|Overall Study||0
9980102|NCT01591785|11101466|FG000|STARTED|Overall Study||30
9980103|NCT01591785|11101467|FG001|STARTED|Overall Study||30
9980104|NCT01591785|11101466|FG000|COMPLETED|Overall Study||26
9980105|NCT01591785|11101467|FG001|COMPLETED|Overall Study||28
9980106|NCT01591785|11101466|FG000|NOT COMPLETED|Overall Study||4
9980107|NCT01591785|11101467|FG001|NOT COMPLETED|Overall Study||2
9980108|NCT01591837|11101475|FG000|STARTED|Overall Study||60
9980109|NCT01591837|11101476|FG001|STARTED|Overall Study||60
9980110|NCT01591837|11101475|FG000|COMPLETED|Overall Study||60
9980111|NCT01591837|11101476|FG001|COMPLETED|Overall Study||60
9980112|NCT01591837|11101475|FG000|NOT COMPLETED|Overall Study||0
9980113|NCT01591837|11101476|FG001|NOT COMPLETED|Overall Study||0
9980114|NCT01591863|11101482|FG000|STARTED|Overall Study||38
9980115|NCT01591863|11101482|FG000|COMPLETED|Overall Study||24
9980116|NCT01591863|11101482|FG000|NOT COMPLETED|Overall Study||14
9980117|NCT01592006|11101486|FG000|STARTED|Overall Study||3
9980118|NCT01592006|11101486|FG000|COMPLETED|Overall Study||3
9980119|NCT01592006|11101486|FG000|NOT COMPLETED|Overall Study||0
9980120|NCT01592045|11101492|FG000|STARTED|Overall Study||14
9980121|NCT01592045|11101493|FG001|STARTED|Overall Study||14
9980122|NCT01592045|11101492|FG000|Completed Course 1|Overall Study||13
9980123|NCT01592045|11101493|FG001|Completed Course 1|Overall Study||14
9980124|NCT01592045|11101492|FG000|Completed Course 2|Overall Study||13
9980125|NCT01592045|11101493|FG001|Completed Course 2|Overall Study||13
9980126|NCT01592045|11101492|FG000|Completed Course 3|Overall Study||11
9980127|NCT01592045|11101493|FG001|Completed Course 3|Overall Study||13
9980128|NCT01592045|11101492|FG000|Completed Course 4|Overall Study||11
9980129|NCT01592045|11101493|FG001|Completed Course 4|Overall Study||12
9980130|NCT01592045|11101492|FG000|Completed Course 5|Overall Study||9
9980131|NCT01592045|11101493|FG001|Completed Course 5|Overall Study||12
9980132|NCT01592045|11101492|FG000|COMPLETED|Overall Study||9
9980133|NCT01592045|11101493|FG001|COMPLETED|Overall Study||12
9980134|NCT01592045|11101492|FG000|NOT COMPLETED|Overall Study||5
9980135|NCT01592045|11101493|FG001|NOT COMPLETED|Overall Study||2
9980136|NCT01592071|11101499|FG000|STARTED|Overall Study||120
9980137|NCT01592071|11101499|FG000|COMPLETED|Overall Study||120
9980138|NCT01592071|11101499|FG000|NOT COMPLETED|Overall Study||0
9980139|NCT01592240|11101510|FG000|STARTED|Overall Study||50
9980140|NCT01592240|11101511|FG001|STARTED|Overall Study||50
9980141|NCT01592240|11101512|FG002|STARTED|Overall Study||52
9980142|NCT01592240|11101513|FG003|STARTED|Overall Study||50
9980143|NCT01592240|11101514|FG004|STARTED|Overall Study||51
9980144|NCT01592240|11101515|FG005|STARTED|Overall Study||50
9980145|NCT01592240|11101516|FG006|STARTED|Overall Study||51
9980146|NCT01592240|11101510|FG000|COMPLETED|Overall Study||47
9980147|NCT01592240|11101511|FG001|COMPLETED|Overall Study||39
9980148|NCT01592240|11101512|FG002|COMPLETED|Overall Study||45
9980149|NCT01592240|11101513|FG003|COMPLETED|Overall Study||47
9980150|NCT01592240|11101514|FG004|COMPLETED|Overall Study||44
9980151|NCT01592240|11101515|FG005|COMPLETED|Overall Study||47
9980152|NCT01592240|11101516|FG006|COMPLETED|Overall Study||48
9980153|NCT01592240|11101510|FG000|NOT COMPLETED|Overall Study||3
9980154|NCT01592240|11101511|FG001|NOT COMPLETED|Overall Study||11
9980155|NCT01592240|11101512|FG002|NOT COMPLETED|Overall Study||7
9980156|NCT01592240|11101513|FG003|NOT COMPLETED|Overall Study||3
9980157|NCT01592240|11101514|FG004|NOT COMPLETED|Overall Study||7
9980158|NCT01592240|11101515|FG005|NOT COMPLETED|Overall Study||3
9980159|NCT01592240|11101516|FG006|NOT COMPLETED|Overall Study||3
9980160|NCT01592292|11101539|FG000|STARTED|Overall Study||46
9980161|NCT01592292|11101540|FG001|STARTED|Overall Study||20
9980162|NCT01592292|11101541|FG002|STARTED|Overall Study||13
9980163|NCT01592292|11101542|FG003|STARTED|Overall Study||11
9980164|NCT01592292|11101539|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
9980165|NCT01592292|11101540|FG001|Intention to Treat (ITT) Set|Overall Study||13
9980166|NCT01592292|11101541|FG002|Intention to Treat (ITT) Set|Overall Study||10
9980167|NCT01592292|11101542|FG003|Intention to Treat (ITT) Set|Overall Study||8
9980168|NCT01592292|11101539|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
9980169|NCT01592292|11101540|FG001|Standard Population Set (SPS)|Overall Study||10
9980170|NCT01592292|11101541|FG002|Standard Population Set (SPS)|Overall Study||7
9980171|NCT01592292|11101542|FG003|Standard Population Set (SPS)|Overall Study||7
9980172|NCT01592292|11101539|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
9980173|NCT01592292|11101540|FG001|COMPLETED|Overall Study||15
9980174|NCT01592292|11101541|FG002|COMPLETED|Overall Study||10
9980175|NCT01592292|11101542|FG003|COMPLETED|Overall Study||10
9980176|NCT01592292|11101539|FG000|NOT COMPLETED|Overall Study||6
9980177|NCT01592292|11101540|FG001|NOT COMPLETED|Overall Study||5
9980178|NCT01592292|11101541|FG002|NOT COMPLETED|Overall Study||3
9980179|NCT01592292|11101542|FG003|NOT COMPLETED|Overall Study||1
9980180|NCT01592344|11101550|FG000|STARTED|Overall Study||45
9980181|NCT01592344|11101551|FG001|STARTED|Overall Study||49
9980182|NCT01592344|11101550|FG000|COMPLETED|Overall Study||41
9980183|NCT01592344|11101551|FG001|COMPLETED|Overall Study||44
9980184|NCT01592344|11101550|FG000|NOT COMPLETED|Overall Study||4
9980185|NCT01592344|11101551|FG001|NOT COMPLETED|Overall Study||5
9980186|NCT01592396|11101559|FG000|STARTED|Overall Study||10
9980187|NCT01592396|11101560|FG001|STARTED|Overall Study||10
9980188|NCT01592396|11101559|FG000|COMPLETED|Overall Study||10
9980189|NCT01592396|11101560|FG001|COMPLETED|Overall Study||10
9980190|NCT01592396|11101559|FG000|NOT COMPLETED|Overall Study||0
9980191|NCT01592396|11101560|FG001|NOT COMPLETED|Overall Study||0
9980192|NCT01592409|11101569|FG000|STARTED|Overall Study||67
9980193|NCT01592409|11101570|FG001|STARTED|Overall Study||32
9980194|NCT01592409|11101569|FG000|COMPLETED|Overall Study||67
10113165|NCT02508935|11244116|FG000|STARTED|Overall Study||23
9980195|NCT01592409|11101570|FG001|COMPLETED|Overall Study||31
9980196|NCT01592409|11101569|FG000|NOT COMPLETED|Overall Study||0
9980197|NCT01592409|11101570|FG001|NOT COMPLETED|Overall Study||1
9980198|NCT01592435|11101576|FG000|STARTED|Overall Study||76
9980199|NCT01592435|11101576|FG000|COMPLETED|Overall Study||76
9980200|NCT01592435|11101576|FG000|NOT COMPLETED|Overall Study||0
9980201|NCT01592500|11101586|FG000|STARTED|Overall Study|Randomized Participants|14
9980202|NCT01592500|11101587|FG001|STARTED|Overall Study||15
9980203|NCT01592500|11101588|FG002|STARTED|Overall Study||14
9980204|NCT01592500|11101589|FG003|STARTED|Overall Study|Randomized Participants|13
9980205|NCT01592500|11101586|FG000|COMPLETED|Overall Study||13
9980206|NCT01592500|11101587|FG001|COMPLETED|Overall Study||15
9980207|NCT01592500|11101588|FG002|COMPLETED|Overall Study||14
9980208|NCT01592500|11101589|FG003|COMPLETED|Overall Study||11
9980209|NCT01592500|11101586|FG000|NOT COMPLETED|Overall Study||1
9980210|NCT01592500|11101587|FG001|NOT COMPLETED|Overall Study||0
9980211|NCT01592500|11101588|FG002|NOT COMPLETED|Overall Study||0
9980212|NCT01592500|11101589|FG003|NOT COMPLETED|Overall Study||2
9980213|NCT01592695|11101601|FG000|STARTED|Overall Study||31
9980214|NCT01592695|11101602|FG001|STARTED|Overall Study||32
9980215|NCT01592695|11101601|FG000|COMPLETED|Overall Study||23
9980216|NCT01592695|11101602|FG001|COMPLETED|Overall Study||28
9980217|NCT01592695|11101601|FG000|NOT COMPLETED|Overall Study||8
9980218|NCT01592695|11101602|FG001|NOT COMPLETED|Overall Study||4
9980219|NCT01592708|11101610|FG000|STARTED|Overall Study||96
9980220|NCT01592708|11101611|FG001|STARTED|Overall Study||137
9980221|NCT01592708|11101610|FG000|COMPLETED|Overall Study||93
9980222|NCT01592708|11101611|FG001|COMPLETED|Overall Study||137
9980223|NCT01592708|11101610|FG000|NOT COMPLETED|Overall Study||3
9980224|NCT01592708|11101611|FG001|NOT COMPLETED|Overall Study||0
9980225|NCT01592747|11101623|FG000|STARTED|Overall Study|Based on Randomized Population|160
9980226|NCT01592747|11101624|FG001|STARTED|Overall Study|Based on Randomized Population|161
10099626|NCT02392507|11228719|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
10099627|NCT02392507|11228719|FG000|COMPLETED|Maintenance Regimen||32
10099628|NCT02392507|11228719|FG000|NOT COMPLETED|Maintenance Regimen||2
10099629|NCT02392559|11228730|FG000|STARTED|Overall Study||53
10099630|NCT02392559|11228731|FG001|STARTED|Overall Study||105
9980227|NCT01592747|11101625|FG002|STARTED|Overall Study|Based on Randomized Population|158
9980228|NCT01592747|11101623|FG000|COMPLETED|Overall Study||44
9980229|NCT01592747|11101624|FG001|COMPLETED|Overall Study||50
9980230|NCT01592747|11101625|FG002|COMPLETED|Overall Study||50
9980231|NCT01592747|11101623|FG000|NOT COMPLETED|Overall Study||116
9980232|NCT01592747|11101624|FG001|NOT COMPLETED|Overall Study||111
9980233|NCT01592747|11101625|FG002|NOT COMPLETED|Overall Study||108
9980234|NCT01592760|11101637|FG000|STARTED|Perioperative to Discharge||90
9980235|NCT01592760|11101638|FG001|STARTED|Perioperative to Discharge||90
9980236|NCT01592760|11101639|FG002|STARTED|Perioperative to Discharge||45
9980237|NCT01592760|11101637|FG000|COMPLETED|Perioperative to Discharge||90
9980238|NCT01592760|11101638|FG001|COMPLETED|Perioperative to Discharge||90
9980239|NCT01592760|11101639|FG002|COMPLETED|Perioperative to Discharge||45
9980240|NCT01592760|11101637|FG000|NOT COMPLETED|Perioperative to Discharge||0
9980241|NCT01592760|11101638|FG001|NOT COMPLETED|Perioperative to Discharge||0
9980242|NCT01592760|11101639|FG002|NOT COMPLETED|Perioperative to Discharge||0
9980243|NCT01592760|11101637|FG000|STARTED|24-hour Follow-Up||90
9980244|NCT01592760|11101638|FG001|STARTED|24-hour Follow-Up||90
9980245|NCT01592760|11101639|FG002|STARTED|24-hour Follow-Up||45
9980246|NCT01592760|11101637|FG000|COMPLETED|24-hour Follow-Up||86
9980247|NCT01592760|11101638|FG001|COMPLETED|24-hour Follow-Up||87
9980248|NCT01592760|11101639|FG002|COMPLETED|24-hour Follow-Up||43
9980249|NCT01592760|11101637|FG000|NOT COMPLETED|24-hour Follow-Up||4
9980250|NCT01592760|11101638|FG001|NOT COMPLETED|24-hour Follow-Up||3
9980251|NCT01592760|11101639|FG002|NOT COMPLETED|24-hour Follow-Up||2
10099631|NCT02392559|11228730|FG000|Randomized and Dosed|Overall Study||53
10099632|NCT02392559|11228731|FG001|Randomized and Dosed|Overall Study||104
10099633|NCT02392559|11228730|FG000|COMPLETED|Overall Study||53
10099634|NCT02392559|11228731|FG001|COMPLETED|Overall Study||104
10099635|NCT02392559|11228730|FG000|NOT COMPLETED|Overall Study||0
10099636|NCT02392559|11228731|FG001|NOT COMPLETED|Overall Study||1
10099637|NCT02392611|11228747|FG000|STARTED|Overall Study||2
10099638|NCT02392611|11228748|FG001|STARTED|Overall Study||1
10099639|NCT02392611|11228749|FG002|STARTED|Overall Study||1
10099640|NCT02392611|11228750|FG003|STARTED|Overall Study||9
10099641|NCT02392611|11228751|FG004|STARTED|Overall Study||6
10099642|NCT02392611|11228752|FG005|STARTED|Overall Study||4
10099643|NCT02392611|11228753|FG006|STARTED|Overall Study||4
10099644|NCT02392611|11228754|FG007|STARTED|Overall Study||3
10099645|NCT02392611|11228755|FG008|STARTED|Overall Study||3
10099646|NCT02392611|11228747|FG000|COMPLETED|Overall Study||1
9980252|NCT01592773|11101650|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
9980253|NCT01592773|11101650|FG000|COMPLETED|Overall Study||81
9980254|NCT01592773|11101650|FG000|NOT COMPLETED|Overall Study||666
9980255|NCT01592786|11101654|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
9980256|NCT01592786|11101654|FG000|COMPLETED|Overall Study||765
9980257|NCT01592786|11101654|FG000|NOT COMPLETED|Overall Study||138
9980258|NCT01592799|11101658|FG000|STARTED|Overall Study||501
9980259|NCT01592799|11101658|FG000|COMPLETED|Overall Study||501
9980260|NCT01592799|11101658|FG000|NOT COMPLETED|Overall Study||0
9980261|NCT01592851|11101666|FG000|STARTED|Overall Study||56
9980262|NCT01592851|11101667|FG001|STARTED|Overall Study||57
9980263|NCT01592851|11101666|FG000|COMPLETED|Overall Study||56
9980264|NCT01592851|11101667|FG001|COMPLETED|Overall Study||57
9980265|NCT01592851|11101666|FG000|NOT COMPLETED|Overall Study||0
9980266|NCT01592851|11101667|FG001|NOT COMPLETED|Overall Study||0
9980267|NCT01592864|11101675|FG000|STARTED|Overall Study||60
9980268|NCT01592864|11101676|FG001|STARTED|Overall Study||58
10099647|NCT02392611|11228748|FG001|COMPLETED|Overall Study||1
10099648|NCT02392611|11228749|FG002|COMPLETED|Overall Study||1
10099649|NCT02392611|11228750|FG003|COMPLETED|Overall Study||3
10099650|NCT02392611|11228751|FG004|COMPLETED|Overall Study||5
10099651|NCT02392611|11228752|FG005|COMPLETED|Overall Study||3
10099652|NCT02392611|11228753|FG006|COMPLETED|Overall Study||3
10099653|NCT02392611|11228754|FG007|COMPLETED|Overall Study||3
10099654|NCT02392611|11228755|FG008|COMPLETED|Overall Study||3
10099655|NCT02392611|11228747|FG000|NOT COMPLETED|Overall Study||1
10099656|NCT02392611|11228748|FG001|NOT COMPLETED|Overall Study||0
10099657|NCT02392611|11228749|FG002|NOT COMPLETED|Overall Study||0
9980269|NCT01592864|11101675|FG000|COMPLETED|Overall Study||60
9980270|NCT01592864|11101676|FG001|COMPLETED|Overall Study||57
9980271|NCT01592864|11101675|FG000|NOT COMPLETED|Overall Study||0
9980272|NCT01592864|11101676|FG001|NOT COMPLETED|Overall Study||1
9980273|NCT01593020|11101684|FG000|STARTED|Overall Study||28
9980274|NCT01593020|11101685|FG001|STARTED|Overall Study||23
9980275|NCT01593020|11101684|FG000|COMPLETED|Overall Study||26
9980276|NCT01593020|11101685|FG001|COMPLETED|Overall Study||21
9980277|NCT01593020|11101684|FG000|NOT COMPLETED|Overall Study||2
9980278|NCT01593020|11101685|FG001|NOT COMPLETED|Overall Study||2
9980279|NCT01593215|11101693|FG000|STARTED|Overall Study||25
9980280|NCT01593215|11101694|FG001|STARTED|Overall Study||25
9980281|NCT01593215|11101693|FG000|COMPLETED|Overall Study||24
9980282|NCT01593215|11101694|FG001|COMPLETED|Overall Study||25
9980283|NCT01593215|11101693|FG000|NOT COMPLETED|Overall Study||1
9980284|NCT01593215|11101694|FG001|NOT COMPLETED|Overall Study||0
9980285|NCT01593592|11101702|FG000|STARTED|Overall Study||35
9980286|NCT01593592|11101703|FG001|STARTED|Overall Study||35
9980287|NCT01593592|11101702|FG000|COMPLETED|Overall Study||35
9980288|NCT01593592|11101703|FG001|COMPLETED|Overall Study||35
9980289|NCT01593592|11101702|FG000|NOT COMPLETED|Overall Study||0
9980290|NCT01593592|11101703|FG001|NOT COMPLETED|Overall Study||0
9980291|NCT01593670|11101709|FG000|STARTED|Overall Study||9
9980292|NCT01593670|11101709|FG000|COMPLETED|Overall Study||9
9980293|NCT01593670|11101709|FG000|NOT COMPLETED|Overall Study||0
9980294|NCT01593696|11101717|FG000|STARTED|Dose Escalation||16
9980295|NCT01593696|11101718|FG001|STARTED|Dose Escalation||5
9980296|NCT01593696|11101719|FG002|STARTED|Dose Escalation||0
9980297|NCT01593696|11101720|FG003|STARTED|Dose Escalation||0
9980298|NCT01593696|11101717|FG000|Prior Transplant|Dose Escalation||7
9980299|NCT01593696|11101718|FG001|Prior Transplant|Dose Escalation||1
9980300|NCT01593696|11101719|FG002|Prior Transplant|Dose Escalation||0
9980301|NCT01593696|11101720|FG003|Prior Transplant|Dose Escalation||0
9980302|NCT01593696|11101717|FG000|No Prior Transplant|Dose Escalation||9
9980303|NCT01593696|11101718|FG001|No Prior Transplant|Dose Escalation||4
9980304|NCT01593696|11101719|FG002|No Prior Transplant|Dose Escalation||0
9980305|NCT01593696|11101720|FG003|No Prior Transplant|Dose Escalation||0
9980306|NCT01593696|11101717|FG000|COMPLETED|Dose Escalation||14
9980307|NCT01593696|11101718|FG001|COMPLETED|Dose Escalation||5
9980308|NCT01593696|11101719|FG002|COMPLETED|Dose Escalation||0
9980309|NCT01593696|11101720|FG003|COMPLETED|Dose Escalation||0
9980310|NCT01593696|11101717|FG000|NOT COMPLETED|Dose Escalation||2
9980311|NCT01593696|11101718|FG001|NOT COMPLETED|Dose Escalation||0
9980312|NCT01593696|11101719|FG002|NOT COMPLETED|Dose Escalation||0
9980313|NCT01593696|11101720|FG003|NOT COMPLETED|Dose Escalation||0
9980314|NCT01593696|11101717|FG000|STARTED|Dose Expansion||0
9980315|NCT01593696|11101718|FG001|STARTED|Dose Expansion||0
9980316|NCT01593696|11101719|FG002|STARTED|Dose Expansion||16
9980317|NCT01593696|11101720|FG003|STARTED|Dose Expansion||16
9980318|NCT01593696|11101717|FG000|COMPLETED|Dose Expansion||0
9980319|NCT01593696|11101718|FG001|COMPLETED|Dose Expansion||0
9980320|NCT01593696|11101719|FG002|COMPLETED|Dose Expansion||15
9980321|NCT01593696|11101720|FG003|COMPLETED|Dose Expansion||16
9980322|NCT01593696|11101717|FG000|NOT COMPLETED|Dose Expansion||0
9980323|NCT01593696|11101718|FG001|NOT COMPLETED|Dose Expansion||0
9980324|NCT01593696|11101719|FG002|NOT COMPLETED|Dose Expansion||1
9980325|NCT01593696|11101720|FG003|NOT COMPLETED|Dose Expansion||0
9980326|NCT01593722|11101732|FG000|STARTED|Overall Study||6
9980327|NCT01593722|11101733|FG001|STARTED|Overall Study||6
9980328|NCT01593722|11101732|FG000|COMPLETED|Overall Study||6
9980329|NCT01593722|11101733|FG001|COMPLETED|Overall Study||6
9980330|NCT01593722|11101732|FG000|NOT COMPLETED|Overall Study||0
9980331|NCT01593722|11101733|FG001|NOT COMPLETED|Overall Study||0
9980332|NCT01593748|11101743|FG000|STARTED|Overall Study||45
9980333|NCT01593748|11101744|FG001|STARTED|Overall Study||45
9980334|NCT01593748|11101743|FG000|COMPLETED|Overall Study||45
9980335|NCT01593748|11101744|FG001|COMPLETED|Overall Study||45
9980336|NCT01593748|11101743|FG000|NOT COMPLETED|Overall Study||0
9980337|NCT01593748|11101744|FG001|NOT COMPLETED|Overall Study||0
9980338|NCT01593787|11101753|FG000|STARTED|Overall Study||6
9980339|NCT01593787|11101754|FG001|STARTED|Overall Study||8
9980340|NCT01593787|11101755|FG002|STARTED|Overall Study||18
9980341|NCT01593787|11101753|FG000|COMPLETED|Overall Study||5
9980342|NCT01593787|11101754|FG001|COMPLETED|Overall Study||8
9980343|NCT01593787|11101755|FG002|COMPLETED|Overall Study||18
9980344|NCT01593787|11101753|FG000|NOT COMPLETED|Overall Study||1
9980345|NCT01593787|11101754|FG001|NOT COMPLETED|Overall Study||0
9980346|NCT01593787|11101755|FG002|NOT COMPLETED|Overall Study||0
9980347|NCT01593917|11101765|FG000|STARTED|Overall Study||329
9980348|NCT01593917|11101765|FG000|COMPLETED|Overall Study||159
9980349|NCT01593917|11101765|FG000|NOT COMPLETED|Overall Study||170
9980350|NCT01594125|11101774|FG000|STARTED|Overall Study||4
9980351|NCT01594125|11101775|FG001|STARTED|Overall Study||12
9980352|NCT01594125|11101776|FG002|STARTED|Overall Study||3
9980353|NCT01594125|11101777|FG003|STARTED|Overall Study||4
9980354|NCT01594125|11101778|FG004|STARTED|Overall Study||7
9980355|NCT01594125|11101774|FG000|COMPLETED|Overall Study||0
9980356|NCT01594125|11101775|FG001|COMPLETED|Overall Study||0
9980357|NCT01594125|11101776|FG002|COMPLETED|Overall Study||0
9980358|NCT01594125|11101777|FG003|COMPLETED|Overall Study||0
9980359|NCT01594125|11101778|FG004|COMPLETED|Overall Study||0
9980360|NCT01594125|11101774|FG000|NOT COMPLETED|Overall Study||4
9980361|NCT01594125|11101775|FG001|NOT COMPLETED|Overall Study||12
9980362|NCT01594125|11101776|FG002|NOT COMPLETED|Overall Study||3
9980363|NCT01594125|11101777|FG003|NOT COMPLETED|Overall Study||4
9980364|NCT01594125|11101778|FG004|NOT COMPLETED|Overall Study||7
9980365|NCT01594281|11101793|FG000|STARTED|Interventional Core Phase||36
9980366|NCT01594281|11101794|FG001|STARTED|Interventional Core Phase||36
9980367|NCT01594281|11101795|FG002|STARTED|Interventional Core Phase||36
9980368|NCT01594281|11101793|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35
9980369|NCT01594281|11101794|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35
9980370|NCT01594281|11101795|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36
9980371|NCT01594281|11101793|FG000|COMPLETED|Interventional Core Phase||29
9980372|NCT01594281|11101794|FG001|COMPLETED|Interventional Core Phase||26
9980373|NCT01594281|11101795|FG002|COMPLETED|Interventional Core Phase||28
9980374|NCT01594281|11101793|FG000|NOT COMPLETED|Interventional Core Phase||7
9980375|NCT01594281|11101794|FG001|NOT COMPLETED|Interventional Core Phase||10
9980376|NCT01594281|11101795|FG002|NOT COMPLETED|Interventional Core Phase||8
9980377|NCT01594281|11101793|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
9980378|NCT01594281|11101794|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
9980379|NCT01594281|11101795|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
9980380|NCT01594281|11101793|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
9980381|NCT01594281|11101794|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
9980382|NCT01594281|11101795|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
9980383|NCT01594281|11101793|FG000|COMPLETED|Non-Interventional Follow Up Phase||25
9980384|NCT01594281|11101794|FG001|COMPLETED|Non-Interventional Follow Up Phase||19
9980385|NCT01594281|11101795|FG002|COMPLETED|Non-Interventional Follow Up Phase||23
9980386|NCT01594281|11101793|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3
9980387|NCT01594281|11101794|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2
9980388|NCT01594281|11101795|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2
9980389|NCT01594294|11101808|FG000|STARTED|Overall Study||39
9980390|NCT01594294|11101809|FG001|STARTED|Overall Study||40
9980391|NCT01594294|11101808|FG000|COMPLETED|Overall Study||36
9980392|NCT01594294|11101809|FG001|COMPLETED|Overall Study||36
9980393|NCT01594294|11101808|FG000|NOT COMPLETED|Overall Study||3
9980394|NCT01594294|11101809|FG001|NOT COMPLETED|Overall Study||4
9980395|NCT01594333|11101817|FG000|STARTED|Overall Study||2391
9980396|NCT01594333|11101818|FG001|STARTED|Overall Study||2395
9980397|NCT01594333|11101817|FG000|COMPLETED|Overall Study||2230
9980398|NCT01594333|11101818|FG001|COMPLETED|Overall Study||2244
9980399|NCT01594333|11101817|FG000|NOT COMPLETED|Overall Study||161
9980400|NCT01594333|11101818|FG001|NOT COMPLETED|Overall Study||151
9980401|NCT01594385|11101826|FG000|STARTED|Overall Study||17
9980402|NCT01594385|11101827|FG001|STARTED|Overall Study||13
9980403|NCT01594385|11101826|FG000|COMPLETED|Overall Study||17
9980404|NCT01594385|11101827|FG001|COMPLETED|Overall Study||13
9980405|NCT01594385|11101826|FG000|NOT COMPLETED|Overall Study||0
9980406|NCT01594385|11101827|FG001|NOT COMPLETED|Overall Study||0
9980407|NCT01594411|11101837|FG000|STARTED|Overall Study||251
9980408|NCT01594411|11101837|FG000|COMPLETED|Overall Study||249
9980409|NCT01594411|11101837|FG000|NOT COMPLETED|Overall Study||2
9980410|NCT01594424|11101844|FG000|STARTED|Overall Study||10
9980411|NCT01594424|11101844|FG000|COMPLETED|Overall Study||8
9980412|NCT01594424|11101844|FG000|NOT COMPLETED|Overall Study||2
9980413|NCT01594476|11101850|FG000|STARTED|Overall Study||101
9980414|NCT01594476|11101851|FG001|STARTED|Overall Study||100
9980415|NCT01594476|11101850|FG000|Received Intervention|Overall Study||66
9980416|NCT01594476|11101851|FG001|Received Intervention|Overall Study||73
9980417|NCT01594476|11101850|FG000|Excluded After Allocation|Overall Study||1
9980418|NCT01594476|11101851|FG001|Excluded After Allocation|Overall Study||3
9980419|NCT01594476|11101850|FG000|IUD Removal|Overall Study||3
9980420|NCT01594476|11101851|FG001|IUD Removal|Overall Study||5
9980421|NCT01594476|11101850|FG000|IUD Expulsion|Overall Study||2
9980422|NCT01594476|11101851|FG001|IUD Expulsion|Overall Study||0
9980423|NCT01594476|11101850|FG000|Pregnant|Overall Study||2
9980424|NCT01594476|11101851|FG001|Pregnant|Overall Study||5
9980425|NCT01594476|11101850|FG000|COMPLETED|Overall Study||100
9980426|NCT01594476|11101851|FG001|COMPLETED|Overall Study||97
9980427|NCT01594476|11101850|FG000|NOT COMPLETED|Overall Study||1
9980428|NCT01594476|11101851|FG001|NOT COMPLETED|Overall Study||3
9980429|NCT01594515|11101871|FG000|STARTED|Overall Study||6
9980430|NCT01594515|11101872|FG001|STARTED|Overall Study||6
9980431|NCT01594515|11101873|FG002|STARTED|Overall Study||6
9980432|NCT01594515|11101874|FG003|STARTED|Overall Study||6
9980433|NCT01594515|11101875|FG004|STARTED|Overall Study||6
9980434|NCT01594515|11101876|FG005|STARTED|Overall Study||6
9980435|NCT01594515|11101877|FG006|STARTED|Overall Study||6
9980436|NCT01594515|11101878|FG007|STARTED|Overall Study||6
9980437|NCT01594515|11101879|FG008|STARTED|Overall Study||6
9980438|NCT01594515|11101880|FG009|STARTED|Overall Study||16
9980439|NCT01594515|11101871|FG000|COMPLETED|Overall Study||6
9980440|NCT01594515|11101872|FG001|COMPLETED|Overall Study||6
9980441|NCT01594515|11101873|FG002|COMPLETED|Overall Study||6
9980442|NCT01594515|11101874|FG003|COMPLETED|Overall Study||6
9980443|NCT01594515|11101875|FG004|COMPLETED|Overall Study||6
9980444|NCT01594515|11101876|FG005|COMPLETED|Overall Study||6
9980445|NCT01594515|11101877|FG006|COMPLETED|Overall Study||6
9980446|NCT01594515|11101878|FG007|COMPLETED|Overall Study||6
9980447|NCT01594515|11101879|FG008|COMPLETED|Overall Study||6
9980448|NCT01594515|11101880|FG009|COMPLETED|Overall Study||16
9980449|NCT01594515|11101871|FG000|NOT COMPLETED|Overall Study||0
9980450|NCT01594515|11101872|FG001|NOT COMPLETED|Overall Study||0
9980451|NCT01594515|11101873|FG002|NOT COMPLETED|Overall Study||0
9980452|NCT01594515|11101874|FG003|NOT COMPLETED|Overall Study||0
9980453|NCT01594515|11101875|FG004|NOT COMPLETED|Overall Study||0
9980454|NCT01594515|11101876|FG005|NOT COMPLETED|Overall Study||0
9980455|NCT01594515|11101877|FG006|NOT COMPLETED|Overall Study||0
9980456|NCT01594515|11101878|FG007|NOT COMPLETED|Overall Study||0
9980457|NCT01594515|11101879|FG008|NOT COMPLETED|Overall Study||0
9980458|NCT01594515|11101880|FG009|NOT COMPLETED|Overall Study||0
9980459|NCT01594528|11101905|FG000|STARTED|Overall Study||16
9980460|NCT01594528|11101906|FG001|STARTED|Overall Study||17
9980461|NCT01594528|11101907|FG002|STARTED|Overall Study||16
9980462|NCT01594528|11101905|FG000|COMPLETED|Overall Study||16
9980463|NCT01594528|11101906|FG001|COMPLETED|Overall Study||17
9980464|NCT01594528|11101907|FG002|COMPLETED|Overall Study||16
9980465|NCT01594528|11101905|FG000|NOT COMPLETED|Overall Study||0
9980466|NCT01594528|11101906|FG001|NOT COMPLETED|Overall Study||0
9980467|NCT01594528|11101907|FG002|NOT COMPLETED|Overall Study||0
9980468|NCT01594749|11101915|FG000|STARTED|Overall Study||507
9980469|NCT01594749|11101916|FG001|STARTED|Overall Study||508
9980470|NCT01594749|11101915|FG000|Treated|Overall Study||503
9980471|NCT01594749|11101916|FG001|Treated|Overall Study||498
9980472|NCT01594749|11101915|FG000|COMPLETED|Overall Study||485
9980473|NCT01594749|11101916|FG001|COMPLETED|Overall Study||490
9980474|NCT01594749|11101915|FG000|NOT COMPLETED|Overall Study||22
9980475|NCT01594749|11101916|FG001|NOT COMPLETED|Overall Study||18
9980476|NCT01594762|11101924|FG000|STARTED|Overall Study||97
9980477|NCT01594762|11101925|FG001|STARTED|Overall Study||103
9980478|NCT01594762|11101924|FG000|COMPLETED|Overall Study||86
9980479|NCT01594762|11101925|FG001|COMPLETED|Overall Study||93
9980480|NCT01594762|11101924|FG000|NOT COMPLETED|Overall Study||11
9980481|NCT01594762|11101925|FG001|NOT COMPLETED|Overall Study||10
9980482|NCT01594827|11101933|FG000|STARTED|Overall Study||14
9980483|NCT01594827|11101934|FG001|STARTED|Overall Study||15
9980484|NCT01594827|11101933|FG000|COMPLETED|Overall Study||10
9980485|NCT01594827|11101934|FG001|COMPLETED|Overall Study||15
9980486|NCT01594827|11101933|FG000|NOT COMPLETED|Overall Study||4
9980487|NCT01594827|11101934|FG001|NOT COMPLETED|Overall Study||0
9980488|NCT01594853|11101944|FG000|STARTED|Overall Study||16
9980489|NCT01594853|11101945|FG001|STARTED|Overall Study||15
9980490|NCT01594853|11101944|FG000|COMPLETED|Overall Study||14
9980491|NCT01594853|11101945|FG001|COMPLETED|Overall Study||12
9980492|NCT01594853|11101944|FG000|NOT COMPLETED|Overall Study||2
9980493|NCT01594853|11101945|FG001|NOT COMPLETED|Overall Study||3
9980494|NCT01594931|11101954|FG000|STARTED|Overall Study||160
9980495|NCT01594931|11101955|FG001|STARTED|Overall Study||157
9980496|NCT01594931|11101956|FG002|STARTED|Overall Study|One randomized subject was not treated.|160
9980497|NCT01594931|11101954|FG000|COMPLETED|Overall Study||131
9980498|NCT01594931|11101955|FG001|COMPLETED|Overall Study||145
9980499|NCT01594931|11101956|FG002|COMPLETED|Overall Study||146
9980500|NCT01594931|11101954|FG000|NOT COMPLETED|Overall Study||29
9980501|NCT01594931|11101955|FG001|NOT COMPLETED|Overall Study||12
9980502|NCT01594931|11101956|FG002|NOT COMPLETED|Overall Study||14
9980503|NCT01594970|11101967|FG000|STARTED|Overall Study||295
9980504|NCT01594970|11101968|FG001|STARTED|Overall Study||248
9980505|NCT01594970|11101969|FG002|STARTED|Overall Study||257
9980506|NCT01594970|11101967|FG000|COMPLETED|Overall Study||220
9980507|NCT01594970|11101968|FG001|COMPLETED|Overall Study||166
9980508|NCT01594970|11101969|FG002|COMPLETED|Overall Study||191
9980509|NCT01594970|11101967|FG000|NOT COMPLETED|Overall Study||75
9980510|NCT01594970|11101968|FG001|NOT COMPLETED|Overall Study||82
9980511|NCT01594970|11101969|FG002|NOT COMPLETED|Overall Study||66
9980512|NCT01595282|11101979|FG000|STARTED|Overall Study||47
9980513|NCT01595282|11101980|FG001|STARTED|Overall Study||47
9980514|NCT01595282|11101979|FG000|COMPLETED|Overall Study||47
9980515|NCT01595282|11101980|FG001|COMPLETED|Overall Study||47
9980516|NCT01595282|11101979|FG000|NOT COMPLETED|Overall Study||0
9980517|NCT01595282|11101980|FG001|NOT COMPLETED|Overall Study||0
9980518|NCT01595386|11101988|FG000|STARTED|Overall Study||21
9980519|NCT01595386|11101989|FG001|STARTED|Overall Study||19
9980520|NCT01595386|11101988|FG000|COMPLETED|Overall Study||21
9980521|NCT01595386|11101989|FG001|COMPLETED|Overall Study||19
9980522|NCT01595386|11101988|FG000|NOT COMPLETED|Overall Study||0
9980523|NCT01595386|11101989|FG001|NOT COMPLETED|Overall Study||0
9980524|NCT01595438|11101997|FG000|STARTED|Overall Study||516
9980525|NCT01595438|11101998|FG001|STARTED|Overall Study||517
9980526|NCT01595438|11101997|FG000|COMPLETED|Overall Study||473
9980527|NCT01595438|11101998|FG001|COMPLETED|Overall Study||476
9980528|NCT01595438|11101997|FG000|NOT COMPLETED|Overall Study||43
9980529|NCT01595438|11101998|FG001|NOT COMPLETED|Overall Study||41
9980530|NCT01595516|11102007|FG000|STARTED|Overall Study||16
9980531|NCT01595516|11102008|FG001|STARTED|Overall Study||16
9980532|NCT01595516|11102009|FG002|STARTED|Overall Study||12
9980533|NCT01595516|11102007|FG000|COMPLETED|Overall Study||16
9980534|NCT01595516|11102008|FG001|COMPLETED|Overall Study||16
9980535|NCT01595516|11102009|FG002|COMPLETED|Overall Study||12
9980536|NCT01595516|11102007|FG000|NOT COMPLETED|Overall Study||0
9980537|NCT01595516|11102008|FG001|NOT COMPLETED|Overall Study||0
9980538|NCT01595516|11102009|FG002|NOT COMPLETED|Overall Study||0
9980539|NCT01595529|11102033|FG000|STARTED|Overall Study||348
9980540|NCT01595529|11102034|FG001|STARTED|Overall Study||345
9980541|NCT01595529|11102033|FG000|Treated|Overall Study||337
9980542|NCT01595529|11102034|FG001|Treated|Overall Study||340
9980543|NCT01595529|11102033|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328
9980544|NCT01595529|11102034|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336
9980545|NCT01595529|11102033|FG000|ITT Without Treatment Failure|Overall Study||326
9980546|NCT01595529|11102034|FG001|ITT Without Treatment Failure|Overall Study||322
9980547|NCT01595529|11102033|FG000|ITT With Stool Sample at TOC|Overall Study||298
9980548|NCT01595529|11102034|FG001|ITT With Stool Sample at TOC|Overall Study||310
9980549|NCT01595529|11102033|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308
9980550|NCT01595529|11102034|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314
9980551|NCT01595529|11102033|FG000|Per-protocol Without Treatment Failure|Overall Study||306
9980552|NCT01595529|11102034|FG001|Per-protocol Without Treatment Failure|Overall Study||305
9980553|NCT01595529|11102033|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280
9980554|NCT01595529|11102034|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289
9980555|NCT01595529|11102033|FG000|Completed All Milestones|Overall Study||318
9980556|NCT01595529|11102034|FG001|Completed All Milestones|Overall Study||318
9980557|NCT01595529|11102033|FG000|COMPLETED|Overall Study||324
9980558|NCT01595529|11102034|FG001|COMPLETED|Overall Study||325
9980559|NCT01595529|11102033|FG000|NOT COMPLETED|Overall Study||24
9980560|NCT01595529|11102034|FG001|NOT COMPLETED|Overall Study||20
9980561|NCT01595646|11102043|FG000|STARTED|Overall Study||13
9980562|NCT01595646|11102044|FG001|STARTED|Overall Study||12
9980563|NCT01595646|11102045|FG002|STARTED|Overall Study||12
9980564|NCT01595646|11102043|FG000|COMPLETED|Overall Study||12
9980565|NCT01595646|11102044|FG001|COMPLETED|Overall Study||12
9980566|NCT01595646|11102045|FG002|COMPLETED|Overall Study||12
9980567|NCT01595646|11102043|FG000|NOT COMPLETED|Overall Study||1
9980568|NCT01595646|11102044|FG001|NOT COMPLETED|Overall Study||0
9980569|NCT01595646|11102045|FG002|NOT COMPLETED|Overall Study||0
9980570|NCT01595854|11102061|FG000|STARTED|Overall Study||8
9980571|NCT01595854|11102062|FG001|STARTED|Overall Study||4
9980572|NCT01595854|11102063|FG002|STARTED|Overall Study||8
9980573|NCT01595854|11102064|FG003|STARTED|Overall Study||4
9980574|NCT01595854|11102065|FG004|STARTED|Overall Study||12
9980575|NCT01595854|11102061|FG000|COMPLETED|Overall Study||8
9980576|NCT01595854|11102062|FG001|COMPLETED|Overall Study||4
9980577|NCT01595854|11102063|FG002|COMPLETED|Overall Study||8
9980578|NCT01595854|11102064|FG003|COMPLETED|Overall Study||4
9980579|NCT01595854|11102065|FG004|COMPLETED|Overall Study||12
9980580|NCT01595854|11102061|FG000|NOT COMPLETED|Overall Study||0
9980581|NCT01595854|11102062|FG001|NOT COMPLETED|Overall Study||0
9980582|NCT01595854|11102063|FG002|NOT COMPLETED|Overall Study||0
9980583|NCT01595854|11102064|FG003|NOT COMPLETED|Overall Study||0
9980584|NCT01595854|11102065|FG004|NOT COMPLETED|Overall Study||0
9980585|NCT01596062|11102086|FG000|STARTED|Overall Study||3
9980586|NCT01596062|11102087|FG001|STARTED|Overall Study||6
9980587|NCT01596062|11102088|FG002|STARTED|Overall Study||7
9980588|NCT01596062|11102086|FG000|COMPLETED|Overall Study||2
9980589|NCT01596062|11102087|FG001|COMPLETED|Overall Study||6
9980590|NCT01596062|11102088|FG002|COMPLETED|Overall Study||4
9980591|NCT01596062|11102086|FG000|NOT COMPLETED|Overall Study||1
9980592|NCT01596062|11102087|FG001|NOT COMPLETED|Overall Study||0
9980593|NCT01596062|11102088|FG002|NOT COMPLETED|Overall Study||3
9980594|NCT01596088|11102096|FG000|STARTED|Overall Study||2
9980595|NCT01596088|11102096|FG000|COMPLETED|Overall Study||2
9980596|NCT01596088|11102096|FG000|NOT COMPLETED|Overall Study||0
9980597|NCT01596127|11102100|FG000|STARTED|Overall Study||4
9980598|NCT01596127|11102100|FG000|COMPLETED|Overall Study||3
9980599|NCT01596127|11102100|FG000|NOT COMPLETED|Overall Study||1
9980600|NCT01596231|11102106|FG000|STARTED|Overall Study||10
9980601|NCT01596231|11102107|FG001|STARTED|Overall Study||10
9980602|NCT01596231|11102106|FG000|COMPLETED|Overall Study||10
9980603|NCT01596231|11102107|FG001|COMPLETED|Overall Study||10
9980604|NCT01596231|11102106|FG000|NOT COMPLETED|Overall Study||0
9980605|NCT01596231|11102107|FG001|NOT COMPLETED|Overall Study||0
9980606|NCT01596283|11102115|FG000|STARTED|Overall Study||69
9980607|NCT01596283|11102116|FG001|STARTED|Overall Study||66
9980608|NCT01596283|11102115|FG000|COMPLETED|Overall Study||69
9980609|NCT01596283|11102116|FG001|COMPLETED|Overall Study||66
9980610|NCT01596283|11102115|FG000|NOT COMPLETED|Overall Study||0
9980611|NCT01596283|11102116|FG001|NOT COMPLETED|Overall Study||0
9980612|NCT01596335|11102126|FG000|STARTED|Overall Study||16
9980613|NCT01596335|11102127|FG001|STARTED|Overall Study||15
9980614|NCT01596335|11102126|FG000|COMPLETED|Overall Study||11
9980615|NCT01596335|11102127|FG001|COMPLETED|Overall Study||6
9980616|NCT01596335|11102126|FG000|NOT COMPLETED|Overall Study||5
9980617|NCT01596335|11102127|FG001|NOT COMPLETED|Overall Study||9
9980618|NCT01596504|11102136|FG000|STARTED|Overall Study||48
9980619|NCT01596504|11102137|FG001|STARTED|Overall Study||47
9980620|NCT01596504|11102138|FG002|STARTED|Overall Study||47
9980621|NCT01596504|11102136|FG000|COMPLETED|Overall Study||46
9980622|NCT01596504|11102137|FG001|COMPLETED|Overall Study||44
9980623|NCT01596504|11102138|FG002|COMPLETED|Overall Study||46
9980624|NCT01596504|11102136|FG000|NOT COMPLETED|Overall Study||2
9980625|NCT01596504|11102137|FG001|NOT COMPLETED|Overall Study||3
9980626|NCT01596504|11102138|FG002|NOT COMPLETED|Overall Study||1
9980627|NCT01596582|11102149|FG000|STARTED|Overall Study||172
9980628|NCT01596582|11102150|FG001|STARTED|Overall Study||180
9980629|NCT01596582|11102149|FG000|COMPLETED|Overall Study||168
9980630|NCT01596582|11102150|FG001|COMPLETED|Overall Study||173
9980631|NCT01596582|11102149|FG000|NOT COMPLETED|Overall Study||4
9980632|NCT01596582|11102150|FG001|NOT COMPLETED|Overall Study||7
9980633|NCT01596595|11102163|FG000|STARTED|Overall Study||1779
9980634|NCT01596595|11102163|FG000|COMPLETED|Overall Study||814
9980635|NCT01596595|11102163|FG000|NOT COMPLETED|Overall Study||965
9980636|NCT01596699|11102169|FG000|STARTED|Overall Study||10
9980637|NCT01596699|11102170|FG001|STARTED|Overall Study||6
9980638|NCT01596699|11102169|FG000|COMPLETED|Overall Study||10
9980639|NCT01596699|11102170|FG001|COMPLETED|Overall Study||6
9980640|NCT01596699|11102169|FG000|NOT COMPLETED|Overall Study||0
9980641|NCT01596699|11102170|FG001|NOT COMPLETED|Overall Study||0
9980642|NCT01596751|11102185|FG000|STARTED|Overall Study||5
9980643|NCT01596751|11102186|FG001|STARTED|Overall Study||4
9980644|NCT01596751|11102187|FG002|STARTED|Overall Study||3
9980645|NCT01596751|11102188|FG003|STARTED|Overall Study||6
9980646|NCT01596751|11102189|FG004|STARTED|Overall Study||4
9980647|NCT01596751|11102190|FG005|STARTED|Overall Study||6
9980648|NCT01596751|11102191|FG006|STARTED|Overall Study||17
9980649|NCT01596751|11102192|FG007|STARTED|Overall Study||22
9980650|NCT01596751|11102185|FG000|COMPLETED|Overall Study||5
9980651|NCT01596751|11102186|FG001|COMPLETED|Overall Study||4
9980652|NCT01596751|11102187|FG002|COMPLETED|Overall Study||3
9980653|NCT01596751|11102188|FG003|COMPLETED|Overall Study||6
9980654|NCT01596751|11102189|FG004|COMPLETED|Overall Study||4
9980655|NCT01596751|11102190|FG005|COMPLETED|Overall Study||6
9980656|NCT01596751|11102191|FG006|COMPLETED|Overall Study||17
9980657|NCT01596751|11102192|FG007|COMPLETED|Overall Study||22
9980658|NCT01596751|11102185|FG000|NOT COMPLETED|Overall Study||0
9980659|NCT01596751|11102186|FG001|NOT COMPLETED|Overall Study||0
9980660|NCT01596751|11102187|FG002|NOT COMPLETED|Overall Study||0
9980661|NCT01596751|11102188|FG003|NOT COMPLETED|Overall Study||0
9980662|NCT01596751|11102189|FG004|NOT COMPLETED|Overall Study||0
9980663|NCT01596751|11102190|FG005|NOT COMPLETED|Overall Study||0
9980664|NCT01596751|11102191|FG006|NOT COMPLETED|Overall Study||0
9980665|NCT01596751|11102192|FG007|NOT COMPLETED|Overall Study||0
9980666|NCT01596842|11102212|FG000|STARTED|Overall Study||10
9980667|NCT01596842|11102213|FG001|STARTED|Overall Study||7
9980668|NCT01596842|11102212|FG000|COMPLETED|Overall Study||8
9980669|NCT01596842|11102213|FG001|COMPLETED|Overall Study||7
9980670|NCT01596842|11102212|FG000|NOT COMPLETED|Overall Study||2
9980671|NCT01596842|11102213|FG001|NOT COMPLETED|Overall Study||0
10017883|NCT01820260|11140877|FG011|STARTED|Phase 1 (Part 1)||0
10017884|NCT01820260|11140878|FG012|STARTED|Phase 1 (Part 1)||0
10017885|NCT01820260|11140879|FG013|STARTED|Phase 1 (Part 1)||0
10017886|NCT01820260|11140866|FG000|COMPLETED|Phase 1 (Part 1)||3
10017887|NCT01820260|11140867|FG001|COMPLETED|Phase 1 (Part 1)||12
10017888|NCT01820260|11140868|FG002|COMPLETED|Phase 1 (Part 1)||10
10017889|NCT01820260|11140869|FG003|COMPLETED|Phase 1 (Part 1)||12
10017890|NCT01820260|11140870|FG004|COMPLETED|Phase 1 (Part 1)||12
10017891|NCT01820260|11140871|FG005|COMPLETED|Phase 1 (Part 1)||10
10017892|NCT01820260|11140872|FG006|COMPLETED|Phase 1 (Part 1)||11
10017893|NCT01820260|11140873|FG007|COMPLETED|Phase 1 (Part 1)||11
10017894|NCT01820260|11140874|FG008|COMPLETED|Phase 1 (Part 1)||0
10017895|NCT01820260|11140875|FG009|COMPLETED|Phase 1 (Part 1)||0
10017896|NCT01820260|11140876|FG010|COMPLETED|Phase 1 (Part 1)||0
10017897|NCT01820260|11140877|FG011|COMPLETED|Phase 1 (Part 1)||0
10017898|NCT01820260|11140878|FG012|COMPLETED|Phase 1 (Part 1)||0
10017899|NCT01820260|11140879|FG013|COMPLETED|Phase 1 (Part 1)||0
10017900|NCT01820260|11140866|FG000|NOT COMPLETED|Phase 1 (Part 1)||0
10017901|NCT01820260|11140867|FG001|NOT COMPLETED|Phase 1 (Part 1)||0
10017902|NCT01820260|11140868|FG002|NOT COMPLETED|Phase 1 (Part 1)||0
10017903|NCT01820260|11140869|FG003|NOT COMPLETED|Phase 1 (Part 1)||0
10017904|NCT01820260|11140870|FG004|NOT COMPLETED|Phase 1 (Part 1)||0
10017905|NCT01820260|11140871|FG005|NOT COMPLETED|Phase 1 (Part 1)||0
10017906|NCT01820260|11140872|FG006|NOT COMPLETED|Phase 1 (Part 1)||1
10017907|NCT01820260|11140873|FG007|NOT COMPLETED|Phase 1 (Part 1)||0
10017908|NCT01820260|11140874|FG008|NOT COMPLETED|Phase 1 (Part 1)||0
10017909|NCT01820260|11140875|FG009|NOT COMPLETED|Phase 1 (Part 1)||0
10017910|NCT01820260|11140876|FG010|NOT COMPLETED|Phase 1 (Part 1)||0
10017911|NCT01820260|11140877|FG011|NOT COMPLETED|Phase 1 (Part 1)||0
10017912|NCT01820260|11140878|FG012|NOT COMPLETED|Phase 1 (Part 1)||0
10017913|NCT01820260|11140879|FG013|NOT COMPLETED|Phase 1 (Part 1)||0
10017914|NCT01820260|11140866|FG000|STARTED|Phase 2 (Part 2)||0
10017915|NCT01820260|11140867|FG001|STARTED|Phase 2 (Part 2)||0
10017916|NCT01820260|11140868|FG002|STARTED|Phase 2 (Part 2)||0
10017917|NCT01820260|11140869|FG003|STARTED|Phase 2 (Part 2)||0
10017918|NCT01820260|11140870|FG004|STARTED|Phase 2 (Part 2)||0
10017919|NCT01820260|11140871|FG005|STARTED|Phase 2 (Part 2)||0
10017920|NCT01820260|11140872|FG006|STARTED|Phase 2 (Part 2)||0
10017921|NCT01820260|11140873|FG007|STARTED|Phase 2 (Part 2)||0
10017922|NCT01820260|11140874|FG008|STARTED|Phase 2 (Part 2)||64
10017923|NCT01820260|11140875|FG009|STARTED|Phase 2 (Part 2)||62
10017924|NCT01820260|11140876|FG010|STARTED|Phase 2 (Part 2)||61
10017925|NCT01820260|11140877|FG011|STARTED|Phase 2 (Part 2)||64
10017926|NCT01820260|11140878|FG012|STARTED|Phase 2 (Part 2)||31
10017927|NCT01820260|11140879|FG013|STARTED|Phase 2 (Part 2)||31
10017928|NCT01820260|11140866|FG000|COMPLETED|Phase 2 (Part 2)||0
10017929|NCT01820260|11140867|FG001|COMPLETED|Phase 2 (Part 2)||0
10017930|NCT01820260|11140868|FG002|COMPLETED|Phase 2 (Part 2)||0
10017931|NCT01820260|11140869|FG003|COMPLETED|Phase 2 (Part 2)||0
10017932|NCT01820260|11140870|FG004|COMPLETED|Phase 2 (Part 2)||0
10017933|NCT01820260|11140871|FG005|COMPLETED|Phase 2 (Part 2)||0
10017934|NCT01820260|11140872|FG006|COMPLETED|Phase 2 (Part 2)||0
10017935|NCT01820260|11140873|FG007|COMPLETED|Phase 2 (Part 2)||0
10017936|NCT01820260|11140874|FG008|COMPLETED|Phase 2 (Part 2)||64
10017937|NCT01820260|11140875|FG009|COMPLETED|Phase 2 (Part 2)||61
10017938|NCT01820260|11140876|FG010|COMPLETED|Phase 2 (Part 2)||61
10017939|NCT01820260|11140877|FG011|COMPLETED|Phase 2 (Part 2)||64
10017940|NCT01820260|11140878|FG012|COMPLETED|Phase 2 (Part 2)||31
9980672|NCT01596972|11102221|FG000|STARTED|Overall Study||25
9980673|NCT01596972|11102222|FG001|STARTED|Overall Study||26
9980674|NCT01596972|11102221|FG000|COMPLETED|Overall Study||24
9980675|NCT01596972|11102222|FG001|COMPLETED|Overall Study||12
9980676|NCT01596972|11102221|FG000|NOT COMPLETED|Overall Study||1
9980677|NCT01596972|11102222|FG001|NOT COMPLETED|Overall Study||14
9980678|NCT01597050|11102230|FG000|STARTED|Overall Study||36
9980679|NCT01597050|11102231|FG001|STARTED|Overall Study||18
9980680|NCT01597050|11102230|FG000|COMPLETED|Overall Study||35
9980681|NCT01597050|11102231|FG001|COMPLETED|Overall Study||18
9980682|NCT01597050|11102230|FG000|NOT COMPLETED|Overall Study||1
9980683|NCT01597050|11102231|FG001|NOT COMPLETED|Overall Study||0
9980684|NCT01597128|11102239|FG000|STARTED|Overall Study||18
9980685|NCT01597128|11102240|FG001|STARTED|Overall Study||17
9980686|NCT01597128|11102239|FG000|COMPLETED|Overall Study||18
9980687|NCT01597128|11102240|FG001|COMPLETED|Overall Study||17
9980688|NCT01597128|11102239|FG000|NOT COMPLETED|Overall Study||0
9980689|NCT01597128|11102240|FG001|NOT COMPLETED|Overall Study||0
9980690|NCT01597141|11102248|FG000|STARTED|Overall Study||50
9980691|NCT01597141|11102249|FG001|STARTED|Overall Study||50
9980692|NCT01597141|11102248|FG000|COMPLETED|Overall Study||50
9980693|NCT01597141|11102249|FG001|COMPLETED|Overall Study||50
9980694|NCT01597141|11102248|FG000|NOT COMPLETED|Overall Study||0
9980695|NCT01597141|11102249|FG001|NOT COMPLETED|Overall Study||0
9980696|NCT01597193|11102264|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7
9980697|NCT01597193|11102265|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8
9980698|NCT01597193|11102266|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0
9980699|NCT01597193|11102267|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0
9980700|NCT01597193|11102268|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0
9980701|NCT01597193|11102269|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0
9980702|NCT01597193|11102270|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0
9980703|NCT01597193|11102264|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980704|NCT01597193|11102265|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980705|NCT01597193|11102266|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980706|NCT01597193|11102267|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980707|NCT01597193|11102268|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980708|NCT01597193|11102269|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980709|NCT01597193|11102270|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980710|NCT01597193|11102264|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
9980711|NCT01597193|11102265|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
9980712|NCT01597193|11102266|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980713|NCT01597193|11102267|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980714|NCT01597193|11102268|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980715|NCT01597193|11102269|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980716|NCT01597193|11102270|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
9980717|NCT01597193|11102264|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0
9980718|NCT01597193|11102265|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0
9980719|NCT01597193|11102266|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14
9980720|NCT01597193|11102267|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20
9980721|NCT01597193|11102268|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16
9980722|NCT01597193|11102269|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23
9980723|NCT01597193|11102270|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11
9980724|NCT01597193|11102264|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10099658|NCT02392611|11228750|FG003|NOT COMPLETED|Overall Study||6
10099659|NCT02392611|11228751|FG004|NOT COMPLETED|Overall Study||1
10099660|NCT02392611|11228752|FG005|NOT COMPLETED|Overall Study||1
10099661|NCT02392611|11228753|FG006|NOT COMPLETED|Overall Study||1
10099662|NCT02392611|11228754|FG007|NOT COMPLETED|Overall Study||0
10099663|NCT02392611|11228755|FG008|NOT COMPLETED|Overall Study||0
10099664|NCT02392624|11228778|FG000|STARTED|Overall Study||71
10099665|NCT02392624|11228779|FG001|STARTED|Overall Study||81
10099666|NCT02392624|11228780|FG002|STARTED|Overall Study||53
10099667|NCT02392624|11228778|FG000|COMPLETED|Overall Study||0
10099668|NCT02392624|11228779|FG001|COMPLETED|Overall Study||66
10099669|NCT02392624|11228780|FG002|COMPLETED|Overall Study||40
10099670|NCT02392624|11228778|FG000|NOT COMPLETED|Overall Study||71
10099671|NCT02392624|11228779|FG001|NOT COMPLETED|Overall Study||15
10099672|NCT02392624|11228780|FG002|NOT COMPLETED|Overall Study||13
10099673|NCT02392767|11228790|FG000|STARTED|Overall Study||12
10099674|NCT02392767|11228791|FG001|STARTED|Overall Study||13
10099675|NCT02392767|11228790|FG000|COMPLETED|Overall Study||12
10099676|NCT02392767|11228791|FG001|COMPLETED|Overall Study||13
9980725|NCT01597193|11102265|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
9980726|NCT01597193|11102266|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10099677|NCT02392767|11228790|FG000|NOT COMPLETED|Overall Study||0
10099678|NCT02392767|11228791|FG001|NOT COMPLETED|Overall Study||0
10099679|NCT02392806|11228801|FG000|STARTED|Overall Study||22
10099680|NCT02392806|11228802|FG001|STARTED|Overall Study||21
10099681|NCT02392806|11228801|FG000|COMPLETED|Overall Study||22
10099682|NCT02392806|11228802|FG001|COMPLETED|Overall Study||21
10099683|NCT02392806|11228801|FG000|NOT COMPLETED|Overall Study||0
9980727|NCT01597193|11102267|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
9980728|NCT01597193|11102268|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
9980729|NCT01597193|11102269|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10099684|NCT02392806|11228802|FG001|NOT COMPLETED|Overall Study||0
9980730|NCT01597193|11102270|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
9980731|NCT01597193|11102264|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
9980732|NCT01597193|11102265|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
9980733|NCT01597193|11102266|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
9980734|NCT01597193|11102267|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
9980735|NCT01597193|11102268|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
9980736|NCT01597193|11102269|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
9980737|NCT01597193|11102270|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
9980738|NCT01597245|11102295|FG000|STARTED|Induction Period (Week 0 - Week 12)||168
9980739|NCT01597245|11102296|FG001|STARTED|Induction Period (Week 0 - Week 12)||358
9980740|NCT01597245|11102297|FG002|STARTED|Induction Period (Week 0 - Week 12)||347
9980741|NCT01597245|11102298|FG003|STARTED|Induction Period (Week 0 - Week 12)||351
9980742|NCT01597245|11102299|FG004|STARTED|Induction Period (Week 0 - Week 12)||0
9980743|NCT01597245|11102300|FG005|STARTED|Induction Period (Week 0 - Week 12)||0
9980744|NCT01597245|11102301|FG006|STARTED|Induction Period (Week 0 - Week 12)||0
9980745|NCT01597245|11102302|FG007|STARTED|Induction Period (Week 0 - Week 12)||0
9980746|NCT01597245|11102303|FG008|STARTED|Induction Period (Week 0 - Week 12)||0
9980747|NCT01597245|11102304|FG009|STARTED|Induction Period (Week 0 - Week 12)||0
9980748|NCT01597245|11102305|FG010|STARTED|Induction Period (Week 0 - Week 12)||0
9980749|NCT01597245|11102306|FG011|STARTED|Induction Period (Week 0 - Week 12)||0
9980750|NCT01597245|11102307|FG012|STARTED|Induction Period (Week 0 - Week 12)||0
9980751|NCT01597245|11102308|FG013|STARTED|Induction Period (Week 0 - Week 12)||0
9980752|NCT01597245|11102309|FG014|STARTED|Induction Period (Week 0 - Week 12)||0
9980753|NCT01597245|11102310|FG015|STARTED|Induction Period (Week 0 - Week 12)||0
9980754|NCT01597245|11102311|FG016|STARTED|Induction Period (Week 0 - Week 12)||0
9980755|NCT01597245|11102312|FG017|STARTED|Induction Period (Week 0 - Week 12)||0
9980756|NCT01597245|11102313|FG018|STARTED|Induction Period (Week 0 - Week 12)||0
9980757|NCT01597245|11102314|FG019|STARTED|Induction Period (Week 0 - Week 12)||0
9980758|NCT01597245|11102315|FG020|STARTED|Induction Period (Week 0 - Week 12)||0
9980759|NCT01597245|11102295|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
9980760|NCT01597245|11102296|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
9980761|NCT01597245|11102297|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
9980762|NCT01597245|11102298|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
9980763|NCT01597245|11102299|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980764|NCT01597245|11102300|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980765|NCT01597245|11102301|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980766|NCT01597245|11102302|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980767|NCT01597245|11102303|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980768|NCT01597245|11102304|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980769|NCT01597245|11102305|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980770|NCT01597245|11102306|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980771|NCT01597245|11102307|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980772|NCT01597245|11102308|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980773|NCT01597245|11102309|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980774|NCT01597245|11102310|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980775|NCT01597245|11102311|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980776|NCT01597245|11102312|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980777|NCT01597245|11102313|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980778|NCT01597245|11102314|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980779|NCT01597245|11102315|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
9980780|NCT01597245|11102295|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158
9980781|NCT01597245|11102296|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
9980782|NCT01597245|11102297|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328
9980783|NCT01597245|11102298|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
9980784|NCT01597245|11102299|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980785|NCT01597245|11102300|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980786|NCT01597245|11102301|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980787|NCT01597245|11102302|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980788|NCT01597245|11102303|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980789|NCT01597245|11102304|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980790|NCT01597245|11102305|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980791|NCT01597245|11102306|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980792|NCT01597245|11102307|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980793|NCT01597245|11102308|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980794|NCT01597245|11102309|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980795|NCT01597245|11102310|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980796|NCT01597245|11102311|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980797|NCT01597245|11102312|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980798|NCT01597245|11102313|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980799|NCT01597245|11102314|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980800|NCT01597245|11102315|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0
9980801|NCT01597245|11102295|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
9980802|NCT01597245|11102296|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
9980803|NCT01597245|11102297|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
9980804|NCT01597245|11102298|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
9980805|NCT01597245|11102299|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980806|NCT01597245|11102300|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980807|NCT01597245|11102301|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980808|NCT01597245|11102302|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980809|NCT01597245|11102303|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980810|NCT01597245|11102304|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980811|NCT01597245|11102305|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980812|NCT01597245|11102306|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980813|NCT01597245|11102307|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10099685|NCT02393209|11228810|FG000|STARTED|Overall Study||6
10099686|NCT02393209|11228811|FG001|STARTED|Overall Study||8
10099687|NCT02393209|11228812|FG002|STARTED|Overall Study||0
10099688|NCT02393209|11228813|FG003|STARTED|Overall Study||0
10099689|NCT02393209|11228810|FG000|COMPLETED|Overall Study||0
10099690|NCT02393209|11228811|FG001|COMPLETED|Overall Study||0
10099691|NCT02393209|11228812|FG002|COMPLETED|Overall Study||0
10099692|NCT02393209|11228813|FG003|COMPLETED|Overall Study||0
10099693|NCT02393209|11228810|FG000|NOT COMPLETED|Overall Study||6
10099694|NCT02393209|11228811|FG001|NOT COMPLETED|Overall Study||8
10099695|NCT02393209|11228812|FG002|NOT COMPLETED|Overall Study||0
10099696|NCT02393209|11228813|FG003|NOT COMPLETED|Overall Study||0
10099697|NCT02393339|11228824|FG000|STARTED|Overall Study||58
10099698|NCT02393339|11228825|FG001|STARTED|Overall Study||56
10099699|NCT02393339|11228824|FG000|COMPLETED|Overall Study||51
10099700|NCT02393339|11228825|FG001|COMPLETED|Overall Study||51
10202061|NCT03441984|11329287|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9980814|NCT01597245|11102308|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980815|NCT01597245|11102309|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980816|NCT01597245|11102310|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980817|NCT01597245|11102311|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980818|NCT01597245|11102312|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980819|NCT01597245|11102313|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980820|NCT01597245|11102314|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980821|NCT01597245|11102315|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
9980822|NCT01597245|11102295|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
9980823|NCT01597245|11102296|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
9980824|NCT01597245|11102297|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
9980825|NCT01597245|11102298|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
9980826|NCT01597245|11102299|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
9980827|NCT01597245|11102300|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
9980828|NCT01597245|11102301|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
9980829|NCT01597245|11102302|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
9980830|NCT01597245|11102303|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
9980831|NCT01597245|11102304|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
9980832|NCT01597245|11102305|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
9980833|NCT01597245|11102306|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
9980834|NCT01597245|11102307|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
9980835|NCT01597245|11102308|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0
9980836|NCT01597245|11102309|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0
9980837|NCT01597245|11102310|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0
9980838|NCT01597245|11102311|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0
9980839|NCT01597245|11102312|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0
10099701|NCT02393339|11228824|FG000|NOT COMPLETED|Overall Study||7
10099702|NCT02393339|11228825|FG001|NOT COMPLETED|Overall Study||5
10099703|NCT02393378|11228833|FG000|STARTED|Overall Study||3
10099704|NCT02393378|11228834|FG001|STARTED|Overall Study||4
10099705|NCT02393378|11228833|FG000|COMPLETED|Overall Study||3
10202062|NCT03441984|11329276|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9980840|NCT01597245|11102313|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0
9980841|NCT01597245|11102314|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0
9980842|NCT01597245|11102315|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0
9980843|NCT01597245|11102295|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980844|NCT01597245|11102296|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980845|NCT01597245|11102297|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980846|NCT01597245|11102298|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980847|NCT01597245|11102299|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
9980848|NCT01597245|11102300|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
9980849|NCT01597245|11102301|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
9980850|NCT01597245|11102302|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
9980851|NCT01597245|11102303|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
9980852|NCT01597245|11102304|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
9980853|NCT01597245|11102305|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
9980854|NCT01597245|11102306|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
9980855|NCT01597245|11102307|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
9980856|NCT01597245|11102308|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980857|NCT01597245|11102309|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980858|NCT01597245|11102310|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980859|NCT01597245|11102311|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980860|NCT01597245|11102312|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980861|NCT01597245|11102313|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980862|NCT01597245|11102314|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980863|NCT01597245|11102315|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
9980864|NCT01597245|11102295|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980865|NCT01597245|11102296|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980866|NCT01597245|11102297|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980867|NCT01597245|11102298|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980868|NCT01597245|11102299|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
9980869|NCT01597245|11102300|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
9980870|NCT01597245|11102301|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
9980871|NCT01597245|11102302|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980872|NCT01597245|11102303|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
9980873|NCT01597245|11102304|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
9980874|NCT01597245|11102305|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
9980875|NCT01597245|11102306|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
9980876|NCT01597245|11102307|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
9980877|NCT01597245|11102308|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980878|NCT01597245|11102309|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980879|NCT01597245|11102310|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980880|NCT01597245|11102311|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980881|NCT01597245|11102312|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980882|NCT01597245|11102313|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980883|NCT01597245|11102314|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980884|NCT01597245|11102315|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980885|NCT01597245|11102295|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980886|NCT01597245|11102296|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980887|NCT01597245|11102297|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980888|NCT01597245|11102298|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980889|NCT01597245|11102299|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
9980890|NCT01597245|11102300|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
9980891|NCT01597245|11102301|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
9980892|NCT01597245|11102302|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
9980893|NCT01597245|11102303|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
9980894|NCT01597245|11102304|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
9980895|NCT01597245|11102305|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
9980896|NCT01597245|11102306|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
9980897|NCT01597245|11102307|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
9980898|NCT01597245|11102308|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980899|NCT01597245|11102309|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980900|NCT01597245|11102310|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980901|NCT01597245|11102311|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980902|NCT01597245|11102312|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980903|NCT01597245|11102313|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980904|NCT01597245|11102314|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980905|NCT01597245|11102315|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
9980906|NCT01597245|11102295|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980907|NCT01597245|11102296|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980908|NCT01597245|11102297|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980909|NCT01597245|11102298|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980910|NCT01597245|11102299|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980911|NCT01597245|11102300|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980912|NCT01597245|11102301|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980913|NCT01597245|11102302|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980914|NCT01597245|11102303|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980915|NCT01597245|11102304|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980916|NCT01597245|11102305|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980917|NCT01597245|11102306|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980918|NCT01597245|11102307|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
9980919|NCT01597245|11102308|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
9980920|NCT01597245|11102309|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
9980921|NCT01597245|11102310|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
9980922|NCT01597245|11102311|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980923|NCT01597245|11102312|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980924|NCT01597245|11102313|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980925|NCT01597245|11102314|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980926|NCT01597245|11102315|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0
9980927|NCT01597245|11102295|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980928|NCT01597245|11102296|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980929|NCT01597245|11102297|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980930|NCT01597245|11102298|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980931|NCT01597245|11102299|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980932|NCT01597245|11102300|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980933|NCT01597245|11102301|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980934|NCT01597245|11102302|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980935|NCT01597245|11102303|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980936|NCT01597245|11102304|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980937|NCT01597245|11102305|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980938|NCT01597245|11102306|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980939|NCT01597245|11102307|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980940|NCT01597245|11102308|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980941|NCT01597245|11102309|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
9980942|NCT01597245|11102310|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
9980943|NCT01597245|11102311|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980944|NCT01597245|11102312|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980945|NCT01597245|11102313|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980946|NCT01597245|11102314|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980947|NCT01597245|11102315|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980948|NCT01597245|11102295|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980949|NCT01597245|11102296|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980950|NCT01597245|11102297|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980951|NCT01597245|11102298|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980952|NCT01597245|11102299|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980953|NCT01597245|11102300|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980954|NCT01597245|11102301|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980955|NCT01597245|11102302|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980956|NCT01597245|11102303|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980957|NCT01597245|11102304|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980958|NCT01597245|11102305|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980959|NCT01597245|11102306|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980960|NCT01597245|11102307|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980961|NCT01597245|11102308|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
9980962|NCT01597245|11102309|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
9980963|NCT01597245|11102310|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
9980964|NCT01597245|11102311|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980965|NCT01597245|11102312|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980966|NCT01597245|11102313|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980967|NCT01597245|11102314|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980968|NCT01597245|11102315|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
9980969|NCT01597245|11102295|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980970|NCT01597245|11102296|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980971|NCT01597245|11102297|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980972|NCT01597245|11102298|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980973|NCT01597245|11102299|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980974|NCT01597245|11102300|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980975|NCT01597245|11102301|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980976|NCT01597245|11102302|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980977|NCT01597245|11102303|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980978|NCT01597245|11102304|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980979|NCT01597245|11102305|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980980|NCT01597245|11102306|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980981|NCT01597245|11102307|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980982|NCT01597245|11102308|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980983|NCT01597245|11102309|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
9980984|NCT01597245|11102310|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
9980985|NCT01597245|11102311|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
9980986|NCT01597245|11102312|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
9980987|NCT01597245|11102313|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
9980988|NCT01597245|11102314|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
9980989|NCT01597245|11102315|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
9980990|NCT01597245|11102295|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980991|NCT01597245|11102296|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980992|NCT01597245|11102297|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980993|NCT01597245|11102298|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980994|NCT01597245|11102299|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980995|NCT01597245|11102300|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980996|NCT01597245|11102301|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980997|NCT01597245|11102302|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980998|NCT01597245|11102303|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9980999|NCT01597245|11102304|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981000|NCT01597245|11102305|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981001|NCT01597245|11102306|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981002|NCT01597245|11102307|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981003|NCT01597245|11102308|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981004|NCT01597245|11102309|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981005|NCT01597245|11102310|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981006|NCT01597245|11102311|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981007|NCT01597245|11102312|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981008|NCT01597245|11102313|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
9981009|NCT01597245|11102314|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
9981010|NCT01597245|11102315|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
9981011|NCT01597245|11102295|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981012|NCT01597245|11102296|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981013|NCT01597245|11102297|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981014|NCT01597245|11102298|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981015|NCT01597245|11102299|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981016|NCT01597245|11102300|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981017|NCT01597245|11102301|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981018|NCT01597245|11102302|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981019|NCT01597245|11102303|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981020|NCT01597245|11102304|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981021|NCT01597245|11102305|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981022|NCT01597245|11102306|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981023|NCT01597245|11102307|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981024|NCT01597245|11102308|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981025|NCT01597245|11102309|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981026|NCT01597245|11102310|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
9981027|NCT01597245|11102311|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
9981028|NCT01597245|11102312|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
9981029|NCT01597245|11102313|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
9981030|NCT01597245|11102314|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
9981031|NCT01597245|11102315|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
9981032|NCT01597258|11102348|FG000|STARTED|Overall Study||2029
9981033|NCT01597258|11102348|FG000|COMPLETED|Overall Study||2028
9981034|NCT01597258|11102348|FG000|NOT COMPLETED|Overall Study||1
9981035|NCT01597375|11102352|FG000|STARTED|First Intervention (4 Weeks)||23
9981036|NCT01597375|11102353|FG001|STARTED|First Intervention (4 Weeks)||23
9981037|NCT01597375|11102352|FG000|COMPLETED|First Intervention (4 Weeks)||21
9981038|NCT01597375|11102353|FG001|COMPLETED|First Intervention (4 Weeks)||22
9981039|NCT01597375|11102352|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
9981040|NCT01597375|11102353|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
9981041|NCT01597375|11102352|FG000|STARTED|Washout (2 Weeks)||21
9981042|NCT01597375|11102353|FG001|STARTED|Washout (2 Weeks)||22
9981043|NCT01597375|11102352|FG000|COMPLETED|Washout (2 Weeks)||20
9981044|NCT01597375|11102353|FG001|COMPLETED|Washout (2 Weeks)||22
9981045|NCT01597375|11102352|FG000|NOT COMPLETED|Washout (2 Weeks)||1
9981046|NCT01597375|11102353|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9981047|NCT01597375|11102352|FG000|STARTED|Second Intervention||20
9981048|NCT01597375|11102353|FG001|STARTED|Second Intervention||22
9981049|NCT01597375|11102352|FG000|COMPLETED|Second Intervention||19
9981050|NCT01597375|11102353|FG001|COMPLETED|Second Intervention||21
9981051|NCT01597375|11102352|FG000|NOT COMPLETED|Second Intervention||1
9981052|NCT01597375|11102353|FG001|NOT COMPLETED|Second Intervention||1
9981053|NCT01597440|11102362|FG000|STARTED|Overall Study||1
9981054|NCT01597440|11102363|FG001|STARTED|Overall Study||0
9981055|NCT01597440|11102362|FG000|COMPLETED|Overall Study||1
9981056|NCT01597440|11102363|FG001|COMPLETED|Overall Study||0
9981057|NCT01597440|11102362|FG000|NOT COMPLETED|Overall Study||0
9981058|NCT01597440|11102363|FG001|NOT COMPLETED|Overall Study||0
9981059|NCT01597479|11102373|FG000|STARTED|Overall Study||26
9981060|NCT01597479|11102374|FG001|STARTED|Overall Study||26
9981061|NCT01597479|11102373|FG000|COMPLETED|Overall Study||24
9981062|NCT01597479|11102374|FG001|COMPLETED|Overall Study||26
9981063|NCT01597479|11102373|FG000|NOT COMPLETED|Overall Study||2
9981064|NCT01597479|11102374|FG001|NOT COMPLETED|Overall Study||0
9981065|NCT01597492|11102383|FG000|STARTED|Overall Study||34
9981066|NCT01597492|11102384|FG001|STARTED|Overall Study||45
9981067|NCT01597492|11102383|FG000|COMPLETED|Overall Study||28
9981068|NCT01597492|11102384|FG001|COMPLETED|Overall Study||41
9981069|NCT01597492|11102383|FG000|NOT COMPLETED|Overall Study||6
9981070|NCT01597492|11102384|FG001|NOT COMPLETED|Overall Study||4
9981071|NCT01597505|11102392|FG000|STARTED|Overall Study|Randomized participants|308
9981072|NCT01597505|11102393|FG001|STARTED|Overall Study|Randomized participants|298
9981073|NCT01597505|11102392|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305
9981074|NCT01597505|11102393|FG001|Treated|Overall Study||286
9981075|NCT01597505|11102392|FG000|COMPLETED|Overall Study||264
9981076|NCT01597505|11102393|FG001|COMPLETED|Overall Study||265
9981077|NCT01597505|11102392|FG000|NOT COMPLETED|Overall Study||44
9981078|NCT01597505|11102393|FG001|NOT COMPLETED|Overall Study||33
9981079|NCT01597557|11102402|FG000|STARTED|Overall Study||132
9981080|NCT01597557|11102403|FG001|STARTED|Overall Study||129
9981081|NCT01597557|11102402|FG000|COMPLETED|Overall Study||128
9981082|NCT01597557|11102403|FG001|COMPLETED|Overall Study||126
9981083|NCT01597557|11102402|FG000|NOT COMPLETED|Overall Study||4
9981084|NCT01597557|11102403|FG001|NOT COMPLETED|Overall Study||3
9981085|NCT01597596|11102411|FG000|STARTED|Overall Study||1
9981086|NCT01597596|11102412|FG001|STARTED|Overall Study||3
9981087|NCT01597596|11102411|FG000|COMPLETED|Overall Study||0
9981088|NCT01597596|11102412|FG001|COMPLETED|Overall Study||2
9981089|NCT01597596|11102411|FG000|NOT COMPLETED|Overall Study||1
9981090|NCT01597596|11102412|FG001|NOT COMPLETED|Overall Study||1
9981091|NCT01597622|11102418|FG000|STARTED|Overall Study||142
9981092|NCT01597622|11102418|FG000|COMPLETED|Overall Study||104
9981093|NCT01597622|11102418|FG000|NOT COMPLETED|Overall Study||38
9981094|NCT01597635|11102425|FG000|STARTED|Part A||5
9981095|NCT01597635|11102426|FG001|STARTED|Part A||0
9981096|NCT01597635|11102427|FG002|STARTED|Part A||0
9981097|NCT01597635|11102425|FG000|COMPLETED|Part A||2
9981098|NCT01597635|11102426|FG001|COMPLETED|Part A||0
9981099|NCT01597635|11102427|FG002|COMPLETED|Part A||0
9981100|NCT01597635|11102425|FG000|NOT COMPLETED|Part A||3
9981101|NCT01597635|11102426|FG001|NOT COMPLETED|Part A||0
9981102|NCT01597635|11102427|FG002|NOT COMPLETED|Part A||0
9981103|NCT01597635|11102425|FG000|STARTED|Part B||0
9981104|NCT01597635|11102426|FG001|STARTED|Part B||20
9981105|NCT01597635|11102427|FG002|STARTED|Part B||19
9981106|NCT01597635|11102425|FG000|COMPLETED|Part B||0
9981107|NCT01597635|11102426|FG001|COMPLETED|Part B||14
9981108|NCT01597635|11102427|FG002|COMPLETED|Part B||15
9981109|NCT01597635|11102425|FG000|NOT COMPLETED|Part B||0
9981110|NCT01597635|11102426|FG001|NOT COMPLETED|Part B||6
9981111|NCT01597635|11102427|FG002|NOT COMPLETED|Part B||4
9981112|NCT01597687|11102439|FG000|STARTED|Overall Study||76
9981113|NCT01597687|11102440|FG001|STARTED|Overall Study||89
9981114|NCT01597687|11102441|FG002|STARTED|Overall Study||147
9981115|NCT01597687|11102439|FG000|COMPLETED|Overall Study||76
9981116|NCT01597687|11102440|FG001|COMPLETED|Overall Study||89
9981117|NCT01597687|11102441|FG002|COMPLETED|Overall Study||147
9981118|NCT01597687|11102439|FG000|NOT COMPLETED|Overall Study||0
9981119|NCT01597687|11102440|FG001|NOT COMPLETED|Overall Study||0
9981120|NCT01597687|11102441|FG002|NOT COMPLETED|Overall Study||0
9981121|NCT01597791|11102467|FG000|STARTED|Overall Study||28
9981122|NCT01597791|11102468|FG001|STARTED|Overall Study||28
9981123|NCT01597791|11102467|FG000|COMPLETED|Overall Study||20
9981124|NCT01597791|11102468|FG001|COMPLETED|Overall Study||18
9981125|NCT01597791|11102467|FG000|NOT COMPLETED|Overall Study||8
9981126|NCT01597791|11102468|FG001|NOT COMPLETED|Overall Study||10
9981127|NCT01597843|11102477|FG000|STARTED|Overall Study||79
9981128|NCT01597843|11102478|FG001|STARTED|Overall Study||122
9981129|NCT01597843|11102479|FG002|STARTED|Overall Study||81
9981130|NCT01597843|11102477|FG000|Survey 1 Responses|Overall Study||45
9981131|NCT01597843|11102478|FG001|Survey 1 Responses|Overall Study||71
9981132|NCT01597843|11102479|FG002|Survey 1 Responses|Overall Study||59
9981133|NCT01597843|11102477|FG000|Survey 2 Responses|Overall Study||52
9981134|NCT01597843|11102478|FG001|Survey 2 Responses|Overall Study||42
9981135|NCT01597843|11102479|FG002|Survey 2 Responses|Overall Study||58
9981136|NCT01597843|11102477|FG000|Survey 3 Responses|Overall Study||65
9981137|NCT01597843|11102478|FG001|Survey 3 Responses|Overall Study||56
9981138|NCT01597843|11102479|FG002|Survey 3 Responses|Overall Study||76
9981139|NCT01597843|11102477|FG000|COMPLETED|Overall Study||79
9981140|NCT01597843|11102478|FG001|COMPLETED|Overall Study||122
9981141|NCT01597843|11102479|FG002|COMPLETED|Overall Study||81
9981142|NCT01597843|11102477|FG000|NOT COMPLETED|Overall Study||0
9981143|NCT01597843|11102478|FG001|NOT COMPLETED|Overall Study||0
9981144|NCT01597843|11102479|FG002|NOT COMPLETED|Overall Study||0
9981145|NCT01597856|11102490|FG000|STARTED|Overall Study||85
9981146|NCT01597856|11102491|FG001|STARTED|Overall Study||87
9981147|NCT01597856|11102492|FG002|STARTED|Overall Study||174
9981148|NCT01597856|11102490|FG000|Week 4 Follow-up|Overall Study||62
9981149|NCT01597856|11102491|FG001|Week 4 Follow-up|Overall Study||67
9981150|NCT01597856|11102492|FG002|Week 4 Follow-up|Overall Study||129
9981151|NCT01597856|11102490|FG000|COMPLETED|Overall Study||63
9981152|NCT01597856|11102491|FG001|COMPLETED|Overall Study||61
9981153|NCT01597856|11102492|FG002|COMPLETED|Overall Study||120
9981154|NCT01597856|11102490|FG000|NOT COMPLETED|Overall Study||22
9981155|NCT01597856|11102491|FG001|NOT COMPLETED|Overall Study||26
9981156|NCT01597856|11102492|FG002|NOT COMPLETED|Overall Study||54
9981157|NCT01597908|11102503|FG000|STARTED|Randomized Phase||352
9981158|NCT01597908|11102504|FG001|STARTED|Randomized Phase||352
9981159|NCT01597908|11102505|FG002|STARTED|Randomized Phase||0
9981160|NCT01597908|11102503|FG000|Safety Set|Randomized Phase||350
9981161|NCT01597908|11102504|FG001|Safety Set|Randomized Phase||349
9981162|NCT01597908|11102505|FG002|Safety Set|Randomized Phase||0
9981163|NCT01597908|11102503|FG000|COMPLETED|Randomized Phase||1
9981164|NCT01597908|11102504|FG001|COMPLETED|Randomized Phase||0
9981165|NCT01597908|11102505|FG002|COMPLETED|Randomized Phase||0
9981166|NCT01597908|11102503|FG000|NOT COMPLETED|Randomized Phase||351
9981167|NCT01597908|11102504|FG001|NOT COMPLETED|Randomized Phase||352
9981168|NCT01597908|11102505|FG002|NOT COMPLETED|Randomized Phase||0
9981169|NCT01597908|11102503|FG000|STARTED|Crossover Phase||0
9981170|NCT01597908|11102504|FG001|STARTED|Crossover Phase||0
9981171|NCT01597908|11102505|FG002|STARTED|Crossover Phase||34
9981172|NCT01597908|11102503|FG000|COMPLETED|Crossover Phase||0
9981173|NCT01597908|11102504|FG001|COMPLETED|Crossover Phase||0
9981174|NCT01597908|11102505|FG002|COMPLETED|Crossover Phase||0
9981175|NCT01597908|11102503|FG000|NOT COMPLETED|Crossover Phase||0
9981176|NCT01597908|11102504|FG001|NOT COMPLETED|Crossover Phase||0
9981177|NCT01597908|11102505|FG002|NOT COMPLETED|Crossover Phase||34
9981178|NCT01597973|11102516|FG000|STARTED|Overall Study||234
9981179|NCT01597973|11102517|FG001|STARTED|Overall Study||230
9981180|NCT01597973|11102516|FG000|Began First Dose|Overall Study||230
9981181|NCT01597973|11102517|FG001|Began First Dose|Overall Study||228
9981182|NCT01597973|11102516|FG000|COMPLETED|Overall Study||214
9981183|NCT01597973|11102517|FG001|COMPLETED|Overall Study||211
9981184|NCT01597973|11102516|FG000|NOT COMPLETED|Overall Study||20
9981185|NCT01597973|11102517|FG001|NOT COMPLETED|Overall Study||19
9981186|NCT01598064|11102527|FG000|STARTED|Overall Study||25
9981187|NCT01598064|11102528|FG001|STARTED|Overall Study||24
9981188|NCT01598064|11102527|FG000|COMPLETED|Overall Study||25
9981189|NCT01598064|11102528|FG001|COMPLETED|Overall Study||24
9981190|NCT01598064|11102527|FG000|NOT COMPLETED|Overall Study||0
9981191|NCT01598064|11102528|FG001|NOT COMPLETED|Overall Study||0
9981192|NCT01598090|11102539|FG000|STARTED|Treatment Period||27
9981193|NCT01598090|11102540|FG001|STARTED|Treatment Period||411
9981194|NCT01598090|11102541|FG002|STARTED|Treatment Period||206
9981195|NCT01598090|11102539|FG000|COMPLETED|Treatment Period||16
9981196|NCT01598090|11102540|FG001|COMPLETED|Treatment Period||339
9981197|NCT01598090|11102541|FG002|COMPLETED|Treatment Period||171
9981198|NCT01598090|11102539|FG000|NOT COMPLETED|Treatment Period||11
9981199|NCT01598090|11102540|FG001|NOT COMPLETED|Treatment Period||72
9981200|NCT01598090|11102541|FG002|NOT COMPLETED|Treatment Period||35
9981201|NCT01598090|11102539|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
9981202|NCT01598090|11102540|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
9981203|NCT01598090|11102541|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
9981204|NCT01598090|11102539|FG000|COMPLETED|Follow-up Period||21
9981205|NCT01598090|11102540|FG001|COMPLETED|Follow-up Period||364
9981206|NCT01598090|11102541|FG002|COMPLETED|Follow-up Period||171
9981207|NCT01598090|11102539|FG000|NOT COMPLETED|Follow-up Period||5
9981208|NCT01598090|11102540|FG001|NOT COMPLETED|Follow-up Period||35
9981209|NCT01598090|11102541|FG002|NOT COMPLETED|Follow-up Period||28
9981210|NCT01598129|11102552|FG000|STARTED|Overall Study||12
9981211|NCT01598129|11102552|FG000|COMPLETED|Overall Study||3
9981212|NCT01598129|11102552|FG000|NOT COMPLETED|Overall Study||9
9981213|NCT01598194|11102559|FG000|STARTED|Overall Study||30
9981214|NCT01598194|11102560|FG001|STARTED|Overall Study||30
9981215|NCT01598194|11102559|FG000|2 Passes With 25G for Cytology|Overall Study||30
9981216|NCT01598194|11102560|FG001|2 Passes With 25G for Cytology|Overall Study||30
9981217|NCT01598194|11102559|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
9981218|NCT01598194|11102560|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30
9981219|NCT01598194|11102559|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
9981220|NCT01598194|11102560|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
9981221|NCT01598194|11102559|FG000|COMPLETED|Overall Study||30
9981222|NCT01598194|11102560|FG001|COMPLETED|Overall Study||30
9981223|NCT01598194|11102559|FG000|NOT COMPLETED|Overall Study||0
9981224|NCT01598194|11102560|FG001|NOT COMPLETED|Overall Study||0
9981225|NCT01598207|11102572|FG000|STARTED|Overall Study||7
9981226|NCT01598207|11102573|FG001|STARTED|Overall Study||6
9981227|NCT01598207|11102572|FG000|COMPLETED|Overall Study||6
9981228|NCT01598207|11102573|FG001|COMPLETED|Overall Study||6
9981229|NCT01598207|11102572|FG000|NOT COMPLETED|Overall Study||1
9981230|NCT01598207|11102573|FG001|NOT COMPLETED|Overall Study||0
9981231|NCT01598298|11102581|FG000|STARTED|Overall Study||150
9981232|NCT01598298|11102582|FG001|STARTED|Overall Study||149
9981233|NCT01598298|11102581|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127
9981234|NCT01598298|11102582|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128
9981235|NCT01598298|11102581|FG000|Patients Evaluable for Adverse Events|Overall Study||138
9981236|NCT01598298|11102582|FG001|Patients Evaluable for Adverse Events|Overall Study||141
9981237|NCT01598298|11102581|FG000|COMPLETED|Overall Study||110
9981238|NCT01598298|11102582|FG001|COMPLETED|Overall Study||108
9981239|NCT01598298|11102581|FG000|NOT COMPLETED|Overall Study||40
9981240|NCT01598298|11102582|FG001|NOT COMPLETED|Overall Study||41
9981241|NCT01598311|11102590|FG000|STARTED|Overall Study||303
9981242|NCT01598311|11102591|FG001|STARTED|Overall Study||305
9981243|NCT01598311|11102590|FG000|Treated|Overall Study||294
9981244|NCT01598311|11102591|FG001|Treated|Overall Study||301
9981245|NCT01598311|11102590|FG000|Treated and Confirmed CDAD|Overall Study||285
9981246|NCT01598311|11102591|FG001|Treated and Confirmed CDAD|Overall Study||292
9981247|NCT01598311|11102590|FG000|COMPLETED|Overall Study||256
9981248|NCT01598311|11102591|FG001|COMPLETED|Overall Study||244
9981249|NCT01598311|11102590|FG000|NOT COMPLETED|Overall Study||47
9981250|NCT01598311|11102591|FG001|NOT COMPLETED|Overall Study||61
9981251|NCT01598350|11102597|FG000|STARTED|Overall Study||6
9981252|NCT01598350|11102597|FG000|COMPLETED|Overall Study||6
9981253|NCT01598350|11102597|FG000|NOT COMPLETED|Overall Study||0
9981254|NCT01598428|11102601|FG000|STARTED|Overall Study||20
9981255|NCT01598428|11102601|FG000|COMPLETED|Overall Study||20
9981256|NCT01598428|11102601|FG000|NOT COMPLETED|Overall Study||0
9981257|NCT01598506|11102606|FG000|STARTED|Overall Study||22
9981258|NCT01598506|11102606|FG000|COMPLETED|Overall Study||20
9981259|NCT01598506|11102606|FG000|NOT COMPLETED|Overall Study||2
9981260|NCT01598532|11102611|FG000|STARTED|Overall Study||22
9981261|NCT01598532|11102611|FG000|COMPLETED|Overall Study||11
9981262|NCT01598532|11102611|FG000|NOT COMPLETED|Overall Study||11
9981263|NCT01598545|11102618|FG000|STARTED|Overall Study||20
9981264|NCT01598545|11102618|FG000|COMPLETED|Overall Study||20
9981265|NCT01598545|11102618|FG000|NOT COMPLETED|Overall Study||0
9981266|NCT01598610|11102622|FG000|STARTED|Overall Study||220
9981267|NCT01598610|11102622|FG000|COMPLETED|Overall Study||219
9981268|NCT01598610|11102622|FG000|NOT COMPLETED|Overall Study||1
9981269|NCT01598662|11102628|FG000|STARTED|Overall Study||11
9981270|NCT01598662|11102629|FG001|STARTED|Overall Study||21
9981271|NCT01598662|11102628|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
9981272|NCT01598662|11102629|FG001|Patients Who Received IUD|Overall Study||18
9981273|NCT01598662|11102628|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0
9981274|NCT01598662|11102629|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2
9981275|NCT01598662|11102628|FG000|COMPLETED|Overall Study||0
9981276|NCT01598662|11102629|FG001|COMPLETED|Overall Study||0
9981277|NCT01598662|11102628|FG000|NOT COMPLETED|Overall Study||11
9981278|NCT01598662|11102629|FG001|NOT COMPLETED|Overall Study||21
9981279|NCT01598701|11102637|FG000|STARTED|Overall Study||50
9981280|NCT01598701|11102638|FG001|STARTED|Overall Study||50
9981281|NCT01598701|11102637|FG000|COMPLETED|Overall Study||45
9981282|NCT01598701|11102638|FG001|COMPLETED|Overall Study||41
9981283|NCT01598701|11102637|FG000|NOT COMPLETED|Overall Study||5
9981284|NCT01598701|11102638|FG001|NOT COMPLETED|Overall Study||9
9981285|NCT01598740|11102646|FG000|STARTED|Period 1||9
9981286|NCT01598740|11102647|FG001|STARTED|Period 1||9
9981287|NCT01598740|11102646|FG000|COMPLETED|Period 1||9
9981288|NCT01598740|11102647|FG001|COMPLETED|Period 1||9
9981289|NCT01598740|11102646|FG000|NOT COMPLETED|Period 1||0
9981290|NCT01598740|11102647|FG001|NOT COMPLETED|Period 1||0
9981291|NCT01598740|11102646|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
9981292|NCT01598740|11102647|FG001|STARTED|Period 2||9
9981293|NCT01598740|11102646|FG000|COMPLETED|Period 2||7
9981294|NCT01598740|11102647|FG001|COMPLETED|Period 2||9
9981295|NCT01598740|11102646|FG000|NOT COMPLETED|Period 2||1
9981296|NCT01598740|11102647|FG001|NOT COMPLETED|Period 2||0
9981297|NCT01598753|11102658|FG000|STARTED|Overall Study||37
9981298|NCT01598753|11102659|FG001|STARTED|Overall Study||31
9981299|NCT01598753|11102660|FG002|STARTED|Overall Study||32
9981300|NCT01598753|11102661|FG003|STARTED|Overall Study||34
9981301|NCT01598753|11102658|FG000|COMPLETED|Overall Study||25
9981302|NCT01598753|11102659|FG001|COMPLETED|Overall Study||16
9981303|NCT01598753|11102660|FG002|COMPLETED|Overall Study||24
9981304|NCT01598753|11102661|FG003|COMPLETED|Overall Study||19
9981305|NCT01598753|11102658|FG000|NOT COMPLETED|Overall Study||12
9981306|NCT01598753|11102659|FG001|NOT COMPLETED|Overall Study||15
9981307|NCT01598753|11102660|FG002|NOT COMPLETED|Overall Study||8
9981308|NCT01598753|11102661|FG003|NOT COMPLETED|Overall Study||15
9981309|NCT01598779|11102671|FG000|STARTED|Overall Study||150
9981310|NCT01598779|11102671|FG000|COMPLETED|Overall Study||150
9981311|NCT01598779|11102671|FG000|NOT COMPLETED|Overall Study||0
9981312|NCT01598831|11102677|FG000|STARTED|Overall Study||402
9981313|NCT01598831|11102678|FG001|STARTED|Overall Study||414
9981314|NCT01598831|11102677|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395
9981315|NCT01598831|11102678|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405
9981316|NCT01598831|11102677|FG000|COMPLETED|Overall Study||283
9981317|NCT01598831|11102678|FG001|COMPLETED|Overall Study||278
9981318|NCT01598831|11102677|FG000|NOT COMPLETED|Overall Study||119
9981319|NCT01598831|11102678|FG001|NOT COMPLETED|Overall Study||136
9981320|NCT01598896|11102686|FG000|STARTED|Overall Study||3
9981321|NCT01598896|11102687|FG001|STARTED|Overall Study||4
9981322|NCT01598896|11102686|FG000|COMPLETED|Overall Study||3
9981323|NCT01598896|11102687|FG001|COMPLETED|Overall Study||2
9981324|NCT01598896|11102686|FG000|NOT COMPLETED|Overall Study||0
9981325|NCT01598896|11102687|FG001|NOT COMPLETED|Overall Study||2
9981326|NCT01598922|11102695|FG000|STARTED|Overall Study||37
9981327|NCT01598922|11102696|FG001|STARTED|Overall Study||40
9981328|NCT01598922|11102695|FG000|COMPLETED|Overall Study||34
9981329|NCT01598922|11102696|FG001|COMPLETED|Overall Study||30
9981330|NCT01598922|11102695|FG000|NOT COMPLETED|Overall Study||3
9981331|NCT01598922|11102696|FG001|NOT COMPLETED|Overall Study||10
9981332|NCT01598987|11102702|FG000|STARTED|Baseline to Month 12||56
9981333|NCT01598987|11102702|FG000|COMPLETED|Baseline to Month 12||50
9981334|NCT01598987|11102702|FG000|NOT COMPLETED|Baseline to Month 12||6
9981335|NCT01598987|11102702|FG000|STARTED|Baseline to 24 Month||56
9981336|NCT01598987|11102702|FG000|COMPLETED|Baseline to 24 Month||48
9981337|NCT01598987|11102702|FG000|NOT COMPLETED|Baseline to 24 Month||8
9981338|NCT01599104|11102716|FG000|STARTED|Overall Study||387
9981339|NCT01599104|11102717|FG001|STARTED|Overall Study||385
9981340|NCT01599104|11102718|FG002|STARTED|Overall Study||389
9981341|NCT01599104|11102716|FG000|COMPLETED|Overall Study||371
9981342|NCT01599104|11102717|FG001|COMPLETED|Overall Study||371
9981343|NCT01599104|11102718|FG002|COMPLETED|Overall Study||363
9981344|NCT01599104|11102716|FG000|NOT COMPLETED|Overall Study||16
9981345|NCT01599104|11102717|FG001|NOT COMPLETED|Overall Study||14
9981346|NCT01599104|11102718|FG002|NOT COMPLETED|Overall Study||26
9981347|NCT01599234|11102728|FG000|STARTED|Overall Study||167
9981348|NCT01599234|11102729|FG001|STARTED|Overall Study||170
9981349|NCT01599234|11102728|FG000|COMPLETED|Overall Study||150
9981350|NCT01599234|11102729|FG001|COMPLETED|Overall Study||155
9981351|NCT01599234|11102728|FG000|NOT COMPLETED|Overall Study||17
9981352|NCT01599234|11102729|FG001|NOT COMPLETED|Overall Study||15
9981353|NCT01599286|11102737|FG000|STARTED|Overall Study||24
9981354|NCT01599286|11102738|FG001|STARTED|Overall Study||23
9981355|NCT01599286|11102737|FG000|COMPLETED|Overall Study||24
9981356|NCT01599286|11102738|FG001|COMPLETED|Overall Study||23
9981357|NCT01599286|11102737|FG000|NOT COMPLETED|Overall Study||0
9981358|NCT01599286|11102738|FG001|NOT COMPLETED|Overall Study||0
9981359|NCT01599325|11102744|FG000|STARTED|Primary Parent Phase||72
9981360|NCT01599325|11102744|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
9981361|NCT01599325|11102744|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
9981362|NCT01599325|11102744|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
9981363|NCT01599325|11102744|FG000|NOT COMPLETED|Primary Parent Phase||57
9981364|NCT01599325|11102744|FG000|STARTED|Extension Phase||15
9981365|NCT01599325|11102744|FG000|COMPLETED|Extension Phase||0
9981366|NCT01599325|11102744|FG000|NOT COMPLETED|Extension Phase||15
9981367|NCT01599585|11102751|FG000|STARTED|Overall Study||62
9981368|NCT01599585|11102752|FG001|STARTED|Overall Study||59
9981369|NCT01599585|11102751|FG000|COMPLETED|Overall Study||40
9981370|NCT01599585|11102752|FG001|COMPLETED|Overall Study||42
9981371|NCT01599585|11102751|FG000|NOT COMPLETED|Overall Study||22
9981372|NCT01599585|11102752|FG001|NOT COMPLETED|Overall Study||17
9981373|NCT01599637|11102761|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
9981374|NCT01599637|11102762|FG001|STARTED|Overall Study||10
9981375|NCT01599637|11102763|FG002|STARTED|Overall Study||10
9981376|NCT01599637|11102761|FG000|COMPLETED|Overall Study||19
9981377|NCT01599637|11102762|FG001|COMPLETED|Overall Study||8
9981378|NCT01599637|11102763|FG002|COMPLETED|Overall Study||10
9981379|NCT01599637|11102761|FG000|NOT COMPLETED|Overall Study||1
9981380|NCT01599637|11102762|FG001|NOT COMPLETED|Overall Study||2
9981381|NCT01599637|11102763|FG002|NOT COMPLETED|Overall Study||0
9981382|NCT01599650|11102776|FG000|STARTED|Overall Study||183
9981383|NCT01599650|11102777|FG001|STARTED|Overall Study||180
9981384|NCT01599650|11102778|FG002|STARTED|Overall Study||92
9981385|NCT01599650|11102776|FG000|Completed 6 Mos|Overall Study||174
9981386|NCT01599650|11102777|FG001|Completed 6 Mos|Overall Study||170
9981387|NCT01599650|11102778|FG002|Completed 6 Mos|Overall Study||80
9981388|NCT01599650|11102776|FG000|COMPLETED|Overall Study||161
9981389|NCT01599650|11102777|FG001|COMPLETED|Overall Study||154
9981390|NCT01599650|11102778|FG002|COMPLETED|Overall Study||65
9981391|NCT01599650|11102776|FG000|NOT COMPLETED|Overall Study||22
9981392|NCT01599650|11102777|FG001|NOT COMPLETED|Overall Study||26
9981393|NCT01599650|11102778|FG002|NOT COMPLETED|Overall Study||27
9981394|NCT01599754|11102790|FG000|STARTED|Overall Study||363
9981395|NCT01599754|11102791|FG001|STARTED|Overall Study||361
9981396|NCT01599754|11102790|FG000|Treated|Overall Study||360
9981397|NCT01599754|11102791|FG001|Treated|Overall Study||360
9981398|NCT01599754|11102790|FG000|COMPLETED|Overall Study||0
9981399|NCT01599754|11102791|FG001|COMPLETED|Overall Study||1
9981400|NCT01599754|11102790|FG000|NOT COMPLETED|Overall Study||363
9981401|NCT01599754|11102791|FG001|NOT COMPLETED|Overall Study||360
9981402|NCT01599793|11102797|FG000|STARTED|Overall Study||19
9981403|NCT01599793|11102797|FG000|COMPLETED|Overall Study||17
9981404|NCT01599793|11102797|FG000|NOT COMPLETED|Overall Study||2
9981405|NCT01599806|11102803|FG000|STARTED|Overall Study||516
9981406|NCT01599806|11102804|FG001|STARTED|Overall Study||517
9981407|NCT01599806|11102803|FG000|COMPLETED|Overall Study||473
9981408|NCT01599806|11102804|FG001|COMPLETED|Overall Study||476
9981409|NCT01599806|11102803|FG000|NOT COMPLETED|Overall Study||43
9981410|NCT01599806|11102804|FG001|NOT COMPLETED|Overall Study||41
9981411|NCT01599832|11102810|FG000|STARTED|Overall Study||20
9981412|NCT01599832|11102810|FG000|COMPLETED|Overall Study||20
9981413|NCT01599832|11102810|FG000|NOT COMPLETED|Overall Study||0
9981414|NCT01600014|11102814|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
9981415|NCT01600014|11102815|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0
9981416|NCT01600014|11102814|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162
9981417|NCT01600014|11102815|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0
9981418|NCT01600014|11102814|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
9981419|NCT01600014|11102815|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
9981420|NCT01600014|11102814|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
9981421|NCT01600014|11102815|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
9981422|NCT01600014|11102814|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
9981423|NCT01600014|11102815|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
9981424|NCT01600014|11102814|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
9981425|NCT01600014|11102815|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
9981426|NCT01600014|11102814|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
9981427|NCT01600014|11102815|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
9981428|NCT01600014|11102814|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
9981429|NCT01600014|11102815|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
9981430|NCT01600014|11102814|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
9981431|NCT01600014|11102815|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
9981432|NCT01600053|11102833|FG000|STARTED|Overall Study||11
9981433|NCT01600053|11102833|FG000|COMPLETED|Overall Study||0
9981434|NCT01600053|11102833|FG000|NOT COMPLETED|Overall Study||11
9981435|NCT01600092|11102839|FG000|STARTED|Overall Study||513
9981436|NCT01600092|11102840|FG001|STARTED|Overall Study||507
9981437|NCT01600092|11102839|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
9981438|NCT01600092|11102840|FG001|Received at Least 1 Vaccination|Overall Study||504
9981439|NCT01600092|11102839|FG000|Received All 3 Vaccinations|Overall Study||500
9981440|NCT01600092|11102840|FG001|Received All 3 Vaccinations|Overall Study||494
9981441|NCT01600092|11102839|FG000|COMPLETED|Overall Study||495
9981442|NCT01600092|11102840|FG001|COMPLETED|Overall Study||491
9981443|NCT01600092|11102839|FG000|NOT COMPLETED|Overall Study||18
9981444|NCT01600092|11102840|FG001|NOT COMPLETED|Overall Study||16
9981445|NCT01600105|11102848|FG000|STARTED|Total Participants||255
9981446|NCT01600105|11102849|FG001|STARTED|Total Participants||21
9981447|NCT01600105|11102848|FG000|COMPLETED|Total Participants||214
9981448|NCT01600105|11102849|FG001|COMPLETED|Total Participants||11
9981449|NCT01600105|11102848|FG000|NOT COMPLETED|Total Participants||41
9981450|NCT01600105|11102849|FG001|NOT COMPLETED|Total Participants||10
9981451|NCT01600105|11102848|FG000|STARTED|Sub Study I||19
9981452|NCT01600105|11102849|FG001|STARTED|Sub Study I||21
9981453|NCT01600105|11102848|FG000|COMPLETED|Sub Study I||19
9981454|NCT01600105|11102849|FG001|COMPLETED|Sub Study I||11
9981455|NCT01600105|11102848|FG000|NOT COMPLETED|Sub Study I||0
9981456|NCT01600105|11102849|FG001|NOT COMPLETED|Sub Study I||10
9981457|NCT01600105|11102848|FG000|STARTED|Sub Study II||65
9981458|NCT01600105|11102849|FG001|STARTED|Sub Study II||0
9981459|NCT01600105|11102848|FG000|COMPLETED|Sub Study II||60
9981460|NCT01600105|11102849|FG001|COMPLETED|Sub Study II||0
9981461|NCT01600105|11102848|FG000|NOT COMPLETED|Sub Study II||5
9981462|NCT01600105|11102849|FG001|NOT COMPLETED|Sub Study II||0
9981463|NCT01600105|11102848|FG000|STARTED|Sub Study III||39
9981464|NCT01600105|11102849|FG001|STARTED|Sub Study III||0
9981465|NCT01600105|11102848|FG000|COMPLETED|Sub Study III||34
9981466|NCT01600105|11102849|FG001|COMPLETED|Sub Study III||0
9981467|NCT01600105|11102848|FG000|NOT COMPLETED|Sub Study III||5
9981468|NCT01600105|11102849|FG001|NOT COMPLETED|Sub Study III||0
9981469|NCT01600105|11102848|FG000|STARTED|Sub Study IV||41
9981470|NCT01600105|11102849|FG001|STARTED|Sub Study IV||8
9981471|NCT01600105|11102848|FG000|COMPLETED|Sub Study IV||41
9981472|NCT01600105|11102849|FG001|COMPLETED|Sub Study IV||8
9981473|NCT01600105|11102848|FG000|NOT COMPLETED|Sub Study IV||0
9981474|NCT01600105|11102849|FG001|NOT COMPLETED|Sub Study IV||0
9981475|NCT01600105|11102848|FG000|STARTED|Sub Study V||52
9981476|NCT01600105|11102849|FG001|STARTED|Sub Study V||0
9981477|NCT01600105|11102848|FG000|COMPLETED|Sub Study V||50
9981478|NCT01600105|11102849|FG001|COMPLETED|Sub Study V||0
9981479|NCT01600105|11102848|FG000|NOT COMPLETED|Sub Study V||2
9981480|NCT01600105|11102849|FG001|NOT COMPLETED|Sub Study V||0
9981481|NCT01600170|11102861|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
9981482|NCT01600170|11102862|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
9981483|NCT01600170|11102861|FG000|COMPLETED|Period 1||6
9981484|NCT01600170|11102862|FG001|COMPLETED|Period 1||5
9981485|NCT01600170|11102861|FG000|NOT COMPLETED|Period 1||0
9981486|NCT01600170|11102862|FG001|NOT COMPLETED|Period 1||0
9981487|NCT01600170|11102861|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
9981488|NCT01600170|11102862|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
9981489|NCT01600170|11102861|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
9981490|NCT01600170|11102862|FG001|COMPLETED|Period 2||5
9981491|NCT01600170|11102861|FG000|NOT COMPLETED|Period 2||1
9981492|NCT01600170|11102862|FG001|NOT COMPLETED|Period 2||0
9981493|NCT01600222|11102870|FG000|STARTED|Overall Study||37
9981494|NCT01600222|11102870|FG000|COMPLETED|Overall Study||35
9981495|NCT01600222|11102870|FG000|NOT COMPLETED|Overall Study||2
9981496|NCT01600287|11102877|FG000|STARTED|Overall Study||20
9981497|NCT01600287|11102878|FG001|STARTED|Overall Study||20
9981498|NCT01600287|11102877|FG000|COMPLETED|Overall Study||20
9981499|NCT01600287|11102878|FG001|COMPLETED|Overall Study||20
9981500|NCT01600287|11102877|FG000|NOT COMPLETED|Overall Study||0
9981501|NCT01600287|11102878|FG001|NOT COMPLETED|Overall Study||0
9981502|NCT01600326|11102886|FG000|STARTED|Overall Study||15
9981503|NCT01600326|11102887|FG001|STARTED|Overall Study||15
9981504|NCT01600326|11102886|FG000|Primary Outcome Measure Data Collection|Overall Study||15
9981505|NCT01600326|11102887|FG001|Primary Outcome Measure Data Collection|Overall Study||15
9981506|NCT01600326|11102886|FG000|COMPLETED|Overall Study||14
9981507|NCT01600326|11102887|FG001|COMPLETED|Overall Study||14
9981508|NCT01600326|11102886|FG000|NOT COMPLETED|Overall Study||1
9981509|NCT01600326|11102887|FG001|NOT COMPLETED|Overall Study||1
9981510|NCT01600482|11102895|FG000|STARTED|Overall Study||148
9981511|NCT01600482|11102896|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
9981512|NCT01600482|11102895|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
9981513|NCT01600482|11102896|FG001|COMPLETED|Overall Study||59
9981514|NCT01600482|11102895|FG000|NOT COMPLETED|Overall Study||0
9981515|NCT01600482|11102896|FG001|NOT COMPLETED|Overall Study||0
9981516|NCT01600495|11102904|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
9981517|NCT01600495|11102905|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
9981518|NCT01600495|11102904|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
9981519|NCT01600495|11102905|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
9981520|NCT01600495|11102904|FG000|NOT COMPLETED|Overall Study||0
9981521|NCT01600495|11102905|FG001|NOT COMPLETED|Overall Study||0
9981522|NCT01600586|11102914|FG000|STARTED|Overall Study||49
9981523|NCT01600586|11102915|FG001|STARTED|Overall Study||51
9981524|NCT01600586|11102914|FG000|COMPLETED|Overall Study||46
9981525|NCT01600586|11102915|FG001|COMPLETED|Overall Study||48
9981526|NCT01600586|11102914|FG000|NOT COMPLETED|Overall Study||3
9981527|NCT01600586|11102915|FG001|NOT COMPLETED|Overall Study||3
9981528|NCT01600638|11102928|FG000|STARTED|Overall Study||25
9981529|NCT01600638|11102928|FG000|COMPLETED|Overall Study||25
9981530|NCT01600638|11102928|FG000|NOT COMPLETED|Overall Study||0
9981531|NCT01600677|11102934|FG000|STARTED|Overall Study||7
9981532|NCT01600677|11102935|FG001|STARTED|Overall Study||4
9981533|NCT01600677|11102934|FG000|COMPLETED|Overall Study||7
9981534|NCT01600677|11102935|FG001|COMPLETED|Overall Study||4
9981535|NCT01600677|11102934|FG000|NOT COMPLETED|Overall Study||0
9981536|NCT01600677|11102935|FG001|NOT COMPLETED|Overall Study||0
9981537|NCT01600703|11102941|FG000|STARTED|First Intervention||7
9981538|NCT01600703|11102942|FG001|STARTED|First Intervention||8
9981539|NCT01600703|11102941|FG000|COMPLETED|First Intervention||7
9981540|NCT01600703|11102942|FG001|COMPLETED|First Intervention||8
9981541|NCT01600703|11102941|FG000|NOT COMPLETED|First Intervention||0
9981542|NCT01600703|11102942|FG001|NOT COMPLETED|First Intervention||0
9981543|NCT01600703|11102941|FG000|STARTED|Second Intervention||7
9981544|NCT01600703|11102942|FG001|STARTED|Second Intervention||8
9981545|NCT01600703|11102941|FG000|COMPLETED|Second Intervention||7
9981546|NCT01600703|11102942|FG001|COMPLETED|Second Intervention||8
9981547|NCT01600703|11102941|FG000|NOT COMPLETED|Second Intervention||0
9981548|NCT01600703|11102942|FG001|NOT COMPLETED|Second Intervention||0
9981549|NCT01600716|11102950|FG000|STARTED|Overall Study||66
9981550|NCT01600716|11102951|FG001|STARTED|Overall Study||78
9981551|NCT01600716|11102950|FG000|COMPLETED|Overall Study||59
9981552|NCT01600716|11102951|FG001|COMPLETED|Overall Study||71
9981553|NCT01600716|11102950|FG000|NOT COMPLETED|Overall Study||7
9981554|NCT01600716|11102951|FG001|NOT COMPLETED|Overall Study||7
9981555|NCT01600729|11102959|FG000|STARTED|Overall Study||66
9981556|NCT01600729|11102959|FG000|COMPLETED|Overall Study||65
9981557|NCT01600729|11102959|FG000|NOT COMPLETED|Overall Study||1
9981558|NCT01600885|11102963|FG000|STARTED|First Period||10
9981559|NCT01600885|11102964|FG001|STARTED|First Period||9
9981560|NCT01600885|11102963|FG000|COMPLETED|First Period||8
9981561|NCT01600885|11102964|FG001|COMPLETED|First Period||8
9981562|NCT01600885|11102963|FG000|NOT COMPLETED|First Period||2
9981563|NCT01600885|11102964|FG001|NOT COMPLETED|First Period||1
9981564|NCT01600885|11102963|FG000|STARTED|Wash Out Period||8
9981565|NCT01600885|11102964|FG001|STARTED|Wash Out Period||8
9981566|NCT01600885|11102963|FG000|COMPLETED|Wash Out Period||8
9981567|NCT01600885|11102964|FG001|COMPLETED|Wash Out Period||8
9981568|NCT01600885|11102963|FG000|NOT COMPLETED|Wash Out Period||0
9981569|NCT01600885|11102964|FG001|NOT COMPLETED|Wash Out Period||0
9981570|NCT01600885|11102963|FG000|STARTED|Second Period||8
9981571|NCT01600885|11102964|FG001|STARTED|Second Period||8
9981572|NCT01600885|11102963|FG000|COMPLETED|Second Period||8
9981573|NCT01600885|11102964|FG001|COMPLETED|Second Period||8
9981574|NCT01600885|11102963|FG000|NOT COMPLETED|Second Period||0
9981575|NCT01600885|11102964|FG001|NOT COMPLETED|Second Period||0
9981576|NCT01600950|11102970|FG000|STARTED|Period 1||10
9981577|NCT01600950|11102971|FG001|STARTED|Period 1||10
9981578|NCT01600950|11102970|FG000|COMPLETED|Period 1||10
9981579|NCT01600950|11102971|FG001|COMPLETED|Period 1||10
9981580|NCT01600950|11102970|FG000|NOT COMPLETED|Period 1||0
9981581|NCT01600950|11102971|FG001|NOT COMPLETED|Period 1||0
9981582|NCT01600950|11102970|FG000|STARTED|Period 2||10
9981583|NCT01600950|11102971|FG001|STARTED|Period 2||10
9981584|NCT01600950|11102970|FG000|COMPLETED|Period 2||10
9981585|NCT01600950|11102971|FG001|COMPLETED|Period 2||10
9981586|NCT01600950|11102970|FG000|NOT COMPLETED|Period 2||0
9981587|NCT01600950|11102971|FG001|NOT COMPLETED|Period 2||0
9981588|NCT01601067|11102979|FG000|STARTED|Overall Study||63
9981589|NCT01601067|11102980|FG001|STARTED|Overall Study||56
9981590|NCT01601067|11102979|FG000|COMPLETED|Overall Study||30
9981591|NCT01601067|11102980|FG001|COMPLETED|Overall Study||34
9981592|NCT01601067|11102979|FG000|NOT COMPLETED|Overall Study||33
9981593|NCT01601067|11102980|FG001|NOT COMPLETED|Overall Study||22
9981594|NCT01601132|11102986|FG000|STARTED|Overall Study||30
9981595|NCT01601132|11102986|FG000|COMPLETED|Overall Study||28
9981596|NCT01601132|11102986|FG000|NOT COMPLETED|Overall Study||2
9981597|NCT01601236|11102999|FG000|STARTED|Overall Study||7
9981598|NCT01601236|11103000|FG001|STARTED|Overall Study||3
9981599|NCT01601236|11103001|FG002|STARTED|Overall Study||14
9981600|NCT01601236|11103002|FG003|STARTED|Overall Study||6
9981601|NCT01601236|11103003|FG004|STARTED|Overall Study||3
9981602|NCT01601236|11103004|FG005|STARTED|Overall Study||1
9981603|NCT01601236|11102999|FG000|COMPLETED|Overall Study||2
9981604|NCT01601236|11103000|FG001|COMPLETED|Overall Study||2
9981605|NCT01601236|11103001|FG002|COMPLETED|Overall Study||8
9981606|NCT01601236|11103002|FG003|COMPLETED|Overall Study||4
9981607|NCT01601236|11103003|FG004|COMPLETED|Overall Study||0
9981608|NCT01601236|11103004|FG005|COMPLETED|Overall Study||0
9981609|NCT01601236|11102999|FG000|NOT COMPLETED|Overall Study||5
9981610|NCT01601236|11103000|FG001|NOT COMPLETED|Overall Study||1
9981611|NCT01601236|11103001|FG002|NOT COMPLETED|Overall Study||6
9981612|NCT01601236|11103002|FG003|NOT COMPLETED|Overall Study||2
9981613|NCT01601236|11103003|FG004|NOT COMPLETED|Overall Study||3
9981614|NCT01601236|11103004|FG005|NOT COMPLETED|Overall Study||1
9981615|NCT01601431|11103015|FG000|STARTED|Overall Study||223
9981616|NCT01601431|11103016|FG001|STARTED|Overall Study||217
9981617|NCT01601431|11103015|FG000|COMPLETED|Overall Study||211
9981618|NCT01601431|11103016|FG001|COMPLETED|Overall Study||214
9981619|NCT01601431|11103015|FG000|NOT COMPLETED|Overall Study||12
9981620|NCT01601431|11103016|FG001|NOT COMPLETED|Overall Study||3
9981621|NCT01601470|11103022|FG000|STARTED|Period 1 - Sildenafil||28
9981622|NCT01601470|11103022|FG000|PK Analysis Set|Period 1 - Sildenafil||28
9981623|NCT01601470|11103022|FG000|Safety Set|Period 1 - Sildenafil||28
9981624|NCT01601470|11103022|FG000|COMPLETED|Period 1 - Sildenafil||28
9981625|NCT01601470|11103022|FG000|NOT COMPLETED|Period 1 - Sildenafil||0
9981626|NCT01601470|11103022|FG000|STARTED|Period 2 - LCZ696||28
9981627|NCT01601470|11103022|FG000|PK Analysis Set|Period 2 - LCZ696||27
9981628|NCT01601470|11103022|FG000|Safety Set|Period 2 - LCZ696||27
9981629|NCT01601470|11103022|FG000|COMPLETED|Period 2 - LCZ696||27
9981630|NCT01601470|11103022|FG000|NOT COMPLETED|Period 2 - LCZ696||1
9981631|NCT01601470|11103022|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27
9981632|NCT01601470|11103022|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
9981633|NCT01601470|11103022|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27
9981634|NCT01601470|11103022|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27
9981635|NCT01601470|11103022|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
9981636|NCT01601496|11103028|FG000|STARTED|Overall Study|Enrolled|117
9981637|NCT01601496|11103028|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102
9981638|NCT01601496|11103028|FG000|NOT COMPLETED|Overall Study||15
9981639|NCT01601535|11103038|FG000|STARTED|Phase 1||6
9981640|NCT01601535|11103039|FG001|STARTED|Phase 1||6
9981641|NCT01601535|11103040|FG002|STARTED|Phase 1||6
9981642|NCT01601535|11103041|FG003|STARTED|Phase 1||4
9981643|NCT01601535|11103042|FG004|STARTED|Phase 1||0
9981644|NCT01601535|11103043|FG005|STARTED|Phase 1||0
9981645|NCT01601535|11103038|FG000|COMPLETED|Phase 1||0
9981646|NCT01601535|11103039|FG001|COMPLETED|Phase 1||0
9981647|NCT01601535|11103040|FG002|COMPLETED|Phase 1||1
9981648|NCT01601535|11103041|FG003|COMPLETED|Phase 1||0
9981649|NCT01601535|11103042|FG004|COMPLETED|Phase 1||0
9981650|NCT01601535|11103043|FG005|COMPLETED|Phase 1||0
9981651|NCT01601535|11103038|FG000|NOT COMPLETED|Phase 1||6
9981652|NCT01601535|11103039|FG001|NOT COMPLETED|Phase 1||6
9981653|NCT01601535|11103040|FG002|NOT COMPLETED|Phase 1||5
9981654|NCT01601535|11103041|FG003|NOT COMPLETED|Phase 1||4
9981655|NCT01601535|11103042|FG004|NOT COMPLETED|Phase 1||0
9981656|NCT01601535|11103043|FG005|NOT COMPLETED|Phase 1||0
9981657|NCT01601535|11103038|FG000|STARTED|Phase 2||0
9981658|NCT01601535|11103039|FG001|STARTED|Phase 2||0
9981659|NCT01601535|11103040|FG002|STARTED|Phase 2||0
9981660|NCT01601535|11103041|FG003|STARTED|Phase 2||0
9981661|NCT01601535|11103042|FG004|STARTED|Phase 2||20
9981662|NCT01601535|11103043|FG005|STARTED|Phase 2||12
9981663|NCT01601535|11103038|FG000|COMPLETED|Phase 2||0
9981664|NCT01601535|11103039|FG001|COMPLETED|Phase 2||0
9981665|NCT01601535|11103040|FG002|COMPLETED|Phase 2||0
9981666|NCT01601535|11103041|FG003|COMPLETED|Phase 2||0
9981667|NCT01601535|11103042|FG004|COMPLETED|Phase 2||1
9981668|NCT01601535|11103043|FG005|COMPLETED|Phase 2||0
9981669|NCT01601535|11103038|FG000|NOT COMPLETED|Phase 2||0
9981670|NCT01601535|11103039|FG001|NOT COMPLETED|Phase 2||0
9981671|NCT01601535|11103040|FG002|NOT COMPLETED|Phase 2||0
9981672|NCT01601535|11103041|FG003|NOT COMPLETED|Phase 2||0
9981673|NCT01601535|11103042|FG004|NOT COMPLETED|Phase 2||19
9981674|NCT01601535|11103043|FG005|NOT COMPLETED|Phase 2||12
9981675|NCT01601626|11103069|FG000|STARTED|Overall Study||24
9981676|NCT01601626|11103070|FG001|STARTED|Overall Study||24
9981677|NCT01601626|11103071|FG002|STARTED|Overall Study||23
9981678|NCT01601626|11103069|FG000|COMPLETED|Overall Study||21
9981679|NCT01601626|11103070|FG001|COMPLETED|Overall Study||19
9981680|NCT01601626|11103071|FG002|COMPLETED|Overall Study||21
9981681|NCT01601626|11103069|FG000|NOT COMPLETED|Overall Study||3
9981682|NCT01601626|11103070|FG001|NOT COMPLETED|Overall Study||5
9981683|NCT01601626|11103071|FG002|NOT COMPLETED|Overall Study||2
9981684|NCT01601652|11103079|FG000|STARTED|Overall Study||12
9981685|NCT01601652|11103079|FG000|COMPLETED|Overall Study||11
9981686|NCT01601652|11103079|FG000|NOT COMPLETED|Overall Study||1
9981687|NCT01601691|11103083|FG000|STARTED|Overall Study||10
9981688|NCT01601691|11103083|FG000|COMPLETED|Overall Study||10
9981689|NCT01601691|11103083|FG000|NOT COMPLETED|Overall Study||0
9981690|NCT01601704|11103089|FG000|STARTED|Overall Study||4456
9981691|NCT01601704|11103090|FG001|STARTED|Overall Study||4454
9981692|NCT01601704|11103089|FG000|Treated|Overall Study||4455
9981693|NCT01601704|11103090|FG001|Treated|Overall Study||4450
9981694|NCT01601704|11103089|FG000|COMPLETED|Overall Study||4455
9981695|NCT01601704|11103090|FG001|COMPLETED|Overall Study||4450
9981696|NCT01601704|11103089|FG000|NOT COMPLETED|Overall Study||1
9981697|NCT01601704|11103090|FG001|NOT COMPLETED|Overall Study||4
9981698|NCT01601782|11103096|FG000|STARTED|Overall Study||16
9981699|NCT01601782|11103096|FG000|COMPLETED|Overall Study||16
9981700|NCT01601782|11103096|FG000|NOT COMPLETED|Overall Study||0
9981701|NCT01601821|11103102|FG000|STARTED|Overall Study||125
9981702|NCT01601821|11103103|FG001|STARTED|Overall Study||120
9981703|NCT01601821|11103102|FG000|COMPLETED|Overall Study||96
9981704|NCT01601821|11103103|FG001|COMPLETED|Overall Study||91
9981705|NCT01601821|11103102|FG000|NOT COMPLETED|Overall Study||29
9981706|NCT01601821|11103103|FG001|NOT COMPLETED|Overall Study||29
9981707|NCT01601847|11103111|FG000|STARTED|Overall Study||153
9981708|NCT01601847|11103112|FG001|STARTED|Overall Study||147
9981709|NCT01601847|11103111|FG000|COMPLETED|Overall Study||140
9981710|NCT01601847|11103112|FG001|COMPLETED|Overall Study||137
9981711|NCT01601847|11103111|FG000|NOT COMPLETED|Overall Study||13
9981712|NCT01601847|11103112|FG001|NOT COMPLETED|Overall Study||10
9981713|NCT01601860|11103120|FG000|STARTED|Overall Study||40
9981714|NCT01601860|11103121|FG001|STARTED|Overall Study||40
9981715|NCT01601860|11103120|FG000|COMPLETED|Overall Study||19
9981716|NCT01601860|11103121|FG001|COMPLETED|Overall Study||31
9981717|NCT01601860|11103120|FG000|NOT COMPLETED|Overall Study||21
9981718|NCT01601860|11103121|FG001|NOT COMPLETED|Overall Study||9
9981719|NCT01601873|11103130|FG000|STARTED|Overall Study||50
9981720|NCT01601873|11103131|FG001|STARTED|Overall Study||47
9981721|NCT01601873|11103130|FG000|COMPLETED|Overall Study||48
9981722|NCT01601873|11103131|FG001|COMPLETED|Overall Study||44
9981723|NCT01601873|11103130|FG000|NOT COMPLETED|Overall Study||2
9981724|NCT01601873|11103131|FG001|NOT COMPLETED|Overall Study||3
9981725|NCT01601977|11103137|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
9981726|NCT01601977|11103137|FG000|COMPLETED|Overall Study||10
9981727|NCT01601977|11103137|FG000|NOT COMPLETED|Overall Study||0
9981728|NCT01602068|11103145|FG000|STARTED|Overall Study|Day before surgery|23
9981729|NCT01602068|11103146|FG001|STARTED|Overall Study|Day before surgery|22
9981730|NCT01602068|11103145|FG000|COMPLETED|Overall Study||23
9981731|NCT01602068|11103146|FG001|COMPLETED|Overall Study||22
9981732|NCT01602068|11103145|FG000|NOT COMPLETED|Overall Study||0
9981733|NCT01602068|11103146|FG001|NOT COMPLETED|Overall Study||0
9981734|NCT01602120|11103156|FG000|STARTED|Overall Study||29
9981735|NCT01602120|11103157|FG001|STARTED|Overall Study||60
9981736|NCT01602120|11103158|FG002|STARTED|Overall Study||17
9981737|NCT01602120|11103159|FG003|STARTED|Overall Study||53
9981738|NCT01602120|11103156|FG000|COMPLETED|Overall Study||0
9981739|NCT01602120|11103157|FG001|COMPLETED|Overall Study||0
9981740|NCT01602120|11103158|FG002|COMPLETED|Overall Study||0
9981741|NCT01602120|11103159|FG003|COMPLETED|Overall Study||0
9981742|NCT01602120|11103156|FG000|NOT COMPLETED|Overall Study||29
9981743|NCT01602120|11103157|FG001|NOT COMPLETED|Overall Study||60
9981744|NCT01602120|11103158|FG002|NOT COMPLETED|Overall Study||17
9981745|NCT01602120|11103159|FG003|NOT COMPLETED|Overall Study||53
9981746|NCT01602172|11103174|FG000|STARTED|Overall Study||37
9981747|NCT01602172|11103175|FG001|STARTED|Overall Study||23
9981748|NCT01602172|11103176|FG002|STARTED|Overall Study||22
9981749|NCT01602172|11103174|FG000|COMPLETED|Overall Study||32
9981750|NCT01602172|11103175|FG001|COMPLETED|Overall Study||17
9981751|NCT01602172|11103176|FG002|COMPLETED|Overall Study||22
9981752|NCT01602172|11103174|FG000|NOT COMPLETED|Overall Study||5
9981753|NCT01602172|11103175|FG001|NOT COMPLETED|Overall Study||6
9981754|NCT01602172|11103176|FG002|NOT COMPLETED|Overall Study||0
9981755|NCT01602224|11103193|FG000|STARTED|Overall Study||74
9981756|NCT01602224|11103194|FG001|STARTED|Overall Study||74
9981757|NCT01602224|11103195|FG002|STARTED|Overall Study||72
9981758|NCT01602224|11103193|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
9981759|NCT01602224|11103194|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
9981760|NCT01602224|11103195|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
9981761|NCT01602224|11103193|FG000|COMPLETED|Overall Study||66
9981762|NCT01602224|11103194|FG001|COMPLETED|Overall Study||66
9981763|NCT01602224|11103195|FG002|COMPLETED|Overall Study||66
9981764|NCT01602224|11103193|FG000|NOT COMPLETED|Overall Study||8
9981765|NCT01602224|11103194|FG001|NOT COMPLETED|Overall Study||8
9981766|NCT01602224|11103195|FG002|NOT COMPLETED|Overall Study||6
9981767|NCT01602315|11103212|FG000|STARTED|Overall Study||16
9981768|NCT01602315|11103213|FG001|STARTED|Overall Study||5
9981769|NCT01602315|11103214|FG002|STARTED|Overall Study||18
10099706|NCT02393378|11228834|FG001|COMPLETED|Overall Study||4
10099707|NCT02393378|11228833|FG000|NOT COMPLETED|Overall Study||0
10099708|NCT02393378|11228834|FG001|NOT COMPLETED|Overall Study||0
10099709|NCT02393417|11228844|FG000|STARTED|Overall Study||43
10099710|NCT02393417|11228845|FG001|STARTED|Overall Study||45
10099711|NCT02393417|11228846|FG002|STARTED|Overall Study||40
10099712|NCT02393417|11228847|FG003|STARTED|Overall Study||41
10099713|NCT02393417|11228844|FG000|Completed Treatment|Overall Study||30
10099714|NCT02393417|11228845|FG001|Completed Treatment|Overall Study||34
10099715|NCT02393417|11228846|FG002|Completed Treatment|Overall Study||32
10099716|NCT02393417|11228847|FG003|Completed Treatment|Overall Study||30
10099717|NCT02393417|11228844|FG000|COMPLETED|Overall Study||28
10099718|NCT02393417|11228845|FG001|COMPLETED|Overall Study||32
10099719|NCT02393417|11228846|FG002|COMPLETED|Overall Study||30
10099720|NCT02393417|11228847|FG003|COMPLETED|Overall Study||29
10099721|NCT02393417|11228844|FG000|NOT COMPLETED|Overall Study||15
10099722|NCT02393417|11228845|FG001|NOT COMPLETED|Overall Study||13
10099723|NCT02393417|11228846|FG002|NOT COMPLETED|Overall Study||10
10099724|NCT02393417|11228847|FG003|NOT COMPLETED|Overall Study||12
10099725|NCT02393547|11228858|FG000|STARTED|Overall Study||20
10099726|NCT02393547|11228858|FG000|COMPLETED|Overall Study||14
10099727|NCT02393547|11228858|FG000|NOT COMPLETED|Overall Study||6
10099728|NCT02393677|11228864|FG000|STARTED|Overall Study||40
10099729|NCT02393677|11228865|FG001|STARTED|Overall Study||40
10099730|NCT02393677|11228864|FG000|COMPLETED|Overall Study||40
10099731|NCT02393677|11228865|FG001|COMPLETED|Overall Study||40
10099732|NCT02393677|11228864|FG000|NOT COMPLETED|Overall Study||0
10099733|NCT02393677|11228865|FG001|NOT COMPLETED|Overall Study||0
9981770|NCT01602315|11103215|FG003|STARTED|Overall Study||6
9981771|NCT01602315|11103216|FG004|STARTED|Overall Study||71
9981772|NCT01602315|11103217|FG005|STARTED|Overall Study||35
9981773|NCT01602315|11103218|FG006|STARTED|Overall Study||29
9981774|NCT01602315|11103212|FG000|COMPLETED|Overall Study||0
9981775|NCT01602315|11103213|FG001|COMPLETED|Overall Study||0
9981776|NCT01602315|11103214|FG002|COMPLETED|Overall Study||0
9981777|NCT01602315|11103215|FG003|COMPLETED|Overall Study||0
9981778|NCT01602315|11103216|FG004|COMPLETED|Overall Study||0
9981779|NCT01602315|11103217|FG005|COMPLETED|Overall Study||0
9981780|NCT01602315|11103218|FG006|COMPLETED|Overall Study||0
9981781|NCT01602315|11103212|FG000|NOT COMPLETED|Overall Study||16
9981782|NCT01602315|11103213|FG001|NOT COMPLETED|Overall Study||5
9981783|NCT01602315|11103214|FG002|NOT COMPLETED|Overall Study||18
9981784|NCT01602315|11103215|FG003|NOT COMPLETED|Overall Study||6
9981785|NCT01602315|11103216|FG004|NOT COMPLETED|Overall Study||71
9981786|NCT01602315|11103217|FG005|NOT COMPLETED|Overall Study||35
9981787|NCT01602315|11103218|FG006|NOT COMPLETED|Overall Study||29
9981788|NCT01602341|11103256|FG000|STARTED|Overall Study||44
9981789|NCT01602341|11103257|FG001|STARTED|Overall Study||42
9981790|NCT01602341|11103256|FG000|COMPLETED|Overall Study||44
9981791|NCT01602341|11103257|FG001|COMPLETED|Overall Study||41
9981792|NCT01602341|11103256|FG000|NOT COMPLETED|Overall Study||0
9981793|NCT01602341|11103257|FG001|NOT COMPLETED|Overall Study||1
10099734|NCT02393755|11228873|FG000|STARTED|Overall Study||3
10099735|NCT02393755|11228874|FG001|STARTED|Overall Study||39
10099736|NCT02393755|11228873|FG000|COMPLETED|Overall Study||3
10099737|NCT02393755|11228874|FG001|COMPLETED|Overall Study||32
9981794|NCT01602419|11103267|FG000|STARTED|Overall Study||120
9981795|NCT01602419|11103267|FG000|SAF Population|Overall Study||111
9981796|NCT01602419|11103267|FG000|ITT Population|Overall Study||102
9981797|NCT01602419|11103267|FG000|EFF Population|Overall Study||91
9981798|NCT01602419|11103267|FG000|COMPLETED|Overall Study||91
9981799|NCT01602419|11103267|FG000|NOT COMPLETED|Overall Study||29
9981800|NCT01602484|11103314|FG000|STARTED|Overall Study||25
9981801|NCT01602484|11103315|FG001|STARTED|Overall Study||25
9981802|NCT01602484|11103314|FG000|COMPLETED|Overall Study||25
9981803|NCT01602484|11103315|FG001|COMPLETED|Overall Study||24
9981804|NCT01602484|11103314|FG000|NOT COMPLETED|Overall Study||0
9981805|NCT01602484|11103315|FG001|NOT COMPLETED|Overall Study||1
9981806|NCT01602510|11103321|FG000|STARTED|Open Label Phase||420
9981807|NCT01602510|11103322|FG001|STARTED|Open Label Phase||0
9981808|NCT01602510|11103323|FG002|STARTED|Open Label Phase||0
9981809|NCT01602510|11103321|FG000|COMPLETED|Open Label Phase||117
9981810|NCT01602510|11103322|FG001|COMPLETED|Open Label Phase||0
9981811|NCT01602510|11103323|FG002|COMPLETED|Open Label Phase||0
9981812|NCT01602510|11103321|FG000|NOT COMPLETED|Open Label Phase||303
9981813|NCT01602510|11103322|FG001|NOT COMPLETED|Open Label Phase||0
9981814|NCT01602510|11103323|FG002|NOT COMPLETED|Open Label Phase||0
9981815|NCT01602510|11103321|FG000|STARTED|Randomized Phase||0
9981816|NCT01602510|11103322|FG001|STARTED|Randomized Phase||133
9981817|NCT01602510|11103323|FG002|STARTED|Randomized Phase||131
9981818|NCT01602510|11103321|FG000|COMPLETED|Randomized Phase||0
9981819|NCT01602510|11103322|FG001|COMPLETED|Randomized Phase||59
9981820|NCT01602510|11103323|FG002|COMPLETED|Randomized Phase||58
9981821|NCT01602510|11103321|FG000|NOT COMPLETED|Randomized Phase||0
9981822|NCT01602510|11103322|FG001|NOT COMPLETED|Randomized Phase||74
9981823|NCT01602510|11103323|FG002|NOT COMPLETED|Randomized Phase||73
9981824|NCT01602549|11103331|FG000|STARTED|Overall Study||19
9981825|NCT01602549|11103332|FG001|STARTED|Overall Study||38
9981826|NCT01602549|11103331|FG000|COMPLETED|Overall Study||18
9981827|NCT01602549|11103332|FG001|COMPLETED|Overall Study||37
9981828|NCT01602549|11103331|FG000|NOT COMPLETED|Overall Study||1
9981829|NCT01602549|11103332|FG001|NOT COMPLETED|Overall Study||1
10017941|NCT01820260|11140879|FG013|COMPLETED|Phase 2 (Part 2)||31
10017942|NCT01820260|11140866|FG000|NOT COMPLETED|Phase 2 (Part 2)||0
10017943|NCT01820260|11140867|FG001|NOT COMPLETED|Phase 2 (Part 2)||0
10017944|NCT01820260|11140868|FG002|NOT COMPLETED|Phase 2 (Part 2)||0
10017945|NCT01820260|11140869|FG003|NOT COMPLETED|Phase 2 (Part 2)||0
10017946|NCT01820260|11140870|FG004|NOT COMPLETED|Phase 2 (Part 2)||0
10017947|NCT01820260|11140871|FG005|NOT COMPLETED|Phase 2 (Part 2)||0
10017948|NCT01820260|11140872|FG006|NOT COMPLETED|Phase 2 (Part 2)||0
10017949|NCT01820260|11140873|FG007|NOT COMPLETED|Phase 2 (Part 2)||0
10017950|NCT01820260|11140874|FG008|NOT COMPLETED|Phase 2 (Part 2)||0
10017951|NCT01820260|11140875|FG009|NOT COMPLETED|Phase 2 (Part 2)||1
10017952|NCT01820260|11140876|FG010|NOT COMPLETED|Phase 2 (Part 2)||0
10017953|NCT01820260|11140877|FG011|NOT COMPLETED|Phase 2 (Part 2)||0
10017954|NCT01820260|11140878|FG012|NOT COMPLETED|Phase 2 (Part 2)||0
10017955|NCT01820260|11140879|FG013|NOT COMPLETED|Phase 2 (Part 2)||0
10017956|NCT01820364|11140915|FG000|STARTED|Part I: LGX818||15
10017957|NCT01820364|11140916|FG001|STARTED|Part I: LGX818||0
10017958|NCT01820364|11140915|FG000|COMPLETED|Part I: LGX818||1
10017959|NCT01820364|11140916|FG001|COMPLETED|Part I: LGX818||0
10017960|NCT01820364|11140915|FG000|NOT COMPLETED|Part I: LGX818||14
10017961|NCT01820364|11140916|FG001|NOT COMPLETED|Part I: LGX818||0
10017962|NCT01820364|11140915|FG000|STARTED|Part II: LGX818 + MEK162||0
10017963|NCT01820364|11140916|FG001|STARTED|Part II: LGX818 + MEK162||1
10017964|NCT01820364|11140915|FG000|COMPLETED|Part II: LGX818 + MEK162||0
10017965|NCT01820364|11140916|FG001|COMPLETED|Part II: LGX818 + MEK162||0
10017966|NCT01820364|11140915|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0
10017967|NCT01820364|11140916|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1
10017968|NCT01820416|11140925|FG000|STARTED|Overall Study||12
10017969|NCT01820416|11140926|FG001|STARTED|Overall Study||12
10017970|NCT01820416|11140927|FG002|STARTED|Overall Study||11
10017971|NCT01820416|11140925|FG000|COMPLETED|Overall Study||9
10017972|NCT01820416|11140926|FG001|COMPLETED|Overall Study||10
10017973|NCT01820416|11140927|FG002|COMPLETED|Overall Study||11
10017974|NCT01820416|11140925|FG000|NOT COMPLETED|Overall Study||3
10017975|NCT01820416|11140926|FG001|NOT COMPLETED|Overall Study||2
10017976|NCT01820416|11140927|FG002|NOT COMPLETED|Overall Study||0
10017977|NCT01820559|11140938|FG000|STARTED|Overall Study||136
10017978|NCT01820559|11140939|FG001|STARTED|Overall Study||135
10017979|NCT01820559|11140940|FG002|STARTED|Overall Study||139
10017980|NCT01820559|11140938|FG000|Randomized and Treated|Overall Study||136
10017981|NCT01820559|11140939|FG001|Randomized and Treated|Overall Study||135
10017982|NCT01820559|11140940|FG002|Randomized and Treated|Overall Study||139
10017983|NCT01820559|11140938|FG000|Completed Tutration Period|Overall Study||130
10017984|NCT01820559|11140939|FG001|Completed Tutration Period|Overall Study||134
10017985|NCT01820559|11140940|FG002|Completed Tutration Period|Overall Study||131
10017986|NCT01820559|11140938|FG000|Entered Maintenance Period|Overall Study||129
10017987|NCT01820559|11140939|FG001|Entered Maintenance Period|Overall Study||133
10017988|NCT01820559|11140940|FG002|Entered Maintenance Period|Overall Study||129
10017989|NCT01820559|11140938|FG000|Completed Maintenance Period|Overall Study||122
10017990|NCT01820559|11140939|FG001|Completed Maintenance Period|Overall Study||123
10017991|NCT01820559|11140940|FG002|Completed Maintenance Period|Overall Study||110
10017992|NCT01820559|11140938|FG000|COMPLETED|Overall Study||122
10017993|NCT01820559|11140939|FG001|COMPLETED|Overall Study||122
10017994|NCT01820559|11140940|FG002|COMPLETED|Overall Study||110
10017995|NCT01820559|11140938|FG000|NOT COMPLETED|Overall Study||14
10017996|NCT01820559|11140939|FG001|NOT COMPLETED|Overall Study||13
10017997|NCT01820559|11140940|FG002|NOT COMPLETED|Overall Study||29
10019155|NCT01828073|11142293|FG001|NOT COMPLETED|Overall Study||2
10019156|NCT01828164|11142305|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
10019157|NCT01828164|11142305|FG000|COMPLETED|Overall Study||32
10019158|NCT01828164|11142305|FG000|NOT COMPLETED|Overall Study||17
10019159|NCT01828216|11142315|FG000|STARTED|Overall Study||159
10019160|NCT01828216|11142316|FG001|STARTED|Overall Study||157
10019161|NCT01828216|11142315|FG000|COMPLETED|Overall Study||159
10019162|NCT01828216|11142316|FG001|COMPLETED|Overall Study||157
10019163|NCT01828216|11142315|FG000|NOT COMPLETED|Overall Study||0
9981830|NCT01602562|11103342|FG000|STARTED|Overall Study||21
9981831|NCT01602562|11103343|FG001|STARTED|Overall Study||19
9981832|NCT01602562|11103342|FG000|COMPLETED|Overall Study||16
9981833|NCT01602562|11103343|FG001|COMPLETED|Overall Study||16
9981834|NCT01602562|11103342|FG000|NOT COMPLETED|Overall Study||5
9981835|NCT01602562|11103343|FG001|NOT COMPLETED|Overall Study||3
9981836|NCT01602614|11103354|FG000|STARTED|Overall Study||0
9981837|NCT01602614|11103355|FG001|STARTED|Overall Study||10
9981838|NCT01602614|11103356|FG002|STARTED|Overall Study||8
9981839|NCT01602614|11103357|FG003|STARTED|Overall Study||0
9981840|NCT01602614|11103354|FG000|COMPLETED|Overall Study||0
9981841|NCT01602614|11103355|FG001|COMPLETED|Overall Study||10
9981842|NCT01602614|11103356|FG002|COMPLETED|Overall Study||8
9981843|NCT01602614|11103357|FG003|COMPLETED|Overall Study||0
9981844|NCT01602614|11103354|FG000|NOT COMPLETED|Overall Study||0
9981845|NCT01602614|11103355|FG001|NOT COMPLETED|Overall Study||0
9981846|NCT01602614|11103356|FG002|NOT COMPLETED|Overall Study||0
9981847|NCT01602614|11103357|FG003|NOT COMPLETED|Overall Study||0
9981848|NCT01602679|11103373|FG000|STARTED|Overall Study||4
9981849|NCT01602679|11103374|FG001|STARTED|Overall Study||3
9981850|NCT01602679|11103373|FG000|COMPLETED|Overall Study||4
9981851|NCT01602679|11103374|FG001|COMPLETED|Overall Study||3
9981852|NCT01602679|11103373|FG000|NOT COMPLETED|Overall Study||0
9981853|NCT01602679|11103374|FG001|NOT COMPLETED|Overall Study||0
9981854|NCT01602692|11103382|FG000|STARTED|Overall Study||20
9981855|NCT01602692|11103383|FG001|STARTED|Overall Study||20
9981856|NCT01602692|11103382|FG000|COMPLETED|Overall Study||20
9981857|NCT01602692|11103383|FG001|COMPLETED|Overall Study||20
9981858|NCT01602692|11103382|FG000|NOT COMPLETED|Overall Study||0
9981859|NCT01602692|11103383|FG001|NOT COMPLETED|Overall Study||0
9981860|NCT01602731|11103393|FG000|STARTED|Overall Study||45
9981861|NCT01602731|11103393|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
9981862|NCT01602731|11103393|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
9981863|NCT01602731|11103393|FG000|COMPLETED|Overall Study||15
9981864|NCT01602731|11103393|FG000|NOT COMPLETED|Overall Study||30
9981865|NCT01602744|11103401|FG000|STARTED|Overall Study||176
9981866|NCT01602744|11103402|FG001|STARTED|Overall Study||183
9981867|NCT01602744|11103401|FG000|COMPLETED|Overall Study||146
9981868|NCT01602744|11103402|FG001|COMPLETED|Overall Study||160
9981869|NCT01602744|11103401|FG000|NOT COMPLETED|Overall Study||30
9981870|NCT01602744|11103402|FG001|NOT COMPLETED|Overall Study||23
9981871|NCT01602965|11103410|FG000|STARTED|Overall Study||20
9981872|NCT01602965|11103411|FG001|STARTED|Overall Study||20
9981873|NCT01602965|11103410|FG000|COMPLETED|Overall Study||16
9981874|NCT01602965|11103411|FG001|COMPLETED|Overall Study||18
9981875|NCT01602965|11103410|FG000|NOT COMPLETED|Overall Study||4
9981876|NCT01602965|11103411|FG001|NOT COMPLETED|Overall Study||2
9981877|NCT01603056|11103419|FG000|STARTED|Overall Study||413
9981878|NCT01603056|11103420|FG001|STARTED|Overall Study||204
9981879|NCT01603056|11103419|FG000|COMPLETED|Overall Study||379
9981880|NCT01603056|11103420|FG001|COMPLETED|Overall Study||190
9981881|NCT01603056|11103419|FG000|NOT COMPLETED|Overall Study||34
9981882|NCT01603056|11103420|FG001|NOT COMPLETED|Overall Study||14
9981883|NCT01603082|11103428|FG000|STARTED|Overall Study|Randomized|51
9981884|NCT01603082|11103429|FG001|STARTED|Overall Study|Randomized|49
9981885|NCT01603082|11103428|FG000|COMPLETED|Overall Study|Completed the study.|49
9981886|NCT01603082|11103429|FG001|COMPLETED|Overall Study|Completed the study|48
9981887|NCT01603082|11103428|FG000|NOT COMPLETED|Overall Study||2
9981888|NCT01603082|11103429|FG001|NOT COMPLETED|Overall Study||1
9981889|NCT01603277|11103437|FG000|STARTED|Overall Study||78
9981890|NCT01603277|11103438|FG001|STARTED|Overall Study||82
9981891|NCT01603277|11103437|FG000|COMPLETED|Overall Study||64
9981892|NCT01603277|11103438|FG001|COMPLETED|Overall Study||64
9981893|NCT01603277|11103437|FG000|NOT COMPLETED|Overall Study||14
9981894|NCT01603277|11103438|FG001|NOT COMPLETED|Overall Study||18
9981895|NCT01603355|11103444|FG000|STARTED|Overall Study||3
9981896|NCT01603355|11103444|FG000|COMPLETED|Overall Study||1
9981897|NCT01603355|11103444|FG000|NOT COMPLETED|Overall Study||2
9981898|NCT01603368|11103450|FG000|STARTED|Overall Study||68
9981899|NCT01603368|11103451|FG001|STARTED|Overall Study||66
9981900|NCT01603368|11103450|FG000|COMPLETED|Overall Study||68
9981901|NCT01603368|11103451|FG001|COMPLETED|Overall Study||66
9981902|NCT01603368|11103450|FG000|NOT COMPLETED|Overall Study||0
9981903|NCT01603368|11103451|FG001|NOT COMPLETED|Overall Study||0
9981904|NCT01603420|11103459|FG000|STARTED|Overall Study||1
9981905|NCT01603420|11103460|FG001|STARTED|Overall Study||1
9981906|NCT01603420|11103459|FG000|COMPLETED|Overall Study||1
9981907|NCT01603420|11103460|FG001|COMPLETED|Overall Study||1
9981908|NCT01603420|11103459|FG000|NOT COMPLETED|Overall Study||0
9981909|NCT01603420|11103460|FG001|NOT COMPLETED|Overall Study||0
9981910|NCT01603459|11103469|FG000|STARTED|Overall Study||155
9981911|NCT01603459|11103469|FG000|COMPLETED|Overall Study||137
9981912|NCT01603459|11103469|FG000|NOT COMPLETED|Overall Study||18
9981913|NCT01603602|11103494|FG000|STARTED|Overall Study||77
9981914|NCT01603602|11103495|FG001|STARTED|Overall Study||78
9981915|NCT01603602|11103496|FG002|STARTED|Overall Study||80
9981916|NCT01603602|11103494|FG000|COMPLETED|Overall Study||75
9981917|NCT01603602|11103495|FG001|COMPLETED|Overall Study||78
9981918|NCT01603602|11103496|FG002|COMPLETED|Overall Study||79
9981919|NCT01603602|11103494|FG000|NOT COMPLETED|Overall Study||2
9981920|NCT01603602|11103495|FG001|NOT COMPLETED|Overall Study||0
9981921|NCT01603602|11103496|FG002|NOT COMPLETED|Overall Study||1
9981922|NCT01603615|11103504|FG000|STARTED|Overall Study||220
9981923|NCT01603615|11103504|FG000|Safety Population (Treated)|Overall Study||213
9981924|NCT01603615|11103504|FG000|COMPLETED|Overall Study||186
9981925|NCT01603615|11103504|FG000|NOT COMPLETED|Overall Study||34
9981926|NCT01603628|11103511|FG000|STARTED|Overall Study||128
9981927|NCT01603628|11103512|FG001|STARTED|Overall Study||126
9981928|NCT01603628|11103513|FG002|STARTED|Overall Study||130
9981929|NCT01603628|11103511|FG000|Safety Population: Received Treatment|Overall Study||128
9981930|NCT01603628|11103512|FG001|Safety Population: Received Treatment|Overall Study||126
9981931|NCT01603628|11103513|FG002|Safety Population: Received Treatment|Overall Study||128
9981932|NCT01603628|11103511|FG000|COMPLETED|Overall Study||125
9981933|NCT01603628|11103512|FG001|COMPLETED|Overall Study||123
9981934|NCT01603628|11103513|FG002|COMPLETED|Overall Study||128
9981935|NCT01603628|11103511|FG000|NOT COMPLETED|Overall Study||3
9981936|NCT01603628|11103512|FG001|NOT COMPLETED|Overall Study||3
9981937|NCT01603628|11103513|FG002|NOT COMPLETED|Overall Study||2
9981938|NCT01603641|11103521|FG000|STARTED|Overall Study||370
9981939|NCT01603641|11103521|FG000|Safety Population (Treated)|Overall Study||367
9981940|NCT01603641|11103521|FG000|Modified Intent-to-treat Population|Overall Study||366
9981941|NCT01603641|11103521|FG000|COMPLETED|Overall Study||335
9981942|NCT01603641|11103521|FG000|NOT COMPLETED|Overall Study||35
9981943|NCT01603875|11103528|FG000|STARTED|Overall Study||35
9981944|NCT01603875|11103529|FG001|STARTED|Overall Study||35
9981945|NCT01603875|11103530|FG002|STARTED|Overall Study||35
9981946|NCT01603875|11103528|FG000|COMPLETED|Overall Study||28
9981947|NCT01603875|11103529|FG001|COMPLETED|Overall Study||27
9981948|NCT01603875|11103530|FG002|COMPLETED|Overall Study||26
9981949|NCT01603875|11103528|FG000|NOT COMPLETED|Overall Study||7
9981950|NCT01603875|11103529|FG001|NOT COMPLETED|Overall Study||8
9981951|NCT01603875|11103530|FG002|NOT COMPLETED|Overall Study||9
9981952|NCT01603940|11103540|FG000|STARTED|Overall Study||16
9981953|NCT01603940|11103541|FG001|STARTED|Overall Study||14
9981954|NCT01603940|11103540|FG000|COMPLETED|Overall Study||16
9981955|NCT01603940|11103541|FG001|COMPLETED|Overall Study||14
9981956|NCT01603940|11103540|FG000|NOT COMPLETED|Overall Study||0
9981957|NCT01603940|11103541|FG001|NOT COMPLETED|Overall Study||0
9981958|NCT01604109|11103549|FG000|STARTED|Overall Study||150
9981959|NCT01604109|11103550|FG001|STARTED|Overall Study||146
9981960|NCT01604109|11103549|FG000|COMPLETED|Overall Study||117
9981961|NCT01604109|11103550|FG001|COMPLETED|Overall Study||112
9981962|NCT01604109|11103549|FG000|NOT COMPLETED|Overall Study||33
9981963|NCT01604109|11103550|FG001|NOT COMPLETED|Overall Study||34
9981964|NCT01604122|11103558|FG000|STARTED|Overall Study||60
9981965|NCT01604122|11103559|FG001|STARTED|Overall Study||32
9981966|NCT01604122|11103558|FG000|COMPLETED|Overall Study||60
9981967|NCT01604122|11103559|FG001|COMPLETED|Overall Study||32
9981968|NCT01604122|11103558|FG000|NOT COMPLETED|Overall Study||0
9981969|NCT01604122|11103559|FG001|NOT COMPLETED|Overall Study||0
9981970|NCT01604265|11103568|FG000|STARTED|Overall Study||34
9981971|NCT01604265|11103569|FG001|STARTED|Overall Study||32
9981972|NCT01604265|11103568|FG000|COMPLETED|Overall Study||32
9981973|NCT01604265|11103569|FG001|COMPLETED|Overall Study||32
9981974|NCT01604265|11103568|FG000|NOT COMPLETED|Overall Study||2
9981975|NCT01604265|11103569|FG001|NOT COMPLETED|Overall Study||0
9981976|NCT01604278|11103577|FG000|STARTED|Overall Study||226
9981977|NCT01604278|11103578|FG001|STARTED|Overall Study||223
9981978|NCT01604278|11103577|FG000|Safety Set|Overall Study||226
9981979|NCT01604278|11103578|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
9981980|NCT01604278|11103577|FG000|Full Analysis Set|Overall Study||226
9981981|NCT01604278|11103578|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
9981982|NCT01604278|11103577|FG000|COMPLETED|Overall Study||212
9981983|NCT01604278|11103578|FG001|COMPLETED|Overall Study||210
9981984|NCT01604278|11103577|FG000|NOT COMPLETED|Overall Study||14
9981985|NCT01604278|11103578|FG001|NOT COMPLETED|Overall Study||13
9981986|NCT01604291|11103588|FG000|STARTED|Overall Study||311
9981987|NCT01604291|11103589|FG001|STARTED|Overall Study||443
9981988|NCT01604291|11103590|FG002|STARTED|Overall Study||193
9981989|NCT01604291|11103591|FG003|STARTED|Overall Study||44
9981990|NCT01604291|11103588|FG000|COMPLETED|Overall Study||311
9981991|NCT01604291|11103589|FG001|COMPLETED|Overall Study||443
9981992|NCT01604291|11103590|FG002|COMPLETED|Overall Study||193
9981993|NCT01604291|11103591|FG003|COMPLETED|Overall Study||44
9981994|NCT01604291|11103588|FG000|NOT COMPLETED|Overall Study||0
9981995|NCT01604291|11103589|FG001|NOT COMPLETED|Overall Study||0
9981996|NCT01604291|11103590|FG002|NOT COMPLETED|Overall Study||0
9981997|NCT01604291|11103591|FG003|NOT COMPLETED|Overall Study||0
9981998|NCT01604343|11103612|FG000|STARTED|Prior to W52 Administration(Through W52)||556
9981999|NCT01604343|11103613|FG001|STARTED|Prior to W52 Administration(Through W52)||0
9982000|NCT01604343|11103614|FG002|STARTED|Prior to W52 Administration(Through W52)||557
9982001|NCT01604343|11103615|FG003|STARTED|Prior to W52 Administration(Through W52)||0
9982002|NCT01604343|11103616|FG004|STARTED|Prior to W52 Administration(Through W52)||557
9982003|NCT01604343|11103612|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
9982004|NCT01604343|11103613|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
9982005|NCT01604343|11103614|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
9982006|NCT01604343|11103615|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
9982007|NCT01604343|11103616|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
9982008|NCT01604343|11103612|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
9982009|NCT01604343|11103613|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
9877379|NCT01011335|10991832|FG000|STARTED|Overall Study||11
9877380|NCT01011335|10991833|FG001|STARTED|Overall Study||12
9877381|NCT01011335|10991834|FG002|STARTED|Overall Study||12
9877382|NCT01011335|10991835|FG003|STARTED|Overall Study||12
9877383|NCT01011335|10991836|FG004|STARTED|Overall Study||13
9877384|NCT01011335|10991837|FG005|STARTED|Overall Study||12
9877385|NCT01011335|10991838|FG006|STARTED|Overall Study||12
9877386|NCT01011335|10991839|FG007|STARTED|Overall Study||12
9877387|NCT01011335|10991840|FG008|STARTED|Overall Study||12
9877388|NCT01011335|10991841|FG009|STARTED|Overall Study||12
9877389|NCT01011335|10991842|FG010|STARTED|Overall Study||12
9877390|NCT01011335|10991843|FG011|STARTED|Overall Study||22
9877391|NCT01011335|10991844|FG012|STARTED|Overall Study||22
9877392|NCT01011335|10991832|FG000|COMPLETED|Overall Study||10
9877393|NCT01011335|10991833|FG001|COMPLETED|Overall Study||11
9877394|NCT01011335|10991834|FG002|COMPLETED|Overall Study||11
9877395|NCT01011335|10991835|FG003|COMPLETED|Overall Study||10
9877396|NCT01011335|10991836|FG004|COMPLETED|Overall Study||12
9877397|NCT01011335|10991837|FG005|COMPLETED|Overall Study||11
9877398|NCT01011335|10991838|FG006|COMPLETED|Overall Study||9
9877399|NCT01011335|10991839|FG007|COMPLETED|Overall Study||10
9877400|NCT01011335|10991840|FG008|COMPLETED|Overall Study||10
9877401|NCT01011335|10991841|FG009|COMPLETED|Overall Study||12
9877402|NCT01011335|10991842|FG010|COMPLETED|Overall Study||6
9877403|NCT01011335|10991843|FG011|COMPLETED|Overall Study||21
9877404|NCT01011335|10991844|FG012|COMPLETED|Overall Study||19
9877405|NCT01011335|10991832|FG000|NOT COMPLETED|Overall Study||1
9877406|NCT01011335|10991833|FG001|NOT COMPLETED|Overall Study||1
9877407|NCT01011335|10991834|FG002|NOT COMPLETED|Overall Study||1
9877408|NCT01011335|10991835|FG003|NOT COMPLETED|Overall Study||2
9877409|NCT01011335|10991836|FG004|NOT COMPLETED|Overall Study||1
9877410|NCT01011335|10991837|FG005|NOT COMPLETED|Overall Study||1
9877411|NCT01011335|10991838|FG006|NOT COMPLETED|Overall Study||3
9877412|NCT01011335|10991839|FG007|NOT COMPLETED|Overall Study||2
9877413|NCT01011335|10991840|FG008|NOT COMPLETED|Overall Study||2
9877414|NCT01011335|10991841|FG009|NOT COMPLETED|Overall Study||0
9877415|NCT01011335|10991842|FG010|NOT COMPLETED|Overall Study||6
9877416|NCT01011335|10991843|FG011|NOT COMPLETED|Overall Study||1
9877417|NCT01011335|10991844|FG012|NOT COMPLETED|Overall Study||3
9877418|NCT01011387|10991881|FG000|STARTED|Overall Study||16
9877419|NCT01011387|10991881|FG000|COMPLETED|Overall Study||10
9877420|NCT01011387|10991881|FG000|NOT COMPLETED|Overall Study||6
9877421|NCT01011413|10991887|FG000|STARTED|Overall Study|312 randomised|312
9877422|NCT01011413|10991888|FG001|STARTED|Overall Study|324 randomised|324
9877423|NCT01011413|10991887|FG000|Did Not Start Study Drug|Overall Study||3
9877424|NCT01011413|10991888|FG001|Did Not Start Study Drug|Overall Study||3
9877425|NCT01011413|10991887|FG000|In Modified ITT|Overall Study||309
9877426|NCT01011413|10991888|FG001|In Modified ITT|Overall Study||321
9877427|NCT01011413|10991887|FG000|Died Before Week 48|Overall Study||3
9877428|NCT01011413|10991888|FG001|Died Before Week 48|Overall Study||2
9877429|NCT01011413|10991887|FG000|Lost to Follow up Before w48|Overall Study||3
9877430|NCT01011413|10991888|FG001|Lost to Follow up Before w48|Overall Study||4
9877431|NCT01011413|10991887|FG000|Withdrew Consent Before w48|Overall Study||3
9877432|NCT01011413|10991888|FG001|Withdrew Consent Before w48|Overall Study||3
9877433|NCT01011413|10991887|FG000|Attended w48 Visit|Overall Study||295
9877434|NCT01011413|10991888|FG001|Attended w48 Visit|Overall Study||311
9877435|NCT01011413|10991887|FG000|Died Between Week 48 and 96|Overall Study||2
9877436|NCT01011413|10991888|FG001|Died Between Week 48 and 96|Overall Study||3
9877437|NCT01011413|10991887|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2
9877438|NCT01011413|10991888|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6
9877439|NCT01011413|10991887|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10
9877440|NCT01011413|10991888|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4
9877441|NCT01011413|10991887|FG000|COMPLETED|Overall Study||286
9877442|NCT01011413|10991888|FG001|COMPLETED|Overall Study||299
9877443|NCT01011413|10991887|FG000|NOT COMPLETED|Overall Study||26
9877444|NCT01011413|10991888|FG001|NOT COMPLETED|Overall Study||25
9877445|NCT01011439|10991901|FG000|STARTED|Overall Study||72
9877446|NCT01011439|10991901|FG000|COMPLETED|Overall Study||15
9877447|NCT01011439|10991901|FG000|NOT COMPLETED|Overall Study||57
9877448|NCT01011465|10991914|FG000|STARTED|Overall Study||36
9877449|NCT01011465|10991915|FG001|STARTED|Overall Study||20
9877450|NCT01011465|10991916|FG002|STARTED|Overall Study||36
9877451|NCT01011465|10991917|FG003|STARTED|Overall Study||18
9877452|NCT01011465|10991918|FG004|STARTED|Overall Study||47
9877453|NCT01011465|10991919|FG005|STARTED|Overall Study||29
9877454|NCT01011465|10991920|FG006|STARTED|Overall Study||52
9877455|NCT01011465|10991921|FG007|STARTED|Overall Study||32
9877456|NCT01011465|10991914|FG000|COMPLETED|Overall Study||34
9877457|NCT01011465|10991915|FG001|COMPLETED|Overall Study||19
9982010|NCT01604343|11103614|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
9982011|NCT01604343|11103615|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
9982012|NCT01604343|11103616|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
9982013|NCT01604343|11103612|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458
9982014|NCT01604343|11103613|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0
9982015|NCT01604343|11103614|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481
9982016|NCT01604343|11103615|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0
9982017|NCT01604343|11103616|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470
9982018|NCT01604343|11103612|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
9982019|NCT01604343|11103613|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
9982020|NCT01604343|11103614|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
9982021|NCT01604343|11103615|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
9982022|NCT01604343|11103616|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
9982023|NCT01604343|11103612|FG000|STARTED|Week 52 to Week 104||0
9982024|NCT01604343|11103613|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
9982025|NCT01604343|11103614|FG002|STARTED|Week 52 to Week 104||481
9982026|NCT01604343|11103615|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
9982027|NCT01604343|11103616|FG004|STARTED|Week 52 to Week 104||470
9982028|NCT01604343|11103612|FG000|Treated|Week 52 to Week 104||0
9982029|NCT01604343|11103613|FG001|Treated|Week 52 to Week 104||242
9982030|NCT01604343|11103614|FG002|Treated|Week 52 to Week 104||481
9982031|NCT01604343|11103615|FG003|Treated|Week 52 to Week 104||241
9982032|NCT01604343|11103616|FG004|Treated|Week 52 to Week 104||470
9982033|NCT01604343|11103612|FG000|COMPLETED|Week 52 to Week 104||0
9982034|NCT01604343|11103613|FG001|COMPLETED|Week 52 to Week 104||200
9982035|NCT01604343|11103614|FG002|COMPLETED|Week 52 to Week 104||414
9982036|NCT01604343|11103615|FG003|COMPLETED|Week 52 to Week 104||195
9982037|NCT01604343|11103616|FG004|COMPLETED|Week 52 to Week 104||429
9982038|NCT01604343|11103612|FG000|NOT COMPLETED|Week 52 to Week 104||0
9982039|NCT01604343|11103613|FG001|NOT COMPLETED|Week 52 to Week 104||43
9982040|NCT01604343|11103614|FG002|NOT COMPLETED|Week 52 to Week 104||67
9982041|NCT01604343|11103615|FG003|NOT COMPLETED|Week 52 to Week 104||46
9982042|NCT01604343|11103616|FG004|NOT COMPLETED|Week 52 to Week 104||41
9982043|NCT01604343|11103612|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109
9982044|NCT01604343|11103613|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27
9982045|NCT01604343|11103614|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105
9982046|NCT01604343|11103615|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36
9982047|NCT01604343|11103616|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114
9982048|NCT01604343|11103612|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109
9982049|NCT01604343|11103613|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26
9982050|NCT01604343|11103614|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105
9982051|NCT01604343|11103615|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36
9982052|NCT01604343|11103616|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114
9982053|NCT01604343|11103612|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79
9982054|NCT01604343|11103613|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20
9982055|NCT01604343|11103614|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72
9982056|NCT01604343|11103615|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26
9982057|NCT01604343|11103616|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85
9982058|NCT01604343|11103612|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
9982059|NCT01604343|11103613|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
9982060|NCT01604343|11103614|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
9982061|NCT01604343|11103615|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
9982062|NCT01604343|11103616|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
10099738|NCT02393755|11228873|FG000|NOT COMPLETED|Overall Study||0
9982063|NCT01604408|11103628|FG000|STARTED|Treatment Period 1||102
9982064|NCT01604408|11103629|FG001|STARTED|Treatment Period 1||99
9982065|NCT01604408|11103628|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
9982066|NCT01604408|11103629|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
9982067|NCT01604408|11103628|FG000|COMPLETED|Treatment Period 1||102
9982068|NCT01604408|11103629|FG001|COMPLETED|Treatment Period 1||98
9982069|NCT01604408|11103628|FG000|NOT COMPLETED|Treatment Period 1||0
9982070|NCT01604408|11103629|FG001|NOT COMPLETED|Treatment Period 1||1
9982071|NCT01604408|11103628|FG000|STARTED|Treatment Period 2||102
9982072|NCT01604408|11103629|FG001|STARTED|Treatment Period 2||98
9982073|NCT01604408|11103628|FG000|COMPLETED|Treatment Period 2||100
9982074|NCT01604408|11103629|FG001|COMPLETED|Treatment Period 2||96
9982075|NCT01604408|11103628|FG000|NOT COMPLETED|Treatment Period 2||2
9982076|NCT01604408|11103629|FG001|NOT COMPLETED|Treatment Period 2||2
9982077|NCT01604408|11103628|FG000|STARTED|Treatment Period 3||100
9982078|NCT01604408|11103629|FG001|STARTED|Treatment Period 3||96
9982079|NCT01604408|11103628|FG000|COMPLETED|Treatment Period 3||95
9982080|NCT01604408|11103629|FG001|COMPLETED|Treatment Period 3||91
9982081|NCT01604408|11103628|FG000|NOT COMPLETED|Treatment Period 3||5
9982082|NCT01604408|11103629|FG001|NOT COMPLETED|Treatment Period 3||5
9982083|NCT01604408|11103628|FG000|STARTED|Treatment Period 4||95
9982084|NCT01604408|11103629|FG001|STARTED|Treatment Period 4||91
10099739|NCT02393755|11228874|FG001|NOT COMPLETED|Overall Study||7
9982085|NCT01604408|11103628|FG000|COMPLETED|Treatment Period 4||92
9982086|NCT01604408|11103629|FG001|COMPLETED|Treatment Period 4||89
9982087|NCT01604408|11103628|FG000|NOT COMPLETED|Treatment Period 4||3
9982088|NCT01604408|11103629|FG001|NOT COMPLETED|Treatment Period 4||2
9982089|NCT01604408|11103628|FG000|STARTED|Treatment Period 5||92
9982090|NCT01604408|11103629|FG001|STARTED|Treatment Period 5||89
9982091|NCT01604408|11103628|FG000|COMPLETED|Treatment Period 5||88
9982092|NCT01604408|11103629|FG001|COMPLETED|Treatment Period 5||89
9982093|NCT01604408|11103628|FG000|NOT COMPLETED|Treatment Period 5||4
9982094|NCT01604408|11103629|FG001|NOT COMPLETED|Treatment Period 5||0
9982095|NCT01604408|11103628|FG000|STARTED|Treatment Period 6||88
9982096|NCT01604408|11103629|FG001|STARTED|Treatment Period 6||89
9982097|NCT01604408|11103628|FG000|COMPLETED|Treatment Period 6||86
9982098|NCT01604408|11103629|FG001|COMPLETED|Treatment Period 6||87
9982099|NCT01604408|11103628|FG000|NOT COMPLETED|Treatment Period 6||2
9982100|NCT01604408|11103629|FG001|NOT COMPLETED|Treatment Period 6||2
9982101|NCT01604408|11103628|FG000|STARTED|Observation Period||86
9982102|NCT01604408|11103629|FG001|STARTED|Observation Period||87
9982103|NCT01604408|11103628|FG000|COMPLETED|Observation Period||85
9982104|NCT01604408|11103629|FG001|COMPLETED|Observation Period||84
9982105|NCT01604408|11103628|FG000|NOT COMPLETED|Observation Period||1
9982106|NCT01604408|11103629|FG001|NOT COMPLETED|Observation Period||3
9982107|NCT01604772|11103635|FG000|STARTED|Overall Study||16
9982108|NCT01604772|11103635|FG000|COMPLETED|Overall Study||16
9982109|NCT01604772|11103635|FG000|NOT COMPLETED|Overall Study||0
9982110|NCT01604785|11103642|FG000|STARTED|Overall Study||37
9982111|NCT01604785|11103643|FG001|STARTED|Overall Study||37
9982112|NCT01604785|11103642|FG000|COMPLETED|Overall Study||30
9982113|NCT01604785|11103643|FG001|COMPLETED|Overall Study||36
9982114|NCT01604785|11103642|FG000|NOT COMPLETED|Overall Study||7
9982115|NCT01604785|11103643|FG001|NOT COMPLETED|Overall Study||1
9982116|NCT01604824|11103653|FG000|STARTED|Double-blind (DB) Period||6
9982117|NCT01604824|11103654|FG001|STARTED|Double-blind (DB) Period||7
9982118|NCT01604824|11103655|FG002|STARTED|Double-blind (DB) Period||5
9982119|NCT01604824|11103656|FG003|STARTED|Double-blind (DB) Period||5
9982120|NCT01604824|11103657|FG004|STARTED|Double-blind (DB) Period||0
9982121|NCT01604824|11103658|FG005|STARTED|Double-blind (DB) Period||0
9982122|NCT01604824|11103653|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6
9982123|NCT01604824|11103654|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7
9982124|NCT01604824|11103655|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5
9982125|NCT01604824|11103656|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5
9982126|NCT01604824|11103657|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0
9982127|NCT01604824|11103658|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0
9982128|NCT01604824|11103653|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
9982129|NCT01604824|11103654|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
9982130|NCT01604824|11103655|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
9982131|NCT01604824|11103656|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
9982132|NCT01604824|11103657|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
9982133|NCT01604824|11103658|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
9982134|NCT01604824|11103653|FG000|COMPLETED|Double-blind (DB) Period||6
9982135|NCT01604824|11103654|FG001|COMPLETED|Double-blind (DB) Period||7
9982136|NCT01604824|11103655|FG002|COMPLETED|Double-blind (DB) Period||5
9982137|NCT01604824|11103656|FG003|COMPLETED|Double-blind (DB) Period||5
9982138|NCT01604824|11103657|FG004|COMPLETED|Double-blind (DB) Period||0
9982139|NCT01604824|11103658|FG005|COMPLETED|Double-blind (DB) Period||0
9982140|NCT01604824|11103653|FG000|NOT COMPLETED|Double-blind (DB) Period||0
9982141|NCT01604824|11103654|FG001|NOT COMPLETED|Double-blind (DB) Period||0
9982142|NCT01604824|11103655|FG002|NOT COMPLETED|Double-blind (DB) Period||0
9982143|NCT01604824|11103656|FG003|NOT COMPLETED|Double-blind (DB) Period||0
9982144|NCT01604824|11103657|FG004|NOT COMPLETED|Double-blind (DB) Period||0
9982145|NCT01604824|11103658|FG005|NOT COMPLETED|Double-blind (DB) Period||0
9982146|NCT01604824|11103653|FG000|STARTED|Open-label Extension (OLE) Period||0
9982147|NCT01604824|11103654|FG001|STARTED|Open-label Extension (OLE) Period||0
9982148|NCT01604824|11103655|FG002|STARTED|Open-label Extension (OLE) Period||0
9982149|NCT01604824|11103656|FG003|STARTED|Open-label Extension (OLE) Period||0
9982150|NCT01604824|11103657|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
9982151|NCT01604824|11103658|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
9982152|NCT01604824|11103653|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
9982153|NCT01604824|11103654|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
9982154|NCT01604824|11103655|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
9982155|NCT01604824|11103656|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
9982156|NCT01604824|11103657|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
9982157|NCT01604824|11103658|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
9982158|NCT01604824|11103653|FG000|Completed Study|Open-label Extension (OLE) Period||0
9982159|NCT01604824|11103654|FG001|Completed Study|Open-label Extension (OLE) Period||0
9982160|NCT01604824|11103655|FG002|Completed Study|Open-label Extension (OLE) Period||0
9982161|NCT01604824|11103656|FG003|Completed Study|Open-label Extension (OLE) Period||0
9982162|NCT01604824|11103657|FG004|Completed Study|Open-label Extension (OLE) Period||10
9982163|NCT01604824|11103658|FG005|Completed Study|Open-label Extension (OLE) Period||10
9982164|NCT01604824|11103653|FG000|COMPLETED|Open-label Extension (OLE) Period||0
9982165|NCT01604824|11103654|FG001|COMPLETED|Open-label Extension (OLE) Period||0
9982166|NCT01604824|11103655|FG002|COMPLETED|Open-label Extension (OLE) Period||0
9982167|NCT01604824|11103656|FG003|COMPLETED|Open-label Extension (OLE) Period||0
9982168|NCT01604824|11103657|FG004|COMPLETED|Open-label Extension (OLE) Period||10
9982169|NCT01604824|11103658|FG005|COMPLETED|Open-label Extension (OLE) Period||10
9982170|NCT01604824|11103653|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0
9982171|NCT01604824|11103654|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0
9982172|NCT01604824|11103655|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0
9982173|NCT01604824|11103656|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0
9982174|NCT01604824|11103657|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3
9982175|NCT01604824|11103658|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0
9982176|NCT01604850|11103672|FG000|STARTED|Overall Study||103
9982177|NCT01604850|11103673|FG001|STARTED|Overall Study||99
9982178|NCT01604850|11103672|FG000|Enrolled and Treated|Overall Study||103
9982179|NCT01604850|11103673|FG001|Enrolled and Treated|Overall Study||98
9982180|NCT01604850|11103672|FG000|COMPLETED|Overall Study||51
9982181|NCT01604850|11103673|FG001|COMPLETED|Overall Study||69
9982182|NCT01604850|11103672|FG000|NOT COMPLETED|Overall Study||52
9982183|NCT01604850|11103673|FG001|NOT COMPLETED|Overall Study||30
9982184|NCT01604941|11103681|FG000|STARTED|Overall Study||11
9982185|NCT01604941|11103682|FG001|STARTED|Overall Study||4
9982186|NCT01604941|11103683|FG002|STARTED|Overall Study||3
9982187|NCT01604941|11103684|FG003|STARTED|Overall Study||3
9982188|NCT01604941|11103685|FG004|STARTED|Overall Study||4
9982189|NCT01604941|11103686|FG005|STARTED|Overall Study||7
9982190|NCT01604941|11103681|FG000|COMPLETED|Overall Study||0
9982191|NCT01604941|11103682|FG001|COMPLETED|Overall Study||0
9982192|NCT01604941|11103683|FG002|COMPLETED|Overall Study||0
9982193|NCT01604941|11103684|FG003|COMPLETED|Overall Study||0
9982194|NCT01604941|11103685|FG004|COMPLETED|Overall Study||3
9982195|NCT01604941|11103686|FG005|COMPLETED|Overall Study||0
9982196|NCT01604941|11103681|FG000|NOT COMPLETED|Overall Study||11
9982197|NCT01604941|11103682|FG001|NOT COMPLETED|Overall Study||4
9982198|NCT01604941|11103683|FG002|NOT COMPLETED|Overall Study||3
9982199|NCT01604941|11103684|FG003|NOT COMPLETED|Overall Study||3
10099740|NCT02393950|11228881|FG000|STARTED|Overall Study||9
10099741|NCT02393950|11228882|FG001|STARTED|Overall Study||9
10099742|NCT02393950|11228881|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
10099743|NCT02393950|11228882|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
10099744|NCT02393950|11228881|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
9982200|NCT01604941|11103685|FG004|NOT COMPLETED|Overall Study||1
9982201|NCT01604941|11103686|FG005|NOT COMPLETED|Overall Study||7
9982202|NCT01605032|11103692|FG000|STARTED|Overall Study||19
9982203|NCT01605032|11103692|FG000|COMPLETED|Overall Study||18
9982204|NCT01605032|11103692|FG000|NOT COMPLETED|Overall Study||1
9982205|NCT01605071|11103698|FG000|STARTED|Overall Study||27
9982206|NCT01605071|11103699|FG001|STARTED|Overall Study||26
9982207|NCT01605071|11103698|FG000|COMPLETED|Overall Study||24
9982208|NCT01605071|11103699|FG001|COMPLETED|Overall Study||24
9982209|NCT01605071|11103698|FG000|NOT COMPLETED|Overall Study||3
9982210|NCT01605071|11103699|FG001|NOT COMPLETED|Overall Study||2
9982211|NCT01605097|11103707|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
9982212|NCT01605097|11103707|FG000|COMPLETED|Overall Study||25
9982213|NCT01605097|11103707|FG000|NOT COMPLETED|Overall Study||1
9982214|NCT01605136|11103714|FG000|STARTED|Study Period||48
9982215|NCT01605136|11103715|FG001|STARTED|Study Period||45
9982216|NCT01605136|11103714|FG000|COMPLETED|Study Period||45
9982217|NCT01605136|11103715|FG001|COMPLETED|Study Period||42
9982218|NCT01605136|11103714|FG000|NOT COMPLETED|Study Period||3
9982219|NCT01605136|11103715|FG001|NOT COMPLETED|Study Period||3
9982220|NCT01605136|11103714|FG000|STARTED|Safety Follow-Up Period||45
9982221|NCT01605136|11103715|FG001|STARTED|Safety Follow-Up Period||42
9982222|NCT01605136|11103714|FG000|COMPLETED|Safety Follow-Up Period||44
9982223|NCT01605136|11103715|FG001|COMPLETED|Safety Follow-Up Period||40
9982224|NCT01605136|11103714|FG000|NOT COMPLETED|Safety Follow-Up Period||1
9982225|NCT01605136|11103715|FG001|NOT COMPLETED|Safety Follow-Up Period||2
9982226|NCT01605227|11103723|FG000|STARTED|Overall Study||682
9982227|NCT01605227|11103724|FG001|STARTED|Overall Study||346
9982228|NCT01605227|11103723|FG000|COMPLETED|Overall Study||61
9982229|NCT01605227|11103724|FG001|COMPLETED|Overall Study||17
9982230|NCT01605227|11103723|FG000|NOT COMPLETED|Overall Study||621
9982231|NCT01605227|11103724|FG001|NOT COMPLETED|Overall Study||329
9982232|NCT01605292|11103732|FG000|STARTED|Overall Study||351
9982233|NCT01605292|11103733|FG001|STARTED|Overall Study||347
9982234|NCT01605292|11103732|FG000|COMPLETED|Overall Study||351
9982235|NCT01605292|11103733|FG001|COMPLETED|Overall Study||347
9982236|NCT01605292|11103732|FG000|NOT COMPLETED|Overall Study||0
9982237|NCT01605292|11103733|FG001|NOT COMPLETED|Overall Study||0
9982238|NCT01605396|11103741|FG000|STARTED|Overall Study||40
9982239|NCT01605396|11103742|FG001|STARTED|Overall Study||40
9982240|NCT01605396|11103741|FG000|Treated|Overall Study||39
9982241|NCT01605396|11103742|FG001|Treated|Overall Study||40
9982242|NCT01605396|11103741|FG000|COMPLETED|Overall Study||0
9982243|NCT01605396|11103742|FG001|COMPLETED|Overall Study||0
9982244|NCT01605396|11103741|FG000|NOT COMPLETED|Overall Study||40
9982245|NCT01605396|11103742|FG001|NOT COMPLETED|Overall Study||40
9982246|NCT01605435|11103748|FG000|STARTED|Overall Study||2
9982247|NCT01605435|11103749|FG001|STARTED|Overall Study||3
9982248|NCT01605435|11103748|FG000|COMPLETED|Overall Study||2
9982249|NCT01605435|11103749|FG001|COMPLETED|Overall Study||3
9982250|NCT01605435|11103748|FG000|NOT COMPLETED|Overall Study||0
9982251|NCT01605435|11103749|FG001|NOT COMPLETED|Overall Study||0
9982252|NCT01605461|11103766|FG000|STARTED|Overall Study||12
9982253|NCT01605461|11103766|FG000|COMPLETED|Overall Study||8
9982254|NCT01605461|11103766|FG000|NOT COMPLETED|Overall Study||4
9982255|NCT01605539|11103772|FG000|STARTED|Overall Study||3
9982256|NCT01605539|11103773|FG001|STARTED|Overall Study||3
9982257|NCT01605539|11103774|FG002|STARTED|Overall Study||4
9982258|NCT01605539|11103772|FG000|COMPLETED|Overall Study||3
9982259|NCT01605539|11103773|FG001|COMPLETED|Overall Study||2
9982260|NCT01605539|11103774|FG002|COMPLETED|Overall Study||4
9982261|NCT01605539|11103772|FG000|NOT COMPLETED|Overall Study||0
9982262|NCT01605539|11103773|FG001|NOT COMPLETED|Overall Study||1
9982263|NCT01605539|11103774|FG002|NOT COMPLETED|Overall Study||0
9982264|NCT01605552|11103785|FG000|STARTED|Overall Study||13
9982265|NCT01605552|11103786|FG001|STARTED|Overall Study||16
9982266|NCT01605552|11103785|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
9982267|NCT01605552|11103786|FG001|COMPLETED|Overall Study||14
9982268|NCT01605552|11103785|FG000|NOT COMPLETED|Overall Study||6
9982269|NCT01605552|11103786|FG001|NOT COMPLETED|Overall Study||2
9982270|NCT01605669|11103792|FG000|STARTED|Overall Study||50
9982271|NCT01605669|11103792|FG000|COMPLETED|Overall Study||50
9982272|NCT01605669|11103792|FG000|NOT COMPLETED|Overall Study||0
9982273|NCT01605799|11103799|FG000|STARTED|Overall Study||17
9982274|NCT01605799|11103800|FG001|STARTED|Overall Study||16
9982275|NCT01605799|11103799|FG000|COMPLETED|Overall Study||15
9982276|NCT01605799|11103800|FG001|COMPLETED|Overall Study||15
9982277|NCT01605799|11103799|FG000|NOT COMPLETED|Overall Study||2
9982278|NCT01605799|11103800|FG001|NOT COMPLETED|Overall Study||1
10099745|NCT02393950|11228882|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
10099746|NCT02393950|11228881|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
10099747|NCT02393950|11228882|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
10099748|NCT02393950|11228881|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
10099749|NCT02393950|11228882|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
10099750|NCT02393950|11228881|FG000|COMPLETED|Overall Study||8
9982279|NCT01605825|11103808|FG000|STARTED|Overall Study||55
9982280|NCT01605825|11103809|FG001|STARTED|Overall Study||28
10099751|NCT02393950|11228882|FG001|COMPLETED|Overall Study||8
10099752|NCT02393950|11228881|FG000|NOT COMPLETED|Overall Study||1
10099753|NCT02393950|11228882|FG001|NOT COMPLETED|Overall Study||1
10099754|NCT02394275|11228917|FG000|STARTED|Overall Study||140
10099755|NCT02394275|11228917|FG000|Safety Population|Overall Study||133
10099756|NCT02394275|11228917|FG000|Evaluable at 13 Weeks|Overall Study||133
10099757|NCT02394275|11228917|FG000|COMPLETED|Overall Study||111
10099758|NCT02394275|11228917|FG000|NOT COMPLETED|Overall Study||29
10099759|NCT02394340|11228922|FG000|STARTED|Overall Study||20
10099760|NCT02394340|11228922|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10099761|NCT02394340|11228922|FG000|COMPLETED|Overall Study||18
10099762|NCT02394340|11228922|FG000|NOT COMPLETED|Overall Study||2
10099763|NCT02394457|11228928|FG000|STARTED|Overall Study||15
10099764|NCT02394457|11228929|FG001|STARTED|Overall Study||13
10099765|NCT02394457|11228928|FG000|COMPLETED|Overall Study||15
10099766|NCT02394457|11228929|FG001|COMPLETED|Overall Study||13
10099767|NCT02394457|11228928|FG000|NOT COMPLETED|Overall Study||0
10099768|NCT02394457|11228929|FG001|NOT COMPLETED|Overall Study||0
10099769|NCT02394561|11228937|FG000|STARTED|CORE Phase||185
10099770|NCT02394561|11228938|FG001|STARTED|CORE Phase||246
10099771|NCT02394561|11228937|FG000|Full Analysis Set|CORE Phase||185
10099772|NCT02394561|11228938|FG001|Full Analysis Set|CORE Phase||246
10099773|NCT02394561|11228937|FG000|Safety Set|CORE Phase||185
10099774|NCT02394561|11228938|FG001|Safety Set|CORE Phase||246
10099775|NCT02394561|11228937|FG000|ITT Set|CORE Phase||184
10099776|NCT02394561|11228938|FG001|ITT Set|CORE Phase||246
10099777|NCT02394561|11228937|FG000|COMPLETED|CORE Phase||172
10099778|NCT02394561|11228938|FG001|COMPLETED|CORE Phase||227
10099779|NCT02394561|11228937|FG000|NOT COMPLETED|CORE Phase||13
10099780|NCT02394561|11228938|FG001|NOT COMPLETED|CORE Phase||19
10099781|NCT02394561|11228937|FG000|STARTED|Extension Phase||162
10099782|NCT02394561|11228938|FG001|STARTED|Extension Phase||219
10099783|NCT02394561|11228937|FG000|COMPLETED|Extension Phase||151
10099784|NCT02394561|11228938|FG001|COMPLETED|Extension Phase||207
9982281|NCT01605825|11103808|FG000|COMPLETED|Overall Study||45
9982282|NCT01605825|11103809|FG001|COMPLETED|Overall Study||25
9982283|NCT01605825|11103808|FG000|NOT COMPLETED|Overall Study||10
9982284|NCT01605825|11103809|FG001|NOT COMPLETED|Overall Study||3
10099785|NCT02394561|11228937|FG000|NOT COMPLETED|Extension Phase||11
10099786|NCT02394561|11228938|FG001|NOT COMPLETED|Extension Phase||12
10099787|NCT02394600|11228949|FG000|STARTED|Overall Study||47
10099788|NCT02394600|11228950|FG001|STARTED|Overall Study||46
10099789|NCT02394600|11228949|FG000|COMPLETED|Overall Study||43
9982285|NCT01605877|11103815|FG000|STARTED|Overall Study||64
9982286|NCT01605877|11103815|FG000|COMPLETED|Overall Study||63
9982287|NCT01605877|11103815|FG000|NOT COMPLETED|Overall Study||1
9982288|NCT01605890|11103837|FG000|STARTED|Overall Study||30
9982289|NCT01605890|11103837|FG000|COMPLETED|Overall Study||28
9982290|NCT01605890|11103837|FG000|NOT COMPLETED|Overall Study||2
9982291|NCT01605903|11103843|FG000|STARTED|Overall Study||345
9982292|NCT01605903|11103844|FG001|STARTED|Overall Study||343
9982293|NCT01605903|11103843|FG000|COMPLETED|Overall Study||345
9982294|NCT01605903|11103844|FG001|COMPLETED|Overall Study||343
9982295|NCT01605903|11103843|FG000|NOT COMPLETED|Overall Study||0
9982296|NCT01605903|11103844|FG001|NOT COMPLETED|Overall Study||0
9982297|NCT01605916|11103855|FG000|STARTED|Overall Study||4
9982298|NCT01605916|11103856|FG001|STARTED|Overall Study||4
9982299|NCT01605916|11103857|FG002|STARTED|Overall Study||4
9982300|NCT01605916|11103858|FG003|STARTED|Overall Study||6
9982301|NCT01605916|11103859|FG004|STARTED|Overall Study||7
9982302|NCT01605916|11103855|FG000|COMPLETED|Overall Study||0
9982303|NCT01605916|11103856|FG001|COMPLETED|Overall Study||0
9982304|NCT01605916|11103857|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
9982305|NCT01605916|11103858|FG003|COMPLETED|Overall Study||0
9982306|NCT01605916|11103859|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
9982307|NCT01605916|11103855|FG000|NOT COMPLETED|Overall Study||4
9982308|NCT01605916|11103856|FG001|NOT COMPLETED|Overall Study||4
9982309|NCT01605916|11103857|FG002|NOT COMPLETED|Overall Study||3
9982310|NCT01605916|11103858|FG003|NOT COMPLETED|Overall Study||6
9982311|NCT01605916|11103859|FG004|NOT COMPLETED|Overall Study||6
9982312|NCT01605942|11103874|FG000|STARTED|Overall Study||6
9982313|NCT01605942|11103875|FG001|STARTED|Overall Study||2
9982314|NCT01605942|11103874|FG000|COMPLETED|Overall Study||6
9982315|NCT01605942|11103875|FG001|COMPLETED|Overall Study||2
9982316|NCT01605942|11103874|FG000|NOT COMPLETED|Overall Study||0
9982317|NCT01605942|11103875|FG001|NOT COMPLETED|Overall Study||0
9982318|NCT01606007|11103884|FG000|STARTED|Overall Study||176
9982319|NCT01606007|11103885|FG001|STARTED|Overall Study||179
9982320|NCT01606007|11103886|FG002|STARTED|Overall Study||179
9982321|NCT01606007|11103884|FG000|COMPLETED|Overall Study||161
9982322|NCT01606007|11103885|FG001|COMPLETED|Overall Study||160
9982323|NCT01606007|11103886|FG002|COMPLETED|Overall Study||169
9982324|NCT01606007|11103884|FG000|NOT COMPLETED|Overall Study||15
9982325|NCT01606007|11103885|FG001|NOT COMPLETED|Overall Study||19
9982326|NCT01606007|11103886|FG002|NOT COMPLETED|Overall Study||10
9982327|NCT01606124|11103896|FG000|STARTED|Overall Study||19
9982328|NCT01606124|11103897|FG001|STARTED|Overall Study||20
9982329|NCT01606124|11103896|FG000|COMPLETED|Overall Study||19
9982330|NCT01606124|11103897|FG001|COMPLETED|Overall Study||20
9982331|NCT01606124|11103896|FG000|NOT COMPLETED|Overall Study||0
9982332|NCT01606124|11103897|FG001|NOT COMPLETED|Overall Study||0
9982333|NCT01606137|11103903|FG000|STARTED|Overall Study||507
9982334|NCT01606137|11103903|FG000|COMPLETED|Overall Study||245
9982335|NCT01606137|11103903|FG000|NOT COMPLETED|Overall Study||262
9982336|NCT01606176|11103909|FG000|STARTED|Overall Study||36
9982337|NCT01606176|11103910|FG001|STARTED|Overall Study||34
9982338|NCT01606176|11103909|FG000|COMPLETED|Overall Study||32
9982339|NCT01606176|11103910|FG001|COMPLETED|Overall Study||31
9982340|NCT01606176|11103909|FG000|NOT COMPLETED|Overall Study||4
9982341|NCT01606176|11103910|FG001|NOT COMPLETED|Overall Study||3
9982342|NCT01606189|11103916|FG000|STARTED|First Intenvention (14-20 Days)||8
9982343|NCT01606189|11103917|FG001|STARTED|First Intenvention (14-20 Days)||8
9982344|NCT01606189|11103918|FG002|STARTED|First Intenvention (14-20 Days)||8
9982345|NCT01606189|11103919|FG003|STARTED|First Intenvention (14-20 Days)||8
9982346|NCT01606189|11103920|FG004|STARTED|First Intenvention (14-20 Days)||8
9982347|NCT01606189|11103921|FG005|STARTED|First Intenvention (14-20 Days)||8
9982348|NCT01606189|11103916|FG000|COMPLETED|First Intenvention (14-20 Days)||8
9982349|NCT01606189|11103917|FG001|COMPLETED|First Intenvention (14-20 Days)||8
9982350|NCT01606189|11103918|FG002|COMPLETED|First Intenvention (14-20 Days)||8
9982351|NCT01606189|11103919|FG003|COMPLETED|First Intenvention (14-20 Days)||8
9982352|NCT01606189|11103920|FG004|COMPLETED|First Intenvention (14-20 Days)||8
9982353|NCT01606189|11103921|FG005|COMPLETED|First Intenvention (14-20 Days)||8
9982354|NCT01606189|11103916|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0
9982355|NCT01606189|11103917|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0
9982356|NCT01606189|11103918|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0
9982357|NCT01606189|11103919|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0
9982358|NCT01606189|11103920|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0
9982359|NCT01606189|11103921|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0
9982360|NCT01606189|11103916|FG000|STARTED|Second Intenvention (14-20 Days)||8
9982361|NCT01606189|11103917|FG001|STARTED|Second Intenvention (14-20 Days)||8
9982362|NCT01606189|11103918|FG002|STARTED|Second Intenvention (14-20 Days)||8
9982363|NCT01606189|11103919|FG003|STARTED|Second Intenvention (14-20 Days)||8
9982364|NCT01606189|11103920|FG004|STARTED|Second Intenvention (14-20 Days)||8
9982365|NCT01606189|11103921|FG005|STARTED|Second Intenvention (14-20 Days)||8
9982366|NCT01606189|11103916|FG000|COMPLETED|Second Intenvention (14-20 Days)||8
9982367|NCT01606189|11103917|FG001|COMPLETED|Second Intenvention (14-20 Days)||8
9982368|NCT01606189|11103918|FG002|COMPLETED|Second Intenvention (14-20 Days)||8
9982369|NCT01606189|11103919|FG003|COMPLETED|Second Intenvention (14-20 Days)||8
9982370|NCT01606189|11103920|FG004|COMPLETED|Second Intenvention (14-20 Days)||8
9982371|NCT01606189|11103921|FG005|COMPLETED|Second Intenvention (14-20 Days)||7
9982372|NCT01606189|11103916|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0
9982373|NCT01606189|11103917|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0
9982374|NCT01606189|11103918|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0
9982375|NCT01606189|11103919|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0
9982376|NCT01606189|11103920|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0
9982377|NCT01606189|11103921|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1
9982378|NCT01606189|11103916|FG000|STARTED|Third Intenvention (14-20 Days)||8
9982379|NCT01606189|11103917|FG001|STARTED|Third Intenvention (14-20 Days)||8
9982380|NCT01606189|11103918|FG002|STARTED|Third Intenvention (14-20 Days)||8
9982381|NCT01606189|11103919|FG003|STARTED|Third Intenvention (14-20 Days)||8
9982382|NCT01606189|11103920|FG004|STARTED|Third Intenvention (14-20 Days)||8
9982383|NCT01606189|11103921|FG005|STARTED|Third Intenvention (14-20 Days)||7
9982384|NCT01606189|11103916|FG000|COMPLETED|Third Intenvention (14-20 Days)||8
9982385|NCT01606189|11103917|FG001|COMPLETED|Third Intenvention (14-20 Days)||8
9982386|NCT01606189|11103918|FG002|COMPLETED|Third Intenvention (14-20 Days)||8
9982387|NCT01606189|11103919|FG003|COMPLETED|Third Intenvention (14-20 Days)||8
9982388|NCT01606189|11103920|FG004|COMPLETED|Third Intenvention (14-20 Days)||8
10099790|NCT02394600|11228950|FG001|COMPLETED|Overall Study||44
10099791|NCT02394600|11228949|FG000|NOT COMPLETED|Overall Study||4
10099792|NCT02394600|11228950|FG001|NOT COMPLETED|Overall Study||2
10099793|NCT02394730|11228958|FG000|STARTED|Overall Study||34
10099794|NCT02394730|11228959|FG001|STARTED|Overall Study||31
10099795|NCT02394730|11228958|FG000|COMPLETED|Overall Study||33
10099796|NCT02394730|11228959|FG001|COMPLETED|Overall Study||30
10099797|NCT02394730|11228958|FG000|NOT COMPLETED|Overall Study||1
10099798|NCT02394730|11228959|FG001|NOT COMPLETED|Overall Study||1
10099799|NCT02394756|11228965|FG000|STARTED|Period 1||7
10099800|NCT02394756|11228966|FG001|STARTED|Period 1||7
10099801|NCT02394756|11228967|FG002|STARTED|Period 1||7
10099802|NCT02394756|11228968|FG003|STARTED|Period 1||7
10099803|NCT02394756|11228969|FG004|STARTED|Period 1||7
10099804|NCT02394756|11228970|FG005|STARTED|Period 1||7
10099805|NCT02394756|11228965|FG000|COMPLETED|Period 1||7
10099806|NCT02394756|11228966|FG001|COMPLETED|Period 1||6
10099807|NCT02394756|11228967|FG002|COMPLETED|Period 1||6
10099808|NCT02394756|11228968|FG003|COMPLETED|Period 1||6
10099809|NCT02394756|11228969|FG004|COMPLETED|Period 1||7
10099810|NCT02394756|11228970|FG005|COMPLETED|Period 1||6
10099811|NCT02394756|11228965|FG000|NOT COMPLETED|Period 1||0
10099812|NCT02394756|11228966|FG001|NOT COMPLETED|Period 1||1
10099813|NCT02394756|11228967|FG002|NOT COMPLETED|Period 1||1
10099814|NCT02394756|11228968|FG003|NOT COMPLETED|Period 1||1
10099815|NCT02394756|11228969|FG004|NOT COMPLETED|Period 1||0
10099816|NCT02394756|11228970|FG005|NOT COMPLETED|Period 1||1
10099817|NCT02394756|11228965|FG000|STARTED|Period 2||7
10099818|NCT02394756|11228966|FG001|STARTED|Period 2||6
10099819|NCT02394756|11228967|FG002|STARTED|Period 2||6
10099820|NCT02394756|11228968|FG003|STARTED|Period 2||6
10099821|NCT02394756|11228969|FG004|STARTED|Period 2||7
10099822|NCT02394756|11228970|FG005|STARTED|Period 2||6
10099823|NCT02394756|11228965|FG000|COMPLETED|Period 2||7
10099824|NCT02394756|11228966|FG001|COMPLETED|Period 2||6
10099825|NCT02394756|11228967|FG002|COMPLETED|Period 2||6
10099826|NCT02394756|11228968|FG003|COMPLETED|Period 2||6
10099827|NCT02394756|11228969|FG004|COMPLETED|Period 2||6
10099828|NCT02394756|11228970|FG005|COMPLETED|Period 2||6
10099829|NCT02394756|11228965|FG000|NOT COMPLETED|Period 2||0
10099830|NCT02394756|11228966|FG001|NOT COMPLETED|Period 2||0
10099831|NCT02394756|11228967|FG002|NOT COMPLETED|Period 2||0
10099832|NCT02394756|11228968|FG003|NOT COMPLETED|Period 2||0
10099833|NCT02394756|11228969|FG004|NOT COMPLETED|Period 2||1
10099834|NCT02394756|11228970|FG005|NOT COMPLETED|Period 2||0
10099835|NCT02394756|11228965|FG000|STARTED|Period 3||7
10099836|NCT02394756|11228966|FG001|STARTED|Period 3||6
10099837|NCT02394756|11228967|FG002|STARTED|Period 3||6
10099838|NCT02394756|11228968|FG003|STARTED|Period 3||6
10099839|NCT02394756|11228969|FG004|STARTED|Period 3||6
10099840|NCT02394756|11228970|FG005|STARTED|Period 3||6
10099841|NCT02394756|11228965|FG000|COMPLETED|Period 3||7
10099842|NCT02394756|11228966|FG001|COMPLETED|Period 3||6
10099843|NCT02394756|11228967|FG002|COMPLETED|Period 3||6
10099844|NCT02394756|11228968|FG003|COMPLETED|Period 3||6
10099845|NCT02394756|11228969|FG004|COMPLETED|Period 3||6
10099846|NCT02394756|11228970|FG005|COMPLETED|Period 3||6
10099847|NCT02394756|11228965|FG000|NOT COMPLETED|Period 3||0
10099848|NCT02394756|11228966|FG001|NOT COMPLETED|Period 3||0
10099849|NCT02394756|11228967|FG002|NOT COMPLETED|Period 3||0
10099850|NCT02394756|11228968|FG003|NOT COMPLETED|Period 3||0
9982389|NCT01606189|11103921|FG005|COMPLETED|Third Intenvention (14-20 Days)||6
9982390|NCT01606189|11103916|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0
9982391|NCT01606189|11103917|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0
9982392|NCT01606189|11103918|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0
9982393|NCT01606189|11103919|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0
9982394|NCT01606189|11103920|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0
9982395|NCT01606189|11103921|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1
10099851|NCT02394756|11228969|FG004|NOT COMPLETED|Period 3||0
10099852|NCT02394756|11228970|FG005|NOT COMPLETED|Period 3||0
10099853|NCT02394769|11228981|FG000|STARTED|Overall Study||60
10099854|NCT02394769|11228982|FG001|STARTED|Overall Study||60
10099855|NCT02394769|11228983|FG002|STARTED|Overall Study||60
10099856|NCT02394769|11228981|FG000|COMPLETED|Overall Study||58
10099857|NCT02394769|11228982|FG001|COMPLETED|Overall Study||57
10099858|NCT02394769|11228983|FG002|COMPLETED|Overall Study||54
10099859|NCT02394769|11228981|FG000|NOT COMPLETED|Overall Study||2
10099860|NCT02394769|11228982|FG001|NOT COMPLETED|Overall Study||3
10099861|NCT02394769|11228983|FG002|NOT COMPLETED|Overall Study||6
9982396|NCT01606202|11103931|FG000|STARTED|Overall Study||56
9982397|NCT01606202|11103932|FG001|STARTED|Overall Study||60
9982398|NCT01606202|11103931|FG000|COMPLETED|Overall Study||49
9982399|NCT01606202|11103932|FG001|COMPLETED|Overall Study||57
9982400|NCT01606202|11103931|FG000|NOT COMPLETED|Overall Study||7
9982401|NCT01606202|11103932|FG001|NOT COMPLETED|Overall Study||3
9982402|NCT01606228|11103938|FG000|STARTED|Overall Study||188
9982403|NCT01606228|11103938|FG000|COMPLETED|Overall Study||159
9982404|NCT01606228|11103938|FG000|NOT COMPLETED|Overall Study||29
9982405|NCT01606254|11103946|FG000|STARTED|Overall Study||14
9982406|NCT01606254|11103947|FG001|STARTED|Overall Study||14
9982407|NCT01606254|11103948|FG002|STARTED|Overall Study||14
9982408|NCT01606254|11103949|FG003|STARTED|Overall Study||14
9982409|NCT01606254|11103946|FG000|COMPLETED|Overall Study||12
9982410|NCT01606254|11103947|FG001|COMPLETED|Overall Study||10
9982411|NCT01606254|11103948|FG002|COMPLETED|Overall Study||14
9982412|NCT01606254|11103949|FG003|COMPLETED|Overall Study||11
9982413|NCT01606254|11103946|FG000|NOT COMPLETED|Overall Study||2
9982414|NCT01606254|11103947|FG001|NOT COMPLETED|Overall Study||4
9982415|NCT01606254|11103948|FG002|NOT COMPLETED|Overall Study||0
9982416|NCT01606254|11103949|FG003|NOT COMPLETED|Overall Study||3
9982417|NCT01606306|11103965|FG000|STARTED|Overall Study||50
9982418|NCT01606306|11103966|FG001|STARTED|Overall Study||49
9982419|NCT01606306|11103967|FG002|STARTED|Overall Study||51
9982420|NCT01606306|11103968|FG003|STARTED|Overall Study||51
9982421|NCT01606306|11103969|FG004|STARTED|Overall Study||52
9982422|NCT01606306|11103970|FG005|STARTED|Overall Study||47
10099862|NCT02394808|11228991|FG000|STARTED|Period 1||25
10099863|NCT02394808|11228992|FG001|STARTED|Period 1||29
10099864|NCT02394808|11228991|FG000|COMPLETED|Period 1||25
10099865|NCT02394808|11228992|FG001|COMPLETED|Period 1||28
10099866|NCT02394808|11228991|FG000|NOT COMPLETED|Period 1||0
10099867|NCT02394808|11228992|FG001|NOT COMPLETED|Period 1||1
10099868|NCT02394808|11228991|FG000|STARTED|Period 2||25
10099869|NCT02394808|11228992|FG001|STARTED|Period 2||28
10099870|NCT02394808|11228991|FG000|COMPLETED|Period 2||24
10099871|NCT02394808|11228992|FG001|COMPLETED|Period 2||28
10099872|NCT02394808|11228991|FG000|NOT COMPLETED|Period 2||1
10099873|NCT02394808|11228992|FG001|NOT COMPLETED|Period 2||0
10099874|NCT02394912|11228998|FG000|STARTED|Overall Study||21
10099875|NCT02394912|11228998|FG000|COMPLETED|Overall Study||21
10099876|NCT02394912|11228998|FG000|NOT COMPLETED|Overall Study||0
10099877|NCT02394925|11229004|FG000|STARTED|Overall Study||108
10099878|NCT02394925|11229004|FG000|COMPLETED|Overall Study||79
10099879|NCT02394925|11229004|FG000|NOT COMPLETED|Overall Study||29
10099880|NCT02394951|11229010|FG000|STARTED|Period I||12
10099881|NCT02394951|11229011|FG001|STARTED|Period I||14
10099882|NCT02394951|11229010|FG000|COMPLETED|Period I||11
10099883|NCT02394951|11229011|FG001|COMPLETED|Period I||13
10099884|NCT02394951|11229010|FG000|NOT COMPLETED|Period I||1
10099885|NCT02394951|11229011|FG001|NOT COMPLETED|Period I||1
10099886|NCT02394951|11229010|FG000|STARTED|Period II||11
10099887|NCT02394951|11229011|FG001|STARTED|Period II||13
10099888|NCT02394951|11229010|FG000|COMPLETED|Period II||11
10099889|NCT02394951|11229011|FG001|COMPLETED|Period II||9
10099890|NCT02394951|11229010|FG000|NOT COMPLETED|Period II||0
10099891|NCT02394951|11229011|FG001|NOT COMPLETED|Period II||4
10099892|NCT02395042|11229020|FG000|STARTED|Treatment 1 Period||12
10099893|NCT02395042|11229021|FG001|STARTED|Treatment 1 Period||31
10099894|NCT02395042|11229022|FG002|STARTED|Treatment 1 Period||16
10099895|NCT02395042|11229020|FG000|COMPLETED|Treatment 1 Period||9
10099896|NCT02395042|11229021|FG001|COMPLETED|Treatment 1 Period||25
10099897|NCT02395042|11229022|FG002|COMPLETED|Treatment 1 Period||14
10099898|NCT02395042|11229020|FG000|NOT COMPLETED|Treatment 1 Period||3
10099899|NCT02395042|11229021|FG001|NOT COMPLETED|Treatment 1 Period||6
10099900|NCT02395042|11229022|FG002|NOT COMPLETED|Treatment 1 Period||2
10099901|NCT02395042|11229020|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
10099902|NCT02395042|11229021|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
10099903|NCT02395042|11229022|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
10099904|NCT02395042|11229020|FG000|COMPLETED|Treatment 2 Period||9
10099905|NCT02395042|11229021|FG001|COMPLETED|Treatment 2 Period||23
10099906|NCT02395042|11229022|FG002|COMPLETED|Treatment 2 Period||13
10099907|NCT02395042|11229020|FG000|NOT COMPLETED|Treatment 2 Period||1
10099908|NCT02395042|11229021|FG001|NOT COMPLETED|Treatment 2 Period||1
10099909|NCT02395042|11229022|FG002|NOT COMPLETED|Treatment 2 Period||0
10099910|NCT02395055|11229035|FG000|STARTED|Overall Study||47
10099911|NCT02395055|11229036|FG001|STARTED|Overall Study||47
10099912|NCT02395055|11229035|FG000|COMPLETED|Overall Study||40
10099913|NCT02395055|11229036|FG001|COMPLETED|Overall Study||44
10099914|NCT02395055|11229035|FG000|NOT COMPLETED|Overall Study||7
10099915|NCT02395055|11229036|FG001|NOT COMPLETED|Overall Study||3
10099916|NCT02395081|11229045|FG000|STARTED|Overall Study||119
10099917|NCT02395081|11229046|FG001|STARTED|Overall Study||121
10099918|NCT02395081|11229047|FG002|STARTED|Overall Study||120
9982423|NCT01606306|11103965|FG000|Completed First Treatment Period|Overall Study||43
9982424|NCT01606306|11103966|FG001|Completed First Treatment Period|Overall Study||47
9982425|NCT01606306|11103967|FG002|Completed First Treatment Period|Overall Study||47
9982426|NCT01606306|11103968|FG003|Completed First Treatment Period|Overall Study||45
9982427|NCT01606306|11103969|FG004|Completed First Treatment Period|Overall Study||47
9982428|NCT01606306|11103970|FG005|Completed First Treatment Period|Overall Study||44
10099919|NCT02395081|11229045|FG000|COMPLETED|Overall Study||112
9982429|NCT01606306|11103965|FG000|Completed Second Treatment Period|Overall Study||41
9982430|NCT01606306|11103966|FG001|Completed Second Treatment Period|Overall Study||38
9982431|NCT01606306|11103967|FG002|Completed Second Treatment Period|Overall Study||43
9982432|NCT01606306|11103968|FG003|Completed Second Treatment Period|Overall Study||44
9982433|NCT01606306|11103969|FG004|Completed Second Treatment Period|Overall Study||46
9982434|NCT01606306|11103970|FG005|Completed Second Treatment Period|Overall Study||41
9982435|NCT01606306|11103965|FG000|Completed Third Treatment Period|Overall Study||35
9982436|NCT01606306|11103966|FG001|Completed Third Treatment Period|Overall Study||39
9982437|NCT01606306|11103967|FG002|Completed Third Treatment Period|Overall Study||37
10099920|NCT02395081|11229046|FG001|COMPLETED|Overall Study||116
10099921|NCT02395081|11229047|FG002|COMPLETED|Overall Study||116
10099922|NCT02395081|11229045|FG000|NOT COMPLETED|Overall Study||7
10099923|NCT02395081|11229046|FG001|NOT COMPLETED|Overall Study||5
10099924|NCT02395081|11229047|FG002|NOT COMPLETED|Overall Study||4
10099925|NCT02395133|11229062|FG000|STARTED|Overall Study||83
10099926|NCT02395133|11229063|FG001|STARTED|Overall Study||84
10099927|NCT02395133|11229064|FG002|STARTED|Overall Study||86
10099928|NCT02395133|11229065|FG003|STARTED|Overall Study||169
10099929|NCT02395133|11229062|FG000|COMPLETED|Overall Study||69
10099930|NCT02395133|11229063|FG001|COMPLETED|Overall Study||75
10099931|NCT02395133|11229064|FG002|COMPLETED|Overall Study||76
10099932|NCT02395133|11229065|FG003|COMPLETED|Overall Study||155
10099933|NCT02395133|11229062|FG000|NOT COMPLETED|Overall Study||14
10099934|NCT02395133|11229063|FG001|NOT COMPLETED|Overall Study||9
10099935|NCT02395133|11229064|FG002|NOT COMPLETED|Overall Study||10
10099936|NCT02395133|11229065|FG003|NOT COMPLETED|Overall Study||14
10099937|NCT02395172|11229077|FG000|STARTED|Overall Study||396
10099938|NCT02395172|11229078|FG001|STARTED|Overall Study||396
10099939|NCT02395172|11229077|FG000|Treated|Overall Study||393
10099940|NCT02395172|11229078|FG001|Treated|Overall Study||365
10099941|NCT02395172|11229077|FG000|COMPLETED|Overall Study||393
10099942|NCT02395172|11229078|FG001|COMPLETED|Overall Study||365
10099943|NCT02395172|11229077|FG000|NOT COMPLETED|Overall Study||3
10099944|NCT02395172|11229078|FG001|NOT COMPLETED|Overall Study||31
10099945|NCT02395185|11229084|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
10099946|NCT02395185|11229084|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
10099947|NCT02395185|11229084|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
10099948|NCT02395185|11229084|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
10099949|NCT02395185|11229084|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
10099950|NCT02395185|11229084|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
10099951|NCT02395185|11229084|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
10099952|NCT02395185|11229084|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
10099953|NCT02395185|11229084|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
10099954|NCT02395185|11229084|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
10099955|NCT02395185|11229084|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
10099956|NCT02395185|11229084|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
10099957|NCT02395185|11229084|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
10099958|NCT02395185|11229084|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
10099959|NCT02395185|11229084|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
10099960|NCT02395185|11229084|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
10099961|NCT02395185|11229084|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
10099962|NCT02395185|11229084|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
10099963|NCT02395185|11229084|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
10099964|NCT02395185|11229084|FG000|COMPLETED|Overall Study||33
10099965|NCT02395185|11229084|FG000|NOT COMPLETED|Overall Study||0
10099966|NCT02395302|11229092|FG000|STARTED|Overall Study||28
10099967|NCT02395302|11229092|FG000|COMPLETED|Overall Study||14
10099968|NCT02395302|11229092|FG000|NOT COMPLETED|Overall Study||14
10099969|NCT02395471|11229098|FG000|STARTED|Overall Study||129
10099970|NCT02395471|11229099|FG001|STARTED|Overall Study||62
10099971|NCT02395471|11229098|FG000|COMPLETED|Overall Study||122
10099972|NCT02395471|11229099|FG001|COMPLETED|Overall Study||59
10099973|NCT02395471|11229098|FG000|NOT COMPLETED|Overall Study||7
10099974|NCT02395471|11229099|FG001|NOT COMPLETED|Overall Study||3
10099975|NCT02395536|11229116|FG000|STARTED|Overall Study||264
10099976|NCT02395536|11229117|FG001|STARTED|Overall Study||257
10099977|NCT02395536|11229116|FG000|REVEAL LINQ Insertion|Overall Study||251
10099978|NCT02395536|11229117|FG001|REVEAL LINQ Insertion|Overall Study||231
10099979|NCT02395536|11229116|FG000|COMPLETED|Overall Study||244
10099980|NCT02395536|11229117|FG001|COMPLETED|Overall Study||227
10099981|NCT02395536|11229116|FG000|NOT COMPLETED|Overall Study||20
10099982|NCT02395536|11229117|FG001|NOT COMPLETED|Overall Study||30
10099983|NCT02395627|11229126|FG000|STARTED|Overall Study||18
10099984|NCT02395627|11229127|FG001|STARTED|Overall Study||16
10099985|NCT02395627|11229128|FG002|STARTED|Overall Study||4
10099986|NCT02395627|11229126|FG000|COMPLETED|Overall Study||15
10099987|NCT02395627|11229127|FG001|COMPLETED|Overall Study||13
10099988|NCT02395627|11229128|FG002|COMPLETED|Overall Study||4
9982438|NCT01606306|11103968|FG003|Completed Third Treatment Period|Overall Study||38
10099989|NCT02395627|11229126|FG000|NOT COMPLETED|Overall Study||3
10099990|NCT02395627|11229127|FG001|NOT COMPLETED|Overall Study||3
10099991|NCT02395627|11229128|FG002|NOT COMPLETED|Overall Study||0
10099992|NCT02395653|11229138|FG000|STARTED|Overall Study||71
10099993|NCT02395653|11229138|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61
10099994|NCT02395653|11229138|FG000|COMPLETED|Overall Study||59
9982439|NCT01606306|11103969|FG004|Completed Third Treatment Period|Overall Study||41
9982440|NCT01606306|11103970|FG005|Completed Third Treatment Period|Overall Study||36
9982441|NCT01606306|11103965|FG000|COMPLETED|Overall Study||35
9982442|NCT01606306|11103966|FG001|COMPLETED|Overall Study||39
9982443|NCT01606306|11103967|FG002|COMPLETED|Overall Study||37
9982444|NCT01606306|11103968|FG003|COMPLETED|Overall Study||38
9982445|NCT01606306|11103969|FG004|COMPLETED|Overall Study||41
9982446|NCT01606306|11103970|FG005|COMPLETED|Overall Study||36
9982447|NCT01606306|11103965|FG000|NOT COMPLETED|Overall Study||15
9982448|NCT01606306|11103966|FG001|NOT COMPLETED|Overall Study||10
9982449|NCT01606306|11103967|FG002|NOT COMPLETED|Overall Study||14
9982450|NCT01606306|11103968|FG003|NOT COMPLETED|Overall Study||13
9982451|NCT01606306|11103969|FG004|NOT COMPLETED|Overall Study||11
9982452|NCT01606306|11103970|FG005|NOT COMPLETED|Overall Study||11
9982453|NCT01606319|11103978|FG000|STARTED|Overall Study||150
9982454|NCT01606319|11103979|FG001|STARTED|Overall Study||150
9982455|NCT01606319|11103978|FG000|COMPLETED|Overall Study||116
9982456|NCT01606319|11103979|FG001|COMPLETED|Overall Study||110
9982457|NCT01606319|11103978|FG000|NOT COMPLETED|Overall Study||34
9982458|NCT01606319|11103979|FG001|NOT COMPLETED|Overall Study||40
9982459|NCT01606670|11103985|FG000|STARTED|Overall Study||93
9982460|NCT01606670|11103985|FG000|Safety Set|Overall Study||93
9982461|NCT01606670|11103985|FG000|Full Analysis Set|Overall Study||70
9982462|NCT01606670|11103985|FG000|COMPLETED|Overall Study||77
9982463|NCT01606670|11103985|FG000|NOT COMPLETED|Overall Study||16
9982464|NCT01606735|11103992|FG000|STARTED|Overall Study||58
9982465|NCT01606735|11103993|FG001|STARTED|Overall Study||56
9982466|NCT01606735|11103994|FG002|STARTED|Overall Study||58
9982467|NCT01606735|11103992|FG000|COMPLETED|Overall Study||58
9982468|NCT01606735|11103993|FG001|COMPLETED|Overall Study||56
9982469|NCT01606735|11103994|FG002|COMPLETED|Overall Study||58
9982470|NCT01606735|11103992|FG000|NOT COMPLETED|Overall Study||0
9982471|NCT01606735|11103993|FG001|NOT COMPLETED|Overall Study||0
9982472|NCT01606735|11103994|FG002|NOT COMPLETED|Overall Study||0
9982473|NCT01606748|11104004|FG000|STARTED|Overall Study||18
9982474|NCT01606748|11104005|FG001|STARTED|Overall Study||17
9982475|NCT01606748|11104004|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
9982476|NCT01606748|11104005|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
9982477|NCT01606748|11104004|FG000|COMPLETED|Overall Study||15
9982478|NCT01606748|11104005|FG001|COMPLETED|Overall Study||17
9982479|NCT01606748|11104004|FG000|NOT COMPLETED|Overall Study||3
9982480|NCT01606748|11104005|FG001|NOT COMPLETED|Overall Study||0
9982481|NCT01606761|11104026|FG000|STARTED|Prior to Week 24||294
9982482|NCT01606761|11104027|FG001|STARTED|Prior to Week 24||292
9982483|NCT01606761|11104028|FG002|STARTED|Prior to Week 24||292
9982484|NCT01606761|11104029|FG003|STARTED|Prior to Week 24||0
9982485|NCT01606761|11104030|FG004|STARTED|Prior to Week 24||0
9982486|NCT01606761|11104026|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
9982487|NCT01606761|11104027|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0
9982488|NCT01606761|11104028|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0
9982489|NCT01606761|11104029|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0
9982490|NCT01606761|11104030|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0
9982491|NCT01606761|11104026|FG000|COMPLETED|Prior to Week 24||252
9982492|NCT01606761|11104027|FG001|COMPLETED|Prior to Week 24||237
9982493|NCT01606761|11104028|FG002|COMPLETED|Prior to Week 24||245
9982494|NCT01606761|11104029|FG003|COMPLETED|Prior to Week 24||0
9982495|NCT01606761|11104030|FG004|COMPLETED|Prior to Week 24||0
9982496|NCT01606761|11104026|FG000|NOT COMPLETED|Prior to Week 24||42
9982497|NCT01606761|11104027|FG001|NOT COMPLETED|Prior to Week 24||55
9982498|NCT01606761|11104028|FG002|NOT COMPLETED|Prior to Week 24||47
9982499|NCT01606761|11104029|FG003|NOT COMPLETED|Prior to Week 24||0
9982500|NCT01606761|11104030|FG004|NOT COMPLETED|Prior to Week 24||0
9982501|NCT01606761|11104026|FG000|STARTED|Week 24 to Week 52||0
10099995|NCT02395653|11229138|FG000|NOT COMPLETED|Overall Study||12
10099996|NCT02395692|11229142|FG000|STARTED|Overall Study||19
10099997|NCT02395692|11229143|FG001|STARTED|Overall Study||0
10099998|NCT02395692|11229142|FG000|COMPLETED|Overall Study||19
10099999|NCT02395692|11229143|FG001|COMPLETED|Overall Study||0
10100000|NCT02395692|11229142|FG000|NOT COMPLETED|Overall Study||0
10100001|NCT02395692|11229143|FG001|NOT COMPLETED|Overall Study||0
10100002|NCT02395822|11229150|FG000|STARTED|Overall Study||17
10100003|NCT02395822|11229150|FG000|COMPLETED|Overall Study||15
10100004|NCT02395822|11229150|FG000|NOT COMPLETED|Overall Study||2
10100005|NCT02395978|11229159|FG000|STARTED|Overall Study||6
10100006|NCT02395978|11229160|FG001|STARTED|Overall Study||6
10100007|NCT02395978|11229161|FG002|STARTED|Overall Study||21
10100008|NCT02395978|11229162|FG003|STARTED|Overall Study||19
10100009|NCT02395978|11229163|FG004|STARTED|Overall Study||20
10100010|NCT02395978|11229159|FG000|COMPLETED|Overall Study||6
10100011|NCT02395978|11229160|FG001|COMPLETED|Overall Study||6
10100012|NCT02395978|11229161|FG002|COMPLETED|Overall Study||19
10100013|NCT02395978|11229162|FG003|COMPLETED|Overall Study||14
10100014|NCT02395978|11229163|FG004|COMPLETED|Overall Study||15
9982502|NCT01606761|11104027|FG001|STARTED|Week 24 to Week 52||237
9982503|NCT01606761|11104028|FG002|STARTED|Week 24 to Week 52||245
9982504|NCT01606761|11104029|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
9982505|NCT01606761|11104030|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
9982506|NCT01606761|11104026|FG000|Treated|Week 24 to Week 52||0
9982507|NCT01606761|11104027|FG001|Treated|Week 24 to Week 52||237
9982508|NCT01606761|11104028|FG002|Treated|Week 24 to Week 52||245
9982509|NCT01606761|11104029|FG003|Treated|Week 24 to Week 52||124
9982510|NCT01606761|11104030|FG004|Treated|Week 24 to Week 52||126
9982511|NCT01606761|11104026|FG000|COMPLETED|Week 24 to Week 52||0
9982512|NCT01606761|11104027|FG001|COMPLETED|Week 24 to Week 52||204
9982513|NCT01606761|11104028|FG002|COMPLETED|Week 24 to Week 52||212
9982514|NCT01606761|11104029|FG003|COMPLETED|Week 24 to Week 52||109
9982515|NCT01606761|11104030|FG004|COMPLETED|Week 24 to Week 52||106
9982516|NCT01606761|11104026|FG000|NOT COMPLETED|Week 24 to Week 52||0
9982517|NCT01606761|11104027|FG001|NOT COMPLETED|Week 24 to Week 52||33
9982518|NCT01606761|11104028|FG002|NOT COMPLETED|Week 24 to Week 52||33
9982519|NCT01606761|11104029|FG003|NOT COMPLETED|Week 24 to Week 52||17
9982520|NCT01606761|11104030|FG004|NOT COMPLETED|Week 24 to Week 52||20
9982521|NCT01606761|11104026|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28
9982522|NCT01606761|11104027|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65
9982523|NCT01606761|11104028|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62
9982524|NCT01606761|11104029|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9
9982525|NCT01606761|11104030|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19
9982526|NCT01606761|11104026|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28
9982527|NCT01606761|11104027|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65
9982528|NCT01606761|11104028|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62
9982529|NCT01606761|11104029|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7
10100015|NCT02395978|11229159|FG000|NOT COMPLETED|Overall Study||0
10100016|NCT02395978|11229160|FG001|NOT COMPLETED|Overall Study||0
10100017|NCT02395978|11229161|FG002|NOT COMPLETED|Overall Study||2
10100018|NCT02395978|11229162|FG003|NOT COMPLETED|Overall Study||5
10100019|NCT02395978|11229163|FG004|NOT COMPLETED|Overall Study||5
10100020|NCT02395991|11229176|FG000|STARTED|Overall Study||60
10100021|NCT02395991|11229176|FG000|COMPLETED|Overall Study||59
10100022|NCT02395991|11229176|FG000|NOT COMPLETED|Overall Study||1
10100023|NCT02396147|11229183|FG000|STARTED|Period 1||27
10100024|NCT02396147|11229184|FG001|STARTED|Period 1||27
10100025|NCT02396147|11229183|FG000|COMPLETED|Period 1||27
10100026|NCT02396147|11229184|FG001|COMPLETED|Period 1||27
10100027|NCT02396147|11229183|FG000|NOT COMPLETED|Period 1||0
10100028|NCT02396147|11229184|FG001|NOT COMPLETED|Period 1||0
10100029|NCT02396147|11229183|FG000|STARTED|Period 2||27
10100030|NCT02396147|11229184|FG001|STARTED|Period 2||27
10100031|NCT02396147|11229183|FG000|COMPLETED|Period 2||27
10100032|NCT02396147|11229184|FG001|COMPLETED|Period 2||27
10100033|NCT02396147|11229183|FG000|NOT COMPLETED|Period 2||0
10100034|NCT02396147|11229184|FG001|NOT COMPLETED|Period 2||0
10100035|NCT02396147|11229183|FG000|STARTED|Period 3||27
10100036|NCT02396147|11229184|FG001|STARTED|Period 3||27
10100037|NCT02396147|11229183|FG000|COMPLETED|Period 3||27
10100038|NCT02396147|11229184|FG001|COMPLETED|Period 3||27
10100039|NCT02396147|11229183|FG000|NOT COMPLETED|Period 3||0
10100040|NCT02396147|11229184|FG001|NOT COMPLETED|Period 3||0
10100041|NCT02396160|11229200|FG000|STARTED|Overall Study||75
10100042|NCT02396160|11229201|FG001|STARTED|Overall Study||75
10100043|NCT02396160|11229200|FG000|COMPLETED|Overall Study||69
10100044|NCT02396160|11229201|FG001|COMPLETED|Overall Study||73
10100045|NCT02396160|11229200|FG000|NOT COMPLETED|Overall Study||6
10100046|NCT02396160|11229201|FG001|NOT COMPLETED|Overall Study||2
10100047|NCT02396212|11229207|FG000|STARTED|Overall Study||19
10100048|NCT02396212|11229207|FG000|COMPLETED|Overall Study||16
10100049|NCT02396212|11229207|FG000|NOT COMPLETED|Overall Study||3
10100050|NCT02396251|11229213|FG000|STARTED|Overall Study||36
10100051|NCT02396251|11229214|FG001|STARTED|Overall Study||12
10100052|NCT02396251|11229213|FG000|COMPLETED|Overall Study||23
10100053|NCT02396251|11229214|FG001|COMPLETED|Overall Study||7
10100054|NCT02396251|11229213|FG000|NOT COMPLETED|Overall Study||13
10100055|NCT02396251|11229214|FG001|NOT COMPLETED|Overall Study||5
10100056|NCT02396316|11229221|FG000|STARTED|Overall Study||27
10100057|NCT02396316|11229222|FG001|STARTED|Overall Study||27
10100058|NCT02396316|11229221|FG000|Treated|Overall Study||27
10100059|NCT02396316|11229222|FG001|Treated|Overall Study||27
10100060|NCT02396316|11229221|FG000|Received Sham Injection at Week 1|Overall Study||10
10100061|NCT02396316|11229222|FG001|Received Sham Injection at Week 1|Overall Study||0
9982530|NCT01606761|11104030|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19
9982531|NCT01606761|11104026|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24
9982532|NCT01606761|11104027|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55
9982533|NCT01606761|11104028|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45
10100062|NCT02396316|11229221|FG000|Received AFL Injection at Week 1|Overall Study||0
10100063|NCT02396316|11229222|FG001|Received AFL Injection at Week 1|Overall Study||22
10100064|NCT02396316|11229221|FG000|Received Active Injection at Week 5|Overall Study||4
10100065|NCT02396316|11229222|FG001|Received Active Injection at Week 5|Overall Study||4
10100066|NCT02396316|11229221|FG000|Received Active Injection at Week 9|Overall Study||2
10100067|NCT02396316|11229222|FG001|Received Active Injection at Week 9|Overall Study||1
10100068|NCT02396316|11229221|FG000|COMPLETED|Overall Study||20
9982534|NCT01606761|11104029|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7
9982535|NCT01606761|11104030|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11
9982536|NCT01606761|11104026|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
9982537|NCT01606761|11104027|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
9982538|NCT01606761|11104028|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
9982539|NCT01606761|11104029|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
9982540|NCT01606761|11104030|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
9982541|NCT01606787|11104047|FG000|STARTED|Overall Study||105
9982542|NCT01606787|11104048|FG001|STARTED|Overall Study||105
9982543|NCT01606787|11104047|FG000|COMPLETED|Overall Study||101
9982544|NCT01606787|11104048|FG001|COMPLETED|Overall Study||98
9982545|NCT01606787|11104047|FG000|NOT COMPLETED|Overall Study||4
9982546|NCT01606787|11104048|FG001|NOT COMPLETED|Overall Study||7
9982547|NCT01606800|11104056|FG000|STARTED|Overall Study||22
9982548|NCT01606800|11104057|FG001|STARTED|Overall Study||23
9982549|NCT01606800|11104056|FG000|Treated|Overall Study||22
9982550|NCT01606800|11104057|FG001|Treated|Overall Study||23
9982551|NCT01606800|11104056|FG000|COMPLETED|Overall Study||17
9982552|NCT01606800|11104057|FG001|COMPLETED|Overall Study||21
9982553|NCT01606800|11104056|FG000|NOT COMPLETED|Overall Study||5
9982554|NCT01606800|11104057|FG001|NOT COMPLETED|Overall Study||2
9982555|NCT01606852|11104065|FG000|STARTED|Overall Study||7
9982556|NCT01606852|11104066|FG001|STARTED|Overall Study||8
9982557|NCT01606852|11104065|FG000|COMPLETED|Overall Study||7
9982558|NCT01606852|11104066|FG001|COMPLETED|Overall Study||8
9982559|NCT01606852|11104065|FG000|NOT COMPLETED|Overall Study||0
9982560|NCT01606852|11104066|FG001|NOT COMPLETED|Overall Study||0
9982561|NCT01607073|11104072|FG000|STARTED|Overall Study||2
9982562|NCT01607073|11104072|FG000|COMPLETED|Overall Study||1
9982563|NCT01607073|11104072|FG000|NOT COMPLETED|Overall Study||1
9982564|NCT01607112|11104081|FG000|STARTED|Overall Study||60
9982565|NCT01607112|11104082|FG001|STARTED|Overall Study||59
9982566|NCT01607112|11104081|FG000|COMPLETED|Overall Study||60
9982567|NCT01607112|11104082|FG001|COMPLETED|Overall Study||59
9982568|NCT01607112|11104081|FG000|NOT COMPLETED|Overall Study||0
9982569|NCT01607112|11104082|FG001|NOT COMPLETED|Overall Study||0
9982570|NCT01607203|11104094|FG000|STARTED|Overall Study||59
9982571|NCT01607203|11104095|FG001|STARTED|Overall Study||61
9982572|NCT01607203|11104094|FG000|COMPLETED|Overall Study||59
9982573|NCT01607203|11104095|FG001|COMPLETED|Overall Study||61
9982574|NCT01607203|11104094|FG000|NOT COMPLETED|Overall Study||0
9982575|NCT01607203|11104095|FG001|NOT COMPLETED|Overall Study||0
9982576|NCT01607255|11104105|FG000|STARTED|Overall Study||161
9982577|NCT01607255|11104106|FG001|STARTED|Overall Study||160
9982578|NCT01607255|11104107|FG002|STARTED|Overall Study||159
10100069|NCT02396316|11229222|FG001|COMPLETED|Overall Study||22
10100070|NCT02396316|11229221|FG000|NOT COMPLETED|Overall Study||7
10100071|NCT02396316|11229222|FG001|NOT COMPLETED|Overall Study||5
10100072|NCT02396381|11229234|FG000|STARTED|Overall Study||488
10100073|NCT02396381|11229235|FG001|STARTED|Overall Study||496
10100074|NCT02396381|11229234|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
10100075|NCT02396381|11229235|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
10100076|NCT02396381|11229234|FG000|COMPLETED|Overall Study||381
10100077|NCT02396381|11229235|FG001|COMPLETED|Overall Study||422
10100078|NCT02396381|11229234|FG000|NOT COMPLETED|Overall Study||107
10100079|NCT02396381|11229235|FG001|NOT COMPLETED|Overall Study||74
10100080|NCT02396420|11229244|FG000|STARTED|Overall Study||2
10100081|NCT02396420|11229244|FG000|1 Month Post PAE|Overall Study||2
10100082|NCT02396420|11229244|FG000|3 Months Post PAE|Overall Study||2
10100083|NCT02396420|11229244|FG000|6 Months Post PAE|Overall Study||2
10100084|NCT02396420|11229244|FG000|COMPLETED|Overall Study||1
10100085|NCT02396420|11229244|FG000|NOT COMPLETED|Overall Study||1
10100086|NCT02396511|11229249|FG000|STARTED|Overall Study||2
10100087|NCT02396511|11229249|FG000|COMPLETED|Overall Study||2
10100088|NCT02396511|11229249|FG000|NOT COMPLETED|Overall Study||0
10100089|NCT02396537|11229255|FG000|STARTED|Overall Study||40
10100090|NCT02396537|11229256|FG001|STARTED|Overall Study||37
10100091|NCT02396537|11229255|FG000|COMPLETED|Overall Study||40
10100092|NCT02396537|11229256|FG001|COMPLETED|Overall Study||36
10100093|NCT02396537|11229255|FG000|NOT COMPLETED|Overall Study||0
10100094|NCT02396537|11229256|FG001|NOT COMPLETED|Overall Study||1
10100095|NCT02396732|11229264|FG000|STARTED|Overall Study||14
9982579|NCT01607255|11104105|FG000|COMPLETED|Overall Study||161
9982580|NCT01607255|11104106|FG001|COMPLETED|Overall Study||160
9982581|NCT01607255|11104107|FG002|COMPLETED|Overall Study||159
9982582|NCT01607255|11104105|FG000|NOT COMPLETED|Overall Study||0
9982583|NCT01607255|11104106|FG001|NOT COMPLETED|Overall Study||0
9982584|NCT01607255|11104107|FG002|NOT COMPLETED|Overall Study||0
9982585|NCT01607346|11104115|FG000|STARTED|Overall Study||10
9982586|NCT01607346|11104115|FG000|COMPLETED|Overall Study||7
9982587|NCT01607346|11104115|FG000|NOT COMPLETED|Overall Study||3
9982588|NCT01607398|11104121|FG000|STARTED|Overall Study||28
9982589|NCT01607398|11104122|FG001|STARTED|Overall Study||28
9982590|NCT01607398|11104121|FG000|COMPLETED|Overall Study||26
9982591|NCT01607398|11104122|FG001|COMPLETED|Overall Study||26
9982592|NCT01607398|11104121|FG000|NOT COMPLETED|Overall Study||2
9982593|NCT01607398|11104122|FG001|NOT COMPLETED|Overall Study||2
9982594|NCT01607411|11104128|FG000|STARTED|Period I||14
9982595|NCT01607411|11104129|FG001|STARTED|Period I||13
9982596|NCT01607411|11104130|FG002|STARTED|Period I||14
10100096|NCT02396732|11229265|FG001|STARTED|Overall Study||17
9982597|NCT01607411|11104131|FG003|STARTED|Period I||14
9982598|NCT01607411|11104128|FG000|COMPLETED|Period I||14
9982599|NCT01607411|11104129|FG001|COMPLETED|Period I||13
9982600|NCT01607411|11104130|FG002|COMPLETED|Period I||14
9982601|NCT01607411|11104131|FG003|COMPLETED|Period I||14
9982602|NCT01607411|11104128|FG000|NOT COMPLETED|Period I||0
9982603|NCT01607411|11104129|FG001|NOT COMPLETED|Period I||0
9982604|NCT01607411|11104130|FG002|NOT COMPLETED|Period I||0
9982605|NCT01607411|11104131|FG003|NOT COMPLETED|Period I||0
9982606|NCT01607411|11104128|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
9982607|NCT01607411|11104129|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
9982608|NCT01607411|11104130|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
9982609|NCT01607411|11104131|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
9982610|NCT01607411|11104128|FG000|COMPLETED|Period II||14
9982611|NCT01607411|11104129|FG001|COMPLETED|Period II||14
9982612|NCT01607411|11104130|FG002|COMPLETED|Period II||13
9982613|NCT01607411|11104131|FG003|COMPLETED|Period II||14
9982614|NCT01607411|11104128|FG000|NOT COMPLETED|Period II||0
9982615|NCT01607411|11104129|FG001|NOT COMPLETED|Period II||0
9982616|NCT01607411|11104130|FG002|NOT COMPLETED|Period II||0
9982617|NCT01607411|11104131|FG003|NOT COMPLETED|Period II||0
9982618|NCT01607411|11104128|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
9982619|NCT01607411|11104129|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
9982620|NCT01607411|11104130|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
9982621|NCT01607411|11104131|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
9982622|NCT01607411|11104128|FG000|COMPLETED|Period III||14
9982623|NCT01607411|11104129|FG001|COMPLETED|Period III||14
9982624|NCT01607411|11104130|FG002|COMPLETED|Period III||14
10100097|NCT02396732|11229264|FG000|COMPLETED|Overall Study||14
10100098|NCT02396732|11229265|FG001|COMPLETED|Overall Study||17
10100099|NCT02396732|11229264|FG000|NOT COMPLETED|Overall Study||0
10100100|NCT02396732|11229265|FG001|NOT COMPLETED|Overall Study||0
10100101|NCT02396745|11229271|FG000|STARTED|Overall Study||1
10100102|NCT02396745|11229271|FG000|COMPLETED|Overall Study||1
10100103|NCT02396745|11229271|FG000|NOT COMPLETED|Overall Study||0
10100104|NCT02396758|11229279|FG000|STARTED|Overall Study||38
10100105|NCT02396758|11229280|FG001|STARTED|Overall Study||37
10100106|NCT02396758|11229281|FG002|STARTED|Overall Study||38
10100107|NCT02396758|11229282|FG003|STARTED|Overall Study||18
10100108|NCT02396758|11229279|FG000|COMPLETED|Overall Study||26
10100109|NCT02396758|11229280|FG001|COMPLETED|Overall Study||31
10100110|NCT02396758|11229281|FG002|COMPLETED|Overall Study||34
10100111|NCT02396758|11229282|FG003|COMPLETED|Overall Study||13
10100112|NCT02396758|11229279|FG000|NOT COMPLETED|Overall Study||12
10100113|NCT02396758|11229280|FG001|NOT COMPLETED|Overall Study||6
10100114|NCT02396758|11229281|FG002|NOT COMPLETED|Overall Study||4
10100115|NCT02396758|11229282|FG003|NOT COMPLETED|Overall Study||5
10100116|NCT02396849|11229294|FG000|STARTED|Overall Study||29
10100117|NCT02396849|11229295|FG001|STARTED|Overall Study||30
10100118|NCT02396849|11229294|FG000|COMPLETED|Overall Study||27
10100119|NCT02396849|11229295|FG001|COMPLETED|Overall Study||28
10100120|NCT02396849|11229294|FG000|NOT COMPLETED|Overall Study||2
10100121|NCT02396849|11229295|FG001|NOT COMPLETED|Overall Study||2
10100122|NCT02396953|11229306|FG000|STARTED|Overall Study||9
10100123|NCT02396953|11229307|FG001|STARTED|Overall Study||9
10100124|NCT02396953|11229308|FG002|STARTED|Overall Study||10
10100125|NCT02396953|11229306|FG000|COMPLETED|Overall Study||5
9982625|NCT01607411|11104131|FG003|COMPLETED|Period III||13
9982626|NCT01607411|11104128|FG000|NOT COMPLETED|Period III||0
9982627|NCT01607411|11104129|FG001|NOT COMPLETED|Period III||0
9982628|NCT01607411|11104130|FG002|NOT COMPLETED|Period III||0
9982629|NCT01607411|11104131|FG003|NOT COMPLETED|Period III||0
9982630|NCT01607411|11104128|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
9982631|NCT01607411|11104129|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
9982632|NCT01607411|11104130|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
9982633|NCT01607411|11104131|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
9982634|NCT01607411|11104128|FG000|COMPLETED|Period IV||13
9982635|NCT01607411|11104129|FG001|COMPLETED|Period IV||14
9982636|NCT01607411|11104130|FG002|COMPLETED|Period IV||14
9982637|NCT01607411|11104131|FG003|COMPLETED|Period IV||14
9982638|NCT01607411|11104128|FG000|NOT COMPLETED|Period IV||0
9982639|NCT01607411|11104129|FG001|NOT COMPLETED|Period IV||0
9982640|NCT01607411|11104130|FG002|NOT COMPLETED|Period IV||0
9982641|NCT01607411|11104131|FG003|NOT COMPLETED|Period IV||0
9982642|NCT01607450|11104148|FG000|STARTED|Overall Study||6
9982643|NCT01607450|11104149|FG001|STARTED|Overall Study||8
9982644|NCT01607450|11104150|FG002|STARTED|Overall Study||7
9982645|NCT01607450|11104151|FG003|STARTED|Overall Study||11
9982646|NCT01607450|11104152|FG004|STARTED|Overall Study||1
9982647|NCT01607450|11104153|FG005|STARTED|Overall Study||0
9982648|NCT01607450|11104154|FG006|STARTED|Overall Study||0
10100126|NCT02396953|11229307|FG001|COMPLETED|Overall Study||6
9982649|NCT01607450|11104148|FG000|COMPLETED|Overall Study||6
10100127|NCT02396953|11229308|FG002|COMPLETED|Overall Study||7
10100128|NCT02396953|11229306|FG000|NOT COMPLETED|Overall Study||4
9982650|NCT01607450|11104149|FG001|COMPLETED|Overall Study||8
9982651|NCT01607450|11104150|FG002|COMPLETED|Overall Study||7
9982652|NCT01607450|11104151|FG003|COMPLETED|Overall Study||11
9982653|NCT01607450|11104152|FG004|COMPLETED|Overall Study||1
9982654|NCT01607450|11104153|FG005|COMPLETED|Overall Study||0
9982655|NCT01607450|11104154|FG006|COMPLETED|Overall Study||0
9982656|NCT01607450|11104148|FG000|NOT COMPLETED|Overall Study||0
9982657|NCT01607450|11104149|FG001|NOT COMPLETED|Overall Study||0
9982658|NCT01607450|11104150|FG002|NOT COMPLETED|Overall Study||0
9982659|NCT01607450|11104151|FG003|NOT COMPLETED|Overall Study||0
9982660|NCT01607450|11104152|FG004|NOT COMPLETED|Overall Study||0
9982661|NCT01607450|11104153|FG005|NOT COMPLETED|Overall Study||0
9982662|NCT01607450|11104154|FG006|NOT COMPLETED|Overall Study||0
9982663|NCT01607476|11104178|FG000|STARTED|Overall Study||25
9982664|NCT01607476|11104179|FG001|STARTED|Overall Study||30
9982665|NCT01607476|11104180|FG002|STARTED|Overall Study||33
9982666|NCT01607476|11104178|FG000|COMPLETED|Overall Study||24
9982667|NCT01607476|11104179|FG001|COMPLETED|Overall Study||30
9982668|NCT01607476|11104180|FG002|COMPLETED|Overall Study||30
9982669|NCT01607476|11104178|FG000|NOT COMPLETED|Overall Study||1
9982670|NCT01607476|11104179|FG001|NOT COMPLETED|Overall Study||0
9982671|NCT01607476|11104180|FG002|NOT COMPLETED|Overall Study||3
9982672|NCT01607554|11104188|FG000|STARTED|Overall Study||2
9982673|NCT01607554|11104188|FG000|COMPLETED|Overall Study||0
9982674|NCT01607554|11104188|FG000|NOT COMPLETED|Overall Study||2
9982675|NCT01607593|11104192|FG000|STARTED|Overall Study||122
9982676|NCT01607593|11104192|FG000|COMPLETED|Overall Study||29
9982677|NCT01607593|11104192|FG000|NOT COMPLETED|Overall Study||93
9982678|NCT01607645|11104198|FG000|STARTED|Overall Study||4
9982679|NCT01607645|11104199|FG001|STARTED|Overall Study||3
9982680|NCT01607645|11104198|FG000|COMPLETED|Overall Study||4
9982681|NCT01607645|11104199|FG001|COMPLETED|Overall Study||3
9982682|NCT01607645|11104198|FG000|NOT COMPLETED|Overall Study||0
9982683|NCT01607645|11104199|FG001|NOT COMPLETED|Overall Study||0
9982684|NCT01607658|11104209|FG000|STARTED|Overall Study||65
9982685|NCT01607658|11104210|FG001|STARTED|Overall Study||67
9982686|NCT01607658|11104211|FG002|STARTED|Overall Study||58
9982687|NCT01607658|11104212|FG003|STARTED|Overall Study||63
9982688|NCT01607658|11104209|FG000|COMPLETED|Overall Study||56
9982689|NCT01607658|11104210|FG001|COMPLETED|Overall Study||56
9982690|NCT01607658|11104211|FG002|COMPLETED|Overall Study||47
9982691|NCT01607658|11104212|FG003|COMPLETED|Overall Study||52
9982692|NCT01607658|11104209|FG000|NOT COMPLETED|Overall Study||9
9982693|NCT01607658|11104210|FG001|NOT COMPLETED|Overall Study||11
9982694|NCT01607658|11104211|FG002|NOT COMPLETED|Overall Study||11
9982695|NCT01607658|11104212|FG003|NOT COMPLETED|Overall Study||11
9982696|NCT01607853|11104222|FG000|STARTED|Overall Study||24
9982697|NCT01607853|11104222|FG000|COMPLETED|Overall Study||24
9982698|NCT01607853|11104222|FG000|NOT COMPLETED|Overall Study||0
9982699|NCT01607892|11104234|FG000|STARTED|Overall Study||58
9982700|NCT01607892|11104235|FG001|STARTED|Overall Study||27
9982701|NCT01607892|11104236|FG002|STARTED|Overall Study||81
9982702|NCT01607892|11104237|FG003|STARTED|Overall Study||95
9982703|NCT01607892|11104238|FG004|STARTED|Overall Study||24
9982704|NCT01607892|11104234|FG000|COMPLETED|Overall Study||0
9982705|NCT01607892|11104235|FG001|COMPLETED|Overall Study||0
9982706|NCT01607892|11104236|FG002|COMPLETED|Overall Study||0
9982707|NCT01607892|11104237|FG003|COMPLETED|Overall Study||0
9982708|NCT01607892|11104238|FG004|COMPLETED|Overall Study||0
9982709|NCT01607892|11104234|FG000|NOT COMPLETED|Overall Study||58
9982710|NCT01607892|11104235|FG001|NOT COMPLETED|Overall Study||27
9982711|NCT01607892|11104236|FG002|NOT COMPLETED|Overall Study||81
9982712|NCT01607892|11104237|FG003|NOT COMPLETED|Overall Study||95
9982713|NCT01607892|11104238|FG004|NOT COMPLETED|Overall Study||24
9982714|NCT01607905|11104271|FG000|STARTED|Overall Study||60
9982715|NCT01607905|11104272|FG001|STARTED|Overall Study||20
10100129|NCT02396953|11229307|FG001|NOT COMPLETED|Overall Study||3
10100130|NCT02396953|11229308|FG002|NOT COMPLETED|Overall Study||3
10100131|NCT02397057|11229325|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105
10100132|NCT02397057|11229326|FG001|STARTED|Overall Study||104
10100133|NCT02397057|11229325|FG000|COMPLETED|Overall Study||94
9982716|NCT01607905|11104273|FG002|STARTED|Overall Study||21
9982717|NCT01607905|11104274|FG003|STARTED|Overall Study||21
9982718|NCT01607905|11104275|FG004|STARTED|Overall Study||7
9982719|NCT01607905|11104276|FG005|STARTED|Overall Study||15
9982720|NCT01607905|11104277|FG006|STARTED|Overall Study||47
9982721|NCT01607905|11104271|FG000|Received Study Drug|Overall Study||59
9982722|NCT01607905|11104272|FG001|Received Study Drug|Overall Study||20
9982723|NCT01607905|11104273|FG002|Received Study Drug|Overall Study||21
9982724|NCT01607905|11104274|FG003|Received Study Drug|Overall Study||21
9982725|NCT01607905|11104275|FG004|Received Study Drug|Overall Study||6
9982726|NCT01607905|11104276|FG005|Received Study Drug|Overall Study||15
9982727|NCT01607905|11104277|FG006|Received Study Drug|Overall Study||47
9982728|NCT01607905|11104271|FG000|Low Dose (<30 mg/m^2)|Overall Study||16
9982729|NCT01607905|11104272|FG001|Low Dose (<30 mg/m^2)|Overall Study||5
9982730|NCT01607905|11104273|FG002|Low Dose (<30 mg/m^2)|Overall Study||3
9982731|NCT01607905|11104274|FG003|Low Dose (<30 mg/m^2)|Overall Study||0
9982732|NCT01607905|11104275|FG004|Low Dose (<30 mg/m^2)|Overall Study||0
9982733|NCT01607905|11104276|FG005|Low Dose (<30 mg/m^2)|Overall Study||2
9982734|NCT01607905|11104277|FG006|Low Dose (<30 mg/m^2)|Overall Study||8
9982735|NCT01607905|11104271|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
10100134|NCT02397057|11229326|FG001|COMPLETED|Overall Study||91
10100135|NCT02397057|11229325|FG000|NOT COMPLETED|Overall Study||11
10100136|NCT02397057|11229326|FG001|NOT COMPLETED|Overall Study||13
10100137|NCT02397096|11229334|FG000|STARTED|Day 1 to Week 24||447
10100138|NCT02397096|11229335|FG001|STARTED|Day 1 to Week 24||223
10100139|NCT02397096|11229334|FG000|COMPLETED|Day 1 to Week 24||427
10100140|NCT02397096|11229335|FG001|COMPLETED|Day 1 to Week 24||209
10100141|NCT02397096|11229334|FG000|NOT COMPLETED|Day 1 to Week 24||20
10100142|NCT02397096|11229335|FG001|NOT COMPLETED|Day 1 to Week 24||14
10100143|NCT02397096|11229334|FG000|STARTED|Week 24 to Week 48||427
10100144|NCT02397096|11229335|FG001|STARTED|Week 24 to Week 48||209
10100145|NCT02397096|11229334|FG000|COMPLETED|Week 24 to Week 48||407
9982736|NCT01607905|11104272|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
9982737|NCT01607905|11104273|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
9982738|NCT01607905|11104274|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
9982739|NCT01607905|11104275|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
9982740|NCT01607905|11104276|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
9982741|NCT01607905|11104277|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
9982742|NCT01607905|11104271|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16
9982743|NCT01607905|11104272|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4
9982744|NCT01607905|11104273|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3
9982745|NCT01607905|11104274|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13
9982746|NCT01607905|11104275|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0
9982747|NCT01607905|11104276|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10
9982748|NCT01607905|11104277|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18
9982749|NCT01607905|11104271|FG000|COMPLETED|Overall Study||0
9982750|NCT01607905|11104272|FG001|COMPLETED|Overall Study||0
9982751|NCT01607905|11104273|FG002|COMPLETED|Overall Study||0
9982752|NCT01607905|11104274|FG003|COMPLETED|Overall Study||0
9982753|NCT01607905|11104275|FG004|COMPLETED|Overall Study||0
9982754|NCT01607905|11104276|FG005|COMPLETED|Overall Study||0
9982755|NCT01607905|11104277|FG006|COMPLETED|Overall Study||0
9982756|NCT01607905|11104271|FG000|NOT COMPLETED|Overall Study||60
9982757|NCT01607905|11104272|FG001|NOT COMPLETED|Overall Study||20
9982758|NCT01607905|11104273|FG002|NOT COMPLETED|Overall Study||21
9982759|NCT01607905|11104274|FG003|NOT COMPLETED|Overall Study||21
9982760|NCT01607905|11104275|FG004|NOT COMPLETED|Overall Study||7
9982761|NCT01607905|11104276|FG005|NOT COMPLETED|Overall Study||15
9982762|NCT01607905|11104277|FG006|NOT COMPLETED|Overall Study||47
9982763|NCT01607957|11104337|FG000|STARTED|Overall Study||534
9982764|NCT01607957|11104338|FG001|STARTED|Overall Study||266
9982765|NCT01607957|11104337|FG000|Treated|Overall Study||533
10100146|NCT02397096|11229335|FG001|COMPLETED|Week 24 to Week 48||202
10100147|NCT02397096|11229334|FG000|NOT COMPLETED|Week 24 to Week 48||20
10100148|NCT02397096|11229335|FG001|NOT COMPLETED|Week 24 to Week 48||7
10100149|NCT02397096|11229334|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
10100150|NCT02397096|11229335|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
10100151|NCT02397096|11229334|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0
10100152|NCT02397096|11229335|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0
10100153|NCT02397096|11229334|FG000|NOT COMPLETED|Study Extensions||399
10100154|NCT02397096|11229335|FG001|NOT COMPLETED|Study Extensions||202
10100155|NCT02397122|11229347|FG000|STARTED|Overall Study||20
10100156|NCT02397122|11229348|FG001|STARTED|Overall Study||20
10100157|NCT02397122|11229347|FG000|COMPLETED|Overall Study||20
9982766|NCT01607957|11104338|FG001|Treated|Overall Study||265
9982767|NCT01607957|11104337|FG000|COMPLETED|Overall Study||162
9982768|NCT01607957|11104338|FG001|COMPLETED|Overall Study||51
9982769|NCT01607957|11104337|FG000|NOT COMPLETED|Overall Study||372
9982770|NCT01607957|11104338|FG001|NOT COMPLETED|Overall Study||215
9982771|NCT01608061|11104346|FG000|STARTED|Blinded Period||21
9982772|NCT01608061|11104347|FG001|STARTED|Blinded Period||21
9982773|NCT01608061|11104346|FG000|COMPLETED|Blinded Period||21
9982774|NCT01608061|11104347|FG001|COMPLETED|Blinded Period||21
9982775|NCT01608061|11104346|FG000|NOT COMPLETED|Blinded Period||0
9982776|NCT01608061|11104347|FG001|NOT COMPLETED|Blinded Period||0
9982777|NCT01608061|11104346|FG000|STARTED|Long Term Follow-Up||21
9982778|NCT01608061|11104347|FG001|STARTED|Long Term Follow-Up||21
9982779|NCT01608061|11104346|FG000|COMPLETED|Long Term Follow-Up||14
9982780|NCT01608061|11104347|FG001|COMPLETED|Long Term Follow-Up||16
9982781|NCT01608061|11104346|FG000|NOT COMPLETED|Long Term Follow-Up||7
9982782|NCT01608061|11104347|FG001|NOT COMPLETED|Long Term Follow-Up||5
9982783|NCT01608061|11104346|FG000|STARTED|Extension Period||14
9982784|NCT01608061|11104347|FG001|STARTED|Extension Period||16
9982785|NCT01608061|11104346|FG000|COMPLETED|Extension Period||14
9982786|NCT01608061|11104347|FG001|COMPLETED|Extension Period||14
9982787|NCT01608061|11104346|FG000|NOT COMPLETED|Extension Period||0
9982788|NCT01608061|11104347|FG001|NOT COMPLETED|Extension Period||2
9982789|NCT01608087|11104357|FG000|STARTED|Overall Study||30
9982790|NCT01608087|11104358|FG001|STARTED|Overall Study||30
10100158|NCT02397122|11229348|FG001|COMPLETED|Overall Study||20
10100159|NCT02397122|11229347|FG000|NOT COMPLETED|Overall Study||0
10100160|NCT02397122|11229348|FG001|NOT COMPLETED|Overall Study||0
10100161|NCT02397265|11229358|FG000|STARTED|First Intervention of Three||2
10100162|NCT02397265|11229359|FG001|STARTED|First Intervention of Three||2
9982791|NCT01608087|11104359|FG002|STARTED|Overall Study||31
9982792|NCT01608087|11104357|FG000|COMPLETED|Overall Study||30
9982793|NCT01608087|11104358|FG001|COMPLETED|Overall Study||28
9982794|NCT01608087|11104359|FG002|COMPLETED|Overall Study||31
9982795|NCT01608087|11104357|FG000|NOT COMPLETED|Overall Study||0
9982796|NCT01608087|11104358|FG001|NOT COMPLETED|Overall Study||2
9982797|NCT01608087|11104359|FG002|NOT COMPLETED|Overall Study||0
9982798|NCT01608100|11104367|FG000|STARTED|Overall Study||1101
9982799|NCT01608100|11104367|FG000|COMPLETED|Overall Study||1101
9982800|NCT01608100|11104367|FG000|NOT COMPLETED|Overall Study||0
9982801|NCT01608295|11104393|FG000|STARTED|Overall Study||26
9982802|NCT01608295|11104394|FG001|STARTED|Overall Study||30
9982803|NCT01608295|11104393|FG000|COMPLETED|Overall Study||20
9982804|NCT01608295|11104394|FG001|COMPLETED|Overall Study||25
9982805|NCT01608295|11104393|FG000|NOT COMPLETED|Overall Study||6
9982806|NCT01608295|11104394|FG001|NOT COMPLETED|Overall Study||5
9982807|NCT01608308|11104405|FG000|STARTED|Overall Study||31
9982808|NCT01608308|11104406|FG001|STARTED|Overall Study||31
9982809|NCT01608308|11104405|FG000|COMPLETED|Overall Study||31
9982810|NCT01608308|11104406|FG001|COMPLETED|Overall Study||29
9982811|NCT01608308|11104405|FG000|NOT COMPLETED|Overall Study||0
9982812|NCT01608308|11104406|FG001|NOT COMPLETED|Overall Study||2
9982813|NCT01608321|11104414|FG000|STARTED|Overall Study||13
9982814|NCT01608321|11104415|FG001|STARTED|Overall Study||4
9982815|NCT01608321|11104414|FG000|COMPLETED|Overall Study||12
9982816|NCT01608321|11104415|FG001|COMPLETED|Overall Study||4
9982817|NCT01608321|11104414|FG000|NOT COMPLETED|Overall Study||1
9982818|NCT01608321|11104415|FG001|NOT COMPLETED|Overall Study||0
9982819|NCT01608490|11104423|FG000|STARTED|Overall Study||158
9982820|NCT01608490|11104424|FG001|STARTED|Overall Study||157
9982821|NCT01608490|11104423|FG000|COMPLETED|Overall Study||141
9982822|NCT01608490|11104424|FG001|COMPLETED|Overall Study||142
9982823|NCT01608490|11104423|FG000|NOT COMPLETED|Overall Study||17
9982824|NCT01608490|11104424|FG001|NOT COMPLETED|Overall Study||15
9982825|NCT01608659|11104430|FG000|STARTED|Overall Study||110
9982826|NCT01608659|11104430|FG000|COMPLETED|Overall Study||94
9982827|NCT01608659|11104430|FG000|NOT COMPLETED|Overall Study||16
9982828|NCT01608672|11104434|FG000|STARTED|Overall Study||207
9982829|NCT01608672|11104434|FG000|COMPLETED|Overall Study||207
9982830|NCT01608672|11104434|FG000|NOT COMPLETED|Overall Study||0
9982831|NCT01608724|11104438|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
9982832|NCT01608724|11104438|FG000|Treated|Overall Study||1361
9982833|NCT01608724|11104438|FG000|COMPLETED|Overall Study||1180
10100163|NCT02397265|11229360|FG002|STARTED|First Intervention of Three||2
10100164|NCT02397265|11229358|FG000|COMPLETED|First Intervention of Three||2
10100165|NCT02397265|11229359|FG001|COMPLETED|First Intervention of Three||2
10100166|NCT02397265|11229360|FG002|COMPLETED|First Intervention of Three||2
10100167|NCT02397265|11229358|FG000|NOT COMPLETED|First Intervention of Three||0
10100168|NCT02397265|11229359|FG001|NOT COMPLETED|First Intervention of Three||0
10100169|NCT02397265|11229360|FG002|NOT COMPLETED|First Intervention of Three||0
10100170|NCT02397265|11229358|FG000|STARTED|Second Intervention of Three||2
10100171|NCT02397265|11229359|FG001|STARTED|Second Intervention of Three||2
10100172|NCT02397265|11229360|FG002|STARTED|Second Intervention of Three||2
10100173|NCT02397265|11229358|FG000|COMPLETED|Second Intervention of Three||2
10100174|NCT02397265|11229359|FG001|COMPLETED|Second Intervention of Three||2
10100175|NCT02397265|11229360|FG002|COMPLETED|Second Intervention of Three||2
10100176|NCT02397265|11229358|FG000|NOT COMPLETED|Second Intervention of Three||0
10100177|NCT02397265|11229359|FG001|NOT COMPLETED|Second Intervention of Three||0
10100178|NCT02397265|11229360|FG002|NOT COMPLETED|Second Intervention of Three||0
10100179|NCT02397265|11229358|FG000|STARTED|Third Intervention of Three||2
10100180|NCT02397265|11229359|FG001|STARTED|Third Intervention of Three||2
10100181|NCT02397265|11229360|FG002|STARTED|Third Intervention of Three||2
10100182|NCT02397265|11229358|FG000|COMPLETED|Third Intervention of Three||2
10100183|NCT02397265|11229359|FG001|COMPLETED|Third Intervention of Three||2
10100184|NCT02397265|11229360|FG002|COMPLETED|Third Intervention of Three||2
10100185|NCT02397265|11229358|FG000|NOT COMPLETED|Third Intervention of Three||0
10100186|NCT02397265|11229359|FG001|NOT COMPLETED|Third Intervention of Three||0
10100187|NCT02397265|11229360|FG002|NOT COMPLETED|Third Intervention of Three||0
10100188|NCT02397278|11229370|FG000|STARTED|Overall Study||7
9982834|NCT01608724|11104438|FG000|NOT COMPLETED|Overall Study||243
9982835|NCT01608815|11104445|FG000|STARTED|Overall Study||188
9982836|NCT01608815|11104446|FG001|STARTED|Overall Study||7
9982837|NCT01608815|11104447|FG002|STARTED|Overall Study||5
9982838|NCT01608815|11104445|FG000|COMPLETED|Overall Study||188
9982839|NCT01608815|11104446|FG001|COMPLETED|Overall Study||7
9982840|NCT01608815|11104447|FG002|COMPLETED|Overall Study||5
9982841|NCT01608815|11104445|FG000|NOT COMPLETED|Overall Study||0
9982842|NCT01608815|11104446|FG001|NOT COMPLETED|Overall Study||0
10100189|NCT02397278|11229371|FG001|STARTED|Overall Study||8
10100190|NCT02397278|11229370|FG000|COMPLETED|Overall Study||6
10100191|NCT02397278|11229371|FG001|COMPLETED|Overall Study||5
9982843|NCT01608815|11104447|FG002|NOT COMPLETED|Overall Study||0
9982844|NCT01608971|11104458|FG000|STARTED|Overall Study||15
9982845|NCT01608971|11104459|FG001|STARTED|Overall Study||15
9982846|NCT01608971|11104458|FG000|COMPLETED|Overall Study||15
9982847|NCT01608971|11104459|FG001|COMPLETED|Overall Study||15
9982848|NCT01608971|11104458|FG000|NOT COMPLETED|Overall Study||0
9982849|NCT01608971|11104459|FG001|NOT COMPLETED|Overall Study||0
9982850|NCT01609010|11104469|FG000|STARTED|Overall Study||156
9982851|NCT01609010|11104470|FG001|STARTED|Overall Study||157
9982852|NCT01609010|11104469|FG000|Entering Cycle 2|Overall Study||120
9982853|NCT01609010|11104470|FG001|Entering Cycle 2|Overall Study||124
9982854|NCT01609010|11104469|FG000|COMPLETED|Overall Study||113
9982855|NCT01609010|11104470|FG001|COMPLETED|Overall Study||120
10100192|NCT02397278|11229370|FG000|NOT COMPLETED|Overall Study||1
10100193|NCT02397278|11229371|FG001|NOT COMPLETED|Overall Study||3
10100194|NCT02397291|11229379|FG000|STARTED|Overall Study||19
10100195|NCT02397291|11229380|FG001|STARTED|Overall Study||5
10100196|NCT02397291|11229379|FG000|COMPLETED|Overall Study||19
10100197|NCT02397291|11229380|FG001|COMPLETED|Overall Study||5
10100198|NCT02397291|11229379|FG000|NOT COMPLETED|Overall Study||0
10100199|NCT02397291|11229380|FG001|NOT COMPLETED|Overall Study||0
10100200|NCT02397408|11229386|FG000|STARTED|Overall Study||18
10100201|NCT02397408|11229386|FG000|Completed Surgery Per Protocol|Overall Study||16
10100202|NCT02397408|11229386|FG000|COMPLETED|Overall Study||12
10100203|NCT02397408|11229386|FG000|NOT COMPLETED|Overall Study||6
10100204|NCT02397447|11229392|FG000|STARTED|Overall Study||12
10100205|NCT02397447|11229393|FG001|STARTED|Overall Study||12
10100206|NCT02397447|11229392|FG000|COMPLETED|Overall Study||10
10100207|NCT02397447|11229393|FG001|COMPLETED|Overall Study||10
10100208|NCT02397447|11229392|FG000|NOT COMPLETED|Overall Study||2
10100209|NCT02397447|11229393|FG001|NOT COMPLETED|Overall Study||2
10100210|NCT02397460|11229407|FG000|STARTED|Treatment Period 1||7
10100211|NCT02397460|11229408|FG001|STARTED|Treatment Period 1||7
10100212|NCT02397460|11229409|FG002|STARTED|Treatment Period 1||6
10100213|NCT02397460|11229410|FG003|STARTED|Treatment Period 1||6
10100214|NCT02397460|11229411|FG004|STARTED|Treatment Period 1||6
10100215|NCT02397460|11229412|FG005|STARTED|Treatment Period 1||6
10100216|NCT02397460|11229413|FG006|STARTED|Treatment Period 1||6
10100217|NCT02397460|11229414|FG007|STARTED|Treatment Period 1||6
10100218|NCT02397460|11229407|FG000|COMPLETED|Treatment Period 1||7
10100219|NCT02397460|11229408|FG001|COMPLETED|Treatment Period 1||7
10100220|NCT02397460|11229409|FG002|COMPLETED|Treatment Period 1||6
10100221|NCT02397460|11229410|FG003|COMPLETED|Treatment Period 1||6
10100222|NCT02397460|11229411|FG004|COMPLETED|Treatment Period 1||6
10100223|NCT02397460|11229412|FG005|COMPLETED|Treatment Period 1||6
10100224|NCT02397460|11229413|FG006|COMPLETED|Treatment Period 1||6
10100225|NCT02397460|11229414|FG007|COMPLETED|Treatment Period 1||6
10100226|NCT02397460|11229407|FG000|NOT COMPLETED|Treatment Period 1||0
10100227|NCT02397460|11229408|FG001|NOT COMPLETED|Treatment Period 1||0
10100228|NCT02397460|11229409|FG002|NOT COMPLETED|Treatment Period 1||0
10100229|NCT02397460|11229410|FG003|NOT COMPLETED|Treatment Period 1||0
10100230|NCT02397460|11229411|FG004|NOT COMPLETED|Treatment Period 1||0
10100231|NCT02397460|11229412|FG005|NOT COMPLETED|Treatment Period 1||0
10100232|NCT02397460|11229413|FG006|NOT COMPLETED|Treatment Period 1||0
10100233|NCT02397460|11229414|FG007|NOT COMPLETED|Treatment Period 1||0
10100234|NCT02397460|11229407|FG000|STARTED|Treatment Period 2||7
10100235|NCT02397460|11229408|FG001|STARTED|Treatment Period 2||7
10100236|NCT02397460|11229409|FG002|STARTED|Treatment Period 2||6
10100237|NCT02397460|11229410|FG003|STARTED|Treatment Period 2||6
10100238|NCT02397460|11229411|FG004|STARTED|Treatment Period 2||6
10100239|NCT02397460|11229412|FG005|STARTED|Treatment Period 2||6
10100240|NCT02397460|11229413|FG006|STARTED|Treatment Period 2||6
10100241|NCT02397460|11229414|FG007|STARTED|Treatment Period 2||6
10100242|NCT02397460|11229407|FG000|COMPLETED|Treatment Period 2||7
10100243|NCT02397460|11229408|FG001|COMPLETED|Treatment Period 2||7
10100244|NCT02397460|11229409|FG002|COMPLETED|Treatment Period 2||6
10100245|NCT02397460|11229410|FG003|COMPLETED|Treatment Period 2||6
10100246|NCT02397460|11229411|FG004|COMPLETED|Treatment Period 2||6
10100247|NCT02397460|11229412|FG005|COMPLETED|Treatment Period 2||6
10100248|NCT02397460|11229413|FG006|COMPLETED|Treatment Period 2||6
10100249|NCT02397460|11229414|FG007|COMPLETED|Treatment Period 2||5
10100250|NCT02397460|11229407|FG000|NOT COMPLETED|Treatment Period 2||0
10100251|NCT02397460|11229408|FG001|NOT COMPLETED|Treatment Period 2||0
10100252|NCT02397460|11229409|FG002|NOT COMPLETED|Treatment Period 2||0
10100253|NCT02397460|11229410|FG003|NOT COMPLETED|Treatment Period 2||0
10100254|NCT02397460|11229411|FG004|NOT COMPLETED|Treatment Period 2||0
10100255|NCT02397460|11229412|FG005|NOT COMPLETED|Treatment Period 2||0
10100256|NCT02397460|11229413|FG006|NOT COMPLETED|Treatment Period 2||0
10100257|NCT02397460|11229414|FG007|NOT COMPLETED|Treatment Period 2||1
10100258|NCT02397460|11229407|FG000|STARTED|Treatment Period 3||7
10100259|NCT02397460|11229408|FG001|STARTED|Treatment Period 3||7
10100260|NCT02397460|11229409|FG002|STARTED|Treatment Period 3||6
10100261|NCT02397460|11229410|FG003|STARTED|Treatment Period 3||6
10100262|NCT02397460|11229411|FG004|STARTED|Treatment Period 3||6
10100263|NCT02397460|11229412|FG005|STARTED|Treatment Period 3||6
10100264|NCT02397460|11229413|FG006|STARTED|Treatment Period 3||6
10100265|NCT02397460|11229414|FG007|STARTED|Treatment Period 3||5
10100266|NCT02397460|11229407|FG000|COMPLETED|Treatment Period 3||7
9982856|NCT01609010|11104469|FG000|NOT COMPLETED|Overall Study||43
10100267|NCT02397460|11229408|FG001|COMPLETED|Treatment Period 3||7
10100268|NCT02397460|11229409|FG002|COMPLETED|Treatment Period 3||6
10100269|NCT02397460|11229410|FG003|COMPLETED|Treatment Period 3||6
10100270|NCT02397460|11229411|FG004|COMPLETED|Treatment Period 3||6
10100271|NCT02397460|11229412|FG005|COMPLETED|Treatment Period 3||6
10100272|NCT02397460|11229413|FG006|COMPLETED|Treatment Period 3||6
10100273|NCT02397460|11229414|FG007|COMPLETED|Treatment Period 3||5
10100274|NCT02397460|11229407|FG000|NOT COMPLETED|Treatment Period 3||0
10100275|NCT02397460|11229408|FG001|NOT COMPLETED|Treatment Period 3||0
9982857|NCT01609010|11104470|FG001|NOT COMPLETED|Overall Study||37
9982858|NCT01609023|11104476|FG000|STARTED|Overall Study||67
9982859|NCT01609023|11104476|FG000|COMPLETED|Overall Study||34
9982860|NCT01609023|11104476|FG000|NOT COMPLETED|Overall Study||33
9982861|NCT01609062|11104482|FG000|STARTED|Primary Phase||15
9982862|NCT01609062|11104483|FG001|STARTED|Primary Phase||10
9982863|NCT01609062|11104482|FG000|COMPLETED|Primary Phase||15
9982864|NCT01609062|11104483|FG001|COMPLETED|Primary Phase||10
9982865|NCT01609062|11104482|FG000|NOT COMPLETED|Primary Phase||0
9982866|NCT01609062|11104483|FG001|NOT COMPLETED|Primary Phase||0
9982867|NCT01609062|11104482|FG000|STARTED|Extension Phase||15
9982868|NCT01609062|11104483|FG001|STARTED|Extension Phase||10
9982869|NCT01609062|11104482|FG000|COMPLETED|Extension Phase||0
9982870|NCT01609062|11104483|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
9982871|NCT01609062|11104482|FG000|NOT COMPLETED|Extension Phase||15
9982872|NCT01609062|11104483|FG001|NOT COMPLETED|Extension Phase||10
10017998|NCT01820572|11140950|FG000|STARTED|Randomization||223
10017999|NCT01820572|11140951|FG001|STARTED|Randomization||223
10018000|NCT01820572|11140950|FG000|COMPLETED|Randomization||221
10018001|NCT01820572|11140951|FG001|COMPLETED|Randomization||222
10018002|NCT01820572|11140950|FG000|NOT COMPLETED|Randomization||2
10018003|NCT01820572|11140951|FG001|NOT COMPLETED|Randomization||1
10018004|NCT01820572|11140950|FG000|STARTED|Treatment Period||221
10018005|NCT01820572|11140951|FG001|STARTED|Treatment Period||222
10018006|NCT01820572|11140950|FG000|COMPLETED|Treatment Period||195
10018007|NCT01820572|11140951|FG001|COMPLETED|Treatment Period||186
10018008|NCT01820572|11140950|FG000|NOT COMPLETED|Treatment Period||26
10018009|NCT01820572|11140951|FG001|NOT COMPLETED|Treatment Period||36
10018010|NCT01820585|11140961|FG000|STARTED|Overall Study||131
10018011|NCT01820585|11140962|FG001|STARTED|Overall Study||130
10018012|NCT01820585|11140963|FG002|STARTED|Overall Study||135
10018013|NCT01820585|11140964|FG003|STARTED|Overall Study||132
10018014|NCT01820585|11140961|FG000|Randomized and Treated|Overall Study||131
10018015|NCT01820585|11140962|FG001|Randomized and Treated|Overall Study||130
10018016|NCT01820585|11140963|FG002|Randomized and Treated|Overall Study||135
10018017|NCT01820585|11140964|FG003|Randomized and Treated|Overall Study||132
10018018|NCT01820585|11140961|FG000|Full Analysis Set|Overall Study||131
10018019|NCT01820585|11140962|FG001|Full Analysis Set|Overall Study||130
10018020|NCT01820585|11140963|FG002|Full Analysis Set|Overall Study||135
10018021|NCT01820585|11140964|FG003|Full Analysis Set|Overall Study||129
10018022|NCT01820585|11140961|FG000|Completed Titration Period|Overall Study||128
10018023|NCT01820585|11140962|FG001|Completed Titration Period|Overall Study||125
10018024|NCT01820585|11140963|FG002|Completed Titration Period|Overall Study||131
10018025|NCT01820585|11140964|FG003|Completed Titration Period|Overall Study||126
10018026|NCT01820585|11140961|FG000|Entered Maintenance Period|Overall Study||128
10100276|NCT02397460|11229409|FG002|NOT COMPLETED|Treatment Period 3||0
10100277|NCT02397460|11229410|FG003|NOT COMPLETED|Treatment Period 3||0
10100278|NCT02397460|11229411|FG004|NOT COMPLETED|Treatment Period 3||0
10100279|NCT02397460|11229412|FG005|NOT COMPLETED|Treatment Period 3||0
10100280|NCT02397460|11229413|FG006|NOT COMPLETED|Treatment Period 3||0
10100281|NCT02397460|11229414|FG007|NOT COMPLETED|Treatment Period 3||0
10100282|NCT02397460|11229407|FG000|STARTED|Treatment Period 4||7
10100283|NCT02397460|11229408|FG001|STARTED|Treatment Period 4||7
10100284|NCT02397460|11229409|FG002|STARTED|Treatment Period 4||6
10100285|NCT02397460|11229410|FG003|STARTED|Treatment Period 4||6
10100286|NCT02397460|11229411|FG004|STARTED|Treatment Period 4||6
10100287|NCT02397460|11229412|FG005|STARTED|Treatment Period 4||6
10100288|NCT02397460|11229413|FG006|STARTED|Treatment Period 4||6
10100289|NCT02397460|11229414|FG007|STARTED|Treatment Period 4||5
10100290|NCT02397460|11229407|FG000|COMPLETED|Treatment Period 4||7
10100291|NCT02397460|11229408|FG001|COMPLETED|Treatment Period 4||6
10100292|NCT02397460|11229409|FG002|COMPLETED|Treatment Period 4||6
10100293|NCT02397460|11229410|FG003|COMPLETED|Treatment Period 4||6
10100294|NCT02397460|11229411|FG004|COMPLETED|Treatment Period 4||5
10100295|NCT02397460|11229412|FG005|COMPLETED|Treatment Period 4||6
10100296|NCT02397460|11229413|FG006|COMPLETED|Treatment Period 4||6
10100297|NCT02397460|11229414|FG007|COMPLETED|Treatment Period 4||5
10100298|NCT02397460|11229407|FG000|NOT COMPLETED|Treatment Period 4||0
10100299|NCT02397460|11229408|FG001|NOT COMPLETED|Treatment Period 4||1
10100300|NCT02397460|11229409|FG002|NOT COMPLETED|Treatment Period 4||0
10100301|NCT02397460|11229410|FG003|NOT COMPLETED|Treatment Period 4||0
10018027|NCT01820585|11140962|FG001|Entered Maintenance Period|Overall Study||124
10018028|NCT01820585|11140963|FG002|Entered Maintenance Period|Overall Study||131
10018029|NCT01820585|11140964|FG003|Entered Maintenance Period|Overall Study||123
10018030|NCT01820585|11140961|FG000|Completed Maintenance Period|Overall Study||105
10018031|NCT01820585|11140962|FG001|Completed Maintenance Period|Overall Study||98
10018032|NCT01820585|11140963|FG002|Completed Maintenance Period|Overall Study||101
10018033|NCT01820585|11140964|FG003|Completed Maintenance Period|Overall Study||84
10018034|NCT01820585|11140961|FG000|COMPLETED|Overall Study||104
10018035|NCT01820585|11140962|FG001|COMPLETED|Overall Study||98
10018036|NCT01820585|11140963|FG002|COMPLETED|Overall Study||101
10018037|NCT01820585|11140964|FG003|COMPLETED|Overall Study||83
10100302|NCT02397460|11229411|FG004|NOT COMPLETED|Treatment Period 4||1
10100303|NCT02397460|11229412|FG005|NOT COMPLETED|Treatment Period 4||0
10100304|NCT02397460|11229413|FG006|NOT COMPLETED|Treatment Period 4||0
10100305|NCT02397460|11229414|FG007|NOT COMPLETED|Treatment Period 4||0
10100306|NCT02397473|11229490|FG000|STARTED|Treatment Phase||57
10100307|NCT02397473|11229491|FG001|STARTED|Treatment Phase||52
9982873|NCT01609218|11104490|FG000|STARTED|Period 1||13
9982874|NCT01609218|11104491|FG001|STARTED|Period 1||14
9982875|NCT01609218|11104490|FG000|Received LY2140023|Period 1||13
9982876|NCT01609218|11104491|FG001|Received LY2140023|Period 1||14
9982877|NCT01609218|11104490|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0
9982878|NCT01609218|11104491|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12
9982879|NCT01609218|11104490|FG000|COMPLETED|Period 1||10
9982880|NCT01609218|11104491|FG001|COMPLETED|Period 1||8
9982881|NCT01609218|11104490|FG000|NOT COMPLETED|Period 1||3
9982882|NCT01609218|11104491|FG001|NOT COMPLETED|Period 1||6
9982883|NCT01609218|11104490|FG000|STARTED|Period 2||10
9982884|NCT01609218|11104491|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9
9982885|NCT01609218|11104490|FG000|Received LY2140023|Period 2||10
9982886|NCT01609218|11104491|FG001|Received LY2140023|Period 2||9
9982887|NCT01609218|11104490|FG000|Received Activated Charcoal|Period 2||9
9982888|NCT01609218|11104491|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0
9982889|NCT01609218|11104490|FG000|COMPLETED|Period 2||9
9982890|NCT01609218|11104491|FG001|COMPLETED|Period 2||9
9982891|NCT01609218|11104490|FG000|NOT COMPLETED|Period 2||1
9982892|NCT01609218|11104491|FG001|NOT COMPLETED|Period 2||0
9982893|NCT01609257|11104499|FG000|STARTED|Overall Study||67
9982894|NCT01609257|11104500|FG001|STARTED|Overall Study||65
9982895|NCT01609257|11104499|FG000|Received 2 Doses|Overall Study||63
9982896|NCT01609257|11104500|FG001|Received 2 Doses|Overall Study||64
9982897|NCT01609257|11104499|FG000|Received Challenge Product|Overall Study||56
9982898|NCT01609257|11104500|FG001|Received Challenge Product|Overall Study||53
9982899|NCT01609257|11104499|FG000|COMPLETED|Overall Study||61
9982900|NCT01609257|11104500|FG001|COMPLETED|Overall Study||57
9982901|NCT01609257|11104499|FG000|NOT COMPLETED|Overall Study||6
9982902|NCT01609257|11104500|FG001|NOT COMPLETED|Overall Study||8
9982903|NCT01609296|11104509|FG000|STARTED|Overall Study||1406
9982904|NCT01609296|11104509|FG000|COMPLETED|Overall Study||918
9982905|NCT01609296|11104509|FG000|NOT COMPLETED|Overall Study||488
9982906|NCT01609348|11104519|FG000|STARTED|Overall Study||3
9982907|NCT01609348|11104520|FG001|STARTED|Overall Study||2
9982908|NCT01609348|11104519|FG000|COMPLETED|Overall Study||3
9982909|NCT01609348|11104520|FG001|COMPLETED|Overall Study||2
9982910|NCT01609348|11104519|FG000|NOT COMPLETED|Overall Study||0
9982911|NCT01609348|11104520|FG001|NOT COMPLETED|Overall Study||0
9982912|NCT01609478|11104529|FG000|STARTED|Overall Study||111
9982913|NCT01609478|11104530|FG001|STARTED|Overall Study||108
9982914|NCT01609478|11104531|FG002|STARTED|Overall Study||116
9982915|NCT01609478|11104529|FG000|Full Analysis Set (FAS)|Overall Study||110
9982916|NCT01609478|11104530|FG001|Full Analysis Set (FAS)|Overall Study||108
9982917|NCT01609478|11104531|FG002|Full Analysis Set (FAS)|Overall Study||115
9982918|NCT01609478|11104529|FG000|COMPLETED|Overall Study||104
9982919|NCT01609478|11104530|FG001|COMPLETED|Overall Study||106
9982920|NCT01609478|11104531|FG002|COMPLETED|Overall Study||107
9982921|NCT01609478|11104529|FG000|NOT COMPLETED|Overall Study||7
9982922|NCT01609478|11104530|FG001|NOT COMPLETED|Overall Study||2
9982923|NCT01609478|11104531|FG002|NOT COMPLETED|Overall Study||9
9982924|NCT01609543|11104539|FG000|STARTED|Overall Study||62
9982925|NCT01609543|11104539|FG000|COMPLETED|Overall Study||20
9982926|NCT01609543|11104539|FG000|NOT COMPLETED|Overall Study||42
9982927|NCT01609556|11104560|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
9982928|NCT01609556|11104561|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
9982929|NCT01609556|11104562|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
9982930|NCT01609556|11104563|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
9982931|NCT01609556|11104564|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
9982932|NCT01609556|11104565|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
9982933|NCT01609556|11104566|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
9982934|NCT01609556|11104567|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
9982935|NCT01609556|11104568|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
9982936|NCT01609556|11104569|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
9982937|NCT01609556|11104570|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
9982938|NCT01609556|11104571|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
9982939|NCT01609556|11104572|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
9982940|NCT01609556|11104573|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
9982941|NCT01609556|11104574|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
9982942|NCT01609556|11104575|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
9982943|NCT01609556|11104560|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
9982944|NCT01609556|11104561|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
9982945|NCT01609556|11104562|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
9982946|NCT01609556|11104563|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
9982947|NCT01609556|11104564|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
9982948|NCT01609556|11104565|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
9982949|NCT01609556|11104566|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
9982950|NCT01609556|11104567|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
9982951|NCT01609556|11104568|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
9982952|NCT01609556|11104569|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
9982953|NCT01609556|11104570|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
9982954|NCT01609556|11104571|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
9982955|NCT01609556|11104572|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
9982956|NCT01609556|11104573|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
9982957|NCT01609556|11104574|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
9982958|NCT01609556|11104575|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
9982959|NCT01609556|11104560|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982960|NCT01609556|11104561|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982961|NCT01609556|11104562|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982962|NCT01609556|11104563|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982963|NCT01609556|11104564|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982964|NCT01609556|11104565|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982965|NCT01609556|11104566|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982966|NCT01609556|11104567|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982967|NCT01609556|11104568|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982968|NCT01609556|11104569|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982969|NCT01609556|11104570|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982970|NCT01609556|11104571|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982971|NCT01609556|11104572|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982972|NCT01609556|11104573|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982973|NCT01609556|11104574|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982974|NCT01609556|11104575|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982975|NCT01609556|11104560|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
9982976|NCT01609556|11104561|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
9982977|NCT01609556|11104562|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
9982978|NCT01609556|11104563|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
9982979|NCT01609556|11104564|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
9982980|NCT01609556|11104565|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
9982981|NCT01609556|11104566|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
10100308|NCT02397473|11229490|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57
10100309|NCT02397473|11229491|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49
10100310|NCT02397473|11229490|FG000|COMPLETED|Treatment Phase||45
10100311|NCT02397473|11229491|FG001|COMPLETED|Treatment Phase||45
10100312|NCT02397473|11229490|FG000|NOT COMPLETED|Treatment Phase||12
10100313|NCT02397473|11229491|FG001|NOT COMPLETED|Treatment Phase||7
10100314|NCT02397473|11229490|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
10100315|NCT02397473|11229491|FG001|STARTED|Post Treatment Follow-up Phase||47
10100316|NCT02397473|11229490|FG000|COMPLETED|Post Treatment Follow-up Phase||47
10100317|NCT02397473|11229491|FG001|COMPLETED|Post Treatment Follow-up Phase||45
10100318|NCT02397473|11229490|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3
10100319|NCT02397473|11229491|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2
10100320|NCT02397564|11229500|FG000|STARTED|Overall Study||20
10100321|NCT02397564|11229500|FG000|COMPLETED|Overall Study||16
10100322|NCT02397564|11229500|FG000|NOT COMPLETED|Overall Study||4
10113166|NCT02508935|11244116|FG000|COMPLETED|Overall Study||0
10113167|NCT02508935|11244116|FG000|NOT COMPLETED|Overall Study||23
10113168|NCT02509026|11244122|FG000|STARTED|Induction Period (24 Weeks)||210
10113169|NCT02509026|11244122|FG000|Treated|Induction Period (24 Weeks)||209
10113170|NCT02509026|11244122|FG000|COMPLETED|Induction Period (24 Weeks)||188
10113171|NCT02509026|11244122|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22
10113172|NCT02509026|11244122|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
10113173|NCT02509026|11244122|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112
10113174|NCT02509026|11244122|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
10113175|NCT02509026|11244122|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
10113176|NCT02509026|11244122|FG000|Treated|Retreatment Period (12 Weeks)||87
10113177|NCT02509026|11244122|FG000|COMPLETED|Retreatment Period (12 Weeks)||84
10113178|NCT02509026|11244122|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4
10113179|NCT02509065|11244131|FG000|STARTED|Overall Study||1
10113180|NCT02509065|11244132|FG001|STARTED|Overall Study||1
10113181|NCT02509065|11244133|FG002|STARTED|Overall Study||2
10113182|NCT02509065|11244134|FG003|STARTED|Overall Study||1
10113183|NCT02509065|11244135|FG004|STARTED|Overall Study||1
10113184|NCT02509065|11244136|FG005|STARTED|Overall Study||1
10113185|NCT02509065|11244137|FG006|STARTED|Overall Study||1
10113186|NCT02509065|11244138|FG007|STARTED|Overall Study||1
10113187|NCT02509065|11244139|FG008|STARTED|Overall Study||1
10113188|NCT02509065|11244140|FG009|STARTED|Overall Study||1
10113189|NCT02509065|11244141|FG010|STARTED|Overall Study||1
10113190|NCT02509065|11244142|FG011|STARTED|Overall Study||1
10113191|NCT02509065|11244143|FG012|STARTED|Overall Study||1
10113192|NCT02509065|11244144|FG013|STARTED|Overall Study||1
10113193|NCT02509065|11244145|FG014|STARTED|Overall Study||1
10113194|NCT02509065|11244146|FG015|STARTED|Overall Study||1
10113195|NCT02509065|11244147|FG016|STARTED|Overall Study||1
10113196|NCT02509065|11244148|FG017|STARTED|Overall Study||1
9982982|NCT01609556|11104567|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
9982983|NCT01609556|11104568|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
9982984|NCT01609556|11104569|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
9982985|NCT01609556|11104570|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
9982986|NCT01609556|11104571|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
9982987|NCT01609556|11104572|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982988|NCT01609556|11104573|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982989|NCT01609556|11104574|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982990|NCT01609556|11104575|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
9982991|NCT01609556|11104560|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0
9982992|NCT01609556|11104561|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0
9982993|NCT01609556|11104562|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0
9982994|NCT01609556|11104563|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0
9982995|NCT01609556|11104564|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0
9982996|NCT01609556|11104565|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0
10100323|NCT02397655|11229505|FG000|STARTED|Overall Study||12012
10100324|NCT02397655|11229505|FG000|COMPLETED|Overall Study||10711
10100325|NCT02397655|11229505|FG000|NOT COMPLETED|Overall Study||1301
10100326|NCT02397694|11229511|FG000|STARTED|Double-Blinded Phase||65
10100327|NCT02397694|11229512|FG001|STARTED|Double-Blinded Phase||33
10100328|NCT02397694|11229511|FG000|COMPLETED|Double-Blinded Phase||62
10100329|NCT02397694|11229512|FG001|COMPLETED|Double-Blinded Phase||30
10100330|NCT02397694|11229511|FG000|NOT COMPLETED|Double-Blinded Phase||3
10100331|NCT02397694|11229512|FG001|NOT COMPLETED|Double-Blinded Phase||3
10100332|NCT02397694|11229511|FG000|STARTED|Open Label Extension Phase||62
10100333|NCT02397694|11229512|FG001|STARTED|Open Label Extension Phase||30
10100334|NCT02397694|11229511|FG000|COMPLETED|Open Label Extension Phase||54
10100335|NCT02397694|11229512|FG001|COMPLETED|Open Label Extension Phase||29
10100336|NCT02397694|11229511|FG000|NOT COMPLETED|Open Label Extension Phase||8
10100337|NCT02397694|11229512|FG001|NOT COMPLETED|Open Label Extension Phase||1
10100338|NCT02397707|11229525|FG000|STARTED|Overall Study||14
10100339|NCT02397707|11229526|FG001|STARTED|Overall Study||10
10100340|NCT02397707|11229527|FG002|STARTED|Overall Study||9
10100341|NCT02397707|11229525|FG000|COMPLETED|Overall Study||14
10100342|NCT02397707|11229526|FG001|COMPLETED|Overall Study||10
10100343|NCT02397707|11229527|FG002|COMPLETED|Overall Study||9
10100344|NCT02397707|11229525|FG000|NOT COMPLETED|Overall Study||0
10100345|NCT02397707|11229526|FG001|NOT COMPLETED|Overall Study||0
10100346|NCT02397707|11229527|FG002|NOT COMPLETED|Overall Study||0
10100347|NCT02397785|11229538|FG000|STARTED|Overall Study||24
10100348|NCT02397785|11229539|FG001|STARTED|Overall Study||34
10100349|NCT02397785|11229538|FG000|COMPLETED|Overall Study||22
10100350|NCT02397785|11229539|FG001|COMPLETED|Overall Study||25
10100351|NCT02397785|11229538|FG000|NOT COMPLETED|Overall Study||2
10100352|NCT02397785|11229539|FG001|NOT COMPLETED|Overall Study||9
10100353|NCT02397837|11229547|FG000|STARTED|Overall Study||33
10100354|NCT02397837|11229548|FG001|STARTED|Overall Study||30
10100355|NCT02397837|11229547|FG000|COMPLETED|Overall Study||26
10100356|NCT02397837|11229548|FG001|COMPLETED|Overall Study||24
10100357|NCT02397837|11229547|FG000|NOT COMPLETED|Overall Study||7
10100358|NCT02397837|11229548|FG001|NOT COMPLETED|Overall Study||6
10100359|NCT02397889|11229556|FG000|STARTED|Overall Study||15
10100360|NCT02397889|11229557|FG001|STARTED|Overall Study||15
10100361|NCT02397889|11229556|FG000|COMPLETED|Overall Study||14
10100362|NCT02397889|11229557|FG001|COMPLETED|Overall Study||15
10100363|NCT02397889|11229556|FG000|NOT COMPLETED|Overall Study||1
10100364|NCT02397889|11229557|FG001|NOT COMPLETED|Overall Study||0
10100365|NCT02397915|11229563|FG000|STARTED|Period 1||150
10100366|NCT02397915|11229564|FG001|STARTED|Period 1||150
10100367|NCT02397915|11229565|FG002|STARTED|Period 1||0
10100368|NCT02397915|11229566|FG003|STARTED|Period 1||0
10100369|NCT02397915|11229563|FG000|COMPLETED|Period 1||149
9982997|NCT01609556|11104566|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0
9982998|NCT01609556|11104567|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0
9982999|NCT01609556|11104568|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0
9983000|NCT01609556|11104569|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0
9983001|NCT01609556|11104570|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0
9983002|NCT01609556|11104571|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0
9983003|NCT01609556|11104572|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46
9983004|NCT01609556|11104573|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24
9983005|NCT01609556|11104574|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27
9983006|NCT01609556|11104575|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40
9983007|NCT01609556|11104560|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983008|NCT01609556|11104561|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983009|NCT01609556|11104562|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983010|NCT01609556|11104563|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983011|NCT01609556|11104564|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983012|NCT01609556|11104565|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10100370|NCT02397915|11229564|FG001|COMPLETED|Period 1||149
10100371|NCT02397915|11229565|FG002|COMPLETED|Period 1||0
10100372|NCT02397915|11229566|FG003|COMPLETED|Period 1||0
10100373|NCT02397915|11229563|FG000|NOT COMPLETED|Period 1||1
10100374|NCT02397915|11229564|FG001|NOT COMPLETED|Period 1||1
10100375|NCT02397915|11229565|FG002|NOT COMPLETED|Period 1||0
10100376|NCT02397915|11229566|FG003|NOT COMPLETED|Period 1||0
10100377|NCT02397915|11229563|FG000|STARTED|Period 2||0
9983013|NCT01609556|11104566|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983014|NCT01609556|11104567|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983015|NCT01609556|11104568|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983016|NCT01609556|11104569|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983017|NCT01609556|11104570|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983018|NCT01609556|11104571|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983019|NCT01609556|11104572|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983020|NCT01609556|11104573|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983021|NCT01609556|11104574|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983022|NCT01609556|11104575|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983023|NCT01609556|11104560|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983024|NCT01609556|11104561|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983025|NCT01609556|11104562|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983026|NCT01609556|11104563|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983027|NCT01609556|11104564|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983028|NCT01609556|11104565|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983029|NCT01609556|11104566|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983030|NCT01609556|11104567|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10100378|NCT02397915|11229564|FG001|STARTED|Period 2||0
10100379|NCT02397915|11229565|FG002|STARTED|Period 2||149
10100380|NCT02397915|11229566|FG003|STARTED|Period 2||149
10100381|NCT02397915|11229563|FG000|COMPLETED|Period 2||0
10100382|NCT02397915|11229564|FG001|COMPLETED|Period 2||0
10100383|NCT02397915|11229565|FG002|COMPLETED|Period 2||149
10100384|NCT02397915|11229566|FG003|COMPLETED|Period 2||149
10100385|NCT02397915|11229563|FG000|NOT COMPLETED|Period 2||0
10100386|NCT02397915|11229564|FG001|NOT COMPLETED|Period 2||0
10100387|NCT02397915|11229565|FG002|NOT COMPLETED|Period 2||0
10100388|NCT02397915|11229566|FG003|NOT COMPLETED|Period 2||0
10100389|NCT02397954|11229574|FG000|STARTED|Overall Study||4
10100390|NCT02397954|11229574|FG000|COMPLETED|Overall Study||4
10100391|NCT02397954|11229574|FG000|NOT COMPLETED|Overall Study||0
10100392|NCT02398188|11229580|FG000|STARTED|Overall Study||398
10100393|NCT02398188|11229581|FG001|STARTED|Overall Study||395
10100394|NCT02398188|11229580|FG000|COMPLETED|Overall Study||371
10100395|NCT02398188|11229581|FG001|COMPLETED|Overall Study||361
10100396|NCT02398188|11229580|FG000|NOT COMPLETED|Overall Study||27
10100397|NCT02398188|11229581|FG001|NOT COMPLETED|Overall Study||34
10100398|NCT02398227|11229589|FG000|STARTED|Overall Study||83
10100399|NCT02398227|11229590|FG001|STARTED|Overall Study||89
10100400|NCT02398227|11229589|FG000|COMPLETED|Overall Study||56
10100401|NCT02398227|11229590|FG001|COMPLETED|Overall Study||71
10100402|NCT02398227|11229589|FG000|NOT COMPLETED|Overall Study||27
10100403|NCT02398227|11229590|FG001|NOT COMPLETED|Overall Study||18
10100404|NCT02398409|11229598|FG000|STARTED|Overall Study||69
10100405|NCT02398409|11229599|FG001|STARTED|Overall Study||68
10100406|NCT02398409|11229598|FG000|COMPLETED|Overall Study||67
10100407|NCT02398409|11229599|FG001|COMPLETED|Overall Study||63
10100408|NCT02398409|11229598|FG000|NOT COMPLETED|Overall Study||2
10100409|NCT02398409|11229599|FG001|NOT COMPLETED|Overall Study||5
10100410|NCT02399085|11229605|FG000|STARTED|Overall Study||81
10100411|NCT02399085|11229605|FG000|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
10100412|NCT02399085|11229605|FG000|NOT COMPLETED|Overall Study||51
10100413|NCT02399163|11229609|FG000|STARTED|Overall Study||62
10100414|NCT02399163|11229609|FG000|COMPLETED|Overall Study||53
10100415|NCT02399163|11229609|FG000|NOT COMPLETED|Overall Study||9
10100416|NCT02399228|11229621|FG000|STARTED|Overall Study||13
10100417|NCT02399228|11229621|FG000|COMPLETED|Overall Study||7
10100418|NCT02399228|11229621|FG000|NOT COMPLETED|Overall Study||6
10100419|NCT02399254|11229625|FG000|STARTED|Overall Study||21
10100420|NCT02399254|11229625|FG000|COMPLETED|Overall Study||19
10100421|NCT02399254|11229625|FG000|NOT COMPLETED|Overall Study||2
10100422|NCT02399345|11229630|FG000|STARTED|Overall Study||10
10100423|NCT02399345|11229630|FG000|COMPLETED|Overall Study||10
10100424|NCT02399345|11229630|FG000|NOT COMPLETED|Overall Study||0
10100425|NCT02399475|11229636|FG000|STARTED|Overall Study||7
10100426|NCT02399475|11229637|FG001|STARTED|Overall Study||7
10100427|NCT02399475|11229636|FG000|COMPLETED|Overall Study||6
10100428|NCT02399475|11229637|FG001|COMPLETED|Overall Study||7
10100429|NCT02399475|11229636|FG000|NOT COMPLETED|Overall Study||1
10100430|NCT02399475|11229637|FG001|NOT COMPLETED|Overall Study||0
10100431|NCT02399917|11229646|FG000|STARTED|Overall Study||6
10100432|NCT02399917|11229647|FG001|STARTED|Overall Study||6
10100433|NCT02399917|11229648|FG002|STARTED|Overall Study||24
10100434|NCT02399917|11229646|FG000|COMPLETED|Overall Study||6
10100435|NCT02399917|11229647|FG001|COMPLETED|Overall Study||6
10100436|NCT02399917|11229648|FG002|COMPLETED|Overall Study||24
10100437|NCT02399917|11229646|FG000|NOT COMPLETED|Overall Study||0
9983031|NCT01609556|11104568|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983032|NCT01609556|11104569|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10100438|NCT02399917|11229647|FG001|NOT COMPLETED|Overall Study||0
10100439|NCT02399917|11229648|FG002|NOT COMPLETED|Overall Study||0
10100440|NCT02400073|11229657|FG000|STARTED|Overall Study||122
10100441|NCT02400073|11229657|FG000|COMPLETED|Overall Study||111
10100442|NCT02400073|11229657|FG000|NOT COMPLETED|Overall Study||11
10100443|NCT02400307|11229663|FG000|STARTED|Overall Study||11
10100444|NCT02400307|11229664|FG001|STARTED|Overall Study||8
10100445|NCT02400307|11229663|FG000|COMPLETED|Overall Study||10
9983033|NCT01609556|11104570|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983034|NCT01609556|11104571|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
9983035|NCT01609556|11104572|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
9983036|NCT01609556|11104573|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
9983037|NCT01609556|11104574|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
9983038|NCT01609556|11104575|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
9983039|NCT01609582|11104618|FG000|STARTED|Overall Study||1603
9983040|NCT01609582|11104619|FG001|STARTED|Overall Study||1604
9983041|NCT01609582|11104618|FG000|Treated|Overall Study||1603
9983042|NCT01609582|11104619|FG001|Treated|Overall Study||1601
9983043|NCT01609582|11104618|FG000|COMPLETED|Overall Study||0
9983044|NCT01609582|11104619|FG001|COMPLETED|Overall Study||0
9983045|NCT01609582|11104618|FG000|NOT COMPLETED|Overall Study||1603
9983046|NCT01609582|11104619|FG001|NOT COMPLETED|Overall Study||1604
9983047|NCT01609933|11104625|FG000|STARTED|Overall Study||32
10100446|NCT02400307|11229664|FG001|COMPLETED|Overall Study||8
10100447|NCT02400307|11229663|FG000|NOT COMPLETED|Overall Study||1
10100448|NCT02400307|11229664|FG001|NOT COMPLETED|Overall Study||0
10100449|NCT02400333|11229674|FG000|STARTED|Overall Study||9
10100450|NCT02400333|11229675|FG001|STARTED|Overall Study||9
10100451|NCT02400333|11229676|FG002|STARTED|Overall Study||9
10100452|NCT02400333|11229677|FG003|STARTED|Overall Study||9
10100453|NCT02400333|11229674|FG000|COMPLETED|Overall Study||8
10100454|NCT02400333|11229675|FG001|COMPLETED|Overall Study||8
10100455|NCT02400333|11229676|FG002|COMPLETED|Overall Study||7
10100456|NCT02400333|11229677|FG003|COMPLETED|Overall Study||7
10100457|NCT02400333|11229674|FG000|NOT COMPLETED|Overall Study||1
10100458|NCT02400333|11229675|FG001|NOT COMPLETED|Overall Study||1
10100459|NCT02400333|11229676|FG002|NOT COMPLETED|Overall Study||2
10100460|NCT02400333|11229677|FG003|NOT COMPLETED|Overall Study||2
10100461|NCT02400346|11229688|FG000|STARTED|Overall Study||132
10100462|NCT02400346|11229688|FG000|COMPLETED|Overall Study||88
10100463|NCT02400346|11229688|FG000|NOT COMPLETED|Overall Study||44
10100464|NCT02400437|11229692|FG000|STARTED|Overall Study||26
10100465|NCT02400437|11229692|FG000|COMPLETED|Overall Study||26
10100466|NCT02400437|11229692|FG000|NOT COMPLETED|Overall Study||0
10100467|NCT02400463|11229698|FG000|STARTED|Overall Study||6
10100468|NCT02400463|11229698|FG000|COMPLETED|Overall Study||6
10100469|NCT02400463|11229698|FG000|NOT COMPLETED|Overall Study||0
10100470|NCT02400580|11229704|FG000|STARTED|Overall Study||91
10100471|NCT02400580|11229705|FG001|STARTED|Overall Study||92
10100472|NCT02400580|11229704|FG000|COMPLETED|Overall Study||89
10100473|NCT02400580|11229705|FG001|COMPLETED|Overall Study||91
10100474|NCT02400580|11229704|FG000|NOT COMPLETED|Overall Study||2
10100475|NCT02400580|11229705|FG001|NOT COMPLETED|Overall Study||1
10100476|NCT02400710|11229713|FG000|STARTED|Overall Study||10
10100477|NCT02400710|11229714|FG001|STARTED|Overall Study||10
10100478|NCT02400710|11229713|FG000|COMPLETED|Overall Study||10
10100479|NCT02400710|11229714|FG001|COMPLETED|Overall Study||10
10100480|NCT02400710|11229713|FG000|NOT COMPLETED|Overall Study||0
10100481|NCT02400710|11229714|FG001|NOT COMPLETED|Overall Study||0
10100482|NCT02400749|11229722|FG000|STARTED|Week 0 -16||50
10100483|NCT02400749|11229723|FG001|STARTED|Week 0 -16||50
10100484|NCT02400749|11229722|FG000|COMPLETED|Week 0 -16||39
10100485|NCT02400749|11229723|FG001|COMPLETED|Week 0 -16||44
10100486|NCT02400749|11229722|FG000|NOT COMPLETED|Week 0 -16||11
10100487|NCT02400749|11229723|FG001|NOT COMPLETED|Week 0 -16||6
10100488|NCT02400749|11229722|FG000|STARTED|Week 17 - 32||39
10100489|NCT02400749|11229723|FG001|STARTED|Week 17 - 32||44
10100490|NCT02400749|11229722|FG000|COMPLETED|Week 17 - 32||34
10100491|NCT02400749|11229723|FG001|COMPLETED|Week 17 - 32||41
10100492|NCT02400749|11229722|FG000|NOT COMPLETED|Week 17 - 32||5
10100493|NCT02400749|11229723|FG001|NOT COMPLETED|Week 17 - 32||3
10100494|NCT02400905|11229729|FG000|STARTED|Overall Study||271
10100495|NCT02400905|11229729|FG000|30-Days Follow-up|Overall Study||268
10100496|NCT02400905|11229729|FG000|12-Months Follow-up|Overall Study||256
10100497|NCT02400905|11229729|FG000|24-Months Follow-up|Overall Study||225
10100498|NCT02400905|11229729|FG000|36 Months-Follow-up|Overall Study||208
10100499|NCT02400905|11229729|FG000|COMPLETED|Overall Study||208
10100500|NCT02400905|11229729|FG000|NOT COMPLETED|Overall Study||63
10100501|NCT02400996|11229734|FG000|STARTED|Overall Study||40
10100502|NCT02400996|11229734|FG000|COMPLETED|Overall Study||40
10100503|NCT02400996|11229734|FG000|NOT COMPLETED|Overall Study||0
10100504|NCT02401022|11229740|FG000|STARTED|Overall Study||104
10100505|NCT02401022|11229741|FG001|STARTED|Overall Study||110
10100506|NCT02401022|11229740|FG000|COMPLETED|Overall Study||89
10100507|NCT02401022|11229741|FG001|COMPLETED|Overall Study||90
10100508|NCT02401022|11229740|FG000|NOT COMPLETED|Overall Study||15
10100509|NCT02401022|11229741|FG001|NOT COMPLETED|Overall Study||20
10100510|NCT02401048|11229749|FG000|STARTED|Overall Study||27
10100511|NCT02401048|11229750|FG001|STARTED|Overall Study||34
10100512|NCT02401048|11229749|FG000|COMPLETED|Overall Study||5
10100513|NCT02401048|11229750|FG001|COMPLETED|Overall Study||4
10100514|NCT02401048|11229749|FG000|NOT COMPLETED|Overall Study||22
10100515|NCT02401048|11229750|FG001|NOT COMPLETED|Overall Study||30
10100516|NCT02401230|11229764|FG000|STARTED|Overall Study||26
9983048|NCT01609933|11104625|FG000|COMPLETED|Overall Study||28
10100517|NCT02401230|11229765|FG001|STARTED|Overall Study||25
10100518|NCT02401230|11229766|FG002|STARTED|Overall Study||25
10100519|NCT02401230|11229764|FG000|COMPLETED|Overall Study||20
10100520|NCT02401230|11229765|FG001|COMPLETED|Overall Study||19
10100521|NCT02401230|11229766|FG002|COMPLETED|Overall Study||21
9983049|NCT01609933|11104625|FG000|NOT COMPLETED|Overall Study||4
9983050|NCT01610011|11104633|FG000|STARTED|Overall Study||19
9983051|NCT01610011|11104634|FG001|STARTED|Overall Study||2
9983052|NCT01610011|11104633|FG000|COMPLETED|Overall Study||9
9983053|NCT01610011|11104634|FG001|COMPLETED|Overall Study||2
9983054|NCT01610011|11104633|FG000|NOT COMPLETED|Overall Study||10
9983055|NCT01610011|11104634|FG001|NOT COMPLETED|Overall Study||0
9983056|NCT01610037|11104643|FG000|STARTED|All Patients||407
9983057|NCT01610037|11104644|FG001|STARTED|All Patients||405
9983058|NCT01610037|11104645|FG002|STARTED|All Patients||404
9983059|NCT01610037|11104643|FG000|Randomized Set (RAN)|All Patients||407
9983060|NCT01610037|11104644|FG001|Randomized Set (RAN)|All Patients||405
9983061|NCT01610037|11104645|FG002|Randomized Set (RAN)|All Patients||404
10100522|NCT02401230|11229764|FG000|NOT COMPLETED|Overall Study||6
10100523|NCT02401230|11229765|FG001|NOT COMPLETED|Overall Study||6
10100524|NCT02401230|11229766|FG002|NOT COMPLETED|Overall Study||4
10100525|NCT02401256|11229778|FG000|STARTED|Overall Study||70
10100526|NCT02401256|11229778|FG000|Finished Phase 1|Overall Study||64
10100527|NCT02401256|11229778|FG000|Finished Phase 2|Overall Study||58
10100528|NCT02401256|11229778|FG000|Finished Phase 3|Overall Study||53
10100529|NCT02401256|11229778|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
10100530|NCT02401256|11229778|FG000|COMPLETED|Overall Study||53
10100531|NCT02401256|11229778|FG000|NOT COMPLETED|Overall Study||17
10100532|NCT02401412|11229786|FG000|STARTED|Overall Study||89
10100533|NCT02401412|11229787|FG001|STARTED|Overall Study||81
10100534|NCT02401412|11229786|FG000|Received Study Device|Overall Study||89
10100535|NCT02401412|11229787|FG001|Received Study Device|Overall Study||80
10100536|NCT02401412|11229786|FG000|COMPLETED|Overall Study||59
10100537|NCT02401412|11229787|FG001|COMPLETED|Overall Study||49
10100538|NCT02401412|11229786|FG000|NOT COMPLETED|Overall Study||30
10100539|NCT02401412|11229787|FG001|NOT COMPLETED|Overall Study||32
10100540|NCT02401464|11229797|FG000|STARTED|Intervention Period 1 (6 Days)||13
10100541|NCT02401464|11229798|FG001|STARTED|Intervention Period 1 (6 Days)||13
10100542|NCT02401464|11229799|FG002|STARTED|Intervention Period 1 (6 Days)||13
10100543|NCT02401464|11229800|FG003|STARTED|Intervention Period 1 (6 Days)||13
10100544|NCT02401464|11229797|FG000|COMPLETED|Intervention Period 1 (6 Days)||13
10100545|NCT02401464|11229798|FG001|COMPLETED|Intervention Period 1 (6 Days)||13
10100546|NCT02401464|11229799|FG002|COMPLETED|Intervention Period 1 (6 Days)||13
10100547|NCT02401464|11229800|FG003|COMPLETED|Intervention Period 1 (6 Days)||13
10100548|NCT02401464|11229797|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10100549|NCT02401464|11229798|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10100550|NCT02401464|11229799|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10100551|NCT02401464|11229800|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10100552|NCT02401464|11229797|FG000|STARTED|Washout Period (At Least 6 Days)||13
10100553|NCT02401464|11229798|FG001|STARTED|Washout Period (At Least 6 Days)||13
10100554|NCT02401464|11229799|FG002|STARTED|Washout Period (At Least 6 Days)||13
10100555|NCT02401464|11229800|FG003|STARTED|Washout Period (At Least 6 Days)||13
10100556|NCT02401464|11229797|FG000|COMPLETED|Washout Period (At Least 6 Days)||13
10100557|NCT02401464|11229798|FG001|COMPLETED|Washout Period (At Least 6 Days)||13
10100558|NCT02401464|11229799|FG002|COMPLETED|Washout Period (At Least 6 Days)||13
10100559|NCT02401464|11229800|FG003|COMPLETED|Washout Period (At Least 6 Days)||13
10100560|NCT02401464|11229797|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10100561|NCT02401464|11229798|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10100562|NCT02401464|11229799|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10100563|NCT02401464|11229800|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10100564|NCT02401464|11229797|FG000|STARTED|Intervention Period 2 (6 Days)||13
10100565|NCT02401464|11229798|FG001|STARTED|Intervention Period 2 (6 Days)||13
10100566|NCT02401464|11229799|FG002|STARTED|Intervention Period 2 (6 Days)||13
10100567|NCT02401464|11229800|FG003|STARTED|Intervention Period 2 (6 Days)||13
10100568|NCT02401464|11229797|FG000|COMPLETED|Intervention Period 2 (6 Days)||13
10100569|NCT02401464|11229798|FG001|COMPLETED|Intervention Period 2 (6 Days)||13
10100570|NCT02401464|11229799|FG002|COMPLETED|Intervention Period 2 (6 Days)||13
10100571|NCT02401464|11229800|FG003|COMPLETED|Intervention Period 2 (6 Days)||13
9983062|NCT01610037|11104643|FG000|Full Analysis Set (FAS)|All Patients||407
9983063|NCT01610037|11104644|FG001|Full Analysis Set (FAS)|All Patients||405
9983064|NCT01610037|11104645|FG002|Full Analysis Set (FAS)|All Patients||403
9983065|NCT01610037|11104643|FG000|COMPLETED|All Patients||348
9983066|NCT01610037|11104644|FG001|COMPLETED|All Patients||354
10100572|NCT02401464|11229797|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10100573|NCT02401464|11229798|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10100574|NCT02401464|11229799|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10100575|NCT02401464|11229800|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10100576|NCT02401529|11229814|FG000|STARTED|Overall Study||59
10100577|NCT02401529|11229815|FG001|STARTED|Overall Study||57
10100578|NCT02401529|11229814|FG000|COMPLETED|Overall Study||50
10100579|NCT02401529|11229815|FG001|COMPLETED|Overall Study||50
9983067|NCT01610037|11104645|FG002|COMPLETED|All Patients||320
9983068|NCT01610037|11104643|FG000|NOT COMPLETED|All Patients||59
9983069|NCT01610037|11104644|FG001|NOT COMPLETED|All Patients||51
10100580|NCT02401529|11229814|FG000|NOT COMPLETED|Overall Study||9
10100581|NCT02401529|11229815|FG001|NOT COMPLETED|Overall Study||7
10100582|NCT02401542|11229825|FG000|STARTED|Overall Study||41
10100583|NCT02401542|11229826|FG001|STARTED|Overall Study||30
9983070|NCT01610037|11104645|FG002|NOT COMPLETED|All Patients||84
9983071|NCT01610037|11104643|FG000|STARTED|Treatment and Follow up Period||407
9983072|NCT01610037|11104644|FG001|STARTED|Treatment and Follow up Period||405
9983073|NCT01610037|11104645|FG002|STARTED|Treatment and Follow up Period||404
9983074|NCT01610037|11104643|FG000|COMPLETED|Treatment and Follow up Period||382
9983075|NCT01610037|11104644|FG001|COMPLETED|Treatment and Follow up Period||377
9983076|NCT01610037|11104645|FG002|COMPLETED|Treatment and Follow up Period||378
9983077|NCT01610037|11104643|FG000|NOT COMPLETED|Treatment and Follow up Period||25
9983078|NCT01610037|11104644|FG001|NOT COMPLETED|Treatment and Follow up Period||28
9983079|NCT01610037|11104645|FG002|NOT COMPLETED|Treatment and Follow up Period||26
9983080|NCT01610063|11104655|FG000|STARTED|Overall Study||114
9983081|NCT01610063|11104656|FG001|STARTED|Overall Study||113
9983082|NCT01610063|11104655|FG000|Baseline|Overall Study||114
9983083|NCT01610063|11104656|FG001|Baseline|Overall Study||113
9983084|NCT01610063|11104655|FG000|Completed 2-week|Overall Study||97
9983085|NCT01610063|11104656|FG001|Completed 2-week|Overall Study||105
9983086|NCT01610063|11104655|FG000|Completed 4-week|Overall Study||86
9983087|NCT01610063|11104656|FG001|Completed 4-week|Overall Study||98
9983088|NCT01610063|11104655|FG000|Completed 8-week|Overall Study||72
9983089|NCT01610063|11104656|FG001|Completed 8-week|Overall Study||93
9983090|NCT01610063|11104655|FG000|COMPLETED|Overall Study||72
9983091|NCT01610063|11104656|FG001|COMPLETED|Overall Study||93
9983092|NCT01610063|11104655|FG000|NOT COMPLETED|Overall Study||42
9983093|NCT01610063|11104656|FG001|NOT COMPLETED|Overall Study||20
9983094|NCT01610076|11104664|FG000|STARTED|Overall Study||103
9983095|NCT01610076|11104665|FG001|STARTED|Overall Study||105
9983096|NCT01610076|11104664|FG000|COMPLETED|Overall Study||100
9983097|NCT01610076|11104665|FG001|COMPLETED|Overall Study||100
9983098|NCT01610076|11104664|FG000|NOT COMPLETED|Overall Study||3
9983099|NCT01610076|11104665|FG001|NOT COMPLETED|Overall Study||5
9983100|NCT01610154|11104672|FG000|STARTED|Overall Study||85
9983101|NCT01610154|11104672|FG000|COMPLETED|Overall Study||84
9983102|NCT01610154|11104672|FG000|NOT COMPLETED|Overall Study||1
9983103|NCT01610167|11104681|FG000|STARTED|Overall Study||52
9983104|NCT01610167|11104682|FG001|STARTED|Overall Study||49
9983105|NCT01610167|11104683|FG002|STARTED|Overall Study||50
9983106|NCT01610167|11104681|FG000|COMPLETED|Overall Study||52
10100584|NCT02401542|11229827|FG002|STARTED|Overall Study||0
10100585|NCT02401542|11229825|FG000|COMPLETED|Overall Study||40
10100586|NCT02401542|11229826|FG001|COMPLETED|Overall Study||30
10100587|NCT02401542|11229827|FG002|COMPLETED|Overall Study||0
10100588|NCT02401542|11229825|FG000|NOT COMPLETED|Overall Study||1
10100589|NCT02401542|11229826|FG001|NOT COMPLETED|Overall Study||0
10100590|NCT02401542|11229827|FG002|NOT COMPLETED|Overall Study||0
10202063|NCT03441984|11329277|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202064|NCT03441984|11329278|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202065|NCT03441984|11329279|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202066|NCT03441984|11329280|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10100591|NCT02401555|11229840|FG000|STARTED|Overall Study||87
10100592|NCT02401555|11229841|FG001|STARTED|Overall Study||212
10100593|NCT02401555|11229842|FG002|STARTED|Overall Study||120
10100594|NCT02401555|11229840|FG000|COMPLETED|Overall Study||87
10100595|NCT02401555|11229841|FG001|COMPLETED|Overall Study||212
10100596|NCT02401555|11229842|FG002|COMPLETED|Overall Study||120
10100597|NCT02401555|11229840|FG000|NOT COMPLETED|Overall Study||0
10100598|NCT02401555|11229841|FG001|NOT COMPLETED|Overall Study||0
10100599|NCT02401555|11229842|FG002|NOT COMPLETED|Overall Study||0
10100600|NCT02401672|11229852|FG000|STARTED|Overall Study||22
10100601|NCT02401672|11229853|FG001|STARTED|Overall Study||20
9983107|NCT01610167|11104682|FG001|COMPLETED|Overall Study||49
9983108|NCT01610167|11104683|FG002|COMPLETED|Overall Study||48
9983109|NCT01610167|11104681|FG000|NOT COMPLETED|Overall Study||0
10202067|NCT03441984|11329281|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202068|NCT03441984|11329282|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202069|NCT03441984|11329283|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202070|NCT03441984|11329284|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202071|NCT03441984|11329285|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202072|NCT03441984|11329286|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202073|NCT03441984|11329287|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10202074|NCT03441984|11329276|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202075|NCT03441984|11329277|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9983110|NCT01610167|11104682|FG001|NOT COMPLETED|Overall Study||0
9983111|NCT01610167|11104683|FG002|NOT COMPLETED|Overall Study||2
9983112|NCT01610206|11104693|FG000|STARTED|Overall Study||73
9983113|NCT01610206|11104694|FG001|STARTED|Overall Study||75
9983114|NCT01610206|11104693|FG000|COMPLETED|Overall Study||63
9983115|NCT01610206|11104694|FG001|COMPLETED|Overall Study||45
9983116|NCT01610206|11104693|FG000|NOT COMPLETED|Overall Study||10
9983117|NCT01610206|11104694|FG001|NOT COMPLETED|Overall Study||30
10100602|NCT02401672|11229852|FG000|COMPLETED|Overall Study||21
9983118|NCT01610271|11104702|FG000|STARTED|Overall Study||150
9983119|NCT01610271|11104703|FG001|STARTED|Overall Study||150
9983120|NCT01610271|11104702|FG000|COMPLETED|Overall Study||148
9983121|NCT01610271|11104703|FG001|COMPLETED|Overall Study||146
9983122|NCT01610271|11104702|FG000|NOT COMPLETED|Overall Study||2
9983123|NCT01610271|11104703|FG001|NOT COMPLETED|Overall Study||4
9983124|NCT01610284|11104713|FG000|STARTED|Randomization Phase||576
9983125|NCT01610284|11104714|FG001|STARTED|Randomization Phase||571
9983126|NCT01610284|11104713|FG000|Safety Set (SS)|Randomization Phase||573
9983127|NCT01610284|11104714|FG001|Safety Set (SS)|Randomization Phase||570
10100603|NCT02401672|11229853|FG001|COMPLETED|Overall Study||17
10100604|NCT02401672|11229852|FG000|NOT COMPLETED|Overall Study||1
10100605|NCT02401672|11229853|FG001|NOT COMPLETED|Overall Study||3
10100606|NCT02401867|11229859|FG000|STARTED|Enrolled||150
10100607|NCT02401867|11229859|FG000|COMPLETED|Enrolled||150
10100608|NCT02401867|11229859|FG000|NOT COMPLETED|Enrolled||0
10100609|NCT02401867|11229859|FG000|STARTED|Specimen Collection||150
10100610|NCT02401867|11229859|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
10100611|NCT02401867|11229859|FG000|NOT COMPLETED|Specimen Collection||10
10100612|NCT02401867|11229859|FG000|STARTED|Analysis||140
10100613|NCT02401867|11229859|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
10100614|NCT02401867|11229859|FG000|NOT COMPLETED|Analysis||9
10100615|NCT02402062|11229864|FG000|STARTED|Overall Study||17
10100616|NCT02402062|11229864|FG000|COMPLETED|Overall Study||17
10100617|NCT02402062|11229864|FG000|NOT COMPLETED|Overall Study||0
10100618|NCT02402127|11229874|FG000|STARTED|First Wear Period (1 Day)||4
10100619|NCT02402127|11229875|FG001|STARTED|First Wear Period (1 Day)||4
10100620|NCT02402127|11229876|FG002|STARTED|First Wear Period (1 Day)||4
10100621|NCT02402127|11229877|FG003|STARTED|First Wear Period (1 Day)||4
10100622|NCT02402127|11229878|FG004|STARTED|First Wear Period (1 Day)||4
10100623|NCT02402127|11229879|FG005|STARTED|First Wear Period (1 Day)||4
10100624|NCT02402127|11229874|FG000|Randomized and Treated|First Wear Period (1 Day)||4
10100625|NCT02402127|11229875|FG001|Randomized and Treated|First Wear Period (1 Day)||4
10100626|NCT02402127|11229876|FG002|Randomized and Treated|First Wear Period (1 Day)||4
10100627|NCT02402127|11229877|FG003|Randomized and Treated|First Wear Period (1 Day)||4
10100628|NCT02402127|11229878|FG004|Randomized and Treated|First Wear Period (1 Day)||4
10100629|NCT02402127|11229879|FG005|Randomized and Treated|First Wear Period (1 Day)||4
10100630|NCT02402127|11229874|FG000|COMPLETED|First Wear Period (1 Day)||4
10100631|NCT02402127|11229875|FG001|COMPLETED|First Wear Period (1 Day)||4
10100632|NCT02402127|11229876|FG002|COMPLETED|First Wear Period (1 Day)||4
10100633|NCT02402127|11229877|FG003|COMPLETED|First Wear Period (1 Day)||4
10100634|NCT02402127|11229878|FG004|COMPLETED|First Wear Period (1 Day)||4
10100635|NCT02402127|11229879|FG005|COMPLETED|First Wear Period (1 Day)||4
10100636|NCT02402127|11229874|FG000|NOT COMPLETED|First Wear Period (1 Day)||0
10100637|NCT02402127|11229875|FG001|NOT COMPLETED|First Wear Period (1 Day)||0
10100638|NCT02402127|11229876|FG002|NOT COMPLETED|First Wear Period (1 Day)||0
10100639|NCT02402127|11229877|FG003|NOT COMPLETED|First Wear Period (1 Day)||0
10100640|NCT02402127|11229878|FG004|NOT COMPLETED|First Wear Period (1 Day)||0
10100641|NCT02402127|11229879|FG005|NOT COMPLETED|First Wear Period (1 Day)||0
10100642|NCT02402127|11229874|FG000|STARTED|Second Wear Period (1 Day)||4
10100643|NCT02402127|11229875|FG001|STARTED|Second Wear Period (1 Day)||4
10100644|NCT02402127|11229876|FG002|STARTED|Second Wear Period (1 Day)||4
10100645|NCT02402127|11229877|FG003|STARTED|Second Wear Period (1 Day)||4
10100646|NCT02402127|11229878|FG004|STARTED|Second Wear Period (1 Day)||4
10100647|NCT02402127|11229879|FG005|STARTED|Second Wear Period (1 Day)||4
10100648|NCT02402127|11229874|FG000|COMPLETED|Second Wear Period (1 Day)||4
10100649|NCT02402127|11229875|FG001|COMPLETED|Second Wear Period (1 Day)||4
10100650|NCT02402127|11229876|FG002|COMPLETED|Second Wear Period (1 Day)||4
10100651|NCT02402127|11229877|FG003|COMPLETED|Second Wear Period (1 Day)||4
10100652|NCT02402127|11229878|FG004|COMPLETED|Second Wear Period (1 Day)||4
10100653|NCT02402127|11229879|FG005|COMPLETED|Second Wear Period (1 Day)||4
10100654|NCT02402127|11229874|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0
10100655|NCT02402127|11229875|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0
10100656|NCT02402127|11229876|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0
10100657|NCT02402127|11229877|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0
10100658|NCT02402127|11229878|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0
10100659|NCT02402127|11229879|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0
10100660|NCT02402127|11229874|FG000|STARTED|Third Wear Period (1 Day)||4
10100661|NCT02402127|11229875|FG001|STARTED|Third Wear Period (1 Day)||4
10100662|NCT02402127|11229876|FG002|STARTED|Third Wear Period (1 Day)||4
10100663|NCT02402127|11229877|FG003|STARTED|Third Wear Period (1 Day)||4
10100664|NCT02402127|11229878|FG004|STARTED|Third Wear Period (1 Day)||4
10100665|NCT02402127|11229879|FG005|STARTED|Third Wear Period (1 Day)||4
10100666|NCT02402127|11229874|FG000|COMPLETED|Third Wear Period (1 Day)||4
10100667|NCT02402127|11229875|FG001|COMPLETED|Third Wear Period (1 Day)||4
9983128|NCT01610284|11104713|FG000|COMPLETED|Randomization Phase||574
9983129|NCT01610284|11104714|FG001|COMPLETED|Randomization Phase||569
9983130|NCT01610284|11104713|FG000|NOT COMPLETED|Randomization Phase||2
9983131|NCT01610284|11104714|FG001|NOT COMPLETED|Randomization Phase||2
9983132|NCT01610284|11104713|FG000|STARTED|Treatment Phase||574
9983133|NCT01610284|11104714|FG001|STARTED|Treatment Phase||569
10100668|NCT02402127|11229876|FG002|COMPLETED|Third Wear Period (1 Day)||4
10100669|NCT02402127|11229877|FG003|COMPLETED|Third Wear Period (1 Day)||4
9983134|NCT01610284|11104713|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
9983135|NCT01610284|11104714|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
9983136|NCT01610284|11104713|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
9983137|NCT01610284|11104714|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
9983138|NCT01610284|11104713|FG000|COMPLETED|Treatment Phase||0
9983139|NCT01610284|11104714|FG001|COMPLETED|Treatment Phase||0
9983140|NCT01610284|11104713|FG000|NOT COMPLETED|Treatment Phase||574
9983141|NCT01610284|11104714|FG001|NOT COMPLETED|Treatment Phase||569
9983142|NCT01610284|11104713|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
9983143|NCT01610284|11104714|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
9983144|NCT01610284|11104713|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
9983145|NCT01610284|11104714|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
9983146|NCT01610284|11104713|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
9983147|NCT01610284|11104714|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
9983148|NCT01610297|11104720|FG000|STARTED|Overall Study||27
9983149|NCT01610297|11104720|FG000|COMPLETED|Overall Study||26
9983150|NCT01610297|11104720|FG000|NOT COMPLETED|Overall Study||1
9983151|NCT01610336|11104735|FG000|STARTED|Overall Study||5
9983152|NCT01610336|11104736|FG001|STARTED|Overall Study||7
9983153|NCT01610336|11104737|FG002|STARTED|Overall Study||6
9983154|NCT01610336|11104738|FG003|STARTED|Overall Study||7
9983155|NCT01610336|11104739|FG004|STARTED|Overall Study||4
9983156|NCT01610336|11104740|FG005|STARTED|Overall Study||12
9983157|NCT01610336|11104741|FG006|STARTED|Overall Study||5
9983158|NCT01610336|11104742|FG007|STARTED|Overall Study||7
9983159|NCT01610336|11104743|FG008|STARTED|Overall Study||8
9983160|NCT01610336|11104744|FG009|STARTED|Overall Study||53
9983161|NCT01610336|11104745|FG010|STARTED|Overall Study||47
10100670|NCT02402127|11229878|FG004|COMPLETED|Third Wear Period (1 Day)||4
10100671|NCT02402127|11229879|FG005|COMPLETED|Third Wear Period (1 Day)||4
10100672|NCT02402127|11229874|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0
10100673|NCT02402127|11229875|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0
10100674|NCT02402127|11229876|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0
10100675|NCT02402127|11229877|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0
10100676|NCT02402127|11229878|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0
10100677|NCT02402127|11229879|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0
10100678|NCT02402153|11229890|FG000|STARTED|Overall Study||18
10100679|NCT02402153|11229890|FG000|COMPLETED|Overall Study||18
10100680|NCT02402153|11229890|FG000|NOT COMPLETED|Overall Study||0
10100681|NCT02402166|11229894|FG000|STARTED|Overall Study||24
10100682|NCT02402166|11229894|FG000|COMPLETED|Overall Study||19
10100683|NCT02402166|11229894|FG000|NOT COMPLETED|Overall Study||5
9758702|NCT01856140|10862265|FG001|NOT COMPLETED|Overall Study||0
9758703|NCT01773395|10862273|FG000|STARTED|Overall Study||64
9758704|NCT01773395|10862274|FG001|STARTED|Overall Study||59
9758705|NCT01773395|10862273|FG000|COMPLETED|Overall Study||30
9758706|NCT01773395|10862274|FG001|COMPLETED|Overall Study||27
9758707|NCT01773395|10862273|FG000|NOT COMPLETED|Overall Study||34
10100684|NCT02402218|11229915|FG000|STARTED|Overall Study||36
10100685|NCT02402218|11229916|FG001|STARTED|Overall Study||54
10100686|NCT02402218|11229917|FG002|STARTED|Overall Study||54
10100687|NCT02402218|11229915|FG000|Initiated Treatment With LDV/SOF|Overall Study||24
10100688|NCT02402218|11229916|FG001|Initiated Treatment With LDV/SOF|Overall Study||45
10100689|NCT02402218|11229917|FG002|Initiated Treatment With LDV/SOF|Overall Study||41
10100690|NCT02402218|11229915|FG000|Completed Treatment With LDV/SOF|Overall Study||23
10100691|NCT02402218|11229916|FG001|Completed Treatment With LDV/SOF|Overall Study||42
10100692|NCT02402218|11229917|FG002|Completed Treatment With LDV/SOF|Overall Study||39
10100693|NCT02402218|11229915|FG000|Achieved Sustained Virologic Response|Overall Study||22
10100694|NCT02402218|11229916|FG001|Achieved Sustained Virologic Response|Overall Study||41
10100695|NCT02402218|11229917|FG002|Achieved Sustained Virologic Response|Overall Study||37
10100696|NCT02402218|11229915|FG000|COMPLETED|Overall Study||22
10100697|NCT02402218|11229916|FG001|COMPLETED|Overall Study||41
10100698|NCT02402218|11229917|FG002|COMPLETED|Overall Study||37
10100699|NCT02402218|11229915|FG000|NOT COMPLETED|Overall Study||14
10100700|NCT02402218|11229916|FG001|NOT COMPLETED|Overall Study||13
10100701|NCT02402218|11229917|FG002|NOT COMPLETED|Overall Study||17
10100702|NCT02402296|11229927|FG000|STARTED|Overall Study||15
10100703|NCT02402296|11229928|FG001|STARTED|Overall Study||15
10100704|NCT02402296|11229927|FG000|COMPLETED|Overall Study||15
10100705|NCT02402296|11229928|FG001|COMPLETED|Overall Study||15
10100706|NCT02402296|11229927|FG000|NOT COMPLETED|Overall Study||0
10100707|NCT02402296|11229928|FG001|NOT COMPLETED|Overall Study||0
10100708|NCT02402322|11229937|FG000|STARTED|Pretreatment||27
10100709|NCT02402322|11229938|FG001|STARTED|Pretreatment||25
10100710|NCT02402322|11229939|FG002|STARTED|Pretreatment||25
10100711|NCT02402322|11229937|FG000|Posttreatment Measures|Pretreatment||24
10100712|NCT02402322|11229938|FG001|Posttreatment Measures|Pretreatment||24
10202076|NCT03441984|11329278|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9983162|NCT01610336|11104735|FG000|COMPLETED|Overall Study||0
9983163|NCT01610336|11104736|FG001|COMPLETED|Overall Study||0
9983164|NCT01610336|11104737|FG002|COMPLETED|Overall Study||0
9983165|NCT01610336|11104738|FG003|COMPLETED|Overall Study||0
9983166|NCT01610336|11104739|FG004|COMPLETED|Overall Study||0
10100713|NCT02402322|11229939|FG002|Posttreatment Measures|Pretreatment||24
10100714|NCT02402322|11229937|FG000|COMPLETED|Pretreatment||24
9983167|NCT01610336|11104740|FG005|COMPLETED|Overall Study||0
9983168|NCT01610336|11104741|FG006|COMPLETED|Overall Study||0
9983169|NCT01610336|11104742|FG007|COMPLETED|Overall Study||0
9983170|NCT01610336|11104743|FG008|COMPLETED|Overall Study||0
9983171|NCT01610336|11104744|FG009|COMPLETED|Overall Study||0
9983172|NCT01610336|11104745|FG010|COMPLETED|Overall Study||0
9983173|NCT01610336|11104735|FG000|NOT COMPLETED|Overall Study||5
9983174|NCT01610336|11104736|FG001|NOT COMPLETED|Overall Study||7
9983175|NCT01610336|11104737|FG002|NOT COMPLETED|Overall Study||6
9983176|NCT01610336|11104738|FG003|NOT COMPLETED|Overall Study||7
9983177|NCT01610336|11104739|FG004|NOT COMPLETED|Overall Study||4
9983178|NCT01610336|11104740|FG005|NOT COMPLETED|Overall Study||12
9983179|NCT01610336|11104741|FG006|NOT COMPLETED|Overall Study||5
10100715|NCT02402322|11229938|FG001|COMPLETED|Pretreatment||24
10100716|NCT02402322|11229939|FG002|COMPLETED|Pretreatment||24
10202077|NCT03441984|11329279|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202078|NCT03441984|11329280|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202079|NCT03441984|11329281|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202080|NCT03441984|11329282|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202081|NCT03441984|11329283|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202082|NCT03441984|11329284|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202083|NCT03441984|11329285|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202084|NCT03441984|11329286|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202085|NCT03441984|11329287|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10202086|NCT03441984|11329276|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0
10202087|NCT03441984|11329277|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0
10202088|NCT03441984|11329278|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0
10202089|NCT03441984|11329279|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0
10202090|NCT03441984|11329280|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0
10202091|NCT03441984|11329281|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0
10202092|NCT03441984|11329282|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3
10202093|NCT03441984|11329283|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3
10202094|NCT03441984|11329284|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3
10202095|NCT03441984|11329285|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3
10202096|NCT03441984|11329286|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3
10202097|NCT03441984|11329287|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3
10202098|NCT03441984|11329276|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202099|NCT03441984|11329277|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202100|NCT03441984|11329278|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202101|NCT03441984|11329279|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202102|NCT03441984|11329280|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202103|NCT03441984|11329281|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202104|NCT03441984|11329282|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10202105|NCT03441984|11329283|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10202106|NCT03441984|11329284|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10202107|NCT03441984|11329285|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10202108|NCT03441984|11329286|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10202109|NCT03441984|11329287|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10202110|NCT03441984|11329276|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202111|NCT03441984|11329277|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202112|NCT03441984|11329278|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202113|NCT03441984|11329279|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202114|NCT03441984|11329280|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202115|NCT03441984|11329281|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202116|NCT03441984|11329282|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202117|NCT03441984|11329283|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202118|NCT03441984|11329284|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202119|NCT03441984|11329285|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202120|NCT03441984|11329286|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9983180|NCT01610336|11104742|FG007|NOT COMPLETED|Overall Study||7
9983181|NCT01610336|11104743|FG008|NOT COMPLETED|Overall Study||8
9983182|NCT01610336|11104744|FG009|NOT COMPLETED|Overall Study||53
10100717|NCT02402322|11229937|FG000|NOT COMPLETED|Pretreatment||3
10100718|NCT02402322|11229938|FG001|NOT COMPLETED|Pretreatment||1
10100719|NCT02402322|11229939|FG002|NOT COMPLETED|Pretreatment||1
10100720|NCT02402322|11229937|FG000|STARTED|Follow-up||24
10100721|NCT02402322|11229938|FG001|STARTED|Follow-up||24
10100722|NCT02402322|11229939|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
9983183|NCT01610336|11104745|FG010|NOT COMPLETED|Overall Study||47
9983184|NCT01610414|11104775|FG000|STARTED|Study Start - Month 13||922
9983185|NCT01610414|11104776|FG001|STARTED|Study Start - Month 13||924
9983186|NCT01610414|11104775|FG000|COMPLETED|Study Start - Month 13||807
9983187|NCT01610414|11104776|FG001|COMPLETED|Study Start - Month 13||795
9983188|NCT01610414|11104775|FG000|NOT COMPLETED|Study Start - Month 13||115
9983189|NCT01610414|11104776|FG001|NOT COMPLETED|Study Start - Month 13||129
9983190|NCT01610414|11104775|FG000|STARTED|Month 13 - Month 25||922
9983191|NCT01610414|11104776|FG001|STARTED|Month 13 - Month 25||924
9983192|NCT01610414|11104775|FG000|COMPLETED|Month 13 - Month 25||857
9983193|NCT01610414|11104776|FG001|COMPLETED|Month 13 - Month 25||854
9983194|NCT01610414|11104775|FG000|NOT COMPLETED|Month 13 - Month 25||65
10100723|NCT02402322|11229937|FG000|COMPLETED|Follow-up||18
10100724|NCT02402322|11229938|FG001|COMPLETED|Follow-up||21
10100725|NCT02402322|11229939|FG002|COMPLETED|Follow-up||0
10100726|NCT02402322|11229937|FG000|NOT COMPLETED|Follow-up||6
9983195|NCT01610414|11104776|FG001|NOT COMPLETED|Month 13 - Month 25||70
9983196|NCT01610414|11104775|FG000|STARTED|After Month 25||922
9983197|NCT01610414|11104776|FG001|STARTED|After Month 25||924
9983198|NCT01610414|11104775|FG000|COMPLETED|After Month 25||874
9983199|NCT01610414|11104776|FG001|COMPLETED|After Month 25||871
9983200|NCT01610414|11104775|FG000|NOT COMPLETED|After Month 25||48
9983201|NCT01610414|11104776|FG001|NOT COMPLETED|After Month 25||53
10100727|NCT02402322|11229938|FG001|NOT COMPLETED|Follow-up||3
10100728|NCT02402322|11229939|FG002|NOT COMPLETED|Follow-up||24
10100729|NCT02402452|11229949|FG000|STARTED|Overall Study||10
10100730|NCT02402452|11229950|FG001|STARTED|Overall Study||10
10100731|NCT02402452|11229949|FG000|COMPLETED|Overall Study||10
10100732|NCT02402452|11229950|FG001|COMPLETED|Overall Study||10
10100733|NCT02402452|11229949|FG000|NOT COMPLETED|Overall Study||0
10100734|NCT02402452|11229950|FG001|NOT COMPLETED|Overall Study||0
10100735|NCT02402764|11229956|FG000|STARTED|Overall Study||10
10100736|NCT02402764|11229956|FG000|COMPLETED|Overall Study||10
10100737|NCT02402764|11229956|FG000|NOT COMPLETED|Overall Study||0
10100738|NCT02402881|11229962|FG000|STARTED|Pre-Intervention Study Period||2222
10100739|NCT02402881|11229963|FG001|STARTED|Pre-Intervention Study Period||5657
10100740|NCT02402881|11229962|FG000|COMPLETED|Pre-Intervention Study Period||2222
10100741|NCT02402881|11229963|FG001|COMPLETED|Pre-Intervention Study Period||5657
10100742|NCT02402881|11229962|FG000|NOT COMPLETED|Pre-Intervention Study Period||0
10100743|NCT02402881|11229963|FG001|NOT COMPLETED|Pre-Intervention Study Period||0
10100744|NCT02402881|11229962|FG000|STARTED|Post-Intervention Study Period||3111
10100745|NCT02402881|11229963|FG001|STARTED|Post-Intervention Study Period||8662
10100746|NCT02402881|11229962|FG000|COMPLETED|Post-Intervention Study Period||3111
10100747|NCT02402881|11229963|FG001|COMPLETED|Post-Intervention Study Period||8662
10100748|NCT02402881|11229962|FG000|NOT COMPLETED|Post-Intervention Study Period||0
10100749|NCT02402881|11229963|FG001|NOT COMPLETED|Post-Intervention Study Period||0
10100750|NCT02402907|11229971|FG000|STARTED|Overall Study||682
10100751|NCT02402907|11229972|FG001|STARTED|Overall Study||674
10100752|NCT02402907|11229971|FG000|COMPLETED|Overall Study||662
10100753|NCT02402907|11229972|FG001|COMPLETED|Overall Study||647
10100754|NCT02402907|11229971|FG000|NOT COMPLETED|Overall Study||20
10100755|NCT02402907|11229972|FG001|NOT COMPLETED|Overall Study||27
10100756|NCT02402933|11229978|FG000|STARTED|Overall Study||26
10100757|NCT02402933|11229978|FG000|Received at Least One Dose of Study Drug|Overall Study||22
10100758|NCT02402933|11229978|FG000|COMPLETED|Overall Study||12
10100759|NCT02402933|11229978|FG000|NOT COMPLETED|Overall Study||14
10113197|NCT02509065|11244149|FG018|STARTED|Overall Study||1
10113198|NCT02509065|11244150|FG019|STARTED|Overall Study||1
10113199|NCT02509065|11244151|FG020|STARTED|Overall Study||1
10113200|NCT02509065|11244152|FG021|STARTED|Overall Study||1
10113201|NCT02509065|11244153|FG022|STARTED|Overall Study||1
10113202|NCT02509065|11244131|FG000|COMPLETED|Overall Study||1
10113203|NCT02509065|11244132|FG001|COMPLETED|Overall Study||1
10113204|NCT02509065|11244133|FG002|COMPLETED|Overall Study||2
10113205|NCT02509065|11244134|FG003|COMPLETED|Overall Study||1
10113206|NCT02509065|11244135|FG004|COMPLETED|Overall Study||1
10113207|NCT02509065|11244136|FG005|COMPLETED|Overall Study||1
10113208|NCT02509065|11244137|FG006|COMPLETED|Overall Study||1
10113209|NCT02509065|11244138|FG007|COMPLETED|Overall Study||1
10113210|NCT02509065|11244139|FG008|COMPLETED|Overall Study||1
10113211|NCT02509065|11244140|FG009|COMPLETED|Overall Study||1
10113212|NCT02509065|11244141|FG010|COMPLETED|Overall Study||1
10113213|NCT02509065|11244142|FG011|COMPLETED|Overall Study||1
10113214|NCT02509065|11244143|FG012|COMPLETED|Overall Study||1
10113215|NCT02509065|11244144|FG013|COMPLETED|Overall Study||1
10113216|NCT02509065|11244145|FG014|COMPLETED|Overall Study||1
10113217|NCT02509065|11244146|FG015|COMPLETED|Overall Study||1
10113218|NCT02509065|11244147|FG016|COMPLETED|Overall Study||1
10113219|NCT02509065|11244148|FG017|COMPLETED|Overall Study||1
10113220|NCT02509065|11244149|FG018|COMPLETED|Overall Study||1
10113221|NCT02509065|11244150|FG019|COMPLETED|Overall Study||1
10113222|NCT02509065|11244151|FG020|COMPLETED|Overall Study||1
10113223|NCT02509065|11244152|FG021|COMPLETED|Overall Study||1
10113224|NCT02509065|11244153|FG022|COMPLETED|Overall Study||1
10113225|NCT02509065|11244131|FG000|NOT COMPLETED|Overall Study||0
10113226|NCT02509065|11244132|FG001|NOT COMPLETED|Overall Study||0
10113227|NCT02509065|11244133|FG002|NOT COMPLETED|Overall Study||0
10113228|NCT02509065|11244134|FG003|NOT COMPLETED|Overall Study||0
10113229|NCT02509065|11244135|FG004|NOT COMPLETED|Overall Study||0
10113230|NCT02509065|11244136|FG005|NOT COMPLETED|Overall Study||0
10113231|NCT02509065|11244137|FG006|NOT COMPLETED|Overall Study||0
10113232|NCT02509065|11244138|FG007|NOT COMPLETED|Overall Study||0
10113233|NCT02509065|11244139|FG008|NOT COMPLETED|Overall Study||0
9983202|NCT01610427|11104783|FG000|STARTED|Overall Study||22
10113234|NCT02509065|11244140|FG009|NOT COMPLETED|Overall Study||0
10113235|NCT02509065|11244141|FG010|NOT COMPLETED|Overall Study||0
10113236|NCT02509065|11244142|FG011|NOT COMPLETED|Overall Study||0
10113237|NCT02509065|11244143|FG012|NOT COMPLETED|Overall Study||0
10113238|NCT02509065|11244144|FG013|NOT COMPLETED|Overall Study||0
9983203|NCT01610427|11104783|FG000|COMPLETED|Overall Study||22
10113239|NCT02509065|11244145|FG014|NOT COMPLETED|Overall Study||0
10113240|NCT02509065|11244146|FG015|NOT COMPLETED|Overall Study||0
10113241|NCT02509065|11244147|FG016|NOT COMPLETED|Overall Study||0
10113242|NCT02509065|11244148|FG017|NOT COMPLETED|Overall Study||0
9983204|NCT01610427|11104783|FG000|NOT COMPLETED|Overall Study||0
9983205|NCT01610453|11104787|FG000|STARTED|Overall Study||150
9983206|NCT01610453|11104787|FG000|COMPLETED|Overall Study||150
9983207|NCT01610453|11104787|FG000|NOT COMPLETED|Overall Study||0
9983208|NCT01610492|11104792|FG000|STARTED|Overall Study||14
9983209|NCT01610492|11104792|FG000|COMPLETED|Overall Study||8
9983210|NCT01610492|11104792|FG000|NOT COMPLETED|Overall Study||6
9983211|NCT01610557|11104800|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
9983212|NCT01610557|11104801|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
9983213|NCT01610557|11104802|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
9983214|NCT01610557|11104803|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
9983215|NCT01610557|11104804|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
9983216|NCT01610557|11104800|FG000|COMPLETED|36-Week Randomized Crossover Phase||16
9983217|NCT01610557|11104801|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
10100760|NCT02403180|11229984|FG000|STARTED|Pre-Treatment Period||36
10100761|NCT02403180|11229985|FG001|STARTED|Pre-Treatment Period||34
10100762|NCT02403180|11229984|FG000|COMPLETED|Pre-Treatment Period||36
10100763|NCT02403180|11229985|FG001|COMPLETED|Pre-Treatment Period||33
10100764|NCT02403180|11229984|FG000|NOT COMPLETED|Pre-Treatment Period||0
10100765|NCT02403180|11229985|FG001|NOT COMPLETED|Pre-Treatment Period||1
10100766|NCT02403180|11229984|FG000|STARTED|Period 1 (5 Days)||36
10100767|NCT02403180|11229985|FG001|STARTED|Period 1 (5 Days)||33
10100768|NCT02403180|11229984|FG000|Randomized|Period 1 (5 Days)||36
10100769|NCT02403180|11229985|FG001|Randomized|Period 1 (5 Days)||33
10100770|NCT02403180|11229984|FG000|COMPLETED|Period 1 (5 Days)||36
10100771|NCT02403180|11229985|FG001|COMPLETED|Period 1 (5 Days)||33
10100772|NCT02403180|11229984|FG000|NOT COMPLETED|Period 1 (5 Days)||0
10100773|NCT02403180|11229985|FG001|NOT COMPLETED|Period 1 (5 Days)||0
10100774|NCT02403180|11229984|FG000|STARTED|Period 2 (5 Days)||36
10100775|NCT02403180|11229985|FG001|STARTED|Period 2 (5 Days)||33
10100776|NCT02403180|11229984|FG000|COMPLETED|Period 2 (5 Days)||36
10100777|NCT02403180|11229985|FG001|COMPLETED|Period 2 (5 Days)||32
10100778|NCT02403180|11229984|FG000|NOT COMPLETED|Period 2 (5 Days)||0
9983218|NCT01610557|11104802|FG002|COMPLETED|36-Week Randomized Crossover Phase||14
9983219|NCT01610557|11104803|FG003|COMPLETED|36-Week Randomized Crossover Phase||13
9983220|NCT01610557|11104804|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
9983221|NCT01610557|11104800|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0
9983222|NCT01610557|11104801|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1
9983223|NCT01610557|11104802|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0
9983224|NCT01610557|11104803|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0
9983225|NCT01610557|11104804|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0
9983226|NCT01610557|11104800|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983227|NCT01610557|11104801|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983228|NCT01610557|11104802|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983229|NCT01610557|11104803|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983230|NCT01610557|11104804|FG004|STARTED|Post-36-Week Extension Phase||55
9983231|NCT01610557|11104800|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983232|NCT01610557|11104801|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983233|NCT01610557|11104802|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983234|NCT01610557|11104803|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
9983235|NCT01610557|11104804|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
9983236|NCT01610557|11104800|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0
9983237|NCT01610557|11104801|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0
9983238|NCT01610557|11104802|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0
9983239|NCT01610557|11104803|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0
9983240|NCT01610557|11104804|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3
9983241|NCT01610570|11104819|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
9983242|NCT01610570|11104820|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
9983243|NCT01610570|11104821|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
9983244|NCT01610570|11104822|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
9983245|NCT01610570|11104819|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
9983246|NCT01610570|11104820|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
9983247|NCT01610570|11104821|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10100779|NCT02403180|11229985|FG001|NOT COMPLETED|Period 2 (5 Days)||1
10100780|NCT02403206|11229993|FG000|STARTED|Overall Study||194
10100781|NCT02403206|11229994|FG001|STARTED|Overall Study||196
10100782|NCT02403206|11229993|FG000|Treated Prior to Randomization|Overall Study||0
10100783|NCT02403206|11229994|FG001|Treated Prior to Randomization|Overall Study||1
9983248|NCT01610570|11104822|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
9983249|NCT01610570|11104819|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
9983250|NCT01610570|11104820|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
9983251|NCT01610570|11104821|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
9983252|NCT01610570|11104822|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
9983253|NCT01610570|11104819|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
9983254|NCT01610570|11104820|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
9983255|NCT01610570|11104821|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
10100784|NCT02403206|11229993|FG000|Randomized and Treated|Overall Study||188
10100785|NCT02403206|11229994|FG001|Randomized and Treated|Overall Study||190
10100786|NCT02403206|11229993|FG000|COMPLETED|Overall Study||183
10100787|NCT02403206|11229994|FG001|COMPLETED|Overall Study||186
10100788|NCT02403206|11229993|FG000|NOT COMPLETED|Overall Study||11
10100789|NCT02403206|11229994|FG001|NOT COMPLETED|Overall Study||10
10100790|NCT02403271|11230001|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
10100791|NCT02403271|11230002|FG001|STARTED|Period 1||0
10100792|NCT02403271|11230001|FG000|COMPLETED|Period 1||6
10100793|NCT02403271|11230002|FG001|COMPLETED|Period 1||0
10100794|NCT02403271|11230001|FG000|NOT COMPLETED|Period 1||1
10100795|NCT02403271|11230002|FG001|NOT COMPLETED|Period 1||0
10100796|NCT02403271|11230001|FG000|STARTED|Period 2||0
10100797|NCT02403271|11230002|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
10100798|NCT02403271|11230001|FG000|COMPLETED|Period 2||0
10100799|NCT02403271|11230002|FG001|COMPLETED|Period 2||0
10100800|NCT02403271|11230001|FG000|NOT COMPLETED|Period 2||0
10100801|NCT02403271|11230002|FG001|NOT COMPLETED|Period 2||124
10100802|NCT02403479|11230010|FG000|STARTED|Overall Study||10
10100803|NCT02403479|11230011|FG001|STARTED|Overall Study||12
10100804|NCT02403479|11230010|FG000|COMPLETED|Overall Study||8
10100805|NCT02403479|11230011|FG001|COMPLETED|Overall Study||12
10100806|NCT02403479|11230010|FG000|NOT COMPLETED|Overall Study||2
10100807|NCT02403479|11230011|FG001|NOT COMPLETED|Overall Study||0
10100808|NCT02403622|11230019|FG000|STARTED|Overall Study||15
10100809|NCT02403622|11230019|FG000|COMPLETED|Overall Study||13
10100810|NCT02403622|11230019|FG000|NOT COMPLETED|Overall Study||2
10100811|NCT02403635|11230023|FG000|STARTED|Overall Study||27
10100812|NCT02403635|11230023|FG000|Screening (28 Days)|Overall Study||27
10100813|NCT02403635|11230023|FG000|Received the First Dose|Overall Study||18
10100814|NCT02403635|11230023|FG000|COMPLETED|Overall Study||18
10100815|NCT02403635|11230023|FG000|NOT COMPLETED|Overall Study||9
10100816|NCT02403674|11230045|FG000|STARTED|Overall Study||368
10100817|NCT02403674|11230046|FG001|STARTED|Overall Study||366
10100818|NCT02403674|11230045|FG000|Treated|Overall Study||364
10100819|NCT02403674|11230046|FG001|Treated|Overall Study||364
10100820|NCT02403674|11230045|FG000|COMPLETED|Overall Study||313
10100821|NCT02403674|11230046|FG001|COMPLETED|Overall Study||303
10100822|NCT02403674|11230045|FG000|NOT COMPLETED|Overall Study||55
10100823|NCT02403674|11230046|FG001|NOT COMPLETED|Overall Study||63
10100824|NCT02403778|11230054|FG000|STARTED|Overall Study||6
10100825|NCT02403778|11230055|FG001|STARTED|Overall Study||4
10100826|NCT02403778|11230054|FG000|COMPLETED|Overall Study||6
10100827|NCT02403778|11230055|FG001|COMPLETED|Overall Study||4
10100828|NCT02403778|11230054|FG000|NOT COMPLETED|Overall Study||0
10100829|NCT02403778|11230055|FG001|NOT COMPLETED|Overall Study||0
10100830|NCT02403817|11230063|FG000|STARTED|Overall Study||28
10100831|NCT02403817|11230064|FG001|STARTED|Overall Study||2
10100832|NCT02403817|11230063|FG000|COMPLETED|Overall Study||23
9983256|NCT01610570|11104822|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
10100833|NCT02403817|11230064|FG001|COMPLETED|Overall Study||2
10100834|NCT02403817|11230063|FG000|NOT COMPLETED|Overall Study||5
10100835|NCT02403817|11230064|FG001|NOT COMPLETED|Overall Study||0
10100836|NCT02403830|11230070|FG000|STARTED|Visit 1||15
10100837|NCT02403830|11230071|FG001|STARTED|Visit 1||15
10100838|NCT02403830|11230070|FG000|COMPLETED|Visit 1||15
10100839|NCT02403830|11230071|FG001|COMPLETED|Visit 1||15
10100840|NCT02403830|11230070|FG000|NOT COMPLETED|Visit 1||0
10100841|NCT02403830|11230071|FG001|NOT COMPLETED|Visit 1||0
10100842|NCT02403830|11230070|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
10100843|NCT02403830|11230071|FG001|STARTED|Visit 2||15
10100844|NCT02403830|11230070|FG000|COMPLETED|Visit 2||14
10100845|NCT02403830|11230071|FG001|COMPLETED|Visit 2||15
10100846|NCT02403830|11230070|FG000|NOT COMPLETED|Visit 2||0
10100847|NCT02403830|11230071|FG001|NOT COMPLETED|Visit 2||0
10100848|NCT02403895|11230077|FG000|STARTED|Overall Study||11
10100849|NCT02403895|11230077|FG000|COMPLETED|Overall Study||11
10100850|NCT02403895|11230077|FG000|NOT COMPLETED|Overall Study||0
10100851|NCT02403986|11230083|FG000|STARTED|Overall Study||26
10100852|NCT02403986|11230084|FG001|STARTED|Overall Study||27
10100853|NCT02403986|11230083|FG000|COMPLETED|Overall Study||21
10100854|NCT02403986|11230084|FG001|COMPLETED|Overall Study||23
10100855|NCT02403986|11230083|FG000|NOT COMPLETED|Overall Study||5
10100856|NCT02403986|11230084|FG001|NOT COMPLETED|Overall Study||4
10100857|NCT02403999|11230093|FG000|STARTED|Overall Study||10
10100858|NCT02403999|11230094|FG001|STARTED|Overall Study||10
10100859|NCT02403999|11230095|FG002|STARTED|Overall Study||11
10100860|NCT02403999|11230093|FG000|COMPLETED|Overall Study||10
10100861|NCT02403999|11230094|FG001|COMPLETED|Overall Study||10
10100862|NCT02403999|11230095|FG002|COMPLETED|Overall Study||11
10100863|NCT02403999|11230093|FG000|NOT COMPLETED|Overall Study||0
10100864|NCT02403999|11230094|FG001|NOT COMPLETED|Overall Study||0
9983257|NCT01610570|11104819|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
9983258|NCT01610570|11104820|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
9983259|NCT01610570|11104821|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
9983260|NCT01610570|11104822|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
9983261|NCT01610570|11104819|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
9983262|NCT01610570|11104820|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
9983263|NCT01610570|11104821|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
9983264|NCT01610570|11104822|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
9983265|NCT01610570|11104819|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0
9983266|NCT01610570|11104820|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0
9983267|NCT01610570|11104821|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0
9983268|NCT01610570|11104822|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0
9983269|NCT01610570|11104819|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983270|NCT01610570|11104820|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983271|NCT01610570|11104821|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983272|NCT01610570|11104822|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983273|NCT01610570|11104819|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983274|NCT01610570|11104820|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983275|NCT01610570|11104821|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983276|NCT01610570|11104822|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
9983277|NCT01610596|11104840|FG000|STARTED|Overall Study||36
9983278|NCT01610596|11104841|FG001|STARTED|Overall Study||36
9983279|NCT01610596|11104840|FG000|COMPLETED|Overall Study||36
9983280|NCT01610596|11104841|FG001|COMPLETED|Overall Study||35
9983281|NCT01610596|11104840|FG000|NOT COMPLETED|Overall Study||0
9983282|NCT01610596|11104841|FG001|NOT COMPLETED|Overall Study||1
9983283|NCT01610687|11104847|FG000|STARTED|Overall Study||137
9983284|NCT01610687|11104847|FG000|COMPLETED|Overall Study||70
9983285|NCT01610687|11104847|FG000|NOT COMPLETED|Overall Study||67
9983286|NCT01610700|11104853|FG000|STARTED|Overall Study||80
9983287|NCT01610700|11104854|FG001|STARTED|Overall Study||80
10100865|NCT02403999|11230095|FG002|NOT COMPLETED|Overall Study||0
10100866|NCT02404025|11230103|FG000|STARTED|Overall Study||10
10100867|NCT02404025|11230103|FG000|COMPLETED|Overall Study||6
10100868|NCT02404025|11230103|FG000|NOT COMPLETED|Overall Study||4
10100869|NCT02404103|11230109|FG000|STARTED|Overall Study||14
10100870|NCT02404103|11230110|FG001|STARTED|Overall Study||12
10100871|NCT02404103|11230109|FG000|COMPLETED|Overall Study||10
10100872|NCT02404103|11230110|FG001|COMPLETED|Overall Study||9
10100873|NCT02404103|11230109|FG000|NOT COMPLETED|Overall Study||4
10100874|NCT02404103|11230110|FG001|NOT COMPLETED|Overall Study||3
10100875|NCT02404168|11230126|FG000|STARTED|Overall Study||4
10100876|NCT02404168|11230126|FG000|COMPLETED|Overall Study||4
10100877|NCT02404168|11230126|FG000|NOT COMPLETED|Overall Study||0
10100878|NCT02404220|11230136|FG000|STARTED|Overall Study||5
10100879|NCT02404220|11230137|FG001|STARTED|Overall Study||8
10100880|NCT02404220|11230138|FG002|STARTED|Overall Study||7
10100881|NCT02404220|11230139|FG003|STARTED|Overall Study||10
10100882|NCT02404220|11230136|FG000|COMPLETED|Overall Study||0
10100883|NCT02404220|11230137|FG001|COMPLETED|Overall Study||0
10100884|NCT02404220|11230138|FG002|COMPLETED|Overall Study||0
10100885|NCT02404220|11230139|FG003|COMPLETED|Overall Study||0
10100886|NCT02404220|11230136|FG000|NOT COMPLETED|Overall Study||5
10100887|NCT02404220|11230137|FG001|NOT COMPLETED|Overall Study||8
10100888|NCT02404220|11230138|FG002|NOT COMPLETED|Overall Study||7
10100889|NCT02404220|11230139|FG003|NOT COMPLETED|Overall Study||10
10100890|NCT02404285|11230151|FG000|STARTED|Overall Study||33
10100891|NCT02404285|11230152|FG001|STARTED|Overall Study||35
10100892|NCT02404285|11230151|FG000|COMPLETED|Overall Study||31
10100893|NCT02404285|11230152|FG001|COMPLETED|Overall Study||33
10100894|NCT02404285|11230151|FG000|NOT COMPLETED|Overall Study||2
10100895|NCT02404285|11230152|FG001|NOT COMPLETED|Overall Study||2
10100896|NCT02404311|11230169|FG000|STARTED|Part A: Month 0-18||210
10100897|NCT02404311|11230170|FG001|STARTED|Part A: Month 0-18||42
10100898|NCT02404311|11230171|FG002|STARTED|Part A: Month 0-18||0
10100899|NCT02404311|11230172|FG003|STARTED|Part A: Month 0-18||0
10100900|NCT02404311|11230173|FG004|STARTED|Part A: Month 0-18||0
10100901|NCT02404311|11230169|FG000|Per Protocol|Part A: Month 0-18||185
10100902|NCT02404311|11230170|FG001|Per Protocol|Part A: Month 0-18||37
10100903|NCT02404311|11230171|FG002|Per Protocol|Part A: Month 0-18||0
10100904|NCT02404311|11230172|FG003|Per Protocol|Part A: Month 0-18||0
9983288|NCT01610700|11104853|FG000|COMPLETED|Overall Study||77
9983289|NCT01610700|11104854|FG001|COMPLETED|Overall Study||77
9983290|NCT01610700|11104853|FG000|NOT COMPLETED|Overall Study||3
9983291|NCT01610700|11104854|FG001|NOT COMPLETED|Overall Study||3
9983292|NCT01610713|11104863|FG000|STARTED|Overall Study||77
9983293|NCT01610713|11104864|FG001|STARTED|Overall Study||77
10100905|NCT02404311|11230173|FG004|Per Protocol|Part A: Month 0-18||0
10100906|NCT02404311|11230169|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
10100907|NCT02404311|11230170|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
10100908|NCT02404311|11230171|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10100909|NCT02404311|11230172|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10100910|NCT02404311|11230173|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10100911|NCT02404311|11230169|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
9983294|NCT01610713|11104863|FG000|COMPLETED|Overall Study||71
10100912|NCT02404311|11230170|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
9983295|NCT01610713|11104864|FG001|COMPLETED|Overall Study||76
9983296|NCT01610713|11104863|FG000|NOT COMPLETED|Overall Study||6
9983297|NCT01610713|11104864|FG001|NOT COMPLETED|Overall Study||1
9983298|NCT01610752|11104873|FG000|STARTED|Overall Study||18
9983299|NCT01610752|11104874|FG001|STARTED|Overall Study||19
9983300|NCT01610752|11104875|FG002|STARTED|Overall Study||17
9983301|NCT01610752|11104873|FG000|COMPLETED|Overall Study||18
9983302|NCT01610752|11104874|FG001|COMPLETED|Overall Study||19
9983303|NCT01610752|11104875|FG002|COMPLETED|Overall Study||13
9983304|NCT01610752|11104873|FG000|NOT COMPLETED|Overall Study||0
9983305|NCT01610752|11104874|FG001|NOT COMPLETED|Overall Study||0
9983306|NCT01610752|11104875|FG002|NOT COMPLETED|Overall Study||4
9983307|NCT01610791|11104883|FG000|STARTED|Overall Study||121
9983308|NCT01610791|11104883|FG000|COMPLETED|Overall Study||100
9983309|NCT01610791|11104883|FG000|NOT COMPLETED|Overall Study||21
9983310|NCT01611090|11104889|FG000|STARTED|Randomized Period||289
9983311|NCT01611090|11104890|FG001|STARTED|Randomized Period||289
9983312|NCT01611090|11104891|FG002|STARTED|Randomized Period||0
9983313|NCT01611090|11104889|FG000|Treated|Randomized Period||287
9983314|NCT01611090|11104890|FG001|Treated|Randomized Period||287
9983315|NCT01611090|11104891|FG002|Treated|Randomized Period||0
9983316|NCT01611090|11104889|FG000|COMPLETED|Randomized Period||259
9983317|NCT01611090|11104890|FG001|COMPLETED|Randomized Period||260
9983318|NCT01611090|11104891|FG002|COMPLETED|Randomized Period||0
9983319|NCT01611090|11104889|FG000|NOT COMPLETED|Randomized Period||30
9983320|NCT01611090|11104890|FG001|NOT COMPLETED|Randomized Period||29
10100913|NCT02404311|11230171|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10100914|NCT02404311|11230172|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10100915|NCT02404311|11230173|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10100916|NCT02404311|11230169|FG000|COMPLETED|Part A: Month 0-18||184
10100917|NCT02404311|11230170|FG001|COMPLETED|Part A: Month 0-18||36
10100918|NCT02404311|11230171|FG002|COMPLETED|Part A: Month 0-18||0
10100919|NCT02404311|11230172|FG003|COMPLETED|Part A: Month 0-18||0
10100920|NCT02404311|11230173|FG004|COMPLETED|Part A: Month 0-18||0
10100921|NCT02404311|11230169|FG000|NOT COMPLETED|Part A: Month 0-18||26
10100922|NCT02404311|11230170|FG001|NOT COMPLETED|Part A: Month 0-18||6
10100923|NCT02404311|11230171|FG002|NOT COMPLETED|Part A: Month 0-18||0
10100924|NCT02404311|11230172|FG003|NOT COMPLETED|Part A: Month 0-18||0
10100925|NCT02404311|11230173|FG004|NOT COMPLETED|Part A: Month 0-18||0
10100926|NCT02404311|11230169|FG000|STARTED|Part B: Month 30-36||0
10100927|NCT02404311|11230170|FG001|STARTED|Part B: Month 30-36||0
10100928|NCT02404311|11230171|FG002|STARTED|Part B: Month 30-36||32
10100929|NCT02404311|11230172|FG003|STARTED|Part B: Month 30-36||31
10100930|NCT02404311|11230173|FG004|STARTED|Part B: Month 30-36||7
10100931|NCT02404311|11230169|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
10100932|NCT02404311|11230170|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
10100933|NCT02404311|11230171|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
10100934|NCT02404311|11230172|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
10100935|NCT02404311|11230173|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
10100936|NCT02404311|11230169|FG000|COMPLETED|Part B: Month 30-36||0
10100937|NCT02404311|11230170|FG001|COMPLETED|Part B: Month 30-36||0
10202121|NCT03441984|11329287|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10202122|NCT03441984|11329276|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202123|NCT03441984|11329277|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10239824|NCT03998189|11371565|FG000|STARTED|Overall Study||0
9983321|NCT01611090|11104891|FG002|NOT COMPLETED|Randomized Period||0
10100938|NCT02404311|11230171|FG002|COMPLETED|Part B: Month 30-36||32
10100939|NCT02404311|11230172|FG003|COMPLETED|Part B: Month 30-36||31
10100940|NCT02404311|11230173|FG004|COMPLETED|Part B: Month 30-36||7
10100941|NCT02404311|11230169|FG000|NOT COMPLETED|Part B: Month 30-36||0
10100942|NCT02404311|11230170|FG001|NOT COMPLETED|Part B: Month 30-36||0
10100943|NCT02404311|11230171|FG002|NOT COMPLETED|Part B: Month 30-36||0
10100944|NCT02404311|11230172|FG003|NOT COMPLETED|Part B: Month 30-36||0
10100945|NCT02404311|11230173|FG004|NOT COMPLETED|Part B: Month 30-36||0
10100946|NCT02404350|11230189|FG000|STARTED|Overall Study||222
10100947|NCT02404350|11230190|FG001|STARTED|Overall Study||220
10100948|NCT02404350|11230191|FG002|STARTED|Overall Study||222
10100949|NCT02404350|11230192|FG003|STARTED|Overall Study||332
10100950|NCT02404350|11230189|FG000|COMPLETED|Overall Study||207
10100951|NCT02404350|11230190|FG001|COMPLETED|Overall Study||214
10100952|NCT02404350|11230191|FG002|COMPLETED|Overall Study||216
10100953|NCT02404350|11230192|FG003|COMPLETED|Overall Study||295
10100954|NCT02404350|11230189|FG000|NOT COMPLETED|Overall Study||15
10100955|NCT02404350|11230190|FG001|NOT COMPLETED|Overall Study||6
10100956|NCT02404350|11230191|FG002|NOT COMPLETED|Overall Study||6
10100957|NCT02404350|11230192|FG003|NOT COMPLETED|Overall Study||37
10100958|NCT02404389|11230208|FG000|STARTED|Overall Study||20
10100959|NCT02404389|11230209|FG001|STARTED|Overall Study||20
10100960|NCT02404389|11230210|FG002|STARTED|Overall Study||11
10100961|NCT02404389|11230211|FG003|STARTED|Overall Study||10
10100962|NCT02404389|11230212|FG004|STARTED|Overall Study||21
10100963|NCT02404389|11230208|FG000|COMPLETED|Overall Study||18
10100964|NCT02404389|11230209|FG001|COMPLETED|Overall Study||20
10100965|NCT02404389|11230210|FG002|COMPLETED|Overall Study||10
9983322|NCT01611090|11104889|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0
9983323|NCT01611090|11104890|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0
9983324|NCT01611090|11104891|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183
9983325|NCT01611090|11104889|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0
9983326|NCT01611090|11104890|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0
9983327|NCT01611090|11104891|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183
9983328|NCT01611090|11104889|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
9983329|NCT01611090|11104890|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
9983330|NCT01611090|11104891|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
9983331|NCT01611090|11104889|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
9983332|NCT01611090|11104890|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
9983333|NCT01611090|11104891|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
9983334|NCT01611155|11104900|FG000|STARTED|Overall Study||25
9983335|NCT01611155|11104901|FG001|STARTED|Overall Study||25
9983336|NCT01611155|11104900|FG000|Received Treatment|Overall Study||25
9983337|NCT01611155|11104901|FG001|Received Treatment|Overall Study||25
10100966|NCT02404389|11230211|FG003|COMPLETED|Overall Study||9
10100967|NCT02404389|11230212|FG004|COMPLETED|Overall Study||18
10100968|NCT02404389|11230208|FG000|NOT COMPLETED|Overall Study||2
10100969|NCT02404389|11230209|FG001|NOT COMPLETED|Overall Study||0
10100970|NCT02404389|11230210|FG002|NOT COMPLETED|Overall Study||1
10100971|NCT02404389|11230211|FG003|NOT COMPLETED|Overall Study||1
10100972|NCT02404389|11230212|FG004|NOT COMPLETED|Overall Study||3
10100973|NCT02404441|11230236|FG000|STARTED|Phase 1 Part||16
10100974|NCT02404441|11230237|FG001|STARTED|Phase 1 Part||15
10100975|NCT02404441|11230238|FG002|STARTED|Phase 1 Part||11
10100976|NCT02404441|11230239|FG003|STARTED|Phase 1 Part||6
10100977|NCT02404441|11230240|FG004|STARTED|Phase 1 Part||10
10100978|NCT02404441|11230241|FG005|STARTED|Phase 1 Part||0
10100979|NCT02404441|11230242|FG006|STARTED|Phase 1 Part||0
10100980|NCT02404441|11230243|FG007|STARTED|Phase 1 Part||0
10100981|NCT02404441|11230244|FG008|STARTED|Phase 1 Part||0
10100982|NCT02404441|11230245|FG009|STARTED|Phase 1 Part||0
10100983|NCT02404441|11230236|FG000|COMPLETED|Phase 1 Part||0
10100984|NCT02404441|11230237|FG001|COMPLETED|Phase 1 Part||0
10100985|NCT02404441|11230238|FG002|COMPLETED|Phase 1 Part||0
10100986|NCT02404441|11230239|FG003|COMPLETED|Phase 1 Part||0
10100987|NCT02404441|11230240|FG004|COMPLETED|Phase 1 Part||0
10100988|NCT02404441|11230241|FG005|COMPLETED|Phase 1 Part||0
10100989|NCT02404441|11230242|FG006|COMPLETED|Phase 1 Part||0
10100990|NCT02404441|11230243|FG007|COMPLETED|Phase 1 Part||0
10100991|NCT02404441|11230244|FG008|COMPLETED|Phase 1 Part||0
10100992|NCT02404441|11230245|FG009|COMPLETED|Phase 1 Part||0
10100993|NCT02404441|11230236|FG000|NOT COMPLETED|Phase 1 Part||16
10100994|NCT02404441|11230237|FG001|NOT COMPLETED|Phase 1 Part||15
10100995|NCT02404441|11230238|FG002|NOT COMPLETED|Phase 1 Part||11
10100996|NCT02404441|11230239|FG003|NOT COMPLETED|Phase 1 Part||6
10100997|NCT02404441|11230240|FG004|NOT COMPLETED|Phase 1 Part||10
10100998|NCT02404441|11230241|FG005|NOT COMPLETED|Phase 1 Part||0
10100999|NCT02404441|11230242|FG006|NOT COMPLETED|Phase 1 Part||0
10101000|NCT02404441|11230243|FG007|NOT COMPLETED|Phase 1 Part||0
10101001|NCT02404441|11230244|FG008|NOT COMPLETED|Phase 1 Part||0
10101002|NCT02404441|11230245|FG009|NOT COMPLETED|Phase 1 Part||0
10101003|NCT02404441|11230236|FG000|STARTED|Phase 2 Part||0
10101004|NCT02404441|11230237|FG001|STARTED|Phase 2 Part||0
10101005|NCT02404441|11230238|FG002|STARTED|Phase 2 Part||0
10101006|NCT02404441|11230239|FG003|STARTED|Phase 2 Part||0
10101007|NCT02404441|11230240|FG004|STARTED|Phase 2 Part||0
10101008|NCT02404441|11230241|FG005|STARTED|Phase 2 Part||59
10101009|NCT02404441|11230242|FG006|STARTED|Phase 2 Part||61
10101010|NCT02404441|11230243|FG007|STARTED|Phase 2 Part||40
10101011|NCT02404441|11230244|FG008|STARTED|Phase 2 Part||59
10101012|NCT02404441|11230245|FG009|STARTED|Phase 2 Part||42
10101013|NCT02404441|11230236|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0
10101014|NCT02404441|11230237|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0
10101015|NCT02404441|11230238|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0
10101016|NCT02404441|11230239|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0
10101017|NCT02404441|11230240|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0
10101018|NCT02404441|11230241|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2
10101019|NCT02404441|11230242|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6
10101020|NCT02404441|11230243|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1
10101021|NCT02404441|11230244|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6
10101022|NCT02404441|11230245|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1
10101023|NCT02404441|11230236|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10101024|NCT02404441|11230237|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10101025|NCT02404441|11230238|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10101026|NCT02404441|11230239|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10101027|NCT02404441|11230240|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10101028|NCT02404441|11230241|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2
10101029|NCT02404441|11230242|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
10101030|NCT02404441|11230243|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
10101031|NCT02404441|11230244|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
10101032|NCT02404441|11230245|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
10101033|NCT02404441|11230236|FG000|Entered Survival Follow-up|Phase 2 Part||0
10101034|NCT02404441|11230237|FG001|Entered Survival Follow-up|Phase 2 Part||0
10101035|NCT02404441|11230238|FG002|Entered Survival Follow-up|Phase 2 Part||0
10101036|NCT02404441|11230239|FG003|Entered Survival Follow-up|Phase 2 Part||0
9983338|NCT01611155|11104900|FG000|COMPLETED|Overall Study||16
9983339|NCT01611155|11104901|FG001|COMPLETED|Overall Study||18
9983340|NCT01611155|11104900|FG000|NOT COMPLETED|Overall Study||9
9983341|NCT01611155|11104901|FG001|NOT COMPLETED|Overall Study||7
9983342|NCT01611194|11104909|FG000|STARTED|Overall Study||36
9983343|NCT01611194|11104910|FG001|STARTED|Overall Study||35
9983344|NCT01611194|11104909|FG000|COMPLETED|Overall Study||36
9983345|NCT01611194|11104910|FG001|COMPLETED|Overall Study||32
9983346|NCT01611194|11104909|FG000|NOT COMPLETED|Overall Study||0
9983347|NCT01611194|11104910|FG001|NOT COMPLETED|Overall Study||3
9983348|NCT01611259|11104916|FG000|STARTED|Overall Study||48
9983349|NCT01611259|11104916|FG000|COMPLETED|Overall Study||34
9983350|NCT01611259|11104916|FG000|NOT COMPLETED|Overall Study||14
9983351|NCT01611298|11104920|FG000|STARTED|Overall Study||7
9983352|NCT01611298|11104920|FG000|COMPLETED|Overall Study||5
9983353|NCT01611298|11104920|FG000|NOT COMPLETED|Overall Study||2
9983354|NCT01611454|11104926|FG000|STARTED|Overall Study||58
9983355|NCT01611454|11104927|FG001|STARTED|Overall Study||48
9983356|NCT01611454|11104926|FG000|COMPLETED|Overall Study||40
9983357|NCT01611454|11104927|FG001|COMPLETED|Overall Study||38
9983358|NCT01611454|11104926|FG000|NOT COMPLETED|Overall Study||18
9983359|NCT01611454|11104927|FG001|NOT COMPLETED|Overall Study||10
9983360|NCT01611558|11104937|FG000|STARTED|Induction Phase||40
9983361|NCT01611558|11104937|FG000|COMPLETED|Induction Phase||2
9983362|NCT01611558|11104937|FG000|NOT COMPLETED|Induction Phase||38
9983363|NCT01611558|11104937|FG000|STARTED|Maintenance Phase||2
9983364|NCT01611558|11104937|FG000|COMPLETED|Maintenance Phase||0
9983365|NCT01611558|11104937|FG000|NOT COMPLETED|Maintenance Phase||2
9983366|NCT01611571|11104945|FG000|STARTED|Overall Study||11
9983367|NCT01611571|11104946|FG001|STARTED|Overall Study||10
9983368|NCT01611571|11104947|FG002|STARTED|Overall Study||10
9983369|NCT01611571|11104945|FG000|COMPLETED|Overall Study||10
9983370|NCT01611571|11104946|FG001|COMPLETED|Overall Study||10
9983371|NCT01611571|11104947|FG002|COMPLETED|Overall Study||9
9983372|NCT01611571|11104945|FG000|NOT COMPLETED|Overall Study||1
9983373|NCT01611571|11104946|FG001|NOT COMPLETED|Overall Study||0
9983374|NCT01611571|11104947|FG002|NOT COMPLETED|Overall Study||1
9983375|NCT01611662|11104955|FG000|STARTED|Overall Study||32
9983376|NCT01611662|11104955|FG000|COMPLETED|Overall Study||31
9983377|NCT01611662|11104955|FG000|NOT COMPLETED|Overall Study||1
9983378|NCT01611779|11104959|FG000|STARTED|Overall Study||5
9983379|NCT01611779|11104959|FG000|COMPLETED|Overall Study||5
9983380|NCT01611779|11104959|FG000|NOT COMPLETED|Overall Study||0
9983381|NCT01611792|11104965|FG000|STARTED|Initial Period: Time 0||29
9983382|NCT01611792|11104966|FG001|STARTED|Initial Period: Time 0||29
9983383|NCT01611792|11104965|FG000|COMPLETED|Initial Period: Time 0||17
9983384|NCT01611792|11104966|FG001|COMPLETED|Initial Period: Time 0||20
9983385|NCT01611792|11104965|FG000|NOT COMPLETED|Initial Period: Time 0||12
9983386|NCT01611792|11104966|FG001|NOT COMPLETED|Initial Period: Time 0||9
9983387|NCT01611792|11104965|FG000|STARTED|Follow-up: at 11 Weeks||17
9983388|NCT01611792|11104966|FG001|STARTED|Follow-up: at 11 Weeks||20
9983389|NCT01611792|11104965|FG000|COMPLETED|Follow-up: at 11 Weeks||17
9983390|NCT01611792|11104966|FG001|COMPLETED|Follow-up: at 11 Weeks||20
9983391|NCT01611792|11104965|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0
9983392|NCT01611792|11104966|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0
9983393|NCT01611792|11104965|FG000|STARTED|Followup: at 6 Months||17
9983394|NCT01611792|11104966|FG001|STARTED|Followup: at 6 Months||20
9983395|NCT01611792|11104965|FG000|COMPLETED|Followup: at 6 Months||11
9983396|NCT01611792|11104966|FG001|COMPLETED|Followup: at 6 Months||7
9983397|NCT01611792|11104965|FG000|NOT COMPLETED|Followup: at 6 Months||6
9983398|NCT01611792|11104966|FG001|NOT COMPLETED|Followup: at 6 Months||13
9983399|NCT01611857|11104975|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
9983400|NCT01611857|11104976|FG001|STARTED|Overall Study||34
9983401|NCT01611857|11104975|FG000|Tivantinib 120 mg|Overall Study||5
9983402|NCT01611857|11104976|FG001|Tivantinib 120 mg|Overall Study||0
9983403|NCT01611857|11104975|FG000|Tivantinib 240 mg|Overall Study||3
9983404|NCT01611857|11104976|FG001|Tivantinib 240 mg|Overall Study||0
9983405|NCT01611857|11104975|FG000|Tivantinib 360 mg|Overall Study||7
9983406|NCT01611857|11104976|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
9983407|NCT01611857|11104975|FG000|COMPLETED|Overall Study||15
9983408|NCT01611857|11104976|FG001|COMPLETED|Overall Study||32
9983409|NCT01611857|11104975|FG000|NOT COMPLETED|Overall Study||0
9983410|NCT01611857|11104976|FG001|NOT COMPLETED|Overall Study||2
9983411|NCT01611935|11104986|FG000|STARTED|Overall Study||50
9983412|NCT01611935|11104987|FG001|STARTED|Overall Study||51
9983413|NCT01611935|11104986|FG000|COMPLETED|Overall Study||49
9983414|NCT01611935|11104987|FG001|COMPLETED|Overall Study||51
9983415|NCT01611935|11104986|FG000|NOT COMPLETED|Overall Study||1
9983416|NCT01611935|11104987|FG001|NOT COMPLETED|Overall Study||0
9983417|NCT01611948|11104995|FG000|STARTED|Overall Study||32
9983418|NCT01611948|11104996|FG001|STARTED|Overall Study||38
9983419|NCT01611948|11104995|FG000|COMPLETED|Overall Study||18
9983420|NCT01611948|11104996|FG001|COMPLETED|Overall Study||26
9983421|NCT01611948|11104995|FG000|NOT COMPLETED|Overall Study||14
9983422|NCT01611948|11104996|FG001|NOT COMPLETED|Overall Study||12
9983423|NCT01611974|11105005|FG000|STARTED|Overall Study||40
9983424|NCT01611974|11105006|FG001|STARTED|Overall Study||40
9983425|NCT01611974|11105007|FG002|STARTED|Overall Study||40
9983426|NCT01611974|11105005|FG000|COMPLETED|Overall Study||25
9983427|NCT01611974|11105006|FG001|COMPLETED|Overall Study||25
9983428|NCT01611974|11105007|FG002|COMPLETED|Overall Study||24
9983429|NCT01611974|11105005|FG000|NOT COMPLETED|Overall Study||15
9983430|NCT01611974|11105006|FG001|NOT COMPLETED|Overall Study||15
9983431|NCT01611974|11105007|FG002|NOT COMPLETED|Overall Study||16
9983432|NCT01612000|11105019|FG000|STARTED|Overall Study||84
9983433|NCT01612000|11105020|FG001|STARTED|Overall Study||86
9983434|NCT01612000|11105021|FG002|STARTED|Overall Study||85
9983435|NCT01612000|11105022|FG003|STARTED|Overall Study||86
9983436|NCT01612000|11105019|FG000|COMPLETED|Overall Study||75
9983437|NCT01612000|11105020|FG001|COMPLETED|Overall Study||81
9983438|NCT01612000|11105021|FG002|COMPLETED|Overall Study||78
9983439|NCT01612000|11105022|FG003|COMPLETED|Overall Study||76
9983440|NCT01612000|11105019|FG000|NOT COMPLETED|Overall Study||9
9983441|NCT01612000|11105020|FG001|NOT COMPLETED|Overall Study||5
9983442|NCT01612000|11105021|FG002|NOT COMPLETED|Overall Study||7
9983443|NCT01612000|11105022|FG003|NOT COMPLETED|Overall Study||10
9983444|NCT01612156|11105034|FG000|STARTED|Overall Study||42
9983445|NCT01612156|11105035|FG001|STARTED|Overall Study||48
9983446|NCT01612156|11105034|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
9983447|NCT01612156|11105035|FG001|COMPLETED|Overall Study||48
9983448|NCT01612156|11105034|FG000|NOT COMPLETED|Overall Study||2
9983449|NCT01612156|11105035|FG001|NOT COMPLETED|Overall Study||0
9983450|NCT01612221|11105043|FG000|STARTED|Overall Study||50
9983451|NCT01612221|11105044|FG001|STARTED|Overall Study||50
9983452|NCT01612221|11105043|FG000|COMPLETED|Overall Study||50
10101037|NCT02404441|11230240|FG004|Entered Survival Follow-up|Phase 2 Part||0
10101038|NCT02404441|11230241|FG005|Entered Survival Follow-up|Phase 2 Part||38
10101039|NCT02404441|11230242|FG006|Entered Survival Follow-up|Phase 2 Part||34
10101040|NCT02404441|11230243|FG007|Entered Survival Follow-up|Phase 2 Part||26
10101041|NCT02404441|11230244|FG008|Entered Survival Follow-up|Phase 2 Part||35
10101042|NCT02404441|11230245|FG009|Entered Survival Follow-up|Phase 2 Part||25
10101043|NCT02404441|11230236|FG000|COMPLETED|Phase 2 Part||0
10101044|NCT02404441|11230237|FG001|COMPLETED|Phase 2 Part||0
10101045|NCT02404441|11230238|FG002|COMPLETED|Phase 2 Part||0
10101046|NCT02404441|11230239|FG003|COMPLETED|Phase 2 Part||0
10101047|NCT02404441|11230240|FG004|COMPLETED|Phase 2 Part||0
10101048|NCT02404441|11230241|FG005|COMPLETED|Phase 2 Part||0
10101049|NCT02404441|11230242|FG006|COMPLETED|Phase 2 Part||0
10101050|NCT02404441|11230243|FG007|COMPLETED|Phase 2 Part||0
10101051|NCT02404441|11230244|FG008|COMPLETED|Phase 2 Part||0
10101052|NCT02404441|11230245|FG009|COMPLETED|Phase 2 Part||0
10101053|NCT02404441|11230236|FG000|NOT COMPLETED|Phase 2 Part||0
10101054|NCT02404441|11230237|FG001|NOT COMPLETED|Phase 2 Part||0
10101055|NCT02404441|11230238|FG002|NOT COMPLETED|Phase 2 Part||0
10101056|NCT02404441|11230239|FG003|NOT COMPLETED|Phase 2 Part||0
10101057|NCT02404441|11230240|FG004|NOT COMPLETED|Phase 2 Part||0
10101058|NCT02404441|11230241|FG005|NOT COMPLETED|Phase 2 Part||59
10101059|NCT02404441|11230242|FG006|NOT COMPLETED|Phase 2 Part||61
10101060|NCT02404441|11230243|FG007|NOT COMPLETED|Phase 2 Part||40
10101061|NCT02404441|11230244|FG008|NOT COMPLETED|Phase 2 Part||59
10101062|NCT02404441|11230245|FG009|NOT COMPLETED|Phase 2 Part||42
10101063|NCT02404493|11230291|FG000|STARTED|Overall Study||17
10101064|NCT02404493|11230292|FG001|STARTED|Overall Study||6
10101065|NCT02404493|11230291|FG000|COMPLETED|Overall Study||16
10101066|NCT02404493|11230292|FG001|COMPLETED|Overall Study||5
10101067|NCT02404493|11230291|FG000|NOT COMPLETED|Overall Study||1
10101068|NCT02404493|11230292|FG001|NOT COMPLETED|Overall Study||1
10101069|NCT02404532|11230298|FG000|STARTED|Overall Study||29
10101070|NCT02404532|11230298|FG000|COMPLETED|Overall Study||29
10101071|NCT02404532|11230298|FG000|NOT COMPLETED|Overall Study||0
10101072|NCT02404610|11230309|FG000|STARTED|Overall Study||54
10101073|NCT02404610|11230310|FG001|STARTED|Overall Study||53
10101074|NCT02404610|11230309|FG000|COMPLETED|Overall Study||54
10101075|NCT02404610|11230310|FG001|COMPLETED|Overall Study||53
10101076|NCT02404610|11230309|FG000|NOT COMPLETED|Overall Study||0
10101077|NCT02404610|11230310|FG001|NOT COMPLETED|Overall Study||0
10101078|NCT02404649|11230318|FG000|STARTED|Overall Study||17
10101079|NCT02404649|11230319|FG001|STARTED|Overall Study||16
10101080|NCT02404649|11230318|FG000|COMPLETED|Overall Study||16
10101081|NCT02404649|11230319|FG001|COMPLETED|Overall Study||14
10101082|NCT02404649|11230318|FG000|NOT COMPLETED|Overall Study||1
10101083|NCT02404649|11230319|FG001|NOT COMPLETED|Overall Study||2
10101084|NCT02404792|11230327|FG000|STARTED|Overall Study||32
10101085|NCT02404792|11230328|FG001|STARTED|Overall Study||37
9983453|NCT01612221|11105044|FG001|COMPLETED|Overall Study||50
9983454|NCT01612221|11105043|FG000|NOT COMPLETED|Overall Study||0
9983455|NCT01612221|11105044|FG001|NOT COMPLETED|Overall Study||0
9983456|NCT01612494|11105052|FG000|STARTED|Overall Study||21
9983457|NCT01612494|11105053|FG001|STARTED|Overall Study||23
9983458|NCT01612494|11105052|FG000|COMPLETED|Overall Study||21
9983459|NCT01612494|11105053|FG001|COMPLETED|Overall Study||23
9983460|NCT01612494|11105052|FG000|NOT COMPLETED|Overall Study||0
9983461|NCT01612494|11105053|FG001|NOT COMPLETED|Overall Study||0
9983462|NCT01612546|11105059|FG000|STARTED|Overall Study||10
9983463|NCT01612546|11105059|FG000|COMPLETED|Overall Study||10
9983464|NCT01612546|11105059|FG000|NOT COMPLETED|Overall Study||0
9983465|NCT01612676|11105067|FG000|STARTED|Overall Study||6
10101086|NCT02404792|11230327|FG000|COMPLETED|Overall Study||27
10101087|NCT02404792|11230328|FG001|COMPLETED|Overall Study||29
10101088|NCT02404792|11230327|FG000|NOT COMPLETED|Overall Study||5
10101089|NCT02404792|11230328|FG001|NOT COMPLETED|Overall Study||8
9983466|NCT01612676|11105068|FG001|STARTED|Overall Study||7
9983467|NCT01612676|11105069|FG002|STARTED|Overall Study||5
9983468|NCT01612676|11105070|FG003|STARTED|Overall Study||13
9983469|NCT01612676|11105067|FG000|Dosed|Overall Study||5
9983470|NCT01612676|11105068|FG001|Dosed|Overall Study||7
9983471|NCT01612676|11105069|FG002|Dosed|Overall Study||5
9983472|NCT01612676|11105070|FG003|Dosed|Overall Study||13
9983473|NCT01612676|11105067|FG000|COMPLETED|Overall Study||4
9983474|NCT01612676|11105068|FG001|COMPLETED|Overall Study||3
9983475|NCT01612676|11105069|FG002|COMPLETED|Overall Study||4
9983476|NCT01612676|11105070|FG003|COMPLETED|Overall Study||10
9983477|NCT01612676|11105067|FG000|NOT COMPLETED|Overall Study||2
9983478|NCT01612676|11105068|FG001|NOT COMPLETED|Overall Study||4
9983479|NCT01612676|11105069|FG002|NOT COMPLETED|Overall Study||1
9983480|NCT01612676|11105070|FG003|NOT COMPLETED|Overall Study||3
9983481|NCT01612702|11105084|FG000|STARTED|Overall Study||146
9983482|NCT01612702|11105085|FG001|STARTED|Overall Study||145
9983483|NCT01612702|11105084|FG000|COMPLETED|Overall Study||135
9983484|NCT01612702|11105085|FG001|COMPLETED|Overall Study||134
9983485|NCT01612702|11105084|FG000|NOT COMPLETED|Overall Study||11
9983486|NCT01612702|11105085|FG001|NOT COMPLETED|Overall Study||11
9983487|NCT01612767|11105091|FG000|STARTED|Overall Study||329
9983488|NCT01612767|11105091|FG000|COMPLETED|Overall Study||287
9983489|NCT01612767|11105091|FG000|NOT COMPLETED|Overall Study||42
9983490|NCT01612780|11105116|FG000|STARTED|Overall Study||82
9983491|NCT01612780|11105116|FG000|COMPLETED|Overall Study||76
9983492|NCT01612780|11105116|FG000|NOT COMPLETED|Overall Study||6
9983493|NCT01612793|11105122|FG000|STARTED|Overall Study||2
9983494|NCT01612793|11105123|FG001|STARTED|Overall Study||2
9983495|NCT01612793|11105122|FG000|COMPLETED|Overall Study||2
9983496|NCT01612793|11105123|FG001|COMPLETED|Overall Study||2
9983497|NCT01612793|11105122|FG000|NOT COMPLETED|Overall Study||0
9983498|NCT01612793|11105123|FG001|NOT COMPLETED|Overall Study||0
9983499|NCT01612858|11105131|FG000|STARTED|Overall Study||16
9983500|NCT01612858|11105132|FG001|STARTED|Overall Study||4
9983501|NCT01612858|11105131|FG000|COMPLETED|Overall Study||11
9983502|NCT01612858|11105132|FG001|COMPLETED|Overall Study||3
9983503|NCT01612858|11105131|FG000|NOT COMPLETED|Overall Study||5
9983504|NCT01612858|11105132|FG001|NOT COMPLETED|Overall Study||1
9983505|NCT01612884|11105140|FG000|STARTED|Overall Study||19
9983506|NCT01612884|11105141|FG001|STARTED|Overall Study||18
9983507|NCT01612884|11105140|FG000|COMPLETED|Overall Study||19
9983508|NCT01612884|11105141|FG001|COMPLETED|Overall Study||18
9983509|NCT01612884|11105140|FG000|NOT COMPLETED|Overall Study||0
9983510|NCT01612884|11105141|FG001|NOT COMPLETED|Overall Study||0
9983511|NCT01613014|11105149|FG000|STARTED|Overall Study||75
9983512|NCT01613014|11105150|FG001|STARTED|Overall Study||75
9983513|NCT01613014|11105149|FG000|COMPLETED|Overall Study||57
9983514|NCT01613014|11105150|FG001|COMPLETED|Overall Study||63
9983515|NCT01613014|11105149|FG000|NOT COMPLETED|Overall Study||18
9983516|NCT01613014|11105150|FG001|NOT COMPLETED|Overall Study||12
9983517|NCT01613027|11105156|FG000|STARTED|Overall Study||135
9983518|NCT01613027|11105156|FG000|COMPLETED|Overall Study||127
9983519|NCT01613027|11105156|FG000|NOT COMPLETED|Overall Study||8
9983520|NCT01613131|11105162|FG000|STARTED|Overall Study||20
10101090|NCT02404805|11230342|FG000|STARTED|Overall Study||5
10101091|NCT02404805|11230343|FG001|STARTED|Overall Study||3
10101092|NCT02404805|11230344|FG002|STARTED|Overall Study||5
10101093|NCT02404805|11230345|FG003|STARTED|Overall Study||5
10101094|NCT02404805|11230346|FG004|STARTED|Overall Study||3
10101095|NCT02404805|11230347|FG005|STARTED|Overall Study||4
10101096|NCT02404805|11230342|FG000|COMPLETED|Overall Study||4
10101097|NCT02404805|11230343|FG001|COMPLETED|Overall Study||3
10101098|NCT02404805|11230344|FG002|COMPLETED|Overall Study||5
10101099|NCT02404805|11230345|FG003|COMPLETED|Overall Study||5
10101100|NCT02404805|11230346|FG004|COMPLETED|Overall Study||3
10101101|NCT02404805|11230347|FG005|COMPLETED|Overall Study||4
10101102|NCT02404805|11230342|FG000|NOT COMPLETED|Overall Study||1
10101103|NCT02404805|11230343|FG001|NOT COMPLETED|Overall Study||0
10101104|NCT02404805|11230344|FG002|NOT COMPLETED|Overall Study||0
10101105|NCT02404805|11230345|FG003|NOT COMPLETED|Overall Study||0
10101106|NCT02404805|11230346|FG004|NOT COMPLETED|Overall Study||0
10101107|NCT02404805|11230347|FG005|NOT COMPLETED|Overall Study||0
10101108|NCT02405091|11230359|FG000|STARTED|Overall Study||49
10101109|NCT02405091|11230360|FG001|STARTED|Overall Study||107
10101110|NCT02405091|11230361|FG002|STARTED|Overall Study||11
10101111|NCT02405091|11230359|FG000|COMPLETED|Overall Study||20
10101112|NCT02405091|11230360|FG001|COMPLETED|Overall Study||74
9983521|NCT01613131|11105163|FG001|STARTED|Overall Study||18
9983522|NCT01613131|11105162|FG000|COMPLETED|Overall Study||17
9983523|NCT01613131|11105163|FG001|COMPLETED|Overall Study||13
9983524|NCT01613131|11105162|FG000|NOT COMPLETED|Overall Study||3
9983525|NCT01613131|11105163|FG001|NOT COMPLETED|Overall Study||5
9983526|NCT01613222|11105169|FG000|STARTED|Overall Study||63
9983527|NCT01613222|11105169|FG000|COMPLETED|Overall Study||51
9983528|NCT01613222|11105169|FG000|NOT COMPLETED|Overall Study||12
9983529|NCT01613248|11105188|FG000|STARTED|Overall Study||139
9983530|NCT01613248|11105189|FG001|STARTED|Overall Study||138
9983531|NCT01613248|11105190|FG002|STARTED|Overall Study||139
9983532|NCT01613248|11105191|FG003|STARTED|Overall Study||139
9983533|NCT01613248|11105192|FG004|STARTED|Overall Study||139
10101113|NCT02405091|11230361|FG002|COMPLETED|Overall Study||9
9983534|NCT01613248|11105193|FG005|STARTED|Overall Study||140
9983535|NCT01613248|11105188|FG000|COMPLETED|Overall Study||110
9983536|NCT01613248|11105189|FG001|COMPLETED|Overall Study||104
9983537|NCT01613248|11105190|FG002|COMPLETED|Overall Study||106
9983538|NCT01613248|11105191|FG003|COMPLETED|Overall Study||101
9983539|NCT01613248|11105192|FG004|COMPLETED|Overall Study||104
9983540|NCT01613248|11105193|FG005|COMPLETED|Overall Study||102
9983541|NCT01613248|11105188|FG000|NOT COMPLETED|Overall Study||29
9983542|NCT01613248|11105189|FG001|NOT COMPLETED|Overall Study||34
9983543|NCT01613248|11105190|FG002|NOT COMPLETED|Overall Study||33
9983544|NCT01613248|11105191|FG003|NOT COMPLETED|Overall Study||38
9983545|NCT01613248|11105192|FG004|NOT COMPLETED|Overall Study||35
9983546|NCT01613248|11105193|FG005|NOT COMPLETED|Overall Study||38
9983547|NCT01613313|11105211|FG000|STARTED|Overall Study||2
9983548|NCT01613313|11105212|FG001|STARTED|Overall Study||4
9983549|NCT01613313|11105213|FG002|STARTED|Overall Study||4
9983550|NCT01613313|11105214|FG003|STARTED|Overall Study||4
9983551|NCT01613313|11105211|FG000|COMPLETED|Overall Study||2
9983552|NCT01613313|11105212|FG001|COMPLETED|Overall Study||4
9983553|NCT01613313|11105213|FG002|COMPLETED|Overall Study||4
9983554|NCT01613313|11105214|FG003|COMPLETED|Overall Study||4
9983555|NCT01613313|11105211|FG000|NOT COMPLETED|Overall Study||0
9983556|NCT01613313|11105212|FG001|NOT COMPLETED|Overall Study||0
9983557|NCT01613313|11105213|FG002|NOT COMPLETED|Overall Study||0
9983558|NCT01613313|11105214|FG003|NOT COMPLETED|Overall Study||0
9983559|NCT01613326|11105226|FG000|STARTED|Overall Study||327
9983560|NCT01613326|11105227|FG001|STARTED|Overall Study||330
9983561|NCT01613326|11105226|FG000|COMPLETED|Overall Study||314
9983562|NCT01613326|11105227|FG001|COMPLETED|Overall Study||316
9983563|NCT01613326|11105226|FG000|NOT COMPLETED|Overall Study||13
9983564|NCT01613326|11105227|FG001|NOT COMPLETED|Overall Study||14
9983565|NCT01613339|11105235|FG000|STARTED|Overall Study||24
9983566|NCT01613339|11105236|FG001|STARTED|Overall Study||22
9983567|NCT01613339|11105235|FG000|COMPLETED|Overall Study||21
9983568|NCT01613339|11105236|FG001|COMPLETED|Overall Study||21
9983569|NCT01613339|11105235|FG000|NOT COMPLETED|Overall Study||3
9983570|NCT01613339|11105236|FG001|NOT COMPLETED|Overall Study||1
9983571|NCT01613378|11105241|FG000|STARTED|Overall Study||200
9983572|NCT01613378|11105241|FG000|COMPLETED|Overall Study||161
9983573|NCT01613378|11105241|FG000|NOT COMPLETED|Overall Study||39
9983574|NCT01613417|11105247|FG000|STARTED|First Injection||113
9983575|NCT01613417|11105248|FG001|STARTED|First Injection||116
9983576|NCT01613417|11105247|FG000|COMPLETED|First Injection||113
9983577|NCT01613417|11105248|FG001|COMPLETED|First Injection||116
9983578|NCT01613417|11105247|FG000|NOT COMPLETED|First Injection||0
9983579|NCT01613417|11105248|FG001|NOT COMPLETED|First Injection||0
9983580|NCT01613417|11105247|FG000|STARTED|Washout (no Second Injection/MRI)||113
9983581|NCT01613417|11105248|FG001|STARTED|Washout (no Second Injection/MRI)||116
9983582|NCT01613417|11105247|FG000|COMPLETED|Washout (no Second Injection/MRI)||100
9983583|NCT01613417|11105248|FG001|COMPLETED|Washout (no Second Injection/MRI)||109
9983584|NCT01613417|11105247|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13
9983585|NCT01613417|11105248|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7
9983586|NCT01613417|11105247|FG000|STARTED|Second Injection||100
9983587|NCT01613417|11105248|FG001|STARTED|Second Injection||109
9983588|NCT01613417|11105247|FG000|COMPLETED|Second Injection||100
9983589|NCT01613417|11105248|FG001|COMPLETED|Second Injection||109
9983590|NCT01613417|11105247|FG000|NOT COMPLETED|Second Injection||0
9983591|NCT01613417|11105248|FG001|NOT COMPLETED|Second Injection||0
9983592|NCT01613599|11105264|FG000|STARTED|Overall Study||97
9983593|NCT01613599|11105264|FG000|COMPLETED|Overall Study||72
9983594|NCT01613599|11105264|FG000|NOT COMPLETED|Overall Study||25
9983595|NCT01613716|11105268|FG000|STARTED|Overall Study||30
9983596|NCT01613716|11105268|FG000|COMPLETED|Overall Study||23
9983597|NCT01613716|11105268|FG000|NOT COMPLETED|Overall Study||7
9983598|NCT01613768|11105272|FG000|STARTED|Overall Study||29
9983599|NCT01613768|11105272|FG000|COMPLETED|Overall Study||29
10101114|NCT02405091|11230359|FG000|NOT COMPLETED|Overall Study||29
10101115|NCT02405091|11230360|FG001|NOT COMPLETED|Overall Study||33
10101116|NCT02405091|11230361|FG002|NOT COMPLETED|Overall Study||2
10101117|NCT02405195|11230372|FG000|STARTED|Overall Study||18
10101118|NCT02405195|11230372|FG000|COMPLETED|Overall Study||18
9983600|NCT01613768|11105272|FG000|NOT COMPLETED|Overall Study||0
9983601|NCT01614093|11105277|FG000|STARTED|Overall Study||17
9983602|NCT01614093|11105277|FG000|COMPLETED|Overall Study||16
9983603|NCT01614093|11105277|FG000|NOT COMPLETED|Overall Study||1
9983604|NCT01614210|11105282|FG000|STARTED|Overall Study||52
9983605|NCT01614210|11105282|FG000|COMPLETED|Overall Study||52
9983606|NCT01614210|11105282|FG000|NOT COMPLETED|Overall Study||0
9983607|NCT01614249|11105288|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
9983608|NCT01614249|11105289|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
9983609|NCT01614249|11105288|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
9983610|NCT01614249|11105289|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
10018038|NCT01820585|11140961|FG000|NOT COMPLETED|Overall Study||27
10018039|NCT01820585|11140962|FG001|NOT COMPLETED|Overall Study||32
10018040|NCT01820585|11140963|FG002|NOT COMPLETED|Overall Study||34
10018041|NCT01820585|11140964|FG003|NOT COMPLETED|Overall Study||49
10018042|NCT01820637|11140974|FG000|STARTED|Overall Study||57
10018043|NCT01820637|11140974|FG000|COMPLETED|Overall Study||54
10018044|NCT01820637|11140974|FG000|NOT COMPLETED|Overall Study||3
10101119|NCT02405195|11230372|FG000|NOT COMPLETED|Overall Study||0
10101120|NCT02405325|11230378|FG000|STARTED|Overall Study||267
10101121|NCT02405325|11230379|FG001|STARTED|Overall Study||209
10101122|NCT02405325|11230378|FG000|COMPLETED|Overall Study||203
10101123|NCT02405325|11230379|FG001|COMPLETED|Overall Study||175
10101124|NCT02405325|11230378|FG000|NOT COMPLETED|Overall Study||64
9983611|NCT01614249|11105288|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
9983612|NCT01614249|11105289|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
9983613|NCT01614249|11105288|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
9983614|NCT01614249|11105289|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
9983615|NCT01614249|11105288|FG000|NOT COMPLETED|Overall Study||11
9983616|NCT01614249|11105289|FG001|NOT COMPLETED|Overall Study||23
9983617|NCT01614392|11105297|FG000|STARTED|Overall Study||25
9983618|NCT01614392|11105298|FG001|STARTED|Overall Study||27
9983619|NCT01614392|11105297|FG000|COMPLETED|Overall Study||24
9983620|NCT01614392|11105298|FG001|COMPLETED|Overall Study||24
9983621|NCT01614392|11105297|FG000|NOT COMPLETED|Overall Study||1
9983622|NCT01614392|11105298|FG001|NOT COMPLETED|Overall Study||3
9983623|NCT01614457|11105306|FG000|STARTED|Overall Study||34
9983624|NCT01614457|11105307|FG001|STARTED|Overall Study||35
9983625|NCT01614457|11105306|FG000|COMPLETED|Overall Study||32
9983626|NCT01614457|11105307|FG001|COMPLETED|Overall Study||35
9983627|NCT01614457|11105306|FG000|NOT COMPLETED|Overall Study||2
9983628|NCT01614457|11105307|FG001|NOT COMPLETED|Overall Study||0
9983629|NCT01614470|11105315|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
9983630|NCT01614470|11105316|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
9983631|NCT01614470|11105317|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
9983632|NCT01614470|11105315|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
9983633|NCT01614470|11105316|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
9983634|NCT01614470|11105317|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
9983635|NCT01614470|11105315|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
9983636|NCT01614470|11105316|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
9983637|NCT01614470|11105317|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
9983638|NCT01614470|11105315|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
9983639|NCT01614470|11105316|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
9983640|NCT01614470|11105317|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
9983641|NCT01614470|11105315|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
9983642|NCT01614470|11105316|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
9983643|NCT01614470|11105317|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
9983644|NCT01614470|11105315|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
9983645|NCT01614470|11105316|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
9983646|NCT01614470|11105317|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
9983647|NCT01614470|11105315|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
9983648|NCT01614470|11105316|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
9983649|NCT01614470|11105317|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
9983650|NCT01614470|11105315|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
9983651|NCT01614470|11105316|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
9983652|NCT01614470|11105317|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
9983653|NCT01614470|11105315|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
9983654|NCT01614470|11105316|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
9983655|NCT01614470|11105317|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
9983656|NCT01614470|11105315|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0
9983657|NCT01614470|11105316|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0
9983658|NCT01614470|11105317|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36
9983659|NCT01614470|11105315|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
9983660|NCT01614470|11105316|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
9983661|NCT01614470|11105317|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
9983662|NCT01614470|11105315|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
9983663|NCT01614470|11105316|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
9983664|NCT01614470|11105317|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
9983665|NCT01614509|11105328|FG000|STARTED|Overall Study||24
9983666|NCT01614509|11105329|FG001|STARTED|Overall Study||21
9983667|NCT01614509|11105328|FG000|COMPLETED|Overall Study||23
9983668|NCT01614509|11105329|FG001|COMPLETED|Overall Study||18
9983669|NCT01614509|11105328|FG000|NOT COMPLETED|Overall Study||1
9983670|NCT01614509|11105329|FG001|NOT COMPLETED|Overall Study||3
10101125|NCT02405325|11230379|FG001|NOT COMPLETED|Overall Study||34
10101126|NCT02405390|11230387|FG000|STARTED|Overall Study||46
10101127|NCT02405390|11230388|FG001|STARTED|Overall Study||46
10101128|NCT02405390|11230387|FG000|COMPLETED|Overall Study||46
9983671|NCT01614574|11105335|FG000|STARTED|Overall Study||6
9983672|NCT01614574|11105335|FG000|COMPLETED|Overall Study||6
10101129|NCT02405390|11230388|FG001|COMPLETED|Overall Study||46
10101130|NCT02405390|11230387|FG000|NOT COMPLETED|Overall Study||0
10101131|NCT02405390|11230388|FG001|NOT COMPLETED|Overall Study||0
10101132|NCT02405429|11230394|FG000|STARTED|Overall Study||49
10101133|NCT02405429|11230394|FG000|COMPLETED|Overall Study||49
10101134|NCT02405429|11230394|FG000|NOT COMPLETED|Overall Study||0
9983673|NCT01614574|11105335|FG000|NOT COMPLETED|Overall Study||0
9983674|NCT01614600|11105339|FG000|STARTED|Overall Study||88
9983675|NCT01614600|11105339|FG000|COMPLETED|Overall Study||84
9983676|NCT01614600|11105339|FG000|NOT COMPLETED|Overall Study||4
9983677|NCT01614613|11105343|FG000|STARTED|Overall Study||146
9983678|NCT01614613|11105343|FG000|COMPLETED|Overall Study||146
9983679|NCT01614613|11105343|FG000|NOT COMPLETED|Overall Study||0
9983680|NCT01614743|11105350|FG000|STARTED|Overall Study||4
9983681|NCT01614743|11105351|FG001|STARTED|Overall Study||5
9983682|NCT01614743|11105350|FG000|COMPLETED|Overall Study||3
9983683|NCT01614743|11105351|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
9983684|NCT01614743|11105350|FG000|NOT COMPLETED|Overall Study||1
9983685|NCT01614743|11105351|FG001|NOT COMPLETED|Overall Study||0
9983686|NCT01614769|11105357|FG000|STARTED|Period 1||2
9983687|NCT01614769|11105358|FG001|STARTED|Period 1||1
9983688|NCT01614769|11105359|FG002|STARTED|Period 1||2
9983689|NCT01614769|11105360|FG003|STARTED|Period 1||2
9983690|NCT01614769|11105361|FG004|STARTED|Period 1||1
9983691|NCT01614769|11105362|FG005|STARTED|Period 1||2
9983692|NCT01614769|11105357|FG000|COMPLETED|Period 1||1
9983693|NCT01614769|11105358|FG001|COMPLETED|Period 1||1
9983694|NCT01614769|11105359|FG002|COMPLETED|Period 1||2
9983695|NCT01614769|11105360|FG003|COMPLETED|Period 1||0
9983696|NCT01614769|11105361|FG004|COMPLETED|Period 1||1
9983697|NCT01614769|11105362|FG005|COMPLETED|Period 1||1
9983698|NCT01614769|11105357|FG000|NOT COMPLETED|Period 1||1
9983699|NCT01614769|11105358|FG001|NOT COMPLETED|Period 1||0
9983700|NCT01614769|11105359|FG002|NOT COMPLETED|Period 1||0
9983701|NCT01614769|11105360|FG003|NOT COMPLETED|Period 1||2
9983702|NCT01614769|11105361|FG004|NOT COMPLETED|Period 1||0
9983703|NCT01614769|11105362|FG005|NOT COMPLETED|Period 1||1
9983704|NCT01614769|11105357|FG000|STARTED|7-Day Washout||1
9983705|NCT01614769|11105358|FG001|STARTED|7-Day Washout||1
9983706|NCT01614769|11105359|FG002|STARTED|7-Day Washout||2
9983707|NCT01614769|11105360|FG003|STARTED|7-Day Washout||0
9983708|NCT01614769|11105361|FG004|STARTED|7-Day Washout||1
9983709|NCT01614769|11105362|FG005|STARTED|7-Day Washout||1
9983710|NCT01614769|11105357|FG000|COMPLETED|7-Day Washout||1
9983711|NCT01614769|11105358|FG001|COMPLETED|7-Day Washout||1
9983712|NCT01614769|11105359|FG002|COMPLETED|7-Day Washout||2
9983713|NCT01614769|11105360|FG003|COMPLETED|7-Day Washout||0
9983714|NCT01614769|11105361|FG004|COMPLETED|7-Day Washout||1
9983715|NCT01614769|11105362|FG005|COMPLETED|7-Day Washout||1
9983716|NCT01614769|11105357|FG000|NOT COMPLETED|7-Day Washout||0
9983717|NCT01614769|11105358|FG001|NOT COMPLETED|7-Day Washout||0
9983718|NCT01614769|11105359|FG002|NOT COMPLETED|7-Day Washout||0
9983719|NCT01614769|11105360|FG003|NOT COMPLETED|7-Day Washout||0
9983720|NCT01614769|11105361|FG004|NOT COMPLETED|7-Day Washout||0
9983721|NCT01614769|11105362|FG005|NOT COMPLETED|7-Day Washout||0
9983722|NCT01614769|11105357|FG000|STARTED|Period 2||1
9983723|NCT01614769|11105358|FG001|STARTED|Period 2||1
10101135|NCT02405442|11230402|FG000|STARTED|Double-Blind Phase (up to Week 8)||53
10101136|NCT02405442|11230403|FG001|STARTED|Double-Blind Phase (up to Week 8)||53
10101137|NCT02405442|11230404|FG002|STARTED|Double-Blind Phase (up to Week 8)||53
10101138|NCT02405442|11230405|FG003|STARTED|Double-Blind Phase (up to Week 8)||28
10101139|NCT02405442|11230402|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52
10101140|NCT02405442|11230403|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48
9983724|NCT01614769|11105359|FG002|STARTED|Period 2||2
9983725|NCT01614769|11105360|FG003|STARTED|Period 2||0
9983726|NCT01614769|11105361|FG004|STARTED|Period 2||1
9983727|NCT01614769|11105362|FG005|STARTED|Period 2||1
9983728|NCT01614769|11105357|FG000|COMPLETED|Period 2||1
9983729|NCT01614769|11105358|FG001|COMPLETED|Period 2||1
9983730|NCT01614769|11105359|FG002|COMPLETED|Period 2||2
9983731|NCT01614769|11105360|FG003|COMPLETED|Period 2||0
9983732|NCT01614769|11105361|FG004|COMPLETED|Period 2||1
9983733|NCT01614769|11105362|FG005|COMPLETED|Period 2||1
9983734|NCT01614769|11105357|FG000|NOT COMPLETED|Period 2||0
9983735|NCT01614769|11105358|FG001|NOT COMPLETED|Period 2||0
10101141|NCT02405442|11230404|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47
10101142|NCT02405442|11230405|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27
10101143|NCT02405442|11230402|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
10101144|NCT02405442|11230403|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
10101145|NCT02405442|11230404|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
9983736|NCT01614769|11105359|FG002|NOT COMPLETED|Period 2||0
9983737|NCT01614769|11105360|FG003|NOT COMPLETED|Period 2||0
9983738|NCT01614769|11105361|FG004|NOT COMPLETED|Period 2||0
9983739|NCT01614769|11105362|FG005|NOT COMPLETED|Period 2||0
9983740|NCT01614769|11105357|FG000|STARTED|7-Day Washout||1
9983741|NCT01614769|11105358|FG001|STARTED|7-Day Washout||1
9983742|NCT01614769|11105359|FG002|STARTED|7-Day Washout||2
9983743|NCT01614769|11105360|FG003|STARTED|7-Day Washout||0
9983744|NCT01614769|11105361|FG004|STARTED|7-Day Washout||1
9983745|NCT01614769|11105362|FG005|STARTED|7-Day Washout||1
9983746|NCT01614769|11105357|FG000|COMPLETED|7-Day Washout||1
9983747|NCT01614769|11105358|FG001|COMPLETED|7-Day Washout||1
9983748|NCT01614769|11105359|FG002|COMPLETED|7-Day Washout||2
9983749|NCT01614769|11105360|FG003|COMPLETED|7-Day Washout||0
9983750|NCT01614769|11105361|FG004|COMPLETED|7-Day Washout||1
9983751|NCT01614769|11105362|FG005|COMPLETED|7-Day Washout||1
9983752|NCT01614769|11105357|FG000|NOT COMPLETED|7-Day Washout||0
9983753|NCT01614769|11105358|FG001|NOT COMPLETED|7-Day Washout||0
9983754|NCT01614769|11105359|FG002|NOT COMPLETED|7-Day Washout||0
9983755|NCT01614769|11105360|FG003|NOT COMPLETED|7-Day Washout||0
9983756|NCT01614769|11105361|FG004|NOT COMPLETED|7-Day Washout||0
9983757|NCT01614769|11105362|FG005|NOT COMPLETED|7-Day Washout||0
9983758|NCT01614769|11105357|FG000|STARTED|Period 3||1
9983759|NCT01614769|11105358|FG001|STARTED|Period 3||1
9983760|NCT01614769|11105359|FG002|STARTED|Period 3||2
9983761|NCT01614769|11105360|FG003|STARTED|Period 3||0
9983762|NCT01614769|11105361|FG004|STARTED|Period 3||1
9983763|NCT01614769|11105362|FG005|STARTED|Period 3||1
9983764|NCT01614769|11105357|FG000|COMPLETED|Period 3||1
9983765|NCT01614769|11105358|FG001|COMPLETED|Period 3||1
9983766|NCT01614769|11105359|FG002|COMPLETED|Period 3||1
9983767|NCT01614769|11105360|FG003|COMPLETED|Period 3||0
9983768|NCT01614769|11105361|FG004|COMPLETED|Period 3||1
9983769|NCT01614769|11105362|FG005|COMPLETED|Period 3||1
9983770|NCT01614769|11105357|FG000|NOT COMPLETED|Period 3||0
9983771|NCT01614769|11105358|FG001|NOT COMPLETED|Period 3||0
9983772|NCT01614769|11105359|FG002|NOT COMPLETED|Period 3||1
9983773|NCT01614769|11105360|FG003|NOT COMPLETED|Period 3||0
9983774|NCT01614769|11105361|FG004|NOT COMPLETED|Period 3||0
9983775|NCT01614769|11105362|FG005|NOT COMPLETED|Period 3||0
9983776|NCT01614795|11105374|FG000|STARTED|Overall Study||11
9983777|NCT01614795|11105375|FG001|STARTED|Overall Study||12
9983778|NCT01614795|11105376|FG002|STARTED|Overall Study||11
9983779|NCT01614795|11105377|FG003|STARTED|Overall Study||12
9983780|NCT01614795|11105374|FG000|COMPLETED|Overall Study||0
9983781|NCT01614795|11105375|FG001|COMPLETED|Overall Study||0
9983782|NCT01614795|11105376|FG002|COMPLETED|Overall Study||0
9983783|NCT01614795|11105377|FG003|COMPLETED|Overall Study||0
9983784|NCT01614795|11105374|FG000|NOT COMPLETED|Overall Study||11
9983785|NCT01614795|11105375|FG001|NOT COMPLETED|Overall Study||12
9983786|NCT01614795|11105376|FG002|NOT COMPLETED|Overall Study||11
9983787|NCT01614795|11105377|FG003|NOT COMPLETED|Overall Study||12
9983788|NCT01614821|11105388|FG000|STARTED|Overall Study||63
9983789|NCT01614821|11105388|FG000|COMPLETED|Overall Study||63
9983790|NCT01614821|11105388|FG000|NOT COMPLETED|Overall Study||0
9983791|NCT01614847|11105394|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
9983792|NCT01614847|11105395|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
9983793|NCT01614847|11105394|FG000|COMPLETED|Day 1||4
9983794|NCT01614847|11105395|FG001|COMPLETED|Day 1|See Arm 1 comments.|4
9983795|NCT01614847|11105394|FG000|NOT COMPLETED|Day 1||0
9983796|NCT01614847|11105395|FG001|NOT COMPLETED|Day 1||0
9983797|NCT01614847|11105394|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
9983798|NCT01614847|11105395|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
9983799|NCT01614847|11105394|FG000|COMPLETED|Day 2 (24 Hours Later)||4
9983800|NCT01614847|11105395|FG001|COMPLETED|Day 2 (24 Hours Later)||4
9983801|NCT01614847|11105394|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0
9983802|NCT01614847|11105395|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0
9983803|NCT01614886|11105408|FG000|STARTED|Overall Study||107
9983804|NCT01614886|11105409|FG001|STARTED|Overall Study||109
9983805|NCT01614886|11105408|FG000|Safety Population (SAF)|Overall Study||107
9983806|NCT01614886|11105409|FG001|Safety Population (SAF)|Overall Study||108
9983807|NCT01614886|11105408|FG000|Full Analysis Set (FAS)|Overall Study||104
9983808|NCT01614886|11105409|FG001|Full Analysis Set (FAS)|Overall Study||105
9983809|NCT01614886|11105408|FG000|COMPLETED|Overall Study||87
9983810|NCT01614886|11105409|FG001|COMPLETED|Overall Study||83
9983811|NCT01614886|11105408|FG000|NOT COMPLETED|Overall Study||20
9983812|NCT01614886|11105409|FG001|NOT COMPLETED|Overall Study||26
9983813|NCT01614925|11105417|FG000|STARTED|Overall Study||18
9983814|NCT01614925|11105418|FG001|STARTED|Overall Study||17
9983815|NCT01614925|11105417|FG000|COMPLETED|Overall Study||14
9983816|NCT01614925|11105418|FG001|COMPLETED|Overall Study||15
9983817|NCT01614925|11105417|FG000|NOT COMPLETED|Overall Study||4
9983818|NCT01614925|11105418|FG001|NOT COMPLETED|Overall Study||2
9983819|NCT01615120|11105426|FG000|STARTED|Overall Study||38
9983820|NCT01615120|11105427|FG001|STARTED|Overall Study||39
9983821|NCT01615120|11105426|FG000|COMPLETED|Overall Study||23
9983822|NCT01615120|11105427|FG001|COMPLETED|Overall Study||19
9983823|NCT01615120|11105426|FG000|NOT COMPLETED|Overall Study||15
9983824|NCT01615120|11105427|FG001|NOT COMPLETED|Overall Study||20
9983825|NCT01615198|11105435|FG000|STARTED|Overall Study||296
9983826|NCT01615198|11105436|FG001|STARTED|Overall Study||292
9983827|NCT01615198|11105435|FG000|Full Analysis Set|Overall Study||296
9983828|NCT01615198|11105436|FG001|Full Analysis Set|Overall Study||292
9983829|NCT01615198|11105435|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
9983830|NCT01615198|11105436|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
9983831|NCT01615198|11105435|FG000|Safety Set|Overall Study||296
9983832|NCT01615198|11105436|FG001|Safety Set|Overall Study||292
9983833|NCT01615198|11105435|FG000|ABPM Dipper Status Subset|Overall Study||82
9983834|NCT01615198|11105436|FG001|ABPM Dipper Status Subset|Overall Study||84
9983835|NCT01615198|11105435|FG000|COMPLETED|Overall Study||272
9983836|NCT01615198|11105436|FG001|COMPLETED|Overall Study||273
9983837|NCT01615198|11105435|FG000|NOT COMPLETED|Overall Study||24
9983838|NCT01615198|11105436|FG001|NOT COMPLETED|Overall Study||19
9983839|NCT01615263|11105444|FG000|STARTED|Overall Study||20
9983840|NCT01615263|11105445|FG001|STARTED|Overall Study||20
9983841|NCT01615263|11105444|FG000|COMPLETED|Overall Study||20
9983842|NCT01615263|11105445|FG001|COMPLETED|Overall Study||18
9983843|NCT01615263|11105444|FG000|NOT COMPLETED|Overall Study||0
9983844|NCT01615263|11105445|FG001|NOT COMPLETED|Overall Study||2
9983845|NCT01615328|11105453|FG000|STARTED|Overall Study||42
9983846|NCT01615328|11105454|FG001|STARTED|Overall Study||43
9983847|NCT01615328|11105453|FG000|COMPLETED|Overall Study||39
9983848|NCT01615328|11105454|FG001|COMPLETED|Overall Study||38
9983849|NCT01615328|11105453|FG000|NOT COMPLETED|Overall Study||3
9983850|NCT01615328|11105454|FG001|NOT COMPLETED|Overall Study||5
9983851|NCT01615367|11105466|FG000|STARTED|Overall Study||19
9983852|NCT01615367|11105467|FG001|STARTED|Overall Study||19
9983853|NCT01615367|11105466|FG000|COMPLETED|Overall Study||14
9983854|NCT01615367|11105467|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
9983855|NCT01615367|11105466|FG000|NOT COMPLETED|Overall Study||5
9983856|NCT01615367|11105467|FG001|NOT COMPLETED|Overall Study||6
9983857|NCT01615484|11105475|FG000|STARTED|Overall Study||0
9983858|NCT01615484|11105476|FG001|STARTED|Overall Study||24
9983859|NCT01615484|11105475|FG000|COMPLETED|Overall Study||0
9983860|NCT01615484|11105476|FG001|COMPLETED|Overall Study||24
9983861|NCT01615484|11105475|FG000|NOT COMPLETED|Overall Study||0
9983862|NCT01615484|11105476|FG001|NOT COMPLETED|Overall Study||0
9983863|NCT01615731|11105484|FG000|STARTED|Overall Study||24
9983864|NCT01615731|11105485|FG001|STARTED|Overall Study||26
9983865|NCT01615731|11105484|FG000|COMPLETED|Overall Study||21
9983866|NCT01615731|11105485|FG001|COMPLETED|Overall Study||24
9983867|NCT01615731|11105484|FG000|NOT COMPLETED|Overall Study||3
9983868|NCT01615731|11105485|FG001|NOT COMPLETED|Overall Study||2
9983869|NCT01615809|11105491|FG000|STARTED|Overall Study|basal visit|32
10101146|NCT02405442|11230405|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
10101147|NCT02405442|11230402|FG000|STARTED|Open-Label Phase (up to Week 52)||52
10101148|NCT02405442|11230403|FG001|STARTED|Open-Label Phase (up to Week 52)||48
10101149|NCT02405442|11230404|FG002|STARTED|Open-Label Phase (up to Week 52)||47
10101150|NCT02405442|11230405|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
9983870|NCT01615809|11105491|FG000|COMPLETED|Overall Study||22
9983871|NCT01615809|11105491|FG000|NOT COMPLETED|Overall Study||10
9983872|NCT01615822|11105498|FG000|STARTED|Period 1||8
9983873|NCT01615822|11105499|FG001|STARTED|Period 1||11
9983874|NCT01615822|11105500|FG002|STARTED|Period 1||6
9983875|NCT01615822|11105498|FG000|COMPLETED|Period 1||7
9983876|NCT01615822|11105499|FG001|COMPLETED|Period 1||9
9983877|NCT01615822|11105500|FG002|COMPLETED|Period 1||6
9983878|NCT01615822|11105498|FG000|NOT COMPLETED|Period 1||1
9983879|NCT01615822|11105499|FG001|NOT COMPLETED|Period 1||2
9983880|NCT01615822|11105500|FG002|NOT COMPLETED|Period 1||0
9983881|NCT01615822|11105498|FG000|STARTED|Period 2||7
9983882|NCT01615822|11105499|FG001|STARTED|Period 2||9
9983883|NCT01615822|11105500|FG002|STARTED|Period 2||6
9983884|NCT01615822|11105498|FG000|COMPLETED|Period 2||7
9983885|NCT01615822|11105499|FG001|COMPLETED|Period 2||8
9983886|NCT01615822|11105500|FG002|COMPLETED|Period 2||4
9983887|NCT01615822|11105498|FG000|NOT COMPLETED|Period 2||0
9983888|NCT01615822|11105499|FG001|NOT COMPLETED|Period 2||1
9983889|NCT01615822|11105500|FG002|NOT COMPLETED|Period 2||2
9983890|NCT01615939|11105513|FG000|STARTED|Overall Study||13
9983891|NCT01615939|11105514|FG001|STARTED|Overall Study||4
9983892|NCT01615939|11105513|FG000|COMPLETED|Overall Study||8
9983893|NCT01615939|11105514|FG001|COMPLETED|Overall Study||4
9983894|NCT01615939|11105513|FG000|NOT COMPLETED|Overall Study||5
9983895|NCT01615939|11105514|FG001|NOT COMPLETED|Overall Study||0
9983896|NCT01616056|11105520|FG000|STARTED|Overall Study||20
9983897|NCT01616056|11105520|FG000|COMPLETED|Overall Study||19
9983898|NCT01616056|11105520|FG000|NOT COMPLETED|Overall Study||1
10018045|NCT01820754|11140978|FG000|STARTED|Overall Study||24
10018046|NCT01820754|11140978|FG000|COMPLETED|Overall Study||24
10018047|NCT01820754|11140978|FG000|NOT COMPLETED|Overall Study||0
10018048|NCT01821105|11140982|FG000|STARTED|Overall Study||21
10018049|NCT01821105|11140982|FG000|COMPLETED|Overall Study||21
10018050|NCT01821105|11140982|FG000|NOT COMPLETED|Overall Study||0
10018051|NCT01821118|11140988|FG000|STARTED|Overall Study||24
10018052|NCT01821118|11140989|FG001|STARTED|Overall Study||12
10018053|NCT01821118|11140988|FG000|COMPLETED|Overall Study||24
10018054|NCT01821118|11140989|FG001|COMPLETED|Overall Study||11
10018055|NCT01821118|11140988|FG000|NOT COMPLETED|Overall Study||0
10018056|NCT01821118|11140989|FG001|NOT COMPLETED|Overall Study||1
10018057|NCT01821300|11140997|FG000|STARTED|Overall Study||154
10018058|NCT01821300|11140998|FG001|STARTED|Overall Study||103
10018059|NCT01821300|11140997|FG000|COMPLETED|Overall Study||154
10018060|NCT01821300|11140998|FG001|COMPLETED|Overall Study||103
10018061|NCT01821300|11140997|FG000|NOT COMPLETED|Overall Study||0
10018062|NCT01821300|11140998|FG001|NOT COMPLETED|Overall Study||0
10018063|NCT01821326|11141010|FG000|STARTED|Overall Study||339
10018064|NCT01821326|11141010|FG000|COMPLETED|Overall Study||339
10018065|NCT01821326|11141010|FG000|NOT COMPLETED|Overall Study||0
10018066|NCT01821352|11141016|FG000|STARTED|Overall Study||28
10018067|NCT01821352|11141017|FG001|STARTED|Overall Study||25
10018068|NCT01821352|11141016|FG000|COMPLETED|Overall Study||28
10018069|NCT01821352|11141017|FG001|COMPLETED|Overall Study||25
10018070|NCT01821352|11141016|FG000|NOT COMPLETED|Overall Study||0
10018071|NCT01821352|11141017|FG001|NOT COMPLETED|Overall Study||0
10018072|NCT01821378|11141026|FG000|STARTED|Overall Study||101
10018073|NCT01821378|11141027|FG001|STARTED|Overall Study||199
10018074|NCT01821378|11141028|FG002|STARTED|Overall Study||112
10018075|NCT01821378|11141026|FG000|COMPLETED|Overall Study||74
10018076|NCT01821378|11141027|FG001|COMPLETED|Overall Study||145
9983899|NCT01616082|11105526|FG000|STARTED|Overall Study||19
9983900|NCT01616082|11105527|FG001|STARTED|Overall Study||20
9983901|NCT01616082|11105526|FG000|COMPLETED|Overall Study||19
9983902|NCT01616082|11105527|FG001|COMPLETED|Overall Study||18
9983903|NCT01616082|11105526|FG000|NOT COMPLETED|Overall Study||0
9983904|NCT01616082|11105527|FG001|NOT COMPLETED|Overall Study||2
9983905|NCT01616160|11105534|FG000|STARTED|Overall Study||11
9983906|NCT01616160|11105534|FG000|COMPLETED|Overall Study||9
9983907|NCT01616160|11105534|FG000|NOT COMPLETED|Overall Study||2
9983908|NCT01616173|11105541|FG000|STARTED|Overall Study||27
9983909|NCT01616173|11105542|FG001|STARTED|Overall Study||26
9983910|NCT01616173|11105543|FG002|STARTED|Overall Study||27
9983911|NCT01616173|11105541|FG000|COMPLETED|Overall Study||27
9983912|NCT01616173|11105542|FG001|COMPLETED|Overall Study||24
9983913|NCT01616173|11105543|FG002|COMPLETED|Overall Study||27
9983914|NCT01616173|11105541|FG000|NOT COMPLETED|Overall Study||0
9983915|NCT01616173|11105542|FG001|NOT COMPLETED|Overall Study||2
9983916|NCT01616173|11105543|FG002|NOT COMPLETED|Overall Study||0
9983917|NCT01616459|11105555|FG000|STARTED|Overall Study||240
9983918|NCT01616459|11105556|FG001|STARTED|Overall Study||240
9983919|NCT01616459|11105557|FG002|STARTED|Overall Study||230
9983920|NCT01616459|11105558|FG003|STARTED|Overall Study||241
9983921|NCT01616459|11105555|FG000|COMPLETED|Overall Study||236
9983922|NCT01616459|11105556|FG001|COMPLETED|Overall Study||223
9983923|NCT01616459|11105557|FG002|COMPLETED|Overall Study||220
9983924|NCT01616459|11105558|FG003|COMPLETED|Overall Study||233
9983925|NCT01616459|11105555|FG000|NOT COMPLETED|Overall Study||4
9983926|NCT01616459|11105556|FG001|NOT COMPLETED|Overall Study||17
9983927|NCT01616459|11105557|FG002|NOT COMPLETED|Overall Study||10
9983928|NCT01616459|11105558|FG003|NOT COMPLETED|Overall Study||8
9983929|NCT01616563|11105573|FG000|STARTED|Overall Study||293
9983930|NCT01616563|11105573|FG000|COMPLETED|Overall Study||253
9983931|NCT01616563|11105573|FG000|NOT COMPLETED|Overall Study||40
9983932|NCT01616576|11105580|FG000|STARTED|Overall Study||18
9983933|NCT01616576|11105581|FG001|STARTED|Overall Study||18
9983934|NCT01616576|11105580|FG000|COMPLETED|Overall Study||18
9983935|NCT01616576|11105581|FG001|COMPLETED|Overall Study||18
9983936|NCT01616576|11105580|FG000|NOT COMPLETED|Overall Study||0
9983937|NCT01616576|11105581|FG001|NOT COMPLETED|Overall Study||0
9983938|NCT01616654|11105595|FG000|STARTED|Overall Study||61
9983939|NCT01616654|11105596|FG001|STARTED|Overall Study||61
9983940|NCT01616654|11105597|FG002|STARTED|Overall Study||60
9983941|NCT01616654|11105598|FG003|STARTED|Overall Study||61
9983942|NCT01616654|11105599|FG004|STARTED|Overall Study||61
9983943|NCT01616654|11105595|FG000|COMPLETED|Overall Study||56
9983944|NCT01616654|11105596|FG001|COMPLETED|Overall Study||53
9983945|NCT01616654|11105597|FG002|COMPLETED|Overall Study||50
9983946|NCT01616654|11105598|FG003|COMPLETED|Overall Study||53
9983947|NCT01616654|11105599|FG004|COMPLETED|Overall Study||49
9983948|NCT01616654|11105595|FG000|NOT COMPLETED|Overall Study||5
9983949|NCT01616654|11105596|FG001|NOT COMPLETED|Overall Study||8
9983950|NCT01616654|11105597|FG002|NOT COMPLETED|Overall Study||10
9983951|NCT01616654|11105598|FG003|NOT COMPLETED|Overall Study||8
9983952|NCT01616654|11105599|FG004|NOT COMPLETED|Overall Study||12
9983953|NCT01616693|11105616|FG000|STARTED|Evaluated for Safety||155
9983954|NCT01616693|11105617|FG001|STARTED|Evaluated for Safety||155
9983955|NCT01616693|11105618|FG002|STARTED|Evaluated for Safety||155
9983956|NCT01616693|11105619|FG003|STARTED|Evaluated for Safety||155
9983957|NCT01616693|11105616|FG000|COMPLETED|Evaluated for Safety||154
9983958|NCT01616693|11105617|FG001|COMPLETED|Evaluated for Safety||155
9983959|NCT01616693|11105618|FG002|COMPLETED|Evaluated for Safety||154
9983960|NCT01616693|11105619|FG003|COMPLETED|Evaluated for Safety||155
9983961|NCT01616693|11105616|FG000|NOT COMPLETED|Evaluated for Safety||1
9983962|NCT01616693|11105617|FG001|NOT COMPLETED|Evaluated for Safety||0
9983963|NCT01616693|11105618|FG002|NOT COMPLETED|Evaluated for Safety||1
9983964|NCT01616693|11105619|FG003|NOT COMPLETED|Evaluated for Safety||0
9983965|NCT01616693|11105616|FG000|STARTED|Received Both Vaccines||154
9983966|NCT01616693|11105617|FG001|STARTED|Received Both Vaccines||155
9983967|NCT01616693|11105618|FG002|STARTED|Received Both Vaccines||154
9983968|NCT01616693|11105619|FG003|STARTED|Received Both Vaccines||155
9983969|NCT01616693|11105616|FG000|COMPLETED|Received Both Vaccines||141
9983970|NCT01616693|11105617|FG001|COMPLETED|Received Both Vaccines||145
9983971|NCT01616693|11105618|FG002|COMPLETED|Received Both Vaccines||142
9983972|NCT01616693|11105619|FG003|COMPLETED|Received Both Vaccines||136
9983973|NCT01616693|11105616|FG000|NOT COMPLETED|Received Both Vaccines||13
9983974|NCT01616693|11105617|FG001|NOT COMPLETED|Received Both Vaccines||10
9983975|NCT01616693|11105618|FG002|NOT COMPLETED|Received Both Vaccines||12
9983976|NCT01616693|11105619|FG003|NOT COMPLETED|Received Both Vaccines||19
9983977|NCT01616693|11105616|FG000|STARTED|Blood Analyzed for Immunogenicity||141
9983978|NCT01616693|11105617|FG001|STARTED|Blood Analyzed for Immunogenicity||145
9983979|NCT01616693|11105618|FG002|STARTED|Blood Analyzed for Immunogenicity||142
9983980|NCT01616693|11105619|FG003|STARTED|Blood Analyzed for Immunogenicity||136
9983981|NCT01616693|11105616|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137
9983982|NCT01616693|11105617|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143
9983983|NCT01616693|11105618|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136
9983984|NCT01616693|11105619|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135
9983985|NCT01616693|11105616|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
9983986|NCT01616693|11105617|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
9983987|NCT01616693|11105618|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
9983988|NCT01616693|11105619|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
9983989|NCT01616771|11105633|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23
9983990|NCT01616771|11105633|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
9983991|NCT01616771|11105633|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
9983992|NCT01616771|11105633|FG000|STARTED|GVL Selected by Weight for 5 Sec||23
9983993|NCT01616771|11105633|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23
9983994|NCT01616771|11105633|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
9983995|NCT01616771|11105633|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
9983996|NCT01616771|11105633|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19
9983997|NCT01616771|11105633|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
9983998|NCT01616953|11105644|FG000|STARTED|Overall Study||10
9983999|NCT01616953|11105645|FG001|STARTED|Overall Study||8
9984000|NCT01616953|11105644|FG000|Implant Placement Surgery|Overall Study||9
9984001|NCT01616953|11105645|FG001|Implant Placement Surgery|Overall Study||8
9984002|NCT01616953|11105644|FG000|Implant Uncovery|Overall Study||8
9984003|NCT01616953|11105645|FG001|Implant Uncovery|Overall Study||8
9984004|NCT01616953|11105644|FG000|6 Months Post-loading|Overall Study||8
9984005|NCT01616953|11105645|FG001|6 Months Post-loading|Overall Study||8
9984006|NCT01616953|11105644|FG000|COMPLETED|Overall Study||8
9984007|NCT01616953|11105645|FG001|COMPLETED|Overall Study||8
9984008|NCT01616953|11105644|FG000|NOT COMPLETED|Overall Study||2
9984009|NCT01616953|11105645|FG001|NOT COMPLETED|Overall Study||0
9984010|NCT01617005|11105651|FG000|STARTED|Overall Study||50
9984011|NCT01617005|11105651|FG000|COMPLETED|Overall Study||48
9984012|NCT01617005|11105651|FG000|NOT COMPLETED|Overall Study||2
9984013|NCT01617070|11105655|FG000|STARTED|LNAA (4 Weeks)||10
9984014|NCT01617070|11105655|FG000|COMPLETED|LNAA (4 Weeks)||10
9984015|NCT01617070|11105655|FG000|NOT COMPLETED|LNAA (4 Weeks)||0
9984016|NCT01617070|11105655|FG000|STARTED|Washout (4 Weeks)||10
9984017|NCT01617070|11105655|FG000|COMPLETED|Washout (4 Weeks)||10
9984018|NCT01617070|11105655|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9984019|NCT01617070|11105655|FG000|STARTED|BH4 Therapy (4 Weeks)||10
9984020|NCT01617070|11105655|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10
9984021|NCT01617070|11105655|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
9984022|NCT01617070|11105655|FG000|STARTED|BH4 and LNAA (4 Weeks)||10
9984023|NCT01617070|11105655|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9
9984024|NCT01617070|11105655|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
9984025|NCT01617083|11105668|FG000|STARTED|Overall Study||18
9984026|NCT01617083|11105669|FG001|STARTED|Overall Study||14
9984027|NCT01617083|11105670|FG002|STARTED|Overall Study||15
9984028|NCT01617083|11105668|FG000|COMPLETED|Overall Study||18
9984029|NCT01617083|11105669|FG001|COMPLETED|Overall Study||14
9984030|NCT01617083|11105670|FG002|COMPLETED|Overall Study||15
9984031|NCT01617083|11105668|FG000|NOT COMPLETED|Overall Study||0
9984032|NCT01617083|11105669|FG001|NOT COMPLETED|Overall Study||0
9984033|NCT01617083|11105670|FG002|NOT COMPLETED|Overall Study||0
9984034|NCT01617148|11105677|FG000|STARTED|Overall Study||26
9984035|NCT01617148|11105677|FG000|COMPLETED|Overall Study||26
9984036|NCT01617148|11105677|FG000|NOT COMPLETED|Overall Study||0
9984037|NCT01617369|11105682|FG000|STARTED|Overall Study||12
9984038|NCT01617369|11105682|FG000|COMPLETED|Overall Study||12
9984039|NCT01617369|11105682|FG000|NOT COMPLETED|Overall Study||0
9984040|NCT01617421|11105688|FG000|STARTED|Overall Study||18
9984041|NCT01617421|11105688|FG000|COMPLETED|Overall Study||12
9984042|NCT01617421|11105688|FG000|NOT COMPLETED|Overall Study||6
9984043|NCT01617434|11105694|FG000|STARTED|Overall Study||226
9984044|NCT01617434|11105695|FG001|STARTED|Overall Study||225
9984045|NCT01617434|11105694|FG000|Exposed|Overall Study||225
9984046|NCT01617434|11105695|FG001|Exposed|Overall Study||225
9984047|NCT01617434|11105694|FG000|COMPLETED|Overall Study||191
9984048|NCT01617434|11105695|FG001|COMPLETED|Overall Study||174
9984049|NCT01617434|11105694|FG000|NOT COMPLETED|Overall Study||35
9984050|NCT01617434|11105695|FG001|NOT COMPLETED|Overall Study||51
9984051|NCT01617447|11105703|FG000|STARTED|Overall Study||47
9984052|NCT01617447|11105704|FG001|STARTED|Overall Study||45
9984053|NCT01617447|11105703|FG000|COMPLETED|Overall Study||47
9984054|NCT01617447|11105704|FG001|COMPLETED|Overall Study||42
9984055|NCT01617447|11105703|FG000|NOT COMPLETED|Overall Study||0
9984056|NCT01617447|11105704|FG001|NOT COMPLETED|Overall Study||3
9984057|NCT01617460|11105710|FG000|STARTED|Overall Study||86
9984058|NCT01617460|11105710|FG000|COMPLETED|Overall Study||46
9984059|NCT01617460|11105710|FG000|NOT COMPLETED|Overall Study||40
9984060|NCT01617577|11105716|FG000|STARTED|Overall Study||5
9984061|NCT01617577|11105717|FG001|STARTED|Overall Study||3
9984062|NCT01617577|11105716|FG000|COMPLETED|Overall Study||5
9984063|NCT01617577|11105717|FG001|COMPLETED|Overall Study||3
9984064|NCT01617577|11105716|FG000|NOT COMPLETED|Overall Study||0
9984065|NCT01617577|11105717|FG001|NOT COMPLETED|Overall Study||0
9984066|NCT01617603|11105727|FG000|STARTED|Overall Study||20
9984067|NCT01617603|11105728|FG001|STARTED|Overall Study||21
9984068|NCT01617603|11105729|FG002|STARTED|Overall Study||21
9984069|NCT01617603|11105727|FG000|COMPLETED|Overall Study||17
9984070|NCT01617603|11105728|FG001|COMPLETED|Overall Study||19
9984071|NCT01617603|11105729|FG002|COMPLETED|Overall Study||20
9984072|NCT01617603|11105727|FG000|NOT COMPLETED|Overall Study||3
9984073|NCT01617603|11105728|FG001|NOT COMPLETED|Overall Study||2
9984074|NCT01617603|11105729|FG002|NOT COMPLETED|Overall Study||1
9984075|NCT01617629|11105737|FG000|STARTED|Overall Study||9
9984076|NCT01617629|11105737|FG000|COMPLETED|Overall Study||3
9984077|NCT01617629|11105737|FG000|NOT COMPLETED|Overall Study||6
9984078|NCT01617655|11105743|FG000|STARTED|Overall Study|Randomized|35
9984079|NCT01617655|11105744|FG001|STARTED|Overall Study|Randomized|72
9984080|NCT01617655|11105743|FG000|Treated|Overall Study||35
9984081|NCT01617655|11105744|FG001|Treated|Overall Study||72
9984082|NCT01617655|11105743|FG000|COMPLETED|Overall Study||26
9984083|NCT01617655|11105744|FG001|COMPLETED|Overall Study||43
9984084|NCT01617655|11105743|FG000|NOT COMPLETED|Overall Study||9
9984085|NCT01617655|11105744|FG001|NOT COMPLETED|Overall Study||29
9984086|NCT01617668|11105754|FG000|STARTED|Overall Study||51
9984087|NCT01617668|11105755|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
9984088|NCT01617668|11105756|FG002|STARTED|Overall Study||55
9984089|NCT01617668|11105757|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
9984090|NCT01617668|11105754|FG000|Randomized Patients|Overall Study||51
9984091|NCT01617668|11105755|FG001|Randomized Patients|Overall Study||54
9984092|NCT01617668|11105756|FG002|Randomized Patients|Overall Study||55
9984093|NCT01617668|11105757|FG003|Randomized Patients|Overall Study||55
9984094|NCT01617668|11105754|FG000|COMPLETED|Overall Study||38
9984095|NCT01617668|11105755|FG001|COMPLETED|Overall Study||41
9984096|NCT01617668|11105756|FG002|COMPLETED|Overall Study||32
9984097|NCT01617668|11105757|FG003|COMPLETED|Overall Study||38
9984098|NCT01617668|11105754|FG000|NOT COMPLETED|Overall Study||13
9984099|NCT01617668|11105755|FG001|NOT COMPLETED|Overall Study||9
9984100|NCT01617668|11105756|FG002|NOT COMPLETED|Overall Study||23
9984101|NCT01617668|11105757|FG003|NOT COMPLETED|Overall Study||15
9984102|NCT01617681|11105775|FG000|STARTED|Period 1 Double Blind||32
9984103|NCT01617681|11105776|FG001|STARTED|Period 1 Double Blind||31
9984104|NCT01617681|11105777|FG002|STARTED|Period 1 Double Blind||33
9984105|NCT01617681|11105778|FG003|STARTED|Period 1 Double Blind||31
9984106|NCT01617681|11105779|FG004|STARTED|Period 1 Double Blind||0
9984107|NCT01617681|11105775|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31
9984108|NCT01617681|11105776|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31
9984109|NCT01617681|11105777|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33
9984110|NCT01617681|11105778|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31
9984111|NCT01617681|11105779|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0
9984112|NCT01617681|11105775|FG000|COMPLETED|Period 1 Double Blind||29
9984113|NCT01617681|11105776|FG001|COMPLETED|Period 1 Double Blind||30
9984114|NCT01617681|11105777|FG002|COMPLETED|Period 1 Double Blind||32
9984115|NCT01617681|11105778|FG003|COMPLETED|Period 1 Double Blind||29
9984116|NCT01617681|11105779|FG004|COMPLETED|Period 1 Double Blind||0
9984117|NCT01617681|11105775|FG000|NOT COMPLETED|Period 1 Double Blind||3
9984118|NCT01617681|11105776|FG001|NOT COMPLETED|Period 1 Double Blind||1
9984119|NCT01617681|11105777|FG002|NOT COMPLETED|Period 1 Double Blind||1
9984120|NCT01617681|11105778|FG003|NOT COMPLETED|Period 1 Double Blind||2
9984121|NCT01617681|11105779|FG004|NOT COMPLETED|Period 1 Double Blind||0
9984122|NCT01617681|11105775|FG000|STARTED|Period 2 Open Label||0
9984123|NCT01617681|11105776|FG001|STARTED|Period 2 Open Label||0
9984124|NCT01617681|11105777|FG002|STARTED|Period 2 Open Label||0
9984125|NCT01617681|11105778|FG003|STARTED|Period 2 Open Label||0
9984126|NCT01617681|11105779|FG004|STARTED|Period 2 Open Label||120
9984127|NCT01617681|11105775|FG000|COMPLETED|Period 2 Open Label||0
9984128|NCT01617681|11105776|FG001|COMPLETED|Period 2 Open Label||0
9984129|NCT01617681|11105777|FG002|COMPLETED|Period 2 Open Label||0
9984130|NCT01617681|11105778|FG003|COMPLETED|Period 2 Open Label||0
9984131|NCT01617681|11105779|FG004|COMPLETED|Period 2 Open Label||114
9984132|NCT01617681|11105775|FG000|NOT COMPLETED|Period 2 Open Label||0
9984133|NCT01617681|11105776|FG001|NOT COMPLETED|Period 2 Open Label||0
9984134|NCT01617681|11105777|FG002|NOT COMPLETED|Period 2 Open Label||0
9984135|NCT01617681|11105778|FG003|NOT COMPLETED|Period 2 Open Label||0
9984136|NCT01617681|11105779|FG004|NOT COMPLETED|Period 2 Open Label||6
9984137|NCT01617967|11105794|FG000|STARTED|Overall Study||4
9984138|NCT01617967|11105795|FG001|STARTED|Overall Study||3
9984139|NCT01617967|11105796|FG002|STARTED|Overall Study||3
9984140|NCT01617967|11105797|FG003|STARTED|Overall Study||7
9984141|NCT01617967|11105798|FG004|STARTED|Overall Study||3
9984142|NCT01617967|11105799|FG005|STARTED|Overall Study||9
9984143|NCT01617967|11105794|FG000|COMPLETED|Overall Study||3
9984144|NCT01617967|11105795|FG001|COMPLETED|Overall Study||3
9984145|NCT01617967|11105796|FG002|COMPLETED|Overall Study||3
9984146|NCT01617967|11105797|FG003|COMPLETED|Overall Study||6
9984147|NCT01617967|11105798|FG004|COMPLETED|Overall Study||3
9984148|NCT01617967|11105799|FG005|COMPLETED|Overall Study||8
9984149|NCT01617967|11105794|FG000|NOT COMPLETED|Overall Study||1
9984150|NCT01617967|11105795|FG001|NOT COMPLETED|Overall Study||0
9984151|NCT01617967|11105796|FG002|NOT COMPLETED|Overall Study||0
9984152|NCT01617967|11105797|FG003|NOT COMPLETED|Overall Study||1
9984153|NCT01617967|11105798|FG004|NOT COMPLETED|Overall Study||0
9984154|NCT01617967|11105799|FG005|NOT COMPLETED|Overall Study||1
9984155|NCT01618019|11105816|FG000|STARTED|Overall Study||55
9984156|NCT01618019|11105817|FG001|STARTED|Overall Study||54
9984157|NCT01618019|11105816|FG000|COMPLETED|Overall Study||41
9984158|NCT01618019|11105817|FG001|COMPLETED|Overall Study||40
9984159|NCT01618019|11105816|FG000|NOT COMPLETED|Overall Study||14
9984160|NCT01618019|11105817|FG001|NOT COMPLETED|Overall Study||14
9984161|NCT01618162|11105825|FG000|STARTED|Overall Study||289
9984162|NCT01618162|11105826|FG001|STARTED|Overall Study||146
9984163|NCT01618162|11105825|FG000|Exposed|Overall Study||288
9984164|NCT01618162|11105826|FG001|Exposed|Overall Study||146
9984165|NCT01618162|11105825|FG000|COMPLETED|Overall Study||251
9984166|NCT01618162|11105826|FG001|COMPLETED|Overall Study||111
9984167|NCT01618162|11105825|FG000|NOT COMPLETED|Overall Study||38
9984168|NCT01618162|11105826|FG001|NOT COMPLETED|Overall Study||35
9984169|NCT01618214|11105834|FG000|STARTED|Overall Study||172
9984170|NCT01618214|11105835|FG001|STARTED|Overall Study||172
9984171|NCT01618214|11105834|FG000|Exposed|Overall Study||172
9984172|NCT01618214|11105835|FG001|Exposed|Overall Study||172
9984173|NCT01618214|11105834|FG000|COMPLETED|Overall Study||162
9984174|NCT01618214|11105835|FG001|COMPLETED|Overall Study||159
9984175|NCT01618214|11105834|FG000|NOT COMPLETED|Overall Study||10
9984176|NCT01618214|11105835|FG001|NOT COMPLETED|Overall Study||13
9984177|NCT01618227|11105843|FG000|STARTED|Overall Study||2
9984178|NCT01618227|11105844|FG001|STARTED|Overall Study||2
9984179|NCT01618227|11105843|FG000|COMPLETED|Overall Study||2
10101151|NCT02405442|11230402|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4
9758708|NCT01773395|10862274|FG001|NOT COMPLETED|Overall Study||32
9758709|NCT01711879|10862282|FG000|STARTED|Overall Study||3
9758710|NCT01711879|10862283|FG001|STARTED|Overall Study||4
9984180|NCT01618227|11105844|FG001|COMPLETED|Overall Study||0
9984181|NCT01618227|11105843|FG000|NOT COMPLETED|Overall Study||0
9984182|NCT01618227|11105844|FG001|NOT COMPLETED|Overall Study||2
9984183|NCT01618240|11105850|FG000|STARTED|Overall Study||30
9984184|NCT01618240|11105850|FG000|COMPLETED|Overall Study||30
9984185|NCT01618240|11105850|FG000|NOT COMPLETED|Overall Study||0
9984186|NCT01618266|11105854|FG000|STARTED|Overall Study||375
9984187|NCT01618266|11105854|FG000|COMPLETED|Overall Study||279
9984188|NCT01618266|11105854|FG000|NOT COMPLETED|Overall Study||96
9984189|NCT01618305|11105860|FG000|STARTED|Overall Study||202
9984190|NCT01618305|11105861|FG001|STARTED|Overall Study||206
9984191|NCT01618305|11105860|FG000|COMPLETED|Overall Study||187
9984192|NCT01618305|11105861|FG001|COMPLETED|Overall Study||196
9984193|NCT01618305|11105860|FG000|NOT COMPLETED|Overall Study||15
9984194|NCT01618305|11105861|FG001|NOT COMPLETED|Overall Study||10
9984195|NCT01618344|11105871|FG000|STARTED|Overall Study||32
9984196|NCT01618344|11105871|FG000|COMPLETED|Overall Study||23
9984197|NCT01618344|11105871|FG000|NOT COMPLETED|Overall Study||9
9984198|NCT01618422|11105877|FG000|STARTED|Overall Study||114
9984199|NCT01618422|11105878|FG001|STARTED|Overall Study||111
9984200|NCT01618422|11105877|FG000|COMPLETED|Overall Study||114
9984201|NCT01618422|11105878|FG001|COMPLETED|Overall Study||111
9984202|NCT01618422|11105877|FG000|NOT COMPLETED|Overall Study||0
9984203|NCT01618422|11105878|FG001|NOT COMPLETED|Overall Study||0
9984204|NCT01618669|11105886|FG000|STARTED|Overall Study||578
9984205|NCT01618669|11105887|FG001|STARTED|Overall Study||569
9984206|NCT01618669|11105886|FG000|Received Treatment|Overall Study||575
9984207|NCT01618669|11105887|FG001|Received Treatment|Overall Study||567
9984208|NCT01618669|11105886|FG000|COMPLETED|Overall Study||544
9984209|NCT01618669|11105887|FG001|COMPLETED|Overall Study||546
9984210|NCT01618669|11105886|FG000|NOT COMPLETED|Overall Study||34
9758711|NCT01711879|10862282|FG000|COMPLETED|Overall Study||2
9758712|NCT01711879|10862283|FG001|COMPLETED|Overall Study||4
9984211|NCT01618669|11105887|FG001|NOT COMPLETED|Overall Study||23
9984212|NCT01618695|11105909|FG000|STARTED|Core Phase||177
9984213|NCT01618695|11105910|FG001|STARTED|Core Phase||176
9984214|NCT01618695|11105911|FG002|STARTED|Core Phase||177
9984215|NCT01618695|11105912|FG003|STARTED|Core Phase||180
9984216|NCT01618695|11105909|FG000|Treated (Safety Analysis Set)|Core Phase||176
9984217|NCT01618695|11105910|FG001|Treated (Safety Analysis Set)|Core Phase||176
9984218|NCT01618695|11105911|FG002|Treated (Safety Analysis Set)|Core Phase||175
9984219|NCT01618695|11105912|FG003|Treated (Safety Analysis Set)|Core Phase||180
9984220|NCT01618695|11105909|FG000|COMPLETED|Core Phase||152
9984221|NCT01618695|11105910|FG001|COMPLETED|Core Phase||156
9984222|NCT01618695|11105911|FG002|COMPLETED|Core Phase||147
9984223|NCT01618695|11105912|FG003|COMPLETED|Core Phase||144
9984224|NCT01618695|11105909|FG000|NOT COMPLETED|Core Phase||25
9984225|NCT01618695|11105910|FG001|NOT COMPLETED|Core Phase||20
9984226|NCT01618695|11105911|FG002|NOT COMPLETED|Core Phase||30
9984227|NCT01618695|11105912|FG003|NOT COMPLETED|Core Phase||36
9984228|NCT01618695|11105909|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
9984229|NCT01618695|11105910|FG001|STARTED|Extension Phase||156
9984230|NCT01618695|11105911|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
9984231|NCT01618695|11105912|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
9984232|NCT01618695|11105909|FG000|COMPLETED|Extension Phase||56
9984233|NCT01618695|11105910|FG001|COMPLETED|Extension Phase||40
9984234|NCT01618695|11105911|FG002|COMPLETED|Extension Phase||54
9984235|NCT01618695|11105912|FG003|COMPLETED|Extension Phase||46
9984236|NCT01618695|11105909|FG000|NOT COMPLETED|Extension Phase||95
9984237|NCT01618695|11105910|FG001|NOT COMPLETED|Extension Phase||116
9984238|NCT01618695|11105911|FG002|NOT COMPLETED|Extension Phase||92
9984239|NCT01618695|11105912|FG003|NOT COMPLETED|Extension Phase||97
9984240|NCT01618708|11105925|FG000|STARTED|Overall Study||175
9984241|NCT01618708|11105926|FG001|STARTED|Overall Study||182
9984242|NCT01618708|11105925|FG000|Treated|Overall Study||172
9984243|NCT01618708|11105926|FG001|Treated|Overall Study||180
9984244|NCT01618708|11105925|FG000|COMPLETED|Overall Study||131
9984245|NCT01618708|11105926|FG001|COMPLETED|Overall Study||136
9984246|NCT01618708|11105925|FG000|NOT COMPLETED|Overall Study||44
9984247|NCT01618708|11105926|FG001|NOT COMPLETED|Overall Study||46
9984248|NCT01618838|11105933|FG000|STARTED|Overall Study||4
9984249|NCT01618838|11105933|FG000|COMPLETED|Overall Study||0
9984250|NCT01618838|11105933|FG000|NOT COMPLETED|Overall Study||4
9984251|NCT01618864|11105938|FG000|STARTED|Overall Study||23
9984252|NCT01618864|11105938|FG000|Completed 2 Weeks|Overall Study||19
9984253|NCT01618864|11105938|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
9984254|NCT01618864|11105938|FG000|NOT COMPLETED|Overall Study||4
9984255|NCT01618916|11105953|FG000|STARTED|Overall Study||12
9984256|NCT01618916|11105954|FG001|STARTED|Overall Study||10
9984257|NCT01618916|11105955|FG002|STARTED|Overall Study||11
9984258|NCT01618916|11105956|FG003|STARTED|Overall Study||9
9984259|NCT01618916|11105957|FG004|STARTED|Overall Study||5
9984260|NCT01618916|11105958|FG005|STARTED|Overall Study||4
9984261|NCT01618916|11105953|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12
9984262|NCT01618916|11105954|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10
9984263|NCT01618916|11105955|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11
9984264|NCT01618916|11105956|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9
9984265|NCT01618916|11105957|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5
9984266|NCT01618916|11105958|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4
9984267|NCT01618916|11105953|FG000|COMPLETED|Overall Study||10
9984268|NCT01618916|11105954|FG001|COMPLETED|Overall Study||9
9984269|NCT01618916|11105955|FG002|COMPLETED|Overall Study||10
9984270|NCT01618916|11105956|FG003|COMPLETED|Overall Study||7
9984271|NCT01618916|11105957|FG004|COMPLETED|Overall Study||4
9984272|NCT01618916|11105958|FG005|COMPLETED|Overall Study||4
9984273|NCT01618916|11105953|FG000|NOT COMPLETED|Overall Study||2
9984274|NCT01618916|11105954|FG001|NOT COMPLETED|Overall Study||1
9984275|NCT01618916|11105955|FG002|NOT COMPLETED|Overall Study||1
9984276|NCT01618916|11105956|FG003|NOT COMPLETED|Overall Study||2
9984277|NCT01618916|11105957|FG004|NOT COMPLETED|Overall Study||1
9984278|NCT01618916|11105958|FG005|NOT COMPLETED|Overall Study||0
9984279|NCT01618942|11105973|FG000|STARTED|Overall Study||50
9984280|NCT01618942|11105974|FG001|STARTED|Overall Study||50
9984281|NCT01618942|11105973|FG000|COMPLETED|Overall Study||50
9984282|NCT01618942|11105974|FG001|COMPLETED|Overall Study||50
9984283|NCT01618942|11105973|FG000|NOT COMPLETED|Overall Study||0
9984284|NCT01618942|11105974|FG001|NOT COMPLETED|Overall Study||0
9984285|NCT01618955|11105984|FG000|STARTED|Overall Study||20
9984286|NCT01618955|11105985|FG001|STARTED|Overall Study||30
9984287|NCT01618955|11105986|FG002|STARTED|Overall Study||31
9984288|NCT01618955|11105987|FG003|STARTED|Overall Study||20
9984289|NCT01618955|11105984|FG000|COMPLETED|Overall Study||20
9984290|NCT01618955|11105985|FG001|COMPLETED|Overall Study||30
9984291|NCT01618955|11105986|FG002|COMPLETED|Overall Study||31
9984292|NCT01618955|11105987|FG003|COMPLETED|Overall Study||20
9984293|NCT01618955|11105984|FG000|NOT COMPLETED|Overall Study||0
9984294|NCT01618955|11105985|FG001|NOT COMPLETED|Overall Study||0
9984295|NCT01618955|11105986|FG002|NOT COMPLETED|Overall Study||0
9984296|NCT01618955|11105987|FG003|NOT COMPLETED|Overall Study||0
10018077|NCT01821378|11141028|FG002|COMPLETED|Overall Study||70
10018078|NCT01821378|11141026|FG000|NOT COMPLETED|Overall Study||27
10018079|NCT01821378|11141027|FG001|NOT COMPLETED|Overall Study||54
10018080|NCT01821378|11141028|FG002|NOT COMPLETED|Overall Study||42
10018081|NCT01821391|11141043|FG000|STARTED|Overall Study||108
10018082|NCT01821391|11141044|FG001|STARTED|Overall Study||23
10018083|NCT01821391|11141043|FG000|COMPLETED|Overall Study||107
10018084|NCT01821391|11141044|FG001|COMPLETED|Overall Study||23
10018085|NCT01821391|11141043|FG000|NOT COMPLETED|Overall Study||1
10018086|NCT01821391|11141044|FG001|NOT COMPLETED|Overall Study||0
10018087|NCT01821417|11141054|FG000|STARTED|Overall Study||37
10018088|NCT01821417|11141055|FG001|STARTED|Overall Study||31
10018089|NCT01821417|11141054|FG000|COMPLETED|Overall Study||37
10018090|NCT01821417|11141055|FG001|COMPLETED|Overall Study||31
10018091|NCT01821417|11141054|FG000|NOT COMPLETED|Overall Study||0
10018092|NCT01821417|11141055|FG001|NOT COMPLETED|Overall Study||0
10018093|NCT01821534|11141061|FG000|STARTED|Overall Study||201
10018094|NCT01821534|11141061|FG000|COMPLETED|Overall Study||201
10018095|NCT01821534|11141061|FG000|NOT COMPLETED|Overall Study||0
10018096|NCT01821560|11141067|FG000|STARTED|Overall Study||22
10018097|NCT01821560|11141068|FG001|STARTED|Overall Study||22
10018098|NCT01821560|11141067|FG000|COMPLETED|Overall Study||16
10018099|NCT01821560|11141068|FG001|COMPLETED|Overall Study||15
10018100|NCT01821560|11141067|FG000|NOT COMPLETED|Overall Study||6
10018101|NCT01821560|11141068|FG001|NOT COMPLETED|Overall Study||7
10018102|NCT01821625|11141074|FG000|STARTED|Overall Study||7
10018103|NCT01821625|11141074|FG000|COMPLETED|Overall Study||1
10018104|NCT01821625|11141074|FG000|NOT COMPLETED|Overall Study||6
10101152|NCT02405442|11230403|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3
10101153|NCT02405442|11230404|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2
10101154|NCT02405442|11230405|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2
10101155|NCT02405442|11230402|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
10101156|NCT02405442|11230403|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
10101157|NCT02405442|11230404|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
10101158|NCT02405442|11230405|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
10018105|NCT01821729|11141078|FG000|STARTED|Overall Study||50
10018106|NCT01821729|11141078|FG000|Received Chemoradiotherapy|Overall Study||45
10018107|NCT01821729|11141078|FG000|Underwent Attempted Surgery|Overall Study||42
10018108|NCT01821729|11141078|FG000|COMPLETED|Overall Study||49
10018109|NCT01821729|11141078|FG000|NOT COMPLETED|Overall Study||1
10018110|NCT01821807|11141084|FG000|STARTED|Overall Study||150
9984297|NCT01618968|11106001|FG000|STARTED|Overall Study||13
9984298|NCT01618968|11106002|FG001|STARTED|Overall Study||12
9984299|NCT01618968|11106003|FG002|STARTED|Overall Study||12
9984300|NCT01618968|11106004|FG003|STARTED|Overall Study||12
9984301|NCT01618968|11106001|FG000|Received Treatment A|Overall Study||12
9984302|NCT01618968|11106002|FG001|Received Treatment A|Overall Study||12
9984303|NCT01618968|11106003|FG002|Received Treatment A|Overall Study||12
9984304|NCT01618968|11106004|FG003|Received Treatment A|Overall Study||11
9984305|NCT01618968|11106001|FG000|Received Treatment B|Overall Study||13
9984306|NCT01618968|11106002|FG001|Received Treatment B|Overall Study||12
9984307|NCT01618968|11106003|FG002|Received Treatment B|Overall Study||12
9984308|NCT01618968|11106004|FG003|Received Treatment B|Overall Study||12
9984309|NCT01618968|11106001|FG000|Received Treatment C|Overall Study||12
9984310|NCT01618968|11106002|FG001|Received Treatment C|Overall Study||12
9984311|NCT01618968|11106003|FG002|Received Treatment C|Overall Study||12
9984312|NCT01618968|11106004|FG003|Received Treatment C|Overall Study||11
9984313|NCT01618968|11106001|FG000|COMPLETED|Overall Study||12
9984314|NCT01618968|11106002|FG001|COMPLETED|Overall Study||12
9984315|NCT01618968|11106003|FG002|COMPLETED|Overall Study||12
9984316|NCT01618968|11106004|FG003|COMPLETED|Overall Study||11
9984317|NCT01618968|11106001|FG000|NOT COMPLETED|Overall Study||1
9984318|NCT01618968|11106002|FG001|NOT COMPLETED|Overall Study||0
9984319|NCT01618968|11106003|FG002|NOT COMPLETED|Overall Study||0
9984320|NCT01618968|11106004|FG003|NOT COMPLETED|Overall Study||1
9984321|NCT01619059|11106015|FG000|STARTED|Short-Term (ST) Treatment Period||162
9984322|NCT01619059|11106016|FG001|STARTED|Short-Term (ST) Treatment Period||153
9984323|NCT01619059|11106015|FG000|COMPLETED|Short-Term (ST) Treatment Period||156
9984324|NCT01619059|11106016|FG001|COMPLETED|Short-Term (ST) Treatment Period||142
9984325|NCT01619059|11106015|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6
9984326|NCT01619059|11106016|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11
9984327|NCT01619059|11106015|FG000|STARTED|Long-Term (LT) Treatment Period||155
9984328|NCT01619059|11106016|FG001|STARTED|Long-Term (LT) Treatment Period||142
9984329|NCT01619059|11106015|FG000|COMPLETED|Long-Term (LT) Treatment Period||147
9984330|NCT01619059|11106016|FG001|COMPLETED|Long-Term (LT) Treatment Period||133
9984331|NCT01619059|11106015|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8
9984332|NCT01619059|11106016|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9
9984333|NCT01619410|11106024|FG000|STARTED|Overall Study||14
9984334|NCT01619410|11106025|FG001|STARTED|Overall Study||11
9984335|NCT01619410|11106024|FG000|COMPLETED|Overall Study||7
9984336|NCT01619410|11106025|FG001|COMPLETED|Overall Study||7
9984337|NCT01619410|11106024|FG000|NOT COMPLETED|Overall Study||7
9984338|NCT01619410|11106025|FG001|NOT COMPLETED|Overall Study||4
9984339|NCT01619423|11106035|FG000|STARTED|Part 1 (Dose Escalation)||0
9984340|NCT01619423|11106036|FG001|STARTED|Part 1 (Dose Escalation)||5
9984341|NCT01619423|11106037|FG002|STARTED|Part 1 (Dose Escalation)||3
9984342|NCT01619423|11106038|FG003|STARTED|Part 1 (Dose Escalation)||5
9984343|NCT01619423|11106035|FG000|COMPLETED|Part 1 (Dose Escalation)||0
9984344|NCT01619423|11106036|FG001|COMPLETED|Part 1 (Dose Escalation)||3
9984345|NCT01619423|11106037|FG002|COMPLETED|Part 1 (Dose Escalation)||3
9984346|NCT01619423|11106038|FG003|COMPLETED|Part 1 (Dose Escalation)||5
9984347|NCT01619423|11106035|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0
9984348|NCT01619423|11106036|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2
9984349|NCT01619423|11106037|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0
9984350|NCT01619423|11106038|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0
9984351|NCT01619423|11106035|FG000|STARTED|Part 2a||15
9984352|NCT01619423|11106036|FG001|STARTED|Part 2a||13
9984353|NCT01619423|11106037|FG002|STARTED|Part 2a||0
9984354|NCT01619423|11106038|FG003|STARTED|Part 2a||11
9984355|NCT01619423|11106035|FG000|COMPLETED|Part 2a||15
9984356|NCT01619423|11106036|FG001|COMPLETED|Part 2a||13
9984357|NCT01619423|11106037|FG002|COMPLETED|Part 2a||0
9984358|NCT01619423|11106038|FG003|COMPLETED|Part 2a||11
9984359|NCT01619423|11106035|FG000|NOT COMPLETED|Part 2a||0
9984360|NCT01619423|11106036|FG001|NOT COMPLETED|Part 2a||0
9984361|NCT01619423|11106037|FG002|NOT COMPLETED|Part 2a||0
9984362|NCT01619423|11106038|FG003|NOT COMPLETED|Part 2a||0
9984363|NCT01619423|11106035|FG000|STARTED|Part 2b||45
9984364|NCT01619423|11106036|FG001|STARTED|Part 2b||44
9984365|NCT01619423|11106037|FG002|STARTED|Part 2b||45
9984366|NCT01619423|11106038|FG003|STARTED|Part 2b||0
9984367|NCT01619423|11106035|FG000|COMPLETED|Part 2b||45
9984368|NCT01619423|11106036|FG001|COMPLETED|Part 2b||44
9984369|NCT01619423|11106037|FG002|COMPLETED|Part 2b||45
9984370|NCT01619423|11106038|FG003|COMPLETED|Part 2b||0
9984371|NCT01619423|11106035|FG000|NOT COMPLETED|Part 2b||0
9984372|NCT01619423|11106036|FG001|NOT COMPLETED|Part 2b||0
9984373|NCT01619423|11106037|FG002|NOT COMPLETED|Part 2b||0
9984374|NCT01619423|11106038|FG003|NOT COMPLETED|Part 2b||0
9984375|NCT01619579|11106051|FG000|STARTED|Overall Study||5
9984376|NCT01619579|11106052|FG001|STARTED|Overall Study||17
9984377|NCT01619579|11106051|FG000|COMPLETED|Overall Study||5
9984378|NCT01619579|11106052|FG001|COMPLETED|Overall Study||14
9984379|NCT01619579|11106051|FG000|NOT COMPLETED|Overall Study||0
9984380|NCT01619579|11106052|FG001|NOT COMPLETED|Overall Study||3
9984381|NCT01619774|11106058|FG000|STARTED|Overall Study||23
9984382|NCT01619774|11106058|FG000|COMPLETED|Overall Study||23
9984383|NCT01619774|11106058|FG000|NOT COMPLETED|Overall Study||0
9984384|NCT01619787|11106064|FG000|STARTED|Overall Study||217
9984385|NCT01619787|11106064|FG000|COMPLETED|Overall Study||212
9984386|NCT01619787|11106064|FG000|NOT COMPLETED|Overall Study||5
9984387|NCT01619839|11106075|FG000|STARTED|Overall Study||48
9984388|NCT01619839|11106076|FG001|STARTED|Overall Study||31
9984389|NCT01619839|11106077|FG002|STARTED|Overall Study||18
9984390|NCT01619839|11106078|FG003|STARTED|Overall Study||10
9984391|NCT01619839|11106079|FG004|STARTED|Overall Study||106
9984392|NCT01619839|11106075|FG000|COMPLETED|Overall Study||43
9984393|NCT01619839|11106076|FG001|COMPLETED|Overall Study||27
9984394|NCT01619839|11106077|FG002|COMPLETED|Overall Study||17
9984395|NCT01619839|11106078|FG003|COMPLETED|Overall Study||9
9984396|NCT01619839|11106079|FG004|COMPLETED|Overall Study||97
9984397|NCT01619839|11106075|FG000|NOT COMPLETED|Overall Study||5
9984398|NCT01619839|11106076|FG001|NOT COMPLETED|Overall Study||4
9984399|NCT01619839|11106077|FG002|NOT COMPLETED|Overall Study||1
9984400|NCT01619839|11106078|FG003|NOT COMPLETED|Overall Study||1
9984401|NCT01619839|11106079|FG004|NOT COMPLETED|Overall Study||9
9984402|NCT01619852|11106090|FG000|STARTED|24 Hour Assessment||75
9984403|NCT01619852|11106091|FG001|STARTED|24 Hour Assessment||75
9984404|NCT01619852|11106090|FG000|COMPLETED|24 Hour Assessment||74
9984405|NCT01619852|11106091|FG001|COMPLETED|24 Hour Assessment||74
9984406|NCT01619852|11106090|FG000|NOT COMPLETED|24 Hour Assessment||1
9984407|NCT01619852|11106091|FG001|NOT COMPLETED|24 Hour Assessment||1
9984408|NCT01619852|11106090|FG000|STARTED|3 Month Follow up||74
9984409|NCT01619852|11106091|FG001|STARTED|3 Month Follow up||74
9984410|NCT01619852|11106090|FG000|COMPLETED|3 Month Follow up||43
9984411|NCT01619852|11106091|FG001|COMPLETED|3 Month Follow up||40
9984412|NCT01619852|11106090|FG000|NOT COMPLETED|3 Month Follow up||31
9984413|NCT01619852|11106091|FG001|NOT COMPLETED|3 Month Follow up||34
9984414|NCT01619865|11106098|FG000|STARTED|Overall Study||223
9984415|NCT01619865|11106098|FG000|COMPLETED|Overall Study||219
9984416|NCT01619865|11106098|FG000|NOT COMPLETED|Overall Study||4
9984417|NCT01619878|11106103|FG000|STARTED|6 Week Follow-up Phase||20
9984418|NCT01619878|11106103|FG000|COMPLETED|6 Week Follow-up Phase||19
9984419|NCT01619878|11106103|FG000|NOT COMPLETED|6 Week Follow-up Phase||1
9984420|NCT01619878|11106103|FG000|STARTED|Follow-up at 12 Months of Age||20
9984421|NCT01619878|11106103|FG000|COMPLETED|Follow-up at 12 Months of Age||17
9984422|NCT01619878|11106103|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3
9984423|NCT01619982|11106109|FG000|STARTED|Overall Study||20
9984424|NCT01619982|11106110|FG001|STARTED|Overall Study||12
9984425|NCT01619982|11106109|FG000|COMPLETED|Overall Study||20
9984426|NCT01619982|11106110|FG001|COMPLETED|Overall Study||12
9984427|NCT01619982|11106109|FG000|NOT COMPLETED|Overall Study||0
9984428|NCT01619982|11106110|FG001|NOT COMPLETED|Overall Study||0
9984429|NCT01620047|11106123|FG000|STARTED|Overall Study||20
9984430|NCT01620047|11106124|FG001|STARTED|Overall Study||20
9984431|NCT01620047|11106125|FG002|STARTED|Overall Study||20
9984432|NCT01620047|11106123|FG000|COMPLETED|Overall Study||20
9984433|NCT01620047|11106124|FG001|COMPLETED|Overall Study||20
9984434|NCT01620047|11106125|FG002|COMPLETED|Overall Study||20
9984435|NCT01620047|11106123|FG000|NOT COMPLETED|Overall Study||0
9984436|NCT01620047|11106124|FG001|NOT COMPLETED|Overall Study||0
9984437|NCT01620047|11106125|FG002|NOT COMPLETED|Overall Study||0
9984438|NCT01620060|11106133|FG000|STARTED|Overall Study||105
9984439|NCT01620060|11106133|FG000|COMPLETED|Overall Study||90
9984440|NCT01620060|11106133|FG000|NOT COMPLETED|Overall Study||15
9984441|NCT01620086|11106139|FG000|STARTED|Overall Study||13
9984442|NCT01620086|11106140|FG001|STARTED|Overall Study||11
9984443|NCT01620086|11106141|FG002|STARTED|Overall Study||2
9984444|NCT01620086|11106139|FG000|COMPLETED|Overall Study||8
9984445|NCT01620086|11106140|FG001|COMPLETED|Overall Study||4
9984446|NCT01620086|11106141|FG002|COMPLETED|Overall Study||2
9984447|NCT01620086|11106139|FG000|NOT COMPLETED|Overall Study||5
9984448|NCT01620086|11106140|FG001|NOT COMPLETED|Overall Study||7
9984449|NCT01620086|11106141|FG002|NOT COMPLETED|Overall Study||0
9984450|NCT01620138|11106152|FG000|STARTED|Overall Study||12
9984451|NCT01620138|11106153|FG001|STARTED|Overall Study||9
9984452|NCT01620138|11106152|FG000|COMPLETED|Overall Study||6
9984453|NCT01620138|11106153|FG001|COMPLETED|Overall Study||9
9984454|NCT01620138|11106152|FG000|NOT COMPLETED|Overall Study||6
9984455|NCT01620138|11106153|FG001|NOT COMPLETED|Overall Study||0
9984456|NCT01620177|11106159|FG000|STARTED|Overall Study||98
9984457|NCT01620177|11106159|FG000|COMPLETED|Overall Study||19
9984458|NCT01620177|11106159|FG000|NOT COMPLETED|Overall Study||79
9984459|NCT01620190|11106176|FG000|STARTED|Overall Study||26
9984460|NCT01620190|11106176|FG000|COMPLETED|Overall Study||26
9984461|NCT01620190|11106176|FG000|NOT COMPLETED|Overall Study||0
9984462|NCT01620216|11106187|FG000|STARTED|Overall Study||4
9984463|NCT01620216|11106188|FG001|STARTED|Overall Study||2
9984464|NCT01620216|11106189|FG002|STARTED|Overall Study||6
9984465|NCT01620216|11106190|FG003|STARTED|Overall Study||0
9984466|NCT01620216|11106191|FG004|STARTED|Overall Study||0
9984467|NCT01620216|11106192|FG005|STARTED|Overall Study||0
9984468|NCT01620216|11106193|FG006|STARTED|Overall Study||0
9984469|NCT01620216|11106187|FG000|COMPLETED|Overall Study||4
9984470|NCT01620216|11106188|FG001|COMPLETED|Overall Study||2
9984471|NCT01620216|11106189|FG002|COMPLETED|Overall Study||6
9984472|NCT01620216|11106190|FG003|COMPLETED|Overall Study||0
9984473|NCT01620216|11106191|FG004|COMPLETED|Overall Study||0
9984474|NCT01620216|11106192|FG005|COMPLETED|Overall Study||0
9984475|NCT01620216|11106193|FG006|COMPLETED|Overall Study||0
9984476|NCT01620216|11106187|FG000|NOT COMPLETED|Overall Study||0
9984477|NCT01620216|11106188|FG001|NOT COMPLETED|Overall Study||0
9984478|NCT01620216|11106189|FG002|NOT COMPLETED|Overall Study||0
9984479|NCT01620216|11106190|FG003|NOT COMPLETED|Overall Study||0
9984480|NCT01620216|11106191|FG004|NOT COMPLETED|Overall Study||0
9984481|NCT01620216|11106192|FG005|NOT COMPLETED|Overall Study||0
9984482|NCT01620216|11106193|FG006|NOT COMPLETED|Overall Study||0
9984483|NCT01620255|11106214|FG000|STARTED|Overall Study||73
9984484|NCT01620255|11106215|FG001|STARTED|Overall Study||71
9984485|NCT01620255|11106216|FG002|STARTED|Overall Study||70
9984486|NCT01620255|11106217|FG003|STARTED|Overall Study||73
9984487|NCT01620255|11106218|FG004|STARTED|Overall Study||70
9984488|NCT01620255|11106214|FG000|Treated|Overall Study||73
9984489|NCT01620255|11106215|FG001|Treated|Overall Study||71
9984490|NCT01620255|11106216|FG002|Treated|Overall Study||70
9984491|NCT01620255|11106217|FG003|Treated|Overall Study||73
9984492|NCT01620255|11106218|FG004|Treated|Overall Study||70
9984493|NCT01620255|11106214|FG000|COMPLETED|Overall Study||69
9984494|NCT01620255|11106215|FG001|COMPLETED|Overall Study||65
9984495|NCT01620255|11106216|FG002|COMPLETED|Overall Study||68
9984496|NCT01620255|11106217|FG003|COMPLETED|Overall Study||70
9984497|NCT01620255|11106218|FG004|COMPLETED|Overall Study||64
9984498|NCT01620255|11106214|FG000|NOT COMPLETED|Overall Study||4
9984499|NCT01620255|11106215|FG001|NOT COMPLETED|Overall Study||6
9984500|NCT01620255|11106216|FG002|NOT COMPLETED|Overall Study||2
9984501|NCT01620255|11106217|FG003|NOT COMPLETED|Overall Study||3
9984502|NCT01620255|11106218|FG004|NOT COMPLETED|Overall Study||6
9984503|NCT01620489|11106232|FG000|STARTED|Overall Study||140
9984504|NCT01620489|11106233|FG001|STARTED|Overall Study||139
9984505|NCT01620489|11106232|FG000|Exposed|Overall Study||140
9984506|NCT01620489|11106233|FG001|Exposed|Overall Study|2 subjects did not take trial product|137
9984507|NCT01620489|11106232|FG000|COMPLETED|Overall Study||105
9984508|NCT01620489|11106233|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105
9984509|NCT01620489|11106232|FG000|NOT COMPLETED|Overall Study||35
9984510|NCT01620489|11106233|FG001|NOT COMPLETED|Overall Study||34
9984511|NCT01620528|11106242|FG000|STARTED|Treatment Period||374
9984512|NCT01620528|11106243|FG001|STARTED|Treatment Period||249
9984513|NCT01620528|11106244|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249
9984514|NCT01620528|11106242|FG000|COMPLETED|Treatment Period||274
9984515|NCT01620528|11106243|FG001|COMPLETED|Treatment Period||196
9984516|NCT01620528|11106244|FG002|COMPLETED|Treatment Period||183
9984517|NCT01620528|11106242|FG000|NOT COMPLETED|Treatment Period||100
9984518|NCT01620528|11106243|FG001|NOT COMPLETED|Treatment Period||53
9984519|NCT01620528|11106244|FG002|NOT COMPLETED|Treatment Period||66
9984520|NCT01620528|11106242|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
9984521|NCT01620528|11106243|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
9984522|NCT01620528|11106244|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
9984523|NCT01620528|11106242|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
9984524|NCT01620528|11106243|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
9984525|NCT01620528|11106244|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
9984526|NCT01620528|11106242|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
9984527|NCT01620528|11106243|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
9984528|NCT01620528|11106244|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
9984529|NCT01620528|11106242|FG000|COMPLETED|Post-Treatment Follow-Up Period||48
9984530|NCT01620528|11106243|FG001|COMPLETED|Post-Treatment Follow-Up Period||31
9984531|NCT01620528|11106244|FG002|COMPLETED|Post-Treatment Follow-Up Period||37
9984532|NCT01620528|11106242|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20
9984533|NCT01620528|11106243|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17
9984534|NCT01620528|11106244|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14
9984535|NCT01620567|11106254|FG000|STARTED|Overall Study||23
9984536|NCT01620567|11106255|FG001|STARTED|Overall Study||25
9984537|NCT01620567|11106254|FG000|COMPLETED|Overall Study||20
9984538|NCT01620567|11106255|FG001|COMPLETED|Overall Study||20
9984539|NCT01620567|11106254|FG000|NOT COMPLETED|Overall Study||3
9984540|NCT01620567|11106255|FG001|NOT COMPLETED|Overall Study||5
9984541|NCT01620593|11106266|FG000|STARTED|Overall Study||21
9984542|NCT01620593|11106267|FG001|STARTED|Overall Study||20
9984543|NCT01620593|11106266|FG000|COMPLETED|Overall Study||17
9984544|NCT01620593|11106267|FG001|COMPLETED|Overall Study||19
9984545|NCT01620593|11106266|FG000|NOT COMPLETED|Overall Study||4
9984546|NCT01620593|11106267|FG001|NOT COMPLETED|Overall Study||1
9984547|NCT01620762|11106276|FG000|STARTED|Overall Study||468
9984548|NCT01620762|11106277|FG001|STARTED|Overall Study||470
9984549|NCT01620762|11106278|FG002|STARTED|Overall Study||470
9984550|NCT01620762|11106276|FG000|COMPLETED|Overall Study||420
9984551|NCT01620762|11106277|FG001|COMPLETED|Overall Study||412
9984552|NCT01620762|11106278|FG002|COMPLETED|Overall Study||417
9984553|NCT01620762|11106276|FG000|NOT COMPLETED|Overall Study||48
9984554|NCT01620762|11106277|FG001|NOT COMPLETED|Overall Study||58
9984555|NCT01620762|11106278|FG002|NOT COMPLETED|Overall Study||53
9984556|NCT01620983|11106289|FG000|STARTED|Overall Study||130
9984557|NCT01620983|11106290|FG001|STARTED|Overall Study||135
9984558|NCT01620983|11106291|FG002|STARTED|Overall Study||137
9984559|NCT01620983|11106289|FG000|COMPLETED|Overall Study||111
9984560|NCT01620983|11106290|FG001|COMPLETED|Overall Study||113
9984561|NCT01620983|11106291|FG002|COMPLETED|Overall Study||122
9984562|NCT01620983|11106289|FG000|NOT COMPLETED|Overall Study||19
9984563|NCT01620983|11106290|FG001|NOT COMPLETED|Overall Study||22
9984564|NCT01620983|11106291|FG002|NOT COMPLETED|Overall Study||15
9984565|NCT01621009|11106303|FG000|STARTED|Overall Study||113
9984566|NCT01621009|11106304|FG001|STARTED|Overall Study||116
9984567|NCT01621009|11106305|FG002|STARTED|Overall Study||121
9984568|NCT01621009|11106306|FG003|STARTED|Overall Study||113
9984569|NCT01621009|11106303|FG000|COMPLETED|Overall Study||70
9984570|NCT01621009|11106304|FG001|COMPLETED|Overall Study||65
9984571|NCT01621009|11106305|FG002|COMPLETED|Overall Study||58
9984572|NCT01621009|11106306|FG003|COMPLETED|Overall Study||60
9984573|NCT01621009|11106303|FG000|NOT COMPLETED|Overall Study||43
9984574|NCT01621009|11106304|FG001|NOT COMPLETED|Overall Study||51
9984575|NCT01621009|11106305|FG002|NOT COMPLETED|Overall Study||63
9984576|NCT01621009|11106306|FG003|NOT COMPLETED|Overall Study||53
9984577|NCT01621126|11106314|FG000|STARTED|Overall Study||40
9984578|NCT01621126|11106314|FG000|COMPLETED|Overall Study||34
9984579|NCT01621126|11106314|FG000|NOT COMPLETED|Overall Study||6
9984580|NCT01621178|11106321|FG000|STARTED|Overall Study||194
9984581|NCT01621178|11106322|FG001|STARTED|Overall Study||190
9984582|NCT01621178|11106323|FG002|STARTED|Overall Study||193
9984583|NCT01621178|11106321|FG000|Received at Least One Dose of Study Drug|Overall Study||194
9984584|NCT01621178|11106322|FG001|Received at Least One Dose of Study Drug|Overall Study||190
9984585|NCT01621178|11106323|FG002|Received at Least One Dose of Study Drug|Overall Study||192
9984586|NCT01621178|11106321|FG000|Modified Intent to Treat Population|Overall Study||186
9984587|NCT01621178|11106322|FG001|Modified Intent to Treat Population|Overall Study||180
9984588|NCT01621178|11106323|FG002|Modified Intent to Treat Population|Overall Study||183
9984589|NCT01621178|11106321|FG000|COMPLETED|Overall Study||163
9984590|NCT01621178|11106322|FG001|COMPLETED|Overall Study||160
9984591|NCT01621178|11106323|FG002|COMPLETED|Overall Study||157
9984592|NCT01621178|11106321|FG000|NOT COMPLETED|Overall Study||31
9984593|NCT01621178|11106322|FG001|NOT COMPLETED|Overall Study||30
9984594|NCT01621178|11106323|FG002|NOT COMPLETED|Overall Study||36
9984595|NCT01621191|11106335|FG000|STARTED|Overall Study||149
9984596|NCT01621191|11106335|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149
9984597|NCT01621191|11106335|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148
9984598|NCT01621191|11106335|FG000|COMPLETED|Overall Study||124
9984599|NCT01621191|11106335|FG000|NOT COMPLETED|Overall Study||25
9984600|NCT01621230|11106342|FG000|STARTED|Overall Study||154
9984601|NCT01621230|11106343|FG001|STARTED|Overall Study||156
9984602|NCT01621230|11106342|FG000|COMPLETED|Overall Study||154
9984603|NCT01621230|11106343|FG001|COMPLETED|Overall Study||156
9984604|NCT01621230|11106342|FG000|NOT COMPLETED|Overall Study||0
9984605|NCT01621230|11106343|FG001|NOT COMPLETED|Overall Study||0
9984606|NCT01621477|11106352|FG000|STARTED|Overall Study||17
9984607|NCT01621477|11106352|FG000|COMPLETED|Overall Study||17
9984608|NCT01621477|11106352|FG000|NOT COMPLETED|Overall Study||0
9984609|NCT01621490|11106365|FG000|STARTED|Overall Study||41
9984610|NCT01621490|11106366|FG001|STARTED|Overall Study||44
9984611|NCT01621490|11106367|FG002|STARTED|Overall Study||11
9984612|NCT01621490|11106368|FG003|STARTED|Overall Study||10
9984613|NCT01621490|11106369|FG004|STARTED|Overall Study||6
9984614|NCT01621490|11106370|FG005|STARTED|Overall Study||25
9984615|NCT01621490|11106371|FG006|STARTED|Overall Study||11
9984616|NCT01621490|11106372|FG007|STARTED|Overall Study||10
9984617|NCT01621490|11106373|FG008|STARTED|Overall Study||10
9984618|NCT01621490|11106365|FG000|COMPLETED|Overall Study||0
9984619|NCT01621490|11106366|FG001|COMPLETED|Overall Study||0
9984620|NCT01621490|11106367|FG002|COMPLETED|Overall Study||0
9984621|NCT01621490|11106368|FG003|COMPLETED|Overall Study||1
9984622|NCT01621490|11106369|FG004|COMPLETED|Overall Study||0
9984623|NCT01621490|11106370|FG005|COMPLETED|Overall Study||1
9984624|NCT01621490|11106371|FG006|COMPLETED|Overall Study||0
9984625|NCT01621490|11106372|FG007|COMPLETED|Overall Study||0
9984626|NCT01621490|11106373|FG008|COMPLETED|Overall Study||2
9984627|NCT01621490|11106365|FG000|NOT COMPLETED|Overall Study||41
9984628|NCT01621490|11106366|FG001|NOT COMPLETED|Overall Study||44
9984629|NCT01621490|11106367|FG002|NOT COMPLETED|Overall Study||11
9984630|NCT01621490|11106368|FG003|NOT COMPLETED|Overall Study||9
9984631|NCT01621490|11106369|FG004|NOT COMPLETED|Overall Study||6
9984632|NCT01621490|11106370|FG005|NOT COMPLETED|Overall Study||24
9984633|NCT01621490|11106371|FG006|NOT COMPLETED|Overall Study||11
9984634|NCT01621490|11106372|FG007|NOT COMPLETED|Overall Study||10
9984635|NCT01621490|11106373|FG008|NOT COMPLETED|Overall Study||8
9984636|NCT01621542|11106492|FG000|STARTED|Overall Study||5
9984637|NCT01621542|11106493|FG001|STARTED|Overall Study||5
9984638|NCT01621542|11106494|FG002|STARTED|Overall Study||6
9984639|NCT01621542|11106495|FG003|STARTED|Overall Study||28
9984640|NCT01621542|11106496|FG004|STARTED|Overall Study||9
9984641|NCT01621542|11106497|FG005|STARTED|Overall Study||9
9984642|NCT01621542|11106492|FG000|COMPLETED|Overall Study||0
9984643|NCT01621542|11106493|FG001|COMPLETED|Overall Study||0
9984644|NCT01621542|11106494|FG002|COMPLETED|Overall Study||0
9984645|NCT01621542|11106495|FG003|COMPLETED|Overall Study||0
9984646|NCT01621542|11106496|FG004|COMPLETED|Overall Study||0
9984647|NCT01621542|11106497|FG005|COMPLETED|Overall Study||0
9984648|NCT01621542|11106492|FG000|NOT COMPLETED|Overall Study||5
9984649|NCT01621542|11106493|FG001|NOT COMPLETED|Overall Study||5
9984650|NCT01621542|11106494|FG002|NOT COMPLETED|Overall Study||6
9984651|NCT01621542|11106495|FG003|NOT COMPLETED|Overall Study||28
9984652|NCT01621542|11106496|FG004|NOT COMPLETED|Overall Study||9
9984653|NCT01621542|11106497|FG005|NOT COMPLETED|Overall Study||9
9984654|NCT01621633|11106515|FG000|STARTED|Overall Study||8
9984655|NCT01621633|11106516|FG001|STARTED|Overall Study||8
9984656|NCT01621633|11106517|FG002|STARTED|Overall Study||8
9984657|NCT01621633|11106518|FG003|STARTED|Overall Study||8
9984658|NCT01621633|11106515|FG000|COMPLETED|Overall Study||8
9984659|NCT01621633|11106516|FG001|COMPLETED|Overall Study||8
9984660|NCT01621633|11106517|FG002|COMPLETED|Overall Study||8
9984661|NCT01621633|11106518|FG003|COMPLETED|Overall Study||8
9984662|NCT01621633|11106515|FG000|NOT COMPLETED|Overall Study||0
9984663|NCT01621633|11106516|FG001|NOT COMPLETED|Overall Study||0
9984664|NCT01621633|11106517|FG002|NOT COMPLETED|Overall Study||0
9984665|NCT01621633|11106518|FG003|NOT COMPLETED|Overall Study||0
9984666|NCT01621672|11106530|FG000|STARTED|Overall Study||25
9984667|NCT01621672|11106531|FG001|STARTED|Overall Study||17
9984668|NCT01621672|11106530|FG000|COMPLETED|Overall Study||25
9984669|NCT01621672|11106531|FG001|COMPLETED|Overall Study||17
9984670|NCT01621672|11106530|FG000|NOT COMPLETED|Overall Study||0
9984671|NCT01621672|11106531|FG001|NOT COMPLETED|Overall Study||0
9984672|NCT01621776|11106540|FG000|STARTED|Overall Study||41
9984673|NCT01621776|11106541|FG001|STARTED|Overall Study||40
10202124|NCT03441984|11329278|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202125|NCT03441984|11329279|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202126|NCT03441984|11329280|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9984674|NCT01621776|11106542|FG002|STARTED|Overall Study||18
9984675|NCT01621776|11106540|FG000|COMPLETED|Overall Study||41
9984676|NCT01621776|11106541|FG001|COMPLETED|Overall Study||40
9984677|NCT01621776|11106542|FG002|COMPLETED|Overall Study||18
9984678|NCT01621776|11106540|FG000|NOT COMPLETED|Overall Study||0
9984679|NCT01621776|11106541|FG001|NOT COMPLETED|Overall Study||0
9984680|NCT01621776|11106542|FG002|NOT COMPLETED|Overall Study||0
9984681|NCT01621802|11106556|FG000|STARTED|Overall Study||802
9984682|NCT01621802|11106557|FG001|STARTED|Overall Study||298
9984683|NCT01621802|11106558|FG002|STARTED|Overall Study||796
9984684|NCT01621802|11106559|FG003|STARTED|Overall Study||303
9984685|NCT01621802|11106560|FG004|STARTED|Overall Study||1319
9984686|NCT01621802|11106561|FG005|STARTED|Overall Study||489
9984687|NCT01621802|11106556|FG000|COMPLETED|Overall Study||755
9984688|NCT01621802|11106557|FG001|COMPLETED|Overall Study||275
9984689|NCT01621802|11106558|FG002|COMPLETED|Overall Study||763
9984690|NCT01621802|11106559|FG003|COMPLETED|Overall Study||292
9984691|NCT01621802|11106560|FG004|COMPLETED|Overall Study||1284
9984692|NCT01621802|11106561|FG005|COMPLETED|Overall Study||477
9984693|NCT01621802|11106556|FG000|NOT COMPLETED|Overall Study||47
9984694|NCT01621802|11106557|FG001|NOT COMPLETED|Overall Study||23
9984695|NCT01621802|11106558|FG002|NOT COMPLETED|Overall Study||33
9984696|NCT01621802|11106559|FG003|NOT COMPLETED|Overall Study||11
9984697|NCT01621802|11106560|FG004|NOT COMPLETED|Overall Study||35
9984698|NCT01621802|11106561|FG005|NOT COMPLETED|Overall Study||12
9984699|NCT01621880|11106580|FG000|STARTED|Overall Study||58
9984700|NCT01621880|11106581|FG001|STARTED|Overall Study||54
9984701|NCT01621880|11106580|FG000|COMPLETED|Overall Study||48
9984702|NCT01621880|11106581|FG001|COMPLETED|Overall Study||49
9984703|NCT01621880|11106580|FG000|NOT COMPLETED|Overall Study||10
9984704|NCT01621880|11106581|FG001|NOT COMPLETED|Overall Study||5
9984705|NCT01622010|11106590|FG000|STARTED|Overall Study||18
9984706|NCT01622010|11106591|FG001|STARTED|Overall Study||12
9984707|NCT01622010|11106590|FG000|COMPLETED|Overall Study||12
9984708|NCT01622010|11106591|FG001|COMPLETED|Overall Study||8
9984709|NCT01622010|11106590|FG000|NOT COMPLETED|Overall Study||6
9984710|NCT01622010|11106591|FG001|NOT COMPLETED|Overall Study||4
9984711|NCT01622231|11106599|FG000|STARTED|Overall Study||61
9984712|NCT01622231|11106599|FG000|COMPLETED|Overall Study||59
9984713|NCT01622231|11106599|FG000|NOT COMPLETED|Overall Study||2
9984714|NCT01622257|11106606|FG000|STARTED|Overall Study||66
10101159|NCT02405442|11230402|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
9984715|NCT01622257|11106607|FG001|STARTED|Overall Study||66
9984716|NCT01622257|11106608|FG002|STARTED|Overall Study||66
9984717|NCT01622257|11106606|FG000|COMPLETED|Overall Study||66
9984718|NCT01622257|11106607|FG001|COMPLETED|Overall Study||66
9984719|NCT01622257|11106608|FG002|COMPLETED|Overall Study||66
9984720|NCT01622257|11106606|FG000|NOT COMPLETED|Overall Study||0
9984721|NCT01622257|11106607|FG001|NOT COMPLETED|Overall Study||0
9984722|NCT01622257|11106608|FG002|NOT COMPLETED|Overall Study||0
9984723|NCT01622296|11106616|FG000|STARTED|First Intervention||10
9984724|NCT01622296|11106617|FG001|STARTED|First Intervention||10
9984725|NCT01622296|11106616|FG000|COMPLETED|First Intervention||10
9984726|NCT01622296|11106617|FG001|COMPLETED|First Intervention||10
9984727|NCT01622296|11106616|FG000|NOT COMPLETED|First Intervention||0
9984728|NCT01622296|11106617|FG001|NOT COMPLETED|First Intervention||0
9984729|NCT01622296|11106616|FG000|STARTED|Washout Period of at Least 1 Week||10
9984730|NCT01622296|11106617|FG001|STARTED|Washout Period of at Least 1 Week||10
9984731|NCT01622296|11106616|FG000|COMPLETED|Washout Period of at Least 1 Week||10
9984732|NCT01622296|11106617|FG001|COMPLETED|Washout Period of at Least 1 Week||10
9984733|NCT01622296|11106616|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
9984734|NCT01622296|11106617|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
9984735|NCT01622296|11106616|FG000|STARTED|Second Intervention||10
9984736|NCT01622296|11106617|FG001|STARTED|Second Intervention||10
9984737|NCT01622296|11106616|FG000|COMPLETED|Second Intervention||10
9984738|NCT01622296|11106617|FG001|COMPLETED|Second Intervention||10
9984739|NCT01622296|11106616|FG000|NOT COMPLETED|Second Intervention||0
9984740|NCT01622296|11106617|FG001|NOT COMPLETED|Second Intervention||0
9984741|NCT01622348|11106625|FG000|STARTED|Overall Study||15
9984742|NCT01622348|11106626|FG001|STARTED|Overall Study||14
9984743|NCT01622348|11106627|FG002|STARTED|Overall Study||15
9984744|NCT01622348|11106625|FG000|COMPLETED|Overall Study||14
9984745|NCT01622348|11106626|FG001|COMPLETED|Overall Study||14
9984746|NCT01622348|11106627|FG002|COMPLETED|Overall Study||14
9984747|NCT01622348|11106625|FG000|NOT COMPLETED|Overall Study||1
9984748|NCT01622348|11106626|FG001|NOT COMPLETED|Overall Study||0
9984749|NCT01622348|11106627|FG002|NOT COMPLETED|Overall Study||1
9984750|NCT01622543|11106637|FG000|STARTED|Overall Study||51
9984751|NCT01622543|11106638|FG001|STARTED|Overall Study||52
9984752|NCT01622543|11106637|FG000|COMPLETED|Overall Study||51
9984753|NCT01622543|11106638|FG001|COMPLETED|Overall Study||52
9984754|NCT01622543|11106637|FG000|NOT COMPLETED|Overall Study||0
9984755|NCT01622543|11106638|FG001|NOT COMPLETED|Overall Study||0
9984756|NCT01622569|11106648|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
9984757|NCT01622569|11106649|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
9984758|NCT01622569|11106650|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
9984759|NCT01622569|11106651|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
9984760|NCT01622569|11106648|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
9984761|NCT01622569|11106649|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
9984762|NCT01622569|11106650|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
9984763|NCT01622569|11106651|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
9984764|NCT01622569|11106648|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
9984765|NCT01622569|11106649|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
9984766|NCT01622569|11106650|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
9984767|NCT01622569|11106651|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
9984768|NCT01622569|11106648|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68
9984769|NCT01622569|11106649|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72
9984770|NCT01622569|11106650|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67
9984771|NCT01622569|11106651|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75
9984772|NCT01622569|11106648|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
9984773|NCT01622569|11106649|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
9984774|NCT01622569|11106650|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
9984775|NCT01622569|11106651|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
9984776|NCT01622569|11106648|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
9984777|NCT01622569|11106649|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
9984778|NCT01622569|11106650|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
9984779|NCT01622569|11106651|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
9984780|NCT01622660|11106671|FG000|STARTED|Overall Study||2
9984781|NCT01622660|11106671|FG000|COMPLETED|Overall Study||1
9984782|NCT01622660|11106671|FG000|NOT COMPLETED|Overall Study||1
9984783|NCT01622673|11106681|FG000|STARTED|Treatment Period 1||4
9984784|NCT01622673|11106682|FG001|STARTED|Treatment Period 1||5
9984785|NCT01622673|11106683|FG002|STARTED|Treatment Period 1||4
9984786|NCT01622673|11106684|FG003|STARTED|Treatment Period 1||6
9984787|NCT01622673|11106685|FG004|STARTED|Treatment Period 1||4
9984788|NCT01622673|11106686|FG005|STARTED|Treatment Period 1||4
9984789|NCT01622673|11106681|FG000|COMPLETED|Treatment Period 1||4
9984790|NCT01622673|11106682|FG001|COMPLETED|Treatment Period 1||4
9984791|NCT01622673|11106683|FG002|COMPLETED|Treatment Period 1||4
9984792|NCT01622673|11106684|FG003|COMPLETED|Treatment Period 1||5
9984793|NCT01622673|11106685|FG004|COMPLETED|Treatment Period 1||4
9984794|NCT01622673|11106686|FG005|COMPLETED|Treatment Period 1||4
9984795|NCT01622673|11106681|FG000|NOT COMPLETED|Treatment Period 1||0
9984796|NCT01622673|11106682|FG001|NOT COMPLETED|Treatment Period 1||1
9984797|NCT01622673|11106683|FG002|NOT COMPLETED|Treatment Period 1||0
9984798|NCT01622673|11106684|FG003|NOT COMPLETED|Treatment Period 1||1
9984799|NCT01622673|11106685|FG004|NOT COMPLETED|Treatment Period 1||0
9984800|NCT01622673|11106686|FG005|NOT COMPLETED|Treatment Period 1||0
9984801|NCT01622673|11106681|FG000|STARTED|Treatment Period 2||4
9984802|NCT01622673|11106682|FG001|STARTED|Treatment Period 2||4
9984803|NCT01622673|11106683|FG002|STARTED|Treatment Period 2||4
9984804|NCT01622673|11106684|FG003|STARTED|Treatment Period 2||5
9984805|NCT01622673|11106685|FG004|STARTED|Treatment Period 2||4
9984806|NCT01622673|11106686|FG005|STARTED|Treatment Period 2||4
9984807|NCT01622673|11106681|FG000|COMPLETED|Treatment Period 2||4
9984808|NCT01622673|11106682|FG001|COMPLETED|Treatment Period 2||4
9984809|NCT01622673|11106683|FG002|COMPLETED|Treatment Period 2||4
9984810|NCT01622673|11106684|FG003|COMPLETED|Treatment Period 2||4
9984811|NCT01622673|11106685|FG004|COMPLETED|Treatment Period 2||4
9984812|NCT01622673|11106686|FG005|COMPLETED|Treatment Period 2||4
9984813|NCT01622673|11106681|FG000|NOT COMPLETED|Treatment Period 2||0
9984814|NCT01622673|11106682|FG001|NOT COMPLETED|Treatment Period 2||0
9984815|NCT01622673|11106683|FG002|NOT COMPLETED|Treatment Period 2||0
9984816|NCT01622673|11106684|FG003|NOT COMPLETED|Treatment Period 2||1
9984817|NCT01622673|11106685|FG004|NOT COMPLETED|Treatment Period 2||0
9984818|NCT01622673|11106686|FG005|NOT COMPLETED|Treatment Period 2||0
9984819|NCT01622673|11106681|FG000|STARTED|Treatment Period 3||4
9984820|NCT01622673|11106682|FG001|STARTED|Treatment Period 3||4
9984821|NCT01622673|11106683|FG002|STARTED|Treatment Period 3||4
9984822|NCT01622673|11106684|FG003|STARTED|Treatment Period 3||4
9984823|NCT01622673|11106685|FG004|STARTED|Treatment Period 3||4
9984824|NCT01622673|11106686|FG005|STARTED|Treatment Period 3||4
9984825|NCT01622673|11106681|FG000|COMPLETED|Treatment Period 3||4
9984826|NCT01622673|11106682|FG001|COMPLETED|Treatment Period 3||3
9984827|NCT01622673|11106683|FG002|COMPLETED|Treatment Period 3||4
9984828|NCT01622673|11106684|FG003|COMPLETED|Treatment Period 3||4
9984829|NCT01622673|11106685|FG004|COMPLETED|Treatment Period 3||4
9984830|NCT01622673|11106686|FG005|COMPLETED|Treatment Period 3||4
9984831|NCT01622673|11106681|FG000|NOT COMPLETED|Treatment Period 3||0
9984832|NCT01622673|11106682|FG001|NOT COMPLETED|Treatment Period 3||1
9984833|NCT01622673|11106683|FG002|NOT COMPLETED|Treatment Period 3||0
9984834|NCT01622673|11106684|FG003|NOT COMPLETED|Treatment Period 3||0
9984835|NCT01622673|11106685|FG004|NOT COMPLETED|Treatment Period 3||0
9984836|NCT01622673|11106686|FG005|NOT COMPLETED|Treatment Period 3||0
9984837|NCT01622673|11106681|FG000|STARTED|Treatment Period 4||4
9984838|NCT01622673|11106682|FG001|STARTED|Treatment Period 4||3
9984839|NCT01622673|11106683|FG002|STARTED|Treatment Period 4||4
9984840|NCT01622673|11106684|FG003|STARTED|Treatment Period 4||4
9984841|NCT01622673|11106685|FG004|STARTED|Treatment Period 4||4
9984842|NCT01622673|11106686|FG005|STARTED|Treatment Period 4||4
9984843|NCT01622673|11106681|FG000|COMPLETED|Treatment Period 4||4
9984844|NCT01622673|11106682|FG001|COMPLETED|Treatment Period 4||3
9984845|NCT01622673|11106683|FG002|COMPLETED|Treatment Period 4||4
9984846|NCT01622673|11106684|FG003|COMPLETED|Treatment Period 4||4
9984847|NCT01622673|11106685|FG004|COMPLETED|Treatment Period 4||4
9984848|NCT01622673|11106686|FG005|COMPLETED|Treatment Period 4||4
9984849|NCT01622673|11106681|FG000|NOT COMPLETED|Treatment Period 4||0
9984850|NCT01622673|11106682|FG001|NOT COMPLETED|Treatment Period 4||0
9984851|NCT01622673|11106683|FG002|NOT COMPLETED|Treatment Period 4||0
9984852|NCT01622673|11106684|FG003|NOT COMPLETED|Treatment Period 4||0
9984853|NCT01622673|11106685|FG004|NOT COMPLETED|Treatment Period 4||0
9984854|NCT01622673|11106686|FG005|NOT COMPLETED|Treatment Period 4||0
9984855|NCT01622673|11106681|FG000|STARTED|Treatment Period 5||4
9984856|NCT01622673|11106682|FG001|STARTED|Treatment Period 5||3
9984857|NCT01622673|11106683|FG002|STARTED|Treatment Period 5||4
9984858|NCT01622673|11106684|FG003|STARTED|Treatment Period 5||4
9984859|NCT01622673|11106685|FG004|STARTED|Treatment Period 5||4
9984860|NCT01622673|11106686|FG005|STARTED|Treatment Period 5||4
9984861|NCT01622673|11106681|FG000|COMPLETED|Treatment Period 5||4
9984862|NCT01622673|11106682|FG001|COMPLETED|Treatment Period 5||3
9984863|NCT01622673|11106683|FG002|COMPLETED|Treatment Period 5||4
9984864|NCT01622673|11106684|FG003|COMPLETED|Treatment Period 5||4
9984865|NCT01622673|11106685|FG004|COMPLETED|Treatment Period 5||4
9984866|NCT01622673|11106686|FG005|COMPLETED|Treatment Period 5||4
9984867|NCT01622673|11106681|FG000|NOT COMPLETED|Treatment Period 5||0
9984868|NCT01622673|11106682|FG001|NOT COMPLETED|Treatment Period 5||0
9984869|NCT01622673|11106683|FG002|NOT COMPLETED|Treatment Period 5||0
9984870|NCT01622673|11106684|FG003|NOT COMPLETED|Treatment Period 5||0
9984871|NCT01622673|11106685|FG004|NOT COMPLETED|Treatment Period 5||0
9984872|NCT01622673|11106686|FG005|NOT COMPLETED|Treatment Period 5||0
9984873|NCT01622699|11106707|FG000|STARTED|Overall Study||213
9984874|NCT01622699|11106708|FG001|STARTED|Overall Study||217
9984875|NCT01622699|11106707|FG000|COMPLETED|Overall Study||213
9984876|NCT01622699|11106708|FG001|COMPLETED|Overall Study||217
9984877|NCT01622699|11106707|FG000|NOT COMPLETED|Overall Study||0
9984878|NCT01622699|11106708|FG001|NOT COMPLETED|Overall Study||0
9984879|NCT01623037|11106714|FG000|STARTED|Overall Study||15
9984880|NCT01623037|11106714|FG000|COMPLETED|Overall Study||15
9984881|NCT01623037|11106714|FG000|NOT COMPLETED|Overall Study||0
9984882|NCT01623050|11106720|FG000|STARTED|Overall Study||36
9984883|NCT01623050|11106720|FG000|Treated|Overall Study||34
9984884|NCT01623050|11106720|FG000|COMPLETED|Overall Study||27
9984885|NCT01623050|11106720|FG000|NOT COMPLETED|Overall Study||9
9984886|NCT01623115|11106726|FG000|STARTED|Overall Study|Randomized|163
9984887|NCT01623115|11106727|FG001|STARTED|Overall Study|Randomized|323
9984888|NCT01623115|11106726|FG000|Treated|Overall Study||163
9984889|NCT01623115|11106727|FG001|Treated|Overall Study||322
9984890|NCT01623115|11106726|FG000|COMPLETED|Overall Study||130
9984891|NCT01623115|11106727|FG001|COMPLETED|Overall Study||246
9984892|NCT01623115|11106726|FG000|NOT COMPLETED|Overall Study||33
9984893|NCT01623115|11106727|FG001|NOT COMPLETED|Overall Study||77
9984894|NCT01623154|11106733|FG000|STARTED|Overall Study||99
9984895|NCT01623154|11106733|FG000|Available for Analysis|Overall Study||95
9984896|NCT01623154|11106733|FG000|COMPLETED|Overall Study||95
9984897|NCT01623154|11106733|FG000|NOT COMPLETED|Overall Study||4
9984898|NCT01623271|11106739|FG000|STARTED|Overall Study||5
9984899|NCT01623271|11106739|FG000|COMPLETED|Overall Study||3
9984900|NCT01623271|11106739|FG000|NOT COMPLETED|Overall Study||2
9984901|NCT01623310|11106743|FG000|STARTED|Overall Study||223
9984902|NCT01623310|11106743|FG000|COMPLETED|Overall Study||144
9984903|NCT01623310|11106743|FG000|NOT COMPLETED|Overall Study||79
9984904|NCT01623323|11106747|FG000|STARTED|Overall Study||705
9984905|NCT01623323|11106747|FG000|COMPLETED|Overall Study||601
9984906|NCT01623323|11106747|FG000|NOT COMPLETED|Overall Study||104
9984907|NCT01623466|11106753|FG000|STARTED|Overall Study||18
9984908|NCT01623466|11106754|FG001|STARTED|Overall Study||18
9984909|NCT01623466|11106753|FG000|COMPLETED|Overall Study||17
9984910|NCT01623466|11106754|FG001|COMPLETED|Overall Study||18
9984911|NCT01623466|11106753|FG000|NOT COMPLETED|Overall Study||1
9984912|NCT01623466|11106754|FG001|NOT COMPLETED|Overall Study||0
10018111|NCT01821807|11141085|FG001|STARTED|Overall Study||110
10018112|NCT01821807|11141084|FG000|COMPLETED|Overall Study||147
9984913|NCT01623479|11106760|FG000|STARTED|Overall Study||585
9984914|NCT01623479|11106760|FG000|COMPLETED|Overall Study||585
9984915|NCT01623479|11106760|FG000|NOT COMPLETED|Overall Study||0
9984916|NCT01623531|11106766|FG000|STARTED|Overall Study||31
9984917|NCT01623531|11106767|FG001|STARTED|Overall Study||31
9984918|NCT01623531|11106766|FG000|COMPLETED|Overall Study||27
9984919|NCT01623531|11106767|FG001|COMPLETED|Overall Study||29
9984920|NCT01623531|11106766|FG000|NOT COMPLETED|Overall Study||4
9984921|NCT01623531|11106767|FG001|NOT COMPLETED|Overall Study||2
9984922|NCT01623596|11106778|FG000|STARTED|Overall Study||436
9984923|NCT01623596|11106779|FG001|STARTED|Overall Study||439
9984924|NCT01623596|11106778|FG000|On Randomized Treatment|Overall Study||352
9984925|NCT01623596|11106779|FG001|On Randomized Treatment|Overall Study||125
9984926|NCT01623596|11106778|FG000|On Switched Treatment|Overall Study||22
9984927|NCT01623596|11106779|FG001|On Switched Treatment|Overall Study||214
9984928|NCT01623596|11106778|FG000|COMPLETED|Overall Study||374
9984929|NCT01623596|11106779|FG001|COMPLETED|Overall Study||339
9984930|NCT01623596|11106778|FG000|NOT COMPLETED|Overall Study||62
9984931|NCT01623596|11106779|FG001|NOT COMPLETED|Overall Study||100
9984932|NCT01623739|11106789|FG000|STARTED|Overall Study||19
9984933|NCT01623739|11106790|FG001|STARTED|Overall Study||19
9984934|NCT01623739|11106789|FG000|COMPLETED|Overall Study||17
9984935|NCT01623739|11106790|FG001|COMPLETED|Overall Study||15
9984936|NCT01623739|11106789|FG000|NOT COMPLETED|Overall Study||2
9984937|NCT01623739|11106790|FG001|NOT COMPLETED|Overall Study||4
9984938|NCT01623752|11106800|FG000|STARTED|Phase 1 (78 Weeks)||1378
9984939|NCT01623752|11106801|FG001|STARTED|Phase 1 (78 Weeks)||440
9984940|NCT01623752|11106802|FG002|STARTED|Phase 1 (78 Weeks)||3
9984941|NCT01623752|11106800|FG000|COMPLETED|Phase 1 (78 Weeks)||747
9984942|NCT01623752|11106801|FG001|COMPLETED|Phase 1 (78 Weeks)||233
9984943|NCT01623752|11106802|FG002|COMPLETED|Phase 1 (78 Weeks)||1
9984944|NCT01623752|11106800|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631
9984945|NCT01623752|11106801|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207
9984946|NCT01623752|11106802|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2
9984947|NCT01623752|11106800|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
9984948|NCT01623752|11106801|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
9984949|NCT01623752|11106802|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
9984950|NCT01623752|11106800|FG000|COMPLETED|Phase 2 (78 Weeks)||225
9984951|NCT01623752|11106801|FG001|COMPLETED|Phase 2 (78 Weeks)||98
9984952|NCT01623752|11106802|FG002|COMPLETED|Phase 2 (78 Weeks)||0
9984953|NCT01623752|11106800|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66
9984954|NCT01623752|11106801|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18
9984955|NCT01623752|11106802|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0
9984956|NCT01623830|11106813|FG000|STARTED|Overall Study||45
9984957|NCT01623830|11106814|FG001|STARTED|Overall Study||44
9984958|NCT01623830|11106813|FG000|COMPLETED|Overall Study||38
9984959|NCT01623830|11106814|FG001|COMPLETED|Overall Study||35
9984960|NCT01623830|11106813|FG000|NOT COMPLETED|Overall Study||7
9984961|NCT01623830|11106814|FG001|NOT COMPLETED|Overall Study||9
9984962|NCT01623869|11106820|FG000|STARTED|Overall Study||16
9984963|NCT01623869|11106820|FG000|COMPLETED|Overall Study||16
9984964|NCT01623869|11106820|FG000|NOT COMPLETED|Overall Study||0
9984965|NCT01624090|11106828|FG000|STARTED|Overall Study||2
9984966|NCT01624090|11106829|FG001|STARTED|Overall Study||2
9984967|NCT01624090|11106830|FG002|STARTED|Overall Study||10
9984968|NCT01624090|11106831|FG003|STARTED|Overall Study||2
9984969|NCT01624090|11106828|FG000|COMPLETED|Overall Study||2
9984970|NCT01624090|11106829|FG001|COMPLETED|Overall Study||0
9984971|NCT01624090|11106830|FG002|COMPLETED|Overall Study||3
9984972|NCT01624090|11106831|FG003|COMPLETED|Overall Study||2
9984973|NCT01624090|11106828|FG000|NOT COMPLETED|Overall Study||0
9984974|NCT01624090|11106829|FG001|NOT COMPLETED|Overall Study||2
9984975|NCT01624090|11106830|FG002|NOT COMPLETED|Overall Study||7
10101160|NCT02405442|11230403|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
10101161|NCT02405442|11230404|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2
10101162|NCT02405442|11230405|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2
10101163|NCT02405442|11230402|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0
10101164|NCT02405442|11230403|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0
9984976|NCT01624090|11106831|FG003|NOT COMPLETED|Overall Study||0
9984977|NCT01624142|11106843|FG000|STARTED|Overall Study||106
9984978|NCT01624142|11106844|FG001|STARTED|Overall Study||194
9984979|NCT01624142|11106843|FG000|COMPLETED|Overall Study||74
9984980|NCT01624142|11106844|FG001|COMPLETED|Overall Study||178
9984981|NCT01624142|11106843|FG000|NOT COMPLETED|Overall Study||32
9984982|NCT01624142|11106844|FG001|NOT COMPLETED|Overall Study||16
9984983|NCT01624168|11106854|FG000|STARTED|Overall Study||19
9984984|NCT01624168|11106855|FG001|STARTED|Overall Study||28
9984985|NCT01624168|11106856|FG002|STARTED|Overall Study||28
9984986|NCT01624168|11106854|FG000|COMPLETED|Overall Study||15
9984987|NCT01624168|11106855|FG001|COMPLETED|Overall Study||16
9984988|NCT01624168|11106856|FG002|COMPLETED|Overall Study||22
9984989|NCT01624168|11106854|FG000|NOT COMPLETED|Overall Study||4
9984990|NCT01624168|11106855|FG001|NOT COMPLETED|Overall Study||12
9984991|NCT01624168|11106856|FG002|NOT COMPLETED|Overall Study||6
9984992|NCT01624194|11106866|FG000|STARTED|Overall Study||16
9984993|NCT01624194|11106867|FG001|STARTED|Overall Study||18
9984994|NCT01624194|11106866|FG000|COMPLETED|Overall Study||14
9984995|NCT01624194|11106867|FG001|COMPLETED|Overall Study||18
9984996|NCT01624194|11106866|FG000|NOT COMPLETED|Overall Study||2
9984997|NCT01624194|11106867|FG001|NOT COMPLETED|Overall Study||0
9984998|NCT01624233|11106874|FG000|STARTED|Period 2 - Induction||91
9984999|NCT01624233|11106874|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
9985000|NCT01624233|11106874|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
9985001|NCT01624233|11106874|FG000|Pustular Ps|Period 2 - Induction||5
9985002|NCT01624233|11106874|FG000|Plaque Ps|Period 2 - Induction||78
9985003|NCT01624233|11106874|FG000|COMPLETED|Period 2 - Induction||90
9985004|NCT01624233|11106874|FG000|NOT COMPLETED|Period 2 - Induction||1
9985005|NCT01624233|11106874|FG000|STARTED|Period 3 - Maintenance||90
9985006|NCT01624233|11106874|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
9985007|NCT01624233|11106874|FG000|COMPLETED|Period 3 - Maintenance||83
9985008|NCT01624233|11106874|FG000|NOT COMPLETED|Period 3 - Maintenance||7
9985009|NCT01624233|11106874|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
9985010|NCT01624233|11106874|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
9985011|NCT01624233|11106874|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
9985012|NCT01624233|11106874|FG000|COMPLETED|Period 4 - Drug Free Period||9
9985013|NCT01624233|11106874|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61
9985014|NCT01624233|11106874|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
9985015|NCT01624233|11106874|FG000|COMPLETED|Period 5 - Retreatment Period||70
9985016|NCT01624233|11106874|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10
9985017|NCT01624233|11106874|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
9985018|NCT01624233|11106874|FG000|COMPLETED|Period 6: Follow-up||79
9985019|NCT01624233|11106874|FG000|NOT COMPLETED|Period 6: Follow-up||9
9985020|NCT01624259|11106884|FG000|STARTED|Overall Study||299
9985021|NCT01624259|11106885|FG001|STARTED|Overall Study||300
9985022|NCT01624259|11106884|FG000|Received at Least One Dose of Study Drug|Overall Study||299
9985023|NCT01624259|11106885|FG001|Received at Least One Dose of Study Drug|Overall Study||300
9985024|NCT01624259|11106884|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269
9985025|NCT01624259|11106885|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269
9985026|NCT01624259|11106884|FG000|NOT COMPLETED|Overall Study||30
9985027|NCT01624259|11106885|FG001|NOT COMPLETED|Overall Study||31
9985028|NCT01624350|11106893|FG000|STARTED|Overall Study||100
9985029|NCT01624350|11106893|FG000|COMPLETED|Overall Study||75
9985030|NCT01624350|11106893|FG000|NOT COMPLETED|Overall Study||25
9985031|NCT01624363|11106913|FG000|STARTED|Overall Study||341
9985032|NCT01624363|11106913|FG000|COMPLETED|Overall Study||341
9985033|NCT01624363|11106913|FG000|NOT COMPLETED|Overall Study||0
9985034|NCT01624467|11106917|FG000|STARTED|Overall Study||75
9985035|NCT01624467|11106917|FG000|Received at Least One Dose of Study Drug|Overall Study||75
9985036|NCT01624467|11106917|FG000|COMPLETED|Overall Study||44
9985037|NCT01624467|11106917|FG000|NOT COMPLETED|Overall Study||31
9985038|NCT01624506|11106925|FG000|STARTED|Overall Study||530
9985039|NCT01624506|11106926|FG001|STARTED|Overall Study||230
9985040|NCT01624506|11106925|FG000|COMPLETED|Overall Study||465
9985041|NCT01624506|11106926|FG001|COMPLETED|Overall Study||213
9985042|NCT01624506|11106925|FG000|NOT COMPLETED|Overall Study||65
9985043|NCT01624506|11106926|FG001|NOT COMPLETED|Overall Study||17
9985044|NCT01624662|11106936|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
9985045|NCT01624662|11106937|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
9985046|NCT01624662|11106938|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
9985047|NCT01624662|11106939|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
9985048|NCT01624662|11106936|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
9985049|NCT01624662|11106937|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
9985050|NCT01624662|11106938|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
9985051|NCT01624662|11106939|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
9985052|NCT01624662|11106936|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
9985053|NCT01624662|11106937|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
9985054|NCT01624662|11106938|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
9985055|NCT01624662|11106939|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
9985056|NCT01624662|11106936|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70
9985057|NCT01624662|11106937|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78
9985058|NCT01624662|11106938|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72
9985059|NCT01624662|11106939|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79
9985060|NCT01624662|11106936|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
9985061|NCT01624662|11106937|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
9985062|NCT01624662|11106938|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
9985063|NCT01624662|11106939|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
9985064|NCT01624662|11106936|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
9985065|NCT01624662|11106937|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
9985066|NCT01624662|11106938|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
9985067|NCT01624662|11106939|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
9985068|NCT01624870|11106960|FG000|STARTED|Overall Study|provided informed consent|200
9985069|NCT01624870|11106960|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173
9985070|NCT01624870|11106960|FG000|NOT COMPLETED|Overall Study||27
9985071|NCT01624740|11106968|FG000|STARTED|First Intervention (3-4 Days)||9
9985072|NCT01624740|11106969|FG001|STARTED|First Intervention (3-4 Days)||9
9985073|NCT01624740|11106968|FG000|COMPLETED|First Intervention (3-4 Days)||9
9985074|NCT01624740|11106969|FG001|COMPLETED|First Intervention (3-4 Days)||9
9985075|NCT01624740|11106968|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0
9985076|NCT01624740|11106969|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0
9985077|NCT01624740|11106968|FG000|STARTED|Washout (1 Hour)||9
9985078|NCT01624740|11106969|FG001|STARTED|Washout (1 Hour)||9
9985079|NCT01624740|11106968|FG000|COMPLETED|Washout (1 Hour)||9
9985080|NCT01624740|11106969|FG001|COMPLETED|Washout (1 Hour)||9
9985081|NCT01624740|11106968|FG000|NOT COMPLETED|Washout (1 Hour)||0
9985082|NCT01624740|11106969|FG001|NOT COMPLETED|Washout (1 Hour)||0
9985083|NCT01624740|11106968|FG000|STARTED|Second Intervention (3-4 Days)||9
9985084|NCT01624740|11106969|FG001|STARTED|Second Intervention (3-4 Days)||9
9985085|NCT01624740|11106968|FG000|COMPLETED|Second Intervention (3-4 Days)||8
9985086|NCT01624740|11106969|FG001|COMPLETED|Second Intervention (3-4 Days)||9
9985087|NCT01624740|11106968|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1
9985088|NCT01624740|11106969|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0
9985089|NCT01624948|11106978|FG000|STARTED|Overall Study||20
9985090|NCT01624948|11106979|FG001|STARTED|Overall Study||20
9985091|NCT01624948|11106978|FG000|COMPLETED|Overall Study||20
9985092|NCT01624948|11106979|FG001|COMPLETED|Overall Study||20
9985093|NCT01624948|11106978|FG000|NOT COMPLETED|Overall Study||0
9985094|NCT01624948|11106979|FG001|NOT COMPLETED|Overall Study||0
9985095|NCT01624974|11106991|FG000|STARTED|Period III of Treatment (4 Weeks)||54
9985096|NCT01624974|11106992|FG001|STARTED|Period III of Treatment (4 Weeks)||53
9985097|NCT01624974|11106991|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47
9985098|NCT01624974|11106992|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45
9985099|NCT01624974|11106991|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
9985100|NCT01624974|11106992|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
9985101|NCT01624974|11106991|FG000|STARTED|Period IV Washout (4 Weeks)||47
9985102|NCT01624974|11106992|FG001|STARTED|Period IV Washout (4 Weeks)||45
9985103|NCT01624974|11106991|FG000|COMPLETED|Period IV Washout (4 Weeks)||44
9985104|NCT01624974|11106992|FG001|COMPLETED|Period IV Washout (4 Weeks)||42
9985105|NCT01624974|11106991|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3
9985106|NCT01624974|11106992|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3
9985107|NCT01624974|11106991|FG000|STARTED|Period V of Treatment (4 Weeks)||44
9985108|NCT01624974|11106992|FG001|STARTED|Period V of Treatment (4 Weeks)||42
9985109|NCT01624974|11106991|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39
9985110|NCT01624974|11106992|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42
9985111|NCT01624974|11106991|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
9985112|NCT01624974|11106992|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
9985113|NCT01625000|11107004|FG000|STARTED|Overall Study||126
9985114|NCT01625000|11107005|FG001|STARTED|Overall Study||133
9985115|NCT01625000|11107006|FG002|STARTED|Overall Study||67
9985116|NCT01625000|11107007|FG003|STARTED|Overall Study||56
9985117|NCT01625000|11107008|FG004|STARTED|Overall Study||126
9985118|NCT01625000|11107004|FG000|COMPLETED|Overall Study||74
9985119|NCT01625000|11107005|FG001|COMPLETED|Overall Study||81
9985120|NCT01625000|11107006|FG002|COMPLETED|Overall Study||34
9985121|NCT01625000|11107007|FG003|COMPLETED|Overall Study||37
9985122|NCT01625000|11107008|FG004|COMPLETED|Overall Study||71
9985123|NCT01625000|11107004|FG000|NOT COMPLETED|Overall Study||52
9985124|NCT01625000|11107005|FG001|NOT COMPLETED|Overall Study||52
9985125|NCT01625000|11107006|FG002|NOT COMPLETED|Overall Study||33
9985126|NCT01625000|11107007|FG003|NOT COMPLETED|Overall Study||19
9985127|NCT01625000|11107008|FG004|NOT COMPLETED|Overall Study||55
9985128|NCT01625013|11107020|FG000|STARTED|Overall Study||51
9985129|NCT01625013|11107020|FG000|COMPLETED|Overall Study||48
9985130|NCT01625013|11107020|FG000|NOT COMPLETED|Overall Study||3
9985131|NCT01625091|11107027|FG000|STARTED|Intervention||96
9985132|NCT01625091|11107028|FG001|STARTED|Intervention||98
9985133|NCT01625091|11107027|FG000|2 Months|Intervention||90
9985134|NCT01625091|11107028|FG001|2 Months|Intervention||93
9985135|NCT01625091|11107027|FG000|4 Months|Intervention||85
9985136|NCT01625091|11107028|FG001|4 Months|Intervention||87
9985137|NCT01625091|11107027|FG000|COMPLETED|Intervention||85
9985138|NCT01625091|11107028|FG001|COMPLETED|Intervention||87
9985139|NCT01625091|11107027|FG000|NOT COMPLETED|Intervention||11
9985140|NCT01625091|11107028|FG001|NOT COMPLETED|Intervention||11
9985141|NCT01625091|11107027|FG000|STARTED|Post-intervention||85
9985142|NCT01625091|11107028|FG001|STARTED|Post-intervention||87
9985143|NCT01625091|11107027|FG000|7 Months|Post-intervention||81
9985144|NCT01625091|11107028|FG001|7 Months|Post-intervention||85
9985145|NCT01625091|11107027|FG000|COMPLETED|Post-intervention||81
9985146|NCT01625091|11107028|FG001|COMPLETED|Post-intervention||85
9985147|NCT01625091|11107027|FG000|NOT COMPLETED|Post-intervention||4
9985148|NCT01625091|11107028|FG001|NOT COMPLETED|Post-intervention||2
9985149|NCT01625104|11107036|FG000|STARTED|Overall Study||448
9985150|NCT01625104|11107037|FG001|STARTED|Overall Study||434
9985151|NCT01625104|11107036|FG000|COMPLETED|Overall Study||448
9985152|NCT01625104|11107037|FG001|COMPLETED|Overall Study||434
9985153|NCT01625104|11107036|FG000|NOT COMPLETED|Overall Study||0
9985154|NCT01625104|11107037|FG001|NOT COMPLETED|Overall Study||0
9985155|NCT01625169|11107043|FG000|STARTED|Overall Study||9
9985156|NCT01625169|11107043|FG000|COMPLETED|Overall Study||9
9985157|NCT01625169|11107043|FG000|NOT COMPLETED|Overall Study||0
9985158|NCT01625182|11107049|FG000|STARTED|Overall Study||54
9985159|NCT01625182|11107050|FG001|STARTED|Overall Study||52
9985160|NCT01625182|11107049|FG000|COMPLETED|Overall Study||34
9985161|NCT01625182|11107050|FG001|COMPLETED|Overall Study||41
10101165|NCT02405442|11230404|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0
10101166|NCT02405442|11230405|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0
10101167|NCT02405442|11230402|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
10101168|NCT02405442|11230403|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
10101169|NCT02405442|11230404|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
10101170|NCT02405442|11230405|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
10101171|NCT02405780|11230423|FG000|STARTED|Period I||216
10101172|NCT02405780|11230424|FG001|STARTED|Period I||108
10101173|NCT02405780|11230425|FG002|STARTED|Period I||108
10101174|NCT02405780|11230426|FG003|STARTED|Period I||213
9985162|NCT01625182|11107049|FG000|NOT COMPLETED|Overall Study||20
9985163|NCT01625182|11107050|FG001|NOT COMPLETED|Overall Study||11
9985164|NCT01625221|11107057|FG000|STARTED|Overall Study||35
9985165|NCT01625221|11107057|FG000|COMPLETED|Overall Study||28
9985166|NCT01625221|11107057|FG000|NOT COMPLETED|Overall Study||7
9985167|NCT01625338|11107064|FG000|STARTED|Overall Study||114
9985168|NCT01625338|11107065|FG001|STARTED|Overall Study||200
9985169|NCT01625338|11107066|FG002|STARTED|Overall Study||220
9985170|NCT01625338|11107064|FG000|COMPLETED|Overall Study||82
9985171|NCT01625338|11107065|FG001|COMPLETED|Overall Study||156
9985172|NCT01625338|11107066|FG002|COMPLETED|Overall Study||181
9985173|NCT01625338|11107064|FG000|NOT COMPLETED|Overall Study||32
9985174|NCT01625338|11107065|FG001|NOT COMPLETED|Overall Study||44
9985175|NCT01625338|11107066|FG002|NOT COMPLETED|Overall Study||39
9985176|NCT01625377|11107076|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95
9985177|NCT01625377|11107077|FG001|STARTED|Overall Study||93
9985178|NCT01625377|11107076|FG000|Safety Set of Population|Overall Study||94
9985179|NCT01625377|11107077|FG001|Safety Set of Population|Overall Study||90
9985180|NCT01625377|11107076|FG000|Intent to Treat Population|Overall Study||93
9985181|NCT01625377|11107077|FG001|Intent to Treat Population|Overall Study||90
9985182|NCT01625377|11107076|FG000|COMPLETED|Overall Study||88
9985183|NCT01625377|11107077|FG001|COMPLETED|Overall Study||71
9985184|NCT01625377|11107076|FG000|NOT COMPLETED|Overall Study||7
9985185|NCT01625377|11107077|FG001|NOT COMPLETED|Overall Study||22
9985186|NCT01625416|11107085|FG000|STARTED|Overall Study||60
9985187|NCT01625416|11107086|FG001|STARTED|Overall Study||61
9985188|NCT01625416|11107085|FG000|COMPLETED|Overall Study||51
9985189|NCT01625416|11107086|FG001|COMPLETED|Overall Study||54
9985190|NCT01625416|11107085|FG000|NOT COMPLETED|Overall Study||9
9985191|NCT01625416|11107086|FG001|NOT COMPLETED|Overall Study||7
9985192|NCT01625455|11107095|FG000|STARTED|Overall Study||2
9985193|NCT01625455|11107096|FG001|STARTED|Overall Study||3
9985194|NCT01625455|11107095|FG000|COMPLETED|Overall Study||2
9985195|NCT01625455|11107096|FG001|COMPLETED|Overall Study||3
9985196|NCT01625455|11107095|FG000|NOT COMPLETED|Overall Study||0
9985197|NCT01625455|11107096|FG001|NOT COMPLETED|Overall Study||0
9985198|NCT01625507|11107102|FG000|STARTED|Overall Study||73
9985199|NCT01625507|11107102|FG000|COMPLETED|Overall Study||63
9985200|NCT01625507|11107102|FG000|NOT COMPLETED|Overall Study||10
9985201|NCT01625689|11107109|FG000|STARTED|Overall Study||150
9985202|NCT01625689|11107110|FG001|STARTED|Overall Study||150
9985203|NCT01625689|11107109|FG000|COMPLETED|Overall Study||148
9985204|NCT01625689|11107110|FG001|COMPLETED|Overall Study||149
9985205|NCT01625689|11107109|FG000|NOT COMPLETED|Overall Study||2
9985206|NCT01625689|11107110|FG001|NOT COMPLETED|Overall Study||1
9985207|NCT01625845|11107118|FG000|STARTED|Overall Study||10
9985208|NCT01625845|11107119|FG001|STARTED|Overall Study||6
9985209|NCT01625845|11107118|FG000|COMPLETED|Overall Study||5
9985210|NCT01625845|11107119|FG001|COMPLETED|Overall Study||3
9985211|NCT01625845|11107118|FG000|NOT COMPLETED|Overall Study||5
9985212|NCT01625845|11107119|FG001|NOT COMPLETED|Overall Study||3
9985213|NCT01625897|11107127|FG000|STARTED|Overall Study||83
9985214|NCT01625897|11107128|FG001|STARTED|Overall Study||42
9985215|NCT01625897|11107127|FG000|COMPLETED|Overall Study||31
9985216|NCT01625897|11107128|FG001|COMPLETED|Overall Study||28
9985217|NCT01625897|11107127|FG000|NOT COMPLETED|Overall Study||52
9985218|NCT01625897|11107128|FG001|NOT COMPLETED|Overall Study||14
9985219|NCT01625910|11107136|FG000|STARTED|Overall Study||35
9985220|NCT01625910|11107137|FG001|STARTED|Overall Study||37
9985221|NCT01625910|11107136|FG000|COMPLETED|Overall Study||32
9985222|NCT01625910|11107137|FG001|COMPLETED|Overall Study||33
9985223|NCT01625910|11107136|FG000|NOT COMPLETED|Overall Study||3
9985224|NCT01625910|11107137|FG001|NOT COMPLETED|Overall Study||4
9985225|NCT01625923|11107145|FG000|STARTED|Overall Study||3
9985226|NCT01625923|11107145|FG000|COMPLETED|Overall Study||3
9985227|NCT01625923|11107145|FG000|NOT COMPLETED|Overall Study||0
10018113|NCT01821807|11141085|FG001|COMPLETED|Overall Study||109
10018114|NCT01821807|11141084|FG000|NOT COMPLETED|Overall Study||3
10018115|NCT01821807|11141085|FG001|NOT COMPLETED|Overall Study||1
10018116|NCT01821937|11141093|FG000|STARTED|Overall Study||10
10018117|NCT01821937|11141094|FG001|STARTED|Overall Study||15
10018118|NCT01821937|11141093|FG000|COMPLETED|Overall Study||10
10018119|NCT01821937|11141094|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
10018120|NCT01821937|11141093|FG000|NOT COMPLETED|Overall Study||0
10018121|NCT01821937|11141094|FG001|NOT COMPLETED|Overall Study||3
10018122|NCT01822119|11141102|FG000|STARTED|Overall Study||27
9985228|NCT01625988|11107152|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
9985229|NCT01625988|11107153|FG001|STARTED|Overall Study||110
9985230|NCT01625988|11107152|FG000|Received at Least One Dose of Study Drug|Overall Study||107
9985231|NCT01625988|11107153|FG001|Received at Least One Dose of Study Drug|Overall Study||110
9985232|NCT01625988|11107152|FG000|COMPLETED|Overall Study||94
9985233|NCT01625988|11107153|FG001|COMPLETED|Overall Study||97
9985234|NCT01625988|11107152|FG000|NOT COMPLETED|Overall Study||14
9985235|NCT01625988|11107153|FG001|NOT COMPLETED|Overall Study||13
9985236|NCT01626092|11107162|FG000|STARTED|Overall Study||3
9985237|NCT01626092|11107162|FG000|COMPLETED|Overall Study||3
9985238|NCT01626092|11107162|FG000|NOT COMPLETED|Overall Study||0
9985239|NCT01626118|11107170|FG000|STARTED|Overall Study||94
9985240|NCT01626118|11107171|FG001|STARTED|Overall Study||93
9985241|NCT01626118|11107172|FG002|STARTED|Overall Study||92
9985242|NCT01626118|11107173|FG003|STARTED|Overall Study||94
9985243|NCT01626118|11107170|FG000|COMPLETED|Overall Study||92
9985244|NCT01626118|11107171|FG001|COMPLETED|Overall Study||91
9985245|NCT01626118|11107172|FG002|COMPLETED|Overall Study||90
9985246|NCT01626118|11107173|FG003|COMPLETED|Overall Study||91
9985247|NCT01626118|11107170|FG000|NOT COMPLETED|Overall Study||2
9985248|NCT01626118|11107171|FG001|NOT COMPLETED|Overall Study||2
9985249|NCT01626118|11107172|FG002|NOT COMPLETED|Overall Study||2
9985250|NCT01626118|11107173|FG003|NOT COMPLETED|Overall Study||3
9985251|NCT01626352|11107183|FG000|STARTED|Overall Study||22
9985252|NCT01626352|11107183|FG000|COMPLETED|Overall Study||12
9985253|NCT01626352|11107183|FG000|NOT COMPLETED|Overall Study||10
9985254|NCT01626391|11107192|FG000|STARTED|Overall Study||5
9985255|NCT01626391|11107193|FG001|STARTED|Overall Study||4
9985256|NCT01626391|11107192|FG000|COMPLETED|Overall Study||3
9985257|NCT01626391|11107193|FG001|COMPLETED|Overall Study||4
9985258|NCT01626391|11107192|FG000|NOT COMPLETED|Overall Study||2
9985259|NCT01626391|11107193|FG001|NOT COMPLETED|Overall Study||0
9985260|NCT01626456|11107201|FG000|STARTED|Overall Study||110
9985261|NCT01626456|11107202|FG001|STARTED|Overall Study||368
9985262|NCT01626456|11107201|FG000|COMPLETED|Overall Study||75
9985263|NCT01626456|11107202|FG001|COMPLETED|Overall Study||251
9985264|NCT01626456|11107201|FG000|NOT COMPLETED|Overall Study||35
9985265|NCT01626456|11107202|FG001|NOT COMPLETED|Overall Study||117
9985266|NCT01626495|11107217|FG000|STARTED|Overall Study|Number of enrolled subjects|73
9985267|NCT01626495|11107217|FG000|Intervention|Overall Study||62
9985268|NCT01626495|11107217|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
9985269|NCT01626495|11107217|FG000|NOT COMPLETED|Overall Study||52
9985270|NCT01626664|11107223|FG000|STARTED|Randomization Period||47
9985271|NCT01626664|11107224|FG001|STARTED|Randomization Period||24
9985272|NCT01626664|11107225|FG002|STARTED|Randomization Period||0
9985273|NCT01626664|11107223|FG000|COMPLETED|Randomization Period||47
9985274|NCT01626664|11107224|FG001|COMPLETED|Randomization Period||24
9985275|NCT01626664|11107225|FG002|COMPLETED|Randomization Period||0
9985276|NCT01626664|11107223|FG000|NOT COMPLETED|Randomization Period||0
9985277|NCT01626664|11107224|FG001|NOT COMPLETED|Randomization Period||0
9985278|NCT01626664|11107225|FG002|NOT COMPLETED|Randomization Period||0
9985279|NCT01626664|11107223|FG000|STARTED|Crossover Period||0
9985280|NCT01626664|11107224|FG001|STARTED|Crossover Period||0
9985281|NCT01626664|11107225|FG002|STARTED|Crossover Period||18
9985282|NCT01626664|11107223|FG000|COMPLETED|Crossover Period||0
9985283|NCT01626664|11107224|FG001|COMPLETED|Crossover Period||0
9985284|NCT01626664|11107225|FG002|COMPLETED|Crossover Period||18
9985285|NCT01626664|11107223|FG000|NOT COMPLETED|Crossover Period||0
9985286|NCT01626664|11107224|FG001|NOT COMPLETED|Crossover Period||0
9985287|NCT01626664|11107225|FG002|NOT COMPLETED|Crossover Period||0
9985288|NCT01626690|11107234|FG000|STARTED|Overall Study||49
9985289|NCT01626690|11107235|FG001|STARTED|Overall Study||51
9985290|NCT01626690|11107234|FG000|COMPLETED|Overall Study||47
9985291|NCT01626690|11107235|FG001|COMPLETED|Overall Study||51
9985292|NCT01626690|11107234|FG000|NOT COMPLETED|Overall Study||2
9985293|NCT01626690|11107235|FG001|NOT COMPLETED|Overall Study||0
9985294|NCT01626820|11107245|FG000|STARTED|Overall Study||56
9985295|NCT01626820|11107246|FG001|STARTED|Overall Study||57
9985296|NCT01626820|11107245|FG000|COMPLETED|Overall Study||56
9985297|NCT01626820|11107246|FG001|COMPLETED|Overall Study||57
9985298|NCT01626820|11107245|FG000|NOT COMPLETED|Overall Study||0
9985299|NCT01626820|11107246|FG001|NOT COMPLETED|Overall Study||0
9985300|NCT01626859|11107256|FG000|STARTED|Overall Study||11
9985301|NCT01626859|11107257|FG001|STARTED|Overall Study||16
9985302|NCT01626859|11107258|FG002|STARTED|Overall Study||11
9985303|NCT01626859|11107256|FG000|COMPLETED|Overall Study||9
9985304|NCT01626859|11107257|FG001|COMPLETED|Overall Study||8
9985305|NCT01626859|11107258|FG002|COMPLETED|Overall Study||7
9985306|NCT01626859|11107256|FG000|NOT COMPLETED|Overall Study||2
9985307|NCT01626859|11107257|FG001|NOT COMPLETED|Overall Study||8
9985308|NCT01626859|11107258|FG002|NOT COMPLETED|Overall Study||4
9985309|NCT01626872|11107269|FG000|STARTED|Overall Study||81
9985310|NCT01626872|11107270|FG001|STARTED|Overall Study||109
9985311|NCT01626872|11107271|FG002|STARTED|Overall Study||58
9985312|NCT01626872|11107269|FG000|COMPLETED|Overall Study||29
9985313|NCT01626872|11107270|FG001|COMPLETED|Overall Study||43
9985314|NCT01626872|11107271|FG002|COMPLETED|Overall Study||34
9985315|NCT01626872|11107269|FG000|NOT COMPLETED|Overall Study||52
9985316|NCT01626872|11107270|FG001|NOT COMPLETED|Overall Study||66
9985317|NCT01626872|11107271|FG002|NOT COMPLETED|Overall Study||24
9985318|NCT01626885|11107279|FG000|STARTED|Overall Study||42
9985319|NCT01626885|11107279|FG000|COMPLETED|Overall Study||30
9985320|NCT01626885|11107279|FG000|NOT COMPLETED|Overall Study||12
9985321|NCT01626989|11107283|FG000|STARTED|Screening Period||44
9985322|NCT01626989|11107284|FG001|STARTED|Screening Period||0
9985323|NCT01626989|11107285|FG002|STARTED|Screening Period||0
9985324|NCT01626989|11107283|FG000|COMPLETED|Screening Period||27
9985325|NCT01626989|11107284|FG001|COMPLETED|Screening Period||0
9985326|NCT01626989|11107285|FG002|COMPLETED|Screening Period||0
9985327|NCT01626989|11107283|FG000|NOT COMPLETED|Screening Period||17
9985328|NCT01626989|11107284|FG001|NOT COMPLETED|Screening Period||0
9985329|NCT01626989|11107285|FG002|NOT COMPLETED|Screening Period||0
9985330|NCT01626989|11107283|FG000|STARTED|Fist Intervention (Night 1)||0
9985331|NCT01626989|11107284|FG001|STARTED|Fist Intervention (Night 1)||15
9985332|NCT01626989|11107285|FG002|STARTED|Fist Intervention (Night 1)||12
9985333|NCT01626989|11107283|FG000|COMPLETED|Fist Intervention (Night 1)||0
9985334|NCT01626989|11107284|FG001|COMPLETED|Fist Intervention (Night 1)||15
9985335|NCT01626989|11107285|FG002|COMPLETED|Fist Intervention (Night 1)||12
9985336|NCT01626989|11107283|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0
9985337|NCT01626989|11107284|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0
9985338|NCT01626989|11107285|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0
9985339|NCT01626989|11107283|FG000|STARTED|Second Intervention (Night 2)||0
9985340|NCT01626989|11107284|FG001|STARTED|Second Intervention (Night 2)||15
9985341|NCT01626989|11107285|FG002|STARTED|Second Intervention (Night 2)||12
9985342|NCT01626989|11107283|FG000|COMPLETED|Second Intervention (Night 2)||0
9985343|NCT01626989|11107284|FG001|COMPLETED|Second Intervention (Night 2)||15
9985344|NCT01626989|11107285|FG002|COMPLETED|Second Intervention (Night 2)||12
9985345|NCT01626989|11107283|FG000|NOT COMPLETED|Second Intervention (Night 2)||0
9985346|NCT01626989|11107284|FG001|NOT COMPLETED|Second Intervention (Night 2)||0
9985347|NCT01626989|11107285|FG002|NOT COMPLETED|Second Intervention (Night 2)||0
9985348|NCT01627002|11107296|FG000|STARTED|Overall Study||4
9985349|NCT01627002|11107297|FG001|STARTED|Overall Study||4
9985350|NCT01627002|11107298|FG002|STARTED|Overall Study||4
9985351|NCT01627002|11107299|FG003|STARTED|Overall Study||4
9985352|NCT01627002|11107300|FG004|STARTED|Overall Study||2
9985353|NCT01627002|11107301|FG005|STARTED|Overall Study||9
9985354|NCT01627002|11107302|FG006|STARTED|Overall Study||10
9985355|NCT01627002|11107303|FG007|STARTED|Overall Study||5
9985356|NCT01627002|11107304|FG008|STARTED|Overall Study||7
9985357|NCT01627002|11107296|FG000|COMPLETED|Overall Study||4
9985358|NCT01627002|11107297|FG001|COMPLETED|Overall Study||4
9985359|NCT01627002|11107298|FG002|COMPLETED|Overall Study||4
9985360|NCT01627002|11107299|FG003|COMPLETED|Overall Study||4
9985361|NCT01627002|11107300|FG004|COMPLETED|Overall Study||2
9985362|NCT01627002|11107301|FG005|COMPLETED|Overall Study||9
9985363|NCT01627002|11107302|FG006|COMPLETED|Overall Study||10
9985364|NCT01627002|11107303|FG007|COMPLETED|Overall Study||5
9985365|NCT01627002|11107304|FG008|COMPLETED|Overall Study||7
9985366|NCT01627002|11107296|FG000|NOT COMPLETED|Overall Study||0
9985367|NCT01627002|11107297|FG001|NOT COMPLETED|Overall Study||0
9985368|NCT01627002|11107298|FG002|NOT COMPLETED|Overall Study||0
9985369|NCT01627002|11107299|FG003|NOT COMPLETED|Overall Study||0
9985370|NCT01627002|11107300|FG004|NOT COMPLETED|Overall Study||0
9985371|NCT01627002|11107301|FG005|NOT COMPLETED|Overall Study||0
9985372|NCT01627002|11107302|FG006|NOT COMPLETED|Overall Study||0
9985373|NCT01627002|11107303|FG007|NOT COMPLETED|Overall Study||0
9985374|NCT01627002|11107304|FG008|NOT COMPLETED|Overall Study||0
9985375|NCT01627067|11107331|FG000|STARTED|Overall Study||23
9985376|NCT01627067|11107331|FG000|COMPLETED|Overall Study||22
9985377|NCT01627067|11107331|FG000|NOT COMPLETED|Overall Study||1
9985378|NCT01627249|11107340|FG000|STARTED|Overall Study||224
9985379|NCT01627249|11107341|FG001|STARTED|Overall Study||218
9985380|NCT01627249|11107342|FG002|STARTED|Overall Study||218
9985381|NCT01627249|11107340|FG000|COMPLETED|Overall Study||208
9985382|NCT01627249|11107341|FG001|COMPLETED|Overall Study||206
9985383|NCT01627249|11107342|FG002|COMPLETED|Overall Study||206
9985384|NCT01627249|11107340|FG000|NOT COMPLETED|Overall Study||16
9985385|NCT01627249|11107341|FG001|NOT COMPLETED|Overall Study||12
9985386|NCT01627249|11107342|FG002|NOT COMPLETED|Overall Study||12
9985387|NCT01627288|11107354|FG000|STARTED|Overall Study||3
9985388|NCT01627288|11107355|FG001|STARTED|Overall Study||3
9985389|NCT01627288|11107356|FG002|STARTED|Overall Study||6
9985390|NCT01627288|11107357|FG003|STARTED|Overall Study||0
9985391|NCT01627288|11107354|FG000|COMPLETED|Overall Study||3
9985392|NCT01627288|11107355|FG001|COMPLETED|Overall Study||3
9985393|NCT01627288|11107356|FG002|COMPLETED|Overall Study||6
9985394|NCT01627288|11107357|FG003|COMPLETED|Overall Study||0
9985395|NCT01627288|11107354|FG000|NOT COMPLETED|Overall Study||0
9985396|NCT01627288|11107355|FG001|NOT COMPLETED|Overall Study||0
9985397|NCT01627288|11107356|FG002|NOT COMPLETED|Overall Study||0
9985398|NCT01627288|11107357|FG003|NOT COMPLETED|Overall Study||0
9985399|NCT01627327|11107371|FG000|STARTED|Overall Study||310
9985400|NCT01627327|11107372|FG001|STARTED|Overall Study||313
9985401|NCT01627327|11107371|FG000|COMPLETED|Overall Study||291
9985402|NCT01627327|11107372|FG001|COMPLETED|Overall Study||274
9985403|NCT01627327|11107371|FG000|NOT COMPLETED|Overall Study||19
9985404|NCT01627327|11107372|FG001|NOT COMPLETED|Overall Study||39
9985405|NCT01627340|11107380|FG000|STARTED|Overall Study||416
9985406|NCT01627340|11107381|FG001|STARTED|Overall Study||258
9985407|NCT01627340|11107380|FG000|COMPLETED|Overall Study||404
9985408|NCT01627340|11107381|FG001|COMPLETED|Overall Study||254
9985409|NCT01627340|11107380|FG000|NOT COMPLETED|Overall Study||12
9985410|NCT01627340|11107381|FG001|NOT COMPLETED|Overall Study||4
9985411|NCT01627691|11107389|FG000|STARTED|Overall Study||250
9985412|NCT01627691|11107389|FG000|Primary Endpoint (30days)|Overall Study||239
9985413|NCT01627691|11107389|FG000|COMPLETED|Overall Study||232
9985414|NCT01627691|11107389|FG000|NOT COMPLETED|Overall Study||18
9985415|NCT01627782|11107397|FG000|STARTED|Overall Study||17
9985416|NCT01627782|11107398|FG001|STARTED|Overall Study||18
9985417|NCT01627782|11107399|FG002|STARTED|Overall Study||16
9985418|NCT01627782|11107400|FG003|STARTED|Overall Study||17
9985419|NCT01627782|11107397|FG000|Treated|Overall Study||16
9985420|NCT01627782|11107398|FG001|Treated|Overall Study||18
9985421|NCT01627782|11107399|FG002|Treated|Overall Study||16
9985422|NCT01627782|11107400|FG003|Treated|Overall Study||17
9985423|NCT01627782|11107397|FG000|COMPLETED|Overall Study||1
9985424|NCT01627782|11107398|FG001|COMPLETED|Overall Study||12
9985425|NCT01627782|11107399|FG002|COMPLETED|Overall Study||1
9985426|NCT01627782|11107400|FG003|COMPLETED|Overall Study||11
9985427|NCT01627782|11107397|FG000|NOT COMPLETED|Overall Study||16
9985428|NCT01627782|11107398|FG001|NOT COMPLETED|Overall Study||6
9985429|NCT01627782|11107399|FG002|NOT COMPLETED|Overall Study||15
9985430|NCT01627782|11107400|FG003|NOT COMPLETED|Overall Study||6
9985431|NCT01627860|11107414|FG000|STARTED|Overall Study||35
9985432|NCT01627860|11107415|FG001|STARTED|Overall Study||20
9985433|NCT01627860|11107414|FG000|COMPLETED|Overall Study||23
9985434|NCT01627860|11107415|FG001|COMPLETED|Overall Study||14
9985435|NCT01627860|11107414|FG000|NOT COMPLETED|Overall Study||12
9985436|NCT01627860|11107415|FG001|NOT COMPLETED|Overall Study||6
9985437|NCT01628016|11107424|FG000|STARTED|Pretraining to Posttraining||27
9985438|NCT01628016|11107425|FG001|STARTED|Pretraining to Posttraining||27
9985439|NCT01628016|11107426|FG002|STARTED|Pretraining to Posttraining||23
9985440|NCT01628016|11107424|FG000|COMPLETED|Pretraining to Posttraining||27
9985441|NCT01628016|11107425|FG001|COMPLETED|Pretraining to Posttraining||27
9985442|NCT01628016|11107426|FG002|COMPLETED|Pretraining to Posttraining||23
9985443|NCT01628016|11107424|FG000|NOT COMPLETED|Pretraining to Posttraining||0
9985444|NCT01628016|11107425|FG001|NOT COMPLETED|Pretraining to Posttraining||0
9985445|NCT01628016|11107426|FG002|NOT COMPLETED|Pretraining to Posttraining||0
9985446|NCT01628016|11107424|FG000|STARTED|Posttraining to 5 Follow-ups||27
9985447|NCT01628016|11107425|FG001|STARTED|Posttraining to 5 Follow-ups||27
9985448|NCT01628016|11107426|FG002|STARTED|Posttraining to 5 Follow-ups||23
9985449|NCT01628016|11107424|FG000|COMPLETED|Posttraining to 5 Follow-ups||23
9985450|NCT01628016|11107425|FG001|COMPLETED|Posttraining to 5 Follow-ups||20
9985451|NCT01628016|11107426|FG002|COMPLETED|Posttraining to 5 Follow-ups||18
9985452|NCT01628016|11107424|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4
9985453|NCT01628016|11107425|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7
9985454|NCT01628016|11107426|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5
9985455|NCT01628042|11107440|FG000|STARTED|Overall Study||8
9985456|NCT01628042|11107441|FG001|STARTED|Overall Study||8
9985457|NCT01628042|11107442|FG002|STARTED|Overall Study||8
10239825|NCT03998189|11371566|FG001|STARTED|Overall Study||1
9985458|NCT01628042|11107443|FG003|STARTED|Overall Study||8
9985459|NCT01628042|11107440|FG000|COMPLETED|Overall Study||8
9985460|NCT01628042|11107441|FG001|COMPLETED|Overall Study||8
9985461|NCT01628042|11107442|FG002|COMPLETED|Overall Study||8
9985462|NCT01628042|11107443|FG003|COMPLETED|Overall Study||8
9985463|NCT01628042|11107440|FG000|NOT COMPLETED|Overall Study||0
9985464|NCT01628042|11107441|FG001|NOT COMPLETED|Overall Study||0
9985465|NCT01628042|11107442|FG002|NOT COMPLETED|Overall Study||0
9985466|NCT01628042|11107443|FG003|NOT COMPLETED|Overall Study||0
9985467|NCT01628107|11107453|FG000|STARTED|Overall Study||414
9985468|NCT01628107|11107453|FG000|Treated|Overall Study||406
9985469|NCT01628107|11107453|FG000|COMPLETED|Overall Study||295
9985470|NCT01628107|11107453|FG000|NOT COMPLETED|Overall Study||119
9985471|NCT01628120|11107457|FG000|STARTED|Overall Study||173
9985472|NCT01628120|11107457|FG000|Treated|Overall Study||170
9985473|NCT01628120|11107457|FG000|COMPLETED|Overall Study||129
9985474|NCT01628120|11107457|FG000|NOT COMPLETED|Overall Study||44
9985475|NCT01628159|11107461|FG000|STARTED|Overall Study||657
9985476|NCT01628159|11107461|FG000|COMPLETED|Overall Study||493
9985477|NCT01628159|11107461|FG000|NOT COMPLETED|Overall Study||164
9985478|NCT01628198|11107465|FG000|STARTED|Overall Study||38
9985479|NCT01628198|11107465|FG000|COMPLETED|Overall Study||20
9985480|NCT01628198|11107465|FG000|NOT COMPLETED|Overall Study||18
10101175|NCT02405780|11230423|FG000|COMPLETED|Period I||189
10101176|NCT02405780|11230424|FG001|COMPLETED|Period I||100
10101177|NCT02405780|11230425|FG002|COMPLETED|Period I||93
10101178|NCT02405780|11230426|FG003|COMPLETED|Period I||190
10101179|NCT02405780|11230423|FG000|NOT COMPLETED|Period I||27
10101180|NCT02405780|11230424|FG001|NOT COMPLETED|Period I||8
10101181|NCT02405780|11230425|FG002|NOT COMPLETED|Period I||15
10101182|NCT02405780|11230426|FG003|NOT COMPLETED|Period I||23
10101183|NCT02405780|11230423|FG000|STARTED|Period II||189
10101184|NCT02405780|11230424|FG001|STARTED|Period II||100
10101185|NCT02405780|11230425|FG002|STARTED|Period II||93
10101186|NCT02405780|11230426|FG003|STARTED|Period II||190
10101187|NCT02405780|11230423|FG000|COMPLETED|Period II||174
10101188|NCT02405780|11230424|FG001|COMPLETED|Period II||88
10101189|NCT02405780|11230425|FG002|COMPLETED|Period II||81
10101190|NCT02405780|11230426|FG003|COMPLETED|Period II||172
10101191|NCT02405780|11230423|FG000|NOT COMPLETED|Period II||15
9985481|NCT01628250|11107471|FG000|STARTED|Overall Study||49
9985482|NCT01628250|11107472|FG001|STARTED|Overall Study||50
9985483|NCT01628250|11107471|FG000|COMPLETED|Overall Study||49
9985484|NCT01628250|11107472|FG001|COMPLETED|Overall Study||50
9985485|NCT01628250|11107471|FG000|NOT COMPLETED|Overall Study||0
9985486|NCT01628250|11107472|FG001|NOT COMPLETED|Overall Study||0
9985487|NCT01628367|11107480|FG000|STARTED|Overall Study||16
9985488|NCT01628367|11107481|FG001|STARTED|Overall Study||16
9985489|NCT01628367|11107480|FG000|COMPLETED|Overall Study||15
9985490|NCT01628367|11107481|FG001|COMPLETED|Overall Study||16
9985491|NCT01628367|11107480|FG000|NOT COMPLETED|Overall Study||1
9985492|NCT01628367|11107481|FG001|NOT COMPLETED|Overall Study||0
9985493|NCT01628393|11107490|FG000|STARTED|Placebo-controlled Treatment Period||88
9985494|NCT01628393|11107491|FG001|STARTED|Placebo-controlled Treatment Period||87
9985495|NCT01628393|11107492|FG002|STARTED|Placebo-controlled Treatment Period||83
9985496|NCT01628393|11107493|FG003|STARTED|Placebo-controlled Treatment Period||0
9985497|NCT01628393|11107494|FG004|STARTED|Placebo-controlled Treatment Period||0
9985498|NCT01628393|11107490|FG000|COMPLETED|Placebo-controlled Treatment Period||85
9985499|NCT01628393|11107491|FG001|COMPLETED|Placebo-controlled Treatment Period||85
9985500|NCT01628393|11107492|FG002|COMPLETED|Placebo-controlled Treatment Period||82
9985501|NCT01628393|11107493|FG003|COMPLETED|Placebo-controlled Treatment Period||0
9985502|NCT01628393|11107494|FG004|COMPLETED|Placebo-controlled Treatment Period||0
9985503|NCT01628393|11107490|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3
9985504|NCT01628393|11107491|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2
9985505|NCT01628393|11107492|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1
9985506|NCT01628393|11107493|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0
9985507|NCT01628393|11107494|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0
9985508|NCT01628393|11107490|FG000|STARTED|Blinded Active Extension Period||0
9985509|NCT01628393|11107491|FG001|STARTED|Blinded Active Extension Period||85
9985510|NCT01628393|11107492|FG002|STARTED|Blinded Active Extension Period||81
9985511|NCT01628393|11107493|FG003|STARTED|Blinded Active Extension Period||41
9985512|NCT01628393|11107494|FG004|STARTED|Blinded Active Extension Period||42
9985513|NCT01628393|11107490|FG000|COMPLETED|Blinded Active Extension Period||0
9985514|NCT01628393|11107491|FG001|COMPLETED|Blinded Active Extension Period||75
9985515|NCT01628393|11107492|FG002|COMPLETED|Blinded Active Extension Period||75
9985516|NCT01628393|11107493|FG003|COMPLETED|Blinded Active Extension Period||37
9985517|NCT01628393|11107494|FG004|COMPLETED|Blinded Active Extension Period||36
9985518|NCT01628393|11107490|FG000|NOT COMPLETED|Blinded Active Extension Period||0
9985519|NCT01628393|11107491|FG001|NOT COMPLETED|Blinded Active Extension Period||10
9985520|NCT01628393|11107492|FG002|NOT COMPLETED|Blinded Active Extension Period||6
9985521|NCT01628393|11107493|FG003|NOT COMPLETED|Blinded Active Extension Period||4
9985522|NCT01628393|11107494|FG004|NOT COMPLETED|Blinded Active Extension Period||6
9985523|NCT01628510|11107510|FG000|STARTED|Overall Study||51
9985524|NCT01628510|11107511|FG001|STARTED|Overall Study||49
9985525|NCT01628510|11107510|FG000|COMPLETED|Overall Study||48
9985526|NCT01628510|11107511|FG001|COMPLETED|Overall Study||44
9985527|NCT01628510|11107510|FG000|NOT COMPLETED|Overall Study||3
9985528|NCT01628510|11107511|FG001|NOT COMPLETED|Overall Study||5
9985529|NCT01628523|11107519|FG000|STARTED|Overall Study||219
9985530|NCT01628523|11107519|FG000|COMPLETED|Overall Study||219
9985531|NCT01628523|11107519|FG000|NOT COMPLETED|Overall Study||0
9985532|NCT01628549|11107528|FG000|STARTED|Overall Study||73
9985533|NCT01628549|11107529|FG001|STARTED|Overall Study||76
9985534|NCT01628549|11107530|FG002|STARTED|Overall Study||70
9985535|NCT01628549|11107531|FG003|STARTED|Overall Study||66
9985536|NCT01628549|11107528|FG000|COMPLETED|Overall Study||64
9985537|NCT01628549|11107529|FG001|COMPLETED|Overall Study||64
9985538|NCT01628549|11107530|FG002|COMPLETED|Overall Study||60
9985539|NCT01628549|11107531|FG003|COMPLETED|Overall Study||57
9985540|NCT01628549|11107528|FG000|NOT COMPLETED|Overall Study||9
9985541|NCT01628549|11107529|FG001|NOT COMPLETED|Overall Study||12
9985542|NCT01628549|11107530|FG002|NOT COMPLETED|Overall Study||10
9985543|NCT01628549|11107531|FG003|NOT COMPLETED|Overall Study||9
9985544|NCT01628588|11107541|FG000|STARTED|Overall Study||854
9985545|NCT01628588|11107541|FG000|COMPLETED|Overall Study||838
9985546|NCT01628588|11107541|FG000|NOT COMPLETED|Overall Study||16
9985547|NCT01628601|11107545|FG000|STARTED|Overall Study||392
9985548|NCT01628601|11107545|FG000|COMPLETED|Overall Study||351
9985549|NCT01628601|11107545|FG000|NOT COMPLETED|Overall Study||41
9985550|NCT01628614|11107549|FG000|STARTED|Overall Study||4812
9985551|NCT01628614|11107549|FG000|COMPLETED|Overall Study||3037
9985552|NCT01628614|11107549|FG000|NOT COMPLETED|Overall Study||1775
9985553|NCT01628692|11107559|FG000|STARTED|Overall Study||53
9985554|NCT01628692|11107560|FG001|STARTED|Overall Study||23
9985555|NCT01628692|11107561|FG002|STARTED|Overall Study||51
9985556|NCT01628692|11107562|FG003|STARTED|Overall Study||20
9985557|NCT01628692|11107563|FG004|STARTED|Overall Study||12
9985558|NCT01628692|11107564|FG005|STARTED|Overall Study||9
9985559|NCT01628692|11107559|FG000|COMPLETED|Overall Study||46
9985560|NCT01628692|11107560|FG001|COMPLETED|Overall Study||17
9985561|NCT01628692|11107561|FG002|COMPLETED|Overall Study||43
9985562|NCT01628692|11107562|FG003|COMPLETED|Overall Study||19
9985563|NCT01628692|11107563|FG004|COMPLETED|Overall Study||8
9985564|NCT01628692|11107564|FG005|COMPLETED|Overall Study||0
9985565|NCT01628692|11107559|FG000|NOT COMPLETED|Overall Study||7
9985566|NCT01628692|11107560|FG001|NOT COMPLETED|Overall Study||6
9985567|NCT01628692|11107561|FG002|NOT COMPLETED|Overall Study||8
9985568|NCT01628692|11107562|FG003|NOT COMPLETED|Overall Study||1
9985569|NCT01628692|11107563|FG004|NOT COMPLETED|Overall Study||4
9985570|NCT01628692|11107564|FG005|NOT COMPLETED|Overall Study||9
9985571|NCT01628718|11107583|FG000|STARTED|Overall Study||60
9985572|NCT01628718|11107584|FG001|STARTED|Overall Study||62
9985573|NCT01628718|11107583|FG000|COMPLETED|Overall Study||33
9985574|NCT01628718|11107584|FG001|COMPLETED|Overall Study||37
9985575|NCT01628718|11107583|FG000|NOT COMPLETED|Overall Study||27
9985576|NCT01628718|11107584|FG001|NOT COMPLETED|Overall Study||25
9985577|NCT01628848|11107592|FG000|STARTED|Overall Study||87
9985578|NCT01628848|11107593|FG001|STARTED|Overall Study||87
9985579|NCT01628848|11107592|FG000|COMPLETED|Overall Study||75
9985580|NCT01628848|11107593|FG001|COMPLETED|Overall Study||73
9985581|NCT01628848|11107592|FG000|NOT COMPLETED|Overall Study||12
9985582|NCT01628848|11107593|FG001|NOT COMPLETED|Overall Study||14
9985583|NCT01628874|11107601|FG000|STARTED|Overall Study||34
9985584|NCT01628874|11107602|FG001|STARTED|Overall Study||32
9985585|NCT01628874|11107601|FG000|COMPLETED|Overall Study||29
9985586|NCT01628874|11107602|FG001|COMPLETED|Overall Study||29
9985587|NCT01628874|11107601|FG000|NOT COMPLETED|Overall Study||5
9985588|NCT01628874|11107602|FG001|NOT COMPLETED|Overall Study||3
9985589|NCT01628913|11107610|FG000|STARTED|Overall Study||31
9985590|NCT01628913|11107611|FG001|STARTED|Overall Study||31
9985591|NCT01628913|11107610|FG000|COMPLETED|Overall Study||0
9985592|NCT01628913|11107611|FG001|COMPLETED|Overall Study||0
9985593|NCT01628913|11107610|FG000|NOT COMPLETED|Overall Study||31
9985594|NCT01628913|11107611|FG001|NOT COMPLETED|Overall Study||31
9985595|NCT01628926|11107620|FG000|STARTED|Overall Study||168
9985596|NCT01628926|11107621|FG001|STARTED|Overall Study||167
9985597|NCT01628926|11107622|FG002|STARTED|Overall Study||85
9985598|NCT01628926|11107620|FG000|COMPLETED|Overall Study||142
9985599|NCT01628926|11107621|FG001|COMPLETED|Overall Study||144
9985600|NCT01628926|11107622|FG002|COMPLETED|Overall Study||68
9985601|NCT01628926|11107620|FG000|NOT COMPLETED|Overall Study||26
9985602|NCT01628926|11107621|FG001|NOT COMPLETED|Overall Study||23
9985603|NCT01628926|11107622|FG002|NOT COMPLETED|Overall Study||17
9985604|NCT01628965|11107631|FG000|STARTED|Overall Study||143
9985605|NCT01628965|11107631|FG000|COMPLETED|Overall Study||94
9985606|NCT01628965|11107631|FG000|NOT COMPLETED|Overall Study||49
9985607|NCT01629134|11107635|FG000|STARTED|Overall Study||62
9985608|NCT01629134|11107635|FG000|COMPLETED|Overall Study||62
9985609|NCT01629134|11107635|FG000|NOT COMPLETED|Overall Study||0
9985610|NCT01629290|11107639|FG000|STARTED|Overall Study||15
9985611|NCT01629290|11107639|FG000|COMPLETED|Overall Study||15
9985612|NCT01629290|11107639|FG000|NOT COMPLETED|Overall Study||0
9985613|NCT01629381|11107651|FG000|STARTED|Overall Study||122
9985614|NCT01629381|11107652|FG001|STARTED|Overall Study||119
9985615|NCT01629381|11107651|FG000|COMPLETED|Overall Study||120
9985616|NCT01629381|11107652|FG001|COMPLETED|Overall Study||114
9985617|NCT01629381|11107651|FG000|NOT COMPLETED|Overall Study||2
9985618|NCT01629381|11107652|FG001|NOT COMPLETED|Overall Study||5
9985619|NCT01629563|11107664|FG000|STARTED|Overall Study||228
9985620|NCT01629563|11107665|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
9985621|NCT01629563|11107664|FG000|Safety Population|Overall Study||230
9985622|NCT01629563|11107665|FG001|Safety Population|Overall Study||221
9985623|NCT01629563|11107664|FG000|Started Treatment Course 2|Overall Study||213
9985624|NCT01629563|11107665|FG001|Started Treatment Course 2|Overall Study||207
9985625|NCT01629563|11107664|FG000|Started Treatment Course 3|Overall Study||191
9985626|NCT01629563|11107665|FG001|Started Treatment Course 3|Overall Study||190
9985627|NCT01629563|11107664|FG000|Started Treatment Course 4|Overall Study||178
9985628|NCT01629563|11107665|FG001|Started Treatment Course 4|Overall Study||176
9985629|NCT01629563|11107664|FG000|COMPLETED|Overall Study||167
9985630|NCT01629563|11107665|FG001|COMPLETED|Overall Study||170
9985631|NCT01629563|11107664|FG000|NOT COMPLETED|Overall Study||61
9985632|NCT01629563|11107665|FG001|NOT COMPLETED|Overall Study||53
9985633|NCT01629589|11107673|FG000|STARTED|Overall Study||212
9985634|NCT01629589|11107674|FG001|STARTED|Overall Study||211
9985635|NCT01629589|11107673|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
9985636|NCT01629589|11107674|FG001|COMPLETED|Overall Study||204
9985637|NCT01629589|11107673|FG000|NOT COMPLETED|Overall Study||8
9985638|NCT01629589|11107674|FG001|NOT COMPLETED|Overall Study||7
9985639|NCT01629615|11107680|FG000|STARTED|Overall Study||50
9985640|NCT01629615|11107680|FG000|COMPLETED|Overall Study||50
9985641|NCT01629615|11107680|FG000|NOT COMPLETED|Overall Study||0
9985642|NCT01629667|11107687|FG000|STARTED|Overall Study||59
9985643|NCT01629667|11107688|FG001|STARTED|Overall Study||58
9985644|NCT01629667|11107689|FG002|STARTED|Overall Study||59
9985645|NCT01629667|11107687|FG000|Randomized and Treated|Overall Study||57
9985646|NCT01629667|11107688|FG001|Randomized and Treated|Overall Study||57
9985647|NCT01629667|11107689|FG002|Randomized and Treated|Overall Study||59
9985648|NCT01629667|11107687|FG000|COMPLETED|Overall Study||12
9985649|NCT01629667|11107688|FG001|COMPLETED|Overall Study||17
9985650|NCT01629667|11107689|FG002|COMPLETED|Overall Study||14
9985651|NCT01629667|11107687|FG000|NOT COMPLETED|Overall Study||47
9985652|NCT01629667|11107688|FG001|NOT COMPLETED|Overall Study||41
9985653|NCT01629667|11107689|FG002|NOT COMPLETED|Overall Study||45
9985654|NCT01629693|11107701|FG000|STARTED|Overall Study||193
9985655|NCT01629693|11107702|FG001|STARTED|Overall Study||188
9985656|NCT01629693|11107701|FG000|COMPLETED|Overall Study||188
9985657|NCT01629693|11107702|FG001|COMPLETED|Overall Study||178
9985658|NCT01629693|11107701|FG000|NOT COMPLETED|Overall Study||5
9985659|NCT01629693|11107702|FG001|NOT COMPLETED|Overall Study||10
9985660|NCT01629706|11107708|FG000|STARTED|Phase 1 PureVision||44
9985661|NCT01629706|11107708|FG000|COMPLETED|Phase 1 PureVision||35
9985662|NCT01629706|11107708|FG000|NOT COMPLETED|Phase 1 PureVision||9
9985663|NCT01629706|11107708|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
9985664|NCT01629706|11107708|FG000|COMPLETED|Phase 2 Habitual||48
9985665|NCT01629706|11107708|FG000|NOT COMPLETED|Phase 2 Habitual||10
9985666|NCT01629771|11107718|FG000|STARTED|Overall Study||36
9985667|NCT01629771|11107719|FG001|STARTED|Overall Study||36
9985668|NCT01629771|11107718|FG000|COMPLETED|Overall Study||36
9985669|NCT01629771|11107719|FG001|COMPLETED|Overall Study||36
9985670|NCT01629771|11107718|FG000|NOT COMPLETED|Overall Study||0
9985671|NCT01629771|11107719|FG001|NOT COMPLETED|Overall Study||0
9985672|NCT01629784|11107725|FG000|STARTED|Overall Study||31
9985673|NCT01629784|11107725|FG000|COMPLETED|Overall Study||25
9985674|NCT01629784|11107725|FG000|NOT COMPLETED|Overall Study||6
9985675|NCT01629797|11107732|FG000|STARTED|Overall Study||100
9985676|NCT01629797|11107732|FG000|COMPLETED|Overall Study||82
9985677|NCT01629797|11107732|FG000|NOT COMPLETED|Overall Study||18
9985678|NCT01629823|11107742|FG000|STARTED|Trial Period||66
9985679|NCT01629823|11107743|FG001|STARTED|Trial Period||69
9985680|NCT01629823|11107744|FG002|STARTED|Trial Period||59
9985681|NCT01629823|11107742|FG000|COMPLETED|Trial Period||53
9985682|NCT01629823|11107743|FG001|COMPLETED|Trial Period||56
9985683|NCT01629823|11107744|FG002|COMPLETED|Trial Period||49
9985684|NCT01629823|11107742|FG000|NOT COMPLETED|Trial Period||13
9985685|NCT01629823|11107743|FG001|NOT COMPLETED|Trial Period||13
9985686|NCT01629823|11107744|FG002|NOT COMPLETED|Trial Period||10
9985687|NCT01629823|11107742|FG000|STARTED|Washout Period||54
9985688|NCT01629823|11107743|FG001|STARTED|Washout Period||57
9985689|NCT01629823|11107744|FG002|STARTED|Washout Period||50
9985690|NCT01629823|11107742|FG000|COMPLETED|Washout Period||51
9985691|NCT01629823|11107743|FG001|COMPLETED|Washout Period||51
9985692|NCT01629823|11107744|FG002|COMPLETED|Washout Period||50
9985693|NCT01629823|11107742|FG000|NOT COMPLETED|Washout Period||3
9985694|NCT01629823|11107743|FG001|NOT COMPLETED|Washout Period||6
9985695|NCT01629823|11107744|FG002|NOT COMPLETED|Washout Period||0
9985696|NCT01629862|11107754|FG000|STARTED|Overall Study||28
9985697|NCT01629862|11107755|FG001|STARTED|Overall Study||25
9985698|NCT01629862|11107754|FG000|COMPLETED|Overall Study||26
9985699|NCT01629862|11107755|FG001|COMPLETED|Overall Study||23
9985700|NCT01629862|11107754|FG000|NOT COMPLETED|Overall Study||2
9985701|NCT01629862|11107755|FG001|NOT COMPLETED|Overall Study||2
9985702|NCT01629953|11107763|FG000|STARTED|Overall Study||65
9985703|NCT01629953|11107764|FG001|STARTED|Overall Study||75
9985704|NCT01629953|11107763|FG000|COMPLETED|Overall Study||52
9985705|NCT01629953|11107764|FG001|COMPLETED|Overall Study||60
9985706|NCT01629953|11107763|FG000|NOT COMPLETED|Overall Study||13
9985707|NCT01629953|11107764|FG001|NOT COMPLETED|Overall Study||15
9985708|NCT01629966|11107773|FG000|STARTED|Overall Study||221
9985709|NCT01629966|11107774|FG001|STARTED|Overall Study||227
9985710|NCT01629966|11107775|FG002|STARTED|Overall Study||225
9985711|NCT01629966|11107773|FG000|COMPLETED|Overall Study||180
9985712|NCT01629966|11107774|FG001|COMPLETED|Overall Study||175
9985713|NCT01629966|11107775|FG002|COMPLETED|Overall Study||159
9985714|NCT01629966|11107773|FG000|NOT COMPLETED|Overall Study||41
9985715|NCT01629966|11107774|FG001|NOT COMPLETED|Overall Study||52
9985716|NCT01629966|11107775|FG002|NOT COMPLETED|Overall Study||66
10018123|NCT01822119|11141102|FG000|COMPLETED|Overall Study||27
10018124|NCT01822119|11141102|FG000|NOT COMPLETED|Overall Study||0
10018125|NCT01822132|11141108|FG000|STARTED|Overall Study||25
10018126|NCT01822132|11141109|FG001|STARTED|Overall Study||27
10018127|NCT01822132|11141108|FG000|COMPLETED|Overall Study||21
10018128|NCT01822132|11141109|FG001|COMPLETED|Overall Study||25
10018129|NCT01822132|11141108|FG000|NOT COMPLETED|Overall Study||4
10018130|NCT01822132|11141109|FG001|NOT COMPLETED|Overall Study||2
10018131|NCT01822197|11141121|FG000|STARTED|Overall Study||30
10018132|NCT01822197|11141121|FG000|COMPLETED|Overall Study||30
10018133|NCT01822197|11141121|FG000|NOT COMPLETED|Overall Study||0
10018134|NCT01822223|11141127|FG000|STARTED|Overall Study||10
10018135|NCT01822223|11141128|FG001|STARTED|Overall Study||10
10018136|NCT01822223|11141127|FG000|COMPLETED|Overall Study||10
10018137|NCT01822223|11141128|FG001|COMPLETED|Overall Study||9
10018138|NCT01822223|11141127|FG000|NOT COMPLETED|Overall Study||0
10018139|NCT01822223|11141128|FG001|NOT COMPLETED|Overall Study||1
10018140|NCT01822301|11141136|FG000|STARTED|Overall Study||5
10018141|NCT01822301|11141136|FG000|COMPLETED|Overall Study||5
10018142|NCT01822301|11141136|FG000|NOT COMPLETED|Overall Study||0
10018143|NCT01822353|11141149|FG000|STARTED|Overall Study||10
10018144|NCT01822353|11141150|FG001|STARTED|Overall Study||9
10018145|NCT01822353|11141151|FG002|STARTED|Overall Study||4
10018146|NCT01822353|11141149|FG000|COMPLETED|Overall Study||6
10018147|NCT01822353|11141150|FG001|COMPLETED|Overall Study||4
10018148|NCT01822353|11141151|FG002|COMPLETED|Overall Study||3
10018149|NCT01822353|11141149|FG000|NOT COMPLETED|Overall Study||4
10018150|NCT01822353|11141150|FG001|NOT COMPLETED|Overall Study||5
10018151|NCT01822353|11141151|FG002|NOT COMPLETED|Overall Study||1
10018152|NCT01822366|11141166|FG000|STARTED|Overall Study||320
10018153|NCT01822366|11141167|FG001|STARTED|Overall Study||320
10018154|NCT01822366|11141168|FG002|STARTED|Overall Study||320
10018155|NCT01822366|11141169|FG003|STARTED|Overall Study||320
9985717|NCT01630109|11107786|FG000|STARTED|Overall Study||1
9985718|NCT01630109|11107787|FG001|STARTED|Overall Study||1
9985719|NCT01630109|11107788|FG002|STARTED|Overall Study||3
9985720|NCT01630109|11107786|FG000|COMPLETED|Overall Study||1
9985721|NCT01630109|11107787|FG001|COMPLETED|Overall Study||1
9985722|NCT01630109|11107788|FG002|COMPLETED|Overall Study||3
9985723|NCT01630109|11107786|FG000|NOT COMPLETED|Overall Study||0
9985724|NCT01630109|11107787|FG001|NOT COMPLETED|Overall Study||0
9985725|NCT01630109|11107788|FG002|NOT COMPLETED|Overall Study||0
9985726|NCT01630135|11107804|FG000|STARTED|Overall Study||131
9985727|NCT01630135|11107805|FG001|STARTED|Overall Study||130
9985728|NCT01630135|11107804|FG000|COMPLETED|Overall Study||131
9985729|NCT01630135|11107805|FG001|COMPLETED|Overall Study||128
9985730|NCT01630135|11107804|FG000|NOT COMPLETED|Overall Study||0
9985731|NCT01630135|11107805|FG001|NOT COMPLETED|Overall Study||2
9985732|NCT01630200|11107813|FG000|STARTED|Overall Study||40
9985733|NCT01630200|11107814|FG001|STARTED|Overall Study||40
9985734|NCT01630200|11107813|FG000|COMPLETED|Overall Study||33
9985735|NCT01630200|11107814|FG001|COMPLETED|Overall Study||34
9985736|NCT01630200|11107813|FG000|NOT COMPLETED|Overall Study||7
9985737|NCT01630200|11107814|FG001|NOT COMPLETED|Overall Study||6
9985738|NCT01630616|11107826|FG000|STARTED|Overall Study||5
9985739|NCT01630616|11107827|FG001|STARTED|Overall Study||3
9985740|NCT01630616|11107828|FG002|STARTED|Overall Study||3
9985741|NCT01630616|11107829|FG003|STARTED|Overall Study||12
9985742|NCT01630616|11107830|FG004|STARTED|Overall Study||6
9985743|NCT01630616|11107831|FG005|STARTED|Overall Study||2
9985744|NCT01630616|11107826|FG000|COMPLETED|Overall Study||5
9985745|NCT01630616|11107827|FG001|COMPLETED|Overall Study||3
9985746|NCT01630616|11107828|FG002|COMPLETED|Overall Study||3
9985747|NCT01630616|11107829|FG003|COMPLETED|Overall Study||9
9985748|NCT01630616|11107830|FG004|COMPLETED|Overall Study||6
9985749|NCT01630616|11107831|FG005|COMPLETED|Overall Study||2
9985750|NCT01630616|11107826|FG000|NOT COMPLETED|Overall Study||0
9985751|NCT01630616|11107827|FG001|NOT COMPLETED|Overall Study||0
9985752|NCT01630616|11107828|FG002|NOT COMPLETED|Overall Study||0
9985753|NCT01630616|11107829|FG003|NOT COMPLETED|Overall Study||3
9985754|NCT01630616|11107830|FG004|NOT COMPLETED|Overall Study||0
9985755|NCT01630616|11107831|FG005|NOT COMPLETED|Overall Study||0
9985756|NCT01630694|11107850|FG000|STARTED|Overall Study||12
9985757|NCT01630694|11107851|FG001|STARTED|Overall Study||16
9985758|NCT01630694|11107850|FG000|COMPLETED|Overall Study||12
9985759|NCT01630694|11107851|FG001|COMPLETED|Overall Study||16
9985760|NCT01630694|11107850|FG000|NOT COMPLETED|Overall Study||0
9985761|NCT01630694|11107851|FG001|NOT COMPLETED|Overall Study||0
9985762|NCT01630811|11107857|FG000|STARTED|First Intervention (8 Weeks)||7
9985763|NCT01630811|11107858|FG001|STARTED|First Intervention (8 Weeks)||6
9985764|NCT01630811|11107857|FG000|COMPLETED|First Intervention (8 Weeks)||7
9985765|NCT01630811|11107858|FG001|COMPLETED|First Intervention (8 Weeks)||6
9985766|NCT01630811|11107857|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
9985767|NCT01630811|11107858|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
9985768|NCT01630811|11107857|FG000|STARTED|Washout (4 Weeks)||7
9985769|NCT01630811|11107858|FG001|STARTED|Washout (4 Weeks)||6
9985770|NCT01630811|11107857|FG000|COMPLETED|Washout (4 Weeks)||7
9985771|NCT01630811|11107858|FG001|COMPLETED|Washout (4 Weeks)||6
9985772|NCT01630811|11107857|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9985773|NCT01630811|11107858|FG001|NOT COMPLETED|Washout (4 Weeks)||0
9985774|NCT01630811|11107857|FG000|STARTED|Second Intervention (8 Weeks)||7
9985775|NCT01630811|11107858|FG001|STARTED|Second Intervention (8 Weeks)||6
9985776|NCT01630811|11107857|FG000|COMPLETED|Second Intervention (8 Weeks)||6
9985777|NCT01630811|11107858|FG001|COMPLETED|Second Intervention (8 Weeks)||6
9985778|NCT01630811|11107857|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1
9985779|NCT01630811|11107858|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
9985780|NCT01630811|11107857|FG000|STARTED|Second Washout (4 Weeks)||6
9985781|NCT01630811|11107858|FG001|STARTED|Second Washout (4 Weeks)||6
9985782|NCT01630811|11107857|FG000|COMPLETED|Second Washout (4 Weeks)||6
9985783|NCT01630811|11107858|FG001|COMPLETED|Second Washout (4 Weeks)||6
9985784|NCT01630811|11107857|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0
9985785|NCT01630811|11107858|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0
9985786|NCT01630889|11107866|FG000|STARTED|Overall Study||15
9985787|NCT01630889|11107866|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
9985788|NCT01630889|11107866|FG000|COMPLETED|Overall Study||5
9985789|NCT01630889|11107866|FG000|NOT COMPLETED|Overall Study||10
9985790|NCT01631071|11107872|FG000|STARTED|Overall Study||55
9985791|NCT01631071|11107873|FG001|STARTED|Overall Study||55
9985792|NCT01631071|11107872|FG000|COMPLETED|Overall Study||55
9985793|NCT01631071|11107873|FG001|COMPLETED|Overall Study||55
9985794|NCT01631071|11107872|FG000|NOT COMPLETED|Overall Study||0
9985795|NCT01631071|11107873|FG001|NOT COMPLETED|Overall Study||0
9985796|NCT01631110|11107881|FG000|STARTED|Overall Study||55
9985797|NCT01631110|11107882|FG001|STARTED|Overall Study||55
9985798|NCT01631110|11107881|FG000|COMPLETED|Overall Study||55
9985799|NCT01631110|11107882|FG001|COMPLETED|Overall Study||55
9985800|NCT01631110|11107881|FG000|NOT COMPLETED|Overall Study||0
9985801|NCT01631110|11107882|FG001|NOT COMPLETED|Overall Study||0
9985802|NCT01631149|11107890|FG000|STARTED|Overall Study||12
9985803|NCT01631149|11107891|FG001|STARTED|Overall Study||12
9985804|NCT01631149|11107890|FG000|COMPLETED|Overall Study||12
9985805|NCT01631149|11107891|FG001|COMPLETED|Overall Study||12
9985806|NCT01631149|11107890|FG000|NOT COMPLETED|Overall Study||0
9985807|NCT01631149|11107891|FG001|NOT COMPLETED|Overall Study||0
9985808|NCT01631188|11107897|FG000|STARTED|Overall Study||100
9985809|NCT01631188|11107897|FG000|COMPLETED|Overall Study||25
9985810|NCT01631188|11107897|FG000|NOT COMPLETED|Overall Study||75
9985811|NCT01631214|11107903|FG000|STARTED|Overall Study||2047
9985812|NCT01631214|11107904|FG001|STARTED|Overall Study||2046
9985813|NCT01631214|11107903|FG000|Received Double-blind Treatment|Overall Study||2040
9985814|NCT01631214|11107904|FG001|Received Double-blind Treatment|Overall Study||2038
9985815|NCT01631214|11107903|FG000|Completed Double-blind Period|Overall Study||1823
9985816|NCT01631214|11107904|FG001|Completed Double-blind Period|Overall Study||1831
9985817|NCT01631214|11107903|FG000|Completed Primary Analysis Period|Overall Study||1576
9985818|NCT01631214|11107904|FG001|Completed Primary Analysis Period|Overall Study||1574
9985819|NCT01631214|11107903|FG000|COMPLETED|Overall Study||1503
9985820|NCT01631214|11107904|FG001|COMPLETED|Overall Study||1523
9985821|NCT01631214|11107903|FG000|NOT COMPLETED|Overall Study||544
9985822|NCT01631214|11107904|FG001|NOT COMPLETED|Overall Study||523
9985823|NCT01631227|11107914|FG000|STARTED|Overall Study||333
9985824|NCT01631227|11107915|FG001|STARTED|Overall Study||332
9985825|NCT01631227|11107914|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
9985826|NCT01631227|11107915|FG001|Safety Subject Sample|Overall Study||332
9985827|NCT01631227|11107914|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
9985828|NCT01631227|11107915|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
9985829|NCT01631227|11107914|FG000|COMPLETED|Overall Study||303
9985830|NCT01631227|11107915|FG001|COMPLETED|Overall Study||310
9985831|NCT01631227|11107914|FG000|NOT COMPLETED|Overall Study||30
9985832|NCT01631227|11107915|FG001|NOT COMPLETED|Overall Study||22
9985833|NCT01631331|11107921|FG000|STARTED|Overall Study||15
9985834|NCT01631331|11107921|FG000|COMPLETED|Overall Study||11
9985835|NCT01631331|11107921|FG000|NOT COMPLETED|Overall Study||4
9985836|NCT01631435|11107926|FG000|STARTED|Overall Study||75
9985837|NCT01631435|11107926|FG000|COMPLETED|Overall Study||66
9985838|NCT01631435|11107926|FG000|NOT COMPLETED|Overall Study||9
9985839|NCT01631474|11107936|FG000|STARTED|Overall Study||72
9985840|NCT01631474|11107937|FG001|STARTED|Overall Study||76
9985841|NCT01631474|11107938|FG002|STARTED|Overall Study||70
9985842|NCT01631474|11107939|FG003|STARTED|Overall Study||70
9985843|NCT01631474|11107940|FG004|STARTED|Overall Study||75
9985844|NCT01631474|11107936|FG000|COMPLETED|Overall Study||58
9985845|NCT01631474|11107937|FG001|COMPLETED|Overall Study||64
9985846|NCT01631474|11107938|FG002|COMPLETED|Overall Study||61
9985847|NCT01631474|11107939|FG003|COMPLETED|Overall Study||59
9985848|NCT01631474|11107940|FG004|COMPLETED|Overall Study||62
9985849|NCT01631474|11107936|FG000|NOT COMPLETED|Overall Study||14
9985850|NCT01631474|11107937|FG001|NOT COMPLETED|Overall Study||12
9985851|NCT01631474|11107938|FG002|NOT COMPLETED|Overall Study||9
9985852|NCT01631474|11107939|FG003|NOT COMPLETED|Overall Study||11
9985853|NCT01631474|11107940|FG004|NOT COMPLETED|Overall Study||13
9985854|NCT01631552|11107956|FG000|STARTED|Overall Study||83
9985855|NCT01631552|11107957|FG001|STARTED|Overall Study||420
9985856|NCT01631552|11107958|FG002|STARTED|Overall Study||9
9985857|NCT01631552|11107959|FG003|STARTED|Overall Study||3
9985858|NCT01631552|11107956|FG000|Enrolled and Treated|Overall Study||81
9985859|NCT01631552|11107957|FG001|Enrolled and Treated|Overall Study||402
9985860|NCT01631552|11107958|FG002|Enrolled and Treated|Overall Study||9
9985861|NCT01631552|11107959|FG003|Enrolled and Treated|Overall Study||3
9985862|NCT01631552|11107956|FG000|COMPLETED|Overall Study||81
9985863|NCT01631552|11107957|FG001|COMPLETED|Overall Study||400
9985864|NCT01631552|11107958|FG002|COMPLETED|Overall Study||9
9985865|NCT01631552|11107959|FG003|COMPLETED|Overall Study||3
9985866|NCT01631552|11107956|FG000|NOT COMPLETED|Overall Study||2
9985867|NCT01631552|11107957|FG001|NOT COMPLETED|Overall Study||20
9985868|NCT01631552|11107958|FG002|NOT COMPLETED|Overall Study||0
9985869|NCT01631552|11107959|FG003|NOT COMPLETED|Overall Study||0
9985870|NCT01631630|11107973|FG000|STARTED|Overall Study||8
9985871|NCT01631630|11107974|FG001|STARTED|Overall Study||8
9985872|NCT01631630|11107973|FG000|COMPLETED|Overall Study||5
9985873|NCT01631630|11107974|FG001|COMPLETED|Overall Study||8
9985874|NCT01631630|11107973|FG000|NOT COMPLETED|Overall Study||3
9985875|NCT01631630|11107974|FG001|NOT COMPLETED|Overall Study||0
9985876|NCT01631656|11107982|FG000|STARTED|Overall Study||5
9985877|NCT01631656|11107983|FG001|STARTED|Overall Study||5
9985878|NCT01631656|11107982|FG000|COMPLETED|Overall Study||5
9985879|NCT01631656|11107983|FG001|COMPLETED|Overall Study||5
9985880|NCT01631656|11107982|FG000|NOT COMPLETED|Overall Study||0
9985881|NCT01631656|11107983|FG001|NOT COMPLETED|Overall Study||0
9985882|NCT01631682|11107993|FG000|STARTED|Overall Study||55
9985883|NCT01631682|11107994|FG001|STARTED|Overall Study||66
9985884|NCT01631682|11107995|FG002|STARTED|Overall Study||44
9985885|NCT01631682|11107996|FG003|STARTED|Overall Study||7
9985886|NCT01631682|11107993|FG000|COMPLETED|Overall Study||24
9985887|NCT01631682|11107994|FG001|COMPLETED|Overall Study||21
9985888|NCT01631682|11107995|FG002|COMPLETED|Overall Study||13
9985889|NCT01631682|11107996|FG003|COMPLETED|Overall Study||5
9985890|NCT01631682|11107993|FG000|NOT COMPLETED|Overall Study||31
9985891|NCT01631682|11107994|FG001|NOT COMPLETED|Overall Study||45
9985892|NCT01631682|11107995|FG002|NOT COMPLETED|Overall Study||31
9985893|NCT01631682|11107996|FG003|NOT COMPLETED|Overall Study||2
9985894|NCT01631747|11108008|FG000|STARTED|Randomization Through End of Pregnancy||141
9985895|NCT01631747|11108009|FG001|STARTED|Randomization Through End of Pregnancy||140
9985896|NCT01631747|11108008|FG000|COMPLETED|Randomization Through End of Pregnancy||140
9985897|NCT01631747|11108009|FG001|COMPLETED|Randomization Through End of Pregnancy||140
9985898|NCT01631747|11108008|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1
9985899|NCT01631747|11108009|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0
9985900|NCT01631747|11108008|FG000|STARTED|Live Birth||140
9985901|NCT01631747|11108009|FG001|STARTED|Live Birth||140
9985902|NCT01631747|11108008|FG000|COMPLETED|Live Birth||136
9985903|NCT01631747|11108009|FG001|COMPLETED|Live Birth||139
9985904|NCT01631747|11108008|FG000|NOT COMPLETED|Live Birth||4
9985905|NCT01631747|11108009|FG001|NOT COMPLETED|Live Birth||1
9985906|NCT01631747|11108008|FG000|STARTED|One Year Infant Outcomes||136
9985907|NCT01631747|11108009|FG001|STARTED|One Year Infant Outcomes||139
9985908|NCT01631747|11108008|FG000|COMPLETED|One Year Infant Outcomes||123
9985909|NCT01631747|11108009|FG001|COMPLETED|One Year Infant Outcomes||130
9985910|NCT01631747|11108008|FG000|NOT COMPLETED|One Year Infant Outcomes||13
9985911|NCT01631747|11108009|FG001|NOT COMPLETED|One Year Infant Outcomes||9
9985912|NCT01631812|11108016|FG000|STARTED|Overall Study||130
9985913|NCT01631812|11108016|FG000|COMPLETED|Overall Study||93
10101192|NCT02405780|11230424|FG001|NOT COMPLETED|Period II||12
10101193|NCT02405780|11230425|FG002|NOT COMPLETED|Period II||12
10101194|NCT02405780|11230426|FG003|NOT COMPLETED|Period II||18
10101195|NCT02405962|11230453|FG000|STARTED|Overall Study||84
10101196|NCT02405962|11230454|FG001|STARTED|Overall Study||84
10101197|NCT02405962|11230453|FG000|Post-intervention|Overall Study||80
9985914|NCT01631812|11108016|FG000|NOT COMPLETED|Overall Study||37
9985915|NCT01631825|11108020|FG000|STARTED|Overall Study||321
9985916|NCT01631825|11108020|FG000|COMPLETED|Overall Study||256
9985917|NCT01631825|11108020|FG000|NOT COMPLETED|Overall Study||65
9985918|NCT01631864|11108026|FG000|STARTED|Overall Study||50
9985919|NCT01631864|11108027|FG001|STARTED|Overall Study||48
9985920|NCT01631864|11108026|FG000|COMPLETED|Overall Study||48
9985921|NCT01631864|11108027|FG001|COMPLETED|Overall Study||44
9985922|NCT01631864|11108026|FG000|NOT COMPLETED|Overall Study||2
9985923|NCT01631864|11108027|FG001|NOT COMPLETED|Overall Study||4
9985924|NCT01631929|11108035|FG000|STARTED|Overall Study||6
9985925|NCT01631929|11108036|FG001|STARTED|Overall Study||6
9985926|NCT01631929|11108035|FG000|COMPLETED|Overall Study||6
9985927|NCT01631929|11108036|FG001|COMPLETED|Overall Study||6
9985928|NCT01631929|11108035|FG000|NOT COMPLETED|Overall Study||0
9985929|NCT01631929|11108036|FG001|NOT COMPLETED|Overall Study||0
9985930|NCT01632150|11108042|FG000|STARTED|Overall Study||40
9985931|NCT01632150|11108042|FG000|Received Cyclophosphamide|Overall Study||11
9985932|NCT01632150|11108042|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0
9985933|NCT01632150|11108042|FG000|NOT COMPLETED|Overall Study||40
9985934|NCT01632202|11108051|FG000|STARTED|Overall Study||1
9985935|NCT01632202|11108052|FG001|STARTED|Overall Study||7
9985936|NCT01632202|11108051|FG000|COMPLETED|Overall Study||1
9985937|NCT01632202|11108052|FG001|COMPLETED|Overall Study||7
9985938|NCT01632202|11108051|FG000|NOT COMPLETED|Overall Study||0
9985939|NCT01632202|11108052|FG001|NOT COMPLETED|Overall Study||0
9985940|NCT01632215|11108060|FG000|STARTED|Overall Study||20
9985941|NCT01632215|11108061|FG001|STARTED|Overall Study||20
9985942|NCT01632215|11108060|FG000|COMPLETED|Overall Study||18
9985943|NCT01632215|11108061|FG001|COMPLETED|Overall Study||19
9985944|NCT01632215|11108060|FG000|NOT COMPLETED|Overall Study||2
9985945|NCT01632215|11108061|FG001|NOT COMPLETED|Overall Study||1
9985946|NCT01632241|11108069|FG000|STARTED|Double-blinded (Up to Week 52)||165
9985947|NCT01632241|11108070|FG001|STARTED|Double-blinded (Up to Week 52)||331
9985948|NCT01632241|11108069|FG000|COMPLETED|Double-blinded (Up to Week 52)||121
9985949|NCT01632241|11108070|FG001|COMPLETED|Double-blinded (Up to Week 52)||252
10101198|NCT02405962|11230454|FG001|Post-intervention|Overall Study||81
10101199|NCT02405962|11230453|FG000|3 Months After the Intervention|Overall Study||80
10101200|NCT02405962|11230454|FG001|3 Months After the Intervention|Overall Study||79
10101201|NCT02405962|11230453|FG000|COMPLETED|Overall Study||83
9985950|NCT01632241|11108069|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44
9985951|NCT01632241|11108070|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79
9985952|NCT01632241|11108069|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
9985953|NCT01632241|11108070|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
9985954|NCT01632241|11108069|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107
9985955|NCT01632241|11108070|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220
9985956|NCT01632241|11108069|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
9985957|NCT01632241|11108070|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
9985958|NCT01632267|11108082|FG000|STARTED|Overall Study||104
9985959|NCT01632267|11108082|FG000|COMPLETED|Overall Study||97
9985960|NCT01632267|11108082|FG000|NOT COMPLETED|Overall Study||7
9985961|NCT01632280|11108088|FG000|STARTED|Overall Study||6
9985962|NCT01632280|11108089|FG001|STARTED|Overall Study||6
9985963|NCT01632280|11108088|FG000|COMPLETED|Overall Study||5
9985964|NCT01632280|11108089|FG001|COMPLETED|Overall Study||6
9985965|NCT01632280|11108088|FG000|NOT COMPLETED|Overall Study||1
9985966|NCT01632280|11108089|FG001|NOT COMPLETED|Overall Study||0
9985967|NCT01632306|11108097|FG000|STARTED|Overall Study||3
9985968|NCT01632306|11108098|FG001|STARTED|Overall Study||10
9985969|NCT01632306|11108099|FG002|STARTED|Overall Study||0
9985970|NCT01632306|11108097|FG000|Received at Least One Dose of Study Drug|Overall Study||3
9985971|NCT01632306|11108098|FG001|Received at Least One Dose of Study Drug|Overall Study||10
9985972|NCT01632306|11108099|FG002|Received at Least One Dose of Study Drug|Overall Study||0
9985973|NCT01632306|11108097|FG000|COMPLETED|Overall Study||2
9985974|NCT01632306|11108098|FG001|COMPLETED|Overall Study||10
9985975|NCT01632306|11108099|FG002|COMPLETED|Overall Study||0
9985976|NCT01632306|11108097|FG000|NOT COMPLETED|Overall Study||1
9985977|NCT01632306|11108098|FG001|NOT COMPLETED|Overall Study||0
9985978|NCT01632306|11108099|FG002|NOT COMPLETED|Overall Study||0
9985979|NCT01632345|11108110|FG000|STARTED|Randomized Participants||41
9985980|NCT01632345|11108111|FG001|STARTED|Randomized Participants||43
9985981|NCT01632345|11108112|FG002|STARTED|Randomized Participants||42
9985982|NCT01632345|11108113|FG003|STARTED|Randomized Participants||41
9985983|NCT01632345|11108114|FG004|STARTED|Randomized Participants||43
9985984|NCT01632345|11108115|FG005|STARTED|Randomized Participants||66
9985985|NCT01632345|11108116|FG006|STARTED|Randomized Participants||66
9985986|NCT01632345|11108110|FG000|COMPLETED|Randomized Participants||41
9985987|NCT01632345|11108111|FG001|COMPLETED|Randomized Participants||43
9985988|NCT01632345|11108112|FG002|COMPLETED|Randomized Participants||42
9985989|NCT01632345|11108113|FG003|COMPLETED|Randomized Participants||41
9985990|NCT01632345|11108114|FG004|COMPLETED|Randomized Participants||43
9985991|NCT01632345|11108115|FG005|COMPLETED|Randomized Participants||66
9985992|NCT01632345|11108116|FG006|COMPLETED|Randomized Participants||66
9985993|NCT01632345|11108110|FG000|NOT COMPLETED|Randomized Participants||0
9985994|NCT01632345|11108111|FG001|NOT COMPLETED|Randomized Participants||0
9985995|NCT01632345|11108112|FG002|NOT COMPLETED|Randomized Participants||0
9985996|NCT01632345|11108113|FG003|NOT COMPLETED|Randomized Participants||0
9985997|NCT01632345|11108114|FG004|NOT COMPLETED|Randomized Participants||0
9985998|NCT01632345|11108115|FG005|NOT COMPLETED|Randomized Participants||0
9985999|NCT01632345|11108116|FG006|NOT COMPLETED|Randomized Participants||0
9986000|NCT01632345|11108110|FG000|STARTED|Treatment: Part I||41
9986001|NCT01632345|11108111|FG001|STARTED|Treatment: Part I||43
9986002|NCT01632345|11108112|FG002|STARTED|Treatment: Part I||42
9986003|NCT01632345|11108113|FG003|STARTED|Treatment: Part I||41
9986004|NCT01632345|11108114|FG004|STARTED|Treatment: Part I||43
9986005|NCT01632345|11108115|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
9986006|NCT01632345|11108116|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
9986007|NCT01632345|11108110|FG000|Treated|Treatment: Part I||40
9986008|NCT01632345|11108111|FG001|Treated|Treatment: Part I||43
9986009|NCT01632345|11108112|FG002|Treated|Treatment: Part I||42
9986010|NCT01632345|11108113|FG003|Treated|Treatment: Part I||41
9986011|NCT01632345|11108114|FG004|Treated|Treatment: Part I||43
9986012|NCT01632345|11108115|FG005|Treated|Treatment: Part I||0
9986013|NCT01632345|11108116|FG006|Treated|Treatment: Part I||0
9986014|NCT01632345|11108110|FG000|COMPLETED|Treatment: Part I||29
9986015|NCT01632345|11108111|FG001|COMPLETED|Treatment: Part I||28
9986016|NCT01632345|11108112|FG002|COMPLETED|Treatment: Part I||32
9986017|NCT01632345|11108113|FG003|COMPLETED|Treatment: Part I||33
9986018|NCT01632345|11108114|FG004|COMPLETED|Treatment: Part I||30
9986019|NCT01632345|11108115|FG005|COMPLETED|Treatment: Part I||0
9986020|NCT01632345|11108116|FG006|COMPLETED|Treatment: Part I||0
9986021|NCT01632345|11108110|FG000|NOT COMPLETED|Treatment: Part I||12
9986022|NCT01632345|11108111|FG001|NOT COMPLETED|Treatment: Part I||15
9986023|NCT01632345|11108112|FG002|NOT COMPLETED|Treatment: Part I||10
9986024|NCT01632345|11108113|FG003|NOT COMPLETED|Treatment: Part I||8
9986025|NCT01632345|11108114|FG004|NOT COMPLETED|Treatment: Part I||13
9986026|NCT01632345|11108115|FG005|NOT COMPLETED|Treatment: Part I||0
9986027|NCT01632345|11108116|FG006|NOT COMPLETED|Treatment: Part I||0
9986028|NCT01632345|11108110|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
9986029|NCT01632345|11108111|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
9986030|NCT01632345|11108112|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
9986031|NCT01632345|11108113|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
9986032|NCT01632345|11108114|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
9986033|NCT01632345|11108115|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
9986034|NCT01632345|11108116|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
9986035|NCT01632345|11108110|FG000|Treated|Treatment: Part II||0
9986036|NCT01632345|11108111|FG001|Treated|Treatment: Part II||0
9986037|NCT01632345|11108112|FG002|Treated|Treatment: Part II||0
9986038|NCT01632345|11108113|FG003|Treated|Treatment: Part II||0
9986039|NCT01632345|11108114|FG004|Treated|Treatment: Part II||0
9986040|NCT01632345|11108115|FG005|Treated|Treatment: Part II||66
9986041|NCT01632345|11108116|FG006|Treated|Treatment: Part II||66
9986042|NCT01632345|11108110|FG000|COMPLETED|Treatment: Part II||0
9986043|NCT01632345|11108111|FG001|COMPLETED|Treatment: Part II||0
9986044|NCT01632345|11108112|FG002|COMPLETED|Treatment: Part II||0
9986045|NCT01632345|11108113|FG003|COMPLETED|Treatment: Part II||0
9986046|NCT01632345|11108114|FG004|COMPLETED|Treatment: Part II||0
9986047|NCT01632345|11108115|FG005|COMPLETED|Treatment: Part II||55
9986048|NCT01632345|11108116|FG006|COMPLETED|Treatment: Part II||55
9986049|NCT01632345|11108110|FG000|NOT COMPLETED|Treatment: Part II||0
9986050|NCT01632345|11108111|FG001|NOT COMPLETED|Treatment: Part II||0
9986051|NCT01632345|11108112|FG002|NOT COMPLETED|Treatment: Part II||0
9986052|NCT01632345|11108113|FG003|NOT COMPLETED|Treatment: Part II||0
9986053|NCT01632345|11108114|FG004|NOT COMPLETED|Treatment: Part II||0
9986054|NCT01632345|11108115|FG005|NOT COMPLETED|Treatment: Part II||11
9986055|NCT01632345|11108116|FG006|NOT COMPLETED|Treatment: Part II||11
9986056|NCT01632423|11108131|FG000|STARTED|Overall Study||10337
9986057|NCT01632423|11108131|FG000|COMPLETED|Overall Study||10091
9986058|NCT01632423|11108131|FG000|NOT COMPLETED|Overall Study||246
9986059|NCT01632566|11108140|FG000|STARTED|Overall Study||8
9986060|NCT01632566|11108141|FG001|STARTED|Overall Study||10
9986061|NCT01632566|11108142|FG002|STARTED|Overall Study||9
9986062|NCT01632566|11108143|FG003|STARTED|Overall Study||6
9986063|NCT01632566|11108144|FG004|STARTED|Overall Study||6
9986064|NCT01632566|11108140|FG000|Received at Least One Dose LY3031207|Overall Study||8
9986065|NCT01632566|11108141|FG001|Received at Least One Dose LY3031207|Overall Study||10
9986066|NCT01632566|11108142|FG002|Received at Least One Dose LY3031207|Overall Study||9
9986067|NCT01632566|11108143|FG003|Received at Least One Dose LY3031207|Overall Study||0
9986068|NCT01632566|11108144|FG004|Received at Least One Dose LY3031207|Overall Study||0
9986069|NCT01632566|11108140|FG000|Received at Least One Dose Simvastatin|Overall Study||0
9986070|NCT01632566|11108141|FG001|Received at Least One Dose Simvastatin|Overall Study||10
9986071|NCT01632566|11108142|FG002|Received at Least One Dose Simvastatin|Overall Study||9
9986072|NCT01632566|11108143|FG003|Received at Least One Dose Simvastatin|Overall Study||4
9986073|NCT01632566|11108144|FG004|Received at Least One Dose Simvastatin|Overall Study||4
9986074|NCT01632566|11108140|FG000|COMPLETED|Overall Study||8
9986075|NCT01632566|11108141|FG001|COMPLETED|Overall Study||7
9986076|NCT01632566|11108142|FG002|COMPLETED|Overall Study||0
9986077|NCT01632566|11108143|FG003|COMPLETED|Overall Study||4
9986078|NCT01632566|11108144|FG004|COMPLETED|Overall Study||4
9986079|NCT01632566|11108140|FG000|NOT COMPLETED|Overall Study||0
9986080|NCT01632566|11108141|FG001|NOT COMPLETED|Overall Study||3
9986081|NCT01632566|11108142|FG002|NOT COMPLETED|Overall Study||9
9986082|NCT01632566|11108143|FG003|NOT COMPLETED|Overall Study||2
9986083|NCT01632566|11108144|FG004|NOT COMPLETED|Overall Study||2
9986084|NCT01632579|11108160|FG000|STARTED|Period 1 (First Intervention)||2
9986085|NCT01632579|11108161|FG001|STARTED|Period 1 (First Intervention)||6
9986086|NCT01632579|11108162|FG002|STARTED|Period 1 (First Intervention)||2
9986087|NCT01632579|11108163|FG003|STARTED|Period 1 (First Intervention)||2
9986088|NCT01632579|11108164|FG004|STARTED|Period 1 (First Intervention)||6
9986089|NCT01632579|11108165|FG005|STARTED|Period 1 (First Intervention)||2
9986090|NCT01632579|11108166|FG006|STARTED|Period 1 (First Intervention)||2
9986091|NCT01632579|11108167|FG007|STARTED|Period 1 (First Intervention)||6
9986092|NCT01632579|11108168|FG008|STARTED|Period 1 (First Intervention)||2
9986093|NCT01632579|11108160|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2
9986094|NCT01632579|11108161|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6
9986095|NCT01632579|11108162|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2
9986096|NCT01632579|11108163|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2
9986097|NCT01632579|11108164|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6
9986098|NCT01632579|11108165|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2
9986099|NCT01632579|11108166|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2
9986100|NCT01632579|11108167|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6
9986101|NCT01632579|11108168|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2
9986102|NCT01632579|11108160|FG000|COMPLETED|Period 1 (First Intervention)||2
9986103|NCT01632579|11108161|FG001|COMPLETED|Period 1 (First Intervention)||6
9986104|NCT01632579|11108162|FG002|COMPLETED|Period 1 (First Intervention)||2
9986105|NCT01632579|11108163|FG003|COMPLETED|Period 1 (First Intervention)||2
9986106|NCT01632579|11108164|FG004|COMPLETED|Period 1 (First Intervention)||6
9986107|NCT01632579|11108165|FG005|COMPLETED|Period 1 (First Intervention)||2
9986108|NCT01632579|11108166|FG006|COMPLETED|Period 1 (First Intervention)||2
9986109|NCT01632579|11108167|FG007|COMPLETED|Period 1 (First Intervention)||6
9986110|NCT01632579|11108168|FG008|COMPLETED|Period 1 (First Intervention)||2
9986111|NCT01632579|11108160|FG000|NOT COMPLETED|Period 1 (First Intervention)||0
9986112|NCT01632579|11108161|FG001|NOT COMPLETED|Period 1 (First Intervention)||0
9986113|NCT01632579|11108162|FG002|NOT COMPLETED|Period 1 (First Intervention)||0
9986114|NCT01632579|11108163|FG003|NOT COMPLETED|Period 1 (First Intervention)||0
9986115|NCT01632579|11108164|FG004|NOT COMPLETED|Period 1 (First Intervention)||0
9986116|NCT01632579|11108165|FG005|NOT COMPLETED|Period 1 (First Intervention)||0
9986117|NCT01632579|11108166|FG006|NOT COMPLETED|Period 1 (First Intervention)||0
9986118|NCT01632579|11108167|FG007|NOT COMPLETED|Period 1 (First Intervention)||0
9986119|NCT01632579|11108168|FG008|NOT COMPLETED|Period 1 (First Intervention)||0
9986120|NCT01632579|11108160|FG000|STARTED|Washout Period||2
9986121|NCT01632579|11108161|FG001|STARTED|Washout Period||6
9986122|NCT01632579|11108162|FG002|STARTED|Washout Period||2
9986123|NCT01632579|11108163|FG003|STARTED|Washout Period||2
9986124|NCT01632579|11108164|FG004|STARTED|Washout Period||6
9986125|NCT01632579|11108165|FG005|STARTED|Washout Period||2
9986126|NCT01632579|11108166|FG006|STARTED|Washout Period||2
9986127|NCT01632579|11108167|FG007|STARTED|Washout Period||6
9986128|NCT01632579|11108168|FG008|STARTED|Washout Period||2
9986129|NCT01632579|11108160|FG000|COMPLETED|Washout Period||1
9986130|NCT01632579|11108161|FG001|COMPLETED|Washout Period||6
9986131|NCT01632579|11108162|FG002|COMPLETED|Washout Period||2
9986132|NCT01632579|11108163|FG003|COMPLETED|Washout Period||2
9986133|NCT01632579|11108164|FG004|COMPLETED|Washout Period||6
9986134|NCT01632579|11108165|FG005|COMPLETED|Washout Period||2
9986135|NCT01632579|11108166|FG006|COMPLETED|Washout Period||2
9986136|NCT01632579|11108167|FG007|COMPLETED|Washout Period||6
9986137|NCT01632579|11108168|FG008|COMPLETED|Washout Period||2
9986138|NCT01632579|11108160|FG000|NOT COMPLETED|Washout Period||1
9986139|NCT01632579|11108161|FG001|NOT COMPLETED|Washout Period||0
9986140|NCT01632579|11108162|FG002|NOT COMPLETED|Washout Period||0
9986141|NCT01632579|11108163|FG003|NOT COMPLETED|Washout Period||0
9986142|NCT01632579|11108164|FG004|NOT COMPLETED|Washout Period||0
9986143|NCT01632579|11108165|FG005|NOT COMPLETED|Washout Period||0
9986144|NCT01632579|11108166|FG006|NOT COMPLETED|Washout Period||0
9986145|NCT01632579|11108167|FG007|NOT COMPLETED|Washout Period||0
9986146|NCT01632579|11108168|FG008|NOT COMPLETED|Washout Period||0
9986147|NCT01632579|11108160|FG000|STARTED|Period 2 (Second Intervention)||1
9986148|NCT01632579|11108161|FG001|STARTED|Period 2 (Second Intervention)||6
9986149|NCT01632579|11108162|FG002|STARTED|Period 2 (Second Intervention)||2
9986150|NCT01632579|11108163|FG003|STARTED|Period 2 (Second Intervention)||2
9986151|NCT01632579|11108164|FG004|STARTED|Period 2 (Second Intervention)||6
9986152|NCT01632579|11108165|FG005|STARTED|Period 2 (Second Intervention)||2
9986153|NCT01632579|11108166|FG006|STARTED|Period 2 (Second Intervention)||2
9986154|NCT01632579|11108167|FG007|STARTED|Period 2 (Second Intervention)||6
9986155|NCT01632579|11108168|FG008|STARTED|Period 2 (Second Intervention)||2
9986156|NCT01632579|11108160|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1
9986157|NCT01632579|11108161|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6
9986158|NCT01632579|11108162|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2
9986159|NCT01632579|11108163|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2
9986160|NCT01632579|11108164|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6
9986161|NCT01632579|11108165|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2
9986162|NCT01632579|11108166|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2
9986163|NCT01632579|11108167|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6
9986164|NCT01632579|11108168|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2
9986165|NCT01632579|11108160|FG000|COMPLETED|Period 2 (Second Intervention)||0
9986166|NCT01632579|11108161|FG001|COMPLETED|Period 2 (Second Intervention)||6
9986167|NCT01632579|11108162|FG002|COMPLETED|Period 2 (Second Intervention)||2
9986168|NCT01632579|11108163|FG003|COMPLETED|Period 2 (Second Intervention)||2
9986169|NCT01632579|11108164|FG004|COMPLETED|Period 2 (Second Intervention)||6
9986170|NCT01632579|11108165|FG005|COMPLETED|Period 2 (Second Intervention)||2
9986171|NCT01632579|11108166|FG006|COMPLETED|Period 2 (Second Intervention)||2
9986172|NCT01632579|11108167|FG007|COMPLETED|Period 2 (Second Intervention)||6
9986173|NCT01632579|11108168|FG008|COMPLETED|Period 2 (Second Intervention)||2
9986174|NCT01632579|11108160|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1
9986175|NCT01632579|11108161|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0
9986176|NCT01632579|11108162|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0
9986177|NCT01632579|11108163|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0
9986178|NCT01632579|11108164|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0
9986179|NCT01632579|11108165|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0
9986180|NCT01632579|11108166|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0
9986181|NCT01632579|11108167|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0
9986182|NCT01632579|11108168|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0
9986183|NCT01632579|11108160|FG000|STARTED|Washout Period||0
9986184|NCT01632579|11108161|FG001|STARTED|Washout Period||6
9986185|NCT01632579|11108162|FG002|STARTED|Washout Period||2
9986186|NCT01632579|11108163|FG003|STARTED|Washout Period||2
9986187|NCT01632579|11108164|FG004|STARTED|Washout Period||6
9986188|NCT01632579|11108165|FG005|STARTED|Washout Period||2
9986189|NCT01632579|11108166|FG006|STARTED|Washout Period||2
9986190|NCT01632579|11108167|FG007|STARTED|Washout Period||6
9986191|NCT01632579|11108168|FG008|STARTED|Washout Period||2
9986192|NCT01632579|11108160|FG000|COMPLETED|Washout Period||0
9986193|NCT01632579|11108161|FG001|COMPLETED|Washout Period||6
9986194|NCT01632579|11108162|FG002|COMPLETED|Washout Period||2
9986195|NCT01632579|11108163|FG003|COMPLETED|Washout Period||2
9986196|NCT01632579|11108164|FG004|COMPLETED|Washout Period||6
9986197|NCT01632579|11108165|FG005|COMPLETED|Washout Period||2
9986198|NCT01632579|11108166|FG006|COMPLETED|Washout Period||2
9986199|NCT01632579|11108167|FG007|COMPLETED|Washout Period||6
9986200|NCT01632579|11108168|FG008|COMPLETED|Washout Period||2
9986201|NCT01632579|11108160|FG000|NOT COMPLETED|Washout Period||0
9986202|NCT01632579|11108161|FG001|NOT COMPLETED|Washout Period||0
9986203|NCT01632579|11108162|FG002|NOT COMPLETED|Washout Period||0
9986204|NCT01632579|11108163|FG003|NOT COMPLETED|Washout Period||0
9986205|NCT01632579|11108164|FG004|NOT COMPLETED|Washout Period||0
9986206|NCT01632579|11108165|FG005|NOT COMPLETED|Washout Period||0
9986207|NCT01632579|11108166|FG006|NOT COMPLETED|Washout Period||0
9986208|NCT01632579|11108167|FG007|NOT COMPLETED|Washout Period||0
9986209|NCT01632579|11108168|FG008|NOT COMPLETED|Washout Period||0
9986210|NCT01632579|11108160|FG000|STARTED|Period 3 (Third Intervention)||0
9986211|NCT01632579|11108161|FG001|STARTED|Period 3 (Third Intervention)||6
10101202|NCT02405962|11230454|FG001|COMPLETED|Overall Study||79
10101203|NCT02405962|11230453|FG000|NOT COMPLETED|Overall Study||1
10101204|NCT02405962|11230454|FG001|NOT COMPLETED|Overall Study||5
10101205|NCT02406248|11230460|FG000|STARTED|Overall Study||108
10101206|NCT02406248|11230460|FG000|COMPLETED|Overall Study||99
9986212|NCT01632579|11108162|FG002|STARTED|Period 3 (Third Intervention)||2
10101207|NCT02406248|11230460|FG000|NOT COMPLETED|Overall Study||9
10101208|NCT02406261|11230466|FG000|STARTED|Period 1||50
10101209|NCT02406261|11230467|FG001|STARTED|Period 1||32
10101210|NCT02406261|11230466|FG000|Received at Least One Dose of Study Drug|Period 1||50
10101211|NCT02406261|11230467|FG001|Received at Least One Dose of Study Drug|Period 1||32
10101212|NCT02406261|11230466|FG000|COMPLETED|Period 1||47
10101213|NCT02406261|11230467|FG001|COMPLETED|Period 1||32
10101214|NCT02406261|11230466|FG000|NOT COMPLETED|Period 1||3
10101215|NCT02406261|11230467|FG001|NOT COMPLETED|Period 1||0
9986213|NCT01632579|11108163|FG003|STARTED|Period 3 (Third Intervention)||2
9986214|NCT01632579|11108164|FG004|STARTED|Period 3 (Third Intervention)||6
9986215|NCT01632579|11108165|FG005|STARTED|Period 3 (Third Intervention)||2
9986216|NCT01632579|11108166|FG006|STARTED|Period 3 (Third Intervention)||2
9986217|NCT01632579|11108167|FG007|STARTED|Period 3 (Third Intervention)||6
9986218|NCT01632579|11108168|FG008|STARTED|Period 3 (Third Intervention)||2
9986219|NCT01632579|11108160|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0
9986220|NCT01632579|11108161|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6
9986221|NCT01632579|11108162|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2
9986222|NCT01632579|11108163|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2
9986223|NCT01632579|11108164|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6
9986224|NCT01632579|11108165|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2
9986225|NCT01632579|11108166|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2
9986226|NCT01632579|11108167|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6
9986227|NCT01632579|11108168|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2
9986228|NCT01632579|11108160|FG000|COMPLETED|Period 3 (Third Intervention)||0
9986229|NCT01632579|11108161|FG001|COMPLETED|Period 3 (Third Intervention)||6
9986230|NCT01632579|11108162|FG002|COMPLETED|Period 3 (Third Intervention)||2
9986231|NCT01632579|11108163|FG003|COMPLETED|Period 3 (Third Intervention)||2
9986232|NCT01632579|11108164|FG004|COMPLETED|Period 3 (Third Intervention)||6
9986233|NCT01632579|11108165|FG005|COMPLETED|Period 3 (Third Intervention)||2
9986234|NCT01632579|11108166|FG006|COMPLETED|Period 3 (Third Intervention)||2
9986235|NCT01632579|11108167|FG007|COMPLETED|Period 3 (Third Intervention)||6
9986236|NCT01632579|11108168|FG008|COMPLETED|Period 3 (Third Intervention)||2
9986237|NCT01632579|11108160|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0
9986238|NCT01632579|11108161|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0
9986239|NCT01632579|11108162|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0
9986240|NCT01632579|11108163|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0
9986241|NCT01632579|11108164|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0
9986242|NCT01632579|11108165|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0
9986243|NCT01632579|11108166|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0
9986244|NCT01632579|11108167|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0
9986245|NCT01632579|11108168|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0
9986246|NCT01632683|11108194|FG000|STARTED|Overall Study||548
9986247|NCT01632683|11108195|FG001|STARTED|Overall Study||552
9986248|NCT01632683|11108194|FG000|COMPLETED|Overall Study||548
9986249|NCT01632683|11108195|FG001|COMPLETED|Overall Study||552
9986250|NCT01632683|11108194|FG000|NOT COMPLETED|Overall Study||0
9986251|NCT01632683|11108195|FG001|NOT COMPLETED|Overall Study||0
9986252|NCT01632709|11108205|FG000|STARTED|Overall Study||4
9986253|NCT01632709|11108206|FG001|STARTED|Overall Study||3
9986254|NCT01632709|11108207|FG002|STARTED|Overall Study||5
9986255|NCT01632709|11108208|FG003|STARTED|Overall Study||4
9986256|NCT01632709|11108205|FG000|Completed Visit 2 (Received Injection)|Overall Study||4
9986257|NCT01632709|11108206|FG001|Completed Visit 2 (Received Injection)|Overall Study||2
9986258|NCT01632709|11108207|FG002|Completed Visit 2 (Received Injection)|Overall Study||5
9986259|NCT01632709|11108208|FG003|Completed Visit 2 (Received Injection)|Overall Study||3
9986260|NCT01632709|11108205|FG000|COMPLETED|Overall Study||2
9986261|NCT01632709|11108206|FG001|COMPLETED|Overall Study||2
9986262|NCT01632709|11108207|FG002|COMPLETED|Overall Study||5
9986263|NCT01632709|11108208|FG003|COMPLETED|Overall Study||3
9986264|NCT01632709|11108205|FG000|NOT COMPLETED|Overall Study||2
9986265|NCT01632709|11108206|FG001|NOT COMPLETED|Overall Study||1
9986266|NCT01632709|11108207|FG002|NOT COMPLETED|Overall Study||0
9986267|NCT01632709|11108208|FG003|NOT COMPLETED|Overall Study||1
9986268|NCT01632735|11108218|FG000|STARTED|Overall Study||40
9986269|NCT01632735|11108219|FG001|STARTED|Overall Study||40
9986270|NCT01632735|11108218|FG000|COMPLETED|Overall Study||36
9986271|NCT01632735|11108219|FG001|COMPLETED|Overall Study||37
9986272|NCT01632735|11108218|FG000|NOT COMPLETED|Overall Study||4
9986273|NCT01632735|11108219|FG001|NOT COMPLETED|Overall Study||3
9986274|NCT01632800|11108225|FG000|STARTED|Overall Study||26
9986275|NCT01632800|11108225|FG000|COMPLETED|Overall Study||25
9986276|NCT01632800|11108225|FG000|NOT COMPLETED|Overall Study||1
9986277|NCT01632891|11108231|FG000|STARTED|Overall Study||26
9986278|NCT01632891|11108232|FG001|STARTED|Overall Study||26
9986279|NCT01632891|11108231|FG000|COMPLETED|Overall Study||25
9986280|NCT01632891|11108232|FG001|COMPLETED|Overall Study||25
9986281|NCT01632891|11108231|FG000|NOT COMPLETED|Overall Study||1
9986282|NCT01632891|11108232|FG001|NOT COMPLETED|Overall Study||1
9986283|NCT01632904|11108244|FG000|STARTED|Overall Study||54
9986284|NCT01632904|11108245|FG001|STARTED|Overall Study||56
9986285|NCT01632904|11108244|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
9986286|NCT01632904|11108245|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
10101216|NCT02406261|11230466|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0
10101217|NCT02406261|11230467|FG001|STARTED|Period 2||32
10101218|NCT02406261|11230466|FG000|COMPLETED|Period 2||0
10101219|NCT02406261|11230467|FG001|COMPLETED|Period 2||29
10101220|NCT02406261|11230466|FG000|NOT COMPLETED|Period 2||0
10101221|NCT02406261|11230467|FG001|NOT COMPLETED|Period 2||3
10101222|NCT02406443|11230476|FG000|STARTED|Overall Study||18
10101223|NCT02406443|11230477|FG001|STARTED|Overall Study||18
10101224|NCT02406443|11230476|FG000|COMPLETED|Overall Study||16
10101225|NCT02406443|11230477|FG001|COMPLETED|Overall Study||16
10101226|NCT02406443|11230476|FG000|NOT COMPLETED|Overall Study||2
10101227|NCT02406443|11230477|FG001|NOT COMPLETED|Overall Study||2
10101228|NCT02406495|11230483|FG000|STARTED|Overall Study||40
10101229|NCT02406495|11230483|FG000|COMPLETED|Overall Study||40
10101230|NCT02406495|11230483|FG000|NOT COMPLETED|Overall Study||0
10101231|NCT02406573|11230496|FG000|STARTED|Overall Study||30
10101232|NCT02406573|11230496|FG000|COMPLETED|Overall Study||30
10101233|NCT02406573|11230496|FG000|NOT COMPLETED|Overall Study||0
10101234|NCT02406586|11230503|FG000|STARTED|Overall Study||12
10101235|NCT02406586|11230504|FG001|STARTED|Overall Study||12
10101236|NCT02406586|11230505|FG002|STARTED|Overall Study||12
10101237|NCT02406586|11230503|FG000|COMPLETED|Overall Study||11
10101238|NCT02406586|11230504|FG001|COMPLETED|Overall Study||8
10101239|NCT02406586|11230505|FG002|COMPLETED|Overall Study||10
10101240|NCT02406586|11230503|FG000|NOT COMPLETED|Overall Study||1
10101241|NCT02406586|11230504|FG001|NOT COMPLETED|Overall Study||4
10101242|NCT02406586|11230505|FG002|NOT COMPLETED|Overall Study||2
10101243|NCT02406612|11230518|FG000|STARTED|Overall Study||26
10101244|NCT02406612|11230519|FG001|STARTED|Overall Study||21
10101245|NCT02406612|11230518|FG000|COMPLETED|Overall Study||22
10101246|NCT02406612|11230519|FG001|COMPLETED|Overall Study||17
10101247|NCT02406612|11230518|FG000|NOT COMPLETED|Overall Study||4
10101248|NCT02406612|11230519|FG001|NOT COMPLETED|Overall Study||4
10101249|NCT02406651|11230525|FG000|STARTED|Overall Study||30
10101250|NCT02406651|11230525|FG000|COMPLETED|Overall Study||27
10101251|NCT02406651|11230525|FG000|NOT COMPLETED|Overall Study||3
10101252|NCT02406677|11230532|FG000|STARTED|Overall Study||6436
9986287|NCT01632904|11108244|FG000|NOT COMPLETED|Overall Study||7
9986288|NCT01632904|11108245|FG001|NOT COMPLETED|Overall Study||6
9986289|NCT01632995|11108251|FG000|STARTED|Pre-screening to Enrollment Period||1069
9986290|NCT01632995|11108251|FG000|COMPLETED|Pre-screening to Enrollment Period||557
9986291|NCT01632995|11108251|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512
9986292|NCT01632995|11108251|FG000|STARTED|Main Study Follow-up Period||557
9986293|NCT01632995|11108251|FG000|COMPLETED|Main Study Follow-up Period||437
9986294|NCT01632995|11108251|FG000|NOT COMPLETED|Main Study Follow-up Period||120
9986295|NCT01633060|11108259|FG000|STARTED|Randomization Phase|All randomized patients|289
9986296|NCT01633060|11108260|FG001|STARTED|Randomization Phase|All randomized patients|143
9986297|NCT01633060|11108259|FG000|COMPLETED|Randomization Phase||288
9986298|NCT01633060|11108260|FG001|COMPLETED|Randomization Phase||140
9986299|NCT01633060|11108259|FG000|NOT COMPLETED|Randomization Phase||1
9986300|NCT01633060|11108260|FG001|NOT COMPLETED|Randomization Phase||3
9986301|NCT01633060|11108259|FG000|STARTED|Treatment Phase||288
9986302|NCT01633060|11108260|FG001|STARTED|Treatment Phase||140
9986303|NCT01633060|11108259|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
9986304|NCT01633060|11108260|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
9986305|NCT01633060|11108259|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
9986306|NCT01633060|11108260|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
9986307|NCT01633060|11108259|FG000|Safety Set (SS)|Treatment Phase||288
9986308|NCT01633060|11108260|FG001|Safety Set (SS)|Treatment Phase||140
9986309|NCT01633060|11108259|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
9986310|NCT01633060|11108260|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
9986311|NCT01633060|11108259|FG000|COMPLETED|Treatment Phase||0
9986312|NCT01633060|11108260|FG001|COMPLETED|Treatment Phase||0
9986313|NCT01633060|11108259|FG000|NOT COMPLETED|Treatment Phase||288
9986314|NCT01633060|11108260|FG001|NOT COMPLETED|Treatment Phase||140
9986315|NCT01633060|11108259|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
9986316|NCT01633060|11108260|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
9986317|NCT01633060|11108259|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
9986318|NCT01633060|11108260|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
9986319|NCT01633060|11108259|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
9986320|NCT01633060|11108260|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
9986321|NCT01633112|11108270|FG000|STARTED|Overall Study||352
9986322|NCT01633112|11108271|FG001|STARTED|Overall Study||370
9986323|NCT01633112|11108272|FG002|STARTED|Overall Study||342
10101253|NCT02406677|11230533|FG001|STARTED|Overall Study||4565
10101254|NCT02406677|11230532|FG000|COMPLETED|Overall Study||6135
9986324|NCT01633112|11108270|FG000|COMPLETED|Overall Study||299
9986325|NCT01633112|11108271|FG001|COMPLETED|Overall Study||310
9986326|NCT01633112|11108272|FG002|COMPLETED|Overall Study||250
9986327|NCT01633112|11108270|FG000|NOT COMPLETED|Overall Study||53
10101255|NCT02406677|11230533|FG001|COMPLETED|Overall Study||3967
10101256|NCT02406677|11230532|FG000|NOT COMPLETED|Overall Study||301
10101257|NCT02406677|11230533|FG001|NOT COMPLETED|Overall Study||598
10101258|NCT02406742|11230546|FG000|STARTED|Overall Study||14
10101259|NCT02406742|11230547|FG001|STARTED|Overall Study||16
10101260|NCT02406742|11230548|FG002|STARTED|Overall Study||16
10101261|NCT02406742|11230546|FG000|Dose Escalation 1|Overall Study||3
9986328|NCT01633112|11108271|FG001|NOT COMPLETED|Overall Study||60
9986329|NCT01633112|11108272|FG002|NOT COMPLETED|Overall Study||92
9986330|NCT01633320|11108283|FG000|STARTED|Overall Study||132
9986331|NCT01633320|11108284|FG001|STARTED|Overall Study||68
9986332|NCT01633320|11108283|FG000|COMPLETED|Overall Study||132
9986333|NCT01633320|11108284|FG001|COMPLETED|Overall Study||68
10101262|NCT02406742|11230547|FG001|Dose Escalation 1|Overall Study||0
10101263|NCT02406742|11230548|FG002|Dose Escalation 1|Overall Study||0
10101264|NCT02406742|11230546|FG000|Dose Escalation 2|Overall Study||9
10101265|NCT02406742|11230547|FG001|Dose Escalation 2|Overall Study||5
10101266|NCT02406742|11230548|FG002|Dose Escalation 2|Overall Study||3
10101267|NCT02406742|11230546|FG000|Dose Escalation 3|Overall Study||2
9986334|NCT01633320|11108283|FG000|NOT COMPLETED|Overall Study||0
9986335|NCT01633320|11108284|FG001|NOT COMPLETED|Overall Study||0
9986336|NCT01633398|11108292|FG000|STARTED|Overall Study||4779
9986337|NCT01633398|11108293|FG001|STARTED|Overall Study||1550
9986338|NCT01633398|11108292|FG000|COMPLETED|Overall Study||4779
9986339|NCT01633398|11108293|FG001|COMPLETED|Overall Study||1550
9986340|NCT01633398|11108292|FG000|NOT COMPLETED|Overall Study||0
9986341|NCT01633398|11108293|FG001|NOT COMPLETED|Overall Study||0
9986342|NCT01633788|11108303|FG000|STARTED|Overall Study||57
9986343|NCT01633788|11108304|FG001|STARTED|Overall Study||58
9986344|NCT01633788|11108305|FG002|STARTED|Overall Study||59
9986345|NCT01633788|11108306|FG003|STARTED|Overall Study||58
9986346|NCT01633788|11108303|FG000|COMPLETED|Overall Study||50
9986347|NCT01633788|11108304|FG001|COMPLETED|Overall Study||50
9986348|NCT01633788|11108305|FG002|COMPLETED|Overall Study||49
9986349|NCT01633788|11108306|FG003|COMPLETED|Overall Study||45
9986350|NCT01633788|11108303|FG000|NOT COMPLETED|Overall Study||7
9986351|NCT01633788|11108304|FG001|NOT COMPLETED|Overall Study||8
9986352|NCT01633788|11108305|FG002|NOT COMPLETED|Overall Study||10
9986353|NCT01633788|11108306|FG003|NOT COMPLETED|Overall Study||13
9986354|NCT01633827|11108316|FG000|STARTED|First Intervention||11
9986355|NCT01633827|11108317|FG001|STARTED|First Intervention||11
9986356|NCT01633827|11108316|FG000|COMPLETED|First Intervention||11
9986357|NCT01633827|11108317|FG001|COMPLETED|First Intervention||11
9986358|NCT01633827|11108316|FG000|NOT COMPLETED|First Intervention||0
9986359|NCT01633827|11108317|FG001|NOT COMPLETED|First Intervention||0
9986360|NCT01633827|11108316|FG000|STARTED|Washout Period||11
9986361|NCT01633827|11108317|FG001|STARTED|Washout Period||11
9986362|NCT01633827|11108316|FG000|COMPLETED|Washout Period||11
9986363|NCT01633827|11108317|FG001|COMPLETED|Washout Period||11
9986364|NCT01633827|11108316|FG000|NOT COMPLETED|Washout Period||0
9986365|NCT01633827|11108317|FG001|NOT COMPLETED|Washout Period||0
9986366|NCT01633827|11108316|FG000|STARTED|Second Intervention||11
9986367|NCT01633827|11108317|FG001|STARTED|Second Intervention||11
9986368|NCT01633827|11108316|FG000|COMPLETED|Second Intervention||11
9986369|NCT01633827|11108317|FG001|COMPLETED|Second Intervention||11
9986370|NCT01633827|11108316|FG000|NOT COMPLETED|Second Intervention||0
9986371|NCT01633827|11108317|FG001|NOT COMPLETED|Second Intervention||0
9986372|NCT01633853|11108332|FG000|STARTED|Overall Study||104
9986373|NCT01633853|11108333|FG001|STARTED|Overall Study||100
9986374|NCT01633853|11108332|FG000|COMPLETED|Overall Study||104
9986375|NCT01633853|11108333|FG001|COMPLETED|Overall Study||100
9986376|NCT01633853|11108332|FG000|NOT COMPLETED|Overall Study||0
9986377|NCT01633853|11108333|FG001|NOT COMPLETED|Overall Study||0
9986378|NCT01633892|11108340|FG000|STARTED|Overall Study||5
9986379|NCT01633892|11108340|FG000|COMPLETED|Overall Study||5
9986380|NCT01633892|11108340|FG000|NOT COMPLETED|Overall Study||0
9986381|NCT01633944|11108346|FG000|STARTED|Open-label Titration Phase||752
9986382|NCT01633944|11108347|FG001|STARTED|Open-label Titration Phase||0
9986383|NCT01633944|11108348|FG002|STARTED|Open-label Titration Phase||0
9986384|NCT01633944|11108346|FG000|COMPLETED|Open-label Titration Phase||462
9986385|NCT01633944|11108347|FG001|COMPLETED|Open-label Titration Phase||0
9986386|NCT01633944|11108348|FG002|COMPLETED|Open-label Titration Phase||0
9986387|NCT01633944|11108346|FG000|NOT COMPLETED|Open-label Titration Phase||290
9986388|NCT01633944|11108347|FG001|NOT COMPLETED|Open-label Titration Phase||0
9986389|NCT01633944|11108348|FG002|NOT COMPLETED|Open-label Titration Phase||0
9986390|NCT01633944|11108346|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
9986391|NCT01633944|11108347|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
9986392|NCT01633944|11108348|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
9986393|NCT01633944|11108346|FG000|COMPLETED|Double-blind Treatment Phase||0
9986394|NCT01633944|11108347|FG001|COMPLETED|Double-blind Treatment Phase||176
9986395|NCT01633944|11108348|FG002|COMPLETED|Double-blind Treatment Phase||174
10101268|NCT02406742|11230547|FG001|Dose Escalation 3|Overall Study||3
10101269|NCT02406742|11230548|FG002|Dose Escalation 3|Overall Study||3
10101270|NCT02406742|11230546|FG000|Dose Escalation 4|Overall Study||0
10101271|NCT02406742|11230547|FG001|Dose Escalation 4|Overall Study||3
9986396|NCT01633944|11108346|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
9986397|NCT01633944|11108347|FG001|NOT COMPLETED|Double-blind Treatment Phase||54
9986398|NCT01633944|11108348|FG002|NOT COMPLETED|Double-blind Treatment Phase||58
10101272|NCT02406742|11230548|FG002|Dose Escalation 4|Overall Study||3
9986399|NCT01634100|11108356|FG000|STARTED|Overall Study||3
9986400|NCT01634100|11108357|FG001|STARTED|Overall Study||3
9986401|NCT01634100|11108358|FG002|STARTED|Overall Study||3
9986402|NCT01634100|11108359|FG003|STARTED|Overall Study||3
9986403|NCT01634100|11108360|FG004|STARTED|Overall Study||3
9986404|NCT01634100|11108361|FG005|STARTED|Overall Study||3
9986405|NCT01634100|11108356|FG000|Received Empa Alone|Overall Study||3
9986406|NCT01634100|11108357|FG001|Received Empa Alone|Overall Study||3
9986407|NCT01634100|11108358|FG002|Received Empa Alone|Overall Study||3
9986408|NCT01634100|11108359|FG003|Received Empa Alone|Overall Study||3
9986409|NCT01634100|11108360|FG004|Received Empa Alone|Overall Study||3
9986410|NCT01634100|11108361|FG005|Received Empa Alone|Overall Study||3
9986411|NCT01634100|11108356|FG000|Received Empa + Rifampicin|Overall Study||3
10101273|NCT02406742|11230546|FG000|Dose Escalation 5|Overall Study||0
10101274|NCT02406742|11230547|FG001|Dose Escalation 5|Overall Study||5
9986412|NCT01634100|11108357|FG001|Received Empa + Rifampicin|Overall Study||3
9986413|NCT01634100|11108358|FG002|Received Empa + Rifampicin|Overall Study||3
9986414|NCT01634100|11108359|FG003|Received Empa + Rifampicin|Overall Study||3
9986415|NCT01634100|11108360|FG004|Received Empa + Rifampicin|Overall Study||3
9986416|NCT01634100|11108361|FG005|Received Empa + Rifampicin|Overall Study||3
9986417|NCT01634100|11108356|FG000|Received Empa + Probenecid|Overall Study||2
9986418|NCT01634100|11108357|FG001|Received Empa + Probenecid|Overall Study||3
9986419|NCT01634100|11108358|FG002|Received Empa + Probenecid|Overall Study||2
9986420|NCT01634100|11108359|FG003|Received Empa + Probenecid|Overall Study||3
9986421|NCT01634100|11108360|FG004|Received Empa + Probenecid|Overall Study||3
9986422|NCT01634100|11108361|FG005|Received Empa + Probenecid|Overall Study||3
9986423|NCT01634100|11108356|FG000|COMPLETED|Overall Study||2
9986424|NCT01634100|11108357|FG001|COMPLETED|Overall Study||3
9986425|NCT01634100|11108358|FG002|COMPLETED|Overall Study||2
9986426|NCT01634100|11108359|FG003|COMPLETED|Overall Study||3
9986427|NCT01634100|11108360|FG004|COMPLETED|Overall Study||3
9986428|NCT01634100|11108361|FG005|COMPLETED|Overall Study||3
9986429|NCT01634100|11108356|FG000|NOT COMPLETED|Overall Study||1
9986430|NCT01634100|11108357|FG001|NOT COMPLETED|Overall Study||0
9986431|NCT01634100|11108358|FG002|NOT COMPLETED|Overall Study||1
9986432|NCT01634100|11108359|FG003|NOT COMPLETED|Overall Study||0
9986433|NCT01634100|11108360|FG004|NOT COMPLETED|Overall Study||0
9986434|NCT01634100|11108361|FG005|NOT COMPLETED|Overall Study||0
9986435|NCT01634113|11108372|FG000|STARTED|Overall Study||34
9986436|NCT01634113|11108373|FG001|STARTED|Overall Study||36
9986437|NCT01634113|11108374|FG002|STARTED|Overall Study||32
9986438|NCT01634113|11108372|FG000|COMPLETED|Overall Study||34
9986439|NCT01634113|11108373|FG001|COMPLETED|Overall Study||36
9986440|NCT01634113|11108374|FG002|COMPLETED|Overall Study||31
9986441|NCT01634113|11108372|FG000|NOT COMPLETED|Overall Study||0
9986442|NCT01634113|11108373|FG001|NOT COMPLETED|Overall Study||0
9986443|NCT01634113|11108374|FG002|NOT COMPLETED|Overall Study||1
9986444|NCT01634139|11108385|FG000|STARTED|Overall Study||132
9986445|NCT01634139|11108386|FG001|STARTED|Overall Study||136
9986446|NCT01634139|11108387|FG002|STARTED|Overall Study||135
9986447|NCT01634139|11108385|FG000|COMPLETED|Overall Study||122
9986448|NCT01634139|11108386|FG001|COMPLETED|Overall Study||130
9986449|NCT01634139|11108387|FG002|COMPLETED|Overall Study||130
9986450|NCT01634139|11108385|FG000|NOT COMPLETED|Overall Study||10
9986451|NCT01634139|11108386|FG001|NOT COMPLETED|Overall Study||6
9986452|NCT01634139|11108387|FG002|NOT COMPLETED|Overall Study||5
9986453|NCT01634152|11108398|FG000|STARTED|Overall Study||134
9986454|NCT01634152|11108399|FG001|STARTED|Overall Study||137
9986455|NCT01634152|11108400|FG002|STARTED|Overall Study||130
9986456|NCT01634152|11108398|FG000|COMPLETED|Overall Study||130
9986457|NCT01634152|11108399|FG001|COMPLETED|Overall Study||136
9986458|NCT01634152|11108400|FG002|COMPLETED|Overall Study||126
9986459|NCT01634152|11108398|FG000|NOT COMPLETED|Overall Study||4
9986460|NCT01634152|11108399|FG001|NOT COMPLETED|Overall Study||1
9986461|NCT01634152|11108400|FG002|NOT COMPLETED|Overall Study||4
9986462|NCT01634165|11108408|FG000|STARTED|Period 1||6
9986463|NCT01634165|11108409|FG001|STARTED|Period 1||6
9986464|NCT01634165|11108410|FG002|STARTED|Period 1||6
9986465|NCT01634165|11108411|FG003|STARTED|Period 1||6
9986466|NCT01634165|11108408|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
9986467|NCT01634165|11108409|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
9986468|NCT01634165|11108410|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
9986469|NCT01634165|11108411|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
9986470|NCT01634165|11108408|FG000|COMPLETED|Period 1||6
10101275|NCT02406742|11230548|FG002|Dose Escalation 5|Overall Study||5
9986471|NCT01634165|11108409|FG001|COMPLETED|Period 1||6
9986472|NCT01634165|11108410|FG002|COMPLETED|Period 1||6
9986473|NCT01634165|11108411|FG003|COMPLETED|Period 1||6
9986474|NCT01634165|11108408|FG000|NOT COMPLETED|Period 1||0
9986475|NCT01634165|11108409|FG001|NOT COMPLETED|Period 1||0
9986476|NCT01634165|11108410|FG002|NOT COMPLETED|Period 1||0
9986477|NCT01634165|11108411|FG003|NOT COMPLETED|Period 1||0
9986478|NCT01634165|11108408|FG000|STARTED|Period 2||6
9986479|NCT01634165|11108409|FG001|STARTED|Period 2||6
9986480|NCT01634165|11108410|FG002|STARTED|Period 2||6
9986481|NCT01634165|11108411|FG003|STARTED|Period 2||6
9986482|NCT01634165|11108408|FG000|COMPLETED|Period 2||6
9986483|NCT01634165|11108409|FG001|COMPLETED|Period 2||5
9986484|NCT01634165|11108410|FG002|COMPLETED|Period 2||6
9986485|NCT01634165|11108411|FG003|COMPLETED|Period 2||6
9986486|NCT01634165|11108408|FG000|NOT COMPLETED|Period 2||0
9986487|NCT01634165|11108409|FG001|NOT COMPLETED|Period 2||1
9986488|NCT01634165|11108410|FG002|NOT COMPLETED|Period 2||0
9986489|NCT01634165|11108411|FG003|NOT COMPLETED|Period 2||0
9986490|NCT01634165|11108408|FG000|STARTED|Period 3||6
9986491|NCT01634165|11108409|FG001|STARTED|Period 3||5
9986492|NCT01634165|11108410|FG002|STARTED|Period 3||6
9986493|NCT01634165|11108411|FG003|STARTED|Period 3||6
9986494|NCT01634165|11108408|FG000|COMPLETED|Period 3||6
9986495|NCT01634165|11108409|FG001|COMPLETED|Period 3||5
9986496|NCT01634165|11108410|FG002|COMPLETED|Period 3||6
9986497|NCT01634165|11108411|FG003|COMPLETED|Period 3||6
9986498|NCT01634165|11108408|FG000|NOT COMPLETED|Period 3||0
9986499|NCT01634165|11108409|FG001|NOT COMPLETED|Period 3||0
9986500|NCT01634165|11108410|FG002|NOT COMPLETED|Period 3||0
9986501|NCT01634165|11108411|FG003|NOT COMPLETED|Period 3||0
9986502|NCT01634165|11108408|FG000|STARTED|Period 4||6
9986503|NCT01634165|11108409|FG001|STARTED|Period 4||5
9986504|NCT01634165|11108410|FG002|STARTED|Period 4||6
9986505|NCT01634165|11108411|FG003|STARTED|Period 4||6
9986506|NCT01634165|11108408|FG000|COMPLETED|Period 4||6
9986507|NCT01634165|11108409|FG001|COMPLETED|Period 4||5
9986508|NCT01634165|11108410|FG002|COMPLETED|Period 4||6
9986509|NCT01634165|11108411|FG003|COMPLETED|Period 4||6
9986510|NCT01634165|11108408|FG000|NOT COMPLETED|Period 4||0
9986511|NCT01634165|11108409|FG001|NOT COMPLETED|Period 4||0
9986512|NCT01634165|11108410|FG002|NOT COMPLETED|Period 4||0
9986513|NCT01634165|11108411|FG003|NOT COMPLETED|Period 4||0
9986514|NCT01634178|11108421|FG000|STARTED|Treatment Period 1||23
9986515|NCT01634178|11108422|FG001|STARTED|Treatment Period 1||23
9986516|NCT01634178|11108421|FG000|COMPLETED|Treatment Period 1||23
9986517|NCT01634178|11108422|FG001|COMPLETED|Treatment Period 1||22
9986518|NCT01634178|11108421|FG000|NOT COMPLETED|Treatment Period 1||0
9986519|NCT01634178|11108422|FG001|NOT COMPLETED|Treatment Period 1||1
9986520|NCT01634178|11108421|FG000|STARTED|Treatment Period 2||23
9986521|NCT01634178|11108422|FG001|STARTED|Treatment Period 2||22
9986522|NCT01634178|11108421|FG000|COMPLETED|Treatment Period 2||22
9986523|NCT01634178|11108422|FG001|COMPLETED|Treatment Period 2||22
9986524|NCT01634178|11108421|FG000|NOT COMPLETED|Treatment Period 2||1
9986525|NCT01634178|11108422|FG001|NOT COMPLETED|Treatment Period 2||0
9986526|NCT01634191|11108433|FG000|STARTED|Overall Study||18
9986527|NCT01634191|11108434|FG001|STARTED|Overall Study||18
9986528|NCT01634191|11108433|FG000|COMPLETED|Overall Study||18
9986529|NCT01634191|11108434|FG001|COMPLETED|Overall Study||18
9986530|NCT01634191|11108433|FG000|NOT COMPLETED|Overall Study||0
9986531|NCT01634191|11108434|FG001|NOT COMPLETED|Overall Study||0
9986532|NCT01634243|11108453|FG000|STARTED|Overall Study||21
9986533|NCT01634243|11108454|FG001|STARTED|Overall Study||43
9986534|NCT01634243|11108453|FG000|COMPLETED|Overall Study||15
9986535|NCT01634243|11108454|FG001|COMPLETED|Overall Study||38
9986536|NCT01634243|11108453|FG000|NOT COMPLETED|Overall Study||6
9986537|NCT01634243|11108454|FG001|NOT COMPLETED|Overall Study||5
9986538|NCT01634256|11108462|FG000|STARTED|Overall Study||30
9986539|NCT01634256|11108463|FG001|STARTED|Overall Study||30
9986540|NCT01634256|11108462|FG000|COMPLETED|Overall Study||26
9986541|NCT01634256|11108463|FG001|COMPLETED|Overall Study||22
9986542|NCT01634256|11108462|FG000|NOT COMPLETED|Overall Study||4
9986543|NCT01634256|11108463|FG001|NOT COMPLETED|Overall Study||8
9986544|NCT01634269|11108469|FG000|STARTED|Overall Study||20
9986545|NCT01634269|11108469|FG000|30 Days|Overall Study||20
9986546|NCT01634269|11108469|FG000|6 Month|Overall Study||20
9986547|NCT01634269|11108469|FG000|12 Month|Overall Study||20
9986548|NCT01634269|11108469|FG000|24 Month|Overall Study||18
9986549|NCT01634269|11108469|FG000|COMPLETED|Overall Study||18
9986550|NCT01634269|11108469|FG000|NOT COMPLETED|Overall Study||2
9986551|NCT01634360|11108481|FG000|STARTED|Overall Study||49
9986552|NCT01634360|11108482|FG001|STARTED|Overall Study||136
9986553|NCT01634360|11108481|FG000|COMPLETED|Overall Study||0
9986554|NCT01634360|11108482|FG001|COMPLETED|Overall Study||0
9986555|NCT01634360|11108481|FG000|NOT COMPLETED|Overall Study||49
9986556|NCT01634360|11108482|FG001|NOT COMPLETED|Overall Study||136
9986557|NCT01634555|11108488|FG000|STARTED|Overall Study||29
9986558|NCT01634555|11108488|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
9986559|NCT01634555|11108488|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
9986560|NCT01634555|11108488|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
9986561|NCT01634555|11108488|FG000|NOT COMPLETED|Overall Study||4
9986562|NCT01634620|11108493|FG000|STARTED|Overall Study||200
9986563|NCT01634620|11108493|FG000|COMPLETED|Overall Study||200
9986564|NCT01634620|11108493|FG000|NOT COMPLETED|Overall Study||0
9986565|NCT01634659|11108504|FG000|STARTED|Period 1 - First 8 Days of Wear||155
9986566|NCT01634659|11108505|FG001|STARTED|Period 1 - First 8 Days of Wear||158
9986567|NCT01634659|11108504|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155
9986568|NCT01634659|11108505|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158
9986569|NCT01634659|11108504|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
9986570|NCT01634659|11108505|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
9986571|NCT01634659|11108504|FG000|STARTED|Period 2 - Second 8 Days of Wear||155
9986572|NCT01634659|11108505|FG001|STARTED|Period 2 - Second 8 Days of Wear||158
9986573|NCT01634659|11108504|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152
9986574|NCT01634659|11108505|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158
9986575|NCT01634659|11108504|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
9986576|NCT01634659|11108505|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
9986577|NCT01634854|11108513|FG000|STARTED|Overall Study||64
9986578|NCT01634854|11108514|FG001|STARTED|Overall Study||66
9986579|NCT01634854|11108513|FG000|COMPLETED|Overall Study||62
9986580|NCT01634854|11108514|FG001|COMPLETED|Overall Study||59
9986581|NCT01634854|11108513|FG000|NOT COMPLETED|Overall Study||2
9986582|NCT01634854|11108514|FG001|NOT COMPLETED|Overall Study||7
9986583|NCT01635062|11108522|FG000|STARTED|Overall Study||9
9986584|NCT01635062|11108523|FG001|STARTED|Overall Study||9
9986585|NCT01635062|11108522|FG000|Sodium Restriction Baseline Visit|Overall Study||9
9986586|NCT01635062|11108523|FG001|Sodium Restriction Baseline Visit|Overall Study||9
9986587|NCT01635062|11108522|FG000|Sodium Loading Baseline Visit|Overall Study||9
9986588|NCT01635062|11108523|FG001|Sodium Loading Baseline Visit|Overall Study||9
9986589|NCT01635062|11108522|FG000|Post-randomization Sodium Restriction|Overall Study||9
9986590|NCT01635062|11108523|FG001|Post-randomization Sodium Restriction|Overall Study||9
9986591|NCT01635062|11108522|FG000|Post-Randomization Sodium Loaded|Overall Study||9
9986592|NCT01635062|11108523|FG001|Post-Randomization Sodium Loaded|Overall Study||9
9986593|NCT01635062|11108522|FG000|COMPLETED|Overall Study||9
9986594|NCT01635062|11108523|FG001|COMPLETED|Overall Study||9
9986595|NCT01635062|11108522|FG000|NOT COMPLETED|Overall Study||0
9986596|NCT01635062|11108523|FG001|NOT COMPLETED|Overall Study||0
9986597|NCT01635101|11108536|FG000|STARTED|Overall Study||61
9986598|NCT01635101|11108537|FG001|STARTED|Overall Study||67
9986599|NCT01635101|11108538|FG002|STARTED|Overall Study||69
9986600|NCT01635101|11108536|FG000|Safety Population|Overall Study||61
9986601|NCT01635101|11108537|FG001|Safety Population|Overall Study||67
9986602|NCT01635101|11108538|FG002|Safety Population|Overall Study||69
9986603|NCT01635101|11108536|FG000|Modified Intent to Treat (mITT)|Overall Study||61
9986604|NCT01635101|11108537|FG001|Modified Intent to Treat (mITT)|Overall Study||67
9986605|NCT01635101|11108538|FG002|Modified Intent to Treat (mITT)|Overall Study||69
9986606|NCT01635101|11108536|FG000|Pharmacokinetics Evaluable Population|Overall Study||50
9986607|NCT01635101|11108537|FG001|Pharmacokinetics Evaluable Population|Overall Study||59
9986608|NCT01635101|11108538|FG002|Pharmacokinetics Evaluable Population|Overall Study||58
9986609|NCT01635101|11108536|FG000|COMPLETED|Overall Study||52
9986610|NCT01635101|11108537|FG001|COMPLETED|Overall Study||55
9986611|NCT01635101|11108538|FG002|COMPLETED|Overall Study||52
9986612|NCT01635101|11108536|FG000|NOT COMPLETED|Overall Study||9
9986613|NCT01635101|11108537|FG001|NOT COMPLETED|Overall Study||12
9986614|NCT01635101|11108538|FG002|NOT COMPLETED|Overall Study||17
9986615|NCT01635153|11108551|FG000|STARTED|Overall Study||72
9986616|NCT01635153|11108552|FG001|STARTED|Overall Study||79
9986617|NCT01635153|11108551|FG000|COMPLETED|Overall Study||32
9986618|NCT01635153|11108552|FG001|COMPLETED|Overall Study||36
9986619|NCT01635153|11108551|FG000|NOT COMPLETED|Overall Study||40
9986620|NCT01635153|11108552|FG001|NOT COMPLETED|Overall Study||43
9986621|NCT01635218|11108561|FG000|STARTED|Overall Study||44
9986622|NCT01635218|11108562|FG001|STARTED|Overall Study||46
9986623|NCT01635218|11108563|FG002|STARTED|Overall Study||43
9986624|NCT01635218|11108561|FG000|COMPLETED|Overall Study||41
9986625|NCT01635218|11108562|FG001|COMPLETED|Overall Study||39
9986626|NCT01635218|11108563|FG002|COMPLETED|Overall Study||37
9986627|NCT01635218|11108561|FG000|NOT COMPLETED|Overall Study||3
9986628|NCT01635218|11108562|FG001|NOT COMPLETED|Overall Study||7
9986629|NCT01635218|11108563|FG002|NOT COMPLETED|Overall Study||6
9986630|NCT01635244|11108574|FG000|STARTED|Overall Study||18
9986631|NCT01635244|11108575|FG001|STARTED|Overall Study||22
9986632|NCT01635244|11108576|FG002|STARTED|Overall Study||20
9986633|NCT01635244|11108574|FG000|COMPLETED|Overall Study||17
9986634|NCT01635244|11108575|FG001|COMPLETED|Overall Study||21
9986635|NCT01635244|11108576|FG002|COMPLETED|Overall Study||18
9986636|NCT01635244|11108574|FG000|NOT COMPLETED|Overall Study||1
9986637|NCT01635244|11108575|FG001|NOT COMPLETED|Overall Study||1
9986638|NCT01635244|11108576|FG002|NOT COMPLETED|Overall Study||2
9986639|NCT01635283|11108584|FG000|STARTED|Overall Study||5
9986640|NCT01635283|11108584|FG000|COMPLETED|Overall Study||1
9986641|NCT01635283|11108584|FG000|NOT COMPLETED|Overall Study||4
9986642|NCT01635439|11108593|FG000|STARTED|Overall Study||100
9986643|NCT01635439|11108594|FG001|STARTED|Overall Study||100
9986644|NCT01635439|11108593|FG000|COMPLETED|Overall Study||100
9986645|NCT01635439|11108594|FG001|COMPLETED|Overall Study||100
9986646|NCT01635439|11108593|FG000|NOT COMPLETED|Overall Study||0
9986647|NCT01635439|11108594|FG001|NOT COMPLETED|Overall Study||0
9986648|NCT01635504|11108600|FG000|STARTED|Overall Study||5
9986649|NCT01635504|11108600|FG000|COMPLETED|Overall Study||5
9986650|NCT01635504|11108600|FG000|NOT COMPLETED|Overall Study||0
9986651|NCT01635764|11108609|FG000|STARTED|Overall Study||508
9986652|NCT01635764|11108609|FG000|COMPLETED|Overall Study||235
9986653|NCT01635764|11108609|FG000|NOT COMPLETED|Overall Study||273
9986654|NCT01635855|11108620|FG000|STARTED|Overall Study||117
9986655|NCT01635855|11108620|FG000|COMPLETED|Overall Study||113
9986656|NCT01635855|11108620|FG000|NOT COMPLETED|Overall Study||4
9986657|NCT01635881|11108624|FG000|STARTED|Overall Study||60
9986658|NCT01635881|11108624|FG000|COMPLETED|Overall Study||60
9986659|NCT01635881|11108624|FG000|NOT COMPLETED|Overall Study||0
9986660|NCT01635920|11108630|FG000|STARTED|Overall Study||125
9986661|NCT01635920|11108631|FG001|STARTED|Overall Study||126
9986662|NCT01635920|11108630|FG000|COMPLETED|Overall Study||122
9986663|NCT01635920|11108631|FG001|COMPLETED|Overall Study||125
9986664|NCT01635920|11108630|FG000|NOT COMPLETED|Overall Study||3
9986665|NCT01635920|11108631|FG001|NOT COMPLETED|Overall Study||1
9986666|NCT01635933|11108640|FG000|STARTED|Overall Study||178
9986667|NCT01635933|11108641|FG001|STARTED|Overall Study||185
9986668|NCT01635933|11108640|FG000|COMPLETED|Overall Study||176
9986669|NCT01635933|11108641|FG001|COMPLETED|Overall Study||177
9986670|NCT01635933|11108640|FG000|NOT COMPLETED|Overall Study||2
9986671|NCT01635933|11108641|FG001|NOT COMPLETED|Overall Study||8
9986672|NCT01635998|11108649|FG000|STARTED|Overall Study||28
9986673|NCT01635998|11108650|FG001|STARTED|Overall Study||22
9986674|NCT01635998|11108649|FG000|COMPLETED|Overall Study||24
9986675|NCT01635998|11108650|FG001|COMPLETED|Overall Study||15
9986676|NCT01635998|11108649|FG000|NOT COMPLETED|Overall Study||4
9986677|NCT01635998|11108650|FG001|NOT COMPLETED|Overall Study||7
9986678|NCT01636063|11108658|FG000|STARTED|Overall Study||21
9986679|NCT01636063|11108659|FG001|STARTED|Overall Study||21
9986680|NCT01636063|11108658|FG000|COMPLETED|Overall Study||21
9986681|NCT01636063|11108659|FG001|COMPLETED|Overall Study||21
9986682|NCT01636063|11108658|FG000|NOT COMPLETED|Overall Study||0
9986683|NCT01636063|11108659|FG001|NOT COMPLETED|Overall Study||0
9986684|NCT01636076|11108667|FG000|STARTED|Overall Study||316
9986685|NCT01636076|11108668|FG001|STARTED|Overall Study||313
9986686|NCT01636076|11108667|FG000|COMPLETED|Overall Study||299
9986687|NCT01636076|11108668|FG001|COMPLETED|Overall Study||288
9986688|NCT01636076|11108667|FG000|NOT COMPLETED|Overall Study||17
9986689|NCT01636076|11108668|FG001|NOT COMPLETED|Overall Study||25
9986690|NCT01636102|11108683|FG000|STARTED|Overall Study||63
9986691|NCT01636102|11108684|FG001|STARTED|Overall Study||63
9986692|NCT01636102|11108683|FG000|COMPLETED|Overall Study||63
9986693|NCT01636102|11108684|FG001|COMPLETED|Overall Study||63
9986694|NCT01636102|11108683|FG000|NOT COMPLETED|Overall Study||0
9986695|NCT01636102|11108684|FG001|NOT COMPLETED|Overall Study||0
9986696|NCT01636206|11108693|FG000|STARTED|Overall Study||111
9986697|NCT01636206|11108694|FG001|STARTED|Overall Study||221
9986698|NCT01636206|11108693|FG000|COMPLETED|Overall Study||92
9986699|NCT01636206|11108694|FG001|COMPLETED|Overall Study||170
9986700|NCT01636206|11108693|FG000|NOT COMPLETED|Overall Study||19
9986701|NCT01636206|11108694|FG001|NOT COMPLETED|Overall Study||51
9986702|NCT01636284|11108700|FG000|STARTED|Overall Study||16
9986703|NCT01636284|11108700|FG000|COMPLETED|Overall Study||16
9986704|NCT01636284|11108700|FG000|NOT COMPLETED|Overall Study||0
9986705|NCT01636297|11108707|FG000|STARTED|Overall Study||40
9986706|NCT01636297|11108708|FG001|STARTED|Overall Study||40
9986707|NCT01636297|11108709|FG002|STARTED|Overall Study||20
9986708|NCT01636297|11108707|FG000|COMPLETED|Overall Study||36
9986709|NCT01636297|11108708|FG001|COMPLETED|Overall Study||36
9986710|NCT01636297|11108709|FG002|COMPLETED|Overall Study||19
9986711|NCT01636297|11108707|FG000|NOT COMPLETED|Overall Study||4
9986712|NCT01636297|11108708|FG001|NOT COMPLETED|Overall Study||4
9986713|NCT01636297|11108709|FG002|NOT COMPLETED|Overall Study||1
9986714|NCT01636362|11108719|FG000|STARTED|Overall Study||45
9986715|NCT01636362|11108719|FG000|COMPLETED|Overall Study||37
9986716|NCT01636362|11108719|FG000|NOT COMPLETED|Overall Study||8
9986717|NCT01636414|11108726|FG000|STARTED|Overall Study||64
9986718|NCT01636414|11108727|FG001|STARTED|Overall Study||66
9986719|NCT01636414|11108728|FG002|STARTED|Overall Study||74
9986720|NCT01636414|11108726|FG000|COMPLETED|Overall Study||61
9986721|NCT01636414|11108727|FG001|COMPLETED|Overall Study||60
9986722|NCT01636414|11108728|FG002|COMPLETED|Overall Study||65
9986723|NCT01636414|11108726|FG000|NOT COMPLETED|Overall Study||3
9986724|NCT01636414|11108727|FG001|NOT COMPLETED|Overall Study||6
9986725|NCT01636414|11108728|FG002|NOT COMPLETED|Overall Study||9
9986726|NCT01636453|11108736|FG000|STARTED|Overall Study||120
9986727|NCT01636453|11108736|FG000|COMPLETED|Overall Study||112
9986728|NCT01636453|11108736|FG000|NOT COMPLETED|Overall Study||8
9986729|NCT01636661|11108742|FG000|STARTED|Overall Study||5
9986730|NCT01636661|11108743|FG001|STARTED|Overall Study||6
9986731|NCT01636661|11108742|FG000|COMPLETED|Overall Study||5
9986732|NCT01636661|11108743|FG001|COMPLETED|Overall Study||6
9986733|NCT01636661|11108742|FG000|NOT COMPLETED|Overall Study||0
9986734|NCT01636661|11108743|FG001|NOT COMPLETED|Overall Study||0
9986735|NCT01636687|11108752|FG000|STARTED|Induction Period||61
9986736|NCT01636687|11108753|FG001|STARTED|Induction Period||60
9986737|NCT01636687|11108754|FG002|STARTED|Induction Period||0
9986738|NCT01636687|11108755|FG003|STARTED|Induction Period||0
9986739|NCT01636687|11108756|FG004|STARTED|Induction Period||61
9986740|NCT01636687|11108752|FG000|COMPLETED|Induction Period||58
9986741|NCT01636687|11108753|FG001|COMPLETED|Induction Period||60
9986742|NCT01636687|11108754|FG002|COMPLETED|Induction Period||0
9986743|NCT01636687|11108755|FG003|COMPLETED|Induction Period||0
9986744|NCT01636687|11108756|FG004|COMPLETED|Induction Period||59
9986745|NCT01636687|11108752|FG000|NOT COMPLETED|Induction Period||3
9986746|NCT01636687|11108753|FG001|NOT COMPLETED|Induction Period||0
9986747|NCT01636687|11108754|FG002|NOT COMPLETED|Induction Period||0
9986748|NCT01636687|11108755|FG003|NOT COMPLETED|Induction Period||0
9986749|NCT01636687|11108756|FG004|NOT COMPLETED|Induction Period||2
9986750|NCT01636687|11108752|FG000|STARTED|Maintenance Period||58
9986751|NCT01636687|11108753|FG001|STARTED|Maintenance Period||60
9986752|NCT01636687|11108754|FG002|STARTED|Maintenance Period||28
9986753|NCT01636687|11108755|FG003|STARTED|Maintenance Period||28
9986754|NCT01636687|11108756|FG004|STARTED|Maintenance Period||3
9986755|NCT01636687|11108752|FG000|COMPLETED|Maintenance Period||50
9986756|NCT01636687|11108753|FG001|COMPLETED|Maintenance Period||58
9986757|NCT01636687|11108754|FG002|COMPLETED|Maintenance Period||26
9986758|NCT01636687|11108755|FG003|COMPLETED|Maintenance Period||28
9986759|NCT01636687|11108756|FG004|COMPLETED|Maintenance Period||1
9986760|NCT01636687|11108752|FG000|NOT COMPLETED|Maintenance Period||8
9986761|NCT01636687|11108753|FG001|NOT COMPLETED|Maintenance Period||2
9986762|NCT01636687|11108754|FG002|NOT COMPLETED|Maintenance Period||2
9986763|NCT01636687|11108755|FG003|NOT COMPLETED|Maintenance Period||0
9986764|NCT01636687|11108756|FG004|NOT COMPLETED|Maintenance Period||2
9986765|NCT01636687|11108752|FG000|STARTED|Extension Period||47
9986766|NCT01636687|11108753|FG001|STARTED|Extension Period||54
9986767|NCT01636687|11108754|FG002|STARTED|Extension Period||25
9986768|NCT01636687|11108755|FG003|STARTED|Extension Period||28
9986769|NCT01636687|11108756|FG004|STARTED|Extension Period||0
9986770|NCT01636687|11108752|FG000|COMPLETED|Extension Period||0
9986771|NCT01636687|11108753|FG001|COMPLETED|Extension Period||0
9986772|NCT01636687|11108754|FG002|COMPLETED|Extension Period||0
9986773|NCT01636687|11108755|FG003|COMPLETED|Extension Period||0
9986774|NCT01636687|11108756|FG004|COMPLETED|Extension Period||0
9986775|NCT01636687|11108752|FG000|NOT COMPLETED|Extension Period||47
9986776|NCT01636687|11108753|FG001|NOT COMPLETED|Extension Period||54
9986777|NCT01636687|11108754|FG002|NOT COMPLETED|Extension Period||25
9986778|NCT01636687|11108755|FG003|NOT COMPLETED|Extension Period||28
9986779|NCT01636687|11108756|FG004|NOT COMPLETED|Extension Period||0
9986780|NCT01636687|11108752|FG000|STARTED|Follow-up Period||38
9986781|NCT01636687|11108753|FG001|STARTED|Follow-up Period||45
9986782|NCT01636687|11108754|FG002|STARTED|Follow-up Period||21
9986783|NCT01636687|11108755|FG003|STARTED|Follow-up Period||20
9986784|NCT01636687|11108756|FG004|STARTED|Follow-up Period||2
9986785|NCT01636687|11108752|FG000|COMPLETED|Follow-up Period||37
9986786|NCT01636687|11108753|FG001|COMPLETED|Follow-up Period||45
9986787|NCT01636687|11108754|FG002|COMPLETED|Follow-up Period||21
9986788|NCT01636687|11108755|FG003|COMPLETED|Follow-up Period||20
9986789|NCT01636687|11108756|FG004|COMPLETED|Follow-up Period||1
9986790|NCT01636687|11108752|FG000|NOT COMPLETED|Follow-up Period||1
9986791|NCT01636687|11108753|FG001|NOT COMPLETED|Follow-up Period||0
9986792|NCT01636687|11108754|FG002|NOT COMPLETED|Follow-up Period||0
9986793|NCT01636687|11108755|FG003|NOT COMPLETED|Follow-up Period||0
9986794|NCT01636687|11108756|FG004|NOT COMPLETED|Follow-up Period||1
9986795|NCT01636713|11108777|FG000|STARTED|Overall Study||193
9986796|NCT01636713|11108778|FG001|STARTED|Overall Study||194
9986797|NCT01636713|11108779|FG002|STARTED|Overall Study||193
9986798|NCT01636713|11108777|FG000|COMPLETED|Overall Study||161
9986799|NCT01636713|11108778|FG001|COMPLETED|Overall Study||166
9986800|NCT01636713|11108779|FG002|COMPLETED|Overall Study||170
9986801|NCT01636713|11108777|FG000|NOT COMPLETED|Overall Study||32
9986802|NCT01636713|11108778|FG001|NOT COMPLETED|Overall Study||28
9986803|NCT01636713|11108779|FG002|NOT COMPLETED|Overall Study||23
9986804|NCT01636765|11108787|FG000|STARTED|Overall Study||104
9986805|NCT01636765|11108787|FG000|COMPLETED|Overall Study||104
9986806|NCT01636765|11108787|FG000|NOT COMPLETED|Overall Study||0
9986807|NCT01636778|11108791|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
9986808|NCT01636778|11108792|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
9986809|NCT01636778|11108793|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
9986810|NCT01636778|11108791|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
9986811|NCT01636778|11108792|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
9986812|NCT01636778|11108793|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
9986813|NCT01636778|11108791|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
9986814|NCT01636778|11108792|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
9986815|NCT01636778|11108793|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
9986816|NCT01636778|11108791|FG000|STARTED|Antiviral Treatment Period (Part 2)||0
9986817|NCT01636778|11108792|FG001|STARTED|Antiviral Treatment Period (Part 2)||41
9986818|NCT01636778|11108793|FG002|STARTED|Antiviral Treatment Period (Part 2)||0
9986819|NCT01636778|11108791|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0
9986820|NCT01636778|11108792|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31
9986821|NCT01636778|11108793|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0
9986822|NCT01636778|11108791|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
9986823|NCT01636778|11108792|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
9986824|NCT01636778|11108793|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
9986825|NCT01636778|11108791|FG000|STARTED|Follow-up Period After Part 2||0
9986826|NCT01636778|11108792|FG001|STARTED|Follow-up Period After Part 2||0
9986827|NCT01636778|11108793|FG002|STARTED|Follow-up Period After Part 2||41
9986828|NCT01636778|11108791|FG000|COMPLETED|Follow-up Period After Part 2||0
9986829|NCT01636778|11108792|FG001|COMPLETED|Follow-up Period After Part 2||0
9986830|NCT01636778|11108793|FG002|COMPLETED|Follow-up Period After Part 2||37
9986831|NCT01636778|11108791|FG000|NOT COMPLETED|Follow-up Period After Part 2||0
9986832|NCT01636778|11108792|FG001|NOT COMPLETED|Follow-up Period After Part 2||0
9986833|NCT01636778|11108793|FG002|NOT COMPLETED|Follow-up Period After Part 2||4
9986834|NCT01636882|11108801|FG000|STARTED|Overall Study||16
9986835|NCT01636882|11108801|FG000|COMPLETED|Overall Study||16
9986836|NCT01636882|11108801|FG000|NOT COMPLETED|Overall Study||0
9986837|NCT01636934|11108807|FG000|STARTED|Overall Study||25
9986838|NCT01636934|11108808|FG001|STARTED|Overall Study||24
9986839|NCT01636934|11108807|FG000|COMPLETED|Overall Study||19
9986840|NCT01636934|11108808|FG001|COMPLETED|Overall Study||21
9986841|NCT01636934|11108807|FG000|NOT COMPLETED|Overall Study||6
9986842|NCT01636934|11108808|FG001|NOT COMPLETED|Overall Study||3
9986843|NCT01636947|11108816|FG000|STARTED|Overall Study||244
9986844|NCT01636947|11108817|FG001|STARTED|Overall Study||250
9986845|NCT01636947|11108816|FG000|Treated|Overall Study||242
9986846|NCT01636947|11108817|FG001|Treated|Overall Study||248
9986847|NCT01636947|11108816|FG000|COMPLETED|Overall Study||232
9986848|NCT01636947|11108817|FG001|COMPLETED|Overall Study||239
9986849|NCT01636947|11108816|FG000|NOT COMPLETED|Overall Study||12
9986850|NCT01636947|11108817|FG001|NOT COMPLETED|Overall Study||11
9986851|NCT01636960|11108823|FG000|STARTED|Induction Phase||9
9986852|NCT01636960|11108823|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
9986853|NCT01636960|11108823|FG000|NOT COMPLETED|Induction Phase||2
9986854|NCT01636960|11108823|FG000|STARTED|Maintenance Phase||7
9986855|NCT01636960|11108823|FG000|COMPLETED|Maintenance Phase||0
9986856|NCT01636960|11108823|FG000|NOT COMPLETED|Maintenance Phase||7
9986857|NCT01636986|11108829|FG000|STARTED|Overall Study||30
9986858|NCT01636986|11108830|FG001|STARTED|Overall Study||32
9986859|NCT01636986|11108829|FG000|COMPLETED|Overall Study||30
9986860|NCT01636986|11108830|FG001|COMPLETED|Overall Study||30
9986861|NCT01636986|11108829|FG000|NOT COMPLETED|Overall Study||0
9986862|NCT01636986|11108830|FG001|NOT COMPLETED|Overall Study||2
10018156|NCT01822366|11141166|FG000|COMPLETED|Overall Study||315
10018157|NCT01822366|11141167|FG001|COMPLETED|Overall Study||298
10018158|NCT01822366|11141168|FG002|COMPLETED|Overall Study||315
10018159|NCT01822366|11141169|FG003|COMPLETED|Overall Study||298
10018160|NCT01822366|11141166|FG000|NOT COMPLETED|Overall Study||5
10018161|NCT01822366|11141167|FG001|NOT COMPLETED|Overall Study||22
10018162|NCT01822366|11141168|FG002|NOT COMPLETED|Overall Study||5
10018163|NCT01822366|11141169|FG003|NOT COMPLETED|Overall Study||22
10101276|NCT02406742|11230546|FG000|COMPLETED|Overall Study||0
10101277|NCT02406742|11230547|FG001|COMPLETED|Overall Study||0
10018164|NCT01822457|11141199|FG000|STARTED|Overall Study||20
10018165|NCT01822457|11141200|FG001|STARTED|Overall Study||17
10018166|NCT01822457|11141199|FG000|COMPLETED|Overall Study||16
10018167|NCT01822457|11141200|FG001|COMPLETED|Overall Study||12
10018168|NCT01822457|11141199|FG000|NOT COMPLETED|Overall Study||4
10018169|NCT01822457|11141200|FG001|NOT COMPLETED|Overall Study||5
10018170|NCT01822496|11141210|FG000|STARTED|Overall Study||16
10018171|NCT01822496|11141211|FG001|STARTED|Overall Study||23
10018172|NCT01822496|11141212|FG002|STARTED|Overall Study||9
10018173|NCT01822496|11141213|FG003|STARTED|Overall Study||11
10018174|NCT01822496|11141210|FG000|Eligible|Overall Study||14
10018175|NCT01822496|11141211|FG001|Eligible|Overall Study||21
10018176|NCT01822496|11141212|FG002|Eligible|Overall Study||9
10018177|NCT01822496|11141213|FG003|Eligible|Overall Study||7
10018178|NCT01822496|11141210|FG000|Eligible With Disease Assessment|Overall Study||10
10018179|NCT01822496|11141211|FG001|Eligible With Disease Assessment|Overall Study||15
10018180|NCT01822496|11141212|FG002|Eligible With Disease Assessment|Overall Study||6
10018181|NCT01822496|11141213|FG003|Eligible With Disease Assessment|Overall Study||4
10018182|NCT01822496|11141210|FG000|Eligible and Started Study Treatment|Overall Study||14
10018183|NCT01822496|11141211|FG001|Eligible and Started Study Treatment|Overall Study||20
10018184|NCT01822496|11141212|FG002|Eligible and Started Study Treatment|Overall Study||9
10018185|NCT01822496|11141213|FG003|Eligible and Started Study Treatment|Overall Study||7
10018186|NCT01822496|11141210|FG000|COMPLETED|Overall Study||14
10101278|NCT02406742|11230548|FG002|COMPLETED|Overall Study||0
10018187|NCT01822496|11141211|FG001|COMPLETED|Overall Study||21
10018188|NCT01822496|11141212|FG002|COMPLETED|Overall Study||9
10018189|NCT01822496|11141213|FG003|COMPLETED|Overall Study||7
10018190|NCT01822496|11141210|FG000|NOT COMPLETED|Overall Study||2
10018191|NCT01822496|11141211|FG001|NOT COMPLETED|Overall Study||2
10018192|NCT01822496|11141212|FG002|NOT COMPLETED|Overall Study||0
10018193|NCT01822496|11141213|FG003|NOT COMPLETED|Overall Study||4
10018194|NCT01822535|11141225|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
10018195|NCT01822535|11141226|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
10018196|NCT01822535|11141225|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
10018197|NCT01822535|11141226|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
10101279|NCT02406742|11230546|FG000|NOT COMPLETED|Overall Study||14
9986863|NCT01637077|11108838|FG000|STARTED|Overall Study||23
9986864|NCT01637077|11108839|FG001|STARTED|Overall Study||23
9986865|NCT01637077|11108838|FG000|COMPLETED|Overall Study||19
9986866|NCT01637077|11108839|FG001|COMPLETED|Overall Study||22
9986867|NCT01637077|11108838|FG000|NOT COMPLETED|Overall Study||4
9758713|NCT01711879|10862282|FG000|NOT COMPLETED|Overall Study||1
9758714|NCT01711879|10862283|FG001|NOT COMPLETED|Overall Study||0
9758715|NCT01697267|10862293|FG000|STARTED|Overall Study||85
9758716|NCT01697267|10862294|FG001|STARTED|Overall Study||85
9758717|NCT01697267|10862293|FG000|Month 24|Overall Study||78
9758718|NCT01697267|10862294|FG001|Month 24|Overall Study||78
9986868|NCT01637077|11108839|FG001|NOT COMPLETED|Overall Study||1
9986869|NCT01637090|11108845|FG000|STARTED|Overall Study||3
9986870|NCT01637090|11108845|FG000|COMPLETED|Overall Study||0
9986871|NCT01637090|11108845|FG000|NOT COMPLETED|Overall Study||3
9986872|NCT01637142|11108849|FG000|STARTED|Treatment Period 1||18
9986873|NCT01637142|11108849|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18
9986874|NCT01637142|11108849|FG000|COMPLETED|Treatment Period 1||18
9986875|NCT01637142|11108849|FG000|NOT COMPLETED|Treatment Period 1||0
9986876|NCT01637142|11108849|FG000|STARTED|Washout Period (at Least 3 Days)||18
9986877|NCT01637142|11108849|FG000|COMPLETED|Washout Period (at Least 3 Days)||17
9986878|NCT01637142|11108849|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1
9986879|NCT01637142|11108849|FG000|STARTED|Treatment Period 2||17
9986880|NCT01637142|11108849|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17
9986881|NCT01637142|11108849|FG000|COMPLETED|Treatment Period 2||17
9986882|NCT01637142|11108849|FG000|NOT COMPLETED|Treatment Period 2||0
9986883|NCT01637246|11108855|FG000|STARTED|Overall Study||4385
9986884|NCT01637246|11108855|FG000|COMPLETED|Overall Study||2246
9986885|NCT01637246|11108855|FG000|NOT COMPLETED|Overall Study||2139
9986886|NCT01637272|11108859|FG000|STARTED|Overall Study||43
9986887|NCT01637272|11108859|FG000|Completed sc Phase|Overall Study||33
9986888|NCT01637272|11108859|FG000|Completed Core Phase (sc + LAR)|Overall Study||31
9986889|NCT01637272|11108859|FG000|Entered Extension Phase|Overall Study||27
9986890|NCT01637272|11108859|FG000|Completed Core But Did no Enter Ext..|Overall Study||4
9986891|NCT01637272|11108859|FG000|COMPLETED|Overall Study||23
9986892|NCT01637272|11108859|FG000|NOT COMPLETED|Overall Study||20
9986893|NCT01637402|11108878|FG000|STARTED|Standard Dose Regimen||41
9986894|NCT01637402|11108879|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
9986895|NCT01637402|11108878|FG000|COMPLETED|Standard Dose Regimen||38
9986896|NCT01637402|11108879|FG001|COMPLETED|Standard Dose Regimen||0
9986897|NCT01637402|11108878|FG000|NOT COMPLETED|Standard Dose Regimen||3
9986898|NCT01637402|11108879|FG001|NOT COMPLETED|Standard Dose Regimen||0
9986899|NCT01637402|11108878|FG000|STARTED|Week 12 Evaluation||38
9986900|NCT01637402|11108879|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
9986901|NCT01637402|11108878|FG000|COMPLETED|Week 12 Evaluation||32
9986902|NCT01637402|11108879|FG001|COMPLETED|Week 12 Evaluation||0
9986903|NCT01637402|11108878|FG000|NOT COMPLETED|Week 12 Evaluation||6
9986904|NCT01637402|11108879|FG001|NOT COMPLETED|Week 12 Evaluation||0
9986905|NCT01637402|11108878|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
9986906|NCT01637402|11108879|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
9986907|NCT01637402|11108878|FG000|COMPLETED|Treatment Regiments Post Week 12||5
9986908|NCT01637402|11108879|FG001|COMPLETED|Treatment Regiments Post Week 12||14
9986909|NCT01637402|11108878|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9
9986910|NCT01637402|11108879|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
9986911|NCT01637584|11108906|FG000|STARTED|Overall Study||20
9986912|NCT01637584|11108907|FG001|STARTED|Overall Study||20
9986913|NCT01637584|11108906|FG000|COMPLETED|Overall Study||19
9986914|NCT01637584|11108907|FG001|COMPLETED|Overall Study||17
9986915|NCT01637584|11108906|FG000|NOT COMPLETED|Overall Study||1
9986916|NCT01637584|11108907|FG001|NOT COMPLETED|Overall Study||3
9986917|NCT01637623|11108917|FG000|STARTED|Overall Study||29
9986918|NCT01637623|11108918|FG001|STARTED|Overall Study||30
9986919|NCT01637623|11108919|FG002|STARTED|Overall Study||28
9986920|NCT01637623|11108917|FG000|Received Intervention|Overall Study||28
9986921|NCT01637623|11108918|FG001|Received Intervention|Overall Study||30
9986922|NCT01637623|11108919|FG002|Received Intervention|Overall Study||27
9986923|NCT01637623|11108917|FG000|Did Not Receive Intervention|Overall Study||1
9986924|NCT01637623|11108918|FG001|Did Not Receive Intervention|Overall Study||0
9986925|NCT01637623|11108919|FG002|Did Not Receive Intervention|Overall Study||1
9986926|NCT01637623|11108917|FG000|Analyzed|Overall Study||28
9986927|NCT01637623|11108918|FG001|Analyzed|Overall Study||30
9986928|NCT01637623|11108919|FG002|Analyzed|Overall Study||28
9986929|NCT01637623|11108917|FG000|COMPLETED|Overall Study||28
9986930|NCT01637623|11108918|FG001|COMPLETED|Overall Study||30
9986931|NCT01637623|11108919|FG002|COMPLETED|Overall Study||25
9986932|NCT01637623|11108917|FG000|NOT COMPLETED|Overall Study||1
9986933|NCT01637623|11108918|FG001|NOT COMPLETED|Overall Study||0
9986934|NCT01637623|11108919|FG002|NOT COMPLETED|Overall Study||3
9986935|NCT01637870|11108927|FG000|STARTED|Overall Study||110
9986936|NCT01637870|11108927|FG000|COMPLETED|Overall Study||110
9986937|NCT01637870|11108927|FG000|NOT COMPLETED|Overall Study||0
9986938|NCT01637922|11108933|FG000|STARTED|Overall Study||15
9758719|NCT01697267|10862293|FG000|COMPLETED|Overall Study||71
9758720|NCT01697267|10862294|FG001|COMPLETED|Overall Study||70
9986939|NCT01637922|11108934|FG001|STARTED|Overall Study||19
9986940|NCT01637922|11108933|FG000|COMPLETED|Overall Study||13
9986941|NCT01637922|11108934|FG001|COMPLETED|Overall Study||14
9986942|NCT01637922|11108933|FG000|NOT COMPLETED|Overall Study||2
9986943|NCT01637922|11108934|FG001|NOT COMPLETED|Overall Study||5
9986944|NCT01637935|11108943|FG000|STARTED|Overall Study||34181
9986945|NCT01637935|11108944|FG001|STARTED|Overall Study||158918
9986946|NCT01637935|11108943|FG000|COMPLETED|Overall Study||34181
9986947|NCT01637935|11108944|FG001|COMPLETED|Overall Study||158918
9986948|NCT01637935|11108943|FG000|NOT COMPLETED|Overall Study||0
9986949|NCT01637935|11108944|FG001|NOT COMPLETED|Overall Study||0
9986950|NCT01637961|11108950|FG000|STARTED|Overall Study||23
9986951|NCT01637961|11108950|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21
9986952|NCT01637961|11108950|FG000|NOT COMPLETED|Overall Study||2
9986953|NCT01638000|11108962|FG000|STARTED|Overall Study||943
9986954|NCT01638000|11108963|FG001|STARTED|Overall Study||944
9986955|NCT01638000|11108962|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936
9986956|NCT01638000|11108963|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934
9986957|NCT01638000|11108962|FG000|COMPLETED|Overall Study||883
9986958|NCT01638000|11108963|FG001|COMPLETED|Overall Study||873
9986959|NCT01638000|11108962|FG000|NOT COMPLETED|Overall Study||60
9986960|NCT01638000|11108963|FG001|NOT COMPLETED|Overall Study||71
9986961|NCT01638013|11108972|FG000|STARTED|Overall Study||201
9986962|NCT01638013|11108973|FG001|STARTED|Overall Study||225
9986963|NCT01638013|11108974|FG002|STARTED|Overall Study||417
9986964|NCT01638013|11108972|FG000|COMPLETED|Overall Study||70
9986965|NCT01638013|11108973|FG001|COMPLETED|Overall Study||147
9986966|NCT01638013|11108974|FG002|COMPLETED|Overall Study||296
9986967|NCT01638013|11108972|FG000|NOT COMPLETED|Overall Study||131
9986968|NCT01638013|11108973|FG001|NOT COMPLETED|Overall Study||78
9986969|NCT01638013|11108974|FG002|NOT COMPLETED|Overall Study||121
9986970|NCT01638052|11108988|FG000|STARTED|Overall Study||28
9986971|NCT01638052|11108989|FG001|STARTED|Overall Study||28
9986972|NCT01638052|11108988|FG000|COMPLETED|Overall Study||28
9986973|NCT01638052|11108989|FG001|COMPLETED|Overall Study||28
9986974|NCT01638052|11108988|FG000|NOT COMPLETED|Overall Study||0
9986975|NCT01638052|11108989|FG001|NOT COMPLETED|Overall Study||0
9986976|NCT01638312|11108997|FG000|STARTED|Overall Study||20
9986977|NCT01638312|11108998|FG001|STARTED|Overall Study||30
9986978|NCT01638312|11108997|FG000|COMPLETED|Overall Study||20
9986979|NCT01638312|11108998|FG001|COMPLETED|Overall Study||30
9986980|NCT01638312|11108997|FG000|NOT COMPLETED|Overall Study||0
9986981|NCT01638312|11108998|FG001|NOT COMPLETED|Overall Study||0
9986982|NCT01638390|11109004|FG000|STARTED|Overall Study|enrolled|357
9986983|NCT01638390|11109004|FG000|COMPLETED|Overall Study|treated eyes|336
9986984|NCT01638390|11109004|FG000|NOT COMPLETED|Overall Study||21
9986985|NCT01638416|11109017|FG000|STARTED|Overall Study||2490
9986986|NCT01638416|11109018|FG001|STARTED|Overall Study||2504
9986987|NCT01638416|11109017|FG000|COMPLETED|Overall Study||2457
9986988|NCT01638416|11109018|FG001|COMPLETED|Overall Study||2462
9986989|NCT01638416|11109017|FG000|NOT COMPLETED|Overall Study||33
9986990|NCT01638416|11109018|FG001|NOT COMPLETED|Overall Study||42
9986991|NCT01638429|11109025|FG000|STARTED|Overall Study||12
9986992|NCT01638429|11109025|FG000|Pre-treatment Testing|Overall Study||11
9986993|NCT01638429|11109025|FG000|Antibiotic Treatment|Overall Study||11
9986994|NCT01638429|11109025|FG000|Post-treatment Testing|Overall Study||11
9986995|NCT01638429|11109025|FG000|COMPLETED|Overall Study||11
9986996|NCT01638429|11109025|FG000|NOT COMPLETED|Overall Study||1
9986997|NCT01638468|11109033|FG000|STARTED|Overall Study||7
9986998|NCT01638468|11109033|FG000|COMPLETED|Overall Study||7
9986999|NCT01638468|11109033|FG000|NOT COMPLETED|Overall Study||0
9987000|NCT01638507|11109037|FG000|STARTED|Overall Study||230
9987001|NCT01638507|11109037|FG000|COMPLETED|Overall Study||224
9987002|NCT01638507|11109037|FG000|NOT COMPLETED|Overall Study||6
9987003|NCT01638546|11109045|FG000|STARTED|Overall Study||52
9987004|NCT01638546|11109046|FG001|STARTED|Overall Study||45
9987005|NCT01638546|11109045|FG000|COMPLETED|Overall Study||51
9987006|NCT01638546|11109046|FG001|COMPLETED|Overall Study||42
9987007|NCT01638546|11109045|FG000|NOT COMPLETED|Overall Study||1
9987008|NCT01638546|11109046|FG001|NOT COMPLETED|Overall Study||3
9987009|NCT01638559|11109054|FG000|STARTED|Overall Study||88
9987010|NCT01638559|11109054|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
9987011|NCT01638559|11109054|FG000|NOT COMPLETED|Overall Study||3
9987012|NCT01638819|11109071|FG000|STARTED|Overall Study||15
9987013|NCT01638819|11109072|FG001|STARTED|Overall Study||15
9987014|NCT01638819|11109071|FG000|First Intervention (8 Weeks)|Overall Study||15
9987015|NCT01638819|11109072|FG001|First Intervention (8 Weeks)|Overall Study||15
9987016|NCT01638819|11109071|FG000|Second Intervention (24 Weeks)|Overall Study||14
9987017|NCT01638819|11109072|FG001|Second Intervention (24 Weeks)|Overall Study||15
9987018|NCT01638819|11109071|FG000|COMPLETED|Overall Study||14
9987019|NCT01638819|11109072|FG001|COMPLETED|Overall Study||15
9987020|NCT01638819|11109071|FG000|NOT COMPLETED|Overall Study||1
9987021|NCT01638819|11109072|FG001|NOT COMPLETED|Overall Study||0
9987022|NCT01639001|11109079|FG000|STARTED|Overall Study||104
9987023|NCT01639001|11109080|FG001|STARTED|Overall Study||103
9987024|NCT01639001|11109079|FG000|Treated|Overall Study||104
9987025|NCT01639001|11109080|FG001|Treated|Overall Study||101
9987026|NCT01639001|11109079|FG000|COMPLETED|Overall Study||29
9987027|NCT01639001|11109080|FG001|COMPLETED|Overall Study||26
9987028|NCT01639001|11109079|FG000|NOT COMPLETED|Overall Study||75
9987029|NCT01639001|11109080|FG001|NOT COMPLETED|Overall Study||77
9987030|NCT01639040|11109090|FG000|STARTED|Overall Study||10
9987031|NCT01639040|11109091|FG001|STARTED|Overall Study||21
9987032|NCT01639040|11109090|FG000|COMPLETED|Overall Study||9
9987033|NCT01639040|11109091|FG001|COMPLETED|Overall Study||21
9987034|NCT01639040|11109090|FG000|NOT COMPLETED|Overall Study||1
9987035|NCT01639040|11109091|FG001|NOT COMPLETED|Overall Study||0
9987036|NCT01639144|11109102|FG000|STARTED|Overall Study||260
9987037|NCT01639144|11109103|FG001|STARTED|Overall Study||255
9987038|NCT01639144|11109102|FG000|COMPLETED|Overall Study||250
9987039|NCT01639144|11109103|FG001|COMPLETED|Overall Study||250
9987040|NCT01639144|11109102|FG000|NOT COMPLETED|Overall Study||10
9987041|NCT01639144|11109103|FG001|NOT COMPLETED|Overall Study||5
9987042|NCT01639157|11109109|FG000|STARTED|Overall Study||4
9987043|NCT01639157|11109110|FG001|STARTED|Overall Study||5
9987044|NCT01639157|11109109|FG000|COMPLETED|Overall Study||4
9987045|NCT01639157|11109110|FG001|COMPLETED|Overall Study||5
9987046|NCT01639157|11109109|FG000|NOT COMPLETED|Overall Study||0
9987047|NCT01639157|11109110|FG001|NOT COMPLETED|Overall Study||0
9987048|NCT01639222|11109116|FG000|STARTED|Overall Study||55
9987049|NCT01639222|11109116|FG000|COMPLETED|Overall Study||55
9987050|NCT01639222|11109116|FG000|NOT COMPLETED|Overall Study||0
9987051|NCT01639339|11109124|FG000|STARTED|Double-blind Period (Up to Week 104)||224
9987052|NCT01639339|11109125|FG001|STARTED|Double-blind Period (Up to Week 104)||224
9987053|NCT01639339|11109124|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170
9987054|NCT01639339|11109125|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186
9987055|NCT01639339|11109124|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
9987056|NCT01639339|11109125|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
9987057|NCT01639339|11109124|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
9987058|NCT01639339|11109125|FG001|STARTED|Open-label Period (Up to Week 28)||132
9987059|NCT01639339|11109124|FG000|COMPLETED|Open-label Period (Up to Week 28)||122
9987060|NCT01639339|11109125|FG001|COMPLETED|Open-label Period (Up to Week 28)||124
9987061|NCT01639339|11109124|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1
9987062|NCT01639339|11109125|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8
9987063|NCT01639352|11109135|FG000|STARTED|Overall Study||20
9987064|NCT01639352|11109135|FG000|COMPLETED|Overall Study||20
9987065|NCT01639352|11109135|FG000|NOT COMPLETED|Overall Study||0
9987066|NCT01639443|11109141|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
9987067|NCT01639443|11109142|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
9987068|NCT01639443|11109141|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
9987069|NCT01639443|11109142|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
9987070|NCT01639443|11109141|FG000|NOT COMPLETED|Overall Study||0
9987071|NCT01639443|11109142|FG001|NOT COMPLETED|Overall Study||0
9987072|NCT01639469|11109150|FG000|STARTED|Overall Study||89
9987073|NCT01639469|11109151|FG001|STARTED|Overall Study||80
9987074|NCT01639469|11109150|FG000|COMPLETED|Overall Study||84
9987075|NCT01639469|11109151|FG001|COMPLETED|Overall Study||77
9987076|NCT01639469|11109150|FG000|NOT COMPLETED|Overall Study||5
9987077|NCT01639469|11109151|FG001|NOT COMPLETED|Overall Study||3
9987078|NCT01639495|11109157|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148
9987079|NCT01639495|11109157|FG000|Safety Cohort|Overall Study||144
9987080|NCT01639495|11109157|FG000|Primary Effectiveness Cohort|Overall Study||138
9987081|NCT01639495|11109157|FG000|COMPLETED|Overall Study||132
9987082|NCT01639495|11109157|FG000|NOT COMPLETED|Overall Study||16
9987083|NCT01639560|11109163|FG000|STARTED|Overall Study||45
9987084|NCT01639560|11109164|FG001|STARTED|Overall Study||48
9987085|NCT01639560|11109163|FG000|End of Treatment|Overall Study||28
9987086|NCT01639560|11109164|FG001|End of Treatment|Overall Study||20
9987087|NCT01639560|11109163|FG000|COMPLETED|Overall Study||26
9987088|NCT01639560|11109164|FG001|COMPLETED|Overall Study||19
9987089|NCT01639560|11109163|FG000|NOT COMPLETED|Overall Study||19
9987090|NCT01639560|11109164|FG001|NOT COMPLETED|Overall Study||29
9987091|NCT01639599|11109173|FG000|STARTED|Overall Study||50
9987092|NCT01639599|11109174|FG001|STARTED|Overall Study||50
9987093|NCT01639599|11109175|FG002|STARTED|Overall Study||50
9987094|NCT01639599|11109173|FG000|COMPLETED|Overall Study||50
9987095|NCT01639599|11109174|FG001|COMPLETED|Overall Study||49
9987096|NCT01639599|11109175|FG002|COMPLETED|Overall Study||50
9987097|NCT01639599|11109173|FG000|NOT COMPLETED|Overall Study||0
9987098|NCT01639599|11109174|FG001|NOT COMPLETED|Overall Study||1
9987099|NCT01639599|11109175|FG002|NOT COMPLETED|Overall Study||0
9987100|NCT01639664|11109185|FG000|STARTED|Overall Study||63
9987101|NCT01639664|11109186|FG001|STARTED|Overall Study||52
9987102|NCT01639664|11109185|FG000|COMPLETED|Overall Study||63
9987103|NCT01639664|11109186|FG001|COMPLETED|Overall Study||52
9987104|NCT01639664|11109185|FG000|NOT COMPLETED|Overall Study||0
9987105|NCT01639664|11109186|FG001|NOT COMPLETED|Overall Study||0
9987106|NCT01639703|11109193|FG000|STARTED|Overall Study||96
9987107|NCT01639703|11109193|FG000|COMPLETED|Overall Study||84
9987108|NCT01639703|11109193|FG000|NOT COMPLETED|Overall Study||12
9987109|NCT01639729|11109209|FG000|STARTED|Overall Study||4
9987110|NCT01639729|11109210|FG001|STARTED|Overall Study||4
9987111|NCT01639729|11109211|FG002|STARTED|Overall Study||4
9987112|NCT01639729|11109212|FG003|STARTED|Overall Study||5
9987113|NCT01639729|11109213|FG004|STARTED|Overall Study||4
9987114|NCT01639729|11109214|FG005|STARTED|Overall Study||4
9987115|NCT01639729|11109209|FG000|COMPLETED|Overall Study||3
9987116|NCT01639729|11109210|FG001|COMPLETED|Overall Study||4
9987117|NCT01639729|11109211|FG002|COMPLETED|Overall Study||3
9987118|NCT01639729|11109212|FG003|COMPLETED|Overall Study||4
9987119|NCT01639729|11109213|FG004|COMPLETED|Overall Study||4
9987120|NCT01639729|11109214|FG005|COMPLETED|Overall Study||4
9987121|NCT01639729|11109209|FG000|NOT COMPLETED|Overall Study||1
9987122|NCT01639729|11109210|FG001|NOT COMPLETED|Overall Study||0
9987123|NCT01639729|11109211|FG002|NOT COMPLETED|Overall Study||1
9987124|NCT01639729|11109212|FG003|NOT COMPLETED|Overall Study||1
9987125|NCT01639729|11109213|FG004|NOT COMPLETED|Overall Study||0
9987126|NCT01639729|11109214|FG005|NOT COMPLETED|Overall Study||0
9987127|NCT01639742|11109224|FG000|STARTED|Overall Study||18
9987128|NCT01639742|11109224|FG000|COMPLETED|Overall Study||0
10101280|NCT02406742|11230547|FG001|NOT COMPLETED|Overall Study||16
10101281|NCT02406742|11230548|FG002|NOT COMPLETED|Overall Study||16
10101282|NCT02406859|11230559|FG000|STARTED|Part 1 - Manometric Parameters||15
10101283|NCT02406859|11230560|FG001|STARTED|Part 1 - Manometric Parameters||14
9987129|NCT01639742|11109224|FG000|NOT COMPLETED|Overall Study||18
9987130|NCT01639755|11109228|FG000|STARTED|Overall Study||19
9987131|NCT01639755|11109228|FG000|COMPLETED|Overall Study||0
9987132|NCT01639755|11109228|FG000|NOT COMPLETED|Overall Study||19
9987133|NCT01639833|11109234|FG000|STARTED|Overall Study||45
9987134|NCT01639833|11109235|FG001|STARTED|Overall Study||45
9987135|NCT01639833|11109234|FG000|COMPLETED|Overall Study||39
9987136|NCT01639833|11109235|FG001|COMPLETED|Overall Study||41
9987137|NCT01639833|11109234|FG000|NOT COMPLETED|Overall Study||6
9987138|NCT01639833|11109235|FG001|NOT COMPLETED|Overall Study||4
9987139|NCT01639872|11109243|FG000|STARTED|Overall Study||24
9987140|NCT01639872|11109244|FG001|STARTED|Overall Study||25
9987141|NCT01639872|11109243|FG000|COMPLETED|Overall Study||14
9987142|NCT01639872|11109244|FG001|COMPLETED|Overall Study||20
9987143|NCT01639872|11109243|FG000|NOT COMPLETED|Overall Study||10
9987144|NCT01639872|11109244|FG001|NOT COMPLETED|Overall Study||5
9987145|NCT01640054|11109250|FG000|STARTED|Overall Study|Patients who received treatment|115
9987146|NCT01640054|11109250|FG000|Did Not Receive Treatment|Overall Study||0
9987147|NCT01640054|11109250|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
10101284|NCT02406859|11230561|FG002|STARTED|Part 1 - Manometric Parameters||21
10101285|NCT02406859|11230559|FG000|COMPLETED|Part 1 - Manometric Parameters||12
10101286|NCT02406859|11230560|FG001|COMPLETED|Part 1 - Manometric Parameters||13
10101287|NCT02406859|11230561|FG002|COMPLETED|Part 1 - Manometric Parameters||17
10101288|NCT02406859|11230559|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3
10101289|NCT02406859|11230560|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1
10101290|NCT02406859|11230561|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4
10101291|NCT02406859|11230559|FG000|STARTED|Part 2 - Biofeedback Training||12
10101292|NCT02406859|11230560|FG001|STARTED|Part 2 - Biofeedback Training||13
10101293|NCT02406859|11230561|FG002|STARTED|Part 2 - Biofeedback Training||17
10101294|NCT02406859|11230559|FG000|COMPLETED|Part 2 - Biofeedback Training||12
10101295|NCT02406859|11230560|FG001|COMPLETED|Part 2 - Biofeedback Training||13
10101296|NCT02406859|11230561|FG002|COMPLETED|Part 2 - Biofeedback Training||17
10101297|NCT02406859|11230559|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0
10101298|NCT02406859|11230560|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0
10101299|NCT02406859|11230561|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0
10101300|NCT02406885|11230580|FG000|STARTED|Overall Study||17
10101301|NCT02406885|11230581|FG001|STARTED|Overall Study||16
10101302|NCT02406885|11230580|FG000|COMPLETED|Overall Study||14
10101303|NCT02406885|11230581|FG001|COMPLETED|Overall Study||14
10101304|NCT02406885|11230580|FG000|NOT COMPLETED|Overall Study||3
10101305|NCT02406885|11230581|FG001|NOT COMPLETED|Overall Study||2
10113243|NCT02509065|11244149|FG018|NOT COMPLETED|Overall Study||0
10113244|NCT02509065|11244150|FG019|NOT COMPLETED|Overall Study||0
10113245|NCT02509065|11244151|FG020|NOT COMPLETED|Overall Study||0
10113246|NCT02509065|11244152|FG021|NOT COMPLETED|Overall Study||0
10113247|NCT02509065|11244153|FG022|NOT COMPLETED|Overall Study||0
10113248|NCT02509078|11244171|FG000|STARTED|Overall Study||502
10113249|NCT02509078|11244172|FG001|STARTED|Overall Study||506
10113250|NCT02509078|11244171|FG000|COMPLETED|Overall Study||501
10113251|NCT02509078|11244172|FG001|COMPLETED|Overall Study||505
10113252|NCT02509078|11244171|FG000|NOT COMPLETED|Overall Study||1
10113253|NCT02509078|11244172|FG001|NOT COMPLETED|Overall Study||1
10113254|NCT02509117|11244190|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113255|NCT02509117|11244191|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113256|NCT02509117|11244192|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113257|NCT02509117|11244193|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113258|NCT02509117|11244194|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
9987148|NCT01640054|11109250|FG000|NOT COMPLETED|Overall Study||6
9987149|NCT01640171|11109254|FG000|STARTED|Overall Study||57
9987150|NCT01640171|11109254|FG000|COMPLETED|Overall Study||57
9987151|NCT01640171|11109254|FG000|NOT COMPLETED|Overall Study||0
9987152|NCT01640184|11109262|FG000|STARTED|Overall Study||34
9987153|NCT01640184|11109263|FG001|STARTED|Overall Study||23
10113259|NCT02509117|11244195|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113260|NCT02509117|11244196|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
9987154|NCT01640184|11109264|FG002|STARTED|Overall Study||22
9987155|NCT01640184|11109262|FG000|COMPLETED|Overall Study||26
9987156|NCT01640184|11109263|FG001|COMPLETED|Overall Study||21
9987157|NCT01640184|11109264|FG002|COMPLETED|Overall Study||20
9987158|NCT01640184|11109262|FG000|NOT COMPLETED|Overall Study||8
9987159|NCT01640184|11109263|FG001|NOT COMPLETED|Overall Study||2
9987160|NCT01640184|11109264|FG002|NOT COMPLETED|Overall Study||2
9987161|NCT01640197|11109277|FG000|STARTED|Overall Study||30
9987162|NCT01640197|11109278|FG001|STARTED|Overall Study||30
9987163|NCT01640197|11109277|FG000|COMPLETED|Overall Study||30
9987164|NCT01640197|11109278|FG001|COMPLETED|Overall Study||30
9987165|NCT01640197|11109277|FG000|NOT COMPLETED|Overall Study||0
9987166|NCT01640197|11109278|FG001|NOT COMPLETED|Overall Study||0
9987167|NCT01640249|11109291|FG000|STARTED|Period 1||3
9987168|NCT01640249|11109292|FG001|STARTED|Period 1||2
9987169|NCT01640249|11109293|FG002|STARTED|Period 1||2
9987170|NCT01640249|11109294|FG003|STARTED|Period 1||2
9987171|NCT01640249|11109295|FG004|STARTED|Period 1||2
9987172|NCT01640249|11109296|FG005|STARTED|Period 1||5
9987173|NCT01640249|11109297|FG006|STARTED|Period 1||2
9987174|NCT01640249|11109291|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
9987175|NCT01640249|11109292|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
9987176|NCT01640249|11109293|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
9987177|NCT01640249|11109294|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
9987178|NCT01640249|11109295|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
9758721|NCT01697267|10862293|FG000|NOT COMPLETED|Overall Study||14
9758722|NCT01697267|10862294|FG001|NOT COMPLETED|Overall Study||15
9758723|NCT01527149|10862300|FG000|STARTED|Overall Study||37
9758724|NCT01527149|10862300|FG000|COMPLETED|Overall Study||35
9758725|NCT01527149|10862300|FG000|NOT COMPLETED|Overall Study||2
9758726|NCT01388920|10862307|FG000|STARTED|Overall Study||1
9987179|NCT01640249|11109296|FG005|Received at Least 1 Dose of Study Drug|Period 1||5
9987180|NCT01640249|11109297|FG006|Received at Least 1 Dose of Study Drug|Period 1||2
9987181|NCT01640249|11109291|FG000|COMPLETED|Period 1||2
9987182|NCT01640249|11109292|FG001|COMPLETED|Period 1||2
9987183|NCT01640249|11109293|FG002|COMPLETED|Period 1||2
9987184|NCT01640249|11109294|FG003|COMPLETED|Period 1||2
9987185|NCT01640249|11109295|FG004|COMPLETED|Period 1||2
9987186|NCT01640249|11109296|FG005|COMPLETED|Period 1||4
9987187|NCT01640249|11109297|FG006|COMPLETED|Period 1||2
10101306|NCT02406937|11230590|FG000|STARTED|Overall Study||60
10101307|NCT02406937|11230591|FG001|STARTED|Overall Study||60
10101308|NCT02406937|11230592|FG002|STARTED|Overall Study||60
10101309|NCT02406937|11230590|FG000|COMPLETED|Overall Study||59
10101310|NCT02406937|11230591|FG001|COMPLETED|Overall Study||59
10101311|NCT02406937|11230592|FG002|COMPLETED|Overall Study||58
10101312|NCT02406937|11230590|FG000|NOT COMPLETED|Overall Study||1
10101313|NCT02406937|11230591|FG001|NOT COMPLETED|Overall Study||1
10101314|NCT02406937|11230592|FG002|NOT COMPLETED|Overall Study||2
10101315|NCT02407041|11230603|FG000|STARTED|Overall Study||5
10101316|NCT02407041|11230603|FG000|COMPLETED|Overall Study||5
10101317|NCT02407041|11230603|FG000|NOT COMPLETED|Overall Study||0
10101318|NCT02407054|11230610|FG000|STARTED|Overall Study||13
10101319|NCT02407054|11230611|FG001|STARTED|Overall Study||65
10101320|NCT02407054|11230612|FG002|STARTED|Overall Study||64
10101321|NCT02407054|11230610|FG000|Received at Least One Dose of Study Drug|Overall Study||13
10101322|NCT02407054|11230611|FG001|Received at Least One Dose of Study Drug|Overall Study||65
10101323|NCT02407054|11230612|FG002|Received at Least One Dose of Study Drug|Overall Study||64
10101324|NCT02407054|11230610|FG000|COMPLETED|Overall Study||6
10101325|NCT02407054|11230611|FG001|COMPLETED|Overall Study||47
10101326|NCT02407054|11230612|FG002|COMPLETED|Overall Study||57
10101327|NCT02407054|11230610|FG000|NOT COMPLETED|Overall Study||7
10101328|NCT02407054|11230611|FG001|NOT COMPLETED|Overall Study||18
10101329|NCT02407054|11230612|FG002|NOT COMPLETED|Overall Study||7
10101330|NCT02407132|11230623|FG000|STARTED|Immediate Post-intervention||110
10101331|NCT02407132|11230624|FG001|STARTED|Immediate Post-intervention||111
10101332|NCT02407132|11230623|FG000|COMPLETED|Immediate Post-intervention||107
10101333|NCT02407132|11230624|FG001|COMPLETED|Immediate Post-intervention||101
10101334|NCT02407132|11230623|FG000|NOT COMPLETED|Immediate Post-intervention||3
10101335|NCT02407132|11230624|FG001|NOT COMPLETED|Immediate Post-intervention||10
10101336|NCT02407132|11230623|FG000|STARTED|6 Months Post-intervention||107
10101337|NCT02407132|11230624|FG001|STARTED|6 Months Post-intervention||101
10101338|NCT02407132|11230623|FG000|COMPLETED|6 Months Post-intervention||96
10101339|NCT02407132|11230624|FG001|COMPLETED|6 Months Post-intervention||92
9987188|NCT01640249|11109291|FG000|NOT COMPLETED|Period 1||1
9987189|NCT01640249|11109292|FG001|NOT COMPLETED|Period 1||0
9987190|NCT01640249|11109293|FG002|NOT COMPLETED|Period 1||0
9987191|NCT01640249|11109294|FG003|NOT COMPLETED|Period 1||0
9987192|NCT01640249|11109295|FG004|NOT COMPLETED|Period 1||0
9987193|NCT01640249|11109296|FG005|NOT COMPLETED|Period 1||1
9987194|NCT01640249|11109297|FG006|NOT COMPLETED|Period 1||0
9987195|NCT01640249|11109291|FG000|STARTED|Period 2||2
9987196|NCT01640249|11109292|FG001|STARTED|Period 2||2
9987197|NCT01640249|11109293|FG002|STARTED|Period 2||2
9987198|NCT01640249|11109294|FG003|STARTED|Period 2||2
9987199|NCT01640249|11109295|FG004|STARTED|Period 2||2
9987200|NCT01640249|11109296|FG005|STARTED|Period 2||4
10101340|NCT02407132|11230623|FG000|NOT COMPLETED|6 Months Post-intervention||11
9758727|NCT01388920|10862308|FG001|STARTED|Overall Study||1
9758728|NCT01388920|10862309|FG002|STARTED|Overall Study||0
9758729|NCT01388920|10862307|FG000|COMPLETED|Overall Study||1
9987201|NCT01640249|11109297|FG006|STARTED|Period 2||2
9987202|NCT01640249|11109291|FG000|COMPLETED|Period 2||2
9987203|NCT01640249|11109292|FG001|COMPLETED|Period 2||2
9987204|NCT01640249|11109293|FG002|COMPLETED|Period 2||2
9987205|NCT01640249|11109294|FG003|COMPLETED|Period 2||2
9987206|NCT01640249|11109295|FG004|COMPLETED|Period 2||2
9987207|NCT01640249|11109296|FG005|COMPLETED|Period 2||4
9987208|NCT01640249|11109297|FG006|COMPLETED|Period 2||2
9987209|NCT01640249|11109291|FG000|NOT COMPLETED|Period 2||0
9987210|NCT01640249|11109292|FG001|NOT COMPLETED|Period 2||0
9987211|NCT01640249|11109293|FG002|NOT COMPLETED|Period 2||0
9987212|NCT01640249|11109294|FG003|NOT COMPLETED|Period 2||0
9987213|NCT01640249|11109295|FG004|NOT COMPLETED|Period 2||0
9987214|NCT01640249|11109296|FG005|NOT COMPLETED|Period 2||0
9987215|NCT01640249|11109297|FG006|NOT COMPLETED|Period 2||0
9987216|NCT01640249|11109291|FG000|STARTED|Period 3||2
9987217|NCT01640249|11109292|FG001|STARTED|Period 3||2
9987218|NCT01640249|11109293|FG002|STARTED|Period 3||2
9987219|NCT01640249|11109294|FG003|STARTED|Period 3||2
9987220|NCT01640249|11109295|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
9987221|NCT01640249|11109296|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
9987222|NCT01640249|11109297|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
9987223|NCT01640249|11109291|FG000|COMPLETED|Period 3||2
9987224|NCT01640249|11109292|FG001|COMPLETED|Period 3||2
9987225|NCT01640249|11109293|FG002|COMPLETED|Period 3||2
9987226|NCT01640249|11109294|FG003|COMPLETED|Period 3||1
9987227|NCT01640249|11109295|FG004|COMPLETED|Period 3||0
9987228|NCT01640249|11109296|FG005|COMPLETED|Period 3||0
9987229|NCT01640249|11109297|FG006|COMPLETED|Period 3||0
9987230|NCT01640249|11109291|FG000|NOT COMPLETED|Period 3||0
9987231|NCT01640249|11109292|FG001|NOT COMPLETED|Period 3||0
9987232|NCT01640249|11109293|FG002|NOT COMPLETED|Period 3||0
9987233|NCT01640249|11109294|FG003|NOT COMPLETED|Period 3||1
9987234|NCT01640249|11109295|FG004|NOT COMPLETED|Period 3||0
9987235|NCT01640249|11109296|FG005|NOT COMPLETED|Period 3||0
9987236|NCT01640249|11109297|FG006|NOT COMPLETED|Period 3||0
9987237|NCT01640288|11109318|FG000|STARTED|Overall Study||100
9987238|NCT01640288|11109319|FG001|STARTED|Overall Study||71
9987239|NCT01640288|11109318|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
9987240|NCT01640288|11109319|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
9987241|NCT01640288|11109318|FG000|Did Not Receive Allocated Intervention|Overall Study||26
9987242|NCT01640288|11109319|FG001|Did Not Receive Allocated Intervention|Overall Study||18
9987243|NCT01640288|11109318|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
9987244|NCT01640288|11109319|FG001|COMPLETED|Overall Study||48
9987245|NCT01640288|11109318|FG000|NOT COMPLETED|Overall Study||30
9987246|NCT01640288|11109319|FG001|NOT COMPLETED|Overall Study||23
9987247|NCT01640314|11109328|FG000|STARTED|Overall Study||63
9987248|NCT01640314|11109329|FG001|STARTED|Overall Study||63
9987249|NCT01640314|11109328|FG000|COMPLETED|Overall Study||63
9987250|NCT01640314|11109329|FG001|COMPLETED|Overall Study||62
9987251|NCT01640314|11109328|FG000|NOT COMPLETED|Overall Study||0
9987252|NCT01640314|11109329|FG001|NOT COMPLETED|Overall Study||1
9987253|NCT01640327|11109337|FG000|STARTED|Overall Study||63
9987254|NCT01640327|11109338|FG001|STARTED|Overall Study||63
9987255|NCT01640327|11109337|FG000|COMPLETED|Overall Study||63
9987256|NCT01640327|11109338|FG001|COMPLETED|Overall Study||63
9987257|NCT01640327|11109337|FG000|NOT COMPLETED|Overall Study||0
9987258|NCT01640327|11109338|FG001|NOT COMPLETED|Overall Study||0
9987259|NCT01640340|11109346|FG000|STARTED|Overall Study||20
9987260|NCT01640340|11109347|FG001|STARTED|Overall Study||20
9987261|NCT01640340|11109346|FG000|Overall Complete Response Rate|Overall Study||20
9987262|NCT01640340|11109347|FG001|Overall Complete Response Rate|Overall Study||20
9987263|NCT01640340|11109346|FG000|COMPLETED|Overall Study||20
9987264|NCT01640340|11109347|FG001|COMPLETED|Overall Study||20
9987265|NCT01640340|11109346|FG000|NOT COMPLETED|Overall Study||0
9987266|NCT01640340|11109347|FG001|NOT COMPLETED|Overall Study||0
9987267|NCT01640353|11109353|FG000|STARTED|Overall Study||194
9987268|NCT01640353|11109353|FG000|Treated|Overall Study||172
9987269|NCT01640353|11109353|FG000|Month 1|Overall Study||171
9987270|NCT01640353|11109353|FG000|Month 3|Overall Study||169
9987271|NCT01640353|11109353|FG000|Month 6|Overall Study||168
9987272|NCT01640353|11109353|FG000|Month 12|Overall Study||160
9987273|NCT01640353|11109353|FG000|Month 18|Overall Study||150
9987274|NCT01640353|11109353|FG000|COMPLETED|Overall Study||149
9987275|NCT01640353|11109353|FG000|NOT COMPLETED|Overall Study||45
9987276|NCT01640366|11109357|FG000|STARTED|Overall Study||200
9987277|NCT01640366|11109357|FG000|Day 21 Follow-up|Overall Study||185
9987278|NCT01640366|11109357|FG000|Day 42 Follow-up|Overall Study||177
9987279|NCT01640366|11109357|FG000|Day 90 Follow-up|Overall Study||178
9987280|NCT01640366|11109357|FG000|COMPLETED|Overall Study||178
9987281|NCT01640366|11109357|FG000|NOT COMPLETED|Overall Study||22
9987282|NCT01640379|11109365|FG000|STARTED|Overall Study||149
9987283|NCT01640379|11109366|FG001|STARTED|Overall Study||137
9987284|NCT01640379|11109365|FG000|COMPLETED|Overall Study||135
9987285|NCT01640379|11109366|FG001|COMPLETED|Overall Study||125
9987286|NCT01640379|11109365|FG000|NOT COMPLETED|Overall Study||14
9987287|NCT01640379|11109366|FG001|NOT COMPLETED|Overall Study||12
9987288|NCT01640548|11109373|FG000|STARTED|Overall Study||309
9987289|NCT01640548|11109373|FG000|COMPLETED|Overall Study||309
9987290|NCT01640548|11109373|FG000|NOT COMPLETED|Overall Study||0
9987291|NCT01640808|11109379|FG000|STARTED|Overall Study||309
9987292|NCT01640808|11109380|FG001|STARTED|Overall Study||307
9987293|NCT01640808|11109379|FG000|Subjects Received Treatment|Overall Study||305
9987294|NCT01640808|11109380|FG001|Subjects Received Treatment|Overall Study||305
9987295|NCT01640808|11109379|FG000|COMPLETED|Overall Study||251
9987296|NCT01640808|11109380|FG001|COMPLETED|Overall Study||291
9987297|NCT01640808|11109379|FG000|NOT COMPLETED|Overall Study||58
9987298|NCT01640808|11109380|FG001|NOT COMPLETED|Overall Study||16
9987299|NCT01640834|11109389|FG000|STARTED|Overall Study||8
9987300|NCT01640834|11109390|FG001|STARTED|Overall Study||8
9987301|NCT01640834|11109391|FG002|STARTED|Overall Study||4
9987302|NCT01640834|11109389|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9987303|NCT01640834|11109390|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
9987304|NCT01640834|11109391|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
9987305|NCT01640834|11109389|FG000|COMPLETED|Overall Study||8
9987306|NCT01640834|11109390|FG001|COMPLETED|Overall Study||8
9987307|NCT01640834|11109391|FG002|COMPLETED|Overall Study||4
9987308|NCT01640834|11109389|FG000|NOT COMPLETED|Overall Study||0
9987309|NCT01640834|11109390|FG001|NOT COMPLETED|Overall Study||0
9987310|NCT01640834|11109391|FG002|NOT COMPLETED|Overall Study||0
9987311|NCT01640873|11109403|FG000|STARTED|Overall Study||22
9987312|NCT01640873|11109404|FG001|STARTED|Overall Study||11
9987313|NCT01640873|11109403|FG000|COMPLETED|Overall Study||20
9987314|NCT01640873|11109404|FG001|COMPLETED|Overall Study||10
9987315|NCT01640873|11109403|FG000|NOT COMPLETED|Overall Study||2
9987316|NCT01640873|11109404|FG001|NOT COMPLETED|Overall Study||1
9987317|NCT01640925|11109412|FG000|STARTED|Overall Study||175
9987318|NCT01640925|11109413|FG001|STARTED|Overall Study||175
9987319|NCT01640925|11109412|FG000|COMPLETED|Overall Study||161
9987320|NCT01640925|11109413|FG001|COMPLETED|Overall Study||164
9987321|NCT01640925|11109412|FG000|NOT COMPLETED|Overall Study||14
9987322|NCT01640925|11109413|FG001|NOT COMPLETED|Overall Study||11
9987323|NCT01640951|11109427|FG000|STARTED|Overall Study||77
9987324|NCT01640951|11109428|FG001|STARTED|Overall Study||75
9987325|NCT01640951|11109429|FG002|STARTED|Overall Study||168
9987326|NCT01640951|11109430|FG003|STARTED|Overall Study||55
9987327|NCT01640951|11109431|FG004|STARTED|Overall Study||95
9987328|NCT01640951|11109432|FG005|STARTED|Overall Study||60
9987329|NCT01640951|11109433|FG006|STARTED|Overall Study||112
9987330|NCT01640951|11109434|FG007|STARTED|Overall Study||33
9987331|NCT01640951|11109427|FG000|COMPLETED|Overall Study||31
9987332|NCT01640951|11109428|FG001|COMPLETED|Overall Study||60
9987333|NCT01640951|11109429|FG002|COMPLETED|Overall Study||126
9987334|NCT01640951|11109430|FG003|COMPLETED|Overall Study||10
9987335|NCT01640951|11109431|FG004|COMPLETED|Overall Study||82
9987336|NCT01640951|11109432|FG005|COMPLETED|Overall Study||13
9987337|NCT01640951|11109433|FG006|COMPLETED|Overall Study||94
9987338|NCT01640951|11109434|FG007|COMPLETED|Overall Study||17
9987339|NCT01640951|11109427|FG000|NOT COMPLETED|Overall Study||46
9987340|NCT01640951|11109428|FG001|NOT COMPLETED|Overall Study||15
9987341|NCT01640951|11109429|FG002|NOT COMPLETED|Overall Study||42
9987342|NCT01640951|11109430|FG003|NOT COMPLETED|Overall Study||45
9987343|NCT01640951|11109431|FG004|NOT COMPLETED|Overall Study||13
9987344|NCT01640951|11109432|FG005|NOT COMPLETED|Overall Study||47
9987345|NCT01640951|11109433|FG006|NOT COMPLETED|Overall Study||18
9987346|NCT01640951|11109434|FG007|NOT COMPLETED|Overall Study||16
9987347|NCT01640964|11109457|FG000|STARTED|Overall Study||20
9987348|NCT01640964|11109458|FG001|STARTED|Overall Study||20
9987349|NCT01640964|11109459|FG002|STARTED|Overall Study||6
9987350|NCT01640964|11109457|FG000|COMPLETED|Overall Study||19
9987351|NCT01640964|11109458|FG001|COMPLETED|Overall Study||19
9987352|NCT01640964|11109459|FG002|COMPLETED|Overall Study||3
9987353|NCT01640964|11109457|FG000|NOT COMPLETED|Overall Study||1
9987354|NCT01640964|11109458|FG001|NOT COMPLETED|Overall Study||1
9987355|NCT01640964|11109459|FG002|NOT COMPLETED|Overall Study||3
9987356|NCT01641042|11109470|FG000|STARTED|Overall Study||43
9987357|NCT01641042|11109471|FG001|STARTED|Overall Study||43
9987358|NCT01641042|11109470|FG000|COMPLETED|Overall Study||43
9987359|NCT01641042|11109471|FG001|COMPLETED|Overall Study||43
9987360|NCT01641042|11109470|FG000|NOT COMPLETED|Overall Study||0
9987361|NCT01641042|11109471|FG001|NOT COMPLETED|Overall Study||0
9987362|NCT01641081|11109477|FG000|STARTED|Period 1||18
9987363|NCT01641081|11109478|FG001|STARTED|Period 1||18
9987364|NCT01641081|11109479|FG002|STARTED|Period 1||15
9987365|NCT01641081|11109480|FG003|STARTED|Period 1||22
9987366|NCT01641081|11109481|FG004|STARTED|Period 1||17
9987367|NCT01641081|11109482|FG005|STARTED|Period 1||19
9987368|NCT01641081|11109483|FG006|STARTED|Period 1||19
9987369|NCT01641081|11109484|FG007|STARTED|Period 1||17
9987370|NCT01641081|11109485|FG008|STARTED|Period 1||15
9987371|NCT01641081|11109486|FG009|STARTED|Period 1||14
9987372|NCT01641081|11109477|FG000|COMPLETED|Period 1||17
9987373|NCT01641081|11109478|FG001|COMPLETED|Period 1||18
9987374|NCT01641081|11109479|FG002|COMPLETED|Period 1||15
9987375|NCT01641081|11109480|FG003|COMPLETED|Period 1||22
9987376|NCT01641081|11109481|FG004|COMPLETED|Period 1||16
9987377|NCT01641081|11109482|FG005|COMPLETED|Period 1||19
9987378|NCT01641081|11109483|FG006|COMPLETED|Period 1||18
9987379|NCT01641081|11109484|FG007|COMPLETED|Period 1||14
9987380|NCT01641081|11109485|FG008|COMPLETED|Period 1||15
9987381|NCT01641081|11109486|FG009|COMPLETED|Period 1||14
9987382|NCT01641081|11109477|FG000|NOT COMPLETED|Period 1||1
9987383|NCT01641081|11109478|FG001|NOT COMPLETED|Period 1||0
9987384|NCT01641081|11109479|FG002|NOT COMPLETED|Period 1||0
9987385|NCT01641081|11109480|FG003|NOT COMPLETED|Period 1||0
9987386|NCT01641081|11109481|FG004|NOT COMPLETED|Period 1||1
9987387|NCT01641081|11109482|FG005|NOT COMPLETED|Period 1||0
9987388|NCT01641081|11109483|FG006|NOT COMPLETED|Period 1||1
9987389|NCT01641081|11109484|FG007|NOT COMPLETED|Period 1||3
9987390|NCT01641081|11109485|FG008|NOT COMPLETED|Period 1||0
9987391|NCT01641081|11109486|FG009|NOT COMPLETED|Period 1||0
9987392|NCT01641081|11109477|FG000|STARTED|Period 2||17
9987393|NCT01641081|11109478|FG001|STARTED|Period 2||18
9987394|NCT01641081|11109479|FG002|STARTED|Period 2||15
9987395|NCT01641081|11109480|FG003|STARTED|Period 2||22
9987396|NCT01641081|11109481|FG004|STARTED|Period 2||16
9987397|NCT01641081|11109482|FG005|STARTED|Period 2||19
9987398|NCT01641081|11109483|FG006|STARTED|Period 2||18
9987399|NCT01641081|11109484|FG007|STARTED|Period 2||14
9987400|NCT01641081|11109485|FG008|STARTED|Period 2||15
9987401|NCT01641081|11109486|FG009|STARTED|Period 2||14
9987402|NCT01641081|11109477|FG000|COMPLETED|Period 2||16
9987403|NCT01641081|11109478|FG001|COMPLETED|Period 2||18
9987404|NCT01641081|11109479|FG002|COMPLETED|Period 2||15
9987405|NCT01641081|11109480|FG003|COMPLETED|Period 2||21
9987406|NCT01641081|11109481|FG004|COMPLETED|Period 2||16
9987407|NCT01641081|11109482|FG005|COMPLETED|Period 2||18
9987408|NCT01641081|11109483|FG006|COMPLETED|Period 2||16
9987409|NCT01641081|11109484|FG007|COMPLETED|Period 2||14
9987410|NCT01641081|11109485|FG008|COMPLETED|Period 2||15
9987411|NCT01641081|11109486|FG009|COMPLETED|Period 2||14
9987412|NCT01641081|11109477|FG000|NOT COMPLETED|Period 2||1
9987413|NCT01641081|11109478|FG001|NOT COMPLETED|Period 2||0
9987414|NCT01641081|11109479|FG002|NOT COMPLETED|Period 2||0
9987415|NCT01641081|11109480|FG003|NOT COMPLETED|Period 2||1
9987416|NCT01641081|11109481|FG004|NOT COMPLETED|Period 2||0
9987417|NCT01641081|11109482|FG005|NOT COMPLETED|Period 2||1
9987418|NCT01641081|11109483|FG006|NOT COMPLETED|Period 2||2
9987419|NCT01641081|11109484|FG007|NOT COMPLETED|Period 2||0
9987420|NCT01641081|11109485|FG008|NOT COMPLETED|Period 2||0
9987421|NCT01641081|11109486|FG009|NOT COMPLETED|Period 2||0
9987422|NCT01641081|11109477|FG000|STARTED|Period 3||16
9987423|NCT01641081|11109478|FG001|STARTED|Period 3||18
9987424|NCT01641081|11109479|FG002|STARTED|Period 3||15
9987425|NCT01641081|11109480|FG003|STARTED|Period 3||21
9987426|NCT01641081|11109481|FG004|STARTED|Period 3||16
9987427|NCT01641081|11109482|FG005|STARTED|Period 3||18
9987428|NCT01641081|11109483|FG006|STARTED|Period 3||16
9987429|NCT01641081|11109484|FG007|STARTED|Period 3||14
9987430|NCT01641081|11109485|FG008|STARTED|Period 3||15
9987431|NCT01641081|11109486|FG009|STARTED|Period 3||14
9987432|NCT01641081|11109477|FG000|COMPLETED|Period 3||16
9987433|NCT01641081|11109478|FG001|COMPLETED|Period 3||18
9987434|NCT01641081|11109479|FG002|COMPLETED|Period 3||14
9987435|NCT01641081|11109480|FG003|COMPLETED|Period 3||21
9987436|NCT01641081|11109481|FG004|COMPLETED|Period 3||16
9987437|NCT01641081|11109482|FG005|COMPLETED|Period 3||18
9987438|NCT01641081|11109483|FG006|COMPLETED|Period 3||16
9987439|NCT01641081|11109484|FG007|COMPLETED|Period 3||14
9987440|NCT01641081|11109485|FG008|COMPLETED|Period 3||14
9987441|NCT01641081|11109486|FG009|COMPLETED|Period 3||14
9987442|NCT01641081|11109477|FG000|NOT COMPLETED|Period 3||0
10101341|NCT02407132|11230624|FG001|NOT COMPLETED|6 Months Post-intervention||9
10101342|NCT02407132|11230623|FG000|STARTED|12 Months Post-intervention||96
10101343|NCT02407132|11230624|FG001|STARTED|12 Months Post-intervention||92
10101344|NCT02407132|11230623|FG000|COMPLETED|12 Months Post-intervention||83
10101345|NCT02407132|11230624|FG001|COMPLETED|12 Months Post-intervention||90
10101346|NCT02407132|11230623|FG000|NOT COMPLETED|12 Months Post-intervention||13
10101347|NCT02407132|11230624|FG001|NOT COMPLETED|12 Months Post-intervention||2
10101348|NCT02407223|11230633|FG000|STARTED|Overall Study||116
10101349|NCT02407223|11230634|FG001|STARTED|Overall Study||118
10101350|NCT02407223|11230635|FG002|STARTED|Overall Study||122
10101351|NCT02407223|11230633|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
10101352|NCT02407223|11230634|FG001|Early Escape at Week 16|Overall Study||0
10101353|NCT02407223|11230635|FG002|Early Escape at Week 16|Overall Study||0
10101354|NCT02407223|11230633|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
10101355|NCT02407223|11230634|FG001|Cross Over at Week 24|Overall Study||0
10101356|NCT02407223|11230635|FG002|Cross Over at Week 24|Overall Study||0
10101357|NCT02407223|11230633|FG000|Qualified Re-randomization at Week 52|Overall Study||0
10101358|NCT02407223|11230634|FG001|Qualified Re-randomization at Week 52|Overall Study||3
10101359|NCT02407223|11230635|FG002|Qualified Re-randomization at Week 52|Overall Study||2
9987443|NCT01641081|11109478|FG001|NOT COMPLETED|Period 3||0
9987444|NCT01641081|11109479|FG002|NOT COMPLETED|Period 3||1
9987445|NCT01641081|11109480|FG003|NOT COMPLETED|Period 3||0
9987446|NCT01641081|11109481|FG004|NOT COMPLETED|Period 3||0
9987447|NCT01641081|11109482|FG005|NOT COMPLETED|Period 3||0
9987448|NCT01641081|11109483|FG006|NOT COMPLETED|Period 3||0
9987449|NCT01641081|11109484|FG007|NOT COMPLETED|Period 3||0
9987450|NCT01641081|11109485|FG008|NOT COMPLETED|Period 3||1
9987451|NCT01641081|11109486|FG009|NOT COMPLETED|Period 3||0
9987452|NCT01641081|11109477|FG000|STARTED|Period 4||16
9987453|NCT01641081|11109478|FG001|STARTED|Period 4||18
9987454|NCT01641081|11109479|FG002|STARTED|Period 4||14
9987455|NCT01641081|11109480|FG003|STARTED|Period 4||21
9987456|NCT01641081|11109481|FG004|STARTED|Period 4||16
9987457|NCT01641081|11109482|FG005|STARTED|Period 4||18
9987458|NCT01641081|11109483|FG006|STARTED|Period 4||16
9987459|NCT01641081|11109484|FG007|STARTED|Period 4||14
9987460|NCT01641081|11109485|FG008|STARTED|Period 4||14
9987461|NCT01641081|11109486|FG009|STARTED|Period 4||14
9987462|NCT01641081|11109477|FG000|COMPLETED|Period 4||16
9987463|NCT01641081|11109478|FG001|COMPLETED|Period 4||17
9987464|NCT01641081|11109479|FG002|COMPLETED|Period 4||14
9987465|NCT01641081|11109480|FG003|COMPLETED|Period 4||20
9987466|NCT01641081|11109481|FG004|COMPLETED|Period 4||16
9987467|NCT01641081|11109482|FG005|COMPLETED|Period 4||18
9987468|NCT01641081|11109483|FG006|COMPLETED|Period 4||16
9987469|NCT01641081|11109484|FG007|COMPLETED|Period 4||14
9987470|NCT01641081|11109485|FG008|COMPLETED|Period 4||14
9987471|NCT01641081|11109486|FG009|COMPLETED|Period 4||14
9987472|NCT01641081|11109477|FG000|NOT COMPLETED|Period 4||0
9987473|NCT01641081|11109478|FG001|NOT COMPLETED|Period 4||1
9987474|NCT01641081|11109479|FG002|NOT COMPLETED|Period 4||0
9987475|NCT01641081|11109480|FG003|NOT COMPLETED|Period 4||1
9987476|NCT01641081|11109481|FG004|NOT COMPLETED|Period 4||0
9987477|NCT01641081|11109482|FG005|NOT COMPLETED|Period 4||0
9987478|NCT01641081|11109483|FG006|NOT COMPLETED|Period 4||0
9987479|NCT01641081|11109484|FG007|NOT COMPLETED|Period 4||0
9987480|NCT01641081|11109485|FG008|NOT COMPLETED|Period 4||0
9987481|NCT01641081|11109486|FG009|NOT COMPLETED|Period 4||0
9987482|NCT01641081|11109477|FG000|STARTED|Period 5||16
9987483|NCT01641081|11109478|FG001|STARTED|Period 5||17
9987484|NCT01641081|11109479|FG002|STARTED|Period 5||14
9987485|NCT01641081|11109480|FG003|STARTED|Period 5||20
9987486|NCT01641081|11109481|FG004|STARTED|Period 5||16
9987487|NCT01641081|11109482|FG005|STARTED|Period 5||18
9987488|NCT01641081|11109483|FG006|STARTED|Period 5||16
9987489|NCT01641081|11109484|FG007|STARTED|Period 5||14
9987490|NCT01641081|11109485|FG008|STARTED|Period 5||14
9987491|NCT01641081|11109486|FG009|STARTED|Period 5||14
9987492|NCT01641081|11109477|FG000|COMPLETED|Period 5||16
9987493|NCT01641081|11109478|FG001|COMPLETED|Period 5||17
9987494|NCT01641081|11109479|FG002|COMPLETED|Period 5||12
9987495|NCT01641081|11109480|FG003|COMPLETED|Period 5||20
9987496|NCT01641081|11109481|FG004|COMPLETED|Period 5||16
9987497|NCT01641081|11109482|FG005|COMPLETED|Period 5||18
9987498|NCT01641081|11109483|FG006|COMPLETED|Period 5||16
9987499|NCT01641081|11109484|FG007|COMPLETED|Period 5||14
9987500|NCT01641081|11109485|FG008|COMPLETED|Period 5||14
9987501|NCT01641081|11109486|FG009|COMPLETED|Period 5||14
9987502|NCT01641081|11109477|FG000|NOT COMPLETED|Period 5||0
9987503|NCT01641081|11109478|FG001|NOT COMPLETED|Period 5||0
9987504|NCT01641081|11109479|FG002|NOT COMPLETED|Period 5||2
9987505|NCT01641081|11109480|FG003|NOT COMPLETED|Period 5||0
9987506|NCT01641081|11109481|FG004|NOT COMPLETED|Period 5||0
9987507|NCT01641081|11109482|FG005|NOT COMPLETED|Period 5||0
9987508|NCT01641081|11109483|FG006|NOT COMPLETED|Period 5||0
9987509|NCT01641081|11109484|FG007|NOT COMPLETED|Period 5||0
9987510|NCT01641081|11109485|FG008|NOT COMPLETED|Period 5||0
9987511|NCT01641081|11109486|FG009|NOT COMPLETED|Period 5||0
9987512|NCT01641120|11109498|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
9987513|NCT01641120|11109498|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
9987514|NCT01641120|11109498|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
9987515|NCT01641120|11109498|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20
9987516|NCT01641120|11109498|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
9987517|NCT01641120|11109498|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
9987518|NCT01641133|11109508|FG000|STARTED|Overall Study||97
9987519|NCT01641133|11109509|FG001|STARTED|Overall Study||99
9987520|NCT01641133|11109510|FG002|STARTED|Overall Study||98
9987521|NCT01641133|11109508|FG000|COMPLETED|Overall Study||87
9987522|NCT01641133|11109509|FG001|COMPLETED|Overall Study||90
9987523|NCT01641133|11109510|FG002|COMPLETED|Overall Study||90
9987524|NCT01641133|11109508|FG000|NOT COMPLETED|Overall Study||10
9987525|NCT01641133|11109509|FG001|NOT COMPLETED|Overall Study||9
9987526|NCT01641133|11109510|FG002|NOT COMPLETED|Overall Study||8
9987527|NCT01641159|11109520|FG000|STARTED|Overall Study||35
9987528|NCT01641159|11109521|FG001|STARTED|Overall Study||27
9987529|NCT01641159|11109520|FG000|COMPLETED|Overall Study||33
9987530|NCT01641159|11109521|FG001|COMPLETED|Overall Study||25
9987531|NCT01641159|11109520|FG000|NOT COMPLETED|Overall Study||2
9987532|NCT01641159|11109521|FG001|NOT COMPLETED|Overall Study||2
9987533|NCT01641198|11109530|FG000|STARTED|After 12 Months of Function||20
9987534|NCT01641198|11109531|FG001|STARTED|After 12 Months of Function||19
9987535|NCT01641198|11109532|FG002|STARTED|After 12 Months of Function||19
9987536|NCT01641198|11109530|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
9987537|NCT01641198|11109531|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
9987538|NCT01641198|11109532|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
9987539|NCT01641198|11109530|FG000|NOT COMPLETED|After 12 Months of Function||4
9987540|NCT01641198|11109531|FG001|NOT COMPLETED|After 12 Months of Function||3
9987541|NCT01641198|11109532|FG002|NOT COMPLETED|After 12 Months of Function||2
9987542|NCT01641198|11109530|FG000|STARTED|After 24 Months of Function||16
9987543|NCT01641198|11109531|FG001|STARTED|After 24 Months of Function||16
9987544|NCT01641198|11109532|FG002|STARTED|After 24 Months of Function||17
9987545|NCT01641198|11109530|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
9987546|NCT01641198|11109531|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
10019164|NCT01828216|11142316|FG001|NOT COMPLETED|Overall Study||0
9987547|NCT01641198|11109532|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
9987548|NCT01641198|11109530|FG000|NOT COMPLETED|After 24 Months of Function||4
9987549|NCT01641198|11109531|FG001|NOT COMPLETED|After 24 Months of Function||9
9987550|NCT01641198|11109532|FG002|NOT COMPLETED|After 24 Months of Function||6
9987551|NCT01641198|11109530|FG000|STARTED|At 15-20 Years of Function||12
9987552|NCT01641198|11109531|FG001|STARTED|At 15-20 Years of Function||7
9987553|NCT01641198|11109532|FG002|STARTED|At 15-20 Years of Function||11
9987554|NCT01641198|11109530|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
9987555|NCT01641198|11109531|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
9987556|NCT01641198|11109532|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
9987557|NCT01641198|11109530|FG000|NOT COMPLETED|At 15-20 Years of Function||6
9987558|NCT01641198|11109531|FG001|NOT COMPLETED|At 15-20 Years of Function||1
9987559|NCT01641198|11109532|FG002|NOT COMPLETED|At 15-20 Years of Function||2
9987560|NCT01641237|11109541|FG000|STARTED|Period I||16
9987561|NCT01641237|11109542|FG001|STARTED|Period I||16
9987562|NCT01641237|11109543|FG002|STARTED|Period I||15
9987563|NCT01641237|11109544|FG003|STARTED|Period I||15
9987564|NCT01641237|11109541|FG000|COMPLETED|Period I||16
9987565|NCT01641237|11109542|FG001|COMPLETED|Period I||16
9987566|NCT01641237|11109543|FG002|COMPLETED|Period I||15
9987567|NCT01641237|11109544|FG003|COMPLETED|Period I||15
9987568|NCT01641237|11109541|FG000|NOT COMPLETED|Period I||0
9987569|NCT01641237|11109542|FG001|NOT COMPLETED|Period I||0
9987570|NCT01641237|11109543|FG002|NOT COMPLETED|Period I||0
9987571|NCT01641237|11109544|FG003|NOT COMPLETED|Period I||0
9987572|NCT01641237|11109541|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
9987573|NCT01641237|11109542|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
9987574|NCT01641237|11109543|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
9987575|NCT01641237|11109544|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
9987576|NCT01641237|11109541|FG000|COMPLETED|Period II||14
9987577|NCT01641237|11109542|FG001|COMPLETED|Period II||16
9987578|NCT01641237|11109543|FG002|COMPLETED|Period II||16
9987579|NCT01641237|11109544|FG003|COMPLETED|Period II||15
9987580|NCT01641237|11109541|FG000|NOT COMPLETED|Period II||1
9987581|NCT01641237|11109542|FG001|NOT COMPLETED|Period II||0
9987582|NCT01641237|11109543|FG002|NOT COMPLETED|Period II||0
9987583|NCT01641237|11109544|FG003|NOT COMPLETED|Period II||0
9987584|NCT01641237|11109541|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
9987585|NCT01641237|11109542|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
9987586|NCT01641237|11109543|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
9987587|NCT01641237|11109544|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
9987588|NCT01641237|11109541|FG000|COMPLETED|Period III||15
9987589|NCT01641237|11109542|FG001|COMPLETED|Period III||14
9987590|NCT01641237|11109543|FG002|COMPLETED|Period III||15
9987591|NCT01641237|11109544|FG003|COMPLETED|Period III||16
9987592|NCT01641237|11109541|FG000|NOT COMPLETED|Period III||1
9987593|NCT01641237|11109542|FG001|NOT COMPLETED|Period III||0
9987594|NCT01641237|11109543|FG002|NOT COMPLETED|Period III||0
9987595|NCT01641237|11109544|FG003|NOT COMPLETED|Period III||0
9987596|NCT01641237|11109541|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
9987597|NCT01641237|11109542|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
9987598|NCT01641237|11109543|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
9987599|NCT01641237|11109544|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
9987600|NCT01641237|11109541|FG000|COMPLETED|Period IV||15
9987601|NCT01641237|11109542|FG001|COMPLETED|Period IV||15
9987602|NCT01641237|11109543|FG002|COMPLETED|Period IV||15
9987603|NCT01641237|11109544|FG003|COMPLETED|Period IV||15
9987604|NCT01641237|11109541|FG000|NOT COMPLETED|Period IV||0
9987605|NCT01641237|11109542|FG001|NOT COMPLETED|Period IV||0
9987606|NCT01641237|11109543|FG002|NOT COMPLETED|Period IV||0
9987607|NCT01641237|11109544|FG003|NOT COMPLETED|Period IV||0
9987608|NCT01641367|11109560|FG000|STARTED|Cohorts||287
9987609|NCT01641367|11109561|FG001|STARTED|Cohorts||74
9987610|NCT01641367|11109562|FG002|STARTED|Cohorts||72
9987611|NCT01641367|11109563|FG003|STARTED|Cohorts||8
9987612|NCT01641367|11109564|FG004|STARTED|Cohorts||70
9987613|NCT01641367|11109565|FG005|STARTED|Cohorts||34
9987614|NCT01641367|11109566|FG006|STARTED|Cohorts||0
9987615|NCT01641367|11109567|FG007|STARTED|Cohorts||0
9987616|NCT01641367|11109560|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211
9987617|NCT01641367|11109561|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60
9987618|NCT01641367|11109562|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60
9987619|NCT01641367|11109563|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6
9987620|NCT01641367|11109564|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52
9987621|NCT01641367|11109565|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30
9987622|NCT01641367|11109566|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0
9987623|NCT01641367|11109567|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0
9987624|NCT01641367|11109560|FG000|COMPLETED|Cohorts||253
9987625|NCT01641367|11109561|FG001|COMPLETED|Cohorts||73
9987626|NCT01641367|11109562|FG002|COMPLETED|Cohorts||68
9987627|NCT01641367|11109563|FG003|COMPLETED|Cohorts||8
9987628|NCT01641367|11109564|FG004|COMPLETED|Cohorts||67
9987629|NCT01641367|11109565|FG005|COMPLETED|Cohorts||33
9987630|NCT01641367|11109566|FG006|COMPLETED|Cohorts||0
9987631|NCT01641367|11109567|FG007|COMPLETED|Cohorts||0
9987632|NCT01641367|11109560|FG000|NOT COMPLETED|Cohorts||34
9987633|NCT01641367|11109561|FG001|NOT COMPLETED|Cohorts||1
9987634|NCT01641367|11109562|FG002|NOT COMPLETED|Cohorts||4
9987635|NCT01641367|11109563|FG003|NOT COMPLETED|Cohorts||0
9987636|NCT01641367|11109564|FG004|NOT COMPLETED|Cohorts||3
9987637|NCT01641367|11109565|FG005|NOT COMPLETED|Cohorts||1
9987638|NCT01641367|11109566|FG006|NOT COMPLETED|Cohorts||0
9987639|NCT01641367|11109567|FG007|NOT COMPLETED|Cohorts||0
9987640|NCT01641367|11109560|FG000|STARTED|Randomized Adherence Intervention||0
9987641|NCT01641367|11109561|FG001|STARTED|Randomized Adherence Intervention||0
9987642|NCT01641367|11109562|FG002|STARTED|Randomized Adherence Intervention||0
9987643|NCT01641367|11109563|FG003|STARTED|Randomized Adherence Intervention||0
9987644|NCT01641367|11109564|FG004|STARTED|Randomized Adherence Intervention||0
9987645|NCT01641367|11109565|FG005|STARTED|Randomized Adherence Intervention||0
9987646|NCT01641367|11109566|FG006|STARTED|Randomized Adherence Intervention||257
9987647|NCT01641367|11109567|FG007|STARTED|Randomized Adherence Intervention||264
9987648|NCT01641367|11109560|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
9987649|NCT01641367|11109561|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
9987650|NCT01641367|11109562|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
9987651|NCT01641367|11109563|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
9987652|NCT01641367|11109564|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
9987653|NCT01641367|11109565|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
9987654|NCT01641367|11109566|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
9987655|NCT01641367|11109567|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
9987656|NCT01641367|11109560|FG000|COMPLETED|Randomized Adherence Intervention||0
9987657|NCT01641367|11109561|FG001|COMPLETED|Randomized Adherence Intervention||0
9987658|NCT01641367|11109562|FG002|COMPLETED|Randomized Adherence Intervention||0
9987659|NCT01641367|11109563|FG003|COMPLETED|Randomized Adherence Intervention||0
9987660|NCT01641367|11109564|FG004|COMPLETED|Randomized Adherence Intervention||0
9987661|NCT01641367|11109565|FG005|COMPLETED|Randomized Adherence Intervention||0
9987662|NCT01641367|11109566|FG006|COMPLETED|Randomized Adherence Intervention||238
9987663|NCT01641367|11109567|FG007|COMPLETED|Randomized Adherence Intervention||240
9987664|NCT01641367|11109560|FG000|NOT COMPLETED|Randomized Adherence Intervention||0
9987665|NCT01641367|11109561|FG001|NOT COMPLETED|Randomized Adherence Intervention||0
9987666|NCT01641367|11109562|FG002|NOT COMPLETED|Randomized Adherence Intervention||0
9987667|NCT01641367|11109563|FG003|NOT COMPLETED|Randomized Adherence Intervention||0
9987668|NCT01641367|11109564|FG004|NOT COMPLETED|Randomized Adherence Intervention||0
9987669|NCT01641367|11109565|FG005|NOT COMPLETED|Randomized Adherence Intervention||0
9987670|NCT01641367|11109566|FG006|NOT COMPLETED|Randomized Adherence Intervention||19
9987671|NCT01641367|11109567|FG007|NOT COMPLETED|Randomized Adherence Intervention||24
9987672|NCT01641380|11109592|FG000|STARTED|First Injection Cycle||50
9987673|NCT01641380|11109593|FG001|STARTED|First Injection Cycle||50
9987674|NCT01641380|11109592|FG000|COMPLETED|First Injection Cycle||43
9987675|NCT01641380|11109593|FG001|COMPLETED|First Injection Cycle||44
9987676|NCT01641380|11109592|FG000|NOT COMPLETED|First Injection Cycle||7
9987677|NCT01641380|11109593|FG001|NOT COMPLETED|First Injection Cycle||6
9987678|NCT01641380|11109592|FG000|STARTED|Second Injection Cycle||43
9987679|NCT01641380|11109593|FG001|STARTED|Second Injection Cycle||44
9987680|NCT01641380|11109592|FG000|COMPLETED|Second Injection Cycle||39
9987681|NCT01641380|11109593|FG001|COMPLETED|Second Injection Cycle||38
9987682|NCT01641380|11109592|FG000|NOT COMPLETED|Second Injection Cycle||4
9987683|NCT01641380|11109593|FG001|NOT COMPLETED|Second Injection Cycle||6
9987684|NCT01641380|11109592|FG000|STARTED|Third Injection Cycle||39
9987685|NCT01641380|11109593|FG001|STARTED|Third Injection Cycle||38
9987686|NCT01641380|11109592|FG000|COMPLETED|Third Injection Cycle||36
9987687|NCT01641380|11109593|FG001|COMPLETED|Third Injection Cycle||33
9987688|NCT01641380|11109592|FG000|NOT COMPLETED|Third Injection Cycle||3
9987689|NCT01641380|11109593|FG001|NOT COMPLETED|Third Injection Cycle||5
9987690|NCT01641445|11109602|FG000|STARTED|Overall Study||41
9987691|NCT01641445|11109603|FG001|STARTED|Overall Study||41
9987692|NCT01641445|11109602|FG000|COMPLETED|Overall Study||31
9987693|NCT01641445|11109603|FG001|COMPLETED|Overall Study||36
9987694|NCT01641445|11109602|FG000|NOT COMPLETED|Overall Study||10
9987695|NCT01641445|11109603|FG001|NOT COMPLETED|Overall Study||5
9987696|NCT01641471|11109611|FG000|STARTED|Overall Study||58
9987697|NCT01641471|11109612|FG001|STARTED|Overall Study||58
9987698|NCT01641471|11109611|FG000|COMPLETED|Overall Study||35
9987699|NCT01641471|11109612|FG001|COMPLETED|Overall Study||31
9987700|NCT01641471|11109611|FG000|NOT COMPLETED|Overall Study||23
9987701|NCT01641471|11109612|FG001|NOT COMPLETED|Overall Study||27
9987702|NCT01641640|11109618|FG000|STARTED|Overall Study||328
9987703|NCT01641640|11109618|FG000|Enrolled and Treated|Overall Study||327
9987704|NCT01641640|11109618|FG000|COMPLETED|Overall Study||292
9987705|NCT01641640|11109618|FG000|NOT COMPLETED|Overall Study||36
9987706|NCT01641653|11109624|FG000|STARTED|Overall Study||30
9987707|NCT01641653|11109625|FG001|STARTED|Overall Study||30
9987708|NCT01641653|11109624|FG000|COMPLETED|Overall Study||30
9987709|NCT01641653|11109625|FG001|COMPLETED|Overall Study||30
9987710|NCT01641653|11109624|FG000|NOT COMPLETED|Overall Study||0
9987711|NCT01641653|11109625|FG001|NOT COMPLETED|Overall Study||0
9987712|NCT01641692|11109634|FG000|STARTED|Treatment Period 1||42
9987713|NCT01641692|11109635|FG001|STARTED|Treatment Period 1||45
9987714|NCT01641692|11109636|FG002|STARTED|Treatment Period 1||51
9987715|NCT01641692|11109637|FG003|STARTED|Treatment Period 1||41
9987716|NCT01641692|11109638|FG004|STARTED|Treatment Period 1||43
9987717|NCT01641692|11109639|FG005|STARTED|Treatment Period 1||39
9987718|NCT01641692|11109640|FG006|STARTED|Treatment Period 1||38
9987719|NCT01641692|11109641|FG007|STARTED|Treatment Period 1||51
9987720|NCT01641692|11109634|FG000|COMPLETED|Treatment Period 1||40
9987721|NCT01641692|11109635|FG001|COMPLETED|Treatment Period 1||45
9987722|NCT01641692|11109636|FG002|COMPLETED|Treatment Period 1||50
9987723|NCT01641692|11109637|FG003|COMPLETED|Treatment Period 1||41
9987724|NCT01641692|11109638|FG004|COMPLETED|Treatment Period 1||39
9987725|NCT01641692|11109639|FG005|COMPLETED|Treatment Period 1||37
9987726|NCT01641692|11109640|FG006|COMPLETED|Treatment Period 1||38
9987727|NCT01641692|11109641|FG007|COMPLETED|Treatment Period 1||48
9987728|NCT01641692|11109634|FG000|NOT COMPLETED|Treatment Period 1||2
9987729|NCT01641692|11109635|FG001|NOT COMPLETED|Treatment Period 1||0
9987730|NCT01641692|11109636|FG002|NOT COMPLETED|Treatment Period 1||1
9987731|NCT01641692|11109637|FG003|NOT COMPLETED|Treatment Period 1||0
9987732|NCT01641692|11109638|FG004|NOT COMPLETED|Treatment Period 1||4
9987733|NCT01641692|11109639|FG005|NOT COMPLETED|Treatment Period 1||2
9987734|NCT01641692|11109640|FG006|NOT COMPLETED|Treatment Period 1||0
9987735|NCT01641692|11109641|FG007|NOT COMPLETED|Treatment Period 1||3
9987736|NCT01641692|11109634|FG000|STARTED|Washout Period 1 (12-14 Days)||40
9987737|NCT01641692|11109635|FG001|STARTED|Washout Period 1 (12-14 Days)||45
9987738|NCT01641692|11109636|FG002|STARTED|Washout Period 1 (12-14 Days)||50
9987739|NCT01641692|11109637|FG003|STARTED|Washout Period 1 (12-14 Days)||41
9987740|NCT01641692|11109638|FG004|STARTED|Washout Period 1 (12-14 Days)||39
9987741|NCT01641692|11109639|FG005|STARTED|Washout Period 1 (12-14 Days)||37
9987742|NCT01641692|11109640|FG006|STARTED|Washout Period 1 (12-14 Days)||38
9987743|NCT01641692|11109641|FG007|STARTED|Washout Period 1 (12-14 Days)||48
9987744|NCT01641692|11109634|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
9987745|NCT01641692|11109635|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
9987746|NCT01641692|11109636|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
9987747|NCT01641692|11109637|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
9987748|NCT01641692|11109638|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
9987749|NCT01641692|11109639|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
9987750|NCT01641692|11109640|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
9987751|NCT01641692|11109641|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
9987752|NCT01641692|11109634|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
9987753|NCT01641692|11109635|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
9987754|NCT01641692|11109636|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
9987755|NCT01641692|11109637|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
9987756|NCT01641692|11109638|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
9987757|NCT01641692|11109639|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
9987758|NCT01641692|11109640|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
9987759|NCT01641692|11109641|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
9987760|NCT01641692|11109634|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
9987761|NCT01641692|11109635|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
9987762|NCT01641692|11109636|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
9987763|NCT01641692|11109637|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
9987764|NCT01641692|11109638|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
9987765|NCT01641692|11109639|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
9987766|NCT01641692|11109640|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
9987767|NCT01641692|11109641|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
9987768|NCT01641692|11109634|FG000|COMPLETED|Treatment Period 2||30
9987769|NCT01641692|11109635|FG001|COMPLETED|Treatment Period 2||46
9987770|NCT01641692|11109636|FG002|COMPLETED|Treatment Period 2||40
9987771|NCT01641692|11109637|FG003|COMPLETED|Treatment Period 2||41
9987772|NCT01641692|11109638|FG004|COMPLETED|Treatment Period 2||37
9987773|NCT01641692|11109639|FG005|COMPLETED|Treatment Period 2||43
9987774|NCT01641692|11109640|FG006|COMPLETED|Treatment Period 2||43
9987775|NCT01641692|11109641|FG007|COMPLETED|Treatment Period 2||35
9987776|NCT01641692|11109634|FG000|NOT COMPLETED|Treatment Period 2||3
9987777|NCT01641692|11109635|FG001|NOT COMPLETED|Treatment Period 2||0
9987778|NCT01641692|11109636|FG002|NOT COMPLETED|Treatment Period 2||0
9987779|NCT01641692|11109637|FG003|NOT COMPLETED|Treatment Period 2||0
9987780|NCT01641692|11109638|FG004|NOT COMPLETED|Treatment Period 2||0
9987781|NCT01641692|11109639|FG005|NOT COMPLETED|Treatment Period 2||2
9987782|NCT01641692|11109640|FG006|NOT COMPLETED|Treatment Period 2||0
9987783|NCT01641692|11109641|FG007|NOT COMPLETED|Treatment Period 2||1
9987784|NCT01641692|11109634|FG000|STARTED|Washout Period 2 (12-14 Days)||30
9987785|NCT01641692|11109635|FG001|STARTED|Washout Period 2 (12-14 Days)||46
9987786|NCT01641692|11109636|FG002|STARTED|Washout Period 2 (12-14 Days)||40
9987787|NCT01641692|11109637|FG003|STARTED|Washout Period 2 (12-14 Days)||41
9987788|NCT01641692|11109638|FG004|STARTED|Washout Period 2 (12-14 Days)||37
9987789|NCT01641692|11109639|FG005|STARTED|Washout Period 2 (12-14 Days)||43
9987790|NCT01641692|11109640|FG006|STARTED|Washout Period 2 (12-14 Days)||43
9987791|NCT01641692|11109641|FG007|STARTED|Washout Period 2 (12-14 Days)||35
9987792|NCT01641692|11109634|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
9987793|NCT01641692|11109635|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
9987794|NCT01641692|11109636|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
9987795|NCT01641692|11109637|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
9987796|NCT01641692|11109638|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
9987797|NCT01641692|11109639|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
9987798|NCT01641692|11109640|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
9987799|NCT01641692|11109641|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
9987800|NCT01641692|11109634|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
9987801|NCT01641692|11109635|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
9987802|NCT01641692|11109636|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
9987803|NCT01641692|11109637|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
9987804|NCT01641692|11109638|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
9987805|NCT01641692|11109639|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
9987806|NCT01641692|11109640|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
9987807|NCT01641692|11109641|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
9987808|NCT01641692|11109634|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
9987809|NCT01641692|11109635|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
9987810|NCT01641692|11109636|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
9987811|NCT01641692|11109637|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
9987812|NCT01641692|11109638|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
9987813|NCT01641692|11109639|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
9987814|NCT01641692|11109640|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
9987815|NCT01641692|11109641|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
9987816|NCT01641692|11109634|FG000|COMPLETED|Treatment Period 3||43
9987817|NCT01641692|11109635|FG001|COMPLETED|Treatment Period 3||32
9987818|NCT01641692|11109636|FG002|COMPLETED|Treatment Period 3||37
9987819|NCT01641692|11109637|FG003|COMPLETED|Treatment Period 3||42
9987820|NCT01641692|11109638|FG004|COMPLETED|Treatment Period 3||40
9987821|NCT01641692|11109639|FG005|COMPLETED|Treatment Period 3||39
9987822|NCT01641692|11109640|FG006|COMPLETED|Treatment Period 3||33
9987823|NCT01641692|11109641|FG007|COMPLETED|Treatment Period 3||38
9987824|NCT01641692|11109634|FG000|NOT COMPLETED|Treatment Period 3||0
9987825|NCT01641692|11109635|FG001|NOT COMPLETED|Treatment Period 3||1
9987826|NCT01641692|11109636|FG002|NOT COMPLETED|Treatment Period 3||1
9987827|NCT01641692|11109637|FG003|NOT COMPLETED|Treatment Period 3||0
9987828|NCT01641692|11109638|FG004|NOT COMPLETED|Treatment Period 3||0
9987829|NCT01641692|11109639|FG005|NOT COMPLETED|Treatment Period 3||0
9987830|NCT01641692|11109640|FG006|NOT COMPLETED|Treatment Period 3||2
9987831|NCT01641692|11109641|FG007|NOT COMPLETED|Treatment Period 3||0
9987832|NCT01641692|11109634|FG000|STARTED|Washout Period 3 or Follow-up||43
9987833|NCT01641692|11109635|FG001|STARTED|Washout Period 3 or Follow-up||32
9987834|NCT01641692|11109636|FG002|STARTED|Washout Period 3 or Follow-up||37
9987835|NCT01641692|11109637|FG003|STARTED|Washout Period 3 or Follow-up||42
9987836|NCT01641692|11109638|FG004|STARTED|Washout Period 3 or Follow-up||40
9987837|NCT01641692|11109639|FG005|STARTED|Washout Period 3 or Follow-up||39
9987838|NCT01641692|11109640|FG006|STARTED|Washout Period 3 or Follow-up||33
9987839|NCT01641692|11109641|FG007|STARTED|Washout Period 3 or Follow-up||38
9987840|NCT01641692|11109634|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
9987841|NCT01641692|11109635|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
9987842|NCT01641692|11109636|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
10101360|NCT02407223|11230633|FG000|COMPLETED|Overall Study||0
10101361|NCT02407223|11230634|FG001|COMPLETED|Overall Study||0
10101362|NCT02407223|11230635|FG002|COMPLETED|Overall Study||0
10101363|NCT02407223|11230633|FG000|NOT COMPLETED|Overall Study||116
9987843|NCT01641692|11109637|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
9987844|NCT01641692|11109638|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
9987845|NCT01641692|11109639|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
9987846|NCT01641692|11109640|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
9987847|NCT01641692|11109641|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
9987848|NCT01641692|11109634|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1
9987849|NCT01641692|11109635|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0
9987850|NCT01641692|11109636|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1
9987851|NCT01641692|11109637|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1
9987852|NCT01641692|11109638|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0
9987853|NCT01641692|11109639|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2
9987854|NCT01641692|11109640|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1
9987855|NCT01641692|11109641|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0
9987856|NCT01641809|11109664|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60
9987857|NCT01641809|11109665|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60
9987858|NCT01641809|11109666|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61
9987859|NCT01641809|11109667|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62
9987860|NCT01641809|11109664|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52
9987861|NCT01641809|11109665|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53
9987862|NCT01641809|11109666|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55
9987863|NCT01641809|11109667|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47
9987864|NCT01641809|11109664|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
9987865|NCT01641809|11109665|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
9987866|NCT01641809|11109666|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
9987867|NCT01641809|11109667|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
9987868|NCT01641809|11109664|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52
9987869|NCT01641809|11109665|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53
9987870|NCT01641809|11109666|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55
9987871|NCT01641809|11109667|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47
9987872|NCT01641809|11109664|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
9987873|NCT01641809|11109665|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
9987874|NCT01641809|11109666|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
9987875|NCT01641809|11109667|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
9987876|NCT01641809|11109664|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
9987877|NCT01641809|11109665|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
9987878|NCT01641809|11109666|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
9987879|NCT01641809|11109667|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
9987880|NCT01641809|11109664|FG000|STARTED|Open-label (Week 96 to Week 324)||46
9987881|NCT01641809|11109665|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
9987882|NCT01641809|11109666|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
9987883|NCT01641809|11109667|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
9987884|NCT01641809|11109664|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30
9987885|NCT01641809|11109665|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35
9987886|NCT01641809|11109666|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43
9987887|NCT01641809|11109667|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0
10101364|NCT02407223|11230634|FG001|NOT COMPLETED|Overall Study||118
10101365|NCT02407223|11230635|FG002|NOT COMPLETED|Overall Study||122
10101366|NCT02407249|11230645|FG000|STARTED|Overall Study||73
10101367|NCT02407249|11230645|FG000|Treated|Overall Study||60
10101368|NCT02407249|11230645|FG000|COMPLETED|Overall Study||47
10101369|NCT02407249|11230645|FG000|NOT COMPLETED|Overall Study||26
10101370|NCT02407457|11230651|FG000|STARTED|Baseline||235
10101371|NCT02407457|11230652|FG001|STARTED|Baseline||220
10101372|NCT02407457|11230651|FG000|COMPLETED|Baseline||235
10101373|NCT02407457|11230652|FG001|COMPLETED|Baseline||220
10101374|NCT02407457|11230651|FG000|NOT COMPLETED|Baseline||0
10101375|NCT02407457|11230652|FG001|NOT COMPLETED|Baseline||0
10101376|NCT02407457|11230651|FG000|STARTED|1 Month||235
10101377|NCT02407457|11230652|FG001|STARTED|1 Month||220
10101378|NCT02407457|11230651|FG000|COMPLETED|1 Month||229
10101379|NCT02407457|11230652|FG001|COMPLETED|1 Month||213
10101380|NCT02407457|11230651|FG000|NOT COMPLETED|1 Month||6
10101381|NCT02407457|11230652|FG001|NOT COMPLETED|1 Month||7
10101382|NCT02407457|11230651|FG000|STARTED|6-Month||231
10101383|NCT02407457|11230652|FG001|STARTED|6-Month||219
10101384|NCT02407457|11230651|FG000|COMPLETED|6-Month||211
10101385|NCT02407457|11230652|FG001|COMPLETED|6-Month||194
10101386|NCT02407457|11230651|FG000|NOT COMPLETED|6-Month||20
10101387|NCT02407457|11230652|FG001|NOT COMPLETED|6-Month||25
10101388|NCT02407457|11230651|FG000|STARTED|1 Year||227
10101389|NCT02407457|11230652|FG001|STARTED|1 Year||208
10101390|NCT02407457|11230651|FG000|COMPLETED|1 Year||194
10101391|NCT02407457|11230652|FG001|COMPLETED|1 Year||180
10101392|NCT02407457|11230651|FG000|NOT COMPLETED|1 Year||33
10101393|NCT02407457|11230652|FG001|NOT COMPLETED|1 Year||28
9987888|NCT01641809|11109664|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
9987889|NCT01641809|11109665|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
9987890|NCT01641809|11109666|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
9987891|NCT01641809|11109667|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
9987892|NCT01641822|11109687|FG000|STARTED|Run-in Phase||107
9987893|NCT01641822|11109688|FG001|STARTED|Run-in Phase||0
9987894|NCT01641822|11109689|FG002|STARTED|Run-in Phase||0
9987895|NCT01641822|11109687|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
9987896|NCT01641822|11109688|FG001|COMPLETED|Run-in Phase||0
9987897|NCT01641822|11109689|FG002|COMPLETED|Run-in Phase||0
9987898|NCT01641822|11109687|FG000|NOT COMPLETED|Run-in Phase||14
9987899|NCT01641822|11109688|FG001|NOT COMPLETED|Run-in Phase||0
9987900|NCT01641822|11109689|FG002|NOT COMPLETED|Run-in Phase||0
9987901|NCT01641822|11109687|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
9987902|NCT01641822|11109688|FG001|STARTED|Comparative Phase||43
9987903|NCT01641822|11109689|FG002|STARTED|Comparative Phase||47
9987904|NCT01641822|11109687|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0
9987905|NCT01641822|11109688|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42
9987906|NCT01641822|11109689|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46
9987907|NCT01641822|11109687|FG000|COMPLETED|Comparative Phase||0
9987908|NCT01641822|11109688|FG001|COMPLETED|Comparative Phase||37
9987909|NCT01641822|11109689|FG002|COMPLETED|Comparative Phase||37
9987910|NCT01641822|11109687|FG000|NOT COMPLETED|Comparative Phase||0
9987911|NCT01641822|11109688|FG001|NOT COMPLETED|Comparative Phase||6
9987912|NCT01641822|11109689|FG002|NOT COMPLETED|Comparative Phase||10
9987913|NCT01641835|11109696|FG000|STARTED|Overall Study||303
9987914|NCT01641835|11109696|FG000|COMPLETED|Overall Study||303
9987915|NCT01641835|11109696|FG000|NOT COMPLETED|Overall Study||0
9987916|NCT01641861|11109702|FG000|STARTED|Overall Study||246
9987917|NCT01641861|11109703|FG001|STARTED|Overall Study||242
9987918|NCT01641861|11109702|FG000|COMPLETED|Overall Study||211
9987919|NCT01641861|11109703|FG001|COMPLETED|Overall Study||217
9987920|NCT01641861|11109702|FG000|NOT COMPLETED|Overall Study||35
9987921|NCT01641861|11109703|FG001|NOT COMPLETED|Overall Study||25
9987922|NCT01641900|11109711|FG000|STARTED|Overall Study||28
9987923|NCT01641900|11109712|FG001|STARTED|Overall Study||31
9987924|NCT01641900|11109711|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
9987925|NCT01641900|11109712|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
9987926|NCT01641900|11109711|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
9987927|NCT01641900|11109712|FG001|Completed Drug Intervention|Overall Study||29
9987928|NCT01641900|11109711|FG000|COMPLETED|Overall Study||26
9987929|NCT01641900|11109712|FG001|COMPLETED|Overall Study||29
9987930|NCT01641900|11109711|FG000|NOT COMPLETED|Overall Study||2
9987931|NCT01641900|11109712|FG001|NOT COMPLETED|Overall Study||2
9987932|NCT01641926|11109724|FG000|STARTED|Overall Study||143
9987933|NCT01641926|11109725|FG001|STARTED|Overall Study||145
9987934|NCT01641926|11109726|FG002|STARTED|Overall Study||57
9987935|NCT01641926|11109727|FG003|STARTED|Overall Study||57
9987936|NCT01641926|11109724|FG000|Treated (All Participants as Treated)|Overall Study||142
9987937|NCT01641926|11109725|FG001|Treated (All Participants as Treated)|Overall Study||144
9987938|NCT01641926|11109726|FG002|Treated (All Participants as Treated)|Overall Study||56
9987939|NCT01641926|11109727|FG003|Treated (All Participants as Treated)|Overall Study||57
9987940|NCT01641926|11109724|FG000|COMPLETED|Overall Study||115
9987941|NCT01641926|11109725|FG001|COMPLETED|Overall Study||130
9987942|NCT01641926|11109726|FG002|COMPLETED|Overall Study||46
9987943|NCT01641926|11109727|FG003|COMPLETED|Overall Study||53
9987944|NCT01641926|11109724|FG000|NOT COMPLETED|Overall Study||28
9987945|NCT01641926|11109725|FG001|NOT COMPLETED|Overall Study||15
9987946|NCT01641926|11109726|FG002|NOT COMPLETED|Overall Study||11
9987947|NCT01641926|11109727|FG003|NOT COMPLETED|Overall Study||4
9987948|NCT01641939|11109740|FG000|STARTED|Overall Study||117
9987949|NCT01641939|11109741|FG001|STARTED|Overall Study||228
9987950|NCT01641939|11109742|FG002|STARTED|Overall Study||70
9987951|NCT01641939|11109740|FG000|Stage 1|Overall Study||37
9987952|NCT01641939|11109741|FG001|Stage 1|Overall Study||75
9987953|NCT01641939|11109742|FG002|Stage 1|Overall Study||70
9987954|NCT01641939|11109740|FG000|Stage 2|Overall Study||80
9987955|NCT01641939|11109741|FG001|Stage 2|Overall Study||153
9987956|NCT01641939|11109742|FG002|Stage 2|Overall Study||0
9987957|NCT01641939|11109740|FG000|COMPLETED|Overall Study||0
9987958|NCT01641939|11109741|FG001|COMPLETED|Overall Study||0
9987959|NCT01641939|11109742|FG002|COMPLETED|Overall Study||0
9987960|NCT01641939|11109740|FG000|NOT COMPLETED|Overall Study||117
9987961|NCT01641939|11109741|FG001|NOT COMPLETED|Overall Study||228
9987962|NCT01641939|11109742|FG002|NOT COMPLETED|Overall Study||70
9987963|NCT01641952|11109752|FG000|STARTED|Overall Study||505
9987964|NCT01641952|11109752|FG000|Treated|Overall Study||504
9987965|NCT01641952|11109752|FG000|COMPLETED|Overall Study||471
9987966|NCT01641952|11109752|FG000|NOT COMPLETED|Overall Study||34
9987967|NCT01641978|11109756|FG000|STARTED|Overall Study||125
9987968|NCT01641978|11109756|FG000|COMPLETED|Overall Study||125
9987969|NCT01641978|11109756|FG000|NOT COMPLETED|Overall Study||0
9987970|NCT01641991|11109768|FG000|STARTED|Overall Study||82
9987971|NCT01641991|11109769|FG001|STARTED|Overall Study||82
9987972|NCT01641991|11109770|FG002|STARTED|Overall Study||82
9987973|NCT01641991|11109771|FG003|STARTED|Overall Study||82
9987974|NCT01641991|11109768|FG000|COMPLETED|Overall Study||73
9987975|NCT01641991|11109769|FG001|COMPLETED|Overall Study||74
9987976|NCT01641991|11109770|FG002|COMPLETED|Overall Study||65
9987977|NCT01641991|11109771|FG003|COMPLETED|Overall Study||66
9987978|NCT01641991|11109768|FG000|NOT COMPLETED|Overall Study||9
9987979|NCT01641991|11109769|FG001|NOT COMPLETED|Overall Study||8
9987980|NCT01641991|11109770|FG002|NOT COMPLETED|Overall Study||17
9987981|NCT01641991|11109771|FG003|NOT COMPLETED|Overall Study||16
9987982|NCT01642056|11109786|FG000|STARTED|First Intervention||10
9987983|NCT01642056|11109787|FG001|STARTED|First Intervention||10
9987984|NCT01642056|11109786|FG000|COMPLETED|First Intervention||9
9987985|NCT01642056|11109787|FG001|COMPLETED|First Intervention||10
9987986|NCT01642056|11109786|FG000|NOT COMPLETED|First Intervention||1
9987987|NCT01642056|11109787|FG001|NOT COMPLETED|First Intervention||0
9987988|NCT01642056|11109786|FG000|STARTED|Second Intervention||9
9987989|NCT01642056|11109787|FG001|STARTED|Second Intervention||10
9987990|NCT01642056|11109786|FG000|COMPLETED|Second Intervention||8
9987991|NCT01642056|11109787|FG001|COMPLETED|Second Intervention||8
9987992|NCT01642056|11109786|FG000|NOT COMPLETED|Second Intervention||1
9987993|NCT01642056|11109787|FG001|NOT COMPLETED|Second Intervention||2
9987994|NCT01642082|11109793|FG000|STARTED|Overall Study||28
9987995|NCT01642082|11109793|FG000|COMPLETED|Overall Study||28
9987996|NCT01642082|11109793|FG000|NOT COMPLETED|Overall Study||0
9987997|NCT01642147|11109806|FG000|STARTED|Overall Study||30
9987998|NCT01642147|11109807|FG001|STARTED|Overall Study||30
9987999|NCT01642147|11109806|FG000|COMPLETED|Overall Study||30
9988000|NCT01642147|11109807|FG001|COMPLETED|Overall Study||30
9988001|NCT01642147|11109806|FG000|NOT COMPLETED|Overall Study||0
9988002|NCT01642147|11109807|FG001|NOT COMPLETED|Overall Study||0
9988003|NCT01642212|11109815|FG000|STARTED|Single-blind Baseline||119
9988004|NCT01642212|11109816|FG001|STARTED|Single-blind Baseline||0
9988005|NCT01642212|11109817|FG002|STARTED|Single-blind Baseline||0
9988006|NCT01642212|11109818|FG003|STARTED|Single-blind Baseline||0
9988007|NCT01642212|11109819|FG004|STARTED|Single-blind Baseline||0
9988008|NCT01642212|11109815|FG000|COMPLETED|Single-blind Baseline||93
9988009|NCT01642212|11109816|FG001|COMPLETED|Single-blind Baseline||0
9988010|NCT01642212|11109817|FG002|COMPLETED|Single-blind Baseline||0
9988011|NCT01642212|11109818|FG003|COMPLETED|Single-blind Baseline||0
9988012|NCT01642212|11109819|FG004|COMPLETED|Single-blind Baseline||0
9988013|NCT01642212|11109815|FG000|NOT COMPLETED|Single-blind Baseline||26
9988014|NCT01642212|11109816|FG001|NOT COMPLETED|Single-blind Baseline||0
9988015|NCT01642212|11109817|FG002|NOT COMPLETED|Single-blind Baseline||0
9988016|NCT01642212|11109818|FG003|NOT COMPLETED|Single-blind Baseline||0
9988017|NCT01642212|11109819|FG004|NOT COMPLETED|Single-blind Baseline||0
9988018|NCT01642212|11109815|FG000|STARTED|Double-blind Treatment||0
9988019|NCT01642212|11109816|FG001|STARTED|Double-blind Treatment||42
9988020|NCT01642212|11109817|FG002|STARTED|Double-blind Treatment||51
9988021|NCT01642212|11109818|FG003|STARTED|Double-blind Treatment||0
9988022|NCT01642212|11109819|FG004|STARTED|Double-blind Treatment||0
9988023|NCT01642212|11109815|FG000|COMPLETED|Double-blind Treatment||0
9988024|NCT01642212|11109816|FG001|COMPLETED|Double-blind Treatment||39
9988025|NCT01642212|11109817|FG002|COMPLETED|Double-blind Treatment||49
9988026|NCT01642212|11109818|FG003|COMPLETED|Double-blind Treatment||0
9988027|NCT01642212|11109819|FG004|COMPLETED|Double-blind Treatment||0
9988028|NCT01642212|11109815|FG000|NOT COMPLETED|Double-blind Treatment||0
9988029|NCT01642212|11109816|FG001|NOT COMPLETED|Double-blind Treatment||3
9988030|NCT01642212|11109817|FG002|NOT COMPLETED|Double-blind Treatment||2
9988031|NCT01642212|11109818|FG003|NOT COMPLETED|Double-blind Treatment||0
9988032|NCT01642212|11109819|FG004|NOT COMPLETED|Double-blind Treatment||0
9988033|NCT01642212|11109815|FG000|STARTED|Open-label Extension||0
9988034|NCT01642212|11109816|FG001|STARTED|Open-label Extension||0
9988035|NCT01642212|11109817|FG002|STARTED|Open-label Extension||0
9988036|NCT01642212|11109818|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
9988037|NCT01642212|11109819|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
9988038|NCT01642212|11109815|FG000|COMPLETED|Open-label Extension||0
9988039|NCT01642212|11109816|FG001|COMPLETED|Open-label Extension||0
9988040|NCT01642212|11109817|FG002|COMPLETED|Open-label Extension||0
9988041|NCT01642212|11109818|FG003|COMPLETED|Open-label Extension||27
9988042|NCT01642212|11109819|FG004|COMPLETED|Open-label Extension||37
9988043|NCT01642212|11109815|FG000|NOT COMPLETED|Open-label Extension||0
9988044|NCT01642212|11109816|FG001|NOT COMPLETED|Open-label Extension||0
9988045|NCT01642212|11109817|FG002|NOT COMPLETED|Open-label Extension||0
9988046|NCT01642212|11109818|FG003|NOT COMPLETED|Open-label Extension||10
9988047|NCT01642212|11109819|FG004|NOT COMPLETED|Open-label Extension||8
9988048|NCT01642238|11109827|FG000|STARTED|First Intervention (1 Day)||7
9988049|NCT01642238|11109828|FG001|STARTED|First Intervention (1 Day)||8
9988050|NCT01642238|11109827|FG000|COMPLETED|First Intervention (1 Day)||7
9988051|NCT01642238|11109828|FG001|COMPLETED|First Intervention (1 Day)||8
9988052|NCT01642238|11109827|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9988053|NCT01642238|11109828|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9988054|NCT01642238|11109827|FG000|STARTED|Washout (1-2 Weeks)||7
9988055|NCT01642238|11109828|FG001|STARTED|Washout (1-2 Weeks)||8
9988056|NCT01642238|11109827|FG000|COMPLETED|Washout (1-2 Weeks)||7
9988057|NCT01642238|11109828|FG001|COMPLETED|Washout (1-2 Weeks)||8
9988058|NCT01642238|11109827|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
9988059|NCT01642238|11109828|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
9988060|NCT01642238|11109827|FG000|STARTED|Second Intervention (1 Day)||7
9988061|NCT01642238|11109828|FG001|STARTED|Second Intervention (1 Day)||8
9988062|NCT01642238|11109827|FG000|COMPLETED|Second Intervention (1 Day)||7
9988063|NCT01642238|11109828|FG001|COMPLETED|Second Intervention (1 Day)||8
9988064|NCT01642238|11109827|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9988065|NCT01642238|11109828|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9988066|NCT01642251|11109837|FG000|STARTED|Overall Study||3
9988067|NCT01642251|11109838|FG001|STARTED|Overall Study||6
9988068|NCT01642251|11109839|FG002|STARTED|Overall Study||75
9988069|NCT01642251|11109840|FG003|STARTED|Overall Study||72
9988070|NCT01642251|11109837|FG000|Started Protocol Therapy|Overall Study||3
9988071|NCT01642251|11109838|FG001|Started Protocol Therapy|Overall Study||6
9988072|NCT01642251|11109839|FG002|Started Protocol Therapy|Overall Study||66
9988073|NCT01642251|11109840|FG003|Started Protocol Therapy|Overall Study||66
9988074|NCT01642251|11109837|FG000|Eligible|Overall Study||3
9988075|NCT01642251|11109838|FG001|Eligible|Overall Study||6
9988076|NCT01642251|11109839|FG002|Eligible|Overall Study||72
9988077|NCT01642251|11109840|FG003|Eligible|Overall Study||69
9988078|NCT01642251|11109837|FG000|Eligible and Treated|Overall Study||3
9988079|NCT01642251|11109838|FG001|Eligible and Treated|Overall Study||6
9988080|NCT01642251|11109839|FG002|Eligible and Treated|Overall Study||64
9988081|NCT01642251|11109840|FG003|Eligible and Treated|Overall Study||64
9988082|NCT01642251|11109837|FG000|COMPLETED|Overall Study||3
9988083|NCT01642251|11109838|FG001|COMPLETED|Overall Study||6
9988084|NCT01642251|11109839|FG002|COMPLETED|Overall Study||53
9988085|NCT01642251|11109840|FG003|COMPLETED|Overall Study||49
10101394|NCT02407457|11230651|FG000|STARTED|2-year||218
10101395|NCT02407457|11230652|FG001|STARTED|2-year||194
10101396|NCT02407457|11230651|FG000|COMPLETED|2-year||184
10101397|NCT02407457|11230652|FG001|COMPLETED|2-year||159
10101398|NCT02407457|11230651|FG000|NOT COMPLETED|2-year||34
10101399|NCT02407457|11230652|FG001|NOT COMPLETED|2-year||35
10101400|NCT02407457|11230651|FG000|STARTED|3-year||198
10101401|NCT02407457|11230652|FG001|STARTED|3-year||175
9988086|NCT01642251|11109837|FG000|NOT COMPLETED|Overall Study||0
9988087|NCT01642251|11109838|FG001|NOT COMPLETED|Overall Study||0
9988088|NCT01642251|11109839|FG002|NOT COMPLETED|Overall Study||22
9988089|NCT01642251|11109840|FG003|NOT COMPLETED|Overall Study||23
9988090|NCT01642277|11109851|FG000|STARTED|Overall Study||74
9988091|NCT01642277|11109852|FG001|STARTED|Overall Study||60
9988092|NCT01642277|11109851|FG000|COMPLETED|Overall Study||50
9988093|NCT01642277|11109852|FG001|COMPLETED|Overall Study||60
9988094|NCT01642277|11109851|FG000|NOT COMPLETED|Overall Study||24
9988095|NCT01642277|11109852|FG001|NOT COMPLETED|Overall Study||0
9988096|NCT01642407|11109859|FG000|STARTED|Part 1 (Screening Till Week 16)||6
9988097|NCT01642407|11109859|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3
9988098|NCT01642407|11109859|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
9988099|NCT01642407|11109859|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
9988100|NCT01642407|11109859|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
9988101|NCT01642407|11109859|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
9988102|NCT01642485|11109863|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
9988103|NCT01642485|11109864|FG001|STARTED|Period 1, Day 1||4
9988104|NCT01642485|11109865|FG002|STARTED|Period 1, Day 1||4
9988105|NCT01642485|11109866|FG003|STARTED|Period 1, Day 1||4
9988106|NCT01642485|11109867|FG004|STARTED|Period 1, Day 1||4
9988107|NCT01642485|11109868|FG005|STARTED|Period 1, Day 1||4
9988108|NCT01642485|11109869|FG006|STARTED|Period 1, Day 1||4
9988109|NCT01642485|11109870|FG007|STARTED|Period 1, Day 1||4
9988110|NCT01642485|11109863|FG000|COMPLETED|Period 1, Day 1||4
9988111|NCT01642485|11109864|FG001|COMPLETED|Period 1, Day 1||4
9988112|NCT01642485|11109865|FG002|COMPLETED|Period 1, Day 1||4
9988113|NCT01642485|11109866|FG003|COMPLETED|Period 1, Day 1||4
9988114|NCT01642485|11109867|FG004|COMPLETED|Period 1, Day 1||4
9988115|NCT01642485|11109868|FG005|COMPLETED|Period 1, Day 1||4
9988116|NCT01642485|11109869|FG006|COMPLETED|Period 1, Day 1||4
9988117|NCT01642485|11109870|FG007|COMPLETED|Period 1, Day 1||4
9988118|NCT01642485|11109863|FG000|NOT COMPLETED|Period 1, Day 1||0
9988119|NCT01642485|11109864|FG001|NOT COMPLETED|Period 1, Day 1||0
9988120|NCT01642485|11109865|FG002|NOT COMPLETED|Period 1, Day 1||0
9988121|NCT01642485|11109866|FG003|NOT COMPLETED|Period 1, Day 1||0
9988122|NCT01642485|11109867|FG004|NOT COMPLETED|Period 1, Day 1||0
9988123|NCT01642485|11109868|FG005|NOT COMPLETED|Period 1, Day 1||0
9988124|NCT01642485|11109869|FG006|NOT COMPLETED|Period 1, Day 1||0
9988125|NCT01642485|11109870|FG007|NOT COMPLETED|Period 1, Day 1||0
9988126|NCT01642485|11109863|FG000|STARTED|Period 1, Day 2||4
9988127|NCT01642485|11109864|FG001|STARTED|Period 1, Day 2||4
9988128|NCT01642485|11109865|FG002|STARTED|Period 1, Day 2||4
9988129|NCT01642485|11109866|FG003|STARTED|Period 1, Day 2||4
9988130|NCT01642485|11109867|FG004|STARTED|Period 1, Day 2||4
9988131|NCT01642485|11109868|FG005|STARTED|Period 1, Day 2||4
10101402|NCT02407457|11230651|FG000|COMPLETED|3-year||156
9988132|NCT01642485|11109869|FG006|STARTED|Period 1, Day 2||4
9988133|NCT01642485|11109870|FG007|STARTED|Period 1, Day 2||4
9988134|NCT01642485|11109863|FG000|COMPLETED|Period 1, Day 2||4
9988135|NCT01642485|11109864|FG001|COMPLETED|Period 1, Day 2||4
9988136|NCT01642485|11109865|FG002|COMPLETED|Period 1, Day 2||4
10101403|NCT02407457|11230652|FG001|COMPLETED|3-year||137
9988137|NCT01642485|11109866|FG003|COMPLETED|Period 1, Day 2||4
9988138|NCT01642485|11109867|FG004|COMPLETED|Period 1, Day 2||4
9988139|NCT01642485|11109868|FG005|COMPLETED|Period 1, Day 2||4
9988140|NCT01642485|11109869|FG006|COMPLETED|Period 1, Day 2||4
9988141|NCT01642485|11109870|FG007|COMPLETED|Period 1, Day 2||4
9988142|NCT01642485|11109863|FG000|NOT COMPLETED|Period 1, Day 2||0
9988143|NCT01642485|11109864|FG001|NOT COMPLETED|Period 1, Day 2||0
9988144|NCT01642485|11109865|FG002|NOT COMPLETED|Period 1, Day 2||0
9988145|NCT01642485|11109866|FG003|NOT COMPLETED|Period 1, Day 2||0
9988146|NCT01642485|11109867|FG004|NOT COMPLETED|Period 1, Day 2||0
9988147|NCT01642485|11109868|FG005|NOT COMPLETED|Period 1, Day 2||0
9988148|NCT01642485|11109869|FG006|NOT COMPLETED|Period 1, Day 2||0
9988149|NCT01642485|11109870|FG007|NOT COMPLETED|Period 1, Day 2||0
9988150|NCT01642485|11109863|FG000|STARTED|Period 1, Day 3||4
9988151|NCT01642485|11109864|FG001|STARTED|Period 1, Day 3||4
9988152|NCT01642485|11109865|FG002|STARTED|Period 1, Day 3||4
9988153|NCT01642485|11109866|FG003|STARTED|Period 1, Day 3||4
9988154|NCT01642485|11109867|FG004|STARTED|Period 1, Day 3||4
9988155|NCT01642485|11109868|FG005|STARTED|Period 1, Day 3||4
9988156|NCT01642485|11109869|FG006|STARTED|Period 1, Day 3||4
9988157|NCT01642485|11109870|FG007|STARTED|Period 1, Day 3||4
9988158|NCT01642485|11109863|FG000|COMPLETED|Period 1, Day 3||4
9988159|NCT01642485|11109864|FG001|COMPLETED|Period 1, Day 3||4
9988160|NCT01642485|11109865|FG002|COMPLETED|Period 1, Day 3||4
9988161|NCT01642485|11109866|FG003|COMPLETED|Period 1, Day 3||4
9988162|NCT01642485|11109867|FG004|COMPLETED|Period 1, Day 3||4
9988163|NCT01642485|11109868|FG005|COMPLETED|Period 1, Day 3||4
9988164|NCT01642485|11109869|FG006|COMPLETED|Period 1, Day 3||4
9988165|NCT01642485|11109870|FG007|COMPLETED|Period 1, Day 3||4
9988166|NCT01642485|11109863|FG000|NOT COMPLETED|Period 1, Day 3||0
9988167|NCT01642485|11109864|FG001|NOT COMPLETED|Period 1, Day 3||0
9988168|NCT01642485|11109865|FG002|NOT COMPLETED|Period 1, Day 3||0
9988169|NCT01642485|11109866|FG003|NOT COMPLETED|Period 1, Day 3||0
9988170|NCT01642485|11109867|FG004|NOT COMPLETED|Period 1, Day 3||0
9988171|NCT01642485|11109868|FG005|NOT COMPLETED|Period 1, Day 3||0
9988172|NCT01642485|11109869|FG006|NOT COMPLETED|Period 1, Day 3||0
9988173|NCT01642485|11109870|FG007|NOT COMPLETED|Period 1, Day 3||0
9988174|NCT01642485|11109863|FG000|STARTED|Period 2, Day 1||4
9988175|NCT01642485|11109864|FG001|STARTED|Period 2, Day 1||4
9988176|NCT01642485|11109865|FG002|STARTED|Period 2, Day 1||4
9988177|NCT01642485|11109866|FG003|STARTED|Period 2, Day 1||4
9988178|NCT01642485|11109867|FG004|STARTED|Period 2, Day 1||4
9988179|NCT01642485|11109868|FG005|STARTED|Period 2, Day 1||4
9988180|NCT01642485|11109869|FG006|STARTED|Period 2, Day 1||4
9988181|NCT01642485|11109870|FG007|STARTED|Period 2, Day 1||4
9988182|NCT01642485|11109863|FG000|COMPLETED|Period 2, Day 1||4
9988183|NCT01642485|11109864|FG001|COMPLETED|Period 2, Day 1||4
9988184|NCT01642485|11109865|FG002|COMPLETED|Period 2, Day 1||4
9988185|NCT01642485|11109866|FG003|COMPLETED|Period 2, Day 1||4
9988186|NCT01642485|11109867|FG004|COMPLETED|Period 2, Day 1||4
9988187|NCT01642485|11109868|FG005|COMPLETED|Period 2, Day 1||4
9988188|NCT01642485|11109869|FG006|COMPLETED|Period 2, Day 1||4
9988189|NCT01642485|11109870|FG007|COMPLETED|Period 2, Day 1||4
9988190|NCT01642485|11109863|FG000|NOT COMPLETED|Period 2, Day 1||0
9988191|NCT01642485|11109864|FG001|NOT COMPLETED|Period 2, Day 1||0
9988192|NCT01642485|11109865|FG002|NOT COMPLETED|Period 2, Day 1||0
9988193|NCT01642485|11109866|FG003|NOT COMPLETED|Period 2, Day 1||0
9988194|NCT01642485|11109867|FG004|NOT COMPLETED|Period 2, Day 1||0
9988195|NCT01642485|11109868|FG005|NOT COMPLETED|Period 2, Day 1||0
9988196|NCT01642485|11109869|FG006|NOT COMPLETED|Period 2, Day 1||0
9988197|NCT01642485|11109870|FG007|NOT COMPLETED|Period 2, Day 1||0
9988198|NCT01642485|11109863|FG000|STARTED|Period 2, Day 2||4
9988199|NCT01642485|11109864|FG001|STARTED|Period 2, Day 2||4
9988200|NCT01642485|11109865|FG002|STARTED|Period 2, Day 2||4
9988201|NCT01642485|11109866|FG003|STARTED|Period 2, Day 2||4
9988202|NCT01642485|11109867|FG004|STARTED|Period 2, Day 2||4
9988203|NCT01642485|11109868|FG005|STARTED|Period 2, Day 2||4
9988204|NCT01642485|11109869|FG006|STARTED|Period 2, Day 2||4
9988205|NCT01642485|11109870|FG007|STARTED|Period 2, Day 2||4
9988206|NCT01642485|11109863|FG000|COMPLETED|Period 2, Day 2||4
9988207|NCT01642485|11109864|FG001|COMPLETED|Period 2, Day 2||4
9988208|NCT01642485|11109865|FG002|COMPLETED|Period 2, Day 2||4
9988209|NCT01642485|11109866|FG003|COMPLETED|Period 2, Day 2||4
9988210|NCT01642485|11109867|FG004|COMPLETED|Period 2, Day 2||4
9988211|NCT01642485|11109868|FG005|COMPLETED|Period 2, Day 2||4
9988212|NCT01642485|11109869|FG006|COMPLETED|Period 2, Day 2||4
9988213|NCT01642485|11109870|FG007|COMPLETED|Period 2, Day 2||4
9988214|NCT01642485|11109863|FG000|NOT COMPLETED|Period 2, Day 2||0
9988215|NCT01642485|11109864|FG001|NOT COMPLETED|Period 2, Day 2||0
9988216|NCT01642485|11109865|FG002|NOT COMPLETED|Period 2, Day 2||0
9988217|NCT01642485|11109866|FG003|NOT COMPLETED|Period 2, Day 2||0
9988218|NCT01642485|11109867|FG004|NOT COMPLETED|Period 2, Day 2||0
9988219|NCT01642485|11109868|FG005|NOT COMPLETED|Period 2, Day 2||0
9988220|NCT01642485|11109869|FG006|NOT COMPLETED|Period 2, Day 2||0
9988221|NCT01642485|11109870|FG007|NOT COMPLETED|Period 2, Day 2||0
9988222|NCT01642485|11109863|FG000|STARTED|Period 2, Day 3||4
9988223|NCT01642485|11109864|FG001|STARTED|Period 2, Day 3||4
9988224|NCT01642485|11109865|FG002|STARTED|Period 2, Day 3||4
9988225|NCT01642485|11109866|FG003|STARTED|Period 2, Day 3||4
9988226|NCT01642485|11109867|FG004|STARTED|Period 2, Day 3||4
9988227|NCT01642485|11109868|FG005|STARTED|Period 2, Day 3||4
9988228|NCT01642485|11109869|FG006|STARTED|Period 2, Day 3||4
9988229|NCT01642485|11109870|FG007|STARTED|Period 2, Day 3||4
9988230|NCT01642485|11109863|FG000|COMPLETED|Period 2, Day 3||4
9988231|NCT01642485|11109864|FG001|COMPLETED|Period 2, Day 3||4
9988232|NCT01642485|11109865|FG002|COMPLETED|Period 2, Day 3||4
9988233|NCT01642485|11109866|FG003|COMPLETED|Period 2, Day 3||4
9988234|NCT01642485|11109867|FG004|COMPLETED|Period 2, Day 3||4
9988235|NCT01642485|11109868|FG005|COMPLETED|Period 2, Day 3||4
9988236|NCT01642485|11109869|FG006|COMPLETED|Period 2, Day 3||4
9988237|NCT01642485|11109870|FG007|COMPLETED|Period 2, Day 3||4
9988238|NCT01642485|11109863|FG000|NOT COMPLETED|Period 2, Day 3||0
9988239|NCT01642485|11109864|FG001|NOT COMPLETED|Period 2, Day 3||0
9988240|NCT01642485|11109865|FG002|NOT COMPLETED|Period 2, Day 3||0
9988241|NCT01642485|11109866|FG003|NOT COMPLETED|Period 2, Day 3||0
9988242|NCT01642485|11109867|FG004|NOT COMPLETED|Period 2, Day 3||0
9988243|NCT01642485|11109868|FG005|NOT COMPLETED|Period 2, Day 3||0
9988244|NCT01642485|11109869|FG006|NOT COMPLETED|Period 2, Day 3||0
9988245|NCT01642485|11109870|FG007|NOT COMPLETED|Period 2, Day 3||0
9988246|NCT01642589|11109890|FG000|STARTED|Overall Study||200
9988247|NCT01642589|11109891|FG001|STARTED|Overall Study||100
9988248|NCT01642589|11109890|FG000|COMPLETED|Overall Study||199
9988249|NCT01642589|11109891|FG001|COMPLETED|Overall Study||99
9988250|NCT01642589|11109890|FG000|NOT COMPLETED|Overall Study||1
9988251|NCT01642589|11109891|FG001|NOT COMPLETED|Overall Study||1
9988252|NCT01642602|11109897|FG000|STARTED|Overall Study||104
9988253|NCT01642602|11109897|FG000|COMPLETED|Overall Study||102
9988254|NCT01642602|11109897|FG000|NOT COMPLETED|Overall Study||2
9988255|NCT01642615|11109901|FG000|STARTED|Open Label Maintenance Phase||63
9988256|NCT01642615|11109902|FG001|STARTED|Open Label Maintenance Phase||0
9988257|NCT01642615|11109903|FG002|STARTED|Open Label Maintenance Phase||0
9988258|NCT01642615|11109901|FG000|Safety Analysis Set|Open Label Maintenance Phase||62
9988259|NCT01642615|11109902|FG001|Safety Analysis Set|Open Label Maintenance Phase||0
9988260|NCT01642615|11109903|FG002|Safety Analysis Set|Open Label Maintenance Phase||0
9988261|NCT01642615|11109901|FG000|COMPLETED|Open Label Maintenance Phase||58
9988262|NCT01642615|11109902|FG001|COMPLETED|Open Label Maintenance Phase||0
9988263|NCT01642615|11109903|FG002|COMPLETED|Open Label Maintenance Phase||0
9988264|NCT01642615|11109901|FG000|NOT COMPLETED|Open Label Maintenance Phase||5
9988265|NCT01642615|11109902|FG001|NOT COMPLETED|Open Label Maintenance Phase||0
9988266|NCT01642615|11109903|FG002|NOT COMPLETED|Open Label Maintenance Phase||0
9988267|NCT01642615|11109901|FG000|STARTED|Double Blind Maintenance Phase||0
9988268|NCT01642615|11109902|FG001|STARTED|Double Blind Maintenance Phase||25
9988269|NCT01642615|11109903|FG002|STARTED|Double Blind Maintenance Phase||26
9988270|NCT01642615|11109901|FG000|COMPLETED|Double Blind Maintenance Phase||0
9988271|NCT01642615|11109902|FG001|COMPLETED|Double Blind Maintenance Phase||18
9988272|NCT01642615|11109903|FG002|COMPLETED|Double Blind Maintenance Phase||20
9988273|NCT01642615|11109901|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0
9988274|NCT01642615|11109902|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7
9988275|NCT01642615|11109903|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6
9988276|NCT01642914|11109914|FG000|STARTED|Overall Study||173
9988277|NCT01642914|11109915|FG001|STARTED|Overall Study||154
9988278|NCT01642914|11109916|FG002|STARTED|Overall Study||160
9988279|NCT01642914|11109914|FG000|COMPLETED|Overall Study||127
9988280|NCT01642914|11109915|FG001|COMPLETED|Overall Study||122
9988281|NCT01642914|11109916|FG002|COMPLETED|Overall Study||120
9988282|NCT01642914|11109914|FG000|NOT COMPLETED|Overall Study||46
9988283|NCT01642914|11109915|FG001|NOT COMPLETED|Overall Study||32
9988284|NCT01642914|11109916|FG002|NOT COMPLETED|Overall Study||40
9988285|NCT01643044|11109928|FG000|STARTED|Overall Study||24
9988286|NCT01643044|11109929|FG001|STARTED|Overall Study||24
9988287|NCT01643044|11109928|FG000|COMPLETED|Overall Study||20
9988288|NCT01643044|11109929|FG001|COMPLETED|Overall Study||19
9988289|NCT01643044|11109928|FG000|NOT COMPLETED|Overall Study||4
9988290|NCT01643044|11109929|FG001|NOT COMPLETED|Overall Study||5
10018198|NCT01822535|11141225|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
10018199|NCT01822535|11141226|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
10018200|NCT01822535|11141225|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
10018201|NCT01822535|11141226|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
10018202|NCT01822535|11141225|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
10018203|NCT01822535|11141226|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
10018204|NCT01822535|11141225|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
10018205|NCT01822535|11141226|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
10018206|NCT01822548|11141237|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
10018207|NCT01822548|11141238|FG001|STARTED|Overall Study||24
10018208|NCT01822548|11141237|FG000|Discontinued Intervention|Overall Study||0
10018209|NCT01822548|11141238|FG001|Discontinued Intervention|Overall Study||5
10018210|NCT01822548|11141237|FG000|COMPLETED|Overall Study||40
10018211|NCT01822548|11141238|FG001|COMPLETED|Overall Study||24
10018212|NCT01822548|11141237|FG000|NOT COMPLETED|Overall Study||0
10018213|NCT01822548|11141238|FG001|NOT COMPLETED|Overall Study||0
10018214|NCT01822561|11141244|FG000|STARTED|Overall Study||15
10018215|NCT01822561|11141244|FG000|COMPLETED|Overall Study||13
10018216|NCT01822561|11141244|FG000|NOT COMPLETED|Overall Study||2
10018217|NCT01822574|11141255|FG000|STARTED|Overall Study||30
10018218|NCT01822574|11141256|FG001|STARTED|Overall Study||30
10018219|NCT01822574|11141257|FG002|STARTED|Overall Study||30
10018220|NCT01822574|11141255|FG000|COMPLETED|Overall Study||30
9988291|NCT01643213|11109937|FG000|STARTED|Overall Study||13
9988292|NCT01643213|11109938|FG001|STARTED|Overall Study||14
9988293|NCT01643213|11109937|FG000|COMPLETED|Overall Study||12
9988294|NCT01643213|11109938|FG001|COMPLETED|Overall Study||14
10101404|NCT02407457|11230651|FG000|NOT COMPLETED|3-year||42
10101405|NCT02407457|11230652|FG001|NOT COMPLETED|3-year||38
10101406|NCT02407457|11230651|FG000|STARTED|4-year||181
10101407|NCT02407457|11230652|FG001|STARTED|4-year||156
9988295|NCT01643213|11109937|FG000|NOT COMPLETED|Overall Study||1
9988296|NCT01643213|11109938|FG001|NOT COMPLETED|Overall Study||0
9988297|NCT01643382|11109946|FG000|STARTED|Overall Study||30
9988298|NCT01643382|11109947|FG001|STARTED|Overall Study||30
9988299|NCT01643382|11109946|FG000|COMPLETED|Overall Study||30
9988300|NCT01643382|11109947|FG001|COMPLETED|Overall Study||30
9988301|NCT01643382|11109946|FG000|NOT COMPLETED|Overall Study||0
9988302|NCT01643382|11109947|FG001|NOT COMPLETED|Overall Study||0
9988303|NCT01643408|11109953|FG000|STARTED|Overall Study||30
9988304|NCT01643408|11109953|FG000|COMPLETED|Overall Study||16
9988305|NCT01643408|11109953|FG000|NOT COMPLETED|Overall Study||14
9988306|NCT01643473|11109959|FG000|STARTED|Overall Study||21
9988307|NCT01643473|11109960|FG001|STARTED|Overall Study||21
9988308|NCT01643473|11109959|FG000|COMPLETED|Overall Study||20
9988309|NCT01643473|11109960|FG001|COMPLETED|Overall Study||21
9988310|NCT01643473|11109959|FG000|NOT COMPLETED|Overall Study||1
9988311|NCT01643473|11109960|FG001|NOT COMPLETED|Overall Study||0
9988312|NCT01643616|11109968|FG000|STARTED|Overall Study||125
9988313|NCT01643616|11109969|FG001|STARTED|Overall Study||125
9988314|NCT01643616|11109968|FG000|COMPLETED|Overall Study||125
9988315|NCT01643616|11109969|FG001|COMPLETED|Overall Study||125
9988316|NCT01643616|11109968|FG000|NOT COMPLETED|Overall Study||0
9988317|NCT01643616|11109969|FG001|NOT COMPLETED|Overall Study||0
9988318|NCT01643668|11109975|FG000|STARTED|Overall Study||34
9988319|NCT01643668|11109975|FG000|COMPLETED|Overall Study||33
9988320|NCT01643668|11109975|FG000|NOT COMPLETED|Overall Study||1
9988321|NCT01643707|11109981|FG000|STARTED|Overall Study||858
9988322|NCT01643707|11109982|FG001|STARTED|Overall Study||484
9988323|NCT01643707|11109981|FG000|COMPLETED|Overall Study||823
10101408|NCT02407457|11230651|FG000|COMPLETED|4-year||100
10101409|NCT02407457|11230652|FG001|COMPLETED|4-year||95
10101410|NCT02407457|11230651|FG000|NOT COMPLETED|4-year||81
9988324|NCT01643707|11109982|FG001|COMPLETED|Overall Study||470
9988325|NCT01643707|11109981|FG000|NOT COMPLETED|Overall Study||35
9988326|NCT01643707|11109982|FG001|NOT COMPLETED|Overall Study||14
9988327|NCT01643772|11109995|FG000|STARTED|Overall Study||15
9988328|NCT01643772|11109996|FG001|STARTED|Overall Study||15
9988329|NCT01643772|11109997|FG002|STARTED|Overall Study||15
9988330|NCT01643772|11109998|FG003|STARTED|Overall Study||16
9988331|NCT01643772|11109995|FG000|COMPLETED|Overall Study||15
9988332|NCT01643772|11109996|FG001|COMPLETED|Overall Study||15
9988333|NCT01643772|11109997|FG002|COMPLETED|Overall Study||15
9988334|NCT01643772|11109998|FG003|COMPLETED|Overall Study||14
9988335|NCT01643772|11109995|FG000|NOT COMPLETED|Overall Study||0
9988336|NCT01643772|11109996|FG001|NOT COMPLETED|Overall Study||0
9988337|NCT01643772|11109997|FG002|NOT COMPLETED|Overall Study||0
9988338|NCT01643772|11109998|FG003|NOT COMPLETED|Overall Study||2
9988339|NCT01643798|11110010|FG000|STARTED|Pretreatment 1 and Stimulation||7
9988340|NCT01643798|11110011|FG001|STARTED|Pretreatment 1 and Stimulation||8
9988341|NCT01643798|11110010|FG000|COMPLETED|Pretreatment 1 and Stimulation||6
9988342|NCT01643798|11110011|FG001|COMPLETED|Pretreatment 1 and Stimulation||8
9988343|NCT01643798|11110010|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1
9988344|NCT01643798|11110011|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0
9988345|NCT01643798|11110010|FG000|STARTED|Pretreatment 2 and Stimulation||6
9988346|NCT01643798|11110011|FG001|STARTED|Pretreatment 2 and Stimulation||8
9988347|NCT01643798|11110010|FG000|COMPLETED|Pretreatment 2 and Stimulation||6
9988348|NCT01643798|11110011|FG001|COMPLETED|Pretreatment 2 and Stimulation||8
9988349|NCT01643798|11110010|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0
9988350|NCT01643798|11110011|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0
9988351|NCT01643850|11110031|FG000|STARTED|Overall Study||5
9988352|NCT01643850|11110032|FG001|STARTED|Overall Study||2
9988353|NCT01643850|11110033|FG002|STARTED|Overall Study||8
9988354|NCT01643850|11110034|FG003|STARTED|Overall Study||3
9988355|NCT01643850|11110035|FG004|STARTED|Overall Study||3
9988356|NCT01643850|11110036|FG005|STARTED|Overall Study||3
9988357|NCT01643850|11110037|FG006|STARTED|Overall Study||4
9988358|NCT01643850|11110038|FG007|STARTED|Overall Study||4
9988359|NCT01643850|11110039|FG008|STARTED|Overall Study||4
9988360|NCT01643850|11110031|FG000|COMPLETED|Overall Study||5
9988361|NCT01643850|11110032|FG001|COMPLETED|Overall Study||2
9988362|NCT01643850|11110033|FG002|COMPLETED|Overall Study||7
9988363|NCT01643850|11110034|FG003|COMPLETED|Overall Study||3
9988364|NCT01643850|11110035|FG004|COMPLETED|Overall Study||0
9988365|NCT01643850|11110036|FG005|COMPLETED|Overall Study||3
9988366|NCT01643850|11110037|FG006|COMPLETED|Overall Study||3
9988367|NCT01643850|11110038|FG007|COMPLETED|Overall Study||4
9988368|NCT01643850|11110039|FG008|COMPLETED|Overall Study||3
9988369|NCT01643850|11110031|FG000|NOT COMPLETED|Overall Study||0
9988370|NCT01643850|11110032|FG001|NOT COMPLETED|Overall Study||0
9988371|NCT01643850|11110033|FG002|NOT COMPLETED|Overall Study||1
9988372|NCT01643850|11110034|FG003|NOT COMPLETED|Overall Study||0
9988373|NCT01643850|11110035|FG004|NOT COMPLETED|Overall Study||3
9988374|NCT01643850|11110036|FG005|NOT COMPLETED|Overall Study||0
9988375|NCT01643850|11110037|FG006|NOT COMPLETED|Overall Study||1
9988376|NCT01643850|11110038|FG007|NOT COMPLETED|Overall Study||0
9988377|NCT01643850|11110039|FG008|NOT COMPLETED|Overall Study||1
9988378|NCT01643876|11110105|FG000|STARTED|Overall Study||48
9988379|NCT01643876|11110105|FG000|COMPLETED|Overall Study||48
9988380|NCT01643876|11110105|FG000|NOT COMPLETED|Overall Study||0
9988381|NCT01643902|11110109|FG000|STARTED|Overall Study||20
9988382|NCT01643902|11110109|FG000|COMPLETED|Overall Study||20
9988383|NCT01643902|11110109|FG000|NOT COMPLETED|Overall Study||0
9988384|NCT01643928|11110119|FG000|STARTED|Overall Study||58
9988385|NCT01643928|11110120|FG001|STARTED|Overall Study||32
9988386|NCT01643928|11110121|FG002|STARTED|Overall Study||33
9988387|NCT01643928|11110122|FG003|STARTED|Overall Study||30
9988388|NCT01643928|11110123|FG004|STARTED|Overall Study||30
9988389|NCT01643928|11110119|FG000|COMPLETED|Overall Study||48
9988390|NCT01643928|11110120|FG001|COMPLETED|Overall Study||30
9988391|NCT01643928|11110121|FG002|COMPLETED|Overall Study||30
9988392|NCT01643928|11110122|FG003|COMPLETED|Overall Study||27
9988393|NCT01643928|11110123|FG004|COMPLETED|Overall Study||28
9988394|NCT01643928|11110119|FG000|NOT COMPLETED|Overall Study||10
9988395|NCT01643928|11110120|FG001|NOT COMPLETED|Overall Study||2
9988396|NCT01643928|11110121|FG002|NOT COMPLETED|Overall Study||3
9988397|NCT01643928|11110122|FG003|NOT COMPLETED|Overall Study||3
9988398|NCT01643928|11110123|FG004|NOT COMPLETED|Overall Study||2
9988399|NCT01644058|11110164|FG000|STARTED|Overall Study||18
9988400|NCT01644058|11110164|FG000|COMPLETED|Overall Study||18
9988401|NCT01644058|11110164|FG000|NOT COMPLETED|Overall Study||0
9988402|NCT01644149|11110171|FG000|STARTED|Overall Study||43
9988403|NCT01644149|11110172|FG001|STARTED|Overall Study||40
9988404|NCT01644149|11110171|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
9988405|NCT01644149|11110172|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
9988406|NCT01644149|11110171|FG000|NOT COMPLETED|Overall Study||4
9988407|NCT01644149|11110172|FG001|NOT COMPLETED|Overall Study||1
9988408|NCT01644175|11110181|FG000|STARTED|Overall Study|Randomized|107
9988409|NCT01644175|11110182|FG001|STARTED|Overall Study|Randomized|209
9988410|NCT01644175|11110181|FG000|Treated|Overall Study||107
9988411|NCT01644175|11110182|FG001|Treated|Overall Study||207
9988412|NCT01644175|11110181|FG000|COMPLETED|Overall Study||75
9988413|NCT01644175|11110182|FG001|COMPLETED|Overall Study||156
9988414|NCT01644175|11110181|FG000|NOT COMPLETED|Overall Study||32
9988415|NCT01644175|11110182|FG001|NOT COMPLETED|Overall Study||53
9988416|NCT01644188|11110190|FG000|STARTED|Overall Study|Randomized|479
9988417|NCT01644188|11110191|FG001|STARTED|Overall Study|Randomized|241
9988418|NCT01644188|11110190|FG000|Treated|Overall Study||479
9988419|NCT01644188|11110191|FG001|Treated|Overall Study||241
9988420|NCT01644188|11110190|FG000|COMPLETED|Overall Study||357
9988421|NCT01644188|11110191|FG001|COMPLETED|Overall Study||166
9988422|NCT01644188|11110190|FG000|NOT COMPLETED|Overall Study||122
9988423|NCT01644188|11110191|FG001|NOT COMPLETED|Overall Study||75
9988424|NCT01644240|11110200|FG000|STARTED|Overall Study||6
9988425|NCT01644240|11110201|FG001|STARTED|Overall Study||4
9988426|NCT01644240|11110202|FG002|STARTED|Overall Study||6
9988427|NCT01644240|11110200|FG000|COMPLETED|Overall Study||6
9988428|NCT01644240|11110201|FG001|COMPLETED|Overall Study||4
9988429|NCT01644240|11110202|FG002|COMPLETED|Overall Study||6
9988430|NCT01644240|11110200|FG000|NOT COMPLETED|Overall Study||0
9988431|NCT01644240|11110201|FG001|NOT COMPLETED|Overall Study||0
9988432|NCT01644240|11110202|FG002|NOT COMPLETED|Overall Study||0
9988433|NCT01644292|11110210|FG000|STARTED|Overall Study||2
9988434|NCT01644292|11110210|FG000|COMPLETED|Overall Study||2
9988435|NCT01644292|11110210|FG000|NOT COMPLETED|Overall Study||0
9988436|NCT01644331|11110216|FG000|STARTED|Overall Study||129
9988437|NCT01644331|11110217|FG001|STARTED|Overall Study||128
9988438|NCT01644331|11110216|FG000|COMPLETED|Overall Study||118
9988439|NCT01644331|11110217|FG001|COMPLETED|Overall Study||118
9988440|NCT01644331|11110216|FG000|NOT COMPLETED|Overall Study||11
9988441|NCT01644331|11110217|FG001|NOT COMPLETED|Overall Study||10
9988442|NCT01644396|11110223|FG000|STARTED|Overall Study||50
9988443|NCT01644396|11110223|FG000|COMPLETED|Overall Study||50
9988444|NCT01644396|11110223|FG000|NOT COMPLETED|Overall Study||0
9988445|NCT01644474|11110230|FG000|STARTED|Overall Study|Randomized|51
9988446|NCT01644474|11110231|FG001|STARTED|Overall Study|Randomized|52
9988447|NCT01644474|11110230|FG000|Treated|Overall Study||51
9988448|NCT01644474|11110231|FG001|Treated|Overall Study||52
9988449|NCT01644474|11110230|FG000|COMPLETED|Overall Study||44
9988450|NCT01644474|11110231|FG001|COMPLETED|Overall Study||44
9988451|NCT01644474|11110230|FG000|NOT COMPLETED|Overall Study||7
9988452|NCT01644474|11110231|FG001|NOT COMPLETED|Overall Study||8
9988453|NCT01644500|11110240|FG000|STARTED|Overall Study||244
9988454|NCT01644500|11110241|FG001|STARTED|Overall Study||248
9988455|NCT01644500|11110242|FG002|STARTED|Overall Study||245
9988456|NCT01644500|11110240|FG000|Received at Least One Dose of Study Drug|Overall Study||244
9988457|NCT01644500|11110241|FG001|Received at Least One Dose of Study Drug|Overall Study||248
9988458|NCT01644500|11110242|FG002|Received at Least One Dose of Study Drug|Overall Study||243
9988459|NCT01644500|11110240|FG000|Modified Intent-to-treat Population|Overall Study||239
9988460|NCT01644500|11110241|FG001|Modified Intent-to-treat Population|Overall Study||239
9988461|NCT01644500|11110242|FG002|Modified Intent-to-treat Population|Overall Study||242
9988462|NCT01644500|11110240|FG000|COMPLETED|Overall Study||222
9988463|NCT01644500|11110241|FG001|COMPLETED|Overall Study||224
9988464|NCT01644500|11110242|FG002|COMPLETED|Overall Study||230
9988465|NCT01644500|11110240|FG000|NOT COMPLETED|Overall Study||22
9988466|NCT01644500|11110241|FG001|NOT COMPLETED|Overall Study||24
9988467|NCT01644500|11110242|FG002|NOT COMPLETED|Overall Study||15
9988468|NCT01644565|11110250|FG000|STARTED|Overall Study||5
9988469|NCT01644565|11110251|FG001|STARTED|Overall Study||5
9988470|NCT01644565|11110252|FG002|STARTED|Overall Study||5
9988471|NCT01644565|11110253|FG003|STARTED|Overall Study||5
9988472|NCT01644565|11110254|FG004|STARTED|Overall Study||5
9988473|NCT01644565|11110255|FG005|STARTED|Overall Study||7
9988474|NCT01644565|11110256|FG006|STARTED|Overall Study||7
9988475|NCT01644565|11110257|FG007|STARTED|Overall Study||10
9988476|NCT01644565|11110258|FG008|STARTED|Overall Study||8
9988477|NCT01644565|11110250|FG000|COMPLETED|Overall Study||4
9988478|NCT01644565|11110251|FG001|COMPLETED|Overall Study||5
9988479|NCT01644565|11110252|FG002|COMPLETED|Overall Study||5
9988480|NCT01644565|11110253|FG003|COMPLETED|Overall Study||4
9988481|NCT01644565|11110254|FG004|COMPLETED|Overall Study||4
9988482|NCT01644565|11110255|FG005|COMPLETED|Overall Study||7
9988483|NCT01644565|11110256|FG006|COMPLETED|Overall Study||7
9988484|NCT01644565|11110257|FG007|COMPLETED|Overall Study||8
9988485|NCT01644565|11110258|FG008|COMPLETED|Overall Study||7
9988486|NCT01644565|11110250|FG000|NOT COMPLETED|Overall Study||1
9988487|NCT01644565|11110251|FG001|NOT COMPLETED|Overall Study||0
9988488|NCT01644565|11110252|FG002|NOT COMPLETED|Overall Study||0
9988489|NCT01644565|11110253|FG003|NOT COMPLETED|Overall Study||1
9988490|NCT01644565|11110254|FG004|NOT COMPLETED|Overall Study||1
9988491|NCT01644565|11110255|FG005|NOT COMPLETED|Overall Study||0
9988492|NCT01644565|11110256|FG006|NOT COMPLETED|Overall Study||0
9988493|NCT01644565|11110257|FG007|NOT COMPLETED|Overall Study||2
9988494|NCT01644565|11110258|FG008|NOT COMPLETED|Overall Study||1
9988495|NCT01644617|11110281|FG000|STARTED|Overall Study||42
9988496|NCT01644617|11110282|FG001|STARTED|Overall Study||41
9988497|NCT01644617|11110283|FG002|STARTED|Overall Study||41
9988498|NCT01644617|11110281|FG000|COMPLETED|Overall Study||36
9988499|NCT01644617|11110282|FG001|COMPLETED|Overall Study||36
9988500|NCT01644617|11110283|FG002|COMPLETED|Overall Study||34
9988501|NCT01644617|11110281|FG000|NOT COMPLETED|Overall Study||6
9988502|NCT01644617|11110282|FG001|NOT COMPLETED|Overall Study||5
9988503|NCT01644617|11110283|FG002|NOT COMPLETED|Overall Study||7
9988504|NCT01644643|11110295|FG000|STARTED|Overall Study||15
9988505|NCT01644643|11110296|FG001|STARTED|Overall Study||12
9988506|NCT01644643|11110297|FG002|STARTED|Overall Study||153
9988507|NCT01644643|11110298|FG003|STARTED|Overall Study||153
9988508|NCT01644643|11110295|FG000|COMPLETED|Overall Study||13
9988509|NCT01644643|11110296|FG001|COMPLETED|Overall Study||12
9988510|NCT01644643|11110297|FG002|COMPLETED|Overall Study||148
9988511|NCT01644643|11110298|FG003|COMPLETED|Overall Study||143
9988512|NCT01644643|11110295|FG000|NOT COMPLETED|Overall Study||2
9988513|NCT01644643|11110296|FG001|NOT COMPLETED|Overall Study||0
9988514|NCT01644643|11110297|FG002|NOT COMPLETED|Overall Study||5
9988515|NCT01644643|11110298|FG003|NOT COMPLETED|Overall Study||10
9988516|NCT01644695|11110314|FG000|STARTED|Overall Study||85
9988517|NCT01644695|11110314|FG000|COMPLETED|Overall Study||85
9988518|NCT01644695|11110314|FG000|NOT COMPLETED|Overall Study||0
9988519|NCT01644734|11110318|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282
9988520|NCT01644734|11110318|FG000|COMPLETED|Overall Study||1016
9988521|NCT01644734|11110318|FG000|NOT COMPLETED|Overall Study||266
9988522|NCT01644890|11110324|FG000|STARTED|Overall Study||218
9988523|NCT01644890|11110325|FG001|STARTED|Overall Study||218
9988524|NCT01644890|11110324|FG000|COMPLETED|Overall Study||2
9988525|NCT01644890|11110325|FG001|COMPLETED|Overall Study||3
9988526|NCT01644890|11110324|FG000|NOT COMPLETED|Overall Study||216
9988527|NCT01644890|11110325|FG001|NOT COMPLETED|Overall Study||215
9988528|NCT01645059|11110331|FG000|STARTED|Overall Study||129
9988529|NCT01645059|11110331|FG000|COMPLETED|Overall Study||129
9988530|NCT01645059|11110331|FG000|NOT COMPLETED|Overall Study||0
9988531|NCT01645098|11110342|FG000|STARTED|Overall Study||24
9988532|NCT01645098|11110343|FG001|STARTED|Overall Study||29
9988533|NCT01645098|11110342|FG000|COMPLETED|Overall Study||24
9988534|NCT01645098|11110343|FG001|COMPLETED|Overall Study||29
9988535|NCT01645098|11110342|FG000|NOT COMPLETED|Overall Study||0
9988536|NCT01645098|11110343|FG001|NOT COMPLETED|Overall Study||0
9988537|NCT01645111|11110349|FG000|STARTED|Overall Study||50
9988538|NCT01645111|11110349|FG000|COMPLETED|Overall Study||35
9988539|NCT01645111|11110349|FG000|NOT COMPLETED|Overall Study||15
9988540|NCT01645176|11110353|FG000|STARTED|Overall Study||21
9988541|NCT01645176|11110353|FG000|COMPLETED|Overall Study||16
9988542|NCT01645176|11110353|FG000|NOT COMPLETED|Overall Study||5
9988543|NCT01645280|11110362|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
10101411|NCT02407457|11230652|FG001|NOT COMPLETED|4-year||61
10101412|NCT02407457|11230651|FG000|STARTED|5-year||123
10101413|NCT02407457|11230652|FG001|STARTED|5-year||113
10101414|NCT02407457|11230651|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31
10101415|NCT02407457|11230652|FG001|COMPLETED|5-year||36
10101416|NCT02407457|11230651|FG000|NOT COMPLETED|5-year||92
10101417|NCT02407457|11230652|FG001|NOT COMPLETED|5-year||77
10101418|NCT02407704|11230662|FG000|STARTED|Overall Study||2
10101419|NCT02407704|11230663|FG001|STARTED|Overall Study||3
10101420|NCT02407704|11230664|FG002|STARTED|Overall Study||5
10101421|NCT02407704|11230665|FG003|STARTED|Overall Study||5
10101422|NCT02407704|11230662|FG000|COMPLETED|Overall Study||2
10101423|NCT02407704|11230663|FG001|COMPLETED|Overall Study||3
10101424|NCT02407704|11230664|FG002|COMPLETED|Overall Study||4
10101425|NCT02407704|11230665|FG003|COMPLETED|Overall Study||2
10101426|NCT02407704|11230662|FG000|NOT COMPLETED|Overall Study||0
10101427|NCT02407704|11230663|FG001|NOT COMPLETED|Overall Study||0
10101428|NCT02407704|11230664|FG002|NOT COMPLETED|Overall Study||1
10101429|NCT02407704|11230665|FG003|NOT COMPLETED|Overall Study||3
10101430|NCT02407756|11230683|FG000|STARTED|Overall Study||20
10101431|NCT02407756|11230684|FG001|STARTED|Overall Study||18
10101432|NCT02407756|11230685|FG002|STARTED|Overall Study||20
10101433|NCT02407756|11230686|FG003|STARTED|Overall Study||19
10101434|NCT02407756|11230683|FG000|Treated|Overall Study||20
10101435|NCT02407756|11230684|FG001|Treated|Overall Study||18
10101436|NCT02407756|11230685|FG002|Treated|Overall Study||20
10101437|NCT02407756|11230686|FG003|Treated|Overall Study||19
10101438|NCT02407756|11230683|FG000|COMPLETED|Overall Study||20
10101439|NCT02407756|11230684|FG001|COMPLETED|Overall Study||18
10101440|NCT02407756|11230685|FG002|COMPLETED|Overall Study||20
10101441|NCT02407756|11230686|FG003|COMPLETED|Overall Study||19
10101442|NCT02407756|11230683|FG000|NOT COMPLETED|Overall Study||0
10101443|NCT02407756|11230684|FG001|NOT COMPLETED|Overall Study||0
10101444|NCT02407756|11230685|FG002|NOT COMPLETED|Overall Study||0
9988544|NCT01645280|11110363|FG001|STARTED|Overall Study||54
9988545|NCT01645280|11110364|FG002|STARTED|Overall Study||55
9988546|NCT01645280|11110365|FG003|STARTED|Overall Study||54
9988547|NCT01645280|11110366|FG004|STARTED|Overall Study||55
9988548|NCT01645280|11110362|FG000|COMPLETED|Overall Study||49
9988549|NCT01645280|11110363|FG001|COMPLETED|Overall Study||51
9988550|NCT01645280|11110364|FG002|COMPLETED|Overall Study||49
9988551|NCT01645280|11110365|FG003|COMPLETED|Overall Study||48
9988552|NCT01645280|11110366|FG004|COMPLETED|Overall Study||47
9988553|NCT01645280|11110362|FG000|NOT COMPLETED|Overall Study||6
9988554|NCT01645280|11110363|FG001|NOT COMPLETED|Overall Study||3
9988555|NCT01645280|11110364|FG002|NOT COMPLETED|Overall Study||6
9988556|NCT01645280|11110365|FG003|NOT COMPLETED|Overall Study||6
9988557|NCT01645280|11110366|FG004|NOT COMPLETED|Overall Study||8
10101445|NCT02407756|11230686|FG003|NOT COMPLETED|Overall Study||0
10101446|NCT02407990|11230704|FG000|STARTED|Overall Study||3
10101447|NCT02407990|11230705|FG001|STARTED|Overall Study||26
10101448|NCT02407990|11230706|FG002|STARTED|Overall Study||26
10101449|NCT02407990|11230707|FG003|STARTED|Overall Study||7
10101450|NCT02407990|11230708|FG004|STARTED|Overall Study||21
10101451|NCT02407990|11230709|FG005|STARTED|Overall Study||20
9988558|NCT01645306|11110382|FG000|STARTED|Overall Study||51
9988559|NCT01645306|11110383|FG001|STARTED|Overall Study||54
9988560|NCT01645306|11110384|FG002|STARTED|Overall Study||53
9988561|NCT01645306|11110382|FG000|COMPLETED|Overall Study||49
9988562|NCT01645306|11110383|FG001|COMPLETED|Overall Study||50
9988563|NCT01645306|11110384|FG002|COMPLETED|Overall Study||48
9988564|NCT01645306|11110382|FG000|NOT COMPLETED|Overall Study||2
9988565|NCT01645306|11110383|FG001|NOT COMPLETED|Overall Study||4
9988566|NCT01645306|11110384|FG002|NOT COMPLETED|Overall Study||5
9988567|NCT01645735|11110394|FG000|STARTED|Overall Study||32
9988568|NCT01645735|11110395|FG001|STARTED|Overall Study||17
9988569|NCT01645735|11110394|FG000|COMPLETED|Overall Study||28
9988570|NCT01645735|11110395|FG001|COMPLETED|Overall Study||16
9988571|NCT01645735|11110394|FG000|NOT COMPLETED|Overall Study||4
9988572|NCT01645735|11110395|FG001|NOT COMPLETED|Overall Study||1
9988573|NCT01645930|11110402|FG000|STARTED|Overall Study||43
9988574|NCT01645930|11110402|FG000|COMPLETED|Overall Study||0
9988575|NCT01645930|11110402|FG000|NOT COMPLETED|Overall Study||43
9988576|NCT01646021|11110408|FG000|STARTED|Overall Study||139
9988577|NCT01646021|11110409|FG001|STARTED|Overall Study||141
9988578|NCT01646021|11110408|FG000|Treated|Overall Study||139
9988579|NCT01646021|11110409|FG001|Treated|Overall Study||139
9988580|NCT01646021|11110408|FG000|COMPLETED|Overall Study||0
9988581|NCT01646021|11110409|FG001|COMPLETED|Overall Study||0
9988582|NCT01646021|11110408|FG000|NOT COMPLETED|Overall Study||139
9988583|NCT01646021|11110409|FG001|NOT COMPLETED|Overall Study||141
9988584|NCT01646073|11110417|FG000|STARTED|Period A (12 Weeks)||87
9988585|NCT01646073|11110418|FG001|STARTED|Period A (12 Weeks)||338
9988586|NCT01646073|11110417|FG000|COMPLETED|Period A (12 Weeks)||85
9988587|NCT01646073|11110418|FG001|COMPLETED|Period A (12 Weeks)||333
9988588|NCT01646073|11110417|FG000|NOT COMPLETED|Period A (12 Weeks)||2
9988589|NCT01646073|11110418|FG001|NOT COMPLETED|Period A (12 Weeks)||5
9988590|NCT01646073|11110417|FG000|STARTED|Period B (12 Weeks)||85
9988591|NCT01646073|11110418|FG001|STARTED|Period B (12 Weeks)||333
9988592|NCT01646073|11110417|FG000|COMPLETED|Period B (12 Weeks)||84
9988593|NCT01646073|11110418|FG001|COMPLETED|Period B (12 Weeks)||320
9988594|NCT01646073|11110417|FG000|NOT COMPLETED|Period B (12 Weeks)||1
9988595|NCT01646073|11110418|FG001|NOT COMPLETED|Period B (12 Weeks)||13
9988596|NCT01646125|11110429|FG000|STARTED|Overall Study||31
9988597|NCT01646125|11110430|FG001|STARTED|Overall Study||28
9988598|NCT01646125|11110429|FG000|COMPLETED|Overall Study||0
9988599|NCT01646125|11110430|FG001|COMPLETED|Overall Study||0
9988600|NCT01646125|11110429|FG000|NOT COMPLETED|Overall Study||31
9988601|NCT01646125|11110430|FG001|NOT COMPLETED|Overall Study||28
9988602|NCT01646138|11110442|FG000|STARTED|Overall Study||5
9988603|NCT01646138|11110443|FG001|STARTED|Overall Study||4
9988604|NCT01646138|11110444|FG002|STARTED|Overall Study||5
9988605|NCT01646138|11110445|FG003|STARTED|Overall Study||19
9988606|NCT01646138|11110446|FG004|STARTED|Overall Study||15
9988607|NCT01646138|11110442|FG000|COMPLETED|Overall Study||5
9988608|NCT01646138|11110443|FG001|COMPLETED|Overall Study||4
9988609|NCT01646138|11110444|FG002|COMPLETED|Overall Study||5
9988610|NCT01646138|11110445|FG003|COMPLETED|Overall Study||19
9988611|NCT01646138|11110446|FG004|COMPLETED|Overall Study||13
9988612|NCT01646138|11110442|FG000|NOT COMPLETED|Overall Study||0
9988613|NCT01646138|11110443|FG001|NOT COMPLETED|Overall Study||0
9988614|NCT01646138|11110444|FG002|NOT COMPLETED|Overall Study||0
9988615|NCT01646138|11110445|FG003|NOT COMPLETED|Overall Study||0
9988616|NCT01646138|11110446|FG004|NOT COMPLETED|Overall Study||2
9988617|NCT01646151|11110458|FG000|STARTED|Overall Study||2580
9988618|NCT01646151|11110458|FG000|COMPLETED|Overall Study||2410
9988619|NCT01646151|11110458|FG000|NOT COMPLETED|Overall Study||170
9988620|NCT01646177|11110466|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193
9988621|NCT01646177|11110467|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382
9988622|NCT01646177|11110468|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386
9988623|NCT01646177|11110469|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385
9988624|NCT01646177|11110470|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988625|NCT01646177|11110471|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988626|NCT01646177|11110472|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988627|NCT01646177|11110473|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988628|NCT01646177|11110474|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988629|NCT01646177|11110475|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988630|NCT01646177|11110476|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988631|NCT01646177|11110477|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0
9988632|NCT01646177|11110466|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
9988633|NCT01646177|11110467|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
9988634|NCT01646177|11110468|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
9988635|NCT01646177|11110469|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
9988636|NCT01646177|11110470|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988637|NCT01646177|11110471|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988638|NCT01646177|11110472|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988639|NCT01646177|11110473|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988640|NCT01646177|11110474|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988641|NCT01646177|11110475|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988642|NCT01646177|11110476|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988643|NCT01646177|11110477|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
9988644|NCT01646177|11110466|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
9988645|NCT01646177|11110467|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
9988646|NCT01646177|11110468|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
9988647|NCT01646177|11110469|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
9988648|NCT01646177|11110470|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988649|NCT01646177|11110471|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988650|NCT01646177|11110472|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988651|NCT01646177|11110473|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988652|NCT01646177|11110474|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988653|NCT01646177|11110475|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988654|NCT01646177|11110476|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988655|NCT01646177|11110477|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988656|NCT01646177|11110466|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
9988657|NCT01646177|11110467|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
9988658|NCT01646177|11110468|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
9988659|NCT01646177|11110469|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
9988660|NCT01646177|11110470|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988661|NCT01646177|11110471|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988662|NCT01646177|11110472|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988663|NCT01646177|11110473|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988664|NCT01646177|11110474|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988665|NCT01646177|11110475|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988666|NCT01646177|11110476|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988667|NCT01646177|11110477|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
9988668|NCT01646177|11110466|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
9988669|NCT01646177|11110467|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
9988670|NCT01646177|11110468|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
9988671|NCT01646177|11110469|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
9988672|NCT01646177|11110470|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
9988673|NCT01646177|11110471|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
9988674|NCT01646177|11110472|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
9988675|NCT01646177|11110473|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
9988676|NCT01646177|11110474|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0
9988677|NCT01646177|11110475|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0
9988678|NCT01646177|11110476|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0
9988679|NCT01646177|11110477|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0
9988680|NCT01646177|11110466|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988681|NCT01646177|11110467|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988682|NCT01646177|11110468|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988683|NCT01646177|11110469|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988684|NCT01646177|11110470|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
9988685|NCT01646177|11110471|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
9988686|NCT01646177|11110472|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
9988687|NCT01646177|11110473|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
9988688|NCT01646177|11110474|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988689|NCT01646177|11110475|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988690|NCT01646177|11110476|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988691|NCT01646177|11110477|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
9988692|NCT01646177|11110466|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988693|NCT01646177|11110467|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988694|NCT01646177|11110468|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988695|NCT01646177|11110469|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988696|NCT01646177|11110470|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135
9988697|NCT01646177|11110471|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256
9988698|NCT01646177|11110472|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244
9988699|NCT01646177|11110473|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255
9988700|NCT01646177|11110474|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988701|NCT01646177|11110475|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988702|NCT01646177|11110476|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988703|NCT01646177|11110477|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988704|NCT01646177|11110466|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988705|NCT01646177|11110467|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988706|NCT01646177|11110468|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988707|NCT01646177|11110469|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988708|NCT01646177|11110470|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
9988709|NCT01646177|11110471|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
9988710|NCT01646177|11110472|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
9988711|NCT01646177|11110473|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
9988712|NCT01646177|11110474|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988713|NCT01646177|11110475|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988714|NCT01646177|11110476|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988715|NCT01646177|11110477|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
9988716|NCT01646177|11110466|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
9988717|NCT01646177|11110467|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
9758730|NCT01388920|10862308|FG001|COMPLETED|Overall Study||1
9758731|NCT01388920|10862309|FG002|COMPLETED|Overall Study||0
9758732|NCT01388920|10862307|FG000|NOT COMPLETED|Overall Study||0
9758733|NCT01388920|10862308|FG001|NOT COMPLETED|Overall Study||0
9758734|NCT01388920|10862309|FG002|NOT COMPLETED|Overall Study||0
9988718|NCT01646177|11110468|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
9988719|NCT01646177|11110469|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
9988720|NCT01646177|11110470|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
9988721|NCT01646177|11110471|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
9988722|NCT01646177|11110472|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
9988723|NCT01646177|11110473|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
9988724|NCT01646177|11110474|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
9988725|NCT01646177|11110475|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
9988726|NCT01646177|11110476|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
9988727|NCT01646177|11110477|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
9988728|NCT01646177|11110466|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988729|NCT01646177|11110467|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988730|NCT01646177|11110468|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988731|NCT01646177|11110469|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988732|NCT01646177|11110470|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988733|NCT01646177|11110471|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988734|NCT01646177|11110472|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988735|NCT01646177|11110473|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
9988736|NCT01646177|11110474|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
9988737|NCT01646177|11110475|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
9988738|NCT01646177|11110476|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
9988739|NCT01646177|11110477|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
9988740|NCT01646177|11110466|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988741|NCT01646177|11110467|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988742|NCT01646177|11110468|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988743|NCT01646177|11110469|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988744|NCT01646177|11110470|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988745|NCT01646177|11110471|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988746|NCT01646177|11110472|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988747|NCT01646177|11110473|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988748|NCT01646177|11110474|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
9988749|NCT01646177|11110475|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
9988750|NCT01646177|11110476|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
9988751|NCT01646177|11110477|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
9988752|NCT01646177|11110466|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988753|NCT01646177|11110467|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988754|NCT01646177|11110468|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988755|NCT01646177|11110469|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988756|NCT01646177|11110470|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988757|NCT01646177|11110471|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988758|NCT01646177|11110472|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9988759|NCT01646177|11110473|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
9758735|NCT01164202|10862319|FG000|STARTED|Overall Study||39
9988760|NCT01646177|11110474|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
9988761|NCT01646177|11110475|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
9988762|NCT01646177|11110476|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
9988763|NCT01646177|11110477|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
9988764|NCT01646203|11110500|FG000|STARTED|Overall Study||2
9988765|NCT01646203|11110501|FG001|STARTED|Overall Study||5
9988766|NCT01646203|11110502|FG002|STARTED|Overall Study||7
9988767|NCT01646203|11110500|FG000|Received at Least One Dose of Study Drug|Overall Study||2
9988768|NCT01646203|11110501|FG001|Received at Least One Dose of Study Drug|Overall Study||5
9988769|NCT01646203|11110502|FG002|Received at Least One Dose of Study Drug|Overall Study||7
9988770|NCT01646203|11110500|FG000|COMPLETED|Overall Study||0
9988771|NCT01646203|11110501|FG001|COMPLETED|Overall Study||3
9988772|NCT01646203|11110502|FG002|COMPLETED|Overall Study||6
9988773|NCT01646203|11110500|FG000|NOT COMPLETED|Overall Study||2
9988774|NCT01646203|11110501|FG001|NOT COMPLETED|Overall Study||2
9988775|NCT01646203|11110502|FG002|NOT COMPLETED|Overall Study||1
9988776|NCT01646216|11110517|FG000|STARTED|Overall Study||17
9988777|NCT01646216|11110518|FG001|STARTED|Overall Study||17
9988778|NCT01646216|11110517|FG000|COMPLETED|Overall Study||6
9988779|NCT01646216|11110518|FG001|COMPLETED|Overall Study||4
9988780|NCT01646216|11110517|FG000|NOT COMPLETED|Overall Study||11
9988781|NCT01646216|11110518|FG001|NOT COMPLETED|Overall Study||13
9988782|NCT01646255|11110530|FG000|STARTED|Overall Study||172
9988783|NCT01646255|11110531|FG001|STARTED|Overall Study||174
9988784|NCT01646255|11110530|FG000|COMPLETED|Overall Study||151
9988785|NCT01646255|11110531|FG001|COMPLETED|Overall Study||160
9988786|NCT01646255|11110530|FG000|NOT COMPLETED|Overall Study||21
9988787|NCT01646255|11110531|FG001|NOT COMPLETED|Overall Study||14
9988788|NCT01646268|11110540|FG000|STARTED|Overall Study||124
9988789|NCT01646268|11110541|FG001|STARTED|Overall Study||123
9988790|NCT01646268|11110540|FG000|COMPLETED|Overall Study||113
9988791|NCT01646268|11110541|FG001|COMPLETED|Overall Study||107
9988792|NCT01646268|11110540|FG000|NOT COMPLETED|Overall Study||11
9988793|NCT01646268|11110541|FG001|NOT COMPLETED|Overall Study||16
9988794|NCT01646320|11110549|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160
9988795|NCT01646320|11110550|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160
9988796|NCT01646320|11110549|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148
9988797|NCT01646320|11110550|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153
9988798|NCT01646320|11110549|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
9988799|NCT01646320|11110550|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
9988800|NCT01646320|11110549|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147
9988801|NCT01646320|11110550|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147
9988802|NCT01646320|11110549|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141
9988803|NCT01646320|11110550|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140
9988804|NCT01646320|11110549|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
9988805|NCT01646320|11110550|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
9988806|NCT01646346|11110556|FG000|STARTED|Overall Study||46
9988807|NCT01646346|11110556|FG000|COMPLETED|Overall Study||46
9988808|NCT01646346|11110556|FG000|NOT COMPLETED|Overall Study||0
9988809|NCT01646385|11110562|FG000|STARTED|Overall Study||3529
9988810|NCT01646385|11110563|FG001|STARTED|Overall Study||2864
9988811|NCT01646385|11110562|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
9988812|NCT01646385|11110563|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
9988813|NCT01646385|11110562|FG000|NOT COMPLETED|Overall Study||838
9988814|NCT01646385|11110563|FG001|NOT COMPLETED|Overall Study||871
9988815|NCT01646398|11110571|FG000|STARTED|Overall Study||382
9988816|NCT01646398|11110572|FG001|STARTED|Overall Study||382
9988817|NCT01646398|11110571|FG000|COMPLETED|Overall Study||381
9988818|NCT01646398|11110572|FG001|COMPLETED|Overall Study||382
9988819|NCT01646398|11110571|FG000|NOT COMPLETED|Overall Study||1
9988820|NCT01646398|11110572|FG001|NOT COMPLETED|Overall Study||0
9988821|NCT01646645|11110578|FG000|STARTED|Overall Study||58
9988822|NCT01646645|11110578|FG000|COMPLETED|Overall Study||28
9988823|NCT01646645|11110578|FG000|NOT COMPLETED|Overall Study||30
9988824|NCT01646671|11110585|FG000|STARTED|Overall Study||3
9988825|NCT01646671|11110586|FG001|STARTED|Overall Study||11
9988826|NCT01646671|11110587|FG002|STARTED|Overall Study||21
9988827|NCT01646671|11110585|FG000|COMPLETED|Overall Study||3
9988828|NCT01646671|11110586|FG001|COMPLETED|Overall Study||11
9988829|NCT01646671|11110587|FG002|COMPLETED|Overall Study||21
9988830|NCT01646671|11110585|FG000|NOT COMPLETED|Overall Study||0
9988831|NCT01646671|11110586|FG001|NOT COMPLETED|Overall Study||0
9988832|NCT01646671|11110587|FG002|NOT COMPLETED|Overall Study||0
9988833|NCT01646762|11110597|FG000|STARTED|Overall Study||13
9988834|NCT01646762|11110597|FG000|COMPLETED|Overall Study||13
9988835|NCT01646762|11110597|FG000|NOT COMPLETED|Overall Study||0
9988836|NCT01646827|11110603|FG000|STARTED|Overall Study||18
9988837|NCT01646827|11110604|FG001|STARTED|Overall Study||19
9988838|NCT01646827|11110603|FG000|COMPLETED|Overall Study||16
9988839|NCT01646827|11110604|FG001|COMPLETED|Overall Study||14
9988840|NCT01646827|11110603|FG000|NOT COMPLETED|Overall Study||2
9988841|NCT01646827|11110604|FG001|NOT COMPLETED|Overall Study||5
9988842|NCT01647217|11110612|FG000|STARTED|Overall Study||8
9988843|NCT01647217|11110613|FG001|STARTED|Overall Study||9
9988844|NCT01647217|11110612|FG000|COMPLETED|Overall Study||7
9988845|NCT01647217|11110613|FG001|COMPLETED|Overall Study||8
9988846|NCT01647217|11110612|FG000|NOT COMPLETED|Overall Study||1
9988847|NCT01647217|11110613|FG001|NOT COMPLETED|Overall Study||1
9988848|NCT01647282|11110623|FG000|STARTED|Overall Study||30
9988849|NCT01647282|11110624|FG001|STARTED|Overall Study||30
9988850|NCT01647282|11110623|FG000|COMPLETED|Overall Study||23
9988851|NCT01647282|11110624|FG001|COMPLETED|Overall Study||25
9988852|NCT01647282|11110623|FG000|NOT COMPLETED|Overall Study||7
9988853|NCT01647282|11110624|FG001|NOT COMPLETED|Overall Study||5
9988854|NCT01647438|11110632|FG000|STARTED|Overall Study||32
9988855|NCT01647438|11110633|FG001|STARTED|Overall Study||31
9988856|NCT01647438|11110632|FG000|COMPLETED|Overall Study||32
9988857|NCT01647438|11110633|FG001|COMPLETED|Overall Study||31
9988858|NCT01647438|11110632|FG000|NOT COMPLETED|Overall Study||0
9988859|NCT01647438|11110633|FG001|NOT COMPLETED|Overall Study||0
9988860|NCT01647464|11110639|FG000|STARTED|Overall Study||10
9988861|NCT01647464|11110639|FG000|COMPLETED|Overall Study||10
9988862|NCT01647464|11110639|FG000|NOT COMPLETED|Overall Study||0
9988863|NCT01647516|11110646|FG000|STARTED|Induction Period (IP)||66
9988864|NCT01647516|11110647|FG001|STARTED|Induction Period (IP)||66
9988865|NCT01647516|11110648|FG002|STARTED|Induction Period (IP)||67
9988866|NCT01647516|11110649|FG003|STARTED|Induction Period (IP)||0
9988867|NCT01647516|11110650|FG004|STARTED|Induction Period (IP)||0
9988868|NCT01647516|11110651|FG005|STARTED|Induction Period (IP)||0
9988869|NCT01647516|11110646|FG000|Received Study Drug|Induction Period (IP)||65
9988870|NCT01647516|11110647|FG001|Received Study Drug|Induction Period (IP)||65
9988871|NCT01647516|11110648|FG002|Received Study Drug|Induction Period (IP)||67
9988872|NCT01647516|11110649|FG003|Received Study Drug|Induction Period (IP)||0
9988873|NCT01647516|11110650|FG004|Received Study Drug|Induction Period (IP)||0
9988874|NCT01647516|11110651|FG005|Received Study Drug|Induction Period (IP)||0
9988875|NCT01647516|11110646|FG000|COMPLETED|Induction Period (IP)||60
9988876|NCT01647516|11110647|FG001|COMPLETED|Induction Period (IP)||63
9988877|NCT01647516|11110648|FG002|COMPLETED|Induction Period (IP)||63
9988878|NCT01647516|11110649|FG003|COMPLETED|Induction Period (IP)||0
9988879|NCT01647516|11110650|FG004|COMPLETED|Induction Period (IP)||0
9988880|NCT01647516|11110651|FG005|COMPLETED|Induction Period (IP)||0
9988881|NCT01647516|11110646|FG000|NOT COMPLETED|Induction Period (IP)||6
9988882|NCT01647516|11110647|FG001|NOT COMPLETED|Induction Period (IP)||3
9988883|NCT01647516|11110648|FG002|NOT COMPLETED|Induction Period (IP)||4
9988884|NCT01647516|11110649|FG003|NOT COMPLETED|Induction Period (IP)||0
9988885|NCT01647516|11110650|FG004|NOT COMPLETED|Induction Period (IP)||0
9988886|NCT01647516|11110651|FG005|NOT COMPLETED|Induction Period (IP)||0
9988887|NCT01647516|11110646|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
9988888|NCT01647516|11110647|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
9988889|NCT01647516|11110648|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
9988890|NCT01647516|11110649|FG003|STARTED|Maintenance Period (MP)||0
9988891|NCT01647516|11110650|FG004|STARTED|Maintenance Period (MP)||0
9988892|NCT01647516|11110651|FG005|STARTED|Maintenance Period (MP)||0
9988893|NCT01647516|11110646|FG000|COMPLETED|Maintenance Period (MP)||21
9988894|NCT01647516|11110647|FG001|COMPLETED|Maintenance Period (MP)||30
9988895|NCT01647516|11110648|FG002|COMPLETED|Maintenance Period (MP)||40
9988896|NCT01647516|11110649|FG003|COMPLETED|Maintenance Period (MP)||0
9988897|NCT01647516|11110650|FG004|COMPLETED|Maintenance Period (MP)||0
9988898|NCT01647516|11110651|FG005|COMPLETED|Maintenance Period (MP)||0
9988899|NCT01647516|11110646|FG000|NOT COMPLETED|Maintenance Period (MP)||4
9988900|NCT01647516|11110647|FG001|NOT COMPLETED|Maintenance Period (MP)||6
9988901|NCT01647516|11110648|FG002|NOT COMPLETED|Maintenance Period (MP)||2
10101452|NCT02407990|11230710|FG006|STARTED|Overall Study||13
10101453|NCT02407990|11230711|FG007|STARTED|Overall Study||335
10101454|NCT02407990|11230704|FG000|COMPLETED|Overall Study||0
10101455|NCT02407990|11230705|FG001|COMPLETED|Overall Study||0
10101456|NCT02407990|11230706|FG002|COMPLETED|Overall Study||0
10101457|NCT02407990|11230707|FG003|COMPLETED|Overall Study||0
10101458|NCT02407990|11230708|FG004|COMPLETED|Overall Study||0
10101459|NCT02407990|11230709|FG005|COMPLETED|Overall Study||0
10101460|NCT02407990|11230710|FG006|COMPLETED|Overall Study||0
10101461|NCT02407990|11230711|FG007|COMPLETED|Overall Study||0
10101462|NCT02407990|11230704|FG000|NOT COMPLETED|Overall Study||3
10101463|NCT02407990|11230705|FG001|NOT COMPLETED|Overall Study||26
10101464|NCT02407990|11230706|FG002|NOT COMPLETED|Overall Study||26
10101465|NCT02407990|11230707|FG003|NOT COMPLETED|Overall Study||7
10101466|NCT02407990|11230708|FG004|NOT COMPLETED|Overall Study||21
10101467|NCT02407990|11230709|FG005|NOT COMPLETED|Overall Study||20
10101468|NCT02407990|11230710|FG006|NOT COMPLETED|Overall Study||13
10101469|NCT02407990|11230711|FG007|NOT COMPLETED|Overall Study||335
10101470|NCT02408016|11230738|FG000|STARTED|Overall Study||6
10101471|NCT02408016|11230739|FG001|STARTED|Overall Study||4
10101472|NCT02408016|11230740|FG002|STARTED|Overall Study||0
10101473|NCT02408016|11230738|FG000|COMPLETED|Overall Study||0
9988902|NCT01647516|11110649|FG003|NOT COMPLETED|Maintenance Period (MP)||0
9988903|NCT01647516|11110650|FG004|NOT COMPLETED|Maintenance Period (MP)||0
9988904|NCT01647516|11110651|FG005|NOT COMPLETED|Maintenance Period (MP)||0
10101474|NCT02408016|11230739|FG001|COMPLETED|Overall Study||1
9988905|NCT01647516|11110646|FG000|STARTED|Open-Label Period||0
10101475|NCT02408016|11230740|FG002|COMPLETED|Overall Study||0
10101476|NCT02408016|11230738|FG000|NOT COMPLETED|Overall Study||6
10101477|NCT02408016|11230739|FG001|NOT COMPLETED|Overall Study||3
10101478|NCT02408016|11230740|FG002|NOT COMPLETED|Overall Study||0
9988906|NCT01647516|11110647|FG001|STARTED|Open-Label Period||0
9988907|NCT01647516|11110648|FG002|STARTED|Open-Label Period||0
9988908|NCT01647516|11110649|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
9988909|NCT01647516|11110650|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
9988910|NCT01647516|11110651|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
9988911|NCT01647516|11110646|FG000|COMPLETED|Open-Label Period||0
9988912|NCT01647516|11110647|FG001|COMPLETED|Open-Label Period||0
9988913|NCT01647516|11110648|FG002|COMPLETED|Open-Label Period||0
9988914|NCT01647516|11110649|FG003|COMPLETED|Open-Label Period||6
9988915|NCT01647516|11110650|FG004|COMPLETED|Open-Label Period||5
9988916|NCT01647516|11110651|FG005|COMPLETED|Open-Label Period||3
9988917|NCT01647516|11110646|FG000|NOT COMPLETED|Open-Label Period||0
9988918|NCT01647516|11110647|FG001|NOT COMPLETED|Open-Label Period||0
9988919|NCT01647516|11110648|FG002|NOT COMPLETED|Open-Label Period||0
9988920|NCT01647516|11110649|FG003|NOT COMPLETED|Open-Label Period||49
9988921|NCT01647516|11110650|FG004|NOT COMPLETED|Open-Label Period||51
9988922|NCT01647516|11110651|FG005|NOT COMPLETED|Open-Label Period||56
9988923|NCT01647542|11110669|FG000|STARTED|Overall Study||131
9988924|NCT01647542|11110670|FG001|STARTED|Overall Study||131
9988925|NCT01647542|11110671|FG002|STARTED|Overall Study||131
9988926|NCT01647542|11110669|FG000|COMPLETED|Overall Study||55
9988927|NCT01647542|11110670|FG001|COMPLETED|Overall Study||58
9988928|NCT01647542|11110671|FG002|COMPLETED|Overall Study||59
9988929|NCT01647542|11110669|FG000|NOT COMPLETED|Overall Study||76
9988930|NCT01647542|11110670|FG001|NOT COMPLETED|Overall Study||73
9988931|NCT01647542|11110671|FG002|NOT COMPLETED|Overall Study||72
9988932|NCT01647581|11110681|FG000|STARTED|Overall Study||547
9988933|NCT01647581|11110682|FG001|STARTED|Overall Study||551
9988934|NCT01647581|11110681|FG000|COMPLETED|Overall Study||530
9988935|NCT01647581|11110682|FG001|COMPLETED|Overall Study||520
9988936|NCT01647581|11110681|FG000|NOT COMPLETED|Overall Study||17
9988937|NCT01647581|11110682|FG001|NOT COMPLETED|Overall Study||31
9988938|NCT01647711|11110693|FG000|STARTED|Overall Study||6
10101479|NCT02408120|11230750|FG000|STARTED|Overall Study||112
10101480|NCT02408120|11230751|FG001|STARTED|Overall Study||112
10101481|NCT02408120|11230750|FG000|COMPLETED|Overall Study||108
10101482|NCT02408120|11230751|FG001|COMPLETED|Overall Study||107
9988939|NCT01647711|11110694|FG001|STARTED|Overall Study||3
9988940|NCT01647711|11110695|FG002|STARTED|Overall Study||9
9988941|NCT01647711|11110696|FG003|STARTED|Overall Study||11
9988942|NCT01647711|11110697|FG004|STARTED|Overall Study||6
9988943|NCT01647711|11110693|FG000|COMPLETED|Overall Study||0
9988944|NCT01647711|11110694|FG001|COMPLETED|Overall Study||0
9988945|NCT01647711|11110695|FG002|COMPLETED|Overall Study||0
9988946|NCT01647711|11110696|FG003|COMPLETED|Overall Study||0
9988947|NCT01647711|11110697|FG004|COMPLETED|Overall Study||0
9988948|NCT01647711|11110693|FG000|NOT COMPLETED|Overall Study||6
9988949|NCT01647711|11110694|FG001|NOT COMPLETED|Overall Study||3
9988950|NCT01647711|11110695|FG002|NOT COMPLETED|Overall Study||9
9988951|NCT01647711|11110696|FG003|NOT COMPLETED|Overall Study||11
9988952|NCT01647711|11110697|FG004|NOT COMPLETED|Overall Study||6
9988953|NCT01647737|11110713|FG000|STARTED|Overall Study||30
9988954|NCT01647737|11110714|FG001|STARTED|Overall Study||30
9988955|NCT01647737|11110713|FG000|COMPLETED|Overall Study||26
9988956|NCT01647737|11110714|FG001|COMPLETED|Overall Study||25
9988957|NCT01647737|11110713|FG000|NOT COMPLETED|Overall Study||4
9988958|NCT01647737|11110714|FG001|NOT COMPLETED|Overall Study||5
9988959|NCT01647945|11110724|FG000|STARTED|Overall Study||6
9988960|NCT01647945|11110725|FG001|STARTED|Overall Study||6
9988961|NCT01647945|11110726|FG002|STARTED|Overall Study||5
9988962|NCT01647945|11110727|FG003|STARTED|Overall Study||6
9988963|NCT01647945|11110724|FG000|COMPLETED|Overall Study||6
9988964|NCT01647945|11110725|FG001|COMPLETED|Overall Study||6
9988965|NCT01647945|11110726|FG002|COMPLETED|Overall Study||3
9988966|NCT01647945|11110727|FG003|COMPLETED|Overall Study||5
9988967|NCT01647945|11110724|FG000|NOT COMPLETED|Overall Study||0
9988968|NCT01647945|11110725|FG001|NOT COMPLETED|Overall Study||0
9988969|NCT01647945|11110726|FG002|NOT COMPLETED|Overall Study||2
9988970|NCT01647945|11110727|FG003|NOT COMPLETED|Overall Study||1
9988971|NCT01647958|11110739|FG000|STARTED|Initial Study||41
9988972|NCT01647958|11110740|FG001|STARTED|Initial Study||24
9988973|NCT01647958|11110739|FG000|COMPLETED|Initial Study||39
9988974|NCT01647958|11110740|FG001|COMPLETED|Initial Study||21
9988975|NCT01647958|11110739|FG000|NOT COMPLETED|Initial Study||2
9988976|NCT01647958|11110740|FG001|NOT COMPLETED|Initial Study||3
9988977|NCT01647958|11110739|FG000|STARTED|Continuation Phase||39
9988978|NCT01647958|11110740|FG001|STARTED|Continuation Phase||21
9988979|NCT01647958|11110739|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
9988980|NCT01647958|11110740|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
9988981|NCT01647958|11110739|FG000|NOT COMPLETED|Continuation Phase||39
9988982|NCT01647958|11110740|FG001|NOT COMPLETED|Continuation Phase||0
9988983|NCT01647958|11110739|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
9988984|NCT01647958|11110740|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
10018221|NCT01822574|11141256|FG001|COMPLETED|Overall Study||30
9988985|NCT01647958|11110739|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
9988986|NCT01647958|11110740|FG001|COMPLETED|Extended Follow-up Phase||0
9988987|NCT01647958|11110739|FG000|NOT COMPLETED|Extended Follow-up Phase||8
9988988|NCT01647958|11110740|FG001|NOT COMPLETED|Extended Follow-up Phase||0
9988989|NCT01648101|11110758|FG000|STARTED|Titration Phase (4 Weeks)||25
9988990|NCT01648101|11110759|FG001|STARTED|Titration Phase (4 Weeks)||26
9988991|NCT01648101|11110760|FG002|STARTED|Titration Phase (4 Weeks)||24
9988992|NCT01648101|11110758|FG000|COMPLETED|Titration Phase (4 Weeks)||23
9988993|NCT01648101|11110759|FG001|COMPLETED|Titration Phase (4 Weeks)||23
9988994|NCT01648101|11110760|FG002|COMPLETED|Titration Phase (4 Weeks)||18
9988995|NCT01648101|11110758|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2
9988996|NCT01648101|11110759|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3
9988997|NCT01648101|11110760|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6
9988998|NCT01648101|11110758|FG000|STARTED|Maintenance Phase (12 Weeks)||23
9988999|NCT01648101|11110759|FG001|STARTED|Maintenance Phase (12 Weeks)||23
9989000|NCT01648101|11110760|FG002|STARTED|Maintenance Phase (12 Weeks)||18
9989001|NCT01648101|11110758|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20
9989002|NCT01648101|11110759|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20
9989003|NCT01648101|11110760|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12
9989004|NCT01648101|11110758|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
9989005|NCT01648101|11110759|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
9989006|NCT01648101|11110760|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
9989007|NCT01648101|11110758|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
9989008|NCT01648101|11110759|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
9989009|NCT01648101|11110760|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
9989010|NCT01648101|11110758|FG000|COMPLETED|Transition Phase (4 Weeks)||12
9989011|NCT01648101|11110759|FG001|COMPLETED|Transition Phase (4 Weeks)||13
9989012|NCT01648101|11110760|FG002|COMPLETED|Transition Phase (4 Weeks)||5
9989013|NCT01648101|11110758|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5
9989014|NCT01648101|11110759|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5
9989015|NCT01648101|11110760|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4
9989016|NCT01648101|11110758|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
9989017|NCT01648101|11110759|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
9989018|NCT01648101|11110760|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
9989019|NCT01648101|11110758|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
9989020|NCT01648101|11110759|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
9989021|NCT01648101|11110760|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
9989022|NCT01648101|11110758|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
9989023|NCT01648101|11110759|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
9989024|NCT01648101|11110760|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
9989025|NCT01648140|11110776|FG000|STARTED|Overall Study||41
9989026|NCT01648140|11110777|FG001|STARTED|Overall Study||40
9989027|NCT01648140|11110778|FG002|STARTED|Overall Study||17
9989028|NCT01648140|11110779|FG003|STARTED|Overall Study||13
9989029|NCT01648140|11110776|FG000|COMPLETED|Overall Study||29
9989030|NCT01648140|11110777|FG001|COMPLETED|Overall Study||28
9989031|NCT01648140|11110778|FG002|COMPLETED|Overall Study||9
9989032|NCT01648140|11110779|FG003|COMPLETED|Overall Study||11
9989033|NCT01648140|11110776|FG000|NOT COMPLETED|Overall Study||12
9989034|NCT01648140|11110777|FG001|NOT COMPLETED|Overall Study||12
9989035|NCT01648140|11110778|FG002|NOT COMPLETED|Overall Study||8
9989036|NCT01648140|11110779|FG003|NOT COMPLETED|Overall Study||2
9989037|NCT01648166|11110800|FG000|STARTED|Overall Study||153
9989038|NCT01648166|11110801|FG001|STARTED|Overall Study||367
9989039|NCT01648166|11110800|FG000|COMPLETED|Overall Study||100
9989040|NCT01648166|11110801|FG001|COMPLETED|Overall Study||267
9989041|NCT01648166|11110800|FG000|NOT COMPLETED|Overall Study||53
9989042|NCT01648166|11110801|FG001|NOT COMPLETED|Overall Study||100
9989043|NCT01648283|11110807|FG000|STARTED|Overall Study||78
9989044|NCT01648283|11110807|FG000|COMPLETED|Overall Study||64
9989045|NCT01648283|11110807|FG000|NOT COMPLETED|Overall Study||14
9989046|NCT01648322|11110817|FG000|STARTED|Overall Study||35
9989047|NCT01648322|11110818|FG001|STARTED|Overall Study||67
9989048|NCT01648322|11110819|FG002|STARTED|Overall Study||65
9989049|NCT01648322|11110820|FG003|STARTED|Overall Study||65
9989050|NCT01648322|11110817|FG000|COMPLETED|Overall Study||33
9989051|NCT01648322|11110818|FG001|COMPLETED|Overall Study||62
9989052|NCT01648322|11110819|FG002|COMPLETED|Overall Study||60
9989053|NCT01648322|11110820|FG003|COMPLETED|Overall Study||61
9989054|NCT01648322|11110817|FG000|NOT COMPLETED|Overall Study||2
9989055|NCT01648322|11110818|FG001|NOT COMPLETED|Overall Study||5
9989056|NCT01648322|11110819|FG002|NOT COMPLETED|Overall Study||5
9989057|NCT01648322|11110820|FG003|NOT COMPLETED|Overall Study||4
9989058|NCT01648348|11110849|FG000|STARTED|Overall Study||5
9989059|NCT01648348|11110850|FG001|STARTED|Overall Study||3
9989060|NCT01648348|11110851|FG002|STARTED|Overall Study||4
9989061|NCT01648348|11110852|FG003|STARTED|Overall Study||3
9989062|NCT01648348|11110853|FG004|STARTED|Overall Study||52
9989063|NCT01648348|11110854|FG005|STARTED|Overall Study||49
9989064|NCT01648348|11110849|FG000|COMPLETED|Overall Study||3
9989065|NCT01648348|11110850|FG001|COMPLETED|Overall Study||3
9989066|NCT01648348|11110851|FG002|COMPLETED|Overall Study||3
9989067|NCT01648348|11110852|FG003|COMPLETED|Overall Study||3
9989068|NCT01648348|11110853|FG004|COMPLETED|Overall Study||49
9989069|NCT01648348|11110854|FG005|COMPLETED|Overall Study||43
9989070|NCT01648348|11110849|FG000|NOT COMPLETED|Overall Study||2
9989071|NCT01648348|11110850|FG001|NOT COMPLETED|Overall Study||0
9989072|NCT01648348|11110851|FG002|NOT COMPLETED|Overall Study||1
9989073|NCT01648348|11110852|FG003|NOT COMPLETED|Overall Study||0
9989074|NCT01648348|11110853|FG004|NOT COMPLETED|Overall Study||3
9989075|NCT01648348|11110854|FG005|NOT COMPLETED|Overall Study||6
9989076|NCT01648452|11110867|FG000|STARTED|Overall Study||5
9989077|NCT01648452|11110867|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
9989078|NCT01648452|11110867|FG000|NOT COMPLETED|Overall Study||0
9989079|NCT01648491|11110873|FG000|STARTED|Overall Study||1
9989080|NCT01648491|11110873|FG000|COMPLETED|Overall Study||1
9989081|NCT01648491|11110873|FG000|NOT COMPLETED|Overall Study||0
9989082|NCT01648530|11110878|FG000|STARTED|Overall Study||16789
9989083|NCT01648530|11110878|FG000|COMPLETED|Overall Study||5915
9989084|NCT01648530|11110878|FG000|NOT COMPLETED|Overall Study||10874
9989085|NCT01648582|11110887|FG000|STARTED|Overall Study||258
9989086|NCT01648582|11110888|FG001|STARTED|Overall Study||257
9989087|NCT01648582|11110889|FG002|STARTED|Overall Study||259
9989088|NCT01648582|11110887|FG000|Received at Least One Dose of Study Drug|Overall Study||258
9989089|NCT01648582|11110888|FG001|Received at Least One Dose of Study Drug|Overall Study||257
9989090|NCT01648582|11110889|FG002|Received at Least One Dose of Study Drug|Overall Study||259
9989091|NCT01648582|11110887|FG000|Modified Intent-to-Treat Population|Overall Study||253
9989092|NCT01648582|11110888|FG001|Modified Intent-to-Treat Population|Overall Study||252
9989093|NCT01648582|11110889|FG002|Modified Intent-to-Treat Population|Overall Study||250
9989094|NCT01648582|11110887|FG000|COMPLETED|Overall Study||226
10101483|NCT02408120|11230750|FG000|NOT COMPLETED|Overall Study||4
10101484|NCT02408120|11230751|FG001|NOT COMPLETED|Overall Study||5
10101485|NCT02408198|11230759|FG000|STARTED|Overall Study||13
10101486|NCT02408198|11230760|FG001|STARTED|Overall Study||5
10101487|NCT02408198|11230759|FG000|COMPLETED|Overall Study||10
10101488|NCT02408198|11230760|FG001|COMPLETED|Overall Study||5
10101489|NCT02408198|11230759|FG000|NOT COMPLETED|Overall Study||3
10101490|NCT02408198|11230760|FG001|NOT COMPLETED|Overall Study||0
10101491|NCT02408263|11230766|FG000|STARTED|Overall Study||25
10101492|NCT02408263|11230767|FG001|STARTED|Overall Study||25
10101493|NCT02408263|11230766|FG000|COMPLETED|Overall Study||25
10101494|NCT02408263|11230767|FG001|COMPLETED|Overall Study||25
10101495|NCT02408263|11230766|FG000|NOT COMPLETED|Overall Study||0
10101496|NCT02408263|11230767|FG001|NOT COMPLETED|Overall Study||0
10101497|NCT02408445|11230774|FG000|STARTED|Overall Study||10
10101498|NCT02408445|11230775|FG001|STARTED|Overall Study||10
10101499|NCT02408445|11230774|FG000|COMPLETED|Overall Study||10
10101500|NCT02408445|11230775|FG001|COMPLETED|Overall Study||10
10101501|NCT02408445|11230774|FG000|NOT COMPLETED|Overall Study||0
10101502|NCT02408445|11230775|FG001|NOT COMPLETED|Overall Study||0
10101503|NCT02408484|11230780|FG000|STARTED|Overall Study||15
10101504|NCT02408484|11230780|FG000|SAF Population|Overall Study||14
10101505|NCT02408484|11230780|FG000|FAS Population|Overall Study||14
10101506|NCT02408484|11230780|FG000|PK Population|Overall Study||13
10101507|NCT02408484|11230780|FG000|firstBLEED Population|Overall Study||8
10101508|NCT02408484|11230780|FG000|BLEED Population|Overall Study||8
10101509|NCT02408484|11230780|FG000|SURG Population|Overall Study||3
10101510|NCT02408484|11230780|FG000|COMPLETED|Overall Study||11
10101511|NCT02408484|11230780|FG000|NOT COMPLETED|Overall Study||4
10101512|NCT02408523|11230802|FG000|STARTED|Overall Study||121
10101513|NCT02408523|11230803|FG001|STARTED|Overall Study||121
10101514|NCT02408523|11230802|FG000|Completed Treatment Period|Overall Study||110
10101515|NCT02408523|11230803|FG001|Completed Treatment Period|Overall Study||103
10101516|NCT02408523|11230802|FG000|Enrolled Transition Period|Overall Study||108
10101517|NCT02408523|11230803|FG001|Enrolled Transition Period|Overall Study||101
10101518|NCT02408523|11230802|FG000|Enrolled Taper Period|Overall Study||7
10101519|NCT02408523|11230803|FG001|Enrolled Taper Period|Overall Study||9
10101520|NCT02408523|11230802|FG000|Enrolled Safety Folllow-up Period|Overall Study||10
9989095|NCT01648582|11110888|FG001|COMPLETED|Overall Study||219
9989096|NCT01648582|11110889|FG002|COMPLETED|Overall Study||227
10101521|NCT02408523|11230803|FG001|Enrolled Safety Folllow-up Period|Overall Study||11
10101522|NCT02408523|11230802|FG000|COMPLETED|Overall Study||110
10101523|NCT02408523|11230803|FG001|COMPLETED|Overall Study||103
10101524|NCT02408523|11230802|FG000|NOT COMPLETED|Overall Study||11
10101525|NCT02408523|11230803|FG001|NOT COMPLETED|Overall Study||18
9989097|NCT01648582|11110887|FG000|NOT COMPLETED|Overall Study||32
10101526|NCT02408692|11230820|FG000|STARTED|Overall Study||5
10101527|NCT02408692|11230821|FG001|STARTED|Overall Study||5
10101528|NCT02408692|11230822|FG002|STARTED|Overall Study||5
10101529|NCT02408692|11230820|FG000|COMPLETED|Overall Study||5
10101530|NCT02408692|11230821|FG001|COMPLETED|Overall Study||5
10101531|NCT02408692|11230822|FG002|COMPLETED|Overall Study||5
10101532|NCT02408692|11230820|FG000|NOT COMPLETED|Overall Study||0
10101533|NCT02408692|11230821|FG001|NOT COMPLETED|Overall Study||0
10101534|NCT02408692|11230822|FG002|NOT COMPLETED|Overall Study||0
10101535|NCT02408796|11230830|FG000|STARTED|Overall Study||39
10101536|NCT02408796|11230830|FG000|COMPLETED|Overall Study||39
9989098|NCT01648582|11110888|FG001|NOT COMPLETED|Overall Study||38
9989099|NCT01648582|11110889|FG002|NOT COMPLETED|Overall Study||32
9989100|NCT01648699|11110900|FG000|STARTED|Overall Study||20
9989101|NCT01648699|11110900|FG000|COMPLETED|Overall Study||15
9989102|NCT01648699|11110900|FG000|NOT COMPLETED|Overall Study||5
9989103|NCT01648764|11110927|FG000|STARTED|Overall Study||3
9989104|NCT01648764|11110928|FG001|STARTED|Overall Study||3
9989105|NCT01648764|11110929|FG002|STARTED|Overall Study||3
9989106|NCT01648764|11110930|FG003|STARTED|Overall Study||3
9989107|NCT01648764|11110931|FG004|STARTED|Overall Study||3
9989108|NCT01648764|11110932|FG005|STARTED|Overall Study||5
9989109|NCT01648764|11110933|FG006|STARTED|Overall Study||9
9989110|NCT01648764|11110934|FG007|STARTED|Overall Study||3
9989111|NCT01648764|11110935|FG008|STARTED|Overall Study||3
9989112|NCT01648764|11110936|FG009|STARTED|Overall Study||7
9989113|NCT01648764|11110937|FG010|STARTED|Overall Study||3
9989114|NCT01648764|11110938|FG011|STARTED|Overall Study||9
9989115|NCT01648764|11110939|FG012|STARTED|Overall Study||7
9989116|NCT01648764|11110940|FG013|STARTED|Overall Study||12
9989117|NCT01648764|11110927|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9989118|NCT01648764|11110928|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9989119|NCT01648764|11110929|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9989120|NCT01648764|11110930|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
9989121|NCT01648764|11110931|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
9989122|NCT01648764|11110932|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
9989123|NCT01648764|11110933|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9
9989124|NCT01648764|11110934|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
9989125|NCT01648764|11110935|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
9989126|NCT01648764|11110936|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7
9989127|NCT01648764|11110937|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
9989128|NCT01648764|11110938|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9
9989129|NCT01648764|11110939|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7
9989130|NCT01648764|11110940|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12
9989131|NCT01648764|11110927|FG000|COMPLETED|Overall Study||3
9989132|NCT01648764|11110928|FG001|COMPLETED|Overall Study||2
9989133|NCT01648764|11110929|FG002|COMPLETED|Overall Study||3
9989134|NCT01648764|11110930|FG003|COMPLETED|Overall Study||3
9989135|NCT01648764|11110931|FG004|COMPLETED|Overall Study||3
9989136|NCT01648764|11110932|FG005|COMPLETED|Overall Study||3
9989137|NCT01648764|11110933|FG006|COMPLETED|Overall Study||4
9989138|NCT01648764|11110934|FG007|COMPLETED|Overall Study||3
9989139|NCT01648764|11110935|FG008|COMPLETED|Overall Study||3
9989140|NCT01648764|11110936|FG009|COMPLETED|Overall Study||4
9989141|NCT01648764|11110937|FG010|COMPLETED|Overall Study||3
9989142|NCT01648764|11110938|FG011|COMPLETED|Overall Study||4
9989143|NCT01648764|11110939|FG012|COMPLETED|Overall Study||3
9989144|NCT01648764|11110940|FG013|COMPLETED|Overall Study||9
9989145|NCT01648764|11110927|FG000|NOT COMPLETED|Overall Study||0
9989146|NCT01648764|11110928|FG001|NOT COMPLETED|Overall Study||1
9989147|NCT01648764|11110929|FG002|NOT COMPLETED|Overall Study||0
9989148|NCT01648764|11110930|FG003|NOT COMPLETED|Overall Study||0
9989149|NCT01648764|11110931|FG004|NOT COMPLETED|Overall Study||0
9989150|NCT01648764|11110932|FG005|NOT COMPLETED|Overall Study||2
9989151|NCT01648764|11110933|FG006|NOT COMPLETED|Overall Study||5
9989152|NCT01648764|11110934|FG007|NOT COMPLETED|Overall Study||0
9989153|NCT01648764|11110935|FG008|NOT COMPLETED|Overall Study||0
9989154|NCT01648764|11110936|FG009|NOT COMPLETED|Overall Study||3
9989155|NCT01648764|11110937|FG010|NOT COMPLETED|Overall Study||0
9989156|NCT01648764|11110938|FG011|NOT COMPLETED|Overall Study||5
9989157|NCT01648764|11110939|FG012|NOT COMPLETED|Overall Study||4
9989158|NCT01648764|11110940|FG013|NOT COMPLETED|Overall Study||3
9989159|NCT01648790|11110974|FG000|STARTED|Treatment 1||4
9989160|NCT01648790|11110975|FG001|STARTED|Treatment 1||4
9989161|NCT01648790|11110976|FG002|STARTED|Treatment 1||4
9989162|NCT01648790|11110977|FG003|STARTED|Treatment 1||4
9989163|NCT01648790|11110978|FG004|STARTED|Treatment 1||4
9989164|NCT01648790|11110974|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4
9989165|NCT01648790|11110975|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4
9989166|NCT01648790|11110976|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4
9989167|NCT01648790|11110977|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4
9989168|NCT01648790|11110978|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4
9989169|NCT01648790|11110974|FG000|COMPLETED|Treatment 1||4
9989170|NCT01648790|11110975|FG001|COMPLETED|Treatment 1||4
9989171|NCT01648790|11110976|FG002|COMPLETED|Treatment 1||4
9989172|NCT01648790|11110977|FG003|COMPLETED|Treatment 1||4
9989173|NCT01648790|11110978|FG004|COMPLETED|Treatment 1||4
9989174|NCT01648790|11110974|FG000|NOT COMPLETED|Treatment 1||0
9989175|NCT01648790|11110975|FG001|NOT COMPLETED|Treatment 1||0
9989176|NCT01648790|11110976|FG002|NOT COMPLETED|Treatment 1||0
9989177|NCT01648790|11110977|FG003|NOT COMPLETED|Treatment 1||0
9989178|NCT01648790|11110978|FG004|NOT COMPLETED|Treatment 1||0
9989179|NCT01648790|11110974|FG000|STARTED|Treatment 2||4
9989180|NCT01648790|11110975|FG001|STARTED|Treatment 2||4
9989181|NCT01648790|11110976|FG002|STARTED|Treatment 2||4
9989182|NCT01648790|11110977|FG003|STARTED|Treatment 2||4
9989183|NCT01648790|11110978|FG004|STARTED|Treatment 2||4
9989184|NCT01648790|11110974|FG000|COMPLETED|Treatment 2||4
9989185|NCT01648790|11110975|FG001|COMPLETED|Treatment 2||4
9989186|NCT01648790|11110976|FG002|COMPLETED|Treatment 2||4
9989187|NCT01648790|11110977|FG003|COMPLETED|Treatment 2||4
9989188|NCT01648790|11110978|FG004|COMPLETED|Treatment 2||4
9989189|NCT01648790|11110974|FG000|NOT COMPLETED|Treatment 2||0
9989190|NCT01648790|11110975|FG001|NOT COMPLETED|Treatment 2||0
9989191|NCT01648790|11110976|FG002|NOT COMPLETED|Treatment 2||0
9989192|NCT01648790|11110977|FG003|NOT COMPLETED|Treatment 2||0
9989193|NCT01648790|11110978|FG004|NOT COMPLETED|Treatment 2||0
9989194|NCT01648790|11110974|FG000|STARTED|Treatment 3||4
9989195|NCT01648790|11110975|FG001|STARTED|Treatment 3||4
9989196|NCT01648790|11110976|FG002|STARTED|Treatment 3||4
9989197|NCT01648790|11110977|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
9989198|NCT01648790|11110978|FG004|STARTED|Treatment 3||4
9989199|NCT01648790|11110974|FG000|COMPLETED|Treatment 3||4
9989200|NCT01648790|11110975|FG001|COMPLETED|Treatment 3||4
9989201|NCT01648790|11110976|FG002|COMPLETED|Treatment 3||4
9989202|NCT01648790|11110977|FG003|COMPLETED|Treatment 3||3
9989203|NCT01648790|11110978|FG004|COMPLETED|Treatment 3||4
9989204|NCT01648790|11110974|FG000|NOT COMPLETED|Treatment 3||0
9989205|NCT01648790|11110975|FG001|NOT COMPLETED|Treatment 3||0
9989206|NCT01648790|11110976|FG002|NOT COMPLETED|Treatment 3||0
9989207|NCT01648790|11110977|FG003|NOT COMPLETED|Treatment 3||1
9989208|NCT01648790|11110978|FG004|NOT COMPLETED|Treatment 3||0
9989209|NCT01648790|11110974|FG000|STARTED|Treatment 4||4
9989210|NCT01648790|11110975|FG001|STARTED|Treatment 4||4
9989211|NCT01648790|11110976|FG002|STARTED|Treatment 4||4
9989212|NCT01648790|11110977|FG003|STARTED|Treatment 4||3
9989213|NCT01648790|11110978|FG004|STARTED|Treatment 4||4
9989214|NCT01648790|11110974|FG000|COMPLETED|Treatment 4||4
9989215|NCT01648790|11110975|FG001|COMPLETED|Treatment 4||4
9989216|NCT01648790|11110976|FG002|COMPLETED|Treatment 4||4
9989217|NCT01648790|11110977|FG003|COMPLETED|Treatment 4||3
9989218|NCT01648790|11110978|FG004|COMPLETED|Treatment 4||4
9989219|NCT01648790|11110974|FG000|NOT COMPLETED|Treatment 4||0
9989220|NCT01648790|11110975|FG001|NOT COMPLETED|Treatment 4||0
9989221|NCT01648790|11110976|FG002|NOT COMPLETED|Treatment 4||0
9989222|NCT01648790|11110977|FG003|NOT COMPLETED|Treatment 4||0
9989223|NCT01648790|11110978|FG004|NOT COMPLETED|Treatment 4||0
9989224|NCT01648790|11110974|FG000|STARTED|Treatment 5||4
9989225|NCT01648790|11110975|FG001|STARTED|Treatment 5||4
9989226|NCT01648790|11110976|FG002|STARTED|Treatment 5||4
9989227|NCT01648790|11110977|FG003|STARTED|Treatment 5||3
9989228|NCT01648790|11110978|FG004|STARTED|Treatment 5||4
9989229|NCT01648790|11110974|FG000|COMPLETED|Treatment 5||4
9989230|NCT01648790|11110975|FG001|COMPLETED|Treatment 5||4
9989231|NCT01648790|11110976|FG002|COMPLETED|Treatment 5||4
9989232|NCT01648790|11110977|FG003|COMPLETED|Treatment 5||3
9989233|NCT01648790|11110978|FG004|COMPLETED|Treatment 5||4
9989234|NCT01648790|11110974|FG000|NOT COMPLETED|Treatment 5||0
9989235|NCT01648790|11110975|FG001|NOT COMPLETED|Treatment 5||0
9989236|NCT01648790|11110976|FG002|NOT COMPLETED|Treatment 5||0
9989237|NCT01648790|11110977|FG003|NOT COMPLETED|Treatment 5||0
9989238|NCT01648790|11110978|FG004|NOT COMPLETED|Treatment 5||0
9989239|NCT01648920|11110990|FG000|STARTED|Overall Study||50
9989240|NCT01648920|11110990|FG000|COMPLETED|Overall Study||50
9989241|NCT01648920|11110990|FG000|NOT COMPLETED|Overall Study||0
9989242|NCT01648959|11110994|FG000|STARTED|Overall Study||5
9989243|NCT01648959|11110994|FG000|COMPLETED|Overall Study||5
9989244|NCT01648959|11110994|FG000|NOT COMPLETED|Overall Study||0
9989245|NCT01649180|11110998|FG000|STARTED|Overall Study||3
9989246|NCT01649180|11110998|FG000|COMPLETED|Overall Study||3
9989247|NCT01649180|11110998|FG000|NOT COMPLETED|Overall Study||0
9989248|NCT01649232|11111004|FG000|STARTED|Overall Study||30
9989249|NCT01649232|11111005|FG001|STARTED|Overall Study||30
9989250|NCT01649232|11111004|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
9989251|NCT01649232|11111005|FG001|COMPLETED|Overall Study||30
9989252|NCT01649232|11111004|FG000|NOT COMPLETED|Overall Study||2
9989253|NCT01649232|11111005|FG001|NOT COMPLETED|Overall Study||0
9989254|NCT01649271|11111019|FG000|STARTED|Overall Study||6
9989255|NCT01649271|11111020|FG001|STARTED|Overall Study||7
9989256|NCT01649271|11111019|FG000|COMPLETED|Overall Study||0
9989257|NCT01649271|11111020|FG001|COMPLETED|Overall Study||0
9989258|NCT01649271|11111019|FG000|NOT COMPLETED|Overall Study||6
9989259|NCT01649271|11111020|FG001|NOT COMPLETED|Overall Study||7
9989260|NCT01649297|11111032|FG000|STARTED|Overall Study|randomised|219
9989261|NCT01649297|11111033|FG001|STARTED|Overall Study|randomised|218
9989262|NCT01649297|11111034|FG002|STARTED|Overall Study|randomised|219
9989263|NCT01649297|11111035|FG003|STARTED|Overall Study|randomised|220
9989264|NCT01649297|11111036|FG004|STARTED|Overall Study|randomised|107
9989265|NCT01649297|11111032|FG000|COMPLETED|Overall Study||205
9989266|NCT01649297|11111033|FG001|COMPLETED|Overall Study||205
9989267|NCT01649297|11111034|FG002|COMPLETED|Overall Study||202
9989268|NCT01649297|11111035|FG003|COMPLETED|Overall Study||201
9989269|NCT01649297|11111036|FG004|COMPLETED|Overall Study||103
9989270|NCT01649297|11111032|FG000|NOT COMPLETED|Overall Study||14
9989271|NCT01649297|11111033|FG001|NOT COMPLETED|Overall Study||13
9989272|NCT01649297|11111034|FG002|NOT COMPLETED|Overall Study||17
9989273|NCT01649297|11111035|FG003|NOT COMPLETED|Overall Study||19
9989274|NCT01649297|11111036|FG004|NOT COMPLETED|Overall Study||4
9989275|NCT01649362|11111050|FG000|STARTED|Overall Study||47
9989276|NCT01649362|11111051|FG001|STARTED|Overall Study||54
9989277|NCT01649362|11111050|FG000|COMPLETED|Overall Study||46
9989278|NCT01649362|11111051|FG001|COMPLETED|Overall Study||40
9989279|NCT01649362|11111050|FG000|NOT COMPLETED|Overall Study||1
9989280|NCT01649362|11111051|FG001|NOT COMPLETED|Overall Study||14
9989281|NCT01649375|11111060|FG000|STARTED|Up to Week 16||73
9989282|NCT01649375|11111061|FG001|STARTED|Up to Week 16||72
9989283|NCT01649375|11111062|FG002|STARTED|Up to Week 16||74
9989284|NCT01649375|11111063|FG003|STARTED|Up to Week 16||0
9989285|NCT01649375|11111064|FG004|STARTED|Up to Week 16||0
9989286|NCT01649375|11111060|FG000|COMPLETED|Up to Week 16||68
9989287|NCT01649375|11111061|FG001|COMPLETED|Up to Week 16||66
9989288|NCT01649375|11111062|FG002|COMPLETED|Up to Week 16||66
9989289|NCT01649375|11111063|FG003|COMPLETED|Up to Week 16||0
9989290|NCT01649375|11111064|FG004|COMPLETED|Up to Week 16||0
9989291|NCT01649375|11111060|FG000|NOT COMPLETED|Up to Week 16||5
9989292|NCT01649375|11111061|FG001|NOT COMPLETED|Up to Week 16||6
9989293|NCT01649375|11111062|FG002|NOT COMPLETED|Up to Week 16||8
9989294|NCT01649375|11111063|FG003|NOT COMPLETED|Up to Week 16||0
9989295|NCT01649375|11111064|FG004|NOT COMPLETED|Up to Week 16||0
9989296|NCT01649375|11111060|FG000|STARTED|Week 16 up to Week 260||68
9989297|NCT01649375|11111061|FG001|STARTED|Week 16 up to Week 260||66
9989298|NCT01649375|11111062|FG002|STARTED|Week 16 up to Week 260||0
9989299|NCT01649375|11111063|FG003|STARTED|Week 16 up to Week 260||32
9989300|NCT01649375|11111064|FG004|STARTED|Week 16 up to Week 260||34
9989301|NCT01649375|11111060|FG000|COMPLETED|Week 16 up to Week 260||48
9989302|NCT01649375|11111061|FG001|COMPLETED|Week 16 up to Week 260||53
9989303|NCT01649375|11111062|FG002|COMPLETED|Week 16 up to Week 260||0
9989304|NCT01649375|11111063|FG003|COMPLETED|Week 16 up to Week 260||20
9989305|NCT01649375|11111064|FG004|COMPLETED|Week 16 up to Week 260||29
9989306|NCT01649375|11111060|FG000|NOT COMPLETED|Week 16 up to Week 260||20
9989307|NCT01649375|11111061|FG001|NOT COMPLETED|Week 16 up to Week 260||13
9989308|NCT01649375|11111062|FG002|NOT COMPLETED|Week 16 up to Week 260||0
9989309|NCT01649375|11111063|FG003|NOT COMPLETED|Week 16 up to Week 260||12
9989310|NCT01649375|11111064|FG004|NOT COMPLETED|Week 16 up to Week 260||5
9989311|NCT01649427|11111074|FG000|STARTED|Overall Study||35
9989312|NCT01649427|11111075|FG001|STARTED|Overall Study||38
9989313|NCT01649427|11111074|FG000|COMPLETED|Overall Study||24
9989314|NCT01649427|11111075|FG001|COMPLETED|Overall Study||26
9989315|NCT01649427|11111074|FG000|NOT COMPLETED|Overall Study||11
9989316|NCT01649427|11111075|FG001|NOT COMPLETED|Overall Study||12
9989317|NCT01649557|11111084|FG000|STARTED|Overall Study||179
9989318|NCT01649557|11111085|FG001|STARTED|Overall Study||41
9989319|NCT01649557|11111086|FG002|STARTED|Overall Study||24
9989320|NCT01649557|11111084|FG000|6-week Enrollers|Overall Study||159
9989321|NCT01649557|11111085|FG001|6-week Enrollers|Overall Study||35
9989322|NCT01649557|11111086|FG002|6-week Enrollers|Overall Study||22
9989323|NCT01649557|11111084|FG000|52-week Enrollers|Overall Study||20
9989324|NCT01649557|11111085|FG001|52-week Enrollers|Overall Study||6
9989325|NCT01649557|11111086|FG002|52-week Enrollers|Overall Study||2
9989326|NCT01649557|11111084|FG000|COMPLETED|Overall Study||135
9989327|NCT01649557|11111085|FG001|COMPLETED|Overall Study||27
9989328|NCT01649557|11111086|FG002|COMPLETED|Overall Study||15
9989329|NCT01649557|11111084|FG000|NOT COMPLETED|Overall Study||44
9989330|NCT01649557|11111085|FG001|NOT COMPLETED|Overall Study||14
9989331|NCT01649557|11111086|FG002|NOT COMPLETED|Overall Study||9
9989332|NCT01649596|11111096|FG000|STARTED|Overall Study||46
9989333|NCT01649596|11111097|FG001|STARTED|Overall Study||48
9989334|NCT01649596|11111096|FG000|COMPLETED|Overall Study||46
9989335|NCT01649596|11111097|FG001|COMPLETED|Overall Study||48
9989336|NCT01649596|11111096|FG000|NOT COMPLETED|Overall Study||0
9989337|NCT01649596|11111097|FG001|NOT COMPLETED|Overall Study||0
9989338|NCT01649609|11111105|FG000|STARTED|Overall Study||20
9989339|NCT01649609|11111106|FG001|STARTED|Overall Study||20
9989340|NCT01649609|11111105|FG000|COMPLETED|Overall Study||20
9989341|NCT01649609|11111106|FG001|COMPLETED|Overall Study||20
9989342|NCT01649609|11111105|FG000|NOT COMPLETED|Overall Study||0
9989343|NCT01649609|11111106|FG001|NOT COMPLETED|Overall Study||0
9989344|NCT01649765|11111114|FG000|STARTED|Overall Study||40
9989345|NCT01649765|11111115|FG001|STARTED|Overall Study||53
9989346|NCT01649765|11111114|FG000|COMPLETED|Overall Study||31
9989347|NCT01649765|11111115|FG001|COMPLETED|Overall Study||45
9989348|NCT01649765|11111114|FG000|NOT COMPLETED|Overall Study||9
9989349|NCT01649765|11111115|FG001|NOT COMPLETED|Overall Study||8
9989350|NCT01649791|11111122|FG000|STARTED|Overall Study||8
9989351|NCT01649791|11111122|FG000|COMPLETED|Overall Study||5
9989352|NCT01649791|11111122|FG000|NOT COMPLETED|Overall Study||3
9989353|NCT01649804|11111126|FG000|STARTED|Overall Study||12
9989354|NCT01649804|11111126|FG000|COMPLETED|Overall Study||4
9989355|NCT01649804|11111126|FG000|NOT COMPLETED|Overall Study||8
9989356|NCT01649856|11111132|FG000|STARTED|Overall Study||369
9989357|NCT01649856|11111133|FG001|STARTED|Overall Study||203
9989358|NCT01649856|11111132|FG000|COMPLETED|Overall Study||230
9989359|NCT01649856|11111133|FG001|COMPLETED|Overall Study||125
9989360|NCT01649856|11111132|FG000|NOT COMPLETED|Overall Study||139
9989361|NCT01649856|11111133|FG001|NOT COMPLETED|Overall Study||78
9989362|NCT01649869|11111141|FG000|STARTED|Overall Study||18
9989363|NCT01649869|11111142|FG001|STARTED|Overall Study||17
9989364|NCT01649869|11111141|FG000|COMPLETED|Overall Study||16
9989365|NCT01649869|11111142|FG001|COMPLETED|Overall Study||16
9989366|NCT01649869|11111141|FG000|NOT COMPLETED|Overall Study||2
9989367|NCT01649869|11111142|FG001|NOT COMPLETED|Overall Study||1
9989368|NCT01649947|11111152|FG000|STARTED|Overall Study||12
9989369|NCT01649947|11111153|FG001|STARTED|Overall Study||20
9989370|NCT01649947|11111152|FG000|COMPLETED|Overall Study||0
9989371|NCT01649947|11111153|FG001|COMPLETED|Overall Study||2
9989372|NCT01649947|11111152|FG000|NOT COMPLETED|Overall Study||12
9989373|NCT01649947|11111153|FG001|NOT COMPLETED|Overall Study||18
9989374|NCT01650194|11111160|FG000|STARTED|Overall Study||60
9989375|NCT01650194|11111160|FG000|Treated|Overall Study||60
9989376|NCT01650194|11111160|FG000|COMPLETED|Overall Study||13
9989377|NCT01650194|11111160|FG000|NOT COMPLETED|Overall Study||47
9989378|NCT01650246|11111165|FG000|STARTED|Overall Study||143
9989379|NCT01650246|11111165|FG000|COMPLETED|Overall Study||0
9989380|NCT01650246|11111165|FG000|NOT COMPLETED|Overall Study||143
9989381|NCT01650259|11111171|FG000|STARTED|Overall Study|Started are the registered patients|2513
9989382|NCT01650259|11111172|FG001|STARTED|Overall Study|Started are the registered patients|2363
9989383|NCT01650259|11111171|FG000|COMPLETED|Overall Study||1470
9989384|NCT01650259|11111172|FG001|COMPLETED|Overall Study||2128
9989385|NCT01650259|11111171|FG000|NOT COMPLETED|Overall Study||1043
9989386|NCT01650259|11111172|FG001|NOT COMPLETED|Overall Study||235
10018222|NCT01822574|11141257|FG002|COMPLETED|Overall Study||30
10018223|NCT01822574|11141255|FG000|NOT COMPLETED|Overall Study||0
10018224|NCT01822574|11141256|FG001|NOT COMPLETED|Overall Study||0
10018225|NCT01822574|11141257|FG002|NOT COMPLETED|Overall Study||0
10018226|NCT01822587|11141268|FG000|STARTED|Overall Study||59
10018227|NCT01822587|11141269|FG001|STARTED|Overall Study||60
10018228|NCT01822587|11141270|FG002|STARTED|Overall Study||62
10018229|NCT01822587|11141268|FG000|COMPLETED|Overall Study||43
10018230|NCT01822587|11141269|FG001|COMPLETED|Overall Study||45
10018231|NCT01822587|11141270|FG002|COMPLETED|Overall Study||44
10018232|NCT01822587|11141268|FG000|NOT COMPLETED|Overall Study||16
10018233|NCT01822587|11141269|FG001|NOT COMPLETED|Overall Study||15
10018234|NCT01822587|11141270|FG002|NOT COMPLETED|Overall Study||18
10018235|NCT01822665|11141278|FG000|STARTED|Overall Study||28
10018236|NCT01822665|11141278|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
10018237|NCT01822665|11141278|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
10018238|NCT01822665|11141278|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
10018239|NCT01822665|11141278|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28
10018240|NCT01822665|11141278|FG000|COMPLETED|Overall Study||20
10018241|NCT01822665|11141278|FG000|NOT COMPLETED|Overall Study||8
10018242|NCT01822678|11141299|FG000|STARTED|Overall Study||57
10018243|NCT01822678|11141300|FG001|STARTED|Overall Study||64
10018244|NCT01822678|11141301|FG002|STARTED|Overall Study||40
10018245|NCT01822678|11141299|FG000|Treated|Overall Study||57
10018246|NCT01822678|11141300|FG001|Treated|Overall Study||64
10018247|NCT01822678|11141301|FG002|Treated|Overall Study||40
10018248|NCT01822678|11141299|FG000|Safety Population|Overall Study||57
10018249|NCT01822678|11141300|FG001|Safety Population|Overall Study||64
10018250|NCT01822678|11141301|FG002|Safety Population|Overall Study||40
10018251|NCT01822678|11141299|FG000|Intention-to-Treat Population (ITT)|Overall Study||57
10018252|NCT01822678|11141300|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
10018253|NCT01822678|11141301|FG002|Intention-to-Treat Population (ITT)|Overall Study||40
10018254|NCT01822678|11141299|FG000|Per Protocol Population|Overall Study||45
10018255|NCT01822678|11141300|FG001|Per Protocol Population|Overall Study||52
10018256|NCT01822678|11141301|FG002|Per Protocol Population|Overall Study||34
10018257|NCT01822678|11141299|FG000|COMPLETED|Overall Study||45
10018258|NCT01822678|11141300|FG001|COMPLETED|Overall Study||49
10018259|NCT01822678|11141301|FG002|COMPLETED|Overall Study||29
10018260|NCT01822678|11141299|FG000|NOT COMPLETED|Overall Study||12
10018261|NCT01822678|11141300|FG001|NOT COMPLETED|Overall Study||15
10018262|NCT01822678|11141301|FG002|NOT COMPLETED|Overall Study||11
10018263|NCT01822691|11141309|FG000|STARTED|Overall Study||15
10018264|NCT01822691|11141309|FG000|COMPLETED|Overall Study||13
10018265|NCT01822691|11141309|FG000|NOT COMPLETED|Overall Study||2
10018266|NCT01822756|11141318|FG000|STARTED|Overall Study||16
10018267|NCT01822756|11141319|FG001|STARTED|Overall Study||4
10018268|NCT01822756|11141320|FG002|STARTED|Overall Study||10
10018269|NCT01822756|11141321|FG003|STARTED|Overall Study||4
10018270|NCT01822756|11141322|FG004|STARTED|Overall Study||8
10018271|NCT01822756|11141318|FG000|Discontinued From the Study|Overall Study||16
10018272|NCT01822756|11141319|FG001|Discontinued From the Study|Overall Study||4
10018273|NCT01822756|11141320|FG002|Discontinued From the Study|Overall Study||10
10018274|NCT01822756|11141321|FG003|Discontinued From the Study|Overall Study||4
10018275|NCT01822756|11141322|FG004|Discontinued From the Study|Overall Study||7
10018276|NCT01822756|11141318|FG000|COMPLETED|Overall Study||0
10018277|NCT01822756|11141319|FG001|COMPLETED|Overall Study||0
10018278|NCT01822756|11141320|FG002|COMPLETED|Overall Study||0
10018279|NCT01822756|11141321|FG003|COMPLETED|Overall Study||0
10018280|NCT01822756|11141322|FG004|COMPLETED|Overall Study||1
10018281|NCT01822756|11141318|FG000|NOT COMPLETED|Overall Study||16
10018282|NCT01822756|11141319|FG001|NOT COMPLETED|Overall Study||4
10018283|NCT01822756|11141320|FG002|NOT COMPLETED|Overall Study||10
10018284|NCT01822756|11141321|FG003|NOT COMPLETED|Overall Study||4
10018285|NCT01822756|11141322|FG004|NOT COMPLETED|Overall Study||7
10018286|NCT01822821|11141336|FG000|STARTED|Overall Study||75
10018287|NCT01822821|11141337|FG001|STARTED|Overall Study||75
10018288|NCT01822821|11141336|FG000|COMPLETED|Overall Study||73
10018289|NCT01822821|11141337|FG001|COMPLETED|Overall Study||74
10018290|NCT01822821|11141336|FG000|NOT COMPLETED|Overall Study||2
9989387|NCT01650298|11111178|FG000|STARTED|Overall Study||16
9989388|NCT01650298|11111179|FG001|STARTED|Overall Study||48
9989389|NCT01650298|11111178|FG000|COMPLETED|Overall Study||11
9989390|NCT01650298|11111179|FG001|COMPLETED|Overall Study||42
9989391|NCT01650298|11111178|FG000|NOT COMPLETED|Overall Study||5
9989392|NCT01650298|11111179|FG001|NOT COMPLETED|Overall Study||6
9989393|NCT01650324|11111190|FG000|STARTED|Overall Study||8
9989394|NCT01650324|11111191|FG001|STARTED|Overall Study||6
9989395|NCT01650324|11111192|FG002|STARTED|Overall Study||6
9989396|NCT01650324|11111193|FG003|STARTED|Overall Study||6
9989397|NCT01650324|11111194|FG004|STARTED|Overall Study||6
9989398|NCT01650324|11111190|FG000|COMPLETED|Overall Study||8
9989399|NCT01650324|11111191|FG001|COMPLETED|Overall Study||6
9989400|NCT01650324|11111192|FG002|COMPLETED|Overall Study||6
9989401|NCT01650324|11111193|FG003|COMPLETED|Overall Study||6
9989402|NCT01650324|11111194|FG004|COMPLETED|Overall Study||6
9989403|NCT01650324|11111190|FG000|NOT COMPLETED|Overall Study||0
9989404|NCT01650324|11111191|FG001|NOT COMPLETED|Overall Study||0
9989405|NCT01650324|11111192|FG002|NOT COMPLETED|Overall Study||0
9989406|NCT01650324|11111193|FG003|NOT COMPLETED|Overall Study||0
9989407|NCT01650324|11111194|FG004|NOT COMPLETED|Overall Study||0
9989408|NCT01650402|11111213|FG000|STARTED|Overall Study||99
9989409|NCT01650402|11111214|FG001|STARTED|Overall Study||100
9989410|NCT01650402|11111213|FG000|COMPLETED|Overall Study||79
9989411|NCT01650402|11111214|FG001|COMPLETED|Overall Study||86
9989412|NCT01650402|11111213|FG000|NOT COMPLETED|Overall Study||20
9989413|NCT01650402|11111214|FG001|NOT COMPLETED|Overall Study||14
9989414|NCT01650519|11111222|FG000|STARTED|Overall Study||20
9989415|NCT01650519|11111223|FG001|STARTED|Overall Study||31
9989416|NCT01650519|11111222|FG000|COMPLETED|Overall Study||19
9989417|NCT01650519|11111223|FG001|COMPLETED|Overall Study||31
9989418|NCT01650519|11111222|FG000|NOT COMPLETED|Overall Study||1
9989419|NCT01650519|11111223|FG001|NOT COMPLETED|Overall Study||0
9989420|NCT01650545|11111231|FG000|STARTED|Overall Study||11
9989421|NCT01650545|11111232|FG001|STARTED|Overall Study||10
9989422|NCT01650545|11111231|FG000|COMPLETED|Overall Study||11
9989423|NCT01650545|11111232|FG001|COMPLETED|Overall Study||10
9989424|NCT01650545|11111231|FG000|NOT COMPLETED|Overall Study||0
9989425|NCT01650545|11111232|FG001|NOT COMPLETED|Overall Study||0
9989426|NCT01650558|11111243|FG000|STARTED|Overall Study||500
9989427|NCT01650558|11111244|FG001|STARTED|Overall Study||500
9989428|NCT01650558|11111245|FG002|STARTED|Overall Study||499
9989429|NCT01650558|11111243|FG000|COMPLETED|Overall Study||417
9989430|NCT01650558|11111244|FG001|COMPLETED|Overall Study||408
9989431|NCT01650558|11111245|FG002|COMPLETED|Overall Study||424
9989432|NCT01650558|11111243|FG000|NOT COMPLETED|Overall Study||83
9989433|NCT01650558|11111244|FG001|NOT COMPLETED|Overall Study||92
9989434|NCT01650558|11111245|FG002|NOT COMPLETED|Overall Study||75
9989435|NCT01650584|11111256|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
10101537|NCT02408796|11230830|FG000|NOT COMPLETED|Overall Study||0
10101538|NCT02408965|11230836|FG000|STARTED|Overall Study||140
10101539|NCT02408965|11230837|FG001|STARTED|Overall Study||144
10101540|NCT02408965|11230836|FG000|COMPLETED|Overall Study||140
10101541|NCT02408965|11230837|FG001|COMPLETED|Overall Study||144
10101542|NCT02408965|11230836|FG000|NOT COMPLETED|Overall Study||0
10101543|NCT02408965|11230837|FG001|NOT COMPLETED|Overall Study||0
10101544|NCT02409277|11230846|FG000|STARTED|Overall Study||267
10101545|NCT02409277|11230847|FG001|STARTED|Overall Study||60
10101546|NCT02409277|11230848|FG002|STARTED|Overall Study||599
10101547|NCT02409277|11230846|FG000|3 Months Follow-up|Overall Study||178
10101548|NCT02409277|11230847|FG001|3 Months Follow-up|Overall Study||40
9989436|NCT01650584|11111256|FG000|COMPLETED|Overall Study||35
9989437|NCT01650584|11111256|FG000|NOT COMPLETED|Overall Study||0
9989438|NCT01650636|11111263|FG000|STARTED|Intervention Phase||150
10101549|NCT02409277|11230848|FG002|3 Months Follow-up|Overall Study||599
10101550|NCT02409277|11230846|FG000|6 Months Follow-up|Overall Study||182
10101551|NCT02409277|11230847|FG001|6 Months Follow-up|Overall Study||42
10101552|NCT02409277|11230848|FG002|6 Months Follow-up|Overall Study||599
10101553|NCT02409277|11230846|FG000|12 Months Follow-up|Overall Study||167
10101554|NCT02409277|11230847|FG001|12 Months Follow-up|Overall Study||43
10101555|NCT02409277|11230848|FG002|12 Months Follow-up|Overall Study||599
10101556|NCT02409277|11230846|FG000|COMPLETED|Overall Study||167
9989439|NCT01650636|11111264|FG001|STARTED|Intervention Phase||150
9989440|NCT01650636|11111263|FG000|COMPLETED|Intervention Phase||150
9989441|NCT01650636|11111264|FG001|COMPLETED|Intervention Phase||150
9989442|NCT01650636|11111263|FG000|NOT COMPLETED|Intervention Phase||0
9989443|NCT01650636|11111264|FG001|NOT COMPLETED|Intervention Phase||0
9989444|NCT01650636|11111263|FG000|STARTED|Washout up to 5 Months||150
9989445|NCT01650636|11111264|FG001|STARTED|Washout up to 5 Months||150
9989446|NCT01650636|11111263|FG000|COMPLETED|Washout up to 5 Months||141
9989447|NCT01650636|11111264|FG001|COMPLETED|Washout up to 5 Months||132
9989448|NCT01650636|11111263|FG000|NOT COMPLETED|Washout up to 5 Months||9
9989449|NCT01650636|11111264|FG001|NOT COMPLETED|Washout up to 5 Months||18
9989450|NCT01650636|11111263|FG000|STARTED|5 Month Visit||141
9989451|NCT01650636|11111264|FG001|STARTED|5 Month Visit||132
9989452|NCT01650636|11111263|FG000|COMPLETED|5 Month Visit||141
9989453|NCT01650636|11111264|FG001|COMPLETED|5 Month Visit||132
9989454|NCT01650636|11111263|FG000|NOT COMPLETED|5 Month Visit||0
9989455|NCT01650636|11111264|FG001|NOT COMPLETED|5 Month Visit||0
10101557|NCT02409277|11230847|FG001|COMPLETED|Overall Study||43
10101558|NCT02409277|11230848|FG002|COMPLETED|Overall Study||599
10101559|NCT02409277|11230846|FG000|NOT COMPLETED|Overall Study||100
9989456|NCT01650636|11111263|FG000|STARTED|Washout up to 9 Months||141
9989457|NCT01650636|11111264|FG001|STARTED|Washout up to 9 Months||132
9989458|NCT01650636|11111263|FG000|COMPLETED|Washout up to 9 Months||135
9989459|NCT01650636|11111264|FG001|COMPLETED|Washout up to 9 Months||129
9989460|NCT01650636|11111263|FG000|NOT COMPLETED|Washout up to 9 Months||6
9989461|NCT01650636|11111264|FG001|NOT COMPLETED|Washout up to 9 Months||3
9989462|NCT01650636|11111263|FG000|STARTED|9 Month Visit||135
9989463|NCT01650636|11111264|FG001|STARTED|9 Month Visit||129
9989464|NCT01650636|11111263|FG000|COMPLETED|9 Month Visit||135
9989465|NCT01650636|11111264|FG001|COMPLETED|9 Month Visit||129
9989466|NCT01650636|11111263|FG000|NOT COMPLETED|9 Month Visit||0
9989467|NCT01650636|11111264|FG001|NOT COMPLETED|9 Month Visit||0
9989468|NCT01650779|11111270|FG000|STARTED|Overall Study||15
9989469|NCT01650779|11111270|FG000|COMPLETED|Overall Study||14
9989470|NCT01650779|11111270|FG000|NOT COMPLETED|Overall Study||1
9989471|NCT01650805|11111276|FG000|STARTED|Overall Study|Started means patient has been randomized.|155
9989472|NCT01650805|11111277|FG001|STARTED|Overall Study||152
9989473|NCT01650805|11111276|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
9989474|NCT01650805|11111277|FG001|COMPLETED|Overall Study||152
9989475|NCT01650805|11111276|FG000|NOT COMPLETED|Overall Study||1
9989476|NCT01650805|11111277|FG001|NOT COMPLETED|Overall Study||0
9989477|NCT01650831|11111283|FG000|STARTED|Overall Study||113
9989478|NCT01650831|11111283|FG000|COMPLETED|Overall Study||112
9989479|NCT01650831|11111283|FG000|NOT COMPLETED|Overall Study||1
9989480|NCT01650844|11111293|FG000|STARTED|Overall Study||200
9989481|NCT01650844|11111294|FG001|STARTED|Overall Study||200
9989482|NCT01650844|11111293|FG000|COMPLETED|Overall Study||199
9989483|NCT01650844|11111294|FG001|COMPLETED|Overall Study||196
9989484|NCT01650844|11111293|FG000|NOT COMPLETED|Overall Study||1
9989485|NCT01650844|11111294|FG001|NOT COMPLETED|Overall Study||4
10101560|NCT02409277|11230847|FG001|NOT COMPLETED|Overall Study||17
10101561|NCT02409277|11230848|FG002|NOT COMPLETED|Overall Study||0
10101562|NCT02409329|11230876|FG000|STARTED|Overall Study||127
10101563|NCT02409329|11230877|FG001|STARTED|Overall Study||126
10101564|NCT02409329|11230878|FG002|STARTED|Overall Study||253
10101565|NCT02409329|11230876|FG000|COMPLETED|Overall Study||122
10101566|NCT02409329|11230877|FG001|COMPLETED|Overall Study||120
10101567|NCT02409329|11230878|FG002|COMPLETED|Overall Study||244
10101568|NCT02409329|11230876|FG000|NOT COMPLETED|Overall Study||5
10101569|NCT02409329|11230877|FG001|NOT COMPLETED|Overall Study||6
10101570|NCT02409329|11230878|FG002|NOT COMPLETED|Overall Study||9
10101571|NCT02409459|11230889|FG000|STARTED|Overall Study||41
10101572|NCT02409459|11230890|FG001|STARTED|Overall Study||40
10101573|NCT02409459|11230889|FG000|COMPLETED|Overall Study||40
10101574|NCT02409459|11230890|FG001|COMPLETED|Overall Study||39
10101575|NCT02409459|11230889|FG000|NOT COMPLETED|Overall Study||1
10101576|NCT02409459|11230890|FG001|NOT COMPLETED|Overall Study||1
10101577|NCT02409667|11230896|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647
10101578|NCT02409667|11230897|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0
10101579|NCT02409667|11230898|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0
10101580|NCT02409667|11230899|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0
10101581|NCT02409667|11230900|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0
10101582|NCT02409667|11230896|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
10101583|NCT02409667|11230897|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101584|NCT02409667|11230898|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101585|NCT02409667|11230899|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101586|NCT02409667|11230900|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101587|NCT02409667|11230896|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
10101588|NCT02409667|11230897|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101589|NCT02409667|11230898|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101590|NCT02409667|11230899|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101591|NCT02409667|11230900|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10101592|NCT02409667|11230896|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0
9989486|NCT01651000|11111302|FG000|STARTED|Overall Study||72
9989487|NCT01651000|11111303|FG001|STARTED|Overall Study||141
9989488|NCT01651000|11111302|FG000|Entered Extension Study|Overall Study||50
9989489|NCT01651000|11111303|FG001|Entered Extension Study|Overall Study||93
9989490|NCT01651000|11111302|FG000|COMPLETED|Overall Study||62
9989491|NCT01651000|11111303|FG001|COMPLETED|Overall Study||113
9989492|NCT01651000|11111302|FG000|NOT COMPLETED|Overall Study||10
9989493|NCT01651000|11111303|FG001|NOT COMPLETED|Overall Study||28
9989494|NCT01651039|11111309|FG000|STARTED|Overall Study||32
9989495|NCT01651039|11111309|FG000|COMPLETED|Overall Study||2
9989496|NCT01651039|11111309|FG000|NOT COMPLETED|Overall Study||30
9989497|NCT01651052|11111313|FG000|STARTED|Overall Study||133
9989498|NCT01651052|11111313|FG000|Study Valve Group|Overall Study||133
9989499|NCT01651052|11111313|FG000|COMPLETED|Overall Study||107
10101593|NCT02409667|11230897|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644
10101594|NCT02409667|11230898|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662
10101595|NCT02409667|11230899|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114
10101596|NCT02409667|11230900|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93
9989500|NCT01651052|11111313|FG000|NOT COMPLETED|Overall Study||26
9989501|NCT01651078|11111317|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
9989502|NCT01651078|11111317|FG000|COMPLETED|Overall Study||16
10239826|NCT03998189|11371565|FG000|COMPLETED|Overall Study||0
9989503|NCT01651078|11111317|FG000|NOT COMPLETED|Overall Study||26
9989504|NCT01651104|11111321|FG000|STARTED|Overall Study||63
9989505|NCT01651104|11111321|FG000|COMPLETED|Overall Study||63
9989506|NCT01651104|11111321|FG000|NOT COMPLETED|Overall Study||0
9989507|NCT01651117|11111329|FG000|STARTED|Overall Study||156
9989508|NCT01651117|11111330|FG001|STARTED|Overall Study||205
9989509|NCT01651117|11111331|FG002|STARTED|Overall Study||49
9989510|NCT01651117|11111332|FG003|STARTED|Overall Study||70
9989511|NCT01651117|11111329|FG000|COMPLETED|Overall Study||154
9989512|NCT01651117|11111330|FG001|COMPLETED|Overall Study||202
9989513|NCT01651117|11111331|FG002|COMPLETED|Overall Study||47
9989514|NCT01651117|11111332|FG003|COMPLETED|Overall Study||68
9989515|NCT01651117|11111329|FG000|NOT COMPLETED|Overall Study||2
9989516|NCT01651117|11111330|FG001|NOT COMPLETED|Overall Study||3
9989517|NCT01651117|11111331|FG002|NOT COMPLETED|Overall Study||2
9989518|NCT01651117|11111332|FG003|NOT COMPLETED|Overall Study||2
9989519|NCT01651195|11111349|FG000|STARTED|Overall Study||284
9989520|NCT01651195|11111350|FG001|STARTED|Overall Study||284
9989521|NCT01651195|11111351|FG002|STARTED|Overall Study||204
9989522|NCT01651195|11111352|FG003|STARTED|Overall Study||211
9989523|NCT01651195|11111349|FG000|COMPLETED|Overall Study||63
9989524|NCT01651195|11111350|FG001|COMPLETED|Overall Study||73
9989525|NCT01651195|11111351|FG002|COMPLETED|Overall Study||121
9989526|NCT01651195|11111352|FG003|COMPLETED|Overall Study||103
9989527|NCT01651195|11111349|FG000|NOT COMPLETED|Overall Study||221
9989528|NCT01651195|11111350|FG001|NOT COMPLETED|Overall Study||211
9989529|NCT01651195|11111351|FG002|NOT COMPLETED|Overall Study||83
9989530|NCT01651195|11111352|FG003|NOT COMPLETED|Overall Study||108
9989531|NCT01651208|11111368|FG000|STARTED|Overall Study||227
9989532|NCT01651208|11111369|FG001|STARTED|Overall Study||225
9989533|NCT01651208|11111368|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
9989534|NCT01651208|11111369|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
9989535|NCT01651208|11111368|FG000|NOT COMPLETED|Overall Study||14
9989536|NCT01651208|11111369|FG001|NOT COMPLETED|Overall Study||16
9989537|NCT01651260|11111376|FG000|STARTED|Overall Study||65
9989538|NCT01651260|11111376|FG000|COMPLETED|Overall Study||62
9989539|NCT01651260|11111376|FG000|NOT COMPLETED|Overall Study||3
9989540|NCT01651351|11111383|FG000|STARTED|Overall Study||15
9989541|NCT01651351|11111384|FG001|STARTED|Overall Study||15
9989542|NCT01651351|11111383|FG000|COMPLETED|Overall Study||15
9989543|NCT01651351|11111384|FG001|COMPLETED|Overall Study||15
9989544|NCT01651351|11111383|FG000|NOT COMPLETED|Overall Study||0
9989545|NCT01651351|11111384|FG001|NOT COMPLETED|Overall Study||0
9989546|NCT01651442|11111393|FG000|STARTED|Phase I Treatment||104
9989547|NCT01651442|11111394|FG001|STARTED|Phase I Treatment||107
9989548|NCT01651442|11111395|FG002|STARTED|Phase I Treatment||0
10101597|NCT02409667|11230896|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
10101598|NCT02409667|11230897|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
10101599|NCT02409667|11230898|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
10101600|NCT02409667|11230899|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
10101601|NCT02409667|11230900|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
10101602|NCT02409667|11230896|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
10101603|NCT02409667|11230897|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
10101604|NCT02409667|11230898|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
10101605|NCT02409667|11230899|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
10101606|NCT02409667|11230900|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
10101607|NCT02409680|11230913|FG000|STARTED|Overall Study||5990
10101608|NCT02409680|11230914|FG001|STARTED|Overall Study||5986
10101609|NCT02409680|11230913|FG000|Treated|Overall Study||5943
10101610|NCT02409680|11230914|FG001|Treated|Overall Study||5936
10101611|NCT02409680|11230913|FG000|Included in mITT Analysis|Overall Study||5787
10101612|NCT02409680|11230914|FG001|Included in mITT Analysis|Overall Study||5771
10101613|NCT02409680|11230913|FG000|COMPLETED|Overall Study||5975
10101614|NCT02409680|11230914|FG001|COMPLETED|Overall Study||5956
10101615|NCT02409680|11230913|FG000|NOT COMPLETED|Overall Study||15
10101616|NCT02409680|11230914|FG001|NOT COMPLETED|Overall Study||30
10101617|NCT02409719|11230922|FG000|STARTED|Overall Study||31
10101618|NCT02409719|11230923|FG001|STARTED|Overall Study||45
10101619|NCT02409719|11230922|FG000|2 Weeks|Overall Study||28
10101620|NCT02409719|11230923|FG001|2 Weeks|Overall Study||42
9989549|NCT01651442|11111396|FG003|STARTED|Phase I Treatment||0
9989550|NCT01651442|11111397|FG004|STARTED|Phase I Treatment||0
9989551|NCT01651442|11111398|FG005|STARTED|Phase I Treatment||0
9989552|NCT01651442|11111393|FG000|COMPLETED|Phase I Treatment||88
9989553|NCT01651442|11111394|FG001|COMPLETED|Phase I Treatment||80
9989554|NCT01651442|11111395|FG002|COMPLETED|Phase I Treatment||0
9989555|NCT01651442|11111396|FG003|COMPLETED|Phase I Treatment||0
9989556|NCT01651442|11111397|FG004|COMPLETED|Phase I Treatment||0
9989557|NCT01651442|11111398|FG005|COMPLETED|Phase I Treatment||0
9989558|NCT01651442|11111393|FG000|NOT COMPLETED|Phase I Treatment||16
9989559|NCT01651442|11111394|FG001|NOT COMPLETED|Phase I Treatment||27
9989560|NCT01651442|11111395|FG002|NOT COMPLETED|Phase I Treatment||0
9989561|NCT01651442|11111396|FG003|NOT COMPLETED|Phase I Treatment||0
9989562|NCT01651442|11111397|FG004|NOT COMPLETED|Phase I Treatment||0
9989563|NCT01651442|11111398|FG005|NOT COMPLETED|Phase I Treatment||0
9989564|NCT01651442|11111393|FG000|STARTED|Phase II Treatment||0
9989565|NCT01651442|11111394|FG001|STARTED|Phase II Treatment||0
10101621|NCT02409719|11230922|FG000|4 Weeks|Overall Study||28
9989566|NCT01651442|11111395|FG002|STARTED|Phase II Treatment||27
9989567|NCT01651442|11111396|FG003|STARTED|Phase II Treatment||27
9989568|NCT01651442|11111397|FG004|STARTED|Phase II Treatment||27
9989569|NCT01651442|11111398|FG005|STARTED|Phase II Treatment||27
9989570|NCT01651442|11111393|FG000|COMPLETED|Phase II Treatment||0
9989571|NCT01651442|11111394|FG001|COMPLETED|Phase II Treatment||0
9989572|NCT01651442|11111395|FG002|COMPLETED|Phase II Treatment||25
9989573|NCT01651442|11111396|FG003|COMPLETED|Phase II Treatment||15
9989574|NCT01651442|11111397|FG004|COMPLETED|Phase II Treatment||21
9989575|NCT01651442|11111398|FG005|COMPLETED|Phase II Treatment||17
9989576|NCT01651442|11111393|FG000|NOT COMPLETED|Phase II Treatment||0
9989577|NCT01651442|11111394|FG001|NOT COMPLETED|Phase II Treatment||0
9989578|NCT01651442|11111395|FG002|NOT COMPLETED|Phase II Treatment||2
9989579|NCT01651442|11111396|FG003|NOT COMPLETED|Phase II Treatment||12
9989580|NCT01651442|11111397|FG004|NOT COMPLETED|Phase II Treatment||6
9989581|NCT01651442|11111398|FG005|NOT COMPLETED|Phase II Treatment||10
9989582|NCT01651780|11111412|FG000|STARTED|Overall Study||405
9989583|NCT01651780|11111413|FG001|STARTED|Overall Study||398
9989584|NCT01651780|11111412|FG000|Intent-To-Treat (ITT) Population|Overall Study||404
9989585|NCT01651780|11111413|FG001|Intent-To-Treat (ITT) Population|Overall Study||398
9989586|NCT01651780|11111412|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
9989587|NCT01651780|11111413|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394
9989588|NCT01651780|11111412|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
9989589|NCT01651780|11111413|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
9989590|NCT01651780|11111412|FG000|COMPLETED|Overall Study||394
9989591|NCT01651780|11111413|FG001|COMPLETED|Overall Study||388
9989592|NCT01651780|11111412|FG000|NOT COMPLETED|Overall Study||11
9989593|NCT01651780|11111413|FG001|NOT COMPLETED|Overall Study||10
9989594|NCT01651793|11111423|FG000|STARTED|Overall Study||6
9989595|NCT01651793|11111424|FG001|STARTED|Overall Study||6
9989596|NCT01651793|11111425|FG002|STARTED|Overall Study||6
9989597|NCT01651793|11111426|FG003|STARTED|Overall Study||6
9989598|NCT01651793|11111423|FG000|COMPLETED|Overall Study||6
9989599|NCT01651793|11111424|FG001|COMPLETED|Overall Study||6
9989600|NCT01651793|11111425|FG002|COMPLETED|Overall Study||6
9989601|NCT01651793|11111426|FG003|COMPLETED|Overall Study||5
9989602|NCT01651793|11111423|FG000|NOT COMPLETED|Overall Study||0
9989603|NCT01651793|11111424|FG001|NOT COMPLETED|Overall Study||0
9989604|NCT01651793|11111425|FG002|NOT COMPLETED|Overall Study||0
9989605|NCT01651793|11111426|FG003|NOT COMPLETED|Overall Study||1
9989606|NCT01651806|11111445|FG000|STARTED|Overall Study||13
9989607|NCT01651806|11111446|FG001|STARTED|Overall Study||12
9989608|NCT01651806|11111447|FG002|STARTED|Overall Study||25
9989609|NCT01651806|11111448|FG003|STARTED|Overall Study||7
9989610|NCT01651806|11111449|FG004|STARTED|Overall Study||8
9989611|NCT01651806|11111445|FG000|COMPLETED|Overall Study||13
9989612|NCT01651806|11111446|FG001|COMPLETED|Overall Study||12
9989613|NCT01651806|11111447|FG002|COMPLETED|Overall Study||25
9989614|NCT01651806|11111448|FG003|COMPLETED|Overall Study||7
9989615|NCT01651806|11111449|FG004|COMPLETED|Overall Study||8
9989616|NCT01651806|11111445|FG000|NOT COMPLETED|Overall Study||0
9989617|NCT01651806|11111446|FG001|NOT COMPLETED|Overall Study||0
9989618|NCT01651806|11111447|FG002|NOT COMPLETED|Overall Study||0
9989619|NCT01651806|11111448|FG003|NOT COMPLETED|Overall Study||0
9989620|NCT01651806|11111449|FG004|NOT COMPLETED|Overall Study||0
9989621|NCT01651936|11111464|FG000|STARTED|Base Study||30
9989622|NCT01651936|11111465|FG001|STARTED|Base Study||26
9989623|NCT01651936|11111466|FG002|STARTED|Base Study||0
9989624|NCT01651936|11111464|FG000|COMPLETED|Base Study||3
9989625|NCT01651936|11111465|FG001|COMPLETED|Base Study||1
9989626|NCT01651936|11111466|FG002|COMPLETED|Base Study||0
9989627|NCT01651936|11111464|FG000|NOT COMPLETED|Base Study||27
9989628|NCT01651936|11111465|FG001|NOT COMPLETED|Base Study||25
9989629|NCT01651936|11111466|FG002|NOT COMPLETED|Base Study||0
9989630|NCT01651936|11111464|FG000|STARTED|Extension Study||0
9989631|NCT01651936|11111465|FG001|STARTED|Extension Study||0
9989632|NCT01651936|11111466|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
9989633|NCT01651936|11111464|FG000|COMPLETED|Extension Study||0
9989634|NCT01651936|11111465|FG001|COMPLETED|Extension Study||0
9989635|NCT01651936|11111466|FG002|COMPLETED|Extension Study||0
9989636|NCT01651936|11111464|FG000|NOT COMPLETED|Extension Study||0
9989637|NCT01651936|11111465|FG001|NOT COMPLETED|Extension Study||0
9989638|NCT01651936|11111466|FG002|NOT COMPLETED|Extension Study||14
9989639|NCT01651949|11111476|FG000|STARTED|Overall Study||1106
9989640|NCT01651949|11111477|FG001|STARTED|Overall Study||1101
9989641|NCT01651949|11111478|FG002|STARTED|Overall Study||313
9989642|NCT01651949|11111476|FG000|Vaccination 1|Overall Study||1103
9989643|NCT01651949|11111477|FG001|Vaccination 1|Overall Study||1099
9989644|NCT01651949|11111478|FG002|Vaccination 1|Overall Study||313
9989645|NCT01651949|11111476|FG000|Vaccination 2|Overall Study||1089
9989646|NCT01651949|11111477|FG001|Vaccination 2|Overall Study||1069
9989647|NCT01651949|11111478|FG002|Vaccination 2|Overall Study||298
9989648|NCT01651949|11111476|FG000|Vaccination 3|Overall Study||1067
9989649|NCT01651949|11111477|FG001|Vaccination 3|Overall Study||1037
9989650|NCT01651949|11111478|FG002|Vaccination 3|Overall Study||291
9989651|NCT01651949|11111476|FG000|COMPLETED|Overall Study||1053
9989652|NCT01651949|11111477|FG001|COMPLETED|Overall Study||1015
9989653|NCT01651949|11111478|FG002|COMPLETED|Overall Study||282
9989654|NCT01651949|11111476|FG000|NOT COMPLETED|Overall Study||53
9989655|NCT01651949|11111477|FG001|NOT COMPLETED|Overall Study||86
9989656|NCT01651949|11111478|FG002|NOT COMPLETED|Overall Study||31
9989657|NCT01652001|11111488|FG000|STARTED|Overall Study||100
9989658|NCT01652001|11111489|FG001|STARTED|Overall Study||85
9989659|NCT01652001|11111488|FG000|COMPLETED|Overall Study||91
9989660|NCT01652001|11111489|FG001|COMPLETED|Overall Study||79
9989661|NCT01652001|11111488|FG000|NOT COMPLETED|Overall Study||9
9989662|NCT01652001|11111489|FG001|NOT COMPLETED|Overall Study||6
9989663|NCT01652040|11111497|FG000|STARTED|Overall Study||13
9989664|NCT01652040|11111498|FG001|STARTED|Overall Study||13
9989665|NCT01652040|11111497|FG000|COMPLETED|Overall Study||11
9989666|NCT01652040|11111498|FG001|COMPLETED|Overall Study||11
9989667|NCT01652040|11111497|FG000|NOT COMPLETED|Overall Study||2
9989668|NCT01652040|11111498|FG001|NOT COMPLETED|Overall Study||2
9989669|NCT01652287|11111507|FG000|STARTED|Overall Study||31
9989670|NCT01652287|11111508|FG001|STARTED|Overall Study||31
9989671|NCT01652287|11111507|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
9989672|NCT01652287|11111508|FG001|COMPLETED|Overall Study||31
9989673|NCT01652287|11111507|FG000|NOT COMPLETED|Overall Study||2
9989674|NCT01652287|11111508|FG001|NOT COMPLETED|Overall Study||0
9989675|NCT01652469|11111516|FG000|STARTED|Overall Study||38
9989676|NCT01652469|11111517|FG001|STARTED|Overall Study||42
9989677|NCT01652469|11111516|FG000|COMPLETED|Overall Study||37
9989678|NCT01652469|11111517|FG001|COMPLETED|Overall Study||36
9989679|NCT01652469|11111516|FG000|NOT COMPLETED|Overall Study||1
9989680|NCT01652469|11111517|FG001|NOT COMPLETED|Overall Study||6
9989681|NCT01652495|11111525|FG000|STARTED|Overall Study||22
9989682|NCT01652495|11111526|FG001|STARTED|Overall Study||22
9989683|NCT01652495|11111525|FG000|COMPLETED|Overall Study||20
9989684|NCT01652495|11111526|FG001|COMPLETED|Overall Study||20
9989685|NCT01652495|11111525|FG000|NOT COMPLETED|Overall Study||2
9989686|NCT01652495|11111526|FG001|NOT COMPLETED|Overall Study||2
9989687|NCT01652573|11111536|FG000|STARTED|Overall Study||10
9989688|NCT01652573|11111537|FG001|STARTED|Overall Study||11
9989689|NCT01652573|11111536|FG000|COMPLETED|Overall Study||10
9989690|NCT01652573|11111537|FG001|COMPLETED|Overall Study||10
9989691|NCT01652573|11111536|FG000|NOT COMPLETED|Overall Study||0
9989692|NCT01652573|11111537|FG001|NOT COMPLETED|Overall Study||1
9989693|NCT01652664|11111545|FG000|STARTED|Overall Study||77
9989694|NCT01652664|11111546|FG001|STARTED|Overall Study||75
9989695|NCT01652664|11111545|FG000|COMPLETED|Overall Study||71
9989696|NCT01652664|11111546|FG001|COMPLETED|Overall Study||74
9989697|NCT01652664|11111545|FG000|NOT COMPLETED|Overall Study||6
9989698|NCT01652664|11111546|FG001|NOT COMPLETED|Overall Study||1
9989699|NCT01652690|11111555|FG000|STARTED|Overall Study||300
9989700|NCT01652690|11111556|FG001|STARTED|Overall Study||300
9989701|NCT01652690|11111555|FG000|COMPLETED|Overall Study||265
10101622|NCT02409719|11230923|FG001|4 Weeks|Overall Study||42
10101623|NCT02409719|11230922|FG000|6 Weeks|Overall Study||28
10101624|NCT02409719|11230923|FG001|6 Weeks|Overall Study||42
10101625|NCT02409719|11230922|FG000|3 Months|Overall Study||28
10101626|NCT02409719|11230923|FG001|3 Months|Overall Study||42
10101627|NCT02409719|11230922|FG000|6 Months|Overall Study||28
10101628|NCT02409719|11230923|FG001|6 Months|Overall Study||42
10101629|NCT02409719|11230922|FG000|12 Months|Overall Study||28
10101630|NCT02409719|11230923|FG001|12 Months|Overall Study||42
10101631|NCT02409719|11230922|FG000|COMPLETED|Overall Study||28
10101632|NCT02409719|11230923|FG001|COMPLETED|Overall Study||42
10101633|NCT02409719|11230922|FG000|NOT COMPLETED|Overall Study||3
10101634|NCT02409719|11230923|FG001|NOT COMPLETED|Overall Study||3
10101635|NCT02409732|11230929|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20
10101636|NCT02409732|11230929|FG000|COMPLETED|Overall Study||14
10101637|NCT02409732|11230929|FG000|NOT COMPLETED|Overall Study||6
10101638|NCT02409784|11230934|FG000|STARTED|Overall Study||10
10101639|NCT02409784|11230934|FG000|COMPLETED|Overall Study||10
10101640|NCT02409784|11230934|FG000|NOT COMPLETED|Overall Study||0
10101641|NCT02409914|11230939|FG000|STARTED|Overall Study||7
10101642|NCT02409914|11230939|FG000|COMPLETED|Overall Study||7
10101643|NCT02409914|11230939|FG000|NOT COMPLETED|Overall Study||0
10101644|NCT02409927|11230943|FG000|STARTED|Overall Study||10
10101645|NCT02409927|11230943|FG000|COMPLETED|Overall Study||10
10101646|NCT02409927|11230943|FG000|NOT COMPLETED|Overall Study||0
10101647|NCT02410018|11230949|FG000|STARTED|Overall Study||2
10101648|NCT02410018|11230950|FG001|STARTED|Overall Study||1
10101649|NCT02410018|11230949|FG000|COMPLETED|Overall Study||2
10101650|NCT02410018|11230950|FG001|COMPLETED|Overall Study||1
10101651|NCT02410018|11230949|FG000|NOT COMPLETED|Overall Study||0
10101652|NCT02410018|11230950|FG001|NOT COMPLETED|Overall Study||0
10101653|NCT02410161|11230958|FG000|STARTED|Overall Study||10
9989702|NCT01652690|11111556|FG001|COMPLETED|Overall Study||279
9989703|NCT01652690|11111555|FG000|NOT COMPLETED|Overall Study||35
9989704|NCT01652690|11111556|FG001|NOT COMPLETED|Overall Study||21
9989705|NCT01652703|11111568|FG000|STARTED|Overall Study||52
9989706|NCT01652703|11111569|FG001|STARTED|Overall Study||51
9989707|NCT01652703|11111570|FG002|STARTED|Overall Study||50
9989708|NCT01652703|11111571|FG003|STARTED|Overall Study||52
9989709|NCT01652703|11111572|FG004|STARTED|Overall Study||52
9989710|NCT01652703|11111573|FG005|STARTED|Overall Study||53
9989711|NCT01652703|11111568|FG000|Received Treatment|Overall Study||52
10101654|NCT02410161|11230959|FG001|STARTED|Overall Study||10
10101655|NCT02410161|11230958|FG000|COMPLETED|Overall Study||10
9989712|NCT01652703|11111569|FG001|Received Treatment|Overall Study||50
9989713|NCT01652703|11111570|FG002|Received Treatment|Overall Study||49
9989714|NCT01652703|11111571|FG003|Received Treatment|Overall Study||52
9989715|NCT01652703|11111572|FG004|Received Treatment|Overall Study||51
9989716|NCT01652703|11111573|FG005|Received Treatment|Overall Study||53
9989717|NCT01652703|11111568|FG000|COMPLETED|Overall Study||52
9989718|NCT01652703|11111569|FG001|COMPLETED|Overall Study||50
9989719|NCT01652703|11111570|FG002|COMPLETED|Overall Study||47
9989720|NCT01652703|11111571|FG003|COMPLETED|Overall Study||50
9989721|NCT01652703|11111572|FG004|COMPLETED|Overall Study||51
9989722|NCT01652703|11111573|FG005|COMPLETED|Overall Study||51
9989723|NCT01652703|11111568|FG000|NOT COMPLETED|Overall Study||0
9989724|NCT01652703|11111569|FG001|NOT COMPLETED|Overall Study||1
9989725|NCT01652703|11111570|FG002|NOT COMPLETED|Overall Study||3
9989726|NCT01652703|11111571|FG003|NOT COMPLETED|Overall Study||2
9989727|NCT01652703|11111572|FG004|NOT COMPLETED|Overall Study||1
9989728|NCT01652703|11111573|FG005|NOT COMPLETED|Overall Study||2
9989729|NCT01652716|11111589|FG000|STARTED|Overall Study||229
9989730|NCT01652716|11111590|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
9989731|NCT01652716|11111589|FG000|Completed 28-week|Overall Study||197
9989732|NCT01652716|11111590|FG001|Completed 28-week|Overall Study||118
9989733|NCT01652716|11111589|FG000|COMPLETED|Overall Study|* completed study|173
9989734|NCT01652716|11111590|FG001|COMPLETED|Overall Study|* completed study|102
9989735|NCT01652716|11111589|FG000|NOT COMPLETED|Overall Study||56
9989736|NCT01652716|11111590|FG001|NOT COMPLETED|Overall Study||46
9989737|NCT01652729|11111599|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
9989738|NCT01652729|11111600|FG001|STARTED|Overall Study||122
9989739|NCT01652729|11111601|FG002|STARTED|Overall Study||61
9989740|NCT01652729|11111599|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
9989741|NCT01652729|11111600|FG001|Modified Intent-to-Treat|Overall Study||122
9989742|NCT01652729|11111601|FG002|Modified Intent-to-Treat|Overall Study||61
9989743|NCT01652729|11111599|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
9989744|NCT01652729|11111600|FG001|Treated|Overall Study||122
9989745|NCT01652729|11111601|FG002|Treated|Overall Study||61
9989746|NCT01652729|11111599|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
9989747|NCT01652729|11111600|FG001|Evaluable|Overall Study||91
9989748|NCT01652729|11111601|FG002|Evaluable|Overall Study||43
9989749|NCT01652729|11111599|FG000|Meal Test Subjects|Overall Study||60
9989750|NCT01652729|11111600|FG001|Meal Test Subjects|Overall Study||41
9989751|NCT01652729|11111601|FG002|Meal Test Subjects|Overall Study||20
9989752|NCT01652729|11111599|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
9989753|NCT01652729|11111600|FG001|Meal Test Evaluable|Overall Study||31
9989754|NCT01652729|11111601|FG002|Meal Test Evaluable|Overall Study||15
9989755|NCT01652729|11111599|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
9989756|NCT01652729|11111600|FG001|COMPLETED|Overall Study||109
9989757|NCT01652729|11111601|FG002|COMPLETED|Overall Study||47
9989758|NCT01652729|11111599|FG000|NOT COMPLETED|Overall Study||27
9989759|NCT01652729|11111600|FG001|NOT COMPLETED|Overall Study||13
9989760|NCT01652729|11111601|FG002|NOT COMPLETED|Overall Study||14
9989761|NCT01652872|11111611|FG000|STARTED|Overall Study||377
9989762|NCT01652872|11111612|FG001|STARTED|Overall Study||379
9989763|NCT01652872|11111611|FG000|Received Investigational Product|Overall Study||377
9989764|NCT01652872|11111612|FG001|Received Investigational Product|Overall Study||377
9989765|NCT01652872|11111611|FG000|COMPLETED|Overall Study||232
9989766|NCT01652872|11111612|FG001|COMPLETED|Overall Study||226
9989767|NCT01652872|11111611|FG000|NOT COMPLETED|Overall Study||145
9989768|NCT01652872|11111612|FG001|NOT COMPLETED|Overall Study||153
9989769|NCT01652885|11111618|FG000|STARTED|Overall Study||23
9989770|NCT01652885|11111618|FG000|COMPLETED|Overall Study||22
9989771|NCT01652885|11111618|FG000|NOT COMPLETED|Overall Study||1
9989772|NCT01652976|11111622|FG000|STARTED|Overall Study||44
9989773|NCT01652976|11111622|FG000|COMPLETED|Overall Study||44
9989774|NCT01652976|11111622|FG000|NOT COMPLETED|Overall Study||0
9989775|NCT01653028|11111631|FG000|STARTED|Overall Study||12
9989776|NCT01653028|11111632|FG001|STARTED|Overall Study||10
9989777|NCT01653028|11111633|FG002|STARTED|Overall Study||11
9989778|NCT01653028|11111634|FG003|STARTED|Overall Study||10
9989779|NCT01653028|11111635|FG004|STARTED|Overall Study||29
9989780|NCT01653028|11111631|FG000|COMPLETED|Overall Study||12
9989781|NCT01653028|11111632|FG001|COMPLETED|Overall Study||10
9989782|NCT01653028|11111633|FG002|COMPLETED|Overall Study||11
9989783|NCT01653028|11111634|FG003|COMPLETED|Overall Study||10
9989784|NCT01653028|11111635|FG004|COMPLETED|Overall Study||29
9989785|NCT01653028|11111631|FG000|NOT COMPLETED|Overall Study||0
9989786|NCT01653028|11111632|FG001|NOT COMPLETED|Overall Study||0
9989787|NCT01653028|11111633|FG002|NOT COMPLETED|Overall Study||0
9989788|NCT01653028|11111634|FG003|NOT COMPLETED|Overall Study||0
9989789|NCT01653028|11111635|FG004|NOT COMPLETED|Overall Study||0
9989790|NCT01653132|11111647|FG000|STARTED|First Intervention||5
9989791|NCT01653132|11111648|FG001|STARTED|First Intervention||5
9989792|NCT01653132|11111647|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
9989793|NCT01653132|11111648|FG001|COMPLETED|First Intervention||5
9989794|NCT01653132|11111647|FG000|NOT COMPLETED|First Intervention||1
9989795|NCT01653132|11111648|FG001|NOT COMPLETED|First Intervention||0
9989796|NCT01653132|11111647|FG000|STARTED|Washout 1-2 Months||4
9989797|NCT01653132|11111648|FG001|STARTED|Washout 1-2 Months||5
9989798|NCT01653132|11111647|FG000|COMPLETED|Washout 1-2 Months||4
9989799|NCT01653132|11111648|FG001|COMPLETED|Washout 1-2 Months||5
9989800|NCT01653132|11111647|FG000|NOT COMPLETED|Washout 1-2 Months||0
9989801|NCT01653132|11111648|FG001|NOT COMPLETED|Washout 1-2 Months||0
9989802|NCT01653132|11111647|FG000|STARTED|Second Intervention||4
9989803|NCT01653132|11111648|FG001|STARTED|Second Intervention||5
9989804|NCT01653132|11111647|FG000|COMPLETED|Second Intervention||4
9989805|NCT01653132|11111648|FG001|COMPLETED|Second Intervention||5
9989806|NCT01653132|11111647|FG000|NOT COMPLETED|Second Intervention||0
9989807|NCT01653132|11111648|FG001|NOT COMPLETED|Second Intervention||0
9989808|NCT01653158|11111658|FG000|STARTED|Overall Study||3
9989809|NCT01653158|11111659|FG001|STARTED|Overall Study||3
9989810|NCT01653158|11111660|FG002|STARTED|Overall Study||3
9989811|NCT01653158|11111661|FG003|STARTED|Overall Study||3
9989812|NCT01653158|11111662|FG004|STARTED|Overall Study||3
9989813|NCT01653158|11111663|FG005|STARTED|Overall Study||3
9989814|NCT01653158|11111664|FG006|STARTED|Overall Study||9
9989815|NCT01653158|11111665|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
9989816|NCT01653158|11111658|FG000|COMPLETED|Overall Study||2
9989817|NCT01653158|11111659|FG001|COMPLETED|Overall Study||3
9989818|NCT01653158|11111660|FG002|COMPLETED|Overall Study||3
9989819|NCT01653158|11111661|FG003|COMPLETED|Overall Study||1
9989820|NCT01653158|11111662|FG004|COMPLETED|Overall Study||2
9989821|NCT01653158|11111663|FG005|COMPLETED|Overall Study||2
9989822|NCT01653158|11111664|FG006|COMPLETED|Overall Study||7
9989823|NCT01653158|11111665|FG007|COMPLETED|Overall Study||4
9989824|NCT01653158|11111658|FG000|NOT COMPLETED|Overall Study||1
9989825|NCT01653158|11111659|FG001|NOT COMPLETED|Overall Study||0
9989826|NCT01653158|11111660|FG002|NOT COMPLETED|Overall Study||0
9989827|NCT01653158|11111661|FG003|NOT COMPLETED|Overall Study||2
9989828|NCT01653158|11111662|FG004|NOT COMPLETED|Overall Study||1
9989829|NCT01653158|11111663|FG005|NOT COMPLETED|Overall Study||1
9989830|NCT01653158|11111664|FG006|NOT COMPLETED|Overall Study||2
9989831|NCT01653158|11111665|FG007|NOT COMPLETED|Overall Study||15
9989832|NCT01653210|11111688|FG000|STARTED|Overall Study||15
9989833|NCT01653210|11111688|FG000|COMPLETED|Overall Study||12
9989834|NCT01653210|11111688|FG000|NOT COMPLETED|Overall Study||3
9989835|NCT01653262|11111692|FG000|STARTED|Overall Study||29
9989836|NCT01653262|11111692|FG000|COMPLETED|Overall Study||26
9989837|NCT01653262|11111692|FG000|NOT COMPLETED|Overall Study||3
9989838|NCT01653288|11111698|FG000|STARTED|Overall Study||36
9989839|NCT01653288|11111699|FG001|STARTED|Overall Study||36
9989840|NCT01653288|11111698|FG000|COMPLETED|Overall Study||26
9989841|NCT01653288|11111699|FG001|COMPLETED|Overall Study||35
9989842|NCT01653288|11111698|FG000|NOT COMPLETED|Overall Study||10
9989843|NCT01653288|11111699|FG001|NOT COMPLETED|Overall Study||1
9989844|NCT01653327|11111707|FG000|STARTED|Overall Study||11
9989845|NCT01653327|11111707|FG000|COMPLETED|Overall Study||10
9989846|NCT01653327|11111707|FG000|NOT COMPLETED|Overall Study||1
9989847|NCT01653405|11111715|FG000|STARTED|Overall Study||11794
9989848|NCT01653405|11111716|FG001|STARTED|Overall Study||1248782
9989849|NCT01653405|11111715|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
9989850|NCT01653405|11111716|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
9989851|NCT01653405|11111715|FG000|NOT COMPLETED|Overall Study||3765
9989852|NCT01653405|11111716|FG001|NOT COMPLETED|Overall Study||1068803
9989853|NCT01653418|11111722|FG000|STARTED|Overall Study||10
9989854|NCT01653418|11111722|FG000|COMPLETED|Overall Study||10
9989855|NCT01653418|11111722|FG000|NOT COMPLETED|Overall Study||0
9989856|NCT01653509|11111728|FG000|STARTED|Overall Study||12
9989857|NCT01653509|11111729|FG001|STARTED|Overall Study||13
9989858|NCT01653509|11111728|FG000|COMPLETED|Overall Study||12
9989859|NCT01653509|11111729|FG001|COMPLETED|Overall Study||13
9989860|NCT01653509|11111728|FG000|NOT COMPLETED|Overall Study||0
9989861|NCT01653509|11111729|FG001|NOT COMPLETED|Overall Study||0
9989862|NCT01653587|11111739|FG000|STARTED|Overall Study||120
9989863|NCT01653587|11111740|FG001|STARTED|Overall Study||120
9989864|NCT01653587|11111739|FG000|COMPLETED|Overall Study||120
9989865|NCT01653587|11111740|FG001|COMPLETED|Overall Study||120
9989866|NCT01653587|11111739|FG000|NOT COMPLETED|Overall Study||0
9989867|NCT01653587|11111740|FG001|NOT COMPLETED|Overall Study||0
9989868|NCT01653704|11111748|FG000|STARTED|Overall Study||21
9989869|NCT01653704|11111749|FG001|STARTED|Overall Study||21
9989870|NCT01653704|11111748|FG000|COMPLETED|Overall Study||19
9989871|NCT01653704|11111749|FG001|COMPLETED|Overall Study||20
9989872|NCT01653704|11111748|FG000|NOT COMPLETED|Overall Study||2
9989873|NCT01653704|11111749|FG001|NOT COMPLETED|Overall Study||1
9989874|NCT01653743|11111757|FG000|STARTED|Overall Study||54
9989875|NCT01653743|11111758|FG001|STARTED|Overall Study||27
9989876|NCT01653743|11111757|FG000|COMPLETED|Overall Study||50
9989877|NCT01653743|11111758|FG001|COMPLETED|Overall Study||27
9989878|NCT01653743|11111757|FG000|NOT COMPLETED|Overall Study||4
9989879|NCT01653743|11111758|FG001|NOT COMPLETED|Overall Study||0
9989880|NCT01653782|11111767|FG000|STARTED|Overall Study||52
9989881|NCT01653782|11111768|FG001|STARTED|Overall Study||55
9989882|NCT01653782|11111769|FG002|STARTED|Overall Study||52
9989883|NCT01653782|11111767|FG000|COMPLETED|Overall Study||36
9989884|NCT01653782|11111768|FG001|COMPLETED|Overall Study||37
9989885|NCT01653782|11111769|FG002|COMPLETED|Overall Study||46
9989886|NCT01653782|11111767|FG000|NOT COMPLETED|Overall Study||16
9989887|NCT01653782|11111768|FG001|NOT COMPLETED|Overall Study||18
9989888|NCT01653782|11111769|FG002|NOT COMPLETED|Overall Study||6
9989889|NCT01653847|11111779|FG000|STARTED|Overall Study||20
9989890|NCT01653847|11111780|FG001|STARTED|Overall Study||20
9989891|NCT01653847|11111779|FG000|COMPLETED|Overall Study||19
9989892|NCT01653847|11111780|FG001|COMPLETED|Overall Study||20
9989893|NCT01653847|11111779|FG000|NOT COMPLETED|Overall Study||1
9989894|NCT01653847|11111780|FG001|NOT COMPLETED|Overall Study||0
9989895|NCT01653912|11111788|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
9989896|NCT01653912|11111789|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989897|NCT01653912|11111790|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989898|NCT01653912|11111791|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989899|NCT01653912|11111792|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989900|NCT01653912|11111793|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989901|NCT01653912|11111788|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
9989902|NCT01653912|11111789|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989903|NCT01653912|11111790|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989904|NCT01653912|11111791|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989905|NCT01653912|11111792|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989906|NCT01653912|11111793|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989907|NCT01653912|11111788|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989908|NCT01653912|11111789|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989909|NCT01653912|11111790|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989910|NCT01653912|11111791|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989911|NCT01653912|11111792|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989912|NCT01653912|11111793|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
9989913|NCT01653912|11111788|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989914|NCT01653912|11111789|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
9989915|NCT01653912|11111790|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989916|NCT01653912|11111791|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989917|NCT01653912|11111792|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989918|NCT01653912|11111793|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989919|NCT01653912|11111788|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989920|NCT01653912|11111789|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
9989921|NCT01653912|11111790|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989922|NCT01653912|11111791|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989923|NCT01653912|11111792|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989924|NCT01653912|11111793|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989925|NCT01653912|11111788|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989926|NCT01653912|11111789|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
10101656|NCT02410161|11230959|FG001|COMPLETED|Overall Study||10
10101657|NCT02410161|11230958|FG000|NOT COMPLETED|Overall Study||0
10101658|NCT02410161|11230959|FG001|NOT COMPLETED|Overall Study||0
10101659|NCT02410200|11230965|FG000|STARTED|Overall Study||22
10101660|NCT02410200|11230965|FG000|COMPLETED|Overall Study||20
10101661|NCT02410200|11230965|FG000|NOT COMPLETED|Overall Study||2
10101662|NCT02410213|11230969|FG000|STARTED|Overall Study||16
10101663|NCT02410213|11230970|FG001|STARTED|Overall Study||19
10101664|NCT02410213|11230969|FG000|COMPLETED|Overall Study||16
10101665|NCT02410213|11230970|FG001|COMPLETED|Overall Study||19
10101666|NCT02410213|11230969|FG000|NOT COMPLETED|Overall Study||0
10101667|NCT02410213|11230970|FG001|NOT COMPLETED|Overall Study||0
10101668|NCT02410252|11230976|FG000|STARTED|Overall Study||25
10101669|NCT02410252|11230976|FG000|COMPLETED|Overall Study||19
10101670|NCT02410252|11230976|FG000|NOT COMPLETED|Overall Study||6
10101671|NCT02410278|11230984|FG000|STARTED|Run-in Period||102
10101672|NCT02410278|11230985|FG001|STARTED|Run-in Period||0
10101673|NCT02410278|11230986|FG002|STARTED|Run-in Period||0
10101674|NCT02410278|11230984|FG000|Received at Least 1 Dose of DMF|Run-in Period||98
10101675|NCT02410278|11230985|FG001|Received at Least 1 Dose of DMF|Run-in Period||0
10101676|NCT02410278|11230986|FG002|Received at Least 1 Dose of DMF|Run-in Period||0
10101677|NCT02410278|11230984|FG000|COMPLETED|Run-in Period||64
10101678|NCT02410278|11230985|FG001|COMPLETED|Run-in Period||0
10101679|NCT02410278|11230986|FG002|COMPLETED|Run-in Period||0
10101680|NCT02410278|11230984|FG000|NOT COMPLETED|Run-in Period||38
10101681|NCT02410278|11230985|FG001|NOT COMPLETED|Run-in Period||0
10202127|NCT03441984|11329281|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202128|NCT03441984|11329282|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9989927|NCT01653912|11111790|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989928|NCT01653912|11111791|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989929|NCT01653912|11111792|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989930|NCT01653912|11111793|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
9989931|NCT01653912|11111788|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989932|NCT01653912|11111789|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10101682|NCT02410278|11230986|FG002|NOT COMPLETED|Run-in Period||0
10101683|NCT02410278|11230984|FG000|STARTED|Study Treatment Period||0
10101684|NCT02410278|11230985|FG001|STARTED|Study Treatment Period||31
10101685|NCT02410278|11230986|FG002|STARTED|Study Treatment Period||33
10101686|NCT02410278|11230984|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
9989933|NCT01653912|11111790|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
9989934|NCT01653912|11111791|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989935|NCT01653912|11111792|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989936|NCT01653912|11111793|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989937|NCT01653912|11111788|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989938|NCT01653912|11111789|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989939|NCT01653912|11111790|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
9989940|NCT01653912|11111791|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989941|NCT01653912|11111792|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989942|NCT01653912|11111793|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989943|NCT01653912|11111788|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989944|NCT01653912|11111789|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989945|NCT01653912|11111790|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
9989946|NCT01653912|11111791|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989947|NCT01653912|11111792|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989948|NCT01653912|11111793|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
9989949|NCT01653912|11111788|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989950|NCT01653912|11111789|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989951|NCT01653912|11111790|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989952|NCT01653912|11111791|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
9989953|NCT01653912|11111792|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989954|NCT01653912|11111793|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989955|NCT01653912|11111788|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989956|NCT01653912|11111789|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989957|NCT01653912|11111790|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989958|NCT01653912|11111791|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
9989959|NCT01653912|11111792|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989960|NCT01653912|11111793|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989961|NCT01653912|11111788|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989962|NCT01653912|11111789|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989963|NCT01653912|11111790|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989964|NCT01653912|11111791|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
9989965|NCT01653912|11111792|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989966|NCT01653912|11111793|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
9989967|NCT01653912|11111788|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989968|NCT01653912|11111789|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989969|NCT01653912|11111790|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989970|NCT01653912|11111791|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989971|NCT01653912|11111792|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
9989972|NCT01653912|11111793|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989973|NCT01653912|11111788|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989974|NCT01653912|11111789|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989975|NCT01653912|11111790|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989976|NCT01653912|11111791|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989977|NCT01653912|11111792|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
9989978|NCT01653912|11111793|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989979|NCT01653912|11111788|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989980|NCT01653912|11111789|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989981|NCT01653912|11111790|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989982|NCT01653912|11111791|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989983|NCT01653912|11111792|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989984|NCT01653912|11111793|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
9989985|NCT01653912|11111788|FG000|STARTED|Phase 2: GSK2110183 125 mg||0
9989986|NCT01653912|11111789|FG001|STARTED|Phase 2: GSK2110183 125 mg||0
9989987|NCT01653912|11111790|FG002|STARTED|Phase 2: GSK2110183 125 mg||0
9989988|NCT01653912|11111791|FG003|STARTED|Phase 2: GSK2110183 125 mg||0
9989989|NCT01653912|11111792|FG004|STARTED|Phase 2: GSK2110183 125 mg||0
9989990|NCT01653912|11111793|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
9989991|NCT01653912|11111788|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0
9989992|NCT01653912|11111789|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0
9989993|NCT01653912|11111790|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0
9989994|NCT01653912|11111791|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0
9989995|NCT01653912|11111792|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0
9989996|NCT01653912|11111793|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22
9989997|NCT01653912|11111788|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
9989998|NCT01653912|11111789|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
9989999|NCT01653912|11111790|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
9990000|NCT01653912|11111791|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
9990001|NCT01653912|11111792|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
9990002|NCT01653912|11111793|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
9990003|NCT01653964|11111799|FG000|STARTED|Overall Study||82
9990004|NCT01653964|11111799|FG000|COMPLETED|Overall Study||82
9990005|NCT01653964|11111799|FG000|NOT COMPLETED|Overall Study||0
9990006|NCT01654068|11111803|FG000|STARTED|Overall Study||14
9990007|NCT01654068|11111803|FG000|COMPLETED|Overall Study||14
9990008|NCT01654068|11111803|FG000|NOT COMPLETED|Overall Study||0
9990009|NCT01654107|11111809|FG000|STARTED|Overall Study||28
9990010|NCT01654107|11111810|FG001|STARTED|Overall Study||30
9990011|NCT01654107|11111809|FG000|COMPLETED|Overall Study||25
9990012|NCT01654107|11111810|FG001|COMPLETED|Overall Study||22
9990013|NCT01654107|11111809|FG000|NOT COMPLETED|Overall Study||3
9990014|NCT01654107|11111810|FG001|NOT COMPLETED|Overall Study||8
9990015|NCT01654224|11111818|FG000|STARTED|Overall Study||95
9990016|NCT01654224|11111819|FG001|STARTED|Overall Study||110
9990017|NCT01654224|11111818|FG000|COMPLETED|Overall Study||89
9990018|NCT01654224|11111819|FG001|COMPLETED|Overall Study||98
9990019|NCT01654224|11111818|FG000|NOT COMPLETED|Overall Study||6
9990020|NCT01654224|11111819|FG001|NOT COMPLETED|Overall Study||12
9990021|NCT01654250|11111827|FG000|STARTED|Overall Study||44
9990022|NCT01654250|11111828|FG001|STARTED|Overall Study||42
9990023|NCT01654250|11111827|FG000|COMPLETED|Overall Study||43
9990024|NCT01654250|11111828|FG001|COMPLETED|Overall Study||42
9990025|NCT01654250|11111827|FG000|NOT COMPLETED|Overall Study||1
9990026|NCT01654250|11111828|FG001|NOT COMPLETED|Overall Study||0
9990027|NCT01654263|11111841|FG000|STARTED|Overall Study||164
9990028|NCT01654263|11111842|FG001|STARTED|Overall Study||147
9990029|NCT01654263|11111843|FG002|STARTED|Overall Study||139
9990030|NCT01654263|11111844|FG003|STARTED|Overall Study||145
10101687|NCT02410278|11230985|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
10101688|NCT02410278|11230986|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
10101689|NCT02410278|11230984|FG000|Completed Randomized Study Treatment|Study Treatment Period||0
10101690|NCT02410278|11230985|FG001|Completed Randomized Study Treatment|Study Treatment Period||20
10101691|NCT02410278|11230986|FG002|Completed Randomized Study Treatment|Study Treatment Period||29
10101692|NCT02410278|11230984|FG000|COMPLETED|Study Treatment Period||0
10101693|NCT02410278|11230985|FG001|COMPLETED|Study Treatment Period||20
10101694|NCT02410278|11230986|FG002|COMPLETED|Study Treatment Period||29
10101695|NCT02410278|11230984|FG000|NOT COMPLETED|Study Treatment Period||0
10101696|NCT02410278|11230985|FG001|NOT COMPLETED|Study Treatment Period||11
10101697|NCT02410278|11230986|FG002|NOT COMPLETED|Study Treatment Period||4
10101698|NCT02410291|11230995|FG000|STARTED|Overall Study||29
10101699|NCT02410291|11230996|FG001|STARTED|Overall Study||29
10101700|NCT02410291|11230995|FG000|COMPLETED|Overall Study||29
10101701|NCT02410291|11230996|FG001|COMPLETED|Overall Study||29
10101702|NCT02410291|11230995|FG000|NOT COMPLETED|Overall Study||0
10101703|NCT02410291|11230996|FG001|NOT COMPLETED|Overall Study||0
10101704|NCT02410382|11231004|FG000|STARTED|Overall Study||0
10101705|NCT02410382|11231005|FG001|STARTED|Overall Study||0
10101706|NCT02410382|11231004|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
10101707|NCT02410382|11231005|FG001|COMPLETED|Overall Study||0
10101708|NCT02410382|11231004|FG000|NOT COMPLETED|Overall Study||0
10101709|NCT02410382|11231005|FG001|NOT COMPLETED|Overall Study||0
10101710|NCT02410629|11231013|FG000|STARTED|Overall Study||8
10101711|NCT02410629|11231014|FG001|STARTED|Overall Study||9
10101712|NCT02410629|11231013|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
10101713|NCT02410629|11231014|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
10101714|NCT02410629|11231013|FG000|NOT COMPLETED|Overall Study||3
10101715|NCT02410629|11231014|FG001|NOT COMPLETED|Overall Study||3
10101716|NCT02410707|11231020|FG000|STARTED|Overall Study||43
10101717|NCT02410707|11231020|FG000|COMPLETED|Overall Study||43
10101718|NCT02410707|11231020|FG000|NOT COMPLETED|Overall Study||0
10101719|NCT02410772|11231029|FG000|STARTED|Overall Study||829
10101720|NCT02410772|11231030|FG001|STARTED|Overall Study||838
10101721|NCT02410772|11231031|FG002|STARTED|Overall Study||849
10101722|NCT02410772|11231029|FG000|Microbiologically Eligible Analysis Population|Overall Study||768
10101723|NCT02410772|11231030|FG001|Microbiologically Eligible Analysis Population|Overall Study||784
10101724|NCT02410772|11231031|FG002|Microbiologically Eligible Analysis Population|Overall Study||791
10101725|NCT02410772|11231029|FG000|Assessable Population|Overall Study||726
10101726|NCT02410772|11231030|FG001|Assessable Population|Overall Study||752
10101727|NCT02410772|11231031|FG002|Assessable Population|Overall Study||756
10101728|NCT02410772|11231029|FG000|COMPLETED|Overall Study||726
10101729|NCT02410772|11231030|FG001|COMPLETED|Overall Study||752
10101730|NCT02410772|11231031|FG002|COMPLETED|Overall Study||756
10101731|NCT02410772|11231029|FG000|NOT COMPLETED|Overall Study||103
10101732|NCT02410772|11231030|FG001|NOT COMPLETED|Overall Study||86
10101733|NCT02410772|11231031|FG002|NOT COMPLETED|Overall Study||93
10101734|NCT02410798|11231039|FG000|STARTED|Overall Study||12
10101735|NCT02410798|11231039|FG000|COMPLETED|Overall Study||12
10101736|NCT02410798|11231039|FG000|NOT COMPLETED|Overall Study||0
10101737|NCT02410811|11231048|FG000|STARTED|Overall Study||5
10101738|NCT02410811|11231049|FG001|STARTED|Overall Study||10
10101739|NCT02410811|11231050|FG002|STARTED|Overall Study||11
10101740|NCT02410811|11231051|FG003|STARTED|Overall Study||7
9990031|NCT01654263|11111845|FG004|STARTED|Overall Study||140
9990032|NCT01654263|11111846|FG005|STARTED|Overall Study||149
9990033|NCT01654263|11111841|FG000|COMPLETED|Overall Study||164
9990034|NCT01654263|11111842|FG001|COMPLETED|Overall Study||147
9990035|NCT01654263|11111843|FG002|COMPLETED|Overall Study||137
9990036|NCT01654263|11111844|FG003|COMPLETED|Overall Study||144
9990037|NCT01654263|11111845|FG004|COMPLETED|Overall Study||139
9990038|NCT01654263|11111846|FG005|COMPLETED|Overall Study||148
10101741|NCT02410811|11231048|FG000|COMPLETED|Overall Study||5
9990039|NCT01654263|11111841|FG000|NOT COMPLETED|Overall Study||0
9990040|NCT01654263|11111842|FG001|NOT COMPLETED|Overall Study||0
9990041|NCT01654263|11111843|FG002|NOT COMPLETED|Overall Study||2
9990042|NCT01654263|11111844|FG003|NOT COMPLETED|Overall Study||1
9990043|NCT01654263|11111845|FG004|NOT COMPLETED|Overall Study||1
9990044|NCT01654263|11111846|FG005|NOT COMPLETED|Overall Study||1
9990045|NCT01654276|11111857|FG000|STARTED|Overall Study||24
9990046|NCT01654276|11111857|FG000|Visit 2 (2 Months)|Overall Study||19
9990047|NCT01654276|11111857|FG000|Visit 3 (4 Months)|Overall Study||18
9990048|NCT01654276|11111857|FG000|Visit 4 (6months)|Overall Study||18
9990049|NCT01654276|11111857|FG000|COMPLETED|Overall Study||18
9990050|NCT01654276|11111857|FG000|NOT COMPLETED|Overall Study||6
9990051|NCT01654289|11111864|FG000|STARTED|Overall Study||138
9990052|NCT01654289|11111865|FG001|STARTED|Overall Study||137
9990053|NCT01654289|11111866|FG002|STARTED|Overall Study||138
9990054|NCT01654289|11111864|FG000|COMPLETED|Overall Study||111
9990055|NCT01654289|11111865|FG001|COMPLETED|Overall Study||109
9990056|NCT01654289|11111866|FG002|COMPLETED|Overall Study||133
9990057|NCT01654289|11111864|FG000|NOT COMPLETED|Overall Study||27
9990058|NCT01654289|11111865|FG001|NOT COMPLETED|Overall Study||28
9990059|NCT01654289|11111866|FG002|NOT COMPLETED|Overall Study||5
9990060|NCT01654302|11111876|FG000|STARTED|First Intervention (Day 1)||20
9990061|NCT01654302|11111877|FG001|STARTED|First Intervention (Day 1)||20
9990062|NCT01654302|11111876|FG000|COMPLETED|First Intervention (Day 1)||20
9990063|NCT01654302|11111877|FG001|COMPLETED|First Intervention (Day 1)||20
9990064|NCT01654302|11111876|FG000|NOT COMPLETED|First Intervention (Day 1)||0
9990065|NCT01654302|11111877|FG001|NOT COMPLETED|First Intervention (Day 1)||0
9990066|NCT01654302|11111876|FG000|STARTED|Second Intervention (Day 7)||20
9990067|NCT01654302|11111877|FG001|STARTED|Second Intervention (Day 7)||20
9990068|NCT01654302|11111876|FG000|COMPLETED|Second Intervention (Day 7)||19
9990069|NCT01654302|11111877|FG001|COMPLETED|Second Intervention (Day 7)||19
9990070|NCT01654302|11111876|FG000|NOT COMPLETED|Second Intervention (Day 7)||1
9990071|NCT01654302|11111877|FG001|NOT COMPLETED|Second Intervention (Day 7)||1
10101742|NCT02410811|11231049|FG001|COMPLETED|Overall Study||10
10101743|NCT02410811|11231050|FG002|COMPLETED|Overall Study||10
10101744|NCT02410811|11231051|FG003|COMPLETED|Overall Study||7
10101745|NCT02410811|11231048|FG000|NOT COMPLETED|Overall Study||0
10101746|NCT02410811|11231049|FG001|NOT COMPLETED|Overall Study||0
10101747|NCT02410811|11231050|FG002|NOT COMPLETED|Overall Study||1
10101748|NCT02410811|11231051|FG003|NOT COMPLETED|Overall Study||0
10101749|NCT02410824|11231061|FG000|STARTED|First Intervention (One Week)||22
10101750|NCT02410824|11231062|FG001|STARTED|First Intervention (One Week)||23
10101751|NCT02410824|11231061|FG000|COMPLETED|First Intervention (One Week)||22
10101752|NCT02410824|11231062|FG001|COMPLETED|First Intervention (One Week)||22
10101753|NCT02410824|11231061|FG000|NOT COMPLETED|First Intervention (One Week)||0
10101754|NCT02410824|11231062|FG001|NOT COMPLETED|First Intervention (One Week)||1
10101755|NCT02410824|11231061|FG000|STARTED|Second Intervention (One Week)||22
10202129|NCT03441984|11329283|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202130|NCT03441984|11329284|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202131|NCT03441984|11329285|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202132|NCT03441984|11329286|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202133|NCT03441984|11329287|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202134|NCT03441984|11329276|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202135|NCT03441984|11329277|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202136|NCT03441984|11329278|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202137|NCT03441984|11329279|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202138|NCT03441984|11329280|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202139|NCT03441984|11329281|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202140|NCT03441984|11329282|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202141|NCT03441984|11329283|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202142|NCT03441984|11329284|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202143|NCT03441984|11329285|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9990072|NCT01654380|11111885|FG000|STARTED|Part A, Period 1||4
10101756|NCT02410824|11231062|FG001|STARTED|Second Intervention (One Week)||22
10101757|NCT02410824|11231061|FG000|COMPLETED|Second Intervention (One Week)||22
10101758|NCT02410824|11231062|FG001|COMPLETED|Second Intervention (One Week)||22
10101759|NCT02410824|11231061|FG000|NOT COMPLETED|Second Intervention (One Week)||0
10101760|NCT02410824|11231062|FG001|NOT COMPLETED|Second Intervention (One Week)||0
10101761|NCT02410837|11231069|FG000|STARTED|Overall Study||1388
10101762|NCT02410837|11231069|FG000|Procedure|Overall Study||1388
10101763|NCT02410837|11231069|FG000|1-Month|Overall Study||1374
10101764|NCT02410837|11231069|FG000|12-Month|Overall Study||1121
10101765|NCT02410837|11231069|FG000|24-Month|Overall Study||900
10101766|NCT02410837|11231069|FG000|COMPLETED|Overall Study||900
10101767|NCT02410837|11231069|FG000|NOT COMPLETED|Overall Study||488
9990073|NCT01654380|11111886|FG001|STARTED|Part A, Period 1||4
9990074|NCT01654380|11111887|FG002|STARTED|Part A, Period 1||0
9990075|NCT01654380|11111888|FG003|STARTED|Part A, Period 1||0
9990076|NCT01654380|11111885|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
9990077|NCT01654380|11111886|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
9990078|NCT01654380|11111887|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
10101768|NCT02410967|11231075|FG000|STARTED|Treatment Phase (4 Weeks)||27
10101769|NCT02410967|11231076|FG001|STARTED|Treatment Phase (4 Weeks)||26
9990079|NCT01654380|11111888|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
9990080|NCT01654380|11111885|FG000|COMPLETED|Part A, Period 1||4
9990081|NCT01654380|11111886|FG001|COMPLETED|Part A, Period 1||4
9990082|NCT01654380|11111887|FG002|COMPLETED|Part A, Period 1||0
9990083|NCT01654380|11111888|FG003|COMPLETED|Part A, Period 1||0
9990084|NCT01654380|11111885|FG000|NOT COMPLETED|Part A, Period 1||0
9990085|NCT01654380|11111886|FG001|NOT COMPLETED|Part A, Period 1||0
9990086|NCT01654380|11111887|FG002|NOT COMPLETED|Part A, Period 1||0
9990087|NCT01654380|11111888|FG003|NOT COMPLETED|Part A, Period 1||0
9990088|NCT01654380|11111885|FG000|STARTED|Part A, Washout of at Least 6 Days||4
9990089|NCT01654380|11111886|FG001|STARTED|Part A, Washout of at Least 6 Days||4
9990090|NCT01654380|11111887|FG002|STARTED|Part A, Washout of at Least 6 Days||0
9990091|NCT01654380|11111888|FG003|STARTED|Part A, Washout of at Least 6 Days||0
9990092|NCT01654380|11111885|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
9990093|NCT01654380|11111886|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
9990094|NCT01654380|11111887|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
9990095|NCT01654380|11111888|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
9990096|NCT01654380|11111885|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990097|NCT01654380|11111886|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990098|NCT01654380|11111887|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990099|NCT01654380|11111888|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990100|NCT01654380|11111885|FG000|STARTED|Part A, Period 2||4
9990101|NCT01654380|11111886|FG001|STARTED|Part A, Period 2||4
9990102|NCT01654380|11111887|FG002|STARTED|Part A, Period 2||0
9990103|NCT01654380|11111888|FG003|STARTED|Part A, Period 2||0
9990104|NCT01654380|11111885|FG000|COMPLETED|Part A, Period 2||4
9990105|NCT01654380|11111886|FG001|COMPLETED|Part A, Period 2||4
9990106|NCT01654380|11111887|FG002|COMPLETED|Part A, Period 2||0
9990107|NCT01654380|11111888|FG003|COMPLETED|Part A, Period 2||0
9990108|NCT01654380|11111885|FG000|NOT COMPLETED|Part A, Period 2||0
9990109|NCT01654380|11111886|FG001|NOT COMPLETED|Part A, Period 2||0
9990110|NCT01654380|11111887|FG002|NOT COMPLETED|Part A, Period 2||0
9990111|NCT01654380|11111888|FG003|NOT COMPLETED|Part A, Period 2||0
9990112|NCT01654380|11111885|FG000|STARTED|Part A, Washout of at Least 6 Days||4
9990113|NCT01654380|11111886|FG001|STARTED|Part A, Washout of at Least 6 Days||4
9990114|NCT01654380|11111887|FG002|STARTED|Part A, Washout of at Least 6 Days||0
9990115|NCT01654380|11111888|FG003|STARTED|Part A, Washout of at Least 6 Days||0
9990116|NCT01654380|11111885|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
9990117|NCT01654380|11111886|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
9990118|NCT01654380|11111887|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
9990119|NCT01654380|11111888|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
9990120|NCT01654380|11111885|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990121|NCT01654380|11111886|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990122|NCT01654380|11111887|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990123|NCT01654380|11111888|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990124|NCT01654380|11111885|FG000|STARTED|Part A, Period 3||4
9990125|NCT01654380|11111886|FG001|STARTED|Part A, Period 3||4
9990126|NCT01654380|11111887|FG002|STARTED|Part A, Period 3||0
9990127|NCT01654380|11111888|FG003|STARTED|Part A, Period 3||0
9990128|NCT01654380|11111885|FG000|COMPLETED|Part A, Period 3||4
9990129|NCT01654380|11111886|FG001|COMPLETED|Part A, Period 3||4
9990130|NCT01654380|11111887|FG002|COMPLETED|Part A, Period 3||0
9990131|NCT01654380|11111888|FG003|COMPLETED|Part A, Period 3||0
9990132|NCT01654380|11111885|FG000|NOT COMPLETED|Part A, Period 3||0
9990133|NCT01654380|11111886|FG001|NOT COMPLETED|Part A, Period 3||0
9990134|NCT01654380|11111887|FG002|NOT COMPLETED|Part A, Period 3||0
9990135|NCT01654380|11111888|FG003|NOT COMPLETED|Part A, Period 3||0
9990136|NCT01654380|11111885|FG000|STARTED|Part A, Washout of at Least 6 Days||4
9990137|NCT01654380|11111886|FG001|STARTED|Part A, Washout of at Least 6 Days||4
9990138|NCT01654380|11111887|FG002|STARTED|Part A, Washout of at Least 6 Days||0
9990139|NCT01654380|11111888|FG003|STARTED|Part A, Washout of at Least 6 Days||0
9990140|NCT01654380|11111885|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
10101770|NCT02410967|11231075|FG000|COMPLETED|Treatment Phase (4 Weeks)||26
10101771|NCT02410967|11231076|FG001|COMPLETED|Treatment Phase (4 Weeks)||22
10101772|NCT02410967|11231075|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1
10101773|NCT02410967|11231076|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4
10101774|NCT02410967|11231075|FG000|STARTED|Follow-up Phase (8 Weeks)||26
10101775|NCT02410967|11231076|FG001|STARTED|Follow-up Phase (8 Weeks)||22
10202144|NCT03441984|11329286|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10202145|NCT03441984|11329287|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9990141|NCT01654380|11111886|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
9990142|NCT01654380|11111887|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
9990143|NCT01654380|11111888|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
9990144|NCT01654380|11111885|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990145|NCT01654380|11111886|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990146|NCT01654380|11111887|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10202146|NCT03441984|11329276|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9990147|NCT01654380|11111888|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
9990148|NCT01654380|11111885|FG000|STARTED|Part A, Period 4||4
9990149|NCT01654380|11111886|FG001|STARTED|Part A, Period 4||4
9990150|NCT01654380|11111887|FG002|STARTED|Part A, Period 4||0
9990151|NCT01654380|11111888|FG003|STARTED|Part A, Period 4||0
9990152|NCT01654380|11111885|FG000|COMPLETED|Part A, Period 4||4
9990153|NCT01654380|11111886|FG001|COMPLETED|Part A, Period 4||4
9990154|NCT01654380|11111887|FG002|COMPLETED|Part A, Period 4||0
9990155|NCT01654380|11111888|FG003|COMPLETED|Part A, Period 4||0
9990156|NCT01654380|11111885|FG000|NOT COMPLETED|Part A, Period 4||0
9990157|NCT01654380|11111886|FG001|NOT COMPLETED|Part A, Period 4||0
9990158|NCT01654380|11111887|FG002|NOT COMPLETED|Part A, Period 4||0
9990159|NCT01654380|11111888|FG003|NOT COMPLETED|Part A, Period 4||0
9990160|NCT01654380|11111885|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
9990161|NCT01654380|11111886|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
9990162|NCT01654380|11111887|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
9990163|NCT01654380|11111888|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
9990164|NCT01654380|11111885|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
9990165|NCT01654380|11111886|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
9990166|NCT01654380|11111887|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
9990167|NCT01654380|11111888|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
9990168|NCT01654380|11111885|FG000|COMPLETED|Part B, Period 1||0
9990169|NCT01654380|11111886|FG001|COMPLETED|Part B, Period 1||0
9990170|NCT01654380|11111887|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
9990171|NCT01654380|11111888|FG003|COMPLETED|Part B, Period 1||7
9990172|NCT01654380|11111885|FG000|NOT COMPLETED|Part B, Period 1||0
9990173|NCT01654380|11111886|FG001|NOT COMPLETED|Part B, Period 1||0
9990174|NCT01654380|11111887|FG002|NOT COMPLETED|Part B, Period 1||1
9990175|NCT01654380|11111888|FG003|NOT COMPLETED|Part B, Period 1||0
9990176|NCT01654380|11111885|FG000|STARTED|Part B, Washout of at Least 6 Days||0
9990177|NCT01654380|11111886|FG001|STARTED|Part B, Washout of at Least 6 Days||0
9990178|NCT01654380|11111887|FG002|STARTED|Part B, Washout of at Least 6 Days||6
9990179|NCT01654380|11111888|FG003|STARTED|Part B, Washout of at Least 6 Days||7
9990180|NCT01654380|11111885|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
9990181|NCT01654380|11111886|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
9990182|NCT01654380|11111887|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
9990183|NCT01654380|11111888|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
9990184|NCT01654380|11111885|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990185|NCT01654380|11111886|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990186|NCT01654380|11111887|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990187|NCT01654380|11111888|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990188|NCT01654380|11111885|FG000|STARTED|Part B, Period 2||0
9990189|NCT01654380|11111886|FG001|STARTED|Part B, Period 2||0
9990190|NCT01654380|11111887|FG002|STARTED|Part B, Period 2||6
9990191|NCT01654380|11111888|FG003|STARTED|Part B, Period 2||7
9990192|NCT01654380|11111885|FG000|COMPLETED|Part B, Period 2||0
9990193|NCT01654380|11111886|FG001|COMPLETED|Part B, Period 2||0
9990194|NCT01654380|11111887|FG002|COMPLETED|Part B, Period 2||6
10101776|NCT02410967|11231075|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22
10101777|NCT02410967|11231076|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16
10101778|NCT02410967|11231075|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
10101779|NCT02410967|11231076|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
10202147|NCT03441984|11329277|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202148|NCT03441984|11329278|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202149|NCT03441984|11329279|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202150|NCT03441984|11329280|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202151|NCT03441984|11329281|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9758736|NCT01164202|10862320|FG001|STARTED|Overall Study||39
9758737|NCT01164202|10862319|FG000|COMPLETED|Overall Study||38
9758738|NCT01164202|10862320|FG001|COMPLETED|Overall Study||39
9758739|NCT01164202|10862319|FG000|NOT COMPLETED|Overall Study||1
9758740|NCT01164202|10862320|FG001|NOT COMPLETED|Overall Study||0
9829191|NCT00758680|10939740|FG000|NOT COMPLETED|Overall Study||0
9829192|NCT00758680|10939741|FG001|NOT COMPLETED|Overall Study||0
9990195|NCT01654380|11111888|FG003|COMPLETED|Part B, Period 2||7
10101780|NCT02411084|11231084|FG000|STARTED|Overall Study||18
10101781|NCT02411084|11231085|FG001|STARTED|Overall Study||18
10101782|NCT02411084|11231084|FG000|COMPLETED|Overall Study||5
10101783|NCT02411084|11231085|FG001|COMPLETED|Overall Study||5
10101784|NCT02411084|11231084|FG000|NOT COMPLETED|Overall Study||13
10101785|NCT02411084|11231085|FG001|NOT COMPLETED|Overall Study||13
10101786|NCT02411110|11231093|FG000|STARTED|Treatment Period 1||65
10101787|NCT02411110|11231094|FG001|STARTED|Treatment Period 1||66
10101788|NCT02411110|11231093|FG000|COMPLETED|Treatment Period 1||56
10101789|NCT02411110|11231094|FG001|COMPLETED|Treatment Period 1||59
10101790|NCT02411110|11231093|FG000|NOT COMPLETED|Treatment Period 1||9
10101791|NCT02411110|11231094|FG001|NOT COMPLETED|Treatment Period 1||7
10101792|NCT02411110|11231093|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50
10101793|NCT02411110|11231094|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48
10101794|NCT02411110|11231093|FG000|COMPLETED|Treatment Period 2||49
10202152|NCT03441984|11329282|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202153|NCT03441984|11329283|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202154|NCT03441984|11329284|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202155|NCT03441984|11329285|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202156|NCT03441984|11329286|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202157|NCT03441984|11329287|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10202158|NCT03441984|11329276|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0
10202159|NCT03441984|11329277|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0
10202160|NCT03441984|11329278|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0
9990196|NCT01654380|11111885|FG000|NOT COMPLETED|Part B, Period 2||0
9990197|NCT01654380|11111886|FG001|NOT COMPLETED|Part B, Period 2||0
9990198|NCT01654380|11111887|FG002|NOT COMPLETED|Part B, Period 2||0
9990199|NCT01654380|11111888|FG003|NOT COMPLETED|Part B, Period 2||0
9990200|NCT01654380|11111885|FG000|STARTED|Part B, Washout of at Least 6 Days||0
9990201|NCT01654380|11111886|FG001|STARTED|Part B, Washout of at Least 6 Days||0
9990202|NCT01654380|11111887|FG002|STARTED|Part B, Washout of at Least 6 Days||6
9990203|NCT01654380|11111888|FG003|STARTED|Part B, Washout of at Least 6 Days||7
9990204|NCT01654380|11111885|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
9990205|NCT01654380|11111886|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
9990206|NCT01654380|11111887|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
9990207|NCT01654380|11111888|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
9990208|NCT01654380|11111885|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990209|NCT01654380|11111886|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990210|NCT01654380|11111887|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990211|NCT01654380|11111888|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990212|NCT01654380|11111885|FG000|STARTED|Part B, Period 3||0
9990213|NCT01654380|11111886|FG001|STARTED|Part B, Period 3||0
9990214|NCT01654380|11111887|FG002|STARTED|Part B, Period 3||6
9990215|NCT01654380|11111888|FG003|STARTED|Part B, Period 3||7
9990216|NCT01654380|11111885|FG000|COMPLETED|Part B, Period 3||0
9990217|NCT01654380|11111886|FG001|COMPLETED|Part B, Period 3||0
9990218|NCT01654380|11111887|FG002|COMPLETED|Part B, Period 3||6
9990219|NCT01654380|11111888|FG003|COMPLETED|Part B, Period 3||7
9990220|NCT01654380|11111885|FG000|NOT COMPLETED|Part B, Period 3||0
9990221|NCT01654380|11111886|FG001|NOT COMPLETED|Part B, Period 3||0
9990222|NCT01654380|11111887|FG002|NOT COMPLETED|Part B, Period 3||0
9990223|NCT01654380|11111888|FG003|NOT COMPLETED|Part B, Period 3||0
9990224|NCT01654380|11111885|FG000|STARTED|Part B, Washout of at Least 6 Days||0
10101795|NCT02411110|11231094|FG001|COMPLETED|Treatment Period 2||44
10101796|NCT02411110|11231093|FG000|NOT COMPLETED|Treatment Period 2||1
10101797|NCT02411110|11231094|FG001|NOT COMPLETED|Treatment Period 2||4
10101798|NCT02411201|11231102|FG000|STARTED|Overall Study||51
10101799|NCT02411201|11231102|FG000|COMPLETED|Overall Study||45
10101800|NCT02411201|11231102|FG000|NOT COMPLETED|Overall Study||6
10101801|NCT02411292|11231108|FG000|STARTED|Overall Study||110
10101802|NCT02411292|11231108|FG000|COMPLETED|Overall Study||89
10101803|NCT02411292|11231108|FG000|NOT COMPLETED|Overall Study||21
10101804|NCT02411396|11231114|FG000|STARTED|Overall Study||483
10101805|NCT02411396|11231114|FG000|COMPLETED|Overall Study||442
10101806|NCT02411396|11231114|FG000|NOT COMPLETED|Overall Study||41
10101807|NCT02411461|11231126|FG000|STARTED|Overall Study||16
10101808|NCT02411461|11231127|FG001|STARTED|Overall Study||8
10101809|NCT02411461|11231128|FG002|STARTED|Overall Study||15
10101810|NCT02411461|11231126|FG000|COMPLETED|Overall Study||16
10101811|NCT02411461|11231127|FG001|COMPLETED|Overall Study||8
10101812|NCT02411461|11231128|FG002|COMPLETED|Overall Study||15
10101813|NCT02411461|11231126|FG000|NOT COMPLETED|Overall Study||0
10101814|NCT02411461|11231127|FG001|NOT COMPLETED|Overall Study||0
10101815|NCT02411461|11231128|FG002|NOT COMPLETED|Overall Study||0
10101816|NCT02411539|11231138|FG000|STARTED|Overall Study||20
10101817|NCT02411539|11231139|FG001|STARTED|Overall Study||20
10101818|NCT02411539|11231138|FG000|COMPLETED|Overall Study||18
10101819|NCT02411539|11231139|FG001|COMPLETED|Overall Study||19
10101820|NCT02411539|11231138|FG000|NOT COMPLETED|Overall Study||2
10101821|NCT02411539|11231139|FG001|NOT COMPLETED|Overall Study||1
10101822|NCT02411565|11231150|FG000|STARTED|Overall Study||1
10101823|NCT02411565|11231151|FG001|STARTED|Overall Study||2
10101824|NCT02411565|11231150|FG000|COMPLETED|Overall Study||1
10101825|NCT02411565|11231151|FG001|COMPLETED|Overall Study||2
10101826|NCT02411565|11231150|FG000|NOT COMPLETED|Overall Study||0
10101827|NCT02411565|11231151|FG001|NOT COMPLETED|Overall Study||0
10101828|NCT02411578|11231159|FG000|STARTED|Crossover Trial Phase||8
10101829|NCT02411578|11231160|FG001|STARTED|Crossover Trial Phase||12
10101830|NCT02411578|11231159|FG000|COMPLETED|Crossover Trial Phase||8
10101831|NCT02411578|11231160|FG001|COMPLETED|Crossover Trial Phase||11
9990225|NCT01654380|11111886|FG001|STARTED|Part B, Washout of at Least 6 Days||0
9990226|NCT01654380|11111887|FG002|STARTED|Part B, Washout of at Least 6 Days||6
9990227|NCT01654380|11111888|FG003|STARTED|Part B, Washout of at Least 6 Days||7
9990228|NCT01654380|11111885|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
9990229|NCT01654380|11111886|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
9990230|NCT01654380|11111887|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
10101832|NCT02411578|11231159|FG000|NOT COMPLETED|Crossover Trial Phase||0
10101833|NCT02411578|11231160|FG001|NOT COMPLETED|Crossover Trial Phase||1
10101834|NCT02411578|11231159|FG000|STARTED|Extension Phase||8
10202161|NCT03441984|11329279|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0
10202162|NCT03441984|11329280|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0
10202163|NCT03441984|11329281|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0
9990231|NCT01654380|11111888|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
9990232|NCT01654380|11111885|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990233|NCT01654380|11111886|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990234|NCT01654380|11111887|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990235|NCT01654380|11111888|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
9990236|NCT01654380|11111885|FG000|STARTED|Part B, Period 4||0
9990237|NCT01654380|11111886|FG001|STARTED|Part B, Period 4||0
9990238|NCT01654380|11111887|FG002|STARTED|Part B, Period 4||6
9990239|NCT01654380|11111888|FG003|STARTED|Part B, Period 4||7
9990240|NCT01654380|11111885|FG000|COMPLETED|Part B, Period 4||0
9990241|NCT01654380|11111886|FG001|COMPLETED|Part B, Period 4||0
9990242|NCT01654380|11111887|FG002|COMPLETED|Part B, Period 4||6
9990243|NCT01654380|11111888|FG003|COMPLETED|Part B, Period 4||7
9990244|NCT01654380|11111885|FG000|NOT COMPLETED|Part B, Period 4||0
9990245|NCT01654380|11111886|FG001|NOT COMPLETED|Part B, Period 4||0
9990246|NCT01654380|11111887|FG002|NOT COMPLETED|Part B, Period 4||0
9990247|NCT01654380|11111888|FG003|NOT COMPLETED|Part B, Period 4||0
9990248|NCT01654445|11111907|FG000|STARTED|Overall Study||25
9990249|NCT01654445|11111908|FG001|STARTED|Overall Study||25
9990250|NCT01654445|11111907|FG000|COMPLETED|Overall Study||25
9990251|NCT01654445|11111908|FG001|COMPLETED|Overall Study||25
9990252|NCT01654445|11111907|FG000|NOT COMPLETED|Overall Study||0
9990253|NCT01654445|11111908|FG001|NOT COMPLETED|Overall Study||0
9990254|NCT01654523|11111914|FG000|STARTED|Overall Study||20
9990255|NCT01654523|11111914|FG000|COMPLETED|Overall Study||19
9990256|NCT01654523|11111914|FG000|NOT COMPLETED|Overall Study||1
9990257|NCT01654536|11111920|FG000|STARTED|Overall Study||368
9990258|NCT01654536|11111921|FG001|STARTED|Overall Study||369
9990259|NCT01654536|11111920|FG000|COMPLETED|Overall Study||324
9990260|NCT01654536|11111921|FG001|COMPLETED|Overall Study||331
9990261|NCT01654536|11111920|FG000|NOT COMPLETED|Overall Study||44
9990262|NCT01654536|11111921|FG001|NOT COMPLETED|Overall Study||38
9990263|NCT01654549|11111930|FG000|STARTED|Overall Study||20
9990264|NCT01654549|11111931|FG001|STARTED|Overall Study||20
9990265|NCT01654549|11111930|FG000|COMPLETED|Overall Study||20
9990266|NCT01654549|11111931|FG001|COMPLETED|Overall Study||19
9990267|NCT01654549|11111930|FG000|NOT COMPLETED|Overall Study||0
9990268|NCT01654549|11111931|FG001|NOT COMPLETED|Overall Study||1
9990269|NCT01654601|11111943|FG000|STARTED|1st Administration||14
9990270|NCT01654601|11111944|FG001|STARTED|1st Administration||14
9990271|NCT01654601|11111943|FG000|COMPLETED|1st Administration||12
9990272|NCT01654601|11111944|FG001|COMPLETED|1st Administration||12
9990273|NCT01654601|11111943|FG000|NOT COMPLETED|1st Administration||2
9990274|NCT01654601|11111944|FG001|NOT COMPLETED|1st Administration||2
9990275|NCT01654601|11111943|FG000|STARTED|2nd Administration||12
9990276|NCT01654601|11111944|FG001|STARTED|2nd Administration||12
9990277|NCT01654601|11111943|FG000|COMPLETED|2nd Administration||11
9990278|NCT01654601|11111944|FG001|COMPLETED|2nd Administration||11
9990279|NCT01654601|11111943|FG000|NOT COMPLETED|2nd Administration||1
9990280|NCT01654601|11111944|FG001|NOT COMPLETED|2nd Administration||1
9990281|NCT01654666|11111953|FG000|STARTED|Overall Study||63
9990282|NCT01654666|11111954|FG001|STARTED|Overall Study||63
9990283|NCT01654666|11111955|FG002|STARTED|Overall Study||63
9990284|NCT01654666|11111953|FG000|Primary Analysis|Overall Study||52
9990285|NCT01654666|11111954|FG001|Primary Analysis|Overall Study||56
9990286|NCT01654666|11111955|FG002|Primary Analysis|Overall Study||54
9990287|NCT01654666|11111953|FG000|COMPLETED|Overall Study||48
9990288|NCT01654666|11111954|FG001|COMPLETED|Overall Study||50
9990289|NCT01654666|11111955|FG002|COMPLETED|Overall Study||49
9990290|NCT01654666|11111953|FG000|NOT COMPLETED|Overall Study||15
9990291|NCT01654666|11111954|FG001|NOT COMPLETED|Overall Study||13
9990292|NCT01654666|11111955|FG002|NOT COMPLETED|Overall Study||14
9990293|NCT01654796|11111966|FG000|STARTED|Overall Study||26
9990294|NCT01654796|11111967|FG001|STARTED|Overall Study||29
9990295|NCT01654796|11111968|FG002|STARTED|Overall Study||29
10101835|NCT02411578|11231160|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
10101836|NCT02411578|11231159|FG000|COMPLETED|Extension Phase||8
10101837|NCT02411578|11231160|FG001|COMPLETED|Extension Phase||9
10101838|NCT02411578|11231159|FG000|NOT COMPLETED|Extension Phase||0
10101839|NCT02411578|11231160|FG001|NOT COMPLETED|Extension Phase||0
9990296|NCT01654796|11111966|FG000|COMPLETED|Overall Study||25
9990297|NCT01654796|11111967|FG001|COMPLETED|Overall Study||26
9990298|NCT01654796|11111968|FG002|COMPLETED|Overall Study||28
9990299|NCT01654796|11111966|FG000|NOT COMPLETED|Overall Study||1
9990300|NCT01654796|11111967|FG001|NOT COMPLETED|Overall Study||3
9990301|NCT01654796|11111968|FG002|NOT COMPLETED|Overall Study||1
10101840|NCT02411591|11231171|FG000|STARTED|Overall Study||3
9990302|NCT01654861|11111977|FG000|STARTED|Overall Study||3
9990303|NCT01654861|11111977|FG000|COMPLETED|Overall Study||3
9990304|NCT01654861|11111977|FG000|NOT COMPLETED|Overall Study||0
9990305|NCT01654887|11111983|FG000|STARTED|Overall Study||103
9990306|NCT01654887|11111984|FG001|STARTED|Overall Study||88
9990307|NCT01654887|11111983|FG000|COMPLETED|Overall Study||103
9990308|NCT01654887|11111984|FG001|COMPLETED|Overall Study||88
9990309|NCT01654887|11111983|FG000|NOT COMPLETED|Overall Study||0
9990310|NCT01654887|11111984|FG001|NOT COMPLETED|Overall Study||0
9990311|NCT01655043|11111991|FG000|STARTED|Overall Study||20
9990312|NCT01655043|11111991|FG000|COMPLETED|Overall Study||20
9990313|NCT01655043|11111991|FG000|NOT COMPLETED|Overall Study||0
9990314|NCT01655069|11111999|FG000|STARTED|Overall Study||61
9990315|NCT01655069|11112000|FG001|STARTED|Overall Study||58
9990316|NCT01655069|11112001|FG002|STARTED|Overall Study||14
9990317|NCT01655069|11112002|FG003|STARTED|Overall Study||15
9990318|NCT01655069|11111999|FG000|Safety Analysis Set (SAF)|Overall Study||61
9990319|NCT01655069|11112000|FG001|Safety Analysis Set (SAF)|Overall Study||57
9990320|NCT01655069|11112001|FG002|Safety Analysis Set (SAF)|Overall Study||14
9990321|NCT01655069|11112002|FG003|Safety Analysis Set (SAF)|Overall Study||15
9990322|NCT01655069|11111999|FG000|Full Analysis Set (FAS)|Overall Study||60
9990323|NCT01655069|11112000|FG001|Full Analysis Set (FAS)|Overall Study||57
9990324|NCT01655069|11112001|FG002|Full Analysis Set (FAS)|Overall Study||14
9990325|NCT01655069|11112002|FG003|Full Analysis Set (FAS)|Overall Study||15
9990326|NCT01655069|11111999|FG000|COMPLETED|Overall Study||53
9990327|NCT01655069|11112000|FG001|COMPLETED|Overall Study||46
10101841|NCT02411591|11231172|FG001|STARTED|Overall Study||57
10101842|NCT02411591|11231173|FG002|STARTED|Overall Study||6
10101843|NCT02411591|11231171|FG000|Part A|Overall Study||3
10101844|NCT02411591|11231172|FG001|Part A|Overall Study||6
10101845|NCT02411591|11231173|FG002|Part A|Overall Study||6
10101846|NCT02411591|11231171|FG000|Expansion Cohort Part B|Overall Study||0
10101847|NCT02411591|11231172|FG001|Expansion Cohort Part B|Overall Study||51
10101848|NCT02411591|11231173|FG002|Expansion Cohort Part B|Overall Study||0
10101849|NCT02411591|11231171|FG000|Progressive Disease|Overall Study||3
10101850|NCT02411591|11231172|FG001|Progressive Disease|Overall Study||42
10101851|NCT02411591|11231173|FG002|Progressive Disease|Overall Study||3
10101852|NCT02411591|11231171|FG000|Death|Overall Study||0
10101853|NCT02411591|11231172|FG001|Death|Overall Study||2
10101854|NCT02411591|11231173|FG002|Death|Overall Study||0
10101855|NCT02411591|11231171|FG000|COMPLETED|Overall Study||3
10101856|NCT02411591|11231172|FG001|COMPLETED|Overall Study||47
10101857|NCT02411591|11231173|FG002|COMPLETED|Overall Study||3
10101858|NCT02411591|11231171|FG000|NOT COMPLETED|Overall Study||0
10101859|NCT02411591|11231172|FG001|NOT COMPLETED|Overall Study||10
10101860|NCT02411591|11231173|FG002|NOT COMPLETED|Overall Study||3
10101861|NCT02411747|11231191|FG000|STARTED|Overall Study||16
10101862|NCT02411747|11231192|FG001|STARTED|Overall Study||16
10101863|NCT02411747|11231191|FG000|Simulation Training Completed|Overall Study||16
10101864|NCT02411747|11231192|FG001|Simulation Training Completed|Overall Study||16
10101865|NCT02411747|11231191|FG000|COMPLETED|Overall Study||13
10101866|NCT02411747|11231192|FG001|COMPLETED|Overall Study||12
10101867|NCT02411747|11231191|FG000|NOT COMPLETED|Overall Study||3
10101868|NCT02411747|11231192|FG001|NOT COMPLETED|Overall Study||4
10101869|NCT02411916|11231200|FG000|STARTED|Overall Study||73
10101870|NCT02411916|11231201|FG001|STARTED|Overall Study||70
10101871|NCT02411916|11231200|FG000|COMPLETED|Overall Study||73
10101872|NCT02411916|11231201|FG001|COMPLETED|Overall Study||70
10101873|NCT02411916|11231200|FG000|NOT COMPLETED|Overall Study||0
10101874|NCT02411916|11231201|FG001|NOT COMPLETED|Overall Study||0
10101875|NCT02411929|11231207|FG000|STARTED|Period 1||8
10101876|NCT02411929|11231207|FG000|COMPLETED|Period 1||8
10101877|NCT02411929|11231207|FG000|NOT COMPLETED|Period 1||0
10101878|NCT02411929|11231207|FG000|STARTED|Washout Period||8
10101879|NCT02411929|11231207|FG000|COMPLETED|Washout Period||8
10101880|NCT02411929|11231207|FG000|NOT COMPLETED|Washout Period||0
10101881|NCT02411929|11231207|FG000|STARTED|Period 2||8
10101882|NCT02411929|11231207|FG000|COMPLETED|Period 2||8
10101883|NCT02411929|11231207|FG000|NOT COMPLETED|Period 2||0
10101884|NCT02412098|11231219|FG000|STARTED|Overall Study||14
10101885|NCT02412098|11231220|FG001|STARTED|Overall Study||14
10101886|NCT02412098|11231221|FG002|STARTED|Overall Study||21
10101887|NCT02412098|11231219|FG000|COMPLETED|Overall Study||14
10101888|NCT02412098|11231220|FG001|COMPLETED|Overall Study||14
10101889|NCT02412098|11231221|FG002|COMPLETED|Overall Study||21
10101890|NCT02412098|11231219|FG000|NOT COMPLETED|Overall Study||0
10101891|NCT02412098|11231220|FG001|NOT COMPLETED|Overall Study||0
10101892|NCT02412098|11231221|FG002|NOT COMPLETED|Overall Study||0
10101893|NCT02412111|11231235|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
10101894|NCT02412111|11231236|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
10101895|NCT02412111|11231237|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
10101896|NCT02412111|11231235|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
10101897|NCT02412111|11231236|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10101898|NCT02412111|11231237|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10101899|NCT02412111|11231235|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
10101900|NCT02412111|11231236|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10101901|NCT02412111|11231237|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10101902|NCT02412111|11231235|FG000|STARTED|Active Comparator Period (8 Weeks)||0
10101903|NCT02412111|11231236|FG001|STARTED|Active Comparator Period (8 Weeks)||76
10101904|NCT02412111|11231237|FG002|STARTED|Active Comparator Period (8 Weeks)||75
10101905|NCT02412111|11231235|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0
10101906|NCT02412111|11231236|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76
10101907|NCT02412111|11231237|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74
10101908|NCT02412111|11231235|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0
10101909|NCT02412111|11231236|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75
9990328|NCT01655069|11112001|FG002|COMPLETED|Overall Study||12
9990329|NCT01655069|11112002|FG003|COMPLETED|Overall Study||11
9990330|NCT01655069|11111999|FG000|NOT COMPLETED|Overall Study||8
9990331|NCT01655069|11112000|FG001|NOT COMPLETED|Overall Study||12
10101910|NCT02412111|11231237|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69
9990332|NCT01655069|11112001|FG002|NOT COMPLETED|Overall Study||2
9990333|NCT01655069|11112002|FG003|NOT COMPLETED|Overall Study||4
9990334|NCT01655329|11112010|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
9990335|NCT01655329|11112010|FG000|COMPLETED|Overall Study||10
9990336|NCT01655329|11112010|FG000|NOT COMPLETED|Overall Study||0
9990337|NCT01655381|11112024|FG000|STARTED|Overall Study||15
9990338|NCT01655381|11112024|FG000|COMPLETED|Overall Study||12
9990339|NCT01655381|11112024|FG000|NOT COMPLETED|Overall Study||3
9990340|NCT01655498|11112029|FG000|STARTED|Overall Study||61
9990341|NCT01655498|11112029|FG000|COMPLETED|Overall Study||56
9990342|NCT01655498|11112029|FG000|NOT COMPLETED|Overall Study||5
9990343|NCT01655563|11112038|FG000|STARTED|Overall Study||18
9990344|NCT01655563|11112039|FG001|STARTED|Overall Study||35
9990345|NCT01655563|11112038|FG000|COMPLETED|Overall Study||18
9990346|NCT01655563|11112039|FG001|COMPLETED|Overall Study||35
9990347|NCT01655563|11112038|FG000|NOT COMPLETED|Overall Study||0
9990348|NCT01655563|11112039|FG001|NOT COMPLETED|Overall Study||0
9990349|NCT01655693|11112048|FG000|STARTED|Overall Study||130
9990350|NCT01655693|11112049|FG001|STARTED|Overall Study||133
9990351|NCT01655693|11112050|FG002|STARTED|Overall Study||134
9990352|NCT01655693|11112048|FG000|COMPLETED|Overall Study||4
9990353|NCT01655693|11112049|FG001|COMPLETED|Overall Study||7
9990354|NCT01655693|11112050|FG002|COMPLETED|Overall Study||4
9990355|NCT01655693|11112048|FG000|NOT COMPLETED|Overall Study||126
9990356|NCT01655693|11112049|FG001|NOT COMPLETED|Overall Study||126
9990357|NCT01655693|11112050|FG002|NOT COMPLETED|Overall Study||130
9990358|NCT01655719|11112068|FG000|STARTED|Overall Study||1
9990359|NCT01655719|11112068|FG000|COMPLETED|Overall Study||1
9990360|NCT01655719|11112068|FG000|NOT COMPLETED|Overall Study||0
9990361|NCT01655823|11112077|FG000|STARTED|Overall Study||25
9990362|NCT01655823|11112078|FG001|STARTED|Overall Study||25
9990363|NCT01655823|11112079|FG002|STARTED|Overall Study||24
9990364|NCT01655823|11112080|FG003|STARTED|Overall Study||25
9990365|NCT01655823|11112081|FG004|STARTED|Overall Study||26
9990366|NCT01655823|11112077|FG000|COMPLETED|Overall Study||25
9990367|NCT01655823|11112078|FG001|COMPLETED|Overall Study||23
9990368|NCT01655823|11112079|FG002|COMPLETED|Overall Study||24
9990369|NCT01655823|11112080|FG003|COMPLETED|Overall Study||24
9990370|NCT01655823|11112081|FG004|COMPLETED|Overall Study||25
10101911|NCT02412111|11231235|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
10101912|NCT02412111|11231236|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
10101913|NCT02412111|11231237|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
10101914|NCT02412228|11231247|FG000|STARTED|Overall Study||12
10101915|NCT02412228|11231247|FG000|COMPLETED|Overall Study||12
10101916|NCT02412228|11231247|FG000|NOT COMPLETED|Overall Study||0
10101917|NCT02412306|11231256|FG000|STARTED|Overall Study||5
10101918|NCT02412306|11231257|FG001|STARTED|Overall Study||9
10101919|NCT02412306|11231258|FG002|STARTED|Overall Study||21
10101920|NCT02412306|11231259|FG003|STARTED|Overall Study||14
10101921|NCT02412306|11231260|FG004|STARTED|Overall Study||17
10101922|NCT02412306|11231256|FG000|COMPLETED|Overall Study||0
10101923|NCT02412306|11231257|FG001|COMPLETED|Overall Study||1
10101924|NCT02412306|11231258|FG002|COMPLETED|Overall Study||5
10101925|NCT02412306|11231259|FG003|COMPLETED|Overall Study||14
10101926|NCT02412306|11231260|FG004|COMPLETED|Overall Study||15
10101927|NCT02412306|11231256|FG000|NOT COMPLETED|Overall Study||5
10101928|NCT02412306|11231257|FG001|NOT COMPLETED|Overall Study||8
10101929|NCT02412306|11231258|FG002|NOT COMPLETED|Overall Study||16
10101930|NCT02412306|11231259|FG003|NOT COMPLETED|Overall Study||0
10101931|NCT02412306|11231260|FG004|NOT COMPLETED|Overall Study||2
10101932|NCT02412371|11231287|FG000|STARTED|Overall Study||7
10101933|NCT02412371|11231288|FG001|STARTED|Overall Study||9
10101934|NCT02412371|11231289|FG002|STARTED|Overall Study||7
10101935|NCT02412371|11231290|FG003|STARTED|Overall Study||8
10101936|NCT02412371|11231291|FG004|STARTED|Overall Study||12
10101937|NCT02412371|11231292|FG005|STARTED|Overall Study||5
10101938|NCT02412371|11231287|FG000|COMPLETED|Overall Study||0
10101939|NCT02412371|11231288|FG001|COMPLETED|Overall Study||0
10101940|NCT02412371|11231289|FG002|COMPLETED|Overall Study||0
10101941|NCT02412371|11231290|FG003|COMPLETED|Overall Study||0
10101942|NCT02412371|11231291|FG004|COMPLETED|Overall Study||0
10101943|NCT02412371|11231292|FG005|COMPLETED|Overall Study||0
10101944|NCT02412371|11231287|FG000|NOT COMPLETED|Overall Study||7
10101945|NCT02412371|11231288|FG001|NOT COMPLETED|Overall Study||9
10101946|NCT02412371|11231289|FG002|NOT COMPLETED|Overall Study||7
10101947|NCT02412371|11231290|FG003|NOT COMPLETED|Overall Study||8
10101948|NCT02412371|11231291|FG004|NOT COMPLETED|Overall Study||12
10101949|NCT02412371|11231292|FG005|NOT COMPLETED|Overall Study||5
10101950|NCT02412436|11231307|FG000|STARTED|Overall Study||62
10101951|NCT02412436|11231307|FG000|COMPLETED|Overall Study||44
10101952|NCT02412436|11231307|FG000|NOT COMPLETED|Overall Study||18
10101953|NCT02412488|11231311|FG000|STARTED|Overall Study||192
10101954|NCT02412488|11231311|FG000|Reveal LINQ Implanted|Overall Study||191
10101955|NCT02412488|11231311|FG000|COMPLETED|Overall Study||174
9990371|NCT01655823|11112077|FG000|NOT COMPLETED|Overall Study||0
9990372|NCT01655823|11112078|FG001|NOT COMPLETED|Overall Study||2
9990373|NCT01655823|11112079|FG002|NOT COMPLETED|Overall Study||0
9990374|NCT01655823|11112080|FG003|NOT COMPLETED|Overall Study||1
9990375|NCT01655823|11112081|FG004|NOT COMPLETED|Overall Study||1
10101956|NCT02412488|11231311|FG000|NOT COMPLETED|Overall Study||18
10101957|NCT02412501|11231315|FG000|STARTED|Overall Study||101
10101958|NCT02412501|11231315|FG000|COMPLETED|Overall Study||101
9990376|NCT01655901|11112093|FG000|STARTED|First Intervention (Hour 1)||5
9990377|NCT01655901|11112094|FG001|STARTED|First Intervention (Hour 1)||5
9990378|NCT01655901|11112095|FG002|STARTED|First Intervention (Hour 1)||5
9990379|NCT01655901|11112096|FG003|STARTED|First Intervention (Hour 1)||5
9990380|NCT01655901|11112097|FG004|STARTED|First Intervention (Hour 1)||5
9990381|NCT01655901|11112098|FG005|STARTED|First Intervention (Hour 1)||5
9990382|NCT01655901|11112093|FG000|COMPLETED|First Intervention (Hour 1)||5
9990383|NCT01655901|11112094|FG001|COMPLETED|First Intervention (Hour 1)||5
9990384|NCT01655901|11112095|FG002|COMPLETED|First Intervention (Hour 1)||5
9990385|NCT01655901|11112096|FG003|COMPLETED|First Intervention (Hour 1)||5
9990386|NCT01655901|11112097|FG004|COMPLETED|First Intervention (Hour 1)||5
9990387|NCT01655901|11112098|FG005|COMPLETED|First Intervention (Hour 1)||5
9990388|NCT01655901|11112093|FG000|NOT COMPLETED|First Intervention (Hour 1)||0
9990389|NCT01655901|11112094|FG001|NOT COMPLETED|First Intervention (Hour 1)||0
9990390|NCT01655901|11112095|FG002|NOT COMPLETED|First Intervention (Hour 1)||0
9990391|NCT01655901|11112096|FG003|NOT COMPLETED|First Intervention (Hour 1)||0
9990392|NCT01655901|11112097|FG004|NOT COMPLETED|First Intervention (Hour 1)||0
9990393|NCT01655901|11112098|FG005|NOT COMPLETED|First Intervention (Hour 1)||0
9990394|NCT01655901|11112093|FG000|STARTED|Washout (1 Week)||5
9990395|NCT01655901|11112094|FG001|STARTED|Washout (1 Week)||5
9990396|NCT01655901|11112095|FG002|STARTED|Washout (1 Week)||5
9990397|NCT01655901|11112096|FG003|STARTED|Washout (1 Week)||5
9990398|NCT01655901|11112097|FG004|STARTED|Washout (1 Week)||5
9990399|NCT01655901|11112098|FG005|STARTED|Washout (1 Week)||5
9990400|NCT01655901|11112093|FG000|COMPLETED|Washout (1 Week)||5
9990401|NCT01655901|11112094|FG001|COMPLETED|Washout (1 Week)||5
9990402|NCT01655901|11112095|FG002|COMPLETED|Washout (1 Week)||5
9990403|NCT01655901|11112096|FG003|COMPLETED|Washout (1 Week)||5
9990404|NCT01655901|11112097|FG004|COMPLETED|Washout (1 Week)||5
9990405|NCT01655901|11112098|FG005|COMPLETED|Washout (1 Week)||5
9990406|NCT01655901|11112093|FG000|NOT COMPLETED|Washout (1 Week)||0
9990407|NCT01655901|11112094|FG001|NOT COMPLETED|Washout (1 Week)||0
9990408|NCT01655901|11112095|FG002|NOT COMPLETED|Washout (1 Week)||0
9990409|NCT01655901|11112096|FG003|NOT COMPLETED|Washout (1 Week)||0
9990410|NCT01655901|11112097|FG004|NOT COMPLETED|Washout (1 Week)||0
9990411|NCT01655901|11112098|FG005|NOT COMPLETED|Washout (1 Week)||0
9990412|NCT01655901|11112093|FG000|STARTED|Second Intervention (Hour 2)||5
9990413|NCT01655901|11112094|FG001|STARTED|Second Intervention (Hour 2)||5
9990414|NCT01655901|11112095|FG002|STARTED|Second Intervention (Hour 2)||5
9990415|NCT01655901|11112096|FG003|STARTED|Second Intervention (Hour 2)||5
9990416|NCT01655901|11112097|FG004|STARTED|Second Intervention (Hour 2)||5
9990417|NCT01655901|11112098|FG005|STARTED|Second Intervention (Hour 2)||5
9990418|NCT01655901|11112093|FG000|COMPLETED|Second Intervention (Hour 2)||5
9990419|NCT01655901|11112094|FG001|COMPLETED|Second Intervention (Hour 2)||5
9990420|NCT01655901|11112095|FG002|COMPLETED|Second Intervention (Hour 2)||5
9990421|NCT01655901|11112096|FG003|COMPLETED|Second Intervention (Hour 2)||5
9990422|NCT01655901|11112097|FG004|COMPLETED|Second Intervention (Hour 2)||5
9990423|NCT01655901|11112098|FG005|COMPLETED|Second Intervention (Hour 2)||5
9990424|NCT01655901|11112093|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0
9990425|NCT01655901|11112094|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0
9990426|NCT01655901|11112095|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0
9990427|NCT01655901|11112096|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0
9990428|NCT01655901|11112097|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0
9990429|NCT01655901|11112098|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0
9990430|NCT01655901|11112093|FG000|STARTED|Washout (1 Week)||5
9990431|NCT01655901|11112094|FG001|STARTED|Washout (1 Week)||5
9990432|NCT01655901|11112095|FG002|STARTED|Washout (1 Week)||5
9990433|NCT01655901|11112096|FG003|STARTED|Washout (1 Week)||5
9990434|NCT01655901|11112097|FG004|STARTED|Washout (1 Week)||5
9990435|NCT01655901|11112098|FG005|STARTED|Washout (1 Week)||5
9990436|NCT01655901|11112093|FG000|COMPLETED|Washout (1 Week)||5
9990437|NCT01655901|11112094|FG001|COMPLETED|Washout (1 Week)||5
9990438|NCT01655901|11112095|FG002|COMPLETED|Washout (1 Week)||5
9990439|NCT01655901|11112096|FG003|COMPLETED|Washout (1 Week)||5
9990440|NCT01655901|11112097|FG004|COMPLETED|Washout (1 Week)||5
9990441|NCT01655901|11112098|FG005|COMPLETED|Washout (1 Week)||5
9990442|NCT01655901|11112093|FG000|NOT COMPLETED|Washout (1 Week)||0
9990443|NCT01655901|11112094|FG001|NOT COMPLETED|Washout (1 Week)||0
9990444|NCT01655901|11112095|FG002|NOT COMPLETED|Washout (1 Week)||0
9990445|NCT01655901|11112096|FG003|NOT COMPLETED|Washout (1 Week)||0
9990446|NCT01655901|11112097|FG004|NOT COMPLETED|Washout (1 Week)||0
9990447|NCT01655901|11112098|FG005|NOT COMPLETED|Washout (1 Week)||0
9990448|NCT01655901|11112093|FG000|STARTED|Third Intervention (Hour 3)||5
9990449|NCT01655901|11112094|FG001|STARTED|Third Intervention (Hour 3)||5
9990450|NCT01655901|11112095|FG002|STARTED|Third Intervention (Hour 3)||5
9990451|NCT01655901|11112096|FG003|STARTED|Third Intervention (Hour 3)||5
9990452|NCT01655901|11112097|FG004|STARTED|Third Intervention (Hour 3)||5
9990453|NCT01655901|11112098|FG005|STARTED|Third Intervention (Hour 3)||5
9990454|NCT01655901|11112093|FG000|COMPLETED|Third Intervention (Hour 3)||4
9990455|NCT01655901|11112094|FG001|COMPLETED|Third Intervention (Hour 3)||4
9990456|NCT01655901|11112095|FG002|COMPLETED|Third Intervention (Hour 3)||4
9990457|NCT01655901|11112096|FG003|COMPLETED|Third Intervention (Hour 3)||5
9990458|NCT01655901|11112097|FG004|COMPLETED|Third Intervention (Hour 3)||4
9990459|NCT01655901|11112098|FG005|COMPLETED|Third Intervention (Hour 3)||5
9990460|NCT01655901|11112093|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1
9990461|NCT01655901|11112094|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1
9990462|NCT01655901|11112095|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1
9990463|NCT01655901|11112096|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0
9990464|NCT01655901|11112097|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1
9990465|NCT01655901|11112098|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0
9990466|NCT01656031|11112107|FG000|STARTED|Overall Study||39
9990467|NCT01656031|11112107|FG000|COMPLETED|Overall Study||39
9990468|NCT01656031|11112107|FG000|NOT COMPLETED|Overall Study||0
9990469|NCT01656161|11112111|FG000|STARTED|Overall Study|Intention to treat analysis set|120
9990470|NCT01656161|11112111|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
9990471|NCT01656161|11112111|FG000|Received Triptorelin at Day 169|Overall Study||115
9990472|NCT01656161|11112111|FG000|COMPLETED|Overall Study|Per protocol analysis set|113
9990473|NCT01656161|11112111|FG000|NOT COMPLETED|Overall Study||7
9990474|NCT01656187|11112120|FG000|STARTED|First Intervention (24 Weeks)||20
9990475|NCT01656187|11112121|FG001|STARTED|First Intervention (24 Weeks)||26
9990476|NCT01656187|11112120|FG000|COMPLETED|First Intervention (24 Weeks)||14
9990477|NCT01656187|11112121|FG001|COMPLETED|First Intervention (24 Weeks)||23
9990478|NCT01656187|11112120|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6
9990479|NCT01656187|11112121|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
9990480|NCT01656187|11112120|FG000|STARTED|Washout (4 Weeks)||14
9990481|NCT01656187|11112121|FG001|STARTED|Washout (4 Weeks)||23
9990482|NCT01656187|11112120|FG000|COMPLETED|Washout (4 Weeks)||14
9990483|NCT01656187|11112121|FG001|COMPLETED|Washout (4 Weeks)||22
9990484|NCT01656187|11112120|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9990485|NCT01656187|11112121|FG001|NOT COMPLETED|Washout (4 Weeks)||1
9990486|NCT01656187|11112120|FG000|STARTED|Second Intervention (24 Weeks)||14
9990487|NCT01656187|11112121|FG001|STARTED|Second Intervention (24 Weeks)||22
9990488|NCT01656187|11112120|FG000|COMPLETED|Second Intervention (24 Weeks)||13
9990489|NCT01656187|11112121|FG001|COMPLETED|Second Intervention (24 Weeks)||19
9990490|NCT01656187|11112120|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1
9990491|NCT01656187|11112121|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3
9990492|NCT01656200|11112127|FG000|STARTED|Overall Study||17
9990493|NCT01656200|11112127|FG000|COMPLETED|Overall Study||16
9990494|NCT01656200|11112127|FG000|NOT COMPLETED|Overall Study||1
9990495|NCT01656252|11112131|FG000|STARTED|Phase I||14
9990496|NCT01656252|11112131|FG000|COMPLETED|Phase I||14
9990497|NCT01656252|11112131|FG000|NOT COMPLETED|Phase I||0
9990498|NCT01656252|11112131|FG000|STARTED|Phase II||0
9990499|NCT01656252|11112131|FG000|COMPLETED|Phase II||0
9990500|NCT01656252|11112131|FG000|NOT COMPLETED|Phase II||0
9990501|NCT01656304|11112137|FG000|STARTED|Overall Study||16
9990502|NCT01656304|11112137|FG000|COMPLETED|Overall Study||15
9990503|NCT01656304|11112137|FG000|NOT COMPLETED|Overall Study||1
9990504|NCT01656395|11112147|FG000|STARTED|Overall Study||60
9990505|NCT01656395|11112148|FG001|STARTED|Overall Study||127
9990506|NCT01656395|11112149|FG002|STARTED|Overall Study||142
9990507|NCT01656395|11112150|FG003|STARTED|Overall Study||53
9990508|NCT01656395|11112151|FG004|STARTED|Overall Study||60
9990509|NCT01656395|11112152|FG005|STARTED|Overall Study||134
9990510|NCT01656395|11112153|FG006|STARTED|Overall Study||0
9990511|NCT01656395|11112154|FG007|STARTED|Overall Study||0
9990512|NCT01656395|11112147|FG000|Treated Participants|Overall Study||58
9990513|NCT01656395|11112148|FG001|Treated Participants|Overall Study||126
9990514|NCT01656395|11112149|FG002|Treated Participants|Overall Study||135
9990515|NCT01656395|11112150|FG003|Treated Participants|Overall Study||52
9990516|NCT01656395|11112151|FG004|Treated Participants|Overall Study||60
9990517|NCT01656395|11112152|FG005|Treated Participants|Overall Study||126
9990518|NCT01656395|11112153|FG006|Treated Participants|Overall Study||0
9990519|NCT01656395|11112154|FG007|Treated Participants|Overall Study||0
9990520|NCT01656395|11112147|FG000|COMPLETED|Overall Study||43
9990521|NCT01656395|11112148|FG001|COMPLETED|Overall Study||93
9990522|NCT01656395|11112149|FG002|COMPLETED|Overall Study||106
9990523|NCT01656395|11112150|FG003|COMPLETED|Overall Study||41
9990524|NCT01656395|11112151|FG004|COMPLETED|Overall Study||46
9990525|NCT01656395|11112152|FG005|COMPLETED|Overall Study||94
9990526|NCT01656395|11112153|FG006|COMPLETED|Overall Study||0
10101959|NCT02412501|11231315|FG000|NOT COMPLETED|Overall Study||0
10101960|NCT02412631|11231322|FG000|STARTED|Overall Study||44
10101961|NCT02412631|11231323|FG001|STARTED|Overall Study||40
10101962|NCT02412631|11231322|FG000|COMPLETED|Overall Study||18
10101963|NCT02412631|11231323|FG001|COMPLETED|Overall Study||16
10101964|NCT02412631|11231322|FG000|NOT COMPLETED|Overall Study||26
10101965|NCT02412631|11231323|FG001|NOT COMPLETED|Overall Study||24
9990527|NCT01656395|11112154|FG007|COMPLETED|Overall Study||0
9990528|NCT01656395|11112147|FG000|NOT COMPLETED|Overall Study||17
9990529|NCT01656395|11112148|FG001|NOT COMPLETED|Overall Study||34
10101966|NCT02412644|11231331|FG000|STARTED|Overall Study||21
10101967|NCT02412644|11231332|FG001|STARTED|Overall Study||8
9990530|NCT01656395|11112149|FG002|NOT COMPLETED|Overall Study||36
9990531|NCT01656395|11112150|FG003|NOT COMPLETED|Overall Study||12
10101968|NCT02412644|11231331|FG000|COMPLETED|Overall Study||6
9990532|NCT01656395|11112151|FG004|NOT COMPLETED|Overall Study||14
9990533|NCT01656395|11112152|FG005|NOT COMPLETED|Overall Study||40
9990534|NCT01656395|11112153|FG006|NOT COMPLETED|Overall Study||0
9990535|NCT01656395|11112154|FG007|NOT COMPLETED|Overall Study||0
9990536|NCT01656408|11112178|FG000|STARTED|Overall Study||8
9990537|NCT01656408|11112179|FG001|STARTED|Overall Study||8
9990538|NCT01656408|11112180|FG002|STARTED|Overall Study||8
9990539|NCT01656408|11112181|FG003|STARTED|Overall Study||7
9990540|NCT01656408|11112182|FG004|STARTED|Overall Study||9
9990541|NCT01656408|11112183|FG005|STARTED|Overall Study||9
9990542|NCT01656408|11112184|FG006|STARTED|Overall Study||10
9990543|NCT01656408|11112185|FG007|STARTED|Overall Study||8
10101969|NCT02412644|11231332|FG001|COMPLETED|Overall Study||4
10101970|NCT02412644|11231331|FG000|NOT COMPLETED|Overall Study||15
10101971|NCT02412644|11231332|FG001|NOT COMPLETED|Overall Study||4
9990544|NCT01656408|11112186|FG008|STARTED|Overall Study||18
9990545|NCT01656408|11112187|FG009|STARTED|Overall Study||18
9990546|NCT01656408|11112178|FG000|COMPLETED|Overall Study||7
9990547|NCT01656408|11112179|FG001|COMPLETED|Overall Study||8
9990548|NCT01656408|11112180|FG002|COMPLETED|Overall Study||6
9990549|NCT01656408|11112181|FG003|COMPLETED|Overall Study||7
9990550|NCT01656408|11112182|FG004|COMPLETED|Overall Study||8
9990551|NCT01656408|11112183|FG005|COMPLETED|Overall Study||7
9990552|NCT01656408|11112184|FG006|COMPLETED|Overall Study||9
9990553|NCT01656408|11112185|FG007|COMPLETED|Overall Study||7
9990554|NCT01656408|11112186|FG008|COMPLETED|Overall Study||16
9990555|NCT01656408|11112187|FG009|COMPLETED|Overall Study||15
9990556|NCT01656408|11112178|FG000|NOT COMPLETED|Overall Study||1
9990557|NCT01656408|11112179|FG001|NOT COMPLETED|Overall Study||0
9990558|NCT01656408|11112180|FG002|NOT COMPLETED|Overall Study||2
9990559|NCT01656408|11112181|FG003|NOT COMPLETED|Overall Study||0
9990560|NCT01656408|11112182|FG004|NOT COMPLETED|Overall Study||1
9990561|NCT01656408|11112183|FG005|NOT COMPLETED|Overall Study||2
9990562|NCT01656408|11112184|FG006|NOT COMPLETED|Overall Study||1
9990563|NCT01656408|11112185|FG007|NOT COMPLETED|Overall Study||1
9990564|NCT01656408|11112186|FG008|NOT COMPLETED|Overall Study||2
9990565|NCT01656408|11112187|FG009|NOT COMPLETED|Overall Study||3
9990566|NCT01656460|11112233|FG000|STARTED|Overall Study||3
9990567|NCT01656460|11112234|FG001|STARTED|Overall Study||3
9990568|NCT01656460|11112235|FG002|STARTED|Overall Study||3
9990569|NCT01656460|11112236|FG003|STARTED|Overall Study||3
9990570|NCT01656460|11112233|FG000|COMPLETED|Overall Study||3
9990571|NCT01656460|11112234|FG001|COMPLETED|Overall Study||3
9990572|NCT01656460|11112235|FG002|COMPLETED|Overall Study||3
9990573|NCT01656460|11112236|FG003|COMPLETED|Overall Study||3
9990574|NCT01656460|11112233|FG000|NOT COMPLETED|Overall Study||0
9990575|NCT01656460|11112234|FG001|NOT COMPLETED|Overall Study||0
9990576|NCT01656460|11112235|FG002|NOT COMPLETED|Overall Study||0
9990577|NCT01656460|11112236|FG003|NOT COMPLETED|Overall Study||0
9990578|NCT01656629|11112249|FG000|STARTED|Overall Study||21
9990579|NCT01656629|11112250|FG001|STARTED|Overall Study||18
9990580|NCT01656629|11112251|FG002|STARTED|Overall Study||16
9990581|NCT01656629|11112249|FG000|COMPLETED|Overall Study||16
9990582|NCT01656629|11112250|FG001|COMPLETED|Overall Study||16
9990583|NCT01656629|11112251|FG002|COMPLETED|Overall Study||14
9990584|NCT01656629|11112249|FG000|NOT COMPLETED|Overall Study||5
9990585|NCT01656629|11112250|FG001|NOT COMPLETED|Overall Study||2
9990586|NCT01656629|11112251|FG002|NOT COMPLETED|Overall Study||2
9990587|NCT01656733|11112261|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
9990588|NCT01656733|11112262|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
9990589|NCT01656733|11112261|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45
10101972|NCT02412657|11231345|FG000|STARTED|Overall Study||25
10101973|NCT02412657|11231346|FG001|STARTED|Overall Study||25
10101974|NCT02412657|11231347|FG002|STARTED|Overall Study||25
10101975|NCT02412657|11231345|FG000|COMPLETED|Overall Study||24
10101976|NCT02412657|11231346|FG001|COMPLETED|Overall Study||23
10101977|NCT02412657|11231347|FG002|COMPLETED|Overall Study||22
10101978|NCT02412657|11231345|FG000|NOT COMPLETED|Overall Study||1
10101979|NCT02412657|11231346|FG001|NOT COMPLETED|Overall Study||2
10101980|NCT02412657|11231347|FG002|NOT COMPLETED|Overall Study||3
10101981|NCT02412722|11231361|FG000|STARTED|Overall Study||11
10101982|NCT02412722|11231362|FG001|STARTED|Overall Study||8
10101983|NCT02412722|11231363|FG002|STARTED|Overall Study||7
10101984|NCT02412722|11231364|FG003|STARTED|Overall Study||15
10101985|NCT02412722|11231365|FG004|STARTED|Overall Study||7
10101986|NCT02412722|11231366|FG005|STARTED|Overall Study||13
10101987|NCT02412722|11231361|FG000|Safety Population|Overall Study||11
9990590|NCT01656733|11112262|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42
9990591|NCT01656733|11112261|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
9990592|NCT01656733|11112262|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
9990593|NCT01656733|11112261|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
9990594|NCT01656733|11112262|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
9990595|NCT01656733|11112261|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
9990596|NCT01656733|11112262|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
10101988|NCT02412722|11231362|FG001|Safety Population|Overall Study||6
10101989|NCT02412722|11231363|FG002|Safety Population|Overall Study||7
10101990|NCT02412722|11231364|FG003|Safety Population|Overall Study||15
10101991|NCT02412722|11231365|FG004|Safety Population|Overall Study||7
10101992|NCT02412722|11231366|FG005|Safety Population|Overall Study||13
10101993|NCT02412722|11231361|FG000|COMPLETED|Overall Study||0
10101994|NCT02412722|11231362|FG001|COMPLETED|Overall Study||0
10101995|NCT02412722|11231363|FG002|COMPLETED|Overall Study||0
10101996|NCT02412722|11231364|FG003|COMPLETED|Overall Study||0
10101997|NCT02412722|11231365|FG004|COMPLETED|Overall Study||0
9990597|NCT01656733|11112261|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
9990598|NCT01656733|11112262|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
10101998|NCT02412722|11231366|FG005|COMPLETED|Overall Study||0
10101999|NCT02412722|11231361|FG000|NOT COMPLETED|Overall Study||11
10102000|NCT02412722|11231362|FG001|NOT COMPLETED|Overall Study||8
9990599|NCT01656733|11112261|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
9990600|NCT01656733|11112262|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
9990601|NCT01656733|11112261|FG000|Participants With Perinatal Outcomes|Overall Study||67
9990602|NCT01656733|11112262|FG001|Participants With Perinatal Outcomes|Overall Study||66
9990603|NCT01656733|11112261|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
9990604|NCT01656733|11112262|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
9990605|NCT01656733|11112261|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30
9990606|NCT01656733|11112262|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28
9990607|NCT01656733|11112261|FG000|COMPLETED|Overall Study||67
9990608|NCT01656733|11112262|FG001|COMPLETED|Overall Study||66
9990609|NCT01656733|11112261|FG000|NOT COMPLETED|Overall Study||0
9990610|NCT01656733|11112262|FG001|NOT COMPLETED|Overall Study||4
9990611|NCT01656759|11112270|FG000|STARTED|Overall Study||27
9990612|NCT01656759|11112271|FG001|STARTED|Overall Study||25
9990613|NCT01656759|11112270|FG000|COMPLETED|Overall Study||25
9990614|NCT01656759|11112271|FG001|COMPLETED|Overall Study||22
9990615|NCT01656759|11112270|FG000|NOT COMPLETED|Overall Study||2
9990616|NCT01656759|11112271|FG001|NOT COMPLETED|Overall Study||3
9990617|NCT01656772|11112279|FG000|STARTED|Overall Study||43
9990618|NCT01656772|11112280|FG001|STARTED|Overall Study||77
9990619|NCT01656772|11112279|FG000|COMPLETED|Overall Study||43
9990620|NCT01656772|11112280|FG001|COMPLETED|Overall Study||77
9990621|NCT01656772|11112279|FG000|NOT COMPLETED|Overall Study||0
9990622|NCT01656772|11112280|FG001|NOT COMPLETED|Overall Study||0
10018291|NCT01822821|11141337|FG001|NOT COMPLETED|Overall Study||1
10018292|NCT01822886|11141343|FG000|STARTED|Overall Study||20
10018293|NCT01822886|11141343|FG000|COMPLETED|Overall Study||5
10018294|NCT01822886|11141343|FG000|NOT COMPLETED|Overall Study||15
10102001|NCT02412722|11231363|FG002|NOT COMPLETED|Overall Study||7
10102002|NCT02412722|11231364|FG003|NOT COMPLETED|Overall Study||15
10102003|NCT02412722|11231365|FG004|NOT COMPLETED|Overall Study||7
10102004|NCT02412722|11231366|FG005|NOT COMPLETED|Overall Study||13
10102005|NCT02412761|11231400|FG000|STARTED|First Intervention (2 Weeks)||5
10102006|NCT02412761|11231401|FG001|STARTED|First Intervention (2 Weeks)||6
10102007|NCT02412761|11231402|FG002|STARTED|First Intervention (2 Weeks)||5
10102008|NCT02412761|11231403|FG003|STARTED|First Intervention (2 Weeks)||8
10102009|NCT02412761|11231404|FG004|STARTED|First Intervention (2 Weeks)||4
10102010|NCT02412761|11231405|FG005|STARTED|First Intervention (2 Weeks)||7
10102011|NCT02412761|11231400|FG000|COMPLETED|First Intervention (2 Weeks)||5
10102012|NCT02412761|11231401|FG001|COMPLETED|First Intervention (2 Weeks)||5
10102013|NCT02412761|11231402|FG002|COMPLETED|First Intervention (2 Weeks)||4
10102014|NCT02412761|11231403|FG003|COMPLETED|First Intervention (2 Weeks)||8
10102015|NCT02412761|11231404|FG004|COMPLETED|First Intervention (2 Weeks)||4
10102016|NCT02412761|11231405|FG005|COMPLETED|First Intervention (2 Weeks)||6
10102017|NCT02412761|11231400|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10102018|NCT02412761|11231401|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
10102019|NCT02412761|11231402|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
10102020|NCT02412761|11231403|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
10102021|NCT02412761|11231404|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
10102022|NCT02412761|11231405|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1
10102023|NCT02412761|11231400|FG000|STARTED|Second Intervention (2 Weeks)||5
10102024|NCT02412761|11231401|FG001|STARTED|Second Intervention (2 Weeks)||5
10102025|NCT02412761|11231402|FG002|STARTED|Second Intervention (2 Weeks)||4
10102026|NCT02412761|11231403|FG003|STARTED|Second Intervention (2 Weeks)||8
10102027|NCT02412761|11231404|FG004|STARTED|Second Intervention (2 Weeks)||4
10102028|NCT02412761|11231405|FG005|STARTED|Second Intervention (2 Weeks)||6
10102029|NCT02412761|11231400|FG000|COMPLETED|Second Intervention (2 Weeks)||5
10102030|NCT02412761|11231401|FG001|COMPLETED|Second Intervention (2 Weeks)||5
10102031|NCT02412761|11231402|FG002|COMPLETED|Second Intervention (2 Weeks)||4
10102032|NCT02412761|11231403|FG003|COMPLETED|Second Intervention (2 Weeks)||8
10102033|NCT02412761|11231404|FG004|COMPLETED|Second Intervention (2 Weeks)||4
10102034|NCT02412761|11231405|FG005|COMPLETED|Second Intervention (2 Weeks)||6
10102035|NCT02412761|11231400|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10102036|NCT02412761|11231401|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10102037|NCT02412761|11231402|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
10102038|NCT02412761|11231403|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
10102039|NCT02412761|11231404|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
10102040|NCT02412761|11231405|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0
10102041|NCT02412761|11231400|FG000|STARTED|Third Intervention (2 Weeks)||5
10102042|NCT02412761|11231401|FG001|STARTED|Third Intervention (2 Weeks)||5
10102043|NCT02412761|11231402|FG002|STARTED|Third Intervention (2 Weeks)||4
10102044|NCT02412761|11231403|FG003|STARTED|Third Intervention (2 Weeks)||8
10018295|NCT01822899|11141349|FG000|STARTED|Overall Study||358
10102045|NCT02412761|11231404|FG004|STARTED|Third Intervention (2 Weeks)||4
10018296|NCT01822899|11141350|FG001|STARTED|Overall Study||358
10018297|NCT01822899|11141349|FG000|COMPLETED|Overall Study||334
10018298|NCT01822899|11141350|FG001|COMPLETED|Overall Study||340
10018299|NCT01822899|11141349|FG000|NOT COMPLETED|Overall Study||24
10018300|NCT01822899|11141350|FG001|NOT COMPLETED|Overall Study||18
10018301|NCT01822925|11141360|FG000|STARTED|Overall Study||32
9990623|NCT01656850|11112288|FG000|STARTED|First Intervention (3 Months)||20
9990624|NCT01656850|11112289|FG001|STARTED|First Intervention (3 Months)||20
9990625|NCT01656850|11112288|FG000|COMPLETED|First Intervention (3 Months)||17
9990626|NCT01656850|11112289|FG001|COMPLETED|First Intervention (3 Months)||16
9990627|NCT01656850|11112288|FG000|NOT COMPLETED|First Intervention (3 Months)||3
9990628|NCT01656850|11112289|FG001|NOT COMPLETED|First Intervention (3 Months)||4
9990629|NCT01656850|11112288|FG000|STARTED|Washout (2 Weeks)||17
9990630|NCT01656850|11112289|FG001|STARTED|Washout (2 Weeks)||16
9990631|NCT01656850|11112288|FG000|COMPLETED|Washout (2 Weeks)||17
9990632|NCT01656850|11112289|FG001|COMPLETED|Washout (2 Weeks)||16
9990633|NCT01656850|11112288|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9990634|NCT01656850|11112289|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9990635|NCT01656850|11112288|FG000|STARTED|Second Intervention (3 Months)||17
9990636|NCT01656850|11112289|FG001|STARTED|Second Intervention (3 Months)||16
9990637|NCT01656850|11112288|FG000|COMPLETED|Second Intervention (3 Months)||17
9990638|NCT01656850|11112289|FG001|COMPLETED|Second Intervention (3 Months)||16
9990639|NCT01656850|11112288|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
9990640|NCT01656850|11112289|FG001|NOT COMPLETED|Second Intervention (3 Months)||0
9990641|NCT01656889|11112301|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
9990642|NCT01656889|11112302|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
9990643|NCT01656889|11112301|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
9990644|NCT01656889|11112302|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
9990645|NCT01656889|11112301|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12
9990646|NCT01656889|11112302|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11
9990647|NCT01656889|11112301|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210
9990648|NCT01656889|11112302|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213
9990649|NCT01656889|11112301|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206
9990650|NCT01656889|11112302|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204
9990651|NCT01656889|11112301|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
9990652|NCT01656889|11112302|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
9990653|NCT01656967|11112310|FG000|STARTED|Overall Study||33
9990654|NCT01656967|11112311|FG001|STARTED|Overall Study||33
9990655|NCT01656967|11112310|FG000|SGA Placement|Overall Study||32
9990656|NCT01656967|11112311|FG001|SGA Placement|Overall Study||33
9990657|NCT01656967|11112310|FG000|ETT Insertion|Overall Study||29
9990658|NCT01656967|11112311|FG001|ETT Insertion|Overall Study||31
10102046|NCT02412761|11231405|FG005|STARTED|Third Intervention (2 Weeks)||6
10102047|NCT02412761|11231400|FG000|COMPLETED|Third Intervention (2 Weeks)||5
10102048|NCT02412761|11231401|FG001|COMPLETED|Third Intervention (2 Weeks)||5
10102049|NCT02412761|11231402|FG002|COMPLETED|Third Intervention (2 Weeks)||4
10102050|NCT02412761|11231403|FG003|COMPLETED|Third Intervention (2 Weeks)||8
10102051|NCT02412761|11231404|FG004|COMPLETED|Third Intervention (2 Weeks)||4
10102052|NCT02412761|11231405|FG005|COMPLETED|Third Intervention (2 Weeks)||6
10102053|NCT02412761|11231400|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
10102054|NCT02412761|11231401|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
10102055|NCT02412761|11231402|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
10102056|NCT02412761|11231403|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
10102057|NCT02412761|11231404|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
10102058|NCT02412761|11231405|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
10102059|NCT02412852|11231417|FG000|STARTED|Overall Study||4
10102060|NCT02412852|11231418|FG001|STARTED|Overall Study||8
10102061|NCT02412852|11231419|FG002|STARTED|Overall Study||5
10102062|NCT02412852|11231420|FG003|STARTED|Overall Study||9
10102063|NCT02412852|11231417|FG000|COMPLETED|Overall Study||4
10102064|NCT02412852|11231418|FG001|COMPLETED|Overall Study||7
10102065|NCT02412852|11231419|FG002|COMPLETED|Overall Study||5
10102066|NCT02412852|11231420|FG003|COMPLETED|Overall Study||8
10102067|NCT02412852|11231417|FG000|NOT COMPLETED|Overall Study||0
10102068|NCT02412852|11231418|FG001|NOT COMPLETED|Overall Study||1
10102069|NCT02412852|11231419|FG002|NOT COMPLETED|Overall Study||0
10102070|NCT02412852|11231420|FG003|NOT COMPLETED|Overall Study||1
10102071|NCT02412878|11231430|FG000|STARTED|Overall Study||238
10102072|NCT02412878|11231431|FG001|STARTED|Overall Study||240
10102073|NCT02412878|11231430|FG000|Received Carfilzomib|Overall Study||235
10102074|NCT02412878|11231431|FG001|Received Carfilzomib|Overall Study||238
10102075|NCT02412878|11231430|FG000|COMPLETED|Overall Study||217
10102076|NCT02412878|11231431|FG001|COMPLETED|Overall Study||227
10102077|NCT02412878|11231430|FG000|NOT COMPLETED|Overall Study||21
10102078|NCT02412878|11231431|FG001|NOT COMPLETED|Overall Study||13
10102079|NCT02412956|11231439|FG000|STARTED|Overall Study||44
10102080|NCT02412956|11231440|FG001|STARTED|Overall Study||47
10102081|NCT02412956|11231441|FG002|STARTED|Overall Study||8
10102082|NCT02412956|11231439|FG000|COMPLETED|Overall Study||35
10102083|NCT02412956|11231440|FG001|COMPLETED|Overall Study||30
10102084|NCT02412956|11231441|FG002|COMPLETED|Overall Study||8
10102085|NCT02412956|11231439|FG000|NOT COMPLETED|Overall Study||9
9990659|NCT01656967|11112310|FG000|COMPLETED|Overall Study||29
9990660|NCT01656967|11112311|FG001|COMPLETED|Overall Study||31
9990661|NCT01656967|11112310|FG000|NOT COMPLETED|Overall Study||4
9990662|NCT01656967|11112311|FG001|NOT COMPLETED|Overall Study||2
10102086|NCT02412956|11231440|FG001|NOT COMPLETED|Overall Study||17
10102087|NCT02412956|11231441|FG002|NOT COMPLETED|Overall Study||0
10102088|NCT02412982|11231449|FG000|STARTED|Primary Endpoint||51
10102089|NCT02412982|11231450|FG001|STARTED|Primary Endpoint||52
9990663|NCT01657019|11112321|FG000|STARTED|Overall Study||604
9990664|NCT01657019|11112321|FG000|COMPLETED|Overall Study||369
9990665|NCT01657019|11112321|FG000|NOT COMPLETED|Overall Study||235
9990666|NCT01657032|11112327|FG000|STARTED|Overall Study||44
9990667|NCT01657032|11112328|FG001|STARTED|Overall Study||44
9990668|NCT01657032|11112327|FG000|COMPLETED|Overall Study||44
9990669|NCT01657032|11112328|FG001|COMPLETED|Overall Study||37
9990670|NCT01657032|11112327|FG000|NOT COMPLETED|Overall Study||0
9990671|NCT01657032|11112328|FG001|NOT COMPLETED|Overall Study||7
9990672|NCT01657162|11112336|FG000|STARTED|Overall Study||558
9990673|NCT01657162|11112337|FG001|STARTED|Overall Study||581
9990674|NCT01657162|11112336|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
10102090|NCT02412982|11231449|FG000|COMPLETED|Primary Endpoint||47
10102091|NCT02412982|11231450|FG001|COMPLETED|Primary Endpoint||49
10102092|NCT02412982|11231449|FG000|NOT COMPLETED|Primary Endpoint||4
10102093|NCT02412982|11231450|FG001|NOT COMPLETED|Primary Endpoint||3
10102094|NCT02412982|11231449|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0
10102095|NCT02412982|11231450|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52
10102096|NCT02412982|11231449|FG000|COMPLETED|Intervention Group: Randomization||0
10102097|NCT02412982|11231450|FG001|COMPLETED|Intervention Group: Randomization||51
10102098|NCT02412982|11231449|FG000|NOT COMPLETED|Intervention Group: Randomization||0
10102099|NCT02412982|11231450|FG001|NOT COMPLETED|Intervention Group: Randomization||1
10102100|NCT02413008|11231458|FG000|STARTED|Overall Study||50
10102101|NCT02413008|11231459|FG001|STARTED|Overall Study||11
10102102|NCT02413008|11231458|FG000|COMPLETED|Overall Study||43
10102103|NCT02413008|11231459|FG001|COMPLETED|Overall Study||9
10102104|NCT02413008|11231458|FG000|NOT COMPLETED|Overall Study||7
10102105|NCT02413008|11231459|FG001|NOT COMPLETED|Overall Study||2
10102106|NCT02413034|11231470|FG000|STARTED|Overall Study||14
10102107|NCT02413034|11231471|FG001|STARTED|Overall Study||14
10102108|NCT02413034|11231470|FG000|COMPLETED|Overall Study||14
10102109|NCT02413034|11231471|FG001|COMPLETED|Overall Study||14
10102110|NCT02413034|11231470|FG000|NOT COMPLETED|Overall Study||0
10102111|NCT02413034|11231471|FG001|NOT COMPLETED|Overall Study||0
10102112|NCT02413151|11231479|FG000|STARTED|Overall Study||32
10102113|NCT02413151|11231480|FG001|STARTED|Overall Study||30
10102114|NCT02413151|11231479|FG000|COMPLETED|Overall Study||22
10102115|NCT02413151|11231480|FG001|COMPLETED|Overall Study||28
10102116|NCT02413151|11231479|FG000|NOT COMPLETED|Overall Study||10
10102117|NCT02413151|11231480|FG001|NOT COMPLETED|Overall Study||2
10102118|NCT02413190|11231487|FG000|STARTED|Overall Study||94
10102119|NCT02413190|11231487|FG000|COMPLETED|Overall Study||94
10102120|NCT02413190|11231487|FG000|NOT COMPLETED|Overall Study||0
10102121|NCT02413203|11231493|FG000|STARTED|Overall Study||10
10102122|NCT02413203|11231494|FG001|STARTED|Overall Study||10
10102123|NCT02413203|11231493|FG000|COMPLETED|Overall Study||10
10102124|NCT02413203|11231494|FG001|COMPLETED|Overall Study||10
10102125|NCT02413203|11231493|FG000|NOT COMPLETED|Overall Study||0
10102126|NCT02413203|11231494|FG001|NOT COMPLETED|Overall Study||0
10102127|NCT02413229|11231508|FG000|STARTED|Overall Study||25
10102128|NCT02413229|11231509|FG001|STARTED|Overall Study||12
10102129|NCT02413229|11231510|FG002|STARTED|Overall Study||26
10102130|NCT02413229|11231511|FG003|STARTED|Overall Study||12
10102131|NCT02413229|11231512|FG004|STARTED|Overall Study||24
10102132|NCT02413229|11231513|FG005|STARTED|Overall Study||12
10102133|NCT02413229|11231514|FG006|STARTED|Overall Study||25
10102134|NCT02413229|11231515|FG007|STARTED|Overall Study||15
10102135|NCT02413229|11231508|FG000|COMPLETED|Overall Study||24
10102136|NCT02413229|11231509|FG001|COMPLETED|Overall Study||11
10102137|NCT02413229|11231510|FG002|COMPLETED|Overall Study||25
10102138|NCT02413229|11231511|FG003|COMPLETED|Overall Study||11
10102139|NCT02413229|11231512|FG004|COMPLETED|Overall Study||21
10102140|NCT02413229|11231513|FG005|COMPLETED|Overall Study||12
10102141|NCT02413229|11231514|FG006|COMPLETED|Overall Study||25
10102142|NCT02413229|11231515|FG007|COMPLETED|Overall Study||11
10102143|NCT02413229|11231508|FG000|NOT COMPLETED|Overall Study||1
10102144|NCT02413229|11231509|FG001|NOT COMPLETED|Overall Study||1
10102145|NCT02413229|11231510|FG002|NOT COMPLETED|Overall Study||1
10102146|NCT02413229|11231511|FG003|NOT COMPLETED|Overall Study||1
10102147|NCT02413229|11231512|FG004|NOT COMPLETED|Overall Study||3
10102148|NCT02413229|11231513|FG005|NOT COMPLETED|Overall Study||0
10102149|NCT02413229|11231514|FG006|NOT COMPLETED|Overall Study||0
10102150|NCT02413229|11231515|FG007|NOT COMPLETED|Overall Study||4
10102151|NCT02413255|11231550|FG000|STARTED|Overall Study||18
9990675|NCT01657162|11112337|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
10102152|NCT02413255|11231551|FG001|STARTED|Overall Study||6
10102153|NCT02413255|11231552|FG002|STARTED|Overall Study||6
10102154|NCT02413255|11231553|FG003|STARTED|Overall Study||6
10102155|NCT02413255|11231554|FG004|STARTED|Overall Study||6
10102156|NCT02413255|11231555|FG005|STARTED|Overall Study||6
10102157|NCT02413255|11231556|FG006|STARTED|Overall Study||6
10102158|NCT02413255|11231557|FG007|STARTED|Overall Study||6
9990676|NCT01657162|11112336|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
10102159|NCT02413255|11231558|FG008|STARTED|Overall Study||6
10102160|NCT02413255|11231559|FG009|STARTED|Overall Study||6
10102161|NCT02413255|11231560|FG010|STARTED|Overall Study||12
9990677|NCT01657162|11112337|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
9990678|NCT01657162|11112336|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
9990679|NCT01657162|11112337|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
9990680|NCT01657162|11112336|FG000|Study 005 ITT Population|Overall Study||558
9990681|NCT01657162|11112337|FG001|Study 005 ITT Population|Overall Study||581
10102162|NCT02413255|11231561|FG011|STARTED|Overall Study||6
10102163|NCT02413255|11231562|FG012|STARTED|Overall Study||6
10102164|NCT02413255|11231563|FG013|STARTED|Overall Study||6
10102165|NCT02413255|11231564|FG014|STARTED|Overall Study||6
10102166|NCT02413255|11231565|FG015|STARTED|Overall Study||6
10102167|NCT02413255|11231566|FG016|STARTED|Overall Study||6
10102168|NCT02413255|11231550|FG000|COMPLETED|Overall Study||18
10102169|NCT02413255|11231551|FG001|COMPLETED|Overall Study||6
10102170|NCT02413255|11231552|FG002|COMPLETED|Overall Study||6
10102171|NCT02413255|11231553|FG003|COMPLETED|Overall Study||6
10102172|NCT02413255|11231554|FG004|COMPLETED|Overall Study||6
10102173|NCT02413255|11231555|FG005|COMPLETED|Overall Study||6
10102174|NCT02413255|11231556|FG006|COMPLETED|Overall Study||6
10102175|NCT02413255|11231557|FG007|COMPLETED|Overall Study||6
10102176|NCT02413255|11231558|FG008|COMPLETED|Overall Study||6
10102177|NCT02413255|11231559|FG009|COMPLETED|Overall Study||6
10102178|NCT02413255|11231560|FG010|COMPLETED|Overall Study||12
10102179|NCT02413255|11231561|FG011|COMPLETED|Overall Study||6
10102180|NCT02413255|11231562|FG012|COMPLETED|Overall Study||6
10102181|NCT02413255|11231563|FG013|COMPLETED|Overall Study||6
10102182|NCT02413255|11231564|FG014|COMPLETED|Overall Study||5
10102183|NCT02413255|11231565|FG015|COMPLETED|Overall Study||6
10102184|NCT02413255|11231566|FG016|COMPLETED|Overall Study||6
10102185|NCT02413255|11231550|FG000|NOT COMPLETED|Overall Study||0
10102186|NCT02413255|11231551|FG001|NOT COMPLETED|Overall Study||0
10102187|NCT02413255|11231552|FG002|NOT COMPLETED|Overall Study||0
10102188|NCT02413255|11231553|FG003|NOT COMPLETED|Overall Study||0
10102189|NCT02413255|11231554|FG004|NOT COMPLETED|Overall Study||0
10102190|NCT02413255|11231555|FG005|NOT COMPLETED|Overall Study||0
10102191|NCT02413255|11231556|FG006|NOT COMPLETED|Overall Study||0
10102192|NCT02413255|11231557|FG007|NOT COMPLETED|Overall Study||0
10102193|NCT02413255|11231558|FG008|NOT COMPLETED|Overall Study||0
10102194|NCT02413255|11231559|FG009|NOT COMPLETED|Overall Study||0
10102195|NCT02413255|11231560|FG010|NOT COMPLETED|Overall Study||0
10102196|NCT02413255|11231561|FG011|NOT COMPLETED|Overall Study||0
10102197|NCT02413255|11231562|FG012|NOT COMPLETED|Overall Study||0
10102198|NCT02413255|11231563|FG013|NOT COMPLETED|Overall Study||0
10102199|NCT02413255|11231564|FG014|NOT COMPLETED|Overall Study||1
10102200|NCT02413255|11231565|FG015|NOT COMPLETED|Overall Study||0
10102201|NCT02413255|11231566|FG016|NOT COMPLETED|Overall Study||0
10102202|NCT02413294|11231617|FG000|STARTED|Overall Study||12
10102203|NCT02413294|11231617|FG000|COMPLETED|Overall Study||11
10102204|NCT02413294|11231617|FG000|NOT COMPLETED|Overall Study||1
10102205|NCT02413320|11231623|FG000|STARTED|Overall Study||49
10102206|NCT02413320|11231624|FG001|STARTED|Overall Study||52
10102207|NCT02413320|11231623|FG000|COMPLETED|Overall Study||48
10102208|NCT02413320|11231624|FG001|COMPLETED|Overall Study||52
10102209|NCT02413320|11231623|FG000|NOT COMPLETED|Overall Study||1
10102210|NCT02413320|11231624|FG001|NOT COMPLETED|Overall Study||0
10102211|NCT02413333|11231634|FG000|STARTED|Period 1||66
10102212|NCT02413333|11231635|FG001|STARTED|Period 1||66
10102213|NCT02413333|11231634|FG000|Randomized and Treated|Period 1||66
10102214|NCT02413333|11231635|FG001|Randomized and Treated|Period 1||66
10102215|NCT02413333|11231634|FG000|COMPLETED|Period 1||65
9990682|NCT01657162|11112336|FG000|Study 005 Safety Population|Overall Study||553
9990683|NCT01657162|11112337|FG001|Study 005 Safety Population|Overall Study||580
9990684|NCT01657162|11112336|FG000|Study 005 mITT Population|Overall Study||544
9990685|NCT01657162|11112337|FG001|Study 005 mITT Population|Overall Study||568
9990686|NCT01657162|11112336|FG000|COMPLETED|Overall Study||499
9990687|NCT01657162|11112337|FG001|COMPLETED|Overall Study||506
9990688|NCT01657162|11112336|FG000|NOT COMPLETED|Overall Study||59
9990689|NCT01657162|11112337|FG001|NOT COMPLETED|Overall Study||75
9990690|NCT01657253|11112345|FG000|STARTED|Overall Study||93
9990691|NCT01657253|11112346|FG001|STARTED|Overall Study||90
9990692|NCT01657253|11112345|FG000|COMPLETED|Overall Study||76
9990693|NCT01657253|11112346|FG001|COMPLETED|Overall Study||72
9990694|NCT01657253|11112345|FG000|NOT COMPLETED|Overall Study||17
9990695|NCT01657253|11112346|FG001|NOT COMPLETED|Overall Study||18
9990696|NCT01657266|11112354|FG000|STARTED|Overall Study||73
9990697|NCT01657266|11112355|FG001|STARTED|Overall Study||75
10102216|NCT02413333|11231635|FG001|COMPLETED|Period 1||65
10102217|NCT02413333|11231634|FG000|NOT COMPLETED|Period 1||1
10102218|NCT02413333|11231635|FG001|NOT COMPLETED|Period 1||1
10102219|NCT02413333|11231634|FG000|STARTED|Period 2||65
10102220|NCT02413333|11231635|FG001|STARTED|Period 2||65
9990698|NCT01657266|11112354|FG000|COMPLETED|Overall Study||69
9990699|NCT01657266|11112355|FG001|COMPLETED|Overall Study||70
9990700|NCT01657266|11112354|FG000|NOT COMPLETED|Overall Study||4
9990701|NCT01657266|11112355|FG001|NOT COMPLETED|Overall Study||5
9990702|NCT01657292|11112361|FG000|STARTED|Overall Study||61
9990703|NCT01657292|11112361|FG000|COMPLETED|Overall Study||51
9990704|NCT01657292|11112361|FG000|NOT COMPLETED|Overall Study||10
9990705|NCT01657305|11112368|FG000|STARTED|Overall Study||107
9990706|NCT01657305|11112368|FG000|COMPLETED|Overall Study||82
9990707|NCT01657305|11112368|FG000|NOT COMPLETED|Overall Study||25
9990708|NCT01657344|11112408|FG000|STARTED|Overall Study||421622
9990709|NCT01657344|11112409|FG001|STARTED|Overall Study||409967
9990710|NCT01657344|11112410|FG002|STARTED|Overall Study||196300
9990711|NCT01657344|11112411|FG003|STARTED|Overall Study||376517
9990712|NCT01657344|11112412|FG004|STARTED|Overall Study||157802
9990713|NCT01657344|11112413|FG005|STARTED|Overall Study||316477
9990714|NCT01657344|11112414|FG006|STARTED|Overall Study||140776
9990715|NCT01657344|11112408|FG000|COMPLETED|Overall Study||421622
9990716|NCT01657344|11112409|FG001|COMPLETED|Overall Study||409967
9990717|NCT01657344|11112410|FG002|COMPLETED|Overall Study||196300
9990718|NCT01657344|11112411|FG003|COMPLETED|Overall Study||376517
9990719|NCT01657344|11112412|FG004|COMPLETED|Overall Study||157802
9990720|NCT01657344|11112413|FG005|COMPLETED|Overall Study||316477
9990721|NCT01657344|11112414|FG006|COMPLETED|Overall Study||140776
9990722|NCT01657344|11112408|FG000|NOT COMPLETED|Overall Study||0
9990723|NCT01657344|11112409|FG001|NOT COMPLETED|Overall Study||0
9990724|NCT01657344|11112410|FG002|NOT COMPLETED|Overall Study||0
9990725|NCT01657344|11112411|FG003|NOT COMPLETED|Overall Study||0
9990726|NCT01657344|11112412|FG004|NOT COMPLETED|Overall Study||0
9990727|NCT01657344|11112413|FG005|NOT COMPLETED|Overall Study||0
9990728|NCT01657344|11112414|FG006|NOT COMPLETED|Overall Study||0
9990729|NCT01657370|11112430|FG000|STARTED|Overall Study||33
9990730|NCT01657370|11112431|FG001|STARTED|Overall Study||32
9990731|NCT01657370|11112432|FG002|STARTED|Overall Study||32
9990732|NCT01657370|11112433|FG003|STARTED|Overall Study||33
9990733|NCT01657370|11112434|FG004|STARTED|Overall Study||34
9990734|NCT01657370|11112435|FG005|STARTED|Overall Study||31
9990735|NCT01657370|11112430|FG000|COMPLETED|Overall Study||27
9990736|NCT01657370|11112431|FG001|COMPLETED|Overall Study||28
10102221|NCT02413333|11231634|FG000|COMPLETED|Period 2||64
10102222|NCT02413333|11231635|FG001|COMPLETED|Period 2||65
10102223|NCT02413333|11231634|FG000|NOT COMPLETED|Period 2||1
10102224|NCT02413333|11231635|FG001|NOT COMPLETED|Period 2||0
10102225|NCT02413346|11231643|FG000|STARTED|Overall Study||236
10102226|NCT02413346|11231644|FG001|STARTED|Overall Study||247
10102227|NCT02413346|11231643|FG000|COMPLETED|Overall Study||177
10102228|NCT02413346|11231644|FG001|COMPLETED|Overall Study||177
10102229|NCT02413346|11231643|FG000|NOT COMPLETED|Overall Study||59
10102230|NCT02413346|11231644|FG001|NOT COMPLETED|Overall Study||70
10102231|NCT02413372|11231653|FG000|STARTED|Treatment||25
10102232|NCT02413372|11231654|FG001|STARTED|Treatment||24
10102233|NCT02413372|11231655|FG002|STARTED|Treatment||26
10102234|NCT02413372|11231653|FG000|COMPLETED|Treatment||24
10102235|NCT02413372|11231654|FG001|COMPLETED|Treatment||22
10102236|NCT02413372|11231655|FG002|COMPLETED|Treatment||25
10102237|NCT02413372|11231653|FG000|NOT COMPLETED|Treatment||1
10102238|NCT02413372|11231654|FG001|NOT COMPLETED|Treatment||2
10102239|NCT02413372|11231655|FG002|NOT COMPLETED|Treatment||1
10102240|NCT02413372|11231653|FG000|STARTED|Follow-up||22
10102241|NCT02413372|11231654|FG001|STARTED|Follow-up||21
10102242|NCT02413372|11231655|FG002|STARTED|Follow-up||25
10102243|NCT02413372|11231653|FG000|COMPLETED|Follow-up||20
10102244|NCT02413372|11231654|FG001|COMPLETED|Follow-up||20
10102245|NCT02413372|11231655|FG002|COMPLETED|Follow-up||23
10102246|NCT02413372|11231653|FG000|NOT COMPLETED|Follow-up||2
10102247|NCT02413372|11231654|FG001|NOT COMPLETED|Follow-up||1
9990737|NCT01657370|11112432|FG002|COMPLETED|Overall Study||25
9990738|NCT01657370|11112433|FG003|COMPLETED|Overall Study||28
9990739|NCT01657370|11112434|FG004|COMPLETED|Overall Study||27
9990740|NCT01657370|11112435|FG005|COMPLETED|Overall Study||27
9990741|NCT01657370|11112430|FG000|NOT COMPLETED|Overall Study||6
9990742|NCT01657370|11112431|FG001|NOT COMPLETED|Overall Study||4
9990743|NCT01657370|11112432|FG002|NOT COMPLETED|Overall Study||7
9990744|NCT01657370|11112433|FG003|NOT COMPLETED|Overall Study||5
9990745|NCT01657370|11112434|FG004|NOT COMPLETED|Overall Study||7
9990746|NCT01657370|11112435|FG005|NOT COMPLETED|Overall Study||4
9990747|NCT01657461|11112456|FG000|STARTED|Overall Study||98
9990748|NCT01657461|11112457|FG001|STARTED|Overall Study||98
9990749|NCT01657461|11112456|FG000|COMPLETED|Overall Study||88
10102248|NCT02413372|11231655|FG002|NOT COMPLETED|Follow-up||2
10102249|NCT02413398|11231665|FG000|STARTED|Overall Study||160
10102250|NCT02413398|11231666|FG001|STARTED|Overall Study||161
10102251|NCT02413398|11231665|FG000|COMPLETED|Overall Study||156
9990750|NCT01657461|11112457|FG001|COMPLETED|Overall Study||78
9990751|NCT01657461|11112456|FG000|NOT COMPLETED|Overall Study||10
10102252|NCT02413398|11231666|FG001|COMPLETED|Overall Study||154
10102253|NCT02413398|11231665|FG000|NOT COMPLETED|Overall Study||4
10102254|NCT02413398|11231666|FG001|NOT COMPLETED|Overall Study||7
10102255|NCT02413463|11231674|FG000|STARTED|Overall Study||30
10102256|NCT02413463|11231675|FG001|STARTED|Overall Study||30
9990752|NCT01657461|11112457|FG001|NOT COMPLETED|Overall Study||20
9990753|NCT01657617|11112463|FG000|STARTED|Overall Study||35
9990754|NCT01657617|11112463|FG000|COMPLETED|Overall Study||35
10102257|NCT02413463|11231674|FG000|COMPLETED|Overall Study||25
10102258|NCT02413463|11231675|FG001|COMPLETED|Overall Study||28
10102259|NCT02413463|11231674|FG000|NOT COMPLETED|Overall Study||5
10102260|NCT02413463|11231675|FG001|NOT COMPLETED|Overall Study||2
10102261|NCT02413489|11231684|FG000|STARTED|Overall Study||15
10102262|NCT02413489|11231685|FG001|STARTED|Overall Study||16
10102263|NCT02413489|11231686|FG002|STARTED|Overall Study||5
10102264|NCT02413489|11231684|FG000|COMPLETED|Overall Study||0
10102265|NCT02413489|11231685|FG001|COMPLETED|Overall Study||0
10102266|NCT02413489|11231686|FG002|COMPLETED|Overall Study||0
10102267|NCT02413489|11231684|FG000|NOT COMPLETED|Overall Study||15
10102268|NCT02413489|11231685|FG001|NOT COMPLETED|Overall Study||16
10102269|NCT02413489|11231686|FG002|NOT COMPLETED|Overall Study||5
10102270|NCT02413580|11231694|FG000|STARTED|Overall Study||49
10102271|NCT02413580|11231694|FG000|COMPLETED|Overall Study||46
10102272|NCT02413580|11231694|FG000|NOT COMPLETED|Overall Study||3
10102273|NCT02413593|11231698|FG000|STARTED|Overall Study||111
10102274|NCT02413593|11231698|FG000|COMPLETED|Overall Study||107
10102275|NCT02413593|11231698|FG000|NOT COMPLETED|Overall Study||4
10102276|NCT02413684|11231702|FG000|STARTED|Overall Study||53
10102277|NCT02413684|11231702|FG000|COMPLETED|Overall Study||40
10102278|NCT02413684|11231702|FG000|NOT COMPLETED|Overall Study||13
10102279|NCT02413879|11231706|FG000|STARTED|Overall Study||86
10102280|NCT02413879|11231706|FG000|COMPLETED|Overall Study||86
10102281|NCT02413879|11231706|FG000|NOT COMPLETED|Overall Study||0
10102282|NCT02413918|11231710|FG000|STARTED|Overall Study||41
10102283|NCT02413918|11231710|FG000|COMPLETED|Overall Study||16
10102284|NCT02413918|11231710|FG000|NOT COMPLETED|Overall Study||25
10102285|NCT02413996|11231719|FG000|STARTED|Overall Study||44
10102286|NCT02413996|11231720|FG001|STARTED|Overall Study||41
10102287|NCT02413996|11231719|FG000|COMPLETED|Overall Study||35
10102288|NCT02413996|11231720|FG001|COMPLETED|Overall Study||39
10102289|NCT02413996|11231719|FG000|NOT COMPLETED|Overall Study||9
10102290|NCT02413996|11231720|FG001|NOT COMPLETED|Overall Study||2
10102291|NCT02414204|11231728|FG000|STARTED|Overall Study||2
10102292|NCT02414204|11231729|FG001|STARTED|Overall Study||2
10102293|NCT02414204|11231728|FG000|COMPLETED|Overall Study||2
10102294|NCT02414204|11231729|FG001|COMPLETED|Overall Study||2
10102295|NCT02414204|11231728|FG000|NOT COMPLETED|Overall Study||0
10102296|NCT02414204|11231729|FG001|NOT COMPLETED|Overall Study||0
10102297|NCT02414243|11231737|FG000|STARTED|Overall Study||19
10102298|NCT02414243|11231738|FG001|STARTED|Overall Study||21
10102299|NCT02414243|11231737|FG000|Moved to the Other Group|Overall Study||17
10102300|NCT02414243|11231738|FG001|Moved to the Other Group|Overall Study||20
10102301|NCT02414243|11231737|FG000|Entered Open Challenge at Home|Overall Study||17
10102302|NCT02414243|11231738|FG001|Entered Open Challenge at Home|Overall Study||20
10102303|NCT02414243|11231737|FG000|COMPLETED|Overall Study||13
10102304|NCT02414243|11231738|FG001|COMPLETED|Overall Study||17
10102305|NCT02414243|11231737|FG000|NOT COMPLETED|Overall Study||6
10102306|NCT02414243|11231738|FG001|NOT COMPLETED|Overall Study||4
10102307|NCT02414633|11231745|FG000|STARTED|Overall Study||148
10102308|NCT02414633|11231745|FG000|COMPLETED|Overall Study||148
10102309|NCT02414633|11231745|FG000|NOT COMPLETED|Overall Study||0
10113261|NCT02509117|11244197|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113262|NCT02509117|11244198|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
10113263|NCT02509117|11244199|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
10113264|NCT02509117|11244190|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113265|NCT02509117|11244191|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
10113266|NCT02509117|11244192|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113267|NCT02509117|11244193|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113268|NCT02509117|11244194|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113269|NCT02509117|11244195|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113270|NCT02509117|11244196|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113271|NCT02509117|11244197|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113272|NCT02509117|11244198|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
10113273|NCT02509117|11244199|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
10113274|NCT02509117|11244190|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113275|NCT02509117|11244191|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
10113276|NCT02509117|11244192|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113277|NCT02509117|11244193|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113278|NCT02509117|11244194|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113279|NCT02509117|11244195|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113280|NCT02509117|11244196|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113281|NCT02509117|11244197|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113282|NCT02509117|11244198|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
10113283|NCT02509117|11244199|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10113284|NCT02509117|11244190|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10113285|NCT02509117|11244191|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
10113286|NCT02509117|11244192|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10113287|NCT02509117|11244193|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10113288|NCT02509117|11244194|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10113289|NCT02509117|11244195|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10113290|NCT02509117|11244196|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10113291|NCT02509117|11244197|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10113292|NCT02509117|11244198|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
9990755|NCT01657617|11112463|FG000|NOT COMPLETED|Overall Study||0
9990756|NCT01657760|11112469|FG000|STARTED|Overall Study||5
9990757|NCT01657760|11112470|FG001|STARTED|Overall Study||7
9990758|NCT01657760|11112471|FG002|STARTED|Overall Study||7
9990759|NCT01657760|11112472|FG003|STARTED|Overall Study||7
9990760|NCT01657760|11112469|FG000|COMPLETED|Overall Study||4
9990761|NCT01657760|11112470|FG001|COMPLETED|Overall Study||6
9990762|NCT01657760|11112471|FG002|COMPLETED|Overall Study||6
9990763|NCT01657760|11112472|FG003|COMPLETED|Overall Study||4
9990764|NCT01657760|11112469|FG000|NOT COMPLETED|Overall Study||1
9990765|NCT01657760|11112470|FG001|NOT COMPLETED|Overall Study||1
9990766|NCT01657760|11112471|FG002|NOT COMPLETED|Overall Study||1
9990767|NCT01657760|11112472|FG003|NOT COMPLETED|Overall Study||3
9990768|NCT01657799|11112487|FG000|STARTED|Overall Study||102
9990769|NCT01657799|11112488|FG001|STARTED|Overall Study||103
9990770|NCT01657799|11112489|FG002|STARTED|Overall Study||102
9990771|NCT01657799|11112487|FG000|Received Treatment|Overall Study||101
9990772|NCT01657799|11112488|FG001|Received Treatment|Overall Study||103
9990773|NCT01657799|11112489|FG002|Received Treatment|Overall Study||102
9990774|NCT01657799|11112487|FG000|COMPLETED|Overall Study||0
9990775|NCT01657799|11112488|FG001|COMPLETED|Overall Study||0
9990776|NCT01657799|11112489|FG002|COMPLETED|Overall Study||0
9990777|NCT01657799|11112487|FG000|NOT COMPLETED|Overall Study||102
9990778|NCT01657799|11112488|FG001|NOT COMPLETED|Overall Study||103
9990779|NCT01657799|11112489|FG002|NOT COMPLETED|Overall Study||102
9990780|NCT01657877|11112497|FG000|STARTED|Overall Study||79
10102310|NCT02414828|11231753|FG000|STARTED|Overall Study||11
10102311|NCT02414828|11231754|FG001|STARTED|Overall Study||10
10102312|NCT02414828|11231755|FG002|STARTED|Overall Study||20
10102313|NCT02414828|11231756|FG003|STARTED|Overall Study||31
10102314|NCT02414828|11231753|FG000|COMPLETED|Overall Study||11
10102315|NCT02414828|11231754|FG001|COMPLETED|Overall Study||9
10102316|NCT02414828|11231755|FG002|COMPLETED|Overall Study||19
10102317|NCT02414828|11231756|FG003|COMPLETED|Overall Study||29
10102318|NCT02414828|11231753|FG000|NOT COMPLETED|Overall Study||0
10102319|NCT02414828|11231754|FG001|NOT COMPLETED|Overall Study||1
10102320|NCT02414828|11231755|FG002|NOT COMPLETED|Overall Study||1
10102321|NCT02414828|11231756|FG003|NOT COMPLETED|Overall Study||2
10102322|NCT02414841|11231769|FG000|STARTED|Overall Study||405
10102323|NCT02414841|11231770|FG001|STARTED|Overall Study||208
10102324|NCT02414841|11231769|FG000|COMPLETED|Overall Study||349
10102325|NCT02414841|11231770|FG001|COMPLETED|Overall Study||175
10102326|NCT02414841|11231769|FG000|NOT COMPLETED|Overall Study||56
10102327|NCT02414841|11231770|FG001|NOT COMPLETED|Overall Study||33
10102328|NCT02414854|11231782|FG000|STARTED|Overall Study||317
10102329|NCT02414854|11231783|FG001|STARTED|Overall Study||631
10102330|NCT02414854|11231784|FG002|STARTED|Overall Study||321
10102331|NCT02414854|11231785|FG003|STARTED|Overall Study||633
10102332|NCT02414854|11231782|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
10102333|NCT02414854|11231783|FG001|Treated|Overall Study||629
10102334|NCT02414854|11231784|FG002|Treated|Overall Study||321
10102335|NCT02414854|11231785|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
10102336|NCT02414854|11231782|FG000|COMPLETED|Overall Study||295
10102337|NCT02414854|11231783|FG001|COMPLETED|Overall Study||586
10102338|NCT02414854|11231784|FG002|COMPLETED|Overall Study||301
10102339|NCT02414854|11231785|FG003|COMPLETED|Overall Study||582
10102340|NCT02414854|11231782|FG000|NOT COMPLETED|Overall Study||22
10102341|NCT02414854|11231783|FG001|NOT COMPLETED|Overall Study||45
10102342|NCT02414854|11231784|FG002|NOT COMPLETED|Overall Study||20
10102343|NCT02414854|11231785|FG003|NOT COMPLETED|Overall Study||51
10102344|NCT02414932|11231797|FG000|STARTED|Overall Study||3
10102345|NCT02414932|11231798|FG001|STARTED|Overall Study||3
10102346|NCT02414932|11231797|FG000|COMPLETED|Overall Study||0
10102347|NCT02414932|11231798|FG001|COMPLETED|Overall Study||0
10102348|NCT02414932|11231797|FG000|NOT COMPLETED|Overall Study||3
10102349|NCT02414932|11231798|FG001|NOT COMPLETED|Overall Study||3
10102350|NCT02414958|11231807|FG000|STARTED|Overall Study||243
10102351|NCT02414958|11231808|FG001|STARTED|Overall Study||243
10102352|NCT02414958|11231809|FG002|STARTED|Overall Study||244
10102353|NCT02414958|11231807|FG000|COMPLETED|Overall Study||211
9990781|NCT01657877|11112497|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
9990782|NCT01657877|11112497|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
9990783|NCT01657877|11112497|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
9990784|NCT01657877|11112497|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
10102354|NCT02414958|11231808|FG001|COMPLETED|Overall Study||223
10102355|NCT02414958|11231809|FG002|COMPLETED|Overall Study||230
10102356|NCT02414958|11231807|FG000|NOT COMPLETED|Overall Study||32
10102357|NCT02414958|11231808|FG001|NOT COMPLETED|Overall Study||20
9990785|NCT01657877|11112497|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
9990786|NCT01657877|11112497|FG000|COMPLETED|Overall Study||65
10102358|NCT02414958|11231809|FG002|NOT COMPLETED|Overall Study||14
10102359|NCT02415127|11231819|FG000|STARTED|Overall Study||47
10102360|NCT02415127|11231820|FG001|STARTED|Overall Study||45
10102361|NCT02415127|11231819|FG000|COMPLETED|Overall Study||46
10102362|NCT02415127|11231820|FG001|COMPLETED|Overall Study||45
9990787|NCT01657877|11112497|FG000|NOT COMPLETED|Overall Study||14
9990788|NCT01657903|11112514|FG000|STARTED|Overall Study||56
9990789|NCT01657903|11112514|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
9990790|NCT01657903|11112514|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
9990791|NCT01657903|11112514|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54
9990792|NCT01657903|11112514|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55
9990793|NCT01657903|11112514|FG000|COMPLETED|Overall Study||54
9990794|NCT01657903|11112514|FG000|NOT COMPLETED|Overall Study||2
9990795|NCT01658020|11112527|FG000|STARTED|Overall Study||175
9990796|NCT01658020|11112528|FG001|STARTED|Overall Study||167
9990797|NCT01658020|11112527|FG000|COMPLETED|Overall Study||167
9990798|NCT01658020|11112528|FG001|COMPLETED|Overall Study||158
9990799|NCT01658020|11112527|FG000|NOT COMPLETED|Overall Study||8
9990800|NCT01658020|11112528|FG001|NOT COMPLETED|Overall Study||9
9990801|NCT01658059|11112535|FG000|STARTED|First Intervention- 2 Days||12
9990802|NCT01658059|11112536|FG001|STARTED|First Intervention- 2 Days||10
9990803|NCT01658059|11112535|FG000|COMPLETED|First Intervention- 2 Days||6
9990804|NCT01658059|11112536|FG001|COMPLETED|First Intervention- 2 Days||5
9990805|NCT01658059|11112535|FG000|NOT COMPLETED|First Intervention- 2 Days||6
9990806|NCT01658059|11112536|FG001|NOT COMPLETED|First Intervention- 2 Days||5
9990807|NCT01658059|11112535|FG000|STARTED|Washout Period- 14 Days||6
9990808|NCT01658059|11112536|FG001|STARTED|Washout Period- 14 Days||5
9990809|NCT01658059|11112535|FG000|COMPLETED|Washout Period- 14 Days||6
9990810|NCT01658059|11112536|FG001|COMPLETED|Washout Period- 14 Days||5
9990811|NCT01658059|11112535|FG000|NOT COMPLETED|Washout Period- 14 Days||0
9990812|NCT01658059|11112536|FG001|NOT COMPLETED|Washout Period- 14 Days||0
9990813|NCT01658059|11112535|FG000|STARTED|Second Intervention- 2 Days||6
9990814|NCT01658059|11112536|FG001|STARTED|Second Intervention- 2 Days||5
9990815|NCT01658059|11112535|FG000|COMPLETED|Second Intervention- 2 Days||6
9990816|NCT01658059|11112536|FG001|COMPLETED|Second Intervention- 2 Days||5
9990817|NCT01658059|11112535|FG000|NOT COMPLETED|Second Intervention- 2 Days||0
9990818|NCT01658059|11112536|FG001|NOT COMPLETED|Second Intervention- 2 Days||0
9990819|NCT01658072|11112544|FG000|STARTED|Overall Study||45
9990820|NCT01658072|11112545|FG001|STARTED|Overall Study||45
9990821|NCT01658072|11112544|FG000|COMPLETED|Overall Study||41
9990822|NCT01658072|11112545|FG001|COMPLETED|Overall Study||43
9990823|NCT01658072|11112544|FG000|NOT COMPLETED|Overall Study||4
9990824|NCT01658072|11112545|FG001|NOT COMPLETED|Overall Study||2
9990825|NCT01658150|11112551|FG000|STARTED|Overall Study||11
9990826|NCT01658150|11112551|FG000|COMPLETED|Overall Study||10
9990827|NCT01658150|11112551|FG000|NOT COMPLETED|Overall Study||1
9990828|NCT01658228|11112558|FG000|STARTED|Overall Study||30
9990829|NCT01658228|11112559|FG001|STARTED|Overall Study||31
9990830|NCT01658228|11112558|FG000|COMPLETED|Overall Study||23
9990831|NCT01658228|11112559|FG001|COMPLETED|Overall Study||23
9990832|NCT01658228|11112558|FG000|NOT COMPLETED|Overall Study||7
9990833|NCT01658228|11112559|FG001|NOT COMPLETED|Overall Study||8
9990834|NCT01658436|11112565|FG000|STARTED|Overall Study||20
9990835|NCT01658436|11112566|FG001|STARTED|Overall Study||11
9990836|NCT01658436|11112565|FG000|COMPLETED|Overall Study||0
9990837|NCT01658436|11112566|FG001|COMPLETED|Overall Study||0
9990838|NCT01658436|11112565|FG000|NOT COMPLETED|Overall Study||20
9990839|NCT01658436|11112566|FG001|NOT COMPLETED|Overall Study||11
9990840|NCT01658514|11112575|FG000|STARTED|Overall Study||14
9990841|NCT01658514|11112576|FG001|STARTED|Overall Study||11
9990842|NCT01658514|11112577|FG002|STARTED|Overall Study||14
9990843|NCT01658514|11112575|FG000|Completed Treatment A|Overall Study||14
9990844|NCT01658514|11112576|FG001|Completed Treatment A|Overall Study||11
9990845|NCT01658514|11112577|FG002|Completed Treatment A|Overall Study||12
9990846|NCT01658514|11112575|FG000|Completed Treatment B|Overall Study||13
9990847|NCT01658514|11112576|FG001|Completed Treatment B|Overall Study||11
9990848|NCT01658514|11112577|FG002|Completed Treatment B|Overall Study||14
9990849|NCT01658514|11112575|FG000|Completed Treatment C|Overall Study||13
9990850|NCT01658514|11112576|FG001|Completed Treatment C|Overall Study||11
9990851|NCT01658514|11112577|FG002|Completed Treatment C|Overall Study||12
9990852|NCT01658514|11112575|FG000|Started - Normal RF Cohort Only|Overall Study||3
9990853|NCT01658514|11112576|FG001|Started - Normal RF Cohort Only|Overall Study||2
9990854|NCT01658514|11112577|FG002|Started - Normal RF Cohort Only|Overall Study||3
9990855|NCT01658514|11112575|FG000|Completed - Normal RF Cohort Only|Overall Study||3
9990856|NCT01658514|11112576|FG001|Completed - Normal RF Cohort Only|Overall Study||2
9990857|NCT01658514|11112577|FG002|Completed - Normal RF Cohort Only|Overall Study||3
9990858|NCT01658514|11112575|FG000|Started - Mild RI Cohort Only|Overall Study||4
9990859|NCT01658514|11112576|FG001|Started - Mild RI Cohort Only|Overall Study||3
9990860|NCT01658514|11112577|FG002|Started - Mild RI Cohort Only|Overall Study||4
9990861|NCT01658514|11112575|FG000|Completed - Mild RI Cohort Only|Overall Study||4
9990862|NCT01658514|11112576|FG001|Completed - Mild RI Cohort Only|Overall Study||3
9990863|NCT01658514|11112577|FG002|Completed - Mild RI Cohort Only|Overall Study||4
9990864|NCT01658514|11112575|FG000|Started - Moderate RI Cohort Only|Overall Study||4
9990865|NCT01658514|11112576|FG001|Started - Moderate RI Cohort Only|Overall Study||4
9990866|NCT01658514|11112577|FG002|Started - Moderate RI Cohort Only|Overall Study||4
9990867|NCT01658514|11112575|FG000|Completed - Moderate RI Cohort Only|Overall Study||3
9990868|NCT01658514|11112576|FG001|Completed - Moderate RI Cohort Only|Overall Study||4
9990869|NCT01658514|11112577|FG002|Completed - Moderate RI Cohort Only|Overall Study||2
9990870|NCT01658514|11112575|FG000|Started - Severe RI Cohort Only|Overall Study||3
9990871|NCT01658514|11112576|FG001|Started - Severe RI Cohort Only|Overall Study||2
9990872|NCT01658514|11112577|FG002|Started - Severe RI Cohort Only|Overall Study||3
9990873|NCT01658514|11112575|FG000|Completed - Severe RI Cohort Only|Overall Study||3
9990874|NCT01658514|11112576|FG001|Completed - Severe RI Cohort Only|Overall Study||2
9990875|NCT01658514|11112577|FG002|Completed - Severe RI Cohort Only|Overall Study||3
9990876|NCT01658514|11112575|FG000|COMPLETED|Overall Study||13
9990877|NCT01658514|11112576|FG001|COMPLETED|Overall Study||11
9990878|NCT01658514|11112577|FG002|COMPLETED|Overall Study||12
9990879|NCT01658514|11112575|FG000|NOT COMPLETED|Overall Study||1
9990880|NCT01658514|11112576|FG001|NOT COMPLETED|Overall Study||0
9990881|NCT01658514|11112577|FG002|NOT COMPLETED|Overall Study||2
9990882|NCT01658579|11112588|FG000|STARTED|Treatment Period A||15
9990883|NCT01658579|11112589|FG001|STARTED|Treatment Period A||15
9990884|NCT01658579|11112590|FG002|STARTED|Treatment Period A||15
9990885|NCT01658579|11112591|FG003|STARTED|Treatment Period A||14
9990886|NCT01658579|11112588|FG000|COMPLETED|Treatment Period A||14
9990887|NCT01658579|11112589|FG001|COMPLETED|Treatment Period A||15
9990888|NCT01658579|11112590|FG002|COMPLETED|Treatment Period A||14
9990889|NCT01658579|11112591|FG003|COMPLETED|Treatment Period A||13
9990890|NCT01658579|11112588|FG000|NOT COMPLETED|Treatment Period A||1
9990891|NCT01658579|11112589|FG001|NOT COMPLETED|Treatment Period A||0
9990892|NCT01658579|11112590|FG002|NOT COMPLETED|Treatment Period A||1
9990893|NCT01658579|11112591|FG003|NOT COMPLETED|Treatment Period A||1
9990894|NCT01658579|11112588|FG000|STARTED|Treatment Period B||14
9990895|NCT01658579|11112589|FG001|STARTED|Treatment Period B||15
9990896|NCT01658579|11112590|FG002|STARTED|Treatment Period B||14
9990897|NCT01658579|11112591|FG003|STARTED|Treatment Period B||13
9990898|NCT01658579|11112588|FG000|COMPLETED|Treatment Period B||14
9990899|NCT01658579|11112589|FG001|COMPLETED|Treatment Period B||15
9990900|NCT01658579|11112590|FG002|COMPLETED|Treatment Period B||14
9990901|NCT01658579|11112591|FG003|COMPLETED|Treatment Period B||12
9990902|NCT01658579|11112588|FG000|NOT COMPLETED|Treatment Period B||0
9990903|NCT01658579|11112589|FG001|NOT COMPLETED|Treatment Period B||0
9990904|NCT01658579|11112590|FG002|NOT COMPLETED|Treatment Period B||0
9990905|NCT01658579|11112591|FG003|NOT COMPLETED|Treatment Period B||1
9990906|NCT01658657|11112599|FG000|STARTED|Overall Study||7
9990907|NCT01658657|11112600|FG001|STARTED|Overall Study||10
9990908|NCT01658657|11112599|FG000|COMPLETED|Overall Study||4
9990909|NCT01658657|11112600|FG001|COMPLETED|Overall Study||7
9990910|NCT01658657|11112599|FG000|NOT COMPLETED|Overall Study||3
9990911|NCT01658657|11112600|FG001|NOT COMPLETED|Overall Study||3
9990912|NCT01658735|11112609|FG000|STARTED|Overall Study||39
9990913|NCT01658735|11112610|FG001|STARTED|Overall Study||36
9990914|NCT01658735|11112611|FG002|STARTED|Overall Study||38
9990915|NCT01658735|11112609|FG000|COMPLETED|Overall Study||34
9990916|NCT01658735|11112610|FG001|COMPLETED|Overall Study||29
9990917|NCT01658735|11112611|FG002|COMPLETED|Overall Study||34
9990918|NCT01658735|11112609|FG000|NOT COMPLETED|Overall Study||5
9990919|NCT01658735|11112610|FG001|NOT COMPLETED|Overall Study||7
9990920|NCT01658735|11112611|FG002|NOT COMPLETED|Overall Study||4
9990921|NCT01658839|11112619|FG000|STARTED|Overall Study||25
9990922|NCT01658839|11112619|FG000|COMPLETED|Overall Study||25
9990923|NCT01658839|11112619|FG000|NOT COMPLETED|Overall Study||0
9990924|NCT01658904|11112626|FG000|STARTED|Overall Study||3
9990925|NCT01658904|11112627|FG001|STARTED|Overall Study||0
9990926|NCT01658904|11112628|FG002|STARTED|Overall Study||0
9990927|NCT01658904|11112626|FG000|COMPLETED|Overall Study||1
9990928|NCT01658904|11112627|FG001|COMPLETED|Overall Study||0
9990929|NCT01658904|11112628|FG002|COMPLETED|Overall Study||0
9990930|NCT01658904|11112626|FG000|NOT COMPLETED|Overall Study||2
9990931|NCT01658904|11112627|FG001|NOT COMPLETED|Overall Study||0
9990932|NCT01658904|11112628|FG002|NOT COMPLETED|Overall Study||0
9990933|NCT01658943|11112641|FG000|STARTED|Overall Study||70
9990934|NCT01658943|11112642|FG001|STARTED|Overall Study||67
9990935|NCT01658943|11112641|FG000|Eligible|Overall Study||63
9990936|NCT01658943|11112642|FG001|Eligible|Overall Study||58
9990937|NCT01658943|11112641|FG000|Eligible and Began Protocol Therapy|Overall Study||62
9990938|NCT01658943|11112642|FG001|Eligible and Began Protocol Therapy|Overall Study||58
9990939|NCT01658943|11112641|FG000|COMPLETED|Overall Study||0
9990940|NCT01658943|11112642|FG001|COMPLETED|Overall Study||0
9990941|NCT01658943|11112641|FG000|NOT COMPLETED|Overall Study||70
9990942|NCT01658943|11112642|FG001|NOT COMPLETED|Overall Study||67
9990943|NCT01658995|11112650|FG000|STARTED|Overall Study||42
9990944|NCT01658995|11112651|FG001|STARTED|Overall Study||40
9990945|NCT01658995|11112650|FG000|COMPLETED|Overall Study||42
9990946|NCT01658995|11112651|FG001|COMPLETED|Overall Study||40
9990947|NCT01658995|11112650|FG000|NOT COMPLETED|Overall Study||0
9990948|NCT01658995|11112651|FG001|NOT COMPLETED|Overall Study||0
9990949|NCT01659021|11112659|FG000|STARTED|Main Study||174
9990950|NCT01659021|11112660|FG001|STARTED|Main Study||87
9990951|NCT01659021|11112659|FG000|Randomized and Treated|Main Study||173
9990952|NCT01659021|11112660|FG001|Randomized and Treated|Main Study||86
9990953|NCT01659021|11112659|FG000|COMPLETED|Main Study||100
9990954|NCT01659021|11112660|FG001|COMPLETED|Main Study||50
9990955|NCT01659021|11112659|FG000|NOT COMPLETED|Main Study||74
9990956|NCT01659021|11112660|FG001|NOT COMPLETED|Main Study||37
9990957|NCT01659021|11112659|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
10018302|NCT01822925|11141361|FG001|STARTED|Overall Study||32
9990958|NCT01659021|11112660|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
9990959|NCT01659021|11112659|FG000|COMPLETED|Long-Term Follow Up||133
9990960|NCT01659021|11112660|FG001|COMPLETED|Long-Term Follow Up||65
9990961|NCT01659021|11112659|FG000|NOT COMPLETED|Long-Term Follow Up||5
9990962|NCT01659021|11112660|FG001|NOT COMPLETED|Long-Term Follow Up||4
9990963|NCT01659125|11112670|FG000|STARTED|Overall Study||26
9990964|NCT01659125|11112670|FG000|Initiated Treatment|Overall Study||24
9990965|NCT01659125|11112670|FG000|Completed the Posttreatment Assessment|Overall Study||17
9990966|NCT01659125|11112670|FG000|Completed 3-month Follow-up|Overall Study||16
9990967|NCT01659125|11112670|FG000|Completed 6-month Follow-up|Overall Study||12
9990968|NCT01659125|11112670|FG000|COMPLETED|Overall Study||12
9990969|NCT01659125|11112670|FG000|NOT COMPLETED|Overall Study||14
9990970|NCT01659255|11112691|FG000|STARTED|Overall Study||3
9990971|NCT01659255|11112692|FG001|STARTED|Overall Study||3
9990972|NCT01659255|11112693|FG002|STARTED|Overall Study||4
9990973|NCT01659255|11112694|FG003|STARTED|Overall Study||3
9990974|NCT01659255|11112695|FG004|STARTED|Overall Study||3
9990975|NCT01659255|11112696|FG005|STARTED|Overall Study||3
9990976|NCT01659255|11112697|FG006|STARTED|Overall Study||3
9990977|NCT01659255|11112698|FG007|STARTED|Overall Study||3
9990978|NCT01659255|11112699|FG008|STARTED|Overall Study||3
9990979|NCT01659255|11112700|FG009|STARTED|Overall Study||3
9990980|NCT01659255|11112701|FG010|STARTED|Overall Study||3
9990981|NCT01659255|11112702|FG011|STARTED|Overall Study||5
9990982|NCT01659255|11112703|FG012|STARTED|Overall Study||8
9990983|NCT01659255|11112704|FG013|STARTED|Overall Study||21
9990984|NCT01659255|11112705|FG014|STARTED|Overall Study||10
9990985|NCT01659255|11112706|FG015|STARTED|Overall Study||9
9990986|NCT01659255|11112707|FG016|STARTED|Overall Study||3
9990987|NCT01659255|11112691|FG000|COMPLETED|Overall Study||1
9990988|NCT01659255|11112692|FG001|COMPLETED|Overall Study||2
9990989|NCT01659255|11112693|FG002|COMPLETED|Overall Study||4
9990990|NCT01659255|11112694|FG003|COMPLETED|Overall Study||3
9990991|NCT01659255|11112695|FG004|COMPLETED|Overall Study||3
9990992|NCT01659255|11112696|FG005|COMPLETED|Overall Study||2
9990993|NCT01659255|11112697|FG006|COMPLETED|Overall Study||1
9990994|NCT01659255|11112698|FG007|COMPLETED|Overall Study||1
9990995|NCT01659255|11112699|FG008|COMPLETED|Overall Study||2
9990996|NCT01659255|11112700|FG009|COMPLETED|Overall Study||0
9990997|NCT01659255|11112701|FG010|COMPLETED|Overall Study||0
9990998|NCT01659255|11112702|FG011|COMPLETED|Overall Study||1
9990999|NCT01659255|11112703|FG012|COMPLETED|Overall Study||0
9991000|NCT01659255|11112704|FG013|COMPLETED|Overall Study||3
9991001|NCT01659255|11112705|FG014|COMPLETED|Overall Study||2
9991002|NCT01659255|11112706|FG015|COMPLETED|Overall Study||4
9991003|NCT01659255|11112707|FG016|COMPLETED|Overall Study||0
9991004|NCT01659255|11112691|FG000|NOT COMPLETED|Overall Study||2
9991005|NCT01659255|11112692|FG001|NOT COMPLETED|Overall Study||1
9991006|NCT01659255|11112693|FG002|NOT COMPLETED|Overall Study||0
9991007|NCT01659255|11112694|FG003|NOT COMPLETED|Overall Study||0
9991008|NCT01659255|11112695|FG004|NOT COMPLETED|Overall Study||0
9991009|NCT01659255|11112696|FG005|NOT COMPLETED|Overall Study||1
9991010|NCT01659255|11112697|FG006|NOT COMPLETED|Overall Study||2
9991011|NCT01659255|11112698|FG007|NOT COMPLETED|Overall Study||2
9991012|NCT01659255|11112699|FG008|NOT COMPLETED|Overall Study||1
9991013|NCT01659255|11112700|FG009|NOT COMPLETED|Overall Study||3
9991014|NCT01659255|11112701|FG010|NOT COMPLETED|Overall Study||3
9991015|NCT01659255|11112702|FG011|NOT COMPLETED|Overall Study||4
9991016|NCT01659255|11112703|FG012|NOT COMPLETED|Overall Study||8
9991017|NCT01659255|11112704|FG013|NOT COMPLETED|Overall Study||18
9991018|NCT01659255|11112705|FG014|NOT COMPLETED|Overall Study||8
9991019|NCT01659255|11112706|FG015|NOT COMPLETED|Overall Study||5
9991020|NCT01659255|11112707|FG016|NOT COMPLETED|Overall Study||3
9991021|NCT01659268|11112747|FG000|STARTED|Overall Study||9
9991022|NCT01659268|11112748|FG001|STARTED|Overall Study||8
9991023|NCT01659268|11112747|FG000|COMPLETED|Overall Study||9
9991024|NCT01659268|11112748|FG001|COMPLETED|Overall Study||8
9991025|NCT01659268|11112747|FG000|NOT COMPLETED|Overall Study||0
9991026|NCT01659268|11112748|FG001|NOT COMPLETED|Overall Study||0
9991027|NCT01659320|11112754|FG000|STARTED|Overall Study||16
9991028|NCT01659320|11112754|FG000|COMPLETED|Overall Study||13
9991029|NCT01659320|11112754|FG000|NOT COMPLETED|Overall Study||3
9991030|NCT01659567|11112758|FG000|STARTED|Overall Study||516
9991031|NCT01659567|11112758|FG000|COMPLETED|Overall Study||393
9991032|NCT01659567|11112758|FG000|NOT COMPLETED|Overall Study||123
9991033|NCT01659736|11112764|FG000|STARTED|Treatment Period||14
9991034|NCT01659736|11112765|FG001|STARTED|Treatment Period||12
9991035|NCT01659736|11112764|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
9991036|NCT01659736|11112765|FG001|COMPLETED|Treatment Period||10
9991037|NCT01659736|11112764|FG000|NOT COMPLETED|Treatment Period||5
9991038|NCT01659736|11112765|FG001|NOT COMPLETED|Treatment Period||2
9991039|NCT01659736|11112764|FG000|STARTED|3-month Follow-up||9
9991040|NCT01659736|11112765|FG001|STARTED|3-month Follow-up||10
9991041|NCT01659736|11112764|FG000|COMPLETED|3-month Follow-up||9
9991042|NCT01659736|11112765|FG001|COMPLETED|3-month Follow-up||9
9991043|NCT01659736|11112764|FG000|NOT COMPLETED|3-month Follow-up||0
9991044|NCT01659736|11112765|FG001|NOT COMPLETED|3-month Follow-up||1
9991045|NCT01659853|11112773|FG000|STARTED|Treatment Period 1||35
9991046|NCT01659853|11112774|FG001|STARTED|Treatment Period 1||35
9991047|NCT01659853|11112773|FG000|COMPLETED|Treatment Period 1||35
9991048|NCT01659853|11112774|FG001|COMPLETED|Treatment Period 1||35
9991049|NCT01659853|11112773|FG000|NOT COMPLETED|Treatment Period 1||0
9991050|NCT01659853|11112774|FG001|NOT COMPLETED|Treatment Period 1||0
9991051|NCT01659853|11112773|FG000|STARTED|Washout , 3 to 7 Days||35
9991052|NCT01659853|11112774|FG001|STARTED|Washout , 3 to 7 Days||35
9991053|NCT01659853|11112773|FG000|COMPLETED|Washout , 3 to 7 Days||33
9991054|NCT01659853|11112774|FG001|COMPLETED|Washout , 3 to 7 Days||35
9991055|NCT01659853|11112773|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2
9991056|NCT01659853|11112774|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0
9991057|NCT01659853|11112773|FG000|STARTED|Treatment Period 2||33
9991058|NCT01659853|11112774|FG001|STARTED|Treatment Period 2||35
9991059|NCT01659853|11112773|FG000|COMPLETED|Treatment Period 2||33
9991060|NCT01659853|11112774|FG001|COMPLETED|Treatment Period 2||35
9991061|NCT01659853|11112773|FG000|NOT COMPLETED|Treatment Period 2||0
9991062|NCT01659853|11112774|FG001|NOT COMPLETED|Treatment Period 2||0
9991063|NCT01659866|11112784|FG000|STARTED|Overall Study||430
9991064|NCT01659866|11112785|FG001|STARTED|Overall Study||80
9991065|NCT01659866|11112784|FG000|COMPLETED|Overall Study||430
9991066|NCT01659866|11112785|FG001|COMPLETED|Overall Study||80
9991067|NCT01659866|11112784|FG000|NOT COMPLETED|Overall Study||0
9991068|NCT01659866|11112785|FG001|NOT COMPLETED|Overall Study||0
9991069|NCT01659996|11112794|FG000|STARTED|Overall Study||421
9991070|NCT01659996|11112795|FG001|STARTED|Overall Study||395
9991071|NCT01659996|11112796|FG002|STARTED|Overall Study||472
9991072|NCT01659996|11112794|FG000|COMPLETED|Overall Study||413
9991073|NCT01659996|11112795|FG001|COMPLETED|Overall Study||388
9991074|NCT01659996|11112796|FG002|COMPLETED|Overall Study||461
9991075|NCT01659996|11112794|FG000|NOT COMPLETED|Overall Study||8
9991076|NCT01659996|11112795|FG001|NOT COMPLETED|Overall Study||7
9991077|NCT01659996|11112796|FG002|NOT COMPLETED|Overall Study||11
9991078|NCT01660022|11112812|FG000|STARTED|First Sequence (7 Days)||8
9991079|NCT01660022|11112813|FG001|STARTED|First Sequence (7 Days)||8
9991080|NCT01660022|11112814|FG002|STARTED|First Sequence (7 Days)||8
9991081|NCT01660022|11112815|FG003|STARTED|First Sequence (7 Days)||8
9991082|NCT01660022|11112816|FG004|STARTED|First Sequence (7 Days)||7
9991083|NCT01660022|11112817|FG005|STARTED|First Sequence (7 Days)||20
9991084|NCT01660022|11112812|FG000|COMPLETED|First Sequence (7 Days)||8
9991085|NCT01660022|11112813|FG001|COMPLETED|First Sequence (7 Days)||7
9991086|NCT01660022|11112814|FG002|COMPLETED|First Sequence (7 Days)||8
9991087|NCT01660022|11112815|FG003|COMPLETED|First Sequence (7 Days)||7
9991088|NCT01660022|11112816|FG004|COMPLETED|First Sequence (7 Days)||6
9991089|NCT01660022|11112817|FG005|COMPLETED|First Sequence (7 Days)||16
9991090|NCT01660022|11112812|FG000|NOT COMPLETED|First Sequence (7 Days)||0
9991091|NCT01660022|11112813|FG001|NOT COMPLETED|First Sequence (7 Days)||1
9991092|NCT01660022|11112814|FG002|NOT COMPLETED|First Sequence (7 Days)||0
9991093|NCT01660022|11112815|FG003|NOT COMPLETED|First Sequence (7 Days)||1
9991094|NCT01660022|11112816|FG004|NOT COMPLETED|First Sequence (7 Days)||1
9991095|NCT01660022|11112817|FG005|NOT COMPLETED|First Sequence (7 Days)||4
9991096|NCT01660022|11112812|FG000|STARTED|Second Sequence (42 Days)||8
9991097|NCT01660022|11112813|FG001|STARTED|Second Sequence (42 Days)||7
9991098|NCT01660022|11112814|FG002|STARTED|Second Sequence (42 Days)||8
9991099|NCT01660022|11112815|FG003|STARTED|Second Sequence (42 Days)||7
9991100|NCT01660022|11112816|FG004|STARTED|Second Sequence (42 Days)||6
9991101|NCT01660022|11112817|FG005|STARTED|Second Sequence (42 Days)||16
9991102|NCT01660022|11112812|FG000|COMPLETED|Second Sequence (42 Days)||8
9991103|NCT01660022|11112813|FG001|COMPLETED|Second Sequence (42 Days)||7
9991104|NCT01660022|11112814|FG002|COMPLETED|Second Sequence (42 Days)||8
9991105|NCT01660022|11112815|FG003|COMPLETED|Second Sequence (42 Days)||7
9991106|NCT01660022|11112816|FG004|COMPLETED|Second Sequence (42 Days)||6
9991107|NCT01660022|11112817|FG005|COMPLETED|Second Sequence (42 Days)||16
9991108|NCT01660022|11112812|FG000|NOT COMPLETED|Second Sequence (42 Days)||0
9991109|NCT01660022|11112813|FG001|NOT COMPLETED|Second Sequence (42 Days)||0
9991110|NCT01660022|11112814|FG002|NOT COMPLETED|Second Sequence (42 Days)||0
9991111|NCT01660022|11112815|FG003|NOT COMPLETED|Second Sequence (42 Days)||0
9991112|NCT01660022|11112816|FG004|NOT COMPLETED|Second Sequence (42 Days)||0
9991113|NCT01660022|11112817|FG005|NOT COMPLETED|Second Sequence (42 Days)||0
9991114|NCT01660191|11112846|FG000|STARTED|Enrollment and Washout||45
9991115|NCT01660191|11112847|FG001|STARTED|Enrollment and Washout||45
9991116|NCT01660191|11112848|FG002|STARTED|Enrollment and Washout||44
9991117|NCT01660191|11112846|FG000|COMPLETED|Enrollment and Washout||45
9991118|NCT01660191|11112847|FG001|COMPLETED|Enrollment and Washout||45
9991119|NCT01660191|11112848|FG002|COMPLETED|Enrollment and Washout||44
9991120|NCT01660191|11112846|FG000|NOT COMPLETED|Enrollment and Washout||0
9991121|NCT01660191|11112847|FG001|NOT COMPLETED|Enrollment and Washout||0
9991122|NCT01660191|11112848|FG002|NOT COMPLETED|Enrollment and Washout||0
9991123|NCT01660191|11112846|FG000|STARTED|Randomization||45
9991124|NCT01660191|11112847|FG001|STARTED|Randomization||45
9991125|NCT01660191|11112848|FG002|STARTED|Randomization||44
9991126|NCT01660191|11112846|FG000|COMPLETED|Randomization||45
9991127|NCT01660191|11112847|FG001|COMPLETED|Randomization||45
9991128|NCT01660191|11112848|FG002|COMPLETED|Randomization||44
9991129|NCT01660191|11112846|FG000|NOT COMPLETED|Randomization||0
9991130|NCT01660191|11112847|FG001|NOT COMPLETED|Randomization||0
9991131|NCT01660191|11112848|FG002|NOT COMPLETED|Randomization||0
9991132|NCT01660191|11112846|FG000|STARTED|End of Treatment||45
9991133|NCT01660191|11112847|FG001|STARTED|End of Treatment||45
9991134|NCT01660191|11112848|FG002|STARTED|End of Treatment||44
9991135|NCT01660191|11112846|FG000|COMPLETED|End of Treatment||44
9991136|NCT01660191|11112847|FG001|COMPLETED|End of Treatment||39
9991137|NCT01660191|11112848|FG002|COMPLETED|End of Treatment||43
9991138|NCT01660191|11112846|FG000|NOT COMPLETED|End of Treatment||1
9991139|NCT01660191|11112847|FG001|NOT COMPLETED|End of Treatment||6
9991140|NCT01660191|11112848|FG002|NOT COMPLETED|End of Treatment||1
9991141|NCT01660230|11112868|FG000|STARTED|Overall Study||4
9991142|NCT01660230|11112869|FG001|STARTED|Overall Study||4
9991143|NCT01660230|11112870|FG002|STARTED|Overall Study||4
9991144|NCT01660230|11112871|FG003|STARTED|Overall Study||4
9991145|NCT01660230|11112872|FG004|STARTED|Overall Study||4
9991146|NCT01660230|11112873|FG005|STARTED|Overall Study||2
9991147|NCT01660230|11112874|FG006|STARTED|Overall Study||4
9991148|NCT01660230|11112875|FG007|STARTED|Overall Study||6
9991149|NCT01660230|11112876|FG008|STARTED|Overall Study||6
9991150|NCT01660230|11112877|FG009|STARTED|Overall Study||6
9991151|NCT01660230|11112878|FG010|STARTED|Overall Study||6
9991152|NCT01660230|11112879|FG011|STARTED|Overall Study||14
9991153|NCT01660230|11112868|FG000|COMPLETED|Overall Study||4
9991154|NCT01660230|11112869|FG001|COMPLETED|Overall Study||4
9991155|NCT01660230|11112870|FG002|COMPLETED|Overall Study||4
9991156|NCT01660230|11112871|FG003|COMPLETED|Overall Study||4
9991157|NCT01660230|11112872|FG004|COMPLETED|Overall Study||4
9991158|NCT01660230|11112873|FG005|COMPLETED|Overall Study||2
9991159|NCT01660230|11112874|FG006|COMPLETED|Overall Study||4
9991160|NCT01660230|11112875|FG007|COMPLETED|Overall Study||6
9991161|NCT01660230|11112876|FG008|COMPLETED|Overall Study||6
9991162|NCT01660230|11112877|FG009|COMPLETED|Overall Study||6
9991163|NCT01660230|11112878|FG010|COMPLETED|Overall Study||6
9991164|NCT01660230|11112879|FG011|COMPLETED|Overall Study||14
9991165|NCT01660230|11112868|FG000|NOT COMPLETED|Overall Study||0
9991166|NCT01660230|11112869|FG001|NOT COMPLETED|Overall Study||0
9991167|NCT01660230|11112870|FG002|NOT COMPLETED|Overall Study||0
9991168|NCT01660230|11112871|FG003|NOT COMPLETED|Overall Study||0
9991169|NCT01660230|11112872|FG004|NOT COMPLETED|Overall Study||0
9991170|NCT01660230|11112873|FG005|NOT COMPLETED|Overall Study||0
9991171|NCT01660230|11112874|FG006|NOT COMPLETED|Overall Study||0
9991172|NCT01660230|11112875|FG007|NOT COMPLETED|Overall Study||0
9991173|NCT01660230|11112876|FG008|NOT COMPLETED|Overall Study||0
9991174|NCT01660230|11112877|FG009|NOT COMPLETED|Overall Study||0
9991175|NCT01660230|11112878|FG010|NOT COMPLETED|Overall Study||0
9991176|NCT01660230|11112879|FG011|NOT COMPLETED|Overall Study||0
9991177|NCT01660256|11112909|FG000|STARTED|Overall Study||84
9991178|NCT01660256|11112910|FG001|STARTED|Overall Study||83
9991179|NCT01660256|11112911|FG002|STARTED|Overall Study||42
9991180|NCT01660256|11112909|FG000|COMPLETED|Overall Study||79
9991181|NCT01660256|11112910|FG001|COMPLETED|Overall Study||83
9991182|NCT01660256|11112911|FG002|COMPLETED|Overall Study||38
9991183|NCT01660256|11112909|FG000|NOT COMPLETED|Overall Study||5
9991184|NCT01660256|11112910|FG001|NOT COMPLETED|Overall Study||0
9991185|NCT01660256|11112911|FG002|NOT COMPLETED|Overall Study||4
9991186|NCT01660321|11112919|FG000|STARTED|Overall Study||26
9991187|NCT01660321|11112919|FG000|COMPLETED|Overall Study||26
9991188|NCT01660321|11112919|FG000|NOT COMPLETED|Overall Study||0
9991189|NCT01660334|11112923|FG000|STARTED|Overall Study||13
9991190|NCT01660334|11112923|FG000|COMPLETED|Overall Study||12
9991191|NCT01660334|11112923|FG000|NOT COMPLETED|Overall Study||1
9991192|NCT01660412|11112927|FG000|STARTED|Overall Study||29
9991193|NCT01660412|11112928|FG001|STARTED|Overall Study||31
9991194|NCT01660412|11112927|FG000|Head|Overall Study||1
9991195|NCT01660412|11112928|FG001|Head|Overall Study||4
9991196|NCT01660412|11112927|FG000|Thorax|Overall Study||9
9991197|NCT01660412|11112928|FG001|Thorax|Overall Study||9
9991198|NCT01660412|11112927|FG000|Appendicular Structures|Overall Study||17
9991199|NCT01660412|11112928|FG001|Appendicular Structures|Overall Study||11
9991200|NCT01660412|11112927|FG000|Other|Overall Study||2
9991201|NCT01660412|11112928|FG001|Other|Overall Study||4
9991202|NCT01660412|11112927|FG000|Injection 1|Overall Study||29
9991203|NCT01660412|11112928|FG001|Injection 1|Overall Study||31
9991204|NCT01660412|11112927|FG000|Injection 2|Overall Study||29
9991205|NCT01660412|11112928|FG001|Injection 2|Overall Study||31
9991206|NCT01660412|11112927|FG000|Injection 3|Overall Study||29
9991207|NCT01660412|11112928|FG001|Injection 3|Overall Study||31
9991208|NCT01660412|11112927|FG000|Injection 4|Overall Study||29
9991209|NCT01660412|11112928|FG001|Injection 4|Overall Study||31
9991210|NCT01660412|11112927|FG000|COMPLETED|Overall Study||29
9991211|NCT01660412|11112928|FG001|COMPLETED|Overall Study||28
9991212|NCT01660412|11112927|FG000|NOT COMPLETED|Overall Study||0
9991213|NCT01660412|11112928|FG001|NOT COMPLETED|Overall Study||3
9991214|NCT01660672|11112934|FG000|STARTED|Overall Study||7
9991215|NCT01660672|11112934|FG000|COMPLETED|Overall Study||7
9991216|NCT01660672|11112934|FG000|NOT COMPLETED|Overall Study||0
9991217|NCT01660698|11112941|FG000|STARTED|Overall Study||10
9991218|NCT01660698|11112942|FG001|STARTED|Overall Study||10
9991219|NCT01660698|11112941|FG000|COMPLETED|Overall Study||10
9991220|NCT01660698|11112942|FG001|COMPLETED|Overall Study||10
9991221|NCT01660698|11112941|FG000|NOT COMPLETED|Overall Study||0
9991222|NCT01660698|11112942|FG001|NOT COMPLETED|Overall Study||0
9991223|NCT01660711|11112948|FG000|STARTED|Overall Study||22
9991224|NCT01660711|11112948|FG000|COMPLETED|Overall Study||14
9991225|NCT01660711|11112948|FG000|NOT COMPLETED|Overall Study||8
9991226|NCT01660737|11112952|FG000|STARTED|Overall Study||123
9991227|NCT01660737|11112952|FG000|COMPLETED|Overall Study||123
9991228|NCT01660737|11112952|FG000|NOT COMPLETED|Overall Study||0
9991229|NCT01660763|11112958|FG000|STARTED|Overall Study||315
9991230|NCT01660763|11112959|FG001|STARTED|Overall Study||104
9991231|NCT01660763|11112958|FG000|COMPLETED|Overall Study||215
9991232|NCT01660763|11112959|FG001|COMPLETED|Overall Study||43
9991233|NCT01660763|11112958|FG000|NOT COMPLETED|Overall Study||100
9991234|NCT01660763|11112959|FG001|NOT COMPLETED|Overall Study||61
9991235|NCT01660802|11112967|FG000|STARTED|Overall Study||130
9991236|NCT01660802|11112968|FG001|STARTED|Overall Study||132
9991237|NCT01660802|11112967|FG000|COMPLETED|Overall Study||126
9991238|NCT01660802|11112968|FG001|COMPLETED|Overall Study||121
9991239|NCT01660802|11112967|FG000|NOT COMPLETED|Overall Study||4
9991240|NCT01660802|11112968|FG001|NOT COMPLETED|Overall Study||11
9991241|NCT01660815|11112974|FG000|STARTED|Overall Study||7
9991242|NCT01660815|11112974|FG000|COMPLETED|Overall Study||7
9991243|NCT01660815|11112974|FG000|NOT COMPLETED|Overall Study||0
9991244|NCT01660893|11112982|FG000|STARTED|Overall Study||10
9991245|NCT01660893|11112983|FG001|STARTED|Overall Study||10
9991246|NCT01660893|11112984|FG002|STARTED|Overall Study||6
9991247|NCT01660893|11112982|FG000|COMPLETED|Overall Study||10
9991248|NCT01660893|11112983|FG001|COMPLETED|Overall Study||10
9991249|NCT01660893|11112984|FG002|COMPLETED|Overall Study||6
9991250|NCT01660893|11112982|FG000|NOT COMPLETED|Overall Study||0
9991251|NCT01660893|11112983|FG001|NOT COMPLETED|Overall Study||0
9991252|NCT01660893|11112984|FG002|NOT COMPLETED|Overall Study||0
9991253|NCT01660906|11112992|FG000|STARTED|Overall Study||39
9991254|NCT01660906|11112992|FG000|COMPLETED|Overall Study||36
9991255|NCT01660906|11112992|FG000|NOT COMPLETED|Overall Study||3
9991256|NCT01661062|11112996|FG000|STARTED|Overall Study||23
9991257|NCT01661062|11112996|FG000|COMPLETED|Overall Study||18
9991258|NCT01661062|11112996|FG000|NOT COMPLETED|Overall Study||5
9991259|NCT01661088|11113000|FG000|STARTED|FOLFIRINOX||25
9991260|NCT01661088|11113000|FG000|COMPLETED|FOLFIRINOX||21
9991261|NCT01661088|11113000|FG000|NOT COMPLETED|FOLFIRINOX||4
9991262|NCT01661088|11113000|FG000|STARTED|IMRT With FDR Gemcitabine||21
9991263|NCT01661088|11113000|FG000|COMPLETED|IMRT With FDR Gemcitabine||19
9991264|NCT01661088|11113000|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2
9991265|NCT01661114|11113004|FG000|STARTED|Overall Study||39
9991266|NCT01661114|11113004|FG000|COMPLETED|Overall Study||39
9991267|NCT01661114|11113004|FG000|NOT COMPLETED|Overall Study||0
9991268|NCT01661140|11113008|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
9991269|NCT01661140|11113009|FG001|STARTED|Open-Label Period||0
9991270|NCT01661140|11113010|FG002|STARTED|Open-Label Period||0
9991271|NCT01661140|11113008|FG000|COMPLETED|Open-Label Period||351
9991272|NCT01661140|11113009|FG001|COMPLETED|Open-Label Period||0
9991273|NCT01661140|11113010|FG002|COMPLETED|Open-Label Period||0
9991274|NCT01661140|11113008|FG000|NOT COMPLETED|Open-Label Period||76
9991275|NCT01661140|11113009|FG001|NOT COMPLETED|Open-Label Period||0
9991276|NCT01661140|11113010|FG002|NOT COMPLETED|Open-Label Period||0
9991277|NCT01661140|11113008|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
9991278|NCT01661140|11113009|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
9991279|NCT01661140|11113010|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
9991280|NCT01661140|11113008|FG000|COMPLETED|Double-Blind Period||0
9991281|NCT01661140|11113009|FG001|COMPLETED|Double-Blind Period||95
9991282|NCT01661140|11113010|FG002|COMPLETED|Double-Blind Period||86
9991283|NCT01661140|11113008|FG000|NOT COMPLETED|Double-Blind Period||0
9991284|NCT01661140|11113009|FG001|NOT COMPLETED|Double-Blind Period||41
9991285|NCT01661140|11113010|FG002|NOT COMPLETED|Double-Blind Period||50
9991286|NCT01661179|11113018|FG000|STARTED|Overall Study||14
9991287|NCT01661179|11113018|FG000|COMPLETED|Overall Study||8
9991288|NCT01661179|11113018|FG000|NOT COMPLETED|Overall Study||6
9991289|NCT01661205|11113022|FG000|STARTED|Overall Study||26
9991290|NCT01661205|11113022|FG000|COMPLETED|Overall Study||24
9991291|NCT01661205|11113022|FG000|NOT COMPLETED|Overall Study||2
9991292|NCT01661270|11113028|FG000|STARTED|Overall Study||109
9991293|NCT01661270|11113029|FG001|STARTED|Overall Study||223
9991294|NCT01661270|11113028|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
9991295|NCT01661270|11113029|FG001|Adverse Event|Overall Study|Met EOT criteria|47
9991296|NCT01661270|11113028|FG000|Disease Progression|Overall Study|Met EOT criteria|67
9991297|NCT01661270|11113029|FG001|Disease Progression|Overall Study|Met EOT criteria|118
9991298|NCT01661270|11113028|FG000|Physician Decision|Overall Study|Met EOT criteria|1
9991299|NCT01661270|11113029|FG001|Physician Decision|Overall Study|Met EOT criteria|8
9991300|NCT01661270|11113028|FG000|Participant's Request|Overall Study|Met EOT criteria|15
9991301|NCT01661270|11113029|FG001|Participant's Request|Overall Study|Met EOT criteria|48
9991302|NCT01661270|11113028|FG000|Other Reasons|Overall Study||0
9991303|NCT01661270|11113029|FG001|Other Reasons|Overall Study||2
9991304|NCT01661270|11113028|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
9991305|NCT01661270|11113029|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
9991306|NCT01661270|11113028|FG000|NOT COMPLETED|Overall Study||0
9991307|NCT01661270|11113029|FG001|NOT COMPLETED|Overall Study||0
9991308|NCT01661283|11113036|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
9991309|NCT01661283|11113036|FG000|COMPLETED|Overall Study||25
9991310|NCT01661283|11113036|FG000|NOT COMPLETED|Overall Study||0
10102363|NCT02415127|11231819|FG000|NOT COMPLETED|Overall Study||1
10102364|NCT02415127|11231820|FG001|NOT COMPLETED|Overall Study||0
10102365|NCT02415244|11231828|FG000|STARTED|Overall Study||50
10102366|NCT02415244|11231829|FG001|STARTED|Overall Study||25
10102367|NCT02415244|11231828|FG000|COMPLETED|Overall Study||50
10102368|NCT02415244|11231829|FG001|COMPLETED|Overall Study||25
10102369|NCT02415244|11231828|FG000|NOT COMPLETED|Overall Study||0
10102370|NCT02415244|11231829|FG001|NOT COMPLETED|Overall Study||0
9991311|NCT01661595|11113044|FG000|STARTED|Phase 1: Week 0-4||5
9991312|NCT01661595|11113045|FG001|STARTED|Phase 1: Week 0-4||4
9991313|NCT01661595|11113046|FG002|STARTED|Phase 1: Week 0-4||5
9991314|NCT01661595|11113047|FG003|STARTED|Phase 1: Week 0-4||4
9991315|NCT01661595|11113044|FG000|COMPLETED|Phase 1: Week 0-4||4
9991316|NCT01661595|11113045|FG001|COMPLETED|Phase 1: Week 0-4||4
9991317|NCT01661595|11113046|FG002|COMPLETED|Phase 1: Week 0-4||5
9991318|NCT01661595|11113047|FG003|COMPLETED|Phase 1: Week 0-4||4
9991319|NCT01661595|11113044|FG000|NOT COMPLETED|Phase 1: Week 0-4||1
9991320|NCT01661595|11113045|FG001|NOT COMPLETED|Phase 1: Week 0-4||0
9991321|NCT01661595|11113046|FG002|NOT COMPLETED|Phase 1: Week 0-4||0
9991322|NCT01661595|11113047|FG003|NOT COMPLETED|Phase 1: Week 0-4||0
9991323|NCT01661595|11113044|FG000|STARTED|Phase 2: Week 5-8.||4
9991324|NCT01661595|11113045|FG001|STARTED|Phase 2: Week 5-8.||4
9991325|NCT01661595|11113046|FG002|STARTED|Phase 2: Week 5-8.||5
9991326|NCT01661595|11113047|FG003|STARTED|Phase 2: Week 5-8.||4
9991327|NCT01661595|11113044|FG000|COMPLETED|Phase 2: Week 5-8.||4
9991328|NCT01661595|11113045|FG001|COMPLETED|Phase 2: Week 5-8.||4
10202164|NCT03441984|11329282|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3
10202165|NCT03441984|11329283|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3
10202166|NCT03441984|11329284|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3
10202167|NCT03441984|11329285|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3
10202168|NCT03441984|11329286|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3
10202169|NCT03441984|11329287|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3
10202170|NCT03441984|11329276|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9991329|NCT01661595|11113046|FG002|COMPLETED|Phase 2: Week 5-8.||4
9991330|NCT01661595|11113047|FG003|COMPLETED|Phase 2: Week 5-8.||4
9991331|NCT01661595|11113044|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0
9991332|NCT01661595|11113045|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0
9991333|NCT01661595|11113046|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1
9991334|NCT01661595|11113047|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0
9991335|NCT01661621|11113066|FG000|STARTED|Overall Study||116
9991336|NCT01661621|11113067|FG001|STARTED|Overall Study||279
9991337|NCT01661621|11113066|FG000|COMPLETED|Overall Study||116
9991338|NCT01661621|11113067|FG001|COMPLETED|Overall Study||279
9991339|NCT01661621|11113066|FG000|NOT COMPLETED|Overall Study||0
9991340|NCT01661621|11113067|FG001|NOT COMPLETED|Overall Study||0
9991341|NCT01661686|11113075|FG000|STARTED|Overall Study||49
9991342|NCT01661686|11113076|FG001|STARTED|Overall Study||49
9991343|NCT01661686|11113075|FG000|COMPLETED|Overall Study||47
9991344|NCT01661686|11113076|FG001|COMPLETED|Overall Study||47
9991345|NCT01661686|11113075|FG000|NOT COMPLETED|Overall Study||2
9991346|NCT01661686|11113076|FG001|NOT COMPLETED|Overall Study||2
9991347|NCT01661712|11113084|FG000|STARTED|Overall Study|initial sham stimulation night|18
9991348|NCT01661712|11113085|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
9991349|NCT01661712|11113084|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
9991350|NCT01661712|11113085|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
9991351|NCT01661712|11113084|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
9991352|NCT01661712|11113085|FG001|COMPLETED|Overall Study|sham stimulation night|18
9991353|NCT01661712|11113084|FG000|NOT COMPLETED|Overall Study||0
9991354|NCT01661712|11113085|FG001|NOT COMPLETED|Overall Study||0
9991355|NCT01661764|11113103|FG000|STARTED|Overall Study||26
9991356|NCT01661764|11113104|FG001|STARTED|Overall Study||25
9991357|NCT01661764|11113105|FG002|STARTED|Overall Study||25
9991358|NCT01661764|11113106|FG003|STARTED|Overall Study||26
9991359|NCT01661764|11113107|FG004|STARTED|Overall Study||19
9991360|NCT01661764|11113108|FG005|STARTED|Overall Study||20
9991361|NCT01661764|11113103|FG000|COMPLETED|Overall Study||24
9991362|NCT01661764|11113104|FG001|COMPLETED|Overall Study||20
9991363|NCT01661764|11113105|FG002|COMPLETED|Overall Study||22
9991364|NCT01661764|11113106|FG003|COMPLETED|Overall Study||24
9991365|NCT01661764|11113107|FG004|COMPLETED|Overall Study||16
9991366|NCT01661764|11113108|FG005|COMPLETED|Overall Study||18
9991367|NCT01661764|11113103|FG000|NOT COMPLETED|Overall Study||2
9991368|NCT01661764|11113104|FG001|NOT COMPLETED|Overall Study||5
9991369|NCT01661764|11113105|FG002|NOT COMPLETED|Overall Study||3
9991370|NCT01661764|11113106|FG003|NOT COMPLETED|Overall Study||2
9991371|NCT01661764|11113107|FG004|NOT COMPLETED|Overall Study||3
9991372|NCT01661764|11113108|FG005|NOT COMPLETED|Overall Study||2
9991373|NCT01661790|11113124|FG000|STARTED|Overall Study||36
9991374|NCT01661790|11113125|FG001|STARTED|Overall Study||36
9991375|NCT01661790|11113124|FG000|COMPLETED|Overall Study||36
9991376|NCT01661790|11113125|FG001|COMPLETED|Overall Study||34
10102371|NCT02415400|11231839|FG000|STARTED|Overall Study||1153
10202171|NCT03441984|11329277|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10102372|NCT02415400|11231840|FG001|STARTED|Overall Study||1153
10102373|NCT02415400|11231841|FG002|STARTED|Overall Study||1154
9991377|NCT01661790|11113124|FG000|NOT COMPLETED|Overall Study||0
9991378|NCT01661790|11113125|FG001|NOT COMPLETED|Overall Study||2
10202172|NCT03441984|11329278|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9991379|NCT01661933|11113131|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
9991380|NCT01661933|11113131|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
9991381|NCT01661933|11113131|FG000|NOT COMPLETED|Gluten Micro-challenge||0
9991382|NCT01661933|11113131|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
9991383|NCT01661933|11113131|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
9991384|NCT01661933|11113131|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2
9991385|NCT01661933|11113131|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
9991386|NCT01661933|11113131|FG000|COMPLETED|High-dose Gluten Challenge||8
9991387|NCT01661933|11113131|FG000|NOT COMPLETED|High-dose Gluten Challenge||2
9991388|NCT01661946|11113139|FG000|STARTED|Overall Study||5
9991389|NCT01661946|11113140|FG001|STARTED|Overall Study||5
9991390|NCT01661946|11113139|FG000|COMPLETED|Overall Study||5
9991391|NCT01661946|11113140|FG001|COMPLETED|Overall Study||5
9991392|NCT01661946|11113139|FG000|NOT COMPLETED|Overall Study||0
9991393|NCT01661946|11113140|FG001|NOT COMPLETED|Overall Study||0
9991394|NCT01661972|11113148|FG000|STARTED|Overall Study||13
9991395|NCT01661972|11113149|FG001|STARTED|Overall Study||50
9991396|NCT01661972|11113148|FG000|COMPLETED|Overall Study||11
9991397|NCT01661972|11113149|FG001|COMPLETED|Overall Study||46
9991398|NCT01661972|11113148|FG000|NOT COMPLETED|Overall Study||2
9991399|NCT01661972|11113149|FG001|NOT COMPLETED|Overall Study||4
9991400|NCT01662024|11113157|FG000|STARTED|Overall Study||20
9991401|NCT01662024|11113157|FG000|COMPLETED|Overall Study||15
9991402|NCT01662024|11113157|FG000|NOT COMPLETED|Overall Study||5
9991403|NCT01662063|11113166|FG000|STARTED|Overall Study||44
9991404|NCT01662063|11113167|FG001|STARTED|Overall Study||173
9991405|NCT01662063|11113168|FG002|STARTED|Overall Study||1
9991406|NCT01662063|11113166|FG000|COMPLETED|Overall Study||39
9991407|NCT01662063|11113167|FG001|COMPLETED|Overall Study||144
9991408|NCT01662063|11113168|FG002|COMPLETED|Overall Study||0
9991409|NCT01662063|11113166|FG000|NOT COMPLETED|Overall Study||5
9991410|NCT01662063|11113167|FG001|NOT COMPLETED|Overall Study||29
9991411|NCT01662063|11113168|FG002|NOT COMPLETED|Overall Study||1
9991412|NCT01662115|11113179|FG000|STARTED|Overall Study||2
9991413|NCT01662115|11113180|FG001|STARTED|Overall Study||2
9991414|NCT01662115|11113181|FG002|STARTED|Overall Study||0
9991415|NCT01662115|11113179|FG000|COMPLETED|Overall Study||2
9991416|NCT01662115|11113180|FG001|COMPLETED|Overall Study||2
9991417|NCT01662115|11113181|FG002|COMPLETED|Overall Study||0
9991418|NCT01662115|11113179|FG000|NOT COMPLETED|Overall Study||0
9991419|NCT01662115|11113180|FG001|NOT COMPLETED|Overall Study||0
9991420|NCT01662115|11113181|FG002|NOT COMPLETED|Overall Study||0
9991421|NCT01662297|11113191|FG000|STARTED|Overall Study||0
9991422|NCT01662297|11113192|FG001|STARTED|Overall Study||1
9991423|NCT01662297|11113191|FG000|COMPLETED|Overall Study||0
9991424|NCT01662297|11113192|FG001|COMPLETED|Overall Study||1
9991425|NCT01662297|11113191|FG000|NOT COMPLETED|Overall Study||0
9991426|NCT01662297|11113192|FG001|NOT COMPLETED|Overall Study||0
9991427|NCT01662310|11113198|FG000|STARTED|Run-In or Stabilization Phase||201
9991428|NCT01662310|11113199|FG001|STARTED|Run-In or Stabilization Phase||0
9991429|NCT01662310|11113200|FG002|STARTED|Run-In or Stabilization Phase||0
9991430|NCT01662310|11113201|FG003|STARTED|Run-In or Stabilization Phase||0
9991431|NCT01662310|11113202|FG004|STARTED|Run-In or Stabilization Phase||0
9991432|NCT01662310|11113198|FG000|COMPLETED|Run-In or Stabilization Phase||136
9991433|NCT01662310|11113199|FG001|COMPLETED|Run-In or Stabilization Phase||0
9991434|NCT01662310|11113200|FG002|COMPLETED|Run-In or Stabilization Phase||0
9991435|NCT01662310|11113201|FG003|COMPLETED|Run-In or Stabilization Phase||0
9991436|NCT01662310|11113202|FG004|COMPLETED|Run-In or Stabilization Phase||0
9991437|NCT01662310|11113198|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65
9991438|NCT01662310|11113199|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0
9991439|NCT01662310|11113200|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0
9991440|NCT01662310|11113201|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0
9991441|NCT01662310|11113202|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0
9991442|NCT01662310|11113198|FG000|STARTED|Double-Blind Phase||0
9991443|NCT01662310|11113199|FG001|STARTED|Double-Blind Phase||65
9991444|NCT01662310|11113200|FG002|STARTED|Double-Blind Phase||71
9991445|NCT01662310|11113201|FG003|STARTED|Double-Blind Phase||0
9991446|NCT01662310|11113202|FG004|STARTED|Double-Blind Phase||0
9991447|NCT01662310|11113198|FG000|Treated|Double-Blind Phase||0
9991448|NCT01662310|11113199|FG001|Treated|Double-Blind Phase||64
9991449|NCT01662310|11113200|FG002|Treated|Double-Blind Phase||71
9991450|NCT01662310|11113201|FG003|Treated|Double-Blind Phase||0
9991451|NCT01662310|11113202|FG004|Treated|Double-Blind Phase||0
9991452|NCT01662310|11113198|FG000|COMPLETED|Double-Blind Phase||0
9991453|NCT01662310|11113199|FG001|COMPLETED|Double-Blind Phase||50
9991454|NCT01662310|11113200|FG002|COMPLETED|Double-Blind Phase||66
9991455|NCT01662310|11113201|FG003|COMPLETED|Double-Blind Phase||0
9991456|NCT01662310|11113202|FG004|COMPLETED|Double-Blind Phase||0
9991457|NCT01662310|11113198|FG000|NOT COMPLETED|Double-Blind Phase||0
9991458|NCT01662310|11113199|FG001|NOT COMPLETED|Double-Blind Phase||15
9991459|NCT01662310|11113200|FG002|NOT COMPLETED|Double-Blind Phase||5
9991460|NCT01662310|11113201|FG003|NOT COMPLETED|Double-Blind Phase||0
9991461|NCT01662310|11113202|FG004|NOT COMPLETED|Double-Blind Phase||0
9991462|NCT01662310|11113198|FG000|STARTED|Open-Label Extension Phase||0
9991463|NCT01662310|11113199|FG001|STARTED|Open-Label Extension Phase||0
9991464|NCT01662310|11113200|FG002|STARTED|Open-Label Extension Phase||0
9991465|NCT01662310|11113201|FG003|STARTED|Open-Label Extension Phase||47
9991466|NCT01662310|11113202|FG004|STARTED|Open-Label Extension Phase||59
9991467|NCT01662310|11113198|FG000|COMPLETED|Open-Label Extension Phase||0
9991468|NCT01662310|11113199|FG001|COMPLETED|Open-Label Extension Phase||0
9991469|NCT01662310|11113200|FG002|COMPLETED|Open-Label Extension Phase||0
9991470|NCT01662310|11113201|FG003|COMPLETED|Open-Label Extension Phase||36
9991471|NCT01662310|11113202|FG004|COMPLETED|Open-Label Extension Phase||49
9991472|NCT01662310|11113198|FG000|NOT COMPLETED|Open-Label Extension Phase||0
9991473|NCT01662310|11113199|FG001|NOT COMPLETED|Open-Label Extension Phase||0
9991474|NCT01662310|11113200|FG002|NOT COMPLETED|Open-Label Extension Phase||0
9991475|NCT01662310|11113201|FG003|NOT COMPLETED|Open-Label Extension Phase||11
9991476|NCT01662310|11113202|FG004|NOT COMPLETED|Open-Label Extension Phase||10
9991477|NCT01662336|11113214|FG000|STARTED|Overall Study||173
9991478|NCT01662336|11113214|FG000|Completed Month 6 Visit|Overall Study||142
9991479|NCT01662336|11113214|FG000|Completed Month 12 Visit|Overall Study||109
9991480|NCT01662336|11113214|FG000|COMPLETED|Overall Study||107
9991481|NCT01662336|11113214|FG000|NOT COMPLETED|Overall Study||66
9991482|NCT01662362|11113223|FG000|STARTED|Overall Study||63
9991483|NCT01662362|11113223|FG000|COMPLETED|Overall Study||25
9991484|NCT01662362|11113223|FG000|NOT COMPLETED|Overall Study||38
9991485|NCT01662440|11113232|FG000|STARTED|Overall Study||167
9991486|NCT01662440|11113233|FG001|STARTED|Overall Study||217
9991487|NCT01662440|11113234|FG002|STARTED|Overall Study||221
9991488|NCT01662440|11113235|FG003|STARTED|Overall Study||56
9991489|NCT01662440|11113232|FG000|COMPLETED|Overall Study||158
9991490|NCT01662440|11113233|FG001|COMPLETED|Overall Study||211
9991491|NCT01662440|11113234|FG002|COMPLETED|Overall Study||215
9991492|NCT01662440|11113235|FG003|COMPLETED|Overall Study||52
9991493|NCT01662440|11113232|FG000|NOT COMPLETED|Overall Study||9
9991494|NCT01662440|11113233|FG001|NOT COMPLETED|Overall Study||6
9991495|NCT01662440|11113234|FG002|NOT COMPLETED|Overall Study||6
9991496|NCT01662440|11113235|FG003|NOT COMPLETED|Overall Study||4
9991497|NCT01662492|11113258|FG000|STARTED|Overall Study||45
9991498|NCT01662492|11113259|FG001|STARTED|Overall Study||43
9991499|NCT01662492|11113260|FG002|STARTED|Overall Study||37
9991500|NCT01662492|11113258|FG000|COMPLETED|Overall Study||42
9991501|NCT01662492|11113259|FG001|COMPLETED|Overall Study||42
10102374|NCT02415400|11231842|FG003|STARTED|Overall Study||1154
10102375|NCT02415400|11231839|FG000|COMPLETED|Overall Study||1087
10102376|NCT02415400|11231840|FG001|COMPLETED|Overall Study||1091
10102377|NCT02415400|11231841|FG002|COMPLETED|Overall Study||1069
10102378|NCT02415400|11231842|FG003|COMPLETED|Overall Study||1071
10102379|NCT02415400|11231839|FG000|NOT COMPLETED|Overall Study||66
9991502|NCT01662492|11113260|FG002|COMPLETED|Overall Study||31
9991503|NCT01662492|11113258|FG000|NOT COMPLETED|Overall Study||3
9991504|NCT01662492|11113259|FG001|NOT COMPLETED|Overall Study||1
9991505|NCT01662492|11113260|FG002|NOT COMPLETED|Overall Study||6
9991506|NCT01662505|11113271|FG000|STARTED|Overall Study||7
9991507|NCT01662505|11113272|FG001|STARTED|Overall Study||4
9991508|NCT01662505|11113273|FG002|STARTED|Overall Study||8
9991509|NCT01662505|11113271|FG000|COMPLETED|Overall Study||0
9991510|NCT01662505|11113272|FG001|COMPLETED|Overall Study||0
9991511|NCT01662505|11113273|FG002|COMPLETED|Overall Study||0
9991512|NCT01662505|11113271|FG000|NOT COMPLETED|Overall Study||7
9991513|NCT01662505|11113272|FG001|NOT COMPLETED|Overall Study||4
9991514|NCT01662505|11113273|FG002|NOT COMPLETED|Overall Study||8
9991515|NCT01662531|11113284|FG000|STARTED|Overall Study||27
9991516|NCT01662531|11113284|FG000|COMPLETED|Overall Study||27
9991517|NCT01662531|11113284|FG000|NOT COMPLETED|Overall Study||0
9991518|NCT01662583|11113293|FG000|STARTED|Overall Study||216
9991519|NCT01662583|11113294|FG001|STARTED|Overall Study||225
9991520|NCT01662583|11113295|FG002|STARTED|Overall Study||219
9991521|NCT01662583|11113293|FG000|COMPLETED|Overall Study||216
9991522|NCT01662583|11113294|FG001|COMPLETED|Overall Study||225
9991523|NCT01662583|11113295|FG002|COMPLETED|Overall Study||219
9991524|NCT01662583|11113293|FG000|NOT COMPLETED|Overall Study||0
9991525|NCT01662583|11113294|FG001|NOT COMPLETED|Overall Study||0
9991526|NCT01662583|11113295|FG002|NOT COMPLETED|Overall Study||0
9991527|NCT01662635|11113303|FG000|STARTED|Overall Study||230
9991528|NCT01662635|11113303|FG000|COMPLETED|Overall Study||200
9991529|NCT01662635|11113303|FG000|NOT COMPLETED|Overall Study||30
9991530|NCT01662648|11113311|FG000|STARTED|Overall Study||520
9991531|NCT01662648|11113312|FG001|STARTED|Overall Study||597
9991532|NCT01662648|11113311|FG000|COMPLETED|Overall Study||373
9991533|NCT01662648|11113312|FG001|COMPLETED|Overall Study||419
9991534|NCT01662648|11113311|FG000|NOT COMPLETED|Overall Study||147
9991535|NCT01662648|11113312|FG001|NOT COMPLETED|Overall Study||178
9991536|NCT01662752|11113318|FG000|STARTED|Overall Study||30
9991537|NCT01662752|11113318|FG000|COMPLETED|Overall Study||30
9991538|NCT01662752|11113318|FG000|NOT COMPLETED|Overall Study||0
9991539|NCT01662765|11113324|FG000|STARTED|Overall Study||42
9991540|NCT01662765|11113325|FG001|STARTED|Overall Study||42
9991541|NCT01662765|11113324|FG000|COMPLETED|Overall Study||41
9991542|NCT01662765|11113325|FG001|COMPLETED|Overall Study||40
9991543|NCT01662765|11113324|FG000|NOT COMPLETED|Overall Study||1
9991544|NCT01662765|11113325|FG001|NOT COMPLETED|Overall Study||2
9991545|NCT01662778|11113336|FG000|STARTED|Period 1||6
9991546|NCT01662778|11113337|FG001|STARTED|Period 1||5
9991547|NCT01662778|11113338|FG002|STARTED|Period 1||6
9991548|NCT01662778|11113339|FG003|STARTED|Period 1||4
9991549|NCT01662778|11113336|FG000|COMPLETED|Period 1||6
9991550|NCT01662778|11113337|FG001|COMPLETED|Period 1||5
9991551|NCT01662778|11113338|FG002|COMPLETED|Period 1||6
9991552|NCT01662778|11113339|FG003|COMPLETED|Period 1||4
9991553|NCT01662778|11113336|FG000|NOT COMPLETED|Period 1||0
9991554|NCT01662778|11113337|FG001|NOT COMPLETED|Period 1||0
9991555|NCT01662778|11113338|FG002|NOT COMPLETED|Period 1||0
9991556|NCT01662778|11113339|FG003|NOT COMPLETED|Period 1||0
9991557|NCT01662778|11113336|FG000|STARTED|Period 2||6
9991558|NCT01662778|11113337|FG001|STARTED|Period 2||5
9991559|NCT01662778|11113338|FG002|STARTED|Period 2||6
9991560|NCT01662778|11113339|FG003|STARTED|Period 2||4
9991561|NCT01662778|11113336|FG000|COMPLETED|Period 2||6
9991562|NCT01662778|11113337|FG001|COMPLETED|Period 2||5
9991563|NCT01662778|11113338|FG002|COMPLETED|Period 2||6
9991564|NCT01662778|11113339|FG003|COMPLETED|Period 2||4
9991565|NCT01662778|11113336|FG000|NOT COMPLETED|Period 2||0
9991566|NCT01662778|11113337|FG001|NOT COMPLETED|Period 2||0
9991567|NCT01662778|11113338|FG002|NOT COMPLETED|Period 2||0
9991568|NCT01662778|11113339|FG003|NOT COMPLETED|Period 2||0
9991569|NCT01662778|11113336|FG000|STARTED|Period 3||6
9991570|NCT01662778|11113337|FG001|STARTED|Period 3||5
9991571|NCT01662778|11113338|FG002|STARTED|Period 3||6
9991572|NCT01662778|11113339|FG003|STARTED|Period 3||4
9991573|NCT01662778|11113336|FG000|COMPLETED|Period 3||6
9991574|NCT01662778|11113337|FG001|COMPLETED|Period 3||5
9991575|NCT01662778|11113338|FG002|COMPLETED|Period 3||6
9991576|NCT01662778|11113339|FG003|COMPLETED|Period 3||4
9991577|NCT01662778|11113336|FG000|NOT COMPLETED|Period 3||0
9991578|NCT01662778|11113337|FG001|NOT COMPLETED|Period 3||0
9991579|NCT01662778|11113338|FG002|NOT COMPLETED|Period 3||0
9991580|NCT01662778|11113339|FG003|NOT COMPLETED|Period 3||0
9991581|NCT01662778|11113336|FG000|STARTED|Period 4||6
9991582|NCT01662778|11113337|FG001|STARTED|Period 4||5
9991583|NCT01662778|11113338|FG002|STARTED|Period 4||6
9991584|NCT01662778|11113339|FG003|STARTED|Period 4||4
9991585|NCT01662778|11113336|FG000|COMPLETED|Period 4||6
9991586|NCT01662778|11113337|FG001|COMPLETED|Period 4||5
9991587|NCT01662778|11113338|FG002|COMPLETED|Period 4||6
9991588|NCT01662778|11113339|FG003|COMPLETED|Period 4||4
9991589|NCT01662778|11113336|FG000|NOT COMPLETED|Period 4||0
9991590|NCT01662778|11113337|FG001|NOT COMPLETED|Period 4||0
9991591|NCT01662778|11113338|FG002|NOT COMPLETED|Period 4||0
9991592|NCT01662778|11113339|FG003|NOT COMPLETED|Period 4||0
9991593|NCT01662791|11113355|FG000|STARTED|Part 1 - Observational||8
9991594|NCT01662791|11113356|FG001|STARTED|Part 1 - Observational||41
9991595|NCT01662791|11113355|FG000|COMPLETED|Part 1 - Observational||8
9991596|NCT01662791|11113356|FG001|COMPLETED|Part 1 - Observational||41
9991597|NCT01662791|11113355|FG000|NOT COMPLETED|Part 1 - Observational||0
9991598|NCT01662791|11113356|FG001|NOT COMPLETED|Part 1 - Observational||0
9991599|NCT01662791|11113355|FG000|STARTED|Part 2 - Interventional||8
9991600|NCT01662791|11113356|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
9991601|NCT01662791|11113355|FG000|COMPLETED|Part 2 - Interventional||8
9991602|NCT01662791|11113356|FG001|COMPLETED|Part 2 - Interventional||0
9991603|NCT01662791|11113355|FG000|NOT COMPLETED|Part 2 - Interventional||0
9991604|NCT01662791|11113356|FG001|NOT COMPLETED|Part 2 - Interventional||0
9991605|NCT01662856|11113364|FG000|STARTED|Part I + Part II (Overall Study)||168
9991606|NCT01662856|11113365|FG001|STARTED|Part I + Part II (Overall Study)||57
9991607|NCT01662856|11113364|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
9991608|NCT01662856|11113365|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
9991609|NCT01662856|11113364|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
9991610|NCT01662856|11113365|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
9991611|NCT01662856|11113364|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16
9991612|NCT01662856|11113365|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2
9991613|NCT01662856|11113364|FG000|STARTED|Primary Part II||109
9991614|NCT01662856|11113365|FG001|STARTED|Primary Part II||57
9991615|NCT01662856|11113364|FG000|Completed Study up to Week 6|Primary Part II||106
9991616|NCT01662856|11113365|FG001|Completed Study up to Week 6|Primary Part II||56
9991617|NCT01662856|11113364|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
9991618|NCT01662856|11113365|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
9991619|NCT01662856|11113364|FG000|NOT COMPLETED|Primary Part II||10
9991620|NCT01662856|11113365|FG001|NOT COMPLETED|Primary Part II||2
9991621|NCT01662882|11113374|FG000|STARTED|Overall Study||15
9991622|NCT01662882|11113375|FG001|STARTED|Overall Study||18
9991623|NCT01662882|11113376|FG002|STARTED|Overall Study||15
9991624|NCT01662882|11113374|FG000|COMPLETED|Overall Study||15
9991625|NCT01662882|11113375|FG001|COMPLETED|Overall Study||18
9991626|NCT01662882|11113376|FG002|COMPLETED|Overall Study||15
9991627|NCT01662882|11113374|FG000|NOT COMPLETED|Overall Study||0
9991628|NCT01662882|11113375|FG001|NOT COMPLETED|Overall Study||0
9991629|NCT01662882|11113376|FG002|NOT COMPLETED|Overall Study||0
9991630|NCT01662895|11113386|FG000|STARTED|Overall Study||21
9991631|NCT01662895|11113387|FG001|STARTED|Overall Study||21
9991632|NCT01662895|11113386|FG000|Initiated Study Drug|Overall Study||21
9991633|NCT01662895|11113387|FG001|Initiated Study Drug|Overall Study||21
9991634|NCT01662895|11113386|FG000|COMPLETED|Overall Study||21
9991635|NCT01662895|11113387|FG001|COMPLETED|Overall Study||20
9991636|NCT01662895|11113386|FG000|NOT COMPLETED|Overall Study||0
9991637|NCT01662895|11113387|FG001|NOT COMPLETED|Overall Study||1
9991638|NCT01662908|11113395|FG000|STARTED|Overall Study||56
9991639|NCT01662908|11113396|FG001|STARTED|Overall Study||28
9991640|NCT01662908|11113395|FG000|COMPLETED|Overall Study||50
9991641|NCT01662908|11113396|FG001|COMPLETED|Overall Study||23
9991642|NCT01662908|11113395|FG000|NOT COMPLETED|Overall Study||6
9991643|NCT01662908|11113396|FG001|NOT COMPLETED|Overall Study||5
9991644|NCT01662960|11113406|FG000|STARTED|End of 4 Week Treatment Period||25
9991645|NCT01662960|11113407|FG001|STARTED|End of 4 Week Treatment Period||23
9991646|NCT01662960|11113408|FG002|STARTED|End of 4 Week Treatment Period||9
9991647|NCT01662960|11113409|FG003|STARTED|End of 4 Week Treatment Period||15
9991648|NCT01662960|11113406|FG000|COMPLETED|End of 4 Week Treatment Period||24
9991649|NCT01662960|11113407|FG001|COMPLETED|End of 4 Week Treatment Period||19
9991650|NCT01662960|11113408|FG002|COMPLETED|End of 4 Week Treatment Period||8
9991651|NCT01662960|11113409|FG003|COMPLETED|End of 4 Week Treatment Period||15
9991652|NCT01662960|11113406|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1
9991653|NCT01662960|11113407|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4
9991654|NCT01662960|11113408|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1
9991655|NCT01662960|11113409|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0
9991656|NCT01662960|11113406|FG000|STARTED|3 Month Follow-up||24
9991657|NCT01662960|11113407|FG001|STARTED|3 Month Follow-up||19
9991658|NCT01662960|11113408|FG002|STARTED|3 Month Follow-up||8
9991659|NCT01662960|11113409|FG003|STARTED|3 Month Follow-up||15
9991660|NCT01662960|11113406|FG000|COMPLETED|3 Month Follow-up||21
9991661|NCT01662960|11113407|FG001|COMPLETED|3 Month Follow-up||16
9991662|NCT01662960|11113408|FG002|COMPLETED|3 Month Follow-up||5
9991663|NCT01662960|11113409|FG003|COMPLETED|3 Month Follow-up||13
9991664|NCT01662960|11113406|FG000|NOT COMPLETED|3 Month Follow-up||3
9991665|NCT01662960|11113407|FG001|NOT COMPLETED|3 Month Follow-up||3
9991666|NCT01662960|11113408|FG002|NOT COMPLETED|3 Month Follow-up||3
9991667|NCT01662960|11113409|FG003|NOT COMPLETED|3 Month Follow-up||2
9991668|NCT01662986|11113421|FG000|STARTED|Overall Study||40
9991669|NCT01662986|11113422|FG001|STARTED|Overall Study||39
9991670|NCT01662986|11113421|FG000|COMPLETED|Overall Study||22
9991671|NCT01662986|11113422|FG001|COMPLETED|Overall Study||26
9991672|NCT01662986|11113421|FG000|NOT COMPLETED|Overall Study||18
9991673|NCT01662986|11113422|FG001|NOT COMPLETED|Overall Study||13
9991674|NCT01662999|11113434|FG000|STARTED|Period 1||7
9991675|NCT01662999|11113435|FG001|STARTED|Period 1||7
9991676|NCT01662999|11113436|FG002|STARTED|Period 1||7
9991677|NCT01662999|11113437|FG003|STARTED|Period 1||7
9991678|NCT01662999|11113438|FG004|STARTED|Period 1||7
9991679|NCT01662999|11113439|FG005|STARTED|Period 1||7
9991680|NCT01662999|11113434|FG000|COMPLETED|Period 1||7
9991681|NCT01662999|11113435|FG001|COMPLETED|Period 1||7
9991682|NCT01662999|11113436|FG002|COMPLETED|Period 1||7
9991683|NCT01662999|11113437|FG003|COMPLETED|Period 1||7
9991684|NCT01662999|11113438|FG004|COMPLETED|Period 1||7
9991685|NCT01662999|11113439|FG005|COMPLETED|Period 1||7
9991686|NCT01662999|11113434|FG000|NOT COMPLETED|Period 1||0
9991687|NCT01662999|11113435|FG001|NOT COMPLETED|Period 1||0
9991688|NCT01662999|11113436|FG002|NOT COMPLETED|Period 1||0
9991689|NCT01662999|11113437|FG003|NOT COMPLETED|Period 1||0
9991690|NCT01662999|11113438|FG004|NOT COMPLETED|Period 1||0
9991691|NCT01662999|11113439|FG005|NOT COMPLETED|Period 1||0
9991692|NCT01662999|11113434|FG000|STARTED|Period 2||7
9991693|NCT01662999|11113435|FG001|STARTED|Period 2||7
9991694|NCT01662999|11113436|FG002|STARTED|Period 2||7
9991695|NCT01662999|11113437|FG003|STARTED|Period 2||7
9991696|NCT01662999|11113438|FG004|STARTED|Period 2||7
9991697|NCT01662999|11113439|FG005|STARTED|Period 2||7
9991698|NCT01662999|11113434|FG000|COMPLETED|Period 2||7
9991699|NCT01662999|11113435|FG001|COMPLETED|Period 2||7
9991700|NCT01662999|11113436|FG002|COMPLETED|Period 2||7
9991701|NCT01662999|11113437|FG003|COMPLETED|Period 2||7
9991702|NCT01662999|11113438|FG004|COMPLETED|Period 2||7
9991703|NCT01662999|11113439|FG005|COMPLETED|Period 2||7
9991704|NCT01662999|11113434|FG000|NOT COMPLETED|Period 2||0
9991705|NCT01662999|11113435|FG001|NOT COMPLETED|Period 2||0
9991706|NCT01662999|11113436|FG002|NOT COMPLETED|Period 2||0
9991707|NCT01662999|11113437|FG003|NOT COMPLETED|Period 2||0
9991708|NCT01662999|11113438|FG004|NOT COMPLETED|Period 2||0
9991709|NCT01662999|11113439|FG005|NOT COMPLETED|Period 2||0
9991710|NCT01662999|11113434|FG000|STARTED|Period 3||7
9991711|NCT01662999|11113435|FG001|STARTED|Period 3||7
9991712|NCT01662999|11113436|FG002|STARTED|Period 3||7
9991713|NCT01662999|11113437|FG003|STARTED|Period 3||7
9991714|NCT01662999|11113438|FG004|STARTED|Period 3||7
9991715|NCT01662999|11113439|FG005|STARTED|Period 3||7
9991716|NCT01662999|11113434|FG000|COMPLETED|Period 3||7
9991717|NCT01662999|11113435|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
9991718|NCT01662999|11113436|FG002|COMPLETED|Period 3||7
9991719|NCT01662999|11113437|FG003|COMPLETED|Period 3||7
9991720|NCT01662999|11113438|FG004|COMPLETED|Period 3||7
9991721|NCT01662999|11113439|FG005|COMPLETED|Period 3||7
9991722|NCT01662999|11113434|FG000|NOT COMPLETED|Period 3||0
9991723|NCT01662999|11113435|FG001|NOT COMPLETED|Period 3||1
9991724|NCT01662999|11113436|FG002|NOT COMPLETED|Period 3||0
9991725|NCT01662999|11113437|FG003|NOT COMPLETED|Period 3||0
9991726|NCT01662999|11113438|FG004|NOT COMPLETED|Period 3||0
9991727|NCT01662999|11113439|FG005|NOT COMPLETED|Period 3||0
10018303|NCT01822925|11141362|FG002|STARTED|Overall Study||32
9991728|NCT01663012|11113469|FG000|STARTED|Overall Study||20
9991729|NCT01663012|11113469|FG000|COMPLETED|Overall Study||20
9991730|NCT01663012|11113469|FG000|NOT COMPLETED|Overall Study||0
9991731|NCT01663103|11113475|FG000|STARTED|Overall Study||21
9991732|NCT01663103|11113476|FG001|STARTED|Overall Study||21
9991733|NCT01663103|11113475|FG000|COMPLETED|Overall Study||18
9991734|NCT01663103|11113476|FG001|COMPLETED|Overall Study||19
9991735|NCT01663103|11113475|FG000|NOT COMPLETED|Overall Study||3
9991736|NCT01663103|11113476|FG001|NOT COMPLETED|Overall Study||2
9991737|NCT01663233|11113488|FG000|STARTED|Overall Study||130
9991738|NCT01663233|11113489|FG001|STARTED|Overall Study||136
9991739|NCT01663233|11113488|FG000|COMPLETED|Overall Study||126
9991740|NCT01663233|11113489|FG001|COMPLETED|Overall Study||129
9991741|NCT01663233|11113488|FG000|NOT COMPLETED|Overall Study||4
9991742|NCT01663233|11113489|FG001|NOT COMPLETED|Overall Study||7
9991743|NCT01663259|11113495|FG000|STARTED|Overall Study||42
9991744|NCT01663259|11113495|FG000|COMPLETED|Overall Study||42
9991745|NCT01663259|11113495|FG000|NOT COMPLETED|Overall Study||0
9991746|NCT01663272|11113499|FG000|STARTED|Overall Study||5
9991747|NCT01663272|11113500|FG001|STARTED|Overall Study||6
9991748|NCT01663272|11113501|FG002|STARTED|Overall Study||1
9991749|NCT01663272|11113499|FG000|COMPLETED|Overall Study||5
9991750|NCT01663272|11113500|FG001|COMPLETED|Overall Study||6
9991751|NCT01663272|11113501|FG002|COMPLETED|Overall Study||1
9991752|NCT01663272|11113499|FG000|NOT COMPLETED|Overall Study||0
9991753|NCT01663272|11113500|FG001|NOT COMPLETED|Overall Study||0
9991754|NCT01663272|11113501|FG002|NOT COMPLETED|Overall Study||0
9991755|NCT01663363|11113505|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
9991756|NCT01663363|11113505|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
9991757|NCT01663363|11113505|FG000|NOT COMPLETED|Overall Study||0
9991758|NCT01663402|11113511|FG000|STARTED|Overall Study||9462
9991759|NCT01663402|11113512|FG001|STARTED|Overall Study||9462
9991760|NCT01663402|11113511|FG000|Treated|Overall Study||9443
9991761|NCT01663402|11113512|FG001|Treated|Overall Study||9451
9991762|NCT01663402|11113511|FG000|COMPLETED|Overall Study||7947
9991763|NCT01663402|11113512|FG001|COMPLETED|Overall Study||7378
9991764|NCT01663402|11113511|FG000|NOT COMPLETED|Overall Study||1515
9991765|NCT01663402|11113512|FG001|NOT COMPLETED|Overall Study||2084
9991766|NCT01663506|11113518|FG000|STARTED|Overall Study||23
9991767|NCT01663506|11113518|FG000|COMPLETED|Overall Study||15
9991768|NCT01663506|11113518|FG000|NOT COMPLETED|Overall Study||8
9991769|NCT01663532|11113524|FG000|STARTED|Overall Study||168
9991770|NCT01663532|11113525|FG001|STARTED|Overall Study||172
9991771|NCT01663532|11113524|FG000|COMPLETED|Overall Study||94
9991772|NCT01663532|11113525|FG001|COMPLETED|Overall Study||65
9991773|NCT01663532|11113524|FG000|NOT COMPLETED|Overall Study||74
9991774|NCT01663532|11113525|FG001|NOT COMPLETED|Overall Study||107
9991775|NCT01663623|11113533|FG000|STARTED|Overall Study||52
9991776|NCT01663623|11113534|FG001|STARTED|Overall Study||53
9991777|NCT01663623|11113533|FG000|COMPLETED|Overall Study||40
9991778|NCT01663623|11113534|FG001|COMPLETED|Overall Study||33
9991779|NCT01663623|11113533|FG000|NOT COMPLETED|Overall Study||12
9991780|NCT01663623|11113534|FG001|NOT COMPLETED|Overall Study||20
9991781|NCT01663636|11113542|FG000|STARTED|Infant SMS Reminder Feasibility Study||160
9991782|NCT01663636|11113543|FG001|STARTED|Infant SMS Reminder Feasibility Study||161
9991783|NCT01663636|11113542|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135
9991784|NCT01663636|11113543|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130
9991785|NCT01663636|11113542|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
9991786|NCT01663636|11113543|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
9991787|NCT01663636|11113542|FG000|STARTED|Parent SMS Acceptability Assessment||135
9991788|NCT01663636|11113543|FG001|STARTED|Parent SMS Acceptability Assessment||130
9991789|NCT01663636|11113542|FG000|COMPLETED|Parent SMS Acceptability Assessment||135
9991790|NCT01663636|11113543|FG001|COMPLETED|Parent SMS Acceptability Assessment||130
9991791|NCT01663636|11113542|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0
9991792|NCT01663636|11113543|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0
9991793|NCT01663714|11113549|FG000|STARTED|Dosimetric and Therapeutic Treatment||30
9991794|NCT01663714|11113549|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
9991795|NCT01663714|11113549|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
9991796|NCT01663714|11113549|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
9991797|NCT01663714|11113549|FG000|COMPLETED|Long-Term Follow-Up||16
9991798|NCT01663714|11113549|FG000|NOT COMPLETED|Long-Term Follow-Up||6
9991799|NCT01663727|11113557|FG000|STARTED|Overall Study||242
9991800|NCT01663727|11113558|FG001|STARTED|Overall Study||239
9991801|NCT01663727|11113557|FG000|COMPLETED|Overall Study||0
9991802|NCT01663727|11113558|FG001|COMPLETED|Overall Study||1
9991803|NCT01663727|11113557|FG000|NOT COMPLETED|Overall Study||242
9991804|NCT01663727|11113558|FG001|NOT COMPLETED|Overall Study||238
9991805|NCT01663740|11113566|FG000|STARTED|Overall Study|Safety Population|38
9991806|NCT01663740|11113567|FG001|STARTED|Overall Study|Safety Population|21
9991807|NCT01663740|11113566|FG000|COMPLETED|Overall Study||22
9991808|NCT01663740|11113567|FG001|COMPLETED|Overall Study||13
9991809|NCT01663740|11113566|FG000|NOT COMPLETED|Overall Study||16
9991810|NCT01663740|11113567|FG001|NOT COMPLETED|Overall Study||8
9991811|NCT01663779|11113575|FG000|STARTED|Overall Study||27
9991812|NCT01663779|11113576|FG001|STARTED|Overall Study||23
9991813|NCT01663779|11113575|FG000|COMPLETED|Overall Study||27
9991814|NCT01663779|11113576|FG001|COMPLETED|Overall Study||23
9991815|NCT01663779|11113575|FG000|NOT COMPLETED|Overall Study||0
9991816|NCT01663779|11113576|FG001|NOT COMPLETED|Overall Study||0
9991817|NCT01663857|11113586|FG000|STARTED|Overall Study||6
9991818|NCT01663857|11113587|FG001|STARTED|Overall Study||2
9991819|NCT01663857|11113588|FG002|STARTED|Overall Study||58
9991820|NCT01663857|11113589|FG003|STARTED|Overall Study||52
9991821|NCT01663857|11113586|FG000|Received at Least One Dose of Study Drug|Overall Study||6
9991822|NCT01663857|11113587|FG001|Received at Least One Dose of Study Drug|Overall Study||2
9991823|NCT01663857|11113588|FG002|Received at Least One Dose of Study Drug|Overall Study||58
9991824|NCT01663857|11113589|FG003|Received at Least One Dose of Study Drug|Overall Study||52
9991825|NCT01663857|11113586|FG000|COMPLETED|Overall Study||6
9991826|NCT01663857|11113587|FG001|COMPLETED|Overall Study||1
9991827|NCT01663857|11113588|FG002|COMPLETED|Overall Study||48
9991828|NCT01663857|11113589|FG003|COMPLETED|Overall Study||48
9991829|NCT01663857|11113586|FG000|NOT COMPLETED|Overall Study||0
9991830|NCT01663857|11113587|FG001|NOT COMPLETED|Overall Study||1
9991831|NCT01663857|11113588|FG002|NOT COMPLETED|Overall Study||10
9991832|NCT01663857|11113589|FG003|NOT COMPLETED|Overall Study||4
9991833|NCT01663896|11113605|FG000|STARTED|Overall Study||418
9991834|NCT01663896|11113605|FG000|COMPLETED|Overall Study||375
9991835|NCT01663896|11113605|FG000|NOT COMPLETED|Overall Study||43
9991836|NCT01663922|11113610|FG000|STARTED|First Intervention (14 Days or 5 Days)||8
9991837|NCT01663922|11113611|FG001|STARTED|First Intervention (14 Days or 5 Days)||9
9991838|NCT01663922|11113610|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8
9991839|NCT01663922|11113611|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9
9991840|NCT01663922|11113610|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
9991841|NCT01663922|11113611|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
9991842|NCT01663922|11113610|FG000|STARTED|Washout (7 Days)||8
9991843|NCT01663922|11113611|FG001|STARTED|Washout (7 Days)||9
9991844|NCT01663922|11113610|FG000|COMPLETED|Washout (7 Days)||8
9991845|NCT01663922|11113611|FG001|COMPLETED|Washout (7 Days)||9
9991846|NCT01663922|11113610|FG000|NOT COMPLETED|Washout (7 Days)||0
9991847|NCT01663922|11113611|FG001|NOT COMPLETED|Washout (7 Days)||0
9991848|NCT01663922|11113610|FG000|STARTED|Second Intervention (14 Days)||8
9991849|NCT01663922|11113611|FG001|STARTED|Second Intervention (14 Days)||9
9991850|NCT01663922|11113610|FG000|COMPLETED|Second Intervention (14 Days)||8
9991851|NCT01663922|11113611|FG001|COMPLETED|Second Intervention (14 Days)||9
9991852|NCT01663922|11113610|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
9991853|NCT01663922|11113611|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
9991854|NCT01663922|11113610|FG000|STARTED|Washout (7 Days)||8
9991855|NCT01663922|11113611|FG001|STARTED|Washout (7 Days)||9
9991856|NCT01663922|11113610|FG000|COMPLETED|Washout (7 Days)||8
9991857|NCT01663922|11113611|FG001|COMPLETED|Washout (7 Days)||9
9991858|NCT01663922|11113610|FG000|NOT COMPLETED|Washout (7 Days)||0
9991859|NCT01663922|11113611|FG001|NOT COMPLETED|Washout (7 Days)||0
9991860|NCT01663922|11113610|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8
9991861|NCT01663922|11113611|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9
9991862|NCT01663922|11113610|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8
9991863|NCT01663922|11113611|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9
9991864|NCT01663922|11113610|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
9991865|NCT01663922|11113611|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
9991866|NCT01663935|11113616|FG000|STARTED|Overall Study||20
9991867|NCT01663935|11113616|FG000|COMPLETED|Overall Study||20
9991868|NCT01663935|11113616|FG000|NOT COMPLETED|Overall Study||0
9991869|NCT01663987|11113622|FG000|STARTED|Overall Study||39
9991870|NCT01663987|11113623|FG001|STARTED|Overall Study||40
9991871|NCT01663987|11113622|FG000|COMPLETED|Overall Study||26
9991872|NCT01663987|11113623|FG001|COMPLETED|Overall Study||34
9991873|NCT01663987|11113622|FG000|NOT COMPLETED|Overall Study||13
9991874|NCT01663987|11113623|FG001|NOT COMPLETED|Overall Study||6
9991875|NCT01664039|11113631|FG000|STARTED|Overall Study||52
9991876|NCT01664039|11113632|FG001|STARTED|Overall Study||52
9991877|NCT01664039|11113631|FG000|COMPLETED|Overall Study||46
9991878|NCT01664039|11113632|FG001|COMPLETED|Overall Study||43
9991879|NCT01664039|11113631|FG000|NOT COMPLETED|Overall Study||6
9991880|NCT01664039|11113632|FG001|NOT COMPLETED|Overall Study||9
9991881|NCT01664052|11113640|FG000|STARTED|Phase 1|Screening and enrollment|31
9991882|NCT01664052|11113641|FG001|STARTED|Phase 1||0
9991883|NCT01664052|11113640|FG000|Insert Placed in at Least One Tube|Phase 1||25
9991884|NCT01664052|11113641|FG001|Insert Placed in at Least One Tube|Phase 1||0
9991885|NCT01664052|11113640|FG000|HSG 1 Hour Post Placement|Phase 1||24
9991886|NCT01664052|11113641|FG001|HSG 1 Hour Post Placement|Phase 1||0
9991887|NCT01664052|11113640|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
9991888|NCT01664052|11113641|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
9991889|NCT01664052|11113640|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
9991890|NCT01664052|11113641|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
9991891|NCT01664052|11113640|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
9991892|NCT01664052|11113641|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
9991893|NCT01664052|11113640|FG000|COMPLETED|Phase 1||24
9991894|NCT01664052|11113641|FG001|COMPLETED|Phase 1||0
9991895|NCT01664052|11113640|FG000|NOT COMPLETED|Phase 1||7
9991896|NCT01664052|11113641|FG001|NOT COMPLETED|Phase 1||0
9991897|NCT01664052|11113640|FG000|STARTED|Phase 2|Screened and enrolled|0
9991898|NCT01664052|11113641|FG001|STARTED|Phase 2||35
9991899|NCT01664052|11113640|FG000|Insert Placed|Phase 2||0
9991900|NCT01664052|11113641|FG001|Insert Placed|Phase 2||31
9991901|NCT01664052|11113640|FG000|HSG 1 Hour Post Placement|Phase 2||0
9991902|NCT01664052|11113641|FG001|HSG 1 Hour Post Placement|Phase 2||31
9991903|NCT01664052|11113640|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
9991904|NCT01664052|11113641|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
9991905|NCT01664052|11113640|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
9991906|NCT01664052|11113641|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
9991907|NCT01664052|11113640|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
9991908|NCT01664052|11113641|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
9991909|NCT01664052|11113640|FG000|COMPLETED|Phase 2||0
9991910|NCT01664052|11113641|FG001|COMPLETED|Phase 2||31
9991911|NCT01664052|11113640|FG000|NOT COMPLETED|Phase 2||0
9991912|NCT01664052|11113641|FG001|NOT COMPLETED|Phase 2||4
9991913|NCT01664078|11113648|FG000|STARTED|Overall Study||190
9991914|NCT01664078|11113648|FG000|COMPLETED|Overall Study||121
9991915|NCT01664078|11113648|FG000|NOT COMPLETED|Overall Study||69
9991916|NCT01664091|11113698|FG000|STARTED|Overall Study||32
9991917|NCT01664091|11113698|FG000|COMPLETED|Overall Study||26
9991918|NCT01664091|11113698|FG000|NOT COMPLETED|Overall Study||6
9991919|NCT01664104|11113703|FG000|STARTED|Overall Study||136
9991920|NCT01664104|11113703|FG000|COMPLETED|Overall Study||120
9991921|NCT01664104|11113703|FG000|NOT COMPLETED|Overall Study||16
9991922|NCT01664117|11113709|FG000|STARTED|Overall Study||209
9991923|NCT01664117|11113709|FG000|COMPLETED|Overall Study||209
9991924|NCT01664117|11113709|FG000|NOT COMPLETED|Overall Study||0
9991925|NCT01664130|11113716|FG000|STARTED|Overall Study||35
9991926|NCT01664130|11113716|FG000|COMPLETED|Overall Study||33
9991927|NCT01664130|11113716|FG000|NOT COMPLETED|Overall Study||2
9991928|NCT01664247|11113725|FG000|STARTED|Overall Study||174
9991929|NCT01664247|11113726|FG001|STARTED|Overall Study||172
9991930|NCT01664247|11113725|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
9991931|NCT01664247|11113726|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
9991932|NCT01664247|11113725|FG000|COMPLETED|Overall Study||160
9991933|NCT01664247|11113726|FG001|COMPLETED|Overall Study||131
9991934|NCT01664247|11113725|FG000|NOT COMPLETED|Overall Study||14
9991935|NCT01664247|11113726|FG001|NOT COMPLETED|Overall Study||41
9991936|NCT01664494|11113732|FG000|STARTED|Overall Study||563
9991937|NCT01664494|11113732|FG000|COMPLETED|Overall Study||370
9991938|NCT01664494|11113732|FG000|NOT COMPLETED|Overall Study||193
9991939|NCT01664533|11113736|FG000|STARTED|Overall Study||57
9991940|NCT01664533|11113736|FG000|COMPLETED|Overall Study||0
9991941|NCT01664533|11113736|FG000|NOT COMPLETED|Overall Study||57
9991942|NCT01664559|11113743|FG000|STARTED|Overall Study||34
9991943|NCT01664559|11113744|FG001|STARTED|Overall Study||33
9991944|NCT01664559|11113743|FG000|COMPLETED|Overall Study||34
9991945|NCT01664559|11113744|FG001|COMPLETED|Overall Study||33
9991946|NCT01664559|11113743|FG000|NOT COMPLETED|Overall Study||0
9991947|NCT01664559|11113744|FG001|NOT COMPLETED|Overall Study||0
9991948|NCT01664624|11113754|FG000|STARTED|Overall Study||10
9991949|NCT01664624|11113755|FG001|STARTED|Overall Study||11
9991950|NCT01664624|11113756|FG002|STARTED|Overall Study||10
9991951|NCT01664624|11113757|FG003|STARTED|Overall Study||9
9991952|NCT01664624|11113754|FG000|COMPLETED|Overall Study||10
9991953|NCT01664624|11113755|FG001|COMPLETED|Overall Study||10
9991954|NCT01664624|11113756|FG002|COMPLETED|Overall Study||10
9991955|NCT01664624|11113757|FG003|COMPLETED|Overall Study||9
9991956|NCT01664624|11113754|FG000|NOT COMPLETED|Overall Study||0
9991957|NCT01664624|11113755|FG001|NOT COMPLETED|Overall Study||1
9991958|NCT01664624|11113756|FG002|NOT COMPLETED|Overall Study||0
9991959|NCT01664624|11113757|FG003|NOT COMPLETED|Overall Study||0
9991960|NCT01664741|11113770|FG000|STARTED|Overall Study||6
9991961|NCT01664741|11113771|FG001|STARTED|Overall Study||6
9991962|NCT01664741|11113772|FG002|STARTED|Overall Study||13
9991963|NCT01664741|11113770|FG000|COMPLETED|Overall Study||6
9991964|NCT01664741|11113771|FG001|COMPLETED|Overall Study||6
9991965|NCT01664741|11113772|FG002|COMPLETED|Overall Study||13
9991966|NCT01664741|11113770|FG000|NOT COMPLETED|Overall Study||0
9991967|NCT01664741|11113771|FG001|NOT COMPLETED|Overall Study||0
9991968|NCT01664741|11113772|FG002|NOT COMPLETED|Overall Study||0
9991969|NCT01664793|11113781|FG000|STARTED|Overall Study||49039
9991970|NCT01664793|11113782|FG001|STARTED|Overall Study||38626
9991971|NCT01664793|11113781|FG000|COMPLETED|Overall Study||49039
9991972|NCT01664793|11113782|FG001|COMPLETED|Overall Study||38626
9991973|NCT01664793|11113781|FG000|NOT COMPLETED|Overall Study||0
9991974|NCT01664793|11113782|FG001|NOT COMPLETED|Overall Study||0
9991975|NCT01664806|11113792|FG000|STARTED|Overall Study||20
9991976|NCT01664806|11113793|FG001|STARTED|Overall Study||20
9991977|NCT01664806|11113792|FG000|COMPLETED|Overall Study||20
9991978|NCT01664806|11113793|FG001|COMPLETED|Overall Study||20
9991979|NCT01664806|11113792|FG000|NOT COMPLETED|Overall Study||0
9991980|NCT01664806|11113793|FG001|NOT COMPLETED|Overall Study||0
9991981|NCT01664858|11113802|FG000|STARTED|Overall Study||481
9991982|NCT01664858|11113803|FG001|STARTED|Overall Study||481
9991983|NCT01664858|11113804|FG002|STARTED|Overall Study||240
9991984|NCT01664858|11113802|FG000|COMPLETED|Overall Study||467
9991985|NCT01664858|11113803|FG001|COMPLETED|Overall Study||468
9991986|NCT01664858|11113804|FG002|COMPLETED|Overall Study||234
9991987|NCT01664858|11113802|FG000|NOT COMPLETED|Overall Study||14
9991988|NCT01664858|11113803|FG001|NOT COMPLETED|Overall Study||13
9991989|NCT01664858|11113804|FG002|NOT COMPLETED|Overall Study||6
9991990|NCT01664897|11113815|FG000|STARTED|Overall Study||29
9991991|NCT01664897|11113815|FG000|COMPLETED|Overall Study||29
9991992|NCT01664897|11113815|FG000|NOT COMPLETED|Overall Study||0
9991993|NCT01664923|11113821|FG000|STARTED|Period1:Double Blind Phase-29 Months||198
9991994|NCT01664923|11113822|FG001|STARTED|Period1:Double Blind Phase-29 Months||198
9991995|NCT01664923|11113821|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
9991996|NCT01664923|11113822|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
9991997|NCT01664923|11113821|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93
9991998|NCT01664923|11113822|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38
9991999|NCT01664923|11113821|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
9877458|NCT01011465|10991916|FG002|COMPLETED|Overall Study||36
9877459|NCT01011465|10991917|FG003|COMPLETED|Overall Study||18
9877460|NCT01011465|10991918|FG004|COMPLETED|Overall Study||46
9992000|NCT01664923|11113822|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
9992001|NCT01664923|11113821|FG000|STARTED|Period 2: Open-label Phase-36 Months||93
9992002|NCT01664923|11113822|FG001|STARTED|Period 2: Open-label Phase-36 Months||38
9992003|NCT01664923|11113821|FG000|Treated|Period 2: Open-label Phase-36 Months||93
9992004|NCT01664923|11113822|FG001|Treated|Period 2: Open-label Phase-36 Months||37
9992005|NCT01664923|11113821|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52
9992006|NCT01664923|11113822|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15
9992007|NCT01664923|11113821|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
9992008|NCT01664923|11113822|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
9992009|NCT01664949|11113834|FG000|STARTED|Overall Study||224
9992010|NCT01664949|11113835|FG001|STARTED|Overall Study||236
9992011|NCT01664949|11113834|FG000|COMPLETED|Overall Study||200
9992012|NCT01664949|11113835|FG001|COMPLETED|Overall Study||211
9992013|NCT01664949|11113834|FG000|NOT COMPLETED|Overall Study||24
9992014|NCT01664949|11113835|FG001|NOT COMPLETED|Overall Study||25
9992015|NCT01664975|11113843|FG000|STARTED|Overall Study||57
9992016|NCT01664975|11113844|FG001|STARTED|Overall Study||54
9992017|NCT01664975|11113843|FG000|COMPLETED|Overall Study||52
9992018|NCT01664975|11113844|FG001|COMPLETED|Overall Study||51
9992019|NCT01664975|11113843|FG000|NOT COMPLETED|Overall Study||5
9992020|NCT01664975|11113844|FG001|NOT COMPLETED|Overall Study||3
9992021|NCT01665040|11113850|FG000|STARTED|Overall Study||40
9992022|NCT01665040|11113850|FG000|COMPLETED|Overall Study||36
9992023|NCT01665040|11113850|FG000|NOT COMPLETED|Overall Study||4
10102380|NCT02415400|11231840|FG001|NOT COMPLETED|Overall Study||62
10102381|NCT02415400|11231841|FG002|NOT COMPLETED|Overall Study||85
10102382|NCT02415400|11231842|FG003|NOT COMPLETED|Overall Study||83
9992024|NCT01665053|11113856|FG000|STARTED|Overall Study||838
9992025|NCT01665053|11113857|FG001|STARTED|Overall Study||846
9992026|NCT01665053|11113856|FG000|Completed 12-Month Clinical F/U|Overall Study||797
9992027|NCT01665053|11113857|FG001|Completed 12-Month Clinical F/U|Overall Study||822
9992028|NCT01665053|11113856|FG000|No 12-Month F/U|Overall Study||32
9992029|NCT01665053|11113857|FG001|No 12-Month F/U|Overall Study||15
9992030|NCT01665053|11113856|FG000|Death With No 12-month Clinical FU|Overall Study||9
9992031|NCT01665053|11113857|FG001|Death With No 12-month Clinical FU|Overall Study||9
9992032|NCT01665053|11113856|FG000|COMPLETED|Overall Study||806
9992033|NCT01665053|11113857|FG001|COMPLETED|Overall Study||831
9992034|NCT01665053|11113856|FG000|NOT COMPLETED|Overall Study||32
9992035|NCT01665053|11113857|FG001|NOT COMPLETED|Overall Study||15
9992036|NCT01665092|11113867|FG000|STARTED|Overall Study||75
9992037|NCT01665092|11113868|FG001|STARTED|Overall Study||35
9992038|NCT01665092|11113869|FG002|STARTED|Overall Study||34
9992039|NCT01665092|11113870|FG003|STARTED|Overall Study||106
9992040|NCT01665092|11113867|FG000|COMPLETED|Overall Study||75
9992041|NCT01665092|11113868|FG001|COMPLETED|Overall Study||35
9992042|NCT01665092|11113869|FG002|COMPLETED|Overall Study||32
9992043|NCT01665092|11113870|FG003|COMPLETED|Overall Study||105
9992044|NCT01665092|11113867|FG000|NOT COMPLETED|Overall Study||0
9992045|NCT01665092|11113868|FG001|NOT COMPLETED|Overall Study||0
9992046|NCT01665092|11113869|FG002|NOT COMPLETED|Overall Study||2
9992047|NCT01665092|11113870|FG003|NOT COMPLETED|Overall Study||1
9992048|NCT01665157|11113883|FG000|STARTED|Overall Study||60
9992049|NCT01665157|11113884|FG001|STARTED|Overall Study||60
9992050|NCT01665157|11113885|FG002|STARTED|Overall Study||60
9992051|NCT01665157|11113883|FG000|COMPLETED|Overall Study||60
9992052|NCT01665157|11113884|FG001|COMPLETED|Overall Study||60
9992053|NCT01665157|11113885|FG002|COMPLETED|Overall Study||60
9992054|NCT01665157|11113883|FG000|NOT COMPLETED|Overall Study||0
9992055|NCT01665157|11113884|FG001|NOT COMPLETED|Overall Study||0
9992056|NCT01665157|11113885|FG002|NOT COMPLETED|Overall Study||0
9992057|NCT01665170|11113900|FG000|STARTED|Overall Study|First patient in|30
9992058|NCT01665170|11113901|FG001|STARTED|Overall Study||30
9992059|NCT01665170|11113900|FG000|Bevore TSST|Overall Study||30
9992060|NCT01665170|11113901|FG001|Bevore TSST|Overall Study||30
10102383|NCT02415439|11231869|FG000|STARTED|Overall Study||6
9877461|NCT01011465|10991919|FG005|COMPLETED|Overall Study||29
9877462|NCT01011465|10991920|FG006|COMPLETED|Overall Study||51
9877463|NCT01011465|10991921|FG007|COMPLETED|Overall Study||32
9877464|NCT01011465|10991914|FG000|NOT COMPLETED|Overall Study||2
9877465|NCT01011465|10991915|FG001|NOT COMPLETED|Overall Study||1
9877466|NCT01011465|10991916|FG002|NOT COMPLETED|Overall Study||0
9877467|NCT01011465|10991917|FG003|NOT COMPLETED|Overall Study||0
9877468|NCT01011465|10991918|FG004|NOT COMPLETED|Overall Study||1
9877469|NCT01011465|10991919|FG005|NOT COMPLETED|Overall Study||0
10102384|NCT02415439|11231870|FG001|STARTED|Overall Study||6
9992061|NCT01665170|11113900|FG000|During TSST|Overall Study||30
9992062|NCT01665170|11113901|FG001|During TSST|Overall Study||30
9992063|NCT01665170|11113900|FG000|After TSST|Overall Study||30
9992064|NCT01665170|11113901|FG001|After TSST|Overall Study||30
9992065|NCT01665170|11113900|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30
9992066|NCT01665170|11113901|FG001|COMPLETED|Overall Study||30
9992067|NCT01665170|11113900|FG000|NOT COMPLETED|Overall Study||0
9992068|NCT01665170|11113901|FG001|NOT COMPLETED|Overall Study||0
9992069|NCT01665430|11113909|FG000|STARTED|Overall Study||38
9992070|NCT01665430|11113909|FG000|COMPLETED|Overall Study||29
9992071|NCT01665430|11113909|FG000|NOT COMPLETED|Overall Study||9
9992072|NCT01665508|11113913|FG000|STARTED|Overall Study||12
9992073|NCT01665508|11113913|FG000|COMPLETED|Overall Study||7
9992074|NCT01665508|11113913|FG000|NOT COMPLETED|Overall Study||5
9992075|NCT01665599|11113922|FG000|STARTED|Overall Study||180
9992076|NCT01665599|11113922|FG000|COMPLETED|Overall Study||172
9992077|NCT01665599|11113922|FG000|NOT COMPLETED|Overall Study||8
9992078|NCT01665768|11113926|FG000|STARTED|Overall Study||49
9992079|NCT01665768|11113926|FG000|COMPLETED|Overall Study||26
9992080|NCT01665768|11113926|FG000|NOT COMPLETED|Overall Study||23
9992081|NCT01665807|11113933|FG000|STARTED|Overall Study||411
9992082|NCT01665807|11113934|FG001|STARTED|Overall Study||58
9992083|NCT01665807|11113935|FG002|STARTED|Overall Study||402
9992084|NCT01665807|11113933|FG000|COMPLETED|Overall Study||409
9992085|NCT01665807|11113934|FG001|COMPLETED|Overall Study||58
9992086|NCT01665807|11113935|FG002|COMPLETED|Overall Study||401
9992087|NCT01665807|11113933|FG000|NOT COMPLETED|Overall Study||2
9992088|NCT01665807|11113934|FG001|NOT COMPLETED|Overall Study||0
9992089|NCT01665807|11113935|FG002|NOT COMPLETED|Overall Study||1
9992090|NCT01665872|11113945|FG000|STARTED|Screening||172
9992091|NCT01665872|11113946|FG001|STARTED|Screening||172
9992092|NCT01665872|11113945|FG000|COMPLETED|Screening||172
9992093|NCT01665872|11113946|FG001|COMPLETED|Screening||172
9992094|NCT01665872|11113945|FG000|NOT COMPLETED|Screening||0
9992095|NCT01665872|11113946|FG001|NOT COMPLETED|Screening||0
9992096|NCT01665872|11113945|FG000|STARTED|Treatment||87
9992097|NCT01665872|11113946|FG001|STARTED|Treatment||67
9992098|NCT01665872|11113945|FG000|COMPLETED|Treatment||72
9992099|NCT01665872|11113946|FG001|COMPLETED|Treatment||50
9992100|NCT01665872|11113945|FG000|NOT COMPLETED|Treatment||15
9992101|NCT01665872|11113946|FG001|NOT COMPLETED|Treatment||17
9992102|NCT01665872|11113945|FG000|STARTED|6 Month Follow-up||72
9992103|NCT01665872|11113946|FG001|STARTED|6 Month Follow-up||50
9992104|NCT01665872|11113945|FG000|COMPLETED|6 Month Follow-up||66
9992105|NCT01665872|11113946|FG001|COMPLETED|6 Month Follow-up||49
9992106|NCT01665872|11113945|FG000|NOT COMPLETED|6 Month Follow-up||6
9992107|NCT01665872|11113946|FG001|NOT COMPLETED|6 Month Follow-up||1
9992108|NCT01665872|11113945|FG000|STARTED|12 Month Follow-up||72
9992109|NCT01665872|11113946|FG001|STARTED|12 Month Follow-up||50
9992110|NCT01665872|11113945|FG000|COMPLETED|12 Month Follow-up||58
9992111|NCT01665872|11113946|FG001|COMPLETED|12 Month Follow-up||47
9992112|NCT01665872|11113945|FG000|NOT COMPLETED|12 Month Follow-up||14
9992113|NCT01665872|11113946|FG001|NOT COMPLETED|12 Month Follow-up||3
9992114|NCT01665911|11113952|FG000|STARTED|Overall Study||28
9992115|NCT01665911|11113952|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22
9992116|NCT01665911|11113952|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
9992117|NCT01665911|11113952|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
9992118|NCT01665911|11113952|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
9992119|NCT01665911|11113952|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
9992120|NCT01665911|11113952|FG000|COMPLETED|Overall Study||22
9992121|NCT01665911|11113952|FG000|NOT COMPLETED|Overall Study||6
9992122|NCT01665950|11113960|FG000|STARTED|Overall Study||2
9992123|NCT01665950|11113961|FG001|STARTED|Overall Study||0
9992124|NCT01665950|11113962|FG002|STARTED|Overall Study||2
9992125|NCT01665950|11113960|FG000|COMPLETED|Overall Study||1
9992126|NCT01665950|11113961|FG001|COMPLETED|Overall Study||0
9992127|NCT01665950|11113962|FG002|COMPLETED|Overall Study||1
9992128|NCT01665950|11113960|FG000|NOT COMPLETED|Overall Study||1
9992129|NCT01665950|11113961|FG001|NOT COMPLETED|Overall Study||0
9992130|NCT01665950|11113962|FG002|NOT COMPLETED|Overall Study||1
9992131|NCT01666002|11113972|FG000|STARTED|Overall Study||17
9992132|NCT01666002|11113973|FG001|STARTED|Overall Study||10
9992133|NCT01666002|11113972|FG000|COMPLETED|Overall Study||12
9992134|NCT01666002|11113973|FG001|COMPLETED|Overall Study||10
9992135|NCT01666002|11113972|FG000|NOT COMPLETED|Overall Study||5
9992136|NCT01666002|11113973|FG001|NOT COMPLETED|Overall Study||0
9992137|NCT01666119|11113980|FG000|STARTED|Overall Study||249
9992138|NCT01666119|11113980|FG000|COMPLETED|Overall Study||197
9992139|NCT01666119|11113980|FG000|NOT COMPLETED|Overall Study||52
9992140|NCT01666197|11113986|FG000|STARTED|Overall Study||50
9992141|NCT01666197|11113987|FG001|STARTED|Overall Study||50
9992142|NCT01666197|11113986|FG000|COMPLETED|Overall Study||50
9992143|NCT01666197|11113987|FG001|COMPLETED|Overall Study||50
9992144|NCT01666197|11113986|FG000|NOT COMPLETED|Overall Study||0
9992145|NCT01666197|11113987|FG001|NOT COMPLETED|Overall Study||0
9992146|NCT01666210|11113995|FG000|STARTED|Overall Study||30
9992147|NCT01666210|11113996|FG001|STARTED|Overall Study||30
9992148|NCT01666210|11113995|FG000|COMPLETED|Overall Study||28
9992149|NCT01666210|11113996|FG001|COMPLETED|Overall Study||29
9992150|NCT01666210|11113995|FG000|NOT COMPLETED|Overall Study||2
9992151|NCT01666210|11113996|FG001|NOT COMPLETED|Overall Study||1
9992152|NCT01666314|11114010|FG000|STARTED|Overall Study||33
9992153|NCT01666314|11114011|FG001|STARTED|Overall Study||32
9992154|NCT01666314|11114012|FG002|STARTED|Overall Study||36
9992155|NCT01666314|11114013|FG003|STARTED|Overall Study||36
9992156|NCT01666314|11114010|FG000|COMPLETED|Overall Study||0
9992157|NCT01666314|11114011|FG001|COMPLETED|Overall Study||0
9992158|NCT01666314|11114012|FG002|COMPLETED|Overall Study||0
9992159|NCT01666314|11114013|FG003|COMPLETED|Overall Study||0
9992160|NCT01666314|11114010|FG000|NOT COMPLETED|Overall Study||33
9992161|NCT01666314|11114011|FG001|NOT COMPLETED|Overall Study||32
9992162|NCT01666314|11114012|FG002|NOT COMPLETED|Overall Study||36
9992163|NCT01666314|11114013|FG003|NOT COMPLETED|Overall Study||36
9992164|NCT01666444|11114036|FG000|STARTED|Overall Study||149
9992165|NCT01666444|11114037|FG001|STARTED|Overall Study||148
9992166|NCT01666444|11114036|FG000|COMPLETED|Overall Study||147
9992167|NCT01666444|11114037|FG001|COMPLETED|Overall Study||147
9992168|NCT01666444|11114036|FG000|NOT COMPLETED|Overall Study||2
9992169|NCT01666444|11114037|FG001|NOT COMPLETED|Overall Study||1
9992170|NCT01666652|11114048|FG000|STARTED|Overall Study||20
9992171|NCT01666652|11114049|FG001|STARTED|Overall Study||20
9992172|NCT01666652|11114050|FG002|STARTED|Overall Study||20
9992173|NCT01666652|11114051|FG003|STARTED|Overall Study||20
9992174|NCT01666652|11114052|FG004|STARTED|Overall Study||20
9992175|NCT01666652|11114048|FG000|COMPLETED|Overall Study||18
9992176|NCT01666652|11114049|FG001|COMPLETED|Overall Study||19
9992177|NCT01666652|11114050|FG002|COMPLETED|Overall Study||19
9992178|NCT01666652|11114051|FG003|COMPLETED|Overall Study||16
9992179|NCT01666652|11114052|FG004|COMPLETED|Overall Study||19
9992180|NCT01666652|11114048|FG000|NOT COMPLETED|Overall Study||2
9992181|NCT01666652|11114049|FG001|NOT COMPLETED|Overall Study||1
9992182|NCT01666652|11114050|FG002|NOT COMPLETED|Overall Study||1
9992183|NCT01666652|11114051|FG003|NOT COMPLETED|Overall Study||4
9992184|NCT01666652|11114052|FG004|NOT COMPLETED|Overall Study||1
9992185|NCT01666730|11114064|FG000|STARTED|Overall Study||50
9992186|NCT01666730|11114064|FG000|COMPLETED|Overall Study||0
9992187|NCT01666730|11114064|FG000|NOT COMPLETED|Overall Study||50
9992188|NCT01666782|11114070|FG000|STARTED|Overall Study||54
9992189|NCT01666782|11114071|FG001|STARTED|Overall Study||51
9992190|NCT01666782|11114070|FG000|COMPLETED|Overall Study||50
9992191|NCT01666782|11114071|FG001|COMPLETED|Overall Study||50
9992192|NCT01666782|11114070|FG000|NOT COMPLETED|Overall Study||4
9992193|NCT01666782|11114071|FG001|NOT COMPLETED|Overall Study||1
9992194|NCT01666912|11114079|FG000|STARTED|Overall Study||48
9992195|NCT01666912|11114080|FG001|STARTED|Overall Study||48
9992196|NCT01666912|11114079|FG000|COMPLETED|Overall Study||27
9992197|NCT01666912|11114080|FG001|COMPLETED|Overall Study||37
9992198|NCT01666912|11114079|FG000|NOT COMPLETED|Overall Study||21
9992199|NCT01666912|11114080|FG001|NOT COMPLETED|Overall Study||11
9992200|NCT01666951|11114088|FG000|STARTED|Overall Study||18
9992201|NCT01666951|11114089|FG001|STARTED|Overall Study||18
9992202|NCT01666951|11114088|FG000|COMPLETED|Overall Study||17
9992203|NCT01666951|11114089|FG001|COMPLETED|Overall Study||17
9992204|NCT01666951|11114088|FG000|NOT COMPLETED|Overall Study||1
9992205|NCT01666951|11114089|FG001|NOT COMPLETED|Overall Study||1
9992206|NCT01667029|11114095|FG000|STARTED|Overall Study||4
9992207|NCT01667029|11114096|FG001|STARTED|Overall Study||4
9992208|NCT01667029|11114095|FG000|COMPLETED|Overall Study||3
9992209|NCT01667029|11114096|FG001|COMPLETED|Overall Study||3
9992210|NCT01667029|11114095|FG000|NOT COMPLETED|Overall Study||1
9992211|NCT01667029|11114096|FG001|NOT COMPLETED|Overall Study||1
9992212|NCT01667107|11114104|FG000|STARTED|Overall Study||8
9992213|NCT01667107|11114105|FG001|STARTED|Overall Study||18
9992214|NCT01667107|11114104|FG000|COMPLETED|Overall Study||4
9992215|NCT01667107|11114105|FG001|COMPLETED|Overall Study||11
9992216|NCT01667107|11114104|FG000|NOT COMPLETED|Overall Study||4
9992217|NCT01667107|11114105|FG001|NOT COMPLETED|Overall Study||7
9992218|NCT01667224|11114113|FG000|STARTED|Overall Study||40
9992219|NCT01667224|11114114|FG001|STARTED|Overall Study||40
9992220|NCT01667224|11114113|FG000|COMPLETED|Overall Study||36
9992221|NCT01667224|11114114|FG001|COMPLETED|Overall Study||38
9992222|NCT01667224|11114113|FG000|NOT COMPLETED|Overall Study||4
9992223|NCT01667224|11114114|FG001|NOT COMPLETED|Overall Study||2
9992224|NCT01667250|11114124|FG000|STARTED|Run-in (no Treatment)||0
9992225|NCT01667250|11114125|FG001|STARTED|Run-in (no Treatment)||0
9992226|NCT01667250|11114126|FG002|STARTED|Run-in (no Treatment)||73
9992227|NCT01667250|11114124|FG000|COMPLETED|Run-in (no Treatment)||0
9992228|NCT01667250|11114125|FG001|COMPLETED|Run-in (no Treatment)||0
9992229|NCT01667250|11114126|FG002|COMPLETED|Run-in (no Treatment)||59
9992230|NCT01667250|11114124|FG000|NOT COMPLETED|Run-in (no Treatment)||0
9992231|NCT01667250|11114125|FG001|NOT COMPLETED|Run-in (no Treatment)||0
9992232|NCT01667250|11114126|FG002|NOT COMPLETED|Run-in (no Treatment)||14
9992233|NCT01667250|11114124|FG000|STARTED|Randomised Period||30
9992234|NCT01667250|11114125|FG001|STARTED|Randomised Period||29
9992235|NCT01667250|11114126|FG002|STARTED|Randomised Period||0
9992236|NCT01667250|11114124|FG000|COMPLETED|Randomised Period||29
9992237|NCT01667250|11114125|FG001|COMPLETED|Randomised Period||28
9992238|NCT01667250|11114126|FG002|COMPLETED|Randomised Period||0
9992239|NCT01667250|11114124|FG000|NOT COMPLETED|Randomised Period||1
9992240|NCT01667250|11114125|FG001|NOT COMPLETED|Randomised Period||1
9992241|NCT01667250|11114126|FG002|NOT COMPLETED|Randomised Period||0
9992242|NCT01667406|11114143|FG000|STARTED|Overall Study||2
9992243|NCT01667406|11114144|FG001|STARTED|Overall Study||3
9992244|NCT01667406|11114145|FG002|STARTED|Overall Study||24
9992245|NCT01667406|11114146|FG003|STARTED|Overall Study||24
9992246|NCT01667406|11114147|FG004|STARTED|Overall Study||5
9992247|NCT01667406|11114148|FG005|STARTED|Overall Study||20
9992248|NCT01667406|11114149|FG006|STARTED|Overall Study||15
9992249|NCT01667406|11114150|FG007|STARTED|Overall Study||20
9992250|NCT01667406|11114151|FG008|STARTED|Overall Study||31
9992251|NCT01667406|11114152|FG009|STARTED|Overall Study||31
9992252|NCT01667406|11114143|FG000|COMPLETED|Overall Study||2
9992253|NCT01667406|11114144|FG001|COMPLETED|Overall Study||3
9992254|NCT01667406|11114145|FG002|COMPLETED|Overall Study||24
9992255|NCT01667406|11114146|FG003|COMPLETED|Overall Study||24
9992256|NCT01667406|11114147|FG004|COMPLETED|Overall Study||5
9992257|NCT01667406|11114148|FG005|COMPLETED|Overall Study||20
9992258|NCT01667406|11114149|FG006|COMPLETED|Overall Study||15
9992259|NCT01667406|11114150|FG007|COMPLETED|Overall Study||20
9992260|NCT01667406|11114151|FG008|COMPLETED|Overall Study||31
9992261|NCT01667406|11114152|FG009|COMPLETED|Overall Study||31
9992262|NCT01667406|11114143|FG000|NOT COMPLETED|Overall Study||0
9992263|NCT01667406|11114144|FG001|NOT COMPLETED|Overall Study||0
9992264|NCT01667406|11114145|FG002|NOT COMPLETED|Overall Study||0
9992265|NCT01667406|11114146|FG003|NOT COMPLETED|Overall Study||0
9992266|NCT01667406|11114147|FG004|NOT COMPLETED|Overall Study||0
9992267|NCT01667406|11114148|FG005|NOT COMPLETED|Overall Study||0
9992268|NCT01667406|11114149|FG006|NOT COMPLETED|Overall Study||0
9992269|NCT01667406|11114150|FG007|NOT COMPLETED|Overall Study||0
9992270|NCT01667406|11114151|FG008|NOT COMPLETED|Overall Study||0
9992271|NCT01667406|11114152|FG009|NOT COMPLETED|Overall Study||0
9992272|NCT01667419|11114208|FG000|STARTED|Overall Study||157
9992273|NCT01667419|11114209|FG001|STARTED|Overall Study||157
9992274|NCT01667419|11114210|FG002|STARTED|Overall Study||93
9992275|NCT01667419|11114211|FG003|STARTED|Overall Study||91
9992276|NCT01667419|11114208|FG000|COMPLETED|Overall Study||114
9992277|NCT01667419|11114209|FG001|COMPLETED|Overall Study||110
9992278|NCT01667419|11114210|FG002|COMPLETED|Overall Study||57
9992279|NCT01667419|11114211|FG003|COMPLETED|Overall Study||52
9992280|NCT01667419|11114208|FG000|NOT COMPLETED|Overall Study||43
9992281|NCT01667419|11114209|FG001|NOT COMPLETED|Overall Study||47
9992282|NCT01667419|11114210|FG002|NOT COMPLETED|Overall Study||36
9992283|NCT01667419|11114211|FG003|NOT COMPLETED|Overall Study||39
9992284|NCT01667432|11114222|FG000|STARTED|Overall Study||141
9992285|NCT01667432|11114222|FG000|COMPLETED|Overall Study||84
9992286|NCT01667432|11114222|FG000|NOT COMPLETED|Overall Study||57
9992287|NCT01667471|11114226|FG000|STARTED|Overall Study||7
9992288|NCT01667471|11114226|FG000|COMPLETED|Overall Study||7
9992289|NCT01667471|11114226|FG000|NOT COMPLETED|Overall Study||0
9992290|NCT01667536|11114231|FG000|STARTED|Overall Study||105
9992291|NCT01667536|11114231|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
9992292|NCT01667536|11114231|FG000|NOT COMPLETED|Overall Study||0
9992293|NCT01667549|11114243|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
9992294|NCT01667549|11114244|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
9992295|NCT01667549|11114245|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
9992296|NCT01667549|11114246|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
9992297|NCT01667549|11114247|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
9992298|NCT01667549|11114243|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
9992299|NCT01667549|11114244|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
9992300|NCT01667549|11114245|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
9992301|NCT01667549|11114246|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
9992302|NCT01667549|11114247|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
9992303|NCT01667549|11114243|FG000|NOT COMPLETED|Overall Study||3
9992304|NCT01667549|11114244|FG001|NOT COMPLETED|Overall Study||5
9992305|NCT01667549|11114245|FG002|NOT COMPLETED|Overall Study||7
9992306|NCT01667549|11114246|FG003|NOT COMPLETED|Overall Study||6
9992307|NCT01667549|11114247|FG004|NOT COMPLETED|Overall Study||1
9992308|NCT01667562|11114264|FG000|STARTED|Diagnostic Phase||375
9992309|NCT01667562|11114265|FG001|STARTED|Diagnostic Phase||0
9992310|NCT01667562|11114264|FG000|COMPLETED|Diagnostic Phase||345
9992311|NCT01667562|11114265|FG001|COMPLETED|Diagnostic Phase||0
9992312|NCT01667562|11114264|FG000|NOT COMPLETED|Diagnostic Phase||30
9992313|NCT01667562|11114265|FG001|NOT COMPLETED|Diagnostic Phase||0
9992314|NCT01667562|11114264|FG000|STARTED|Erlotinib Phase||0
9992315|NCT01667562|11114265|FG001|STARTED|Erlotinib Phase||30
9992316|NCT01667562|11114264|FG000|COMPLETED|Erlotinib Phase||0
9992317|NCT01667562|11114265|FG001|COMPLETED|Erlotinib Phase||27
9992318|NCT01667562|11114264|FG000|NOT COMPLETED|Erlotinib Phase||0
9992319|NCT01667562|11114265|FG001|NOT COMPLETED|Erlotinib Phase||3
9992320|NCT01667679|11114272|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138
9992321|NCT01667679|11114273|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137
9992322|NCT01667679|11114272|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
9992323|NCT01667679|11114273|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
9992324|NCT01667679|11114272|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
9992325|NCT01667679|11114273|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
9992326|NCT01667679|11114272|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122
9992327|NCT01667679|11114273|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107
9992328|NCT01667679|11114272|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
9992329|NCT01667679|11114273|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
9992330|NCT01667679|11114272|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
9992331|NCT01667679|11114273|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
9992332|NCT01667731|11114286|FG000|STARTED|Overall Study||26
9992333|NCT01667731|11114287|FG001|STARTED|Overall Study||42
9992334|NCT01667731|11114288|FG002|STARTED|Overall Study||24
9992335|NCT01667731|11114289|FG003|STARTED|Overall Study||17
9992336|NCT01667731|11114290|FG004|STARTED|Overall Study||115
9992337|NCT01667731|11114286|FG000|COMPLETED|Overall Study||21
9992338|NCT01667731|11114287|FG001|COMPLETED|Overall Study||26
9992339|NCT01667731|11114288|FG002|COMPLETED|Overall Study||22
9992340|NCT01667731|11114289|FG003|COMPLETED|Overall Study||15
9992341|NCT01667731|11114290|FG004|COMPLETED|Overall Study||87
9992342|NCT01667731|11114286|FG000|NOT COMPLETED|Overall Study||5
9992343|NCT01667731|11114287|FG001|NOT COMPLETED|Overall Study||16
9992344|NCT01667731|11114288|FG002|NOT COMPLETED|Overall Study||2
9992345|NCT01667731|11114289|FG003|NOT COMPLETED|Overall Study||2
9992346|NCT01667731|11114290|FG004|NOT COMPLETED|Overall Study||28
9992347|NCT01667796|11114305|FG000|STARTED|Overall Study||27
9992348|NCT01667796|11114306|FG001|STARTED|Overall Study||30
9992349|NCT01667796|11114305|FG000|COMPLETED|Overall Study||24
9992350|NCT01667796|11114306|FG001|COMPLETED|Overall Study||29
9992351|NCT01667796|11114305|FG000|NOT COMPLETED|Overall Study||3
9992352|NCT01667796|11114306|FG001|NOT COMPLETED|Overall Study||1
9992353|NCT01667848|11114318|FG000|STARTED|Overall Study||67
9992354|NCT01667848|11114319|FG001|STARTED|Overall Study||81
9992355|NCT01667848|11114318|FG000|COMPLETED|Overall Study||67
9992356|NCT01667848|11114319|FG001|COMPLETED|Overall Study||81
9992357|NCT01667848|11114318|FG000|NOT COMPLETED|Overall Study||0
9992358|NCT01667848|11114319|FG001|NOT COMPLETED|Overall Study||0
9992359|NCT01667900|11114330|FG000|STARTED|Part A, Period 1||1
9992360|NCT01667900|11114331|FG001|STARTED|Part A, Period 1||1
9992361|NCT01667900|11114332|FG002|STARTED|Part A, Period 1||1
9992362|NCT01667900|11114333|FG003|STARTED|Part A, Period 1||1
9992363|NCT01667900|11114334|FG004|STARTED|Part A, Period 1||1
9992364|NCT01667900|11114335|FG005|STARTED|Part A, Period 1||1
9992365|NCT01667900|11114336|FG006|STARTED|Part A, Period 1||1
9992366|NCT01667900|11114337|FG007|STARTED|Part A, Period 1||1
9992367|NCT01667900|11114338|FG008|STARTED|Part A, Period 1||1
9992368|NCT01667900|11114339|FG009|STARTED|Part A, Period 1||1
9992369|NCT01667900|11114340|FG010|STARTED|Part A, Period 1||1
9992370|NCT01667900|11114341|FG011|STARTED|Part A, Period 1||1
9992371|NCT01667900|11114342|FG012|STARTED|Part A, Period 1||1
9992372|NCT01667900|11114343|FG013|STARTED|Part A, Period 1||1
9992373|NCT01667900|11114344|FG014|STARTED|Part A, Period 1||1
9992374|NCT01667900|11114345|FG015|STARTED|Part A, Period 1||1
9992375|NCT01667900|11114346|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
9992376|NCT01667900|11114347|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
9992377|NCT01667900|11114348|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
9992378|NCT01667900|11114349|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
9992379|NCT01667900|11114330|FG000|COMPLETED|Part A, Period 1||1
9992380|NCT01667900|11114331|FG001|COMPLETED|Part A, Period 1||1
9992381|NCT01667900|11114332|FG002|COMPLETED|Part A, Period 1||1
9992382|NCT01667900|11114333|FG003|COMPLETED|Part A, Period 1||1
9992383|NCT01667900|11114334|FG004|COMPLETED|Part A, Period 1||1
9992384|NCT01667900|11114335|FG005|COMPLETED|Part A, Period 1||1
9992385|NCT01667900|11114336|FG006|COMPLETED|Part A, Period 1||1
9992386|NCT01667900|11114337|FG007|COMPLETED|Part A, Period 1||1
9992387|NCT01667900|11114338|FG008|COMPLETED|Part A, Period 1||1
9992388|NCT01667900|11114339|FG009|COMPLETED|Part A, Period 1||1
9992389|NCT01667900|11114340|FG010|COMPLETED|Part A, Period 1||1
9992390|NCT01667900|11114341|FG011|COMPLETED|Part A, Period 1||1
9992391|NCT01667900|11114342|FG012|COMPLETED|Part A, Period 1||1
9992392|NCT01667900|11114343|FG013|COMPLETED|Part A, Period 1||1
9992393|NCT01667900|11114344|FG014|COMPLETED|Part A, Period 1||1
9992394|NCT01667900|11114345|FG015|COMPLETED|Part A, Period 1||1
9992395|NCT01667900|11114346|FG016|COMPLETED|Part A, Period 1||0
9992396|NCT01667900|11114347|FG017|COMPLETED|Part A, Period 1||0
9992397|NCT01667900|11114348|FG018|COMPLETED|Part A, Period 1||0
9992398|NCT01667900|11114349|FG019|COMPLETED|Part A, Period 1||0
9992399|NCT01667900|11114330|FG000|NOT COMPLETED|Part A, Period 1||0
9992400|NCT01667900|11114331|FG001|NOT COMPLETED|Part A, Period 1||0
9992401|NCT01667900|11114332|FG002|NOT COMPLETED|Part A, Period 1||0
9992402|NCT01667900|11114333|FG003|NOT COMPLETED|Part A, Period 1||0
9992403|NCT01667900|11114334|FG004|NOT COMPLETED|Part A, Period 1||0
9992404|NCT01667900|11114335|FG005|NOT COMPLETED|Part A, Period 1||0
9992405|NCT01667900|11114336|FG006|NOT COMPLETED|Part A, Period 1||0
9992406|NCT01667900|11114337|FG007|NOT COMPLETED|Part A, Period 1||0
9992407|NCT01667900|11114338|FG008|NOT COMPLETED|Part A, Period 1||0
9992408|NCT01667900|11114339|FG009|NOT COMPLETED|Part A, Period 1||0
9992409|NCT01667900|11114340|FG010|NOT COMPLETED|Part A, Period 1||0
9992410|NCT01667900|11114341|FG011|NOT COMPLETED|Part A, Period 1||0
9992411|NCT01667900|11114342|FG012|NOT COMPLETED|Part A, Period 1||0
9992412|NCT01667900|11114343|FG013|NOT COMPLETED|Part A, Period 1||0
9992413|NCT01667900|11114344|FG014|NOT COMPLETED|Part A, Period 1||0
9992414|NCT01667900|11114345|FG015|NOT COMPLETED|Part A, Period 1||0
9992415|NCT01667900|11114346|FG016|NOT COMPLETED|Part A, Period 1||0
9992416|NCT01667900|11114347|FG017|NOT COMPLETED|Part A, Period 1||0
9992417|NCT01667900|11114348|FG018|NOT COMPLETED|Part A, Period 1||0
9992418|NCT01667900|11114349|FG019|NOT COMPLETED|Part A, Period 1||0
9992419|NCT01667900|11114330|FG000|STARTED|Part A, Washout 1||1
9992420|NCT01667900|11114331|FG001|STARTED|Part A, Washout 1||1
9992421|NCT01667900|11114332|FG002|STARTED|Part A, Washout 1||1
9992422|NCT01667900|11114333|FG003|STARTED|Part A, Washout 1||1
9992423|NCT01667900|11114334|FG004|STARTED|Part A, Washout 1||1
9992424|NCT01667900|11114335|FG005|STARTED|Part A, Washout 1||1
9992425|NCT01667900|11114336|FG006|STARTED|Part A, Washout 1||1
9992426|NCT01667900|11114337|FG007|STARTED|Part A, Washout 1||1
9992427|NCT01667900|11114338|FG008|STARTED|Part A, Washout 1||1
9992428|NCT01667900|11114339|FG009|STARTED|Part A, Washout 1||1
9992429|NCT01667900|11114340|FG010|STARTED|Part A, Washout 1||1
9992430|NCT01667900|11114341|FG011|STARTED|Part A, Washout 1||1
9992431|NCT01667900|11114342|FG012|STARTED|Part A, Washout 1||1
9992432|NCT01667900|11114343|FG013|STARTED|Part A, Washout 1||1
9992433|NCT01667900|11114344|FG014|STARTED|Part A, Washout 1||1
9992434|NCT01667900|11114345|FG015|STARTED|Part A, Washout 1||1
9992435|NCT01667900|11114346|FG016|STARTED|Part A, Washout 1||0
9992436|NCT01667900|11114347|FG017|STARTED|Part A, Washout 1||0
9992437|NCT01667900|11114348|FG018|STARTED|Part A, Washout 1||0
9992438|NCT01667900|11114349|FG019|STARTED|Part A, Washout 1||0
9992439|NCT01667900|11114330|FG000|COMPLETED|Part A, Washout 1||1
9992440|NCT01667900|11114331|FG001|COMPLETED|Part A, Washout 1||1
9992441|NCT01667900|11114332|FG002|COMPLETED|Part A, Washout 1||1
9992442|NCT01667900|11114333|FG003|COMPLETED|Part A, Washout 1||1
9992443|NCT01667900|11114334|FG004|COMPLETED|Part A, Washout 1||1
9992444|NCT01667900|11114335|FG005|COMPLETED|Part A, Washout 1||1
9992445|NCT01667900|11114336|FG006|COMPLETED|Part A, Washout 1||1
9992446|NCT01667900|11114337|FG007|COMPLETED|Part A, Washout 1||1
9992447|NCT01667900|11114338|FG008|COMPLETED|Part A, Washout 1||1
9992448|NCT01667900|11114339|FG009|COMPLETED|Part A, Washout 1||1
9992449|NCT01667900|11114340|FG010|COMPLETED|Part A, Washout 1||1
9992450|NCT01667900|11114341|FG011|COMPLETED|Part A, Washout 1||1
9992451|NCT01667900|11114342|FG012|COMPLETED|Part A, Washout 1||1
9992452|NCT01667900|11114343|FG013|COMPLETED|Part A, Washout 1||1
9992453|NCT01667900|11114344|FG014|COMPLETED|Part A, Washout 1||1
9992454|NCT01667900|11114345|FG015|COMPLETED|Part A, Washout 1||1
9992455|NCT01667900|11114346|FG016|COMPLETED|Part A, Washout 1||0
9992456|NCT01667900|11114347|FG017|COMPLETED|Part A, Washout 1||0
9992457|NCT01667900|11114348|FG018|COMPLETED|Part A, Washout 1||0
9992458|NCT01667900|11114349|FG019|COMPLETED|Part A, Washout 1||0
9992459|NCT01667900|11114330|FG000|NOT COMPLETED|Part A, Washout 1||0
9992460|NCT01667900|11114331|FG001|NOT COMPLETED|Part A, Washout 1||0
9992461|NCT01667900|11114332|FG002|NOT COMPLETED|Part A, Washout 1||0
9992462|NCT01667900|11114333|FG003|NOT COMPLETED|Part A, Washout 1||0
9992463|NCT01667900|11114334|FG004|NOT COMPLETED|Part A, Washout 1||0
9992464|NCT01667900|11114335|FG005|NOT COMPLETED|Part A, Washout 1||0
9992465|NCT01667900|11114336|FG006|NOT COMPLETED|Part A, Washout 1||0
9992466|NCT01667900|11114337|FG007|NOT COMPLETED|Part A, Washout 1||0
9992467|NCT01667900|11114338|FG008|NOT COMPLETED|Part A, Washout 1||0
9992468|NCT01667900|11114339|FG009|NOT COMPLETED|Part A, Washout 1||0
9992469|NCT01667900|11114340|FG010|NOT COMPLETED|Part A, Washout 1||0
9992470|NCT01667900|11114341|FG011|NOT COMPLETED|Part A, Washout 1||0
9992471|NCT01667900|11114342|FG012|NOT COMPLETED|Part A, Washout 1||0
9992472|NCT01667900|11114343|FG013|NOT COMPLETED|Part A, Washout 1||0
9992473|NCT01667900|11114344|FG014|NOT COMPLETED|Part A, Washout 1||0
9992474|NCT01667900|11114345|FG015|NOT COMPLETED|Part A, Washout 1||0
9992475|NCT01667900|11114346|FG016|NOT COMPLETED|Part A, Washout 1||0
9992476|NCT01667900|11114347|FG017|NOT COMPLETED|Part A, Washout 1||0
9992477|NCT01667900|11114348|FG018|NOT COMPLETED|Part A, Washout 1||0
9992478|NCT01667900|11114349|FG019|NOT COMPLETED|Part A, Washout 1||0
9992479|NCT01667900|11114330|FG000|STARTED|Part A, Period 2||1
9992480|NCT01667900|11114331|FG001|STARTED|Part A, Period 2||1
9992481|NCT01667900|11114332|FG002|STARTED|Part A, Period 2||1
9992482|NCT01667900|11114333|FG003|STARTED|Part A, Period 2||1
9992483|NCT01667900|11114334|FG004|STARTED|Part A, Period 2||1
9992484|NCT01667900|11114335|FG005|STARTED|Part A, Period 2||1
9992485|NCT01667900|11114336|FG006|STARTED|Part A, Period 2||1
9992486|NCT01667900|11114337|FG007|STARTED|Part A, Period 2||1
9992487|NCT01667900|11114338|FG008|STARTED|Part A, Period 2||1
9992488|NCT01667900|11114339|FG009|STARTED|Part A, Period 2||1
9992489|NCT01667900|11114340|FG010|STARTED|Part A, Period 2||1
9992490|NCT01667900|11114341|FG011|STARTED|Part A, Period 2||1
9992491|NCT01667900|11114342|FG012|STARTED|Part A, Period 2||1
9992492|NCT01667900|11114343|FG013|STARTED|Part A, Period 2||1
9992493|NCT01667900|11114344|FG014|STARTED|Part A, Period 2||1
9992494|NCT01667900|11114345|FG015|STARTED|Part A, Period 2||1
9992495|NCT01667900|11114346|FG016|STARTED|Part A, Period 2||0
9992496|NCT01667900|11114347|FG017|STARTED|Part A, Period 2||0
9992497|NCT01667900|11114348|FG018|STARTED|Part A, Period 2||0
9992498|NCT01667900|11114349|FG019|STARTED|Part A, Period 2||0
9992499|NCT01667900|11114330|FG000|COMPLETED|Part A, Period 2||1
9992500|NCT01667900|11114331|FG001|COMPLETED|Part A, Period 2||1
9992501|NCT01667900|11114332|FG002|COMPLETED|Part A, Period 2||1
9992502|NCT01667900|11114333|FG003|COMPLETED|Part A, Period 2||1
9992503|NCT01667900|11114334|FG004|COMPLETED|Part A, Period 2||1
9992504|NCT01667900|11114335|FG005|COMPLETED|Part A, Period 2||1
9992505|NCT01667900|11114336|FG006|COMPLETED|Part A, Period 2||1
9992506|NCT01667900|11114337|FG007|COMPLETED|Part A, Period 2||1
9992507|NCT01667900|11114338|FG008|COMPLETED|Part A, Period 2||1
9992508|NCT01667900|11114339|FG009|COMPLETED|Part A, Period 2||1
9992509|NCT01667900|11114340|FG010|COMPLETED|Part A, Period 2||1
9992510|NCT01667900|11114341|FG011|COMPLETED|Part A, Period 2||1
9992511|NCT01667900|11114342|FG012|COMPLETED|Part A, Period 2||1
9992512|NCT01667900|11114343|FG013|COMPLETED|Part A, Period 2||1
9992513|NCT01667900|11114344|FG014|COMPLETED|Part A, Period 2||1
9992514|NCT01667900|11114345|FG015|COMPLETED|Part A, Period 2||1
9992515|NCT01667900|11114346|FG016|COMPLETED|Part A, Period 2||0
9992516|NCT01667900|11114347|FG017|COMPLETED|Part A, Period 2||0
9992517|NCT01667900|11114348|FG018|COMPLETED|Part A, Period 2||0
9992518|NCT01667900|11114349|FG019|COMPLETED|Part A, Period 2||0
9992519|NCT01667900|11114330|FG000|NOT COMPLETED|Part A, Period 2||0
9992520|NCT01667900|11114331|FG001|NOT COMPLETED|Part A, Period 2||0
9992521|NCT01667900|11114332|FG002|NOT COMPLETED|Part A, Period 2||0
9992522|NCT01667900|11114333|FG003|NOT COMPLETED|Part A, Period 2||0
9992523|NCT01667900|11114334|FG004|NOT COMPLETED|Part A, Period 2||0
9992524|NCT01667900|11114335|FG005|NOT COMPLETED|Part A, Period 2||0
9992525|NCT01667900|11114336|FG006|NOT COMPLETED|Part A, Period 2||0
9992526|NCT01667900|11114337|FG007|NOT COMPLETED|Part A, Period 2||0
9992527|NCT01667900|11114338|FG008|NOT COMPLETED|Part A, Period 2||0
9992528|NCT01667900|11114339|FG009|NOT COMPLETED|Part A, Period 2||0
9992529|NCT01667900|11114340|FG010|NOT COMPLETED|Part A, Period 2||0
9992530|NCT01667900|11114341|FG011|NOT COMPLETED|Part A, Period 2||0
9992531|NCT01667900|11114342|FG012|NOT COMPLETED|Part A, Period 2||0
9992532|NCT01667900|11114343|FG013|NOT COMPLETED|Part A, Period 2||0
9992533|NCT01667900|11114344|FG014|NOT COMPLETED|Part A, Period 2||0
9992534|NCT01667900|11114345|FG015|NOT COMPLETED|Part A, Period 2||0
9992535|NCT01667900|11114346|FG016|NOT COMPLETED|Part A, Period 2||0
9992536|NCT01667900|11114347|FG017|NOT COMPLETED|Part A, Period 2||0
9992537|NCT01667900|11114348|FG018|NOT COMPLETED|Part A, Period 2||0
9992538|NCT01667900|11114349|FG019|NOT COMPLETED|Part A, Period 2||0
9992539|NCT01667900|11114330|FG000|STARTED|Part A, Washout 2||1
9992540|NCT01667900|11114331|FG001|STARTED|Part A, Washout 2||1
9992541|NCT01667900|11114332|FG002|STARTED|Part A, Washout 2||1
9992542|NCT01667900|11114333|FG003|STARTED|Part A, Washout 2||1
9992543|NCT01667900|11114334|FG004|STARTED|Part A, Washout 2||1
9992544|NCT01667900|11114335|FG005|STARTED|Part A, Washout 2||1
9992545|NCT01667900|11114336|FG006|STARTED|Part A, Washout 2||1
9992546|NCT01667900|11114337|FG007|STARTED|Part A, Washout 2||1
9992547|NCT01667900|11114338|FG008|STARTED|Part A, Washout 2||1
9992548|NCT01667900|11114339|FG009|STARTED|Part A, Washout 2||1
9992549|NCT01667900|11114340|FG010|STARTED|Part A, Washout 2||1
9992550|NCT01667900|11114341|FG011|STARTED|Part A, Washout 2||1
9992551|NCT01667900|11114342|FG012|STARTED|Part A, Washout 2||1
9992552|NCT01667900|11114343|FG013|STARTED|Part A, Washout 2||1
9992553|NCT01667900|11114344|FG014|STARTED|Part A, Washout 2||1
9992554|NCT01667900|11114345|FG015|STARTED|Part A, Washout 2||1
9992555|NCT01667900|11114346|FG016|STARTED|Part A, Washout 2||0
9992556|NCT01667900|11114347|FG017|STARTED|Part A, Washout 2||0
9992557|NCT01667900|11114348|FG018|STARTED|Part A, Washout 2||0
9992558|NCT01667900|11114349|FG019|STARTED|Part A, Washout 2||0
9992559|NCT01667900|11114330|FG000|COMPLETED|Part A, Washout 2||1
9992560|NCT01667900|11114331|FG001|COMPLETED|Part A, Washout 2||1
9992561|NCT01667900|11114332|FG002|COMPLETED|Part A, Washout 2||1
9992562|NCT01667900|11114333|FG003|COMPLETED|Part A, Washout 2||1
9992563|NCT01667900|11114334|FG004|COMPLETED|Part A, Washout 2||1
9992564|NCT01667900|11114335|FG005|COMPLETED|Part A, Washout 2||1
9992565|NCT01667900|11114336|FG006|COMPLETED|Part A, Washout 2||1
9992566|NCT01667900|11114337|FG007|COMPLETED|Part A, Washout 2||1
9992567|NCT01667900|11114338|FG008|COMPLETED|Part A, Washout 2||1
9992568|NCT01667900|11114339|FG009|COMPLETED|Part A, Washout 2||1
10102385|NCT02415439|11231871|FG002|STARTED|Overall Study||6
10102386|NCT02415439|11231872|FG003|STARTED|Overall Study||6
10102387|NCT02415439|11231873|FG004|STARTED|Overall Study||6
10102388|NCT02415439|11231874|FG005|STARTED|Overall Study||6
10102389|NCT02415439|11231875|FG006|STARTED|Overall Study||6
9992569|NCT01667900|11114340|FG010|COMPLETED|Part A, Washout 2||1
9992570|NCT01667900|11114341|FG011|COMPLETED|Part A, Washout 2||1
9992571|NCT01667900|11114342|FG012|COMPLETED|Part A, Washout 2||1
9992572|NCT01667900|11114343|FG013|COMPLETED|Part A, Washout 2||1
9992573|NCT01667900|11114344|FG014|COMPLETED|Part A, Washout 2||1
9992574|NCT01667900|11114345|FG015|COMPLETED|Part A, Washout 2||1
9992575|NCT01667900|11114346|FG016|COMPLETED|Part A, Washout 2||0
9992576|NCT01667900|11114347|FG017|COMPLETED|Part A, Washout 2||0
9992577|NCT01667900|11114348|FG018|COMPLETED|Part A, Washout 2||0
9992578|NCT01667900|11114349|FG019|COMPLETED|Part A, Washout 2||0
9992579|NCT01667900|11114330|FG000|NOT COMPLETED|Part A, Washout 2||0
9992580|NCT01667900|11114331|FG001|NOT COMPLETED|Part A, Washout 2||0
9992581|NCT01667900|11114332|FG002|NOT COMPLETED|Part A, Washout 2||0
9992582|NCT01667900|11114333|FG003|NOT COMPLETED|Part A, Washout 2||0
9992583|NCT01667900|11114334|FG004|NOT COMPLETED|Part A, Washout 2||0
9992584|NCT01667900|11114335|FG005|NOT COMPLETED|Part A, Washout 2||0
9992585|NCT01667900|11114336|FG006|NOT COMPLETED|Part A, Washout 2||0
9992586|NCT01667900|11114337|FG007|NOT COMPLETED|Part A, Washout 2||0
9992587|NCT01667900|11114338|FG008|NOT COMPLETED|Part A, Washout 2||0
9992588|NCT01667900|11114339|FG009|NOT COMPLETED|Part A, Washout 2||0
9992589|NCT01667900|11114340|FG010|NOT COMPLETED|Part A, Washout 2||0
9992590|NCT01667900|11114341|FG011|NOT COMPLETED|Part A, Washout 2||0
9992591|NCT01667900|11114342|FG012|NOT COMPLETED|Part A, Washout 2||0
9992592|NCT01667900|11114343|FG013|NOT COMPLETED|Part A, Washout 2||0
9992593|NCT01667900|11114344|FG014|NOT COMPLETED|Part A, Washout 2||0
9992594|NCT01667900|11114345|FG015|NOT COMPLETED|Part A, Washout 2||0
9992595|NCT01667900|11114346|FG016|NOT COMPLETED|Part A, Washout 2||0
10102390|NCT02415439|11231876|FG007|STARTED|Overall Study||12
10102391|NCT02415439|11231877|FG008|STARTED|Overall Study||6
9992596|NCT01667900|11114347|FG017|NOT COMPLETED|Part A, Washout 2||0
9992597|NCT01667900|11114348|FG018|NOT COMPLETED|Part A, Washout 2||0
9992598|NCT01667900|11114349|FG019|NOT COMPLETED|Part A, Washout 2||0
10102392|NCT02415439|11231878|FG009|STARTED|Overall Study||6
10102393|NCT02415439|11231879|FG010|STARTED|Overall Study||6
9992599|NCT01667900|11114330|FG000|STARTED|Part A, Period 3||1
9992600|NCT01667900|11114331|FG001|STARTED|Part A, Period 3||1
9992601|NCT01667900|11114332|FG002|STARTED|Part A, Period 3||1
9992602|NCT01667900|11114333|FG003|STARTED|Part A, Period 3||1
9992603|NCT01667900|11114334|FG004|STARTED|Part A, Period 3||1
9992604|NCT01667900|11114335|FG005|STARTED|Part A, Period 3||1
9992605|NCT01667900|11114336|FG006|STARTED|Part A, Period 3||1
9992606|NCT01667900|11114337|FG007|STARTED|Part A, Period 3||1
9992607|NCT01667900|11114338|FG008|STARTED|Part A, Period 3||1
9992608|NCT01667900|11114339|FG009|STARTED|Part A, Period 3||1
9992609|NCT01667900|11114340|FG010|STARTED|Part A, Period 3||1
9992610|NCT01667900|11114341|FG011|STARTED|Part A, Period 3||1
9992611|NCT01667900|11114342|FG012|STARTED|Part A, Period 3||1
9992612|NCT01667900|11114343|FG013|STARTED|Part A, Period 3||1
9992613|NCT01667900|11114344|FG014|STARTED|Part A, Period 3||1
9992614|NCT01667900|11114345|FG015|STARTED|Part A, Period 3||1
9992615|NCT01667900|11114346|FG016|STARTED|Part A, Period 3||0
9992616|NCT01667900|11114347|FG017|STARTED|Part A, Period 3||0
9992617|NCT01667900|11114348|FG018|STARTED|Part A, Period 3||0
9992618|NCT01667900|11114349|FG019|STARTED|Part A, Period 3||0
9992619|NCT01667900|11114330|FG000|COMPLETED|Part A, Period 3||1
9992620|NCT01667900|11114331|FG001|COMPLETED|Part A, Period 3||1
9992621|NCT01667900|11114332|FG002|COMPLETED|Part A, Period 3||1
9992622|NCT01667900|11114333|FG003|COMPLETED|Part A, Period 3||1
9992623|NCT01667900|11114334|FG004|COMPLETED|Part A, Period 3||1
9992624|NCT01667900|11114335|FG005|COMPLETED|Part A, Period 3||1
9992625|NCT01667900|11114336|FG006|COMPLETED|Part A, Period 3||1
9992626|NCT01667900|11114337|FG007|COMPLETED|Part A, Period 3||1
9992627|NCT01667900|11114338|FG008|COMPLETED|Part A, Period 3||1
9992628|NCT01667900|11114339|FG009|COMPLETED|Part A, Period 3||1
9992629|NCT01667900|11114340|FG010|COMPLETED|Part A, Period 3||1
9992630|NCT01667900|11114341|FG011|COMPLETED|Part A, Period 3||1
9992631|NCT01667900|11114342|FG012|COMPLETED|Part A, Period 3||1
9992632|NCT01667900|11114343|FG013|COMPLETED|Part A, Period 3||1
9992633|NCT01667900|11114344|FG014|COMPLETED|Part A, Period 3||1
9992634|NCT01667900|11114345|FG015|COMPLETED|Part A, Period 3||1
9992635|NCT01667900|11114346|FG016|COMPLETED|Part A, Period 3||0
9992636|NCT01667900|11114347|FG017|COMPLETED|Part A, Period 3||0
9992637|NCT01667900|11114348|FG018|COMPLETED|Part A, Period 3||0
9992638|NCT01667900|11114349|FG019|COMPLETED|Part A, Period 3||0
9992639|NCT01667900|11114330|FG000|NOT COMPLETED|Part A, Period 3||0
9992640|NCT01667900|11114331|FG001|NOT COMPLETED|Part A, Period 3||0
9992641|NCT01667900|11114332|FG002|NOT COMPLETED|Part A, Period 3||0
9992642|NCT01667900|11114333|FG003|NOT COMPLETED|Part A, Period 3||0
9992643|NCT01667900|11114334|FG004|NOT COMPLETED|Part A, Period 3||0
9992644|NCT01667900|11114335|FG005|NOT COMPLETED|Part A, Period 3||0
9992645|NCT01667900|11114336|FG006|NOT COMPLETED|Part A, Period 3||0
9992646|NCT01667900|11114337|FG007|NOT COMPLETED|Part A, Period 3||0
9992647|NCT01667900|11114338|FG008|NOT COMPLETED|Part A, Period 3||0
9992648|NCT01667900|11114339|FG009|NOT COMPLETED|Part A, Period 3||0
9992649|NCT01667900|11114340|FG010|NOT COMPLETED|Part A, Period 3||0
9992650|NCT01667900|11114341|FG011|NOT COMPLETED|Part A, Period 3||0
9992651|NCT01667900|11114342|FG012|NOT COMPLETED|Part A, Period 3||0
9992652|NCT01667900|11114343|FG013|NOT COMPLETED|Part A, Period 3||0
9992653|NCT01667900|11114344|FG014|NOT COMPLETED|Part A, Period 3||0
9992654|NCT01667900|11114345|FG015|NOT COMPLETED|Part A, Period 3||0
9992655|NCT01667900|11114346|FG016|NOT COMPLETED|Part A, Period 3||0
9992656|NCT01667900|11114347|FG017|NOT COMPLETED|Part A, Period 3||0
9992657|NCT01667900|11114348|FG018|NOT COMPLETED|Part A, Period 3||0
9992658|NCT01667900|11114349|FG019|NOT COMPLETED|Part A, Period 3||0
9992659|NCT01667900|11114330|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0
9992660|NCT01667900|11114331|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0
9992661|NCT01667900|11114332|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0
9992662|NCT01667900|11114333|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0
9992663|NCT01667900|11114334|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0
9992664|NCT01667900|11114335|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0
9992665|NCT01667900|11114336|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0
9992666|NCT01667900|11114337|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0
9992667|NCT01667900|11114338|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0
9992668|NCT01667900|11114339|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0
9992669|NCT01667900|11114340|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0
9992670|NCT01667900|11114341|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0
9992671|NCT01667900|11114342|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0
9992672|NCT01667900|11114343|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0
9992673|NCT01667900|11114344|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0
9992674|NCT01667900|11114345|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0
9992675|NCT01667900|11114346|FG016|STARTED|Part B||11
9992676|NCT01667900|11114347|FG017|STARTED|Part B||11
10102394|NCT02415439|11231880|FG011|STARTED|Overall Study||6
9992677|NCT01667900|11114348|FG018|STARTED|Part B||10
9992678|NCT01667900|11114349|FG019|STARTED|Part B||10
9992679|NCT01667900|11114330|FG000|COMPLETED|Part B||0
9992680|NCT01667900|11114331|FG001|COMPLETED|Part B||0
9992681|NCT01667900|11114332|FG002|COMPLETED|Part B||0
9992682|NCT01667900|11114333|FG003|COMPLETED|Part B||0
9992683|NCT01667900|11114334|FG004|COMPLETED|Part B||0
9992684|NCT01667900|11114335|FG005|COMPLETED|Part B||0
9992685|NCT01667900|11114336|FG006|COMPLETED|Part B||0
9992686|NCT01667900|11114337|FG007|COMPLETED|Part B||0
9992687|NCT01667900|11114338|FG008|COMPLETED|Part B||0
9992688|NCT01667900|11114339|FG009|COMPLETED|Part B||0
9992689|NCT01667900|11114340|FG010|COMPLETED|Part B||0
9992690|NCT01667900|11114341|FG011|COMPLETED|Part B||0
9992691|NCT01667900|11114342|FG012|COMPLETED|Part B||0
9992692|NCT01667900|11114343|FG013|COMPLETED|Part B||0
9992693|NCT01667900|11114344|FG014|COMPLETED|Part B||0
9992694|NCT01667900|11114345|FG015|COMPLETED|Part B||0
9992695|NCT01667900|11114346|FG016|COMPLETED|Part B||10
9992696|NCT01667900|11114347|FG017|COMPLETED|Part B||11
9992697|NCT01667900|11114348|FG018|COMPLETED|Part B||10
9992698|NCT01667900|11114349|FG019|COMPLETED|Part B||10
9992699|NCT01667900|11114330|FG000|NOT COMPLETED|Part B||0
9992700|NCT01667900|11114331|FG001|NOT COMPLETED|Part B||0
9992701|NCT01667900|11114332|FG002|NOT COMPLETED|Part B||0
9992702|NCT01667900|11114333|FG003|NOT COMPLETED|Part B||0
9992703|NCT01667900|11114334|FG004|NOT COMPLETED|Part B||0
9992704|NCT01667900|11114335|FG005|NOT COMPLETED|Part B||0
9992705|NCT01667900|11114336|FG006|NOT COMPLETED|Part B||0
9992706|NCT01667900|11114337|FG007|NOT COMPLETED|Part B||0
9992707|NCT01667900|11114338|FG008|NOT COMPLETED|Part B||0
9992708|NCT01667900|11114339|FG009|NOT COMPLETED|Part B||0
9992709|NCT01667900|11114340|FG010|NOT COMPLETED|Part B||0
9992710|NCT01667900|11114341|FG011|NOT COMPLETED|Part B||0
9992711|NCT01667900|11114342|FG012|NOT COMPLETED|Part B||0
9992712|NCT01667900|11114343|FG013|NOT COMPLETED|Part B||0
9992713|NCT01667900|11114344|FG014|NOT COMPLETED|Part B||0
9992714|NCT01667900|11114345|FG015|NOT COMPLETED|Part B||0
9992715|NCT01667900|11114346|FG016|NOT COMPLETED|Part B||1
9992716|NCT01667900|11114347|FG017|NOT COMPLETED|Part B||0
9992717|NCT01667900|11114348|FG018|NOT COMPLETED|Part B||0
9992718|NCT01667900|11114349|FG019|NOT COMPLETED|Part B||0
9992719|NCT01667926|11114371|FG000|STARTED|Overall Study||13
9992720|NCT01667926|11114372|FG001|STARTED|Overall Study||13
9992721|NCT01667926|11114373|FG002|STARTED|Overall Study||11
9992722|NCT01667926|11114371|FG000|COMPLETED|Overall Study||8
9992723|NCT01667926|11114372|FG001|COMPLETED|Overall Study||9
9992724|NCT01667926|11114373|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
9992725|NCT01667926|11114371|FG000|NOT COMPLETED|Overall Study||5
9992726|NCT01667926|11114372|FG001|NOT COMPLETED|Overall Study||4
9992727|NCT01667926|11114373|FG002|NOT COMPLETED|Overall Study||11
9992728|NCT01667978|11114381|FG000|STARTED|Overall Study||18
9992729|NCT01667978|11114382|FG001|STARTED|Overall Study||17
9992730|NCT01667978|11114381|FG000|COMPLETED|Overall Study||16
9992731|NCT01667978|11114382|FG001|COMPLETED|Overall Study||17
9992732|NCT01667978|11114381|FG000|NOT COMPLETED|Overall Study||2
9992733|NCT01667978|11114382|FG001|NOT COMPLETED|Overall Study||0
9992734|NCT01668004|11114388|FG000|STARTED|Overall Study||101
9992735|NCT01668004|11114388|FG000|Treated|Overall Study||101
9992736|NCT01668004|11114388|FG000|COMPLETED|Overall Study||76
9992737|NCT01668004|11114388|FG000|NOT COMPLETED|Overall Study||25
9992738|NCT01668017|11114399|FG000|STARTED|Overall Study||4
9992739|NCT01668017|11114400|FG001|STARTED|Overall Study||9
9992740|NCT01668017|11114401|FG002|STARTED|Overall Study||6
9992741|NCT01668017|11114402|FG003|STARTED|Overall Study||5
9992742|NCT01668017|11114403|FG004|STARTED|Overall Study||2
9992743|NCT01668017|11114399|FG000|COMPLETED|Overall Study||4
9992744|NCT01668017|11114400|FG001|COMPLETED|Overall Study||9
9992745|NCT01668017|11114401|FG002|COMPLETED|Overall Study||6
10102395|NCT02415439|11231881|FG012|STARTED|Overall Study||8
9992746|NCT01668017|11114402|FG003|COMPLETED|Overall Study||5
9992747|NCT01668017|11114403|FG004|COMPLETED|Overall Study||2
9992748|NCT01668017|11114399|FG000|NOT COMPLETED|Overall Study||0
9992749|NCT01668017|11114400|FG001|NOT COMPLETED|Overall Study||0
9992750|NCT01668017|11114401|FG002|NOT COMPLETED|Overall Study||0
9992751|NCT01668017|11114402|FG003|NOT COMPLETED|Overall Study||0
9992752|NCT01668017|11114403|FG004|NOT COMPLETED|Overall Study||0
9992753|NCT01668030|11114430|FG000|STARTED|Overall Study||10
9992754|NCT01668030|11114431|FG001|STARTED|Overall Study||10
9992755|NCT01668030|11114430|FG000|COMPLETED|Overall Study||10
9992756|NCT01668030|11114431|FG001|COMPLETED|Overall Study||10
9992757|NCT01668030|11114430|FG000|NOT COMPLETED|Overall Study||0
9992758|NCT01668030|11114431|FG001|NOT COMPLETED|Overall Study||0
9992759|NCT01668173|11114436|FG000|STARTED|Overall Study||7
9992760|NCT01668173|11114436|FG000|COMPLETED|Overall Study||0
9992761|NCT01668173|11114436|FG000|NOT COMPLETED|Overall Study||7
9992762|NCT01668355|11114442|FG000|STARTED|Overall Study||164
9992763|NCT01668355|11114443|FG001|STARTED|Overall Study||167
9992764|NCT01668355|11114442|FG000|COMPLETED|Overall Study||155
9992765|NCT01668355|11114443|FG001|COMPLETED|Overall Study||165
9992766|NCT01668355|11114442|FG000|NOT COMPLETED|Overall Study||9
9992767|NCT01668355|11114443|FG001|NOT COMPLETED|Overall Study||2
9992768|NCT01668537|11114452|FG000|STARTED|Overall Study||327
9992769|NCT01668537|11114453|FG001|STARTED|Overall Study||324
9992770|NCT01668537|11114452|FG000|COMPLETED|Overall Study||305
9992771|NCT01668537|11114453|FG001|COMPLETED|Overall Study||314
9992772|NCT01668537|11114452|FG000|NOT COMPLETED|Overall Study||22
9992773|NCT01668537|11114453|FG001|NOT COMPLETED|Overall Study||10
9992774|NCT01668589|11114463|FG000|STARTED|Overall Study||600
9992775|NCT01668589|11114464|FG001|STARTED|Overall Study||300
9992776|NCT01668589|11114465|FG002|STARTED|Overall Study||300
9992777|NCT01668589|11114466|FG003|STARTED|Overall Study||301
9992778|NCT01668589|11114463|FG000|Received Denosumab|Overall Study||599
9992779|NCT01668589|11114464|FG001|Received Denosumab|Overall Study||300
9992780|NCT01668589|11114465|FG002|Received Denosumab|Overall Study||300
10102396|NCT02415439|11231869|FG000|COMPLETED|Overall Study||6
10102397|NCT02415439|11231870|FG001|COMPLETED|Overall Study||6
9992781|NCT01668589|11114466|FG003|Received Denosumab|Overall Study||301
9992782|NCT01668589|11114463|FG000|COMPLETED|Overall Study||461
9992783|NCT01668589|11114464|FG001|COMPLETED|Overall Study||242
9992784|NCT01668589|11114465|FG002|COMPLETED|Overall Study||265
9992785|NCT01668589|11114466|FG003|COMPLETED|Overall Study||266
9992786|NCT01668589|11114463|FG000|NOT COMPLETED|Overall Study||139
9992787|NCT01668589|11114464|FG001|NOT COMPLETED|Overall Study||58
9992788|NCT01668589|11114465|FG002|NOT COMPLETED|Overall Study||35
9992789|NCT01668589|11114466|FG003|NOT COMPLETED|Overall Study||35
9992790|NCT01668602|11114478|FG000|STARTED|Overall Study||2
9992791|NCT01668602|11114479|FG001|STARTED|Overall Study||22
9992792|NCT01668602|11114478|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
9992793|NCT01668602|11114479|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20
9992794|NCT01668602|11114478|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
9992795|NCT01668602|11114479|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
9992796|NCT01668602|11114478|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
9992797|NCT01668602|11114479|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
9992798|NCT01668602|11114478|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
9992799|NCT01668602|11114479|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
9992800|NCT01668602|11114478|FG000|COMPLETED|Overall Study||2
9992801|NCT01668602|11114479|FG001|COMPLETED|Overall Study||18
9992802|NCT01668602|11114478|FG000|NOT COMPLETED|Overall Study||0
9992803|NCT01668602|11114479|FG001|NOT COMPLETED|Overall Study||4
9992804|NCT01668628|11114490|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
9992805|NCT01668628|11114491|FG001|STARTED|Overall Study||359
9992806|NCT01668628|11114492|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
9992807|NCT01668628|11114490|FG000|COMPLETED|Overall Study||347
9992808|NCT01668628|11114491|FG001|COMPLETED|Overall Study||359
9992809|NCT01668628|11114492|FG002|COMPLETED|Overall Study||367
9992810|NCT01668628|11114490|FG000|NOT COMPLETED|Overall Study||2
9992811|NCT01668628|11114491|FG001|NOT COMPLETED|Overall Study||0
9992812|NCT01668628|11114492|FG002|NOT COMPLETED|Overall Study||0
9992813|NCT01668654|11114504|FG000|STARTED|Overall Study||4
9992814|NCT01668654|11114504|FG000|COMPLETED|Overall Study||0
9992815|NCT01668654|11114504|FG000|NOT COMPLETED|Overall Study||4
9992816|NCT01668667|11114512|FG000|STARTED|Overall Study||126
9992817|NCT01668667|11114513|FG001|STARTED|Overall Study||125
9992818|NCT01668667|11114514|FG002|STARTED|Overall Study||125
9992819|NCT01668667|11114515|FG003|STARTED|Overall Study||125
9992820|NCT01668667|11114512|FG000|COMPLETED|Overall Study||95
9992821|NCT01668667|11114513|FG001|COMPLETED|Overall Study||99
9992822|NCT01668667|11114514|FG002|COMPLETED|Overall Study||94
9992823|NCT01668667|11114515|FG003|COMPLETED|Overall Study||102
9992824|NCT01668667|11114512|FG000|NOT COMPLETED|Overall Study||31
9992825|NCT01668667|11114513|FG001|NOT COMPLETED|Overall Study||26
9992826|NCT01668667|11114514|FG002|NOT COMPLETED|Overall Study||31
9992827|NCT01668667|11114515|FG003|NOT COMPLETED|Overall Study||23
9992828|NCT01668797|11114527|FG000|STARTED|Phase A (Conversion Phase)||406
9992829|NCT01668797|11114528|FG001|STARTED|Phase A (Conversion Phase)||0
9992830|NCT01668797|11114529|FG002|STARTED|Phase A (Conversion Phase)||0
9992831|NCT01668797|11114530|FG003|STARTED|Phase A (Conversion Phase)||0
9992832|NCT01668797|11114527|FG000|COMPLETED|Phase A (Conversion Phase)||346
9992833|NCT01668797|11114528|FG001|COMPLETED|Phase A (Conversion Phase)||0
9992834|NCT01668797|11114529|FG002|COMPLETED|Phase A (Conversion Phase)||0
9992835|NCT01668797|11114530|FG003|COMPLETED|Phase A (Conversion Phase)||0
9992836|NCT01668797|11114527|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60
9992837|NCT01668797|11114528|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0
9992838|NCT01668797|11114529|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0
9992839|NCT01668797|11114530|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0
9992840|NCT01668797|11114527|FG000|STARTED|Phase B (Stabilization Phase)||0
9992841|NCT01668797|11114528|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
9992842|NCT01668797|11114529|FG002|STARTED|Phase B (Stabilization Phase)||0
9992843|NCT01668797|11114530|FG003|STARTED|Phase B (Stabilization Phase)||0
9992844|NCT01668797|11114527|FG000|COMPLETED|Phase B (Stabilization Phase)||0
9992845|NCT01668797|11114528|FG001|COMPLETED|Phase B (Stabilization Phase)||202
9992846|NCT01668797|11114529|FG002|COMPLETED|Phase B (Stabilization Phase)||0
9992847|NCT01668797|11114530|FG003|COMPLETED|Phase B (Stabilization Phase)||0
9992848|NCT01668797|11114527|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0
9992849|NCT01668797|11114528|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262
9992850|NCT01668797|11114529|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0
9992851|NCT01668797|11114530|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0
9992852|NCT01668797|11114527|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0
9992853|NCT01668797|11114528|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0
9992854|NCT01668797|11114529|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
9992855|NCT01668797|11114530|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105
9992856|NCT01668797|11114527|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
9992857|NCT01668797|11114528|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
9992858|NCT01668797|11114529|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
9992859|NCT01668797|11114530|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
9992860|NCT01668797|11114527|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
9992861|NCT01668797|11114528|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
9992862|NCT01668797|11114529|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
9992863|NCT01668797|11114530|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
9992864|NCT01668836|11114541|FG000|STARTED|Overall Study||12
9992865|NCT01668836|11114542|FG001|STARTED|Overall Study||12
9992866|NCT01668836|11114543|FG002|STARTED|Overall Study||12
9992867|NCT01668836|11114544|FG003|STARTED|Overall Study||12
10102398|NCT02415439|11231871|FG002|COMPLETED|Overall Study||6
10102399|NCT02415439|11231872|FG003|COMPLETED|Overall Study||6
10102400|NCT02415439|11231873|FG004|COMPLETED|Overall Study||6
10102401|NCT02415439|11231874|FG005|COMPLETED|Overall Study||6
10102402|NCT02415439|11231875|FG006|COMPLETED|Overall Study||6
10102403|NCT02415439|11231876|FG007|COMPLETED|Overall Study||12
10102404|NCT02415439|11231877|FG008|COMPLETED|Overall Study||5
10102405|NCT02415439|11231878|FG009|COMPLETED|Overall Study||6
10102406|NCT02415439|11231879|FG010|COMPLETED|Overall Study||6
9992868|NCT01668836|11114541|FG000|COMPLETED|Overall Study||12
9992869|NCT01668836|11114542|FG001|COMPLETED|Overall Study||12
9992870|NCT01668836|11114543|FG002|COMPLETED|Overall Study||12
9992871|NCT01668836|11114544|FG003|COMPLETED|Overall Study||12
9992872|NCT01668836|11114541|FG000|NOT COMPLETED|Overall Study||0
9992873|NCT01668836|11114542|FG001|NOT COMPLETED|Overall Study||0
9992874|NCT01668836|11114543|FG002|NOT COMPLETED|Overall Study||0
9992875|NCT01668836|11114544|FG003|NOT COMPLETED|Overall Study||0
9992876|NCT01668966|11114560|FG000|STARTED|Overall Study||23
9992877|NCT01668966|11114560|FG000|Treated|Overall Study||21
9992878|NCT01668966|11114560|FG000|COMPLETED|Overall Study||19
9992879|NCT01668966|11114560|FG000|NOT COMPLETED|Overall Study||4
10102407|NCT02415439|11231880|FG011|COMPLETED|Overall Study||6
10102408|NCT02415439|11231881|FG012|COMPLETED|Overall Study||8
10102409|NCT02415439|11231869|FG000|NOT COMPLETED|Overall Study||0
10102410|NCT02415439|11231870|FG001|NOT COMPLETED|Overall Study||0
10102411|NCT02415439|11231871|FG002|NOT COMPLETED|Overall Study||0
10102412|NCT02415439|11231872|FG003|NOT COMPLETED|Overall Study||0
9992880|NCT01669096|11114564|FG000|STARTED|Overall Study||20
9992881|NCT01669096|11114564|FG000|COMPLETED|Overall Study||20
9992882|NCT01669096|11114564|FG000|NOT COMPLETED|Overall Study||0
9992883|NCT01669122|11114568|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
9992884|NCT01669122|11114568|FG000|Safety Population|Period I||39
9992885|NCT01669122|11114568|FG000|COMPLETED|Period I||39
9992886|NCT01669122|11114568|FG000|NOT COMPLETED|Period I||1
9992887|NCT01669122|11114568|FG000|STARTED|Washout Period I||39
9992888|NCT01669122|11114568|FG000|COMPLETED|Washout Period I||39
9992889|NCT01669122|11114568|FG000|NOT COMPLETED|Washout Period I||0
9992890|NCT01669122|11114568|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
9992891|NCT01669122|11114568|FG000|COMPLETED|Period II||39
9992892|NCT01669122|11114568|FG000|NOT COMPLETED|Period II||0
9992893|NCT01669122|11114568|FG000|STARTED|Washout Period II||39
9992894|NCT01669122|11114568|FG000|COMPLETED|Washout Period II||37
9992895|NCT01669122|11114568|FG000|NOT COMPLETED|Washout Period II||2
9992896|NCT01669122|11114568|FG000|STARTED|Washout Period III||37
9992897|NCT01669122|11114568|FG000|COMPLETED|Washout Period III||37
9992898|NCT01669122|11114568|FG000|NOT COMPLETED|Washout Period III||0
9992899|NCT01669122|11114568|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
9992900|NCT01669122|11114568|FG000|COMPLETED|Period III||37
9992901|NCT01669122|11114568|FG000|NOT COMPLETED|Period III||0
9992902|NCT01669122|11114568|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
9992903|NCT01669122|11114568|FG000|COMPLETED|Period IV||37
9992904|NCT01669122|11114568|FG000|NOT COMPLETED|Period IV||0
9992905|NCT01669174|11114581|FG000|STARTED|Overall Study||33
9992906|NCT01669174|11114582|FG001|STARTED|Overall Study||34
9992907|NCT01669174|11114581|FG000|COMPLETED|Overall Study||27
9992908|NCT01669174|11114582|FG001|COMPLETED|Overall Study||28
9992909|NCT01669174|11114581|FG000|NOT COMPLETED|Overall Study||6
9992910|NCT01669174|11114582|FG001|NOT COMPLETED|Overall Study||6
9992911|NCT01669343|11114588|FG000|STARTED|Part A: All Patients||121
9992912|NCT01669343|11114588|FG000|COMPLETED|Part A: All Patients||112
9992913|NCT01669343|11114588|FG000|NOT COMPLETED|Part A: All Patients||9
9992914|NCT01669343|11114588|FG000|STARTED|Part B: Patients With BMI>=25||48
10102413|NCT02415439|11231873|FG004|NOT COMPLETED|Overall Study||0
10102414|NCT02415439|11231874|FG005|NOT COMPLETED|Overall Study||0
10102415|NCT02415439|11231875|FG006|NOT COMPLETED|Overall Study||0
10102416|NCT02415439|11231876|FG007|NOT COMPLETED|Overall Study||0
10102417|NCT02415439|11231877|FG008|NOT COMPLETED|Overall Study||1
10102418|NCT02415439|11231878|FG009|NOT COMPLETED|Overall Study||0
9992915|NCT01669343|11114588|FG000|COMPLETED|Part B: Patients With BMI>=25||31
9992916|NCT01669343|11114588|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17
10018304|NCT01822925|11141363|FG003|STARTED|Overall Study||32
10018305|NCT01822925|11141360|FG000|COMPLETED|Overall Study||26
10018306|NCT01822925|11141361|FG001|COMPLETED|Overall Study||30
10018307|NCT01822925|11141362|FG002|COMPLETED|Overall Study||29
10018308|NCT01822925|11141363|FG003|COMPLETED|Overall Study||27
10018309|NCT01822925|11141360|FG000|NOT COMPLETED|Overall Study||6
10018310|NCT01822925|11141361|FG001|NOT COMPLETED|Overall Study||2
10018311|NCT01822925|11141362|FG002|NOT COMPLETED|Overall Study||3
10018312|NCT01822925|11141363|FG003|NOT COMPLETED|Overall Study||5
10018313|NCT01823107|11141373|FG000|STARTED|Overall Study||25
10018314|NCT01823107|11141373|FG000|COMPLETED|Overall Study||24
10018315|NCT01823107|11141373|FG000|NOT COMPLETED|Overall Study||1
10018316|NCT01823146|11141379|FG000|STARTED|Overall Study||55
10018317|NCT01823146|11141380|FG001|STARTED|Overall Study||51
10018318|NCT01823146|11141379|FG000|COMPLETED|Overall Study||53
10018319|NCT01823146|11141380|FG001|COMPLETED|Overall Study||49
10018320|NCT01823146|11141379|FG000|NOT COMPLETED|Overall Study||2
10018321|NCT01823146|11141380|FG001|NOT COMPLETED|Overall Study||2
10018322|NCT01823224|11141388|FG000|STARTED|Overall Study||34
10018323|NCT01823224|11141389|FG001|STARTED|Overall Study||33
10018324|NCT01823224|11141388|FG000|COMPLETED|Overall Study||28
10018325|NCT01823224|11141389|FG001|COMPLETED|Overall Study||22
10018326|NCT01823224|11141388|FG000|NOT COMPLETED|Overall Study||6
10018327|NCT01823224|11141389|FG001|NOT COMPLETED|Overall Study||11
10018328|NCT01823289|11141397|FG000|STARTED|Overall Study||71
10018329|NCT01823289|11141397|FG000|COMPLETED|Overall Study||47
10018330|NCT01823289|11141397|FG000|NOT COMPLETED|Overall Study||24
10018331|NCT01823328|11141403|FG000|STARTED|Overall Study||70
10018332|NCT01823328|11141404|FG001|STARTED|Overall Study||73
10018333|NCT01823328|11141403|FG000|COMPLETED|Overall Study||62
10018334|NCT01823328|11141404|FG001|COMPLETED|Overall Study||67
10018335|NCT01823328|11141403|FG000|NOT COMPLETED|Overall Study||8
10018336|NCT01823328|11141404|FG001|NOT COMPLETED|Overall Study||6
10018337|NCT01823341|11141410|FG000|STARTED|Overall Study||97
10018338|NCT01823341|11141410|FG000|COMPLETED|Overall Study||82
10018339|NCT01823341|11141410|FG000|NOT COMPLETED|Overall Study||15
10018340|NCT01823497|11141419|FG000|STARTED|Overall Study||19
10018341|NCT01823497|11141420|FG001|STARTED|Overall Study||17
10018342|NCT01823497|11141419|FG000|COMPLETED|Overall Study||16
10018343|NCT01823497|11141420|FG001|COMPLETED|Overall Study||9
10018344|NCT01823497|11141419|FG000|NOT COMPLETED|Overall Study||3
10018345|NCT01823497|11141420|FG001|NOT COMPLETED|Overall Study||8
10018346|NCT01823510|11141426|FG000|STARTED|Days 1-7||10
10018347|NCT01823510|11141427|FG001|STARTED|Days 1-7||10
10018348|NCT01823510|11141426|FG000|COMPLETED|Days 1-7||10
10018349|NCT01823510|11141427|FG001|COMPLETED|Days 1-7||10
10018350|NCT01823510|11141426|FG000|NOT COMPLETED|Days 1-7||0
10018351|NCT01823510|11141427|FG001|NOT COMPLETED|Days 1-7||0
10018352|NCT01823510|11141426|FG000|STARTED|Days 8-21||10
10018353|NCT01823510|11141427|FG001|STARTED|Days 8-21||10
10018354|NCT01823510|11141426|FG000|COMPLETED|Days 8-21||10
10018355|NCT01823510|11141427|FG001|COMPLETED|Days 8-21||10
10018356|NCT01823510|11141426|FG000|NOT COMPLETED|Days 8-21||0
10018357|NCT01823510|11141427|FG001|NOT COMPLETED|Days 8-21||0
10018358|NCT01823510|11141426|FG000|STARTED|Days 22-28||10
10018359|NCT01823510|11141427|FG001|STARTED|Days 22-28||10
10018360|NCT01823510|11141426|FG000|COMPLETED|Days 22-28||10
10018361|NCT01823510|11141427|FG001|COMPLETED|Days 22-28||10
10018362|NCT01823510|11141426|FG000|NOT COMPLETED|Days 22-28||0
10018363|NCT01823510|11141427|FG001|NOT COMPLETED|Days 22-28||0
10018364|NCT01823536|11141439|FG000|STARTED|Overall Study||73
10018365|NCT01823536|11141440|FG001|STARTED|Overall Study||103
10018366|NCT01823536|11141441|FG002|STARTED|Overall Study||120
10018367|NCT01823536|11141442|FG003|STARTED|Overall Study||66
10018368|NCT01823536|11141443|FG004|STARTED|Overall Study||101
10018369|NCT01823536|11141444|FG005|STARTED|Overall Study||2
10018370|NCT01823536|11141439|FG000|COMPLETED|Overall Study||71
10018371|NCT01823536|11141440|FG001|COMPLETED|Overall Study||101
10018372|NCT01823536|11141441|FG002|COMPLETED|Overall Study||119
10018373|NCT01823536|11141442|FG003|COMPLETED|Overall Study||64
10018374|NCT01823536|11141443|FG004|COMPLETED|Overall Study||99
10018375|NCT01823536|11141444|FG005|COMPLETED|Overall Study||2
10018376|NCT01823536|11141439|FG000|NOT COMPLETED|Overall Study||2
10018377|NCT01823536|11141440|FG001|NOT COMPLETED|Overall Study||2
10018378|NCT01823536|11141441|FG002|NOT COMPLETED|Overall Study||1
10018379|NCT01823536|11141442|FG003|NOT COMPLETED|Overall Study||2
10018380|NCT01823536|11141443|FG004|NOT COMPLETED|Overall Study||2
10018381|NCT01823536|11141444|FG005|NOT COMPLETED|Overall Study||0
10018382|NCT01823614|11141463|FG000|STARTED|Overall Study||179
10018383|NCT01823614|11141464|FG001|STARTED|Overall Study||140
10018384|NCT01823614|11141465|FG002|STARTED|Overall Study||176
10018385|NCT01823614|11141466|FG003|STARTED|Overall Study||122
10018386|NCT01823614|11141467|FG004|STARTED|Overall Study||172
10018387|NCT01823614|11141468|FG005|STARTED|Overall Study||154
10018388|NCT01823614|11141463|FG000|COMPLETED|Overall Study||179
10018389|NCT01823614|11141464|FG001|COMPLETED|Overall Study||140
10018390|NCT01823614|11141465|FG002|COMPLETED|Overall Study||176
10018391|NCT01823614|11141466|FG003|COMPLETED|Overall Study||122
10018392|NCT01823614|11141467|FG004|COMPLETED|Overall Study||172
10018393|NCT01823614|11141468|FG005|COMPLETED|Overall Study||154
10018394|NCT01823614|11141463|FG000|NOT COMPLETED|Overall Study||0
10018395|NCT01823614|11141464|FG001|NOT COMPLETED|Overall Study||0
9992917|NCT01669421|11114595|FG000|STARTED|Phase 1: Standard Dose Therapy||10
9992918|NCT01669421|11114595|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8
9992919|NCT01669421|11114595|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
9992920|NCT01669421|11114595|FG000|STARTED|Phase 2: Double Dose Therapy||8
9992921|NCT01669421|11114595|FG000|COMPLETED|Phase 2: Double Dose Therapy||8
9992922|NCT01669421|11114595|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0
9992923|NCT01669421|11114595|FG000|STARTED|Phase 3: Standard Dose Therapy||8
9992924|NCT01669421|11114595|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8
9992925|NCT01669421|11114595|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
9992926|NCT01669434|11114611|FG000|STARTED|Overall Study||146
9992927|NCT01669434|11114612|FG001|STARTED|Overall Study||145
9992928|NCT01669434|11114611|FG000|COMPLETED|Overall Study||137
9992929|NCT01669434|11114612|FG001|COMPLETED|Overall Study||138
9992930|NCT01669434|11114611|FG000|NOT COMPLETED|Overall Study||9
9992931|NCT01669434|11114612|FG001|NOT COMPLETED|Overall Study||7
9992932|NCT01669538|11114620|FG000|STARTED|Overall Study||40
9992933|NCT01669538|11114621|FG001|STARTED|Overall Study||42
9992934|NCT01669538|11114620|FG000|COMPLETED|Overall Study||28
9992935|NCT01669538|11114621|FG001|COMPLETED|Overall Study||33
9992936|NCT01669538|11114620|FG000|NOT COMPLETED|Overall Study||12
9992937|NCT01669538|11114621|FG001|NOT COMPLETED|Overall Study||9
9992938|NCT01669577|11114627|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
9992939|NCT01669577|11114627|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
9992940|NCT01669577|11114627|FG000|NOT COMPLETED|Overall Study||134
9992941|NCT01669603|11114633|FG000|STARTED|Overall Study||95
9992942|NCT01669603|11114634|FG001|STARTED|Overall Study||95
9992943|NCT01669603|11114633|FG000|COMPLETED|Overall Study||58
9992944|NCT01669603|11114634|FG001|COMPLETED|Overall Study||57
9992945|NCT01669603|11114633|FG000|NOT COMPLETED|Overall Study||37
9992946|NCT01669603|11114634|FG001|NOT COMPLETED|Overall Study||38
9992947|NCT01669629|11114640|FG000|STARTED|Period 1||92
9992948|NCT01669629|11114641|FG001|STARTED|Period 1||91
9992949|NCT01669629|11114640|FG000|COMPLETED|Period 1||91
9992950|NCT01669629|11114641|FG001|COMPLETED|Period 1||89
9992951|NCT01669629|11114640|FG000|NOT COMPLETED|Period 1||1
9992952|NCT01669629|11114641|FG001|NOT COMPLETED|Period 1||2
9992953|NCT01669629|11114640|FG000|STARTED|Period 2||91
9992954|NCT01669629|11114641|FG001|STARTED|Period 2||89
9992955|NCT01669629|11114640|FG000|COMPLETED|Period 2||91
9992956|NCT01669629|11114641|FG001|COMPLETED|Period 2||89
9992957|NCT01669629|11114640|FG000|NOT COMPLETED|Period 2||0
9992958|NCT01669629|11114641|FG001|NOT COMPLETED|Period 2||0
9992959|NCT01669642|11114652|FG000|STARTED|Overall Study||20
9992960|NCT01669642|11114653|FG001|STARTED|Overall Study||20
9992961|NCT01669642|11114654|FG002|STARTED|Overall Study||20
9992962|NCT01669642|11114655|FG003|STARTED|Overall Study||21
9992963|NCT01669642|11114656|FG004|STARTED|Overall Study||20
9992964|NCT01669642|11114657|FG005|STARTED|Overall Study||10
9992965|NCT01669642|11114652|FG000|COMPLETED|Overall Study||20
9992966|NCT01669642|11114653|FG001|COMPLETED|Overall Study||20
9992967|NCT01669642|11114654|FG002|COMPLETED|Overall Study||20
9992968|NCT01669642|11114655|FG003|COMPLETED|Overall Study||20
9992969|NCT01669642|11114656|FG004|COMPLETED|Overall Study||20
9992970|NCT01669642|11114657|FG005|COMPLETED|Overall Study||0
9992971|NCT01669642|11114652|FG000|NOT COMPLETED|Overall Study||0
9992972|NCT01669642|11114653|FG001|NOT COMPLETED|Overall Study||0
9992973|NCT01669642|11114654|FG002|NOT COMPLETED|Overall Study||0
9992974|NCT01669642|11114655|FG003|NOT COMPLETED|Overall Study||1
9992975|NCT01669642|11114656|FG004|NOT COMPLETED|Overall Study||0
9992976|NCT01669642|11114657|FG005|NOT COMPLETED|Overall Study||10
9992977|NCT01669720|11114676|FG000|STARTED|Overall Study||7
9992978|NCT01669720|11114677|FG001|STARTED|Overall Study||3
9992979|NCT01669720|11114676|FG000|COMPLETED|Overall Study||7
9992980|NCT01669720|11114677|FG001|COMPLETED|Overall Study||3
9992981|NCT01669720|11114676|FG000|NOT COMPLETED|Overall Study||0
9992982|NCT01669720|11114677|FG001|NOT COMPLETED|Overall Study||0
9992983|NCT01669785|11114686|FG000|STARTED|Overall Study||45
9992984|NCT01669785|11114687|FG001|STARTED|Overall Study||48
9992985|NCT01669785|11114688|FG002|STARTED|Overall Study||46
9992986|NCT01669785|11114686|FG000|COMPLETED|Overall Study||45
9992987|NCT01669785|11114687|FG001|COMPLETED|Overall Study||48
9992988|NCT01669785|11114688|FG002|COMPLETED|Overall Study||46
9992989|NCT01669785|11114686|FG000|NOT COMPLETED|Overall Study||0
9992990|NCT01669785|11114687|FG001|NOT COMPLETED|Overall Study||0
9992991|NCT01669785|11114688|FG002|NOT COMPLETED|Overall Study||0
9992992|NCT01669798|11114697|FG000|STARTED|Overall Study||32
9992993|NCT01669798|11114697|FG000|COMPLETED|Overall Study||27
9992994|NCT01669798|11114697|FG000|NOT COMPLETED|Overall Study||5
9992995|NCT01669811|11114703|FG000|STARTED|Overall Study||145
9992996|NCT01669811|11114704|FG001|STARTED|Overall Study||142
9992997|NCT01669811|11114703|FG000|COMPLETED|Overall Study||142
9992998|NCT01669811|11114704|FG001|COMPLETED|Overall Study||131
9992999|NCT01669811|11114703|FG000|NOT COMPLETED|Overall Study||3
9993000|NCT01669811|11114704|FG001|NOT COMPLETED|Overall Study||11
9993001|NCT01669863|11114710|FG000|STARTED|Overall Study||6
9993002|NCT01669863|11114710|FG000|COMPLETED|Overall Study||6
9993003|NCT01669863|11114710|FG000|NOT COMPLETED|Overall Study||0
9993004|NCT01669902|11114715|FG000|STARTED|Overall Study||107
9993005|NCT01669902|11114715|FG000|COMPLETED|Overall Study||78
9993006|NCT01669902|11114715|FG000|NOT COMPLETED|Overall Study||29
9993007|NCT01669928|11114721|FG000|STARTED|First Intervention||51
9993008|NCT01669928|11114722|FG001|STARTED|First Intervention||52
9993009|NCT01669928|11114721|FG000|COMPLETED|First Intervention||48
9993010|NCT01669928|11114722|FG001|COMPLETED|First Intervention||47
9993011|NCT01669928|11114721|FG000|NOT COMPLETED|First Intervention||3
9993012|NCT01669928|11114722|FG001|NOT COMPLETED|First Intervention||5
9993013|NCT01669928|11114721|FG000|STARTED|Second Intervention||48
9993014|NCT01669928|11114722|FG001|STARTED|Second Intervention||47
9993015|NCT01669928|11114721|FG000|COMPLETED|Second Intervention||48
9993016|NCT01669928|11114722|FG001|COMPLETED|Second Intervention||47
9993017|NCT01669928|11114721|FG000|NOT COMPLETED|Second Intervention||0
10202173|NCT03441984|11329279|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202174|NCT03441984|11329280|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202175|NCT03441984|11329281|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202176|NCT03441984|11329282|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10202177|NCT03441984|11329283|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10202178|NCT03441984|11329284|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9993018|NCT01669928|11114722|FG001|NOT COMPLETED|Second Intervention||0
9993019|NCT01670019|11114732|FG000|STARTED|Overall Study||23
9993020|NCT01670019|11114733|FG001|STARTED|Overall Study||23
9993021|NCT01670019|11114732|FG000|COMPLETED|Overall Study||14
9993022|NCT01670019|11114733|FG001|COMPLETED|Overall Study||23
9993023|NCT01670019|11114732|FG000|NOT COMPLETED|Overall Study||9
9993024|NCT01670019|11114733|FG001|NOT COMPLETED|Overall Study||0
9993025|NCT01670045|11114739|FG000|STARTED|Overall Study||43
9993026|NCT01670045|11114739|FG000|COMPLETED|Overall Study||27
9993027|NCT01670045|11114739|FG000|NOT COMPLETED|Overall Study||16
9993028|NCT01670097|11114745|FG000|STARTED|Overall Study||20
9993029|NCT01670097|11114746|FG001|STARTED|Overall Study||21
9993030|NCT01670097|11114745|FG000|Completed Week 1 Intervention|Overall Study||18
9993031|NCT01670097|11114746|FG001|Completed Week 1 Intervention|Overall Study||17
9993032|NCT01670097|11114745|FG000|Completed Week 2 Intervention|Overall Study||13
9993033|NCT01670097|11114746|FG001|Completed Week 2 Intervention|Overall Study||15
9993034|NCT01670097|11114745|FG000|COMPLETED|Overall Study||18
9993035|NCT01670097|11114746|FG001|COMPLETED|Overall Study||17
9993036|NCT01670097|11114745|FG000|NOT COMPLETED|Overall Study||2
9993037|NCT01670097|11114746|FG001|NOT COMPLETED|Overall Study||4
9993038|NCT01670110|11114754|FG000|STARTED|Overall Study||33
9993039|NCT01670110|11114755|FG001|STARTED|Overall Study||15
9993040|NCT01670110|11114754|FG000|COMPLETED|Overall Study||29
9993041|NCT01670110|11114755|FG001|COMPLETED|Overall Study||12
9993042|NCT01670110|11114754|FG000|NOT COMPLETED|Overall Study||4
9993043|NCT01670110|11114755|FG001|NOT COMPLETED|Overall Study||3
9993044|NCT01670188|11114763|FG000|STARTED|Overall Study||38
9993045|NCT01670188|11114764|FG001|STARTED|Overall Study||40
9993046|NCT01670188|11114763|FG000|COMPLETED|Overall Study||38
9993047|NCT01670188|11114764|FG001|COMPLETED|Overall Study||39
9993048|NCT01670188|11114763|FG000|NOT COMPLETED|Overall Study||0
9993049|NCT01670188|11114764|FG001|NOT COMPLETED|Overall Study||1
9993050|NCT01670201|11114770|FG000|STARTED|Overall Study||8
9993051|NCT01670201|11114770|FG000|COMPLETED|Overall Study||8
9993052|NCT01670201|11114770|FG000|NOT COMPLETED|Overall Study||0
9993053|NCT01670279|11114777|FG000|STARTED|Overall Study||6
9993054|NCT01670279|11114778|FG001|STARTED|Overall Study||7
9993055|NCT01670279|11114779|FG002|STARTED|Overall Study||0
9993056|NCT01670279|11114780|FG003|STARTED|Overall Study||5
9993057|NCT01670279|11114777|FG000|COMPLETED|Overall Study||6
9993058|NCT01670279|11114778|FG001|COMPLETED|Overall Study||5
9993059|NCT01670279|11114779|FG002|COMPLETED|Overall Study||0
9993060|NCT01670279|11114780|FG003|COMPLETED|Overall Study||4
9993061|NCT01670279|11114777|FG000|NOT COMPLETED|Overall Study||0
9993062|NCT01670279|11114778|FG001|NOT COMPLETED|Overall Study||2
9993063|NCT01670279|11114779|FG002|NOT COMPLETED|Overall Study||0
9993064|NCT01670279|11114780|FG003|NOT COMPLETED|Overall Study||1
9993065|NCT01670292|11114788|FG000|STARTED|Overall Study||82
9993066|NCT01670292|11114788|FG000|COMPLETED|Overall Study||68
9993067|NCT01670292|11114788|FG000|NOT COMPLETED|Overall Study||14
9993068|NCT01670487|11114802|FG000|STARTED|Overall Study||150
9993069|NCT01670487|11114803|FG001|STARTED|Overall Study||150
9993070|NCT01670487|11114802|FG000|COMPLETED|Overall Study||150
9993071|NCT01670487|11114803|FG001|COMPLETED|Overall Study||150
9993072|NCT01670487|11114802|FG000|NOT COMPLETED|Overall Study||0
9993073|NCT01670487|11114803|FG001|NOT COMPLETED|Overall Study||0
9993074|NCT01670526|11114811|FG000|STARTED|Overall Study||49
9993075|NCT01670526|11114812|FG001|STARTED|Overall Study||45
9993076|NCT01670526|11114811|FG000|COMPLETED|Overall Study||37
10202179|NCT03441984|11329285|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9993077|NCT01670526|11114812|FG001|COMPLETED|Overall Study||39
9993078|NCT01670526|11114811|FG000|NOT COMPLETED|Overall Study||12
9993079|NCT01670526|11114812|FG001|NOT COMPLETED|Overall Study||6
9993080|NCT01670721|11114818|FG000|STARTED|Overall Study||175
9993081|NCT01670721|11114818|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
9993082|NCT01670721|11114818|FG000|NOT COMPLETED|Overall Study||53
9993083|NCT01670760|11114822|FG000|STARTED|Overall Study||20
9993084|NCT01670760|11114822|FG000|COMPLETED|Overall Study||20
9993085|NCT01670760|11114822|FG000|NOT COMPLETED|Overall Study||0
9993086|NCT01670825|11114828|FG000|STARTED|Overall Study||42
9993087|NCT01670825|11114829|FG001|STARTED|Overall Study||39
9993088|NCT01670825|11114828|FG000|COMPLETED|Overall Study||42
9993089|NCT01670825|11114829|FG001|COMPLETED|Overall Study||39
10202180|NCT03441984|11329286|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9993090|NCT01670825|11114828|FG000|NOT COMPLETED|Overall Study||0
9993091|NCT01670825|11114829|FG001|NOT COMPLETED|Overall Study||0
9993092|NCT01671007|11114846|FG000|STARTED|Overall Study||2089
9993093|NCT01671007|11114847|FG001|STARTED|Overall Study||2834
9993094|NCT01671007|11114848|FG002|STARTED|Overall Study||2033
9993095|NCT01671007|11114849|FG003|STARTED|Overall Study||2214
9993096|NCT01671007|11114850|FG004|STARTED|Overall Study||180
9993097|NCT01671007|11114851|FG005|STARTED|Overall Study||513
9993098|NCT01671007|11114852|FG006|STARTED|Overall Study||80
9993099|NCT01671007|11114853|FG007|STARTED|Overall Study||526
9993100|NCT01671007|11114854|FG008|STARTED|Overall Study||2
9993101|NCT01671007|11114846|FG000|All Eligible|Overall Study||2066
9993102|NCT01671007|11114847|FG001|All Eligible|Overall Study||2758
9993103|NCT01671007|11114848|FG002|All Eligible|Overall Study||2008
9993104|NCT01671007|11114849|FG003|All Eligible|Overall Study||2197
9993105|NCT01671007|11114850|FG004|All Eligible|Overall Study||180
9993106|NCT01671007|11114851|FG005|All Eligible|Overall Study||507
9993107|NCT01671007|11114852|FG006|All Eligible|Overall Study||79
9993108|NCT01671007|11114853|FG007|All Eligible|Overall Study||507
9993109|NCT01671007|11114854|FG008|All Eligible|Overall Study||2
9993110|NCT01671007|11114846|FG000|COMPLETED|Overall Study||1768
9993111|NCT01671007|11114847|FG001|COMPLETED|Overall Study||2183
9993112|NCT01671007|11114848|FG002|COMPLETED|Overall Study||1667
9993113|NCT01671007|11114849|FG003|COMPLETED|Overall Study||1846
9993114|NCT01671007|11114850|FG004|COMPLETED|Overall Study||155
9993115|NCT01671007|11114851|FG005|COMPLETED|Overall Study||401
9993116|NCT01671007|11114852|FG006|COMPLETED|Overall Study||59
9993117|NCT01671007|11114853|FG007|COMPLETED|Overall Study||394
9993118|NCT01671007|11114854|FG008|COMPLETED|Overall Study||2
9993119|NCT01671007|11114846|FG000|NOT COMPLETED|Overall Study||321
9993120|NCT01671007|11114847|FG001|NOT COMPLETED|Overall Study||651
9993121|NCT01671007|11114848|FG002|NOT COMPLETED|Overall Study||366
9993122|NCT01671007|11114849|FG003|NOT COMPLETED|Overall Study||368
9993123|NCT01671007|11114850|FG004|NOT COMPLETED|Overall Study||25
9993124|NCT01671007|11114851|FG005|NOT COMPLETED|Overall Study||112
9993125|NCT01671007|11114852|FG006|NOT COMPLETED|Overall Study||21
9993126|NCT01671007|11114853|FG007|NOT COMPLETED|Overall Study||132
9993127|NCT01671007|11114854|FG008|NOT COMPLETED|Overall Study||0
9993128|NCT01671059|11114865|FG000|STARTED|Overall Study||80
9993129|NCT01671059|11114865|FG000|COMPLETED|Overall Study||75
9993130|NCT01671059|11114865|FG000|NOT COMPLETED|Overall Study||5
9993131|NCT01671085|11114872|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11
9993132|NCT01671085|11114873|FG001|STARTED|Overall Study||2
9993133|NCT01671085|11114872|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
9993134|NCT01671085|11114873|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
9993135|NCT01671085|11114872|FG000|COMPLETED|Overall Study||10
9993136|NCT01671085|11114873|FG001|COMPLETED|Overall Study||2
9993137|NCT01671085|11114872|FG000|NOT COMPLETED|Overall Study||1
9993138|NCT01671085|11114873|FG001|NOT COMPLETED|Overall Study||0
9993139|NCT01671111|11114880|FG000|STARTED|Overall Study||30
9993140|NCT01671111|11114880|FG000|COMPLETED|Overall Study||0
9993141|NCT01671111|11114880|FG000|NOT COMPLETED|Overall Study||30
9993142|NCT01671176|11114884|FG000|STARTED|Overall Study||30
9993143|NCT01671176|11114884|FG000|COMPLETED|Overall Study||30
9993144|NCT01671176|11114884|FG000|NOT COMPLETED|Overall Study||0
9993145|NCT01671280|11114888|FG000|STARTED|Overall Study|The number is enrollment.|403
9993146|NCT01671280|11114888|FG000|COMPLETED|Overall Study||401
9993147|NCT01671280|11114888|FG000|NOT COMPLETED|Overall Study||2
9993148|NCT01671293|11114894|FG000|STARTED|Overall Study||36
9993149|NCT01671293|11114895|FG001|STARTED|Overall Study||34
9993150|NCT01671293|11114894|FG000|COMPLETED|Overall Study||33
9993151|NCT01671293|11114895|FG001|COMPLETED|Overall Study||32
9993152|NCT01671293|11114894|FG000|NOT COMPLETED|Overall Study||3
9993153|NCT01671293|11114895|FG001|NOT COMPLETED|Overall Study||2
9993154|NCT01671319|11114901|FG000|STARTED|Overall Study||42
9993155|NCT01671319|11114901|FG000|COMPLETED|Overall Study||41
9993156|NCT01671319|11114901|FG000|NOT COMPLETED|Overall Study||1
9993157|NCT01671332|11114907|FG000|STARTED|Overall Study||40
9993158|NCT01671332|11114908|FG001|STARTED|Overall Study||40
9993159|NCT01671332|11114907|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
9993160|NCT01671332|11114908|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
9993161|NCT01671332|11114907|FG000|COMPLETED|Overall Study||39
9993162|NCT01671332|11114908|FG001|COMPLETED|Overall Study||39
9993163|NCT01671332|11114907|FG000|NOT COMPLETED|Overall Study||1
9993164|NCT01671332|11114908|FG001|NOT COMPLETED|Overall Study||1
9993165|NCT01671345|11114916|FG000|STARTED|Overall Study||77
9993166|NCT01671345|11114917|FG001|STARTED|Overall Study||92
9993167|NCT01671345|11114916|FG000|COMPLETED|Overall Study||64
9993168|NCT01671345|11114917|FG001|COMPLETED|Overall Study||83
9993169|NCT01671345|11114916|FG000|NOT COMPLETED|Overall Study||13
9993170|NCT01671345|11114917|FG001|NOT COMPLETED|Overall Study||9
9993171|NCT01671423|11114928|FG000|STARTED|Overall Study||20
9993172|NCT01671423|11114929|FG001|STARTED|Overall Study||20
9993173|NCT01671423|11114928|FG000|COMPLETED|Overall Study||14
9993174|NCT01671423|11114929|FG001|COMPLETED|Overall Study||9
9993175|NCT01671423|11114928|FG000|NOT COMPLETED|Overall Study||6
9993176|NCT01671423|11114929|FG001|NOT COMPLETED|Overall Study||11
9993177|NCT01671488|11114935|FG000|STARTED|Overall Study||11
9993178|NCT01671488|11114935|FG000|COMPLETED|Overall Study||10
9993179|NCT01671488|11114935|FG000|NOT COMPLETED|Overall Study||1
9993180|NCT01671605|11114941|FG000|STARTED|Overall Study||72
9993181|NCT01671605|11114942|FG001|STARTED|Overall Study||31
9993182|NCT01671605|11114941|FG000|COMPLETED|Overall Study||72
9993183|NCT01671605|11114942|FG001|COMPLETED|Overall Study||31
9993184|NCT01671605|11114941|FG000|NOT COMPLETED|Overall Study||0
9993185|NCT01671605|11114942|FG001|NOT COMPLETED|Overall Study||0
9993186|NCT01671748|11114950|FG000|STARTED|4 Week run-in Phase||47
9993187|NCT01671748|11114951|FG001|STARTED|4 Week run-in Phase||0
9993188|NCT01671748|11114950|FG000|COMPLETED|4 Week run-in Phase||36
9993189|NCT01671748|11114951|FG001|COMPLETED|4 Week run-in Phase||0
9993190|NCT01671748|11114950|FG000|NOT COMPLETED|4 Week run-in Phase||11
9993191|NCT01671748|11114951|FG001|NOT COMPLETED|4 Week run-in Phase||0
9993192|NCT01671748|11114950|FG000|STARTED|12 Week Treatment Phase||19
9993193|NCT01671748|11114951|FG001|STARTED|12 Week Treatment Phase||17
9993194|NCT01671748|11114950|FG000|COMPLETED|12 Week Treatment Phase||19
9993195|NCT01671748|11114951|FG001|COMPLETED|12 Week Treatment Phase||17
9993196|NCT01671748|11114950|FG000|NOT COMPLETED|12 Week Treatment Phase||0
9993197|NCT01671748|11114951|FG001|NOT COMPLETED|12 Week Treatment Phase||0
9993198|NCT01671839|11114957|FG000|STARTED|Overall Study||55
9993199|NCT01671839|11114957|FG000|3-year Follow-up|Overall Study||45
9993200|NCT01671839|11114957|FG000|5-year Follow-up|Overall Study||37
9993201|NCT01671839|11114957|FG000|COMPLETED|Overall Study||37
9993202|NCT01671839|11114957|FG000|NOT COMPLETED|Overall Study||18
9993203|NCT01672294|11114968|FG000|STARTED|Overall Study||71
9993204|NCT01672294|11114969|FG001|STARTED|Overall Study||71
9993205|NCT01672294|11114970|FG002|STARTED|Overall Study||72
9993206|NCT01672294|11114971|FG003|STARTED|Overall Study||72
9993207|NCT01672294|11114968|FG000|COMPLETED|Overall Study||65
9993208|NCT01672294|11114969|FG001|COMPLETED|Overall Study||50
9993209|NCT01672294|11114970|FG002|COMPLETED|Overall Study||61
9993210|NCT01672294|11114971|FG003|COMPLETED|Overall Study||59
9993211|NCT01672294|11114968|FG000|NOT COMPLETED|Overall Study||6
9993212|NCT01672294|11114969|FG001|NOT COMPLETED|Overall Study||21
9993213|NCT01672294|11114970|FG002|NOT COMPLETED|Overall Study||11
9993214|NCT01672294|11114971|FG003|NOT COMPLETED|Overall Study||13
9993215|NCT01672658|11114983|FG000|STARTED|Overall Study||16
9993216|NCT01672658|11114984|FG001|STARTED|Overall Study||15
9993217|NCT01672658|11114983|FG000|COMPLETED|Overall Study||16
9993218|NCT01672658|11114984|FG001|COMPLETED|Overall Study||14
9993219|NCT01672658|11114983|FG000|NOT COMPLETED|Overall Study||0
9993220|NCT01672658|11114984|FG001|NOT COMPLETED|Overall Study||1
9993221|NCT01672710|11114992|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22
9993222|NCT01672710|11114993|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10
9993223|NCT01672710|11114992|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
9993224|NCT01672710|11114993|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
9993225|NCT01672710|11114992|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
9993226|NCT01672710|11114993|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
9993227|NCT01672710|11114992|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
9993228|NCT01672710|11114993|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
9993229|NCT01672710|11114992|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
9993230|NCT01672710|11114993|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9
9993231|NCT01672710|11114992|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
9993232|NCT01672710|11114993|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
9993233|NCT01672710|11114992|FG000|STARTED|3 Month Follow up||22
9993234|NCT01672710|11114993|FG001|STARTED|3 Month Follow up||9
9993235|NCT01672710|11114992|FG000|COMPLETED|3 Month Follow up||16
9993236|NCT01672710|11114993|FG001|COMPLETED|3 Month Follow up||5
9993237|NCT01672710|11114992|FG000|NOT COMPLETED|3 Month Follow up||6
9993238|NCT01672710|11114993|FG001|NOT COMPLETED|3 Month Follow up||4
9993239|NCT01672723|11114999|FG000|STARTED|First Intervention||19
9993240|NCT01672723|11115000|FG001|STARTED|First Intervention||15
9993241|NCT01672723|11114999|FG000|COMPLETED|First Intervention||16
9993242|NCT01672723|11115000|FG001|COMPLETED|First Intervention||15
9993243|NCT01672723|11114999|FG000|NOT COMPLETED|First Intervention||3
9993244|NCT01672723|11115000|FG001|NOT COMPLETED|First Intervention||0
9993245|NCT01672723|11114999|FG000|STARTED|Washout Period of 10 Days||16
9993246|NCT01672723|11115000|FG001|STARTED|Washout Period of 10 Days||15
9993247|NCT01672723|11114999|FG000|COMPLETED|Washout Period of 10 Days||16
9993248|NCT01672723|11115000|FG001|COMPLETED|Washout Period of 10 Days||15
9993249|NCT01672723|11114999|FG000|NOT COMPLETED|Washout Period of 10 Days||0
9993250|NCT01672723|11115000|FG001|NOT COMPLETED|Washout Period of 10 Days||0
9993251|NCT01672723|11114999|FG000|STARTED|Second Intervention||16
9993252|NCT01672723|11115000|FG001|STARTED|Second Intervention||15
9993253|NCT01672723|11114999|FG000|COMPLETED|Second Intervention||16
9993254|NCT01672723|11115000|FG001|COMPLETED|Second Intervention||15
9993255|NCT01672723|11114999|FG000|NOT COMPLETED|Second Intervention||0
9993256|NCT01672723|11115000|FG001|NOT COMPLETED|Second Intervention||0
9993257|NCT01672736|11115006|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
9993258|NCT01672736|11115006|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
9993259|NCT01672736|11115006|FG000|NOT COMPLETED|Overall Study||3
9993260|NCT01672788|11115010|FG000|STARTED|Treatment Period 1 (3 Days)||9
9993261|NCT01672788|11115011|FG001|STARTED|Treatment Period 1 (3 Days)||9
9993262|NCT01672788|11115012|FG002|STARTED|Treatment Period 1 (3 Days)||9
9993263|NCT01672788|11115013|FG003|STARTED|Treatment Period 1 (3 Days)||9
9993264|NCT01672788|11115010|FG000|COMPLETED|Treatment Period 1 (3 Days)||9
9993265|NCT01672788|11115011|FG001|COMPLETED|Treatment Period 1 (3 Days)||9
9993266|NCT01672788|11115012|FG002|COMPLETED|Treatment Period 1 (3 Days)||9
9993267|NCT01672788|11115013|FG003|COMPLETED|Treatment Period 1 (3 Days)||9
9993268|NCT01672788|11115010|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9993269|NCT01672788|11115011|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9993270|NCT01672788|11115012|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9993271|NCT01672788|11115013|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9993272|NCT01672788|11115010|FG000|STARTED|Washout Period 1 (7 Days)||9
9993273|NCT01672788|11115011|FG001|STARTED|Washout Period 1 (7 Days)||9
9993274|NCT01672788|11115012|FG002|STARTED|Washout Period 1 (7 Days)||9
9993275|NCT01672788|11115013|FG003|STARTED|Washout Period 1 (7 Days)||9
9993276|NCT01672788|11115010|FG000|COMPLETED|Washout Period 1 (7 Days)||9
9993277|NCT01672788|11115011|FG001|COMPLETED|Washout Period 1 (7 Days)||9
9993278|NCT01672788|11115012|FG002|COMPLETED|Washout Period 1 (7 Days)||9
9993279|NCT01672788|11115013|FG003|COMPLETED|Washout Period 1 (7 Days)||9
9993280|NCT01672788|11115010|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9993281|NCT01672788|11115011|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9993282|NCT01672788|11115012|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9993283|NCT01672788|11115013|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
9993284|NCT01672788|11115010|FG000|STARTED|Treatment Period 2 (3 Days)||9
9993285|NCT01672788|11115011|FG001|STARTED|Treatment Period 2 (3 Days)||9
9993286|NCT01672788|11115012|FG002|STARTED|Treatment Period 2 (3 Days)||9
9993287|NCT01672788|11115013|FG003|STARTED|Treatment Period 2 (3 Days)||9
9993288|NCT01672788|11115010|FG000|COMPLETED|Treatment Period 2 (3 Days)||9
9993289|NCT01672788|11115011|FG001|COMPLETED|Treatment Period 2 (3 Days)||9
9993290|NCT01672788|11115012|FG002|COMPLETED|Treatment Period 2 (3 Days)||9
9993291|NCT01672788|11115013|FG003|COMPLETED|Treatment Period 2 (3 Days)||9
9993292|NCT01672788|11115010|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9993293|NCT01672788|11115011|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9993294|NCT01672788|11115012|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9993295|NCT01672788|11115013|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9993296|NCT01672788|11115010|FG000|STARTED|Washout Period 2 (7 Days)||9
9993297|NCT01672788|11115011|FG001|STARTED|Washout Period 2 (7 Days)||9
9993298|NCT01672788|11115012|FG002|STARTED|Washout Period 2 (7 Days)||9
9993299|NCT01672788|11115013|FG003|STARTED|Washout Period 2 (7 Days)||9
9993300|NCT01672788|11115010|FG000|COMPLETED|Washout Period 2 (7 Days)||9
9993301|NCT01672788|11115011|FG001|COMPLETED|Washout Period 2 (7 Days)||9
9993302|NCT01672788|11115012|FG002|COMPLETED|Washout Period 2 (7 Days)||9
9993303|NCT01672788|11115013|FG003|COMPLETED|Washout Period 2 (7 Days)||8
9993304|NCT01672788|11115010|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9993305|NCT01672788|11115011|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9993306|NCT01672788|11115012|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9993307|NCT01672788|11115013|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
9993308|NCT01672788|11115010|FG000|STARTED|Treatment Period 3 (3 Days)||9
9993309|NCT01672788|11115011|FG001|STARTED|Treatment Period 3 (3 Days)||9
9993310|NCT01672788|11115012|FG002|STARTED|Treatment Period 3 (3 Days)||9
9993311|NCT01672788|11115013|FG003|STARTED|Treatment Period 3 (3 Days)||8
9993312|NCT01672788|11115010|FG000|COMPLETED|Treatment Period 3 (3 Days)||9
9993313|NCT01672788|11115011|FG001|COMPLETED|Treatment Period 3 (3 Days)||9
9993314|NCT01672788|11115012|FG002|COMPLETED|Treatment Period 3 (3 Days)||9
9993315|NCT01672788|11115013|FG003|COMPLETED|Treatment Period 3 (3 Days)||8
9993316|NCT01672788|11115010|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9993317|NCT01672788|11115011|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9993318|NCT01672788|11115012|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9993319|NCT01672788|11115013|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9993320|NCT01672788|11115010|FG000|STARTED|Washout Period 3 (7 Days)||9
9993321|NCT01672788|11115011|FG001|STARTED|Washout Period 3 (7 Days)||9
9993322|NCT01672788|11115012|FG002|STARTED|Washout Period 3 (7 Days)||9
9993323|NCT01672788|11115013|FG003|STARTED|Washout Period 3 (7 Days)||8
9993324|NCT01672788|11115010|FG000|COMPLETED|Washout Period 3 (7 Days)||9
9993325|NCT01672788|11115011|FG001|COMPLETED|Washout Period 3 (7 Days)||9
9993326|NCT01672788|11115012|FG002|COMPLETED|Washout Period 3 (7 Days)||9
9993327|NCT01672788|11115013|FG003|COMPLETED|Washout Period 3 (7 Days)||8
9993328|NCT01672788|11115010|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
9993329|NCT01672788|11115011|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
9993330|NCT01672788|11115012|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
9993331|NCT01672788|11115013|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
9993332|NCT01672788|11115010|FG000|STARTED|Treatment Period 4 (3 Days)||9
9993333|NCT01672788|11115011|FG001|STARTED|Treatment Period 4 (3 Days)||9
9993334|NCT01672788|11115012|FG002|STARTED|Treatment Period 4 (3 Days)||9
9993335|NCT01672788|11115013|FG003|STARTED|Treatment Period 4 (3 Days)||8
9993336|NCT01672788|11115010|FG000|COMPLETED|Treatment Period 4 (3 Days)||9
9993337|NCT01672788|11115011|FG001|COMPLETED|Treatment Period 4 (3 Days)||9
9993338|NCT01672788|11115012|FG002|COMPLETED|Treatment Period 4 (3 Days)||9
9993339|NCT01672788|11115013|FG003|COMPLETED|Treatment Period 4 (3 Days)||8
9993340|NCT01672788|11115010|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
9993341|NCT01672788|11115011|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
9993342|NCT01672788|11115012|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
9993343|NCT01672788|11115013|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0
9993344|NCT01672801|11115025|FG000|STARTED|Overall Study||9
9993345|NCT01672801|11115026|FG001|STARTED|Overall Study||9
9993346|NCT01672801|11115025|FG000|COMPLETED|Overall Study||9
9993347|NCT01672801|11115026|FG001|COMPLETED|Overall Study||8
9993348|NCT01672801|11115025|FG000|NOT COMPLETED|Overall Study||0
9993349|NCT01672801|11115026|FG001|NOT COMPLETED|Overall Study||1
9993350|NCT01672827|11115032|FG000|STARTED|Overall Study||276
9993351|NCT01672827|11115032|FG000|COMPLETED|Overall Study||276
9993352|NCT01672827|11115032|FG000|NOT COMPLETED|Overall Study||0
9993353|NCT01672853|11115041|FG000|STARTED|Overall Study||79
9993354|NCT01672853|11115042|FG001|STARTED|Overall Study||77
9993355|NCT01672853|11115043|FG002|STARTED|Overall Study||79
9993356|NCT01672853|11115041|FG000|COMPLETED|Overall Study||69
9993357|NCT01672853|11115042|FG001|COMPLETED|Overall Study||60
9993358|NCT01672853|11115043|FG002|COMPLETED|Overall Study||65
9993359|NCT01672853|11115041|FG000|NOT COMPLETED|Overall Study||10
9993360|NCT01672853|11115042|FG001|NOT COMPLETED|Overall Study||17
9993361|NCT01672853|11115043|FG002|NOT COMPLETED|Overall Study||14
9993362|NCT01672866|11115054|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74
9993363|NCT01672866|11115055|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74
9993364|NCT01672866|11115056|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74
9993365|NCT01672866|11115054|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0
9993366|NCT01672866|11115055|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0
9993367|NCT01672866|11115056|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0
9993368|NCT01672866|11115054|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
9993369|NCT01672866|11115055|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
9993370|NCT01672866|11115056|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
9993371|NCT01672866|11115054|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
9993372|NCT01672866|11115055|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
9993373|NCT01672866|11115056|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
9993374|NCT01672866|11115054|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
9993375|NCT01672866|11115055|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
9993376|NCT01672866|11115056|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
9993377|NCT01672866|11115054|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
9993378|NCT01672866|11115055|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
9993379|NCT01672866|11115056|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
9993380|NCT01672879|11115069|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87
9993381|NCT01672879|11115070|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86
9993382|NCT01672879|11115071|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86
9993383|NCT01672879|11115069|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
9993384|NCT01672879|11115070|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
9993385|NCT01672879|11115071|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
9993386|NCT01672879|11115069|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
9993387|NCT01672879|11115070|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
9993388|NCT01672879|11115071|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
9993389|NCT01672879|11115069|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
9993390|NCT01672879|11115070|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
9993391|NCT01672879|11115071|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
9993392|NCT01672879|11115069|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
9993393|NCT01672879|11115070|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
9993394|NCT01672879|11115071|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
9993395|NCT01672879|11115069|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
9993396|NCT01672879|11115070|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
9993397|NCT01672879|11115071|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
9993398|NCT01672957|11115080|FG000|STARTED|Overall Study||128
9993399|NCT01672957|11115080|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
9993400|NCT01672957|11115080|FG000|COMPLETED|Overall Study||73
9993401|NCT01672957|11115080|FG000|NOT COMPLETED|Overall Study||55
9993402|NCT01672970|11115084|FG000|STARTED|Overall Study||291
9993403|NCT01672970|11115084|FG000|Treated|Overall Study||290
9993404|NCT01672970|11115084|FG000|COMPLETED|Overall Study||244
9993405|NCT01672970|11115084|FG000|NOT COMPLETED|Overall Study||47
9993406|NCT01672983|11115094|FG000|STARTED|Overall Study||18
9993407|NCT01672983|11115095|FG001|STARTED|Overall Study||18
9993408|NCT01672983|11115096|FG002|STARTED|Overall Study||19
9993409|NCT01672983|11115097|FG003|STARTED|Overall Study||18
9993410|NCT01672983|11115098|FG004|STARTED|Overall Study||19
9993411|NCT01672983|11115099|FG005|STARTED|Overall Study||18
9993412|NCT01672983|11115094|FG000|Completed Study Drug|Overall Study||18
9993413|NCT01672983|11115095|FG001|Completed Study Drug|Overall Study||17
9993414|NCT01672983|11115096|FG002|Completed Study Drug|Overall Study||18
9993415|NCT01672983|11115097|FG003|Completed Study Drug|Overall Study||18
9993416|NCT01672983|11115098|FG004|Completed Study Drug|Overall Study||12
9993417|NCT01672983|11115099|FG005|Completed Study Drug|Overall Study||17
9993418|NCT01672983|11115094|FG000|COMPLETED|Overall Study||18
9993419|NCT01672983|11115095|FG001|COMPLETED|Overall Study||18
9993420|NCT01672983|11115096|FG002|COMPLETED|Overall Study||19
9993421|NCT01672983|11115097|FG003|COMPLETED|Overall Study||18
9993422|NCT01672983|11115098|FG004|COMPLETED|Overall Study||19
9993423|NCT01672983|11115099|FG005|COMPLETED|Overall Study||18
9993424|NCT01672983|11115094|FG000|NOT COMPLETED|Overall Study||0
9993425|NCT01672983|11115095|FG001|NOT COMPLETED|Overall Study||0
9993426|NCT01672983|11115096|FG002|NOT COMPLETED|Overall Study||0
9993427|NCT01672983|11115097|FG003|NOT COMPLETED|Overall Study||0
9993428|NCT01672983|11115098|FG004|NOT COMPLETED|Overall Study||0
9993429|NCT01672983|11115099|FG005|NOT COMPLETED|Overall Study||0
9993430|NCT01672996|11115128|FG000|STARTED|Overall Study||30
9993431|NCT01672996|11115129|FG001|STARTED|Overall Study||30
9993432|NCT01672996|11115130|FG002|STARTED|Overall Study||6
9993433|NCT01672996|11115128|FG000|COMPLETED|Overall Study||30
9993434|NCT01672996|11115129|FG001|COMPLETED|Overall Study||30
9993435|NCT01672996|11115130|FG002|COMPLETED|Overall Study||6
9993436|NCT01672996|11115128|FG000|NOT COMPLETED|Overall Study||0
9993437|NCT01672996|11115129|FG001|NOT COMPLETED|Overall Study||0
9993438|NCT01672996|11115130|FG002|NOT COMPLETED|Overall Study||0
9993439|NCT01673009|11115146|FG000|STARTED|Overall Study||36
9993440|NCT01673009|11115146|FG000|COMPLETED|Overall Study||23
9993441|NCT01673009|11115146|FG000|NOT COMPLETED|Overall Study||13
9993442|NCT01673022|11115150|FG000|STARTED|Overall Study||430
9993443|NCT01673022|11115150|FG000|COMPLETED|Overall Study||422
9993444|NCT01673022|11115150|FG000|NOT COMPLETED|Overall Study||8
9993445|NCT01673113|11115156|FG000|STARTED|Overall Study||11
9993446|NCT01673113|11115157|FG001|STARTED|Overall Study||11
9993447|NCT01673113|11115156|FG000|COMPLETED|Overall Study||11
10102419|NCT02415439|11231879|FG010|NOT COMPLETED|Overall Study||0
10102420|NCT02415439|11231880|FG011|NOT COMPLETED|Overall Study||0
10102421|NCT02415439|11231881|FG012|NOT COMPLETED|Overall Study||0
9993448|NCT01673113|11115157|FG001|COMPLETED|Overall Study||11
9993449|NCT01673113|11115156|FG000|NOT COMPLETED|Overall Study||0
9993450|NCT01673113|11115157|FG001|NOT COMPLETED|Overall Study||0
9993451|NCT01673126|11115166|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
9993452|NCT01673126|11115167|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
9993453|NCT01673126|11115166|FG000|COMPLETED|Overall Study||32
9993454|NCT01673126|11115167|FG001|COMPLETED|Overall Study||23
9993455|NCT01673126|11115166|FG000|NOT COMPLETED|Overall Study||4
9993456|NCT01673126|11115167|FG001|NOT COMPLETED|Overall Study||3
9993457|NCT01673178|11115178|FG000|STARTED|Overall Study||22
9993458|NCT01673178|11115179|FG001|STARTED|Overall Study||21
9993459|NCT01673178|11115180|FG002|STARTED|Overall Study||21
9993460|NCT01673178|11115181|FG003|STARTED|Overall Study||22
9993461|NCT01673178|11115182|FG004|STARTED|Overall Study||21
9993462|NCT01673178|11115178|FG000|COMPLETED|Overall Study||19
9993463|NCT01673178|11115179|FG001|COMPLETED|Overall Study||19
9993464|NCT01673178|11115180|FG002|COMPLETED|Overall Study||18
9993465|NCT01673178|11115181|FG003|COMPLETED|Overall Study||14
9993466|NCT01673178|11115182|FG004|COMPLETED|Overall Study||19
9993467|NCT01673178|11115178|FG000|NOT COMPLETED|Overall Study||3
9993468|NCT01673178|11115179|FG001|NOT COMPLETED|Overall Study||2
9993469|NCT01673178|11115180|FG002|NOT COMPLETED|Overall Study||3
9993470|NCT01673178|11115181|FG003|NOT COMPLETED|Overall Study||8
9993471|NCT01673178|11115182|FG004|NOT COMPLETED|Overall Study||2
9993472|NCT01673191|11115200|FG000|STARTED|Overall Study||26
9993473|NCT01673191|11115201|FG001|STARTED|Overall Study||11
9993474|NCT01673191|11115200|FG000|COMPLETED|Overall Study||26
9993475|NCT01673191|11115201|FG001|COMPLETED|Overall Study||11
9993476|NCT01673191|11115200|FG000|NOT COMPLETED|Overall Study||0
9993477|NCT01673191|11115201|FG001|NOT COMPLETED|Overall Study||0
9993478|NCT01673256|11115207|FG000|STARTED|Overall Study||90
9993479|NCT01673256|11115207|FG000|COMPLETED|Overall Study||90
9993480|NCT01673256|11115207|FG000|NOT COMPLETED|Overall Study||0
9993481|NCT01673282|11115213|FG000|STARTED|Overall Study||153
9993482|NCT01673282|11115214|FG001|STARTED|Overall Study||158
9993483|NCT01673282|11115213|FG000|COMPLETED|Overall Study||120
9993484|NCT01673282|11115214|FG001|COMPLETED|Overall Study||132
9993485|NCT01673282|11115213|FG000|NOT COMPLETED|Overall Study||33
9993486|NCT01673282|11115214|FG001|NOT COMPLETED|Overall Study||26
9993487|NCT01673347|11115220|FG000|STARTED|Overall Study||24
9993488|NCT01673347|11115220|FG000|COMPLETED|Overall Study||17
9993489|NCT01673347|11115220|FG000|NOT COMPLETED|Overall Study||7
9993490|NCT01673373|11115224|FG000|STARTED|Overall Study||68
9993491|NCT01673373|11115224|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
9993492|NCT01673373|11115224|FG000|NOT COMPLETED|Overall Study||2
9993493|NCT01673386|11115228|FG000|STARTED|Overall Study||27
9993494|NCT01673386|11115229|FG001|STARTED|Overall Study||31
10102422|NCT02415595|11231915|FG000|STARTED|Overall Study||50
9993495|NCT01673386|11115228|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
9993496|NCT01673386|11115229|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
9993497|NCT01673386|11115228|FG000|NOT COMPLETED|Overall Study||25
9993498|NCT01673386|11115229|FG001|NOT COMPLETED|Overall Study||27
9993499|NCT01673490|11115235|FG000|STARTED|Overall Study||59
9993500|NCT01673490|11115235|FG000|COMPLETED|Overall Study||52
9993501|NCT01673490|11115235|FG000|NOT COMPLETED|Overall Study||7
9993502|NCT01673568|11115241|FG000|STARTED|Overall Study||28
9993503|NCT01673568|11115242|FG001|STARTED|Overall Study||28
9993504|NCT01673568|11115241|FG000|COMPLETED|Overall Study||28
9993505|NCT01673568|11115242|FG001|COMPLETED|Overall Study||28
9993506|NCT01673568|11115241|FG000|NOT COMPLETED|Overall Study||0
9993507|NCT01673568|11115242|FG001|NOT COMPLETED|Overall Study||0
9993508|NCT01673594|11115250|FG000|STARTED|Overall Study||18
9993509|NCT01673594|11115251|FG001|STARTED|Overall Study||19
9993510|NCT01673594|11115250|FG000|COMPLETED|Overall Study||12
9993511|NCT01673594|11115251|FG001|COMPLETED|Overall Study||13
9993512|NCT01673594|11115250|FG000|NOT COMPLETED|Overall Study||6
9993513|NCT01673594|11115251|FG001|NOT COMPLETED|Overall Study||6
9993514|NCT01673646|11115260|FG000|STARTED|Overall Study||11
9993515|NCT01673646|11115261|FG001|STARTED|Overall Study||11
9993516|NCT01673646|11115262|FG002|STARTED|Overall Study||11
9993517|NCT01673646|11115260|FG000|Entered/Treated in Core Phase|Overall Study||11
9993518|NCT01673646|11115261|FG001|Entered/Treated in Core Phase|Overall Study||11
9993519|NCT01673646|11115262|FG002|Entered/Treated in Core Phase|Overall Study||11
9993520|NCT01673646|11115260|FG000|Completed Core Phase|Overall Study||9
9993521|NCT01673646|11115261|FG001|Completed Core Phase|Overall Study||10
9993522|NCT01673646|11115262|FG002|Completed Core Phase|Overall Study||10
9993523|NCT01673646|11115260|FG000|Entered Ext. Phase|Overall Study||7
9993524|NCT01673646|11115261|FG001|Entered Ext. Phase|Overall Study||9
9993525|NCT01673646|11115262|FG002|Entered Ext. Phase|Overall Study||9
9993526|NCT01673646|11115260|FG000|Did Not Enter Ext. Phase|Overall Study||2
9993527|NCT01673646|11115261|FG001|Did Not Enter Ext. Phase|Overall Study||1
9993528|NCT01673646|11115262|FG002|Did Not Enter Ext. Phase|Overall Study||1
9993529|NCT01673646|11115260|FG000|Treated Beyond 24 Months|Overall Study||7
9993530|NCT01673646|11115261|FG001|Treated Beyond 24 Months|Overall Study||8
9993531|NCT01673646|11115262|FG002|Treated Beyond 24 Months|Overall Study||8
9993532|NCT01673646|11115260|FG000|Discontinued Beyond 24 Months|Overall Study||0
9993533|NCT01673646|11115261|FG001|Discontinued Beyond 24 Months|Overall Study||4
9993534|NCT01673646|11115262|FG002|Discontinued Beyond 24 Months|Overall Study||1
9993535|NCT01673646|11115260|FG000|COMPLETED|Overall Study||7
9993536|NCT01673646|11115261|FG001|COMPLETED|Overall Study||4
9993537|NCT01673646|11115262|FG002|COMPLETED|Overall Study||7
9993538|NCT01673646|11115260|FG000|NOT COMPLETED|Overall Study||4
9993539|NCT01673646|11115261|FG001|NOT COMPLETED|Overall Study||7
10202181|NCT03441984|11329287|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10202182|NCT03441984|11329276|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202183|NCT03441984|11329277|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9993540|NCT01673646|11115262|FG002|NOT COMPLETED|Overall Study||4
9993541|NCT01673698|11115276|FG000|STARTED|Overall Study||187
9993542|NCT01673698|11115277|FG001|STARTED|Overall Study||139
9993543|NCT01673698|11115276|FG000|COMPLETED|Overall Study||136
9993544|NCT01673698|11115277|FG001|COMPLETED|Overall Study||126
9993545|NCT01673698|11115276|FG000|NOT COMPLETED|Overall Study||51
9993546|NCT01673698|11115277|FG001|NOT COMPLETED|Overall Study||13
9993547|NCT01673802|11115284|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
9993548|NCT01673802|11115284|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
9993549|NCT01673802|11115284|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
9993550|NCT01673802|11115284|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
9993551|NCT01673802|11115284|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
9993552|NCT01673802|11115284|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
9993553|NCT01673828|11115290|FG000|STARTED|Overall Study||7
9993554|NCT01673828|11115291|FG001|STARTED|Overall Study||6
9993555|NCT01673828|11115290|FG000|COMPLETED|Overall Study||7
9993556|NCT01673828|11115291|FG001|COMPLETED|Overall Study||6
9993557|NCT01673828|11115290|FG000|NOT COMPLETED|Overall Study||0
9993558|NCT01673828|11115291|FG001|NOT COMPLETED|Overall Study||0
9993559|NCT01673854|11115297|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
9993560|NCT01673854|11115297|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
9993561|NCT01673854|11115297|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
9993562|NCT01673854|11115297|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
9993563|NCT01673854|11115297|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
9993564|NCT01673854|11115297|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
9993565|NCT01673854|11115297|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
10102423|NCT02415595|11231916|FG001|STARTED|Overall Study||52
10102424|NCT02415595|11231917|FG002|STARTED|Overall Study||51
10102425|NCT02415595|11231918|FG003|STARTED|Overall Study||53
10102426|NCT02415595|11231915|FG000|COMPLETED|Overall Study||0
9993566|NCT01673854|11115297|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
9993567|NCT01673854|11115297|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
9993568|NCT01673893|11115303|FG000|STARTED|Overall Study||59
9993569|NCT01673893|11115303|FG000|COMPLETED|Overall Study||59
10102427|NCT02415595|11231916|FG001|COMPLETED|Overall Study||0
10102428|NCT02415595|11231917|FG002|COMPLETED|Overall Study||0
10102429|NCT02415595|11231918|FG003|COMPLETED|Overall Study||0
9993570|NCT01673893|11115303|FG000|NOT COMPLETED|Overall Study||0
9993571|NCT01673919|11115309|FG000|STARTED|Overall Study||7
9993572|NCT01673919|11115309|FG000|COMPLETED|Overall Study||7
9993573|NCT01673919|11115309|FG000|NOT COMPLETED|Overall Study||0
9993574|NCT01673984|11115315|FG000|STARTED|Overall Study||14
9993575|NCT01673984|11115316|FG001|STARTED|Overall Study||7
9993576|NCT01673984|11115315|FG000|COMPLETED|Overall Study||4
9993577|NCT01673984|11115316|FG001|COMPLETED|Overall Study||1
9993578|NCT01673984|11115315|FG000|NOT COMPLETED|Overall Study||10
9993579|NCT01673984|11115316|FG001|NOT COMPLETED|Overall Study||6
9993580|NCT01674010|11115322|FG000|STARTED|Open Treatment Phase 1||309
9993581|NCT01674010|11115323|FG001|STARTED|Open Treatment Phase 1||0
9993582|NCT01674010|11115324|FG002|STARTED|Open Treatment Phase 1||0
9993583|NCT01674010|11115322|FG000|COMPLETED|Open Treatment Phase 1||129
9993584|NCT01674010|11115323|FG001|COMPLETED|Open Treatment Phase 1||0
9993585|NCT01674010|11115324|FG002|COMPLETED|Open Treatment Phase 1||0
9993586|NCT01674010|11115322|FG000|NOT COMPLETED|Open Treatment Phase 1||180
9993587|NCT01674010|11115323|FG001|NOT COMPLETED|Open Treatment Phase 1||0
9993588|NCT01674010|11115324|FG002|NOT COMPLETED|Open Treatment Phase 1||0
9993589|NCT01674010|11115322|FG000|STARTED|Randomization Phase 2||0
9993590|NCT01674010|11115323|FG001|STARTED|Randomization Phase 2||65
9993591|NCT01674010|11115324|FG002|STARTED|Randomization Phase 2||64
9993592|NCT01674010|11115322|FG000|COMPLETED|Randomization Phase 2||0
9993593|NCT01674010|11115323|FG001|COMPLETED|Randomization Phase 2||3
9993594|NCT01674010|11115324|FG002|COMPLETED|Randomization Phase 2||3
9993595|NCT01674010|11115322|FG000|NOT COMPLETED|Randomization Phase 2||0
9993596|NCT01674010|11115323|FG001|NOT COMPLETED|Randomization Phase 2||62
9993597|NCT01674010|11115324|FG002|NOT COMPLETED|Randomization Phase 2||61
9993598|NCT01674062|11115334|FG000|STARTED|Overall Study||66
9993599|NCT01674062|11115335|FG001|STARTED|Overall Study||29
9993600|NCT01674062|11115334|FG000|COMPLETED|Overall Study||0
9993601|NCT01674062|11115335|FG001|COMPLETED|Overall Study||0
9993602|NCT01674062|11115334|FG000|NOT COMPLETED|Overall Study||66
9993603|NCT01674062|11115335|FG001|NOT COMPLETED|Overall Study||29
9993604|NCT01674478|11115343|FG000|STARTED|Overall Study||9
9993605|NCT01674478|11115344|FG001|STARTED|Overall Study||9
9993606|NCT01674478|11115343|FG000|COMPLETED|Overall Study||9
9993607|NCT01674478|11115344|FG001|COMPLETED|Overall Study||9
9993608|NCT01674478|11115343|FG000|NOT COMPLETED|Overall Study||0
9993609|NCT01674478|11115344|FG001|NOT COMPLETED|Overall Study||0
9993610|NCT01674569|11115350|FG000|STARTED|Overall Study||3
9993611|NCT01674569|11115351|FG001|STARTED|Overall Study||8
9993612|NCT01674569|11115352|FG002|STARTED|Overall Study||4
9993613|NCT01674569|11115353|FG003|STARTED|Overall Study||10
9993614|NCT01674569|11115354|FG004|STARTED|Overall Study||7
9993615|NCT01674569|11115355|FG005|STARTED|Overall Study||3
10102430|NCT02415595|11231915|FG000|NOT COMPLETED|Overall Study||50
10102431|NCT02415595|11231916|FG001|NOT COMPLETED|Overall Study||52
10102432|NCT02415595|11231917|FG002|NOT COMPLETED|Overall Study||51
10102433|NCT02415595|11231918|FG003|NOT COMPLETED|Overall Study||53
9993616|NCT01674569|11115350|FG000|COMPLETED|Overall Study||3
9993617|NCT01674569|11115351|FG001|COMPLETED|Overall Study||5
9993618|NCT01674569|11115352|FG002|COMPLETED|Overall Study||2
9993619|NCT01674569|11115353|FG003|COMPLETED|Overall Study||9
9993620|NCT01674569|11115354|FG004|COMPLETED|Overall Study||5
9993621|NCT01674569|11115355|FG005|COMPLETED|Overall Study||1
9993622|NCT01674569|11115350|FG000|NOT COMPLETED|Overall Study||0
9993623|NCT01674569|11115351|FG001|NOT COMPLETED|Overall Study||3
9993624|NCT01674569|11115352|FG002|NOT COMPLETED|Overall Study||2
9993625|NCT01674569|11115353|FG003|NOT COMPLETED|Overall Study||1
9993626|NCT01674569|11115354|FG004|NOT COMPLETED|Overall Study||2
9993627|NCT01674569|11115355|FG005|NOT COMPLETED|Overall Study||2
9993628|NCT01674621|11115364|FG000|STARTED|Overall Study||50
9993629|NCT01674621|11115365|FG001|STARTED|Overall Study||51
9993630|NCT01674621|11115366|FG002|STARTED|Overall Study||48
9993631|NCT01674621|11115367|FG003|STARTED|Overall Study||51
9993632|NCT01674621|11115368|FG004|STARTED|Overall Study||50
9993633|NCT01674621|11115364|FG000|Modified Intent-to-Treat Population|Overall Study||47
9993634|NCT01674621|11115365|FG001|Modified Intent-to-Treat Population|Overall Study||46
9993635|NCT01674621|11115366|FG002|Modified Intent-to-Treat Population|Overall Study||43
9993636|NCT01674621|11115367|FG003|Modified Intent-to-Treat Population|Overall Study||49
9993637|NCT01674621|11115368|FG004|Modified Intent-to-Treat Population|Overall Study||46
9993638|NCT01674621|11115364|FG000|Safety Population|Overall Study||50
9993639|NCT01674621|11115365|FG001|Safety Population|Overall Study||51
9993640|NCT01674621|11115366|FG002|Safety Population|Overall Study||47
9993641|NCT01674621|11115367|FG003|Safety Population|Overall Study||51
9993642|NCT01674621|11115368|FG004|Safety Population|Overall Study||50
9993643|NCT01674621|11115364|FG000|COMPLETED|Overall Study||45
9993644|NCT01674621|11115365|FG001|COMPLETED|Overall Study||43
10102434|NCT02415608|11231931|FG000|STARTED|Overall Study||3
10102435|NCT02415608|11231932|FG001|STARTED|Overall Study||1
10102436|NCT02415608|11231931|FG000|COMPLETED|Overall Study||3
9993645|NCT01674621|11115366|FG002|COMPLETED|Overall Study||41
9993646|NCT01674621|11115367|FG003|COMPLETED|Overall Study||45
9993647|NCT01674621|11115368|FG004|COMPLETED|Overall Study||44
10102437|NCT02415608|11231932|FG001|COMPLETED|Overall Study||1
9993648|NCT01674621|11115364|FG000|NOT COMPLETED|Overall Study||5
9993649|NCT01674621|11115365|FG001|NOT COMPLETED|Overall Study||8
9993650|NCT01674621|11115366|FG002|NOT COMPLETED|Overall Study||7
9993651|NCT01674621|11115367|FG003|NOT COMPLETED|Overall Study||6
9993652|NCT01674621|11115368|FG004|NOT COMPLETED|Overall Study||6
9993653|NCT01674634|11115381|FG000|STARTED|Overall Study||715
9993654|NCT01674634|11115381|FG000|COMPLETED|Overall Study||709
9993655|NCT01674634|11115381|FG000|NOT COMPLETED|Overall Study||6
9993656|NCT01674647|11115391|FG000|STARTED|Treatment Period||1002
9993657|NCT01674647|11115392|FG001|STARTED|Treatment Period||502
9993658|NCT01674647|11115391|FG000|Subjects Received Treatment|Treatment Period||988
9993659|NCT01674647|11115392|FG001|Subjects Received Treatment|Treatment Period||499
9993660|NCT01674647|11115391|FG000|COMPLETED|Treatment Period||846
9993661|NCT01674647|11115392|FG001|COMPLETED|Treatment Period||400
9993662|NCT01674647|11115391|FG000|NOT COMPLETED|Treatment Period||156
9993663|NCT01674647|11115392|FG001|NOT COMPLETED|Treatment Period||102
9993664|NCT01674647|11115391|FG000|STARTED|30-day Safety Follow-up Period||982
9993665|NCT01674647|11115392|FG001|STARTED|30-day Safety Follow-up Period||487
9993666|NCT01674647|11115391|FG000|COMPLETED|30-day Safety Follow-up Period||924
9993667|NCT01674647|11115392|FG001|COMPLETED|30-day Safety Follow-up Period||446
9993668|NCT01674647|11115391|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58
9993669|NCT01674647|11115392|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41
9993670|NCT01674712|11115403|FG000|STARTED|Overall Study||114
9993671|NCT01674712|11115404|FG001|STARTED|Overall Study||117
9993672|NCT01674712|11115405|FG002|STARTED|Overall Study||115
9993673|NCT01674712|11115406|FG003|STARTED|Overall Study||116
9993674|NCT01674712|11115407|FG004|STARTED|Overall Study||113
9993675|NCT01674712|11115403|FG000|Full Analysis Subject Sample|Overall Study||109
9993676|NCT01674712|11115404|FG001|Full Analysis Subject Sample|Overall Study||114
9993677|NCT01674712|11115405|FG002|Full Analysis Subject Sample|Overall Study||110
9993678|NCT01674712|11115406|FG003|Full Analysis Subject Sample|Overall Study||112
9993679|NCT01674712|11115407|FG004|Full Analysis Subject Sample|Overall Study||111
9993680|NCT01674712|11115403|FG000|Safety Subject Sample|Overall Study||111
9993681|NCT01674712|11115404|FG001|Safety Subject Sample|Overall Study||117
9993682|NCT01674712|11115405|FG002|Safety Subject Sample|Overall Study||113
9993683|NCT01674712|11115406|FG003|Safety Subject Sample|Overall Study||115
9993684|NCT01674712|11115407|FG004|Safety Subject Sample|Overall Study||112
9993685|NCT01674712|11115403|FG000|COMPLETED|Overall Study||104
9993686|NCT01674712|11115404|FG001|COMPLETED|Overall Study||108
9993687|NCT01674712|11115405|FG002|COMPLETED|Overall Study||106
9993688|NCT01674712|11115406|FG003|COMPLETED|Overall Study||108
9993689|NCT01674712|11115407|FG004|COMPLETED|Overall Study||102
9993690|NCT01674712|11115403|FG000|NOT COMPLETED|Overall Study||10
9993691|NCT01674712|11115404|FG001|NOT COMPLETED|Overall Study||9
9993692|NCT01674712|11115405|FG002|NOT COMPLETED|Overall Study||9
9993693|NCT01674712|11115406|FG003|NOT COMPLETED|Overall Study||8
9993694|NCT01674712|11115407|FG004|NOT COMPLETED|Overall Study||11
9993695|NCT01674725|11115421|FG000|STARTED|Overall Study||92
9993696|NCT01674725|11115422|FG001|STARTED|Overall Study||95
9993697|NCT01674725|11115421|FG000|COMPLETED|Overall Study||89
9993698|NCT01674725|11115422|FG001|COMPLETED|Overall Study||94
9993699|NCT01674725|11115421|FG000|NOT COMPLETED|Overall Study||3
9993700|NCT01674725|11115422|FG001|NOT COMPLETED|Overall Study||1
9993701|NCT01675050|11115430|FG000|STARTED|Period One Treatment||2
9993702|NCT01675050|11115431|FG001|STARTED|Period One Treatment||2
9993703|NCT01675050|11115430|FG000|COMPLETED|Period One Treatment||1
9993704|NCT01675050|11115431|FG001|COMPLETED|Period One Treatment||2
9993705|NCT01675050|11115430|FG000|NOT COMPLETED|Period One Treatment||1
9993706|NCT01675050|11115431|FG001|NOT COMPLETED|Period One Treatment||0
9993707|NCT01675050|11115430|FG000|STARTED|Wash Out Period||1
9993708|NCT01675050|11115431|FG001|STARTED|Wash Out Period||2
9993709|NCT01675050|11115430|FG000|COMPLETED|Wash Out Period||1
9993710|NCT01675050|11115431|FG001|COMPLETED|Wash Out Period||2
9993711|NCT01675050|11115430|FG000|NOT COMPLETED|Wash Out Period||0
9993712|NCT01675050|11115431|FG001|NOT COMPLETED|Wash Out Period||0
9993713|NCT01675050|11115430|FG000|STARTED|Second Period Treatment||1
9993714|NCT01675050|11115431|FG001|STARTED|Second Period Treatment||2
9993715|NCT01675050|11115430|FG000|COMPLETED|Second Period Treatment||1
9993716|NCT01675050|11115431|FG001|COMPLETED|Second Period Treatment||2
9993717|NCT01675050|11115430|FG000|NOT COMPLETED|Second Period Treatment||0
9993718|NCT01675050|11115431|FG001|NOT COMPLETED|Second Period Treatment||0
9993719|NCT01675063|11115437|FG000|STARTED|Overall Study||77
9993720|NCT01675063|11115437|FG000|COMPLETED|Overall Study||77
9993721|NCT01675063|11115437|FG000|NOT COMPLETED|Overall Study||0
9993722|NCT01675128|11115444|FG000|STARTED|Overall Study||4
9993723|NCT01675128|11115445|FG001|STARTED|Overall Study||10
9993724|NCT01675128|11115446|FG002|STARTED|Overall Study||10
9993725|NCT01675128|11115444|FG000|COMPLETED|Overall Study||2
9993726|NCT01675128|11115445|FG001|COMPLETED|Overall Study||8
9993727|NCT01675128|11115446|FG002|COMPLETED|Overall Study||9
9993728|NCT01675128|11115444|FG000|NOT COMPLETED|Overall Study||2
9993729|NCT01675128|11115445|FG001|NOT COMPLETED|Overall Study||2
9993730|NCT01675128|11115446|FG002|NOT COMPLETED|Overall Study||1
9993731|NCT01675141|11115461|FG000|STARTED|Overall Study||11
9993732|NCT01675141|11115461|FG000|COMPLETED|Overall Study||0
9993733|NCT01675141|11115461|FG000|NOT COMPLETED|Overall Study||11
9993734|NCT01675154|11115469|FG000|STARTED|First Intervention Period (4 Weeks)||2
9993735|NCT01675154|11115470|FG001|STARTED|First Intervention Period (4 Weeks)||1
9993736|NCT01675154|11115471|FG002|STARTED|First Intervention Period (4 Weeks)||1
9993737|NCT01675154|11115472|FG003|STARTED|First Intervention Period (4 Weeks)||1
9993738|NCT01675154|11115469|FG000|COMPLETED|First Intervention Period (4 Weeks)||2
9993739|NCT01675154|11115470|FG001|COMPLETED|First Intervention Period (4 Weeks)||1
9993740|NCT01675154|11115471|FG002|COMPLETED|First Intervention Period (4 Weeks)||1
9993741|NCT01675154|11115472|FG003|COMPLETED|First Intervention Period (4 Weeks)||1
9993742|NCT01675154|11115469|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0
9993743|NCT01675154|11115470|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0
9993744|NCT01675154|11115471|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0
9993745|NCT01675154|11115472|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0
10018396|NCT01823614|11141465|FG002|NOT COMPLETED|Overall Study||0
9993746|NCT01675154|11115469|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
9993747|NCT01675154|11115470|FG001|STARTED|First Washout Period (1 Week)||1
9993748|NCT01675154|11115471|FG002|STARTED|First Washout Period (1 Week)||1
9993749|NCT01675154|11115472|FG003|STARTED|First Washout Period (1 Week)||1
9993750|NCT01675154|11115469|FG000|COMPLETED|First Washout Period (1 Week)||2
9993751|NCT01675154|11115470|FG001|COMPLETED|First Washout Period (1 Week)||1
9993752|NCT01675154|11115471|FG002|COMPLETED|First Washout Period (1 Week)||1
9993753|NCT01675154|11115472|FG003|COMPLETED|First Washout Period (1 Week)||1
9993754|NCT01675154|11115469|FG000|NOT COMPLETED|First Washout Period (1 Week)||0
9993755|NCT01675154|11115470|FG001|NOT COMPLETED|First Washout Period (1 Week)||0
9993756|NCT01675154|11115471|FG002|NOT COMPLETED|First Washout Period (1 Week)||0
9993757|NCT01675154|11115472|FG003|NOT COMPLETED|First Washout Period (1 Week)||0
9993758|NCT01675154|11115469|FG000|STARTED|Second Intervention Period (4 Weeks)||1
9993759|NCT01675154|11115470|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
9993760|NCT01675154|11115471|FG002|STARTED|Second Intervention Period (4 Weeks)||1
9993761|NCT01675154|11115472|FG003|STARTED|Second Intervention Period (4 Weeks)||2
9993762|NCT01675154|11115469|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0
9993763|NCT01675154|11115470|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1
9993764|NCT01675154|11115471|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1
9993765|NCT01675154|11115472|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1
9993766|NCT01675154|11115469|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
9993767|NCT01675154|11115470|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
9993768|NCT01675154|11115471|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
9993769|NCT01675154|11115472|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
9993770|NCT01675154|11115469|FG000|STARTED|Second Washout Period (1 Week)||1
9993771|NCT01675154|11115470|FG001|STARTED|Second Washout Period (1 Week)||1
9993772|NCT01675154|11115471|FG002|STARTED|Second Washout Period (1 Week)||1
9993773|NCT01675154|11115472|FG003|STARTED|Second Washout Period (1 Week)||2
9993774|NCT01675154|11115469|FG000|COMPLETED|Second Washout Period (1 Week)||1
9993775|NCT01675154|11115470|FG001|COMPLETED|Second Washout Period (1 Week)||1
9993776|NCT01675154|11115471|FG002|COMPLETED|Second Washout Period (1 Week)||1
9993777|NCT01675154|11115472|FG003|COMPLETED|Second Washout Period (1 Week)||2
9993778|NCT01675154|11115469|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0
9993779|NCT01675154|11115470|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0
9993780|NCT01675154|11115471|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0
9993781|NCT01675154|11115472|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0
9993782|NCT01675154|11115469|FG000|STARTED|Third Intervention Period (4 Weeks)||1
9993783|NCT01675154|11115470|FG001|STARTED|Third Intervention Period (4 Weeks)||1
9993784|NCT01675154|11115471|FG002|STARTED|Third Intervention Period (4 Weeks)||1
9993785|NCT01675154|11115472|FG003|STARTED|Third Intervention Period (4 Weeks)||0
9993786|NCT01675154|11115469|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1
9993787|NCT01675154|11115470|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0
9993788|NCT01675154|11115471|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1
9993789|NCT01675154|11115472|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0
9993790|NCT01675154|11115469|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
9993791|NCT01675154|11115470|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
9993792|NCT01675154|11115471|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
9993793|NCT01675154|11115472|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
9993794|NCT01675154|11115469|FG000|STARTED|Third Washout Period (1 Week)||1
9993795|NCT01675154|11115470|FG001|STARTED|Third Washout Period (1 Week)||0
9993796|NCT01675154|11115471|FG002|STARTED|Third Washout Period (1 Week)||1
9993797|NCT01675154|11115472|FG003|STARTED|Third Washout Period (1 Week)||0
9993798|NCT01675154|11115469|FG000|COMPLETED|Third Washout Period (1 Week)||1
9993799|NCT01675154|11115470|FG001|COMPLETED|Third Washout Period (1 Week)||0
9993800|NCT01675154|11115471|FG002|COMPLETED|Third Washout Period (1 Week)||1
9993801|NCT01675154|11115472|FG003|COMPLETED|Third Washout Period (1 Week)||0
9993802|NCT01675154|11115469|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0
9993803|NCT01675154|11115470|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0
9993804|NCT01675154|11115471|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0
9993805|NCT01675154|11115472|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0
9993806|NCT01675154|11115469|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1
9993807|NCT01675154|11115470|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0
9993808|NCT01675154|11115471|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1
9993809|NCT01675154|11115472|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0
9993810|NCT01675154|11115469|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1
9993811|NCT01675154|11115470|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0
9993812|NCT01675154|11115471|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1
9993813|NCT01675154|11115472|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0
9993814|NCT01675154|11115469|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
9993815|NCT01675154|11115470|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
9993816|NCT01675154|11115471|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
9993817|NCT01675154|11115472|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
9993818|NCT01675167|11115496|FG000|STARTED|Open-label Titration Phase||815
9993819|NCT01675167|11115497|FG001|STARTED|Open-label Titration Phase||0
9993820|NCT01675167|11115498|FG002|STARTED|Open-label Titration Phase||0
9993821|NCT01675167|11115496|FG000|COMPLETED|Open-label Titration Phase||511
9993822|NCT01675167|11115497|FG001|COMPLETED|Open-label Titration Phase||0
9993823|NCT01675167|11115498|FG002|COMPLETED|Open-label Titration Phase||0
9993824|NCT01675167|11115496|FG000|NOT COMPLETED|Open-label Titration Phase||304
9993825|NCT01675167|11115497|FG001|NOT COMPLETED|Open-label Titration Phase||0
9993826|NCT01675167|11115498|FG002|NOT COMPLETED|Open-label Titration Phase||0
10102438|NCT02415608|11231931|FG000|NOT COMPLETED|Overall Study||0
10102439|NCT02415608|11231932|FG001|NOT COMPLETED|Overall Study||0
10102440|NCT02415842|11231951|FG000|STARTED|Overall Study||29
10102441|NCT02415842|11231952|FG001|STARTED|Overall Study||29
10102442|NCT02415842|11231953|FG002|STARTED|Overall Study||29
9993827|NCT01675167|11115496|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
9993828|NCT01675167|11115497|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
9993829|NCT01675167|11115498|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
9993830|NCT01675167|11115496|FG000|COMPLETED|Double-blind Treatment Phase||0
9993831|NCT01675167|11115497|FG001|COMPLETED|Double-blind Treatment Phase||206
9993832|NCT01675167|11115498|FG002|COMPLETED|Double-blind Treatment Phase||147
9993833|NCT01675167|11115496|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
9993834|NCT01675167|11115497|FG001|NOT COMPLETED|Double-blind Treatment Phase||48
9993835|NCT01675167|11115498|FG002|NOT COMPLETED|Double-blind Treatment Phase||110
9993836|NCT01675297|11115508|FG000|STARTED|Overall Study||806
9993837|NCT01675297|11115509|FG001|STARTED|Overall Study||247
9993838|NCT01675297|11115508|FG000|COMPLETED|Overall Study||642
9993839|NCT01675297|11115509|FG001|COMPLETED|Overall Study||199
9993840|NCT01675297|11115508|FG000|NOT COMPLETED|Overall Study||164
9993841|NCT01675297|11115509|FG001|NOT COMPLETED|Overall Study||48
9993842|NCT01675427|11115515|FG000|STARTED|Overall Study||4766
9993843|NCT01675427|11115515|FG000|COMPLETED|Overall Study||4732
9993844|NCT01675427|11115515|FG000|NOT COMPLETED|Overall Study||34
9993845|NCT01675453|11115551|FG000|STARTED|Overall Study||20
9993846|NCT01675453|11115552|FG001|STARTED|Overall Study||20
9993847|NCT01675453|11115551|FG000|COMPLETED|Overall Study||20
9993848|NCT01675453|11115552|FG001|COMPLETED|Overall Study||20
9993849|NCT01675453|11115551|FG000|NOT COMPLETED|Overall Study||0
9993850|NCT01675453|11115552|FG001|NOT COMPLETED|Overall Study||0
9993851|NCT01675492|11115558|FG000|STARTED|Overall Study||84
9993852|NCT01675492|11115558|FG000|COMPLETED|Overall Study||42
9993853|NCT01675492|11115558|FG000|NOT COMPLETED|Overall Study||42
9993854|NCT01675531|11115563|FG000|STARTED|Overall Study||66
9993855|NCT01675531|11115563|FG000|COMPLETED|Overall Study||41
9993856|NCT01675531|11115563|FG000|NOT COMPLETED|Overall Study||25
9993857|NCT01675544|11115568|FG000|STARTED|Overall Study||46
9993858|NCT01675544|11115568|FG000|COMPLETED|Overall Study||44
9993859|NCT01675544|11115568|FG000|NOT COMPLETED|Overall Study||2
10018397|NCT01823614|11141466|FG003|NOT COMPLETED|Overall Study||0
10018398|NCT01823614|11141467|FG004|NOT COMPLETED|Overall Study||0
10018399|NCT01823614|11141468|FG005|NOT COMPLETED|Overall Study||0
10018400|NCT01823653|11141488|FG000|STARTED|Overall Study||60
10018401|NCT01823653|11141488|FG000|COMPLETED|Overall Study||60
10018402|NCT01823653|11141488|FG000|NOT COMPLETED|Overall Study||0
10018403|NCT01823679|11141495|FG000|STARTED|Overall Study||2
10018404|NCT01823679|11141495|FG000|COMPLETED|Overall Study||1
10018405|NCT01823679|11141495|FG000|NOT COMPLETED|Overall Study||1
10018406|NCT01823835|11141515|FG000|STARTED|Overall Study||3
10018407|NCT01823835|11141516|FG001|STARTED|Overall Study||4
10018408|NCT01823835|11141517|FG002|STARTED|Overall Study||4
10018409|NCT01823835|11141518|FG003|STARTED|Overall Study||6
10018410|NCT01823835|11141519|FG004|STARTED|Overall Study||6
10018411|NCT01823835|11141520|FG005|STARTED|Overall Study||6
10018412|NCT01823835|11141521|FG006|STARTED|Overall Study||6
10018413|NCT01823835|11141522|FG007|STARTED|Overall Study||3
10018414|NCT01823835|11141523|FG008|STARTED|Overall Study||3
10018415|NCT01823835|11141524|FG009|STARTED|Overall Study||19
10018416|NCT01823835|11141525|FG010|STARTED|Overall Study||10
10018417|NCT01823835|11141526|FG011|STARTED|Overall Study||53
10018418|NCT01823835|11141527|FG012|STARTED|Overall Study||19
10018419|NCT01823835|11141528|FG013|STARTED|Overall Study||4
10018420|NCT01823835|11141529|FG014|STARTED|Overall Study||6
10018421|NCT01823835|11141515|FG000|COMPLETED|Overall Study||0
10018422|NCT01823835|11141516|FG001|COMPLETED|Overall Study||0
10018423|NCT01823835|11141517|FG002|COMPLETED|Overall Study||0
10018424|NCT01823835|11141518|FG003|COMPLETED|Overall Study||0
10018425|NCT01823835|11141519|FG004|COMPLETED|Overall Study||0
10018426|NCT01823835|11141520|FG005|COMPLETED|Overall Study||0
10018427|NCT01823835|11141521|FG006|COMPLETED|Overall Study||0
10018428|NCT01823835|11141522|FG007|COMPLETED|Overall Study||0
10018429|NCT01823835|11141523|FG008|COMPLETED|Overall Study||0
10018430|NCT01823835|11141524|FG009|COMPLETED|Overall Study||0
10018431|NCT01823835|11141525|FG010|COMPLETED|Overall Study||0
10018432|NCT01823835|11141526|FG011|COMPLETED|Overall Study||0
10018433|NCT01823835|11141527|FG012|COMPLETED|Overall Study||0
10018434|NCT01823835|11141528|FG013|COMPLETED|Overall Study||0
10018435|NCT01823835|11141529|FG014|COMPLETED|Overall Study||0
10018436|NCT01823835|11141515|FG000|NOT COMPLETED|Overall Study||3
10102443|NCT02415842|11231954|FG003|STARTED|Overall Study||27
10018437|NCT01823835|11141516|FG001|NOT COMPLETED|Overall Study||4
10018438|NCT01823835|11141517|FG002|NOT COMPLETED|Overall Study||4
10018439|NCT01823835|11141518|FG003|NOT COMPLETED|Overall Study||6
9993860|NCT01675596|11115572|FG000|STARTED|Overall Study|One patient did not receive the study device.|199
9993861|NCT01675596|11115572|FG000|COMPLETED|Overall Study||191
9993862|NCT01675596|11115572|FG000|NOT COMPLETED|Overall Study||8
9993863|NCT01675622|11115578|FG000|STARTED|Overall Study||122
9993864|NCT01675622|11115579|FG001|STARTED|Overall Study||120
9993865|NCT01675622|11115578|FG000|COMPLETED|Overall Study||96
9993866|NCT01675622|11115579|FG001|COMPLETED|Overall Study||96
9993867|NCT01675622|11115578|FG000|NOT COMPLETED|Overall Study||26
9993868|NCT01675622|11115579|FG001|NOT COMPLETED|Overall Study||24
9993869|NCT01675635|11115587|FG000|STARTED|Overall Study||117
9993870|NCT01675635|11115588|FG001|STARTED|Overall Study||117
9993871|NCT01675635|11115587|FG000|COMPLETED|Overall Study||117
9993872|NCT01675635|11115588|FG001|COMPLETED|Overall Study||117
9993873|NCT01675635|11115587|FG000|NOT COMPLETED|Overall Study||0
9993874|NCT01675635|11115588|FG001|NOT COMPLETED|Overall Study||0
9993875|NCT01675661|11115601|FG000|STARTED|Overall Study||153
9993876|NCT01675661|11115602|FG001|STARTED|Overall Study||149
9993877|NCT01675661|11115601|FG000|COMPLETED|Overall Study||113
9993878|NCT01675661|11115602|FG001|COMPLETED|Overall Study||103
9993879|NCT01675661|11115601|FG000|NOT COMPLETED|Overall Study||40
9993880|NCT01675661|11115602|FG001|NOT COMPLETED|Overall Study||46
9993881|NCT01675765|11115610|FG000|STARTED|Overall Study||38
9993882|NCT01675765|11115611|FG001|STARTED|Overall Study||22
9993883|NCT01675765|11115610|FG000|COMPLETED|Overall Study||27
9993884|NCT01675765|11115611|FG001|COMPLETED|Overall Study||14
9993885|NCT01675765|11115610|FG000|NOT COMPLETED|Overall Study||11
9993886|NCT01675765|11115611|FG001|NOT COMPLETED|Overall Study||8
9993887|NCT01675778|11115617|FG000|STARTED|Overall Study||174
9993888|NCT01675778|11115617|FG000|COMPLETED|Overall Study||174
9993889|NCT01675778|11115617|FG000|NOT COMPLETED|Overall Study||0
9993890|NCT01675830|11115622|FG000|STARTED|Overall Study||10
9993891|NCT01675830|11115622|FG000|COMPLETED|Overall Study||10
9993892|NCT01675830|11115622|FG000|NOT COMPLETED|Overall Study||0
9993893|NCT01675882|11115630|FG000|STARTED|Overall Study||53
9993894|NCT01675882|11115631|FG001|STARTED|Overall Study||56
9993895|NCT01675882|11115632|FG002|STARTED|Overall Study||56
9993896|NCT01675882|11115633|FG003|STARTED|Overall Study||56
9993897|NCT01675882|11115630|FG000|COMPLETED|Overall Study||51
9993898|NCT01675882|11115631|FG001|COMPLETED|Overall Study||49
9993899|NCT01675882|11115632|FG002|COMPLETED|Overall Study||53
9993900|NCT01675882|11115633|FG003|COMPLETED|Overall Study||54
9993901|NCT01675882|11115630|FG000|NOT COMPLETED|Overall Study||2
9993902|NCT01675882|11115631|FG001|NOT COMPLETED|Overall Study||7
9993903|NCT01675882|11115632|FG002|NOT COMPLETED|Overall Study||3
9993904|NCT01675882|11115633|FG003|NOT COMPLETED|Overall Study||2
9993905|NCT01676012|11115643|FG000|STARTED|Overall Study||32
9993906|NCT01676012|11115643|FG000|COMPLETED|Overall Study||29
9993907|NCT01676012|11115643|FG000|NOT COMPLETED|Overall Study||3
9993908|NCT01676116|11115649|FG000|STARTED|Overall Study||292
9993909|NCT01676116|11115650|FG001|STARTED|Overall Study||146
9993910|NCT01676116|11115649|FG000|COMPLETED|Overall Study||276
9993911|NCT01676116|11115650|FG001|COMPLETED|Overall Study||117
9993912|NCT01676116|11115649|FG000|NOT COMPLETED|Overall Study||16
9993913|NCT01676116|11115650|FG001|NOT COMPLETED|Overall Study||29
9993914|NCT01676220|11115658|FG000|STARTED|Overall Study||439
9993915|NCT01676220|11115659|FG001|STARTED|Overall Study||439
9993916|NCT01676220|11115658|FG000|Treated|Overall Study||435
9993917|NCT01676220|11115659|FG001|Treated|Overall Study||438
9993918|NCT01676220|11115658|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
9993919|NCT01676220|11115659|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
9993920|NCT01676220|11115658|FG000|COMPLETED|Overall Study||337
9993921|NCT01676220|11115659|FG001|COMPLETED|Overall Study||314
9993922|NCT01676220|11115658|FG000|NOT COMPLETED|Overall Study||102
9993923|NCT01676220|11115659|FG001|NOT COMPLETED|Overall Study||125
9993924|NCT01676298|11115675|FG000|STARTED|Overall Study||1
9993925|NCT01676298|11115676|FG001|STARTED|Overall Study||1
9993926|NCT01676298|11115677|FG002|STARTED|Overall Study||1
9993927|NCT01676298|11115678|FG003|STARTED|Overall Study||1
9993928|NCT01676298|11115679|FG004|STARTED|Overall Study||1
9993929|NCT01676298|11115680|FG005|STARTED|Overall Study||1
9993930|NCT01676298|11115681|FG006|STARTED|Overall Study||1
9993931|NCT01676298|11115682|FG007|STARTED|Overall Study||1
9993932|NCT01676298|11115675|FG000|All Genotypes Confirmed With Reference|Overall Study||1
9993933|NCT01676298|11115676|FG001|All Genotypes Confirmed With Reference|Overall Study||1
9993934|NCT01676298|11115677|FG002|All Genotypes Confirmed With Reference|Overall Study||1
9993935|NCT01676298|11115678|FG003|All Genotypes Confirmed With Reference|Overall Study||1
9993936|NCT01676298|11115679|FG004|All Genotypes Confirmed With Reference|Overall Study||1
9993937|NCT01676298|11115680|FG005|All Genotypes Confirmed With Reference|Overall Study||1
9993938|NCT01676298|11115681|FG006|All Genotypes Confirmed With Reference|Overall Study||1
9993939|NCT01676298|11115682|FG007|All Genotypes Confirmed With Reference|Overall Study||1
9993940|NCT01676298|11115675|FG000|Participated in All Tests|Overall Study||1
9993941|NCT01676298|11115676|FG001|Participated in All Tests|Overall Study||1
9993942|NCT01676298|11115677|FG002|Participated in All Tests|Overall Study||1
9993943|NCT01676298|11115678|FG003|Participated in All Tests|Overall Study||1
9993944|NCT01676298|11115679|FG004|Participated in All Tests|Overall Study||1
9993945|NCT01676298|11115680|FG005|Participated in All Tests|Overall Study||1
9993946|NCT01676298|11115681|FG006|Participated in All Tests|Overall Study||1
9993947|NCT01676298|11115682|FG007|Participated in All Tests|Overall Study||1
9993948|NCT01676298|11115675|FG000|COMPLETED|Overall Study||1
9993949|NCT01676298|11115676|FG001|COMPLETED|Overall Study||1
9993950|NCT01676298|11115677|FG002|COMPLETED|Overall Study||1
9993951|NCT01676298|11115678|FG003|COMPLETED|Overall Study||1
9993952|NCT01676298|11115679|FG004|COMPLETED|Overall Study||1
9993953|NCT01676298|11115680|FG005|COMPLETED|Overall Study||1
9993954|NCT01676298|11115681|FG006|COMPLETED|Overall Study||1
9993955|NCT01676298|11115682|FG007|COMPLETED|Overall Study||1
9993956|NCT01676298|11115675|FG000|NOT COMPLETED|Overall Study||0
9993957|NCT01676298|11115676|FG001|NOT COMPLETED|Overall Study||0
9993958|NCT01676298|11115677|FG002|NOT COMPLETED|Overall Study||0
9993959|NCT01676298|11115678|FG003|NOT COMPLETED|Overall Study||0
9993960|NCT01676298|11115679|FG004|NOT COMPLETED|Overall Study||0
9993961|NCT01676298|11115680|FG005|NOT COMPLETED|Overall Study||0
9993962|NCT01676298|11115681|FG006|NOT COMPLETED|Overall Study||0
9993963|NCT01676298|11115682|FG007|NOT COMPLETED|Overall Study||0
9993964|NCT01676311|11115702|FG000|STARTED|Overall Study||7
9993965|NCT01676311|11115703|FG001|STARTED|Overall Study||7
9993966|NCT01676311|11115702|FG000|COMPLETED|Overall Study||7
9993967|NCT01676311|11115703|FG001|COMPLETED|Overall Study||5
9993968|NCT01676311|11115702|FG000|NOT COMPLETED|Overall Study||0
9993969|NCT01676311|11115703|FG001|NOT COMPLETED|Overall Study||2
9993970|NCT01676415|11115711|FG000|STARTED|Overall Study||4
9993971|NCT01676415|11115712|FG001|STARTED|Overall Study||5
9993972|NCT01676415|11115711|FG000|COMPLETED|Overall Study||4
9993973|NCT01676415|11115712|FG001|COMPLETED|Overall Study||5
9993974|NCT01676415|11115711|FG000|NOT COMPLETED|Overall Study||0
9993975|NCT01676415|11115712|FG001|NOT COMPLETED|Overall Study||0
9993976|NCT01676532|11115718|FG000|STARTED|Overall Study||127
9993977|NCT01676532|11115718|FG000|COMPLETED|Overall Study||127
9993978|NCT01676532|11115718|FG000|NOT COMPLETED|Overall Study||0
9993979|NCT01676714|11115727|FG000|STARTED|Overall Study||10
9993980|NCT01676714|11115727|FG000|COMPLETED|Overall Study||10
9993981|NCT01676714|11115727|FG000|NOT COMPLETED|Overall Study||0
9993982|NCT01676727|11115732|FG000|STARTED|Overall Study||100
9993983|NCT01676727|11115732|FG000|Implanted|Overall Study||92
9993984|NCT01676727|11115732|FG000|COMPLETED|Overall Study||68
9993985|NCT01676727|11115732|FG000|NOT COMPLETED|Overall Study||32
9993986|NCT01676831|11115739|FG000|STARTED|Overall Study||8
9993987|NCT01676831|11115740|FG001|STARTED|Overall Study||5
9993988|NCT01676831|11115739|FG000|COMPLETED|Overall Study||8
9993989|NCT01676831|11115740|FG001|COMPLETED|Overall Study||4
9993990|NCT01676831|11115739|FG000|NOT COMPLETED|Overall Study||0
9993991|NCT01676831|11115740|FG001|NOT COMPLETED|Overall Study||1
9993992|NCT01676896|11115749|FG000|STARTED|Overall Study||96
9993993|NCT01676896|11115750|FG001|STARTED|Overall Study||96
9993994|NCT01676896|11115751|FG002|STARTED|Overall Study||100
9993995|NCT01676896|11115749|FG000|COMPLETED|Overall Study||84
9993996|NCT01676896|11115750|FG001|COMPLETED|Overall Study||89
9993997|NCT01676896|11115751|FG002|COMPLETED|Overall Study||81
9993998|NCT01676896|11115749|FG000|NOT COMPLETED|Overall Study||12
9993999|NCT01676896|11115750|FG001|NOT COMPLETED|Overall Study||7
9994000|NCT01676896|11115751|FG002|NOT COMPLETED|Overall Study||19
9994001|NCT01676909|11115761|FG000|STARTED|Overall Study||124
9994002|NCT01676909|11115762|FG001|STARTED|Overall Study||118
9994003|NCT01676909|11115761|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
9994004|NCT01676909|11115762|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
9994005|NCT01676909|11115761|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
9994006|NCT01676909|11115762|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
9994007|NCT01676909|11115761|FG000|NOT COMPLETED|Overall Study||18
9994008|NCT01676909|11115762|FG001|NOT COMPLETED|Overall Study||14
9994009|NCT01677182|11115773|FG000|STARTED|Overall Study||184
9994010|NCT01677182|11115774|FG001|STARTED|Overall Study||169
9994011|NCT01677182|11115775|FG002|STARTED|Overall Study||182
9994012|NCT01677182|11115773|FG000|COMPLETED|Overall Study||150
9994013|NCT01677182|11115774|FG001|COMPLETED|Overall Study||141
9994014|NCT01677182|11115775|FG002|COMPLETED|Overall Study||143
9994015|NCT01677182|11115773|FG000|NOT COMPLETED|Overall Study||34
9994016|NCT01677182|11115774|FG001|NOT COMPLETED|Overall Study||28
9994017|NCT01677182|11115775|FG002|NOT COMPLETED|Overall Study||39
9994018|NCT01677195|11115786|FG000|STARTED|Overall Study||71
9994019|NCT01677195|11115787|FG001|STARTED|Overall Study||83
9994020|NCT01677195|11115788|FG002|STARTED|Overall Study||80
9994021|NCT01677195|11115786|FG000|COMPLETED|Overall Study||42
9994022|NCT01677195|11115787|FG001|COMPLETED|Overall Study||51
9994023|NCT01677195|11115788|FG002|COMPLETED|Overall Study||50
9994024|NCT01677195|11115786|FG000|NOT COMPLETED|Overall Study||29
9994025|NCT01677195|11115787|FG001|NOT COMPLETED|Overall Study||32
9994026|NCT01677195|11115788|FG002|NOT COMPLETED|Overall Study||30
9994027|NCT01677286|11115796|FG000|STARTED|Overall Study||25
9994028|NCT01677286|11115796|FG000|COMPLETED|Overall Study||14
9994029|NCT01677286|11115796|FG000|NOT COMPLETED|Overall Study||11
9994030|NCT01677299|11115806|FG000|STARTED|Overall Study||6
9994031|NCT01677299|11115807|FG001|STARTED|Overall Study||6
9994032|NCT01677299|11115808|FG002|STARTED|Overall Study||6
9994033|NCT01677299|11115809|FG003|STARTED|Overall Study||6
9994034|NCT01677299|11115806|FG000|COMPLETED|Overall Study||6
9994035|NCT01677299|11115807|FG001|COMPLETED|Overall Study||3
9994036|NCT01677299|11115808|FG002|COMPLETED|Overall Study||5
9994037|NCT01677299|11115809|FG003|COMPLETED|Overall Study||5
9994038|NCT01677299|11115806|FG000|NOT COMPLETED|Overall Study||0
9994039|NCT01677299|11115807|FG001|NOT COMPLETED|Overall Study||3
9994040|NCT01677299|11115808|FG002|NOT COMPLETED|Overall Study||1
9994041|NCT01677299|11115809|FG003|NOT COMPLETED|Overall Study||1
9994042|NCT01677312|11115825|FG000|STARTED|Overall Study||36
9994043|NCT01677312|11115826|FG001|STARTED|Overall Study||36
9994044|NCT01677312|11115825|FG000|COMPLETED|Overall Study||36
9994045|NCT01677312|11115826|FG001|COMPLETED|Overall Study||36
9994046|NCT01677312|11115825|FG000|NOT COMPLETED|Overall Study||0
9994047|NCT01677312|11115826|FG001|NOT COMPLETED|Overall Study||0
9994048|NCT01677377|11115835|FG000|STARTED|Overall Study||15
9994049|NCT01677377|11115836|FG001|STARTED|Overall Study||15
9994050|NCT01677377|11115837|FG002|STARTED|Overall Study||15
9994051|NCT01677377|11115835|FG000|COMPLETED|Overall Study||14
9994052|NCT01677377|11115836|FG001|COMPLETED|Overall Study||14
9994053|NCT01677377|11115837|FG002|COMPLETED|Overall Study||9
9994054|NCT01677377|11115835|FG000|NOT COMPLETED|Overall Study||1
9994055|NCT01677377|11115836|FG001|NOT COMPLETED|Overall Study||1
9994056|NCT01677377|11115837|FG002|NOT COMPLETED|Overall Study||6
9994057|NCT01677507|11115845|FG000|STARTED|Initial Assignment||63
9994058|NCT01677507|11115846|FG001|STARTED|Initial Assignment||58
9994059|NCT01677507|11115845|FG000|COMPLETED|Initial Assignment||63
9994060|NCT01677507|11115846|FG001|COMPLETED|Initial Assignment||56
9994061|NCT01677507|11115845|FG000|NOT COMPLETED|Initial Assignment||0
9994062|NCT01677507|11115846|FG001|NOT COMPLETED|Initial Assignment||2
9994063|NCT01677507|11115845|FG000|STARTED|Second Assigment||63
9994064|NCT01677507|11115846|FG001|STARTED|Second Assigment||56
9994065|NCT01677507|11115845|FG000|COMPLETED|Second Assigment||60
9994066|NCT01677507|11115846|FG001|COMPLETED|Second Assigment||51
9994067|NCT01677507|11115845|FG000|NOT COMPLETED|Second Assigment||3
9994068|NCT01677507|11115846|FG001|NOT COMPLETED|Second Assigment||5
9994069|NCT01677624|11115854|FG000|STARTED|Overall Study||28
9994070|NCT01677624|11115854|FG000|COMPLETED|Overall Study||27
9994071|NCT01677624|11115854|FG000|NOT COMPLETED|Overall Study||1
9994072|NCT01677741|11115866|FG000|STARTED|Overall Study||3
9994073|NCT01677741|11115867|FG001|STARTED|Overall Study||10
9994074|NCT01677741|11115868|FG002|STARTED|Overall Study||8
9994075|NCT01677741|11115869|FG003|STARTED|Overall Study||6
9994076|NCT01677741|11115870|FG004|STARTED|Overall Study||17
9994077|NCT01677741|11115871|FG005|STARTED|Overall Study||28
9994078|NCT01677741|11115872|FG006|STARTED|Overall Study||11
9994079|NCT01677741|11115873|FG007|STARTED|Overall Study||2
9994080|NCT01677741|11115866|FG000|DLT Evaluable Population|Overall Study||3
9994081|NCT01677741|11115867|FG001|DLT Evaluable Population|Overall Study||10
9994082|NCT01677741|11115868|FG002|DLT Evaluable Population|Overall Study||8
9994083|NCT01677741|11115869|FG003|DLT Evaluable Population|Overall Study||6
9994084|NCT01677741|11115870|FG004|DLT Evaluable Population|Overall Study||0
9994085|NCT01677741|11115871|FG005|DLT Evaluable Population|Overall Study||0
9994086|NCT01677741|11115872|FG006|DLT Evaluable Population|Overall Study||0
9994087|NCT01677741|11115873|FG007|DLT Evaluable Population|Overall Study||0
9994088|NCT01677741|11115866|FG000|PK Population|Overall Study||3
9994089|NCT01677741|11115867|FG001|PK Population|Overall Study||10
9994090|NCT01677741|11115868|FG002|PK Population|Overall Study||8
9994091|NCT01677741|11115869|FG003|PK Population|Overall Study||6
9994092|NCT01677741|11115870|FG004|PK Population|Overall Study||17
9994093|NCT01677741|11115871|FG005|PK Population|Overall Study||28
9994094|NCT01677741|11115872|FG006|PK Population|Overall Study||11
9994095|NCT01677741|11115873|FG007|PK Population|Overall Study||2
9994096|NCT01677741|11115866|FG000|COMPLETED|Overall Study||0
9994097|NCT01677741|11115867|FG001|COMPLETED|Overall Study||0
9994098|NCT01677741|11115868|FG002|COMPLETED|Overall Study||0
9994099|NCT01677741|11115869|FG003|COMPLETED|Overall Study||0
9994100|NCT01677741|11115870|FG004|COMPLETED|Overall Study||0
9994101|NCT01677741|11115871|FG005|COMPLETED|Overall Study||0
9994102|NCT01677741|11115872|FG006|COMPLETED|Overall Study||0
9994103|NCT01677741|11115873|FG007|COMPLETED|Overall Study||0
9994104|NCT01677741|11115866|FG000|NOT COMPLETED|Overall Study||3
9994105|NCT01677741|11115867|FG001|NOT COMPLETED|Overall Study||10
9994106|NCT01677741|11115868|FG002|NOT COMPLETED|Overall Study||8
9994107|NCT01677741|11115869|FG003|NOT COMPLETED|Overall Study||6
9994108|NCT01677741|11115870|FG004|NOT COMPLETED|Overall Study||17
9994109|NCT01677741|11115871|FG005|NOT COMPLETED|Overall Study||28
9994110|NCT01677741|11115872|FG006|NOT COMPLETED|Overall Study||11
9994111|NCT01677741|11115873|FG007|NOT COMPLETED|Overall Study||2
9994112|NCT01677767|11115907|FG000|STARTED|Overall Study||124
9994113|NCT01677767|11115907|FG000|COMPLETED|Overall Study||102
9994114|NCT01677767|11115907|FG000|NOT COMPLETED|Overall Study||22
9994115|NCT01677858|11115918|FG000|STARTED|Overall Study||3
9994116|NCT01677858|11115919|FG001|STARTED|Overall Study||3
9994117|NCT01677858|11115920|FG002|STARTED|Overall Study||15
9994118|NCT01677858|11115921|FG003|STARTED|Overall Study||6
9994119|NCT01677858|11115922|FG004|STARTED|Overall Study||89
9994120|NCT01677858|11115918|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
9994121|NCT01677858|11115919|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
9994122|NCT01677858|11115920|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
9994123|NCT01677858|11115921|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
9994124|NCT01677858|11115922|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
9994125|NCT01677858|11115918|FG000|NOT COMPLETED|Overall Study||3
9994126|NCT01677858|11115919|FG001|NOT COMPLETED|Overall Study||2
9994127|NCT01677858|11115920|FG002|NOT COMPLETED|Overall Study||14
9994128|NCT01677858|11115921|FG003|NOT COMPLETED|Overall Study||6
9994129|NCT01677858|11115922|FG004|NOT COMPLETED|Overall Study||85
9994130|NCT01677910|11115942|FG000|STARTED|Double-Blind Treatment Period||45
9994131|NCT01677910|11115943|FG001|STARTED|Double-Blind Treatment Period||45
9994132|NCT01677910|11115944|FG002|STARTED|Double-Blind Treatment Period||45
9994133|NCT01677910|11115945|FG003|STARTED|Double-Blind Treatment Period||0
9994134|NCT01677910|11115942|FG000|COMPLETED|Double-Blind Treatment Period||38
9994135|NCT01677910|11115943|FG001|COMPLETED|Double-Blind Treatment Period||42
9994136|NCT01677910|11115944|FG002|COMPLETED|Double-Blind Treatment Period||38
9994137|NCT01677910|11115945|FG003|COMPLETED|Double-Blind Treatment Period||0
9994138|NCT01677910|11115942|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
9994139|NCT01677910|11115943|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
9994140|NCT01677910|11115944|FG002|NOT COMPLETED|Double-Blind Treatment Period||7
9994141|NCT01677910|11115945|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
9994142|NCT01677910|11115942|FG000|STARTED|Open-Label Extension Period (OLE)||0
9994143|NCT01677910|11115943|FG001|STARTED|Open-Label Extension Period (OLE)||0
9994144|NCT01677910|11115944|FG002|STARTED|Open-Label Extension Period (OLE)||0
9994145|NCT01677910|11115945|FG003|STARTED|Open-Label Extension Period (OLE)||115
9994146|NCT01677910|11115942|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
9994147|NCT01677910|11115943|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
9994148|NCT01677910|11115944|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
9994149|NCT01677910|11115945|FG003|COMPLETED|Open-Label Extension Period (OLE)||79
9994150|NCT01677910|11115942|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
9994151|NCT01677910|11115943|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
9994152|NCT01677910|11115944|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
9994153|NCT01677910|11115945|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36
10102444|NCT02415842|11231955|FG004|STARTED|Overall Study||30
10102445|NCT02415842|11231956|FG005|STARTED|Overall Study||30
10102446|NCT02415842|11231957|FG006|STARTED|Overall Study||30
10102447|NCT02415842|11231958|FG007|STARTED|Overall Study||26
10102448|NCT02415842|11231959|FG008|STARTED|Overall Study||29
10102449|NCT02415842|11231960|FG009|STARTED|Overall Study||53
10102450|NCT02415842|11231961|FG010|STARTED|Overall Study||49
10102451|NCT02415842|11231962|FG011|STARTED|Overall Study||33
10102452|NCT02415842|11231963|FG012|STARTED|Overall Study||20
10102453|NCT02415842|11231951|FG000|COMPLETED|Overall Study||29
10102454|NCT02415842|11231952|FG001|COMPLETED|Overall Study||29
10102455|NCT02415842|11231953|FG002|COMPLETED|Overall Study||29
9994154|NCT01677936|11115957|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
9994155|NCT01677936|11115958|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
9994156|NCT01677936|11115957|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22
9994157|NCT01677936|11115958|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15
9994158|NCT01677936|11115957|FG000|NOT COMPLETED|Overall Study||9
10102456|NCT02415842|11231954|FG003|COMPLETED|Overall Study||27
10102457|NCT02415842|11231955|FG004|COMPLETED|Overall Study||30
10102458|NCT02415842|11231956|FG005|COMPLETED|Overall Study||30
10102459|NCT02415842|11231957|FG006|COMPLETED|Overall Study||30
10102460|NCT02415842|11231958|FG007|COMPLETED|Overall Study||26
10102461|NCT02415842|11231959|FG008|COMPLETED|Overall Study||29
10102462|NCT02415842|11231960|FG009|COMPLETED|Overall Study||53
10102463|NCT02415842|11231961|FG010|COMPLETED|Overall Study||49
10102464|NCT02415842|11231962|FG011|COMPLETED|Overall Study||33
10102465|NCT02415842|11231963|FG012|COMPLETED|Overall Study||20
10102466|NCT02415842|11231951|FG000|NOT COMPLETED|Overall Study||0
10102467|NCT02415842|11231952|FG001|NOT COMPLETED|Overall Study||0
10102468|NCT02415842|11231953|FG002|NOT COMPLETED|Overall Study||0
10102469|NCT02415842|11231954|FG003|NOT COMPLETED|Overall Study||0
10102470|NCT02415842|11231955|FG004|NOT COMPLETED|Overall Study||0
10102471|NCT02415842|11231956|FG005|NOT COMPLETED|Overall Study||0
10102472|NCT02415842|11231957|FG006|NOT COMPLETED|Overall Study||0
10102473|NCT02415842|11231958|FG007|NOT COMPLETED|Overall Study||0
10102474|NCT02415842|11231959|FG008|NOT COMPLETED|Overall Study||0
10102475|NCT02415842|11231960|FG009|NOT COMPLETED|Overall Study||0
10102476|NCT02415842|11231961|FG010|NOT COMPLETED|Overall Study||0
10102477|NCT02415842|11231962|FG011|NOT COMPLETED|Overall Study||0
10102478|NCT02415842|11231963|FG012|NOT COMPLETED|Overall Study||0
10102479|NCT02415855|11232010|FG000|STARTED|Overall Study||37
10102480|NCT02415855|11232011|FG001|STARTED|Overall Study||64
10102481|NCT02415855|11232010|FG000|COMPLETED|Overall Study||34
10102482|NCT02415855|11232011|FG001|COMPLETED|Overall Study||62
10102483|NCT02415855|11232010|FG000|NOT COMPLETED|Overall Study||3
10102484|NCT02415855|11232011|FG001|NOT COMPLETED|Overall Study||2
10102485|NCT02415959|11232022|FG000|STARTED|Overall Study||14
10102486|NCT02415959|11232023|FG001|STARTED|Overall Study||14
10102487|NCT02415959|11232024|FG002|STARTED|Overall Study||14
10102488|NCT02415959|11232025|FG003|STARTED|Overall Study||14
10102489|NCT02415959|11232026|FG004|STARTED|Overall Study||14
10102490|NCT02415959|11232022|FG000|COMPLETED|Overall Study||14
10102491|NCT02415959|11232023|FG001|COMPLETED|Overall Study||13
10102492|NCT02415959|11232024|FG002|COMPLETED|Overall Study||14
10102493|NCT02415959|11232025|FG003|COMPLETED|Overall Study||13
10102494|NCT02415959|11232026|FG004|COMPLETED|Overall Study||14
9994159|NCT01677936|11115958|FG001|NOT COMPLETED|Overall Study||5
9994160|NCT01677988|11115964|FG000|STARTED|Overall Study||3
9994161|NCT01677988|11115964|FG000|COMPLETED|Overall Study||1
9994162|NCT01677988|11115964|FG000|NOT COMPLETED|Overall Study||2
9994163|NCT01678131|11115972|FG000|STARTED|Overall Study||10
9994164|NCT01678131|11115973|FG001|STARTED|Overall Study||10
9994165|NCT01678131|11115974|FG002|STARTED|Overall Study||11
9994166|NCT01678131|11115972|FG000|COMPLETED|Overall Study||10
9994167|NCT01678131|11115973|FG001|COMPLETED|Overall Study||9
9994168|NCT01678131|11115974|FG002|COMPLETED|Overall Study||9
9994169|NCT01678131|11115972|FG000|NOT COMPLETED|Overall Study||0
9994170|NCT01678131|11115973|FG001|NOT COMPLETED|Overall Study||1
9994171|NCT01678131|11115974|FG002|NOT COMPLETED|Overall Study||2
9994172|NCT01678144|11115982|FG000|STARTED|Stage 1: MAR Classic||7
9994173|NCT01678144|11115982|FG000|COMPLETED|Stage 1: MAR Classic||6
9994174|NCT01678144|11115982|FG000|NOT COMPLETED|Stage 1: MAR Classic||1
9994175|NCT01678144|11115982|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5
9994176|NCT01678144|11115982|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
9994177|NCT01678144|11115982|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
9994178|NCT01678196|11115988|FG000|STARTED|Overall Study||34
9994179|NCT01678196|11115989|FG001|STARTED|Overall Study||32
9994180|NCT01678196|11115988|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
9994181|NCT01678196|11115989|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
9994182|NCT01678196|11115988|FG000|NOT COMPLETED|Overall Study||0
9994183|NCT01678196|11115989|FG001|NOT COMPLETED|Overall Study||0
9994184|NCT01678209|11115998|FG000|STARTED|Overall Study||47
9994185|NCT01678209|11115999|FG001|STARTED|Overall Study||40
9994186|NCT01678209|11116000|FG002|STARTED|Overall Study||40
9994187|NCT01678209|11115998|FG000|COMPLETED|Overall Study||30
9994188|NCT01678209|11115999|FG001|COMPLETED|Overall Study||22
9994189|NCT01678209|11116000|FG002|COMPLETED|Overall Study||22
9994190|NCT01678209|11115998|FG000|NOT COMPLETED|Overall Study||17
9994191|NCT01678209|11115999|FG001|NOT COMPLETED|Overall Study||18
9994192|NCT01678209|11116000|FG002|NOT COMPLETED|Overall Study||18
9994193|NCT01678313|11116010|FG000|STARTED|Completed the 3-month Therapy||70
9994194|NCT01678313|11116011|FG001|STARTED|Completed the 3-month Therapy||70
9994195|NCT01678313|11116010|FG000|COMPLETED|Completed the 3-month Therapy||64
9994196|NCT01678313|11116011|FG001|COMPLETED|Completed the 3-month Therapy||58
9994197|NCT01678313|11116010|FG000|NOT COMPLETED|Completed the 3-month Therapy||6
9994198|NCT01678313|11116011|FG001|NOT COMPLETED|Completed the 3-month Therapy||12
9994199|NCT01678313|11116010|FG000|STARTED|PSA >4 ng/dL at 3 Months||64
9994200|NCT01678313|11116011|FG001|STARTED|PSA >4 ng/dL at 3 Months||58
9994201|NCT01678313|11116010|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56
9994202|NCT01678313|11116011|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49
9994203|NCT01678313|11116010|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
9994204|NCT01678313|11116011|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
9994205|NCT01678313|11116010|FG000|STARTED|Prostate Biopsy at 3 Months||56
9994206|NCT01678313|11116011|FG001|STARTED|Prostate Biopsy at 3 Months||49
9994207|NCT01678313|11116010|FG000|COMPLETED|Prostate Biopsy at 3 Months||45
9994208|NCT01678313|11116011|FG001|COMPLETED|Prostate Biopsy at 3 Months||37
9994209|NCT01678313|11116010|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11
9994210|NCT01678313|11116011|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12
9994211|NCT01678443|11116017|FG000|STARTED|Overall Study||2
9994212|NCT01678443|11116017|FG000|COMPLETED|Overall Study||2
9994213|NCT01678443|11116017|FG000|NOT COMPLETED|Overall Study||0
9994214|NCT01678560|11116023|FG000|STARTED|Overall Study||26
9994215|NCT01678560|11116024|FG001|STARTED|Overall Study||26
9994216|NCT01678560|11116023|FG000|COMPLETED|Overall Study||22
9994217|NCT01678560|11116024|FG001|COMPLETED|Overall Study||20
9994218|NCT01678560|11116023|FG000|NOT COMPLETED|Overall Study||4
9994219|NCT01678560|11116024|FG001|NOT COMPLETED|Overall Study||6
9994220|NCT01678794|11116036|FG000|STARTED|Overall Study||16
9994221|NCT01678794|11116037|FG001|STARTED|Overall Study||17
9994222|NCT01678794|11116036|FG000|COMPLETED|Overall Study||16
9994223|NCT01678794|11116037|FG001|COMPLETED|Overall Study||17
9994224|NCT01678794|11116036|FG000|NOT COMPLETED|Overall Study||0
9994225|NCT01678794|11116037|FG001|NOT COMPLETED|Overall Study||0
9994226|NCT01678807|11116046|FG000|STARTED|Overall Study||65
9994227|NCT01678807|11116047|FG001|STARTED|Overall Study||65
9994228|NCT01678807|11116048|FG002|STARTED|Overall Study||65
9994229|NCT01678807|11116046|FG000|COMPLETED|Overall Study||61
9994230|NCT01678807|11116047|FG001|COMPLETED|Overall Study||60
9994231|NCT01678807|11116048|FG002|COMPLETED|Overall Study||65
9994232|NCT01678807|11116046|FG000|NOT COMPLETED|Overall Study||4
9994233|NCT01678807|11116047|FG001|NOT COMPLETED|Overall Study||5
9994234|NCT01678807|11116048|FG002|NOT COMPLETED|Overall Study||0
9994235|NCT01678820|11116059|FG000|STARTED|Overall Study||100
9994236|NCT01678820|11116060|FG001|STARTED|Overall Study||99
9994237|NCT01678820|11116061|FG002|STARTED|Overall Study||100
9994238|NCT01678820|11116059|FG000|Treated With Double-blind Study Drug|Overall Study||100
9994239|NCT01678820|11116060|FG001|Treated With Double-blind Study Drug|Overall Study||97
9994240|NCT01678820|11116061|FG002|Treated With Double-blind Study Drug|Overall Study||98
9994241|NCT01678820|11116059|FG000|COMPLETED|Overall Study||38
9994242|NCT01678820|11116060|FG001|COMPLETED|Overall Study||36
9994243|NCT01678820|11116061|FG002|COMPLETED|Overall Study||43
9994244|NCT01678820|11116059|FG000|NOT COMPLETED|Overall Study||62
9994245|NCT01678820|11116060|FG001|NOT COMPLETED|Overall Study||63
9994246|NCT01678820|11116061|FG002|NOT COMPLETED|Overall Study||57
9994247|NCT01678846|11116072|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
9994248|NCT01678846|11116073|FG001|STARTED|Overall Study||1899
9994249|NCT01678846|11116072|FG000|COMPLETED|Overall Study||1921
9994250|NCT01678846|11116073|FG001|COMPLETED|Overall Study||1899
9994251|NCT01678846|11116072|FG000|NOT COMPLETED|Overall Study||0
9994252|NCT01678846|11116073|FG001|NOT COMPLETED|Overall Study||0
9994253|NCT01678885|11116081|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
9994254|NCT01678885|11116082|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
9994255|NCT01678885|11116083|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
9994256|NCT01678885|11116084|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
9994257|NCT01678885|11116085|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
9994258|NCT01678885|11116081|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
9994259|NCT01678885|11116082|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
9994260|NCT01678885|11116083|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
9994261|NCT01678885|11116084|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
9994262|NCT01678885|11116085|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
9994263|NCT01678885|11116081|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
9994264|NCT01678885|11116082|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
9994265|NCT01678885|11116083|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
9994266|NCT01678885|11116084|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
9994267|NCT01678885|11116085|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
9994268|NCT01678885|11116081|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0
9994269|NCT01678885|11116082|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0
9994270|NCT01678885|11116083|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0
9994271|NCT01678885|11116084|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0
9994272|NCT01678885|11116085|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87
9994273|NCT01678885|11116081|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994274|NCT01678885|11116082|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994275|NCT01678885|11116083|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994276|NCT01678885|11116084|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994277|NCT01678885|11116085|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
9994278|NCT01678885|11116081|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994279|NCT01678885|11116082|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994280|NCT01678885|11116083|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994281|NCT01678885|11116084|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
9994282|NCT01678885|11116085|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
9994283|NCT01678898|11116096|FG000|STARTED|PB-102-F01||6
9994284|NCT01678898|11116097|FG001|STARTED|PB-102-F01||8
9994285|NCT01678898|11116098|FG002|STARTED|PB-102-F01||4
9994286|NCT01678898|11116096|FG000|COMPLETED|PB-102-F01||6
9994287|NCT01678898|11116097|FG001|COMPLETED|PB-102-F01||6
9994288|NCT01678898|11116098|FG002|COMPLETED|PB-102-F01||4
9994289|NCT01678898|11116096|FG000|NOT COMPLETED|PB-102-F01||0
9994290|NCT01678898|11116097|FG001|NOT COMPLETED|PB-102-F01||2
9994291|NCT01678898|11116098|FG002|NOT COMPLETED|PB-102-F01||0
9994292|NCT01678898|11116096|FG000|STARTED|PB-102-F02||6
9994293|NCT01678898|11116097|FG001|STARTED|PB-102-F02||6
9994294|NCT01678898|11116098|FG002|STARTED|PB-102-F02||4
9994295|NCT01678898|11116096|FG000|COMPLETED|PB-102-F02||6
9994296|NCT01678898|11116097|FG001|COMPLETED|PB-102-F02||6
9994297|NCT01678898|11116098|FG002|COMPLETED|PB-102-F02||4
9994298|NCT01678898|11116096|FG000|NOT COMPLETED|PB-102-F02||0
9994299|NCT01678898|11116097|FG001|NOT COMPLETED|PB-102-F02||0
9994300|NCT01678898|11116098|FG002|NOT COMPLETED|PB-102-F02||0
9994301|NCT01678911|11116115|FG000|STARTED|First Intervention||4
9994302|NCT01678911|11116116|FG001|STARTED|First Intervention||1
9994303|NCT01678911|11116115|FG000|Cross Over|First Intervention||4
9994304|NCT01678911|11116116|FG001|Cross Over|First Intervention||1
9994305|NCT01678911|11116115|FG000|COMPLETED|First Intervention||4
9994306|NCT01678911|11116116|FG001|COMPLETED|First Intervention||1
9994307|NCT01678911|11116115|FG000|NOT COMPLETED|First Intervention||0
9994308|NCT01678911|11116116|FG001|NOT COMPLETED|First Intervention||0
9994309|NCT01678911|11116115|FG000|STARTED|Second Intervention||4
9994310|NCT01678911|11116116|FG001|STARTED|Second Intervention||1
9994311|NCT01678911|11116115|FG000|COMPLETED|Second Intervention||2
9994312|NCT01678911|11116116|FG001|COMPLETED|Second Intervention||1
9994313|NCT01678911|11116115|FG000|NOT COMPLETED|Second Intervention||2
9994314|NCT01678911|11116116|FG001|NOT COMPLETED|Second Intervention||0
9994315|NCT01678924|11116126|FG000|STARTED|Overall Study||64
9994316|NCT01678924|11116127|FG001|STARTED|Overall Study||63
9994317|NCT01678924|11116128|FG002|STARTED|Overall Study||30
9994318|NCT01678924|11116129|FG003|STARTED|Overall Study||123
9994319|NCT01678924|11116126|FG000|COMPLETED|Overall Study||54
9994320|NCT01678924|11116127|FG001|COMPLETED|Overall Study||51
9994321|NCT01678924|11116128|FG002|COMPLETED|Overall Study||28
9994322|NCT01678924|11116129|FG003|COMPLETED|Overall Study||105
9994323|NCT01678924|11116126|FG000|NOT COMPLETED|Overall Study||10
9994324|NCT01678924|11116127|FG001|NOT COMPLETED|Overall Study||12
9994325|NCT01678924|11116128|FG002|NOT COMPLETED|Overall Study||2
9994326|NCT01678924|11116129|FG003|NOT COMPLETED|Overall Study||18
9994327|NCT01678976|11116142|FG000|STARTED|First Period||6
9994328|NCT01678976|11116143|FG001|STARTED|First Period||7
9994329|NCT01678976|11116142|FG000|COMPLETED|First Period||6
9994330|NCT01678976|11116143|FG001|COMPLETED|First Period||6
9994331|NCT01678976|11116142|FG000|NOT COMPLETED|First Period||0
9994332|NCT01678976|11116143|FG001|NOT COMPLETED|First Period||1
9994333|NCT01678976|11116142|FG000|STARTED|Second Period||6
9994334|NCT01678976|11116143|FG001|STARTED|Second Period||6
9994335|NCT01678976|11116142|FG000|COMPLETED|Second Period||6
9994336|NCT01678976|11116143|FG001|COMPLETED|Second Period||6
9994337|NCT01678976|11116142|FG000|NOT COMPLETED|Second Period||0
9994338|NCT01678976|11116143|FG001|NOT COMPLETED|Second Period||0
9994339|NCT01679002|11116155|FG000|STARTED|Overall Study||4
9994340|NCT01679002|11116156|FG001|STARTED|Overall Study||4
9994341|NCT01679002|11116157|FG002|STARTED|Overall Study||4
9994342|NCT01679002|11116155|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4
9994343|NCT01679002|11116156|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3
9994344|NCT01679002|11116157|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4
10202184|NCT03441984|11329278|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202185|NCT03441984|11329279|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9994345|NCT01679002|11116155|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
9994346|NCT01679002|11116156|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
9994347|NCT01679002|11116157|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
9994348|NCT01679002|11116155|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
9994349|NCT01679002|11116156|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
9994350|NCT01679002|11116157|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
9994351|NCT01679002|11116155|FG000|COMPLETED|Overall Study||3
9994352|NCT01679002|11116156|FG001|COMPLETED|Overall Study||3
9994353|NCT01679002|11116157|FG002|COMPLETED|Overall Study||4
9994354|NCT01679002|11116155|FG000|NOT COMPLETED|Overall Study||1
9994355|NCT01679002|11116156|FG001|NOT COMPLETED|Overall Study||1
9994356|NCT01679002|11116157|FG002|NOT COMPLETED|Overall Study||0
9994357|NCT01679028|11116171|FG000|STARTED|Overall Study||2
9994358|NCT01679028|11116172|FG001|STARTED|Overall Study||4
9994359|NCT01679028|11116173|FG002|STARTED|Overall Study||2
9994360|NCT01679028|11116174|FG003|STARTED|Overall Study||4
9994361|NCT01679028|11116175|FG004|STARTED|Overall Study||2
9994362|NCT01679028|11116176|FG005|STARTED|Overall Study||6
9994363|NCT01679028|11116171|FG000|COMPLETED|Overall Study||2
9994364|NCT01679028|11116172|FG001|COMPLETED|Overall Study||4
9994365|NCT01679028|11116173|FG002|COMPLETED|Overall Study||2
9994366|NCT01679028|11116174|FG003|COMPLETED|Overall Study||4
9994367|NCT01679028|11116175|FG004|COMPLETED|Overall Study||2
9994368|NCT01679028|11116176|FG005|COMPLETED|Overall Study||6
9994369|NCT01679028|11116171|FG000|NOT COMPLETED|Overall Study||0
9994370|NCT01679028|11116172|FG001|NOT COMPLETED|Overall Study||0
9994371|NCT01679028|11116173|FG002|NOT COMPLETED|Overall Study||0
9994372|NCT01679028|11116174|FG003|NOT COMPLETED|Overall Study||0
9994373|NCT01679028|11116175|FG004|NOT COMPLETED|Overall Study||0
9994374|NCT01679028|11116176|FG005|NOT COMPLETED|Overall Study||0
9994375|NCT01679197|11116190|FG000|STARTED|Overall Study||23
9994376|NCT01679197|11116190|FG000|COMPLETED|Overall Study||19
9994377|NCT01679197|11116190|FG000|NOT COMPLETED|Overall Study||4
9994378|NCT01679236|11116202|FG000|STARTED|Overall Study||30
9994379|NCT01679236|11116203|FG001|STARTED|Overall Study||25
9994380|NCT01679236|11116202|FG000|COMPLETED|Overall Study||15
9994381|NCT01679236|11116203|FG001|COMPLETED|Overall Study||10
9994382|NCT01679236|11116202|FG000|NOT COMPLETED|Overall Study||15
9994383|NCT01679236|11116203|FG001|NOT COMPLETED|Overall Study||15
9994384|NCT01679301|11116209|FG000|STARTED|Screening Period||11
9994385|NCT01679301|11116210|FG001|STARTED|Screening Period||0
9994386|NCT01679301|11116211|FG002|STARTED|Screening Period||0
9994387|NCT01679301|11116209|FG000|COMPLETED|Screening Period||8
9994388|NCT01679301|11116210|FG001|COMPLETED|Screening Period||0
9994389|NCT01679301|11116211|FG002|COMPLETED|Screening Period||0
9994390|NCT01679301|11116209|FG000|NOT COMPLETED|Screening Period||3
9994391|NCT01679301|11116210|FG001|NOT COMPLETED|Screening Period||0
9994392|NCT01679301|11116211|FG002|NOT COMPLETED|Screening Period||0
9994393|NCT01679301|11116209|FG000|STARTED|Study Period||0
9994394|NCT01679301|11116210|FG001|STARTED|Study Period||4
9994395|NCT01679301|11116211|FG002|STARTED|Study Period||4
9994396|NCT01679301|11116209|FG000|COMPLETED|Study Period||0
9994397|NCT01679301|11116210|FG001|COMPLETED|Study Period||4
9994398|NCT01679301|11116211|FG002|COMPLETED|Study Period||4
9994399|NCT01679301|11116209|FG000|NOT COMPLETED|Study Period||0
9994400|NCT01679301|11116210|FG001|NOT COMPLETED|Study Period||0
9994401|NCT01679301|11116211|FG002|NOT COMPLETED|Study Period||0
9994402|NCT01679314|11116219|FG000|STARTED|Overall Study||26
9994403|NCT01679314|11116220|FG001|STARTED|Overall Study||28
9994404|NCT01679314|11116219|FG000|COMPLETED|Overall Study||24
10102495|NCT02415959|11232022|FG000|NOT COMPLETED|Overall Study||0
10102496|NCT02415959|11232023|FG001|NOT COMPLETED|Overall Study||1
10102497|NCT02415959|11232024|FG002|NOT COMPLETED|Overall Study||0
9994405|NCT01679314|11116220|FG001|COMPLETED|Overall Study||28
9994406|NCT01679314|11116219|FG000|NOT COMPLETED|Overall Study||2
9994407|NCT01679314|11116220|FG001|NOT COMPLETED|Overall Study||0
9994408|NCT01679405|11116232|FG000|STARTED|Overall Study||3
9994409|NCT01679405|11116233|FG001|STARTED|Overall Study||6
10102498|NCT02415959|11232025|FG003|NOT COMPLETED|Overall Study||1
9994410|NCT01679405|11116232|FG000|COMPLETED|Overall Study||1
9994411|NCT01679405|11116233|FG001|COMPLETED|Overall Study||1
9994412|NCT01679405|11116232|FG000|NOT COMPLETED|Overall Study||2
9994413|NCT01679405|11116233|FG001|NOT COMPLETED|Overall Study||5
9994414|NCT01679600|11116241|FG000|STARTED|Overall Study||7
9994415|NCT01679600|11116242|FG001|STARTED|Overall Study||7
9994416|NCT01679600|11116241|FG000|COMPLETED|Overall Study||7
9994417|NCT01679600|11116242|FG001|COMPLETED|Overall Study||7
9994418|NCT01679600|11116241|FG000|NOT COMPLETED|Overall Study||0
9994419|NCT01679600|11116242|FG001|NOT COMPLETED|Overall Study||0
9994420|NCT01679613|11116248|FG000|STARTED|Overall Study||4
9994421|NCT01679613|11116249|FG001|STARTED|Overall Study||4
9994422|NCT01679613|11116250|FG002|STARTED|Overall Study||13
9994423|NCT01679613|11116251|FG003|STARTED|Overall Study||13
9994424|NCT01679613|11116248|FG000|Received Nintedanib (Pilot)|Overall Study||4
9994425|NCT01679613|11116249|FG001|Received Nintedanib (Pilot)|Overall Study||3
9994426|NCT01679613|11116250|FG002|Received Nintedanib (Pilot)|Overall Study||0
9994427|NCT01679613|11116251|FG003|Received Nintedanib (Pilot)|Overall Study||0
9994428|NCT01679613|11116248|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
9994429|NCT01679613|11116249|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
9994430|NCT01679613|11116250|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
9994431|NCT01679613|11116251|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
9994432|NCT01679613|11116248|FG000|Received Nintedanib (Main)|Overall Study||0
9994433|NCT01679613|11116249|FG001|Received Nintedanib (Main)|Overall Study||0
9994434|NCT01679613|11116250|FG002|Received Nintedanib (Main)|Overall Study||13
9994435|NCT01679613|11116251|FG003|Received Nintedanib (Main)|Overall Study||11
9994436|NCT01679613|11116248|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
9994437|NCT01679613|11116249|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
9994438|NCT01679613|11116250|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
9994439|NCT01679613|11116251|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
9994440|NCT01679613|11116248|FG000|COMPLETED|Overall Study||4
9994441|NCT01679613|11116249|FG001|COMPLETED|Overall Study||3
9994442|NCT01679613|11116250|FG002|COMPLETED|Overall Study||11
9994443|NCT01679613|11116251|FG003|COMPLETED|Overall Study||11
9994444|NCT01679613|11116248|FG000|NOT COMPLETED|Overall Study||0
9994445|NCT01679613|11116249|FG001|NOT COMPLETED|Overall Study||1
9994446|NCT01679613|11116250|FG002|NOT COMPLETED|Overall Study||2
9994447|NCT01679613|11116251|FG003|NOT COMPLETED|Overall Study||2
9994448|NCT01680016|11116260|FG000|STARTED|Overall Study||121
9994449|NCT01680016|11116261|FG001|STARTED|Overall Study||122
9994450|NCT01680016|11116262|FG002|STARTED|Overall Study||201
9994451|NCT01680016|11116263|FG003|STARTED|Overall Study||200
9994452|NCT01680016|11116260|FG000|COMPLETED|Overall Study||115
9994453|NCT01680016|11116261|FG001|COMPLETED|Overall Study||114
9994454|NCT01680016|11116262|FG002|COMPLETED|Overall Study||196
9994455|NCT01680016|11116263|FG003|COMPLETED|Overall Study||195
9994456|NCT01680016|11116260|FG000|NOT COMPLETED|Overall Study||6
9994457|NCT01680016|11116261|FG001|NOT COMPLETED|Overall Study||8
9994458|NCT01680016|11116262|FG002|NOT COMPLETED|Overall Study||5
9994459|NCT01680016|11116263|FG003|NOT COMPLETED|Overall Study||5
9994460|NCT01680159|11116289|FG000|STARTED|Screening Period||46
9994461|NCT01680159|11116289|FG000|COMPLETED|Screening Period||39
9994462|NCT01680159|11116289|FG000|NOT COMPLETED|Screening Period||7
9994463|NCT01680159|11116289|FG000|STARTED|Increased Dose Period||51
9994464|NCT01680159|11116289|FG000|COMPLETED|Increased Dose Period||43
9994465|NCT01680159|11116289|FG000|NOT COMPLETED|Increased Dose Period||8
9994466|NCT01680172|11116311|FG000|STARTED|Overall Study||3
9994467|NCT01680172|11116312|FG001|STARTED|Overall Study||2
9994468|NCT01680172|11116311|FG000|COMPLETED|Overall Study||3
9994469|NCT01680172|11116312|FG001|COMPLETED|Overall Study||2
9994470|NCT01680172|11116311|FG000|NOT COMPLETED|Overall Study||0
9994471|NCT01680172|11116312|FG001|NOT COMPLETED|Overall Study||0
9994472|NCT01680328|11116318|FG000|STARTED|Overall Study||82
9994473|NCT01680328|11116318|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
9994474|NCT01680328|11116318|FG000|COMPLETED|Overall Study||80
9994475|NCT01680328|11116318|FG000|NOT COMPLETED|Overall Study||2
9994476|NCT01680341|11116355|FG000|STARTED|Overall Study||136
9994477|NCT01680341|11116356|FG001|STARTED|Overall Study||136
9994478|NCT01680341|11116355|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
9994479|NCT01680341|11116356|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
9994480|NCT01680341|11116355|FG000|COMPLETED|Overall Study||115
9994481|NCT01680341|11116356|FG001|COMPLETED|Overall Study||119
9994482|NCT01680341|11116355|FG000|NOT COMPLETED|Overall Study||21
9994483|NCT01680341|11116356|FG001|NOT COMPLETED|Overall Study||17
9994484|NCT01680458|11116362|FG000|STARTED|Overall Study||30
9994485|NCT01680458|11116362|FG000|COMPLETED|Overall Study||27
9994486|NCT01680458|11116362|FG000|NOT COMPLETED|Overall Study||3
9994487|NCT01680497|11116366|FG000|STARTED|Overall Study||70
9994488|NCT01680497|11116366|FG000|COMPLETED|Overall Study||68
9994489|NCT01680497|11116366|FG000|NOT COMPLETED|Overall Study||2
9994490|NCT01680549|11116372|FG000|STARTED|Overall Study||25
9994491|NCT01680549|11116373|FG001|STARTED|Overall Study||25
9994492|NCT01680549|11116372|FG000|COMPLETED|Overall Study||20
9994493|NCT01680549|11116373|FG001|COMPLETED|Overall Study||17
9994494|NCT01680549|11116372|FG000|NOT COMPLETED|Overall Study||5
9994495|NCT01680549|11116373|FG001|NOT COMPLETED|Overall Study||8
9994496|NCT01680640|11116387|FG000|STARTED|Overall Study||55
9994497|NCT01680640|11116388|FG001|STARTED|Overall Study||49
9994498|NCT01680640|11116387|FG000|COMPLETED|Overall Study||45
9994499|NCT01680640|11116388|FG001|COMPLETED|Overall Study||44
9994500|NCT01680640|11116387|FG000|NOT COMPLETED|Overall Study||10
9994501|NCT01680640|11116388|FG001|NOT COMPLETED|Overall Study||5
9994502|NCT01680653|11116394|FG000|STARTED|Overall Study||57
9994503|NCT01680653|11116394|FG000|COMPLETED|Overall Study||57
9994504|NCT01680653|11116394|FG000|NOT COMPLETED|Overall Study||0
9994505|NCT01680666|11116406|FG000|STARTED|Overall Study||84
9994506|NCT01680666|11116407|FG001|STARTED|Overall Study||66
9994507|NCT01680666|11116406|FG000|COMPLETED|Overall Study||84
9994508|NCT01680666|11116407|FG001|COMPLETED|Overall Study||66
9994509|NCT01680666|11116406|FG000|NOT COMPLETED|Overall Study||0
9994510|NCT01680666|11116407|FG001|NOT COMPLETED|Overall Study||0
9994511|NCT01680783|11116416|FG000|STARTED|Overall Study||39
9994512|NCT01680783|11116417|FG001|STARTED|Overall Study||44
9994513|NCT01680783|11116416|FG000|COMPLETED|Overall Study||39
9994514|NCT01680783|11116417|FG001|COMPLETED|Overall Study||44
9994515|NCT01680783|11116416|FG000|NOT COMPLETED|Overall Study||0
9994516|NCT01680783|11116417|FG001|NOT COMPLETED|Overall Study||0
9994517|NCT01680835|11116423|FG000|STARTED|Overall Study||108
9994518|NCT01680835|11116423|FG000|COMPLETED|Overall Study||83
9994519|NCT01680835|11116423|FG000|NOT COMPLETED|Overall Study||25
9994520|NCT01680848|11116427|FG000|STARTED|Overall Study||282
9994521|NCT01680848|11116427|FG000|COMPLETED|Overall Study||189
9994522|NCT01680848|11116427|FG000|NOT COMPLETED|Overall Study||93
9994523|NCT01680861|11116433|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
9994524|NCT01680861|11116434|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
9994525|NCT01680861|11116433|FG000|COMPLETED|Early Post-transplant Period||15
9994526|NCT01680861|11116434|FG001|COMPLETED|Early Post-transplant Period||15
9994527|NCT01680861|11116433|FG000|NOT COMPLETED|Early Post-transplant Period||1
9994528|NCT01680861|11116434|FG001|NOT COMPLETED|Early Post-transplant Period||1
9994529|NCT01680861|11116433|FG000|STARTED|First 12 Months Post-transplant||15
9994530|NCT01680861|11116434|FG001|STARTED|First 12 Months Post-transplant||15
9994531|NCT01680861|11116433|FG000|COMPLETED|First 12 Months Post-transplant||15
9994532|NCT01680861|11116434|FG001|COMPLETED|First 12 Months Post-transplant||15
9994533|NCT01680861|11116433|FG000|NOT COMPLETED|First 12 Months Post-transplant||0
9994534|NCT01680861|11116434|FG001|NOT COMPLETED|First 12 Months Post-transplant||0
9994535|NCT01680887|11116444|FG000|STARTED|Overall Study||80
9994536|NCT01680887|11116445|FG001|STARTED|Overall Study||76
9994537|NCT01680887|11116444|FG000|COMPLETED|Overall Study||51
9994538|NCT01680887|11116445|FG001|COMPLETED|Overall Study||52
9994539|NCT01680887|11116444|FG000|NOT COMPLETED|Overall Study||29
9994540|NCT01680887|11116445|FG001|NOT COMPLETED|Overall Study||24
9994541|NCT01680900|11116453|FG000|STARTED|Overall Study||24
9994542|NCT01680900|11116454|FG001|STARTED|Overall Study||12
9994543|NCT01680900|11116453|FG000|COMPLETED|Overall Study||20
9994544|NCT01680900|11116454|FG001|COMPLETED|Overall Study||11
9994545|NCT01680900|11116453|FG000|NOT COMPLETED|Overall Study||4
9994546|NCT01680900|11116454|FG001|NOT COMPLETED|Overall Study||1
9994547|NCT01680991|11116463|FG000|STARTED|Overall Study||12
9994548|NCT01680991|11116464|FG001|STARTED|Overall Study||23
9994549|NCT01680991|11116465|FG002|STARTED|Overall Study||13
9994550|NCT01680991|11116463|FG000|COMPLETED|Overall Study||4
9994551|NCT01680991|11116464|FG001|COMPLETED|Overall Study||4
9994552|NCT01680991|11116465|FG002|COMPLETED|Overall Study||9
9994553|NCT01680991|11116463|FG000|NOT COMPLETED|Overall Study||8
9994554|NCT01680991|11116464|FG001|NOT COMPLETED|Overall Study||19
9994555|NCT01680991|11116465|FG002|NOT COMPLETED|Overall Study||4
9994556|NCT01681004|11116477|FG000|STARTED|Primary Endpoint: 6 Months||102
9994557|NCT01681004|11116478|FG001|STARTED|Primary Endpoint: 6 Months||46
9994558|NCT01681004|11116477|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
9994559|NCT01681004|11116478|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
9994560|NCT01681004|11116477|FG000|COMPLETED|Primary Endpoint: 6 Months||101
9994561|NCT01681004|11116478|FG001|COMPLETED|Primary Endpoint: 6 Months||44
9994562|NCT01681004|11116477|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1
9994563|NCT01681004|11116478|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2
9994564|NCT01681004|11116477|FG000|STARTED|Study Completion||101
9994565|NCT01681004|11116478|FG001|STARTED|Study Completion||44
9994566|NCT01681004|11116477|FG000|COMPLETED|Study Completion||89
9994567|NCT01681004|11116478|FG001|COMPLETED|Study Completion||36
9994568|NCT01681004|11116477|FG000|NOT COMPLETED|Study Completion||12
9994569|NCT01681004|11116478|FG001|NOT COMPLETED|Study Completion||8
9994570|NCT01681030|11116491|FG000|STARTED|Overall Study||13
9994571|NCT01681030|11116492|FG001|STARTED|Overall Study||18
9994572|NCT01681030|11116493|FG002|STARTED|Overall Study||11
9994573|NCT01681030|11116491|FG000|COMPLETED|Overall Study||13
9994574|NCT01681030|11116492|FG001|COMPLETED|Overall Study||18
9994575|NCT01681030|11116493|FG002|COMPLETED|Overall Study||11
9994576|NCT01681030|11116491|FG000|NOT COMPLETED|Overall Study||0
9994577|NCT01681030|11116492|FG001|NOT COMPLETED|Overall Study||0
9994578|NCT01681030|11116493|FG002|NOT COMPLETED|Overall Study||0
9994579|NCT01681069|11116503|FG000|STARTED|Overall Study||60
9994580|NCT01681069|11116504|FG001|STARTED|Overall Study||60
9994581|NCT01681069|11116503|FG000|Full Analysis Set (FAS)|Overall Study||57
9994582|NCT01681069|11116504|FG001|Full Analysis Set (FAS)|Overall Study||60
9994583|NCT01681069|11116503|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
9994584|NCT01681069|11116504|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
9994585|NCT01681069|11116503|FG000|NOT COMPLETED|Overall Study||5
9994586|NCT01681069|11116504|FG001|NOT COMPLETED|Overall Study||7
9994587|NCT01681095|11116512|FG000|STARTED|Overall Study||55
9994588|NCT01681095|11116513|FG001|STARTED|Overall Study||55
9994589|NCT01681095|11116512|FG000|COMPLETED|Overall Study||55
9994590|NCT01681095|11116513|FG001|COMPLETED|Overall Study||55
9994591|NCT01681095|11116512|FG000|NOT COMPLETED|Overall Study||0
9994592|NCT01681095|11116513|FG001|NOT COMPLETED|Overall Study||0
9994593|NCT01681121|11116521|FG000|STARTED|Overall Study||44
9994594|NCT01681121|11116522|FG001|STARTED|Overall Study||49
9994595|NCT01681121|11116521|FG000|COMPLETED|Overall Study||36
9994596|NCT01681121|11116522|FG001|COMPLETED|Overall Study||38
9994597|NCT01681121|11116521|FG000|NOT COMPLETED|Overall Study||8
9994598|NCT01681121|11116522|FG001|NOT COMPLETED|Overall Study||11
9994599|NCT01681186|11116538|FG000|STARTED|First Intervention||4
9994600|NCT01681186|11116539|FG001|STARTED|First Intervention||2
9994601|NCT01681186|11116540|FG002|STARTED|First Intervention||2
9994602|NCT01681186|11116541|FG003|STARTED|First Intervention||3
9994603|NCT01681186|11116542|FG004|STARTED|First Intervention||3
9994604|NCT01681186|11116543|FG005|STARTED|First Intervention||2
9994605|NCT01681186|11116544|FG006|STARTED|First Intervention||7
9994606|NCT01681186|11116545|FG007|STARTED|First Intervention||7
9994607|NCT01681186|11116538|FG000|COMPLETED|First Intervention||4
9994608|NCT01681186|11116539|FG001|COMPLETED|First Intervention||2
9994609|NCT01681186|11116540|FG002|COMPLETED|First Intervention||2
9994610|NCT01681186|11116541|FG003|COMPLETED|First Intervention||3
9994611|NCT01681186|11116542|FG004|COMPLETED|First Intervention||3
9994612|NCT01681186|11116543|FG005|COMPLETED|First Intervention||2
9994613|NCT01681186|11116544|FG006|COMPLETED|First Intervention||7
9994614|NCT01681186|11116545|FG007|COMPLETED|First Intervention||7
9994615|NCT01681186|11116538|FG000|NOT COMPLETED|First Intervention||0
9994616|NCT01681186|11116539|FG001|NOT COMPLETED|First Intervention||0
9994617|NCT01681186|11116540|FG002|NOT COMPLETED|First Intervention||0
9994618|NCT01681186|11116541|FG003|NOT COMPLETED|First Intervention||0
9994619|NCT01681186|11116542|FG004|NOT COMPLETED|First Intervention||0
9994620|NCT01681186|11116543|FG005|NOT COMPLETED|First Intervention||0
9994621|NCT01681186|11116544|FG006|NOT COMPLETED|First Intervention||0
9994622|NCT01681186|11116545|FG007|NOT COMPLETED|First Intervention||0
9994623|NCT01681186|11116538|FG000|STARTED|Washout Period From First Intervention||4
9994624|NCT01681186|11116539|FG001|STARTED|Washout Period From First Intervention||2
9994625|NCT01681186|11116540|FG002|STARTED|Washout Period From First Intervention||2
9994626|NCT01681186|11116541|FG003|STARTED|Washout Period From First Intervention||3
9994627|NCT01681186|11116542|FG004|STARTED|Washout Period From First Intervention||3
9994628|NCT01681186|11116543|FG005|STARTED|Washout Period From First Intervention||2
9994629|NCT01681186|11116544|FG006|STARTED|Washout Period From First Intervention||7
9994630|NCT01681186|11116545|FG007|STARTED|Washout Period From First Intervention||7
9994631|NCT01681186|11116538|FG000|COMPLETED|Washout Period From First Intervention||4
9994632|NCT01681186|11116539|FG001|COMPLETED|Washout Period From First Intervention||2
9994633|NCT01681186|11116540|FG002|COMPLETED|Washout Period From First Intervention||2
9994634|NCT01681186|11116541|FG003|COMPLETED|Washout Period From First Intervention||3
9994635|NCT01681186|11116542|FG004|COMPLETED|Washout Period From First Intervention||3
9994636|NCT01681186|11116543|FG005|COMPLETED|Washout Period From First Intervention||2
9994637|NCT01681186|11116544|FG006|COMPLETED|Washout Period From First Intervention||7
9994638|NCT01681186|11116545|FG007|COMPLETED|Washout Period From First Intervention||7
9994639|NCT01681186|11116538|FG000|NOT COMPLETED|Washout Period From First Intervention||0
9994640|NCT01681186|11116539|FG001|NOT COMPLETED|Washout Period From First Intervention||0
9994641|NCT01681186|11116540|FG002|NOT COMPLETED|Washout Period From First Intervention||0
9994642|NCT01681186|11116541|FG003|NOT COMPLETED|Washout Period From First Intervention||0
9994643|NCT01681186|11116542|FG004|NOT COMPLETED|Washout Period From First Intervention||0
9994644|NCT01681186|11116543|FG005|NOT COMPLETED|Washout Period From First Intervention||0
9994645|NCT01681186|11116544|FG006|NOT COMPLETED|Washout Period From First Intervention||0
9994646|NCT01681186|11116545|FG007|NOT COMPLETED|Washout Period From First Intervention||0
9994647|NCT01681186|11116538|FG000|STARTED|Second Intervention||4
9994648|NCT01681186|11116539|FG001|STARTED|Second Intervention||2
9994649|NCT01681186|11116540|FG002|STARTED|Second Intervention||2
9994650|NCT01681186|11116541|FG003|STARTED|Second Intervention||3
9994651|NCT01681186|11116542|FG004|STARTED|Second Intervention||3
9994652|NCT01681186|11116543|FG005|STARTED|Second Intervention||2
9994653|NCT01681186|11116544|FG006|STARTED|Second Intervention||7
9994654|NCT01681186|11116545|FG007|STARTED|Second Intervention||7
9994655|NCT01681186|11116538|FG000|COMPLETED|Second Intervention||4
9994656|NCT01681186|11116539|FG001|COMPLETED|Second Intervention||2
9994657|NCT01681186|11116540|FG002|COMPLETED|Second Intervention||2
9994658|NCT01681186|11116541|FG003|COMPLETED|Second Intervention||3
9994659|NCT01681186|11116542|FG004|COMPLETED|Second Intervention||3
9994660|NCT01681186|11116543|FG005|COMPLETED|Second Intervention||2
9994661|NCT01681186|11116544|FG006|COMPLETED|Second Intervention||7
9994662|NCT01681186|11116545|FG007|COMPLETED|Second Intervention||7
9994663|NCT01681186|11116538|FG000|NOT COMPLETED|Second Intervention||0
9994664|NCT01681186|11116539|FG001|NOT COMPLETED|Second Intervention||0
10102499|NCT02415959|11232026|FG004|NOT COMPLETED|Overall Study||0
10102500|NCT02415998|11232038|FG000|STARTED|Overall Study||25
9994665|NCT01681186|11116540|FG002|NOT COMPLETED|Second Intervention||0
9994666|NCT01681186|11116541|FG003|NOT COMPLETED|Second Intervention||0
9994667|NCT01681186|11116542|FG004|NOT COMPLETED|Second Intervention||0
9994668|NCT01681186|11116543|FG005|NOT COMPLETED|Second Intervention||0
9994669|NCT01681186|11116544|FG006|NOT COMPLETED|Second Intervention||0
9994670|NCT01681186|11116545|FG007|NOT COMPLETED|Second Intervention||0
9994671|NCT01681186|11116538|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
9994672|NCT01681186|11116539|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
9994673|NCT01681186|11116540|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
9994674|NCT01681186|11116541|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
9994675|NCT01681186|11116542|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
9994676|NCT01681186|11116543|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
9994677|NCT01681186|11116544|FG006|STARTED|Washout Period From Second Intervention||7
9994678|NCT01681186|11116545|FG007|STARTED|Washout Period From Second Intervention||7
9994679|NCT01681186|11116538|FG000|COMPLETED|Washout Period From Second Intervention||0
9994680|NCT01681186|11116539|FG001|COMPLETED|Washout Period From Second Intervention||0
9994681|NCT01681186|11116540|FG002|COMPLETED|Washout Period From Second Intervention||0
9994682|NCT01681186|11116541|FG003|COMPLETED|Washout Period From Second Intervention||0
9994683|NCT01681186|11116542|FG004|COMPLETED|Washout Period From Second Intervention||0
9994684|NCT01681186|11116543|FG005|COMPLETED|Washout Period From Second Intervention||0
9994685|NCT01681186|11116544|FG006|COMPLETED|Washout Period From Second Intervention||6
9994686|NCT01681186|11116545|FG007|COMPLETED|Washout Period From Second Intervention||6
9994687|NCT01681186|11116538|FG000|NOT COMPLETED|Washout Period From Second Intervention||0
9994688|NCT01681186|11116539|FG001|NOT COMPLETED|Washout Period From Second Intervention||0
9994689|NCT01681186|11116540|FG002|NOT COMPLETED|Washout Period From Second Intervention||0
9994690|NCT01681186|11116541|FG003|NOT COMPLETED|Washout Period From Second Intervention||0
9994691|NCT01681186|11116542|FG004|NOT COMPLETED|Washout Period From Second Intervention||0
9994692|NCT01681186|11116543|FG005|NOT COMPLETED|Washout Period From Second Intervention||0
9994693|NCT01681186|11116544|FG006|NOT COMPLETED|Washout Period From Second Intervention||1
9994694|NCT01681186|11116545|FG007|NOT COMPLETED|Washout Period From Second Intervention||1
9994695|NCT01681186|11116538|FG000|STARTED|Third Intervention||0
9994696|NCT01681186|11116539|FG001|STARTED|Third Intervention||0
9994697|NCT01681186|11116540|FG002|STARTED|Third Intervention||0
9994698|NCT01681186|11116541|FG003|STARTED|Third Intervention||0
9994699|NCT01681186|11116542|FG004|STARTED|Third Intervention||0
9994700|NCT01681186|11116543|FG005|STARTED|Third Intervention||0
9994701|NCT01681186|11116544|FG006|STARTED|Third Intervention||6
9994702|NCT01681186|11116545|FG007|STARTED|Third Intervention||6
9994703|NCT01681186|11116538|FG000|COMPLETED|Third Intervention||0
9994704|NCT01681186|11116539|FG001|COMPLETED|Third Intervention||0
9994705|NCT01681186|11116540|FG002|COMPLETED|Third Intervention||0
9994706|NCT01681186|11116541|FG003|COMPLETED|Third Intervention||0
9994707|NCT01681186|11116542|FG004|COMPLETED|Third Intervention||0
9994708|NCT01681186|11116543|FG005|COMPLETED|Third Intervention||0
9994709|NCT01681186|11116544|FG006|COMPLETED|Third Intervention||6
9994710|NCT01681186|11116545|FG007|COMPLETED|Third Intervention||6
9994711|NCT01681186|11116538|FG000|NOT COMPLETED|Third Intervention||0
9994712|NCT01681186|11116539|FG001|NOT COMPLETED|Third Intervention||0
9994713|NCT01681186|11116540|FG002|NOT COMPLETED|Third Intervention||0
9994714|NCT01681186|11116541|FG003|NOT COMPLETED|Third Intervention||0
9994715|NCT01681186|11116542|FG004|NOT COMPLETED|Third Intervention||0
9994716|NCT01681186|11116543|FG005|NOT COMPLETED|Third Intervention||0
9994717|NCT01681186|11116544|FG006|NOT COMPLETED|Third Intervention||0
9994718|NCT01681186|11116545|FG007|NOT COMPLETED|Third Intervention||0
9994719|NCT01681186|11116538|FG000|STARTED|Washout Period From Third Intervention||0
9994720|NCT01681186|11116539|FG001|STARTED|Washout Period From Third Intervention||0
9994721|NCT01681186|11116540|FG002|STARTED|Washout Period From Third Intervention||0
9994722|NCT01681186|11116541|FG003|STARTED|Washout Period From Third Intervention||0
9994723|NCT01681186|11116542|FG004|STARTED|Washout Period From Third Intervention||0
9994724|NCT01681186|11116543|FG005|STARTED|Washout Period From Third Intervention||0
9994725|NCT01681186|11116544|FG006|STARTED|Washout Period From Third Intervention||6
9994726|NCT01681186|11116545|FG007|STARTED|Washout Period From Third Intervention||6
9994727|NCT01681186|11116538|FG000|COMPLETED|Washout Period From Third Intervention||0
9994728|NCT01681186|11116539|FG001|COMPLETED|Washout Period From Third Intervention||0
9994729|NCT01681186|11116540|FG002|COMPLETED|Washout Period From Third Intervention||0
9994730|NCT01681186|11116541|FG003|COMPLETED|Washout Period From Third Intervention||0
9994731|NCT01681186|11116542|FG004|COMPLETED|Washout Period From Third Intervention||0
9994732|NCT01681186|11116543|FG005|COMPLETED|Washout Period From Third Intervention||0
9994733|NCT01681186|11116544|FG006|COMPLETED|Washout Period From Third Intervention||5
9994734|NCT01681186|11116545|FG007|COMPLETED|Washout Period From Third Intervention||6
9994735|NCT01681186|11116538|FG000|NOT COMPLETED|Washout Period From Third Intervention||0
10102501|NCT02415998|11232038|FG000|COMPLETED|Overall Study||20
9994736|NCT01681186|11116539|FG001|NOT COMPLETED|Washout Period From Third Intervention||0
9994737|NCT01681186|11116540|FG002|NOT COMPLETED|Washout Period From Third Intervention||0
9994738|NCT01681186|11116541|FG003|NOT COMPLETED|Washout Period From Third Intervention||0
9994739|NCT01681186|11116542|FG004|NOT COMPLETED|Washout Period From Third Intervention||0
9994740|NCT01681186|11116543|FG005|NOT COMPLETED|Washout Period From Third Intervention||0
9994741|NCT01681186|11116544|FG006|NOT COMPLETED|Washout Period From Third Intervention||1
9994742|NCT01681186|11116545|FG007|NOT COMPLETED|Washout Period From Third Intervention||0
9994743|NCT01681186|11116538|FG000|STARTED|Fourth Intervention||0
9994744|NCT01681186|11116539|FG001|STARTED|Fourth Intervention||0
9994745|NCT01681186|11116540|FG002|STARTED|Fourth Intervention||0
9994746|NCT01681186|11116541|FG003|STARTED|Fourth Intervention||0
9994747|NCT01681186|11116542|FG004|STARTED|Fourth Intervention||0
9994748|NCT01681186|11116543|FG005|STARTED|Fourth Intervention||0
9994749|NCT01681186|11116544|FG006|STARTED|Fourth Intervention||5
9994750|NCT01681186|11116545|FG007|STARTED|Fourth Intervention||6
9994751|NCT01681186|11116538|FG000|COMPLETED|Fourth Intervention||0
9994752|NCT01681186|11116539|FG001|COMPLETED|Fourth Intervention||0
9994753|NCT01681186|11116540|FG002|COMPLETED|Fourth Intervention||0
9994754|NCT01681186|11116541|FG003|COMPLETED|Fourth Intervention||0
9994755|NCT01681186|11116542|FG004|COMPLETED|Fourth Intervention||0
9994756|NCT01681186|11116543|FG005|COMPLETED|Fourth Intervention||0
9994757|NCT01681186|11116544|FG006|COMPLETED|Fourth Intervention||5
9994758|NCT01681186|11116545|FG007|COMPLETED|Fourth Intervention||5
9994759|NCT01681186|11116538|FG000|NOT COMPLETED|Fourth Intervention||0
9994760|NCT01681186|11116539|FG001|NOT COMPLETED|Fourth Intervention||0
9994761|NCT01681186|11116540|FG002|NOT COMPLETED|Fourth Intervention||0
9994762|NCT01681186|11116541|FG003|NOT COMPLETED|Fourth Intervention||0
9994763|NCT01681186|11116542|FG004|NOT COMPLETED|Fourth Intervention||0
9994764|NCT01681186|11116543|FG005|NOT COMPLETED|Fourth Intervention||0
9994765|NCT01681186|11116544|FG006|NOT COMPLETED|Fourth Intervention||0
9994766|NCT01681186|11116545|FG007|NOT COMPLETED|Fourth Intervention||1
9994767|NCT01681212|11116575|FG000|STARTED|Overall Study|Enrolled|21
9994768|NCT01681212|11116575|FG000|Received Treatment|Overall Study||15
9994769|NCT01681212|11116575|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
9994770|NCT01681212|11116575|FG000|NOT COMPLETED|Overall Study||6
9994771|NCT01681277|11116584|FG000|STARTED|Overall Study||12
9994772|NCT01681277|11116585|FG001|STARTED|Overall Study||9
9994773|NCT01681277|11116586|FG002|STARTED|Overall Study||9
9994774|NCT01681277|11116587|FG003|STARTED|Overall Study||9
9994775|NCT01681277|11116588|FG004|STARTED|Overall Study||9
9994776|NCT01681277|11116584|FG000|COMPLETED|Overall Study||11
9994777|NCT01681277|11116585|FG001|COMPLETED|Overall Study||9
9994778|NCT01681277|11116586|FG002|COMPLETED|Overall Study||9
9994779|NCT01681277|11116587|FG003|COMPLETED|Overall Study||9
9994780|NCT01681277|11116588|FG004|COMPLETED|Overall Study||9
9994781|NCT01681277|11116584|FG000|NOT COMPLETED|Overall Study||1
9994782|NCT01681277|11116585|FG001|NOT COMPLETED|Overall Study||0
9994783|NCT01681277|11116586|FG002|NOT COMPLETED|Overall Study||0
9994784|NCT01681277|11116587|FG003|NOT COMPLETED|Overall Study||0
9994785|NCT01681277|11116588|FG004|NOT COMPLETED|Overall Study||0
9994786|NCT01681368|11116604|FG000|STARTED|Overall Study||11
9994787|NCT01681368|11116604|FG000|COMPLETED|Overall Study||9
9994788|NCT01681368|11116604|FG000|NOT COMPLETED|Overall Study||2
9994789|NCT01681433|11116610|FG000|STARTED|Overall Study||36
9994790|NCT01681433|11116611|FG001|STARTED|Overall Study||36
9994791|NCT01681433|11116610|FG000|COMPLETED|Overall Study||4
9994792|NCT01681433|11116611|FG001|COMPLETED|Overall Study||3
9994793|NCT01681433|11116610|FG000|NOT COMPLETED|Overall Study||32
9994794|NCT01681433|11116611|FG001|NOT COMPLETED|Overall Study||33
9994795|NCT01681472|11116621|FG000|STARTED|Overall Study||8
9994796|NCT01681472|11116622|FG001|STARTED|Overall Study||8
9994797|NCT01681472|11116623|FG002|STARTED|Overall Study||8
9994798|NCT01681472|11116624|FG003|STARTED|Overall Study||8
9994799|NCT01681472|11116621|FG000|COMPLETED|Overall Study||8
9994800|NCT01681472|11116622|FG001|COMPLETED|Overall Study||7
9994801|NCT01681472|11116623|FG002|COMPLETED|Overall Study||8
9994802|NCT01681472|11116624|FG003|COMPLETED|Overall Study||8
9994803|NCT01681472|11116621|FG000|NOT COMPLETED|Overall Study||0
9994804|NCT01681472|11116622|FG001|NOT COMPLETED|Overall Study||1
9994805|NCT01681472|11116623|FG002|NOT COMPLETED|Overall Study||0
9994806|NCT01681472|11116624|FG003|NOT COMPLETED|Overall Study||0
9994807|NCT01681511|11116645|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
9994808|NCT01681511|11116646|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
9994809|NCT01681511|11116645|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
9994810|NCT01681511|11116646|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
9994811|NCT01681511|11116645|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
9994812|NCT01681511|11116646|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
9994813|NCT01681511|11116645|FG000|COMPLETED|Overall Study||28
9994814|NCT01681511|11116646|FG001|COMPLETED|Overall Study||35
9994815|NCT01681511|11116645|FG000|NOT COMPLETED|Overall Study||18
9994816|NCT01681511|11116646|FG001|NOT COMPLETED|Overall Study||14
9994817|NCT01681576|11116654|FG000|STARTED|Period 1||36
9994818|NCT01681576|11116655|FG001|STARTED|Period 1||36
9994819|NCT01681576|11116654|FG000|COMPLETED|Period 1||34
9994820|NCT01681576|11116655|FG001|COMPLETED|Period 1||36
9994821|NCT01681576|11116654|FG000|NOT COMPLETED|Period 1||2
9994822|NCT01681576|11116655|FG001|NOT COMPLETED|Period 1||0
9994823|NCT01681576|11116654|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34
9994824|NCT01681576|11116655|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36
9994825|NCT01681576|11116654|FG000|COMPLETED|Period 2||30
9994826|NCT01681576|11116655|FG001|COMPLETED|Period 2||35
9994827|NCT01681576|11116654|FG000|NOT COMPLETED|Period 2||4
9994828|NCT01681576|11116655|FG001|NOT COMPLETED|Period 2||1
9994829|NCT01681628|11116665|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
9994830|NCT01681628|11116666|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
9994831|NCT01681628|11116665|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
9994832|NCT01681628|11116666|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
9994833|NCT01681628|11116665|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
9994834|NCT01681628|11116666|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
9994835|NCT01681628|11116665|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
9994836|NCT01681628|11116666|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122
9994837|NCT01681628|11116665|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
9994838|NCT01681628|11116666|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107
9994839|NCT01681628|11116665|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
9994840|NCT01681628|11116666|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
9994841|NCT01681628|11116665|FG000|STARTED|19 Months Follow-up||114
9994842|NCT01681628|11116666|FG001|STARTED|19 Months Follow-up||107
9994843|NCT01681628|11116665|FG000|COMPLETED|19 Months Follow-up||52
9994844|NCT01681628|11116666|FG001|COMPLETED|19 Months Follow-up||64
9994845|NCT01681628|11116665|FG000|NOT COMPLETED|19 Months Follow-up||62
9994846|NCT01681628|11116666|FG001|NOT COMPLETED|19 Months Follow-up||43
9994847|NCT01681771|11116677|FG000|STARTED|Overall Study||25
9994848|NCT01681771|11116678|FG001|STARTED|Overall Study||25
9994849|NCT01681771|11116677|FG000|COMPLETED|Overall Study||21
9994850|NCT01681771|11116678|FG001|COMPLETED|Overall Study||23
9994851|NCT01681771|11116677|FG000|NOT COMPLETED|Overall Study||4
9994852|NCT01681771|11116678|FG001|NOT COMPLETED|Overall Study||2
9994853|NCT01681810|11116684|FG000|STARTED|Overall Study||20
9994854|NCT01681810|11116684|FG000|COMPLETED|Overall Study||20
9994855|NCT01681810|11116684|FG000|NOT COMPLETED|Overall Study||0
9994856|NCT01681836|11116688|FG000|STARTED|First Intervention||6
9994857|NCT01681836|11116689|FG001|STARTED|First Intervention||5
9994858|NCT01681836|11116688|FG000|COMPLETED|First Intervention||6
9994859|NCT01681836|11116689|FG001|COMPLETED|First Intervention||5
9994860|NCT01681836|11116688|FG000|NOT COMPLETED|First Intervention||0
9994861|NCT01681836|11116689|FG001|NOT COMPLETED|First Intervention||0
9994862|NCT01681836|11116688|FG000|STARTED|Washout Period of 3-7 Days||6
9994863|NCT01681836|11116689|FG001|STARTED|Washout Period of 3-7 Days||5
9994864|NCT01681836|11116688|FG000|COMPLETED|Washout Period of 3-7 Days||6
9994865|NCT01681836|11116689|FG001|COMPLETED|Washout Period of 3-7 Days||5
9994866|NCT01681836|11116688|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0
9994867|NCT01681836|11116689|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0
9994868|NCT01681836|11116688|FG000|STARTED|Second Intervention||6
9994869|NCT01681836|11116689|FG001|STARTED|Second Intervention||5
9994870|NCT01681836|11116688|FG000|COMPLETED|Second Intervention||6
9994871|NCT01681836|11116689|FG001|COMPLETED|Second Intervention||4
9994872|NCT01681836|11116688|FG000|NOT COMPLETED|Second Intervention||0
9994873|NCT01681836|11116689|FG001|NOT COMPLETED|Second Intervention||1
9994874|NCT01681849|11116698|FG000|STARTED|Overall Study||15
9994875|NCT01681849|11116699|FG001|STARTED|Overall Study||13
9994876|NCT01681849|11116700|FG002|STARTED|Overall Study||56
9994877|NCT01681849|11116698|FG000|COMPLETED|Overall Study||7
9994878|NCT01681849|11116699|FG001|COMPLETED|Overall Study||6
9994879|NCT01681849|11116700|FG002|COMPLETED|Overall Study||17
9994880|NCT01681849|11116698|FG000|NOT COMPLETED|Overall Study||8
9994881|NCT01681849|11116699|FG001|NOT COMPLETED|Overall Study||7
9994882|NCT01681849|11116700|FG002|NOT COMPLETED|Overall Study||39
9994883|NCT01681992|11116710|FG000|STARTED|Overall Study||1493
9994884|NCT01681992|11116711|FG001|STARTED|Overall Study||1497
9994885|NCT01681992|11116712|FG002|STARTED|Overall Study||1526
9994886|NCT01681992|11116710|FG000|COMPLETED|Overall Study||1427
9994887|NCT01681992|11116711|FG001|COMPLETED|Overall Study||1427
9994888|NCT01681992|11116712|FG002|COMPLETED|Overall Study||1443
9994889|NCT01681992|11116710|FG000|NOT COMPLETED|Overall Study||66
9994890|NCT01681992|11116711|FG001|NOT COMPLETED|Overall Study||70
9994891|NCT01681992|11116712|FG002|NOT COMPLETED|Overall Study||83
9994892|NCT01682031|11116722|FG000|STARTED|Overall Study||8
9994893|NCT01682031|11116723|FG001|STARTED|Overall Study||10
9994894|NCT01682031|11116722|FG000|COMPLETED|Overall Study||7
9994895|NCT01682031|11116723|FG001|COMPLETED|Overall Study||5
9994896|NCT01682031|11116722|FG000|NOT COMPLETED|Overall Study||1
9994897|NCT01682031|11116723|FG001|NOT COMPLETED|Overall Study||5
9994898|NCT01682044|11116729|FG000|STARTED|Overall Study||20
9994899|NCT01682044|11116729|FG000|COMPLETED|Overall Study||16
9994900|NCT01682044|11116729|FG000|NOT COMPLETED|Overall Study||4
9994901|NCT01682083|11116735|FG000|STARTED|Overall Study||438
9994902|NCT01682083|11116736|FG001|STARTED|Overall Study||432
9994903|NCT01682083|11116735|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
9994904|NCT01682083|11116736|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
9994905|NCT01682083|11116735|FG000|NOT COMPLETED|Overall Study||107
9994906|NCT01682083|11116736|FG001|NOT COMPLETED|Overall Study||155
9994907|NCT01682135|11116745|FG000|STARTED|Overall Study||6
9994908|NCT01682135|11116746|FG001|STARTED|Overall Study||10
9994909|NCT01682135|11116747|FG002|STARTED|Overall Study||12
9994910|NCT01682135|11116745|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9994911|NCT01682135|11116746|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
9994912|NCT01682135|11116747|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
9994913|NCT01682135|11116745|FG000|COMPLETED|Overall Study||6
9994914|NCT01682135|11116746|FG001|COMPLETED|Overall Study||10
9994915|NCT01682135|11116747|FG002|COMPLETED|Overall Study||12
9994916|NCT01682135|11116745|FG000|NOT COMPLETED|Overall Study||0
9994917|NCT01682135|11116746|FG001|NOT COMPLETED|Overall Study||0
9994918|NCT01682135|11116747|FG002|NOT COMPLETED|Overall Study||0
10018440|NCT01823835|11141519|FG004|NOT COMPLETED|Overall Study||6
10018441|NCT01823835|11141520|FG005|NOT COMPLETED|Overall Study||6
10018442|NCT01823835|11141521|FG006|NOT COMPLETED|Overall Study||6
10018443|NCT01823835|11141522|FG007|NOT COMPLETED|Overall Study||3
10018444|NCT01823835|11141523|FG008|NOT COMPLETED|Overall Study||3
10018445|NCT01823835|11141524|FG009|NOT COMPLETED|Overall Study||19
10018446|NCT01823835|11141525|FG010|NOT COMPLETED|Overall Study||10
10018447|NCT01823835|11141526|FG011|NOT COMPLETED|Overall Study||53
10018448|NCT01823835|11141527|FG012|NOT COMPLETED|Overall Study||19
10018449|NCT01823835|11141528|FG013|NOT COMPLETED|Overall Study||4
10018450|NCT01823835|11141529|FG014|NOT COMPLETED|Overall Study||6
10018451|NCT01823861|11141571|FG000|STARTED|4 Month Follow up||249
10018452|NCT01823861|11141572|FG001|STARTED|4 Month Follow up||251
10018453|NCT01823861|11141571|FG000|COMPLETED|4 Month Follow up||211
10018454|NCT01823861|11141572|FG001|COMPLETED|4 Month Follow up||220
10018455|NCT01823861|11141571|FG000|NOT COMPLETED|4 Month Follow up||38
10018456|NCT01823861|11141572|FG001|NOT COMPLETED|4 Month Follow up||31
10018457|NCT01823861|11141571|FG000|STARTED|12 Month Follow up||211
10018458|NCT01823861|11141572|FG001|STARTED|12 Month Follow up||220
10018459|NCT01823861|11141571|FG000|COMPLETED|12 Month Follow up||169
10018460|NCT01823861|11141572|FG001|COMPLETED|12 Month Follow up||159
10018461|NCT01823861|11141571|FG000|NOT COMPLETED|12 Month Follow up||42
10018462|NCT01823861|11141572|FG001|NOT COMPLETED|12 Month Follow up||61
10018463|NCT01823991|11141580|FG000|STARTED|Overall Study||18
10018464|NCT01823991|11141581|FG001|STARTED|Overall Study||18
10018465|NCT01823991|11141580|FG000|COMPLETED|Overall Study||10
10018466|NCT01823991|11141581|FG001|COMPLETED|Overall Study||13
10018467|NCT01823991|11141580|FG000|NOT COMPLETED|Overall Study||8
10018468|NCT01823991|11141581|FG001|NOT COMPLETED|Overall Study||5
10018469|NCT01824082|11141593|FG000|STARTED|Initial Treatment||71
10018470|NCT01824082|11141594|FG001|STARTED|Initial Treatment||73
10018471|NCT01824082|11141593|FG000|COMPLETED|Initial Treatment||71
10018472|NCT01824082|11141594|FG001|COMPLETED|Initial Treatment||73
10018473|NCT01824082|11141593|FG000|NOT COMPLETED|Initial Treatment||0
10018474|NCT01824082|11141594|FG001|NOT COMPLETED|Initial Treatment||0
10018475|NCT01824082|11141593|FG000|STARTED|Optional Crossover Treatment||40
10018476|NCT01824082|11141594|FG001|STARTED|Optional Crossover Treatment||25
10018477|NCT01824082|11141593|FG000|COMPLETED|Optional Crossover Treatment||40
10018478|NCT01824082|11141594|FG001|COMPLETED|Optional Crossover Treatment||25
10018479|NCT01824082|11141593|FG000|NOT COMPLETED|Optional Crossover Treatment||0
10018480|NCT01824082|11141594|FG001|NOT COMPLETED|Optional Crossover Treatment||0
10018481|NCT01824160|11141604|FG000|STARTED|Overall Study||50
10018482|NCT01824160|11141604|FG000|COMPLETED|Overall Study||50
10018483|NCT01824160|11141604|FG000|NOT COMPLETED|Overall Study||0
10018484|NCT01824290|11141610|FG000|STARTED|Period 1: Double Blind||18
10018485|NCT01824290|11141611|FG001|STARTED|Period 1: Double Blind||17
10018486|NCT01824290|11141612|FG002|STARTED|Period 1: Double Blind||0
10018487|NCT01824290|11141613|FG003|STARTED|Period 1: Double Blind||0
10018488|NCT01824290|11141610|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18
10018489|NCT01824290|11141611|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17
10018490|NCT01824290|11141612|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
10018491|NCT01824290|11141613|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
10018492|NCT01824290|11141610|FG000|Received 20 mg|Period 1: Double Blind||0
10018493|NCT01824290|11141611|FG001|Received 20 mg|Period 1: Double Blind||4
10018494|NCT01824290|11141612|FG002|Received 20 mg|Period 1: Double Blind||0
10018495|NCT01824290|11141613|FG003|Received 20 mg|Period 1: Double Blind||0
10018496|NCT01824290|11141610|FG000|Received 40 mg|Period 1: Double Blind||0
10018497|NCT01824290|11141611|FG001|Received 40 mg|Period 1: Double Blind||13
10018498|NCT01824290|11141612|FG002|Received 40 mg|Period 1: Double Blind||0
10018499|NCT01824290|11141613|FG003|Received 40 mg|Period 1: Double Blind||0
10018500|NCT01824290|11141610|FG000|COMPLETED|Period 1: Double Blind||15
10018501|NCT01824290|11141611|FG001|COMPLETED|Period 1: Double Blind||15
10018502|NCT01824290|11141612|FG002|COMPLETED|Period 1: Double Blind||0
10018503|NCT01824290|11141613|FG003|COMPLETED|Period 1: Double Blind||0
10018504|NCT01824290|11141610|FG000|NOT COMPLETED|Period 1: Double Blind||3
10018505|NCT01824290|11141611|FG001|NOT COMPLETED|Period 1: Double Blind||2
10018506|NCT01824290|11141612|FG002|NOT COMPLETED|Period 1: Double Blind||0
10018507|NCT01824290|11141613|FG003|NOT COMPLETED|Period 1: Double Blind||0
10018508|NCT01824290|11141610|FG000|STARTED|Period 2: Open-Label Treatment||0
10018509|NCT01824290|11141611|FG001|STARTED|Period 2: Open-Label Treatment||0
10019165|NCT01828255|11142326|FG000|STARTED|Overall Study||20
9994919|NCT01682148|11116759|FG000|STARTED|Overall Study||44
9994920|NCT01682148|11116760|FG001|STARTED|Overall Study||44
9994921|NCT01682148|11116759|FG000|COMPLETED|Overall Study||40
9994922|NCT01682148|11116760|FG001|COMPLETED|Overall Study||41
9994923|NCT01682148|11116759|FG000|NOT COMPLETED|Overall Study||4
9994924|NCT01682148|11116760|FG001|NOT COMPLETED|Overall Study||3
9994925|NCT01682213|11116771|FG000|STARTED|Overall Study||23
9994926|NCT01682213|11116771|FG000|COMPLETED|Overall Study||21
9994927|NCT01682213|11116771|FG000|NOT COMPLETED|Overall Study||2
9994928|NCT01682460|11116776|FG000|STARTED|Overall Study||15
9994929|NCT01682460|11116776|FG000|COMPLETED|Overall Study||11
9994930|NCT01682460|11116776|FG000|NOT COMPLETED|Overall Study||4
9994931|NCT01682512|11116783|FG000|STARTED|Overall Study||116
9994932|NCT01682512|11116784|FG001|STARTED|Overall Study||111
9994933|NCT01682512|11116785|FG002|STARTED|Overall Study||66
9994934|NCT01682512|11116783|FG000|Randomized in Part-I|Overall Study||66
9994935|NCT01682512|11116784|FG001|Randomized in Part-I|Overall Study||65
9994936|NCT01682512|11116785|FG002|Randomized in Part-I|Overall Study||66
9994937|NCT01682512|11116783|FG000|Randomized in Part-II|Overall Study||50
9994938|NCT01682512|11116784|FG001|Randomized in Part-II|Overall Study||46
9994939|NCT01682512|11116785|FG002|Randomized in Part-II|Overall Study||0
9994940|NCT01682512|11116783|FG000|COMPLETED|Overall Study||44
9994941|NCT01682512|11116784|FG001|COMPLETED|Overall Study||40
9994942|NCT01682512|11116785|FG002|COMPLETED|Overall Study||48
9994943|NCT01682512|11116783|FG000|NOT COMPLETED|Overall Study||72
9994944|NCT01682512|11116784|FG001|NOT COMPLETED|Overall Study||71
9994945|NCT01682512|11116785|FG002|NOT COMPLETED|Overall Study||18
9994946|NCT01682538|11116793|FG000|STARTED|Overall Study||12
9994947|NCT01682538|11116793|FG000|COMPLETED|Overall Study||12
9994948|NCT01682538|11116793|FG000|NOT COMPLETED|Overall Study||0
9994949|NCT01682603|11116808|FG000|STARTED|Overall Study||37
9994950|NCT01682603|11116808|FG000|COMPLETED|Overall Study||34
9994951|NCT01682603|11116808|FG000|NOT COMPLETED|Overall Study||3
9994952|NCT01682642|11116816|FG000|STARTED|Overall Study||61
9994953|NCT01682642|11116817|FG001|STARTED|Overall Study||59
9994954|NCT01682642|11116816|FG000|COMPLETED|Overall Study||61
9994955|NCT01682642|11116817|FG001|COMPLETED|Overall Study||58
9994956|NCT01682642|11116816|FG000|NOT COMPLETED|Overall Study||0
9994957|NCT01682642|11116817|FG001|NOT COMPLETED|Overall Study||1
9994958|NCT01682681|11116829|FG000|STARTED|Overall Study||1234
9994959|NCT01682681|11116829|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
9994960|NCT01682681|11116829|FG000|COMPLETED|Overall Study||902
9994961|NCT01682681|11116829|FG000|NOT COMPLETED|Overall Study||332
9994962|NCT01682720|11116837|FG000|STARTED|Overall Study||85
9994963|NCT01682720|11116838|FG001|STARTED|Overall Study||74
9994964|NCT01682720|11116839|FG002|STARTED|Overall Study||12
9994965|NCT01682720|11116840|FG003|STARTED|Overall Study||250
9994966|NCT01682720|11116837|FG000|Included in Full Analysis Set|Overall Study||0
9994967|NCT01682720|11116838|FG001|Included in Full Analysis Set|Overall Study||73
9994968|NCT01682720|11116839|FG002|Included in Full Analysis Set|Overall Study||11
9994969|NCT01682720|11116840|FG003|Included in Full Analysis Set|Overall Study||250
9994970|NCT01682720|11116837|FG000|COMPLETED|Overall Study||0
9994971|NCT01682720|11116838|FG001|COMPLETED|Overall Study||69
9994972|NCT01682720|11116839|FG002|COMPLETED|Overall Study||5
9994973|NCT01682720|11116840|FG003|COMPLETED|Overall Study||211
9994974|NCT01682720|11116837|FG000|NOT COMPLETED|Overall Study||85
9994975|NCT01682720|11116838|FG001|NOT COMPLETED|Overall Study||5
9994976|NCT01682720|11116839|FG002|NOT COMPLETED|Overall Study||7
9994977|NCT01682720|11116840|FG003|NOT COMPLETED|Overall Study||39
9994978|NCT01682759|11116852|FG000|STARTED|Overall Study||376
9994979|NCT01682759|11116853|FG001|STARTED|Overall Study||375
9994980|NCT01682759|11116852|FG000|Treated|Overall Study||375
9994981|NCT01682759|11116853|FG001|Treated|Overall Study||375
9994982|NCT01682759|11116852|FG000|COMPLETED|Overall Study||307
9994983|NCT01682759|11116853|FG001|COMPLETED|Overall Study||305
9994984|NCT01682759|11116852|FG000|NOT COMPLETED|Overall Study||69
9994985|NCT01682759|11116853|FG001|NOT COMPLETED|Overall Study||70
9994986|NCT01682811|11116866|FG000|STARTED|Part 1 Levulan Injection||1
9994987|NCT01682811|11116867|FG001|STARTED|Part 1 Levulan Injection||0
9994988|NCT01682811|11116868|FG002|STARTED|Part 1 Levulan Injection||0
9994989|NCT01682811|11116869|FG003|STARTED|Part 1 Levulan Injection||0
9994990|NCT01682811|11116870|FG004|STARTED|Part 1 Levulan Injection||0
9994991|NCT01682811|11116871|FG005|STARTED|Part 1 Levulan Injection||0
9994992|NCT01682811|11116872|FG006|STARTED|Part 1 Levulan Injection||0
9994993|NCT01682811|11116866|FG000|Control|Part 1 Levulan Injection||1
9994994|NCT01682811|11116867|FG001|Control|Part 1 Levulan Injection||0
9994995|NCT01682811|11116868|FG002|Control|Part 1 Levulan Injection||0
9994996|NCT01682811|11116869|FG003|Control|Part 1 Levulan Injection||0
9994997|NCT01682811|11116870|FG004|Control|Part 1 Levulan Injection||0
9994998|NCT01682811|11116871|FG005|Control|Part 1 Levulan Injection||0
9994999|NCT01682811|11116872|FG006|Control|Part 1 Levulan Injection||0
9995000|NCT01682811|11116866|FG000|Treated 3 Hours|Part 1 Levulan Injection||1
9995001|NCT01682811|11116867|FG001|Treated 3 Hours|Part 1 Levulan Injection||0
9995002|NCT01682811|11116868|FG002|Treated 3 Hours|Part 1 Levulan Injection||0
9995003|NCT01682811|11116869|FG003|Treated 3 Hours|Part 1 Levulan Injection||0
9995004|NCT01682811|11116870|FG004|Treated 3 Hours|Part 1 Levulan Injection||0
9995005|NCT01682811|11116871|FG005|Treated 3 Hours|Part 1 Levulan Injection||0
9995006|NCT01682811|11116872|FG006|Treated 3 Hours|Part 1 Levulan Injection||0
9995007|NCT01682811|11116866|FG000|Treated 24 Hours|Part 1 Levulan Injection||1
9995008|NCT01682811|11116867|FG001|Treated 24 Hours|Part 1 Levulan Injection||0
9995009|NCT01682811|11116868|FG002|Treated 24 Hours|Part 1 Levulan Injection||0
9995010|NCT01682811|11116869|FG003|Treated 24 Hours|Part 1 Levulan Injection||0
9995011|NCT01682811|11116870|FG004|Treated 24 Hours|Part 1 Levulan Injection||0
9995012|NCT01682811|11116871|FG005|Treated 24 Hours|Part 1 Levulan Injection||0
9995013|NCT01682811|11116872|FG006|Treated 24 Hours|Part 1 Levulan Injection||0
9995014|NCT01682811|11116866|FG000|COMPLETED|Part 1 Levulan Injection||1
9995015|NCT01682811|11116867|FG001|COMPLETED|Part 1 Levulan Injection||0
9995016|NCT01682811|11116868|FG002|COMPLETED|Part 1 Levulan Injection||0
9995017|NCT01682811|11116869|FG003|COMPLETED|Part 1 Levulan Injection||0
9995018|NCT01682811|11116870|FG004|COMPLETED|Part 1 Levulan Injection||0
9995019|NCT01682811|11116871|FG005|COMPLETED|Part 1 Levulan Injection||0
9995020|NCT01682811|11116872|FG006|COMPLETED|Part 1 Levulan Injection||0
9995021|NCT01682811|11116866|FG000|NOT COMPLETED|Part 1 Levulan Injection||0
9995022|NCT01682811|11116867|FG001|NOT COMPLETED|Part 1 Levulan Injection||0
9995023|NCT01682811|11116868|FG002|NOT COMPLETED|Part 1 Levulan Injection||0
9995024|NCT01682811|11116869|FG003|NOT COMPLETED|Part 1 Levulan Injection||0
9995025|NCT01682811|11116870|FG004|NOT COMPLETED|Part 1 Levulan Injection||0
9995026|NCT01682811|11116871|FG005|NOT COMPLETED|Part 1 Levulan Injection||0
9995027|NCT01682811|11116872|FG006|NOT COMPLETED|Part 1 Levulan Injection||0
9995028|NCT01682811|11116866|FG000|STARTED|Part 1 Levulan Painting||0
9995029|NCT01682811|11116867|FG001|STARTED|Part 1 Levulan Painting||1
9995030|NCT01682811|11116868|FG002|STARTED|Part 1 Levulan Painting||0
9995031|NCT01682811|11116869|FG003|STARTED|Part 1 Levulan Painting||0
9995032|NCT01682811|11116870|FG004|STARTED|Part 1 Levulan Painting||0
9995033|NCT01682811|11116871|FG005|STARTED|Part 1 Levulan Painting||0
9995034|NCT01682811|11116872|FG006|STARTED|Part 1 Levulan Painting||0
9995035|NCT01682811|11116866|FG000|Control|Part 1 Levulan Painting||0
9995036|NCT01682811|11116867|FG001|Control|Part 1 Levulan Painting||1
9995037|NCT01682811|11116868|FG002|Control|Part 1 Levulan Painting||0
9995038|NCT01682811|11116869|FG003|Control|Part 1 Levulan Painting||0
9995039|NCT01682811|11116870|FG004|Control|Part 1 Levulan Painting||0
9995040|NCT01682811|11116871|FG005|Control|Part 1 Levulan Painting||0
9995041|NCT01682811|11116872|FG006|Control|Part 1 Levulan Painting||0
9995042|NCT01682811|11116866|FG000|Treated 3 Hours|Part 1 Levulan Painting||0
9995043|NCT01682811|11116867|FG001|Treated 3 Hours|Part 1 Levulan Painting||1
9995044|NCT01682811|11116868|FG002|Treated 3 Hours|Part 1 Levulan Painting||0
9995045|NCT01682811|11116869|FG003|Treated 3 Hours|Part 1 Levulan Painting||0
9995046|NCT01682811|11116870|FG004|Treated 3 Hours|Part 1 Levulan Painting||0
9995047|NCT01682811|11116871|FG005|Treated 3 Hours|Part 1 Levulan Painting||0
9995048|NCT01682811|11116872|FG006|Treated 3 Hours|Part 1 Levulan Painting||0
9995049|NCT01682811|11116866|FG000|Treated 24 Hours|Part 1 Levulan Painting||0
9995050|NCT01682811|11116867|FG001|Treated 24 Hours|Part 1 Levulan Painting||1
9995051|NCT01682811|11116868|FG002|Treated 24 Hours|Part 1 Levulan Painting||0
9995052|NCT01682811|11116869|FG003|Treated 24 Hours|Part 1 Levulan Painting||0
9995053|NCT01682811|11116870|FG004|Treated 24 Hours|Part 1 Levulan Painting||0
9995054|NCT01682811|11116871|FG005|Treated 24 Hours|Part 1 Levulan Painting||0
9995055|NCT01682811|11116872|FG006|Treated 24 Hours|Part 1 Levulan Painting||0
9995056|NCT01682811|11116866|FG000|COMPLETED|Part 1 Levulan Painting||0
9995057|NCT01682811|11116867|FG001|COMPLETED|Part 1 Levulan Painting||1
9995058|NCT01682811|11116868|FG002|COMPLETED|Part 1 Levulan Painting||0
9995059|NCT01682811|11116869|FG003|COMPLETED|Part 1 Levulan Painting||0
9995060|NCT01682811|11116870|FG004|COMPLETED|Part 1 Levulan Painting||0
9995061|NCT01682811|11116871|FG005|COMPLETED|Part 1 Levulan Painting||0
9995062|NCT01682811|11116872|FG006|COMPLETED|Part 1 Levulan Painting||0
9995063|NCT01682811|11116866|FG000|NOT COMPLETED|Part 1 Levulan Painting||0
9995064|NCT01682811|11116867|FG001|NOT COMPLETED|Part 1 Levulan Painting||0
9995065|NCT01682811|11116868|FG002|NOT COMPLETED|Part 1 Levulan Painting||0
9995066|NCT01682811|11116869|FG003|NOT COMPLETED|Part 1 Levulan Painting||0
9995067|NCT01682811|11116870|FG004|NOT COMPLETED|Part 1 Levulan Painting||0
9995068|NCT01682811|11116871|FG005|NOT COMPLETED|Part 1 Levulan Painting||0
9995069|NCT01682811|11116872|FG006|NOT COMPLETED|Part 1 Levulan Painting||0
9995070|NCT01682811|11116866|FG000|STARTED|Part 1 Levulan Painted Twice||0
9995071|NCT01682811|11116867|FG001|STARTED|Part 1 Levulan Painted Twice||0
9995072|NCT01682811|11116868|FG002|STARTED|Part 1 Levulan Painted Twice||2
9995073|NCT01682811|11116869|FG003|STARTED|Part 1 Levulan Painted Twice||0
9995074|NCT01682811|11116870|FG004|STARTED|Part 1 Levulan Painted Twice||0
9995075|NCT01682811|11116871|FG005|STARTED|Part 1 Levulan Painted Twice||0
9995076|NCT01682811|11116872|FG006|STARTED|Part 1 Levulan Painted Twice||0
9995077|NCT01682811|11116866|FG000|Control|Part 1 Levulan Painted Twice||0
9995078|NCT01682811|11116867|FG001|Control|Part 1 Levulan Painted Twice||0
9995079|NCT01682811|11116868|FG002|Control|Part 1 Levulan Painted Twice||2
9995080|NCT01682811|11116869|FG003|Control|Part 1 Levulan Painted Twice||0
9995081|NCT01682811|11116870|FG004|Control|Part 1 Levulan Painted Twice||0
9995082|NCT01682811|11116871|FG005|Control|Part 1 Levulan Painted Twice||0
9995083|NCT01682811|11116872|FG006|Control|Part 1 Levulan Painted Twice||0
9995084|NCT01682811|11116866|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0
9995085|NCT01682811|11116867|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0
9995086|NCT01682811|11116868|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2
9995087|NCT01682811|11116869|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0
9995088|NCT01682811|11116870|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0
9995089|NCT01682811|11116871|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0
9995090|NCT01682811|11116872|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0
9995091|NCT01682811|11116866|FG000|COMPLETED|Part 1 Levulan Painted Twice||0
9995092|NCT01682811|11116867|FG001|COMPLETED|Part 1 Levulan Painted Twice||0
9995093|NCT01682811|11116868|FG002|COMPLETED|Part 1 Levulan Painted Twice||2
9995094|NCT01682811|11116869|FG003|COMPLETED|Part 1 Levulan Painted Twice||0
9995095|NCT01682811|11116870|FG004|COMPLETED|Part 1 Levulan Painted Twice||0
9995096|NCT01682811|11116871|FG005|COMPLETED|Part 1 Levulan Painted Twice||0
9995097|NCT01682811|11116872|FG006|COMPLETED|Part 1 Levulan Painted Twice||0
9995098|NCT01682811|11116866|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0
9995099|NCT01682811|11116867|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0
9995100|NCT01682811|11116868|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0
9995101|NCT01682811|11116869|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0
9995102|NCT01682811|11116870|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0
9995103|NCT01682811|11116871|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0
9995104|NCT01682811|11116872|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0
9995105|NCT01682811|11116866|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0
9995106|NCT01682811|11116867|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0
9995107|NCT01682811|11116868|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0
9995108|NCT01682811|11116869|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2
9995109|NCT01682811|11116870|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0
9995110|NCT01682811|11116871|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0
9995111|NCT01682811|11116872|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0
9995112|NCT01682811|11116866|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0
9995113|NCT01682811|11116867|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0
9995114|NCT01682811|11116868|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0
9995115|NCT01682811|11116869|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2
9995116|NCT01682811|11116870|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0
9995117|NCT01682811|11116871|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0
9995118|NCT01682811|11116872|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0
9995119|NCT01682811|11116866|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
9995120|NCT01682811|11116867|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
9995121|NCT01682811|11116868|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
9995122|NCT01682811|11116869|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
9995123|NCT01682811|11116870|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
9995124|NCT01682811|11116871|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
9995125|NCT01682811|11116872|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
9995126|NCT01682811|11116866|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995127|NCT01682811|11116867|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995128|NCT01682811|11116868|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995129|NCT01682811|11116869|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
9995130|NCT01682811|11116870|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995131|NCT01682811|11116871|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995132|NCT01682811|11116872|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995133|NCT01682811|11116866|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995134|NCT01682811|11116867|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995135|NCT01682811|11116868|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995136|NCT01682811|11116869|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995137|NCT01682811|11116870|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995138|NCT01682811|11116871|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995139|NCT01682811|11116872|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
9995140|NCT01682811|11116866|FG000|STARTED|Part 2 Dose Level 1||0
9995141|NCT01682811|11116867|FG001|STARTED|Part 2 Dose Level 1||0
9995142|NCT01682811|11116868|FG002|STARTED|Part 2 Dose Level 1||0
9995143|NCT01682811|11116869|FG003|STARTED|Part 2 Dose Level 1||0
9995144|NCT01682811|11116870|FG004|STARTED|Part 2 Dose Level 1||11
9995145|NCT01682811|11116871|FG005|STARTED|Part 2 Dose Level 1||0
9995146|NCT01682811|11116872|FG006|STARTED|Part 2 Dose Level 1||0
9995147|NCT01682811|11116866|FG000|Control|Part 2 Dose Level 1||0
9995148|NCT01682811|11116867|FG001|Control|Part 2 Dose Level 1||0
9995149|NCT01682811|11116868|FG002|Control|Part 2 Dose Level 1||0
9995150|NCT01682811|11116869|FG003|Control|Part 2 Dose Level 1||0
9995151|NCT01682811|11116870|FG004|Control|Part 2 Dose Level 1||10
9995152|NCT01682811|11116871|FG005|Control|Part 2 Dose Level 1||0
9995153|NCT01682811|11116872|FG006|Control|Part 2 Dose Level 1||0
9995154|NCT01682811|11116866|FG000|Treated|Part 2 Dose Level 1||0
9995155|NCT01682811|11116867|FG001|Treated|Part 2 Dose Level 1||0
9995156|NCT01682811|11116868|FG002|Treated|Part 2 Dose Level 1||0
9995157|NCT01682811|11116869|FG003|Treated|Part 2 Dose Level 1||0
9995158|NCT01682811|11116870|FG004|Treated|Part 2 Dose Level 1||10
9995159|NCT01682811|11116871|FG005|Treated|Part 2 Dose Level 1||0
9995160|NCT01682811|11116872|FG006|Treated|Part 2 Dose Level 1||0
9995161|NCT01682811|11116866|FG000|COMPLETED|Part 2 Dose Level 1||0
9995162|NCT01682811|11116867|FG001|COMPLETED|Part 2 Dose Level 1||0
9995163|NCT01682811|11116868|FG002|COMPLETED|Part 2 Dose Level 1||0
9995164|NCT01682811|11116869|FG003|COMPLETED|Part 2 Dose Level 1||0
9995165|NCT01682811|11116870|FG004|COMPLETED|Part 2 Dose Level 1||0
9995166|NCT01682811|11116871|FG005|COMPLETED|Part 2 Dose Level 1||0
9995167|NCT01682811|11116872|FG006|COMPLETED|Part 2 Dose Level 1||0
9995168|NCT01682811|11116866|FG000|NOT COMPLETED|Part 2 Dose Level 1||0
9995169|NCT01682811|11116867|FG001|NOT COMPLETED|Part 2 Dose Level 1||0
9995170|NCT01682811|11116868|FG002|NOT COMPLETED|Part 2 Dose Level 1||0
9995171|NCT01682811|11116869|FG003|NOT COMPLETED|Part 2 Dose Level 1||0
9995172|NCT01682811|11116870|FG004|NOT COMPLETED|Part 2 Dose Level 1||11
9995173|NCT01682811|11116871|FG005|NOT COMPLETED|Part 2 Dose Level 1||0
9995174|NCT01682811|11116872|FG006|NOT COMPLETED|Part 2 Dose Level 1||0
9995175|NCT01682811|11116866|FG000|STARTED|Part 2 Dose Level 2||0
9995176|NCT01682811|11116867|FG001|STARTED|Part 2 Dose Level 2||0
9995177|NCT01682811|11116868|FG002|STARTED|Part 2 Dose Level 2||0
9995178|NCT01682811|11116869|FG003|STARTED|Part 2 Dose Level 2||0
9995179|NCT01682811|11116870|FG004|STARTED|Part 2 Dose Level 2||0
9995180|NCT01682811|11116871|FG005|STARTED|Part 2 Dose Level 2||3
9995181|NCT01682811|11116872|FG006|STARTED|Part 2 Dose Level 2||0
9995182|NCT01682811|11116866|FG000|Control|Part 2 Dose Level 2||0
9995183|NCT01682811|11116867|FG001|Control|Part 2 Dose Level 2||0
9995184|NCT01682811|11116868|FG002|Control|Part 2 Dose Level 2||0
9995185|NCT01682811|11116869|FG003|Control|Part 2 Dose Level 2||0
9995186|NCT01682811|11116870|FG004|Control|Part 2 Dose Level 2||0
9995187|NCT01682811|11116871|FG005|Control|Part 2 Dose Level 2||3
9995188|NCT01682811|11116872|FG006|Control|Part 2 Dose Level 2||0
9995189|NCT01682811|11116866|FG000|Treated|Part 2 Dose Level 2||0
9995190|NCT01682811|11116867|FG001|Treated|Part 2 Dose Level 2||0
9995191|NCT01682811|11116868|FG002|Treated|Part 2 Dose Level 2||0
9995192|NCT01682811|11116869|FG003|Treated|Part 2 Dose Level 2||0
9995193|NCT01682811|11116870|FG004|Treated|Part 2 Dose Level 2||0
9995194|NCT01682811|11116871|FG005|Treated|Part 2 Dose Level 2||3
9995195|NCT01682811|11116872|FG006|Treated|Part 2 Dose Level 2||0
9995196|NCT01682811|11116866|FG000|COMPLETED|Part 2 Dose Level 2||0
9995197|NCT01682811|11116867|FG001|COMPLETED|Part 2 Dose Level 2||0
9995198|NCT01682811|11116868|FG002|COMPLETED|Part 2 Dose Level 2||0
9995199|NCT01682811|11116869|FG003|COMPLETED|Part 2 Dose Level 2||0
9995200|NCT01682811|11116870|FG004|COMPLETED|Part 2 Dose Level 2||0
9995201|NCT01682811|11116871|FG005|COMPLETED|Part 2 Dose Level 2||0
9995202|NCT01682811|11116872|FG006|COMPLETED|Part 2 Dose Level 2||0
9995203|NCT01682811|11116866|FG000|NOT COMPLETED|Part 2 Dose Level 2||0
9995204|NCT01682811|11116867|FG001|NOT COMPLETED|Part 2 Dose Level 2||0
9995205|NCT01682811|11116868|FG002|NOT COMPLETED|Part 2 Dose Level 2||0
9995206|NCT01682811|11116869|FG003|NOT COMPLETED|Part 2 Dose Level 2||0
9995207|NCT01682811|11116870|FG004|NOT COMPLETED|Part 2 Dose Level 2||0
9995208|NCT01682811|11116871|FG005|NOT COMPLETED|Part 2 Dose Level 2||3
9995209|NCT01682811|11116872|FG006|NOT COMPLETED|Part 2 Dose Level 2||0
9995210|NCT01682811|11116866|FG000|STARTED|Part 2 Dose Level 3||0
9995211|NCT01682811|11116867|FG001|STARTED|Part 2 Dose Level 3||0
9995212|NCT01682811|11116868|FG002|STARTED|Part 2 Dose Level 3||0
9995213|NCT01682811|11116869|FG003|STARTED|Part 2 Dose Level 3||0
9995214|NCT01682811|11116870|FG004|STARTED|Part 2 Dose Level 3||0
9995215|NCT01682811|11116871|FG005|STARTED|Part 2 Dose Level 3||0
9995216|NCT01682811|11116872|FG006|STARTED|Part 2 Dose Level 3||0
9995217|NCT01682811|11116866|FG000|Control|Part 2 Dose Level 3||0
9995218|NCT01682811|11116867|FG001|Control|Part 2 Dose Level 3||0
9995219|NCT01682811|11116868|FG002|Control|Part 2 Dose Level 3||0
9995220|NCT01682811|11116869|FG003|Control|Part 2 Dose Level 3||0
9995221|NCT01682811|11116870|FG004|Control|Part 2 Dose Level 3||0
9995222|NCT01682811|11116871|FG005|Control|Part 2 Dose Level 3||0
9995223|NCT01682811|11116872|FG006|Control|Part 2 Dose Level 3||0
9995224|NCT01682811|11116866|FG000|Treated|Part 2 Dose Level 3||0
9995225|NCT01682811|11116867|FG001|Treated|Part 2 Dose Level 3||0
9995226|NCT01682811|11116868|FG002|Treated|Part 2 Dose Level 3||0
9995227|NCT01682811|11116869|FG003|Treated|Part 2 Dose Level 3||0
9995228|NCT01682811|11116870|FG004|Treated|Part 2 Dose Level 3||0
9995229|NCT01682811|11116871|FG005|Treated|Part 2 Dose Level 3||0
9995230|NCT01682811|11116872|FG006|Treated|Part 2 Dose Level 3||0
9995231|NCT01682811|11116866|FG000|COMPLETED|Part 2 Dose Level 3||0
9995232|NCT01682811|11116867|FG001|COMPLETED|Part 2 Dose Level 3||0
9995233|NCT01682811|11116868|FG002|COMPLETED|Part 2 Dose Level 3||0
9995234|NCT01682811|11116869|FG003|COMPLETED|Part 2 Dose Level 3||0
9995235|NCT01682811|11116870|FG004|COMPLETED|Part 2 Dose Level 3||0
9995236|NCT01682811|11116871|FG005|COMPLETED|Part 2 Dose Level 3||0
9995237|NCT01682811|11116872|FG006|COMPLETED|Part 2 Dose Level 3||0
9995238|NCT01682811|11116866|FG000|NOT COMPLETED|Part 2 Dose Level 3||0
9995239|NCT01682811|11116867|FG001|NOT COMPLETED|Part 2 Dose Level 3||0
9995240|NCT01682811|11116868|FG002|NOT COMPLETED|Part 2 Dose Level 3||0
9995241|NCT01682811|11116869|FG003|NOT COMPLETED|Part 2 Dose Level 3||0
9995242|NCT01682811|11116870|FG004|NOT COMPLETED|Part 2 Dose Level 3||0
9995243|NCT01682811|11116871|FG005|NOT COMPLETED|Part 2 Dose Level 3||0
9995244|NCT01682811|11116872|FG006|NOT COMPLETED|Part 2 Dose Level 3||0
9995245|NCT01682837|11116891|FG000|STARTED|Baseline||35
9995246|NCT01682837|11116891|FG000|COMPLETED|Baseline||30
9995247|NCT01682837|11116891|FG000|NOT COMPLETED|Baseline||5
9995248|NCT01682837|11116891|FG000|STARTED|First Intervention (4 Weeks)||30
9995249|NCT01682837|11116891|FG000|Received KMgCit|First Intervention (4 Weeks)||8
9995250|NCT01682837|11116891|FG000|Received KCit|First Intervention (4 Weeks)||8
9995251|NCT01682837|11116891|FG000|Received KCl|First Intervention (4 Weeks)||7
9995252|NCT01682837|11116891|FG000|Received Placebo|First Intervention (4 Weeks)||7
9995253|NCT01682837|11116891|FG000|COMPLETED|First Intervention (4 Weeks)||30
9995254|NCT01682837|11116891|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
9995255|NCT01682837|11116891|FG000|STARTED|Second Intervention (4 Weeks)||30
9995256|NCT01682837|11116891|FG000|Received KMgCit|Second Intervention (4 Weeks)||7
9995257|NCT01682837|11116891|FG000|Received KCit|Second Intervention (4 Weeks)||6
9995258|NCT01682837|11116891|FG000|Received KCl|Second Intervention (4 Weeks)||8
9995259|NCT01682837|11116891|FG000|Received Placebo|Second Intervention (4 Weeks)||9
9995260|NCT01682837|11116891|FG000|COMPLETED|Second Intervention (4 Weeks)||30
9995261|NCT01682837|11116891|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
9995262|NCT01682837|11116891|FG000|STARTED|Third Intervention (4 Weeks)||30
9995263|NCT01682837|11116891|FG000|Received KMgCit|Third Intervention (4 Weeks)||9
9995264|NCT01682837|11116891|FG000|Received KCit|Third Intervention (4 Weeks)||7
9995265|NCT01682837|11116891|FG000|Received KCl|Third Intervention (4 Weeks)||7
9995266|NCT01682837|11116891|FG000|Received Placebo|Third Intervention (4 Weeks)||7
9995267|NCT01682837|11116891|FG000|COMPLETED|Third Intervention (4 Weeks)||30
9995268|NCT01682837|11116891|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
9995269|NCT01682837|11116891|FG000|STARTED|Fourth Intervention (4 Weeks)||30
9995270|NCT01682837|11116891|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6
9995271|NCT01682837|11116891|FG000|Received KCit|Fourth Intervention (4 Weeks)||9
9995272|NCT01682837|11116891|FG000|Received KCl|Fourth Intervention (4 Weeks)||8
9995273|NCT01682837|11116891|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7
9995274|NCT01682837|11116891|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30
9995275|NCT01682837|11116891|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
9995276|NCT01682863|11116904|FG000|STARTED|Overall Study||204
9995277|NCT01682863|11116905|FG001|STARTED|Overall Study||204
9995278|NCT01682863|11116906|FG002|STARTED|Overall Study||207
9995279|NCT01682863|11116904|FG000|Safety Set|Overall Study||204
9995280|NCT01682863|11116905|FG001|Safety Set|Overall Study||204
9995281|NCT01682863|11116906|FG002|Safety Set|Overall Study||206
9995282|NCT01682863|11116904|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
9995283|NCT01682863|11116905|FG001|Full Analysis Set (FAS)|Overall Study||204
9995284|NCT01682863|11116906|FG002|Full Analysis Set (FAS)|Overall Study||206
9995285|NCT01682863|11116904|FG000|Randomized Set|Overall Study||204
9995286|NCT01682863|11116905|FG001|Randomized Set|Overall Study||204
9995287|NCT01682863|11116906|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
9995288|NCT01682863|11116904|FG000|COMPLETED|Overall Study||177
9995289|NCT01682863|11116905|FG001|COMPLETED|Overall Study||187
9995290|NCT01682863|11116906|FG002|COMPLETED|Overall Study||183
9995291|NCT01682863|11116904|FG000|NOT COMPLETED|Overall Study||27
9995292|NCT01682863|11116905|FG001|NOT COMPLETED|Overall Study||17
9995293|NCT01682863|11116906|FG002|NOT COMPLETED|Overall Study||24
9995294|NCT01682876|11116918|FG000|STARTED|Overall Study||176
9995295|NCT01682876|11116919|FG001|STARTED|Overall Study||183
9995296|NCT01682876|11116920|FG002|STARTED|Overall Study||180
9995297|NCT01682876|11116921|FG003|STARTED|Overall Study||176
9995298|NCT01682876|11116918|FG000|COMPLETED|Overall Study||155
9995299|NCT01682876|11116919|FG001|COMPLETED|Overall Study||163
9995300|NCT01682876|11116920|FG002|COMPLETED|Overall Study||169
9995301|NCT01682876|11116921|FG003|COMPLETED|Overall Study||157
9995302|NCT01682876|11116918|FG000|NOT COMPLETED|Overall Study||21
9995303|NCT01682876|11116919|FG001|NOT COMPLETED|Overall Study||20
9995304|NCT01682876|11116920|FG002|NOT COMPLETED|Overall Study||11
9995305|NCT01682876|11116921|FG003|NOT COMPLETED|Overall Study||19
9995306|NCT01682954|11116936|FG000|STARTED|Overall Study||40
9995307|NCT01682954|11116937|FG001|STARTED|Overall Study||38
9995308|NCT01682954|11116936|FG000|COMPLETED|Overall Study||35
9995309|NCT01682954|11116937|FG001|COMPLETED|Overall Study||33
9995310|NCT01682954|11116936|FG000|NOT COMPLETED|Overall Study||5
9995311|NCT01682954|11116937|FG001|NOT COMPLETED|Overall Study||5
9995312|NCT01683019|11116946|FG000|STARTED|Overall Study||18
9995313|NCT01683019|11116947|FG001|STARTED|Overall Study||15
9995314|NCT01683019|11116948|FG002|STARTED|Overall Study||19
9995315|NCT01683019|11116946|FG000|COMPLETED|Overall Study||16
9995316|NCT01683019|11116947|FG001|COMPLETED|Overall Study||14
9995317|NCT01683019|11116948|FG002|COMPLETED|Overall Study||15
9995318|NCT01683019|11116946|FG000|NOT COMPLETED|Overall Study||2
9995319|NCT01683019|11116947|FG001|NOT COMPLETED|Overall Study||1
9995320|NCT01683019|11116948|FG002|NOT COMPLETED|Overall Study||4
9995321|NCT01683058|11116956|FG000|STARTED|Overall Study||74
9995322|NCT01683058|11116956|FG000|COMPLETED|Overall Study||45
9995323|NCT01683058|11116956|FG000|NOT COMPLETED|Overall Study||29
9995324|NCT01683071|11116967|FG000|STARTED|Part 1||25
9995325|NCT01683071|11116968|FG001|STARTED|Part 1||26
9995326|NCT01683071|11116969|FG002|STARTED|Part 1||25
9995327|NCT01683071|11116970|FG003|STARTED|Part 1||25
9995328|NCT01683071|11116971|FG004|STARTED|Part 1||0
9995329|NCT01683071|11116972|FG005|STARTED|Part 1||0
9995330|NCT01683071|11116967|FG000|COMPLETED|Part 1||21
9995331|NCT01683071|11116968|FG001|COMPLETED|Part 1||22
9995332|NCT01683071|11116969|FG002|COMPLETED|Part 1||22
9995333|NCT01683071|11116970|FG003|COMPLETED|Part 1||20
9995334|NCT01683071|11116971|FG004|COMPLETED|Part 1||0
9995335|NCT01683071|11116972|FG005|COMPLETED|Part 1||0
9995336|NCT01683071|11116967|FG000|NOT COMPLETED|Part 1||4
9995337|NCT01683071|11116968|FG001|NOT COMPLETED|Part 1||4
9995338|NCT01683071|11116969|FG002|NOT COMPLETED|Part 1||3
9995339|NCT01683071|11116970|FG003|NOT COMPLETED|Part 1||5
9995340|NCT01683071|11116971|FG004|NOT COMPLETED|Part 1||0
9995341|NCT01683071|11116972|FG005|NOT COMPLETED|Part 1||0
9995342|NCT01683071|11116967|FG000|STARTED|Part 2||0
9995343|NCT01683071|11116968|FG001|STARTED|Part 2||0
9995344|NCT01683071|11116969|FG002|STARTED|Part 2||0
9995345|NCT01683071|11116970|FG003|STARTED|Part 2||0
9995346|NCT01683071|11116971|FG004|STARTED|Part 2||99
9995347|NCT01683071|11116972|FG005|STARTED|Part 2||97
9995348|NCT01683071|11116967|FG000|COMPLETED|Part 2||0
9995349|NCT01683071|11116968|FG001|COMPLETED|Part 2||0
9995350|NCT01683071|11116969|FG002|COMPLETED|Part 2||0
9995351|NCT01683071|11116970|FG003|COMPLETED|Part 2||0
9995352|NCT01683071|11116971|FG004|COMPLETED|Part 2||82
9995353|NCT01683071|11116972|FG005|COMPLETED|Part 2||82
9995354|NCT01683071|11116967|FG000|NOT COMPLETED|Part 2||0
9995355|NCT01683071|11116968|FG001|NOT COMPLETED|Part 2||0
9995356|NCT01683071|11116969|FG002|NOT COMPLETED|Part 2||0
9995357|NCT01683071|11116970|FG003|NOT COMPLETED|Part 2||0
9995358|NCT01683071|11116971|FG004|NOT COMPLETED|Part 2||17
9995359|NCT01683071|11116972|FG005|NOT COMPLETED|Part 2||15
9995360|NCT01683266|11116994|FG000|STARTED|Overall Study||274
9995361|NCT01683266|11116995|FG001|STARTED|Overall Study||275
9995362|NCT01683266|11116994|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
9995363|NCT01683266|11116995|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
9995364|NCT01683266|11116994|FG000|COMPLETED|Overall Study||219
9995365|NCT01683266|11116995|FG001|COMPLETED|Overall Study||225
9995366|NCT01683266|11116994|FG000|NOT COMPLETED|Overall Study||55
9995367|NCT01683266|11116995|FG001|NOT COMPLETED|Overall Study||50
9995368|NCT01683331|11117003|FG000|STARTED|Overall Study||18
9995369|NCT01683331|11117004|FG001|STARTED|Overall Study||18
9995370|NCT01683331|11117003|FG000|Began Dosage|Overall Study||18
9995371|NCT01683331|11117004|FG001|Began Dosage|Overall Study||18
9995372|NCT01683331|11117003|FG000|12 Months|Overall Study||18
9995373|NCT01683331|11117004|FG001|12 Months|Overall Study||18
9995374|NCT01683331|11117003|FG000|24 Months|Overall Study||18
9995375|NCT01683331|11117004|FG001|24 Months|Overall Study||18
9995376|NCT01683331|11117003|FG000|COMPLETED|Overall Study||18
9995377|NCT01683331|11117004|FG001|COMPLETED|Overall Study||18
9995378|NCT01683331|11117003|FG000|NOT COMPLETED|Overall Study||0
9995379|NCT01683331|11117004|FG001|NOT COMPLETED|Overall Study||0
9995380|NCT01683383|11117012|FG000|STARTED|Overall Study||50
9995381|NCT01683383|11117013|FG001|STARTED|Overall Study||51
9995382|NCT01683383|11117012|FG000|Transported and Treated|Overall Study||49
9995383|NCT01683383|11117013|FG001|Transported and Treated|Overall Study||51
9995384|NCT01683383|11117012|FG000|COMPLETED|Overall Study||49
9995385|NCT01683383|11117013|FG001|COMPLETED|Overall Study||51
9995386|NCT01683383|11117012|FG000|NOT COMPLETED|Overall Study||1
9995387|NCT01683383|11117013|FG001|NOT COMPLETED|Overall Study||0
9995388|NCT01683409|11117024|FG000|STARTED|Treatment Period (Weeks 1-24)||27
9995389|NCT01683409|11117025|FG001|STARTED|Treatment Period (Weeks 1-24)||25
9995390|NCT01683409|11117026|FG002|STARTED|Treatment Period (Weeks 1-24)||27
9995391|NCT01683409|11117027|FG003|STARTED|Treatment Period (Weeks 1-24)||26
9995392|NCT01683409|11117028|FG004|STARTED|Treatment Period (Weeks 1-24)||25
9995393|NCT01683409|11117024|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
9995394|NCT01683409|11117025|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
9995395|NCT01683409|11117026|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
9995396|NCT01683409|11117027|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
9995397|NCT01683409|11117028|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
9995398|NCT01683409|11117024|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27
9995399|NCT01683409|11117025|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21
9995400|NCT01683409|11117026|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26
9995401|NCT01683409|11117027|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24
9995402|NCT01683409|11117028|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23
9995403|NCT01683409|11117024|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
9995404|NCT01683409|11117025|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
9995405|NCT01683409|11117026|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
9995406|NCT01683409|11117027|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
9995407|NCT01683409|11117028|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
9995408|NCT01683409|11117024|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27
9995409|NCT01683409|11117025|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21
9995410|NCT01683409|11117026|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26
9995411|NCT01683409|11117027|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24
9995412|NCT01683409|11117028|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23
9995413|NCT01683409|11117024|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24
9995414|NCT01683409|11117025|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17
9995415|NCT01683409|11117026|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25
9995416|NCT01683409|11117027|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22
9995417|NCT01683409|11117028|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20
9995418|NCT01683409|11117024|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
9995419|NCT01683409|11117025|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
9995420|NCT01683409|11117026|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
9995421|NCT01683409|11117027|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
9995422|NCT01683409|11117028|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
9995423|NCT01683409|11117024|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
9995424|NCT01683409|11117025|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
9995425|NCT01683409|11117026|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
9995426|NCT01683409|11117027|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
9995427|NCT01683409|11117028|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
9995428|NCT01683409|11117024|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6
9995429|NCT01683409|11117025|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6
9995430|NCT01683409|11117026|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7
9995431|NCT01683409|11117027|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6
9995432|NCT01683409|11117028|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9
9995433|NCT01683409|11117024|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
9995434|NCT01683409|11117025|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
9995435|NCT01683409|11117026|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
9995436|NCT01683409|11117027|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
9995437|NCT01683409|11117028|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
9995438|NCT01683422|11117054|FG000|STARTED|Overall Study||9
9995439|NCT01683422|11117054|FG000|COMPLETED|Overall Study||9
9995440|NCT01683422|11117054|FG000|NOT COMPLETED|Overall Study||0
9995441|NCT01683526|11117060|FG000|STARTED|Overall Study||60
9995442|NCT01683526|11117061|FG001|STARTED|Overall Study||57
9995443|NCT01683526|11117060|FG000|COMPLETED|Overall Study||60
9995444|NCT01683526|11117061|FG001|COMPLETED|Overall Study||57
9995445|NCT01683526|11117060|FG000|NOT COMPLETED|Overall Study||0
9995446|NCT01683526|11117061|FG001|NOT COMPLETED|Overall Study||0
9995447|NCT01683565|11117069|FG000|STARTED|Overall Study||15
9995448|NCT01683565|11117070|FG001|STARTED|Overall Study||16
9995449|NCT01683565|11117069|FG000|COMPLETED|Overall Study||12
9995450|NCT01683565|11117070|FG001|COMPLETED|Overall Study||15
9995451|NCT01683565|11117069|FG000|NOT COMPLETED|Overall Study||3
9995452|NCT01683565|11117070|FG001|NOT COMPLETED|Overall Study||1
9995453|NCT01683604|11117078|FG000|STARTED|Overall Study||37
9995454|NCT01683604|11117078|FG000|COMPLETED|Overall Study||32
9995455|NCT01683604|11117078|FG000|NOT COMPLETED|Overall Study||5
9995456|NCT01683630|11117089|FG000|STARTED|Overall Study||1404
9995457|NCT01683630|11117090|FG001|STARTED|Overall Study||445
9995458|NCT01683630|11117089|FG000|COMPLETED|Overall Study||1404
9995459|NCT01683630|11117090|FG001|COMPLETED|Overall Study||445
9995460|NCT01683630|11117089|FG000|NOT COMPLETED|Overall Study||0
9995461|NCT01683630|11117090|FG001|NOT COMPLETED|Overall Study||0
9995462|NCT01683812|11117096|FG000|STARTED|Overall Study||23
9995463|NCT01683812|11117096|FG000|COMPLETED|Overall Study||23
9995464|NCT01683812|11117096|FG000|NOT COMPLETED|Overall Study||0
9995465|NCT01683838|11117102|FG000|STARTED|Overall Study||104
9995466|NCT01683838|11117103|FG001|STARTED|Overall Study||100
9995467|NCT01683838|11117102|FG000|Intent to Treat (ITT) Population|Overall Study||103
9995468|NCT01683838|11117103|FG001|Intent to Treat (ITT) Population|Overall Study||100
9995469|NCT01683838|11117102|FG000|Safety Population|Overall Study||103
9995470|NCT01683838|11117103|FG001|Safety Population|Overall Study||100
9995471|NCT01683838|11117102|FG000|Efficacy Population|Overall Study||89
9995472|NCT01683838|11117103|FG001|Efficacy Population|Overall Study||93
9995473|NCT01683838|11117102|FG000|COMPLETED|Overall Study||78
9995474|NCT01683838|11117103|FG001|COMPLETED|Overall Study||88
9995475|NCT01683838|11117102|FG000|NOT COMPLETED|Overall Study||26
9995476|NCT01683838|11117103|FG001|NOT COMPLETED|Overall Study||12
9995477|NCT01683994|11117114|FG000|STARTED|Overall Study||4
9995478|NCT01683994|11117115|FG001|STARTED|Overall Study||8
9995479|NCT01683994|11117116|FG002|STARTED|Overall Study||7
9995480|NCT01683994|11117117|FG003|STARTED|Overall Study||13
9995481|NCT01683994|11117118|FG004|STARTED|Overall Study||13
9995482|NCT01683994|11117114|FG000|# of Patients Who Received Treatment|Overall Study||4
9995483|NCT01683994|11117115|FG001|# of Patients Who Received Treatment|Overall Study||8
9995484|NCT01683994|11117116|FG002|# of Patients Who Received Treatment|Overall Study||7
9995485|NCT01683994|11117117|FG003|# of Patients Who Received Treatment|Overall Study||12
9995486|NCT01683994|11117118|FG004|# of Patients Who Received Treatment|Overall Study||13
9995487|NCT01683994|11117114|FG000|COMPLETED|Overall Study||3
10102502|NCT02415998|11232038|FG000|NOT COMPLETED|Overall Study||5
10102503|NCT02416102|11232045|FG000|STARTED|Overall Study||16
10102504|NCT02416102|11232046|FG001|STARTED|Overall Study||15
10102505|NCT02416102|11232047|FG002|STARTED|Overall Study||0
10102506|NCT02416102|11232045|FG000|COMPLETED|Overall Study||7
10102507|NCT02416102|11232046|FG001|COMPLETED|Overall Study||7
10102508|NCT02416102|11232047|FG002|COMPLETED|Overall Study||0
10102509|NCT02416102|11232045|FG000|NOT COMPLETED|Overall Study||9
10102510|NCT02416102|11232046|FG001|NOT COMPLETED|Overall Study||8
10102511|NCT02416102|11232047|FG002|NOT COMPLETED|Overall Study||0
10102512|NCT02416180|11232055|FG000|STARTED|Overall Study||111
10102513|NCT02416180|11232055|FG000|COMPLETED|Overall Study||110
10102514|NCT02416180|11232055|FG000|NOT COMPLETED|Overall Study||1
10102515|NCT02416193|11232061|FG000|STARTED|Overall Study||15
9995488|NCT01683994|11117115|FG001|COMPLETED|Overall Study||8
9995489|NCT01683994|11117116|FG002|COMPLETED|Overall Study||7
9995490|NCT01683994|11117117|FG003|COMPLETED|Overall Study||10
9995491|NCT01683994|11117118|FG004|COMPLETED|Overall Study||12
9995492|NCT01683994|11117114|FG000|NOT COMPLETED|Overall Study||1
9995493|NCT01683994|11117115|FG001|NOT COMPLETED|Overall Study||0
9995494|NCT01683994|11117116|FG002|NOT COMPLETED|Overall Study||0
9995495|NCT01683994|11117117|FG003|NOT COMPLETED|Overall Study||3
9995496|NCT01683994|11117118|FG004|NOT COMPLETED|Overall Study||1
9995497|NCT01684007|11117138|FG000|STARTED|Overall Study||53
9995498|NCT01684007|11117139|FG001|STARTED|Overall Study||50
9995499|NCT01684007|11117138|FG000|COMPLETED|Overall Study||53
9995500|NCT01684007|11117139|FG001|COMPLETED|Overall Study||50
9995501|NCT01684007|11117138|FG000|NOT COMPLETED|Overall Study||0
9995502|NCT01684007|11117139|FG001|NOT COMPLETED|Overall Study||0
9995503|NCT01684020|11117147|FG000|STARTED|Overall Study||5
9995504|NCT01684020|11117148|FG001|STARTED|Overall Study||5
9995505|NCT01684020|11117147|FG000|COMPLETED|Overall Study||4
9995506|NCT01684020|11117148|FG001|COMPLETED|Overall Study||5
9995507|NCT01684020|11117147|FG000|NOT COMPLETED|Overall Study||1
9995508|NCT01684020|11117148|FG001|NOT COMPLETED|Overall Study||0
9995509|NCT01684033|11117154|FG000|STARTED|Period 1, First 30 Days||99
9995510|NCT01684033|11117155|FG001|STARTED|Period 1, First 30 Days||99
9995511|NCT01684033|11117154|FG000|COMPLETED|Period 1, First 30 Days||95
9995512|NCT01684033|11117155|FG001|COMPLETED|Period 1, First 30 Days||98
9995513|NCT01684033|11117154|FG000|NOT COMPLETED|Period 1, First 30 Days||4
9995514|NCT01684033|11117155|FG001|NOT COMPLETED|Period 1, First 30 Days||1
9995515|NCT01684033|11117154|FG000|STARTED|Period 2, Second 30 Days||95
9995516|NCT01684033|11117155|FG001|STARTED|Period 2, Second 30 Days||98
9995517|NCT01684033|11117154|FG000|COMPLETED|Period 2, Second 30 Days||94
9995518|NCT01684033|11117155|FG001|COMPLETED|Period 2, Second 30 Days||98
9995519|NCT01684033|11117154|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
9995520|NCT01684033|11117155|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
9995521|NCT01684046|11117161|FG000|STARTED|Period 1, First 30 Days||97
9995522|NCT01684046|11117162|FG001|STARTED|Period 1, First 30 Days||95
9995523|NCT01684046|11117161|FG000|COMPLETED|Period 1, First 30 Days||97
9995524|NCT01684046|11117162|FG001|COMPLETED|Period 1, First 30 Days||93
9995525|NCT01684046|11117161|FG000|NOT COMPLETED|Period 1, First 30 Days||0
9995526|NCT01684046|11117162|FG001|NOT COMPLETED|Period 1, First 30 Days||2
9995527|NCT01684046|11117161|FG000|STARTED|Period 2, Second 30 Days||97
9995528|NCT01684046|11117162|FG001|STARTED|Period 2, Second 30 Days||93
9995529|NCT01684046|11117161|FG000|COMPLETED|Period 2, Second 30 Days||97
9995530|NCT01684046|11117162|FG001|COMPLETED|Period 2, Second 30 Days||93
9995531|NCT01684046|11117161|FG000|NOT COMPLETED|Period 2, Second 30 Days||0
9995532|NCT01684046|11117162|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
9995533|NCT01684202|11117172|FG000|STARTED|Dose-escalation Period||15
9995534|NCT01684202|11117173|FG001|STARTED|Dose-escalation Period||8
9995535|NCT01684202|11117174|FG002|STARTED|Dose-escalation Period||9
9995536|NCT01684202|11117175|FG003|STARTED|Dose-escalation Period||11
9995537|NCT01684202|11117172|FG000|COMPLETED|Dose-escalation Period||14
9995538|NCT01684202|11117173|FG001|COMPLETED|Dose-escalation Period||7
9995539|NCT01684202|11117174|FG002|COMPLETED|Dose-escalation Period||9
9995540|NCT01684202|11117175|FG003|COMPLETED|Dose-escalation Period||11
9995541|NCT01684202|11117172|FG000|NOT COMPLETED|Dose-escalation Period||1
9995542|NCT01684202|11117173|FG001|NOT COMPLETED|Dose-escalation Period||1
9995543|NCT01684202|11117174|FG002|NOT COMPLETED|Dose-escalation Period||0
9995544|NCT01684202|11117175|FG003|NOT COMPLETED|Dose-escalation Period||0
9995545|NCT01684202|11117172|FG000|STARTED|Maintenance Period||14
9995546|NCT01684202|11117173|FG001|STARTED|Maintenance Period||7
9995547|NCT01684202|11117174|FG002|STARTED|Maintenance Period||9
9995548|NCT01684202|11117175|FG003|STARTED|Maintenance Period||11
9995549|NCT01684202|11117172|FG000|COMPLETED|Maintenance Period||13
9995550|NCT01684202|11117173|FG001|COMPLETED|Maintenance Period||4
9995551|NCT01684202|11117174|FG002|COMPLETED|Maintenance Period||8
9995552|NCT01684202|11117175|FG003|COMPLETED|Maintenance Period||10
9995553|NCT01684202|11117172|FG000|NOT COMPLETED|Maintenance Period||1
9995554|NCT01684202|11117173|FG001|NOT COMPLETED|Maintenance Period||3
9995555|NCT01684202|11117174|FG002|NOT COMPLETED|Maintenance Period||1
9995556|NCT01684202|11117175|FG003|NOT COMPLETED|Maintenance Period||1
9995557|NCT01684215|11117189|FG000|STARTED|Phase 1, Part 1||6
9995558|NCT01684215|11117190|FG001|STARTED|Phase 1, Part 1||6
9995559|NCT01684215|11117191|FG002|STARTED|Phase 1, Part 1||0
9995560|NCT01684215|11117192|FG003|STARTED|Phase 1, Part 1||0
9995561|NCT01684215|11117189|FG000|Treated|Phase 1, Part 1||6
9995562|NCT01684215|11117190|FG001|Treated|Phase 1, Part 1||6
9995563|NCT01684215|11117191|FG002|Treated|Phase 1, Part 1||0
9995564|NCT01684215|11117192|FG003|Treated|Phase 1, Part 1||0
9995565|NCT01684215|11117189|FG000|COMPLETED|Phase 1, Part 1||0
9995566|NCT01684215|11117190|FG001|COMPLETED|Phase 1, Part 1||0
9995567|NCT01684215|11117191|FG002|COMPLETED|Phase 1, Part 1||0
9995568|NCT01684215|11117192|FG003|COMPLETED|Phase 1, Part 1||0
9995569|NCT01684215|11117189|FG000|NOT COMPLETED|Phase 1, Part 1||6
9995570|NCT01684215|11117190|FG001|NOT COMPLETED|Phase 1, Part 1||6
9995571|NCT01684215|11117191|FG002|NOT COMPLETED|Phase 1, Part 1||0
9995572|NCT01684215|11117192|FG003|NOT COMPLETED|Phase 1, Part 1||0
9995573|NCT01684215|11117189|FG000|STARTED|Phase 1, Part 2||0
9995574|NCT01684215|11117190|FG001|STARTED|Phase 1, Part 2||0
9995575|NCT01684215|11117191|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
9995576|NCT01684215|11117192|FG003|STARTED|Phase 1, Part 2||0
9995577|NCT01684215|11117189|FG000|COMPLETED|Phase 1, Part 2||0
9995578|NCT01684215|11117190|FG001|COMPLETED|Phase 1, Part 2||0
9995579|NCT01684215|11117191|FG002|COMPLETED|Phase 1, Part 2||0
9995580|NCT01684215|11117192|FG003|COMPLETED|Phase 1, Part 2||0
9995581|NCT01684215|11117189|FG000|NOT COMPLETED|Phase 1, Part 2||0
9995582|NCT01684215|11117190|FG001|NOT COMPLETED|Phase 1, Part 2||0
9995583|NCT01684215|11117191|FG002|NOT COMPLETED|Phase 1, Part 2||6
9995584|NCT01684215|11117192|FG003|NOT COMPLETED|Phase 1, Part 2||0
9995585|NCT01684215|11117189|FG000|STARTED|Phase 2||0
9995586|NCT01684215|11117190|FG001|STARTED|Phase 2||0
9995587|NCT01684215|11117191|FG002|STARTED|Phase 2||0
9995588|NCT01684215|11117192|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
9995589|NCT01684215|11117189|FG000|Treated|Phase 2||0
9995590|NCT01684215|11117190|FG001|Treated|Phase 2||0
10102516|NCT02416193|11232062|FG001|STARTED|Overall Study||15
10102517|NCT02416193|11232061|FG000|COMPLETED|Overall Study||15
10102518|NCT02416193|11232062|FG001|COMPLETED|Overall Study||15
10102519|NCT02416193|11232061|FG000|NOT COMPLETED|Overall Study||0
10102520|NCT02416193|11232062|FG001|NOT COMPLETED|Overall Study||0
10102521|NCT02416453|11232079|FG000|STARTED|Overall Study||10
10102522|NCT02416453|11232080|FG001|STARTED|Overall Study||10
10102523|NCT02416453|11232081|FG002|STARTED|Overall Study||10
10102524|NCT02416453|11232082|FG003|STARTED|Overall Study||112
9995591|NCT01684215|11117191|FG002|Treated|Phase 2||0
9995592|NCT01684215|11117192|FG003|Treated|Phase 2||42
9995593|NCT01684215|11117189|FG000|COMPLETED|Phase 2||0
9995594|NCT01684215|11117190|FG001|COMPLETED|Phase 2||0
9995595|NCT01684215|11117191|FG002|COMPLETED|Phase 2||0
9995596|NCT01684215|11117192|FG003|COMPLETED|Phase 2||0
9995597|NCT01684215|11117189|FG000|NOT COMPLETED|Phase 2||0
9995598|NCT01684215|11117190|FG001|NOT COMPLETED|Phase 2||0
9995599|NCT01684215|11117191|FG002|NOT COMPLETED|Phase 2||0
9995600|NCT01684215|11117192|FG003|NOT COMPLETED|Phase 2||43
9995601|NCT01684410|11117208|FG000|STARTED|Overall Study||10
9995602|NCT01684410|11117209|FG001|STARTED|Overall Study||10
9995603|NCT01684410|11117210|FG002|STARTED|Overall Study||10
9995604|NCT01684410|11117208|FG000|COMPLETED|Overall Study||10
9995605|NCT01684410|11117209|FG001|COMPLETED|Overall Study||10
9995606|NCT01684410|11117210|FG002|COMPLETED|Overall Study||10
9995607|NCT01684410|11117208|FG000|NOT COMPLETED|Overall Study||0
9995608|NCT01684410|11117209|FG001|NOT COMPLETED|Overall Study||0
9995609|NCT01684410|11117210|FG002|NOT COMPLETED|Overall Study||0
9995610|NCT01684423|11117223|FG000|STARTED|Overall Study||11
9995611|NCT01684423|11117224|FG001|STARTED|Overall Study||13
9995612|NCT01684423|11117225|FG002|STARTED|Overall Study||13
9995613|NCT01684423|11117226|FG003|STARTED|Overall Study||19
9995614|NCT01684423|11117227|FG004|STARTED|Overall Study||7
9995615|NCT01684423|11117223|FG000|COMPLETED|Overall Study||11
9995616|NCT01684423|11117224|FG001|COMPLETED|Overall Study||13
9995617|NCT01684423|11117225|FG002|COMPLETED|Overall Study||12
9995618|NCT01684423|11117226|FG003|COMPLETED|Overall Study||19
9995619|NCT01684423|11117227|FG004|COMPLETED|Overall Study||7
9995620|NCT01684423|11117223|FG000|NOT COMPLETED|Overall Study||0
9995621|NCT01684423|11117224|FG001|NOT COMPLETED|Overall Study||0
9995622|NCT01684423|11117225|FG002|NOT COMPLETED|Overall Study||1
9995623|NCT01684423|11117226|FG003|NOT COMPLETED|Overall Study||0
9995624|NCT01684423|11117227|FG004|NOT COMPLETED|Overall Study||0
9995625|NCT01684436|11117241|FG000|STARTED|Overall Study||30
9995626|NCT01684436|11117241|FG000|COMPLETED|Overall Study||29
9995627|NCT01684436|11117241|FG000|NOT COMPLETED|Overall Study||1
9995628|NCT01684566|11117247|FG000|STARTED|Overall Study||60
9995629|NCT01684566|11117248|FG001|STARTED|Overall Study||56
9995630|NCT01684566|11117247|FG000|Treated (ITT)|Overall Study||57
9995631|NCT01684566|11117248|FG001|Treated (ITT)|Overall Study||52
9995632|NCT01684566|11117247|FG000|COMPLETED|Overall Study||44
9995633|NCT01684566|11117248|FG001|COMPLETED|Overall Study||49
9995634|NCT01684566|11117247|FG000|NOT COMPLETED|Overall Study||16
9995635|NCT01684566|11117248|FG001|NOT COMPLETED|Overall Study||7
9995636|NCT01684592|11117256|FG000|STARTED|Overall Study||64
9995637|NCT01684592|11117257|FG001|STARTED|Overall Study||64
9995638|NCT01684592|11117256|FG000|COMPLETED|Overall Study||38
9995639|NCT01684592|11117257|FG001|COMPLETED|Overall Study||40
9995640|NCT01684592|11117256|FG000|NOT COMPLETED|Overall Study||26
9995641|NCT01684592|11117257|FG001|NOT COMPLETED|Overall Study||24
9995642|NCT01684748|11117265|FG000|STARTED|First Intervention - 8 Weeks||10
9995643|NCT01684748|11117266|FG001|STARTED|First Intervention - 8 Weeks||10
9995644|NCT01684748|11117265|FG000|COMPLETED|First Intervention - 8 Weeks||8
9995645|NCT01684748|11117266|FG001|COMPLETED|First Intervention - 8 Weeks||8
9995646|NCT01684748|11117265|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
10102525|NCT02416453|11232083|FG004|STARTED|Overall Study||13
10102526|NCT02416453|11232084|FG005|STARTED|Overall Study||114
10102527|NCT02416453|11232085|FG006|STARTED|Overall Study||13
10102528|NCT02416453|11232086|FG007|STARTED|Overall Study||106
10102529|NCT02416453|11232087|FG008|STARTED|Overall Study||18
10102530|NCT02416453|11232088|FG009|STARTED|Overall Study||13
10102531|NCT02416453|11232089|FG010|STARTED|Overall Study||2
10102532|NCT02416453|11232079|FG000|COMPLETED|Overall Study||7
10102533|NCT02416453|11232080|FG001|COMPLETED|Overall Study||7
10102534|NCT02416453|11232081|FG002|COMPLETED|Overall Study||9
10102535|NCT02416453|11232082|FG003|COMPLETED|Overall Study||97
10102536|NCT02416453|11232083|FG004|COMPLETED|Overall Study||12
10102537|NCT02416453|11232084|FG005|COMPLETED|Overall Study||98
9995647|NCT01684748|11117266|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2
9995648|NCT01684748|11117265|FG000|STARTED|Second Intervention - 8 Weeks||8
9995649|NCT01684748|11117266|FG001|STARTED|Second Intervention - 8 Weeks||8
9995650|NCT01684748|11117265|FG000|COMPLETED|Second Intervention - 8 Weeks||8
9995651|NCT01684748|11117266|FG001|COMPLETED|Second Intervention - 8 Weeks||8
9995652|NCT01684748|11117265|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
9995653|NCT01684748|11117266|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
9995654|NCT01684839|11117272|FG000|STARTED|Overall Study||9
9995655|NCT01684839|11117272|FG000|COMPLETED|Overall Study||9
10102538|NCT02416453|11232085|FG006|COMPLETED|Overall Study||11
9995656|NCT01684839|11117272|FG000|NOT COMPLETED|Overall Study||0
9995657|NCT01684878|11117280|FG000|STARTED|Part 1: Safety Run in Phase||22
9995658|NCT01684878|11117281|FG001|STARTED|Part 1: Safety Run in Phase||28
9995659|NCT01684878|11117282|FG002|STARTED|Part 1: Safety Run in Phase||0
9995660|NCT01684878|11117283|FG003|STARTED|Part 1: Safety Run in Phase||0
9995661|NCT01684878|11117280|FG000|COMPLETED|Part 1: Safety Run in Phase||6
9995662|NCT01684878|11117281|FG001|COMPLETED|Part 1: Safety Run in Phase||5
9995663|NCT01684878|11117282|FG002|COMPLETED|Part 1: Safety Run in Phase||0
9995664|NCT01684878|11117283|FG003|COMPLETED|Part 1: Safety Run in Phase||0
9995665|NCT01684878|11117280|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16
9995666|NCT01684878|11117281|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23
9995667|NCT01684878|11117282|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0
9995668|NCT01684878|11117283|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0
9995669|NCT01684878|11117280|FG000|STARTED|Part 2: Randomized Phase||0
9995670|NCT01684878|11117281|FG001|STARTED|Part 2: Randomized Phase||0
9995671|NCT01684878|11117282|FG002|STARTED|Part 2: Randomized Phase||78
9995672|NCT01684878|11117283|FG003|STARTED|Part 2: Randomized Phase||78
9995673|NCT01684878|11117280|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
9995674|NCT01684878|11117281|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
9995675|NCT01684878|11117282|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
9995676|NCT01684878|11117283|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
9995677|NCT01684878|11117280|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0
9995678|NCT01684878|11117281|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0
9995679|NCT01684878|11117282|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2
9995680|NCT01684878|11117283|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0
9995681|NCT01684878|11117280|FG000|COMPLETED|Part 2: Randomized Phase||0
9995682|NCT01684878|11117281|FG001|COMPLETED|Part 2: Randomized Phase||0
9995683|NCT01684878|11117282|FG002|COMPLETED|Part 2: Randomized Phase||0
9995684|NCT01684878|11117283|FG003|COMPLETED|Part 2: Randomized Phase||0
9995685|NCT01684878|11117280|FG000|NOT COMPLETED|Part 2: Randomized Phase||0
9995686|NCT01684878|11117281|FG001|NOT COMPLETED|Part 2: Randomized Phase||0
9995687|NCT01684878|11117282|FG002|NOT COMPLETED|Part 2: Randomized Phase||78
9995688|NCT01684878|11117283|FG003|NOT COMPLETED|Part 2: Randomized Phase||78
9995689|NCT01684917|11117297|FG000|STARTED|Overall Study||11
9995690|NCT01684917|11117298|FG001|STARTED|Overall Study||7
9995691|NCT01684917|11117299|FG002|STARTED|Overall Study||13
9995692|NCT01684917|11117300|FG003|STARTED|Overall Study||5
9995693|NCT01684917|11117297|FG000|COMPLETED|Overall Study||11
9995694|NCT01684917|11117298|FG001|COMPLETED|Overall Study||7
9995695|NCT01684917|11117299|FG002|COMPLETED|Overall Study||13
9995696|NCT01684917|11117300|FG003|COMPLETED|Overall Study||5
9995697|NCT01684917|11117297|FG000|NOT COMPLETED|Overall Study||0
9995698|NCT01684917|11117298|FG001|NOT COMPLETED|Overall Study||0
9995699|NCT01684917|11117299|FG002|NOT COMPLETED|Overall Study||0
9995700|NCT01684917|11117300|FG003|NOT COMPLETED|Overall Study||0
9995701|NCT01684930|11117312|FG000|STARTED|Overall Study||12
9995702|NCT01684930|11117313|FG001|STARTED|Overall Study||14
9995703|NCT01684930|11117312|FG000|COMPLETED|Overall Study||9
9995704|NCT01684930|11117313|FG001|COMPLETED|Overall Study||13
9995705|NCT01684930|11117312|FG000|NOT COMPLETED|Overall Study||3
9995706|NCT01684930|11117313|FG001|NOT COMPLETED|Overall Study||1
9995707|NCT01684943|11117322|FG000|STARTED|Overall Study||29
9995708|NCT01684943|11117323|FG001|STARTED|Overall Study||3
9995709|NCT01684943|11117324|FG002|STARTED|Overall Study||1
9995710|NCT01684943|11117322|FG000|COMPLETED|Overall Study||20
9995711|NCT01684943|11117323|FG001|COMPLETED|Overall Study||2
9995712|NCT01684943|11117324|FG002|COMPLETED|Overall Study||0
9995713|NCT01684943|11117322|FG000|NOT COMPLETED|Overall Study||9
9995714|NCT01684943|11117323|FG001|NOT COMPLETED|Overall Study||1
9995715|NCT01684943|11117324|FG002|NOT COMPLETED|Overall Study||1
9995716|NCT01685021|11117337|FG000|STARTED|Overall Study||22
9995717|NCT01685021|11117337|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
9995718|NCT01685021|11117337|FG000|NOT COMPLETED|Overall Study||16
9995719|NCT01685047|11117341|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
9995720|NCT01685047|11117341|FG000|COMPLETED|Overall Study||396
9995721|NCT01685047|11117341|FG000|NOT COMPLETED|Overall Study||85
9995722|NCT01685060|11117345|FG000|STARTED|Overall Study||140
9995723|NCT01685060|11117345|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7
9995724|NCT01685060|11117345|FG000|Entered Survival Follow up|Overall Study||98
9995725|NCT01685060|11117345|FG000|Discontinued From Study|Overall Study||35
9995726|NCT01685060|11117345|FG000|COMPLETED|Overall Study||0
9995727|NCT01685060|11117345|FG000|NOT COMPLETED|Overall Study||140
9995728|NCT01685073|11117351|FG000|STARTED|Overall Study|Randomized|62
9995729|NCT01685073|11117352|FG001|STARTED|Overall Study|Randomized|65
9995730|NCT01685073|11117351|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
9995731|NCT01685073|11117352|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
9995732|NCT01685073|11117351|FG000|NOT COMPLETED|Overall Study||30
9995733|NCT01685073|11117352|FG001|NOT COMPLETED|Overall Study||32
9995734|NCT01685138|11117358|FG000|STARTED|Overall Study||124
9995735|NCT01685138|11117358|FG000|Discontinued From Treatment Phase|Overall Study||124
9995736|NCT01685138|11117358|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10
9995737|NCT01685138|11117358|FG000|Entered Survival Follow-up|Overall Study||63
9995738|NCT01685138|11117358|FG000|Discontinued From Study|Overall Study||51
10102539|NCT02416453|11232086|FG007|COMPLETED|Overall Study||94
10102540|NCT02416453|11232087|FG008|COMPLETED|Overall Study||13
10102541|NCT02416453|11232088|FG009|COMPLETED|Overall Study||13
10102542|NCT02416453|11232089|FG010|COMPLETED|Overall Study||2
10102543|NCT02416453|11232079|FG000|NOT COMPLETED|Overall Study||3
10102544|NCT02416453|11232080|FG001|NOT COMPLETED|Overall Study||3
10102545|NCT02416453|11232081|FG002|NOT COMPLETED|Overall Study||1
10102546|NCT02416453|11232082|FG003|NOT COMPLETED|Overall Study||15
10102547|NCT02416453|11232083|FG004|NOT COMPLETED|Overall Study||1
10102548|NCT02416453|11232084|FG005|NOT COMPLETED|Overall Study||16
10102549|NCT02416453|11232085|FG006|NOT COMPLETED|Overall Study||2
10102550|NCT02416453|11232086|FG007|NOT COMPLETED|Overall Study||12
9995739|NCT01685138|11117358|FG000|COMPLETED|Overall Study||32
9995740|NCT01685138|11117358|FG000|NOT COMPLETED|Overall Study||92
9995741|NCT01685203|11117369|FG000|STARTED|Overall Study||44
9995742|NCT01685203|11117370|FG001|STARTED|Overall Study||42
9995743|NCT01685203|11117371|FG002|STARTED|Overall Study||40
9995744|NCT01685203|11117372|FG003|STARTED|Overall Study||42
9995745|NCT01685203|11117373|FG004|STARTED|Overall Study||49
9995746|NCT01685203|11117374|FG005|STARTED|Overall Study||47
9995747|NCT01685203|11117375|FG006|STARTED|Overall Study||52
9995748|NCT01685203|11117369|FG000|Completed Study Drug|Overall Study||42
9995749|NCT01685203|11117370|FG001|Completed Study Drug|Overall Study||40
9995750|NCT01685203|11117371|FG002|Completed Study Drug|Overall Study||39
9995751|NCT01685203|11117372|FG003|Completed Study Drug|Overall Study||42
9995752|NCT01685203|11117373|FG004|Completed Study Drug|Overall Study||49
9995753|NCT01685203|11117374|FG005|Completed Study Drug|Overall Study||43
9995754|NCT01685203|11117375|FG006|Completed Study Drug|Overall Study||52
9995755|NCT01685203|11117369|FG000|COMPLETED|Overall Study||40
9995756|NCT01685203|11117370|FG001|COMPLETED|Overall Study||39
9995757|NCT01685203|11117371|FG002|COMPLETED|Overall Study||40
9995758|NCT01685203|11117372|FG003|COMPLETED|Overall Study||41
9995759|NCT01685203|11117373|FG004|COMPLETED|Overall Study||49
9995760|NCT01685203|11117374|FG005|COMPLETED|Overall Study||44
9995761|NCT01685203|11117375|FG006|COMPLETED|Overall Study||52
9995762|NCT01685203|11117369|FG000|NOT COMPLETED|Overall Study||4
9995763|NCT01685203|11117370|FG001|NOT COMPLETED|Overall Study||3
9995764|NCT01685203|11117371|FG002|NOT COMPLETED|Overall Study||0
9995765|NCT01685203|11117372|FG003|NOT COMPLETED|Overall Study||1
9995766|NCT01685203|11117373|FG004|NOT COMPLETED|Overall Study||0
9995767|NCT01685203|11117374|FG005|NOT COMPLETED|Overall Study||3
9995768|NCT01685203|11117375|FG006|NOT COMPLETED|Overall Study||0
9995769|NCT01685216|11117391|FG000|STARTED|Overall Study||7
9995770|NCT01685216|11117391|FG000|COMPLETED|Overall Study||6
9995771|NCT01685216|11117391|FG000|NOT COMPLETED|Overall Study||1
9995772|NCT01685229|11117397|FG000|STARTED|Overall Study||146
9995773|NCT01685229|11117398|FG001|STARTED|Overall Study||52
9995774|NCT01685229|11117397|FG000|COMPLETED|Overall Study||120
9995775|NCT01685229|11117398|FG001|COMPLETED|Overall Study||36
10102551|NCT02416453|11232087|FG008|NOT COMPLETED|Overall Study||5
10102552|NCT02416453|11232088|FG009|NOT COMPLETED|Overall Study||0
10102553|NCT02416453|11232089|FG010|NOT COMPLETED|Overall Study||0
10102554|NCT02416622|11232122|FG000|STARTED|Overall Study||6
10102555|NCT02416622|11232123|FG001|STARTED|Overall Study||8
10102556|NCT02416622|11232124|FG002|STARTED|Overall Study||13
10102557|NCT02416622|11232122|FG000|Completed Month 12|Overall Study||6
10102558|NCT02416622|11232123|FG001|Completed Month 12|Overall Study||8
10102559|NCT02416622|11232124|FG002|Completed Month 12|Overall Study||13
10102560|NCT02416622|11232122|FG000|Started Long-Term Follow-Up|Overall Study||6
10102561|NCT02416622|11232123|FG001|Started Long-Term Follow-Up|Overall Study||8
10102562|NCT02416622|11232124|FG002|Started Long-Term Follow-Up|Overall Study||13
9995776|NCT01685229|11117397|FG000|NOT COMPLETED|Overall Study||26
9995777|NCT01685229|11117398|FG001|NOT COMPLETED|Overall Study||16
9995778|NCT01685242|11117409|FG000|STARTED|Overall Study||50
9995779|NCT01685242|11117410|FG001|STARTED|Overall Study||50
9995780|NCT01685242|11117409|FG000|COMPLETED|Overall Study||49
9995781|NCT01685242|11117410|FG001|COMPLETED|Overall Study||47
9995782|NCT01685242|11117409|FG000|NOT COMPLETED|Overall Study||1
9995783|NCT01685242|11117410|FG001|NOT COMPLETED|Overall Study||3
9995784|NCT01685320|11117418|FG000|STARTED|Overall Study||15
9995785|NCT01685320|11117419|FG001|STARTED|Overall Study||15
9995786|NCT01685320|11117418|FG000|COMPLETED|Overall Study||15
9995787|NCT01685320|11117419|FG001|COMPLETED|Overall Study||15
10102563|NCT02416622|11232122|FG000|COMPLETED|Overall Study||0
10102564|NCT02416622|11232123|FG001|COMPLETED|Overall Study||0
10102565|NCT02416622|11232124|FG002|COMPLETED|Overall Study||0
10102566|NCT02416622|11232122|FG000|NOT COMPLETED|Overall Study||6
10102567|NCT02416622|11232123|FG001|NOT COMPLETED|Overall Study||8
10102568|NCT02416622|11232124|FG002|NOT COMPLETED|Overall Study||13
10102569|NCT02416713|11232136|FG000|STARTED|Overall Study||8
10102570|NCT02416713|11232137|FG001|STARTED|Overall Study||9
10102571|NCT02416713|11232138|FG002|STARTED|Overall Study||8
9995788|NCT01685320|11117418|FG000|NOT COMPLETED|Overall Study||0
9995789|NCT01685320|11117419|FG001|NOT COMPLETED|Overall Study||0
9995790|NCT01685372|11117427|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
9995791|NCT01685372|11117428|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
9995792|NCT01685372|11117427|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
9995793|NCT01685372|11117428|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
10019166|NCT01828255|11142327|FG001|STARTED|Overall Study||20
9995794|NCT01685372|11117427|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
9995795|NCT01685372|11117428|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
9995796|NCT01685372|11117427|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
9995797|NCT01685372|11117428|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
9995798|NCT01685372|11117427|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
9995799|NCT01685372|11117428|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
9995800|NCT01685372|11117427|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
9995801|NCT01685372|11117428|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
9995802|NCT01685372|11117427|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
9995803|NCT01685372|11117428|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
9995804|NCT01685372|11117427|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
9995805|NCT01685372|11117428|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
9995806|NCT01685372|11117427|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
9995807|NCT01685372|11117428|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
9995808|NCT01685411|11117434|FG000|STARTED|Overall Study||5
9995809|NCT01685411|11117434|FG000|COMPLETED|Overall Study||5
9995810|NCT01685411|11117434|FG000|NOT COMPLETED|Overall Study||0
9995811|NCT01685437|11117438|FG000|STARTED|Overall Study||189
9995812|NCT01685437|11117438|FG000|COMPLETED|Overall Study||158
9995813|NCT01685437|11117438|FG000|NOT COMPLETED|Overall Study||31
9995814|NCT01685463|11117444|FG000|STARTED|Overall Study||10
9995815|NCT01685463|11117445|FG001|STARTED|Overall Study||8
9995816|NCT01685463|11117444|FG000|COMPLETED|Overall Study||10
9995817|NCT01685463|11117445|FG001|COMPLETED|Overall Study||8
9995818|NCT01685463|11117444|FG000|NOT COMPLETED|Overall Study||0
9995819|NCT01685463|11117445|FG001|NOT COMPLETED|Overall Study||0
9995820|NCT01685567|11117451|FG000|STARTED|Overall Study||219
9995821|NCT01685567|11117451|FG000|COMPLETED|Overall Study||219
9995822|NCT01685567|11117451|FG000|NOT COMPLETED|Overall Study||0
9995823|NCT01685684|11117457|FG000|STARTED|Titration Phase||740
9995824|NCT01685684|11117458|FG001|STARTED|Titration Phase||0
9995825|NCT01685684|11117459|FG002|STARTED|Titration Phase||0
9995826|NCT01685684|11117457|FG000|COMPLETED|Titration Phase||389
9995827|NCT01685684|11117458|FG001|COMPLETED|Titration Phase||0
9995828|NCT01685684|11117459|FG002|COMPLETED|Titration Phase||0
9995829|NCT01685684|11117457|FG000|NOT COMPLETED|Titration Phase||351
9995830|NCT01685684|11117458|FG001|NOT COMPLETED|Titration Phase||0
9995831|NCT01685684|11117459|FG002|NOT COMPLETED|Titration Phase||0
9995832|NCT01685684|11117457|FG000|STARTED|Double-blind Maintenance Phase||0
9995833|NCT01685684|11117458|FG001|STARTED|Double-blind Maintenance Phase||193
9995834|NCT01685684|11117459|FG002|STARTED|Double-blind Maintenance Phase||196
9995835|NCT01685684|11117457|FG000|COMPLETED|Double-blind Maintenance Phase||0
9995836|NCT01685684|11117458|FG001|COMPLETED|Double-blind Maintenance Phase||122
9995837|NCT01685684|11117459|FG002|COMPLETED|Double-blind Maintenance Phase||100
9995838|NCT01685684|11117457|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
9995839|NCT01685684|11117458|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71
9995840|NCT01685684|11117459|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96
9995841|NCT01685697|11117469|FG000|STARTED|Overall Study||31
9995842|NCT01685697|11117470|FG001|STARTED|Overall Study||31
9995843|NCT01685697|11117469|FG000|COMPLETED|Overall Study||28
9995844|NCT01685697|11117470|FG001|COMPLETED|Overall Study||28
9995845|NCT01685697|11117469|FG000|NOT COMPLETED|Overall Study||3
9995846|NCT01685697|11117470|FG001|NOT COMPLETED|Overall Study||3
9995847|NCT01685801|11117480|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5
9995848|NCT01685801|11117481|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6
9995849|NCT01685801|11117482|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7
9995850|NCT01685801|11117483|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6
9995851|NCT01685801|11117480|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
9995852|NCT01685801|11117481|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
9995853|NCT01685801|11117482|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
9995854|NCT01685801|11117483|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
9995855|NCT01685801|11117480|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
9995856|NCT01685801|11117481|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
9995857|NCT01685801|11117482|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
9995858|NCT01685801|11117483|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
9995859|NCT01685801|11117480|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5
9995860|NCT01685801|11117481|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6
9995861|NCT01685801|11117482|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7
9995862|NCT01685801|11117483|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6
9995863|NCT01685801|11117480|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
9995864|NCT01685801|11117481|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
9995865|NCT01685801|11117482|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
9995866|NCT01685801|11117483|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
9995867|NCT01685801|11117480|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
9995868|NCT01685801|11117481|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
9995869|NCT01685801|11117482|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
9995870|NCT01685801|11117483|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
9995871|NCT01685801|11117480|FG000|STARTED|Washout Period 1 (4 Weeks)||5
9995872|NCT01685801|11117481|FG001|STARTED|Washout Period 1 (4 Weeks)||6
9995873|NCT01685801|11117482|FG002|STARTED|Washout Period 1 (4 Weeks)||7
9995874|NCT01685801|11117483|FG003|STARTED|Washout Period 1 (4 Weeks)||5
9995875|NCT01685801|11117480|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5
9995876|NCT01685801|11117481|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6
9995877|NCT01685801|11117482|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7
9995878|NCT01685801|11117483|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5
9995879|NCT01685801|11117480|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
9995880|NCT01685801|11117481|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
9995881|NCT01685801|11117482|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
9995882|NCT01685801|11117483|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
9995883|NCT01685801|11117480|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5
9995884|NCT01685801|11117481|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6
9995885|NCT01685801|11117482|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7
9995886|NCT01685801|11117483|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5
9995887|NCT01685801|11117480|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
9995888|NCT01685801|11117481|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
9995889|NCT01685801|11117482|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
9995890|NCT01685801|11117483|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
9995891|NCT01685801|11117480|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
9995892|NCT01685801|11117481|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
9995893|NCT01685801|11117482|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
9995894|NCT01685801|11117483|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
9995895|NCT01685801|11117480|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5
9995896|NCT01685801|11117481|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6
9995897|NCT01685801|11117482|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7
9995898|NCT01685801|11117483|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5
9995899|NCT01685801|11117480|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
9995900|NCT01685801|11117481|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
9995901|NCT01685801|11117482|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
9995902|NCT01685801|11117483|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
9995903|NCT01685801|11117480|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
9995904|NCT01685801|11117481|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
9995905|NCT01685801|11117482|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
9995906|NCT01685801|11117483|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
9995907|NCT01685801|11117480|FG000|STARTED|Washout Period 2 (4 Weeks)||5
9995908|NCT01685801|11117481|FG001|STARTED|Washout Period 2 (4 Weeks)||5
9995909|NCT01685801|11117482|FG002|STARTED|Washout Period 2 (4 Weeks)||7
9995910|NCT01685801|11117483|FG003|STARTED|Washout Period 2 (4 Weeks)||4
9995911|NCT01685801|11117480|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5
9995912|NCT01685801|11117481|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5
9995913|NCT01685801|11117482|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7
9995914|NCT01685801|11117483|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4
9995915|NCT01685801|11117480|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
9995916|NCT01685801|11117481|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
9995917|NCT01685801|11117482|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
9995918|NCT01685801|11117483|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
9995919|NCT01685801|11117480|FG000|STARTED|Open-label Period (8 Weeks)||5
9995920|NCT01685801|11117481|FG001|STARTED|Open-label Period (8 Weeks)||5
9995921|NCT01685801|11117482|FG002|STARTED|Open-label Period (8 Weeks)||7
9995922|NCT01685801|11117483|FG003|STARTED|Open-label Period (8 Weeks)||4
9995923|NCT01685801|11117480|FG000|COMPLETED|Open-label Period (8 Weeks)||5
9995924|NCT01685801|11117481|FG001|COMPLETED|Open-label Period (8 Weeks)||5
9995925|NCT01685801|11117482|FG002|COMPLETED|Open-label Period (8 Weeks)||7
9995926|NCT01685801|11117483|FG003|COMPLETED|Open-label Period (8 Weeks)||4
9995927|NCT01685801|11117480|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0
9995928|NCT01685801|11117481|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0
9995929|NCT01685801|11117482|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0
9995930|NCT01685801|11117483|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0
9995931|NCT01685840|11117502|FG000|STARTED|Overall Study||448
9995932|NCT01685840|11117503|FG001|STARTED|Overall Study||446
9995933|NCT01685840|11117502|FG000|COMPLETED|Overall Study||119
9995934|NCT01685840|11117503|FG001|COMPLETED|Overall Study||114
9995935|NCT01685840|11117502|FG000|NOT COMPLETED|Overall Study||329
9995936|NCT01685840|11117503|FG001|NOT COMPLETED|Overall Study||332
9995937|NCT01685983|11117511|FG000|STARTED|Overall Study||82
9995938|NCT01685983|11117511|FG000|COMPLETED|Overall Study||0
9995939|NCT01685983|11117511|FG000|NOT COMPLETED|Overall Study||82
9995940|NCT01685996|11117517|FG000|STARTED|Overall Study||34
9995941|NCT01685996|11117518|FG001|STARTED|Overall Study||40
9995942|NCT01685996|11117517|FG000|COMPLETED|Overall Study||18
9995943|NCT01685996|11117518|FG001|COMPLETED|Overall Study||27
9995944|NCT01685996|11117517|FG000|NOT COMPLETED|Overall Study||16
9995945|NCT01685996|11117518|FG001|NOT COMPLETED|Overall Study||13
9995946|NCT01686152|11117527|FG000|STARTED|Overall Study||252
9995947|NCT01686152|11117528|FG001|STARTED|Overall Study||253
9995948|NCT01686152|11117529|FG002|STARTED|Overall Study||84
9995949|NCT01686152|11117527|FG000|COMPLETED|Overall Study||211
9995950|NCT01686152|11117528|FG001|COMPLETED|Overall Study||218
9995951|NCT01686152|11117529|FG002|COMPLETED|Overall Study||75
9995952|NCT01686152|11117527|FG000|NOT COMPLETED|Overall Study||41
9995953|NCT01686152|11117528|FG001|NOT COMPLETED|Overall Study||35
9995954|NCT01686152|11117529|FG002|NOT COMPLETED|Overall Study||9
9995955|NCT01686165|11117537|FG000|STARTED|Overall Study||5
9995956|NCT01686165|11117537|FG000|COMPLETED|Overall Study||5
9995957|NCT01686165|11117537|FG000|NOT COMPLETED|Overall Study||0
9995958|NCT01686373|11117543|FG000|STARTED|Overall Study||34
9995959|NCT01686373|11117544|FG001|STARTED|Overall Study||40
9995960|NCT01686373|11117543|FG000|Received 15 Treatment Sessions|Overall Study||33
9995961|NCT01686373|11117544|FG001|Received 15 Treatment Sessions|Overall Study||39
9995962|NCT01686373|11117543|FG000|COMPLETED|Overall Study||31
9995963|NCT01686373|11117544|FG001|COMPLETED|Overall Study||38
9995964|NCT01686373|11117543|FG000|NOT COMPLETED|Overall Study||3
9995965|NCT01686373|11117544|FG001|NOT COMPLETED|Overall Study||2
9995966|NCT01686438|11117553|FG000|STARTED|Overall Study||15
9995967|NCT01686438|11117554|FG001|STARTED|Overall Study||35
9995968|NCT01686438|11117555|FG002|STARTED|Overall Study||37
9995969|NCT01686438|11117553|FG000|2-Week Follow Up|Overall Study||12
9995970|NCT01686438|11117554|FG001|2-Week Follow Up|Overall Study||31
9995971|NCT01686438|11117555|FG002|2-Week Follow Up|Overall Study||27
9995972|NCT01686438|11117553|FG000|3-Month Follow Up|Overall Study||7
9995973|NCT01686438|11117554|FG001|3-Month Follow Up|Overall Study||21
9995974|NCT01686438|11117555|FG002|3-Month Follow Up|Overall Study||17
9995975|NCT01686438|11117553|FG000|6-Month Follow Up|Overall Study||7
9995976|NCT01686438|11117554|FG001|6-Month Follow Up|Overall Study||26
9995977|NCT01686438|11117555|FG002|6-Month Follow Up|Overall Study||24
9995978|NCT01686438|11117553|FG000|COMPLETED|Overall Study||7
9995979|NCT01686438|11117554|FG001|COMPLETED|Overall Study||26
9995980|NCT01686438|11117555|FG002|COMPLETED|Overall Study||24
9995981|NCT01686438|11117553|FG000|NOT COMPLETED|Overall Study||8
9995982|NCT01686438|11117554|FG001|NOT COMPLETED|Overall Study||9
9995983|NCT01686438|11117555|FG002|NOT COMPLETED|Overall Study||13
9995984|NCT01686451|11117567|FG000|STARTED|Overall Study||33
9995985|NCT01686451|11117568|FG001|STARTED|Overall Study||27
9995986|NCT01686451|11117567|FG000|COMPLETED|Overall Study||33
9995987|NCT01686451|11117568|FG001|COMPLETED|Overall Study||27
9995988|NCT01686451|11117567|FG000|NOT COMPLETED|Overall Study||0
9995989|NCT01686451|11117568|FG001|NOT COMPLETED|Overall Study||0
9995990|NCT01686503|11117580|FG000|STARTED|Overall Study||66
9995991|NCT01686503|11117581|FG001|STARTED|Overall Study||66
9995992|NCT01686503|11117582|FG002|STARTED|Overall Study||66
9995993|NCT01686503|11117583|FG003|STARTED|Overall Study||33
9995994|NCT01686503|11117580|FG000|COMPLETED|Overall Study||65
9995995|NCT01686503|11117581|FG001|COMPLETED|Overall Study||63
9995996|NCT01686503|11117582|FG002|COMPLETED|Overall Study||64
9995997|NCT01686503|11117583|FG003|COMPLETED|Overall Study||32
9995998|NCT01686503|11117580|FG000|NOT COMPLETED|Overall Study||1
9995999|NCT01686503|11117581|FG001|NOT COMPLETED|Overall Study||3
9996000|NCT01686503|11117582|FG002|NOT COMPLETED|Overall Study||2
9996001|NCT01686503|11117583|FG003|NOT COMPLETED|Overall Study||1
9996002|NCT01686568|11117595|FG000|STARTED|Main Study||16
9996003|NCT01686568|11117596|FG001|STARTED|Main Study||15
9996004|NCT01686568|11117595|FG000|COMPLETED|Main Study||14
9996005|NCT01686568|11117596|FG001|COMPLETED|Main Study||11
9996006|NCT01686568|11117595|FG000|NOT COMPLETED|Main Study||2
9996007|NCT01686568|11117596|FG001|NOT COMPLETED|Main Study||4
9996008|NCT01686568|11117595|FG000|STARTED|Sub-Study||14
9996009|NCT01686568|11117596|FG001|STARTED|Sub-Study||11
9996010|NCT01686568|11117595|FG000|COMPLETED|Sub-Study||12
9996011|NCT01686568|11117596|FG001|COMPLETED|Sub-Study||9
9996012|NCT01686568|11117595|FG000|NOT COMPLETED|Sub-Study||2
9996013|NCT01686568|11117596|FG001|NOT COMPLETED|Sub-Study||2
9996014|NCT01686581|11117602|FG000|STARTED|Overall Study||641
9996015|NCT01686581|11117602|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633
9996016|NCT01686581|11117602|FG000|Completed 24 Months|Overall Study||128
9996017|NCT01686581|11117602|FG000|COMPLETED|Overall Study||464
9996018|NCT01686581|11117602|FG000|NOT COMPLETED|Overall Study||177
9996019|NCT01686633|11117609|FG000|STARTED|Overall Study||347
9996020|NCT01686633|11117610|FG001|STARTED|Overall Study||346
9996021|NCT01686633|11117611|FG002|STARTED|Overall Study||346
9996022|NCT01686633|11117609|FG000|COMPLETED|Overall Study||296
9996023|NCT01686633|11117610|FG001|COMPLETED|Overall Study||314
9996024|NCT01686633|11117611|FG002|COMPLETED|Overall Study||321
9996025|NCT01686633|11117609|FG000|NOT COMPLETED|Overall Study||51
9996026|NCT01686633|11117610|FG001|NOT COMPLETED|Overall Study||32
9996027|NCT01686633|11117611|FG002|NOT COMPLETED|Overall Study||25
9996028|NCT01686646|11117623|FG000|STARTED|Overall Study||45
9996029|NCT01686646|11117624|FG001|STARTED|Overall Study||45
9996030|NCT01686646|11117625|FG002|STARTED|Overall Study||75
9996031|NCT01686646|11117626|FG003|STARTED|Overall Study||75
9996032|NCT01686646|11117623|FG000|Intent to Treat Population|Overall Study||45
9996033|NCT01686646|11117624|FG001|Intent to Treat Population|Overall Study||45
9996034|NCT01686646|11117625|FG002|Intent to Treat Population|Overall Study||75
9996035|NCT01686646|11117626|FG003|Intent to Treat Population|Overall Study||75
9996036|NCT01686646|11117623|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
9996037|NCT01686646|11117624|FG001|Safety Population|Overall Study||45
9996038|NCT01686646|11117625|FG002|Safety Population|Overall Study||74
9996039|NCT01686646|11117626|FG003|Safety Population|Overall Study||75
9996040|NCT01686646|11117623|FG000|COMPLETED|Overall Study||45
9996041|NCT01686646|11117624|FG001|COMPLETED|Overall Study||45
9996042|NCT01686646|11117625|FG002|COMPLETED|Overall Study||75
9996043|NCT01686646|11117626|FG003|COMPLETED|Overall Study||75
9996044|NCT01686646|11117623|FG000|NOT COMPLETED|Overall Study||0
9996045|NCT01686646|11117624|FG001|NOT COMPLETED|Overall Study||0
9996046|NCT01686646|11117625|FG002|NOT COMPLETED|Overall Study||0
9996047|NCT01686646|11117626|FG003|NOT COMPLETED|Overall Study||0
9996048|NCT01686750|11117638|FG000|STARTED|Overall Study||11001
9996049|NCT01686750|11117639|FG001|STARTED|Overall Study||10725
9996050|NCT01686750|11117638|FG000|COMPLETED|Overall Study||11001
9996051|NCT01686750|11117639|FG001|COMPLETED|Overall Study||10725
9996052|NCT01686750|11117638|FG000|NOT COMPLETED|Overall Study||0
9996053|NCT01686750|11117639|FG001|NOT COMPLETED|Overall Study||0
9996054|NCT01686828|11117651|FG000|STARTED|Overall Study||13
9996055|NCT01686828|11117652|FG001|STARTED|Overall Study||14
9996056|NCT01686828|11117653|FG002|STARTED|Overall Study||13
9996057|NCT01686828|11117654|FG003|STARTED|Overall Study||13
9996058|NCT01686828|11117651|FG000|COMPLETED|Overall Study||12
9996059|NCT01686828|11117652|FG001|COMPLETED|Overall Study||13
9996060|NCT01686828|11117653|FG002|COMPLETED|Overall Study||12
9996061|NCT01686828|11117654|FG003|COMPLETED|Overall Study||13
9996062|NCT01686828|11117651|FG000|NOT COMPLETED|Overall Study||1
9996063|NCT01686828|11117652|FG001|NOT COMPLETED|Overall Study||1
9996064|NCT01686828|11117653|FG002|NOT COMPLETED|Overall Study||1
9996065|NCT01686828|11117654|FG003|NOT COMPLETED|Overall Study||0
9996066|NCT01686932|11117670|FG000|STARTED|Period 1||25
9996067|NCT01686932|11117671|FG001|STARTED|Period 1||26
9996068|NCT01686932|11117670|FG000|COMPLETED|Period 1||24
9996069|NCT01686932|11117671|FG001|COMPLETED|Period 1||25
9996070|NCT01686932|11117670|FG000|NOT COMPLETED|Period 1||1
9996071|NCT01686932|11117671|FG001|NOT COMPLETED|Period 1||1
9996072|NCT01686932|11117670|FG000|STARTED|Period 2||24
9996073|NCT01686932|11117671|FG001|STARTED|Period 2||25
9996074|NCT01686932|11117670|FG000|COMPLETED|Period 2||24
9996075|NCT01686932|11117671|FG001|COMPLETED|Period 2||25
9996076|NCT01686932|11117670|FG000|NOT COMPLETED|Period 2||0
9996077|NCT01686932|11117671|FG001|NOT COMPLETED|Period 2||0
9996078|NCT01686958|11117677|FG000|STARTED|Overall Study||30
9996079|NCT01686958|11117677|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
9996080|NCT01686958|11117677|FG000|NOT COMPLETED|Overall Study||1
9996081|NCT01687036|11117682|FG000|STARTED|Overall Study||10
9996082|NCT01687036|11117682|FG000|COMPLETED|Overall Study||10
9996083|NCT01687036|11117682|FG000|NOT COMPLETED|Overall Study||0
9996084|NCT01687088|11117688|FG000|STARTED|Overall Study||50
9996085|NCT01687088|11117689|FG001|STARTED|Overall Study||50
9996086|NCT01687088|11117688|FG000|COMPLETED|Overall Study||50
9996087|NCT01687088|11117689|FG001|COMPLETED|Overall Study||50
9996088|NCT01687088|11117688|FG000|NOT COMPLETED|Overall Study||0
9758741|NCT00554840|10862330|FG000|STARTED|Overall Study||4
9758742|NCT00554840|10862331|FG001|STARTED|Overall Study||5
9758743|NCT00554840|10862330|FG000|COMPLETED|Overall Study||4
9758744|NCT00554840|10862331|FG001|COMPLETED|Overall Study||4
9758745|NCT00554840|10862330|FG000|NOT COMPLETED|Overall Study||0
9758746|NCT00554840|10862331|FG001|NOT COMPLETED|Overall Study||1
9758747|NCT00003656|10862341|FG000|STARTED|Overall Study||12
9758748|NCT00003656|10862342|FG001|STARTED|Overall Study||14
9758749|NCT00003656|10862341|FG000|COMPLETED|Overall Study||12
9996089|NCT01687088|11117689|FG001|NOT COMPLETED|Overall Study||0
9996090|NCT01687101|11117695|FG000|STARTED|Overall Study||32
9996091|NCT01687101|11117695|FG000|COMPLETED|Overall Study||25
9996092|NCT01687101|11117695|FG000|NOT COMPLETED|Overall Study||7
9996093|NCT01687114|11117699|FG000|STARTED|Overall Study||5
9996094|NCT01687114|11117699|FG000|COMPLETED|Overall Study||5
9996095|NCT01687114|11117699|FG000|NOT COMPLETED|Overall Study||0
9996096|NCT01687166|11117707|FG000|STARTED|Overall Study||167
9996097|NCT01687166|11117708|FG001|STARTED|Overall Study||172
9996098|NCT01687166|11117709|FG002|STARTED|Overall Study||56
9996099|NCT01687166|11117710|FG003|STARTED|Overall Study||3
9996100|NCT01687166|11117707|FG000|COMPLETED|Overall Study||139
9996101|NCT01687166|11117708|FG001|COMPLETED|Overall Study||145
9996102|NCT01687166|11117709|FG002|COMPLETED|Overall Study||42
9996103|NCT01687166|11117710|FG003|COMPLETED|Overall Study||1
9996104|NCT01687166|11117707|FG000|NOT COMPLETED|Overall Study||28
9996105|NCT01687166|11117708|FG001|NOT COMPLETED|Overall Study||27
9996106|NCT01687166|11117709|FG002|NOT COMPLETED|Overall Study||14
9996107|NCT01687166|11117710|FG003|NOT COMPLETED|Overall Study||2
9996108|NCT01687179|11117718|FG000|STARTED|Overall Study||3
9996109|NCT01687179|11117719|FG001|STARTED|Overall Study||10
9996110|NCT01687179|11117718|FG000|COMPLETED|Overall Study||2
9996111|NCT01687179|11117719|FG001|COMPLETED|Overall Study||6
9996112|NCT01687179|11117718|FG000|NOT COMPLETED|Overall Study||1
9996113|NCT01687179|11117719|FG001|NOT COMPLETED|Overall Study||4
9996114|NCT01687218|11117731|FG000|STARTED|Overall Study||33
9996115|NCT01687218|11117732|FG001|STARTED|Overall Study||32
9996116|NCT01687218|11117733|FG002|STARTED|Overall Study||31
9996117|NCT01687218|11117734|FG003|STARTED|Overall Study||34
9996118|NCT01687218|11117735|FG004|STARTED|Overall Study||33
9996119|NCT01687218|11117736|FG005|STARTED|Overall Study||32
9996120|NCT01687218|11117731|FG000|COMPLETED|Overall Study||30
9996121|NCT01687218|11117732|FG001|COMPLETED|Overall Study||29
9996122|NCT01687218|11117733|FG002|COMPLETED|Overall Study||30
9996123|NCT01687218|11117734|FG003|COMPLETED|Overall Study||32
9996124|NCT01687218|11117735|FG004|COMPLETED|Overall Study||32
9996125|NCT01687218|11117736|FG005|COMPLETED|Overall Study||32
9996126|NCT01687218|11117731|FG000|NOT COMPLETED|Overall Study||3
9996127|NCT01687218|11117732|FG001|NOT COMPLETED|Overall Study||3
9996128|NCT01687218|11117733|FG002|NOT COMPLETED|Overall Study||1
9996129|NCT01687218|11117734|FG003|NOT COMPLETED|Overall Study||2
9758750|NCT00003656|10862342|FG001|COMPLETED|Overall Study||13
9758751|NCT00003656|10862341|FG000|NOT COMPLETED|Overall Study||0
9758752|NCT00003656|10862342|FG001|NOT COMPLETED|Overall Study||1
9758753|NCT00370331|10862351|FG000|STARTED|Overall Study||62
9996130|NCT01687218|11117735|FG004|NOT COMPLETED|Overall Study||1
9996131|NCT01687218|11117736|FG005|NOT COMPLETED|Overall Study||0
9996132|NCT01687244|11117746|FG000|STARTED|Overall Study||21
9996133|NCT01687244|11117747|FG001|STARTED|Overall Study||19
9996134|NCT01687244|11117746|FG000|COMPLETED|Overall Study||21
9996135|NCT01687244|11117747|FG001|COMPLETED|Overall Study||19
9996136|NCT01687244|11117746|FG000|NOT COMPLETED|Overall Study||0
9996137|NCT01687244|11117747|FG001|NOT COMPLETED|Overall Study||0
9996138|NCT01687257|11117763|FG000|STARTED|Overall Study||25
9996139|NCT01687257|11117764|FG001|STARTED|Overall Study||4
9996140|NCT01687257|11117765|FG002|STARTED|Overall Study||21
9996141|NCT01687257|11117763|FG000|COMPLETED|Overall Study||17
9996142|NCT01687257|11117764|FG001|COMPLETED|Overall Study||0
9996143|NCT01687257|11117765|FG002|COMPLETED|Overall Study||15
9996144|NCT01687257|11117763|FG000|NOT COMPLETED|Overall Study||8
9996145|NCT01687257|11117764|FG001|NOT COMPLETED|Overall Study||4
9996146|NCT01687257|11117765|FG002|NOT COMPLETED|Overall Study||6
9996147|NCT01687270|11117779|FG000|STARTED|Overall Study||40
9996148|NCT01687270|11117779|FG000|COMPLETED|Overall Study||28
9996149|NCT01687270|11117779|FG000|NOT COMPLETED|Overall Study||12
9996150|NCT01687283|11117785|FG000|STARTED|Overall Study||158
9996151|NCT01687283|11117786|FG001|STARTED|Overall Study||157
9996152|NCT01687283|11117785|FG000|COMPLETED|Overall Study||123
9996153|NCT01687283|11117786|FG001|COMPLETED|Overall Study||130
9996154|NCT01687283|11117785|FG000|NOT COMPLETED|Overall Study||35
9996155|NCT01687283|11117786|FG001|NOT COMPLETED|Overall Study||27
9996156|NCT01687296|11117794|FG000|STARTED|Overall Study||123
9996157|NCT01687296|11117795|FG001|STARTED|Overall Study||128
9996158|NCT01687296|11117794|FG000|COMPLETED|Overall Study||116
9996159|NCT01687296|11117795|FG001|COMPLETED|Overall Study||123
9996160|NCT01687296|11117794|FG000|NOT COMPLETED|Overall Study||7
9996161|NCT01687296|11117795|FG001|NOT COMPLETED|Overall Study||5
9996162|NCT01687387|11117804|FG000|STARTED|Overall Study||51
9996163|NCT01687387|11117805|FG001|STARTED|Overall Study||50
9996164|NCT01687387|11117806|FG002|STARTED|Overall Study||51
9996165|NCT01687387|11117804|FG000|COMPLETED|Overall Study||10
9996166|NCT01687387|11117805|FG001|COMPLETED|Overall Study||12
9996167|NCT01687387|11117806|FG002|COMPLETED|Overall Study||13
9996168|NCT01687387|11117804|FG000|NOT COMPLETED|Overall Study||41
9996169|NCT01687387|11117805|FG001|NOT COMPLETED|Overall Study||38
9996170|NCT01687387|11117806|FG002|NOT COMPLETED|Overall Study||38
9996171|NCT01687400|11117814|FG000|STARTED|Overall Study||114
9996172|NCT01687400|11117814|FG000|COMPLETED|Overall Study||114
9996173|NCT01687400|11117814|FG000|NOT COMPLETED|Overall Study||0
9996174|NCT01687413|11117825|FG000|STARTED|Overall Study||27
9996175|NCT01687413|11117826|FG001|STARTED|Overall Study||15
9996176|NCT01687413|11117825|FG000|COMPLETED|Overall Study||26
9996177|NCT01687413|11117826|FG001|COMPLETED|Overall Study||11
9996178|NCT01687413|11117825|FG000|NOT COMPLETED|Overall Study||1
9996179|NCT01687413|11117826|FG001|NOT COMPLETED|Overall Study||4
9996180|NCT01687478|11117852|FG000|STARTED|Overall Study||88
9996181|NCT01687478|11117853|FG001|STARTED|Overall Study||88
9996182|NCT01687478|11117852|FG000|Safety Analysis Set|Overall Study||88
9996183|NCT01687478|11117853|FG001|Safety Analysis Set|Overall Study||87
9996184|NCT01687478|11117852|FG000|COMPLETED|Overall Study||56
9996185|NCT01687478|11117853|FG001|COMPLETED|Overall Study||49
9996186|NCT01687478|11117852|FG000|NOT COMPLETED|Overall Study||32
9996187|NCT01687478|11117853|FG001|NOT COMPLETED|Overall Study||39
9996188|NCT01687595|11117861|FG000|STARTED|Overall Study||70
9996189|NCT01687595|11117862|FG001|STARTED|Overall Study||10
9996190|NCT01687595|11117861|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70
9996191|NCT01687595|11117862|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
9996192|NCT01687595|11117861|FG000|COMPLETED|Overall Study||0
9996193|NCT01687595|11117862|FG001|COMPLETED|Overall Study||0
9996194|NCT01687595|11117861|FG000|NOT COMPLETED|Overall Study||70
9996195|NCT01687595|11117862|FG001|NOT COMPLETED|Overall Study||10
9996196|NCT01687673|11117868|FG000|STARTED|Overall Study||29
9996197|NCT01687673|11117868|FG000|COMPLETED|Overall Study||28
9996198|NCT01687673|11117868|FG000|NOT COMPLETED|Overall Study||1
10018510|NCT01824290|11141612|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
10018511|NCT01824290|11141613|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
10018512|NCT01824290|11141610|FG000|Received 20 mg|Period 2: Open-Label Treatment||0
10018513|NCT01824290|11141611|FG001|Received 20 mg|Period 2: Open-Label Treatment||0
10018514|NCT01824290|11141612|FG002|Received 20 mg|Period 2: Open-Label Treatment||3
10018515|NCT01824290|11141613|FG003|Received 20 mg|Period 2: Open-Label Treatment||3
10018516|NCT01824290|11141610|FG000|Received 40 mg|Period 2: Open-Label Treatment||0
10018517|NCT01824290|11141611|FG001|Received 40 mg|Period 2: Open-Label Treatment||0
10018518|NCT01824290|11141612|FG002|Received 40 mg|Period 2: Open-Label Treatment||13
10018519|NCT01824290|11141613|FG003|Received 40 mg|Period 2: Open-Label Treatment||13
10018520|NCT01824290|11141610|FG000|COMPLETED|Period 2: Open-Label Treatment||0
10018521|NCT01824290|11141611|FG001|COMPLETED|Period 2: Open-Label Treatment||0
10018522|NCT01824290|11141612|FG002|COMPLETED|Period 2: Open-Label Treatment||13
10018523|NCT01824290|11141613|FG003|COMPLETED|Period 2: Open-Label Treatment||13
10018524|NCT01824290|11141610|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0
10018525|NCT01824290|11141611|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0
10018526|NCT01824290|11141612|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3
10018527|NCT01824290|11141613|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3
9996199|NCT01687712|11117874|FG000|STARTED|Cycle 1||549
9996200|NCT01687712|11117875|FG001|STARTED|Cycle 1||551
9996201|NCT01687712|11117874|FG000|Received hCG|Cycle 1||516
9996202|NCT01687712|11117875|FG001|Received hCG|Cycle 1||520
9996203|NCT01687712|11117874|FG000|Oocyte/Ovum Pick Up|Cycle 1||513
9996204|NCT01687712|11117875|FG001|Oocyte/Ovum Pick Up|Cycle 1||517
9996205|NCT01687712|11117874|FG000|Fertilization Performed|Cycle 1||508
9996206|NCT01687712|11117875|FG001|Fertilization Performed|Cycle 1||512
9996207|NCT01687712|11117874|FG000|Embryo Transfer|Cycle 1||466
9996208|NCT01687712|11117875|FG001|Embryo Transfer|Cycle 1||483
9996209|NCT01687712|11117874|FG000|Biochemical Pregnancy|Cycle 1||163
9996210|NCT01687712|11117875|FG001|Biochemical Pregnancy|Cycle 1||203
9996211|NCT01687712|11117874|FG000|Clinical Pregnancy|Cycle 1||114
9996212|NCT01687712|11117875|FG001|Clinical Pregnancy|Cycle 1||138
9996213|NCT01687712|11117874|FG000|COMPLETED|Cycle 1||101
9996214|NCT01687712|11117875|FG001|COMPLETED|Cycle 1||122
9996215|NCT01687712|11117874|FG000|NOT COMPLETED|Cycle 1||448
9996216|NCT01687712|11117875|FG001|NOT COMPLETED|Cycle 1||429
9996217|NCT01687712|11117874|FG000|STARTED|Cycle 2||109
9996218|NCT01687712|11117875|FG001|STARTED|Cycle 2||120
9996219|NCT01687712|11117874|FG000|Received hCG|Cycle 2||107
9996220|NCT01687712|11117875|FG001|Received hCG|Cycle 2||119
9996221|NCT01687712|11117874|FG000|Oocyte/Ovum Pick Up|Cycle 2||107
9996222|NCT01687712|11117875|FG001|Oocyte/Ovum Pick Up|Cycle 2||119
9758754|NCT00370331|10862352|FG001|STARTED|Overall Study||135
9758755|NCT00370331|10862351|FG000|COMPLETED|Overall Study||55
9758756|NCT00370331|10862352|FG001|COMPLETED|Overall Study||112
9758757|NCT00370331|10862351|FG000|NOT COMPLETED|Overall Study||7
9758758|NCT00370331|10862352|FG001|NOT COMPLETED|Overall Study||23
9758759|NCT00370396|10862361|FG000|STARTED|Overall Study||737
9758760|NCT00370396|10862362|FG001|STARTED|Overall Study||92
9758761|NCT00370396|10862363|FG002|STARTED|Overall Study||283
9758762|NCT00370396|10862361|FG000|COMPLETED|Overall Study||726
9758763|NCT00370396|10862362|FG001|COMPLETED|Overall Study||91
9758764|NCT00370396|10862363|FG002|COMPLETED|Overall Study||282
9758765|NCT00370396|10862361|FG000|NOT COMPLETED|Overall Study||11
9758766|NCT00370396|10862362|FG001|NOT COMPLETED|Overall Study||1
9758767|NCT00370396|10862363|FG002|NOT COMPLETED|Overall Study||1
9758768|NCT00370552|10862374|FG000|STARTED|Overall Study|Randomized|46
9996223|NCT01687712|11117874|FG000|Fertilization Performed|Cycle 2||106
9996224|NCT01687712|11117875|FG001|Fertilization Performed|Cycle 2||119
9996225|NCT01687712|11117874|FG000|Embryo Transfer|Cycle 2||101
9996226|NCT01687712|11117875|FG001|Embryo Transfer|Cycle 2||117
9996227|NCT01687712|11117874|FG000|Biochemical Pregnancy|Cycle 2||35
9996228|NCT01687712|11117875|FG001|Biochemical Pregnancy|Cycle 2||43
9996229|NCT01687712|11117874|FG000|Clinical Pregnancy|Cycle 2||17
9996230|NCT01687712|11117875|FG001|Clinical Pregnancy|Cycle 2||26
9996231|NCT01687712|11117874|FG000|COMPLETED|Cycle 2||16
9996232|NCT01687712|11117875|FG001|COMPLETED|Cycle 2||25
9996233|NCT01687712|11117874|FG000|NOT COMPLETED|Cycle 2||93
9996234|NCT01687712|11117875|FG001|NOT COMPLETED|Cycle 2||95
9996235|NCT01687712|11117874|FG000|STARTED|Cycle 3||28
9996236|NCT01687712|11117875|FG001|STARTED|Cycle 3||24
9996237|NCT01687712|11117874|FG000|Received hCG|Cycle 3||27
9996238|NCT01687712|11117875|FG001|Received hCG|Cycle 3||24
9996239|NCT01687712|11117874|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27
9996240|NCT01687712|11117875|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24
9996241|NCT01687712|11117874|FG000|Fertilization Performed|Cycle 3||27
9996242|NCT01687712|11117875|FG001|Fertilization Performed|Cycle 3||24
9996243|NCT01687712|11117874|FG000|Embryo Transfer|Cycle 3||26
9996244|NCT01687712|11117875|FG001|Embryo Transfer|Cycle 3||24
9996245|NCT01687712|11117874|FG000|Biochemically Pregnant|Cycle 3||7
9996246|NCT01687712|11117875|FG001|Biochemically Pregnant|Cycle 3||2
9996247|NCT01687712|11117874|FG000|Clinical Pregnancy|Cycle 3||5
9996248|NCT01687712|11117875|FG001|Clinical Pregnancy|Cycle 3||0
9996249|NCT01687712|11117874|FG000|COMPLETED|Cycle 3||4
9996250|NCT01687712|11117875|FG001|COMPLETED|Cycle 3||0
9996251|NCT01687712|11117874|FG000|NOT COMPLETED|Cycle 3||24
9996252|NCT01687712|11117875|FG001|NOT COMPLETED|Cycle 3||24
9996253|NCT01687790|11117885|FG000|STARTED|Overall Study||60
9996254|NCT01687790|11117885|FG000|COMPLETED|Overall Study||60
9996255|NCT01687790|11117885|FG000|NOT COMPLETED|Overall Study||0
9996256|NCT01687972|11117892|FG000|STARTED|Overall Study||44
9996257|NCT01687972|11117893|FG001|STARTED|Overall Study||44
9996258|NCT01687972|11117892|FG000|COMPLETED|Overall Study||44
9996259|NCT01687972|11117893|FG001|COMPLETED|Overall Study||44
9996260|NCT01687972|11117892|FG000|NOT COMPLETED|Overall Study||0
9996261|NCT01687972|11117893|FG001|NOT COMPLETED|Overall Study||0
9996262|NCT01687998|11117901|FG000|STARTED|Overall Study||6038
9996263|NCT01687998|11117902|FG001|STARTED|Overall Study||6054
9758769|NCT00370552|10862375|FG001|STARTED|Overall Study|Randomized|45
9758770|NCT00370552|10862376|FG002|STARTED|Overall Study|Randomized|32
9758771|NCT00370552|10862374|FG000|COMPLETED|Overall Study||0
9758772|NCT00370552|10862375|FG001|COMPLETED|Overall Study||0
9996264|NCT01687998|11117901|FG000|Received at Least One Dose of Study Drug|Overall Study||6036
9996265|NCT01687998|11117902|FG001|Received at Least One Dose of Study Drug|Overall Study||6052
9996266|NCT01687998|11117901|FG000|COMPLETED|Overall Study||5926
9996267|NCT01687998|11117902|FG001|COMPLETED|Overall Study||5934
9996268|NCT01687998|11117901|FG000|NOT COMPLETED|Overall Study||112
9996269|NCT01687998|11117902|FG001|NOT COMPLETED|Overall Study||120
9996270|NCT01688037|11117911|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54
9996271|NCT01688037|11117912|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28
9996272|NCT01688037|11117913|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27
9996273|NCT01688037|11117911|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47
9996274|NCT01688037|11117912|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25
9996275|NCT01688037|11117913|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21
9996276|NCT01688037|11117911|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
9996277|NCT01688037|11117912|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
9996278|NCT01688037|11117913|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
9996279|NCT01688037|11117911|FG000|STARTED|Open-Label Period (Week 6 to 12)||47
9996280|NCT01688037|11117912|FG001|STARTED|Open-Label Period (Week 6 to 12)||25
9996281|NCT01688037|11117913|FG002|STARTED|Open-Label Period (Week 6 to 12)||21
9996282|NCT01688037|11117911|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42
9996283|NCT01688037|11117912|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22
9996284|NCT01688037|11117913|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17
9996285|NCT01688037|11117911|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
9996286|NCT01688037|11117912|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
9996287|NCT01688037|11117913|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
9996288|NCT01688037|11117911|FG000|STARTED|Follow-up Period (Week 12 to 16)||42
9996289|NCT01688037|11117912|FG001|STARTED|Follow-up Period (Week 12 to 16)||22
9996290|NCT01688037|11117913|FG002|STARTED|Follow-up Period (Week 12 to 16)||17
9996291|NCT01688037|11117911|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42
9996292|NCT01688037|11117912|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21
9996293|NCT01688037|11117913|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17
9996294|NCT01688037|11117911|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
9996295|NCT01688037|11117912|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
9996296|NCT01688037|11117913|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
9996297|NCT01688050|11117925|FG000|STARTED|Overall Study||50
10102572|NCT02416713|11232139|FG003|STARTED|Overall Study||10
10102573|NCT02416713|11232136|FG000|COMPLETED|Overall Study||8
10102574|NCT02416713|11232137|FG001|COMPLETED|Overall Study||9
10102575|NCT02416713|11232138|FG002|COMPLETED|Overall Study||8
10102576|NCT02416713|11232139|FG003|COMPLETED|Overall Study||10
10102577|NCT02416713|11232136|FG000|NOT COMPLETED|Overall Study||0
10102578|NCT02416713|11232137|FG001|NOT COMPLETED|Overall Study||0
10102579|NCT02416713|11232138|FG002|NOT COMPLETED|Overall Study||0
10102580|NCT02416713|11232139|FG003|NOT COMPLETED|Overall Study||0
10102581|NCT02416791|11232152|FG000|STARTED|6 Weeks||3
10102582|NCT02416791|11232153|FG001|STARTED|6 Weeks||3
10102583|NCT02416791|11232154|FG002|STARTED|6 Weeks||3
10102584|NCT02416791|11232152|FG000|COMPLETED|6 Weeks||3
10102585|NCT02416791|11232153|FG001|COMPLETED|6 Weeks||3
10102586|NCT02416791|11232154|FG002|COMPLETED|6 Weeks||3
10102587|NCT02416791|11232152|FG000|NOT COMPLETED|6 Weeks||0
10102588|NCT02416791|11232153|FG001|NOT COMPLETED|6 Weeks||0
10102589|NCT02416791|11232154|FG002|NOT COMPLETED|6 Weeks||0
10102590|NCT02416791|11232152|FG000|STARTED|6 Months||3
10102591|NCT02416791|11232153|FG001|STARTED|6 Months||3
10102592|NCT02416791|11232154|FG002|STARTED|6 Months||3
10102593|NCT02416791|11232152|FG000|COMPLETED|6 Months||3
10102594|NCT02416791|11232153|FG001|COMPLETED|6 Months||3
10102595|NCT02416791|11232154|FG002|COMPLETED|6 Months||2
10102596|NCT02416791|11232152|FG000|NOT COMPLETED|6 Months||0
10102597|NCT02416791|11232153|FG001|NOT COMPLETED|6 Months||0
10102598|NCT02416791|11232154|FG002|NOT COMPLETED|6 Months||1
10102599|NCT02416908|11232165|FG000|STARTED|Dose Escalation Phase||6
10102600|NCT02416908|11232166|FG001|STARTED|Dose Escalation Phase||0
10102601|NCT02416908|11232167|FG002|STARTED|Dose Escalation Phase||34
10102602|NCT02416908|11232168|FG003|STARTED|Dose Escalation Phase||0
10102603|NCT02416908|11232165|FG000|COMPLETED|Dose Escalation Phase||6
10102604|NCT02416908|11232166|FG001|COMPLETED|Dose Escalation Phase||0
10102605|NCT02416908|11232167|FG002|COMPLETED|Dose Escalation Phase||30
10102606|NCT02416908|11232168|FG003|COMPLETED|Dose Escalation Phase||0
10102607|NCT02416908|11232165|FG000|NOT COMPLETED|Dose Escalation Phase||0
10102608|NCT02416908|11232166|FG001|NOT COMPLETED|Dose Escalation Phase||0
10102609|NCT02416908|11232167|FG002|NOT COMPLETED|Dose Escalation Phase||4
10102610|NCT02416908|11232168|FG003|NOT COMPLETED|Dose Escalation Phase||0
10102611|NCT02416908|11232165|FG000|STARTED|Maintenance Phase||0
10102612|NCT02416908|11232166|FG001|STARTED|Maintenance Phase||0
10102613|NCT02416908|11232167|FG002|STARTED|Maintenance Phase||0
10102614|NCT02416908|11232168|FG003|STARTED|Maintenance Phase||2
10102615|NCT02416908|11232165|FG000|COMPLETED|Maintenance Phase||0
10102616|NCT02416908|11232166|FG001|COMPLETED|Maintenance Phase||0
10102617|NCT02416908|11232167|FG002|COMPLETED|Maintenance Phase||0
10102618|NCT02416908|11232168|FG003|COMPLETED|Maintenance Phase||2
10102619|NCT02416908|11232165|FG000|NOT COMPLETED|Maintenance Phase||0
10102620|NCT02416908|11232166|FG001|NOT COMPLETED|Maintenance Phase||0
10102621|NCT02416908|11232167|FG002|NOT COMPLETED|Maintenance Phase||0
10102622|NCT02416908|11232168|FG003|NOT COMPLETED|Maintenance Phase||0
10102623|NCT02416934|11232177|FG000|STARTED|Overall Study||36
10102624|NCT02416934|11232178|FG001|STARTED|Overall Study||38
10102625|NCT02416934|11232177|FG000|Double Blind (0-52 Weeks)|Overall Study||36
10102626|NCT02416934|11232178|FG001|Double Blind (0-52 Weeks)|Overall Study||38
10102627|NCT02416934|11232177|FG000|Last Participant Completed 1 yr|Overall Study||33
10102628|NCT02416934|11232178|FG001|Last Participant Completed 1 yr|Overall Study||31
10102629|NCT02416934|11232177|FG000|COMPLETED|Overall Study||33
10102630|NCT02416934|11232178|FG001|COMPLETED|Overall Study||31
10102631|NCT02416934|11232177|FG000|NOT COMPLETED|Overall Study||3
10102632|NCT02416934|11232178|FG001|NOT COMPLETED|Overall Study||7
10102633|NCT02416973|11232193|FG000|STARTED|Overall Study||14
10102634|NCT02416973|11232194|FG001|STARTED|Overall Study||13
9996298|NCT01688050|11117925|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
9996299|NCT01688050|11117925|FG000|COMPLETED|Overall Study||19
9996300|NCT01688050|11117925|FG000|NOT COMPLETED|Overall Study||31
9996301|NCT01688102|11117931|FG000|STARTED|Overall Study||60
9996302|NCT01688102|11117932|FG001|STARTED|Overall Study||58
9996303|NCT01688102|11117931|FG000|COMPLETED|Overall Study||44
9996304|NCT01688102|11117932|FG001|COMPLETED|Overall Study||40
9996305|NCT01688102|11117931|FG000|NOT COMPLETED|Overall Study||16
9996306|NCT01688102|11117932|FG001|NOT COMPLETED|Overall Study||18
9996307|NCT01688141|11117940|FG000|STARTED|Overall Study||11706
9996308|NCT01688141|11117941|FG001|STARTED|Overall Study||11651
9996309|NCT01688141|11117940|FG000|COMPLETED|Overall Study||11706
9996310|NCT01688141|11117941|FG001|COMPLETED|Overall Study||11651
9996311|NCT01688141|11117940|FG000|NOT COMPLETED|Overall Study||0
9996312|NCT01688141|11117941|FG001|NOT COMPLETED|Overall Study||0
9996313|NCT01688310|11117949|FG000|STARTED|Overall Study||100
9996314|NCT01688310|11117950|FG001|STARTED|Overall Study||100
9996315|NCT01688310|11117949|FG000|COMPLETED|Overall Study||100
9996316|NCT01688310|11117950|FG001|COMPLETED|Overall Study||100
9996317|NCT01688310|11117949|FG000|NOT COMPLETED|Overall Study||0
9996318|NCT01688310|11117950|FG001|NOT COMPLETED|Overall Study||0
9996319|NCT01688336|11117958|FG000|STARTED|Overall Study||9
9996320|NCT01688336|11117958|FG000|COMPLETED|Overall Study||9
9996321|NCT01688336|11117958|FG000|NOT COMPLETED|Overall Study||0
9996322|NCT01688466|11117965|FG000|STARTED|Overall Study||17
9996323|NCT01688466|11117966|FG001|STARTED|Overall Study||17
9996324|NCT01688466|11117965|FG000|COMPLETED|Overall Study||15
9996325|NCT01688466|11117966|FG001|COMPLETED|Overall Study||10
9996326|NCT01688466|11117965|FG000|NOT COMPLETED|Overall Study||2
9996327|NCT01688466|11117966|FG001|NOT COMPLETED|Overall Study||7
9996328|NCT01688596|11117974|FG000|STARTED|Overall Study||67
9996329|NCT01688596|11117975|FG001|STARTED|Overall Study||68
9996330|NCT01688596|11117974|FG000|COMPLETED|Overall Study||59
9996331|NCT01688596|11117975|FG001|COMPLETED|Overall Study||59
9996332|NCT01688596|11117974|FG000|NOT COMPLETED|Overall Study||8
9996333|NCT01688596|11117975|FG001|NOT COMPLETED|Overall Study||9
9996334|NCT01688609|11117981|FG000|STARTED|Overall Study||18
9996335|NCT01688609|11117981|FG000|COMPLETED|Overall Study||18
9996336|NCT01688609|11117981|FG000|NOT COMPLETED|Overall Study||0
9996337|NCT01688635|11117985|FG000|STARTED|Period 1||45
9996338|NCT01688635|11117986|FG001|STARTED|Period 1||46
9996339|NCT01688635|11117985|FG000|Received at Least 1 Dose of Study Drug|Period 1||45
9996340|NCT01688635|11117986|FG001|Received at Least 1 Dose of Study Drug|Period 1||46
9996341|NCT01688635|11117985|FG000|COMPLETED|Period 1||45
9996342|NCT01688635|11117986|FG001|COMPLETED|Period 1||46
9996343|NCT01688635|11117985|FG000|NOT COMPLETED|Period 1||0
9996344|NCT01688635|11117986|FG001|NOT COMPLETED|Period 1||0
9996345|NCT01688635|11117985|FG000|STARTED|Washout 1||45
9996346|NCT01688635|11117986|FG001|STARTED|Washout 1||46
9996347|NCT01688635|11117985|FG000|COMPLETED|Washout 1||44
9996348|NCT01688635|11117986|FG001|COMPLETED|Washout 1||44
9996349|NCT01688635|11117985|FG000|NOT COMPLETED|Washout 1||1
9996350|NCT01688635|11117986|FG001|NOT COMPLETED|Washout 1||2
9996351|NCT01688635|11117985|FG000|STARTED|Period 2||44
9996352|NCT01688635|11117986|FG001|STARTED|Period 2||44
9996353|NCT01688635|11117985|FG000|COMPLETED|Period 2||44
9996354|NCT01688635|11117986|FG001|COMPLETED|Period 2||44
9996355|NCT01688635|11117985|FG000|NOT COMPLETED|Period 2||0
9996356|NCT01688635|11117986|FG001|NOT COMPLETED|Period 2||0
9996357|NCT01688635|11117985|FG000|STARTED|Washout 2||44
9996358|NCT01688635|11117986|FG001|STARTED|Washout 2||44
9996359|NCT01688635|11117985|FG000|COMPLETED|Washout 2||41
9996360|NCT01688635|11117986|FG001|COMPLETED|Washout 2||42
9996361|NCT01688635|11117985|FG000|NOT COMPLETED|Washout 2||3
9996362|NCT01688635|11117986|FG001|NOT COMPLETED|Washout 2||2
9996363|NCT01688635|11117985|FG000|STARTED|Period 3||41
9996364|NCT01688635|11117986|FG001|STARTED|Period 3||42
9996365|NCT01688635|11117985|FG000|COMPLETED|Period 3||41
9996366|NCT01688635|11117986|FG001|COMPLETED|Period 3||42
9996367|NCT01688635|11117985|FG000|NOT COMPLETED|Period 3||0
9996368|NCT01688635|11117986|FG001|NOT COMPLETED|Period 3||0
10102635|NCT02416973|11232195|FG002|STARTED|Overall Study||14
10102636|NCT02416973|11232193|FG000|COMPLETED|Overall Study||13
10102637|NCT02416973|11232194|FG001|COMPLETED|Overall Study||10
10102638|NCT02416973|11232195|FG002|COMPLETED|Overall Study||13
10102639|NCT02416973|11232193|FG000|NOT COMPLETED|Overall Study||1
10102640|NCT02416973|11232194|FG001|NOT COMPLETED|Overall Study||3
10102641|NCT02416973|11232195|FG002|NOT COMPLETED|Overall Study||1
9996369|NCT01688635|11117985|FG000|STARTED|Washout 3||41
9996370|NCT01688635|11117986|FG001|STARTED|Washout 3||42
9996371|NCT01688635|11117985|FG000|COMPLETED|Washout 3||40
9996372|NCT01688635|11117986|FG001|COMPLETED|Washout 3||42
9996373|NCT01688635|11117985|FG000|NOT COMPLETED|Washout 3||1
10102642|NCT02417064|11232206|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117
10102643|NCT02417064|11232207|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116
10102644|NCT02417064|11232208|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113
9996374|NCT01688635|11117986|FG001|NOT COMPLETED|Washout 3||0
9996375|NCT01688635|11117985|FG000|STARTED|Period 4||40
9996376|NCT01688635|11117986|FG001|STARTED|Period 4||42
9996377|NCT01688635|11117985|FG000|COMPLETED|Period 4||40
9996378|NCT01688635|11117986|FG001|COMPLETED|Period 4||42
9996379|NCT01688635|11117985|FG000|NOT COMPLETED|Period 4||0
9996380|NCT01688635|11117986|FG001|NOT COMPLETED|Period 4||0
9996381|NCT01688726|11117995|FG000|STARTED|Overall Study||46
9996382|NCT01688726|11117996|FG001|STARTED|Overall Study||45
9996383|NCT01688726|11117995|FG000|COMPLETED|Overall Study||45
9996384|NCT01688726|11117996|FG001|COMPLETED|Overall Study||44
9996385|NCT01688726|11117995|FG000|NOT COMPLETED|Overall Study||1
9996386|NCT01688726|11117996|FG001|NOT COMPLETED|Overall Study||1
9996387|NCT01688739|11118016|FG000|STARTED|Overall Study||13
9996388|NCT01688739|11118017|FG001|STARTED|Overall Study||3
9996389|NCT01688739|11118018|FG002|STARTED|Overall Study||3
9996390|NCT01688739|11118019|FG003|STARTED|Overall Study||6
9996391|NCT01688739|11118020|FG004|STARTED|Overall Study||6
9996392|NCT01688739|11118021|FG005|STARTED|Overall Study||6
9996393|NCT01688739|11118022|FG006|STARTED|Overall Study||6
9996394|NCT01688739|11118023|FG007|STARTED|Overall Study||6
9996395|NCT01688739|11118024|FG008|STARTED|Overall Study||6
9996396|NCT01688739|11118025|FG009|STARTED|Overall Study||6
9996397|NCT01688739|11118016|FG000|Received Study Drug|Overall Study||12
9996398|NCT01688739|11118017|FG001|Received Study Drug|Overall Study||3
9996399|NCT01688739|11118018|FG002|Received Study Drug|Overall Study||3
9996400|NCT01688739|11118019|FG003|Received Study Drug|Overall Study||6
9996401|NCT01688739|11118020|FG004|Received Study Drug|Overall Study||6
9996402|NCT01688739|11118021|FG005|Received Study Drug|Overall Study||6
9996403|NCT01688739|11118022|FG006|Received Study Drug|Overall Study||6
9996404|NCT01688739|11118023|FG007|Received Study Drug|Overall Study||6
9996405|NCT01688739|11118024|FG008|Received Study Drug|Overall Study||6
9996406|NCT01688739|11118025|FG009|Received Study Drug|Overall Study||6
9996407|NCT01688739|11118016|FG000|COMPLETED|Overall Study||12
9996408|NCT01688739|11118017|FG001|COMPLETED|Overall Study||3
9996409|NCT01688739|11118018|FG002|COMPLETED|Overall Study||3
9996410|NCT01688739|11118019|FG003|COMPLETED|Overall Study||6
9996411|NCT01688739|11118020|FG004|COMPLETED|Overall Study||6
9996412|NCT01688739|11118021|FG005|COMPLETED|Overall Study||6
9996413|NCT01688739|11118022|FG006|COMPLETED|Overall Study||6
9996414|NCT01688739|11118023|FG007|COMPLETED|Overall Study||6
9996415|NCT01688739|11118024|FG008|COMPLETED|Overall Study||6
9996416|NCT01688739|11118025|FG009|COMPLETED|Overall Study||6
9996417|NCT01688739|11118016|FG000|NOT COMPLETED|Overall Study||1
9996418|NCT01688739|11118017|FG001|NOT COMPLETED|Overall Study||0
9996419|NCT01688739|11118018|FG002|NOT COMPLETED|Overall Study||0
9996420|NCT01688739|11118019|FG003|NOT COMPLETED|Overall Study||0
9996421|NCT01688739|11118020|FG004|NOT COMPLETED|Overall Study||0
9996422|NCT01688739|11118021|FG005|NOT COMPLETED|Overall Study||0
9996423|NCT01688739|11118022|FG006|NOT COMPLETED|Overall Study||0
9996424|NCT01688739|11118023|FG007|NOT COMPLETED|Overall Study||0
9996425|NCT01688739|11118024|FG008|NOT COMPLETED|Overall Study||0
9996426|NCT01688739|11118025|FG009|NOT COMPLETED|Overall Study||0
9996427|NCT01688830|11118076|FG000|STARTED|Overall Study||21
9996428|NCT01688830|11118077|FG001|STARTED|Overall Study||6
9996429|NCT01688830|11118078|FG002|STARTED|Overall Study||6
9996430|NCT01688830|11118079|FG003|STARTED|Overall Study||6
9996431|NCT01688830|11118080|FG004|STARTED|Overall Study||5
9996432|NCT01688830|11118081|FG005|STARTED|Overall Study||6
9996433|NCT01688830|11118082|FG006|STARTED|Overall Study||12
9996434|NCT01688830|11118083|FG007|STARTED|Overall Study||6
9996435|NCT01688830|11118084|FG008|STARTED|Overall Study||6
9996436|NCT01688830|11118085|FG009|STARTED|Overall Study||6
10102645|NCT02417064|11232206|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
10102646|NCT02417064|11232207|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
10102647|NCT02417064|11232208|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
10102648|NCT02417064|11232206|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
10102649|NCT02417064|11232207|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
10102650|NCT02417064|11232208|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
10102651|NCT02417064|11232206|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
10102652|NCT02417064|11232207|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
10102653|NCT02417064|11232208|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
10102654|NCT02417064|11232206|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
10102655|NCT02417064|11232207|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
10102656|NCT02417064|11232208|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
10102657|NCT02417064|11232206|FG000|STARTED|Follow-up Phase (24 Weeks)||47
10102658|NCT02417064|11232207|FG001|STARTED|Follow-up Phase (24 Weeks)||52
10102659|NCT02417064|11232208|FG002|STARTED|Follow-up Phase (24 Weeks)||69
10102660|NCT02417064|11232206|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8
10102661|NCT02417064|11232207|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10
10102662|NCT02417064|11232208|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18
10102663|NCT02417064|11232206|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
10102664|NCT02417064|11232207|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
10102665|NCT02417064|11232208|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
10102666|NCT02417129|11232219|FG000|STARTED|Overall Study||2
9996437|NCT01688830|11118086|FG010|STARTED|Overall Study||6
9996438|NCT01688830|11118087|FG011|STARTED|Overall Study||6
9996439|NCT01688830|11118088|FG012|STARTED|Overall Study||6
9996440|NCT01688830|11118089|FG013|STARTED|Overall Study||6
9996441|NCT01688830|11118090|FG014|STARTED|Overall Study||6
9996442|NCT01688830|11118091|FG015|STARTED|Overall Study||9
9996443|NCT01688830|11118092|FG016|STARTED|Overall Study||9
9996444|NCT01688830|11118093|FG017|STARTED|Overall Study||9
9996445|NCT01688830|11118094|FG018|STARTED|Overall Study||8
9996446|NCT01688830|11118095|FG019|STARTED|Overall Study||3
9996447|NCT01688830|11118096|FG020|STARTED|Overall Study||9
9996448|NCT01688830|11118076|FG000|COMPLETED|Overall Study||21
9996449|NCT01688830|11118077|FG001|COMPLETED|Overall Study||6
9996450|NCT01688830|11118078|FG002|COMPLETED|Overall Study||6
9996451|NCT01688830|11118079|FG003|COMPLETED|Overall Study||6
9996452|NCT01688830|11118080|FG004|COMPLETED|Overall Study||5
9996453|NCT01688830|11118081|FG005|COMPLETED|Overall Study||6
9996454|NCT01688830|11118082|FG006|COMPLETED|Overall Study||12
9996455|NCT01688830|11118083|FG007|COMPLETED|Overall Study||6
9996456|NCT01688830|11118084|FG008|COMPLETED|Overall Study||6
9996457|NCT01688830|11118085|FG009|COMPLETED|Overall Study||6
10102667|NCT02417129|11232220|FG001|STARTED|Overall Study||0
10102668|NCT02417129|11232219|FG000|COMPLETED|Overall Study||2
10102669|NCT02417129|11232220|FG001|COMPLETED|Overall Study||0
10102670|NCT02417129|11232219|FG000|NOT COMPLETED|Overall Study||0
10102671|NCT02417129|11232220|FG001|NOT COMPLETED|Overall Study||0
9996458|NCT01688830|11118086|FG010|COMPLETED|Overall Study||5
9996459|NCT01688830|11118087|FG011|COMPLETED|Overall Study||6
9996460|NCT01688830|11118088|FG012|COMPLETED|Overall Study||6
9996461|NCT01688830|11118089|FG013|COMPLETED|Overall Study||6
9996462|NCT01688830|11118090|FG014|COMPLETED|Overall Study||6
9996463|NCT01688830|11118091|FG015|COMPLETED|Overall Study||9
9996464|NCT01688830|11118092|FG016|COMPLETED|Overall Study||9
9996465|NCT01688830|11118093|FG017|COMPLETED|Overall Study||9
9996466|NCT01688830|11118094|FG018|COMPLETED|Overall Study||8
9996467|NCT01688830|11118095|FG019|COMPLETED|Overall Study||3
9996468|NCT01688830|11118096|FG020|COMPLETED|Overall Study||9
9996469|NCT01688830|11118076|FG000|NOT COMPLETED|Overall Study||0
9996470|NCT01688830|11118077|FG001|NOT COMPLETED|Overall Study||0
9996471|NCT01688830|11118078|FG002|NOT COMPLETED|Overall Study||0
9996472|NCT01688830|11118079|FG003|NOT COMPLETED|Overall Study||0
9996473|NCT01688830|11118080|FG004|NOT COMPLETED|Overall Study||0
9996474|NCT01688830|11118081|FG005|NOT COMPLETED|Overall Study||0
9996475|NCT01688830|11118082|FG006|NOT COMPLETED|Overall Study||0
9996476|NCT01688830|11118083|FG007|NOT COMPLETED|Overall Study||0
9996477|NCT01688830|11118084|FG008|NOT COMPLETED|Overall Study||0
9996478|NCT01688830|11118085|FG009|NOT COMPLETED|Overall Study||0
9996479|NCT01688830|11118086|FG010|NOT COMPLETED|Overall Study||1
9996480|NCT01688830|11118087|FG011|NOT COMPLETED|Overall Study||0
9996481|NCT01688830|11118088|FG012|NOT COMPLETED|Overall Study||0
9996482|NCT01688830|11118089|FG013|NOT COMPLETED|Overall Study||0
9996483|NCT01688830|11118090|FG014|NOT COMPLETED|Overall Study||0
9996484|NCT01688830|11118091|FG015|NOT COMPLETED|Overall Study||0
9996485|NCT01688830|11118092|FG016|NOT COMPLETED|Overall Study||0
9996486|NCT01688830|11118093|FG017|NOT COMPLETED|Overall Study||0
9996487|NCT01688830|11118094|FG018|NOT COMPLETED|Overall Study||0
9996488|NCT01688830|11118095|FG019|NOT COMPLETED|Overall Study||0
9996489|NCT01688830|11118096|FG020|NOT COMPLETED|Overall Study||0
9996490|NCT01688843|11118180|FG000|STARTED|Overall Study||1060
9996491|NCT01688843|11118180|FG000|COMPLETED|Overall Study||1060
9996492|NCT01688843|11118180|FG000|NOT COMPLETED|Overall Study||0
9996493|NCT01688856|11118189|FG000|STARTED|Overall Study||28
9996494|NCT01688856|11118190|FG001|STARTED|Overall Study||28
9996495|NCT01688856|11118191|FG002|STARTED|Overall Study||11
9996496|NCT01688856|11118189|FG000|COMPLETED|Overall Study||21
9996497|NCT01688856|11118190|FG001|COMPLETED|Overall Study||24
9996498|NCT01688856|11118191|FG002|COMPLETED|Overall Study||8
9996499|NCT01688856|11118189|FG000|NOT COMPLETED|Overall Study||7
9996500|NCT01688856|11118190|FG001|NOT COMPLETED|Overall Study||4
9996501|NCT01688856|11118191|FG002|NOT COMPLETED|Overall Study||3
9996502|NCT01688882|11118201|FG000|STARTED|Overall Study||13
9996503|NCT01688882|11118202|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
9996504|NCT01688882|11118201|FG000|Safety Follow-up|Overall Study||11
9996505|NCT01688882|11118202|FG001|Safety Follow-up|Overall Study||5
9996506|NCT01688882|11118201|FG000|COMPLETED|Overall Study||10
9996507|NCT01688882|11118202|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
9996508|NCT01688882|11118201|FG000|NOT COMPLETED|Overall Study||3
9996509|NCT01688882|11118202|FG001|NOT COMPLETED|Overall Study||1
9996510|NCT01688895|11118212|FG000|STARTED|Overall Study||150
9996511|NCT01688895|11118212|FG000|COMPLETED|Overall Study||150
9996512|NCT01688895|11118212|FG000|NOT COMPLETED|Overall Study||0
9996513|NCT01688921|11118218|FG000|STARTED|Overall Study||627
9996514|NCT01688921|11118219|FG001|STARTED|Overall Study||623
9996515|NCT01688921|11118218|FG000|COMPLETED|Overall Study||611
9996516|NCT01688921|11118219|FG001|COMPLETED|Overall Study||608
9996517|NCT01688921|11118218|FG000|NOT COMPLETED|Overall Study||16
9996518|NCT01688921|11118219|FG001|NOT COMPLETED|Overall Study||15
9996519|NCT01688973|11118228|FG000|STARTED|Overall Study||27
9996520|NCT01688973|11118229|FG001|STARTED|Overall Study||28
9996521|NCT01688973|11118228|FG000|Eligible/Evaluable Patients|Overall Study||25
9996522|NCT01688973|11118229|FG001|Eligible/Evaluable Patients|Overall Study||25
9996523|NCT01688973|11118228|FG000|COMPLETED|Overall Study||25
10102672|NCT02417233|11232229|FG000|STARTED|Overall Study||169
9996524|NCT01688973|11118229|FG001|COMPLETED|Overall Study||25
9996525|NCT01688973|11118228|FG000|NOT COMPLETED|Overall Study||2
9996526|NCT01688973|11118229|FG001|NOT COMPLETED|Overall Study||3
9996527|NCT01688999|11118239|FG000|STARTED|Overall Study||50
9996528|NCT01688999|11118240|FG001|STARTED|Overall Study||6
10102673|NCT02417233|11232230|FG001|STARTED|Overall Study||289
9996529|NCT01688999|11118241|FG002|STARTED|Overall Study||13
9996530|NCT01688999|11118239|FG000|COMPLETED|Overall Study||42
9996531|NCT01688999|11118240|FG001|COMPLETED|Overall Study||5
9996532|NCT01688999|11118241|FG002|COMPLETED|Overall Study||10
9996533|NCT01688999|11118239|FG000|NOT COMPLETED|Overall Study||8
9996534|NCT01688999|11118240|FG001|NOT COMPLETED|Overall Study||1
9996535|NCT01688999|11118241|FG002|NOT COMPLETED|Overall Study||3
9996536|NCT01689155|11118248|FG000|STARTED|Overall Study||116
9996537|NCT01689155|11118248|FG000|COMPLETED|Overall Study||116
9996538|NCT01689155|11118248|FG000|NOT COMPLETED|Overall Study||0
9996539|NCT01689207|11118264|FG000|STARTED|Overall Study|Subjects randomised|4
9996540|NCT01689207|11118265|FG001|STARTED|Overall Study|Subjects randomised|8
9996541|NCT01689207|11118266|FG002|STARTED|Overall Study|Subjects randomised|16
9996542|NCT01689207|11118267|FG003|STARTED|Overall Study|Subjects randomised|8
9996543|NCT01689207|11118268|FG004|STARTED|Overall Study|Subjects randomised|4
9996544|NCT01689207|11118269|FG005|STARTED|Overall Study|Subjects randomised|8
9996545|NCT01689207|11118270|FG006|STARTED|Overall Study|Subjects randomised|10
9996546|NCT01689207|11118271|FG007|STARTED|Overall Study|Subjects randomised|10
9996547|NCT01689207|11118272|FG008|STARTED|Overall Study|Subjects randomised|6
9996548|NCT01689207|11118273|FG009|STARTED|Overall Study|Subjects randomised|10
9996549|NCT01689207|11118274|FG010|STARTED|Overall Study|Subjects randomised|8
9996550|NCT01689207|11118264|FG000|COMPLETED|Overall Study|Subjects completed study|4
9996551|NCT01689207|11118265|FG001|COMPLETED|Overall Study|Subjects completed study|7
9996552|NCT01689207|11118266|FG002|COMPLETED|Overall Study|Subjects completed study|16
9996553|NCT01689207|11118267|FG003|COMPLETED|Overall Study|Subjects completed study|8
9996554|NCT01689207|11118268|FG004|COMPLETED|Overall Study|Subjects completed study|2
9996555|NCT01689207|11118269|FG005|COMPLETED|Overall Study|Subjects completed study|7
10102674|NCT02417233|11232231|FG002|STARTED|Overall Study||298
10102675|NCT02417233|11232229|FG000|COMPLETED|Overall Study||133
10102676|NCT02417233|11232230|FG001|COMPLETED|Overall Study||238
10102677|NCT02417233|11232231|FG002|COMPLETED|Overall Study||239
10102678|NCT02417233|11232229|FG000|NOT COMPLETED|Overall Study||36
10102679|NCT02417233|11232230|FG001|NOT COMPLETED|Overall Study||51
9996556|NCT01689207|11118270|FG006|COMPLETED|Overall Study|Subjects completed study|10
9996557|NCT01689207|11118271|FG007|COMPLETED|Overall Study|Subjects completed study|10
9996558|NCT01689207|11118272|FG008|COMPLETED|Overall Study|Subjects completed study|5
9996559|NCT01689207|11118273|FG009|COMPLETED|Overall Study|Subjects completed study|10
9996560|NCT01689207|11118274|FG010|COMPLETED|Overall Study|Subjects completed study|8
9996561|NCT01689207|11118264|FG000|NOT COMPLETED|Overall Study||0
9996562|NCT01689207|11118265|FG001|NOT COMPLETED|Overall Study||1
9996563|NCT01689207|11118266|FG002|NOT COMPLETED|Overall Study||0
9996564|NCT01689207|11118267|FG003|NOT COMPLETED|Overall Study||0
9996565|NCT01689207|11118268|FG004|NOT COMPLETED|Overall Study||2
9996566|NCT01689207|11118269|FG005|NOT COMPLETED|Overall Study||1
9996567|NCT01689207|11118270|FG006|NOT COMPLETED|Overall Study||0
9996568|NCT01689207|11118271|FG007|NOT COMPLETED|Overall Study||0
9996569|NCT01689207|11118272|FG008|NOT COMPLETED|Overall Study||1
9996570|NCT01689207|11118273|FG009|NOT COMPLETED|Overall Study||0
9996571|NCT01689207|11118274|FG010|NOT COMPLETED|Overall Study||0
9996572|NCT01689324|11118304|FG000|STARTED|Overall Study||43
9996573|NCT01689324|11118304|FG000|COMPLETED|Overall Study||43
9996574|NCT01689324|11118304|FG000|NOT COMPLETED|Overall Study||0
9996575|NCT01689337|11118308|FG000|STARTED|Overall Study||1
9996576|NCT01689337|11118308|FG000|COMPLETED|Overall Study||0
9996577|NCT01689337|11118308|FG000|NOT COMPLETED|Overall Study||1
9996578|NCT01689350|11118316|FG000|STARTED|Overall Study||47
9996579|NCT01689350|11118317|FG001|STARTED|Overall Study||45
9996580|NCT01689350|11118316|FG000|COMPLETED|Overall Study||47
9996581|NCT01689350|11118317|FG001|COMPLETED|Overall Study||45
9996582|NCT01689350|11118316|FG000|NOT COMPLETED|Overall Study||0
9996583|NCT01689350|11118317|FG001|NOT COMPLETED|Overall Study||0
9996584|NCT01689363|11118323|FG000|STARTED|Overall Study||32
9996585|NCT01689363|11118324|FG001|STARTED|Overall Study||32
9996586|NCT01689363|11118325|FG002|STARTED|Overall Study||32
9996587|NCT01689363|11118326|FG003|STARTED|Overall Study||31
9996588|NCT01689363|11118327|FG004|STARTED|Overall Study||31
9996589|NCT01689363|11118328|FG005|STARTED|Overall Study||31
9996590|NCT01689363|11118329|FG006|STARTED|Overall Study||32
9996591|NCT01689363|11118330|FG007|STARTED|Overall Study||32
9996592|NCT01689363|11118323|FG000|COMPLETED|Overall Study||32
9996593|NCT01689363|11118324|FG001|COMPLETED|Overall Study||31
9996594|NCT01689363|11118325|FG002|COMPLETED|Overall Study||32
9996595|NCT01689363|11118326|FG003|COMPLETED|Overall Study||31
9996596|NCT01689363|11118327|FG004|COMPLETED|Overall Study||31
9996597|NCT01689363|11118328|FG005|COMPLETED|Overall Study||31
9996598|NCT01689363|11118329|FG006|COMPLETED|Overall Study||32
9996599|NCT01689363|11118330|FG007|COMPLETED|Overall Study||32
9996600|NCT01689363|11118323|FG000|NOT COMPLETED|Overall Study||0
9996601|NCT01689363|11118324|FG001|NOT COMPLETED|Overall Study||1
9996602|NCT01689363|11118325|FG002|NOT COMPLETED|Overall Study||0
9996603|NCT01689363|11118326|FG003|NOT COMPLETED|Overall Study||0
9996604|NCT01689363|11118327|FG004|NOT COMPLETED|Overall Study||0
9996605|NCT01689363|11118328|FG005|NOT COMPLETED|Overall Study||0
9996606|NCT01689363|11118329|FG006|NOT COMPLETED|Overall Study||0
9996607|NCT01689363|11118330|FG007|NOT COMPLETED|Overall Study||0
9996608|NCT01689441|11118343|FG000|STARTED|Overall Study||36
9996609|NCT01689441|11118344|FG001|STARTED|Overall Study||31
9996610|NCT01689441|11118343|FG000|COMPLETED|Overall Study||36
9996611|NCT01689441|11118344|FG001|COMPLETED|Overall Study||31
10102680|NCT02417233|11232231|FG002|NOT COMPLETED|Overall Study||59
9996612|NCT01689441|11118343|FG000|NOT COMPLETED|Overall Study||0
9996613|NCT01689441|11118344|FG001|NOT COMPLETED|Overall Study||0
9996614|NCT01689532|11118352|FG000|STARTED|Overall Study||61
9996615|NCT01689532|11118353|FG001|STARTED|Overall Study||61
9996616|NCT01689532|11118352|FG000|COMPLETED|Overall Study||47
9996617|NCT01689532|11118353|FG001|COMPLETED|Overall Study||52
9996618|NCT01689532|11118352|FG000|NOT COMPLETED|Overall Study||14
9996619|NCT01689532|11118353|FG001|NOT COMPLETED|Overall Study||9
9996620|NCT01689649|11118359|FG000|STARTED|Overall Study||139
9996621|NCT01689649|11118359|FG000|COMPLETED|Overall Study||117
9996622|NCT01689649|11118359|FG000|NOT COMPLETED|Overall Study||22
9996623|NCT01689701|11118365|FG000|STARTED|Overall Study||27
9996624|NCT01689701|11118366|FG001|STARTED|Overall Study||27
9996625|NCT01689701|11118365|FG000|COMPLETED|Overall Study||22
9996626|NCT01689701|11118366|FG001|COMPLETED|Overall Study||21
9996627|NCT01689701|11118365|FG000|NOT COMPLETED|Overall Study||5
9996628|NCT01689701|11118366|FG001|NOT COMPLETED|Overall Study||6
9996629|NCT01689779|11118374|FG000|STARTED|Overall Study||28
9996630|NCT01689779|11118375|FG001|STARTED|Overall Study||32
9996631|NCT01689779|11118374|FG000|COMPLETED|Overall Study||28
9996632|NCT01689779|11118375|FG001|COMPLETED|Overall Study||32
9996633|NCT01689779|11118374|FG000|NOT COMPLETED|Overall Study||0
9996634|NCT01689779|11118375|FG001|NOT COMPLETED|Overall Study||0
9996635|NCT01689857|11118383|FG000|STARTED|Overall Study||20
9996636|NCT01689857|11118384|FG001|STARTED|Overall Study||20
9996637|NCT01689857|11118383|FG000|COMPLETED|Overall Study||15
9996638|NCT01689857|11118384|FG001|COMPLETED|Overall Study||18
9996639|NCT01689857|11118383|FG000|NOT COMPLETED|Overall Study||5
9996640|NCT01689857|11118384|FG001|NOT COMPLETED|Overall Study||2
9996641|NCT01690000|11118392|FG000|STARTED|Overall Study||40
9996642|NCT01690000|11118393|FG001|STARTED|Overall Study||41
9996643|NCT01690000|11118392|FG000|COMPLETED|Overall Study||37
9996644|NCT01690000|11118393|FG001|COMPLETED|Overall Study||35
9996645|NCT01690000|11118392|FG000|NOT COMPLETED|Overall Study||3
9996646|NCT01690000|11118393|FG001|NOT COMPLETED|Overall Study||6
9996647|NCT01690052|11118399|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7
9996648|NCT01690052|11118400|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8
9996649|NCT01690052|11118399|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
9996650|NCT01690052|11118400|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
9996651|NCT01690052|11118399|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
9996652|NCT01690052|11118400|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
9996653|NCT01690052|11118399|FG000|STARTED|Washout Period of 1 Week||6
9996654|NCT01690052|11118400|FG001|STARTED|Washout Period of 1 Week||6
9996655|NCT01690052|11118399|FG000|COMPLETED|Washout Period of 1 Week||6
9996656|NCT01690052|11118400|FG001|COMPLETED|Washout Period of 1 Week||6
9996657|NCT01690052|11118399|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9996658|NCT01690052|11118400|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9996659|NCT01690052|11118399|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6
9996660|NCT01690052|11118400|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6
9996661|NCT01690052|11118399|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
9996662|NCT01690052|11118400|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
9996663|NCT01690052|11118399|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
9996664|NCT01690052|11118400|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
9996665|NCT01690117|11118408|FG000|STARTED|Overall Study||47
9996666|NCT01690117|11118409|FG001|STARTED|Overall Study||45
9996667|NCT01690117|11118408|FG000|Post-Measurement|Overall Study||41
9996668|NCT01690117|11118409|FG001|Post-Measurement|Overall Study||40
9996669|NCT01690117|11118408|FG000|COMPLETED|Overall Study||31
9996670|NCT01690117|11118409|FG001|COMPLETED|Overall Study||31
9996671|NCT01690117|11118408|FG000|NOT COMPLETED|Overall Study||16
9996672|NCT01690117|11118409|FG001|NOT COMPLETED|Overall Study||14
9996673|NCT01690130|11118419|FG000|STARTED|Overall Study||10
9996674|NCT01690130|11118420|FG001|STARTED|Overall Study||9
9996675|NCT01690130|11118419|FG000|COMPLETED|Overall Study||9
9996676|NCT01690130|11118420|FG001|COMPLETED|Overall Study||9
9996677|NCT01690130|11118419|FG000|NOT COMPLETED|Overall Study||1
9996678|NCT01690130|11118420|FG001|NOT COMPLETED|Overall Study||0
9996679|NCT01690143|11118426|FG000|STARTED|Overall Study||45
9996680|NCT01690143|11118426|FG000|COMPLETED|Overall Study||44
9996681|NCT01690143|11118426|FG000|NOT COMPLETED|Overall Study||1
9996682|NCT01690273|11118434|FG000|STARTED|Overall Study||18
9996683|NCT01690273|11118435|FG001|STARTED|Overall Study||17
9996684|NCT01690273|11118436|FG002|STARTED|Overall Study||20
9996685|NCT01690273|11118434|FG000|COMPLETED|Overall Study||18
9996686|NCT01690273|11118435|FG001|COMPLETED|Overall Study||17
9996687|NCT01690273|11118436|FG002|COMPLETED|Overall Study||20
9996688|NCT01690273|11118434|FG000|NOT COMPLETED|Overall Study||0
9996689|NCT01690273|11118435|FG001|NOT COMPLETED|Overall Study||0
9996690|NCT01690273|11118436|FG002|NOT COMPLETED|Overall Study||0
9996691|NCT01690520|11118450|FG000|STARTED|Overall Study||78
9996692|NCT01690520|11118451|FG001|STARTED|Overall Study||82
9996693|NCT01690520|11118450|FG000|Modified Intent to Treat (mITT)|Overall Study||78
9996694|NCT01690520|11118451|FG001|Modified Intent to Treat (mITT)|Overall Study||80
9996695|NCT01690520|11118450|FG000|COMPLETED|Overall Study||27
9996696|NCT01690520|11118451|FG001|COMPLETED|Overall Study||35
9996697|NCT01690520|11118450|FG000|NOT COMPLETED|Overall Study||51
9996698|NCT01690520|11118451|FG001|NOT COMPLETED|Overall Study||47
9996699|NCT01690546|11118457|FG000|STARTED|Overall Study||35
9996700|NCT01690546|11118457|FG000|Extended Release Injectable NTX|Overall Study||27
9996701|NCT01690546|11118457|FG000|COMPLETED|Overall Study||26
9996702|NCT01690546|11118457|FG000|NOT COMPLETED|Overall Study||9
9996703|NCT01690663|11118465|FG000|STARTED|Overall Study||23
9996704|NCT01690663|11118466|FG001|STARTED|Overall Study||20
9996705|NCT01690663|11118467|FG002|STARTED|Overall Study||22
9996706|NCT01690663|11118468|FG003|STARTED|Overall Study||24
9996707|NCT01690663|11118465|FG000|COMPLETED|Overall Study||20
9996708|NCT01690663|11118466|FG001|COMPLETED|Overall Study||17
9996709|NCT01690663|11118467|FG002|COMPLETED|Overall Study||19
9996710|NCT01690663|11118468|FG003|COMPLETED|Overall Study||20
9996711|NCT01690663|11118465|FG000|NOT COMPLETED|Overall Study||3
9996712|NCT01690663|11118466|FG001|NOT COMPLETED|Overall Study||3
9996713|NCT01690663|11118467|FG002|NOT COMPLETED|Overall Study||3
9996714|NCT01690663|11118468|FG003|NOT COMPLETED|Overall Study||4
9996715|NCT01690923|11118478|FG000|STARTED|Overall Study||10
9996716|NCT01690923|11118479|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
9996717|NCT01690923|11118478|FG000|COMPLETED|Overall Study||10
9996718|NCT01690923|11118479|FG001|COMPLETED|Overall Study||10
9996719|NCT01690923|11118478|FG000|NOT COMPLETED|Overall Study||0
9996720|NCT01690923|11118479|FG001|NOT COMPLETED|Overall Study||1
9996721|NCT01690988|11118486|FG000|STARTED|Overall Study||227
9996722|NCT01690988|11118487|FG001|STARTED|Overall Study||222
9996723|NCT01690988|11118488|FG002|STARTED|Overall Study||223
9996724|NCT01690988|11118486|FG000|COMPLETED|Overall Study||221
9996725|NCT01690988|11118487|FG001|COMPLETED|Overall Study||217
9996726|NCT01690988|11118488|FG002|COMPLETED|Overall Study||216
9996727|NCT01690988|11118486|FG000|NOT COMPLETED|Overall Study||6
9996728|NCT01690988|11118487|FG001|NOT COMPLETED|Overall Study||5
9996729|NCT01690988|11118488|FG002|NOT COMPLETED|Overall Study||7
9996730|NCT01691014|11118503|FG000|STARTED|Overall Study||8
9996731|NCT01691014|11118504|FG001|STARTED|Overall Study||26
9996732|NCT01691014|11118505|FG002|STARTED|Overall Study||36
9996733|NCT01691014|11118506|FG003|STARTED|Overall Study||9
9996734|NCT01691014|11118503|FG000|COMPLETED|Overall Study||5
9996735|NCT01691014|11118504|FG001|COMPLETED|Overall Study||11
9996736|NCT01691014|11118505|FG002|COMPLETED|Overall Study||25
9996737|NCT01691014|11118506|FG003|COMPLETED|Overall Study||4
9996738|NCT01691014|11118503|FG000|NOT COMPLETED|Overall Study||3
9996739|NCT01691014|11118504|FG001|NOT COMPLETED|Overall Study||15
9996740|NCT01691014|11118505|FG002|NOT COMPLETED|Overall Study||11
9996741|NCT01691014|11118506|FG003|NOT COMPLETED|Overall Study||5
9996742|NCT01691027|11118516|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
9996743|NCT01691027|11118516|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
9996744|NCT01691027|11118516|FG000|NOT COMPLETED|Scotoma Awareness||0
9996745|NCT01691027|11118516|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
9996746|NCT01691027|11118516|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
9996747|NCT01691027|11118516|FG000|NOT COMPLETED|Line and Circle Tracing Training||0
9996748|NCT01691027|11118516|FG000|STARTED|Video Games Training|Four subjects started video game training module|4
9996749|NCT01691027|11118516|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
9996750|NCT01691027|11118516|FG000|NOT COMPLETED|Video Games Training||0
9996751|NCT01691092|11118521|FG000|STARTED|Overall Study||79
9996752|NCT01691092|11118521|FG000|COMPLETED|Overall Study||38
9996753|NCT01691092|11118521|FG000|NOT COMPLETED|Overall Study||41
9996754|NCT01691105|11118527|FG000|STARTED|Baseline||477
9996755|NCT01691105|11118528|FG001|STARTED|Baseline||567
9996756|NCT01691105|11118527|FG000|COMPLETED|Baseline||477
9996757|NCT01691105|11118528|FG001|COMPLETED|Baseline||567
9996758|NCT01691105|11118527|FG000|NOT COMPLETED|Baseline||0
9996759|NCT01691105|11118528|FG001|NOT COMPLETED|Baseline||0
9996760|NCT01691105|11118527|FG000|STARTED|1 Month Follow-up||477
9996761|NCT01691105|11118528|FG001|STARTED|1 Month Follow-up||567
9996762|NCT01691105|11118527|FG000|COMPLETED|1 Month Follow-up||434
9996763|NCT01691105|11118528|FG001|COMPLETED|1 Month Follow-up||526
9996764|NCT01691105|11118527|FG000|NOT COMPLETED|1 Month Follow-up||43
9996765|NCT01691105|11118528|FG001|NOT COMPLETED|1 Month Follow-up||41
9996766|NCT01691105|11118527|FG000|STARTED|6 Month Follow-up||477
9996767|NCT01691105|11118528|FG001|STARTED|6 Month Follow-up||567
9996768|NCT01691105|11118527|FG000|COMPLETED|6 Month Follow-up||425
9996769|NCT01691105|11118528|FG001|COMPLETED|6 Month Follow-up||496
9996770|NCT01691105|11118527|FG000|NOT COMPLETED|6 Month Follow-up||52
9996771|NCT01691105|11118528|FG001|NOT COMPLETED|6 Month Follow-up||71
9996772|NCT01691105|11118527|FG000|STARTED|12 Month Follow-up||477
9996773|NCT01691105|11118528|FG001|STARTED|12 Month Follow-up||567
9996774|NCT01691105|11118527|FG000|COMPLETED|12 Month Follow-up||405
9996775|NCT01691105|11118528|FG001|COMPLETED|12 Month Follow-up||466
9996776|NCT01691105|11118527|FG000|NOT COMPLETED|12 Month Follow-up||72
9996777|NCT01691105|11118528|FG001|NOT COMPLETED|12 Month Follow-up||101
9996778|NCT01691105|11118527|FG000|STARTED|12 Month Biochemical Verification||477
9996779|NCT01691105|11118528|FG001|STARTED|12 Month Biochemical Verification||567
9996780|NCT01691105|11118527|FG000|COMPLETED|12 Month Biochemical Verification||53
9996781|NCT01691105|11118528|FG001|COMPLETED|12 Month Biochemical Verification||65
9996782|NCT01691105|11118527|FG000|NOT COMPLETED|12 Month Biochemical Verification||424
9996783|NCT01691105|11118528|FG001|NOT COMPLETED|12 Month Biochemical Verification||502
9996784|NCT01691248|11118536|FG000|STARTED|Overall Study|Randomized|305
9996785|NCT01691248|11118537|FG001|STARTED|Overall Study|Randomized|306
9996786|NCT01691248|11118536|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301
9996787|NCT01691248|11118537|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299
9996788|NCT01691248|11118536|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
9996789|NCT01691248|11118537|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
9996790|NCT01691248|11118536|FG000|COMPLETED|Overall Study||194
9996791|NCT01691248|11118537|FG001|COMPLETED|Overall Study||192
9996792|NCT01691248|11118536|FG000|NOT COMPLETED|Overall Study||111
9996793|NCT01691248|11118537|FG001|NOT COMPLETED|Overall Study||114
9996794|NCT01691313|11118547|FG000|STARTED|Overall Study||22
9996795|NCT01691313|11118548|FG001|STARTED|Overall Study||32
9996796|NCT01691313|11118549|FG002|STARTED|Overall Study||25
9996797|NCT01691313|11118550|FG003|STARTED|Overall Study||25
9996798|NCT01691313|11118547|FG000|COMPLETED|Overall Study||22
9996799|NCT01691313|11118548|FG001|COMPLETED|Overall Study||32
9996800|NCT01691313|11118549|FG002|COMPLETED|Overall Study||25
9996801|NCT01691313|11118550|FG003|COMPLETED|Overall Study||25
9996802|NCT01691313|11118547|FG000|NOT COMPLETED|Overall Study||0
9996803|NCT01691313|11118548|FG001|NOT COMPLETED|Overall Study||0
9996804|NCT01691313|11118549|FG002|NOT COMPLETED|Overall Study||0
9996805|NCT01691313|11118550|FG003|NOT COMPLETED|Overall Study||0
9996806|NCT01691326|11118562|FG000|STARTED|Overall Study||30
9996807|NCT01691326|11118563|FG001|STARTED|Overall Study||30
9996808|NCT01691326|11118562|FG000|COMPLETED|Overall Study||30
9996809|NCT01691326|11118563|FG001|COMPLETED|Overall Study||30
9996810|NCT01691326|11118562|FG000|NOT COMPLETED|Overall Study||0
9996811|NCT01691326|11118563|FG001|NOT COMPLETED|Overall Study||0
9996812|NCT01691339|11118575|FG000|STARTED|Overall Study||50
9996813|NCT01691339|11118576|FG001|STARTED|Overall Study||50
9996814|NCT01691339|11118577|FG002|STARTED|Overall Study||51
9996815|NCT01691339|11118578|FG003|STARTED|Overall Study||49
9996816|NCT01691339|11118575|FG000|COMPLETED|Overall Study||50
9996817|NCT01691339|11118576|FG001|COMPLETED|Overall Study||50
9996818|NCT01691339|11118577|FG002|COMPLETED|Overall Study||51
9996819|NCT01691339|11118578|FG003|COMPLETED|Overall Study||49
9996820|NCT01691339|11118575|FG000|NOT COMPLETED|Overall Study||0
9996821|NCT01691339|11118576|FG001|NOT COMPLETED|Overall Study||0
9996822|NCT01691339|11118577|FG002|NOT COMPLETED|Overall Study||0
9996823|NCT01691339|11118578|FG003|NOT COMPLETED|Overall Study||0
9996824|NCT01691378|11118590|FG000|STARTED|Overall Study||22
9996825|NCT01691378|11118591|FG001|STARTED|Overall Study||22
9996826|NCT01691378|11118590|FG000|COMPLETED|Overall Study||15
9996827|NCT01691378|11118591|FG001|COMPLETED|Overall Study||20
9996828|NCT01691378|11118590|FG000|NOT COMPLETED|Overall Study||7
9996829|NCT01691378|11118591|FG001|NOT COMPLETED|Overall Study||2
9996830|NCT01691430|11118599|FG000|STARTED|Overall Study||92
9996831|NCT01691430|11118600|FG001|STARTED|Overall Study||93
9996832|NCT01691430|11118599|FG000|Received Medication|Overall Study||92
9996833|NCT01691430|11118600|FG001|Received Medication|Overall Study||93
9996834|NCT01691430|11118599|FG000|COMPLETED|Overall Study||70
9996835|NCT01691430|11118600|FG001|COMPLETED|Overall Study||73
9996836|NCT01691430|11118599|FG000|NOT COMPLETED|Overall Study||22
9996837|NCT01691430|11118600|FG001|NOT COMPLETED|Overall Study||20
9996838|NCT01691482|11118606|FG000|STARTED|Treatment Period 1||28
9996839|NCT01691482|11118607|FG001|STARTED|Treatment Period 1||28
9996840|NCT01691482|11118606|FG000|COMPLETED|Treatment Period 1||28
9996841|NCT01691482|11118607|FG001|COMPLETED|Treatment Period 1||28
9996842|NCT01691482|11118606|FG000|NOT COMPLETED|Treatment Period 1||0
9996843|NCT01691482|11118607|FG001|NOT COMPLETED|Treatment Period 1||0
9996844|NCT01691482|11118606|FG000|STARTED|Treatment Period 2||28
9996845|NCT01691482|11118607|FG001|STARTED|Treatment Period 2||28
9996846|NCT01691482|11118606|FG000|COMPLETED|Treatment Period 2||27
9996847|NCT01691482|11118607|FG001|COMPLETED|Treatment Period 2||26
9996848|NCT01691482|11118606|FG000|NOT COMPLETED|Treatment Period 2||1
9996849|NCT01691482|11118607|FG001|NOT COMPLETED|Treatment Period 2||2
9996850|NCT01691508|11118616|FG000|STARTED|Overall Study||66
9996851|NCT01691508|11118617|FG001|STARTED|Overall Study||69
9996852|NCT01691508|11118616|FG000|COMPLETED|Overall Study||62
9996853|NCT01691508|11118617|FG001|COMPLETED|Overall Study||66
9996854|NCT01691508|11118616|FG000|NOT COMPLETED|Overall Study||4
9996855|NCT01691508|11118617|FG001|NOT COMPLETED|Overall Study||3
9996856|NCT01691521|11118626|FG000|STARTED|Overall Study||191
9996857|NCT01691521|11118627|FG001|STARTED|Overall Study||191
9996858|NCT01691521|11118628|FG002|STARTED|Overall Study||194
9996859|NCT01691521|11118626|FG000|COMPLETED|Overall Study||179
9996860|NCT01691521|11118627|FG001|COMPLETED|Overall Study||175
9996861|NCT01691521|11118628|FG002|COMPLETED|Overall Study||185
9996862|NCT01691521|11118626|FG000|NOT COMPLETED|Overall Study||12
9996863|NCT01691521|11118627|FG001|NOT COMPLETED|Overall Study||16
9996864|NCT01691521|11118628|FG002|NOT COMPLETED|Overall Study||9
9996865|NCT01691534|11118644|FG000|STARTED|Overall Study||15
9996866|NCT01691534|11118645|FG001|STARTED|Overall Study||15
9996867|NCT01691534|11118646|FG002|STARTED|Overall Study||15
9996868|NCT01691534|11118647|FG003|STARTED|Overall Study||15
9996869|NCT01691534|11118648|FG004|STARTED|Overall Study||15
9996870|NCT01691534|11118649|FG005|STARTED|Overall Study||15
9996871|NCT01691534|11118650|FG006|STARTED|Overall Study||15
9996872|NCT01691534|11118644|FG000|COMPLETED|Overall Study||15
9996873|NCT01691534|11118645|FG001|COMPLETED|Overall Study||14
9996874|NCT01691534|11118646|FG002|COMPLETED|Overall Study||14
9996875|NCT01691534|11118647|FG003|COMPLETED|Overall Study||14
9996876|NCT01691534|11118648|FG004|COMPLETED|Overall Study||15
9996877|NCT01691534|11118649|FG005|COMPLETED|Overall Study||14
9996878|NCT01691534|11118650|FG006|COMPLETED|Overall Study||14
9996879|NCT01691534|11118644|FG000|NOT COMPLETED|Overall Study||0
9996880|NCT01691534|11118645|FG001|NOT COMPLETED|Overall Study||1
9996881|NCT01691534|11118646|FG002|NOT COMPLETED|Overall Study||1
9996882|NCT01691534|11118647|FG003|NOT COMPLETED|Overall Study||1
9996883|NCT01691534|11118648|FG004|NOT COMPLETED|Overall Study||0
9996884|NCT01691534|11118649|FG005|NOT COMPLETED|Overall Study||1
9996885|NCT01691534|11118650|FG006|NOT COMPLETED|Overall Study||1
9996886|NCT01691560|11118671|FG000|STARTED|Overall Study||34
9996887|NCT01691560|11118672|FG001|STARTED|Overall Study||33
9996888|NCT01691560|11118673|FG002|STARTED|Overall Study||34
9996889|NCT01691560|11118674|FG003|STARTED|Overall Study||33
9996890|NCT01691560|11118671|FG000|COMPLETED|Overall Study||34
9996891|NCT01691560|11118672|FG001|COMPLETED|Overall Study||33
9996892|NCT01691560|11118673|FG002|COMPLETED|Overall Study||34
9996893|NCT01691560|11118674|FG003|COMPLETED|Overall Study||33
9996894|NCT01691560|11118671|FG000|NOT COMPLETED|Overall Study||0
9996895|NCT01691560|11118672|FG001|NOT COMPLETED|Overall Study||0
9996896|NCT01691560|11118673|FG002|NOT COMPLETED|Overall Study||0
9996897|NCT01691560|11118674|FG003|NOT COMPLETED|Overall Study||0
9996898|NCT01691612|11118684|FG000|STARTED|Overall Study||14
9996899|NCT01691612|11118684|FG000|First Visit (Allergen Challenge)|Overall Study||8
9996900|NCT01691612|11118684|FG000|Second Visit (Bronchoscopy)|Overall Study||7
9996901|NCT01691612|11118684|FG000|COMPLETED|Overall Study||7
9996902|NCT01691612|11118684|FG000|NOT COMPLETED|Overall Study||7
9996903|NCT01691690|11118690|FG000|STARTED|Overall Study||125
9996904|NCT01691690|11118691|FG001|STARTED|Overall Study||125
9996905|NCT01691690|11118690|FG000|COMPLETED|Overall Study||118
9996906|NCT01691690|11118691|FG001|COMPLETED|Overall Study||121
9996907|NCT01691690|11118690|FG000|NOT COMPLETED|Overall Study||7
9996908|NCT01691690|11118691|FG001|NOT COMPLETED|Overall Study||4
9996909|NCT01691768|11118702|FG000|STARTED|Overall Study||189
9996910|NCT01691768|11118703|FG001|STARTED|Overall Study||183
9996911|NCT01691768|11118702|FG000|COMPLETED|Overall Study||174
9996912|NCT01691768|11118703|FG001|COMPLETED|Overall Study||167
9996913|NCT01691768|11118702|FG000|NOT COMPLETED|Overall Study||15
9996914|NCT01691768|11118703|FG001|NOT COMPLETED|Overall Study||16
9996915|NCT01691781|11118712|FG000|STARTED|Overall Study||19
9996916|NCT01691781|11118713|FG001|STARTED|Overall Study||22
9996917|NCT01691781|11118712|FG000|COMPLETED|Overall Study||12
9996918|NCT01691781|11118713|FG001|COMPLETED|Overall Study||15
9996919|NCT01691781|11118712|FG000|NOT COMPLETED|Overall Study||7
9996920|NCT01691781|11118713|FG001|NOT COMPLETED|Overall Study||7
9996921|NCT01691794|11118722|FG000|STARTED|Overall Study||3
9996922|NCT01691794|11118723|FG001|STARTED|Overall Study||33
9996923|NCT01691794|11118724|FG002|STARTED|Overall Study||23
9996924|NCT01691794|11118722|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2
9996925|NCT01691794|11118723|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15
9996926|NCT01691794|11118724|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13
9996927|NCT01691794|11118722|FG000|NOT COMPLETED|Overall Study||1
9996928|NCT01691794|11118723|FG001|NOT COMPLETED|Overall Study||18
9996929|NCT01691794|11118724|FG002|NOT COMPLETED|Overall Study||10
9996930|NCT01691820|11118734|FG000|STARTED|Overall Study||210
9996931|NCT01691820|11118735|FG001|STARTED|Overall Study||152
9996932|NCT01691820|11118734|FG000|COMPLETED|Overall Study||184
9996933|NCT01691820|11118735|FG001|COMPLETED|Overall Study||115
9996934|NCT01691820|11118734|FG000|NOT COMPLETED|Overall Study||26
9996935|NCT01691820|11118735|FG001|NOT COMPLETED|Overall Study||37
9996936|NCT01691833|11118748|FG000|STARTED|Overall Study||50
9996937|NCT01691833|11118749|FG001|STARTED|Overall Study||50
9996938|NCT01691833|11118750|FG002|STARTED|Overall Study||13
9996939|NCT01691833|11118748|FG000|COMPLETED|Overall Study||49
9996940|NCT01691833|11118749|FG001|COMPLETED|Overall Study||49
9996941|NCT01691833|11118750|FG002|COMPLETED|Overall Study||13
9996942|NCT01691833|11118748|FG000|NOT COMPLETED|Overall Study||1
9996943|NCT01691833|11118749|FG001|NOT COMPLETED|Overall Study||1
9996944|NCT01691833|11118750|FG002|NOT COMPLETED|Overall Study||0
9996945|NCT01691859|11118758|FG000|STARTED|Overall Study||347
9996946|NCT01691859|11118758|FG000|COMPLETED|Overall Study||0
9996947|NCT01691859|11118758|FG000|NOT COMPLETED|Overall Study||347
9996948|NCT01691885|11118762|FG000|STARTED|Treatment Period 1(7-14 Days)||22
9996949|NCT01691885|11118763|FG001|STARTED|Treatment Period 1(7-14 Days)||23
9996950|NCT01691885|11118762|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21
9996951|NCT01691885|11118763|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22
9996952|NCT01691885|11118762|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
9996953|NCT01691885|11118763|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
9996954|NCT01691885|11118762|FG000|STARTED|Washout Period (7-9 Days)||21
9996955|NCT01691885|11118763|FG001|STARTED|Washout Period (7-9 Days)||22
9996956|NCT01691885|11118762|FG000|COMPLETED|Washout Period (7-9 Days)||21
9996957|NCT01691885|11118763|FG001|COMPLETED|Washout Period (7-9 Days)||21
9996958|NCT01691885|11118762|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0
9996959|NCT01691885|11118763|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1
9996960|NCT01691885|11118762|FG000|STARTED|Treatment Period 2 (7-14 Days)||21
9996961|NCT01691885|11118763|FG001|STARTED|Treatment Period 2 (7-14 Days)||21
9996962|NCT01691885|11118762|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21
9996963|NCT01691885|11118763|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21
9996964|NCT01691885|11118762|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
9996965|NCT01691885|11118763|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
9996966|NCT01691898|11118775|FG000|STARTED|Overall Study||63
9996967|NCT01691898|11118776|FG001|STARTED|Overall Study||59
9996968|NCT01691898|11118777|FG002|STARTED|Overall Study||20
9996969|NCT01691898|11118778|FG003|STARTED|Overall Study||9
9996970|NCT01691898|11118779|FG004|STARTED|Overall Study||40
9996971|NCT01691898|11118780|FG005|STARTED|Overall Study||40
9996972|NCT01691898|11118775|FG000|COMPLETED|Overall Study||16
9996973|NCT01691898|11118776|FG001|COMPLETED|Overall Study||15
9996974|NCT01691898|11118777|FG002|COMPLETED|Overall Study||11
9996975|NCT01691898|11118778|FG003|COMPLETED|Overall Study||4
9996976|NCT01691898|11118779|FG004|COMPLETED|Overall Study||26
9996977|NCT01691898|11118780|FG005|COMPLETED|Overall Study||5
9996978|NCT01691898|11118775|FG000|NOT COMPLETED|Overall Study||47
9996979|NCT01691898|11118776|FG001|NOT COMPLETED|Overall Study||44
9996980|NCT01691898|11118777|FG002|NOT COMPLETED|Overall Study||9
9996981|NCT01691898|11118778|FG003|NOT COMPLETED|Overall Study||5
9996982|NCT01691898|11118779|FG004|NOT COMPLETED|Overall Study||14
9996983|NCT01691898|11118780|FG005|NOT COMPLETED|Overall Study||35
9996984|NCT01691950|11118814|FG000|STARTED|Overall Study||20
9996985|NCT01691950|11118815|FG001|STARTED|Overall Study||10
9996986|NCT01691950|11118814|FG000|COMPLETED|Overall Study||10
9996987|NCT01691950|11118815|FG001|COMPLETED|Overall Study||10
9996988|NCT01691950|11118814|FG000|NOT COMPLETED|Overall Study||10
9996989|NCT01691950|11118815|FG001|NOT COMPLETED|Overall Study||0
9996990|NCT01692119|11118823|FG000|STARTED|Overall Study||130
9996991|NCT01692119|11118824|FG001|STARTED|Overall Study||128
9996992|NCT01692119|11118823|FG000|COMPLETED|Overall Study||110
9996993|NCT01692119|11118824|FG001|COMPLETED|Overall Study||127
9996994|NCT01692119|11118823|FG000|NOT COMPLETED|Overall Study||20
9996995|NCT01692119|11118824|FG001|NOT COMPLETED|Overall Study||1
9996996|NCT01692197|11118830|FG000|STARTED|Overall Study||43
9996997|NCT01692197|11118830|FG000|COMPLETED|Overall Study||40
9996998|NCT01692197|11118830|FG000|NOT COMPLETED|Overall Study||3
9996999|NCT01692275|11118841|FG000|STARTED|Overall Study||375
9997000|NCT01692275|11118842|FG001|STARTED|Overall Study||375
9997001|NCT01692275|11118841|FG000|COMPLETED|Overall Study||309
9997002|NCT01692275|11118842|FG001|COMPLETED|Overall Study||316
9997003|NCT01692275|11118841|FG000|NOT COMPLETED|Overall Study||66
9997004|NCT01692275|11118842|FG001|NOT COMPLETED|Overall Study||59
9997005|NCT01692301|11118862|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
9997006|NCT01692301|11118863|FG001|STARTED|Overall Study||225
9997007|NCT01692301|11118862|FG000|COMPLETED|Overall Study||184
9997008|NCT01692301|11118863|FG001|COMPLETED|Overall Study||183
9997009|NCT01692301|11118862|FG000|NOT COMPLETED|Overall Study||45
9997010|NCT01692301|11118863|FG001|NOT COMPLETED|Overall Study||42
9997011|NCT01692340|11118872|FG000|STARTED|Overall Study||8
9997012|NCT01692340|11118873|FG001|STARTED|Overall Study||4
9997013|NCT01692340|11118874|FG002|STARTED|Overall Study||0
9997014|NCT01692340|11118872|FG000|COMPLETED|Overall Study||8
9997015|NCT01692340|11118873|FG001|COMPLETED|Overall Study||4
9997016|NCT01692340|11118874|FG002|COMPLETED|Overall Study||0
9997017|NCT01692340|11118872|FG000|NOT COMPLETED|Overall Study||0
9997018|NCT01692340|11118873|FG001|NOT COMPLETED|Overall Study||0
9997019|NCT01692340|11118874|FG002|NOT COMPLETED|Overall Study||0
9997020|NCT01692496|11118883|FG000|STARTED|Overall Study||52
9997021|NCT01692496|11118883|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
9997022|NCT01692496|11118883|FG000|COMPLETED|Overall Study||52
9997023|NCT01692496|11118883|FG000|NOT COMPLETED|Overall Study||0
9997024|NCT01692626|11118887|FG000|STARTED|Overall Study||6
9997025|NCT01692626|11118888|FG001|STARTED|Overall Study||7
9997026|NCT01692626|11118887|FG000|COMPLETED|Overall Study||2
9997027|NCT01692626|11118888|FG001|COMPLETED|Overall Study||1
9997028|NCT01692626|11118887|FG000|NOT COMPLETED|Overall Study||4
9997029|NCT01692626|11118888|FG001|NOT COMPLETED|Overall Study||6
9997030|NCT01692730|11118895|FG000|STARTED|Overall Study||723
9997031|NCT01692730|11118896|FG001|STARTED|Overall Study||729
9997032|NCT01692730|11118895|FG000|COMPLETED|Overall Study||498
9997033|NCT01692730|11118896|FG001|COMPLETED|Overall Study||502
9997034|NCT01692730|11118895|FG000|NOT COMPLETED|Overall Study||225
9997035|NCT01692730|11118896|FG001|NOT COMPLETED|Overall Study||227
9997036|NCT01692743|11118905|FG000|STARTED|Overall Study||117
9997037|NCT01692743|11118906|FG001|STARTED|Overall Study||116
9997038|NCT01692743|11118907|FG002|STARTED|Overall Study||115
9997039|NCT01692743|11118905|FG000|COMPLETED|Overall Study||90
9997040|NCT01692743|11118906|FG001|COMPLETED|Overall Study||81
9997041|NCT01692743|11118907|FG002|COMPLETED|Overall Study||88
9997042|NCT01692743|11118905|FG000|NOT COMPLETED|Overall Study||27
9997043|NCT01692743|11118906|FG001|NOT COMPLETED|Overall Study||35
9997044|NCT01692743|11118907|FG002|NOT COMPLETED|Overall Study||27
9997045|NCT01692756|11118919|FG000|STARTED|Overall Study||12
9997046|NCT01692756|11118920|FG001|STARTED|Overall Study||12
9997047|NCT01692756|11118921|FG002|STARTED|Overall Study||13
9997048|NCT01692756|11118922|FG003|STARTED|Overall Study||12
9997049|NCT01692756|11118919|FG000|COMPLETED|Overall Study||11
9997050|NCT01692756|11118920|FG001|COMPLETED|Overall Study||11
9997051|NCT01692756|11118921|FG002|COMPLETED|Overall Study||11
9997052|NCT01692756|11118922|FG003|COMPLETED|Overall Study||12
9997053|NCT01692756|11118919|FG000|NOT COMPLETED|Overall Study||1
9997054|NCT01692756|11118920|FG001|NOT COMPLETED|Overall Study||1
9997055|NCT01692756|11118921|FG002|NOT COMPLETED|Overall Study||2
9997056|NCT01692756|11118922|FG003|NOT COMPLETED|Overall Study||0
9997057|NCT01692782|11118935|FG000|STARTED|Overall Study||116
9997058|NCT01692782|11118936|FG001|STARTED|Overall Study||115
9997059|NCT01692782|11118937|FG002|STARTED|Overall Study||110
9997060|NCT01692782|11118935|FG000|COMPLETED|Overall Study||96
9997061|NCT01692782|11118936|FG001|COMPLETED|Overall Study||59
9997062|NCT01692782|11118937|FG002|COMPLETED|Overall Study||100
9997063|NCT01692782|11118935|FG000|NOT COMPLETED|Overall Study||20
9997064|NCT01692782|11118936|FG001|NOT COMPLETED|Overall Study||56
9997065|NCT01692782|11118937|FG002|NOT COMPLETED|Overall Study||10
9997066|NCT01692938|11118947|FG000|STARTED|Overall Study||16
9997067|NCT01692938|11118948|FG001|STARTED|Overall Study||16
9997068|NCT01692938|11118947|FG000|COMPLETED|Overall Study||12
9997069|NCT01692938|11118948|FG001|COMPLETED|Overall Study||12
9997070|NCT01692938|11118947|FG000|NOT COMPLETED|Overall Study||4
9997071|NCT01692938|11118948|FG001|NOT COMPLETED|Overall Study||4
9997072|NCT01692951|11118958|FG000|STARTED|Overall Study||37
9997073|NCT01692951|11118959|FG001|STARTED|Overall Study||111
9997074|NCT01692951|11118960|FG002|STARTED|Overall Study||18
9997075|NCT01692951|11118961|FG003|STARTED|Overall Study||54
9997076|NCT01692951|11118958|FG000|COMPLETED|Overall Study||37
9997077|NCT01692951|11118959|FG001|COMPLETED|Overall Study||111
9997078|NCT01692951|11118960|FG002|COMPLETED|Overall Study||18
9997079|NCT01692951|11118961|FG003|COMPLETED|Overall Study||54
9997080|NCT01692951|11118958|FG000|NOT COMPLETED|Overall Study||0
9997081|NCT01692951|11118959|FG001|NOT COMPLETED|Overall Study||0
9997082|NCT01692951|11118960|FG002|NOT COMPLETED|Overall Study||0
9997083|NCT01692951|11118961|FG003|NOT COMPLETED|Overall Study||0
9997084|NCT01692964|11118971|FG000|STARTED|Overall Study||237
9997085|NCT01692964|11118971|FG000|COMPLETED|Overall Study||237
9997086|NCT01692964|11118971|FG000|NOT COMPLETED|Overall Study||0
9997087|NCT01693029|11118978|FG000|STARTED|Overall Study||217
9997088|NCT01693029|11118979|FG001|STARTED|Overall Study||218
9997089|NCT01693029|11118978|FG000|COMPLETED|Overall Study||173
9997090|NCT01693029|11118979|FG001|COMPLETED|Overall Study||161
9997091|NCT01693029|11118978|FG000|NOT COMPLETED|Overall Study||44
9997092|NCT01693029|11118979|FG001|NOT COMPLETED|Overall Study||57
9997093|NCT01693068|11118987|FG000|STARTED|Randomization Period||64
9997094|NCT01693068|11118988|FG001|STARTED|Randomization Period||130
9997095|NCT01693068|11118989|FG002|STARTED|Randomization Period||0
9997096|NCT01693068|11118987|FG000|Treated|Randomization Period||61
9997097|NCT01693068|11118988|FG001|Treated|Randomization Period||130
9997098|NCT01693068|11118989|FG002|Treated|Randomization Period||0
9997099|NCT01693068|11118987|FG000|COMPLETED|Randomization Period||62
9997100|NCT01693068|11118988|FG001|COMPLETED|Randomization Period||125
9997101|NCT01693068|11118989|FG002|COMPLETED|Randomization Period||0
9997102|NCT01693068|11118987|FG000|NOT COMPLETED|Randomization Period||2
9997103|NCT01693068|11118988|FG001|NOT COMPLETED|Randomization Period||5
9997104|NCT01693068|11118989|FG002|NOT COMPLETED|Randomization Period||0
9997105|NCT01693068|11118987|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
9997106|NCT01693068|11118988|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
9997107|NCT01693068|11118989|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
9997108|NCT01693068|11118987|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0
9997109|NCT01693068|11118988|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0
9997110|NCT01693068|11118989|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41
9997111|NCT01693068|11118987|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
9997112|NCT01693068|11118988|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
9997113|NCT01693068|11118989|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
9997114|NCT01693068|11118987|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
9997115|NCT01693068|11118988|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
9997116|NCT01693068|11118989|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
9997117|NCT01693120|11118997|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
9997118|NCT01693120|11118997|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
9997119|NCT01693120|11118997|FG000|NOT COMPLETED|Enrollment||70
9997120|NCT01693120|11118997|FG000|STARTED|Phased RF Study Procedure and Follow-up||129
9997121|NCT01693120|11118997|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
9997122|NCT01693120|11118997|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
9997123|NCT01693185|11119003|FG000|STARTED|Overall Study||27
9997124|NCT01693185|11119004|FG001|STARTED|Overall Study||33
9997125|NCT01693185|11119003|FG000|COMPLETED|Overall Study||27
9997126|NCT01693185|11119004|FG001|COMPLETED|Overall Study||27
9997127|NCT01693185|11119003|FG000|NOT COMPLETED|Overall Study||0
9997128|NCT01693185|11119004|FG001|NOT COMPLETED|Overall Study||6
9997129|NCT01693250|11119012|FG000|STARTED|Overall Study|3 months post baseline assessment|23
9997130|NCT01693250|11119013|FG001|STARTED|Overall Study|three month post baseline assessment|17
9997131|NCT01693250|11119012|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
9997132|NCT01693250|11119013|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
9997133|NCT01693250|11119012|FG000|NOT COMPLETED|Overall Study||2
9997134|NCT01693250|11119013|FG001|NOT COMPLETED|Overall Study||2
9997135|NCT01693523|11119024|FG000|STARTED|Overall Study||23
9997136|NCT01693523|11119025|FG001|STARTED|Overall Study||21
9997137|NCT01693523|11119026|FG002|STARTED|Overall Study||35
9997138|NCT01693523|11119024|FG000|COMPLETED|Overall Study||18
9997139|NCT01693523|11119025|FG001|COMPLETED|Overall Study||13
9997140|NCT01693523|11119026|FG002|COMPLETED|Overall Study||27
9997141|NCT01693523|11119024|FG000|NOT COMPLETED|Overall Study||5
9997142|NCT01693523|11119025|FG001|NOT COMPLETED|Overall Study||8
9997143|NCT01693523|11119026|FG002|NOT COMPLETED|Overall Study||8
9997144|NCT01693562|11119056|FG000|STARTED|Escalation Phase||4
9997145|NCT01693562|11119057|FG001|STARTED|Escalation Phase||4
9997146|NCT01693562|11119058|FG002|STARTED|Escalation Phase||3
9997147|NCT01693562|11119059|FG003|STARTED|Escalation Phase||3
9997148|NCT01693562|11119060|FG004|STARTED|Escalation Phase||6
9997149|NCT01693562|11119061|FG005|STARTED|Escalation Phase||7
9997150|NCT01693562|11119062|FG006|STARTED|Escalation Phase||0
9997151|NCT01693562|11119063|FG007|STARTED|Escalation Phase||0
9997152|NCT01693562|11119064|FG008|STARTED|Escalation Phase||0
9997153|NCT01693562|11119065|FG009|STARTED|Escalation Phase||0
9997154|NCT01693562|11119066|FG010|STARTED|Escalation Phase||0
9997155|NCT01693562|11119067|FG011|STARTED|Escalation Phase||0
9997156|NCT01693562|11119068|FG012|STARTED|Escalation Phase||0
9997157|NCT01693562|11119069|FG013|STARTED|Escalation Phase||0
9997158|NCT01693562|11119070|FG014|STARTED|Escalation Phase||0
9997159|NCT01693562|11119071|FG015|STARTED|Escalation Phase||0
9997160|NCT01693562|11119072|FG016|STARTED|Escalation Phase||0
9997161|NCT01693562|11119073|FG017|STARTED|Escalation Phase||0
9997162|NCT01693562|11119074|FG018|STARTED|Escalation Phase||0
9997163|NCT01693562|11119075|FG019|STARTED|Escalation Phase||0
9997164|NCT01693562|11119076|FG020|STARTED|Escalation Phase||0
9997165|NCT01693562|11119077|FG021|STARTED|Escalation Phase||0
9997166|NCT01693562|11119078|FG022|STARTED|Escalation Phase||0
9997167|NCT01693562|11119056|FG000|COMPLETED|Escalation Phase||0
9997168|NCT01693562|11119057|FG001|COMPLETED|Escalation Phase||0
9997169|NCT01693562|11119058|FG002|COMPLETED|Escalation Phase||0
9997170|NCT01693562|11119059|FG003|COMPLETED|Escalation Phase||0
9997171|NCT01693562|11119060|FG004|COMPLETED|Escalation Phase||0
9997172|NCT01693562|11119061|FG005|COMPLETED|Escalation Phase||0
9997173|NCT01693562|11119062|FG006|COMPLETED|Escalation Phase||0
9997174|NCT01693562|11119063|FG007|COMPLETED|Escalation Phase||0
9997175|NCT01693562|11119064|FG008|COMPLETED|Escalation Phase||0
9997176|NCT01693562|11119065|FG009|COMPLETED|Escalation Phase||0
9997177|NCT01693562|11119066|FG010|COMPLETED|Escalation Phase||0
9997178|NCT01693562|11119067|FG011|COMPLETED|Escalation Phase||0
9997179|NCT01693562|11119068|FG012|COMPLETED|Escalation Phase||0
9997180|NCT01693562|11119069|FG013|COMPLETED|Escalation Phase||0
9997181|NCT01693562|11119070|FG014|COMPLETED|Escalation Phase||0
9997182|NCT01693562|11119071|FG015|COMPLETED|Escalation Phase||0
9997183|NCT01693562|11119072|FG016|COMPLETED|Escalation Phase||0
9997184|NCT01693562|11119073|FG017|COMPLETED|Escalation Phase||0
9997185|NCT01693562|11119074|FG018|COMPLETED|Escalation Phase||0
9997186|NCT01693562|11119075|FG019|COMPLETED|Escalation Phase||0
9997187|NCT01693562|11119076|FG020|COMPLETED|Escalation Phase||0
9997188|NCT01693562|11119077|FG021|COMPLETED|Escalation Phase||0
9997189|NCT01693562|11119078|FG022|COMPLETED|Escalation Phase||0
9997190|NCT01693562|11119056|FG000|NOT COMPLETED|Escalation Phase||4
9997191|NCT01693562|11119057|FG001|NOT COMPLETED|Escalation Phase||4
9997192|NCT01693562|11119058|FG002|NOT COMPLETED|Escalation Phase||3
9997193|NCT01693562|11119059|FG003|NOT COMPLETED|Escalation Phase||3
9997194|NCT01693562|11119060|FG004|NOT COMPLETED|Escalation Phase||6
9997195|NCT01693562|11119061|FG005|NOT COMPLETED|Escalation Phase||7
9997196|NCT01693562|11119062|FG006|NOT COMPLETED|Escalation Phase||0
9997197|NCT01693562|11119063|FG007|NOT COMPLETED|Escalation Phase||0
9997198|NCT01693562|11119064|FG008|NOT COMPLETED|Escalation Phase||0
9997199|NCT01693562|11119065|FG009|NOT COMPLETED|Escalation Phase||0
9997200|NCT01693562|11119066|FG010|NOT COMPLETED|Escalation Phase||0
9997201|NCT01693562|11119067|FG011|NOT COMPLETED|Escalation Phase||0
9997202|NCT01693562|11119068|FG012|NOT COMPLETED|Escalation Phase||0
9997203|NCT01693562|11119069|FG013|NOT COMPLETED|Escalation Phase||0
9997204|NCT01693562|11119070|FG014|NOT COMPLETED|Escalation Phase||0
9997205|NCT01693562|11119071|FG015|NOT COMPLETED|Escalation Phase||0
9997206|NCT01693562|11119072|FG016|NOT COMPLETED|Escalation Phase||0
9997207|NCT01693562|11119073|FG017|NOT COMPLETED|Escalation Phase||0
9997208|NCT01693562|11119074|FG018|NOT COMPLETED|Escalation Phase||0
9997209|NCT01693562|11119075|FG019|NOT COMPLETED|Escalation Phase||0
9997210|NCT01693562|11119076|FG020|NOT COMPLETED|Escalation Phase||0
9997211|NCT01693562|11119077|FG021|NOT COMPLETED|Escalation Phase||0
9997212|NCT01693562|11119078|FG022|NOT COMPLETED|Escalation Phase||0
9997213|NCT01693562|11119056|FG000|STARTED|Exploration Phase||0
9997214|NCT01693562|11119057|FG001|STARTED|Exploration Phase||0
9997215|NCT01693562|11119058|FG002|STARTED|Exploration Phase||0
9997216|NCT01693562|11119059|FG003|STARTED|Exploration Phase||0
9997217|NCT01693562|11119060|FG004|STARTED|Exploration Phase||0
9997218|NCT01693562|11119061|FG005|STARTED|Exploration Phase||0
9997219|NCT01693562|11119062|FG006|STARTED|Exploration Phase||21
9997220|NCT01693562|11119063|FG007|STARTED|Exploration Phase||0
9997221|NCT01693562|11119064|FG008|STARTED|Exploration Phase||0
9997222|NCT01693562|11119065|FG009|STARTED|Exploration Phase||0
9997223|NCT01693562|11119066|FG010|STARTED|Exploration Phase||0
9997224|NCT01693562|11119067|FG011|STARTED|Exploration Phase||0
9997225|NCT01693562|11119068|FG012|STARTED|Exploration Phase||0
9997226|NCT01693562|11119069|FG013|STARTED|Exploration Phase||0
9997227|NCT01693562|11119070|FG014|STARTED|Exploration Phase||0
9997228|NCT01693562|11119071|FG015|STARTED|Exploration Phase||0
9997229|NCT01693562|11119072|FG016|STARTED|Exploration Phase||0
9997230|NCT01693562|11119073|FG017|STARTED|Exploration Phase||0
9997231|NCT01693562|11119074|FG018|STARTED|Exploration Phase||0
9997232|NCT01693562|11119075|FG019|STARTED|Exploration Phase||0
9997233|NCT01693562|11119076|FG020|STARTED|Exploration Phase||0
9997234|NCT01693562|11119077|FG021|STARTED|Exploration Phase||0
9997235|NCT01693562|11119078|FG022|STARTED|Exploration Phase||0
9997236|NCT01693562|11119056|FG000|COMPLETED|Exploration Phase||0
9997237|NCT01693562|11119057|FG001|COMPLETED|Exploration Phase||0
9997238|NCT01693562|11119058|FG002|COMPLETED|Exploration Phase||0
9997239|NCT01693562|11119059|FG003|COMPLETED|Exploration Phase||0
9997240|NCT01693562|11119060|FG004|COMPLETED|Exploration Phase||0
9997241|NCT01693562|11119061|FG005|COMPLETED|Exploration Phase||0
9997242|NCT01693562|11119062|FG006|COMPLETED|Exploration Phase||0
9997243|NCT01693562|11119063|FG007|COMPLETED|Exploration Phase||0
9997244|NCT01693562|11119064|FG008|COMPLETED|Exploration Phase||0
10102681|NCT02417246|11232242|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24
10102682|NCT02417246|11232243|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24
10102683|NCT02417246|11232242|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
10102684|NCT02417246|11232243|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
10102685|NCT02417246|11232242|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
10102686|NCT02417246|11232243|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
10102687|NCT02417246|11232242|FG000|STARTED|Phase 2 1st Generic Administered||20
10102688|NCT02417246|11232243|FG001|STARTED|Phase 2 1st Generic Administered||20
10102689|NCT02417246|11232242|FG000|COMPLETED|Phase 2 1st Generic Administered||19
10102690|NCT02417246|11232243|FG001|COMPLETED|Phase 2 1st Generic Administered||20
10102691|NCT02417246|11232242|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1
10102692|NCT02417246|11232243|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0
10102693|NCT02417246|11232242|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
10102694|NCT02417246|11232243|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
10102695|NCT02417246|11232242|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
10102696|NCT02417246|11232243|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
10102697|NCT02417246|11232242|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
10102698|NCT02417246|11232243|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
10102699|NCT02417246|11232242|FG000|STARTED|Phase 4 2nd Generic Administered||18
10102700|NCT02417246|11232243|FG001|STARTED|Phase 4 2nd Generic Administered||20
10102701|NCT02417246|11232242|FG000|COMPLETED|Phase 4 2nd Generic Administered||18
10102702|NCT02417246|11232243|FG001|COMPLETED|Phase 4 2nd Generic Administered||20
10102703|NCT02417246|11232242|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0
10102704|NCT02417246|11232243|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0
10102705|NCT02417376|11232253|FG000|STARTED|Overall Study||35
10102706|NCT02417376|11232254|FG001|STARTED|Overall Study||35
10102707|NCT02417376|11232253|FG000|COMPLETED|Overall Study||30
10102708|NCT02417376|11232254|FG001|COMPLETED|Overall Study||25
10102709|NCT02417376|11232253|FG000|NOT COMPLETED|Overall Study||5
10102710|NCT02417376|11232254|FG001|NOT COMPLETED|Overall Study||10
10102711|NCT02417441|11232262|FG000|STARTED|Overall Study||645
10102712|NCT02417441|11232263|FG001|STARTED|Overall Study||325
10102713|NCT02417441|11232262|FG000|COMPLETED|Overall Study||593
10102714|NCT02417441|11232263|FG001|COMPLETED|Overall Study||306
10102715|NCT02417441|11232262|FG000|NOT COMPLETED|Overall Study||52
10102716|NCT02417441|11232263|FG001|NOT COMPLETED|Overall Study||19
10102717|NCT02417532|11232270|FG000|STARTED|Overall Study||56
10102718|NCT02417532|11232270|FG000|COMPLETED|Overall Study||56
10102719|NCT02417532|11232270|FG000|NOT COMPLETED|Overall Study||0
10102720|NCT02417753|11232276|FG000|STARTED|Overall Study||1
10102721|NCT02417753|11232276|FG000|COMPLETED|Overall Study||0
10102722|NCT02417753|11232276|FG000|NOT COMPLETED|Overall Study||1
10102723|NCT02417831|11232280|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17
10102724|NCT02417831|11232281|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17
10102725|NCT02417831|11232280|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17
10102726|NCT02417831|11232281|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17
10102727|NCT02417831|11232280|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10102728|NCT02417831|11232281|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10102729|NCT02417831|11232280|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17
10102730|NCT02417831|11232281|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17
10102731|NCT02417831|11232280|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17
10102732|NCT02417831|11232281|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17
10102733|NCT02417831|11232280|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
10102734|NCT02417831|11232281|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
10102735|NCT02417844|11232287|FG000|STARTED|Overall Study||17
10102736|NCT02417844|11232288|FG001|STARTED|Overall Study||17
10102737|NCT02417844|11232287|FG000|COMPLETED|Overall Study||17
10102738|NCT02417844|11232288|FG001|COMPLETED|Overall Study||17
10102739|NCT02417844|11232287|FG000|NOT COMPLETED|Overall Study||0
9997245|NCT01693562|11119065|FG009|COMPLETED|Exploration Phase||0
9997246|NCT01693562|11119066|FG010|COMPLETED|Exploration Phase||0
9997247|NCT01693562|11119067|FG011|COMPLETED|Exploration Phase||0
9997248|NCT01693562|11119068|FG012|COMPLETED|Exploration Phase||0
9997249|NCT01693562|11119069|FG013|COMPLETED|Exploration Phase||0
9997250|NCT01693562|11119070|FG014|COMPLETED|Exploration Phase||0
9997251|NCT01693562|11119071|FG015|COMPLETED|Exploration Phase||0
9997252|NCT01693562|11119072|FG016|COMPLETED|Exploration Phase||0
9997253|NCT01693562|11119073|FG017|COMPLETED|Exploration Phase||0
9997254|NCT01693562|11119074|FG018|COMPLETED|Exploration Phase||0
9997255|NCT01693562|11119075|FG019|COMPLETED|Exploration Phase||0
9997256|NCT01693562|11119076|FG020|COMPLETED|Exploration Phase||0
9997257|NCT01693562|11119077|FG021|COMPLETED|Exploration Phase||0
9997258|NCT01693562|11119078|FG022|COMPLETED|Exploration Phase||0
9997259|NCT01693562|11119056|FG000|NOT COMPLETED|Exploration Phase||0
9997260|NCT01693562|11119057|FG001|NOT COMPLETED|Exploration Phase||0
9997261|NCT01693562|11119058|FG002|NOT COMPLETED|Exploration Phase||0
9997262|NCT01693562|11119059|FG003|NOT COMPLETED|Exploration Phase||0
9997263|NCT01693562|11119060|FG004|NOT COMPLETED|Exploration Phase||0
9997264|NCT01693562|11119061|FG005|NOT COMPLETED|Exploration Phase||0
9997265|NCT01693562|11119062|FG006|NOT COMPLETED|Exploration Phase||21
9997266|NCT01693562|11119063|FG007|NOT COMPLETED|Exploration Phase||0
9997267|NCT01693562|11119064|FG008|NOT COMPLETED|Exploration Phase||0
9997268|NCT01693562|11119065|FG009|NOT COMPLETED|Exploration Phase||0
9997269|NCT01693562|11119066|FG010|NOT COMPLETED|Exploration Phase||0
9997270|NCT01693562|11119067|FG011|NOT COMPLETED|Exploration Phase||0
9997271|NCT01693562|11119068|FG012|NOT COMPLETED|Exploration Phase||0
9997272|NCT01693562|11119069|FG013|NOT COMPLETED|Exploration Phase||0
9997273|NCT01693562|11119070|FG014|NOT COMPLETED|Exploration Phase||0
9997274|NCT01693562|11119071|FG015|NOT COMPLETED|Exploration Phase||0
9997275|NCT01693562|11119072|FG016|NOT COMPLETED|Exploration Phase||0
9997276|NCT01693562|11119073|FG017|NOT COMPLETED|Exploration Phase||0
9997277|NCT01693562|11119074|FG018|NOT COMPLETED|Exploration Phase||0
9997278|NCT01693562|11119075|FG019|NOT COMPLETED|Exploration Phase||0
10102740|NCT02417844|11232288|FG001|NOT COMPLETED|Overall Study||0
10102741|NCT02417935|11232296|FG000|STARTED|Treatment Period||151
10102742|NCT02417935|11232297|FG001|STARTED|Treatment Period||153
10102743|NCT02417935|11232296|FG000|Received at Least One Dose of Study Drug|Treatment Period||151
10102744|NCT02417935|11232297|FG001|Received at Least One Dose of Study Drug|Treatment Period||152
10102745|NCT02417935|11232296|FG000|COMPLETED|Treatment Period||130
9997279|NCT01693562|11119076|FG020|NOT COMPLETED|Exploration Phase||0
9997280|NCT01693562|11119077|FG021|NOT COMPLETED|Exploration Phase||0
9997281|NCT01693562|11119078|FG022|NOT COMPLETED|Exploration Phase||0
10102746|NCT02417935|11232297|FG001|COMPLETED|Treatment Period||137
10102747|NCT02417935|11232296|FG000|NOT COMPLETED|Treatment Period||21
10102748|NCT02417935|11232297|FG001|NOT COMPLETED|Treatment Period||16
10102749|NCT02417935|11232296|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
10102750|NCT02417935|11232297|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
10102751|NCT02417935|11232296|FG000|COMPLETED|Tapering Period||134
10102752|NCT02417935|11232297|FG001|COMPLETED|Tapering Period||142
10102753|NCT02417935|11232296|FG000|NOT COMPLETED|Tapering Period||0
10102754|NCT02417935|11232297|FG001|NOT COMPLETED|Tapering Period||0
10102755|NCT02417961|11232303|FG000|STARTED|Overall Study||116
10102756|NCT02417961|11232303|FG000|COMPLETED|Overall Study||112
10102757|NCT02417961|11232303|FG000|NOT COMPLETED|Overall Study||4
10102758|NCT02418000|11232312|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
10102759|NCT02418000|11232313|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102760|NCT02418000|11232314|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102761|NCT02418000|11232315|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102762|NCT02418000|11232316|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102763|NCT02418000|11232312|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102764|NCT02418000|11232313|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102765|NCT02418000|11232314|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102766|NCT02418000|11232315|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102767|NCT02418000|11232316|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102768|NCT02418000|11232312|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
10102769|NCT02418000|11232313|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102770|NCT02418000|11232314|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102771|NCT02418000|11232315|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102772|NCT02418000|11232316|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10102773|NCT02418000|11232312|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102774|NCT02418000|11232313|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
10102775|NCT02418000|11232314|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102776|NCT02418000|11232315|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102777|NCT02418000|11232316|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102778|NCT02418000|11232312|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102779|NCT02418000|11232313|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
9997282|NCT01693562|11119056|FG000|STARTED|Expansion Phase||0
9997283|NCT01693562|11119057|FG001|STARTED|Expansion Phase||0
9997284|NCT01693562|11119058|FG002|STARTED|Expansion Phase||0
9997285|NCT01693562|11119059|FG003|STARTED|Expansion Phase||0
9997286|NCT01693562|11119060|FG004|STARTED|Expansion Phase||0
9997287|NCT01693562|11119061|FG005|STARTED|Expansion Phase||0
9997288|NCT01693562|11119062|FG006|STARTED|Expansion Phase||0
10102780|NCT02418000|11232314|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102781|NCT02418000|11232315|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102782|NCT02418000|11232316|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102783|NCT02418000|11232312|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102784|NCT02418000|11232313|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
10102785|NCT02418000|11232314|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
9997289|NCT01693562|11119063|FG007|STARTED|Expansion Phase||62
9997290|NCT01693562|11119064|FG008|STARTED|Expansion Phase||22
9997291|NCT01693562|11119065|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
10102786|NCT02418000|11232315|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102787|NCT02418000|11232316|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10102788|NCT02418000|11232312|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
9997292|NCT01693562|11119066|FG010|STARTED|Expansion Phase||40
9997293|NCT01693562|11119067|FG011|STARTED|Expansion Phase||21
9997294|NCT01693562|11119068|FG012|STARTED|Expansion Phase||24
9997295|NCT01693562|11119069|FG013|STARTED|Expansion Phase||51
9997296|NCT01693562|11119070|FG014|STARTED|Expansion Phase||40
9997297|NCT01693562|11119071|FG015|STARTED|Expansion Phase||31
9997298|NCT01693562|11119072|FG016|STARTED|Expansion Phase||201
9997299|NCT01693562|11119073|FG017|STARTED|Expansion Phase||20
9997300|NCT01693562|11119074|FG018|STARTED|Expansion Phase||47
9997301|NCT01693562|11119075|FG019|STARTED|Expansion Phase||20
9997302|NCT01693562|11119076|FG020|STARTED|Expansion Phase||21
9997303|NCT01693562|11119077|FG021|STARTED|Expansion Phase||62
9997304|NCT01693562|11119078|FG022|STARTED|Expansion Phase||10
9997305|NCT01693562|11119056|FG000|COMPLETED|Expansion Phase||0
9997306|NCT01693562|11119057|FG001|COMPLETED|Expansion Phase||0
9997307|NCT01693562|11119058|FG002|COMPLETED|Expansion Phase||0
9997308|NCT01693562|11119059|FG003|COMPLETED|Expansion Phase||0
9997309|NCT01693562|11119060|FG004|COMPLETED|Expansion Phase||0
9997310|NCT01693562|11119061|FG005|COMPLETED|Expansion Phase||0
9997311|NCT01693562|11119062|FG006|COMPLETED|Expansion Phase||0
9997312|NCT01693562|11119063|FG007|COMPLETED|Expansion Phase||0
9997313|NCT01693562|11119064|FG008|COMPLETED|Expansion Phase||0
9997314|NCT01693562|11119065|FG009|COMPLETED|Expansion Phase||4
9997315|NCT01693562|11119066|FG010|COMPLETED|Expansion Phase||0
9997316|NCT01693562|11119067|FG011|COMPLETED|Expansion Phase||0
9997317|NCT01693562|11119068|FG012|COMPLETED|Expansion Phase||1
9997318|NCT01693562|11119069|FG013|COMPLETED|Expansion Phase||0
9997319|NCT01693562|11119070|FG014|COMPLETED|Expansion Phase||0
9997320|NCT01693562|11119071|FG015|COMPLETED|Expansion Phase||0
9997321|NCT01693562|11119072|FG016|COMPLETED|Expansion Phase||4
9997322|NCT01693562|11119073|FG017|COMPLETED|Expansion Phase||0
9997323|NCT01693562|11119074|FG018|COMPLETED|Expansion Phase||0
9997324|NCT01693562|11119075|FG019|COMPLETED|Expansion Phase||0
9997325|NCT01693562|11119076|FG020|COMPLETED|Expansion Phase||0
9997326|NCT01693562|11119077|FG021|COMPLETED|Expansion Phase||0
9997327|NCT01693562|11119078|FG022|COMPLETED|Expansion Phase||0
9997328|NCT01693562|11119056|FG000|NOT COMPLETED|Expansion Phase||0
10102789|NCT02418000|11232313|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102790|NCT02418000|11232314|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
10102791|NCT02418000|11232315|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102792|NCT02418000|11232316|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102793|NCT02418000|11232312|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102794|NCT02418000|11232313|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102795|NCT02418000|11232314|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102796|NCT02418000|11232315|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102797|NCT02418000|11232316|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102798|NCT02418000|11232312|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102799|NCT02418000|11232313|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102800|NCT02418000|11232314|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
10102801|NCT02418000|11232315|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102802|NCT02418000|11232316|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10102803|NCT02418000|11232312|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102804|NCT02418000|11232313|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102805|NCT02418000|11232314|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102806|NCT02418000|11232315|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
10102807|NCT02418000|11232316|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102808|NCT02418000|11232312|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102809|NCT02418000|11232313|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102810|NCT02418000|11232314|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102811|NCT02418000|11232315|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102812|NCT02418000|11232316|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102813|NCT02418000|11232312|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102814|NCT02418000|11232313|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102815|NCT02418000|11232314|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102816|NCT02418000|11232315|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
10102817|NCT02418000|11232316|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10102818|NCT02418000|11232312|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102819|NCT02418000|11232313|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102820|NCT02418000|11232314|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102821|NCT02418000|11232315|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102822|NCT02418000|11232316|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
10102823|NCT02418000|11232312|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102824|NCT02418000|11232313|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102825|NCT02418000|11232314|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
9997329|NCT01693562|11119057|FG001|NOT COMPLETED|Expansion Phase||0
9997330|NCT01693562|11119058|FG002|NOT COMPLETED|Expansion Phase||0
9997331|NCT01693562|11119059|FG003|NOT COMPLETED|Expansion Phase||0
9997332|NCT01693562|11119060|FG004|NOT COMPLETED|Expansion Phase||0
9997333|NCT01693562|11119061|FG005|NOT COMPLETED|Expansion Phase||0
9997334|NCT01693562|11119062|FG006|NOT COMPLETED|Expansion Phase||0
9997335|NCT01693562|11119063|FG007|NOT COMPLETED|Expansion Phase||62
9997336|NCT01693562|11119064|FG008|NOT COMPLETED|Expansion Phase||22
9997337|NCT01693562|11119065|FG009|NOT COMPLETED|Expansion Phase||300
9997338|NCT01693562|11119066|FG010|NOT COMPLETED|Expansion Phase||40
9997339|NCT01693562|11119067|FG011|NOT COMPLETED|Expansion Phase||21
9997340|NCT01693562|11119068|FG012|NOT COMPLETED|Expansion Phase||23
9997341|NCT01693562|11119069|FG013|NOT COMPLETED|Expansion Phase||51
9997342|NCT01693562|11119070|FG014|NOT COMPLETED|Expansion Phase||40
9997343|NCT01693562|11119071|FG015|NOT COMPLETED|Expansion Phase||31
9997344|NCT01693562|11119072|FG016|NOT COMPLETED|Expansion Phase||197
9997345|NCT01693562|11119073|FG017|NOT COMPLETED|Expansion Phase||20
9997346|NCT01693562|11119074|FG018|NOT COMPLETED|Expansion Phase||47
9997347|NCT01693562|11119075|FG019|NOT COMPLETED|Expansion Phase||20
9997348|NCT01693562|11119076|FG020|NOT COMPLETED|Expansion Phase||21
9997349|NCT01693562|11119077|FG021|NOT COMPLETED|Expansion Phase||62
9997350|NCT01693562|11119078|FG022|NOT COMPLETED|Expansion Phase||10
9997351|NCT01693614|11119164|FG000|STARTED|Overall Study||26
9997352|NCT01693614|11119165|FG001|STARTED|Overall Study||22
9997353|NCT01693614|11119166|FG002|STARTED|Overall Study||24
9997354|NCT01693614|11119164|FG000|COMPLETED|Overall Study||0
9997355|NCT01693614|11119165|FG001|COMPLETED|Overall Study||0
9997356|NCT01693614|11119166|FG002|COMPLETED|Overall Study||0
9997357|NCT01693614|11119164|FG000|NOT COMPLETED|Overall Study||26
9997358|NCT01693614|11119165|FG001|NOT COMPLETED|Overall Study||22
9997359|NCT01693614|11119166|FG002|NOT COMPLETED|Overall Study||24
9997360|NCT01693900|11119177|FG000|STARTED|Overall Study||25
9997361|NCT01693900|11119178|FG001|STARTED|Overall Study||25
9997362|NCT01693900|11119177|FG000|COMPLETED|Overall Study||25
9997363|NCT01693900|11119178|FG001|COMPLETED|Overall Study||25
9997364|NCT01693900|11119177|FG000|NOT COMPLETED|Overall Study||0
9997365|NCT01693900|11119178|FG001|NOT COMPLETED|Overall Study||0
9997366|NCT01694108|11119186|FG000|STARTED|Overall Study||2129
9997367|NCT01694108|11119187|FG001|STARTED|Overall Study||2133
9997368|NCT01694108|11119186|FG000|COMPLETED|Overall Study|100% follow-up|2129
9997369|NCT01694108|11119187|FG001|COMPLETED|Overall Study|100% follow-up|2133
9997370|NCT01694108|11119186|FG000|NOT COMPLETED|Overall Study||0
10102826|NCT02418000|11232315|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102827|NCT02418000|11232316|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102828|NCT02418000|11232312|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102829|NCT02418000|11232313|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102830|NCT02418000|11232314|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102831|NCT02418000|11232315|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10102832|NCT02418000|11232316|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
10102833|NCT02418026|11232342|FG000|STARTED|Overall Study||44
10102834|NCT02418026|11232343|FG001|STARTED|Overall Study||35
10102835|NCT02418026|11232342|FG000|COMPLETED|Overall Study||44
10102836|NCT02418026|11232343|FG001|COMPLETED|Overall Study||35
10102837|NCT02418026|11232342|FG000|NOT COMPLETED|Overall Study||0
10102838|NCT02418026|11232343|FG001|NOT COMPLETED|Overall Study||0
10102839|NCT02418156|11232349|FG000|STARTED|Overall Study||38
10102840|NCT02418156|11232349|FG000|COMPLETED|Overall Study||21
10102841|NCT02418156|11232349|FG000|NOT COMPLETED|Overall Study||17
10102842|NCT02418182|11232355|FG000|STARTED|Overall Study||49
10102843|NCT02418182|11232356|FG001|STARTED|Overall Study||50
10102844|NCT02418182|11232355|FG000|COMPLETED|Overall Study||31
10102845|NCT02418182|11232356|FG001|COMPLETED|Overall Study||33
10102846|NCT02418182|11232355|FG000|NOT COMPLETED|Overall Study||18
10102847|NCT02418182|11232356|FG001|NOT COMPLETED|Overall Study||17
10102848|NCT02418234|11232362|FG000|STARTED|Overall Study||314
10102849|NCT02418234|11232362|FG000|COMPLETED|Overall Study||314
10102850|NCT02418234|11232362|FG000|NOT COMPLETED|Overall Study||0
10102851|NCT02418312|11232372|FG000|STARTED|Overall Study||114
10102852|NCT02418312|11232373|FG001|STARTED|Overall Study||114
10102853|NCT02418312|11232372|FG000|COMPLETED|Overall Study||114
10102854|NCT02418312|11232373|FG001|COMPLETED|Overall Study||114
10102855|NCT02418312|11232372|FG000|NOT COMPLETED|Overall Study||0
10102856|NCT02418312|11232373|FG001|NOT COMPLETED|Overall Study||0
10102857|NCT02418455|11232379|FG000|STARTED|48-Week Treatment Period||8
10102858|NCT02418455|11232379|FG000|Emergency IND (eIND)|48-Week Treatment Period||1
10102859|NCT02418455|11232379|FG000|COMPLETED|48-Week Treatment Period||7
10102860|NCT02418455|11232379|FG000|NOT COMPLETED|48-Week Treatment Period||1
10102861|NCT02418455|11232379|FG000|STARTED|Continuation Period||7
10102862|NCT02418455|11232379|FG000|COMPLETED|Continuation Period||0
10102863|NCT02418455|11232379|FG000|NOT COMPLETED|Continuation Period||7
10102864|NCT02418468|11232387|FG000|STARTED|Overall Study||13
10102865|NCT02418468|11232388|FG001|STARTED|Overall Study||11
10102866|NCT02418468|11232387|FG000|COMPLETED|Overall Study||11
10102867|NCT02418468|11232388|FG001|COMPLETED|Overall Study||10
10102868|NCT02418468|11232387|FG000|NOT COMPLETED|Overall Study||2
10102869|NCT02418468|11232388|FG001|NOT COMPLETED|Overall Study||1
10102870|NCT02418546|11232397|FG000|STARTED|Overall Study||26
10102871|NCT02418546|11232398|FG001|STARTED|Overall Study||26
10102872|NCT02418546|11232399|FG002|STARTED|Overall Study||26
10102873|NCT02418546|11232397|FG000|COMPLETED|Overall Study||19
10102874|NCT02418546|11232398|FG001|COMPLETED|Overall Study||20
10102875|NCT02418546|11232399|FG002|COMPLETED|Overall Study||23
9997371|NCT01694108|11119187|FG001|NOT COMPLETED|Overall Study||0
9997372|NCT01694121|11119202|FG000|STARTED|Overall Study||228
9997373|NCT01694121|11119203|FG001|STARTED|Overall Study||227
10102876|NCT02418546|11232397|FG000|NOT COMPLETED|Overall Study||7
9997374|NCT01694121|11119202|FG000|COMPLETED|Overall Study||227
9997375|NCT01694121|11119203|FG001|COMPLETED|Overall Study||227
10102877|NCT02418546|11232398|FG001|NOT COMPLETED|Overall Study||6
10102878|NCT02418546|11232399|FG002|NOT COMPLETED|Overall Study||3
9997376|NCT01694121|11119202|FG000|NOT COMPLETED|Overall Study||1
9997377|NCT01694121|11119203|FG001|NOT COMPLETED|Overall Study||0
9997378|NCT01694186|11119211|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
9997379|NCT01694186|11119212|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
9997380|NCT01694186|11119211|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
9997381|NCT01694186|11119212|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
9997382|NCT01694186|11119211|FG000|NOT COMPLETED|Overall Study||6
9997383|NCT01694186|11119212|FG001|NOT COMPLETED|Overall Study||7
9997384|NCT01694199|11119220|FG000|STARTED|Overall Study||71
9997385|NCT01694199|11119221|FG001|STARTED|Overall Study||68
9997386|NCT01694199|11119220|FG000|COMPLETED|Overall Study||71
9997387|NCT01694199|11119221|FG001|COMPLETED|Overall Study||68
9997388|NCT01694199|11119220|FG000|NOT COMPLETED|Overall Study||0
9997389|NCT01694199|11119221|FG001|NOT COMPLETED|Overall Study||0
10018528|NCT01824303|11141627|FG000|STARTED|Randomized Study||16
10018529|NCT01824303|11141628|FG001|STARTED|Randomized Study||14
10018530|NCT01824303|11141627|FG000|COMPLETED|Randomized Study||14
10018531|NCT01824303|11141628|FG001|COMPLETED|Randomized Study||13
10018532|NCT01824303|11141627|FG000|NOT COMPLETED|Randomized Study||2
10018533|NCT01824303|11141628|FG001|NOT COMPLETED|Randomized Study||1
10018534|NCT01824303|11141627|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
10018535|NCT01824303|11141628|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
10018536|NCT01824303|11141627|FG000|COMPLETED|Open Label Extension||12
10018537|NCT01824303|11141628|FG001|COMPLETED|Open Label Extension||11
10018538|NCT01824303|11141627|FG000|NOT COMPLETED|Open Label Extension||0
10018539|NCT01824303|11141628|FG001|NOT COMPLETED|Open Label Extension||0
10018540|NCT01824342|11141638|FG000|STARTED|Overall Study||11
10018541|NCT01824342|11141639|FG001|STARTED|Overall Study||7
10018542|NCT01824342|11141638|FG000|COMPLETED|Overall Study||2
10018543|NCT01824342|11141639|FG001|COMPLETED|Overall Study||2
10018544|NCT01824342|11141638|FG000|NOT COMPLETED|Overall Study||9
10018545|NCT01824342|11141639|FG001|NOT COMPLETED|Overall Study||5
10018546|NCT01824355|11141645|FG000|STARTED|Overall Study||113
10018547|NCT01824355|11141645|FG000|COMPLETED|Overall Study||110
10018548|NCT01824355|11141645|FG000|NOT COMPLETED|Overall Study||3
10018549|NCT01824394|11141652|FG000|STARTED|Overall Study||174
10018550|NCT01824394|11141653|FG001|STARTED|Overall Study||169
10018551|NCT01824394|11141654|FG002|STARTED|Overall Study||125
10018552|NCT01824394|11141652|FG000|Intent to Treat Population|Overall Study||151
10018553|NCT01824394|11141653|FG001|Intent to Treat Population|Overall Study||149
10018554|NCT01824394|11141654|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
10018555|NCT01824394|11141652|FG000|Safety Population|Overall Study||151
10018556|NCT01824394|11141653|FG001|Safety Population|Overall Study||149
10018557|NCT01824394|11141654|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
10018558|NCT01824394|11141652|FG000|Per-Protocol Population|Overall Study||150
10018559|NCT01824394|11141653|FG001|Per-Protocol Population|Overall Study||148
10018560|NCT01824394|11141654|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
10018561|NCT01824394|11141652|FG000|COMPLETED|Overall Study||55
10018562|NCT01824394|11141653|FG001|COMPLETED|Overall Study||53
10018563|NCT01824394|11141654|FG002|COMPLETED|Overall Study||51
10018564|NCT01824394|11141652|FG000|NOT COMPLETED|Overall Study||119
10018565|NCT01824394|11141653|FG001|NOT COMPLETED|Overall Study||116
10018566|NCT01824394|11141654|FG002|NOT COMPLETED|Overall Study||74
10018567|NCT01824446|11141662|FG000|STARTED|Overall Study||6
10018568|NCT01824446|11141662|FG000|COMPLETED|Overall Study||6
10018569|NCT01824446|11141662|FG000|NOT COMPLETED|Overall Study||0
10018570|NCT01824472|11141669|FG000|STARTED|Overall Study||17
10018571|NCT01824472|11141670|FG001|STARTED|Overall Study||13
10018572|NCT01824472|11141671|FG002|STARTED|Overall Study||15
10102879|NCT02418585|11232409|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116
10102880|NCT02418585|11232410|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111
10102881|NCT02418585|11232409|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
10102882|NCT02418585|11232410|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
10102883|NCT02418585|11232409|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
10102884|NCT02418585|11232410|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
10102885|NCT02418585|11232409|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
10102886|NCT02418585|11232410|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
10102887|NCT02418585|11232409|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
10102888|NCT02418585|11232410|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
10102889|NCT02418585|11232409|FG000|STARTED|Follow-up Phase (24 Weeks)||34
10102890|NCT02418585|11232410|FG001|STARTED|Follow-up Phase (24 Weeks)||52
10102891|NCT02418585|11232409|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16
10102892|NCT02418585|11232410|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27
10102893|NCT02418585|11232409|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
10018573|NCT01824472|11141669|FG000|COMPLETED|Overall Study||16
10018574|NCT01824472|11141670|FG001|COMPLETED|Overall Study||6
10018575|NCT01824472|11141671|FG002|COMPLETED|Overall Study||11
10018576|NCT01824472|11141669|FG000|NOT COMPLETED|Overall Study||1
10102894|NCT02418585|11232410|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
9997390|NCT01694420|11119227|FG000|STARTED|Overall Study||33
9997391|NCT01694420|11119227|FG000|COMPLETED|Overall Study||30
9997392|NCT01694420|11119227|FG000|NOT COMPLETED|Overall Study||3
9997393|NCT01694433|11119233|FG000|STARTED|Overall Study||33
9997394|NCT01694433|11119234|FG001|STARTED|Overall Study||33
9997395|NCT01694433|11119233|FG000|Baseline Visit|Overall Study||33
9997396|NCT01694433|11119234|FG001|Baseline Visit|Overall Study||32
9997397|NCT01694433|11119233|FG000|COMPLETED|Overall Study||22
9997398|NCT01694433|11119234|FG001|COMPLETED|Overall Study||29
9997399|NCT01694433|11119233|FG000|NOT COMPLETED|Overall Study||11
9997400|NCT01694433|11119234|FG001|NOT COMPLETED|Overall Study||4
9997401|NCT01694485|11119245|FG000|STARTED|Overall Study||117
9997402|NCT01694485|11119246|FG001|STARTED|Overall Study||22
9997403|NCT01694485|11119247|FG002|STARTED|Overall Study||40
9997404|NCT01694485|11119248|FG003|STARTED|Overall Study||100
9997405|NCT01694485|11119249|FG004|STARTED|Overall Study||80
9997406|NCT01694485|11119245|FG000|Received Treatment|Overall Study||116
9997407|NCT01694485|11119246|FG001|Received Treatment|Overall Study||21
9997408|NCT01694485|11119247|FG002|Received Treatment|Overall Study||40
9997409|NCT01694485|11119248|FG003|Received Treatment|Overall Study||98
9997410|NCT01694485|11119249|FG004|Received Treatment|Overall Study||79
9997411|NCT01694485|11119245|FG000|Completed Week 8 Assessment|Overall Study||106
9997412|NCT01694485|11119246|FG001|Completed Week 8 Assessment|Overall Study||18
9997413|NCT01694485|11119247|FG002|Completed Week 8 Assessment|Overall Study||38
9997414|NCT01694485|11119248|FG003|Completed Week 8 Assessment|Overall Study||94
9997415|NCT01694485|11119249|FG004|Completed Week 8 Assessment|Overall Study||76
9997416|NCT01694485|11119245|FG000|Entered Open-label Period|Overall Study||100
9997417|NCT01694485|11119246|FG001|Entered Open-label Period|Overall Study||19
9997418|NCT01694485|11119247|FG002|Entered Open-label Period|Overall Study||36
9997419|NCT01694485|11119248|FG003|Entered Open-label Period|Overall Study||88
9997420|NCT01694485|11119249|FG004|Entered Open-label Period|Overall Study||68
9997421|NCT01694485|11119245|FG000|COMPLETED|Overall Study||84
9997422|NCT01694485|11119246|FG001|COMPLETED|Overall Study||15
9997423|NCT01694485|11119247|FG002|COMPLETED|Overall Study||27
9997424|NCT01694485|11119248|FG003|COMPLETED|Overall Study||62
9997425|NCT01694485|11119249|FG004|COMPLETED|Overall Study||55
9997426|NCT01694485|11119245|FG000|NOT COMPLETED|Overall Study||33
9997427|NCT01694485|11119246|FG001|NOT COMPLETED|Overall Study||7
9997428|NCT01694485|11119247|FG002|NOT COMPLETED|Overall Study||13
9997429|NCT01694485|11119248|FG003|NOT COMPLETED|Overall Study||38
9997430|NCT01694485|11119249|FG004|NOT COMPLETED|Overall Study||25
9997431|NCT01694563|11119266|FG000|STARTED|Overall Study||365
9997432|NCT01694563|11119266|FG000|COMPLETED|Overall Study||278
9997433|NCT01694563|11119266|FG000|NOT COMPLETED|Overall Study||87
9997434|NCT01694641|11119275|FG000|STARTED|Overall Study||80
9997435|NCT01694641|11119276|FG001|STARTED|Overall Study||81
9997436|NCT01694641|11119275|FG000|COMPLETED|Overall Study||68
9997437|NCT01694641|11119276|FG001|COMPLETED|Overall Study||71
9997438|NCT01694641|11119275|FG000|NOT COMPLETED|Overall Study||12
9997439|NCT01694641|11119276|FG001|NOT COMPLETED|Overall Study||10
9997440|NCT01694667|11119285|FG000|STARTED|Overall Study||29
9997441|NCT01694667|11119286|FG001|STARTED|Overall Study||28
9997442|NCT01694667|11119285|FG000|COMPLETED|Overall Study||29
9997443|NCT01694667|11119286|FG001|COMPLETED|Overall Study||28
9997444|NCT01694667|11119285|FG000|NOT COMPLETED|Overall Study||0
9997445|NCT01694667|11119286|FG001|NOT COMPLETED|Overall Study||0
9997446|NCT01694706|11119292|FG000|STARTED|Overall Study||5
9997447|NCT01694706|11119293|FG001|STARTED|Overall Study||5
9997448|NCT01694706|11119294|FG002|STARTED|Overall Study||5
9997449|NCT01694706|11119292|FG000|Received Faldaprevir|Overall Study||5
9997450|NCT01694706|11119293|FG001|Received Faldaprevir|Overall Study||5
9997451|NCT01694706|11119294|FG002|Received Faldaprevir|Overall Study||5
9997452|NCT01694706|11119292|FG000|Received Faldaprevir +OMP|Overall Study||5
9997453|NCT01694706|11119293|FG001|Received Faldaprevir +OMP|Overall Study||5
9997454|NCT01694706|11119294|FG002|Received Faldaprevir +OMP|Overall Study||5
9997455|NCT01694706|11119292|FG000|Received Faldaprevir Fed|Overall Study||4
9997456|NCT01694706|11119293|FG001|Received Faldaprevir Fed|Overall Study||5
9997457|NCT01694706|11119294|FG002|Received Faldaprevir Fed|Overall Study||5
9997458|NCT01694706|11119292|FG000|COMPLETED|Overall Study||4
9997459|NCT01694706|11119293|FG001|COMPLETED|Overall Study||4
9997460|NCT01694706|11119294|FG002|COMPLETED|Overall Study||5
9997461|NCT01694706|11119292|FG000|NOT COMPLETED|Overall Study||1
9997462|NCT01694706|11119293|FG001|NOT COMPLETED|Overall Study||1
9997463|NCT01694706|11119294|FG002|NOT COMPLETED|Overall Study||0
9997464|NCT01694771|11119305|FG000|STARTED|Overall Study||567
9997465|NCT01694771|11119306|FG001|STARTED|Overall Study||565
9997466|NCT01694771|11119305|FG000|COMPLETED|Overall Study||527
9997467|NCT01694771|11119306|FG001|COMPLETED|Overall Study||525
9997468|NCT01694771|11119305|FG000|NOT COMPLETED|Overall Study||40
9997469|NCT01694771|11119306|FG001|NOT COMPLETED|Overall Study||40
9997470|NCT01694966|11119315|FG000|STARTED|Overall Study||504
9997471|NCT01694966|11119316|FG001|STARTED|Overall Study||247
9997472|NCT01694966|11119317|FG002|STARTED|Overall Study||498
9997473|NCT01694966|11119315|FG000|COMPLETED|Overall Study||470
9997474|NCT01694966|11119316|FG001|COMPLETED|Overall Study||232
9997475|NCT01694966|11119317|FG002|COMPLETED|Overall Study||464
9997476|NCT01694966|11119315|FG000|NOT COMPLETED|Overall Study||34
9997477|NCT01694966|11119316|FG001|NOT COMPLETED|Overall Study||15
9997478|NCT01694966|11119317|FG002|NOT COMPLETED|Overall Study||34
9997479|NCT01695044|11119327|FG000|STARTED|Overall Study||119
9997480|NCT01695044|11119327|FG000|COMPLETED|Overall Study||17
9997481|NCT01695044|11119327|FG000|NOT COMPLETED|Overall Study||102
9997482|NCT01695135|11119337|FG000|STARTED|Double-blind Treatment Phase||71
9997483|NCT01695135|11119338|FG001|STARTED|Double-blind Treatment Phase||143
9997484|NCT01695135|11119339|FG002|STARTED|Double-blind Treatment Phase||0
9997485|NCT01695135|11119340|FG003|STARTED|Double-blind Treatment Phase||0
9997486|NCT01695135|11119337|FG000|COMPLETED|Double-blind Treatment Phase||0
9997487|NCT01695135|11119338|FG001|COMPLETED|Double-blind Treatment Phase||4
9997488|NCT01695135|11119339|FG002|COMPLETED|Double-blind Treatment Phase||0
9997489|NCT01695135|11119340|FG003|COMPLETED|Double-blind Treatment Phase||0
9997490|NCT01695135|11119337|FG000|NOT COMPLETED|Double-blind Treatment Phase||71
9997491|NCT01695135|11119338|FG001|NOT COMPLETED|Double-blind Treatment Phase||139
9997492|NCT01695135|11119339|FG002|NOT COMPLETED|Double-blind Treatment Phase||0
9997493|NCT01695135|11119340|FG003|NOT COMPLETED|Double-blind Treatment Phase||0
9997494|NCT01695135|11119337|FG000|STARTED|Open Label Extension Treatment Phase||0
9997495|NCT01695135|11119338|FG001|STARTED|Open Label Extension Treatment Phase||0
9997496|NCT01695135|11119339|FG002|STARTED|Open Label Extension Treatment Phase||49
9997497|NCT01695135|11119340|FG003|STARTED|Open Label Extension Treatment Phase||80
9997498|NCT01695135|11119337|FG000|COMPLETED|Open Label Extension Treatment Phase||0
9997499|NCT01695135|11119338|FG001|COMPLETED|Open Label Extension Treatment Phase||0
9997500|NCT01695135|11119339|FG002|COMPLETED|Open Label Extension Treatment Phase||9
9997501|NCT01695135|11119340|FG003|COMPLETED|Open Label Extension Treatment Phase||10
9997502|NCT01695135|11119337|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0
9997503|NCT01695135|11119338|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0
9997504|NCT01695135|11119339|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40
9997505|NCT01695135|11119340|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70
9997506|NCT01695239|11119352|FG000|STARTED|Double-Blind (DB) Treatment Period||106
9997507|NCT01695239|11119353|FG001|STARTED|Double-Blind (DB) Treatment Period||101
9997508|NCT01695239|11119354|FG002|STARTED|Double-Blind (DB) Treatment Period||107
9997509|NCT01695239|11119355|FG003|STARTED|Double-Blind (DB) Treatment Period||103
9997510|NCT01695239|11119356|FG004|STARTED|Double-Blind (DB) Treatment Period||0
9997511|NCT01695239|11119357|FG005|STARTED|Double-Blind (DB) Treatment Period||0
9997512|NCT01695239|11119358|FG006|STARTED|Double-Blind (DB) Treatment Period||0
9997513|NCT01695239|11119359|FG007|STARTED|Double-Blind (DB) Treatment Period||0
9997514|NCT01695239|11119360|FG008|STARTED|Double-Blind (DB) Treatment Period||0
9997515|NCT01695239|11119361|FG009|STARTED|Double-Blind (DB) Treatment Period||0
9997516|NCT01695239|11119362|FG010|STARTED|Double-Blind (DB) Treatment Period||0
10102895|NCT02418676|11232421|FG000|STARTED|Overall Study||5
10102896|NCT02418676|11232422|FG001|STARTED|Overall Study||5
10102897|NCT02418676|11232423|FG002|STARTED|Overall Study||5
10102898|NCT02418676|11232421|FG000|COMPLETED|Overall Study||5
10102899|NCT02418676|11232422|FG001|COMPLETED|Overall Study||5
10102900|NCT02418676|11232423|FG002|COMPLETED|Overall Study||5
10102901|NCT02418676|11232421|FG000|NOT COMPLETED|Overall Study||0
10102902|NCT02418676|11232422|FG001|NOT COMPLETED|Overall Study||0
9997517|NCT01695239|11119363|FG011|STARTED|Double-Blind (DB) Treatment Period||0
9997518|NCT01695239|11119364|FG012|STARTED|Double-Blind (DB) Treatment Period||0
9997519|NCT01695239|11119365|FG013|STARTED|Double-Blind (DB) Treatment Period||0
9997520|NCT01695239|11119352|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
9997521|NCT01695239|11119353|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
9997522|NCT01695239|11119354|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
9997523|NCT01695239|11119355|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
9997524|NCT01695239|11119356|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997525|NCT01695239|11119357|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997526|NCT01695239|11119358|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997527|NCT01695239|11119359|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10102903|NCT02418676|11232423|FG002|NOT COMPLETED|Overall Study||0
10102904|NCT02418754|11232434|FG000|STARTED|Period 1 (Day 1 to Week 12)||103
10102905|NCT02418754|11232435|FG001|STARTED|Period 1 (Day 1 to Week 12)||200
10102906|NCT02418754|11232436|FG002|STARTED|Period 1 (Day 1 to Week 12)||202
10102907|NCT02418754|11232437|FG003|STARTED|Period 1 (Day 1 to Week 12)||0
10102908|NCT02418754|11232438|FG004|STARTED|Period 1 (Day 1 to Week 12)||0
10102909|NCT02418754|11232434|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101
10102910|NCT02418754|11232435|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196
10102911|NCT02418754|11232436|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200
10102912|NCT02418754|11232437|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0
10102913|NCT02418754|11232438|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0
10102914|NCT02418754|11232434|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
10102915|NCT02418754|11232435|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
10102916|NCT02418754|11232436|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
10102917|NCT02418754|11232437|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
10102918|NCT02418754|11232438|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
10102919|NCT02418754|11232434|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
10102920|NCT02418754|11232435|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
10102921|NCT02418754|11232436|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
10102922|NCT02418754|11232437|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
9997528|NCT01695239|11119360|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997529|NCT01695239|11119361|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997530|NCT01695239|11119362|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997531|NCT01695239|11119363|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997532|NCT01695239|11119364|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997533|NCT01695239|11119365|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
9997534|NCT01695239|11119352|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
9997535|NCT01695239|11119353|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
9997536|NCT01695239|11119354|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
9997537|NCT01695239|11119355|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
9997538|NCT01695239|11119356|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997539|NCT01695239|11119357|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997540|NCT01695239|11119358|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997541|NCT01695239|11119359|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997542|NCT01695239|11119360|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997543|NCT01695239|11119361|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997544|NCT01695239|11119362|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997545|NCT01695239|11119363|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997546|NCT01695239|11119364|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997547|NCT01695239|11119365|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
9997548|NCT01695239|11119352|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91
9997549|NCT01695239|11119353|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97
9997550|NCT01695239|11119354|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97
9997551|NCT01695239|11119355|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96
9997552|NCT01695239|11119356|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0
9997553|NCT01695239|11119357|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0
9997554|NCT01695239|11119358|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0
9997555|NCT01695239|11119359|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0
9997556|NCT01695239|11119360|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0
9997557|NCT01695239|11119361|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0
9997558|NCT01695239|11119362|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0
9997559|NCT01695239|11119363|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0
9997560|NCT01695239|11119364|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0
9997561|NCT01695239|11119365|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0
9997562|NCT01695239|11119352|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
9997563|NCT01695239|11119353|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
9997564|NCT01695239|11119354|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
9997565|NCT01695239|11119355|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
9997566|NCT01695239|11119356|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997567|NCT01695239|11119357|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997568|NCT01695239|11119358|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997569|NCT01695239|11119359|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997570|NCT01695239|11119360|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997571|NCT01695239|11119361|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997572|NCT01695239|11119362|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997573|NCT01695239|11119363|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997574|NCT01695239|11119364|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997575|NCT01695239|11119365|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9997576|NCT01695239|11119352|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
9997577|NCT01695239|11119353|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
9997578|NCT01695239|11119354|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
9997579|NCT01695239|11119355|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
9997580|NCT01695239|11119356|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
9997581|NCT01695239|11119357|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
9997582|NCT01695239|11119358|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
9997583|NCT01695239|11119359|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0
9997584|NCT01695239|11119360|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0
9997585|NCT01695239|11119361|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0
9997586|NCT01695239|11119362|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0
9997587|NCT01695239|11119363|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0
9997588|NCT01695239|11119364|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0
9997589|NCT01695239|11119365|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0
9997590|NCT01695239|11119352|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997591|NCT01695239|11119353|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997592|NCT01695239|11119354|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997593|NCT01695239|11119355|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997594|NCT01695239|11119356|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
9997595|NCT01695239|11119357|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
9997596|NCT01695239|11119358|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
9997597|NCT01695239|11119359|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997598|NCT01695239|11119360|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997599|NCT01695239|11119361|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997600|NCT01695239|11119362|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997601|NCT01695239|11119363|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997602|NCT01695239|11119364|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997603|NCT01695239|11119365|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997604|NCT01695239|11119352|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997605|NCT01695239|11119353|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997606|NCT01695239|11119354|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997607|NCT01695239|11119355|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997608|NCT01695239|11119356|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997609|NCT01695239|11119357|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997610|NCT01695239|11119358|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997611|NCT01695239|11119359|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997612|NCT01695239|11119360|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997613|NCT01695239|11119361|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997614|NCT01695239|11119362|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997615|NCT01695239|11119363|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997616|NCT01695239|11119364|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
9997617|NCT01695239|11119365|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10102923|NCT02418754|11232438|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
10102924|NCT02418754|11232434|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
10102925|NCT02418754|11232435|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
10102926|NCT02418754|11232436|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
10102927|NCT02418754|11232437|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
10102928|NCT02418754|11232438|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
10102929|NCT02418754|11232434|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
10102930|NCT02418754|11232435|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
10102931|NCT02418754|11232436|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
10102932|NCT02418754|11232437|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
10102933|NCT02418754|11232438|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
10102934|NCT02418819|11232452|FG000|STARTED|Overall Study||22
10102935|NCT02418819|11232453|FG001|STARTED|Overall Study||16
10102936|NCT02418819|11232454|FG002|STARTED|Overall Study||33
10102937|NCT02418819|11232455|FG003|STARTED|Overall Study||29
10102938|NCT02418819|11232452|FG000|COMPLETED|Overall Study||21
10202186|NCT03441984|11329280|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202187|NCT03441984|11329281|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202188|NCT03441984|11329282|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202189|NCT03441984|11329283|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202190|NCT03441984|11329284|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202191|NCT03441984|11329285|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202192|NCT03441984|11329286|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202193|NCT03441984|11329287|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10202194|NCT03442036|11329304|FG000|STARTED|Overall Study||35
10202195|NCT03442036|11329305|FG001|STARTED|Overall Study||35
10102939|NCT02418819|11232453|FG001|COMPLETED|Overall Study||16
10102940|NCT02418819|11232454|FG002|COMPLETED|Overall Study||29
10102941|NCT02418819|11232455|FG003|COMPLETED|Overall Study||28
10102942|NCT02418819|11232452|FG000|NOT COMPLETED|Overall Study||1
10102943|NCT02418819|11232453|FG001|NOT COMPLETED|Overall Study||0
10102944|NCT02418819|11232454|FG002|NOT COMPLETED|Overall Study||4
10102945|NCT02418819|11232455|FG003|NOT COMPLETED|Overall Study||1
10102946|NCT02418845|11232467|FG000|STARTED|Overall Study||125
10102947|NCT02418845|11232468|FG001|STARTED|Overall Study||64
10102948|NCT02418845|11232467|FG000|COMPLETED|Overall Study||109
10102949|NCT02418845|11232468|FG001|COMPLETED|Overall Study||52
10102950|NCT02418845|11232467|FG000|NOT COMPLETED|Overall Study||16
10102951|NCT02418845|11232468|FG001|NOT COMPLETED|Overall Study||12
10102952|NCT02418910|11232474|FG000|STARTED|Overall Study||50
10102953|NCT02418910|11232474|FG000|COMPLETED|Overall Study||43
10102954|NCT02418910|11232474|FG000|NOT COMPLETED|Overall Study||7
10102955|NCT02418949|11232482|FG000|STARTED|Overall Study||23
10102956|NCT02418949|11232483|FG001|STARTED|Overall Study||22
10102957|NCT02418949|11232484|FG002|STARTED|Overall Study||26
10102958|NCT02418949|11232485|FG003|STARTED|Overall Study||25
10102959|NCT02418949|11232482|FG000|COMPLETED|Overall Study||20
10102960|NCT02418949|11232483|FG001|COMPLETED|Overall Study||21
10102961|NCT02418949|11232484|FG002|COMPLETED|Overall Study||23
10102962|NCT02418949|11232485|FG003|COMPLETED|Overall Study||24
10102963|NCT02418949|11232482|FG000|NOT COMPLETED|Overall Study||3
10102964|NCT02418949|11232483|FG001|NOT COMPLETED|Overall Study||1
10102965|NCT02418949|11232484|FG002|NOT COMPLETED|Overall Study||3
10102966|NCT02418949|11232485|FG003|NOT COMPLETED|Overall Study||1
10202196|NCT03442036|11329304|FG000|COMPLETED|Overall Study||35
9997618|NCT01695239|11119352|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997619|NCT01695239|11119353|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997620|NCT01695239|11119354|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997621|NCT01695239|11119355|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997622|NCT01695239|11119356|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
9997623|NCT01695239|11119357|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
9997624|NCT01695239|11119358|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
9997625|NCT01695239|11119359|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
9997626|NCT01695239|11119360|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997627|NCT01695239|11119361|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997628|NCT01695239|11119362|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997629|NCT01695239|11119363|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997630|NCT01695239|11119364|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997631|NCT01695239|11119365|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
9997632|NCT01695239|11119352|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997633|NCT01695239|11119353|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997634|NCT01695239|11119354|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997635|NCT01695239|11119355|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997636|NCT01695239|11119356|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997637|NCT01695239|11119357|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997638|NCT01695239|11119358|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997639|NCT01695239|11119359|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
9997640|NCT01695239|11119360|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997641|NCT01695239|11119361|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997642|NCT01695239|11119362|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997643|NCT01695239|11119363|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997644|NCT01695239|11119364|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997645|NCT01695239|11119365|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997646|NCT01695239|11119352|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997647|NCT01695239|11119353|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997648|NCT01695239|11119354|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997649|NCT01695239|11119355|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997650|NCT01695239|11119356|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997651|NCT01695239|11119357|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997652|NCT01695239|11119358|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997653|NCT01695239|11119359|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
9997654|NCT01695239|11119360|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997655|NCT01695239|11119361|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997656|NCT01695239|11119362|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997657|NCT01695239|11119363|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997658|NCT01695239|11119364|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997659|NCT01695239|11119365|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
9997660|NCT01695239|11119352|FG000|STARTED|Extension Long-Term Extension Periods||0
9997661|NCT01695239|11119353|FG001|STARTED|Extension Long-Term Extension Periods||0
9997662|NCT01695239|11119354|FG002|STARTED|Extension Long-Term Extension Periods||0
9997663|NCT01695239|11119355|FG003|STARTED|Extension Long-Term Extension Periods||0
9997664|NCT01695239|11119356|FG004|STARTED|Extension Long-Term Extension Periods||0
9997665|NCT01695239|11119357|FG005|STARTED|Extension Long-Term Extension Periods||0
9997666|NCT01695239|11119358|FG006|STARTED|Extension Long-Term Extension Periods||0
9997667|NCT01695239|11119359|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
9997668|NCT01695239|11119360|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
9997669|NCT01695239|11119361|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
9997670|NCT01695239|11119362|FG010|STARTED|Extension Long-Term Extension Periods||0
9997671|NCT01695239|11119363|FG011|STARTED|Extension Long-Term Extension Periods||0
9997672|NCT01695239|11119364|FG012|STARTED|Extension Long-Term Extension Periods||0
9997673|NCT01695239|11119365|FG013|STARTED|Extension Long-Term Extension Periods||0
9997674|NCT01695239|11119352|FG000|COMPLETED|Extension Long-Term Extension Periods||0
9997675|NCT01695239|11119353|FG001|COMPLETED|Extension Long-Term Extension Periods||0
9997676|NCT01695239|11119354|FG002|COMPLETED|Extension Long-Term Extension Periods||0
9997677|NCT01695239|11119355|FG003|COMPLETED|Extension Long-Term Extension Periods||0
9997678|NCT01695239|11119356|FG004|COMPLETED|Extension Long-Term Extension Periods||0
9997679|NCT01695239|11119357|FG005|COMPLETED|Extension Long-Term Extension Periods||0
9997680|NCT01695239|11119358|FG006|COMPLETED|Extension Long-Term Extension Periods||0
9997681|NCT01695239|11119359|FG007|COMPLETED|Extension Long-Term Extension Periods||0
9997682|NCT01695239|11119360|FG008|COMPLETED|Extension Long-Term Extension Periods||121
9997683|NCT01695239|11119361|FG009|COMPLETED|Extension Long-Term Extension Periods||122
9997684|NCT01695239|11119362|FG010|COMPLETED|Extension Long-Term Extension Periods||0
9997685|NCT01695239|11119363|FG011|COMPLETED|Extension Long-Term Extension Periods||0
9997686|NCT01695239|11119364|FG012|COMPLETED|Extension Long-Term Extension Periods||0
9997687|NCT01695239|11119365|FG013|COMPLETED|Extension Long-Term Extension Periods||0
9997688|NCT01695239|11119352|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997689|NCT01695239|11119353|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997690|NCT01695239|11119354|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997691|NCT01695239|11119355|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997692|NCT01695239|11119356|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997693|NCT01695239|11119357|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997694|NCT01695239|11119358|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997695|NCT01695239|11119359|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997696|NCT01695239|11119360|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66
9997697|NCT01695239|11119361|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61
9997698|NCT01695239|11119362|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997699|NCT01695239|11119363|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997700|NCT01695239|11119364|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997701|NCT01695239|11119365|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0
9997702|NCT01695239|11119352|FG000|STARTED|Post-Treatment Follow-Up Period||0
9997703|NCT01695239|11119353|FG001|STARTED|Post-Treatment Follow-Up Period||0
9997704|NCT01695239|11119354|FG002|STARTED|Post-Treatment Follow-Up Period||0
9997705|NCT01695239|11119355|FG003|STARTED|Post-Treatment Follow-Up Period||0
9997706|NCT01695239|11119356|FG004|STARTED|Post-Treatment Follow-Up Period||0
9997707|NCT01695239|11119357|FG005|STARTED|Post-Treatment Follow-Up Period||0
9997708|NCT01695239|11119358|FG006|STARTED|Post-Treatment Follow-Up Period||0
9997709|NCT01695239|11119359|FG007|STARTED|Post-Treatment Follow-Up Period||0
9997710|NCT01695239|11119360|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
9997711|NCT01695239|11119361|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
9997712|NCT01695239|11119362|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
9997713|NCT01695239|11119363|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
9997714|NCT01695239|11119364|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
9997715|NCT01695239|11119365|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
9997716|NCT01695239|11119352|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
9997717|NCT01695239|11119353|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
9997718|NCT01695239|11119354|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
9997719|NCT01695239|11119355|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
9997720|NCT01695239|11119356|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
9997721|NCT01695239|11119357|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
9997722|NCT01695239|11119358|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
9997723|NCT01695239|11119359|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
9997724|NCT01695239|11119360|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
9997725|NCT01695239|11119361|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
9997726|NCT01695239|11119362|FG010|COMPLETED|Post-Treatment Follow-Up Period||20
9997727|NCT01695239|11119363|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
9997728|NCT01695239|11119364|FG012|COMPLETED|Post-Treatment Follow-Up Period||156
9997729|NCT01695239|11119365|FG013|COMPLETED|Post-Treatment Follow-Up Period||166
9997730|NCT01695239|11119352|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997731|NCT01695239|11119353|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997732|NCT01695239|11119354|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997733|NCT01695239|11119355|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997734|NCT01695239|11119356|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997735|NCT01695239|11119357|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997736|NCT01695239|11119358|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997737|NCT01695239|11119359|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997738|NCT01695239|11119360|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997739|NCT01695239|11119361|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997740|NCT01695239|11119362|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9997741|NCT01695239|11119363|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1
9997742|NCT01695239|11119364|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9
9997743|NCT01695239|11119365|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5
9997744|NCT01695291|11119389|FG000|STARTED|Overall Study||10
9997745|NCT01695291|11119390|FG001|STARTED|Overall Study||21
9997746|NCT01695291|11119389|FG000|COMPLETED|Overall Study||8
9997747|NCT01695291|11119390|FG001|COMPLETED|Overall Study||14
9997748|NCT01695291|11119389|FG000|NOT COMPLETED|Overall Study||2
9997749|NCT01695291|11119390|FG001|NOT COMPLETED|Overall Study||7
9997750|NCT01695304|11119398|FG000|STARTED|Overall Study||120
9997751|NCT01695304|11119399|FG001|STARTED|Overall Study||120
9997752|NCT01695304|11119398|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
9997753|NCT01695304|11119399|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
9997754|NCT01695304|11119398|FG000|NOT COMPLETED|Overall Study||0
9997755|NCT01695304|11119399|FG001|NOT COMPLETED|Overall Study||0
9997756|NCT01695330|11119407|FG000|STARTED|Overall Study||52
9997757|NCT01695330|11119408|FG001|STARTED|Overall Study||0
9997758|NCT01695330|11119407|FG000|COMPLETED|Overall Study||5
9997759|NCT01695330|11119408|FG001|COMPLETED|Overall Study||0
9997760|NCT01695330|11119407|FG000|NOT COMPLETED|Overall Study||47
9997761|NCT01695330|11119408|FG001|NOT COMPLETED|Overall Study||0
9997762|NCT01695369|11119412|FG000|STARTED|Overall Study||61
9997763|NCT01695369|11119412|FG000|COMPLETED|Overall Study||61
9997764|NCT01695369|11119412|FG000|NOT COMPLETED|Overall Study||0
9997765|NCT01695473|11119418|FG000|STARTED|Overall Study||11
9997766|NCT01695473|11119418|FG000|COMPLETED|Overall Study||11
9997767|NCT01695473|11119418|FG000|NOT COMPLETED|Overall Study||0
9997768|NCT01695668|11119425|FG000|STARTED|Overall Study||38
9997769|NCT01695668|11119426|FG001|STARTED|Overall Study||37
9997770|NCT01695668|11119425|FG000|COMPLETED|Overall Study||23
9997771|NCT01695668|11119426|FG001|COMPLETED|Overall Study||20
9997772|NCT01695668|11119425|FG000|NOT COMPLETED|Overall Study||15
9997773|NCT01695668|11119426|FG001|NOT COMPLETED|Overall Study||17
9997774|NCT01695746|11119432|FG000|STARTED|Overall Study||108
9997775|NCT01695746|11119432|FG000|COMPLETED|Overall Study||96
9997776|NCT01695746|11119432|FG000|NOT COMPLETED|Overall Study||12
9997777|NCT01695772|11119437|FG000|STARTED|Overall Study||50
9997778|NCT01695772|11119437|FG000|COMPLETED|Overall Study||12
9997779|NCT01695772|11119437|FG000|NOT COMPLETED|Overall Study||38
9997780|NCT01695954|11119443|FG000|STARTED|Overall Study||18
9997781|NCT01695954|11119444|FG001|STARTED|Overall Study||16
9997782|NCT01695954|11119443|FG000|COMPLETED|Overall Study||14
9997783|NCT01695954|11119444|FG001|COMPLETED|Overall Study||14
9997784|NCT01695954|11119443|FG000|NOT COMPLETED|Overall Study||4
9997785|NCT01695954|11119444|FG001|NOT COMPLETED|Overall Study||2
9997786|NCT01695993|11119455|FG000|STARTED|Overall Study||81
9997787|NCT01695993|11119456|FG001|STARTED|Overall Study||80
9997788|NCT01695993|11119457|FG002|STARTED|Overall Study||81
9997789|NCT01695993|11119455|FG000|COMPLETED|Overall Study||76
9997790|NCT01695993|11119456|FG001|COMPLETED|Overall Study||75
9997791|NCT01695993|11119457|FG002|COMPLETED|Overall Study||75
9997792|NCT01695993|11119455|FG000|NOT COMPLETED|Overall Study||5
9997793|NCT01695993|11119456|FG001|NOT COMPLETED|Overall Study||5
9997794|NCT01695993|11119457|FG002|NOT COMPLETED|Overall Study||6
9997795|NCT01696032|11119469|FG000|STARTED|Overall Study||14
9997796|NCT01696032|11119470|FG001|STARTED|Overall Study||6
9997797|NCT01696032|11119471|FG002|STARTED|Overall Study||51
9997798|NCT01696032|11119472|FG003|STARTED|Overall Study||49
9997799|NCT01696032|11119469|FG000|COMPLETED|Overall Study||0
9997800|NCT01696032|11119470|FG001|COMPLETED|Overall Study||0
9997801|NCT01696032|11119471|FG002|COMPLETED|Overall Study||0
9997802|NCT01696032|11119472|FG003|COMPLETED|Overall Study||27
9997803|NCT01696032|11119469|FG000|NOT COMPLETED|Overall Study||14
9997804|NCT01696032|11119470|FG001|NOT COMPLETED|Overall Study||6
9997805|NCT01696032|11119471|FG002|NOT COMPLETED|Overall Study||51
9997806|NCT01696032|11119472|FG003|NOT COMPLETED|Overall Study||22
9997807|NCT01696045|11119488|FG000|STARTED|Overall Study||4
9997808|NCT01696045|11119489|FG001|STARTED|Overall Study||8
9997809|NCT01696045|11119488|FG000|COMPLETED|Overall Study||1
9997810|NCT01696045|11119489|FG001|COMPLETED|Overall Study||1
9997811|NCT01696045|11119488|FG000|NOT COMPLETED|Overall Study||3
9997812|NCT01696045|11119489|FG001|NOT COMPLETED|Overall Study||7
9997813|NCT01696058|11119497|FG000|STARTED|Overall Study||566
9997814|NCT01696058|11119498|FG001|STARTED|Overall Study||569
9997815|NCT01696058|11119497|FG000|COMPLETED|Overall Study||523
9997816|NCT01696058|11119498|FG001|COMPLETED|Overall Study||538
9997817|NCT01696058|11119497|FG000|NOT COMPLETED|Overall Study||43
9997818|NCT01696058|11119498|FG001|NOT COMPLETED|Overall Study||31
9997819|NCT01696071|11119504|FG000|STARTED|Treatment Period 1: 4 Weeks||51
9997820|NCT01696071|11119505|FG001|STARTED|Treatment Period 1: 4 Weeks||47
9997821|NCT01696071|11119504|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51
9997822|NCT01696071|11119505|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47
9997823|NCT01696071|11119504|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
9997824|NCT01696071|11119505|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
9997825|NCT01696071|11119504|FG000|STARTED|Treatment Period 2: 4 Weeks||51
9997826|NCT01696071|11119505|FG001|STARTED|Treatment Period 2: 4 Weeks||47
9997827|NCT01696071|11119504|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50
9997828|NCT01696071|11119505|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47
9997829|NCT01696071|11119504|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
9997830|NCT01696071|11119505|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
9997831|NCT01696084|11119514|FG000|STARTED|Overall Study||153
9997832|NCT01696084|11119515|FG001|STARTED|Overall Study||156
9997833|NCT01696084|11119514|FG000|COMPLETED|Overall Study||22
9997834|NCT01696084|11119515|FG001|COMPLETED|Overall Study||10
9997835|NCT01696084|11119514|FG000|NOT COMPLETED|Overall Study||131
9997836|NCT01696084|11119515|FG001|NOT COMPLETED|Overall Study||146
9997837|NCT01696188|11119523|FG000|STARTED|Overall Study||41
9997838|NCT01696188|11119524|FG001|STARTED|Overall Study||43
9997839|NCT01696188|11119523|FG000|COMPLETED|Overall Study||40
9997840|NCT01696188|11119524|FG001|COMPLETED|Overall Study||42
9997841|NCT01696188|11119523|FG000|NOT COMPLETED|Overall Study||1
9997842|NCT01696188|11119524|FG001|NOT COMPLETED|Overall Study||1
9997843|NCT01696214|11119534|FG000|STARTED|Overall Study||5
9997844|NCT01696214|11119535|FG001|STARTED|Overall Study||5
9997845|NCT01696214|11119536|FG002|STARTED|Overall Study||5
9997846|NCT01696214|11119537|FG003|STARTED|Overall Study||5
9997847|NCT01696214|11119534|FG000|COMPLETED|Overall Study||4
9997848|NCT01696214|11119535|FG001|COMPLETED|Overall Study||5
9997849|NCT01696214|11119536|FG002|COMPLETED|Overall Study||5
9997850|NCT01696214|11119537|FG003|COMPLETED|Overall Study||5
9997851|NCT01696214|11119534|FG000|NOT COMPLETED|Overall Study||1
9997852|NCT01696214|11119535|FG001|NOT COMPLETED|Overall Study||0
9997853|NCT01696214|11119536|FG002|NOT COMPLETED|Overall Study||0
9997854|NCT01696214|11119537|FG003|NOT COMPLETED|Overall Study||0
9997855|NCT01696279|11119555|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
9997856|NCT01696279|11119556|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
9997857|NCT01696279|11119557|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
9997858|NCT01696279|11119558|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
9997859|NCT01696279|11119555|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
9997860|NCT01696279|11119556|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
9997861|NCT01696279|11119557|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
9997862|NCT01696279|11119558|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
9997863|NCT01696279|11119555|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
9997864|NCT01696279|11119556|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
9997865|NCT01696279|11119557|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
9997866|NCT01696279|11119558|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
9997867|NCT01696279|11119555|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
9997868|NCT01696279|11119556|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
9997869|NCT01696279|11119557|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
9997870|NCT01696279|11119558|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
9997871|NCT01696279|11119555|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
9997872|NCT01696279|11119556|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
9997873|NCT01696279|11119557|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
9997874|NCT01696279|11119558|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
9997875|NCT01696279|11119555|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
9997876|NCT01696279|11119556|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
9997877|NCT01696279|11119557|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
9997878|NCT01696279|11119558|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
9997879|NCT01696279|11119555|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
9997880|NCT01696279|11119556|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
9997881|NCT01696279|11119557|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
9997882|NCT01696279|11119558|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
9997883|NCT01696279|11119555|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
9997884|NCT01696279|11119556|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
9997885|NCT01696279|11119557|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
9997886|NCT01696279|11119558|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
9997887|NCT01696279|11119555|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
9997888|NCT01696279|11119556|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
9997889|NCT01696279|11119557|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
9997890|NCT01696279|11119558|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
9997891|NCT01696279|11119555|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
9997892|NCT01696279|11119556|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
9997893|NCT01696279|11119557|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
9997894|NCT01696279|11119558|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
9997895|NCT01696279|11119555|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
9997896|NCT01696279|11119556|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
9997897|NCT01696279|11119557|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
10102967|NCT02419001|11232497|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6
9997898|NCT01696279|11119558|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
9997899|NCT01696279|11119555|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
9997900|NCT01696279|11119556|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
9997901|NCT01696279|11119557|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
9997902|NCT01696279|11119558|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
9997903|NCT01696279|11119555|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
9997904|NCT01696279|11119556|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
9997905|NCT01696279|11119557|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
9997906|NCT01696279|11119558|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
9997907|NCT01696279|11119555|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997908|NCT01696279|11119556|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997909|NCT01696279|11119557|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
9997910|NCT01696279|11119558|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997911|NCT01696279|11119555|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997912|NCT01696279|11119556|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997913|NCT01696279|11119557|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
9997914|NCT01696279|11119558|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997915|NCT01696279|11119555|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997916|NCT01696279|11119556|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997917|NCT01696279|11119557|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
9997918|NCT01696279|11119558|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997919|NCT01696279|11119555|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997920|NCT01696279|11119556|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10102968|NCT02419001|11232498|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5
9997921|NCT01696279|11119557|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997922|NCT01696279|11119558|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997923|NCT01696279|11119555|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997924|NCT01696279|11119556|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997925|NCT01696279|11119557|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
9997926|NCT01696279|11119558|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997927|NCT01696279|11119555|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997928|NCT01696279|11119556|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997929|NCT01696279|11119557|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
9997930|NCT01696279|11119558|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997931|NCT01696279|11119555|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997932|NCT01696279|11119556|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997933|NCT01696279|11119557|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
9997934|NCT01696279|11119558|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
9997935|NCT01696279|11119555|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
9997936|NCT01696279|11119556|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
9997937|NCT01696279|11119557|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
9997938|NCT01696279|11119558|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
9997939|NCT01696279|11119555|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
9997940|NCT01696279|11119556|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
9997941|NCT01696279|11119557|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
9997942|NCT01696279|11119558|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
9997943|NCT01696279|11119555|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
9997944|NCT01696279|11119556|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
9997945|NCT01696279|11119557|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
9997946|NCT01696279|11119558|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
9997947|NCT01696357|11119569|FG000|STARTED|Overall Study||42
9997948|NCT01696357|11119570|FG001|STARTED|Overall Study||42
9997949|NCT01696357|11119569|FG000|COMPLETED|Overall Study||40
9997950|NCT01696357|11119570|FG001|COMPLETED|Overall Study||41
9997951|NCT01696357|11119569|FG000|NOT COMPLETED|Overall Study||2
9997952|NCT01696357|11119570|FG001|NOT COMPLETED|Overall Study||1
9997953|NCT01696396|11119580|FG000|STARTED|Overall Study||100
9997954|NCT01696396|11119581|FG001|STARTED|Overall Study||27
9997955|NCT01696396|11119582|FG002|STARTED|Overall Study||85
9997956|NCT01696396|11119583|FG003|STARTED|Overall Study||42
9997957|NCT01696396|11119580|FG000|Received Study Drug|Overall Study||98
9997958|NCT01696396|11119581|FG001|Received Study Drug|Overall Study||26
9997959|NCT01696396|11119582|FG002|Received Study Drug|Overall Study||84
9997960|NCT01696396|11119583|FG003|Received Study Drug|Overall Study||41
9997961|NCT01696396|11119580|FG000|Entered Open-label Period|Overall Study||84
9997962|NCT01696396|11119581|FG001|Entered Open-label Period|Overall Study||21
9997963|NCT01696396|11119582|FG002|Entered Open-label Period|Overall Study||75
9997964|NCT01696396|11119583|FG003|Entered Open-label Period|Overall Study||37
9997965|NCT01696396|11119580|FG000|COMPLETED|Overall Study||69
9997966|NCT01696396|11119581|FG001|COMPLETED|Overall Study||20
9997967|NCT01696396|11119582|FG002|COMPLETED|Overall Study||59
9997968|NCT01696396|11119583|FG003|COMPLETED|Overall Study||28
9997969|NCT01696396|11119580|FG000|NOT COMPLETED|Overall Study||31
9997970|NCT01696396|11119581|FG001|NOT COMPLETED|Overall Study||7
9997971|NCT01696396|11119582|FG002|NOT COMPLETED|Overall Study||26
9997972|NCT01696396|11119583|FG003|NOT COMPLETED|Overall Study||14
9997973|NCT01696643|11119599|FG000|STARTED|Overall Study||703
9997974|NCT01696643|11119600|FG001|STARTED|Overall Study||704
9997975|NCT01696643|11119599|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701
9997976|NCT01696643|11119600|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
9997977|NCT01696643|11119599|FG000|COMPLETED|Overall Study||174
9997978|NCT01696643|11119600|FG001|COMPLETED|Overall Study||169
9997979|NCT01696643|11119599|FG000|NOT COMPLETED|Overall Study||529
9997980|NCT01696643|11119600|FG001|NOT COMPLETED|Overall Study||535
9997981|NCT01696695|11119606|FG000|STARTED|Overall Study||882
9997982|NCT01696695|11119606|FG000|COMPLETED|Overall Study||0
9997983|NCT01696695|11119606|FG000|NOT COMPLETED|Overall Study||882
9997984|NCT01696760|11119612|FG000|STARTED|Overall Study||9
9997985|NCT01696760|11119613|FG001|STARTED|Overall Study||3
9997986|NCT01696760|11119612|FG000|COMPLETED|Overall Study||9
9997987|NCT01696760|11119613|FG001|COMPLETED|Overall Study||3
9997988|NCT01696760|11119612|FG000|NOT COMPLETED|Overall Study||0
9997989|NCT01696760|11119613|FG001|NOT COMPLETED|Overall Study||0
9997990|NCT01696773|11119621|FG000|STARTED|Days 1-13, Washout||6
9997991|NCT01696773|11119622|FG001|STARTED|Days 1-13, Washout||6
9997992|NCT01696773|11119621|FG000|COMPLETED|Days 1-13, Washout||6
9997993|NCT01696773|11119622|FG001|COMPLETED|Days 1-13, Washout||6
9997994|NCT01696773|11119621|FG000|NOT COMPLETED|Days 1-13, Washout||0
9997995|NCT01696773|11119622|FG001|NOT COMPLETED|Days 1-13, Washout||0
9997996|NCT01696773|11119621|FG000|STARTED|Day 14, First Intervention||6
9997997|NCT01696773|11119622|FG001|STARTED|Day 14, First Intervention||6
9997998|NCT01696773|11119621|FG000|COMPLETED|Day 14, First Intervention||6
9997999|NCT01696773|11119622|FG001|COMPLETED|Day 14, First Intervention||6
9998000|NCT01696773|11119621|FG000|NOT COMPLETED|Day 14, First Intervention||0
9998001|NCT01696773|11119622|FG001|NOT COMPLETED|Day 14, First Intervention||0
9998002|NCT01696773|11119621|FG000|STARTED|Days 15-27, Washout||6
9998003|NCT01696773|11119622|FG001|STARTED|Days 15-27, Washout||6
9998004|NCT01696773|11119621|FG000|COMPLETED|Days 15-27, Washout||5
9998005|NCT01696773|11119622|FG001|COMPLETED|Days 15-27, Washout||6
9998006|NCT01696773|11119621|FG000|NOT COMPLETED|Days 15-27, Washout||1
9998007|NCT01696773|11119622|FG001|NOT COMPLETED|Days 15-27, Washout||0
9998008|NCT01696773|11119621|FG000|STARTED|Day 28, Second Intervention||5
9998009|NCT01696773|11119622|FG001|STARTED|Day 28, Second Intervention||6
9998010|NCT01696773|11119621|FG000|COMPLETED|Day 28, Second Intervention||5
9998011|NCT01696773|11119622|FG001|COMPLETED|Day 28, Second Intervention||6
9998012|NCT01696773|11119621|FG000|NOT COMPLETED|Day 28, Second Intervention||0
9998013|NCT01696773|11119622|FG001|NOT COMPLETED|Day 28, Second Intervention||0
9998014|NCT01696877|11119630|FG000|STARTED|Overall Study||15
9998015|NCT01696877|11119631|FG001|STARTED|Overall Study||14
9998016|NCT01696877|11119630|FG000|COMPLETED|Overall Study||15
9998017|NCT01696877|11119631|FG001|COMPLETED|Overall Study||13
9998018|NCT01696877|11119630|FG000|NOT COMPLETED|Overall Study||0
9998019|NCT01696877|11119631|FG001|NOT COMPLETED|Overall Study||1
9998020|NCT01696929|11119639|FG000|STARTED|Overall Study||6
9998021|NCT01696929|11119639|FG000|COMPLETED|Overall Study||5
9998022|NCT01696929|11119639|FG000|NOT COMPLETED|Overall Study||1
9998023|NCT01696942|11119645|FG000|STARTED|Overall Study||5
9998024|NCT01696942|11119646|FG001|STARTED|Overall Study||5
9998025|NCT01696942|11119645|FG000|COMPLETED|Overall Study||3
9998026|NCT01696942|11119646|FG001|COMPLETED|Overall Study||2
9998027|NCT01696942|11119645|FG000|NOT COMPLETED|Overall Study||2
9998028|NCT01696942|11119646|FG001|NOT COMPLETED|Overall Study||3
9998029|NCT01696955|11119654|FG000|STARTED|Main Study||42
9998030|NCT01696955|11119655|FG001|STARTED|Main Study||39
9998031|NCT01696955|11119654|FG000|COMPLETED|Main Study||40
9998032|NCT01696955|11119655|FG001|COMPLETED|Main Study||38
9998033|NCT01696955|11119654|FG000|NOT COMPLETED|Main Study||2
9998034|NCT01696955|11119655|FG001|NOT COMPLETED|Main Study||1
9998035|NCT01696955|11119654|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0
9998036|NCT01696955|11119655|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15
9998037|NCT01696955|11119654|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
9998038|NCT01696955|11119655|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
9998039|NCT01696955|11119654|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
9998040|NCT01696955|11119655|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
10102969|NCT02419001|11232497|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
10102970|NCT02419001|11232498|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
10102971|NCT02419001|11232497|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
10102972|NCT02419001|11232498|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
10102973|NCT02419001|11232497|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5
10102974|NCT02419001|11232498|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5
10102975|NCT02419001|11232497|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
10102976|NCT02419001|11232498|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
10102977|NCT02419001|11232497|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
10102978|NCT02419001|11232498|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
10102979|NCT02419313|11232504|FG000|STARTED|First Intervention||18
10102980|NCT02419313|11232505|FG001|STARTED|First Intervention||15
10102981|NCT02419313|11232504|FG000|COMPLETED|First Intervention||16
10102982|NCT02419313|11232505|FG001|COMPLETED|First Intervention||15
10102983|NCT02419313|11232504|FG000|NOT COMPLETED|First Intervention||2
10102984|NCT02419313|11232505|FG001|NOT COMPLETED|First Intervention||0
10102985|NCT02419313|11232504|FG000|STARTED|Second Intervention||16
10102986|NCT02419313|11232505|FG001|STARTED|Second Intervention||15
10102987|NCT02419313|11232504|FG000|COMPLETED|Second Intervention||15
10102988|NCT02419313|11232505|FG001|COMPLETED|Second Intervention||15
10102989|NCT02419313|11232504|FG000|NOT COMPLETED|Second Intervention||1
10102990|NCT02419313|11232505|FG001|NOT COMPLETED|Second Intervention||0
10102991|NCT02419469|11232511|FG000|STARTED|Overall Study||1
10102992|NCT02419469|11232511|FG000|COMPLETED|Overall Study||0
10102993|NCT02419469|11232511|FG000|NOT COMPLETED|Overall Study||1
10102994|NCT02419508|11232517|FG000|STARTED|Overall Study||96
10102995|NCT02419508|11232518|FG001|STARTED|Overall Study||92
10102996|NCT02419508|11232517|FG000|Full Analysis Set|Overall Study||95
10102997|NCT02419508|11232518|FG001|Full Analysis Set|Overall Study||92
10102998|NCT02419508|11232517|FG000|Safety Analysis Set|Overall Study||95
10102999|NCT02419508|11232518|FG001|Safety Analysis Set|Overall Study||92
10103000|NCT02419508|11232517|FG000|COMPLETED|Overall Study||86
10103001|NCT02419508|11232518|FG001|COMPLETED|Overall Study||88
10103002|NCT02419508|11232517|FG000|NOT COMPLETED|Overall Study||10
9998059|NCT01697319|11119698|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
9998060|NCT01697319|11119698|FG000|COMPLETED|Primary Phase||15
9998061|NCT01697319|11119698|FG000|NOT COMPLETED|Primary Phase||1
9998062|NCT01697319|11119698|FG000|STARTED|Extension Phase||15
9998063|NCT01697319|11119698|FG000|COMPLETED|Extension Phase||0
9998064|NCT01697319|11119698|FG000|NOT COMPLETED|Extension Phase||15
9998065|NCT01697345|11119702|FG000|STARTED|Overall Study||13
9998066|NCT01697345|11119702|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
9998067|NCT01697345|11119702|FG000|NOT COMPLETED|Overall Study||1
9998068|NCT01697358|11119723|FG000|STARTED|Period I: Randomization to 6 Months||110
9998069|NCT01697358|11119724|FG001|STARTED|Period I: Randomization to 6 Months||108
9998070|NCT01697358|11119723|FG000|COMPLETED|Period I: Randomization to 6 Months||97
9998071|NCT01697358|11119724|FG001|COMPLETED|Period I: Randomization to 6 Months||107
10103003|NCT02419508|11232518|FG001|NOT COMPLETED|Overall Study||4
10103004|NCT02419521|11232524|FG000|STARTED|Overall Study||75
10103005|NCT02419521|11232524|FG000|COMPLETED|Overall Study||74
10103006|NCT02419521|11232524|FG000|NOT COMPLETED|Overall Study||1
10103007|NCT02419547|11232528|FG000|STARTED|Overall Study||11
10103008|NCT02419547|11232528|FG000|COMPLETED|Overall Study||11
10103009|NCT02419547|11232528|FG000|NOT COMPLETED|Overall Study||0
10103010|NCT02419573|11232534|FG000|STARTED|Overall Study||1499
9998072|NCT01697358|11119723|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13
9998073|NCT01697358|11119724|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1
9998074|NCT01697358|11119723|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97
9998075|NCT01697358|11119724|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107
9998076|NCT01697358|11119723|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48
9998077|NCT01697358|11119724|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52
9998078|NCT01697358|11119723|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
9998079|NCT01697358|11119724|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
9998080|NCT01697449|11119730|FG000|STARTED|Overall Study||191
9998081|NCT01697449|11119730|FG000|COMPLETED|Overall Study||101
9998082|NCT01697449|11119730|FG000|NOT COMPLETED|Overall Study||90
9998083|NCT01697462|11119737|FG000|STARTED|Overall Study||258
9998084|NCT01697462|11119737|FG000|COMPLETED|Overall Study||181
9998085|NCT01697462|11119737|FG000|NOT COMPLETED|Overall Study||77
9998086|NCT01697501|11119741|FG000|STARTED|Overall Study||88
9998087|NCT01697501|11119741|FG000|COMPLETED|Overall Study||86
9998088|NCT01697501|11119741|FG000|NOT COMPLETED|Overall Study||2
9998089|NCT01697579|11119759|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
10103011|NCT02419573|11232535|FG001|STARTED|Overall Study||1505
10103012|NCT02419573|11232534|FG000|COMPLETED|Overall Study||1495
10103013|NCT02419573|11232535|FG001|COMPLETED|Overall Study||1505
10103014|NCT02419573|11232534|FG000|NOT COMPLETED|Overall Study||4
10103015|NCT02419573|11232535|FG001|NOT COMPLETED|Overall Study||0
10103016|NCT02419612|11232543|FG000|STARTED|Short-term Treatment Period||227
10103017|NCT02419612|11232544|FG001|STARTED|Short-term Treatment Period||217
10103018|NCT02419612|11232543|FG000|Recevied Treatment|Short-term Treatment Period||227
10103019|NCT02419612|11232544|FG001|Recevied Treatment|Short-term Treatment Period||216
10103020|NCT02419612|11232543|FG000|COMPLETED|Short-term Treatment Period||210
10103021|NCT02419612|11232544|FG001|COMPLETED|Short-term Treatment Period||194
10103022|NCT02419612|11232543|FG000|NOT COMPLETED|Short-term Treatment Period||17
10103023|NCT02419612|11232544|FG001|NOT COMPLETED|Short-term Treatment Period||23
10103024|NCT02419612|11232543|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
10103025|NCT02419612|11232544|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
10103026|NCT02419612|11232543|FG000|Received Treatment|Long-term Treatment Period||196
10103027|NCT02419612|11232544|FG001|Received Treatment|Long-term Treatment Period||183
10103028|NCT02419612|11232543|FG000|COMPLETED|Long-term Treatment Period||174
10103029|NCT02419612|11232544|FG001|COMPLETED|Long-term Treatment Period||164
10103030|NCT02419612|11232543|FG000|NOT COMPLETED|Long-term Treatment Period||22
10103031|NCT02419612|11232544|FG001|NOT COMPLETED|Long-term Treatment Period||22
10103032|NCT02419690|11232552|FG000|STARTED|Overall Study||122
10103033|NCT02419690|11232553|FG001|STARTED|Overall Study||122
10103034|NCT02419690|11232552|FG000|COMPLETED|Overall Study||122
10103035|NCT02419690|11232553|FG001|COMPLETED|Overall Study||122
10103036|NCT02419690|11232552|FG000|NOT COMPLETED|Overall Study||0
9998090|NCT01697579|11119760|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
9998091|NCT01697579|11119761|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
10018577|NCT01824472|11141670|FG001|NOT COMPLETED|Overall Study||7
10103037|NCT02419690|11232553|FG001|NOT COMPLETED|Overall Study||0
10103038|NCT02419755|11232561|FG000|STARTED|Overall Study||6
10103039|NCT02419755|11232562|FG001|STARTED|Overall Study||6
10103040|NCT02419755|11232561|FG000|COMPLETED|Overall Study||3
10103041|NCT02419755|11232562|FG001|COMPLETED|Overall Study||2
10103042|NCT02419755|11232561|FG000|NOT COMPLETED|Overall Study||3
10103043|NCT02419755|11232562|FG001|NOT COMPLETED|Overall Study||4
9998092|NCT01697579|11119762|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
9998093|NCT01697579|11119763|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
9998094|NCT01697579|11119764|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
9998095|NCT01697579|11119765|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
9998096|NCT01697579|11119759|FG000|COMPLETED|Base Study-Cycle 1||72
9998097|NCT01697579|11119760|FG001|COMPLETED|Base Study-Cycle 1||42
9998098|NCT01697579|11119761|FG002|COMPLETED|Base Study-Cycle 1||43
9998099|NCT01697579|11119762|FG003|COMPLETED|Base Study-Cycle 1||40
9998100|NCT01697579|11119763|FG004|COMPLETED|Base Study-Cycle 1||35
9998101|NCT01697579|11119764|FG005|COMPLETED|Base Study-Cycle 1||0
9998102|NCT01697579|11119765|FG006|COMPLETED|Base Study-Cycle 1||0
9998103|NCT01697579|11119759|FG000|NOT COMPLETED|Base Study-Cycle 1||2
9998104|NCT01697579|11119760|FG001|NOT COMPLETED|Base Study-Cycle 1||1
9998105|NCT01697579|11119761|FG002|NOT COMPLETED|Base Study-Cycle 1||1
9998106|NCT01697579|11119762|FG003|NOT COMPLETED|Base Study-Cycle 1||1
9998107|NCT01697579|11119763|FG004|NOT COMPLETED|Base Study-Cycle 1||3
9998108|NCT01697579|11119764|FG005|NOT COMPLETED|Base Study-Cycle 1||0
9998109|NCT01697579|11119765|FG006|NOT COMPLETED|Base Study-Cycle 1||0
9998110|NCT01697579|11119759|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
9998111|NCT01697579|11119760|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
9998112|NCT01697579|11119761|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
9998113|NCT01697579|11119762|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
9998114|NCT01697579|11119763|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
9998115|NCT01697579|11119764|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
9998116|NCT01697579|11119765|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
9998117|NCT01697579|11119759|FG000|COMPLETED|Optional Extension-Cycles 2-6||0
10103047|NCT02419924|11232572|FG000|STARTED|Overall Study||12
10103048|NCT02419924|11232572|FG000|COMPLETED|Overall Study||12
10103049|NCT02419924|11232572|FG000|NOT COMPLETED|Overall Study||0
10103050|NCT02419937|11232578|FG000|STARTED|Overall Study||12
10103051|NCT02419937|11232579|FG001|STARTED|Overall Study||16
10103052|NCT02419937|11232578|FG000|COMPLETED|Overall Study||11
10103053|NCT02419937|11232579|FG001|COMPLETED|Overall Study||16
10202197|NCT03442036|11329305|FG001|COMPLETED|Overall Study||35
10202198|NCT03442036|11329304|FG000|NOT COMPLETED|Overall Study||0
10202199|NCT03442036|11329305|FG001|NOT COMPLETED|Overall Study||0
10202200|NCT03442296|11329315|FG000|STARTED|3 Month Follow-up||78
10202201|NCT03442296|11329316|FG001|STARTED|3 Month Follow-up||73
10202202|NCT03442296|11329315|FG000|COMPLETED|3 Month Follow-up||73
10202203|NCT03442296|11329316|FG001|COMPLETED|3 Month Follow-up||70
10202204|NCT03442296|11329315|FG000|NOT COMPLETED|3 Month Follow-up||5
10202205|NCT03442296|11329316|FG001|NOT COMPLETED|3 Month Follow-up||3
10202206|NCT03442296|11329315|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (6), or withdrew consent (6)|58
10202207|NCT03442296|11329316|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52
10202208|NCT03442296|11329315|FG000|COMPLETED|12 Month Follow-up||57
10202209|NCT03442296|11329316|FG001|COMPLETED|12 Month Follow-up||51
10202210|NCT03442296|11329315|FG000|NOT COMPLETED|12 Month Follow-up||1
10202211|NCT03442296|11329316|FG001|NOT COMPLETED|12 Month Follow-up||1
10202212|NCT03442569|11329322|FG000|STARTED|Overall Study||56
10202213|NCT03442569|11329322|FG000|Started Treatment|Overall Study||55
10202214|NCT03442569|11329322|FG000|COMPLETED|Overall Study||55
10202215|NCT03442569|11329322|FG000|NOT COMPLETED|Overall Study||1
10202216|NCT03442595|11329328|FG000|STARTED|Overall Study||460
10202217|NCT03442595|11329329|FG001|STARTED|Overall Study||366
10202218|NCT03442595|11329328|FG000|COMPLETED|Overall Study||366
10202219|NCT03442595|11329329|FG001|COMPLETED|Overall Study||366
10202220|NCT03442595|11329328|FG000|NOT COMPLETED|Overall Study||94
10202221|NCT03442595|11329329|FG001|NOT COMPLETED|Overall Study||0
10202222|NCT03442699|11329334|FG000|STARTED|Overall Study||6
10202223|NCT03442699|11329334|FG000|COMPLETED|Overall Study||6
10202224|NCT03442699|11329334|FG000|NOT COMPLETED|Overall Study||0
10202225|NCT03442725|11329342|FG000|STARTED|Overall Study||8
10202226|NCT03442725|11329343|FG001|STARTED|Overall Study||8
10202227|NCT03442725|11329342|FG000|COMPLETED|Overall Study||8
10202228|NCT03442725|11329343|FG001|COMPLETED|Overall Study||8
10202229|NCT03442725|11329342|FG000|NOT COMPLETED|Overall Study||0
10202230|NCT03442725|11329343|FG001|NOT COMPLETED|Overall Study||0
10202231|NCT03442777|11329352|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542
10202232|NCT03442777|11329353|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
10103054|NCT02419937|11232578|FG000|NOT COMPLETED|Overall Study||1
10103055|NCT02419937|11232579|FG001|NOT COMPLETED|Overall Study||0
10103056|NCT02420015|11232587|FG000|STARTED|Overall Study||21
10103057|NCT02420015|11232588|FG001|STARTED|Overall Study||13
9998118|NCT01697579|11119760|FG001|COMPLETED|Optional Extension-Cycles 2-6||0
9998119|NCT01697579|11119761|FG002|COMPLETED|Optional Extension-Cycles 2-6||0
9998120|NCT01697579|11119762|FG003|COMPLETED|Optional Extension-Cycles 2-6||0
9998121|NCT01697579|11119763|FG004|COMPLETED|Optional Extension-Cycles 2-6||0
9998122|NCT01697579|11119764|FG005|COMPLETED|Optional Extension-Cycles 2-6||12
9998123|NCT01697579|11119765|FG006|COMPLETED|Optional Extension-Cycles 2-6||37
9998124|NCT01697579|11119759|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0
9998125|NCT01697579|11119760|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0
9998126|NCT01697579|11119761|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0
9998127|NCT01697579|11119762|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0
9998128|NCT01697579|11119763|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0
9998129|NCT01697579|11119764|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35
9998130|NCT01697579|11119765|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69
9998131|NCT01697592|11119803|FG000|STARTED|Phase A (Up to 24 Weeks)||126
9998132|NCT01697592|11119804|FG001|STARTED|Phase A (Up to 24 Weeks)||65
9998133|NCT01697592|11119805|FG002|STARTED|Phase A (Up to 24 Weeks)||66
9998134|NCT01697592|11119806|FG003|STARTED|Phase A (Up to 24 Weeks)||65
9998135|NCT01697592|11119807|FG004|STARTED|Phase A (Up to 24 Weeks)||67
9998136|NCT01697592|11119808|FG005|STARTED|Phase A (Up to 24 Weeks)||63
9998137|NCT01697592|11119809|FG006|STARTED|Phase A (Up to 24 Weeks)||34
9998138|NCT01697592|11119810|FG007|STARTED|Phase A (Up to 24 Weeks)||33
9998139|NCT01697592|11119811|FG008|STARTED|Phase A (Up to 24 Weeks)||34
9998140|NCT01697592|11119812|FG009|STARTED|Phase A (Up to 24 Weeks)||32
9998141|NCT01697592|11119803|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123
9998142|NCT01697592|11119804|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62
9998143|NCT01697592|11119805|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65
9998144|NCT01697592|11119806|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63
9998145|NCT01697592|11119807|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67
9998146|NCT01697592|11119808|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62
9998147|NCT01697592|11119809|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32
9998148|NCT01697592|11119810|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33
9998149|NCT01697592|11119811|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34
9998150|NCT01697592|11119812|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30
9998151|NCT01697592|11119803|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
9998152|NCT01697592|11119804|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
9998153|NCT01697592|11119805|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
9998154|NCT01697592|11119806|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
9998155|NCT01697592|11119807|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
9998156|NCT01697592|11119808|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
9998157|NCT01697592|11119809|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
9998158|NCT01697592|11119810|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
9998159|NCT01697592|11119811|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
9998160|NCT01697592|11119812|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
9998161|NCT01697592|11119803|FG000|STARTED|Phase B (Week 25 to Week 52)||123
9998162|NCT01697592|11119804|FG001|STARTED|Phase B (Week 25 to Week 52)||62
9998163|NCT01697592|11119805|FG002|STARTED|Phase B (Week 25 to Week 52)||65
9998164|NCT01697592|11119806|FG003|STARTED|Phase B (Week 25 to Week 52)||63
9998165|NCT01697592|11119807|FG004|STARTED|Phase B (Week 25 to Week 52)||67
9998166|NCT01697592|11119808|FG005|STARTED|Phase B (Week 25 to Week 52)||62
9998167|NCT01697592|11119809|FG006|STARTED|Phase B (Week 25 to Week 52)||32
9998168|NCT01697592|11119810|FG007|STARTED|Phase B (Week 25 to Week 52)||33
9998169|NCT01697592|11119811|FG008|STARTED|Phase B (Week 25 to Week 52)||34
9998170|NCT01697592|11119812|FG009|STARTED|Phase B (Week 25 to Week 52)||30
9998171|NCT01697592|11119803|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118
9998172|NCT01697592|11119804|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61
9998173|NCT01697592|11119805|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64
9998174|NCT01697592|11119806|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60
9998175|NCT01697592|11119807|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67
9998176|NCT01697592|11119808|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60
9998177|NCT01697592|11119809|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31
9998178|NCT01697592|11119810|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32
9998179|NCT01697592|11119811|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32
9998180|NCT01697592|11119812|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30
9998181|NCT01697592|11119803|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
9998182|NCT01697592|11119804|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
9998183|NCT01697592|11119805|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
9998184|NCT01697592|11119806|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
9998185|NCT01697592|11119807|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
9998186|NCT01697592|11119808|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
9998187|NCT01697592|11119809|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
9998188|NCT01697592|11119810|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
9998189|NCT01697592|11119811|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
9998190|NCT01697592|11119812|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
9998191|NCT01697696|11119850|FG000|STARTED|Overall Study||254
9998192|NCT01697696|11119851|FG001|STARTED|Overall Study||257
9998193|NCT01697696|11119850|FG000|Safety Set|Overall Study||251
9998194|NCT01697696|11119851|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
9998195|NCT01697696|11119850|FG000|Full Analysis Set (FAS)|Overall Study||251
9998196|NCT01697696|11119851|FG001|Full Analysis Set (FAS)|Overall Study||255
9998197|NCT01697696|11119850|FG000|COMPLETED|Overall Study||207
9998198|NCT01697696|11119851|FG001|COMPLETED|Overall Study||210
9998199|NCT01697696|11119850|FG000|NOT COMPLETED|Overall Study||47
9998200|NCT01697696|11119851|FG001|NOT COMPLETED|Overall Study||47
9998201|NCT01697709|11119859|FG000|STARTED|Overall Study||64
9998202|NCT01697709|11119860|FG001|STARTED|Overall Study||66
9998203|NCT01697709|11119859|FG000|COMPLETED|Overall Study||34
9998204|NCT01697709|11119860|FG001|COMPLETED|Overall Study||38
9998205|NCT01697709|11119859|FG000|NOT COMPLETED|Overall Study||30
9998206|NCT01697709|11119860|FG001|NOT COMPLETED|Overall Study||28
9998207|NCT01697748|11119868|FG000|STARTED|Overall Study||329
9998208|NCT01697748|11119869|FG001|STARTED|Overall Study||328
9998209|NCT01697748|11119868|FG000|COMPLETED|Overall Study||271
9998210|NCT01697748|11119869|FG001|COMPLETED|Overall Study||260
9998211|NCT01697748|11119868|FG000|NOT COMPLETED|Overall Study||58
9998212|NCT01697748|11119869|FG001|NOT COMPLETED|Overall Study||68
9998213|NCT01697956|11119877|FG000|STARTED|Overall Study|enrolled and randomized|67
9998214|NCT01697956|11119878|FG001|STARTED|Overall Study|enrolled and randomized|32
9998215|NCT01697956|11119877|FG000|Per Protocol Population|Overall Study||66
9998216|NCT01697956|11119878|FG001|Per Protocol Population|Overall Study||31
9998217|NCT01697956|11119877|FG000|COMPLETED|Overall Study||66
9998218|NCT01697956|11119878|FG001|COMPLETED|Overall Study||31
9998219|NCT01697956|11119877|FG000|NOT COMPLETED|Overall Study||1
9998220|NCT01697956|11119878|FG001|NOT COMPLETED|Overall Study||1
9998221|NCT01697969|11119890|FG000|STARTED|Overall Study||13
9998222|NCT01697969|11119890|FG000|COMPLETED|Overall Study||10
9998223|NCT01697969|11119890|FG000|NOT COMPLETED|Overall Study||3
9998224|NCT01698008|11119897|FG000|STARTED|Overall Study||3
9998225|NCT01698008|11119898|FG001|STARTED|Overall Study||2
9998226|NCT01698008|11119897|FG000|COMPLETED|Overall Study||2
9998227|NCT01698008|11119898|FG001|COMPLETED|Overall Study||0
9998228|NCT01698008|11119897|FG000|NOT COMPLETED|Overall Study||1
9998229|NCT01698008|11119898|FG001|NOT COMPLETED|Overall Study||2
9998230|NCT01698268|11119906|FG000|STARTED|Overall Study||25
9998231|NCT01698268|11119907|FG001|STARTED|Overall Study||25
9998232|NCT01698268|11119906|FG000|COMPLETED|Overall Study||23
9998233|NCT01698268|11119907|FG001|COMPLETED|Overall Study||24
9998234|NCT01698268|11119906|FG000|NOT COMPLETED|Overall Study||2
9998235|NCT01698268|11119907|FG001|NOT COMPLETED|Overall Study||1
9998236|NCT01698320|11119915|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364
9998237|NCT01698320|11119916|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0
9998238|NCT01698320|11119917|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0
9998239|NCT01698320|11119915|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337
9998240|NCT01698320|11119916|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0
9998241|NCT01698320|11119917|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0
9998242|NCT01698320|11119915|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
9998243|NCT01698320|11119916|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
9998244|NCT01698320|11119917|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
9998245|NCT01698320|11119915|FG000|STARTED|12-Week Double-Blind Period||0
9998246|NCT01698320|11119916|FG001|STARTED|12-Week Double-Blind Period||169
9998247|NCT01698320|11119917|FG002|STARTED|12-Week Double-Blind Period||168
9998248|NCT01698320|11119915|FG000|Safety Population|12-Week Double-Blind Period||0
9998249|NCT01698320|11119916|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
9998250|NCT01698320|11119917|FG002|Safety Population|12-Week Double-Blind Period||168
9998251|NCT01698320|11119915|FG000|COMPLETED|12-Week Double-Blind Period||0
9998252|NCT01698320|11119916|FG001|COMPLETED|12-Week Double-Blind Period||165
9998253|NCT01698320|11119917|FG002|COMPLETED|12-Week Double-Blind Period||156
9998254|NCT01698320|11119915|FG000|NOT COMPLETED|12-Week Double-Blind Period||0
9998255|NCT01698320|11119916|FG001|NOT COMPLETED|12-Week Double-Blind Period||4
9998256|NCT01698320|11119917|FG002|NOT COMPLETED|12-Week Double-Blind Period||12
9998257|NCT01698320|11119915|FG000|STARTED|40-Week Open-Label Period||0
9998258|NCT01698320|11119916|FG001|STARTED|40-Week Open-Label Period||165
9998259|NCT01698320|11119917|FG002|STARTED|40-Week Open-Label Period||156
9998260|NCT01698320|11119915|FG000|COMPLETED|40-Week Open-Label Period||0
9998261|NCT01698320|11119916|FG001|COMPLETED|40-Week Open-Label Period||146
9998262|NCT01698320|11119917|FG002|COMPLETED|40-Week Open-Label Period||146
9998263|NCT01698320|11119915|FG000|NOT COMPLETED|40-Week Open-Label Period||0
9998264|NCT01698320|11119916|FG001|NOT COMPLETED|40-Week Open-Label Period||19
9998265|NCT01698320|11119917|FG002|NOT COMPLETED|40-Week Open-Label Period||10
9998266|NCT01698333|11119925|FG000|STARTED|Overall Study||25
9998267|NCT01698333|11119925|FG000|COMPLETED|Overall Study||25
9998268|NCT01698333|11119925|FG000|NOT COMPLETED|Overall Study||0
9998269|NCT01698463|11119929|FG000|STARTED|Overall Study||11
9998270|NCT01698463|11119929|FG000|COMPLETED|Overall Study||11
9998271|NCT01698463|11119929|FG000|NOT COMPLETED|Overall Study||0
9998272|NCT01698502|11119935|FG000|STARTED|Overall Study||11
9998273|NCT01698502|11119936|FG001|STARTED|Overall Study||10
9998274|NCT01698502|11119935|FG000|COMPLETED|Overall Study||11
9998275|NCT01698502|11119936|FG001|COMPLETED|Overall Study||10
9998276|NCT01698502|11119935|FG000|NOT COMPLETED|Overall Study||0
9998277|NCT01698502|11119936|FG001|NOT COMPLETED|Overall Study||0
9998278|NCT01698528|11119944|FG000|STARTED|Overall Study||20
9998279|NCT01698528|11119945|FG001|STARTED|Overall Study||20
9998280|NCT01698528|11119944|FG000|COMPLETED|Overall Study||19
9998281|NCT01698528|11119945|FG001|COMPLETED|Overall Study||16
9998282|NCT01698528|11119944|FG000|NOT COMPLETED|Overall Study||1
9998283|NCT01698528|11119945|FG001|NOT COMPLETED|Overall Study||4
9998284|NCT01698554|11119955|FG000|STARTED|Overall Study||153
9998285|NCT01698554|11119956|FG001|STARTED|Overall Study||157
9998286|NCT01698554|11119957|FG002|STARTED|Overall Study||75
9998287|NCT01698554|11119958|FG003|STARTED|Overall Study||79
9998288|NCT01698554|11119955|FG000|COMPLETED|Overall Study||147
9998289|NCT01698554|11119956|FG001|COMPLETED|Overall Study||147
9998290|NCT01698554|11119957|FG002|COMPLETED|Overall Study||73
9998291|NCT01698554|11119958|FG003|COMPLETED|Overall Study||77
9998292|NCT01698554|11119955|FG000|NOT COMPLETED|Overall Study||6
9998293|NCT01698554|11119956|FG001|NOT COMPLETED|Overall Study||10
9998294|NCT01698554|11119957|FG002|NOT COMPLETED|Overall Study||2
9998295|NCT01698554|11119958|FG003|NOT COMPLETED|Overall Study||2
9998296|NCT01698684|11119971|FG000|STARTED|Overall Study||145
9998297|NCT01698684|11119972|FG001|STARTED|Overall Study||147
9998298|NCT01698684|11119973|FG002|STARTED|Overall Study||148
9998299|NCT01698684|11119971|FG000|ITT Population|Overall Study||136
9998300|NCT01698684|11119972|FG001|ITT Population|Overall Study||139
9998301|NCT01698684|11119973|FG002|ITT Population|Overall Study||139
9998302|NCT01698684|11119971|FG000|Safety Population|Overall Study||143
9998303|NCT01698684|11119972|FG001|Safety Population|Overall Study||146
9998304|NCT01698684|11119973|FG002|Safety Population|Overall Study||146
9998305|NCT01698684|11119971|FG000|COMPLETED|Overall Study||116
9998306|NCT01698684|11119972|FG001|COMPLETED|Overall Study||124
9998307|NCT01698684|11119973|FG002|COMPLETED|Overall Study||127
9998308|NCT01698684|11119971|FG000|NOT COMPLETED|Overall Study||29
9998309|NCT01698684|11119972|FG001|NOT COMPLETED|Overall Study||23
9998310|NCT01698684|11119973|FG002|NOT COMPLETED|Overall Study||21
9998311|NCT01698710|11119981|FG000|STARTED|Overall Study||5
9998312|NCT01698710|11119981|FG000|COMPLETED|Overall Study||5
9998313|NCT01698710|11119981|FG000|NOT COMPLETED|Overall Study||0
9998314|NCT01698775|11119987|FG000|STARTED|Phase A||107
9998315|NCT01698775|11119988|FG001|STARTED|Phase A||106
9998316|NCT01698775|11119987|FG000|COMPLETED|Phase A||98
9998317|NCT01698775|11119988|FG001|COMPLETED|Phase A||97
9998318|NCT01698775|11119987|FG000|NOT COMPLETED|Phase A||9
9998319|NCT01698775|11119988|FG001|NOT COMPLETED|Phase A||9
9998320|NCT01698775|11119987|FG000|STARTED|Phase B||98
9998321|NCT01698775|11119988|FG001|STARTED|Phase B||97
9998322|NCT01698775|11119987|FG000|COMPLETED|Phase B||84
9998323|NCT01698775|11119988|FG001|COMPLETED|Phase B||86
9998324|NCT01698775|11119987|FG000|NOT COMPLETED|Phase B||14
9998325|NCT01698775|11119988|FG001|NOT COMPLETED|Phase B||11
9998326|NCT01698801|11119998|FG000|STARTED|Treatment Phase||26
10103058|NCT02420015|11232587|FG000|COMPLETED|Overall Study||21
10103059|NCT02420015|11232588|FG001|COMPLETED|Overall Study||13
10103060|NCT02420015|11232587|FG000|NOT COMPLETED|Overall Study||0
10103061|NCT02420015|11232588|FG001|NOT COMPLETED|Overall Study||0
10103062|NCT02420041|11232596|FG000|STARTED|Overall Study||14
9998327|NCT01698801|11119998|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
9998328|NCT01698801|11119998|FG000|NOT COMPLETED|Treatment Phase||11
9998329|NCT01698801|11119998|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
9998330|NCT01698801|11119998|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
9998331|NCT01698801|11119998|FG000|NOT COMPLETED|Follow Up Phase||5
9998332|NCT01698814|11120005|FG000|STARTED|Overall Study||331
9998333|NCT01698814|11120006|FG001|STARTED|Overall Study||169
9998334|NCT01698814|11120005|FG000|COMPLETED|Overall Study||329
9998335|NCT01698814|11120006|FG001|COMPLETED|Overall Study||166
9998336|NCT01698814|11120005|FG000|NOT COMPLETED|Overall Study||2
9998337|NCT01698814|11120006|FG001|NOT COMPLETED|Overall Study||3
9998338|NCT01698879|11120015|FG000|STARTED|Overall Study||6
9998339|NCT01698879|11120016|FG001|STARTED|Overall Study||20
9998340|NCT01698879|11120017|FG002|STARTED|Overall Study||20
9998341|NCT01698879|11120015|FG000|COMPLETED|Overall Study||5
9998342|NCT01698879|11120016|FG001|COMPLETED|Overall Study||20
9998343|NCT01698879|11120017|FG002|COMPLETED|Overall Study||20
9998344|NCT01698879|11120015|FG000|NOT COMPLETED|Overall Study||1
9998345|NCT01698879|11120016|FG001|NOT COMPLETED|Overall Study||0
9998346|NCT01698879|11120017|FG002|NOT COMPLETED|Overall Study||0
9998347|NCT01699022|11120031|FG000|STARTED|Overall Study||17
9998348|NCT01699022|11120031|FG000|COMPLETED|Overall Study||14
9998349|NCT01699022|11120031|FG000|NOT COMPLETED|Overall Study||3
9998350|NCT01699087|11120036|FG000|STARTED|Overall Study||176
9998351|NCT01699087|11120036|FG000|Treated|Overall Study||161
9998352|NCT01699087|11120036|FG000|COMPLETED|Overall Study||152
9998353|NCT01699087|11120036|FG000|NOT COMPLETED|Overall Study||24
9998354|NCT01699178|11120043|FG000|STARTED|Overall Study||88
10103063|NCT02420041|11232597|FG001|STARTED|Overall Study||14
9998355|NCT01699178|11120044|FG001|STARTED|Overall Study||94
9998356|NCT01699178|11120043|FG000|COMPLETED|Overall Study||69
9998357|NCT01699178|11120044|FG001|COMPLETED|Overall Study||62
9998358|NCT01699178|11120043|FG000|NOT COMPLETED|Overall Study||19
9998359|NCT01699178|11120044|FG001|NOT COMPLETED|Overall Study||32
9998360|NCT01699373|11120052|FG000|STARTED|Overall Study||85
9998361|NCT01699373|11120053|FG001|STARTED|Overall Study||85
10103064|NCT02420041|11232596|FG000|COMPLETED|Overall Study||14
10103065|NCT02420041|11232597|FG001|COMPLETED|Overall Study||14
10103066|NCT02420041|11232596|FG000|NOT COMPLETED|Overall Study||0
10103067|NCT02420041|11232597|FG001|NOT COMPLETED|Overall Study||0
10103068|NCT02420093|11232605|FG000|STARTED|Overall Study||9
10103069|NCT02420093|11232606|FG001|STARTED|Overall Study||8
10103070|NCT02420093|11232605|FG000|COMPLETED|Overall Study||8
9998362|NCT01699373|11120052|FG000|COMPLETED|Overall Study||85
9998363|NCT01699373|11120053|FG001|COMPLETED|Overall Study||85
9998364|NCT01699373|11120052|FG000|NOT COMPLETED|Overall Study||0
9998365|NCT01699373|11120053|FG001|NOT COMPLETED|Overall Study||0
9998366|NCT01699503|11120061|FG000|STARTED|Overall Study||2008
9998367|NCT01699503|11120062|FG001|STARTED|Overall Study||1997
9998368|NCT01699503|11120061|FG000|Baseline|Overall Study||1723
9998369|NCT01699503|11120062|FG001|Baseline|Overall Study||1693
9998370|NCT01699503|11120061|FG000|1 Month Follow-up|Overall Study||998
9998371|NCT01699503|11120062|FG001|1 Month Follow-up|Overall Study||1022
9998372|NCT01699503|11120061|FG000|6 Month Follow-up|Overall Study||903
9998373|NCT01699503|11120062|FG001|6 Month Follow-up|Overall Study||893
9998374|NCT01699503|11120061|FG000|COMPLETED|Overall Study||1008
9998375|NCT01699503|11120062|FG001|COMPLETED|Overall Study||992
9998376|NCT01699503|11120061|FG000|NOT COMPLETED|Overall Study||1000
9998377|NCT01699503|11120062|FG001|NOT COMPLETED|Overall Study||1005
9998378|NCT01699542|11120070|FG000|STARTED|Overall Study||9
9998379|NCT01699542|11120071|FG001|STARTED|Overall Study||9
9998380|NCT01699542|11120070|FG000|COMPLETED|Overall Study||9
9998381|NCT01699542|11120071|FG001|COMPLETED|Overall Study||9
9998382|NCT01699542|11120070|FG000|NOT COMPLETED|Overall Study||0
9998383|NCT01699542|11120071|FG001|NOT COMPLETED|Overall Study||0
9998384|NCT01699607|11120079|FG000|STARTED|Overall Study||6
9998385|NCT01699607|11120080|FG001|STARTED|Overall Study||4
9998386|NCT01699607|11120079|FG000|COMPLETED|Overall Study||6
9998387|NCT01699607|11120080|FG001|COMPLETED|Overall Study||4
9998388|NCT01699607|11120079|FG000|NOT COMPLETED|Overall Study||0
9998389|NCT01699607|11120080|FG001|NOT COMPLETED|Overall Study||0
9998390|NCT01699685|11120087|FG000|STARTED|Period 1||39
9998391|NCT01699685|11120088|FG001|STARTED|Period 1||39
9998392|NCT01699685|11120087|FG000|Safety Population|Period 1||39
9998393|NCT01699685|11120088|FG001|Safety Population|Period 1||38
9998394|NCT01699685|11120087|FG000|Full Analysis Population (FAS)|Period 1||38
9998395|NCT01699685|11120088|FG001|Full Analysis Population (FAS)|Period 1||38
9998396|NCT01699685|11120087|FG000|COMPLETED|Period 1||36
9998397|NCT01699685|11120088|FG001|COMPLETED|Period 1||36
9998398|NCT01699685|11120087|FG000|NOT COMPLETED|Period 1||3
9998399|NCT01699685|11120088|FG001|NOT COMPLETED|Period 1||3
9998400|NCT01699685|11120087|FG000|STARTED|Period 2||36
9998401|NCT01699685|11120088|FG001|STARTED|Period 2||36
9998402|NCT01699685|11120087|FG000|COMPLETED|Period 2||35
9998403|NCT01699685|11120088|FG001|COMPLETED|Period 2||36
9998404|NCT01699685|11120087|FG000|NOT COMPLETED|Period 2||1
9998405|NCT01699685|11120088|FG001|NOT COMPLETED|Period 2||0
9998406|NCT01699698|11120096|FG000|STARTED|Overall Study||44
9998407|NCT01699698|11120097|FG001|STARTED|Overall Study||61
9998408|NCT01699698|11120096|FG000|COMPLETED|Overall Study||42
9998409|NCT01699698|11120097|FG001|COMPLETED|Overall Study||56
9998410|NCT01699698|11120096|FG000|NOT COMPLETED|Overall Study||2
9998411|NCT01699698|11120097|FG001|NOT COMPLETED|Overall Study||5
9998412|NCT01699750|11120106|FG000|STARTED|Overall Study||34
9998413|NCT01699750|11120107|FG001|STARTED|Overall Study||36
9998414|NCT01699750|11120106|FG000|COMPLETED|Overall Study||34
9998415|NCT01699750|11120107|FG001|COMPLETED|Overall Study||33
9998416|NCT01699750|11120106|FG000|NOT COMPLETED|Overall Study||0
9998417|NCT01699750|11120107|FG001|NOT COMPLETED|Overall Study||3
9998418|NCT01699763|11120117|FG000|STARTED|Overall Study||112
9998419|NCT01699763|11120117|FG000|COMPLETED|Overall Study||112
9998420|NCT01699763|11120117|FG000|NOT COMPLETED|Overall Study||0
9998421|NCT01699789|11120123|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
9998422|NCT01699789|11120124|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
9998423|NCT01699789|11120123|FG000|Baseline|Overall Study||492
9998424|NCT01699789|11120124|FG001|Baseline|Overall Study||489
9998425|NCT01699789|11120123|FG000|6-Month Follow-Up|Overall Study||380
9998426|NCT01699789|11120124|FG001|6-Month Follow-Up|Overall Study||379
9998427|NCT01699789|11120123|FG000|12-Month Follow-Up|Overall Study||364
9998428|NCT01699789|11120124|FG001|12-Month Follow-Up|Overall Study||369
9998429|NCT01699789|11120123|FG000|3-Year Follow-up|Overall Study||293
9998430|NCT01699789|11120124|FG001|3-Year Follow-up|Overall Study||307
9998431|NCT01699789|11120123|FG000|4-Year Follow-up|Overall Study||143
9998432|NCT01699789|11120124|FG001|4-Year Follow-up|Overall Study||140
9998433|NCT01699789|11120123|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
9998434|NCT01699789|11120124|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
9998435|NCT01699789|11120123|FG000|NOT COMPLETED|Overall Study||102
9998436|NCT01699789|11120124|FG001|NOT COMPLETED|Overall Study||126
9998437|NCT01699815|11120134|FG000|STARTED|Overall Study||62
9998438|NCT01699815|11120135|FG001|STARTED|Overall Study||64
9998439|NCT01699815|11120134|FG000|COMPLETED|Overall Study||57
9998440|NCT01699815|11120135|FG001|COMPLETED|Overall Study||56
9998441|NCT01699815|11120134|FG000|NOT COMPLETED|Overall Study||5
9998442|NCT01699815|11120135|FG001|NOT COMPLETED|Overall Study||8
9998443|NCT01699867|11120141|FG000|STARTED|Overall Study||50
9998444|NCT01699867|11120141|FG000|COMPLETED|Overall Study||47
9998445|NCT01699867|11120141|FG000|NOT COMPLETED|Overall Study||3
9998446|NCT01700036|11120145|FG000|STARTED|Overall Study||40
9998447|NCT01700036|11120145|FG000|COMPLETED|Overall Study||40
9998448|NCT01700036|11120145|FG000|NOT COMPLETED|Overall Study||0
9998449|NCT01700049|11120149|FG000|STARTED|Overall Study||28
9998450|NCT01700049|11120149|FG000|COMPLETED|Overall Study||27
9998451|NCT01700049|11120149|FG000|NOT COMPLETED|Overall Study||1
9998452|NCT01700140|11120157|FG000|STARTED|Overall Study||61
9998453|NCT01700140|11120158|FG001|STARTED|Overall Study||66
9998454|NCT01700140|11120159|FG002|STARTED|Overall Study||62
9998455|NCT01700140|11120157|FG000|COMPLETED|Overall Study||55
9998456|NCT01700140|11120158|FG001|COMPLETED|Overall Study||57
9998457|NCT01700140|11120159|FG002|COMPLETED|Overall Study||61
9998458|NCT01700140|11120157|FG000|NOT COMPLETED|Overall Study||6
9998459|NCT01700140|11120158|FG001|NOT COMPLETED|Overall Study||9
9998460|NCT01700140|11120159|FG002|NOT COMPLETED|Overall Study||1
9998461|NCT01700179|11120170|FG000|STARTED|Overall Study||8
9998462|NCT01700179|11120170|FG000|COMPLETED|Overall Study||6
9998463|NCT01700179|11120170|FG000|NOT COMPLETED|Overall Study||2
9998464|NCT01700192|11120176|FG000|STARTED|Overall Study||741
9998465|NCT01700192|11120177|FG001|STARTED|Overall Study||741
9998466|NCT01700192|11120176|FG000|Treated|Overall Study||740
9998467|NCT01700192|11120177|FG001|Treated|Overall Study||741
9998468|NCT01700192|11120176|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
9998469|NCT01700192|11120177|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
9998470|NCT01700192|11120176|FG000|COMPLETED|Overall Study||561
9998471|NCT01700192|11120177|FG001|COMPLETED|Overall Study||613
9998472|NCT01700192|11120176|FG000|NOT COMPLETED|Overall Study||180
9998473|NCT01700192|11120177|FG001|NOT COMPLETED|Overall Study||128
9998474|NCT01700205|11120185|FG000|STARTED|Overall Study|Mother-Infant Dyads|59
9998475|NCT01700205|11120186|FG001|STARTED|Overall Study|Mother-Infant Dyads|54
9998476|NCT01700205|11120185|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44
9998477|NCT01700205|11120186|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39
9998478|NCT01700205|11120185|FG000|NOT COMPLETED|Overall Study||15
9998479|NCT01700205|11120186|FG001|NOT COMPLETED|Overall Study||15
9998480|NCT01700335|11120192|FG000|STARTED|Overall Study||3
9998481|NCT01700335|11120193|FG001|STARTED|Overall Study||6
9998482|NCT01700335|11120192|FG000|COMPLETED|Overall Study||2
9998483|NCT01700335|11120193|FG001|COMPLETED|Overall Study||2
9998484|NCT01700335|11120192|FG000|NOT COMPLETED|Overall Study||1
9998485|NCT01700335|11120193|FG001|NOT COMPLETED|Overall Study||4
9998486|NCT01700387|11120202|FG000|STARTED|Overall Study||10
9998487|NCT01700387|11120203|FG001|STARTED|Overall Study||10
9998488|NCT01700387|11120202|FG000|COMPLETED|Overall Study||6
9998489|NCT01700387|11120203|FG001|COMPLETED|Overall Study||6
9998490|NCT01700387|11120202|FG000|NOT COMPLETED|Overall Study||4
9998491|NCT01700387|11120203|FG001|NOT COMPLETED|Overall Study||4
9998492|NCT01700517|11120216|FG000|STARTED|Overall Study||40
9998493|NCT01700517|11120217|FG001|STARTED|Overall Study||40
9998494|NCT01700517|11120218|FG002|STARTED|Overall Study||40
9998495|NCT01700517|11120216|FG000|COMPLETED|Overall Study||40
9998496|NCT01700517|11120217|FG001|COMPLETED|Overall Study||40
9998497|NCT01700517|11120218|FG002|COMPLETED|Overall Study||40
9998498|NCT01700517|11120216|FG000|NOT COMPLETED|Overall Study||0
9998499|NCT01700517|11120217|FG001|NOT COMPLETED|Overall Study||0
9998500|NCT01700517|11120218|FG002|NOT COMPLETED|Overall Study||0
9998501|NCT01700530|11120229|FG000|STARTED|Overall Study||9
9998502|NCT01700530|11120230|FG001|STARTED|Overall Study||21
9998503|NCT01700530|11120231|FG002|STARTED|Overall Study||20
9998504|NCT01700530|11120229|FG000|COMPLETED|Overall Study||9
9998505|NCT01700530|11120230|FG001|COMPLETED|Overall Study||18
9998506|NCT01700530|11120231|FG002|COMPLETED|Overall Study||19
9998507|NCT01700530|11120229|FG000|NOT COMPLETED|Overall Study||0
9998508|NCT01700530|11120230|FG001|NOT COMPLETED|Overall Study||3
9998509|NCT01700530|11120231|FG002|NOT COMPLETED|Overall Study||1
9998510|NCT01700621|11120241|FG000|STARTED|Received Study Vaccines||240
9998511|NCT01700621|11120242|FG001|STARTED|Received Study Vaccines||240
9998512|NCT01700621|11120241|FG000|COMPLETED|Received Study Vaccines||240
9998513|NCT01700621|11120242|FG001|COMPLETED|Received Study Vaccines||240
9998514|NCT01700621|11120241|FG000|NOT COMPLETED|Received Study Vaccines||0
9998515|NCT01700621|11120242|FG001|NOT COMPLETED|Received Study Vaccines||0
9998516|NCT01700621|11120241|FG000|STARTED|Analyzed for Immunogenicity||240
9998517|NCT01700621|11120242|FG001|STARTED|Analyzed for Immunogenicity||240
9998518|NCT01700621|11120241|FG000|COMPLETED|Analyzed for Immunogenicity||227
9998519|NCT01700621|11120242|FG001|COMPLETED|Analyzed for Immunogenicity||233
9998520|NCT01700621|11120241|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13
9998521|NCT01700621|11120242|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7
9998522|NCT01700725|11120252|FG000|STARTED|Overall Study||14
9998523|NCT01700725|11120253|FG001|STARTED|Overall Study||14
9998524|NCT01700725|11120254|FG002|STARTED|Overall Study||12
9998525|NCT01700725|11120252|FG000|COMPLETED|Overall Study||14
9998526|NCT01700725|11120253|FG001|COMPLETED|Overall Study||14
9998527|NCT01700725|11120254|FG002|COMPLETED|Overall Study||12
9998528|NCT01700725|11120252|FG000|NOT COMPLETED|Overall Study||0
9998529|NCT01700725|11120253|FG001|NOT COMPLETED|Overall Study||0
9998530|NCT01700725|11120254|FG002|NOT COMPLETED|Overall Study||0
9998531|NCT01700816|11120264|FG000|STARTED|Overall Study||21
9998532|NCT01700816|11120265|FG001|STARTED|Overall Study||19
9998533|NCT01700816|11120264|FG000|COMPLETED|Overall Study||21
9998534|NCT01700816|11120265|FG001|COMPLETED|Overall Study||19
9998535|NCT01700816|11120264|FG000|NOT COMPLETED|Overall Study||0
9998536|NCT01700816|11120265|FG001|NOT COMPLETED|Overall Study||0
9998537|NCT01700829|11120273|FG000|STARTED|Overall Study||41
9998538|NCT01700829|11120274|FG001|STARTED|Overall Study||41
9998539|NCT01700829|11120273|FG000|COMPLETED|Overall Study||40
9998540|NCT01700829|11120274|FG001|COMPLETED|Overall Study||40
10103071|NCT02420093|11232606|FG001|COMPLETED|Overall Study||7
10103072|NCT02420093|11232605|FG000|NOT COMPLETED|Overall Study||1
10103073|NCT02420093|11232606|FG001|NOT COMPLETED|Overall Study||1
10103074|NCT02420210|11232612|FG000|STARTED|Overall Study||2
9998541|NCT01700829|11120273|FG000|NOT COMPLETED|Overall Study||1
9998542|NCT01700829|11120274|FG001|NOT COMPLETED|Overall Study||1
9998543|NCT01700907|11120282|FG000|STARTED|Overall Study||10
9998544|NCT01700907|11120283|FG001|STARTED|Overall Study||10
9998545|NCT01700907|11120282|FG000|COMPLETED|Overall Study||10
9998546|NCT01700907|11120283|FG001|COMPLETED|Overall Study||10
9998547|NCT01700907|11120282|FG000|NOT COMPLETED|Overall Study||0
9998548|NCT01700907|11120283|FG001|NOT COMPLETED|Overall Study||0
9998549|NCT01700959|11120295|FG000|STARTED|Overall Study||89
9998550|NCT01700959|11120296|FG001|STARTED|Overall Study||88
9998551|NCT01700959|11120297|FG002|STARTED|Overall Study||105
9998552|NCT01700959|11120298|FG003|STARTED|Overall Study||105
9998553|NCT01700959|11120299|FG004|STARTED|Overall Study||96
9998554|NCT01700959|11120300|FG005|STARTED|Overall Study||97
9998555|NCT01700959|11120295|FG000|COMPLETED|Overall Study||62
9998556|NCT01700959|11120296|FG001|COMPLETED|Overall Study||64
9998557|NCT01700959|11120297|FG002|COMPLETED|Overall Study||65
9998558|NCT01700959|11120298|FG003|COMPLETED|Overall Study||70
9998559|NCT01700959|11120299|FG004|COMPLETED|Overall Study||69
9998560|NCT01700959|11120300|FG005|COMPLETED|Overall Study||72
9998561|NCT01700959|11120295|FG000|NOT COMPLETED|Overall Study||27
9998562|NCT01700959|11120296|FG001|NOT COMPLETED|Overall Study||24
9998563|NCT01700959|11120297|FG002|NOT COMPLETED|Overall Study||40
9998564|NCT01700959|11120298|FG003|NOT COMPLETED|Overall Study||35
9998565|NCT01700959|11120299|FG004|NOT COMPLETED|Overall Study||27
9998566|NCT01700959|11120300|FG005|NOT COMPLETED|Overall Study||25
10018578|NCT01824472|11141671|FG002|NOT COMPLETED|Overall Study||4
10018579|NCT01824498|11141685|FG000|STARTED|1st Intervention (8 Weeks)||5
10018580|NCT01824498|11141686|FG001|STARTED|1st Intervention (8 Weeks)||2
10018581|NCT01824498|11141687|FG002|STARTED|1st Intervention (8 Weeks)||6
10018582|NCT01824498|11141688|FG003|STARTED|1st Intervention (8 Weeks)||3
10018583|NCT01824498|11141689|FG004|STARTED|1st Intervention (8 Weeks)||4
10018584|NCT01824498|11141690|FG005|STARTED|1st Intervention (8 Weeks)||4
10018585|NCT01824498|11141685|FG000|COMPLETED|1st Intervention (8 Weeks)||5
10018586|NCT01824498|11141686|FG001|COMPLETED|1st Intervention (8 Weeks)||2
10018587|NCT01824498|11141687|FG002|COMPLETED|1st Intervention (8 Weeks)||6
10018588|NCT01824498|11141688|FG003|COMPLETED|1st Intervention (8 Weeks)||3
10018589|NCT01824498|11141689|FG004|COMPLETED|1st Intervention (8 Weeks)||4
10018590|NCT01824498|11141690|FG005|COMPLETED|1st Intervention (8 Weeks)||4
10018591|NCT01824498|11141685|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0
10018592|NCT01824498|11141686|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0
10018593|NCT01824498|11141687|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0
10018594|NCT01824498|11141688|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0
10018595|NCT01824498|11141689|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0
10018596|NCT01824498|11141690|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0
10018597|NCT01824498|11141685|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5
10018598|NCT01824498|11141686|FG001|STARTED|Washout (8 Weeks)||2
10018599|NCT01824498|11141687|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6
10018600|NCT01824498|11141688|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3
10018601|NCT01824498|11141689|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4
10018602|NCT01824498|11141690|FG005|STARTED|Washout (8 Weeks)||4
10103075|NCT02420210|11232612|FG000|COMPLETED|Overall Study||2
10103076|NCT02420210|11232612|FG000|NOT COMPLETED|Overall Study||0
10103077|NCT02420223|11232618|FG000|STARTED|Overall Study||12
10103078|NCT02420223|11232619|FG001|STARTED|Overall Study||13
10103079|NCT02420223|11232618|FG000|COMPLETED|Overall Study||11
10103080|NCT02420223|11232619|FG001|COMPLETED|Overall Study||11
10103081|NCT02420223|11232618|FG000|NOT COMPLETED|Overall Study||1
10103082|NCT02420223|11232619|FG001|NOT COMPLETED|Overall Study||2
10103083|NCT02420262|11232627|FG000|STARTED|Overall Study||252
10103084|NCT02420262|11232628|FG001|STARTED|Overall Study||254
10103085|NCT02420262|11232627|FG000|Exposed|Overall Study||252
10103086|NCT02420262|11232628|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
10103087|NCT02420262|11232627|FG000|COMPLETED|Overall Study||250
10103088|NCT02420262|11232628|FG001|COMPLETED|Overall Study||249
10103089|NCT02420262|11232627|FG000|NOT COMPLETED|Overall Study||2
10103090|NCT02420262|11232628|FG001|NOT COMPLETED|Overall Study||5
10103091|NCT02420327|11232634|FG000|STARTED|Overall Study||43
10103092|NCT02420327|11232634|FG000|COMPLETED|Overall Study||27
10103093|NCT02420327|11232634|FG000|NOT COMPLETED|Overall Study||16
10103094|NCT02420353|11232646|FG000|STARTED|Overall Study||10
10103095|NCT02420353|11232647|FG001|STARTED|Overall Study||10
10103096|NCT02420353|11232646|FG000|Allocation to Intervention|Overall Study||10
10103097|NCT02420353|11232647|FG001|Allocation to Intervention|Overall Study||10
10018603|NCT01824498|11141685|FG000|COMPLETED|Washout (8 Weeks)||3
10018604|NCT01824498|11141686|FG001|COMPLETED|Washout (8 Weeks)||2
10018605|NCT01824498|11141687|FG002|COMPLETED|Washout (8 Weeks)||4
10018606|NCT01824498|11141688|FG003|COMPLETED|Washout (8 Weeks)||2
10018607|NCT01824498|11141689|FG004|COMPLETED|Washout (8 Weeks)||3
10103098|NCT02420353|11232646|FG000|COMPLETED|Overall Study||10
10103099|NCT02420353|11232647|FG001|COMPLETED|Overall Study||9
10103100|NCT02420353|11232646|FG000|NOT COMPLETED|Overall Study||0
10103101|NCT02420353|11232647|FG001|NOT COMPLETED|Overall Study||1
9998567|NCT01700985|11120318|FG000|STARTED|Overall Study||23
9998568|NCT01700985|11120319|FG001|STARTED|Overall Study||21
9998569|NCT01700985|11120318|FG000|COMPLETED|Overall Study||23
9998570|NCT01700985|11120319|FG001|COMPLETED|Overall Study||20
9998571|NCT01700985|11120318|FG000|NOT COMPLETED|Overall Study||0
9998572|NCT01700985|11120319|FG001|NOT COMPLETED|Overall Study||1
10103102|NCT02420379|11232655|FG000|STARTED|Overall Study||26
10103103|NCT02420379|11232656|FG001|STARTED|Overall Study||7
10103104|NCT02420379|11232655|FG000|COMPLETED|Overall Study||25
10103105|NCT02420379|11232656|FG001|COMPLETED|Overall Study||3
10103106|NCT02420379|11232655|FG000|NOT COMPLETED|Overall Study||1
10103107|NCT02420379|11232656|FG001|NOT COMPLETED|Overall Study||4
10103108|NCT02420639|11232662|FG000|STARTED|Overall Study|Study obtained 12 patients|12
10103109|NCT02420639|11232662|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12
10103110|NCT02420639|11232662|FG000|NOT COMPLETED|Overall Study||0
10103111|NCT02420691|11232666|FG000|STARTED|Overall Study||20
9998573|NCT01701011|11120328|FG000|STARTED|Overall Study||127
9998574|NCT01701011|11120329|FG001|STARTED|Overall Study||126
9998575|NCT01701011|11120330|FG002|STARTED|Overall Study||124
9998576|NCT01701011|11120328|FG000|COMPLETED|Overall Study||92
9998577|NCT01701011|11120329|FG001|COMPLETED|Overall Study||102
9998578|NCT01701011|11120330|FG002|COMPLETED|Overall Study||90
9998579|NCT01701011|11120328|FG000|NOT COMPLETED|Overall Study||35
9998580|NCT01701011|11120329|FG001|NOT COMPLETED|Overall Study||24
9998581|NCT01701011|11120330|FG002|NOT COMPLETED|Overall Study||34
9998582|NCT01701024|11120341|FG000|STARTED|Overall Study||253
9998583|NCT01701024|11120342|FG001|STARTED|Overall Study||245
9998584|NCT01701024|11120341|FG000|COMPLETED|Overall Study||243
9998585|NCT01701024|11120342|FG001|COMPLETED|Overall Study||236
9998586|NCT01701024|11120341|FG000|NOT COMPLETED|Overall Study||10
9998587|NCT01701024|11120342|FG001|NOT COMPLETED|Overall Study||9
9998588|NCT01701037|11120348|FG000|STARTED|Overall Study||13
9998589|NCT01701037|11120348|FG000|COMPLETED|Overall Study||13
9998590|NCT01701037|11120348|FG000|NOT COMPLETED|Overall Study||0
9998591|NCT01701063|11120356|FG000|STARTED|Overall Study||13
9998592|NCT01701063|11120357|FG001|STARTED|Overall Study||19
9998593|NCT01701063|11120358|FG002|STARTED|Overall Study||10
9998594|NCT01701063|11120356|FG000|COMPLETED|Overall Study||13
9998595|NCT01701063|11120357|FG001|COMPLETED|Overall Study||18
9998596|NCT01701063|11120358|FG002|COMPLETED|Overall Study||8
9998597|NCT01701063|11120356|FG000|NOT COMPLETED|Overall Study||0
9998598|NCT01701063|11120357|FG001|NOT COMPLETED|Overall Study||1
9998599|NCT01701063|11120358|FG002|NOT COMPLETED|Overall Study||2
9998600|NCT01701102|11120371|FG000|STARTED|Overall Study||22
9998601|NCT01701102|11120372|FG001|STARTED|Overall Study||6
9998602|NCT01701102|11120373|FG002|STARTED|Overall Study||10
9998603|NCT01701102|11120374|FG003|STARTED|Overall Study||18
9998604|NCT01701102|11120371|FG000|COMPLETED|Overall Study||22
9998605|NCT01701102|11120372|FG001|COMPLETED|Overall Study||6
9998606|NCT01701102|11120373|FG002|COMPLETED|Overall Study||10
10103112|NCT02420691|11232666|FG000|COMPLETED|Overall Study||14
10103113|NCT02420691|11232666|FG000|NOT COMPLETED|Overall Study||6
10103114|NCT02420873|11232673|FG000|STARTED|Overall Study||9
10103115|NCT02420873|11232674|FG001|STARTED|Overall Study||0
10103116|NCT02420873|11232675|FG002|STARTED|Overall Study||0
10103117|NCT02420873|11232673|FG000|COMPLETED|Overall Study||9
10103118|NCT02420873|11232674|FG001|COMPLETED|Overall Study||0
10103119|NCT02420873|11232675|FG002|COMPLETED|Overall Study||0
10103120|NCT02420873|11232673|FG000|NOT COMPLETED|Overall Study||0
10103121|NCT02420873|11232674|FG001|NOT COMPLETED|Overall Study||0
10103122|NCT02420873|11232675|FG002|NOT COMPLETED|Overall Study||0
10103123|NCT02420951|11232685|FG000|STARTED|Overall Study||25
10103124|NCT02420951|11232686|FG001|STARTED|Overall Study||25
10103125|NCT02420951|11232685|FG000|COMPLETED|Overall Study||25
10103126|NCT02420951|11232686|FG001|COMPLETED|Overall Study||25
10103127|NCT02420951|11232685|FG000|NOT COMPLETED|Overall Study||0
10103128|NCT02420951|11232686|FG001|NOT COMPLETED|Overall Study||0
10103129|NCT02421055|11232694|FG000|STARTED|Overall Study||34
10103130|NCT02421055|11232695|FG001|STARTED|Overall Study||50
10103131|NCT02421055|11232696|FG002|STARTED|Overall Study||74
10103132|NCT02421055|11232694|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34
10103133|NCT02421055|11232695|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50
10103134|NCT02421055|11232696|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74
9998607|NCT01701102|11120374|FG003|COMPLETED|Overall Study||18
9998608|NCT01701102|11120371|FG000|NOT COMPLETED|Overall Study||0
9998609|NCT01701102|11120372|FG001|NOT COMPLETED|Overall Study||0
9998610|NCT01701102|11120373|FG002|NOT COMPLETED|Overall Study||0
9998611|NCT01701102|11120374|FG003|NOT COMPLETED|Overall Study||0
9998612|NCT01701115|11120386|FG000|STARTED|Overall Study||77
9998613|NCT01701115|11120387|FG001|STARTED|Overall Study||77
10103135|NCT02421055|11232694|FG000|Pre-operative Complete Sample Set|Overall Study||23
10103136|NCT02421055|11232695|FG001|Pre-operative Complete Sample Set|Overall Study||22
10103137|NCT02421055|11232696|FG002|Pre-operative Complete Sample Set|Overall Study||36
10103138|NCT02421055|11232694|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0
10103139|NCT02421055|11232695|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23
10103140|NCT02421055|11232696|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26
10103141|NCT02421055|11232694|FG000|Post-operative Complete Sample Set|Overall Study||0
10103142|NCT02421055|11232695|FG001|Post-operative Complete Sample Set|Overall Study||13
10103143|NCT02421055|11232696|FG002|Post-operative Complete Sample Set|Overall Study||14
10103144|NCT02421055|11232694|FG000|COMPLETED|Overall Study||0
9998614|NCT01701115|11120386|FG000|COMPLETED|Overall Study||75
9998615|NCT01701115|11120387|FG001|COMPLETED|Overall Study||77
9998616|NCT01701115|11120386|FG000|NOT COMPLETED|Overall Study||2
9998617|NCT01701115|11120387|FG001|NOT COMPLETED|Overall Study||0
9998618|NCT01701193|11120397|FG000|STARTED|Overall Study||18
9998619|NCT01701193|11120398|FG001|STARTED|Overall Study||19
9998620|NCT01701193|11120399|FG002|STARTED|Overall Study||5
9998621|NCT01701193|11120400|FG003|STARTED|Overall Study||5
9998622|NCT01701193|11120397|FG000|COMPLETED|Overall Study||15
9998623|NCT01701193|11120398|FG001|COMPLETED|Overall Study||17
9998624|NCT01701193|11120399|FG002|COMPLETED|Overall Study||4
9998625|NCT01701193|11120400|FG003|COMPLETED|Overall Study||3
9998626|NCT01701193|11120397|FG000|NOT COMPLETED|Overall Study||3
9998627|NCT01701193|11120398|FG001|NOT COMPLETED|Overall Study||2
9998628|NCT01701193|11120399|FG002|NOT COMPLETED|Overall Study||1
9998629|NCT01701193|11120400|FG003|NOT COMPLETED|Overall Study||2
9998630|NCT01701245|11120415|FG000|STARTED|Overall Study||49
9998631|NCT01701245|11120416|FG001|STARTED|Overall Study||48
9998632|NCT01701245|11120415|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
9998633|NCT01701245|11120416|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
9998634|NCT01701245|11120415|FG000|FAS Matched Data|Overall Study||42
9998635|NCT01701245|11120416|FG001|FAS Matched Data|Overall Study||32
9998636|NCT01701245|11120415|FG000|COMPLETED|Overall Study||37
9998637|NCT01701245|11120416|FG001|COMPLETED|Overall Study||33
9998638|NCT01701245|11120415|FG000|NOT COMPLETED|Overall Study||12
9998639|NCT01701245|11120416|FG001|NOT COMPLETED|Overall Study||15
9998640|NCT01701258|11120426|FG000|STARTED|Assessment and Scheduling||153
9998641|NCT01701258|11120427|FG001|STARTED|Assessment and Scheduling||0
9998642|NCT01701258|11120428|FG002|STARTED|Assessment and Scheduling||0
9998643|NCT01701258|11120429|FG003|STARTED|Assessment and Scheduling||0
9998644|NCT01701258|11120430|FG004|STARTED|Assessment and Scheduling||0
9998645|NCT01701258|11120431|FG005|STARTED|Assessment and Scheduling||0
9998646|NCT01701258|11120432|FG006|STARTED|Assessment and Scheduling||0
9998647|NCT01701258|11120433|FG007|STARTED|Assessment and Scheduling||0
9998648|NCT01701258|11120434|FG008|STARTED|Assessment and Scheduling||0
9998649|NCT01701258|11120435|FG009|STARTED|Assessment and Scheduling||0
9998650|NCT01701258|11120436|FG010|STARTED|Assessment and Scheduling||0
10103145|NCT02421055|11232695|FG001|COMPLETED|Overall Study||50
10103146|NCT02421055|11232696|FG002|COMPLETED|Overall Study||74
10103147|NCT02421055|11232694|FG000|NOT COMPLETED|Overall Study||34
10103148|NCT02421055|11232695|FG001|NOT COMPLETED|Overall Study||0
10103149|NCT02421055|11232696|FG002|NOT COMPLETED|Overall Study||0
10103150|NCT02421094|11232707|FG000|STARTED|Overall Study||15
10103151|NCT02421094|11232708|FG001|STARTED|Overall Study||15
10103152|NCT02421094|11232707|FG000|COMPLETED|Overall Study||15
10103153|NCT02421094|11232708|FG001|COMPLETED|Overall Study||15
10103154|NCT02421094|11232707|FG000|NOT COMPLETED|Overall Study||0
10103155|NCT02421094|11232708|FG001|NOT COMPLETED|Overall Study||0
10103156|NCT02421120|11232714|FG000|STARTED|Overall Study||21
10103157|NCT02421120|11232714|FG000|COMPLETED|Overall Study||20
10103158|NCT02421120|11232714|FG000|NOT COMPLETED|Overall Study||1
10103159|NCT02421146|11232722|FG000|STARTED|Overall Study||2
10103160|NCT02421146|11232723|FG001|STARTED|Overall Study||4
10103161|NCT02421146|11232724|FG002|STARTED|Overall Study||3
10103162|NCT02421146|11232725|FG003|STARTED|Overall Study||3
10103163|NCT02421146|11232722|FG000|COMPLETED|Overall Study||2
10103164|NCT02421146|11232723|FG001|COMPLETED|Overall Study||4
10103165|NCT02421146|11232724|FG002|COMPLETED|Overall Study||3
10103166|NCT02421146|11232725|FG003|COMPLETED|Overall Study||3
10103167|NCT02421146|11232722|FG000|NOT COMPLETED|Overall Study||0
10103168|NCT02421146|11232723|FG001|NOT COMPLETED|Overall Study||0
10103169|NCT02421146|11232724|FG002|NOT COMPLETED|Overall Study||0
10103170|NCT02421146|11232725|FG003|NOT COMPLETED|Overall Study||0
10103171|NCT02421172|11232737|FG000|STARTED|Period 1||33
10103172|NCT02421172|11232738|FG001|STARTED|Period 1||33
10103173|NCT02421172|11232739|FG002|STARTED|Period 1||0
10103174|NCT02421172|11232740|FG003|STARTED|Period 1||0
9998651|NCT01701258|11120437|FG011|STARTED|Assessment and Scheduling||0
9998652|NCT01701258|11120438|FG012|STARTED|Assessment and Scheduling||0
9998653|NCT01701258|11120426|FG000|Eligible After Screening Visit|Assessment and Scheduling||96
9998654|NCT01701258|11120427|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
9998655|NCT01701258|11120428|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
9998656|NCT01701258|11120429|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
9998657|NCT01701258|11120430|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
9998658|NCT01701258|11120431|FG005|Eligible After Screening Visit|Assessment and Scheduling||0
9998659|NCT01701258|11120432|FG006|Eligible After Screening Visit|Assessment and Scheduling||0
9998660|NCT01701258|11120433|FG007|Eligible After Screening Visit|Assessment and Scheduling||0
9998661|NCT01701258|11120434|FG008|Eligible After Screening Visit|Assessment and Scheduling||0
10103175|NCT02421172|11232741|FG004|STARTED|Period 1||0
10103176|NCT02421172|11232737|FG000|PD Analysis Set Period 1|Period 1||31
10103177|NCT02421172|11232738|FG001|PD Analysis Set Period 1|Period 1||33
10103178|NCT02421172|11232739|FG002|PD Analysis Set Period 1|Period 1||0
10103179|NCT02421172|11232740|FG003|PD Analysis Set Period 1|Period 1||0
10103180|NCT02421172|11232741|FG004|PD Analysis Set Period 1|Period 1||0
10103181|NCT02421172|11232737|FG000|PK Analysis Set Period 1|Period 1||33
10103182|NCT02421172|11232738|FG001|PK Analysis Set Period 1|Period 1||0
10103183|NCT02421172|11232739|FG002|PK Analysis Set Period 1|Period 1||0
10103184|NCT02421172|11232740|FG003|PK Analysis Set Period 1|Period 1||0
9998662|NCT01701258|11120435|FG009|Eligible After Screening Visit|Assessment and Scheduling||0
9998663|NCT01701258|11120436|FG010|Eligible After Screening Visit|Assessment and Scheduling||0
9998664|NCT01701258|11120437|FG011|Eligible After Screening Visit|Assessment and Scheduling||0
9998665|NCT01701258|11120438|FG012|Eligible After Screening Visit|Assessment and Scheduling||0
9998666|NCT01701258|11120426|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
9998667|NCT01701258|11120427|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998668|NCT01701258|11120428|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998669|NCT01701258|11120429|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998670|NCT01701258|11120430|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998671|NCT01701258|11120431|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998672|NCT01701258|11120432|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998673|NCT01701258|11120433|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998674|NCT01701258|11120434|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998675|NCT01701258|11120435|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998676|NCT01701258|11120436|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998677|NCT01701258|11120437|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998678|NCT01701258|11120438|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
9998679|NCT01701258|11120426|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73
9998680|NCT01701258|11120427|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0
9998681|NCT01701258|11120428|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0
10103185|NCT02421172|11232741|FG004|PK Analysis Set Period 1|Period 1||0
10103186|NCT02421172|11232737|FG000|COMPLETED|Period 1||29
10103187|NCT02421172|11232738|FG001|COMPLETED|Period 1||31
10103188|NCT02421172|11232739|FG002|COMPLETED|Period 1||0
10103189|NCT02421172|11232740|FG003|COMPLETED|Period 1||0
10103190|NCT02421172|11232741|FG004|COMPLETED|Period 1||0
10103191|NCT02421172|11232737|FG000|NOT COMPLETED|Period 1||4
10103192|NCT02421172|11232738|FG001|NOT COMPLETED|Period 1||2
10103193|NCT02421172|11232739|FG002|NOT COMPLETED|Period 1||0
10103194|NCT02421172|11232740|FG003|NOT COMPLETED|Period 1||0
10103195|NCT02421172|11232741|FG004|NOT COMPLETED|Period 1||0
10103196|NCT02421172|11232737|FG000|STARTED|Period 2||0
10103197|NCT02421172|11232738|FG001|STARTED|Period 2||0
10103198|NCT02421172|11232739|FG002|STARTED|Period 2||29
10103199|NCT02421172|11232740|FG003|STARTED|Period 2||16
10103200|NCT02421172|11232741|FG004|STARTED|Period 2||15
10103201|NCT02421172|11232737|FG000|COMPLETED|Period 2||0
10103202|NCT02421172|11232738|FG001|COMPLETED|Period 2||0
10103203|NCT02421172|11232739|FG002|COMPLETED|Period 2||22
10103204|NCT02421172|11232740|FG003|COMPLETED|Period 2||13
9998682|NCT01701258|11120429|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0
9998683|NCT01701258|11120430|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0
9998684|NCT01701258|11120431|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0
9998685|NCT01701258|11120432|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0
9998686|NCT01701258|11120433|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0
9998687|NCT01701258|11120434|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0
9998688|NCT01701258|11120435|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0
9998689|NCT01701258|11120436|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0
9998690|NCT01701258|11120437|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0
9998691|NCT01701258|11120438|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0
9998692|NCT01701258|11120426|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66
9998693|NCT01701258|11120427|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998694|NCT01701258|11120428|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998695|NCT01701258|11120429|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998696|NCT01701258|11120430|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998697|NCT01701258|11120431|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998698|NCT01701258|11120432|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998699|NCT01701258|11120433|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0
10103205|NCT02421172|11232741|FG004|COMPLETED|Period 2||14
10103206|NCT02421172|11232737|FG000|NOT COMPLETED|Period 2||0
10103207|NCT02421172|11232738|FG001|NOT COMPLETED|Period 2||0
10103208|NCT02421172|11232739|FG002|NOT COMPLETED|Period 2||7
9998700|NCT01701258|11120434|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998701|NCT01701258|11120435|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998702|NCT01701258|11120436|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998703|NCT01701258|11120437|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0
9998704|NCT01701258|11120438|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0
10103209|NCT02421172|11232740|FG003|NOT COMPLETED|Period 2||3
10103210|NCT02421172|11232741|FG004|NOT COMPLETED|Period 2||1
10103211|NCT02421211|11232754|FG000|STARTED|Overall Study||20
10103212|NCT02421211|11232755|FG001|STARTED|Overall Study||20
10103213|NCT02421211|11232754|FG000|COMPLETED|Overall Study||20
10103214|NCT02421211|11232755|FG001|COMPLETED|Overall Study||20
10103215|NCT02421211|11232754|FG000|NOT COMPLETED|Overall Study||0
10103216|NCT02421211|11232755|FG001|NOT COMPLETED|Overall Study||0
10103217|NCT02421224|11232774|FG000|STARTED|Overall Study||444
10103218|NCT02421224|11232775|FG001|STARTED|Overall Study||397
10103219|NCT02421224|11232776|FG002|STARTED|Overall Study||508
10103220|NCT02421224|11232777|FG003|STARTED|Overall Study||482
9998705|NCT01701258|11120426|FG000|COMPLETED|Assessment and Scheduling||70
9998706|NCT01701258|11120427|FG001|COMPLETED|Assessment and Scheduling||0
9998707|NCT01701258|11120428|FG002|COMPLETED|Assessment and Scheduling||0
9998708|NCT01701258|11120429|FG003|COMPLETED|Assessment and Scheduling||0
9998709|NCT01701258|11120430|FG004|COMPLETED|Assessment and Scheduling||0
9998710|NCT01701258|11120431|FG005|COMPLETED|Assessment and Scheduling||0
9998711|NCT01701258|11120432|FG006|COMPLETED|Assessment and Scheduling||0
9998712|NCT01701258|11120433|FG007|COMPLETED|Assessment and Scheduling||0
9998713|NCT01701258|11120434|FG008|COMPLETED|Assessment and Scheduling||0
9998714|NCT01701258|11120435|FG009|COMPLETED|Assessment and Scheduling||0
9998715|NCT01701258|11120436|FG010|COMPLETED|Assessment and Scheduling||0
9998716|NCT01701258|11120437|FG011|COMPLETED|Assessment and Scheduling||0
9998717|NCT01701258|11120438|FG012|COMPLETED|Assessment and Scheduling||0
9998718|NCT01701258|11120426|FG000|NOT COMPLETED|Assessment and Scheduling||83
9998719|NCT01701258|11120427|FG001|NOT COMPLETED|Assessment and Scheduling||0
9998720|NCT01701258|11120428|FG002|NOT COMPLETED|Assessment and Scheduling||0
9998721|NCT01701258|11120429|FG003|NOT COMPLETED|Assessment and Scheduling||0
9998722|NCT01701258|11120430|FG004|NOT COMPLETED|Assessment and Scheduling||0
9998723|NCT01701258|11120431|FG005|NOT COMPLETED|Assessment and Scheduling||0
9998724|NCT01701258|11120432|FG006|NOT COMPLETED|Assessment and Scheduling||0
9998725|NCT01701258|11120433|FG007|NOT COMPLETED|Assessment and Scheduling||0
9998726|NCT01701258|11120434|FG008|NOT COMPLETED|Assessment and Scheduling||0
9998727|NCT01701258|11120435|FG009|NOT COMPLETED|Assessment and Scheduling||0
9998728|NCT01701258|11120436|FG010|NOT COMPLETED|Assessment and Scheduling||0
9998729|NCT01701258|11120437|FG011|NOT COMPLETED|Assessment and Scheduling||0
9998730|NCT01701258|11120438|FG012|NOT COMPLETED|Assessment and Scheduling||0
9998731|NCT01701258|11120426|FG000|STARTED|Drug+fMRI (Session 2)||0
9998732|NCT01701258|11120427|FG001|STARTED|Drug+fMRI (Session 2)||0
9998733|NCT01701258|11120428|FG002|STARTED|Drug+fMRI (Session 2)||11
9998734|NCT01701258|11120429|FG003|STARTED|Drug+fMRI (Session 2)||11
9998735|NCT01701258|11120430|FG004|STARTED|Drug+fMRI (Session 2)||0
9998736|NCT01701258|11120431|FG005|STARTED|Drug+fMRI (Session 2)||9
9998737|NCT01701258|11120432|FG006|STARTED|Drug+fMRI (Session 2)||8
9998738|NCT01701258|11120433|FG007|STARTED|Drug+fMRI (Session 2)||0
9998739|NCT01701258|11120434|FG008|STARTED|Drug+fMRI (Session 2)||6
9998740|NCT01701258|11120435|FG009|STARTED|Drug+fMRI (Session 2)||6
9998741|NCT01701258|11120436|FG010|STARTED|Drug+fMRI (Session 2)||0
9998742|NCT01701258|11120437|FG011|STARTED|Drug+fMRI (Session 2)||10
9998743|NCT01701258|11120438|FG012|STARTED|Drug+fMRI (Session 2)||7
9998744|NCT01701258|11120426|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0
9998745|NCT01701258|11120427|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0
9998746|NCT01701258|11120428|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11
10103221|NCT02421224|11232778|FG004|STARTED|Overall Study||495
10103222|NCT02421224|11232779|FG005|STARTED|Overall Study||515
10103223|NCT02421224|11232780|FG006|STARTED|Overall Study||489
10103224|NCT02421224|11232781|FG007|STARTED|Overall Study||364
10103225|NCT02421224|11232782|FG008|STARTED|Overall Study||496
10103226|NCT02421224|11232774|FG000|COMPLETED|Overall Study||442
10103227|NCT02421224|11232775|FG001|COMPLETED|Overall Study||394
10103228|NCT02421224|11232776|FG002|COMPLETED|Overall Study||507
10103229|NCT02421224|11232777|FG003|COMPLETED|Overall Study||479
10103230|NCT02421224|11232778|FG004|COMPLETED|Overall Study||491
10103231|NCT02421224|11232779|FG005|COMPLETED|Overall Study||513
10103232|NCT02421224|11232780|FG006|COMPLETED|Overall Study||489
10103233|NCT02421224|11232781|FG007|COMPLETED|Overall Study||362
10103234|NCT02421224|11232782|FG008|COMPLETED|Overall Study||495
10103235|NCT02421224|11232774|FG000|NOT COMPLETED|Overall Study||2
10103236|NCT02421224|11232775|FG001|NOT COMPLETED|Overall Study||3
10103237|NCT02421224|11232776|FG002|NOT COMPLETED|Overall Study||1
10103238|NCT02421224|11232777|FG003|NOT COMPLETED|Overall Study||3
10103239|NCT02421224|11232778|FG004|NOT COMPLETED|Overall Study||4
10103240|NCT02421224|11232779|FG005|NOT COMPLETED|Overall Study||2
10103241|NCT02421224|11232780|FG006|NOT COMPLETED|Overall Study||0
10103242|NCT02421224|11232781|FG007|NOT COMPLETED|Overall Study||2
10103243|NCT02421224|11232782|FG008|NOT COMPLETED|Overall Study||1
9998747|NCT01701258|11120429|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11
9998748|NCT01701258|11120430|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0
9998749|NCT01701258|11120431|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9
9998750|NCT01701258|11120432|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8
9998751|NCT01701258|11120433|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0
9998752|NCT01701258|11120434|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6
9998753|NCT01701258|11120435|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6
9998754|NCT01701258|11120436|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0
9998755|NCT01701258|11120437|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10
9998756|NCT01701258|11120438|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7
9998757|NCT01701258|11120426|FG000|COMPLETED|Drug+fMRI (Session 2)||0
9998758|NCT01701258|11120427|FG001|COMPLETED|Drug+fMRI (Session 2)||0
9998759|NCT01701258|11120428|FG002|COMPLETED|Drug+fMRI (Session 2)||11
9998760|NCT01701258|11120429|FG003|COMPLETED|Drug+fMRI (Session 2)||11
9998761|NCT01701258|11120430|FG004|COMPLETED|Drug+fMRI (Session 2)||0
10103244|NCT02421354|11232802|FG000|STARTED|Overall Study||8
10103245|NCT02421354|11232802|FG000|COMPLETED|Overall Study||8
10103246|NCT02421354|11232802|FG000|NOT COMPLETED|Overall Study||0
10103247|NCT02421419|11232809|FG000|STARTED|Overall Study||6
10103248|NCT02421419|11232810|FG001|STARTED|Overall Study||11
9998762|NCT01701258|11120431|FG005|COMPLETED|Drug+fMRI (Session 2)||9
9998763|NCT01701258|11120432|FG006|COMPLETED|Drug+fMRI (Session 2)||8
9998764|NCT01701258|11120433|FG007|COMPLETED|Drug+fMRI (Session 2)||0
9998765|NCT01701258|11120434|FG008|COMPLETED|Drug+fMRI (Session 2)||6
9998766|NCT01701258|11120435|FG009|COMPLETED|Drug+fMRI (Session 2)||6
9998767|NCT01701258|11120436|FG010|COMPLETED|Drug+fMRI (Session 2)||0
9998768|NCT01701258|11120437|FG011|COMPLETED|Drug+fMRI (Session 2)||10
9998769|NCT01701258|11120438|FG012|COMPLETED|Drug+fMRI (Session 2)||7
9998770|NCT01701258|11120426|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0
10103249|NCT02421419|11232811|FG002|STARTED|Overall Study||9
10103250|NCT02421419|11232809|FG000|COMPLETED|Overall Study||6
10103251|NCT02421419|11232810|FG001|COMPLETED|Overall Study||11
10103252|NCT02421419|11232811|FG002|COMPLETED|Overall Study||8
10103253|NCT02421419|11232809|FG000|NOT COMPLETED|Overall Study||0
10103254|NCT02421419|11232810|FG001|NOT COMPLETED|Overall Study||0
10103255|NCT02421419|11232811|FG002|NOT COMPLETED|Overall Study||1
10103256|NCT02421510|11232822|FG000|STARTED|Overall Study||258
10103257|NCT02421510|11232823|FG001|STARTED|Overall Study||261
10103258|NCT02421510|11232824|FG002|STARTED|Overall Study||263
10103259|NCT02421510|11232822|FG000|Completed the 24 Week Treatment Period|Overall Study||236
10103260|NCT02421510|11232823|FG001|Completed the 24 Week Treatment Period|Overall Study||239
10103261|NCT02421510|11232824|FG002|Completed the 24 Week Treatment Period|Overall Study||240
10103262|NCT02421510|11232822|FG000|COMPLETED|Overall Study||225
10103263|NCT02421510|11232823|FG001|COMPLETED|Overall Study||226
10103264|NCT02421510|11232824|FG002|COMPLETED|Overall Study||227
10103265|NCT02421510|11232822|FG000|NOT COMPLETED|Overall Study||33
10103266|NCT02421510|11232823|FG001|NOT COMPLETED|Overall Study||35
10103267|NCT02421510|11232824|FG002|NOT COMPLETED|Overall Study||36
10103268|NCT02421588|11232834|FG000|STARTED|Overall Study||221
10103269|NCT02421588|11232835|FG001|STARTED|Overall Study||221
10103270|NCT02421588|11232834|FG000|COMPLETED|Overall Study||0
10103271|NCT02421588|11232835|FG001|COMPLETED|Overall Study||0
10103272|NCT02421588|11232834|FG000|NOT COMPLETED|Overall Study||221
10103273|NCT02421588|11232835|FG001|NOT COMPLETED|Overall Study||221
10103274|NCT02421601|11232841|FG000|STARTED|Overall Study||991
10103275|NCT02421601|11232841|FG000|COMPLETED|Overall Study||909
10103276|NCT02421601|11232841|FG000|NOT COMPLETED|Overall Study||82
10103277|NCT02421666|11232847|FG000|STARTED|Overall Study Baseline||272
10103278|NCT02421666|11232848|FG001|STARTED|Overall Study Baseline||260
10103279|NCT02421666|11232847|FG000|COMPLETED|Overall Study Baseline||272
10103280|NCT02421666|11232848|FG001|COMPLETED|Overall Study Baseline||260
10103281|NCT02421666|11232847|FG000|NOT COMPLETED|Overall Study Baseline||0
10103282|NCT02421666|11232848|FG001|NOT COMPLETED|Overall Study Baseline||0
10103283|NCT02421666|11232847|FG000|STARTED|6-month Follow-up||272
10103284|NCT02421666|11232848|FG001|STARTED|6-month Follow-up||260
10103285|NCT02421666|11232847|FG000|COMPLETED|6-month Follow-up||259
10103286|NCT02421666|11232848|FG001|COMPLETED|6-month Follow-up||247
10103287|NCT02421666|11232847|FG000|NOT COMPLETED|6-month Follow-up||13
10103288|NCT02421666|11232848|FG001|NOT COMPLETED|6-month Follow-up||13
10103289|NCT02421666|11232847|FG000|STARTED|12-month Follow-up||259
10103290|NCT02421666|11232848|FG001|STARTED|12-month Follow-up||247
10103291|NCT02421666|11232847|FG000|COMPLETED|12-month Follow-up||248
10103292|NCT02421666|11232848|FG001|COMPLETED|12-month Follow-up||231
10103293|NCT02421666|11232847|FG000|NOT COMPLETED|12-month Follow-up||11
10103294|NCT02421666|11232848|FG001|NOT COMPLETED|12-month Follow-up||16
10103295|NCT02421757|11232856|FG000|STARTED|Overall Study||11
10103296|NCT02421757|11232857|FG001|STARTED|Overall Study||9
10103297|NCT02421757|11232856|FG000|COMPLETED|Overall Study||11
10103298|NCT02421757|11232857|FG001|COMPLETED|Overall Study||9
10103299|NCT02421757|11232856|FG000|NOT COMPLETED|Overall Study||0
10103300|NCT02421757|11232857|FG001|NOT COMPLETED|Overall Study||0
10103301|NCT02421887|11232865|FG000|STARTED|Overall Study||85
10103302|NCT02421887|11232866|FG001|STARTED|Overall Study||86
10103303|NCT02421887|11232865|FG000|COMPLETED|Overall Study||68
10103304|NCT02421887|11232866|FG001|COMPLETED|Overall Study||77
10103305|NCT02421887|11232865|FG000|NOT COMPLETED|Overall Study||17
10103306|NCT02421887|11232866|FG001|NOT COMPLETED|Overall Study||9
10103307|NCT02421952|11232872|FG000|STARTED|Overall Study||208
10103308|NCT02421952|11232872|FG000|Excluded From PACU and Post-Analysis|Overall Study||16
9998771|NCT01701258|11120427|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998772|NCT01701258|11120428|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998773|NCT01701258|11120429|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998774|NCT01701258|11120430|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998775|NCT01701258|11120431|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0
10103309|NCT02421952|11232872|FG000|Included in PACU Analysis|Overall Study||192
10103310|NCT02421952|11232872|FG000|COMPLETED|Overall Study||99
10103311|NCT02421952|11232872|FG000|NOT COMPLETED|Overall Study||109
10103312|NCT02422186|11232881|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72
10103313|NCT02422186|11232882|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66
10103314|NCT02422186|11232881|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
10103315|NCT02422186|11232882|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
10103316|NCT02422186|11232881|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
10103317|NCT02422186|11232882|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
10103318|NCT02422186|11232881|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
9998776|NCT01701258|11120432|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998777|NCT01701258|11120433|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998778|NCT01701258|11120434|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998779|NCT01701258|11120435|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998780|NCT01701258|11120436|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0
10103319|NCT02422186|11232882|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
10103320|NCT02422186|11232881|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
10103321|NCT02422186|11232882|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
10103322|NCT02422186|11232881|FG000|STARTED|Follow-up Phase (2 Weeks)||12
10103323|NCT02422186|11232882|FG001|STARTED|Follow-up Phase (2 Weeks)||3
10103324|NCT02422186|11232881|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8
9998781|NCT01701258|11120437|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998782|NCT01701258|11120438|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0
9998783|NCT01701258|11120426|FG000|STARTED|PET (Session 3)||0
9998784|NCT01701258|11120427|FG001|STARTED|PET (Session 3)||20
9998785|NCT01701258|11120428|FG002|STARTED|PET (Session 3)||0
9998786|NCT01701258|11120429|FG003|STARTED|PET (Session 3)||0
9998787|NCT01701258|11120430|FG004|STARTED|PET (Session 3)||16
9998788|NCT01701258|11120431|FG005|STARTED|PET (Session 3)||0
9998789|NCT01701258|11120432|FG006|STARTED|PET (Session 3)||0
9998790|NCT01701258|11120433|FG007|STARTED|PET (Session 3)||19
10103325|NCT02422186|11232882|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3
10103326|NCT02422186|11232881|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
10103327|NCT02422186|11232882|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
10103328|NCT02422264|11232892|FG000|STARTED|Overall Study||296
10103329|NCT02422264|11232893|FG001|STARTED|Overall Study||305
10103330|NCT02422264|11232892|FG000|COMPLETED|Overall Study||291
10103331|NCT02422264|11232893|FG001|COMPLETED|Overall Study||301
10103332|NCT02422264|11232892|FG000|NOT COMPLETED|Overall Study||5
10103333|NCT02422264|11232893|FG001|NOT COMPLETED|Overall Study||4
10103334|NCT02422290|11232899|FG000|STARTED|Overall Study||5
10103335|NCT02422290|11232899|FG000|COMPLETED|Overall Study||5
10103336|NCT02422290|11232899|FG000|NOT COMPLETED|Overall Study||0
10103337|NCT02422511|11232911|FG000|STARTED|Overall Study||255
10103338|NCT02422511|11232912|FG001|STARTED|Overall Study||128
10103339|NCT02422511|11232913|FG002|STARTED|Overall Study||257
10103340|NCT02422511|11232914|FG003|STARTED|Overall Study||129
10103341|NCT02422511|11232915|FG004|STARTED|Overall Study||66
10103342|NCT02422511|11232916|FG005|STARTED|Overall Study||33
10103343|NCT02422511|11232917|FG006|STARTED|Overall Study||68
10103344|NCT02422511|11232918|FG007|STARTED|Overall Study||34
10103345|NCT02422511|11232911|FG000|Received Disclosure|Overall Study||158
10103346|NCT02422511|11232912|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
10103347|NCT02422511|11232913|FG002|Received Disclosure|Overall Study||194
10103348|NCT02422511|11232914|FG003|Received Disclosure|Overall Study||97
10103349|NCT02422511|11232915|FG004|Received Disclosure|Overall Study||43
10103350|NCT02422511|11232916|FG005|Received Disclosure|Overall Study||21
10103351|NCT02422511|11232917|FG006|Received Disclosure|Overall Study||38
10103352|NCT02422511|11232918|FG007|Received Disclosure|Overall Study||19
10103353|NCT02422511|11232911|FG000|COMPLETED|Overall Study||143
10103354|NCT02422511|11232912|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0
10103355|NCT02422511|11232913|FG002|COMPLETED|Overall Study||168
10103356|NCT02422511|11232914|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0
10103357|NCT02422511|11232915|FG004|COMPLETED|Overall Study||39
10103358|NCT02422511|11232916|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0
10103359|NCT02422511|11232917|FG006|COMPLETED|Overall Study||38
10103360|NCT02422511|11232918|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0
10103361|NCT02422511|11232911|FG000|NOT COMPLETED|Overall Study||112
10103362|NCT02422511|11232912|FG001|NOT COMPLETED|Overall Study||128
10103363|NCT02422511|11232913|FG002|NOT COMPLETED|Overall Study||89
10103364|NCT02422511|11232914|FG003|NOT COMPLETED|Overall Study||129
10103365|NCT02422511|11232915|FG004|NOT COMPLETED|Overall Study||27
10103366|NCT02422511|11232916|FG005|NOT COMPLETED|Overall Study||33
10103367|NCT02422511|11232917|FG006|NOT COMPLETED|Overall Study||30
10103368|NCT02422511|11232918|FG007|NOT COMPLETED|Overall Study||34
10103369|NCT02422940|11232938|FG000|STARTED|Overall Study||152
10103370|NCT02422940|11232939|FG001|STARTED|Overall Study||142
10103371|NCT02422940|11232938|FG000|COMPLETED|Overall Study||31
10103372|NCT02422940|11232939|FG001|COMPLETED|Overall Study||21
10103373|NCT02422940|11232938|FG000|NOT COMPLETED|Overall Study||121
10103374|NCT02422940|11232939|FG001|NOT COMPLETED|Overall Study||121
10113293|NCT02509117|11244199|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10113294|NCT02509117|11244190|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2
10113295|NCT02509117|11244191|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1
10113296|NCT02509117|11244192|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2
10113297|NCT02509117|11244193|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2
10113298|NCT02509117|11244194|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0
9998791|NCT01701258|11120434|FG008|STARTED|PET (Session 3)||0
9998792|NCT01701258|11120435|FG009|STARTED|PET (Session 3)||0
10113299|NCT02509117|11244195|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0
10113300|NCT02509117|11244196|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0
10113301|NCT02509117|11244197|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0
9998793|NCT01701258|11120436|FG010|STARTED|PET (Session 3)||18
9998794|NCT01701258|11120437|FG011|STARTED|PET (Session 3)||0
9998795|NCT01701258|11120438|FG012|STARTED|PET (Session 3)||0
9998796|NCT01701258|11120426|FG000|COMPLETED|PET (Session 3)||0
9998797|NCT01701258|11120427|FG001|COMPLETED|PET (Session 3)||20
9998798|NCT01701258|11120428|FG002|COMPLETED|PET (Session 3)||0
10113302|NCT02509117|11244198|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0
9998799|NCT01701258|11120429|FG003|COMPLETED|PET (Session 3)||0
9998800|NCT01701258|11120430|FG004|COMPLETED|PET (Session 3)||16
9998801|NCT01701258|11120431|FG005|COMPLETED|PET (Session 3)||0
9998802|NCT01701258|11120432|FG006|COMPLETED|PET (Session 3)||0
9998803|NCT01701258|11120433|FG007|COMPLETED|PET (Session 3)||19
9998804|NCT01701258|11120434|FG008|COMPLETED|PET (Session 3)||0
9998805|NCT01701258|11120435|FG009|COMPLETED|PET (Session 3)||0
9998806|NCT01701258|11120436|FG010|COMPLETED|PET (Session 3)||18
9998807|NCT01701258|11120437|FG011|COMPLETED|PET (Session 3)||0
9998808|NCT01701258|11120438|FG012|COMPLETED|PET (Session 3)||0
9998809|NCT01701258|11120426|FG000|NOT COMPLETED|PET (Session 3)||0
9998810|NCT01701258|11120427|FG001|NOT COMPLETED|PET (Session 3)||0
9998811|NCT01701258|11120428|FG002|NOT COMPLETED|PET (Session 3)||0
9998812|NCT01701258|11120429|FG003|NOT COMPLETED|PET (Session 3)||0
10103375|NCT02423109|11232945|FG000|STARTED|Lens 1||19
10103376|NCT02423109|11232946|FG001|STARTED|Lens 1||14
10103377|NCT02423109|11232945|FG000|COMPLETED|Lens 1||18
10103378|NCT02423109|11232946|FG001|COMPLETED|Lens 1||14
10103379|NCT02423109|11232945|FG000|NOT COMPLETED|Lens 1||1
10103380|NCT02423109|11232946|FG001|NOT COMPLETED|Lens 1||0
10103381|NCT02423109|11232945|FG000|STARTED|Lens 2||18
10103382|NCT02423109|11232946|FG001|STARTED|Lens 2||14
10103383|NCT02423109|11232945|FG000|COMPLETED|Lens 2||18
10103384|NCT02423109|11232946|FG001|COMPLETED|Lens 2||14
10103385|NCT02423109|11232945|FG000|NOT COMPLETED|Lens 2||0
10103386|NCT02423109|11232946|FG001|NOT COMPLETED|Lens 2||0
10103387|NCT02423122|11232956|FG000|STARTED|Overall Study||9
10103388|NCT02423122|11232957|FG001|STARTED|Overall Study||7
10103389|NCT02423122|11232956|FG000|COMPLETED|Overall Study||9
10103390|NCT02423122|11232957|FG001|COMPLETED|Overall Study||7
10103391|NCT02423122|11232956|FG000|NOT COMPLETED|Overall Study||0
10103392|NCT02423122|11232957|FG001|NOT COMPLETED|Overall Study||0
10103393|NCT02423200|11232965|FG000|STARTED|Overall Study||8
10103394|NCT02423200|11232966|FG001|STARTED|Overall Study||1
10103395|NCT02423200|11232965|FG000|COMPLETED|Overall Study||7
10103396|NCT02423200|11232966|FG001|COMPLETED|Overall Study||1
10103397|NCT02423200|11232965|FG000|NOT COMPLETED|Overall Study||1
10103398|NCT02423200|11232966|FG001|NOT COMPLETED|Overall Study||0
10103399|NCT02423291|11232973|FG000|STARTED|Overall Study|Patients enrolled|15
10103400|NCT02423291|11232973|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0
10103401|NCT02423291|11232973|FG000|NOT COMPLETED|Overall Study||15
10103402|NCT02423317|11232979|FG000|STARTED|Overall Study||30
10103403|NCT02423317|11232980|FG001|STARTED|Overall Study||30
10103404|NCT02423317|11232979|FG000|COMPLETED|Overall Study||30
10103405|NCT02423317|11232980|FG001|COMPLETED|Overall Study||30
10103406|NCT02423317|11232979|FG000|NOT COMPLETED|Overall Study||0
10103407|NCT02423317|11232980|FG001|NOT COMPLETED|Overall Study||0
10103408|NCT02423343|11232992|FG000|STARTED|Overall Study||3
10103409|NCT02423343|11232993|FG001|STARTED|Overall Study||5
10103410|NCT02423343|11232994|FG002|STARTED|Overall Study||3
10103411|NCT02423343|11232995|FG003|STARTED|Overall Study||4
10103412|NCT02423343|11232996|FG004|STARTED|Overall Study||25
10103413|NCT02423343|11232997|FG005|STARTED|Overall Study||1
10103414|NCT02423343|11232992|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10103415|NCT02423343|11232993|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10103416|NCT02423343|11232994|FG002|Received at Least One Dose of Study Drug|Overall Study||3
10103417|NCT02423343|11232995|FG003|Received at Least One Dose of Study Drug|Overall Study||4
10103418|NCT02423343|11232996|FG004|Received at Least One Dose of Study Drug|Overall Study||25
10103419|NCT02423343|11232997|FG005|Received at Least One Dose of Study Drug|Overall Study||1
10103420|NCT02423343|11232992|FG000|COMPLETED|Overall Study||3
10103421|NCT02423343|11232993|FG001|COMPLETED|Overall Study||4
10103422|NCT02423343|11232994|FG002|COMPLETED|Overall Study||3
10103423|NCT02423343|11232995|FG003|COMPLETED|Overall Study||4
10103424|NCT02423343|11232996|FG004|COMPLETED|Overall Study||20
10103425|NCT02423343|11232997|FG005|COMPLETED|Overall Study||1
10103426|NCT02423343|11232992|FG000|NOT COMPLETED|Overall Study||0
10103427|NCT02423343|11232993|FG001|NOT COMPLETED|Overall Study||1
10103428|NCT02423343|11232994|FG002|NOT COMPLETED|Overall Study||0
10103429|NCT02423343|11232995|FG003|NOT COMPLETED|Overall Study||0
10103430|NCT02423343|11232996|FG004|NOT COMPLETED|Overall Study||5
10103431|NCT02423343|11232997|FG005|NOT COMPLETED|Overall Study||0
10103432|NCT02423408|11233027|FG000|STARTED|Overall Study||83
10103433|NCT02423408|11233028|FG001|STARTED|Overall Study||82
10103434|NCT02423408|11233027|FG000|COMPLETED|Overall Study||82
10103435|NCT02423408|11233028|FG001|COMPLETED|Overall Study||80
10103436|NCT02423408|11233027|FG000|NOT COMPLETED|Overall Study||1
9998813|NCT01701258|11120430|FG004|NOT COMPLETED|PET (Session 3)||0
9998814|NCT01701258|11120431|FG005|NOT COMPLETED|PET (Session 3)||0
9998815|NCT01701258|11120432|FG006|NOT COMPLETED|PET (Session 3)||0
9998816|NCT01701258|11120433|FG007|NOT COMPLETED|PET (Session 3)||0
10103437|NCT02423408|11233028|FG001|NOT COMPLETED|Overall Study||2
10103438|NCT02423447|11233034|FG000|STARTED|Overall Study||13
10103439|NCT02423447|11233035|FG001|STARTED|Overall Study||12
10103440|NCT02423447|11233034|FG000|COMPLETED|Overall Study||13
10103441|NCT02423447|11233035|FG001|COMPLETED|Overall Study||12
10103442|NCT02423447|11233034|FG000|NOT COMPLETED|Overall Study||0
10103443|NCT02423447|11233035|FG001|NOT COMPLETED|Overall Study||0
10103444|NCT02423577|11233046|FG000|STARTED|Overall Study||53
10103445|NCT02423577|11233047|FG001|STARTED|Overall Study||26
9998817|NCT01701258|11120434|FG008|NOT COMPLETED|PET (Session 3)||0
9998818|NCT01701258|11120435|FG009|NOT COMPLETED|PET (Session 3)||0
9998819|NCT01701258|11120436|FG010|NOT COMPLETED|PET (Session 3)||0
9998820|NCT01701258|11120437|FG011|NOT COMPLETED|PET (Session 3)||0
9998821|NCT01701258|11120438|FG012|NOT COMPLETED|PET (Session 3)||0
9998822|NCT01701258|11120426|FG000|STARTED|EEG (Session 4)||0
9998823|NCT01701258|11120427|FG001|STARTED|EEG (Session 4)||19
9998824|NCT01701258|11120428|FG002|STARTED|EEG (Session 4)||0
9998825|NCT01701258|11120429|FG003|STARTED|EEG (Session 4)||0
9998826|NCT01701258|11120430|FG004|STARTED|EEG (Session 4)||14
9998827|NCT01701258|11120431|FG005|STARTED|EEG (Session 4)||0
9998828|NCT01701258|11120432|FG006|STARTED|EEG (Session 4)||0
9998829|NCT01701258|11120433|FG007|STARTED|EEG (Session 4)||16
9998830|NCT01701258|11120434|FG008|STARTED|EEG (Session 4)||0
9998831|NCT01701258|11120435|FG009|STARTED|EEG (Session 4)||0
9998832|NCT01701258|11120436|FG010|STARTED|EEG (Session 4)||17
9998833|NCT01701258|11120437|FG011|STARTED|EEG (Session 4)||0
9998834|NCT01701258|11120438|FG012|STARTED|EEG (Session 4)||0
9998835|NCT01701258|11120426|FG000|COMPLETED|EEG (Session 4)||0
9998836|NCT01701258|11120427|FG001|COMPLETED|EEG (Session 4)||19
9998837|NCT01701258|11120428|FG002|COMPLETED|EEG (Session 4)||0
9998838|NCT01701258|11120429|FG003|COMPLETED|EEG (Session 4)||0
10103446|NCT02423577|11233046|FG000|COMPLETED|Overall Study||53
10103447|NCT02423577|11233047|FG001|COMPLETED|Overall Study||26
10103448|NCT02423577|11233046|FG000|NOT COMPLETED|Overall Study||0
10103449|NCT02423577|11233047|FG001|NOT COMPLETED|Overall Study||0
10103450|NCT02423798|11233053|FG000|STARTED|Overall Study||24
10103451|NCT02423798|11233053|FG000|COMPLETED|Overall Study||21
10103452|NCT02423798|11233053|FG000|NOT COMPLETED|Overall Study||3
10103453|NCT02423980|11233058|FG000|STARTED|Overall Study||7
10103454|NCT02423980|11233058|FG000|COMPLETED|Overall Study||7
10103455|NCT02423980|11233058|FG000|NOT COMPLETED|Overall Study||0
10103456|NCT02423993|11233068|FG000|STARTED|Overall Study||19
10103457|NCT02423993|11233069|FG001|STARTED|Overall Study||16
10103458|NCT02423993|11233070|FG002|STARTED|Overall Study||23
10103459|NCT02423993|11233071|FG003|STARTED|Overall Study||19
10103460|NCT02423993|11233068|FG000|COMPLETED|Overall Study||19
10103461|NCT02423993|11233069|FG001|COMPLETED|Overall Study||16
10103462|NCT02423993|11233070|FG002|COMPLETED|Overall Study||23
10103463|NCT02423993|11233071|FG003|COMPLETED|Overall Study||19
10103464|NCT02423993|11233068|FG000|NOT COMPLETED|Overall Study||0
10103465|NCT02423993|11233069|FG001|NOT COMPLETED|Overall Study||0
10103466|NCT02423993|11233070|FG002|NOT COMPLETED|Overall Study||0
10103467|NCT02423993|11233071|FG003|NOT COMPLETED|Overall Study||0
10103468|NCT02424097|11233083|FG000|STARTED|Overall Study||20
10103469|NCT02424097|11233084|FG001|STARTED|Overall Study||20
10103470|NCT02424097|11233083|FG000|COMPLETED|Overall Study||19
10103471|NCT02424097|11233084|FG001|COMPLETED|Overall Study||18
10103472|NCT02424097|11233083|FG000|NOT COMPLETED|Overall Study||1
10103473|NCT02424097|11233084|FG001|NOT COMPLETED|Overall Study||2
10103474|NCT02424149|11233092|FG000|STARTED|Overall Study||54
10103475|NCT02424149|11233093|FG001|STARTED|Overall Study||53
10103476|NCT02424149|11233092|FG000|COMPLETED|Overall Study||52
10103477|NCT02424149|11233093|FG001|COMPLETED|Overall Study||52
10103478|NCT02424149|11233092|FG000|NOT COMPLETED|Overall Study||2
10103479|NCT02424149|11233093|FG001|NOT COMPLETED|Overall Study||1
10103480|NCT02424175|11233099|FG000|STARTED|Overall Study||10
10103481|NCT02424175|11233099|FG000|COMPLETED|Overall Study||10
10103482|NCT02424175|11233099|FG000|NOT COMPLETED|Overall Study||0
10103483|NCT02424253|11233105|FG000|STARTED|Overall Study||65
10103484|NCT02424253|11233106|FG001|STARTED|Overall Study||33
10103485|NCT02424253|11233105|FG000|COMPLETED|Overall Study||54
10103486|NCT02424253|11233106|FG001|COMPLETED|Overall Study||24
10103487|NCT02424253|11233105|FG000|NOT COMPLETED|Overall Study||11
10103488|NCT02424253|11233106|FG001|NOT COMPLETED|Overall Study||9
10103489|NCT02424344|11233114|FG000|STARTED|Overall Study||134
10103490|NCT02424344|11233115|FG001|STARTED|Overall Study||133
10103491|NCT02424344|11233114|FG000|COMPLETED|Overall Study||127
10103492|NCT02424344|11233115|FG001|COMPLETED|Overall Study||123
10103493|NCT02424344|11233114|FG000|NOT COMPLETED|Overall Study||7
10103494|NCT02424344|11233115|FG001|NOT COMPLETED|Overall Study||10
10103495|NCT02424357|11233123|FG000|STARTED|Overall Study||35
10103496|NCT02424357|11233124|FG001|STARTED|Overall Study||30
10103497|NCT02424357|11233123|FG000|COMPLETED|Overall Study||35
10103498|NCT02424357|11233124|FG001|COMPLETED|Overall Study||30
10103499|NCT02424357|11233123|FG000|NOT COMPLETED|Overall Study||0
10103500|NCT02424357|11233124|FG001|NOT COMPLETED|Overall Study||0
10103501|NCT02424383|11233132|FG000|STARTED|Overall Study||1005
10103502|NCT02424383|11233132|FG000|Per-Protocol Population|Overall Study||966
10103503|NCT02424383|11233132|FG000|COMPLETED|Overall Study||629
9998839|NCT01701258|11120430|FG004|COMPLETED|EEG (Session 4)||14
9998840|NCT01701258|11120431|FG005|COMPLETED|EEG (Session 4)||0
9998841|NCT01701258|11120432|FG006|COMPLETED|EEG (Session 4)||0
9998842|NCT01701258|11120433|FG007|COMPLETED|EEG (Session 4)||16
10103504|NCT02424383|11233132|FG000|NOT COMPLETED|Overall Study||376
10103505|NCT02424526|11233138|FG000|STARTED|Overall Study||9
10103506|NCT02424526|11233139|FG001|STARTED|Overall Study||10
10103507|NCT02424526|11233138|FG000|COMPLETED|Overall Study||9
10103508|NCT02424526|11233139|FG001|COMPLETED|Overall Study||10
10103509|NCT02424526|11233138|FG000|NOT COMPLETED|Overall Study||0
10103510|NCT02424526|11233139|FG001|NOT COMPLETED|Overall Study||0
10103511|NCT02424539|11233150|FG000|STARTED|Overall Study||120
9998843|NCT01701258|11120434|FG008|COMPLETED|EEG (Session 4)||0
9998844|NCT01701258|11120435|FG009|COMPLETED|EEG (Session 4)||0
9998845|NCT01701258|11120436|FG010|COMPLETED|EEG (Session 4)||17
9998846|NCT01701258|11120437|FG011|COMPLETED|EEG (Session 4)||0
9998847|NCT01701258|11120438|FG012|COMPLETED|EEG (Session 4)||0
9998848|NCT01701258|11120426|FG000|NOT COMPLETED|EEG (Session 4)||0
9998849|NCT01701258|11120427|FG001|NOT COMPLETED|EEG (Session 4)||0
9998850|NCT01701258|11120428|FG002|NOT COMPLETED|EEG (Session 4)||0
9998851|NCT01701258|11120429|FG003|NOT COMPLETED|EEG (Session 4)||0
9998852|NCT01701258|11120430|FG004|NOT COMPLETED|EEG (Session 4)||0
9998853|NCT01701258|11120431|FG005|NOT COMPLETED|EEG (Session 4)||0
9998854|NCT01701258|11120432|FG006|NOT COMPLETED|EEG (Session 4)||0
9998855|NCT01701258|11120433|FG007|NOT COMPLETED|EEG (Session 4)||0
9998856|NCT01701258|11120434|FG008|NOT COMPLETED|EEG (Session 4)||0
9998857|NCT01701258|11120435|FG009|NOT COMPLETED|EEG (Session 4)||0
9998858|NCT01701258|11120436|FG010|NOT COMPLETED|EEG (Session 4)||0
9998859|NCT01701258|11120437|FG011|NOT COMPLETED|EEG (Session 4)||0
9998860|NCT01701258|11120438|FG012|NOT COMPLETED|EEG (Session 4)||0
9998861|NCT01701271|11120466|FG000|STARTED|Overall Study||20
9998862|NCT01701271|11120466|FG000|COMPLETED|Overall Study||20
9998863|NCT01701271|11120466|FG000|NOT COMPLETED|Overall Study||0
9998864|NCT01701362|11120473|FG000|STARTED|Overall Study||275
9998865|NCT01701362|11120474|FG001|STARTED|Overall Study||267
9998866|NCT01701362|11120473|FG000|TREATED|Overall Study||274
9998867|NCT01701362|11120474|FG001|TREATED|Overall Study||265
10103512|NCT02424539|11233151|FG001|STARTED|Overall Study||119
10103513|NCT02424539|11233152|FG002|STARTED|Overall Study||119
10103514|NCT02424539|11233150|FG000|COMPLETED|Overall Study||106
10103515|NCT02424539|11233151|FG001|COMPLETED|Overall Study||111
10103516|NCT02424539|11233152|FG002|COMPLETED|Overall Study||111
10103517|NCT02424539|11233150|FG000|NOT COMPLETED|Overall Study||14
10103518|NCT02424539|11233151|FG001|NOT COMPLETED|Overall Study||8
10103519|NCT02424539|11233152|FG002|NOT COMPLETED|Overall Study||8
10103520|NCT02424578|11233162|FG000|STARTED|Overall Study||15
10103521|NCT02424578|11233163|FG001|STARTED|Overall Study||15
10103522|NCT02424578|11233162|FG000|COMPLETED|Overall Study||15
10103523|NCT02424578|11233163|FG001|COMPLETED|Overall Study||14
10103524|NCT02424578|11233162|FG000|NOT COMPLETED|Overall Study||0
10103525|NCT02424578|11233163|FG001|NOT COMPLETED|Overall Study||1
10103526|NCT02424591|11233171|FG000|STARTED|Overall Study||22
10103527|NCT02424591|11233172|FG001|STARTED|Overall Study||23
10103528|NCT02424591|11233171|FG000|COMPLETED|Overall Study||20
10103529|NCT02424591|11233172|FG001|COMPLETED|Overall Study||20
10103530|NCT02424591|11233171|FG000|NOT COMPLETED|Overall Study||2
10103531|NCT02424591|11233172|FG001|NOT COMPLETED|Overall Study||3
10103532|NCT02424630|11233180|FG000|STARTED|Overall Study||25
10103533|NCT02424630|11233181|FG001|STARTED|Overall Study||27
10103534|NCT02424630|11233180|FG000|COMPLETED|Overall Study||24
10103535|NCT02424630|11233181|FG001|COMPLETED|Overall Study||24
10103536|NCT02424630|11233180|FG000|NOT COMPLETED|Overall Study||1
10103537|NCT02424630|11233181|FG001|NOT COMPLETED|Overall Study||3
10103538|NCT02424734|11233190|FG000|STARTED|Overall Study||4
10103539|NCT02424734|11233191|FG001|STARTED|Overall Study||5
10103540|NCT02424734|11233192|FG002|STARTED|Overall Study||2
10103541|NCT02424734|11233190|FG000|Treated|Overall Study||4
10103542|NCT02424734|11233191|FG001|Treated|Overall Study||5
10103543|NCT02424734|11233192|FG002|Treated|Overall Study||2
10103544|NCT02424734|11233190|FG000|COMPLETED|Overall Study||2
10103545|NCT02424734|11233191|FG001|COMPLETED|Overall Study||3
10103546|NCT02424734|11233192|FG002|COMPLETED|Overall Study||2
10103547|NCT02424734|11233190|FG000|NOT COMPLETED|Overall Study||2
10103548|NCT02424734|11233191|FG001|NOT COMPLETED|Overall Study||2
10103549|NCT02424734|11233192|FG002|NOT COMPLETED|Overall Study||0
10103550|NCT02424799|11233207|FG000|STARTED|Part A (Up to Day 11)||9
10103551|NCT02424799|11233208|FG001|STARTED|Part A (Up to Day 11)||8
10103552|NCT02424799|11233209|FG002|STARTED|Part A (Up to Day 11)||0
10103553|NCT02424799|11233210|FG003|STARTED|Part A (Up to Day 11)||0
10103554|NCT02424799|11233211|FG004|STARTED|Part A (Up to Day 11)||0
10103555|NCT02424799|11233212|FG005|STARTED|Part A (Up to Day 11)||0
10103556|NCT02424799|11233207|FG000|COMPLETED|Part A (Up to Day 11)||9
10103557|NCT02424799|11233208|FG001|COMPLETED|Part A (Up to Day 11)||8
10103558|NCT02424799|11233209|FG002|COMPLETED|Part A (Up to Day 11)||0
10103559|NCT02424799|11233210|FG003|COMPLETED|Part A (Up to Day 11)||0
10103560|NCT02424799|11233211|FG004|COMPLETED|Part A (Up to Day 11)||0
10103561|NCT02424799|11233212|FG005|COMPLETED|Part A (Up to Day 11)||0
10103562|NCT02424799|11233207|FG000|NOT COMPLETED|Part A (Up to Day 11)||0
10103563|NCT02424799|11233208|FG001|NOT COMPLETED|Part A (Up to Day 11)||0
10103564|NCT02424799|11233209|FG002|NOT COMPLETED|Part A (Up to Day 11)||0
10103565|NCT02424799|11233210|FG003|NOT COMPLETED|Part A (Up to Day 11)||0
10103566|NCT02424799|11233211|FG004|NOT COMPLETED|Part A (Up to Day 11)||0
10103567|NCT02424799|11233212|FG005|NOT COMPLETED|Part A (Up to Day 11)||0
10103568|NCT02424799|11233207|FG000|STARTED|Part B (Up to Day 19)||0
10103569|NCT02424799|11233208|FG001|STARTED|Part B (Up to Day 19)||0
10103570|NCT02424799|11233209|FG002|STARTED|Part B (Up to Day 19)||3
10103571|NCT02424799|11233210|FG003|STARTED|Part B (Up to Day 19)||9
10103572|NCT02424799|11233211|FG004|STARTED|Part B (Up to Day 19)||0
10103573|NCT02424799|11233212|FG005|STARTED|Part B (Up to Day 19)||0
9998868|NCT01701362|11120473|FG000|COMPLETED|Overall Study||233
9998869|NCT01701362|11120474|FG001|COMPLETED|Overall Study||211
9998870|NCT01701362|11120473|FG000|NOT COMPLETED|Overall Study||42
9998871|NCT01701362|11120474|FG001|NOT COMPLETED|Overall Study||56
9998872|NCT01701375|11120480|FG000|STARTED|Overall Study||2
9998873|NCT01701375|11120480|FG000|COMPLETED|Overall Study||2
10103574|NCT02424799|11233207|FG000|COMPLETED|Part B (Up to Day 19)||0
10103575|NCT02424799|11233208|FG001|COMPLETED|Part B (Up to Day 19)||0
10103576|NCT02424799|11233209|FG002|COMPLETED|Part B (Up to Day 19)||3
10103577|NCT02424799|11233210|FG003|COMPLETED|Part B (Up to Day 19)||9
10103578|NCT02424799|11233211|FG004|COMPLETED|Part B (Up to Day 19)||0
10103579|NCT02424799|11233212|FG005|COMPLETED|Part B (Up to Day 19)||0
10103580|NCT02424799|11233207|FG000|NOT COMPLETED|Part B (Up to Day 19)||0
10103581|NCT02424799|11233208|FG001|NOT COMPLETED|Part B (Up to Day 19)||0
10103582|NCT02424799|11233209|FG002|NOT COMPLETED|Part B (Up to Day 19)||0
10103583|NCT02424799|11233210|FG003|NOT COMPLETED|Part B (Up to Day 19)||0
10103584|NCT02424799|11233211|FG004|NOT COMPLETED|Part B (Up to Day 19)||0
10103585|NCT02424799|11233212|FG005|NOT COMPLETED|Part B (Up to Day 19)||0
10103586|NCT02424799|11233207|FG000|STARTED|Part C (Up to Day 23)||0
10103587|NCT02424799|11233208|FG001|STARTED|Part C (Up to Day 23)||0
10103588|NCT02424799|11233209|FG002|STARTED|Part C (Up to Day 23)||0
10103589|NCT02424799|11233210|FG003|STARTED|Part C (Up to Day 23)||0
10103590|NCT02424799|11233211|FG004|STARTED|Part C (Up to Day 23)||1
10103591|NCT02424799|11233212|FG005|STARTED|Part C (Up to Day 23)||4
10103592|NCT02424799|11233207|FG000|COMPLETED|Part C (Up to Day 23)||0
10103593|NCT02424799|11233208|FG001|COMPLETED|Part C (Up to Day 23)||0
10103594|NCT02424799|11233209|FG002|COMPLETED|Part C (Up to Day 23)||0
10103595|NCT02424799|11233210|FG003|COMPLETED|Part C (Up to Day 23)||0
10103596|NCT02424799|11233211|FG004|COMPLETED|Part C (Up to Day 23)||1
10103597|NCT02424799|11233212|FG005|COMPLETED|Part C (Up to Day 23)||4
10103598|NCT02424799|11233207|FG000|NOT COMPLETED|Part C (Up to Day 23)||0
10103599|NCT02424799|11233208|FG001|NOT COMPLETED|Part C (Up to Day 23)||0
10103600|NCT02424799|11233209|FG002|NOT COMPLETED|Part C (Up to Day 23)||0
10103601|NCT02424799|11233210|FG003|NOT COMPLETED|Part C (Up to Day 23)||0
10103602|NCT02424799|11233211|FG004|NOT COMPLETED|Part C (Up to Day 23)||0
10103603|NCT02424799|11233212|FG005|NOT COMPLETED|Part C (Up to Day 23)||0
10103604|NCT02424968|11233244|FG000|STARTED|Overall Study||18
10103605|NCT02424968|11233244|FG000|COMPLETED|Overall Study||18
10103606|NCT02424968|11233244|FG000|NOT COMPLETED|Overall Study||0
10103607|NCT02425098|11233250|FG000|STARTED|Overall Study||176
10103608|NCT02425098|11233251|FG001|STARTED|Overall Study||175
10103609|NCT02425098|11233250|FG000|COMPLETED|Overall Study||163
10103610|NCT02425098|11233251|FG001|COMPLETED|Overall Study||159
10103611|NCT02425098|11233250|FG000|NOT COMPLETED|Overall Study||13
10103612|NCT02425098|11233251|FG001|NOT COMPLETED|Overall Study||16
10103613|NCT02425111|11233257|FG000|STARTED|Part A: Treatment Period||101
10103614|NCT02425111|11233257|FG000|COMPLETED|Part A: Treatment Period||78
10103615|NCT02425111|11233257|FG000|NOT COMPLETED|Part A: Treatment Period||23
10103616|NCT02425111|11233257|FG000|STARTED|Part B: Treatment Extension Period||56
10103617|NCT02425111|11233257|FG000|COMPLETED|Part B: Treatment Extension Period||46
10103618|NCT02425111|11233257|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10
10103619|NCT02425449|11233267|FG000|STARTED|Overall Study||0
10103620|NCT02425449|11233268|FG001|STARTED|Overall Study||4
10103621|NCT02425449|11233269|FG002|STARTED|Overall Study||5
10103622|NCT02425449|11233270|FG003|STARTED|Overall Study||5
10103623|NCT02425449|11233271|FG004|STARTED|Overall Study||5
10103624|NCT02425449|11233267|FG000|COMPLETED|Overall Study||0
10103625|NCT02425449|11233268|FG001|COMPLETED|Overall Study||4
10103626|NCT02425449|11233269|FG002|COMPLETED|Overall Study||5
10103627|NCT02425449|11233270|FG003|COMPLETED|Overall Study||5
10103628|NCT02425449|11233271|FG004|COMPLETED|Overall Study||5
10103629|NCT02425449|11233267|FG000|NOT COMPLETED|Overall Study||0
10103630|NCT02425449|11233268|FG001|NOT COMPLETED|Overall Study||0
10103631|NCT02425449|11233269|FG002|NOT COMPLETED|Overall Study||0
10103632|NCT02425449|11233270|FG003|NOT COMPLETED|Overall Study||0
10103633|NCT02425449|11233271|FG004|NOT COMPLETED|Overall Study||0
10103634|NCT02425891|11233285|FG000|STARTED|Overall Study||451
10103635|NCT02425891|11233286|FG001|STARTED|Overall Study||451
10103636|NCT02425891|11233285|FG000|COMPLETED|Overall Study||0
10103637|NCT02425891|11233286|FG001|COMPLETED|Overall Study||0
10103638|NCT02425891|11233285|FG000|NOT COMPLETED|Overall Study||451
10103639|NCT02425891|11233286|FG001|NOT COMPLETED|Overall Study||451
10103640|NCT02425956|11233293|FG000|STARTED|Overall Study||21
10103641|NCT02425956|11233293|FG000|COMPLETED|Overall Study||21
10103642|NCT02425956|11233293|FG000|NOT COMPLETED|Overall Study||0
10103643|NCT02426086|11233299|FG000|STARTED|Overall Study||48
10103644|NCT02426086|11233300|FG001|STARTED|Overall Study||59
10103645|NCT02426086|11233299|FG000|Treated|Overall Study||48
10103646|NCT02426086|11233300|FG001|Treated|Overall Study||59
10103647|NCT02426086|11233299|FG000|COMPLETED|Overall Study||0
10103648|NCT02426086|11233300|FG001|COMPLETED|Overall Study||0
10103649|NCT02426086|11233299|FG000|NOT COMPLETED|Overall Study||48
10103650|NCT02426086|11233300|FG001|NOT COMPLETED|Overall Study||59
10103651|NCT02426138|11233313|FG000|STARTED|First Intervention (12 Weeks)||21
10103652|NCT02426138|11233314|FG001|STARTED|First Intervention (12 Weeks)||23
10103653|NCT02426138|11233313|FG000|COMPLETED|First Intervention (12 Weeks)||20
10103654|NCT02426138|11233314|FG001|COMPLETED|First Intervention (12 Weeks)||22
10103655|NCT02426138|11233313|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
10103656|NCT02426138|11233314|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10103657|NCT02426138|11233313|FG000|STARTED|Second Intervention (12 Weeks)||20
10103658|NCT02426138|11233314|FG001|STARTED|Second Intervention (12 Weeks)||22
10103659|NCT02426138|11233313|FG000|COMPLETED|Second Intervention (12 Weeks)||20
10103660|NCT02426138|11233314|FG001|COMPLETED|Second Intervention (12 Weeks)||22
10103661|NCT02426138|11233313|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10103662|NCT02426138|11233314|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10103663|NCT02426138|11233313|FG000|STARTED|Intent to Treat Population Milestone||20
9998874|NCT01701375|11120480|FG000|NOT COMPLETED|Overall Study||0
9998875|NCT01701401|11120488|FG000|STARTED|Overall Study||217
9998876|NCT01701401|11120489|FG001|STARTED|Overall Study||218
9998877|NCT01701401|11120490|FG002|STARTED|Overall Study||217
9998878|NCT01701401|11120491|FG003|STARTED|Overall Study||218
9998879|NCT01701401|11120488|FG000|COMPLETED|Overall Study||207
9998880|NCT01701401|11120489|FG001|COMPLETED|Overall Study||209
9998881|NCT01701401|11120490|FG002|COMPLETED|Overall Study||212
9998882|NCT01701401|11120491|FG003|COMPLETED|Overall Study||212
9998883|NCT01701401|11120488|FG000|NOT COMPLETED|Overall Study||10
9998884|NCT01701401|11120489|FG001|NOT COMPLETED|Overall Study||9
9998885|NCT01701401|11120490|FG002|NOT COMPLETED|Overall Study||5
9998886|NCT01701401|11120491|FG003|NOT COMPLETED|Overall Study||6
9998887|NCT01701414|11120503|FG000|STARTED|Overall Study||19
9998888|NCT01701414|11120504|FG001|STARTED|Overall Study||19
9998889|NCT01701414|11120503|FG000|COMPLETED|Overall Study||18
9998890|NCT01701414|11120504|FG001|COMPLETED|Overall Study||18
9998891|NCT01701414|11120503|FG000|NOT COMPLETED|Overall Study||1
9998892|NCT01701414|11120504|FG001|NOT COMPLETED|Overall Study||1
9998893|NCT01701505|11120516|FG000|STARTED|Overall Study||8
9998894|NCT01701505|11120517|FG001|STARTED|Overall Study||8
9998895|NCT01701505|11120518|FG002|STARTED|Overall Study||8
9998896|NCT01701505|11120519|FG003|STARTED|Overall Study||8
9998897|NCT01701505|11120520|FG004|STARTED|Overall Study||8
9998898|NCT01701505|11120521|FG005|STARTED|Overall Study||8
9998899|NCT01701505|11120516|FG000|COMPLETED|Overall Study||8
9998900|NCT01701505|11120517|FG001|COMPLETED|Overall Study||8
9998901|NCT01701505|11120518|FG002|COMPLETED|Overall Study||8
9998902|NCT01701505|11120519|FG003|COMPLETED|Overall Study||8
9998903|NCT01701505|11120520|FG004|COMPLETED|Overall Study||8
9998904|NCT01701505|11120521|FG005|COMPLETED|Overall Study||8
9998905|NCT01701505|11120516|FG000|NOT COMPLETED|Overall Study||0
9998906|NCT01701505|11120517|FG001|NOT COMPLETED|Overall Study||0
9998907|NCT01701505|11120518|FG002|NOT COMPLETED|Overall Study||0
9998908|NCT01701505|11120519|FG003|NOT COMPLETED|Overall Study||0
9998909|NCT01701505|11120520|FG004|NOT COMPLETED|Overall Study||0
9998910|NCT01701505|11120521|FG005|NOT COMPLETED|Overall Study||0
9998911|NCT01701973|11120538|FG000|STARTED|Aim 1: First Intervention (1 Day)||23
9998912|NCT01701973|11120539|FG001|STARTED|Aim 1: First Intervention (1 Day)||21
9998913|NCT01701973|11120540|FG002|STARTED|Aim 1: First Intervention (1 Day)||0
9998914|NCT01701973|11120541|FG003|STARTED|Aim 1: First Intervention (1 Day)||0
9998915|NCT01701973|11120542|FG004|STARTED|Aim 1: First Intervention (1 Day)||0
9998916|NCT01701973|11120543|FG005|STARTED|Aim 1: First Intervention (1 Day)||0
9998917|NCT01701973|11120544|FG006|STARTED|Aim 1: First Intervention (1 Day)||0
9998918|NCT01701973|11120545|FG007|STARTED|Aim 1: First Intervention (1 Day)||0
9998919|NCT01701973|11120538|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23
9998920|NCT01701973|11120539|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20
9998921|NCT01701973|11120540|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0
9998922|NCT01701973|11120541|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0
9998923|NCT01701973|11120542|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0
9998924|NCT01701973|11120543|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0
9998925|NCT01701973|11120544|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0
9998926|NCT01701973|11120545|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0
9998927|NCT01701973|11120538|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
9998928|NCT01701973|11120539|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
9998929|NCT01701973|11120540|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
9998930|NCT01701973|11120541|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
9998931|NCT01701973|11120542|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
9998932|NCT01701973|11120543|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
9998933|NCT01701973|11120544|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
9998934|NCT01701973|11120545|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
9998935|NCT01701973|11120538|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
9998936|NCT01701973|11120539|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
9998937|NCT01701973|11120540|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0
9998938|NCT01701973|11120541|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0
9998939|NCT01701973|11120542|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0
9998940|NCT01701973|11120543|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0
9998941|NCT01701973|11120544|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0
9998942|NCT01701973|11120545|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0
9998943|NCT01701973|11120538|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22
9998944|NCT01701973|11120539|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17
9998945|NCT01701973|11120540|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998946|NCT01701973|11120541|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998947|NCT01701973|11120542|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998948|NCT01701973|11120543|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998949|NCT01701973|11120544|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998950|NCT01701973|11120545|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998951|NCT01701973|11120538|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998952|NCT01701973|11120539|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998953|NCT01701973|11120540|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998954|NCT01701973|11120541|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998955|NCT01701973|11120542|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998956|NCT01701973|11120543|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998957|NCT01701973|11120544|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998958|NCT01701973|11120545|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
9998959|NCT01701973|11120538|FG000|STARTED|Aim 2: First Intervention (1 Day)||0
9998960|NCT01701973|11120539|FG001|STARTED|Aim 2: First Intervention (1 Day)||0
9998961|NCT01701973|11120540|FG002|STARTED|Aim 2: First Intervention (1 Day)||5
9998962|NCT01701973|11120541|FG003|STARTED|Aim 2: First Intervention (1 Day)||4
9998963|NCT01701973|11120542|FG004|STARTED|Aim 2: First Intervention (1 Day)||2
9998964|NCT01701973|11120543|FG005|STARTED|Aim 2: First Intervention (1 Day)||3
9998965|NCT01701973|11120544|FG006|STARTED|Aim 2: First Intervention (1 Day)||5
9998966|NCT01701973|11120545|FG007|STARTED|Aim 2: First Intervention (1 Day)||4
9998967|NCT01701973|11120538|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0
9998968|NCT01701973|11120539|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0
9998969|NCT01701973|11120540|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5
9998970|NCT01701973|11120541|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4
9998971|NCT01701973|11120542|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2
9998972|NCT01701973|11120543|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3
9998973|NCT01701973|11120544|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5
9998974|NCT01701973|11120545|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4
9998975|NCT01701973|11120538|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998976|NCT01701973|11120539|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998977|NCT01701973|11120540|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998978|NCT01701973|11120541|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998979|NCT01701973|11120542|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998980|NCT01701973|11120543|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998981|NCT01701973|11120544|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998982|NCT01701973|11120545|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
9998983|NCT01701973|11120538|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0
9998984|NCT01701973|11120539|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0
9998985|NCT01701973|11120540|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5
9998986|NCT01701973|11120541|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4
9998987|NCT01701973|11120542|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2
9998988|NCT01701973|11120543|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3
9998989|NCT01701973|11120544|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5
9998990|NCT01701973|11120545|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
9998991|NCT01701973|11120538|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0
9998992|NCT01701973|11120539|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0
9998993|NCT01701973|11120540|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5
9998994|NCT01701973|11120541|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4
9998995|NCT01701973|11120542|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2
9998996|NCT01701973|11120543|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3
9998997|NCT01701973|11120544|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5
9998998|NCT01701973|11120545|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3
9998999|NCT01701973|11120538|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999000|NCT01701973|11120539|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999001|NCT01701973|11120540|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999002|NCT01701973|11120541|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999003|NCT01701973|11120542|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999004|NCT01701973|11120543|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999005|NCT01701973|11120544|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999006|NCT01701973|11120545|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
9999007|NCT01701999|11120587|FG000|STARTED|Overall Study||8
9999008|NCT01701999|11120588|FG001|STARTED|Overall Study||37
9999009|NCT01701999|11120587|FG000|COMPLETED|Overall Study||8
9999010|NCT01701999|11120588|FG001|COMPLETED|Overall Study||37
9999011|NCT01701999|11120587|FG000|NOT COMPLETED|Overall Study||0
9999012|NCT01701999|11120588|FG001|NOT COMPLETED|Overall Study||0
9999013|NCT01702025|11120598|FG000|STARTED|Overall Study||11
9999014|NCT01702025|11120599|FG001|STARTED|Overall Study||10
9999015|NCT01702025|11120600|FG002|STARTED|Overall Study||10
9999016|NCT01702025|11120601|FG003|STARTED|Overall Study||10
9999017|NCT01702025|11120598|FG000|COMPLETED|Overall Study||9
9999018|NCT01702025|11120599|FG001|COMPLETED|Overall Study||9
9999019|NCT01702025|11120600|FG002|COMPLETED|Overall Study||9
10103664|NCT02426138|11233314|FG001|STARTED|Intent to Treat Population Milestone||22
10103665|NCT02426138|11233313|FG000|COMPLETED|Intent to Treat Population Milestone||20
10103666|NCT02426138|11233314|FG001|COMPLETED|Intent to Treat Population Milestone||22
10103667|NCT02426138|11233313|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0
10103668|NCT02426138|11233314|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0
10103669|NCT02426476|11233324|FG000|STARTED|Overall Study||57
10103670|NCT02426476|11233325|FG001|STARTED|Overall Study||56
10103671|NCT02426476|11233324|FG000|COMPLETED|Overall Study||38
10103672|NCT02426476|11233325|FG001|COMPLETED|Overall Study||39
10103673|NCT02426476|11233324|FG000|NOT COMPLETED|Overall Study||19
10103674|NCT02426476|11233325|FG001|NOT COMPLETED|Overall Study||17
10103675|NCT02426541|11233335|FG000|STARTED|Overall Study||16
9999020|NCT01702025|11120601|FG003|COMPLETED|Overall Study||10
9999021|NCT01702025|11120598|FG000|NOT COMPLETED|Overall Study||2
9999022|NCT01702025|11120599|FG001|NOT COMPLETED|Overall Study||1
9999023|NCT01702025|11120600|FG002|NOT COMPLETED|Overall Study||1
9999024|NCT01702025|11120601|FG003|NOT COMPLETED|Overall Study||0
9999025|NCT01702233|11120618|FG000|STARTED|Overall Study||72
9999026|NCT01702233|11120619|FG001|STARTED|Overall Study||67
9999027|NCT01702233|11120620|FG002|STARTED|Overall Study||36
9999028|NCT01702233|11120618|FG000|Full Analysis Set (ITT)|Overall Study||66
9999029|NCT01702233|11120619|FG001|Full Analysis Set (ITT)|Overall Study||63
9999030|NCT01702233|11120620|FG002|Full Analysis Set (ITT)|Overall Study||31
9999031|NCT01702233|11120618|FG000|Per Protocol Set|Overall Study||58
9999032|NCT01702233|11120619|FG001|Per Protocol Set|Overall Study||58
9999033|NCT01702233|11120620|FG002|Per Protocol Set|Overall Study||27
9999034|NCT01702233|11120618|FG000|COMPLETED|Overall Study||66
9999035|NCT01702233|11120619|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
9999036|NCT01702233|11120620|FG002|COMPLETED|Overall Study||31
9999037|NCT01702233|11120618|FG000|NOT COMPLETED|Overall Study||6
9999038|NCT01702233|11120619|FG001|NOT COMPLETED|Overall Study||3
9999039|NCT01702233|11120620|FG002|NOT COMPLETED|Overall Study||5
9999040|NCT01702246|11120629|FG000|STARTED|Overall Study||24
9999041|NCT01702246|11120629|FG000|COMPLETED|Overall Study||19
9999042|NCT01702246|11120629|FG000|NOT COMPLETED|Overall Study||5
9999043|NCT01702259|11120638|FG000|STARTED|Overall Study||34
9999044|NCT01702259|11120639|FG001|STARTED|Overall Study||34
9999045|NCT01702259|11120638|FG000|COMPLETED|Overall Study||34
9999046|NCT01702259|11120639|FG001|COMPLETED|Overall Study||34
9999047|NCT01702259|11120638|FG000|NOT COMPLETED|Overall Study||0
9999048|NCT01702259|11120639|FG001|NOT COMPLETED|Overall Study||0
9999049|NCT01702298|11120645|FG000|STARTED|Overall Study||42
9999050|NCT01702298|11120645|FG000|COMPLETED|Overall Study||41
9999051|NCT01702298|11120645|FG000|NOT COMPLETED|Overall Study||1
9999052|NCT01702311|11120651|FG000|STARTED|Overall Study||122
9999053|NCT01702311|11120652|FG001|STARTED|Overall Study||113
9999054|NCT01702311|11120651|FG000|COMPLETED|Overall Study||106
9999055|NCT01702311|11120652|FG001|COMPLETED|Overall Study||100
9999056|NCT01702311|11120651|FG000|NOT COMPLETED|Overall Study||16
9999057|NCT01702311|11120652|FG001|NOT COMPLETED|Overall Study||13
9999058|NCT01702363|11120661|FG000|STARTED|Overall Study||131
9999059|NCT01702363|11120661|FG000|COMPLETED|Overall Study||111
9999060|NCT01702363|11120661|FG000|NOT COMPLETED|Overall Study||20
9999061|NCT01702428|11120670|FG000|STARTED|Overall Study||1239
9999062|NCT01702428|11120671|FG001|STARTED|Overall Study||1232
9999063|NCT01702428|11120672|FG002|STARTED|Overall Study||1243
9999064|NCT01702428|11120673|FG003|STARTED|Overall Study||1289
9999065|NCT01702428|11120670|FG000|COMPLETED|Overall Study||1175
9999066|NCT01702428|11120671|FG001|COMPLETED|Overall Study||1162
9999067|NCT01702428|11120672|FG002|COMPLETED|Overall Study||1190
9999068|NCT01702428|11120673|FG003|COMPLETED|Overall Study||1232
9999069|NCT01702428|11120670|FG000|NOT COMPLETED|Overall Study||64
9999070|NCT01702428|11120671|FG001|NOT COMPLETED|Overall Study||70
9999071|NCT01702428|11120672|FG002|NOT COMPLETED|Overall Study||53
9999072|NCT01702428|11120673|FG003|NOT COMPLETED|Overall Study||57
9999073|NCT01702454|11120692|FG000|STARTED|Overall Study||241
9999074|NCT01702454|11120693|FG001|STARTED|Overall Study||229
9999075|NCT01702454|11120692|FG000|COMPLETED|Overall Study||238
9999076|NCT01702454|11120693|FG001|COMPLETED|Overall Study||221
9999077|NCT01702454|11120692|FG000|NOT COMPLETED|Overall Study||3
9999078|NCT01702454|11120693|FG001|NOT COMPLETED|Overall Study||8
9999079|NCT01702519|11120704|FG000|STARTED|Period 1||20
9999080|NCT01702519|11120705|FG001|STARTED|Period 1||20
9999081|NCT01702519|11120704|FG000|COMPLETED|Period 1||20
9999082|NCT01702519|11120705|FG001|COMPLETED|Period 1||20
9999083|NCT01702519|11120704|FG000|NOT COMPLETED|Period 1||0
9999084|NCT01702519|11120705|FG001|NOT COMPLETED|Period 1||0
9999085|NCT01702519|11120704|FG000|STARTED|Washout Period||20
9999086|NCT01702519|11120705|FG001|STARTED|Washout Period||20
9999087|NCT01702519|11120704|FG000|COMPLETED|Washout Period||19
9999088|NCT01702519|11120705|FG001|COMPLETED|Washout Period||18
9999089|NCT01702519|11120704|FG000|NOT COMPLETED|Washout Period||1
9999090|NCT01702519|11120705|FG001|NOT COMPLETED|Washout Period||2
9999091|NCT01702519|11120704|FG000|STARTED|Period 2||19
9999092|NCT01702519|11120705|FG001|STARTED|Period 2||18
9999093|NCT01702519|11120704|FG000|COMPLETED|Period 2||19
9999094|NCT01702519|11120705|FG001|COMPLETED|Period 2||18
9999095|NCT01702519|11120704|FG000|NOT COMPLETED|Period 2||0
9999096|NCT01702519|11120705|FG001|NOT COMPLETED|Period 2||0
9999097|NCT01702532|11120717|FG000|STARTED|Overall Study||161
9999098|NCT01702532|11120718|FG001|STARTED|Overall Study||161
9999099|NCT01702532|11120717|FG000|Safety Population|Overall Study||161
9999100|NCT01702532|11120718|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
9999101|NCT01702532|11120717|FG000|COMPLETED|Overall Study||161
9999102|NCT01702532|11120718|FG001|COMPLETED|Overall Study||160
9999103|NCT01702532|11120717|FG000|NOT COMPLETED|Overall Study||0
9999104|NCT01702532|11120718|FG001|NOT COMPLETED|Overall Study||1
9999105|NCT01702558|11120730|FG000|STARTED|Overall Study||7
9999106|NCT01702558|11120731|FG001|STARTED|Overall Study||5
9999107|NCT01702558|11120732|FG002|STARTED|Overall Study||6
9999108|NCT01702558|11120733|FG003|STARTED|Overall Study||81
9999109|NCT01702558|11120734|FG004|STARTED|Overall Study||80
9999110|NCT01702558|11120730|FG000|COMPLETED|Overall Study||3
9999111|NCT01702558|11120731|FG001|COMPLETED|Overall Study||1
9999112|NCT01702558|11120732|FG002|COMPLETED|Overall Study||1
9999113|NCT01702558|11120733|FG003|COMPLETED|Overall Study||34
9999114|NCT01702558|11120734|FG004|COMPLETED|Overall Study||38
9999115|NCT01702558|11120730|FG000|NOT COMPLETED|Overall Study||4
9999116|NCT01702558|11120731|FG001|NOT COMPLETED|Overall Study||4
9999117|NCT01702558|11120732|FG002|NOT COMPLETED|Overall Study||5
9999118|NCT01702558|11120733|FG003|NOT COMPLETED|Overall Study||47
9999119|NCT01702558|11120734|FG004|NOT COMPLETED|Overall Study||42
9999120|NCT01702844|11120747|FG000|STARTED|Overall Study||42
9999121|NCT01702844|11120747|FG000|Disease Progression|Overall Study||23
9999122|NCT01702844|11120747|FG000|COMPLETED|Overall Study||23
9999123|NCT01702844|11120747|FG000|NOT COMPLETED|Overall Study||19
9999124|NCT01702961|11120751|FG000|STARTED|Overall Study||75
9999125|NCT01702961|11120751|FG000|COMPLETED|Overall Study||28
9999126|NCT01702961|11120751|FG000|NOT COMPLETED|Overall Study||47
9999127|NCT01702987|11120757|FG000|STARTED|Overall Study||10
9999128|NCT01702987|11120758|FG001|STARTED|Overall Study||12
9999129|NCT01702987|11120757|FG000|COMPLETED|Overall Study||9
9999130|NCT01702987|11120758|FG001|COMPLETED|Overall Study||12
9999131|NCT01702987|11120757|FG000|NOT COMPLETED|Overall Study||1
9999132|NCT01702987|11120758|FG001|NOT COMPLETED|Overall Study||0
9999133|NCT01703000|11120764|FG000|STARTED|Overall Study||100
9999134|NCT01703000|11120764|FG000|COMPLETED|Overall Study||99
9999135|NCT01703000|11120764|FG000|NOT COMPLETED|Overall Study||1
9999136|NCT01703039|11120770|FG000|STARTED|Overall Study||9
9999137|NCT01703039|11120771|FG001|STARTED|Overall Study||12
9999138|NCT01703039|11120770|FG000|COMPLETED|Overall Study||6
9999139|NCT01703039|11120771|FG001|COMPLETED|Overall Study||7
9999140|NCT01703039|11120770|FG000|NOT COMPLETED|Overall Study||3
9999141|NCT01703039|11120771|FG001|NOT COMPLETED|Overall Study||5
9999142|NCT01703065|11120781|FG000|STARTED|Overall Study||9
9999143|NCT01703065|11120782|FG001|STARTED|Overall Study||0
9999144|NCT01703065|11120781|FG000|COMPLETED|Overall Study||8
9999145|NCT01703065|11120782|FG001|COMPLETED|Overall Study||0
9999146|NCT01703065|11120781|FG000|NOT COMPLETED|Overall Study||1
9999147|NCT01703065|11120782|FG001|NOT COMPLETED|Overall Study||0
9999148|NCT01703091|11120791|FG000|STARTED|Overall Study||98
9999149|NCT01703091|11120792|FG001|STARTED|Overall Study||99
9999150|NCT01703091|11120791|FG000|Received at Least One Dose of Study Drug|Overall Study||94
9999151|NCT01703091|11120792|FG001|Received at Least One Dose of Study Drug|Overall Study||98
9999152|NCT01703091|11120791|FG000|COMPLETED|Overall Study||89
9999153|NCT01703091|11120792|FG001|COMPLETED|Overall Study||95
9999154|NCT01703091|11120791|FG000|NOT COMPLETED|Overall Study||9
9999155|NCT01703091|11120792|FG001|NOT COMPLETED|Overall Study||4
9999156|NCT01703117|11120800|FG000|STARTED|Overall Study||26
9999157|NCT01703117|11120801|FG001|STARTED|Overall Study||24
9999158|NCT01703117|11120800|FG000|COMPLETED|Overall Study||22
9999159|NCT01703117|11120801|FG001|COMPLETED|Overall Study||20
9999160|NCT01703117|11120800|FG000|NOT COMPLETED|Overall Study||4
9999161|NCT01703117|11120801|FG001|NOT COMPLETED|Overall Study||4
9999162|NCT01703169|11120809|FG000|STARTED|Overall Study||13
9999163|NCT01703169|11120809|FG000|COMPLETED|Overall Study||13
9999164|NCT01703169|11120809|FG000|NOT COMPLETED|Overall Study||0
9999165|NCT01703208|11120815|FG000|STARTED|Overall Study||2100
9999166|NCT01703208|11120816|FG001|STARTED|Overall Study||2102
9999167|NCT01703208|11120815|FG000|Treated|Overall Study||2092
9999168|NCT01703208|11120816|FG001|Treated|Overall Study||2100
9999169|NCT01703208|11120815|FG000|COMPLETED|Overall Study||0
9999170|NCT01703208|11120816|FG001|COMPLETED|Overall Study||0
9999171|NCT01703208|11120815|FG000|NOT COMPLETED|Overall Study||2100
9999172|NCT01703208|11120816|FG001|NOT COMPLETED|Overall Study||2102
9999173|NCT01703221|11120825|FG000|STARTED|Phase A (Up to 24 Weeks)||166
9999174|NCT01703221|11120826|FG001|STARTED|Phase A (Up to 24 Weeks)||165
9999175|NCT01703221|11120827|FG002|STARTED|Phase A (Up to 24 Weeks)||83
9999176|NCT01703221|11120825|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159
9999177|NCT01703221|11120826|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161
9999178|NCT01703221|11120827|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80
9999179|NCT01703221|11120825|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
9999180|NCT01703221|11120826|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
9999181|NCT01703221|11120827|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
9999182|NCT01703221|11120825|FG000|STARTED|Phase B - (Week 25 to 52)||159
9999183|NCT01703221|11120826|FG001|STARTED|Phase B - (Week 25 to 52)||161
9999184|NCT01703221|11120827|FG002|STARTED|Phase B - (Week 25 to 52)||80
9999185|NCT01703221|11120825|FG000|COMPLETED|Phase B - (Week 25 to 52)||143
9999186|NCT01703221|11120826|FG001|COMPLETED|Phase B - (Week 25 to 52)||147
9999187|NCT01703221|11120827|FG002|COMPLETED|Phase B - (Week 25 to 52)||75
9999188|NCT01703221|11120825|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16
9999189|NCT01703221|11120826|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14
9999190|NCT01703221|11120827|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5
9999191|NCT01703260|11120844|FG000|STARTED|Overall Study||7
9999192|NCT01703260|11120845|FG001|STARTED|Overall Study||7
9999193|NCT01703260|11120846|FG002|STARTED|Overall Study||6
9999194|NCT01703260|11120844|FG000|COMPLETED|Overall Study||4
9999195|NCT01703260|11120845|FG001|COMPLETED|Overall Study||3
9999196|NCT01703260|11120846|FG002|COMPLETED|Overall Study||3
9999197|NCT01703260|11120844|FG000|NOT COMPLETED|Overall Study||3
9999198|NCT01703260|11120845|FG001|NOT COMPLETED|Overall Study||4
9999199|NCT01703260|11120846|FG002|NOT COMPLETED|Overall Study||3
9999200|NCT01703286|11120854|FG000|STARTED|Period 1 Including Washout||7
9999201|NCT01703286|11120855|FG001|STARTED|Period 1 Including Washout||7
9999202|NCT01703286|11120856|FG002|STARTED|Period 1 Including Washout||7
9999203|NCT01703286|11120857|FG003|STARTED|Period 1 Including Washout||7
9999204|NCT01703286|11120858|FG004|STARTED|Period 1 Including Washout||7
9999205|NCT01703286|11120859|FG005|STARTED|Period 1 Including Washout||7
9999206|NCT01703286|11120854|FG000|COMPLETED|Period 1 Including Washout||7
9999207|NCT01703286|11120855|FG001|COMPLETED|Period 1 Including Washout||7
9999208|NCT01703286|11120856|FG002|COMPLETED|Period 1 Including Washout||7
9999209|NCT01703286|11120857|FG003|COMPLETED|Period 1 Including Washout||6
9999210|NCT01703286|11120858|FG004|COMPLETED|Period 1 Including Washout||7
9999211|NCT01703286|11120859|FG005|COMPLETED|Period 1 Including Washout||6
9999212|NCT01703286|11120854|FG000|NOT COMPLETED|Period 1 Including Washout||0
9999213|NCT01703286|11120855|FG001|NOT COMPLETED|Period 1 Including Washout||0
9999214|NCT01703286|11120856|FG002|NOT COMPLETED|Period 1 Including Washout||0
9999215|NCT01703286|11120857|FG003|NOT COMPLETED|Period 1 Including Washout||1
9999216|NCT01703286|11120858|FG004|NOT COMPLETED|Period 1 Including Washout||0
9999217|NCT01703286|11120859|FG005|NOT COMPLETED|Period 1 Including Washout||1
9999218|NCT01703286|11120854|FG000|STARTED|Period 2 Including Washout||7
9999219|NCT01703286|11120855|FG001|STARTED|Period 2 Including Washout||7
9999220|NCT01703286|11120856|FG002|STARTED|Period 2 Including Washout||7
9999221|NCT01703286|11120857|FG003|STARTED|Period 2 Including Washout||6
9999222|NCT01703286|11120858|FG004|STARTED|Period 2 Including Washout||7
9999223|NCT01703286|11120859|FG005|STARTED|Period 2 Including Washout||6
9999224|NCT01703286|11120854|FG000|COMPLETED|Period 2 Including Washout||7
9999225|NCT01703286|11120855|FG001|COMPLETED|Period 2 Including Washout||7
9999226|NCT01703286|11120856|FG002|COMPLETED|Period 2 Including Washout||7
9999227|NCT01703286|11120857|FG003|COMPLETED|Period 2 Including Washout||5
9999228|NCT01703286|11120858|FG004|COMPLETED|Period 2 Including Washout||7
9999229|NCT01703286|11120859|FG005|COMPLETED|Period 2 Including Washout||6
9999230|NCT01703286|11120854|FG000|NOT COMPLETED|Period 2 Including Washout||0
9999231|NCT01703286|11120855|FG001|NOT COMPLETED|Period 2 Including Washout||0
9999232|NCT01703286|11120856|FG002|NOT COMPLETED|Period 2 Including Washout||0
9999233|NCT01703286|11120857|FG003|NOT COMPLETED|Period 2 Including Washout||1
9999234|NCT01703286|11120858|FG004|NOT COMPLETED|Period 2 Including Washout||0
9999235|NCT01703286|11120859|FG005|NOT COMPLETED|Period 2 Including Washout||0
9999236|NCT01703286|11120854|FG000|STARTED|Period 3 Including Washout||7
9999237|NCT01703286|11120855|FG001|STARTED|Period 3 Including Washout||7
9999238|NCT01703286|11120856|FG002|STARTED|Period 3 Including Washout||7
9999239|NCT01703286|11120857|FG003|STARTED|Period 3 Including Washout||5
9999240|NCT01703286|11120858|FG004|STARTED|Period 3 Including Washout||7
9999241|NCT01703286|11120859|FG005|STARTED|Period 3 Including Washout||6
9999242|NCT01703286|11120854|FG000|COMPLETED|Period 3 Including Washout||7
9999243|NCT01703286|11120855|FG001|COMPLETED|Period 3 Including Washout||7
9999244|NCT01703286|11120856|FG002|COMPLETED|Period 3 Including Washout||7
9999245|NCT01703286|11120857|FG003|COMPLETED|Period 3 Including Washout||5
9999246|NCT01703286|11120858|FG004|COMPLETED|Period 3 Including Washout||7
9999247|NCT01703286|11120859|FG005|COMPLETED|Period 3 Including Washout||6
9999248|NCT01703286|11120854|FG000|NOT COMPLETED|Period 3 Including Washout||0
9999249|NCT01703286|11120855|FG001|NOT COMPLETED|Period 3 Including Washout||0
9999250|NCT01703286|11120856|FG002|NOT COMPLETED|Period 3 Including Washout||0
9999251|NCT01703286|11120857|FG003|NOT COMPLETED|Period 3 Including Washout||0
9999252|NCT01703286|11120858|FG004|NOT COMPLETED|Period 3 Including Washout||0
9999253|NCT01703286|11120859|FG005|NOT COMPLETED|Period 3 Including Washout||0
9999254|NCT01703507|11120872|FG000|STARTED|Overall Study||6
9999255|NCT01703507|11120873|FG001|STARTED|Overall Study||11
9999256|NCT01703507|11120872|FG000|COMPLETED|Overall Study||5
9999257|NCT01703507|11120873|FG001|COMPLETED|Overall Study||11
9999258|NCT01703507|11120872|FG000|NOT COMPLETED|Overall Study||1
9999259|NCT01703507|11120873|FG001|NOT COMPLETED|Overall Study||0
9999260|NCT01703598|11120879|FG000|STARTED|Overall Study||69
9999261|NCT01703598|11120879|FG000|COMPLETED|Overall Study||69
9999262|NCT01703598|11120879|FG000|NOT COMPLETED|Overall Study||0
9999263|NCT01703663|11120883|FG000|STARTED|First Treatment Period||20
9999264|NCT01703663|11120884|FG001|STARTED|First Treatment Period||20
9999265|NCT01703663|11120883|FG000|COMPLETED|First Treatment Period||20
9999266|NCT01703663|11120884|FG001|COMPLETED|First Treatment Period||20
9999267|NCT01703663|11120883|FG000|NOT COMPLETED|First Treatment Period||0
9999268|NCT01703663|11120884|FG001|NOT COMPLETED|First Treatment Period||0
9999269|NCT01703663|11120883|FG000|STARTED|Second Treatment Period||11
9999270|NCT01703663|11120884|FG001|STARTED|Second Treatment Period||8
9999271|NCT01703663|11120883|FG000|COMPLETED|Second Treatment Period||11
9999272|NCT01703663|11120884|FG001|COMPLETED|Second Treatment Period||8
9999273|NCT01703663|11120883|FG000|NOT COMPLETED|Second Treatment Period||0
9999274|NCT01703663|11120884|FG001|NOT COMPLETED|Second Treatment Period||0
9999275|NCT01703702|11120892|FG000|STARTED|Overall Study||308
9999276|NCT01703702|11120893|FG001|STARTED|Overall Study||310
9999277|NCT01703702|11120892|FG000|COMPLETED|Overall Study||272
9999278|NCT01703702|11120893|FG001|COMPLETED|Overall Study||288
9999279|NCT01703702|11120892|FG000|NOT COMPLETED|Overall Study||36
9999280|NCT01703702|11120893|FG001|NOT COMPLETED|Overall Study||22
9999281|NCT01703741|11120904|FG000|STARTED|Overall Study||145
9999282|NCT01703741|11120904|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
9999283|NCT01703741|11120904|FG000|COMPLETED|Overall Study||127
9999284|NCT01703741|11120904|FG000|NOT COMPLETED|Overall Study||18
9999285|NCT01703819|11120910|FG000|STARTED|Overall Study||34
9999286|NCT01703819|11120911|FG001|STARTED|Overall Study||32
9999287|NCT01703819|11120910|FG000|COMPLETED|Overall Study||34
9999288|NCT01703819|11120911|FG001|COMPLETED|Overall Study||30
9999289|NCT01703819|11120910|FG000|NOT COMPLETED|Overall Study||0
9999290|NCT01703819|11120911|FG001|NOT COMPLETED|Overall Study||2
9999291|NCT01703832|11120919|FG000|STARTED|Overall Study||33
9999292|NCT01703832|11120920|FG001|STARTED|Overall Study||32
9999293|NCT01703832|11120919|FG000|COMPLETED|Overall Study||32
9999294|NCT01703832|11120920|FG001|COMPLETED|Overall Study||32
9999295|NCT01703832|11120919|FG000|NOT COMPLETED|Overall Study||1
9999296|NCT01703832|11120920|FG001|NOT COMPLETED|Overall Study||0
9999297|NCT01703845|11120928|FG000|STARTED|Overall Study|started are actually the randomized|16
9999298|NCT01703845|11120929|FG001|STARTED|Overall Study|started are actually the randomized|16
9999299|NCT01703845|11120928|FG000|COMPLETED|Overall Study||13
9999300|NCT01703845|11120929|FG001|COMPLETED|Overall Study||16
9999301|NCT01703845|11120928|FG000|NOT COMPLETED|Overall Study||3
9999302|NCT01703845|11120929|FG001|NOT COMPLETED|Overall Study||0
9999303|NCT01703858|11120940|FG000|STARTED|Overall Study||5
9999304|NCT01703858|11120941|FG001|STARTED|Overall Study||5
9999305|NCT01703858|11120942|FG002|STARTED|Overall Study||5
9999306|NCT01703858|11120940|FG000|COMPLETED|Overall Study||5
9999307|NCT01703858|11120941|FG001|COMPLETED|Overall Study||4
9999308|NCT01703858|11120942|FG002|COMPLETED|Overall Study||5
9999309|NCT01703858|11120940|FG000|NOT COMPLETED|Overall Study||0
9999310|NCT01703858|11120941|FG001|NOT COMPLETED|Overall Study||1
9999311|NCT01703858|11120942|FG002|NOT COMPLETED|Overall Study||0
9999312|NCT01703988|11120959|FG000|STARTED|Overall Study||8
9999313|NCT01703988|11120960|FG001|STARTED|Overall Study||8
9999314|NCT01703988|11120961|FG002|STARTED|Overall Study||9
9999315|NCT01703988|11120962|FG003|STARTED|Overall Study||9
9999316|NCT01703988|11120959|FG000|COMPLETED|Overall Study||8
9999317|NCT01703988|11120960|FG001|COMPLETED|Overall Study||8
9999318|NCT01703988|11120961|FG002|COMPLETED|Overall Study||9
9999319|NCT01703988|11120962|FG003|COMPLETED|Overall Study||8
9999320|NCT01703988|11120959|FG000|NOT COMPLETED|Overall Study||0
9999321|NCT01703988|11120960|FG001|NOT COMPLETED|Overall Study||0
9999322|NCT01703988|11120961|FG002|NOT COMPLETED|Overall Study||0
9999323|NCT01703988|11120962|FG003|NOT COMPLETED|Overall Study||1
9999324|NCT01704079|11120975|FG000|STARTED|Overall Study||72
9999325|NCT01704079|11120976|FG001|STARTED|Overall Study||144
9999326|NCT01704079|11120975|FG000|Entered Extension Study|Overall Study||53
9999327|NCT01704079|11120976|FG001|Entered Extension Study|Overall Study||102
9999328|NCT01704079|11120975|FG000|COMPLETED|Overall Study||58
9999329|NCT01704079|11120976|FG001|COMPLETED|Overall Study||121
9999330|NCT01704079|11120975|FG000|NOT COMPLETED|Overall Study||14
9999331|NCT01704079|11120976|FG001|NOT COMPLETED|Overall Study||23
9999332|NCT01704196|11120984|FG000|STARTED|Overall Study||90
9999333|NCT01704196|11120985|FG001|STARTED|Overall Study||89
9999334|NCT01704196|11120984|FG000|COMPLETED|Overall Study||71
9999335|NCT01704196|11120985|FG001|COMPLETED|Overall Study||65
9999336|NCT01704196|11120984|FG000|NOT COMPLETED|Overall Study||19
9999337|NCT01704196|11120985|FG001|NOT COMPLETED|Overall Study||24
9999338|NCT01704261|11120993|FG000|STARTED|Overall Study||154
9999339|NCT01704261|11120994|FG001|STARTED|Overall Study||153
9999340|NCT01704261|11120993|FG000|COMPLETED|Overall Study||141
9999341|NCT01704261|11120994|FG001|COMPLETED|Overall Study||138
9999342|NCT01704261|11120993|FG000|NOT COMPLETED|Overall Study||13
9999343|NCT01704261|11120994|FG001|NOT COMPLETED|Overall Study||15
9999344|NCT01704287|11121003|FG000|STARTED|Initial Treatment Period||180
9999345|NCT01704287|11121004|FG001|STARTED|Initial Treatment Period||181
9999346|NCT01704287|11121005|FG002|STARTED|Initial Treatment Period||179
9999347|NCT01704287|11121006|FG003|STARTED|Initial Treatment Period||0
9999348|NCT01704287|11121007|FG004|STARTED|Initial Treatment Period||0
9999349|NCT01704287|11121003|FG000|Treated|Initial Treatment Period||178
9999350|NCT01704287|11121004|FG001|Treated|Initial Treatment Period||179
9999351|NCT01704287|11121005|FG002|Treated|Initial Treatment Period||171
9999352|NCT01704287|11121006|FG003|Treated|Initial Treatment Period||0
9999353|NCT01704287|11121007|FG004|Treated|Initial Treatment Period||0
9999354|NCT01704287|11121003|FG000|COMPLETED|Initial Treatment Period||33
9999355|NCT01704287|11121004|FG001|COMPLETED|Initial Treatment Period||47
9999356|NCT01704287|11121005|FG002|COMPLETED|Initial Treatment Period||6
9999357|NCT01704287|11121006|FG003|COMPLETED|Initial Treatment Period||0
9999358|NCT01704287|11121007|FG004|COMPLETED|Initial Treatment Period||0
9999359|NCT01704287|11121003|FG000|NOT COMPLETED|Initial Treatment Period||147
9999360|NCT01704287|11121004|FG001|NOT COMPLETED|Initial Treatment Period||134
9999361|NCT01704287|11121005|FG002|NOT COMPLETED|Initial Treatment Period||173
9999362|NCT01704287|11121006|FG003|NOT COMPLETED|Initial Treatment Period||0
9999363|NCT01704287|11121007|FG004|NOT COMPLETED|Initial Treatment Period||0
9999364|NCT01704287|11121003|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0
9999365|NCT01704287|11121004|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0
9999366|NCT01704287|11121005|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0
9999367|NCT01704287|11121006|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53
9999368|NCT01704287|11121007|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45
9999369|NCT01704287|11121003|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0
9999370|NCT01704287|11121004|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0
9999371|NCT01704287|11121005|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0
9999372|NCT01704287|11121006|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15
9999373|NCT01704287|11121007|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7
9999374|NCT01704287|11121003|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
9999375|NCT01704287|11121004|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
9999376|NCT01704287|11121005|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
9999377|NCT01704287|11121006|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
9999378|NCT01704287|11121007|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
9999379|NCT01704456|11121028|FG000|STARTED|Overall Study||67
9999380|NCT01704456|11121029|FG001|STARTED|Overall Study||63
9999381|NCT01704456|11121028|FG000|COMPLETED|Overall Study||59
9999382|NCT01704456|11121029|FG001|COMPLETED|Overall Study||49
9999383|NCT01704456|11121028|FG000|NOT COMPLETED|Overall Study||8
9999384|NCT01704456|11121029|FG001|NOT COMPLETED|Overall Study||14
9999385|NCT01704495|11121039|FG000|STARTED|Subjects Randomized||162
9999386|NCT01704495|11121040|FG001|STARTED|Subjects Randomized||156
9999387|NCT01704495|11121041|FG002|STARTED|Subjects Randomized||160
9999388|NCT01704495|11121042|FG003|STARTED|Subjects Randomized||162
9999389|NCT01704495|11121039|FG000|COMPLETED|Subjects Randomized||140
9999390|NCT01704495|11121040|FG001|COMPLETED|Subjects Randomized||141
9999391|NCT01704495|11121041|FG002|COMPLETED|Subjects Randomized||144
9999392|NCT01704495|11121042|FG003|COMPLETED|Subjects Randomized||145
9999393|NCT01704495|11121039|FG000|NOT COMPLETED|Subjects Randomized||22
9999394|NCT01704495|11121040|FG001|NOT COMPLETED|Subjects Randomized||15
9999395|NCT01704495|11121041|FG002|NOT COMPLETED|Subjects Randomized||16
9999396|NCT01704495|11121042|FG003|NOT COMPLETED|Subjects Randomized||17
9999397|NCT01704495|11121039|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
9999398|NCT01704495|11121040|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
9999399|NCT01704495|11121041|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
9999400|NCT01704495|11121042|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
9999401|NCT01704495|11121039|FG000|COMPLETED|Optional Safety Extension||87
9999402|NCT01704495|11121040|FG001|COMPLETED|Optional Safety Extension||88
9999403|NCT01704495|11121041|FG002|COMPLETED|Optional Safety Extension||83
9999404|NCT01704495|11121042|FG003|COMPLETED|Optional Safety Extension||85
9999405|NCT01704495|11121039|FG000|NOT COMPLETED|Optional Safety Extension||29
9999406|NCT01704495|11121040|FG001|NOT COMPLETED|Optional Safety Extension||33
9999407|NCT01704495|11121041|FG002|NOT COMPLETED|Optional Safety Extension||31
9999408|NCT01704495|11121042|FG003|NOT COMPLETED|Optional Safety Extension||31
9999409|NCT01704521|11121054|FG000|STARTED|Overall Study||3
9999410|NCT01704521|11121055|FG001|STARTED|Overall Study||2
9999411|NCT01704521|11121054|FG000|COMPLETED|Overall Study||3
9999412|NCT01704521|11121055|FG001|COMPLETED|Overall Study||2
9999413|NCT01704521|11121054|FG000|NOT COMPLETED|Overall Study||0
9999414|NCT01704521|11121055|FG001|NOT COMPLETED|Overall Study||0
9999415|NCT01704599|11121061|FG000|STARTED|Overall Study|Study was started January 22, 2010|8
9999416|NCT01704599|11121061|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
9999417|NCT01704599|11121061|FG000|NOT COMPLETED|Overall Study||1
9999418|NCT01704651|11121090|FG000|STARTED|Overall Study||71
9999419|NCT01704651|11121091|FG001|STARTED|Overall Study||75
9999420|NCT01704651|11121090|FG000|COMPLETED|Overall Study||66
9999421|NCT01704651|11121091|FG001|COMPLETED|Overall Study||68
9999422|NCT01704651|11121090|FG000|NOT COMPLETED|Overall Study||5
9999423|NCT01704651|11121091|FG001|NOT COMPLETED|Overall Study||7
9999424|NCT01704755|11121099|FG000|STARTED|Overall Study||208
9999425|NCT01704755|11121100|FG001|STARTED|Overall Study||172
9999426|NCT01704755|11121099|FG000|Completed Study Drug|Overall Study||204
9999427|NCT01704755|11121100|FG001|Completed Study Drug|Overall Study||163
9999428|NCT01704755|11121099|FG000|COMPLETED|Overall Study||196
9999429|NCT01704755|11121100|FG001|COMPLETED|Overall Study||165
9999430|NCT01704755|11121099|FG000|NOT COMPLETED|Overall Study||12
9999431|NCT01704755|11121100|FG001|NOT COMPLETED|Overall Study||7
9999432|NCT01704781|11121111|FG000|STARTED|Overall Study||3
9999433|NCT01704781|11121112|FG001|STARTED|Overall Study||3
9999434|NCT01704781|11121113|FG002|STARTED|Overall Study||6
9999435|NCT01704781|11121114|FG003|STARTED|Overall Study||12
9999436|NCT01704781|11121115|FG004|STARTED|Overall Study||12
9999437|NCT01704781|11121111|FG000|COMPLETED|Overall Study||3
9999438|NCT01704781|11121112|FG001|COMPLETED|Overall Study||3
9999439|NCT01704781|11121113|FG002|COMPLETED|Overall Study||6
9999440|NCT01704781|11121114|FG003|COMPLETED|Overall Study||12
9999441|NCT01704781|11121115|FG004|COMPLETED|Overall Study||12
9999442|NCT01704781|11121111|FG000|NOT COMPLETED|Overall Study||0
9999443|NCT01704781|11121112|FG001|NOT COMPLETED|Overall Study||0
9999444|NCT01704781|11121113|FG002|NOT COMPLETED|Overall Study||0
9999445|NCT01704781|11121114|FG003|NOT COMPLETED|Overall Study||0
9999446|NCT01704781|11121115|FG004|NOT COMPLETED|Overall Study||0
9999447|NCT01704846|11121131|FG000|STARTED|Treatment Period 1||30
9999448|NCT01704846|11121132|FG001|STARTED|Treatment Period 1||30
9999449|NCT01704846|11121131|FG000|COMPLETED|Treatment Period 1||30
9999450|NCT01704846|11121132|FG001|COMPLETED|Treatment Period 1||30
9999451|NCT01704846|11121131|FG000|NOT COMPLETED|Treatment Period 1||0
9999452|NCT01704846|11121132|FG001|NOT COMPLETED|Treatment Period 1||0
9999453|NCT01704846|11121131|FG000|STARTED|Treatment Period 2||30
9999454|NCT01704846|11121132|FG001|STARTED|Treatment Period 2||30
9999455|NCT01704846|11121131|FG000|COMPLETED|Treatment Period 2||30
9999456|NCT01704846|11121132|FG001|COMPLETED|Treatment Period 2||29
9999457|NCT01704846|11121131|FG000|NOT COMPLETED|Treatment Period 2||0
9999458|NCT01704846|11121132|FG001|NOT COMPLETED|Treatment Period 2||1
9999459|NCT01704846|11121131|FG000|STARTED|Treatment Period 3||30
9999460|NCT01704846|11121132|FG001|STARTED|Treatment Period 3||29
9999461|NCT01704846|11121131|FG000|COMPLETED|Treatment Period 3||30
9999462|NCT01704846|11121132|FG001|COMPLETED|Treatment Period 3||29
9999463|NCT01704846|11121131|FG000|NOT COMPLETED|Treatment Period 3||0
9999464|NCT01704846|11121132|FG001|NOT COMPLETED|Treatment Period 3||0
9999465|NCT01704846|11121131|FG000|STARTED|Treatment Period 4||30
9999466|NCT01704846|11121132|FG001|STARTED|Treatment Period 4||29
9999467|NCT01704846|11121131|FG000|COMPLETED|Treatment Period 4||30
9999468|NCT01704846|11121132|FG001|COMPLETED|Treatment Period 4||29
9999469|NCT01704846|11121131|FG000|NOT COMPLETED|Treatment Period 4||0
9999470|NCT01704846|11121132|FG001|NOT COMPLETED|Treatment Period 4||0
9999471|NCT01704976|11121140|FG000|STARTED|Overall Study||14
9999472|NCT01704976|11121141|FG001|STARTED|Overall Study||13
9999473|NCT01704976|11121140|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
9999474|NCT01704976|11121141|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
9999475|NCT01704976|11121140|FG000|NOT COMPLETED|Overall Study||1
9999476|NCT01704976|11121141|FG001|NOT COMPLETED|Overall Study||2
9999477|NCT01705080|11121150|FG000|STARTED|Overall Study||147
9999478|NCT01705080|11121151|FG001|STARTED|Overall Study||101
9999479|NCT01705080|11121152|FG002|STARTED|Overall Study||28
9999480|NCT01705080|11121150|FG000|Renal Artery Ablation Procedure|Overall Study||147
9999481|NCT01705080|11121151|FG001|Renal Artery Ablation Procedure|Overall Study||101
9999482|NCT01705080|11121152|FG002|Renal Artery Ablation Procedure|Overall Study||28
9999483|NCT01705080|11121150|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
9999484|NCT01705080|11121151|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
9999485|NCT01705080|11121152|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
9999486|NCT01705080|11121150|FG000|COMPLETED|Overall Study||72
9999487|NCT01705080|11121151|FG001|COMPLETED|Overall Study||49
9999488|NCT01705080|11121152|FG002|COMPLETED|Overall Study||12
9999489|NCT01705080|11121150|FG000|NOT COMPLETED|Overall Study||75
9999490|NCT01705080|11121151|FG001|NOT COMPLETED|Overall Study||52
9999491|NCT01705080|11121152|FG002|NOT COMPLETED|Overall Study||16
9999492|NCT01705145|11121160|FG000|STARTED|Part A||9
9999493|NCT01705145|11121160|FG000|COMPLETED|Part A||9
9999494|NCT01705145|11121160|FG000|NOT COMPLETED|Part A||0
9999495|NCT01705145|11121160|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
9999496|NCT01705145|11121160|FG000|COMPLETED|Part B||33
9999497|NCT01705145|11121160|FG000|NOT COMPLETED|Part B||1
9999498|NCT01705236|11121176|FG000|STARTED|Overall Study||87
9999499|NCT01705236|11121176|FG000|COMPLETED|Overall Study||60
9999500|NCT01705236|11121176|FG000|NOT COMPLETED|Overall Study||27
9999501|NCT01705288|11121182|FG000|STARTED|Overall Study||52
9999502|NCT01705288|11121183|FG001|STARTED|Overall Study||51
9999503|NCT01705288|11121182|FG000|COMPLETED|Overall Study||52
9999504|NCT01705288|11121183|FG001|COMPLETED|Overall Study||51
9999505|NCT01705288|11121182|FG000|NOT COMPLETED|Overall Study||0
9999506|NCT01705288|11121183|FG001|NOT COMPLETED|Overall Study||0
9999507|NCT01705496|11121189|FG000|STARTED|Overall Study||23
9999508|NCT01705496|11121189|FG000|COMPLETED|Overall Study||19
9999509|NCT01705496|11121189|FG000|NOT COMPLETED|Overall Study||4
9999510|NCT01705509|11121193|FG000|STARTED|Inclusion CPET||14
9999511|NCT01705509|11121193|FG000|COMPLETED|Inclusion CPET||7
9999512|NCT01705509|11121193|FG000|NOT COMPLETED|Inclusion CPET||7
9999513|NCT01705509|11121193|FG000|STARTED|CPET w/ Ranexa||7
9999514|NCT01705509|11121193|FG000|COMPLETED|CPET w/ Ranexa||5
9999515|NCT01705509|11121193|FG000|NOT COMPLETED|CPET w/ Ranexa||2
9999516|NCT01705574|11121199|FG000|STARTED|Double-Blind Phase||293
9999517|NCT01705574|11121200|FG001|STARTED|Double-Blind Phase||290
9999518|NCT01705574|11121201|FG002|STARTED|Double-Blind Phase||0
9999519|NCT01705574|11121202|FG003|STARTED|Double-Blind Phase||0
9999520|NCT01705574|11121199|FG000|COMPLETED|Double-Blind Phase||260
9999521|NCT01705574|11121200|FG001|COMPLETED|Double-Blind Phase||249
9999522|NCT01705574|11121201|FG002|COMPLETED|Double-Blind Phase||0
9999523|NCT01705574|11121202|FG003|COMPLETED|Double-Blind Phase||0
9999524|NCT01705574|11121199|FG000|NOT COMPLETED|Double-Blind Phase||33
9999525|NCT01705574|11121200|FG001|NOT COMPLETED|Double-Blind Phase||41
9999526|NCT01705574|11121201|FG002|NOT COMPLETED|Double-Blind Phase||0
9999527|NCT01705574|11121202|FG003|NOT COMPLETED|Double-Blind Phase||0
9999528|NCT01705574|11121199|FG000|STARTED|Open-Label Extension Phase||246
9999529|NCT01705574|11121200|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
9999530|NCT01705574|11121201|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
9999531|NCT01705574|11121202|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
9999532|NCT01705574|11121199|FG000|COMPLETED|Open-Label Extension Phase||231
9999533|NCT01705574|11121200|FG001|COMPLETED|Open-Label Extension Phase||0
9999534|NCT01705574|11121201|FG002|COMPLETED|Open-Label Extension Phase||148
9999535|NCT01705574|11121202|FG003|COMPLETED|Open-Label Extension Phase||48
9999536|NCT01705574|11121199|FG000|NOT COMPLETED|Open-Label Extension Phase||15
9999537|NCT01705574|11121200|FG001|NOT COMPLETED|Open-Label Extension Phase||0
9999538|NCT01705574|11121201|FG002|NOT COMPLETED|Open-Label Extension Phase||11
9999539|NCT01705574|11121202|FG003|NOT COMPLETED|Open-Label Extension Phase||5
9999540|NCT01705587|11121220|FG000|STARTED|Overall Study||7
9999541|NCT01705587|11121221|FG001|STARTED|Overall Study||6
9999542|NCT01705587|11121220|FG000|COMPLETED|Overall Study||7
9999543|NCT01705587|11121221|FG001|COMPLETED|Overall Study||5
9999544|NCT01705587|11121220|FG000|NOT COMPLETED|Overall Study||0
9999545|NCT01705587|11121221|FG001|NOT COMPLETED|Overall Study||1
9999546|NCT01705652|11121229|FG000|STARTED|Overall Study||9
9999547|NCT01705652|11121230|FG001|STARTED|Overall Study||12
9999548|NCT01705652|11121229|FG000|COMPLETED|Overall Study||6
9999549|NCT01705652|11121230|FG001|COMPLETED|Overall Study||9
9999550|NCT01705652|11121229|FG000|NOT COMPLETED|Overall Study||3
9999551|NCT01705652|11121230|FG001|NOT COMPLETED|Overall Study||3
9999552|NCT01705691|11121238|FG000|STARTED|Overall Study||19
9999553|NCT01705691|11121239|FG001|STARTED|Overall Study||30
9999554|NCT01705691|11121238|FG000|COMPLETED|Overall Study||16
9999555|NCT01705691|11121239|FG001|COMPLETED|Overall Study||24
9999556|NCT01705691|11121238|FG000|NOT COMPLETED|Overall Study||3
9999557|NCT01705691|11121239|FG001|NOT COMPLETED|Overall Study||6
9999558|NCT01705717|11121247|FG000|STARTED|Overall Study||37
9999559|NCT01705717|11121248|FG001|STARTED|Overall Study||12
9999560|NCT01705717|11121247|FG000|COMPLETED|Overall Study||35
9999561|NCT01705717|11121248|FG001|COMPLETED|Overall Study||7
9999562|NCT01705717|11121247|FG000|NOT COMPLETED|Overall Study||2
9999563|NCT01705717|11121248|FG001|NOT COMPLETED|Overall Study||5
9999564|NCT01705730|11121253|FG000|STARTED|Overall Study|Participants who received study drug|68
9999565|NCT01705730|11121253|FG000|COMPLETED|Overall Study||59
9999566|NCT01705730|11121253|FG000|NOT COMPLETED|Overall Study||9
9999567|NCT01705964|11121259|FG000|STARTED|Overall Study||25
9999568|NCT01705964|11121260|FG001|STARTED|Overall Study||24
9999569|NCT01705964|11121259|FG000|COMPLETED|Overall Study||25
9999570|NCT01705964|11121260|FG001|COMPLETED|Overall Study||24
9999571|NCT01705964|11121259|FG000|NOT COMPLETED|Overall Study||0
9999572|NCT01705964|11121260|FG001|NOT COMPLETED|Overall Study||0
9999573|NCT01706003|11121268|FG000|STARTED|Overall Study||23
9999574|NCT01706003|11121269|FG001|STARTED|Overall Study||22
9999575|NCT01706003|11121268|FG000|COMPLETED|Overall Study||12
9999576|NCT01706003|11121269|FG001|COMPLETED|Overall Study||18
9999577|NCT01706003|11121268|FG000|NOT COMPLETED|Overall Study||11
9999578|NCT01706003|11121269|FG001|NOT COMPLETED|Overall Study||4
9999579|NCT01706081|11121277|FG000|STARTED|Overall Study||40
9999580|NCT01706081|11121278|FG001|STARTED|Overall Study||42
9999581|NCT01706081|11121277|FG000|COMPLETED|Overall Study||40
9999582|NCT01706081|11121278|FG001|COMPLETED|Overall Study||42
9999583|NCT01706081|11121277|FG000|NOT COMPLETED|Overall Study||0
9999584|NCT01706081|11121278|FG001|NOT COMPLETED|Overall Study||0
9999585|NCT01706146|11121284|FG000|STARTED|Overall Study||59
9999586|NCT01706146|11121284|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
9999587|NCT01706146|11121284|FG000|NOT COMPLETED|Overall Study||6
9999588|NCT01706159|11121290|FG000|STARTED|Overall Study||14
9999589|NCT01706159|11121291|FG001|STARTED|Overall Study||6
9999590|NCT01706159|11121290|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
9999591|NCT01706159|11121291|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5
9999592|NCT01706159|11121290|FG000|Completers (With Baron Score at Week 8)|Overall Study||6
9999593|NCT01706159|11121291|FG001|Completers (With Baron Score at Week 8)|Overall Study||3
9999594|NCT01706159|11121290|FG000|COMPLETED|Overall Study||6
9999595|NCT01706159|11121291|FG001|COMPLETED|Overall Study||4
9999596|NCT01706159|11121290|FG000|NOT COMPLETED|Overall Study||8
9999597|NCT01706159|11121291|FG001|NOT COMPLETED|Overall Study||2
9999598|NCT01706198|11121299|FG000|STARTED|Overall Study||2119
9999599|NCT01706198|11121300|FG001|STARTED|Overall Study||2114
9999600|NCT01706198|11121299|FG000|COMPLETED|Overall Study||1946
9999601|NCT01706198|11121300|FG001|COMPLETED|Overall Study||1920
9999602|NCT01706198|11121299|FG000|NOT COMPLETED|Overall Study||173
9999603|NCT01706198|11121300|FG001|NOT COMPLETED|Overall Study||194
9999604|NCT01706250|11121306|FG000|STARTED|Overall Study||20
9999605|NCT01706250|11121306|FG000|COMPLETED|Overall Study||18
9999606|NCT01706250|11121306|FG000|NOT COMPLETED|Overall Study||2
9999607|NCT01706263|11121315|FG000|STARTED|Overall Study||28
9999608|NCT01706263|11121315|FG000|COMPLETED|Overall Study||28
9999609|NCT01706263|11121315|FG000|NOT COMPLETED|Overall Study||0
9999610|NCT01706328|11121322|FG000|STARTED|2-week Run-in Period||993
10202233|NCT03442777|11329354|FG002|STARTED|Overall Study|No participants received dressings|546
10202234|NCT03442777|11329352|FG000|COMPLETED|Overall Study||534
9999611|NCT01706328|11121323|FG001|STARTED|2-week Run-in Period||0
9999612|NCT01706328|11121324|FG002|STARTED|2-week Run-in Period||0
9999613|NCT01706328|11121322|FG000|COMPLETED|2-week Run-in Period||828
10103676|NCT02426541|11233336|FG001|STARTED|Overall Study||16
10103677|NCT02426541|11233335|FG000|COMPLETED|Overall Study||15
9999614|NCT01706328|11121323|FG001|COMPLETED|2-week Run-in Period||0
9999615|NCT01706328|11121324|FG002|COMPLETED|2-week Run-in Period||0
9999616|NCT01706328|11121322|FG000|NOT COMPLETED|2-week Run-in Period||165
9999617|NCT01706328|11121323|FG001|NOT COMPLETED|2-week Run-in Period||0
9999618|NCT01706328|11121324|FG002|NOT COMPLETED|2-week Run-in Period||0
9999619|NCT01706328|11121322|FG000|STARTED|12-week Double-blind Treatment Period||0
9999620|NCT01706328|11121323|FG001|STARTED|12-week Double-blind Treatment Period||412
9999621|NCT01706328|11121324|FG002|STARTED|12-week Double-blind Treatment Period||416
9999622|NCT01706328|11121322|FG000|COMPLETED|12-week Double-blind Treatment Period||0
9999623|NCT01706328|11121323|FG001|COMPLETED|12-week Double-blind Treatment Period||366
10103678|NCT02426541|11233336|FG001|COMPLETED|Overall Study||16
9999624|NCT01706328|11121324|FG002|COMPLETED|12-week Double-blind Treatment Period||371
9999625|NCT01706328|11121322|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0
9999626|NCT01706328|11121323|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46
9999627|NCT01706328|11121324|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45
10202235|NCT03442777|11329353|FG001|COMPLETED|Overall Study||532
10202236|NCT03442777|11329354|FG002|COMPLETED|Overall Study||539
10202237|NCT03442777|11329352|FG000|NOT COMPLETED|Overall Study||8
9999628|NCT01706458|11121332|FG000|STARTED|Overall Study||9
9999629|NCT01706458|11121333|FG001|STARTED|Overall Study||9
10202238|NCT03442777|11329353|FG001|NOT COMPLETED|Overall Study||13
10202239|NCT03442777|11329354|FG002|NOT COMPLETED|Overall Study||7
10202240|NCT03442829|11329362|FG000|STARTED|Overall Study||27
10202241|NCT03442829|11329363|FG001|STARTED|Overall Study||27
9999630|NCT01706458|11121332|FG000|COMPLETED|Overall Study||6
9999631|NCT01706458|11121333|FG001|COMPLETED|Overall Study||5
9999632|NCT01706458|11121332|FG000|NOT COMPLETED|Overall Study||3
9999633|NCT01706458|11121333|FG001|NOT COMPLETED|Overall Study||4
9999634|NCT01706497|11121339|FG000|STARTED|Overall Study||177
9999635|NCT01706497|11121339|FG000|COMPLETED|Overall Study||177
9999636|NCT01706497|11121339|FG000|NOT COMPLETED|Overall Study||0
9999637|NCT01706536|11121348|FG000|STARTED|Overall Study||57
9999638|NCT01706536|11121349|FG001|STARTED|Overall Study||55
9999639|NCT01706536|11121350|FG002|STARTED|Overall Study||54
9999640|NCT01706536|11121351|FG003|STARTED|Overall Study||57
9999641|NCT01706536|11121352|FG004|STARTED|Overall Study||59
9999642|NCT01706536|11121348|FG000|COMPLETED|Overall Study||53
9999643|NCT01706536|11121349|FG001|COMPLETED|Overall Study||51
9999644|NCT01706536|11121350|FG002|COMPLETED|Overall Study||49
9999645|NCT01706536|11121351|FG003|COMPLETED|Overall Study||53
9999646|NCT01706536|11121352|FG004|COMPLETED|Overall Study||57
9999647|NCT01706536|11121348|FG000|NOT COMPLETED|Overall Study||4
9999648|NCT01706536|11121349|FG001|NOT COMPLETED|Overall Study||4
9999649|NCT01706536|11121350|FG002|NOT COMPLETED|Overall Study||5
9999650|NCT01706536|11121351|FG003|NOT COMPLETED|Overall Study||4
9999651|NCT01706536|11121352|FG004|NOT COMPLETED|Overall Study||2
9999652|NCT01706549|11121365|FG000|STARTED|Overall Study||16
9999653|NCT01706549|11121365|FG000|COMPLETED|Overall Study||16
9999654|NCT01706549|11121365|FG000|NOT COMPLETED|Overall Study||0
9999655|NCT01706575|11121369|FG000|STARTED|Overall Study||76
9999656|NCT01706575|11121369|FG000|Treated|Overall Study||70
9999657|NCT01706575|11121369|FG000|COMPLETED|Overall Study||64
9999658|NCT01706575|11121369|FG000|NOT COMPLETED|Overall Study||12
9999659|NCT01706588|11121378|FG000|STARTED|Overall Study||15
9999660|NCT01706588|11121379|FG001|STARTED|Overall Study||15
9999661|NCT01706588|11121380|FG002|STARTED|Overall Study||15
9999662|NCT01706588|11121381|FG003|STARTED|Overall Study||14
9999663|NCT01706588|11121382|FG004|STARTED|Overall Study||16
9999664|NCT01706588|11121378|FG000|COMPLETED|Overall Study||15
9999665|NCT01706588|11121379|FG001|COMPLETED|Overall Study||15
9999666|NCT01706588|11121380|FG002|COMPLETED|Overall Study||15
9999667|NCT01706588|11121381|FG003|COMPLETED|Overall Study||14
9999668|NCT01706588|11121382|FG004|COMPLETED|Overall Study||16
9999669|NCT01706588|11121378|FG000|NOT COMPLETED|Overall Study||0
9999670|NCT01706588|11121379|FG001|NOT COMPLETED|Overall Study||0
9999671|NCT01706588|11121380|FG002|NOT COMPLETED|Overall Study||0
9999672|NCT01706588|11121381|FG003|NOT COMPLETED|Overall Study||0
9999673|NCT01706588|11121382|FG004|NOT COMPLETED|Overall Study||0
9999674|NCT01706666|11121397|FG000|STARTED|Overall Study||1
9999675|NCT01706666|11121398|FG001|STARTED|Overall Study||1
9999676|NCT01706666|11121399|FG002|STARTED|Overall Study||1
9999677|NCT01706666|11121397|FG000|COMPLETED|Overall Study||1
9999678|NCT01706666|11121398|FG001|COMPLETED|Overall Study||1
9999679|NCT01706666|11121399|FG002|COMPLETED|Overall Study||1
9999680|NCT01706666|11121397|FG000|NOT COMPLETED|Overall Study||0
9999681|NCT01706666|11121398|FG001|NOT COMPLETED|Overall Study||0
9999682|NCT01706666|11121399|FG002|NOT COMPLETED|Overall Study||0
9999683|NCT01706770|11121409|FG000|STARTED|Overall Study||33
9999684|NCT01706770|11121410|FG001|STARTED|Overall Study||17
9999685|NCT01706770|11121409|FG000|COMPLETED|Overall Study||31
9999686|NCT01706770|11121410|FG001|COMPLETED|Overall Study||17
9999687|NCT01706770|11121409|FG000|NOT COMPLETED|Overall Study||2
9999688|NCT01706770|11121410|FG001|NOT COMPLETED|Overall Study||0
9999689|NCT01706822|11121416|FG000|STARTED|Overall Study||8
9999690|NCT01706822|11121416|FG000|COMPLETED|Overall Study||8
9999691|NCT01706822|11121416|FG000|NOT COMPLETED|Overall Study||0
9999692|NCT01706926|11121424|FG000|STARTED|Overall Study||81
9999693|NCT01706926|11121425|FG001|STARTED|Overall Study||81
9999694|NCT01706926|11121426|FG002|STARTED|Overall Study||85
9999695|NCT01706926|11121427|FG003|STARTED|Overall Study||79
9999696|NCT01706926|11121424|FG000|COMPLETED|Overall Study||75
9999697|NCT01706926|11121425|FG001|COMPLETED|Overall Study||77
9999698|NCT01706926|11121426|FG002|COMPLETED|Overall Study||79
9999699|NCT01706926|11121427|FG003|COMPLETED|Overall Study||74
9999700|NCT01706926|11121424|FG000|NOT COMPLETED|Overall Study||6
9999701|NCT01706926|11121425|FG001|NOT COMPLETED|Overall Study||4
10202242|NCT03442829|11329362|FG000|COMPLETED|Overall Study||23
10202243|NCT03442829|11329363|FG001|COMPLETED|Overall Study||25
9999702|NCT01706926|11121426|FG002|NOT COMPLETED|Overall Study||6
9999703|NCT01706926|11121427|FG003|NOT COMPLETED|Overall Study||5
9999704|NCT01706952|11121440|FG000|STARTED|Overall Study||45
9999705|NCT01706952|11121440|FG000|COMPLETED|Overall Study||37
9999706|NCT01706952|11121440|FG000|NOT COMPLETED|Overall Study||8
9999707|NCT01706965|11121448|FG000|STARTED|Overall Study||14
9999708|NCT01706965|11121449|FG001|STARTED|Overall Study||13
9999709|NCT01706965|11121448|FG000|COMPLETED|Overall Study||13
9999710|NCT01706965|11121449|FG001|COMPLETED|Overall Study||12
9999711|NCT01706965|11121448|FG000|NOT COMPLETED|Overall Study||1
9999712|NCT01706965|11121449|FG001|NOT COMPLETED|Overall Study||1
9999713|NCT01706978|11121457|FG000|STARTED|Overall Study||47
9999714|NCT01706978|11121458|FG001|STARTED|Overall Study||41
9999715|NCT01706978|11121457|FG000|COMPLETED|Overall Study||38
9999716|NCT01706978|11121458|FG001|COMPLETED|Overall Study||35
9999717|NCT01706978|11121457|FG000|NOT COMPLETED|Overall Study||9
9999718|NCT01706978|11121458|FG001|NOT COMPLETED|Overall Study||6
10018608|NCT01824498|11141690|FG005|COMPLETED|Washout (8 Weeks)||4
10018609|NCT01824498|11141685|FG000|NOT COMPLETED|Washout (8 Weeks)||2
10018610|NCT01824498|11141686|FG001|NOT COMPLETED|Washout (8 Weeks)||0
10018611|NCT01824498|11141687|FG002|NOT COMPLETED|Washout (8 Weeks)||2
10018612|NCT01824498|11141688|FG003|NOT COMPLETED|Washout (8 Weeks)||1
10018613|NCT01824498|11141689|FG004|NOT COMPLETED|Washout (8 Weeks)||1
10018614|NCT01824498|11141690|FG005|NOT COMPLETED|Washout (8 Weeks)||0
10018615|NCT01824498|11141685|FG000|STARTED|2nd Intervention (8 Weeks)||3
10018616|NCT01824498|11141686|FG001|STARTED|2nd Intervention (8 Weeks)||2
10018617|NCT01824498|11141687|FG002|STARTED|2nd Intervention (8 Weeks)||4
10018618|NCT01824498|11141688|FG003|STARTED|2nd Intervention (8 Weeks)||2
10018619|NCT01824498|11141689|FG004|STARTED|2nd Intervention (8 Weeks)||3
10018620|NCT01824498|11141690|FG005|STARTED|2nd Intervention (8 Weeks)||4
10018621|NCT01824498|11141685|FG000|COMPLETED|2nd Intervention (8 Weeks)||3
10018622|NCT01824498|11141686|FG001|COMPLETED|2nd Intervention (8 Weeks)||2
10018623|NCT01824498|11141687|FG002|COMPLETED|2nd Intervention (8 Weeks)||4
10018624|NCT01824498|11141688|FG003|COMPLETED|2nd Intervention (8 Weeks)||2
10018625|NCT01824498|11141689|FG004|COMPLETED|2nd Intervention (8 Weeks)||3
10018626|NCT01824498|11141690|FG005|COMPLETED|2nd Intervention (8 Weeks)||4
10018627|NCT01824498|11141685|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10018628|NCT01824498|11141686|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10018629|NCT01824498|11141687|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10018630|NCT01824498|11141688|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10018631|NCT01824498|11141689|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10018632|NCT01824498|11141690|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10018633|NCT01824498|11141685|FG000|STARTED|Washout (8 Weeks)||3
10018634|NCT01824498|11141686|FG001|STARTED|Washout (8 Weeks)||2
10018635|NCT01824498|11141687|FG002|STARTED|Washout (8 Weeks)||4
10018636|NCT01824498|11141688|FG003|STARTED|Washout (8 Weeks)||2
10018637|NCT01824498|11141689|FG004|STARTED|Washout (8 Weeks)||3
10018638|NCT01824498|11141690|FG005|STARTED|Washout (8 Weeks)||4
10018639|NCT01824498|11141685|FG000|COMPLETED|Washout (8 Weeks)||3
10018640|NCT01824498|11141686|FG001|COMPLETED|Washout (8 Weeks)||2
10018641|NCT01824498|11141687|FG002|COMPLETED|Washout (8 Weeks)||4
10018642|NCT01824498|11141688|FG003|COMPLETED|Washout (8 Weeks)||2
10018643|NCT01824498|11141689|FG004|COMPLETED|Washout (8 Weeks)||3
10018644|NCT01824498|11141690|FG005|COMPLETED|Washout (8 Weeks)||4
10018645|NCT01824498|11141685|FG000|NOT COMPLETED|Washout (8 Weeks)||0
10018646|NCT01824498|11141686|FG001|NOT COMPLETED|Washout (8 Weeks)||0
10018647|NCT01824498|11141687|FG002|NOT COMPLETED|Washout (8 Weeks)||0
10018648|NCT01824498|11141688|FG003|NOT COMPLETED|Washout (8 Weeks)||0
10018649|NCT01824498|11141689|FG004|NOT COMPLETED|Washout (8 Weeks)||0
10018650|NCT01824498|11141690|FG005|NOT COMPLETED|Washout (8 Weeks)||0
10018651|NCT01824498|11141685|FG000|STARTED|3rd Intervention (8 Weeks)||3
10018652|NCT01824498|11141686|FG001|STARTED|3rd Intervention (8 Weeks)||2
10018653|NCT01824498|11141687|FG002|STARTED|3rd Intervention (8 Weeks)||4
10018654|NCT01824498|11141688|FG003|STARTED|3rd Intervention (8 Weeks)||2
10018655|NCT01824498|11141689|FG004|STARTED|3rd Intervention (8 Weeks)||3
10018656|NCT01824498|11141690|FG005|STARTED|3rd Intervention (8 Weeks)||4
10018657|NCT01824498|11141685|FG000|COMPLETED|3rd Intervention (8 Weeks)||3
10018658|NCT01824498|11141686|FG001|COMPLETED|3rd Intervention (8 Weeks)||2
10018659|NCT01824498|11141687|FG002|COMPLETED|3rd Intervention (8 Weeks)||4
10018660|NCT01824498|11141688|FG003|COMPLETED|3rd Intervention (8 Weeks)||2
10018661|NCT01824498|11141689|FG004|COMPLETED|3rd Intervention (8 Weeks)||3
10018662|NCT01824498|11141690|FG005|COMPLETED|3rd Intervention (8 Weeks)||4
10018663|NCT01824498|11141685|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10018664|NCT01824498|11141686|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10018665|NCT01824498|11141687|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10018666|NCT01824498|11141688|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10018667|NCT01824498|11141689|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10018668|NCT01824498|11141690|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10018669|NCT01824576|11141698|FG000|STARTED|Overall Study||9
10018670|NCT01824576|11141698|FG000|COMPLETED|Overall Study||7
10018671|NCT01824576|11141698|FG000|NOT COMPLETED|Overall Study||2
10018672|NCT01824589|11141706|FG000|STARTED|Overall Study||1
10018673|NCT01824589|11141707|FG001|STARTED|Overall Study||0
10018674|NCT01824589|11141708|FG002|STARTED|Overall Study||0
10018675|NCT01824589|11141709|FG003|STARTED|Overall Study||0
10018676|NCT01824589|11141706|FG000|COMPLETED|Overall Study||1
10018677|NCT01824589|11141707|FG001|COMPLETED|Overall Study||0
10018678|NCT01824589|11141708|FG002|COMPLETED|Overall Study||0
10018679|NCT01824589|11141709|FG003|COMPLETED|Overall Study||0
10018680|NCT01824589|11141706|FG000|NOT COMPLETED|Overall Study||0
10018681|NCT01824589|11141707|FG001|NOT COMPLETED|Overall Study||0
10018682|NCT01824589|11141708|FG002|NOT COMPLETED|Overall Study||0
9999719|NCT01707004|11121464|FG000|STARTED|Overall Study||20
9999720|NCT01707004|11121464|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
9999721|NCT01707004|11121464|FG000|NOT COMPLETED|Overall Study||3
9999722|NCT01707030|11121471|FG000|STARTED|Overall Study||67
9999723|NCT01707030|11121472|FG001|STARTED|Overall Study||71
9999724|NCT01707030|11121471|FG000|COMPLETED|Overall Study||56
9999725|NCT01707030|11121472|FG001|COMPLETED|Overall Study||54
9999726|NCT01707030|11121471|FG000|NOT COMPLETED|Overall Study||11
9999727|NCT01707030|11121472|FG001|NOT COMPLETED|Overall Study||17
9999728|NCT01707043|11121484|FG000|STARTED|Overall Study||10
9999729|NCT01707043|11121485|FG001|STARTED|Overall Study||10
9999730|NCT01707043|11121484|FG000|COMPLETED|Overall Study||10
9999731|NCT01707043|11121485|FG001|COMPLETED|Overall Study||10
9999732|NCT01707043|11121484|FG000|NOT COMPLETED|Overall Study||0
9999733|NCT01707043|11121485|FG001|NOT COMPLETED|Overall Study||0
9999734|NCT01707095|11121493|FG000|STARTED|Overall Study||42
9999735|NCT01707095|11121494|FG001|STARTED|Overall Study||42
9999736|NCT01707095|11121493|FG000|COMPLETED|Overall Study||42
9999737|NCT01707095|11121494|FG001|COMPLETED|Overall Study||42
9999738|NCT01707095|11121493|FG000|NOT COMPLETED|Overall Study||0
9999739|NCT01707095|11121494|FG001|NOT COMPLETED|Overall Study||0
9999740|NCT01707108|11121500|FG000|STARTED|Overall Study||60
9999741|NCT01707108|11121500|FG000|1 Year|Overall Study||60
9999742|NCT01707108|11121500|FG000|COMPLETED|Overall Study||60
9999743|NCT01707108|11121500|FG000|NOT COMPLETED|Overall Study||0
9999744|NCT01707147|11121505|FG000|STARTED|Overall Study||3219
9999745|NCT01707147|11121505|FG000|COMPLETED|Overall Study||3119
9999746|NCT01707147|11121505|FG000|NOT COMPLETED|Overall Study||100
9999747|NCT01707225|11121509|FG000|STARTED|Overall Study||10
9999748|NCT01707225|11121509|FG000|COMPLETED|Overall Study||10
9999749|NCT01707225|11121509|FG000|NOT COMPLETED|Overall Study||0
9999750|NCT01707238|11121515|FG000|STARTED|Overall Study||48
9999751|NCT01707238|11121516|FG001|STARTED|Overall Study||52
9999752|NCT01707238|11121515|FG000|COMPLETED|Overall Study||48
9999753|NCT01707238|11121516|FG001|COMPLETED|Overall Study||52
9999754|NCT01707238|11121515|FG000|NOT COMPLETED|Overall Study||0
9999755|NCT01707238|11121516|FG001|NOT COMPLETED|Overall Study||0
9999756|NCT01707290|11121525|FG000|STARTED|Overall Study||121
9999757|NCT01707290|11121526|FG001|STARTED|Overall Study||4
9999758|NCT01707290|11121525|FG000|COMPLETED|Overall Study||35
9999759|NCT01707290|11121526|FG001|COMPLETED|Overall Study||3
9999760|NCT01707290|11121525|FG000|NOT COMPLETED|Overall Study||86
9999761|NCT01707290|11121526|FG001|NOT COMPLETED|Overall Study||1
9999762|NCT01707368|11121535|FG000|STARTED|Overall Study||561
9999763|NCT01707368|11121535|FG000|COMPLETED|Overall Study||393
9999764|NCT01707368|11121535|FG000|NOT COMPLETED|Overall Study||168
9999765|NCT01707381|11121539|FG000|STARTED|Period 1||12
9999766|NCT01707381|11121540|FG001|STARTED|Period 1||13
9999767|NCT01707381|11121539|FG000|COMPLETED|Period 1||10
9999768|NCT01707381|11121540|FG001|COMPLETED|Period 1||11
9999769|NCT01707381|11121539|FG000|NOT COMPLETED|Period 1||2
9999770|NCT01707381|11121540|FG001|NOT COMPLETED|Period 1||2
9999771|NCT01707381|11121539|FG000|STARTED|Period 2||10
9999772|NCT01707381|11121540|FG001|STARTED|Period 2||11
9999773|NCT01707381|11121539|FG000|COMPLETED|Period 2||10
9999774|NCT01707381|11121540|FG001|COMPLETED|Period 2||11
9999775|NCT01707381|11121539|FG000|NOT COMPLETED|Period 2||0
9999776|NCT01707381|11121540|FG001|NOT COMPLETED|Period 2||0
9999777|NCT01707420|11121548|FG000|STARTED|Overall Study||18
9999778|NCT01707420|11121549|FG001|STARTED|Overall Study||18
9999779|NCT01707420|11121548|FG000|COMPLETED|Overall Study||18
9999780|NCT01707420|11121549|FG001|COMPLETED|Overall Study||18
9999781|NCT01707420|11121548|FG000|NOT COMPLETED|Overall Study||0
9999782|NCT01707420|11121549|FG001|NOT COMPLETED|Overall Study||0
9999783|NCT01707472|11121560|FG000|STARTED|Overall Study||4
9999784|NCT01707472|11121561|FG001|STARTED|Overall Study||6
9999785|NCT01707472|11121562|FG002|STARTED|Overall Study||8
9999786|NCT01707472|11121560|FG000|COMPLETED|Overall Study||4
9999787|NCT01707472|11121561|FG001|COMPLETED|Overall Study||6
9999788|NCT01707472|11121562|FG002|COMPLETED|Overall Study||8
9999789|NCT01707472|11121560|FG000|NOT COMPLETED|Overall Study||0
9999790|NCT01707472|11121561|FG001|NOT COMPLETED|Overall Study||0
9999791|NCT01707472|11121562|FG002|NOT COMPLETED|Overall Study||0
9999792|NCT01707654|11121570|FG000|STARTED|Overall Study||9
9999793|NCT01707654|11121570|FG000|COMPLETED|Overall Study||9
9999794|NCT01707654|11121570|FG000|NOT COMPLETED|Overall Study||0
9999795|NCT01707667|11121576|FG000|STARTED|Period 1||7
9999796|NCT01707667|11121577|FG001|STARTED|Period 1||6
9999797|NCT01707667|11121576|FG000|COMPLETED|Period 1||6
9999798|NCT01707667|11121577|FG001|COMPLETED|Period 1||6
9999799|NCT01707667|11121576|FG000|NOT COMPLETED|Period 1||1
9999800|NCT01707667|11121577|FG001|NOT COMPLETED|Period 1||0
9999801|NCT01707667|11121576|FG000|STARTED|Period 2||6
9999802|NCT01707667|11121577|FG001|STARTED|Period 2||6
9999803|NCT01707667|11121576|FG000|COMPLETED|Period 2||6
9999804|NCT01707667|11121577|FG001|COMPLETED|Period 2||6
9999805|NCT01707667|11121576|FG000|NOT COMPLETED|Period 2||0
9999806|NCT01707667|11121577|FG001|NOT COMPLETED|Period 2||0
9999807|NCT01707693|11121585|FG000|STARTED|Overall Study Allocation||59
9999808|NCT01707693|11121586|FG001|STARTED|Overall Study Allocation||62
9999809|NCT01707693|11121585|FG000|COMPLETED|Overall Study Allocation||46
9999810|NCT01707693|11121586|FG001|COMPLETED|Overall Study Allocation||54
9999811|NCT01707693|11121585|FG000|NOT COMPLETED|Overall Study Allocation||13
10103679|NCT02426541|11233335|FG000|NOT COMPLETED|Overall Study||1
10103680|NCT02426541|11233336|FG001|NOT COMPLETED|Overall Study||0
10103681|NCT02426580|11233344|FG000|STARTED|Overall Study|April 2015|70
10103682|NCT02426580|11233345|FG001|STARTED|Overall Study|January 2014|70
10103683|NCT02426580|11233344|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
10103684|NCT02426580|11233345|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
10103685|NCT02426580|11233344|FG000|NOT COMPLETED|Overall Study||11
10103686|NCT02426580|11233345|FG001|NOT COMPLETED|Overall Study||16
9999812|NCT01707693|11121586|FG001|NOT COMPLETED|Overall Study Allocation||8
9999813|NCT01707693|11121585|FG000|STARTED|Time 3 Measures @ 6 Mth||46
9999814|NCT01707693|11121586|FG001|STARTED|Time 3 Measures @ 6 Mth||54
9999815|NCT01707693|11121585|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46
9999816|NCT01707693|11121586|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49
9999817|NCT01707693|11121585|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
9999818|NCT01707693|11121586|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
9999819|NCT01707992|11121596|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740
9999820|NCT01707992|11121597|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727
9999821|NCT01707992|11121598|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732
9999822|NCT01707992|11121599|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0
9999823|NCT01707992|11121600|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0
9999824|NCT01707992|11121601|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0
9999825|NCT01707992|11121596|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596
9999826|NCT01707992|11121597|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623
9999827|NCT01707992|11121598|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532
9999828|NCT01707992|11121599|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0
9999829|NCT01707992|11121600|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0
9999830|NCT01707992|11121601|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0
9999831|NCT01707992|11121596|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
9999832|NCT01707992|11121597|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
9999833|NCT01707992|11121598|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
9999834|NCT01707992|11121599|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
9999835|NCT01707992|11121600|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
9999836|NCT01707992|11121601|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
9999837|NCT01707992|11121596|FG000|STARTED|Active Treatment Phase (24 Months)||0
9999838|NCT01707992|11121597|FG001|STARTED|Active Treatment Phase (24 Months)||0
9999839|NCT01707992|11121598|FG002|STARTED|Active Treatment Phase (24 Months)||0
9999840|NCT01707992|11121599|FG003|STARTED|Active Treatment Phase (24 Months)||891
9999841|NCT01707992|11121600|FG004|STARTED|Active Treatment Phase (24 Months)||504
9999842|NCT01707992|11121601|FG005|STARTED|Active Treatment Phase (24 Months)||215
9999843|NCT01707992|11121596|FG000|COMPLETED|Active Treatment Phase (24 Months)||0
9999844|NCT01707992|11121597|FG001|COMPLETED|Active Treatment Phase (24 Months)||0
9999845|NCT01707992|11121598|FG002|COMPLETED|Active Treatment Phase (24 Months)||0
9999846|NCT01707992|11121599|FG003|COMPLETED|Active Treatment Phase (24 Months)||7
9999847|NCT01707992|11121600|FG004|COMPLETED|Active Treatment Phase (24 Months)||10
9999848|NCT01707992|11121601|FG005|COMPLETED|Active Treatment Phase (24 Months)||0
9999849|NCT01707992|11121596|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0
9999850|NCT01707992|11121597|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0
9999851|NCT01707992|11121598|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0
9999852|NCT01707992|11121599|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884
9999853|NCT01707992|11121600|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494
9999854|NCT01707992|11121601|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215
9999855|NCT01708122|11121618|FG000|STARTED|Overall Study||27
10202244|NCT03442829|11329362|FG000|NOT COMPLETED|Overall Study||4
10202245|NCT03442829|11329363|FG001|NOT COMPLETED|Overall Study||2
10202246|NCT03442868|11329369|FG000|STARTED|Overall Study||15
10202247|NCT03442868|11329369|FG000|COMPLETED|Overall Study||15
10202248|NCT03442868|11329369|FG000|NOT COMPLETED|Overall Study||0
10202249|NCT03442933|11329373|FG000|STARTED|Overall Study||20
10202250|NCT03442933|11329374|FG001|STARTED|Overall Study||20
10202251|NCT03442933|11329373|FG000|COMPLETED|Overall Study||20
10202252|NCT03442933|11329374|FG001|COMPLETED|Overall Study||20
10202253|NCT03442933|11329373|FG000|NOT COMPLETED|Overall Study||0
10202254|NCT03442933|11329374|FG001|NOT COMPLETED|Overall Study||0
10202255|NCT03443024|11329387|FG000|STARTED|Overall Study||73
10202256|NCT03443024|11329388|FG001|STARTED|Overall Study||80
10202257|NCT03443024|11329389|FG002|STARTED|Overall Study||75
10202258|NCT03443024|11329390|FG003|STARTED|Overall Study||52
10202259|NCT03443024|11329387|FG000|Received at Least One Dose of Study Drug|Overall Study||73
10202260|NCT03443024|11329388|FG001|Received at Least One Dose of Study Drug|Overall Study||80
10202261|NCT03443024|11329389|FG002|Received at Least One Dose of Study Drug|Overall Study||75
10202262|NCT03443024|11329390|FG003|Received at Least One Dose of Study Drug|Overall Study||52
10202263|NCT03443024|11329387|FG000|COMPLETED|Overall Study||52
10202264|NCT03443024|11329388|FG001|COMPLETED|Overall Study||49
10202265|NCT03443024|11329389|FG002|COMPLETED|Overall Study||56
10202266|NCT03443024|11329390|FG003|COMPLETED|Overall Study||20
10202267|NCT03443024|11329387|FG000|NOT COMPLETED|Overall Study||21
10202268|NCT03443024|11329388|FG001|NOT COMPLETED|Overall Study||31
10202269|NCT03443024|11329389|FG002|NOT COMPLETED|Overall Study||19
10202270|NCT03443024|11329390|FG003|NOT COMPLETED|Overall Study||32
10202271|NCT03443063|11329402|FG000|STARTED|Overall Study||8
10202272|NCT03443063|11329403|FG001|STARTED|Overall Study||8
10202273|NCT03443063|11329402|FG000|COMPLETED|Overall Study||8
10202274|NCT03443063|11329403|FG001|COMPLETED|Overall Study||8
10202275|NCT03443063|11329402|FG000|NOT COMPLETED|Overall Study||0
10202276|NCT03443063|11329403|FG001|NOT COMPLETED|Overall Study||0
10202277|NCT03443414|11329416|FG000|STARTED|Overall Study||82
10202278|NCT03443414|11329417|FG001|STARTED|Overall Study||81
10202279|NCT03443414|11329418|FG002|STARTED|Overall Study||82
10202280|NCT03443414|11329419|FG003|STARTED|Overall Study||80
10202281|NCT03443414|11329420|FG004|STARTED|Overall Study||80
10202282|NCT03443414|11329416|FG000|Received Treatment|Overall Study||81
10202283|NCT03443414|11329417|FG001|Received Treatment|Overall Study||81
9999856|NCT01708122|11121619|FG001|STARTED|Overall Study||26
9999857|NCT01708122|11121618|FG000|COMPLETED|Overall Study||27
9999858|NCT01708122|11121619|FG001|COMPLETED|Overall Study||26
9999859|NCT01708122|11121618|FG000|NOT COMPLETED|Overall Study||0
9999860|NCT01708122|11121619|FG001|NOT COMPLETED|Overall Study||0
9999861|NCT01708161|11121631|FG000|STARTED|Overall Study||4
9999862|NCT01708161|11121632|FG001|STARTED|Overall Study||10
9999863|NCT01708161|11121633|FG002|STARTED|Overall Study||10
9999864|NCT01708161|11121634|FG003|STARTED|Overall Study||16
9999865|NCT01708161|11121635|FG004|STARTED|Overall Study||6
9999866|NCT01708161|11121636|FG005|STARTED|Overall Study||1
9999867|NCT01708161|11121631|FG000|COMPLETED|Overall Study||0
9999868|NCT01708161|11121632|FG001|COMPLETED|Overall Study||0
9999869|NCT01708161|11121633|FG002|COMPLETED|Overall Study||0
9999870|NCT01708161|11121634|FG003|COMPLETED|Overall Study||0
9999871|NCT01708161|11121635|FG004|COMPLETED|Overall Study||0
9999872|NCT01708161|11121636|FG005|COMPLETED|Overall Study||0
9999873|NCT01708161|11121631|FG000|NOT COMPLETED|Overall Study||4
9999874|NCT01708161|11121632|FG001|NOT COMPLETED|Overall Study||10
9999875|NCT01708161|11121633|FG002|NOT COMPLETED|Overall Study||10
9999876|NCT01708161|11121634|FG003|NOT COMPLETED|Overall Study||16
9999877|NCT01708161|11121635|FG004|NOT COMPLETED|Overall Study||6
9999878|NCT01708161|11121636|FG005|NOT COMPLETED|Overall Study||1
9999879|NCT01708174|11121653|FG000|STARTED|Treatment Period||2
9999880|NCT01708174|11121654|FG001|STARTED|Treatment Period||16
9999881|NCT01708174|11121655|FG002|STARTED|Treatment Period||4
9999882|NCT01708174|11121653|FG000|Pharmacokinetic Analysis Set|Treatment Period||2
9999883|NCT01708174|11121654|FG001|Pharmacokinetic Analysis Set|Treatment Period||13
9999884|NCT01708174|11121655|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
9999885|NCT01708174|11121653|FG000|COMPLETED|Treatment Period||1
9999886|NCT01708174|11121654|FG001|COMPLETED|Treatment Period||14
9999887|NCT01708174|11121655|FG002|COMPLETED|Treatment Period||3
9999888|NCT01708174|11121653|FG000|NOT COMPLETED|Treatment Period||1
9999889|NCT01708174|11121654|FG001|NOT COMPLETED|Treatment Period||2
9999890|NCT01708174|11121655|FG002|NOT COMPLETED|Treatment Period||1
9999891|NCT01708174|11121653|FG000|STARTED|Survival Follow-up||1
9999892|NCT01708174|11121654|FG001|STARTED|Survival Follow-up||10
9999893|NCT01708174|11121655|FG002|STARTED|Survival Follow-up||0
9999894|NCT01708174|11121653|FG000|COMPLETED|Survival Follow-up||1
9999895|NCT01708174|11121654|FG001|COMPLETED|Survival Follow-up||10
9999896|NCT01708174|11121655|FG002|COMPLETED|Survival Follow-up||0
9999897|NCT01708174|11121653|FG000|NOT COMPLETED|Survival Follow-up||0
9999898|NCT01708174|11121654|FG001|NOT COMPLETED|Survival Follow-up||0
9999899|NCT01708174|11121655|FG002|NOT COMPLETED|Survival Follow-up||0
9999900|NCT01708187|11121666|FG000|STARTED|Overall Study||1
9999901|NCT01708187|11121667|FG001|STARTED|Overall Study||1
9999902|NCT01708187|11121666|FG000|COMPLETED|Overall Study||1
9999903|NCT01708187|11121667|FG001|COMPLETED|Overall Study||0
9999904|NCT01708187|11121666|FG000|NOT COMPLETED|Overall Study||0
9999905|NCT01708187|11121667|FG001|NOT COMPLETED|Overall Study||1
9999906|NCT01708213|11121673|FG000|STARTED|Overall Study||72
9999907|NCT01708213|11121673|FG000|COMPLETED|Overall Study||71
9999908|NCT01708213|11121673|FG000|NOT COMPLETED|Overall Study||1
9999909|NCT01708278|11121683|FG000|STARTED|Overall Study||1
9999910|NCT01708278|11121684|FG001|STARTED|Overall Study||2
9999911|NCT01708278|11121685|FG002|STARTED|Overall Study||2
9999912|NCT01708278|11121686|FG003|STARTED|Overall Study||2
9999913|NCT01708278|11121687|FG004|STARTED|Overall Study||1
9999914|NCT01708278|11121688|FG005|STARTED|Overall Study||1
9999915|NCT01708278|11121683|FG000|COMPLETED|Overall Study||1
9999916|NCT01708278|11121684|FG001|COMPLETED|Overall Study||2
10202284|NCT03443414|11329418|FG002|Received Treatment|Overall Study||82
10202285|NCT03443414|11329419|FG003|Received Treatment|Overall Study||80
9999917|NCT01708278|11121685|FG002|COMPLETED|Overall Study||2
9999918|NCT01708278|11121686|FG003|COMPLETED|Overall Study||2
9999919|NCT01708278|11121687|FG004|COMPLETED|Overall Study||1
9999920|NCT01708278|11121688|FG005|COMPLETED|Overall Study||1
9999921|NCT01708278|11121683|FG000|NOT COMPLETED|Overall Study||0
10202286|NCT03443414|11329420|FG004|Received Treatment|Overall Study||79
9999922|NCT01708278|11121684|FG001|NOT COMPLETED|Overall Study||0
9999923|NCT01708278|11121685|FG002|NOT COMPLETED|Overall Study||0
9999924|NCT01708278|11121686|FG003|NOT COMPLETED|Overall Study||0
9999925|NCT01708278|11121687|FG004|NOT COMPLETED|Overall Study||0
9999926|NCT01708278|11121688|FG005|NOT COMPLETED|Overall Study||0
9999927|NCT01708291|11121704|FG000|STARTED|Overall Study||21
10202287|NCT03443414|11329416|FG000|COMPLETED|Overall Study||71
10202288|NCT03443414|11329417|FG001|COMPLETED|Overall Study||78
9999928|NCT01708291|11121705|FG001|STARTED|Overall Study||21
9999929|NCT01708291|11121704|FG000|COMPLETED|Overall Study||19
9999930|NCT01708291|11121705|FG001|COMPLETED|Overall Study||20
9999931|NCT01708291|11121704|FG000|NOT COMPLETED|Overall Study||2
9999932|NCT01708291|11121705|FG001|NOT COMPLETED|Overall Study||1
9999933|NCT01708317|11121711|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
9999934|NCT01708317|11121711|FG000|COMPLETED|2010 Control Period||3929
9999935|NCT01708317|11121711|FG000|NOT COMPLETED|2010 Control Period||0
9999936|NCT01708317|11121711|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
9999937|NCT01708317|11121711|FG000|COMPLETED|Initial Education Period||982
9999938|NCT01708317|11121711|FG000|NOT COMPLETED|Initial Education Period||0
9999939|NCT01708317|11121711|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
9999940|NCT01708317|11121711|FG000|COMPLETED|ACASI + Education Period||2601
9999941|NCT01708317|11121711|FG000|NOT COMPLETED|ACASI + Education Period||0
9999942|NCT01708317|11121711|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
9999943|NCT01708317|11121711|FG000|COMPLETED|Final Education Period||909
9999944|NCT01708317|11121711|FG000|NOT COMPLETED|Final Education Period||0
9999945|NCT01708525|11121718|FG000|STARTED|Overall Study||2
9999946|NCT01708525|11121718|FG000|COMPLETED|Overall Study||2
9999947|NCT01708525|11121718|FG000|NOT COMPLETED|Overall Study||0
9999948|NCT01708590|11121726|FG000|STARTED|Induction Phase||222
9999949|NCT01708590|11121727|FG001|STARTED|Induction Phase||219
9999950|NCT01708590|11121728|FG002|STARTED|Induction Phase||220
9999951|NCT01708590|11121729|FG003|STARTED|Induction Phase||0
9999952|NCT01708590|11121730|FG004|STARTED|Induction Phase||0
9999953|NCT01708590|11121731|FG005|STARTED|Induction Phase||0
9999954|NCT01708590|11121732|FG006|STARTED|Induction Phase||0
9999955|NCT01708590|11121726|FG000|COMPLETED|Induction Phase||212
9999956|NCT01708590|11121727|FG001|COMPLETED|Induction Phase||212
9999957|NCT01708590|11121728|FG002|COMPLETED|Induction Phase||209
9999958|NCT01708590|11121729|FG003|COMPLETED|Induction Phase||0
9999959|NCT01708590|11121730|FG004|COMPLETED|Induction Phase||0
9999960|NCT01708590|11121731|FG005|COMPLETED|Induction Phase||0
9999961|NCT01708590|11121732|FG006|COMPLETED|Induction Phase||0
9999962|NCT01708590|11121726|FG000|NOT COMPLETED|Induction Phase||10
9999963|NCT01708590|11121727|FG001|NOT COMPLETED|Induction Phase||7
9999964|NCT01708590|11121728|FG002|NOT COMPLETED|Induction Phase||11
9999965|NCT01708590|11121729|FG003|NOT COMPLETED|Induction Phase||0
9999966|NCT01708590|11121730|FG004|NOT COMPLETED|Induction Phase||0
9999967|NCT01708590|11121731|FG005|NOT COMPLETED|Induction Phase||0
9999968|NCT01708590|11121732|FG006|NOT COMPLETED|Induction Phase||0
9999969|NCT01708590|11121726|FG000|STARTED|Withdrawal Phase||0
9999970|NCT01708590|11121727|FG001|STARTED|Withdrawal Phase||0
9999971|NCT01708590|11121728|FG002|STARTED|Withdrawal Phase||0
9999972|NCT01708590|11121729|FG003|STARTED|Withdrawal Phase||59
9999973|NCT01708590|11121730|FG004|STARTED|Withdrawal Phase||57
9999974|NCT01708590|11121731|FG005|STARTED|Withdrawal Phase||84
9999975|NCT01708590|11121732|FG006|STARTED|Withdrawal Phase||83
9999976|NCT01708590|11121726|FG000|COMPLETED|Withdrawal Phase||0
9999977|NCT01708590|11121727|FG001|COMPLETED|Withdrawal Phase||0
9999978|NCT01708590|11121728|FG002|COMPLETED|Withdrawal Phase||0
9999979|NCT01708590|11121729|FG003|COMPLETED|Withdrawal Phase||6
9999980|NCT01708590|11121730|FG004|COMPLETED|Withdrawal Phase||45
9999981|NCT01708590|11121731|FG005|COMPLETED|Withdrawal Phase||2
9999982|NCT01708590|11121732|FG006|COMPLETED|Withdrawal Phase||74
9999983|NCT01708590|11121726|FG000|NOT COMPLETED|Withdrawal Phase||0
9999984|NCT01708590|11121727|FG001|NOT COMPLETED|Withdrawal Phase||0
9999985|NCT01708590|11121728|FG002|NOT COMPLETED|Withdrawal Phase||0
9999986|NCT01708590|11121729|FG003|NOT COMPLETED|Withdrawal Phase||53
9999987|NCT01708590|11121730|FG004|NOT COMPLETED|Withdrawal Phase||12
9999988|NCT01708590|11121731|FG005|NOT COMPLETED|Withdrawal Phase||82
9999989|NCT01708590|11121732|FG006|NOT COMPLETED|Withdrawal Phase||9
9999990|NCT01708603|11121749|FG000|STARTED|Overall Study||612
9999991|NCT01708603|11121750|FG001|STARTED|Overall Study||610
9999992|NCT01708603|11121751|FG002|STARTED|Overall Study||300
9999993|NCT01708603|11121752|FG003|STARTED|Overall Study||309
9999994|NCT01708603|11121749|FG000|COMPLETED|Overall Study||597
9999995|NCT01708603|11121750|FG001|COMPLETED|Overall Study||588
9999996|NCT01708603|11121751|FG002|COMPLETED|Overall Study||291
9999997|NCT01708603|11121752|FG003|COMPLETED|Overall Study||300
9999998|NCT01708603|11121749|FG000|NOT COMPLETED|Overall Study||15
9999999|NCT01708603|11121750|FG001|NOT COMPLETED|Overall Study||22
10000000|NCT01708603|11121751|FG002|NOT COMPLETED|Overall Study||9
10000001|NCT01708603|11121752|FG003|NOT COMPLETED|Overall Study||9
10000002|NCT01708629|11121771|FG000|STARTED|Overall Study||624
10000003|NCT01708629|11121772|FG001|STARTED|Overall Study||629
10000004|NCT01708629|11121773|FG002|STARTED|Overall Study||313
10000005|NCT01708629|11121774|FG003|STARTED|Overall Study||315
10000006|NCT01708629|11121771|FG000|COMPLETED|Overall Study||608
10000007|NCT01708629|11121772|FG001|COMPLETED|Overall Study||604
10000008|NCT01708629|11121773|FG002|COMPLETED|Overall Study||303
10000009|NCT01708629|11121774|FG003|COMPLETED|Overall Study||301
10000010|NCT01708629|11121771|FG000|NOT COMPLETED|Overall Study||16
10000011|NCT01708629|11121772|FG001|NOT COMPLETED|Overall Study||25
10000012|NCT01708629|11121773|FG002|NOT COMPLETED|Overall Study||10
10000013|NCT01708629|11121774|FG003|NOT COMPLETED|Overall Study||14
10000014|NCT01708902|11121791|FG000|STARTED|Overall Study||147
10000015|NCT01708902|11121792|FG001|STARTED|Overall Study||145
10000016|NCT01708902|11121793|FG002|STARTED|Overall Study||144
10000017|NCT01708902|11121794|FG003|STARTED|Overall Study||147
10000018|NCT01708902|11121795|FG004|STARTED|Overall Study||147
10000019|NCT01708902|11121796|FG005|STARTED|Overall Study||71
10000020|NCT01708902|11121797|FG006|STARTED|Overall Study||72
10000021|NCT01708902|11121791|FG000|COMPLETED|Overall Study||130
10000022|NCT01708902|11121792|FG001|COMPLETED|Overall Study||137
10000023|NCT01708902|11121793|FG002|COMPLETED|Overall Study||127
10000024|NCT01708902|11121794|FG003|COMPLETED|Overall Study||137
10103690|NCT02426918|11233358|FG000|STARTED|Overall Study||110
10103691|NCT02426918|11233359|FG001|STARTED|Overall Study||109
10103692|NCT02426918|11233360|FG002|STARTED|Overall Study||111
10000025|NCT01708902|11121795|FG004|COMPLETED|Overall Study||131
10000026|NCT01708902|11121796|FG005|COMPLETED|Overall Study||64
10000027|NCT01708902|11121797|FG006|COMPLETED|Overall Study||65
10000028|NCT01708902|11121791|FG000|NOT COMPLETED|Overall Study||17
10000029|NCT01708902|11121792|FG001|NOT COMPLETED|Overall Study||8
10000030|NCT01708902|11121793|FG002|NOT COMPLETED|Overall Study||17
10000031|NCT01708902|11121794|FG003|NOT COMPLETED|Overall Study||10
10000032|NCT01708902|11121795|FG004|NOT COMPLETED|Overall Study||16
10000033|NCT01708902|11121796|FG005|NOT COMPLETED|Overall Study||7
10000034|NCT01708902|11121797|FG006|NOT COMPLETED|Overall Study||7
10000035|NCT01708915|11121820|FG000|STARTED|Overall Study||204
10000036|NCT01708915|11121821|FG001|STARTED|Overall Study||201
10000037|NCT01708915|11121822|FG002|STARTED|Overall Study||198
10000038|NCT01708915|11121823|FG003|STARTED|Overall Study||202
10000039|NCT01708915|11121820|FG000|COMPLETED|Overall Study||118
10000040|NCT01708915|11121821|FG001|COMPLETED|Overall Study||139
10000041|NCT01708915|11121822|FG002|COMPLETED|Overall Study||152
10000042|NCT01708915|11121823|FG003|COMPLETED|Overall Study||169
10000043|NCT01708915|11121820|FG000|NOT COMPLETED|Overall Study||86
10000044|NCT01708915|11121821|FG001|NOT COMPLETED|Overall Study||62
10000045|NCT01708915|11121822|FG002|NOT COMPLETED|Overall Study||46
10000046|NCT01708915|11121823|FG003|NOT COMPLETED|Overall Study||33
10000047|NCT01708967|11121835|FG000|STARTED|Overall Study||50
10000048|NCT01708967|11121836|FG001|STARTED|Overall Study||50
10000049|NCT01708967|11121835|FG000|COMPLETED|Overall Study||50
10000050|NCT01708967|11121836|FG001|COMPLETED|Overall Study||43
10000051|NCT01708967|11121835|FG000|NOT COMPLETED|Overall Study||0
10000052|NCT01708967|11121836|FG001|NOT COMPLETED|Overall Study||7
10000053|NCT01709032|11121842|FG000|STARTED|Overall Study||9
10000054|NCT01709032|11121842|FG000|COMPLETED|Overall Study||6
10000055|NCT01709032|11121842|FG000|NOT COMPLETED|Overall Study||3
10000056|NCT01709084|11121849|FG000|STARTED|Overall Study||213
10000057|NCT01709084|11121850|FG001|STARTED|Overall Study||213
10000058|NCT01709084|11121849|FG000|Treated|Overall Study||213
10000059|NCT01709084|11121850|FG001|Treated|Overall Study||211
10000060|NCT01709084|11121849|FG000|COMPLETED|Overall Study||197
10000061|NCT01709084|11121850|FG001|COMPLETED|Overall Study||198
10000062|NCT01709084|11121849|FG000|NOT COMPLETED|Overall Study||16
10000063|NCT01709084|11121850|FG001|NOT COMPLETED|Overall Study||15
10000064|NCT01709110|11121858|FG000|STARTED|Overall Study||683
10000065|NCT01709110|11121859|FG001|STARTED|Overall Study||683
10000066|NCT01709110|11121858|FG000|Received at Least One Dose of Study Drug|Overall Study||680
10000067|NCT01709110|11121859|FG001|Received at Least One Dose of Study Drug|Overall Study||680
10000068|NCT01709110|11121858|FG000|COMPLETED|Overall Study||498
10000069|NCT01709110|11121859|FG001|COMPLETED|Overall Study||515
10000070|NCT01709110|11121858|FG000|NOT COMPLETED|Overall Study||185
10000071|NCT01709110|11121859|FG001|NOT COMPLETED|Overall Study||168
10000072|NCT01709149|11121868|FG000|STARTED|Open-label Lead-in Phase||711
10000073|NCT01709149|11121869|FG001|STARTED|Open-label Lead-in Phase||0
10000074|NCT01709149|11121870|FG002|STARTED|Open-label Lead-in Phase||0
10000075|NCT01709149|11121868|FG000|COMPLETED|Open-label Lead-in Phase||596
10000076|NCT01709149|11121869|FG001|COMPLETED|Open-label Lead-in Phase||0
10000077|NCT01709149|11121870|FG002|COMPLETED|Open-label Lead-in Phase||0
10000078|NCT01709149|11121868|FG000|NOT COMPLETED|Open-label Lead-in Phase||115
10000079|NCT01709149|11121869|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
10000080|NCT01709149|11121870|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
10000081|NCT01709149|11121868|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
10000082|NCT01709149|11121869|FG001|STARTED|Double-blind, Placebo-controlled Phase||295
10000083|NCT01709149|11121870|FG002|STARTED|Double-blind, Placebo-controlled Phase||301
10000084|NCT01709149|11121868|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
10000085|NCT01709149|11121869|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269
10000086|NCT01709149|11121870|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204
10000087|NCT01709149|11121868|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10000088|NCT01709149|11121869|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
10000089|NCT01709149|11121870|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
10000090|NCT01709162|11121879|FG000|STARTED|Overall Study|Randomized|18
10000091|NCT01709162|11121880|FG001|STARTED|Overall Study|Randomized|5
10000092|NCT01709162|11121879|FG000|Received Treatment|Overall Study||18
10000093|NCT01709162|11121880|FG001|Received Treatment|Overall Study||4
10000094|NCT01709162|11121879|FG000|Still Receiving Treatment|Overall Study||0
10103693|NCT02426918|11233358|FG000|Safety Population|Overall Study||110
10000095|NCT01709162|11121880|FG001|Still Receiving Treatment|Overall Study||0
10000096|NCT01709162|11121879|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12
10000097|NCT01709162|11121880|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0
10000098|NCT01709162|11121879|FG000|NOT COMPLETED|Overall Study||6
10000099|NCT01709162|11121880|FG001|NOT COMPLETED|Overall Study||5
10000100|NCT01709227|11121888|FG000|STARTED|Overall Study||32
10000101|NCT01709227|11121889|FG001|STARTED|Overall Study||41
10000102|NCT01709227|11121888|FG000|COMPLETED|Overall Study||31
10000103|NCT01709227|11121889|FG001|COMPLETED|Overall Study||32
10000104|NCT01709227|11121888|FG000|NOT COMPLETED|Overall Study||1
10000105|NCT01709227|11121889|FG001|NOT COMPLETED|Overall Study||9
10000106|NCT01709305|11121896|FG000|STARTED|Phase 1||5570
10000107|NCT01709305|11121897|FG001|STARTED|Phase 1||0
10000108|NCT01709305|11121898|FG002|STARTED|Phase 1||0
10000109|NCT01709305|11121899|FG003|STARTED|Phase 1||0
10000110|NCT01709305|11121900|FG004|STARTED|Phase 1||0
10000111|NCT01709305|11121896|FG000|COMPLETED|Phase 1||4933
10000112|NCT01709305|11121897|FG001|COMPLETED|Phase 1||0
10000113|NCT01709305|11121898|FG002|COMPLETED|Phase 1||0
10000114|NCT01709305|11121899|FG003|COMPLETED|Phase 1||0
10000115|NCT01709305|11121900|FG004|COMPLETED|Phase 1||0
10000116|NCT01709305|11121896|FG000|NOT COMPLETED|Phase 1||637
10000117|NCT01709305|11121897|FG001|NOT COMPLETED|Phase 1||0
10000118|NCT01709305|11121898|FG002|NOT COMPLETED|Phase 1||0
10000119|NCT01709305|11121899|FG003|NOT COMPLETED|Phase 1||0
10000120|NCT01709305|11121900|FG004|NOT COMPLETED|Phase 1||0
10000121|NCT01709305|11121896|FG000|STARTED|Phase 2||0
10000122|NCT01709305|11121897|FG001|STARTED|Phase 2||552
10000123|NCT01709305|11121898|FG002|STARTED|Phase 2||550
10000124|NCT01709305|11121899|FG003|STARTED|Phase 2||556
10000125|NCT01709305|11121900|FG004|STARTED|Phase 2||554
10000126|NCT01709305|11121896|FG000|COMPLETED|Phase 2||0
10000127|NCT01709305|11121897|FG001|COMPLETED|Phase 2||500
10000128|NCT01709305|11121898|FG002|COMPLETED|Phase 2||505
10000129|NCT01709305|11121899|FG003|COMPLETED|Phase 2||508
10000130|NCT01709305|11121900|FG004|COMPLETED|Phase 2||507
10000131|NCT01709305|11121896|FG000|NOT COMPLETED|Phase 2||0
10000132|NCT01709305|11121897|FG001|NOT COMPLETED|Phase 2||52
10000133|NCT01709305|11121898|FG002|NOT COMPLETED|Phase 2||45
10000134|NCT01709305|11121899|FG003|NOT COMPLETED|Phase 2||48
10000135|NCT01709305|11121900|FG004|NOT COMPLETED|Phase 2||47
10000136|NCT01709383|11121917|FG000|STARTED|Overall Study||24
10000137|NCT01709383|11121918|FG001|STARTED|Overall Study||14
10000138|NCT01709383|11121917|FG000|Completed Treatment|Overall Study||24
10000139|NCT01709383|11121918|FG001|Completed Treatment|Overall Study||14
10000140|NCT01709383|11121917|FG000|Completed Follow-ups|Overall Study||23
10000141|NCT01709383|11121918|FG001|Completed Follow-ups|Overall Study||14
10000142|NCT01709383|11121917|FG000|Included in Analysis|Overall Study||22
10000143|NCT01709383|11121918|FG001|Included in Analysis|Overall Study||13
10000144|NCT01709383|11121917|FG000|COMPLETED|Overall Study||23
10000145|NCT01709383|11121918|FG001|COMPLETED|Overall Study||14
10000146|NCT01709383|11121917|FG000|NOT COMPLETED|Overall Study||1
10000147|NCT01709383|11121918|FG001|NOT COMPLETED|Overall Study||0
10000148|NCT01709409|11121928|FG000|STARTED|Overall Study||43
10000149|NCT01709409|11121929|FG001|STARTED|Overall Study||45
10000150|NCT01709409|11121928|FG000|COMPLETED|Overall Study||42
10000151|NCT01709409|11121929|FG001|COMPLETED|Overall Study||45
10000152|NCT01709409|11121928|FG000|NOT COMPLETED|Overall Study||1
10000153|NCT01709409|11121929|FG001|NOT COMPLETED|Overall Study||0
10000154|NCT01709422|11121937|FG000|STARTED|Overall Study||70
10000155|NCT01709422|11121938|FG001|STARTED|Overall Study||70
10000156|NCT01709422|11121937|FG000|COMPLETED|Overall Study||70
10000157|NCT01709422|11121938|FG001|COMPLETED|Overall Study||70
10000158|NCT01709422|11121937|FG000|NOT COMPLETED|Overall Study||0
10000159|NCT01709422|11121938|FG001|NOT COMPLETED|Overall Study||0
10000160|NCT01709474|11121948|FG000|STARTED|Overall Study||3
10000161|NCT01709474|11121949|FG001|STARTED|Overall Study||4
10000162|NCT01709474|11121948|FG000|COMPLETED|Overall Study||3
10000163|NCT01709474|11121949|FG001|COMPLETED|Overall Study||4
10000164|NCT01709474|11121948|FG000|NOT COMPLETED|Overall Study||0
10000165|NCT01709474|11121949|FG001|NOT COMPLETED|Overall Study||0
10000166|NCT01709500|11121957|FG000|STARTED|Overall Study||167
10000167|NCT01709500|11121958|FG001|STARTED|Overall Study||82
10000168|NCT01709500|11121957|FG000|Treated|Overall Study||167
10000169|NCT01709500|11121958|FG001|Treated|Overall Study||81
10000170|NCT01709500|11121957|FG000|COMPLETED|Overall Study||0
10000171|NCT01709500|11121958|FG001|COMPLETED|Overall Study||0
10000172|NCT01709500|11121957|FG000|NOT COMPLETED|Overall Study||167
10000173|NCT01709500|11121958|FG001|NOT COMPLETED|Overall Study||82
10000174|NCT01709513|11121967|FG000|STARTED|Overall Study||63
10000175|NCT01709513|11121968|FG001|STARTED|Overall Study||125
10000176|NCT01709513|11121969|FG002|STARTED|Overall Study||126
10000177|NCT01709513|11121967|FG000|Treated|Overall Study||63
10000178|NCT01709513|11121968|FG001|Treated|Overall Study||124
10000179|NCT01709513|11121969|FG002|Treated|Overall Study||126
10000180|NCT01709513|11121967|FG000|COMPLETED|Overall Study||42
10000181|NCT01709513|11121968|FG001|COMPLETED|Overall Study||82
10000182|NCT01709513|11121969|FG002|COMPLETED|Overall Study||96
10000183|NCT01709513|11121967|FG000|NOT COMPLETED|Overall Study||21
10000184|NCT01709513|11121968|FG001|NOT COMPLETED|Overall Study||43
10000185|NCT01709513|11121969|FG002|NOT COMPLETED|Overall Study||30
10000186|NCT01709578|11121983|FG000|STARTED|Overall Study||181
10000187|NCT01709578|11121984|FG001|STARTED|Overall Study||181
10000188|NCT01709578|11121985|FG002|STARTED|Overall Study||184
10000189|NCT01709578|11121983|FG000|COMPLETED|Overall Study||101
10000190|NCT01709578|11121984|FG001|COMPLETED|Overall Study||125
10000191|NCT01709578|11121985|FG002|COMPLETED|Overall Study||133
10000192|NCT01709578|11121983|FG000|NOT COMPLETED|Overall Study||80
10000193|NCT01709578|11121984|FG001|NOT COMPLETED|Overall Study||56
10000194|NCT01709578|11121985|FG002|NOT COMPLETED|Overall Study||51
10000195|NCT01709695|11121995|FG000|STARTED|Overall Study||13
10000196|NCT01709695|11121996|FG001|STARTED|Overall Study||14
10000197|NCT01709695|11121995|FG000|COMPLETED|Overall Study||12
10000198|NCT01709695|11121996|FG001|COMPLETED|Overall Study||13
10000199|NCT01709695|11121995|FG000|NOT COMPLETED|Overall Study||1
10000200|NCT01709695|11121996|FG001|NOT COMPLETED|Overall Study||1
10000201|NCT01709708|11122004|FG000|STARTED|Overall Study||27
10000202|NCT01709708|11122005|FG001|STARTED|Overall Study||14
10000203|NCT01709708|11122004|FG000|COMPLETED|Overall Study||26
10000204|NCT01709708|11122005|FG001|COMPLETED|Overall Study||12
10000205|NCT01709708|11122004|FG000|NOT COMPLETED|Overall Study||1
10000206|NCT01709708|11122005|FG001|NOT COMPLETED|Overall Study||2
10000207|NCT01709721|11122015|FG000|STARTED|Open Label Phase||41
10000208|NCT01709721|11122016|FG001|STARTED|Open Label Phase||40
10000209|NCT01709721|11122017|FG002|STARTED|Open Label Phase||72
10000210|NCT01709721|11122015|FG000|COMPLETED|Open Label Phase||41
10000211|NCT01709721|11122016|FG001|COMPLETED|Open Label Phase||40
10000212|NCT01709721|11122017|FG002|COMPLETED|Open Label Phase||0
10000213|NCT01709721|11122015|FG000|NOT COMPLETED|Open Label Phase||0
10000214|NCT01709721|11122016|FG001|NOT COMPLETED|Open Label Phase||0
10000215|NCT01709721|11122017|FG002|NOT COMPLETED|Open Label Phase||72
10000216|NCT01709721|11122015|FG000|STARTED|Randomized Phase||41
10000217|NCT01709721|11122016|FG001|STARTED|Randomized Phase||40
10000218|NCT01709721|11122017|FG002|STARTED|Randomized Phase||0
10000219|NCT01709721|11122015|FG000|COMPLETED|Randomized Phase||38
10000220|NCT01709721|11122016|FG001|COMPLETED|Randomized Phase||34
10000221|NCT01709721|11122017|FG002|COMPLETED|Randomized Phase||0
10000222|NCT01709721|11122015|FG000|NOT COMPLETED|Randomized Phase||3
10000223|NCT01709721|11122016|FG001|NOT COMPLETED|Randomized Phase||6
10000224|NCT01709721|11122017|FG002|NOT COMPLETED|Randomized Phase||0
10000225|NCT01709747|11122025|FG000|STARTED|Overall Study||364
10000226|NCT01709747|11122025|FG000|COMPLETED|Overall Study||287
10000227|NCT01709747|11122025|FG000|NOT COMPLETED|Overall Study||77
10000228|NCT01709786|11122030|FG000|STARTED|Overall Study||88
10000229|NCT01709786|11122030|FG000|COMPLETED|Overall Study||88
10000230|NCT01709786|11122030|FG000|NOT COMPLETED|Overall Study||0
10000231|NCT01709799|11122039|FG000|STARTED|Overall Study||25
10000232|NCT01709799|11122040|FG001|STARTED|Overall Study||21
10000233|NCT01709799|11122041|FG002|STARTED|Overall Study||18
10000234|NCT01709799|11122039|FG000|COMPLETED|Overall Study||22
10000235|NCT01709799|11122040|FG001|COMPLETED|Overall Study||18
10000236|NCT01709799|11122041|FG002|COMPLETED|Overall Study||15
10000237|NCT01709799|11122039|FG000|NOT COMPLETED|Overall Study||3
10000238|NCT01709799|11122040|FG001|NOT COMPLETED|Overall Study||3
10000239|NCT01709799|11122041|FG002|NOT COMPLETED|Overall Study||3
10000240|NCT01709838|11122049|FG000|STARTED|Overall Study||134
10000241|NCT01709838|11122049|FG000|COMPLETED|Overall Study||67
10000242|NCT01709838|11122049|FG000|NOT COMPLETED|Overall Study||67
10000243|NCT01709864|11122057|FG000|STARTED|Overall Study||222
10000244|NCT01709864|11122058|FG001|STARTED|Overall Study||219
10000245|NCT01709864|11122057|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
10000246|NCT01709864|11122058|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
10000247|NCT01709864|11122057|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
10000248|NCT01709864|11122058|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
10000249|NCT01709864|11122057|FG000|COMPLETED|Overall Study||215
10000250|NCT01709864|11122058|FG001|COMPLETED|Overall Study||208
10000251|NCT01709864|11122057|FG000|NOT COMPLETED|Overall Study||7
10000252|NCT01709864|11122058|FG001|NOT COMPLETED|Overall Study||11
10000253|NCT01709903|11122066|FG000|STARTED|Overall Study|Randomized set|372
10000254|NCT01709903|11122067|FG001|STARTED|Overall Study|Randomized set|372
10000255|NCT01709903|11122066|FG000|COMPLETED|Overall Study||343
10000256|NCT01709903|11122067|FG001|COMPLETED|Overall Study||333
10000257|NCT01709903|11122066|FG000|NOT COMPLETED|Overall Study||29
10000258|NCT01709903|11122067|FG001|NOT COMPLETED|Overall Study||39
10000259|NCT01710020|11122073|FG000|STARTED|Period 1||12
10000260|NCT01710020|11122073|FG000|COMPLETED|Period 1||11
10000261|NCT01710020|11122073|FG000|NOT COMPLETED|Period 1||1
10000262|NCT01710020|11122073|FG000|STARTED|Washout Period (at Least 14 Days)||11
10000263|NCT01710020|11122073|FG000|COMPLETED|Washout Period (at Least 14 Days)||11
10000264|NCT01710020|11122073|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10000265|NCT01710020|11122073|FG000|STARTED|Period 2||11
10000266|NCT01710020|11122073|FG000|COMPLETED|Period 2||11
10000267|NCT01710020|11122073|FG000|NOT COMPLETED|Period 2||0
10000268|NCT01710033|11122083|FG000|STARTED|Stage 1||6
10000269|NCT01710033|11122084|FG001|STARTED|Stage 1||6
10000270|NCT01710033|11122085|FG002|STARTED|Stage 1||6
10000271|NCT01710033|11122086|FG003|STARTED|Stage 1||6
10000272|NCT01710033|11122087|FG004|STARTED|Stage 1||0
10000273|NCT01710033|11122083|FG000|COMPLETED|Stage 1||6
10000274|NCT01710033|11122084|FG001|COMPLETED|Stage 1||6
10000275|NCT01710033|11122085|FG002|COMPLETED|Stage 1||6
10000276|NCT01710033|11122086|FG003|COMPLETED|Stage 1||6
10000277|NCT01710033|11122087|FG004|COMPLETED|Stage 1||0
10000278|NCT01710033|11122083|FG000|NOT COMPLETED|Stage 1||0
10000279|NCT01710033|11122084|FG001|NOT COMPLETED|Stage 1||0
10000280|NCT01710033|11122085|FG002|NOT COMPLETED|Stage 1||0
10000281|NCT01710033|11122086|FG003|NOT COMPLETED|Stage 1||0
10000282|NCT01710033|11122087|FG004|NOT COMPLETED|Stage 1||0
10000283|NCT01710033|11122083|FG000|STARTED|Stage 2||0
10000284|NCT01710033|11122084|FG001|STARTED|Stage 2||0
10000285|NCT01710033|11122085|FG002|STARTED|Stage 2||0
10000286|NCT01710033|11122086|FG003|STARTED|Stage 2||0
10000287|NCT01710033|11122087|FG004|STARTED|Stage 2||4
10000288|NCT01710033|11122083|FG000|COMPLETED|Stage 2||0
10000289|NCT01710033|11122084|FG001|COMPLETED|Stage 2||0
10000290|NCT01710033|11122085|FG002|COMPLETED|Stage 2||0
10000291|NCT01710033|11122086|FG003|COMPLETED|Stage 2||0
10000292|NCT01710033|11122087|FG004|COMPLETED|Stage 2||3
10000293|NCT01710033|11122083|FG000|NOT COMPLETED|Stage 2||0
10000294|NCT01710033|11122084|FG001|NOT COMPLETED|Stage 2||0
10000295|NCT01710033|11122085|FG002|NOT COMPLETED|Stage 2||0
10000296|NCT01710033|11122086|FG003|NOT COMPLETED|Stage 2||0
10000297|NCT01710033|11122087|FG004|NOT COMPLETED|Stage 2||1
10000298|NCT01710046|11122102|FG000|STARTED|Overall Study||9
10000299|NCT01710046|11122103|FG001|STARTED|Overall Study||3
10000300|NCT01710046|11122102|FG000|COMPLETED|Overall Study||8
10000301|NCT01710046|11122103|FG001|COMPLETED|Overall Study||3
10000302|NCT01710046|11122102|FG000|NOT COMPLETED|Overall Study||1
10000303|NCT01710046|11122103|FG001|NOT COMPLETED|Overall Study||0
10000304|NCT01710137|11122111|FG000|STARTED|Overall Study||89
10000305|NCT01710137|11122112|FG001|STARTED|Overall Study||90
10000306|NCT01710137|11122111|FG000|COMPLETED|Overall Study||65
10000307|NCT01710137|11122112|FG001|COMPLETED|Overall Study||76
10000308|NCT01710137|11122111|FG000|NOT COMPLETED|Overall Study||24
10000309|NCT01710137|11122112|FG001|NOT COMPLETED|Overall Study||14
10000310|NCT01710254|11122118|FG000|STARTED|Overall Study||30
10000311|NCT01710254|11122118|FG000|COMPLETED|Overall Study||30
10000312|NCT01710254|11122118|FG000|NOT COMPLETED|Overall Study||0
10000313|NCT01710306|11122124|FG000|STARTED|Overall Study||86
10000314|NCT01710306|11122125|FG001|STARTED|Overall Study||85
10000315|NCT01710306|11122124|FG000|COMPLETED|Overall Study||68
10000316|NCT01710306|11122125|FG001|COMPLETED|Overall Study||55
10000317|NCT01710306|11122124|FG000|NOT COMPLETED|Overall Study||18
10000318|NCT01710306|11122125|FG001|NOT COMPLETED|Overall Study||30
10000319|NCT01710332|11122134|FG000|STARTED|Overall Study||6
10000320|NCT01710332|11122135|FG001|STARTED|Overall Study||6
10000321|NCT01710332|11122134|FG000|COMPLETED|Overall Study||6
10000322|NCT01710332|11122135|FG001|COMPLETED|Overall Study||6
10000323|NCT01710332|11122134|FG000|NOT COMPLETED|Overall Study||0
10000324|NCT01710332|11122135|FG001|NOT COMPLETED|Overall Study||0
10000325|NCT01710345|11122144|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
10000326|NCT01710345|11122145|FG001|STARTED|Overall Study||40
10000327|NCT01710345|11122146|FG002|STARTED|Overall Study||20
10000328|NCT01710345|11122144|FG000|COMPLETED|Overall Study||37
10000329|NCT01710345|11122145|FG001|COMPLETED|Overall Study||35
10000330|NCT01710345|11122146|FG002|COMPLETED|Overall Study||19
10000331|NCT01710345|11122144|FG000|NOT COMPLETED|Overall Study||3
10000332|NCT01710345|11122145|FG001|NOT COMPLETED|Overall Study||5
10000333|NCT01710345|11122146|FG002|NOT COMPLETED|Overall Study||1
10000334|NCT01710358|11122157|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
10000335|NCT01710358|11122158|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
10000336|NCT01710358|11122159|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
10000337|NCT01710358|11122157|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
10000338|NCT01710358|11122158|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
10000339|NCT01710358|11122159|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
10000340|NCT01710358|11122157|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
10000341|NCT01710358|11122158|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
10000342|NCT01710358|11122159|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
10000343|NCT01710358|11122157|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
10000344|NCT01710358|11122158|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
10000345|NCT01710358|11122159|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
10000346|NCT01710358|11122157|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
10000347|NCT01710358|11122158|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
10000348|NCT01710358|11122159|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
10000349|NCT01710358|11122157|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
10000350|NCT01710358|11122158|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
10000351|NCT01710358|11122159|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
10000352|NCT01710358|11122157|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
10000353|NCT01710358|11122158|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
10000354|NCT01710358|11122159|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
10000355|NCT01710358|11122157|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
10000356|NCT01710358|11122158|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
10000357|NCT01710358|11122159|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
10000358|NCT01710358|11122157|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
10000359|NCT01710358|11122158|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
10018683|NCT01824589|11141709|FG003|NOT COMPLETED|Overall Study||0
10000360|NCT01710358|11122159|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
10000361|NCT01710358|11122157|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
10000362|NCT01710358|11122158|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
10000363|NCT01710358|11122159|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
10000364|NCT01710358|11122157|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10000365|NCT01710358|11122158|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
10000366|NCT01710358|11122159|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10000367|NCT01710358|11122157|FG000|COMPLETED|Rescue Period||0
10000368|NCT01710358|11122158|FG001|COMPLETED|Rescue Period||196
10000369|NCT01710358|11122159|FG002|COMPLETED|Rescue Period||0
10000370|NCT01710358|11122157|FG000|NOT COMPLETED|Rescue Period||0
10000371|NCT01710358|11122158|FG001|NOT COMPLETED|Rescue Period||31
10000372|NCT01710358|11122159|FG002|NOT COMPLETED|Rescue Period||0
10000373|NCT01710358|11122157|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
10000374|NCT01710358|11122158|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
10000375|NCT01710358|11122159|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
10000376|NCT01710358|11122157|FG000|COMPLETED|Follow-up Period||33
10000377|NCT01710358|11122158|FG001|COMPLETED|Follow-up Period||76
10000378|NCT01710358|11122159|FG002|COMPLETED|Follow-up Period||20
10000379|NCT01710358|11122157|FG000|NOT COMPLETED|Follow-up Period||0
10000380|NCT01710358|11122158|FG001|NOT COMPLETED|Follow-up Period||0
10000381|NCT01710358|11122159|FG002|NOT COMPLETED|Follow-up Period||0
10000382|NCT01710501|11122183|FG000|STARTED|Overall Study||29
10000383|NCT01710501|11122184|FG001|STARTED|Overall Study||28
10000384|NCT01710501|11122185|FG002|STARTED|Overall Study||30
10000385|NCT01710501|11122183|FG000|COMPLETED|Overall Study||27
10000386|NCT01710501|11122184|FG001|COMPLETED|Overall Study||28
10000387|NCT01710501|11122185|FG002|COMPLETED|Overall Study||30
10000388|NCT01710501|11122183|FG000|NOT COMPLETED|Overall Study||2
10000389|NCT01710501|11122184|FG001|NOT COMPLETED|Overall Study||0
10000390|NCT01710501|11122185|FG002|NOT COMPLETED|Overall Study||0
10000391|NCT01710514|11122195|FG000|STARTED|Overall Study||54
10000392|NCT01710514|11122196|FG001|STARTED|Overall Study||54
10000393|NCT01710514|11122195|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
10000394|NCT01710514|11122196|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
10000395|NCT01710514|11122195|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
10000396|NCT01710514|11122196|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
10000397|NCT01710514|11122195|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
10000398|NCT01710514|11122196|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
10000399|NCT01710514|11122195|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
10000400|NCT01710514|11122196|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
10000401|NCT01710514|11122195|FG000|COMPLETED|Overall Study||47
10000402|NCT01710514|11122196|FG001|COMPLETED|Overall Study||47
10000403|NCT01710514|11122195|FG000|NOT COMPLETED|Overall Study||7
10000404|NCT01710514|11122196|FG001|NOT COMPLETED|Overall Study||7
10000405|NCT01710527|11122205|FG000|STARTED|Period 1: Intervention Period 1||16
10000406|NCT01710527|11122206|FG001|STARTED|Period 1: Intervention Period 1||16
10000407|NCT01710527|11122205|FG000|COMPLETED|Period 1: Intervention Period 1||16
10000408|NCT01710527|11122206|FG001|COMPLETED|Period 1: Intervention Period 1||16
10000409|NCT01710527|11122205|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
10000410|NCT01710527|11122206|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
10000411|NCT01710527|11122205|FG000|STARTED|Period 2: Washout Period (7 Days)||16
10000412|NCT01710527|11122206|FG001|STARTED|Period 2: Washout Period (7 Days)||16
10000413|NCT01710527|11122205|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16
10000414|NCT01710527|11122206|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15
10000415|NCT01710527|11122205|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10000416|NCT01710527|11122206|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
10000417|NCT01710527|11122205|FG000|STARTED|Period 3: Intervention Period 2||16
10000418|NCT01710527|11122206|FG001|STARTED|Period 3: Intervention Period 2||15
10000419|NCT01710527|11122205|FG000|COMPLETED|Period 3: Intervention Period 2||16
10000420|NCT01710527|11122206|FG001|COMPLETED|Period 3: Intervention Period 2||15
10000421|NCT01710527|11122205|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
10000422|NCT01710527|11122206|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
10000423|NCT01710657|11122215|FG000|STARTED|Overall Study||184
10000424|NCT01710657|11122216|FG001|STARTED|Overall Study||183
10000425|NCT01710657|11122217|FG002|STARTED|Overall Study||180
10000426|NCT01710657|11122215|FG000|Titration Period (4 Weeks)|Overall Study||184
10000427|NCT01710657|11122216|FG001|Titration Period (4 Weeks)|Overall Study||183
10000428|NCT01710657|11122217|FG002|Titration Period (4 Weeks)|Overall Study||180
10000429|NCT01710657|11122215|FG000|Maintenance Period (12 Weeks)|Overall Study||176
10000430|NCT01710657|11122216|FG001|Maintenance Period (12 Weeks)|Overall Study||175
10000431|NCT01710657|11122217|FG002|Maintenance Period (12 Weeks)|Overall Study||168
10000432|NCT01710657|11122215|FG000|COMPLETED|Overall Study||166
10000433|NCT01710657|11122216|FG001|COMPLETED|Overall Study||171
10000434|NCT01710657|11122217|FG002|COMPLETED|Overall Study||148
10000435|NCT01710657|11122215|FG000|NOT COMPLETED|Overall Study||18
10000436|NCT01710657|11122216|FG001|NOT COMPLETED|Overall Study||12
10000437|NCT01710657|11122217|FG002|NOT COMPLETED|Overall Study||32
10000438|NCT01710709|11122225|FG000|STARTED|Overall Study||464
10000439|NCT01710709|11122225|FG000|COMPLETED|Overall Study||291
10000440|NCT01710709|11122225|FG000|NOT COMPLETED|Overall Study||173
10000441|NCT01710787|11122233|FG000|STARTED|Overall Study||44
10000442|NCT01710787|11122234|FG001|STARTED|Overall Study||44
10000443|NCT01710787|11122235|FG002|STARTED|Overall Study||22
10000444|NCT01710787|11122233|FG000|COMPLETED|Overall Study||44
10000445|NCT01710787|11122234|FG001|COMPLETED|Overall Study||44
10000446|NCT01710787|11122235|FG002|COMPLETED|Overall Study||22
10000447|NCT01710787|11122233|FG000|NOT COMPLETED|Overall Study||0
10000448|NCT01710787|11122234|FG001|NOT COMPLETED|Overall Study||0
10000449|NCT01710787|11122235|FG002|NOT COMPLETED|Overall Study||0
10000450|NCT01710800|11122243|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63
10000451|NCT01710800|11122243|FG000|Received PPI Intervention|Overall Study||44
10000452|NCT01710800|11122243|FG000|Received Placebo Intervention|Overall Study||45
10000453|NCT01710800|11122243|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
10000454|NCT01710800|11122243|FG000|NOT COMPLETED|Overall Study||22
10000455|NCT01710839|11122251|FG000|STARTED|Overall Study||24
10000456|NCT01710839|11122252|FG001|STARTED|Overall Study||6
10000457|NCT01710839|11122251|FG000|COMPLETED|Overall Study||23
10000458|NCT01710839|11122252|FG001|COMPLETED|Overall Study||0
10000459|NCT01710839|11122251|FG000|NOT COMPLETED|Overall Study||1
10000460|NCT01710839|11122252|FG001|NOT COMPLETED|Overall Study||6
10000461|NCT01710891|11122260|FG000|STARTED|Overall Study||95
10000462|NCT01710891|11122261|FG001|STARTED|Overall Study||103
10000463|NCT01710891|11122260|FG000|COMPLETED|Overall Study||95
10000464|NCT01710891|11122261|FG001|COMPLETED|Overall Study||103
10000465|NCT01710891|11122260|FG000|NOT COMPLETED|Overall Study||0
10000466|NCT01710891|11122261|FG001|NOT COMPLETED|Overall Study||0
10000467|NCT01711177|11122270|FG000|STARTED|Overall Study||10
10000468|NCT01711177|11122271|FG001|STARTED|Overall Study||3
10000469|NCT01711177|11122272|FG002|STARTED|Overall Study||3
10000470|NCT01711177|11122270|FG000|COMPLETED|Overall Study||10
10000471|NCT01711177|11122271|FG001|COMPLETED|Overall Study||3
10000472|NCT01711177|11122272|FG002|COMPLETED|Overall Study||3
10000473|NCT01711177|11122270|FG000|NOT COMPLETED|Overall Study||0
10000474|NCT01711177|11122271|FG001|NOT COMPLETED|Overall Study||0
10000475|NCT01711177|11122272|FG002|NOT COMPLETED|Overall Study||0
10000476|NCT01711216|11122280|FG000|STARTED|Overall Study||999
10000477|NCT01711216|11122280|FG000|COMPLETED|Overall Study||782
10000478|NCT01711216|11122280|FG000|NOT COMPLETED|Overall Study||217
10000479|NCT01711294|11122287|FG000|STARTED|Overall Study||121
10000480|NCT01711294|11122288|FG001|STARTED|Overall Study||65
10000481|NCT01711294|11122289|FG002|STARTED|Overall Study||64
10000482|NCT01711294|11122287|FG000|COMPLETED|Overall Study||121
10000483|NCT01711294|11122288|FG001|COMPLETED|Overall Study||65
10000484|NCT01711294|11122289|FG002|COMPLETED|Overall Study||64
10000485|NCT01711294|11122287|FG000|NOT COMPLETED|Overall Study||0
10000486|NCT01711294|11122288|FG001|NOT COMPLETED|Overall Study||0
10000487|NCT01711294|11122289|FG002|NOT COMPLETED|Overall Study||0
10000488|NCT01711359|11122300|FG000|STARTED|Treatment Period||213
10000489|NCT01711359|11122301|FG001|STARTED|Treatment Period||160
10000490|NCT01711359|11122302|FG002|STARTED|Treatment Period||215
10000491|NCT01711359|11122300|FG000|Received at Least One Dose of Study Drug|Treatment Period||210
10000492|NCT01711359|11122301|FG001|Received at Least One Dose of Study Drug|Treatment Period||159
10000493|NCT01711359|11122302|FG002|Received at Least One Dose of Study Drug|Treatment Period||215
10000494|NCT01711359|11122300|FG000|Rescued|Treatment Period||26
10000495|NCT01711359|11122301|FG001|Rescued|Treatment Period||7
10000496|NCT01711359|11122302|FG002|Rescued|Treatment Period||6
10000497|NCT01711359|11122300|FG000|COMPLETED|Treatment Period||161
10000498|NCT01711359|11122301|FG001|COMPLETED|Treatment Period||136
10000499|NCT01711359|11122302|FG002|COMPLETED|Treatment Period||173
10000500|NCT01711359|11122300|FG000|NOT COMPLETED|Treatment Period||52
10000501|NCT01711359|11122301|FG001|NOT COMPLETED|Treatment Period||24
10000502|NCT01711359|11122302|FG002|NOT COMPLETED|Treatment Period||42
10000503|NCT01711359|11122300|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
10000504|NCT01711359|11122301|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
10000505|NCT01711359|11122302|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
10000506|NCT01711359|11122300|FG000|COMPLETED|Follow Up||0
10000507|NCT01711359|11122301|FG001|COMPLETED|Follow Up||0
10000508|NCT01711359|11122302|FG002|COMPLETED|Follow Up||0
10000509|NCT01711359|11122300|FG000|NOT COMPLETED|Follow Up||25
10000510|NCT01711359|11122301|FG001|NOT COMPLETED|Follow Up||15
10000511|NCT01711359|11122302|FG002|NOT COMPLETED|Follow Up||28
10000512|NCT01711372|11122317|FG000|STARTED|Overall Study||66
10000513|NCT01711372|11122318|FG001|STARTED|Overall Study||47
10000514|NCT01711372|11122317|FG000|COMPLETED|Overall Study||66
10000515|NCT01711372|11122318|FG001|COMPLETED|Overall Study||47
10000516|NCT01711372|11122317|FG000|NOT COMPLETED|Overall Study||0
10000517|NCT01711372|11122318|FG001|NOT COMPLETED|Overall Study||0
10000518|NCT01711424|11122323|FG000|STARTED|Overall Study||1209
10000519|NCT01711424|11122323|FG000|COMPLETED|Overall Study||1209
10000520|NCT01711424|11122323|FG000|NOT COMPLETED|Overall Study||0
10000521|NCT01711619|11122329|FG000|STARTED|Overall Study||56
10000522|NCT01711619|11122330|FG001|STARTED|Overall Study||60
10000523|NCT01711619|11122329|FG000|COMPLETED|Overall Study||38
10000524|NCT01711619|11122330|FG001|COMPLETED|Overall Study||36
10000525|NCT01711619|11122329|FG000|NOT COMPLETED|Overall Study||18
10000526|NCT01711619|11122330|FG001|NOT COMPLETED|Overall Study||24
10000527|NCT01711645|11122336|FG000|STARTED|Overall Study||55
10000528|NCT01711645|11122336|FG000|COMPLETED|Overall Study||36
10000529|NCT01711645|11122336|FG000|NOT COMPLETED|Overall Study||19
10000530|NCT01711658|11122342|FG000|STARTED|Overall Study||64
10000531|NCT01711658|11122343|FG001|STARTED|Overall Study||63
10000532|NCT01711658|11122342|FG000|Participants Who Started Protocol Treatment|Overall Study||59
10000533|NCT01711658|11122343|FG001|Participants Who Started Protocol Treatment|Overall Study||60
10000534|NCT01711658|11122342|FG000|COMPLETED|Overall Study||64
10000535|NCT01711658|11122343|FG001|COMPLETED|Overall Study||63
10000536|NCT01711658|11122342|FG000|NOT COMPLETED|Overall Study||0
10000537|NCT01711658|11122343|FG001|NOT COMPLETED|Overall Study||0
10000538|NCT01711736|11122351|FG000|STARTED|Overall Study||299
10000539|NCT01711736|11122352|FG001|STARTED|Overall Study||302
10000540|NCT01711736|11122351|FG000|COMPLETED|Overall Study|Up to Day 180|287
10000541|NCT01711736|11122352|FG001|COMPLETED|Overall Study|Up to Day 180|294
10000542|NCT01711736|11122351|FG000|NOT COMPLETED|Overall Study||12
10000543|NCT01711736|11122352|FG001|NOT COMPLETED|Overall Study||8
10000544|NCT01711853|11122359|FG000|STARTED|Overall Study||19
10000545|NCT01711853|11122359|FG000|COMPLETED|Overall Study||16
10000546|NCT01711853|11122359|FG000|NOT COMPLETED|Overall Study||3
10000547|NCT01711866|11122363|FG000|STARTED|Overall Study||87
10000548|NCT01711866|11122363|FG000|COMPLETED|Overall Study||79
10000549|NCT01711866|11122363|FG000|NOT COMPLETED|Overall Study||8
10000550|NCT01711918|11122367|FG000|STARTED|Overall Study||9
10000551|NCT01711918|11122367|FG000|COMPLETED|Overall Study||7
10000552|NCT01711918|11122367|FG000|NOT COMPLETED|Overall Study||2
10000553|NCT01711983|11122371|FG000|STARTED|6-Month Clinical Success Evaluation||400
10000554|NCT01711983|11122371|FG000|COMPLETED|6-Month Clinical Success Evaluation||368
10000555|NCT01711983|11122371|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32
10000556|NCT01711983|11122371|FG000|STARTED|6-Month Closure Evaluation||368
10000557|NCT01711983|11122371|FG000|COMPLETED|6-Month Closure Evaluation||342
10000558|NCT01711983|11122371|FG000|NOT COMPLETED|6-Month Closure Evaluation||26
10000559|NCT01711983|11122371|FG000|STARTED|36-Month Closure Evaluation||342
10000560|NCT01711983|11122371|FG000|COMPLETED|36-Month Closure Evaluation||278
10000561|NCT01711983|11122371|FG000|NOT COMPLETED|36-Month Closure Evaluation||64
10000562|NCT01712009|11122378|FG000|STARTED|Overall Study||198
10000563|NCT01712009|11122379|FG001|STARTED|Overall Study||200
10000564|NCT01712009|11122380|FG002|STARTED|Overall Study||202
10000565|NCT01712009|11122378|FG000|Received Pegfilgrastim|Overall Study||191
10000566|NCT01712009|11122379|FG001|Received Pegfilgrastim|Overall Study||196
10000567|NCT01712009|11122380|FG002|Received Pegfilgrastim|Overall Study||200
10000568|NCT01712009|11122378|FG000|Received Naproxen / Loratadine|Overall Study||0
10000569|NCT01712009|11122379|FG001|Received Naproxen / Loratadine|Overall Study||193
10000570|NCT01712009|11122380|FG002|Received Naproxen / Loratadine|Overall Study||198
10000571|NCT01712009|11122378|FG000|COMPLETED|Overall Study||160
10000572|NCT01712009|11122379|FG001|COMPLETED|Overall Study||171
10000573|NCT01712009|11122380|FG002|COMPLETED|Overall Study||181
10000574|NCT01712009|11122378|FG000|NOT COMPLETED|Overall Study||38
10000575|NCT01712009|11122379|FG001|NOT COMPLETED|Overall Study||29
10000576|NCT01712009|11122380|FG002|NOT COMPLETED|Overall Study||21
10000577|NCT01712061|11122390|FG000|STARTED|Overall Study||30
10000578|NCT01712061|11122391|FG001|STARTED|Overall Study||140
10000579|NCT01712061|11122392|FG002|STARTED|Overall Study||56
10000580|NCT01712061|11122390|FG000|COMPLETED|Overall Study||20
10000581|NCT01712061|11122391|FG001|COMPLETED|Overall Study||114
10000582|NCT01712061|11122392|FG002|COMPLETED|Overall Study||45
10000583|NCT01712061|11122390|FG000|NOT COMPLETED|Overall Study||10
10000584|NCT01712061|11122391|FG001|NOT COMPLETED|Overall Study||26
10000585|NCT01712061|11122392|FG002|NOT COMPLETED|Overall Study||11
10000586|NCT01712074|11122404|FG000|STARTED|Placebo Run-in Period||195
10000587|NCT01712074|11122405|FG001|STARTED|Placebo Run-in Period||0
10000588|NCT01712074|11122406|FG002|STARTED|Placebo Run-in Period||0
10000589|NCT01712074|11122404|FG000|COMPLETED|Placebo Run-in Period||185
10000590|NCT01712074|11122405|FG001|COMPLETED|Placebo Run-in Period||0
10000591|NCT01712074|11122406|FG002|COMPLETED|Placebo Run-in Period||0
10000592|NCT01712074|11122404|FG000|NOT COMPLETED|Placebo Run-in Period||10
10000593|NCT01712074|11122405|FG001|NOT COMPLETED|Placebo Run-in Period||0
10000594|NCT01712074|11122406|FG002|NOT COMPLETED|Placebo Run-in Period||0
10000595|NCT01712074|11122404|FG000|STARTED|Double Blind Period||0
10000596|NCT01712074|11122405|FG001|STARTED|Double Blind Period||91
10000597|NCT01712074|11122406|FG002|STARTED|Double Blind Period||94
10000598|NCT01712074|11122404|FG000|COMPLETED|Double Blind Period||0
10103694|NCT02426918|11233359|FG001|Safety Population|Overall Study||107
10103695|NCT02426918|11233360|FG002|Safety Population|Overall Study||107
10103696|NCT02426918|11233358|FG000|COMPLETED|Overall Study||93
10103697|NCT02426918|11233359|FG001|COMPLETED|Overall Study||90
10103698|NCT02426918|11233360|FG002|COMPLETED|Overall Study||97
10103699|NCT02426918|11233358|FG000|NOT COMPLETED|Overall Study||17
10000599|NCT01712074|11122405|FG001|COMPLETED|Double Blind Period||77
10000600|NCT01712074|11122406|FG002|COMPLETED|Double Blind Period||86
10000601|NCT01712074|11122404|FG000|NOT COMPLETED|Double Blind Period||0
10000602|NCT01712074|11122405|FG001|NOT COMPLETED|Double Blind Period||14
10000603|NCT01712074|11122406|FG002|NOT COMPLETED|Double Blind Period||8
10000604|NCT01712178|11122423|FG000|STARTED|Overall Study||50
10000605|NCT01712178|11122424|FG001|STARTED|Overall Study||50
10000606|NCT01712178|11122423|FG000|COMPLETED|Overall Study||49
10000607|NCT01712178|11122424|FG001|COMPLETED|Overall Study||47
10000608|NCT01712178|11122423|FG000|NOT COMPLETED|Overall Study||1
10000609|NCT01712178|11122424|FG001|NOT COMPLETED|Overall Study||3
10000610|NCT01712204|11122432|FG000|STARTED|Overall Study||41
10000611|NCT01712204|11122433|FG001|STARTED|Overall Study||41
10000612|NCT01712204|11122432|FG000|COMPLETED|Overall Study||33
10000613|NCT01712204|11122433|FG001|COMPLETED|Overall Study||36
10000614|NCT01712204|11122432|FG000|NOT COMPLETED|Overall Study||8
10000615|NCT01712204|11122433|FG001|NOT COMPLETED|Overall Study||5
10000616|NCT01712230|11122442|FG000|STARTED|Overall Study||11
10000617|NCT01712230|11122443|FG001|STARTED|Overall Study||18
10000618|NCT01712230|11122444|FG002|STARTED|Overall Study||18
10000619|NCT01712230|11122442|FG000|COMPLETED|Overall Study||9
10000620|NCT01712230|11122443|FG001|COMPLETED|Overall Study||14
10000621|NCT01712230|11122444|FG002|COMPLETED|Overall Study||11
10000622|NCT01712230|11122442|FG000|NOT COMPLETED|Overall Study||2
10000623|NCT01712230|11122443|FG001|NOT COMPLETED|Overall Study||4
10000624|NCT01712230|11122444|FG002|NOT COMPLETED|Overall Study||7
10000625|NCT01712256|11122452|FG000|STARTED|Overall Study||33
10000626|NCT01712256|11122452|FG000|COMPLETED|Overall Study||32
10000627|NCT01712256|11122452|FG000|NOT COMPLETED|Overall Study||1
10000628|NCT01712334|11122456|FG000|STARTED|Treatment Period 1||44
10000629|NCT01712334|11122457|FG001|STARTED|Treatment Period 1||43
10000630|NCT01712334|11122456|FG000|Received Treatment|Treatment Period 1||44
10000631|NCT01712334|11122457|FG001|Received Treatment|Treatment Period 1||41
10000632|NCT01712334|11122456|FG000|COMPLETED|Treatment Period 1||44
10000633|NCT01712334|11122457|FG001|COMPLETED|Treatment Period 1||41
10000634|NCT01712334|11122456|FG000|NOT COMPLETED|Treatment Period 1||0
10000635|NCT01712334|11122457|FG001|NOT COMPLETED|Treatment Period 1||2
10000636|NCT01712334|11122456|FG000|STARTED|Treatment Period 2||44
10000637|NCT01712334|11122457|FG001|STARTED|Treatment Period 2||41
10000638|NCT01712334|11122456|FG000|COMPLETED|Treatment Period 2||44
10000639|NCT01712334|11122457|FG001|COMPLETED|Treatment Period 2||41
10000640|NCT01712334|11122456|FG000|NOT COMPLETED|Treatment Period 2||0
10000641|NCT01712334|11122457|FG001|NOT COMPLETED|Treatment Period 2||0
10000642|NCT01712360|11122467|FG000|STARTED|Overall Study||22
10000643|NCT01712360|11122468|FG001|STARTED|Overall Study||22
10000644|NCT01712360|11122469|FG002|STARTED|Overall Study||6
10000645|NCT01712360|11122470|FG003|STARTED|Overall Study||6
10000646|NCT01712360|11122467|FG000|COMPLETED|Overall Study||22
10000647|NCT01712360|11122468|FG001|COMPLETED|Overall Study||21
10000648|NCT01712360|11122469|FG002|COMPLETED|Overall Study||6
10000649|NCT01712360|11122470|FG003|COMPLETED|Overall Study||4
10000650|NCT01712360|11122467|FG000|NOT COMPLETED|Overall Study||0
10000651|NCT01712360|11122468|FG001|NOT COMPLETED|Overall Study||1
10000652|NCT01712360|11122469|FG002|NOT COMPLETED|Overall Study||0
10000653|NCT01712360|11122470|FG003|NOT COMPLETED|Overall Study||2
10000654|NCT01712399|11122486|FG000|STARTED|Overall Study||397
10000655|NCT01712399|11122486|FG000|COMPLETED|Overall Study||0
10000656|NCT01712399|11122486|FG000|NOT COMPLETED|Overall Study||397
10000657|NCT01712438|11122490|FG000|STARTED|Overall Study||110
10000658|NCT01712438|11122490|FG000|SAF Population|Overall Study||108
10000659|NCT01712438|11122490|FG000|ITT Population|Overall Study||108
10000660|NCT01712438|11122490|FG000|PP Population|Overall Study||95
10000661|NCT01712438|11122490|FG000|PROPH Population|Overall Study||103
10000662|NCT01712438|11122490|FG000|BLEED Population|Overall Study||94
10000663|NCT01712438|11122490|FG000|SURG Population|Overall Study||24
10000664|NCT01712438|11122490|FG000|COMPLETED|Overall Study||73
10000665|NCT01712438|11122490|FG000|NOT COMPLETED|Overall Study||37
10000666|NCT01712516|11122503|FG000|STARTED|Overall Study||250
10000667|NCT01712516|11122504|FG001|STARTED|Overall Study||251
10000668|NCT01712516|11122505|FG002|STARTED|Overall Study||251
10000669|NCT01712516|11122506|FG003|STARTED|Overall Study||249
10000670|NCT01712516|11122503|FG000|Safety Set|Overall Study||250
10000671|NCT01712516|11122504|FG001|Safety Set|Overall Study||251
10000672|NCT01712516|11122505|FG002|Safety Set|Overall Study||251
10000673|NCT01712516|11122506|FG003|Safety Set|Overall Study||248
10000674|NCT01712516|11122503|FG000|Full Analysis Set|Overall Study||250
10000675|NCT01712516|11122504|FG001|Full Analysis Set|Overall Study||251
10000676|NCT01712516|11122505|FG002|Full Analysis Set|Overall Study||250
10000677|NCT01712516|11122506|FG003|Full Analysis Set|Overall Study||247
10000678|NCT01712516|11122503|FG000|COMPLETED|Overall Study||244
10000679|NCT01712516|11122504|FG001|COMPLETED|Overall Study||241
10103700|NCT02426918|11233359|FG001|NOT COMPLETED|Overall Study||19
10000680|NCT01712516|11122505|FG002|COMPLETED|Overall Study||245
10000681|NCT01712516|11122506|FG003|COMPLETED|Overall Study||236
10000682|NCT01712516|11122503|FG000|NOT COMPLETED|Overall Study||6
10000683|NCT01712516|11122504|FG001|NOT COMPLETED|Overall Study||10
10000684|NCT01712516|11122505|FG002|NOT COMPLETED|Overall Study||6
10000685|NCT01712516|11122506|FG003|NOT COMPLETED|Overall Study||13
10000686|NCT01712685|11122516|FG000|STARTED|Overall Study||12
10000687|NCT01712685|11122516|FG000|COMPLETED|Overall Study||11
10000688|NCT01712685|11122516|FG000|NOT COMPLETED|Overall Study||1
10018684|NCT01824602|11141723|FG000|STARTED|Overall Study||11
10018685|NCT01824602|11141724|FG001|STARTED|Overall Study||8
10018686|NCT01824602|11141725|FG002|STARTED|Overall Study||9
10018687|NCT01824602|11141726|FG003|STARTED|Overall Study||10
10018688|NCT01824602|11141723|FG000|Safety Population|Overall Study||11
10018689|NCT01824602|11141724|FG001|Safety Population|Overall Study||8
10018690|NCT01824602|11141725|FG002|Safety Population|Overall Study||9
10018691|NCT01824602|11141726|FG003|Safety Population|Overall Study||10
10018692|NCT01824602|11141723|FG000|Intent-to-treat Population|Overall Study||11
10018693|NCT01824602|11141724|FG001|Intent-to-treat Population|Overall Study||8
10018694|NCT01824602|11141725|FG002|Intent-to-treat Population|Overall Study||9
10018695|NCT01824602|11141726|FG003|Intent-to-treat Population|Overall Study||9
10018696|NCT01824602|11141723|FG000|COMPLETED|Overall Study||10
10018697|NCT01824602|11141724|FG001|COMPLETED|Overall Study||8
10018698|NCT01824602|11141725|FG002|COMPLETED|Overall Study||5
10018699|NCT01824602|11141726|FG003|COMPLETED|Overall Study||5
10018700|NCT01824602|11141723|FG000|NOT COMPLETED|Overall Study||1
10018701|NCT01824602|11141724|FG001|NOT COMPLETED|Overall Study||0
10018702|NCT01824602|11141725|FG002|NOT COMPLETED|Overall Study||4
10018703|NCT01824602|11141726|FG003|NOT COMPLETED|Overall Study||5
10018704|NCT01824693|11141739|FG000|STARTED|Overall Study||6
10018705|NCT01824693|11141740|FG001|STARTED|Overall Study||9
10018706|NCT01824693|11141741|FG002|STARTED|Overall Study||15
10018707|NCT01824693|11141739|FG000|COMPLETED|Overall Study||5
10018708|NCT01824693|11141740|FG001|COMPLETED|Overall Study||2
10018709|NCT01824693|11141741|FG002|COMPLETED|Overall Study||0
10018710|NCT01824693|11141739|FG000|NOT COMPLETED|Overall Study||1
10018711|NCT01824693|11141740|FG001|NOT COMPLETED|Overall Study||7
10018712|NCT01824693|11141741|FG002|NOT COMPLETED|Overall Study||15
10018713|NCT01824823|11141750|FG000|STARTED|Overall Study||2
10018714|NCT01824823|11141751|FG001|STARTED|Overall Study||1
10018715|NCT01824823|11141750|FG000|COMPLETED|Overall Study||0
10018716|NCT01824823|11141751|FG001|COMPLETED|Overall Study||0
10018717|NCT01824823|11141750|FG000|NOT COMPLETED|Overall Study||2
10018718|NCT01824823|11141751|FG001|NOT COMPLETED|Overall Study||1
10018719|NCT01824901|11141757|FG000|STARTED|Overall Study||2
10018720|NCT01824901|11141758|FG001|STARTED|Overall Study||0
10018721|NCT01824901|11141759|FG002|STARTED|Overall Study||0
10018722|NCT01824901|11141760|FG003|STARTED|Overall Study||0
10018723|NCT01824901|11141757|FG000|COMPLETED|Overall Study||2
10018724|NCT01824901|11141758|FG001|COMPLETED|Overall Study||0
10018725|NCT01824901|11141759|FG002|COMPLETED|Overall Study||0
10018726|NCT01824901|11141760|FG003|COMPLETED|Overall Study||0
10018727|NCT01824901|11141757|FG000|NOT COMPLETED|Overall Study||0
10018728|NCT01824901|11141758|FG001|NOT COMPLETED|Overall Study||0
10018729|NCT01824901|11141759|FG002|NOT COMPLETED|Overall Study||0
10018730|NCT01824901|11141760|FG003|NOT COMPLETED|Overall Study||0
10018731|NCT01824979|11141766|FG000|STARTED|Overall Study||50
10018732|NCT01824979|11141767|FG001|STARTED|Overall Study||50
10018733|NCT01824979|11141766|FG000|COMPLETED|Overall Study||37
10018734|NCT01824979|11141767|FG001|COMPLETED|Overall Study||37
10018735|NCT01824979|11141766|FG000|NOT COMPLETED|Overall Study||13
10018736|NCT01824979|11141767|FG001|NOT COMPLETED|Overall Study||13
10018737|NCT01825057|11141776|FG000|STARTED|Patient Study Flow||336
10018738|NCT01825057|11141777|FG001|STARTED|Patient Study Flow||379
10018739|NCT01825057|11141778|FG002|STARTED|Patient Study Flow||458
10018740|NCT01825057|11141776|FG000|COMPLETED|Patient Study Flow||336
10018741|NCT01825057|11141777|FG001|COMPLETED|Patient Study Flow||379
10018742|NCT01825057|11141778|FG002|COMPLETED|Patient Study Flow||458
10018743|NCT01825057|11141776|FG000|NOT COMPLETED|Patient Study Flow||0
10018744|NCT01825057|11141777|FG001|NOT COMPLETED|Patient Study Flow||0
10018745|NCT01825057|11141778|FG002|NOT COMPLETED|Patient Study Flow||0
10018746|NCT01825057|11141776|FG000|STARTED|Provider Study Flow||13
10018747|NCT01825057|11141777|FG001|STARTED|Provider Study Flow||12
10018748|NCT01825057|11141778|FG002|STARTED|Provider Study Flow||13
10018749|NCT01825057|11141776|FG000|COMPLETED|Provider Study Flow||13
10018750|NCT01825057|11141777|FG001|COMPLETED|Provider Study Flow||12
10018751|NCT01825057|11141778|FG002|COMPLETED|Provider Study Flow||13
10018752|NCT01825057|11141776|FG000|NOT COMPLETED|Provider Study Flow||0
10018753|NCT01825057|11141777|FG001|NOT COMPLETED|Provider Study Flow||0
10018754|NCT01825057|11141778|FG002|NOT COMPLETED|Provider Study Flow||0
10018755|NCT01825122|11141791|FG000|STARTED|Overall Study||77
10018756|NCT01825122|11141792|FG001|STARTED|Overall Study||78
10018757|NCT01825122|11141791|FG000|COMPLETED|Overall Study||67
10018758|NCT01825122|11141792|FG001|COMPLETED|Overall Study||59
10018759|NCT01825122|11141791|FG000|NOT COMPLETED|Overall Study||10
10018760|NCT01825122|11141792|FG001|NOT COMPLETED|Overall Study||19
10018761|NCT01825200|11141800|FG000|STARTED|Overall Study||1319
10018762|NCT01825200|11141801|FG001|STARTED|Overall Study||1321
10018763|NCT01825200|11141800|FG000|COMPLETED|Overall Study||1314
10018764|NCT01825200|11141801|FG001|COMPLETED|Overall Study||1314
10018765|NCT01825200|11141800|FG000|NOT COMPLETED|Overall Study||5
10000689|NCT01712711|11122522|FG000|STARTED|Overall Study||20
10000690|NCT01712711|11122523|FG001|STARTED|Overall Study||20
10000691|NCT01712711|11122522|FG000|COMPLETED|Overall Study||20
10000692|NCT01712711|11122523|FG001|COMPLETED|Overall Study||20
10000693|NCT01712711|11122522|FG000|NOT COMPLETED|Overall Study||0
10000694|NCT01712711|11122523|FG001|NOT COMPLETED|Overall Study||0
10000695|NCT01712776|11122531|FG000|STARTED|Overall Study||50
10000696|NCT01712776|11122532|FG001|STARTED|Overall Study||50
10000697|NCT01712776|11122531|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
10000698|NCT01712776|11122532|FG001|COMPLETED|Overall Study||50
10000699|NCT01712776|11122531|FG000|NOT COMPLETED|Overall Study||0
10000700|NCT01712776|11122532|FG001|NOT COMPLETED|Overall Study||0
10000701|NCT01712984|11122541|FG000|STARTED|Overall Study||1672
10000702|NCT01712984|11122542|FG001|STARTED|Overall Study||837
10000703|NCT01712984|11122543|FG002|STARTED|Overall Study||846
10000704|NCT01712984|11122541|FG000|COMPLETED|Overall Study||1656
10000705|NCT01712984|11122542|FG001|COMPLETED|Overall Study||821
10000706|NCT01712984|11122543|FG002|COMPLETED|Overall Study||836
10000707|NCT01712984|11122541|FG000|NOT COMPLETED|Overall Study||16
10000708|NCT01712984|11122542|FG001|NOT COMPLETED|Overall Study||16
10000709|NCT01712984|11122543|FG002|NOT COMPLETED|Overall Study||10
10000710|NCT01713036|11122551|FG000|STARTED|Overall Study||6
10000711|NCT01713036|11122551|FG000|COMPLETED|Overall Study||5
10000712|NCT01713036|11122551|FG000|NOT COMPLETED|Overall Study||1
10000713|NCT01713283|11122565|FG000|STARTED|Overall Study||31
10000714|NCT01713283|11122566|FG001|STARTED|Overall Study||29
10000715|NCT01713283|11122565|FG000|COMPLETED|Overall Study||20
10000716|NCT01713283|11122566|FG001|COMPLETED|Overall Study||26
10000717|NCT01713283|11122565|FG000|NOT COMPLETED|Overall Study||11
10000718|NCT01713283|11122566|FG001|NOT COMPLETED|Overall Study||3
10000719|NCT01713348|11122580|FG000|STARTED|Overall Study||29
10000720|NCT01713348|11122581|FG001|STARTED|Overall Study||13
10000721|NCT01713348|11122582|FG002|STARTED|Overall Study||30
10000722|NCT01713348|11122583|FG003|STARTED|Overall Study||15
10000723|NCT01713348|11122580|FG000|COMPLETED|Overall Study||25
10000724|NCT01713348|11122581|FG001|COMPLETED|Overall Study||11
10000725|NCT01713348|11122582|FG002|COMPLETED|Overall Study||28
10000726|NCT01713348|11122583|FG003|COMPLETED|Overall Study||15
10000727|NCT01713348|11122580|FG000|NOT COMPLETED|Overall Study||4
10000728|NCT01713348|11122581|FG001|NOT COMPLETED|Overall Study||2
10000729|NCT01713348|11122582|FG002|NOT COMPLETED|Overall Study||2
10000730|NCT01713348|11122583|FG003|NOT COMPLETED|Overall Study||0
10000731|NCT01713400|11122595|FG000|STARTED|Overall Study||15
10000732|NCT01713400|11122596|FG001|STARTED|Overall Study||15
10000733|NCT01713400|11122595|FG000|COMPLETED|Overall Study||15
10000734|NCT01713400|11122596|FG001|COMPLETED|Overall Study||15
10000735|NCT01713400|11122595|FG000|NOT COMPLETED|Overall Study||0
10000736|NCT01713400|11122596|FG001|NOT COMPLETED|Overall Study||0
10000737|NCT01713530|11122604|FG000|STARTED|Overall Study||138
10000738|NCT01713530|11122605|FG001|STARTED|Overall Study||136
10000739|NCT01713530|11122604|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
10000740|NCT01713530|11122605|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
10000741|NCT01713530|11122604|FG000|COMPLETED|Overall Study||113
10000742|NCT01713530|11122605|FG001|COMPLETED|Overall Study||117
10000743|NCT01713530|11122604|FG000|NOT COMPLETED|Overall Study||25
10000744|NCT01713530|11122605|FG001|NOT COMPLETED|Overall Study||19
10000745|NCT01713582|11122632|FG000|STARTED|Overall Study|Number treated|3
10000746|NCT01713582|11122633|FG001|STARTED|Overall Study|Number treated|3
10000747|NCT01713582|11122634|FG002|STARTED|Overall Study|Number treated|4
10000748|NCT01713582|11122635|FG003|STARTED|Overall Study|Number treated|3
10000749|NCT01713582|11122636|FG004|STARTED|Overall Study|Number treated|4
10000750|NCT01713582|11122637|FG005|STARTED|Overall Study|Number treated|8
10000751|NCT01713582|11122638|FG006|STARTED|Overall Study|Number treated|7
10000752|NCT01713582|11122639|FG007|STARTED|Overall Study|Number treated|6
10000753|NCT01713582|11122640|FG008|STARTED|Overall Study|Number treated|6
10000754|NCT01713582|11122641|FG009|STARTED|Overall Study|Number treated|18
10000755|NCT01713582|11122642|FG010|STARTED|Overall Study|Number treated|16
10000756|NCT01713582|11122643|FG011|STARTED|Overall Study|Number treated|5
10000757|NCT01713582|11122644|FG012|STARTED|Overall Study|Number treated|3
10000758|NCT01713582|11122645|FG013|STARTED|Overall Study|Number treated|4
10000759|NCT01713582|11122646|FG014|STARTED|Overall Study|Number treated|7
10000760|NCT01713582|11122647|FG015|STARTED|Overall Study|Number treated|6
10000761|NCT01713582|11122648|FG016|STARTED|Overall Study|Number treated|7
10000762|NCT01713582|11122649|FG017|STARTED|Overall Study|Number treated|3
10000763|NCT01713582|11122650|FG018|STARTED|Overall Study|Number treated|5
10000764|NCT01713582|11122651|FG019|STARTED|Overall Study|Number treated|5
10000765|NCT01713582|11122652|FG020|STARTED|Overall Study|Number treated|15
10000766|NCT01713582|11122632|FG000|COMPLETED|Overall Study||0
10000767|NCT01713582|11122633|FG001|COMPLETED|Overall Study||0
10000768|NCT01713582|11122634|FG002|COMPLETED|Overall Study||0
10000769|NCT01713582|11122635|FG003|COMPLETED|Overall Study||0
10000770|NCT01713582|11122636|FG004|COMPLETED|Overall Study||0
10000771|NCT01713582|11122637|FG005|COMPLETED|Overall Study||0
10000772|NCT01713582|11122638|FG006|COMPLETED|Overall Study||0
10000773|NCT01713582|11122639|FG007|COMPLETED|Overall Study||0
10000774|NCT01713582|11122640|FG008|COMPLETED|Overall Study||0
10000775|NCT01713582|11122641|FG009|COMPLETED|Overall Study||0
10000776|NCT01713582|11122642|FG010|COMPLETED|Overall Study||0
10000777|NCT01713582|11122643|FG011|COMPLETED|Overall Study||0
10000778|NCT01713582|11122644|FG012|COMPLETED|Overall Study||0
10000779|NCT01713582|11122645|FG013|COMPLETED|Overall Study||0
10000780|NCT01713582|11122646|FG014|COMPLETED|Overall Study||0
10000781|NCT01713582|11122647|FG015|COMPLETED|Overall Study||0
10000782|NCT01713582|11122648|FG016|COMPLETED|Overall Study||0
10000783|NCT01713582|11122649|FG017|COMPLETED|Overall Study||0
10000784|NCT01713582|11122650|FG018|COMPLETED|Overall Study||0
10000785|NCT01713582|11122651|FG019|COMPLETED|Overall Study||0
10000786|NCT01713582|11122652|FG020|COMPLETED|Overall Study||0
10000787|NCT01713582|11122632|FG000|NOT COMPLETED|Overall Study||3
10000788|NCT01713582|11122633|FG001|NOT COMPLETED|Overall Study||3
10000789|NCT01713582|11122634|FG002|NOT COMPLETED|Overall Study||4
10000790|NCT01713582|11122635|FG003|NOT COMPLETED|Overall Study||3
10000791|NCT01713582|11122636|FG004|NOT COMPLETED|Overall Study||4
10000792|NCT01713582|11122637|FG005|NOT COMPLETED|Overall Study||8
10000793|NCT01713582|11122638|FG006|NOT COMPLETED|Overall Study||7
10000794|NCT01713582|11122639|FG007|NOT COMPLETED|Overall Study||6
10000795|NCT01713582|11122640|FG008|NOT COMPLETED|Overall Study||6
10000796|NCT01713582|11122641|FG009|NOT COMPLETED|Overall Study||18
10000797|NCT01713582|11122642|FG010|NOT COMPLETED|Overall Study||16
10000798|NCT01713582|11122643|FG011|NOT COMPLETED|Overall Study||5
10000799|NCT01713582|11122644|FG012|NOT COMPLETED|Overall Study||3
10000800|NCT01713582|11122645|FG013|NOT COMPLETED|Overall Study||4
10000801|NCT01713582|11122646|FG014|NOT COMPLETED|Overall Study||7
10000802|NCT01713582|11122647|FG015|NOT COMPLETED|Overall Study||6
10000803|NCT01713582|11122648|FG016|NOT COMPLETED|Overall Study||7
10000804|NCT01713582|11122649|FG017|NOT COMPLETED|Overall Study||3
10000805|NCT01713582|11122650|FG018|NOT COMPLETED|Overall Study||5
10000806|NCT01713582|11122651|FG019|NOT COMPLETED|Overall Study||5
10000807|NCT01713582|11122652|FG020|NOT COMPLETED|Overall Study||15
10000808|NCT01713608|11122714|FG000|STARTED|Overall Study||8
10000809|NCT01713608|11122715|FG001|STARTED|Overall Study||6
10000810|NCT01713608|11122716|FG002|STARTED|Overall Study||8
10000811|NCT01713608|11122717|FG003|STARTED|Overall Study||12
10000812|NCT01713608|11122714|FG000|COMPLETED|Overall Study||8
10000813|NCT01713608|11122715|FG001|COMPLETED|Overall Study||6
10000814|NCT01713608|11122716|FG002|COMPLETED|Overall Study||8
10000815|NCT01713608|11122717|FG003|COMPLETED|Overall Study||12
10000816|NCT01713608|11122714|FG000|NOT COMPLETED|Overall Study||0
10000817|NCT01713608|11122715|FG001|NOT COMPLETED|Overall Study||0
10000818|NCT01713608|11122716|FG002|NOT COMPLETED|Overall Study||0
10000819|NCT01713608|11122717|FG003|NOT COMPLETED|Overall Study||0
10000820|NCT01713621|11122728|FG000|STARTED|Overall Study||8
10000821|NCT01713621|11122729|FG001|STARTED|Overall Study||17
10000822|NCT01713621|11122728|FG000|COMPLETED|Overall Study||1
10000823|NCT01713621|11122729|FG001|COMPLETED|Overall Study||1
10000824|NCT01713621|11122728|FG000|NOT COMPLETED|Overall Study||7
10000825|NCT01713621|11122729|FG001|NOT COMPLETED|Overall Study||16
10000826|NCT01713660|11122735|FG000|STARTED|Overall Study||37
10000827|NCT01713660|11122735|FG000|COMPLETED|Overall Study||37
10000828|NCT01713660|11122735|FG000|NOT COMPLETED|Overall Study||0
10000829|NCT01713686|11122739|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
10000830|NCT01713686|11122739|FG000|COMPLETED|Overall Study||110
10000831|NCT01713686|11122739|FG000|NOT COMPLETED|Overall Study||15
10000832|NCT01713868|11122747|FG000|STARTED|Overall Study||400
10000833|NCT01713868|11122748|FG001|STARTED|Overall Study||400
10000834|NCT01713868|11122749|FG002|STARTED|Overall Study||400
10000835|NCT01713868|11122750|FG003|STARTED|Overall Study||400
10000836|NCT01713868|11122747|FG000|COMPLETED|Overall Study||303
10000837|NCT01713868|11122748|FG001|COMPLETED|Overall Study||335
10000838|NCT01713868|11122749|FG002|COMPLETED|Overall Study||320
10000839|NCT01713868|11122750|FG003|COMPLETED|Overall Study||305
10000840|NCT01713868|11122747|FG000|NOT COMPLETED|Overall Study||97
10000841|NCT01713868|11122748|FG001|NOT COMPLETED|Overall Study||65
10000842|NCT01713868|11122749|FG002|NOT COMPLETED|Overall Study||80
10000843|NCT01713868|11122750|FG003|NOT COMPLETED|Overall Study||95
10000844|NCT01713933|11122762|FG000|STARTED|Overall Study||37
10000845|NCT01713933|11122762|FG000|COMPLETED|Overall Study||31
10000846|NCT01713933|11122762|FG000|NOT COMPLETED|Overall Study||6
10000847|NCT01713946|11122769|FG000|STARTED|Overall Study||117
10000848|NCT01713946|11122770|FG001|STARTED|Overall Study||130
10000849|NCT01713946|11122771|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
10000850|NCT01713946|11122769|FG000|Completed Core Phase|Overall Study||110
10000851|NCT01713946|11122770|FG001|Completed Core Phase|Overall Study||122
10000852|NCT01713946|11122771|FG002|Completed Core Phase|Overall Study||114
10000853|NCT01713946|11122769|FG000|Continued in Ext. Phase|Overall Study||110
10000854|NCT01713946|11122770|FG001|Continued in Ext. Phase|Overall Study||119
10000855|NCT01713946|11122771|FG002|Continued in Ext. Phase|Overall Study||114
10000856|NCT01713946|11122769|FG000|Completed Ext. Phase|Overall Study||79
10000857|NCT01713946|11122770|FG001|Completed Ext. Phase|Overall Study||92
10000858|NCT01713946|11122771|FG002|Completed Ext. Phase|Overall Study||81
10000859|NCT01713946|11122769|FG000|Continued in Post-Ext. Phase|Overall Study||78
10000860|NCT01713946|11122770|FG001|Continued in Post-Ext. Phase|Overall Study||90
10000861|NCT01713946|11122771|FG002|Continued in Post-Ext. Phase|Overall Study||81
10000862|NCT01713946|11122769|FG000|Completed Post-Ext Phase|Overall Study||74
10000863|NCT01713946|11122770|FG001|Completed Post-Ext Phase|Overall Study||85
10000864|NCT01713946|11122771|FG002|Completed Post-Ext Phase|Overall Study||75
10018766|NCT01825200|11141801|FG001|NOT COMPLETED|Overall Study||7
10000865|NCT01713946|11122769|FG000|Did Not Continue in Ext Phase|Overall Study||0
10000866|NCT01713946|11122770|FG001|Did Not Continue in Ext Phase|Overall Study||3
10000867|NCT01713946|11122771|FG002|Did Not Continue in Ext Phase|Overall Study||0
10000868|NCT01713946|11122769|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1
10000869|NCT01713946|11122770|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2
10000870|NCT01713946|11122771|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0
10000871|NCT01713946|11122769|FG000|COMPLETED|Overall Study||74
10000872|NCT01713946|11122770|FG001|COMPLETED|Overall Study||85
10000873|NCT01713946|11122771|FG002|COMPLETED|Overall Study||75
10000874|NCT01713946|11122769|FG000|NOT COMPLETED|Overall Study||43
10000875|NCT01713946|11122770|FG001|NOT COMPLETED|Overall Study||45
10000876|NCT01713946|11122771|FG002|NOT COMPLETED|Overall Study||44
10000877|NCT01713998|11122800|FG000|STARTED|Overall Study||16
10000878|NCT01713998|11122801|FG001|STARTED|Overall Study||15
10000879|NCT01713998|11122802|FG002|STARTED|Overall Study||16
10000880|NCT01713998|11122800|FG000|COMPLETED|Overall Study||13
10000881|NCT01713998|11122801|FG001|COMPLETED|Overall Study||15
10000882|NCT01713998|11122802|FG002|COMPLETED|Overall Study||14
10000883|NCT01713998|11122800|FG000|NOT COMPLETED|Overall Study||3
10000884|NCT01713998|11122801|FG001|NOT COMPLETED|Overall Study||0
10000885|NCT01713998|11122802|FG002|NOT COMPLETED|Overall Study||2
10000886|NCT01714024|11122813|FG000|STARTED|Overall Study||13
10000887|NCT01714024|11122814|FG001|STARTED|Overall Study||18
10000888|NCT01714024|11122815|FG002|STARTED|Overall Study||11
10000889|NCT01714024|11122813|FG000|COMPLETED|Overall Study||12
10000890|NCT01714024|11122814|FG001|COMPLETED|Overall Study||12
10000891|NCT01714024|11122815|FG002|COMPLETED|Overall Study||8
10000892|NCT01714024|11122813|FG000|NOT COMPLETED|Overall Study||1
10000893|NCT01714024|11122814|FG001|NOT COMPLETED|Overall Study||6
10000894|NCT01714024|11122815|FG002|NOT COMPLETED|Overall Study||3
10000895|NCT01714063|11122832|FG000|STARTED|Overall Study||34
10000896|NCT01714063|11122832|FG000|COMPLETED|Overall Study||32
10000897|NCT01714063|11122832|FG000|NOT COMPLETED|Overall Study||2
10000898|NCT01714232|11122840|FG000|STARTED|Overall Study||106
10000899|NCT01714232|11122840|FG000|COMPLETED|Overall Study||106
10000900|NCT01714232|11122840|FG000|NOT COMPLETED|Overall Study||0
10000901|NCT01714310|11122847|FG000|STARTED|Open Lisdexamfetamine Titration||0
10000902|NCT01714310|11122848|FG001|STARTED|Open Lisdexamfetamine Titration||0
10000903|NCT01714310|11122849|FG002|STARTED|Open Lisdexamfetamine Titration||34
10000904|NCT01714310|11122847|FG000|COMPLETED|Open Lisdexamfetamine Titration||0
10000905|NCT01714310|11122848|FG001|COMPLETED|Open Lisdexamfetamine Titration||0
10000906|NCT01714310|11122849|FG002|COMPLETED|Open Lisdexamfetamine Titration||30
10000907|NCT01714310|11122847|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0
10000908|NCT01714310|11122848|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0
10000909|NCT01714310|11122849|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4
10000910|NCT01714310|11122847|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
10000911|NCT01714310|11122848|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
10000912|NCT01714310|11122849|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
10000913|NCT01714310|11122847|FG000|COMPLETED|Double Blind Adjunctive Treatment||10
10000914|NCT01714310|11122848|FG001|COMPLETED|Double Blind Adjunctive Treatment||11
10000915|NCT01714310|11122849|FG002|COMPLETED|Double Blind Adjunctive Treatment||0
10000916|NCT01714310|11122847|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2
10000917|NCT01714310|11122848|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3
10000918|NCT01714310|11122849|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0
10000919|NCT01714323|11122869|FG000|STARTED|Overall Study||677
10000920|NCT01714323|11122870|FG001|STARTED|Overall Study||680
10000921|NCT01714323|11122869|FG000|COMPLETED|Overall Study||513
10000922|NCT01714323|11122870|FG001|COMPLETED|Overall Study||508
10000923|NCT01714323|11122869|FG000|NOT COMPLETED|Overall Study||164
10000924|NCT01714323|11122870|FG001|NOT COMPLETED|Overall Study||172
10000925|NCT01714336|11122878|FG000|STARTED|Overall Study||69
10000926|NCT01714336|11122879|FG001|STARTED|Overall Study||69
10000927|NCT01714336|11122878|FG000|COMPLETED|Overall Study||69
10000928|NCT01714336|11122879|FG001|COMPLETED|Overall Study||69
10000929|NCT01714336|11122878|FG000|NOT COMPLETED|Overall Study||0
10000930|NCT01714336|11122879|FG001|NOT COMPLETED|Overall Study||0
10000931|NCT01714492|11122885|FG000|STARTED|Overall Study||8
10000932|NCT01714492|11122885|FG000|COMPLETED|Overall Study||8
10000933|NCT01714492|11122885|FG000|NOT COMPLETED|Overall Study||0
10000934|NCT01714505|11122890|FG000|STARTED|Admission 1 (40 Hours)||10
10000935|NCT01714505|11122891|FG001|STARTED|Admission 1 (40 Hours)||10
10000936|NCT01714505|11122890|FG000|COMPLETED|Admission 1 (40 Hours)||9
10000937|NCT01714505|11122891|FG001|COMPLETED|Admission 1 (40 Hours)||9
10000938|NCT01714505|11122890|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1
10000939|NCT01714505|11122891|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1
10000940|NCT01714505|11122890|FG000|STARTED|Admission 2 (40 Hours)||9
10000941|NCT01714505|11122891|FG001|STARTED|Admission 2 (40 Hours)||9
10000942|NCT01714505|11122890|FG000|COMPLETED|Admission 2 (40 Hours)||9
10000943|NCT01714505|11122891|FG001|COMPLETED|Admission 2 (40 Hours)||9
10000944|NCT01714505|11122890|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0
10000945|NCT01714505|11122891|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0
10000946|NCT01714544|11122897|FG000|STARTED|Overall Study||60
10000947|NCT01714544|11122897|FG000|COMPLETED|Overall Study||57
10000948|NCT01714544|11122897|FG000|NOT COMPLETED|Overall Study||3
10000949|NCT01714609|11122903|FG000|STARTED|Overall Study||5
10000950|NCT01714609|11122904|FG001|STARTED|Overall Study||5
10000951|NCT01714609|11122903|FG000|COMPLETED|Overall Study||4
10000952|NCT01714609|11122904|FG001|COMPLETED|Overall Study||5
10000953|NCT01714609|11122903|FG000|NOT COMPLETED|Overall Study||1
10000954|NCT01714609|11122904|FG001|NOT COMPLETED|Overall Study||0
10000955|NCT01714635|11122913|FG000|STARTED|Overall Study||147
10000956|NCT01714635|11122914|FG001|STARTED|Overall Study||150
10000957|NCT01714635|11122915|FG002|STARTED|Overall Study||148
10000958|NCT01714635|11122913|FG000|COMPLETED|Overall Study||145
10000959|NCT01714635|11122914|FG001|COMPLETED|Overall Study||150
10000960|NCT01714635|11122915|FG002|COMPLETED|Overall Study||146
10000961|NCT01714635|11122913|FG000|NOT COMPLETED|Overall Study||2
10000962|NCT01714635|11122914|FG001|NOT COMPLETED|Overall Study||0
10000963|NCT01714635|11122915|FG002|NOT COMPLETED|Overall Study||2
10000964|NCT01714687|11122925|FG000|STARTED|Overall Study||29
10000965|NCT01714687|11122926|FG001|STARTED|Overall Study||30
10000966|NCT01714687|11122925|FG000|COMPLETED|Overall Study||26
10000967|NCT01714687|11122926|FG001|COMPLETED|Overall Study||26
10000968|NCT01714687|11122925|FG000|NOT COMPLETED|Overall Study||3
10000969|NCT01714687|11122926|FG001|NOT COMPLETED|Overall Study||4
10000970|NCT01714726|11122936|FG000|STARTED|Double-Blinded Induction Period||60
10000971|NCT01714726|11122937|FG001|STARTED|Double-Blinded Induction Period||59
10000972|NCT01714726|11122938|FG002|STARTED|Double-Blinded Induction Period||0
10000973|NCT01714726|11122939|FG003|STARTED|Double-Blinded Induction Period||0
10000974|NCT01714726|11122936|FG000|COMPLETED|Double-Blinded Induction Period||52
10000975|NCT01714726|11122937|FG001|COMPLETED|Double-Blinded Induction Period||52
10000976|NCT01714726|11122938|FG002|COMPLETED|Double-Blinded Induction Period||0
10000977|NCT01714726|11122939|FG003|COMPLETED|Double-Blinded Induction Period||0
10000978|NCT01714726|11122936|FG000|NOT COMPLETED|Double-Blinded Induction Period||8
10000979|NCT01714726|11122937|FG001|NOT COMPLETED|Double-Blinded Induction Period||7
10000980|NCT01714726|11122938|FG002|NOT COMPLETED|Double-Blinded Induction Period||0
10000981|NCT01714726|11122939|FG003|NOT COMPLETED|Double-Blinded Induction Period||0
10000982|NCT01714726|11122936|FG000|STARTED|Open-Label Period||0
10000983|NCT01714726|11122937|FG001|STARTED|Open-Label Period||0
10000984|NCT01714726|11122938|FG002|STARTED|Open-Label Period||52
10000985|NCT01714726|11122939|FG003|STARTED|Open-Label Period||52
10000986|NCT01714726|11122936|FG000|COMPLETED|Open-Label Period||0
10000987|NCT01714726|11122937|FG001|COMPLETED|Open-Label Period||0
10000988|NCT01714726|11122938|FG002|COMPLETED|Open-Label Period||33
10000989|NCT01714726|11122939|FG003|COMPLETED|Open-Label Period||24
10000990|NCT01714726|11122936|FG000|NOT COMPLETED|Open-Label Period||0
10000991|NCT01714726|11122937|FG001|NOT COMPLETED|Open-Label Period||0
10000992|NCT01714726|11122938|FG002|NOT COMPLETED|Open-Label Period||19
10000993|NCT01714726|11122939|FG003|NOT COMPLETED|Open-Label Period||28
10000994|NCT01714804|11122951|FG000|STARTED|Overall Study||30
10000995|NCT01714804|11122952|FG001|STARTED|Overall Study||30
10000996|NCT01714804|11122951|FG000|COMPLETED|Overall Study||29
10000997|NCT01714804|11122952|FG001|COMPLETED|Overall Study||30
10000998|NCT01714804|11122951|FG000|NOT COMPLETED|Overall Study||1
10000999|NCT01714804|11122952|FG001|NOT COMPLETED|Overall Study||0
10001000|NCT01714921|11122960|FG000|STARTED|Overall Study||504
10001001|NCT01714921|11122960|FG000|COMPLETED|Overall Study||311
10001002|NCT01714921|11122960|FG000|NOT COMPLETED|Overall Study||193
10001003|NCT01714947|11122965|FG000|STARTED|Part A||3
10001004|NCT01714947|11122965|FG000|COMPLETED|Part A||3
10001005|NCT01714947|11122965|FG000|NOT COMPLETED|Part A||0
10001006|NCT01714947|11122965|FG000|STARTED|Part B||3
10001007|NCT01714947|11122965|FG000|COMPLETED|Part B||0
10001008|NCT01714947|11122965|FG000|NOT COMPLETED|Part B||3
10001009|NCT01715064|11122971|FG000|STARTED|Overall Study||18
10001010|NCT01715064|11122972|FG001|STARTED|Overall Study||18
10001011|NCT01715064|11122971|FG000|COMPLETED|Overall Study||18
10001012|NCT01715064|11122972|FG001|COMPLETED|Overall Study||18
10001013|NCT01715064|11122971|FG000|NOT COMPLETED|Overall Study||0
10001014|NCT01715064|11122972|FG001|NOT COMPLETED|Overall Study||0
10001015|NCT01715129|11122978|FG000|STARTED|Overall Study||126
10001016|NCT01715129|11122978|FG000|COMPLETED|Overall Study||117
10001017|NCT01715129|11122978|FG000|NOT COMPLETED|Overall Study||9
10001018|NCT01715207|11122984|FG000|STARTED|Overall Study||15
10001019|NCT01715207|11122985|FG001|STARTED|Overall Study||15
10001020|NCT01715207|11122984|FG000|COMPLETED|Overall Study||14
10001021|NCT01715207|11122985|FG001|COMPLETED|Overall Study||14
10001022|NCT01715207|11122984|FG000|NOT COMPLETED|Overall Study||1
10001023|NCT01715207|11122985|FG001|NOT COMPLETED|Overall Study||1
10001024|NCT01715233|11122993|FG000|STARTED|Overall Study||21
10001025|NCT01715233|11122993|FG000|COMPLETED|Overall Study||21
10001026|NCT01715233|11122993|FG000|NOT COMPLETED|Overall Study||0
10001027|NCT01715298|11123000|FG000|STARTED|Overall Study||216
10001028|NCT01715298|11123001|FG001|STARTED|Overall Study||216
10001029|NCT01715298|11123000|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
10001030|NCT01715298|11123001|FG001|Full Analysis Set (FAS)|Overall Study||214
10001031|NCT01715298|11123000|FG000|COMPLETED|Overall Study||209
10001032|NCT01715298|11123001|FG001|COMPLETED|Overall Study||205
10001033|NCT01715298|11123000|FG000|NOT COMPLETED|Overall Study||7
10001034|NCT01715298|11123001|FG001|NOT COMPLETED|Overall Study||11
10001035|NCT01715415|11123009|FG000|STARTED|Double-blind Treatment||297
10001036|NCT01715415|11123010|FG001|STARTED|Double-blind Treatment||98
10001037|NCT01715415|11123009|FG000|Randomized But Not Treated|Double-blind Treatment||0
10001038|NCT01715415|11123010|FG001|Randomized But Not Treated|Double-blind Treatment||1
10001039|NCT01715415|11123009|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
10001040|NCT01715415|11123010|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
10001041|NCT01715415|11123009|FG000|NOT COMPLETED|Double-blind Treatment||5
10001042|NCT01715415|11123010|FG001|NOT COMPLETED|Double-blind Treatment||2
10001043|NCT01715415|11123009|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
10001044|NCT01715415|11123010|FG001|STARTED|Open-label Treatment||96
10001045|NCT01715415|11123009|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
10001046|NCT01715415|11123010|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
10001047|NCT01715415|11123009|FG000|NOT COMPLETED|Open-label Treatment||0
10001048|NCT01715415|11123010|FG001|NOT COMPLETED|Open-label Treatment||2
10001049|NCT01715571|11123017|FG000|STARTED|Overall Study||11
10001050|NCT01715571|11123017|FG000|COMPLETED|Overall Study||3
10001051|NCT01715571|11123017|FG000|NOT COMPLETED|Overall Study||8
10001052|NCT01715805|11123021|FG000|STARTED|Placebo + ADT Lead-in Period||1022
10001053|NCT01715805|11123022|FG001|STARTED|Placebo + ADT Lead-in Period||0
10001054|NCT01715805|11123023|FG002|STARTED|Placebo + ADT Lead-in Period||0
10001055|NCT01715805|11123024|FG003|STARTED|Placebo + ADT Lead-in Period||0
10001056|NCT01715805|11123021|FG000|COMPLETED|Placebo + ADT Lead-in Period||807
10001057|NCT01715805|11123022|FG001|COMPLETED|Placebo + ADT Lead-in Period||0
10001058|NCT01715805|11123023|FG002|COMPLETED|Placebo + ADT Lead-in Period||0
10001059|NCT01715805|11123024|FG003|COMPLETED|Placebo + ADT Lead-in Period||0
10001060|NCT01715805|11123021|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215
10001061|NCT01715805|11123022|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0
10001062|NCT01715805|11123023|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0
10001063|NCT01715805|11123024|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0
10001064|NCT01715805|11123021|FG000|STARTED|Double-Blind or Continued Treatment||0
10001065|NCT01715805|11123022|FG001|STARTED|Double-Blind or Continued Treatment||261
10001066|NCT01715805|11123023|FG002|STARTED|Double-Blind or Continued Treatment||269
10001067|NCT01715805|11123024|FG003|STARTED|Double-Blind or Continued Treatment||270
10001068|NCT01715805|11123021|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
10001069|NCT01715805|11123022|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
10001070|NCT01715805|11123023|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
10001071|NCT01715805|11123024|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
10001072|NCT01715805|11123021|FG000|COMPLETED|Double-Blind or Continued Treatment||0
10001073|NCT01715805|11123022|FG001|COMPLETED|Double-Blind or Continued Treatment||222
10001074|NCT01715805|11123023|FG002|COMPLETED|Double-Blind or Continued Treatment||213
10001075|NCT01715805|11123024|FG003|COMPLETED|Double-Blind or Continued Treatment||222
10001076|NCT01715805|11123021|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0
10001077|NCT01715805|11123022|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39
10001078|NCT01715805|11123023|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56
10001079|NCT01715805|11123024|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48
10001080|NCT01715831|11123032|FG000|STARTED|Overall Study||26
10001081|NCT01715831|11123032|FG000|COMPLETED|Overall Study||25
10001082|NCT01715831|11123032|FG000|NOT COMPLETED|Overall Study||1
10001083|NCT01715857|11123036|FG000|STARTED|Overall Study||4100
10001084|NCT01715857|11123036|FG000|COMPLETED|Overall Study||4004
10001085|NCT01715857|11123036|FG000|NOT COMPLETED|Overall Study||96
10001086|NCT01715883|11123040|FG000|STARTED|Overall Study||3
10001087|NCT01715883|11123040|FG000|COMPLETED|Overall Study||2
10001088|NCT01715883|11123040|FG000|NOT COMPLETED|Overall Study||1
10001089|NCT01715896|11123047|FG000|STARTED|Overall Study||68
10001090|NCT01715896|11123048|FG001|STARTED|Overall Study||70
10001091|NCT01715896|11123047|FG000|COMPLETED|Overall Study||65
10001092|NCT01715896|11123048|FG001|COMPLETED|Overall Study||59
10001093|NCT01715896|11123047|FG000|NOT COMPLETED|Overall Study||3
10001094|NCT01715896|11123048|FG001|NOT COMPLETED|Overall Study||11
10001095|NCT01715948|11123055|FG000|STARTED|Overall Study||9
10001096|NCT01715948|11123055|FG000|COMPLETED|Overall Study||8
10001097|NCT01715948|11123055|FG000|NOT COMPLETED|Overall Study||1
10001098|NCT01716013|11123076|FG000|STARTED|Overall Study||108
10001099|NCT01716013|11123077|FG001|STARTED|Overall Study||54
10001100|NCT01716013|11123076|FG000|COMPLETED|Overall Study||105
10001101|NCT01716013|11123077|FG001|COMPLETED|Overall Study||54
10001102|NCT01716013|11123076|FG000|NOT COMPLETED|Overall Study||3
10001103|NCT01716013|11123077|FG001|NOT COMPLETED|Overall Study||0
10001104|NCT01716039|11123086|FG000|STARTED|Overall Study||4
10001105|NCT01716039|11123087|FG001|STARTED|Overall Study||8
10001106|NCT01716039|11123088|FG002|STARTED|Overall Study||10
10001107|NCT01716039|11123086|FG000|COMPLETED|Overall Study||3
10001108|NCT01716039|11123087|FG001|COMPLETED|Overall Study||6
10001109|NCT01716039|11123088|FG002|COMPLETED|Overall Study||8
10001110|NCT01716039|11123086|FG000|NOT COMPLETED|Overall Study||1
10001111|NCT01716039|11123087|FG001|NOT COMPLETED|Overall Study||2
10001112|NCT01716039|11123088|FG002|NOT COMPLETED|Overall Study||2
10001113|NCT01716104|11123100|FG000|STARTED|Overall Study||125
10001114|NCT01716104|11123101|FG001|STARTED|Overall Study||124
10001115|NCT01716104|11123100|FG000|COMPLETED|Overall Study||119
10001116|NCT01716104|11123101|FG001|COMPLETED|Overall Study||117
10001117|NCT01716104|11123100|FG000|NOT COMPLETED|Overall Study||6
10001118|NCT01716104|11123101|FG001|NOT COMPLETED|Overall Study||7
10001119|NCT01716156|11123110|FG000|STARTED|Overall Study||9
10001120|NCT01716156|11123111|FG001|STARTED|Overall Study||4
10001121|NCT01716156|11123112|FG002|STARTED|Overall Study||13
10001122|NCT01716156|11123110|FG000|COMPLETED|Overall Study||7
10001123|NCT01716156|11123111|FG001|COMPLETED|Overall Study||3
10001124|NCT01716156|11123112|FG002|COMPLETED|Overall Study||11
10001125|NCT01716156|11123110|FG000|NOT COMPLETED|Overall Study||2
10001126|NCT01716156|11123111|FG001|NOT COMPLETED|Overall Study||1
10001127|NCT01716156|11123112|FG002|NOT COMPLETED|Overall Study||2
10001128|NCT01716169|11123124|FG000|STARTED|Overall Study||10
10001129|NCT01716169|11123124|FG000|Standard of Care Dressings Used|Overall Study||7
10001130|NCT01716169|11123124|FG000|COMPLETED|Overall Study||6
10001131|NCT01716169|11123124|FG000|NOT COMPLETED|Overall Study||4
10001132|NCT01716195|11123130|FG000|STARTED|Overall Study||18
10001133|NCT01716195|11123130|FG000|COMPLETED|Overall Study||17
10001134|NCT01716195|11123130|FG000|NOT COMPLETED|Overall Study||1
10001135|NCT01716208|11123134|FG000|STARTED|Overall Study||12
10001136|NCT01716208|11123134|FG000|COMPLETED|Overall Study||12
10001137|NCT01716208|11123134|FG000|NOT COMPLETED|Overall Study||0
10001138|NCT01716221|11123138|FG000|STARTED|Overall Study||1
10001139|NCT01716221|11123138|FG000|COMPLETED|Overall Study||1
10001140|NCT01716221|11123138|FG000|NOT COMPLETED|Overall Study||0
10001141|NCT01716234|11123161|FG000|STARTED|Overall Study||24
10001142|NCT01716234|11123162|FG001|STARTED|Overall Study||22
10001143|NCT01716234|11123163|FG002|STARTED|Overall Study||20
10001144|NCT01716234|11123164|FG003|STARTED|Overall Study||28
10001145|NCT01716234|11123165|FG004|STARTED|Overall Study||15
10001146|NCT01716234|11123166|FG005|STARTED|Overall Study||32
10001147|NCT01716234|11123167|FG006|STARTED|Overall Study||1
10001148|NCT01716234|11123161|FG000|Treated|Overall Study||22
10001149|NCT01716234|11123162|FG001|Treated|Overall Study||21
10001150|NCT01716234|11123163|FG002|Treated|Overall Study||19
10001151|NCT01716234|11123164|FG003|Treated|Overall Study||28
10001152|NCT01716234|11123165|FG004|Treated|Overall Study||15
10001153|NCT01716234|11123166|FG005|Treated|Overall Study||30
10001154|NCT01716234|11123167|FG006|Treated|Overall Study||1
10001155|NCT01716234|11123161|FG000|COMPLETED|Overall Study||14
10001156|NCT01716234|11123162|FG001|COMPLETED|Overall Study||12
10001157|NCT01716234|11123163|FG002|COMPLETED|Overall Study||15
10001158|NCT01716234|11123164|FG003|COMPLETED|Overall Study||16
10001159|NCT01716234|11123165|FG004|COMPLETED|Overall Study||10
10001160|NCT01716234|11123166|FG005|COMPLETED|Overall Study||18
10001161|NCT01716234|11123167|FG006|COMPLETED|Overall Study||1
10001162|NCT01716234|11123161|FG000|NOT COMPLETED|Overall Study||10
10001163|NCT01716234|11123162|FG001|NOT COMPLETED|Overall Study||10
10001164|NCT01716234|11123163|FG002|NOT COMPLETED|Overall Study||5
10001165|NCT01716234|11123164|FG003|NOT COMPLETED|Overall Study||12
10001166|NCT01716234|11123165|FG004|NOT COMPLETED|Overall Study||5
10001167|NCT01716234|11123166|FG005|NOT COMPLETED|Overall Study||14
10001168|NCT01716234|11123167|FG006|NOT COMPLETED|Overall Study||0
10001169|NCT01716455|11123189|FG000|STARTED|Overall Study||8
10001170|NCT01716455|11123190|FG001|STARTED|Overall Study||8
10001171|NCT01716455|11123191|FG002|STARTED|Overall Study||8
10001172|NCT01716455|11123192|FG003|STARTED|Overall Study||8
10001173|NCT01716455|11123193|FG004|STARTED|Overall Study||26
10001174|NCT01716455|11123194|FG005|STARTED|Overall Study||8
10001175|NCT01716455|11123189|FG000|COMPLETED|Overall Study||8
10001176|NCT01716455|11123190|FG001|COMPLETED|Overall Study||8
10001177|NCT01716455|11123191|FG002|COMPLETED|Overall Study||8
10001178|NCT01716455|11123192|FG003|COMPLETED|Overall Study||8
10001179|NCT01716455|11123193|FG004|COMPLETED|Overall Study||26
10001180|NCT01716455|11123194|FG005|COMPLETED|Overall Study||8
10001181|NCT01716455|11123189|FG000|NOT COMPLETED|Overall Study||0
10001182|NCT01716455|11123190|FG001|NOT COMPLETED|Overall Study||0
10001183|NCT01716455|11123191|FG002|NOT COMPLETED|Overall Study||0
10001184|NCT01716455|11123192|FG003|NOT COMPLETED|Overall Study||0
10001185|NCT01716455|11123193|FG004|NOT COMPLETED|Overall Study||0
10001186|NCT01716455|11123194|FG005|NOT COMPLETED|Overall Study||0
10001187|NCT01716468|11123205|FG000|STARTED|Overall Study||17
10001188|NCT01716468|11123205|FG000|COMPLETED|Overall Study||11
10001189|NCT01716468|11123205|FG000|NOT COMPLETED|Overall Study||6
10001190|NCT01716520|11123209|FG000|STARTED|Treatment Period 1 (14 Days)||31
10001191|NCT01716520|11123210|FG001|STARTED|Treatment Period 1 (14 Days)||30
10001192|NCT01716520|11123211|FG002|STARTED|Treatment Period 1 (14 Days)||30
10001193|NCT01716520|11123212|FG003|STARTED|Treatment Period 1 (14 Days)||30
10001194|NCT01716520|11123213|FG004|STARTED|Treatment Period 1 (14 Days)||31
10001195|NCT01716520|11123214|FG005|STARTED|Treatment Period 1 (14 Days)||30
10001196|NCT01716520|11123209|FG000|COMPLETED|Treatment Period 1 (14 Days)||29
10001197|NCT01716520|11123210|FG001|COMPLETED|Treatment Period 1 (14 Days)||29
10001198|NCT01716520|11123211|FG002|COMPLETED|Treatment Period 1 (14 Days)||28
10001199|NCT01716520|11123212|FG003|COMPLETED|Treatment Period 1 (14 Days)||29
10001200|NCT01716520|11123213|FG004|COMPLETED|Treatment Period 1 (14 Days)||31
10001201|NCT01716520|11123214|FG005|COMPLETED|Treatment Period 1 (14 Days)||29
10001202|NCT01716520|11123209|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10001203|NCT01716520|11123210|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10001204|NCT01716520|11123211|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10001205|NCT01716520|11123212|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10001206|NCT01716520|11123213|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10001207|NCT01716520|11123214|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10001208|NCT01716520|11123209|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29
10001209|NCT01716520|11123210|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29
10001210|NCT01716520|11123211|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28
10001211|NCT01716520|11123212|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29
10001212|NCT01716520|11123213|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31
10001213|NCT01716520|11123214|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29
10001214|NCT01716520|11123209|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29
10001215|NCT01716520|11123210|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28
10001216|NCT01716520|11123211|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27
10001217|NCT01716520|11123212|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29
10001218|NCT01716520|11123213|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31
10001219|NCT01716520|11123214|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27
10001220|NCT01716520|11123209|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10001221|NCT01716520|11123210|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
10001222|NCT01716520|11123211|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
10001223|NCT01716520|11123212|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10001224|NCT01716520|11123213|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10001225|NCT01716520|11123214|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
10001226|NCT01716520|11123209|FG000|STARTED|Treatment Period 2 (14 Days)||29
10001227|NCT01716520|11123210|FG001|STARTED|Treatment Period 2 (14 Days)||28
10001228|NCT01716520|11123211|FG002|STARTED|Treatment Period 2 (14 Days)||27
10001229|NCT01716520|11123212|FG003|STARTED|Treatment Period 2 (14 Days)||29
10001230|NCT01716520|11123213|FG004|STARTED|Treatment Period 2 (14 Days)||31
10001231|NCT01716520|11123214|FG005|STARTED|Treatment Period 2 (14 Days)||27
10001232|NCT01716520|11123209|FG000|COMPLETED|Treatment Period 2 (14 Days)||29
10001233|NCT01716520|11123210|FG001|COMPLETED|Treatment Period 2 (14 Days)||28
10001234|NCT01716520|11123211|FG002|COMPLETED|Treatment Period 2 (14 Days)||27
10001235|NCT01716520|11123212|FG003|COMPLETED|Treatment Period 2 (14 Days)||28
10001236|NCT01716520|11123213|FG004|COMPLETED|Treatment Period 2 (14 Days)||29
10001237|NCT01716520|11123214|FG005|COMPLETED|Treatment Period 2 (14 Days)||27
10001238|NCT01716520|11123209|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10001239|NCT01716520|11123210|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10001240|NCT01716520|11123211|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10001241|NCT01716520|11123212|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10001242|NCT01716520|11123213|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2
10001243|NCT01716520|11123214|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10001244|NCT01716520|11123209|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29
10001245|NCT01716520|11123210|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28
10001246|NCT01716520|11123211|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27
10001247|NCT01716520|11123212|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28
10001248|NCT01716520|11123213|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29
10001249|NCT01716520|11123214|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27
10001250|NCT01716520|11123209|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27
10001251|NCT01716520|11123210|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27
10001252|NCT01716520|11123211|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26
10001253|NCT01716520|11123212|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28
10001254|NCT01716520|11123213|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29
10001255|NCT01716520|11123214|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25
10001256|NCT01716520|11123209|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
10001257|NCT01716520|11123210|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
10001258|NCT01716520|11123211|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
10001259|NCT01716520|11123212|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10001260|NCT01716520|11123213|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10001261|NCT01716520|11123214|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
10001262|NCT01716520|11123209|FG000|STARTED|Treatment Period 3 (14 Days)||27
10001263|NCT01716520|11123210|FG001|STARTED|Treatment Period 3 (14 Days)||27
10001264|NCT01716520|11123211|FG002|STARTED|Treatment Period 3 (14 Days)||26
10001265|NCT01716520|11123212|FG003|STARTED|Treatment Period 3 (14 Days)||28
10001266|NCT01716520|11123213|FG004|STARTED|Treatment Period 3 (14 Days)||29
10001267|NCT01716520|11123214|FG005|STARTED|Treatment Period 3 (14 Days)||25
10001268|NCT01716520|11123209|FG000|COMPLETED|Treatment Period 3 (14 Days)||27
10001269|NCT01716520|11123210|FG001|COMPLETED|Treatment Period 3 (14 Days)||27
10001270|NCT01716520|11123211|FG002|COMPLETED|Treatment Period 3 (14 Days)||25
10001271|NCT01716520|11123212|FG003|COMPLETED|Treatment Period 3 (14 Days)||28
10001272|NCT01716520|11123213|FG004|COMPLETED|Treatment Period 3 (14 Days)||29
10001273|NCT01716520|11123214|FG005|COMPLETED|Treatment Period 3 (14 Days)||23
10001274|NCT01716520|11123209|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10001275|NCT01716520|11123210|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10001276|NCT01716520|11123211|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10001277|NCT01716520|11123212|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10001278|NCT01716520|11123213|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10001279|NCT01716520|11123214|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
10001280|NCT01716533|11123226|FG000|STARTED|Overall Study||7
10001281|NCT01716533|11123227|FG001|STARTED|Overall Study||25
10001282|NCT01716533|11123228|FG002|STARTED|Overall Study||5
10001283|NCT01716533|11123229|FG003|STARTED|Overall Study||9
10001284|NCT01716533|11123226|FG000|COMPLETED|Overall Study||7
10001285|NCT01716533|11123227|FG001|COMPLETED|Overall Study||25
10001286|NCT01716533|11123228|FG002|COMPLETED|Overall Study||0
10001287|NCT01716533|11123229|FG003|COMPLETED|Overall Study||1
10001288|NCT01716533|11123226|FG000|NOT COMPLETED|Overall Study||0
10001289|NCT01716533|11123227|FG001|NOT COMPLETED|Overall Study||0
10001290|NCT01716533|11123228|FG002|NOT COMPLETED|Overall Study||5
10001291|NCT01716533|11123229|FG003|NOT COMPLETED|Overall Study||8
10001292|NCT01716559|11123243|FG000|STARTED|Overall Study||160
10001293|NCT01716559|11123243|FG000|COMPLETED|Overall Study||49
10001294|NCT01716559|11123243|FG000|NOT COMPLETED|Overall Study||111
10001295|NCT01716585|11123249|FG000|STARTED|Double-blind Treatment||477
10001296|NCT01716585|11123250|FG001|STARTED|Double-blind Treatment||159
10001297|NCT01716585|11123249|FG000|Randomized But Not Treated|Double-blind Treatment||4
10001298|NCT01716585|11123250|FG001|Randomized But Not Treated|Double-blind Treatment||1
10001299|NCT01716585|11123249|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
10001300|NCT01716585|11123250|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
10001301|NCT01716585|11123249|FG000|NOT COMPLETED|Double-blind Treatment||13
10001302|NCT01716585|11123250|FG001|NOT COMPLETED|Double-blind Treatment||2
10001303|NCT01716585|11123249|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
10001304|NCT01716585|11123250|FG001|STARTED|Open-label Treatment||157
10001305|NCT01716585|11123249|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
10001306|NCT01716585|11123250|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
10001307|NCT01716585|11123249|FG000|NOT COMPLETED|Open-label Treatment||0
10001308|NCT01716585|11123250|FG001|NOT COMPLETED|Open-label Treatment||7
10001309|NCT01716663|11123257|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
10001310|NCT01716663|11123257|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
10001311|NCT01716663|11123257|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
10001312|NCT01716663|11123257|FG000|NOT COMPLETED|Overall Study||6
10001313|NCT01716715|11123263|FG000|STARTED|Overall Study||57
10001314|NCT01716715|11123264|FG001|STARTED|Overall Study||54
10001315|NCT01716715|11123263|FG000|COMPLETED|Overall Study||55
10001316|NCT01716715|11123264|FG001|COMPLETED|Overall Study||50
10001317|NCT01716715|11123263|FG000|NOT COMPLETED|Overall Study||2
10001318|NCT01716715|11123264|FG001|NOT COMPLETED|Overall Study||4
10001319|NCT01716754|11123276|FG000|STARTED|Overall Study||199
10001320|NCT01716754|11123277|FG001|STARTED|Overall Study||40
10001321|NCT01716754|11123278|FG002|STARTED|Overall Study||135
10001322|NCT01716754|11123279|FG003|STARTED|Overall Study||97
10001323|NCT01716754|11123276|FG000|FAS|Overall Study||199
10001324|NCT01716754|11123277|FG001|FAS|Overall Study||40
10001325|NCT01716754|11123278|FG002|FAS|Overall Study||131
10001326|NCT01716754|11123279|FG003|FAS|Overall Study||96
10001327|NCT01716754|11123276|FG000|Safety Set|Overall Study||199
10001328|NCT01716754|11123277|FG001|Safety Set|Overall Study||40
10001329|NCT01716754|11123278|FG002|Safety Set|Overall Study||131
10001330|NCT01716754|11123279|FG003|Safety Set|Overall Study||96
10001331|NCT01716754|11123276|FG000|COMPLETED|Overall Study||188
10001332|NCT01716754|11123277|FG001|COMPLETED|Overall Study||36
10001333|NCT01716754|11123278|FG002|COMPLETED|Overall Study||121
10001334|NCT01716754|11123279|FG003|COMPLETED|Overall Study||89
10001335|NCT01716754|11123276|FG000|NOT COMPLETED|Overall Study||11
10001336|NCT01716754|11123277|FG001|NOT COMPLETED|Overall Study||4
10001337|NCT01716754|11123278|FG002|NOT COMPLETED|Overall Study||14
10001338|NCT01716754|11123279|FG003|NOT COMPLETED|Overall Study||8
10001339|NCT01717001|11123290|FG000|STARTED|Overall Study||38
10001340|NCT01717001|11123291|FG001|STARTED|Overall Study||28
10001341|NCT01717001|11123290|FG000|COMPLETED|Overall Study||32
10001342|NCT01717001|11123291|FG001|COMPLETED|Overall Study||24
10001343|NCT01717001|11123290|FG000|NOT COMPLETED|Overall Study||6
10001344|NCT01717001|11123291|FG001|NOT COMPLETED|Overall Study||4
10001345|NCT01717014|11123297|FG000|STARTED|Overall Study||8
10001346|NCT01717014|11123297|FG000|COMPLETED|Overall Study||8
10001347|NCT01717014|11123297|FG000|NOT COMPLETED|Overall Study||0
10001348|NCT01717040|11123303|FG000|STARTED|Overall Study||17
10001349|NCT01717040|11123304|FG001|STARTED|Overall Study||20
10001350|NCT01717040|11123303|FG000|COMPLETED|Overall Study||12
10001351|NCT01717040|11123304|FG001|COMPLETED|Overall Study||15
10001352|NCT01717040|11123303|FG000|NOT COMPLETED|Overall Study||5
10001353|NCT01717040|11123304|FG001|NOT COMPLETED|Overall Study||5
10001354|NCT01717053|11123310|FG000|STARTED|Overall Study||37
10202289|NCT03443414|11329418|FG002|COMPLETED|Overall Study||76
10202290|NCT03443414|11329419|FG003|COMPLETED|Overall Study||75
10202291|NCT03443414|11329420|FG004|COMPLETED|Overall Study||75
10001355|NCT01717053|11123310|FG000|COMPLETED|Overall Study||33
10001356|NCT01717053|11123310|FG000|NOT COMPLETED|Overall Study||4
10001357|NCT01717209|11123314|FG000|STARTED|Overall Study||14
10001358|NCT01717209|11123314|FG000|COMPLETED|Overall Study||14
10001359|NCT01717209|11123314|FG000|NOT COMPLETED|Overall Study||0
10001360|NCT01717287|11123320|FG000|STARTED|Overall Study||4
10001361|NCT01717287|11123321|FG001|STARTED|Overall Study||28
10001362|NCT01717287|11123320|FG000|COMPLETED|Overall Study||4
10001363|NCT01717287|11123321|FG001|COMPLETED|Overall Study||25
10001364|NCT01717287|11123320|FG000|NOT COMPLETED|Overall Study||0
10001365|NCT01717287|11123321|FG001|NOT COMPLETED|Overall Study||3
10001366|NCT01717313|11123329|FG000|STARTED|Phase A (Weeks 0 to 24)||165
10001367|NCT01717313|11123330|FG001|STARTED|Phase A (Weeks 0 to 24)||164
10001368|NCT01717313|11123329|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147
10001369|NCT01717313|11123330|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151
10001370|NCT01717313|11123329|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
10001371|NCT01717313|11123330|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
10001372|NCT01717313|11123329|FG000|STARTED|Interphase||147
10001373|NCT01717313|11123330|FG001|STARTED|Interphase||151
10001374|NCT01717313|11123329|FG000|COMPLETED|Interphase||146
10001375|NCT01717313|11123330|FG001|COMPLETED|Interphase||151
10001376|NCT01717313|11123329|FG000|NOT COMPLETED|Interphase||1
10001377|NCT01717313|11123330|FG001|NOT COMPLETED|Interphase||0
10001378|NCT01717313|11123329|FG000|STARTED|Phase B (Weeks 24 to 54)||146
10001379|NCT01717313|11123330|FG001|STARTED|Phase B (Weeks 24 to 54)||151
10001380|NCT01717313|11123329|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134
10001381|NCT01717313|11123330|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135
10001382|NCT01717313|11123329|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
10001383|NCT01717313|11123330|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
10001384|NCT01717326|11123356|FG000|STARTED|Overall Study||25
10001385|NCT01717326|11123357|FG001|STARTED|Overall Study||27
10001386|NCT01717326|11123358|FG002|STARTED|Overall Study||13
10001387|NCT01717326|11123359|FG003|STARTED|Overall Study||30
10001388|NCT01717326|11123360|FG004|STARTED|Overall Study||33
10001389|NCT01717326|11123361|FG005|STARTED|Overall Study||31
10001390|NCT01717326|11123362|FG006|STARTED|Overall Study||31
10001391|NCT01717326|11123363|FG007|STARTED|Overall Study||29
10001392|NCT01717326|11123364|FG008|STARTED|Overall Study||32
10001393|NCT01717326|11123365|FG009|STARTED|Overall Study||31
10001394|NCT01717326|11123366|FG010|STARTED|Overall Study||32
10001395|NCT01717326|11123367|FG011|STARTED|Overall Study||33
10001396|NCT01717326|11123368|FG012|STARTED|Overall Study||33
10001397|NCT01717326|11123369|FG013|STARTED|Overall Study||32
10001398|NCT01717326|11123370|FG014|STARTED|Overall Study||29
10001399|NCT01717326|11123371|FG015|STARTED|Overall Study||30
10001400|NCT01717326|11123372|FG016|STARTED|Overall Study||30
10001401|NCT01717326|11123373|FG017|STARTED|Overall Study||31
10001402|NCT01717326|11123374|FG018|STARTED|Overall Study||20
10001403|NCT01717326|11123375|FG019|STARTED|Overall Study||21
10001404|NCT01717326|11123356|FG000|Treated|Overall Study||25
10001405|NCT01717326|11123357|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
10001406|NCT01717326|11123358|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
10001407|NCT01717326|11123359|FG003|Treated|Overall Study||30
10001408|NCT01717326|11123360|FG004|Treated|Overall Study||33
10001409|NCT01717326|11123361|FG005|Treated|Overall Study||31
10001410|NCT01717326|11123362|FG006|Treated|Overall Study||31
10001411|NCT01717326|11123363|FG007|Treated|Overall Study||29
10001412|NCT01717326|11123364|FG008|Treated|Overall Study||32
10001413|NCT01717326|11123365|FG009|Treated|Overall Study||31
10001414|NCT01717326|11123366|FG010|Treated|Overall Study||32
10001415|NCT01717326|11123367|FG011|Treated|Overall Study||33
10001416|NCT01717326|11123368|FG012|Treated|Overall Study||33
10001417|NCT01717326|11123369|FG013|Treated|Overall Study||32
10001418|NCT01717326|11123370|FG014|Treated|Overall Study||29
10001419|NCT01717326|11123371|FG015|Treated|Overall Study||30
10001420|NCT01717326|11123372|FG016|Treated|Overall Study||30
10001421|NCT01717326|11123373|FG017|Treated|Overall Study||31
10001422|NCT01717326|11123374|FG018|Treated|Overall Study||20
10001423|NCT01717326|11123375|FG019|Treated|Overall Study||21
10001424|NCT01717326|11123356|FG000|COMPLETED|Overall Study||22
10001425|NCT01717326|11123357|FG001|COMPLETED|Overall Study||26
10001426|NCT01717326|11123358|FG002|COMPLETED|Overall Study||13
10001427|NCT01717326|11123359|FG003|COMPLETED|Overall Study||28
10001428|NCT01717326|11123360|FG004|COMPLETED|Overall Study||31
10001429|NCT01717326|11123361|FG005|COMPLETED|Overall Study||31
10001430|NCT01717326|11123362|FG006|COMPLETED|Overall Study||30
10001431|NCT01717326|11123363|FG007|COMPLETED|Overall Study||29
10001432|NCT01717326|11123364|FG008|COMPLETED|Overall Study||32
10001433|NCT01717326|11123365|FG009|COMPLETED|Overall Study||29
10001434|NCT01717326|11123366|FG010|COMPLETED|Overall Study||30
10001435|NCT01717326|11123367|FG011|COMPLETED|Overall Study||33
10001436|NCT01717326|11123368|FG012|COMPLETED|Overall Study||32
10001437|NCT01717326|11123369|FG013|COMPLETED|Overall Study||32
10001438|NCT01717326|11123370|FG014|COMPLETED|Overall Study||29
10001439|NCT01717326|11123371|FG015|COMPLETED|Overall Study||27
10001440|NCT01717326|11123372|FG016|COMPLETED|Overall Study||29
10001441|NCT01717326|11123373|FG017|COMPLETED|Overall Study||31
10001442|NCT01717326|11123374|FG018|COMPLETED|Overall Study||16
10001443|NCT01717326|11123375|FG019|COMPLETED|Overall Study||15
10001444|NCT01717326|11123356|FG000|NOT COMPLETED|Overall Study||3
10001445|NCT01717326|11123357|FG001|NOT COMPLETED|Overall Study||1
10001446|NCT01717326|11123358|FG002|NOT COMPLETED|Overall Study||0
10001447|NCT01717326|11123359|FG003|NOT COMPLETED|Overall Study||2
10001448|NCT01717326|11123360|FG004|NOT COMPLETED|Overall Study||2
10001449|NCT01717326|11123361|FG005|NOT COMPLETED|Overall Study||0
10001450|NCT01717326|11123362|FG006|NOT COMPLETED|Overall Study||1
10001451|NCT01717326|11123363|FG007|NOT COMPLETED|Overall Study||0
10001452|NCT01717326|11123364|FG008|NOT COMPLETED|Overall Study||0
10001453|NCT01717326|11123365|FG009|NOT COMPLETED|Overall Study||2
10001454|NCT01717326|11123366|FG010|NOT COMPLETED|Overall Study||2
10001455|NCT01717326|11123367|FG011|NOT COMPLETED|Overall Study||0
10001456|NCT01717326|11123368|FG012|NOT COMPLETED|Overall Study||1
10001457|NCT01717326|11123369|FG013|NOT COMPLETED|Overall Study||0
10001458|NCT01717326|11123370|FG014|NOT COMPLETED|Overall Study||0
10001459|NCT01717326|11123371|FG015|NOT COMPLETED|Overall Study||3
10001460|NCT01717326|11123372|FG016|NOT COMPLETED|Overall Study||1
10001461|NCT01717326|11123373|FG017|NOT COMPLETED|Overall Study||0
10001462|NCT01717326|11123374|FG018|NOT COMPLETED|Overall Study||4
10001463|NCT01717326|11123375|FG019|NOT COMPLETED|Overall Study||6
10001464|NCT01717391|11123417|FG000|STARTED|Overall Study||36
10001465|NCT01717391|11123417|FG000|COMPLETED|Overall Study||27
10001466|NCT01717391|11123417|FG000|NOT COMPLETED|Overall Study||9
10001467|NCT01717456|11123425|FG000|STARTED|End of Treatment||11
10001468|NCT01717456|11123426|FG001|STARTED|End of Treatment||8
10001469|NCT01717456|11123425|FG000|COMPLETED|End of Treatment||11
10001470|NCT01717456|11123426|FG001|COMPLETED|End of Treatment||6
10001471|NCT01717456|11123425|FG000|NOT COMPLETED|End of Treatment||0
10001472|NCT01717456|11123426|FG001|NOT COMPLETED|End of Treatment||2
10001473|NCT01717456|11123425|FG000|STARTED|Follow-Up 6 Months After End of Tx||11
10001474|NCT01717456|11123426|FG001|STARTED|Follow-Up 6 Months After End of Tx||6
10001475|NCT01717456|11123425|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7
10001476|NCT01717456|11123426|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2
10001477|NCT01717456|11123425|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
10001478|NCT01717456|11123426|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
10001479|NCT01717521|11123433|FG000|STARTED|Overall Study||20
10001480|NCT01717521|11123433|FG000|COMPLETED|Overall Study||20
10001481|NCT01717521|11123433|FG000|NOT COMPLETED|Overall Study||0
10001482|NCT01717638|11123450|FG000|STARTED|Overall Study||67
10001483|NCT01717638|11123451|FG001|STARTED|Overall Study||61
10001484|NCT01717638|11123452|FG002|STARTED|Overall Study||60
10001485|NCT01717638|11123453|FG003|STARTED|Overall Study||66
10001486|NCT01717638|11123454|FG004|STARTED|Overall Study||64
10001487|NCT01717638|11123455|FG005|STARTED|Overall Study||55
10001488|NCT01717638|11123456|FG006|STARTED|Overall Study||43
10001489|NCT01717638|11123457|FG007|STARTED|Overall Study||29
10001490|NCT01717638|11123458|FG008|STARTED|Overall Study||28
10001491|NCT01717638|11123459|FG009|STARTED|Overall Study||100
10001492|NCT01717638|11123460|FG010|STARTED|Overall Study||11
10001493|NCT01717638|11123461|FG011|STARTED|Overall Study||12
10001494|NCT01717638|11123462|FG012|STARTED|Overall Study||209
10001495|NCT01717638|11123450|FG000|COMPLETED|Overall Study||67
10001496|NCT01717638|11123451|FG001|COMPLETED|Overall Study||60
10001497|NCT01717638|11123452|FG002|COMPLETED|Overall Study||59
10001498|NCT01717638|11123453|FG003|COMPLETED|Overall Study||66
10001499|NCT01717638|11123454|FG004|COMPLETED|Overall Study||63
10001500|NCT01717638|11123455|FG005|COMPLETED|Overall Study||54
10001501|NCT01717638|11123456|FG006|COMPLETED|Overall Study||41
10001502|NCT01717638|11123457|FG007|COMPLETED|Overall Study||28
10001503|NCT01717638|11123458|FG008|COMPLETED|Overall Study||26
10001504|NCT01717638|11123459|FG009|COMPLETED|Overall Study||99
10001505|NCT01717638|11123460|FG010|COMPLETED|Overall Study||11
10001506|NCT01717638|11123461|FG011|COMPLETED|Overall Study||12
10001507|NCT01717638|11123462|FG012|COMPLETED|Overall Study||190
10001508|NCT01717638|11123450|FG000|NOT COMPLETED|Overall Study||0
10001509|NCT01717638|11123451|FG001|NOT COMPLETED|Overall Study||1
10001510|NCT01717638|11123452|FG002|NOT COMPLETED|Overall Study||1
10001511|NCT01717638|11123453|FG003|NOT COMPLETED|Overall Study||0
10001512|NCT01717638|11123454|FG004|NOT COMPLETED|Overall Study||1
10001513|NCT01717638|11123455|FG005|NOT COMPLETED|Overall Study||1
10001514|NCT01717638|11123456|FG006|NOT COMPLETED|Overall Study||2
10001515|NCT01717638|11123457|FG007|NOT COMPLETED|Overall Study||1
10001516|NCT01717638|11123458|FG008|NOT COMPLETED|Overall Study||2
10001517|NCT01717638|11123459|FG009|NOT COMPLETED|Overall Study||1
10001518|NCT01717638|11123460|FG010|NOT COMPLETED|Overall Study||0
10001519|NCT01717638|11123461|FG011|NOT COMPLETED|Overall Study||0
10001520|NCT01717638|11123462|FG012|NOT COMPLETED|Overall Study||19
10001521|NCT01717742|11123498|FG000|STARTED|Overall Study||48
10001522|NCT01717742|11123499|FG001|STARTED|Overall Study||49
10001523|NCT01717742|11123498|FG000|COMPLETED|Overall Study||43
10001524|NCT01717742|11123499|FG001|COMPLETED|Overall Study||47
10001525|NCT01717742|11123498|FG000|NOT COMPLETED|Overall Study||5
10001526|NCT01717742|11123499|FG001|NOT COMPLETED|Overall Study||2
10001527|NCT01717768|11123515|FG000|STARTED|Part 1 (Duration of 15 Days)||17
10001528|NCT01717768|11123516|FG001|STARTED|Part 1 (Duration of 15 Days)||17
10001529|NCT01717768|11123517|FG002|STARTED|Part 1 (Duration of 15 Days)||0
10001530|NCT01717768|11123518|FG003|STARTED|Part 1 (Duration of 15 Days)||0
10001531|NCT01717768|11123519|FG004|STARTED|Part 1 (Duration of 15 Days)||0
10001532|NCT01717768|11123520|FG005|STARTED|Part 1 (Duration of 15 Days)||0
10001533|NCT01717768|11123521|FG006|STARTED|Part 1 (Duration of 15 Days)||0
10001534|NCT01717768|11123522|FG007|STARTED|Part 1 (Duration of 15 Days)||0
10001535|NCT01717768|11123523|FG008|STARTED|Part 1 (Duration of 15 Days)||0
10001536|NCT01717768|11123524|FG009|STARTED|Part 1 (Duration of 15 Days)||0
10001537|NCT01717768|11123525|FG010|STARTED|Part 1 (Duration of 15 Days)||0
10001538|NCT01717768|11123526|FG011|STARTED|Part 1 (Duration of 15 Days)||0
10001539|NCT01717768|11123515|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17
10001540|NCT01717768|11123516|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16
10001541|NCT01717768|11123517|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0
10001542|NCT01717768|11123518|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0
10001543|NCT01717768|11123519|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0
10001544|NCT01717768|11123520|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0
10001545|NCT01717768|11123521|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0
10001546|NCT01717768|11123522|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0
10001547|NCT01717768|11123523|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0
10001548|NCT01717768|11123524|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0
10001549|NCT01717768|11123525|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0
10001550|NCT01717768|11123526|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0
10001551|NCT01717768|11123515|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001552|NCT01717768|11123516|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
10001553|NCT01717768|11123517|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001554|NCT01717768|11123518|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001555|NCT01717768|11123519|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001556|NCT01717768|11123520|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001557|NCT01717768|11123521|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001558|NCT01717768|11123522|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001559|NCT01717768|11123523|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001560|NCT01717768|11123524|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001561|NCT01717768|11123525|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001562|NCT01717768|11123526|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10001563|NCT01717768|11123515|FG000|STARTED|Part 2 (Duration of 15 Days)||0
10001564|NCT01717768|11123516|FG001|STARTED|Part 2 (Duration of 15 Days)||0
10001565|NCT01717768|11123517|FG002|STARTED|Part 2 (Duration of 15 Days)||17
10001566|NCT01717768|11123518|FG003|STARTED|Part 2 (Duration of 15 Days)||0
10001567|NCT01717768|11123519|FG004|STARTED|Part 2 (Duration of 15 Days)||0
10001568|NCT01717768|11123520|FG005|STARTED|Part 2 (Duration of 15 Days)||0
10001569|NCT01717768|11123521|FG006|STARTED|Part 2 (Duration of 15 Days)||0
10001570|NCT01717768|11123522|FG007|STARTED|Part 2 (Duration of 15 Days)||0
10001571|NCT01717768|11123523|FG008|STARTED|Part 2 (Duration of 15 Days)||0
10001572|NCT01717768|11123524|FG009|STARTED|Part 2 (Duration of 15 Days)||0
10001573|NCT01717768|11123525|FG010|STARTED|Part 2 (Duration of 15 Days)||0
10001574|NCT01717768|11123526|FG011|STARTED|Part 2 (Duration of 15 Days)||0
10001575|NCT01717768|11123515|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0
10001576|NCT01717768|11123516|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0
10001577|NCT01717768|11123517|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17
10001578|NCT01717768|11123518|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0
10001579|NCT01717768|11123519|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0
10001580|NCT01717768|11123520|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0
10001581|NCT01717768|11123521|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0
10001582|NCT01717768|11123522|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0
10001583|NCT01717768|11123523|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0
10001584|NCT01717768|11123524|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0
10001585|NCT01717768|11123525|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0
10001586|NCT01717768|11123526|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0
10001587|NCT01717768|11123515|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001588|NCT01717768|11123516|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001589|NCT01717768|11123517|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001590|NCT01717768|11123518|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001591|NCT01717768|11123519|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001592|NCT01717768|11123520|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001593|NCT01717768|11123521|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001594|NCT01717768|11123522|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001595|NCT01717768|11123523|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001596|NCT01717768|11123524|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001597|NCT01717768|11123525|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001598|NCT01717768|11123526|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10001599|NCT01717768|11123515|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001600|NCT01717768|11123516|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001601|NCT01717768|11123517|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001602|NCT01717768|11123518|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
10001603|NCT01717768|11123519|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10001604|NCT01717768|11123520|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10001605|NCT01717768|11123521|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001606|NCT01717768|11123522|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001607|NCT01717768|11123523|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001608|NCT01717768|11123524|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001609|NCT01717768|11123525|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001610|NCT01717768|11123526|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001611|NCT01717768|11123515|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001612|NCT01717768|11123516|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001613|NCT01717768|11123517|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001614|NCT01717768|11123518|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
10001615|NCT01717768|11123519|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10001616|NCT01717768|11123520|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10001617|NCT01717768|11123521|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001618|NCT01717768|11123522|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001619|NCT01717768|11123523|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001620|NCT01717768|11123524|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001621|NCT01717768|11123525|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001622|NCT01717768|11123526|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001623|NCT01717768|11123515|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001624|NCT01717768|11123516|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001625|NCT01717768|11123517|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001626|NCT01717768|11123518|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001627|NCT01717768|11123519|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001628|NCT01717768|11123520|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001629|NCT01717768|11123521|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001630|NCT01717768|11123522|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001631|NCT01717768|11123523|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001632|NCT01717768|11123524|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001633|NCT01717768|11123525|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001634|NCT01717768|11123526|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10001635|NCT01717768|11123515|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001636|NCT01717768|11123516|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001637|NCT01717768|11123517|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001638|NCT01717768|11123518|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
10001639|NCT01717768|11123519|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10001640|NCT01717768|11123520|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10001641|NCT01717768|11123521|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001642|NCT01717768|11123522|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001643|NCT01717768|11123523|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001644|NCT01717768|11123524|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001645|NCT01717768|11123525|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001646|NCT01717768|11123526|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001647|NCT01717768|11123515|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001648|NCT01717768|11123516|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001649|NCT01717768|11123517|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001650|NCT01717768|11123518|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
10001651|NCT01717768|11123519|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10001652|NCT01717768|11123520|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10001653|NCT01717768|11123521|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001654|NCT01717768|11123522|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001655|NCT01717768|11123523|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001656|NCT01717768|11123524|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001657|NCT01717768|11123525|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001658|NCT01717768|11123526|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001659|NCT01717768|11123515|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001660|NCT01717768|11123516|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001661|NCT01717768|11123517|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001662|NCT01717768|11123518|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001663|NCT01717768|11123519|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001664|NCT01717768|11123520|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001665|NCT01717768|11123521|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001666|NCT01717768|11123522|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001667|NCT01717768|11123523|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001668|NCT01717768|11123524|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001669|NCT01717768|11123525|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001670|NCT01717768|11123526|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10001671|NCT01717768|11123515|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001672|NCT01717768|11123516|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001673|NCT01717768|11123517|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001674|NCT01717768|11123518|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
10001675|NCT01717768|11123519|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10001676|NCT01717768|11123520|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10001677|NCT01717768|11123521|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001678|NCT01717768|11123522|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001679|NCT01717768|11123523|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001680|NCT01717768|11123524|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001681|NCT01717768|11123525|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001682|NCT01717768|11123526|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001683|NCT01717768|11123515|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001684|NCT01717768|11123516|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001685|NCT01717768|11123517|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001686|NCT01717768|11123518|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
10001687|NCT01717768|11123519|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10001688|NCT01717768|11123520|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10001689|NCT01717768|11123521|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001690|NCT01717768|11123522|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001691|NCT01717768|11123523|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001692|NCT01717768|11123524|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001693|NCT01717768|11123525|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001694|NCT01717768|11123526|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001695|NCT01717768|11123515|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001696|NCT01717768|11123516|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001697|NCT01717768|11123517|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001698|NCT01717768|11123518|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001699|NCT01717768|11123519|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001700|NCT01717768|11123520|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001701|NCT01717768|11123521|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001702|NCT01717768|11123522|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001703|NCT01717768|11123523|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001704|NCT01717768|11123524|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001705|NCT01717768|11123525|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001706|NCT01717768|11123526|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10001707|NCT01717768|11123515|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001708|NCT01717768|11123516|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001709|NCT01717768|11123517|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001710|NCT01717768|11123518|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001711|NCT01717768|11123519|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001712|NCT01717768|11123520|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001713|NCT01717768|11123521|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
10001714|NCT01717768|11123522|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001715|NCT01717768|11123523|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
10001716|NCT01717768|11123524|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001717|NCT01717768|11123525|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
10001718|NCT01717768|11123526|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
10001719|NCT01717768|11123515|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001720|NCT01717768|11123516|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001721|NCT01717768|11123517|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001722|NCT01717768|11123518|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001723|NCT01717768|11123519|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001724|NCT01717768|11123520|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001725|NCT01717768|11123521|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
10001726|NCT01717768|11123522|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001727|NCT01717768|11123523|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
10001728|NCT01717768|11123524|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001729|NCT01717768|11123525|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
10001730|NCT01717768|11123526|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
10001731|NCT01717768|11123515|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001732|NCT01717768|11123516|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001733|NCT01717768|11123517|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001734|NCT01717768|11123518|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001735|NCT01717768|11123519|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001736|NCT01717768|11123520|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001737|NCT01717768|11123521|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001738|NCT01717768|11123522|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001739|NCT01717768|11123523|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001740|NCT01717768|11123524|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001741|NCT01717768|11123525|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10001742|NCT01717768|11123526|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
10001743|NCT01717768|11123515|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001744|NCT01717768|11123516|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001745|NCT01717768|11123517|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001746|NCT01717768|11123518|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001747|NCT01717768|11123519|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001748|NCT01717768|11123520|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001749|NCT01717768|11123521|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001750|NCT01717768|11123522|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
10001751|NCT01717768|11123523|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001752|NCT01717768|11123524|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
10001753|NCT01717768|11123525|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001754|NCT01717768|11123526|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001755|NCT01717768|11123515|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001756|NCT01717768|11123516|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001757|NCT01717768|11123517|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001758|NCT01717768|11123518|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001759|NCT01717768|11123519|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001760|NCT01717768|11123520|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001761|NCT01717768|11123521|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001762|NCT01717768|11123522|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
10001763|NCT01717768|11123523|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001764|NCT01717768|11123524|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
10001765|NCT01717768|11123525|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001766|NCT01717768|11123526|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001767|NCT01717768|11123515|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001768|NCT01717768|11123516|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001769|NCT01717768|11123517|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001770|NCT01717768|11123518|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001771|NCT01717768|11123519|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001772|NCT01717768|11123520|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001773|NCT01717768|11123521|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001774|NCT01717768|11123522|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
10001775|NCT01717768|11123523|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001776|NCT01717768|11123524|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
10001777|NCT01717768|11123525|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
9758773|NCT00370552|10862376|FG002|COMPLETED|Overall Study||0
9758774|NCT00370552|10862374|FG000|NOT COMPLETED|Overall Study||46
9758775|NCT00370552|10862375|FG001|NOT COMPLETED|Overall Study||45
9758776|NCT00370552|10862376|FG002|NOT COMPLETED|Overall Study||32
9758777|NCT00370682|10862387|FG000|STARTED|Overall Study||40
9758778|NCT00370682|10862388|FG001|STARTED|Overall Study||40
9758779|NCT00370682|10862389|FG002|STARTED|Overall Study||40
9758780|NCT00370682|10862387|FG000|COMPLETED|Overall Study||40
10001778|NCT01717768|11123526|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10001779|NCT01717859|11123552|FG000|STARTED|Overall Study||54
10001780|NCT01717859|11123552|FG000|3 Month|Overall Study||50
10001781|NCT01717859|11123552|FG000|COMPLETED|Overall Study||44
10001782|NCT01717859|11123552|FG000|NOT COMPLETED|Overall Study||10
10001783|NCT01717872|11123565|FG000|STARTED|Overall Study||25
10001784|NCT01717872|11123566|FG001|STARTED|Overall Study||25
10001785|NCT01717872|11123565|FG000|COMPLETED|Overall Study||25
10001786|NCT01717872|11123566|FG001|COMPLETED|Overall Study||25
10001787|NCT01717872|11123565|FG000|NOT COMPLETED|Overall Study||0
10001788|NCT01717872|11123566|FG001|NOT COMPLETED|Overall Study||0
10001789|NCT01717898|11123576|FG000|STARTED|Overall Study||6
10001790|NCT01717898|11123577|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10001791|NCT01717898|11123578|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10001792|NCT01717898|11123579|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10001793|NCT01717898|11123576|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10001794|NCT01717898|11123577|FG001|COMPLETED|Overall Study||0
10001795|NCT01717898|11123578|FG002|COMPLETED|Overall Study||0
10001796|NCT01717898|11123579|FG003|COMPLETED|Overall Study||0
10001797|NCT01717898|11123576|FG000|NOT COMPLETED|Overall Study||6
10001798|NCT01717898|11123577|FG001|NOT COMPLETED|Overall Study||0
10001799|NCT01717898|11123578|FG002|NOT COMPLETED|Overall Study||0
10001800|NCT01717898|11123579|FG003|NOT COMPLETED|Overall Study||0
10001801|NCT01717976|11123591|FG000|STARTED|Overall Study||257
10001802|NCT01717976|11123592|FG001|STARTED|Overall Study||257
10001803|NCT01717976|11123591|FG000|COMPLETED|Overall Study||257
10001804|NCT01717976|11123592|FG001|COMPLETED|Overall Study||256
10001805|NCT01717976|11123591|FG000|NOT COMPLETED|Overall Study||0
10001806|NCT01717976|11123592|FG001|NOT COMPLETED|Overall Study||1
10001807|NCT01717989|11123598|FG000|STARTED|Overall Study||2248
10001808|NCT01717989|11123598|FG000|COMPLETED|Overall Study||1182
10001809|NCT01717989|11123598|FG000|NOT COMPLETED|Overall Study||1066
10001810|NCT01718028|11123619|FG000|STARTED|Overall Study||25
10001811|NCT01718028|11123620|FG001|STARTED|Overall Study||24
10001812|NCT01718028|11123619|FG000|COMPLETED|Overall Study||25
10001813|NCT01718028|11123620|FG001|COMPLETED|Overall Study||24
10001814|NCT01718028|11123619|FG000|NOT COMPLETED|Overall Study||0
10001815|NCT01718028|11123620|FG001|NOT COMPLETED|Overall Study||0
10001816|NCT01718353|11123628|FG000|STARTED|Overall Study||41
10001817|NCT01718353|11123629|FG001|STARTED|Overall Study||22
10001818|NCT01718353|11123628|FG000|Treated|Overall Study||39
10001819|NCT01718353|11123629|FG001|Treated|Overall Study||22
10001820|NCT01718353|11123628|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
10001821|NCT01718353|11123629|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
10001822|NCT01718353|11123628|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
10001823|NCT01718353|11123629|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
10001824|NCT01718353|11123628|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
10001825|NCT01718353|11123629|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
10001826|NCT01718353|11123628|FG000|NOT COMPLETED|Overall Study||12
10001827|NCT01718353|11123629|FG001|NOT COMPLETED|Overall Study||5
10001828|NCT01718483|11123639|FG000|STARTED|Overall Study||191
10001829|NCT01718483|11123640|FG001|STARTED|Overall Study||192
10001830|NCT01718483|11123639|FG000|Treated|Overall Study||187
10001831|NCT01718483|11123640|FG001|Treated|Overall Study||192
10001832|NCT01718483|11123639|FG000|COMPLETED|Overall Study||157
10001833|NCT01718483|11123640|FG001|COMPLETED|Overall Study||158
10001834|NCT01718483|11123639|FG000|NOT COMPLETED|Overall Study||34
10001835|NCT01718483|11123640|FG001|NOT COMPLETED|Overall Study||34
10001836|NCT01718509|11123648|FG000|STARTED|Overall Study||195
10001837|NCT01718509|11123649|FG001|STARTED|Overall Study||195
10001838|NCT01718509|11123648|FG000|COMPLETED|Overall Study||147
9758781|NCT00370682|10862388|FG001|COMPLETED|Overall Study||37
9758782|NCT00370682|10862389|FG002|COMPLETED|Overall Study||39
9758783|NCT00370682|10862387|FG000|NOT COMPLETED|Overall Study||0
9758784|NCT00370682|10862388|FG001|NOT COMPLETED|Overall Study||3
10001839|NCT01718509|11123649|FG001|COMPLETED|Overall Study||147
10001840|NCT01718509|11123648|FG000|NOT COMPLETED|Overall Study||48
10001841|NCT01718509|11123649|FG001|NOT COMPLETED|Overall Study||48
10001842|NCT01718522|11123655|FG000|STARTED|Overall Study||75
10001843|NCT01718522|11123655|FG000|COMPLETED|Overall Study||67
10001844|NCT01718522|11123655|FG000|NOT COMPLETED|Overall Study||8
10001845|NCT01718535|11123672|FG000|STARTED|Overall Study||131
10001846|NCT01718535|11123673|FG001|STARTED|Overall Study||95
10001847|NCT01718535|11123674|FG002|STARTED|Overall Study||19
10001848|NCT01718535|11123675|FG003|STARTED|Overall Study||8
10001849|NCT01718535|11123676|FG004|STARTED|Overall Study||1
10001850|NCT01718535|11123677|FG005|STARTED|Overall Study||40
10001851|NCT01718535|11123678|FG006|STARTED|Overall Study||11
10001852|NCT01718535|11123679|FG007|STARTED|Overall Study||6
10001853|NCT01718535|11123680|FG008|STARTED|Overall Study||15
10001854|NCT01718535|11123681|FG009|STARTED|Overall Study||1
10001855|NCT01718535|11123672|FG000|First Pass|Overall Study||128
10001856|NCT01718535|11123673|FG001|First Pass|Overall Study||94
10001857|NCT01718535|11123674|FG002|First Pass|Overall Study||19
10001858|NCT01718535|11123675|FG003|First Pass|Overall Study||7
10001859|NCT01718535|11123676|FG004|First Pass|Overall Study||1
10001860|NCT01718535|11123677|FG005|First Pass|Overall Study||39
10001861|NCT01718535|11123678|FG006|First Pass|Overall Study||11
10001862|NCT01718535|11123679|FG007|First Pass|Overall Study||6
10001863|NCT01718535|11123680|FG008|First Pass|Overall Study||15
10001864|NCT01718535|11123681|FG009|First Pass|Overall Study||1
10001865|NCT01718535|11123672|FG000|COMPLETED|Overall Study||130
10001866|NCT01718535|11123673|FG001|COMPLETED|Overall Study||95
10001867|NCT01718535|11123674|FG002|COMPLETED|Overall Study||19
10001868|NCT01718535|11123675|FG003|COMPLETED|Overall Study||7
10001869|NCT01718535|11123676|FG004|COMPLETED|Overall Study||1
10001870|NCT01718535|11123677|FG005|COMPLETED|Overall Study||40
10001871|NCT01718535|11123678|FG006|COMPLETED|Overall Study||11
10001872|NCT01718535|11123679|FG007|COMPLETED|Overall Study||6
10001873|NCT01718535|11123680|FG008|COMPLETED|Overall Study||15
10001874|NCT01718535|11123681|FG009|COMPLETED|Overall Study||1
10001875|NCT01718535|11123672|FG000|NOT COMPLETED|Overall Study||1
10001876|NCT01718535|11123673|FG001|NOT COMPLETED|Overall Study||0
10001877|NCT01718535|11123674|FG002|NOT COMPLETED|Overall Study||0
10001878|NCT01718535|11123675|FG003|NOT COMPLETED|Overall Study||1
10001879|NCT01718535|11123676|FG004|NOT COMPLETED|Overall Study||0
10001880|NCT01718535|11123677|FG005|NOT COMPLETED|Overall Study||0
10001881|NCT01718535|11123678|FG006|NOT COMPLETED|Overall Study||0
10001882|NCT01718535|11123679|FG007|NOT COMPLETED|Overall Study||0
10001883|NCT01718535|11123680|FG008|NOT COMPLETED|Overall Study||0
10001884|NCT01718535|11123681|FG009|NOT COMPLETED|Overall Study||0
10001885|NCT01718691|11123705|FG000|STARTED|Overall Study||60
10001886|NCT01718691|11123706|FG001|STARTED|Overall Study||10
10001887|NCT01718691|11123705|FG000|COMPLETED|Overall Study||42
10001888|NCT01718691|11123706|FG001|COMPLETED|Overall Study||9
10001889|NCT01718691|11123705|FG000|NOT COMPLETED|Overall Study||18
10001890|NCT01718691|11123706|FG001|NOT COMPLETED|Overall Study||1
10001891|NCT01719003|11123725|FG000|STARTED|Overall Study||170
10001892|NCT01719003|11123726|FG001|STARTED|Overall Study||170
10001893|NCT01719003|11123727|FG002|STARTED|Overall Study||171
10001894|NCT01719003|11123728|FG003|STARTED|Overall Study||169
10001895|NCT01719003|11123729|FG004|STARTED|Overall Study||167
10001896|NCT01719003|11123730|FG005|STARTED|Overall Study||172
10001897|NCT01719003|11123731|FG006|STARTED|Overall Study||170
10001898|NCT01719003|11123732|FG007|STARTED|Overall Study||171
10001899|NCT01719003|11123733|FG008|STARTED|Overall Study||53
10001900|NCT01719003|11123725|FG000|COMPLETED|Overall Study||161
10001901|NCT01719003|11123726|FG001|COMPLETED|Overall Study||153
10001902|NCT01719003|11123727|FG002|COMPLETED|Overall Study||154
10001903|NCT01719003|11123728|FG003|COMPLETED|Overall Study||156
10001904|NCT01719003|11123729|FG004|COMPLETED|Overall Study||150
10001905|NCT01719003|11123730|FG005|COMPLETED|Overall Study||160
10001906|NCT01719003|11123731|FG006|COMPLETED|Overall Study||150
10001907|NCT01719003|11123732|FG007|COMPLETED|Overall Study||151
10001908|NCT01719003|11123733|FG008|COMPLETED|Overall Study||49
10001909|NCT01719003|11123725|FG000|NOT COMPLETED|Overall Study||9
10001910|NCT01719003|11123726|FG001|NOT COMPLETED|Overall Study||17
10001911|NCT01719003|11123727|FG002|NOT COMPLETED|Overall Study||17
10001912|NCT01719003|11123728|FG003|NOT COMPLETED|Overall Study||13
10001913|NCT01719003|11123729|FG004|NOT COMPLETED|Overall Study||17
10001914|NCT01719003|11123730|FG005|NOT COMPLETED|Overall Study||12
10001915|NCT01719003|11123731|FG006|NOT COMPLETED|Overall Study||20
10001916|NCT01719003|11123732|FG007|NOT COMPLETED|Overall Study||20
10001917|NCT01719003|11123733|FG008|NOT COMPLETED|Overall Study||4
10001918|NCT01719172|11123752|FG000|STARTED|Overall Study||30
10001919|NCT01719172|11123752|FG000|COMPLETED|Overall Study||28
10001920|NCT01719172|11123752|FG000|NOT COMPLETED|Overall Study||2
10001921|NCT01719224|11123756|FG000|STARTED|Intervention 1: Sleeping Position 1||18
10001922|NCT01719224|11123757|FG001|STARTED|Intervention 1: Sleeping Position 1||18
10001923|NCT01719224|11123756|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14
10001924|NCT01719224|11123757|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16
10001925|NCT01719224|11123756|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
10001926|NCT01719224|11123757|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
10001927|NCT01719224|11123756|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14
10001928|NCT01719224|11123757|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16
10001929|NCT01719224|11123756|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
10001930|NCT01719224|11123757|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
10001931|NCT01719224|11123756|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
10001932|NCT01719224|11123757|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
10001933|NCT01719367|11123766|FG000|STARTED|Overall Study||19
10001934|NCT01719367|11123767|FG001|STARTED|Overall Study||19
10001935|NCT01719367|11123766|FG000|COMPLETED|Overall Study||19
10001936|NCT01719367|11123767|FG001|COMPLETED|Overall Study||19
10001937|NCT01719367|11123766|FG000|NOT COMPLETED|Overall Study||0
10001938|NCT01719367|11123767|FG001|NOT COMPLETED|Overall Study||0
10001939|NCT01719380|11123783|FG000|STARTED|Overall Study||2
10001940|NCT01719380|11123784|FG001|STARTED|Overall Study||7
10001941|NCT01719380|11123785|FG002|STARTED|Overall Study||9
10001942|NCT01719380|11123786|FG003|STARTED|Overall Study||8
10001943|NCT01719380|11123787|FG004|STARTED|Overall Study||3
10001944|NCT01719380|11123788|FG005|STARTED|Overall Study||8
10001945|NCT01719380|11123789|FG006|STARTED|Overall Study||10
10001946|NCT01719380|11123790|FG007|STARTED|Overall Study||7
10001947|NCT01719380|11123791|FG008|STARTED|Overall Study||50
10001948|NCT01719380|11123792|FG009|STARTED|Overall Study||52
10001949|NCT01719380|11123783|FG000|COMPLETED|Overall Study||0
10001950|NCT01719380|11123784|FG001|COMPLETED|Overall Study||0
10001951|NCT01719380|11123785|FG002|COMPLETED|Overall Study||0
10001952|NCT01719380|11123786|FG003|COMPLETED|Overall Study||0
10001953|NCT01719380|11123787|FG004|COMPLETED|Overall Study||0
10001954|NCT01719380|11123788|FG005|COMPLETED|Overall Study||0
10001955|NCT01719380|11123789|FG006|COMPLETED|Overall Study||0
10001956|NCT01719380|11123790|FG007|COMPLETED|Overall Study||0
10001957|NCT01719380|11123791|FG008|COMPLETED|Overall Study||0
10001958|NCT01719380|11123792|FG009|COMPLETED|Overall Study||1
10001959|NCT01719380|11123783|FG000|NOT COMPLETED|Overall Study||2
10001960|NCT01719380|11123784|FG001|NOT COMPLETED|Overall Study||7
10001961|NCT01719380|11123785|FG002|NOT COMPLETED|Overall Study||9
10001962|NCT01719380|11123786|FG003|NOT COMPLETED|Overall Study||8
10001963|NCT01719380|11123787|FG004|NOT COMPLETED|Overall Study||3
10001964|NCT01719380|11123788|FG005|NOT COMPLETED|Overall Study||8
10001965|NCT01719380|11123789|FG006|NOT COMPLETED|Overall Study||10
10001966|NCT01719380|11123790|FG007|NOT COMPLETED|Overall Study||7
10001967|NCT01719380|11123791|FG008|NOT COMPLETED|Overall Study||50
10001968|NCT01719380|11123792|FG009|NOT COMPLETED|Overall Study||51
10001969|NCT01719653|11123826|FG000|STARTED|Overall Study||209
10001970|NCT01719653|11123827|FG001|STARTED|Overall Study||213
10001971|NCT01719653|11123828|FG002|STARTED|Overall Study||218
10001972|NCT01719653|11123829|FG003|STARTED|Overall Study||218
10001973|NCT01719653|11123830|FG004|STARTED|Overall Study||221
10001974|NCT01719653|11123826|FG000|COMPLETED|Overall Study||200
10001975|NCT01719653|11123827|FG001|COMPLETED|Overall Study||200
10001976|NCT01719653|11123828|FG002|COMPLETED|Overall Study||200
10001977|NCT01719653|11123829|FG003|COMPLETED|Overall Study||200
10001978|NCT01719653|11123830|FG004|COMPLETED|Overall Study||200
10001979|NCT01719653|11123826|FG000|NOT COMPLETED|Overall Study||9
10001980|NCT01719653|11123827|FG001|NOT COMPLETED|Overall Study||13
10001981|NCT01719653|11123828|FG002|NOT COMPLETED|Overall Study||18
10001982|NCT01719653|11123829|FG003|NOT COMPLETED|Overall Study||18
10001983|NCT01719653|11123830|FG004|NOT COMPLETED|Overall Study||21
10001984|NCT01719757|11123842|FG000|STARTED|Overall Study||359
10001985|NCT01719757|11123842|FG000|COMPLETED|Overall Study||258
10001986|NCT01719757|11123842|FG000|NOT COMPLETED|Overall Study||101
10001987|NCT01719783|11123850|FG000|STARTED|Dose 1||30
10001988|NCT01719783|11123851|FG001|STARTED|Dose 1||10
10001989|NCT01719783|11123850|FG000|COMPLETED|Dose 1||30
10001990|NCT01719783|11123851|FG001|COMPLETED|Dose 1||10
10001991|NCT01719783|11123850|FG000|NOT COMPLETED|Dose 1||0
10001992|NCT01719783|11123851|FG001|NOT COMPLETED|Dose 1||0
10001993|NCT01719783|11123850|FG000|STARTED|Dose 2||30
10001994|NCT01719783|11123851|FG001|STARTED|Dose 2||10
10001995|NCT01719783|11123850|FG000|COMPLETED|Dose 2||29
10001996|NCT01719783|11123851|FG001|COMPLETED|Dose 2||10
10001997|NCT01719783|11123850|FG000|NOT COMPLETED|Dose 2||1
10001998|NCT01719783|11123851|FG001|NOT COMPLETED|Dose 2||0
10001999|NCT01719861|11123877|FG000|STARTED|Cycle 1||6
10002000|NCT01719861|11123877|FG000|COMPLETED|Cycle 1||2
10002001|NCT01719861|11123877|FG000|NOT COMPLETED|Cycle 1||4
10002002|NCT01719861|11123877|FG000|STARTED|Cycle 2||2
10002003|NCT01719861|11123877|FG000|COMPLETED|Cycle 2||1
10002004|NCT01719861|11123877|FG000|NOT COMPLETED|Cycle 2||1
10002005|NCT01719900|11123884|FG000|STARTED|Overall Study||29
10002006|NCT01719900|11123885|FG001|STARTED|Overall Study||24
10002007|NCT01719900|11123884|FG000|COMPLETED|Overall Study||22
10002008|NCT01719900|11123885|FG001|COMPLETED|Overall Study||22
10002009|NCT01719900|11123884|FG000|NOT COMPLETED|Overall Study||7
10002010|NCT01719900|11123885|FG001|NOT COMPLETED|Overall Study||2
10018767|NCT01825408|11141811|FG000|STARTED|Overall Study||7
10018768|NCT01825408|11141812|FG001|STARTED|Overall Study||7
10018769|NCT01825408|11141813|FG002|STARTED|Overall Study||14
10018770|NCT01825408|11141814|FG003|STARTED|Overall Study||12
10018771|NCT01825408|11141811|FG000|COMPLETED|Overall Study||7
10018772|NCT01825408|11141812|FG001|COMPLETED|Overall Study||7
10018773|NCT01825408|11141813|FG002|COMPLETED|Overall Study||14
10018774|NCT01825408|11141814|FG003|COMPLETED|Overall Study||12
10018775|NCT01825408|11141811|FG000|NOT COMPLETED|Overall Study||0
10018776|NCT01825408|11141812|FG001|NOT COMPLETED|Overall Study||0
10018777|NCT01825408|11141813|FG002|NOT COMPLETED|Overall Study||0
10018778|NCT01825408|11141814|FG003|NOT COMPLETED|Overall Study||0
10018779|NCT01825512|11141826|FG000|STARTED|Baseline||194
10018780|NCT01825512|11141827|FG001|STARTED|Baseline||199
10002011|NCT01720043|11123891|FG000|STARTED|Overall Study||8
10002012|NCT01720043|11123891|FG000|COMPLETED|Overall Study||7
10002013|NCT01720043|11123891|FG000|NOT COMPLETED|Overall Study||1
10002014|NCT01720069|11123898|FG000|STARTED|Overall Study||62
10002015|NCT01720069|11123899|FG001|STARTED|Overall Study||71
10002016|NCT01720069|11123900|FG002|STARTED|Overall Study||63
10002017|NCT01720069|11123898|FG000|Full Anaylsis Set|Overall Study||62
10002018|NCT01720069|11123899|FG001|Full Anaylsis Set|Overall Study||71
10002019|NCT01720069|11123900|FG002|Full Anaylsis Set|Overall Study||63
10002020|NCT01720069|11123898|FG000|COMPLETED|Overall Study||57
10002021|NCT01720069|11123899|FG001|COMPLETED|Overall Study||56
10002022|NCT01720069|11123900|FG002|COMPLETED|Overall Study||48
10002023|NCT01720069|11123898|FG000|NOT COMPLETED|Overall Study||5
10002024|NCT01720069|11123899|FG001|NOT COMPLETED|Overall Study||15
10002025|NCT01720069|11123900|FG002|NOT COMPLETED|Overall Study||15
10002026|NCT01720173|11123908|FG000|STARTED|Overall Study||30
10002027|NCT01720173|11123908|FG000|COMPLETED|Overall Study||30
10002028|NCT01720173|11123908|FG000|NOT COMPLETED|Overall Study||0
10002029|NCT01720225|11123914|FG000|STARTED|Overall Study||73
10002030|NCT01720225|11123915|FG001|STARTED|Overall Study||40
10002031|NCT01720225|11123914|FG000|COMPLETED|Overall Study||70
10002032|NCT01720225|11123915|FG001|COMPLETED|Overall Study||39
10002033|NCT01720225|11123914|FG000|NOT COMPLETED|Overall Study||3
10002034|NCT01720225|11123915|FG001|NOT COMPLETED|Overall Study||1
10002035|NCT01720251|11123924|FG000|STARTED|Overall Study||79
10002036|NCT01720251|11123925|FG001|STARTED|Overall Study||79
10002037|NCT01720251|11123926|FG002|STARTED|Overall Study||82
10002038|NCT01720251|11123924|FG000|COMPLETED|Overall Study||78
10002039|NCT01720251|11123925|FG001|COMPLETED|Overall Study||77
10002040|NCT01720251|11123926|FG002|COMPLETED|Overall Study||82
10002041|NCT01720251|11123924|FG000|NOT COMPLETED|Overall Study||1
10002042|NCT01720251|11123925|FG001|NOT COMPLETED|Overall Study||2
10002043|NCT01720251|11123926|FG002|NOT COMPLETED|Overall Study||0
10002044|NCT01720264|11123934|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15
10002045|NCT01720264|11123934|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14
10002046|NCT01720264|11123934|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
10002047|NCT01720264|11123934|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14
10002048|NCT01720264|11123934|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2
10002049|NCT01720264|11123934|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
10002050|NCT01720277|11123940|FG000|STARTED|Overall Study||1461
10002051|NCT01720277|11123941|FG001|STARTED|Overall Study||1496
10002052|NCT01720277|11123940|FG000|COMPLETED|Overall Study|intent-to-treat approach|958
10002053|NCT01720277|11123941|FG001|COMPLETED|Overall Study|intent-to-treat approach|938
10002054|NCT01720277|11123940|FG000|NOT COMPLETED|Overall Study||503
10002055|NCT01720277|11123941|FG001|NOT COMPLETED|Overall Study||558
10002056|NCT01720316|11123951|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1
10002057|NCT01720316|11123952|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1
10002058|NCT01720316|11123951|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1
10002059|NCT01720316|11123952|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1
10002060|NCT01720316|11123951|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
10002061|NCT01720316|11123952|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
10002062|NCT01720316|11123951|FG000|STARTED|Open-label Glycine||1
10002063|NCT01720316|11123952|FG001|STARTED|Open-label Glycine||1
10002064|NCT01720316|11123951|FG000|COMPLETED|Open-label Glycine||1
10002065|NCT01720316|11123952|FG001|COMPLETED|Open-label Glycine||1
10002066|NCT01720316|11123951|FG000|NOT COMPLETED|Open-label Glycine||0
10002067|NCT01720316|11123952|FG001|NOT COMPLETED|Open-label Glycine||0
10002068|NCT01720446|11123988|FG000|STARTED|Overall Study||826
10002069|NCT01720446|11123989|FG001|STARTED|Overall Study||822
10002070|NCT01720446|11123990|FG002|STARTED|Overall Study||824
10002071|NCT01720446|11123991|FG003|STARTED|Overall Study||825
10002072|NCT01720446|11123988|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
10002073|NCT01720446|11123989|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
10002074|NCT01720446|11123990|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
10002075|NCT01720446|11123991|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
10002076|NCT01720446|11123988|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
10002077|NCT01720446|11123989|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
10002078|NCT01720446|11123990|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
10002079|NCT01720446|11123991|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
10002080|NCT01720446|11123988|FG000|NOT COMPLETED|Overall Study||14
10002081|NCT01720446|11123989|FG001|NOT COMPLETED|Overall Study||11
10002082|NCT01720446|11123990|FG002|NOT COMPLETED|Overall Study||20
10002083|NCT01720446|11123991|FG003|NOT COMPLETED|Overall Study||20
10002084|NCT01720524|11124006|FG000|STARTED|Part A||29
10002085|NCT01720524|11124007|FG001|STARTED|Part A||30
10002086|NCT01720524|11124006|FG000|COMPLETED|Part A||22
10002087|NCT01720524|11124007|FG001|COMPLETED|Part A||18
10002088|NCT01720524|11124006|FG000|NOT COMPLETED|Part A||7
10002089|NCT01720524|11124007|FG001|NOT COMPLETED|Part A||12
10002090|NCT01720524|11124006|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
10002091|NCT01720524|11124007|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
10002092|NCT01720524|11124006|FG000|COMPLETED|Part B||22
10002093|NCT01720524|11124007|FG001|COMPLETED|Part B||17
10002094|NCT01720524|11124006|FG000|NOT COMPLETED|Part B||5
10002095|NCT01720524|11124007|FG001|NOT COMPLETED|Part B||9
10002096|NCT01720602|11124015|FG000|STARTED|Overall Study||15
10002097|NCT01720602|11124015|FG000|COMPLETED|Overall Study||10
10002098|NCT01720602|11124015|FG000|NOT COMPLETED|Overall Study||5
10002099|NCT01720667|11124021|FG000|STARTED|Overall Study||64
10002100|NCT01720667|11124022|FG001|STARTED|Overall Study||42
10002101|NCT01720667|11124021|FG000|Recieved Second Infusion of Same Drug|Overall Study||50
10002102|NCT01720667|11124022|FG001|Recieved Second Infusion of Same Drug|Overall Study||20
10002103|NCT01720667|11124021|FG000|Recieved Alternate Intervention|Overall Study||45
10002104|NCT01720667|11124022|FG001|Recieved Alternate Intervention|Overall Study||10
10002105|NCT01720667|11124021|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27
10002106|NCT01720667|11124022|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6
10002107|NCT01720667|11124021|FG000|Modified ITT|Overall Study||53
10002108|NCT01720667|11124022|FG001|Modified ITT|Overall Study||30
10002109|NCT01720667|11124021|FG000|COMPLETED|Overall Study||60
10002110|NCT01720667|11124022|FG001|COMPLETED|Overall Study||41
10002111|NCT01720667|11124021|FG000|NOT COMPLETED|Overall Study||4
10002112|NCT01720667|11124022|FG001|NOT COMPLETED|Overall Study||1
10002113|NCT01720797|11124032|FG000|STARTED|Overall Study||12
10002114|NCT01720797|11124033|FG001|STARTED|Overall Study||9
10002115|NCT01720797|11124032|FG000|COMPLETED|Overall Study||9
10002116|NCT01720797|11124033|FG001|COMPLETED|Overall Study||9
10002117|NCT01720797|11124032|FG000|NOT COMPLETED|Overall Study||3
10002118|NCT01720797|11124033|FG001|NOT COMPLETED|Overall Study||0
10002119|NCT01721044|11124042|FG000|STARTED|Treatment Period||176
10002120|NCT01721044|11124043|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
10002121|NCT01721044|11124044|FG002|STARTED|Treatment Period||177
10002122|NCT01721044|11124042|FG000|Rescue Week 16-24|Treatment Period||56
10002123|NCT01721044|11124043|FG001|Rescue Week 16-24|Treatment Period||38
10002124|NCT01721044|11124044|FG002|Rescue Week 16-24|Treatment Period||33
10002125|NCT01721044|11124042|FG000|COMPLETED|Treatment Period||144
10002126|NCT01721044|11124043|FG001|COMPLETED|Treatment Period||157
10002127|NCT01721044|11124044|FG002|COMPLETED|Treatment Period||158
10002128|NCT01721044|11124042|FG000|NOT COMPLETED|Treatment Period||32
10002129|NCT01721044|11124043|FG001|NOT COMPLETED|Treatment Period||17
10002130|NCT01721044|11124044|FG002|NOT COMPLETED|Treatment Period||19
10002131|NCT01721044|11124042|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
10002132|NCT01721044|11124043|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
10002133|NCT01721044|11124044|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
10002134|NCT01721044|11124042|FG000|COMPLETED|Follow Up||19
10002135|NCT01721044|11124043|FG001|COMPLETED|Follow Up||9
10002136|NCT01721044|11124044|FG002|COMPLETED|Follow Up||20
10002137|NCT01721044|11124042|FG000|NOT COMPLETED|Follow Up||0
10002138|NCT01721044|11124043|FG001|NOT COMPLETED|Follow Up||0
10002139|NCT01721044|11124044|FG002|NOT COMPLETED|Follow Up||0
10002140|NCT01721057|11124066|FG000|STARTED|Treatment Period||228
10002141|NCT01721057|11124067|FG001|STARTED|Treatment Period||229
10002142|NCT01721057|11124068|FG002|STARTED|Treatment Period||227
10002143|NCT01721057|11124069|FG003|STARTED|Treatment Period||0
10002144|NCT01721057|11124070|FG004|STARTED|Treatment Period||0
10002145|NCT01721057|11124071|FG005|STARTED|Treatment Period||0
10002146|NCT01721057|11124072|FG006|STARTED|Treatment Period||0
10002147|NCT01721057|11124066|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228
10002148|NCT01721057|11124067|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229
10002149|NCT01721057|11124068|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227
10002150|NCT01721057|11124069|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
10002151|NCT01721057|11124070|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
10002152|NCT01721057|11124071|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0
10002153|NCT01721057|11124072|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0
10002154|NCT01721057|11124066|FG000|Rescued|Treatment Period||55
10002155|NCT01721057|11124067|FG001|Rescued|Treatment Period||21
10002156|NCT01721057|11124068|FG002|Rescued|Treatment Period||15
10002157|NCT01721057|11124069|FG003|Rescued|Treatment Period||0
10002158|NCT01721057|11124070|FG004|Rescued|Treatment Period||0
10002159|NCT01721057|11124071|FG005|Rescued|Treatment Period||0
10002160|NCT01721057|11124072|FG006|Rescued|Treatment Period||0
10002161|NCT01721057|11124066|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200
10002162|NCT01721057|11124067|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210
10002163|NCT01721057|11124068|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204
10002164|NCT01721057|11124069|FG003|COMPLETED|Treatment Period||0
10002165|NCT01721057|11124070|FG004|COMPLETED|Treatment Period||0
10002166|NCT01721057|11124071|FG005|COMPLETED|Treatment Period||0
10002167|NCT01721057|11124072|FG006|COMPLETED|Treatment Period||0
10002168|NCT01721057|11124066|FG000|NOT COMPLETED|Treatment Period||28
10002169|NCT01721057|11124067|FG001|NOT COMPLETED|Treatment Period||19
10002170|NCT01721057|11124068|FG002|NOT COMPLETED|Treatment Period||23
10002171|NCT01721057|11124069|FG003|NOT COMPLETED|Treatment Period||0
10002172|NCT01721057|11124070|FG004|NOT COMPLETED|Treatment Period||0
10002173|NCT01721057|11124071|FG005|NOT COMPLETED|Treatment Period||0
10002174|NCT01721057|11124072|FG006|NOT COMPLETED|Treatment Period||0
10002175|NCT01721057|11124066|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10002176|NCT01721057|11124067|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10002177|NCT01721057|11124068|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10002178|NCT01721057|11124069|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
10002179|NCT01721057|11124070|FG004|STARTED|Rescue Period||0
10002180|NCT01721057|11124071|FG005|STARTED|Rescue Period||0
10002181|NCT01721057|11124072|FG006|STARTED|Rescue Period||0
10002182|NCT01721057|11124066|FG000|COMPLETED|Rescue Period||0
10002183|NCT01721057|11124067|FG001|COMPLETED|Rescue Period||0
10002184|NCT01721057|11124068|FG002|COMPLETED|Rescue Period||0
10002185|NCT01721057|11124069|FG003|COMPLETED|Rescue Period||88
10002186|NCT01721057|11124070|FG004|COMPLETED|Rescue Period||0
10002187|NCT01721057|11124071|FG005|COMPLETED|Rescue Period||0
10002188|NCT01721057|11124072|FG006|COMPLETED|Rescue Period||0
10002189|NCT01721057|11124066|FG000|NOT COMPLETED|Rescue Period||0
10002190|NCT01721057|11124067|FG001|NOT COMPLETED|Rescue Period||0
10002191|NCT01721057|11124068|FG002|NOT COMPLETED|Rescue Period||0
10002192|NCT01721057|11124069|FG003|NOT COMPLETED|Rescue Period||3
10002193|NCT01721057|11124070|FG004|NOT COMPLETED|Rescue Period||0
10002194|NCT01721057|11124071|FG005|NOT COMPLETED|Rescue Period||0
10002195|NCT01721057|11124072|FG006|NOT COMPLETED|Rescue Period||0
10002196|NCT01721057|11124066|FG000|STARTED|Follow Up||0
10002197|NCT01721057|11124067|FG001|STARTED|Follow Up||0
10002198|NCT01721057|11124068|FG002|STARTED|Follow Up||0
10002199|NCT01721057|11124069|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
10002200|NCT01721057|11124070|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
10002201|NCT01721057|11124071|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
10002202|NCT01721057|11124072|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
10002203|NCT01721057|11124066|FG000|COMPLETED|Follow Up||0
10002204|NCT01721057|11124067|FG001|COMPLETED|Follow Up||0
10002205|NCT01721057|11124068|FG002|COMPLETED|Follow Up||0
10002206|NCT01721057|11124069|FG003|COMPLETED|Follow Up||0
10002207|NCT01721057|11124070|FG004|COMPLETED|Follow Up||17
10002208|NCT01721057|11124071|FG005|COMPLETED|Follow Up||19
10002209|NCT01721057|11124072|FG006|COMPLETED|Follow Up||22
10002210|NCT01721057|11124066|FG000|NOT COMPLETED|Follow Up||0
10002211|NCT01721057|11124067|FG001|NOT COMPLETED|Follow Up||0
10002212|NCT01721057|11124068|FG002|NOT COMPLETED|Follow Up||0
10002213|NCT01721057|11124069|FG003|NOT COMPLETED|Follow Up||0
10002214|NCT01721057|11124070|FG004|NOT COMPLETED|Follow Up||0
10002215|NCT01721057|11124071|FG005|NOT COMPLETED|Follow Up||0
10002216|NCT01721057|11124072|FG006|NOT COMPLETED|Follow Up||0
10002217|NCT01721070|11124099|FG000|STARTED|SUF NT 15 mcg||19
10002218|NCT01721070|11124099|FG000|COMPLETED|SUF NT 15 mcg||19
10002219|NCT01721070|11124099|FG000|NOT COMPLETED|SUF NT 15 mcg||0
10002220|NCT01721070|11124099|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
10002221|NCT01721070|11124099|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
10002222|NCT01721070|11124099|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
10002223|NCT01721096|11124108|FG000|STARTED|Overall Study||323
10002224|NCT01721096|11124109|FG001|STARTED|Overall Study||213
10002225|NCT01721096|11124108|FG000|COMPLETED|Overall Study||3
10002226|NCT01721096|11124109|FG001|COMPLETED|Overall Study||9
10002227|NCT01721096|11124108|FG000|NOT COMPLETED|Overall Study||320
10002228|NCT01721096|11124109|FG001|NOT COMPLETED|Overall Study||204
10002229|NCT01721109|11124117|FG000|STARTED|Overall Study||50
10002230|NCT01721109|11124117|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
10002231|NCT01721109|11124117|FG000|NOT COMPLETED|Overall Study||7
10002232|NCT01721161|11124123|FG000|STARTED|Overall Study||41
10002233|NCT01721161|11124124|FG001|STARTED|Overall Study||41
10002234|NCT01721161|11124123|FG000|COMPLETED|Overall Study||37
10002235|NCT01721161|11124124|FG001|COMPLETED|Overall Study||34
10002236|NCT01721161|11124123|FG000|NOT COMPLETED|Overall Study||4
10002237|NCT01721161|11124124|FG001|NOT COMPLETED|Overall Study||7
10002238|NCT01721200|11124133|FG000|STARTED|Overall Study||62
10002239|NCT01721200|11124134|FG001|STARTED|Overall Study||63
10002240|NCT01721200|11124133|FG000|Completed 2 Week Follow-up|Overall Study||60
10002241|NCT01721200|11124134|FG001|Completed 2 Week Follow-up|Overall Study||61
10002242|NCT01721200|11124133|FG000|COMPLETED|Overall Study||59
10002243|NCT01721200|11124134|FG001|COMPLETED|Overall Study||58
10002244|NCT01721200|11124133|FG000|NOT COMPLETED|Overall Study||3
10002245|NCT01721200|11124134|FG001|NOT COMPLETED|Overall Study||5
10002246|NCT01721226|11124147|FG000|STARTED|Overall Study||55
10002247|NCT01721226|11124148|FG001|STARTED|Overall Study||57
10002248|NCT01721226|11124147|FG000|Baseline|Overall Study||53
10002249|NCT01721226|11124148|FG001|Baseline|Overall Study||57
10002250|NCT01721226|11124147|FG000|Week 12|Overall Study||48
10002251|NCT01721226|11124148|FG001|Week 12|Overall Study||53
10002252|NCT01721226|11124147|FG000|Week 24|Overall Study||50
10002253|NCT01721226|11124148|FG001|Week 24|Overall Study||50
10002254|NCT01721226|11124147|FG000|COMPLETED|Overall Study||50
10002255|NCT01721226|11124148|FG001|COMPLETED|Overall Study||50
10002256|NCT01721226|11124147|FG000|NOT COMPLETED|Overall Study||5
10002257|NCT01721226|11124148|FG001|NOT COMPLETED|Overall Study||7
10002258|NCT01721317|11124156|FG000|STARTED|Overall Study||2
10002259|NCT01721317|11124157|FG001|STARTED|Overall Study||4
10002260|NCT01721317|11124156|FG000|COMPLETED|Overall Study||0
10002261|NCT01721317|11124157|FG001|COMPLETED|Overall Study||0
10002262|NCT01721317|11124156|FG000|NOT COMPLETED|Overall Study||2
10002263|NCT01721317|11124157|FG001|NOT COMPLETED|Overall Study||4
10002264|NCT01721330|11124165|FG000|STARTED|Overall Study||1
10002265|NCT01721330|11124166|FG001|STARTED|Overall Study||2
10002266|NCT01721330|11124165|FG000|COMPLETED|Overall Study||1
10002267|NCT01721330|11124166|FG001|COMPLETED|Overall Study||1
10002268|NCT01721330|11124165|FG000|NOT COMPLETED|Overall Study||0
10002269|NCT01721330|11124166|FG001|NOT COMPLETED|Overall Study||1
10002270|NCT01721369|11124172|FG000|STARTED|Overall Study||581
10002271|NCT01721369|11124172|FG000|COMPLETED|Overall Study||569
10002272|NCT01721369|11124172|FG000|NOT COMPLETED|Overall Study||12
10002273|NCT01721408|11124178|FG000|STARTED|Overall Study|Number of participants treated.|232
10002274|NCT01721408|11124179|FG001|STARTED|Overall Study|Number of participants treated.|231
10002275|NCT01721408|11124178|FG000|COMPLETED|Overall Study||196
10002276|NCT01721408|11124179|FG001|COMPLETED|Overall Study||207
10002277|NCT01721408|11124178|FG000|NOT COMPLETED|Overall Study||36
10002278|NCT01721408|11124179|FG001|NOT COMPLETED|Overall Study||24
10002279|NCT01721447|11124185|FG000|STARTED|Overall Study||100
10002280|NCT01721447|11124185|FG000|COMPLETED|Overall Study||100
10002281|NCT01721447|11124185|FG000|NOT COMPLETED|Overall Study||0
10002282|NCT01721460|11124190|FG000|STARTED|Overall Study||6
10002283|NCT01721460|11124190|FG000|COMPLETED|Overall Study||5
10002284|NCT01721460|11124190|FG000|NOT COMPLETED|Overall Study||1
10002285|NCT01721473|11124202|FG000|STARTED|Overall Study||47
10002286|NCT01721473|11124203|FG001|STARTED|Overall Study||22
10002287|NCT01721473|11124204|FG002|STARTED|Overall Study||41
10002288|NCT01721473|11124205|FG003|STARTED|Overall Study||34
10002289|NCT01721473|11124206|FG004|STARTED|Overall Study||22
10002290|NCT01721473|11124207|FG005|STARTED|Overall Study||18
10002291|NCT01721473|11124202|FG000|COMPLETED|Overall Study||47
10002292|NCT01721473|11124203|FG001|COMPLETED|Overall Study||22
10002293|NCT01721473|11124204|FG002|COMPLETED|Overall Study||41
10002294|NCT01721473|11124205|FG003|COMPLETED|Overall Study||34
10002295|NCT01721473|11124206|FG004|COMPLETED|Overall Study||22
10002296|NCT01721473|11124207|FG005|COMPLETED|Overall Study||18
10002297|NCT01721473|11124202|FG000|NOT COMPLETED|Overall Study||0
10002298|NCT01721473|11124203|FG001|NOT COMPLETED|Overall Study||0
10002299|NCT01721473|11124204|FG002|NOT COMPLETED|Overall Study||0
10002300|NCT01721473|11124205|FG003|NOT COMPLETED|Overall Study||0
10002301|NCT01721473|11124206|FG004|NOT COMPLETED|Overall Study||0
10002302|NCT01721473|11124207|FG005|NOT COMPLETED|Overall Study||0
10002303|NCT01721486|11124218|FG000|STARTED|Overall Study||21
10002304|NCT01721486|11124219|FG001|STARTED|Overall Study||20
10002305|NCT01721486|11124218|FG000|COMPLETED|Overall Study||20
10002306|NCT01721486|11124219|FG001|COMPLETED|Overall Study||19
10002307|NCT01721486|11124218|FG000|NOT COMPLETED|Overall Study||1
10002308|NCT01721486|11124219|FG001|NOT COMPLETED|Overall Study||1
10002309|NCT01721564|11124225|FG000|STARTED|Overall Study||8
10002310|NCT01721564|11124225|FG000|COMPLETED|Overall Study||8
10002311|NCT01721564|11124225|FG000|NOT COMPLETED|Overall Study||0
10002312|NCT01721603|11124229|FG000|STARTED|Overall Study||2
10002313|NCT01721603|11124229|FG000|COMPLETED|Overall Study||2
10002314|NCT01721603|11124229|FG000|NOT COMPLETED|Overall Study||0
10002315|NCT01721681|11124233|FG000|STARTED|Overall Study||9
10002316|NCT01721681|11124233|FG000|COMPLETED|Overall Study||9
10002317|NCT01721681|11124233|FG000|NOT COMPLETED|Overall Study||0
10002318|NCT01721772|11124239|FG000|STARTED|Overall Study||206
10002319|NCT01721772|11124240|FG001|STARTED|Overall Study||205
10002320|NCT01721772|11124239|FG000|COMPLETED|Overall Study|Continuing in treatment period|95
10002321|NCT01721772|11124240|FG001|COMPLETED|Overall Study|Continuing in treatment period|13
10002322|NCT01721772|11124239|FG000|NOT COMPLETED|Overall Study||111
10002323|NCT01721772|11124240|FG001|NOT COMPLETED|Overall Study||192
10002324|NCT01721837|11124246|FG000|STARTED|Overall Study||2120
10002325|NCT01721837|11124246|FG000|COMPLETED|Overall Study||2120
10002326|NCT01721837|11124246|FG000|NOT COMPLETED|Overall Study||0
10002327|NCT01721876|11124252|FG000|STARTED|Overall Study||222
10002328|NCT01721876|11124253|FG001|STARTED|Overall Study||444
10002329|NCT01721876|11124252|FG000|Treated|Overall Study||221
10002330|NCT01721876|11124253|FG001|Treated|Overall Study||440
10002331|NCT01721876|11124252|FG000|COMPLETED|Overall Study||0
10002332|NCT01721876|11124253|FG001|COMPLETED|Overall Study||0
10002333|NCT01721876|11124252|FG000|NOT COMPLETED|Overall Study||222
10002334|NCT01721876|11124253|FG001|NOT COMPLETED|Overall Study||444
10002335|NCT01721954|11124261|FG000|STARTED|Overall Study||105
10002336|NCT01721954|11124262|FG001|STARTED|Overall Study||104
10002337|NCT01721954|11124261|FG000|COMPLETED|Overall Study||35
10002338|NCT01721954|11124262|FG001|COMPLETED|Overall Study||35
10002339|NCT01721954|11124261|FG000|NOT COMPLETED|Overall Study||70
10002340|NCT01721954|11124262|FG001|NOT COMPLETED|Overall Study||69
10002341|NCT01721967|11124268|FG000|STARTED|Overall Study||14
10002342|NCT01721967|11124268|FG000|COMPLETED|Overall Study||11
10002343|NCT01721967|11124268|FG000|NOT COMPLETED|Overall Study||3
10002344|NCT01722045|11124272|FG000|STARTED|Overall Study||154
10002345|NCT01722045|11124272|FG000|COMPLETED|Overall Study||126
10002346|NCT01722045|11124272|FG000|NOT COMPLETED|Overall Study||28
10002347|NCT01722071|11124276|FG000|STARTED|Overall Study||10
10002348|NCT01722071|11124277|FG001|STARTED|Overall Study||10
10002349|NCT01722071|11124276|FG000|COMPLETED|Overall Study||9
10002350|NCT01722071|11124277|FG001|COMPLETED|Overall Study||10
10002351|NCT01722071|11124276|FG000|NOT COMPLETED|Overall Study||1
10002352|NCT01722071|11124277|FG001|NOT COMPLETED|Overall Study||0
10002353|NCT01722097|11124285|FG000|STARTED|Overall Study||55
10002354|NCT01722097|11124286|FG001|STARTED|Overall Study||55
10002355|NCT01722097|11124285|FG000|COMPLETED|Overall Study||49
10002356|NCT01722097|11124286|FG001|COMPLETED|Overall Study||50
10002357|NCT01722097|11124285|FG000|NOT COMPLETED|Overall Study||6
10002358|NCT01722097|11124286|FG001|NOT COMPLETED|Overall Study||5
10002359|NCT01722162|11124294|FG000|STARTED|Overall Study||23
10002360|NCT01722162|11124295|FG001|STARTED|Overall Study||24
10002361|NCT01722162|11124294|FG000|COMPLETED|Overall Study||18
10002362|NCT01722162|11124295|FG001|COMPLETED|Overall Study||18
10002363|NCT01722162|11124294|FG000|NOT COMPLETED|Overall Study||5
10002364|NCT01722162|11124295|FG001|NOT COMPLETED|Overall Study||6
10002365|NCT01722266|11124305|FG000|STARTED|Overall Study||18
10002366|NCT01722266|11124306|FG001|STARTED|Overall Study||18
10002367|NCT01722266|11124307|FG002|STARTED|Overall Study||18
10002368|NCT01722266|11124308|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
10002369|NCT01722266|11124305|FG000|COMPLETED|Overall Study||17
10002370|NCT01722266|11124306|FG001|COMPLETED|Overall Study||15
10002371|NCT01722266|11124307|FG002|COMPLETED|Overall Study||13
10002372|NCT01722266|11124308|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
10002373|NCT01722266|11124305|FG000|NOT COMPLETED|Overall Study||1
10002374|NCT01722266|11124306|FG001|NOT COMPLETED|Overall Study||3
10002375|NCT01722266|11124307|FG002|NOT COMPLETED|Overall Study||5
10002376|NCT01722266|11124308|FG003|NOT COMPLETED|Overall Study||0
10002377|NCT01722292|11124321|FG000|STARTED|Overall Study||6
10002378|NCT01722292|11124322|FG001|STARTED|Overall Study||6
10002379|NCT01722292|11124323|FG002|STARTED|Overall Study||14
10002380|NCT01722292|11124321|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10002381|NCT01722292|11124322|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10002382|NCT01722292|11124323|FG002|Received at Least One Dose of Study Drug|Overall Study||14
10002383|NCT01722292|11124321|FG000|COMPLETED|Overall Study||6
10002384|NCT01722292|11124322|FG001|COMPLETED|Overall Study||6
10002385|NCT01722292|11124323|FG002|COMPLETED|Overall Study||14
10002386|NCT01722292|11124321|FG000|NOT COMPLETED|Overall Study||0
10002387|NCT01722292|11124322|FG001|NOT COMPLETED|Overall Study||0
10002388|NCT01722292|11124323|FG002|NOT COMPLETED|Overall Study||0
10002389|NCT01722318|11124353|FG000|STARTED|Overall Study||86
10002390|NCT01722318|11124354|FG001|STARTED|Overall Study||85
10002391|NCT01722318|11124355|FG002|STARTED|Overall Study||86
10002392|NCT01722318|11124356|FG003|STARTED|Overall Study||85
10002393|NCT01722318|11124357|FG004|STARTED|Overall Study||86
10002394|NCT01722318|11124353|FG000|COMPLETED|Overall Study||72
10002395|NCT01722318|11124354|FG001|COMPLETED|Overall Study||65
10002396|NCT01722318|11124355|FG002|COMPLETED|Overall Study||66
10002397|NCT01722318|11124356|FG003|COMPLETED|Overall Study||65
10002398|NCT01722318|11124357|FG004|COMPLETED|Overall Study||68
10002399|NCT01722318|11124353|FG000|NOT COMPLETED|Overall Study||14
10002400|NCT01722318|11124354|FG001|NOT COMPLETED|Overall Study||20
10002401|NCT01722318|11124355|FG002|NOT COMPLETED|Overall Study||20
10002402|NCT01722318|11124356|FG003|NOT COMPLETED|Overall Study||20
10002403|NCT01722318|11124357|FG004|NOT COMPLETED|Overall Study||18
10002404|NCT01722435|11124369|FG000|STARTED|Overall Study||78
10002405|NCT01722435|11124369|FG000|COMPLETED|Overall Study||78
10002406|NCT01722435|11124369|FG000|NOT COMPLETED|Overall Study||0
10002407|NCT01722487|11124379|FG000|STARTED|Overall Study||136
10002408|NCT01722487|11124380|FG001|STARTED|Overall Study||133
10002409|NCT01722487|11124379|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
10002410|NCT01722487|11124380|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
10002411|NCT01722487|11124379|FG000|NOT COMPLETED|Overall Study||2
10002412|NCT01722487|11124380|FG001|NOT COMPLETED|Overall Study||7
10002413|NCT01722552|11124387|FG000|STARTED|Overall Study|Number of subjects enrolled|120
10002414|NCT01722552|11124387|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
10002415|NCT01722552|11124387|FG000|NOT COMPLETED|Overall Study||4
10002416|NCT01722604|11124395|FG000|STARTED|Overall Study||129
10002417|NCT01722604|11124396|FG001|STARTED|Overall Study||129
10002418|NCT01722604|11124395|FG000|COMPLETED|Overall Study||123
10002419|NCT01722604|11124396|FG001|COMPLETED|Overall Study||120
10002420|NCT01722604|11124395|FG000|NOT COMPLETED|Overall Study||6
10002421|NCT01722604|11124396|FG001|NOT COMPLETED|Overall Study||9
10002422|NCT01722643|11124404|FG000|STARTED|Overall Study||30
10002423|NCT01722643|11124405|FG001|STARTED|Overall Study||31
10002424|NCT01722643|11124404|FG000|COMPLETED|Overall Study||30
10002425|NCT01722643|11124405|FG001|COMPLETED|Overall Study||30
10002426|NCT01722643|11124404|FG000|NOT COMPLETED|Overall Study||0
10002427|NCT01722643|11124405|FG001|NOT COMPLETED|Overall Study||1
10002428|NCT01722669|11124417|FG000|STARTED|Overall Study||5
10002429|NCT01722669|11124418|FG001|STARTED|Overall Study||5
10002430|NCT01722669|11124419|FG002|STARTED|Overall Study||5
10002431|NCT01722669|11124420|FG003|STARTED|Overall Study||5
10002432|NCT01722669|11124421|FG004|STARTED|Overall Study||10
10002433|NCT01722669|11124422|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
10002434|NCT01722669|11124417|FG000|COMPLETED|Overall Study||5
10002435|NCT01722669|11124418|FG001|COMPLETED|Overall Study||5
10002436|NCT01722669|11124419|FG002|COMPLETED|Overall Study||5
10002437|NCT01722669|11124420|FG003|COMPLETED|Overall Study||5
10002438|NCT01722669|11124421|FG004|COMPLETED|Overall Study||10
10002439|NCT01722669|11124422|FG005|COMPLETED|Overall Study||6
10002440|NCT01722669|11124417|FG000|NOT COMPLETED|Overall Study||0
10002441|NCT01722669|11124418|FG001|NOT COMPLETED|Overall Study||0
10002442|NCT01722669|11124419|FG002|NOT COMPLETED|Overall Study||0
10002443|NCT01722669|11124420|FG003|NOT COMPLETED|Overall Study||0
10002444|NCT01722669|11124421|FG004|NOT COMPLETED|Overall Study||0
10002445|NCT01722669|11124422|FG005|NOT COMPLETED|Overall Study||2
10002446|NCT01722734|11124445|FG000|STARTED|Overall Study||554
10002447|NCT01722734|11124446|FG001|STARTED|Overall Study||277
10002448|NCT01722734|11124447|FG002|STARTED|Overall Study||309
10002449|NCT01722734|11124445|FG000|COMPLETED|Overall Study||552
10002450|NCT01722734|11124446|FG001|COMPLETED|Overall Study||276
10002451|NCT01722734|11124447|FG002|COMPLETED|Overall Study||307
10002452|NCT01722734|11124445|FG000|NOT COMPLETED|Overall Study||2
10002453|NCT01722734|11124446|FG001|NOT COMPLETED|Overall Study||1
10002454|NCT01722734|11124447|FG002|NOT COMPLETED|Overall Study||2
10002455|NCT01722877|11124455|FG000|STARTED|Overall Study||29
10002456|NCT01722877|11124455|FG000|COMPLETED|Overall Study||27
10002457|NCT01722877|11124455|FG000|NOT COMPLETED|Overall Study||2
10002458|NCT01722994|11124463|FG000|STARTED|Overall Study||49
10002459|NCT01722994|11124464|FG001|STARTED|Overall Study||48
10002460|NCT01722994|11124463|FG000|COMPLETED|Overall Study||24
10002461|NCT01722994|11124464|FG001|COMPLETED|Overall Study||31
10002462|NCT01722994|11124463|FG000|NOT COMPLETED|Overall Study||25
10002463|NCT01722994|11124464|FG001|NOT COMPLETED|Overall Study||17
10002464|NCT01723072|11124474|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
10002465|NCT01723072|11124475|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
10002466|NCT01723072|11124474|FG000|COMPLETED|Overall Study||33
10002467|NCT01723072|11124475|FG001|COMPLETED|Overall Study||26
10002468|NCT01723072|11124474|FG000|NOT COMPLETED|Overall Study||11
10002469|NCT01723072|11124475|FG001|NOT COMPLETED|Overall Study||21
10002470|NCT01723163|11124483|FG000|STARTED|Baseline||156
10002471|NCT01723163|11124484|FG001|STARTED|Baseline||154
10002472|NCT01723163|11124483|FG000|COMPLETED|Baseline||156
10002473|NCT01723163|11124484|FG001|COMPLETED|Baseline||154
10002474|NCT01723163|11124483|FG000|NOT COMPLETED|Baseline||0
10002475|NCT01723163|11124484|FG001|NOT COMPLETED|Baseline||0
10002476|NCT01723163|11124483|FG000|STARTED|Treatment Phase||156
10002477|NCT01723163|11124484|FG001|STARTED|Treatment Phase||154
10002478|NCT01723163|11124483|FG000|COMPLETED|Treatment Phase||137
10002479|NCT01723163|11124484|FG001|COMPLETED|Treatment Phase||147
10002480|NCT01723163|11124483|FG000|NOT COMPLETED|Treatment Phase||19
10002481|NCT01723163|11124484|FG001|NOT COMPLETED|Treatment Phase||7
10002482|NCT01723163|11124483|FG000|STARTED|3-Month Follow-up||137
10002483|NCT01723163|11124484|FG001|STARTED|3-Month Follow-up||147
10002484|NCT01723163|11124483|FG000|COMPLETED|3-Month Follow-up||124
10002485|NCT01723163|11124484|FG001|COMPLETED|3-Month Follow-up||128
10002486|NCT01723163|11124483|FG000|NOT COMPLETED|3-Month Follow-up||13
10002487|NCT01723163|11124484|FG001|NOT COMPLETED|3-Month Follow-up||19
10002488|NCT01723163|11124483|FG000|STARTED|6-Month Follow-up||136
10002489|NCT01723163|11124484|FG001|STARTED|6-Month Follow-up||147
10002490|NCT01723163|11124483|FG000|COMPLETED|6-Month Follow-up||118
10002491|NCT01723163|11124484|FG001|COMPLETED|6-Month Follow-up||132
10002492|NCT01723163|11124483|FG000|NOT COMPLETED|6-Month Follow-up||18
10002493|NCT01723163|11124484|FG001|NOT COMPLETED|6-Month Follow-up||15
10002494|NCT01723163|11124483|FG000|STARTED|12-Month Follow-up||135
10002495|NCT01723163|11124484|FG001|STARTED|12-Month Follow-up||147
10002496|NCT01723163|11124483|FG000|COMPLETED|12-Month Follow-up||111
10002497|NCT01723163|11124484|FG001|COMPLETED|12-Month Follow-up||119
10002498|NCT01723163|11124483|FG000|NOT COMPLETED|12-Month Follow-up||24
10002499|NCT01723163|11124484|FG001|NOT COMPLETED|12-Month Follow-up||28
10002500|NCT01723228|11124492|FG000|STARTED|Overall Study||86
10002501|NCT01723228|11124493|FG001|STARTED|Overall Study||84
10002502|NCT01723228|11124492|FG000|COMPLETED|Overall Study||78
10002503|NCT01723228|11124493|FG001|COMPLETED|Overall Study||73
10002504|NCT01723228|11124492|FG000|NOT COMPLETED|Overall Study||8
10002505|NCT01723228|11124493|FG001|NOT COMPLETED|Overall Study||11
10002506|NCT01723254|11124507|FG000|STARTED|Overall Study||6
10002507|NCT01723254|11124508|FG001|STARTED|Overall Study||21
10002508|NCT01723254|11124509|FG002|STARTED|Overall Study||20
10002509|NCT01723254|11124510|FG003|STARTED|Overall Study||20
10002510|NCT01723254|11124511|FG004|STARTED|Overall Study||20
10002511|NCT01723254|11124512|FG005|STARTED|Overall Study||20
10002512|NCT01723254|11124513|FG006|STARTED|Overall Study||20
10002513|NCT01723254|11124514|FG007|STARTED|Overall Study||63
10002514|NCT01723254|11124507|FG000|COMPLETED|Overall Study||5
10002515|NCT01723254|11124508|FG001|COMPLETED|Overall Study||18
10002516|NCT01723254|11124509|FG002|COMPLETED|Overall Study||17
10002517|NCT01723254|11124510|FG003|COMPLETED|Overall Study||18
10002518|NCT01723254|11124511|FG004|COMPLETED|Overall Study||18
10002519|NCT01723254|11124512|FG005|COMPLETED|Overall Study||18
10002520|NCT01723254|11124513|FG006|COMPLETED|Overall Study||19
10002521|NCT01723254|11124514|FG007|COMPLETED|Overall Study||60
10002522|NCT01723254|11124507|FG000|NOT COMPLETED|Overall Study||1
10002523|NCT01723254|11124508|FG001|NOT COMPLETED|Overall Study||3
10002524|NCT01723254|11124509|FG002|NOT COMPLETED|Overall Study||3
10002525|NCT01723254|11124510|FG003|NOT COMPLETED|Overall Study||2
10002526|NCT01723254|11124511|FG004|NOT COMPLETED|Overall Study||2
10002527|NCT01723254|11124512|FG005|NOT COMPLETED|Overall Study||2
10002528|NCT01723254|11124513|FG006|NOT COMPLETED|Overall Study||1
10002529|NCT01723254|11124514|FG007|NOT COMPLETED|Overall Study||3
10002530|NCT01723384|11124534|FG000|STARTED|Overall Study||15
10002531|NCT01723384|11124535|FG001|STARTED|Overall Study||15
10002532|NCT01723384|11124534|FG000|COMPLETED|Overall Study||15
10002533|NCT01723384|11124535|FG001|COMPLETED|Overall Study||15
10002534|NCT01723384|11124534|FG000|NOT COMPLETED|Overall Study||0
10002535|NCT01723384|11124535|FG001|NOT COMPLETED|Overall Study||0
10002536|NCT01723397|11124543|FG000|STARTED|Study Period 1||7
10002537|NCT01723397|11124544|FG001|STARTED|Study Period 1||7
10002538|NCT01723397|11124543|FG000|COMPLETED|Study Period 1||7
10002539|NCT01723397|11124544|FG001|COMPLETED|Study Period 1||6
10002540|NCT01723397|11124543|FG000|NOT COMPLETED|Study Period 1||0
10002541|NCT01723397|11124544|FG001|NOT COMPLETED|Study Period 1||1
10002542|NCT01723397|11124543|FG000|STARTED|Washout||7
10002543|NCT01723397|11124544|FG001|STARTED|Washout||6
10002544|NCT01723397|11124543|FG000|COMPLETED|Washout||7
10002545|NCT01723397|11124544|FG001|COMPLETED|Washout||6
10002546|NCT01723397|11124543|FG000|NOT COMPLETED|Washout||0
10002547|NCT01723397|11124544|FG001|NOT COMPLETED|Washout||0
10002548|NCT01723397|11124543|FG000|STARTED|Study Period 2||7
10002549|NCT01723397|11124544|FG001|STARTED|Study Period 2||6
10002550|NCT01723397|11124543|FG000|COMPLETED|Study Period 2||7
10002551|NCT01723397|11124544|FG001|COMPLETED|Study Period 2||5
10002552|NCT01723397|11124543|FG000|NOT COMPLETED|Study Period 2||0
10002553|NCT01723397|11124544|FG001|NOT COMPLETED|Study Period 2||1
10002554|NCT01723514|11124558|FG000|STARTED|Overall Study||8
10002555|NCT01723514|11124559|FG001|STARTED|Overall Study||6
10002556|NCT01723514|11124560|FG002|STARTED|Overall Study||6
10002557|NCT01723514|11124561|FG003|STARTED|Overall Study||6
10002558|NCT01723514|11124562|FG004|STARTED|Overall Study||6
10002559|NCT01723514|11124563|FG005|STARTED|Overall Study||4
10002560|NCT01723514|11124564|FG006|STARTED|Overall Study||6
10002561|NCT01723514|11124565|FG007|STARTED|Overall Study||6
10002562|NCT01723514|11124558|FG000|COMPLETED|Overall Study||8
10002563|NCT01723514|11124559|FG001|COMPLETED|Overall Study||6
10002564|NCT01723514|11124560|FG002|COMPLETED|Overall Study||6
10002565|NCT01723514|11124561|FG003|COMPLETED|Overall Study||6
10002566|NCT01723514|11124562|FG004|COMPLETED|Overall Study||6
10002567|NCT01723514|11124563|FG005|COMPLETED|Overall Study||4
10002568|NCT01723514|11124564|FG006|COMPLETED|Overall Study||6
10002569|NCT01723514|11124565|FG007|COMPLETED|Overall Study||6
10002570|NCT01723514|11124558|FG000|NOT COMPLETED|Overall Study||0
10002571|NCT01723514|11124559|FG001|NOT COMPLETED|Overall Study||0
10002572|NCT01723514|11124560|FG002|NOT COMPLETED|Overall Study||0
10002573|NCT01723514|11124561|FG003|NOT COMPLETED|Overall Study||0
10002574|NCT01723514|11124562|FG004|NOT COMPLETED|Overall Study||0
10002575|NCT01723514|11124563|FG005|NOT COMPLETED|Overall Study||0
10002576|NCT01723514|11124564|FG006|NOT COMPLETED|Overall Study||0
10002577|NCT01723514|11124565|FG007|NOT COMPLETED|Overall Study||0
10002578|NCT01723696|11124585|FG000|STARTED|Overall Study||126
10002579|NCT01723696|11124586|FG001|STARTED|Overall Study||126
10002580|NCT01723696|11124585|FG000|COMPLETED|Overall Study||109
10002581|NCT01723696|11124586|FG001|COMPLETED|Overall Study||113
10002582|NCT01723696|11124585|FG000|NOT COMPLETED|Overall Study||17
10002583|NCT01723696|11124586|FG001|NOT COMPLETED|Overall Study||13
10002584|NCT01723722|11124596|FG000|STARTED|Overall Study||20
10002585|NCT01723722|11124597|FG001|STARTED|Overall Study||20
10002586|NCT01723722|11124596|FG000|COMPLETED|Overall Study||20
10002587|NCT01723722|11124597|FG001|COMPLETED|Overall Study||20
10002588|NCT01723722|11124596|FG000|NOT COMPLETED|Overall Study||0
10002589|NCT01723722|11124597|FG001|NOT COMPLETED|Overall Study||0
10002590|NCT01723826|11124607|FG000|STARTED|Overall Study||47
10002591|NCT01723826|11124608|FG001|STARTED|Overall Study||63
10002592|NCT01723826|11124609|FG002|STARTED|Overall Study||101
10002593|NCT01723826|11124610|FG003|STARTED|Overall Study||149
10103701|NCT02426918|11233360|FG002|NOT COMPLETED|Overall Study||14
10103702|NCT02427100|11233370|FG000|STARTED|Overall Study||15
10103703|NCT02427100|11233371|FG001|STARTED|Overall Study||17
10103704|NCT02427100|11233370|FG000|COMPLETED|Overall Study||15
10103705|NCT02427100|11233371|FG001|COMPLETED|Overall Study||15
10103706|NCT02427100|11233370|FG000|NOT COMPLETED|Overall Study||0
10002594|NCT01723826|11124607|FG000|COMPLETED|Overall Study||20
10002595|NCT01723826|11124608|FG001|COMPLETED|Overall Study||27
10002596|NCT01723826|11124609|FG002|COMPLETED|Overall Study||44
10002597|NCT01723826|11124610|FG003|COMPLETED|Overall Study||59
10002598|NCT01723826|11124607|FG000|NOT COMPLETED|Overall Study||27
10002599|NCT01723826|11124608|FG001|NOT COMPLETED|Overall Study||36
10002600|NCT01723826|11124609|FG002|NOT COMPLETED|Overall Study||57
10002601|NCT01723826|11124610|FG003|NOT COMPLETED|Overall Study||90
10103707|NCT02427100|11233371|FG001|NOT COMPLETED|Overall Study||2
10002602|NCT01723904|11124620|FG000|STARTED|Overall Study||90
10002603|NCT01723904|11124620|FG000|COMPLETED|Overall Study||79
10002604|NCT01723904|11124620|FG000|NOT COMPLETED|Overall Study||11
10002605|NCT01724021|11124626|FG000|STARTED|Overall Study||371
10002606|NCT01724021|11124627|FG001|STARTED|Overall Study||369
10002607|NCT01724021|11124626|FG000|COMPLETED|Overall Study||244
10002608|NCT01724021|11124627|FG001|COMPLETED|Overall Study||236
10002609|NCT01724021|11124626|FG000|NOT COMPLETED|Overall Study||127
10002610|NCT01724021|11124627|FG001|NOT COMPLETED|Overall Study||133
10002611|NCT01724060|11124643|FG000|STARTED|Overall Study||10
10002612|NCT01724060|11124644|FG001|STARTED|Overall Study||10
10002613|NCT01724060|11124645|FG002|STARTED|Overall Study||10
10002614|NCT01724060|11124646|FG003|STARTED|Overall Study||10
10002615|NCT01724060|11124647|FG004|STARTED|Overall Study||10
10002616|NCT01724060|11124648|FG005|STARTED|Overall Study||10
10002617|NCT01724060|11124649|FG006|STARTED|Overall Study||10
10002618|NCT01724060|11124650|FG007|STARTED|Overall Study||10
10002619|NCT01724060|11124643|FG000|COMPLETED|Overall Study||10
10002620|NCT01724060|11124644|FG001|COMPLETED|Overall Study||10
10002621|NCT01724060|11124645|FG002|COMPLETED|Overall Study||10
10002622|NCT01724060|11124646|FG003|COMPLETED|Overall Study||10
10002623|NCT01724060|11124647|FG004|COMPLETED|Overall Study||10
10002624|NCT01724060|11124648|FG005|COMPLETED|Overall Study||10
10002625|NCT01724060|11124649|FG006|COMPLETED|Overall Study||10
10002626|NCT01724060|11124650|FG007|COMPLETED|Overall Study||10
10002627|NCT01724060|11124643|FG000|NOT COMPLETED|Overall Study||0
10002628|NCT01724060|11124644|FG001|NOT COMPLETED|Overall Study||0
10002629|NCT01724060|11124645|FG002|NOT COMPLETED|Overall Study||0
10002630|NCT01724060|11124646|FG003|NOT COMPLETED|Overall Study||0
10002631|NCT01724060|11124647|FG004|NOT COMPLETED|Overall Study||0
10002632|NCT01724060|11124648|FG005|NOT COMPLETED|Overall Study||0
10002633|NCT01724060|11124649|FG006|NOT COMPLETED|Overall Study||0
10002634|NCT01724060|11124650|FG007|NOT COMPLETED|Overall Study||0
10002635|NCT01724177|11124668|FG000|STARTED|Overall Study||26
10002636|NCT01724177|11124668|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
10002637|NCT01724177|11124668|FG000|COMPLETED|Overall Study||0
10002638|NCT01724177|11124668|FG000|NOT COMPLETED|Overall Study||26
10002639|NCT01724216|11124673|FG000|STARTED|Overall Study||11
10002640|NCT01724216|11124673|FG000|COMPLETED|Overall Study||10
10002641|NCT01724216|11124673|FG000|NOT COMPLETED|Overall Study||1
10002642|NCT01724359|11124677|FG000|STARTED|Overall Study||95
10002643|NCT01724359|11124677|FG000|COMPLETED|Overall Study||64
10002644|NCT01724359|11124677|FG000|NOT COMPLETED|Overall Study||31
10002645|NCT01724489|11124685|FG000|STARTED|Overall Study||39
10002646|NCT01724489|11124686|FG001|STARTED|Overall Study||38
10002647|NCT01724489|11124685|FG000|COMPLETED|Overall Study||23
10002648|NCT01724489|11124686|FG001|COMPLETED|Overall Study||26
10002649|NCT01724489|11124685|FG000|NOT COMPLETED|Overall Study||16
10002650|NCT01724489|11124686|FG001|NOT COMPLETED|Overall Study||12
10002651|NCT01724528|11124694|FG000|STARTED|Overall Study||173
10002652|NCT01724528|11124695|FG001|STARTED|Overall Study||173
10002653|NCT01724528|11124694|FG000|COMPLETED|Overall Study||169
10002654|NCT01724528|11124695|FG001|COMPLETED|Overall Study||170
10002655|NCT01724528|11124694|FG000|NOT COMPLETED|Overall Study||4
10002656|NCT01724528|11124695|FG001|NOT COMPLETED|Overall Study||3
10002657|NCT01725126|11124707|FG000|STARTED|Overall Study||4
10002658|NCT01725126|11124708|FG001|STARTED|Overall Study||11
10002659|NCT01725126|11124709|FG002|STARTED|Overall Study||6
10002660|NCT01725126|11124710|FG003|STARTED|Overall Study||14
10002661|NCT01725126|11124711|FG004|STARTED|Overall Study||6
10002662|NCT01725126|11124712|FG005|STARTED|Overall Study||12
10002663|NCT01725126|11124707|FG000|COMPLETED|Overall Study||4
10002664|NCT01725126|11124708|FG001|COMPLETED|Overall Study||10
10002665|NCT01725126|11124709|FG002|COMPLETED|Overall Study||6
10002666|NCT01725126|11124710|FG003|COMPLETED|Overall Study||13
10002667|NCT01725126|11124711|FG004|COMPLETED|Overall Study||6
10002668|NCT01725126|11124712|FG005|COMPLETED|Overall Study||12
10002669|NCT01725126|11124707|FG000|NOT COMPLETED|Overall Study||0
10002670|NCT01725126|11124708|FG001|NOT COMPLETED|Overall Study||1
10002671|NCT01725126|11124709|FG002|NOT COMPLETED|Overall Study||0
10002672|NCT01725126|11124710|FG003|NOT COMPLETED|Overall Study||1
10002673|NCT01725126|11124711|FG004|NOT COMPLETED|Overall Study||0
10002674|NCT01725126|11124712|FG005|NOT COMPLETED|Overall Study||0
10002675|NCT01725217|11124738|FG000|STARTED|Overall Study||66
10002676|NCT01725217|11124739|FG001|STARTED|Overall Study||66
10002677|NCT01725217|11124740|FG002|STARTED|Overall Study||66
10002678|NCT01725217|11124738|FG000|COMPLETED|Overall Study||65
10002679|NCT01725217|11124739|FG001|COMPLETED|Overall Study||66
10002680|NCT01725217|11124740|FG002|COMPLETED|Overall Study||66
10002681|NCT01725217|11124738|FG000|NOT COMPLETED|Overall Study||1
10002682|NCT01725217|11124739|FG001|NOT COMPLETED|Overall Study||0
10002683|NCT01725217|11124740|FG002|NOT COMPLETED|Overall Study||0
10002684|NCT01725282|11124761|FG000|STARTED|Overall Study||44
10002685|NCT01725282|11124762|FG001|STARTED|Overall Study||44
10002686|NCT01725282|11124763|FG002|STARTED|Overall Study||41
10002687|NCT01725282|11124764|FG003|STARTED|Overall Study||43
10002688|NCT01725282|11124761|FG000|COMPLETED|Overall Study||42
10002689|NCT01725282|11124762|FG001|COMPLETED|Overall Study||39
10002690|NCT01725282|11124763|FG002|COMPLETED|Overall Study||33
10002691|NCT01725282|11124764|FG003|COMPLETED|Overall Study||36
10002692|NCT01725282|11124761|FG000|NOT COMPLETED|Overall Study||2
10002693|NCT01725282|11124762|FG001|NOT COMPLETED|Overall Study||5
10002694|NCT01725282|11124763|FG002|NOT COMPLETED|Overall Study||8
10002695|NCT01725282|11124764|FG003|NOT COMPLETED|Overall Study||7
10002696|NCT01725308|11124777|FG000|STARTED|Treatment Period I||178
10002697|NCT01725308|11124778|FG001|STARTED|Treatment Period I||74
10002698|NCT01725308|11124779|FG002|STARTED|Treatment Period I||179
10002699|NCT01725308|11124777|FG000|Treated|Treatment Period I||177
10002700|NCT01725308|11124778|FG001|Treated|Treatment Period I||74
10002701|NCT01725308|11124779|FG002|Treated|Treatment Period I||179
10002702|NCT01725308|11124777|FG000|COMPLETED|Treatment Period I||134
10002703|NCT01725308|11124778|FG001|COMPLETED|Treatment Period I||60
10002704|NCT01725308|11124779|FG002|COMPLETED|Treatment Period I||138
10002705|NCT01725308|11124777|FG000|NOT COMPLETED|Treatment Period I||44
10002706|NCT01725308|11124778|FG001|NOT COMPLETED|Treatment Period I||14
10002707|NCT01725308|11124779|FG002|NOT COMPLETED|Treatment Period I||41
10002708|NCT01725308|11124777|FG000|STARTED|Treatment Period II||134
10002709|NCT01725308|11124778|FG001|STARTED|Treatment Period II||60
10002710|NCT01725308|11124779|FG002|STARTED|Treatment Period II||138
10002711|NCT01725308|11124777|FG000|Treated|Treatment Period II||120
10002712|NCT01725308|11124778|FG001|Treated|Treatment Period II||53
10002713|NCT01725308|11124779|FG002|Treated|Treatment Period II||130
10002714|NCT01725308|11124777|FG000|COMPLETED|Treatment Period II||79
10002715|NCT01725308|11124778|FG001|COMPLETED|Treatment Period II||31
10002716|NCT01725308|11124779|FG002|COMPLETED|Treatment Period II||74
10002717|NCT01725308|11124777|FG000|NOT COMPLETED|Treatment Period II||55
10002718|NCT01725308|11124778|FG001|NOT COMPLETED|Treatment Period II||29
10002719|NCT01725308|11124779|FG002|NOT COMPLETED|Treatment Period II||64
10002720|NCT01725386|11124796|FG000|STARTED|Overall Study||188
10002721|NCT01725386|11124797|FG001|STARTED|Overall Study||63
10002722|NCT01725386|11124796|FG000|COMPLETED|Overall Study||13
10002723|NCT01725386|11124797|FG001|COMPLETED|Overall Study||17
10002724|NCT01725386|11124796|FG000|NOT COMPLETED|Overall Study||175
10002725|NCT01725386|11124797|FG001|NOT COMPLETED|Overall Study||46
10002726|NCT01725451|11124803|FG000|STARTED|Period 1||8
10002727|NCT01725451|11124804|FG001|STARTED|Period 1||7
10002728|NCT01725451|11124805|FG002|STARTED|Period 1||8
10002729|NCT01725451|11124806|FG003|STARTED|Period 1||7
10002730|NCT01725451|11124803|FG000|COMPLETED|Period 1||7
10002731|NCT01725451|11124804|FG001|COMPLETED|Period 1||7
10002732|NCT01725451|11124805|FG002|COMPLETED|Period 1||8
10002733|NCT01725451|11124806|FG003|COMPLETED|Period 1||7
10002734|NCT01725451|11124803|FG000|NOT COMPLETED|Period 1||1
10002735|NCT01725451|11124804|FG001|NOT COMPLETED|Period 1||0
10002736|NCT01725451|11124805|FG002|NOT COMPLETED|Period 1||0
10002737|NCT01725451|11124806|FG003|NOT COMPLETED|Period 1||0
10002738|NCT01725451|11124803|FG000|STARTED|Washout From Period 1||7
10002739|NCT01725451|11124804|FG001|STARTED|Washout From Period 1||7
10002740|NCT01725451|11124805|FG002|STARTED|Washout From Period 1||8
10002741|NCT01725451|11124806|FG003|STARTED|Washout From Period 1||7
10002742|NCT01725451|11124803|FG000|COMPLETED|Washout From Period 1||7
10002743|NCT01725451|11124804|FG001|COMPLETED|Washout From Period 1||7
10002744|NCT01725451|11124805|FG002|COMPLETED|Washout From Period 1||8
10002745|NCT01725451|11124806|FG003|COMPLETED|Washout From Period 1||7
10002746|NCT01725451|11124803|FG000|NOT COMPLETED|Washout From Period 1||0
10002747|NCT01725451|11124804|FG001|NOT COMPLETED|Washout From Period 1||0
10002748|NCT01725451|11124805|FG002|NOT COMPLETED|Washout From Period 1||0
10002749|NCT01725451|11124806|FG003|NOT COMPLETED|Washout From Period 1||0
10002750|NCT01725451|11124803|FG000|STARTED|Period 2||7
10002751|NCT01725451|11124804|FG001|STARTED|Period 2||7
10002752|NCT01725451|11124805|FG002|STARTED|Period 2||8
10002753|NCT01725451|11124806|FG003|STARTED|Period 2||7
10002754|NCT01725451|11124803|FG000|COMPLETED|Period 2||7
10002755|NCT01725451|11124804|FG001|COMPLETED|Period 2||7
10002756|NCT01725451|11124805|FG002|COMPLETED|Period 2||8
10002757|NCT01725451|11124806|FG003|COMPLETED|Period 2||7
10002758|NCT01725451|11124803|FG000|NOT COMPLETED|Period 2||0
10002759|NCT01725451|11124804|FG001|NOT COMPLETED|Period 2||0
10002760|NCT01725451|11124805|FG002|NOT COMPLETED|Period 2||0
10002761|NCT01725451|11124806|FG003|NOT COMPLETED|Period 2||0
10002762|NCT01725451|11124803|FG000|STARTED|Washout From Period 2||7
10002763|NCT01725451|11124804|FG001|STARTED|Washout From Period 2||7
10002764|NCT01725451|11124805|FG002|STARTED|Washout From Period 2||8
10002765|NCT01725451|11124806|FG003|STARTED|Washout From Period 2||7
10002766|NCT01725451|11124803|FG000|COMPLETED|Washout From Period 2||7
10002767|NCT01725451|11124804|FG001|COMPLETED|Washout From Period 2||7
10002768|NCT01725451|11124805|FG002|COMPLETED|Washout From Period 2||8
10002769|NCT01725451|11124806|FG003|COMPLETED|Washout From Period 2||7
10002770|NCT01725451|11124803|FG000|NOT COMPLETED|Washout From Period 2||0
10002771|NCT01725451|11124804|FG001|NOT COMPLETED|Washout From Period 2||0
10002772|NCT01725451|11124805|FG002|NOT COMPLETED|Washout From Period 2||0
10002773|NCT01725451|11124806|FG003|NOT COMPLETED|Washout From Period 2||0
10002774|NCT01725451|11124803|FG000|STARTED|Period 3||7
10002775|NCT01725451|11124804|FG001|STARTED|Period 3||7
10002776|NCT01725451|11124805|FG002|STARTED|Period 3||8
10002777|NCT01725451|11124806|FG003|STARTED|Period 3||7
10002778|NCT01725451|11124803|FG000|COMPLETED|Period 3||7
10002779|NCT01725451|11124804|FG001|COMPLETED|Period 3||7
10002780|NCT01725451|11124805|FG002|COMPLETED|Period 3||8
10002781|NCT01725451|11124806|FG003|COMPLETED|Period 3||7
10002782|NCT01725451|11124803|FG000|NOT COMPLETED|Period 3||0
10002783|NCT01725451|11124804|FG001|NOT COMPLETED|Period 3||0
10002784|NCT01725451|11124805|FG002|NOT COMPLETED|Period 3||0
10002785|NCT01725451|11124806|FG003|NOT COMPLETED|Period 3||0
10002786|NCT01725451|11124803|FG000|STARTED|Washout From Period 3||7
10002787|NCT01725451|11124804|FG001|STARTED|Washout From Period 3||7
10002788|NCT01725451|11124805|FG002|STARTED|Washout From Period 3||8
10002789|NCT01725451|11124806|FG003|STARTED|Washout From Period 3||7
10002790|NCT01725451|11124803|FG000|COMPLETED|Washout From Period 3||7
10002791|NCT01725451|11124804|FG001|COMPLETED|Washout From Period 3||6
10002792|NCT01725451|11124805|FG002|COMPLETED|Washout From Period 3||7
10002793|NCT01725451|11124806|FG003|COMPLETED|Washout From Period 3||7
10002794|NCT01725451|11124803|FG000|NOT COMPLETED|Washout From Period 3||0
10002795|NCT01725451|11124804|FG001|NOT COMPLETED|Washout From Period 3||1
10002796|NCT01725451|11124805|FG002|NOT COMPLETED|Washout From Period 3||1
10002797|NCT01725451|11124806|FG003|NOT COMPLETED|Washout From Period 3||0
10002798|NCT01725451|11124803|FG000|STARTED|Period 4||7
10002799|NCT01725451|11124804|FG001|STARTED|Period 4||6
10002800|NCT01725451|11124805|FG002|STARTED|Period 4||7
10002801|NCT01725451|11124806|FG003|STARTED|Period 4||7
10002802|NCT01725451|11124803|FG000|COMPLETED|Period 4||7
10002803|NCT01725451|11124804|FG001|COMPLETED|Period 4||6
10002804|NCT01725451|11124805|FG002|COMPLETED|Period 4||6
10002805|NCT01725451|11124806|FG003|COMPLETED|Period 4||7
10002806|NCT01725451|11124803|FG000|NOT COMPLETED|Period 4||0
10002807|NCT01725451|11124804|FG001|NOT COMPLETED|Period 4||0
10002808|NCT01725451|11124805|FG002|NOT COMPLETED|Period 4||1
10002809|NCT01725451|11124806|FG003|NOT COMPLETED|Period 4||0
10002810|NCT01725451|11124803|FG000|STARTED|Washout From Period 4||7
10002811|NCT01725451|11124804|FG001|STARTED|Washout From Period 4||6
10002812|NCT01725451|11124805|FG002|STARTED|Washout From Period 4||6
10002813|NCT01725451|11124806|FG003|STARTED|Washout From Period 4||7
10002814|NCT01725451|11124803|FG000|COMPLETED|Washout From Period 4||7
10002815|NCT01725451|11124804|FG001|COMPLETED|Washout From Period 4||6
10002816|NCT01725451|11124805|FG002|COMPLETED|Washout From Period 4||6
10002817|NCT01725451|11124806|FG003|COMPLETED|Washout From Period 4||7
10002818|NCT01725451|11124803|FG000|NOT COMPLETED|Washout From Period 4||0
10002819|NCT01725451|11124804|FG001|NOT COMPLETED|Washout From Period 4||0
10002820|NCT01725451|11124805|FG002|NOT COMPLETED|Washout From Period 4||0
10002821|NCT01725451|11124806|FG003|NOT COMPLETED|Washout From Period 4||0
10002822|NCT01725451|11124803|FG000|STARTED|Period 5||7
10002823|NCT01725451|11124804|FG001|STARTED|Period 5||6
10002824|NCT01725451|11124805|FG002|STARTED|Period 5||6
10002825|NCT01725451|11124806|FG003|STARTED|Period 5||7
10002826|NCT01725451|11124803|FG000|COMPLETED|Period 5||7
10002827|NCT01725451|11124804|FG001|COMPLETED|Period 5||6
10002828|NCT01725451|11124805|FG002|COMPLETED|Period 5||6
10002829|NCT01725451|11124806|FG003|COMPLETED|Period 5||7
10002830|NCT01725451|11124803|FG000|NOT COMPLETED|Period 5||0
10002831|NCT01725451|11124804|FG001|NOT COMPLETED|Period 5||0
10002832|NCT01725451|11124805|FG002|NOT COMPLETED|Period 5||0
10002833|NCT01725451|11124806|FG003|NOT COMPLETED|Period 5||0
10002834|NCT01725451|11124803|FG000|STARTED|Washout From Period 5||7
10002835|NCT01725451|11124804|FG001|STARTED|Washout From Period 5||6
10002836|NCT01725451|11124805|FG002|STARTED|Washout From Period 5||6
10002837|NCT01725451|11124806|FG003|STARTED|Washout From Period 5||7
10002838|NCT01725451|11124803|FG000|COMPLETED|Washout From Period 5||7
10002839|NCT01725451|11124804|FG001|COMPLETED|Washout From Period 5||6
10002840|NCT01725451|11124805|FG002|COMPLETED|Washout From Period 5||6
10002841|NCT01725451|11124806|FG003|COMPLETED|Washout From Period 5||7
10002842|NCT01725451|11124803|FG000|NOT COMPLETED|Washout From Period 5||0
10002843|NCT01725451|11124804|FG001|NOT COMPLETED|Washout From Period 5||0
10002844|NCT01725451|11124805|FG002|NOT COMPLETED|Washout From Period 5||0
10002845|NCT01725451|11124806|FG003|NOT COMPLETED|Washout From Period 5||0
10002846|NCT01725451|11124803|FG000|STARTED|Period 6||7
10002847|NCT01725451|11124804|FG001|STARTED|Period 6||6
10002848|NCT01725451|11124805|FG002|STARTED|Period 6||6
10002849|NCT01725451|11124806|FG003|STARTED|Period 6||7
10002850|NCT01725451|11124803|FG000|COMPLETED|Period 6||7
10002851|NCT01725451|11124804|FG001|COMPLETED|Period 6||6
10002852|NCT01725451|11124805|FG002|COMPLETED|Period 6||6
10002853|NCT01725451|11124806|FG003|COMPLETED|Period 6||7
10002854|NCT01725451|11124803|FG000|NOT COMPLETED|Period 6||0
10002855|NCT01725451|11124804|FG001|NOT COMPLETED|Period 6||0
10002856|NCT01725451|11124805|FG002|NOT COMPLETED|Period 6||0
10002857|NCT01725451|11124806|FG003|NOT COMPLETED|Period 6||0
10002858|NCT01725529|11124824|FG000|STARTED|Overall Study||152
10002859|NCT01725529|11124825|FG001|STARTED|Overall Study||153
10002860|NCT01725529|11124826|FG002|STARTED|Overall Study||152
10002861|NCT01725529|11124824|FG000|COMPLETED|Overall Study||137
10002862|NCT01725529|11124825|FG001|COMPLETED|Overall Study||137
10002863|NCT01725529|11124826|FG002|COMPLETED|Overall Study||142
10002864|NCT01725529|11124824|FG000|NOT COMPLETED|Overall Study||15
10002865|NCT01725529|11124825|FG001|NOT COMPLETED|Overall Study||16
10002866|NCT01725529|11124826|FG002|NOT COMPLETED|Overall Study||10
10002867|NCT01725750|11124836|FG000|STARTED|Overall Study||44
10002868|NCT01725750|11124837|FG001|STARTED|Overall Study||44
10002869|NCT01725750|11124836|FG000|COMPLETED|Overall Study||42
10002870|NCT01725750|11124837|FG001|COMPLETED|Overall Study||34
10002871|NCT01725750|11124836|FG000|NOT COMPLETED|Overall Study||2
10002872|NCT01725750|11124837|FG001|NOT COMPLETED|Overall Study||10
10002873|NCT01725815|11124847|FG000|STARTED|Overall Study||198
10002874|NCT01725815|11124848|FG001|STARTED|Overall Study||202
10002875|NCT01725815|11124847|FG000|COMPLETED|Overall Study||198
10002876|NCT01725815|11124848|FG001|COMPLETED|Overall Study||202
10002877|NCT01725815|11124847|FG000|NOT COMPLETED|Overall Study||0
10002878|NCT01725815|11124848|FG001|NOT COMPLETED|Overall Study||0
10002879|NCT01725984|11124856|FG000|STARTED|Overall Study||39
10002880|NCT01725984|11124857|FG001|STARTED|Overall Study||41
10002881|NCT01725984|11124856|FG000|COMPLETED|Overall Study||39
10002882|NCT01725984|11124857|FG001|COMPLETED|Overall Study||41
10002883|NCT01725984|11124856|FG000|NOT COMPLETED|Overall Study||0
10002884|NCT01725984|11124857|FG001|NOT COMPLETED|Overall Study||0
10002885|NCT01726023|11124865|FG000|STARTED|Overall Study||219
10002886|NCT01726023|11124866|FG001|STARTED|Overall Study||222
10002887|NCT01726023|11124865|FG000|COMPLETED|Overall Study||190
10002888|NCT01726023|11124866|FG001|COMPLETED|Overall Study||196
10002889|NCT01726023|11124865|FG000|NOT COMPLETED|Overall Study||29
10002890|NCT01726023|11124866|FG001|NOT COMPLETED|Overall Study||26
10002891|NCT01726036|11124881|FG000|STARTED|Overall Study||137
10002892|NCT01726036|11124882|FG001|STARTED|Overall Study||137
10002893|NCT01726036|11124881|FG000|COMPLETED|Overall Study||121
10002894|NCT01726036|11124882|FG001|COMPLETED|Overall Study||130
10002895|NCT01726036|11124881|FG000|NOT COMPLETED|Overall Study||16
10002896|NCT01726036|11124882|FG001|NOT COMPLETED|Overall Study||7
10002897|NCT01726049|11124890|FG000|STARTED|Overall Study||26
10002898|NCT01726049|11124891|FG001|STARTED|Overall Study||26
10002899|NCT01726049|11124890|FG000|COMPLETED|Overall Study||21
10002900|NCT01726049|11124891|FG001|COMPLETED|Overall Study||22
10002901|NCT01726049|11124890|FG000|NOT COMPLETED|Overall Study||5
10002902|NCT01726049|11124891|FG001|NOT COMPLETED|Overall Study||4
10002903|NCT01726270|11124897|FG000|STARTED|Part 1, Self-Selection Phase||689
10002904|NCT01726270|11124897|FG000|COMPLETED|Part 1, Self-Selection Phase||679
10002905|NCT01726270|11124897|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10
10002906|NCT01726270|11124897|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
10002907|NCT01726270|11124897|FG000|COMPLETED|Eligibility for Part 2||369
10002908|NCT01726270|11124897|FG000|NOT COMPLETED|Eligibility for Part 2||20
10002909|NCT01726270|11124897|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
10002910|NCT01726270|11124897|FG000|COMPLETED|Part 2, Actual-Use Phase||330
10002911|NCT01726270|11124897|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39
10002912|NCT01726335|11124903|FG000|STARTED|Overall Study||53
10002913|NCT01726335|11124903|FG000|COMPLETED|Overall Study||29
10002914|NCT01726335|11124903|FG000|NOT COMPLETED|Overall Study||24
10002915|NCT01726504|11124909|FG000|STARTED|Overall Study||536
10002916|NCT01726504|11124910|FG001|STARTED|Overall Study||539
10002917|NCT01726504|11124909|FG000|COMPLETED|Overall Study||524
10002918|NCT01726504|11124910|FG001|COMPLETED|Overall Study||511
10002919|NCT01726504|11124909|FG000|NOT COMPLETED|Overall Study||12
10002920|NCT01726504|11124910|FG001|NOT COMPLETED|Overall Study||28
10002921|NCT01726517|11124921|FG000|STARTED|Overall Study||20
10002922|NCT01726517|11124922|FG001|STARTED|Overall Study||21
10002923|NCT01726517|11124923|FG002|STARTED|Overall Study||19
10002924|NCT01726517|11124924|FG003|STARTED|Overall Study||19
10002925|NCT01726517|11124925|FG004|STARTED|Overall Study||21
10002926|NCT01726517|11124921|FG000|COMPLETED|Overall Study||20
10002927|NCT01726517|11124922|FG001|COMPLETED|Overall Study||21
10002928|NCT01726517|11124923|FG002|COMPLETED|Overall Study||18
10002929|NCT01726517|11124924|FG003|COMPLETED|Overall Study||19
10002930|NCT01726517|11124925|FG004|COMPLETED|Overall Study||21
10002931|NCT01726517|11124921|FG000|NOT COMPLETED|Overall Study||0
10002932|NCT01726517|11124922|FG001|NOT COMPLETED|Overall Study||0
10002933|NCT01726517|11124923|FG002|NOT COMPLETED|Overall Study||1
10002934|NCT01726517|11124924|FG003|NOT COMPLETED|Overall Study||0
10002935|NCT01726517|11124925|FG004|NOT COMPLETED|Overall Study||0
10002936|NCT01726621|11124937|FG000|STARTED|Overall Study||55
10002937|NCT01726621|11124937|FG000|COMPLETED|Overall Study||51
10002938|NCT01726621|11124937|FG000|NOT COMPLETED|Overall Study||4
10002939|NCT01726673|11124943|FG000|STARTED|Overall Study||30
10002940|NCT01726673|11124944|FG001|STARTED|Overall Study||24
10002941|NCT01726673|11124943|FG000|COMPLETED|Overall Study||24
10002942|NCT01726673|11124944|FG001|COMPLETED|Overall Study||21
10002943|NCT01726673|11124943|FG000|NOT COMPLETED|Overall Study||6
10002944|NCT01726673|11124944|FG001|NOT COMPLETED|Overall Study||3
10002945|NCT01726738|11124950|FG000|STARTED|Overall Study||17
10002946|NCT01726738|11124950|FG000|COMPLETED|Overall Study||17
10002947|NCT01726738|11124950|FG000|NOT COMPLETED|Overall Study||0
10002948|NCT01726803|11124956|FG000|STARTED|Overall Study||112
10002949|NCT01726803|11124957|FG001|STARTED|Overall Study||108
10002950|NCT01726803|11124956|FG000|COMPLETED|Overall Study||105
10002951|NCT01726803|11124957|FG001|COMPLETED|Overall Study||107
10002952|NCT01726803|11124956|FG000|NOT COMPLETED|Overall Study||7
10002953|NCT01726803|11124957|FG001|NOT COMPLETED|Overall Study||1
10002954|NCT01727024|11124963|FG000|STARTED|Period 1||71
10002955|NCT01727024|11124964|FG001|STARTED|Period 1||68
10002956|NCT01727024|11124963|FG000|COMPLETED|Period 1||68
10002957|NCT01727024|11124964|FG001|COMPLETED|Period 1||64
10002958|NCT01727024|11124963|FG000|NOT COMPLETED|Period 1||3
10002959|NCT01727024|11124964|FG001|NOT COMPLETED|Period 1||4
10002960|NCT01727024|11124963|FG000|STARTED|Period 2||68
10002961|NCT01727024|11124964|FG001|STARTED|Period 2||64
10002962|NCT01727024|11124963|FG000|COMPLETED|Period 2||68
10002963|NCT01727024|11124964|FG001|COMPLETED|Period 2||64
10002964|NCT01727024|11124963|FG000|NOT COMPLETED|Period 2||0
10002965|NCT01727024|11124964|FG001|NOT COMPLETED|Period 2||0
10002966|NCT01727089|11124972|FG000|STARTED|Overall Study||29
10002967|NCT01727089|11124973|FG001|STARTED|Overall Study||30
10002968|NCT01727089|11124972|FG000|COMPLETED|Overall Study||29
10002969|NCT01727089|11124973|FG001|COMPLETED|Overall Study||30
10002970|NCT01727089|11124972|FG000|NOT COMPLETED|Overall Study||0
10002971|NCT01727089|11124973|FG001|NOT COMPLETED|Overall Study||0
10002972|NCT01727141|11124983|FG000|STARTED|Overall Study||260
10002973|NCT01727141|11124984|FG001|STARTED|Overall Study||260
10002974|NCT01727141|11124985|FG002|STARTED|Overall Study||261
10002975|NCT01727141|11124986|FG003|STARTED|Overall Study||261
10002976|NCT01727141|11124983|FG000|Safety Set|Overall Study||258
10002977|NCT01727141|11124984|FG001|Safety Set|Overall Study||260
10002978|NCT01727141|11124985|FG002|Safety Set|Overall Study||262
10002979|NCT01727141|11124986|FG003|Safety Set|Overall Study||260
10002980|NCT01727141|11124983|FG000|Full Analysis Set|Overall Study||258
10002981|NCT01727141|11124984|FG001|Full Analysis Set|Overall Study||260
10002982|NCT01727141|11124985|FG002|Full Analysis Set|Overall Study||261
10002983|NCT01727141|11124986|FG003|Full Analysis Set|Overall Study||261
10002984|NCT01727141|11124983|FG000|COMPLETED|Overall Study||255
10002985|NCT01727141|11124984|FG001|COMPLETED|Overall Study||251
10002986|NCT01727141|11124985|FG002|COMPLETED|Overall Study||258
10002987|NCT01727141|11124986|FG003|COMPLETED|Overall Study||246
10002988|NCT01727141|11124983|FG000|NOT COMPLETED|Overall Study||5
10002989|NCT01727141|11124984|FG001|NOT COMPLETED|Overall Study||9
10002990|NCT01727141|11124985|FG002|NOT COMPLETED|Overall Study||3
10002991|NCT01727141|11124986|FG003|NOT COMPLETED|Overall Study||15
10002992|NCT01727154|11124996|FG000|STARTED|Overall Study||139
10002993|NCT01727154|11124996|FG000|COMPLETED|Overall Study||80
10002994|NCT01727154|11124996|FG000|NOT COMPLETED|Overall Study||59
10002995|NCT01727180|11125000|FG000|STARTED|Overall Study||108
10002996|NCT01727180|11125000|FG000|COMPLETED|Overall Study||108
10002997|NCT01727180|11125000|FG000|NOT COMPLETED|Overall Study||0
10002998|NCT01727258|11125007|FG000|STARTED|Overall Study||51
10002999|NCT01727258|11125008|FG001|STARTED|Overall Study||51
10003000|NCT01727258|11125009|FG002|STARTED|Overall Study||51
10003001|NCT01727258|11125007|FG000|COMPLETED|Overall Study||49
10003002|NCT01727258|11125008|FG001|COMPLETED|Overall Study||48
10003003|NCT01727258|11125009|FG002|COMPLETED|Overall Study||50
10003004|NCT01727258|11125007|FG000|NOT COMPLETED|Overall Study||2
10003005|NCT01727258|11125008|FG001|NOT COMPLETED|Overall Study||3
10003006|NCT01727258|11125009|FG002|NOT COMPLETED|Overall Study||1
10003007|NCT01727297|11125017|FG000|STARTED|Overall Study||395
10003008|NCT01727297|11125018|FG001|STARTED|Overall Study||51
10003009|NCT01727297|11125017|FG000|COMPLETED|Overall Study||293
10003010|NCT01727297|11125018|FG001|COMPLETED|Overall Study||0
10003011|NCT01727297|11125017|FG000|NOT COMPLETED|Overall Study||102
10003012|NCT01727297|11125018|FG001|NOT COMPLETED|Overall Study||51
10003013|NCT01727336|11125037|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6
10003014|NCT01727336|11125038|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9
10003015|NCT01727336|11125039|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14
10003016|NCT01727336|11125040|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0
10003017|NCT01727336|11125041|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0
10003018|NCT01727336|11125042|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0
10003019|NCT01727336|11125037|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3
10003020|NCT01727336|11125038|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7
10003021|NCT01727336|11125039|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6
10003022|NCT01727336|11125040|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0
10003023|NCT01727336|11125041|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0
10003024|NCT01727336|11125042|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0
10003025|NCT01727336|11125037|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3
10003026|NCT01727336|11125038|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2
10003027|NCT01727336|11125039|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8
10003028|NCT01727336|11125040|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
10003029|NCT01727336|11125041|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
10003030|NCT01727336|11125042|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
10003031|NCT01727336|11125037|FG000|STARTED|Part 2 Blinded||0
10003032|NCT01727336|11125038|FG001|STARTED|Part 2 Blinded||0
10003033|NCT01727336|11125039|FG002|STARTED|Part 2 Blinded||0
10003034|NCT01727336|11125040|FG003|STARTED|Part 2 Blinded||0
10003035|NCT01727336|11125041|FG004|STARTED|Part 2 Blinded||63
10003036|NCT01727336|11125042|FG005|STARTED|Part 2 Blinded||68
10003037|NCT01727336|11125037|FG000|COMPLETED|Part 2 Blinded||0
10003038|NCT01727336|11125038|FG001|COMPLETED|Part 2 Blinded||0
10003039|NCT01727336|11125039|FG002|COMPLETED|Part 2 Blinded||0
10003040|NCT01727336|11125040|FG003|COMPLETED|Part 2 Blinded||0
10003041|NCT01727336|11125041|FG004|COMPLETED|Part 2 Blinded||0
10003042|NCT01727336|11125042|FG005|COMPLETED|Part 2 Blinded||0
10003043|NCT01727336|11125037|FG000|NOT COMPLETED|Part 2 Blinded||0
10003044|NCT01727336|11125038|FG001|NOT COMPLETED|Part 2 Blinded||0
10003045|NCT01727336|11125039|FG002|NOT COMPLETED|Part 2 Blinded||0
10003046|NCT01727336|11125040|FG003|NOT COMPLETED|Part 2 Blinded||0
10003047|NCT01727336|11125041|FG004|NOT COMPLETED|Part 2 Blinded||63
10003048|NCT01727336|11125042|FG005|NOT COMPLETED|Part 2 Blinded||68
10018781|NCT01825512|11141826|FG000|COMPLETED|Baseline||193
10018782|NCT01825512|11141827|FG001|COMPLETED|Baseline||197
10018783|NCT01825512|11141826|FG000|NOT COMPLETED|Baseline||1
10018784|NCT01825512|11141827|FG001|NOT COMPLETED|Baseline||2
10018785|NCT01825512|11141826|FG000|STARTED|Treatment||193
10018786|NCT01825512|11141827|FG001|STARTED|Treatment||197
10018787|NCT01825512|11141826|FG000|COMPLETED|Treatment||140
10018788|NCT01825512|11141827|FG001|COMPLETED|Treatment||170
10018789|NCT01825512|11141826|FG000|NOT COMPLETED|Treatment||53
10018790|NCT01825512|11141827|FG001|NOT COMPLETED|Treatment||27
10018791|NCT01825577|11141833|FG000|STARTED|Overall Study||14
10018792|NCT01825577|11141833|FG000|COMPLETED|Overall Study||6
10018793|NCT01825577|11141833|FG000|NOT COMPLETED|Overall Study||8
10018794|NCT01825655|11141839|FG000|STARTED|Overall Study||0
10018795|NCT01825655|11141840|FG001|STARTED|Overall Study||2
10018796|NCT01825655|11141839|FG000|COMPLETED|Overall Study||0
10018797|NCT01825655|11141840|FG001|COMPLETED|Overall Study||2
10018798|NCT01825655|11141839|FG000|NOT COMPLETED|Overall Study||0
10018799|NCT01825655|11141840|FG001|NOT COMPLETED|Overall Study||0
10018800|NCT01825785|11141853|FG000|STARTED|Overall Study||12
10018801|NCT01825785|11141854|FG001|STARTED|Overall Study||6
10018802|NCT01825785|11141855|FG002|STARTED|Overall Study||6
10018803|NCT01825785|11141856|FG003|STARTED|Overall Study||6
10018804|NCT01825785|11141857|FG004|STARTED|Overall Study||6
10018805|NCT01825785|11141858|FG005|STARTED|Overall Study||6
10003049|NCT01727414|11125064|FG000|STARTED|Overall Study||126
10003050|NCT01727414|11125065|FG001|STARTED|Overall Study||45
10003051|NCT01727414|11125064|FG000|COMPLETED|Overall Study||123
10003052|NCT01727414|11125065|FG001|COMPLETED|Overall Study||45
10003053|NCT01727414|11125064|FG000|NOT COMPLETED|Overall Study||3
10003054|NCT01727414|11125065|FG001|NOT COMPLETED|Overall Study||0
10003055|NCT01727505|11125071|FG000|STARTED|First 24 Hours||14
10003056|NCT01727505|11125072|FG001|STARTED|First 24 Hours||12
10003057|NCT01727505|11125071|FG000|COMPLETED|First 24 Hours||14
10003058|NCT01727505|11125072|FG001|COMPLETED|First 24 Hours||11
10003059|NCT01727505|11125071|FG000|NOT COMPLETED|First 24 Hours||0
10003060|NCT01727505|11125072|FG001|NOT COMPLETED|First 24 Hours||1
10003061|NCT01727505|11125071|FG000|STARTED|Second 24 Hours||14
10003062|NCT01727505|11125072|FG001|STARTED|Second 24 Hours||11
10003063|NCT01727505|11125071|FG000|COMPLETED|Second 24 Hours||14
10003064|NCT01727505|11125072|FG001|COMPLETED|Second 24 Hours||10
10003065|NCT01727505|11125071|FG000|NOT COMPLETED|Second 24 Hours||0
10003066|NCT01727505|11125072|FG001|NOT COMPLETED|Second 24 Hours||1
10003067|NCT01727700|11125081|FG000|STARTED|Overall Study||44
10003068|NCT01727700|11125082|FG001|STARTED|Overall Study||45
10003069|NCT01727700|11125083|FG002|STARTED|Overall Study||44
10003070|NCT01727700|11125081|FG000|COMPLETED|Overall Study||42
10003071|NCT01727700|11125082|FG001|COMPLETED|Overall Study||35
10003072|NCT01727700|11125083|FG002|COMPLETED|Overall Study||42
10003073|NCT01727700|11125081|FG000|NOT COMPLETED|Overall Study||2
10003074|NCT01727700|11125082|FG001|NOT COMPLETED|Overall Study||10
10003075|NCT01727700|11125083|FG002|NOT COMPLETED|Overall Study||2
10003076|NCT01727713|11125091|FG000|STARTED|Overall Study||110
10003077|NCT01727713|11125091|FG000|COMPLETED|Overall Study||75
10003078|NCT01727713|11125091|FG000|NOT COMPLETED|Overall Study||35
10003079|NCT01727726|11125098|FG000|STARTED|Overall Study||197
10003080|NCT01727726|11125099|FG001|STARTED|Overall Study||100
10003081|NCT01727726|11125100|FG002|STARTED|Overall Study||206
10003082|NCT01727726|11125098|FG000|COMPLETED|Overall Study||171
10003083|NCT01727726|11125099|FG001|COMPLETED|Overall Study||86
10003084|NCT01727726|11125100|FG002|COMPLETED|Overall Study||186
10003085|NCT01727726|11125098|FG000|NOT COMPLETED|Overall Study||26
10003086|NCT01727726|11125099|FG001|NOT COMPLETED|Overall Study||14
10003087|NCT01727726|11125100|FG002|NOT COMPLETED|Overall Study||20
10003088|NCT01727765|11125110|FG000|STARTED|Overall Study||8
10003089|NCT01727765|11125111|FG001|STARTED|Overall Study||8
10003090|NCT01727765|11125110|FG000|COMPLETED|Overall Study||8
10003091|NCT01727765|11125111|FG001|COMPLETED|Overall Study||8
10003092|NCT01727765|11125110|FG000|NOT COMPLETED|Overall Study||0
10003093|NCT01727765|11125111|FG001|NOT COMPLETED|Overall Study||0
10003094|NCT01727791|11125117|FG000|STARTED|Overall Study||10
10003095|NCT01727791|11125117|FG000|COMPLETED|Overall Study||10
10003096|NCT01727791|11125117|FG000|NOT COMPLETED|Overall Study||0
10003097|NCT01727895|11125123|FG000|STARTED|Overall Study||10
10003098|NCT01727895|11125124|FG001|STARTED|Overall Study||5
10003099|NCT01727895|11125123|FG000|COMPLETED|Overall Study||10
10003100|NCT01727895|11125124|FG001|COMPLETED|Overall Study||5
10003101|NCT01727895|11125123|FG000|NOT COMPLETED|Overall Study||0
10003102|NCT01727895|11125124|FG001|NOT COMPLETED|Overall Study||0
10003103|NCT01728077|11125132|FG000|STARTED|Overall Study||19
10003104|NCT01728077|11125133|FG001|STARTED|Overall Study||7
10003105|NCT01728077|11125132|FG000|COMPLETED|Overall Study||11
10003106|NCT01728077|11125133|FG001|COMPLETED|Overall Study||2
10003107|NCT01728077|11125132|FG000|NOT COMPLETED|Overall Study||8
10003108|NCT01728077|11125133|FG001|NOT COMPLETED|Overall Study||5
10003109|NCT01728116|11125142|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213
10003110|NCT01728116|11125143|FG001|STARTED|Overall Study|Sham mITT subjects|107
10003111|NCT01728116|11125142|FG000|COMPLETED|Overall Study|Completed to Week 78|52
10003112|NCT01728116|11125143|FG001|COMPLETED|Overall Study|Completed to Week 52|60
10003113|NCT01728116|11125142|FG000|NOT COMPLETED|Overall Study||161
10003114|NCT01728116|11125143|FG001|NOT COMPLETED|Overall Study||47
10003115|NCT01728194|11125152|FG000|STARTED|Overall Study||54
10003116|NCT01728194|11125153|FG001|STARTED|Overall Study||67
10003117|NCT01728194|11125152|FG000|COMPLETED|Overall Study||34
10003118|NCT01728194|11125153|FG001|COMPLETED|Overall Study||61
10003119|NCT01728194|11125152|FG000|NOT COMPLETED|Overall Study||20
10003120|NCT01728194|11125153|FG001|NOT COMPLETED|Overall Study||6
10003121|NCT01728246|11125161|FG000|STARTED|Overall Study||242
10003122|NCT01728246|11125162|FG001|STARTED|Overall Study||231
10003123|NCT01728246|11125161|FG000|COMPLETED|Overall Study||206
10003124|NCT01728246|11125162|FG001|COMPLETED|Overall Study||195
10003125|NCT01728246|11125161|FG000|NOT COMPLETED|Overall Study||36
10003126|NCT01728246|11125162|FG001|NOT COMPLETED|Overall Study||36
10003127|NCT01728324|11125171|FG000|STARTED|Termination of DBV||211
10003128|NCT01728324|11125172|FG001|STARTED|Termination of DBV||213
10003129|NCT01728324|11125173|FG002|STARTED|Termination of DBV||72
10003130|NCT01728324|11125171|FG000|COMPLETED|Termination of DBV||173
10003131|NCT01728324|11125172|FG001|COMPLETED|Termination of DBV||177
10003132|NCT01728324|11125173|FG002|COMPLETED|Termination of DBV||58
10003133|NCT01728324|11125171|FG000|NOT COMPLETED|Termination of DBV||38
10003134|NCT01728324|11125172|FG001|NOT COMPLETED|Termination of DBV||36
10003135|NCT01728324|11125173|FG002|NOT COMPLETED|Termination of DBV||14
10003136|NCT01728324|11125171|FG000|STARTED|Termination of FDV||211
10003137|NCT01728324|11125172|FG001|STARTED|Termination of FDV||213
10003138|NCT01728324|11125173|FG002|STARTED|Termination of FDV||72
10003139|NCT01728324|11125171|FG000|COMPLETED|Termination of FDV||173
10003140|NCT01728324|11125172|FG001|COMPLETED|Termination of FDV||177
10003141|NCT01728324|11125173|FG002|COMPLETED|Termination of FDV||58
10003142|NCT01728324|11125171|FG000|NOT COMPLETED|Termination of FDV||38
10003143|NCT01728324|11125172|FG001|NOT COMPLETED|Termination of FDV||36
10003144|NCT01728324|11125173|FG002|NOT COMPLETED|Termination of FDV||14
10003145|NCT01728324|11125171|FG000|STARTED|Termination of RBV||211
10003146|NCT01728324|11125172|FG001|STARTED|Termination of RBV||213
10003147|NCT01728324|11125173|FG002|STARTED|Termination of RBV||72
10003148|NCT01728324|11125171|FG000|COMPLETED|Termination of RBV||172
10003149|NCT01728324|11125172|FG001|COMPLETED|Termination of RBV||176
10003150|NCT01728324|11125173|FG002|COMPLETED|Termination of RBV||57
10003151|NCT01728324|11125171|FG000|NOT COMPLETED|Termination of RBV||39
10003152|NCT01728324|11125172|FG001|NOT COMPLETED|Termination of RBV||37
10003153|NCT01728324|11125173|FG002|NOT COMPLETED|Termination of RBV||15
10003154|NCT01728337|11125183|FG000|STARTED|Overall Study||80
10003155|NCT01728337|11125183|FG000|COMPLETED|Overall Study||80
10003156|NCT01728337|11125183|FG000|NOT COMPLETED|Overall Study||0
10003157|NCT01728376|11125195|FG000|STARTED|Overall Study||22
10003158|NCT01728376|11125196|FG001|STARTED|Overall Study||11
10003159|NCT01728376|11125197|FG002|STARTED|Overall Study||19
10003160|NCT01728376|11125198|FG003|STARTED|Overall Study||9
10003161|NCT01728376|11125199|FG004|STARTED|Overall Study||14
10003162|NCT01728376|11125200|FG005|STARTED|Overall Study||7
10003163|NCT01728376|11125195|FG000|Treated|Overall Study||22
10003164|NCT01728376|11125196|FG001|Treated|Overall Study||10
10003165|NCT01728376|11125197|FG002|Treated|Overall Study||19
10003166|NCT01728376|11125198|FG003|Treated|Overall Study||9
10003167|NCT01728376|11125199|FG004|Treated|Overall Study||14
10003168|NCT01728376|11125200|FG005|Treated|Overall Study||7
10003169|NCT01728376|11125195|FG000|COMPLETED|Overall Study||18
10003170|NCT01728376|11125196|FG001|COMPLETED|Overall Study||9
10003171|NCT01728376|11125197|FG002|COMPLETED|Overall Study||17
10003172|NCT01728376|11125198|FG003|COMPLETED|Overall Study||7
10103708|NCT02427399|11233382|FG000|STARTED|Overall Study||220
10103709|NCT02427399|11233383|FG001|STARTED|Overall Study||220
10103710|NCT02427399|11233384|FG002|STARTED|Overall Study||220
10103711|NCT02427399|11233385|FG003|STARTED|Overall Study||220
10103712|NCT02427399|11233386|FG004|STARTED|Overall Study||220
10103713|NCT02427399|11233382|FG000|COMPLETED|Overall Study||206
10003173|NCT01728376|11125199|FG004|COMPLETED|Overall Study||12
10003174|NCT01728376|11125200|FG005|COMPLETED|Overall Study||5
10003175|NCT01728376|11125195|FG000|NOT COMPLETED|Overall Study||4
10003176|NCT01728376|11125196|FG001|NOT COMPLETED|Overall Study||2
10003177|NCT01728376|11125197|FG002|NOT COMPLETED|Overall Study||2
10003178|NCT01728376|11125198|FG003|NOT COMPLETED|Overall Study||2
10003179|NCT01728376|11125199|FG004|NOT COMPLETED|Overall Study||2
10003180|NCT01728376|11125200|FG005|NOT COMPLETED|Overall Study||2
10003181|NCT01728454|11125217|FG000|STARTED|Stage 1 and 2||17
10003182|NCT01728454|11125218|FG001|STARTED|Stage 1 and 2||20
10003183|NCT01728454|11125219|FG002|STARTED|Stage 1 and 2||23
10003184|NCT01728454|11125217|FG000|COMPLETED|Stage 1 and 2||12
10003185|NCT01728454|11125218|FG001|COMPLETED|Stage 1 and 2||16
10003186|NCT01728454|11125219|FG002|COMPLETED|Stage 1 and 2||19
10003187|NCT01728454|11125217|FG000|NOT COMPLETED|Stage 1 and 2||5
10003188|NCT01728454|11125218|FG001|NOT COMPLETED|Stage 1 and 2||4
10003189|NCT01728454|11125219|FG002|NOT COMPLETED|Stage 1 and 2||4
10003190|NCT01728454|11125217|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
10003191|NCT01728454|11125218|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
10003192|NCT01728454|11125219|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
10003193|NCT01728454|11125217|FG000|COMPLETED|Stage 3||3
10003194|NCT01728454|11125218|FG001|COMPLETED|Stage 3||1
10003195|NCT01728454|11125219|FG002|COMPLETED|Stage 3||7
10003196|NCT01728454|11125217|FG000|NOT COMPLETED|Stage 3||3
10003197|NCT01728454|11125218|FG001|NOT COMPLETED|Stage 3||4
10003198|NCT01728454|11125219|FG002|NOT COMPLETED|Stage 3||4
10003199|NCT01728584|11125234|FG000|STARTED|Overall Study|Randomized|36
10003200|NCT01728584|11125235|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
10003201|NCT01728584|11125236|FG002|STARTED|Overall Study|Randomized|31
10003202|NCT01728584|11125237|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
10003203|NCT01728584|11125234|FG000|COMPLETED|Overall Study||28
10003204|NCT01728584|11125235|FG001|COMPLETED|Overall Study||30
10003205|NCT01728584|11125236|FG002|COMPLETED|Overall Study||30
10003206|NCT01728584|11125237|FG003|COMPLETED|Overall Study||29
10003207|NCT01728584|11125234|FG000|NOT COMPLETED|Overall Study||8
10003208|NCT01728584|11125235|FG001|NOT COMPLETED|Overall Study||0
10003209|NCT01728584|11125236|FG002|NOT COMPLETED|Overall Study||1
10103714|NCT02427399|11233383|FG001|COMPLETED|Overall Study||204
10003210|NCT01728584|11125237|FG003|NOT COMPLETED|Overall Study||1
10003211|NCT01728623|11125254|FG000|STARTED|Overall Study||51
10003212|NCT01728623|11125254|FG000|DTC|Overall Study||25
10003213|NCT01728623|11125254|FG000|MTC|Overall Study||9
10003214|NCT01728623|11125254|FG000|ATC|Overall Study||17
10003215|NCT01728623|11125254|FG000|COMPLETED|Overall Study||23
10003216|NCT01728623|11125254|FG000|NOT COMPLETED|Overall Study||28
10003217|NCT01728636|11125263|FG000|STARTED|Overall Study||31
10003218|NCT01728636|11125264|FG001|STARTED|Overall Study||30
10003219|NCT01728636|11125263|FG000|COMPLETED|Overall Study||31
10003220|NCT01728636|11125264|FG001|COMPLETED|Overall Study||30
10003221|NCT01728636|11125263|FG000|NOT COMPLETED|Overall Study||0
10003222|NCT01728636|11125264|FG001|NOT COMPLETED|Overall Study||0
10003223|NCT01728779|11125270|FG000|STARTED|Overall Study||38
10003224|NCT01728779|11125270|FG000|COMPLETED|Overall Study||37
10003225|NCT01728779|11125270|FG000|NOT COMPLETED|Overall Study||1
10003226|NCT01728792|11125279|FG000|STARTED|Overall Study||14
10003227|NCT01728792|11125280|FG001|STARTED|Overall Study||16
10003228|NCT01728792|11125281|FG002|STARTED|Overall Study||17
10003229|NCT01728792|11125282|FG003|STARTED|Overall Study||17
10003230|NCT01728792|11125283|FG004|STARTED|Overall Study||16
10003231|NCT01728792|11125279|FG000|COMPLETED|Overall Study||11
10003232|NCT01728792|11125280|FG001|COMPLETED|Overall Study||14
10003233|NCT01728792|11125281|FG002|COMPLETED|Overall Study||13
10003234|NCT01728792|11125282|FG003|COMPLETED|Overall Study||14
10003235|NCT01728792|11125283|FG004|COMPLETED|Overall Study||16
10003236|NCT01728792|11125279|FG000|NOT COMPLETED|Overall Study||3
10003237|NCT01728792|11125280|FG001|NOT COMPLETED|Overall Study||2
10003238|NCT01728792|11125281|FG002|NOT COMPLETED|Overall Study||4
10003239|NCT01728792|11125282|FG003|NOT COMPLETED|Overall Study||3
10003240|NCT01728792|11125283|FG004|NOT COMPLETED|Overall Study||0
10003241|NCT01728805|11125297|FG000|STARTED|Randomization Period||186
10003242|NCT01728805|11125298|FG001|STARTED|Randomization Period||186
10003243|NCT01728805|11125299|FG002|STARTED|Randomization Period||0
10003244|NCT01728805|11125297|FG000|COMPLETED|Randomization Period||186
10003245|NCT01728805|11125298|FG001|COMPLETED|Randomization Period||186
10003246|NCT01728805|11125299|FG002|COMPLETED|Randomization Period||0
10003247|NCT01728805|11125297|FG000|NOT COMPLETED|Randomization Period||0
10003248|NCT01728805|11125298|FG001|NOT COMPLETED|Randomization Period||0
10003249|NCT01728805|11125299|FG002|NOT COMPLETED|Randomization Period||0
10003250|NCT01728805|11125297|FG000|STARTED|Crossover Period||0
10003251|NCT01728805|11125298|FG001|STARTED|Crossover Period||0
10003252|NCT01728805|11125299|FG002|STARTED|Crossover Period||136
10003253|NCT01728805|11125297|FG000|COMPLETED|Crossover Period||0
10003254|NCT01728805|11125298|FG001|COMPLETED|Crossover Period||0
10003255|NCT01728805|11125299|FG002|COMPLETED|Crossover Period||136
10003256|NCT01728805|11125297|FG000|NOT COMPLETED|Crossover Period||0
10003257|NCT01728805|11125298|FG001|NOT COMPLETED|Crossover Period||0
10003258|NCT01728805|11125299|FG002|NOT COMPLETED|Crossover Period||0
10003259|NCT01728844|11125310|FG000|STARTED|Overall Study||22
10003260|NCT01728844|11125311|FG001|STARTED|Overall Study||21
10003261|NCT01728844|11125312|FG002|STARTED|Overall Study||22
10003262|NCT01728844|11125313|FG003|STARTED|Overall Study||23
10003263|NCT01728844|11125310|FG000|COMPLETED|Overall Study||21
10003264|NCT01728844|11125311|FG001|COMPLETED|Overall Study||21
10003265|NCT01728844|11125312|FG002|COMPLETED|Overall Study||22
10003266|NCT01728844|11125313|FG003|COMPLETED|Overall Study||21
10003267|NCT01728844|11125310|FG000|NOT COMPLETED|Overall Study||1
10003268|NCT01728844|11125311|FG001|NOT COMPLETED|Overall Study||0
10003269|NCT01728844|11125312|FG002|NOT COMPLETED|Overall Study||0
10003270|NCT01728844|11125313|FG003|NOT COMPLETED|Overall Study||2
10003271|NCT01729026|11125325|FG000|STARTED|Randomization to 3-month Follow-up||9
10003272|NCT01729026|11125326|FG001|STARTED|Randomization to 3-month Follow-up||10
10003273|NCT01729026|11125325|FG000|COMPLETED|Randomization to 3-month Follow-up||7
10003274|NCT01729026|11125326|FG001|COMPLETED|Randomization to 3-month Follow-up||8
10003275|NCT01729026|11125325|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2
10003276|NCT01729026|11125326|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2
10003277|NCT01729026|11125325|FG000|STARTED|3-month to 6-month (Final) Follow-up||7
10003278|NCT01729026|11125326|FG001|STARTED|3-month to 6-month (Final) Follow-up||8
10003279|NCT01729026|11125325|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6
10003280|NCT01729026|11125326|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6
10003281|NCT01729026|11125325|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
10003282|NCT01729026|11125326|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
10003283|NCT01729039|11125337|FG000|STARTED|Overall Study||23
10003284|NCT01729039|11125338|FG001|STARTED|Overall Study||26
10003285|NCT01729039|11125337|FG000|COMPLETED|Overall Study||13
10003286|NCT01729039|11125338|FG001|COMPLETED|Overall Study||14
10003287|NCT01729039|11125337|FG000|NOT COMPLETED|Overall Study||10
10003288|NCT01729039|11125338|FG001|NOT COMPLETED|Overall Study||12
10003289|NCT01729156|11125350|FG000|STARTED|Overall Study||12
10003290|NCT01729156|11125351|FG001|STARTED|Overall Study||12
10003291|NCT01729156|11125352|FG002|STARTED|Overall Study||12
10003292|NCT01729156|11125350|FG000|COMPLETED|Overall Study||11
10003293|NCT01729156|11125351|FG001|COMPLETED|Overall Study||12
10003294|NCT01729156|11125352|FG002|COMPLETED|Overall Study||12
10003295|NCT01729156|11125350|FG000|NOT COMPLETED|Overall Study||1
10003296|NCT01729156|11125351|FG001|NOT COMPLETED|Overall Study||0
10003297|NCT01729156|11125352|FG002|NOT COMPLETED|Overall Study||0
10003298|NCT01729208|11125363|FG000|STARTED|Baseline||70
10003299|NCT01729208|11125364|FG001|STARTED|Baseline||74
10003300|NCT01729208|11125363|FG000|COMPLETED|Baseline||65
10003301|NCT01729208|11125364|FG001|COMPLETED|Baseline||70
10003302|NCT01729208|11125363|FG000|NOT COMPLETED|Baseline||5
10003303|NCT01729208|11125364|FG001|NOT COMPLETED|Baseline||4
10003304|NCT01729208|11125363|FG000|STARTED|12 Months Follow-up||65
10003305|NCT01729208|11125364|FG001|STARTED|12 Months Follow-up||70
10003306|NCT01729208|11125363|FG000|COMPLETED|12 Months Follow-up||58
10003307|NCT01729208|11125364|FG001|COMPLETED|12 Months Follow-up||60
10003308|NCT01729208|11125363|FG000|NOT COMPLETED|12 Months Follow-up||7
10003309|NCT01729208|11125364|FG001|NOT COMPLETED|12 Months Follow-up||10
10003310|NCT01729208|11125363|FG000|STARTED|24 Months Follow-up||58
10003311|NCT01729208|11125364|FG001|STARTED|24 Months Follow-up||60
10003312|NCT01729208|11125363|FG000|COMPLETED|24 Months Follow-up||55
10003313|NCT01729208|11125364|FG001|COMPLETED|24 Months Follow-up||60
10003314|NCT01729208|11125363|FG000|NOT COMPLETED|24 Months Follow-up||3
10003315|NCT01729208|11125364|FG001|NOT COMPLETED|24 Months Follow-up||0
10003316|NCT01729208|11125363|FG000|STARTED|36 Months Follow-up||55
10003317|NCT01729208|11125364|FG001|STARTED|36 Months Follow-up||60
10003318|NCT01729208|11125363|FG000|COMPLETED|36 Months Follow-up||52
10003319|NCT01729208|11125364|FG001|COMPLETED|36 Months Follow-up||56
10003320|NCT01729208|11125363|FG000|NOT COMPLETED|36 Months Follow-up||3
10003321|NCT01729208|11125364|FG001|NOT COMPLETED|36 Months Follow-up||4
10003322|NCT01729247|11125370|FG000|STARTED|Overall Study||50
10003323|NCT01729247|11125370|FG000|COMPLETED|Overall Study||50
10003324|NCT01729247|11125370|FG000|NOT COMPLETED|Overall Study||0
10103715|NCT02427399|11233384|FG002|COMPLETED|Overall Study||208
10103716|NCT02427399|11233385|FG003|COMPLETED|Overall Study||202
10103717|NCT02427399|11233386|FG004|COMPLETED|Overall Study||205
10003325|NCT01729338|11125381|FG000|STARTED|Overall Study||16
10003326|NCT01729338|11125381|FG000|COMPLETED|Overall Study||14
10003327|NCT01729338|11125381|FG000|NOT COMPLETED|Overall Study||2
10003328|NCT01729494|11125388|FG000|STARTED|Overall Study||107
10003329|NCT01729494|11125389|FG001|STARTED|Overall Study||104
10003330|NCT01729494|11125390|FG002|STARTED|Overall Study||105
10003331|NCT01729494|11125388|FG000|COMPLETED|Overall Study||97
10003332|NCT01729494|11125389|FG001|COMPLETED|Overall Study||93
10003333|NCT01729494|11125390|FG002|COMPLETED|Overall Study||94
10003334|NCT01729494|11125388|FG000|NOT COMPLETED|Overall Study||10
10003335|NCT01729494|11125389|FG001|NOT COMPLETED|Overall Study||11
10003336|NCT01729494|11125390|FG002|NOT COMPLETED|Overall Study||11
10003337|NCT01729559|11125400|FG000|STARTED|Overall Study||251
10003338|NCT01729559|11125401|FG001|STARTED|Overall Study||244
10003339|NCT01729559|11125400|FG000|COMPLETED|Overall Study||220
10003340|NCT01729559|11125401|FG001|COMPLETED|Overall Study||216
10003341|NCT01729559|11125400|FG000|NOT COMPLETED|Overall Study||31
10003342|NCT01729559|11125401|FG001|NOT COMPLETED|Overall Study||28
10003343|NCT01729598|11125409|FG000|STARTED|Overall Study||10
10003344|NCT01729598|11125410|FG001|STARTED|Overall Study||4
10003345|NCT01729598|11125409|FG000|COMPLETED|Overall Study||10
10003346|NCT01729598|11125410|FG001|COMPLETED|Overall Study||4
10003347|NCT01729598|11125409|FG000|NOT COMPLETED|Overall Study||0
10003348|NCT01729598|11125410|FG001|NOT COMPLETED|Overall Study||0
10003349|NCT01729728|11125419|FG000|STARTED|Overall Study||21
10003350|NCT01729728|11125420|FG001|STARTED|Overall Study||28
10003351|NCT01729728|11125421|FG002|STARTED|Overall Study||17
10003352|NCT01729728|11125419|FG000|COMPLETED|Overall Study||20
10003353|NCT01729728|11125420|FG001|COMPLETED|Overall Study||22
10003354|NCT01729728|11125421|FG002|COMPLETED|Overall Study||16
10003355|NCT01729728|11125419|FG000|NOT COMPLETED|Overall Study||1
10003356|NCT01729728|11125420|FG001|NOT COMPLETED|Overall Study||6
10003357|NCT01729728|11125421|FG002|NOT COMPLETED|Overall Study||1
10003358|NCT01729819|11125554|FG000|STARTED|Overall Study||49
10003359|NCT01729819|11125555|FG001|STARTED|Overall Study||57
10003360|NCT01729819|11125554|FG000|COMPLETED|Overall Study||43
10003361|NCT01729819|11125555|FG001|COMPLETED|Overall Study||50
10003362|NCT01729819|11125554|FG000|NOT COMPLETED|Overall Study||6
10003363|NCT01729819|11125555|FG001|NOT COMPLETED|Overall Study||7
10003364|NCT01729845|11125567|FG000|STARTED|Safety/Tolerability of Dec/MEC||6
10003365|NCT01729845|11125568|FG001|STARTED|Safety/Tolerability of Dec/MEC||34
10003366|NCT01729845|11125569|FG002|STARTED|Safety/Tolerability of Dec/MEC||12
10003367|NCT01729845|11125567|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6
10003368|NCT01729845|11125568|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34
10003369|NCT01729845|11125569|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12
10103718|NCT02427399|11233382|FG000|NOT COMPLETED|Overall Study||14
10103719|NCT02427399|11233383|FG001|NOT COMPLETED|Overall Study||16
10103720|NCT02427399|11233384|FG002|NOT COMPLETED|Overall Study||12
10103721|NCT02427399|11233385|FG003|NOT COMPLETED|Overall Study||18
10103722|NCT02427399|11233386|FG004|NOT COMPLETED|Overall Study||15
10103723|NCT02427477|11233400|FG000|STARTED|Period 1||60
10103724|NCT02427477|11233401|FG001|STARTED|Period 1||60
10103725|NCT02427477|11233400|FG000|COMPLETED|Period 1||59
10103726|NCT02427477|11233401|FG001|COMPLETED|Period 1||60
10103727|NCT02427477|11233400|FG000|NOT COMPLETED|Period 1||1
10103728|NCT02427477|11233401|FG001|NOT COMPLETED|Period 1||0
10103729|NCT02427477|11233400|FG000|STARTED|Period 2||59
10103730|NCT02427477|11233401|FG001|STARTED|Period 2||60
10103731|NCT02427477|11233400|FG000|COMPLETED|Period 2||59
10103732|NCT02427477|11233401|FG001|COMPLETED|Period 2||60
10103733|NCT02427477|11233400|FG000|NOT COMPLETED|Period 2||0
10103734|NCT02427477|11233401|FG001|NOT COMPLETED|Period 2||0
10003370|NCT01729845|11125567|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
10003371|NCT01729845|11125568|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
10103735|NCT02427477|11233400|FG000|STARTED|Period 3||59
10003372|NCT01729845|11125569|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
10003373|NCT01729845|11125567|FG000|STARTED|Efficacy of Dec/MEC||0
10003374|NCT01729845|11125568|FG001|STARTED|Efficacy of Dec/MEC||22
10003375|NCT01729845|11125569|FG002|STARTED|Efficacy of Dec/MEC||0
10103736|NCT02427477|11233401|FG001|STARTED|Period 3||60
10103737|NCT02427477|11233400|FG000|COMPLETED|Period 3||59
10003376|NCT01729845|11125567|FG000|COMPLETED|Efficacy of Dec/MEC||0
10003377|NCT01729845|11125568|FG001|COMPLETED|Efficacy of Dec/MEC||22
10003378|NCT01729845|11125569|FG002|COMPLETED|Efficacy of Dec/MEC||0
10103738|NCT02427477|11233401|FG001|COMPLETED|Period 3||60
10103739|NCT02427477|11233400|FG000|NOT COMPLETED|Period 3||0
10103740|NCT02427477|11233401|FG001|NOT COMPLETED|Period 3||0
10003379|NCT01729845|11125567|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0
10003380|NCT01729845|11125568|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0
10003381|NCT01729845|11125569|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0
10003382|NCT01729871|11125581|FG000|STARTED|Overall Study||124
10003383|NCT01729871|11125582|FG001|STARTED|Overall Study||124
10003384|NCT01729871|11125581|FG000|COMPLETED|Overall Study||112
10003385|NCT01729871|11125582|FG001|COMPLETED|Overall Study||101
10003386|NCT01729871|11125581|FG000|NOT COMPLETED|Overall Study||12
10003387|NCT01729871|11125582|FG001|NOT COMPLETED|Overall Study||23
10003388|NCT01729923|11125588|FG000|STARTED|Overall Study||27
10003389|NCT01729923|11125588|FG000|COMPLETED|Overall Study||0
10003390|NCT01729923|11125588|FG000|NOT COMPLETED|Overall Study||27
10003391|NCT01730040|11125599|FG000|STARTED|Overall Study||57
10003392|NCT01730040|11125600|FG001|STARTED|Overall Study||55
10003393|NCT01730040|11125601|FG002|STARTED|Overall Study||57
10003394|NCT01730040|11125602|FG003|STARTED|Overall Study||47
10003395|NCT01730040|11125603|FG004|STARTED|Overall Study||45
10003396|NCT01730040|11125604|FG005|STARTED|Overall Study||47
10003397|NCT01730040|11125605|FG006|STARTED|Overall Study||47
10003398|NCT01730040|11125599|FG000|Treated|Overall Study||57
10003399|NCT01730040|11125600|FG001|Treated|Overall Study||55
10003400|NCT01730040|11125601|FG002|Treated|Overall Study||57
10003401|NCT01730040|11125602|FG003|Treated|Overall Study||47
10003402|NCT01730040|11125603|FG004|Treated|Overall Study||45
10003403|NCT01730040|11125604|FG005|Treated|Overall Study||46
10003404|NCT01730040|11125605|FG006|Treated|Overall Study||47
10003405|NCT01730040|11125599|FG000|COMPLETED|Overall Study||44
10003406|NCT01730040|11125600|FG001|COMPLETED|Overall Study||40
10003407|NCT01730040|11125601|FG002|COMPLETED|Overall Study||46
10003408|NCT01730040|11125602|FG003|COMPLETED|Overall Study||39
10003409|NCT01730040|11125603|FG004|COMPLETED|Overall Study||39
10003410|NCT01730040|11125604|FG005|COMPLETED|Overall Study||40
10003411|NCT01730040|11125605|FG006|COMPLETED|Overall Study||38
10003412|NCT01730040|11125599|FG000|NOT COMPLETED|Overall Study||13
10003413|NCT01730040|11125600|FG001|NOT COMPLETED|Overall Study||15
10003414|NCT01730040|11125601|FG002|NOT COMPLETED|Overall Study||11
10003415|NCT01730040|11125602|FG003|NOT COMPLETED|Overall Study||8
10003416|NCT01730040|11125603|FG004|NOT COMPLETED|Overall Study||6
10003417|NCT01730040|11125604|FG005|NOT COMPLETED|Overall Study||7
10003418|NCT01730040|11125605|FG006|NOT COMPLETED|Overall Study||9
10003419|NCT01730053|11125627|FG000|STARTED|Overall Study||48
10003420|NCT01730053|11125628|FG001|STARTED|Overall Study||48
10003421|NCT01730053|11125629|FG002|STARTED|Overall Study||49
10003422|NCT01730053|11125630|FG003|STARTED|Overall Study||53
10003423|NCT01730053|11125631|FG004|STARTED|Overall Study||53
10003424|NCT01730053|11125632|FG005|STARTED|Overall Study||54
10003425|NCT01730053|11125627|FG000|Treated|Overall Study||48
10003426|NCT01730053|11125628|FG001|Treated|Overall Study||48
10003427|NCT01730053|11125629|FG002|Treated|Overall Study||49
10003428|NCT01730053|11125630|FG003|Treated|Overall Study||53
10003429|NCT01730053|11125631|FG004|Treated|Overall Study||53
10003430|NCT01730053|11125632|FG005|Treated|Overall Study||54
10003431|NCT01730053|11125627|FG000|COMPLETED|Overall Study||43
10003432|NCT01730053|11125628|FG001|COMPLETED|Overall Study||34
10003433|NCT01730053|11125629|FG002|COMPLETED|Overall Study||38
10003434|NCT01730053|11125630|FG003|COMPLETED|Overall Study||45
10003435|NCT01730053|11125631|FG004|COMPLETED|Overall Study||44
10003436|NCT01730053|11125632|FG005|COMPLETED|Overall Study||41
10003437|NCT01730053|11125627|FG000|NOT COMPLETED|Overall Study||5
10003438|NCT01730053|11125628|FG001|NOT COMPLETED|Overall Study||14
10003439|NCT01730053|11125629|FG002|NOT COMPLETED|Overall Study||11
10003440|NCT01730053|11125630|FG003|NOT COMPLETED|Overall Study||8
10003441|NCT01730053|11125631|FG004|NOT COMPLETED|Overall Study||9
10003442|NCT01730053|11125632|FG005|NOT COMPLETED|Overall Study||13
10003443|NCT01730339|11125649|FG000|STARTED|Overall Study||45
10003444|NCT01730339|11125650|FG001|STARTED|Overall Study||55
10003445|NCT01730339|11125649|FG000|COMPLETED|Overall Study||40
10003446|NCT01730339|11125650|FG001|COMPLETED|Overall Study||52
10003447|NCT01730339|11125649|FG000|NOT COMPLETED|Overall Study||5
10003448|NCT01730339|11125650|FG001|NOT COMPLETED|Overall Study||3
10003449|NCT01730378|11125668|FG000|STARTED|Overall Study||84
10003450|NCT01730378|11125669|FG001|STARTED|Overall Study||47
10003451|NCT01730378|11125668|FG000|COMPLETED|Overall Study||83
10003452|NCT01730378|11125669|FG001|COMPLETED|Overall Study||47
10003453|NCT01730378|11125668|FG000|NOT COMPLETED|Overall Study||1
10003454|NCT01730378|11125669|FG001|NOT COMPLETED|Overall Study||0
10003455|NCT01730534|11125678|FG000|STARTED|Overall Study||8582
10003456|NCT01730534|11125679|FG001|STARTED|Overall Study||8578
10003457|NCT01730534|11125678|FG000|COMPLETED|Overall Study||8473
10003458|NCT01730534|11125679|FG001|COMPLETED|Overall Study||8433
10003459|NCT01730534|11125678|FG000|NOT COMPLETED|Overall Study||109
10003460|NCT01730534|11125679|FG001|NOT COMPLETED|Overall Study||145
10003461|NCT01730586|11125685|FG000|STARTED|Overall Study||34
10003462|NCT01730586|11125685|FG000|COMPLETED|Overall Study||21
10003463|NCT01730586|11125685|FG000|NOT COMPLETED|Overall Study||13
10003464|NCT01730729|11125691|FG000|STARTED|Overall Study||20
10003465|NCT01730729|11125691|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18
10003466|NCT01730729|11125691|FG000|Treated Cycle 3 and Beyond|Overall Study||6
10003467|NCT01730729|11125691|FG000|COMPLETED|Overall Study||6
10003468|NCT01730729|11125691|FG000|NOT COMPLETED|Overall Study||14
10003469|NCT01730846|11125698|FG000|STARTED|Overall Study||11
10003470|NCT01730846|11125699|FG001|STARTED|Overall Study||11
10003471|NCT01730846|11125700|FG002|STARTED|Overall Study||13
10003472|NCT01730846|11125698|FG000|COMPLETED|Overall Study||11
10003473|NCT01730846|11125699|FG001|COMPLETED|Overall Study||11
10003474|NCT01730846|11125700|FG002|COMPLETED|Overall Study||13
10003475|NCT01730846|11125698|FG000|NOT COMPLETED|Overall Study||0
10003476|NCT01730846|11125699|FG001|NOT COMPLETED|Overall Study||0
10003477|NCT01730846|11125700|FG002|NOT COMPLETED|Overall Study||0
10003478|NCT01730872|11125711|FG000|STARTED|Overall Study||8
10003479|NCT01730872|11125712|FG001|STARTED|Overall Study||5
10003480|NCT01730872|11125713|FG002|STARTED|Overall Study||3
10003481|NCT01730872|11125711|FG000|Full Analysis Set|Overall Study||8
10003482|NCT01730872|11125712|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
10003483|NCT01730872|11125713|FG002|Full Analysis Set|Overall Study||0
10003484|NCT01730872|11125711|FG000|COMPLETED|Overall Study||8
10003485|NCT01730872|11125712|FG001|COMPLETED|Overall Study||5
10003486|NCT01730872|11125713|FG002|COMPLETED|Overall Study||3
10003487|NCT01730872|11125711|FG000|NOT COMPLETED|Overall Study||0
10003488|NCT01730872|11125712|FG001|NOT COMPLETED|Overall Study||0
10003489|NCT01730872|11125713|FG002|NOT COMPLETED|Overall Study||0
10003490|NCT01730950|11125722|FG000|STARTED|Overall Study||90
10003491|NCT01730950|11125723|FG001|STARTED|Overall Study||92
10003492|NCT01730950|11125722|FG000|Eligible Population|Overall Study||84
10003493|NCT01730950|11125723|FG001|Eligible Population|Overall Study||86
10003494|NCT01730950|11125722|FG000|Adverse Event Population|Overall Study||76
10003495|NCT01730950|11125723|FG001|Adverse Event Population|Overall Study||83
10003496|NCT01730950|11125722|FG000|Response Population|Overall Study||78
10003497|NCT01730950|11125723|FG001|Response Population|Overall Study||77
10003498|NCT01730950|11125722|FG000|6-month Progression-free Analysis|Overall Study||79
10003499|NCT01730950|11125723|FG001|6-month Progression-free Analysis|Overall Study||81
10003500|NCT01730950|11125722|FG000|Delayed Toxicity Population|Overall Study||0
10003501|NCT01730950|11125723|FG001|Delayed Toxicity Population|Overall Study||83
10003502|NCT01730950|11125722|FG000|COMPLETED|Overall Study||84
10003503|NCT01730950|11125723|FG001|COMPLETED|Overall Study||86
10003504|NCT01730950|11125722|FG000|NOT COMPLETED|Overall Study||6
10003505|NCT01730950|11125723|FG001|NOT COMPLETED|Overall Study||6
10003506|NCT01731002|11125733|FG000|STARTED|Overall Study||75
10003507|NCT01731002|11125734|FG001|STARTED|Overall Study||72
10003508|NCT01731002|11125735|FG002|STARTED|Overall Study||77
10003509|NCT01731002|11125733|FG000|COMPLETED|Overall Study||71
10003510|NCT01731002|11125734|FG001|COMPLETED|Overall Study||68
10003511|NCT01731002|11125735|FG002|COMPLETED|Overall Study||74
10003512|NCT01731002|11125733|FG000|NOT COMPLETED|Overall Study||4
10003513|NCT01731002|11125734|FG001|NOT COMPLETED|Overall Study||4
10003514|NCT01731002|11125735|FG002|NOT COMPLETED|Overall Study||3
10003515|NCT01731041|11125745|FG000|STARTED|Overall Study||30
10003516|NCT01731041|11125746|FG001|STARTED|Overall Study||30
10003517|NCT01731041|11125745|FG000|COMPLETED|Overall Study||30
10003518|NCT01731041|11125746|FG001|COMPLETED|Overall Study||30
10003519|NCT01731041|11125745|FG000|NOT COMPLETED|Overall Study||0
10003520|NCT01731041|11125746|FG001|NOT COMPLETED|Overall Study||0
10003521|NCT01731119|11125752|FG000|STARTED|Overall Study||9
10003522|NCT01731119|11125752|FG000|COMPLETED|Overall Study||7
10003523|NCT01731119|11125752|FG000|NOT COMPLETED|Overall Study||2
10003524|NCT01731171|11125758|FG000|STARTED|Overall Study||33
10003525|NCT01731171|11125759|FG001|STARTED|Overall Study||33
10003526|NCT01731171|11125758|FG000|COMPLETED|Overall Study||26
10003527|NCT01731171|11125759|FG001|COMPLETED|Overall Study||26
10003528|NCT01731171|11125758|FG000|NOT COMPLETED|Overall Study||7
10003529|NCT01731171|11125759|FG001|NOT COMPLETED|Overall Study||7
10003530|NCT01731470|11125765|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16
10003531|NCT01731470|11125765|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14
10003532|NCT01731470|11125765|FG000|NOT COMPLETED|Overall Study||2
10003533|NCT01731600|11125771|FG000|STARTED|Overall Study||34
10003534|NCT01731600|11125772|FG001|STARTED|Overall Study||34
10003535|NCT01731600|11125771|FG000|COMPLETED|Overall Study||28
10003536|NCT01731600|11125772|FG001|COMPLETED|Overall Study||34
10003537|NCT01731600|11125771|FG000|NOT COMPLETED|Overall Study||6
10003538|NCT01731600|11125772|FG001|NOT COMPLETED|Overall Study||0
10003539|NCT01731678|11125782|FG000|STARTED|Overall Study||39
10003540|NCT01731678|11125782|FG000|COMPLETED|Overall Study||32
10003541|NCT01731678|11125782|FG000|NOT COMPLETED|Overall Study||7
10003542|NCT01731691|11125789|FG000|STARTED|Overall Study||3
10003543|NCT01731691|11125790|FG001|STARTED|Overall Study||5
10003544|NCT01731691|11125791|FG002|STARTED|Overall Study||4
10003545|NCT01731691|11125789|FG000|COMPLETED|Overall Study||3
10003546|NCT01731691|11125790|FG001|COMPLETED|Overall Study||5
10003547|NCT01731691|11125791|FG002|COMPLETED|Overall Study||4
10003548|NCT01731691|11125789|FG000|NOT COMPLETED|Overall Study||0
10003549|NCT01731691|11125790|FG001|NOT COMPLETED|Overall Study||0
10003550|NCT01731691|11125791|FG002|NOT COMPLETED|Overall Study||0
10003551|NCT01731886|11125804|FG000|STARTED|Overall Study||31
10003552|NCT01731886|11125805|FG001|STARTED|Overall Study||29
10003553|NCT01731886|11125804|FG000|COMPLETED|Overall Study||29
10003554|NCT01731886|11125805|FG001|COMPLETED|Overall Study||28
10003555|NCT01731886|11125804|FG000|NOT COMPLETED|Overall Study||2
10003556|NCT01731886|11125805|FG001|NOT COMPLETED|Overall Study||1
10003557|NCT01731912|11125812|FG000|STARTED|Overall Study||16
10003558|NCT01731912|11125812|FG000|COMPLETED|Overall Study||14
10003559|NCT01731912|11125812|FG000|NOT COMPLETED|Overall Study||2
10003560|NCT01731938|11125820|FG000|STARTED|Preliminary Part I||51
10003561|NCT01731938|11125821|FG001|STARTED|Preliminary Part I||52
10003562|NCT01731938|11125820|FG000|COMPLETED|Preliminary Part I||48
10003563|NCT01731938|11125821|FG001|COMPLETED|Preliminary Part I||44
10003564|NCT01731938|11125820|FG000|NOT COMPLETED|Preliminary Part I||3
10202292|NCT03443414|11329416|FG000|NOT COMPLETED|Overall Study||11
10202293|NCT03443414|11329417|FG001|NOT COMPLETED|Overall Study||3
10003565|NCT01731938|11125821|FG001|NOT COMPLETED|Preliminary Part I||8
10003566|NCT01731938|11125820|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
10003567|NCT01731938|11125821|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
10003568|NCT01731938|11125820|FG000|COMPLETED|Primary Part II||103
10003569|NCT01731938|11125821|FG001|COMPLETED|Primary Part II||95
10003570|NCT01731938|11125820|FG000|NOT COMPLETED|Primary Part II||13
10003571|NCT01731938|11125821|FG001|NOT COMPLETED|Primary Part II||13
10003572|NCT01731951|11125834|FG000|STARTED|Overall Study||19
10003573|NCT01731951|11125835|FG001|STARTED|Overall Study||16
10003574|NCT01731951|11125836|FG002|STARTED|Overall Study||9
10003575|NCT01731951|11125837|FG003|STARTED|Overall Study||9
10003576|NCT01731951|11125838|FG004|STARTED|Overall Study||18
10003577|NCT01731951|11125839|FG005|STARTED|Overall Study||9
10003578|NCT01731951|11125834|FG000|COMPLETED|Overall Study||2
10003579|NCT01731951|11125835|FG001|COMPLETED|Overall Study||1
10003580|NCT01731951|11125836|FG002|COMPLETED|Overall Study||0
10003581|NCT01731951|11125837|FG003|COMPLETED|Overall Study||0
10003582|NCT01731951|11125838|FG004|COMPLETED|Overall Study||6
10003583|NCT01731951|11125839|FG005|COMPLETED|Overall Study||0
10003584|NCT01731951|11125834|FG000|NOT COMPLETED|Overall Study||17
10003585|NCT01731951|11125835|FG001|NOT COMPLETED|Overall Study||15
10003586|NCT01731951|11125836|FG002|NOT COMPLETED|Overall Study||9
10003587|NCT01731951|11125837|FG003|NOT COMPLETED|Overall Study||9
10003588|NCT01731951|11125838|FG004|NOT COMPLETED|Overall Study||12
10003589|NCT01731951|11125839|FG005|NOT COMPLETED|Overall Study||9
10003590|NCT01731990|11125859|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
10003591|NCT01731990|11125860|FG001|STARTED|Overall Study||20
10003592|NCT01731990|11125859|FG000|COMPLETED|Overall Study||14
10003593|NCT01731990|11125860|FG001|COMPLETED|Overall Study||12
10003594|NCT01731990|11125859|FG000|NOT COMPLETED|Overall Study||4
10003595|NCT01731990|11125860|FG001|NOT COMPLETED|Overall Study||8
10003596|NCT01732107|11125866|FG000|STARTED|Overall Study||13
10003597|NCT01732107|11125866|FG000|COMPLETED|Overall Study||0
10003598|NCT01732107|11125866|FG000|NOT COMPLETED|Overall Study||13
10003599|NCT01732263|11125872|FG000|STARTED|Overall Study||23
10003600|NCT01732263|11125873|FG001|STARTED|Overall Study||20
10003601|NCT01732263|11125872|FG000|COMPLETED|Overall Study||23
10003602|NCT01732263|11125873|FG001|COMPLETED|Overall Study||20
10003603|NCT01732263|11125872|FG000|NOT COMPLETED|Overall Study||0
10003604|NCT01732263|11125873|FG001|NOT COMPLETED|Overall Study||0
10003605|NCT01732406|11125886|FG000|STARTED|Overall Study||31
10003606|NCT01732406|11125887|FG001|STARTED|Overall Study||60
10003607|NCT01732406|11125888|FG002|STARTED|Overall Study||35
10003608|NCT01732406|11125886|FG000|COMPLETED|Overall Study||31
10003609|NCT01732406|11125887|FG001|COMPLETED|Overall Study||60
10003610|NCT01732406|11125888|FG002|COMPLETED|Overall Study||35
10003611|NCT01732406|11125886|FG000|NOT COMPLETED|Overall Study||0
10003612|NCT01732406|11125887|FG001|NOT COMPLETED|Overall Study||0
10003613|NCT01732406|11125888|FG002|NOT COMPLETED|Overall Study||0
10003614|NCT01732419|11125902|FG000|STARTED|Overall Study||45
10003615|NCT01732419|11125903|FG001|STARTED|Overall Study||45
10003616|NCT01732419|11125902|FG000|COMPLETED|Overall Study||37
10003617|NCT01732419|11125903|FG001|COMPLETED|Overall Study||41
10003618|NCT01732419|11125902|FG000|NOT COMPLETED|Overall Study||8
10003619|NCT01732419|11125903|FG001|NOT COMPLETED|Overall Study||4
10003620|NCT01732445|11125909|FG000|STARTED|Overall Study||14
10003621|NCT01732445|11125909|FG000|COMPLETED|Overall Study||14
10003622|NCT01732445|11125909|FG000|NOT COMPLETED|Overall Study||0
10003623|NCT01732458|11125917|FG000|STARTED|Overall Study||60
10003624|NCT01732458|11125918|FG001|STARTED|Overall Study||58
10003625|NCT01732458|11125919|FG002|STARTED|Overall Study||58
10003626|NCT01732458|11125920|FG003|STARTED|Overall Study||52
10003627|NCT01732458|11125917|FG000|Treated|Overall Study||57
10003628|NCT01732458|11125918|FG001|Treated|Overall Study||55
10003629|NCT01732458|11125919|FG002|Treated|Overall Study||56
10003630|NCT01732458|11125920|FG003|Treated|Overall Study||52
10003631|NCT01732458|11125917|FG000|COMPLETED|Overall Study||57
10003632|NCT01732458|11125918|FG001|COMPLETED|Overall Study||53
10003633|NCT01732458|11125919|FG002|COMPLETED|Overall Study||55
10003634|NCT01732458|11125920|FG003|COMPLETED|Overall Study||50
10003635|NCT01732458|11125917|FG000|NOT COMPLETED|Overall Study||3
10003636|NCT01732458|11125918|FG001|NOT COMPLETED|Overall Study||5
10003637|NCT01732458|11125919|FG002|NOT COMPLETED|Overall Study||3
10003638|NCT01732458|11125920|FG003|NOT COMPLETED|Overall Study||2
10003639|NCT01732471|11125942|FG000|STARTED|Overall Study||90
10003640|NCT01732471|11125942|FG000|COMPLETED|Overall Study||89
10003641|NCT01732471|11125942|FG000|NOT COMPLETED|Overall Study||1
10003642|NCT01732484|11125946|FG000|STARTED|Overall Study||100
10003643|NCT01732484|11125946|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
10003644|NCT01732484|11125946|FG000|Allocation|Overall Study||100
10202294|NCT03443414|11329418|FG002|NOT COMPLETED|Overall Study||6
10003645|NCT01732484|11125946|FG000|COMPLETED|Overall Study||74
10003646|NCT01732484|11125946|FG000|NOT COMPLETED|Overall Study||26
10003647|NCT01732510|11125959|FG000|STARTED|Overall Study||9
10003648|NCT01732510|11125960|FG001|STARTED|Overall Study||9
10003649|NCT01732510|11125961|FG002|STARTED|Overall Study||8
10003650|NCT01732510|11125962|FG003|STARTED|Overall Study||10
10003651|NCT01732510|11125963|FG004|STARTED|Overall Study||8
10003652|NCT01732510|11125964|FG005|STARTED|Overall Study||13
10003653|NCT01732510|11125965|FG006|STARTED|Overall Study||8
10003654|NCT01732510|11125959|FG000|COMPLETED|Overall Study||8
10003655|NCT01732510|11125960|FG001|COMPLETED|Overall Study||4
10003656|NCT01732510|11125961|FG002|COMPLETED|Overall Study||4
10003657|NCT01732510|11125962|FG003|COMPLETED|Overall Study||5
10003658|NCT01732510|11125963|FG004|COMPLETED|Overall Study||3
10003659|NCT01732510|11125964|FG005|COMPLETED|Overall Study||0
10003660|NCT01732510|11125965|FG006|COMPLETED|Overall Study||0
10003661|NCT01732510|11125959|FG000|NOT COMPLETED|Overall Study||1
10003662|NCT01732510|11125960|FG001|NOT COMPLETED|Overall Study||5
10003663|NCT01732510|11125961|FG002|NOT COMPLETED|Overall Study||4
10003664|NCT01732510|11125962|FG003|NOT COMPLETED|Overall Study||5
10003665|NCT01732510|11125963|FG004|NOT COMPLETED|Overall Study||5
10003666|NCT01732510|11125964|FG005|NOT COMPLETED|Overall Study||13
10003667|NCT01732510|11125965|FG006|NOT COMPLETED|Overall Study||8
10003668|NCT01732536|11125986|FG000|STARTED|Overall Study||53
10003669|NCT01732536|11125987|FG001|STARTED|Overall Study||47
10003670|NCT01732536|11125986|FG000|COMPLETED|Overall Study||52
10003671|NCT01732536|11125987|FG001|COMPLETED|Overall Study||46
10003672|NCT01732536|11125986|FG000|NOT COMPLETED|Overall Study||1
10003673|NCT01732536|11125987|FG001|NOT COMPLETED|Overall Study||1
10003674|NCT01732549|11125998|FG000|STARTED|Overall Study||71
10003675|NCT01732549|11125999|FG001|STARTED|Overall Study||73
10003676|NCT01732549|11125998|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
10003677|NCT01732549|11125999|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
10003678|NCT01732549|11125998|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
10003679|NCT01732549|11125999|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
10003680|NCT01732549|11125998|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0
10003681|NCT01732549|11125999|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0
10003682|NCT01732549|11125998|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71
10003683|NCT01732549|11125999|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73
10003684|NCT01732549|11125998|FG000|COMPLETED|Overall Study||0
10103741|NCT02427607|11233407|FG000|STARTED|Overall Study||7
10103742|NCT02427607|11233407|FG000|COMPLETED|Overall Study||6
10103743|NCT02427607|11233407|FG000|NOT COMPLETED|Overall Study||1
10103744|NCT02427646|11233413|FG000|STARTED|Overall Study||24
10103745|NCT02427646|11233414|FG001|STARTED|Overall Study||28
10103746|NCT02427646|11233413|FG000|COMPLETED|Overall Study||16
10003685|NCT01732549|11125999|FG001|COMPLETED|Overall Study||0
10003686|NCT01732549|11125998|FG000|NOT COMPLETED|Overall Study||71
10003687|NCT01732549|11125999|FG001|NOT COMPLETED|Overall Study||73
10003688|NCT01732588|11126009|FG000|STARTED|First Intervention (7 Days)||4
10003689|NCT01732588|11126010|FG001|STARTED|First Intervention (7 Days)||3
10003690|NCT01732588|11126011|FG002|STARTED|First Intervention (7 Days)||4
10003691|NCT01732588|11126009|FG000|COMPLETED|First Intervention (7 Days)||4
10003692|NCT01732588|11126010|FG001|COMPLETED|First Intervention (7 Days)||2
10003693|NCT01732588|11126011|FG002|COMPLETED|First Intervention (7 Days)||4
10003694|NCT01732588|11126009|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10003695|NCT01732588|11126010|FG001|NOT COMPLETED|First Intervention (7 Days)||1
10003696|NCT01732588|11126011|FG002|NOT COMPLETED|First Intervention (7 Days)||0
10003697|NCT01732588|11126009|FG000|STARTED|Second Intervention (7 Days)||4
10003698|NCT01732588|11126010|FG001|STARTED|Second Intervention (7 Days)||2
10003699|NCT01732588|11126011|FG002|STARTED|Second Intervention (7 Days)||4
10003700|NCT01732588|11126009|FG000|COMPLETED|Second Intervention (7 Days)||4
10003701|NCT01732588|11126010|FG001|COMPLETED|Second Intervention (7 Days)||2
10003702|NCT01732588|11126011|FG002|COMPLETED|Second Intervention (7 Days)||4
10003703|NCT01732588|11126009|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10003704|NCT01732588|11126010|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10003705|NCT01732588|11126011|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
10103747|NCT02427646|11233414|FG001|COMPLETED|Overall Study||14
10103748|NCT02427646|11233413|FG000|NOT COMPLETED|Overall Study||8
10103749|NCT02427646|11233414|FG001|NOT COMPLETED|Overall Study||14
10003706|NCT01732588|11126009|FG000|STARTED|Third Intervention (7 Days)||4
10003707|NCT01732588|11126010|FG001|STARTED|Third Intervention (7 Days)||2
10003708|NCT01732588|11126011|FG002|STARTED|Third Intervention (7 Days)||4
10003709|NCT01732588|11126009|FG000|COMPLETED|Third Intervention (7 Days)||4
10003710|NCT01732588|11126010|FG001|COMPLETED|Third Intervention (7 Days)||2
10003711|NCT01732588|11126011|FG002|COMPLETED|Third Intervention (7 Days)||4
10003712|NCT01732588|11126009|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
10103750|NCT02427672|11233424|FG000|STARTED|Overall Study||40
10103751|NCT02427672|11233425|FG001|STARTED|Overall Study||44
10103752|NCT02427672|11233424|FG000|COMPLETED|Overall Study||39
10003713|NCT01732588|11126010|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
10003714|NCT01732588|11126011|FG002|NOT COMPLETED|Third Intervention (7 Days)||0
10003715|NCT01732640|11126019|FG000|STARTED|Overall Study||6
10003716|NCT01732640|11126020|FG001|STARTED|Overall Study||3
10003717|NCT01732640|11126019|FG000|COMPLETED|Overall Study||6
10003718|NCT01732640|11126020|FG001|COMPLETED|Overall Study||1
10003719|NCT01732640|11126019|FG000|NOT COMPLETED|Overall Study||0
10003720|NCT01732640|11126020|FG001|NOT COMPLETED|Overall Study||2
10003721|NCT01732692|11126032|FG000|STARTED|Overall Study||70
10003722|NCT01732692|11126033|FG001|STARTED|Overall Study||70
10003723|NCT01732692|11126032|FG000|COMPLETED|Overall Study||70
10003724|NCT01732692|11126033|FG001|COMPLETED|Overall Study||69
10003725|NCT01732692|11126032|FG000|NOT COMPLETED|Overall Study||0
10003726|NCT01732692|11126033|FG001|NOT COMPLETED|Overall Study||1
10003727|NCT01732718|11126039|FG000|STARTED|First Intervention||7
10003728|NCT01732718|11126040|FG001|STARTED|First Intervention||6
10003729|NCT01732718|11126039|FG000|COMPLETED|First Intervention||7
10003730|NCT01732718|11126040|FG001|COMPLETED|First Intervention||6
10003731|NCT01732718|11126039|FG000|NOT COMPLETED|First Intervention||0
10003732|NCT01732718|11126040|FG001|NOT COMPLETED|First Intervention||0
10003733|NCT01732718|11126039|FG000|STARTED|Washout (4 Weeks)||7
10003734|NCT01732718|11126040|FG001|STARTED|Washout (4 Weeks)||6
10003735|NCT01732718|11126039|FG000|COMPLETED|Washout (4 Weeks)||7
10003736|NCT01732718|11126040|FG001|COMPLETED|Washout (4 Weeks)||6
10003737|NCT01732718|11126039|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10003738|NCT01732718|11126040|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10003739|NCT01732718|11126039|FG000|STARTED|Second Intervention||7
10003740|NCT01732718|11126040|FG001|STARTED|Second Intervention||6
10003741|NCT01732718|11126039|FG000|COMPLETED|Second Intervention||7
10003742|NCT01732718|11126040|FG001|COMPLETED|Second Intervention||6
10003743|NCT01732718|11126039|FG000|NOT COMPLETED|Second Intervention||0
10003744|NCT01732718|11126040|FG001|NOT COMPLETED|Second Intervention||0
10003745|NCT01732757|11126055|FG000|STARTED|Overall Study||53
10003746|NCT01732757|11126056|FG001|STARTED|Overall Study||52
10003747|NCT01732757|11126057|FG002|STARTED|Overall Study||52
10003748|NCT01732757|11126055|FG000|COMPLETED|Overall Study||52
10003749|NCT01732757|11126056|FG001|COMPLETED|Overall Study||52
10003750|NCT01732757|11126057|FG002|COMPLETED|Overall Study||52
10003751|NCT01732757|11126055|FG000|NOT COMPLETED|Overall Study||1
10003752|NCT01732757|11126056|FG001|NOT COMPLETED|Overall Study||0
10003753|NCT01732757|11126057|FG002|NOT COMPLETED|Overall Study||0
10003754|NCT01732770|11126067|FG000|STARTED|Overall Study||322
10003755|NCT01732770|11126068|FG001|STARTED|Overall Study||321
10003756|NCT01732770|11126067|FG000|Received Study Treatment|Overall Study||320
10003757|NCT01732770|11126068|FG001|Received Study Treatment|Overall Study||320
10003758|NCT01732770|11126067|FG000|COMPLETED|Overall Study||312
10003759|NCT01732770|11126068|FG001|COMPLETED|Overall Study||313
10003760|NCT01732770|11126067|FG000|NOT COMPLETED|Overall Study||10
10003761|NCT01732770|11126068|FG001|NOT COMPLETED|Overall Study||8
10003762|NCT01732783|11126077|FG000|STARTED|Overall Study||164
10003763|NCT01732783|11126078|FG001|STARTED|Overall Study||37
10003764|NCT01732783|11126079|FG002|STARTED|Overall Study||12
10003765|NCT01732783|11126077|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29
10003766|NCT01732783|11126078|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5
10003767|NCT01732783|11126079|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2
10003768|NCT01732783|11126077|FG000|NOT COMPLETED|Overall Study||135
10003769|NCT01732783|11126078|FG001|NOT COMPLETED|Overall Study||32
10003770|NCT01732783|11126079|FG002|NOT COMPLETED|Overall Study||10
10003771|NCT01732796|11126090|FG000|STARTED|Overall Study||208
10003772|NCT01732796|11126091|FG001|STARTED|Overall Study||211
10003773|NCT01732796|11126092|FG002|STARTED|Overall Study||51
10003774|NCT01732796|11126090|FG000|COMPLETED|Overall Study||162
10003775|NCT01732796|11126091|FG001|COMPLETED|Overall Study||169
10003776|NCT01732796|11126092|FG002|COMPLETED|Overall Study||38
10003777|NCT01732796|11126090|FG000|NOT COMPLETED|Overall Study||46
10003778|NCT01732796|11126091|FG001|NOT COMPLETED|Overall Study||42
10003779|NCT01732796|11126092|FG002|NOT COMPLETED|Overall Study||13
10018806|NCT01825785|11141859|FG006|STARTED|Overall Study||6
10018807|NCT01825785|11141853|FG000|COMPLETED|Overall Study||12
10018808|NCT01825785|11141854|FG001|COMPLETED|Overall Study||6
10018809|NCT01825785|11141855|FG002|COMPLETED|Overall Study||6
10018810|NCT01825785|11141856|FG003|COMPLETED|Overall Study||6
10018811|NCT01825785|11141857|FG004|COMPLETED|Overall Study||4
10018812|NCT01825785|11141858|FG005|COMPLETED|Overall Study||5
10018813|NCT01825785|11141859|FG006|COMPLETED|Overall Study||6
10018814|NCT01825785|11141853|FG000|NOT COMPLETED|Overall Study||0
10018815|NCT01825785|11141854|FG001|NOT COMPLETED|Overall Study||0
10018816|NCT01825785|11141855|FG002|NOT COMPLETED|Overall Study||0
10018817|NCT01825785|11141856|FG003|NOT COMPLETED|Overall Study||0
10018818|NCT01825785|11141857|FG004|NOT COMPLETED|Overall Study||2
10018819|NCT01825785|11141858|FG005|NOT COMPLETED|Overall Study||1
10018820|NCT01825785|11141859|FG006|NOT COMPLETED|Overall Study||0
10018821|NCT01825798|11141883|FG000|STARTED|Overall Study||32
10018822|NCT01825798|11141884|FG001|STARTED|Overall Study||28
10018823|NCT01825798|11141883|FG000|COMPLETED|Overall Study||30
10018824|NCT01825798|11141884|FG001|COMPLETED|Overall Study||23
10018825|NCT01825798|11141883|FG000|NOT COMPLETED|Overall Study||2
10018826|NCT01825798|11141884|FG001|NOT COMPLETED|Overall Study||5
10018827|NCT01825837|11141894|FG000|STARTED|PART I||0
10018828|NCT01825837|11141895|FG001|STARTED|PART I||0
10018829|NCT01825837|11141896|FG002|STARTED|PART I||0
10003780|NCT04537234|11126104|FG000|STARTED|Overall Study||82
10003781|NCT04537234|11126105|FG001|STARTED|Overall Study||83
10003782|NCT04537234|11126104|FG000|COMPLETED|Overall Study||80
10003783|NCT04537234|11126105|FG001|COMPLETED|Overall Study||83
10003784|NCT04537234|11126104|FG000|NOT COMPLETED|Overall Study||2
10003785|NCT04537234|11126105|FG001|NOT COMPLETED|Overall Study||0
10003786|NCT04371471|11126111|FG000|STARTED|Overall Study||91
10003787|NCT04371471|11126111|FG000|COMPLETED|Overall Study||81
10003788|NCT04371471|11126111|FG000|NOT COMPLETED|Overall Study||10
10003789|NCT04172701|11126119|FG000|STARTED|Overall Study||6352
10003790|NCT04172701|11126120|FG001|STARTED|Overall Study||2932
10003791|NCT04172701|11126119|FG000|Propensity Score (PS) Matched Population|Overall Study||2444
10003792|NCT04172701|11126120|FG001|Propensity Score (PS) Matched Population|Overall Study||2444
10003793|NCT04172701|11126119|FG000|COMPLETED|Overall Study||6352
10003794|NCT04172701|11126120|FG001|COMPLETED|Overall Study||2932
10003795|NCT04172701|11126119|FG000|NOT COMPLETED|Overall Study||0
10003796|NCT04172701|11126120|FG001|NOT COMPLETED|Overall Study||0
10003797|NCT03813199|11126129|FG000|STARTED|Overall Study||21
10003798|NCT03813199|11126130|FG001|STARTED|Overall Study||19
10003799|NCT03813199|11126131|FG002|STARTED|Overall Study||20
10003800|NCT03813199|11126129|FG000|COMPLETED|Overall Study||18
10103753|NCT02427672|11233425|FG001|COMPLETED|Overall Study||42
10103754|NCT02427672|11233424|FG000|NOT COMPLETED|Overall Study||1
10103755|NCT02427672|11233425|FG001|NOT COMPLETED|Overall Study||2
10103756|NCT02427737|11233433|FG000|STARTED|OSU Baseline Q4FY15||4158
10103757|NCT02427737|11233434|FG001|STARTED|OSU Baseline Q4FY15||3446
10103758|NCT02427737|11233433|FG000|COMPLETED|OSU Baseline Q4FY15||3940
10103759|NCT02427737|11233434|FG001|COMPLETED|OSU Baseline Q4FY15||3230
10103760|NCT02427737|11233433|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218
10103761|NCT02427737|11233434|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216
10103762|NCT02427737|11233433|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
10103763|NCT02427737|11233434|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
10103764|NCT02427737|11233433|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
10103765|NCT02427737|11233434|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
10103766|NCT02427737|11233433|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
10103767|NCT02427737|11233434|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
10103768|NCT02427737|11233433|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
10003801|NCT03813199|11126130|FG001|COMPLETED|Overall Study||6
10003802|NCT03813199|11126131|FG002|COMPLETED|Overall Study||19
10003803|NCT03813199|11126129|FG000|NOT COMPLETED|Overall Study||3
10003804|NCT03813199|11126130|FG001|NOT COMPLETED|Overall Study||13
10003805|NCT03813199|11126131|FG002|NOT COMPLETED|Overall Study||1
10003806|NCT03478956|11126141|FG000|STARTED|Overall Study||12
10003807|NCT03478956|11126142|FG001|STARTED|Overall Study||12
10003808|NCT03478956|11126141|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10003809|NCT03478956|11126142|FG001|Received at Least One Dose of Study Drug|Overall Study||12
10003810|NCT03478956|11126141|FG000|Completed Randomized Treatment Phase|Overall Study||11
10003811|NCT03478956|11126142|FG001|Completed Randomized Treatment Phase|Overall Study||10
10003812|NCT03478956|11126141|FG000|Started OLE Treatment Phase|Overall Study||11
10003813|NCT03478956|11126142|FG001|Started OLE Treatment Phase|Overall Study||10
10003814|NCT03478956|11126141|FG000|Completed OLE Treatment Phase|Overall Study||0
10003815|NCT03478956|11126142|FG001|Completed OLE Treatment Phase|Overall Study||0
10003816|NCT03478956|11126141|FG000|Started PML Safety Monitoring Phase|Overall Study||1
10003817|NCT03478956|11126142|FG001|Started PML Safety Monitoring Phase|Overall Study||2
10003818|NCT03478956|11126141|FG000|COMPLETED|Overall Study||0
10003819|NCT03478956|11126142|FG001|COMPLETED|Overall Study||0
10003820|NCT03478956|11126141|FG000|NOT COMPLETED|Overall Study||12
10003821|NCT03478956|11126142|FG001|NOT COMPLETED|Overall Study||12
10003822|NCT03348930|11126148|FG000|STARTED|First Intervention (2 Weeks)||10
10003823|NCT03348930|11126149|FG001|STARTED|First Intervention (2 Weeks)||10
10003824|NCT03348930|11126148|FG000|COMPLETED|First Intervention (2 Weeks)||10
10003825|NCT03348930|11126149|FG001|COMPLETED|First Intervention (2 Weeks)||10
10003826|NCT03348930|11126148|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10003827|NCT03348930|11126149|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10003828|NCT03348930|11126148|FG000|STARTED|Washout (1 Week)||10
10003829|NCT03348930|11126149|FG001|STARTED|Washout (1 Week)||10
10003830|NCT03348930|11126148|FG000|COMPLETED|Washout (1 Week)||9
10003831|NCT03348930|11126149|FG001|COMPLETED|Washout (1 Week)||9
10003832|NCT03348930|11126148|FG000|NOT COMPLETED|Washout (1 Week)||1
10003833|NCT03348930|11126149|FG001|NOT COMPLETED|Washout (1 Week)||1
10003834|NCT03348930|11126148|FG000|STARTED|Second Intervention (2 Weeks)||9
10003835|NCT03348930|11126149|FG001|STARTED|Second Intervention (2 Weeks)||9
10003836|NCT03348930|11126148|FG000|COMPLETED|Second Intervention (2 Weeks)||9
10003837|NCT03348930|11126149|FG001|COMPLETED|Second Intervention (2 Weeks)||9
10003838|NCT03348930|11126148|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10003839|NCT03348930|11126149|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10003840|NCT03282240|11126158|FG000|STARTED|Overall Study||1777
10003841|NCT03282240|11126159|FG001|STARTED|Overall Study||443
10003842|NCT03282240|11126160|FG002|STARTED|Overall Study||450
10003843|NCT03282240|11126158|FG000|COMPLETED|Overall Study||1767
10003844|NCT03282240|11126159|FG001|COMPLETED|Overall Study||440
10003845|NCT03282240|11126160|FG002|COMPLETED|Overall Study||447
10003846|NCT03282240|11126158|FG000|NOT COMPLETED|Overall Study||10
10103769|NCT02427737|11233434|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
10103770|NCT02427737|11233433|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
10003847|NCT03282240|11126159|FG001|NOT COMPLETED|Overall Study||3
10003848|NCT03282240|11126160|FG002|NOT COMPLETED|Overall Study||3
10103771|NCT02427737|11233434|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
10103772|NCT02427737|11233433|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
10003849|NCT03260868|11126173|FG000|STARTED|Overall Study||8
10003850|NCT03260868|11126174|FG001|STARTED|Overall Study||7
10003851|NCT03260868|11126173|FG000|Safety Population|Overall Study||8
10003852|NCT03260868|11126174|FG001|Safety Population|Overall Study||6
10003853|NCT03260868|11126173|FG000|COMPLETED|Overall Study||5
10003854|NCT03260868|11126174|FG001|COMPLETED|Overall Study||4
10003855|NCT03260868|11126173|FG000|NOT COMPLETED|Overall Study||3
10003856|NCT03260868|11126174|FG001|NOT COMPLETED|Overall Study||3
10003857|NCT03245580|11126182|FG000|STARTED|Overall Study||75
10003858|NCT03245580|11126183|FG001|STARTED|Overall Study||78
10003859|NCT03245580|11126182|FG000|COMPLETED|Overall Study||75
10003860|NCT03245580|11126183|FG001|COMPLETED|Overall Study||78
10003861|NCT03245580|11126182|FG000|NOT COMPLETED|Overall Study||0
10003862|NCT03245580|11126183|FG001|NOT COMPLETED|Overall Study||0
10003863|NCT03157037|11126189|FG000|STARTED|Overall Study||15
10003864|NCT03157037|11126189|FG000|COMPLETED|Overall Study||14
10003865|NCT03157037|11126189|FG000|NOT COMPLETED|Overall Study||1
10003866|NCT03143218|11126203|FG000|STARTED|Overall Study||1965
10003867|NCT03143218|11126204|FG001|STARTED|Overall Study||1988
10003868|NCT03143218|11126205|FG002|STARTED|Overall Study||1967
10003869|NCT03143218|11126203|FG000|COMPLETED|Overall Study||1716
10003870|NCT03143218|11126204|FG001|COMPLETED|Overall Study||1734
10003871|NCT03143218|11126205|FG002|COMPLETED|Overall Study||1740
10003872|NCT03143218|11126203|FG000|NOT COMPLETED|Overall Study||249
10003873|NCT03143218|11126204|FG001|NOT COMPLETED|Overall Study||254
10003874|NCT03143218|11126205|FG002|NOT COMPLETED|Overall Study||227
10003875|NCT03128931|11126213|FG000|STARTED|Overall Study||45
10003876|NCT03128931|11126213|FG000|COMPLETED|Overall Study||41
10003877|NCT03128931|11126213|FG000|NOT COMPLETED|Overall Study||4
10018830|NCT01825837|11141897|FG003|STARTED|PART I||104
10018831|NCT01825837|11141894|FG000|Enrolled|PART I||0
10018832|NCT01825837|11141895|FG001|Enrolled|PART I||0
10018833|NCT01825837|11141896|FG002|Enrolled|PART I||0
10018834|NCT01825837|11141897|FG003|Enrolled|PART I||104
10018835|NCT01825837|11141894|FG000|Safety Population (Open-Label)|PART I||0
10018836|NCT01825837|11141895|FG001|Safety Population (Open-Label)|PART I||0
10018837|NCT01825837|11141896|FG002|Safety Population (Open-Label)|PART I||0
10018838|NCT01825837|11141897|FG003|Safety Population (Open-Label)|PART I||104
10018839|NCT01825837|11141894|FG000|COMPLETED|PART I||0
10018840|NCT01825837|11141895|FG001|COMPLETED|PART I||0
10018841|NCT01825837|11141896|FG002|COMPLETED|PART I||0
10018842|NCT01825837|11141897|FG003|COMPLETED|PART I||87
10018843|NCT01825837|11141894|FG000|NOT COMPLETED|PART I||0
10018844|NCT01825837|11141895|FG001|NOT COMPLETED|PART I||0
10018845|NCT01825837|11141896|FG002|NOT COMPLETED|PART I||0
10018846|NCT01825837|11141897|FG003|NOT COMPLETED|PART I||17
10018847|NCT01825837|11141894|FG000|STARTED|PART II||35
10018848|NCT01825837|11141895|FG001|STARTED|PART II||26
10018849|NCT01825837|11141896|FG002|STARTED|PART II||26
10018850|NCT01825837|11141897|FG003|STARTED|PART II||0
10018851|NCT01825837|11141894|FG000|Randomized Patients|PART II||35
10018852|NCT01825837|11141895|FG001|Randomized Patients|PART II||26
10018853|NCT01825837|11141896|FG002|Randomized Patients|PART II||26
10018854|NCT01825837|11141897|FG003|Randomized Patients|PART II||0
10018855|NCT01825837|11141894|FG000|Safety Population (Double-Blind)|PART II||35
10018856|NCT01825837|11141895|FG001|Safety Population (Double-Blind)|PART II||26
10018857|NCT01825837|11141896|FG002|Safety Population (Double-Blind)|PART II||26
10018858|NCT01825837|11141897|FG003|Safety Population (Double-Blind)|PART II||0
10018859|NCT01825837|11141894|FG000|Intent-to-Treat Population|PART II||34
10018860|NCT01825837|11141895|FG001|Intent-to-Treat Population|PART II||25
10018861|NCT01825837|11141896|FG002|Intent-to-Treat Population|PART II||26
10018862|NCT01825837|11141897|FG003|Intent-to-Treat Population|PART II||0
10018863|NCT01825837|11141894|FG000|Per-Protocol Population|PART II||32
10018864|NCT01825837|11141895|FG001|Per-Protocol Population|PART II||23
10018865|NCT01825837|11141896|FG002|Per-Protocol Population|PART II||24
10018866|NCT01825837|11141897|FG003|Per-Protocol Population|PART II||0
10018867|NCT01825837|11141894|FG000|COMPLETED|PART II||16
10018868|NCT01825837|11141895|FG001|COMPLETED|PART II||12
9758785|NCT00370682|10862389|FG002|NOT COMPLETED|Overall Study||1
9758786|NCT00370838|10862403|FG000|STARTED|Period 1 (Days 8-50)||7
10103773|NCT02427737|11233434|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
10103774|NCT02427737|11233433|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
10103775|NCT02427737|11233434|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
10103776|NCT02427737|11233433|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
10103777|NCT02427737|11233434|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
9758787|NCT00370838|10862404|FG001|STARTED|Period 1 (Days 8-50)||3
9758788|NCT00370838|10862403|FG000|COMPLETED|Period 1 (Days 8-50)||7
9758789|NCT00370838|10862404|FG001|COMPLETED|Period 1 (Days 8-50)||3
9758790|NCT00370838|10862403|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0
9758791|NCT00370838|10862404|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0
9758792|NCT00370838|10862403|FG000|STARTED|Washout (Days 51-64)||7
9758793|NCT00370838|10862404|FG001|STARTED|Washout (Days 51-64)||3
9758794|NCT00370838|10862403|FG000|COMPLETED|Washout (Days 51-64)||7
9758795|NCT00370838|10862404|FG001|COMPLETED|Washout (Days 51-64)||3
9758796|NCT00370838|10862403|FG000|NOT COMPLETED|Washout (Days 51-64)||0
9758797|NCT00370838|10862404|FG001|NOT COMPLETED|Washout (Days 51-64)||0
9758798|NCT00370838|10862403|FG000|STARTED|Period 2 (Days 65-107)||7
9758799|NCT00370838|10862404|FG001|STARTED|Period 2 (Days 65-107)||3
10003878|NCT02498392|11126219|FG000|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||160
10003879|NCT02498392|11126220|FG001|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||0
10003880|NCT02498392|11126219|FG000|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||153
10003881|NCT02498392|11126220|FG001|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||0
10003882|NCT02498392|11126219|FG000|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||153
10003883|NCT02498392|11126220|FG001|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
10003884|NCT02498392|11126219|FG000|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||7
10003885|NCT02498392|11126220|FG001|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
10003886|NCT02498392|11126219|FG000|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||76
10003887|NCT02498392|11126220|FG001|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||77
10003888|NCT02498392|11126219|FG000|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||70
10003889|NCT02498392|11126220|FG001|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||67
10003890|NCT02498392|11126219|FG000|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||6
10003891|NCT02498392|11126220|FG001|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||10
10003892|NCT02478775|11126231|FG000|STARTED|Overall Study||6
10003893|NCT02478775|11126232|FG001|STARTED|Overall Study||27
10003894|NCT02478775|11126233|FG002|STARTED|Overall Study||27
10003895|NCT02478775|11126231|FG000|COMPLETED|Overall Study||6
10003896|NCT02478775|11126232|FG001|COMPLETED|Overall Study||27
10003897|NCT02478775|11126233|FG002|COMPLETED|Overall Study||27
10003898|NCT02478775|11126231|FG000|NOT COMPLETED|Overall Study||0
10003899|NCT02478775|11126232|FG001|NOT COMPLETED|Overall Study||0
10003900|NCT02478775|11126233|FG002|NOT COMPLETED|Overall Study||0
10003901|NCT01899729|11126245|FG000|STARTED|Overall Study||9
10003902|NCT01899729|11126246|FG001|STARTED|Overall Study||9
10003903|NCT01899729|11126247|FG002|STARTED|Overall Study||8
10003904|NCT01899729|11126248|FG003|STARTED|Overall Study||9
10003905|NCT01899729|11126249|FG004|STARTED|Overall Study||11
10003906|NCT01899729|11126245|FG000|COMPLETED|Overall Study||7
10003907|NCT01899729|11126246|FG001|COMPLETED|Overall Study||7
10003908|NCT01899729|11126247|FG002|COMPLETED|Overall Study||6
10003909|NCT01899729|11126248|FG003|COMPLETED|Overall Study||9
10003910|NCT01899729|11126249|FG004|COMPLETED|Overall Study||9
10003911|NCT01899729|11126245|FG000|NOT COMPLETED|Overall Study||2
10003912|NCT01899729|11126246|FG001|NOT COMPLETED|Overall Study||2
10003913|NCT01899729|11126247|FG002|NOT COMPLETED|Overall Study||2
10003914|NCT01899729|11126248|FG003|NOT COMPLETED|Overall Study||0
10003915|NCT01899729|11126249|FG004|NOT COMPLETED|Overall Study||2
10003916|NCT01784848|11126263|FG000|STARTED|Overall Study||50
10003917|NCT01784848|11126264|FG001|STARTED|Overall Study||50
10003918|NCT01784848|11126263|FG000|COMPLETED|Overall Study||49
10003919|NCT01784848|11126264|FG001|COMPLETED|Overall Study||47
10003920|NCT01784848|11126263|FG000|NOT COMPLETED|Overall Study||1
10003921|NCT01784848|11126264|FG001|NOT COMPLETED|Overall Study||3
10003922|NCT01648205|11126270|FG000|STARTED|Placebo||25
10003923|NCT01648205|11126270|FG000|COMPLETED|Placebo||21
10003924|NCT01648205|11126270|FG000|NOT COMPLETED|Placebo||4
10003925|NCT01648205|11126270|FG000|STARTED|Ranolazine||23
10003926|NCT01648205|11126270|FG000|COMPLETED|Ranolazine||18
10003927|NCT01648205|11126270|FG000|NOT COMPLETED|Ranolazine||5
10003928|NCT01312922|11126281|FG000|STARTED|Overall Study||185
10003929|NCT01312922|11126282|FG001|STARTED|Overall Study||185
10003930|NCT01312922|11126283|FG002|STARTED|Overall Study||185
10003931|NCT01312922|11126281|FG000|COMPLETED|Overall Study||117
10003932|NCT01312922|11126282|FG001|COMPLETED|Overall Study||131
10003933|NCT01312922|11126283|FG002|COMPLETED|Overall Study||135
10003934|NCT01312922|11126281|FG000|NOT COMPLETED|Overall Study||68
10003935|NCT01312922|11126282|FG001|NOT COMPLETED|Overall Study||54
10003936|NCT01312922|11126283|FG002|NOT COMPLETED|Overall Study||50
10103778|NCT02427737|11233433|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
10103779|NCT02427737|11233434|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
10103780|NCT02427737|11233433|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
10103781|NCT02427737|11233434|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
10103782|NCT02427737|11233433|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879
10103783|NCT02427737|11233434|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051
10103784|NCT02427737|11233433|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
10103785|NCT02427737|11233434|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
10103786|NCT02427750|11233450|FG000|STARTED|Overall Study||63
10103787|NCT02427750|11233451|FG001|STARTED|Overall Study||63
10103788|NCT02427750|11233450|FG000|COMPLETED|Overall Study||63
10103789|NCT02427750|11233451|FG001|COMPLETED|Overall Study||63
10003945|NCT00915681|11126300|FG000|STARTED|Overall Study||148
10003946|NCT00915681|11126300|FG000|COMPLETED|Overall Study||102
10003947|NCT00915681|11126300|FG000|NOT COMPLETED|Overall Study||46
10003948|NCT00145158|11126306|FG000|STARTED|Overall Study||16
10003949|NCT00145158|11126307|FG001|STARTED|Overall Study||7
10003950|NCT00145158|11126306|FG000|COMPLETED|Overall Study||14
10003951|NCT00145158|11126307|FG001|COMPLETED|Overall Study||4
10003952|NCT00145158|11126306|FG000|NOT COMPLETED|Overall Study||2
10003953|NCT00145158|11126307|FG001|NOT COMPLETED|Overall Study||3
10003954|NCT01732809|11126316|FG000|STARTED|Overall Study||9
10003955|NCT01732809|11126317|FG001|STARTED|Overall Study||10
10003956|NCT01732809|11126316|FG000|COMPLETED|Overall Study||9
10003957|NCT01732809|11126317|FG001|COMPLETED|Overall Study||9
10003958|NCT01732809|11126316|FG000|NOT COMPLETED|Overall Study||0
10003959|NCT01732809|11126317|FG001|NOT COMPLETED|Overall Study||1
10003960|NCT01732822|11126325|FG000|STARTED|Overall Study||6930
10003961|NCT01732822|11126326|FG001|STARTED|Overall Study||6955
10003962|NCT01732822|11126325|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
10003963|NCT01732822|11126326|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
10003964|NCT01732822|11126325|FG000|NOT COMPLETED|Overall Study||123
10003965|NCT01732822|11126326|FG001|NOT COMPLETED|Overall Study||113
10003966|NCT01732835|11126354|FG000|STARTED|6-month Primary Endpoint||68
10003967|NCT01732835|11126354|FG000|COMPLETED|6-month Primary Endpoint||44
10003968|NCT01732835|11126354|FG000|NOT COMPLETED|6-month Primary Endpoint||24
10003969|NCT01732835|11126354|FG000|STARTED|2-year Extended Follow-up||44
10003970|NCT01732835|11126354|FG000|COMPLETED|2-year Extended Follow-up||39
10003971|NCT01732835|11126354|FG000|NOT COMPLETED|2-year Extended Follow-up||5
10003972|NCT01732874|11126360|FG000|STARTED|Overall Study||16
10003973|NCT01732874|11126361|FG001|STARTED|Overall Study||11
10003974|NCT01732874|11126360|FG000|COMPLETED|Overall Study||8
10003975|NCT01732874|11126361|FG001|COMPLETED|Overall Study||8
10003976|NCT01732874|11126360|FG000|NOT COMPLETED|Overall Study||8
10003977|NCT01732874|11126361|FG001|NOT COMPLETED|Overall Study||3
10003978|NCT01733056|11126370|FG000|STARTED|Overall Study||21
10003979|NCT01733056|11126371|FG001|STARTED|Overall Study||10
10003980|NCT01733056|11126372|FG002|STARTED|Overall Study||12
10003981|NCT01733056|11126370|FG000|COMPLETED|Overall Study||21
10003982|NCT01733056|11126371|FG001|COMPLETED|Overall Study||10
10003983|NCT01733056|11126372|FG002|COMPLETED|Overall Study||12
10003984|NCT01733056|11126370|FG000|NOT COMPLETED|Overall Study||0
10003985|NCT01733056|11126371|FG001|NOT COMPLETED|Overall Study||0
10003986|NCT01733056|11126372|FG002|NOT COMPLETED|Overall Study||0
10003987|NCT01733069|11126385|FG000|STARTED|Overall Study||264
10003988|NCT01733069|11126386|FG001|STARTED|Overall Study||1598
10003989|NCT01733069|11126385|FG000|COMPLETED|Overall Study||264
10003990|NCT01733069|11126386|FG001|COMPLETED|Overall Study||1598
10003991|NCT01733069|11126385|FG000|NOT COMPLETED|Overall Study||0
10003992|NCT01733069|11126386|FG001|NOT COMPLETED|Overall Study||0
10003993|NCT01733121|11126394|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51
10003994|NCT01733121|11126395|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51
10003995|NCT01733121|11126394|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44
10003996|NCT01733121|11126395|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46
10003997|NCT01733121|11126394|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
10003998|NCT01733121|11126395|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
10003999|NCT01733121|11126394|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44
10004000|NCT01733121|11126395|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46
10004001|NCT01733121|11126394|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44
10004002|NCT01733121|11126395|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46
10004003|NCT01733121|11126394|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
10004004|NCT01733121|11126395|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
10004005|NCT01733186|11126405|FG000|STARTED|Overall Study||6
10004006|NCT01733186|11126406|FG001|STARTED|Overall Study||6
10004007|NCT01733186|11126405|FG000|COMPLETED|Overall Study||6
10004008|NCT01733186|11126406|FG001|COMPLETED|Overall Study||6
10004009|NCT01733186|11126405|FG000|NOT COMPLETED|Overall Study||0
10004010|NCT01733186|11126406|FG001|NOT COMPLETED|Overall Study||0
10004011|NCT01733212|11126414|FG000|STARTED|Overall Study||116
10004012|NCT01733212|11126415|FG001|STARTED|Overall Study||123
10004013|NCT01733212|11126414|FG000|COMPLETED|Overall Study||116
10004014|NCT01733212|11126415|FG001|COMPLETED|Overall Study||123
10004015|NCT01733212|11126414|FG000|NOT COMPLETED|Overall Study||0
10004016|NCT01733212|11126415|FG001|NOT COMPLETED|Overall Study||0
10004017|NCT01733238|11126421|FG000|STARTED|Overall Study||13
10004018|NCT01733238|11126421|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
10004019|NCT01733238|11126421|FG000|NOT COMPLETED|Overall Study||5
10004020|NCT01733277|11126427|FG000|STARTED|Overall Study||25
10004021|NCT01733277|11126428|FG001|STARTED|Overall Study||25
10004022|NCT01733277|11126427|FG000|COMPLETED|Overall Study||25
10004023|NCT01733277|11126428|FG001|COMPLETED|Overall Study||25
10004024|NCT01733277|11126427|FG000|NOT COMPLETED|Overall Study||0
10004025|NCT01733277|11126428|FG001|NOT COMPLETED|Overall Study||0
10004026|NCT01733316|11126434|FG000|STARTED|Cystagon® Phase||41
10004027|NCT01733316|11126434|FG000|COMPLETED|Cystagon® Phase||41
10004028|NCT01733316|11126434|FG000|NOT COMPLETED|Cystagon® Phase||0
10004029|NCT01733316|11126434|FG000|STARTED|RP103 Phase||41
10004030|NCT01733316|11126434|FG000|COMPLETED|RP103 Phase||40
10004031|NCT01733316|11126434|FG000|NOT COMPLETED|RP103 Phase||1
10004032|NCT01733316|11126434|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
10004033|NCT01733316|11126434|FG000|COMPLETED|Long Term Extension Phase||33
10004034|NCT01733316|11126434|FG000|NOT COMPLETED|Long Term Extension Phase||5
10004035|NCT01733329|11126447|FG000|STARTED|Overall Study||62
10004036|NCT01733329|11126448|FG001|STARTED|Overall Study||61
10004037|NCT01733329|11126447|FG000|COMPLETED|Overall Study||60
10004038|NCT01733329|11126448|FG001|COMPLETED|Overall Study||60
10004039|NCT01733329|11126447|FG000|NOT COMPLETED|Overall Study||2
10004040|NCT01733329|11126448|FG001|NOT COMPLETED|Overall Study||1
10004041|NCT01733368|11126454|FG000|STARTED|Overall Study||198
10004042|NCT01733368|11126454|FG000|COMPLETED|Overall Study||167
10004043|NCT01733368|11126454|FG000|NOT COMPLETED|Overall Study||31
10004044|NCT01733407|11126462|FG000|STARTED|Overall Study||9
10004045|NCT01733407|11126463|FG001|STARTED|Overall Study||9
10004046|NCT01733407|11126462|FG000|COMPLETED|Overall Study||7
10004047|NCT01733407|11126463|FG001|COMPLETED|Overall Study||9
10004048|NCT01733407|11126462|FG000|NOT COMPLETED|Overall Study||2
10004049|NCT01733407|11126463|FG001|NOT COMPLETED|Overall Study||0
10004050|NCT01733472|11126471|FG000|STARTED|Overall Study||60
10004051|NCT01733472|11126472|FG001|STARTED|Overall Study||60
10004052|NCT01733472|11126471|FG000|COMPLETED|Overall Study||60
10004053|NCT01733472|11126472|FG001|COMPLETED|Overall Study||60
10004054|NCT01733472|11126471|FG000|NOT COMPLETED|Overall Study||0
10004055|NCT01733472|11126472|FG001|NOT COMPLETED|Overall Study||0
10004056|NCT01733628|11126479|FG000|STARTED|Overall Study||143
10004057|NCT01733628|11126479|FG000|COMPLETED|Overall Study||143
10004058|NCT01733628|11126479|FG000|NOT COMPLETED|Overall Study||0
10004059|NCT01733680|11126485|FG000|STARTED|Overall Study||2
10004060|NCT01733680|11126486|FG001|STARTED|Overall Study||1
10004061|NCT01733680|11126485|FG000|COMPLETED|Overall Study||2
10004062|NCT01733680|11126486|FG001|COMPLETED|Overall Study||0
10004063|NCT01733680|11126485|FG000|NOT COMPLETED|Overall Study||0
10004064|NCT01733680|11126486|FG001|NOT COMPLETED|Overall Study||1
10004065|NCT01733732|11126498|FG000|STARTED|Overall Study||27
10004066|NCT01733732|11126499|FG001|STARTED|Overall Study||27
10004067|NCT01733732|11126498|FG000|COMPLETED|Overall Study||25
10004068|NCT01733732|11126499|FG001|COMPLETED|Overall Study||27
10004069|NCT01733732|11126498|FG000|NOT COMPLETED|Overall Study||2
10004070|NCT01733732|11126499|FG001|NOT COMPLETED|Overall Study||0
10004071|NCT01733745|11126517|FG000|STARTED|Overall Study||13
10004072|NCT01733745|11126518|FG001|STARTED|Overall Study||13
10004073|NCT01733745|11126517|FG000|COMPLETED|Overall Study||13
10004074|NCT01733745|11126518|FG001|COMPLETED|Overall Study||13
10004075|NCT01733745|11126517|FG000|NOT COMPLETED|Overall Study||0
10004076|NCT01733745|11126518|FG001|NOT COMPLETED|Overall Study||0
10004077|NCT01733758|11126528|FG000|STARTED|Overall Study||77
10004078|NCT01733758|11126529|FG001|STARTED|Overall Study||160
10004079|NCT01733758|11126530|FG002|STARTED|Overall Study||150
10004080|NCT01733758|11126531|FG003|STARTED|Overall Study||103
10004081|NCT01733758|11126528|FG000|COMPLETED|Overall Study||62
10004082|NCT01733758|11126529|FG001|COMPLETED|Overall Study||148
10004083|NCT01733758|11126530|FG002|COMPLETED|Overall Study||135
10004084|NCT01733758|11126531|FG003|COMPLETED|Overall Study||95
10004085|NCT01733758|11126528|FG000|NOT COMPLETED|Overall Study||15
10004086|NCT01733758|11126529|FG001|NOT COMPLETED|Overall Study||12
10004087|NCT01733758|11126530|FG002|NOT COMPLETED|Overall Study||15
10004088|NCT01733758|11126531|FG003|NOT COMPLETED|Overall Study||8
10004089|NCT01733953|11126545|FG000|STARTED|Overall Study||14
10004090|NCT01733953|11126546|FG001|STARTED|Overall Study||13
10004091|NCT01733953|11126545|FG000|COMPLETED|Overall Study||9
10004092|NCT01733953|11126546|FG001|COMPLETED|Overall Study||6
10004093|NCT01733953|11126545|FG000|NOT COMPLETED|Overall Study||5
10004094|NCT01733953|11126546|FG001|NOT COMPLETED|Overall Study||7
10004095|NCT01734161|11126554|FG000|STARTED|Overall Study||61
10004096|NCT01734161|11126555|FG001|STARTED|Overall Study||61
10004097|NCT01734161|11126554|FG000|COMPLETED|Overall Study||55
10004098|NCT01734161|11126555|FG001|COMPLETED|Overall Study||53
10004099|NCT01734161|11126554|FG000|NOT COMPLETED|Overall Study||6
10004100|NCT01734161|11126555|FG001|NOT COMPLETED|Overall Study||8
10004101|NCT01734239|11126563|FG000|STARTED|Overall Study||52
10004102|NCT01734239|11126564|FG001|STARTED|Overall Study||50
10004103|NCT01734239|11126563|FG000|COMPLETED|Overall Study||52
10004104|NCT01734239|11126564|FG001|COMPLETED|Overall Study||50
10004105|NCT01734239|11126563|FG000|NOT COMPLETED|Overall Study||0
10004106|NCT01734239|11126564|FG001|NOT COMPLETED|Overall Study||0
10004107|NCT01734317|11126569|FG000|STARTED|Overall Study||10
10004108|NCT01734317|11126569|FG000|COMPLETED|Overall Study||10
10004109|NCT01734317|11126569|FG000|NOT COMPLETED|Overall Study||0
10004110|NCT01734382|11126577|FG000|STARTED|Part 1||19
10004111|NCT01734382|11126578|FG001|STARTED|Part 1||0
10004112|NCT01734382|11126579|FG002|STARTED|Part 1||0
10004113|NCT01734382|11126577|FG000|COMPLETED|Part 1||17
10004114|NCT01734382|11126578|FG001|COMPLETED|Part 1||0
10004115|NCT01734382|11126579|FG002|COMPLETED|Part 1||0
10004116|NCT01734382|11126577|FG000|NOT COMPLETED|Part 1||2
10004117|NCT01734382|11126578|FG001|NOT COMPLETED|Part 1||0
10004118|NCT01734382|11126579|FG002|NOT COMPLETED|Part 1||0
10004119|NCT01734382|11126577|FG000|STARTED|Part 2||0
10004120|NCT01734382|11126578|FG001|STARTED|Part 2||7
10004121|NCT01734382|11126579|FG002|STARTED|Part 2||15
10004122|NCT01734382|11126577|FG000|COMPLETED|Part 2||0
10004123|NCT01734382|11126578|FG001|COMPLETED|Part 2||5
10004124|NCT01734382|11126579|FG002|COMPLETED|Part 2||8
10004125|NCT01734382|11126577|FG000|NOT COMPLETED|Part 2||0
10004126|NCT01734382|11126578|FG001|NOT COMPLETED|Part 2||2
10004127|NCT01734382|11126579|FG002|NOT COMPLETED|Part 2||7
10004128|NCT01734395|11126591|FG000|STARTED|Overall Study||1882
10004129|NCT01734395|11126591|FG000|COMPLETED|Overall Study||1472
10004130|NCT01734395|11126591|FG000|NOT COMPLETED|Overall Study||410
10004131|NCT01734434|11126599|FG000|STARTED|Overall Study||500
10004132|NCT01734434|11126600|FG001|STARTED|Overall Study||500
10004133|NCT01734434|11126601|FG002|STARTED|Overall Study||1992
10004134|NCT01734434|11126602|FG003|STARTED|Overall Study||251
10004135|NCT01734434|11126599|FG000|COMPLETED|Overall Study||490
10004136|NCT01734434|11126600|FG001|COMPLETED|Overall Study||488
10004137|NCT01734434|11126601|FG002|COMPLETED|Overall Study||1863
10004138|NCT01734434|11126602|FG003|COMPLETED|Overall Study||228
10103790|NCT02427750|11233450|FG000|NOT COMPLETED|Overall Study||0
10103791|NCT02427750|11233451|FG001|NOT COMPLETED|Overall Study||0
10103792|NCT02427802|11233461|FG000|STARTED|Overall Study||305
10103793|NCT02427802|11233462|FG001|STARTED|Overall Study||154
10103794|NCT02427802|11233463|FG002|STARTED|Overall Study||153
10103795|NCT02427802|11233461|FG000|COMPLETED|Overall Study||246
10004139|NCT01734434|11126599|FG000|NOT COMPLETED|Overall Study||10
10004140|NCT01734434|11126600|FG001|NOT COMPLETED|Overall Study||12
10004141|NCT01734434|11126601|FG002|NOT COMPLETED|Overall Study||129
10004142|NCT01734434|11126602|FG003|NOT COMPLETED|Overall Study||23
10004146|NCT01734525|11126624|FG000|STARTED|Overall Study||85
10004147|NCT01734525|11126624|FG000|COMPLETED|Overall Study||85
10004148|NCT01734525|11126624|FG000|NOT COMPLETED|Overall Study||0
10004149|NCT01734551|11126630|FG000|STARTED|Overall Study||15
10004150|NCT01734551|11126631|FG001|STARTED|Overall Study||16
10004151|NCT01734551|11126630|FG000|COMPLETED|Overall Study||15
10004152|NCT01734551|11126631|FG001|COMPLETED|Overall Study||16
10004153|NCT01734551|11126630|FG000|NOT COMPLETED|Overall Study||0
10004154|NCT01734551|11126631|FG001|NOT COMPLETED|Overall Study||0
10004155|NCT01734655|11126637|FG000|STARTED|Overall Study||40
10004156|NCT01734655|11126637|FG000|COMPLETED|Overall Study||40
10004157|NCT01734655|11126637|FG000|NOT COMPLETED|Overall Study||0
10004158|NCT01734746|11126644|FG000|STARTED|Overall Study||22
10004159|NCT01734746|11126644|FG000|COMPLETED|Overall Study||21
10004160|NCT01734746|11126644|FG000|NOT COMPLETED|Overall Study||1
10004161|NCT01734772|11126651|FG000|STARTED|Overall Study||24
10004162|NCT01734772|11126652|FG001|STARTED|Overall Study||24
10004163|NCT01734772|11126651|FG000|COMPLETED|Overall Study||23
10004164|NCT01734772|11126652|FG001|COMPLETED|Overall Study||21
10004165|NCT01734772|11126651|FG000|NOT COMPLETED|Overall Study||1
10004166|NCT01734772|11126652|FG001|NOT COMPLETED|Overall Study||3
10004167|NCT01734785|11126667|FG000|STARTED|Open-Label Period||0
10004168|NCT01734785|11126668|FG001|STARTED|Open-Label Period||0
10004169|NCT01734785|11126669|FG002|STARTED|Open-Label Period||0
10004170|NCT01734785|11126670|FG003|STARTED|Open-Label Period||606
10004171|NCT01734785|11126667|FG000|COMPLETED|Open-Label Period||0
10004172|NCT01734785|11126668|FG001|COMPLETED|Open-Label Period||0
10004173|NCT01734785|11126669|FG002|COMPLETED|Open-Label Period||0
10004174|NCT01734785|11126670|FG003|COMPLETED|Open-Label Period||333
10004175|NCT01734785|11126667|FG000|NOT COMPLETED|Open-Label Period||0
10004176|NCT01734785|11126668|FG001|NOT COMPLETED|Open-Label Period||0
10004177|NCT01734785|11126669|FG002|NOT COMPLETED|Open-Label Period||0
10004178|NCT01734785|11126670|FG003|NOT COMPLETED|Open-Label Period||273
10004179|NCT01734785|11126667|FG000|STARTED|Double-Blind Period||111
10004180|NCT01734785|11126668|FG001|STARTED|Double-Blind Period||112
10004181|NCT01734785|11126669|FG002|STARTED|Double-Blind Period||110
10004182|NCT01734785|11126670|FG003|STARTED|Double-Blind Period||0
10004183|NCT01734785|11126667|FG000|COMPLETED|Double-Blind Period||106
10004184|NCT01734785|11126668|FG001|COMPLETED|Double-Blind Period||103
10004185|NCT01734785|11126669|FG002|COMPLETED|Double-Blind Period||105
10004186|NCT01734785|11126670|FG003|COMPLETED|Double-Blind Period||0
10004187|NCT01734785|11126667|FG000|NOT COMPLETED|Double-Blind Period||5
10004188|NCT01734785|11126668|FG001|NOT COMPLETED|Double-Blind Period||9
10004189|NCT01734785|11126669|FG002|NOT COMPLETED|Double-Blind Period||5
10004190|NCT01734785|11126670|FG003|NOT COMPLETED|Double-Blind Period||0
10004191|NCT01734811|11126681|FG000|STARTED|Overall Study||58
10004192|NCT01734811|11126682|FG001|STARTED|Overall Study||62
10004193|NCT01734811|11126681|FG000|COMPLETED|Overall Study||54
10004194|NCT01734811|11126682|FG001|COMPLETED|Overall Study||59
10004195|NCT01734811|11126681|FG000|NOT COMPLETED|Overall Study||4
10004196|NCT01734811|11126682|FG001|NOT COMPLETED|Overall Study||3
10004197|NCT01734850|11126691|FG000|STARTED|Overall Study||4
10103796|NCT02427802|11233462|FG001|COMPLETED|Overall Study||120
10103797|NCT02427802|11233463|FG002|COMPLETED|Overall Study||110
10103798|NCT02427802|11233461|FG000|NOT COMPLETED|Overall Study||59
10103799|NCT02427802|11233462|FG001|NOT COMPLETED|Overall Study||34
10103800|NCT02427802|11233463|FG002|NOT COMPLETED|Overall Study||43
10103801|NCT02427841|11233471|FG000|STARTED|Overall Study||19
10103802|NCT02427841|11233471|FG000|COMPLETED|Overall Study||11
10004198|NCT01734850|11126692|FG001|STARTED|Overall Study||4
10004199|NCT01734850|11126693|FG002|STARTED|Overall Study||5
10004200|NCT01734850|11126691|FG000|COMPLETED|Overall Study||1
10004201|NCT01734850|11126692|FG001|COMPLETED|Overall Study||2
10004202|NCT01734850|11126693|FG002|COMPLETED|Overall Study||1
10004203|NCT01734850|11126691|FG000|NOT COMPLETED|Overall Study||3
10004204|NCT01734850|11126692|FG001|NOT COMPLETED|Overall Study||2
10004205|NCT01734850|11126693|FG002|NOT COMPLETED|Overall Study||4
10004206|NCT01734889|11126704|FG000|STARTED|Overall Study||18
10004207|NCT01734889|11126704|FG000|COMPLETED|Overall Study||18
10004208|NCT01734889|11126704|FG000|NOT COMPLETED|Overall Study||0
10004209|NCT01734902|11126711|FG000|STARTED|Overall Study||14
10004210|NCT01734902|11126712|FG001|STARTED|Overall Study||16
10004211|NCT01734902|11126711|FG000|COMPLETED|Overall Study||14
10004212|NCT01734902|11126712|FG001|COMPLETED|Overall Study||14
10004213|NCT01734902|11126711|FG000|NOT COMPLETED|Overall Study||0
10004214|NCT01734902|11126712|FG001|NOT COMPLETED|Overall Study||2
10004215|NCT01734993|11126718|FG000|STARTED|Overall Study||11
10004216|NCT01734993|11126718|FG000|COMPLETED|Overall Study||9
10004217|NCT01734993|11126718|FG000|NOT COMPLETED|Overall Study||2
10004218|NCT01735175|11126725|FG000|STARTED|Overall Study||159
10004219|NCT01735175|11126726|FG001|STARTED|Overall Study||157
10103803|NCT02427841|11233471|FG000|NOT COMPLETED|Overall Study||8
10103804|NCT02427984|11233478|FG000|STARTED|Overall Study||53
10103805|NCT02427984|11233479|FG001|STARTED|Overall Study||45
10103806|NCT02427984|11233480|FG002|STARTED|Overall Study||50
10103807|NCT02427984|11233478|FG000|COMPLETED|Overall Study||40
10103808|NCT02427984|11233479|FG001|COMPLETED|Overall Study||40
10103809|NCT02427984|11233480|FG002|COMPLETED|Overall Study||32
10103810|NCT02427984|11233478|FG000|NOT COMPLETED|Overall Study||13
10004220|NCT01735175|11126725|FG000|Completed All Cycles|Overall Study||141
10004221|NCT01735175|11126726|FG001|Completed All Cycles|Overall Study||150
10004222|NCT01735175|11126725|FG000|Completed All Treatments as Planned|Overall Study||140
10004223|NCT01735175|11126726|FG001|Completed All Treatments as Planned|Overall Study||150
10004224|NCT01735175|11126725|FG000|Completed the 6-month SFU Visit|Overall Study||120
10004225|NCT01735175|11126726|FG001|Completed the 6-month SFU Visit|Overall Study||138
10004226|NCT01735175|11126725|FG000|COMPLETED|Overall Study||130
10004227|NCT01735175|11126726|FG001|COMPLETED|Overall Study||144
10004228|NCT01735175|11126725|FG000|NOT COMPLETED|Overall Study||29
10004229|NCT01735175|11126726|FG001|NOT COMPLETED|Overall Study||13
10004230|NCT01735201|11126740|FG000|STARTED|Overall Study||45
10004231|NCT01735201|11126741|FG001|STARTED|Overall Study||44
10004232|NCT01735201|11126742|FG002|STARTED|Overall Study||44
10004233|NCT01735201|11126743|FG003|STARTED|Overall Study||44
10004234|NCT01735201|11126744|FG004|STARTED|Overall Study||45
10004235|NCT01735201|11126745|FG005|STARTED|Overall Study||45
10004236|NCT01735201|11126746|FG006|STARTED|Overall Study||45
10004237|NCT01735201|11126747|FG007|STARTED|Overall Study||44
10004238|NCT01735201|11126740|FG000|COMPLETED|Overall Study||42
10004239|NCT01735201|11126741|FG001|COMPLETED|Overall Study||43
10004240|NCT01735201|11126742|FG002|COMPLETED|Overall Study||44
10004241|NCT01735201|11126743|FG003|COMPLETED|Overall Study||42
10004242|NCT01735201|11126744|FG004|COMPLETED|Overall Study||44
10004243|NCT01735201|11126745|FG005|COMPLETED|Overall Study||40
10004244|NCT01735201|11126746|FG006|COMPLETED|Overall Study||42
10004245|NCT01735201|11126747|FG007|COMPLETED|Overall Study||42
10004246|NCT01735201|11126740|FG000|NOT COMPLETED|Overall Study||3
10004247|NCT01735201|11126741|FG001|NOT COMPLETED|Overall Study||1
10004248|NCT01735201|11126742|FG002|NOT COMPLETED|Overall Study||0
10004249|NCT01735201|11126743|FG003|NOT COMPLETED|Overall Study||2
10004250|NCT01735201|11126744|FG004|NOT COMPLETED|Overall Study||1
10004251|NCT01735201|11126745|FG005|NOT COMPLETED|Overall Study||5
10004252|NCT01735201|11126746|FG006|NOT COMPLETED|Overall Study||3
10004253|NCT01735201|11126747|FG007|NOT COMPLETED|Overall Study||2
10004254|NCT01735214|11126765|FG000|STARTED|Overall Study||358
10004255|NCT01735214|11126765|FG000|COMPLETED|Overall Study||358
10004256|NCT01735214|11126765|FG000|NOT COMPLETED|Overall Study||0
10004257|NCT01735279|11126771|FG000|STARTED|Overall Study||29
10004258|NCT01735279|11126772|FG001|STARTED|Overall Study||29
10004259|NCT01735279|11126771|FG000|COMPLETED|Overall Study||18
10004260|NCT01735279|11126772|FG001|COMPLETED|Overall Study||21
10004261|NCT01735279|11126771|FG000|NOT COMPLETED|Overall Study||11
10004262|NCT01735279|11126772|FG001|NOT COMPLETED|Overall Study||8
10004263|NCT01735396|11126778|FG000|STARTED|Overall Study||11
10004264|NCT01735396|11126778|FG000|COMPLETED|Overall Study||10
10004265|NCT01735396|11126778|FG000|NOT COMPLETED|Overall Study||1
10004266|NCT01735617|11126782|FG000|STARTED|Overall Study||16
10004267|NCT01735617|11126782|FG000|COMPLETED|Overall Study||16
10004268|NCT01735617|11126782|FG000|NOT COMPLETED|Overall Study||0
10103811|NCT02427984|11233479|FG001|NOT COMPLETED|Overall Study||5
10103812|NCT02427984|11233480|FG002|NOT COMPLETED|Overall Study||18
10103813|NCT02428296|11233489|FG000|STARTED|Overall Study||39
10103814|NCT02428296|11233489|FG000|Treated|Overall Study||39
10103815|NCT02428296|11233489|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
10004269|NCT01735630|11126791|FG000|STARTED|Overall Study||175
10004270|NCT01735630|11126792|FG001|STARTED|Overall Study||175
10004271|NCT01735630|11126791|FG000|COMPLETED|Overall Study||157
10004272|NCT01735630|11126792|FG001|COMPLETED|Overall Study||157
10004273|NCT01735630|11126791|FG000|NOT COMPLETED|Overall Study||18
10004274|NCT01735630|11126792|FG001|NOT COMPLETED|Overall Study||18
10004275|NCT01735877|11126800|FG000|STARTED|Overall Study||27
10004276|NCT01735877|11126801|FG001|STARTED|Overall Study||21
10004277|NCT01735877|11126800|FG000|COMPLETED|Overall Study||26
10004278|NCT01735877|11126801|FG001|COMPLETED|Overall Study||21
10103816|NCT02428296|11233489|FG000|NOT COMPLETED|Overall Study||9
10004279|NCT01735877|11126800|FG000|NOT COMPLETED|Overall Study||1
10004280|NCT01735877|11126801|FG001|NOT COMPLETED|Overall Study||0
10004281|NCT01735916|11126810|FG000|STARTED|Overall Study||18
10004282|NCT01735916|11126811|FG001|STARTED|Overall Study||19
10004283|NCT01735916|11126812|FG002|STARTED|Overall Study||7
10004284|NCT01735916|11126810|FG000|COMPLETED|Overall Study||0
10018869|NCT01825837|11141896|FG002|COMPLETED|PART II||7
10018870|NCT01825837|11141897|FG003|COMPLETED|PART II||0
10004285|NCT01735916|11126811|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
10004286|NCT01735916|11126812|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
10004287|NCT01735916|11126810|FG000|NOT COMPLETED|Overall Study||18
10004288|NCT01735916|11126811|FG001|NOT COMPLETED|Overall Study||19
10004289|NCT01735916|11126812|FG002|NOT COMPLETED|Overall Study||7
10004290|NCT01735981|11126821|FG000|STARTED|Allocated||13
10004291|NCT01735981|11126822|FG001|STARTED|Allocated||11
10004292|NCT01735981|11126821|FG000|COMPLETED|Allocated||11
10004293|NCT01735981|11126822|FG001|COMPLETED|Allocated||8
10004294|NCT01735981|11126821|FG000|NOT COMPLETED|Allocated||2
10004295|NCT01735981|11126822|FG001|NOT COMPLETED|Allocated||3
10004296|NCT01735981|11126821|FG000|STARTED|Crossed Over||11
10004297|NCT01735981|11126822|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
10004298|NCT01735981|11126821|FG000|COMPLETED|Crossed Over||11
10004299|NCT01735981|11126822|FG001|COMPLETED|Crossed Over||7
10004300|NCT01735981|11126821|FG000|NOT COMPLETED|Crossed Over||0
10004301|NCT01735981|11126822|FG001|NOT COMPLETED|Crossed Over||0
10004302|NCT01735994|11126832|FG000|STARTED|Overall Study||263
10004303|NCT01735994|11126833|FG001|STARTED|Overall Study||218
10004304|NCT01735994|11126832|FG000|Post Intervention (3 Weeks)|Overall Study||239
10004305|NCT01735994|11126833|FG001|Post Intervention (3 Weeks)|Overall Study||198
10004306|NCT01735994|11126832|FG000|Follow-Up #1 (6 Months)|Overall Study||213
10004307|NCT01735994|11126833|FG001|Follow-Up #1 (6 Months)|Overall Study||163
10004308|NCT01735994|11126832|FG000|Follow-Up #2 (12 Months)|Overall Study||212
10004309|NCT01735994|11126833|FG001|Follow-Up #2 (12 Months)|Overall Study||174
10004310|NCT01735994|11126832|FG000|COMPLETED|Overall Study||200
10004311|NCT01735994|11126833|FG001|COMPLETED|Overall Study||152
10004312|NCT01735994|11126832|FG000|NOT COMPLETED|Overall Study||63
10004313|NCT01735994|11126833|FG001|NOT COMPLETED|Overall Study||66
10004314|NCT01736085|11126845|FG000|STARTED|Overall Study||529
10004315|NCT01736085|11126846|FG001|STARTED|Overall Study||530
10004316|NCT01736085|11126847|FG002|STARTED|Overall Study||793
10004317|NCT01736085|11126848|FG003|STARTED|Overall Study||530
10004318|NCT01736085|11126849|FG004|STARTED|Overall Study||530
10004319|NCT01736085|11126850|FG005|STARTED|Overall Study||794
10004320|NCT01736085|11126845|FG000|COMPLETED|Overall Study||529
10004321|NCT01736085|11126846|FG001|COMPLETED|Overall Study||530
10004322|NCT01736085|11126847|FG002|COMPLETED|Overall Study||793
10004323|NCT01736085|11126848|FG003|COMPLETED|Overall Study||530
10004324|NCT01736085|11126849|FG004|COMPLETED|Overall Study||530
10004325|NCT01736085|11126850|FG005|COMPLETED|Overall Study||794
10004326|NCT01736085|11126845|FG000|NOT COMPLETED|Overall Study||0
10004327|NCT01736085|11126846|FG001|NOT COMPLETED|Overall Study||0
10004328|NCT01736085|11126847|FG002|NOT COMPLETED|Overall Study||0
10004329|NCT01736085|11126848|FG003|NOT COMPLETED|Overall Study||0
10004330|NCT01736085|11126849|FG004|NOT COMPLETED|Overall Study||0
10004331|NCT01736085|11126850|FG005|NOT COMPLETED|Overall Study||0
10004332|NCT01736124|11126863|FG000|STARTED|Baseline||90
10004333|NCT01736124|11126864|FG001|STARTED|Baseline||90
10004334|NCT01736124|11126863|FG000|COMPLETED|Baseline||90
10004335|NCT01736124|11126864|FG001|COMPLETED|Baseline||90
10004336|NCT01736124|11126863|FG000|NOT COMPLETED|Baseline||0
10004337|NCT01736124|11126864|FG001|NOT COMPLETED|Baseline||0
10004338|NCT01736124|11126863|FG000|STARTED|Post-intervention Assessment||90
10004339|NCT01736124|11126864|FG001|STARTED|Post-intervention Assessment||90
10004340|NCT01736124|11126863|FG000|COMPLETED|Post-intervention Assessment||59
10004341|NCT01736124|11126864|FG001|COMPLETED|Post-intervention Assessment||69
10004342|NCT01736124|11126863|FG000|NOT COMPLETED|Post-intervention Assessment||31
10004343|NCT01736124|11126864|FG001|NOT COMPLETED|Post-intervention Assessment||21
10004344|NCT01736124|11126863|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
10004345|NCT01736124|11126864|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
10004346|NCT01736124|11126863|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57
10004347|NCT01736124|11126864|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58
10004348|NCT01736124|11126863|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
10004349|NCT01736124|11126864|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
10004350|NCT01736124|11126863|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
10004351|NCT01736124|11126864|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
10004352|NCT01736124|11126863|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46
10004353|NCT01736124|11126864|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50
10004354|NCT01736124|11126863|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
10004355|NCT01736124|11126864|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
10004356|NCT01736176|11126872|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
10004357|NCT01736176|11126872|FG000|Received LCIG|Overall Study||38
10004358|NCT01736176|11126872|FG000|COMPLETED|Overall Study||28
10004359|NCT01736176|11126872|FG000|NOT COMPLETED|Overall Study||11
10004360|NCT01736189|11126880|FG000|STARTED|Overall Study||346
10004361|NCT01736189|11126880|FG000|COMPLETED|Overall Study||300
10004362|NCT01736189|11126880|FG000|NOT COMPLETED|Overall Study||46
10004363|NCT01736215|11126884|FG000|STARTED|Overall Study||33
10004364|NCT01736215|11126884|FG000|Treated|Overall Study||25
10004365|NCT01736215|11126884|FG000|COMPLETED|Overall Study||19
10004366|NCT01736215|11126884|FG000|NOT COMPLETED|Overall Study||14
10004367|NCT01736241|11126895|FG000|STARTED|Overall Study||6
10004368|NCT01736241|11126896|FG001|STARTED|Overall Study||6
10004369|NCT01736241|11126897|FG002|STARTED|Overall Study||6
10004370|NCT01736241|11126898|FG003|STARTED|Overall Study||5
10004371|NCT01736241|11126899|FG004|STARTED|Overall Study||6
10004372|NCT01736241|11126900|FG005|STARTED|Overall Study||6
10004373|NCT01736241|11126901|FG006|STARTED|Overall Study||6
10004374|NCT01736241|11126895|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10004375|NCT01736241|11126896|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10004376|NCT01736241|11126897|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10004377|NCT01736241|11126898|FG003|Received at Least One Dose of Study Drug|Overall Study||5
10004378|NCT01736241|11126899|FG004|Received at Least One Dose of Study Drug|Overall Study||6
10004379|NCT01736241|11126900|FG005|Received at Least One Dose of Study Drug|Overall Study||6
10004380|NCT01736241|11126901|FG006|Received at Least One Dose of Study Drug|Overall Study||6
10004381|NCT01736241|11126895|FG000|COMPLETED|Overall Study||6
10004382|NCT01736241|11126896|FG001|COMPLETED|Overall Study||6
10004383|NCT01736241|11126897|FG002|COMPLETED|Overall Study||6
10004384|NCT01736241|11126898|FG003|COMPLETED|Overall Study||5
10004385|NCT01736241|11126899|FG004|COMPLETED|Overall Study||6
10004386|NCT01736241|11126900|FG005|COMPLETED|Overall Study||6
10004387|NCT01736241|11126901|FG006|COMPLETED|Overall Study||6
10004388|NCT01736241|11126895|FG000|NOT COMPLETED|Overall Study||0
10004389|NCT01736241|11126896|FG001|NOT COMPLETED|Overall Study||0
10004390|NCT01736241|11126897|FG002|NOT COMPLETED|Overall Study||0
10004391|NCT01736241|11126898|FG003|NOT COMPLETED|Overall Study||0
10004392|NCT01736241|11126899|FG004|NOT COMPLETED|Overall Study||0
10004393|NCT01736241|11126900|FG005|NOT COMPLETED|Overall Study||0
10004394|NCT01736241|11126901|FG006|NOT COMPLETED|Overall Study||0
10004395|NCT01736254|11126918|FG000|STARTED|Period 1 (Day 1)||24
10004396|NCT01736254|11126918|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
10004397|NCT01736254|11126918|FG000|COMPLETED|Period 1 (Day 1)||24
10004398|NCT01736254|11126918|FG000|NOT COMPLETED|Period 1 (Day 1)||0
10004399|NCT01736254|11126918|FG000|STARTED|Period 2 (Days 2 to 12)||24
10004400|NCT01736254|11126918|FG000|COMPLETED|Period 2 (Days 2 to 12)||21
10004401|NCT01736254|11126918|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3
10004402|NCT01736254|11126918|FG000|STARTED|Period 3 (Days 13 to 23)||21
10004403|NCT01736254|11126918|FG000|COMPLETED|Period 3 (Days 13 to 23)||20
10004404|NCT01736254|11126918|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1
10004405|NCT01736267|11126926|FG000|STARTED|Overall Study||3
10004406|NCT01736267|11126926|FG000|COMPLETED|Overall Study||3
10004407|NCT01736267|11126926|FG000|NOT COMPLETED|Overall Study||0
10004408|NCT01736358|11126932|FG000|STARTED|Overall Study||25
10004409|NCT01736358|11126933|FG001|STARTED|Overall Study||25
10004410|NCT01736358|11126932|FG000|COMPLETED|Overall Study||20
10004411|NCT01736358|11126933|FG001|COMPLETED|Overall Study||23
10004412|NCT01736358|11126932|FG000|NOT COMPLETED|Overall Study||5
10004413|NCT01736358|11126933|FG001|NOT COMPLETED|Overall Study||2
10004414|NCT01736397|11126941|FG000|STARTED|Overall Study||75
10004415|NCT01736397|11126942|FG001|STARTED|Overall Study||74
10004416|NCT01736397|11126941|FG000|COMPLETED|Overall Study||61
10004417|NCT01736397|11126942|FG001|COMPLETED|Overall Study||50
10004418|NCT01736397|11126941|FG000|NOT COMPLETED|Overall Study||14
10004419|NCT01736397|11126942|FG001|NOT COMPLETED|Overall Study||24
10004420|NCT01736475|11126950|FG000|STARTED|Overall Study||121
10004421|NCT01736475|11126951|FG001|STARTED|Overall Study||17
10004422|NCT01736475|11126950|FG000|COMPLETED|Overall Study||109
10004423|NCT01736475|11126951|FG001|COMPLETED|Overall Study||17
10004424|NCT01736475|11126950|FG000|NOT COMPLETED|Overall Study||12
10004425|NCT01736475|11126951|FG001|NOT COMPLETED|Overall Study||0
10004426|NCT01736527|11126968|FG000|STARTED|Overall Study||12
10004427|NCT01736527|11126968|FG000|COMPLETED|Overall Study||12
10004428|NCT01736527|11126968|FG000|NOT COMPLETED|Overall Study||0
10004429|NCT01736540|11126972|FG000|STARTED|Overall Study||243
10004430|NCT01736540|11126972|FG000|COMPLETED|Overall Study||228
10004431|NCT01736540|11126972|FG000|NOT COMPLETED|Overall Study||15
10004432|NCT01736553|11126985|FG000|STARTED|Overall Study||26
10004433|NCT01736553|11126986|FG001|STARTED|Overall Study||27
10004434|NCT01736553|11126985|FG000|COMPLETED|Overall Study||7
10004435|NCT01736553|11126986|FG001|COMPLETED|Overall Study||23
10004436|NCT01736553|11126985|FG000|NOT COMPLETED|Overall Study||19
10004437|NCT01736553|11126986|FG001|NOT COMPLETED|Overall Study||4
10004438|NCT01736566|11127015|FG000|STARTED|Main Study||51
10004439|NCT01736566|11127016|FG001|STARTED|Main Study||50
10004440|NCT01736566|11127017|FG002|STARTED|Main Study||50
10004441|NCT01736566|11127018|FG003|STARTED|Main Study||52
10004442|NCT01736566|11127019|FG004|STARTED|Main Study||10
10004443|NCT01736566|11127015|FG000|COMPLETED|Main Study||50
10004444|NCT01736566|11127016|FG001|COMPLETED|Main Study||50
10004445|NCT01736566|11127017|FG002|COMPLETED|Main Study||49
10103817|NCT02428309|11233496|FG000|STARTED|Overall Study||1
10103818|NCT02428309|11233496|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
10004446|NCT01736566|11127018|FG003|COMPLETED|Main Study||51
10004447|NCT01736566|11127019|FG004|COMPLETED|Main Study||6
10103819|NCT02428309|11233496|FG000|NOT COMPLETED|Overall Study||0
10004448|NCT01736566|11127015|FG000|NOT COMPLETED|Main Study||1
10004449|NCT01736566|11127016|FG001|NOT COMPLETED|Main Study||0
10004450|NCT01736566|11127017|FG002|NOT COMPLETED|Main Study||1
10004451|NCT01736566|11127018|FG003|NOT COMPLETED|Main Study||1
10004452|NCT01736566|11127019|FG004|NOT COMPLETED|Main Study||4
10004453|NCT01736566|11127015|FG000|STARTED|Long Term Follow-up||42
10004454|NCT01736566|11127016|FG001|STARTED|Long Term Follow-up||0
10004455|NCT01736566|11127017|FG002|STARTED|Long Term Follow-up||49
10004456|NCT01736566|11127018|FG003|STARTED|Long Term Follow-up||0
10004457|NCT01736566|11127019|FG004|STARTED|Long Term Follow-up||1
10004458|NCT01736566|11127015|FG000|COMPLETED|Long Term Follow-up||0
10004459|NCT01736566|11127016|FG001|COMPLETED|Long Term Follow-up||0
10004460|NCT01736566|11127017|FG002|COMPLETED|Long Term Follow-up||0
10004461|NCT01736566|11127018|FG003|COMPLETED|Long Term Follow-up||0
10004462|NCT01736566|11127019|FG004|COMPLETED|Long Term Follow-up||0
10004463|NCT01736566|11127015|FG000|NOT COMPLETED|Long Term Follow-up||42
10004464|NCT01736566|11127016|FG001|NOT COMPLETED|Long Term Follow-up||0
10004465|NCT01736566|11127017|FG002|NOT COMPLETED|Long Term Follow-up||49
10004466|NCT01736566|11127018|FG003|NOT COMPLETED|Long Term Follow-up||0
10004467|NCT01736566|11127019|FG004|NOT COMPLETED|Long Term Follow-up||1
10004468|NCT01736579|11127046|FG000|STARTED|Overall Study||2
10004469|NCT01736579|11127047|FG001|STARTED|Overall Study||2
10004470|NCT01736579|11127046|FG000|COMPLETED|Overall Study||0
10004471|NCT01736579|11127047|FG001|COMPLETED|Overall Study||0
10004472|NCT01736579|11127046|FG000|NOT COMPLETED|Overall Study||2
10004473|NCT01736579|11127047|FG001|NOT COMPLETED|Overall Study||2
10004474|NCT01736657|11127053|FG000|STARTED|Overall Study||73
10004475|NCT01736657|11127053|FG000|COMPLETED|Overall Study||72
10004476|NCT01736657|11127053|FG000|NOT COMPLETED|Overall Study||1
10004477|NCT01736683|11127062|FG000|STARTED|Overall Study||7
10004478|NCT01736683|11127063|FG001|STARTED|Overall Study||6
10004479|NCT01736683|11127064|FG002|STARTED|Overall Study||21
10004480|NCT01736683|11127065|FG003|STARTED|Overall Study||35
10004481|NCT01736683|11127066|FG004|STARTED|Overall Study||5
10004482|NCT01736683|11127062|FG000|COMPLETED|Overall Study|# who completed treatment|0
10004483|NCT01736683|11127063|FG001|COMPLETED|Overall Study|# who completed treatment|0
10004484|NCT01736683|11127064|FG002|COMPLETED|Overall Study|# who completed treatment|0
10004485|NCT01736683|11127065|FG003|COMPLETED|Overall Study|# who completed treatment|0
10004486|NCT01736683|11127066|FG004|COMPLETED|Overall Study|# who completed treatment|0
10004487|NCT01736683|11127062|FG000|NOT COMPLETED|Overall Study||7
10004488|NCT01736683|11127063|FG001|NOT COMPLETED|Overall Study||6
10004489|NCT01736683|11127064|FG002|NOT COMPLETED|Overall Study||21
10004490|NCT01736683|11127065|FG003|NOT COMPLETED|Overall Study||35
10004491|NCT01736683|11127066|FG004|NOT COMPLETED|Overall Study||5
10004492|NCT01736696|11127087|FG000|STARTED|Overall Study||5
10004493|NCT01736696|11127088|FG001|STARTED|Overall Study||5
10004494|NCT01736696|11127089|FG002|STARTED|Overall Study||10
10004495|NCT01736696|11127090|FG003|STARTED|Overall Study||9
10004496|NCT01736696|11127091|FG004|STARTED|Overall Study||9
10004497|NCT01736696|11127092|FG005|STARTED|Overall Study||8
10004498|NCT01736696|11127093|FG006|STARTED|Overall Study||13
10004499|NCT01736696|11127087|FG000|COMPLETED|Overall Study||5
10004500|NCT01736696|11127088|FG001|COMPLETED|Overall Study||5
10004501|NCT01736696|11127089|FG002|COMPLETED|Overall Study||9
10004502|NCT01736696|11127090|FG003|COMPLETED|Overall Study||9
10004503|NCT01736696|11127091|FG004|COMPLETED|Overall Study||9
10004504|NCT01736696|11127092|FG005|COMPLETED|Overall Study||8
10004505|NCT01736696|11127093|FG006|COMPLETED|Overall Study||13
10004506|NCT01736696|11127087|FG000|NOT COMPLETED|Overall Study||0
10004507|NCT01736696|11127088|FG001|NOT COMPLETED|Overall Study||0
10004508|NCT01736696|11127089|FG002|NOT COMPLETED|Overall Study||1
10004509|NCT01736696|11127090|FG003|NOT COMPLETED|Overall Study||0
10004510|NCT01736696|11127091|FG004|NOT COMPLETED|Overall Study||0
10004511|NCT01736696|11127092|FG005|NOT COMPLETED|Overall Study||0
10004512|NCT01736696|11127093|FG006|NOT COMPLETED|Overall Study||0
10004513|NCT01736852|11127119|FG000|STARTED|Overall Study||65
10004514|NCT01736852|11127120|FG001|STARTED|Overall Study||64
10004515|NCT01736852|11127119|FG000|COMPLETED|Overall Study||63
10004516|NCT01736852|11127120|FG001|COMPLETED|Overall Study||61
10004517|NCT01736852|11127119|FG000|NOT COMPLETED|Overall Study||2
10004518|NCT01736852|11127120|FG001|NOT COMPLETED|Overall Study||3
10004519|NCT01736865|11127128|FG000|STARTED|Overall Study||61
10004520|NCT01736865|11127129|FG001|STARTED|Overall Study||66
10004521|NCT01736865|11127128|FG000|COMPLETED|Overall Study||61
10004522|NCT01736865|11127129|FG001|COMPLETED|Overall Study||66
10004523|NCT01736865|11127128|FG000|NOT COMPLETED|Overall Study||0
10004524|NCT01736865|11127129|FG001|NOT COMPLETED|Overall Study||0
10004525|NCT01736917|11127135|FG000|STARTED|Overall Study||65
10004526|NCT01736917|11127135|FG000|COMPLETED|Overall Study||54
10004527|NCT01736917|11127135|FG000|NOT COMPLETED|Overall Study||11
10004528|NCT01736930|11127141|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
10004529|NCT01736930|11127141|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
10004530|NCT01736930|11127141|FG000|NOT COMPLETED|Overall Study||1
10004531|NCT01736943|11127147|FG000|STARTED|Overall Study||25
10004532|NCT01736943|11127147|FG000|COMPLETED|Overall Study||25
10004533|NCT01736943|11127147|FG000|NOT COMPLETED|Overall Study||0
10004534|NCT01737268|11127151|FG000|STARTED|Overall Study||20
10004535|NCT01737268|11127151|FG000|Treated|Overall Study||20
10004536|NCT01737268|11127151|FG000|COMPLETED|Overall Study||11
10004537|NCT01737268|11127151|FG000|NOT COMPLETED|Overall Study||9
10004538|NCT01737281|11127158|FG000|STARTED|Overall Study||969
10004539|NCT01737281|11127159|FG001|STARTED|Overall Study||969
10004540|NCT01737281|11127158|FG000|COMPLETED|Overall Study||603
10004541|NCT01737281|11127159|FG001|COMPLETED|Overall Study||689
10004542|NCT01737281|11127158|FG000|NOT COMPLETED|Overall Study||366
10004543|NCT01737281|11127159|FG001|NOT COMPLETED|Overall Study||280
10018871|NCT01825837|11141894|FG000|NOT COMPLETED|PART II||19
10018872|NCT01825837|11141895|FG001|NOT COMPLETED|PART II||14
10018873|NCT01825837|11141896|FG002|NOT COMPLETED|PART II||19
10018874|NCT01825837|11141897|FG003|NOT COMPLETED|PART II||0
10018875|NCT01825876|11141905|FG000|STARTED|Period 1||17
10018876|NCT01825876|11141906|FG001|STARTED|Period 1||0
10018877|NCT01825876|11141905|FG000|Received 1 Dose of Study Drug|Period 1||17
10018878|NCT01825876|11141906|FG001|Received 1 Dose of Study Drug|Period 1||0
10018879|NCT01825876|11141905|FG000|COMPLETED|Period 1||17
10018880|NCT01825876|11141906|FG001|COMPLETED|Period 1||0
10018881|NCT01825876|11141905|FG000|NOT COMPLETED|Period 1||0
10018882|NCT01825876|11141906|FG001|NOT COMPLETED|Period 1||0
10018883|NCT01825876|11141905|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0
10018884|NCT01825876|11141906|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17
10018885|NCT01825876|11141905|FG000|Received 1 Dose of Study Drug|Period 2||0
10018886|NCT01825876|11141906|FG001|Received 1 Dose of Study Drug|Period 2||17
10018887|NCT01825876|11141905|FG000|COMPLETED|Period 2||0
10018888|NCT01825876|11141906|FG001|COMPLETED|Period 2||16
10018889|NCT01825876|11141905|FG000|NOT COMPLETED|Period 2||0
10018890|NCT01825876|11141906|FG001|NOT COMPLETED|Period 2||1
10018891|NCT01825889|11141917|FG000|STARTED|Overall Study||10
10018892|NCT01825889|11141918|FG001|STARTED|Overall Study||10
10018893|NCT01825889|11141917|FG000|Received One Dose of Study Drug|Overall Study||10
10018894|NCT01825889|11141918|FG001|Received One Dose of Study Drug|Overall Study||10
10018895|NCT01825889|11141917|FG000|COMPLETED|Overall Study||10
10018896|NCT01825889|11141918|FG001|COMPLETED|Overall Study||10
10018897|NCT01825889|11141917|FG000|NOT COMPLETED|Overall Study||0
10018898|NCT01825889|11141918|FG001|NOT COMPLETED|Overall Study||0
10018899|NCT01825941|11141926|FG000|STARTED|Overall Study||104
10018900|NCT01825941|11141927|FG001|STARTED|Overall Study||104
10018901|NCT01825941|11141926|FG000|COMPLETED|Overall Study||100
10018902|NCT01825941|11141927|FG001|COMPLETED|Overall Study||103
10018903|NCT01825941|11141926|FG000|NOT COMPLETED|Overall Study||4
10018904|NCT01825941|11141927|FG001|NOT COMPLETED|Overall Study||1
10018905|NCT01826201|11141933|FG000|STARTED|Overall Study|Subjects in each arm are same|21
10018906|NCT01826201|11141933|FG000|COMPLETED|Overall Study||17
10018907|NCT01826201|11141933|FG000|NOT COMPLETED|Overall Study||4
10018908|NCT01826214|11141941|FG000|STARTED|Overall Study||35
10018909|NCT01826214|11141942|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
10018910|NCT01826214|11141941|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0
10018911|NCT01826214|11141942|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1
10018912|NCT01826214|11141941|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35
10018913|NCT01826214|11141942|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34
10018914|NCT01826214|11141941|FG000|COMPLETED|Overall Study||0
10018915|NCT01826214|11141942|FG001|COMPLETED|Overall Study||0
10018916|NCT01826214|11141941|FG000|NOT COMPLETED|Overall Study||35
10018917|NCT01826214|11141942|FG001|NOT COMPLETED|Overall Study||34
10018918|NCT01826227|11141948|FG000|STARTED|Overall Study||5
10018919|NCT01826227|11141948|FG000|COMPLETED|Overall Study||5
10018920|NCT01826227|11141948|FG000|NOT COMPLETED|Overall Study||0
10018921|NCT01826370|11141952|FG000|STARTED|Overall Study||678
10018922|NCT01826370|11141952|FG000|COMPLETED|Overall Study||658
10018923|NCT01826370|11141952|FG000|NOT COMPLETED|Overall Study||20
10018924|NCT01826422|11141958|FG000|STARTED|Overall Study||18
10018925|NCT01826422|11141959|FG001|STARTED|Overall Study||22
10103820|NCT02428413|11233503|FG000|STARTED|Overall Study||64
10103821|NCT02428413|11233504|FG001|STARTED|Overall Study||61
10103822|NCT02428413|11233503|FG000|COMPLETED|Overall Study||56
10103823|NCT02428413|11233504|FG001|COMPLETED|Overall Study||52
10103824|NCT02428413|11233503|FG000|NOT COMPLETED|Overall Study||8
10103825|NCT02428413|11233504|FG001|NOT COMPLETED|Overall Study||9
10103826|NCT02428478|11233510|FG000|STARTED|First Study Night||9
10103827|NCT02428478|11233511|FG001|STARTED|First Study Night||8
10103828|NCT02428478|11233510|FG000|COMPLETED|First Study Night||9
10103829|NCT02428478|11233511|FG001|COMPLETED|First Study Night||8
10018926|NCT01826422|11141958|FG000|COMPLETED|Overall Study||17
10018927|NCT01826422|11141959|FG001|COMPLETED|Overall Study||19
10018928|NCT01826422|11141958|FG000|NOT COMPLETED|Overall Study||1
10018929|NCT01826422|11141959|FG001|NOT COMPLETED|Overall Study||3
10018930|NCT01826448|11141967|FG000|STARTED|Overall Study||4
10018931|NCT01826448|11141968|FG001|STARTED|Overall Study||9
10018932|NCT01826448|11141967|FG000|COMPLETED|Overall Study||0
10018933|NCT01826448|11141968|FG001|COMPLETED|Overall Study||0
10018934|NCT01826448|11141967|FG000|NOT COMPLETED|Overall Study||4
10018935|NCT01826448|11141968|FG001|NOT COMPLETED|Overall Study||9
10018936|NCT01826487|11141976|FG000|STARTED|Overall Study||115
10103830|NCT02428478|11233510|FG000|NOT COMPLETED|First Study Night||0
10103831|NCT02428478|11233511|FG001|NOT COMPLETED|First Study Night||0
10103832|NCT02428478|11233510|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8
10018937|NCT01826487|11141977|FG001|STARTED|Overall Study||115
10018938|NCT01826487|11141976|FG000|As-treated Population|Overall Study||115
10018939|NCT01826487|11141977|FG001|As-treated Population|Overall Study||115
10018940|NCT01826487|11141976|FG000|ITT Population|Overall Study||114
10018941|NCT01826487|11141977|FG001|ITT Population|Overall Study||114
10004544|NCT01737398|11127167|FG000|STARTED|Overall Study||113
10004545|NCT01737398|11127168|FG001|STARTED|Overall Study||60
10004546|NCT01737398|11127167|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112
10004547|NCT01737398|11127168|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
10004548|NCT01737398|11127167|FG000|Safety Set|Overall Study||112
10004549|NCT01737398|11127168|FG001|Safety Set|Overall Study||60
10004550|NCT01737398|11127167|FG000|COMPLETED|Overall Study||87
10004551|NCT01737398|11127168|FG001|COMPLETED|Overall Study||52
10004552|NCT01737398|11127167|FG000|NOT COMPLETED|Overall Study||26
10004553|NCT01737398|11127168|FG001|NOT COMPLETED|Overall Study||8
10004554|NCT01737593|11127180|FG000|STARTED|Overall Study||37
10004555|NCT01737593|11127181|FG001|STARTED|Overall Study||32
10004556|NCT01737593|11127182|FG002|STARTED|Overall Study||39
10004557|NCT01737593|11127180|FG000|COMPLETED|Overall Study||37
10004558|NCT01737593|11127181|FG001|COMPLETED|Overall Study||32
10004559|NCT01737593|11127182|FG002|COMPLETED|Overall Study||39
10004560|NCT01737593|11127180|FG000|NOT COMPLETED|Overall Study||0
10004561|NCT01737593|11127181|FG001|NOT COMPLETED|Overall Study||0
10004562|NCT01737593|11127182|FG002|NOT COMPLETED|Overall Study||0
10004563|NCT01737684|11127195|FG000|STARTED|Overall Study||8
10004564|NCT01737684|11127196|FG001|STARTED|Overall Study||8
10004565|NCT01737684|11127197|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
10004566|NCT01737684|11127195|FG000|COMPLETED|Overall Study||8
10004567|NCT01737684|11127196|FG001|COMPLETED|Overall Study||8
10004568|NCT01737684|11127197|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
10004569|NCT01737684|11127195|FG000|NOT COMPLETED|Overall Study||0
10004570|NCT01737684|11127196|FG001|NOT COMPLETED|Overall Study||0
10004571|NCT01737684|11127197|FG002|NOT COMPLETED|Overall Study||0
10004572|NCT01737697|11127208|FG000|STARTED|Acute Phase-Initial 48 Hours||158
10004573|NCT01737697|11127209|FG001|STARTED|Acute Phase-Initial 48 Hours||154
10004574|NCT01737697|11127210|FG002|STARTED|Acute Phase-Initial 48 Hours||141
10004575|NCT01737697|11127211|FG003|STARTED|Acute Phase-Initial 48 Hours||158
10004576|NCT01737697|11127212|FG004|STARTED|Acute Phase-Initial 48 Hours||143
10004577|NCT01737697|11127213|FG005|STARTED|Acute Phase-Initial 48 Hours||0
10004578|NCT01737697|11127214|FG006|STARTED|Acute Phase-Initial 48 Hours||0
10004579|NCT01737697|11127215|FG007|STARTED|Acute Phase-Initial 48 Hours||0
10004580|NCT01737697|11127216|FG008|STARTED|Acute Phase-Initial 48 Hours||0
10004581|NCT01737697|11127217|FG009|STARTED|Acute Phase-Initial 48 Hours||0
10004582|NCT01737697|11127218|FG010|STARTED|Acute Phase-Initial 48 Hours||0
10004583|NCT01737697|11127219|FG011|STARTED|Acute Phase-Initial 48 Hours||0
10004584|NCT01737697|11127220|FG012|STARTED|Acute Phase-Initial 48 Hours||0
10004585|NCT01737697|11127221|FG013|STARTED|Acute Phase-Initial 48 Hours||0
10004586|NCT01737697|11127222|FG014|STARTED|Acute Phase-Initial 48 Hours||0
10004587|NCT01737697|11127208|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157
10004588|NCT01737697|11127209|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150
10004589|NCT01737697|11127210|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137
10004590|NCT01737697|11127211|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152
10004591|NCT01737697|11127212|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140
10004592|NCT01737697|11127213|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0
10004593|NCT01737697|11127214|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0
10004594|NCT01737697|11127215|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0
10004595|NCT01737697|11127216|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0
10004596|NCT01737697|11127217|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0
10004597|NCT01737697|11127218|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0
10004598|NCT01737697|11127219|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0
10004599|NCT01737697|11127220|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0
10004600|NCT01737697|11127221|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0
10004601|NCT01737697|11127222|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0
10004602|NCT01737697|11127208|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
10004603|NCT01737697|11127209|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
10004604|NCT01737697|11127210|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
10004605|NCT01737697|11127211|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
10004606|NCT01737697|11127212|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
10004607|NCT01737697|11127213|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004608|NCT01737697|11127214|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004609|NCT01737697|11127215|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004610|NCT01737697|11127216|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004611|NCT01737697|11127217|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004612|NCT01737697|11127218|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004613|NCT01737697|11127219|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004614|NCT01737697|11127220|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004615|NCT01737697|11127221|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004616|NCT01737697|11127222|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10004617|NCT01737697|11127208|FG000|STARTED|Subacute Phase||0
10004618|NCT01737697|11127209|FG001|STARTED|Subacute Phase||0
10004619|NCT01737697|11127210|FG002|STARTED|Subacute Phase||0
10004620|NCT01737697|11127211|FG003|STARTED|Subacute Phase||0
10004621|NCT01737697|11127212|FG004|STARTED|Subacute Phase||0
10004622|NCT01737697|11127213|FG005|STARTED|Subacute Phase||41
10004623|NCT01737697|11127214|FG006|STARTED|Subacute Phase||49
10004624|NCT01737697|11127215|FG007|STARTED|Subacute Phase||46
10004625|NCT01737697|11127216|FG008|STARTED|Subacute Phase||54
10004626|NCT01737697|11127217|FG009|STARTED|Subacute Phase||68
10004627|NCT01737697|11127218|FG010|STARTED|Subacute Phase||65
10004628|NCT01737697|11127219|FG011|STARTED|Subacute Phase||61
10004629|NCT01737697|11127220|FG012|STARTED|Subacute Phase||63
10004630|NCT01737697|11127221|FG013|STARTED|Subacute Phase||46
10004631|NCT01737697|11127222|FG014|STARTED|Subacute Phase||50
10004632|NCT01737697|11127208|FG000|COMPLETED|Subacute Phase||0
10004633|NCT01737697|11127209|FG001|COMPLETED|Subacute Phase||0
10004634|NCT01737697|11127210|FG002|COMPLETED|Subacute Phase||0
10004635|NCT01737697|11127211|FG003|COMPLETED|Subacute Phase||0
10004636|NCT01737697|11127212|FG004|COMPLETED|Subacute Phase||0
10004637|NCT01737697|11127213|FG005|COMPLETED|Subacute Phase||38
10004638|NCT01737697|11127214|FG006|COMPLETED|Subacute Phase||48
10004639|NCT01737697|11127215|FG007|COMPLETED|Subacute Phase||43
10004640|NCT01737697|11127216|FG008|COMPLETED|Subacute Phase||52
10004641|NCT01737697|11127217|FG009|COMPLETED|Subacute Phase||66
10004642|NCT01737697|11127218|FG010|COMPLETED|Subacute Phase||59
10004643|NCT01737697|11127219|FG011|COMPLETED|Subacute Phase||58
10004644|NCT01737697|11127220|FG012|COMPLETED|Subacute Phase||61
10004645|NCT01737697|11127221|FG013|COMPLETED|Subacute Phase||44
10004646|NCT01737697|11127222|FG014|COMPLETED|Subacute Phase||49
10004647|NCT01737697|11127208|FG000|NOT COMPLETED|Subacute Phase||0
10004648|NCT01737697|11127209|FG001|NOT COMPLETED|Subacute Phase||0
10004649|NCT01737697|11127210|FG002|NOT COMPLETED|Subacute Phase||0
10004650|NCT01737697|11127211|FG003|NOT COMPLETED|Subacute Phase||0
10004651|NCT01737697|11127212|FG004|NOT COMPLETED|Subacute Phase||0
10004652|NCT01737697|11127213|FG005|NOT COMPLETED|Subacute Phase||3
10004653|NCT01737697|11127214|FG006|NOT COMPLETED|Subacute Phase||1
10004654|NCT01737697|11127215|FG007|NOT COMPLETED|Subacute Phase||3
10004655|NCT01737697|11127216|FG008|NOT COMPLETED|Subacute Phase||2
10004656|NCT01737697|11127217|FG009|NOT COMPLETED|Subacute Phase||2
10004657|NCT01737697|11127218|FG010|NOT COMPLETED|Subacute Phase||6
10004658|NCT01737697|11127219|FG011|NOT COMPLETED|Subacute Phase||3
10004659|NCT01737697|11127220|FG012|NOT COMPLETED|Subacute Phase||2
10004660|NCT01737697|11127221|FG013|NOT COMPLETED|Subacute Phase||2
10004661|NCT01737697|11127222|FG014|NOT COMPLETED|Subacute Phase||1
10004662|NCT01737710|11127260|FG000|STARTED|Overall Study||114
10004663|NCT01737710|11127261|FG001|STARTED|Overall Study||105
10004664|NCT01737710|11127262|FG002|STARTED|Overall Study||105
10004665|NCT01737710|11127263|FG003|STARTED|Overall Study||23
10004666|NCT01737710|11127264|FG004|STARTED|Overall Study||21
10004667|NCT01737710|11127260|FG000|COMPLETED|Overall Study||112
10004668|NCT01737710|11127261|FG001|COMPLETED|Overall Study||101
10004669|NCT01737710|11127262|FG002|COMPLETED|Overall Study||102
10004670|NCT01737710|11127263|FG003|COMPLETED|Overall Study||23
10004671|NCT01737710|11127264|FG004|COMPLETED|Overall Study||21
10004672|NCT01737710|11127260|FG000|NOT COMPLETED|Overall Study||2
10004673|NCT01737710|11127261|FG001|NOT COMPLETED|Overall Study||4
10004674|NCT01737710|11127262|FG002|NOT COMPLETED|Overall Study||3
10004675|NCT01737710|11127263|FG003|NOT COMPLETED|Overall Study||0
10004676|NCT01737710|11127264|FG004|NOT COMPLETED|Overall Study||0
10004677|NCT01737762|11127277|FG000|STARTED|Overall Study||77
10004678|NCT01737762|11127278|FG001|STARTED|Overall Study||78
10004679|NCT01737762|11127277|FG000|COMPLETED|Overall Study||57
10004680|NCT01737762|11127278|FG001|COMPLETED|Overall Study||61
10004681|NCT01737762|11127277|FG000|NOT COMPLETED|Overall Study||20
10004682|NCT01737762|11127278|FG001|NOT COMPLETED|Overall Study||17
10004683|NCT01737840|11127286|FG000|STARTED|Overall Study||35
10004684|NCT01737840|11127287|FG001|STARTED|Overall Study||35
10004685|NCT01737840|11127286|FG000|COMPLETED|Overall Study||33
10103833|NCT02428478|11233511|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6
10103834|NCT02428478|11233510|FG000|COMPLETED|Second Study Night||8
10103835|NCT02428478|11233511|FG001|COMPLETED|Second Study Night||6
10103836|NCT02428478|11233510|FG000|NOT COMPLETED|Second Study Night||0
10103837|NCT02428478|11233511|FG001|NOT COMPLETED|Second Study Night||0
10103838|NCT02428595|11233517|FG000|STARTED|Fitting||137
10103839|NCT02428595|11233517|FG000|COMPLETED|Fitting||73
10103840|NCT02428595|11233517|FG000|NOT COMPLETED|Fitting||64
10103841|NCT02428595|11233517|FG000|STARTED|Treatment||73
10103842|NCT02428595|11233517|FG000|COMPLETED|Treatment||54
10103843|NCT02428595|11233517|FG000|NOT COMPLETED|Treatment||19
10103844|NCT02428608|11233530|FG000|STARTED|Overall Study||570
10103845|NCT02428608|11233530|FG000|COMPLETED|Overall Study||487
10103846|NCT02428608|11233530|FG000|NOT COMPLETED|Overall Study||83
10103847|NCT02428699|11233535|FG000|STARTED|Period 1||25
10103848|NCT02428699|11233536|FG001|STARTED|Period 1||25
10103849|NCT02428699|11233535|FG000|COMPLETED|Period 1||25
10103850|NCT02428699|11233536|FG001|COMPLETED|Period 1||25
10103851|NCT02428699|11233535|FG000|NOT COMPLETED|Period 1||0
10202295|NCT03443414|11329419|FG003|NOT COMPLETED|Overall Study||5
10202296|NCT03443414|11329420|FG004|NOT COMPLETED|Overall Study||5
10004686|NCT01737840|11127287|FG001|COMPLETED|Overall Study||33
10004687|NCT01737840|11127286|FG000|NOT COMPLETED|Overall Study||2
10004688|NCT01737840|11127287|FG001|NOT COMPLETED|Overall Study||2
10004689|NCT01737879|11127295|FG000|STARTED|Overall Study||41
10004690|NCT01737879|11127295|FG000|Received Peginesatide|Overall Study||34
10004691|NCT01737879|11127295|FG000|Transitioned to Epoetin Alfa|Overall Study||0
10004692|NCT01737879|11127295|FG000|COMPLETED|Overall Study||0
10004693|NCT01737879|11127295|FG000|NOT COMPLETED|Overall Study||41
10004694|NCT01737931|11127302|FG000|STARTED|Overall Study||38
10004695|NCT01737931|11127303|FG001|STARTED|Overall Study||40
10004696|NCT01737931|11127304|FG002|STARTED|Overall Study||39
10004697|NCT01737931|11127302|FG000|COMPLETED|Overall Study||38
10004698|NCT01737931|11127303|FG001|COMPLETED|Overall Study||38
10004699|NCT01737931|11127304|FG002|COMPLETED|Overall Study||38
10004700|NCT01737931|11127302|FG000|NOT COMPLETED|Overall Study||0
10004701|NCT01737931|11127303|FG001|NOT COMPLETED|Overall Study||2
10004702|NCT01737931|11127304|FG002|NOT COMPLETED|Overall Study||1
10004703|NCT01737944|11127314|FG000|STARTED|Overall Study||9
10004704|NCT01737944|11127315|FG001|STARTED|Overall Study||9
10004705|NCT01737944|11127316|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
10004706|NCT01737944|11127317|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
10004707|NCT01737944|11127314|FG000|COMPLETED|Overall Study||9
10004708|NCT01737944|11127315|FG001|COMPLETED|Overall Study||9
10004709|NCT01737944|11127316|FG002|COMPLETED|Overall Study||9
10004710|NCT01737944|11127317|FG003|COMPLETED|Overall Study||9
10004711|NCT01737944|11127314|FG000|NOT COMPLETED|Overall Study||0
10004712|NCT01737944|11127315|FG001|NOT COMPLETED|Overall Study||0
10004713|NCT01737944|11127316|FG002|NOT COMPLETED|Overall Study||0
10004714|NCT01737944|11127317|FG003|NOT COMPLETED|Overall Study||0
10004715|NCT01737996|11127329|FG000|STARTED|Overall Study||8
10004716|NCT01737996|11127330|FG001|STARTED|Overall Study||8
10004717|NCT01737996|11127331|FG002|STARTED|Overall Study||16
10004718|NCT01737996|11127329|FG000|COMPLETED|Overall Study||8
10004719|NCT01737996|11127330|FG001|COMPLETED|Overall Study||7
10004720|NCT01737996|11127331|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
10004721|NCT01737996|11127329|FG000|NOT COMPLETED|Overall Study||0
10004722|NCT01737996|11127330|FG001|NOT COMPLETED|Overall Study||1
10004723|NCT01737996|11127331|FG002|NOT COMPLETED|Overall Study||2
10004724|NCT01738191|11127341|FG000|STARTED|Overall Study||15
10004725|NCT01738191|11127342|FG001|STARTED|Overall Study||15
10004726|NCT01738191|11127341|FG000|COMPLETED|Overall Study||11
10004727|NCT01738191|11127342|FG001|COMPLETED|Overall Study||14
10004728|NCT01738191|11127341|FG000|NOT COMPLETED|Overall Study||4
10004729|NCT01738191|11127342|FG001|NOT COMPLETED|Overall Study||1
10004730|NCT01738321|11127350|FG000|STARTED|Overall Study||33
10004731|NCT01738321|11127351|FG001|STARTED|Overall Study||30
10004732|NCT01738321|11127350|FG000|COMPLETED|Overall Study||33
10004733|NCT01738321|11127351|FG001|COMPLETED|Overall Study||30
10004734|NCT01738321|11127350|FG000|NOT COMPLETED|Overall Study||0
10004735|NCT01738321|11127351|FG001|NOT COMPLETED|Overall Study||0
10004736|NCT01738438|11127357|FG000|STARTED|Overall Study||35
10004737|NCT01738438|11127357|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
10004738|NCT01738438|11127357|FG000|NOT COMPLETED|Overall Study||35
10004739|NCT01738477|11127363|FG000|STARTED|Overall Study||37
10004740|NCT01738477|11127364|FG001|STARTED|Overall Study||128
10004741|NCT01738477|11127363|FG000|COMPLETED|Overall Study||36
10004742|NCT01738477|11127364|FG001|COMPLETED|Overall Study||124
10004743|NCT01738477|11127363|FG000|NOT COMPLETED|Overall Study||1
10004744|NCT01738477|11127364|FG001|NOT COMPLETED|Overall Study||4
10004745|NCT01738503|11127378|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124
10004746|NCT01738503|11127379|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0
10004747|NCT01738503|11127380|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0
10004748|NCT01738503|11127381|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0
10004749|NCT01738503|11127382|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0
10004750|NCT01738503|11127383|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0
10004751|NCT01738503|11127384|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0
10004752|NCT01738503|11127378|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
10004753|NCT01738503|11127379|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004754|NCT01738503|11127380|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004755|NCT01738503|11127381|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004756|NCT01738503|11127382|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004757|NCT01738503|11127383|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004758|NCT01738503|11127384|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10103852|NCT02428699|11233536|FG001|NOT COMPLETED|Period 1||0
10103853|NCT02428699|11233535|FG000|STARTED|Washout Period 1||25
10103854|NCT02428699|11233536|FG001|STARTED|Washout Period 1||25
10103855|NCT02428699|11233535|FG000|COMPLETED|Washout Period 1||24
10103856|NCT02428699|11233536|FG001|COMPLETED|Washout Period 1||23
10103857|NCT02428699|11233535|FG000|NOT COMPLETED|Washout Period 1||1
10103858|NCT02428699|11233536|FG001|NOT COMPLETED|Washout Period 1||2
10103859|NCT02428699|11233535|FG000|STARTED|Period 2||24
10103860|NCT02428699|11233536|FG001|STARTED|Period 2||23
10103861|NCT02428699|11233535|FG000|COMPLETED|Period 2||24
10103862|NCT02428699|11233536|FG001|COMPLETED|Period 2||23
10103863|NCT02428699|11233535|FG000|NOT COMPLETED|Period 2||0
10103864|NCT02428699|11233536|FG001|NOT COMPLETED|Period 2||0
10103865|NCT02428855|11233547|FG000|STARTED|Overall Study||8
10103866|NCT02428855|11233547|FG000|COMPLETED|Overall Study||6
10103867|NCT02428855|11233547|FG000|NOT COMPLETED|Overall Study||2
10103868|NCT02429115|11233557|FG000|STARTED|Overall Study||52
10103869|NCT02429115|11233558|FG001|STARTED|Overall Study||52
10103870|NCT02429115|11233559|FG002|STARTED|Overall Study||51
10004759|NCT01738503|11127378|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
10103871|NCT02429115|11233560|FG003|STARTED|Overall Study||29
10103872|NCT02429115|11233561|FG004|STARTED|Overall Study||29
10103873|NCT02429115|11233562|FG005|STARTED|Overall Study||28
10103874|NCT02429115|11233557|FG000|COMPLETED|Overall Study||40
10103875|NCT02429115|11233558|FG001|COMPLETED|Overall Study||42
10004760|NCT01738503|11127379|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004761|NCT01738503|11127380|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004762|NCT01738503|11127381|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004763|NCT01738503|11127382|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004764|NCT01738503|11127383|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004765|NCT01738503|11127384|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10004766|NCT01738503|11127378|FG000|STARTED|Treatment Period||0
10004767|NCT01738503|11127379|FG001|STARTED|Treatment Period||15
10004768|NCT01738503|11127380|FG002|STARTED|Treatment Period||15
10004769|NCT01738503|11127381|FG003|STARTED|Treatment Period||15
10004770|NCT01738503|11127382|FG004|STARTED|Treatment Period||15
10004771|NCT01738503|11127383|FG005|STARTED|Treatment Period||15
10004772|NCT01738503|11127384|FG006|STARTED|Treatment Period||14
10004773|NCT01738503|11127378|FG000|COMPLETED|Treatment Period||0
10004774|NCT01738503|11127379|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
10004775|NCT01738503|11127380|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
10004776|NCT01738503|11127381|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
10004777|NCT01738503|11127382|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
10004778|NCT01738503|11127383|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
10004779|NCT01738503|11127384|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
10004780|NCT01738503|11127378|FG000|NOT COMPLETED|Treatment Period||0
10004781|NCT01738503|11127379|FG001|NOT COMPLETED|Treatment Period||5
10004782|NCT01738503|11127380|FG002|NOT COMPLETED|Treatment Period||5
10004783|NCT01738503|11127381|FG003|NOT COMPLETED|Treatment Period||6
10004784|NCT01738503|11127382|FG004|NOT COMPLETED|Treatment Period||8
10004785|NCT01738503|11127383|FG005|NOT COMPLETED|Treatment Period||6
10004786|NCT01738503|11127384|FG006|NOT COMPLETED|Treatment Period||8
10004787|NCT01738503|11127378|FG000|STARTED|PET Imaging Sub-study||0
10004788|NCT01738503|11127379|FG001|STARTED|PET Imaging Sub-study||0
10004789|NCT01738503|11127380|FG002|STARTED|PET Imaging Sub-study||0
10004790|NCT01738503|11127381|FG003|STARTED|PET Imaging Sub-study||0
10004791|NCT01738503|11127382|FG004|STARTED|PET Imaging Sub-study||0
10004792|NCT01738503|11127383|FG005|STARTED|PET Imaging Sub-study||3
10004793|NCT01738503|11127384|FG006|STARTED|PET Imaging Sub-study||2
10004794|NCT01738503|11127378|FG000|COMPLETED|PET Imaging Sub-study||0
10004795|NCT01738503|11127379|FG001|COMPLETED|PET Imaging Sub-study||0
10004796|NCT01738503|11127380|FG002|COMPLETED|PET Imaging Sub-study||0
10004797|NCT01738503|11127381|FG003|COMPLETED|PET Imaging Sub-study||0
10004798|NCT01738503|11127382|FG004|COMPLETED|PET Imaging Sub-study||0
10004799|NCT01738503|11127383|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
10004800|NCT01738503|11127384|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
10004801|NCT01738503|11127378|FG000|NOT COMPLETED|PET Imaging Sub-study||0
10004802|NCT01738503|11127379|FG001|NOT COMPLETED|PET Imaging Sub-study||0
10004803|NCT01738503|11127380|FG002|NOT COMPLETED|PET Imaging Sub-study||0
10004804|NCT01738503|11127381|FG003|NOT COMPLETED|PET Imaging Sub-study||0
10004805|NCT01738503|11127382|FG004|NOT COMPLETED|PET Imaging Sub-study||0
10004806|NCT01738503|11127383|FG005|NOT COMPLETED|PET Imaging Sub-study||2
10004807|NCT01738503|11127384|FG006|NOT COMPLETED|PET Imaging Sub-study||1
10004808|NCT01738581|11127408|FG000|STARTED|Overall Study||5
10004809|NCT01738581|11127409|FG001|STARTED|Overall Study||4
10004810|NCT01738581|11127408|FG000|COMPLETED|Overall Study||4
10004811|NCT01738581|11127409|FG001|COMPLETED|Overall Study||4
10004812|NCT01738581|11127408|FG000|NOT COMPLETED|Overall Study||1
10004813|NCT01738581|11127409|FG001|NOT COMPLETED|Overall Study||0
10004814|NCT01738594|11127418|FG000|STARTED|Registration and Treatment Start||0
10004815|NCT01738594|11127419|FG001|STARTED|Registration and Treatment Start||3
10004816|NCT01738594|11127420|FG002|STARTED|Registration and Treatment Start||0
10004817|NCT01738594|11127421|FG003|STARTED|Registration and Treatment Start||0
10004818|NCT01738594|11127422|FG004|STARTED|Registration and Treatment Start||1
10004819|NCT01738594|11127423|FG005|STARTED|Registration and Treatment Start||3
10004820|NCT01738594|11127424|FG006|STARTED|Registration and Treatment Start||0
10004821|NCT01738594|11127425|FG007|STARTED|Registration and Treatment Start||0
10004822|NCT01738594|11127418|FG000|Registered to Study|Registration and Treatment Start||0
10004823|NCT01738594|11127419|FG001|Registered to Study|Registration and Treatment Start||3
10004824|NCT01738594|11127420|FG002|Registered to Study|Registration and Treatment Start||0
10004825|NCT01738594|11127421|FG003|Registered to Study|Registration and Treatment Start||0
10004826|NCT01738594|11127422|FG004|Registered to Study|Registration and Treatment Start||1
10004827|NCT01738594|11127423|FG005|Registered to Study|Registration and Treatment Start||3
10004828|NCT01738594|11127424|FG006|Registered to Study|Registration and Treatment Start||0
10103876|NCT02429115|11233559|FG002|COMPLETED|Overall Study||35
10103877|NCT02429115|11233560|FG003|COMPLETED|Overall Study||21
10103878|NCT02429115|11233561|FG004|COMPLETED|Overall Study||22
10103879|NCT02429115|11233562|FG005|COMPLETED|Overall Study||27
10004829|NCT01738594|11127425|FG007|Registered to Study|Registration and Treatment Start||0
10004830|NCT01738594|11127418|FG000|Treatment Started|Registration and Treatment Start||0
10004831|NCT01738594|11127419|FG001|Treatment Started|Registration and Treatment Start||2
10004832|NCT01738594|11127420|FG002|Treatment Started|Registration and Treatment Start||0
10004833|NCT01738594|11127421|FG003|Treatment Started|Registration and Treatment Start||0
10103880|NCT02429115|11233557|FG000|NOT COMPLETED|Overall Study||12
10004834|NCT01738594|11127422|FG004|Treatment Started|Registration and Treatment Start||1
10004835|NCT01738594|11127423|FG005|Treatment Started|Registration and Treatment Start||3
10004836|NCT01738594|11127424|FG006|Treatment Started|Registration and Treatment Start||0
10004837|NCT01738594|11127425|FG007|Treatment Started|Registration and Treatment Start||0
10004838|NCT01738594|11127418|FG000|COMPLETED|Registration and Treatment Start||0
10004839|NCT01738594|11127419|FG001|COMPLETED|Registration and Treatment Start||2
10004840|NCT01738594|11127420|FG002|COMPLETED|Registration and Treatment Start||0
10004841|NCT01738594|11127421|FG003|COMPLETED|Registration and Treatment Start||0
10004842|NCT01738594|11127422|FG004|COMPLETED|Registration and Treatment Start||1
10004843|NCT01738594|11127423|FG005|COMPLETED|Registration and Treatment Start||3
10004844|NCT01738594|11127424|FG006|COMPLETED|Registration and Treatment Start||0
10004845|NCT01738594|11127425|FG007|COMPLETED|Registration and Treatment Start||0
10004846|NCT01738594|11127418|FG000|NOT COMPLETED|Registration and Treatment Start||0
10004847|NCT01738594|11127419|FG001|NOT COMPLETED|Registration and Treatment Start||1
10004848|NCT01738594|11127420|FG002|NOT COMPLETED|Registration and Treatment Start||0
10004849|NCT01738594|11127421|FG003|NOT COMPLETED|Registration and Treatment Start||0
10004850|NCT01738594|11127422|FG004|NOT COMPLETED|Registration and Treatment Start||0
10004851|NCT01738594|11127423|FG005|NOT COMPLETED|Registration and Treatment Start||0
10004852|NCT01738594|11127424|FG006|NOT COMPLETED|Registration and Treatment Start||0
10004853|NCT01738594|11127425|FG007|NOT COMPLETED|Registration and Treatment Start||0
10004854|NCT01738594|11127418|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0
10004855|NCT01738594|11127419|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2
10004856|NCT01738594|11127420|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0
10004857|NCT01738594|11127421|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0
10004858|NCT01738594|11127422|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1
10004859|NCT01738594|11127423|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3
10004860|NCT01738594|11127424|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0
10004861|NCT01738594|11127425|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0
10004862|NCT01738594|11127418|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004863|NCT01738594|11127419|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
10004864|NCT01738594|11127420|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004865|NCT01738594|11127421|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004866|NCT01738594|11127422|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
10004867|NCT01738594|11127423|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
10004868|NCT01738594|11127424|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004869|NCT01738594|11127425|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004870|NCT01738594|11127418|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004871|NCT01738594|11127419|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004872|NCT01738594|11127420|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004873|NCT01738594|11127421|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004874|NCT01738594|11127422|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004875|NCT01738594|11127423|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
10004876|NCT01738594|11127424|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004877|NCT01738594|11127425|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10004878|NCT01738594|11127418|FG000|STARTED|Completed 4 Cycles of Treatment||0
10004879|NCT01738594|11127419|FG001|STARTED|Completed 4 Cycles of Treatment||2
10004880|NCT01738594|11127420|FG002|STARTED|Completed 4 Cycles of Treatment||0
10004881|NCT01738594|11127421|FG003|STARTED|Completed 4 Cycles of Treatment||0
10004882|NCT01738594|11127422|FG004|STARTED|Completed 4 Cycles of Treatment||1
10004883|NCT01738594|11127423|FG005|STARTED|Completed 4 Cycles of Treatment||2
10004884|NCT01738594|11127424|FG006|STARTED|Completed 4 Cycles of Treatment||0
10004885|NCT01738594|11127425|FG007|STARTED|Completed 4 Cycles of Treatment||0
10004886|NCT01738594|11127418|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
10004887|NCT01738594|11127419|FG001|COMPLETED|Completed 4 Cycles of Treatment||0
10004888|NCT01738594|11127420|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
10004889|NCT01738594|11127421|FG003|COMPLETED|Completed 4 Cycles of Treatment||0
10004890|NCT01738594|11127422|FG004|COMPLETED|Completed 4 Cycles of Treatment||1
10004891|NCT01738594|11127423|FG005|COMPLETED|Completed 4 Cycles of Treatment||1
10004892|NCT01738594|11127424|FG006|COMPLETED|Completed 4 Cycles of Treatment||0
10004893|NCT01738594|11127425|FG007|COMPLETED|Completed 4 Cycles of Treatment||0
10004894|NCT01738594|11127418|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10004895|NCT01738594|11127419|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2
10004896|NCT01738594|11127420|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10004897|NCT01738594|11127421|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10004898|NCT01738594|11127422|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10004899|NCT01738594|11127423|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1
10004900|NCT01738594|11127424|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10004901|NCT01738594|11127425|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10004902|NCT01738594|11127418|FG000|STARTED|Went on to Continue Treatment Cycle 5||0
10004903|NCT01738594|11127419|FG001|STARTED|Went on to Continue Treatment Cycle 5||0
10004904|NCT01738594|11127420|FG002|STARTED|Went on to Continue Treatment Cycle 5||0
10004905|NCT01738594|11127421|FG003|STARTED|Went on to Continue Treatment Cycle 5||0
10004906|NCT01738594|11127422|FG004|STARTED|Went on to Continue Treatment Cycle 5||1
10004907|NCT01738594|11127423|FG005|STARTED|Went on to Continue Treatment Cycle 5||1
10004908|NCT01738594|11127424|FG006|STARTED|Went on to Continue Treatment Cycle 5||0
10004909|NCT01738594|11127425|FG007|STARTED|Went on to Continue Treatment Cycle 5||0
10004910|NCT01738594|11127418|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004911|NCT01738594|11127419|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004912|NCT01738594|11127420|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004913|NCT01738594|11127421|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004914|NCT01738594|11127422|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004915|NCT01738594|11127423|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004916|NCT01738594|11127424|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004917|NCT01738594|11127425|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0
10004918|NCT01738594|11127418|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10004919|NCT01738594|11127419|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10004920|NCT01738594|11127420|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10004921|NCT01738594|11127421|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10004922|NCT01738594|11127422|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
10004923|NCT01738594|11127423|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
10004924|NCT01738594|11127424|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10004925|NCT01738594|11127425|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10004926|NCT01738594|11127418|FG000|STARTED|Follow up for 1 Year||0
10004927|NCT01738594|11127419|FG001|STARTED|Follow up for 1 Year||2
10004928|NCT01738594|11127420|FG002|STARTED|Follow up for 1 Year||0
10004929|NCT01738594|11127421|FG003|STARTED|Follow up for 1 Year||0
10004930|NCT01738594|11127422|FG004|STARTED|Follow up for 1 Year||1
10004931|NCT01738594|11127423|FG005|STARTED|Follow up for 1 Year||3
10004932|NCT01738594|11127424|FG006|STARTED|Follow up for 1 Year||0
10004933|NCT01738594|11127425|FG007|STARTED|Follow up for 1 Year||0
10004934|NCT01738594|11127418|FG000|COMPLETED|Follow up for 1 Year||0
10004935|NCT01738594|11127419|FG001|COMPLETED|Follow up for 1 Year||2
10004936|NCT01738594|11127420|FG002|COMPLETED|Follow up for 1 Year||0
10004937|NCT01738594|11127421|FG003|COMPLETED|Follow up for 1 Year||0
10004938|NCT01738594|11127422|FG004|COMPLETED|Follow up for 1 Year||1
10004939|NCT01738594|11127423|FG005|COMPLETED|Follow up for 1 Year||0
10004940|NCT01738594|11127424|FG006|COMPLETED|Follow up for 1 Year||0
10004941|NCT01738594|11127425|FG007|COMPLETED|Follow up for 1 Year||0
10004942|NCT01738594|11127418|FG000|NOT COMPLETED|Follow up for 1 Year||0
10004943|NCT01738594|11127419|FG001|NOT COMPLETED|Follow up for 1 Year||0
10004944|NCT01738594|11127420|FG002|NOT COMPLETED|Follow up for 1 Year||0
10004945|NCT01738594|11127421|FG003|NOT COMPLETED|Follow up for 1 Year||0
10004946|NCT01738594|11127422|FG004|NOT COMPLETED|Follow up for 1 Year||0
10004947|NCT01738594|11127423|FG005|NOT COMPLETED|Follow up for 1 Year||3
10004948|NCT01738594|11127424|FG006|NOT COMPLETED|Follow up for 1 Year||0
10004949|NCT01738594|11127425|FG007|NOT COMPLETED|Follow up for 1 Year||0
10004950|NCT01738646|11127435|FG000|STARTED|Overall Study||40
10004951|NCT01738646|11127435|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
10004952|NCT01738646|11127435|FG000|NOT COMPLETED|Overall Study||2
10004953|NCT01738672|11127440|FG000|STARTED|Overall Study||16
10004954|NCT01738672|11127440|FG000|COMPLETED|Overall Study||11
10004955|NCT01738672|11127440|FG000|NOT COMPLETED|Overall Study||5
10004956|NCT01738737|11127449|FG000|STARTED|Overall Study||29
10004957|NCT01738737|11127450|FG001|STARTED|Overall Study||29
10004958|NCT01738737|11127451|FG002|STARTED|Overall Study||29
10004959|NCT01738737|11127452|FG003|STARTED|Overall Study||29
10004960|NCT01738737|11127453|FG004|STARTED|Overall Study||29
10004961|NCT01738737|11127449|FG000|COMPLETED|Overall Study||25
10004962|NCT01738737|11127450|FG001|COMPLETED|Overall Study||25
10004963|NCT01738737|11127451|FG002|COMPLETED|Overall Study||25
10004964|NCT01738737|11127452|FG003|COMPLETED|Overall Study||25
10004965|NCT01738737|11127453|FG004|COMPLETED|Overall Study||25
10004966|NCT01738737|11127449|FG000|NOT COMPLETED|Overall Study||4
10004967|NCT01738737|11127450|FG001|NOT COMPLETED|Overall Study||4
10004968|NCT01738737|11127451|FG002|NOT COMPLETED|Overall Study||4
10004969|NCT01738737|11127452|FG003|NOT COMPLETED|Overall Study||4
10004970|NCT01738737|11127453|FG004|NOT COMPLETED|Overall Study||4
10004971|NCT01738750|11127467|FG000|STARTED|Overall Study||49
10004972|NCT01738750|11127468|FG001|STARTED|Overall Study||51
10004973|NCT01738750|11127467|FG000|COMPLETED|Overall Study||49
10004974|NCT01738750|11127468|FG001|COMPLETED|Overall Study||51
10004975|NCT01738750|11127467|FG000|NOT COMPLETED|Overall Study||0
10004976|NCT01738750|11127468|FG001|NOT COMPLETED|Overall Study||0
10004977|NCT01738919|11127478|FG000|STARTED|Overall Study||15
10004978|NCT01738919|11127479|FG001|STARTED|Overall Study||17
10004979|NCT01738919|11127478|FG000|COMPLETED|Overall Study||14
10004980|NCT01738919|11127479|FG001|COMPLETED|Overall Study||14
10004981|NCT01738919|11127478|FG000|NOT COMPLETED|Overall Study||1
10004982|NCT01738919|11127479|FG001|NOT COMPLETED|Overall Study||3
10004983|NCT01738971|11127490|FG000|STARTED|Overall Study|54 participants recruited to this arm|54
10004984|NCT01738971|11127491|FG001|STARTED|Overall Study|58 participants recruited to this arm|58
10004985|NCT01738971|11127492|FG002|STARTED|Overall Study|56 participants recruited to this arm|56
10004986|NCT01738971|11127490|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
10004987|NCT01738971|11127491|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
10004988|NCT01738971|11127492|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
10004989|NCT01738971|11127490|FG000|NOT COMPLETED|Overall Study||19
10004990|NCT01738971|11127491|FG001|NOT COMPLETED|Overall Study||30
10004991|NCT01738971|11127492|FG002|NOT COMPLETED|Overall Study||17
10004992|NCT01738984|11127502|FG000|STARTED|Overall Study||250
10004993|NCT01738984|11127503|FG001|STARTED|Overall Study||249
10004994|NCT01738984|11127502|FG000|COMPLETED|Overall Study||186
10004995|NCT01738984|11127503|FG001|COMPLETED|Overall Study||210
10004996|NCT01738984|11127502|FG000|NOT COMPLETED|Overall Study||64
10004997|NCT01738984|11127503|FG001|NOT COMPLETED|Overall Study||39
10004998|NCT01739231|11127515|FG000|STARTED|Part A||24
10004999|NCT01739231|11127516|FG001|STARTED|Part A||24
10005000|NCT01739231|11127517|FG002|STARTED|Part A||12
10005001|NCT01739231|11127518|FG003|STARTED|Part A||0
10005002|NCT01739231|11127515|FG000|Received All 3 Vaccinations|Part A||21
10005003|NCT01739231|11127516|FG001|Received All 3 Vaccinations|Part A||20
10005004|NCT01739231|11127517|FG002|Received All 3 Vaccinations|Part A||12
10005005|NCT01739231|11127518|FG003|Received All 3 Vaccinations|Part A||0
10005006|NCT01739231|11127515|FG000|COMPLETED|Part A||20
10005007|NCT01739231|11127516|FG001|COMPLETED|Part A||17
10005008|NCT01739231|11127517|FG002|COMPLETED|Part A||12
10005009|NCT01739231|11127518|FG003|COMPLETED|Part A||0
10005010|NCT01739231|11127515|FG000|NOT COMPLETED|Part A||4
10005011|NCT01739231|11127516|FG001|NOT COMPLETED|Part A||7
10005012|NCT01739231|11127517|FG002|NOT COMPLETED|Part A||0
10005013|NCT01739231|11127518|FG003|NOT COMPLETED|Part A||0
10005014|NCT01739231|11127515|FG000|STARTED|Part B||20
10005015|NCT01739231|11127516|FG001|STARTED|Part B||17
10005016|NCT01739231|11127517|FG002|STARTED|Part B||12
10005017|NCT01739231|11127518|FG003|STARTED|Part B||21
10005018|NCT01739231|11127515|FG000|Challenged|Part B||13
10005019|NCT01739231|11127516|FG001|Challenged|Part B||13
10005020|NCT01739231|11127517|FG002|Challenged|Part B||10
10005021|NCT01739231|11127518|FG003|Challenged|Part B||21
10005022|NCT01739231|11127515|FG000|COMPLETED|Part B||13
10005023|NCT01739231|11127516|FG001|COMPLETED|Part B||12
10005024|NCT01739231|11127517|FG002|COMPLETED|Part B||10
10005025|NCT01739231|11127518|FG003|COMPLETED|Part B||19
10005026|NCT01739231|11127515|FG000|NOT COMPLETED|Part B||7
10005027|NCT01739231|11127516|FG001|NOT COMPLETED|Part B||5
10005028|NCT01739231|11127517|FG002|NOT COMPLETED|Part B||2
10005029|NCT01739231|11127518|FG003|NOT COMPLETED|Part B||2
10005030|NCT01739309|11127536|FG000|STARTED|Overall Study||28
10005031|NCT01739309|11127536|FG000|Received at Least One Dose of Study Drug|Overall Study||28
10005032|NCT01739309|11127536|FG000|Death Due to Any Cause|Overall Study||17
10005033|NCT01739309|11127536|FG000|Alive and on Study, Off Treatment|Overall Study||8
10005034|NCT01739309|11127536|FG000|COMPLETED|Overall Study||25
10005035|NCT01739309|11127536|FG000|NOT COMPLETED|Overall Study||3
10005036|NCT01739335|11127544|FG000|STARTED|Overall Study||41
10005037|NCT01739335|11127545|FG001|STARTED|Overall Study||40
10005038|NCT01739335|11127544|FG000|COMPLETED|Overall Study||34
10005039|NCT01739335|11127545|FG001|COMPLETED|Overall Study||35
10005040|NCT01739335|11127544|FG000|NOT COMPLETED|Overall Study||7
10005041|NCT01739335|11127545|FG001|NOT COMPLETED|Overall Study||5
10005042|NCT01739348|11127559|FG000|STARTED|Part I (Base Study)||703
10005043|NCT01739348|11127560|FG001|STARTED|Part I (Base Study)||700
10005044|NCT01739348|11127561|FG002|STARTED|Part I (Base Study)||103
10005045|NCT01739348|11127562|FG003|STARTED|Part I (Base Study)||705
10005046|NCT01739348|11127559|FG000|Treated|Part I (Base Study)||702
10005047|NCT01739348|11127560|FG001|Treated|Part I (Base Study)||700
10005048|NCT01739348|11127561|FG002|Treated|Part I (Base Study)||103
10005049|NCT01739348|11127562|FG003|Treated|Part I (Base Study)||705
10005050|NCT01739348|11127559|FG000|COMPLETED|Part I (Base Study)||501
10005051|NCT01739348|11127560|FG001|COMPLETED|Part I (Base Study)||497
10005052|NCT01739348|11127561|FG002|COMPLETED|Part I (Base Study)||77
10005053|NCT01739348|11127562|FG003|COMPLETED|Part I (Base Study)||516
10005054|NCT01739348|11127559|FG000|NOT COMPLETED|Part I (Base Study)||202
10005055|NCT01739348|11127560|FG001|NOT COMPLETED|Part I (Base Study)||203
10005056|NCT01739348|11127561|FG002|NOT COMPLETED|Part I (Base Study)||26
10005057|NCT01739348|11127562|FG003|NOT COMPLETED|Part I (Base Study)||189
10005058|NCT01739348|11127559|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
10005059|NCT01739348|11127560|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
10005060|NCT01739348|11127561|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
10005061|NCT01739348|11127562|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
10005062|NCT01739348|11127559|FG000|Treated|Part II (Extension Study)||379
10005063|NCT01739348|11127560|FG001|Treated|Part II (Extension Study)||365
10005064|NCT01739348|11127561|FG002|Treated|Part II (Extension Study)||61
10005065|NCT01739348|11127562|FG003|Treated|Part II (Extension Study)||394
10005066|NCT01739348|11127559|FG000|COMPLETED|Part II (Extension Study)||0
10005067|NCT01739348|11127560|FG001|COMPLETED|Part II (Extension Study)||0
10005068|NCT01739348|11127561|FG002|COMPLETED|Part II (Extension Study)||0
10005069|NCT01739348|11127562|FG003|COMPLETED|Part II (Extension Study)||0
10005070|NCT01739348|11127559|FG000|NOT COMPLETED|Part II (Extension Study)||379
10005071|NCT01739348|11127560|FG001|NOT COMPLETED|Part II (Extension Study)||366
10005072|NCT01739348|11127561|FG002|NOT COMPLETED|Part II (Extension Study)||61
10005073|NCT01739348|11127562|FG003|NOT COMPLETED|Part II (Extension Study)||396
10005074|NCT01739361|11127578|FG000|STARTED|Overall Study||21
10005075|NCT01739361|11127579|FG001|STARTED|Overall Study||23
10005076|NCT01739361|11127578|FG000|COMPLETED|Overall Study||18
10005077|NCT01739361|11127579|FG001|COMPLETED|Overall Study||22
10005078|NCT01739361|11127578|FG000|NOT COMPLETED|Overall Study||3
10005079|NCT01739361|11127579|FG001|NOT COMPLETED|Overall Study||1
10005080|NCT01739400|11127587|FG000|STARTED|Overall Study||109
10005081|NCT01739400|11127588|FG001|STARTED|Overall Study||108
10005082|NCT01739400|11127587|FG000|Treated With 10 mg Macitentan|Overall Study||109
10005083|NCT01739400|11127588|FG001|Treated With 10 mg Macitentan|Overall Study||108
10005084|NCT01739400|11127587|FG000|COMPLETED|Overall Study||92
10005085|NCT01739400|11127588|FG001|COMPLETED|Overall Study||99
10005086|NCT01739400|11127587|FG000|NOT COMPLETED|Overall Study||17
10005087|NCT01739400|11127588|FG001|NOT COMPLETED|Overall Study||9
10005088|NCT01739595|11127596|FG000|STARTED|Overall Study||112
10005089|NCT01739595|11127597|FG001|STARTED|Overall Study||22
10005090|NCT01739595|11127598|FG002|STARTED|Overall Study||47
10005091|NCT01739595|11127596|FG000|COMPLETED|Overall Study||99
10005092|NCT01739595|11127597|FG001|COMPLETED|Overall Study||21
10005093|NCT01739595|11127598|FG002|COMPLETED|Overall Study||45
10005094|NCT01739595|11127596|FG000|NOT COMPLETED|Overall Study||13
10005095|NCT01739595|11127597|FG001|NOT COMPLETED|Overall Study||1
10005096|NCT01739595|11127598|FG002|NOT COMPLETED|Overall Study||2
10005097|NCT01739699|11127607|FG000|STARTED|Overall Study||70
10005098|NCT01739699|11127608|FG001|STARTED|Overall Study||70
10005099|NCT01739699|11127607|FG000|COMPLETED|Overall Study||66
10005100|NCT01739699|11127608|FG001|COMPLETED|Overall Study||65
10005101|NCT01739699|11127607|FG000|NOT COMPLETED|Overall Study||4
10005102|NCT01739699|11127608|FG001|NOT COMPLETED|Overall Study||5
10005103|NCT01739764|11127617|FG000|STARTED|Overall Study||29
10005104|NCT01739764|11127618|FG001|STARTED|Overall Study||40
10005105|NCT01739764|11127619|FG002|STARTED|Overall Study||146
10005106|NCT01739764|11127617|FG000|COMPLETED|Overall Study||3
10005107|NCT01739764|11127618|FG001|COMPLETED|Overall Study||4
10005108|NCT01739764|11127619|FG002|COMPLETED|Overall Study||20
10005109|NCT01739764|11127617|FG000|NOT COMPLETED|Overall Study||26
10005110|NCT01739764|11127618|FG001|NOT COMPLETED|Overall Study||36
10005111|NCT01739764|11127619|FG002|NOT COMPLETED|Overall Study||126
10005112|NCT01739790|11127629|FG000|STARTED|Overall Study||24
10005113|NCT01739790|11127630|FG001|STARTED|Overall Study||27
10005114|NCT01739790|11127629|FG000|COMPLETED|Overall Study||22
10005115|NCT01739790|11127630|FG001|COMPLETED|Overall Study||23
10005116|NCT01739790|11127629|FG000|NOT COMPLETED|Overall Study||2
10005117|NCT01739790|11127630|FG001|NOT COMPLETED|Overall Study||4
10005118|NCT01739803|11127638|FG000|STARTED|Overall Study||76
10005119|NCT01739803|11127639|FG001|STARTED|Overall Study||74
10005120|NCT01739803|11127638|FG000|COMPLETED|Overall Study||67
10005121|NCT01739803|11127639|FG001|COMPLETED|Overall Study||68
10005122|NCT01739803|11127638|FG000|NOT COMPLETED|Overall Study||9
10005123|NCT01739803|11127639|FG001|NOT COMPLETED|Overall Study||6
10005124|NCT01739933|11127647|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214
10005125|NCT01739933|11127648|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208
10005126|NCT01739933|11127647|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
10005127|NCT01739933|11127648|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
10005128|NCT01739933|11127647|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
10005129|NCT01739933|11127648|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
10005130|NCT01739933|11127647|FG000|NOT COMPLETED|Overall Study||106
10005131|NCT01739933|11127648|FG001|NOT COMPLETED|Overall Study||107
10005132|NCT01740089|11127657|FG000|STARTED|First 12 Weeks of Treatment||50
10005133|NCT01740089|11127658|FG001|STARTED|First 12 Weeks of Treatment||50
10005134|NCT01740089|11127659|FG002|STARTED|First 12 Weeks of Treatment||50
10005135|NCT01740089|11127657|FG000|COMPLETED|First 12 Weeks of Treatment||50
10005136|NCT01740089|11127658|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
10005137|NCT01740089|11127659|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
10005138|NCT01740089|11127657|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0
10005139|NCT01740089|11127658|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2
10005140|NCT01740089|11127659|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2
10005141|NCT01740089|11127657|FG000|STARTED|After 12 Weeks||50
10005142|NCT01740089|11127658|FG001|STARTED|After 12 Weeks||48
10005143|NCT01740089|11127659|FG002|STARTED|After 12 Weeks||48
10005144|NCT01740089|11127657|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
10005145|NCT01740089|11127658|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
10005146|NCT01740089|11127659|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
10005147|NCT01740089|11127657|FG000|NOT COMPLETED|After 12 Weeks||7
10005148|NCT01740089|11127658|FG001|NOT COMPLETED|After 12 Weeks||3
10005149|NCT01740089|11127659|FG002|NOT COMPLETED|After 12 Weeks||11
10005150|NCT01740128|11127670|FG000|STARTED|Overall Study||10
10005151|NCT01740128|11127671|FG001|STARTED|Overall Study||11
10005152|NCT01740128|11127670|FG000|COMPLETED|Overall Study||4
10005153|NCT01740128|11127671|FG001|COMPLETED|Overall Study||4
10005154|NCT01740128|11127670|FG000|NOT COMPLETED|Overall Study||6
10005155|NCT01740128|11127671|FG001|NOT COMPLETED|Overall Study||7
10005156|NCT01740206|11127679|FG000|STARTED|Overall Study||14
10005157|NCT01740206|11127680|FG001|STARTED|Overall Study||34
10005158|NCT01740206|11127679|FG000|COMPLETED|Overall Study||14
10005159|NCT01740206|11127680|FG001|COMPLETED|Overall Study||34
10103881|NCT02429115|11233558|FG001|NOT COMPLETED|Overall Study||10
10103882|NCT02429115|11233559|FG002|NOT COMPLETED|Overall Study||16
10103883|NCT02429115|11233560|FG003|NOT COMPLETED|Overall Study||8
10103884|NCT02429115|11233561|FG004|NOT COMPLETED|Overall Study||7
10103885|NCT02429115|11233562|FG005|NOT COMPLETED|Overall Study||1
10103886|NCT02429258|11233578|FG000|STARTED|Overall Study||50
10103887|NCT02429258|11233579|FG001|STARTED|Overall Study||50
10005160|NCT01740206|11127679|FG000|NOT COMPLETED|Overall Study||0
10005161|NCT01740206|11127680|FG001|NOT COMPLETED|Overall Study||0
10005162|NCT01740258|11127686|FG000|STARTED|Overall Study||68
10005163|NCT01740258|11127686|FG000|Entered Part A|Overall Study||68
10005164|NCT01740258|11127686|FG000|Entered Part B|Overall Study||62
10005165|NCT01740258|11127686|FG000|Entered Part C|Overall Study||20
10005166|NCT01740258|11127686|FG000|Entered Part D|Overall Study||42
10005167|NCT01740258|11127686|FG000|COMPLETED|Overall Study||68
10005168|NCT01740258|11127686|FG000|NOT COMPLETED|Overall Study||0
10005169|NCT01740323|11127692|FG000|STARTED|Overall Study||15
10005170|NCT01740323|11127693|FG001|STARTED|Overall Study||15
10005171|NCT01740323|11127692|FG000|COMPLETED|Overall Study||13
10005172|NCT01740323|11127693|FG001|COMPLETED|Overall Study||15
10005173|NCT01740323|11127692|FG000|NOT COMPLETED|Overall Study||2
10005174|NCT01740323|11127693|FG001|NOT COMPLETED|Overall Study||0
10005175|NCT01740362|11127703|FG000|STARTED|Overall Study||6
10005176|NCT01740362|11127704|FG001|STARTED|Overall Study||6
10005177|NCT01740362|11127705|FG002|STARTED|Overall Study||6
10005178|NCT01740362|11127706|FG003|STARTED|Overall Study||6
10005179|NCT01740362|11127703|FG000|COMPLETED|Overall Study||6
10005180|NCT01740362|11127704|FG001|COMPLETED|Overall Study||6
10005181|NCT01740362|11127705|FG002|COMPLETED|Overall Study||6
10005182|NCT01740362|11127706|FG003|COMPLETED|Overall Study||6
10005183|NCT01740362|11127703|FG000|NOT COMPLETED|Overall Study||0
10005184|NCT01740362|11127704|FG001|NOT COMPLETED|Overall Study||0
10005185|NCT01740362|11127705|FG002|NOT COMPLETED|Overall Study||0
10005186|NCT01740362|11127706|FG003|NOT COMPLETED|Overall Study||0
10005187|NCT01740388|11127718|FG000|STARTED|Overall Study||64
10005188|NCT01740388|11127719|FG001|STARTED|Overall Study||72
10005189|NCT01740388|11127718|FG000|COMPLETED|Overall Study||18
10005190|NCT01740388|11127719|FG001|COMPLETED|Overall Study||28
10005191|NCT01740388|11127718|FG000|NOT COMPLETED|Overall Study||46
10005192|NCT01740388|11127719|FG001|NOT COMPLETED|Overall Study||44
10005193|NCT01740401|11127725|FG000|STARTED|Overall Study||10
10005194|NCT01740401|11127725|FG000|COMPLETED|Overall Study||0
10005195|NCT01740401|11127725|FG000|NOT COMPLETED|Overall Study||10
10005196|NCT01740414|11127731|FG000|STARTED|Overall Study||12
10005197|NCT01740414|11127732|FG001|STARTED|Overall Study||16
10005198|NCT01740414|11127731|FG000|COMPLETED|Overall Study||3
10005199|NCT01740414|11127732|FG001|COMPLETED|Overall Study||8
10005200|NCT01740414|11127731|FG000|NOT COMPLETED|Overall Study||9
10005201|NCT01740414|11127732|FG001|NOT COMPLETED|Overall Study||8
10005202|NCT01740440|11127743|FG000|STARTED|Overall Study||30
10005203|NCT01740440|11127743|FG000|COMPLETED|Overall Study||27
10005204|NCT01740440|11127743|FG000|NOT COMPLETED|Overall Study||3
10005205|NCT01740713|11127751|FG000|STARTED|Overall Study||6
10005206|NCT01740713|11127752|FG001|STARTED|Overall Study||8
10005207|NCT01740713|11127753|FG002|STARTED|Overall Study||7
10103888|NCT02429258|11233578|FG000|COMPLETED|Overall Study||48
10005208|NCT01740713|11127751|FG000|COMPLETED|Overall Study||6
10005209|NCT01740713|11127752|FG001|COMPLETED|Overall Study||6
10005210|NCT01740713|11127753|FG002|COMPLETED|Overall Study||6
10005211|NCT01740713|11127751|FG000|NOT COMPLETED|Overall Study||0
10005212|NCT01740713|11127752|FG001|NOT COMPLETED|Overall Study||2
10005213|NCT01740713|11127753|FG002|NOT COMPLETED|Overall Study||1
10005214|NCT01740726|11127765|FG000|STARTED|Overall Study||0
10005215|NCT01740726|11127766|FG001|STARTED|Overall Study||1
10005216|NCT01740726|11127765|FG000|COMPLETED|Overall Study||0
10005217|NCT01740726|11127766|FG001|COMPLETED|Overall Study||1
10005218|NCT01740726|11127765|FG000|NOT COMPLETED|Overall Study||0
10005219|NCT01740726|11127766|FG001|NOT COMPLETED|Overall Study||0
10005220|NCT01740791|11127778|FG000|STARTED|Overall Study||22
10005221|NCT01740791|11127779|FG001|STARTED|Overall Study||7
10005222|NCT01740791|11127780|FG002|STARTED|Overall Study||17
10005223|NCT01740791|11127781|FG003|STARTED|Overall Study||14
10005224|NCT01740791|11127782|FG004|STARTED|Overall Study||9
10005225|NCT01740791|11127783|FG005|STARTED|Overall Study||34
10005226|NCT01740791|11127778|FG000|COMPLETED|Overall Study||10
10103889|NCT02429258|11233579|FG001|COMPLETED|Overall Study||49
10103890|NCT02429258|11233578|FG000|NOT COMPLETED|Overall Study||2
10103891|NCT02429258|11233579|FG001|NOT COMPLETED|Overall Study||1
10103892|NCT02429310|11233587|FG000|STARTED|Overall Study||22
10005227|NCT01740791|11127779|FG001|COMPLETED|Overall Study||4
10103893|NCT02429310|11233588|FG001|STARTED|Overall Study||20
10005228|NCT01740791|11127780|FG002|COMPLETED|Overall Study||11
10005229|NCT01740791|11127781|FG003|COMPLETED|Overall Study||7
10005230|NCT01740791|11127782|FG004|COMPLETED|Overall Study||6
10005231|NCT01740791|11127783|FG005|COMPLETED|Overall Study||23
10005232|NCT01740791|11127778|FG000|NOT COMPLETED|Overall Study||12
10005233|NCT01740791|11127779|FG001|NOT COMPLETED|Overall Study||3
10005234|NCT01740791|11127780|FG002|NOT COMPLETED|Overall Study||6
10005235|NCT01740791|11127781|FG003|NOT COMPLETED|Overall Study||7
10005236|NCT01740791|11127782|FG004|NOT COMPLETED|Overall Study||3
10005237|NCT01740791|11127783|FG005|NOT COMPLETED|Overall Study||11
10005238|NCT01740817|11127838|FG000|STARTED|First Intervention (48 h)||8
10005239|NCT01740817|11127839|FG001|STARTED|First Intervention (48 h)||4
10005240|NCT01740817|11127838|FG000|COMPLETED|First Intervention (48 h)||8
10005241|NCT01740817|11127839|FG001|COMPLETED|First Intervention (48 h)||4
10005242|NCT01740817|11127838|FG000|NOT COMPLETED|First Intervention (48 h)||0
10005243|NCT01740817|11127839|FG001|NOT COMPLETED|First Intervention (48 h)||0
10005244|NCT01740817|11127838|FG000|STARTED|Washout (4-6 Weeks)||8
10005245|NCT01740817|11127839|FG001|STARTED|Washout (4-6 Weeks)||4
10005246|NCT01740817|11127838|FG000|COMPLETED|Washout (4-6 Weeks)||8
10005247|NCT01740817|11127839|FG001|COMPLETED|Washout (4-6 Weeks)||4
10005248|NCT01740817|11127838|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0
10005249|NCT01740817|11127839|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0
10005250|NCT01740817|11127838|FG000|STARTED|Second Intervention (48 h)||8
10005251|NCT01740817|11127839|FG001|STARTED|Second Intervention (48 h)||4
10005252|NCT01740817|11127838|FG000|COMPLETED|Second Intervention (48 h)||8
10005253|NCT01740817|11127839|FG001|COMPLETED|Second Intervention (48 h)||4
10005254|NCT01740817|11127838|FG000|NOT COMPLETED|Second Intervention (48 h)||0
10005255|NCT01740817|11127839|FG001|NOT COMPLETED|Second Intervention (48 h)||0
10005256|NCT01741012|11127845|FG000|STARTED|Overall Study||37
10005257|NCT01741012|11127845|FG000|COMPLETED|Overall Study||34
10005258|NCT01741012|11127845|FG000|NOT COMPLETED|Overall Study||3
10005259|NCT01741259|11127852|FG000|STARTED|Overall Study||133
10005260|NCT01741259|11127853|FG001|STARTED|Overall Study||135
10005261|NCT01741259|11127852|FG000|COMPLETED|Overall Study||127
10005262|NCT01741259|11127853|FG001|COMPLETED|Overall Study||129
10005263|NCT01741259|11127852|FG000|NOT COMPLETED|Overall Study||6
10005264|NCT01741259|11127853|FG001|NOT COMPLETED|Overall Study||6
10005265|NCT01741272|11127861|FG000|STARTED|Overall Study||92
10005266|NCT01741272|11127862|FG001|STARTED|Overall Study||97
10005267|NCT01741272|11127861|FG000|COMPLETED|Overall Study||92
10005268|NCT01741272|11127862|FG001|COMPLETED|Overall Study||97
10005269|NCT01741272|11127861|FG000|NOT COMPLETED|Overall Study||0
10005270|NCT01741272|11127862|FG001|NOT COMPLETED|Overall Study||0
10005271|NCT01741350|11127870|FG000|STARTED|Study Intervention||149
10005272|NCT01741350|11127871|FG001|STARTED|Study Intervention||155
10005273|NCT01741350|11127870|FG000|COMPLETED|Study Intervention||149
10005274|NCT01741350|11127871|FG001|COMPLETED|Study Intervention||155
10005275|NCT01741350|11127870|FG000|NOT COMPLETED|Study Intervention||0
10005276|NCT01741350|11127871|FG001|NOT COMPLETED|Study Intervention||0
10005277|NCT01741350|11127870|FG000|STARTED|Post Intervention Assessment (at Week 4)||149
10005278|NCT01741350|11127871|FG001|STARTED|Post Intervention Assessment (at Week 4)||155
10005279|NCT01741350|11127870|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135
10005280|NCT01741350|11127871|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141
10005281|NCT01741350|11127870|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
10005282|NCT01741350|11127871|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
10005283|NCT01741350|11127870|FG000|STARTED|3-Month Follow-up Assessment||135
10005284|NCT01741350|11127871|FG001|STARTED|3-Month Follow-up Assessment||141
10005285|NCT01741350|11127870|FG000|COMPLETED|3-Month Follow-up Assessment||129
10005286|NCT01741350|11127871|FG001|COMPLETED|3-Month Follow-up Assessment||119
10005287|NCT01741350|11127870|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6
10005288|NCT01741350|11127871|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22
10005289|NCT01741350|11127870|FG000|STARTED|6-Month Follow-up Assessment||129
10005290|NCT01741350|11127871|FG001|STARTED|6-Month Follow-up Assessment||119
10005291|NCT01741350|11127870|FG000|COMPLETED|6-Month Follow-up Assessment||114
10005292|NCT01741350|11127871|FG001|COMPLETED|6-Month Follow-up Assessment||111
10005293|NCT01741350|11127870|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15
10005294|NCT01741350|11127871|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8
10005295|NCT01741350|11127870|FG000|STARTED|12-Month Follow-up Assessment||114
10005296|NCT01741350|11127871|FG001|STARTED|12-Month Follow-up Assessment||111
10005297|NCT01741350|11127870|FG000|COMPLETED|12-Month Follow-up Assessment||111
10005298|NCT01741350|11127871|FG001|COMPLETED|12-Month Follow-up Assessment||109
10005299|NCT01741350|11127870|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3
10005300|NCT01741350|11127871|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2
10005301|NCT01741454|11127881|FG000|STARTED|Overall Study||49
10005302|NCT01741454|11127882|FG001|STARTED|Overall Study||50
10005303|NCT01741454|11127883|FG002|STARTED|Overall Study||39
10005304|NCT01741454|11127884|FG003|STARTED|Overall Study||43
10005305|NCT01741454|11127881|FG000|COMPLETED|Overall Study||36
10005306|NCT01741454|11127882|FG001|COMPLETED|Overall Study||44
10005307|NCT01741454|11127883|FG002|COMPLETED|Overall Study||22
10103894|NCT02429310|11233587|FG000|COMPLETED|Overall Study||20
10103895|NCT02429310|11233588|FG001|COMPLETED|Overall Study||17
10103896|NCT02429310|11233587|FG000|NOT COMPLETED|Overall Study||2
10103897|NCT02429310|11233588|FG001|NOT COMPLETED|Overall Study||3
10103898|NCT02429427|11233596|FG000|STARTED|Overall Study||1763
10103899|NCT02429427|11233597|FG001|STARTED|Overall Study||876
10103900|NCT02429427|11233596|FG000|COMPLETED|Overall Study||1392
10103901|NCT02429427|11233597|FG001|COMPLETED|Overall Study||697
10103902|NCT02429427|11233596|FG000|NOT COMPLETED|Overall Study||371
10103903|NCT02429427|11233597|FG001|NOT COMPLETED|Overall Study||179
10005308|NCT01741454|11127884|FG003|COMPLETED|Overall Study||21
10005309|NCT01741454|11127881|FG000|NOT COMPLETED|Overall Study||13
10005310|NCT01741454|11127882|FG001|NOT COMPLETED|Overall Study||6
10005311|NCT01741454|11127883|FG002|NOT COMPLETED|Overall Study||17
10005312|NCT01741454|11127884|FG003|NOT COMPLETED|Overall Study||22
10005313|NCT01741532|11127900|FG000|STARTED|Overall Study||59
10005314|NCT01741532|11127901|FG001|STARTED|Overall Study||30
10103904|NCT02429778|11233605|FG000|STARTED|Overall Study||20
10005315|NCT01741532|11127900|FG000|Exposed|Overall Study||58
10005316|NCT01741532|11127901|FG001|Exposed|Overall Study||30
10005317|NCT01741532|11127900|FG000|Provided Post-baseline Efficacy Data|Overall Study||58
10005318|NCT01741532|11127901|FG001|Provided Post-baseline Efficacy Data|Overall Study||28
10005319|NCT01741532|11127900|FG000|COMPLETED|Overall Study||49
10005320|NCT01741532|11127901|FG001|COMPLETED|Overall Study||27
10005321|NCT01741532|11127900|FG000|NOT COMPLETED|Overall Study||10
10005322|NCT01741532|11127901|FG001|NOT COMPLETED|Overall Study||3
10005323|NCT01741545|11127913|FG000|STARTED|Treatment Period||12
10005324|NCT01741545|11127914|FG001|STARTED|Treatment Period||39
10005325|NCT01741545|11127913|FG000|COMPLETED|Treatment Period||11
10005326|NCT01741545|11127914|FG001|COMPLETED|Treatment Period||35
10005327|NCT01741545|11127913|FG000|NOT COMPLETED|Treatment Period||1
10005328|NCT01741545|11127914|FG001|NOT COMPLETED|Treatment Period||4
10005329|NCT01741545|11127913|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
10005330|NCT01741545|11127914|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
10005331|NCT01741545|11127913|FG000|COMPLETED|Follow-up Period (24 Weeks)||11
10005332|NCT01741545|11127914|FG001|COMPLETED|Follow-up Period (24 Weeks)||37
10005333|NCT01741545|11127913|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
10005334|NCT01741545|11127914|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2
10103905|NCT02429778|11233606|FG001|STARTED|Overall Study||20
10103906|NCT02429778|11233605|FG000|COMPLETED|Overall Study||13
10103907|NCT02429778|11233606|FG001|COMPLETED|Overall Study||20
10103908|NCT02429778|11233605|FG000|NOT COMPLETED|Overall Study||7
10103909|NCT02429778|11233606|FG001|NOT COMPLETED|Overall Study||0
10005335|NCT01741688|11127920|FG000|STARTED|Overall Study||16
10005336|NCT01741688|11127920|FG000|COMPLETED|Overall Study||13
10005337|NCT01741688|11127920|FG000|NOT COMPLETED|Overall Study||3
10005338|NCT01741701|11127927|FG000|STARTED|Overall Study||18
10005339|NCT01741701|11127928|FG001|STARTED|Overall Study||15
10005340|NCT01741701|11127927|FG000|COMPLETED|Overall Study||13
10005341|NCT01741701|11127928|FG001|COMPLETED|Overall Study||13
10005342|NCT01741701|11127927|FG000|NOT COMPLETED|Overall Study||5
10005343|NCT01741701|11127928|FG001|NOT COMPLETED|Overall Study||2
10005344|NCT01741792|11127937|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
10005345|NCT01741792|11127938|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
10005346|NCT01741792|11127939|FG002|STARTED|Overall Study||14
10005347|NCT01741792|11127937|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
10005348|NCT01741792|11127938|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
10005349|NCT01741792|11127939|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
10005350|NCT01741792|11127937|FG000|COMPLETED|Overall Study||3
10005351|NCT01741792|11127938|FG001|COMPLETED|Overall Study||1
10005352|NCT01741792|11127939|FG002|COMPLETED|Overall Study||2
10005353|NCT01741792|11127937|FG000|NOT COMPLETED|Overall Study||6
10005354|NCT01741792|11127938|FG001|NOT COMPLETED|Overall Study||1
10005355|NCT01741792|11127939|FG002|NOT COMPLETED|Overall Study||12
10005356|NCT01742065|11127955|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
10005357|NCT01742065|11127956|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
10005358|NCT01742065|11127955|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
10005359|NCT01742065|11127956|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
10005360|NCT01742065|11127955|FG000|NOT COMPLETED|Overall Study||0
10005361|NCT01742065|11127956|FG001|NOT COMPLETED|Overall Study||0
10005362|NCT01742078|11127971|FG000|STARTED|Overall Study||6
10005363|NCT01742078|11127972|FG001|STARTED|Overall Study||6
10005364|NCT01742078|11127973|FG002|STARTED|Overall Study||6
10005365|NCT01742078|11127974|FG003|STARTED|Overall Study||6
10005366|NCT01742078|11127975|FG004|STARTED|Overall Study||6
10005367|NCT01742078|11127976|FG005|STARTED|Overall Study||6
10005368|NCT01742078|11127977|FG006|STARTED|Overall Study||6
10005369|NCT01742078|11127978|FG007|STARTED|Overall Study||6
10005370|NCT01742078|11127979|FG008|STARTED|Overall Study||12
10005371|NCT01742078|11127971|FG000|RECEIVED STUDY DRUG|Overall Study||6
10005372|NCT01742078|11127972|FG001|RECEIVED STUDY DRUG|Overall Study||6
10005373|NCT01742078|11127973|FG002|RECEIVED STUDY DRUG|Overall Study||6
10005374|NCT01742078|11127974|FG003|RECEIVED STUDY DRUG|Overall Study||6
10005375|NCT01742078|11127975|FG004|RECEIVED STUDY DRUG|Overall Study||6
10005376|NCT01742078|11127976|FG005|RECEIVED STUDY DRUG|Overall Study||6
10005377|NCT01742078|11127977|FG006|RECEIVED STUDY DRUG|Overall Study||6
10005378|NCT01742078|11127978|FG007|RECEIVED STUDY DRUG|Overall Study||6
10005379|NCT01742078|11127979|FG008|RECEIVED STUDY DRUG|Overall Study||12
10005380|NCT01742078|11127971|FG000|COMPLETED|Overall Study||6
10005381|NCT01742078|11127972|FG001|COMPLETED|Overall Study||6
10005382|NCT01742078|11127973|FG002|COMPLETED|Overall Study||6
10005383|NCT01742078|11127974|FG003|COMPLETED|Overall Study||5
10005384|NCT01742078|11127975|FG004|COMPLETED|Overall Study||6
10005385|NCT01742078|11127976|FG005|COMPLETED|Overall Study||6
10005386|NCT01742078|11127977|FG006|COMPLETED|Overall Study||6
10005387|NCT01742078|11127978|FG007|COMPLETED|Overall Study||6
10005388|NCT01742078|11127979|FG008|COMPLETED|Overall Study||12
10005389|NCT01742078|11127971|FG000|NOT COMPLETED|Overall Study||0
10005390|NCT01742078|11127972|FG001|NOT COMPLETED|Overall Study||0
10103910|NCT02429856|11233614|FG000|STARTED|Overall Study||49
10103911|NCT02429856|11233615|FG001|STARTED|Overall Study||51
10103912|NCT02429856|11233614|FG000|COMPLETED|Overall Study||30
10103913|NCT02429856|11233615|FG001|COMPLETED|Overall Study||32
10103914|NCT02429856|11233614|FG000|NOT COMPLETED|Overall Study||19
10103915|NCT02429856|11233615|FG001|NOT COMPLETED|Overall Study||19
10103916|NCT02429869|11233623|FG000|STARTED|Overall Study||10
10103917|NCT02429869|11233623|FG000|COMPLETED|Overall Study||10
10103918|NCT02429869|11233623|FG000|NOT COMPLETED|Overall Study||0
10103919|NCT02429934|11233629|FG000|STARTED|Overall Study||15
10103920|NCT02429934|11233630|FG001|STARTED|Overall Study||13
10103921|NCT02429934|11233629|FG000|COMPLETED|Overall Study||11
10103922|NCT02429934|11233630|FG001|COMPLETED|Overall Study||10
10005391|NCT01742078|11127973|FG002|NOT COMPLETED|Overall Study||0
10005392|NCT01742078|11127974|FG003|NOT COMPLETED|Overall Study||1
10005393|NCT01742078|11127975|FG004|NOT COMPLETED|Overall Study||0
10005394|NCT01742078|11127976|FG005|NOT COMPLETED|Overall Study||0
10005395|NCT01742078|11127977|FG006|NOT COMPLETED|Overall Study||0
10005396|NCT01742078|11127978|FG007|NOT COMPLETED|Overall Study||0
10005397|NCT01742078|11127979|FG008|NOT COMPLETED|Overall Study||0
10005398|NCT01742091|11128007|FG000|STARTED|Overall Study||9
10005399|NCT01742091|11128008|FG001|STARTED|Overall Study||11
10005400|NCT01742091|11128009|FG002|STARTED|Overall Study||10
10005401|NCT01742091|11128010|FG003|STARTED|Overall Study||9
10005402|NCT01742091|11128011|FG004|STARTED|Overall Study||8
10005403|NCT01742091|11128012|FG005|STARTED|Overall Study||12
10005404|NCT01742091|11128007|FG000|RECEIVED STUDY DRUG|Overall Study||9
10005405|NCT01742091|11128008|FG001|RECEIVED STUDY DRUG|Overall Study||11
10005406|NCT01742091|11128009|FG002|RECEIVED STUDY DRUG|Overall Study||10
10005407|NCT01742091|11128010|FG003|RECEIVED STUDY DRUG|Overall Study||9
10005408|NCT01742091|11128011|FG004|RECEIVED STUDY DRUG|Overall Study||8
10005409|NCT01742091|11128012|FG005|RECEIVED STUDY DRUG|Overall Study||12
10005410|NCT01742091|11128007|FG000|COMPLETED|Overall Study||9
10005411|NCT01742091|11128008|FG001|COMPLETED|Overall Study||11
10005412|NCT01742091|11128009|FG002|COMPLETED|Overall Study||10
10005413|NCT01742091|11128010|FG003|COMPLETED|Overall Study||8
10005414|NCT01742091|11128011|FG004|COMPLETED|Overall Study||7
10005415|NCT01742091|11128012|FG005|COMPLETED|Overall Study||10
10005416|NCT01742091|11128007|FG000|NOT COMPLETED|Overall Study||0
10005417|NCT01742091|11128008|FG001|NOT COMPLETED|Overall Study||0
10005418|NCT01742091|11128009|FG002|NOT COMPLETED|Overall Study||0
10005419|NCT01742091|11128010|FG003|NOT COMPLETED|Overall Study||1
10005420|NCT01742091|11128011|FG004|NOT COMPLETED|Overall Study||1
10005421|NCT01742091|11128012|FG005|NOT COMPLETED|Overall Study||2
10005422|NCT01742117|11128028|FG000|STARTED|Overall Study||2641
10005423|NCT01742117|11128029|FG001|STARTED|Overall Study||2635
10005424|NCT01742117|11128028|FG000|COMPLETED|Overall Study||2641
10005425|NCT01742117|11128029|FG001|COMPLETED|Overall Study||2635
10005426|NCT01742117|11128028|FG000|NOT COMPLETED|Overall Study||0
10005427|NCT01742117|11128029|FG001|NOT COMPLETED|Overall Study||0
10005428|NCT01742208|11128038|FG000|STARTED|Overall Study||3
10005429|NCT01742208|11128039|FG001|STARTED|Overall Study||17
10005430|NCT01742208|11128040|FG002|STARTED|Overall Study||16
10005431|NCT01742208|11128038|FG000|COMPLETED|Overall Study||3
10005432|NCT01742208|11128039|FG001|COMPLETED|Overall Study||17
10005433|NCT01742208|11128040|FG002|COMPLETED|Overall Study||16
10005434|NCT01742208|11128038|FG000|NOT COMPLETED|Overall Study||0
10005435|NCT01742208|11128039|FG001|NOT COMPLETED|Overall Study||0
10005436|NCT01742208|11128040|FG002|NOT COMPLETED|Overall Study||0
10005437|NCT01742286|11128057|FG000|STARTED|Escalation Phase||5
10103923|NCT02429934|11233629|FG000|NOT COMPLETED|Overall Study||4
10103924|NCT02429934|11233630|FG001|NOT COMPLETED|Overall Study||3
10103925|NCT02430090|11233641|FG000|STARTED|Overall Study||15
10103926|NCT02430090|11233642|FG001|STARTED|Overall Study||15
10103927|NCT02430090|11233643|FG002|STARTED|Overall Study||15
10103928|NCT02430090|11233641|FG000|COMPLETED|Overall Study||15
10103929|NCT02430090|11233642|FG001|COMPLETED|Overall Study||15
10103930|NCT02430090|11233643|FG002|COMPLETED|Overall Study||15
10103931|NCT02430090|11233641|FG000|NOT COMPLETED|Overall Study||0
10103932|NCT02430090|11233642|FG001|NOT COMPLETED|Overall Study||0
10103933|NCT02430090|11233643|FG002|NOT COMPLETED|Overall Study||0
10005438|NCT01742286|11128058|FG001|STARTED|Escalation Phase||12
10005439|NCT01742286|11128059|FG002|STARTED|Escalation Phase||6
10005440|NCT01742286|11128060|FG003|STARTED|Escalation Phase||2
10005441|NCT01742286|11128061|FG004|STARTED|Escalation Phase||4
10005442|NCT01742286|11128062|FG005|STARTED|Escalation Phase||5
10005443|NCT01742286|11128063|FG006|STARTED|Escalation Phase||6
10005444|NCT01742286|11128057|FG000|Ended Treatment = Not Completed)|Escalation Phase||5
10005445|NCT01742286|11128058|FG001|Ended Treatment = Not Completed)|Escalation Phase||12
10005446|NCT01742286|11128059|FG002|Ended Treatment = Not Completed)|Escalation Phase||6
10005447|NCT01742286|11128060|FG003|Ended Treatment = Not Completed)|Escalation Phase||2
10005448|NCT01742286|11128061|FG004|Ended Treatment = Not Completed)|Escalation Phase||4
10005449|NCT01742286|11128062|FG005|Ended Treatment = Not Completed)|Escalation Phase||5
10103934|NCT02430311|11233653|FG000|STARTED|Part A||20
10103935|NCT02430311|11233654|FG001|STARTED|Part A||16
10103936|NCT02430311|11233653|FG000|Received Olaparib|Part A||20
10103937|NCT02430311|11233654|FG001|Received Olaparib|Part A||16
10103938|NCT02430311|11233653|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
10103939|NCT02430311|11233654|FG001|Received Paclitaxel|Part A||16
10103940|NCT02430311|11233653|FG000|COMPLETED|Part A||19
10103941|NCT02430311|11233654|FG001|COMPLETED|Part A||15
10103942|NCT02430311|11233653|FG000|NOT COMPLETED|Part A||1
10103943|NCT02430311|11233654|FG001|NOT COMPLETED|Part A||1
10005450|NCT01742286|11128063|FG006|Ended Treatment = Not Completed)|Escalation Phase||6
10005451|NCT01742286|11128057|FG000|COMPLETED|Escalation Phase||0
10005452|NCT01742286|11128058|FG001|COMPLETED|Escalation Phase||0
10005453|NCT01742286|11128059|FG002|COMPLETED|Escalation Phase||0
10005454|NCT01742286|11128060|FG003|COMPLETED|Escalation Phase||0
10005455|NCT01742286|11128061|FG004|COMPLETED|Escalation Phase||0
10005456|NCT01742286|11128062|FG005|COMPLETED|Escalation Phase||0
10005457|NCT01742286|11128063|FG006|COMPLETED|Escalation Phase||0
10005458|NCT01742286|11128057|FG000|NOT COMPLETED|Escalation Phase||5
10005459|NCT01742286|11128058|FG001|NOT COMPLETED|Escalation Phase||12
10005460|NCT01742286|11128059|FG002|NOT COMPLETED|Escalation Phase||6
10005461|NCT01742286|11128060|FG003|NOT COMPLETED|Escalation Phase||2
10005462|NCT01742286|11128061|FG004|NOT COMPLETED|Escalation Phase||4
10005463|NCT01742286|11128062|FG005|NOT COMPLETED|Escalation Phase||5
10005464|NCT01742286|11128063|FG006|NOT COMPLETED|Escalation Phase||6
10005465|NCT01742286|11128057|FG000|STARTED|Expansion Phase||0
10005466|NCT01742286|11128058|FG001|STARTED|Expansion Phase||0
10005467|NCT01742286|11128059|FG002|STARTED|Expansion Phase||7
10005468|NCT01742286|11128060|FG003|STARTED|Expansion Phase||0
10005469|NCT01742286|11128061|FG004|STARTED|Expansion Phase||0
10005470|NCT01742286|11128062|FG005|STARTED|Expansion Phase||0
10005471|NCT01742286|11128063|FG006|STARTED|Expansion Phase||36
10005472|NCT01742286|11128057|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0
10005473|NCT01742286|11128058|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0
10005474|NCT01742286|11128059|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7
10005475|NCT01742286|11128060|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0
10005476|NCT01742286|11128061|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0
10005477|NCT01742286|11128062|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0
10005478|NCT01742286|11128063|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36
10005479|NCT01742286|11128057|FG000|COMPLETED|Expansion Phase||0
10005480|NCT01742286|11128058|FG001|COMPLETED|Expansion Phase||0
10005481|NCT01742286|11128059|FG002|COMPLETED|Expansion Phase||0
10005482|NCT01742286|11128060|FG003|COMPLETED|Expansion Phase||0
10005483|NCT01742286|11128061|FG004|COMPLETED|Expansion Phase||0
10005484|NCT01742286|11128062|FG005|COMPLETED|Expansion Phase||0
10005485|NCT01742286|11128063|FG006|COMPLETED|Expansion Phase||0
10005486|NCT01742286|11128057|FG000|NOT COMPLETED|Expansion Phase||0
10005487|NCT01742286|11128058|FG001|NOT COMPLETED|Expansion Phase||0
10005488|NCT01742286|11128059|FG002|NOT COMPLETED|Expansion Phase||7
10005489|NCT01742286|11128060|FG003|NOT COMPLETED|Expansion Phase||0
10005490|NCT01742286|11128061|FG004|NOT COMPLETED|Expansion Phase||0
10005491|NCT01742286|11128062|FG005|NOT COMPLETED|Expansion Phase||0
10005492|NCT01742286|11128063|FG006|NOT COMPLETED|Expansion Phase||36
10005493|NCT01742364|11128090|FG000|STARTED|Overall Study||33
10005494|NCT01742364|11128091|FG001|STARTED|Overall Study||33
10005495|NCT01742364|11128092|FG002|STARTED|Overall Study||15
10005496|NCT01742364|11128093|FG003|STARTED|Overall Study||15
10005497|NCT01742364|11128090|FG000|COMPLETED|Overall Study||33
10005498|NCT01742364|11128091|FG001|COMPLETED|Overall Study||33
10005499|NCT01742364|11128092|FG002|COMPLETED|Overall Study||15
10005500|NCT01742364|11128093|FG003|COMPLETED|Overall Study||15
10005501|NCT01742364|11128090|FG000|NOT COMPLETED|Overall Study||0
10005502|NCT01742364|11128091|FG001|NOT COMPLETED|Overall Study||0
10005503|NCT01742364|11128092|FG002|NOT COMPLETED|Overall Study||0
10005504|NCT01742364|11128093|FG003|NOT COMPLETED|Overall Study||0
10005505|NCT01742832|11128106|FG000|STARTED|Overall Study||20
10005506|NCT01742832|11128107|FG001|STARTED|Overall Study||28
10005507|NCT01742832|11128106|FG000|COMPLETED|Overall Study||19
10005508|NCT01742832|11128107|FG001|COMPLETED|Overall Study||23
10005509|NCT01742832|11128106|FG000|NOT COMPLETED|Overall Study||1
10005510|NCT01742832|11128107|FG001|NOT COMPLETED|Overall Study||5
10005511|NCT01742897|11128113|FG000|STARTED|Overall Study||35
10005512|NCT01742897|11128113|FG000|Treated|Overall Study||33
10005513|NCT01742897|11128113|FG000|COMPLETED|Overall Study||30
10005514|NCT01742897|11128113|FG000|NOT COMPLETED|Overall Study||5
10005515|NCT01742936|11128119|FG000|STARTED|Overall Study||50
10005516|NCT01742936|11128120|FG001|STARTED|Overall Study||50
10005517|NCT01742936|11128119|FG000|COMPLETED|Overall Study||50
10005518|NCT01742936|11128120|FG001|COMPLETED|Overall Study||50
10005519|NCT01742936|11128119|FG000|NOT COMPLETED|Overall Study||0
10005520|NCT01742936|11128120|FG001|NOT COMPLETED|Overall Study||0
10005521|NCT01742949|11128126|FG000|STARTED|Overall Study||20
10005522|NCT01742949|11128127|FG001|STARTED|Overall Study||20
10005523|NCT01742949|11128126|FG000|COMPLETED|Overall Study||20
10005524|NCT01742949|11128127|FG001|COMPLETED|Overall Study||20
10005525|NCT01742949|11128126|FG000|NOT COMPLETED|Overall Study||0
10005526|NCT01742949|11128127|FG001|NOT COMPLETED|Overall Study||0
10005527|NCT01743001|11128138|FG000|STARTED|Overall Study||114
10005528|NCT01743001|11128139|FG001|STARTED|Overall Study||112
10005529|NCT01743001|11128138|FG000|COMPLETED|Overall Study||111
10005530|NCT01743001|11128139|FG001|COMPLETED|Overall Study||112
10005531|NCT01743001|11128138|FG000|NOT COMPLETED|Overall Study||3
10005532|NCT01743001|11128139|FG001|NOT COMPLETED|Overall Study||0
10005533|NCT01743027|11128149|FG000|STARTED|Overall Study||98
10005534|NCT01743027|11128150|FG001|STARTED|Overall Study||99
10005535|NCT01743027|11128151|FG002|STARTED|Overall Study||99
10005536|NCT01743027|11128152|FG003|STARTED|Overall Study||49
10005537|NCT01743027|11128149|FG000|COMPLETED|Overall Study||93
10005538|NCT01743027|11128150|FG001|COMPLETED|Overall Study||94
10005539|NCT01743027|11128151|FG002|COMPLETED|Overall Study||90
10005540|NCT01743027|11128152|FG003|COMPLETED|Overall Study||48
10005541|NCT01743027|11128149|FG000|NOT COMPLETED|Overall Study||5
10005542|NCT01743027|11128150|FG001|NOT COMPLETED|Overall Study||5
10005543|NCT01743027|11128151|FG002|NOT COMPLETED|Overall Study||9
10005544|NCT01743027|11128152|FG003|NOT COMPLETED|Overall Study||1
10005545|NCT01743040|11128162|FG000|STARTED|Overall Study||1014
10005546|NCT01743040|11128162|FG000|CADence Testing|Overall Study||1013
10005547|NCT01743040|11128162|FG000|Nuclear Stress Test|Overall Study||992
10005548|NCT01743040|11128162|FG000|CT and/or Standard Angiogram|Overall Study||785
10005549|NCT01743040|11128162|FG000|COMPLETED|Overall Study||785
10005550|NCT01743040|11128162|FG000|NOT COMPLETED|Overall Study||229
10005551|NCT01743092|11128168|FG000|STARTED|Overall Study||33
10005552|NCT01743092|11128169|FG001|STARTED|Overall Study||26
10005553|NCT01743092|11128168|FG000|COMPLETED|Overall Study||19
10005554|NCT01743092|11128169|FG001|COMPLETED|Overall Study||11
10005555|NCT01743092|11128168|FG000|NOT COMPLETED|Overall Study||14
10005556|NCT01743092|11128169|FG001|NOT COMPLETED|Overall Study||15
10005557|NCT01743131|11128179|FG000|STARTED|Overall Study||73
10005558|NCT01743131|11128180|FG001|STARTED|Overall Study||69
10005559|NCT01743131|11128181|FG002|STARTED|Overall Study||43
10005560|NCT01743131|11128182|FG003|STARTED|Overall Study||1
10005561|NCT01743131|11128183|FG004|STARTED|Overall Study||127
10005562|NCT01743131|11128179|FG000|Not Included in Analysis|Overall Study||0
10005563|NCT01743131|11128180|FG001|Not Included in Analysis|Overall Study||0
10005564|NCT01743131|11128181|FG002|Not Included in Analysis|Overall Study||0
10005565|NCT01743131|11128182|FG003|Not Included in Analysis|Overall Study||1
10005566|NCT01743131|11128183|FG004|Not Included in Analysis|Overall Study||0
10005567|NCT01743131|11128179|FG000|COMPLETED|Overall Study||73
10005568|NCT01743131|11128180|FG001|COMPLETED|Overall Study||69
10005569|NCT01743131|11128181|FG002|COMPLETED|Overall Study||43
10005570|NCT01743131|11128182|FG003|COMPLETED|Overall Study||1
10005571|NCT01743131|11128183|FG004|COMPLETED|Overall Study||127
10005572|NCT01743131|11128179|FG000|NOT COMPLETED|Overall Study||0
10005573|NCT01743131|11128180|FG001|NOT COMPLETED|Overall Study||0
10005574|NCT01743131|11128181|FG002|NOT COMPLETED|Overall Study||0
10005575|NCT01743131|11128182|FG003|NOT COMPLETED|Overall Study||0
10005576|NCT01743131|11128183|FG004|NOT COMPLETED|Overall Study||0
10005577|NCT01743469|11128196|FG000|STARTED|Active Treatment Phase||53
10005578|NCT01743469|11128197|FG001|STARTED|Active Treatment Phase||55
10005579|NCT01743469|11128198|FG002|STARTED|Active Treatment Phase||38
10005580|NCT01743469|11128199|FG003|STARTED|Active Treatment Phase||21
10005581|NCT01743469|11128196|FG000|COMPLETED|Active Treatment Phase||0
10005582|NCT01743469|11128197|FG001|COMPLETED|Active Treatment Phase||0
10005583|NCT01743469|11128198|FG002|COMPLETED|Active Treatment Phase||0
10005584|NCT01743469|11128199|FG003|COMPLETED|Active Treatment Phase||0
10005585|NCT01743469|11128196|FG000|NOT COMPLETED|Active Treatment Phase||53
10005586|NCT01743469|11128197|FG001|NOT COMPLETED|Active Treatment Phase||55
10005587|NCT01743469|11128198|FG002|NOT COMPLETED|Active Treatment Phase||38
10005588|NCT01743469|11128199|FG003|NOT COMPLETED|Active Treatment Phase||21
10005589|NCT01743469|11128196|FG000|STARTED|Follow-up Period - Post-Treatment||51
10005590|NCT01743469|11128197|FG001|STARTED|Follow-up Period - Post-Treatment||53
10005591|NCT01743469|11128198|FG002|STARTED|Follow-up Period - Post-Treatment||37
10005592|NCT01743469|11128199|FG003|STARTED|Follow-up Period - Post-Treatment||21
10005593|NCT01743469|11128196|FG000|COMPLETED|Follow-up Period - Post-Treatment||6
10005594|NCT01743469|11128197|FG001|COMPLETED|Follow-up Period - Post-Treatment||5
10005595|NCT01743469|11128198|FG002|COMPLETED|Follow-up Period - Post-Treatment||14
10005596|NCT01743469|11128199|FG003|COMPLETED|Follow-up Period - Post-Treatment||5
10005597|NCT01743469|11128196|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45
10005598|NCT01743469|11128197|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48
10005599|NCT01743469|11128198|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23
10005600|NCT01743469|11128199|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16
10005601|NCT01743521|11128213|FG000|STARTED|Overall Study||7
10005602|NCT01743521|11128214|FG001|STARTED|Overall Study||3
10005603|NCT01743521|11128215|FG002|STARTED|Overall Study||2
10005604|NCT01743521|11128216|FG003|STARTED|Overall Study||2
10005605|NCT01743521|11128213|FG000|COMPLETED|Overall Study||7
10005606|NCT01743521|11128214|FG001|COMPLETED|Overall Study||3
10005607|NCT01743521|11128215|FG002|COMPLETED|Overall Study||2
10005608|NCT01743521|11128216|FG003|COMPLETED|Overall Study||2
10005609|NCT01743521|11128213|FG000|NOT COMPLETED|Overall Study||0
10005610|NCT01743521|11128214|FG001|NOT COMPLETED|Overall Study||0
10005611|NCT01743521|11128215|FG002|NOT COMPLETED|Overall Study||0
10005612|NCT01743521|11128216|FG003|NOT COMPLETED|Overall Study||0
10005613|NCT01743560|11128224|FG000|STARTED|Overall Study||52
10005614|NCT01743560|11128224|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
10005615|NCT01743560|11128224|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
10005616|NCT01743560|11128224|FG000|COMPLETED|Overall Study||9
10005617|NCT01743560|11128224|FG000|NOT COMPLETED|Overall Study||43
10005618|NCT01743677|11128237|FG000|STARTED|First Intervention Period||10
10005619|NCT01743677|11128238|FG001|STARTED|First Intervention Period||10
10005620|NCT01743677|11128239|FG002|STARTED|First Intervention Period||10
10005621|NCT01743677|11128240|FG003|STARTED|First Intervention Period||10
10005622|NCT01743677|11128241|FG004|STARTED|First Intervention Period||10
10005623|NCT01743677|11128242|FG005|STARTED|First Intervention Period||10
10005624|NCT01743677|11128237|FG000|COMPLETED|First Intervention Period||10
10005625|NCT01743677|11128238|FG001|COMPLETED|First Intervention Period||10
10005626|NCT01743677|11128239|FG002|COMPLETED|First Intervention Period||10
10005627|NCT01743677|11128240|FG003|COMPLETED|First Intervention Period||10
10005628|NCT01743677|11128241|FG004|COMPLETED|First Intervention Period||10
10005629|NCT01743677|11128242|FG005|COMPLETED|First Intervention Period||10
10005630|NCT01743677|11128237|FG000|NOT COMPLETED|First Intervention Period||0
10005631|NCT01743677|11128238|FG001|NOT COMPLETED|First Intervention Period||0
10005632|NCT01743677|11128239|FG002|NOT COMPLETED|First Intervention Period||0
10005633|NCT01743677|11128240|FG003|NOT COMPLETED|First Intervention Period||0
10005634|NCT01743677|11128241|FG004|NOT COMPLETED|First Intervention Period||0
10005635|NCT01743677|11128242|FG005|NOT COMPLETED|First Intervention Period||0
10005636|NCT01743677|11128237|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10
10005637|NCT01743677|11128238|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10
10005638|NCT01743677|11128239|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10
10005639|NCT01743677|11128240|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10
10005640|NCT01743677|11128241|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10
10005641|NCT01743677|11128242|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10
10005642|NCT01743677|11128237|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10005643|NCT01743677|11128238|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10005644|NCT01743677|11128239|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10005645|NCT01743677|11128240|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10005646|NCT01743677|11128241|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10005647|NCT01743677|11128242|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10005648|NCT01743677|11128237|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10005649|NCT01743677|11128238|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10005650|NCT01743677|11128239|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10005651|NCT01743677|11128240|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10005652|NCT01743677|11128241|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10005653|NCT01743677|11128242|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10005654|NCT01743677|11128237|FG000|STARTED|Second Intervention Period||10
10005655|NCT01743677|11128238|FG001|STARTED|Second Intervention Period||10
10005656|NCT01743677|11128239|FG002|STARTED|Second Intervention Period||10
10005657|NCT01743677|11128240|FG003|STARTED|Second Intervention Period||10
10005658|NCT01743677|11128241|FG004|STARTED|Second Intervention Period||10
10005659|NCT01743677|11128242|FG005|STARTED|Second Intervention Period||10
10005660|NCT01743677|11128237|FG000|COMPLETED|Second Intervention Period||10
10005661|NCT01743677|11128238|FG001|COMPLETED|Second Intervention Period||10
10005662|NCT01743677|11128239|FG002|COMPLETED|Second Intervention Period||10
10005663|NCT01743677|11128240|FG003|COMPLETED|Second Intervention Period||10
10005664|NCT01743677|11128241|FG004|COMPLETED|Second Intervention Period||10
10005665|NCT01743677|11128242|FG005|COMPLETED|Second Intervention Period||10
10005666|NCT01743677|11128237|FG000|NOT COMPLETED|Second Intervention Period||0
10005667|NCT01743677|11128238|FG001|NOT COMPLETED|Second Intervention Period||0
10005668|NCT01743677|11128239|FG002|NOT COMPLETED|Second Intervention Period||0
10005669|NCT01743677|11128240|FG003|NOT COMPLETED|Second Intervention Period||0
10005670|NCT01743677|11128241|FG004|NOT COMPLETED|Second Intervention Period||0
10005671|NCT01743677|11128242|FG005|NOT COMPLETED|Second Intervention Period||0
10005672|NCT01743677|11128237|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10
10005673|NCT01743677|11128238|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10
10005674|NCT01743677|11128239|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10
10103944|NCT02430311|11233653|FG000|STARTED|Part B||19
10103945|NCT02430311|11233654|FG001|STARTED|Part B||15
10103946|NCT02430311|11233653|FG000|Received Olaparib|Part B||19
10103947|NCT02430311|11233654|FG001|Received Olaparib|Part B||15
10103948|NCT02430311|11233653|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
10103949|NCT02430311|11233654|FG001|Received Paclitaxel|Part B||14
10103950|NCT02430311|11233653|FG000|COMPLETED|Part B||9
10103951|NCT02430311|11233654|FG001|COMPLETED|Part B||7
10103952|NCT02430311|11233653|FG000|NOT COMPLETED|Part B||10
10103953|NCT02430311|11233654|FG001|NOT COMPLETED|Part B||8
10103954|NCT02430337|11233671|FG000|STARTED|Overall Study||11
10103955|NCT02430337|11233672|FG001|STARTED|Overall Study||20
10103956|NCT02430337|11233671|FG000|COMPLETED|Overall Study||11
10103957|NCT02430337|11233672|FG001|COMPLETED|Overall Study||20
10103958|NCT02430337|11233671|FG000|NOT COMPLETED|Overall Study||0
10103959|NCT02430337|11233672|FG001|NOT COMPLETED|Overall Study||0
10103960|NCT02430389|11233682|FG000|STARTED|Overall Study||10
10103961|NCT02430389|11233683|FG001|STARTED|Overall Study||10
10103962|NCT02430389|11233682|FG000|COMPLETED|Overall Study||10
10103963|NCT02430389|11233683|FG001|COMPLETED|Overall Study||10
10005675|NCT01743677|11128240|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10
10005676|NCT01743677|11128241|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10
10005677|NCT01743677|11128242|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10
10005678|NCT01743677|11128237|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10005679|NCT01743677|11128238|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10103964|NCT02430389|11233682|FG000|NOT COMPLETED|Overall Study||0
10103965|NCT02430389|11233683|FG001|NOT COMPLETED|Overall Study||0
10103966|NCT02430480|11233691|FG000|STARTED|Overall Study||39
10103967|NCT02430480|11233691|FG000|COMPLETED|Overall Study||36
10103968|NCT02430480|11233691|FG000|NOT COMPLETED|Overall Study||3
10103969|NCT02430818|11233700|FG000|STARTED|Overall Study||7
10103970|NCT02430818|11233701|FG001|STARTED|Overall Study||6
10103971|NCT02430818|11233700|FG000|COMPLETED|Overall Study||7
10103972|NCT02430818|11233701|FG001|COMPLETED|Overall Study||6
10103973|NCT02430818|11233700|FG000|NOT COMPLETED|Overall Study||0
10005680|NCT01743677|11128239|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10005681|NCT01743677|11128240|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10005682|NCT01743677|11128241|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10005683|NCT01743677|11128242|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10005684|NCT01743677|11128237|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10005685|NCT01743677|11128238|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10005686|NCT01743677|11128239|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10005687|NCT01743677|11128240|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10005688|NCT01743677|11128241|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10005689|NCT01743677|11128242|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10005690|NCT01743677|11128237|FG000|STARTED|Third Intervention Period||10
10005691|NCT01743677|11128238|FG001|STARTED|Third Intervention Period||10
10005692|NCT01743677|11128239|FG002|STARTED|Third Intervention Period||10
10005693|NCT01743677|11128240|FG003|STARTED|Third Intervention Period||10
10005694|NCT01743677|11128241|FG004|STARTED|Third Intervention Period||10
10005695|NCT01743677|11128242|FG005|STARTED|Third Intervention Period||10
10005696|NCT01743677|11128237|FG000|COMPLETED|Third Intervention Period||10
10005697|NCT01743677|11128238|FG001|COMPLETED|Third Intervention Period||10
10005698|NCT01743677|11128239|FG002|COMPLETED|Third Intervention Period||10
10005699|NCT01743677|11128240|FG003|COMPLETED|Third Intervention Period||10
10005700|NCT01743677|11128241|FG004|COMPLETED|Third Intervention Period||10
10005701|NCT01743677|11128242|FG005|COMPLETED|Third Intervention Period||10
10005702|NCT01743677|11128237|FG000|NOT COMPLETED|Third Intervention Period||0
10005703|NCT01743677|11128238|FG001|NOT COMPLETED|Third Intervention Period||0
10005704|NCT01743677|11128239|FG002|NOT COMPLETED|Third Intervention Period||0
10005705|NCT01743677|11128240|FG003|NOT COMPLETED|Third Intervention Period||0
10005706|NCT01743677|11128241|FG004|NOT COMPLETED|Third Intervention Period||0
10005707|NCT01743677|11128242|FG005|NOT COMPLETED|Third Intervention Period||0
10005708|NCT01743729|11128254|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
10103974|NCT02430818|11233701|FG001|NOT COMPLETED|Overall Study||0
10103975|NCT02430870|11233719|FG000|STARTED|Part 1||6
10103976|NCT02430870|11233720|FG001|STARTED|Part 1||6
10103977|NCT02430870|11233721|FG002|STARTED|Part 1||4
10103978|NCT02430870|11233722|FG003|STARTED|Part 1||0
10103979|NCT02430870|11233723|FG004|STARTED|Part 1||0
10103980|NCT02430870|11233724|FG005|STARTED|Part 1||0
10103981|NCT02430870|11233725|FG006|STARTED|Part 1||0
10103982|NCT02430870|11233726|FG007|STARTED|Part 1||0
10103983|NCT02430870|11233719|FG000|COMPLETED|Part 1||6
10103984|NCT02430870|11233720|FG001|COMPLETED|Part 1||6
10103985|NCT02430870|11233721|FG002|COMPLETED|Part 1||4
10103986|NCT02430870|11233722|FG003|COMPLETED|Part 1||0
10103987|NCT02430870|11233723|FG004|COMPLETED|Part 1||0
10103988|NCT02430870|11233724|FG005|COMPLETED|Part 1||0
10103989|NCT02430870|11233725|FG006|COMPLETED|Part 1||0
10103990|NCT02430870|11233726|FG007|COMPLETED|Part 1||0
10103991|NCT02430870|11233719|FG000|NOT COMPLETED|Part 1||0
10103992|NCT02430870|11233720|FG001|NOT COMPLETED|Part 1||0
10103993|NCT02430870|11233721|FG002|NOT COMPLETED|Part 1||0
10103994|NCT02430870|11233722|FG003|NOT COMPLETED|Part 1||0
10103995|NCT02430870|11233723|FG004|NOT COMPLETED|Part 1||0
10103996|NCT02430870|11233724|FG005|NOT COMPLETED|Part 1||0
10103997|NCT02430870|11233725|FG006|NOT COMPLETED|Part 1||0
10103998|NCT02430870|11233726|FG007|NOT COMPLETED|Part 1||0
10103999|NCT02430870|11233719|FG000|STARTED|Part 2||0
10104000|NCT02430870|11233720|FG001|STARTED|Part 2||0
10005709|NCT01743729|11128255|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
10005710|NCT01743729|11128254|FG000|COMPLETED|Overall Study||321
10005711|NCT01743729|11128255|FG001|COMPLETED|Overall Study||348
10005712|NCT01743729|11128254|FG000|NOT COMPLETED|Overall Study||37
10005713|NCT01743729|11128255|FG001|NOT COMPLETED|Overall Study||12
10005714|NCT01743859|11128261|FG000|STARTED|Overall Study||37
10005715|NCT01743859|11128261|FG000|COMPLETED|Overall Study||28
10005716|NCT01743859|11128261|FG000|NOT COMPLETED|Overall Study||9
10005717|NCT01743963|11128267|FG000|STARTED|Overall Study||21
10005718|NCT01743963|11128268|FG001|STARTED|Overall Study||17
10005719|NCT01743963|11128267|FG000|COMPLETED|Overall Study||21
10005720|NCT01743963|11128268|FG001|COMPLETED|Overall Study||17
10005721|NCT01743963|11128267|FG000|NOT COMPLETED|Overall Study||0
10104001|NCT02430870|11233721|FG002|STARTED|Part 2||0
10104002|NCT02430870|11233722|FG003|STARTED|Part 2||6
10104003|NCT02430870|11233723|FG004|STARTED|Part 2||6
10104004|NCT02430870|11233724|FG005|STARTED|Part 2||6
10104005|NCT02430870|11233725|FG006|STARTED|Part 2||6
10104006|NCT02430870|11233726|FG007|STARTED|Part 2||8
10104007|NCT02430870|11233719|FG000|COMPLETED|Part 2||0
10104008|NCT02430870|11233720|FG001|COMPLETED|Part 2||0
10104009|NCT02430870|11233721|FG002|COMPLETED|Part 2||0
10104010|NCT02430870|11233722|FG003|COMPLETED|Part 2||6
10104011|NCT02430870|11233723|FG004|COMPLETED|Part 2||6
10104012|NCT02430870|11233724|FG005|COMPLETED|Part 2||6
10104013|NCT02430870|11233725|FG006|COMPLETED|Part 2||5
10104014|NCT02430870|11233726|FG007|COMPLETED|Part 2||7
10104015|NCT02430870|11233719|FG000|NOT COMPLETED|Part 2||0
10104016|NCT02430870|11233720|FG001|NOT COMPLETED|Part 2||0
10104017|NCT02430870|11233721|FG002|NOT COMPLETED|Part 2||0
10104018|NCT02430870|11233722|FG003|NOT COMPLETED|Part 2||0
10104019|NCT02430870|11233723|FG004|NOT COMPLETED|Part 2||0
10104020|NCT02430870|11233724|FG005|NOT COMPLETED|Part 2||0
10104021|NCT02430870|11233725|FG006|NOT COMPLETED|Part 2||1
10104022|NCT02430870|11233726|FG007|NOT COMPLETED|Part 2||1
10005722|NCT01743963|11128268|FG001|NOT COMPLETED|Overall Study||0
10005723|NCT01743976|11128276|FG000|STARTED|Overall Study||2
10005724|NCT01743976|11128277|FG001|STARTED|Overall Study||3
10005725|NCT01743976|11128276|FG000|COMPLETED|Overall Study||2
10005726|NCT01743976|11128277|FG001|COMPLETED|Overall Study||3
10005727|NCT01743976|11128276|FG000|NOT COMPLETED|Overall Study||0
10005728|NCT01743976|11128277|FG001|NOT COMPLETED|Overall Study||0
10005729|NCT01743989|11128286|FG000|STARTED|Treatment Phase||120
10005730|NCT01743989|11128287|FG001|STARTED|Treatment Phase||119
10005731|NCT01743989|11128288|FG002|STARTED|Treatment Phase||381
10005732|NCT01743989|11128286|FG000|Participants Who Signed Informed Consent|Treatment Phase||120
10005733|NCT01743989|11128287|FG001|Participants Who Signed Informed Consent|Treatment Phase||118
10005734|NCT01743989|11128288|FG002|Participants Who Signed Informed Consent|Treatment Phase||381
10005735|NCT01743989|11128286|FG000|COMPLETED|Treatment Phase||119
10005736|NCT01743989|11128287|FG001|COMPLETED|Treatment Phase||104
10005737|NCT01743989|11128288|FG002|COMPLETED|Treatment Phase||0
10005738|NCT01743989|11128286|FG000|NOT COMPLETED|Treatment Phase||1
10005739|NCT01743989|11128287|FG001|NOT COMPLETED|Treatment Phase||15
10005740|NCT01743989|11128288|FG002|NOT COMPLETED|Treatment Phase||381
10005741|NCT01743989|11128286|FG000|STARTED|TFR Phase||119
10005742|NCT01743989|11128287|FG001|STARTED|TFR Phase||104
10005743|NCT01743989|11128288|FG002|STARTED|TFR Phase||0
10005744|NCT01743989|11128286|FG000|COMPLETED|TFR Phase||37
10005745|NCT01743989|11128287|FG001|COMPLETED|TFR Phase||36
10005746|NCT01743989|11128288|FG002|COMPLETED|TFR Phase||0
10005747|NCT01743989|11128286|FG000|NOT COMPLETED|TFR Phase||82
10005748|NCT01743989|11128287|FG001|NOT COMPLETED|TFR Phase||68
10005749|NCT01743989|11128288|FG002|NOT COMPLETED|TFR Phase||0
10005750|NCT01743989|11128286|FG000|STARTED|Re-treatment Phase||74
10005751|NCT01743989|11128287|FG001|STARTED|Re-treatment Phase||55
10005752|NCT01743989|11128288|FG002|STARTED|Re-treatment Phase||0
10005753|NCT01743989|11128286|FG000|COMPLETED|Re-treatment Phase||58
10005754|NCT01743989|11128287|FG001|COMPLETED|Re-treatment Phase||46
10005755|NCT01743989|11128288|FG002|COMPLETED|Re-treatment Phase||0
10005756|NCT01743989|11128286|FG000|NOT COMPLETED|Re-treatment Phase||16
10005757|NCT01743989|11128287|FG001|NOT COMPLETED|Re-treatment Phase||9
10005758|NCT01743989|11128288|FG002|NOT COMPLETED|Re-treatment Phase||0
10005759|NCT01744197|11128301|FG000|STARTED|Overall Study||32
10005760|NCT01744197|11128302|FG001|STARTED|Overall Study||29
10005761|NCT01744197|11128301|FG000|COMPLETED|Overall Study||28
10005762|NCT01744197|11128302|FG001|COMPLETED|Overall Study||26
10005763|NCT01744197|11128301|FG000|NOT COMPLETED|Overall Study||4
10005764|NCT01744197|11128302|FG001|NOT COMPLETED|Overall Study||3
10005765|NCT01744340|11128310|FG000|STARTED|Overall Study||8
10005766|NCT01744340|11128311|FG001|STARTED|Overall Study||15
10005767|NCT01744340|11128310|FG000|COMPLETED|Overall Study||8
10005768|NCT01744340|11128311|FG001|COMPLETED|Overall Study||15
10005769|NCT01744340|11128310|FG000|NOT COMPLETED|Overall Study||0
10005770|NCT01744340|11128311|FG001|NOT COMPLETED|Overall Study||0
10005771|NCT01744353|11128320|FG000|STARTED|Overall Study||6
10005772|NCT01744353|11128321|FG001|STARTED|Overall Study||26
10005773|NCT01744353|11128322|FG002|STARTED|Overall Study||3
10005774|NCT01744353|11128320|FG000|COMPLETED|Overall Study||6
10005775|NCT01744353|11128321|FG001|COMPLETED|Overall Study||26
10005776|NCT01744353|11128322|FG002|COMPLETED|Overall Study||3
10005777|NCT01744353|11128320|FG000|NOT COMPLETED|Overall Study||0
10005778|NCT01744353|11128321|FG001|NOT COMPLETED|Overall Study||0
10005779|NCT01744353|11128322|FG002|NOT COMPLETED|Overall Study||0
10005780|NCT01744392|11128328|FG000|STARTED|Overall Study||23
10005781|NCT01744392|11128328|FG000|COMPLETED|Overall Study||22
10005782|NCT01744392|11128328|FG000|NOT COMPLETED|Overall Study||1
10005783|NCT01744483|11128336|FG000|STARTED|Overall Study||44
10005784|NCT01744483|11128337|FG001|STARTED|Overall Study||35
10005785|NCT01744483|11128338|FG002|STARTED|Overall Study||38
10005786|NCT01744483|11128336|FG000|COMPLETED|Overall Study||15
10005787|NCT01744483|11128337|FG001|COMPLETED|Overall Study||13
10005788|NCT01744483|11128338|FG002|COMPLETED|Overall Study||10
10005789|NCT01744483|11128336|FG000|NOT COMPLETED|Overall Study||29
10005790|NCT01744483|11128337|FG001|NOT COMPLETED|Overall Study||22
10005791|NCT01744483|11128338|FG002|NOT COMPLETED|Overall Study||28
10005792|NCT01744496|11128348|FG000|STARTED|Titration Period||33
10005793|NCT01744496|11128349|FG001|STARTED|Titration Period||35
10104023|NCT02431052|11233749|FG000|STARTED|Overall Study||53
10104024|NCT02431052|11233750|FG001|STARTED|Overall Study||50
10104025|NCT02431052|11233751|FG002|STARTED|Overall Study||106
10104026|NCT02431052|11233752|FG003|STARTED|Overall Study||110
10104027|NCT02431052|11233753|FG004|STARTED|Overall Study||101
10005794|NCT01744496|11128348|FG000|COMPLETED|Titration Period||31
10005795|NCT01744496|11128349|FG001|COMPLETED|Titration Period||33
10005796|NCT01744496|11128348|FG000|NOT COMPLETED|Titration Period||2
10005797|NCT01744496|11128349|FG001|NOT COMPLETED|Titration Period||2
10005798|NCT01744496|11128348|FG000|STARTED|Maintenance Period||31
10005799|NCT01744496|11128349|FG001|STARTED|Maintenance Period||33
10005800|NCT01744496|11128348|FG000|COMPLETED|Maintenance Period||27
10005801|NCT01744496|11128349|FG001|COMPLETED|Maintenance Period||29
10005802|NCT01744496|11128348|FG000|NOT COMPLETED|Maintenance Period||4
10005803|NCT01744496|11128349|FG001|NOT COMPLETED|Maintenance Period||4
10005804|NCT01744574|11128359|FG000|STARTED|Overall Study||57
10005805|NCT01744574|11128360|FG001|STARTED|Overall Study||56
10005806|NCT01744574|11128361|FG002|STARTED|Overall Study||52
10104028|NCT02431052|11233749|FG000|COMPLETED|Overall Study||42
10104029|NCT02431052|11233750|FG001|COMPLETED|Overall Study||46
10005807|NCT01744574|11128362|FG003|STARTED|Overall Study||51
10005808|NCT01744574|11128359|FG000|COMPLETED|Overall Study||33
10005809|NCT01744574|11128360|FG001|COMPLETED|Overall Study||31
10005810|NCT01744574|11128361|FG002|COMPLETED|Overall Study||32
10005811|NCT01744574|11128362|FG003|COMPLETED|Overall Study||40
10005812|NCT01744574|11128359|FG000|NOT COMPLETED|Overall Study||24
10005813|NCT01744574|11128360|FG001|NOT COMPLETED|Overall Study||25
10005814|NCT01744574|11128361|FG002|NOT COMPLETED|Overall Study||20
10005815|NCT01744574|11128362|FG003|NOT COMPLETED|Overall Study||11
10005816|NCT01744665|11128372|FG000|STARTED|Monitoring Phase||59
10005817|NCT01744665|11128372|FG000|COMPLETED|Monitoring Phase||41
10005818|NCT01744665|11128372|FG000|NOT COMPLETED|Monitoring Phase||18
10005819|NCT01744665|11128372|FG000|STARTED|Consolidation Phase||41
10005820|NCT01744665|11128372|FG000|COMPLETED|Consolidation Phase||22
10005821|NCT01744665|11128372|FG000|NOT COMPLETED|Consolidation Phase||19
10005822|NCT01744665|11128372|FG000|STARTED|Treatment Free Remission Phase||32
10005823|NCT01744665|11128372|FG000|COMPLETED|Treatment Free Remission Phase||32
10005824|NCT01744665|11128372|FG000|NOT COMPLETED|Treatment Free Remission Phase||0
10005825|NCT01744665|11128372|FG000|STARTED|Re-initiation Phase||17
10005826|NCT01744665|11128372|FG000|COMPLETED|Re-initiation Phase||4
10005827|NCT01744665|11128372|FG000|NOT COMPLETED|Re-initiation Phase||13
10005828|NCT01744691|11128379|FG000|STARTED|Overall Study|Participants who received study treatment|144
10005829|NCT01744691|11128379|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
10005830|NCT01744691|11128379|FG000|NOT COMPLETED|Overall Study||43
10005831|NCT01744704|11128395|FG000|STARTED|Overall Study||3
10005832|NCT01744704|11128396|FG001|STARTED|Overall Study||3
10005833|NCT01744704|11128397|FG002|STARTED|Overall Study||3
10005834|NCT01744704|11128398|FG003|STARTED|Overall Study||6
10005835|NCT01744704|11128399|FG004|STARTED|Overall Study||6
10005836|NCT01744704|11128400|FG005|STARTED|Overall Study||7
10005837|NCT01744704|11128401|FG006|STARTED|Overall Study||6
10005838|NCT01744704|11128402|FG007|STARTED|Overall Study||9
10005839|NCT01744704|11128403|FG008|STARTED|Overall Study||3
10005840|NCT01744704|11128404|FG009|STARTED|Overall Study||9
10005841|NCT01744704|11128405|FG010|STARTED|Overall Study||9
10005842|NCT01744704|11128406|FG011|STARTED|Overall Study||10
10005843|NCT01744704|11128395|FG000|COMPLETED|Overall Study||3
10005844|NCT01744704|11128396|FG001|COMPLETED|Overall Study||3
10005845|NCT01744704|11128397|FG002|COMPLETED|Overall Study||3
10005846|NCT01744704|11128398|FG003|COMPLETED|Overall Study||6
10005847|NCT01744704|11128399|FG004|COMPLETED|Overall Study||6
10005848|NCT01744704|11128400|FG005|COMPLETED|Overall Study||7
10005849|NCT01744704|11128401|FG006|COMPLETED|Overall Study||6
10005850|NCT01744704|11128402|FG007|COMPLETED|Overall Study||9
10005851|NCT01744704|11128403|FG008|COMPLETED|Overall Study||3
10005852|NCT01744704|11128404|FG009|COMPLETED|Overall Study||9
10005853|NCT01744704|11128405|FG010|COMPLETED|Overall Study||9
10005854|NCT01744704|11128406|FG011|COMPLETED|Overall Study||10
10005855|NCT01744704|11128395|FG000|NOT COMPLETED|Overall Study||0
10104030|NCT02431052|11233751|FG002|COMPLETED|Overall Study||94
10104031|NCT02431052|11233752|FG003|COMPLETED|Overall Study||94
10104032|NCT02431052|11233753|FG004|COMPLETED|Overall Study||86
10104033|NCT02431052|11233749|FG000|NOT COMPLETED|Overall Study||11
10104034|NCT02431052|11233750|FG001|NOT COMPLETED|Overall Study||4
10104035|NCT02431052|11233751|FG002|NOT COMPLETED|Overall Study||12
10104036|NCT02431052|11233752|FG003|NOT COMPLETED|Overall Study||16
10104037|NCT02431052|11233753|FG004|NOT COMPLETED|Overall Study||15
10104038|NCT02431260|11233784|FG000|STARTED|Overall Study||4
10104039|NCT02431260|11233785|FG001|STARTED|Overall Study||5
10104040|NCT02431260|11233786|FG002|STARTED|Overall Study||6
10104041|NCT02431260|11233787|FG003|STARTED|Overall Study||5
10104042|NCT02431260|11233788|FG004|STARTED|Overall Study||3
10104043|NCT02431260|11233789|FG005|STARTED|Overall Study||4
10104044|NCT02431260|11233790|FG006|STARTED|Overall Study||4
10104045|NCT02431260|11233791|FG007|STARTED|Overall Study||3
10104046|NCT02431260|11233792|FG008|STARTED|Overall Study||8
10104047|NCT02431260|11233793|FG009|STARTED|Overall Study||8
10104048|NCT02431260|11233794|FG010|STARTED|Overall Study||4
10104049|NCT02431260|11233795|FG011|STARTED|Overall Study||4
10104050|NCT02431260|11233796|FG012|STARTED|Overall Study||10
10104051|NCT02431260|11233797|FG013|STARTED|Overall Study||1
10005856|NCT01744704|11128396|FG001|NOT COMPLETED|Overall Study||0
10005857|NCT01744704|11128397|FG002|NOT COMPLETED|Overall Study||0
10005858|NCT01744704|11128398|FG003|NOT COMPLETED|Overall Study||0
10005859|NCT01744704|11128399|FG004|NOT COMPLETED|Overall Study||0
10005860|NCT01744704|11128400|FG005|NOT COMPLETED|Overall Study||0
10005861|NCT01744704|11128401|FG006|NOT COMPLETED|Overall Study||0
10005862|NCT01744704|11128402|FG007|NOT COMPLETED|Overall Study||0
10104052|NCT02431260|11233784|FG000|COMPLETED|Overall Study||0
10104053|NCT02431260|11233785|FG001|COMPLETED|Overall Study||0
10104054|NCT02431260|11233786|FG002|COMPLETED|Overall Study||0
10104055|NCT02431260|11233787|FG003|COMPLETED|Overall Study||0
10104056|NCT02431260|11233788|FG004|COMPLETED|Overall Study||0
10104057|NCT02431260|11233789|FG005|COMPLETED|Overall Study||0
10104058|NCT02431260|11233790|FG006|COMPLETED|Overall Study||0
10104059|NCT02431260|11233791|FG007|COMPLETED|Overall Study||0
10104060|NCT02431260|11233792|FG008|COMPLETED|Overall Study||0
10104061|NCT02431260|11233793|FG009|COMPLETED|Overall Study||0
10104062|NCT02431260|11233794|FG010|COMPLETED|Overall Study||0
10104063|NCT02431260|11233795|FG011|COMPLETED|Overall Study||0
10104064|NCT02431260|11233796|FG012|COMPLETED|Overall Study||0
10104065|NCT02431260|11233797|FG013|COMPLETED|Overall Study||0
10005863|NCT01744704|11128403|FG008|NOT COMPLETED|Overall Study||0
10005864|NCT01744704|11128404|FG009|NOT COMPLETED|Overall Study||0
10005865|NCT01744704|11128405|FG010|NOT COMPLETED|Overall Study||0
10005866|NCT01744704|11128406|FG011|NOT COMPLETED|Overall Study||0
10005867|NCT01744730|11128438|FG000|STARTED|Overall Study||4
10005868|NCT01744730|11128439|FG001|STARTED|Overall Study||3
10005869|NCT01744730|11128440|FG002|STARTED|Overall Study||4
10005870|NCT01744730|11128441|FG003|STARTED|Overall Study||11
10005871|NCT01744730|11128442|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
10005872|NCT01744730|11128438|FG000|COMPLETED|Overall Study||4
10005873|NCT01744730|11128439|FG001|COMPLETED|Overall Study||3
10005874|NCT01744730|11128440|FG002|COMPLETED|Overall Study||4
10005875|NCT01744730|11128441|FG003|COMPLETED|Overall Study||11
10005876|NCT01744730|11128442|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
10005877|NCT01744730|11128438|FG000|NOT COMPLETED|Overall Study||0
10005878|NCT01744730|11128439|FG001|NOT COMPLETED|Overall Study||0
10005879|NCT01744730|11128440|FG002|NOT COMPLETED|Overall Study||0
10005880|NCT01744730|11128441|FG003|NOT COMPLETED|Overall Study||0
10005881|NCT01744730|11128442|FG004|NOT COMPLETED|Overall Study||0
10005882|NCT01744782|11128455|FG000|STARTED|Overall Study||17
10005883|NCT01744782|11128455|FG000|COMPLETED|Overall Study||16
10005884|NCT01744782|11128455|FG000|NOT COMPLETED|Overall Study||1
10005885|NCT01744821|11128463|FG000|STARTED|Overall Study||1
10005886|NCT01744821|11128464|FG001|STARTED|Overall Study||3
10005887|NCT01744821|11128465|FG002|STARTED|Overall Study||2
10005888|NCT01744821|11128466|FG003|STARTED|Overall Study||1
10005889|NCT01744821|11128463|FG000|COMPLETED|Overall Study||1
10005890|NCT01744821|11128464|FG001|COMPLETED|Overall Study||3
10005891|NCT01744821|11128465|FG002|COMPLETED|Overall Study||2
10005892|NCT01744821|11128466|FG003|COMPLETED|Overall Study||1
10005893|NCT01744821|11128463|FG000|NOT COMPLETED|Overall Study||0
10005894|NCT01744821|11128464|FG001|NOT COMPLETED|Overall Study||0
10005895|NCT01744821|11128465|FG002|NOT COMPLETED|Overall Study||0
10005896|NCT01744821|11128466|FG003|NOT COMPLETED|Overall Study||0
10005897|NCT01744860|11128476|FG000|STARTED|Overall Study||420
10005898|NCT01744860|11128476|FG000|COMPLETED|Overall Study||420
10005899|NCT01744860|11128476|FG000|NOT COMPLETED|Overall Study||0
10018942|NCT01826487|11141976|FG000|COMPLETED|Overall Study||111
10018943|NCT01826487|11141977|FG001|COMPLETED|Overall Study||110
10018944|NCT01826487|11141976|FG000|NOT COMPLETED|Overall Study||4
10018945|NCT01826487|11141977|FG001|NOT COMPLETED|Overall Study||5
10018946|NCT01826513|11141987|FG000|STARTED|Overall Study||5
10018947|NCT01826513|11141988|FG001|STARTED|Overall Study||10
10018948|NCT01826513|11141989|FG002|STARTED|Overall Study||10
10018949|NCT01826513|11141987|FG000|COMPLETED|Overall Study||5
10018950|NCT01826513|11141988|FG001|COMPLETED|Overall Study||10
10018951|NCT01826513|11141989|FG002|COMPLETED|Overall Study||10
10018952|NCT01826513|11141987|FG000|NOT COMPLETED|Overall Study||0
10018953|NCT01826513|11141988|FG001|NOT COMPLETED|Overall Study||0
10018954|NCT01826513|11141989|FG002|NOT COMPLETED|Overall Study||0
10018955|NCT01826604|11141998|FG000|STARTED|Overall Study||144
10018956|NCT01826604|11141999|FG001|STARTED|Overall Study||157
10018957|NCT01826604|11141998|FG000|COMPLETED|Overall Study||136
10104066|NCT02431260|11233784|FG000|NOT COMPLETED|Overall Study||4
10104067|NCT02431260|11233785|FG001|NOT COMPLETED|Overall Study||5
10104068|NCT02431260|11233786|FG002|NOT COMPLETED|Overall Study||6
10104069|NCT02431260|11233787|FG003|NOT COMPLETED|Overall Study||5
10104070|NCT02431260|11233788|FG004|NOT COMPLETED|Overall Study||3
10104071|NCT02431260|11233789|FG005|NOT COMPLETED|Overall Study||4
10104072|NCT02431260|11233790|FG006|NOT COMPLETED|Overall Study||4
10104073|NCT02431260|11233791|FG007|NOT COMPLETED|Overall Study||3
10104074|NCT02431260|11233792|FG008|NOT COMPLETED|Overall Study||8
10104075|NCT02431260|11233793|FG009|NOT COMPLETED|Overall Study||8
10104076|NCT02431260|11233794|FG010|NOT COMPLETED|Overall Study||4
10104077|NCT02431260|11233795|FG011|NOT COMPLETED|Overall Study||4
10104078|NCT02431260|11233796|FG012|NOT COMPLETED|Overall Study||10
10104079|NCT02431260|11233797|FG013|NOT COMPLETED|Overall Study||1
10104080|NCT02431273|11233840|FG000|STARTED|TDF (Single IVR)||6
10104081|NCT02431273|11233840|FG000|COMPLETED|TDF (Single IVR)||6
10104082|NCT02431273|11233840|FG000|NOT COMPLETED|TDF (Single IVR)||0
10018958|NCT01826604|11141999|FG001|COMPLETED|Overall Study||148
10018959|NCT01826604|11141998|FG000|NOT COMPLETED|Overall Study||8
10018960|NCT01826604|11141999|FG001|NOT COMPLETED|Overall Study||9
10018961|NCT01826812|11142007|FG000|STARTED|Overall Study||167
10018962|NCT01826812|11142008|FG001|STARTED|Overall Study||33
10018963|NCT01826812|11142007|FG000|COMPLETED|Overall Study||167
10018964|NCT01826812|11142008|FG001|COMPLETED|Overall Study||32
10018965|NCT01826812|11142007|FG000|NOT COMPLETED|Overall Study||0
10104083|NCT02431273|11233840|FG000|STARTED|TDF-FTC (Dual IVR)||6
10104084|NCT02431273|11233840|FG000|COMPLETED|TDF-FTC (Dual IVR)||6
10104085|NCT02431273|11233840|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0
10104086|NCT02431273|11233840|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6
10104087|NCT02431273|11233840|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
10104088|NCT02431273|11233840|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
10104089|NCT02431299|11233850|FG000|STARTED|Overall Study||236
10104090|NCT02431299|11233851|FG001|STARTED|Overall Study||63
10104091|NCT02431299|11233850|FG000|COMPLETED|Overall Study||183
10104092|NCT02431299|11233851|FG001|COMPLETED|Overall Study||62
10104093|NCT02431299|11233850|FG000|NOT COMPLETED|Overall Study||53
10005900|NCT01744977|11128490|FG000|STARTED|Overall Study||120
10005901|NCT01744977|11128491|FG001|STARTED|Overall Study||120
10005902|NCT01744977|11128490|FG000|6 Month Completed|Overall Study||113
10005903|NCT01744977|11128491|FG001|6 Month Completed|Overall Study||115
10005904|NCT01744977|11128490|FG000|COMPLETED|Overall Study||109
10005905|NCT01744977|11128491|FG001|COMPLETED|Overall Study||115
10005906|NCT01744977|11128490|FG000|NOT COMPLETED|Overall Study||11
10005907|NCT01744977|11128491|FG001|NOT COMPLETED|Overall Study||5
10005908|NCT01745055|11128497|FG000|STARTED|Overall Study||12
10005909|NCT01745055|11128497|FG000|COMPLETED|Overall Study||12
10005910|NCT01745055|11128497|FG000|NOT COMPLETED|Overall Study||0
10005911|NCT01745094|11128510|FG000|STARTED|Overall Study||35
10005912|NCT01745094|11128511|FG001|STARTED|Overall Study||37
10005913|NCT01745094|11128512|FG002|STARTED|Overall Study||58
10005914|NCT01745094|11128513|FG003|STARTED|Overall Study||93
10005915|NCT01745094|11128510|FG000|COMPLETED|Overall Study||30
10005916|NCT01745094|11128511|FG001|COMPLETED|Overall Study||37
10005917|NCT01745094|11128512|FG002|COMPLETED|Overall Study||46
10005918|NCT01745094|11128513|FG003|COMPLETED|Overall Study||90
10005919|NCT01745094|11128510|FG000|NOT COMPLETED|Overall Study||5
10005920|NCT01745094|11128511|FG001|NOT COMPLETED|Overall Study||0
10005921|NCT01745094|11128512|FG002|NOT COMPLETED|Overall Study||12
10005922|NCT01745094|11128513|FG003|NOT COMPLETED|Overall Study||3
10005923|NCT01745120|11128528|FG000|STARTED|Overall Study||11
10005924|NCT01745120|11128529|FG001|STARTED|Overall Study||8
10005925|NCT01745120|11128528|FG000|COMPLETED|Overall Study||10
10005926|NCT01745120|11128529|FG001|COMPLETED|Overall Study||8
10005927|NCT01745120|11128528|FG000|NOT COMPLETED|Overall Study||1
10005928|NCT01745120|11128529|FG001|NOT COMPLETED|Overall Study||0
10005929|NCT01745133|11128541|FG000|STARTED|Overall Study||19
10005930|NCT01745133|11128542|FG001|STARTED|Overall Study||20
10005931|NCT01745133|11128543|FG002|STARTED|Overall Study||19
10005932|NCT01745133|11128541|FG000|COMPLETED|Overall Study||13
10005933|NCT01745133|11128542|FG001|COMPLETED|Overall Study||16
10005934|NCT01745133|11128543|FG002|COMPLETED|Overall Study||15
10005935|NCT01745133|11128541|FG000|NOT COMPLETED|Overall Study||6
10005936|NCT01745133|11128542|FG001|NOT COMPLETED|Overall Study||4
10005937|NCT01745133|11128543|FG002|NOT COMPLETED|Overall Study||4
10005938|NCT01745146|11128553|FG000|STARTED|Overall Study||30
10005939|NCT01745146|11128554|FG001|STARTED|Overall Study||60
10005940|NCT01745146|11128553|FG000|Allocation to Intervention|Overall Study||30
10005941|NCT01745146|11128554|FG001|Allocation to Intervention|Overall Study||60
10005942|NCT01745146|11128553|FG000|Primary Outcome Assessment|Overall Study||27
10005943|NCT01745146|11128554|FG001|Primary Outcome Assessment|Overall Study||57
10005944|NCT01745146|11128553|FG000|Analysis|Overall Study||27
10005945|NCT01745146|11128554|FG001|Analysis|Overall Study||57
10005946|NCT01745146|11128553|FG000|COMPLETED|Overall Study||27
10005947|NCT01745146|11128554|FG001|COMPLETED|Overall Study||57
10005948|NCT01745146|11128553|FG000|NOT COMPLETED|Overall Study||3
10005949|NCT01745146|11128554|FG001|NOT COMPLETED|Overall Study||3
10005950|NCT01745211|11128561|FG000|STARTED|Overall Study||45
10005951|NCT01745211|11128561|FG000|COMPLETED|Overall Study||27
10005952|NCT01745211|11128561|FG000|NOT COMPLETED|Overall Study||18
10005953|NCT01745367|11128567|FG000|STARTED|Overall Study||8
10005954|NCT01745367|11128568|FG001|STARTED|Overall Study||22
10005955|NCT01745367|11128567|FG000|Treated|Overall Study||8
10005956|NCT01745367|11128568|FG001|Treated|Overall Study||21
10005957|NCT01745367|11128567|FG000|COMPLETED|Overall Study||0
10005958|NCT01745367|11128568|FG001|COMPLETED|Overall Study||0
10005959|NCT01745367|11128567|FG000|NOT COMPLETED|Overall Study||8
10005960|NCT01745367|11128568|FG001|NOT COMPLETED|Overall Study||22
10005961|NCT01745380|11128576|FG000|STARTED|Overall Study||100
10005962|NCT01745380|11128577|FG001|STARTED|Overall Study||50
10005963|NCT01745380|11128576|FG000|COMPLETED|Overall Study||99
10005964|NCT01745380|11128577|FG001|COMPLETED|Overall Study||49
10005965|NCT01745380|11128576|FG000|NOT COMPLETED|Overall Study||1
10005966|NCT01745380|11128577|FG001|NOT COMPLETED|Overall Study||1
10005967|NCT01745393|11128585|FG000|STARTED|Treatment to End-of-treatment Assessment||163
10005968|NCT01745393|11128586|FG001|STARTED|Treatment to End-of-treatment Assessment||164
10005969|NCT01745393|11128585|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
10005970|NCT01745393|11128586|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
10005971|NCT01745393|11128585|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142
10005972|NCT01745393|11128586|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156
10005973|NCT01745393|11128585|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
10005974|NCT01745393|11128586|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
10005975|NCT01745393|11128585|FG000|STARTED|12-month Follow-up||142
10005976|NCT01745393|11128586|FG001|STARTED|12-month Follow-up||156
10005977|NCT01745393|11128585|FG000|COMPLETED|12-month Follow-up||136
10005978|NCT01745393|11128586|FG001|COMPLETED|12-month Follow-up||151
10005979|NCT01745393|11128585|FG000|NOT COMPLETED|12-month Follow-up||6
10005980|NCT01745393|11128586|FG001|NOT COMPLETED|12-month Follow-up||5
10005981|NCT01745627|11128592|FG000|STARTED|Overall Study||42
10005982|NCT01745627|11128592|FG000|COMPLETED|Overall Study||20
10005983|NCT01745627|11128592|FG000|NOT COMPLETED|Overall Study||22
10005984|NCT01745822|11128598|FG000|STARTED|Overall Study|168 mothers and 163 infants|331
10005985|NCT01745822|11128599|FG001|STARTED|Overall Study|163 mothers and 160 infants|323
10005986|NCT01745822|11128598|FG000|COMPLETED|Overall Study||331
10005987|NCT01745822|11128599|FG001|COMPLETED|Overall Study||323
10005988|NCT01745822|11128598|FG000|NOT COMPLETED|Overall Study||0
10005989|NCT01745822|11128599|FG001|NOT COMPLETED|Overall Study||0
10005990|NCT01745848|11128605|FG000|STARTED|Overall Study||26
10005991|NCT01745848|11128605|FG000|COMPLETED|Overall Study||20
10005992|NCT01745848|11128605|FG000|NOT COMPLETED|Overall Study||6
10005993|NCT01745952|11128609|FG000|STARTED|Overall Study||4
10005994|NCT01745952|11128610|FG001|STARTED|Overall Study||4
10005995|NCT01745952|11128611|FG002|STARTED|Overall Study||3
10005996|NCT01745952|11128609|FG000|COMPLETED|Overall Study||3
10005997|NCT01745952|11128610|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
10005998|NCT01745952|11128611|FG002|COMPLETED|Overall Study||3
10005999|NCT01745952|11128609|FG000|NOT COMPLETED|Overall Study||1
10006000|NCT01745952|11128610|FG001|NOT COMPLETED|Overall Study||1
10006001|NCT01745952|11128611|FG002|NOT COMPLETED|Overall Study||0
10006002|NCT01746017|11128636|FG000|STARTED|Period 1||2
10006003|NCT01746017|11128637|FG001|STARTED|Period 1||2
10006004|NCT01746017|11128638|FG002|STARTED|Period 1||2
10006005|NCT01746017|11128639|FG003|STARTED|Period 1||2
10006006|NCT01746017|11128640|FG004|STARTED|Period 1||2
10006007|NCT01746017|11128641|FG005|STARTED|Period 1||2
10006008|NCT01746017|11128642|FG006|STARTED|Period 1||3
10006009|NCT01746017|11128643|FG007|STARTED|Period 1||2
10006010|NCT01746017|11128644|FG008|STARTED|Period 1||3
10006011|NCT01746017|11128645|FG009|STARTED|Period 1||3
10006012|NCT01746017|11128646|FG010|STARTED|Period 1||3
10006013|NCT01746017|11128636|FG000|Received at Least 1 Dose of Study Drug|Period 1||2
10006014|NCT01746017|11128637|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
10006015|NCT01746017|11128638|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
10006016|NCT01746017|11128639|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
10006017|NCT01746017|11128640|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
10006018|NCT01746017|11128641|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
10006019|NCT01746017|11128642|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
10006020|NCT01746017|11128643|FG007|Received at Least 1 Dose of Study Drug|Period 1||2
10006021|NCT01746017|11128644|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
10006022|NCT01746017|11128645|FG009|Received at Least 1 Dose of Study Drug|Period 1||3
10006023|NCT01746017|11128646|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
10006024|NCT01746017|11128636|FG000|COMPLETED|Period 1||2
10006025|NCT01746017|11128637|FG001|COMPLETED|Period 1||2
10006026|NCT01746017|11128638|FG002|COMPLETED|Period 1||2
10006027|NCT01746017|11128639|FG003|COMPLETED|Period 1||2
10006028|NCT01746017|11128640|FG004|COMPLETED|Period 1||2
10006029|NCT01746017|11128641|FG005|COMPLETED|Period 1||2
10006030|NCT01746017|11128642|FG006|COMPLETED|Period 1||2
10006031|NCT01746017|11128643|FG007|COMPLETED|Period 1||2
10006032|NCT01746017|11128644|FG008|COMPLETED|Period 1||3
10006033|NCT01746017|11128645|FG009|COMPLETED|Period 1||3
10006034|NCT01746017|11128646|FG010|COMPLETED|Period 1||3
10006035|NCT01746017|11128636|FG000|NOT COMPLETED|Period 1||0
10006036|NCT01746017|11128637|FG001|NOT COMPLETED|Period 1||0
10006037|NCT01746017|11128638|FG002|NOT COMPLETED|Period 1||0
10006038|NCT01746017|11128639|FG003|NOT COMPLETED|Period 1||0
10202297|NCT03443427|11329434|FG000|STARTED|Overall Study||100
10202298|NCT03443427|11329435|FG001|STARTED|Overall Study||100
10202299|NCT03443427|11329434|FG000|COMPLETED|Overall Study||88
10006039|NCT01746017|11128640|FG004|NOT COMPLETED|Period 1||0
10006040|NCT01746017|11128641|FG005|NOT COMPLETED|Period 1||0
10006041|NCT01746017|11128642|FG006|NOT COMPLETED|Period 1||1
10006042|NCT01746017|11128643|FG007|NOT COMPLETED|Period 1||0
10006043|NCT01746017|11128644|FG008|NOT COMPLETED|Period 1||0
10104094|NCT02431299|11233851|FG001|NOT COMPLETED|Overall Study||1
10104095|NCT02431364|11233862|FG000|STARTED|Overall Study||8
10104096|NCT02431364|11233863|FG001|STARTED|Overall Study||6
10104097|NCT02431364|11233864|FG002|STARTED|Overall Study||6
10104098|NCT02431364|11233865|FG003|STARTED|Overall Study||7
10104099|NCT02431364|11233866|FG004|STARTED|Overall Study||6
10104100|NCT02431364|11233862|FG000|Treated|Overall Study||8
10104101|NCT02431364|11233863|FG001|Treated|Overall Study||6
10104102|NCT02431364|11233864|FG002|Treated|Overall Study||6
10104103|NCT02431364|11233865|FG003|Treated|Overall Study||6
10202300|NCT03443427|11329435|FG001|COMPLETED|Overall Study||89
10202301|NCT03443427|11329434|FG000|NOT COMPLETED|Overall Study||12
10202302|NCT03443427|11329435|FG001|NOT COMPLETED|Overall Study||11
10202303|NCT03443713|11329444|FG000|STARTED|Start up Visit (2 Hours)||8
10202304|NCT03443713|11329445|FG001|STARTED|Start up Visit (2 Hours)||8
10202305|NCT03443713|11329446|FG002|STARTED|Start up Visit (2 Hours)||9
10202306|NCT03443713|11329444|FG000|COMPLETED|Start up Visit (2 Hours)||8
10202307|NCT03443713|11329445|FG001|COMPLETED|Start up Visit (2 Hours)||8
10202308|NCT03443713|11329446|FG002|COMPLETED|Start up Visit (2 Hours)||9
10006044|NCT01746017|11128645|FG009|NOT COMPLETED|Period 1||0
10006045|NCT01746017|11128646|FG010|NOT COMPLETED|Period 1||0
10006046|NCT01746017|11128636|FG000|STARTED|Period 2||2
10104104|NCT02431364|11233866|FG004|Treated|Overall Study||6
10202309|NCT03443713|11329444|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0
10202310|NCT03443713|11329445|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0
10006047|NCT01746017|11128637|FG001|STARTED|Period 2||2
10006048|NCT01746017|11128638|FG002|STARTED|Period 2||2
10006049|NCT01746017|11128639|FG003|STARTED|Period 2||2
10006050|NCT01746017|11128640|FG004|STARTED|Period 2||2
10006051|NCT01746017|11128641|FG005|STARTED|Period 2||2
10104105|NCT02431364|11233862|FG000|COMPLETED|Overall Study||8
10104106|NCT02431364|11233863|FG001|COMPLETED|Overall Study||5
10104107|NCT02431364|11233864|FG002|COMPLETED|Overall Study||6
10006052|NCT01746017|11128642|FG006|STARTED|Period 2||2
10006053|NCT01746017|11128643|FG007|STARTED|Period 2||2
10006054|NCT01746017|11128644|FG008|STARTED|Period 2||3
10006055|NCT01746017|11128645|FG009|STARTED|Period 2||3
10006056|NCT01746017|11128646|FG010|STARTED|Period 2||3
10006057|NCT01746017|11128636|FG000|COMPLETED|Period 2||2
10006058|NCT01746017|11128637|FG001|COMPLETED|Period 2||2
10006059|NCT01746017|11128638|FG002|COMPLETED|Period 2||2
10006060|NCT01746017|11128639|FG003|COMPLETED|Period 2||2
10006061|NCT01746017|11128640|FG004|COMPLETED|Period 2||2
10006062|NCT01746017|11128641|FG005|COMPLETED|Period 2||2
10006063|NCT01746017|11128642|FG006|COMPLETED|Period 2||2
10006064|NCT01746017|11128643|FG007|COMPLETED|Period 2||2
10006065|NCT01746017|11128644|FG008|COMPLETED|Period 2||3
10006066|NCT01746017|11128645|FG009|COMPLETED|Period 2||3
10006067|NCT01746017|11128646|FG010|COMPLETED|Period 2||3
10006068|NCT01746017|11128636|FG000|NOT COMPLETED|Period 2||0
10006069|NCT01746017|11128637|FG001|NOT COMPLETED|Period 2||0
10006070|NCT01746017|11128638|FG002|NOT COMPLETED|Period 2||0
10006071|NCT01746017|11128639|FG003|NOT COMPLETED|Period 2||0
10006072|NCT01746017|11128640|FG004|NOT COMPLETED|Period 2||0
10006073|NCT01746017|11128641|FG005|NOT COMPLETED|Period 2||0
10006074|NCT01746017|11128642|FG006|NOT COMPLETED|Period 2||0
10006075|NCT01746017|11128643|FG007|NOT COMPLETED|Period 2||0
10006076|NCT01746017|11128644|FG008|NOT COMPLETED|Period 2||0
10006077|NCT01746017|11128645|FG009|NOT COMPLETED|Period 2||0
10006078|NCT01746017|11128646|FG010|NOT COMPLETED|Period 2||0
10006079|NCT01746017|11128636|FG000|STARTED|Period 3||2
10006080|NCT01746017|11128637|FG001|STARTED|Period 3||2
10006081|NCT01746017|11128638|FG002|STARTED|Period 3||2
10006082|NCT01746017|11128639|FG003|STARTED|Period 3||2
10104108|NCT02431364|11233865|FG003|COMPLETED|Overall Study||6
10104109|NCT02431364|11233866|FG004|COMPLETED|Overall Study||6
10104110|NCT02431364|11233862|FG000|NOT COMPLETED|Overall Study||0
10104111|NCT02431364|11233863|FG001|NOT COMPLETED|Overall Study||1
10104112|NCT02431364|11233864|FG002|NOT COMPLETED|Overall Study||0
10104113|NCT02431364|11233865|FG003|NOT COMPLETED|Overall Study||1
10104114|NCT02431364|11233866|FG004|NOT COMPLETED|Overall Study||0
10104115|NCT02431455|11233884|FG000|STARTED|Overall Study||112
10104116|NCT02431455|11233885|FG001|STARTED|Overall Study||112
10104117|NCT02431455|11233884|FG000|COMPLETED|Overall Study||112
10104118|NCT02431455|11233885|FG001|COMPLETED|Overall Study||112
10104119|NCT02431455|11233884|FG000|NOT COMPLETED|Overall Study||0
10104120|NCT02431455|11233885|FG001|NOT COMPLETED|Overall Study||0
10104121|NCT02431468|11233894|FG000|STARTED|Overall Study||46
10104122|NCT02431468|11233895|FG001|STARTED|Overall Study||47
10104123|NCT02431468|11233896|FG002|STARTED|Overall Study||48
10104124|NCT02431468|11233894|FG000|COMPLETED|Overall Study||38
10104125|NCT02431468|11233895|FG001|COMPLETED|Overall Study||29
10104126|NCT02431468|11233896|FG002|COMPLETED|Overall Study||39
10104127|NCT02431468|11233894|FG000|NOT COMPLETED|Overall Study||8
10104128|NCT02431468|11233895|FG001|NOT COMPLETED|Overall Study||18
10104129|NCT02431468|11233896|FG002|NOT COMPLETED|Overall Study||9
10104130|NCT02431533|11233912|FG000|STARTED|Overall Study||25
10104131|NCT02431533|11233913|FG001|STARTED|Overall Study||25
10104132|NCT02431533|11233912|FG000|COMPLETED|Overall Study||23
10104133|NCT02431533|11233913|FG001|COMPLETED|Overall Study||22
10104134|NCT02431533|11233912|FG000|NOT COMPLETED|Overall Study||2
10104135|NCT02431533|11233913|FG001|NOT COMPLETED|Overall Study||3
10104136|NCT02431559|11233923|FG000|STARTED|Overall Study||3
10104137|NCT02431559|11233924|FG001|STARTED|Overall Study||4
10104138|NCT02431559|11233925|FG002|STARTED|Overall Study||6
10104139|NCT02431559|11233926|FG003|STARTED|Overall Study||40
10104140|NCT02431559|11233923|FG000|COMPLETED|Overall Study||1
10104141|NCT02431559|11233924|FG001|COMPLETED|Overall Study||1
10104142|NCT02431559|11233925|FG002|COMPLETED|Overall Study||2
10104143|NCT02431559|11233926|FG003|COMPLETED|Overall Study||9
10104144|NCT02431559|11233923|FG000|NOT COMPLETED|Overall Study||2
10104145|NCT02431559|11233924|FG001|NOT COMPLETED|Overall Study||3
10104146|NCT02431559|11233925|FG002|NOT COMPLETED|Overall Study||4
10104147|NCT02431559|11233926|FG003|NOT COMPLETED|Overall Study||31
10104148|NCT02431572|11233939|FG000|STARTED|Overall Study||1
10104149|NCT02431572|11233940|FG001|STARTED|Overall Study||1
10104150|NCT02431572|11233941|FG002|STARTED|Overall Study||9
10104151|NCT02431572|11233939|FG000|COMPLETED|Overall Study||0
10104152|NCT02431572|11233940|FG001|COMPLETED|Overall Study||1
10104153|NCT02431572|11233941|FG002|COMPLETED|Overall Study||9
10104154|NCT02431572|11233939|FG000|NOT COMPLETED|Overall Study||1
10104155|NCT02431572|11233940|FG001|NOT COMPLETED|Overall Study||0
10104156|NCT02431572|11233941|FG002|NOT COMPLETED|Overall Study||0
10006083|NCT01746017|11128640|FG004|STARTED|Period 3||2
10006084|NCT01746017|11128641|FG005|STARTED|Period 3||2
10006085|NCT01746017|11128642|FG006|STARTED|Period 3||2
10006086|NCT01746017|11128643|FG007|STARTED|Period 3||2
10006087|NCT01746017|11128644|FG008|STARTED|Period 3||3
10006088|NCT01746017|11128645|FG009|STARTED|Period 3||3
10006089|NCT01746017|11128646|FG010|STARTED|Period 3||3
10006090|NCT01746017|11128636|FG000|COMPLETED|Period 3||2
10006091|NCT01746017|11128637|FG001|COMPLETED|Period 3||2
10006092|NCT01746017|11128638|FG002|COMPLETED|Period 3||2
10104157|NCT02431598|11233949|FG000|STARTED|Overall Study||6
10104158|NCT02431598|11233950|FG001|STARTED|Overall Study||9
10104159|NCT02431598|11233951|FG002|STARTED|Overall Study||9
10104160|NCT02431598|11233952|FG003|STARTED|Overall Study||7
10104161|NCT02431598|11233953|FG004|STARTED|Overall Study||7
10104162|NCT02431598|11233954|FG005|STARTED|Overall Study||6
10006093|NCT01746017|11128639|FG003|COMPLETED|Period 3||2
10006094|NCT01746017|11128640|FG004|COMPLETED|Period 3||2
10006095|NCT01746017|11128641|FG005|COMPLETED|Period 3||1
10006096|NCT01746017|11128642|FG006|COMPLETED|Period 3||2
10006097|NCT01746017|11128643|FG007|COMPLETED|Period 3||2
10006098|NCT01746017|11128644|FG008|COMPLETED|Period 3||3
10006099|NCT01746017|11128645|FG009|COMPLETED|Period 3||3
10006100|NCT01746017|11128646|FG010|COMPLETED|Period 3||3
10006101|NCT01746017|11128636|FG000|NOT COMPLETED|Period 3||0
10006102|NCT01746017|11128637|FG001|NOT COMPLETED|Period 3||0
10006103|NCT01746017|11128638|FG002|NOT COMPLETED|Period 3||0
10006104|NCT01746017|11128639|FG003|NOT COMPLETED|Period 3||0
10006105|NCT01746017|11128640|FG004|NOT COMPLETED|Period 3||0
10006106|NCT01746017|11128641|FG005|NOT COMPLETED|Period 3||1
10006107|NCT01746017|11128642|FG006|NOT COMPLETED|Period 3||0
10006108|NCT01746017|11128643|FG007|NOT COMPLETED|Period 3||0
10006109|NCT01746017|11128644|FG008|NOT COMPLETED|Period 3||0
10006110|NCT01746017|11128645|FG009|NOT COMPLETED|Period 3||0
10006111|NCT01746017|11128646|FG010|NOT COMPLETED|Period 3||0
10006112|NCT01746017|11128636|FG000|STARTED|Period 4||2
10006113|NCT01746017|11128637|FG001|STARTED|Period 4||2
10006114|NCT01746017|11128638|FG002|STARTED|Period 4||2
10006115|NCT01746017|11128639|FG003|STARTED|Period 4||2
10006116|NCT01746017|11128640|FG004|STARTED|Period 4||2
10006117|NCT01746017|11128641|FG005|STARTED|Period 4||1
10006118|NCT01746017|11128642|FG006|STARTED|Period 4||2
10006119|NCT01746017|11128643|FG007|STARTED|Period 4||2
10006120|NCT01746017|11128644|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0
10006121|NCT01746017|11128645|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0
10006122|NCT01746017|11128646|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0
10006123|NCT01746017|11128636|FG000|COMPLETED|Period 4||2
10006124|NCT01746017|11128637|FG001|COMPLETED|Period 4||2
10006125|NCT01746017|11128638|FG002|COMPLETED|Period 4||2
10006126|NCT01746017|11128639|FG003|COMPLETED|Period 4||2
10006127|NCT01746017|11128640|FG004|COMPLETED|Period 4||2
10006128|NCT01746017|11128641|FG005|COMPLETED|Period 4||1
10006129|NCT01746017|11128642|FG006|COMPLETED|Period 4||2
10006130|NCT01746017|11128643|FG007|COMPLETED|Period 4||2
10006131|NCT01746017|11128644|FG008|COMPLETED|Period 4||0
10006132|NCT01746017|11128645|FG009|COMPLETED|Period 4||0
10006133|NCT01746017|11128646|FG010|COMPLETED|Period 4||0
10006134|NCT01746017|11128636|FG000|NOT COMPLETED|Period 4||0
10006135|NCT01746017|11128637|FG001|NOT COMPLETED|Period 4||0
10006136|NCT01746017|11128638|FG002|NOT COMPLETED|Period 4||0
10006137|NCT01746017|11128639|FG003|NOT COMPLETED|Period 4||0
10006138|NCT01746017|11128640|FG004|NOT COMPLETED|Period 4||0
10006139|NCT01746017|11128641|FG005|NOT COMPLETED|Period 4||0
10006140|NCT01746017|11128642|FG006|NOT COMPLETED|Period 4||0
10006141|NCT01746017|11128643|FG007|NOT COMPLETED|Period 4||0
10006142|NCT01746017|11128644|FG008|NOT COMPLETED|Period 4||0
10006143|NCT01746017|11128645|FG009|NOT COMPLETED|Period 4||0
10006144|NCT01746017|11128646|FG010|NOT COMPLETED|Period 4||0
10006145|NCT01746043|11128689|FG000|STARTED|Overall Study||5
10006146|NCT01746043|11128690|FG001|STARTED|Overall Study||4
10006147|NCT01746043|11128691|FG002|STARTED|Overall Study||5
10006148|NCT01746043|11128692|FG003|STARTED|Overall Study||5
10006149|NCT01746043|11128689|FG000|COMPLETED|Overall Study||5
10006150|NCT01746043|11128690|FG001|COMPLETED|Overall Study||4
10006151|NCT01746043|11128691|FG002|COMPLETED|Overall Study||5
10006152|NCT01746043|11128692|FG003|COMPLETED|Overall Study||5
10006153|NCT01746043|11128689|FG000|NOT COMPLETED|Overall Study||0
10006154|NCT01746043|11128690|FG001|NOT COMPLETED|Overall Study||0
10006155|NCT01746043|11128691|FG002|NOT COMPLETED|Overall Study||0
10006156|NCT01746043|11128692|FG003|NOT COMPLETED|Overall Study||0
10006157|NCT01746095|11128706|FG000|STARTED|Overall Study||20
10006158|NCT01746095|11128707|FG001|STARTED|Overall Study||20
10006159|NCT01746095|11128708|FG002|STARTED|Overall Study||24
10006160|NCT01746095|11128709|FG003|STARTED|Overall Study||23
10006161|NCT01746095|11128706|FG000|COMPLETED|Overall Study||16
10006162|NCT01746095|11128707|FG001|COMPLETED|Overall Study||16
10006163|NCT01746095|11128708|FG002|COMPLETED|Overall Study||11
10006164|NCT01746095|11128709|FG003|COMPLETED|Overall Study||15
10006165|NCT01746095|11128706|FG000|NOT COMPLETED|Overall Study||4
10006166|NCT01746095|11128707|FG001|NOT COMPLETED|Overall Study||4
10006167|NCT01746095|11128708|FG002|NOT COMPLETED|Overall Study||13
10006168|NCT01746095|11128709|FG003|NOT COMPLETED|Overall Study||8
10006169|NCT01746108|11128722|FG000|STARTED|Overall Study||18
10006170|NCT01746108|11128723|FG001|STARTED|Overall Study||28
10006171|NCT01746108|11128724|FG002|STARTED|Overall Study||6
10006172|NCT01746108|11128722|FG000|COMPLETED|Overall Study||18
10006173|NCT01746108|11128723|FG001|COMPLETED|Overall Study||24
10006174|NCT01746108|11128724|FG002|COMPLETED|Overall Study||6
10006175|NCT01746108|11128722|FG000|NOT COMPLETED|Overall Study||0
10006176|NCT01746108|11128723|FG001|NOT COMPLETED|Overall Study||4
10006177|NCT01746108|11128724|FG002|NOT COMPLETED|Overall Study||0
10006181|NCT01746225|11128747|FG000|STARTED|Overall Study||83
10006182|NCT01746225|11128748|FG001|STARTED|Overall Study||86
10006183|NCT01746225|11128749|FG002|STARTED|Overall Study||86
10006184|NCT01746225|11128747|FG000|COMPLETED|Overall Study||43
10006185|NCT01746225|11128748|FG001|COMPLETED|Overall Study||40
10006186|NCT01746225|11128749|FG002|COMPLETED|Overall Study||43
10006187|NCT01746225|11128747|FG000|NOT COMPLETED|Overall Study||40
10006188|NCT01746225|11128748|FG001|NOT COMPLETED|Overall Study||46
10006189|NCT01746225|11128749|FG002|NOT COMPLETED|Overall Study||43
10006190|NCT01746264|11128757|FG000|STARTED|Overall Study||19
10006191|NCT01746264|11128757|FG000|COMPLETED|Overall Study||19
10006192|NCT01746264|11128757|FG000|NOT COMPLETED|Overall Study||0
10006193|NCT01746368|11128763|FG000|STARTED|Overall Study||33
10006194|NCT01746368|11128764|FG001|STARTED|Overall Study||17
10006195|NCT01746368|11128763|FG000|Recieved Allocated Intervention|Overall Study||31
10006196|NCT01746368|11128764|FG001|Recieved Allocated Intervention|Overall Study||8
10006197|NCT01746368|11128763|FG000|Assessment Completed|Overall Study||31
10006198|NCT01746368|11128764|FG001|Assessment Completed|Overall Study||16
10006199|NCT01746368|11128763|FG000|Analyzed for AD Completion Rate|Overall Study||32
10006200|NCT01746368|11128764|FG001|Analyzed for AD Completion Rate|Overall Study||17
10006201|NCT01746368|11128763|FG000|Analyzed for Satisfaction|Overall Study||30
10006202|NCT01746368|11128764|FG001|Analyzed for Satisfaction|Overall Study||16
10006203|NCT01746368|11128763|FG000|COMPLETED|Overall Study||31
10006204|NCT01746368|11128764|FG001|COMPLETED|Overall Study||16
10006205|NCT01746368|11128763|FG000|NOT COMPLETED|Overall Study||2
10006206|NCT01746368|11128764|FG001|NOT COMPLETED|Overall Study||1
10006207|NCT01746420|11128775|FG000|STARTED|Overall Study||20
10006208|NCT01746420|11128776|FG001|STARTED|Overall Study||20
10006209|NCT01746420|11128777|FG002|STARTED|Overall Study||20
10006210|NCT01746420|11128778|FG003|STARTED|Overall Study||20
10006211|NCT01746420|11128779|FG004|STARTED|Overall Study||20
10006212|NCT01746420|11128775|FG000|COMPLETED|Overall Study||17
10006213|NCT01746420|11128776|FG001|COMPLETED|Overall Study||18
10006214|NCT01746420|11128777|FG002|COMPLETED|Overall Study||17
10006215|NCT01746420|11128778|FG003|COMPLETED|Overall Study||20
10006216|NCT01746420|11128779|FG004|COMPLETED|Overall Study||20
10006217|NCT01746420|11128775|FG000|NOT COMPLETED|Overall Study||3
10006218|NCT01746420|11128776|FG001|NOT COMPLETED|Overall Study||2
10006219|NCT01746420|11128777|FG002|NOT COMPLETED|Overall Study||3
10006220|NCT01746420|11128778|FG003|NOT COMPLETED|Overall Study||0
10006221|NCT01746420|11128779|FG004|NOT COMPLETED|Overall Study||0
10006222|NCT01746511|11128794|FG000|STARTED|Overall Study||40
10006223|NCT01746511|11128795|FG001|STARTED|Overall Study||39
10006224|NCT01746511|11128794|FG000|COMPLETED|Overall Study||40
10006225|NCT01746511|11128795|FG001|COMPLETED|Overall Study||39
10006226|NCT01746511|11128794|FG000|NOT COMPLETED|Overall Study||0
10006227|NCT01746511|11128795|FG001|NOT COMPLETED|Overall Study||0
10006228|NCT01746732|11128801|FG000|STARTED|Lead-In Period||23
10006229|NCT01746732|11128802|FG001|STARTED|Lead-In Period||0
10006230|NCT01746732|11128803|FG002|STARTED|Lead-In Period||0
10006231|NCT01746732|11128801|FG000|Participants Received at Least 1 Dose|Lead-In Period||22
10006232|NCT01746732|11128802|FG001|Participants Received at Least 1 Dose|Lead-In Period||0
10006233|NCT01746732|11128803|FG002|Participants Received at Least 1 Dose|Lead-In Period||0
10006234|NCT01746732|11128801|FG000|COMPLETED|Lead-In Period||22
10006235|NCT01746732|11128802|FG001|COMPLETED|Lead-In Period||0
10006236|NCT01746732|11128803|FG002|COMPLETED|Lead-In Period||0
10006237|NCT01746732|11128801|FG000|NOT COMPLETED|Lead-In Period||1
10006238|NCT01746732|11128802|FG001|NOT COMPLETED|Lead-In Period||0
10006239|NCT01746732|11128803|FG002|NOT COMPLETED|Lead-In Period||0
10006240|NCT01746732|11128801|FG000|STARTED|Period 1||0
10006241|NCT01746732|11128802|FG001|STARTED|Period 1||11
10006242|NCT01746732|11128803|FG002|STARTED|Period 1||11
10006243|NCT01746732|11128801|FG000|COMPLETED|Period 1||0
10006244|NCT01746732|11128802|FG001|COMPLETED|Period 1||10
10006245|NCT01746732|11128803|FG002|COMPLETED|Period 1||11
10006246|NCT01746732|11128801|FG000|NOT COMPLETED|Period 1||0
10104163|NCT02431598|11233949|FG000|COMPLETED|Overall Study||6
10104164|NCT02431598|11233950|FG001|COMPLETED|Overall Study||9
10104165|NCT02431598|11233951|FG002|COMPLETED|Overall Study||9
10104166|NCT02431598|11233952|FG003|COMPLETED|Overall Study||7
10104167|NCT02431598|11233953|FG004|COMPLETED|Overall Study||7
10104168|NCT02431598|11233954|FG005|COMPLETED|Overall Study||6
10104169|NCT02431598|11233949|FG000|NOT COMPLETED|Overall Study||0
10104170|NCT02431598|11233950|FG001|NOT COMPLETED|Overall Study||0
10104171|NCT02431598|11233951|FG002|NOT COMPLETED|Overall Study||0
10104172|NCT02431598|11233952|FG003|NOT COMPLETED|Overall Study||0
10104173|NCT02431598|11233953|FG004|NOT COMPLETED|Overall Study||0
10104174|NCT02431598|11233954|FG005|NOT COMPLETED|Overall Study||0
10104175|NCT02431637|11233971|FG000|STARTED|Overall Study||6
10104176|NCT02431637|11233971|FG000|COMPLETED|Overall Study||6
10104177|NCT02431637|11233971|FG000|NOT COMPLETED|Overall Study||0
10104178|NCT02431650|11233977|FG000|STARTED|Overall Study||5
10104179|NCT02431650|11233978|FG001|STARTED|Overall Study||6
10104180|NCT02431650|11233977|FG000|COMPLETED|Overall Study||5
10006247|NCT01746732|11128802|FG001|NOT COMPLETED|Period 1||1
10006248|NCT01746732|11128803|FG002|NOT COMPLETED|Period 1||0
10006249|NCT01746732|11128801|FG000|STARTED|Period 2||0
10006250|NCT01746732|11128802|FG001|STARTED|Period 2||10
10006251|NCT01746732|11128803|FG002|STARTED|Period 2||11
10006252|NCT01746732|11128801|FG000|COMPLETED|Period 2||0
10104181|NCT02431650|11233978|FG001|COMPLETED|Overall Study||6
10104182|NCT02431650|11233977|FG000|NOT COMPLETED|Overall Study||0
10006253|NCT01746732|11128802|FG001|COMPLETED|Period 2||10
10006254|NCT01746732|11128803|FG002|COMPLETED|Period 2||7
10006255|NCT01746732|11128801|FG000|NOT COMPLETED|Period 2||0
10006256|NCT01746732|11128802|FG001|NOT COMPLETED|Period 2||0
10104183|NCT02431650|11233978|FG001|NOT COMPLETED|Overall Study||0
10104184|NCT02431676|11233987|FG000|STARTED|Overall Study||40
10104185|NCT02431676|11233988|FG001|STARTED|Overall Study||39
10006257|NCT01746732|11128803|FG002|NOT COMPLETED|Period 2||4
10006258|NCT01746745|11128811|FG000|STARTED|Overall Study||6
10006259|NCT01746745|11128811|FG000|Received Study Drug|Overall Study||6
10006260|NCT01746745|11128811|FG000|COMPLETED|Overall Study||6
10006261|NCT01746745|11128811|FG000|NOT COMPLETED|Overall Study||0
10006262|NCT01746784|11128820|FG000|STARTED|Overall Study||19
10006263|NCT01746784|11128821|FG001|STARTED|Overall Study||10
10006264|NCT01746784|11128822|FG002|STARTED|Overall Study||9
10006265|NCT01746784|11128823|FG003|STARTED|Overall Study||9
10006266|NCT01746784|11128824|FG004|STARTED|Overall Study||19
10006267|NCT01746784|11128820|FG000|Enrolled|Overall Study||19
10006268|NCT01746784|11128821|FG001|Enrolled|Overall Study||10
10006269|NCT01746784|11128822|FG002|Enrolled|Overall Study||9
10006270|NCT01746784|11128823|FG003|Enrolled|Overall Study||9
10006271|NCT01746784|11128824|FG004|Enrolled|Overall Study||19
10006272|NCT01746784|11128820|FG000|COMPLETED|Overall Study||19
10006273|NCT01746784|11128821|FG001|COMPLETED|Overall Study||10
10006274|NCT01746784|11128822|FG002|COMPLETED|Overall Study||9
10006275|NCT01746784|11128823|FG003|COMPLETED|Overall Study||9
10006276|NCT01746784|11128824|FG004|COMPLETED|Overall Study||19
10006277|NCT01746784|11128820|FG000|NOT COMPLETED|Overall Study||0
10006278|NCT01746784|11128821|FG001|NOT COMPLETED|Overall Study||0
10006279|NCT01746784|11128822|FG002|NOT COMPLETED|Overall Study||0
10006280|NCT01746784|11128823|FG003|NOT COMPLETED|Overall Study||0
10006281|NCT01746784|11128824|FG004|NOT COMPLETED|Overall Study||0
10006282|NCT01746862|11128847|FG000|STARTED|Overall Study||60
10006283|NCT01746862|11128848|FG001|STARTED|Overall Study||30
10006284|NCT01746862|11128847|FG000|Treated|Overall Study||59
10006285|NCT01746862|11128848|FG001|Treated|Overall Study||30
10006286|NCT01746862|11128847|FG000|COMPLETED|Overall Study||52
10006287|NCT01746862|11128848|FG001|COMPLETED|Overall Study||27
10006288|NCT01746862|11128847|FG000|NOT COMPLETED|Overall Study||8
10006289|NCT01746862|11128848|FG001|NOT COMPLETED|Overall Study||3
10006290|NCT01746901|11128855|FG000|STARTED|Naloxone Challenge Phase||75
10006291|NCT01746901|11128856|FG001|STARTED|Naloxone Challenge Phase||0
10006292|NCT01746901|11128857|FG002|STARTED|Naloxone Challenge Phase||0
10006293|NCT01746901|11128858|FG003|STARTED|Naloxone Challenge Phase||0
10006294|NCT01746901|11128859|FG004|STARTED|Naloxone Challenge Phase||0
10006295|NCT01746901|11128860|FG005|STARTED|Naloxone Challenge Phase||0
10006296|NCT01746901|11128861|FG006|STARTED|Naloxone Challenge Phase||0
10006297|NCT01746901|11128862|FG007|STARTED|Naloxone Challenge Phase||0
10006298|NCT01746901|11128863|FG008|STARTED|Naloxone Challenge Phase||0
10006299|NCT01746901|11128855|FG000|COMPLETED|Naloxone Challenge Phase||72
10006300|NCT01746901|11128856|FG001|COMPLETED|Naloxone Challenge Phase||0
10006301|NCT01746901|11128857|FG002|COMPLETED|Naloxone Challenge Phase||0
10006302|NCT01746901|11128858|FG003|COMPLETED|Naloxone Challenge Phase||0
10006303|NCT01746901|11128859|FG004|COMPLETED|Naloxone Challenge Phase||0
10006304|NCT01746901|11128860|FG005|COMPLETED|Naloxone Challenge Phase||0
10006305|NCT01746901|11128861|FG006|COMPLETED|Naloxone Challenge Phase||0
10006306|NCT01746901|11128862|FG007|COMPLETED|Naloxone Challenge Phase||0
10006307|NCT01746901|11128863|FG008|COMPLETED|Naloxone Challenge Phase||0
10006308|NCT01746901|11128855|FG000|NOT COMPLETED|Naloxone Challenge Phase||3
10006309|NCT01746901|11128856|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
10006310|NCT01746901|11128857|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
10006311|NCT01746901|11128858|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
10006312|NCT01746901|11128859|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
10006313|NCT01746901|11128860|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
10006314|NCT01746901|11128861|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
10006315|NCT01746901|11128862|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
10006316|NCT01746901|11128863|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
10104186|NCT02431676|11233989|FG002|STARTED|Overall Study||42
10104187|NCT02431676|11233987|FG000|COMPLETED|Overall Study||40
10104188|NCT02431676|11233988|FG001|COMPLETED|Overall Study||38
10104189|NCT02431676|11233989|FG002|COMPLETED|Overall Study||40
10104190|NCT02431676|11233987|FG000|NOT COMPLETED|Overall Study||0
10104191|NCT02431676|11233988|FG001|NOT COMPLETED|Overall Study||1
10104192|NCT02431676|11233989|FG002|NOT COMPLETED|Overall Study||2
10104193|NCT02431741|11233997|FG000|STARTED|Overall Study||14
10104194|NCT02431741|11233997|FG000|COMPLETED|Overall Study||14
10104195|NCT02431741|11233997|FG000|NOT COMPLETED|Overall Study||0
10104196|NCT02431754|11234003|FG000|STARTED|Period 1 (8 Weeks)||85
10104197|NCT02431754|11234004|FG001|STARTED|Period 1 (8 Weeks)||86
10104198|NCT02431754|11234003|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
10104199|NCT02431754|11234004|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
10104200|NCT02431754|11234003|FG000|COMPLETED|Period 1 (8 Weeks)||79
10104201|NCT02431754|11234004|FG001|COMPLETED|Period 1 (8 Weeks)||82
10104202|NCT02431754|11234003|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6
10104203|NCT02431754|11234004|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4
10104204|NCT02431754|11234003|FG000|STARTED|Wash-out Period (4 Weeks)||79
10104205|NCT02431754|11234004|FG001|STARTED|Wash-out Period (4 Weeks)||82
10104206|NCT02431754|11234003|FG000|COMPLETED|Wash-out Period (4 Weeks)||75
10006317|NCT01746901|11128855|FG000|STARTED|Drug Discrimination Phase: Day 1||0
10006318|NCT01746901|11128856|FG001|STARTED|Drug Discrimination Phase: Day 1||36
10006319|NCT01746901|11128857|FG002|STARTED|Drug Discrimination Phase: Day 1||36
10006320|NCT01746901|11128858|FG003|STARTED|Drug Discrimination Phase: Day 1||0
10006321|NCT01746901|11128859|FG004|STARTED|Drug Discrimination Phase: Day 1||0
10006322|NCT01746901|11128860|FG005|STARTED|Drug Discrimination Phase: Day 1||0
10104207|NCT02431754|11234004|FG001|COMPLETED|Wash-out Period (4 Weeks)||82
10006323|NCT01746901|11128861|FG006|STARTED|Drug Discrimination Phase: Day 1||0
10006324|NCT01746901|11128862|FG007|STARTED|Drug Discrimination Phase: Day 1||0
10006325|NCT01746901|11128863|FG008|STARTED|Drug Discrimination Phase: Day 1||0
10006326|NCT01746901|11128855|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
10006327|NCT01746901|11128856|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33
10006328|NCT01746901|11128857|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36
10006329|NCT01746901|11128858|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
10006330|NCT01746901|11128859|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
10006331|NCT01746901|11128860|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
10006332|NCT01746901|11128861|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
10006333|NCT01746901|11128862|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
10006334|NCT01746901|11128863|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
10006335|NCT01746901|11128855|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006336|NCT01746901|11128856|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
10006337|NCT01746901|11128857|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006338|NCT01746901|11128858|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006339|NCT01746901|11128859|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006340|NCT01746901|11128860|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006341|NCT01746901|11128861|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006342|NCT01746901|11128862|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006343|NCT01746901|11128863|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10006344|NCT01746901|11128855|FG000|STARTED|Drug Discrimination Phase: Day 2||0
10006345|NCT01746901|11128856|FG001|STARTED|Drug Discrimination Phase: Day 2||33
10006346|NCT01746901|11128857|FG002|STARTED|Drug Discrimination Phase: Day 2||36
10006347|NCT01746901|11128858|FG003|STARTED|Drug Discrimination Phase: Day 2||0
10104208|NCT02431754|11234003|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4
10104209|NCT02431754|11234004|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0
10104210|NCT02431754|11234003|FG000|STARTED|Period 2 (8 Weeks)||75
10104211|NCT02431754|11234004|FG001|STARTED|Period 2 (8 Weeks)||82
10104212|NCT02431754|11234003|FG000|COMPLETED|Period 2 (8 Weeks)||74
10104213|NCT02431754|11234004|FG001|COMPLETED|Period 2 (8 Weeks)||78
10104214|NCT02431754|11234003|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1
10104215|NCT02431754|11234004|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4
10104216|NCT02431793|11234015|FG000|STARTED|Overall Study||202
10104217|NCT02431793|11234016|FG001|STARTED|Overall Study||243
10104218|NCT02431793|11234017|FG002|STARTED|Overall Study||207
10104219|NCT02431793|11234015|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
10104220|NCT02431793|11234016|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
10104221|NCT02431793|11234017|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
10104222|NCT02431793|11234015|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
10104223|NCT02431793|11234016|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
10104224|NCT02431793|11234017|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
10104225|NCT02431793|11234015|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85
10104226|NCT02431793|11234016|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113
10104227|NCT02431793|11234017|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93
10104228|NCT02431793|11234015|FG000|COMPLETED|Overall Study||83
10104229|NCT02431793|11234016|FG001|COMPLETED|Overall Study||109
10104230|NCT02431793|11234017|FG002|COMPLETED|Overall Study||90
10104231|NCT02431793|11234015|FG000|NOT COMPLETED|Overall Study||119
10104232|NCT02431793|11234016|FG001|NOT COMPLETED|Overall Study||134
10104233|NCT02431793|11234017|FG002|NOT COMPLETED|Overall Study||117
10104234|NCT02431806|11234029|FG000|STARTED|Double-blind Treatment Period||142
10104235|NCT02431806|11234030|FG001|STARTED|Double-blind Treatment Period||136
10104236|NCT02431806|11234031|FG002|STARTED|Double-blind Treatment Period||139
10104237|NCT02431806|11234032|FG003|STARTED|Double-blind Treatment Period||135
10104238|NCT02431806|11234029|FG000|Safety Population|Double-blind Treatment Period||141
10104239|NCT02431806|11234030|FG001|Safety Population|Double-blind Treatment Period||134
10104240|NCT02431806|11234031|FG002|Safety Population|Double-blind Treatment Period||138
10104241|NCT02431806|11234032|FG003|Safety Population|Double-blind Treatment Period||134
10104242|NCT02431806|11234029|FG000|COMPLETED|Double-blind Treatment Period||117
10104243|NCT02431806|11234030|FG001|COMPLETED|Double-blind Treatment Period||115
10104244|NCT02431806|11234031|FG002|COMPLETED|Double-blind Treatment Period||107
10104245|NCT02431806|11234032|FG003|COMPLETED|Double-blind Treatment Period||109
10104246|NCT02431806|11234029|FG000|NOT COMPLETED|Double-blind Treatment Period||25
10104247|NCT02431806|11234030|FG001|NOT COMPLETED|Double-blind Treatment Period||21
10104248|NCT02431806|11234031|FG002|NOT COMPLETED|Double-blind Treatment Period||32
10104249|NCT02431806|11234032|FG003|NOT COMPLETED|Double-blind Treatment Period||26
10104250|NCT02431806|11234029|FG000|STARTED|Double-blind Down-taper Period||111
10104251|NCT02431806|11234030|FG001|STARTED|Double-blind Down-taper Period||109
10104252|NCT02431806|11234031|FG002|STARTED|Double-blind Down-taper Period||104
10104253|NCT02431806|11234032|FG003|STARTED|Double-blind Down-taper Period||107
10104254|NCT02431806|11234029|FG000|COMPLETED|Double-blind Down-taper Period||111
10104255|NCT02431806|11234030|FG001|COMPLETED|Double-blind Down-taper Period||109
10104256|NCT02431806|11234031|FG002|COMPLETED|Double-blind Down-taper Period||104
10006348|NCT01746901|11128859|FG004|STARTED|Drug Discrimination Phase: Day 2||0
10006349|NCT01746901|11128860|FG005|STARTED|Drug Discrimination Phase: Day 2||0
10006350|NCT01746901|11128861|FG006|STARTED|Drug Discrimination Phase: Day 2||0
10006351|NCT01746901|11128862|FG007|STARTED|Drug Discrimination Phase: Day 2||0
10006352|NCT01746901|11128863|FG008|STARTED|Drug Discrimination Phase: Day 2||0
10006353|NCT01746901|11128855|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
10006354|NCT01746901|11128856|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19
10006355|NCT01746901|11128857|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22
10006356|NCT01746901|11128858|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
10006357|NCT01746901|11128859|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
10006358|NCT01746901|11128860|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
10006359|NCT01746901|11128861|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
10006360|NCT01746901|11128862|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
10006361|NCT01746901|11128863|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
10006362|NCT01746901|11128855|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10006363|NCT01746901|11128856|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
10006364|NCT01746901|11128857|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
10006365|NCT01746901|11128858|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10006366|NCT01746901|11128859|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10006367|NCT01746901|11128860|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10006368|NCT01746901|11128861|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10006369|NCT01746901|11128862|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10006370|NCT01746901|11128863|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10006371|NCT01746901|11128855|FG000|STARTED|Treatment Phase: First Intervention||0
10006372|NCT01746901|11128856|FG001|STARTED|Treatment Phase: First Intervention||0
10006373|NCT01746901|11128857|FG002|STARTED|Treatment Phase: First Intervention||0
10006374|NCT01746901|11128858|FG003|STARTED|Treatment Phase: First Intervention||6
10006375|NCT01746901|11128859|FG004|STARTED|Treatment Phase: First Intervention||6
10006376|NCT01746901|11128860|FG005|STARTED|Treatment Phase: First Intervention||7
10006377|NCT01746901|11128861|FG006|STARTED|Treatment Phase: First Intervention||8
10006378|NCT01746901|11128862|FG007|STARTED|Treatment Phase: First Intervention||7
10006379|NCT01746901|11128863|FG008|STARTED|Treatment Phase: First Intervention||7
10006380|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: First Intervention||0
10006381|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: First Intervention||0
10006382|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: First Intervention||0
10006383|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: First Intervention||6
10006384|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: First Intervention||6
10006385|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: First Intervention||7
10006386|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: First Intervention||7
10006387|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: First Intervention||7
10006388|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: First Intervention||7
10006389|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
10006390|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
10006391|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
10006392|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
10006393|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
10104257|NCT02431806|11234032|FG003|COMPLETED|Double-blind Down-taper Period||107
10104258|NCT02431806|11234029|FG000|NOT COMPLETED|Double-blind Down-taper Period||0
10104259|NCT02431806|11234030|FG001|NOT COMPLETED|Double-blind Down-taper Period||0
10104260|NCT02431806|11234031|FG002|NOT COMPLETED|Double-blind Down-taper Period||0
10104261|NCT02431806|11234032|FG003|NOT COMPLETED|Double-blind Down-taper Period||0
10104262|NCT02432040|11234044|FG000|STARTED|Overall Study||14
10006394|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
10006395|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1
10006396|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
10006397|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
10006398|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Washout Period 1||0
10006399|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Washout Period 1||0
10006400|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Washout Period 1||0
10006401|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Washout Period 1||6
10006402|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Washout Period 1||6
10006403|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Washout Period 1||7
10006404|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Washout Period 1||7
10104263|NCT02432040|11234045|FG001|STARTED|Overall Study||14
10104264|NCT02432040|11234044|FG000|COMPLETED|Overall Study||6
10104265|NCT02432040|11234045|FG001|COMPLETED|Overall Study||8
10104266|NCT02432040|11234044|FG000|NOT COMPLETED|Overall Study||8
10104267|NCT02432040|11234045|FG001|NOT COMPLETED|Overall Study||6
10104268|NCT02432105|11234054|FG000|STARTED|Overall Study||164
10104269|NCT02432105|11234055|FG001|STARTED|Overall Study||110
10104270|NCT02432105|11234056|FG002|STARTED|Overall Study||111
10104271|NCT02432105|11234054|FG000|COMPLETED|Overall Study||162
10104272|NCT02432105|11234055|FG001|COMPLETED|Overall Study||108
10104273|NCT02432105|11234056|FG002|COMPLETED|Overall Study||108
10104274|NCT02432105|11234054|FG000|NOT COMPLETED|Overall Study||2
10104275|NCT02432105|11234055|FG001|NOT COMPLETED|Overall Study||2
10104276|NCT02432105|11234056|FG002|NOT COMPLETED|Overall Study||3
10104277|NCT02432144|11234065|FG000|STARTED|Overall Study||12
10104278|NCT02432144|11234065|FG000|COMPLETED|Overall Study||11
10104279|NCT02432144|11234065|FG000|NOT COMPLETED|Overall Study||1
10104280|NCT02432183|11234073|FG000|STARTED|Overall Study||44
10104281|NCT02432183|11234074|FG001|STARTED|Overall Study||47
10104282|NCT02432183|11234075|FG002|STARTED|Overall Study||26
10104283|NCT02432183|11234076|FG003|STARTED|Overall Study||17
10006405|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Washout Period 1||7
10006406|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Washout Period 1||7
10006407|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
10006408|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
10006409|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
10006410|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Washout Period 1||6
10006411|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Washout Period 1||6
10006412|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
10006413|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Washout Period 1||7
10006414|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Washout Period 1||7
10006415|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Washout Period 1||7
10006416|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006417|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10104284|NCT02432183|11234073|FG000|COMPLETED|Overall Study||44
10104285|NCT02432183|11234074|FG001|COMPLETED|Overall Study||47
10104286|NCT02432183|11234075|FG002|COMPLETED|Overall Study||26
10104287|NCT02432183|11234076|FG003|COMPLETED|Overall Study||17
10104288|NCT02432183|11234073|FG000|NOT COMPLETED|Overall Study||0
10104289|NCT02432183|11234074|FG001|NOT COMPLETED|Overall Study||0
10006418|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006419|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006420|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006421|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006422|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006423|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006424|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10006425|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Second Intervention||0
10006426|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Second Intervention||0
10006427|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Second Intervention||0
10006428|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Second Intervention||6
10006429|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Second Intervention||6
10104290|NCT02432183|11234075|FG002|NOT COMPLETED|Overall Study||0
10104291|NCT02432183|11234076|FG003|NOT COMPLETED|Overall Study||0
10104292|NCT02432235|11234098|FG000|STARTED|Overall Study||2
10104293|NCT02432235|11234099|FG001|STARTED|Overall Study||2
10104294|NCT02432235|11234100|FG002|STARTED|Overall Study||2
10104295|NCT02432235|11234101|FG003|STARTED|Overall Study||3
10104296|NCT02432235|11234102|FG004|STARTED|Overall Study||2
10104297|NCT02432235|11234103|FG005|STARTED|Overall Study||20
10104298|NCT02432235|11234104|FG006|STARTED|Overall Study||41
10104299|NCT02432235|11234105|FG007|STARTED|Overall Study||29
10104300|NCT02432235|11234106|FG008|STARTED|Overall Study||26
10104301|NCT02432235|11234107|FG009|STARTED|Overall Study||3
10104302|NCT02432235|11234108|FG010|STARTED|Overall Study||2
10104303|NCT02432235|11234109|FG011|STARTED|Overall Study||1
10104304|NCT02432235|11234098|FG000|COMPLETED|Overall Study||1
10104305|NCT02432235|11234099|FG001|COMPLETED|Overall Study||0
10104306|NCT02432235|11234100|FG002|COMPLETED|Overall Study||0
10104307|NCT02432235|11234101|FG003|COMPLETED|Overall Study||1
10104308|NCT02432235|11234102|FG004|COMPLETED|Overall Study||0
10104309|NCT02432235|11234103|FG005|COMPLETED|Overall Study||8
10104310|NCT02432235|11234104|FG006|COMPLETED|Overall Study||23
10104311|NCT02432235|11234105|FG007|COMPLETED|Overall Study||9
10104312|NCT02432235|11234106|FG008|COMPLETED|Overall Study||5
10104313|NCT02432235|11234107|FG009|COMPLETED|Overall Study||0
10104314|NCT02432235|11234108|FG010|COMPLETED|Overall Study||1
10104315|NCT02432235|11234109|FG011|COMPLETED|Overall Study||0
10104316|NCT02432235|11234098|FG000|NOT COMPLETED|Overall Study||1
10104317|NCT02432235|11234099|FG001|NOT COMPLETED|Overall Study||2
10104318|NCT02432235|11234100|FG002|NOT COMPLETED|Overall Study||2
10104319|NCT02432235|11234101|FG003|NOT COMPLETED|Overall Study||2
10104320|NCT02432235|11234102|FG004|NOT COMPLETED|Overall Study||2
10104321|NCT02432235|11234103|FG005|NOT COMPLETED|Overall Study||12
10104322|NCT02432235|11234104|FG006|NOT COMPLETED|Overall Study||18
10104323|NCT02432235|11234105|FG007|NOT COMPLETED|Overall Study||20
10104324|NCT02432235|11234106|FG008|NOT COMPLETED|Overall Study||21
10104325|NCT02432235|11234107|FG009|NOT COMPLETED|Overall Study||3
10104326|NCT02432235|11234108|FG010|NOT COMPLETED|Overall Study||1
10104327|NCT02432235|11234109|FG011|NOT COMPLETED|Overall Study||1
10113303|NCT02509117|11244199|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0
10006430|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Second Intervention||7
10006431|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Second Intervention||7
10006432|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Second Intervention||7
10006433|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Second Intervention||7
10006434|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Second Intervention||0
10006435|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Second Intervention||0
10006436|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Second Intervention||0
10006437|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Second Intervention||6
10006438|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Second Intervention||6
10006439|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Second Intervention||7
10006440|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Second Intervention||7
10006441|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Second Intervention||6
10006442|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Second Intervention||7
10006443|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
10006444|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
10006445|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
10006446|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
10006447|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
10006448|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
10006449|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
10006450|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1
10006451|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
10104368|NCT02432287|11234184|FG000|STARTED|First Intervention||8
10104369|NCT02432287|11234185|FG001|STARTED|First Intervention||8
10104370|NCT02432287|11234184|FG000|COMPLETED|First Intervention||8
10104371|NCT02432287|11234185|FG001|COMPLETED|First Intervention||7
10104372|NCT02432287|11234184|FG000|NOT COMPLETED|First Intervention||0
10104373|NCT02432287|11234185|FG001|NOT COMPLETED|First Intervention||1
10104374|NCT02432287|11234184|FG000|STARTED|Washout Period||7
10104375|NCT02432287|11234185|FG001|STARTED|Washout Period||7
10104376|NCT02432287|11234184|FG000|COMPLETED|Washout Period||7
10104377|NCT02432287|11234185|FG001|COMPLETED|Washout Period||7
10104378|NCT02432287|11234184|FG000|NOT COMPLETED|Washout Period||0
10104379|NCT02432287|11234185|FG001|NOT COMPLETED|Washout Period||0
10104380|NCT02432287|11234184|FG000|STARTED|Second Intervention||7
10104381|NCT02432287|11234185|FG001|STARTED|Second Intervention||7
10104382|NCT02432287|11234184|FG000|COMPLETED|Second Intervention||7
10104383|NCT02432287|11234185|FG001|COMPLETED|Second Intervention||7
10104384|NCT02432287|11234184|FG000|NOT COMPLETED|Second Intervention||0
10104385|NCT02432287|11234185|FG001|NOT COMPLETED|Second Intervention||0
10104386|NCT02432300|11234193|FG000|STARTED|Overall Study||17
10104387|NCT02432300|11234193|FG000|COMPLETED|Overall Study||13
10006452|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Washout Period 2||0
10006453|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Washout Period 2||0
10104388|NCT02432300|11234193|FG000|NOT COMPLETED|Overall Study||4
10104389|NCT02432456|11234199|FG000|STARTED|Overall Study||75
10104390|NCT02432456|11234200|FG001|STARTED|Overall Study||75
10104391|NCT02432456|11234199|FG000|COMPLETED|Overall Study||75
10104392|NCT02432456|11234200|FG001|COMPLETED|Overall Study||75
10104393|NCT02432456|11234199|FG000|NOT COMPLETED|Overall Study||0
10104394|NCT02432456|11234200|FG001|NOT COMPLETED|Overall Study||0
10113304|NCT02509117|11244190|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
10113305|NCT02509117|11244191|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
10113306|NCT02509117|11244192|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
10113307|NCT02509117|11244193|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
10006454|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Washout Period 2||0
10006455|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Washout Period 2||6
10104395|NCT02432703|11234208|FG000|STARTED|Overall Study||75
10104396|NCT02432703|11234209|FG001|STARTED|Overall Study||74
10104397|NCT02432703|11234208|FG000|COMPLETED|Overall Study||53
10006456|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Washout Period 2||6
10006457|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Washout Period 2||7
10006458|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Washout Period 2||7
10006459|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Washout Period 2||6
10006460|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Washout Period 2||7
10006461|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
10006462|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
10006463|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
10006464|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Washout Period 2||6
10006465|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Washout Period 2||6
10006466|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
10006467|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Washout Period 2||7
10006468|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Washout Period 2||6
10006469|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Washout Period 2||7
10006470|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10006471|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10006472|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10006473|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10006474|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10104398|NCT02432703|11234209|FG001|COMPLETED|Overall Study||56
10104399|NCT02432703|11234208|FG000|NOT COMPLETED|Overall Study||22
10104400|NCT02432703|11234209|FG001|NOT COMPLETED|Overall Study||18
10104401|NCT02432716|11234215|FG000|STARTED|Overall Study||6
10104402|NCT02432716|11234216|FG001|STARTED|Overall Study||6
10104403|NCT02432716|11234215|FG000|COMPLETED|Overall Study||6
10104404|NCT02432716|11234216|FG001|COMPLETED|Overall Study||6
10104405|NCT02432716|11234215|FG000|NOT COMPLETED|Overall Study||0
10104406|NCT02432716|11234216|FG001|NOT COMPLETED|Overall Study||0
10104407|NCT02432729|11234224|FG000|STARTED|Month 3 Visit||720
10104408|NCT02432729|11234224|FG000|COMPLETED|Month 3 Visit||718
10104409|NCT02432729|11234224|FG000|NOT COMPLETED|Month 3 Visit||2
10104410|NCT02432729|11234224|FG000|STARTED|Month 6 Visit||718
10104411|NCT02432729|11234224|FG000|COMPLETED|Month 6 Visit||632
10104412|NCT02432729|11234224|FG000|NOT COMPLETED|Month 6 Visit||86
10104413|NCT02432729|11234224|FG000|STARTED|Month 12 Visit||632
10104414|NCT02432729|11234224|FG000|COMPLETED|Month 12 Visit||436
10104415|NCT02432729|11234224|FG000|NOT COMPLETED|Month 12 Visit||196
10006475|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10104416|NCT02432742|11234229|FG000|STARTED|Overall Study||100
10104417|NCT02432742|11234229|FG000|COMPLETED|Overall Study||95
10104418|NCT02432742|11234229|FG000|NOT COMPLETED|Overall Study||5
10104419|NCT02433080|11234236|FG000|STARTED|Overall Study||26
10104420|NCT02433080|11234237|FG001|STARTED|Overall Study||28
10104421|NCT02433080|11234236|FG000|8 Weeks|Overall Study||25
10104422|NCT02433080|11234237|FG001|8 Weeks|Overall Study||24
10104423|NCT02433080|11234236|FG000|COMPLETED|Overall Study||25
10104424|NCT02433080|11234237|FG001|COMPLETED|Overall Study||24
10104425|NCT02433080|11234236|FG000|NOT COMPLETED|Overall Study||1
10104426|NCT02433080|11234237|FG001|NOT COMPLETED|Overall Study||4
10104427|NCT02433288|11234246|FG000|STARTED|Overall Study||443
10104428|NCT02433288|11234247|FG001|STARTED|Overall Study||442
10104429|NCT02433288|11234246|FG000|COMPLETED|Overall Study||320
10104430|NCT02433288|11234247|FG001|COMPLETED|Overall Study||316
10104431|NCT02433288|11234246|FG000|NOT COMPLETED|Overall Study||123
10104432|NCT02433288|11234247|FG001|NOT COMPLETED|Overall Study||126
10104433|NCT02433340|11234257|FG000|STARTED|Overall Study||42
10104434|NCT02433340|11234258|FG001|STARTED|Overall Study||37
10104435|NCT02433340|11234259|FG002|STARTED|Overall Study||39
10104436|NCT02433340|11234260|FG003|STARTED|Overall Study||40
10104437|NCT02433340|11234257|FG000|COMPLETED|Overall Study||40
10104438|NCT02433340|11234258|FG001|COMPLETED|Overall Study||35
10104439|NCT02433340|11234259|FG002|COMPLETED|Overall Study||37
10104440|NCT02433340|11234260|FG003|COMPLETED|Overall Study||38
10104441|NCT02433340|11234257|FG000|NOT COMPLETED|Overall Study||2
10104442|NCT02433340|11234258|FG001|NOT COMPLETED|Overall Study||2
10104443|NCT02433340|11234259|FG002|NOT COMPLETED|Overall Study||2
10104444|NCT02433340|11234260|FG003|NOT COMPLETED|Overall Study||2
10104445|NCT02433366|11234274|FG000|STARTED|Overall Study||411
10104446|NCT02433366|11234275|FG001|STARTED|Overall Study||802
10104447|NCT02433366|11234274|FG000|COMPLETED|Overall Study||411
10104448|NCT02433366|11234275|FG001|COMPLETED|Overall Study||802
10104449|NCT02433366|11234274|FG000|NOT COMPLETED|Overall Study||0
10104450|NCT02433366|11234275|FG001|NOT COMPLETED|Overall Study||0
10104451|NCT02433379|11234281|FG000|STARTED|Overall Study||1173
10104452|NCT02433379|11234281|FG000|COMPLETED|Overall Study||852
10104453|NCT02433379|11234281|FG000|NOT COMPLETED|Overall Study||321
10104454|NCT02433483|11234287|FG000|STARTED|Overall Study||2
10104455|NCT02433483|11234287|FG000|COMPLETED|Overall Study||0
10104456|NCT02433483|11234287|FG000|NOT COMPLETED|Overall Study||2
10104457|NCT02433496|11234294|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
10104458|NCT02433496|11234295|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
10104459|NCT02433496|11234296|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
10104460|NCT02433496|11234294|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
10104461|NCT02433496|11234295|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
10104462|NCT02433496|11234296|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
10104463|NCT02433496|11234294|FG000|NOT COMPLETED|Overall Study||0
10104464|NCT02433496|11234295|FG001|NOT COMPLETED|Overall Study||0
10104465|NCT02433496|11234296|FG002|NOT COMPLETED|Overall Study||0
10104466|NCT02433613|11234303|FG000|STARTED|Overall Study||1071
10104467|NCT02433613|11234303|FG000|COMPLETED|Overall Study||1054
10104468|NCT02433613|11234303|FG000|NOT COMPLETED|Overall Study||17
10104469|NCT02433665|11234309|FG000|STARTED|Overall Study||77
10104470|NCT02433665|11234310|FG001|STARTED|Overall Study||79
10104471|NCT02433665|11234309|FG000|COMPLETED|Overall Study||77
9758800|NCT00370838|10862403|FG000|COMPLETED|Period 2 (Days 65-107)||7
9758801|NCT00370838|10862404|FG001|COMPLETED|Period 2 (Days 65-107)||3
9758802|NCT00370838|10862403|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0
9758803|NCT00370838|10862404|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0
9758804|NCT00370838|10862403|FG000|STARTED|Taper||7
9758805|NCT00370838|10862404|FG001|STARTED|Taper||3
9758806|NCT00370838|10862403|FG000|COMPLETED|Taper||7
9758807|NCT00370838|10862404|FG001|COMPLETED|Taper||3
9758808|NCT00370838|10862403|FG000|NOT COMPLETED|Taper||0
9758809|NCT00370838|10862404|FG001|NOT COMPLETED|Taper||0
9758810|NCT00370994|10862412|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
9758811|NCT00370994|10862413|FG001|STARTED|Overall Study||60
9758812|NCT00370994|10862412|FG000|COMPLETED|Overall Study||60
9758813|NCT00370994|10862413|FG001|COMPLETED|Overall Study||60
9758814|NCT00370994|10862412|FG000|NOT COMPLETED|Overall Study||0
9758815|NCT00370994|10862413|FG001|NOT COMPLETED|Overall Study||0
9758816|NCT00371137|10862422|FG000|STARTED|Overall Study||183
9758817|NCT00371137|10862423|FG001|STARTED|Overall Study||182
9758818|NCT00371137|10862424|FG002|STARTED|Overall Study||183
9758819|NCT00371137|10862422|FG000|Treated|Overall Study||183
9758820|NCT00371137|10862423|FG001|Treated|Overall Study||182
9758821|NCT00371137|10862424|FG002|Treated|Overall Study||182
9758822|NCT00371137|10862422|FG000|COMPLETED|Overall Study||111
9758823|NCT00371137|10862423|FG001|COMPLETED|Overall Study||119
9758824|NCT00371137|10862424|FG002|COMPLETED|Overall Study||104
9758825|NCT00371137|10862422|FG000|NOT COMPLETED|Overall Study||72
9758826|NCT00371137|10862423|FG001|NOT COMPLETED|Overall Study||63
9758827|NCT00371137|10862424|FG002|NOT COMPLETED|Overall Study||79
9758828|NCT00371150|10862434|FG000|STARTED|Overall Study||40
9758829|NCT00371150|10862435|FG001|STARTED|Overall Study||6
9758830|NCT00371150|10862434|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1
9758831|NCT00371150|10862435|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1
9758832|NCT00371150|10862434|FG000|Discontinued at or After Week 48 Visit|Overall Study||2
9758833|NCT00371150|10862435|FG001|Discontinued at or After Week 48 Visit|Overall Study||1
9758834|NCT00371150|10862434|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
9758835|NCT00371150|10862435|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
9758836|NCT00371150|10862434|FG000|NOT COMPLETED|Overall Study||3
9758837|NCT00371150|10862435|FG001|NOT COMPLETED|Overall Study||2
9758838|NCT00371176|10862447|FG000|STARTED|Overall Study||13
9758839|NCT00371176|10862448|FG001|STARTED|Overall Study||13
9758840|NCT00371176|10862447|FG000|Completed Treatment|Overall Study||10
9758841|NCT00371176|10862448|FG001|Completed Treatment|Overall Study||9
10104472|NCT02433665|11234310|FG001|COMPLETED|Overall Study||79
10104473|NCT02433665|11234309|FG000|NOT COMPLETED|Overall Study||0
10104474|NCT02433665|11234310|FG001|NOT COMPLETED|Overall Study||0
10104475|NCT02433678|11234318|FG000|STARTED|Overall Study||26
10104476|NCT02433678|11234319|FG001|STARTED|Overall Study||26
10104477|NCT02433678|11234318|FG000|COMPLETED|Overall Study||25
10104478|NCT02433678|11234319|FG001|COMPLETED|Overall Study||24
10104479|NCT02433678|11234318|FG000|NOT COMPLETED|Overall Study||1
10104480|NCT02433678|11234319|FG001|NOT COMPLETED|Overall Study||2
10104481|NCT02433834|11234325|FG000|STARTED|Overall Study||248
9758842|NCT00371176|10862447|FG000|COMPLETED|Overall Study||8
9758843|NCT00371176|10862448|FG001|COMPLETED|Overall Study||5
9758844|NCT00371176|10862447|FG000|NOT COMPLETED|Overall Study||5
9758845|NCT00371176|10862448|FG001|NOT COMPLETED|Overall Study||8
9758846|NCT00371254|10862456|FG000|STARTED|Overall Study|Number of participants treated|23
9758847|NCT00371254|10862457|FG001|STARTED|Overall Study|Number of participants treated|21
9758848|NCT00371254|10862456|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
9758849|NCT00371254|10862457|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
9758850|NCT00371254|10862456|FG000|NOT COMPLETED|Overall Study||23
9758851|NCT00371254|10862457|FG001|NOT COMPLETED|Overall Study||21
9758852|NCT00371267|10862465|FG000|STARTED|Overall Study||48
9758853|NCT00371267|10862466|FG001|STARTED|Overall Study||50
9758854|NCT00371267|10862465|FG000|COMPLETED|Overall Study||39
9758855|NCT00371267|10862466|FG001|COMPLETED|Overall Study||32
10104482|NCT02433834|11234325|FG000|GP MDI 28.8 µg|Overall Study||112
10104483|NCT02433834|11234325|FG000|GP MDI 14.4 µg|Overall Study||230
10104484|NCT02433834|11234325|FG000|GP MDI 7.2 µg|Overall Study||228
9758856|NCT00371267|10862465|FG000|NOT COMPLETED|Overall Study||9
9758857|NCT00371267|10862466|FG001|NOT COMPLETED|Overall Study||18
9758858|NCT00371293|10862475|FG000|STARTED|Overall Study||58
9758859|NCT00371293|10862476|FG001|STARTED|Overall Study||61
9758860|NCT00371293|10862477|FG002|STARTED|Overall Study||62
9758861|NCT00371293|10862475|FG000|COMPLETED|Overall Study||48
9758862|NCT00371293|10862476|FG001|COMPLETED|Overall Study||42
9758863|NCT00371293|10862477|FG002|COMPLETED|Overall Study||46
9758864|NCT00371293|10862475|FG000|NOT COMPLETED|Overall Study||10
9758865|NCT00371293|10862476|FG001|NOT COMPLETED|Overall Study||19
9758866|NCT00371293|10862477|FG002|NOT COMPLETED|Overall Study||16
9758867|NCT00371345|10862488|FG000|STARTED|Overall Study||24
9758868|NCT00371345|10862489|FG001|STARTED|Overall Study||46
9758869|NCT00371345|10862488|FG000|COMPLETED|Overall Study||0
9758870|NCT00371345|10862489|FG001|COMPLETED|Overall Study||0
9758871|NCT00371345|10862488|FG000|NOT COMPLETED|Overall Study||24
9758872|NCT00371345|10862489|FG001|NOT COMPLETED|Overall Study||46
9758873|NCT00371397|10862509|FG000|STARTED|Session 1||5
9758874|NCT00371397|10862510|FG001|STARTED|Session 1||7
9758875|NCT00371397|10862511|FG002|STARTED|Session 1||5
9758876|NCT00371397|10862512|FG003|STARTED|Session 1||2
9758877|NCT00371397|10862513|FG004|STARTED|Session 1||3
9758878|NCT00371397|10862514|FG005|STARTED|Session 1||4
9758879|NCT00371397|10862515|FG006|STARTED|Session 1||4
9758880|NCT00371397|10862516|FG007|STARTED|Session 1||5
9758881|NCT00371397|10862517|FG008|STARTED|Session 1||6
9758882|NCT00371397|10862518|FG009|STARTED|Session 1||5
9758883|NCT00371397|10862519|FG010|STARTED|Session 1||4
9758884|NCT00371397|10862520|FG011|STARTED|Session 1||2
9758885|NCT00371397|10862509|FG000|COMPLETED|Session 1||4
9758886|NCT00371397|10862510|FG001|COMPLETED|Session 1||7
9758887|NCT00371397|10862511|FG002|COMPLETED|Session 1||5
9758888|NCT00371397|10862512|FG003|COMPLETED|Session 1||2
9758889|NCT00371397|10862513|FG004|COMPLETED|Session 1||3
9758890|NCT00371397|10862514|FG005|COMPLETED|Session 1||4
9758891|NCT00371397|10862515|FG006|COMPLETED|Session 1||4
9758892|NCT00371397|10862516|FG007|COMPLETED|Session 1||4
10104485|NCT02433834|11234325|FG000|GP MDI 3.6 µg|Overall Study||118
10104486|NCT02433834|11234325|FG000|GP MDI 1.9 µg|Overall Study||107
10104487|NCT02433834|11234325|FG000|Placebo MDI|Overall Study||174
10104488|NCT02433834|11234325|FG000|SAL 50 µg|Overall Study||167
10104489|NCT02433834|11234325|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
10104490|NCT02433834|11234325|FG000|NOT COMPLETED|Overall Study||37
10104491|NCT02433977|11234341|FG000|STARTED|Overall Study||6
10104492|NCT02433977|11234341|FG000|COMPLETED|Overall Study||6
10104493|NCT02433977|11234341|FG000|NOT COMPLETED|Overall Study||0
10104494|NCT02434081|11234345|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79
10104495|NCT02434081|11234345|FG000|COMPLETED|Overall Study||31
10104496|NCT02434081|11234345|FG000|NOT COMPLETED|Overall Study||48
10104497|NCT02434328|11234351|FG000|STARTED|Overall Study||372
10104498|NCT02434328|11234352|FG001|STARTED|Overall Study||371
10104499|NCT02434328|11234351|FG000|Randomized and Treated|Overall Study||370
10104500|NCT02434328|11234352|FG001|Randomized and Treated|Overall Study||369
10104501|NCT02434328|11234351|FG000|COMPLETED|Overall Study||342
10104502|NCT02434328|11234352|FG001|COMPLETED|Overall Study||329
10104503|NCT02434328|11234351|FG000|NOT COMPLETED|Overall Study||30
10104504|NCT02434328|11234352|FG001|NOT COMPLETED|Overall Study||42
10104505|NCT02434471|11234359|FG000|STARTED|Overall Study||34
10104506|NCT02434471|11234359|FG000|COMPLETED|Overall Study||25
10104507|NCT02434471|11234359|FG000|NOT COMPLETED|Overall Study||9
10104508|NCT02434497|11234364|FG000|STARTED|Overall Study||9
10104509|NCT02434497|11234364|FG000|COMPLETED|Overall Study||4
10104510|NCT02434497|11234364|FG000|NOT COMPLETED|Overall Study||5
10104511|NCT02434523|11234372|FG000|STARTED|Overall Study||15
10104512|NCT02434523|11234373|FG001|STARTED|Overall Study||15
10104513|NCT02434523|11234372|FG000|COMPLETED|Overall Study||10
10104514|NCT02434523|11234373|FG001|COMPLETED|Overall Study||9
10104515|NCT02434523|11234372|FG000|NOT COMPLETED|Overall Study||5
10104516|NCT02434523|11234373|FG001|NOT COMPLETED|Overall Study||6
10104517|NCT02434770|11234384|FG000|STARTED|Week 1 to Week 18||250
10202311|NCT03443713|11329446|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0
9758893|NCT00371397|10862517|FG008|COMPLETED|Session 1||6
9758894|NCT00371397|10862518|FG009|COMPLETED|Session 1||5
9758895|NCT00371397|10862519|FG010|COMPLETED|Session 1||4
9758896|NCT00371397|10862520|FG011|COMPLETED|Session 1||2
9758897|NCT00371397|10862509|FG000|NOT COMPLETED|Session 1||1
9758898|NCT00371397|10862510|FG001|NOT COMPLETED|Session 1||0
9758899|NCT00371397|10862511|FG002|NOT COMPLETED|Session 1||0
9758900|NCT00371397|10862512|FG003|NOT COMPLETED|Session 1||0
9758901|NCT00371397|10862513|FG004|NOT COMPLETED|Session 1||0
9758902|NCT00371397|10862514|FG005|NOT COMPLETED|Session 1||0
9758903|NCT00371397|10862515|FG006|NOT COMPLETED|Session 1||0
9758904|NCT00371397|10862516|FG007|NOT COMPLETED|Session 1||1
9758905|NCT00371397|10862517|FG008|NOT COMPLETED|Session 1||0
10104518|NCT02434770|11234385|FG001|STARTED|Week 1 to Week 18||250
10104519|NCT02434770|11234386|FG002|STARTED|Week 1 to Week 18||250
10202312|NCT03443713|11329444|FG000|STARTED|First at Home Period (9-14 Days)||8
9758906|NCT00371397|10862518|FG009|NOT COMPLETED|Session 1||0
9758907|NCT00371397|10862519|FG010|NOT COMPLETED|Session 1||0
9758908|NCT00371397|10862520|FG011|NOT COMPLETED|Session 1||0
9758909|NCT00371397|10862509|FG000|STARTED|Session 2||4
9758910|NCT00371397|10862510|FG001|STARTED|Session 2||7
9758911|NCT00371397|10862511|FG002|STARTED|Session 2||5
9758912|NCT00371397|10862512|FG003|STARTED|Session 2||2
9758913|NCT00371397|10862513|FG004|STARTED|Session 2||3
9758914|NCT00371397|10862514|FG005|STARTED|Session 2||4
9758915|NCT00371397|10862515|FG006|STARTED|Session 2||4
9758916|NCT00371397|10862516|FG007|STARTED|Session 2||4
9758917|NCT00371397|10862517|FG008|STARTED|Session 2||6
9758918|NCT00371397|10862518|FG009|STARTED|Session 2||5
9758919|NCT00371397|10862519|FG010|STARTED|Session 2||4
9758920|NCT00371397|10862520|FG011|STARTED|Session 2||2
9758921|NCT00371397|10862509|FG000|COMPLETED|Session 2||4
9758922|NCT00371397|10862510|FG001|COMPLETED|Session 2||7
9758923|NCT00371397|10862511|FG002|COMPLETED|Session 2||5
9758924|NCT00371397|10862512|FG003|COMPLETED|Session 2||2
9758925|NCT00371397|10862513|FG004|COMPLETED|Session 2||3
9758926|NCT00371397|10862514|FG005|COMPLETED|Session 2||4
9758927|NCT00371397|10862515|FG006|COMPLETED|Session 2||4
9758928|NCT00371397|10862516|FG007|COMPLETED|Session 2||4
9758929|NCT00371397|10862517|FG008|COMPLETED|Session 2||6
9758930|NCT00371397|10862518|FG009|COMPLETED|Session 2||5
9758931|NCT00371397|10862519|FG010|COMPLETED|Session 2||4
9758932|NCT00371397|10862520|FG011|COMPLETED|Session 2||2
9758933|NCT00371397|10862509|FG000|NOT COMPLETED|Session 2||0
9758934|NCT00371397|10862510|FG001|NOT COMPLETED|Session 2||0
9758935|NCT00371397|10862511|FG002|NOT COMPLETED|Session 2||0
9758936|NCT00371397|10862512|FG003|NOT COMPLETED|Session 2||0
9758937|NCT00371397|10862513|FG004|NOT COMPLETED|Session 2||0
9758938|NCT00371397|10862514|FG005|NOT COMPLETED|Session 2||0
9758939|NCT00371397|10862515|FG006|NOT COMPLETED|Session 2||0
9758940|NCT00371397|10862516|FG007|NOT COMPLETED|Session 2||0
9758941|NCT00371397|10862517|FG008|NOT COMPLETED|Session 2||0
9758942|NCT00371397|10862518|FG009|NOT COMPLETED|Session 2||0
9758943|NCT00371397|10862519|FG010|NOT COMPLETED|Session 2||0
9758944|NCT00371397|10862520|FG011|NOT COMPLETED|Session 2||0
9758945|NCT00371397|10862509|FG000|STARTED|Session 3||4
9758946|NCT00371397|10862510|FG001|STARTED|Session 3||7
9758947|NCT00371397|10862511|FG002|STARTED|Session 3||5
9758948|NCT00371397|10862512|FG003|STARTED|Session 3||2
9758949|NCT00371397|10862513|FG004|STARTED|Session 3||3
9758950|NCT00371397|10862514|FG005|STARTED|Session 3||4
9758951|NCT00371397|10862515|FG006|STARTED|Session 3||4
9758952|NCT00371397|10862516|FG007|STARTED|Session 3||4
9758953|NCT00371397|10862517|FG008|STARTED|Session 3||6
9758954|NCT00371397|10862518|FG009|STARTED|Session 3||5
9758955|NCT00371397|10862519|FG010|STARTED|Session 3||4
9758956|NCT00371397|10862520|FG011|STARTED|Session 3||2
9758957|NCT00371397|10862509|FG000|COMPLETED|Session 3||4
9758958|NCT00371397|10862510|FG001|COMPLETED|Session 3||7
9758959|NCT00371397|10862511|FG002|COMPLETED|Session 3||5
9758960|NCT00371397|10862512|FG003|COMPLETED|Session 3||2
9758961|NCT00371397|10862513|FG004|COMPLETED|Session 3||3
9758962|NCT00371397|10862514|FG005|COMPLETED|Session 3||4
9758963|NCT00371397|10862515|FG006|COMPLETED|Session 3||4
9758964|NCT00371397|10862516|FG007|COMPLETED|Session 3||4
9758965|NCT00371397|10862517|FG008|COMPLETED|Session 3||6
9758966|NCT00371397|10862518|FG009|COMPLETED|Session 3||5
9758967|NCT00371397|10862519|FG010|COMPLETED|Session 3||4
9758968|NCT00371397|10862520|FG011|COMPLETED|Session 3||2
9758969|NCT00371397|10862509|FG000|NOT COMPLETED|Session 3||0
9758970|NCT00371397|10862510|FG001|NOT COMPLETED|Session 3||0
9758971|NCT00371397|10862511|FG002|NOT COMPLETED|Session 3||0
9758972|NCT00371397|10862512|FG003|NOT COMPLETED|Session 3||0
9758973|NCT00371397|10862513|FG004|NOT COMPLETED|Session 3||0
9758974|NCT00371397|10862514|FG005|NOT COMPLETED|Session 3||0
9758975|NCT00371397|10862515|FG006|NOT COMPLETED|Session 3||0
9758976|NCT00371397|10862516|FG007|NOT COMPLETED|Session 3||0
9758977|NCT00371397|10862517|FG008|NOT COMPLETED|Session 3||0
9758978|NCT00371397|10862518|FG009|NOT COMPLETED|Session 3||0
9758979|NCT00371397|10862519|FG010|NOT COMPLETED|Session 3||0
9758980|NCT00371397|10862520|FG011|NOT COMPLETED|Session 3||0
9758981|NCT00371436|10862528|FG000|STARTED|Overall Study||92
9758982|NCT00371436|10862529|FG001|STARTED|Overall Study||89
9758983|NCT00371436|10862528|FG000|COMPLETED|Overall Study||58
9758984|NCT00371436|10862529|FG001|COMPLETED|Overall Study||68
9758985|NCT00371436|10862528|FG000|NOT COMPLETED|Overall Study||34
9758986|NCT00371436|10862529|FG001|NOT COMPLETED|Overall Study||21
9758987|NCT00371449|10862535|FG000|STARTED|Overall Study||120
9758988|NCT00371449|10862535|FG000|COMPLETED|Overall Study||120
9758989|NCT00371449|10862535|FG000|NOT COMPLETED|Overall Study||0
9758990|NCT00371540|10862543|FG000|STARTED|Overall Study||112
9758991|NCT00371540|10862544|FG001|STARTED|Overall Study||96
9758992|NCT00371540|10862543|FG000|COMPLETED|Overall Study||102
9758993|NCT00371540|10862544|FG001|COMPLETED|Overall Study||87
9758994|NCT00371540|10862543|FG000|NOT COMPLETED|Overall Study||10
9758995|NCT00371540|10862544|FG001|NOT COMPLETED|Overall Study||9
9758996|NCT00371566|10862552|FG000|STARTED|Treatment Phase||36
9758997|NCT00371566|10862553|FG001|STARTED|Treatment Phase||71
9758998|NCT00371566|10862552|FG000|COMPLETED|Treatment Phase||36
9758999|NCT00371566|10862553|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
9759000|NCT00371566|10862552|FG000|NOT COMPLETED|Treatment Phase||0
9759001|NCT00371566|10862553|FG001|NOT COMPLETED|Treatment Phase||3
9759002|NCT00371566|10862552|FG000|STARTED|Chemoradiation Phase||36
9759003|NCT00371566|10862553|FG001|STARTED|Chemoradiation Phase||68
9759004|NCT00371566|10862552|FG000|COMPLETED|Chemoradiation Phase||31
9759005|NCT00371566|10862553|FG001|COMPLETED|Chemoradiation Phase||65
9759006|NCT00371566|10862552|FG000|NOT COMPLETED|Chemoradiation Phase||5
10006476|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10006477|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10006478|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10006479|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Third Intervention||0
10006480|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Third Intervention||0
10006481|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Third Intervention||0
10006482|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Third Intervention||6
10006483|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Third Intervention||6
10006484|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Third Intervention||7
10006485|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Third Intervention||7
10006486|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Third Intervention||6
10006487|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Third Intervention||7
10006488|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Third Intervention||0
10006489|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Third Intervention||0
10006490|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Third Intervention||0
10104520|NCT02434770|11234384|FG000|Received at Least One Vaccination|Week 1 to Week 18||249
10104521|NCT02434770|11234385|FG001|Received at Least One Vaccination|Week 1 to Week 18||250
10104522|NCT02434770|11234386|FG002|Received at Least One Vaccination|Week 1 to Week 18||250
10104523|NCT02434770|11234384|FG000|COMPLETED|Week 1 to Week 18||235
10104524|NCT02434770|11234385|FG001|COMPLETED|Week 1 to Week 18||228
10104525|NCT02434770|11234386|FG002|COMPLETED|Week 1 to Week 18||233
10104526|NCT02434770|11234384|FG000|NOT COMPLETED|Week 1 to Week 18||15
10104527|NCT02434770|11234385|FG001|NOT COMPLETED|Week 1 to Week 18||22
10104528|NCT02434770|11234386|FG002|NOT COMPLETED|Week 1 to Week 18||17
10104529|NCT02434770|11234384|FG000|STARTED|Week 18 to Week||235
10104530|NCT02434770|11234385|FG001|STARTED|Week 18 to Week||228
10104531|NCT02434770|11234386|FG002|STARTED|Week 18 to Week||233
10104532|NCT02434770|11234384|FG000|COMPLETED|Week 18 to Week||227
10104533|NCT02434770|11234385|FG001|COMPLETED|Week 18 to Week||220
10104534|NCT02434770|11234386|FG002|COMPLETED|Week 18 to Week||227
10104535|NCT02434770|11234384|FG000|NOT COMPLETED|Week 18 to Week||8
10104536|NCT02434770|11234385|FG001|NOT COMPLETED|Week 18 to Week||8
10104537|NCT02434770|11234386|FG002|NOT COMPLETED|Week 18 to Week||6
10104538|NCT02434939|11234398|FG000|STARTED|Overall Study||120
10104539|NCT02434939|11234399|FG001|STARTED|Overall Study||120
10104540|NCT02434939|11234398|FG000|COMPLETED|Overall Study||83
10104541|NCT02434939|11234399|FG001|COMPLETED|Overall Study||71
10104542|NCT02434939|11234398|FG000|NOT COMPLETED|Overall Study||37
10104543|NCT02434939|11234399|FG001|NOT COMPLETED|Overall Study||49
10104544|NCT02435069|11234406|FG000|STARTED|Preoperative Baseline Phase||5
10104545|NCT02435069|11234407|FG001|STARTED|Preoperative Baseline Phase||0
10104546|NCT02435069|11234408|FG002|STARTED|Preoperative Baseline Phase||0
10104547|NCT02435069|11234409|FG003|STARTED|Preoperative Baseline Phase||0
10104548|NCT02435069|11234410|FG004|STARTED|Preoperative Baseline Phase||0
10104549|NCT02435069|11234406|FG000|COMPLETED|Preoperative Baseline Phase||5
10104550|NCT02435069|11234407|FG001|COMPLETED|Preoperative Baseline Phase||0
10104551|NCT02435069|11234408|FG002|COMPLETED|Preoperative Baseline Phase||0
10104552|NCT02435069|11234409|FG003|COMPLETED|Preoperative Baseline Phase||0
10104553|NCT02435069|11234410|FG004|COMPLETED|Preoperative Baseline Phase||0
10104554|NCT02435069|11234406|FG000|NOT COMPLETED|Preoperative Baseline Phase||0
10104555|NCT02435069|11234407|FG001|NOT COMPLETED|Preoperative Baseline Phase||0
10104556|NCT02435069|11234408|FG002|NOT COMPLETED|Preoperative Baseline Phase||0
10104557|NCT02435069|11234409|FG003|NOT COMPLETED|Preoperative Baseline Phase||0
10104558|NCT02435069|11234410|FG004|NOT COMPLETED|Preoperative Baseline Phase||0
10104559|NCT02435069|11234406|FG000|STARTED|Dose Response - First Intervention||0
10104560|NCT02435069|11234407|FG001|STARTED|Dose Response - First Intervention||3
10104561|NCT02435069|11234408|FG002|STARTED|Dose Response - First Intervention||2
10104562|NCT02435069|11234409|FG003|STARTED|Dose Response - First Intervention||0
10104563|NCT02435069|11234410|FG004|STARTED|Dose Response - First Intervention||0
10104564|NCT02435069|11234406|FG000|COMPLETED|Dose Response - First Intervention||0
10104565|NCT02435069|11234407|FG001|COMPLETED|Dose Response - First Intervention||2
10104566|NCT02435069|11234408|FG002|COMPLETED|Dose Response - First Intervention||1
10104567|NCT02435069|11234409|FG003|COMPLETED|Dose Response - First Intervention||0
10104568|NCT02435069|11234410|FG004|COMPLETED|Dose Response - First Intervention||0
10104569|NCT02435069|11234406|FG000|NOT COMPLETED|Dose Response - First Intervention||0
10104570|NCT02435069|11234407|FG001|NOT COMPLETED|Dose Response - First Intervention||1
10104571|NCT02435069|11234408|FG002|NOT COMPLETED|Dose Response - First Intervention||1
10104572|NCT02435069|11234409|FG003|NOT COMPLETED|Dose Response - First Intervention||0
10104573|NCT02435069|11234410|FG004|NOT COMPLETED|Dose Response - First Intervention||0
10104574|NCT02435069|11234406|FG000|STARTED|Effectiveness - Second Intervention||0
10104575|NCT02435069|11234407|FG001|STARTED|Effectiveness - Second Intervention||0
10104576|NCT02435069|11234408|FG002|STARTED|Effectiveness - Second Intervention||0
10104577|NCT02435069|11234409|FG003|STARTED|Effectiveness - Second Intervention||1
10104578|NCT02435069|11234410|FG004|STARTED|Effectiveness - Second Intervention||1
10104579|NCT02435069|11234406|FG000|COMPLETED|Effectiveness - Second Intervention||0
10104580|NCT02435069|11234407|FG001|COMPLETED|Effectiveness - Second Intervention||0
10104581|NCT02435069|11234408|FG002|COMPLETED|Effectiveness - Second Intervention||0
10006491|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Third Intervention||6
10006492|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Third Intervention||6
10006493|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Third Intervention||6
10104582|NCT02435069|11234409|FG003|COMPLETED|Effectiveness - Second Intervention||1
10104583|NCT02435069|11234410|FG004|COMPLETED|Effectiveness - Second Intervention||0
10104584|NCT02435069|11234406|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0
10104585|NCT02435069|11234407|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0
10104586|NCT02435069|11234408|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0
10104587|NCT02435069|11234409|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0
10104588|NCT02435069|11234410|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1
10104589|NCT02435147|11234430|FG000|STARTED|Overall Study||86
10104590|NCT02435147|11234430|FG000|COMPLETED|Overall Study||75
10104591|NCT02435147|11234430|FG000|NOT COMPLETED|Overall Study||11
10104592|NCT02435277|11234438|FG000|STARTED|Overall Study||12
10104593|NCT02435277|11234439|FG001|STARTED|Overall Study||16
10104594|NCT02435277|11234440|FG002|STARTED|Overall Study||11
10104595|NCT02435277|11234441|FG003|STARTED|Overall Study||11
10104596|NCT02435277|11234438|FG000|COMPLETED|Overall Study||10
10104597|NCT02435277|11234439|FG001|COMPLETED|Overall Study||15
10104598|NCT02435277|11234440|FG002|COMPLETED|Overall Study||11
10104599|NCT02435277|11234441|FG003|COMPLETED|Overall Study||11
10104600|NCT02435277|11234438|FG000|NOT COMPLETED|Overall Study||2
10006494|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Third Intervention||6
10006495|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Third Intervention||6
10104601|NCT02435277|11234439|FG001|NOT COMPLETED|Overall Study||1
10104602|NCT02435277|11234440|FG002|NOT COMPLETED|Overall Study||0
10104603|NCT02435277|11234441|FG003|NOT COMPLETED|Overall Study||0
10104604|NCT02435381|11234451|FG000|STARTED|Overall Study||5
10104605|NCT02435381|11234452|FG001|STARTED|Overall Study||6
10104606|NCT02435381|11234451|FG000|COMPLETED|Overall Study||3
10104607|NCT02435381|11234452|FG001|COMPLETED|Overall Study||5
10104608|NCT02435381|11234451|FG000|NOT COMPLETED|Overall Study||2
10104609|NCT02435381|11234452|FG001|NOT COMPLETED|Overall Study||1
10104610|NCT02435524|11234470|FG000|STARTED|Baseline Survey||1111
10104611|NCT02435524|11234471|FG001|STARTED|Baseline Survey||1177
10104612|NCT02435524|11234470|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
10104613|NCT02435524|11234471|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
10104614|NCT02435524|11234470|FG000|NOT COMPLETED|Baseline Survey||0
10104615|NCT02435524|11234471|FG001|NOT COMPLETED|Baseline Survey||0
10104616|NCT02435524|11234470|FG000|STARTED|Endline Survey||1092
10104617|NCT02435524|11234471|FG001|STARTED|Endline Survey||1161
10104618|NCT02435524|11234470|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
10104619|NCT02435524|11234471|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
10104620|NCT02435524|11234470|FG000|NOT COMPLETED|Endline Survey||0
10104621|NCT02435524|11234471|FG001|NOT COMPLETED|Endline Survey||0
10104622|NCT02435680|11234480|FG000|STARTED|Overall Study||21
10104623|NCT02435680|11234481|FG001|STARTED|Overall Study||13
10104624|NCT02435680|11234482|FG002|STARTED|Overall Study||16
10104625|NCT02435680|11234480|FG000|COMPLETED|Overall Study||0
10104626|NCT02435680|11234481|FG001|COMPLETED|Overall Study||0
10104627|NCT02435680|11234482|FG002|COMPLETED|Overall Study||0
10006496|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Third Intervention||7
10006497|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
10006498|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
10006499|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
10006500|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
10006501|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
10006502|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1
10006503|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1
10006504|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
10006505|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0
10006506|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Washout Period 3||0
10006507|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Washout Period 3||0
10006508|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Washout Period 3||0
10006509|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Washout Period 3||6
10006510|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Washout Period 3||6
10006511|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Washout Period 3||6
10006512|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Washout Period 3||6
10006513|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Washout Period 3||6
10006514|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Washout Period 3||7
10006515|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
10006516|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
10006517|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
10006518|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
10006519|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Washout Period 3||6
10006520|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Washout Period 3||6
10006521|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Washout Period 3||6
10006522|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Washout Period 3||6
10006523|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Washout Period 3||7
10006524|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006525|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006526|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006527|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006528|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006529|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006530|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006531|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006532|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10006533|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Fourth Intervention||0
10006534|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Fourth Intervention||0
10006535|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Fourth Intervention||0
10006536|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Fourth Intervention||6
10006537|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Fourth Intervention||6
10006538|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Fourth Intervention||6
10006539|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Fourth Intervention||6
10006540|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Fourth Intervention||6
10006541|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Fourth Intervention||7
10006542|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
10006543|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
10006544|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
10006545|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5
10006546|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6
10006547|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5
10006548|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5
10006549|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6
10006550|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5
10006551|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10006552|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10006553|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10006554|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
10006555|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10006556|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
10006557|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
10006558|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10006559|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
10006560|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Washout Period 4||0
10006561|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Washout Period 4||0
10006562|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Washout Period 4||0
10006563|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Washout Period 4||5
10006564|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Washout Period 4||6
10006565|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Washout Period 4||5
10006566|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Washout Period 4||5
10006567|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Washout Period 4||6
10006568|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Washout Period 4||5
10006569|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Washout Period 4||0
10104628|NCT02435680|11234480|FG000|NOT COMPLETED|Overall Study||21
10104629|NCT02435680|11234481|FG001|NOT COMPLETED|Overall Study||13
10104630|NCT02435680|11234482|FG002|NOT COMPLETED|Overall Study||16
10104631|NCT02435706|11234496|FG000|STARTED|Overall Study||18
10104632|NCT02435706|11234497|FG001|STARTED|Overall Study||21
10104633|NCT02435706|11234496|FG000|COMPLETED|Overall Study||16
10104634|NCT02435706|11234497|FG001|COMPLETED|Overall Study||20
10104635|NCT02435706|11234496|FG000|NOT COMPLETED|Overall Study||2
10104636|NCT02435706|11234497|FG001|NOT COMPLETED|Overall Study||1
10104637|NCT02435836|11234503|FG000|STARTED|Overall Study||631
10104638|NCT02435836|11234503|FG000|COMPLETED|Overall Study||0
10104639|NCT02435836|11234503|FG000|NOT COMPLETED|Overall Study||631
10104640|NCT02435901|11234507|FG000|STARTED|Overall Study||29
10104641|NCT02435901|11234507|FG000|COMPLETED|Overall Study||29
10104642|NCT02435901|11234507|FG000|NOT COMPLETED|Overall Study||0
10104643|NCT02435914|11234516|FG000|STARTED|Overall Study||58
10104644|NCT02435914|11234517|FG001|STARTED|Overall Study||59
10104645|NCT02435914|11234518|FG002|STARTED|Overall Study||60
10104646|NCT02435914|11234519|FG003|STARTED|Overall Study||59
10104647|NCT02435914|11234516|FG000|COMPLETED|Overall Study||57
10104648|NCT02435914|11234517|FG001|COMPLETED|Overall Study||58
10104649|NCT02435914|11234518|FG002|COMPLETED|Overall Study||59
10104650|NCT02435914|11234519|FG003|COMPLETED|Overall Study||59
10104651|NCT02435914|11234516|FG000|NOT COMPLETED|Overall Study||1
10104652|NCT02435914|11234517|FG001|NOT COMPLETED|Overall Study||1
10104653|NCT02435914|11234518|FG002|NOT COMPLETED|Overall Study||1
10104654|NCT02435914|11234519|FG003|NOT COMPLETED|Overall Study||0
10104655|NCT02435966|11234532|FG000|STARTED|Overall Study||47
10104656|NCT02435966|11234533|FG001|STARTED|Overall Study||54
10104657|NCT02435966|11234534|FG002|STARTED|Overall Study||30
10104658|NCT02435966|11234532|FG000|First Intervention|Overall Study||47
10104659|NCT02435966|11234533|FG001|First Intervention|Overall Study||54
10104660|NCT02435966|11234534|FG002|First Intervention|Overall Study||30
10104661|NCT02435966|11234532|FG000|Second Intervention|Overall Study||47
10104662|NCT02435966|11234533|FG001|Second Intervention|Overall Study||53
10104663|NCT02435966|11234534|FG002|Second Intervention|Overall Study||30
10104664|NCT02435966|11234532|FG000|Follow-up|Overall Study||47
10006570|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Washout Period 4||0
10006571|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Washout Period 4||0
10006572|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Washout Period 4||5
10006573|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Washout Period 4||6
10006574|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Washout Period 4||5
10006575|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Washout Period 4||5
10006576|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Washout Period 4||6
10006577|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Washout Period 4||5
10006578|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006579|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006580|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006581|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006582|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006583|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006584|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006585|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006586|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10006587|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Fifth Intervention||0
10006588|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Fifth Intervention||0
10006589|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Fifth Intervention||0
10006590|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Fifth Intervention||5
10006591|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Fifth Intervention||6
10006592|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Fifth Intervention||5
10006593|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Fifth Intervention||5
10006594|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Fifth Intervention||6
10006595|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Fifth Intervention||5
10006596|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0
10006597|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0
10006598|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0
10006599|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5
10006600|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6
10006601|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5
10006602|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5
10006603|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6
10006604|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5
10006605|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006606|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006607|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006608|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006609|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10104665|NCT02435966|11234533|FG001|Follow-up|Overall Study||53
10104666|NCT02435966|11234534|FG002|Follow-up|Overall Study||30
10104667|NCT02435966|11234532|FG000|COMPLETED|Overall Study||47
10104668|NCT02435966|11234533|FG001|COMPLETED|Overall Study||53
10104669|NCT02435966|11234534|FG002|COMPLETED|Overall Study||30
10104670|NCT02435966|11234532|FG000|NOT COMPLETED|Overall Study||0
10104671|NCT02435966|11234533|FG001|NOT COMPLETED|Overall Study||1
10104672|NCT02435966|11234534|FG002|NOT COMPLETED|Overall Study||0
10104673|NCT02435992|11234547|FG000|STARTED|Overall Study||429
10104674|NCT02435992|11234548|FG001|STARTED|Overall Study||216
10104675|NCT02435992|11234549|FG002|STARTED|Overall Study||367
10104676|NCT02435992|11234550|FG003|STARTED|Overall Study||0
10104677|NCT02435992|11234551|FG004|STARTED|Overall Study||0
10104678|NCT02435992|11234547|FG000|Transition to Maintenance Period|Overall Study||233
10104679|NCT02435992|11234548|FG001|Transition to Maintenance Period|Overall Study||69
10104680|NCT02435992|11234549|FG002|Transition to Maintenance Period|Overall Study||224
10104681|NCT02435992|11234550|FG003|Transition to Maintenance Period|Overall Study||0
10104682|NCT02435992|11234551|FG004|Transition to Maintenance Period|Overall Study||0
10104683|NCT02435992|11234547|FG000|Treated in Maintenance Period|Overall Study||0
10104684|NCT02435992|11234548|FG001|Treated in Maintenance Period|Overall Study||69
10104685|NCT02435992|11234549|FG002|Treated in Maintenance Period|Overall Study||0
10104686|NCT02435992|11234550|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230
10104687|NCT02435992|11234551|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227
10104688|NCT02435992|11234547|FG000|COMPLETED|Overall Study||401
10104689|NCT02435992|11234548|FG001|COMPLETED|Overall Study||192
10104690|NCT02435992|11234549|FG002|COMPLETED|Overall Study||324
10104691|NCT02435992|11234550|FG003|COMPLETED|Overall Study||0
10104692|NCT02435992|11234551|FG004|COMPLETED|Overall Study||0
10104693|NCT02435992|11234547|FG000|NOT COMPLETED|Overall Study||28
10104694|NCT02435992|11234548|FG001|NOT COMPLETED|Overall Study||24
10104695|NCT02435992|11234549|FG002|NOT COMPLETED|Overall Study||43
10104696|NCT02435992|11234550|FG003|NOT COMPLETED|Overall Study||0
10104697|NCT02435992|11234551|FG004|NOT COMPLETED|Overall Study||0
10104698|NCT02436005|11234563|FG000|STARTED|First Intervention||12
10104699|NCT02436005|11234564|FG001|STARTED|First Intervention||13
10104700|NCT02436005|11234563|FG000|COMPLETED|First Intervention||12
10104701|NCT02436005|11234564|FG001|COMPLETED|First Intervention||13
10104702|NCT02436005|11234563|FG000|NOT COMPLETED|First Intervention||0
10104703|NCT02436005|11234564|FG001|NOT COMPLETED|First Intervention||0
10006610|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006611|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006612|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006613|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10006614|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Washout Period 5||0
10006615|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Washout Period 5||0
10006616|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Washout Period 5||0
10006617|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Washout Period 5||5
10104704|NCT02436005|11234563|FG000|STARTED|Second Intervention||12
10104705|NCT02436005|11234564|FG001|STARTED|Second Intervention||13
10104706|NCT02436005|11234563|FG000|COMPLETED|Second Intervention||12
10104707|NCT02436005|11234564|FG001|COMPLETED|Second Intervention||12
10104708|NCT02436005|11234563|FG000|NOT COMPLETED|Second Intervention||0
10104709|NCT02436005|11234564|FG001|NOT COMPLETED|Second Intervention||1
10104710|NCT02436031|11234570|FG000|STARTED|First Study Night||8
10104711|NCT02436031|11234571|FG001|STARTED|First Study Night||8
10104712|NCT02436031|11234570|FG000|COMPLETED|First Study Night||8
10104713|NCT02436031|11234571|FG001|COMPLETED|First Study Night||8
10104714|NCT02436031|11234570|FG000|NOT COMPLETED|First Study Night||0
10104715|NCT02436031|11234571|FG001|NOT COMPLETED|First Study Night||0
10104716|NCT02436031|11234570|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
10104717|NCT02436031|11234571|FG001|STARTED|Second Study Night||8
10104718|NCT02436031|11234570|FG000|COMPLETED|Second Study Night||7
10104719|NCT02436031|11234571|FG001|COMPLETED|Second Study Night||8
10104720|NCT02436031|11234570|FG000|NOT COMPLETED|Second Study Night||0
10104721|NCT02436031|11234571|FG001|NOT COMPLETED|Second Study Night||0
10104722|NCT02436135|11234579|FG000|STARTED|Overall Study||6
10104723|NCT02436135|11234580|FG001|STARTED|Overall Study||4
10104724|NCT02436135|11234579|FG000|COMPLETED|Overall Study||0
10104725|NCT02436135|11234580|FG001|COMPLETED|Overall Study||0
10104726|NCT02436135|11234579|FG000|NOT COMPLETED|Overall Study||6
10104727|NCT02436135|11234580|FG001|NOT COMPLETED|Overall Study||4
10104728|NCT02436200|11234586|FG000|STARTED|Overall Study||21
10104729|NCT02436200|11234586|FG000|COMPLETED|Overall Study||20
10104730|NCT02436200|11234586|FG000|NOT COMPLETED|Overall Study||1
10104731|NCT02436239|11234594|FG000|STARTED|Open-Lable Treatment Period||122
10104732|NCT02436239|11234595|FG001|STARTED|Open-Lable Treatment Period||131
10104733|NCT02436239|11234596|FG002|STARTED|Open-Lable Treatment Period||65
10104734|NCT02436239|11234597|FG003|STARTED|Open-Lable Treatment Period||12
10104735|NCT02436239|11234594|FG000|COMPLETED|Open-Lable Treatment Period||89
10104736|NCT02436239|11234595|FG001|COMPLETED|Open-Lable Treatment Period||97
10104737|NCT02436239|11234596|FG002|COMPLETED|Open-Lable Treatment Period||38
10104738|NCT02436239|11234597|FG003|COMPLETED|Open-Lable Treatment Period||7
10104739|NCT02436239|11234594|FG000|NOT COMPLETED|Open-Lable Treatment Period||33
10104740|NCT02436239|11234595|FG001|NOT COMPLETED|Open-Lable Treatment Period||34
10104741|NCT02436239|11234596|FG002|NOT COMPLETED|Open-Lable Treatment Period||27
10104742|NCT02436239|11234597|FG003|NOT COMPLETED|Open-Lable Treatment Period||5
10104743|NCT02436239|11234594|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
10104744|NCT02436239|11234595|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
10104745|NCT02436239|11234596|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
10104746|NCT02436239|11234597|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
10104747|NCT02436239|11234594|FG000|COMPLETED|Down-Taper Period||86
10104748|NCT02436239|11234595|FG001|COMPLETED|Down-Taper Period||99
10104749|NCT02436239|11234596|FG002|COMPLETED|Down-Taper Period||43
10104750|NCT02436239|11234597|FG003|COMPLETED|Down-Taper Period||4
10104751|NCT02436239|11234594|FG000|NOT COMPLETED|Down-Taper Period||4
10104752|NCT02436239|11234595|FG001|NOT COMPLETED|Down-Taper Period||4
10104753|NCT02436239|11234596|FG002|NOT COMPLETED|Down-Taper Period||1
10104754|NCT02436239|11234597|FG003|NOT COMPLETED|Down-Taper Period||2
10104755|NCT02436304|11234610|FG000|STARTED|Overall Study||153
10104756|NCT02436304|11234611|FG001|STARTED|Overall Study||102
10104757|NCT02436304|11234612|FG002|STARTED|Overall Study||101
10104758|NCT02436304|11234610|FG000|COMPLETED|Overall Study||153
10104759|NCT02436304|11234611|FG001|COMPLETED|Overall Study||100
10104760|NCT02436304|11234612|FG002|COMPLETED|Overall Study||100
10104761|NCT02436304|11234610|FG000|NOT COMPLETED|Overall Study||0
10104762|NCT02436304|11234611|FG001|NOT COMPLETED|Overall Study||2
10104763|NCT02436304|11234612|FG002|NOT COMPLETED|Overall Study||1
10104764|NCT02436330|11234623|FG000|STARTED|Cohort 1||14
10104765|NCT02436330|11234624|FG001|STARTED|Cohort 1||4
10104766|NCT02436330|11234623|FG000|COMPLETED|Cohort 1||9
10104767|NCT02436330|11234624|FG001|COMPLETED|Cohort 1||1
10104768|NCT02436330|11234623|FG000|NOT COMPLETED|Cohort 1||5
10104769|NCT02436330|11234624|FG001|NOT COMPLETED|Cohort 1||3
10104770|NCT02436330|11234623|FG000|STARTED|Cohort 2||14
10104771|NCT02436330|11234624|FG001|STARTED|Cohort 2||10
10104772|NCT02436330|11234623|FG000|COMPLETED|Cohort 2||10
10104773|NCT02436330|11234624|FG001|COMPLETED|Cohort 2||7
10104774|NCT02436330|11234623|FG000|NOT COMPLETED|Cohort 2||4
10104775|NCT02436330|11234624|FG001|NOT COMPLETED|Cohort 2||3
10006618|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Washout Period 5||6
10006619|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Washout Period 5||5
10104776|NCT02436330|11234623|FG000|STARTED|Cohort 3||12
10006620|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Washout Period 5||5
10006621|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Washout Period 5||6
10006622|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Washout Period 5||5
10006623|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Washout Period 5||0
10104777|NCT02436330|11234624|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
10104778|NCT02436330|11234623|FG000|COMPLETED|Cohort 3||7
10104779|NCT02436330|11234624|FG001|COMPLETED|Cohort 3||0
10104780|NCT02436330|11234623|FG000|NOT COMPLETED|Cohort 3||5
10104781|NCT02436330|11234624|FG001|NOT COMPLETED|Cohort 3||0
10104782|NCT02436330|11234623|FG000|STARTED|Cohort 4||6
10104783|NCT02436330|11234624|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
10104784|NCT02436330|11234623|FG000|COMPLETED|Cohort 4||4
10104785|NCT02436330|11234624|FG001|COMPLETED|Cohort 4||0
10104786|NCT02436330|11234623|FG000|NOT COMPLETED|Cohort 4||2
10104787|NCT02436330|11234624|FG001|NOT COMPLETED|Cohort 4||0
10104788|NCT02436330|11234623|FG000|STARTED|Cohort 5||10
10104789|NCT02436330|11234624|FG001|STARTED|Cohort 5||5
10104790|NCT02436330|11234623|FG000|COMPLETED|Cohort 5||4
10104791|NCT02436330|11234624|FG001|COMPLETED|Cohort 5||1
10104792|NCT02436330|11234623|FG000|NOT COMPLETED|Cohort 5||6
10104793|NCT02436330|11234624|FG001|NOT COMPLETED|Cohort 5||4
10104794|NCT02436330|11234623|FG000|STARTED|Cohort 6||4
10104795|NCT02436330|11234624|FG001|STARTED|Cohort 6||5
10104796|NCT02436330|11234623|FG000|COMPLETED|Cohort 6||1
10104797|NCT02436330|11234624|FG001|COMPLETED|Cohort 6||4
10104798|NCT02436330|11234623|FG000|NOT COMPLETED|Cohort 6||3
10104799|NCT02436330|11234624|FG001|NOT COMPLETED|Cohort 6||1
10104800|NCT02436356|11234639|FG000|STARTED|Overall Study||33
10104801|NCT02436356|11234640|FG001|STARTED|Overall Study||11
10104802|NCT02436356|11234641|FG002|STARTED|Overall Study||4
10104803|NCT02436356|11234639|FG000|High Energy Fracture|Overall Study||14
10104804|NCT02436356|11234640|FG001|High Energy Fracture|Overall Study||0
10104805|NCT02436356|11234641|FG002|High Energy Fracture|Overall Study||4
10104806|NCT02436356|11234639|FG000|Low Energy Fracture|Overall Study||19
10104807|NCT02436356|11234640|FG001|Low Energy Fracture|Overall Study||0
10104808|NCT02436356|11234641|FG002|Low Energy Fracture|Overall Study||0
10104809|NCT02436356|11234639|FG000|COMPLETED|Overall Study||28
10006624|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Washout Period 5||0
10006625|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Washout Period 5||0
10006626|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Washout Period 5||5
10006627|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Washout Period 5||6
10006628|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Washout Period 5||5
10006629|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Washout Period 5||5
10006630|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Washout Period 5||6
10006631|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Washout Period 5||5
10006632|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006633|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006634|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006635|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006636|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006637|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006638|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006639|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006640|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10006641|NCT01746901|11128855|FG000|STARTED|Treatment Phase: Sixth Intervention||0
10006642|NCT01746901|11128856|FG001|STARTED|Treatment Phase: Sixth Intervention||0
10006643|NCT01746901|11128857|FG002|STARTED|Treatment Phase: Sixth Intervention||0
10006644|NCT01746901|11128858|FG003|STARTED|Treatment Phase: Sixth Intervention||5
10006645|NCT01746901|11128859|FG004|STARTED|Treatment Phase: Sixth Intervention||6
10006646|NCT01746901|11128860|FG005|STARTED|Treatment Phase: Sixth Intervention||5
10006647|NCT01746901|11128861|FG006|STARTED|Treatment Phase: Sixth Intervention||5
10006648|NCT01746901|11128862|FG007|STARTED|Treatment Phase: Sixth Intervention||6
10006649|NCT01746901|11128863|FG008|STARTED|Treatment Phase: Sixth Intervention||5
10006650|NCT01746901|11128855|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0
10006651|NCT01746901|11128856|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0
10006652|NCT01746901|11128857|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0
10006653|NCT01746901|11128858|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5
10006654|NCT01746901|11128859|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6
10006655|NCT01746901|11128860|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5
10006656|NCT01746901|11128861|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5
10006657|NCT01746901|11128862|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6
10006658|NCT01746901|11128863|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5
10006659|NCT01746901|11128855|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10104810|NCT02436356|11234640|FG001|COMPLETED|Overall Study||10
10104811|NCT02436356|11234641|FG002|COMPLETED|Overall Study||2
10104812|NCT02436356|11234639|FG000|NOT COMPLETED|Overall Study||5
10104813|NCT02436356|11234640|FG001|NOT COMPLETED|Overall Study||1
10104814|NCT02436356|11234641|FG002|NOT COMPLETED|Overall Study||2
10104815|NCT02436408|11234654|FG000|STARTED|Overall Study||35
10104816|NCT02436408|11234654|FG000|COMPLETED|Overall Study||34
10104817|NCT02436408|11234654|FG000|NOT COMPLETED|Overall Study||1
10006660|NCT01746901|11128856|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10104818|NCT02436577|11234664|FG000|STARTED|Overall Study||7
10104819|NCT02436577|11234665|FG001|STARTED|Overall Study||7
10104820|NCT02436577|11234666|FG002|STARTED|Overall Study||7
10104821|NCT02436577|11234667|FG003|STARTED|Overall Study||7
10104822|NCT02436577|11234668|FG004|STARTED|Overall Study||7
10104823|NCT02436577|11234669|FG005|STARTED|Overall Study||7
10104824|NCT02436577|11234664|FG000|COMPLETED|Overall Study||7
10104825|NCT02436577|11234665|FG001|COMPLETED|Overall Study||6
10104826|NCT02436577|11234666|FG002|COMPLETED|Overall Study||7
10104827|NCT02436577|11234667|FG003|COMPLETED|Overall Study||7
10104828|NCT02436577|11234668|FG004|COMPLETED|Overall Study||7
10104829|NCT02436577|11234669|FG005|COMPLETED|Overall Study||7
10104830|NCT02436577|11234664|FG000|NOT COMPLETED|Overall Study||0
10104831|NCT02436577|11234665|FG001|NOT COMPLETED|Overall Study||1
10104832|NCT02436577|11234666|FG002|NOT COMPLETED|Overall Study||0
10104833|NCT02436577|11234667|FG003|NOT COMPLETED|Overall Study||0
10104834|NCT02436577|11234668|FG004|NOT COMPLETED|Overall Study||0
10104835|NCT02436577|11234669|FG005|NOT COMPLETED|Overall Study||0
10104836|NCT02436668|11234679|FG000|STARTED|Overall Study||213
10104837|NCT02436668|11234680|FG001|STARTED|Overall Study||211
10104838|NCT02436668|11234679|FG000|COMPLETED|Overall Study||212
10104839|NCT02436668|11234680|FG001|COMPLETED|Overall Study||207
10104840|NCT02436668|11234679|FG000|NOT COMPLETED|Overall Study||1
10104841|NCT02436668|11234680|FG001|NOT COMPLETED|Overall Study||4
10104842|NCT02436681|11234689|FG000|STARTED|Overall Study||41
10104843|NCT02436681|11234689|FG000|COMPLETED|Overall Study||27
10104844|NCT02436681|11234689|FG000|NOT COMPLETED|Overall Study||14
10104845|NCT02436759|11234695|FG000|STARTED|Overall Study||94
10104846|NCT02436759|11234696|FG001|STARTED|Overall Study||46
10104847|NCT02436759|11234695|FG000|Subjects Randomized|Overall Study||94
10104848|NCT02436759|11234696|FG001|Subjects Randomized|Overall Study||46
10104849|NCT02436759|11234695|FG000|Subjects Treated|Overall Study||94
10104850|NCT02436759|11234696|FG001|Subjects Treated|Overall Study||46
10104851|NCT02436759|11234695|FG000|COMPLETED|Overall Study||90
10104852|NCT02436759|11234696|FG001|COMPLETED|Overall Study||45
10104853|NCT02436759|11234695|FG000|NOT COMPLETED|Overall Study||4
10104854|NCT02436759|11234696|FG001|NOT COMPLETED|Overall Study||1
10104855|NCT02436811|11234705|FG000|STARTED|Overall Study||60
10104856|NCT02436811|11234706|FG001|STARTED|Overall Study||60
10104857|NCT02436811|11234707|FG002|STARTED|Overall Study||60
10104858|NCT02436811|11234705|FG000|COMPLETED|Overall Study||58
10104859|NCT02436811|11234706|FG001|COMPLETED|Overall Study||51
10104860|NCT02436811|11234707|FG002|COMPLETED|Overall Study||53
10104861|NCT02436811|11234705|FG000|NOT COMPLETED|Overall Study||2
10104862|NCT02436811|11234706|FG001|NOT COMPLETED|Overall Study||9
10104863|NCT02436811|11234707|FG002|NOT COMPLETED|Overall Study||7
10104864|NCT02436876|11234719|FG000|STARTED|Overall Study||6
10104865|NCT02436876|11234720|FG001|STARTED|Overall Study||9
10104866|NCT02436876|11234721|FG002|STARTED|Overall Study||7
10104867|NCT02436876|11234722|FG003|STARTED|Overall Study||7
10104868|NCT02436876|11234719|FG000|Treated|Overall Study||6
10104869|NCT02436876|11234720|FG001|Treated|Overall Study||6
10104870|NCT02436876|11234721|FG002|Treated|Overall Study||6
10104871|NCT02436876|11234722|FG003|Treated|Overall Study||7
10104872|NCT02436876|11234719|FG000|COMPLETED|Overall Study||5
10104873|NCT02436876|11234720|FG001|COMPLETED|Overall Study||5
10104874|NCT02436876|11234721|FG002|COMPLETED|Overall Study||5
10006661|NCT01746901|11128857|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10006662|NCT01746901|11128858|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10006663|NCT01746901|11128859|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10006664|NCT01746901|11128860|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10006665|NCT01746901|11128861|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10006666|NCT01746901|11128862|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10006667|NCT01746901|11128863|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10006668|NCT01746940|11128903|FG000|STARTED|Safety and Efficacy First Phase||39
10006669|NCT01746940|11128904|FG001|STARTED|Safety and Efficacy First Phase||41
10006670|NCT01746940|11128905|FG002|STARTED|Safety and Efficacy First Phase||40
10006671|NCT01746940|11128906|FG003|STARTED|Safety and Efficacy First Phase||3
10006672|NCT01746940|11128903|FG000|COMPLETED|Safety and Efficacy First Phase||39
10006673|NCT01746940|11128904|FG001|COMPLETED|Safety and Efficacy First Phase||41
10006674|NCT01746940|11128905|FG002|COMPLETED|Safety and Efficacy First Phase||40
10006675|NCT01746940|11128906|FG003|COMPLETED|Safety and Efficacy First Phase||0
10006676|NCT01746940|11128903|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0
10104875|NCT02436876|11234722|FG003|COMPLETED|Overall Study||5
10104876|NCT02436876|11234719|FG000|NOT COMPLETED|Overall Study||1
10104877|NCT02436876|11234720|FG001|NOT COMPLETED|Overall Study||4
10104878|NCT02436876|11234721|FG002|NOT COMPLETED|Overall Study||2
10104879|NCT02436876|11234722|FG003|NOT COMPLETED|Overall Study||2
10006677|NCT01746940|11128904|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0
10104880|NCT02436889|11234739|FG000|STARTED|Overall Study||12
10104881|NCT02436889|11234740|FG001|STARTED|Overall Study||11
10104882|NCT02436889|11234739|FG000|COMPLETED|Overall Study||11
10104883|NCT02436889|11234740|FG001|COMPLETED|Overall Study||10
10104884|NCT02436889|11234739|FG000|NOT COMPLETED|Overall Study||1
10104885|NCT02436889|11234740|FG001|NOT COMPLETED|Overall Study||1
10104886|NCT02436915|11234748|FG000|STARTED|Overall Study||9
10104887|NCT02436915|11234749|FG001|STARTED|Overall Study||10
10104888|NCT02436915|11234748|FG000|COMPLETED|Overall Study||9
10006678|NCT01746940|11128905|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0
10006679|NCT01746940|11128906|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3
10006680|NCT01746940|11128903|FG000|STARTED|Safety Second Phase||18
10006681|NCT01746940|11128904|FG001|STARTED|Safety Second Phase||18
10006682|NCT01746940|11128905|FG002|STARTED|Safety Second Phase||0
10006683|NCT01746940|11128906|FG003|STARTED|Safety Second Phase||0
10006684|NCT01746940|11128903|FG000|COMPLETED|Safety Second Phase||18
10006685|NCT01746940|11128904|FG001|COMPLETED|Safety Second Phase||18
10104889|NCT02436915|11234749|FG001|COMPLETED|Overall Study||9
10104890|NCT02436915|11234748|FG000|NOT COMPLETED|Overall Study||0
10104891|NCT02436915|11234749|FG001|NOT COMPLETED|Overall Study||1
10104892|NCT02437084|11234757|FG000|STARTED|Overall Study||75
10104893|NCT02437084|11234757|FG000|COMPLETED|Overall Study||72
10104894|NCT02437084|11234757|FG000|NOT COMPLETED|Overall Study||3
10104895|NCT02437162|11234764|FG000|STARTED|Overall Study||116
10104896|NCT02437162|11234765|FG001|STARTED|Overall Study||116
10104897|NCT02437162|11234766|FG002|STARTED|Overall Study||115
10104898|NCT02437162|11234764|FG000|Treated|Overall Study||116
10104899|NCT02437162|11234765|FG001|Treated|Overall Study||116
10104900|NCT02437162|11234766|FG002|Treated|Overall Study||114
10104901|NCT02437162|11234764|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
10104902|NCT02437162|11234765|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
10104903|NCT02437162|11234766|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
10104904|NCT02437162|11234764|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
10104905|NCT02437162|11234765|FG001|Cross Over at Week 24|Overall Study||0
10104906|NCT02437162|11234766|FG002|Cross Over at Week 24|Overall Study||0
10104907|NCT02437162|11234764|FG000|COMPLETED|Overall Study||9
10104908|NCT02437162|11234765|FG001|COMPLETED|Overall Study||8
10104909|NCT02437162|11234766|FG002|COMPLETED|Overall Study||6
10104910|NCT02437162|11234764|FG000|NOT COMPLETED|Overall Study||107
10104911|NCT02437162|11234765|FG001|NOT COMPLETED|Overall Study||108
10104912|NCT02437162|11234766|FG002|NOT COMPLETED|Overall Study||109
10104913|NCT02437188|11234781|FG000|STARTED|Overall Study||44
10104914|NCT02437188|11234782|FG001|STARTED|Overall Study||44
10104915|NCT02437188|11234781|FG000|COMPLETED|Overall Study||40
10104916|NCT02437188|11234782|FG001|COMPLETED|Overall Study||35
10104917|NCT02437188|11234781|FG000|NOT COMPLETED|Overall Study||4
10104918|NCT02437188|11234782|FG001|NOT COMPLETED|Overall Study||9
10104919|NCT02437253|11234793|FG000|STARTED|Overall Study||1
10104920|NCT02437253|11234794|FG001|STARTED|Overall Study||1
10104921|NCT02437253|11234793|FG000|COMPLETED|Overall Study||1
10104922|NCT02437253|11234794|FG001|COMPLETED|Overall Study||1
10104923|NCT02437253|11234793|FG000|NOT COMPLETED|Overall Study||0
10202313|NCT03443713|11329445|FG001|STARTED|First at Home Period (9-14 Days)||8
10202314|NCT03443713|11329446|FG002|STARTED|First at Home Period (9-14 Days)||9
10202315|NCT03443713|11329444|FG000|COMPLETED|First at Home Period (9-14 Days)||8
10202316|NCT03443713|11329445|FG001|COMPLETED|First at Home Period (9-14 Days)||8
10202317|NCT03443713|11329446|FG002|COMPLETED|First at Home Period (9-14 Days)||8
10202318|NCT03443713|11329444|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0
10202319|NCT03443713|11329445|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0
10202320|NCT03443713|11329446|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1
10202321|NCT03443713|11329444|FG000|STARTED|First Exercise Visit (1 Hour)||8
10202322|NCT03443713|11329445|FG001|STARTED|First Exercise Visit (1 Hour)||8
10202323|NCT03443713|11329446|FG002|STARTED|First Exercise Visit (1 Hour)||8
10202324|NCT03443713|11329444|FG000|COMPLETED|First Exercise Visit (1 Hour)||8
10202325|NCT03443713|11329445|FG001|COMPLETED|First Exercise Visit (1 Hour)||8
10202326|NCT03443713|11329446|FG002|COMPLETED|First Exercise Visit (1 Hour)||8
10202327|NCT03443713|11329444|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0
10202328|NCT03443713|11329445|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0
10202329|NCT03443713|11329446|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0
10202330|NCT03443713|11329444|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8
10202331|NCT03443713|11329445|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8
10202332|NCT03443713|11329446|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8
10202333|NCT03443713|11329444|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
10202334|NCT03443713|11329445|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
10202335|NCT03443713|11329446|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
10202336|NCT03443713|11329444|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
10202337|NCT03443713|11329445|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
10202338|NCT03443713|11329446|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
10202339|NCT03443713|11329444|FG000|STARTED|Second at Home Period (2-11 Days)||8
10202340|NCT03443713|11329445|FG001|STARTED|Second at Home Period (2-11 Days)||8
10202341|NCT03443713|11329446|FG002|STARTED|Second at Home Period (2-11 Days)||8
10006686|NCT01746940|11128905|FG002|COMPLETED|Safety Second Phase||0
10006687|NCT01746940|11128906|FG003|COMPLETED|Safety Second Phase||0
10006688|NCT01746940|11128903|FG000|NOT COMPLETED|Safety Second Phase||0
10006689|NCT01746940|11128904|FG001|NOT COMPLETED|Safety Second Phase||0
10202342|NCT03443713|11329444|FG000|COMPLETED|Second at Home Period (2-11 Days)||8
10202343|NCT03443713|11329445|FG001|COMPLETED|Second at Home Period (2-11 Days)||8
10202344|NCT03443713|11329446|FG002|COMPLETED|Second at Home Period (2-11 Days)||8
10202345|NCT03443713|11329444|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0
10006690|NCT01746940|11128905|FG002|NOT COMPLETED|Safety Second Phase||0
10006691|NCT01746940|11128906|FG003|NOT COMPLETED|Safety Second Phase||0
10006692|NCT01746979|11128916|FG000|STARTED|Overall Study||346
10006693|NCT01746979|11128917|FG001|STARTED|Overall Study||347
10006694|NCT01746979|11128916|FG000|COMPLETED|Overall Study||0
10006695|NCT01746979|11128917|FG001|COMPLETED|Overall Study||0
10006696|NCT01746979|11128916|FG000|NOT COMPLETED|Overall Study||346
10006697|NCT01746979|11128917|FG001|NOT COMPLETED|Overall Study||347
10006698|NCT01747330|11128923|FG000|STARTED|Overall Study||40
10006699|NCT01747330|11128923|FG000|COMPLETED|Overall Study||40
10006700|NCT01747330|11128923|FG000|NOT COMPLETED|Overall Study||0
10006701|NCT01747343|11128927|FG000|STARTED|Baseline||4
10006702|NCT01747343|11128927|FG000|COMPLETED|Baseline||4
10006703|NCT01747343|11128927|FG000|NOT COMPLETED|Baseline||0
10006704|NCT01747343|11128927|FG000|STARTED|Underwear||4
10006705|NCT01747343|11128927|FG000|COMPLETED|Underwear||4
10006706|NCT01747343|11128927|FG000|NOT COMPLETED|Underwear||0
10006707|NCT01747343|11128927|FG000|STARTED|Underwear/Differential Reinforcement||4
10006708|NCT01747343|11128927|FG000|COMPLETED|Underwear/Differential Reinforcement||4
10006709|NCT01747343|11128927|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0
10006710|NCT01747486|11128933|FG000|STARTED|Stage 1||15
10006711|NCT01747486|11128934|FG001|STARTED|Stage 1||15
10006712|NCT01747486|11128933|FG000|COMPLETED|Stage 1||3
10006713|NCT01747486|11128934|FG001|COMPLETED|Stage 1||2
10006714|NCT01747486|11128933|FG000|NOT COMPLETED|Stage 1||12
10006715|NCT01747486|11128934|FG001|NOT COMPLETED|Stage 1||13
10006716|NCT01747486|11128933|FG000|STARTED|Stage 2||12
10006717|NCT01747486|11128934|FG001|STARTED|Stage 2||0
10006718|NCT01747486|11128933|FG000|COMPLETED|Stage 2||3
10006719|NCT01747486|11128934|FG001|COMPLETED|Stage 2||0
10006720|NCT01747486|11128933|FG000|NOT COMPLETED|Stage 2||9
10006721|NCT01747486|11128934|FG001|NOT COMPLETED|Stage 2||0
10006722|NCT01747499|11128945|FG000|STARTED|Overall Study||3
10006723|NCT01747499|11128946|FG001|STARTED|Overall Study||3
10006724|NCT01747499|11128947|FG002|STARTED|Overall Study||3
10006725|NCT01747499|11128948|FG003|STARTED|Overall Study||6
10006726|NCT01747499|11128949|FG004|STARTED|Overall Study||39
10006727|NCT01747499|11128945|FG000|COMPLETED|Overall Study||2
10006728|NCT01747499|11128946|FG001|COMPLETED|Overall Study||2
10006729|NCT01747499|11128947|FG002|COMPLETED|Overall Study||3
10006730|NCT01747499|11128948|FG003|COMPLETED|Overall Study||4
10006731|NCT01747499|11128949|FG004|COMPLETED|Overall Study||24
10006732|NCT01747499|11128945|FG000|NOT COMPLETED|Overall Study||1
10006733|NCT01747499|11128946|FG001|NOT COMPLETED|Overall Study||1
10006734|NCT01747499|11128947|FG002|NOT COMPLETED|Overall Study||0
10006735|NCT01747499|11128948|FG003|NOT COMPLETED|Overall Study||2
10006736|NCT01747499|11128949|FG004|NOT COMPLETED|Overall Study||15
10006737|NCT01747551|11128965|FG000|STARTED|Overall Study||43
10006738|NCT01747551|11128966|FG001|STARTED|Overall Study||21
10006739|NCT01747551|11128965|FG000|COMPLETED|Overall Study||0
10006740|NCT01747551|11128966|FG001|COMPLETED|Overall Study||0
10006741|NCT01747551|11128965|FG000|NOT COMPLETED|Overall Study||43
10006742|NCT01747551|11128966|FG001|NOT COMPLETED|Overall Study||21
10006743|NCT01747629|11128974|FG000|STARTED|Overall Study||85
10006744|NCT01747629|11128975|FG001|STARTED|Overall Study||75
10006745|NCT01747629|11128974|FG000|Treated|Overall Study|Safety set and full analysis set|84
10006746|NCT01747629|11128975|FG001|Treated|Overall Study|Safety set and full analysis set|75
10006747|NCT01747629|11128974|FG000|COMPLETED|Overall Study||77
10006748|NCT01747629|11128975|FG001|COMPLETED|Overall Study||69
10006749|NCT01747629|11128974|FG000|NOT COMPLETED|Overall Study||8
10006750|NCT01747629|11128975|FG001|NOT COMPLETED|Overall Study||6
10006751|NCT01747655|11128981|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
10006752|NCT01747655|11128982|FG001|STARTED|Temporary Naso-jejunal Tube Period||0
10006753|NCT01747655|11128981|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64
10006754|NCT01747655|11128982|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0
10006755|NCT01747655|11128981|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
10006756|NCT01747655|11128982|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
10006757|NCT01747655|11128981|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
10006758|NCT01747655|11128982|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
10006759|NCT01747655|11128981|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44
10006760|NCT01747655|11128982|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6
10006761|NCT01747655|11128981|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
10006762|NCT01747655|11128982|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
10006763|NCT01747655|11128981|FG000|STARTED|PEG-J Period (Continued Treatment)||41
10006764|NCT01747655|11128982|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
10006765|NCT01747655|11128981|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41
10006766|NCT01747655|11128982|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15
10006767|NCT01747655|11128981|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
10006768|NCT01747655|11128982|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
10006769|NCT01747772|11128988|FG000|STARTED|Overall Study||180
10006770|NCT01747772|11128988|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
10006771|NCT01747772|11128988|FG000|COMPLETED|Overall Study||171
10006772|NCT01747772|11128988|FG000|NOT COMPLETED|Overall Study||9
10006773|NCT01747811|11128998|FG000|STARTED|Overall Study||16
10006774|NCT01747811|11128999|FG001|STARTED|Overall Study||16
10006775|NCT01747811|11128998|FG000|COMPLETED|Overall Study||14
10006776|NCT01747811|11128999|FG001|COMPLETED|Overall Study||12
10006777|NCT01747811|11128998|FG000|NOT COMPLETED|Overall Study||2
10006778|NCT01747811|11128999|FG001|NOT COMPLETED|Overall Study||4
10006779|NCT01747837|11129009|FG000|STARTED|Overall Study||25
10006780|NCT01747837|11129010|FG001|STARTED|Overall Study||23
10006781|NCT01747837|11129009|FG000|COMPLETED|Overall Study||16
10006782|NCT01747837|11129010|FG001|COMPLETED|Overall Study||17
10006783|NCT01747837|11129009|FG000|NOT COMPLETED|Overall Study||9
10006784|NCT01747837|11129010|FG001|NOT COMPLETED|Overall Study||6
10006785|NCT01747850|11129019|FG000|STARTED|Overall Study||5
10006786|NCT01747850|11129020|FG001|STARTED|Overall Study||20
10006787|NCT01747850|11129021|FG002|STARTED|Overall Study||20
10006788|NCT01747850|11129019|FG000|COMPLETED|Overall Study||4
10006789|NCT01747850|11129020|FG001|COMPLETED|Overall Study||13
10006790|NCT01747850|11129021|FG002|COMPLETED|Overall Study||14
10006791|NCT01747850|11129019|FG000|NOT COMPLETED|Overall Study||1
10104924|NCT02437253|11234794|FG001|NOT COMPLETED|Overall Study||0
10104925|NCT02437305|11234804|FG000|STARTED|Overall Study||50
10104926|NCT02437305|11234805|FG001|STARTED|Overall Study||50
10104927|NCT02437305|11234804|FG000|COMPLETED|Overall Study||32
10104928|NCT02437305|11234805|FG001|COMPLETED|Overall Study||38
10104929|NCT02437305|11234804|FG000|NOT COMPLETED|Overall Study||18
10104930|NCT02437305|11234805|FG001|NOT COMPLETED|Overall Study||12
10104931|NCT02437344|11234811|FG000|STARTED|Overall Study||16
10104932|NCT02437344|11234811|FG000|COMPLETED|Overall Study||15
10104933|NCT02437344|11234811|FG000|NOT COMPLETED|Overall Study||1
10104934|NCT02437383|11234817|FG000|STARTED|Overall Study||100
10104935|NCT02437383|11234818|FG001|STARTED|Overall Study||100
10104936|NCT02437383|11234817|FG000|COMPLETED|Overall Study||87
10104937|NCT02437383|11234818|FG001|COMPLETED|Overall Study||87
10104938|NCT02437383|11234817|FG000|NOT COMPLETED|Overall Study||13
10104939|NCT02437383|11234818|FG001|NOT COMPLETED|Overall Study||13
10104940|NCT02437409|11234824|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
10104941|NCT02437409|11234824|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
10104942|NCT02437409|11234824|FG000|NOT COMPLETED|Overall Study||15
10104943|NCT02437487|11234831|FG000|STARTED|Overall Study||59
10104944|NCT02437487|11234832|FG001|STARTED|Overall Study||30
10104945|NCT02437487|11234831|FG000|Actual Treatment Received|Overall Study||60
10104946|NCT02437487|11234832|FG001|Actual Treatment Received|Overall Study||29
10104947|NCT02437487|11234831|FG000|Intention-to-Treat Population|Overall Study||59
10104948|NCT02437487|11234832|FG001|Intention-to-Treat Population|Overall Study||30
10104949|NCT02437487|11234831|FG000|COMPLETED|Overall Study||32
10104950|NCT02437487|11234832|FG001|COMPLETED|Overall Study||16
10104951|NCT02437487|11234831|FG000|NOT COMPLETED|Overall Study||27
10104952|NCT02437487|11234832|FG001|NOT COMPLETED|Overall Study||14
10104953|NCT02437513|11234838|FG000|STARTED|Overall Study||2
10104954|NCT02437513|11234838|FG000|COMPLETED|Overall Study||0
10104955|NCT02437513|11234838|FG000|NOT COMPLETED|Overall Study||2
10104956|NCT02437669|11234842|FG000|STARTED|Overall Study||35
10104957|NCT02437669|11234842|FG000|COMPLETED|Overall Study||35
10104958|NCT02437669|11234842|FG000|NOT COMPLETED|Overall Study||0
10104959|NCT02437864|11234849|FG000|STARTED|Overall Study||200
10104960|NCT02437864|11234850|FG001|STARTED|Overall Study||160
10104961|NCT02437864|11234849|FG000|COMPLETED|Overall Study||196
10104962|NCT02437864|11234850|FG001|COMPLETED|Overall Study||160
10104963|NCT02437864|11234849|FG000|NOT COMPLETED|Overall Study||4
10104964|NCT02437864|11234850|FG001|NOT COMPLETED|Overall Study||0
10104965|NCT02437890|11234861|FG000|STARTED|Overall Study||62
10104966|NCT02437890|11234862|FG001|STARTED|Overall Study||64
10104967|NCT02437890|11234863|FG002|STARTED|Overall Study||62
10104968|NCT02437890|11234864|FG003|STARTED|Overall Study||62
10104969|NCT02437890|11234865|FG004|STARTED|Overall Study||62
10104970|NCT02437890|11234861|FG000|COMPLETED|Overall Study||54
10104971|NCT02437890|11234862|FG001|COMPLETED|Overall Study||48
10104972|NCT02437890|11234863|FG002|COMPLETED|Overall Study||47
10104973|NCT02437890|11234864|FG003|COMPLETED|Overall Study||40
10202346|NCT03443713|11329445|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0
10202347|NCT03443713|11329446|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0
10202348|NCT03443713|11329444|FG000|STARTED|Second Exercise Visit (1 Hour)||8
10202349|NCT03443713|11329445|FG001|STARTED|Second Exercise Visit (1 Hour)||8
10202350|NCT03443713|11329446|FG002|STARTED|Second Exercise Visit (1 Hour)||8
10202351|NCT03443713|11329444|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8
10202352|NCT03443713|11329445|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8
10202353|NCT03443713|11329446|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8
10006792|NCT01747850|11129020|FG001|NOT COMPLETED|Overall Study||7
10006793|NCT01747850|11129021|FG002|NOT COMPLETED|Overall Study||6
10104974|NCT02437890|11234865|FG004|COMPLETED|Overall Study||46
10104975|NCT02437890|11234861|FG000|NOT COMPLETED|Overall Study||8
10104976|NCT02437890|11234862|FG001|NOT COMPLETED|Overall Study||16
10104977|NCT02437890|11234863|FG002|NOT COMPLETED|Overall Study||15
10104978|NCT02437890|11234864|FG003|NOT COMPLETED|Overall Study||22
10104979|NCT02437890|11234865|FG004|NOT COMPLETED|Overall Study||16
10104980|NCT02437903|11234881|FG000|STARTED|Overall Study||30
10006794|NCT01747876|11129044|FG000|STARTED|Overall Study||5
10006795|NCT01747876|11129045|FG001|STARTED|Overall Study||15
10104981|NCT02437903|11234881|FG000|COMPLETED|Overall Study||25
10104982|NCT02437903|11234881|FG000|NOT COMPLETED|Overall Study||5
10104983|NCT02438137|11234888|FG000|STARTED|Overall Study||44
10006796|NCT01747876|11129046|FG002|STARTED|Overall Study||12
10006797|NCT01747876|11129044|FG000|COMPLETED|Overall Study||0
10006798|NCT01747876|11129045|FG001|COMPLETED|Overall Study||0
10006799|NCT01747876|11129046|FG002|COMPLETED|Overall Study||0
10006800|NCT01747876|11129044|FG000|NOT COMPLETED|Overall Study||5
10006801|NCT01747876|11129045|FG001|NOT COMPLETED|Overall Study||15
10006802|NCT01747876|11129046|FG002|NOT COMPLETED|Overall Study||12
10006803|NCT01747915|11129060|FG000|STARTED|Overall Study||75
10104984|NCT02438137|11234889|FG001|STARTED|Overall Study||21
10104985|NCT02438137|11234888|FG000|COMPLETED|Overall Study||36
10104986|NCT02438137|11234889|FG001|COMPLETED|Overall Study||15
10104987|NCT02438137|11234888|FG000|NOT COMPLETED|Overall Study||8
10104988|NCT02438137|11234889|FG001|NOT COMPLETED|Overall Study||6
10104989|NCT02438280|11234899|FG000|STARTED|Overall Study||14
10104990|NCT02438280|11234900|FG001|STARTED|Overall Study||13
10104991|NCT02438280|11234899|FG000|COMPLETED|Overall Study||13
10104992|NCT02438280|11234900|FG001|COMPLETED|Overall Study||13
10104993|NCT02438280|11234899|FG000|NOT COMPLETED|Overall Study||1
10104994|NCT02438280|11234900|FG001|NOT COMPLETED|Overall Study||0
10104995|NCT02438371|11234909|FG000|STARTED|Overall Study||24
10104996|NCT02438371|11234910|FG001|STARTED|Overall Study||25
10104997|NCT02438371|11234909|FG000|Received Intervention|Overall Study||24
10104998|NCT02438371|11234910|FG001|Received Intervention|Overall Study||25
10104999|NCT02438371|11234909|FG000|COMPLETED|Overall Study||20
10105000|NCT02438371|11234910|FG001|COMPLETED|Overall Study||22
10105001|NCT02438371|11234909|FG000|NOT COMPLETED|Overall Study||4
10105002|NCT02438371|11234910|FG001|NOT COMPLETED|Overall Study||3
10105003|NCT02438384|11234919|FG000|STARTED|Overall Study||25
10105004|NCT02438384|11234920|FG001|STARTED|Overall Study||25
10105005|NCT02438384|11234921|FG002|STARTED|Overall Study||25
10105006|NCT02438384|11234919|FG000|COMPLETED|Overall Study||17
10105007|NCT02438384|11234920|FG001|COMPLETED|Overall Study||19
10105008|NCT02438384|11234921|FG002|COMPLETED|Overall Study||21
10105009|NCT02438384|11234919|FG000|NOT COMPLETED|Overall Study||8
10105010|NCT02438384|11234920|FG001|NOT COMPLETED|Overall Study||6
10105011|NCT02438384|11234921|FG002|NOT COMPLETED|Overall Study||4
10105012|NCT02438423|11234933|FG000|STARTED|Overall Study||25
10105013|NCT02438423|11234934|FG001|STARTED|Overall Study||25
10105014|NCT02438423|11234935|FG002|STARTED|Overall Study||25
10105015|NCT02438423|11234936|FG003|STARTED|Overall Study||25
10105016|NCT02438423|11234933|FG000|COMPLETED|Overall Study||25
10105017|NCT02438423|11234934|FG001|COMPLETED|Overall Study||25
10105018|NCT02438423|11234935|FG002|COMPLETED|Overall Study||25
10105019|NCT02438423|11234936|FG003|COMPLETED|Overall Study||25
10105020|NCT02438423|11234933|FG000|NOT COMPLETED|Overall Study||0
10105021|NCT02438423|11234934|FG001|NOT COMPLETED|Overall Study||0
10105022|NCT02438423|11234935|FG002|NOT COMPLETED|Overall Study||0
10105023|NCT02438423|11234936|FG003|NOT COMPLETED|Overall Study||0
10105024|NCT02438475|11234950|FG000|STARTED|Overall Study||104
10105025|NCT02438475|11234951|FG001|STARTED|Overall Study||104
10105026|NCT02438475|11234950|FG000|COMPLETED|Overall Study||102
10105027|NCT02438475|11234951|FG001|COMPLETED|Overall Study||104
10105028|NCT02438475|11234950|FG000|NOT COMPLETED|Overall Study||2
10105029|NCT02438475|11234951|FG001|NOT COMPLETED|Overall Study||0
10105030|NCT02438540|11234959|FG000|STARTED|Overall Study||19
10105031|NCT02438540|11234960|FG001|STARTED|Overall Study||20
10105032|NCT02438540|11234959|FG000|COMPLETED|Overall Study||19
10105033|NCT02438540|11234960|FG001|COMPLETED|Overall Study||20
10105034|NCT02438540|11234959|FG000|NOT COMPLETED|Overall Study||0
10105035|NCT02438540|11234960|FG001|NOT COMPLETED|Overall Study||0
10105036|NCT02438787|11234970|FG000|STARTED|Overall Study||104
10105037|NCT02438787|11234971|FG001|STARTED|Overall Study||106
10105038|NCT02438787|11234972|FG002|STARTED|Overall Study||105
10105039|NCT02438787|11234970|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
10105040|NCT02438787|11234971|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
10105041|NCT02438787|11234972|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
10105042|NCT02438787|11234970|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
10105043|NCT02438787|11234971|FG001|Cross Over at Week 24|Overall Study||0
10006804|NCT01747915|11129061|FG001|STARTED|Overall Study||72
10006805|NCT01747915|11129062|FG002|STARTED|Overall Study||72
10006806|NCT01747915|11129060|FG000|COMPLETED|Overall Study||60
10006807|NCT01747915|11129061|FG001|COMPLETED|Overall Study||61
10006808|NCT01747915|11129062|FG002|COMPLETED|Overall Study||66
10006809|NCT01747915|11129060|FG000|NOT COMPLETED|Overall Study||15
10006810|NCT01747915|11129061|FG001|NOT COMPLETED|Overall Study||11
10006811|NCT01747915|11129062|FG002|NOT COMPLETED|Overall Study||6
10006812|NCT01747928|11129078|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10006813|NCT01747928|11129079|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10018966|NCT01826812|11142008|FG001|NOT COMPLETED|Overall Study||1
10105044|NCT02438787|11234972|FG002|Cross Over at Week 24|Overall Study||0
10105045|NCT02438787|11234970|FG000|COMPLETED|Overall Study||23
10105046|NCT02438787|11234971|FG001|COMPLETED|Overall Study||23
10105047|NCT02438787|11234972|FG002|COMPLETED|Overall Study||22
10105048|NCT02438787|11234970|FG000|NOT COMPLETED|Overall Study||81
10105049|NCT02438787|11234971|FG001|NOT COMPLETED|Overall Study||83
10105050|NCT02438787|11234972|FG002|NOT COMPLETED|Overall Study||83
10105051|NCT02438813|11234985|FG000|STARTED|Overall Study||1029
10006814|NCT01747928|11129080|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10006815|NCT01747928|11129081|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10006816|NCT01747928|11129082|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10006817|NCT01747928|11129083|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10006818|NCT01747928|11129084|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10018967|NCT01826825|11142018|FG000|STARTED|Overall Study||100
10105052|NCT02438813|11234985|FG000|Received Treatment for SMF|Overall Study||676
10105053|NCT02438813|11234985|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353
10105054|NCT02438813|11234985|FG000|COMPLETED|Overall Study||504
10105055|NCT02438813|11234985|FG000|NOT COMPLETED|Overall Study||525
10105056|NCT02438826|11235001|FG000|STARTED|Double-Blind Treatment Phase||123
10105057|NCT02438826|11235002|FG001|STARTED|Double-Blind Treatment Phase||117
10105058|NCT02438826|11235003|FG002|STARTED|Double-Blind Treatment Phase||0
10105059|NCT02438826|11235004|FG003|STARTED|Double-Blind Treatment Phase||0
10105060|NCT02438826|11235001|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
10105061|NCT02438826|11235002|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
10105062|NCT02438826|11235003|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
10105063|NCT02438826|11235004|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
10105064|NCT02438826|11235001|FG000|COMPLETED|Double-Blind Treatment Phase||117
10105065|NCT02438826|11235002|FG001|COMPLETED|Double-Blind Treatment Phase||113
10105066|NCT02438826|11235003|FG002|COMPLETED|Double-Blind Treatment Phase||0
10105067|NCT02438826|11235004|FG003|COMPLETED|Double-Blind Treatment Phase||0
10105068|NCT02438826|11235001|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6
10105069|NCT02438826|11235002|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4
10105070|NCT02438826|11235003|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
10105071|NCT02438826|11235004|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10105072|NCT02438826|11235001|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
10105073|NCT02438826|11235002|FG001|STARTED|Open-Label Treatment Phase||113
10105074|NCT02438826|11235003|FG002|STARTED|Open-Label Treatment Phase||0
10105075|NCT02438826|11235004|FG003|STARTED|Open-Label Treatment Phase||0
10105076|NCT02438826|11235001|FG000|COMPLETED|Open-Label Treatment Phase||72
10105077|NCT02438826|11235002|FG001|COMPLETED|Open-Label Treatment Phase||80
10105078|NCT02438826|11235003|FG002|COMPLETED|Open-Label Treatment Phase||0
10105079|NCT02438826|11235004|FG003|COMPLETED|Open-Label Treatment Phase||0
10105080|NCT02438826|11235001|FG000|NOT COMPLETED|Open-Label Treatment Phase||44
10105081|NCT02438826|11235002|FG001|NOT COMPLETED|Open-Label Treatment Phase||33
10105082|NCT02438826|11235003|FG002|NOT COMPLETED|Open-Label Treatment Phase||0
10105083|NCT02438826|11235004|FG003|NOT COMPLETED|Open-Label Treatment Phase||0
10105084|NCT02438826|11235001|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
10105085|NCT02438826|11235002|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
10105086|NCT02438826|11235003|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
10105087|NCT02438826|11235004|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
10105088|NCT02438826|11235001|FG000|COMPLETED|Post-Treatment Phase||84
10105089|NCT02438826|11235002|FG001|COMPLETED|Post-Treatment Phase||92
10105090|NCT02438826|11235003|FG002|COMPLETED|Post-Treatment Phase||2
10105091|NCT02438826|11235004|FG003|COMPLETED|Post-Treatment Phase||4
10105092|NCT02438826|11235001|FG000|NOT COMPLETED|Post-Treatment Phase||9
10105093|NCT02438826|11235002|FG001|NOT COMPLETED|Post-Treatment Phase||1
10105094|NCT02438826|11235003|FG002|NOT COMPLETED|Post-Treatment Phase||0
10105095|NCT02438826|11235004|FG003|NOT COMPLETED|Post-Treatment Phase||0
10105096|NCT02439138|11235019|FG000|STARTED|Overall Study||5
10105097|NCT02439138|11235019|FG000|COMPLETED|Overall Study||2
10105098|NCT02439138|11235019|FG000|NOT COMPLETED|Overall Study||3
10105099|NCT02439164|11235025|FG000|STARTED|Overall Study||18
10105100|NCT02439164|11235026|FG001|STARTED|Overall Study||18
10105101|NCT02439164|11235025|FG000|COMPLETED|Overall Study||18
10105102|NCT02439164|11235026|FG001|COMPLETED|Overall Study||18
10105103|NCT02439164|11235025|FG000|NOT COMPLETED|Overall Study||0
10105104|NCT02439164|11235026|FG001|NOT COMPLETED|Overall Study||0
10105105|NCT02439281|11235035|FG000|STARTED|Overall Study||24
10105106|NCT02439281|11235036|FG001|STARTED|Overall Study||26
10105107|NCT02439281|11235035|FG000|COMPLETED|Overall Study||24
10105108|NCT02439281|11235036|FG001|COMPLETED|Overall Study||26
10105109|NCT02439281|11235035|FG000|NOT COMPLETED|Overall Study||0
10105110|NCT02439281|11235036|FG001|NOT COMPLETED|Overall Study||0
10105111|NCT02439320|11235047|FG000|STARTED|Overall Study||744
10105112|NCT02439320|11235048|FG001|STARTED|Overall Study||745
10105113|NCT02439320|11235049|FG002|STARTED|Overall Study||742
10105114|NCT02439320|11235047|FG000|Confirmed Eligibility|Overall Study||710
10105115|NCT02439320|11235048|FG001|Confirmed Eligibility|Overall Study||695
10105116|NCT02439320|11235049|FG002|Confirmed Eligibility|Overall Study||705
10105117|NCT02439320|11235047|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
10105118|NCT02439320|11235048|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
10105119|NCT02439320|11235049|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
10105120|NCT02439320|11235047|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289
10105121|NCT02439320|11235048|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238
10105122|NCT02439320|11235049|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401
10105123|NCT02439320|11235047|FG000|COMPLETED|Overall Study||648
10105124|NCT02439320|11235048|FG001|COMPLETED|Overall Study||631
10105125|NCT02439320|11235049|FG002|COMPLETED|Overall Study||643
10105126|NCT02439320|11235047|FG000|NOT COMPLETED|Overall Study||96
10105127|NCT02439320|11235048|FG001|NOT COMPLETED|Overall Study||114
10105128|NCT02439320|11235049|FG002|NOT COMPLETED|Overall Study||99
10105129|NCT02439710|11235063|FG000|STARTED|Overall Study||656
10105130|NCT02439710|11235063|FG000|COMPLETED|Overall Study||656
10105131|NCT02439710|11235063|FG000|NOT COMPLETED|Overall Study||0
10105132|NCT02439814|11235069|FG000|STARTED|Overall Study||11
10105133|NCT02439814|11235070|FG001|STARTED|Overall Study||10
10105134|NCT02439814|11235069|FG000|COMPLETED|Overall Study||11
10105135|NCT02439814|11235070|FG001|COMPLETED|Overall Study||10
10105136|NCT02439814|11235069|FG000|NOT COMPLETED|Overall Study||0
10105137|NCT02439814|11235070|FG001|NOT COMPLETED|Overall Study||0
10105138|NCT02439879|11235078|FG000|STARTED|Overall Study||16
10105139|NCT02439879|11235079|FG001|STARTED|Overall Study||17
10105140|NCT02439879|11235078|FG000|COMPLETED|Overall Study||16
10105141|NCT02439879|11235079|FG001|COMPLETED|Overall Study||17
10105142|NCT02439879|11235078|FG000|NOT COMPLETED|Overall Study||0
10105143|NCT02439879|11235079|FG001|NOT COMPLETED|Overall Study||0
10105144|NCT02440022|11235087|FG000|STARTED|Overall Study||141
10105145|NCT02440022|11235088|FG001|STARTED|Overall Study||144
10105146|NCT02440022|11235087|FG000|COMPLETED|Overall Study||114
10105147|NCT02440022|11235088|FG001|COMPLETED|Overall Study||131
10105148|NCT02440022|11235087|FG000|NOT COMPLETED|Overall Study||27
10105149|NCT02440022|11235088|FG001|NOT COMPLETED|Overall Study||13
10105150|NCT02440139|11235094|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12
10105151|NCT02440139|11235094|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12
10105152|NCT02440139|11235094|FG000|NOT COMPLETED|Overall Study||0
10105153|NCT02440178|11235102|FG000|STARTED|Overall Study||66
10105154|NCT02440178|11235102|FG000|COMPLETED|Overall Study||46
10105155|NCT02440178|11235102|FG000|NOT COMPLETED|Overall Study||20
10105156|NCT02440204|11235111|FG000|STARTED|Overall Study||22
10105157|NCT02440204|11235112|FG001|STARTED|Overall Study||24
10105158|NCT02440204|11235113|FG002|STARTED|Overall Study||22
10105159|NCT02440204|11235111|FG000|COMPLETED|Overall Study||22
10105160|NCT02440204|11235112|FG001|COMPLETED|Overall Study||24
10105161|NCT02440204|11235113|FG002|COMPLETED|Overall Study||22
10105162|NCT02440204|11235111|FG000|NOT COMPLETED|Overall Study||0
10105163|NCT02440204|11235112|FG001|NOT COMPLETED|Overall Study||0
10105164|NCT02440204|11235113|FG002|NOT COMPLETED|Overall Study||0
10105165|NCT02440308|11235121|FG000|STARTED|Overall Study||10
10105166|NCT02440308|11235121|FG000|COMPLETED|Overall Study||10
10105167|NCT02440308|11235121|FG000|NOT COMPLETED|Overall Study||0
10105168|NCT02440334|11235125|FG000|STARTED|Overall Study||53
10105169|NCT02440334|11235125|FG000|COMPLETED|Overall Study||53
10105170|NCT02440334|11235125|FG000|NOT COMPLETED|Overall Study||0
10105171|NCT02440451|11235129|FG000|STARTED|Overall Study||15
10105172|NCT02440451|11235129|FG000|COMPLETED|Overall Study||15
10105173|NCT02440451|11235129|FG000|NOT COMPLETED|Overall Study||0
10105174|NCT02440568|11235137|FG000|STARTED|Overall Study||5
10105175|NCT02440568|11235138|FG001|STARTED|Overall Study||4
10105176|NCT02440568|11235139|FG002|STARTED|Overall Study||10
10105177|NCT02440568|11235140|FG003|STARTED|Overall Study||3
10105178|NCT02440568|11235137|FG000|COMPLETED|Overall Study||1
10105179|NCT02440568|11235138|FG001|COMPLETED|Overall Study||1
10105180|NCT02440568|11235139|FG002|COMPLETED|Overall Study||5
10105181|NCT02440568|11235140|FG003|COMPLETED|Overall Study||1
10105182|NCT02440568|11235137|FG000|NOT COMPLETED|Overall Study||4
10105183|NCT02440568|11235138|FG001|NOT COMPLETED|Overall Study||3
10105184|NCT02440568|11235139|FG002|NOT COMPLETED|Overall Study||5
10105185|NCT02440568|11235140|FG003|NOT COMPLETED|Overall Study||2
10105186|NCT02440594|11235159|FG000|STARTED|Overall Study||509
10105187|NCT02440594|11235160|FG001|STARTED|Overall Study||509
10105188|NCT02440594|11235161|FG002|STARTED|Overall Study||436
10105189|NCT02440594|11235162|FG003|STARTED|Overall Study||429
10105190|NCT02440594|11235163|FG004|STARTED|Overall Study||55
10105191|NCT02440594|11235164|FG005|STARTED|Overall Study||54
10105192|NCT02440594|11235165|FG006|STARTED|Overall Study||150
10105193|NCT02440594|11235166|FG007|STARTED|Overall Study||290
10105194|NCT02440594|11235159|FG000|COMPLETED|Overall Study||377
10105195|NCT02440594|11235160|FG001|COMPLETED|Overall Study||401
10105196|NCT02440594|11235161|FG002|COMPLETED|Overall Study||319
10105197|NCT02440594|11235162|FG003|COMPLETED|Overall Study||340
10105198|NCT02440594|11235163|FG004|COMPLETED|Overall Study||46
10105199|NCT02440594|11235164|FG005|COMPLETED|Overall Study||47
10105200|NCT02440594|11235165|FG006|COMPLETED|Overall Study||113
10105201|NCT02440594|11235166|FG007|COMPLETED|Overall Study||234
10105202|NCT02440594|11235159|FG000|NOT COMPLETED|Overall Study||132
10105203|NCT02440594|11235160|FG001|NOT COMPLETED|Overall Study||108
10105204|NCT02440594|11235161|FG002|NOT COMPLETED|Overall Study||117
10105205|NCT02440594|11235162|FG003|NOT COMPLETED|Overall Study||89
10105206|NCT02440594|11235163|FG004|NOT COMPLETED|Overall Study||9
10105207|NCT02440594|11235164|FG005|NOT COMPLETED|Overall Study||7
10105208|NCT02440594|11235165|FG006|NOT COMPLETED|Overall Study||37
10105209|NCT02440594|11235166|FG007|NOT COMPLETED|Overall Study||56
10105210|NCT02440633|11235191|FG000|STARTED|Overall Study||8
10105211|NCT02440633|11235191|FG000|COMPLETED|Overall Study||8
10105212|NCT02440633|11235191|FG000|NOT COMPLETED|Overall Study||0
10105213|NCT02440659|11235201|FG000|STARTED|Overall Study||1997
10105214|NCT02440659|11235202|FG001|STARTED|Overall Study||949
10105215|NCT02440659|11235201|FG000|COMPLETED|Overall Study||1346
10105216|NCT02440659|11235202|FG001|COMPLETED|Overall Study||614
10105217|NCT02440659|11235201|FG000|NOT COMPLETED|Overall Study||651
10105218|NCT02440659|11235202|FG001|NOT COMPLETED|Overall Study||335
10105219|NCT02440789|11235208|FG000|STARTED|Overall Study||32
10105220|NCT02440789|11235208|FG000|Initiated Sirolimus|Overall Study||30
10105221|NCT02440789|11235208|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16
10105222|NCT02440789|11235208|FG000|COMPLETED|Overall Study||28
10105223|NCT02440789|11235208|FG000|NOT COMPLETED|Overall Study||4
10105224|NCT02441062|11235212|FG000|STARTED|Overall Study||122
10105225|NCT02441062|11235212|FG000|COMPLETED|Overall Study||122
10105226|NCT02441062|11235212|FG000|NOT COMPLETED|Overall Study||0
10105227|NCT02441114|11235216|FG000|STARTED|Period1||10
10105228|NCT02441114|11235216|FG000|COMPLETED|Period1||10
10105229|NCT02441114|11235216|FG000|NOT COMPLETED|Period1||0
10105230|NCT02441114|11235216|FG000|STARTED|Washout1||10
10105231|NCT02441114|11235216|FG000|COMPLETED|Washout1||10
10105232|NCT02441114|11235216|FG000|NOT COMPLETED|Washout1||0
10105233|NCT02441114|11235216|FG000|STARTED|Period2||10
10105234|NCT02441114|11235216|FG000|COMPLETED|Period2||10
10105235|NCT02441114|11235216|FG000|NOT COMPLETED|Period2||0
10105236|NCT02441114|11235216|FG000|STARTED|Washout2||10
10105237|NCT02441114|11235216|FG000|COMPLETED|Washout2||6
10105238|NCT02441114|11235216|FG000|NOT COMPLETED|Washout2||4
10105239|NCT02441114|11235216|FG000|STARTED|Period3||6
10105240|NCT02441114|11235216|FG000|COMPLETED|Period3||6
10105241|NCT02441114|11235216|FG000|NOT COMPLETED|Period3||0
10105242|NCT02441179|11235222|FG000|STARTED|Overall Study||18
10105243|NCT02441179|11235223|FG001|STARTED|Overall Study||17
10105244|NCT02441179|11235222|FG000|COMPLETED|Overall Study||17
10105245|NCT02441179|11235223|FG001|COMPLETED|Overall Study||16
10105246|NCT02441179|11235222|FG000|NOT COMPLETED|Overall Study||1
10105247|NCT02441179|11235223|FG001|NOT COMPLETED|Overall Study||1
10105248|NCT02441218|11235232|FG000|STARTED|Overall Study||3241
10105249|NCT02441218|11235233|FG001|STARTED|Overall Study||3264
10105250|NCT02441218|11235232|FG000|COMPLETED|Overall Study||2663
10105251|NCT02441218|11235233|FG001|COMPLETED|Overall Study||2652
10105252|NCT02441218|11235232|FG000|NOT COMPLETED|Overall Study||578
10105253|NCT02441218|11235233|FG001|NOT COMPLETED|Overall Study||612
10105254|NCT02441283|11235239|FG000|STARTED|Overall Study||377
10105255|NCT02441283|11235239|FG000|COMPLETED|Overall Study||287
10105256|NCT02441283|11235239|FG000|NOT COMPLETED|Overall Study||90
10113308|NCT02509117|11244194|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113309|NCT02509117|11244195|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113310|NCT02509117|11244196|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113311|NCT02509117|11244197|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113312|NCT02509117|11244198|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113313|NCT02509117|11244199|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113314|NCT02509117|11244190|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113315|NCT02509117|11244191|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113316|NCT02509117|11244192|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113317|NCT02509117|11244193|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113318|NCT02509117|11244194|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113319|NCT02509117|11244195|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113320|NCT02509117|11244196|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113321|NCT02509117|11244197|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113322|NCT02509117|11244198|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113323|NCT02509117|11244199|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10113324|NCT02509117|11244190|FG000|STARTED|Period 2 -Part A: 4 Days||2
10006819|NCT01747928|11129085|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10006820|NCT01747928|11129078|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10006821|NCT01747928|11129079|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10006822|NCT01747928|11129080|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10006823|NCT01747928|11129081|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10006824|NCT01747928|11129082|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10006825|NCT01747928|11129083|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10018968|NCT01826825|11142019|FG001|STARTED|Overall Study||100
10113325|NCT02509117|11244191|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
10113326|NCT02509117|11244192|FG002|STARTED|Period 2 -Part A: 4 Days||2
10113327|NCT02509117|11244193|FG003|STARTED|Period 2 -Part A: 4 Days||2
10113328|NCT02509117|11244194|FG004|STARTED|Period 2 -Part A: 4 Days||0
10113329|NCT02509117|11244195|FG005|STARTED|Period 2 -Part A: 4 Days||0
10113330|NCT02509117|11244196|FG006|STARTED|Period 2 -Part A: 4 Days||0
10113331|NCT02509117|11244197|FG007|STARTED|Period 2 -Part A: 4 Days||0
10113332|NCT02509117|11244198|FG008|STARTED|Period 2 -Part A: 4 Days||0
10113333|NCT02509117|11244199|FG009|STARTED|Period 2 -Part A: 4 Days||0
10113334|NCT02509117|11244190|FG000|Treated|Period 2 -Part A: 4 Days||2
10113335|NCT02509117|11244191|FG001|Treated|Period 2 -Part A: 4 Days||2
10113336|NCT02509117|11244192|FG002|Treated|Period 2 -Part A: 4 Days||2
10113337|NCT02509117|11244193|FG003|Treated|Period 2 -Part A: 4 Days||2
10105257|NCT02441309|11235246|FG000|STARTED|Overall Study||3
10105258|NCT02441309|11235247|FG001|STARTED|Overall Study||2
10105259|NCT02441309|11235248|FG002|STARTED|Overall Study||3
10105260|NCT02441309|11235246|FG000|Received Allocated Intervention|Overall Study||1
10105261|NCT02441309|11235247|FG001|Received Allocated Intervention|Overall Study||2
10105262|NCT02441309|11235248|FG002|Received Allocated Intervention|Overall Study||3
10105263|NCT02441309|11235246|FG000|COMPLETED|Overall Study||0
10105264|NCT02441309|11235247|FG001|COMPLETED|Overall Study||0
10105265|NCT02441309|11235248|FG002|COMPLETED|Overall Study||0
10105266|NCT02441309|11235246|FG000|NOT COMPLETED|Overall Study||3
10105267|NCT02441309|11235247|FG001|NOT COMPLETED|Overall Study||2
10105268|NCT02441309|11235248|FG002|NOT COMPLETED|Overall Study||3
10105269|NCT02441517|11235259|FG000|STARTED|Overall Study||4
10105270|NCT02441517|11235259|FG000|Received Treatment|Overall Study||4
10105271|NCT02441517|11235259|FG000|COMPLETED|Overall Study||0
10105272|NCT02441517|11235259|FG000|NOT COMPLETED|Overall Study||4
10105273|NCT02441946|11235266|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74
10105274|NCT02441946|11235267|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76
10105275|NCT02441946|11235268|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74
10105276|NCT02441946|11235266|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
10105277|NCT02441946|11235267|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
10105278|NCT02441946|11235268|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
10105279|NCT02441946|11235266|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
10105280|NCT02441946|11235267|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
10105281|NCT02441946|11235268|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
10105282|NCT02441946|11235266|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
10105283|NCT02441946|11235267|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
10105284|NCT02441946|11235268|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
10105285|NCT02441946|11235266|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
10105286|NCT02441946|11235267|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
10105287|NCT02441946|11235268|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
10105288|NCT02441946|11235266|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
10105289|NCT02441946|11235267|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
10105290|NCT02441946|11235268|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
10105291|NCT02441946|11235266|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
10105292|NCT02441946|11235267|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
10105293|NCT02441946|11235268|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
10105294|NCT02441946|11235266|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
10105295|NCT02441946|11235267|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10105296|NCT02441946|11235268|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10105297|NCT02441946|11235266|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
10105298|NCT02441946|11235267|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10105299|NCT02441946|11235268|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10105300|NCT02441946|11235266|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
10105301|NCT02441946|11235267|FG001|STARTED|Extension Period (8 Weeks)||0
10105302|NCT02441946|11235268|FG002|STARTED|Extension Period (8 Weeks)||0
10105303|NCT02441946|11235266|FG000|COMPLETED|Extension Period (8 Weeks)||40
10105304|NCT02441946|11235267|FG001|COMPLETED|Extension Period (8 Weeks)||0
10105305|NCT02441946|11235268|FG002|COMPLETED|Extension Period (8 Weeks)||0
10105306|NCT02441946|11235266|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2
10105307|NCT02441946|11235267|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0
10105308|NCT02441946|11235268|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0
10105309|NCT02442206|11235281|FG000|STARTED|Period 1||30
10105310|NCT02442206|11235282|FG001|STARTED|Period 1||32
10105311|NCT02442206|11235281|FG000|COMPLETED|Period 1||29
10105312|NCT02442206|11235282|FG001|COMPLETED|Period 1||29
10105313|NCT02442206|11235281|FG000|NOT COMPLETED|Period 1||1
10105314|NCT02442206|11235282|FG001|NOT COMPLETED|Period 1||3
10105315|NCT02442206|11235281|FG000|STARTED|Period 2||29
10105316|NCT02442206|11235282|FG001|STARTED|Period 2||29
10105317|NCT02442206|11235281|FG000|COMPLETED|Period 2||28
10105318|NCT02442206|11235282|FG001|COMPLETED|Period 2||29
10105319|NCT02442206|11235281|FG000|NOT COMPLETED|Period 2||1
10105320|NCT02442206|11235282|FG001|NOT COMPLETED|Period 2||0
10105321|NCT02442271|11235289|FG000|STARTED|Overall Study||222
10105322|NCT02442271|11235289|FG000|COMPLETED|Overall Study||218
10105323|NCT02442271|11235289|FG000|NOT COMPLETED|Overall Study||4
10105324|NCT02442284|11235307|FG000|STARTED|Overall Study||99
10105325|NCT02442284|11235307|FG000|COMPLETED|Overall Study||92
10105326|NCT02442284|11235307|FG000|NOT COMPLETED|Overall Study||7
10105327|NCT02442310|11235311|FG000|STARTED|Overall Study||20
10105328|NCT02442310|11235311|FG000|COMPLETED|Overall Study||17
10105329|NCT02442310|11235311|FG000|NOT COMPLETED|Overall Study||3
10105330|NCT02442336|11235321|FG000|STARTED|Overall Study||80
10105331|NCT02442336|11235321|FG000|Developmental Phase|Overall Study||6
10105332|NCT02442336|11235321|FG000|Evaluation Phase|Overall Study||74
10105333|NCT02442336|11235321|FG000|Provided Access to Intervention|Overall Study||55
10105334|NCT02442336|11235321|FG000|COMPLETED|Overall Study||44
10105335|NCT02442336|11235321|FG000|NOT COMPLETED|Overall Study||36
10105336|NCT02442622|11235327|FG000|STARTED|Overall Study||15
10105337|NCT02442622|11235328|FG001|STARTED|Overall Study||17
10105338|NCT02442622|11235327|FG000|COMPLETED|Overall Study||12
10105339|NCT02442622|11235328|FG001|COMPLETED|Overall Study||16
10105340|NCT02442622|11235327|FG000|NOT COMPLETED|Overall Study||3
10105341|NCT02442622|11235328|FG001|NOT COMPLETED|Overall Study||1
10105342|NCT02442687|11235337|FG000|STARTED|Overall Study||21
10105343|NCT02442687|11235338|FG001|STARTED|Overall Study||22
10105344|NCT02442687|11235339|FG002|STARTED|Overall Study||22
10105345|NCT02442687|11235337|FG000|COMPLETED|Overall Study||13
10105346|NCT02442687|11235338|FG001|COMPLETED|Overall Study||11
10105347|NCT02442687|11235339|FG002|COMPLETED|Overall Study||19
10105348|NCT02442687|11235337|FG000|NOT COMPLETED|Overall Study||8
10105349|NCT02442687|11235338|FG001|NOT COMPLETED|Overall Study||11
10105350|NCT02442687|11235339|FG002|NOT COMPLETED|Overall Study||3
10105351|NCT02442700|11235350|FG000|STARTED|First 12 Weeks||12
10105352|NCT02442700|11235351|FG001|STARTED|First 12 Weeks||12
10105353|NCT02442700|11235350|FG000|COMPLETED|First 12 Weeks||12
10105354|NCT02442700|11235351|FG001|COMPLETED|First 12 Weeks||12
10105355|NCT02442700|11235350|FG000|NOT COMPLETED|First 12 Weeks||0
10105356|NCT02442700|11235351|FG001|NOT COMPLETED|First 12 Weeks||0
10105357|NCT02442700|11235350|FG000|STARTED|Later 12 Weeks||12
10105358|NCT02442700|11235351|FG001|STARTED|Later 12 Weeks||12
10105359|NCT02442700|11235350|FG000|COMPLETED|Later 12 Weeks||12
10105360|NCT02442700|11235351|FG001|COMPLETED|Later 12 Weeks||12
10105361|NCT02442700|11235350|FG000|NOT COMPLETED|Later 12 Weeks||0
10105362|NCT02442700|11235351|FG001|NOT COMPLETED|Later 12 Weeks||0
10105363|NCT02442804|11235359|FG000|STARTED|Overall Study||8
10105364|NCT02442804|11235360|FG001|STARTED|Overall Study||8
10105365|NCT02442804|11235359|FG000|COMPLETED|Overall Study||7
10105366|NCT02442804|11235360|FG001|COMPLETED|Overall Study||7
10105367|NCT02442804|11235359|FG000|NOT COMPLETED|Overall Study||1
10105368|NCT02442804|11235360|FG001|NOT COMPLETED|Overall Study||1
10105369|NCT02442830|11235368|FG000|STARTED|Overall Study||42
10105370|NCT02442830|11235369|FG001|STARTED|Overall Study||45
10105371|NCT02442830|11235368|FG000|COMPLETED|Overall Study||42
10105372|NCT02442830|11235369|FG001|COMPLETED|Overall Study||44
10105373|NCT02442830|11235368|FG000|NOT COMPLETED|Overall Study||0
10105374|NCT02442830|11235369|FG001|NOT COMPLETED|Overall Study||1
10105375|NCT02442856|11235376|FG000|STARTED|Overall Study||21
10105376|NCT02442856|11235376|FG000|COMPLETED|Overall Study||21
10105377|NCT02442856|11235376|FG000|NOT COMPLETED|Overall Study||0
10105378|NCT02442869|11235386|FG000|STARTED|Overall Study||18
10105379|NCT02442869|11235387|FG001|STARTED|Overall Study||29
10105380|NCT02442869|11235388|FG002|STARTED|Overall Study||6
10105381|NCT02442869|11235389|FG003|STARTED|Overall Study||2
10105382|NCT02442869|11235390|FG004|STARTED|Overall Study||5
10105383|NCT02442869|11235391|FG005|STARTED|Overall Study||2
10105384|NCT02442869|11235386|FG000|COMPLETED|Overall Study||13
10105385|NCT02442869|11235387|FG001|COMPLETED|Overall Study||20
10105386|NCT02442869|11235388|FG002|COMPLETED|Overall Study||6
10105387|NCT02442869|11235389|FG003|COMPLETED|Overall Study||1
10105388|NCT02442869|11235390|FG004|COMPLETED|Overall Study||3
10105389|NCT02442869|11235391|FG005|COMPLETED|Overall Study||2
10105390|NCT02442869|11235386|FG000|NOT COMPLETED|Overall Study||5
10105391|NCT02442869|11235387|FG001|NOT COMPLETED|Overall Study||9
10105392|NCT02442869|11235388|FG002|NOT COMPLETED|Overall Study||0
10105393|NCT02442869|11235389|FG003|NOT COMPLETED|Overall Study||1
10105394|NCT02442869|11235390|FG004|NOT COMPLETED|Overall Study||2
10105395|NCT02442869|11235391|FG005|NOT COMPLETED|Overall Study||0
10105396|NCT02443103|11235415|FG000|STARTED|Overall Study||4
10105397|NCT02443103|11235415|FG000|COMPLETED|Overall Study||1
10105398|NCT02443103|11235415|FG000|NOT COMPLETED|Overall Study||3
10105399|NCT02443155|11235423|FG000|STARTED|Overall Study||77
10105400|NCT02443155|11235424|FG001|STARTED|Overall Study||77
10105401|NCT02443155|11235425|FG002|STARTED|Overall Study||76
10105402|NCT02443155|11235426|FG003|STARTED|Overall Study||77
10105403|NCT02443155|11235423|FG000|Full Analysis Set|Overall Study||77
10105404|NCT02443155|11235424|FG001|Full Analysis Set|Overall Study||77
10105405|NCT02443155|11235425|FG002|Full Analysis Set|Overall Study||76
10105406|NCT02443155|11235426|FG003|Full Analysis Set|Overall Study||77
10105407|NCT02443155|11235423|FG000|PK Analysis Set|Overall Study||21
10105408|NCT02443155|11235424|FG001|PK Analysis Set|Overall Study||21
10105409|NCT02443155|11235425|FG002|PK Analysis Set|Overall Study||22
10105410|NCT02443155|11235426|FG003|PK Analysis Set|Overall Study||20
10105411|NCT02443155|11235423|FG000|Safety Analysis Set|Overall Study||77
10105412|NCT02443155|11235424|FG001|Safety Analysis Set|Overall Study||77
10105413|NCT02443155|11235425|FG002|Safety Analysis Set|Overall Study||76
10105414|NCT02443155|11235426|FG003|Safety Analysis Set|Overall Study||77
10105415|NCT02443155|11235423|FG000|COMPLETED|Overall Study||65
10105416|NCT02443155|11235424|FG001|COMPLETED|Overall Study||63
10105417|NCT02443155|11235425|FG002|COMPLETED|Overall Study||67
10105418|NCT02443155|11235426|FG003|COMPLETED|Overall Study||61
10105419|NCT02443155|11235423|FG000|NOT COMPLETED|Overall Study||12
10105420|NCT02443155|11235424|FG001|NOT COMPLETED|Overall Study||14
10105421|NCT02443155|11235425|FG002|NOT COMPLETED|Overall Study||9
10105422|NCT02443155|11235426|FG003|NOT COMPLETED|Overall Study||16
10105423|NCT02443298|11235439|FG000|STARTED|Overall Study||105
10105424|NCT02443298|11235440|FG001|STARTED|Overall Study||109
10105425|NCT02443298|11235439|FG000|COMPLETED|Overall Study||101
10105426|NCT02443298|11235440|FG001|COMPLETED|Overall Study||104
10105427|NCT02443298|11235439|FG000|NOT COMPLETED|Overall Study||4
10105428|NCT02443298|11235440|FG001|NOT COMPLETED|Overall Study||5
10105429|NCT02443337|11235448|FG000|STARTED|Overall Study||15
10105430|NCT02443337|11235449|FG001|STARTED|Overall Study||16
10105431|NCT02443337|11235448|FG000|Received at Least One Dose of Study Drug|Overall Study||15
10105432|NCT02443337|11235449|FG001|Received at Least One Dose of Study Drug|Overall Study||16
10105433|NCT02443337|11235448|FG000|COMPLETED|Overall Study||10
10105434|NCT02443337|11235449|FG001|COMPLETED|Overall Study||14
10105435|NCT02443337|11235448|FG000|NOT COMPLETED|Overall Study||5
10105436|NCT02443337|11235449|FG001|NOT COMPLETED|Overall Study||2
10105437|NCT02443402|11235462|FG000|STARTED|Overall Study||36
10105438|NCT02443402|11235463|FG001|STARTED|Overall Study||31
10105439|NCT02443402|11235462|FG000|COMPLETED|Overall Study||32
10105440|NCT02443402|11235463|FG001|COMPLETED|Overall Study||28
10105441|NCT02443402|11235462|FG000|NOT COMPLETED|Overall Study||4
10105442|NCT02443402|11235463|FG001|NOT COMPLETED|Overall Study||3
10105443|NCT02443519|11235471|FG000|STARTED|Overall Study||31
10105444|NCT02443519|11235472|FG001|STARTED|Overall Study||29
10105445|NCT02443519|11235471|FG000|COMPLETED|Overall Study||29
10105446|NCT02443519|11235472|FG001|COMPLETED|Overall Study||26
10105447|NCT02443519|11235471|FG000|NOT COMPLETED|Overall Study||2
10105448|NCT02443519|11235472|FG001|NOT COMPLETED|Overall Study||3
10105449|NCT02443571|11235481|FG000|STARTED|Overall Study||596
10105450|NCT02443571|11235482|FG001|STARTED|Overall Study||95
10105451|NCT02443571|11235483|FG002|STARTED|Overall Study||23
10105452|NCT02443571|11235481|FG000|COMPLETED|Overall Study||596
10105453|NCT02443571|11235482|FG001|COMPLETED|Overall Study||95
10105454|NCT02443571|11235483|FG002|COMPLETED|Overall Study||23
10105455|NCT02443571|11235481|FG000|NOT COMPLETED|Overall Study||0
10105456|NCT02443571|11235482|FG001|NOT COMPLETED|Overall Study||0
10105457|NCT02443571|11235483|FG002|NOT COMPLETED|Overall Study||0
10105458|NCT02443688|11235494|FG000|STARTED|Overall Study||66
10105459|NCT02443688|11235495|FG001|STARTED|Overall Study||67
10105460|NCT02443688|11235496|FG002|STARTED|Overall Study||67
10105461|NCT02443688|11235494|FG000|COMPLETED|Overall Study||54
10105462|NCT02443688|11235495|FG001|COMPLETED|Overall Study||58
10105463|NCT02443688|11235496|FG002|COMPLETED|Overall Study||55
10105464|NCT02443688|11235494|FG000|NOT COMPLETED|Overall Study||12
10105465|NCT02443688|11235495|FG001|NOT COMPLETED|Overall Study||9
10105466|NCT02443688|11235496|FG002|NOT COMPLETED|Overall Study||12
10105467|NCT02443740|11235512|FG000|STARTED|Intervention Period 1 (3 Days)||2
10105468|NCT02443740|11235513|FG001|STARTED|Intervention Period 1 (3 Days)||2
10105469|NCT02443740|11235514|FG002|STARTED|Intervention Period 1 (3 Days)||2
10105470|NCT02443740|11235515|FG003|STARTED|Intervention Period 1 (3 Days)||3
10105471|NCT02443740|11235516|FG004|STARTED|Intervention Period 1 (3 Days)||2
10105472|NCT02443740|11235517|FG005|STARTED|Intervention Period 1 (3 Days)||4
10105473|NCT02443740|11235518|FG006|STARTED|Intervention Period 1 (3 Days)||3
10105474|NCT02443740|11235519|FG007|STARTED|Intervention Period 1 (3 Days)||2
10105475|NCT02443740|11235520|FG008|STARTED|Intervention Period 1 (3 Days)||6
10105476|NCT02443740|11235521|FG009|STARTED|Intervention Period 1 (3 Days)||3
10105477|NCT02443740|11235522|FG010|STARTED|Intervention Period 1 (3 Days)||3
10105478|NCT02443740|11235512|FG000|COMPLETED|Intervention Period 1 (3 Days)||1
10105479|NCT02443740|11235513|FG001|COMPLETED|Intervention Period 1 (3 Days)||2
10105480|NCT02443740|11235514|FG002|COMPLETED|Intervention Period 1 (3 Days)||2
10105481|NCT02443740|11235515|FG003|COMPLETED|Intervention Period 1 (3 Days)||3
10105482|NCT02443740|11235516|FG004|COMPLETED|Intervention Period 1 (3 Days)||2
10105483|NCT02443740|11235517|FG005|COMPLETED|Intervention Period 1 (3 Days)||2
10105484|NCT02443740|11235518|FG006|COMPLETED|Intervention Period 1 (3 Days)||2
10105485|NCT02443740|11235519|FG007|COMPLETED|Intervention Period 1 (3 Days)||2
10105486|NCT02443740|11235520|FG008|COMPLETED|Intervention Period 1 (3 Days)||6
10105487|NCT02443740|11235521|FG009|COMPLETED|Intervention Period 1 (3 Days)||3
10105488|NCT02443740|11235522|FG010|COMPLETED|Intervention Period 1 (3 Days)||3
10105489|NCT02443740|11235512|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1
10105490|NCT02443740|11235513|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105491|NCT02443740|11235514|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105492|NCT02443740|11235515|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105493|NCT02443740|11235516|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105494|NCT02443740|11235517|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2
10105495|NCT02443740|11235518|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1
10105496|NCT02443740|11235519|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105497|NCT02443740|11235520|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105498|NCT02443740|11235521|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105499|NCT02443740|11235522|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10105500|NCT02443740|11235512|FG000|STARTED|Washout Period 1 (7 Days)||1
10105501|NCT02443740|11235513|FG001|STARTED|Washout Period 1 (7 Days)||2
10105502|NCT02443740|11235514|FG002|STARTED|Washout Period 1 (7 Days)||2
10105503|NCT02443740|11235515|FG003|STARTED|Washout Period 1 (7 Days)||3
10105504|NCT02443740|11235516|FG004|STARTED|Washout Period 1 (7 Days)||2
10105505|NCT02443740|11235517|FG005|STARTED|Washout Period 1 (7 Days)||2
10105506|NCT02443740|11235518|FG006|STARTED|Washout Period 1 (7 Days)||2
10105507|NCT02443740|11235519|FG007|STARTED|Washout Period 1 (7 Days)||2
10105508|NCT02443740|11235520|FG008|STARTED|Washout Period 1 (7 Days)||0
10105509|NCT02443740|11235521|FG009|STARTED|Washout Period 1 (7 Days)||3
10105510|NCT02443740|11235522|FG010|STARTED|Washout Period 1 (7 Days)||3
10105511|NCT02443740|11235512|FG000|COMPLETED|Washout Period 1 (7 Days)||1
10105512|NCT02443740|11235513|FG001|COMPLETED|Washout Period 1 (7 Days)||2
10105513|NCT02443740|11235514|FG002|COMPLETED|Washout Period 1 (7 Days)||2
10105514|NCT02443740|11235515|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10105515|NCT02443740|11235516|FG004|COMPLETED|Washout Period 1 (7 Days)||2
10105516|NCT02443740|11235517|FG005|COMPLETED|Washout Period 1 (7 Days)||2
10105517|NCT02443740|11235518|FG006|COMPLETED|Washout Period 1 (7 Days)||2
10105518|NCT02443740|11235519|FG007|COMPLETED|Washout Period 1 (7 Days)||2
10105519|NCT02443740|11235520|FG008|COMPLETED|Washout Period 1 (7 Days)||0
10105520|NCT02443740|11235521|FG009|COMPLETED|Washout Period 1 (7 Days)||3
10105521|NCT02443740|11235522|FG010|COMPLETED|Washout Period 1 (7 Days)||3
10105522|NCT02443740|11235512|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105523|NCT02443740|11235513|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105524|NCT02443740|11235514|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105525|NCT02443740|11235515|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105526|NCT02443740|11235516|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105527|NCT02443740|11235517|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105528|NCT02443740|11235518|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105529|NCT02443740|11235519|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105530|NCT02443740|11235520|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105531|NCT02443740|11235521|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105532|NCT02443740|11235522|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
10105533|NCT02443740|11235512|FG000|STARTED|Intervention Period 2 (3 Days)||1
10105534|NCT02443740|11235513|FG001|STARTED|Intervention Period 2 (3 Days)||2
10105535|NCT02443740|11235514|FG002|STARTED|Intervention Period 2 (3 Days)||2
10105536|NCT02443740|11235515|FG003|STARTED|Intervention Period 2 (3 Days)||3
10105537|NCT02443740|11235516|FG004|STARTED|Intervention Period 2 (3 Days)||2
10105538|NCT02443740|11235517|FG005|STARTED|Intervention Period 2 (3 Days)||2
10105539|NCT02443740|11235518|FG006|STARTED|Intervention Period 2 (3 Days)||2
10105540|NCT02443740|11235519|FG007|STARTED|Intervention Period 2 (3 Days)||2
10105541|NCT02443740|11235520|FG008|STARTED|Intervention Period 2 (3 Days)||0
10105542|NCT02443740|11235521|FG009|STARTED|Intervention Period 2 (3 Days)||3
10105543|NCT02443740|11235522|FG010|STARTED|Intervention Period 2 (3 Days)||3
10105544|NCT02443740|11235512|FG000|COMPLETED|Intervention Period 2 (3 Days)||1
10105545|NCT02443740|11235513|FG001|COMPLETED|Intervention Period 2 (3 Days)||2
10105546|NCT02443740|11235514|FG002|COMPLETED|Intervention Period 2 (3 Days)||2
10105547|NCT02443740|11235515|FG003|COMPLETED|Intervention Period 2 (3 Days)||3
10105548|NCT02443740|11235516|FG004|COMPLETED|Intervention Period 2 (3 Days)||2
10105549|NCT02443740|11235517|FG005|COMPLETED|Intervention Period 2 (3 Days)||2
10105550|NCT02443740|11235518|FG006|COMPLETED|Intervention Period 2 (3 Days)||2
10105551|NCT02443740|11235519|FG007|COMPLETED|Intervention Period 2 (3 Days)||2
10105552|NCT02443740|11235520|FG008|COMPLETED|Intervention Period 2 (3 Days)||0
10105553|NCT02443740|11235521|FG009|COMPLETED|Intervention Period 2 (3 Days)||3
10105554|NCT02443740|11235522|FG010|COMPLETED|Intervention Period 2 (3 Days)||3
10105555|NCT02443740|11235512|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105556|NCT02443740|11235513|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105557|NCT02443740|11235514|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105558|NCT02443740|11235515|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105559|NCT02443740|11235516|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105560|NCT02443740|11235517|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105561|NCT02443740|11235518|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105562|NCT02443740|11235519|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105563|NCT02443740|11235520|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105564|NCT02443740|11235521|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105565|NCT02443740|11235522|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10105566|NCT02443740|11235512|FG000|STARTED|Washout Period 2 (7 Days)||1
10105567|NCT02443740|11235513|FG001|STARTED|Washout Period 2 (7 Days)||2
10105568|NCT02443740|11235514|FG002|STARTED|Washout Period 2 (7 Days)||2
10105569|NCT02443740|11235515|FG003|STARTED|Washout Period 2 (7 Days)||3
10105570|NCT02443740|11235516|FG004|STARTED|Washout Period 2 (7 Days)||2
10105571|NCT02443740|11235517|FG005|STARTED|Washout Period 2 (7 Days)||2
10105572|NCT02443740|11235518|FG006|STARTED|Washout Period 2 (7 Days)||2
10105573|NCT02443740|11235519|FG007|STARTED|Washout Period 2 (7 Days)||2
10105574|NCT02443740|11235520|FG008|STARTED|Washout Period 2 (7 Days)||0
10105575|NCT02443740|11235521|FG009|STARTED|Washout Period 2 (7 Days)||0
10105576|NCT02443740|11235522|FG010|STARTED|Washout Period 2 (7 Days)||0
10105577|NCT02443740|11235512|FG000|COMPLETED|Washout Period 2 (7 Days)||1
10105578|NCT02443740|11235513|FG001|COMPLETED|Washout Period 2 (7 Days)||2
10105579|NCT02443740|11235514|FG002|COMPLETED|Washout Period 2 (7 Days)||2
10105580|NCT02443740|11235515|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10105581|NCT02443740|11235516|FG004|COMPLETED|Washout Period 2 (7 Days)||2
10105582|NCT02443740|11235517|FG005|COMPLETED|Washout Period 2 (7 Days)||2
10105583|NCT02443740|11235518|FG006|COMPLETED|Washout Period 2 (7 Days)||2
10105584|NCT02443740|11235519|FG007|COMPLETED|Washout Period 2 (7 Days)||2
10105585|NCT02443740|11235520|FG008|COMPLETED|Washout Period 2 (7 Days)||0
10105586|NCT02443740|11235521|FG009|COMPLETED|Washout Period 2 (7 Days)||0
10105587|NCT02443740|11235522|FG010|COMPLETED|Washout Period 2 (7 Days)||0
10105588|NCT02443740|11235512|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105589|NCT02443740|11235513|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105590|NCT02443740|11235514|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105591|NCT02443740|11235515|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105592|NCT02443740|11235516|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105593|NCT02443740|11235517|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105594|NCT02443740|11235518|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105595|NCT02443740|11235519|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105596|NCT02443740|11235520|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105597|NCT02443740|11235521|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105598|NCT02443740|11235522|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
10105599|NCT02443740|11235512|FG000|STARTED|Intervention Period 3 (3 Days)||1
10105600|NCT02443740|11235513|FG001|STARTED|Intervention Period 3 (3 Days)||2
10105601|NCT02443740|11235514|FG002|STARTED|Intervention Period 3 (3 Days)||2
10105602|NCT02443740|11235515|FG003|STARTED|Intervention Period 3 (3 Days)||3
10105603|NCT02443740|11235516|FG004|STARTED|Intervention Period 3 (3 Days)||2
10105604|NCT02443740|11235517|FG005|STARTED|Intervention Period 3 (3 Days)||2
10105605|NCT02443740|11235518|FG006|STARTED|Intervention Period 3 (3 Days)||2
10105606|NCT02443740|11235519|FG007|STARTED|Intervention Period 3 (3 Days)||2
10105607|NCT02443740|11235520|FG008|STARTED|Intervention Period 3 (3 Days)||0
10105608|NCT02443740|11235521|FG009|STARTED|Intervention Period 3 (3 Days)||0
10105609|NCT02443740|11235522|FG010|STARTED|Intervention Period 3 (3 Days)||0
10105610|NCT02443740|11235512|FG000|COMPLETED|Intervention Period 3 (3 Days)||1
10105611|NCT02443740|11235513|FG001|COMPLETED|Intervention Period 3 (3 Days)||2
10105612|NCT02443740|11235514|FG002|COMPLETED|Intervention Period 3 (3 Days)||2
10105613|NCT02443740|11235515|FG003|COMPLETED|Intervention Period 3 (3 Days)||3
10105614|NCT02443740|11235516|FG004|COMPLETED|Intervention Period 3 (3 Days)||2
10105615|NCT02443740|11235517|FG005|COMPLETED|Intervention Period 3 (3 Days)||2
10105616|NCT02443740|11235518|FG006|COMPLETED|Intervention Period 3 (3 Days)||2
10105617|NCT02443740|11235519|FG007|COMPLETED|Intervention Period 3 (3 Days)||2
10105618|NCT02443740|11235520|FG008|COMPLETED|Intervention Period 3 (3 Days)||0
10105619|NCT02443740|11235521|FG009|COMPLETED|Intervention Period 3 (3 Days)||0
10105620|NCT02443740|11235522|FG010|COMPLETED|Intervention Period 3 (3 Days)||0
10105621|NCT02443740|11235512|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105622|NCT02443740|11235513|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105623|NCT02443740|11235514|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105624|NCT02443740|11235515|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105625|NCT02443740|11235516|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105626|NCT02443740|11235517|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105627|NCT02443740|11235518|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105628|NCT02443740|11235519|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105629|NCT02443740|11235520|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105630|NCT02443740|11235521|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105631|NCT02443740|11235522|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10105632|NCT02443740|11235512|FG000|STARTED|Washout Period 3 (7 Days)||1
10105633|NCT02443740|11235513|FG001|STARTED|Washout Period 3 (7 Days)||2
10105634|NCT02443740|11235514|FG002|STARTED|Washout Period 3 (7 Days)||2
10105635|NCT02443740|11235515|FG003|STARTED|Washout Period 3 (7 Days)||3
10105636|NCT02443740|11235516|FG004|STARTED|Washout Period 3 (7 Days)||2
10105637|NCT02443740|11235517|FG005|STARTED|Washout Period 3 (7 Days)||2
10105638|NCT02443740|11235518|FG006|STARTED|Washout Period 3 (7 Days)||2
10105639|NCT02443740|11235519|FG007|STARTED|Washout Period 3 (7 Days)||2
10105640|NCT02443740|11235520|FG008|STARTED|Washout Period 3 (7 Days)||0
10105641|NCT02443740|11235521|FG009|STARTED|Washout Period 3 (7 Days)||0
10105642|NCT02443740|11235522|FG010|STARTED|Washout Period 3 (7 Days)||0
10105643|NCT02443740|11235512|FG000|COMPLETED|Washout Period 3 (7 Days)||1
10105644|NCT02443740|11235513|FG001|COMPLETED|Washout Period 3 (7 Days)||2
10105645|NCT02443740|11235514|FG002|COMPLETED|Washout Period 3 (7 Days)||2
10105646|NCT02443740|11235515|FG003|COMPLETED|Washout Period 3 (7 Days)||3
10105647|NCT02443740|11235516|FG004|COMPLETED|Washout Period 3 (7 Days)||2
10105648|NCT02443740|11235517|FG005|COMPLETED|Washout Period 3 (7 Days)||2
10105649|NCT02443740|11235518|FG006|COMPLETED|Washout Period 3 (7 Days)||2
10105650|NCT02443740|11235519|FG007|COMPLETED|Washout Period 3 (7 Days)||2
10105651|NCT02443740|11235520|FG008|COMPLETED|Washout Period 3 (7 Days)||0
10105652|NCT02443740|11235521|FG009|COMPLETED|Washout Period 3 (7 Days)||0
10105653|NCT02443740|11235522|FG010|COMPLETED|Washout Period 3 (7 Days)||0
10105654|NCT02443740|11235512|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105655|NCT02443740|11235513|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105656|NCT02443740|11235514|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105657|NCT02443740|11235515|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105658|NCT02443740|11235516|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105659|NCT02443740|11235517|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105660|NCT02443740|11235518|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105661|NCT02443740|11235519|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105662|NCT02443740|11235520|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105663|NCT02443740|11235521|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105664|NCT02443740|11235522|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
10105665|NCT02443740|11235512|FG000|STARTED|Intervention Period 4 (3 Days)||1
10105666|NCT02443740|11235513|FG001|STARTED|Intervention Period 4 (3 Days)||2
10202354|NCT03443713|11329444|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
10202355|NCT03443713|11329445|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
10105667|NCT02443740|11235514|FG002|STARTED|Intervention Period 4 (3 Days)||2
10105668|NCT02443740|11235515|FG003|STARTED|Intervention Period 4 (3 Days)||3
10105669|NCT02443740|11235516|FG004|STARTED|Intervention Period 4 (3 Days)||2
10105670|NCT02443740|11235517|FG005|STARTED|Intervention Period 4 (3 Days)||2
10105671|NCT02443740|11235518|FG006|STARTED|Intervention Period 4 (3 Days)||2
10105672|NCT02443740|11235519|FG007|STARTED|Intervention Period 4 (3 Days)||2
10105673|NCT02443740|11235520|FG008|STARTED|Intervention Period 4 (3 Days)||0
10105674|NCT02443740|11235521|FG009|STARTED|Intervention Period 4 (3 Days)||0
10105675|NCT02443740|11235522|FG010|STARTED|Intervention Period 4 (3 Days)||0
10105676|NCT02443740|11235512|FG000|COMPLETED|Intervention Period 4 (3 Days)||1
10105677|NCT02443740|11235513|FG001|COMPLETED|Intervention Period 4 (3 Days)||2
10105678|NCT02443740|11235514|FG002|COMPLETED|Intervention Period 4 (3 Days)||2
10105679|NCT02443740|11235515|FG003|COMPLETED|Intervention Period 4 (3 Days)||3
10105680|NCT02443740|11235516|FG004|COMPLETED|Intervention Period 4 (3 Days)||2
10105681|NCT02443740|11235517|FG005|COMPLETED|Intervention Period 4 (3 Days)||2
10105682|NCT02443740|11235518|FG006|COMPLETED|Intervention Period 4 (3 Days)||2
10105683|NCT02443740|11235519|FG007|COMPLETED|Intervention Period 4 (3 Days)||2
10105684|NCT02443740|11235520|FG008|COMPLETED|Intervention Period 4 (3 Days)||0
10105685|NCT02443740|11235521|FG009|COMPLETED|Intervention Period 4 (3 Days)||0
10105686|NCT02443740|11235522|FG010|COMPLETED|Intervention Period 4 (3 Days)||0
10105687|NCT02443740|11235512|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105688|NCT02443740|11235513|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105689|NCT02443740|11235514|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105690|NCT02443740|11235515|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105691|NCT02443740|11235516|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105692|NCT02443740|11235517|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105693|NCT02443740|11235518|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105694|NCT02443740|11235519|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105695|NCT02443740|11235520|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105696|NCT02443740|11235521|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105697|NCT02443740|11235522|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10105698|NCT02443792|11235554|FG000|STARTED|Overall Study||50
10105699|NCT02443792|11235555|FG001|STARTED|Overall Study||25
10105700|NCT02443792|11235554|FG000|COMPLETED|Overall Study||43
10105701|NCT02443792|11235555|FG001|COMPLETED|Overall Study||23
10105702|NCT02443792|11235554|FG000|NOT COMPLETED|Overall Study||7
10105703|NCT02443792|11235555|FG001|NOT COMPLETED|Overall Study||2
10105704|NCT02443805|11235563|FG000|STARTED|Overall Study||802
10105705|NCT02443805|11235564|FG001|STARTED|Overall Study||805
10105706|NCT02443805|11235563|FG000|COMPLETED|Overall Study||589
10105707|NCT02443805|11235564|FG001|COMPLETED|Overall Study||678
10105708|NCT02443805|11235563|FG000|NOT COMPLETED|Overall Study||213
10105709|NCT02443805|11235564|FG001|NOT COMPLETED|Overall Study||127
10105710|NCT02443883|11235574|FG000|STARTED|Overall Study||40
10105711|NCT02443883|11235575|FG001|STARTED|Overall Study||42
10105712|NCT02443883|11235576|FG002|STARTED|Overall Study||41
10105713|NCT02443883|11235577|FG003|STARTED|Overall Study||41
10105714|NCT02443883|11235574|FG000|Received at Least One Dose of Study Drug|Overall Study||38
10105715|NCT02443883|11235575|FG001|Received at Least One Dose of Study Drug|Overall Study||42
10105716|NCT02443883|11235576|FG002|Received at Least One Dose of Study Drug|Overall Study||41
10105717|NCT02443883|11235577|FG003|Received at Least One Dose of Study Drug|Overall Study||40
10105718|NCT02443883|11235574|FG000|COMPLETED|Overall Study||34
10105719|NCT02443883|11235575|FG001|COMPLETED|Overall Study||38
10105720|NCT02443883|11235576|FG002|COMPLETED|Overall Study||40
10105721|NCT02443883|11235577|FG003|COMPLETED|Overall Study||36
10105722|NCT02443883|11235574|FG000|NOT COMPLETED|Overall Study||6
10105723|NCT02443883|11235575|FG001|NOT COMPLETED|Overall Study||4
10105724|NCT02443883|11235576|FG002|NOT COMPLETED|Overall Study||1
10105725|NCT02443883|11235577|FG003|NOT COMPLETED|Overall Study||5
10105726|NCT02444143|11235589|FG000|STARTED|Overall Study||10
10105727|NCT02444143|11235590|FG001|STARTED|Overall Study||10
10105728|NCT02444143|11235589|FG000|COMPLETED|Overall Study||10
10105729|NCT02444143|11235590|FG001|COMPLETED|Overall Study|1 patient withdrawal|9
10105730|NCT02444143|11235589|FG000|NOT COMPLETED|Overall Study||0
10105731|NCT02444143|11235590|FG001|NOT COMPLETED|Overall Study||1
10105732|NCT02444182|11235600|FG000|STARTED|Overall Study||54
10105733|NCT02444182|11235601|FG001|STARTED|Overall Study||54
10105734|NCT02444182|11235600|FG000|COMPLETED|Overall Study||52
10105735|NCT02444182|11235601|FG001|COMPLETED|Overall Study||49
10105736|NCT02444182|11235600|FG000|NOT COMPLETED|Overall Study||2
10105737|NCT02444182|11235601|FG001|NOT COMPLETED|Overall Study||5
10105738|NCT02444234|11235607|FG000|STARTED|First Intervention (3 Days)||6
10105739|NCT02444234|11235608|FG001|STARTED|First Intervention (3 Days)||5
10105740|NCT02444234|11235607|FG000|COMPLETED|First Intervention (3 Days)||6
10105741|NCT02444234|11235608|FG001|COMPLETED|First Intervention (3 Days)||5
10105742|NCT02444234|11235607|FG000|NOT COMPLETED|First Intervention (3 Days)||0
10105743|NCT02444234|11235608|FG001|NOT COMPLETED|First Intervention (3 Days)||0
10105744|NCT02444234|11235607|FG000|STARTED|Washout (2 Day Minimum)||6
10105745|NCT02444234|11235608|FG001|STARTED|Washout (2 Day Minimum)||5
10105746|NCT02444234|11235607|FG000|COMPLETED|Washout (2 Day Minimum)||6
10105747|NCT02444234|11235608|FG001|COMPLETED|Washout (2 Day Minimum)||5
10105748|NCT02444234|11235607|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0
10105749|NCT02444234|11235608|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0
10105750|NCT02444234|11235607|FG000|STARTED|Second Intervention (3 Days)||6
10105751|NCT02444234|11235608|FG001|STARTED|Second Intervention (3 Days)||5
10105752|NCT02444234|11235607|FG000|COMPLETED|Second Intervention (3 Days)||6
10105753|NCT02444234|11235608|FG001|COMPLETED|Second Intervention (3 Days)||5
10105754|NCT02444234|11235607|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
10105755|NCT02444234|11235608|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
10105756|NCT02444533|11235618|FG000|STARTED|Overall Study||17
10105757|NCT02444533|11235619|FG001|STARTED|Overall Study||22
10105758|NCT02444533|11235618|FG000|COMPLETED|Overall Study||15
10105759|NCT02444533|11235619|FG001|COMPLETED|Overall Study||18
10105760|NCT02444533|11235618|FG000|NOT COMPLETED|Overall Study||2
10105761|NCT02444533|11235619|FG001|NOT COMPLETED|Overall Study||4
10105762|NCT02444663|11235625|FG000|STARTED|Clinician Valgus||9
10105763|NCT02444663|11235625|FG000|COMPLETED|Clinician Valgus||9
10105764|NCT02444663|11235625|FG000|NOT COMPLETED|Clinician Valgus||0
10105765|NCT02444663|11235625|FG000|STARTED|Clinician Varus||9
10105766|NCT02444663|11235625|FG000|COMPLETED|Clinician Varus||9
10105767|NCT02444663|11235625|FG000|NOT COMPLETED|Clinician Varus||0
10105768|NCT02444663|11235625|FG000|STARTED|Device Valgus 0N||9
10105769|NCT02444663|11235625|FG000|COMPLETED|Device Valgus 0N||9
10105770|NCT02444663|11235625|FG000|NOT COMPLETED|Device Valgus 0N||0
10105771|NCT02444663|11235625|FG000|STARTED|Device Valgus 10N||9
10105772|NCT02444663|11235625|FG000|COMPLETED|Device Valgus 10N||9
10105773|NCT02444663|11235625|FG000|NOT COMPLETED|Device Valgus 10N||0
10105774|NCT02444663|11235625|FG000|STARTED|Device Valgus 20N||9
10105775|NCT02444663|11235625|FG000|COMPLETED|Device Valgus 20N||9
10105776|NCT02444663|11235625|FG000|NOT COMPLETED|Device Valgus 20N||0
10105777|NCT02444663|11235625|FG000|STARTED|Device Valgus 30N||9
10105778|NCT02444663|11235625|FG000|COMPLETED|Device Valgus 30N||9
10105779|NCT02444663|11235625|FG000|NOT COMPLETED|Device Valgus 30N||0
10105780|NCT02444663|11235625|FG000|STARTED|Device Varus 0N||9
10105781|NCT02444663|11235625|FG000|COMPLETED|Device Varus 0N||9
10105782|NCT02444663|11235625|FG000|NOT COMPLETED|Device Varus 0N||0
10105783|NCT02444663|11235625|FG000|STARTED|Device Varus 10N||9
10105784|NCT02444663|11235625|FG000|COMPLETED|Device Varus 10N||9
10105785|NCT02444663|11235625|FG000|NOT COMPLETED|Device Varus 10N||0
10105786|NCT02444663|11235625|FG000|STARTED|Device Varus 20N||9
10105787|NCT02444663|11235625|FG000|COMPLETED|Device Varus 20N||9
10105788|NCT02444663|11235625|FG000|NOT COMPLETED|Device Varus 20N||0
10105789|NCT02444663|11235625|FG000|STARTED|Device Varus 30N||9
10105790|NCT02444663|11235625|FG000|COMPLETED|Device Varus 30N||9
10105791|NCT02444663|11235625|FG000|NOT COMPLETED|Device Varus 30N||0
10105792|NCT02444715|11235649|FG000|STARTED|Overall Study||46
10105793|NCT02444715|11235650|FG001|STARTED|Overall Study||48
10105794|NCT02444715|11235649|FG000|COMPLETED|Overall Study||36
10105795|NCT02444715|11235650|FG001|COMPLETED|Overall Study||32
10105796|NCT02444715|11235649|FG000|NOT COMPLETED|Overall Study||10
10105797|NCT02444715|11235650|FG001|NOT COMPLETED|Overall Study||16
10105798|NCT02444793|11235661|FG000|STARTED|Overall Study||11
10105799|NCT02444793|11235662|FG001|STARTED|Overall Study||6
10105800|NCT02444793|11235663|FG002|STARTED|Overall Study||4
10105801|NCT02444793|11235664|FG003|STARTED|Overall Study||3
10105802|NCT02444793|11235661|FG000|COMPLETED|Overall Study||0
10105803|NCT02444793|11235662|FG001|COMPLETED|Overall Study||0
10105804|NCT02444793|11235663|FG002|COMPLETED|Overall Study||0
10105805|NCT02444793|11235664|FG003|COMPLETED|Overall Study||0
10105806|NCT02444793|11235661|FG000|NOT COMPLETED|Overall Study||11
10105807|NCT02444793|11235662|FG001|NOT COMPLETED|Overall Study||6
10105808|NCT02444793|11235663|FG002|NOT COMPLETED|Overall Study||4
10105809|NCT02444793|11235664|FG003|NOT COMPLETED|Overall Study||3
10105810|NCT02444936|11235677|FG000|STARTED|Overall Study||10
10105811|NCT02444936|11235678|FG001|STARTED|Overall Study||12
10105812|NCT02444936|11235677|FG000|COMPLETED|Overall Study||10
10105813|NCT02444936|11235678|FG001|COMPLETED|Overall Study||12
10105814|NCT02444936|11235677|FG000|NOT COMPLETED|Overall Study||0
10105815|NCT02444936|11235678|FG001|NOT COMPLETED|Overall Study||0
10105816|NCT02444988|11235686|FG000|STARTED|Overall Study||2646
10105817|NCT02444988|11235687|FG001|STARTED|Overall Study||2735
10105818|NCT02444988|11235686|FG000|COMPLETED|Overall Study||2646
10105819|NCT02444988|11235687|FG001|COMPLETED|Overall Study||2735
10105820|NCT02444988|11235686|FG000|NOT COMPLETED|Overall Study||0
10105821|NCT02444988|11235687|FG001|NOT COMPLETED|Overall Study||0
10105822|NCT02445014|11235693|FG000|STARTED|Overall Study||3
10105823|NCT02445014|11235693|FG000|COMPLETED|Overall Study||3
10105824|NCT02445014|11235693|FG000|NOT COMPLETED|Overall Study||0
10105825|NCT02445027|11235697|FG000|STARTED|Overall Study||60
10105826|NCT02445027|11235697|FG000|COMPLETED|Overall Study||45
10105827|NCT02445027|11235697|FG000|NOT COMPLETED|Overall Study||15
10105828|NCT02445196|11235703|FG000|STARTED|Overall Study||62
10105829|NCT02445196|11235704|FG001|STARTED|Overall Study||58
10105830|NCT02445196|11235703|FG000|COMPLETED|Overall Study||51
10105831|NCT02445196|11235704|FG001|COMPLETED|Overall Study||52
10105832|NCT02445196|11235703|FG000|NOT COMPLETED|Overall Study||11
10105833|NCT02445196|11235704|FG001|NOT COMPLETED|Overall Study||6
10105834|NCT02445287|11235712|FG000|STARTED|Overall Study||35
10105835|NCT02445287|11235713|FG001|STARTED|Overall Study||13
10105836|NCT02445287|11235712|FG000|COMPLETED|Overall Study||35
10105837|NCT02445287|11235713|FG001|COMPLETED|Overall Study||13
10105838|NCT02445287|11235712|FG000|NOT COMPLETED|Overall Study||0
10105839|NCT02445287|11235713|FG001|NOT COMPLETED|Overall Study||0
10105840|NCT02445326|11235726|FG000|STARTED|Overall Study||35
10105841|NCT02445326|11235727|FG001|STARTED|Overall Study||38
10105842|NCT02445326|11235726|FG000|COMPLETED|Overall Study||33
10105843|NCT02445326|11235727|FG001|COMPLETED|Overall Study||37
10105844|NCT02445326|11235726|FG000|NOT COMPLETED|Overall Study||2
10105845|NCT02445326|11235727|FG001|NOT COMPLETED|Overall Study||1
10105846|NCT02445573|11235735|FG000|STARTED|Overall Study||40
10105847|NCT02445573|11235736|FG001|STARTED|Overall Study||40
10105848|NCT02445573|11235735|FG000|COMPLETED|Overall Study||39
10105849|NCT02445573|11235736|FG001|COMPLETED|Overall Study||38
10105850|NCT02445573|11235735|FG000|NOT COMPLETED|Overall Study||1
10105851|NCT02445573|11235736|FG001|NOT COMPLETED|Overall Study||2
10105852|NCT02445586|11235742|FG000|STARTED|Overall Study||52
10105853|NCT02445586|11235742|FG000|Received at Least One Dose of Study Drug|Overall Study||52
10105854|NCT02445586|11235742|FG000|COMPLETED|Overall Study||13
10105855|NCT02445586|11235742|FG000|NOT COMPLETED|Overall Study||39
10105856|NCT02445625|11235746|FG000|STARTED|Overall Study||15
10105857|NCT02445625|11235746|FG000|COMPLETED|Overall Study||15
10105858|NCT02445625|11235746|FG000|NOT COMPLETED|Overall Study||0
10105859|NCT02445755|11235751|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
10105860|NCT02445755|11235751|FG000|COMPLETED|Overall Study||100
10105861|NCT02445755|11235751|FG000|NOT COMPLETED|Overall Study||13
10105862|NCT02445794|11235762|FG000|STARTED|Overall Study||6
10105863|NCT02445794|11235763|FG001|STARTED|Overall Study||3
10105864|NCT02445794|11235764|FG002|STARTED|Overall Study||7
10105865|NCT02445794|11235765|FG003|STARTED|Overall Study||3
10105866|NCT02445794|11235762|FG000|COMPLETED|Overall Study||6
10105867|NCT02445794|11235763|FG001|COMPLETED|Overall Study||3
10105868|NCT02445794|11235764|FG002|COMPLETED|Overall Study||5
10105869|NCT02445794|11235765|FG003|COMPLETED|Overall Study||3
10105870|NCT02445794|11235762|FG000|NOT COMPLETED|Overall Study||0
10105871|NCT02445794|11235763|FG001|NOT COMPLETED|Overall Study||0
10105872|NCT02445794|11235764|FG002|NOT COMPLETED|Overall Study||2
10105873|NCT02445794|11235765|FG003|NOT COMPLETED|Overall Study||0
10105874|NCT02445807|11235782|FG000|STARTED|Overall Study||176
10105875|NCT02445807|11235783|FG001|STARTED|Overall Study||89
10105876|NCT02445807|11235782|FG000|COMPLETED|Overall Study||176
10105877|NCT02445807|11235783|FG001|COMPLETED|Overall Study||89
10105878|NCT02445807|11235782|FG000|NOT COMPLETED|Overall Study||0
10105879|NCT02445807|11235783|FG001|NOT COMPLETED|Overall Study||0
10105880|NCT02445859|11235791|FG000|STARTED|Overall Study||45
10105881|NCT02445859|11235792|FG001|STARTED|Overall Study||45
10105882|NCT02445859|11235791|FG000|COMPLETED|Overall Study||43
10105883|NCT02445859|11235792|FG001|COMPLETED|Overall Study||42
10105884|NCT02445859|11235791|FG000|NOT COMPLETED|Overall Study||2
10105885|NCT02445859|11235792|FG001|NOT COMPLETED|Overall Study||3
10105886|NCT02445911|11235802|FG000|STARTED|Overall Study||20
10105887|NCT02445911|11235803|FG001|STARTED|Overall Study||20
10105888|NCT02445911|11235804|FG002|STARTED|Overall Study||21
10105889|NCT02445911|11235805|FG003|STARTED|Overall Study||20
10105890|NCT02445911|11235802|FG000|COMPLETED|Overall Study||20
10105891|NCT02445911|11235803|FG001|COMPLETED|Overall Study||20
10105892|NCT02445911|11235804|FG002|COMPLETED|Overall Study||21
10202356|NCT03443713|11329446|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
10202357|NCT03443713|11329444|FG000|STARTED|Third at Home Period (8-12 Days)||8
10202358|NCT03443713|11329445|FG001|STARTED|Third at Home Period (8-12 Days)||8
10202359|NCT03443713|11329446|FG002|STARTED|Third at Home Period (8-12 Days)||8
10202360|NCT03443713|11329444|FG000|COMPLETED|Third at Home Period (8-12 Days)||8
10202361|NCT03443713|11329445|FG001|COMPLETED|Third at Home Period (8-12 Days)||8
10202362|NCT03443713|11329446|FG002|COMPLETED|Third at Home Period (8-12 Days)||8
10202363|NCT03443713|11329444|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0
10202364|NCT03443713|11329445|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0
10202365|NCT03443713|11329446|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0
10202366|NCT03443713|11329444|FG000|STARTED|Close-out Visit (30 Minutes)||8
10202367|NCT03443713|11329445|FG001|STARTED|Close-out Visit (30 Minutes)||8
10202368|NCT03443713|11329446|FG002|STARTED|Close-out Visit (30 Minutes)||8
10202369|NCT03443713|11329444|FG000|COMPLETED|Close-out Visit (30 Minutes)||8
10202370|NCT03443713|11329445|FG001|COMPLETED|Close-out Visit (30 Minutes)||8
10202371|NCT03443713|11329446|FG002|COMPLETED|Close-out Visit (30 Minutes)||8
10202372|NCT03443713|11329444|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0
10202373|NCT03443713|11329445|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0
10202374|NCT03443713|11329446|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0
10202375|NCT03444090|11329460|FG000|STARTED|Overall Study||214
10202376|NCT03444090|11329461|FG001|STARTED|Overall Study||214
10202377|NCT03444090|11329460|FG000|COMPLETED|Overall Study||211
10202378|NCT03444090|11329461|FG001|COMPLETED|Overall Study||210
10202379|NCT03444090|11329460|FG000|NOT COMPLETED|Overall Study||3
10202380|NCT03444090|11329461|FG001|NOT COMPLETED|Overall Study||4
10202381|NCT03444155|11329469|FG000|STARTED|First Intervention (6 Weeks)||15
10202382|NCT03444155|11329470|FG001|STARTED|First Intervention (6 Weeks)||15
10202383|NCT03444155|11329469|FG000|COMPLETED|First Intervention (6 Weeks)||14
10202384|NCT03444155|11329470|FG001|COMPLETED|First Intervention (6 Weeks)||15
10202385|NCT03444155|11329469|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
10202386|NCT03444155|11329470|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10202387|NCT03444155|11329469|FG000|STARTED|Washout (2 Weeks)||14
10202388|NCT03444155|11329470|FG001|STARTED|Washout (2 Weeks)||15
10202389|NCT03444155|11329469|FG000|COMPLETED|Washout (2 Weeks)||14
10202390|NCT03444155|11329470|FG001|COMPLETED|Washout (2 Weeks)||15
10105893|NCT02445911|11235805|FG003|COMPLETED|Overall Study||20
10105894|NCT02445911|11235802|FG000|NOT COMPLETED|Overall Study||0
10105895|NCT02445911|11235803|FG001|NOT COMPLETED|Overall Study||0
10105896|NCT02445911|11235804|FG002|NOT COMPLETED|Overall Study||0
10105897|NCT02445911|11235805|FG003|NOT COMPLETED|Overall Study||0
10105898|NCT02445963|11235819|FG000|STARTED|Overall Study||9
10105899|NCT02445963|11235820|FG001|STARTED|Overall Study||9
10105900|NCT02445963|11235821|FG002|STARTED|Overall Study||10
10006826|NCT01747928|11129084|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10006827|NCT01747928|11129085|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10006828|NCT01747928|11129078|FG000|NOT COMPLETED|Overall Study||0
10105901|NCT02445963|11235822|FG003|STARTED|Overall Study||10
10105902|NCT02445963|11235819|FG000|COMPLETED|Overall Study||7
10105903|NCT02445963|11235820|FG001|COMPLETED|Overall Study||9
10105904|NCT02445963|11235821|FG002|COMPLETED|Overall Study||9
10105905|NCT02445963|11235822|FG003|COMPLETED|Overall Study||10
10105906|NCT02445963|11235819|FG000|NOT COMPLETED|Overall Study||2
10105907|NCT02445963|11235820|FG001|NOT COMPLETED|Overall Study||0
10105908|NCT02445963|11235821|FG002|NOT COMPLETED|Overall Study||1
10105909|NCT02445963|11235822|FG003|NOT COMPLETED|Overall Study||0
10105910|NCT02446015|11235836|FG000|STARTED|Overall Study||34
10105911|NCT02446015|11235837|FG001|STARTED|Overall Study||63
10105912|NCT02446015|11235836|FG000|COMPLETED|Overall Study||33
10105913|NCT02446015|11235837|FG001|COMPLETED|Overall Study||62
10105914|NCT02446015|11235836|FG000|NOT COMPLETED|Overall Study||1
10105915|NCT02446015|11235837|FG001|NOT COMPLETED|Overall Study||1
10105916|NCT02446171|11235848|FG000|STARTED|Overall Study||11
10105917|NCT02446171|11235849|FG001|STARTED|Overall Study||11
10105918|NCT02446171|11235850|FG002|STARTED|Overall Study||11
10105919|NCT02446171|11235851|FG003|STARTED|Overall Study||11
10105920|NCT02446171|11235848|FG000|COMPLETED|Overall Study||11
10105921|NCT02446171|11235849|FG001|COMPLETED|Overall Study||11
10105922|NCT02446171|11235850|FG002|COMPLETED|Overall Study||9
10105923|NCT02446171|11235851|FG003|COMPLETED|Overall Study||11
10105924|NCT02446171|11235848|FG000|NOT COMPLETED|Overall Study||0
10105925|NCT02446171|11235849|FG001|NOT COMPLETED|Overall Study||0
9759007|NCT00371566|10862553|FG001|NOT COMPLETED|Chemoradiation Phase||3
9759008|NCT00371566|10862552|FG000|STARTED|Follow Up Phase||31
10006829|NCT01747928|11129079|FG001|NOT COMPLETED|Overall Study||0
10105926|NCT02446171|11235850|FG002|NOT COMPLETED|Overall Study||2
10105927|NCT02446171|11235851|FG003|NOT COMPLETED|Overall Study||0
10105928|NCT02446223|11235863|FG000|STARTED|Overall Study||21
10105929|NCT02446223|11235863|FG000|COMPLETED|Overall Study||20
10105930|NCT02446223|11235863|FG000|NOT COMPLETED|Overall Study||1
10105931|NCT02446314|11235871|FG000|STARTED|Zero to Twelve Weeks.||30
10105932|NCT02446314|11235872|FG001|STARTED|Zero to Twelve Weeks.||30
10105933|NCT02446314|11235873|FG002|STARTED|Zero to Twelve Weeks.||31
10105934|NCT02446314|11235874|FG003|STARTED|Zero to Twelve Weeks.||31
10105935|NCT02446314|11235871|FG000|COMPLETED|Zero to Twelve Weeks.||27
10105936|NCT02446314|11235872|FG001|COMPLETED|Zero to Twelve Weeks.||29
10105937|NCT02446314|11235873|FG002|COMPLETED|Zero to Twelve Weeks.||31
10105938|NCT02446314|11235874|FG003|COMPLETED|Zero to Twelve Weeks.||29
10105939|NCT02446314|11235871|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3
10105940|NCT02446314|11235872|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1
10105941|NCT02446314|11235873|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0
10105942|NCT02446314|11235874|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2
10105943|NCT02446314|11235871|FG000|STARTED|Thirteen to Twenty Four Weeks||27
10105944|NCT02446314|11235872|FG001|STARTED|Thirteen to Twenty Four Weeks||29
10105945|NCT02446314|11235873|FG002|STARTED|Thirteen to Twenty Four Weeks||31
10105946|NCT02446314|11235874|FG003|STARTED|Thirteen to Twenty Four Weeks||29
10105947|NCT02446314|11235871|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27
10105948|NCT02446314|11235872|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28
10105949|NCT02446314|11235873|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29
10105950|NCT02446314|11235874|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28
10105951|NCT02446314|11235871|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
10105952|NCT02446314|11235872|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
10105953|NCT02446314|11235873|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
10105954|NCT02446314|11235874|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
10105955|NCT02446418|11235890|FG000|STARTED|Overall Study||210
10105956|NCT02446418|11235891|FG001|STARTED|Overall Study||210
10105957|NCT02446418|11235890|FG000|COMPLETED|Overall Study||192
10105958|NCT02446418|11235891|FG001|COMPLETED|Overall Study||194
10105959|NCT02446418|11235890|FG000|NOT COMPLETED|Overall Study||18
10105960|NCT02446418|11235891|FG001|NOT COMPLETED|Overall Study||16
10105961|NCT02446483|11235897|FG000|STARTED|Period 1: Intervention Period 1||30
10006830|NCT01747928|11129080|FG002|NOT COMPLETED|Overall Study||0
10006831|NCT01747928|11129081|FG003|NOT COMPLETED|Overall Study||0
10006832|NCT01747928|11129082|FG004|NOT COMPLETED|Overall Study||0
10006833|NCT01747928|11129083|FG005|NOT COMPLETED|Overall Study||0
10006834|NCT01747928|11129084|FG006|NOT COMPLETED|Overall Study||0
10006835|NCT01747928|11129085|FG007|NOT COMPLETED|Overall Study||0
10006836|NCT01748045|11129106|FG000|STARTED|Overall Study||2
10006837|NCT01748045|11129107|FG001|STARTED|Overall Study||1
10006838|NCT01748045|11129106|FG000|COMPLETED|Overall Study||2
10006839|NCT01748045|11129107|FG001|COMPLETED|Overall Study||1
10006840|NCT01748045|11129106|FG000|NOT COMPLETED|Overall Study||0
10006841|NCT01748045|11129107|FG001|NOT COMPLETED|Overall Study||0
10006842|NCT01748071|11129122|FG000|STARTED|Overall Study||40
10105962|NCT02446483|11235898|FG001|STARTED|Period 1: Intervention Period 1||30
10105963|NCT02446483|11235897|FG000|COMPLETED|Period 1: Intervention Period 1||30
10105964|NCT02446483|11235898|FG001|COMPLETED|Period 1: Intervention Period 1||30
10105965|NCT02446483|11235897|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
10105966|NCT02446483|11235898|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
10105967|NCT02446483|11235897|FG000|STARTED|Period 2: Washout Period (7 Days)||30
10105968|NCT02446483|11235898|FG001|STARTED|Period 2: Washout Period (7 Days)||30
10105969|NCT02446483|11235897|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30
10105970|NCT02446483|11235898|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30
10105971|NCT02446483|11235897|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10105972|NCT02446483|11235898|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10105973|NCT02446483|11235897|FG000|STARTED|Period 3: Intervention Period 2||30
10105974|NCT02446483|11235898|FG001|STARTED|Period 3: Intervention Period 2||30
10105975|NCT02446483|11235897|FG000|COMPLETED|Period 3: Intervention Period 2||30
10105976|NCT02446483|11235898|FG001|COMPLETED|Period 3: Intervention Period 2||30
10105977|NCT02446483|11235897|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
10105978|NCT02446483|11235898|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
10105979|NCT02446496|11235904|FG000|STARTED|Overall Study||24
10105980|NCT02446496|11235904|FG000|COMPLETED|Overall Study||24
10105981|NCT02446496|11235904|FG000|NOT COMPLETED|Overall Study||0
10105982|NCT02446613|11235912|FG000|STARTED|Overall Study||6
10105983|NCT02446613|11235913|FG001|STARTED|Overall Study||10
10105984|NCT02446613|11235912|FG000|COMPLETED|Overall Study||6
10105985|NCT02446613|11235913|FG001|COMPLETED|Overall Study||10
10105986|NCT02446613|11235912|FG000|NOT COMPLETED|Overall Study||0
10105987|NCT02446613|11235913|FG001|NOT COMPLETED|Overall Study||0
10105988|NCT02446691|11235923|FG000|STARTED|Overall Study||128
10105989|NCT02446691|11235923|FG000|COMPLETED|Overall Study||117
10105990|NCT02446691|11235923|FG000|NOT COMPLETED|Overall Study||11
10105991|NCT02446717|11235932|FG000|STARTED|Overall Study||6
10105992|NCT02446717|11235933|FG001|STARTED|Overall Study||22
10105993|NCT02446717|11235934|FG002|STARTED|Overall Study||22
10105994|NCT02446717|11235935|FG003|STARTED|Overall Study||44
10105995|NCT02446717|11235936|FG004|STARTED|Overall Study||47
10105996|NCT02446717|11235932|FG000|COMPLETED|Overall Study||6
10105997|NCT02446717|11235933|FG001|COMPLETED|Overall Study||21
10105998|NCT02446717|11235934|FG002|COMPLETED|Overall Study||20
10105999|NCT02446717|11235935|FG003|COMPLETED|Overall Study||43
10106000|NCT02446717|11235936|FG004|COMPLETED|Overall Study||46
10106001|NCT02446717|11235932|FG000|NOT COMPLETED|Overall Study||0
10106002|NCT02446717|11235933|FG001|NOT COMPLETED|Overall Study||1
10106003|NCT02446717|11235934|FG002|NOT COMPLETED|Overall Study||2
10106004|NCT02446717|11235935|FG003|NOT COMPLETED|Overall Study||1
10106005|NCT02446717|11235936|FG004|NOT COMPLETED|Overall Study||1
10106006|NCT02446743|11235950|FG000|STARTED|Overall Study||276
10106007|NCT02446743|11235951|FG001|STARTED|Overall Study||255
10106008|NCT02446743|11235950|FG000|COMPLETED|Overall Study||271
10106009|NCT02446743|11235951|FG001|COMPLETED|Overall Study||250
10106010|NCT02446743|11235950|FG000|NOT COMPLETED|Overall Study||5
10106011|NCT02446743|11235951|FG001|NOT COMPLETED|Overall Study||5
10106012|NCT02446769|11235966|FG000|STARTED|Screening Period||18
10106013|NCT02446769|11235967|FG001|STARTED|Screening Period||0
10106014|NCT02446769|11235968|FG002|STARTED|Screening Period||0
10106015|NCT02446769|11235966|FG000|COMPLETED|Screening Period||7
10106016|NCT02446769|11235967|FG001|COMPLETED|Screening Period||0
10106017|NCT02446769|11235968|FG002|COMPLETED|Screening Period||0
10106018|NCT02446769|11235966|FG000|NOT COMPLETED|Screening Period||11
10106019|NCT02446769|11235967|FG001|NOT COMPLETED|Screening Period||0
10106020|NCT02446769|11235968|FG002|NOT COMPLETED|Screening Period||0
10106021|NCT02446769|11235966|FG000|STARTED|Study Period||0
10106022|NCT02446769|11235967|FG001|STARTED|Study Period||4
10106023|NCT02446769|11235968|FG002|STARTED|Study Period||3
10106024|NCT02446769|11235966|FG000|COMPLETED|Study Period||0
10106025|NCT02446769|11235967|FG001|COMPLETED|Study Period||2
10106026|NCT02446769|11235968|FG002|COMPLETED|Study Period||3
10106027|NCT02446769|11235966|FG000|NOT COMPLETED|Study Period||0
10106028|NCT02446769|11235967|FG001|NOT COMPLETED|Study Period||2
10106029|NCT02446769|11235968|FG002|NOT COMPLETED|Study Period||0
10006843|NCT01748071|11129123|FG001|STARTED|Overall Study||40
10006844|NCT01748071|11129124|FG002|STARTED|Overall Study||40
10006845|NCT01748071|11129122|FG000|COMPLETED|Overall Study||38
10006846|NCT01748071|11129123|FG001|COMPLETED|Overall Study||38
10006847|NCT01748071|11129124|FG002|COMPLETED|Overall Study||40
10006848|NCT01748071|11129122|FG000|NOT COMPLETED|Overall Study||2
10006849|NCT01748071|11129123|FG001|NOT COMPLETED|Overall Study||2
10006850|NCT01748071|11129124|FG002|NOT COMPLETED|Overall Study||0
10006851|NCT01748227|11129132|FG000|STARTED|Overall Study||20
10006852|NCT01748227|11129132|FG000|COMPLETED|Overall Study||17
10006853|NCT01748227|11129132|FG000|NOT COMPLETED|Overall Study||3
10006854|NCT01748240|11129137|FG000|STARTED|Overall Study||21
10006855|NCT01748240|11129137|FG000|COMPLETED|Overall Study||21
10006856|NCT01748240|11129137|FG000|NOT COMPLETED|Overall Study||0
10006857|NCT01748292|11129143|FG000|STARTED|Overall Study||20
10006858|NCT01748292|11129144|FG001|STARTED|Overall Study||40
10006859|NCT01748292|11129143|FG000|COMPLETED|Overall Study||18
10006860|NCT01748292|11129144|FG001|COMPLETED|Overall Study||28
10106030|NCT02446847|11235977|FG000|STARTED|Overall Study||8
10106031|NCT02446847|11235978|FG001|STARTED|Overall Study||8
10106032|NCT02446847|11235977|FG000|COMPLETED|Overall Study||8
10106033|NCT02446847|11235978|FG001|COMPLETED|Overall Study||6
10106034|NCT02446847|11235977|FG000|NOT COMPLETED|Overall Study||0
10106035|NCT02446847|11235978|FG001|NOT COMPLETED|Overall Study||2
10106036|NCT02446886|11235986|FG000|STARTED|Overall Study||8
10106037|NCT02446886|11235987|FG001|STARTED|Overall Study||7
10106038|NCT02446886|11235986|FG000|COMPLETED|Overall Study||6
10106039|NCT02446886|11235987|FG001|COMPLETED|Overall Study||3
10106040|NCT02446886|11235986|FG000|NOT COMPLETED|Overall Study||2
10006861|NCT01748292|11129143|FG000|NOT COMPLETED|Overall Study||2
10106041|NCT02446886|11235987|FG001|NOT COMPLETED|Overall Study||4
10006862|NCT01748292|11129144|FG001|NOT COMPLETED|Overall Study||12
10006863|NCT01748552|11129162|FG000|STARTED|Intervention Period 1 and Washout||3
10006864|NCT01748552|11129163|FG001|STARTED|Intervention Period 1 and Washout||3
10006865|NCT01748552|11129164|FG002|STARTED|Intervention Period 1 and Washout||3
10006866|NCT01748552|11129165|FG003|STARTED|Intervention Period 1 and Washout||3
10006867|NCT01748552|11129166|FG004|STARTED|Intervention Period 1 and Washout||3
10006868|NCT01748552|11129167|FG005|STARTED|Intervention Period 1 and Washout||3
10006869|NCT01748552|11129168|FG006|STARTED|Intervention Period 1 and Washout||3
10006870|NCT01748552|11129169|FG007|STARTED|Intervention Period 1 and Washout||3
10006871|NCT01748552|11129170|FG008|STARTED|Intervention Period 1 and Washout||3
10006872|NCT01748552|11129171|FG009|STARTED|Intervention Period 1 and Washout||3
10006873|NCT01748552|11129172|FG010|STARTED|Intervention Period 1 and Washout||3
10006874|NCT01748552|11129173|FG011|STARTED|Intervention Period 1 and Washout||3
10006875|NCT01748552|11129162|FG000|COMPLETED|Intervention Period 1 and Washout||3
10006876|NCT01748552|11129163|FG001|COMPLETED|Intervention Period 1 and Washout||3
10006877|NCT01748552|11129164|FG002|COMPLETED|Intervention Period 1 and Washout||3
10006878|NCT01748552|11129165|FG003|COMPLETED|Intervention Period 1 and Washout||3
10006879|NCT01748552|11129166|FG004|COMPLETED|Intervention Period 1 and Washout||3
10006880|NCT01748552|11129167|FG005|COMPLETED|Intervention Period 1 and Washout||3
10006881|NCT01748552|11129168|FG006|COMPLETED|Intervention Period 1 and Washout||3
10006882|NCT01748552|11129169|FG007|COMPLETED|Intervention Period 1 and Washout||3
10006883|NCT01748552|11129170|FG008|COMPLETED|Intervention Period 1 and Washout||3
10006884|NCT01748552|11129171|FG009|COMPLETED|Intervention Period 1 and Washout||3
10006885|NCT01748552|11129172|FG010|COMPLETED|Intervention Period 1 and Washout||3
10006886|NCT01748552|11129173|FG011|COMPLETED|Intervention Period 1 and Washout||3
10006887|NCT01748552|11129162|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0
10006888|NCT01748552|11129163|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0
10006889|NCT01748552|11129164|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0
10006890|NCT01748552|11129165|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0
10006891|NCT01748552|11129166|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0
10006892|NCT01748552|11129167|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0
10006893|NCT01748552|11129168|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0
10006894|NCT01748552|11129169|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0
10006895|NCT01748552|11129170|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0
10006896|NCT01748552|11129171|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0
10006897|NCT01748552|11129172|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0
10006898|NCT01748552|11129173|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0
10006899|NCT01748552|11129162|FG000|STARTED|Intervention Period 2 and Washout||3
10006900|NCT01748552|11129163|FG001|STARTED|Intervention Period 2 and Washout||3
10006901|NCT01748552|11129164|FG002|STARTED|Intervention Period 2 and Washout||3
10006902|NCT01748552|11129165|FG003|STARTED|Intervention Period 2 and Washout||3
10006903|NCT01748552|11129166|FG004|STARTED|Intervention Period 2 and Washout||3
10006904|NCT01748552|11129167|FG005|STARTED|Intervention Period 2 and Washout||3
10006905|NCT01748552|11129168|FG006|STARTED|Intervention Period 2 and Washout||3
9759009|NCT00371566|10862553|FG001|STARTED|Follow Up Phase||65
9759010|NCT00371566|10862552|FG000|COMPLETED|Follow Up Phase||28
9759011|NCT00371566|10862553|FG001|COMPLETED|Follow Up Phase||58
9759012|NCT00371566|10862552|FG000|NOT COMPLETED|Follow Up Phase||3
9759013|NCT00371566|10862553|FG001|NOT COMPLETED|Follow Up Phase||7
9759014|NCT00371631|10862559|FG000|STARTED|Overall Study||13
9759015|NCT00371631|10862559|FG000|COMPLETED|Overall Study||13
9759016|NCT00371631|10862559|FG000|NOT COMPLETED|Overall Study||0
9759017|NCT00371644|10862565|FG000|STARTED|Overall Study||72
9759018|NCT00371644|10862566|FG001|STARTED|Overall Study||57
9759019|NCT00371644|10862565|FG000|COMPLETED|Overall Study||44
9759020|NCT00371644|10862566|FG001|COMPLETED|Overall Study||44
9759021|NCT00371644|10862565|FG000|NOT COMPLETED|Overall Study||28
9759022|NCT00371644|10862566|FG001|NOT COMPLETED|Overall Study||13
9759023|NCT00371683|10862574|FG000|STARTED|DB Treatment Period-Randomized Patients||1599
9759024|NCT00371683|10862575|FG001|STARTED|DB Treatment Period-Randomized Patients||1596
9759025|NCT00371683|10862574|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509
10006906|NCT01748552|11129169|FG007|STARTED|Intervention Period 2 and Washout||3
9759026|NCT00371683|10862575|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489
9759027|NCT00371683|10862574|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
9759028|NCT00371683|10862575|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
9759029|NCT00371683|10862574|FG000|STARTED|Follow-Up Period - Randomized Patients||1553
9759030|NCT00371683|10862575|FG001|STARTED|Follow-Up Period - Randomized Patients||1533
9759031|NCT00371683|10862574|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492
9759032|NCT00371683|10862575|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461
9759033|NCT00371683|10862574|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
9759034|NCT00371683|10862575|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
9759035|NCT00371761|10862593|FG000|STARTED|Overall Study||13
9759036|NCT00371761|10862594|FG001|STARTED|Overall Study||12
9759037|NCT00371761|10862593|FG000|COMPLETED|Overall Study||5
9759038|NCT00371761|10862594|FG001|COMPLETED|Overall Study||2
9759039|NCT00371761|10862593|FG000|NOT COMPLETED|Overall Study||8
9759040|NCT00371761|10862594|FG001|NOT COMPLETED|Overall Study||10
9759041|NCT00371787|10862602|FG000|STARTED|Overall Study||26
9759042|NCT00371787|10862603|FG001|STARTED|Overall Study||12
9759043|NCT00371787|10862602|FG000|COMPLETED|Overall Study||23
9759044|NCT00371787|10862603|FG001|COMPLETED|Overall Study||11
9759045|NCT00371787|10862602|FG000|NOT COMPLETED|Overall Study||3
9759046|NCT00371787|10862603|FG001|NOT COMPLETED|Overall Study||1
9759047|NCT00371826|10862612|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
9759048|NCT00371826|10862613|FG001|STARTED|Core Phase (12 Months)||47
9759049|NCT00371826|10862614|FG002|STARTED|Core Phase (12 Months)||30
9759050|NCT00371826|10862612|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
9759051|NCT00371826|10862613|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
9759052|NCT00371826|10862614|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
9759053|NCT00371826|10862612|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
9759054|NCT00371826|10862613|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
9759055|NCT00371826|10862614|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
9759056|NCT00371826|10862612|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
9759057|NCT00371826|10862613|FG001|COMPLETED|Core Phase (12 Months)||39
9759058|NCT00371826|10862614|FG002|COMPLETED|Core Phase (12 Months)||6
9759059|NCT00371826|10862612|FG000|NOT COMPLETED|Core Phase (12 Months)||24
9759060|NCT00371826|10862613|FG001|NOT COMPLETED|Core Phase (12 Months)||8
9759061|NCT00371826|10862614|FG002|NOT COMPLETED|Core Phase (12 Months)||24
9759062|NCT00371826|10862612|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
9759063|NCT00371826|10862613|FG001|STARTED|Extension Phase (24 Months)||39
9759064|NCT00371826|10862614|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
9759065|NCT00371826|10862612|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
9759066|NCT00371826|10862613|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
9759067|NCT00371826|10862614|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
9829193|NCT00758680|10939742|FG002|NOT COMPLETED|Overall Study||0
10006907|NCT01748552|11129170|FG008|STARTED|Intervention Period 2 and Washout||3
10006908|NCT01748552|11129171|FG009|STARTED|Intervention Period 2 and Washout||3
10006909|NCT01748552|11129172|FG010|STARTED|Intervention Period 2 and Washout||3
10006910|NCT01748552|11129173|FG011|STARTED|Intervention Period 2 and Washout||3
10006911|NCT01748552|11129162|FG000|COMPLETED|Intervention Period 2 and Washout||3
10006912|NCT01748552|11129163|FG001|COMPLETED|Intervention Period 2 and Washout||3
10006913|NCT01748552|11129164|FG002|COMPLETED|Intervention Period 2 and Washout||2
10006914|NCT01748552|11129165|FG003|COMPLETED|Intervention Period 2 and Washout||3
10006915|NCT01748552|11129166|FG004|COMPLETED|Intervention Period 2 and Washout||3
10006916|NCT01748552|11129167|FG005|COMPLETED|Intervention Period 2 and Washout||3
10006917|NCT01748552|11129168|FG006|COMPLETED|Intervention Period 2 and Washout||0
10006918|NCT01748552|11129169|FG007|COMPLETED|Intervention Period 2 and Washout||0
10006919|NCT01748552|11129170|FG008|COMPLETED|Intervention Period 2 and Washout||0
10006920|NCT01748552|11129171|FG009|COMPLETED|Intervention Period 2 and Washout||3
10006921|NCT01748552|11129172|FG010|COMPLETED|Intervention Period 2 and Washout||3
10006922|NCT01748552|11129173|FG011|COMPLETED|Intervention Period 2 and Washout||3
9759068|NCT00371826|10862612|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
9759069|NCT00371826|10862613|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
9759070|NCT00371826|10862614|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
9759071|NCT00371826|10862612|FG000|COMPLETED|Extension Phase (24 Months)||18
9759072|NCT00371826|10862613|FG001|COMPLETED|Extension Phase (24 Months)||29
9759073|NCT00371826|10862614|FG002|COMPLETED|Extension Phase (24 Months)||3
9759074|NCT00371826|10862612|FG000|NOT COMPLETED|Extension Phase (24 Months)||5
9759075|NCT00371826|10862613|FG001|NOT COMPLETED|Extension Phase (24 Months)||10
9759076|NCT00371826|10862614|FG002|NOT COMPLETED|Extension Phase (24 Months)||2
9759077|NCT00371839|10862625|FG000|STARTED|Overall Study||49
9759078|NCT00371839|10862626|FG001|STARTED|Overall Study||20
9759079|NCT00371839|10862627|FG002|STARTED|Overall Study||9
9759080|NCT00371839|10862625|FG000|COMPLETED|Overall Study||32
9759081|NCT00371839|10862626|FG001|COMPLETED|Overall Study||13
9759082|NCT00371839|10862627|FG002|COMPLETED|Overall Study||7
9759083|NCT00371839|10862625|FG000|NOT COMPLETED|Overall Study||17
9759084|NCT00371839|10862626|FG001|NOT COMPLETED|Overall Study||7
9759085|NCT00371839|10862627|FG002|NOT COMPLETED|Overall Study||2
9759086|NCT00371865|10862635|FG000|STARTED|Overall Study||57
9759087|NCT00371865|10862636|FG001|STARTED|Overall Study||57
9759088|NCT00371865|10862635|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
9759089|NCT00371865|10862636|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
9759090|NCT00371865|10862635|FG000|NOT COMPLETED|Overall Study||15
9759091|NCT00371865|10862636|FG001|NOT COMPLETED|Overall Study||14
9759092|NCT00372060|10862644|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
9759093|NCT00372060|10862645|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68
9759094|NCT00372060|10862644|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
9759095|NCT00372060|10862645|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
9759096|NCT00372060|10862644|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
9759097|NCT00372060|10862645|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
9759098|NCT00372060|10862644|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63
9759099|NCT00372060|10862645|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67
9759100|NCT00372060|10862644|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49
9759101|NCT00372060|10862645|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59
9759102|NCT00372060|10862644|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
9759103|NCT00372060|10862645|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
9759104|NCT00372112|10862658|FG000|STARTED|Overall Study||17
9759105|NCT00372112|10862659|FG001|STARTED|Overall Study||16
9759106|NCT00372112|10862660|FG002|STARTED|Overall Study||17
9759107|NCT00372112|10862661|FG003|STARTED|Overall Study||18
9759108|NCT00372112|10862658|FG000|COMPLETED|Overall Study||16
9759109|NCT00372112|10862659|FG001|COMPLETED|Overall Study||15
9759110|NCT00372112|10862660|FG002|COMPLETED|Overall Study||13
9759111|NCT00372112|10862661|FG003|COMPLETED|Overall Study||14
9759112|NCT00372112|10862658|FG000|NOT COMPLETED|Overall Study||1
9759113|NCT00372112|10862659|FG001|NOT COMPLETED|Overall Study||1
9759114|NCT00372112|10862660|FG002|NOT COMPLETED|Overall Study||4
9759115|NCT00372112|10862661|FG003|NOT COMPLETED|Overall Study||4
9759116|NCT00372190|10862676|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
9759117|NCT00372190|10862677|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
9759118|NCT00372190|10862676|FG000|COMPLETED|Overall Study||90
9759119|NCT00372190|10862677|FG001|COMPLETED|Overall Study||96
9759120|NCT00372190|10862676|FG000|NOT COMPLETED|Overall Study||3
9759121|NCT00372190|10862677|FG001|NOT COMPLETED|Overall Study||1
9759122|NCT00372255|10862687|FG000|STARTED|Overall Study||110
9759123|NCT00372255|10862688|FG001|STARTED|Overall Study||114
9759124|NCT00372255|10862687|FG000|COMPLETED|Overall Study||108
9759125|NCT00372255|10862688|FG001|COMPLETED|Overall Study||113
9759126|NCT00372255|10862687|FG000|NOT COMPLETED|Overall Study||2
9759127|NCT00372255|10862688|FG001|NOT COMPLETED|Overall Study||1
9759128|NCT00372385|10862699|FG000|STARTED|Overall Study||82
9759129|NCT00372385|10862700|FG001|STARTED|Overall Study||81
9759130|NCT00372385|10862701|FG002|STARTED|Overall Study||82
9759131|NCT00372385|10862702|FG003|STARTED|Overall Study||78
10006923|NCT01748552|11129162|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0
10006924|NCT01748552|11129163|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0
10006925|NCT01748552|11129164|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1
10006926|NCT01748552|11129165|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0
9759132|NCT00372385|10862699|FG000|COMPLETED|Overall Study||49
9759133|NCT00372385|10862700|FG001|COMPLETED|Overall Study||61
9759134|NCT00372385|10862701|FG002|COMPLETED|Overall Study||72
9759135|NCT00372385|10862702|FG003|COMPLETED|Overall Study||70
9759136|NCT00372385|10862699|FG000|NOT COMPLETED|Overall Study||33
9759137|NCT00372385|10862700|FG001|NOT COMPLETED|Overall Study||20
9759138|NCT00372385|10862701|FG002|NOT COMPLETED|Overall Study||10
9759139|NCT00372385|10862702|FG003|NOT COMPLETED|Overall Study||8
9759140|NCT00372411|10862716|FG000|STARTED|Overall Study||49
9759141|NCT00372411|10862717|FG001|STARTED|Overall Study||50
10006927|NCT01748552|11129166|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0
10006928|NCT01748552|11129167|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0
10006929|NCT01748552|11129168|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3
10006930|NCT01748552|11129169|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3
10006931|NCT01748552|11129170|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3
10006932|NCT01748552|11129171|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0
10006933|NCT01748552|11129172|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0
9759142|NCT00372411|10862718|FG002|STARTED|Overall Study||28
9759143|NCT00372411|10862716|FG000|COMPLETED|Overall Study||44
9759144|NCT00372411|10862717|FG001|COMPLETED|Overall Study||42
9759145|NCT00372411|10862718|FG002|COMPLETED|Overall Study||25
9759146|NCT00372411|10862716|FG000|NOT COMPLETED|Overall Study||5
9759147|NCT00372411|10862717|FG001|NOT COMPLETED|Overall Study||8
9759148|NCT00372411|10862718|FG002|NOT COMPLETED|Overall Study||3
10006934|NCT01748552|11129173|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0
10006935|NCT01748552|11129162|FG000|STARTED|Intervention Period 3 and Washout||3
10006936|NCT01748552|11129163|FG001|STARTED|Intervention Period 3 and Washout||3
10006937|NCT01748552|11129164|FG002|STARTED|Intervention Period 3 and Washout||2
10006938|NCT01748552|11129165|FG003|STARTED|Intervention Period 3 and Washout||3
10006939|NCT01748552|11129166|FG004|STARTED|Intervention Period 3 and Washout||3
10006940|NCT01748552|11129167|FG005|STARTED|Intervention Period 3 and Washout||3
10106042|NCT02446899|11235996|FG000|STARTED|Overall Study||181
10106043|NCT02446899|11235997|FG001|STARTED|Overall Study||184
10006941|NCT01748552|11129168|FG006|STARTED|Intervention Period 3 and Washout||0
10006942|NCT01748552|11129169|FG007|STARTED|Intervention Period 3 and Washout||0
10006943|NCT01748552|11129170|FG008|STARTED|Intervention Period 3 and Washout||0
10106044|NCT02446899|11235996|FG000|Received Study Drug|Overall Study||180
10106045|NCT02446899|11235997|FG001|Received Study Drug|Overall Study||182
10106046|NCT02446899|11235996|FG000|COMPLETED|Overall Study||156
9759149|NCT00372424|10862726|FG000|STARTED|Overall Study||26
10106047|NCT02446899|11235997|FG001|COMPLETED|Overall Study||136
9759150|NCT00372424|10862726|FG000|Treated|Overall Study||25
9759151|NCT00372424|10862726|FG000|COMPLETED|Overall Study||0
9759152|NCT00372424|10862726|FG000|NOT COMPLETED|Overall Study||26
10006944|NCT01748552|11129171|FG009|STARTED|Intervention Period 3 and Washout||3
10006945|NCT01748552|11129172|FG010|STARTED|Intervention Period 3 and Washout||3
10006946|NCT01748552|11129173|FG011|STARTED|Intervention Period 3 and Washout||3
10006947|NCT01748552|11129162|FG000|COMPLETED|Intervention Period 3 and Washout||3
10006948|NCT01748552|11129163|FG001|COMPLETED|Intervention Period 3 and Washout||3
10006949|NCT01748552|11129164|FG002|COMPLETED|Intervention Period 3 and Washout||2
10006950|NCT01748552|11129165|FG003|COMPLETED|Intervention Period 3 and Washout||3
10006951|NCT01748552|11129166|FG004|COMPLETED|Intervention Period 3 and Washout||3
10006952|NCT01748552|11129167|FG005|COMPLETED|Intervention Period 3 and Washout||3
10006953|NCT01748552|11129168|FG006|COMPLETED|Intervention Period 3 and Washout||0
10006954|NCT01748552|11129169|FG007|COMPLETED|Intervention Period 3 and Washout||0
10006955|NCT01748552|11129170|FG008|COMPLETED|Intervention Period 3 and Washout||0
10006956|NCT01748552|11129171|FG009|COMPLETED|Intervention Period 3 and Washout||3
10006957|NCT01748552|11129172|FG010|COMPLETED|Intervention Period 3 and Washout||3
10006958|NCT01748552|11129173|FG011|COMPLETED|Intervention Period 3 and Washout||3
10006959|NCT01748552|11129162|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0
10006960|NCT01748552|11129163|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0
10006961|NCT01748552|11129164|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0
10006962|NCT01748552|11129165|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0
10006963|NCT01748552|11129166|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0
10006964|NCT01748552|11129167|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0
10006965|NCT01748552|11129168|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0
10006966|NCT01748552|11129169|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0
10006967|NCT01748552|11129170|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0
10006968|NCT01748552|11129171|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0
10006969|NCT01748552|11129172|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0
10006970|NCT01748552|11129173|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0
10006971|NCT01748643|11129215|FG000|STARTED|Overall Study||30
10006972|NCT01748643|11129216|FG001|STARTED|Overall Study||30
10006973|NCT01748643|11129215|FG000|COMPLETED|Overall Study||30
10006974|NCT01748643|11129216|FG001|COMPLETED|Overall Study||30
10006975|NCT01748643|11129215|FG000|NOT COMPLETED|Overall Study||0
10106048|NCT02446899|11235996|FG000|NOT COMPLETED|Overall Study||25
10106049|NCT02446899|11235997|FG001|NOT COMPLETED|Overall Study||48
10106050|NCT02446912|11236006|FG000|STARTED|Overall Study||93
10106051|NCT02446912|11236007|FG001|STARTED|Overall Study||180
10106052|NCT02446912|11236008|FG002|STARTED|Overall Study||184
10106053|NCT02446912|11236006|FG000|Participants Who Completed Week 52|Overall Study||80
10106054|NCT02446912|11236007|FG001|Participants Who Completed Week 52|Overall Study||153
10106055|NCT02446912|11236008|FG002|Participants Who Completed Week 52|Overall Study||157
10106056|NCT02446912|11236006|FG000|COMPLETED|Overall Study||75
10106057|NCT02446912|11236007|FG001|COMPLETED|Overall Study||145
10106058|NCT02446912|11236008|FG002|COMPLETED|Overall Study||149
10106059|NCT02446912|11236006|FG000|NOT COMPLETED|Overall Study||18
10106060|NCT02446912|11236007|FG001|NOT COMPLETED|Overall Study||35
10106061|NCT02446912|11236008|FG002|NOT COMPLETED|Overall Study||35
10106062|NCT02446990|11236018|FG000|STARTED|Overall Study||9550
10106063|NCT02446990|11236019|FG001|STARTED|Overall Study||9552
10106064|NCT02446990|11236018|FG000|COMPLETED|Overall Study||8830
10106065|NCT02446990|11236019|FG001|COMPLETED|Overall Study||8894
10202391|NCT03444155|11329469|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10202392|NCT03444155|11329470|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10202393|NCT03444155|11329469|FG000|STARTED|Second Intervention (6 Weeks)||14
10202394|NCT03444155|11329470|FG001|STARTED|Second Intervention (6 Weeks)||15
10202395|NCT03444155|11329469|FG000|COMPLETED|Second Intervention (6 Weeks)||14
10202396|NCT03444155|11329470|FG001|COMPLETED|Second Intervention (6 Weeks)||15
10202397|NCT03444155|11329469|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10202398|NCT03444155|11329470|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10202399|NCT03444584|11329478|FG000|STARTED|Overall Study||24
10202400|NCT03444584|11329479|FG001|STARTED|Overall Study||25
10202401|NCT03444584|11329478|FG000|COMPLETED|Overall Study||24
10202402|NCT03444584|11329479|FG001|COMPLETED|Overall Study||23
10202403|NCT03444584|11329478|FG000|NOT COMPLETED|Overall Study||0
10202404|NCT03444584|11329479|FG001|NOT COMPLETED|Overall Study||2
10202405|NCT03444766|11329486|FG000|STARTED|Overall Study||100
10202406|NCT03444766|11329486|FG000|COMPLETED|Overall Study||34
10202407|NCT03444766|11329486|FG000|NOT COMPLETED|Overall Study||66
10202408|NCT03444961|11329490|FG000|STARTED|Overall Study||4
10202409|NCT03444961|11329490|FG000|COMPLETED|Overall Study||4
10202410|NCT03444961|11329490|FG000|NOT COMPLETED|Overall Study||0
10202411|NCT03445065|11329502|FG000|STARTED|Overall Study||97
10202412|NCT03445065|11329503|FG001|STARTED|Overall Study||52
10202413|NCT03445065|11329504|FG002|STARTED|Overall Study||62
10202414|NCT03445065|11329505|FG003|STARTED|Overall Study||28
10202415|NCT03445065|11329502|FG000|COMPLETED|Overall Study||90
10202416|NCT03445065|11329503|FG001|COMPLETED|Overall Study||43
10202417|NCT03445065|11329504|FG002|COMPLETED|Overall Study||57
10202418|NCT03445065|11329505|FG003|COMPLETED|Overall Study||25
10202419|NCT03445065|11329502|FG000|NOT COMPLETED|Overall Study||7
9759153|NCT00372489|10862730|FG000|STARTED|Overall Study||81
9759154|NCT00372489|10862730|FG000|COMPLETED|Overall Study||2
9759155|NCT00372489|10862730|FG000|NOT COMPLETED|Overall Study||79
9759156|NCT00372528|10862734|FG000|STARTED|Overall Study||21
9877470|NCT01011465|10991920|FG006|NOT COMPLETED|Overall Study||1
9877471|NCT01011465|10991921|FG007|NOT COMPLETED|Overall Study||0
9877472|NCT01011556|10991941|FG000|STARTED|Overall Study||58
9877473|NCT01011556|10991942|FG001|STARTED|Overall Study||56
10006976|NCT01748643|11129216|FG001|NOT COMPLETED|Overall Study||0
10006977|NCT01748695|11129222|FG000|STARTED|First Intervention (4 Weeks)||14
10006978|NCT01748695|11129223|FG001|STARTED|First Intervention (4 Weeks)||11
10006979|NCT01748695|11129222|FG000|COMPLETED|First Intervention (4 Weeks)||14
10006980|NCT01748695|11129223|FG001|COMPLETED|First Intervention (4 Weeks)||11
9759157|NCT00372528|10862734|FG000|COMPLETED|Overall Study||0
9759158|NCT00372528|10862734|FG000|NOT COMPLETED|Overall Study||21
9759159|NCT00372567|10862741|FG000|STARTED|Phase 1 Sub-study||0
9759160|NCT00372567|10862742|FG001|STARTED|Phase 1 Sub-study||0
9759161|NCT00372567|10862743|FG002|STARTED|Phase 1 Sub-study||12
9759162|NCT00372567|10862741|FG000|COMPLETED|Phase 1 Sub-study||0
9759163|NCT00372567|10862742|FG001|COMPLETED|Phase 1 Sub-study||0
9759164|NCT00372567|10862743|FG002|COMPLETED|Phase 1 Sub-study||12
9759165|NCT00372567|10862741|FG000|NOT COMPLETED|Phase 1 Sub-study||0
9759166|NCT00372567|10862742|FG001|NOT COMPLETED|Phase 1 Sub-study||0
9759167|NCT00372567|10862743|FG002|NOT COMPLETED|Phase 1 Sub-study||0
9759168|NCT00372567|10862741|FG000|STARTED|Phase 3 Study||31
9759169|NCT00372567|10862742|FG001|STARTED|Phase 3 Study||26
9759170|NCT00372567|10862743|FG002|STARTED|Phase 3 Study||12
9759171|NCT00372567|10862741|FG000|Received Treatment|Phase 3 Study||31
9759172|NCT00372567|10862742|FG001|Received Treatment|Phase 3 Study||25
9759173|NCT00372567|10862743|FG002|Received Treatment|Phase 3 Study||12
9759174|NCT00372567|10862741|FG000|COMPLETED|Phase 3 Study||0
9759175|NCT00372567|10862742|FG001|COMPLETED|Phase 3 Study||0
9759176|NCT00372567|10862743|FG002|COMPLETED|Phase 3 Study||0
9759177|NCT00372567|10862741|FG000|NOT COMPLETED|Phase 3 Study||31
9759178|NCT00372567|10862742|FG001|NOT COMPLETED|Phase 3 Study||26
9759179|NCT00372567|10862743|FG002|NOT COMPLETED|Phase 3 Study||12
9759180|NCT00372593|10862754|FG000|STARTED|Overall Study||531
9759181|NCT00372593|10862755|FG001|STARTED|Overall Study||532
9759182|NCT00372593|10862756|FG002|STARTED|Overall Study||7
9759183|NCT00372593|10862754|FG000|COMPLETED|Overall Study||327
9759184|NCT00372593|10862755|FG001|COMPLETED|Overall Study||334
9759185|NCT00372593|10862756|FG002|COMPLETED|Overall Study||3
9759186|NCT00372593|10862754|FG000|NOT COMPLETED|Overall Study||204
9759187|NCT00372593|10862755|FG001|NOT COMPLETED|Overall Study||198
9759188|NCT00372593|10862756|FG002|NOT COMPLETED|Overall Study||4
9759189|NCT00372619|10862772|FG000|STARTED|Overall Study||8
9759190|NCT00372619|10862773|FG001|STARTED|Overall Study||2
9759191|NCT00372619|10862774|FG002|STARTED|Overall Study||3
9759192|NCT00372619|10862775|FG003|STARTED|Overall Study||10
9759193|NCT00372619|10862776|FG004|STARTED|Overall Study||7
9759194|NCT00372619|10862777|FG005|STARTED|Overall Study||42
9759195|NCT00372619|10862778|FG006|STARTED|Overall Study||2
9759196|NCT00372619|10862772|FG000|COMPLETED|Overall Study||8
9759197|NCT00372619|10862773|FG001|COMPLETED|Overall Study||2
9877474|NCT01011556|10991943|FG002|STARTED|Overall Study||55
9877475|NCT01011556|10991944|FG003|STARTED|Overall Study||64
9877476|NCT01011556|10991941|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57
9877477|NCT01011556|10991942|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
9877478|NCT01011556|10991943|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54
9877479|NCT01011556|10991944|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64
9877480|NCT01011556|10991941|FG000|COMPLETED|Overall Study||52
9877481|NCT01011556|10991942|FG001|COMPLETED|Overall Study||48
9877482|NCT01011556|10991943|FG002|COMPLETED|Overall Study||45
9877483|NCT01011556|10991944|FG003|COMPLETED|Overall Study||51
9877484|NCT01011556|10991941|FG000|NOT COMPLETED|Overall Study||6
9877485|NCT01011556|10991942|FG001|NOT COMPLETED|Overall Study||8
10006981|NCT01748695|11129222|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10006982|NCT01748695|11129223|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10006983|NCT01748695|11129222|FG000|STARTED|Second Intervention (4 Weeks)||14
10006984|NCT01748695|11129223|FG001|STARTED|Second Intervention (4 Weeks)||11
10006985|NCT01748695|11129222|FG000|COMPLETED|Second Intervention (4 Weeks)||14
10006986|NCT01748695|11129223|FG001|COMPLETED|Second Intervention (4 Weeks)||11
10006987|NCT01748695|11129222|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10006988|NCT01748695|11129223|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10006989|NCT01748760|11129231|FG000|STARTED|Overall Study||25
10006990|NCT01748760|11129232|FG001|STARTED|Overall Study||25
10006991|NCT01748760|11129231|FG000|COMPLETED|Overall Study||19
10006992|NCT01748760|11129232|FG001|COMPLETED|Overall Study||23
10106066|NCT02446990|11236018|FG000|NOT COMPLETED|Overall Study||720
10106067|NCT02446990|11236019|FG001|NOT COMPLETED|Overall Study||658
10106068|NCT02447003|11236027|FG000|STARTED|Overall Study||170
10106069|NCT02447003|11236028|FG001|STARTED|Overall Study||84
10106070|NCT02447003|11236027|FG000|COMPLETED|Overall Study||0
10106071|NCT02447003|11236028|FG001|COMPLETED|Overall Study||0
10106072|NCT02447003|11236027|FG000|NOT COMPLETED|Overall Study||170
10106073|NCT02447003|11236028|FG001|NOT COMPLETED|Overall Study||84
10106074|NCT02447029|11236038|FG000|STARTED|Overall Study||72
10106075|NCT02447029|11236039|FG001|STARTED|Overall Study||70
10106076|NCT02447029|11236038|FG000|Treated|Overall Study||69
10106077|NCT02447029|11236039|FG001|Treated|Overall Study||68
10106078|NCT02447029|11236038|FG000|COMPLETED|Overall Study||69
10106079|NCT02447029|11236039|FG001|COMPLETED|Overall Study||68
10106080|NCT02447029|11236038|FG000|NOT COMPLETED|Overall Study||3
10106081|NCT02447029|11236039|FG001|NOT COMPLETED|Overall Study||2
10106082|NCT02447081|11236045|FG000|STARTED|Overall Study||1088
10106083|NCT02447081|11236045|FG000|COMPLETED|Overall Study||864
10106084|NCT02447081|11236045|FG000|NOT COMPLETED|Overall Study||224
10106085|NCT02447172|11236052|FG000|STARTED|Overall Study||262
9759198|NCT00372619|10862774|FG002|COMPLETED|Overall Study||3
9759199|NCT00372619|10862775|FG003|COMPLETED|Overall Study||10
9759200|NCT00372619|10862776|FG004|COMPLETED|Overall Study||7
9759201|NCT00372619|10862777|FG005|COMPLETED|Overall Study||39
9759202|NCT00372619|10862778|FG006|COMPLETED|Overall Study||2
9759203|NCT00372619|10862772|FG000|NOT COMPLETED|Overall Study||0
9759204|NCT00372619|10862773|FG001|NOT COMPLETED|Overall Study||0
9759205|NCT00372619|10862774|FG002|NOT COMPLETED|Overall Study||0
9759206|NCT00372619|10862775|FG003|NOT COMPLETED|Overall Study||0
9759207|NCT00372619|10862776|FG004|NOT COMPLETED|Overall Study||0
9759208|NCT00372619|10862777|FG005|NOT COMPLETED|Overall Study||3
9759209|NCT00372619|10862778|FG006|NOT COMPLETED|Overall Study||0
9759210|NCT00372697|10862796|FG000|STARTED|Overall Study||16
10006993|NCT01748760|11129231|FG000|NOT COMPLETED|Overall Study||6
10006994|NCT01748760|11129232|FG001|NOT COMPLETED|Overall Study||2
10202420|NCT03445065|11329503|FG001|NOT COMPLETED|Overall Study||9
10202421|NCT03445065|11329504|FG002|NOT COMPLETED|Overall Study||5
10202422|NCT03445065|11329505|FG003|NOT COMPLETED|Overall Study||3
10202423|NCT03445156|11329530|FG000|STARTED|Pilot Study||20
10202424|NCT03445156|11329531|FG001|STARTED|Pilot Study||20
10202425|NCT03445156|11329532|FG002|STARTED|Pilot Study||0
10202426|NCT03445156|11329530|FG000|COMPLETED|Pilot Study||20
10202427|NCT03445156|11329531|FG001|COMPLETED|Pilot Study||20
10202428|NCT03445156|11329532|FG002|COMPLETED|Pilot Study||0
10202429|NCT03445156|11329530|FG000|NOT COMPLETED|Pilot Study||0
10202430|NCT03445156|11329531|FG001|NOT COMPLETED|Pilot Study||0
10202431|NCT03445156|11329532|FG002|NOT COMPLETED|Pilot Study||0
10202432|NCT03445156|11329530|FG000|STARTED|Experiment Proper||113
10202433|NCT03445156|11329531|FG001|STARTED|Experiment Proper||115
10202434|NCT03445156|11329532|FG002|STARTED|Experiment Proper||59
10202435|NCT03445156|11329530|FG000|COMPLETED|Experiment Proper||113
10202436|NCT03445156|11329531|FG001|COMPLETED|Experiment Proper||115
10202437|NCT03445156|11329532|FG002|COMPLETED|Experiment Proper||59
10202438|NCT03445156|11329530|FG000|NOT COMPLETED|Experiment Proper||0
10202439|NCT03445156|11329531|FG001|NOT COMPLETED|Experiment Proper||0
10202440|NCT03445156|11329532|FG002|NOT COMPLETED|Experiment Proper||0
10202441|NCT03445195|11329546|FG000|STARTED|Overall Study||53
10202442|NCT03445195|11329547|FG001|STARTED|Overall Study||27
10202443|NCT03445195|11329546|FG000|COMPLETED|Overall Study||51
10202444|NCT03445195|11329547|FG001|COMPLETED|Overall Study||27
10202445|NCT03445195|11329546|FG000|NOT COMPLETED|Overall Study||2
10202446|NCT03445195|11329547|FG001|NOT COMPLETED|Overall Study||0
10202447|NCT03445390|11329553|FG000|STARTED|First Intervention||14
10202448|NCT03445390|11329554|FG001|STARTED|First Intervention||13
10202449|NCT03445390|11329553|FG000|COMPLETED|First Intervention||12
10202450|NCT03445390|11329554|FG001|COMPLETED|First Intervention||11
10202451|NCT03445390|11329553|FG000|NOT COMPLETED|First Intervention||2
10202452|NCT03445390|11329554|FG001|NOT COMPLETED|First Intervention||2
10202453|NCT03445390|11329553|FG000|STARTED|Second Intervention||12
10202454|NCT03445390|11329554|FG001|STARTED|Second Intervention||11
10202455|NCT03445390|11329553|FG000|COMPLETED|Second Intervention||10
10202456|NCT03445390|11329554|FG001|COMPLETED|Second Intervention||10
10202457|NCT03445390|11329553|FG000|NOT COMPLETED|Second Intervention||2
10202458|NCT03445390|11329554|FG001|NOT COMPLETED|Second Intervention||1
10202459|NCT03445793|11329560|FG000|STARTED|Overall Study||5
10202460|NCT03445793|11329560|FG000|COMPLETED|Overall Study||5
10202461|NCT03445793|11329560|FG000|NOT COMPLETED|Overall Study||0
10202462|NCT03446053|11329569|FG000|STARTED|Overall Study||2
10202463|NCT03446053|11329570|FG001|STARTED|Overall Study||6
10202464|NCT03446053|11329571|FG002|STARTED|Overall Study||6
10202465|NCT03446053|11329572|FG003|STARTED|Overall Study||7
10202466|NCT03446053|11329573|FG004|STARTED|Overall Study||6
10202467|NCT03446053|11329574|FG005|STARTED|Overall Study||6
10202468|NCT03446053|11329569|FG000|Randomized Set|Overall Study||2
10202469|NCT03446053|11329570|FG001|Randomized Set|Overall Study||6
10202470|NCT03446053|11329571|FG002|Randomized Set|Overall Study||6
10202471|NCT03446053|11329572|FG003|Randomized Set|Overall Study||7
10202472|NCT03446053|11329573|FG004|Randomized Set|Overall Study||6
10202473|NCT03446053|11329574|FG005|Randomized Set|Overall Study||6
10202474|NCT03446053|11329569|FG000|Safety Analysis Set|Overall Study||2
10202475|NCT03446053|11329570|FG001|Safety Analysis Set|Overall Study||6
10202476|NCT03446053|11329571|FG002|Safety Analysis Set|Overall Study||6
10202477|NCT03446053|11329572|FG003|Safety Analysis Set|Overall Study||6
10202478|NCT03446053|11329573|FG004|Safety Analysis Set|Overall Study||6
10202479|NCT03446053|11329574|FG005|Safety Analysis Set|Overall Study||6
10202480|NCT03446053|11329569|FG000|PK/PD Analysis Set|Overall Study||2
10202481|NCT03446053|11329570|FG001|PK/PD Analysis Set|Overall Study||6
10202482|NCT03446053|11329571|FG002|PK/PD Analysis Set|Overall Study||6
10202483|NCT03446053|11329572|FG003|PK/PD Analysis Set|Overall Study||6
10202484|NCT03446053|11329573|FG004|PK/PD Analysis Set|Overall Study||6
10202485|NCT03446053|11329574|FG005|PK/PD Analysis Set|Overall Study||5
10202486|NCT03446053|11329569|FG000|COMPLETED|Overall Study||2
10202487|NCT03446053|11329570|FG001|COMPLETED|Overall Study||5
10202488|NCT03446053|11329571|FG002|COMPLETED|Overall Study||6
9759211|NCT00372697|10862797|FG001|STARTED|Overall Study||12
9759212|NCT00372697|10862796|FG000|COMPLETED|Overall Study||15
9759213|NCT00372697|10862797|FG001|COMPLETED|Overall Study||11
10106086|NCT02447172|11236053|FG001|STARTED|Overall Study||130
10106087|NCT02447172|11236054|FG002|STARTED|Overall Study||132
10106088|NCT02447172|11236052|FG000|COMPLETED|Overall Study||231
10106089|NCT02447172|11236053|FG001|COMPLETED|Overall Study||115
10106090|NCT02447172|11236054|FG002|COMPLETED|Overall Study||114
10106091|NCT02447172|11236052|FG000|NOT COMPLETED|Overall Study||31
10106092|NCT02447172|11236053|FG001|NOT COMPLETED|Overall Study||15
10106093|NCT02447172|11236054|FG002|NOT COMPLETED|Overall Study||18
10106094|NCT02447250|11236062|FG000|STARTED|First Dose (180 mcg Albuterol)||14
10106095|NCT02447250|11236062|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14
10106096|NCT02447250|11236062|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
10106097|NCT02447250|11236062|FG000|STARTED|Second Dose (270 mcg Albuterol)||14
10106098|NCT02447250|11236062|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13
10106099|NCT02447250|11236062|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
10106100|NCT02447250|11236062|FG000|STARTED|Third Dose (360 mcg Albuterol)||13
10106101|NCT02447250|11236062|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8
10106102|NCT02447250|11236062|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
10106103|NCT02447302|11236070|FG000|STARTED|Overall Study||52
10106104|NCT02447302|11236071|FG001|STARTED|Overall Study||50
10106105|NCT02447302|11236072|FG002|STARTED|Overall Study||54
10106106|NCT02447302|11236070|FG000|COMPLETED|Overall Study||47
10006995|NCT01748799|11129246|FG000|STARTED|Overall Study||6
10006996|NCT01748799|11129247|FG001|STARTED|Overall Study||1
10006997|NCT01748799|11129248|FG002|STARTED|Overall Study||1
10006998|NCT01748799|11129249|FG003|STARTED|Overall Study||2
10106107|NCT02447302|11236071|FG001|COMPLETED|Overall Study||46
10106108|NCT02447302|11236072|FG002|COMPLETED|Overall Study||48
10106109|NCT02447302|11236070|FG000|NOT COMPLETED|Overall Study||5
10106110|NCT02447302|11236071|FG001|NOT COMPLETED|Overall Study||4
10106111|NCT02447302|11236072|FG002|NOT COMPLETED|Overall Study||6
10106112|NCT02447328|11236080|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
10106113|NCT02447328|11236080|FG000|COMPLETED|Overall Study||82
10106114|NCT02447328|11236080|FG000|NOT COMPLETED|Overall Study||1
10106115|NCT02447432|11236086|FG000|STARTED|Epoch 001||160
9759214|NCT00372697|10862796|FG000|NOT COMPLETED|Overall Study||1
9759215|NCT00372697|10862797|FG001|NOT COMPLETED|Overall Study||1
9759216|NCT00372775|10862803|FG000|STARTED|Overall Study||66
9759217|NCT00372775|10862803|FG000|Received Treatment|Overall Study||64
9759218|NCT00372775|10862803|FG000|COMPLETED|Overall Study||3
9759219|NCT00372775|10862803|FG000|NOT COMPLETED|Overall Study||63
9759220|NCT00372905|10862807|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
9759221|NCT00372905|10862808|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
9759222|NCT00372905|10862809|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
9759223|NCT00372905|10862810|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
9759224|NCT00372905|10862807|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
9759225|NCT00372905|10862808|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
9759226|NCT00372905|10862809|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
9759227|NCT00372905|10862810|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
9759228|NCT00372905|10862807|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
9759229|NCT00372905|10862808|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
9759230|NCT00372905|10862809|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
9759231|NCT00372905|10862810|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
9759232|NCT00372905|10862807|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
9759233|NCT00372905|10862808|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
9759234|NCT00372905|10862809|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
9759235|NCT00372905|10862810|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
9759236|NCT00372905|10862807|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
9759237|NCT00372905|10862808|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
9759238|NCT00372905|10862809|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
9759239|NCT00372905|10862810|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
9759240|NCT00372905|10862807|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
9759241|NCT00372905|10862808|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
9759242|NCT00372905|10862809|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
9759243|NCT00372905|10862810|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
9759244|NCT00372905|10862807|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
10006999|NCT01748799|11129250|FG004|STARTED|Overall Study||1
10007000|NCT01748799|11129251|FG005|STARTED|Overall Study||2
10007001|NCT01748799|11129252|FG006|STARTED|Overall Study||2
10007002|NCT01748799|11129253|FG007|STARTED|Overall Study||1
10007003|NCT01748799|11129246|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2
10007004|NCT01748799|11129247|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1
10007005|NCT01748799|11129248|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1
10007006|NCT01748799|11129249|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2
10007007|NCT01748799|11129250|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1
10007008|NCT01748799|11129251|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1
10007009|NCT01748799|11129252|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1
10007010|NCT01748799|11129253|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1
10106116|NCT02447432|11236087|FG001|STARTED|Epoch 001||160
10106117|NCT02447432|11236086|FG000|COMPLETED|Epoch 001||155
10007011|NCT01748799|11129246|FG000|Completed Fixed Dose Placebo|Overall Study||2
10007012|NCT01748799|11129247|FG001|Completed Fixed Dose Placebo|Overall Study||1
10007013|NCT01748799|11129248|FG002|Completed Fixed Dose Placebo|Overall Study||1
10007014|NCT01748799|11129249|FG003|Completed Fixed Dose Placebo|Overall Study||2
10007015|NCT01748799|11129250|FG004|Completed Fixed Dose Placebo|Overall Study||1
10106118|NCT02447432|11236087|FG001|COMPLETED|Epoch 001||147
10106119|NCT02447432|11236086|FG000|NOT COMPLETED|Epoch 001||5
10106120|NCT02447432|11236087|FG001|NOT COMPLETED|Epoch 001||13
10202489|NCT03446053|11329572|FG003|COMPLETED|Overall Study||6
10106121|NCT02447432|11236086|FG000|STARTED|Epoch 002||152
10106122|NCT02447432|11236087|FG001|STARTED|Epoch 002||145
10202490|NCT03446053|11329573|FG004|COMPLETED|Overall Study||6
10202491|NCT03446053|11329574|FG005|COMPLETED|Overall Study||5
10202492|NCT03446053|11329569|FG000|NOT COMPLETED|Overall Study||0
10202493|NCT03446053|11329570|FG001|NOT COMPLETED|Overall Study||1
10202494|NCT03446053|11329571|FG002|NOT COMPLETED|Overall Study||0
10202495|NCT03446053|11329572|FG003|NOT COMPLETED|Overall Study||1
10202496|NCT03446053|11329573|FG004|NOT COMPLETED|Overall Study||0
10202497|NCT03446053|11329574|FG005|NOT COMPLETED|Overall Study||1
10202498|NCT03446690|11329603|FG000|STARTED|Overall Study||33
10202499|NCT03446690|11329604|FG001|STARTED|Overall Study||29
10202500|NCT03446690|11329603|FG000|COMPLETED|Overall Study||26
10202501|NCT03446690|11329604|FG001|COMPLETED|Overall Study||29
10202502|NCT03446690|11329603|FG000|NOT COMPLETED|Overall Study||7
10202503|NCT03446690|11329604|FG001|NOT COMPLETED|Overall Study||0
10202504|NCT03446781|11329612|FG000|STARTED|Overall Study||214
10202505|NCT03446781|11329613|FG001|STARTED|Overall Study||208
10202506|NCT03446781|11329612|FG000|COMPLETED|Overall Study||186
10202507|NCT03446781|11329613|FG001|COMPLETED|Overall Study||191
10202508|NCT03446781|11329612|FG000|NOT COMPLETED|Overall Study||28
10202509|NCT03446781|11329613|FG001|NOT COMPLETED|Overall Study||17
10202510|NCT03446846|11329644|FG000|STARTED|Overall Study||90
10202511|NCT03446846|11329645|FG001|STARTED|Overall Study||92
10202512|NCT03446846|11329646|FG002|STARTED|Overall Study||178
10202513|NCT03446846|11329644|FG000|COMPLETED|Overall Study||83
10202514|NCT03446846|11329645|FG001|COMPLETED|Overall Study||87
10202515|NCT03446846|11329646|FG002|COMPLETED|Overall Study||162
10202516|NCT03446846|11329644|FG000|NOT COMPLETED|Overall Study||7
10202517|NCT03446846|11329645|FG001|NOT COMPLETED|Overall Study||5
10202518|NCT03446846|11329646|FG002|NOT COMPLETED|Overall Study||16
10202519|NCT03446885|11329654|FG000|STARTED|Overall Study||12
10202520|NCT03446885|11329655|FG001|STARTED|Overall Study||10
10202521|NCT03446885|11329654|FG000|COMPLETED|Overall Study||10
10202522|NCT03446885|11329655|FG001|COMPLETED|Overall Study||10
10202523|NCT03446885|11329654|FG000|NOT COMPLETED|Overall Study||2
10202524|NCT03446885|11329655|FG001|NOT COMPLETED|Overall Study||0
10202525|NCT03447015|11329665|FG000|STARTED|Overall Study||140
10202526|NCT03447015|11329666|FG001|STARTED|Overall Study||150
10202527|NCT03447015|11329665|FG000|COMPLETED|Overall Study||95
10202528|NCT03447015|11329666|FG001|COMPLETED|Overall Study||106
10202529|NCT03447015|11329665|FG000|NOT COMPLETED|Overall Study||45
10202530|NCT03447015|11329666|FG001|NOT COMPLETED|Overall Study||44
10202531|NCT03447249|11329674|FG000|STARTED|Overall Study||190
10202532|NCT03447249|11329675|FG001|STARTED|Overall Study||192
10202533|NCT03447249|11329674|FG000|Safety Set|Overall Study||189
10202534|NCT03447249|11329675|FG001|Safety Set|Overall Study||193
10202535|NCT03447249|11329674|FG000|COMPLETED|Overall Study||185
10202536|NCT03447249|11329675|FG001|COMPLETED|Overall Study||192
10106123|NCT02447432|11236086|FG000|COMPLETED|Epoch 002||152
10106124|NCT02447432|11236087|FG001|COMPLETED|Epoch 002||145
10106125|NCT02447432|11236086|FG000|NOT COMPLETED|Epoch 002||0
10106126|NCT02447432|11236087|FG001|NOT COMPLETED|Epoch 002||0
10106127|NCT02447458|11236099|FG000|STARTED|Overall Study||5
10202537|NCT03447249|11329674|FG000|NOT COMPLETED|Overall Study||5
10202538|NCT03447249|11329675|FG001|NOT COMPLETED|Overall Study||0
10202539|NCT03447353|11329683|FG000|STARTED|Overall Study||18
10202540|NCT03447353|11329683|FG000|COMPLETED|Overall Study||8
10202541|NCT03447353|11329683|FG000|NOT COMPLETED|Overall Study||10
10202542|NCT03447730|11329696|FG000|STARTED|Overall Study||6
10202543|NCT03447730|11329697|FG001|STARTED|Overall Study||9
10202544|NCT03447730|11329698|FG002|STARTED|Overall Study||8
10202545|NCT03447730|11329696|FG000|COMPLETED|Overall Study||6
10202546|NCT03447730|11329697|FG001|COMPLETED|Overall Study||7
10202547|NCT03447730|11329698|FG002|COMPLETED|Overall Study||8
10202548|NCT03447730|11329696|FG000|NOT COMPLETED|Overall Study||0
10202549|NCT03447730|11329697|FG001|NOT COMPLETED|Overall Study||2
10202550|NCT03447730|11329698|FG002|NOT COMPLETED|Overall Study||0
10202551|NCT03447821|11329709|FG000|STARTED|Overall Study||14
10202552|NCT03447821|11329710|FG001|STARTED|Overall Study||13
10202553|NCT03447821|11329711|FG002|STARTED|Overall Study||13
10202554|NCT03447821|11329709|FG000|COMPLETED|Overall Study||13
10202555|NCT03447821|11329710|FG001|COMPLETED|Overall Study||12
10007016|NCT01748799|11129251|FG005|Completed Fixed Dose Placebo|Overall Study||1
10007017|NCT01748799|11129252|FG006|Completed Fixed Dose Placebo|Overall Study||1
10007018|NCT01748799|11129253|FG007|Completed Fixed Dose Placebo|Overall Study||1
10007019|NCT01748799|11129246|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1
10007020|NCT01748799|11129247|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1
10007021|NCT01748799|11129248|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1
10007022|NCT01748799|11129249|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2
10007023|NCT01748799|11129250|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1
10007024|NCT01748799|11129251|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1
10007025|NCT01748799|11129252|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1
10007026|NCT01748799|11129253|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1
10007027|NCT01748799|11129246|FG000|Completed Fixed Dose Sativex|Overall Study||1
10106128|NCT02447458|11236100|FG001|STARTED|Overall Study||6
10106129|NCT02447458|11236101|FG002|STARTED|Overall Study||6
10106130|NCT02447458|11236102|FG003|STARTED|Overall Study||6
10106131|NCT02447458|11236103|FG004|STARTED|Overall Study||6
10106132|NCT02447458|11236104|FG005|STARTED|Overall Study||10
10106133|NCT02447458|11236099|FG000|COMPLETED|Overall Study||5
10106134|NCT02447458|11236100|FG001|COMPLETED|Overall Study||6
10106135|NCT02447458|11236101|FG002|COMPLETED|Overall Study||5
10106136|NCT02447458|11236102|FG003|COMPLETED|Overall Study||6
10106137|NCT02447458|11236103|FG004|COMPLETED|Overall Study||6
10106138|NCT02447458|11236104|FG005|COMPLETED|Overall Study||10
10106139|NCT02447458|11236099|FG000|NOT COMPLETED|Overall Study||0
10106140|NCT02447458|11236100|FG001|NOT COMPLETED|Overall Study||0
10202556|NCT03447821|11329711|FG002|COMPLETED|Overall Study||12
10202557|NCT03447821|11329709|FG000|NOT COMPLETED|Overall Study||1
10106141|NCT02447458|11236101|FG002|NOT COMPLETED|Overall Study||1
10106142|NCT02447458|11236102|FG003|NOT COMPLETED|Overall Study||0
10106143|NCT02447458|11236103|FG004|NOT COMPLETED|Overall Study||0
10106144|NCT02447458|11236104|FG005|NOT COMPLETED|Overall Study||0
10106145|NCT02447497|11236127|FG000|STARTED|Overall Study||25
10106146|NCT02447497|11236128|FG001|STARTED|Overall Study||25
10106147|NCT02447497|11236129|FG002|STARTED|Overall Study||23
10106148|NCT02447497|11236130|FG003|STARTED|Overall Study||23
10106149|NCT02447497|11236127|FG000|COMPLETED|Overall Study||19
10202558|NCT03447821|11329710|FG001|NOT COMPLETED|Overall Study||1
10202559|NCT03447821|11329711|FG002|NOT COMPLETED|Overall Study||1
10202560|NCT03448068|11329721|FG000|STARTED|Overall Study||17
10106150|NCT02447497|11236128|FG001|COMPLETED|Overall Study||19
10106151|NCT02447497|11236129|FG002|COMPLETED|Overall Study||21
10106152|NCT02447497|11236130|FG003|COMPLETED|Overall Study||21
10106153|NCT02447497|11236127|FG000|NOT COMPLETED|Overall Study||6
10106154|NCT02447497|11236128|FG001|NOT COMPLETED|Overall Study||6
10202561|NCT03448068|11329722|FG001|STARTED|Overall Study||17
10202562|NCT03448068|11329721|FG000|COMPLETED|Overall Study||17
10202563|NCT03448068|11329722|FG001|COMPLETED|Overall Study||17
10202564|NCT03448068|11329721|FG000|NOT COMPLETED|Overall Study||0
10202565|NCT03448068|11329722|FG001|NOT COMPLETED|Overall Study||0
10202566|NCT03448224|11329730|FG000|STARTED|Overall Study||28
10202567|NCT03448224|11329731|FG001|STARTED|Overall Study||26
10202568|NCT03448224|11329730|FG000|COMPLETED|Overall Study||27
9759245|NCT00372905|10862808|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
9759246|NCT00372905|10862809|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
9759247|NCT00372905|10862810|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
9759248|NCT00372905|10862807|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
9759249|NCT00372905|10862808|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
9759250|NCT00372905|10862809|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
9759251|NCT00372905|10862810|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
9759252|NCT00372905|10862807|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
9759253|NCT00372905|10862808|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
9759254|NCT00372905|10862809|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
9759255|NCT00372905|10862810|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
9759256|NCT00372905|10862807|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
9759257|NCT00372905|10862808|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
9759258|NCT00372905|10862809|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
9759259|NCT00372905|10862810|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
9759260|NCT00372905|10862807|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
9759261|NCT00372905|10862808|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
9759262|NCT00372905|10862809|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
9759263|NCT00372905|10862810|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
9759264|NCT00372905|10862807|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
9759265|NCT00372905|10862808|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
9759266|NCT00372905|10862809|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
9759267|NCT00372905|10862810|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
9759268|NCT00372905|10862807|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
9759269|NCT00372905|10862808|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
9759270|NCT00372905|10862809|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
9759271|NCT00372905|10862810|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
9759272|NCT00372905|10862807|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0
9759273|NCT00372905|10862808|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0
9759274|NCT00372905|10862809|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4
9759275|NCT00372905|10862810|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0
9759276|NCT00372905|10862807|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
9759277|NCT00372905|10862808|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
9759278|NCT00372905|10862809|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
9759279|NCT00372905|10862810|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
9759280|NCT00372905|10862807|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
9759281|NCT00372905|10862808|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
9759282|NCT00372905|10862809|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
9759283|NCT00372905|10862810|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
9759284|NCT00372905|10862807|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
9759285|NCT00372905|10862808|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
9759286|NCT00372905|10862809|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
9759287|NCT00372905|10862810|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
9759288|NCT00372905|10862807|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
9759289|NCT00372905|10862808|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
9759290|NCT00372905|10862809|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
9759291|NCT00372905|10862810|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
9759292|NCT00372905|10862807|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0
9759293|NCT00372905|10862808|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0
9759294|NCT00372905|10862809|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0
9759295|NCT00372905|10862810|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8
9759296|NCT00372905|10862807|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0
9759297|NCT00372905|10862808|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0
9759298|NCT00372905|10862809|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0
9759299|NCT00372905|10862810|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8
9759300|NCT00372905|10862807|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
9759301|NCT00372905|10862808|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
9759302|NCT00372905|10862809|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
9759303|NCT00372905|10862810|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
9759304|NCT00372905|10862807|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
9759305|NCT00372905|10862808|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
9759306|NCT00372905|10862809|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
9759307|NCT00372905|10862810|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
10007028|NCT01748799|11129247|FG001|Completed Fixed Dose Sativex|Overall Study||1
10007029|NCT01748799|11129248|FG002|Completed Fixed Dose Sativex|Overall Study||1
10007030|NCT01748799|11129249|FG003|Completed Fixed Dose Sativex|Overall Study||2
10007031|NCT01748799|11129250|FG004|Completed Fixed Dose Sativex|Overall Study||1
10007032|NCT01748799|11129251|FG005|Completed Fixed Dose Sativex|Overall Study||1
10007033|NCT01748799|11129252|FG006|Completed Fixed Dose Sativex|Overall Study||1
10007034|NCT01748799|11129253|FG007|Completed Fixed Dose Sativex|Overall Study||1
10007035|NCT01748799|11129246|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5
10007036|NCT01748799|11129247|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1
10007037|NCT01748799|11129248|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1
10007038|NCT01748799|11129249|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2
10007039|NCT01748799|11129250|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1
10007040|NCT01748799|11129251|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2
10007041|NCT01748799|11129252|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1
10007042|NCT01748799|11129253|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1
10007043|NCT01748799|11129246|FG000|Completed Self-titrated Placebo|Overall Study||4
10007044|NCT01748799|11129247|FG001|Completed Self-titrated Placebo|Overall Study||1
10007045|NCT01748799|11129248|FG002|Completed Self-titrated Placebo|Overall Study||1
10007046|NCT01748799|11129249|FG003|Completed Self-titrated Placebo|Overall Study||2
10007047|NCT01748799|11129250|FG004|Completed Self-titrated Placebo|Overall Study||1
10007048|NCT01748799|11129251|FG005|Completed Self-titrated Placebo|Overall Study||2
10007049|NCT01748799|11129252|FG006|Completed Self-titrated Placebo|Overall Study||1
10007050|NCT01748799|11129253|FG007|Completed Self-titrated Placebo|Overall Study||1
10007051|NCT01748799|11129246|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2
10007052|NCT01748799|11129247|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1
10007053|NCT01748799|11129248|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1
10007054|NCT01748799|11129249|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2
10018969|NCT01826825|11142018|FG000|COMPLETED|Overall Study||100
9759308|NCT00372905|10862807|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
9759309|NCT00372905|10862808|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
9759310|NCT00372905|10862809|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
9759311|NCT00372905|10862810|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
9759312|NCT00372905|10862807|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
9759313|NCT00372905|10862808|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
9759314|NCT00372905|10862809|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
9759315|NCT00372905|10862810|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
9759316|NCT00372905|10862807|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
9759317|NCT00372905|10862808|FG001|STARTED|Follow up Until Relapse or Progression||3
9759318|NCT00372905|10862809|FG002|STARTED|Follow up Until Relapse or Progression||3
9759319|NCT00372905|10862810|FG003|STARTED|Follow up Until Relapse or Progression||8
9759320|NCT00372905|10862807|FG000|COMPLETED|Follow up Until Relapse or Progression||3
9759321|NCT00372905|10862808|FG001|COMPLETED|Follow up Until Relapse or Progression||2
9759322|NCT00372905|10862809|FG002|COMPLETED|Follow up Until Relapse or Progression||3
9759323|NCT00372905|10862810|FG003|COMPLETED|Follow up Until Relapse or Progression||5
9759324|NCT00372905|10862807|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0
9759325|NCT00372905|10862808|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1
9759326|NCT00372905|10862809|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0
9759327|NCT00372905|10862810|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3
9759328|NCT00372957|10862823|FG000|STARTED|Overall Study||10
9759329|NCT00372957|10862824|FG001|STARTED|Overall Study||10
9759330|NCT00372957|10862825|FG002|STARTED|Overall Study||10
9759331|NCT00372957|10862823|FG000|COMPLETED|Overall Study||10
9759332|NCT00372957|10862824|FG001|COMPLETED|Overall Study||10
9759333|NCT00372957|10862825|FG002|COMPLETED|Overall Study||10
9759334|NCT00372957|10862823|FG000|NOT COMPLETED|Overall Study||0
9759335|NCT00372957|10862824|FG001|NOT COMPLETED|Overall Study||0
9759336|NCT00372957|10862825|FG002|NOT COMPLETED|Overall Study||0
9759337|NCT00372970|10862837|FG000|STARTED|Overall Study||16
9759338|NCT00372970|10862838|FG001|STARTED|Overall Study||16
9759339|NCT00372970|10862837|FG000|COMPLETED|Overall Study||16
9759340|NCT00372970|10862838|FG001|COMPLETED|Overall Study||16
9759341|NCT00372970|10862837|FG000|NOT COMPLETED|Overall Study||0
9759342|NCT00372970|10862838|FG001|NOT COMPLETED|Overall Study||0
9759343|NCT00372996|10862846|FG000|STARTED|Overall Study||79
9759344|NCT00372996|10862847|FG001|STARTED|Overall Study||36
9759345|NCT00372996|10862848|FG002|STARTED|Overall Study||61
10106155|NCT02447497|11236129|FG002|NOT COMPLETED|Overall Study||2
10106156|NCT02447497|11236130|FG003|NOT COMPLETED|Overall Study||2
10106157|NCT02447575|11236148|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
10106158|NCT02447575|11236148|FG000|COMPLETED|Overall Study||23
10106159|NCT02447575|11236148|FG000|NOT COMPLETED|Overall Study||0
10106160|NCT02447744|11236154|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
10106161|NCT02447744|11236155|FG001|STARTED|Overall Study||22
10106162|NCT02447744|11236154|FG000|COMPLETED|Overall Study||15
10106163|NCT02447744|11236155|FG001|COMPLETED|Overall Study||21
10106164|NCT02447744|11236154|FG000|NOT COMPLETED|Overall Study||6
10106165|NCT02447744|11236155|FG001|NOT COMPLETED|Overall Study||1
10106166|NCT02447848|11236161|FG000|STARTED|Overall Study||76
10106167|NCT02447848|11236161|FG000|COMPLETED|Overall Study||65
10106168|NCT02447848|11236161|FG000|NOT COMPLETED|Overall Study||11
10106169|NCT02447926|11236165|FG000|STARTED|Overall Study||1
10106170|NCT02447926|11236165|FG000|COMPLETED|Overall Study||1
10106171|NCT02447926|11236165|FG000|NOT COMPLETED|Overall Study||0
10106172|NCT02447952|11236169|FG000|STARTED|Overall Study||25
10007055|NCT01748799|11129250|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1
10106173|NCT02447952|11236169|FG000|COMPLETED|Overall Study||18
10106174|NCT02447952|11236169|FG000|NOT COMPLETED|Overall Study||7
10007056|NCT01748799|11129251|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2
10007057|NCT01748799|11129252|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1
10007058|NCT01748799|11129253|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1
10007059|NCT01748799|11129246|FG000|Completed Self-titrated Sativex|Overall Study||1
10007060|NCT01748799|11129247|FG001|Completed Self-titrated Sativex|Overall Study||1
10007061|NCT01748799|11129248|FG002|Completed Self-titrated Sativex|Overall Study||1
10007062|NCT01748799|11129249|FG003|Completed Self-titrated Sativex|Overall Study||2
10106175|NCT02447991|11236175|FG000|STARTED|Overall Study||45
10007063|NCT01748799|11129250|FG004|Completed Self-titrated Sativex|Overall Study||1
10007064|NCT01748799|11129251|FG005|Completed Self-titrated Sativex|Overall Study||1
10007065|NCT01748799|11129252|FG006|Completed Self-titrated Sativex|Overall Study||1
10007066|NCT01748799|11129253|FG007|Completed Self-titrated Sativex|Overall Study||1
10007067|NCT01748799|11129246|FG000|COMPLETED|Overall Study||1
10007068|NCT01748799|11129247|FG001|COMPLETED|Overall Study||1
10007069|NCT01748799|11129248|FG002|COMPLETED|Overall Study||1
9759346|NCT00372996|10862849|FG003|STARTED|Overall Study||43
9759347|NCT00372996|10862846|FG000|COMPLETED|Overall Study||42
9759348|NCT00372996|10862847|FG001|COMPLETED|Overall Study||22
9759349|NCT00372996|10862848|FG002|COMPLETED|Overall Study||33
9759350|NCT00372996|10862849|FG003|COMPLETED|Overall Study||23
9759351|NCT00372996|10862846|FG000|NOT COMPLETED|Overall Study||37
9759352|NCT00372996|10862847|FG001|NOT COMPLETED|Overall Study||14
9759353|NCT00372996|10862848|FG002|NOT COMPLETED|Overall Study||28
9759354|NCT00372996|10862849|FG003|NOT COMPLETED|Overall Study||20
9759355|NCT00373113|10862861|FG000|STARTED|Overall Study||238
9759356|NCT00373113|10862862|FG001|STARTED|Overall Study||244
9759357|NCT00373113|10862861|FG000|Received Treatment|Overall Study||238
9759358|NCT00373113|10862862|FG001|Received Treatment|Overall Study||240
9759359|NCT00373113|10862861|FG000|COMPLETED|Overall Study||0
9759360|NCT00373113|10862862|FG001|COMPLETED|Overall Study||0
9759361|NCT00373113|10862861|FG000|NOT COMPLETED|Overall Study||238
9759362|NCT00373113|10862862|FG001|NOT COMPLETED|Overall Study||244
9759363|NCT00373256|10862870|FG000|STARTED|Overall Study||241
9759364|NCT00373256|10862871|FG001|STARTED|Overall Study||247
9759365|NCT00373256|10862870|FG000|Treated|Overall Study||235
9759366|NCT00373256|10862871|FG001|Treated|Overall Study||236
9759367|NCT00373256|10862870|FG000|COMPLETED|Overall Study||0
9759368|NCT00373256|10862871|FG001|COMPLETED|Overall Study||0
9759369|NCT00373256|10862870|FG000|NOT COMPLETED|Overall Study||241
9759370|NCT00373256|10862871|FG001|NOT COMPLETED|Overall Study||247
9759371|NCT00373269|10862879|FG000|STARTED|Overall Study||11
9759372|NCT00373269|10862880|FG001|STARTED|Overall Study||10
9759373|NCT00373269|10862879|FG000|COMPLETED|Overall Study||11
9759374|NCT00373269|10862880|FG001|COMPLETED|Overall Study||10
9759375|NCT00373269|10862879|FG000|NOT COMPLETED|Overall Study||0
9759376|NCT00373269|10862880|FG001|NOT COMPLETED|Overall Study||0
9759377|NCT00373295|10862886|FG000|STARTED|Intervention 1 (8 Days)||2
9759378|NCT00373295|10862887|FG001|STARTED|Intervention 1 (8 Days)||3
9759379|NCT00373295|10862888|FG002|STARTED|Intervention 1 (8 Days)||1
9759380|NCT00373295|10862889|FG003|STARTED|Intervention 1 (8 Days)||2
9759381|NCT00373295|10862890|FG004|STARTED|Intervention 1 (8 Days)||3
9759382|NCT00373295|10862891|FG005|STARTED|Intervention 1 (8 Days)||2
10007070|NCT01748799|11129249|FG003|COMPLETED|Overall Study||2
10007071|NCT01748799|11129250|FG004|COMPLETED|Overall Study||1
9759383|NCT00373295|10862886|FG000|COMPLETED|Intervention 1 (8 Days)||2
9759384|NCT00373295|10862887|FG001|COMPLETED|Intervention 1 (8 Days)||1
10202569|NCT03448224|11329731|FG001|COMPLETED|Overall Study||26
10202570|NCT03448224|11329730|FG000|NOT COMPLETED|Overall Study||1
10202571|NCT03448224|11329731|FG001|NOT COMPLETED|Overall Study||0
10202572|NCT03448406|11329739|FG000|STARTED|Overall Study||158
10202573|NCT03448406|11329740|FG001|STARTED|Overall Study||157
10202574|NCT03448406|11329739|FG000|COMPLETED|Overall Study||147
10202575|NCT03448406|11329740|FG001|COMPLETED|Overall Study||144
10202576|NCT03448406|11329739|FG000|NOT COMPLETED|Overall Study||11
10202577|NCT03448406|11329740|FG001|NOT COMPLETED|Overall Study||13
10202578|NCT03448419|11329748|FG000|STARTED|Overall Study||156
10202579|NCT03448419|11329749|FG001|STARTED|Overall Study||156
10202580|NCT03448419|11329748|FG000|Treated|Overall Study||156
10202581|NCT03448419|11329749|FG001|Treated|Overall Study||155
10202582|NCT03448419|11329748|FG000|COMPLETED|Overall Study||143
10202583|NCT03448419|11329749|FG001|COMPLETED|Overall Study||140
10202584|NCT03448419|11329748|FG000|NOT COMPLETED|Overall Study||13
9759385|NCT00373295|10862888|FG002|COMPLETED|Intervention 1 (8 Days)||1
9759386|NCT00373295|10862889|FG003|COMPLETED|Intervention 1 (8 Days)||2
9759387|NCT00373295|10862890|FG004|COMPLETED|Intervention 1 (8 Days)||2
9759388|NCT00373295|10862891|FG005|COMPLETED|Intervention 1 (8 Days)||2
9759389|NCT00373295|10862886|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0
10106176|NCT02447991|11236176|FG001|STARTED|Overall Study||89
10106177|NCT02447991|11236175|FG000|COMPLETED|Overall Study||35
10106178|NCT02447991|11236176|FG001|COMPLETED|Overall Study||59
10106179|NCT02447991|11236175|FG000|NOT COMPLETED|Overall Study||10
9759390|NCT00373295|10862887|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2
9759391|NCT00373295|10862888|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0
9759392|NCT00373295|10862889|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0
9759393|NCT00373295|10862890|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1
9759394|NCT00373295|10862891|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0
10106180|NCT02447991|11236176|FG001|NOT COMPLETED|Overall Study||30
9759395|NCT00373295|10862886|FG000|STARTED|Intervention 2 (8 Days)||2
9759396|NCT00373295|10862887|FG001|STARTED|Intervention 2 (8 Days)||1
9759397|NCT00373295|10862888|FG002|STARTED|Intervention 2 (8 Days)||1
10106181|NCT02448043|11236188|FG000|STARTED|Overall Study||23
10106182|NCT02448043|11236189|FG001|STARTED|Overall Study||22
10106183|NCT02448043|11236188|FG000|COMPLETED|Overall Study||20
10106184|NCT02448043|11236189|FG001|COMPLETED|Overall Study||18
10106185|NCT02448043|11236188|FG000|NOT COMPLETED|Overall Study||3
10106186|NCT02448043|11236189|FG001|NOT COMPLETED|Overall Study||4
10106187|NCT02448303|11236200|FG000|STARTED|Overall Study||38
10106188|NCT02448303|11236201|FG001|STARTED|Overall Study||36
10106189|NCT02448303|11236200|FG000|Enrolled|Overall Study||38
10106190|NCT02448303|11236201|FG001|Enrolled|Overall Study||36
10106191|NCT02448303|11236200|FG000|Received Study Medication|Overall Study||33
10106192|NCT02448303|11236201|FG001|Received Study Medication|Overall Study||35
10106193|NCT02448303|11236200|FG000|Discontinued Study|Overall Study||38
10106194|NCT02448303|11236201|FG001|Discontinued Study|Overall Study||36
10106195|NCT02448303|11236200|FG000|COMPLETED|Overall Study||0
10106196|NCT02448303|11236201|FG001|COMPLETED|Overall Study||0
10106197|NCT02448303|11236200|FG000|NOT COMPLETED|Overall Study||38
10106198|NCT02448303|11236201|FG001|NOT COMPLETED|Overall Study||36
10106199|NCT02448368|11236209|FG000|STARTED|Overall Study||2
10106200|NCT02448368|11236210|FG001|STARTED|Overall Study||2
10106201|NCT02448368|11236211|FG002|STARTED|Overall Study||2
10106202|NCT02448368|11236212|FG003|STARTED|Overall Study||2
10106203|NCT02448368|11236213|FG004|STARTED|Overall Study||2
10106204|NCT02448368|11236214|FG005|STARTED|Overall Study||2
10106205|NCT02448368|11236215|FG006|STARTED|Overall Study||2
10106206|NCT02448368|11236216|FG007|STARTED|Overall Study||2
10106207|NCT02448368|11236217|FG008|STARTED|Overall Study||2
10106208|NCT02448368|11236218|FG009|STARTED|Overall Study||2
10106209|NCT02448368|11236219|FG010|STARTED|Overall Study||5
10106210|NCT02448368|11236220|FG011|STARTED|Overall Study||5
10106211|NCT02448368|11236221|FG012|STARTED|Overall Study||5
10106212|NCT02448368|11236209|FG000|COMPLETED|Overall Study||2
10106213|NCT02448368|11236210|FG001|COMPLETED|Overall Study||2
10106214|NCT02448368|11236211|FG002|COMPLETED|Overall Study||2
10106215|NCT02448368|11236212|FG003|COMPLETED|Overall Study||2
10106216|NCT02448368|11236213|FG004|COMPLETED|Overall Study||2
10106217|NCT02448368|11236214|FG005|COMPLETED|Overall Study||2
9759398|NCT00373295|10862889|FG003|STARTED|Intervention 2 (8 Days)||2
9759399|NCT00373295|10862890|FG004|STARTED|Intervention 2 (8 Days)||2
9759400|NCT00373295|10862891|FG005|STARTED|Intervention 2 (8 Days)||2
9759401|NCT00373295|10862886|FG000|COMPLETED|Intervention 2 (8 Days)||2
9759402|NCT00373295|10862887|FG001|COMPLETED|Intervention 2 (8 Days)||1
9759403|NCT00373295|10862888|FG002|COMPLETED|Intervention 2 (8 Days)||1
9759404|NCT00373295|10862889|FG003|COMPLETED|Intervention 2 (8 Days)||2
9759405|NCT00373295|10862890|FG004|COMPLETED|Intervention 2 (8 Days)||2
9759406|NCT00373295|10862891|FG005|COMPLETED|Intervention 2 (8 Days)||2
9759407|NCT00373295|10862886|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
9759408|NCT00373295|10862887|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
9759409|NCT00373295|10862888|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0
9759410|NCT00373295|10862889|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0
9759411|NCT00373295|10862890|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0
9759412|NCT00373295|10862891|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0
9759413|NCT00373295|10862886|FG000|STARTED|Intervention 3 (8 Days)||2
9759414|NCT00373295|10862887|FG001|STARTED|Intervention 3 (8 Days)||1
9759415|NCT00373295|10862888|FG002|STARTED|Intervention 3 (8 Days)||1
9759416|NCT00373295|10862889|FG003|STARTED|Intervention 3 (8 Days)||2
9759417|NCT00373295|10862890|FG004|STARTED|Intervention 3 (8 Days)||2
10106218|NCT02448368|11236215|FG006|COMPLETED|Overall Study||2
10106219|NCT02448368|11236216|FG007|COMPLETED|Overall Study||2
9759418|NCT00373295|10862891|FG005|STARTED|Intervention 3 (8 Days)||2
10106220|NCT02448368|11236217|FG008|COMPLETED|Overall Study||2
10106221|NCT02448368|11236218|FG009|COMPLETED|Overall Study||2
10106222|NCT02448368|11236219|FG010|COMPLETED|Overall Study||5
10106223|NCT02448368|11236220|FG011|COMPLETED|Overall Study||5
10106224|NCT02448368|11236221|FG012|COMPLETED|Overall Study||5
10106225|NCT02448368|11236209|FG000|NOT COMPLETED|Overall Study||0
10106226|NCT02448368|11236210|FG001|NOT COMPLETED|Overall Study||0
10106227|NCT02448368|11236211|FG002|NOT COMPLETED|Overall Study||0
10106228|NCT02448368|11236212|FG003|NOT COMPLETED|Overall Study||0
10106229|NCT02448368|11236213|FG004|NOT COMPLETED|Overall Study||0
10106230|NCT02448368|11236214|FG005|NOT COMPLETED|Overall Study||0
10106231|NCT02448368|11236215|FG006|NOT COMPLETED|Overall Study||0
10106232|NCT02448368|11236216|FG007|NOT COMPLETED|Overall Study||0
9759419|NCT00373295|10862886|FG000|COMPLETED|Intervention 3 (8 Days)||2
9759420|NCT00373295|10862887|FG001|COMPLETED|Intervention 3 (8 Days)||1
9759421|NCT00373295|10862888|FG002|COMPLETED|Intervention 3 (8 Days)||1
9759422|NCT00373295|10862889|FG003|COMPLETED|Intervention 3 (8 Days)||2
9759423|NCT00373295|10862890|FG004|COMPLETED|Intervention 3 (8 Days)||2
9759424|NCT00373295|10862891|FG005|COMPLETED|Intervention 3 (8 Days)||2
9759425|NCT00373295|10862886|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0
9759426|NCT00373295|10862887|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0
9759427|NCT00373295|10862888|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0
9759428|NCT00373295|10862889|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0
9759429|NCT00373295|10862890|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0
9759430|NCT00373295|10862891|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0
9759431|NCT00373334|10862902|FG000|STARTED|Overall Study||43
9759432|NCT00373334|10862903|FG001|STARTED|Overall Study||50
9759433|NCT00373334|10862904|FG002|STARTED|Overall Study||45
9759434|NCT00373334|10862902|FG000|COMPLETED|Overall Study||33
9759435|NCT00373334|10862903|FG001|COMPLETED|Overall Study||32
9759436|NCT00373334|10862904|FG002|COMPLETED|Overall Study||32
9759437|NCT00373334|10862902|FG000|NOT COMPLETED|Overall Study||10
9759438|NCT00373334|10862903|FG001|NOT COMPLETED|Overall Study||18
9759439|NCT00373334|10862904|FG002|NOT COMPLETED|Overall Study||13
9759440|NCT00373360|10862912|FG000|STARTED|Overall Study||10
9759441|NCT00373360|10862912|FG000|COMPLETED|Overall Study||10
9759442|NCT00373360|10862912|FG000|NOT COMPLETED|Overall Study||0
9759443|NCT00373386|10862916|FG000|STARTED|Overall Study||9
9759444|NCT00373386|10862916|FG000|COMPLETED|Overall Study||9
9759445|NCT00373386|10862916|FG000|NOT COMPLETED|Overall Study||0
9759446|NCT00373399|10862922|FG000|STARTED|Overall Study||5
9759447|NCT00373399|10862923|FG001|STARTED|Overall Study||7
9759448|NCT00373399|10862924|FG002|STARTED|Overall Study||4
9759449|NCT00373399|10862925|FG003|STARTED|Overall Study||6
9759450|NCT00373399|10862926|FG004|STARTED|Overall Study||7
9759451|NCT00373399|10862927|FG005|STARTED|Overall Study||7
9759452|NCT00373399|10862922|FG000|COMPLETED|Overall Study||5
9759453|NCT00373399|10862923|FG001|COMPLETED|Overall Study||7
9759454|NCT00373399|10862924|FG002|COMPLETED|Overall Study||4
9759455|NCT00373399|10862925|FG003|COMPLETED|Overall Study||6
9759456|NCT00373399|10862926|FG004|COMPLETED|Overall Study||7
9759457|NCT00373399|10862927|FG005|COMPLETED|Overall Study||7
9759458|NCT00373399|10862922|FG000|NOT COMPLETED|Overall Study||0
9759459|NCT00373399|10862923|FG001|NOT COMPLETED|Overall Study||0
9759460|NCT00373399|10862924|FG002|NOT COMPLETED|Overall Study||0
9759461|NCT00373399|10862925|FG003|NOT COMPLETED|Overall Study||0
9759462|NCT00373399|10862926|FG004|NOT COMPLETED|Overall Study||0
9759463|NCT00373399|10862927|FG005|NOT COMPLETED|Overall Study||0
9759464|NCT00373425|10862940|FG000|STARTED|Overall Study||623
9759465|NCT00373425|10862941|FG001|STARTED|Overall Study||350
9759466|NCT00373425|10862942|FG002|STARTED|Overall Study||134
10106233|NCT02448368|11236217|FG008|NOT COMPLETED|Overall Study||0
10106234|NCT02448368|11236218|FG009|NOT COMPLETED|Overall Study||0
10106235|NCT02448368|11236219|FG010|NOT COMPLETED|Overall Study||0
10106236|NCT02448368|11236220|FG011|NOT COMPLETED|Overall Study||0
10106237|NCT02448368|11236221|FG012|NOT COMPLETED|Overall Study||0
10106238|NCT02448446|11236248|FG000|STARTED|Overall Study||13
10106239|NCT02448446|11236249|FG001|STARTED|Overall Study||12
10106240|NCT02448446|11236248|FG000|COMPLETED|Overall Study||12
10106241|NCT02448446|11236249|FG001|COMPLETED|Overall Study||12
10106242|NCT02448446|11236248|FG000|NOT COMPLETED|Overall Study||1
10106243|NCT02448446|11236249|FG001|NOT COMPLETED|Overall Study||0
10106244|NCT02448537|11236258|FG000|STARTED|Overall Study||20
10106245|NCT02448537|11236259|FG001|STARTED|Overall Study||10
10106246|NCT02448537|11236260|FG002|STARTED|Overall Study||12
10007072|NCT01748799|11129251|FG005|COMPLETED|Overall Study||1
10007073|NCT01748799|11129252|FG006|COMPLETED|Overall Study||1
10007074|NCT01748799|11129253|FG007|COMPLETED|Overall Study||1
10007075|NCT01748799|11129246|FG000|NOT COMPLETED|Overall Study||5
10106247|NCT02448537|11236258|FG000|COMPLETED|Overall Study||19
10106248|NCT02448537|11236259|FG001|COMPLETED|Overall Study||9
10106249|NCT02448537|11236260|FG002|COMPLETED|Overall Study||11
10106250|NCT02448537|11236258|FG000|NOT COMPLETED|Overall Study||1
10106251|NCT02448537|11236259|FG001|NOT COMPLETED|Overall Study||1
10106252|NCT02448537|11236260|FG002|NOT COMPLETED|Overall Study||1
10106253|NCT02448563|11236272|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32
10106254|NCT02448563|11236273|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30
10007076|NCT01748799|11129247|FG001|NOT COMPLETED|Overall Study||0
10007077|NCT01748799|11129248|FG002|NOT COMPLETED|Overall Study||0
10007078|NCT01748799|11129249|FG003|NOT COMPLETED|Overall Study||0
10007079|NCT01748799|11129250|FG004|NOT COMPLETED|Overall Study||0
10007080|NCT01748799|11129251|FG005|NOT COMPLETED|Overall Study||1
10007081|NCT01748799|11129252|FG006|NOT COMPLETED|Overall Study||1
9759467|NCT00373425|10862943|FG003|STARTED|Overall Study||11
9759468|NCT00373425|10862944|FG004|STARTED|Overall Study||132
9759469|NCT00373425|10862940|FG000|Received Treatment|Overall Study||612
9759470|NCT00373425|10862941|FG001|Received Treatment|Overall Study||342
9759471|NCT00373425|10862942|FG002|Received Treatment|Overall Study||134
9759472|NCT00373425|10862943|FG003|Received Treatment|Overall Study||7
9759473|NCT00373425|10862944|FG004|Received Treatment|Overall Study||132
10202585|NCT03448419|11329749|FG001|NOT COMPLETED|Overall Study||16
10202586|NCT03448536|11329759|FG000|STARTED|Overall Study||100
10202587|NCT03448536|11329760|FG001|STARTED|Overall Study||101
10202588|NCT03448536|11329759|FG000|Completed First Intervention|Overall Study||83
10202589|NCT03448536|11329760|FG001|Completed First Intervention|Overall Study||78
10202590|NCT03448536|11329759|FG000|Completed First Intervention|Overall Study||95
10202591|NCT03448536|11329760|FG001|Completed First Intervention|Overall Study||97
10202592|NCT03448536|11329759|FG000|Completed Second Intervention|Overall Study||82
10202593|NCT03448536|11329760|FG001|Completed Second Intervention|Overall Study||87
10202594|NCT03448536|11329759|FG000|COMPLETED|Overall Study||88
10202595|NCT03448536|11329760|FG001|COMPLETED|Overall Study||97
10202596|NCT03448536|11329759|FG000|NOT COMPLETED|Overall Study||12
10202597|NCT03448536|11329760|FG001|NOT COMPLETED|Overall Study||4
10202598|NCT03449030|11329776|FG000|STARTED|Overall Study||1
10202599|NCT03449030|11329777|FG001|STARTED|Overall Study||1
10202600|NCT03449030|11329778|FG002|STARTED|Overall Study||1
10202601|NCT03449030|11329779|FG003|STARTED|Overall Study||5
10202602|NCT03449030|11329780|FG004|STARTED|Overall Study||7
10202603|NCT03449030|11329781|FG005|STARTED|Overall Study||7
10202604|NCT03449030|11329782|FG006|STARTED|Overall Study||2
10202605|NCT03449030|11329783|FG007|STARTED|Overall Study||3
9759474|NCT00373425|10862940|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253
9759475|NCT00373425|10862941|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197
10202606|NCT03449030|11329784|FG008|STARTED|Overall Study||3
10202607|NCT03449030|11329785|FG009|STARTED|Overall Study||1
10007082|NCT01748799|11129253|FG007|NOT COMPLETED|Overall Study||0
10007083|NCT01748825|11129289|FG000|STARTED|Dose Escalation||6
10007084|NCT01748825|11129290|FG001|STARTED|Dose Escalation||4
10202608|NCT03449030|11329776|FG000|COMPLETED|Overall Study||0
10202609|NCT03449030|11329777|FG001|COMPLETED|Overall Study||0
10202610|NCT03449030|11329778|FG002|COMPLETED|Overall Study||0
10202611|NCT03449030|11329779|FG003|COMPLETED|Overall Study||0
10202612|NCT03449030|11329780|FG004|COMPLETED|Overall Study||0
10106255|NCT02448563|11236272|FG000|COMPLETED|Overall Study||16
10106256|NCT02448563|11236273|FG001|COMPLETED|Overall Study||19
10106257|NCT02448563|11236272|FG000|NOT COMPLETED|Overall Study||16
10106258|NCT02448563|11236273|FG001|NOT COMPLETED|Overall Study||11
10106259|NCT02448641|11236286|FG000|STARTED|Overall Study||55
9759476|NCT00373425|10862942|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0
9759477|NCT00373425|10862943|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0
9759478|NCT00373425|10862944|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60
9759479|NCT00373425|10862940|FG000|NOT COMPLETED|Overall Study||370
9759480|NCT00373425|10862941|FG001|NOT COMPLETED|Overall Study||153
9759481|NCT00373425|10862942|FG002|NOT COMPLETED|Overall Study||134
9759482|NCT00373425|10862943|FG003|NOT COMPLETED|Overall Study||11
9759483|NCT00373425|10862944|FG004|NOT COMPLETED|Overall Study||72
9759484|NCT00373490|10862955|FG000|STARTED|Overall Study||10
9759485|NCT00373490|10862956|FG001|STARTED|Overall Study||6
9759486|NCT00373490|10862955|FG000|COMPLETED|Overall Study||1
9759487|NCT00373490|10862956|FG001|COMPLETED|Overall Study||0
9759488|NCT00373490|10862955|FG000|NOT COMPLETED|Overall Study||9
9759489|NCT00373490|10862956|FG001|NOT COMPLETED|Overall Study||6
9759490|NCT00373529|10862962|FG000|STARTED|Overall Study||116
9759491|NCT00373529|10862962|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
9759492|NCT00373529|10862962|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
9759493|NCT00373529|10862962|FG000|NOT COMPLETED|Overall Study||108
9759494|NCT00373685|10862968|FG000|STARTED|Overall Study||4035
9759495|NCT00373685|10862969|FG001|STARTED|Overall Study||4032
9759496|NCT00373685|10862968|FG000|Treated|Overall Study||3984
9759497|NCT00373685|10862969|FG001|Treated|Overall Study||3955
9759498|NCT00373685|10862968|FG000|COMPLETED|Overall Study||2596
9759499|NCT00373685|10862969|FG001|COMPLETED|Overall Study||2611
9759500|NCT00373685|10862968|FG000|NOT COMPLETED|Overall Study||1439
9759501|NCT00373685|10862969|FG001|NOT COMPLETED|Overall Study||1421
9759502|NCT00373698|10862977|FG000|STARTED|Overall Study||96
9759503|NCT00373698|10862978|FG001|STARTED|Overall Study||99
9759504|NCT00373698|10862977|FG000|COMPLETED|Overall Study||85
9759505|NCT00373698|10862978|FG001|COMPLETED|Overall Study||99
9759506|NCT00373698|10862977|FG000|NOT COMPLETED|Overall Study||11
9759507|NCT00373698|10862978|FG001|NOT COMPLETED|Overall Study||0
9759508|NCT00373880|10862986|FG000|STARTED|Overall Study||26
9759509|NCT00373880|10862986|FG000|COMPLETED|Overall Study||8
9759510|NCT00373880|10862986|FG000|NOT COMPLETED|Overall Study||18
9759511|NCT00373958|10863000|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334
9759512|NCT00373958|10863001|FG001|STARTED|Infant Series||332
9759513|NCT00373958|10863000|FG000|Vaccinated Dose 1|Infant Series||332
9759514|NCT00373958|10863001|FG001|Vaccinated Dose 1|Infant Series||331
10106260|NCT02448641|11236287|FG001|STARTED|Overall Study||56
9759515|NCT00373958|10863000|FG000|Vaccinated Dose 2|Infant Series||309
9759516|NCT00373958|10863001|FG001|Vaccinated Dose 2|Infant Series||305
9759517|NCT00373958|10863000|FG000|Vaccinated Dose 3|Infant Series||298
10106261|NCT02448641|11236288|FG002|STARTED|Overall Study||52
10106262|NCT02448641|11236286|FG000|COMPLETED|Overall Study||54
10007085|NCT01748825|11129291|FG002|STARTED|Dose Escalation||6
10007086|NCT01748825|11129292|FG003|STARTED|Dose Escalation||3
10007087|NCT01748825|11129293|FG004|STARTED|Dose Escalation||3
10007088|NCT01748825|11129294|FG005|STARTED|Dose Escalation||6
10007089|NCT01748825|11129295|FG006|STARTED|Dose Escalation||3
10007090|NCT01748825|11129296|FG007|STARTED|Dose Escalation||3
10007091|NCT01748825|11129297|FG008|STARTED|Dose Escalation||0
10007092|NCT01748825|11129298|FG009|STARTED|Dose Escalation||0
10007093|NCT01748825|11129289|FG000|COMPLETED|Dose Escalation||4
10007094|NCT01748825|11129290|FG001|COMPLETED|Dose Escalation||2
10007095|NCT01748825|11129291|FG002|COMPLETED|Dose Escalation||6
10106263|NCT02448641|11236287|FG001|COMPLETED|Overall Study||51
10106264|NCT02448641|11236288|FG002|COMPLETED|Overall Study||48
10106265|NCT02448641|11236286|FG000|NOT COMPLETED|Overall Study||1
10106266|NCT02448641|11236287|FG001|NOT COMPLETED|Overall Study||5
10106267|NCT02448641|11236288|FG002|NOT COMPLETED|Overall Study||4
10106268|NCT02448654|11236305|FG000|STARTED|Overall Study||19
10106269|NCT02448654|11236306|FG001|STARTED|Overall Study||17
10106270|NCT02448654|11236305|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17
10106271|NCT02448654|11236306|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15
10106272|NCT02448654|11236305|FG000|COMPLETED|Overall Study||16
10106273|NCT02448654|11236306|FG001|COMPLETED|Overall Study||13
10106274|NCT02448654|11236305|FG000|NOT COMPLETED|Overall Study||3
10106275|NCT02448654|11236306|FG001|NOT COMPLETED|Overall Study||4
10106276|NCT02448706|11236312|FG000|STARTED|Overall Study||25
10106277|NCT02448706|11236313|FG001|STARTED|Overall Study||24
10106278|NCT02448706|11236312|FG000|Withdrew for Personal Reasons|Overall Study||1
10106279|NCT02448706|11236313|FG001|Withdrew for Personal Reasons|Overall Study||1
10106280|NCT02448706|11236312|FG000|Completed Baseline Testing|Overall Study||24
10106281|NCT02448706|11236313|FG001|Completed Baseline Testing|Overall Study||23
10106282|NCT02448706|11236312|FG000|COMPLETED|Overall Study||20
10106283|NCT02448706|11236313|FG001|COMPLETED|Overall Study||20
10106284|NCT02448706|11236312|FG000|NOT COMPLETED|Overall Study||5
10106285|NCT02448706|11236313|FG001|NOT COMPLETED|Overall Study||4
10106286|NCT02448719|11236332|FG000|STARTED|Overall Study||12
10106287|NCT02448719|11236333|FG001|STARTED|Overall Study||6
10106288|NCT02448719|11236334|FG002|STARTED|Overall Study||6
10106289|NCT02448719|11236335|FG003|STARTED|Overall Study||6
10106290|NCT02448719|11236336|FG004|STARTED|Overall Study||6
10106291|NCT02448719|11236337|FG005|STARTED|Overall Study||6
10106292|NCT02448719|11236338|FG006|STARTED|Overall Study||6
10106293|NCT02448719|11236339|FG007|STARTED|Overall Study||6
10106294|NCT02448719|11236340|FG008|STARTED|Overall Study||6
10106295|NCT02448719|11236341|FG009|STARTED|Overall Study||6
10106296|NCT02448719|11236342|FG010|STARTED|Overall Study||6
10106297|NCT02448719|11236332|FG000|COMPLETED|Overall Study||12
10106298|NCT02448719|11236333|FG001|COMPLETED|Overall Study||6
10106299|NCT02448719|11236334|FG002|COMPLETED|Overall Study||6
10106300|NCT02448719|11236335|FG003|COMPLETED|Overall Study||6
10106301|NCT02448719|11236336|FG004|COMPLETED|Overall Study||5
10106302|NCT02448719|11236337|FG005|COMPLETED|Overall Study||6
10106303|NCT02448719|11236338|FG006|COMPLETED|Overall Study||6
10106304|NCT02448719|11236339|FG007|COMPLETED|Overall Study||6
10106305|NCT02448719|11236340|FG008|COMPLETED|Overall Study||6
10106306|NCT02448719|11236341|FG009|COMPLETED|Overall Study||6
10106307|NCT02448719|11236342|FG010|COMPLETED|Overall Study||6
10106308|NCT02448719|11236332|FG000|NOT COMPLETED|Overall Study||0
10106309|NCT02448719|11236333|FG001|NOT COMPLETED|Overall Study||0
10106310|NCT02448719|11236334|FG002|NOT COMPLETED|Overall Study||0
10106311|NCT02448719|11236335|FG003|NOT COMPLETED|Overall Study||0
10106312|NCT02448719|11236336|FG004|NOT COMPLETED|Overall Study||1
10106313|NCT02448719|11236337|FG005|NOT COMPLETED|Overall Study||0
10106314|NCT02448719|11236338|FG006|NOT COMPLETED|Overall Study||0
10106315|NCT02448719|11236339|FG007|NOT COMPLETED|Overall Study||0
10106316|NCT02448719|11236340|FG008|NOT COMPLETED|Overall Study||0
10106317|NCT02448719|11236341|FG009|NOT COMPLETED|Overall Study||0
10106318|NCT02448719|11236342|FG010|NOT COMPLETED|Overall Study||0
10106319|NCT02448771|11236403|FG000|STARTED|Overall Study||36
10106320|NCT02448771|11236403|FG000|COMPLETED|Overall Study||0
10106321|NCT02448771|11236403|FG000|NOT COMPLETED|Overall Study||36
10106322|NCT02448810|11236416|FG000|STARTED|Overall Study||3
10106323|NCT02448810|11236417|FG001|STARTED|Overall Study||3
10106324|NCT02448810|11236418|FG002|STARTED|Overall Study||3
10106325|NCT02448810|11236419|FG003|STARTED|Overall Study||3
10106326|NCT02448810|11236420|FG004|STARTED|Overall Study||31
10106327|NCT02448810|11236421|FG005|STARTED|Overall Study||16
10106328|NCT02448810|11236422|FG006|STARTED|Overall Study||18
10106329|NCT02448810|11236423|FG007|STARTED|Overall Study||8
10106330|NCT02448810|11236416|FG000|Treated|Overall Study||3
10106331|NCT02448810|11236417|FG001|Treated|Overall Study||3
10106332|NCT02448810|11236418|FG002|Treated|Overall Study||3
10106333|NCT02448810|11236419|FG003|Treated|Overall Study||3
10106334|NCT02448810|11236420|FG004|Treated|Overall Study||29
10106335|NCT02448810|11236421|FG005|Treated|Overall Study||13
10106336|NCT02448810|11236422|FG006|Treated|Overall Study||18
10106337|NCT02448810|11236423|FG007|Treated|Overall Study||7
10106338|NCT02448810|11236416|FG000|COMPLETED|Overall Study||0
10106339|NCT02448810|11236417|FG001|COMPLETED|Overall Study||0
10106340|NCT02448810|11236418|FG002|COMPLETED|Overall Study||0
10106341|NCT02448810|11236419|FG003|COMPLETED|Overall Study||0
10106342|NCT02448810|11236420|FG004|COMPLETED|Overall Study||0
10106343|NCT02448810|11236421|FG005|COMPLETED|Overall Study||0
10106344|NCT02448810|11236422|FG006|COMPLETED|Overall Study||0
10106345|NCT02448810|11236423|FG007|COMPLETED|Overall Study||0
10106346|NCT02448810|11236416|FG000|NOT COMPLETED|Overall Study||3
10106347|NCT02448810|11236417|FG001|NOT COMPLETED|Overall Study||3
10106348|NCT02448810|11236418|FG002|NOT COMPLETED|Overall Study||3
10106349|NCT02448810|11236419|FG003|NOT COMPLETED|Overall Study||3
10106350|NCT02448810|11236420|FG004|NOT COMPLETED|Overall Study||31
10106351|NCT02448810|11236421|FG005|NOT COMPLETED|Overall Study||16
10106352|NCT02448810|11236422|FG006|NOT COMPLETED|Overall Study||18
10106353|NCT02448810|11236423|FG007|NOT COMPLETED|Overall Study||8
10106354|NCT02448862|11236447|FG000|STARTED|Overall Study||4525
10106355|NCT02448862|11236448|FG001|STARTED|Overall Study||6050
10106356|NCT02448862|11236447|FG000|COMPLETED|Overall Study||4525
10106357|NCT02448862|11236448|FG001|COMPLETED|Overall Study||6050
10106358|NCT02448862|11236447|FG000|NOT COMPLETED|Overall Study||0
10106359|NCT02448862|11236448|FG001|NOT COMPLETED|Overall Study||0
10106360|NCT02448875|11236457|FG000|STARTED|Overall Study||60
10106361|NCT02448875|11236458|FG001|STARTED|Overall Study||21
10106362|NCT02448875|11236459|FG002|STARTED|Overall Study||61
10106363|NCT02448875|11236457|FG000|Completed Dose Selection Phase|Overall Study||20
10106364|NCT02448875|11236458|FG001|Completed Dose Selection Phase|Overall Study||21
10106365|NCT02448875|11236459|FG002|Completed Dose Selection Phase|Overall Study||20
10106366|NCT02448875|11236457|FG000|Full Analysis Set|Overall Study||60
10106367|NCT02448875|11236458|FG001|Full Analysis Set|Overall Study||21
10106368|NCT02448875|11236459|FG002|Full Analysis Set|Overall Study||61
10106369|NCT02448875|11236457|FG000|Safety Analysis Set|Overall Study||60
10106370|NCT02448875|11236458|FG001|Safety Analysis Set|Overall Study||21
10106371|NCT02448875|11236459|FG002|Safety Analysis Set|Overall Study||61
10106372|NCT02448875|11236457|FG000|COMPLETED|Overall Study||53
10106373|NCT02448875|11236458|FG001|COMPLETED|Overall Study||20
10106374|NCT02448875|11236459|FG002|COMPLETED|Overall Study||60
10106375|NCT02448875|11236457|FG000|NOT COMPLETED|Overall Study||7
10106376|NCT02448875|11236458|FG001|NOT COMPLETED|Overall Study||1
10106377|NCT02448875|11236459|FG002|NOT COMPLETED|Overall Study||1
10106378|NCT02448914|11236470|FG000|STARTED|First Intervention (1 Day)||6
10106379|NCT02448914|11236471|FG001|STARTED|First Intervention (1 Day)||5
10106380|NCT02448914|11236470|FG000|COMPLETED|First Intervention (1 Day)||6
10106381|NCT02448914|11236471|FG001|COMPLETED|First Intervention (1 Day)||5
10106382|NCT02448914|11236470|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10106383|NCT02448914|11236471|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10106384|NCT02448914|11236470|FG000|STARTED|Second Intervention (1 Day)||6
10106385|NCT02448914|11236471|FG001|STARTED|Second Intervention (1 Day)||5
10106386|NCT02448914|11236470|FG000|COMPLETED|Second Intervention (1 Day)||6
10106387|NCT02448914|11236471|FG001|COMPLETED|Second Intervention (1 Day)||5
10106388|NCT02448914|11236470|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10106389|NCT02448914|11236471|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10106390|NCT02449018|11236480|FG000|STARTED|Overall Study||64
10106391|NCT02449018|11236481|FG001|STARTED|Overall Study||28
10106392|NCT02449018|11236480|FG000|COMPLETED|Overall Study||52
10106393|NCT02449018|11236481|FG001|COMPLETED|Overall Study||26
10106394|NCT02449018|11236480|FG000|NOT COMPLETED|Overall Study||12
10106395|NCT02449018|11236481|FG001|NOT COMPLETED|Overall Study||2
10106396|NCT02449044|11236487|FG000|STARTED|Overall Study||111
10106397|NCT02449044|11236487|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
10106398|NCT02449044|11236487|FG000|NOT COMPLETED|Overall Study||64
10113338|NCT02509117|11244194|FG004|Treated|Period 2 -Part A: 4 Days||0
10113339|NCT02509117|11244195|FG005|Treated|Period 2 -Part A: 4 Days||0
10113340|NCT02509117|11244196|FG006|Treated|Period 2 -Part A: 4 Days||0
10113341|NCT02509117|11244197|FG007|Treated|Period 2 -Part A: 4 Days||0
10113342|NCT02509117|11244198|FG008|Treated|Period 2 -Part A: 4 Days||0
10113343|NCT02509117|11244199|FG009|Treated|Period 2 -Part A: 4 Days||0
10113344|NCT02509117|11244190|FG000|COMPLETED|Period 2 -Part A: 4 Days||2
10106399|NCT02449174|11236493|FG000|STARTED|Overall Study||36
10106400|NCT02449174|11236494|FG001|STARTED|Overall Study||32
10106401|NCT02449174|11236493|FG000|COMPLETED|Overall Study||36
10106402|NCT02449174|11236494|FG001|COMPLETED|Overall Study||32
10106403|NCT02449174|11236493|FG000|NOT COMPLETED|Overall Study||0
10106404|NCT02449174|11236494|FG001|NOT COMPLETED|Overall Study||0
10106405|NCT02449291|11236503|FG000|STARTED|Overall Study||191
10106406|NCT02449291|11236504|FG001|STARTED|Overall Study||188
10106407|NCT02449291|11236505|FG002|STARTED|Overall Study||181
10106408|NCT02449291|11236503|FG000|COMPLETED|Overall Study||186
10106409|NCT02449291|11236504|FG001|COMPLETED|Overall Study||186
10106410|NCT02449291|11236505|FG002|COMPLETED|Overall Study||180
10106411|NCT02449291|11236503|FG000|NOT COMPLETED|Overall Study||5
10106412|NCT02449291|11236504|FG001|NOT COMPLETED|Overall Study||2
10106413|NCT02449291|11236505|FG002|NOT COMPLETED|Overall Study||1
10106414|NCT02449356|11236518|FG000|STARTED|Overall Study||30
10106415|NCT02449356|11236519|FG001|STARTED|Overall Study||30
10106416|NCT02449356|11236518|FG000|COMPLETED|Overall Study||30
10106417|NCT02449356|11236519|FG001|COMPLETED|Overall Study||30
9759518|NCT00373958|10863001|FG001|Vaccinated Dose 3|Infant Series||300
9759519|NCT00373958|10863000|FG000|COMPLETED|Infant Series||294
9759520|NCT00373958|10863001|FG001|COMPLETED|Infant Series||290
9759521|NCT00373958|10863000|FG000|NOT COMPLETED|Infant Series||40
9759522|NCT00373958|10863001|FG001|NOT COMPLETED|Infant Series||42
9759523|NCT00373958|10863000|FG000|STARTED|Toddler Dose||294
9759524|NCT00373958|10863001|FG001|STARTED|Toddler Dose||290
9759525|NCT00373958|10863000|FG000|Withdrawn After Infant Series|Toddler Dose||22
9759526|NCT00373958|10863001|FG001|Withdrawn After Infant Series|Toddler Dose||25
9759527|NCT00373958|10863000|FG000|Vaccinated Toddler Dose|Toddler Dose||272
9759528|NCT00373958|10863001|FG001|Vaccinated Toddler Dose|Toddler Dose||265
9759529|NCT00373958|10863000|FG000|COMPLETED|Toddler Dose||264
9759530|NCT00373958|10863001|FG001|COMPLETED|Toddler Dose||252
9759531|NCT00373958|10863000|FG000|NOT COMPLETED|Toddler Dose||30
9759532|NCT00373958|10863001|FG001|NOT COMPLETED|Toddler Dose||38
9759533|NCT00374088|10863032|FG000|STARTED|Overall Study||10
9759534|NCT00374088|10863033|FG001|STARTED|Overall Study||11
9759535|NCT00374088|10863032|FG000|COMPLETED|Overall Study||9
9759536|NCT00374088|10863033|FG001|COMPLETED|Overall Study||10
9759537|NCT00374088|10863032|FG000|NOT COMPLETED|Overall Study||1
9759538|NCT00374088|10863033|FG001|NOT COMPLETED|Overall Study||1
9759539|NCT00374127|10863039|FG000|STARTED|Overall Study||35
9759540|NCT00374127|10863039|FG000|COMPLETED|Overall Study||24
9759541|NCT00374127|10863039|FG000|NOT COMPLETED|Overall Study||11
9759542|NCT00374140|10863049|FG000|STARTED|Overall Study||40
9759543|NCT00374140|10863049|FG000|COMPLETED|Overall Study||38
9759544|NCT00374140|10863049|FG000|NOT COMPLETED|Overall Study||2
9759545|NCT00374231|10863053|FG000|STARTED|Overall Study||40
9759546|NCT00374231|10863053|FG000|COMPLETED|Overall Study||40
9759547|NCT00374231|10863053|FG000|NOT COMPLETED|Overall Study||0
9759548|NCT00374244|10863060|FG000|STARTED|Overall Study||14
9759549|NCT00374244|10863061|FG001|STARTED|Overall Study||14
9759550|NCT00374244|10863060|FG000|COMPLETED|Overall Study||14
9759551|NCT00374244|10863061|FG001|COMPLETED|Overall Study||14
9759552|NCT00374244|10863060|FG000|NOT COMPLETED|Overall Study||0
9759553|NCT00374244|10863061|FG001|NOT COMPLETED|Overall Study||0
9759554|NCT00374322|10863069|FG000|STARTED|Overall Study||1579
9759555|NCT00374322|10863070|FG001|STARTED|Overall Study||1582
9759556|NCT00374322|10863069|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571
9759557|NCT00374322|10863070|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576
9759558|NCT00374322|10863069|FG000|COMPLETED|Overall Study||322
9759559|NCT00374322|10863070|FG001|COMPLETED|Overall Study||278
9759560|NCT00374322|10863069|FG000|NOT COMPLETED|Overall Study||1257
9759561|NCT00374322|10863070|FG001|NOT COMPLETED|Overall Study||1304
9759562|NCT00374335|10863077|FG000|STARTED|Overall Study||261
9759563|NCT00374335|10863077|FG000|COMPLETED|Overall Study||261
9759564|NCT00374335|10863077|FG000|NOT COMPLETED|Overall Study||0
9759565|NCT00374452|10863083|FG000|STARTED|Overall Study||34
9759566|NCT00374452|10863084|FG001|STARTED|Overall Study||48
9759567|NCT00374452|10863083|FG000|Intervention Started|Overall Study||30
9759568|NCT00374452|10863084|FG001|Intervention Started|Overall Study||46
9759569|NCT00374452|10863083|FG000|COMPLETED|Overall Study||29
9759570|NCT00374452|10863084|FG001|COMPLETED|Overall Study||43
9759571|NCT00374452|10863083|FG000|NOT COMPLETED|Overall Study||5
9759572|NCT00374452|10863084|FG001|NOT COMPLETED|Overall Study||5
9759573|NCT00374556|10863092|FG000|STARTED|Overall Study||14
9759574|NCT00374556|10863093|FG001|STARTED|Overall Study||16
9759575|NCT00374556|10863092|FG000|COMPLETED|Overall Study||13
9759576|NCT00374556|10863093|FG001|COMPLETED|Overall Study||15
10007096|NCT01748825|11129292|FG003|COMPLETED|Dose Escalation||2
10007097|NCT01748825|11129293|FG004|COMPLETED|Dose Escalation||2
10007098|NCT01748825|11129294|FG005|COMPLETED|Dose Escalation||4
10007099|NCT01748825|11129295|FG006|COMPLETED|Dose Escalation||2
10007100|NCT01748825|11129296|FG007|COMPLETED|Dose Escalation||3
10007101|NCT01748825|11129297|FG008|COMPLETED|Dose Escalation||0
10007102|NCT01748825|11129298|FG009|COMPLETED|Dose Escalation||0
10007103|NCT01748825|11129289|FG000|NOT COMPLETED|Dose Escalation||2
10007104|NCT01748825|11129290|FG001|NOT COMPLETED|Dose Escalation||2
10007105|NCT01748825|11129291|FG002|NOT COMPLETED|Dose Escalation||0
10007106|NCT01748825|11129292|FG003|NOT COMPLETED|Dose Escalation||1
10007107|NCT01748825|11129293|FG004|NOT COMPLETED|Dose Escalation||1
10007108|NCT01748825|11129294|FG005|NOT COMPLETED|Dose Escalation||2
10106418|NCT02449356|11236518|FG000|NOT COMPLETED|Overall Study||0
10106419|NCT02449356|11236519|FG001|NOT COMPLETED|Overall Study||0
10007109|NCT01748825|11129295|FG006|NOT COMPLETED|Dose Escalation||1
10007110|NCT01748825|11129296|FG007|NOT COMPLETED|Dose Escalation||0
10106420|NCT02449434|11236529|FG000|STARTED|Overall Study||300
10007111|NCT01748825|11129297|FG008|NOT COMPLETED|Dose Escalation||0
10007112|NCT01748825|11129298|FG009|NOT COMPLETED|Dose Escalation||0
10106421|NCT02449434|11236530|FG001|STARTED|Overall Study||300
10007113|NCT01748825|11129289|FG000|STARTED|Dose Expansion||0
10007114|NCT01748825|11129290|FG001|STARTED|Dose Expansion||0
10007115|NCT01748825|11129291|FG002|STARTED|Dose Expansion||0
10007116|NCT01748825|11129292|FG003|STARTED|Dose Expansion||0
10007117|NCT01748825|11129293|FG004|STARTED|Dose Expansion||0
10007118|NCT01748825|11129294|FG005|STARTED|Dose Expansion||0
10007119|NCT01748825|11129295|FG006|STARTED|Dose Expansion||0
10007120|NCT01748825|11129296|FG007|STARTED|Dose Expansion||0
10007121|NCT01748825|11129297|FG008|STARTED|Dose Expansion||13
10007122|NCT01748825|11129298|FG009|STARTED|Dose Expansion||20
10007123|NCT01748825|11129289|FG000|COMPLETED|Dose Expansion||0
10106422|NCT02449434|11236529|FG000|COMPLETED|Overall Study||300
10106423|NCT02449434|11236530|FG001|COMPLETED|Overall Study||300
10106424|NCT02449434|11236529|FG000|NOT COMPLETED|Overall Study||0
10106425|NCT02449434|11236530|FG001|NOT COMPLETED|Overall Study||0
10106426|NCT02449473|11236538|FG000|STARTED|Overall Study||39
10106427|NCT02449473|11236539|FG001|STARTED|Overall Study||40
10106428|NCT02449473|11236538|FG000|COMPLETED|Overall Study||39
10106429|NCT02449473|11236539|FG001|COMPLETED|Overall Study||40
10106430|NCT02449473|11236538|FG000|NOT COMPLETED|Overall Study||0
10106431|NCT02449473|11236539|FG001|NOT COMPLETED|Overall Study||0
10106432|NCT02449798|11236545|FG000|STARTED|Overall Study||120
10106433|NCT02449798|11236545|FG000|COMPLETED|Overall Study||120
10106434|NCT02449798|11236545|FG000|NOT COMPLETED|Overall Study||0
10106435|NCT02449889|11236552|FG000|STARTED|Overall Study||58
10106436|NCT02449889|11236553|FG001|STARTED|Overall Study||58
10106437|NCT02449889|11236554|FG002|STARTED|Overall Study||60
10106438|NCT02449889|11236552|FG000|COMPLETED|Overall Study||57
10106439|NCT02449889|11236553|FG001|COMPLETED|Overall Study||52
10106440|NCT02449889|11236554|FG002|COMPLETED|Overall Study||59
10106441|NCT02449889|11236552|FG000|NOT COMPLETED|Overall Study||1
10106442|NCT02449889|11236553|FG001|NOT COMPLETED|Overall Study||6
10106443|NCT02449889|11236554|FG002|NOT COMPLETED|Overall Study||1
10106444|NCT02449902|11236564|FG000|STARTED|Overall Study||24
10106445|NCT02449902|11236565|FG001|STARTED|Overall Study||26
10106446|NCT02449902|11236564|FG000|COMPLETED|Overall Study||24
10106447|NCT02449902|11236565|FG001|COMPLETED|Overall Study||24
10106448|NCT02449902|11236564|FG000|NOT COMPLETED|Overall Study||0
10106449|NCT02449902|11236565|FG001|NOT COMPLETED|Overall Study||2
10106450|NCT02449915|11236575|FG000|STARTED|Overall Study||35
10106451|NCT02449915|11236576|FG001|STARTED|Overall Study||35
10106452|NCT02449915|11236575|FG000|COMPLETED|Overall Study||33
10106453|NCT02449915|11236576|FG001|COMPLETED|Overall Study||31
10106454|NCT02449915|11236575|FG000|NOT COMPLETED|Overall Study||2
10106455|NCT02449915|11236576|FG001|NOT COMPLETED|Overall Study||4
10106456|NCT02450383|11236584|FG000|STARTED|Overall Study||10
10106457|NCT02450383|11236585|FG001|STARTED|Overall Study||10
10106458|NCT02450383|11236584|FG000|COMPLETED|Overall Study||10
10106459|NCT02450383|11236585|FG001|COMPLETED|Overall Study||10
10106460|NCT02450383|11236584|FG000|NOT COMPLETED|Overall Study||0
10106461|NCT02450383|11236585|FG001|NOT COMPLETED|Overall Study||0
10106462|NCT02450487|11236591|FG000|STARTED|Overall Study||105
10106463|NCT02450487|11236591|FG000|COMPLETED|Overall Study||102
10106464|NCT02450487|11236591|FG000|NOT COMPLETED|Overall Study||3
10106465|NCT02450526|11236600|FG000|STARTED|DB Period (Cycle 1)||325
10106466|NCT02450526|11236601|FG001|STARTED|DB Period (Cycle 1)||66
10106467|NCT02450526|11236602|FG002|STARTED|DB Period (Cycle 1)||107
10106468|NCT02450526|11236603|FG003|STARTED|DB Period (Cycle 1)||22
10106469|NCT02450526|11236604|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
10106470|NCT02450526|11236600|FG000|Safety Population|DB Period (Cycle 1)||326
10106471|NCT02450526|11236601|FG001|Safety Population|DB Period (Cycle 1)||66
10106472|NCT02450526|11236602|FG002|Safety Population|DB Period (Cycle 1)||107
10106473|NCT02450526|11236603|FG003|Safety Population|DB Period (Cycle 1)||21
10106474|NCT02450526|11236604|FG004|Safety Population|DB Period (Cycle 1)||0
10106475|NCT02450526|11236600|FG000|COMPLETED|DB Period (Cycle 1)||294
10106476|NCT02450526|11236601|FG001|COMPLETED|DB Period (Cycle 1)||63
10106477|NCT02450526|11236602|FG002|COMPLETED|DB Period (Cycle 1)||97
10106478|NCT02450526|11236603|FG003|COMPLETED|DB Period (Cycle 1)||20
10113345|NCT02509117|11244191|FG001|COMPLETED|Period 2 -Part A: 4 Days||2
10106479|NCT02450526|11236604|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
10106480|NCT02450526|11236600|FG000|NOT COMPLETED|DB Period (Cycle 1)||31
10106481|NCT02450526|11236601|FG001|NOT COMPLETED|DB Period (Cycle 1)||3
10106482|NCT02450526|11236602|FG002|NOT COMPLETED|DB Period (Cycle 1)||10
10106483|NCT02450526|11236603|FG003|NOT COMPLETED|DB Period (Cycle 1)||2
10106484|NCT02450526|11236604|FG004|NOT COMPLETED|DB Period (Cycle 1)||0
10106485|NCT02450526|11236600|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10106486|NCT02450526|11236601|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10106487|NCT02450526|11236602|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10106488|NCT02450526|11236603|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10106489|NCT02450526|11236604|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
10106490|NCT02450526|11236600|FG000|Safety Population|OL Period (Cycles 2-5)||0
10106491|NCT02450526|11236601|FG001|Safety Population|OL Period (Cycles 2-5)||0
10106492|NCT02450526|11236602|FG002|Safety Population|OL Period (Cycles 2-5)||0
10106493|NCT02450526|11236603|FG003|Safety Population|OL Period (Cycles 2-5)||0
10106494|NCT02450526|11236604|FG004|Safety Population|OL Period (Cycles 2-5)||465
10106495|NCT02450526|11236600|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10106496|NCT02450526|11236601|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10106497|NCT02450526|11236602|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10106498|NCT02450526|11236603|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10106499|NCT02450526|11236604|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
10106500|NCT02450526|11236600|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10106501|NCT02450526|11236601|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10106502|NCT02450526|11236602|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10106503|NCT02450526|11236603|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10106504|NCT02450526|11236604|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
10106505|NCT02450526|11236600|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10106506|NCT02450526|11236601|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10106507|NCT02450526|11236602|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10106508|NCT02450526|11236603|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10106509|NCT02450526|11236604|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
10106510|NCT02450526|11236600|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10106511|NCT02450526|11236601|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10106512|NCT02450526|11236602|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10106513|NCT02450526|11236603|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10106514|NCT02450526|11236604|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10106515|NCT02450526|11236600|FG000|COMPLETED|OL Period (Cycles 2-5)||0
10106516|NCT02450526|11236601|FG001|COMPLETED|OL Period (Cycles 2-5)||0
10106517|NCT02450526|11236602|FG002|COMPLETED|OL Period (Cycles 2-5)||0
10106518|NCT02450526|11236603|FG003|COMPLETED|OL Period (Cycles 2-5)||0
10106519|NCT02450526|11236604|FG004|COMPLETED|OL Period (Cycles 2-5)||424
10106520|NCT02450526|11236600|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0
10106521|NCT02450526|11236601|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0
10106522|NCT02450526|11236602|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0
10106523|NCT02450526|11236603|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0
10106524|NCT02450526|11236604|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41
10106525|NCT02450539|11236626|FG000|STARTED|Overall Study||106
10106526|NCT02450539|11236627|FG001|STARTED|Overall Study||53
10106527|NCT02450539|11236626|FG000|Received at Least One Dose of Study Drug|Overall Study||106
10106528|NCT02450539|11236627|FG001|Received at Least One Dose of Study Drug|Overall Study||52
10106529|NCT02450539|11236626|FG000|COMPLETED|Overall Study||90
10106530|NCT02450539|11236627|FG001|COMPLETED|Overall Study||46
10106531|NCT02450539|11236626|FG000|NOT COMPLETED|Overall Study||16
10106532|NCT02450539|11236627|FG001|NOT COMPLETED|Overall Study||7
10007124|NCT01748825|11129290|FG001|COMPLETED|Dose Expansion||0
10007125|NCT01748825|11129291|FG002|COMPLETED|Dose Expansion||0
10007126|NCT01748825|11129292|FG003|COMPLETED|Dose Expansion||0
10007127|NCT01748825|11129293|FG004|COMPLETED|Dose Expansion||0
10106533|NCT02450552|11236639|FG000|STARTED|Overall Study||19
10106534|NCT02450552|11236640|FG001|STARTED|Overall Study||23
10106535|NCT02450552|11236641|FG002|STARTED|Overall Study||23
10106536|NCT02450552|11236639|FG000|COMPLETED|Overall Study||14
10106537|NCT02450552|11236640|FG001|COMPLETED|Overall Study||23
10106538|NCT02450552|11236641|FG002|COMPLETED|Overall Study||18
10106539|NCT02450552|11236639|FG000|NOT COMPLETED|Overall Study||5
10106540|NCT02450552|11236640|FG001|NOT COMPLETED|Overall Study||0
10106541|NCT02450552|11236641|FG002|NOT COMPLETED|Overall Study||5
10106542|NCT02450578|11236653|FG000|STARTED|Overall Study||6
10106543|NCT02450578|11236654|FG001|STARTED|Overall Study||6
10106544|NCT02450578|11236655|FG002|STARTED|Overall Study||6
10106545|NCT02450578|11236656|FG003|STARTED|Overall Study||4
10106546|NCT02450578|11236653|FG000|COMPLETED|Overall Study||5
10106547|NCT02450578|11236654|FG001|COMPLETED|Overall Study||6
10106548|NCT02450578|11236655|FG002|COMPLETED|Overall Study||6
10106549|NCT02450578|11236656|FG003|COMPLETED|Overall Study||4
10106550|NCT02450578|11236653|FG000|NOT COMPLETED|Overall Study||1
10106551|NCT02450578|11236654|FG001|NOT COMPLETED|Overall Study||0
10106552|NCT02450578|11236655|FG002|NOT COMPLETED|Overall Study||0
10106553|NCT02450578|11236656|FG003|NOT COMPLETED|Overall Study||0
10106554|NCT02450747|11236670|FG000|STARTED|Overall Study||39
10007128|NCT01748825|11129294|FG005|COMPLETED|Dose Expansion||0
10007129|NCT01748825|11129295|FG006|COMPLETED|Dose Expansion||0
10007130|NCT01748825|11129296|FG007|COMPLETED|Dose Expansion||0
10007131|NCT01748825|11129297|FG008|COMPLETED|Dose Expansion||11
10007132|NCT01748825|11129298|FG009|COMPLETED|Dose Expansion||15
10007133|NCT01748825|11129289|FG000|NOT COMPLETED|Dose Expansion||0
10007134|NCT01748825|11129290|FG001|NOT COMPLETED|Dose Expansion||0
10007135|NCT01748825|11129291|FG002|NOT COMPLETED|Dose Expansion||0
10007136|NCT01748825|11129292|FG003|NOT COMPLETED|Dose Expansion||0
10007137|NCT01748825|11129293|FG004|NOT COMPLETED|Dose Expansion||0
10106555|NCT02450747|11236670|FG000|COMPLETED|Overall Study||39
10106556|NCT02450747|11236670|FG000|NOT COMPLETED|Overall Study||0
10106557|NCT02450799|11236681|FG000|STARTED|Overall Study||31
9759577|NCT00374556|10863092|FG000|NOT COMPLETED|Overall Study||1
9759578|NCT00374556|10863093|FG001|NOT COMPLETED|Overall Study||1
9759579|NCT00374803|10863101|FG000|STARTED|Overall Study||22
10007138|NCT01748825|11129294|FG005|NOT COMPLETED|Dose Expansion||0
10007139|NCT01748825|11129295|FG006|NOT COMPLETED|Dose Expansion||0
10007140|NCT01748825|11129296|FG007|NOT COMPLETED|Dose Expansion||0
10106558|NCT02450799|11236682|FG001|STARTED|Overall Study||37
10106559|NCT02450799|11236683|FG002|STARTED|Overall Study||30
10106560|NCT02450799|11236681|FG000|COMPLETED|Overall Study||31
9759580|NCT00374803|10863102|FG001|STARTED|Overall Study||23
9759581|NCT00374803|10863101|FG000|COMPLETED|Overall Study||22
9759582|NCT00374803|10863102|FG001|COMPLETED|Overall Study||23
9759583|NCT00374803|10863101|FG000|NOT COMPLETED|Overall Study||0
9759584|NCT00374803|10863102|FG001|NOT COMPLETED|Overall Study||0
9759585|NCT00374842|10863113|FG000|STARTED|Overall Study||100
9759586|NCT00374842|10863114|FG001|STARTED|Overall Study||100
9759587|NCT00374842|10863115|FG002|STARTED|Overall Study||100
9759588|NCT00374842|10863113|FG000|COMPLETED|Overall Study||100
10007141|NCT01748825|11129297|FG008|NOT COMPLETED|Dose Expansion||2
10007142|NCT01748825|11129298|FG009|NOT COMPLETED|Dose Expansion||5
10007143|NCT01748916|11129327|FG000|STARTED|Overall Study||2
10007144|NCT01748916|11129328|FG001|STARTED|Overall Study||3
10007145|NCT01748916|11129329|FG002|STARTED|Overall Study||2
10007146|NCT01748916|11129330|FG003|STARTED|Overall Study||3
10106561|NCT02450799|11236682|FG001|COMPLETED|Overall Study||37
10106562|NCT02450799|11236683|FG002|COMPLETED|Overall Study||30
10106563|NCT02450799|11236681|FG000|NOT COMPLETED|Overall Study||0
10106564|NCT02450799|11236682|FG001|NOT COMPLETED|Overall Study||0
10106565|NCT02450799|11236683|FG002|NOT COMPLETED|Overall Study||0
10106566|NCT02450903|11236694|FG000|STARTED|Overall Study||20
10106567|NCT02450903|11236694|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4
10106568|NCT02450903|11236694|FG000|Entered Survival Follow-up Phase|Overall Study||15
10106569|NCT02450903|11236694|FG000|COMPLETED|Overall Study||0
10106570|NCT02450903|11236694|FG000|NOT COMPLETED|Overall Study||20
10106571|NCT02451007|11236698|FG000|STARTED|Overall Study||39
10106572|NCT02451007|11236698|FG000|COMPLETED|Overall Study||32
10106573|NCT02451007|11236698|FG000|NOT COMPLETED|Overall Study||7
10106574|NCT02451124|11236702|FG000|STARTED|Overall Study||156
10106575|NCT02451124|11236702|FG000|COMPLETED|Overall Study||155
10106576|NCT02451124|11236702|FG000|NOT COMPLETED|Overall Study||1
10106577|NCT02451137|11236712|FG000|STARTED|Overall Study||1651
10007147|NCT01748916|11129331|FG004|STARTED|Overall Study||3
10007148|NCT01748916|11129332|FG005|STARTED|Overall Study||3
10007149|NCT01748916|11129327|FG000|COMPLETED|Overall Study||2
10106578|NCT02451137|11236713|FG001|STARTED|Overall Study||1653
10106579|NCT02451137|11236712|FG000|Treated|Overall Study||1632
9759589|NCT00374842|10863114|FG001|COMPLETED|Overall Study||100
9759590|NCT00374842|10863115|FG002|COMPLETED|Overall Study||100
10007150|NCT01748916|11129328|FG001|COMPLETED|Overall Study||3
10007151|NCT01748916|11129329|FG002|COMPLETED|Overall Study||2
10106580|NCT02451137|11236713|FG001|Treated|Overall Study||1626
9759591|NCT00374842|10863113|FG000|NOT COMPLETED|Overall Study||0
9759592|NCT00374842|10863114|FG001|NOT COMPLETED|Overall Study||0
9759593|NCT00374842|10863115|FG002|NOT COMPLETED|Overall Study||0
9759594|NCT00374868|10863125|FG000|STARTED|Overall Study||38
9759595|NCT00374868|10863125|FG000|COMPLETED|Overall Study||2
9759596|NCT00374868|10863125|FG000|NOT COMPLETED|Overall Study||36
9759597|NCT00374907|10863131|FG000|STARTED|12-Week Short-term Period||20
9759598|NCT00374907|10863132|FG001|STARTED|12-Week Short-term Period||16
9759599|NCT00374907|10863131|FG000|COMPLETED|12-Week Short-term Period||17
9759600|NCT00374907|10863132|FG001|COMPLETED|12-Week Short-term Period||15
9759601|NCT00374907|10863131|FG000|NOT COMPLETED|12-Week Short-term Period||3
9759602|NCT00374907|10863132|FG001|NOT COMPLETED|12-Week Short-term Period||1
9759603|NCT00374907|10863131|FG000|STARTED|116-Week Short-term + Long-term Period||20
9759604|NCT00374907|10863132|FG001|STARTED|116-Week Short-term + Long-term Period||16
9759605|NCT00374907|10863131|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
9759606|NCT00374907|10863132|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
9759607|NCT00374907|10863131|FG000|COMPLETED|116-Week Short-term + Long-term Period||7
9759608|NCT00374907|10863132|FG001|COMPLETED|116-Week Short-term + Long-term Period||2
9759609|NCT00374907|10863131|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13
9759610|NCT00374907|10863132|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14
9759611|NCT00375167|10863142|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
9759612|NCT00375167|10863143|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
9759613|NCT00375167|10863142|FG000|COMPLETED|Overall Study||16
9759614|NCT00375167|10863143|FG001|COMPLETED|Overall Study||17
9759615|NCT00375167|10863142|FG000|NOT COMPLETED|Overall Study||0
9759616|NCT00375167|10863143|FG001|NOT COMPLETED|Overall Study||0
9759617|NCT00375219|10863154|FG000|STARTED|Overall Study||62
9759618|NCT00375219|10863155|FG001|STARTED|Overall Study||20
9759619|NCT00375219|10863156|FG002|STARTED|Overall Study||21
9759620|NCT00375219|10863154|FG000|COMPLETED|Overall Study||3
9759621|NCT00375219|10863155|FG001|COMPLETED|Overall Study||0
9759622|NCT00375219|10863156|FG002|COMPLETED|Overall Study||0
9759623|NCT00375219|10863154|FG000|NOT COMPLETED|Overall Study||59
9759624|NCT00375219|10863155|FG001|NOT COMPLETED|Overall Study||20
9759625|NCT00375219|10863156|FG002|NOT COMPLETED|Overall Study||21
9759626|NCT00375427|10863165|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
9759627|NCT00375427|10863166|FG001|STARTED|Overall Study||216
9759628|NCT00375427|10863165|FG000|COMPLETED|Overall Study||149
9759629|NCT00375427|10863166|FG001|COMPLETED|Overall Study||142
9759630|NCT00375427|10863165|FG000|NOT COMPLETED|Overall Study||60
9759631|NCT00375427|10863166|FG001|NOT COMPLETED|Overall Study||74
9759632|NCT00375492|10863174|FG000|STARTED|Overall Study||96
9759633|NCT00375492|10863175|FG001|STARTED|Overall Study||98
9759634|NCT00375492|10863174|FG000|COMPLETED|Overall Study||70
9759635|NCT00375492|10863175|FG001|COMPLETED|Overall Study||72
9759636|NCT00375492|10863174|FG000|NOT COMPLETED|Overall Study||26
9759637|NCT00375492|10863175|FG001|NOT COMPLETED|Overall Study||26
9759638|NCT00375505|10863183|FG000|STARTED|Overall Study||36
9759639|NCT00375505|10863184|FG001|STARTED|Overall Study||34
9759640|NCT00375505|10863183|FG000|COMPLETED|Overall Study||35
9759641|NCT00375505|10863184|FG001|COMPLETED|Overall Study||32
9759642|NCT00375505|10863183|FG000|NOT COMPLETED|Overall Study||1
10106581|NCT02451137|11236712|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
10106582|NCT02451137|11236713|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
10106583|NCT02451137|11236712|FG000|COMPLETED|Overall Study||1405
10106584|NCT02451137|11236713|FG001|COMPLETED|Overall Study||1355
10106585|NCT02451137|11236712|FG000|NOT COMPLETED|Overall Study||246
10106586|NCT02451137|11236713|FG001|NOT COMPLETED|Overall Study||298
10106587|NCT02451150|11236721|FG000|STARTED|Overall Study||3
10106588|NCT02451150|11236722|FG001|STARTED|Overall Study||3
10106589|NCT02451150|11236721|FG000|COMPLETED|Overall Study||3
10106590|NCT02451150|11236722|FG001|COMPLETED|Overall Study||3
10106591|NCT02451150|11236721|FG000|NOT COMPLETED|Overall Study||0
10106592|NCT02451150|11236722|FG001|NOT COMPLETED|Overall Study||0
10106593|NCT02451202|11236730|FG000|STARTED|Overall Study||51
10106594|NCT02451202|11236731|FG001|STARTED|Overall Study||51
10106595|NCT02451202|11236730|FG000|COMPLETED|Overall Study||49
10106596|NCT02451202|11236731|FG001|COMPLETED|Overall Study||48
10106597|NCT02451202|11236730|FG000|NOT COMPLETED|Overall Study||2
10106598|NCT02451202|11236731|FG001|NOT COMPLETED|Overall Study||3
10106599|NCT02451488|11236741|FG000|STARTED|Overall Study||4
10106600|NCT02451488|11236742|FG001|STARTED|Overall Study||4
10106601|NCT02451488|11236741|FG000|COMPLETED|Overall Study||4
10106602|NCT02451488|11236742|FG001|COMPLETED|Overall Study||4
10106603|NCT02451488|11236741|FG000|NOT COMPLETED|Overall Study||0
10106604|NCT02451488|11236742|FG001|NOT COMPLETED|Overall Study||0
10106605|NCT02451514|11236751|FG000|STARTED|Overall Study||33
10106606|NCT02451514|11236752|FG001|STARTED|Overall Study||46
10106607|NCT02451514|11236753|FG002|STARTED|Overall Study||50
10106608|NCT02451514|11236751|FG000|COMPLETED|Overall Study||33
10106609|NCT02451514|11236752|FG001|COMPLETED|Overall Study||46
10106610|NCT02451514|11236753|FG002|COMPLETED|Overall Study||50
10106611|NCT02451514|11236751|FG000|NOT COMPLETED|Overall Study||0
10106612|NCT02451514|11236752|FG001|NOT COMPLETED|Overall Study||0
10106613|NCT02451514|11236753|FG002|NOT COMPLETED|Overall Study||0
10106614|NCT02451670|11236771|FG000|STARTED|Overall Study||5264
10106615|NCT02451670|11236772|FG001|STARTED|Overall Study||5083
10106616|NCT02451670|11236771|FG000|COMPLETED|Overall Study||4550
10106617|NCT02451670|11236772|FG001|COMPLETED|Overall Study||4387
10106618|NCT02451670|11236771|FG000|NOT COMPLETED|Overall Study||714
10106619|NCT02451670|11236772|FG001|NOT COMPLETED|Overall Study||696
10106620|NCT02451696|11236780|FG000|STARTED|Overall Study||5
10106621|NCT02451696|11236781|FG001|STARTED|Overall Study||10
10106622|NCT02451696|11236780|FG000|COMPLETED|Overall Study||4
10106623|NCT02451696|11236781|FG001|COMPLETED|Overall Study||10
10106624|NCT02451696|11236780|FG000|NOT COMPLETED|Overall Study||1
10106625|NCT02451696|11236781|FG001|NOT COMPLETED|Overall Study||0
10106626|NCT02451839|11236789|FG000|STARTED|Overall Study||72
10106627|NCT02451839|11236790|FG001|STARTED|Overall Study||59
10106628|NCT02451839|11236791|FG002|STARTED|Overall Study||37
10106629|NCT02451839|11236789|FG000|Baseline WHODAS Data Recorded|Overall Study||70
10106630|NCT02451839|11236790|FG001|Baseline WHODAS Data Recorded|Overall Study||57
10106631|NCT02451839|11236791|FG002|Baseline WHODAS Data Recorded|Overall Study||37
10106632|NCT02451839|11236789|FG000|COMPLETED|Overall Study||44
10106633|NCT02451839|11236790|FG001|COMPLETED|Overall Study||40
10106634|NCT02451839|11236791|FG002|COMPLETED|Overall Study||30
10106635|NCT02451839|11236789|FG000|NOT COMPLETED|Overall Study||28
10106636|NCT02451839|11236790|FG001|NOT COMPLETED|Overall Study||19
10106637|NCT02451839|11236791|FG002|NOT COMPLETED|Overall Study||7
10106638|NCT02451917|11236801|FG000|STARTED|First Intervention (24 Weeks)||16
10106639|NCT02451917|11236802|FG001|STARTED|First Intervention (24 Weeks)||18
10106640|NCT02451917|11236801|FG000|COMPLETED|First Intervention (24 Weeks)||14
10106641|NCT02451917|11236802|FG001|COMPLETED|First Intervention (24 Weeks)||15
10106642|NCT02451917|11236801|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2
10106643|NCT02451917|11236802|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
10106644|NCT02451917|11236801|FG000|STARTED|Second Intervention (24 Weeks)||14
10106645|NCT02451917|11236802|FG001|STARTED|Second Intervention (24 Weeks)||15
10106646|NCT02451917|11236801|FG000|COMPLETED|Second Intervention (24 Weeks)||14
10106647|NCT02451917|11236802|FG001|COMPLETED|Second Intervention (24 Weeks)||15
10007152|NCT01748916|11129330|FG003|COMPLETED|Overall Study||3
10007153|NCT01748916|11129331|FG004|COMPLETED|Overall Study||3
10007154|NCT01748916|11129332|FG005|COMPLETED|Overall Study||3
10007155|NCT01748916|11129327|FG000|NOT COMPLETED|Overall Study||0
10007156|NCT01748916|11129328|FG001|NOT COMPLETED|Overall Study||0
10007157|NCT01748916|11129329|FG002|NOT COMPLETED|Overall Study||0
10007158|NCT01748916|11129330|FG003|NOT COMPLETED|Overall Study||0
10007159|NCT01748916|11129331|FG004|NOT COMPLETED|Overall Study||0
10007160|NCT01748916|11129332|FG005|NOT COMPLETED|Overall Study||0
10007161|NCT01748942|11129342|FG000|STARTED|Overall Study||39
10007162|NCT01748942|11129343|FG001|STARTED|Overall Study||37
10007163|NCT01748942|11129342|FG000|COMPLETED|Overall Study||35
10007164|NCT01748942|11129343|FG001|COMPLETED|Overall Study||33
10007165|NCT01748942|11129342|FG000|NOT COMPLETED|Overall Study||4
10007166|NCT01748942|11129343|FG001|NOT COMPLETED|Overall Study||4
10007167|NCT01748955|11129351|FG000|STARTED|Overall Study||6
10007168|NCT01748955|11129352|FG001|STARTED|Overall Study||9
10007169|NCT01748955|11129351|FG000|COMPLETED|Overall Study||3
10007170|NCT01748955|11129352|FG001|COMPLETED|Overall Study||4
10007171|NCT01748955|11129351|FG000|NOT COMPLETED|Overall Study||3
10007172|NCT01748955|11129352|FG001|NOT COMPLETED|Overall Study||5
10007173|NCT01748994|11129360|FG000|STARTED|Overall Study||31
9759643|NCT00375505|10863184|FG001|NOT COMPLETED|Overall Study||2
9759644|NCT00375518|10863192|FG000|STARTED|Overall Study||80
9759645|NCT00375518|10863193|FG001|STARTED|Overall Study||82
9759646|NCT00375518|10863192|FG000|COMPLETED|Overall Study||72
9759647|NCT00375518|10863193|FG001|COMPLETED|Overall Study||65
9759648|NCT00375518|10863192|FG000|NOT COMPLETED|Overall Study||8
9759649|NCT00375518|10863193|FG001|NOT COMPLETED|Overall Study||17
9759650|NCT00375609|10863202|FG000|STARTED|Overall Study||88
9759651|NCT00375609|10863203|FG001|STARTED|Overall Study||84
9759652|NCT00375609|10863204|FG002|STARTED|Overall Study||43
9759653|NCT00375609|10863202|FG000|COMPLETED|Overall Study||84
9759654|NCT00375609|10863203|FG001|COMPLETED|Overall Study||77
9759655|NCT00375609|10863204|FG002|COMPLETED|Overall Study||42
9759656|NCT00375609|10863202|FG000|NOT COMPLETED|Overall Study||4
9759657|NCT00375609|10863203|FG001|NOT COMPLETED|Overall Study||7
9759658|NCT00375609|10863204|FG002|NOT COMPLETED|Overall Study||1
9759659|NCT00375674|10863214|FG000|STARTED|Overall Study||309
9759660|NCT00375674|10863215|FG001|STARTED|Overall Study||306
9759661|NCT00375674|10863214|FG000|Intent-to-Treat Population|Overall Study||309
9759662|NCT00375674|10863215|FG001|Intent-to-Treat Population|Overall Study||306
9759663|NCT00375674|10863214|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
9759664|NCT00375674|10863215|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
9759665|NCT00375674|10863214|FG000|COMPLETED|Overall Study||165
9759666|NCT00375674|10863215|FG001|COMPLETED|Overall Study||165
9759667|NCT00375674|10863214|FG000|NOT COMPLETED|Overall Study||144
9759668|NCT00375674|10863215|FG001|NOT COMPLETED|Overall Study||141
9759669|NCT00375713|10863223|FG000|STARTED|Overall Study|Randomized population (N=232).|232
9759670|NCT00375713|10863224|FG001|STARTED|Overall Study|Randomized population (N=234).|234
9759671|NCT00375713|10863223|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
9759672|NCT00375713|10863224|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
9759673|NCT00375713|10863223|FG000|NOT COMPLETED|Overall Study||20
9759674|NCT00375713|10863224|FG001|NOT COMPLETED|Overall Study||23
9759675|NCT00375752|10863232|FG000|STARTED|Overall Study||79
9759676|NCT00375752|10863233|FG001|STARTED|Overall Study||89
9759677|NCT00375752|10863232|FG000|COMPLETED|Overall Study||67
9759678|NCT00375752|10863233|FG001|COMPLETED|Overall Study||74
9759679|NCT00375752|10863232|FG000|NOT COMPLETED|Overall Study||12
9759680|NCT00375752|10863233|FG001|NOT COMPLETED|Overall Study||15
9759681|NCT00375830|10863242|FG000|STARTED|Overall Study||10
9759682|NCT00375830|10863243|FG001|STARTED|Overall Study||30
9759683|NCT00375830|10863244|FG002|STARTED|Overall Study||74
9759684|NCT00375830|10863242|FG000|COMPLETED|Overall Study||10
9759685|NCT00375830|10863243|FG001|COMPLETED|Overall Study||30
9759686|NCT00375830|10863244|FG002|COMPLETED|Overall Study||74
9759687|NCT00375830|10863242|FG000|NOT COMPLETED|Overall Study||0
9759688|NCT00375830|10863243|FG001|NOT COMPLETED|Overall Study||0
9759689|NCT00375830|10863244|FG002|NOT COMPLETED|Overall Study||0
9759690|NCT00375934|10863266|FG000|STARTED|Overall Study||99
9759691|NCT00375934|10863267|FG001|STARTED|Overall Study||101
9759692|NCT00375934|10863266|FG000|COMPLETED|Overall Study||96
9759693|NCT00375934|10863267|FG001|COMPLETED|Overall Study||95
9759694|NCT00375934|10863266|FG000|NOT COMPLETED|Overall Study||3
9759695|NCT00375934|10863267|FG001|NOT COMPLETED|Overall Study||6
9759696|NCT00375973|10863275|FG000|STARTED|Overall Study||30
9759697|NCT00375973|10863276|FG001|STARTED|Overall Study||30
9759698|NCT00375973|10863275|FG000|COMPLETED|Overall Study||20
9759699|NCT00375973|10863276|FG001|COMPLETED|Overall Study||28
9759700|NCT00375973|10863275|FG000|NOT COMPLETED|Overall Study||10
9759701|NCT00375973|10863276|FG001|NOT COMPLETED|Overall Study||2
10007174|NCT01748994|11129361|FG001|STARTED|Overall Study||32
10007175|NCT01748994|11129360|FG000|COMPLETED|Overall Study||23
10007176|NCT01748994|11129361|FG001|COMPLETED|Overall Study||26
9759702|NCT00375999|10863282|FG000|STARTED|Overall Study||34
9759703|NCT00375999|10863282|FG000|COMPLETED|Overall Study||32
9759704|NCT00375999|10863282|FG000|NOT COMPLETED|Overall Study||2
9759705|NCT00376168|10863288|FG000|STARTED|Overall Study||16
9759706|NCT00376168|10863289|FG001|STARTED|Overall Study|One patient randomized but not treated|16
9759707|NCT00376168|10863288|FG000|COMPLETED|Overall Study||14
9759708|NCT00376168|10863289|FG001|COMPLETED|Overall Study||15
9759709|NCT00376168|10863288|FG000|NOT COMPLETED|Overall Study||2
10007177|NCT01748994|11129360|FG000|NOT COMPLETED|Overall Study||8
10106648|NCT02451917|11236801|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
10106649|NCT02451917|11236802|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
10106650|NCT02451930|11236814|FG000|STARTED|Overall Study||3
10106651|NCT02451930|11236815|FG001|STARTED|Overall Study||68
10106652|NCT02451930|11236814|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10106653|NCT02451930|11236815|FG001|Received at Least One Dose of Study Drug|Overall Study||68
10106654|NCT02451930|11236814|FG000|Part A Cohort 2 Participants|Overall Study||0
10106655|NCT02451930|11236815|FG001|Part A Cohort 2 Participants|Overall Study||6
10106656|NCT02451930|11236814|FG000|Part B Participants|Overall Study||0
10106657|NCT02451930|11236815|FG001|Part B Participants|Overall Study||55
10106658|NCT02451930|11236814|FG000|Part C Participants|Overall Study||0
10106659|NCT02451930|11236815|FG001|Part C Participants|Overall Study||7
10106660|NCT02451930|11236814|FG000|COMPLETED|Overall Study||1
10106661|NCT02451930|11236815|FG001|COMPLETED|Overall Study||38
10106662|NCT02451930|11236814|FG000|NOT COMPLETED|Overall Study||2
10106663|NCT02451930|11236815|FG001|NOT COMPLETED|Overall Study||30
10106664|NCT02451995|11236833|FG000|STARTED|Overall Study||42
10106665|NCT02451995|11236834|FG001|STARTED|Overall Study||41
10106666|NCT02451995|11236833|FG000|COMPLETED|Overall Study||42
10106667|NCT02451995|11236834|FG001|COMPLETED|Overall Study||41
10106668|NCT02451995|11236833|FG000|NOT COMPLETED|Overall Study||0
10106669|NCT02451995|11236834|FG001|NOT COMPLETED|Overall Study||0
10106670|NCT02452034|11236846|FG000|STARTED|Overall Study||16
10106671|NCT02452034|11236847|FG001|STARTED|Overall Study||21
10202613|NCT03449030|11329781|FG005|COMPLETED|Overall Study||0
10202614|NCT03449030|11329782|FG006|COMPLETED|Overall Study||0
10202615|NCT03449030|11329783|FG007|COMPLETED|Overall Study||0
10202616|NCT03449030|11329784|FG008|COMPLETED|Overall Study||0
10202617|NCT03449030|11329785|FG009|COMPLETED|Overall Study||0
10202618|NCT03449030|11329776|FG000|NOT COMPLETED|Overall Study||1
10202619|NCT03449030|11329777|FG001|NOT COMPLETED|Overall Study||1
10202620|NCT03449030|11329778|FG002|NOT COMPLETED|Overall Study||1
10202621|NCT03449030|11329779|FG003|NOT COMPLETED|Overall Study||5
10202622|NCT03449030|11329780|FG004|NOT COMPLETED|Overall Study||7
10202623|NCT03449030|11329781|FG005|NOT COMPLETED|Overall Study||7
10202624|NCT03449030|11329782|FG006|NOT COMPLETED|Overall Study||2
10202625|NCT03449030|11329783|FG007|NOT COMPLETED|Overall Study||3
10202626|NCT03449030|11329784|FG008|NOT COMPLETED|Overall Study||3
10202627|NCT03449030|11329785|FG009|NOT COMPLETED|Overall Study||1
10202628|NCT03449134|11329811|FG000|STARTED|52-Week Treatment Period||244
10202629|NCT03449134|11329812|FG001|STARTED|52-Week Treatment Period||244
10202630|NCT03449134|11329813|FG002|STARTED|52-Week Treatment Period||244
10202631|NCT03449134|11329811|FG000|Treated|52-Week Treatment Period||243
10202632|NCT03449134|11329812|FG001|Treated|52-Week Treatment Period||244
10202633|NCT03449134|11329813|FG002|Treated|52-Week Treatment Period||243
10202634|NCT03449134|11329811|FG000|COMPLETED|52-Week Treatment Period||199
10202635|NCT03449134|11329812|FG001|COMPLETED|52-Week Treatment Period||200
10202636|NCT03449134|11329813|FG002|COMPLETED|52-Week Treatment Period||184
10202637|NCT03449134|11329811|FG000|NOT COMPLETED|52-Week Treatment Period||45
10202638|NCT03449134|11329812|FG001|NOT COMPLETED|52-Week Treatment Period||44
10202639|NCT03449134|11329813|FG002|NOT COMPLETED|52-Week Treatment Period||60
10202640|NCT03449134|11329811|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
10202641|NCT03449134|11329812|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
10202642|NCT03449134|11329813|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
10202643|NCT03449134|11329811|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10
10202644|NCT03449134|11329812|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18
10202645|NCT03449134|11329813|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13
10202646|NCT03449134|11329811|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10202647|NCT03449134|11329812|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10202648|NCT03449134|11329813|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10202649|NCT03449147|11329827|FG000|STARTED|52-week Treatment Period||436
10202650|NCT03449147|11329828|FG001|STARTED|52-week Treatment Period||442
10202651|NCT03449147|11329829|FG002|STARTED|52-week Treatment Period||439
10202652|NCT03449147|11329827|FG000|COMPLETED|52-week Treatment Period||382
10202653|NCT03449147|11329828|FG001|COMPLETED|52-week Treatment Period||368
10202654|NCT03449147|11329829|FG002|COMPLETED|52-week Treatment Period||355
10202655|NCT03449147|11329827|FG000|NOT COMPLETED|52-week Treatment Period||54
10202656|NCT03449147|11329828|FG001|NOT COMPLETED|52-week Treatment Period||74
10202657|NCT03449147|11329829|FG002|NOT COMPLETED|52-week Treatment Period||84
10202658|NCT03449147|11329827|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48
10238717|NCT00484718|11370187|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10238718|NCT00484718|11370188|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10238719|NCT00484718|11370189|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10238720|NCT00484718|11370190|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10238721|NCT00484718|11370191|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10238722|NCT00484718|11370192|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10238723|NCT00484718|11370187|FG000|STARTED|Washout Period (2 Weeks)||1
10238724|NCT00484718|11370188|FG001|STARTED|Washout Period (2 Weeks)||1
10238725|NCT00484718|11370189|FG002|STARTED|Washout Period (2 Weeks)||1
10238726|NCT00484718|11370190|FG003|STARTED|Washout Period (2 Weeks)||1
10238727|NCT00484718|11370191|FG004|STARTED|Washout Period (2 Weeks)||1
10238728|NCT00484718|11370192|FG005|STARTED|Washout Period (2 Weeks)||1
10238729|NCT00484718|11370187|FG000|COMPLETED|Washout Period (2 Weeks)||1
10238730|NCT00484718|11370188|FG001|COMPLETED|Washout Period (2 Weeks)||1
10106672|NCT02452034|11236848|FG002|STARTED|Overall Study||15
10106673|NCT02452034|11236849|FG003|STARTED|Overall Study||17
10106674|NCT02452034|11236850|FG004|STARTED|Overall Study||20
10106675|NCT02452034|11236851|FG005|STARTED|Overall Study||29
10106676|NCT02452034|11236846|FG000|Treated|Overall Study||14
10106677|NCT02452034|11236847|FG001|Treated|Overall Study||21
10106678|NCT02452034|11236848|FG002|Treated|Overall Study||15
10106679|NCT02452034|11236849|FG003|Treated|Overall Study||16
10106680|NCT02452034|11236850|FG004|Treated|Overall Study||20
10106681|NCT02452034|11236851|FG005|Treated|Overall Study||29
10106682|NCT02452034|11236846|FG000|COMPLETED|Overall Study||14
10106683|NCT02452034|11236847|FG001|COMPLETED|Overall Study||20
10106684|NCT02452034|11236848|FG002|COMPLETED|Overall Study||14
10106685|NCT02452034|11236849|FG003|COMPLETED|Overall Study||16
10106686|NCT02452034|11236850|FG004|COMPLETED|Overall Study||19
10106687|NCT02452034|11236851|FG005|COMPLETED|Overall Study||26
10106688|NCT02452034|11236846|FG000|NOT COMPLETED|Overall Study||2
10106689|NCT02452034|11236847|FG001|NOT COMPLETED|Overall Study||1
10106690|NCT02452034|11236848|FG002|NOT COMPLETED|Overall Study||1
10106691|NCT02452034|11236849|FG003|NOT COMPLETED|Overall Study||1
10106692|NCT02452034|11236850|FG004|NOT COMPLETED|Overall Study||1
10106693|NCT02452034|11236851|FG005|NOT COMPLETED|Overall Study||3
10106694|NCT02452047|11236868|FG000|STARTED|Overall Study||31
10106695|NCT02452047|11236869|FG001|STARTED|Overall Study||16
10106696|NCT02452047|11236870|FG002|STARTED|Overall Study||3
10106697|NCT02452047|11236868|FG000|COMPLETED|Overall Study||27
10106698|NCT02452047|11236869|FG001|COMPLETED|Overall Study||11
10106699|NCT02452047|11236870|FG002|COMPLETED|Overall Study||1
10106700|NCT02452047|11236868|FG000|NOT COMPLETED|Overall Study||4
10106701|NCT02452047|11236869|FG001|NOT COMPLETED|Overall Study||5
10106702|NCT02452047|11236870|FG002|NOT COMPLETED|Overall Study||2
10106703|NCT02452060|11236880|FG000|STARTED|Overall Study||46
10106704|NCT02452060|11236881|FG001|STARTED|Overall Study||44
10106705|NCT02452060|11236880|FG000|COMPLETED|Overall Study||46
10106706|NCT02452060|11236881|FG001|COMPLETED|Overall Study||44
10106707|NCT02452060|11236880|FG000|NOT COMPLETED|Overall Study||0
10106708|NCT02452060|11236881|FG001|NOT COMPLETED|Overall Study||0
10106709|NCT02452190|11236889|FG000|STARTED|Overall Study||232
10106710|NCT02452190|11236890|FG001|STARTED|Overall Study||236
10106711|NCT02452190|11236889|FG000|Intent to Treat (ITT) Population|Overall Study||230
10106712|NCT02452190|11236890|FG001|Intent to Treat (ITT) Population|Overall Study||234
10106713|NCT02452190|11236889|FG000|Safety Population|Overall Study||231
10106714|NCT02452190|11236890|FG001|Safety Population|Overall Study||237
10106715|NCT02452190|11236889|FG000|COMPLETED|Overall Study||197
10106716|NCT02452190|11236890|FG001|COMPLETED|Overall Study||212
10106717|NCT02452190|11236889|FG000|NOT COMPLETED|Overall Study||35
10106718|NCT02452190|11236890|FG001|NOT COMPLETED|Overall Study||24
10106719|NCT02452320|11236898|FG000|STARTED|Overall Study||64
10106720|NCT02452320|11236899|FG001|STARTED|Overall Study||64
10106721|NCT02452320|11236898|FG000|COMPLETED|Overall Study||64
10106722|NCT02452320|11236899|FG001|COMPLETED|Overall Study||63
10106723|NCT02452320|11236898|FG000|NOT COMPLETED|Overall Study||0
10106724|NCT02452320|11236899|FG001|NOT COMPLETED|Overall Study||1
10106725|NCT02452346|11236905|FG000|STARTED|Overall Study||12
10106726|NCT02452346|11236905|FG000|COMPLETED|Overall Study||3
10106727|NCT02452346|11236905|FG000|NOT COMPLETED|Overall Study||9
10106728|NCT02452424|11236920|FG000|STARTED|Overall Study||4
10106729|NCT02452424|11236921|FG001|STARTED|Overall Study||3
10106730|NCT02452424|11236922|FG002|STARTED|Overall Study||7
10106731|NCT02452424|11236923|FG003|STARTED|Overall Study||9
10106732|NCT02452424|11236924|FG004|STARTED|Overall Study||4
10106733|NCT02452424|11236925|FG005|STARTED|Overall Study||6
10106734|NCT02452424|11236926|FG006|STARTED|Overall Study||13
10106735|NCT02452424|11236927|FG007|STARTED|Overall Study||8
10106736|NCT02452424|11236928|FG008|STARTED|Overall Study||15
10106737|NCT02452424|11236929|FG009|STARTED|Overall Study||3
10106738|NCT02452424|11236930|FG010|STARTED|Overall Study||6
10106739|NCT02452424|11236920|FG000|COMPLETED|Overall Study||2
10106740|NCT02452424|11236921|FG001|COMPLETED|Overall Study||0
10106741|NCT02452424|11236922|FG002|COMPLETED|Overall Study||0
10106742|NCT02452424|11236923|FG003|COMPLETED|Overall Study||1
10106743|NCT02452424|11236924|FG004|COMPLETED|Overall Study||2
10106744|NCT02452424|11236925|FG005|COMPLETED|Overall Study||5
10106745|NCT02452424|11236926|FG006|COMPLETED|Overall Study||3
10106746|NCT02452424|11236927|FG007|COMPLETED|Overall Study||4
10106747|NCT02452424|11236928|FG008|COMPLETED|Overall Study||9
10106748|NCT02452424|11236929|FG009|COMPLETED|Overall Study||1
10106749|NCT02452424|11236930|FG010|COMPLETED|Overall Study||4
10106750|NCT02452424|11236920|FG000|NOT COMPLETED|Overall Study||2
10106751|NCT02452424|11236921|FG001|NOT COMPLETED|Overall Study||3
10106752|NCT02452424|11236922|FG002|NOT COMPLETED|Overall Study||7
10106753|NCT02452424|11236923|FG003|NOT COMPLETED|Overall Study||8
10106754|NCT02452424|11236924|FG004|NOT COMPLETED|Overall Study||2
10106755|NCT02452424|11236925|FG005|NOT COMPLETED|Overall Study||1
10106756|NCT02452424|11236926|FG006|NOT COMPLETED|Overall Study||10
10106757|NCT02452424|11236927|FG007|NOT COMPLETED|Overall Study||4
10106758|NCT02452424|11236928|FG008|NOT COMPLETED|Overall Study||6
10106759|NCT02452424|11236929|FG009|NOT COMPLETED|Overall Study||2
10106760|NCT02452424|11236930|FG010|NOT COMPLETED|Overall Study||2
10106761|NCT02452463|11236959|FG000|STARTED|Overall Study||5
10106762|NCT02452463|11236960|FG001|STARTED|Overall Study||3
9759710|NCT00376168|10863289|FG001|NOT COMPLETED|Overall Study||1
9829194|NCT00758680|10939743|FG003|NOT COMPLETED|Overall Study||0
9829195|NCT00758680|10939744|FG004|NOT COMPLETED|Overall Study||0
10106763|NCT02452463|11236961|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
10106764|NCT02452463|11236959|FG000|COMPLETED|Overall Study||3
10106765|NCT02452463|11236960|FG001|COMPLETED|Overall Study||1
10106766|NCT02452463|11236961|FG002|COMPLETED|Overall Study||0
10106767|NCT02452463|11236959|FG000|NOT COMPLETED|Overall Study||2
10106768|NCT02452463|11236960|FG001|NOT COMPLETED|Overall Study||2
10106769|NCT02452463|11236961|FG002|NOT COMPLETED|Overall Study||0
10106770|NCT02452476|11236971|FG000|STARTED|Overall Study||64
10106771|NCT02452476|11236972|FG001|STARTED|Overall Study||59
10106772|NCT02452476|11236971|FG000|COMPLETED|Overall Study||53
10106773|NCT02452476|11236972|FG001|COMPLETED|Overall Study||49
10106774|NCT02452476|11236971|FG000|NOT COMPLETED|Overall Study||11
10106775|NCT02452476|11236972|FG001|NOT COMPLETED|Overall Study||10
10106776|NCT02452528|11236980|FG000|STARTED|Overall Study||2
10106777|NCT02452528|11236981|FG001|STARTED|Overall Study||2
10106778|NCT02452528|11236980|FG000|COMPLETED|Overall Study||1
10106779|NCT02452528|11236981|FG001|COMPLETED|Overall Study||1
10106780|NCT02452528|11236980|FG000|NOT COMPLETED|Overall Study||1
10106781|NCT02452528|11236981|FG001|NOT COMPLETED|Overall Study||1
10106782|NCT02452762|11236989|FG000|STARTED|Overall Study||45
10106783|NCT02452762|11236990|FG001|STARTED|Overall Study||22
10106784|NCT02452762|11236989|FG000|COMPLETED|Overall Study||40
10106785|NCT02452762|11236990|FG001|COMPLETED|Overall Study||19
10106786|NCT02452762|11236989|FG000|NOT COMPLETED|Overall Study||5
10106787|NCT02452762|11236990|FG001|NOT COMPLETED|Overall Study||3
10106788|NCT02452866|11236997|FG000|STARTED|Overall Study||325
10106789|NCT02452866|11236997|FG000|COMPLETED|Overall Study||321
10106790|NCT02452866|11236997|FG000|NOT COMPLETED|Overall Study||4
10106791|NCT02452892|11237005|FG000|STARTED|Week 1 Initial Randommization||41
10106792|NCT02452892|11237006|FG001|STARTED|Week 1 Initial Randommization||40
10106793|NCT02452892|11237007|FG002|STARTED|Week 1 Initial Randommization||41
10106794|NCT02452892|11237008|FG003|STARTED|Week 1 Initial Randommization||0
10106795|NCT02452892|11237005|FG000|COMPLETED|Week 1 Initial Randommization||40
10106796|NCT02452892|11237006|FG001|COMPLETED|Week 1 Initial Randommization||40
10106797|NCT02452892|11237007|FG002|COMPLETED|Week 1 Initial Randommization||40
10106798|NCT02452892|11237008|FG003|COMPLETED|Week 1 Initial Randommization||0
10106799|NCT02452892|11237005|FG000|NOT COMPLETED|Week 1 Initial Randommization||1
10106800|NCT02452892|11237006|FG001|NOT COMPLETED|Week 1 Initial Randommization||0
10106801|NCT02452892|11237007|FG002|NOT COMPLETED|Week 1 Initial Randommization||1
10106802|NCT02452892|11237008|FG003|NOT COMPLETED|Week 1 Initial Randommization||0
10113346|NCT02509117|11244192|FG002|COMPLETED|Period 2 -Part A: 4 Days||2
10106803|NCT02452892|11237005|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
10106804|NCT02452892|11237006|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
10106805|NCT02452892|11237007|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
10106806|NCT02452892|11237008|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
10106807|NCT02452892|11237005|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38
10106808|NCT02452892|11237006|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0
10106809|NCT02452892|11237007|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0
10106810|NCT02452892|11237008|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41
10106811|NCT02452892|11237005|FG000|Responders|Week 2 Stratification & Re-Randomization||27
10106812|NCT02452892|11237006|FG001|Responders|Week 2 Stratification & Re-Randomization||7
10106813|NCT02452892|11237007|FG002|Responders|Week 2 Stratification & Re-Randomization||7
10106814|NCT02452892|11237008|FG003|Responders|Week 2 Stratification & Re-Randomization||0
10106815|NCT02452892|11237005|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63
10106816|NCT02452892|11237006|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7
10106817|NCT02452892|11237007|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7
10106818|NCT02452892|11237008|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39
10106819|NCT02452892|11237005|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
10106820|NCT02452892|11237006|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
10106821|NCT02452892|11237007|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
10106822|NCT02452892|11237008|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
10106823|NCT02452892|11237005|FG000|STARTED|Follow-up||63
10106824|NCT02452892|11237006|FG001|STARTED|Follow-up||7
10106825|NCT02452892|11237007|FG002|STARTED|Follow-up||7
10106826|NCT02452892|11237008|FG003|STARTED|Follow-up||39
10106827|NCT02452892|11237005|FG000|COMPLETED|Follow-up||62
10106828|NCT02452892|11237006|FG001|COMPLETED|Follow-up||7
10106829|NCT02452892|11237007|FG002|COMPLETED|Follow-up||7
10106830|NCT02452892|11237008|FG003|COMPLETED|Follow-up||38
10106831|NCT02452892|11237005|FG000|NOT COMPLETED|Follow-up||1
10106832|NCT02452892|11237006|FG001|NOT COMPLETED|Follow-up||0
10106833|NCT02452892|11237007|FG002|NOT COMPLETED|Follow-up||0
10106834|NCT02452892|11237008|FG003|NOT COMPLETED|Follow-up||1
10106835|NCT02452931|11237021|FG000|STARTED|Overall Study||64
10106836|NCT02452931|11237021|FG000|COMPLETED|Overall Study||60
10106837|NCT02452931|11237021|FG000|NOT COMPLETED|Overall Study||4
10106838|NCT02452944|11237027|FG000|STARTED|Overall Study||31
10106839|NCT02452944|11237028|FG001|STARTED|Overall Study||31
10106840|NCT02452944|11237027|FG000|COMPLETED|Overall Study||31
10106841|NCT02452944|11237028|FG001|COMPLETED|Overall Study||31
10106842|NCT02452944|11237027|FG000|NOT COMPLETED|Overall Study||0
10106843|NCT02452944|11237028|FG001|NOT COMPLETED|Overall Study||0
10106844|NCT02453048|11237041|FG000|STARTED|Overall Study||12
10106845|NCT02453048|11237042|FG001|STARTED|Overall Study||12
10106846|NCT02453048|11237043|FG002|STARTED|Overall Study||12
10106847|NCT02453048|11237044|FG003|STARTED|Overall Study||12
10106848|NCT02453048|11237045|FG004|STARTED|Overall Study||6
10106849|NCT02453048|11237041|FG000|6-month Follow-up|Overall Study||12
10106850|NCT02453048|11237042|FG001|6-month Follow-up|Overall Study||12
10106851|NCT02453048|11237043|FG002|6-month Follow-up|Overall Study||12
10106852|NCT02453048|11237044|FG003|6-month Follow-up|Overall Study||12
10106853|NCT02453048|11237045|FG004|6-month Follow-up|Overall Study||6
10106854|NCT02453048|11237041|FG000|COMPLETED|Overall Study||12
10106855|NCT02453048|11237042|FG001|COMPLETED|Overall Study||11
10106856|NCT02453048|11237043|FG002|COMPLETED|Overall Study||10
10106857|NCT02453048|11237044|FG003|COMPLETED|Overall Study||12
10106858|NCT02453048|11237045|FG004|COMPLETED|Overall Study||0
10106859|NCT02453048|11237041|FG000|NOT COMPLETED|Overall Study||0
10106860|NCT02453048|11237042|FG001|NOT COMPLETED|Overall Study||1
10106861|NCT02453048|11237043|FG002|NOT COMPLETED|Overall Study||2
10106862|NCT02453048|11237044|FG003|NOT COMPLETED|Overall Study||0
10106863|NCT02453048|11237045|FG004|NOT COMPLETED|Overall Study||6
10106864|NCT02453113|11237057|FG000|STARTED|Overall Study||10
10106865|NCT02453113|11237057|FG000|COMPLETED|Overall Study||10
10106866|NCT02453113|11237057|FG000|NOT COMPLETED|Overall Study||0
10106867|NCT02453191|11237061|FG000|STARTED|Overall Study||30
10106868|NCT02453191|11237061|FG000|COMPLETED|Overall Study||29
10106869|NCT02453191|11237061|FG000|NOT COMPLETED|Overall Study||1
10106870|NCT02453256|11237067|FG000|STARTED|Double Blind Period||106
10106871|NCT02453256|11237068|FG001|STARTED|Double Blind Period||104
10106872|NCT02453256|11237067|FG000|COMPLETED|Double Blind Period||93
10106873|NCT02453256|11237068|FG001|COMPLETED|Double Blind Period||95
10106874|NCT02453256|11237067|FG000|NOT COMPLETED|Double Blind Period||13
10106875|NCT02453256|11237068|FG001|NOT COMPLETED|Double Blind Period||9
10106876|NCT02453256|11237067|FG000|STARTED|Open Label Period||89
10106877|NCT02453256|11237068|FG001|STARTED|Open Label Period||92
10106878|NCT02453256|11237067|FG000|COMPLETED|Open Label Period||82
10106879|NCT02453256|11237068|FG001|COMPLETED|Open Label Period||85
9759711|NCT00376220|10863297|FG000|STARTED|Overall Study||47
10106880|NCT02453256|11237067|FG000|NOT COMPLETED|Open Label Period||7
10106881|NCT02453256|11237068|FG001|NOT COMPLETED|Open Label Period||7
10106882|NCT02453282|11237084|FG000|STARTED|Overall Study||374
10106883|NCT02453282|11237085|FG001|STARTED|Overall Study||372
9759712|NCT00376220|10863298|FG001|STARTED|Overall Study||47
10106884|NCT02453282|11237086|FG002|STARTED|Overall Study||372
10106885|NCT02453282|11237084|FG000|Received Treatment|Overall Study||369
10106886|NCT02453282|11237085|FG001|Received Treatment|Overall Study||371
10106887|NCT02453282|11237086|FG002|Received Treatment|Overall Study||352
10106888|NCT02453282|11237084|FG000|COMPLETED|Overall Study||0
10106889|NCT02453282|11237085|FG001|COMPLETED|Overall Study||0
10106890|NCT02453282|11237086|FG002|COMPLETED|Overall Study||0
10106891|NCT02453282|11237084|FG000|NOT COMPLETED|Overall Study||374
10106892|NCT02453282|11237085|FG001|NOT COMPLETED|Overall Study||372
10106893|NCT02453282|11237086|FG002|NOT COMPLETED|Overall Study||372
10106894|NCT02453321|11237099|FG000|STARTED|Overall Study||20
10106895|NCT02453321|11237100|FG001|STARTED|Overall Study||21
10106896|NCT02453321|11237101|FG002|STARTED|Overall Study||21
10106897|NCT02453321|11237099|FG000|COMPLETED|Overall Study||19
10106898|NCT02453321|11237100|FG001|COMPLETED|Overall Study||19
10106899|NCT02453321|11237101|FG002|COMPLETED|Overall Study||19
10106900|NCT02453321|11237099|FG000|NOT COMPLETED|Overall Study||1
10106901|NCT02453321|11237100|FG001|NOT COMPLETED|Overall Study||2
10106902|NCT02453321|11237101|FG002|NOT COMPLETED|Overall Study||2
10106903|NCT02453334|11237114|FG000|STARTED|Overall Study||122
10106904|NCT02453334|11237115|FG001|STARTED|Overall Study||122
10106905|NCT02453334|11237114|FG000|COMPLETED|Overall Study||81
10106906|NCT02453334|11237115|FG001|COMPLETED|Overall Study||82
10106907|NCT02453334|11237114|FG000|NOT COMPLETED|Overall Study||41
10106908|NCT02453334|11237115|FG001|NOT COMPLETED|Overall Study||40
10106909|NCT02453347|11237121|FG000|STARTED|Overall Study||6
10106910|NCT02453347|11237121|FG000|COMPLETED|Overall Study||6
10106911|NCT02453347|11237121|FG000|NOT COMPLETED|Overall Study||0
10106912|NCT02453360|11237128|FG000|STARTED|Overall Study||20
10106913|NCT02453360|11237129|FG001|STARTED|Overall Study||20
10106914|NCT02453360|11237130|FG002|STARTED|Overall Study||20
10106915|NCT02453360|11237128|FG000|COMPLETED|Overall Study||20
10202659|NCT03449147|11329828|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
10202660|NCT03449147|11329829|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
10202661|NCT03449147|11329827|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47
10106916|NCT02453360|11237129|FG001|COMPLETED|Overall Study||20
10106917|NCT02453360|11237130|FG002|COMPLETED|Overall Study||20
10106918|NCT02453360|11237128|FG000|NOT COMPLETED|Overall Study||0
10106919|NCT02453360|11237129|FG001|NOT COMPLETED|Overall Study||0
10106920|NCT02453360|11237130|FG002|NOT COMPLETED|Overall Study||0
10106921|NCT02453386|11237141|FG000|STARTED|Overall Study||151
10106922|NCT02453386|11237142|FG001|STARTED|Overall Study||149
10106923|NCT02453386|11237143|FG002|STARTED|Overall Study||149
10106924|NCT02453386|11237141|FG000|COMPLETED|Overall Study||102
10106925|NCT02453386|11237142|FG001|COMPLETED|Overall Study||100
10106926|NCT02453386|11237143|FG002|COMPLETED|Overall Study||108
10106927|NCT02453386|11237141|FG000|NOT COMPLETED|Overall Study||49
10106928|NCT02453386|11237142|FG001|NOT COMPLETED|Overall Study||49
10106929|NCT02453386|11237143|FG002|NOT COMPLETED|Overall Study||41
10106930|NCT02453555|11237160|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
10106931|NCT02453555|11237161|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
10106932|NCT02453555|11237162|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10106933|NCT02453555|11237163|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10106934|NCT02453555|11237164|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10106935|NCT02453555|11237165|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10106936|NCT02453555|11237160|FG000|COMPLETED|24-week Double-blind Treatment Period||177
10106937|NCT02453555|11237161|FG001|COMPLETED|24-week Double-blind Treatment Period||86
10106938|NCT02453555|11237162|FG002|COMPLETED|24-week Double-blind Treatment Period||0
10106939|NCT02453555|11237163|FG003|COMPLETED|24-week Double-blind Treatment Period||0
10106940|NCT02453555|11237164|FG004|COMPLETED|24-week Double-blind Treatment Period||0
10106941|NCT02453555|11237165|FG005|COMPLETED|24-week Double-blind Treatment Period||0
10106942|NCT02453555|11237160|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5
10106943|NCT02453555|11237161|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7
10106944|NCT02453555|11237162|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0
10106945|NCT02453555|11237163|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0
10106946|NCT02453555|11237164|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0
10106947|NCT02453555|11237165|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0
10106948|NCT02453555|11237160|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0
10106949|NCT02453555|11237161|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0
10106950|NCT02453555|11237162|FG002|STARTED|Extension Period||126
10106951|NCT02453555|11237163|FG003|STARTED|Extension Period||51
10106952|NCT02453555|11237164|FG004|STARTED|Extension Period||80
10106953|NCT02453555|11237165|FG005|STARTED|Extension Period||6
10106954|NCT02453555|11237160|FG000|COMPLETED|Extension Period||0
10106955|NCT02453555|11237161|FG001|COMPLETED|Extension Period||0
10106956|NCT02453555|11237162|FG002|COMPLETED|Extension Period||123
10106957|NCT02453555|11237163|FG003|COMPLETED|Extension Period||49
10106958|NCT02453555|11237164|FG004|COMPLETED|Extension Period||79
10106959|NCT02453555|11237165|FG005|COMPLETED|Extension Period||5
10106960|NCT02453555|11237160|FG000|NOT COMPLETED|Extension Period||0
10106961|NCT02453555|11237161|FG001|NOT COMPLETED|Extension Period||0
10106962|NCT02453555|11237162|FG002|NOT COMPLETED|Extension Period||3
10106963|NCT02453555|11237163|FG003|NOT COMPLETED|Extension Period||2
10106964|NCT02453555|11237164|FG004|NOT COMPLETED|Extension Period||1
10106965|NCT02453555|11237165|FG005|NOT COMPLETED|Extension Period||1
10106966|NCT02453581|11237175|FG000|STARTED|Overall Study||8
10106967|NCT02453581|11237176|FG001|STARTED|Overall Study||8
10106968|NCT02453581|11237177|FG002|STARTED|Overall Study||8
10106969|NCT02453581|11237175|FG000|COMPLETED|Overall Study||8
10106970|NCT02453581|11237176|FG001|COMPLETED|Overall Study||8
10106971|NCT02453581|11237177|FG002|COMPLETED|Overall Study||8
9877486|NCT01011556|10991943|FG002|NOT COMPLETED|Overall Study||10
9877487|NCT01011556|10991944|FG003|NOT COMPLETED|Overall Study||13
9877488|NCT01011673|10991959|FG000|STARTED|Randomized||62
9877489|NCT01011673|10991960|FG001|STARTED|Randomized||61
9877490|NCT01011673|10991959|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
10106972|NCT02453581|11237175|FG000|NOT COMPLETED|Overall Study||0
10106973|NCT02453581|11237176|FG001|NOT COMPLETED|Overall Study||0
10106974|NCT02453581|11237177|FG002|NOT COMPLETED|Overall Study||0
10106975|NCT02453672|11237197|FG000|STARTED|Overall Study||40
10106976|NCT02453672|11237198|FG001|STARTED|Overall Study||40
10106977|NCT02453672|11237199|FG002|STARTED|Overall Study||39
10106978|NCT02453672|11237197|FG000|COMPLETED|Overall Study||37
10106979|NCT02453672|11237198|FG001|COMPLETED|Overall Study||38
10106980|NCT02453672|11237199|FG002|COMPLETED|Overall Study||38
10106981|NCT02453672|11237197|FG000|NOT COMPLETED|Overall Study||3
10106982|NCT02453672|11237198|FG001|NOT COMPLETED|Overall Study||2
10106983|NCT02453672|11237199|FG002|NOT COMPLETED|Overall Study||1
10106984|NCT02453685|11237209|FG000|STARTED|Overall Study||168
10106985|NCT02453685|11237210|FG001|STARTED|Overall Study||167
10106986|NCT02453685|11237209|FG000|Exposed|Overall Study||166
10106987|NCT02453685|11237210|FG001|Exposed|Overall Study||166
10106988|NCT02453685|11237209|FG000|COMPLETED|Overall Study||149
10106989|NCT02453685|11237210|FG001|COMPLETED|Overall Study||155
10106990|NCT02453685|11237209|FG000|NOT COMPLETED|Overall Study||19
10106991|NCT02453685|11237210|FG001|NOT COMPLETED|Overall Study||12
10106992|NCT02453711|11237225|FG000|STARTED|Overall Study||103
10106993|NCT02453711|11237226|FG001|STARTED|Overall Study||102
10106994|NCT02453711|11237227|FG002|STARTED|Overall Study||103
10106995|NCT02453711|11237228|FG003|STARTED|Overall Study||103
10106996|NCT02453711|11237229|FG004|STARTED|Overall Study||102
10106997|NCT02453711|11237230|FG005|STARTED|Overall Study||102
10106998|NCT02453711|11237231|FG006|STARTED|Overall Study||103
10106999|NCT02453711|11237232|FG007|STARTED|Overall Study||103
10107000|NCT02453711|11237233|FG008|STARTED|Overall Study||136
10107001|NCT02453711|11237225|FG000|Full Analysis Set|Overall Study||103
10107002|NCT02453711|11237226|FG001|Full Analysis Set|Overall Study||102
10107003|NCT02453711|11237227|FG002|Full Analysis Set|Overall Study||103
10107004|NCT02453711|11237228|FG003|Full Analysis Set|Overall Study||103
10107005|NCT02453711|11237229|FG004|Full Analysis Set|Overall Study||102
10107006|NCT02453711|11237230|FG005|Full Analysis Set|Overall Study||102
10107007|NCT02453711|11237231|FG006|Full Analysis Set|Overall Study||103
10107008|NCT02453711|11237232|FG007|Full Analysis Set|Overall Study||103
10107009|NCT02453711|11237233|FG008|Full Analysis Set|Overall Study||136
10107010|NCT02453711|11237225|FG000|Safety Analysis Set|Overall Study||103
10107011|NCT02453711|11237226|FG001|Safety Analysis Set|Overall Study||102
10107012|NCT02453711|11237227|FG002|Safety Analysis Set|Overall Study||103
10107013|NCT02453711|11237228|FG003|Safety Analysis Set|Overall Study||103
10107014|NCT02453711|11237229|FG004|Safety Analysis Set|Overall Study||102
10107015|NCT02453711|11237230|FG005|Safety Analysis Set|Overall Study||102
10107016|NCT02453711|11237231|FG006|Safety Analysis Set|Overall Study||103
10107017|NCT02453711|11237232|FG007|Safety Analysis Set|Overall Study||103
10107018|NCT02453711|11237233|FG008|Safety Analysis Set|Overall Study||136
10107019|NCT02453711|11237225|FG000|COMPLETED|Overall Study||92
10107020|NCT02453711|11237226|FG001|COMPLETED|Overall Study||95
10107021|NCT02453711|11237227|FG002|COMPLETED|Overall Study||94
10107022|NCT02453711|11237228|FG003|COMPLETED|Overall Study||96
10107023|NCT02453711|11237229|FG004|COMPLETED|Overall Study||100
10107024|NCT02453711|11237230|FG005|COMPLETED|Overall Study||96
10107025|NCT02453711|11237231|FG006|COMPLETED|Overall Study||100
10107026|NCT02453711|11237232|FG007|COMPLETED|Overall Study||96
10107027|NCT02453711|11237233|FG008|COMPLETED|Overall Study||123
10107028|NCT02453711|11237225|FG000|NOT COMPLETED|Overall Study||11
10107029|NCT02453711|11237226|FG001|NOT COMPLETED|Overall Study||7
10107030|NCT02453711|11237227|FG002|NOT COMPLETED|Overall Study||9
10107031|NCT02453711|11237228|FG003|NOT COMPLETED|Overall Study||7
10107032|NCT02453711|11237229|FG004|NOT COMPLETED|Overall Study||2
10107033|NCT02453711|11237230|FG005|NOT COMPLETED|Overall Study||6
10107034|NCT02453711|11237231|FG006|NOT COMPLETED|Overall Study||3
10107035|NCT02453711|11237232|FG007|NOT COMPLETED|Overall Study||7
10107036|NCT02453711|11237233|FG008|NOT COMPLETED|Overall Study||13
10107037|NCT02453750|11237253|FG000|STARTED|Overall Study||21
10107038|NCT02453750|11237253|FG000|COMPLETED|Overall Study||21
10107039|NCT02453750|11237253|FG000|NOT COMPLETED|Overall Study||0
10107040|NCT02453841|11237260|FG000|STARTED|Overall Study||30
10107041|NCT02453841|11237260|FG000|COMPLETED|Overall Study||27
10107042|NCT02453841|11237260|FG000|NOT COMPLETED|Overall Study||3
10107043|NCT02454075|11237264|FG000|STARTED|Overall Study||3
10107044|NCT02454075|11237264|FG000|COMPLETED|Overall Study||3
10107045|NCT02454075|11237264|FG000|NOT COMPLETED|Overall Study||0
10107046|NCT02454101|11237272|FG000|STARTED|Overall Study||150
10107047|NCT02454101|11237273|FG001|STARTED|Overall Study||150
10107048|NCT02454101|11237272|FG000|COMPLETED|Overall Study||145
10107049|NCT02454101|11237273|FG001|COMPLETED|Overall Study||143
10107050|NCT02454101|11237272|FG000|NOT COMPLETED|Overall Study||5
10107051|NCT02454101|11237273|FG001|NOT COMPLETED|Overall Study||7
10107052|NCT02454127|11237283|FG000|STARTED|Overall Study||40
10107053|NCT02454127|11237284|FG001|STARTED|Overall Study||40
10107054|NCT02454127|11237285|FG002|STARTED|Overall Study||40
10107055|NCT02454127|11237286|FG003|STARTED|Overall Study||40
10107056|NCT02454127|11237283|FG000|COMPLETED|Overall Study||21
10107057|NCT02454127|11237284|FG001|COMPLETED|Overall Study||26
10107058|NCT02454127|11237285|FG002|COMPLETED|Overall Study||26
10107059|NCT02454127|11237286|FG003|COMPLETED|Overall Study||20
10107060|NCT02454127|11237283|FG000|NOT COMPLETED|Overall Study||19
10107061|NCT02454127|11237284|FG001|NOT COMPLETED|Overall Study||14
10107062|NCT02454127|11237285|FG002|NOT COMPLETED|Overall Study||14
10107063|NCT02454127|11237286|FG003|NOT COMPLETED|Overall Study||20
10107064|NCT02454153|11237298|FG000|STARTED|Overall Study||92
10107065|NCT02454153|11237299|FG001|STARTED|Overall Study||92
10107066|NCT02454153|11237298|FG000|COMPLETED|Overall Study||92
10107067|NCT02454153|11237299|FG001|COMPLETED|Overall Study||92
10107068|NCT02454153|11237298|FG000|NOT COMPLETED|Overall Study||0
10107069|NCT02454153|11237299|FG001|NOT COMPLETED|Overall Study||0
10107070|NCT02454179|11237308|FG000|STARTED|Overall Study||39
10107071|NCT02454179|11237309|FG001|STARTED|Overall Study||39
10107072|NCT02454179|11237308|FG000|Enrolled|Overall Study||39
10107073|NCT02454179|11237309|FG001|Enrolled|Overall Study||39
10107074|NCT02454179|11237308|FG000|Received Study Medication|Overall Study||39
10107075|NCT02454179|11237309|FG001|Received Study Medication|Overall Study||37
10107076|NCT02454179|11237308|FG000|Discontinue Study|Overall Study||39
10107077|NCT02454179|11237309|FG001|Discontinue Study|Overall Study||39
10107078|NCT02454179|11237308|FG000|COMPLETED|Overall Study||0
10107079|NCT02454179|11237309|FG001|COMPLETED|Overall Study||0
10107080|NCT02454179|11237308|FG000|NOT COMPLETED|Overall Study||39
10107081|NCT02454179|11237309|FG001|NOT COMPLETED|Overall Study||39
10107082|NCT02454283|11237317|FG000|STARTED|Overall Study||26
10107083|NCT02454283|11237318|FG001|STARTED|Overall Study||15
10107084|NCT02454283|11237317|FG000|COMPLETED|Overall Study||26
10107085|NCT02454283|11237318|FG001|COMPLETED|Overall Study||15
10107086|NCT02454283|11237317|FG000|NOT COMPLETED|Overall Study||0
10107087|NCT02454283|11237318|FG001|NOT COMPLETED|Overall Study||0
10107088|NCT02454296|11237326|FG000|STARTED|Overall Study||20
10107089|NCT02454296|11237327|FG001|STARTED|Overall Study||21
10107090|NCT02454296|11237326|FG000|COMPLETED|Overall Study||20
10107091|NCT02454296|11237327|FG001|COMPLETED|Overall Study||21
10107092|NCT02454296|11237326|FG000|NOT COMPLETED|Overall Study||0
10107093|NCT02454296|11237327|FG001|NOT COMPLETED|Overall Study||0
10107094|NCT02454478|11237335|FG000|STARTED|Overall Study||7
10107095|NCT02454478|11237335|FG000|COMPLETED|Overall Study||6
10107096|NCT02454478|11237335|FG000|NOT COMPLETED|Overall Study||1
10107097|NCT02454530|11237341|FG000|STARTED|Overall Study||552
10107098|NCT02454530|11237342|FG001|STARTED|Overall Study||608
10107099|NCT02454530|11237341|FG000|COMPLETED|Overall Study||482
10107100|NCT02454530|11237342|FG001|COMPLETED|Overall Study||481
10107101|NCT02454530|11237341|FG000|NOT COMPLETED|Overall Study||70
10107102|NCT02454530|11237342|FG001|NOT COMPLETED|Overall Study||127
10107103|NCT02454608|11237352|FG000|STARTED|Double-Blind Period||15
10107104|NCT02454608|11237353|FG001|STARTED|Double-Blind Period||14
10107105|NCT02454608|11237354|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
10107106|NCT02454608|11237352|FG000|COMPLETED|Double-Blind Period||15
10107107|NCT02454608|11237353|FG001|COMPLETED|Double-Blind Period||12
10107108|NCT02454608|11237354|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
10107109|NCT02454608|11237352|FG000|NOT COMPLETED|Double-Blind Period||0
10107110|NCT02454608|11237353|FG001|NOT COMPLETED|Double-Blind Period||2
10107111|NCT02454608|11237354|FG002|NOT COMPLETED|Double-Blind Period||0
10107112|NCT02454608|11237352|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0
10107113|NCT02454608|11237353|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0
10107114|NCT02454608|11237354|FG002|STARTED|Open Label Period||29
10107115|NCT02454608|11237352|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
10107116|NCT02454608|11237353|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
10107117|NCT02454608|11237354|FG002|COMPLETED|Open Label Period||10
10107118|NCT02454608|11237352|FG000|NOT COMPLETED|Open Label Period||0
10107119|NCT02454608|11237353|FG001|NOT COMPLETED|Open Label Period||0
10107120|NCT02454608|11237354|FG002|NOT COMPLETED|Open Label Period||19
10107121|NCT02454959|11237362|FG000|STARTED|Overall Study||79
10107122|NCT02454959|11237362|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73
10107123|NCT02454959|11237362|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77
10107124|NCT02454959|11237362|FG000|COMPLETED|Overall Study||70
10107125|NCT02454959|11237362|FG000|NOT COMPLETED|Overall Study||9
10107126|NCT02454972|11237377|FG000|STARTED|Overall Study||19
10107127|NCT02454972|11237378|FG001|STARTED|Overall Study||19
10107128|NCT02454972|11237379|FG002|STARTED|Overall Study||76
10107129|NCT02454972|11237380|FG003|STARTED|Overall Study||29
10107130|NCT02454972|11237381|FG004|STARTED|Overall Study||24
10107131|NCT02454972|11237382|FG005|STARTED|Overall Study||15
10107132|NCT02454972|11237383|FG006|STARTED|Overall Study||21
10107133|NCT02454972|11237384|FG007|STARTED|Overall Study||32
10107134|NCT02454972|11237385|FG008|STARTED|Overall Study||110
10107135|NCT02454972|11237377|FG000|Treated|Overall Study||19
10107136|NCT02454972|11237378|FG001|Treated|Overall Study||19
10107137|NCT02454972|11237379|FG002|Treated|Overall Study||73
10107138|NCT02454972|11237380|FG003|Treated|Overall Study||28
10107139|NCT02454972|11237381|FG004|Treated|Overall Study||23
10107140|NCT02454972|11237382|FG005|Treated|Overall Study||15
10107141|NCT02454972|11237383|FG006|Treated|Overall Study||21
10107142|NCT02454972|11237384|FG007|Treated|Overall Study||32
10107143|NCT02454972|11237385|FG008|Treated|Overall Study||105
10107144|NCT02454972|11237377|FG000|COMPLETED|Overall Study||0
10107145|NCT02454972|11237378|FG001|COMPLETED|Overall Study||0
10107146|NCT02454972|11237379|FG002|COMPLETED|Overall Study||0
10107147|NCT02454972|11237380|FG003|COMPLETED|Overall Study||0
10107148|NCT02454972|11237381|FG004|COMPLETED|Overall Study||0
10107149|NCT02454972|11237382|FG005|COMPLETED|Overall Study||0
10107150|NCT02454972|11237383|FG006|COMPLETED|Overall Study||0
10107151|NCT02454972|11237384|FG007|COMPLETED|Overall Study||0
10107152|NCT02454972|11237385|FG008|COMPLETED|Overall Study||0
10107153|NCT02454972|11237377|FG000|NOT COMPLETED|Overall Study||19
10107154|NCT02454972|11237378|FG001|NOT COMPLETED|Overall Study||19
10107155|NCT02454972|11237379|FG002|NOT COMPLETED|Overall Study||76
10107156|NCT02454972|11237380|FG003|NOT COMPLETED|Overall Study||29
10107157|NCT02454972|11237381|FG004|NOT COMPLETED|Overall Study||24
10107158|NCT02454972|11237382|FG005|NOT COMPLETED|Overall Study||15
10107159|NCT02454972|11237383|FG006|NOT COMPLETED|Overall Study||21
10107160|NCT02454972|11237384|FG007|NOT COMPLETED|Overall Study||32
10107161|NCT02454972|11237385|FG008|NOT COMPLETED|Overall Study||110
10107162|NCT02455050|11237401|FG000|STARTED|Treatment Period 1||20
10107163|NCT02455050|11237402|FG001|STARTED|Treatment Period 1||19
10107164|NCT02455050|11237403|FG002|STARTED|Treatment Period 1||20
10107165|NCT02455050|11237404|FG003|STARTED|Treatment Period 1||20
10107166|NCT02455050|11237401|FG000|COMPLETED|Treatment Period 1||19
10107167|NCT02455050|11237402|FG001|COMPLETED|Treatment Period 1||18
10107168|NCT02455050|11237403|FG002|COMPLETED|Treatment Period 1||19
10107169|NCT02455050|11237404|FG003|COMPLETED|Treatment Period 1||18
10107170|NCT02455050|11237401|FG000|NOT COMPLETED|Treatment Period 1||1
10107171|NCT02455050|11237402|FG001|NOT COMPLETED|Treatment Period 1||1
10107172|NCT02455050|11237403|FG002|NOT COMPLETED|Treatment Period 1||1
10107173|NCT02455050|11237404|FG003|NOT COMPLETED|Treatment Period 1||2
10107174|NCT02455050|11237401|FG000|STARTED|Treatment Period 2||19
10107175|NCT02455050|11237402|FG001|STARTED|Treatment Period 2||18
10107176|NCT02455050|11237403|FG002|STARTED|Treatment Period 2||19
10107177|NCT02455050|11237404|FG003|STARTED|Treatment Period 2||18
10107178|NCT02455050|11237401|FG000|COMPLETED|Treatment Period 2||18
10107179|NCT02455050|11237402|FG001|COMPLETED|Treatment Period 2||18
10107180|NCT02455050|11237403|FG002|COMPLETED|Treatment Period 2||17
10107181|NCT02455050|11237404|FG003|COMPLETED|Treatment Period 2||17
10107182|NCT02455050|11237401|FG000|NOT COMPLETED|Treatment Period 2||1
10107183|NCT02455050|11237402|FG001|NOT COMPLETED|Treatment Period 2||0
10107184|NCT02455050|11237403|FG002|NOT COMPLETED|Treatment Period 2||2
10107185|NCT02455050|11237404|FG003|NOT COMPLETED|Treatment Period 2||1
10107186|NCT02455076|11237429|FG000|STARTED|Inpatient||47
10107187|NCT02455076|11237430|FG001|STARTED|Inpatient||51
10107188|NCT02455076|11237431|FG002|STARTED|Inpatient||52
10107189|NCT02455076|11237432|FG003|STARTED|Inpatient||0
10107190|NCT02455076|11237433|FG004|STARTED|Inpatient||0
10107191|NCT02455076|11237429|FG000|COMPLETED|Inpatient||43
10107192|NCT02455076|11237430|FG001|COMPLETED|Inpatient||50
10107193|NCT02455076|11237431|FG002|COMPLETED|Inpatient||52
10107194|NCT02455076|11237432|FG003|COMPLETED|Inpatient||0
10107195|NCT02455076|11237433|FG004|COMPLETED|Inpatient||0
10107196|NCT02455076|11237429|FG000|NOT COMPLETED|Inpatient||4
10107197|NCT02455076|11237430|FG001|NOT COMPLETED|Inpatient||1
10107198|NCT02455076|11237431|FG002|NOT COMPLETED|Inpatient||0
10107199|NCT02455076|11237432|FG003|NOT COMPLETED|Inpatient||0
10107200|NCT02455076|11237433|FG004|NOT COMPLETED|Inpatient||0
10107201|NCT02455076|11237429|FG000|STARTED|Outpatient||0
10107202|NCT02455076|11237430|FG001|STARTED|Outpatient||0
10107203|NCT02455076|11237431|FG002|STARTED|Outpatient||0
10107204|NCT02455076|11237432|FG003|STARTED|Outpatient||48
10107205|NCT02455076|11237433|FG004|STARTED|Outpatient||55
10107206|NCT02455076|11237429|FG000|COMPLETED|Outpatient||0
10107207|NCT02455076|11237430|FG001|COMPLETED|Outpatient||0
10107208|NCT02455076|11237431|FG002|COMPLETED|Outpatient||0
10107209|NCT02455076|11237432|FG003|COMPLETED|Outpatient||42
10107210|NCT02455076|11237433|FG004|COMPLETED|Outpatient||43
10107211|NCT02455076|11237429|FG000|NOT COMPLETED|Outpatient||0
10107212|NCT02455076|11237430|FG001|NOT COMPLETED|Outpatient||0
10107213|NCT02455076|11237431|FG002|NOT COMPLETED|Outpatient||0
10107214|NCT02455076|11237432|FG003|NOT COMPLETED|Outpatient||6
10107215|NCT02455076|11237433|FG004|NOT COMPLETED|Outpatient||12
10107216|NCT02455167|11237445|FG000|STARTED|Overall Study||4
10107217|NCT02455167|11237445|FG000|COMPLETED|Overall Study||4
10107218|NCT02455167|11237445|FG000|NOT COMPLETED|Overall Study||0
10107219|NCT02455336|11237451|FG000|STARTED|Overall Study||15
10107220|NCT02455336|11237452|FG001|STARTED|Overall Study||8
10107221|NCT02455336|11237451|FG000|COMPLETED|Overall Study||10
10107222|NCT02455336|11237452|FG001|COMPLETED|Overall Study||6
10107223|NCT02455336|11237451|FG000|NOT COMPLETED|Overall Study||5
10107224|NCT02455336|11237452|FG001|NOT COMPLETED|Overall Study||2
10107225|NCT02455388|11237460|FG000|STARTED|Overall Study||18
10107226|NCT02455388|11237461|FG001|STARTED|Overall Study||15
10107227|NCT02455388|11237462|FG002|STARTED|Overall Study||337
10107228|NCT02455388|11237460|FG000|COMPLETED|Overall Study||17
10107229|NCT02455388|11237461|FG001|COMPLETED|Overall Study||15
10107230|NCT02455388|11237462|FG002|COMPLETED|Overall Study||326
10107231|NCT02455388|11237460|FG000|NOT COMPLETED|Overall Study||1
10107232|NCT02455388|11237461|FG001|NOT COMPLETED|Overall Study||0
10107233|NCT02455388|11237462|FG002|NOT COMPLETED|Overall Study||11
10107234|NCT02455453|11237470|FG000|STARTED|Overall Study||47
10107235|NCT02455453|11237470|FG000|COMPLETED|Overall Study||47
10107236|NCT02455453|11237470|FG000|NOT COMPLETED|Overall Study||0
10107237|NCT02455518|11237478|FG000|STARTED|Overall Study||104
10107238|NCT02455518|11237479|FG001|STARTED|Overall Study||104
10107239|NCT02455518|11237480|FG002|STARTED|Overall Study||104
10107240|NCT02455518|11237481|FG003|STARTED|Overall Study||104
10107241|NCT02455518|11237478|FG000|COMPLETED|Overall Study||104
10107242|NCT02455518|11237479|FG001|COMPLETED|Overall Study||103
10107243|NCT02455518|11237480|FG002|COMPLETED|Overall Study||103
10107244|NCT02455518|11237481|FG003|COMPLETED|Overall Study||101
10107245|NCT02455518|11237478|FG000|NOT COMPLETED|Overall Study||0
10107246|NCT02455518|11237479|FG001|NOT COMPLETED|Overall Study||1
10107247|NCT02455518|11237480|FG002|NOT COMPLETED|Overall Study||1
10107248|NCT02455518|11237481|FG003|NOT COMPLETED|Overall Study||3
10107249|NCT02456103|11237491|FG000|STARTED|Overall Study||246
10107250|NCT02456103|11237491|FG000|As-Treated Population|Overall Study||245
10107251|NCT02456103|11237491|FG000|Intent-to-treat (ITT) Population|Overall Study||244
10107252|NCT02456103|11237491|FG000|COMPLETED|Overall Study||0
10107253|NCT02456103|11237491|FG000|NOT COMPLETED|Overall Study||246
10107254|NCT02456636|11237498|FG000|STARTED|Overall Study||478
10107255|NCT02456636|11237499|FG001|STARTED|Overall Study||479
10107256|NCT02456636|11237500|FG002|STARTED|Overall Study||475
10107257|NCT02456636|11237498|FG000|6 Month|Overall Study||474
10107258|NCT02456636|11237499|FG001|6 Month|Overall Study||474
10107259|NCT02456636|11237500|FG002|6 Month|Overall Study||468
10107260|NCT02456636|11237498|FG000|18 Month|Overall Study||467
10107261|NCT02456636|11237499|FG001|18 Month|Overall Study||463
10107262|NCT02456636|11237500|FG002|18 Month|Overall Study||461
10107263|NCT02456636|11237498|FG000|COMPLETED|Overall Study||410
10107264|NCT02456636|11237499|FG001|COMPLETED|Overall Study||410
10107265|NCT02456636|11237500|FG002|COMPLETED|Overall Study||400
10107266|NCT02456636|11237498|FG000|NOT COMPLETED|Overall Study||68
10107267|NCT02456636|11237499|FG001|NOT COMPLETED|Overall Study||69
10107268|NCT02456636|11237500|FG002|NOT COMPLETED|Overall Study||75
10107269|NCT02456662|11237510|FG000|STARTED|Overall Study||159
10107270|NCT02456662|11237511|FG001|STARTED|Overall Study||160
10107271|NCT02456662|11237510|FG000|COMPLETED|Overall Study||157
10107272|NCT02456662|11237511|FG001|COMPLETED|Overall Study||159
10107273|NCT02456662|11237510|FG000|NOT COMPLETED|Overall Study||2
10107274|NCT02456662|11237511|FG001|NOT COMPLETED|Overall Study||1
10107275|NCT02456727|11237519|FG000|STARTED|Overall Study||389
10107276|NCT02456727|11237520|FG001|STARTED|Overall Study||390
10107277|NCT02456727|11237519|FG000|Initiated Treatment|Overall Study||346
10107278|NCT02456727|11237520|FG001|Initiated Treatment|Overall Study||360
10107279|NCT02456727|11237519|FG000|6 Week|Overall Study||298
10107280|NCT02456727|11237520|FG001|6 Week|Overall Study||320
10107281|NCT02456727|11237519|FG000|12 Week|Overall Study||295
10107282|NCT02456727|11237520|FG001|12 Week|Overall Study||310
10107283|NCT02456727|11237519|FG000|24 Week|Overall Study||280
10107284|NCT02456727|11237520|FG001|24 Week|Overall Study||284
10107285|NCT02456727|11237519|FG000|COMPLETED|Overall Study||280
10107286|NCT02456727|11237520|FG001|COMPLETED|Overall Study||284
10107287|NCT02456727|11237519|FG000|NOT COMPLETED|Overall Study||109
10107288|NCT02456727|11237520|FG001|NOT COMPLETED|Overall Study||106
10107289|NCT02456896|11237544|FG000|STARTED|Overall Study||25
10107290|NCT02456896|11237545|FG001|STARTED|Overall Study||25
10107291|NCT02456896|11237544|FG000|COMPLETED|Overall Study||19
10107292|NCT02456896|11237545|FG001|COMPLETED|Overall Study||21
10107293|NCT02456896|11237544|FG000|NOT COMPLETED|Overall Study||6
10107294|NCT02456896|11237545|FG001|NOT COMPLETED|Overall Study||4
10107295|NCT02456909|11237553|FG000|STARTED|Overall Study||88
10107296|NCT02456909|11237554|FG001|STARTED|Overall Study||88
10107297|NCT02456909|11237553|FG000|COMPLETED|Overall Study||64
10107298|NCT02456909|11237554|FG001|COMPLETED|Overall Study||61
10107299|NCT02456909|11237553|FG000|NOT COMPLETED|Overall Study||24
10107300|NCT02456909|11237554|FG001|NOT COMPLETED|Overall Study||27
10107301|NCT02457065|11237562|FG000|STARTED|Overall Study||27
10107302|NCT02457065|11237563|FG001|STARTED|Overall Study||27
10107303|NCT02457065|11237562|FG000|COMPLETED|Overall Study||18
10107304|NCT02457065|11237563|FG001|COMPLETED|Overall Study||16
10107305|NCT02457065|11237562|FG000|NOT COMPLETED|Overall Study||9
10107306|NCT02457065|11237563|FG001|NOT COMPLETED|Overall Study||11
10107307|NCT02457182|11237571|FG000|STARTED|Overall Study||9
10107308|NCT02457182|11237572|FG001|STARTED|Overall Study||11
10107309|NCT02457182|11237571|FG000|COMPLETED|Overall Study||8
10107310|NCT02457182|11237572|FG001|COMPLETED|Overall Study||11
10107311|NCT02457182|11237571|FG000|NOT COMPLETED|Overall Study||1
10107312|NCT02457182|11237572|FG001|NOT COMPLETED|Overall Study||0
10107313|NCT02457195|11237578|FG000|STARTED|Overall Study||50
10107314|NCT02457195|11237578|FG000|COMPLETED|Overall Study||41
10107315|NCT02457195|11237578|FG000|NOT COMPLETED|Overall Study||9
10107316|NCT02457247|11237586|FG000|STARTED|Period 1||68
10107317|NCT02457247|11237587|FG001|STARTED|Period 1||70
10107318|NCT02457247|11237588|FG002|STARTED|Period 1||68
10107319|NCT02457247|11237589|FG003|STARTED|Period 1||70
10107320|NCT02457247|11237586|FG000|COMPLETED|Period 1||66
10107321|NCT02457247|11237587|FG001|COMPLETED|Period 1||68
10107322|NCT02457247|11237588|FG002|COMPLETED|Period 1||68
10107323|NCT02457247|11237589|FG003|COMPLETED|Period 1||70
10107324|NCT02457247|11237586|FG000|NOT COMPLETED|Period 1||2
10107325|NCT02457247|11237587|FG001|NOT COMPLETED|Period 1||2
10107326|NCT02457247|11237588|FG002|NOT COMPLETED|Period 1||0
10107327|NCT02457247|11237589|FG003|NOT COMPLETED|Period 1||0
10107328|NCT02457247|11237586|FG000|STARTED|Period 2||66
10107329|NCT02457247|11237587|FG001|STARTED|Period 2||68
10107330|NCT02457247|11237588|FG002|STARTED|Period 2||68
10107331|NCT02457247|11237589|FG003|STARTED|Period 2||70
10107332|NCT02457247|11237586|FG000|COMPLETED|Period 2||64
10107333|NCT02457247|11237587|FG001|COMPLETED|Period 2||65
10107334|NCT02457247|11237588|FG002|COMPLETED|Period 2||68
10107335|NCT02457247|11237589|FG003|COMPLETED|Period 2||70
10107336|NCT02457247|11237586|FG000|NOT COMPLETED|Period 2||2
10107337|NCT02457247|11237587|FG001|NOT COMPLETED|Period 2||3
10107338|NCT02457247|11237588|FG002|NOT COMPLETED|Period 2||0
10107339|NCT02457247|11237589|FG003|NOT COMPLETED|Period 2||0
10107340|NCT02457260|11237608|FG000|STARTED|Overall Study||12
10107341|NCT02457260|11237609|FG001|STARTED|Overall Study||7
10107342|NCT02457260|11237610|FG002|STARTED|Overall Study||2
10107343|NCT02457260|11237608|FG000|COMPLETED|Overall Study||10
10107344|NCT02457260|11237609|FG001|COMPLETED|Overall Study||4
10107345|NCT02457260|11237610|FG002|COMPLETED|Overall Study||1
10107346|NCT02457260|11237608|FG000|NOT COMPLETED|Overall Study||2
10107347|NCT02457260|11237609|FG001|NOT COMPLETED|Overall Study||3
10107348|NCT02457260|11237610|FG002|NOT COMPLETED|Overall Study||1
10107349|NCT02457325|11237621|FG000|STARTED|First Intervention (1 Day)||25
10107350|NCT02457325|11237622|FG001|STARTED|First Intervention (1 Day)||25
10107351|NCT02457325|11237621|FG000|COMPLETED|First Intervention (1 Day)||23
10107352|NCT02457325|11237622|FG001|COMPLETED|First Intervention (1 Day)||23
10107353|NCT02457325|11237621|FG000|NOT COMPLETED|First Intervention (1 Day)||2
10107354|NCT02457325|11237622|FG001|NOT COMPLETED|First Intervention (1 Day)||2
10107355|NCT02457325|11237621|FG000|STARTED|Washout (1-2 Months)||23
10107356|NCT02457325|11237622|FG001|STARTED|Washout (1-2 Months)||23
10107357|NCT02457325|11237621|FG000|COMPLETED|Washout (1-2 Months)||23
10107358|NCT02457325|11237622|FG001|COMPLETED|Washout (1-2 Months)||23
10107359|NCT02457325|11237621|FG000|NOT COMPLETED|Washout (1-2 Months)||0
10107360|NCT02457325|11237622|FG001|NOT COMPLETED|Washout (1-2 Months)||0
10107361|NCT02457325|11237621|FG000|STARTED|Second Intervention (1 Day)||23
10107362|NCT02457325|11237622|FG001|STARTED|Second Intervention (1 Day)||23
10107363|NCT02457325|11237621|FG000|COMPLETED|Second Intervention (1 Day)||23
10107364|NCT02457325|11237622|FG001|COMPLETED|Second Intervention (1 Day)||23
10107365|NCT02457325|11237621|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10107366|NCT02457325|11237622|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10107367|NCT02457403|11237630|FG000|STARTED|Overall Study|34 participants|34
10107368|NCT02457403|11237631|FG001|STARTED|Overall Study|34 historic controls|34
10107369|NCT02457403|11237630|FG000|COMPLETED|Overall Study||34
10107370|NCT02457403|11237631|FG001|COMPLETED|Overall Study||34
10107371|NCT02457403|11237630|FG000|NOT COMPLETED|Overall Study||0
10107372|NCT02457403|11237631|FG001|NOT COMPLETED|Overall Study||0
10107373|NCT02457520|11237639|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
10107374|NCT02457520|11237639|FG000|COMPLETED|Active Treatment Phase||167
10107375|NCT02457520|11237639|FG000|NOT COMPLETED|Active Treatment Phase||34
10107376|NCT02457520|11237639|FG000|STARTED|Post-treatment Period||167
10107377|NCT02457520|11237639|FG000|COMPLETED|Post-treatment Period||119
10107378|NCT02457520|11237639|FG000|NOT COMPLETED|Post-treatment Period||48
10107379|NCT02457546|11237671|FG000|STARTED|Overall Study||114
10107380|NCT02457546|11237672|FG001|STARTED|Overall Study||120
10107381|NCT02457546|11237671|FG000|COMPLETED|Overall Study||105
10107382|NCT02457546|11237672|FG001|COMPLETED|Overall Study||116
10107383|NCT02457546|11237671|FG000|NOT COMPLETED|Overall Study||9
10107384|NCT02457546|11237672|FG001|NOT COMPLETED|Overall Study||4
10107385|NCT02457611|11237678|FG000|STARTED|Overall Study||26
10107386|NCT02457611|11237678|FG000|COMPLETED|Overall Study||23
10107387|NCT02457611|11237678|FG000|NOT COMPLETED|Overall Study||3
10107388|NCT02457637|11237682|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
10107389|NCT02457637|11237682|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
10107390|NCT02457637|11237682|FG000|NOT COMPLETED|Recruitment||0
10107391|NCT02457637|11237682|FG000|STARTED|28-Days Hospitalization and Observation||2600
10107392|NCT02457637|11237682|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124
10107393|NCT02457637|11237682|FG000|Death|28-Days Hospitalization and Observation||74
10107394|NCT02457637|11237682|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
10107395|NCT02457637|11237682|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0
10107396|NCT02457637|11237682|FG000|STARTED|Clinic or Telephone Follow-up||2600
10107397|NCT02457637|11237682|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
10107398|NCT02457637|11237682|FG000|One-year Death|Clinic or Telephone Follow-up||475
10107399|NCT02457637|11237682|FG000|COMPLETED|Clinic or Telephone Follow-up||2529
10107400|NCT02457637|11237682|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71
10107401|NCT02457728|11237687|FG000|STARTED|Overall Study||34
10107402|NCT02457728|11237687|FG000|COMPLETED|Overall Study||34
10107403|NCT02457728|11237687|FG000|NOT COMPLETED|Overall Study||0
10113347|NCT02509117|11244193|FG003|COMPLETED|Period 2 -Part A: 4 Days||2
10113348|NCT02509117|11244194|FG004|COMPLETED|Period 2 -Part A: 4 Days||0
10113349|NCT02509117|11244195|FG005|COMPLETED|Period 2 -Part A: 4 Days||0
10113350|NCT02509117|11244196|FG006|COMPLETED|Period 2 -Part A: 4 Days||0
10113351|NCT02509117|11244197|FG007|COMPLETED|Period 2 -Part A: 4 Days||0
10113352|NCT02509117|11244198|FG008|COMPLETED|Period 2 -Part A: 4 Days||0
10113353|NCT02509117|11244199|FG009|COMPLETED|Period 2 -Part A: 4 Days||0
10113354|NCT02509117|11244190|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10107404|NCT02457793|11237697|FG000|STARTED|Overall Study||1
10107405|NCT02457793|11237698|FG001|STARTED|Overall Study||5
10107406|NCT02457793|11237699|FG002|STARTED|Overall Study||3
10107407|NCT02457793|11237700|FG003|STARTED|Overall Study||5
10107408|NCT02457793|11237701|FG004|STARTED|Overall Study||4
10107409|NCT02457793|11237702|FG005|STARTED|Overall Study||6
10107410|NCT02457793|11237697|FG000|COMPLETED|Overall Study||0
10107411|NCT02457793|11237698|FG001|COMPLETED|Overall Study||1
10107412|NCT02457793|11237699|FG002|COMPLETED|Overall Study||0
10107413|NCT02457793|11237700|FG003|COMPLETED|Overall Study||0
10107414|NCT02457793|11237701|FG004|COMPLETED|Overall Study||0
10107415|NCT02457793|11237702|FG005|COMPLETED|Overall Study||0
10107416|NCT02457793|11237697|FG000|NOT COMPLETED|Overall Study||1
10107417|NCT02457793|11237698|FG001|NOT COMPLETED|Overall Study||4
10107418|NCT02457793|11237699|FG002|NOT COMPLETED|Overall Study||3
10107419|NCT02457793|11237700|FG003|NOT COMPLETED|Overall Study||5
10107420|NCT02457793|11237701|FG004|NOT COMPLETED|Overall Study||4
10107421|NCT02457793|11237702|FG005|NOT COMPLETED|Overall Study||6
10107422|NCT02457819|11237717|FG000|STARTED|Overall Study||237
10107423|NCT02457819|11237717|FG000|Safety Population|Overall Study||236
10107424|NCT02457819|11237717|FG000|COMPLETED|Overall Study||138
10107425|NCT02457819|11237717|FG000|NOT COMPLETED|Overall Study||99
10107426|NCT02457897|11237721|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7
10107427|NCT02457897|11237721|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
10107428|NCT02457897|11237721|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
10107429|NCT02457897|11237721|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
10107430|NCT02457897|11237721|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5
10107431|NCT02457897|11237721|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
10107432|NCT02458092|11237727|FG000|STARTED|Overall Study||20
10107433|NCT02458092|11237728|FG001|STARTED|Overall Study||10
10107434|NCT02458092|11237727|FG000|COMPLETED|Overall Study||19
10107435|NCT02458092|11237728|FG001|COMPLETED|Overall Study||10
10107436|NCT02458092|11237727|FG000|NOT COMPLETED|Overall Study||1
10107437|NCT02458092|11237728|FG001|NOT COMPLETED|Overall Study||0
10107438|NCT02458235|11237735|FG000|STARTED|Overall Study||17
10107439|NCT02458235|11237735|FG000|COMPLETED|Overall Study||17
10107440|NCT02458235|11237735|FG000|NOT COMPLETED|Overall Study||0
10107441|NCT02458287|11237743|FG000|STARTED|Overall Study||50
10107442|NCT02458287|11237744|FG001|STARTED|Overall Study||100
10107443|NCT02458287|11237745|FG002|STARTED|Overall Study||49
10107444|NCT02458287|11237746|FG003|STARTED|Overall Study||100
10107445|NCT02458287|11237743|FG000|COMPLETED|Overall Study||50
10107446|NCT02458287|11237744|FG001|COMPLETED|Overall Study||96
10107447|NCT02458287|11237745|FG002|COMPLETED|Overall Study||46
10107448|NCT02458287|11237746|FG003|COMPLETED|Overall Study||97
10107449|NCT02458287|11237743|FG000|NOT COMPLETED|Overall Study||0
10107450|NCT02458287|11237744|FG001|NOT COMPLETED|Overall Study||4
10107451|NCT02458287|11237745|FG002|NOT COMPLETED|Overall Study||3
10107452|NCT02458287|11237746|FG003|NOT COMPLETED|Overall Study||3
10107453|NCT02458352|11237762|FG000|STARTED|Overall Study||105
10107454|NCT02458352|11237762|FG000|COMPLETED|Overall Study||105
10107455|NCT02458352|11237762|FG000|NOT COMPLETED|Overall Study||0
10107456|NCT02458365|11237770|FG000|STARTED|Overall Study||2000
10107457|NCT02458365|11237771|FG001|STARTED|Overall Study||1901
10107458|NCT02458365|11237770|FG000|COMPLETED|Overall Study||1723
10107459|NCT02458365|11237771|FG001|COMPLETED|Overall Study||1607
10107460|NCT02458365|11237770|FG000|NOT COMPLETED|Overall Study||277
10107461|NCT02458365|11237771|FG001|NOT COMPLETED|Overall Study||294
10107462|NCT02458469|11237778|FG000|STARTED|First Intervention (2 Weeks)||3
10107463|NCT02458469|11237779|FG001|STARTED|First Intervention (2 Weeks)||2
10107464|NCT02458469|11237780|FG002|STARTED|First Intervention (2 Weeks)||3
10107465|NCT02458469|11237781|FG003|STARTED|First Intervention (2 Weeks)||0
10107466|NCT02458469|11237782|FG004|STARTED|First Intervention (2 Weeks)||1
10107467|NCT02458469|11237783|FG005|STARTED|First Intervention (2 Weeks)||2
10107468|NCT02458469|11237778|FG000|COMPLETED|First Intervention (2 Weeks)||2
10107469|NCT02458469|11237779|FG001|COMPLETED|First Intervention (2 Weeks)||2
10107470|NCT02458469|11237780|FG002|COMPLETED|First Intervention (2 Weeks)||2
10107471|NCT02458469|11237781|FG003|COMPLETED|First Intervention (2 Weeks)||0
10107472|NCT02458469|11237782|FG004|COMPLETED|First Intervention (2 Weeks)||1
10107473|NCT02458469|11237783|FG005|COMPLETED|First Intervention (2 Weeks)||2
10107474|NCT02458469|11237778|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1
10107475|NCT02458469|11237779|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10107476|NCT02458469|11237780|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
10107477|NCT02458469|11237781|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
10107478|NCT02458469|11237782|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
10107479|NCT02458469|11237783|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0
10107480|NCT02458469|11237778|FG000|STARTED|First Washout (2 Weeks)||2
10107481|NCT02458469|11237779|FG001|STARTED|First Washout (2 Weeks)||2
10107482|NCT02458469|11237780|FG002|STARTED|First Washout (2 Weeks)||2
10107483|NCT02458469|11237781|FG003|STARTED|First Washout (2 Weeks)||0
10107484|NCT02458469|11237782|FG004|STARTED|First Washout (2 Weeks)||1
10107485|NCT02458469|11237783|FG005|STARTED|First Washout (2 Weeks)||2
10107486|NCT02458469|11237778|FG000|COMPLETED|First Washout (2 Weeks)||2
10107487|NCT02458469|11237779|FG001|COMPLETED|First Washout (2 Weeks)||2
10107488|NCT02458469|11237780|FG002|COMPLETED|First Washout (2 Weeks)||2
10107489|NCT02458469|11237781|FG003|COMPLETED|First Washout (2 Weeks)||0
10107490|NCT02458469|11237782|FG004|COMPLETED|First Washout (2 Weeks)||1
10107491|NCT02458469|11237783|FG005|COMPLETED|First Washout (2 Weeks)||2
10107492|NCT02458469|11237778|FG000|NOT COMPLETED|First Washout (2 Weeks)||0
10107493|NCT02458469|11237779|FG001|NOT COMPLETED|First Washout (2 Weeks)||0
10107494|NCT02458469|11237780|FG002|NOT COMPLETED|First Washout (2 Weeks)||0
10107495|NCT02458469|11237781|FG003|NOT COMPLETED|First Washout (2 Weeks)||0
10107496|NCT02458469|11237782|FG004|NOT COMPLETED|First Washout (2 Weeks)||0
10107497|NCT02458469|11237783|FG005|NOT COMPLETED|First Washout (2 Weeks)||0
10107498|NCT02458469|11237778|FG000|STARTED|Second Intervention (2 Weeks)||2
10107499|NCT02458469|11237779|FG001|STARTED|Second Intervention (2 Weeks)||2
10107500|NCT02458469|11237780|FG002|STARTED|Second Intervention (2 Weeks)||2
10107501|NCT02458469|11237781|FG003|STARTED|Second Intervention (2 Weeks)||0
10107502|NCT02458469|11237782|FG004|STARTED|Second Intervention (2 Weeks)||1
10107503|NCT02458469|11237783|FG005|STARTED|Second Intervention (2 Weeks)||2
9877491|NCT01011673|10991960|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
10107504|NCT02458469|11237778|FG000|COMPLETED|Second Intervention (2 Weeks)||2
10107505|NCT02458469|11237779|FG001|COMPLETED|Second Intervention (2 Weeks)||2
10107506|NCT02458469|11237780|FG002|COMPLETED|Second Intervention (2 Weeks)||2
10107507|NCT02458469|11237781|FG003|COMPLETED|Second Intervention (2 Weeks)||0
10107508|NCT02458469|11237782|FG004|COMPLETED|Second Intervention (2 Weeks)||1
10107509|NCT02458469|11237783|FG005|COMPLETED|Second Intervention (2 Weeks)||1
10107510|NCT02458469|11237778|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10107511|NCT02458469|11237779|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10107512|NCT02458469|11237780|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
10107513|NCT02458469|11237781|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
10107514|NCT02458469|11237782|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
10107515|NCT02458469|11237783|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1
10107516|NCT02458469|11237778|FG000|STARTED|Second Washout (2 Weeks)||2
10107517|NCT02458469|11237779|FG001|STARTED|Second Washout (2 Weeks)||2
10107518|NCT02458469|11237780|FG002|STARTED|Second Washout (2 Weeks)||2
10107519|NCT02458469|11237781|FG003|STARTED|Second Washout (2 Weeks)||0
10107520|NCT02458469|11237782|FG004|STARTED|Second Washout (2 Weeks)||1
10107521|NCT02458469|11237783|FG005|STARTED|Second Washout (2 Weeks)||1
10107522|NCT02458469|11237778|FG000|COMPLETED|Second Washout (2 Weeks)||2
10107523|NCT02458469|11237779|FG001|COMPLETED|Second Washout (2 Weeks)||2
10107524|NCT02458469|11237780|FG002|COMPLETED|Second Washout (2 Weeks)||2
10107525|NCT02458469|11237781|FG003|COMPLETED|Second Washout (2 Weeks)||0
10107526|NCT02458469|11237782|FG004|COMPLETED|Second Washout (2 Weeks)||1
10107527|NCT02458469|11237783|FG005|COMPLETED|Second Washout (2 Weeks)||1
10107528|NCT02458469|11237778|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0
10107529|NCT02458469|11237779|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0
10107530|NCT02458469|11237780|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0
10107531|NCT02458469|11237781|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0
10107532|NCT02458469|11237782|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0
10107533|NCT02458469|11237783|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0
10107534|NCT02458469|11237778|FG000|STARTED|Third Intervention (2 Weeks)||2
10107535|NCT02458469|11237779|FG001|STARTED|Third Intervention (2 Weeks)||2
10107536|NCT02458469|11237780|FG002|STARTED|Third Intervention (2 Weeks)||2
10107537|NCT02458469|11237781|FG003|STARTED|Third Intervention (2 Weeks)||0
10107538|NCT02458469|11237782|FG004|STARTED|Third Intervention (2 Weeks)||1
10107539|NCT02458469|11237783|FG005|STARTED|Third Intervention (2 Weeks)||1
10107540|NCT02458469|11237778|FG000|COMPLETED|Third Intervention (2 Weeks)||2
10107541|NCT02458469|11237779|FG001|COMPLETED|Third Intervention (2 Weeks)||2
10107542|NCT02458469|11237780|FG002|COMPLETED|Third Intervention (2 Weeks)||2
10107543|NCT02458469|11237781|FG003|COMPLETED|Third Intervention (2 Weeks)||0
10107544|NCT02458469|11237782|FG004|COMPLETED|Third Intervention (2 Weeks)||1
10107545|NCT02458469|11237783|FG005|COMPLETED|Third Intervention (2 Weeks)||1
10107546|NCT02458469|11237778|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
10107547|NCT02458469|11237779|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
10107548|NCT02458469|11237780|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
10107549|NCT02458469|11237781|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
10107550|NCT02458469|11237782|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
10107551|NCT02458469|11237783|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
10107552|NCT02458638|11237791|FG000|STARTED|Overall Study||474
10107553|NCT02458638|11237791|FG000|COMPLETED|Overall Study||15
10107554|NCT02458638|11237791|FG000|NOT COMPLETED|Overall Study||459
10107555|NCT02458690|11237797|FG000|STARTED|Overall Study||107
10107556|NCT02458690|11237798|FG001|STARTED|Overall Study||109
10107557|NCT02458690|11237797|FG000|COMPLETED|Overall Study||99
10107558|NCT02458690|11237798|FG001|COMPLETED|Overall Study||100
10107559|NCT02458690|11237797|FG000|NOT COMPLETED|Overall Study||8
10107560|NCT02458690|11237798|FG001|NOT COMPLETED|Overall Study||9
10107561|NCT02458768|11237806|FG000|STARTED|Overall Study||57
10107562|NCT02458768|11237807|FG001|STARTED|Overall Study||55
10107563|NCT02458768|11237806|FG000|COMPLETED|Overall Study||50
10107564|NCT02458768|11237807|FG001|COMPLETED|Overall Study||50
10107565|NCT02458768|11237806|FG000|NOT COMPLETED|Overall Study||7
10107566|NCT02458768|11237807|FG001|NOT COMPLETED|Overall Study||5
10107567|NCT02459093|11237815|FG000|STARTED|Overall Study||275
10107568|NCT02459093|11237816|FG001|STARTED|Overall Study||275
10107569|NCT02459093|11237815|FG000|COMPLETED|Overall Study||263
10107570|NCT02459093|11237816|FG001|COMPLETED|Overall Study||257
9759713|NCT00376220|10863297|FG000|COMPLETED|Overall Study||37
9759714|NCT00376220|10863298|FG001|COMPLETED|Overall Study||35
9759715|NCT00376220|10863297|FG000|NOT COMPLETED|Overall Study||10
9759716|NCT00376220|10863298|FG001|NOT COMPLETED|Overall Study||12
9759717|NCT00376246|10863304|FG000|STARTED|First Intervention (2 Weeks)||14
9759718|NCT00376246|10863305|FG001|STARTED|First Intervention (2 Weeks)||14
9759719|NCT00376246|10863304|FG000|COMPLETED|First Intervention (2 Weeks)||10
9759720|NCT00376246|10863305|FG001|COMPLETED|First Intervention (2 Weeks)||12
9759721|NCT00376246|10863304|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4
9759722|NCT00376246|10863305|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
9759723|NCT00376246|10863304|FG000|STARTED|Washout (2 Weeks)||10
9759724|NCT00376246|10863305|FG001|STARTED|Washout (2 Weeks)||12
9759725|NCT00376246|10863304|FG000|COMPLETED|Washout (2 Weeks)||10
9759726|NCT00376246|10863305|FG001|COMPLETED|Washout (2 Weeks)||12
9759727|NCT00376246|10863304|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9759728|NCT00376246|10863305|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9759729|NCT00376246|10863304|FG000|STARTED|Second Intervention (2 Weeks)||10
9759730|NCT00376246|10863305|FG001|STARTED|Second Intervention (2 Weeks)||12
9759731|NCT00376246|10863304|FG000|COMPLETED|Second Intervention (2 Weeks)||10
9759732|NCT00376246|10863305|FG001|COMPLETED|Second Intervention (2 Weeks)||12
9759733|NCT00376246|10863304|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
9759734|NCT00376246|10863305|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
9759735|NCT00376259|10863315|FG000|STARTED|Overall Study||22
9759736|NCT00376259|10863316|FG001|STARTED|Overall Study||21
9759737|NCT00376259|10863315|FG000|Received Study Drug|Overall Study||21
9759738|NCT00376259|10863316|FG001|Received Study Drug|Overall Study||21
9759739|NCT00376259|10863315|FG000|COMPLETED|Overall Study||0
9759740|NCT00376259|10863316|FG001|COMPLETED|Overall Study||0
9759741|NCT00376259|10863315|FG000|NOT COMPLETED|Overall Study||22
9759742|NCT00376259|10863316|FG001|NOT COMPLETED|Overall Study||21
9759743|NCT00376363|10863324|FG000|STARTED|Overall Study||143
9759744|NCT00376363|10863325|FG001|STARTED|Overall Study||133
9759745|NCT00376363|10863324|FG000|COMPLETED|Overall Study||87
10007178|NCT01748994|11129361|FG001|NOT COMPLETED|Overall Study||6
10007179|NCT01749033|11129370|FG000|STARTED|Overall Study||150
10007180|NCT01749033|11129371|FG001|STARTED|Overall Study||150
10007181|NCT01749033|11129372|FG002|STARTED|Overall Study||150
10007182|NCT01749033|11129370|FG000|COMPLETED|Overall Study||147
10007183|NCT01749033|11129371|FG001|COMPLETED|Overall Study||145
10007184|NCT01749033|11129372|FG002|COMPLETED|Overall Study||149
10007185|NCT01749033|11129370|FG000|NOT COMPLETED|Overall Study||3
10007186|NCT01749033|11129371|FG001|NOT COMPLETED|Overall Study||5
10007187|NCT01749033|11129372|FG002|NOT COMPLETED|Overall Study||1
9759746|NCT00376363|10863325|FG001|COMPLETED|Overall Study||87
9759747|NCT00376363|10863324|FG000|NOT COMPLETED|Overall Study||56
9759748|NCT00376363|10863325|FG001|NOT COMPLETED|Overall Study||46
9759749|NCT00376506|10863333|FG000|STARTED|Overall Study||4
9759750|NCT00376506|10863334|FG001|STARTED|Overall Study||6
9759751|NCT00376506|10863333|FG000|COMPLETED|Overall Study||4
9759752|NCT00376506|10863334|FG001|COMPLETED|Overall Study||4
9759753|NCT00376506|10863333|FG000|NOT COMPLETED|Overall Study||0
9759754|NCT00376506|10863334|FG001|NOT COMPLETED|Overall Study||2
9759755|NCT00376532|10863345|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
9759756|NCT00376532|10863346|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
9759757|NCT00376532|10863345|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
9759758|NCT00376532|10863346|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
9759759|NCT00376532|10863345|FG000|NOT COMPLETED|Overall Study||6
9759760|NCT00376532|10863346|FG001|NOT COMPLETED|Overall Study||6
10107571|NCT02459093|11237815|FG000|NOT COMPLETED|Overall Study||12
10107572|NCT02459093|11237816|FG001|NOT COMPLETED|Overall Study||18
10107573|NCT02459119|11237822|FG000|STARTED|Overall Study||17
9759761|NCT00376558|10863354|FG000|STARTED|Overall Study||25
9759762|NCT00376558|10863355|FG001|STARTED|Overall Study||25
9759763|NCT00376558|10863354|FG000|COMPLETED|Overall Study||25
9759764|NCT00376558|10863355|FG001|COMPLETED|Overall Study||25
9759765|NCT00376558|10863354|FG000|NOT COMPLETED|Overall Study||0
9759766|NCT00376558|10863355|FG001|NOT COMPLETED|Overall Study||0
9759767|NCT00376597|10863364|FG000|STARTED|Overall Study||253
9759768|NCT00376597|10863365|FG001|STARTED|Overall Study||315
9759769|NCT00376597|10863364|FG000|COMPLETED|Overall Study||242
9759770|NCT00376597|10863365|FG001|COMPLETED|Overall Study||312
9759771|NCT00376597|10863364|FG000|NOT COMPLETED|Overall Study||11
9759772|NCT00376597|10863365|FG001|NOT COMPLETED|Overall Study||3
9759773|NCT00376675|10863375|FG000|STARTED|Overall Study||69
10107574|NCT02459119|11237822|FG000|COMPLETED|Overall Study||17
9877492|NCT01011673|10991959|FG000|NOT COMPLETED|Randomized||2
9877493|NCT01011673|10991960|FG001|NOT COMPLETED|Randomized||1
9877494|NCT01011673|10991959|FG000|STARTED|Emergency Department Portion||60
9877495|NCT01011673|10991960|FG001|STARTED|Emergency Department Portion||60
9877496|NCT01011673|10991959|FG000|COMPLETED|Emergency Department Portion||60
9877497|NCT01011673|10991960|FG001|COMPLETED|Emergency Department Portion||60
9759774|NCT00376675|10863376|FG001|STARTED|Overall Study||70
9759775|NCT00376675|10863375|FG000|COMPLETED|Overall Study||49
9759776|NCT00376675|10863376|FG001|COMPLETED|Overall Study||56
9759777|NCT00376675|10863375|FG000|NOT COMPLETED|Overall Study||20
9759778|NCT00376675|10863376|FG001|NOT COMPLETED|Overall Study||14
9759779|NCT00376688|10863382|FG000|STARTED|Overall Study||31
9759780|NCT00376688|10863382|FG000|COMPLETED|Overall Study||27
9759781|NCT00376688|10863382|FG000|NOT COMPLETED|Overall Study||4
9759782|NCT00376805|10863386|FG000|STARTED|Overall Study||6
9759783|NCT00376805|10863386|FG000|COMPLETED|Overall Study||6
9759784|NCT00376805|10863386|FG000|NOT COMPLETED|Overall Study||0
9759785|NCT00376935|10863394|FG000|STARTED|Overall Study||25
9759786|NCT00376935|10863395|FG001|STARTED|Overall Study||25
10107575|NCT02459119|11237822|FG000|NOT COMPLETED|Overall Study||0
10107576|NCT02459197|11237828|FG000|STARTED|Overall Study||58
10107577|NCT02459197|11237829|FG001|STARTED|Overall Study||56
10107578|NCT02459197|11237828|FG000|COMPLETED|Overall Study||58
10107579|NCT02459197|11237829|FG001|COMPLETED|Overall Study||55
10107580|NCT02459197|11237828|FG000|NOT COMPLETED|Overall Study||0
10107581|NCT02459197|11237829|FG001|NOT COMPLETED|Overall Study||1
10007188|NCT01749215|11129383|FG000|STARTED|Overall Study||72
10007189|NCT01749215|11129384|FG001|STARTED|Overall Study||79
9759787|NCT00376935|10863396|FG002|STARTED|Overall Study||25
9759788|NCT00376935|10863397|FG003|STARTED|Overall Study||24
9759789|NCT00376935|10863394|FG000|COMPLETED|Overall Study||25
9759790|NCT00376935|10863395|FG001|COMPLETED|Overall Study||25
9759791|NCT00376935|10863396|FG002|COMPLETED|Overall Study||25
10007190|NCT01749215|11129383|FG000|COMPLETED|Overall Study||47
10007191|NCT01749215|11129384|FG001|COMPLETED|Overall Study||53
10007192|NCT01749215|11129383|FG000|NOT COMPLETED|Overall Study||25
10007193|NCT01749215|11129384|FG001|NOT COMPLETED|Overall Study||26
10007194|NCT01749293|11129390|FG000|STARTED|Overall Study||3
10007195|NCT01749293|11129390|FG000|COMPLETED|Overall Study||3
10007196|NCT01749293|11129390|FG000|NOT COMPLETED|Overall Study||0
10007197|NCT01749410|11129395|FG000|STARTED|Overall Study||33
10007198|NCT01749410|11129395|FG000|COMPLETED|Overall Study||33
10007199|NCT01749410|11129395|FG000|NOT COMPLETED|Overall Study||0
10007200|NCT01749501|11129401|FG000|STARTED|Overall Study||22
10007201|NCT01749501|11129402|FG001|STARTED|Overall Study||23
10007202|NCT01749501|11129401|FG000|COMPLETED|Overall Study||22
10007203|NCT01749501|11129402|FG001|COMPLETED|Overall Study||23
10007204|NCT01749501|11129401|FG000|NOT COMPLETED|Overall Study||0
10107582|NCT02459262|11237846|FG000|STARTED|Overall Study||8
10007205|NCT01749501|11129402|FG001|NOT COMPLETED|Overall Study||0
10007206|NCT01749605|11129410|FG000|STARTED|Overall Study||18
10107583|NCT02459262|11237847|FG001|STARTED|Overall Study||8
10107584|NCT02459262|11237848|FG002|STARTED|Overall Study||8
10107585|NCT02459262|11237849|FG003|STARTED|Overall Study||8
10107586|NCT02459262|11237850|FG004|STARTED|Overall Study||8
10107587|NCT02459262|11237851|FG005|STARTED|Overall Study||8
10107588|NCT02459262|11237852|FG006|STARTED|Overall Study||12
10107589|NCT02459262|11237853|FG007|STARTED|Overall Study||45
10107590|NCT02459262|11237854|FG008|STARTED|Overall Study||45
10107591|NCT02459262|11237855|FG009|STARTED|Overall Study||45
10107592|NCT02459262|11237856|FG010|STARTED|Overall Study||45
10107593|NCT02459262|11237846|FG000|COMPLETED|Overall Study||8
10107594|NCT02459262|11237847|FG001|COMPLETED|Overall Study||8
10107595|NCT02459262|11237848|FG002|COMPLETED|Overall Study||8
10107596|NCT02459262|11237849|FG003|COMPLETED|Overall Study||8
10107597|NCT02459262|11237850|FG004|COMPLETED|Overall Study||8
10107598|NCT02459262|11237851|FG005|COMPLETED|Overall Study||8
10107599|NCT02459262|11237852|FG006|COMPLETED|Overall Study||12
10107600|NCT02459262|11237853|FG007|COMPLETED|Overall Study||45
10107601|NCT02459262|11237854|FG008|COMPLETED|Overall Study||45
9877498|NCT01011673|10991959|FG000|NOT COMPLETED|Emergency Department Portion||0
9877499|NCT01011673|10991960|FG001|NOT COMPLETED|Emergency Department Portion||0
9877500|NCT01011673|10991959|FG000|STARTED|24 Hour Follow-up||60
9759792|NCT00376935|10863397|FG003|COMPLETED|Overall Study||24
9759793|NCT00376935|10863394|FG000|NOT COMPLETED|Overall Study||0
9759794|NCT00376935|10863395|FG001|NOT COMPLETED|Overall Study||0
9759795|NCT00376935|10863396|FG002|NOT COMPLETED|Overall Study||0
9759796|NCT00376935|10863397|FG003|NOT COMPLETED|Overall Study||0
9759797|NCT00376948|10863407|FG000|STARTED|Overall Study||20
9759798|NCT00376948|10863407|FG000|COMPLETED|Overall Study||20
9759799|NCT00376948|10863407|FG000|NOT COMPLETED|Overall Study||0
9759800|NCT00376961|10863411|FG000|STARTED|Initial Registration||68
9759801|NCT00376961|10863412|FG001|STARTED|Initial Registration||0
9759802|NCT00376961|10863411|FG000|Eligible|Initial Registration||65
9759803|NCT00376961|10863412|FG001|Eligible|Initial Registration||0
9759804|NCT00376961|10863411|FG000|COMPLETED|Initial Registration||61
9759805|NCT00376961|10863412|FG001|COMPLETED|Initial Registration||0
9759806|NCT00376961|10863411|FG000|NOT COMPLETED|Initial Registration||7
9759807|NCT00376961|10863412|FG001|NOT COMPLETED|Initial Registration||0
9759808|NCT00376961|10863411|FG000|STARTED|Maintenance||0
9759809|NCT00376961|10863412|FG001|STARTED|Maintenance||50
9759810|NCT00376961|10863411|FG000|Eligible|Maintenance||0
9759811|NCT00376961|10863412|FG001|Eligible|Maintenance||47
9759812|NCT00376961|10863411|FG000|COMPLETED|Maintenance||0
9759813|NCT00376961|10863412|FG001|COMPLETED|Maintenance||27
9759814|NCT00376961|10863411|FG000|NOT COMPLETED|Maintenance||0
9759815|NCT00376961|10863412|FG001|NOT COMPLETED|Maintenance||23
9759816|NCT00377156|10863422|FG000|STARTED|Overall Study||111
9759817|NCT00377156|10863423|FG001|STARTED|Overall Study||102
9759818|NCT00377156|10863422|FG000|COMPLETED|Overall Study||63
9759819|NCT00377156|10863423|FG001|COMPLETED|Overall Study||48
9759820|NCT00377156|10863422|FG000|NOT COMPLETED|Overall Study||48
9759821|NCT00377156|10863423|FG001|NOT COMPLETED|Overall Study||54
9877501|NCT01011673|10991960|FG001|STARTED|24 Hour Follow-up||60
9877502|NCT01011673|10991959|FG000|COMPLETED|24 Hour Follow-up||57
9759822|NCT00377234|10863433|FG000|STARTED|Overall Study||180
9759823|NCT00377234|10863434|FG001|STARTED|Overall Study||176
9759824|NCT00377234|10863433|FG000|Randomized|Overall Study||180
9759825|NCT00377234|10863434|FG001|Randomized|Overall Study||176
9759826|NCT00377234|10863433|FG000|Did Not Receive Study Treatment|Overall Study||3
10107602|NCT02459262|11237855|FG009|COMPLETED|Overall Study||44
10107603|NCT02459262|11237856|FG010|COMPLETED|Overall Study||45
10107604|NCT02459262|11237846|FG000|NOT COMPLETED|Overall Study||0
10107605|NCT02459262|11237847|FG001|NOT COMPLETED|Overall Study||0
10107606|NCT02459262|11237848|FG002|NOT COMPLETED|Overall Study||0
10107607|NCT02459262|11237849|FG003|NOT COMPLETED|Overall Study||0
10107608|NCT02459262|11237850|FG004|NOT COMPLETED|Overall Study||0
10107609|NCT02459262|11237851|FG005|NOT COMPLETED|Overall Study||0
10107610|NCT02459262|11237852|FG006|NOT COMPLETED|Overall Study||0
10107611|NCT02459262|11237853|FG007|NOT COMPLETED|Overall Study||0
10107612|NCT02459262|11237854|FG008|NOT COMPLETED|Overall Study||0
9759827|NCT00377234|10863434|FG001|Did Not Receive Study Treatment|Overall Study||2
9759828|NCT00377234|10863433|FG000|Received Treatment|Overall Study||177
9759829|NCT00377234|10863434|FG001|Received Treatment|Overall Study||174
9759830|NCT00377234|10863433|FG000|Safety Analysis Set: Period 1|Overall Study||177
9759831|NCT00377234|10863434|FG001|Safety Analysis Set: Period 1|Overall Study||174
9759832|NCT00377234|10863433|FG000|Safety Analysis Set: Period 2|Overall Study||153
9759833|NCT00377234|10863434|FG001|Safety Analysis Set: Period 2|Overall Study||150
9759834|NCT00377234|10863433|FG000|Safety Analysis Set: Ibandronate|Overall Study||177
9759835|NCT00377234|10863434|FG001|Safety Analysis Set: Ibandronate|Overall Study||150
9759836|NCT00377234|10863433|FG000|Safety Analysis Set: Risedronate|Overall Study||153
9759837|NCT00377234|10863434|FG001|Safety Analysis Set: Risedronate|Overall Study||174
9759838|NCT00377234|10863433|FG000|COMPLETED|Overall Study||146
9759839|NCT00377234|10863434|FG001|COMPLETED|Overall Study||145
9759840|NCT00377234|10863433|FG000|NOT COMPLETED|Overall Study||34
9759841|NCT00377234|10863434|FG001|NOT COMPLETED|Overall Study||31
9759842|NCT00377260|10863448|FG000|STARTED|Overall Study||144
9759843|NCT00377260|10863449|FG001|STARTED|Overall Study||147
9759844|NCT00377260|10863448|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
9759845|NCT00377260|10863449|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
9759846|NCT00377260|10863448|FG000|NOT COMPLETED|Overall Study||2
9759847|NCT00377260|10863449|FG001|NOT COMPLETED|Overall Study||5
9759848|NCT00377299|10863457|FG000|STARTED|Overall Study||32
10007207|NCT01749605|11129411|FG001|STARTED|Overall Study||17
10007208|NCT01749605|11129410|FG000|COMPLETED|Overall Study||14
10007209|NCT01749605|11129411|FG001|COMPLETED|Overall Study||14
10007210|NCT01749605|11129410|FG000|NOT COMPLETED|Overall Study||4
10007211|NCT01749605|11129411|FG001|NOT COMPLETED|Overall Study||3
10007212|NCT01749631|11129417|FG000|STARTED|Overall Study||97
10007213|NCT01749631|11129417|FG000|COMPLETED|Overall Study||97
10007214|NCT01749631|11129417|FG000|NOT COMPLETED|Overall Study||0
10007215|NCT01749735|11129423|FG000|STARTED|Overall Study||2
10007216|NCT01749735|11129424|FG001|STARTED|Overall Study||0
10007217|NCT01749735|11129423|FG000|COMPLETED|Overall Study||1
10007218|NCT01749735|11129424|FG001|COMPLETED|Overall Study||0
10007219|NCT01749735|11129423|FG000|NOT COMPLETED|Overall Study||1
10007220|NCT01749735|11129424|FG001|NOT COMPLETED|Overall Study||0
10007221|NCT01749800|11129433|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
10007222|NCT01749800|11129434|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
10007223|NCT01749800|11129435|FG002|STARTED|Overall Study||0
10007224|NCT01749800|11129433|FG000|COMPLETED|Overall Study||3
10007225|NCT01749800|11129434|FG001|COMPLETED|Overall Study||0
10007226|NCT01749800|11129435|FG002|COMPLETED|Overall Study||0
10007227|NCT01749800|11129433|FG000|NOT COMPLETED|Overall Study||3
10007228|NCT01749800|11129434|FG001|NOT COMPLETED|Overall Study||1
10007229|NCT01749800|11129435|FG002|NOT COMPLETED|Overall Study||0
10007230|NCT01749904|11129445|FG000|STARTED|Overall Study|randomized population|286
10007231|NCT01749904|11129446|FG001|STARTED|Overall Study|randomized population|134
10007232|NCT01749904|11129445|FG000|COMPLETED|Overall Study|randomized population|264
10007233|NCT01749904|11129446|FG001|COMPLETED|Overall Study|randomized population|123
10007234|NCT01749904|11129445|FG000|NOT COMPLETED|Overall Study||22
10107613|NCT02459262|11237855|FG009|NOT COMPLETED|Overall Study||1
10107614|NCT02459262|11237856|FG010|NOT COMPLETED|Overall Study||0
10107615|NCT02459275|11237882|FG000|STARTED|Overall Study||19
10107616|NCT02459275|11237883|FG001|STARTED|Overall Study||17
10107617|NCT02459275|11237882|FG000|COMPLETED|Overall Study||19
10107618|NCT02459275|11237883|FG001|COMPLETED|Overall Study||17
9759849|NCT00377299|10863458|FG001|STARTED|Overall Study||28
9759850|NCT00377299|10863457|FG000|COMPLETED|Overall Study||13
9759851|NCT00377299|10863458|FG001|COMPLETED|Overall Study||4
9759852|NCT00377299|10863457|FG000|NOT COMPLETED|Overall Study||19
9759853|NCT00377299|10863458|FG001|NOT COMPLETED|Overall Study||24
9759854|NCT00377312|10863467|FG000|STARTED|Overall Study||6
9759855|NCT00377312|10863468|FG001|STARTED|Overall Study||5
9759856|NCT00377312|10863467|FG000|COMPLETED|Overall Study||5
9759857|NCT00377312|10863468|FG001|COMPLETED|Overall Study||4
9759858|NCT00377312|10863467|FG000|NOT COMPLETED|Overall Study||1
9759859|NCT00377312|10863468|FG001|NOT COMPLETED|Overall Study||1
9759860|NCT00377364|10863476|FG000|STARTED|Overall Study||16
9759861|NCT00377364|10863477|FG001|STARTED|Overall Study||14
9759862|NCT00377364|10863476|FG000|COMPLETED|Overall Study||14
9759863|NCT00377364|10863477|FG001|COMPLETED|Overall Study||14
9759864|NCT00377364|10863476|FG000|NOT COMPLETED|Overall Study||2
9759865|NCT00377364|10863477|FG001|NOT COMPLETED|Overall Study||0
9759866|NCT00377403|10863487|FG000|STARTED|Overall Study||85
9759867|NCT00377403|10863488|FG001|STARTED|Overall Study||81
9759868|NCT00377403|10863487|FG000|Day -3 Assessment|Overall Study||81
9759869|NCT00377403|10863488|FG001|Day -3 Assessment|Overall Study||74
9759870|NCT00377403|10863487|FG000|Day 7 Assessment|Overall Study||80
9759871|NCT00377403|10863488|FG001|Day 7 Assessment|Overall Study||75
9759872|NCT00377403|10863487|FG000|Day 10 Assessment|Overall Study||81
9759873|NCT00377403|10863488|FG001|Day 10 Assessment|Overall Study||71
9759874|NCT00377403|10863487|FG000|Day 28 Assessment|Overall Study||82
9759875|NCT00377403|10863488|FG001|Day 28 Assessment|Overall Study||77
10107619|NCT02459275|11237882|FG000|NOT COMPLETED|Overall Study||0
9759876|NCT00377403|10863487|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
9759877|NCT00377403|10863488|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
9759878|NCT00377403|10863487|FG000|NOT COMPLETED|Overall Study||4
9759879|NCT00377403|10863488|FG001|NOT COMPLETED|Overall Study||7
9759880|NCT00377429|10863494|FG000|STARTED|Overall Study|Treated|47
9759881|NCT00377429|10863494|FG000|COMPLETED|Overall Study|Completed main study|32
9759882|NCT00377429|10863494|FG000|NOT COMPLETED|Overall Study||15
9759883|NCT00377520|10863498|FG000|STARTED|Overall Study||27
9759884|NCT00377520|10863498|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
9759885|NCT00377520|10863498|FG000|NOT COMPLETED|Overall Study||1
9759886|NCT00377572|10863504|FG000|STARTED|Overall Study||208
10107620|NCT02459275|11237883|FG001|NOT COMPLETED|Overall Study||0
10107621|NCT02459418|11237891|FG000|STARTED|Overall Study||21
9759887|NCT00377572|10863505|FG001|STARTED|Overall Study||211
9759888|NCT00377572|10863504|FG000|COMPLETED|Overall Study||155
9759889|NCT00377572|10863505|FG001|COMPLETED|Overall Study||157
9759890|NCT00377572|10863504|FG000|NOT COMPLETED|Overall Study||53
9759891|NCT00377572|10863505|FG001|NOT COMPLETED|Overall Study||54
9759892|NCT00377611|10863513|FG000|STARTED|Overall Study||1047
9759893|NCT00377611|10863514|FG001|STARTED|Overall Study||2007
9759894|NCT00377611|10863513|FG000|COMPLETED|Overall Study||1025
9759895|NCT00377611|10863514|FG001|COMPLETED|Overall Study||1974
9759896|NCT00377611|10863513|FG000|NOT COMPLETED|Overall Study||22
9759897|NCT00377611|10863514|FG001|NOT COMPLETED|Overall Study||33
9759898|NCT00377637|10863525|FG000|STARTED|Induction Phase|Intent-To-Treat|185
9759899|NCT00377637|10863526|FG001|STARTED|Induction Phase|Intent-To-Treat|185
9759900|NCT00377637|10863527|FG002|STARTED|Induction Phase||0
9759901|NCT00377637|10863528|FG003|STARTED|Induction Phase||0
9759902|NCT00377637|10863525|FG000|Safety Population|Induction Phase||180
9759903|NCT00377637|10863526|FG001|Safety Population|Induction Phase||184
9759904|NCT00377637|10863527|FG002|Safety Population|Induction Phase||0
9759905|NCT00377637|10863528|FG003|Safety Population|Induction Phase||0
9759906|NCT00377637|10863525|FG000|COMPLETED|Induction Phase||156
9759907|NCT00377637|10863526|FG001|COMPLETED|Induction Phase||150
9759908|NCT00377637|10863527|FG002|COMPLETED|Induction Phase||0
9759909|NCT00377637|10863528|FG003|COMPLETED|Induction Phase||0
9759910|NCT00377637|10863525|FG000|NOT COMPLETED|Induction Phase||29
9759911|NCT00377637|10863526|FG001|NOT COMPLETED|Induction Phase||35
9759912|NCT00377637|10863527|FG002|NOT COMPLETED|Induction Phase||0
9759913|NCT00377637|10863528|FG003|NOT COMPLETED|Induction Phase||0
9759914|NCT00377637|10863525|FG000|STARTED|Maintenance Phase||0
9759915|NCT00377637|10863526|FG001|STARTED|Maintenance Phase||0
9759916|NCT00377637|10863527|FG002|STARTED|Maintenance Phase||116
9759917|NCT00377637|10863528|FG003|STARTED|Maintenance Phase||111
9759918|NCT00377637|10863525|FG000|COMPLETED|Maintenance Phase||0
9759919|NCT00377637|10863526|FG001|COMPLETED|Maintenance Phase||0
9759920|NCT00377637|10863527|FG002|COMPLETED|Maintenance Phase||73
9759921|NCT00377637|10863528|FG003|COMPLETED|Maintenance Phase||54
9759922|NCT00377637|10863525|FG000|NOT COMPLETED|Maintenance Phase||0
9759923|NCT00377637|10863526|FG001|NOT COMPLETED|Maintenance Phase||0
9759924|NCT00377637|10863527|FG002|NOT COMPLETED|Maintenance Phase||43
9759925|NCT00377637|10863528|FG003|NOT COMPLETED|Maintenance Phase||57
9759926|NCT00377676|10863544|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
10007235|NCT01749904|11129446|FG001|NOT COMPLETED|Overall Study||11
10007236|NCT01749930|11129458|FG000|STARTED|Overall Study|randomized population|283
9759927|NCT00377676|10863545|FG001|STARTED|Overall Study||1016
9759928|NCT00377676|10863544|FG000|COMPLETED|Overall Study||1093
9759929|NCT00377676|10863545|FG001|COMPLETED|Overall Study||694
9759930|NCT00377676|10863544|FG000|NOT COMPLETED|Overall Study||961
9759931|NCT00377676|10863545|FG001|NOT COMPLETED|Overall Study||322
9759932|NCT00377741|10863553|FG000|STARTED|Overall Study||16
9759933|NCT00377741|10863554|FG001|STARTED|Overall Study||15
9759934|NCT00377741|10863553|FG000|COMPLETED|Overall Study||16
9759935|NCT00377741|10863554|FG001|COMPLETED|Overall Study||15
9759936|NCT00377741|10863553|FG000|NOT COMPLETED|Overall Study||0
9759937|NCT00377741|10863554|FG001|NOT COMPLETED|Overall Study||0
9759938|NCT00377819|10863562|FG000|STARTED|Overall Study||251
9759939|NCT00377819|10863563|FG001|STARTED|Overall Study||253
9759940|NCT00377819|10863562|FG000|Received Study Medication|Overall Study||249
9759941|NCT00377819|10863563|FG001|Received Study Medication|Overall Study||253
9759942|NCT00377819|10863562|FG000|COMPLETED|Overall Study||238
9759943|NCT00377819|10863563|FG001|COMPLETED|Overall Study||243
9759944|NCT00377819|10863562|FG000|NOT COMPLETED|Overall Study||13
9759945|NCT00377819|10863563|FG001|NOT COMPLETED|Overall Study||10
9759946|NCT00377832|10863571|FG000|STARTED|Overall Study||7
9759947|NCT00377832|10863572|FG001|STARTED|Overall Study||6
9759948|NCT00377832|10863571|FG000|COMPLETED|Overall Study||7
9759949|NCT00377832|10863572|FG001|COMPLETED|Overall Study||6
9759950|NCT00377832|10863571|FG000|NOT COMPLETED|Overall Study||0
9759951|NCT00377832|10863572|FG001|NOT COMPLETED|Overall Study||0
9759952|NCT00377858|10863583|FG000|STARTED|Overall Study||242
9759953|NCT00377858|10863584|FG001|STARTED|Overall Study||242
9759954|NCT00377858|10863583|FG000|Had at Least One Post-Baseline Value|Overall Study||239
9759955|NCT00377858|10863584|FG001|Had at Least One Post-Baseline Value|Overall Study||240
9759956|NCT00377858|10863583|FG000|COMPLETED|Overall Study||211
10007237|NCT01749930|11129459|FG001|STARTED|Overall Study|randomized population|137
10007238|NCT01749930|11129458|FG000|COMPLETED|Overall Study|randomized population|253
10007239|NCT01749930|11129459|FG001|COMPLETED|Overall Study|randomized population|125
10007240|NCT01749930|11129458|FG000|NOT COMPLETED|Overall Study||30
10007241|NCT01749930|11129459|FG001|NOT COMPLETED|Overall Study||12
10007242|NCT01749956|11129469|FG000|STARTED|Overall Study||39
9759957|NCT00377858|10863584|FG001|COMPLETED|Overall Study||215
9759958|NCT00377858|10863583|FG000|NOT COMPLETED|Overall Study||31
10007243|NCT01749956|11129469|FG000|COMPLETED|Overall Study||24
10007244|NCT01749956|11129469|FG000|NOT COMPLETED|Overall Study||15
10007245|NCT01749982|11129478|FG000|STARTED|Overall Study||15
10007246|NCT01749982|11129479|FG001|STARTED|Overall Study||15
10007247|NCT01749982|11129480|FG002|STARTED|Overall Study||15
10007248|NCT01749982|11129481|FG003|STARTED|Overall Study||15
10007249|NCT01749982|11129478|FG000|COMPLETED|Overall Study||15
10007250|NCT01749982|11129479|FG001|COMPLETED|Overall Study||15
10007251|NCT01749982|11129480|FG002|COMPLETED|Overall Study||15
10007252|NCT01749982|11129481|FG003|COMPLETED|Overall Study||12
10007253|NCT01749982|11129478|FG000|NOT COMPLETED|Overall Study||0
10007254|NCT01749982|11129479|FG001|NOT COMPLETED|Overall Study||0
10007255|NCT01749982|11129480|FG002|NOT COMPLETED|Overall Study||0
10007256|NCT01749982|11129481|FG003|NOT COMPLETED|Overall Study||3
10007257|NCT01749995|11129491|FG000|STARTED|Overall Study||200
10007258|NCT01749995|11129491|FG000|COMPLETED|Overall Study||196
10007259|NCT01749995|11129491|FG000|NOT COMPLETED|Overall Study||4
10007260|NCT01750086|11129497|FG000|STARTED|Overall Study||13
10007261|NCT01750086|11129498|FG001|STARTED|Overall Study||14
10007262|NCT01750086|11129497|FG000|COMPLETED|Overall Study||12
10007263|NCT01750086|11129498|FG001|COMPLETED|Overall Study||13
10007264|NCT01750086|11129497|FG000|NOT COMPLETED|Overall Study||1
10007265|NCT01750086|11129498|FG001|NOT COMPLETED|Overall Study||1
10007266|NCT01750190|11129506|FG000|STARTED|Overall Study||616
10007267|NCT01750190|11129507|FG001|STARTED|Overall Study||306
10007268|NCT01750190|11129506|FG000|Safety Population|Overall Study||611
10007269|NCT01750190|11129507|FG001|Safety Population|Overall Study||305
10007270|NCT01750190|11129506|FG000|Full Analysis Set (FAS)|Overall Study||608
10007271|NCT01750190|11129507|FG001|Full Analysis Set (FAS)|Overall Study||305
10007272|NCT01750190|11129506|FG000|COMPLETED|Overall Study||349
10007273|NCT01750190|11129507|FG001|COMPLETED|Overall Study||98
10007274|NCT01750190|11129506|FG000|NOT COMPLETED|Overall Study||267
10007275|NCT01750190|11129507|FG001|NOT COMPLETED|Overall Study||208
10007276|NCT01750229|11129513|FG000|STARTED|Randomized Crossover Phase||30
10007277|NCT01750229|11129513|FG000|Subject Received Sham|Randomized Crossover Phase||24
10007278|NCT01750229|11129513|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24
10007279|NCT01750229|11129513|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24
10007280|NCT01750229|11129513|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24
10007281|NCT01750229|11129513|FG000|Protocol Violation|Randomized Crossover Phase||4
10007282|NCT01750229|11129513|FG000|COMPLETED|Randomized Crossover Phase||28
10007283|NCT01750229|11129513|FG000|NOT COMPLETED|Randomized Crossover Phase||2
10007284|NCT01750229|11129513|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
10007285|NCT01750229|11129513|FG000|COMPLETED|Long-term Follow-up Phase||25
10007286|NCT01750229|11129513|FG000|NOT COMPLETED|Long-term Follow-up Phase||3
10007287|NCT01750242|11129523|FG000|STARTED|Overall Study||23
10007288|NCT01750242|11129523|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
10007289|NCT01750242|11129523|FG000|COMPLETED|Overall Study||20
10007290|NCT01750242|11129523|FG000|NOT COMPLETED|Overall Study||3
10007291|NCT01750255|11129530|FG000|STARTED|Overall Study||49
10007292|NCT01750255|11129531|FG001|STARTED|Overall Study||43
10007293|NCT01750255|11129530|FG000|COMPLETED|Overall Study||43
10007294|NCT01750255|11129531|FG001|COMPLETED|Overall Study||38
10007295|NCT01750255|11129530|FG000|NOT COMPLETED|Overall Study||6
10007296|NCT01750255|11129531|FG001|NOT COMPLETED|Overall Study||5
10007297|NCT01750268|11129540|FG000|STARTED|Overall Study||15
10007298|NCT01750268|11129541|FG001|STARTED|Overall Study||17
10007299|NCT01750268|11129540|FG000|COMPLETED|Overall Study||13
10007300|NCT01750268|11129541|FG001|COMPLETED|Overall Study||12
10007301|NCT01750268|11129540|FG000|NOT COMPLETED|Overall Study||2
10007302|NCT01750268|11129541|FG001|NOT COMPLETED|Overall Study||5
10007303|NCT01750294|11129547|FG000|STARTED|Overall Study||14
10007304|NCT01750294|11129547|FG000|COMPLETED|Overall Study||12
10007305|NCT01750294|11129547|FG000|NOT COMPLETED|Overall Study||2
10007306|NCT01750346|11129554|FG000|STARTED|Overall Study||3
10007307|NCT01750346|11129555|FG001|STARTED|Overall Study||2
10007308|NCT01750346|11129556|FG002|STARTED|Overall Study||3
10007309|NCT01750346|11129554|FG000|COMPLETED|Overall Study||2
10007310|NCT01750346|11129555|FG001|COMPLETED|Overall Study||2
10007311|NCT01750346|11129556|FG002|COMPLETED|Overall Study||3
10007312|NCT01750346|11129554|FG000|NOT COMPLETED|Overall Study||1
10007313|NCT01750346|11129555|FG001|NOT COMPLETED|Overall Study||0
10007314|NCT01750346|11129556|FG002|NOT COMPLETED|Overall Study||0
10007315|NCT01750398|11129564|FG000|STARTED|ADT Lead In Phase||33
10007316|NCT01750398|11129564|FG000|COMPLETED|ADT Lead In Phase||29
10007317|NCT01750398|11129564|FG000|NOT COMPLETED|ADT Lead In Phase||4
10007318|NCT01750398|11129564|FG000|STARTED|Bipolar Androgen Thearpy Phase||29
10007319|NCT01750398|11129564|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26
10007320|NCT01750398|11129564|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
10007321|NCT01750502|11129570|FG000|STARTED|Overall Study||70
9759959|NCT00377858|10863584|FG001|NOT COMPLETED|Overall Study||27
9759960|NCT00377962|10863592|FG000|STARTED|Core Study: 0-12 Months||140
9759961|NCT00377962|10863593|FG001|STARTED|Core Study: 0-12 Months||142
9759962|NCT00377962|10863592|FG000|COMPLETED|Core Study: 0-12 Months||112
9759963|NCT00377962|10863593|FG001|COMPLETED|Core Study: 0-12 Months||133
10007322|NCT01750502|11129571|FG001|STARTED|Overall Study||186
10007323|NCT01750502|11129570|FG000|COMPLETED|Overall Study||70
10007324|NCT01750502|11129571|FG001|COMPLETED|Overall Study||186
10007325|NCT01750502|11129570|FG000|NOT COMPLETED|Overall Study||0
10007326|NCT01750502|11129571|FG001|NOT COMPLETED|Overall Study||0
10007327|NCT01750684|11129584|FG000|STARTED|Overall Study||6
10007328|NCT01750684|11129585|FG001|STARTED|Overall Study||7
10007329|NCT01750684|11129584|FG000|COMPLETED|Overall Study||4
10007330|NCT01750684|11129585|FG001|COMPLETED|Overall Study||5
10007331|NCT01750684|11129584|FG000|NOT COMPLETED|Overall Study||2
10007332|NCT01750684|11129585|FG001|NOT COMPLETED|Overall Study||2
10007333|NCT01750697|11129592|FG000|STARTED|Overall Study||25
10007334|NCT01750697|11129592|FG000|Completed|Overall Study||25
10007335|NCT01750697|11129592|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24
10007336|NCT01750697|11129592|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
10007337|NCT01750697|11129592|FG000|NOT COMPLETED|Overall Study||9
10007338|NCT01750840|11129599|FG000|STARTED|Overall Study||8
10007339|NCT01750840|11129599|FG000|COMPLETED|Overall Study||4
10007340|NCT01750840|11129599|FG000|NOT COMPLETED|Overall Study||4
10007341|NCT01750879|11129606|FG000|STARTED|Overall Study||30
10007342|NCT01750879|11129607|FG001|STARTED|Overall Study||11
10007343|NCT01750879|11129606|FG000|DBPCFC2|Overall Study||20
10007344|NCT01750879|11129607|FG001|DBPCFC2|Overall Study||8
10007345|NCT01750879|11129606|FG000|DBPCFC3|Overall Study||20
10007346|NCT01750879|11129607|FG001|DBPCFC3|Overall Study||0
10007347|NCT01750879|11129606|FG000|COMPLETED|Overall Study||20
10007348|NCT01750879|11129607|FG001|COMPLETED|Overall Study||8
10007349|NCT01750879|11129606|FG000|NOT COMPLETED|Overall Study||10
9877503|NCT01011673|10991960|FG001|COMPLETED|24 Hour Follow-up||57
9877504|NCT01011673|10991959|FG000|NOT COMPLETED|24 Hour Follow-up||3
9877505|NCT01011673|10991960|FG001|NOT COMPLETED|24 Hour Follow-up||3
9877506|NCT01011738|10991969|FG000|STARTED|Overall Study||877
9877507|NCT01011738|10991970|FG001|STARTED|Overall Study||912
9877508|NCT01011738|10991971|FG002|STARTED|Overall Study||53
9877509|NCT01011738|10991969|FG000|COMPLETED|Overall Study||553
9877510|NCT01011738|10991970|FG001|COMPLETED|Overall Study||618
9877511|NCT01011738|10991971|FG002|COMPLETED|Overall Study||36
9877512|NCT01011738|10991969|FG000|NOT COMPLETED|Overall Study||324
9877513|NCT01011738|10991970|FG001|NOT COMPLETED|Overall Study||294
9877514|NCT01011738|10991971|FG002|NOT COMPLETED|Overall Study||17
9877515|NCT01011816|10991982|FG000|STARTED|26-Week Primary Endpoint||164
9877516|NCT01011816|10991983|FG001|STARTED|26-Week Primary Endpoint||56
9877517|NCT01011816|10991982|FG000|COMPLETED|26-Week Primary Endpoint||157
9877518|NCT01011816|10991983|FG001|COMPLETED|26-Week Primary Endpoint||54
9877519|NCT01011816|10991982|FG000|NOT COMPLETED|26-Week Primary Endpoint||7
9877520|NCT01011816|10991983|FG001|NOT COMPLETED|26-Week Primary Endpoint||2
9877521|NCT01011816|10991982|FG000|STARTED|78-Week Extended Follow-up||157
9877522|NCT01011816|10991983|FG001|STARTED|78-Week Extended Follow-up||54
10007350|NCT01750879|11129607|FG001|NOT COMPLETED|Overall Study||3
9759964|NCT00377962|10863592|FG000|NOT COMPLETED|Core Study: 0-12 Months||28
9759965|NCT00377962|10863593|FG001|NOT COMPLETED|Core Study: 0-12 Months||9
9759966|NCT00377962|10863592|FG000|STARTED|Extension Study: 12-24 Months||108
9759967|NCT00377962|10863593|FG001|STARTED|Extension Study: 12-24 Months||127
9759968|NCT00377962|10863592|FG000|COMPLETED|Extension Study: 12-24 Months||98
9759969|NCT00377962|10863593|FG001|COMPLETED|Extension Study: 12-24 Months||123
9759970|NCT00377962|10863592|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10
9877523|NCT01011816|10991982|FG000|COMPLETED|78-Week Extended Follow-up||85
9877524|NCT01011816|10991983|FG001|COMPLETED|78-Week Extended Follow-up||26
9759971|NCT00377962|10863593|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4
9759972|NCT00378014|10863607|FG000|STARTED|Core (Randomization to Month 11)||101
9759973|NCT00378014|10863608|FG001|STARTED|Core (Randomization to Month 11)||102
9759974|NCT00378014|10863607|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
9759975|NCT00378014|10863608|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
9759976|NCT00378014|10863607|FG000|COMPLETED|Core (Randomization to Month 11)||87
9759977|NCT00378014|10863608|FG001|COMPLETED|Core (Randomization to Month 11)||90
9759978|NCT00378014|10863607|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14
9759979|NCT00378014|10863608|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12
9759980|NCT00378014|10863607|FG000|STARTED|Extension (Month 12 to Month 59)||41
9759981|NCT00378014|10863608|FG001|STARTED|Extension (Month 12 to Month 59)||40
9759982|NCT00378014|10863607|FG000|COMPLETED|Extension (Month 12 to Month 59)||27
9759983|NCT00378014|10863608|FG001|COMPLETED|Extension (Month 12 to Month 59)||26
9759984|NCT00378014|10863607|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14
9759985|NCT00378014|10863608|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14
9759986|NCT00378079|10863619|FG000|STARTED|Overall Study||70
9759987|NCT00378079|10863620|FG001|STARTED|Overall Study||70
9759988|NCT00378079|10863621|FG002|STARTED|Overall Study||71
10007351|NCT01750918|11129634|FG000|STARTED|Overall Study||3
10007352|NCT01750918|11129635|FG001|STARTED|Overall Study||4
10007353|NCT01750918|11129636|FG002|STARTED|Overall Study||36
10007354|NCT01750918|11129637|FG003|STARTED|Overall Study||50
9759989|NCT00378079|10863619|FG000|COMPLETED|Overall Study||64
9759990|NCT00378079|10863620|FG001|COMPLETED|Overall Study||69
9759991|NCT00378079|10863621|FG002|COMPLETED|Overall Study||71
9759992|NCT00378079|10863619|FG000|NOT COMPLETED|Overall Study||6
9759993|NCT00378079|10863620|FG001|NOT COMPLETED|Overall Study||1
9759994|NCT00378079|10863621|FG002|NOT COMPLETED|Overall Study||0
9759995|NCT00378105|10863631|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
9759996|NCT00378105|10863632|FG001|STARTED|Overall Study||35
9759997|NCT00378105|10863631|FG000|COMPLETED|Overall Study||11
9759998|NCT00378105|10863632|FG001|COMPLETED|Overall Study||5
9759999|NCT00378105|10863631|FG000|NOT COMPLETED|Overall Study||20
9760000|NCT00378105|10863632|FG001|NOT COMPLETED|Overall Study||30
9760001|NCT00378209|10863639|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
9760002|NCT00378209|10863639|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
9760003|NCT00378209|10863639|FG000|NOT COMPLETED|Overall Study||22
9760004|NCT00378326|10863644|FG000|STARTED|Overall Study||26
9760005|NCT00378326|10863644|FG000|COMPLETED|Overall Study||26
9760006|NCT00378326|10863644|FG000|NOT COMPLETED|Overall Study||0
9760007|NCT00378352|10863652|FG000|STARTED|Dose Escalation 15,000 Units||20
10007355|NCT01750918|11129638|FG004|STARTED|Overall Study||13
10007356|NCT01750918|11129639|FG005|STARTED|Overall Study||20
10007357|NCT01750918|11129640|FG006|STARTED|Overall Study||20
9760008|NCT00378352|10863653|FG001|STARTED|Dose Escalation 15,000 Units||0
9760009|NCT00378352|10863654|FG002|STARTED|Dose Escalation 15,000 Units||0
9760010|NCT00378352|10863655|FG003|STARTED|Dose Escalation 15,000 Units||11
9760011|NCT00378352|10863656|FG004|STARTED|Dose Escalation 15,000 Units||0
9760012|NCT00378352|10863657|FG005|STARTED|Dose Escalation 15,000 Units||0
9760013|NCT00378352|10863652|FG000|Safety Analysis|Dose Escalation 15,000 Units||19
9760014|NCT00378352|10863653|FG001|Safety Analysis|Dose Escalation 15,000 Units||0
9760015|NCT00378352|10863654|FG002|Safety Analysis|Dose Escalation 15,000 Units||0
9760016|NCT00378352|10863655|FG003|Safety Analysis|Dose Escalation 15,000 Units||11
9760017|NCT00378352|10863656|FG004|Safety Analysis|Dose Escalation 15,000 Units||0
9760018|NCT00378352|10863657|FG005|Safety Analysis|Dose Escalation 15,000 Units||0
9760019|NCT00378352|10863652|FG000|COMPLETED|Dose Escalation 15,000 Units||15
9760020|NCT00378352|10863653|FG001|COMPLETED|Dose Escalation 15,000 Units||0
9760021|NCT00378352|10863654|FG002|COMPLETED|Dose Escalation 15,000 Units||0
9760022|NCT00378352|10863655|FG003|COMPLETED|Dose Escalation 15,000 Units||10
9760023|NCT00378352|10863656|FG004|COMPLETED|Dose Escalation 15,000 Units||0
9760024|NCT00378352|10863657|FG005|COMPLETED|Dose Escalation 15,000 Units||0
9760025|NCT00378352|10863652|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5
9760026|NCT00378352|10863653|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0
9760027|NCT00378352|10863654|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0
9760028|NCT00378352|10863655|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1
9760029|NCT00378352|10863656|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0
9760030|NCT00378352|10863657|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0
9760031|NCT00378352|10863652|FG000|STARTED|Dose Escalation 30,000 Units||0
9760032|NCT00378352|10863653|FG001|STARTED|Dose Escalation 30,000 Units||19
9760033|NCT00378352|10863654|FG002|STARTED|Dose Escalation 30,000 Units||0
9760034|NCT00378352|10863655|FG003|STARTED|Dose Escalation 30,000 Units||11
9760035|NCT00378352|10863656|FG004|STARTED|Dose Escalation 30,000 Units||0
9760036|NCT00378352|10863657|FG005|STARTED|Dose Escalation 30,000 Units||0
9760037|NCT00378352|10863652|FG000|Safety Analysis|Dose Escalation 30,000 Units||0
9760038|NCT00378352|10863653|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
9760039|NCT00378352|10863654|FG002|Safety Analysis|Dose Escalation 30,000 Units||0
9760040|NCT00378352|10863655|FG003|Safety Analysis|Dose Escalation 30,000 Units||11
10007358|NCT01750918|11129641|FG007|STARTED|Overall Study||20
10007359|NCT01750918|11129634|FG000|Pharmacokinetic Population|Overall Study||3
10007360|NCT01750918|11129635|FG001|Pharmacokinetic Population|Overall Study||4
10007361|NCT01750918|11129636|FG002|Pharmacokinetic Population|Overall Study||35
10007362|NCT01750918|11129637|FG003|Pharmacokinetic Population|Overall Study||48
10007363|NCT01750918|11129638|FG004|Pharmacokinetic Population|Overall Study||12
10007364|NCT01750918|11129639|FG005|Pharmacokinetic Population|Overall Study||19
10007365|NCT01750918|11129640|FG006|Pharmacokinetic Population|Overall Study||18
10007366|NCT01750918|11129641|FG007|Pharmacokinetic Population|Overall Study||20
10007367|NCT01750918|11129634|FG000|Biomarker Population|Overall Study||3
10007368|NCT01750918|11129635|FG001|Biomarker Population|Overall Study||4
10007369|NCT01750918|11129636|FG002|Biomarker Population|Overall Study||36
10007370|NCT01750918|11129637|FG003|Biomarker Population|Overall Study||50
10007371|NCT01750918|11129638|FG004|Biomarker Population|Overall Study||13
10007372|NCT01750918|11129639|FG005|Biomarker Population|Overall Study||17
10007373|NCT01750918|11129640|FG006|Biomarker Population|Overall Study||19
10007374|NCT01750918|11129641|FG007|Biomarker Population|Overall Study||20
10007375|NCT01750918|11129634|FG000|Crossover Population|Overall Study||0
10007376|NCT01750918|11129635|FG001|Crossover Population|Overall Study||0
10007377|NCT01750918|11129636|FG002|Crossover Population|Overall Study||0
10007378|NCT01750918|11129637|FG003|Crossover Population|Overall Study||0
10007379|NCT01750918|11129638|FG004|Crossover Population|Overall Study||4
10007380|NCT01750918|11129639|FG005|Crossover Population|Overall Study||2
10007381|NCT01750918|11129640|FG006|Crossover Population|Overall Study||5
10007382|NCT01750918|11129641|FG007|Crossover Population|Overall Study||5
10007383|NCT01750918|11129634|FG000|COMPLETED|Overall Study||3
10007384|NCT01750918|11129635|FG001|COMPLETED|Overall Study||4
10007385|NCT01750918|11129636|FG002|COMPLETED|Overall Study||28
10007386|NCT01750918|11129637|FG003|COMPLETED|Overall Study||44
10007387|NCT01750918|11129638|FG004|COMPLETED|Overall Study||12
10007388|NCT01750918|11129639|FG005|COMPLETED|Overall Study||17
10007389|NCT01750918|11129640|FG006|COMPLETED|Overall Study||17
10007390|NCT01750918|11129641|FG007|COMPLETED|Overall Study||16
10007391|NCT01750918|11129634|FG000|NOT COMPLETED|Overall Study||0
10007392|NCT01750918|11129635|FG001|NOT COMPLETED|Overall Study||0
10007393|NCT01750918|11129636|FG002|NOT COMPLETED|Overall Study||8
10007394|NCT01750918|11129637|FG003|NOT COMPLETED|Overall Study||6
10007395|NCT01750918|11129638|FG004|NOT COMPLETED|Overall Study||1
10007396|NCT01750918|11129639|FG005|NOT COMPLETED|Overall Study||3
10007397|NCT01750918|11129640|FG006|NOT COMPLETED|Overall Study||3
10007398|NCT01750918|11129641|FG007|NOT COMPLETED|Overall Study||4
10007399|NCT01750931|11129671|FG000|STARTED|Period 1||14
10007400|NCT01750931|11129672|FG001|STARTED|Period 1||14
10007401|NCT01750931|11129671|FG000|COMPLETED|Period 1||14
10007402|NCT01750931|11129672|FG001|COMPLETED|Period 1||14
10007403|NCT01750931|11129671|FG000|NOT COMPLETED|Period 1||0
10007404|NCT01750931|11129672|FG001|NOT COMPLETED|Period 1||0
10007405|NCT01750931|11129671|FG000|STARTED|Wash Out||14
10007406|NCT01750931|11129672|FG001|STARTED|Wash Out||14
10007407|NCT01750931|11129671|FG000|COMPLETED|Wash Out||14
10007408|NCT01750931|11129672|FG001|COMPLETED|Wash Out||14
10007409|NCT01750931|11129671|FG000|NOT COMPLETED|Wash Out||0
10007410|NCT01750931|11129672|FG001|NOT COMPLETED|Wash Out||0
10007411|NCT01750931|11129671|FG000|STARTED|Period 2||14
10007412|NCT01750931|11129672|FG001|STARTED|Period 2||14
10007413|NCT01750931|11129671|FG000|COMPLETED|Period 2||14
10007414|NCT01750931|11129672|FG001|COMPLETED|Period 2||14
10007415|NCT01750931|11129671|FG000|NOT COMPLETED|Period 2||0
10007416|NCT01750931|11129672|FG001|NOT COMPLETED|Period 2||0
10007417|NCT01751022|11129681|FG000|STARTED|Overall Study||499
10007418|NCT01751022|11129682|FG001|STARTED|Overall Study||326
10007419|NCT01751022|11129683|FG002|STARTED|Overall Study||300
10007420|NCT01751022|11129681|FG000|COMPLETED|Overall Study|6 month visit|443
10007421|NCT01751022|11129682|FG001|COMPLETED|Overall Study|6 month visit|282
10007422|NCT01751022|11129683|FG002|COMPLETED|Overall Study|6 month visit|273
10007423|NCT01751022|11129681|FG000|NOT COMPLETED|Overall Study||56
10007424|NCT01751022|11129682|FG001|NOT COMPLETED|Overall Study||44
10007425|NCT01751022|11129683|FG002|NOT COMPLETED|Overall Study||27
10007426|NCT01751061|11129712|FG000|STARTED|Overall Study||210
10007427|NCT01751061|11129713|FG001|STARTED|Overall Study||206
10007428|NCT01751061|11129712|FG000|COMPLETED|Overall Study||154
10007429|NCT01751061|11129713|FG001|COMPLETED|Overall Study||172
10007430|NCT01751061|11129712|FG000|NOT COMPLETED|Overall Study||56
10007431|NCT01751061|11129713|FG001|NOT COMPLETED|Overall Study||34
10007432|NCT01751087|11129722|FG000|STARTED|Overall Study||100
10007433|NCT01751087|11129723|FG001|STARTED|Overall Study||100
10007434|NCT01751087|11129724|FG002|STARTED|Overall Study||100
10007435|NCT01751087|11129722|FG000|COMPLETED|Overall Study||99
10007436|NCT01751087|11129723|FG001|COMPLETED|Overall Study||100
10007437|NCT01751087|11129724|FG002|COMPLETED|Overall Study||99
10007438|NCT01751087|11129722|FG000|NOT COMPLETED|Overall Study||1
10007439|NCT01751087|11129723|FG001|NOT COMPLETED|Overall Study||0
10007440|NCT01751087|11129724|FG002|NOT COMPLETED|Overall Study||1
10007441|NCT01751113|11129732|FG000|STARTED|Treatment Period 1 (4 Weeks)||8
10007442|NCT01751113|11129733|FG001|STARTED|Treatment Period 1 (4 Weeks)||8
10007443|NCT01751113|11129734|FG002|STARTED|Treatment Period 1 (4 Weeks)||9
10107622|NCT02459418|11237892|FG001|STARTED|Overall Study||21
10107623|NCT02459418|11237891|FG000|Received First Treatment|Overall Study||21
10107624|NCT02459418|11237892|FG001|Received First Treatment|Overall Study||21
10107625|NCT02459418|11237891|FG000|Received Second Treatment|Overall Study||13
10107626|NCT02459418|11237892|FG001|Received Second Treatment|Overall Study||15
10107627|NCT02459418|11237891|FG000|COMPLETED|Overall Study||13
10107628|NCT02459418|11237892|FG001|COMPLETED|Overall Study||15
10107629|NCT02459418|11237891|FG000|NOT COMPLETED|Overall Study||8
10107630|NCT02459418|11237892|FG001|NOT COMPLETED|Overall Study||6
10107631|NCT02459587|11237903|FG000|STARTED|3-Month Follow-up Assessment||157
10107632|NCT02459587|11237904|FG001|STARTED|3-Month Follow-up Assessment||150
10107633|NCT02459587|11237903|FG000|COMPLETED|3-Month Follow-up Assessment||125
10107634|NCT02459587|11237904|FG001|COMPLETED|3-Month Follow-up Assessment||119
10107635|NCT02459587|11237903|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32
10107636|NCT02459587|11237904|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31
10107637|NCT02459587|11237903|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
10107638|NCT02459587|11237904|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
10107639|NCT02459587|11237903|FG000|COMPLETED|6-month Follow-up Assessment||128
10107640|NCT02459587|11237904|FG001|COMPLETED|6-month Follow-up Assessment||116
10107641|NCT02459587|11237903|FG000|NOT COMPLETED|6-month Follow-up Assessment||24
10107642|NCT02459587|11237904|FG001|NOT COMPLETED|6-month Follow-up Assessment||25
10107643|NCT02459587|11237903|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
10107644|NCT02459587|11237904|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
10107645|NCT02459587|11237903|FG000|COMPLETED|12-month Follow-up Assessment||127
10007444|NCT01751113|11129735|FG003|STARTED|Treatment Period 1 (4 Weeks)||9
10007445|NCT01751113|11129736|FG004|STARTED|Treatment Period 1 (4 Weeks)||9
10007446|NCT01751113|11129737|FG005|STARTED|Treatment Period 1 (4 Weeks)||10
10007447|NCT01751113|11129732|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8
10107646|NCT02459587|11237904|FG001|COMPLETED|12-month Follow-up Assessment||111
10107647|NCT02459587|11237903|FG000|NOT COMPLETED|12-month Follow-up Assessment||22
10107648|NCT02459587|11237904|FG001|NOT COMPLETED|12-month Follow-up Assessment||27
10107649|NCT02459665|11237915|FG000|STARTED|Overall Study||17
10107650|NCT02459665|11237916|FG001|STARTED|Overall Study||17
10107651|NCT02459665|11237917|FG002|STARTED|Overall Study||17
10107652|NCT02459665|11237918|FG003|STARTED|Overall Study||17
10007448|NCT01751113|11129733|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8
10007449|NCT01751113|11129734|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9
10007450|NCT01751113|11129735|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8
10107653|NCT02459665|11237915|FG000|Day 7 Visit|Overall Study||17
10007451|NCT01751113|11129736|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8
10007452|NCT01751113|11129737|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10
10107654|NCT02459665|11237916|FG001|Day 7 Visit|Overall Study||17
10107655|NCT02459665|11237917|FG002|Day 7 Visit|Overall Study||17
10107656|NCT02459665|11237918|FG003|Day 7 Visit|Overall Study||16
10007453|NCT01751113|11129732|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10107657|NCT02459665|11237915|FG000|Month 1 Visit|Overall Study||17
10107658|NCT02459665|11237916|FG001|Month 1 Visit|Overall Study||17
10107659|NCT02459665|11237917|FG002|Month 1 Visit|Overall Study||17
10107660|NCT02459665|11237918|FG003|Month 1 Visit|Overall Study||16
10107661|NCT02459665|11237915|FG000|Month 2 Visit|Overall Study||17
10007454|NCT01751113|11129733|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10007455|NCT01751113|11129734|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
9760041|NCT00378352|10863656|FG004|Safety Analysis|Dose Escalation 30,000 Units||0
9760042|NCT00378352|10863657|FG005|Safety Analysis|Dose Escalation 30,000 Units||0
9760043|NCT00378352|10863652|FG000|COMPLETED|Dose Escalation 30,000 Units||0
9760044|NCT00378352|10863653|FG001|COMPLETED|Dose Escalation 30,000 Units||16
9760045|NCT00378352|10863654|FG002|COMPLETED|Dose Escalation 30,000 Units||0
9760046|NCT00378352|10863655|FG003|COMPLETED|Dose Escalation 30,000 Units||9
9760047|NCT00378352|10863656|FG004|COMPLETED|Dose Escalation 30,000 Units||0
9760048|NCT00378352|10863657|FG005|COMPLETED|Dose Escalation 30,000 Units||0
9760049|NCT00378352|10863652|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0
9829196|NCT00758680|10939745|FG005|NOT COMPLETED|Overall Study||0
9877525|NCT01011816|10991982|FG000|NOT COMPLETED|78-Week Extended Follow-up||72
9877526|NCT01011816|10991983|FG001|NOT COMPLETED|78-Week Extended Follow-up||28
9877527|NCT01011829|10991993|FG000|STARTED|Overall Study||10
9877528|NCT01011829|10991994|FG001|STARTED|Overall Study||10
9877529|NCT01011829|10991993|FG000|COMPLETED|Overall Study||6
9877530|NCT01011829|10991994|FG001|COMPLETED|Overall Study||1
10007456|NCT01751113|11129735|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
10007457|NCT01751113|11129736|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
10007458|NCT01751113|11129737|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10007459|NCT01751113|11129732|FG000|STARTED|Washout Period 1 (2 Weeks)||8
10007460|NCT01751113|11129733|FG001|STARTED|Washout Period 1 (2 Weeks)||8
10007461|NCT01751113|11129734|FG002|STARTED|Washout Period 1 (2 Weeks)||9
10107662|NCT02459665|11237916|FG001|Month 2 Visit|Overall Study||16
10107663|NCT02459665|11237917|FG002|Month 2 Visit|Overall Study||17
10107664|NCT02459665|11237918|FG003|Month 2 Visit|Overall Study||16
10107665|NCT02459665|11237915|FG000|Month 6 Visit|Overall Study||17
10107666|NCT02459665|11237916|FG001|Month 6 Visit|Overall Study||16
10107667|NCT02459665|11237917|FG002|Month 6 Visit|Overall Study||16
10007462|NCT01751113|11129735|FG003|STARTED|Washout Period 1 (2 Weeks)||8
9760050|NCT00378352|10863653|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3
9760051|NCT00378352|10863654|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0
9760052|NCT00378352|10863655|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2
9760053|NCT00378352|10863656|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0
9760054|NCT00378352|10863657|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0
9760055|NCT00378352|10863652|FG000|STARTED|Dose Escalation 60,000 Units||0
9760056|NCT00378352|10863653|FG001|STARTED|Dose Escalation 60,000 Units||0
9760057|NCT00378352|10863654|FG002|STARTED|Dose Escalation 60,000 Units||20
9760058|NCT00378352|10863655|FG003|STARTED|Dose Escalation 60,000 Units||11
9760059|NCT00378352|10863656|FG004|STARTED|Dose Escalation 60,000 Units||0
9760060|NCT00378352|10863657|FG005|STARTED|Dose Escalation 60,000 Units||0
9760061|NCT00378352|10863652|FG000|Safety Analysis|Dose Escalation 60,000 Units||0
9760062|NCT00378352|10863653|FG001|Safety Analysis|Dose Escalation 60,000 Units||0
9760063|NCT00378352|10863654|FG002|Safety Analysis|Dose Escalation 60,000 Units||19
9760064|NCT00378352|10863655|FG003|Safety Analysis|Dose Escalation 60,000 Units||11
9760065|NCT00378352|10863656|FG004|Safety Analysis|Dose Escalation 60,000 Units||0
9760066|NCT00378352|10863657|FG005|Safety Analysis|Dose Escalation 60,000 Units||0
9760067|NCT00378352|10863652|FG000|COMPLETED|Dose Escalation 60,000 Units||0
9760068|NCT00378352|10863653|FG001|COMPLETED|Dose Escalation 60,000 Units||0
9760069|NCT00378352|10863654|FG002|COMPLETED|Dose Escalation 60,000 Units||17
9760070|NCT00378352|10863655|FG003|COMPLETED|Dose Escalation 60,000 Units||10
9760071|NCT00378352|10863656|FG004|COMPLETED|Dose Escalation 60,000 Units||0
9760072|NCT00378352|10863657|FG005|COMPLETED|Dose Escalation 60,000 Units||0
9760073|NCT00378352|10863652|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0
9760074|NCT00378352|10863653|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0
9760075|NCT00378352|10863654|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3
9760076|NCT00378352|10863655|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1
9760077|NCT00378352|10863656|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0
9760078|NCT00378352|10863657|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0
9760079|NCT00378352|10863652|FG000|STARTED|Efficacy Phase||0
9760080|NCT00378352|10863653|FG001|STARTED|Efficacy Phase||0
9760081|NCT00378352|10863654|FG002|STARTED|Efficacy Phase||0
9760082|NCT00378352|10863655|FG003|STARTED|Efficacy Phase||0
9760083|NCT00378352|10863656|FG004|STARTED|Efficacy Phase||65
9760084|NCT00378352|10863657|FG005|STARTED|Efficacy Phase||66
9760085|NCT00378352|10863652|FG000|Safety Analysis|Efficacy Phase||0
9760086|NCT00378352|10863653|FG001|Safety Analysis|Efficacy Phase||0
9760087|NCT00378352|10863654|FG002|Safety Analysis|Efficacy Phase||0
9760088|NCT00378352|10863655|FG003|Safety Analysis|Efficacy Phase||0
9829197|NCT00758680|10939746|FG006|NOT COMPLETED|Overall Study||1
9829198|NCT00758680|10939747|FG007|NOT COMPLETED|Overall Study||1
10107668|NCT02459665|11237918|FG003|Month 6 Visit|Overall Study||15
10107669|NCT02459665|11237915|FG000|COMPLETED|Overall Study||17
10107670|NCT02459665|11237916|FG001|COMPLETED|Overall Study||16
10107671|NCT02459665|11237917|FG002|COMPLETED|Overall Study||16
10107672|NCT02459665|11237918|FG003|COMPLETED|Overall Study||15
10107673|NCT02459665|11237915|FG000|NOT COMPLETED|Overall Study||0
10107674|NCT02459665|11237916|FG001|NOT COMPLETED|Overall Study||1
10107675|NCT02459665|11237917|FG002|NOT COMPLETED|Overall Study||1
10107676|NCT02459665|11237918|FG003|NOT COMPLETED|Overall Study||2
10107677|NCT02459795|11237938|FG000|STARTED|Overall Study||187
10107678|NCT02459795|11237939|FG001|STARTED|Overall Study||189
10107679|NCT02459795|11237940|FG002|STARTED|Overall Study||93
10107680|NCT02459795|11237938|FG000|COMPLETED|Overall Study||181
10107681|NCT02459795|11237939|FG001|COMPLETED|Overall Study||186
10107682|NCT02459795|11237940|FG002|COMPLETED|Overall Study||92
10107683|NCT02459795|11237938|FG000|NOT COMPLETED|Overall Study||6
10107684|NCT02459795|11237939|FG001|NOT COMPLETED|Overall Study||3
10107685|NCT02459795|11237940|FG002|NOT COMPLETED|Overall Study||1
9829199|NCT00758680|10939748|FG008|NOT COMPLETED|Overall Study||2
9829200|NCT00758680|10939749|FG009|NOT COMPLETED|Overall Study||1
9829201|NCT00758706|10939774|FG000|STARTED|Overall Study||26
9829202|NCT00758706|10939775|FG001|STARTED|Overall Study||29
9829203|NCT00758706|10939774|FG000|COMPLETED|Overall Study||22
9829204|NCT00758706|10939775|FG001|COMPLETED|Overall Study||25
9829205|NCT00758706|10939774|FG000|NOT COMPLETED|Overall Study||4
9829206|NCT00758706|10939775|FG001|NOT COMPLETED|Overall Study||4
10007463|NCT01751113|11129736|FG004|STARTED|Washout Period 1 (2 Weeks)||8
10007464|NCT01751113|11129737|FG005|STARTED|Washout Period 1 (2 Weeks)||10
10007465|NCT01751113|11129732|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8
10007466|NCT01751113|11129733|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8
10007467|NCT01751113|11129734|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9
10007468|NCT01751113|11129735|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8
10007469|NCT01751113|11129736|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8
10007470|NCT01751113|11129737|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10
10007471|NCT01751113|11129732|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10007472|NCT01751113|11129733|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10007473|NCT01751113|11129734|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10007474|NCT01751113|11129735|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10007475|NCT01751113|11129736|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10007476|NCT01751113|11129737|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10007477|NCT01751113|11129732|FG000|STARTED|Treatment Period 2 (4 Weeks)||8
10007478|NCT01751113|11129733|FG001|STARTED|Treatment Period 2 (4 Weeks)||8
10007479|NCT01751113|11129734|FG002|STARTED|Treatment Period 2 (4 Weeks)||9
10007480|NCT01751113|11129735|FG003|STARTED|Treatment Period 2 (4 Weeks)||8
10007481|NCT01751113|11129736|FG004|STARTED|Treatment Period 2 (4 Weeks)||8
10007482|NCT01751113|11129737|FG005|STARTED|Treatment Period 2 (4 Weeks)||10
10007483|NCT01751113|11129732|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8
10007484|NCT01751113|11129733|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8
10007485|NCT01751113|11129734|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9
10202662|NCT03449147|11329828|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36
10202663|NCT03449147|11329829|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37
10202664|NCT03449147|11329827|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
10202665|NCT03449147|11329828|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
10202666|NCT03449147|11329829|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10202667|NCT03449342|11329843|FG000|STARTED|Overall Study||10
10202668|NCT03449342|11329844|FG001|STARTED|Overall Study||50
10202669|NCT03449342|11329843|FG000|COMPLETED|Overall Study||10
10202670|NCT03449342|11329844|FG001|COMPLETED|Overall Study||50
10202671|NCT03449342|11329843|FG000|NOT COMPLETED|Overall Study||0
10202672|NCT03449342|11329844|FG001|NOT COMPLETED|Overall Study||0
10202673|NCT03449433|11329852|FG000|STARTED|Period 1||17
10202674|NCT03449433|11329853|FG001|STARTED|Period 1||16
10202675|NCT03449433|11329854|FG002|STARTED|Period 1||18
10202676|NCT03449433|11329855|FG003|STARTED|Period 1||17
10202677|NCT03449433|11329856|FG004|STARTED|Period 1||12
10202678|NCT03449433|11329852|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
10202679|NCT03449433|11329853|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
10202680|NCT03449433|11329854|FG002|Received at Least 1 Dose of Study Drug|Period 1||18
10202681|NCT03449433|11329855|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
10202682|NCT03449433|11329856|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
10202683|NCT03449433|11329852|FG000|COMPLETED|Period 1||17
10202684|NCT03449433|11329853|FG001|COMPLETED|Period 1||16
10202685|NCT03449433|11329854|FG002|COMPLETED|Period 1||18
10202686|NCT03449433|11329855|FG003|COMPLETED|Period 1||17
10202687|NCT03449433|11329856|FG004|COMPLETED|Period 1||12
10202688|NCT03449433|11329852|FG000|NOT COMPLETED|Period 1||0
10202689|NCT03449433|11329853|FG001|NOT COMPLETED|Period 1||0
10202690|NCT03449433|11329854|FG002|NOT COMPLETED|Period 1||0
10202691|NCT03449433|11329855|FG003|NOT COMPLETED|Period 1||0
10202692|NCT03449433|11329856|FG004|NOT COMPLETED|Period 1||0
10202693|NCT03449433|11329852|FG000|STARTED|Period 2||17
10202694|NCT03449433|11329853|FG001|STARTED|Period 2||16
10202695|NCT03449433|11329854|FG002|STARTED|Period 2||18
10202696|NCT03449433|11329855|FG003|STARTED|Period 2||17
10202697|NCT03449433|11329856|FG004|STARTED|Period 2||12
10202698|NCT03449433|11329852|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
10202699|NCT03449433|11329853|FG001|Received at Least 1 Dose of Study Drug|Period 2||16
10202700|NCT03449433|11329854|FG002|Received at Least 1 Dose of Study Drug|Period 2||18
10202701|NCT03449433|11329855|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
10202702|NCT03449433|11329856|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
10202703|NCT03449433|11329852|FG000|COMPLETED|Period 2||17
10202704|NCT03449433|11329853|FG001|COMPLETED|Period 2||16
10202705|NCT03449433|11329854|FG002|COMPLETED|Period 2||18
10202706|NCT03449433|11329855|FG003|COMPLETED|Period 2||17
10202707|NCT03449433|11329856|FG004|COMPLETED|Period 2||12
10202708|NCT03449433|11329852|FG000|NOT COMPLETED|Period 2||0
10202709|NCT03449433|11329853|FG001|NOT COMPLETED|Period 2||0
10202710|NCT03449433|11329854|FG002|NOT COMPLETED|Period 2||0
10202711|NCT03449433|11329855|FG003|NOT COMPLETED|Period 2||0
10202712|NCT03449433|11329856|FG004|NOT COMPLETED|Period 2||0
10202713|NCT03449433|11329852|FG000|STARTED|Period 3||17
10202714|NCT03449433|11329853|FG001|STARTED|Period 3||16
10202715|NCT03449433|11329854|FG002|STARTED|Period 3||18
10202716|NCT03449433|11329855|FG003|STARTED|Period 3||17
10202717|NCT03449433|11329856|FG004|STARTED|Period 3||12
10202718|NCT03449433|11329852|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
10202719|NCT03449433|11329853|FG001|Received at Least 1 Dose of Study Drug|Period 3||15
10202720|NCT03449433|11329854|FG002|Received at Least 1 Dose of Study Drug|Period 3||18
10202721|NCT03449433|11329855|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
10202722|NCT03449433|11329856|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
10202723|NCT03449433|11329852|FG000|COMPLETED|Period 3||17
10202724|NCT03449433|11329853|FG001|COMPLETED|Period 3||15
10202725|NCT03449433|11329854|FG002|COMPLETED|Period 3||18
10007486|NCT01751113|11129735|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8
9760089|NCT00378352|10863656|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
9760090|NCT00378352|10863657|FG005|Safety Analysis|Efficacy Phase||64
9760091|NCT00378352|10863652|FG000|COMPLETED|Efficacy Phase||0
9760092|NCT00378352|10863653|FG001|COMPLETED|Efficacy Phase||0
9760093|NCT00378352|10863654|FG002|COMPLETED|Efficacy Phase||0
9760094|NCT00378352|10863655|FG003|COMPLETED|Efficacy Phase||0
9760095|NCT00378352|10863656|FG004|COMPLETED|Efficacy Phase||54
9760096|NCT00378352|10863657|FG005|COMPLETED|Efficacy Phase||59
9760097|NCT00378352|10863652|FG000|NOT COMPLETED|Efficacy Phase||0
9760098|NCT00378352|10863653|FG001|NOT COMPLETED|Efficacy Phase||0
9760099|NCT00378352|10863654|FG002|NOT COMPLETED|Efficacy Phase||0
9760100|NCT00378352|10863655|FG003|NOT COMPLETED|Efficacy Phase||0
9760101|NCT00378352|10863656|FG004|NOT COMPLETED|Efficacy Phase||11
9760102|NCT00378352|10863657|FG005|NOT COMPLETED|Efficacy Phase||7
9760103|NCT00378508|10863667|FG000|STARTED|Overall Study||29
9760104|NCT00378508|10863668|FG001|STARTED|Overall Study||34
9760105|NCT00378508|10863667|FG000|Randomized|Overall Study||29
9760106|NCT00378508|10863668|FG001|Randomized|Overall Study||34
9760107|NCT00378508|10863667|FG000|Received Intervention/Placebo|Overall Study||28
9760108|NCT00378508|10863668|FG001|Received Intervention/Placebo|Overall Study||31
9760109|NCT00378508|10863667|FG000|COMPLETED|Overall Study||27
9760110|NCT00378508|10863668|FG001|COMPLETED|Overall Study||31
9760111|NCT00378508|10863667|FG000|NOT COMPLETED|Overall Study||2
9760112|NCT00378508|10863668|FG001|NOT COMPLETED|Overall Study||3
9760113|NCT00378534|10863677|FG000|STARTED|Overall Study||58
9760114|NCT00378534|10863678|FG001|STARTED|Overall Study||58
9760115|NCT00378534|10863677|FG000|COMPLETED|Overall Study||55
9760116|NCT00378534|10863678|FG001|COMPLETED|Overall Study||58
9760117|NCT00378534|10863677|FG000|NOT COMPLETED|Overall Study||3
9760118|NCT00378534|10863678|FG001|NOT COMPLETED|Overall Study||0
9760119|NCT00378560|10863685|FG000|STARTED|Overall Study||509
9760120|NCT00378560|10863686|FG001|STARTED|Overall Study||512
9760121|NCT00378560|10863685|FG000|Vaccinated|Overall Study||509
9760122|NCT00378560|10863686|FG001|Vaccinated|Overall Study||512
9760123|NCT00378560|10863685|FG000|COMPLETED|Overall Study||453
9760124|NCT00378560|10863686|FG001|COMPLETED|Overall Study||454
9760125|NCT00378560|10863685|FG000|NOT COMPLETED|Overall Study||56
9760126|NCT00378560|10863686|FG001|NOT COMPLETED|Overall Study||58
9760127|NCT00378573|10863692|FG000|STARTED|Treatment Period||17
9760128|NCT00378573|10863692|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
9760129|NCT00378573|10863692|FG000|NOT COMPLETED|Treatment Period||17
9760130|NCT00378573|10863692|FG000|STARTED|Follow-up||17
9760131|NCT00378573|10863692|FG000|COMPLETED|Follow-up||3
9760132|NCT00378573|10863692|FG000|NOT COMPLETED|Follow-up||14
9760133|NCT00378599|10863696|FG000|STARTED|Overall Study||125
9760134|NCT00378599|10863696|FG000|COMPLETED|Overall Study||73
9760135|NCT00378599|10863696|FG000|NOT COMPLETED|Overall Study||52
9760136|NCT00378703|10863704|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
9760137|NCT00378703|10863705|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
9760138|NCT00378703|10863706|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
9760139|NCT00378703|10863707|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
9760140|NCT00378703|10863704|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
9760141|NCT00378703|10863705|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
9760142|NCT00378703|10863706|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
9760143|NCT00378703|10863707|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
9760144|NCT00378703|10863704|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
9760145|NCT00378703|10863705|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
10007487|NCT01751113|11129736|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8
10007488|NCT01751113|11129737|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10
10007489|NCT01751113|11129732|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10007490|NCT01751113|11129733|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10007491|NCT01751113|11129734|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10007492|NCT01751113|11129735|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
9877531|NCT01011829|10991993|FG000|NOT COMPLETED|Overall Study||4
9877532|NCT01011829|10991994|FG001|NOT COMPLETED|Overall Study||9
9877533|NCT01011868|10992003|FG000|STARTED|After Week 18 Follow-up||170
9877534|NCT01011868|10992004|FG001|STARTED|After Week 18 Follow-up||169
9877535|NCT01011868|10992005|FG002|STARTED|After Week 18 Follow-up||155
10007493|NCT01751113|11129736|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10007494|NCT01751113|11129737|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10007495|NCT01751113|11129732|FG000|STARTED|Washout Period 2 (2 Weeks)||8
10007496|NCT01751113|11129733|FG001|STARTED|Washout Period 2 (2 Weeks)||8
10007497|NCT01751113|11129734|FG002|STARTED|Washout Period 2 (2 Weeks)||9
9877536|NCT01011868|10992003|FG000|COMPLETED|After Week 18 Follow-up||147
9760146|NCT00378703|10863706|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
9760147|NCT00378703|10863707|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
10107686|NCT02459899|11237952|FG000|STARTED|Overall Study||36
10107687|NCT02459899|11237953|FG001|STARTED|Overall Study||35
10107688|NCT02459899|11237954|FG002|STARTED|Overall Study||35
10107689|NCT02459899|11237955|FG003|STARTED|Overall Study||35
9760148|NCT00378703|10863704|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
9760149|NCT00378703|10863705|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
9760150|NCT00378703|10863706|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
9760151|NCT00378703|10863707|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
9760152|NCT00378703|10863704|FG000|NOT COMPLETED|Overall Study||89
9760153|NCT00378703|10863705|FG001|NOT COMPLETED|Overall Study||91
9760154|NCT00378703|10863706|FG002|NOT COMPLETED|Overall Study||90
9760155|NCT00378703|10863707|FG003|NOT COMPLETED|Overall Study||91
9760156|NCT00378898|10863719|FG000|STARTED|Overall Study||22
9760157|NCT00378898|10863720|FG001|STARTED|Overall Study||17
9760158|NCT00378898|10863719|FG000|COMPLETED|Overall Study||11
9760159|NCT00378898|10863720|FG001|COMPLETED|Overall Study||11
9760160|NCT00378898|10863719|FG000|NOT COMPLETED|Overall Study||11
9760161|NCT00378898|10863720|FG001|NOT COMPLETED|Overall Study||6
10007498|NCT01751113|11129735|FG003|STARTED|Washout Period 2 (2 Weeks)||8
10007499|NCT01751113|11129736|FG004|STARTED|Washout Period 2 (2 Weeks)||8
9760162|NCT00379080|10863731|FG000|STARTED|Overall Study||6
9760163|NCT00379080|10863732|FG001|STARTED|Overall Study||19
9760164|NCT00379080|10863733|FG002|STARTED|Overall Study||31
9760165|NCT00379080|10863731|FG000|COMPLETED|Overall Study||6
9760166|NCT00379080|10863732|FG001|COMPLETED|Overall Study||15
9760167|NCT00379080|10863733|FG002|COMPLETED|Overall Study||31
9760168|NCT00379080|10863731|FG000|NOT COMPLETED|Overall Study||0
9760169|NCT00379080|10863732|FG001|NOT COMPLETED|Overall Study||4
9760170|NCT00379080|10863733|FG002|NOT COMPLETED|Overall Study||0
9760171|NCT00379145|10863756|FG000|STARTED|Overall Study||20
9760172|NCT00379145|10863756|FG000|COMPLETED|Overall Study||20
9760173|NCT00379145|10863756|FG000|NOT COMPLETED|Overall Study||0
9760174|NCT00379197|10863765|FG000|STARTED|Overall Study||13
9760175|NCT00379197|10863765|FG000|COMPLETED|Overall Study||8
9760176|NCT00379197|10863765|FG000|NOT COMPLETED|Overall Study||5
9760177|NCT00379210|10863772|FG000|STARTED|Overall Study||30
9760178|NCT00379210|10863773|FG001|STARTED|Overall Study||30
10202726|NCT03449433|11329855|FG003|COMPLETED|Period 3||17
10202727|NCT03449433|11329856|FG004|COMPLETED|Period 3||12
10202728|NCT03449433|11329852|FG000|NOT COMPLETED|Period 3||0
9760179|NCT00379210|10863772|FG000|COMPLETED|Overall Study||20
9760180|NCT00379210|10863773|FG001|COMPLETED|Overall Study||23
9760181|NCT00379210|10863772|FG000|NOT COMPLETED|Overall Study||10
9760182|NCT00379210|10863773|FG001|NOT COMPLETED|Overall Study||7
9760183|NCT00379236|10863781|FG000|STARTED|Double-blind||293
9760184|NCT00379236|10863782|FG001|STARTED|Double-blind||295
9760185|NCT00379236|10863783|FG002|STARTED|Double-blind||0
9760186|NCT00379236|10863781|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
9760187|NCT00379236|10863782|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
9760188|NCT00379236|10863783|FG002|COMPLETED|Double-blind||0
9760189|NCT00379236|10863781|FG000|NOT COMPLETED|Double-blind||36
9760190|NCT00379236|10863782|FG001|NOT COMPLETED|Double-blind||36
9760191|NCT00379236|10863783|FG002|NOT COMPLETED|Double-blind||0
9760192|NCT00379236|10863781|FG000|STARTED|Open-label Extension||0
9760193|NCT00379236|10863782|FG001|STARTED|Open-label Extension||0
9760194|NCT00379236|10863783|FG002|STARTED|Open-label Extension||433
9760195|NCT00379236|10863781|FG000|COMPLETED|Open-label Extension||0
9760196|NCT00379236|10863782|FG001|COMPLETED|Open-label Extension||0
9760197|NCT00379236|10863783|FG002|COMPLETED|Open-label Extension||378
9760198|NCT00379236|10863781|FG000|NOT COMPLETED|Open-label Extension||0
9760199|NCT00379236|10863782|FG001|NOT COMPLETED|Open-label Extension||0
9760200|NCT00379236|10863783|FG002|NOT COMPLETED|Open-label Extension||55
9760201|NCT00379353|10863797|FG000|STARTED|Overall Study||16
9760202|NCT00379353|10863798|FG001|STARTED|Overall Study||15
9760203|NCT00379353|10863797|FG000|COMPLETED|Overall Study||5
9760204|NCT00379353|10863798|FG001|COMPLETED|Overall Study||9
9760205|NCT00379353|10863797|FG000|NOT COMPLETED|Overall Study||11
9760206|NCT00379353|10863798|FG001|NOT COMPLETED|Overall Study||6
9760207|NCT00379574|10863814|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
9760208|NCT00379574|10863814|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
9760209|NCT00379574|10863814|FG000|NOT COMPLETED|Overall Study||0
9760210|NCT00379587|10863818|FG000|STARTED|Overall Study||65
10007500|NCT01751113|11129737|FG005|STARTED|Washout Period 2 (2 Weeks)||10
9760211|NCT00379587|10863818|FG000|COMPLETED|Overall Study||63
9760212|NCT00379587|10863818|FG000|NOT COMPLETED|Overall Study||2
10007501|NCT01751113|11129732|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8
10007502|NCT01751113|11129733|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8
10007503|NCT01751113|11129734|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9
10007504|NCT01751113|11129735|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8
10007505|NCT01751113|11129736|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8
10007506|NCT01751113|11129737|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10
10007507|NCT01751113|11129732|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10007508|NCT01751113|11129733|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10007509|NCT01751113|11129734|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10007510|NCT01751113|11129735|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10007511|NCT01751113|11129736|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10007512|NCT01751113|11129737|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10007513|NCT01751113|11129732|FG000|STARTED|Treatment Period 3 (4 Weeks)||8
10007514|NCT01751113|11129733|FG001|STARTED|Treatment Period 3 (4 Weeks)||8
10007515|NCT01751113|11129734|FG002|STARTED|Treatment Period 3 (4 Weeks)||9
10007516|NCT01751113|11129735|FG003|STARTED|Treatment Period 3 (4 Weeks)||8
10007517|NCT01751113|11129736|FG004|STARTED|Treatment Period 3 (4 Weeks)||8
10007518|NCT01751113|11129737|FG005|STARTED|Treatment Period 3 (4 Weeks)||10
10007519|NCT01751113|11129732|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8
10007520|NCT01751113|11129733|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8
10007521|NCT01751113|11129734|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9
10007522|NCT01751113|11129735|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8
10007523|NCT01751113|11129736|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8
10007524|NCT01751113|11129737|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9
10107690|NCT02459899|11237952|FG000|COMPLETED|Overall Study||33
10107691|NCT02459899|11237953|FG001|COMPLETED|Overall Study||29
10107692|NCT02459899|11237954|FG002|COMPLETED|Overall Study||35
10007525|NCT01751113|11129732|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10007526|NCT01751113|11129733|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10007527|NCT01751113|11129734|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10007528|NCT01751113|11129735|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10007529|NCT01751113|11129736|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10007530|NCT01751113|11129737|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
10007531|NCT01751139|11129746|FG000|STARTED|Overall Study||3300
10007532|NCT01751139|11129746|FG000|COMPLETED|Overall Study||1033
10107693|NCT02459899|11237955|FG003|COMPLETED|Overall Study||33
10007533|NCT01751139|11129746|FG000|NOT COMPLETED|Overall Study||2267
10007534|NCT01751165|11129753|FG000|STARTED|Overall Study||119
10007535|NCT01751165|11129754|FG001|STARTED|Overall Study||119
10007536|NCT01751165|11129755|FG002|STARTED|Overall Study||116
10007537|NCT01751165|11129753|FG000|COMPLETED|Overall Study||117
10007538|NCT01751165|11129754|FG001|COMPLETED|Overall Study||116
10107694|NCT02459899|11237952|FG000|NOT COMPLETED|Overall Study||3
10007539|NCT01751165|11129755|FG002|COMPLETED|Overall Study||113
10007540|NCT01751165|11129753|FG000|NOT COMPLETED|Overall Study||2
10007541|NCT01751165|11129754|FG001|NOT COMPLETED|Overall Study||3
10007542|NCT01751165|11129755|FG002|NOT COMPLETED|Overall Study||3
10007543|NCT01751178|11129768|FG000|STARTED|Overall Study||108
10007544|NCT01751178|11129769|FG001|STARTED|Overall Study||109
10007545|NCT01751178|11129770|FG002|STARTED|Overall Study||107
10007546|NCT01751178|11129768|FG000|COMPLETED|Overall Study||105
10007547|NCT01751178|11129769|FG001|COMPLETED|Overall Study||109
9760213|NCT00379639|10863827|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
9760214|NCT00379639|10863828|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
9760215|NCT00379639|10863829|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
9760216|NCT00379639|10863830|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
9760217|NCT00379639|10863831|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
9760218|NCT00379639|10863827|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
9760219|NCT00379639|10863828|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
9760220|NCT00379639|10863829|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
9760221|NCT00379639|10863830|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
9760222|NCT00379639|10863831|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
9760223|NCT00379639|10863827|FG000|Completed 6 Cycles of Therapy|Overall Study||4
9760224|NCT00379639|10863828|FG001|Completed 6 Cycles of Therapy|Overall Study||2
9760225|NCT00379639|10863829|FG002|Completed 6 Cycles of Therapy|Overall Study||1
9760226|NCT00379639|10863830|FG003|Completed 6 Cycles of Therapy|Overall Study||0
9760227|NCT00379639|10863831|FG004|Completed 6 Cycles of Therapy|Overall Study||0
9760228|NCT00379639|10863827|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
9760229|NCT00379639|10863828|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
9760230|NCT00379639|10863829|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
9760231|NCT00379639|10863830|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
9760232|NCT00379639|10863831|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
9760233|NCT00379639|10863827|FG000|NOT COMPLETED|Overall Study||3
9760234|NCT00379639|10863828|FG001|NOT COMPLETED|Overall Study||5
9760235|NCT00379639|10863829|FG002|NOT COMPLETED|Overall Study||9
9760236|NCT00379639|10863830|FG003|NOT COMPLETED|Overall Study||6
9760237|NCT00379639|10863831|FG004|NOT COMPLETED|Overall Study||6
9760238|NCT00379769|10863847|FG000|STARTED|Main Study||1117
10007548|NCT01751178|11129770|FG002|COMPLETED|Overall Study||105
10007549|NCT01751178|11129768|FG000|NOT COMPLETED|Overall Study||3
10007550|NCT01751178|11129769|FG001|NOT COMPLETED|Overall Study||0
10007551|NCT01751178|11129770|FG002|NOT COMPLETED|Overall Study||2
10007552|NCT01751230|11129784|FG000|STARTED|Overall Study||20
10007553|NCT01751230|11129785|FG001|STARTED|Overall Study||20
10007554|NCT01751230|11129784|FG000|COMPLETED|Overall Study||19
9760239|NCT00379769|10863848|FG001|STARTED|Main Study||1105
9760240|NCT00379769|10863849|FG002|STARTED|Main Study||1103
9760241|NCT00379769|10863850|FG003|STARTED|Main Study||1122
9760242|NCT00379769|10863851|FG004|STARTED|Main Study||0
9760243|NCT00379769|10863852|FG005|STARTED|Main Study||0
9760244|NCT00379769|10863847|FG000|COMPLETED|Main Study||939
9760245|NCT00379769|10863848|FG001|COMPLETED|Main Study||906
9760246|NCT00379769|10863849|FG002|COMPLETED|Main Study||896
9760247|NCT00379769|10863850|FG003|COMPLETED|Main Study||892
9760248|NCT00379769|10863851|FG004|COMPLETED|Main Study||0
9760249|NCT00379769|10863852|FG005|COMPLETED|Main Study||0
9760250|NCT00379769|10863847|FG000|NOT COMPLETED|Main Study||178
9760251|NCT00379769|10863848|FG001|NOT COMPLETED|Main Study||199
9760252|NCT00379769|10863849|FG002|NOT COMPLETED|Main Study||207
9760253|NCT00379769|10863850|FG003|NOT COMPLETED|Main Study||230
9760254|NCT00379769|10863851|FG004|NOT COMPLETED|Main Study||0
9760255|NCT00379769|10863852|FG005|NOT COMPLETED|Main Study||0
9760256|NCT00379769|10863847|FG000|STARTED|Observational Follow-up||0
9760257|NCT00379769|10863848|FG001|STARTED|Observational Follow-up||0
10007555|NCT01751230|11129785|FG001|COMPLETED|Overall Study||16
10007556|NCT01751230|11129784|FG000|NOT COMPLETED|Overall Study||1
10007557|NCT01751230|11129785|FG001|NOT COMPLETED|Overall Study||4
10007558|NCT01751308|11129800|FG000|STARTED|Phase 1||6
10007559|NCT01751308|11129801|FG001|STARTED|Phase 1||3
10007560|NCT01751308|11129802|FG002|STARTED|Phase 1||7
10007561|NCT01751308|11129803|FG003|STARTED|Phase 1||7
9760258|NCT00379769|10863849|FG002|STARTED|Observational Follow-up||0
9760259|NCT00379769|10863850|FG003|STARTED|Observational Follow-up||0
10107695|NCT02459899|11237953|FG001|NOT COMPLETED|Overall Study||6
10107696|NCT02459899|11237954|FG002|NOT COMPLETED|Overall Study||0
10107697|NCT02459899|11237955|FG003|NOT COMPLETED|Overall Study||2
10107698|NCT02459951|11237965|FG000|STARTED|Overall Study||10
10107699|NCT02459951|11237965|FG000|COMPLETED|Overall Study||9
10007562|NCT01751308|11129804|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
10007563|NCT01751308|11129800|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
10007564|NCT01751308|11129801|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
10007565|NCT01751308|11129802|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
10007566|NCT01751308|11129803|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
10007567|NCT01751308|11129804|FG004|COMPLETED|Phase 1||0
10007568|NCT01751308|11129800|FG000|NOT COMPLETED|Phase 1||0
10007569|NCT01751308|11129801|FG001|NOT COMPLETED|Phase 1||0
10007570|NCT01751308|11129802|FG002|NOT COMPLETED|Phase 1||0
10007571|NCT01751308|11129803|FG003|NOT COMPLETED|Phase 1||0
10007572|NCT01751308|11129804|FG004|NOT COMPLETED|Phase 1||0
10007573|NCT01751308|11129800|FG000|STARTED|Phase 2||0
10007574|NCT01751308|11129801|FG001|STARTED|Phase 2||0
10007575|NCT01751308|11129802|FG002|STARTED|Phase 2||0
10007576|NCT01751308|11129803|FG003|STARTED|Phase 2||0
10007577|NCT01751308|11129804|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
10107700|NCT02459951|11237965|FG000|NOT COMPLETED|Overall Study||1
10007578|NCT01751308|11129800|FG000|COMPLETED|Phase 2||0
10007579|NCT01751308|11129801|FG001|COMPLETED|Phase 2||0
10007580|NCT01751308|11129802|FG002|COMPLETED|Phase 2||0
10007581|NCT01751308|11129803|FG003|COMPLETED|Phase 2||0
10007582|NCT01751308|11129804|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
10007583|NCT01751308|11129800|FG000|NOT COMPLETED|Phase 2||0
10007584|NCT01751308|11129801|FG001|NOT COMPLETED|Phase 2||0
10007585|NCT01751308|11129802|FG002|NOT COMPLETED|Phase 2||0
10007586|NCT01751308|11129803|FG003|NOT COMPLETED|Phase 2||0
10007587|NCT01751308|11129804|FG004|NOT COMPLETED|Phase 2||0
10007588|NCT01751386|11129822|FG000|STARTED|Overall Study||20
10007589|NCT01751386|11129823|FG001|STARTED|Overall Study||19
10007590|NCT01751386|11129822|FG000|COMPLETED|Overall Study||18
9760260|NCT00379769|10863851|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
9760261|NCT00379769|10863852|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
9760262|NCT00379769|10863847|FG000|COMPLETED|Observational Follow-up||0
9760263|NCT00379769|10863848|FG001|COMPLETED|Observational Follow-up||0
9760264|NCT00379769|10863849|FG002|COMPLETED|Observational Follow-up||0
9760265|NCT00379769|10863850|FG003|COMPLETED|Observational Follow-up||0
9760266|NCT00379769|10863851|FG004|COMPLETED|Observational Follow-up||1131
9760267|NCT00379769|10863852|FG005|COMPLETED|Observational Follow-up||1102
9760268|NCT00379769|10863847|FG000|NOT COMPLETED|Observational Follow-up||0
9760269|NCT00379769|10863848|FG001|NOT COMPLETED|Observational Follow-up||0
9760270|NCT00379769|10863849|FG002|NOT COMPLETED|Observational Follow-up||0
9760271|NCT00379769|10863850|FG003|NOT COMPLETED|Observational Follow-up||0
9760272|NCT00379769|10863851|FG004|NOT COMPLETED|Observational Follow-up||149
9760273|NCT00379769|10863852|FG005|NOT COMPLETED|Observational Follow-up||148
9760274|NCT00379795|10863884|FG000|STARTED|Overall Study||526
9760275|NCT00379795|10863885|FG001|STARTED|Overall Study||74
9760276|NCT00379795|10863886|FG002|STARTED|Overall Study||116
9760277|NCT00379795|10863887|FG003|STARTED|Overall Study||74
9760278|NCT00379795|10863888|FG004|STARTED|Overall Study||63
9760279|NCT00379795|10863884|FG000|Received Ranibizumab in Extension Study|Overall Study||377
9760280|NCT00379795|10863885|FG001|Received Ranibizumab in Extension Study|Overall Study||41
9760281|NCT00379795|10863886|FG002|Received Ranibizumab in Extension Study|Overall Study||113
9760282|NCT00379795|10863887|FG003|Received Ranibizumab in Extension Study|Overall Study||55
9760283|NCT00379795|10863888|FG004|Received Ranibizumab in Extension Study|Overall Study||0
9760284|NCT00379795|10863884|FG000|COMPLETED|Overall Study||50
9760285|NCT00379795|10863885|FG001|COMPLETED|Overall Study||23
9760286|NCT00379795|10863886|FG002|COMPLETED|Overall Study||23
9760287|NCT00379795|10863887|FG003|COMPLETED|Overall Study||6
9760288|NCT00379795|10863888|FG004|COMPLETED|Overall Study||14
9760289|NCT00379795|10863884|FG000|NOT COMPLETED|Overall Study||476
9760290|NCT00379795|10863885|FG001|NOT COMPLETED|Overall Study||51
9760291|NCT00379795|10863886|FG002|NOT COMPLETED|Overall Study||93
9760292|NCT00379795|10863887|FG003|NOT COMPLETED|Overall Study||68
9760293|NCT00379795|10863888|FG004|NOT COMPLETED|Overall Study||49
9760294|NCT00379808|10863903|FG000|STARTED|Intervention Period 1 (4 Weeks)||11
9760295|NCT00379808|10863904|FG001|STARTED|Intervention Period 1 (4 Weeks)||11
9760296|NCT00379808|10863903|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11
9760297|NCT00379808|10863904|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11
9760298|NCT00379808|10863903|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
9760299|NCT00379808|10863904|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
9760300|NCT00379808|10863903|FG000|STARTED|Intervention Period 2 (4 Weeks)||11
9760301|NCT00379808|10863904|FG001|STARTED|Intervention Period 2 (4 Weeks)||11
9760302|NCT00379808|10863903|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11
9760303|NCT00379808|10863904|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10
9760304|NCT00379808|10863903|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
9760305|NCT00379808|10863904|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
9760306|NCT00379821|10863914|FG000|STARTED|Overall Study||160
9760307|NCT00379821|10863915|FG001|STARTED|Overall Study||160
9760308|NCT00379821|10863916|FG002|STARTED|Overall Study||160
9760309|NCT00379821|10863917|FG003|STARTED|Overall Study||160
9760310|NCT00379821|10863914|FG000|COMPLETED|Overall Study||87
9760311|NCT00379821|10863915|FG001|COMPLETED|Overall Study||71
9760312|NCT00379821|10863916|FG002|COMPLETED|Overall Study||93
9760313|NCT00379821|10863917|FG003|COMPLETED|Overall Study||81
9760314|NCT00379821|10863914|FG000|NOT COMPLETED|Overall Study||73
9760315|NCT00379821|10863915|FG001|NOT COMPLETED|Overall Study||89
9760316|NCT00379821|10863916|FG002|NOT COMPLETED|Overall Study||67
9760317|NCT00379821|10863917|FG003|NOT COMPLETED|Overall Study||79
9760318|NCT00379834|10863934|FG000|STARTED|Overall Study||10
9760319|NCT00379834|10863934|FG000|COMPLETED|Overall Study||8
9760320|NCT00379834|10863934|FG000|NOT COMPLETED|Overall Study||2
9760321|NCT00379899|10863940|FG000|STARTED|Overall Study||180
9760322|NCT00379899|10863941|FG001|STARTED|Overall Study||180
9760323|NCT00379899|10863940|FG000|COMPLETED|Overall Study||140
9760324|NCT00379899|10863941|FG001|COMPLETED|Overall Study||140
9760325|NCT00379899|10863940|FG000|NOT COMPLETED|Overall Study||40
9760326|NCT00379899|10863941|FG001|NOT COMPLETED|Overall Study||40
9760327|NCT00379912|10863949|FG000|STARTED|Overall Study||7
9760328|NCT00379912|10863950|FG001|STARTED|Overall Study||8
9760329|NCT00379912|10863949|FG000|COMPLETED|Overall Study||6
9760330|NCT00379912|10863950|FG001|COMPLETED|Overall Study||8
9760331|NCT00379912|10863949|FG000|NOT COMPLETED|Overall Study||1
9760332|NCT00379912|10863950|FG001|NOT COMPLETED|Overall Study||0
9760333|NCT00380029|10863962|FG000|STARTED|Overall Study||20
9760334|NCT00380029|10863962|FG000|COMPLETED|Overall Study||20
9760335|NCT00380029|10863962|FG000|NOT COMPLETED|Overall Study||0
9760336|NCT00380068|10863970|FG000|STARTED|Overall Study||224
9760337|NCT00380068|10863970|FG000|COMPLETED|Overall Study||155
9760338|NCT00380068|10863970|FG000|NOT COMPLETED|Overall Study||69
9760339|NCT00380081|10863980|FG000|STARTED|Overall Study||14
9760340|NCT00380081|10863981|FG001|STARTED|Overall Study||13
9760341|NCT00380081|10863982|FG002|STARTED|Overall Study||13
9877537|NCT01011868|10992004|FG001|COMPLETED|After Week 18 Follow-up||153
9877538|NCT01011868|10992005|FG002|COMPLETED|After Week 18 Follow-up||129
9877539|NCT01011868|10992003|FG000|NOT COMPLETED|After Week 18 Follow-up||23
9877540|NCT01011868|10992004|FG001|NOT COMPLETED|After Week 18 Follow-up||16
9877541|NCT01011868|10992005|FG002|NOT COMPLETED|After Week 18 Follow-up||26
9877542|NCT01011868|10992003|FG000|STARTED|After Week 78 Follow-up||170
9877543|NCT01011868|10992004|FG001|STARTED|After Week 78 Follow-up||169
9877544|NCT01011868|10992005|FG002|STARTED|After Week 78 Follow-up||155
9877545|NCT01011868|10992003|FG000|COMPLETED|After Week 78 Follow-up||118
9877546|NCT01011868|10992004|FG001|COMPLETED|After Week 78 Follow-up||131
9877547|NCT01011868|10992005|FG002|COMPLETED|After Week 78 Follow-up||111
9877548|NCT01011868|10992003|FG000|NOT COMPLETED|After Week 78 Follow-up||52
9877549|NCT01011868|10992004|FG001|NOT COMPLETED|After Week 78 Follow-up||38
9877550|NCT01011868|10992005|FG002|NOT COMPLETED|After Week 78 Follow-up||44
9877551|NCT01011894|10992013|FG000|STARTED|Overall Study||26
9877552|NCT01011894|10992013|FG000|COMPLETED|Overall Study||26
9877553|NCT01011894|10992013|FG000|NOT COMPLETED|Overall Study||0
9877554|NCT01011907|10992019|FG000|STARTED|Overall Study||31
9877555|NCT01011907|10992020|FG001|STARTED|Overall Study||33
9877556|NCT01011907|10992019|FG000|COMPLETED|Overall Study||17
9877557|NCT01011907|10992020|FG001|COMPLETED|Overall Study||18
9877558|NCT01011907|10992019|FG000|NOT COMPLETED|Overall Study||14
9877559|NCT01011907|10992020|FG001|NOT COMPLETED|Overall Study||15
9877560|NCT01011933|10992026|FG000|STARTED|Overall Study|total enrolled|54
9877561|NCT01011933|10992026|FG000|COMPLETED|Overall Study|total eligible and evaluable|50
9877562|NCT01011933|10992026|FG000|NOT COMPLETED|Overall Study||4
9877563|NCT01011946|10992036|FG000|STARTED|Overall Study||36
9877564|NCT01011946|10992036|FG000|COMPLETED|Overall Study||33
9877565|NCT01011946|10992036|FG000|NOT COMPLETED|Overall Study||3
9877566|NCT01012037|10992043|FG000|STARTED|Overall Study||44
9877567|NCT01012037|10992044|FG001|STARTED|Overall Study||223
9877568|NCT01012037|10992045|FG002|STARTED|Overall Study||224
9877569|NCT01012037|10992043|FG000|COMPLETED|Overall Study||43
9877570|NCT01012037|10992044|FG001|COMPLETED|Overall Study||207
9877571|NCT01012037|10992045|FG002|COMPLETED|Overall Study||214
9877572|NCT01012037|10992043|FG000|NOT COMPLETED|Overall Study||1
9877573|NCT01012037|10992044|FG001|NOT COMPLETED|Overall Study||16
9877574|NCT01012037|10992045|FG002|NOT COMPLETED|Overall Study||10
9760342|NCT00380081|10863983|FG003|STARTED|Overall Study||15
9760343|NCT00380081|10863984|FG004|STARTED|Overall Study||13
9760344|NCT00380081|10863985|FG005|STARTED|Overall Study||14
9760345|NCT00380081|10863980|FG000|COMPLETED|Overall Study||14
9760346|NCT00380081|10863981|FG001|COMPLETED|Overall Study||13
9877575|NCT01012089|10992055|FG000|STARTED|Overall Study||6
9877576|NCT01012089|10992055|FG000|COMPLETED|Overall Study||6
9877577|NCT01012089|10992055|FG000|NOT COMPLETED|Overall Study||0
9877578|NCT01012219|10992061|FG000|STARTED|Period 1|Number randomized|36
9877579|NCT01012219|10992061|FG000|COMPLETED|Period 1||35
9877580|NCT01012219|10992061|FG000|NOT COMPLETED|Period 1||1
9877581|NCT01012219|10992061|FG000|STARTED|Period 2|Number who completed Period 1|35
9877582|NCT01012219|10992061|FG000|COMPLETED|Period 2||34
9877583|NCT01012219|10992061|FG000|NOT COMPLETED|Period 2||1
9877584|NCT01012219|10992061|FG000|STARTED|Period 3|of the 36 who started Period 1|20
9877585|NCT01012219|10992061|FG000|COMPLETED|Period 3||20
9877586|NCT01012219|10992061|FG000|NOT COMPLETED|Period 3||0
9877587|NCT01012245|10992072|FG000|STARTED|Overall Study||28812
9877588|NCT01012245|10992072|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
9877589|NCT01012245|10992072|FG000|NOT COMPLETED|Overall Study||2427
9877590|NCT01012258|10992083|FG000|STARTED|Overall Study||66
9877591|NCT01012258|10992083|FG000|COMPLETED|Overall Study||0
9877592|NCT01012258|10992083|FG000|NOT COMPLETED|Overall Study||66
9877593|NCT01012297|10992090|FG000|STARTED|Overall Study||54
10007591|NCT01751386|11129823|FG001|COMPLETED|Overall Study||16
10007592|NCT01751386|11129822|FG000|NOT COMPLETED|Overall Study||2
10007593|NCT01751386|11129823|FG001|NOT COMPLETED|Overall Study||3
10018970|NCT01826825|11142019|FG001|COMPLETED|Overall Study||98
10107701|NCT02459964|11237973|FG000|STARTED|Overall Study||42
9877594|NCT01012297|10992091|FG001|STARTED|Overall Study||53
9877595|NCT01012297|10992090|FG000|COMPLETED|Overall Study||54
9877596|NCT01012297|10992091|FG001|COMPLETED|Overall Study||53
9877597|NCT01012297|10992090|FG000|NOT COMPLETED|Overall Study||0
9877598|NCT01012297|10992091|FG001|NOT COMPLETED|Overall Study||0
9877599|NCT01012323|10992097|FG000|STARTED|Overall Study||51
9877600|NCT01012323|10992097|FG000|COMPLETED|Overall Study||50
9877601|NCT01012323|10992097|FG000|NOT COMPLETED|Overall Study||1
9877602|NCT01012336|10992101|FG000|STARTED|Overall Study||85
9877603|NCT01012336|10992101|FG000|COMPLETED|Overall Study||85
9877604|NCT01012336|10992101|FG000|NOT COMPLETED|Overall Study||0
9877605|NCT01012362|10992110|FG000|STARTED|Overall Study||9
9877606|NCT01012362|10992111|FG001|STARTED|Overall Study||6
9877607|NCT01012362|10992112|FG002|STARTED|Overall Study||3
9877608|NCT01012362|10992113|FG003|STARTED|Overall Study||4
9877609|NCT01012362|10992114|FG004|STARTED|Overall Study||9
9877610|NCT01012362|10992110|FG000|COMPLETED|Overall Study||9
9877611|NCT01012362|10992111|FG001|COMPLETED|Overall Study||6
9877612|NCT01012362|10992112|FG002|COMPLETED|Overall Study||3
9877613|NCT01012362|10992113|FG003|COMPLETED|Overall Study||4
9877614|NCT01012362|10992114|FG004|COMPLETED|Overall Study||9
9877615|NCT01012362|10992110|FG000|NOT COMPLETED|Overall Study||0
9877616|NCT01012362|10992111|FG001|NOT COMPLETED|Overall Study||0
9877617|NCT01012362|10992112|FG002|NOT COMPLETED|Overall Study||0
9877618|NCT01012362|10992113|FG003|NOT COMPLETED|Overall Study||0
9877619|NCT01012362|10992114|FG004|NOT COMPLETED|Overall Study||0
9877620|NCT01012388|10992130|FG000|STARTED|Overall Study||100
9877621|NCT01012388|10992130|FG000|COMPLETED|Overall Study||100
9877622|NCT01012388|10992130|FG000|NOT COMPLETED|Overall Study||0
9877623|NCT01012440|10992134|FG000|STARTED|Overall Study||5
9877624|NCT01012440|10992134|FG000|COMPLETED|Overall Study||3
9877625|NCT01012440|10992134|FG000|NOT COMPLETED|Overall Study||2
9877626|NCT01012492|10992138|FG000|STARTED|Overall Study||10
9877627|NCT01012492|10992138|FG000|COMPLETED|Overall Study||10
9877628|NCT01012492|10992138|FG000|NOT COMPLETED|Overall Study||0
9877629|NCT01012622|10992142|FG000|STARTED|Overall Study||142
9877630|NCT01012622|10992142|FG000|COMPLETED|Overall Study||111
9877631|NCT01012622|10992142|FG000|NOT COMPLETED|Overall Study||31
9877632|NCT01012661|10992146|FG000|STARTED|Overall Study||50
9877633|NCT01012661|10992146|FG000|COMPLETED|Overall Study||50
9877634|NCT01012661|10992146|FG000|NOT COMPLETED|Overall Study||0
9877635|NCT01012674|10992152|FG000|STARTED|Overall Study||211
9877636|NCT01012674|10992152|FG000|COMPLETED|Overall Study||187
9877637|NCT01012674|10992152|FG000|NOT COMPLETED|Overall Study||24
9877638|NCT01012713|10992160|FG000|STARTED|Overall Study||30
9877639|NCT01012713|10992160|FG000|COMPLETED|Overall Study||27
9877640|NCT01012713|10992160|FG000|NOT COMPLETED|Overall Study||3
9877641|NCT01012739|10992165|FG000|STARTED|Treatment Period 1||9
9877642|NCT01012739|10992166|FG001|STARTED|Treatment Period 1||8
9877643|NCT01012739|10992167|FG002|STARTED|Treatment Period 1||9
9877644|NCT01012739|10992168|FG003|STARTED|Treatment Period 1||9
9877645|NCT01012739|10992165|FG000|COMPLETED|Treatment Period 1||9
9877646|NCT01012739|10992166|FG001|COMPLETED|Treatment Period 1||8
9877647|NCT01012739|10992167|FG002|COMPLETED|Treatment Period 1||9
9877648|NCT01012739|10992168|FG003|COMPLETED|Treatment Period 1||8
9877649|NCT01012739|10992165|FG000|NOT COMPLETED|Treatment Period 1||0
10018971|NCT01826825|11142018|FG000|NOT COMPLETED|Overall Study||0
10018972|NCT01826825|11142019|FG001|NOT COMPLETED|Overall Study||2
9877650|NCT01012739|10992166|FG001|NOT COMPLETED|Treatment Period 1||0
9877651|NCT01012739|10992167|FG002|NOT COMPLETED|Treatment Period 1||0
9877652|NCT01012739|10992168|FG003|NOT COMPLETED|Treatment Period 1||1
9877653|NCT01012739|10992165|FG000|STARTED|Treatment Period 2||9
9877654|NCT01012739|10992166|FG001|STARTED|Treatment Period 2||8
9877655|NCT01012739|10992167|FG002|STARTED|Treatment Period 2||9
9877656|NCT01012739|10992168|FG003|STARTED|Treatment Period 2||8
9877657|NCT01012739|10992165|FG000|COMPLETED|Treatment Period 2||9
9877658|NCT01012739|10992166|FG001|COMPLETED|Treatment Period 2||8
9877659|NCT01012739|10992167|FG002|COMPLETED|Treatment Period 2||9
9877660|NCT01012739|10992168|FG003|COMPLETED|Treatment Period 2||7
9877661|NCT01012739|10992165|FG000|NOT COMPLETED|Treatment Period 2||0
9877662|NCT01012739|10992166|FG001|NOT COMPLETED|Treatment Period 2||0
9877663|NCT01012739|10992167|FG002|NOT COMPLETED|Treatment Period 2||0
9877664|NCT01012739|10992168|FG003|NOT COMPLETED|Treatment Period 2||1
9877665|NCT01012739|10992165|FG000|STARTED|Treatment Period 3||9
9877666|NCT01012739|10992166|FG001|STARTED|Treatment Period 3||8
9877667|NCT01012739|10992167|FG002|STARTED|Treatment Period 3||9
9877668|NCT01012739|10992168|FG003|STARTED|Treatment Period 3||7
9877669|NCT01012739|10992165|FG000|COMPLETED|Treatment Period 3||9
9877670|NCT01012739|10992166|FG001|COMPLETED|Treatment Period 3||8
9877671|NCT01012739|10992167|FG002|COMPLETED|Treatment Period 3||9
9877672|NCT01012739|10992168|FG003|COMPLETED|Treatment Period 3||7
9877673|NCT01012739|10992165|FG000|NOT COMPLETED|Treatment Period 3||0
9877674|NCT01012739|10992166|FG001|NOT COMPLETED|Treatment Period 3||0
9877675|NCT01012739|10992167|FG002|NOT COMPLETED|Treatment Period 3||0
9877676|NCT01012739|10992168|FG003|NOT COMPLETED|Treatment Period 3||0
9877677|NCT01012739|10992165|FG000|STARTED|Treatment Period 4||9
9877678|NCT01012739|10992166|FG001|STARTED|Treatment Period 4||8
10107702|NCT02459964|11237974|FG001|STARTED|Overall Study||40
10107703|NCT02459964|11237975|FG002|STARTED|Overall Study||2
9877679|NCT01012739|10992167|FG002|STARTED|Treatment Period 4||9
9877680|NCT01012739|10992168|FG003|STARTED|Treatment Period 4||7
9877681|NCT01012739|10992165|FG000|COMPLETED|Treatment Period 4||9
9877682|NCT01012739|10992166|FG001|COMPLETED|Treatment Period 4||8
9877683|NCT01012739|10992167|FG002|COMPLETED|Treatment Period 4||9
9877684|NCT01012739|10992168|FG003|COMPLETED|Treatment Period 4||7
9877685|NCT01012739|10992165|FG000|NOT COMPLETED|Treatment Period 4||0
9877686|NCT01012739|10992166|FG001|NOT COMPLETED|Treatment Period 4||0
9877687|NCT01012739|10992167|FG002|NOT COMPLETED|Treatment Period 4||0
9877688|NCT01012739|10992168|FG003|NOT COMPLETED|Treatment Period 4||0
9877689|NCT01012765|10992179|FG000|STARTED|Treatment Period 1||20
9877690|NCT01012765|10992180|FG001|STARTED|Treatment Period 1||21
9877691|NCT01012765|10992181|FG002|STARTED|Treatment Period 1||23
9877692|NCT01012765|10992182|FG003|STARTED|Treatment Period 1||18
9877693|NCT01012765|10992183|FG004|STARTED|Treatment Period 1||22
9877694|NCT01012765|10992184|FG005|STARTED|Treatment Period 1||25
9877695|NCT01012765|10992179|FG000|COMPLETED|Treatment Period 1||17
9877696|NCT01012765|10992180|FG001|COMPLETED|Treatment Period 1||21
9877697|NCT01012765|10992181|FG002|COMPLETED|Treatment Period 1||21
9877698|NCT01012765|10992182|FG003|COMPLETED|Treatment Period 1||15
9877699|NCT01012765|10992183|FG004|COMPLETED|Treatment Period 1||19
9877700|NCT01012765|10992184|FG005|COMPLETED|Treatment Period 1||25
9877701|NCT01012765|10992179|FG000|NOT COMPLETED|Treatment Period 1||3
9877702|NCT01012765|10992180|FG001|NOT COMPLETED|Treatment Period 1||0
9877703|NCT01012765|10992181|FG002|NOT COMPLETED|Treatment Period 1||2
9877704|NCT01012765|10992182|FG003|NOT COMPLETED|Treatment Period 1||3
9877705|NCT01012765|10992183|FG004|NOT COMPLETED|Treatment Period 1||3
9877706|NCT01012765|10992184|FG005|NOT COMPLETED|Treatment Period 1||0
9877707|NCT01012765|10992179|FG000|STARTED|Treatment Period 2||17
9877708|NCT01012765|10992180|FG001|STARTED|Treatment Period 2||21
9877709|NCT01012765|10992181|FG002|STARTED|Treatment Period 2||21
9877710|NCT01012765|10992182|FG003|STARTED|Treatment Period 2||15
9877711|NCT01012765|10992183|FG004|STARTED|Treatment Period 2||19
9877712|NCT01012765|10992184|FG005|STARTED|Treatment Period 2||25
9877713|NCT01012765|10992179|FG000|COMPLETED|Treatment Period 2||16
9877714|NCT01012765|10992180|FG001|COMPLETED|Treatment Period 2||19
9877715|NCT01012765|10992181|FG002|COMPLETED|Treatment Period 2||18
9877716|NCT01012765|10992182|FG003|COMPLETED|Treatment Period 2||15
9877717|NCT01012765|10992183|FG004|COMPLETED|Treatment Period 2||18
9877718|NCT01012765|10992184|FG005|COMPLETED|Treatment Period 2||24
9877719|NCT01012765|10992179|FG000|NOT COMPLETED|Treatment Period 2||1
9877720|NCT01012765|10992180|FG001|NOT COMPLETED|Treatment Period 2||2
9877721|NCT01012765|10992181|FG002|NOT COMPLETED|Treatment Period 2||3
9877722|NCT01012765|10992182|FG003|NOT COMPLETED|Treatment Period 2||0
9877723|NCT01012765|10992183|FG004|NOT COMPLETED|Treatment Period 2||1
9877724|NCT01012765|10992184|FG005|NOT COMPLETED|Treatment Period 2||1
9877725|NCT01012765|10992179|FG000|STARTED|Treatment Period 3||16
9877726|NCT01012765|10992180|FG001|STARTED|Treatment Period 3||19
9877727|NCT01012765|10992181|FG002|STARTED|Treatment Period 3||18
9877728|NCT01012765|10992182|FG003|STARTED|Treatment Period 3||15
9877729|NCT01012765|10992183|FG004|STARTED|Treatment Period 3||18
9877730|NCT01012765|10992184|FG005|STARTED|Treatment Period 3||24
9877731|NCT01012765|10992179|FG000|COMPLETED|Treatment Period 3||16
9877732|NCT01012765|10992180|FG001|COMPLETED|Treatment Period 3||19
9877733|NCT01012765|10992181|FG002|COMPLETED|Treatment Period 3||18
9877734|NCT01012765|10992182|FG003|COMPLETED|Treatment Period 3||15
9877735|NCT01012765|10992183|FG004|COMPLETED|Treatment Period 3||18
9877736|NCT01012765|10992184|FG005|COMPLETED|Treatment Period 3||24
9877737|NCT01012765|10992179|FG000|NOT COMPLETED|Treatment Period 3||0
9877738|NCT01012765|10992180|FG001|NOT COMPLETED|Treatment Period 3||0
9877739|NCT01012765|10992181|FG002|NOT COMPLETED|Treatment Period 3||0
9877740|NCT01012765|10992182|FG003|NOT COMPLETED|Treatment Period 3||0
9877741|NCT01012765|10992183|FG004|NOT COMPLETED|Treatment Period 3||0
10107704|NCT02459964|11237973|FG000|COMPLETED|Overall Study||42
10107705|NCT02459964|11237974|FG001|COMPLETED|Overall Study||40
9877742|NCT01012765|10992184|FG005|NOT COMPLETED|Treatment Period 3||0
9877743|NCT01012921|10992194|FG000|STARTED|Overall Study||57
9877744|NCT01012921|10992195|FG001|STARTED|Overall Study||60
9877745|NCT01012921|10992194|FG000|COMPLETED|Overall Study||47
9877746|NCT01012921|10992195|FG001|COMPLETED|Overall Study||47
9877747|NCT01012921|10992194|FG000|NOT COMPLETED|Overall Study||10
9877748|NCT01012921|10992195|FG001|NOT COMPLETED|Overall Study||13
9877749|NCT01012947|10992206|FG000|STARTED|Overall Study||212
9877750|NCT01012947|10992207|FG001|STARTED|Overall Study||215
9877751|NCT01012947|10992208|FG002|STARTED|Overall Study||241
9877752|NCT01012947|10992209|FG003|STARTED|Overall Study||211
9877753|NCT01012947|10992210|FG004|STARTED|Overall Study||236
9877754|NCT01012947|10992206|FG000|COMPLETED|Overall Study||81
9877755|NCT01012947|10992207|FG001|COMPLETED|Overall Study||80
9877756|NCT01012947|10992208|FG002|COMPLETED|Overall Study||111
9877757|NCT01012947|10992209|FG003|COMPLETED|Overall Study||93
9877758|NCT01012947|10992210|FG004|COMPLETED|Overall Study||94
9877759|NCT01012947|10992206|FG000|NOT COMPLETED|Overall Study||131
9877760|NCT01012947|10992207|FG001|NOT COMPLETED|Overall Study||135
9877761|NCT01012947|10992208|FG002|NOT COMPLETED|Overall Study||130
9877762|NCT01012947|10992209|FG003|NOT COMPLETED|Overall Study||118
9877763|NCT01012947|10992210|FG004|NOT COMPLETED|Overall Study||142
9877764|NCT01012973|10992224|FG000|STARTED|Overall Study||106
9877765|NCT01012973|10992225|FG001|STARTED|Overall Study||71
9877766|NCT01012973|10992224|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
9877767|NCT01012973|10992225|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
9877768|NCT01012973|10992224|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
9877769|NCT01012973|10992225|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
9877770|NCT01012973|10992224|FG000|Completed Week 24, From FAS|Overall Study||97
9877771|NCT01012973|10992225|FG001|Completed Week 24, From FAS|Overall Study||57
9877772|NCT01012973|10992224|FG000|Completed Week 52, From FAS|Overall Study||91
9877773|NCT01012973|10992225|FG001|Completed Week 52, From FAS|Overall Study||52
9877774|NCT01012973|10992224|FG000|COMPLETED|Overall Study||90
9877775|NCT01012973|10992225|FG001|COMPLETED|Overall Study||52
9877776|NCT01012973|10992224|FG000|NOT COMPLETED|Overall Study||16
9877777|NCT01012973|10992225|FG001|NOT COMPLETED|Overall Study||19
9877778|NCT01012999|10992235|FG000|STARTED|Overall Study||16
9877779|NCT01012999|10992235|FG000|COMPLETED|Overall Study||15
9877780|NCT01012999|10992235|FG000|NOT COMPLETED|Overall Study||1
9877781|NCT01013194|10992241|FG000|STARTED|Overall Study||9
9877782|NCT01013194|10992242|FG001|STARTED|Overall Study||16
9877783|NCT01013194|10992241|FG000|COMPLETED|Overall Study|Consecutive patients|9
9877784|NCT01013194|10992242|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
9877785|NCT01013194|10992241|FG000|NOT COMPLETED|Overall Study||0
9877786|NCT01013194|10992242|FG001|NOT COMPLETED|Overall Study||0
9877787|NCT01013207|10992252|FG000|STARTED|CPAP Pre Nexus (S9)||50
9877788|NCT01013207|10992252|FG000|COMPLETED|CPAP Pre Nexus (S9)||50
9877789|NCT01013207|10992252|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0
9877790|NCT01013207|10992252|FG000|STARTED|Nexus (S9)||50
9877791|NCT01013207|10992252|FG000|COMPLETED|Nexus (S9)||50
9877792|NCT01013207|10992252|FG000|NOT COMPLETED|Nexus (S9)||0
9877793|NCT01013207|10992252|FG000|STARTED|CPAP Post Nexus (S9)||50
9877794|NCT01013207|10992252|FG000|COMPLETED|CPAP Post Nexus (S9)||44
9877795|NCT01013207|10992252|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6
9877796|NCT01013285|10992258|FG000|STARTED|Overall Study||70
9877797|NCT01013285|10992259|FG001|STARTED|Overall Study||110
9877798|NCT01013285|10992258|FG000|COMPLETED|Overall Study||22
9877799|NCT01013285|10992259|FG001|COMPLETED|Overall Study||21
9877800|NCT01013285|10992258|FG000|NOT COMPLETED|Overall Study||48
9877801|NCT01013285|10992259|FG001|NOT COMPLETED|Overall Study||89
9877802|NCT01013350|10992266|FG000|STARTED|Overall Study||198
9877803|NCT01013350|10992267|FG001|STARTED|Overall Study||963
9877804|NCT01013350|10992266|FG000|Safety Analysis Set|Overall Study||198
9877805|NCT01013350|10992267|FG001|Safety Analysis Set|Overall Study||950
9877806|NCT01013350|10992266|FG000|COMPLETED|Overall Study||160
9877807|NCT01013350|10992267|FG001|COMPLETED|Overall Study||771
9877808|NCT01013350|10992266|FG000|NOT COMPLETED|Overall Study||38
9877809|NCT01013350|10992267|FG001|NOT COMPLETED|Overall Study||192
9877810|NCT01013597|10992274|FG000|STARTED|Overall Study||13
9877811|NCT01013597|10992274|FG000|COMPLETED|Overall Study||12
9877812|NCT01013597|10992274|FG000|NOT COMPLETED|Overall Study||1
9877813|NCT01013740|10992280|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
9877814|NCT01013740|10992281|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
9877815|NCT01013740|10992280|FG000|Ongoing|Overall Study||0
9877816|NCT01013740|10992281|FG001|Ongoing|Overall Study||0
9877817|NCT01013740|10992280|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
9877818|NCT01013740|10992281|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
9877819|NCT01013740|10992280|FG000|NOT COMPLETED|Overall Study||11
9877820|NCT01013740|10992281|FG001|NOT COMPLETED|Overall Study||19
9877821|NCT01013753|10992289|FG000|STARTED|Overall Study|Entered and treated|198
9877822|NCT01013753|10992289|FG000|Received Placebo|Overall Study||125
9877823|NCT01013753|10992289|FG000|Received Olo 2 mcg qd|Overall Study||121
9877824|NCT01013753|10992289|FG000|Received Olo 5 mcg qd|Overall Study||130
9877825|NCT01013753|10992289|FG000|Received Olo 10 mcg qd|Overall Study||127
9877826|NCT01013753|10992289|FG000|Received Olo 20 mcg qd|Overall Study||124
9877827|NCT01013753|10992289|FG000|Received Form 12 mcg Bid|Overall Study||125
9877828|NCT01013753|10992289|FG000|COMPLETED|Overall Study||182
9877829|NCT01013753|10992289|FG000|NOT COMPLETED|Overall Study||16
9877830|NCT01013792|10992305|FG000|STARTED|Overall Study||14
9877831|NCT01013792|10992306|FG001|STARTED|Overall Study||16
9877832|NCT01013792|10992305|FG000|COMPLETED|Overall Study||12
9877833|NCT01013792|10992306|FG001|COMPLETED|Overall Study||11
9877834|NCT01013792|10992305|FG000|NOT COMPLETED|Overall Study||2
9877835|NCT01013792|10992306|FG001|NOT COMPLETED|Overall Study||5
9877836|NCT01013844|10992314|FG000|STARTED|Overall Study||65
9877837|NCT01013844|10992315|FG001|STARTED|Overall Study||65
9877838|NCT01013844|10992314|FG000|COMPLETED|Overall Study||65
9877839|NCT01013844|10992315|FG001|COMPLETED|Overall Study||65
9877840|NCT01013844|10992314|FG000|NOT COMPLETED|Overall Study||0
9877841|NCT01013844|10992315|FG001|NOT COMPLETED|Overall Study||0
9877842|NCT01013870|10992327|FG000|STARTED|Overall Study||28
9877843|NCT01013870|10992328|FG001|STARTED|Overall Study||24
9877844|NCT01013870|10992327|FG000|COMPLETED|Overall Study||27
9877845|NCT01013870|10992328|FG001|COMPLETED|Overall Study||21
9877846|NCT01013870|10992327|FG000|NOT COMPLETED|Overall Study||1
9877847|NCT01013870|10992328|FG001|NOT COMPLETED|Overall Study||3
9877848|NCT01013883|10992336|FG000|STARTED|Overall Study||270
9877849|NCT01013883|10992337|FG001|STARTED|Overall Study||243
9877850|NCT01013883|10992336|FG000|COMPLETED|Overall Study||268
9877851|NCT01013883|10992337|FG001|COMPLETED|Overall Study||241
9877852|NCT01013883|10992336|FG000|NOT COMPLETED|Overall Study||2
9877853|NCT01013883|10992337|FG001|NOT COMPLETED|Overall Study||2
9877854|NCT01013961|10992345|FG000|STARTED|Overall Study||16
9877855|NCT01013961|10992346|FG001|STARTED|Overall Study||15
9877856|NCT01013961|10992345|FG000|COMPLETED|Overall Study||13
9877857|NCT01013961|10992346|FG001|COMPLETED|Overall Study||12
9877858|NCT01013961|10992345|FG000|NOT COMPLETED|Overall Study||3
9877859|NCT01013961|10992346|FG001|NOT COMPLETED|Overall Study||3
9877860|NCT01014013|10992354|FG000|STARTED|Overall Study||135
9877861|NCT01014013|10992355|FG001|STARTED|Overall Study||136
9877862|NCT01014013|10992354|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
9877863|NCT01014013|10992355|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
9877864|NCT01014013|10992354|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
9877865|NCT01014013|10992355|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
9877866|NCT01014013|10992354|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
9877867|NCT01014013|10992355|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
9877868|NCT01014013|10992354|FG000|NOT COMPLETED|Overall Study||51
9877869|NCT01014013|10992355|FG001|NOT COMPLETED|Overall Study||56
9877870|NCT01014091|10992369|FG000|STARTED|Overall Study||7
9877871|NCT01014091|10992370|FG001|STARTED|Overall Study||13
9877872|NCT01014091|10992371|FG002|STARTED|Overall Study||5
9877873|NCT01014091|10992372|FG003|STARTED|Overall Study||15
9877874|NCT01014091|10992373|FG004|STARTED|Overall Study||6
9877875|NCT01014091|10992374|FG005|STARTED|Overall Study||12
9877876|NCT01014091|10992369|FG000|COMPLETED|Overall Study||7
9877877|NCT01014091|10992370|FG001|COMPLETED|Overall Study||13
9877878|NCT01014091|10992371|FG002|COMPLETED|Overall Study||5
9877879|NCT01014091|10992372|FG003|COMPLETED|Overall Study||15
9877880|NCT01014091|10992373|FG004|COMPLETED|Overall Study||6
9877881|NCT01014091|10992374|FG005|COMPLETED|Overall Study||12
9877882|NCT01014091|10992369|FG000|NOT COMPLETED|Overall Study||0
9877883|NCT01014091|10992370|FG001|NOT COMPLETED|Overall Study||0
9877884|NCT01014091|10992371|FG002|NOT COMPLETED|Overall Study||0
9877885|NCT01014091|10992372|FG003|NOT COMPLETED|Overall Study||0
9877886|NCT01014091|10992373|FG004|NOT COMPLETED|Overall Study||0
9877887|NCT01014091|10992374|FG005|NOT COMPLETED|Overall Study||0
9877888|NCT01014143|10992400|FG000|STARTED|First Intervention||10
9877889|NCT01014143|10992401|FG001|STARTED|First Intervention||9
9877890|NCT01014143|10992402|FG002|STARTED|First Intervention||9
9877891|NCT01014143|10992400|FG000|COMPLETED|First Intervention||10
9877892|NCT01014143|10992401|FG001|COMPLETED|First Intervention||9
9877893|NCT01014143|10992402|FG002|COMPLETED|First Intervention||9
9877894|NCT01014143|10992400|FG000|NOT COMPLETED|First Intervention||0
9877895|NCT01014143|10992401|FG001|NOT COMPLETED|First Intervention||0
9877896|NCT01014143|10992402|FG002|NOT COMPLETED|First Intervention||0
9877897|NCT01014143|10992400|FG000|STARTED|Washout Period After 1st Intervention||10
9877898|NCT01014143|10992401|FG001|STARTED|Washout Period After 1st Intervention||9
9877899|NCT01014143|10992402|FG002|STARTED|Washout Period After 1st Intervention||9
9877900|NCT01014143|10992400|FG000|COMPLETED|Washout Period After 1st Intervention||10
9877901|NCT01014143|10992401|FG001|COMPLETED|Washout Period After 1st Intervention||9
9877902|NCT01014143|10992402|FG002|COMPLETED|Washout Period After 1st Intervention||9
9877903|NCT01014143|10992400|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0
9877904|NCT01014143|10992401|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0
9877905|NCT01014143|10992402|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0
9877906|NCT01014143|10992400|FG000|STARTED|Second Intervention||10
9877907|NCT01014143|10992401|FG001|STARTED|Second Intervention||9
9877908|NCT01014143|10992402|FG002|STARTED|Second Intervention||9
9877909|NCT01014143|10992400|FG000|COMPLETED|Second Intervention||8
9877910|NCT01014143|10992401|FG001|COMPLETED|Second Intervention||9
9877911|NCT01014143|10992402|FG002|COMPLETED|Second Intervention||9
9877912|NCT01014143|10992400|FG000|NOT COMPLETED|Second Intervention||2
9877913|NCT01014143|10992401|FG001|NOT COMPLETED|Second Intervention||0
9877914|NCT01014143|10992402|FG002|NOT COMPLETED|Second Intervention||0
9877915|NCT01014143|10992400|FG000|STARTED|Washout After 2nd Intervention||8
9877916|NCT01014143|10992401|FG001|STARTED|Washout After 2nd Intervention||9
9877917|NCT01014143|10992402|FG002|STARTED|Washout After 2nd Intervention||9
9877918|NCT01014143|10992400|FG000|COMPLETED|Washout After 2nd Intervention||8
9877919|NCT01014143|10992401|FG001|COMPLETED|Washout After 2nd Intervention||9
9877920|NCT01014143|10992402|FG002|COMPLETED|Washout After 2nd Intervention||9
9877921|NCT01014143|10992400|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
9877922|NCT01014143|10992401|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
9877923|NCT01014143|10992402|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
9877924|NCT01014143|10992400|FG000|STARTED|Third Intervention||8
9877925|NCT01014143|10992401|FG001|STARTED|Third Intervention||9
9877926|NCT01014143|10992402|FG002|STARTED|Third Intervention||9
9877927|NCT01014143|10992400|FG000|COMPLETED|Third Intervention||8
9877928|NCT01014143|10992401|FG001|COMPLETED|Third Intervention||9
9877929|NCT01014143|10992402|FG002|COMPLETED|Third Intervention||9
9877930|NCT01014143|10992400|FG000|NOT COMPLETED|Third Intervention||0
9877931|NCT01014143|10992401|FG001|NOT COMPLETED|Third Intervention||0
9877932|NCT01014143|10992402|FG002|NOT COMPLETED|Third Intervention||0
9877933|NCT01014169|10992412|FG000|STARTED|Overall Study||65
9877934|NCT01014169|10992413|FG001|STARTED|Overall Study||61
9877935|NCT01014169|10992412|FG000|COMPLETED|Overall Study||58
9877936|NCT01014169|10992413|FG001|COMPLETED|Overall Study||48
9877937|NCT01014169|10992412|FG000|NOT COMPLETED|Overall Study||7
9877938|NCT01014169|10992413|FG001|NOT COMPLETED|Overall Study||13
9877939|NCT01014208|10992421|FG000|STARTED|Overall Study||225
9877940|NCT01014208|10992422|FG001|STARTED|Overall Study||222
9877941|NCT01014208|10992421|FG000|Intent-to-Treat Population|Overall Study||223
9877942|NCT01014208|10992422|FG001|Intent-to-Treat Population|Overall Study||222
9877943|NCT01014208|10992421|FG000|COMPLETED|Overall Study||131
9877944|NCT01014208|10992422|FG001|COMPLETED|Overall Study||122
9877945|NCT01014208|10992421|FG000|NOT COMPLETED|Overall Study||94
9877946|NCT01014208|10992422|FG001|NOT COMPLETED|Overall Study||100
9877947|NCT01014351|10992428|FG000|STARTED|Overall Study||70
9877948|NCT01014351|10992428|FG000|COMPLETED|Overall Study||33
9877949|NCT01014351|10992428|FG000|NOT COMPLETED|Overall Study||37
9877950|NCT01014390|10992432|FG000|STARTED|Overall Study||187
9877951|NCT01014390|10992432|FG000|COMPLETED|Overall Study||177
9877952|NCT01014390|10992432|FG000|NOT COMPLETED|Overall Study||10
9877953|NCT01014403|10992438|FG000|STARTED|Overall Study||34
9877954|NCT01014403|10992439|FG001|STARTED|Overall Study||28
9877955|NCT01014403|10992438|FG000|COMPLETED|Overall Study||34
9877956|NCT01014403|10992439|FG001|COMPLETED|Overall Study||28
9877957|NCT01014403|10992438|FG000|NOT COMPLETED|Overall Study||0
9877958|NCT01014403|10992439|FG001|NOT COMPLETED|Overall Study||0
9877959|NCT01014442|10992447|FG000|STARTED|Overall Study||33
9877960|NCT01014442|10992448|FG001|STARTED|Overall Study||35
9877961|NCT01014442|10992447|FG000|COMPLETED|Overall Study||26
9877962|NCT01014442|10992448|FG001|COMPLETED|Overall Study||16
9877963|NCT01014442|10992447|FG000|NOT COMPLETED|Overall Study||7
9877964|NCT01014442|10992448|FG001|NOT COMPLETED|Overall Study||19
9877965|NCT01014455|10992460|FG000|STARTED|Overall Study||82
9877966|NCT01014455|10992461|FG001|STARTED|Overall Study||87
9877967|NCT01014455|10992460|FG000|COMPLETED|Overall Study||82
9877968|NCT01014455|10992461|FG001|COMPLETED|Overall Study||87
9877969|NCT01014455|10992460|FG000|NOT COMPLETED|Overall Study||0
9877970|NCT01014455|10992461|FG001|NOT COMPLETED|Overall Study||0
9877971|NCT01014533|10992469|FG000|STARTED|Overall Study||29
9877972|NCT01014533|10992470|FG001|STARTED|Overall Study||30
9877973|NCT01014533|10992469|FG000|COMPLETED|Overall Study||24
9877974|NCT01014533|10992470|FG001|COMPLETED|Overall Study||25
9877975|NCT01014533|10992469|FG000|NOT COMPLETED|Overall Study||5
9877976|NCT01014533|10992470|FG001|NOT COMPLETED|Overall Study||5
9877977|NCT01014585|10992481|FG000|STARTED|Overall Study||51
9877978|NCT01014585|10992482|FG001|STARTED|Overall Study||100
9877979|NCT01014585|10992483|FG002|STARTED|Overall Study||60
9877980|NCT01014585|10992484|FG003|STARTED|Overall Study||129
9877981|NCT01014585|10992481|FG000|COMPLETED|Overall Study||31
9877982|NCT01014585|10992482|FG001|COMPLETED|Overall Study||75
9877983|NCT01014585|10992483|FG002|COMPLETED|Overall Study||37
9877984|NCT01014585|10992484|FG003|COMPLETED|Overall Study||99
9877985|NCT01014585|10992481|FG000|NOT COMPLETED|Overall Study||20
9877986|NCT01014585|10992482|FG001|NOT COMPLETED|Overall Study||25
9877987|NCT01014585|10992483|FG002|NOT COMPLETED|Overall Study||23
9877988|NCT01014585|10992484|FG003|NOT COMPLETED|Overall Study||30
9877989|NCT01014624|10992496|FG000|STARTED|Overall Study||29
9877990|NCT01014624|10992497|FG001|STARTED|Overall Study||27
9877991|NCT01014624|10992496|FG000|COMPLETED|Overall Study||27
9877992|NCT01014624|10992497|FG001|COMPLETED|Overall Study||26
9877993|NCT01014624|10992496|FG000|NOT COMPLETED|Overall Study||2
9877994|NCT01014624|10992497|FG001|NOT COMPLETED|Overall Study||1
9877995|NCT01014689|10992507|FG000|STARTED|Overall Study||191
9877996|NCT01014689|10992508|FG001|STARTED|Overall Study||187
9877997|NCT01014689|10992507|FG000|COMPLETED|Overall Study||178
9877998|NCT01014689|10992508|FG001|COMPLETED|Overall Study||174
9877999|NCT01014689|10992507|FG000|NOT COMPLETED|Overall Study||13
9878000|NCT01014689|10992508|FG001|NOT COMPLETED|Overall Study||13
9878001|NCT01014728|10992516|FG000|STARTED|Overall Study||18
9878002|NCT01014728|10992517|FG001|STARTED|Overall Study||15
9878003|NCT01014728|10992516|FG000|COMPLETED|Overall Study||18
9878004|NCT01014728|10992517|FG001|COMPLETED|Overall Study||15
9878005|NCT01014728|10992516|FG000|NOT COMPLETED|Overall Study||0
9878006|NCT01014728|10992517|FG001|NOT COMPLETED|Overall Study||0
9878007|NCT01014741|10992525|FG000|STARTED|Overall Study||105
9878008|NCT01014741|10992526|FG001|STARTED|Overall Study||95
9878009|NCT01014741|10992525|FG000|COMPLETED|Overall Study||94
9878010|NCT01014741|10992526|FG001|COMPLETED|Overall Study||90
9878011|NCT01014741|10992525|FG000|NOT COMPLETED|Overall Study||11
9878012|NCT01014741|10992526|FG001|NOT COMPLETED|Overall Study||5
9878013|NCT01014871|10992532|FG000|STARTED|Overall Study||30
9878014|NCT01014871|10992532|FG000|COMPLETED|Overall Study||30
9878015|NCT01014871|10992532|FG000|NOT COMPLETED|Overall Study||0
9953948|NCT01428713|11072601|FG001|COMPLETED|Overall Study||3
9953949|NCT01428713|11072600|FG000|NOT COMPLETED|Overall Study||3
9953950|NCT01428713|11072601|FG001|NOT COMPLETED|Overall Study||5
9953951|NCT01428765|11072607|FG000|STARTED|Overall Study||1063
9953952|NCT01428765|11072607|FG000|COMPLETED|Overall Study||1063
9953953|NCT01428765|11072607|FG000|NOT COMPLETED|Overall Study||0
9953954|NCT01428882|11072613|FG000|STARTED|Overall Study||67
9953955|NCT01428882|11072614|FG001|STARTED|Overall Study||68
9953956|NCT01428882|11072613|FG000|COMPLETED|Overall Study||61
9953957|NCT01428882|11072614|FG001|COMPLETED|Overall Study||58
9953958|NCT01428882|11072613|FG000|NOT COMPLETED|Overall Study||6
10007594|NCT01751399|11129833|FG000|STARTED|Overall Study||12
10007595|NCT01751399|11129834|FG001|STARTED|Overall Study||8
10007596|NCT01751399|11129835|FG002|STARTED|Overall Study||8
10007597|NCT01751399|11129836|FG003|STARTED|Overall Study||7
10007598|NCT01751399|11129833|FG000|Received 1 Dose of Study Drug|Overall Study||12
10007599|NCT01751399|11129834|FG001|Received 1 Dose of Study Drug|Overall Study||8
9760347|NCT00380081|10863982|FG002|COMPLETED|Overall Study||13
9760348|NCT00380081|10863983|FG003|COMPLETED|Overall Study||15
9760349|NCT00380081|10863984|FG004|COMPLETED|Overall Study||12
9760350|NCT00380081|10863985|FG005|COMPLETED|Overall Study||13
9760351|NCT00380081|10863980|FG000|NOT COMPLETED|Overall Study||0
9760352|NCT00380081|10863981|FG001|NOT COMPLETED|Overall Study||0
9760353|NCT00380081|10863982|FG002|NOT COMPLETED|Overall Study||0
9760354|NCT00380081|10863983|FG003|NOT COMPLETED|Overall Study||0
9760355|NCT00380081|10863984|FG004|NOT COMPLETED|Overall Study||1
9760356|NCT00380081|10863985|FG005|NOT COMPLETED|Overall Study||1
10007600|NCT01751399|11129835|FG002|Received 1 Dose of Study Drug|Overall Study||8
10018973|NCT01826851|11142029|FG000|STARTED|Overall Study||38
10202729|NCT03449433|11329853|FG001|NOT COMPLETED|Period 3||1
10202730|NCT03449433|11329854|FG002|NOT COMPLETED|Period 3||0
10202731|NCT03449433|11329855|FG003|NOT COMPLETED|Period 3||0
10202732|NCT03449433|11329856|FG004|NOT COMPLETED|Period 3||0
10202733|NCT03449433|11329852|FG000|STARTED|Period 4||17
10202734|NCT03449433|11329853|FG001|STARTED|Period 4||15
10202735|NCT03449433|11329854|FG002|STARTED|Period 4||18
10202736|NCT03449433|11329855|FG003|STARTED|Period 4||17
10202737|NCT03449433|11329856|FG004|STARTED|Period 4||12
10202738|NCT03449433|11329852|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
10202739|NCT03449433|11329853|FG001|Received at Least 1 Dose of Study Drug|Period 4||15
10202740|NCT03449433|11329854|FG002|Received at Least 1 Dose of Study Drug|Period 4||18
10202741|NCT03449433|11329855|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
9953959|NCT01428882|11072614|FG001|NOT COMPLETED|Overall Study||10
9953960|NCT01429051|11072620|FG000|STARTED|Titration Phase||45
9953961|NCT01429051|11072620|FG000|COMPLETED|Titration Phase||33
9953962|NCT01429051|11072620|FG000|NOT COMPLETED|Titration Phase||12
9953963|NCT01429051|11072620|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
9953964|NCT01429051|11072620|FG000|COMPLETED|Efficacy Phase||13
9953965|NCT01429051|11072620|FG000|NOT COMPLETED|Efficacy Phase||2
9953966|NCT01429051|11072620|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
9953967|NCT01429051|11072620|FG000|COMPLETED|Tolerability Phase||16
9953968|NCT01429051|11072620|FG000|NOT COMPLETED|Tolerability Phase||15
9953969|NCT01429064|11072635|FG000|STARTED|Overall Study||19
9953970|NCT01429064|11072636|FG001|STARTED|Overall Study||22
9953971|NCT01429064|11072637|FG002|STARTED|Overall Study||19
9953972|NCT01429064|11072638|FG003|STARTED|Overall Study||16
9953973|NCT01429064|11072635|FG000|COMPLETED|Overall Study||19
9953974|NCT01429064|11072636|FG001|COMPLETED|Overall Study||22
10202742|NCT03449433|11329856|FG004|Received at Least 1 Dose of Study Drug|Period 4||0
9953975|NCT01429064|11072637|FG002|COMPLETED|Overall Study||19
9953976|NCT01429064|11072638|FG003|COMPLETED|Overall Study||16
9953977|NCT01429064|11072635|FG000|NOT COMPLETED|Overall Study||0
9953978|NCT01429064|11072636|FG001|NOT COMPLETED|Overall Study||0
9953979|NCT01429064|11072637|FG002|NOT COMPLETED|Overall Study||0
9953980|NCT01429064|11072638|FG003|NOT COMPLETED|Overall Study||0
9953981|NCT01429077|11072650|FG000|STARTED|Overall Study||19
9953982|NCT01429077|11072651|FG001|STARTED|Overall Study||17
9953983|NCT01429077|11072650|FG000|Completed 6-week Intervention|Overall Study||19
10202743|NCT03449433|11329852|FG000|COMPLETED|Period 4||17
10202744|NCT03449433|11329853|FG001|COMPLETED|Period 4||15
10202745|NCT03449433|11329854|FG002|COMPLETED|Period 4||18
9760357|NCT00380250|10863995|FG000|STARTED|Overall Study||396
9760358|NCT00380250|10863996|FG001|STARTED|Overall Study||194
9878016|NCT01014910|10992540|FG000|STARTED|Overall Study||80
9878017|NCT01014910|10992541|FG001|STARTED|Overall Study||81
9878018|NCT01014910|10992540|FG000|COMPLETED|Overall Study||80
9878019|NCT01014910|10992541|FG001|COMPLETED|Overall Study||79
9878020|NCT01014910|10992540|FG000|NOT COMPLETED|Overall Study||0
9878021|NCT01014910|10992541|FG001|NOT COMPLETED|Overall Study||2
9878022|NCT01014936|10992550|FG000|STARTED|Overall Study||42
9878023|NCT01014936|10992551|FG001|STARTED|Overall Study||45
9878024|NCT01014936|10992552|FG002|STARTED|Overall Study||62
9878025|NCT01014936|10992550|FG000|COMPLETED|Overall Study||42
9878026|NCT01014936|10992551|FG001|COMPLETED|Overall Study||45
9878027|NCT01014936|10992552|FG002|COMPLETED|Overall Study||62
9878028|NCT01014936|10992550|FG000|NOT COMPLETED|Overall Study||0
9878029|NCT01014936|10992551|FG001|NOT COMPLETED|Overall Study||0
9878030|NCT01014936|10992552|FG002|NOT COMPLETED|Overall Study||0
9878031|NCT01014975|10992618|FG000|STARTED|Overall Study||8
9878032|NCT01014975|10992619|FG001|STARTED|Overall Study||16
9878033|NCT01014975|10992620|FG002|STARTED|Overall Study||16
9878034|NCT01014975|10992618|FG000|COMPLETED|Overall Study||4
9878035|NCT01014975|10992619|FG001|COMPLETED|Overall Study||13
9878036|NCT01014975|10992620|FG002|COMPLETED|Overall Study||10
9878037|NCT01014975|10992618|FG000|NOT COMPLETED|Overall Study||4
9878038|NCT01014975|10992619|FG001|NOT COMPLETED|Overall Study||3
9878039|NCT01014975|10992620|FG002|NOT COMPLETED|Overall Study||6
10202746|NCT03449433|11329855|FG003|COMPLETED|Period 4||17
10202747|NCT03449433|11329856|FG004|COMPLETED|Period 4||12
10202748|NCT03449433|11329852|FG000|NOT COMPLETED|Period 4||0
10202749|NCT03449433|11329853|FG001|NOT COMPLETED|Period 4||0
9878040|NCT01014988|10992634|FG000|STARTED|Overall Study||130
9878041|NCT01014988|10992635|FG001|STARTED|Overall Study||7
9878042|NCT01014988|10992636|FG002|STARTED|Overall Study||11
9878043|NCT01014988|10992637|FG003|STARTED|Overall Study||12
9878044|NCT01014988|10992638|FG004|STARTED|Overall Study||27
9878045|NCT01014988|10992639|FG005|STARTED|Overall Study||14
9878046|NCT01014988|10992634|FG000|COMPLETED|Overall Study||107
9878047|NCT01014988|10992635|FG001|COMPLETED|Overall Study||7
9878048|NCT01014988|10992636|FG002|COMPLETED|Overall Study||9
9878049|NCT01014988|10992637|FG003|COMPLETED|Overall Study||12
9878050|NCT01014988|10992638|FG004|COMPLETED|Overall Study||26
9878051|NCT01014988|10992639|FG005|COMPLETED|Overall Study||11
9878052|NCT01014988|10992634|FG000|NOT COMPLETED|Overall Study||23
9878053|NCT01014988|10992635|FG001|NOT COMPLETED|Overall Study||0
9878054|NCT01014988|10992636|FG002|NOT COMPLETED|Overall Study||2
9878055|NCT01014988|10992637|FG003|NOT COMPLETED|Overall Study||0
9878056|NCT01014988|10992638|FG004|NOT COMPLETED|Overall Study||1
9878057|NCT01014988|10992639|FG005|NOT COMPLETED|Overall Study||3
9878058|NCT01015118|10992663|FG000|STARTED|Overall Study||911
9878059|NCT01015118|10992664|FG001|STARTED|Overall Study||455
9878060|NCT01015118|10992663|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
9878061|NCT01015118|10992664|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
9878062|NCT01015118|10992663|FG000|NOT COMPLETED|Overall Study||669
9878063|NCT01015118|10992664|FG001|NOT COMPLETED|Overall Study||327
9878064|NCT01015131|10992670|FG000|STARTED|Overall Study||44
9878065|NCT01015131|10992670|FG000|COMPLETED|Overall Study||36
9878066|NCT01015131|10992670|FG000|NOT COMPLETED|Overall Study||8
9878067|NCT01015170|10992674|FG000|STARTED|Overall Study||454
9878068|NCT01015170|10992674|FG000|COMPLETED|Overall Study||215
9878069|NCT01015170|10992674|FG000|NOT COMPLETED|Overall Study||239
9878070|NCT01015287|10992682|FG000|STARTED|Overall Study||1996
9878071|NCT01015287|10992683|FG001|STARTED|Overall Study||2037
9878072|NCT01015287|10992682|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996
9878073|NCT01015287|10992683|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037
9878074|NCT01015287|10992682|FG000|COMPLETED|Overall Study||1924
9878075|NCT01015287|10992683|FG001|COMPLETED|Overall Study||1958
9878076|NCT01015287|10992682|FG000|NOT COMPLETED|Overall Study||72
9878077|NCT01015287|10992683|FG001|NOT COMPLETED|Overall Study||79
9878078|NCT01015326|10992693|FG000|STARTED|Overall Study||12
9878079|NCT01015326|10992694|FG001|STARTED|Overall Study||20
9878080|NCT01015326|10992693|FG000|COMPLETED|Overall Study||11
9878081|NCT01015326|10992694|FG001|COMPLETED|Overall Study||18
9878082|NCT01015326|10992693|FG000|NOT COMPLETED|Overall Study||1
9878083|NCT01015326|10992694|FG001|NOT COMPLETED|Overall Study||2
9878084|NCT01015443|10992702|FG000|STARTED|Overall Study||191
9878085|NCT01015443|10992703|FG001|STARTED|Overall Study||94
9878086|NCT01015443|10992702|FG000|Treated|Overall Study||191
9878087|NCT01015443|10992703|FG001|Treated|Overall Study||93
9878088|NCT01015443|10992702|FG000|COMPLETED|Overall Study||191
9878089|NCT01015443|10992703|FG001|COMPLETED|Overall Study||94
9878090|NCT01015443|10992702|FG000|NOT COMPLETED|Overall Study||0
9878091|NCT01015443|10992703|FG001|NOT COMPLETED|Overall Study||0
10202750|NCT03449433|11329854|FG002|NOT COMPLETED|Period 4||0
9878092|NCT01015534|10992711|FG000|STARTED|Overall Study||28
10202751|NCT03449433|11329855|FG003|NOT COMPLETED|Period 4||0
9878093|NCT01015534|10992712|FG001|STARTED|Overall Study||27
9878094|NCT01015534|10992711|FG000|COMPLETED|Overall Study||27
9878095|NCT01015534|10992712|FG001|COMPLETED|Overall Study||27
9878096|NCT01015534|10992711|FG000|NOT COMPLETED|Overall Study||1
9878097|NCT01015534|10992712|FG001|NOT COMPLETED|Overall Study||0
9878098|NCT01015560|10992721|FG000|STARTED|Overall Study||44
9878099|NCT01015560|10992721|FG000|Eligible and Analyzable|Overall Study||43
9878100|NCT01015560|10992721|FG000|COMPLETED|Overall Study||41
9878101|NCT01015560|10992721|FG000|NOT COMPLETED|Overall Study||3
9878102|NCT01015586|10992727|FG000|STARTED|Overall Study||21
9878103|NCT01015586|10992728|FG001|STARTED|Overall Study||22
9878104|NCT01015586|10992727|FG000|COMPLETED|Overall Study||14
9878105|NCT01015586|10992728|FG001|COMPLETED|Overall Study||11
9878106|NCT01015586|10992727|FG000|NOT COMPLETED|Overall Study||7
9878107|NCT01015586|10992728|FG001|NOT COMPLETED|Overall Study||11
9878108|NCT01015612|10992734|FG000|STARTED|Overall Study||634
9878109|NCT01015612|10992734|FG000|COMPLETED|Overall Study||481
9878110|NCT01015612|10992734|FG000|NOT COMPLETED|Overall Study||153
9878111|NCT01015638|10992740|FG000|STARTED|Overall Study||17
9878112|NCT01015638|10992741|FG001|STARTED|Overall Study||19
9878113|NCT01015638|10992740|FG000|COMPLETED|Overall Study||16
9878114|NCT01015638|10992741|FG001|COMPLETED|Overall Study||19
9878115|NCT01015638|10992740|FG000|NOT COMPLETED|Overall Study||1
9878116|NCT01015638|10992741|FG001|NOT COMPLETED|Overall Study||0
9878117|NCT01015677|10992750|FG000|STARTED|Overall Study||34
9878118|NCT01015677|10992751|FG001|STARTED|Overall Study||32
9878119|NCT01015677|10992752|FG002|STARTED|Overall Study||33
9878120|NCT01015677|10992750|FG000|COMPLETED|Overall Study||33
9878121|NCT01015677|10992751|FG001|COMPLETED|Overall Study||28
9878122|NCT01015677|10992752|FG002|COMPLETED|Overall Study||33
9878123|NCT01015677|10992750|FG000|NOT COMPLETED|Overall Study||1
9878124|NCT01015677|10992751|FG001|NOT COMPLETED|Overall Study||4
9878125|NCT01015677|10992752|FG002|NOT COMPLETED|Overall Study||0
9878126|NCT01015703|10992765|FG000|STARTED|Overall Study||10
9878127|NCT01015703|10992766|FG001|STARTED|Overall Study||10
9878128|NCT01015703|10992767|FG002|STARTED|Overall Study||10
9878129|NCT01015703|10992768|FG003|STARTED|Overall Study||10
9878130|NCT01015703|10992769|FG004|STARTED|Overall Study||10
9878131|NCT01015703|10992765|FG000|COMPLETED|Overall Study||8
9878132|NCT01015703|10992766|FG001|COMPLETED|Overall Study||9
9878133|NCT01015703|10992767|FG002|COMPLETED|Overall Study||10
9878134|NCT01015703|10992768|FG003|COMPLETED|Overall Study||10
9878135|NCT01015703|10992769|FG004|COMPLETED|Overall Study||10
9878136|NCT01015703|10992765|FG000|NOT COMPLETED|Overall Study||2
9878137|NCT01015703|10992766|FG001|NOT COMPLETED|Overall Study||1
9878138|NCT01015703|10992767|FG002|NOT COMPLETED|Overall Study||0
9878139|NCT01015703|10992768|FG003|NOT COMPLETED|Overall Study||0
9878140|NCT01015703|10992769|FG004|NOT COMPLETED|Overall Study||0
9878141|NCT01015768|10992781|FG000|STARTED|Overall Study||30
9878142|NCT01015768|10992782|FG001|STARTED|Overall Study||30
9878143|NCT01015768|10992781|FG000|COMPLETED|Overall Study||26
9878144|NCT01015768|10992782|FG001|COMPLETED|Overall Study||26
9878145|NCT01015768|10992781|FG000|NOT COMPLETED|Overall Study||4
9878146|NCT01015768|10992782|FG001|NOT COMPLETED|Overall Study||4
9878147|NCT01015781|10992792|FG000|STARTED|Overall Study||150
9878148|NCT01015781|10992793|FG001|STARTED|Overall Study||150
9878149|NCT01015781|10992792|FG000|COMPLETED|Overall Study||113
9878150|NCT01015781|10992793|FG001|COMPLETED|Overall Study||121
9878151|NCT01015781|10992792|FG000|NOT COMPLETED|Overall Study||37
9878152|NCT01015781|10992793|FG001|NOT COMPLETED|Overall Study||29
9878153|NCT01015807|10992802|FG000|STARTED|Overall Study||30
9878154|NCT01015807|10992803|FG001|STARTED|Overall Study||30
9878155|NCT01015807|10992804|FG002|STARTED|Overall Study||30
9878156|NCT01015807|10992802|FG000|COMPLETED|Overall Study||30
9878157|NCT01015807|10992803|FG001|COMPLETED|Overall Study||30
9878158|NCT01015807|10992804|FG002|COMPLETED|Overall Study||30
9878159|NCT01015807|10992802|FG000|NOT COMPLETED|Overall Study||0
9878160|NCT01015807|10992803|FG001|NOT COMPLETED|Overall Study||0
9878161|NCT01015807|10992804|FG002|NOT COMPLETED|Overall Study||0
9878162|NCT01015820|10992814|FG000|STARTED|Overall Study||15
9878163|NCT01015820|10992815|FG001|STARTED|Overall Study||15
9878164|NCT01015820|10992814|FG000|COMPLETED|Overall Study||14
9878165|NCT01015820|10992815|FG001|COMPLETED|Overall Study||15
9878166|NCT01015820|10992814|FG000|NOT COMPLETED|Overall Study||1
9878167|NCT01015820|10992815|FG001|NOT COMPLETED|Overall Study||0
9878168|NCT01015976|10992821|FG000|STARTED|Overall Study||5
9878169|NCT01015976|10992822|FG001|STARTED|Overall Study||5
9878170|NCT01015976|10992821|FG000|COMPLETED|Overall Study||5
9878171|NCT01015976|10992822|FG001|COMPLETED|Overall Study||5
9878172|NCT01015976|10992821|FG000|NOT COMPLETED|Overall Study||0
9878173|NCT01015976|10992822|FG001|NOT COMPLETED|Overall Study||0
9878174|NCT01016015|10992826|FG000|STARTED|Overall Study||178
10202752|NCT03449433|11329856|FG004|NOT COMPLETED|Period 4||0
10202753|NCT03449446|11329877|FG000|STARTED|Overall Study||39
10202754|NCT03449446|11329878|FG001|STARTED|Overall Study||40
10202755|NCT03449446|11329879|FG002|STARTED|Overall Study||41
9878175|NCT01016015|10992826|FG000|COMPLETED|Overall Study||159
9878176|NCT01016015|10992826|FG000|NOT COMPLETED|Overall Study||19
9878177|NCT01016067|10992832|FG000|STARTED|Overall Study||11
9878178|NCT01016067|10992833|FG001|STARTED|Overall Study||12
10202756|NCT03449446|11329880|FG003|STARTED|Overall Study||80
10202757|NCT03449446|11329881|FG004|STARTED|Overall Study||78
10202758|NCT03449446|11329882|FG005|STARTED|Overall Study||78
9878179|NCT01016067|10992832|FG000|COMPLETED|Overall Study||9
9878180|NCT01016067|10992833|FG001|COMPLETED|Overall Study||8
9878181|NCT01016067|10992832|FG000|NOT COMPLETED|Overall Study||2
9878182|NCT01016067|10992833|FG001|NOT COMPLETED|Overall Study||4
9878183|NCT01016106|10992841|FG000|STARTED|Overall Study||17
9878184|NCT01016106|10992842|FG001|STARTED|Overall Study||18
9878185|NCT01016106|10992841|FG000|COMPLETED|Overall Study||17
9878186|NCT01016106|10992842|FG001|COMPLETED|Overall Study||18
9878187|NCT01016106|10992841|FG000|NOT COMPLETED|Overall Study||0
9878188|NCT01016106|10992842|FG001|NOT COMPLETED|Overall Study||0
9878189|NCT01016132|10992848|FG000|STARTED|Overall Study||152
9878190|NCT01016132|10992848|FG000|COMPLETED|Overall Study||151
9878191|NCT01016132|10992848|FG000|NOT COMPLETED|Overall Study||1
9878192|NCT01016262|10992855|FG000|STARTED|Double-blind Phase||41
9878193|NCT01016262|10992856|FG001|STARTED|Double-blind Phase||39
9878194|NCT01016262|10992857|FG002|STARTED|Double-blind Phase||39
9878195|NCT01016262|10992858|FG003|STARTED|Double-blind Phase||0
9878196|NCT01016262|10992859|FG004|STARTED|Double-blind Phase||0
9878197|NCT01016262|10992860|FG005|STARTED|Double-blind Phase||0
9878198|NCT01016262|10992855|FG000|COMPLETED|Double-blind Phase||40
9878199|NCT01016262|10992856|FG001|COMPLETED|Double-blind Phase||38
9878200|NCT01016262|10992857|FG002|COMPLETED|Double-blind Phase||30
9878201|NCT01016262|10992858|FG003|COMPLETED|Double-blind Phase||0
9878202|NCT01016262|10992859|FG004|COMPLETED|Double-blind Phase||0
9878203|NCT01016262|10992860|FG005|COMPLETED|Double-blind Phase||0
9878204|NCT01016262|10992855|FG000|NOT COMPLETED|Double-blind Phase||1
9878205|NCT01016262|10992856|FG001|NOT COMPLETED|Double-blind Phase||1
9878206|NCT01016262|10992857|FG002|NOT COMPLETED|Double-blind Phase||9
9878207|NCT01016262|10992858|FG003|NOT COMPLETED|Double-blind Phase||0
9878208|NCT01016262|10992859|FG004|NOT COMPLETED|Double-blind Phase||0
9878209|NCT01016262|10992860|FG005|NOT COMPLETED|Double-blind Phase||0
9878210|NCT01016262|10992855|FG000|STARTED|Open-Label Phase||0
9878211|NCT01016262|10992856|FG001|STARTED|Open-Label Phase||0
9878212|NCT01016262|10992857|FG002|STARTED|Open-Label Phase||0
9878213|NCT01016262|10992858|FG003|STARTED|Open-Label Phase||44
9878214|NCT01016262|10992859|FG004|STARTED|Open-Label Phase||52
9878215|NCT01016262|10992860|FG005|STARTED|Open-Label Phase||20
9878216|NCT01016262|10992855|FG000|COMPLETED|Open-Label Phase||0
10202759|NCT03449446|11329883|FG006|STARTED|Overall Study||39
9878217|NCT01016262|10992856|FG001|COMPLETED|Open-Label Phase||0
10107706|NCT02459964|11237975|FG002|COMPLETED|Overall Study||0
9878218|NCT01016262|10992857|FG002|COMPLETED|Open-Label Phase||0
9878219|NCT01016262|10992858|FG003|COMPLETED|Open-Label Phase||42
9878220|NCT01016262|10992859|FG004|COMPLETED|Open-Label Phase||50
9878221|NCT01016262|10992860|FG005|COMPLETED|Open-Label Phase||20
9878222|NCT01016262|10992855|FG000|NOT COMPLETED|Open-Label Phase||0
9878223|NCT01016262|10992856|FG001|NOT COMPLETED|Open-Label Phase||0
9878224|NCT01016262|10992857|FG002|NOT COMPLETED|Open-Label Phase||0
9878225|NCT01016262|10992858|FG003|NOT COMPLETED|Open-Label Phase||2
9878226|NCT01016262|10992859|FG004|NOT COMPLETED|Open-Label Phase||2
9878227|NCT01016262|10992860|FG005|NOT COMPLETED|Open-Label Phase||0
9878228|NCT01016353|10992873|FG000|STARTED|Overall Study||180
9878229|NCT01016353|10992874|FG001|STARTED|Overall Study||103
9878230|NCT01016353|10992873|FG000|COMPLETED|Overall Study||178
9878231|NCT01016353|10992874|FG001|COMPLETED|Overall Study||102
9878232|NCT01016353|10992873|FG000|NOT COMPLETED|Overall Study||2
9878233|NCT01016353|10992874|FG001|NOT COMPLETED|Overall Study||1
9878234|NCT01016483|10992884|FG000|STARTED|Safety Run-in Part||27
9878235|NCT01016483|10992885|FG001|STARTED|Safety Run-in Part||26
9878236|NCT01016483|10992886|FG002|STARTED|Safety Run-in Part||0
9878237|NCT01016483|10992887|FG003|STARTED|Safety Run-in Part||0
9878238|NCT01016483|10992884|FG000|COMPLETED|Safety Run-in Part||27
9878239|NCT01016483|10992885|FG001|COMPLETED|Safety Run-in Part||26
9878240|NCT01016483|10992886|FG002|COMPLETED|Safety Run-in Part||0
9878241|NCT01016483|10992887|FG003|COMPLETED|Safety Run-in Part||0
9878242|NCT01016483|10992884|FG000|NOT COMPLETED|Safety Run-in Part||0
9878243|NCT01016483|10992885|FG001|NOT COMPLETED|Safety Run-in Part||0
9878244|NCT01016483|10992886|FG002|NOT COMPLETED|Safety Run-in Part||0
9878245|NCT01016483|10992887|FG003|NOT COMPLETED|Safety Run-in Part||0
9878246|NCT01016483|10992884|FG000|STARTED|Phase II||0
9878247|NCT01016483|10992885|FG001|STARTED|Phase II||0
9878248|NCT01016483|10992886|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
9878249|NCT01016483|10992887|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
9878250|NCT01016483|10992884|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0
10007601|NCT01751399|11129836|FG003|Received 1 Dose of Study Drug|Overall Study||7
10007602|NCT01751399|11129833|FG000|COMPLETED|Overall Study||12
10007603|NCT01751399|11129834|FG001|COMPLETED|Overall Study||8
10007604|NCT01751399|11129835|FG002|COMPLETED|Overall Study||8
10007605|NCT01751399|11129836|FG003|COMPLETED|Overall Study||7
10107707|NCT02459964|11237973|FG000|NOT COMPLETED|Overall Study||0
10107708|NCT02459964|11237974|FG001|NOT COMPLETED|Overall Study||0
10202760|NCT03449446|11329877|FG000|COMPLETED|Overall Study||3
9878251|NCT01016483|10992885|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0
9878252|NCT01016483|10992886|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
9878253|NCT01016483|10992887|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
9878254|NCT01016483|10992884|FG000|COMPLETED|Phase II||0
9878255|NCT01016483|10992885|FG001|COMPLETED|Phase II||0
9878256|NCT01016483|10992886|FG002|COMPLETED|Phase II||44
9878257|NCT01016483|10992887|FG003|COMPLETED|Phase II||44
9878258|NCT01016483|10992884|FG000|NOT COMPLETED|Phase II||0
9878259|NCT01016483|10992885|FG001|NOT COMPLETED|Phase II||0
9878260|NCT01016483|10992886|FG002|NOT COMPLETED|Phase II||0
9878261|NCT01016483|10992887|FG003|NOT COMPLETED|Phase II||0
10007606|NCT01751399|11129833|FG000|NOT COMPLETED|Overall Study||0
10007607|NCT01751399|11129834|FG001|NOT COMPLETED|Overall Study||0
10007608|NCT01751399|11129835|FG002|NOT COMPLETED|Overall Study||0
10107709|NCT02459964|11237975|FG002|NOT COMPLETED|Overall Study||2
10107710|NCT02460172|11237982|FG000|STARTED|Overall Study||25
9878262|NCT01016600|10992929|FG000|STARTED|Overall Study||9
9878263|NCT01016600|10992930|FG001|STARTED|Overall Study||4
9878264|NCT01016600|10992931|FG002|STARTED|Overall Study||6
9878265|NCT01016600|10992932|FG003|STARTED|Overall Study||12
9878266|NCT01016600|10992929|FG000|COMPLETED|Overall Study||8
9878267|NCT01016600|10992930|FG001|COMPLETED|Overall Study||4
9878268|NCT01016600|10992931|FG002|COMPLETED|Overall Study||6
9878269|NCT01016600|10992932|FG003|COMPLETED|Overall Study||12
9878270|NCT01016600|10992929|FG000|NOT COMPLETED|Overall Study||1
9878271|NCT01016600|10992930|FG001|NOT COMPLETED|Overall Study||0
9878272|NCT01016600|10992931|FG002|NOT COMPLETED|Overall Study||0
9878273|NCT01016600|10992932|FG003|NOT COMPLETED|Overall Study||0
9878274|NCT01016652|10992945|FG000|STARTED|Period 1||25
9878275|NCT01016652|10992946|FG001|STARTED|Period 1||24
9878276|NCT01016652|10992945|FG000|COMPLETED|Period 1||25
9878277|NCT01016652|10992946|FG001|COMPLETED|Period 1||24
9878278|NCT01016652|10992945|FG000|NOT COMPLETED|Period 1||0
9878279|NCT01016652|10992946|FG001|NOT COMPLETED|Period 1||0
9878280|NCT01016652|10992945|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
9878281|NCT01016652|10992946|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
9878282|NCT01016652|10992945|FG000|COMPLETED|Period 2||25
9878283|NCT01016652|10992946|FG001|COMPLETED|Period 2||24
9878284|NCT01016652|10992945|FG000|NOT COMPLETED|Period 2||0
9878285|NCT01016652|10992946|FG001|NOT COMPLETED|Period 2||0
9878286|NCT01016678|10992954|FG000|STARTED|Overall Study||20
9878287|NCT01016678|10992955|FG001|STARTED|Overall Study||17
9878288|NCT01016678|10992956|FG002|STARTED|Overall Study||19
9878289|NCT01016678|10992957|FG003|STARTED|Overall Study||19
9878290|NCT01016678|10992958|FG004|STARTED|Overall Study||19
9878291|NCT01016678|10992954|FG000|COMPLETED|Overall Study||18
9878292|NCT01016678|10992955|FG001|COMPLETED|Overall Study||14
9878293|NCT01016678|10992956|FG002|COMPLETED|Overall Study||15
9878294|NCT01016678|10992957|FG003|COMPLETED|Overall Study||19
9878295|NCT01016678|10992958|FG004|COMPLETED|Overall Study||13
9878296|NCT01016678|10992954|FG000|NOT COMPLETED|Overall Study||2
9878297|NCT01016678|10992955|FG001|NOT COMPLETED|Overall Study||3
9878298|NCT01016678|10992956|FG002|NOT COMPLETED|Overall Study||4
9878299|NCT01016678|10992957|FG003|NOT COMPLETED|Overall Study||0
9878300|NCT01016678|10992958|FG004|NOT COMPLETED|Overall Study||6
9878301|NCT01016691|10992979|FG000|STARTED|Overall Study||17
9878302|NCT01016691|10992980|FG001|STARTED|Overall Study||12
9878303|NCT01016691|10992981|FG002|STARTED|Overall Study||18
9878304|NCT01016691|10992979|FG000|COMPLETED|Overall Study||17
9878305|NCT01016691|10992980|FG001|COMPLETED|Overall Study||12
9878306|NCT01016691|10992981|FG002|COMPLETED|Overall Study||18
9878307|NCT01016691|10992979|FG000|NOT COMPLETED|Overall Study||0
9878308|NCT01016691|10992980|FG001|NOT COMPLETED|Overall Study||0
10007609|NCT01751399|11129836|FG003|NOT COMPLETED|Overall Study||0
10007610|NCT01751412|11129846|FG000|STARTED|Overall Study||12
9878309|NCT01016691|10992981|FG002|NOT COMPLETED|Overall Study||0
9878310|NCT01016769|10992993|FG000|STARTED|Overall Study||4
9878311|NCT01016769|10992994|FG001|STARTED|Overall Study||7
9878312|NCT01016769|10992995|FG002|STARTED|Overall Study||7
9878313|NCT01016769|10992996|FG003|STARTED|Overall Study||30
9878314|NCT01016769|10992993|FG000|COMPLETED|Overall Study||3
9878315|NCT01016769|10992994|FG001|COMPLETED|Overall Study||6
9878316|NCT01016769|10992995|FG002|COMPLETED|Overall Study||6
9878317|NCT01016769|10992996|FG003|COMPLETED|Overall Study||30
9878318|NCT01016769|10992993|FG000|NOT COMPLETED|Overall Study||1
9878319|NCT01016769|10992994|FG001|NOT COMPLETED|Overall Study||1
9878320|NCT01016769|10992995|FG002|NOT COMPLETED|Overall Study||1
9878321|NCT01016769|10992996|FG003|NOT COMPLETED|Overall Study||0
9878322|NCT01016834|10993005|FG000|STARTED|Overall Study||242
9878323|NCT01016834|10993005|FG000|COMPLETED|Overall Study||220
9878324|NCT01016834|10993005|FG000|NOT COMPLETED|Overall Study||22
9878325|NCT01016873|10993012|FG000|STARTED|12 Months||75
9878326|NCT01016873|10993013|FG001|STARTED|12 Months||75
9878327|NCT01016873|10993014|FG002|STARTED|12 Months||80
9878328|NCT01016873|10993012|FG000|COMPLETED|12 Months||74
9878329|NCT01016873|10993013|FG001|COMPLETED|12 Months||72
9878330|NCT01016873|10993014|FG002|COMPLETED|12 Months||79
9878331|NCT01016873|10993012|FG000|NOT COMPLETED|12 Months||1
9878332|NCT01016873|10993013|FG001|NOT COMPLETED|12 Months||3
9878333|NCT01016873|10993014|FG002|NOT COMPLETED|12 Months||1
9878334|NCT01016873|10993012|FG000|STARTED|24 Months||74
9878335|NCT01016873|10993013|FG001|STARTED|24 Months||72
9878336|NCT01016873|10993014|FG002|STARTED|24 Months||79
9878337|NCT01016873|10993012|FG000|COMPLETED|24 Months||69
9878338|NCT01016873|10993013|FG001|COMPLETED|24 Months||68
9878339|NCT01016873|10993014|FG002|COMPLETED|24 Months||73
9878340|NCT01016873|10993012|FG000|NOT COMPLETED|24 Months||5
9878341|NCT01016873|10993013|FG001|NOT COMPLETED|24 Months||4
9878342|NCT01016873|10993014|FG002|NOT COMPLETED|24 Months||6
9878343|NCT01016873|10993012|FG000|STARTED|36 Months||69
9878344|NCT01016873|10993013|FG001|STARTED|36 Months||68
9878345|NCT01016873|10993014|FG002|STARTED|36 Months||73
9878346|NCT01016873|10993012|FG000|COMPLETED|36 Months||58
9878347|NCT01016873|10993013|FG001|COMPLETED|36 Months||64
9878348|NCT01016873|10993014|FG002|COMPLETED|36 Months||67
9878349|NCT01016873|10993012|FG000|NOT COMPLETED|36 Months||11
9878350|NCT01016873|10993013|FG001|NOT COMPLETED|36 Months||4
9878351|NCT01016873|10993014|FG002|NOT COMPLETED|36 Months||6
9878352|NCT01016912|10993027|FG000|STARTED|End of Treatment Period||8
10007611|NCT01751412|11129846|FG000|COMPLETED|Overall Study||11
9878353|NCT01016912|10993028|FG001|STARTED|End of Treatment Period||9
9878354|NCT01016912|10993029|FG002|STARTED|End of Treatment Period||10
9878355|NCT01016912|10993030|FG003|STARTED|End of Treatment Period||9
9878356|NCT01016912|10993031|FG004|STARTED|End of Treatment Period||9
9878357|NCT01016912|10993027|FG000|Received Treatment|End of Treatment Period||8
9878358|NCT01016912|10993028|FG001|Received Treatment|End of Treatment Period||9
9878359|NCT01016912|10993029|FG002|Received Treatment|End of Treatment Period||10
9878360|NCT01016912|10993030|FG003|Received Treatment|End of Treatment Period||9
9878361|NCT01016912|10993031|FG004|Received Treatment|End of Treatment Period||9
9878362|NCT01016912|10993027|FG000|COMPLETED|End of Treatment Period||8
9878363|NCT01016912|10993028|FG001|COMPLETED|End of Treatment Period||6
9878364|NCT01016912|10993029|FG002|COMPLETED|End of Treatment Period||9
9878365|NCT01016912|10993030|FG003|COMPLETED|End of Treatment Period||5
9878366|NCT01016912|10993031|FG004|COMPLETED|End of Treatment Period||5
9878367|NCT01016912|10993027|FG000|NOT COMPLETED|End of Treatment Period||0
9878368|NCT01016912|10993028|FG001|NOT COMPLETED|End of Treatment Period||3
9878369|NCT01016912|10993029|FG002|NOT COMPLETED|End of Treatment Period||1
9878370|NCT01016912|10993030|FG003|NOT COMPLETED|End of Treatment Period||4
9878371|NCT01016912|10993031|FG004|NOT COMPLETED|End of Treatment Period||4
9878372|NCT01016912|10993027|FG000|STARTED|Follow-up Period||8
9878373|NCT01016912|10993028|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
9878374|NCT01016912|10993029|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
9878375|NCT01016912|10993030|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
9878376|NCT01016912|10993031|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
9878377|NCT01016912|10993027|FG000|COMPLETED|Follow-up Period||8
9878378|NCT01016912|10993028|FG001|COMPLETED|Follow-up Period||9
9878379|NCT01016912|10993029|FG002|COMPLETED|Follow-up Period||9
9878380|NCT01016912|10993030|FG003|COMPLETED|Follow-up Period||8
9878381|NCT01016912|10993031|FG004|COMPLETED|Follow-up Period||9
9878382|NCT01016912|10993027|FG000|NOT COMPLETED|Follow-up Period||0
9878383|NCT01016912|10993028|FG001|NOT COMPLETED|Follow-up Period||0
9878384|NCT01016912|10993029|FG002|NOT COMPLETED|Follow-up Period||1
9878385|NCT01016912|10993030|FG003|NOT COMPLETED|Follow-up Period||1
9878386|NCT01016912|10993031|FG004|NOT COMPLETED|Follow-up Period||0
9878387|NCT01016938|10993063|FG000|STARTED|Overall Study||16
9878388|NCT01016938|10993063|FG000|COMPLETED|Overall Study||7
9878389|NCT01016938|10993063|FG000|NOT COMPLETED|Overall Study||9
9878390|NCT01016964|10993070|FG000|STARTED|Overall Study||21
9878391|NCT01016964|10993071|FG001|STARTED|Overall Study||42
9878392|NCT01016964|10993070|FG000|COMPLETED|Overall Study||18
9878393|NCT01016964|10993071|FG001|COMPLETED|Overall Study||39
9878394|NCT01016964|10993070|FG000|NOT COMPLETED|Overall Study||3
9878395|NCT01016964|10993071|FG001|NOT COMPLETED|Overall Study||3
9878396|NCT01016977|10993079|FG000|STARTED|Overall Study||20
9878397|NCT01016977|10993080|FG001|STARTED|Overall Study||20
9878398|NCT01016977|10993079|FG000|COMPLETED|Overall Study||17
9878399|NCT01016977|10993080|FG001|COMPLETED|Overall Study||18
9878400|NCT01016977|10993079|FG000|NOT COMPLETED|Overall Study||3
9878401|NCT01016977|10993080|FG001|NOT COMPLETED|Overall Study||2
9878402|NCT01017003|10993089|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
9878403|NCT01017003|10993089|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
9878404|NCT01017003|10993089|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
9878405|NCT01017003|10993089|FG000|STARTED|14 Day Washout Period||13
9878406|NCT01017003|10993089|FG000|COMPLETED|14 Day Washout Period||13
9878407|NCT01017003|10993089|FG000|NOT COMPLETED|14 Day Washout Period||0
9878408|NCT01017003|10993089|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
9878409|NCT01017003|10993089|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
9878410|NCT01017003|10993089|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
9878411|NCT01017003|10993089|FG000|STARTED|Colchicine 0.6 mg Final Dose||13
9878412|NCT01017003|10993089|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13
9878413|NCT01017003|10993089|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
9878414|NCT01017029|10993097|FG000|STARTED|Overall Study||89
9878415|NCT01017029|10993098|FG001|STARTED|Overall Study||92
9878416|NCT01017029|10993097|FG000|COMPLETED|Overall Study||85
9878417|NCT01017029|10993098|FG001|COMPLETED|Overall Study||90
9878418|NCT01017029|10993097|FG000|NOT COMPLETED|Overall Study||4
9878419|NCT01017029|10993098|FG001|NOT COMPLETED|Overall Study||2
9878420|NCT01017042|10993104|FG000|STARTED|Overall Study||13
9878421|NCT01017042|10993104|FG000|COMPLETED|Overall Study||13
9878422|NCT01017042|10993104|FG000|NOT COMPLETED|Overall Study||0
9878423|NCT01017120|10993115|FG000|STARTED|Overall Study||373
9878424|NCT01017120|10993116|FG001|STARTED|Overall Study||369
9878425|NCT01017120|10993115|FG000|COMPLETED|Overall Study||307
9878426|NCT01017120|10993116|FG001|COMPLETED|Overall Study||334
9878427|NCT01017120|10993115|FG000|NOT COMPLETED|Overall Study||66
9878428|NCT01017120|10993116|FG001|NOT COMPLETED|Overall Study||35
9878429|NCT01017146|10993124|FG000|STARTED|Overall Study||372
9878430|NCT01017146|10993125|FG001|STARTED|Overall Study||372
9878431|NCT01017146|10993124|FG000|COMPLETED|Overall Study||306
9878432|NCT01017146|10993125|FG001|COMPLETED|Overall Study||333
9878433|NCT01017146|10993124|FG000|NOT COMPLETED|Overall Study||66
9878434|NCT01017146|10993125|FG001|NOT COMPLETED|Overall Study||39
9878435|NCT01017237|10993133|FG000|STARTED|Overall Study||10
10007612|NCT01751412|11129846|FG000|NOT COMPLETED|Overall Study||1
9878436|NCT01017237|10993134|FG001|STARTED|Overall Study||8
9878437|NCT01017237|10993133|FG000|COMPLETED|Overall Study||5
9878438|NCT01017237|10993134|FG001|COMPLETED|Overall Study||6
9878439|NCT01017237|10993133|FG000|NOT COMPLETED|Overall Study||5
9878440|NCT01017237|10993134|FG001|NOT COMPLETED|Overall Study||2
9878441|NCT01017250|10993143|FG000|STARTED|Overall Study||15
9878442|NCT01017250|10993143|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
9878443|NCT01017250|10993143|FG000|COMPLETED|Overall Study||15
9878444|NCT01017250|10993143|FG000|NOT COMPLETED|Overall Study||0
9878445|NCT01017497|10993148|FG000|STARTED|Overall Study||49
9878446|NCT01017497|10993148|FG000|COMPLETED|Overall Study||49
9878447|NCT01017497|10993148|FG000|NOT COMPLETED|Overall Study||0
9878448|NCT01017536|10993156|FG000|STARTED|Overall Study||13
9878449|NCT01017536|10993157|FG001|STARTED|Overall Study||13
9878450|NCT01017536|10993156|FG000|COMPLETED|Overall Study||13
9878451|NCT01017536|10993157|FG001|COMPLETED|Overall Study||13
9878452|NCT01017536|10993156|FG000|NOT COMPLETED|Overall Study||0
9878453|NCT01017536|10993157|FG001|NOT COMPLETED|Overall Study||0
9878454|NCT01017549|10993163|FG000|STARTED|Eligibility Through 6 Month Follow-up||44
9878455|NCT01017549|10993163|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
9878456|NCT01017549|10993163|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
9878457|NCT01017549|10993163|FG000|STARTED|One-year Follow-up||43
9878458|NCT01017549|10993163|FG000|COMPLETED|One-year Follow-up||36
9878459|NCT01017549|10993163|FG000|NOT COMPLETED|One-year Follow-up||7
9878460|NCT01017549|10993163|FG000|STARTED|5 Year Follow-up||36
9878461|NCT01017549|10993163|FG000|COMPLETED|5 Year Follow-up||24
9878462|NCT01017549|10993163|FG000|NOT COMPLETED|5 Year Follow-up||12
9878463|NCT01017575|10993172|FG000|STARTED|Overall Study||8
9878464|NCT01017575|10993173|FG001|STARTED|Overall Study||9
9878465|NCT01017575|10993174|FG002|STARTED|Overall Study||8
9878466|NCT01017575|10993175|FG003|STARTED|Overall Study||8
9878467|NCT01017575|10993176|FG004|STARTED|Overall Study||9
9878468|NCT01017575|10993172|FG000|COMPLETED|Overall Study||7
9878469|NCT01017575|10993173|FG001|COMPLETED|Overall Study||7
9878470|NCT01017575|10993174|FG002|COMPLETED|Overall Study||8
9878471|NCT01017575|10993175|FG003|COMPLETED|Overall Study||7
9878472|NCT01017575|10993176|FG004|COMPLETED|Overall Study||6
9878473|NCT01017575|10993172|FG000|NOT COMPLETED|Overall Study||1
9878474|NCT01017575|10993173|FG001|NOT COMPLETED|Overall Study||2
9878475|NCT01017575|10993174|FG002|NOT COMPLETED|Overall Study||0
9878476|NCT01017575|10993175|FG003|NOT COMPLETED|Overall Study||1
9878477|NCT01017575|10993176|FG004|NOT COMPLETED|Overall Study||3
9878478|NCT01017601|10993190|FG000|STARTED|Overall Study||26
9878479|NCT01017601|10993191|FG001|STARTED|Overall Study||24
9878480|NCT01017601|10993190|FG000|COMPLETED|Overall Study||14
9878481|NCT01017601|10993191|FG001|COMPLETED|Overall Study||11
9878482|NCT01017601|10993190|FG000|NOT COMPLETED|Overall Study||12
9878483|NCT01017601|10993191|FG001|NOT COMPLETED|Overall Study||13
9878484|NCT01017653|10993197|FG000|STARTED|Overall Study||16
9878485|NCT01017653|10993197|FG000|COMPLETED|Overall Study||16
9878486|NCT01017653|10993197|FG000|NOT COMPLETED|Overall Study||0
9878487|NCT01017731|10993201|FG000|STARTED|Overall Study||68
9878488|NCT01017731|10993201|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
9878489|NCT01017731|10993201|FG000|COMPLETED|Overall Study||60
9878490|NCT01017731|10993201|FG000|NOT COMPLETED|Overall Study||8
9878491|NCT01017874|10993208|FG000|STARTED|Overall Study||118
9878492|NCT01017874|10993209|FG001|STARTED|Overall Study||118
9878493|NCT01017874|10993208|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114
9878494|NCT01017874|10993209|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118
9878495|NCT01017874|10993208|FG000|COMPLETED|Overall Study||88
9878496|NCT01017874|10993209|FG001|COMPLETED|Overall Study||92
9878497|NCT01017874|10993208|FG000|NOT COMPLETED|Overall Study||30
9878498|NCT01017874|10993209|FG001|NOT COMPLETED|Overall Study||26
9878499|NCT01017952|10993219|FG000|STARTED|4-week, Open-label Run-In Period||2092
9878500|NCT01017952|10993220|FG001|STARTED|4-week, Open-label Run-In Period||0
9878501|NCT01017952|10993221|FG002|STARTED|4-week, Open-label Run-In Period||0
9878502|NCT01017952|10993222|FG003|STARTED|4-week, Open-label Run-In Period||0
9878503|NCT01017952|10993223|FG004|STARTED|4-week, Open-label Run-In Period||0
9878504|NCT01017952|10993219|FG000|COMPLETED|4-week, Open-label Run-In Period||1633
9878505|NCT01017952|10993220|FG001|COMPLETED|4-week, Open-label Run-In Period||0
9878506|NCT01017952|10993221|FG002|COMPLETED|4-week, Open-label Run-In Period||0
9878507|NCT01017952|10993222|FG003|COMPLETED|4-week, Open-label Run-In Period||0
9878508|NCT01017952|10993223|FG004|COMPLETED|4-week, Open-label Run-In Period||0
9878509|NCT01017952|10993219|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459
9878510|NCT01017952|10993220|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
9878511|NCT01017952|10993221|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
9878512|NCT01017952|10993222|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
9878513|NCT01017952|10993223|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
9878514|NCT01017952|10993219|FG000|STARTED|52-week, Double-blind Treatment Period||0
9878515|NCT01017952|10993220|FG001|STARTED|52-week, Double-blind Treatment Period||409
9878516|NCT01017952|10993221|FG002|STARTED|52-week, Double-blind Treatment Period||412
9878517|NCT01017952|10993222|FG003|STARTED|52-week, Double-blind Treatment Period||403
9878518|NCT01017952|10993223|FG004|STARTED|52-week, Double-blind Treatment Period||409
9878519|NCT01017952|10993219|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
9878520|NCT01017952|10993220|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
9878521|NCT01017952|10993221|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
9878522|NCT01017952|10993222|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
9878523|NCT01017952|10993223|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
9878524|NCT01017952|10993219|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
9878525|NCT01017952|10993220|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
9878526|NCT01017952|10993221|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
9878527|NCT01017952|10993222|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
9878528|NCT01017952|10993223|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
9878529|NCT01017952|10993219|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
9878530|NCT01017952|10993220|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125
9878531|NCT01017952|10993221|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109
9878532|NCT01017952|10993222|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112
9878533|NCT01017952|10993223|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103
9878534|NCT01018030|10993236|FG000|STARTED|Overall Study||246
9878535|NCT01018030|10993237|FG001|STARTED|Overall Study||243
9878536|NCT01018030|10993238|FG002|STARTED|Overall Study||252
9878537|NCT01018030|10993236|FG000|COMPLETED|Overall Study||227
9878538|NCT01018030|10993237|FG001|COMPLETED|Overall Study||232
9878539|NCT01018030|10993238|FG002|COMPLETED|Overall Study||239
9878540|NCT01018030|10993236|FG000|NOT COMPLETED|Overall Study||19
9878541|NCT01018030|10993237|FG001|NOT COMPLETED|Overall Study||11
9878542|NCT01018030|10993238|FG002|NOT COMPLETED|Overall Study||13
9878543|NCT01018056|10993251|FG000|STARTED|Overall Study||12
9878544|NCT01018056|10993252|FG001|STARTED|Overall Study||12
9878545|NCT01018056|10993253|FG002|STARTED|Overall Study||6
9878546|NCT01018056|10993251|FG000|COMPLETED|Overall Study||9
9878547|NCT01018056|10993252|FG001|COMPLETED|Overall Study||10
9878548|NCT01018056|10993253|FG002|COMPLETED|Overall Study||5
9878549|NCT01018056|10993251|FG000|NOT COMPLETED|Overall Study||3
9878550|NCT01018056|10993252|FG001|NOT COMPLETED|Overall Study||2
9878551|NCT01018056|10993253|FG002|NOT COMPLETED|Overall Study||1
9878552|NCT01018095|10993266|FG000|STARTED|Overall Study||135
9878553|NCT01018095|10993267|FG001|STARTED|Overall Study||135
9878554|NCT01018095|10993266|FG000|COMPLETED|Overall Study||79
9878555|NCT01018095|10993267|FG001|COMPLETED|Overall Study||73
9878556|NCT01018095|10993266|FG000|NOT COMPLETED|Overall Study||56
9878557|NCT01018095|10993267|FG001|NOT COMPLETED|Overall Study||62
9878558|NCT01018134|10993279|FG000|STARTED|Overall Study||30
9878559|NCT01018134|10993280|FG001|STARTED|Overall Study||31
9878560|NCT01018134|10993281|FG002|STARTED|Overall Study||30
9878561|NCT01018134|10993282|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
9878562|NCT01018134|10993283|FG004|STARTED|Overall Study||15
9878563|NCT01018134|10993284|FG005|STARTED|Overall Study||15
9878564|NCT01018134|10993279|FG000|COMPLETED|Overall Study||30
9878565|NCT01018134|10993280|FG001|COMPLETED|Overall Study||30
9878566|NCT01018134|10993281|FG002|COMPLETED|Overall Study||29
9878567|NCT01018134|10993282|FG003|COMPLETED|Overall Study||29
9878568|NCT01018134|10993283|FG004|COMPLETED|Overall Study||15
9878569|NCT01018134|10993284|FG005|COMPLETED|Overall Study||15
9878570|NCT01018134|10993279|FG000|NOT COMPLETED|Overall Study||0
9878571|NCT01018134|10993280|FG001|NOT COMPLETED|Overall Study||1
9878572|NCT01018134|10993281|FG002|NOT COMPLETED|Overall Study||1
9878573|NCT01018134|10993282|FG003|NOT COMPLETED|Overall Study||0
9878574|NCT01018134|10993283|FG004|NOT COMPLETED|Overall Study||0
9878575|NCT01018134|10993284|FG005|NOT COMPLETED|Overall Study||0
9878576|NCT01018186|10993301|FG000|STARTED|2-week Run-in Period||617
9878577|NCT01018186|10993302|FG001|STARTED|2-week Run-in Period||0
9878578|NCT01018186|10993303|FG002|STARTED|2-week Run-in Period||0
9878579|NCT01018186|10993304|FG003|STARTED|2-week Run-in Period||0
9878580|NCT01018186|10993301|FG000|COMPLETED|2-week Run-in Period||503
9878581|NCT01018186|10993302|FG001|COMPLETED|2-week Run-in Period||0
9878582|NCT01018186|10993303|FG002|COMPLETED|2-week Run-in Period||0
9878583|NCT01018186|10993304|FG003|COMPLETED|2-week Run-in Period||0
9878584|NCT01018186|10993301|FG000|NOT COMPLETED|2-week Run-in Period||114
9878585|NCT01018186|10993302|FG001|NOT COMPLETED|2-week Run-in Period||0
9878586|NCT01018186|10993303|FG002|NOT COMPLETED|2-week Run-in Period||0
9878587|NCT01018186|10993304|FG003|NOT COMPLETED|2-week Run-in Period||0
9878588|NCT01018186|10993301|FG000|STARTED|52-week Double-blind Treatment Period||0
9878589|NCT01018186|10993302|FG001|STARTED|52-week Double-blind Treatment Period||201
9878590|NCT01018186|10993303|FG002|STARTED|52-week Double-blind Treatment Period||202
9878591|NCT01018186|10993304|FG003|STARTED|52-week Double-blind Treatment Period||100
9878592|NCT01018186|10993301|FG000|COMPLETED|52-week Double-blind Treatment Period||0
9878593|NCT01018186|10993302|FG001|COMPLETED|52-week Double-blind Treatment Period||161
9878594|NCT01018186|10993303|FG002|COMPLETED|52-week Double-blind Treatment Period||161
9878595|NCT01018186|10993304|FG003|COMPLETED|52-week Double-blind Treatment Period||71
9878596|NCT01018186|10993301|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
9878597|NCT01018186|10993302|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40
9878598|NCT01018186|10993303|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41
9878599|NCT01018186|10993304|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29
9878600|NCT01018264|10993318|FG000|STARTED|Overall Study||10
9878601|NCT01018264|10993319|FG001|STARTED|Overall Study||13
9878602|NCT01018264|10993318|FG000|COMPLETED|Overall Study||9
9878603|NCT01018264|10993319|FG001|COMPLETED|Overall Study||12
9878604|NCT01018264|10993318|FG000|NOT COMPLETED|Overall Study||1
9878605|NCT01018264|10993319|FG001|NOT COMPLETED|Overall Study||1
9878606|NCT01018394|10993327|FG000|STARTED|Overall Study||40
9878607|NCT01018394|10993328|FG001|STARTED|Overall Study||41
9878608|NCT01018394|10993327|FG000|COMPLETED|Overall Study||31
9878609|NCT01018394|10993328|FG001|COMPLETED|Overall Study||33
9878610|NCT01018394|10993327|FG000|NOT COMPLETED|Overall Study||9
9878611|NCT01018394|10993328|FG001|NOT COMPLETED|Overall Study||8
9878612|NCT01018420|10993336|FG000|STARTED|Overall Study||15
9878613|NCT01018420|10993337|FG001|STARTED|Overall Study||3
9878614|NCT01018420|10993336|FG000|COMPLETED|Overall Study||15
10107711|NCT02460172|11237982|FG000|COMPLETED|Overall Study||25
10107712|NCT02460172|11237982|FG000|NOT COMPLETED|Overall Study||0
10107713|NCT02460263|11237988|FG000|STARTED|In-Center Period||30
9878615|NCT01018420|10993337|FG001|COMPLETED|Overall Study||3
9878616|NCT01018420|10993336|FG000|NOT COMPLETED|Overall Study||0
9878617|NCT01018420|10993337|FG001|NOT COMPLETED|Overall Study||0
9878618|NCT01018511|10993364|FG000|STARTED|Overall Study||341
9878619|NCT01018511|10993365|FG001|STARTED|Overall Study||327
9878620|NCT01018511|10993366|FG002|STARTED|Overall Study||339
9878621|NCT01018511|10993367|FG003|STARTED|Overall Study||327
9878622|NCT01018511|10993364|FG000|Randomized and Treated|Overall Study||341
9878623|NCT01018511|10993365|FG001|Randomized and Treated|Overall Study||326
9878624|NCT01018511|10993366|FG002|Randomized and Treated|Overall Study||338
9878625|NCT01018511|10993367|FG003|Randomized and Treated|Overall Study||324
9878626|NCT01018511|10993364|FG000|COMPLETED|Overall Study||315
9878627|NCT01018511|10993365|FG001|COMPLETED|Overall Study||295
9878628|NCT01018511|10993366|FG002|COMPLETED|Overall Study||299
9878629|NCT01018511|10993367|FG003|COMPLETED|Overall Study||294
9878630|NCT01018511|10993364|FG000|NOT COMPLETED|Overall Study||26
9878631|NCT01018511|10993365|FG001|NOT COMPLETED|Overall Study||32
9878632|NCT01018511|10993366|FG002|NOT COMPLETED|Overall Study||40
9878633|NCT01018511|10993367|FG003|NOT COMPLETED|Overall Study||33
9878634|NCT01018680|10993385|FG000|STARTED|Overall Study||260
9878635|NCT01018680|10993386|FG001|STARTED|Overall Study||264
9878636|NCT01018680|10993385|FG000|COMPLETED|Overall Study||199
9878637|NCT01018680|10993386|FG001|COMPLETED|Overall Study||189
9878638|NCT01018680|10993385|FG000|NOT COMPLETED|Overall Study||61
9878639|NCT01018680|10993386|FG001|NOT COMPLETED|Overall Study||75
9878640|NCT01018732|10993395|FG000|STARTED|Overall Study||50
9878641|NCT01018732|10993396|FG001|STARTED|Overall Study||51
9878642|NCT01018732|10993397|FG002|STARTED|Overall Study||54
9878643|NCT01018732|10993395|FG000|COMPLETED|Overall Study||49
9878644|NCT01018732|10993396|FG001|COMPLETED|Overall Study||49
10007613|NCT01751451|11129853|FG000|STARTED|Overall Study||42
10007614|NCT01751451|11129854|FG001|STARTED|Overall Study||40
10007615|NCT01751451|11129855|FG002|STARTED|Overall Study||42
10107714|NCT02460263|11237988|FG000|COMPLETED|In-Center Period||30
10107715|NCT02460263|11237988|FG000|NOT COMPLETED|In-Center Period||0
10107716|NCT02460263|11237988|FG000|STARTED|Transition Period||30
10107717|NCT02460263|11237988|FG000|COMPLETED|Transition Period||28
10107718|NCT02460263|11237988|FG000|NOT COMPLETED|Transition Period||2
10107719|NCT02460263|11237988|FG000|STARTED|In-Home Period||28
10107720|NCT02460263|11237988|FG000|COMPLETED|In-Home Period||28
10107721|NCT02460263|11237988|FG000|NOT COMPLETED|In-Home Period||0
9878645|NCT01018732|10993397|FG002|COMPLETED|Overall Study||50
9878646|NCT01018732|10993395|FG000|NOT COMPLETED|Overall Study||1
9878647|NCT01018732|10993396|FG001|NOT COMPLETED|Overall Study||2
9878648|NCT01018732|10993397|FG002|NOT COMPLETED|Overall Study||4
9878649|NCT01018862|10993408|FG000|STARTED|Overall Study||161
9878650|NCT01018862|10993409|FG001|STARTED|Overall Study||166
9878651|NCT01018862|10993410|FG002|STARTED|Overall Study||162
9878652|NCT01018862|10993408|FG000|COMPLETED|Overall Study||148
10007616|NCT01751451|11129853|FG000|COMPLETED|Overall Study||42
10007617|NCT01751451|11129854|FG001|COMPLETED|Overall Study||40
10007618|NCT01751451|11129855|FG002|COMPLETED|Overall Study||42
10007619|NCT01751451|11129853|FG000|NOT COMPLETED|Overall Study||0
10007620|NCT01751451|11129854|FG001|NOT COMPLETED|Overall Study||0
10007621|NCT01751451|11129855|FG002|NOT COMPLETED|Overall Study||0
10007622|NCT01751568|11129866|FG000|STARTED|Overall Study||13
10107722|NCT02460380|11237998|FG000|STARTED|Overall Study||45
9878653|NCT01018862|10993409|FG001|COMPLETED|Overall Study||156
9878654|NCT01018862|10993410|FG002|COMPLETED|Overall Study||146
9878655|NCT01018862|10993408|FG000|NOT COMPLETED|Overall Study||13
10007623|NCT01751568|11129867|FG001|STARTED|Overall Study||14
10007624|NCT01751568|11129868|FG002|STARTED|Overall Study||13
10107723|NCT02460380|11237999|FG001|STARTED|Overall Study||23
10107724|NCT02460380|11237998|FG000|COMPLETED|Overall Study||35
10107725|NCT02460380|11237999|FG001|COMPLETED|Overall Study||18
10107726|NCT02460380|11237998|FG000|NOT COMPLETED|Overall Study||10
10107727|NCT02460380|11237999|FG001|NOT COMPLETED|Overall Study||5
9878656|NCT01018862|10993409|FG001|NOT COMPLETED|Overall Study||10
9878657|NCT01018862|10993410|FG002|NOT COMPLETED|Overall Study||16
9878658|NCT01018953|10993418|FG000|STARTED|Overall Study||8
9878659|NCT01018953|10993418|FG000|BIM 23A760 1 mg|Overall Study||3
9878660|NCT01018953|10993418|FG000|BIM 23A760 2 mg|Overall Study||2
9878661|NCT01018953|10993418|FG000|BIM 23A760 4 mg|Overall Study||3
9878662|NCT01018953|10993418|FG000|COMPLETED|Overall Study||0
9878663|NCT01018953|10993418|FG000|NOT COMPLETED|Overall Study||8
9878664|NCT01018979|10993425|FG000|STARTED|Overall Study||7
9878665|NCT01018979|10993426|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13
9878666|NCT01018979|10993425|FG000|Received at Least One Dose|Overall Study||7
9878667|NCT01018979|10993426|FG001|Received at Least One Dose|Overall Study||12
9878668|NCT01018979|10993425|FG000|COMPLETED|Overall Study||4
9878669|NCT01018979|10993426|FG001|COMPLETED|Overall Study||3
9878670|NCT01018979|10993425|FG000|NOT COMPLETED|Overall Study||3
9878671|NCT01018979|10993426|FG001|NOT COMPLETED|Overall Study||10
9878672|NCT01018992|10993437|FG000|STARTED|Overall Study||63
9878673|NCT01018992|10993438|FG001|STARTED|Overall Study||65
9878674|NCT01018992|10993437|FG000|COMPLETED|Overall Study||47
9878675|NCT01018992|10993438|FG001|COMPLETED|Overall Study||49
9878676|NCT01018992|10993437|FG000|NOT COMPLETED|Overall Study||16
9878677|NCT01018992|10993438|FG001|NOT COMPLETED|Overall Study||16
9878678|NCT01019135|10993447|FG000|STARTED|Overall Study||55
9878679|NCT01019135|10993448|FG001|STARTED|Overall Study||59
9878680|NCT01019135|10993449|FG002|STARTED|Overall Study||55
9878681|NCT01019135|10993447|FG000|COMPLETED|Overall Study||35
9878682|NCT01019135|10993448|FG001|COMPLETED|Overall Study||40
9878683|NCT01019135|10993449|FG002|COMPLETED|Overall Study||24
9878684|NCT01019135|10993447|FG000|NOT COMPLETED|Overall Study||20
9878685|NCT01019135|10993448|FG001|NOT COMPLETED|Overall Study||19
9878686|NCT01019135|10993449|FG002|NOT COMPLETED|Overall Study||31
9878687|NCT01019252|10993459|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
9878688|NCT01019252|10993460|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
9878689|NCT01019252|10993459|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21
9878690|NCT01019252|10993460|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22
9878691|NCT01019252|10993459|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
9878692|NCT01019252|10993460|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
9878693|NCT01019252|10993459|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
9878694|NCT01019252|10993460|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22
9878695|NCT01019252|10993459|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21
9878696|NCT01019252|10993460|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15
9878697|NCT01019252|10993459|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
9878698|NCT01019252|10993460|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
9878699|NCT01019317|10993466|FG000|STARTED|Overall Study||151
9878700|NCT01019317|10993466|FG000|COMPLETED|Overall Study||147
9878701|NCT01019317|10993466|FG000|NOT COMPLETED|Overall Study||4
9878702|NCT01019369|10993472|FG000|STARTED|Overall Study||86
9878703|NCT01019369|10993473|FG001|STARTED|Overall Study||46
9878704|NCT01019369|10993472|FG000|COMPLETED|Overall Study||76
9878705|NCT01019369|10993473|FG001|COMPLETED|Overall Study||39
9878706|NCT01019369|10993472|FG000|NOT COMPLETED|Overall Study||10
9878707|NCT01019369|10993473|FG001|NOT COMPLETED|Overall Study||7
9878708|NCT01019486|10993483|FG000|STARTED|Overall Study||5
9878709|NCT01019486|10993484|FG001|STARTED|Overall Study||5
9878710|NCT01019486|10993485|FG002|STARTED|Overall Study||16
9878711|NCT01019486|10993483|FG000|COMPLETED|Overall Study||4
9878712|NCT01019486|10993484|FG001|COMPLETED|Overall Study||4
9878713|NCT01019486|10993485|FG002|COMPLETED|Overall Study||15
9878714|NCT01019486|10993483|FG000|NOT COMPLETED|Overall Study||1
9878715|NCT01019486|10993484|FG001|NOT COMPLETED|Overall Study||1
9878716|NCT01019486|10993485|FG002|NOT COMPLETED|Overall Study||1
9878717|NCT01019694|10993497|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
9878718|NCT01019694|10993498|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
9878719|NCT01019694|10993499|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
9878720|NCT01019694|10993497|FG000|COMPLETED|Overall Study||133
9878721|NCT01019694|10993498|FG001|COMPLETED|Overall Study||118
9878722|NCT01019694|10993499|FG002|COMPLETED|Overall Study||110
9878723|NCT01019694|10993497|FG000|NOT COMPLETED|Overall Study||24
9878724|NCT01019694|10993498|FG001|NOT COMPLETED|Overall Study||38
9878725|NCT01019694|10993499|FG002|NOT COMPLETED|Overall Study||47
9878726|NCT01019707|10993507|FG000|STARTED|First Phase||3
9878727|NCT01019707|10993508|FG001|STARTED|First Phase||3
9878728|NCT01019707|10993507|FG000|COMPLETED|First Phase||3
10007625|NCT01751568|11129866|FG000|COMPLETED|Overall Study||12
10007626|NCT01751568|11129867|FG001|COMPLETED|Overall Study||14
10007627|NCT01751568|11129868|FG002|COMPLETED|Overall Study||13
10007628|NCT01751568|11129866|FG000|NOT COMPLETED|Overall Study||1
9878729|NCT01019707|10993508|FG001|COMPLETED|First Phase||3
9878730|NCT01019707|10993507|FG000|NOT COMPLETED|First Phase||0
9878731|NCT01019707|10993508|FG001|NOT COMPLETED|First Phase||0
9878732|NCT01019707|10993507|FG000|STARTED|Washout||3
10007629|NCT01751568|11129867|FG001|NOT COMPLETED|Overall Study||0
10007630|NCT01751568|11129868|FG002|NOT COMPLETED|Overall Study||0
9878733|NCT01019707|10993508|FG001|STARTED|Washout||3
9878734|NCT01019707|10993507|FG000|COMPLETED|Washout||3
9878735|NCT01019707|10993508|FG001|COMPLETED|Washout||1
9878736|NCT01019707|10993507|FG000|NOT COMPLETED|Washout||0
9878737|NCT01019707|10993508|FG001|NOT COMPLETED|Washout||2
9878738|NCT01019707|10993507|FG000|STARTED|Second Phase||3
9878739|NCT01019707|10993508|FG001|STARTED|Second Phase||1
9878740|NCT01019707|10993507|FG000|COMPLETED|Second Phase||3
9878741|NCT01019707|10993508|FG001|COMPLETED|Second Phase||1
9878742|NCT01019707|10993507|FG000|NOT COMPLETED|Second Phase||0
9878743|NCT01019707|10993508|FG001|NOT COMPLETED|Second Phase||0
9878744|NCT01019928|10993516|FG000|STARTED|Period 1||7
9878745|NCT01019928|10993517|FG001|STARTED|Period 1||7
9878746|NCT01019928|10993516|FG000|COMPLETED|Period 1||7
9878747|NCT01019928|10993517|FG001|COMPLETED|Period 1||7
9878748|NCT01019928|10993516|FG000|NOT COMPLETED|Period 1||0
9878749|NCT01019928|10993517|FG001|NOT COMPLETED|Period 1||0
9878750|NCT01019928|10993516|FG000|STARTED|Period 2||7
9878751|NCT01019928|10993517|FG001|STARTED|Period 2||7
9878752|NCT01019928|10993516|FG000|COMPLETED|Period 2||7
9878753|NCT01019928|10993517|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
9878754|NCT01019928|10993516|FG000|NOT COMPLETED|Period 2||0
9878755|NCT01019928|10993517|FG001|NOT COMPLETED|Period 2||1
9878756|NCT01019928|10993516|FG000|STARTED|Period 3||7
9878757|NCT01019928|10993517|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
9878758|NCT01019928|10993516|FG000|COMPLETED|Period 3||7
9878759|NCT01019928|10993517|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
9878760|NCT01019928|10993516|FG000|NOT COMPLETED|Period 3||0
9878761|NCT01019928|10993517|FG001|NOT COMPLETED|Period 3||0
9878762|NCT01020006|10993526|FG000|STARTED|Overall Study||8
9878763|NCT01020006|10993527|FG001|STARTED|Overall Study||18
9878764|NCT01020006|10993528|FG002|STARTED|Overall Study||16
9878765|NCT01020006|10993526|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
9878766|NCT01020006|10993527|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
9878767|NCT01020006|10993528|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
9878768|NCT01020006|10993526|FG000|NOT COMPLETED|Overall Study||8
9878769|NCT01020006|10993527|FG001|NOT COMPLETED|Overall Study||18
9878770|NCT01020006|10993528|FG002|NOT COMPLETED|Overall Study||16
9878771|NCT01020019|10993538|FG000|STARTED|Overall Study||61
9878772|NCT01020019|10993539|FG001|STARTED|Overall Study||61
9878773|NCT01020019|10993538|FG000|COMPLETED|Overall Study||35
9878774|NCT01020019|10993539|FG001|COMPLETED|Overall Study||32
9878775|NCT01020019|10993538|FG000|NOT COMPLETED|Overall Study||26
9878776|NCT01020019|10993539|FG001|NOT COMPLETED|Overall Study||29
9878777|NCT01020123|10993552|FG000|STARTED|Main Period||93
9878778|NCT01020123|10993553|FG001|STARTED|Main Period||91
9878779|NCT01020123|10993554|FG002|STARTED|Main Period||52
9878780|NCT01020123|10993555|FG003|STARTED|Main Period||40
9878781|NCT01020123|10993556|FG004|STARTED|Main Period||88
9878782|NCT01020123|10993557|FG005|STARTED|Main Period||94
9878783|NCT01020123|10993558|FG006|STARTED|Main Period||72
9878784|NCT01020123|10993552|FG000|COMPLETED|Main Period||76
9878785|NCT01020123|10993553|FG001|COMPLETED|Main Period||77
10007631|NCT01751646|11129878|FG000|STARTED|Overall Study||109
10007632|NCT01751646|11129879|FG001|STARTED|Overall Study||105
10007633|NCT01751646|11129878|FG000|COMPLETED|Overall Study||98
10007634|NCT01751646|11129879|FG001|COMPLETED|Overall Study||87
10007635|NCT01751646|11129878|FG000|NOT COMPLETED|Overall Study||11
10007636|NCT01751646|11129879|FG001|NOT COMPLETED|Overall Study||18
10007637|NCT01751724|11129891|FG000|STARTED|Overall Study||42
10007638|NCT01751724|11129892|FG001|STARTED|Overall Study||44
10007639|NCT01751724|11129891|FG000|COMPLETED|Overall Study||41
10007640|NCT01751724|11129892|FG001|COMPLETED|Overall Study||42
10007641|NCT01751724|11129891|FG000|NOT COMPLETED|Overall Study||1
10007642|NCT01751724|11129892|FG001|NOT COMPLETED|Overall Study||2
10007643|NCT01751802|11129900|FG000|STARTED|Overall Study||5
9878786|NCT01020123|10993554|FG002|COMPLETED|Main Period||44
9878787|NCT01020123|10993555|FG003|COMPLETED|Main Period||33
9878788|NCT01020123|10993556|FG004|COMPLETED|Main Period||77
9878789|NCT01020123|10993557|FG005|COMPLETED|Main Period||83
9878790|NCT01020123|10993558|FG006|COMPLETED|Main Period||61
9878791|NCT01020123|10993552|FG000|NOT COMPLETED|Main Period||17
9878792|NCT01020123|10993553|FG001|NOT COMPLETED|Main Period||14
9878793|NCT01020123|10993554|FG002|NOT COMPLETED|Main Period||8
9878794|NCT01020123|10993555|FG003|NOT COMPLETED|Main Period||7
9878795|NCT01020123|10993556|FG004|NOT COMPLETED|Main Period||11
9878796|NCT01020123|10993557|FG005|NOT COMPLETED|Main Period||11
9878797|NCT01020123|10993558|FG006|NOT COMPLETED|Main Period||11
9878798|NCT01020123|10993552|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
9953984|NCT01429077|11072651|FG001|Completed 6-week Intervention|Overall Study||17
9953985|NCT01429077|11072650|FG000|COMPLETED|Overall Study||19
9953986|NCT01429077|11072651|FG001|COMPLETED|Overall Study||14
9953987|NCT01429077|11072650|FG000|NOT COMPLETED|Overall Study||0
9953988|NCT01429077|11072651|FG001|NOT COMPLETED|Overall Study||3
9953989|NCT01429259|11072657|FG000|STARTED|Overall Study||30
9953990|NCT01429259|11072657|FG000|COMPLETED|Overall Study||30
9953991|NCT01429259|11072657|FG000|NOT COMPLETED|Overall Study||0
9953992|NCT01429272|11072665|FG000|STARTED|Overall Study||30
9953993|NCT01429272|11072666|FG001|STARTED|Overall Study||31
9953994|NCT01429272|11072667|FG002|STARTED|Overall Study||19
9878799|NCT01020123|10993553|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
9878800|NCT01020123|10993554|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
9878801|NCT01020123|10993555|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
9878802|NCT01020123|10993556|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
9878803|NCT01020123|10993557|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
9878804|NCT01020123|10993558|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
9878805|NCT01020123|10993552|FG000|COMPLETED|Extention Period||37
9878806|NCT01020123|10993553|FG001|COMPLETED|Extention Period||33
9878807|NCT01020123|10993554|FG002|COMPLETED|Extention Period||17
9878808|NCT01020123|10993555|FG003|COMPLETED|Extention Period||12
9878809|NCT01020123|10993556|FG004|COMPLETED|Extention Period||31
9878810|NCT01020123|10993557|FG005|COMPLETED|Extention Period||36
9878811|NCT01020123|10993558|FG006|COMPLETED|Extention Period||18
9878812|NCT01020123|10993552|FG000|NOT COMPLETED|Extention Period||3
9878813|NCT01020123|10993553|FG001|NOT COMPLETED|Extention Period||2
9878814|NCT01020123|10993554|FG002|NOT COMPLETED|Extention Period||2
9878815|NCT01020123|10993555|FG003|NOT COMPLETED|Extention Period||1
9878816|NCT01020123|10993556|FG004|NOT COMPLETED|Extention Period||0
9878817|NCT01020123|10993557|FG005|NOT COMPLETED|Extention Period||2
9878818|NCT01020123|10993558|FG006|NOT COMPLETED|Extention Period||1
9878819|NCT01020305|10993575|FG000|STARTED|Overall Study||5
9878820|NCT01020305|10993575|FG000|COMPLETED|Overall Study||3
9878821|NCT01020305|10993575|FG000|NOT COMPLETED|Overall Study||2
9878822|NCT01020435|10993581|FG000|STARTED|Overall Study||24
9878823|NCT01020435|10993582|FG001|STARTED|Overall Study||27
9878824|NCT01020435|10993581|FG000|COMPLETED|Overall Study||24
9878825|NCT01020435|10993582|FG001|COMPLETED|Overall Study||26
9878826|NCT01020435|10993581|FG000|NOT COMPLETED|Overall Study||0
9878827|NCT01020435|10993582|FG001|NOT COMPLETED|Overall Study||1
9878828|NCT01020448|10993589|FG000|STARTED|Pre-assignment||339
9878829|NCT01020448|10993589|FG000|COMPLETED|Pre-assignment||326
9878830|NCT01020448|10993589|FG000|NOT COMPLETED|Pre-assignment||13
9878831|NCT01020448|10993589|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
9878832|NCT01020448|10993589|FG000|COMPLETED|Treatment||299
9878833|NCT01020448|10993589|FG000|NOT COMPLETED|Treatment||26
9878834|NCT01020474|10993596|FG000|STARTED|Overall Study||54
9878835|NCT01020474|10993597|FG001|STARTED|Overall Study||53
9878836|NCT01020474|10993596|FG000|COMPLETED|Overall Study||44
9878837|NCT01020474|10993597|FG001|COMPLETED|Overall Study||36
9878838|NCT01020474|10993596|FG000|NOT COMPLETED|Overall Study||10
9878839|NCT01020474|10993597|FG001|NOT COMPLETED|Overall Study||17
9878840|NCT01020487|10993606|FG000|STARTED|Part 1||12
9878841|NCT01020487|10993607|FG001|STARTED|Part 1||0
9878842|NCT01020487|10993608|FG002|STARTED|Part 1||0
9878843|NCT01020487|10993606|FG000|COMPLETED|Part 1||12
9878844|NCT01020487|10993607|FG001|COMPLETED|Part 1||0
9878845|NCT01020487|10993608|FG002|COMPLETED|Part 1||0
9878846|NCT01020487|10993606|FG000|NOT COMPLETED|Part 1||0
9878847|NCT01020487|10993607|FG001|NOT COMPLETED|Part 1||0
9878848|NCT01020487|10993608|FG002|NOT COMPLETED|Part 1||0
9878849|NCT01020487|10993606|FG000|STARTED|Part 2 Double-blind Treatment Period||0
9878850|NCT01020487|10993607|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
9878851|NCT01020487|10993608|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
9878852|NCT01020487|10993606|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0
9878853|NCT01020487|10993607|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18
9878854|NCT01020487|10993608|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18
9878855|NCT01020487|10993606|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0
9878856|NCT01020487|10993607|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16
9878857|NCT01020487|10993608|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13
9878858|NCT01020487|10993606|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
9878859|NCT01020487|10993607|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
9878860|NCT01020487|10993608|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
9878861|NCT01020487|10993606|FG000|STARTED|Part 2 Open-label Period||0
9878862|NCT01020487|10993607|FG001|STARTED|Part 2 Open-label Period||16
9878863|NCT01020487|10993608|FG002|STARTED|Part 2 Open-label Period||13
9878864|NCT01020487|10993606|FG000|COMPLETED|Part 2 Open-label Period||0
9878865|NCT01020487|10993607|FG001|COMPLETED|Part 2 Open-label Period||12
9878866|NCT01020487|10993608|FG002|COMPLETED|Part 2 Open-label Period||12
9878867|NCT01020487|10993606|FG000|NOT COMPLETED|Part 2 Open-label Period||0
9878868|NCT01020487|10993607|FG001|NOT COMPLETED|Part 2 Open-label Period||4
9878869|NCT01020487|10993608|FG002|NOT COMPLETED|Part 2 Open-label Period||1
9878870|NCT01020526|10993618|FG000|STARTED|Overall Study||63
9878871|NCT01020526|10993618|FG000|COMPLETED|Overall Study||49
9878872|NCT01020526|10993618|FG000|NOT COMPLETED|Overall Study||14
9878873|NCT01020591|10993624|FG000|STARTED|Overall Study||15
9878874|NCT01020591|10993625|FG001|STARTED|Overall Study||15
9878875|NCT01020591|10993624|FG000|COMPLETED|Overall Study||15
9878876|NCT01020591|10993625|FG001|COMPLETED|Overall Study||15
9878877|NCT01020591|10993624|FG000|NOT COMPLETED|Overall Study||0
9878878|NCT01020591|10993625|FG001|NOT COMPLETED|Overall Study||0
9878879|NCT01020747|10993633|FG000|STARTED|Overall Study||20
9878880|NCT01020747|10993633|FG000|COMPLETED|Overall Study||19
9878881|NCT01020747|10993633|FG000|NOT COMPLETED|Overall Study||1
9878882|NCT01020773|10993640|FG000|STARTED|Overall Study||35
9878883|NCT01020773|10993641|FG001|STARTED|Overall Study||32
9878884|NCT01020773|10993640|FG000|COMPLETED|Overall Study||31
9878885|NCT01020773|10993641|FG001|COMPLETED|Overall Study||29
9878886|NCT01020773|10993640|FG000|NOT COMPLETED|Overall Study||4
9878887|NCT01020773|10993641|FG001|NOT COMPLETED|Overall Study||3
9878888|NCT01020786|10993647|FG000|STARTED|Induction Period||109
9878889|NCT01020786|10993647|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
9878890|NCT01020786|10993647|FG000|NOT COMPLETED|Induction Period||49
9878891|NCT01020786|10993647|FG000|STARTED|Maintenance Period||60
9878892|NCT01020786|10993647|FG000|COMPLETED|Maintenance Period||0
9878893|NCT01020786|10993647|FG000|NOT COMPLETED|Maintenance Period||60
9878894|NCT01020799|10993655|FG000|STARTED|Overall Study||98
9878895|NCT01020799|10993656|FG001|STARTED|Overall Study||99
9878896|NCT01020799|10993657|FG002|STARTED|Overall Study||50
9878897|NCT01020799|10993655|FG000|Patients Received Treatment|Overall Study||96
9878898|NCT01020799|10993656|FG001|Patients Received Treatment|Overall Study||99
9878899|NCT01020799|10993657|FG002|Patients Received Treatment|Overall Study||50
9878900|NCT01020799|10993655|FG000|Full Analysis Set|Overall Study||91
9878901|NCT01020799|10993656|FG001|Full Analysis Set|Overall Study||94
9878902|NCT01020799|10993657|FG002|Full Analysis Set|Overall Study||49
9878903|NCT01020799|10993655|FG000|COMPLETED|Overall Study||79
9878904|NCT01020799|10993656|FG001|COMPLETED|Overall Study||85
9878905|NCT01020799|10993657|FG002|COMPLETED|Overall Study||43
9878906|NCT01020799|10993655|FG000|NOT COMPLETED|Overall Study||19
9878907|NCT01020799|10993656|FG001|NOT COMPLETED|Overall Study||14
9878908|NCT01020799|10993657|FG002|NOT COMPLETED|Overall Study||7
9878909|NCT01020812|10993665|FG000|STARTED|Overall Study||11
9878910|NCT01020812|10993665|FG000|COMPLETED|Overall Study||8
9878911|NCT01020812|10993665|FG000|NOT COMPLETED|Overall Study||3
9878912|NCT01020838|10993669|FG000|STARTED|Overall Study||218
9878913|NCT01020838|10993669|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
9878914|NCT01020838|10993669|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
9878915|NCT01020838|10993669|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
9878916|NCT01020838|10993669|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
9878917|NCT01020838|10993669|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
9878918|NCT01020838|10993669|FG000|COMPLETED|Overall Study||35
9878919|NCT01020838|10993669|FG000|NOT COMPLETED|Overall Study||183
9878920|NCT01020877|10993684|FG000|STARTED|First Intervention||19
9878921|NCT01020877|10993685|FG001|STARTED|First Intervention||19
9878922|NCT01020877|10993684|FG000|COMPLETED|First Intervention||19
9878923|NCT01020877|10993685|FG001|COMPLETED|First Intervention||19
9878924|NCT01020877|10993684|FG000|NOT COMPLETED|First Intervention||0
9878925|NCT01020877|10993685|FG001|NOT COMPLETED|First Intervention||0
9878926|NCT01020877|10993684|FG000|STARTED|Washout of 7 Days||19
9878927|NCT01020877|10993685|FG001|STARTED|Washout of 7 Days||19
9878928|NCT01020877|10993684|FG000|COMPLETED|Washout of 7 Days||19
9878929|NCT01020877|10993685|FG001|COMPLETED|Washout of 7 Days||19
9878930|NCT01020877|10993684|FG000|NOT COMPLETED|Washout of 7 Days||0
9878931|NCT01020877|10993685|FG001|NOT COMPLETED|Washout of 7 Days||0
9878932|NCT01020877|10993684|FG000|STARTED|Second Intervention||19
9878933|NCT01020877|10993685|FG001|STARTED|Second Intervention||19
9878934|NCT01020877|10993684|FG000|COMPLETED|Second Intervention||18
9878935|NCT01020877|10993685|FG001|COMPLETED|Second Intervention||19
9878936|NCT01020877|10993684|FG000|NOT COMPLETED|Second Intervention||1
9878937|NCT01020877|10993685|FG001|NOT COMPLETED|Second Intervention||0
9878938|NCT01020981|10993693|FG000|STARTED|Overall Study||150
9878939|NCT01020981|10993694|FG001|STARTED|Overall Study||150
9878940|NCT01020981|10993693|FG000|COMPLETED|Overall Study||66
10107728|NCT02460562|11238008|FG000|STARTED|Overall Study||74
10107729|NCT02460562|11238009|FG001|STARTED|Overall Study||76
10107730|NCT02460562|11238008|FG000|COMPLETED|Overall Study||59
10107731|NCT02460562|11238009|FG001|COMPLETED|Overall Study||60
10107732|NCT02460562|11238008|FG000|NOT COMPLETED|Overall Study||15
10107733|NCT02460562|11238009|FG001|NOT COMPLETED|Overall Study||16
10107734|NCT02460575|11238017|FG000|STARTED|Overall Study||40
10107735|NCT02460575|11238018|FG001|STARTED|Overall Study||20
10107736|NCT02460575|11238017|FG000|COMPLETED|Overall Study||39
10107737|NCT02460575|11238018|FG001|COMPLETED|Overall Study||20
10107738|NCT02460575|11238017|FG000|NOT COMPLETED|Overall Study||1
10107739|NCT02460575|11238018|FG001|NOT COMPLETED|Overall Study||0
10107740|NCT02460666|11238026|FG000|STARTED|Overall Study||89
10107741|NCT02460666|11238027|FG001|STARTED|Overall Study||89
9760359|NCT00380250|10863995|FG000|COMPLETED|Overall Study||297
9760360|NCT00380250|10863996|FG001|COMPLETED|Overall Study||139
9760361|NCT00380250|10863995|FG000|NOT COMPLETED|Overall Study||99
9760362|NCT00380250|10863996|FG001|NOT COMPLETED|Overall Study||55
9760363|NCT00380367|10864002|FG000|STARTED|Overall Study||110
9760364|NCT00380367|10864002|FG000|COMPLETED|Overall Study||108
9760365|NCT00380367|10864002|FG000|NOT COMPLETED|Overall Study||2
9760366|NCT00380393|10864008|FG000|STARTED|Month 8 (Cross-sectional Visit)||447
9760367|NCT00380393|10864009|FG001|STARTED|Month 8 (Cross-sectional Visit)||447
9760368|NCT00380393|10864008|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398
9760369|NCT00380393|10864009|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407
9760370|NCT00380393|10864008|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
9760371|NCT00380393|10864009|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
9760372|NCT00380393|10864008|FG000|STARTED|Month 14||447
9760373|NCT00380393|10864009|FG001|STARTED|Month 14||447
9760374|NCT00380393|10864008|FG000|COMPLETED|Month 14||390
9760375|NCT00380393|10864009|FG001|COMPLETED|Month 14||391
9760376|NCT00380393|10864008|FG000|NOT COMPLETED|Month 14||57
9760377|NCT00380393|10864009|FG001|NOT COMPLETED|Month 14||56
9760378|NCT00380588|10864017|FG000|STARTED|Overall Study||42
9760379|NCT00380588|10864018|FG001|STARTED|Overall Study||42
9760380|NCT00380588|10864017|FG000|Received at Least One Dose of Study Drug|Overall Study||41
9760381|NCT00380588|10864018|FG001|Received at Least One Dose of Study Drug|Overall Study||42
9760382|NCT00380588|10864017|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
9760383|NCT00380588|10864018|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
9760384|NCT00380588|10864017|FG000|NOT COMPLETED|Overall Study||39
9760385|NCT00380588|10864018|FG001|NOT COMPLETED|Overall Study||40
9760386|NCT00380692|10864026|FG000|STARTED|Study Period II - Double Blind||48
9760387|NCT00380692|10864027|FG001|STARTED|Study Period II - Double Blind||49
9760388|NCT00380692|10864026|FG000|COMPLETED|Study Period II - Double Blind||43
9760389|NCT00380692|10864027|FG001|COMPLETED|Study Period II - Double Blind||46
9760390|NCT00380692|10864026|FG000|NOT COMPLETED|Study Period II - Double Blind||5
9760391|NCT00380692|10864027|FG001|NOT COMPLETED|Study Period II - Double Blind||3
9760392|NCT00380692|10864026|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
9760393|NCT00380692|10864027|FG001|STARTED|Study Period III - Open Label||46
9878941|NCT01020981|10993694|FG001|COMPLETED|Overall Study||60
9878942|NCT01020981|10993693|FG000|NOT COMPLETED|Overall Study||84
9878943|NCT01020981|10993694|FG001|NOT COMPLETED|Overall Study||90
9878944|NCT01021007|10993704|FG000|STARTED|Overall Study||36
9878945|NCT01021007|10993705|FG001|STARTED|Overall Study||37
9878946|NCT01021007|10993704|FG000|COMPLETED|Overall Study||34
9878947|NCT01021007|10993705|FG001|COMPLETED|Overall Study||33
9878948|NCT01021007|10993704|FG000|NOT COMPLETED|Overall Study||2
9878949|NCT01021007|10993705|FG001|NOT COMPLETED|Overall Study||4
9878950|NCT01021020|10993711|FG000|STARTED|Period I||28
9878951|NCT01021020|10993711|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
9878952|NCT01021020|10993711|FG000|NOT COMPLETED|Period I||2
9878953|NCT01021020|10993711|FG000|STARTED|14 Day Washout Period A||26
9878954|NCT01021020|10993711|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
9878955|NCT01021020|10993711|FG000|NOT COMPLETED|14 Day Washout Period A||1
9878956|NCT01021020|10993711|FG000|STARTED|Period II||25
9878957|NCT01021020|10993711|FG000|COMPLETED|Period II||25
9878958|NCT01021020|10993711|FG000|NOT COMPLETED|Period II||0
9878959|NCT01021020|10993711|FG000|STARTED|14 Day Washout Period B||25
9878960|NCT01021020|10993711|FG000|COMPLETED|14 Day Washout Period B||25
9878961|NCT01021020|10993711|FG000|NOT COMPLETED|14 Day Washout Period B||0
9878962|NCT01021020|10993711|FG000|STARTED|Period III||25
9878963|NCT01021020|10993711|FG000|COMPLETED|Period III||25
9878964|NCT01021020|10993711|FG000|NOT COMPLETED|Period III||0
9878965|NCT01021111|10993723|FG000|STARTED|Overall Study||17
9878966|NCT01021111|10993723|FG000|COMPLETED|Overall Study||17
9878967|NCT01021111|10993723|FG000|NOT COMPLETED|Overall Study||0
9953995|NCT01429272|11072668|FG003|STARTED|Overall Study||19
9953996|NCT01429272|11072665|FG000|COMPLETED|Overall Study||24
9953997|NCT01429272|11072666|FG001|COMPLETED|Overall Study||22
9953998|NCT01429272|11072667|FG002|COMPLETED|Overall Study||15
9953999|NCT01429272|11072668|FG003|COMPLETED|Overall Study||14
9954000|NCT01429272|11072665|FG000|NOT COMPLETED|Overall Study||6
9954001|NCT01429272|11072666|FG001|NOT COMPLETED|Overall Study||9
9954002|NCT01429272|11072667|FG002|NOT COMPLETED|Overall Study||4
9954003|NCT01429272|11072668|FG003|NOT COMPLETED|Overall Study||5
9954004|NCT01429285|11072680|FG000|STARTED|Overall Study||175
9954005|NCT01429285|11072681|FG001|STARTED|Overall Study||175
9954006|NCT01429285|11072680|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
9954007|NCT01429285|11072681|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
9954008|NCT01429285|11072680|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
9954009|NCT01429285|11072681|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
9954010|NCT01429285|11072680|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
9954011|NCT01429285|11072681|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
9954012|NCT01429285|11072680|FG000|COMPLETED|Overall Study||153
9954013|NCT01429285|11072681|FG001|COMPLETED|Overall Study||166
9954014|NCT01429285|11072680|FG000|NOT COMPLETED|Overall Study||22
9954015|NCT01429285|11072681|FG001|NOT COMPLETED|Overall Study||9
9954016|NCT01429298|11072689|FG000|STARTED|Overall Study||175
9954017|NCT01429298|11072690|FG001|STARTED|Overall Study||175
9954018|NCT01429298|11072689|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171
9954019|NCT01429298|11072690|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169
9954020|NCT01429298|11072689|FG000|COMPLETED|Overall Study||171
9878968|NCT01021137|10993731|FG000|STARTED|Overall Study||62
9878969|NCT01021137|10993732|FG001|STARTED|Overall Study||20
9878970|NCT01021137|10993733|FG002|STARTED|Overall Study||11
9878971|NCT01021137|10993734|FG003|STARTED|Overall Study||41
9878972|NCT01021137|10993731|FG000|COMPLETED|Overall Study||52
9878973|NCT01021137|10993732|FG001|COMPLETED|Overall Study||16
9878974|NCT01021137|10993733|FG002|COMPLETED|Overall Study||9
9878975|NCT01021137|10993734|FG003|COMPLETED|Overall Study||32
9878976|NCT01021137|10993731|FG000|NOT COMPLETED|Overall Study||10
9878977|NCT01021137|10993732|FG001|NOT COMPLETED|Overall Study||4
9878978|NCT01021137|10993733|FG002|NOT COMPLETED|Overall Study||2
9878979|NCT01021137|10993734|FG003|NOT COMPLETED|Overall Study||9
9878980|NCT01021215|10993747|FG000|STARTED|Overall Study||60
9878981|NCT01021215|10993748|FG001|STARTED|Overall Study||20
9878982|NCT01021215|10993747|FG000|Received Allocated Intervention|Overall Study||60
9878983|NCT01021215|10993748|FG001|Received Allocated Intervention|Overall Study||20
9878984|NCT01021215|10993747|FG000|COMPLETED|Overall Study||57
9878985|NCT01021215|10993748|FG001|COMPLETED|Overall Study||20
9878986|NCT01021215|10993747|FG000|NOT COMPLETED|Overall Study||3
9878987|NCT01021215|10993748|FG001|NOT COMPLETED|Overall Study||0
9954021|NCT01429298|11072690|FG001|COMPLETED|Overall Study||169
9954022|NCT01429298|11072689|FG000|NOT COMPLETED|Overall Study||4
9954023|NCT01429298|11072690|FG001|NOT COMPLETED|Overall Study||6
9954024|NCT01429350|11072698|FG000|STARTED|Overall Study||53
9954025|NCT01429350|11072699|FG001|STARTED|Overall Study||55
9954026|NCT01429350|11072698|FG000|As-Treated|Overall Study||62
9954027|NCT01429350|11072699|FG001|As-Treated|Overall Study||43
9954028|NCT01429350|11072698|FG000|Per Protocol|Overall Study||41
9954029|NCT01429350|11072699|FG001|Per Protocol|Overall Study||37
9954030|NCT01429350|11072698|FG000|90 Day|Overall Study||46
9954031|NCT01429350|11072699|FG001|90 Day|Overall Study||50
9954032|NCT01429350|11072698|FG000|COMPLETED|Overall Study||46
9954033|NCT01429350|11072699|FG001|COMPLETED|Overall Study||50
9954034|NCT01429350|11072698|FG000|NOT COMPLETED|Overall Study||7
10107742|NCT02460666|11238026|FG000|COMPLETED|Overall Study||62
10107743|NCT02460666|11238027|FG001|COMPLETED|Overall Study||63
10107744|NCT02460666|11238026|FG000|NOT COMPLETED|Overall Study||27
10107745|NCT02460666|11238027|FG001|NOT COMPLETED|Overall Study||26
10107746|NCT02460679|11238033|FG000|STARTED|Overall Study||19
10107747|NCT02460679|11238033|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
9954035|NCT01429350|11072699|FG001|NOT COMPLETED|Overall Study||5
9954036|NCT01429441|11072707|FG000|STARTED|Overall Study||146
9954037|NCT01429441|11072708|FG001|STARTED|Overall Study||74
9954038|NCT01429441|11072707|FG000|COMPLETED|Overall Study||108
9954039|NCT01429441|11072708|FG001|COMPLETED|Overall Study||51
9954040|NCT01429441|11072707|FG000|NOT COMPLETED|Overall Study||38
9954041|NCT01429441|11072708|FG001|NOT COMPLETED|Overall Study||23
9954042|NCT01429454|11072716|FG000|STARTED|Overall Study||62
9954043|NCT01429454|11072717|FG001|STARTED|Overall Study||65
9954044|NCT01429454|11072716|FG000|COMPLETED|Overall Study||35
9954045|NCT01429454|11072717|FG001|COMPLETED|Overall Study||35
9954046|NCT01429454|11072716|FG000|NOT COMPLETED|Overall Study||27
9954047|NCT01429454|11072717|FG001|NOT COMPLETED|Overall Study||30
9954048|NCT01429532|11072727|FG000|STARTED|Overall Study||40
9954049|NCT01429532|11072728|FG001|STARTED|Overall Study||40
9954050|NCT01429532|11072729|FG002|STARTED|Overall Study||40
9954051|NCT01429532|11072727|FG000|COMPLETED|Overall Study||40
9954052|NCT01429532|11072728|FG001|COMPLETED|Overall Study||40
9954053|NCT01429532|11072729|FG002|COMPLETED|Overall Study||40
9954054|NCT01429532|11072727|FG000|NOT COMPLETED|Overall Study||0
9954055|NCT01429532|11072728|FG001|NOT COMPLETED|Overall Study||0
9954056|NCT01429532|11072729|FG002|NOT COMPLETED|Overall Study||0
9954057|NCT01429584|11072739|FG000|STARTED|Overall Study||15
9954058|NCT01429584|11072740|FG001|STARTED|Overall Study||15
9954059|NCT01429584|11072739|FG000|COMPLETED|Overall Study||14
9954060|NCT01429584|11072740|FG001|COMPLETED|Overall Study||14
9954061|NCT01429584|11072739|FG000|NOT COMPLETED|Overall Study||1
10202761|NCT03449446|11329878|FG001|COMPLETED|Overall Study||33
10202762|NCT03449446|11329879|FG002|COMPLETED|Overall Study||34
10202763|NCT03449446|11329880|FG003|COMPLETED|Overall Study||71
10202764|NCT03449446|11329881|FG004|COMPLETED|Overall Study||66
10107748|NCT02460679|11238033|FG000|COMPLETED|Overall Study||14
10107749|NCT02460679|11238033|FG000|NOT COMPLETED|Overall Study||5
10107750|NCT02460822|11238037|FG000|STARTED|Overall Study||16
10107751|NCT02460822|11238037|FG000|COMPLETED|Overall Study||15
10202765|NCT03449446|11329882|FG005|COMPLETED|Overall Study||69
9954062|NCT01429584|11072740|FG001|NOT COMPLETED|Overall Study||1
9954063|NCT01429623|11072748|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
9954064|NCT01429623|11072749|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
10107752|NCT02460822|11238037|FG000|NOT COMPLETED|Overall Study||1
10107753|NCT02460978|11238044|FG000|STARTED|Overall Study||271
10107754|NCT02460978|11238045|FG001|STARTED|Overall Study||270
10107755|NCT02460978|11238046|FG002|STARTED|Overall Study||272
10202766|NCT03449446|11329883|FG006|COMPLETED|Overall Study||38
9954065|NCT01429623|11072748|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14
9954066|NCT01429623|11072749|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21
9954067|NCT01429623|11072748|FG000|COMPLETED|Overall Study||51
9954068|NCT01429623|11072749|FG001|COMPLETED|Overall Study||48
9954069|NCT01429623|11072748|FG000|NOT COMPLETED|Overall Study||51
9954070|NCT01429623|11072749|FG001|NOT COMPLETED|Overall Study||59
9954071|NCT01429792|11072755|FG000|STARTED|Overall Study||1013
9878988|NCT04525456|10993754|FG000|STARTED|Overall Study||20
9878989|NCT04525456|10993754|FG000|COMPLETED|Overall Study||20
9878990|NCT04525456|10993754|FG000|NOT COMPLETED|Overall Study||0
9879016|NCT03554850|10993792|FG000|STARTED|Overall Study||201
9879017|NCT03554850|10993792|FG000|COMPLETED|Overall Study||190
9879018|NCT03554850|10993792|FG000|NOT COMPLETED|Overall Study||11
9879019|NCT03426566|10993800|FG000|STARTED|Overall Study||974
9879020|NCT03426566|10993800|FG000|COMPLETED|Overall Study||974
9879021|NCT03426566|10993800|FG000|NOT COMPLETED|Overall Study||0
9879022|NCT03398356|10993809|FG000|STARTED|Before Treatment||15
9879023|NCT03398356|10993810|FG001|STARTED|Before Treatment||21
9879024|NCT03398356|10993811|FG002|STARTED|Before Treatment||11
9879025|NCT03398356|10993809|FG000|COMPLETED|Before Treatment||12
9879026|NCT03398356|10993810|FG001|COMPLETED|Before Treatment||13
9879027|NCT03398356|10993811|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
9879028|NCT03398356|10993809|FG000|NOT COMPLETED|Before Treatment||3
9879029|NCT03398356|10993810|FG001|NOT COMPLETED|Before Treatment||8
9879030|NCT03398356|10993811|FG002|NOT COMPLETED|Before Treatment||11
9879031|NCT03398356|10993809|FG000|STARTED|After 6 Weeks of Treatment||12
9879032|NCT03398356|10993810|FG001|STARTED|After 6 Weeks of Treatment||13
9879033|NCT03398356|10993811|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
9879034|NCT03398356|10993809|FG000|COMPLETED|After 6 Weeks of Treatment||12
9879035|NCT03398356|10993810|FG001|COMPLETED|After 6 Weeks of Treatment||11
9879036|NCT03398356|10993811|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
9879037|NCT03398356|10993809|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0
9879038|NCT03398356|10993810|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2
9879039|NCT03398356|10993811|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0
9879040|NCT03398356|10993809|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
9879041|NCT03398356|10993810|FG001|STARTED|Post 6 Week Period Initial Evaluation||11
9879042|NCT03398356|10993811|FG002|STARTED|Post 6 Week Period Initial Evaluation||0
9879043|NCT03398356|10993809|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14
9879044|NCT03398356|10993810|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11
9879045|NCT03398356|10993811|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0
9879046|NCT03398356|10993809|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
9879047|NCT03398356|10993810|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
9879048|NCT03398356|10993811|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
9879049|NCT03398356|10993809|FG000|STARTED|After 12 Weeks of Treatment||14
9879050|NCT03398356|10993810|FG001|STARTED|After 12 Weeks of Treatment||11
9879051|NCT03398356|10993811|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
9879052|NCT03398356|10993809|FG000|COMPLETED|After 12 Weeks of Treatment||14
9879053|NCT03398356|10993810|FG001|COMPLETED|After 12 Weeks of Treatment||11
9879054|NCT03398356|10993811|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
9879055|NCT03398356|10993809|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0
9879056|NCT03398356|10993810|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0
9879057|NCT03398356|10993811|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0
9879058|NCT03398356|10993809|FG000|STARTED|After 15 Weeks of Treatment||14
9879059|NCT03398356|10993810|FG001|STARTED|After 15 Weeks of Treatment||11
9879060|NCT03398356|10993811|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
9879061|NCT03398356|10993809|FG000|COMPLETED|After 15 Weeks of Treatment||14
9879062|NCT03398356|10993810|FG001|COMPLETED|After 15 Weeks of Treatment||11
9879063|NCT03398356|10993811|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
9879064|NCT03398356|10993809|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0
9879065|NCT03398356|10993810|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0
9879066|NCT03398356|10993811|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0
9879067|NCT03365791|10993819|FG000|STARTED|Overall Study||76
9879068|NCT03365791|10993819|FG000|Full Analysis Set (FAS)|Overall Study||75
9879069|NCT03365791|10993819|FG000|COMPLETED|Overall Study||4
9879070|NCT03365791|10993819|FG000|NOT COMPLETED|Overall Study||72
9879071|NCT03350750|10993826|FG000|STARTED|Overall Study||9
9879072|NCT03350750|10993827|FG001|STARTED|Overall Study||9
9879073|NCT03350750|10993826|FG000|4-month Follow-up (Randomized Evaluation)|Overall Study||8
9879074|NCT03350750|10993827|FG001|4-month Follow-up (Randomized Evaluation)|Overall Study||8
9879075|NCT03350750|10993826|FG000|12-Month Follow-up (Entire Study)|Overall Study||8
9879076|NCT03350750|10993827|FG001|12-Month Follow-up (Entire Study)|Overall Study||8
9879077|NCT03350750|10993826|FG000|COMPLETED|Overall Study||8
9879078|NCT03350750|10993827|FG001|COMPLETED|Overall Study||8
9879079|NCT03350750|10993826|FG000|NOT COMPLETED|Overall Study||1
9879080|NCT03350750|10993827|FG001|NOT COMPLETED|Overall Study||1
9879081|NCT03125148|10993837|FG000|STARTED|Overall Study||9
9879082|NCT03125148|10993838|FG001|STARTED|Overall Study||8
9879083|NCT03125148|10993837|FG000|COMPLETED|Overall Study||9
9879084|NCT03125148|10993838|FG001|COMPLETED|Overall Study||8
9879085|NCT03125148|10993837|FG000|NOT COMPLETED|Overall Study||0
9879086|NCT03125148|10993838|FG001|NOT COMPLETED|Overall Study||0
9879087|NCT02819440|10993846|FG000|STARTED|Overall Study||61
9879088|NCT02819440|10993847|FG001|STARTED|Overall Study||64
9879089|NCT02819440|10993846|FG000|COMPLETED|Overall Study||48
9878991|NCT04161131|10993759|FG000|STARTED|Overall Study||28
9878992|NCT04161131|10993759|FG000|Completed Baseline Surveys|Overall Study||27
9878993|NCT04161131|10993759|FG000|Received Intervention|Overall Study||22
9878994|NCT04161131|10993759|FG000|COMPLETED|Overall Study||22
9878995|NCT04161131|10993759|FG000|NOT COMPLETED|Overall Study||6
9878996|NCT04102501|10993765|FG000|STARTED|Overall Study||33
9878997|NCT04102501|10993766|FG001|STARTED|Overall Study||32
9878998|NCT04102501|10993765|FG000|11 Month Visit|Overall Study||25
9878999|NCT04102501|10993766|FG001|11 Month Visit|Overall Study||20
9879000|NCT04102501|10993765|FG000|COMPLETED|Overall Study||25
9879001|NCT04102501|10993766|FG001|COMPLETED|Overall Study||20
9879002|NCT04102501|10993765|FG000|NOT COMPLETED|Overall Study||8
9879003|NCT04102501|10993766|FG001|NOT COMPLETED|Overall Study||12
9879004|NCT04087343|10993776|FG000|STARTED|Overall Study||4
9879005|NCT04087343|10993777|FG001|STARTED|Overall Study||5
9879006|NCT04087343|10993776|FG000|COMPLETED|Overall Study||4
9879007|NCT04087343|10993777|FG001|COMPLETED|Overall Study||5
9879008|NCT04087343|10993776|FG000|NOT COMPLETED|Overall Study||0
9879009|NCT04087343|10993777|FG001|NOT COMPLETED|Overall Study||0
9879010|NCT03656107|10993785|FG000|STARTED|Overall Study||28
9879011|NCT03656107|10993786|FG001|STARTED|Overall Study||28
9879012|NCT03656107|10993785|FG000|COMPLETED|Overall Study||25
9879013|NCT03656107|10993786|FG001|COMPLETED|Overall Study||27
9879014|NCT03656107|10993785|FG000|NOT COMPLETED|Overall Study||3
9879015|NCT03656107|10993786|FG001|NOT COMPLETED|Overall Study||1
9879090|NCT02819440|10993847|FG001|COMPLETED|Overall Study||52
9879091|NCT02819440|10993846|FG000|NOT COMPLETED|Overall Study||13
9879092|NCT02819440|10993847|FG001|NOT COMPLETED|Overall Study||12
9879093|NCT02782741|10993855|FG000|STARTED|Blinded Treatment Period: up to Week 49||51
9879094|NCT02782741|10993856|FG001|STARTED|Blinded Treatment Period: up to Week 49||49
9879095|NCT02782741|10993855|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51
9879096|NCT02782741|10993856|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49
9879097|NCT02782741|10993855|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51
9879098|NCT02782741|10993856|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44
9879099|NCT02782741|10993855|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
9879100|NCT02782741|10993856|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
9879101|NCT02782741|10993855|FG000|STARTED|Open-label Long-term: Week 50 to 145||51
9879102|NCT02782741|10993856|FG001|STARTED|Open-label Long-term: Week 50 to 145||44
9879103|NCT02782741|10993855|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51
9879104|NCT02782741|10993856|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44
9879105|NCT02782741|10993855|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0
9879106|NCT02782741|10993856|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0
9879107|NCT02782741|10993855|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
9879108|NCT02782741|10993856|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
9879115|NCT02647359|10993877|FG000|STARTED|Stage 1: Double-Masked Period (48 Weeks)||26
9879116|NCT02647359|10993878|FG001|STARTED|Stage 1: Double-Masked Period (48 Weeks)||13
9879117|NCT02647359|10993877|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||26
9879118|NCT02647359|10993878|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||13
9879119|NCT02647359|10993877|FG000|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||22
10107756|NCT02460978|11238044|FG000|COMPLETED|Overall Study||244
10107757|NCT02460978|11238045|FG001|COMPLETED|Overall Study||245
10107758|NCT02460978|11238046|FG002|COMPLETED|Overall Study||239
9879120|NCT02647359|10993878|FG001|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||12
9879121|NCT02647359|10993877|FG000|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||4
9879122|NCT02647359|10993878|FG001|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||1
9879123|NCT02647359|10993877|FG000|STARTED|Stage 2: Open-Label Extension (96 Weeks)||22
9879124|NCT02647359|10993878|FG001|STARTED|Stage 2: Open-Label Extension (96 Weeks)|1 participant completed Stage 1 but did not enter open-label part|11
9879125|NCT02647359|10993877|FG000|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||12
9879126|NCT02647359|10993878|FG001|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||7
9879127|NCT02647359|10993877|FG000|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||10
9879128|NCT02647359|10993878|FG001|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||4
9879129|NCT02647359|10993877|FG000|STARTED|Open-Label Sub-Study (96 Weeks)|2 participants completed open-label 144-weeks but did not enter open-label sub-study|10
9879130|NCT02647359|10993878|FG001|STARTED|Open-Label Sub-Study (96 Weeks)||7
9879131|NCT02647359|10993877|FG000|COMPLETED|Open-Label Sub-Study (96 Weeks)||2
9879132|NCT02647359|10993878|FG001|COMPLETED|Open-Label Sub-Study (96 Weeks)||3
9879133|NCT02647359|10993877|FG000|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||8
9879134|NCT02647359|10993878|FG001|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||4
10107759|NCT02460978|11238044|FG000|NOT COMPLETED|Overall Study||27
10107760|NCT02460978|11238045|FG001|NOT COMPLETED|Overall Study||25
10107761|NCT02460978|11238046|FG002|NOT COMPLETED|Overall Study||33
10107762|NCT02460991|11238056|FG000|STARTED|Overall Study||0
9879135|NCT02485691|10993890|FG000|STARTED|Overall Study||129
10107763|NCT02460991|11238057|FG001|STARTED|Overall Study||2
10107764|NCT02460991|11238056|FG000|COMPLETED|Overall Study||0
9879136|NCT02485691|10993891|FG001|STARTED|Overall Study||126
9879137|NCT02485691|10993890|FG000|Treated|Overall Study||126
9879138|NCT02485691|10993891|FG001|Treated|Overall Study||124
9879139|NCT02485691|10993890|FG000|COMPLETED|Overall Study||0
9879140|NCT02485691|10993891|FG001|COMPLETED|Overall Study||0
9879141|NCT02485691|10993890|FG000|NOT COMPLETED|Overall Study||129
9879142|NCT02485691|10993891|FG001|NOT COMPLETED|Overall Study||126
9879143|NCT02201251|10993900|FG000|STARTED|Overall Study||28
9879144|NCT02201251|10993901|FG001|STARTED|Overall Study||35
9879145|NCT02201251|10993900|FG000|COMPLETED|Overall Study||24
9879146|NCT02201251|10993901|FG001|COMPLETED|Overall Study||32
9879147|NCT02201251|10993900|FG000|NOT COMPLETED|Overall Study||4
9879148|NCT02201251|10993901|FG001|NOT COMPLETED|Overall Study||3
9954072|NCT01429792|11072755|FG000|Genotype 1|Overall Study||687
9954073|NCT01429792|11072755|FG000|Genotype 2 & 3|Overall Study||305
9954074|NCT01429792|11072755|FG000|Genotype 4|Overall Study||5
9954075|NCT01429792|11072755|FG000|COMPLETED|Overall Study||607
9954076|NCT01429792|11072755|FG000|NOT COMPLETED|Overall Study||406
9954077|NCT01429987|11072763|FG000|STARTED|Overall Study||238
9954078|NCT01429987|11072764|FG001|STARTED|Overall Study||238
9954079|NCT01429987|11072765|FG002|STARTED|Overall Study||238
9954080|NCT01429987|11072766|FG003|STARTED|Overall Study||237
9954081|NCT01429987|11072763|FG000|COMPLETED|Overall Study||189
9954082|NCT01429987|11072764|FG001|COMPLETED|Overall Study||176
9954083|NCT01429987|11072765|FG002|COMPLETED|Overall Study||202
9954084|NCT01429987|11072766|FG003|COMPLETED|Overall Study||171
9954085|NCT01429987|11072763|FG000|NOT COMPLETED|Overall Study||49
9954086|NCT01429987|11072764|FG001|NOT COMPLETED|Overall Study||62
9954087|NCT01429987|11072765|FG002|NOT COMPLETED|Overall Study||36
9954088|NCT01429987|11072766|FG003|NOT COMPLETED|Overall Study||66
9954089|NCT01430091|11072776|FG000|STARTED|Overall Study||18
9954090|NCT01430091|11072776|FG000|COMPLETED|Overall Study||18
10107765|NCT02460991|11238057|FG001|COMPLETED|Overall Study||0
10107766|NCT02460991|11238056|FG000|NOT COMPLETED|Overall Study||0
10107767|NCT02460991|11238057|FG001|NOT COMPLETED|Overall Study||2
10107768|NCT02461134|11238068|FG000|STARTED|Overall Study||1
10107769|NCT02461134|11238068|FG000|COMPLETED|Overall Study||0
10107770|NCT02461134|11238068|FG000|NOT COMPLETED|Overall Study||1
10107771|NCT02461160|11238085|FG000|STARTED|Overall Study||8
10107772|NCT02461160|11238086|FG001|STARTED|Overall Study||6
10107773|NCT02461160|11238087|FG002|STARTED|Overall Study||6
10107774|NCT02461160|11238088|FG003|STARTED|Overall Study||12
10107775|NCT02461160|11238089|FG004|STARTED|Overall Study||6
10107776|NCT02461160|11238090|FG005|STARTED|Overall Study||6
9954091|NCT01430091|11072776|FG000|NOT COMPLETED|Overall Study||0
9954092|NCT01430104|11072790|FG000|STARTED|14-Day Lead-In Period||30
9954093|NCT01430104|11072790|FG000|COMPLETED|14-Day Lead-In Period||30
9954094|NCT01430104|11072790|FG000|NOT COMPLETED|14-Day Lead-In Period||0
9954095|NCT01430104|11072790|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
9954096|NCT01430104|11072790|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
9954097|NCT01430104|11072790|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28
9954098|NCT01430104|11072790|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
9954099|NCT01430130|11072797|FG000|STARTED|Overall Study||12
10107777|NCT02461160|11238091|FG006|STARTED|Overall Study||6
10107778|NCT02461160|11238092|FG007|STARTED|Overall Study||6
10107779|NCT02461160|11238093|FG008|STARTED|Overall Study||12
10107780|NCT02461160|11238094|FG009|STARTED|Overall Study||4
10107781|NCT02461160|11238095|FG010|STARTED|Overall Study||4
10107782|NCT02461160|11238096|FG011|STARTED|Overall Study||4
10107783|NCT02461160|11238097|FG012|STARTED|Overall Study||8
10107784|NCT02461160|11238085|FG000|COMPLETED|Overall Study||8
10107785|NCT02461160|11238086|FG001|COMPLETED|Overall Study||6
10107786|NCT02461160|11238087|FG002|COMPLETED|Overall Study||6
10107787|NCT02461160|11238088|FG003|COMPLETED|Overall Study||12
10107788|NCT02461160|11238089|FG004|COMPLETED|Overall Study||6
10107789|NCT02461160|11238090|FG005|COMPLETED|Overall Study||6
10107790|NCT02461160|11238091|FG006|COMPLETED|Overall Study||6
10107791|NCT02461160|11238092|FG007|COMPLETED|Overall Study||5
10107792|NCT02461160|11238093|FG008|COMPLETED|Overall Study||12
9954100|NCT01430130|11072797|FG000|COMPLETED|Overall Study||10
9954101|NCT01430130|11072797|FG000|NOT COMPLETED|Overall Study||2
9954102|NCT01430169|11072803|FG000|STARTED|Overall Study||20
9954103|NCT01430169|11072803|FG000|COMPLETED|Overall Study||20
9954104|NCT01430169|11072803|FG000|NOT COMPLETED|Overall Study||0
10107793|NCT02461160|11238094|FG009|COMPLETED|Overall Study||4
10107794|NCT02461160|11238095|FG010|COMPLETED|Overall Study||4
9954105|NCT01430182|11072809|FG000|STARTED|Overall Study||9
9954106|NCT01430182|11072810|FG001|STARTED|Overall Study||8
9954107|NCT01430182|11072809|FG000|COMPLETED|Overall Study||9
10107795|NCT02461160|11238096|FG011|COMPLETED|Overall Study||4
10107796|NCT02461160|11238097|FG012|COMPLETED|Overall Study||8
10107797|NCT02461160|11238085|FG000|NOT COMPLETED|Overall Study||0
10107798|NCT02461160|11238086|FG001|NOT COMPLETED|Overall Study||0
10107799|NCT02461160|11238087|FG002|NOT COMPLETED|Overall Study||0
9954108|NCT01430182|11072810|FG001|COMPLETED|Overall Study||8
9954109|NCT01430182|11072809|FG000|NOT COMPLETED|Overall Study||0
9954110|NCT01430182|11072810|FG001|NOT COMPLETED|Overall Study||0
9954111|NCT01430299|11072818|FG000|STARTED|Overall Study||20
10107800|NCT02461160|11238088|FG003|NOT COMPLETED|Overall Study||0
10107801|NCT02461160|11238089|FG004|NOT COMPLETED|Overall Study||0
10107802|NCT02461160|11238090|FG005|NOT COMPLETED|Overall Study||0
9879149|NCT02000596|10993910|FG000|STARTED|Cohort 1||2
9879150|NCT02000596|10993911|FG001|STARTED|Cohort 1||0
9879151|NCT02000596|10993912|FG002|STARTED|Cohort 1||0
9879152|NCT02000596|10993910|FG000|COMPLETED|Cohort 1||2
9879153|NCT02000596|10993911|FG001|COMPLETED|Cohort 1||0
9879154|NCT02000596|10993912|FG002|COMPLETED|Cohort 1||0
9879155|NCT02000596|10993910|FG000|NOT COMPLETED|Cohort 1||0
9879156|NCT02000596|10993911|FG001|NOT COMPLETED|Cohort 1||0
9879157|NCT02000596|10993912|FG002|NOT COMPLETED|Cohort 1||0
9879158|NCT02000596|10993910|FG000|STARTED|Cohort 2||0
9879159|NCT02000596|10993911|FG001|STARTED|Cohort 2||0
9879160|NCT02000596|10993912|FG002|STARTED|Cohort 2||2
9879161|NCT02000596|10993910|FG000|COMPLETED|Cohort 2||0
9879162|NCT02000596|10993911|FG001|COMPLETED|Cohort 2||0
9879163|NCT02000596|10993912|FG002|COMPLETED|Cohort 2||2
9879164|NCT02000596|10993910|FG000|NOT COMPLETED|Cohort 2||0
9879165|NCT02000596|10993911|FG001|NOT COMPLETED|Cohort 2||0
9879166|NCT02000596|10993912|FG002|NOT COMPLETED|Cohort 2||0
9879167|NCT00929253|10993922|FG000|STARTED|Overall Study||91
9879168|NCT00929253|10993923|FG001|STARTED|Overall Study||79
9879169|NCT00929253|10993922|FG000|COMPLETED|Overall Study||91
9879170|NCT00929253|10993923|FG001|COMPLETED|Overall Study||79
9879171|NCT00929253|10993922|FG000|NOT COMPLETED|Overall Study||0
9879172|NCT00929253|10993923|FG001|NOT COMPLETED|Overall Study||0
9879173|NCT00657241|10993931|FG000|STARTED|Overall Study||15
9879174|NCT00657241|10993932|FG001|STARTED|Overall Study||15
9879175|NCT00657241|10993931|FG000|COMPLETED|Overall Study||15
9879176|NCT00657241|10993932|FG001|COMPLETED|Overall Study||15
9879177|NCT00657241|10993931|FG000|NOT COMPLETED|Overall Study||0
9879178|NCT00657241|10993932|FG001|NOT COMPLETED|Overall Study||0
9879179|NCT01021293|10993944|FG000|STARTED|Overall Study||550
9879180|NCT01021293|10993945|FG001|STARTED|Overall Study||550
9879181|NCT01021293|10993944|FG000|COMPLETED|Overall Study||538
9879182|NCT01021293|10993945|FG001|COMPLETED|Overall Study||526
9879183|NCT01021293|10993944|FG000|NOT COMPLETED|Overall Study||12
9879184|NCT01021293|10993945|FG001|NOT COMPLETED|Overall Study||24
9879185|NCT01021306|10993956|FG000|STARTED|2 Month (Primary Outcome)||20
9879186|NCT01021306|10993957|FG001|STARTED|2 Month (Primary Outcome)||20
9879187|NCT01021306|10993958|FG002|STARTED|2 Month (Primary Outcome)||19
9879188|NCT01021306|10993959|FG003|STARTED|2 Month (Primary Outcome)||21
9879189|NCT01021306|10993956|FG000|COMPLETED|2 Month (Primary Outcome)||14
9879190|NCT01021306|10993957|FG001|COMPLETED|2 Month (Primary Outcome)||14
9879191|NCT01021306|10993958|FG002|COMPLETED|2 Month (Primary Outcome)||14
9879192|NCT01021306|10993959|FG003|COMPLETED|2 Month (Primary Outcome)||17
9879193|NCT01021306|10993956|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6
9879194|NCT01021306|10993957|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6
9879195|NCT01021306|10993958|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5
9879196|NCT01021306|10993959|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4
9879197|NCT01021306|10993956|FG000|STARTED|6 Month (Follow-up)||14
9879198|NCT01021306|10993957|FG001|STARTED|6 Month (Follow-up)||14
9879199|NCT01021306|10993958|FG002|STARTED|6 Month (Follow-up)||14
9879200|NCT01021306|10993959|FG003|STARTED|6 Month (Follow-up)||17
9879201|NCT01021306|10993956|FG000|COMPLETED|6 Month (Follow-up)||11
9879202|NCT01021306|10993957|FG001|COMPLETED|6 Month (Follow-up)||13
9879203|NCT01021306|10993958|FG002|COMPLETED|6 Month (Follow-up)||14
9879204|NCT01021306|10993959|FG003|COMPLETED|6 Month (Follow-up)||14
9879205|NCT01021306|10993956|FG000|NOT COMPLETED|6 Month (Follow-up)||3
9879206|NCT01021306|10993957|FG001|NOT COMPLETED|6 Month (Follow-up)||1
9879207|NCT01021306|10993958|FG002|NOT COMPLETED|6 Month (Follow-up)||0
9879208|NCT01021306|10993959|FG003|NOT COMPLETED|6 Month (Follow-up)||3
9879209|NCT01021332|10993969|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
9879210|NCT01021332|10993969|FG000|Safety Analysis Set (SAF)|Overall Study||1066
9879211|NCT01021332|10993969|FG000|Full Analysis Set (FAS)|Overall Study||1009
9879212|NCT01021332|10993969|FG000|COMPLETED|Overall Study||960
9879213|NCT01021332|10993969|FG000|NOT COMPLETED|Overall Study||106
9879214|NCT01021423|10993977|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
9879215|NCT01021423|10993978|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
9879216|NCT01021423|10993977|FG000|COMPLETED|Overall Study||0
9879217|NCT01021423|10993978|FG001|COMPLETED|Overall Study||0
9879218|NCT01021423|10993977|FG000|NOT COMPLETED|Overall Study||4
9879219|NCT01021423|10993978|FG001|NOT COMPLETED|Overall Study||5
9879220|NCT01021553|10993987|FG000|STARTED|Overall Study||27
9879221|NCT01021553|10993988|FG001|STARTED|Overall Study||22
9879222|NCT01021553|10993989|FG002|STARTED|Overall Study||28
9879223|NCT01021553|10993987|FG000|COMPLETED|Overall Study||23
9879224|NCT01021553|10993988|FG001|COMPLETED|Overall Study||17
9879225|NCT01021553|10993989|FG002|COMPLETED|Overall Study||25
9879226|NCT01021553|10993987|FG000|NOT COMPLETED|Overall Study||4
9879227|NCT01021553|10993988|FG001|NOT COMPLETED|Overall Study||5
9879228|NCT01021553|10993989|FG002|NOT COMPLETED|Overall Study||3
9879229|NCT01021618|10994004|FG000|STARTED|Overall Study||44
9879230|NCT01021618|10994005|FG001|STARTED|Overall Study||96
9879231|NCT01021618|10994004|FG000|COMPLETED|Overall Study||44
9879232|NCT01021618|10994005|FG001|COMPLETED|Overall Study||96
9879233|NCT01021618|10994004|FG000|NOT COMPLETED|Overall Study||0
9879234|NCT01021618|10994005|FG001|NOT COMPLETED|Overall Study||0
9879235|NCT01021683|10994011|FG000|STARTED|Overall Study||203
9879236|NCT01021683|10994011|FG000|COMPLETED|Overall Study||132
9879237|NCT01021683|10994011|FG000|NOT COMPLETED|Overall Study||71
9879238|NCT01021748|10994024|FG000|STARTED|Overall Study||6
9879239|NCT01021748|10994025|FG001|STARTED|Overall Study||5
9879240|NCT01021748|10994026|FG002|STARTED|Overall Study||7
9879241|NCT01021748|10994027|FG003|STARTED|Overall Study||7
9879242|NCT01021748|10994028|FG004|STARTED|Overall Study||9
9879243|NCT01021748|10994029|FG005|STARTED|Overall Study||3
9879244|NCT01021748|10994030|FG006|STARTED|Overall Study||3
9879245|NCT01021748|10994031|FG007|STARTED|Overall Study||6
9879246|NCT01021748|10994032|FG008|STARTED|Overall Study||17
9879247|NCT01021748|10994024|FG000|Treated|Overall Study||6
9879248|NCT01021748|10994025|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4
9879249|NCT01021748|10994026|FG002|Treated|Overall Study||7
9879250|NCT01021748|10994027|FG003|Treated|Overall Study||7
9879251|NCT01021748|10994028|FG004|Treated|Overall Study||9
9879252|NCT01021748|10994029|FG005|Treated|Overall Study||3
9879253|NCT01021748|10994030|FG006|Treated|Overall Study||3
9879254|NCT01021748|10994031|FG007|Treated|Overall Study||6
10007644|NCT01751802|11129901|FG001|STARTED|Overall Study||4
10007645|NCT01751802|11129900|FG000|Completed Period 1|Overall Study||2
10007646|NCT01751802|11129901|FG001|Completed Period 1|Overall Study||4
10007647|NCT01751802|11129900|FG000|Completed Period 2|Overall Study||2
9879255|NCT01021748|10994032|FG008|Treated|Overall Study||17
9879256|NCT01021748|10994024|FG000|COMPLETED|Overall Study||0
9879257|NCT01021748|10994025|FG001|COMPLETED|Overall Study||0
9879258|NCT01021748|10994026|FG002|COMPLETED|Overall Study||0
9879259|NCT01021748|10994027|FG003|COMPLETED|Overall Study||0
9879260|NCT01021748|10994028|FG004|COMPLETED|Overall Study||0
9879261|NCT01021748|10994029|FG005|COMPLETED|Overall Study||0
9879262|NCT01021748|10994030|FG006|COMPLETED|Overall Study||0
9879263|NCT01021748|10994031|FG007|COMPLETED|Overall Study||0
9879264|NCT01021748|10994032|FG008|COMPLETED|Overall Study||1
9879265|NCT01021748|10994024|FG000|NOT COMPLETED|Overall Study||6
9879266|NCT01021748|10994025|FG001|NOT COMPLETED|Overall Study||5
9879267|NCT01021748|10994026|FG002|NOT COMPLETED|Overall Study||7
9879268|NCT01021748|10994027|FG003|NOT COMPLETED|Overall Study||7
9879269|NCT01021748|10994028|FG004|NOT COMPLETED|Overall Study||9
9879270|NCT01021748|10994029|FG005|NOT COMPLETED|Overall Study||3
9879271|NCT01021748|10994030|FG006|NOT COMPLETED|Overall Study||3
9879272|NCT01021748|10994031|FG007|NOT COMPLETED|Overall Study||6
9879273|NCT01021748|10994032|FG008|NOT COMPLETED|Overall Study||16
9879274|NCT01021761|10994055|FG000|STARTED|Overall Study||42
9879275|NCT01021761|10994056|FG001|STARTED|Overall Study||42
9879276|NCT01021761|10994057|FG002|STARTED|Overall Study||42
9879277|NCT01021761|10994055|FG000|COMPLETED|Overall Study||41
9879278|NCT01021761|10994056|FG001|COMPLETED|Overall Study||38
9879279|NCT01021761|10994057|FG002|COMPLETED|Overall Study||42
9879280|NCT01021761|10994055|FG000|NOT COMPLETED|Overall Study||1
9879281|NCT01021761|10994056|FG001|NOT COMPLETED|Overall Study||4
9879282|NCT01021761|10994057|FG002|NOT COMPLETED|Overall Study||0
9879283|NCT01021813|10994067|FG000|STARTED|DB Treatment Phase||522
9879284|NCT01021813|10994068|FG001|STARTED|DB Treatment Phase||259
9879285|NCT01021813|10994069|FG002|STARTED|DB Treatment Phase||0
9879286|NCT01021813|10994070|FG003|STARTED|DB Treatment Phase||0
9879287|NCT01021813|10994071|FG004|STARTED|DB Treatment Phase||0
9879288|NCT01021813|10994067|FG000|Treated|DB Treatment Phase||521
9879289|NCT01021813|10994068|FG001|Treated|DB Treatment Phase||258
9879290|NCT01021813|10994069|FG002|Treated|DB Treatment Phase||0
9879291|NCT01021813|10994070|FG003|Treated|DB Treatment Phase||0
9879292|NCT01021813|10994071|FG004|Treated|DB Treatment Phase||0
10007648|NCT01751802|11129901|FG001|Completed Period 2|Overall Study||1
10007649|NCT01751802|11129900|FG000|Completed Period 3|Overall Study||2
10007650|NCT01751802|11129901|FG001|Completed Period 3|Overall Study||1
10007651|NCT01751802|11129900|FG000|COMPLETED|Overall Study||1
9879293|NCT01021813|10994067|FG000|COMPLETED|DB Treatment Phase||322
9879294|NCT01021813|10994068|FG001|COMPLETED|DB Treatment Phase||162
9879295|NCT01021813|10994069|FG002|COMPLETED|DB Treatment Phase||0
9879296|NCT01021813|10994070|FG003|COMPLETED|DB Treatment Phase||0
9879297|NCT01021813|10994071|FG004|COMPLETED|DB Treatment Phase||0
10007652|NCT01751802|11129901|FG001|COMPLETED|Overall Study||2
10007653|NCT01751802|11129900|FG000|NOT COMPLETED|Overall Study||4
10007654|NCT01751802|11129901|FG001|NOT COMPLETED|Overall Study||2
10007655|NCT01751867|11129915|FG000|STARTED|Overall Study||36
10007656|NCT01751867|11129916|FG001|STARTED|Overall Study||99
10007657|NCT01751867|11129915|FG000|Treated|Overall Study||34
10007658|NCT01751867|11129916|FG001|Treated|Overall Study||98
10007659|NCT01751867|11129915|FG000|COMPLETED|Overall Study||0
10007660|NCT01751867|11129916|FG001|COMPLETED|Overall Study||0
10007661|NCT01751867|11129915|FG000|NOT COMPLETED|Overall Study||36
10007662|NCT01751867|11129916|FG001|NOT COMPLETED|Overall Study||99
10007663|NCT01751971|11129924|FG000|STARTED|Overall Study||22
10007664|NCT01751971|11129925|FG001|STARTED|Overall Study||25
10007665|NCT01751971|11129924|FG000|COMPLETED|Overall Study||20
10007666|NCT01751971|11129925|FG001|COMPLETED|Overall Study||24
10007667|NCT01751971|11129924|FG000|NOT COMPLETED|Overall Study||2
10007668|NCT01751971|11129925|FG001|NOT COMPLETED|Overall Study||1
10007669|NCT01752036|11129937|FG000|STARTED|Overall Study||33
9879298|NCT01021813|10994067|FG000|NOT COMPLETED|DB Treatment Phase||200
9879299|NCT01021813|10994068|FG001|NOT COMPLETED|DB Treatment Phase||97
9879300|NCT01021813|10994069|FG002|NOT COMPLETED|DB Treatment Phase||0
10007670|NCT01752036|11129937|FG000|COMPLETED|Overall Study||31
10007671|NCT01752036|11129937|FG000|NOT COMPLETED|Overall Study||2
9879301|NCT01021813|10994070|FG003|NOT COMPLETED|DB Treatment Phase||0
9879302|NCT01021813|10994071|FG004|NOT COMPLETED|DB Treatment Phase||0
9879303|NCT01021813|10994067|FG000|STARTED|DB Randomized Discontinuation Phase||0
9879304|NCT01021813|10994068|FG001|STARTED|DB Randomized Discontinuation Phase||0
9879305|NCT01021813|10994069|FG002|STARTED|DB Randomized Discontinuation Phase||156
9879306|NCT01021813|10994070|FG003|STARTED|DB Randomized Discontinuation Phase||166
9879307|NCT01021813|10994071|FG004|STARTED|DB Randomized Discontinuation Phase||162
9879308|NCT01021813|10994067|FG000|COMPLETED|DB Randomized Discontinuation Phase||0
9879309|NCT01021813|10994068|FG001|COMPLETED|DB Randomized Discontinuation Phase||0
9879310|NCT01021813|10994069|FG002|COMPLETED|DB Randomized Discontinuation Phase||152
9879311|NCT01021813|10994070|FG003|COMPLETED|DB Randomized Discontinuation Phase||161
9879312|NCT01021813|10994071|FG004|COMPLETED|DB Randomized Discontinuation Phase||157
9879313|NCT01021813|10994067|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0
9879314|NCT01021813|10994068|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0
9879315|NCT01021813|10994069|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4
9879316|NCT01021813|10994070|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5
9879317|NCT01021813|10994071|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5
9879318|NCT01021852|10994096|FG000|STARTED|Treatment Period 1||40
9879319|NCT01021852|10994097|FG001|STARTED|Treatment Period 1||40
9879320|NCT01021852|10994098|FG002|STARTED|Treatment Period 1||41
9879321|NCT01021852|10994099|FG003|STARTED|Treatment Period 1||40
9879322|NCT01021852|10994100|FG004|STARTED|Treatment Period 1||42
9879323|NCT01021852|10994101|FG005|STARTED|Treatment Period 1||41
9879324|NCT01021852|10994102|FG006|STARTED|Treatment Period 1||41
9879325|NCT01021852|10994103|FG007|STARTED|Treatment Period 1||41
9879326|NCT01021852|10994096|FG000|Treated|Treatment Period 1||40
9879327|NCT01021852|10994097|FG001|Treated|Treatment Period 1||40
9879328|NCT01021852|10994098|FG002|Treated|Treatment Period 1||41
9879329|NCT01021852|10994099|FG003|Treated|Treatment Period 1||38
9879330|NCT01021852|10994100|FG004|Treated|Treatment Period 1||42
9879331|NCT01021852|10994101|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
9879332|NCT01021852|10994102|FG006|Treated|Treatment Period 1||41
9879333|NCT01021852|10994103|FG007|Treated|Treatment Period 1||41
9879334|NCT01021852|10994096|FG000|COMPLETED|Treatment Period 1||37
9879335|NCT01021852|10994097|FG001|COMPLETED|Treatment Period 1||39
9879336|NCT01021852|10994098|FG002|COMPLETED|Treatment Period 1||39
9879337|NCT01021852|10994099|FG003|COMPLETED|Treatment Period 1||38
9879338|NCT01021852|10994100|FG004|COMPLETED|Treatment Period 1||39
9879339|NCT01021852|10994101|FG005|COMPLETED|Treatment Period 1||39
9879340|NCT01021852|10994102|FG006|COMPLETED|Treatment Period 1||41
9879341|NCT01021852|10994103|FG007|COMPLETED|Treatment Period 1||40
9879342|NCT01021852|10994096|FG000|NOT COMPLETED|Treatment Period 1||3
9879343|NCT01021852|10994097|FG001|NOT COMPLETED|Treatment Period 1||1
9879344|NCT01021852|10994098|FG002|NOT COMPLETED|Treatment Period 1||2
9879345|NCT01021852|10994099|FG003|NOT COMPLETED|Treatment Period 1||2
9879346|NCT01021852|10994100|FG004|NOT COMPLETED|Treatment Period 1||3
9879347|NCT01021852|10994101|FG005|NOT COMPLETED|Treatment Period 1||2
9879348|NCT01021852|10994102|FG006|NOT COMPLETED|Treatment Period 1||0
9879349|NCT01021852|10994103|FG007|NOT COMPLETED|Treatment Period 1||1
9879350|NCT01021852|10994096|FG000|STARTED|Washout Period-Placebo||37
9879351|NCT01021852|10994097|FG001|STARTED|Washout Period-Placebo||39
9879352|NCT01021852|10994098|FG002|STARTED|Washout Period-Placebo||39
9879353|NCT01021852|10994099|FG003|STARTED|Washout Period-Placebo||38
9879354|NCT01021852|10994100|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
9879355|NCT01021852|10994101|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
9879356|NCT01021852|10994102|FG006|STARTED|Washout Period-Placebo||41
9879357|NCT01021852|10994103|FG007|STARTED|Washout Period-Placebo||40
9879358|NCT01021852|10994096|FG000|COMPLETED|Washout Period-Placebo||37
9879359|NCT01021852|10994097|FG001|COMPLETED|Washout Period-Placebo||39
9879360|NCT01021852|10994098|FG002|COMPLETED|Washout Period-Placebo||39
9879361|NCT01021852|10994099|FG003|COMPLETED|Washout Period-Placebo||37
9879362|NCT01021852|10994100|FG004|COMPLETED|Washout Period-Placebo||39
9879363|NCT01021852|10994101|FG005|COMPLETED|Washout Period-Placebo||38
9879364|NCT01021852|10994102|FG006|COMPLETED|Washout Period-Placebo||40
9879365|NCT01021852|10994103|FG007|COMPLETED|Washout Period-Placebo||40
9879366|NCT01021852|10994096|FG000|NOT COMPLETED|Washout Period-Placebo||0
10107803|NCT02461160|11238091|FG006|NOT COMPLETED|Overall Study||0
10107804|NCT02461160|11238092|FG007|NOT COMPLETED|Overall Study||1
10107805|NCT02461160|11238093|FG008|NOT COMPLETED|Overall Study||0
10107806|NCT02461160|11238094|FG009|NOT COMPLETED|Overall Study||0
10107807|NCT02461160|11238095|FG010|NOT COMPLETED|Overall Study||0
10107808|NCT02461160|11238096|FG011|NOT COMPLETED|Overall Study||0
9879367|NCT01021852|10994097|FG001|NOT COMPLETED|Washout Period-Placebo||0
9879368|NCT01021852|10994098|FG002|NOT COMPLETED|Washout Period-Placebo||0
9879369|NCT01021852|10994099|FG003|NOT COMPLETED|Washout Period-Placebo||1
9879370|NCT01021852|10994100|FG004|NOT COMPLETED|Washout Period-Placebo||1
9879371|NCT01021852|10994101|FG005|NOT COMPLETED|Washout Period-Placebo||1
9879372|NCT01021852|10994102|FG006|NOT COMPLETED|Washout Period-Placebo||1
9879373|NCT01021852|10994103|FG007|NOT COMPLETED|Washout Period-Placebo||0
9954112|NCT01430299|11072819|FG001|STARTED|Overall Study||23
10107809|NCT02461160|11238097|FG012|NOT COMPLETED|Overall Study||0
10107810|NCT02461290|11238146|FG000|STARTED|Overall Study||99
10107811|NCT02461290|11238146|FG000|COMPLETED|Overall Study||89
9879374|NCT01021852|10994096|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
9879375|NCT01021852|10994097|FG001|STARTED|Washout Period-No Drug||39
9879376|NCT01021852|10994098|FG002|STARTED|Washout Period-No Drug||39
9879377|NCT01021852|10994099|FG003|STARTED|Washout Period-No Drug||37
9879378|NCT01021852|10994100|FG004|STARTED|Washout Period-No Drug||39
9879379|NCT01021852|10994101|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
9879380|NCT01021852|10994102|FG006|STARTED|Washout Period-No Drug||40
9879381|NCT01021852|10994103|FG007|STARTED|Washout Period-No Drug||40
9879382|NCT01021852|10994096|FG000|COMPLETED|Washout Period-No Drug||37
9879383|NCT01021852|10994097|FG001|COMPLETED|Washout Period-No Drug||39
9879384|NCT01021852|10994098|FG002|COMPLETED|Washout Period-No Drug||39
9879385|NCT01021852|10994099|FG003|COMPLETED|Washout Period-No Drug||37
9879386|NCT01021852|10994100|FG004|COMPLETED|Washout Period-No Drug||39
9879387|NCT01021852|10994101|FG005|COMPLETED|Washout Period-No Drug||38
9879388|NCT01021852|10994102|FG006|COMPLETED|Washout Period-No Drug||40
9879389|NCT01021852|10994103|FG007|COMPLETED|Washout Period-No Drug||40
9879390|NCT01021852|10994096|FG000|NOT COMPLETED|Washout Period-No Drug||1
9879391|NCT01021852|10994097|FG001|NOT COMPLETED|Washout Period-No Drug||0
9879392|NCT01021852|10994098|FG002|NOT COMPLETED|Washout Period-No Drug||0
9879393|NCT01021852|10994099|FG003|NOT COMPLETED|Washout Period-No Drug||0
9879394|NCT01021852|10994100|FG004|NOT COMPLETED|Washout Period-No Drug||0
9879395|NCT01021852|10994101|FG005|NOT COMPLETED|Washout Period-No Drug||1
9879396|NCT01021852|10994102|FG006|NOT COMPLETED|Washout Period-No Drug||0
9879397|NCT01021852|10994103|FG007|NOT COMPLETED|Washout Period-No Drug||0
9879398|NCT01021852|10994096|FG000|STARTED|Treatment Period 2||37
9879399|NCT01021852|10994097|FG001|STARTED|Treatment Period 2||39
9879400|NCT01021852|10994098|FG002|STARTED|Treatment Period 2||39
9879401|NCT01021852|10994099|FG003|STARTED|Treatment Period 2||37
9879402|NCT01021852|10994100|FG004|STARTED|Treatment Period 2||39
9879403|NCT01021852|10994101|FG005|STARTED|Treatment Period 2||38
10007672|NCT01752400|11129942|FG000|STARTED|Overall Study||6
9879404|NCT01021852|10994102|FG006|STARTED|Treatment Period 2||40
9879405|NCT01021852|10994103|FG007|STARTED|Treatment Period 2||40
9879406|NCT01021852|10994096|FG000|COMPLETED|Treatment Period 2||37
9879407|NCT01021852|10994097|FG001|COMPLETED|Treatment Period 2||38
9879408|NCT01021852|10994098|FG002|COMPLETED|Treatment Period 2||38
9879409|NCT01021852|10994099|FG003|COMPLETED|Treatment Period 2||37
9879410|NCT01021852|10994100|FG004|COMPLETED|Treatment Period 2||37
9879411|NCT01021852|10994101|FG005|COMPLETED|Treatment Period 2||37
9879412|NCT01021852|10994102|FG006|COMPLETED|Treatment Period 2||37
9879413|NCT01021852|10994103|FG007|COMPLETED|Treatment Period 2||38
9879414|NCT01021852|10994096|FG000|NOT COMPLETED|Treatment Period 2||0
9879415|NCT01021852|10994097|FG001|NOT COMPLETED|Treatment Period 2||1
9879416|NCT01021852|10994098|FG002|NOT COMPLETED|Treatment Period 2||1
9879417|NCT01021852|10994099|FG003|NOT COMPLETED|Treatment Period 2||0
9879418|NCT01021852|10994100|FG004|NOT COMPLETED|Treatment Period 2||2
9879419|NCT01021852|10994101|FG005|NOT COMPLETED|Treatment Period 2||1
9879420|NCT01021852|10994102|FG006|NOT COMPLETED|Treatment Period 2||3
9879421|NCT01021852|10994103|FG007|NOT COMPLETED|Treatment Period 2||2
9879422|NCT01021878|10994119|FG000|STARTED|Overall Study||33
9879423|NCT01021878|10994120|FG001|STARTED|Overall Study||27
9879424|NCT01021878|10994119|FG000|Completed Follow-up|Overall Study||17
9879425|NCT01021878|10994120|FG001|Completed Follow-up|Overall Study||17
9879426|NCT01021878|10994119|FG000|COMPLETED|Overall Study||17
9879427|NCT01021878|10994120|FG001|COMPLETED|Overall Study||17
9879428|NCT01021878|10994119|FG000|NOT COMPLETED|Overall Study||16
9879429|NCT01021878|10994120|FG001|NOT COMPLETED|Overall Study||10
9879430|NCT01021956|10994133|FG000|STARTED|Overall Study||3
9879431|NCT01021956|10994134|FG001|STARTED|Overall Study||3
9879432|NCT01021956|10994135|FG002|STARTED|Overall Study||3
9879433|NCT01021956|10994136|FG003|STARTED|Overall Study||1
9879434|NCT01021956|10994133|FG000|COMPLETED|Overall Study||3
9879435|NCT01021956|10994134|FG001|COMPLETED|Overall Study||3
9879436|NCT01021956|10994135|FG002|COMPLETED|Overall Study||3
9879437|NCT01021956|10994136|FG003|COMPLETED|Overall Study||1
9879438|NCT01021956|10994133|FG000|NOT COMPLETED|Overall Study||0
9879439|NCT01021956|10994134|FG001|NOT COMPLETED|Overall Study||0
9879440|NCT01021956|10994135|FG002|NOT COMPLETED|Overall Study||0
9879441|NCT01021956|10994136|FG003|NOT COMPLETED|Overall Study||0
9879442|NCT01022073|10994149|FG000|STARTED|Overall Study||86
9879443|NCT01022073|10994150|FG001|STARTED|Overall Study||70
9879444|NCT01022073|10994149|FG000|COMPLETED|Overall Study||67
9879445|NCT01022073|10994150|FG001|COMPLETED|Overall Study||52
9879446|NCT01022073|10994149|FG000|NOT COMPLETED|Overall Study||19
9879447|NCT01022073|10994150|FG001|NOT COMPLETED|Overall Study||18
9879448|NCT01022112|10994161|FG000|STARTED|Overall Study||82
9879449|NCT01022112|10994162|FG001|STARTED|Overall Study||74
9879450|NCT01022112|10994163|FG002|STARTED|Overall Study||77
9879451|NCT01022112|10994164|FG003|STARTED|Overall Study||75
9879452|NCT01022112|10994165|FG004|STARTED|Overall Study||75
9879453|NCT01022112|10994161|FG000|COMPLETED|Overall Study||79
9879454|NCT01022112|10994162|FG001|COMPLETED|Overall Study||71
9879455|NCT01022112|10994163|FG002|COMPLETED|Overall Study||74
9879456|NCT01022112|10994164|FG003|COMPLETED|Overall Study||72
10007673|NCT01752400|11129942|FG000|COMPLETED|Overall Study||6
9879457|NCT01022112|10994165|FG004|COMPLETED|Overall Study||65
9879458|NCT01022112|10994161|FG000|NOT COMPLETED|Overall Study||3
9879459|NCT01022112|10994162|FG001|NOT COMPLETED|Overall Study||3
9879460|NCT01022112|10994163|FG002|NOT COMPLETED|Overall Study||3
9879461|NCT01022112|10994164|FG003|NOT COMPLETED|Overall Study||3
9879462|NCT01022112|10994165|FG004|NOT COMPLETED|Overall Study||10
9879463|NCT01022190|10994177|FG000|STARTED|Overall Study||42
9879464|NCT01022190|10994177|FG000|COMPLETED|Overall Study||42
9879465|NCT01022190|10994177|FG000|NOT COMPLETED|Overall Study||0
9879466|NCT01022203|10994183|FG000|STARTED|PreTreatment Assessment||58
9879467|NCT01022203|10994184|FG001|STARTED|PreTreatment Assessment||56
9879468|NCT01022203|10994183|FG000|COMPLETED|PreTreatment Assessment||58
9879469|NCT01022203|10994184|FG001|COMPLETED|PreTreatment Assessment||56
9879470|NCT01022203|10994183|FG000|NOT COMPLETED|PreTreatment Assessment||0
9879471|NCT01022203|10994184|FG001|NOT COMPLETED|PreTreatment Assessment||0
9879472|NCT01022203|10994183|FG000|STARTED|Post Treatment Assessment||58
9879473|NCT01022203|10994184|FG001|STARTED|Post Treatment Assessment||56
9879474|NCT01022203|10994183|FG000|COMPLETED|Post Treatment Assessment||44
9879475|NCT01022203|10994184|FG001|COMPLETED|Post Treatment Assessment||42
9879476|NCT01022203|10994183|FG000|NOT COMPLETED|Post Treatment Assessment||14
9879477|NCT01022203|10994184|FG001|NOT COMPLETED|Post Treatment Assessment||14
9879478|NCT01022203|10994183|FG000|STARTED|Follow-Up Assessment||44
9879479|NCT01022203|10994184|FG001|STARTED|Follow-Up Assessment||42
9879480|NCT01022203|10994183|FG000|COMPLETED|Follow-Up Assessment||42
9879481|NCT01022203|10994184|FG001|COMPLETED|Follow-Up Assessment||40
9879482|NCT01022203|10994183|FG000|NOT COMPLETED|Follow-Up Assessment||2
9879483|NCT01022203|10994184|FG001|NOT COMPLETED|Follow-Up Assessment||2
9879484|NCT01022242|10994195|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
9879485|NCT01022242|10994196|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
9879486|NCT01022242|10994195|FG000|COMPLETED|Overall Study||49
9879487|NCT01022242|10994196|FG001|COMPLETED|Overall Study||46
9879488|NCT01022242|10994195|FG000|NOT COMPLETED|Overall Study||21
9879489|NCT01022242|10994196|FG001|NOT COMPLETED|Overall Study||19
9879490|NCT01022307|10994204|FG000|STARTED|Overall Study||184
9879491|NCT01022307|10994205|FG001|STARTED|Overall Study||28
9879492|NCT01022307|10994204|FG000|COMPLETED|Overall Study||184
9879493|NCT01022307|10994205|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
9879494|NCT01022307|10994204|FG000|NOT COMPLETED|Overall Study||0
9879495|NCT01022307|10994205|FG001|NOT COMPLETED|Overall Study||4
9879496|NCT01022359|10994213|FG000|STARTED|Overall Study||39
9879497|NCT01022359|10994214|FG001|STARTED|Overall Study||41
9879498|NCT01022359|10994213|FG000|COMPLETED|Overall Study||39
9879499|NCT01022359|10994214|FG001|COMPLETED|Overall Study||41
9879500|NCT01022359|10994213|FG000|NOT COMPLETED|Overall Study||0
9879501|NCT01022359|10994214|FG001|NOT COMPLETED|Overall Study||0
9879502|NCT01022424|10994220|FG000|STARTED|Overall Study||13
9879503|NCT01022424|10994220|FG000|COMPLETED|Overall Study||9
9879504|NCT01022424|10994220|FG000|NOT COMPLETED|Overall Study||4
9879505|NCT01022502|10994228|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
9879506|NCT01022502|10994228|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
9879507|NCT01022502|10994228|FG000|NOT COMPLETED|Overall Study||3
9879508|NCT01022567|10994236|FG000|STARTED|Overall Study||273
9879509|NCT01022567|10994237|FG001|STARTED|Overall Study||257
9879510|NCT01022567|10994236|FG000|COMPLETED|Overall Study||272
9879511|NCT01022567|10994237|FG001|COMPLETED|Overall Study||242
9879512|NCT01022567|10994236|FG000|NOT COMPLETED|Overall Study||1
9879513|NCT01022567|10994237|FG001|NOT COMPLETED|Overall Study||15
9879514|NCT01022580|10994245|FG000|STARTED|Overall Study||252
9879515|NCT01022580|10994246|FG001|STARTED|Overall Study||259
9879516|NCT01022580|10994245|FG000|COMPLETED|Overall Study|Survived to discharge|234
9879517|NCT01022580|10994246|FG001|COMPLETED|Overall Study|Survived to discharge.|237
9879518|NCT01022580|10994245|FG000|NOT COMPLETED|Overall Study||18
9879519|NCT01022580|10994246|FG001|NOT COMPLETED|Overall Study||22
9879520|NCT01022762|10994260|FG000|STARTED|Overall Study||218
9879521|NCT01022762|10994261|FG001|STARTED|Overall Study||222
9879522|NCT01022762|10994260|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
9879523|NCT01022762|10994261|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
9879524|NCT01022762|10994260|FG000|COMPLETED|Overall Study||196
9879525|NCT01022762|10994261|FG001|COMPLETED|Overall Study||194
9879526|NCT01022762|10994260|FG000|NOT COMPLETED|Overall Study||22
9879527|NCT01022762|10994261|FG001|NOT COMPLETED|Overall Study||28
9879528|NCT01022853|10994272|FG000|STARTED|Overall Study|entered and treated|3
9879529|NCT01022853|10994273|FG001|STARTED|Overall Study|entered and treated|4
9879530|NCT01022853|10994274|FG002|STARTED|Overall Study|entered and treated|13
9879531|NCT01022853|10994275|FG003|STARTED|Overall Study|entered and treated|8
9879532|NCT01022853|10994276|FG004|STARTED|Overall Study|entered and treated|2
9879533|NCT01022853|10994272|FG000|COMPLETED|Overall Study||0
9879534|NCT01022853|10994273|FG001|COMPLETED|Overall Study||0
9879535|NCT01022853|10994274|FG002|COMPLETED|Overall Study||0
9879536|NCT01022853|10994275|FG003|COMPLETED|Overall Study||0
9879537|NCT01022853|10994276|FG004|COMPLETED|Overall Study||0
9879538|NCT01022853|10994272|FG000|NOT COMPLETED|Overall Study||3
9879539|NCT01022853|10994273|FG001|NOT COMPLETED|Overall Study||4
9879540|NCT01022853|10994274|FG002|NOT COMPLETED|Overall Study||13
9879541|NCT01022853|10994275|FG003|NOT COMPLETED|Overall Study||8
9879542|NCT01022853|10994276|FG004|NOT COMPLETED|Overall Study||2
9879543|NCT01022996|10994291|FG000|STARTED|Overall Study||57
9879544|NCT01022996|10994291|FG000|COMPLETED|Overall Study||0
9879545|NCT01022996|10994291|FG000|NOT COMPLETED|Overall Study||57
9879546|NCT01023022|10994295|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
10007674|NCT01752400|11129942|FG000|NOT COMPLETED|Overall Study||0
10007675|NCT01752413|11129948|FG000|STARTED|Overall Study||170
10007676|NCT01752413|11129949|FG001|STARTED|Overall Study||27
9879547|NCT01023022|10994295|FG000|COMPLETED|Overall Study||162
9879548|NCT01023022|10994295|FG000|NOT COMPLETED|Overall Study||14
10107812|NCT02461290|11238146|FG000|NOT COMPLETED|Overall Study||10
10107813|NCT02461433|11238152|FG000|STARTED|Overall Study||1
10107814|NCT02461433|11238153|FG001|STARTED|Overall Study||1
10107815|NCT02461433|11238152|FG000|COMPLETED|Overall Study||1
10107816|NCT02461433|11238153|FG001|COMPLETED|Overall Study||1
10107817|NCT02461433|11238152|FG000|NOT COMPLETED|Overall Study||0
10107818|NCT02461433|11238153|FG001|NOT COMPLETED|Overall Study||0
10107819|NCT02461563|11238163|FG000|STARTED|Overall Study||3
9879549|NCT01023035|10994302|FG000|STARTED|Treatment Period||249
9879550|NCT01023035|10994303|FG001|STARTED|Treatment Period||251
9879551|NCT01023035|10994304|FG002|STARTED|Treatment Period||187
10007677|NCT01752413|11129948|FG000|COMPLETED|Overall Study||58
10007678|NCT01752413|11129949|FG001|COMPLETED|Overall Study||6
10107820|NCT02461563|11238164|FG001|STARTED|Overall Study||3
9879552|NCT01023035|10994302|FG000|COMPLETED|Treatment Period||177
9879553|NCT01023035|10994303|FG001|COMPLETED|Treatment Period||166
9879554|NCT01023035|10994304|FG002|COMPLETED|Treatment Period||69
9879555|NCT01023035|10994302|FG000|NOT COMPLETED|Treatment Period||72
9879556|NCT01023035|10994303|FG001|NOT COMPLETED|Treatment Period||85
9879557|NCT01023035|10994304|FG002|NOT COMPLETED|Treatment Period||118
9879558|NCT01023035|10994302|FG000|STARTED|Follow-up Period (up to Week 72)||238
9879559|NCT01023035|10994303|FG001|STARTED|Follow-up Period (up to Week 72)||235
9879560|NCT01023035|10994304|FG002|STARTED|Follow-up Period (up to Week 72)||147
9879561|NCT01023035|10994302|FG000|COMPLETED|Follow-up Period (up to Week 72)||210
9879562|NCT01023035|10994303|FG001|COMPLETED|Follow-up Period (up to Week 72)||207
9879563|NCT01023035|10994304|FG002|COMPLETED|Follow-up Period (up to Week 72)||108
9879564|NCT01023035|10994302|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28
9879565|NCT01023035|10994303|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28
9879566|NCT01023035|10994304|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39
9879567|NCT01023061|10994314|FG000|STARTED|Overall Study||24
9879568|NCT01023061|10994314|FG000|COMPLETED|Overall Study||22
9879569|NCT01023061|10994314|FG000|NOT COMPLETED|Overall Study||2
9879570|NCT01023074|10994321|FG000|STARTED|Overall Study||26
9879571|NCT01023074|10994322|FG001|STARTED|Overall Study||13
9879572|NCT01023074|10994323|FG002|STARTED|Overall Study||13
9879573|NCT01023074|10994321|FG000|COMPLETED|Overall Study||26
9879574|NCT01023074|10994322|FG001|COMPLETED|Overall Study||13
9879575|NCT01023074|10994323|FG002|COMPLETED|Overall Study||13
9879576|NCT01023074|10994321|FG000|NOT COMPLETED|Overall Study||0
9879577|NCT01023074|10994322|FG001|NOT COMPLETED|Overall Study||0
9879578|NCT01023074|10994323|FG002|NOT COMPLETED|Overall Study||0
9879579|NCT01023178|10994338|FG000|STARTED|Overall Study||5
9879580|NCT01023178|10994339|FG001|STARTED|Overall Study||8
9879581|NCT01023178|10994340|FG002|STARTED|Overall Study||7
9879582|NCT01023178|10994338|FG000|COMPLETED|Overall Study||3
9879583|NCT01023178|10994339|FG001|COMPLETED|Overall Study||6
9879584|NCT01023178|10994340|FG002|COMPLETED|Overall Study||4
10007679|NCT01752413|11129948|FG000|NOT COMPLETED|Overall Study||112
10107821|NCT02461563|11238165|FG002|STARTED|Overall Study||3
10107822|NCT02461563|11238166|FG003|STARTED|Overall Study||3
10107823|NCT02461563|11238163|FG000|COMPLETED|Overall Study||3
10107824|NCT02461563|11238164|FG001|COMPLETED|Overall Study||3
10107825|NCT02461563|11238165|FG002|COMPLETED|Overall Study||3
10107826|NCT02461563|11238166|FG003|COMPLETED|Overall Study||3
10107827|NCT02461563|11238163|FG000|NOT COMPLETED|Overall Study||0
10107828|NCT02461563|11238164|FG001|NOT COMPLETED|Overall Study||0
10107829|NCT02461563|11238165|FG002|NOT COMPLETED|Overall Study||0
10107830|NCT02461563|11238166|FG003|NOT COMPLETED|Overall Study||0
10107831|NCT02461589|11238192|FG000|STARTED|Overall Study||64
10107832|NCT02461589|11238193|FG001|STARTED|Overall Study||63
10107833|NCT02461589|11238194|FG002|STARTED|Overall Study||65
10107834|NCT02461589|11238195|FG003|STARTED|Overall Study||63
10007680|NCT01752413|11129949|FG001|NOT COMPLETED|Overall Study||21
10007681|NCT01752426|11129955|FG000|STARTED|Overall Study||30
10007682|NCT01752426|11129955|FG000|COMPLETED|Overall Study||30
10107835|NCT02461589|11238196|FG004|STARTED|Overall Study||64
10107836|NCT02461589|11238197|FG005|STARTED|Overall Study||64
10007683|NCT01752426|11129955|FG000|NOT COMPLETED|Overall Study||0
10107837|NCT02461589|11238198|FG006|STARTED|Overall Study||64
10107838|NCT02461589|11238199|FG007|STARTED|Overall Study||65
10107839|NCT02461589|11238200|FG008|STARTED|Overall Study||129
10107840|NCT02461589|11238201|FG009|STARTED|Overall Study||65
10107841|NCT02461589|11238192|FG000|Exposed|Overall Study||64
10107842|NCT02461589|11238193|FG001|Exposed|Overall Study||63
10107843|NCT02461589|11238194|FG002|Exposed|Overall Study||65
10107844|NCT02461589|11238195|FG003|Exposed|Overall Study||63
9879585|NCT01023178|10994338|FG000|NOT COMPLETED|Overall Study||2
9879586|NCT01023178|10994339|FG001|NOT COMPLETED|Overall Study||2
9879587|NCT01023178|10994340|FG002|NOT COMPLETED|Overall Study||3
9879588|NCT01023217|10994350|FG000|STARTED|Overall Study||45
10007684|NCT01752634|11129965|FG000|STARTED|Up to Week 24 (Primary Analysis)||99
9879589|NCT01023217|10994351|FG001|STARTED|Overall Study||45
9879590|NCT01023217|10994350|FG000|COMPLETED|Overall Study||44
9879591|NCT01023217|10994351|FG001|COMPLETED|Overall Study||45
9879592|NCT01023217|10994350|FG000|NOT COMPLETED|Overall Study||1
9879593|NCT01023217|10994351|FG001|NOT COMPLETED|Overall Study||0
9879594|NCT01023256|10994361|FG000|STARTED|Overall Study||25
9879595|NCT01023256|10994362|FG001|STARTED|Overall Study||22
9879596|NCT01023256|10994363|FG002|STARTED|Overall Study||24
9879597|NCT01023256|10994364|FG003|STARTED|Overall Study||27
9879598|NCT01023256|10994361|FG000|COMPLETED|Overall Study||21
9879599|NCT01023256|10994362|FG001|COMPLETED|Overall Study||19
9879600|NCT01023256|10994363|FG002|COMPLETED|Overall Study||23
9879601|NCT01023256|10994364|FG003|COMPLETED|Overall Study||22
9879602|NCT01023256|10994361|FG000|NOT COMPLETED|Overall Study||4
9879603|NCT01023256|10994362|FG001|NOT COMPLETED|Overall Study||3
9879604|NCT01023256|10994363|FG002|NOT COMPLETED|Overall Study||1
9879605|NCT01023256|10994364|FG003|NOT COMPLETED|Overall Study||5
9879606|NCT01023269|10994377|FG000|STARTED|Overall Study||3
9879607|NCT01023269|10994378|FG001|STARTED|Overall Study||2
9879608|NCT01023269|10994377|FG000|COMPLETED|Overall Study||1
9879609|NCT01023269|10994378|FG001|COMPLETED|Overall Study||2
9879610|NCT01023269|10994377|FG000|NOT COMPLETED|Overall Study||2
9879611|NCT01023269|10994378|FG001|NOT COMPLETED|Overall Study||0
9879612|NCT01023308|10994384|FG000|STARTED|Overall Study||387
9879613|NCT01023308|10994385|FG001|STARTED|Overall Study||381
9879614|NCT01023308|10994384|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
9879615|NCT01023308|10994385|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
9879616|NCT01023308|10994384|FG000|NOT COMPLETED|Overall Study||285
9879617|NCT01023308|10994385|FG001|NOT COMPLETED|Overall Study||279
9879618|NCT01023477|10994393|FG000|STARTED|Overall Study||7
9879619|NCT01023477|10994394|FG001|STARTED|Overall Study||5
9879620|NCT01023477|10994393|FG000|COMPLETED|Overall Study||7
9879621|NCT01023477|10994394|FG001|COMPLETED|Overall Study||5
9879622|NCT01023477|10994393|FG000|NOT COMPLETED|Overall Study||0
9879623|NCT01023477|10994394|FG001|NOT COMPLETED|Overall Study||0
9879624|NCT01023516|10994402|FG000|STARTED|Overall Study||313
9879625|NCT01023516|10994403|FG001|STARTED|Overall Study||302
9879626|NCT01023516|10994402|FG000|COMPLETED|Overall Study||289
9879627|NCT01023516|10994403|FG001|COMPLETED|Overall Study||284
9879628|NCT01023516|10994402|FG000|NOT COMPLETED|Overall Study||24
9879629|NCT01023516|10994403|FG001|NOT COMPLETED|Overall Study||18
9879630|NCT01023568|10994412|FG000|STARTED|Overall Study||45
9879631|NCT01023568|10994413|FG001|STARTED|Overall Study||44
9879632|NCT01023568|10994414|FG002|STARTED|Overall Study||45
9879633|NCT01023568|10994412|FG000|COMPLETED|Overall Study||45
9879634|NCT01023568|10994413|FG001|COMPLETED|Overall Study||44
9879635|NCT01023568|10994414|FG002|COMPLETED|Overall Study||45
9879636|NCT01023568|10994412|FG000|NOT COMPLETED|Overall Study||0
9879637|NCT01023568|10994413|FG001|NOT COMPLETED|Overall Study||0
9879638|NCT01023568|10994414|FG002|NOT COMPLETED|Overall Study||0
9879639|NCT01023581|10994429|FG000|STARTED|Overall Study||109
9879640|NCT01023581|10994430|FG001|STARTED|Overall Study||112
9879641|NCT01023581|10994431|FG002|STARTED|Overall Study||113
9879642|NCT01023581|10994432|FG003|STARTED|Overall Study||114
9879643|NCT01023581|10994433|FG004|STARTED|Overall Study||111
9879644|NCT01023581|10994434|FG005|STARTED|Overall Study||111
9879645|NCT01023581|10994435|FG006|STARTED|Overall Study||114
9879646|NCT01023581|10994429|FG000|Received Study Treatment|Overall Study||106
9879647|NCT01023581|10994430|FG001|Received Study Treatment|Overall Study||112
9879648|NCT01023581|10994431|FG002|Received Study Treatment|Overall Study||110
9879649|NCT01023581|10994432|FG003|Received Study Treatment|Overall Study||109
9879650|NCT01023581|10994433|FG004|Received Study Treatment|Overall Study||111
9879651|NCT01023581|10994434|FG005|Received Study Treatment|Overall Study||106
9879652|NCT01023581|10994435|FG006|Received Study Treatment|Overall Study||114
10107845|NCT02461589|11238196|FG004|Exposed|Overall Study||64
10107846|NCT02461589|11238197|FG005|Exposed|Overall Study||64
10107847|NCT02461589|11238198|FG006|Exposed|Overall Study||64
10107848|NCT02461589|11238199|FG007|Exposed|Overall Study||65
10107849|NCT02461589|11238200|FG008|Exposed|Overall Study||129
10107850|NCT02461589|11238201|FG009|Exposed|Overall Study||64
10107851|NCT02461589|11238192|FG000|COMPLETED|Overall Study||58
10107852|NCT02461589|11238193|FG001|COMPLETED|Overall Study||61
10107853|NCT02461589|11238194|FG002|COMPLETED|Overall Study||60
10107854|NCT02461589|11238195|FG003|COMPLETED|Overall Study||58
10107855|NCT02461589|11238196|FG004|COMPLETED|Overall Study||62
9879653|NCT01023581|10994429|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
9879654|NCT01023581|10994430|FG001|COMPLETED|Overall Study||89
9879655|NCT01023581|10994431|FG002|COMPLETED|Overall Study||71
9879656|NCT01023581|10994432|FG003|COMPLETED|Overall Study||94
9879657|NCT01023581|10994433|FG004|COMPLETED|Overall Study||95
9879658|NCT01023581|10994434|FG005|COMPLETED|Overall Study||92
9879659|NCT01023581|10994435|FG006|COMPLETED|Overall Study||94
9879660|NCT01023581|10994429|FG000|NOT COMPLETED|Overall Study||35
9879661|NCT01023581|10994430|FG001|NOT COMPLETED|Overall Study||23
9879662|NCT01023581|10994431|FG002|NOT COMPLETED|Overall Study||42
9879663|NCT01023581|10994432|FG003|NOT COMPLETED|Overall Study||20
9879664|NCT01023581|10994433|FG004|NOT COMPLETED|Overall Study||16
9879665|NCT01023581|10994434|FG005|NOT COMPLETED|Overall Study||19
9879666|NCT01023581|10994435|FG006|NOT COMPLETED|Overall Study||20
9879667|NCT01023659|10994454|FG000|STARTED|Overall Study||258
9879668|NCT01023659|10994455|FG001|STARTED|Overall Study||365
9879669|NCT01023659|10994456|FG002|STARTED|Overall Study||264
9879670|NCT01023659|10994454|FG000|COMPLETED|Overall Study||185
9879671|NCT01023659|10994455|FG001|COMPLETED|Overall Study||137
9879672|NCT01023659|10994456|FG002|COMPLETED|Overall Study||165
9879673|NCT01023659|10994454|FG000|NOT COMPLETED|Overall Study||73
9879674|NCT01023659|10994455|FG001|NOT COMPLETED|Overall Study||228
9879675|NCT01023659|10994456|FG002|NOT COMPLETED|Overall Study||99
9879676|NCT01023672|10994465|FG000|STARTED|Overall Study||20
9879677|NCT01023672|10994465|FG000|COMPLETED|Overall Study||17
9879678|NCT01023672|10994465|FG000|NOT COMPLETED|Overall Study||3
9879679|NCT01023711|10994469|FG000|STARTED|Overall Study||107
9879680|NCT01023711|10994469|FG000|COMPLETED|Overall Study||107
9879681|NCT01023711|10994469|FG000|NOT COMPLETED|Overall Study||0
9879682|NCT01023724|10994476|FG000|STARTED|Overall Study||25
9879683|NCT01023724|10994477|FG001|STARTED|Overall Study||25
9879684|NCT01023724|10994476|FG000|COMPLETED|Overall Study||21
9879685|NCT01023724|10994477|FG001|COMPLETED|Overall Study||22
9879686|NCT01023724|10994476|FG000|NOT COMPLETED|Overall Study||4
9879687|NCT01023724|10994477|FG001|NOT COMPLETED|Overall Study||3
9879688|NCT01023776|10994483|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
9879689|NCT01023776|10994483|FG000|COMPLETED|Overall Study||20
9879690|NCT01023776|10994483|FG000|NOT COMPLETED|Overall Study||0
9879691|NCT01023789|10994487|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
9879692|NCT01023789|10994487|FG000|COMPLETED|30-day Follow-up Visit||812
9879693|NCT01023789|10994487|FG000|NOT COMPLETED|30-day Follow-up Visit||0
9879694|NCT01023789|10994487|FG000|STARTED|180-day Clinical Follow-up||812
9879695|NCT01023789|10994487|FG000|COMPLETED|180-day Clinical Follow-up||812
9879696|NCT01023789|10994487|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
9879697|NCT01023789|10994487|FG000|STARTED|1 - Year Visit||812
9879698|NCT01023789|10994487|FG000|COMPLETED|1 - Year Visit||812
9879699|NCT01023789|10994487|FG000|NOT COMPLETED|1 - Year Visit||0
9879700|NCT01023789|10994487|FG000|STARTED|2 - Year Visit||812
9879701|NCT01023789|10994487|FG000|COMPLETED|2 - Year Visit||812
9879702|NCT01023789|10994487|FG000|NOT COMPLETED|2 - Year Visit||0
9879703|NCT01023789|10994487|FG000|STARTED|3 - Year Visit||812
9879704|NCT01023789|10994487|FG000|COMPLETED|3 - Year Visit||769
9879705|NCT01023789|10994487|FG000|NOT COMPLETED|3 - Year Visit||43
9879706|NCT01023815|10994495|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
9879707|NCT01023815|10994496|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0
9879708|NCT01023815|10994497|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0
9879709|NCT01023815|10994498|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0
9879710|NCT01023815|10994495|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
9879711|NCT01023815|10994496|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
9879712|NCT01023815|10994497|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
9879713|NCT01023815|10994498|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
9879714|NCT01023815|10994495|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
10107856|NCT02461589|11238197|FG005|COMPLETED|Overall Study||61
10107857|NCT02461589|11238198|FG006|COMPLETED|Overall Study||58
10107858|NCT02461589|11238199|FG007|COMPLETED|Overall Study||60
10107859|NCT02461589|11238200|FG008|COMPLETED|Overall Study||123
10107860|NCT02461589|11238201|FG009|COMPLETED|Overall Study||60
10107861|NCT02461589|11238192|FG000|NOT COMPLETED|Overall Study||6
10107862|NCT02461589|11238193|FG001|NOT COMPLETED|Overall Study||2
10107863|NCT02461589|11238194|FG002|NOT COMPLETED|Overall Study||5
10107864|NCT02461589|11238195|FG003|NOT COMPLETED|Overall Study||5
10107865|NCT02461589|11238196|FG004|NOT COMPLETED|Overall Study||2
10107866|NCT02461589|11238197|FG005|NOT COMPLETED|Overall Study||3
10107867|NCT02461589|11238198|FG006|NOT COMPLETED|Overall Study||6
10107868|NCT02461589|11238199|FG007|NOT COMPLETED|Overall Study||5
10107869|NCT02461589|11238200|FG008|NOT COMPLETED|Overall Study||6
10107870|NCT02461589|11238201|FG009|NOT COMPLETED|Overall Study||5
10107871|NCT02461628|11238225|FG000|STARTED|Overall Study||3733
10107872|NCT02461628|11238226|FG001|STARTED|Overall Study||3632
10107873|NCT02461628|11238225|FG000|Baseline Survey|Overall Study||1038
10107874|NCT02461628|11238226|FG001|Baseline Survey|Overall Study||974
10107875|NCT02461628|11238225|FG000|6 Month Survey|Overall Study||814
10107876|NCT02461628|11238226|FG001|6 Month Survey|Overall Study||832
10107877|NCT02461628|11238225|FG000|12 Month Survey|Overall Study||882
10107878|NCT02461628|11238226|FG001|12 Month Survey|Overall Study||914
10107879|NCT02461628|11238225|FG000|18 Month Survey|Overall Study||995
10107880|NCT02461628|11238226|FG001|18 Month Survey|Overall Study||905
10107881|NCT02461628|11238225|FG000|COMPLETED|Overall Study||3729
10107882|NCT02461628|11238226|FG001|COMPLETED|Overall Study||3625
10107883|NCT02461628|11238225|FG000|NOT COMPLETED|Overall Study||4
10107884|NCT02461628|11238226|FG001|NOT COMPLETED|Overall Study||7
10107885|NCT02461693|11238234|FG000|STARTED|Overall Study||103
10107886|NCT02461693|11238235|FG001|STARTED|Overall Study||102
10107887|NCT02461693|11238234|FG000|COMPLETED|Overall Study||103
10107888|NCT02461693|11238235|FG001|COMPLETED|Overall Study||102
10107889|NCT02461693|11238234|FG000|NOT COMPLETED|Overall Study||0
10107890|NCT02461693|11238235|FG001|NOT COMPLETED|Overall Study||0
10107891|NCT02461745|11238243|FG000|STARTED|Overall Study||130
10107892|NCT02461745|11238244|FG001|STARTED|Overall Study||70
10107893|NCT02461745|11238243|FG000|COMPLETED|Overall Study||116
10107894|NCT02461745|11238244|FG001|COMPLETED|Overall Study||66
10107895|NCT02461745|11238243|FG000|NOT COMPLETED|Overall Study||14
10107896|NCT02461745|11238244|FG001|NOT COMPLETED|Overall Study||4
10007685|NCT01752634|11129966|FG001|STARTED|Up to Week 24 (Primary Analysis)||100
10007686|NCT01752634|11129967|FG002|STARTED|Up to Week 24 (Primary Analysis)||100
9879715|NCT01023815|10994496|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
9879716|NCT01023815|10994497|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
9879717|NCT01023815|10994498|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
9879718|NCT01023815|10994495|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0
9879719|NCT01023815|10994496|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
9879720|NCT01023815|10994497|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68
9879721|NCT01023815|10994498|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71
9879722|NCT01023815|10994495|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0
9879723|NCT01023815|10994496|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42
9879724|NCT01023815|10994497|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60
9879725|NCT01023815|10994498|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68
9879726|NCT01023815|10994495|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
9879727|NCT01023815|10994496|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
9879728|NCT01023815|10994497|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
9879729|NCT01023815|10994498|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
9879730|NCT01023841|10994511|FG000|STARTED|Overall Study||48
9879731|NCT01023841|10994512|FG001|STARTED|Overall Study||23
9879732|NCT01023841|10994511|FG000|COMPLETED|Overall Study||47
9879733|NCT01023841|10994512|FG001|COMPLETED|Overall Study||23
9879734|NCT01023841|10994511|FG000|NOT COMPLETED|Overall Study||1
9879735|NCT01023841|10994512|FG001|NOT COMPLETED|Overall Study||0
9879736|NCT01023958|10994518|FG000|STARTED|Overall Study||50
9879737|NCT01023958|10994518|FG000|COMPLETED|Overall Study||0
9879738|NCT01023958|10994518|FG000|NOT COMPLETED|Overall Study||50
9879739|NCT01024010|10994524|FG000|STARTED|Overall Study||48
9879740|NCT01024010|10994525|FG001|STARTED|Overall Study||34
9879741|NCT01024010|10994524|FG000|COMPLETED|Overall Study||48
9879742|NCT01024010|10994525|FG001|COMPLETED|Overall Study||34
9879743|NCT01024010|10994524|FG000|NOT COMPLETED|Overall Study||0
9879744|NCT01024010|10994525|FG001|NOT COMPLETED|Overall Study||0
9879745|NCT01024036|10994533|FG000|STARTED|Blinded Treatment||53
9879746|NCT01024036|10994534|FG001|STARTED|Blinded Treatment||26
9879747|NCT01024036|10994533|FG000|COMPLETED|Blinded Treatment||31
9879748|NCT01024036|10994534|FG001|COMPLETED|Blinded Treatment||6
9879749|NCT01024036|10994533|FG000|NOT COMPLETED|Blinded Treatment||22
9879750|NCT01024036|10994534|FG001|NOT COMPLETED|Blinded Treatment||20
9879751|NCT01024036|10994533|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
9879752|NCT01024036|10994534|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
9879753|NCT01024036|10994533|FG000|COMPLETED|Unblinded Treatment||0
9879754|NCT01024036|10994534|FG001|COMPLETED|Unblinded Treatment||10
9879755|NCT01024036|10994533|FG000|NOT COMPLETED|Unblinded Treatment||0
9879756|NCT01024036|10994534|FG001|NOT COMPLETED|Unblinded Treatment||3
9879757|NCT01024036|10994533|FG000|STARTED|Follow-Up Period||14
9879758|NCT01024036|10994534|FG001|STARTED|Follow-Up Period||6
9879759|NCT01024036|10994533|FG000|COMPLETED|Follow-Up Period||9
9879760|NCT01024036|10994534|FG001|COMPLETED|Follow-Up Period||3
9879761|NCT01024036|10994533|FG000|NOT COMPLETED|Follow-Up Period||5
9879762|NCT01024036|10994534|FG001|NOT COMPLETED|Follow-Up Period||3
9879763|NCT01024231|10994550|FG000|STARTED|Overall Study||14
9879764|NCT01024231|10994551|FG001|STARTED|Overall Study||17
9879765|NCT01024231|10994552|FG002|STARTED|Overall Study||16
9879766|NCT01024231|10994553|FG003|STARTED|Overall Study||6
9879767|NCT01024231|10994554|FG004|STARTED|Overall Study||17
9879768|NCT01024231|10994555|FG005|STARTED|Overall Study||16
9879769|NCT01024231|10994556|FG006|STARTED|Overall Study||41
9879770|NCT01024231|10994550|FG000|COMPLETED|Overall Study||2
9879771|NCT01024231|10994551|FG001|COMPLETED|Overall Study||2
9879772|NCT01024231|10994552|FG002|COMPLETED|Overall Study||6
9879773|NCT01024231|10994553|FG003|COMPLETED|Overall Study||1
9879774|NCT01024231|10994554|FG004|COMPLETED|Overall Study||0
9879775|NCT01024231|10994555|FG005|COMPLETED|Overall Study||0
9879776|NCT01024231|10994556|FG006|COMPLETED|Overall Study||20
9879777|NCT01024231|10994550|FG000|NOT COMPLETED|Overall Study||12
9879778|NCT01024231|10994551|FG001|NOT COMPLETED|Overall Study||15
9879779|NCT01024231|10994552|FG002|NOT COMPLETED|Overall Study||10
9879780|NCT01024231|10994553|FG003|NOT COMPLETED|Overall Study||5
9879781|NCT01024231|10994554|FG004|NOT COMPLETED|Overall Study||17
9879782|NCT01024231|10994555|FG005|NOT COMPLETED|Overall Study||16
9879783|NCT01024231|10994556|FG006|NOT COMPLETED|Overall Study||21
9879784|NCT01024244|10994582|FG000|STARTED|Overall Study||22
9879785|NCT01024244|10994583|FG001|STARTED|Overall Study||12
9879786|NCT01024244|10994584|FG002|STARTED|Overall Study||15
9879787|NCT01024244|10994585|FG003|STARTED|Overall Study||14
9879788|NCT01024244|10994586|FG004|STARTED|Overall Study||15
9879789|NCT01024244|10994582|FG000|COMPLETED|Overall Study||5
9879790|NCT01024244|10994583|FG001|COMPLETED|Overall Study||1
9879791|NCT01024244|10994584|FG002|COMPLETED|Overall Study||1
9879792|NCT01024244|10994585|FG003|COMPLETED|Overall Study||1
9879793|NCT01024244|10994586|FG004|COMPLETED|Overall Study||1
9879794|NCT01024244|10994582|FG000|NOT COMPLETED|Overall Study||17
9879795|NCT01024244|10994583|FG001|NOT COMPLETED|Overall Study||11
9879796|NCT01024244|10994584|FG002|NOT COMPLETED|Overall Study||14
10007687|NCT01752634|11129968|FG003|STARTED|Up to Week 24 (Primary Analysis)||43
9879797|NCT01024244|10994585|FG003|NOT COMPLETED|Overall Study||13
10107897|NCT02461758|11238256|FG000|STARTED|Overall Study||20
10107898|NCT02461758|11238257|FG001|STARTED|Overall Study||20
10107899|NCT02461758|11238258|FG002|STARTED|Overall Study||26
10107900|NCT02461758|11238259|FG003|STARTED|Overall Study||15
10107901|NCT02461758|11238256|FG000|COMPLETED|Overall Study||20
10107902|NCT02461758|11238257|FG001|COMPLETED|Overall Study||19
9879798|NCT01024244|10994586|FG004|NOT COMPLETED|Overall Study||14
9879799|NCT01024296|10994598|FG000|STARTED|Overall Study||4
9879800|NCT01024296|10994598|FG000|COMPLETED|Overall Study||4
9879801|NCT01024296|10994598|FG000|NOT COMPLETED|Overall Study||0
9879802|NCT01024309|10994604|FG000|STARTED|Overall Study||35
9879803|NCT01024309|10994605|FG001|STARTED|Overall Study||31
9879804|NCT01024309|10994604|FG000|COMPLETED|Overall Study||27
9879805|NCT01024309|10994605|FG001|COMPLETED|Overall Study||27
9879806|NCT01024309|10994604|FG000|NOT COMPLETED|Overall Study||8
9879807|NCT01024309|10994605|FG001|NOT COMPLETED|Overall Study||4
9879808|NCT01024335|10994613|FG000|STARTED|Overall Study||20
9879809|NCT01024335|10994614|FG001|STARTED|Overall Study||40
9879810|NCT01024335|10994613|FG000|COMPLETED|Overall Study||7
9879811|NCT01024335|10994614|FG001|COMPLETED|Overall Study||14
9879812|NCT01024335|10994613|FG000|NOT COMPLETED|Overall Study||13
9879813|NCT01024335|10994614|FG001|NOT COMPLETED|Overall Study||26
9879814|NCT01024387|10994620|FG000|STARTED|Overall Study||60
9879815|NCT01024387|10994620|FG000|Evaluable for PFS|Overall Study||54
9879816|NCT01024387|10994620|FG000|Evaluable for Response|Overall Study||53
9879817|NCT01024387|10994620|FG000|COMPLETED|Overall Study||0
9879818|NCT01024387|10994620|FG000|NOT COMPLETED|Overall Study||60
9879819|NCT01024465|10994624|FG000|STARTED|Overall Study||26
9879820|NCT01024465|10994624|FG000|COMPLETED|Overall Study||23
9879821|NCT01024465|10994624|FG000|NOT COMPLETED|Overall Study||3
9879822|NCT01024569|10994630|FG000|STARTED|Overall Study||276
9879823|NCT01024569|10994631|FG001|STARTED|Overall Study||279
9879824|NCT01024569|10994630|FG000|COMPLETED|Overall Study||251
9879825|NCT01024569|10994631|FG001|COMPLETED|Overall Study||268
9879826|NCT01024569|10994630|FG000|NOT COMPLETED|Overall Study||25
9879827|NCT01024569|10994631|FG001|NOT COMPLETED|Overall Study||11
9879828|NCT01024686|10994642|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
9879829|NCT01024686|10994643|FG001|STARTED|Overall Study||0
9879830|NCT01024686|10994644|FG002|STARTED|Overall Study||0
9879831|NCT01024686|10994642|FG000|COMPLETED|Overall Study||6
9879832|NCT01024686|10994643|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
9879833|NCT01024686|10994644|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
9879834|NCT01024686|10994642|FG000|NOT COMPLETED|Overall Study||0
9879835|NCT01024686|10994643|FG001|NOT COMPLETED|Overall Study||0
9879836|NCT01024686|10994644|FG002|NOT COMPLETED|Overall Study||0
9879837|NCT01024738|10994655|FG000|STARTED|First Intervention:||7
9879838|NCT01024738|10994656|FG001|STARTED|First Intervention:||7
9879839|NCT01024738|10994657|FG002|STARTED|First Intervention:||8
9879840|NCT01024738|10994655|FG000|COMPLETED|First Intervention:||7
9879841|NCT01024738|10994656|FG001|COMPLETED|First Intervention:||7
9879842|NCT01024738|10994657|FG002|COMPLETED|First Intervention:||8
9879843|NCT01024738|10994655|FG000|NOT COMPLETED|First Intervention:||0
9879844|NCT01024738|10994656|FG001|NOT COMPLETED|First Intervention:||0
9879845|NCT01024738|10994657|FG002|NOT COMPLETED|First Intervention:||0
9879846|NCT01024738|10994655|FG000|STARTED|Washout After 1st Intervention||7
9879847|NCT01024738|10994656|FG001|STARTED|Washout After 1st Intervention||7
9879848|NCT01024738|10994657|FG002|STARTED|Washout After 1st Intervention||8
9879849|NCT01024738|10994655|FG000|COMPLETED|Washout After 1st Intervention||7
9879850|NCT01024738|10994656|FG001|COMPLETED|Washout After 1st Intervention||7
9879851|NCT01024738|10994657|FG002|COMPLETED|Washout After 1st Intervention||8
9879852|NCT01024738|10994655|FG000|NOT COMPLETED|Washout After 1st Intervention||0
9879853|NCT01024738|10994656|FG001|NOT COMPLETED|Washout After 1st Intervention||0
9879854|NCT01024738|10994657|FG002|NOT COMPLETED|Washout After 1st Intervention||0
9879855|NCT01024738|10994655|FG000|STARTED|Second Intervention:||7
9879856|NCT01024738|10994656|FG001|STARTED|Second Intervention:||7
9879857|NCT01024738|10994657|FG002|STARTED|Second Intervention:||8
9879858|NCT01024738|10994655|FG000|COMPLETED|Second Intervention:||7
9879859|NCT01024738|10994656|FG001|COMPLETED|Second Intervention:||7
9879860|NCT01024738|10994657|FG002|COMPLETED|Second Intervention:||8
9879861|NCT01024738|10994655|FG000|NOT COMPLETED|Second Intervention:||0
9879862|NCT01024738|10994656|FG001|NOT COMPLETED|Second Intervention:||0
9879863|NCT01024738|10994657|FG002|NOT COMPLETED|Second Intervention:||0
9879864|NCT01024738|10994655|FG000|STARTED|Washout After 2nd Intervention||7
9879865|NCT01024738|10994656|FG001|STARTED|Washout After 2nd Intervention||7
9879866|NCT01024738|10994657|FG002|STARTED|Washout After 2nd Intervention||8
9879867|NCT01024738|10994655|FG000|COMPLETED|Washout After 2nd Intervention||7
9879868|NCT01024738|10994656|FG001|COMPLETED|Washout After 2nd Intervention||7
9879869|NCT01024738|10994657|FG002|COMPLETED|Washout After 2nd Intervention||8
9879870|NCT01024738|10994655|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
9879871|NCT01024738|10994656|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
10107903|NCT02461758|11238258|FG002|COMPLETED|Overall Study||25
10107904|NCT02461758|11238259|FG003|COMPLETED|Overall Study||15
10107905|NCT02461758|11238256|FG000|NOT COMPLETED|Overall Study||0
10107906|NCT02461758|11238257|FG001|NOT COMPLETED|Overall Study||1
9879872|NCT01024738|10994657|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
9879873|NCT01024738|10994655|FG000|STARTED|Third Intervention:||7
9879874|NCT01024738|10994656|FG001|STARTED|Third Intervention:||7
9879875|NCT01024738|10994657|FG002|STARTED|Third Intervention:||8
9879876|NCT01024738|10994655|FG000|COMPLETED|Third Intervention:||7
9879877|NCT01024738|10994656|FG001|COMPLETED|Third Intervention:||7
9879878|NCT01024738|10994657|FG002|COMPLETED|Third Intervention:||8
9879879|NCT01024738|10994655|FG000|NOT COMPLETED|Third Intervention:||0
9879880|NCT01024738|10994656|FG001|NOT COMPLETED|Third Intervention:||0
9879881|NCT01024738|10994657|FG002|NOT COMPLETED|Third Intervention:||0
9879882|NCT01024751|10994667|FG000|STARTED|Enrolled Participants||156
9879883|NCT01024751|10994668|FG001|STARTED|Enrolled Participants||156
9879884|NCT01024751|10994667|FG000|COMPLETED|Enrolled Participants||153
9879885|NCT01024751|10994668|FG001|COMPLETED|Enrolled Participants||152
9879886|NCT01024751|10994667|FG000|NOT COMPLETED|Enrolled Participants||3
9879887|NCT01024751|10994668|FG001|NOT COMPLETED|Enrolled Participants||4
9879888|NCT01024751|10994667|FG000|STARTED|Eligible Participants||153
9879889|NCT01024751|10994668|FG001|STARTED|Eligible Participants||152
9879890|NCT01024751|10994667|FG000|COMPLETED|Eligible Participants||153
10007688|NCT01752634|11129969|FG004|STARTED|Up to Week 24 (Primary Analysis)||45
10007689|NCT01752634|11129970|FG005|STARTED|Up to Week 24 (Primary Analysis)||10
10007690|NCT01752634|11129965|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93
9879891|NCT01024751|10994668|FG001|COMPLETED|Eligible Participants||149
9879892|NCT01024751|10994667|FG000|NOT COMPLETED|Eligible Participants||0
9879893|NCT01024751|10994668|FG001|NOT COMPLETED|Eligible Participants||3
9879894|NCT01024855|10994674|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
9879895|NCT01024855|10994674|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
9879896|NCT01024855|10994674|FG000|NOT COMPLETED|Overall Study||1
9879897|NCT01024920|10994681|FG000|STARTED|Overall Study||67
9879898|NCT01024920|10994682|FG001|STARTED|Overall Study||32
9879899|NCT01024920|10994681|FG000|Treated|Overall Study||64
9879900|NCT01024920|10994682|FG001|Treated|Overall Study||32
9879901|NCT01024920|10994681|FG000|COMPLETED|Overall Study||0
9879902|NCT01024920|10994682|FG001|COMPLETED|Overall Study||0
9879903|NCT01024920|10994681|FG000|NOT COMPLETED|Overall Study||67
9879904|NCT01024920|10994682|FG001|NOT COMPLETED|Overall Study||32
10007691|NCT01752634|11129966|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95
10007692|NCT01752634|11129967|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97
10007693|NCT01752634|11129968|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43
9879905|NCT01024946|10994688|FG000|STARTED|Overall Study||11
9879906|NCT01024946|10994688|FG000|COMPLETED|Overall Study||6
9879907|NCT01024946|10994688|FG000|NOT COMPLETED|Overall Study||5
9879908|NCT01024959|10994692|FG000|STARTED|Overall Study||507
9879909|NCT01024959|10994692|FG000|COMPLETED|Overall Study||466
9879910|NCT01024959|10994692|FG000|NOT COMPLETED|Overall Study||41
9879911|NCT01024972|10994703|FG000|STARTED|Overall Study||16
9879912|NCT01024972|10994704|FG001|STARTED|Overall Study||15
9879913|NCT01024972|10994703|FG000|COMPLETED|Overall Study||16
9879914|NCT01024972|10994704|FG001|COMPLETED|Overall Study||15
9879915|NCT01024972|10994703|FG000|NOT COMPLETED|Overall Study||0
10107907|NCT02461758|11238258|FG002|NOT COMPLETED|Overall Study||1
10107908|NCT02461758|11238259|FG003|NOT COMPLETED|Overall Study||0
10107909|NCT02461771|11238275|FG000|STARTED|Overall Study||3
10107910|NCT02461771|11238276|FG001|STARTED|Overall Study||3
10107911|NCT02461771|11238277|FG002|STARTED|Overall Study||7
9879916|NCT01024972|10994704|FG001|NOT COMPLETED|Overall Study||0
9879917|NCT01025037|10994711|FG000|STARTED|Overall Study||61
9879918|NCT01025037|10994711|FG000|COMPLETED|Overall Study||50
9879919|NCT01025037|10994711|FG000|NOT COMPLETED|Overall Study||11
9954113|NCT01430299|11072818|FG000|COMPLETED|Overall Study||16
10007694|NCT01752634|11129969|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45
10007695|NCT01752634|11129970|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0
10007696|NCT01752634|11129965|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
10107912|NCT02461771|11238275|FG000|COMPLETED|Overall Study||3
9954114|NCT01430299|11072819|FG001|COMPLETED|Overall Study||21
9954115|NCT01430299|11072818|FG000|NOT COMPLETED|Overall Study||4
9954116|NCT01430299|11072819|FG001|NOT COMPLETED|Overall Study||2
9954117|NCT01430325|11072829|FG000|STARTED|Overall Study||10
9954118|NCT01430325|11072830|FG001|STARTED|Overall Study||12
9954119|NCT01430325|11072831|FG002|STARTED|Overall Study||8
9954120|NCT01430325|11072832|FG003|STARTED|Overall Study||12
9954121|NCT01430325|11072829|FG000|COMPLETED|Overall Study||10
9954122|NCT01430325|11072830|FG001|COMPLETED|Overall Study||12
9954123|NCT01430325|11072831|FG002|COMPLETED|Overall Study||8
9954124|NCT01430325|11072832|FG003|COMPLETED|Overall Study||12
9954125|NCT01430325|11072829|FG000|NOT COMPLETED|Overall Study||0
9954126|NCT01430325|11072830|FG001|NOT COMPLETED|Overall Study||0
9954127|NCT01430325|11072831|FG002|NOT COMPLETED|Overall Study||0
9954128|NCT01430325|11072832|FG003|NOT COMPLETED|Overall Study||0
9954129|NCT01430403|11072845|FG000|STARTED|Overall Study|Intent-to-treat|259
9954130|NCT01430403|11072846|FG001|STARTED|Overall Study|Intent-to-treat|130
9954131|NCT01430403|11072847|FG002|STARTED|Overall Study|Intent-to-treat|89
9879920|NCT01025076|10994715|FG000|STARTED|Overall Study||14
9879921|NCT01025076|10994715|FG000|COMPLETED|Overall Study||14
9879922|NCT01025076|10994715|FG000|NOT COMPLETED|Overall Study||0
9879923|NCT01025154|10994719|FG000|STARTED|Overall Study||59
9879924|NCT01025154|10994719|FG000|COMPLETED|Overall Study||57
9879925|NCT01025154|10994719|FG000|NOT COMPLETED|Overall Study||2
9879926|NCT01025193|10994723|FG000|STARTED|Overall Study||8
9879927|NCT01025193|10994723|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
9879928|NCT01025193|10994723|FG000|NOT COMPLETED|Overall Study||4
9879929|NCT01025232|10994733|FG000|STARTED|Overall Study||46
9879930|NCT01025232|10994734|FG001|STARTED|Overall Study||42
9879931|NCT01025232|10994733|FG000|COMPLETED|Overall Study||43
9879932|NCT01025232|10994734|FG001|COMPLETED|Overall Study||36
9879933|NCT01025232|10994733|FG000|NOT COMPLETED|Overall Study||3
9879934|NCT01025232|10994734|FG001|NOT COMPLETED|Overall Study||6
9879935|NCT01025284|10994743|FG000|STARTED|Overall Study||38
9879936|NCT01025284|10994744|FG001|STARTED|Overall Study||18
9879937|NCT01025284|10994745|FG002|STARTED|Overall Study||8
9879938|NCT01025284|10994743|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38
9879939|NCT01025284|10994744|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
9879940|NCT01025284|10994745|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
9879941|NCT01025284|10994743|FG000|COMPLETED|Overall Study||38
9879942|NCT01025284|10994744|FG001|COMPLETED|Overall Study||16
9879943|NCT01025284|10994745|FG002|COMPLETED|Overall Study||8
9879944|NCT01025284|10994743|FG000|NOT COMPLETED|Overall Study||0
9879945|NCT01025284|10994744|FG001|NOT COMPLETED|Overall Study||2
9879946|NCT01025284|10994745|FG002|NOT COMPLETED|Overall Study||0
9879947|NCT01025336|10994760|FG000|STARTED|Overall Study||130
9879948|NCT01025336|10994761|FG001|STARTED|Overall Study||210
9879949|NCT01025336|10994762|FG002|STARTED|Overall Study||179
9879950|NCT01025336|10994763|FG003|STARTED|Overall Study||221
9879951|NCT01025336|10994764|FG004|STARTED|Overall Study||222
9879952|NCT01025336|10994760|FG000|COMPLETED|Overall Study||130
9879953|NCT01025336|10994761|FG001|COMPLETED|Overall Study||210
9879954|NCT01025336|10994762|FG002|COMPLETED|Overall Study||179
9879955|NCT01025336|10994763|FG003|COMPLETED|Overall Study||219
9879956|NCT01025336|10994764|FG004|COMPLETED|Overall Study||222
9879957|NCT01025336|10994760|FG000|NOT COMPLETED|Overall Study||0
9879958|NCT01025336|10994761|FG001|NOT COMPLETED|Overall Study||0
9879959|NCT01025336|10994762|FG002|NOT COMPLETED|Overall Study||0
9879960|NCT01025336|10994763|FG003|NOT COMPLETED|Overall Study||2
9879961|NCT01025336|10994764|FG004|NOT COMPLETED|Overall Study||0
9879962|NCT01025427|10994788|FG000|STARTED|Overall Study||16
9879963|NCT01025427|10994788|FG000|COMPLETED|Overall Study||16
9879964|NCT01025427|10994788|FG000|NOT COMPLETED|Overall Study||0
9879965|NCT01025453|10994792|FG000|STARTED|Overall Study||37
9879966|NCT01025453|10994792|FG000|COMPLETED|Overall Study||37
9879967|NCT01025453|10994792|FG000|NOT COMPLETED|Overall Study||0
9879968|NCT01025635|10994798|FG000|STARTED|Overall Study||198
9879969|NCT01025635|10994799|FG001|STARTED|Overall Study||203
9879970|NCT01025635|10994798|FG000|COMPLETED|Overall Study||175
9879971|NCT01025635|10994799|FG001|COMPLETED|Overall Study||178
9879972|NCT01025635|10994798|FG000|NOT COMPLETED|Overall Study||23
9879973|NCT01025635|10994799|FG001|NOT COMPLETED|Overall Study||25
9879974|NCT01025752|10994807|FG000|STARTED|Overall Study||62
9879975|NCT01025752|10994808|FG001|STARTED|Overall Study||63
9879976|NCT01025752|10994807|FG000|COMPLETED|Overall Study||54
9879977|NCT01025752|10994808|FG001|COMPLETED|Overall Study||50
9879978|NCT01025752|10994807|FG000|NOT COMPLETED|Overall Study||8
9879979|NCT01025752|10994808|FG001|NOT COMPLETED|Overall Study||13
9879980|NCT01025791|10994817|FG000|STARTED|Period 1||2
9879981|NCT01025791|10994818|FG001|STARTED|Period 1||2
9879982|NCT01025791|10994819|FG002|STARTED|Period 1||2
9879983|NCT01025791|10994820|FG003|STARTED|Period 1||2
9879984|NCT01025791|10994821|FG004|STARTED|Period 1||2
9879985|NCT01025791|10994822|FG005|STARTED|Period 1||2
9879986|NCT01025791|10994823|FG006|STARTED|Period 1||2
9879987|NCT01025791|10994824|FG007|STARTED|Period 1||2
10107913|NCT02461771|11238276|FG001|COMPLETED|Overall Study||3
10107914|NCT02461771|11238277|FG002|COMPLETED|Overall Study||7
10107915|NCT02461771|11238275|FG000|NOT COMPLETED|Overall Study||0
10107916|NCT02461771|11238276|FG001|NOT COMPLETED|Overall Study||0
10107917|NCT02461771|11238277|FG002|NOT COMPLETED|Overall Study||0
10107918|NCT02461966|11238288|FG000|STARTED|Overall Study||160
10107919|NCT02461966|11238289|FG001|STARTED|Overall Study||80
10107920|NCT02461966|11238290|FG002|STARTED|Overall Study||60
10107921|NCT02461966|11238288|FG000|COMPLETED|Overall Study||160
10107922|NCT02461966|11238289|FG001|COMPLETED|Overall Study||80
10107923|NCT02461966|11238290|FG002|COMPLETED|Overall Study||60
9879988|NCT01025791|10994825|FG008|STARTED|Period 1||2
9879989|NCT01025791|10994826|FG009|STARTED|Period 1||1
10107924|NCT02461966|11238288|FG000|NOT COMPLETED|Overall Study||0
10107925|NCT02461966|11238289|FG001|NOT COMPLETED|Overall Study||0
10107926|NCT02461966|11238290|FG002|NOT COMPLETED|Overall Study||0
10107927|NCT02461992|11238298|FG000|STARTED|Overall Study||13
9879990|NCT01025791|10994827|FG010|STARTED|Period 1||2
9879991|NCT01025791|10994828|FG011|STARTED|Period 1||1
9879992|NCT01025791|10994829|FG012|STARTED|Period 1||2
9879993|NCT01025791|10994830|FG013|STARTED|Period 1||1
9879994|NCT01025791|10994817|FG000|COMPLETED|Period 1||2
9879995|NCT01025791|10994818|FG001|COMPLETED|Period 1||2
9879996|NCT01025791|10994819|FG002|COMPLETED|Period 1||2
10107928|NCT02461992|11238298|FG000|COMPLETED|Overall Study||13
9879997|NCT01025791|10994820|FG003|COMPLETED|Period 1||2
9879998|NCT01025791|10994821|FG004|COMPLETED|Period 1||2
9879999|NCT01025791|10994822|FG005|COMPLETED|Period 1||2
9880000|NCT01025791|10994823|FG006|COMPLETED|Period 1||2
9880001|NCT01025791|10994824|FG007|COMPLETED|Period 1||2
9880002|NCT01025791|10994825|FG008|COMPLETED|Period 1||2
9880003|NCT01025791|10994826|FG009|COMPLETED|Period 1||1
9880004|NCT01025791|10994827|FG010|COMPLETED|Period 1||2
9880005|NCT01025791|10994828|FG011|COMPLETED|Period 1||1
9880006|NCT01025791|10994829|FG012|COMPLETED|Period 1||2
9880007|NCT01025791|10994830|FG013|COMPLETED|Period 1||1
9880008|NCT01025791|10994817|FG000|NOT COMPLETED|Period 1||0
9880009|NCT01025791|10994818|FG001|NOT COMPLETED|Period 1||0
9880010|NCT01025791|10994819|FG002|NOT COMPLETED|Period 1||0
9880011|NCT01025791|10994820|FG003|NOT COMPLETED|Period 1||0
9880012|NCT01025791|10994821|FG004|NOT COMPLETED|Period 1||0
9880013|NCT01025791|10994822|FG005|NOT COMPLETED|Period 1||0
9880014|NCT01025791|10994823|FG006|NOT COMPLETED|Period 1||0
9880015|NCT01025791|10994824|FG007|NOT COMPLETED|Period 1||0
9880016|NCT01025791|10994825|FG008|NOT COMPLETED|Period 1||0
9880017|NCT01025791|10994826|FG009|NOT COMPLETED|Period 1||0
9880018|NCT01025791|10994827|FG010|NOT COMPLETED|Period 1||0
9880019|NCT01025791|10994828|FG011|NOT COMPLETED|Period 1||0
9880020|NCT01025791|10994829|FG012|NOT COMPLETED|Period 1||0
9880021|NCT01025791|10994830|FG013|NOT COMPLETED|Period 1||0
9880022|NCT01025791|10994817|FG000|STARTED|Period 2||2
9880023|NCT01025791|10994818|FG001|STARTED|Period 2||2
9880024|NCT01025791|10994819|FG002|STARTED|Period 2||2
9880025|NCT01025791|10994820|FG003|STARTED|Period 2||2
9880026|NCT01025791|10994821|FG004|STARTED|Period 2||2
9880027|NCT01025791|10994822|FG005|STARTED|Period 2||2
9880028|NCT01025791|10994823|FG006|STARTED|Period 2||2
9880029|NCT01025791|10994824|FG007|STARTED|Period 2||2
9880030|NCT01025791|10994825|FG008|STARTED|Period 2||2
9880031|NCT01025791|10994826|FG009|STARTED|Period 2||1
9880032|NCT01025791|10994827|FG010|STARTED|Period 2||2
9880033|NCT01025791|10994828|FG011|STARTED|Period 2||1
9880034|NCT01025791|10994829|FG012|STARTED|Period 2||2
9880035|NCT01025791|10994830|FG013|STARTED|Period 2||1
9880036|NCT01025791|10994817|FG000|COMPLETED|Period 2||2
9880037|NCT01025791|10994818|FG001|COMPLETED|Period 2||2
9880038|NCT01025791|10994819|FG002|COMPLETED|Period 2||2
9880039|NCT01025791|10994820|FG003|COMPLETED|Period 2||2
9880040|NCT01025791|10994821|FG004|COMPLETED|Period 2||2
9880041|NCT01025791|10994822|FG005|COMPLETED|Period 2||2
9880042|NCT01025791|10994823|FG006|COMPLETED|Period 2||2
9880043|NCT01025791|10994824|FG007|COMPLETED|Period 2||2
9880044|NCT01025791|10994825|FG008|COMPLETED|Period 2||2
9880045|NCT01025791|10994826|FG009|COMPLETED|Period 2||1
9880046|NCT01025791|10994827|FG010|COMPLETED|Period 2||2
9880047|NCT01025791|10994828|FG011|COMPLETED|Period 2||1
9880048|NCT01025791|10994829|FG012|COMPLETED|Period 2||2
9880049|NCT01025791|10994830|FG013|COMPLETED|Period 2||1
9880050|NCT01025791|10994817|FG000|NOT COMPLETED|Period 2||0
9880051|NCT01025791|10994818|FG001|NOT COMPLETED|Period 2||0
9880052|NCT01025791|10994819|FG002|NOT COMPLETED|Period 2||0
9880053|NCT01025791|10994820|FG003|NOT COMPLETED|Period 2||0
9880054|NCT01025791|10994821|FG004|NOT COMPLETED|Period 2||0
9880055|NCT01025791|10994822|FG005|NOT COMPLETED|Period 2||0
9880056|NCT01025791|10994823|FG006|NOT COMPLETED|Period 2||0
9880057|NCT01025791|10994824|FG007|NOT COMPLETED|Period 2||0
10107929|NCT02461992|11238298|FG000|NOT COMPLETED|Overall Study||0
10107930|NCT02462057|11238307|FG000|STARTED|Overall Study||791
10107931|NCT02462057|11238308|FG001|STARTED|Overall Study||793
10107932|NCT02462057|11238309|FG002|STARTED|Overall Study||812
10107933|NCT02462057|11238310|FG003|STARTED|Overall Study||752
10107934|NCT02462057|11238311|FG004|STARTED|Overall Study||758
10107935|NCT02462057|11238307|FG000|COMPLETED|Overall Study||737
10107936|NCT02462057|11238308|FG001|COMPLETED|Overall Study||753
10107937|NCT02462057|11238309|FG002|COMPLETED|Overall Study||766
10107938|NCT02462057|11238310|FG003|COMPLETED|Overall Study||701
10107939|NCT02462057|11238311|FG004|COMPLETED|Overall Study||708
10107940|NCT02462057|11238307|FG000|NOT COMPLETED|Overall Study||54
10107941|NCT02462057|11238308|FG001|NOT COMPLETED|Overall Study||40
10107942|NCT02462057|11238309|FG002|NOT COMPLETED|Overall Study||46
10107943|NCT02462057|11238310|FG003|NOT COMPLETED|Overall Study||51
10107944|NCT02462057|11238311|FG004|NOT COMPLETED|Overall Study||50
10107945|NCT02462070|11238325|FG000|STARTED|Overall Study||135
10107946|NCT02462070|11238326|FG001|STARTED|Overall Study||68
10107947|NCT02462070|11238325|FG000|COMPLETED|Overall Study||112
10107948|NCT02462070|11238326|FG001|COMPLETED|Overall Study||57
9880058|NCT01025791|10994825|FG008|NOT COMPLETED|Period 2||0
9880059|NCT01025791|10994826|FG009|NOT COMPLETED|Period 2||0
10107949|NCT02462070|11238325|FG000|NOT COMPLETED|Overall Study||23
9880060|NCT01025791|10994827|FG010|NOT COMPLETED|Period 2||0
9880061|NCT01025791|10994828|FG011|NOT COMPLETED|Period 2||0
9880062|NCT01025791|10994829|FG012|NOT COMPLETED|Period 2||0
9880063|NCT01025791|10994830|FG013|NOT COMPLETED|Period 2||0
9880064|NCT01025791|10994817|FG000|STARTED|Period 3||2
9880065|NCT01025791|10994818|FG001|STARTED|Period 3||2
9880066|NCT01025791|10994819|FG002|STARTED|Period 3||2
9880067|NCT01025791|10994820|FG003|STARTED|Period 3||2
9880068|NCT01025791|10994821|FG004|STARTED|Period 3||2
9880069|NCT01025791|10994822|FG005|STARTED|Period 3||2
9880070|NCT01025791|10994823|FG006|STARTED|Period 3||2
9880071|NCT01025791|10994824|FG007|STARTED|Period 3||2
9880072|NCT01025791|10994825|FG008|STARTED|Period 3||2
10107950|NCT02462070|11238326|FG001|NOT COMPLETED|Overall Study||11
9880073|NCT01025791|10994826|FG009|STARTED|Period 3||1
9880074|NCT01025791|10994827|FG010|STARTED|Period 3||2
9880075|NCT01025791|10994828|FG011|STARTED|Period 3||1
9880076|NCT01025791|10994829|FG012|STARTED|Period 3||2
9880077|NCT01025791|10994830|FG013|STARTED|Period 3||1
9880078|NCT01025791|10994817|FG000|COMPLETED|Period 3||2
9880079|NCT01025791|10994818|FG001|COMPLETED|Period 3||2
9880080|NCT01025791|10994819|FG002|COMPLETED|Period 3||2
9880081|NCT01025791|10994820|FG003|COMPLETED|Period 3||2
9880082|NCT01025791|10994821|FG004|COMPLETED|Period 3||2
9880083|NCT01025791|10994822|FG005|COMPLETED|Period 3||2
9880084|NCT01025791|10994823|FG006|COMPLETED|Period 3||2
9880085|NCT01025791|10994824|FG007|COMPLETED|Period 3||2
9880086|NCT01025791|10994825|FG008|COMPLETED|Period 3||2
9880087|NCT01025791|10994826|FG009|COMPLETED|Period 3||1
9880088|NCT01025791|10994827|FG010|COMPLETED|Period 3||2
9880089|NCT01025791|10994828|FG011|COMPLETED|Period 3||1
9880090|NCT01025791|10994829|FG012|COMPLETED|Period 3||2
9880091|NCT01025791|10994830|FG013|COMPLETED|Period 3||1
9880092|NCT01025791|10994817|FG000|NOT COMPLETED|Period 3||0
9880093|NCT01025791|10994818|FG001|NOT COMPLETED|Period 3||0
9880094|NCT01025791|10994819|FG002|NOT COMPLETED|Period 3||0
9880095|NCT01025791|10994820|FG003|NOT COMPLETED|Period 3||0
9880096|NCT01025791|10994821|FG004|NOT COMPLETED|Period 3||0
9880097|NCT01025791|10994822|FG005|NOT COMPLETED|Period 3||0
9880098|NCT01025791|10994823|FG006|NOT COMPLETED|Period 3||0
9880099|NCT01025791|10994824|FG007|NOT COMPLETED|Period 3||0
9880100|NCT01025791|10994825|FG008|NOT COMPLETED|Period 3||0
9880101|NCT01025791|10994826|FG009|NOT COMPLETED|Period 3||0
9880102|NCT01025791|10994827|FG010|NOT COMPLETED|Period 3||0
9880103|NCT01025791|10994828|FG011|NOT COMPLETED|Period 3||0
9880104|NCT01025791|10994829|FG012|NOT COMPLETED|Period 3||0
9880105|NCT01025791|10994830|FG013|NOT COMPLETED|Period 3||0
10007697|NCT01752634|11129966|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
10007698|NCT01752634|11129967|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
10007699|NCT01752634|11129968|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
10007700|NCT01752634|11129969|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
10007701|NCT01752634|11129970|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
10007702|NCT01752634|11129965|FG000|STARTED|Week 24 to Week 260||93
10107951|NCT02462083|11238332|FG000|STARTED|Overall Study||555
10107952|NCT02462083|11238332|FG000|Safety Population|Overall Study||550
10107953|NCT02462083|11238332|FG000|COMPLETED|Overall Study||136
10107954|NCT02462083|11238332|FG000|NOT COMPLETED|Overall Study||419
10107955|NCT02462122|11238338|FG000|STARTED|Overall Study||141
10107956|NCT02462122|11238339|FG001|STARTED|Overall Study||74
10107957|NCT02462122|11238338|FG000|COMPLETED|Overall Study||120
10107958|NCT02462122|11238339|FG001|COMPLETED|Overall Study||61
10107959|NCT02462122|11238338|FG000|NOT COMPLETED|Overall Study||21
10107960|NCT02462122|11238339|FG001|NOT COMPLETED|Overall Study||13
10107961|NCT02462148|11238348|FG000|STARTED|Overall Study||37
10107962|NCT02462148|11238349|FG001|STARTED|Overall Study||36
10107963|NCT02462148|11238350|FG002|STARTED|Overall Study||12
10107964|NCT02462148|11238348|FG000|COMPLETED|Overall Study||36
10107965|NCT02462148|11238349|FG001|COMPLETED|Overall Study||36
10107966|NCT02462148|11238350|FG002|COMPLETED|Overall Study||12
10107967|NCT02462148|11238348|FG000|NOT COMPLETED|Overall Study||1
10107968|NCT02462148|11238349|FG001|NOT COMPLETED|Overall Study||0
10107969|NCT02462148|11238350|FG002|NOT COMPLETED|Overall Study||0
10107970|NCT02462291|11238363|FG000|STARTED|Overall Study||82
10107971|NCT02462291|11238364|FG001|STARTED|Overall Study||81
10107972|NCT02462291|11238363|FG000|COMPLETED|Overall Study||77
10107973|NCT02462291|11238364|FG001|COMPLETED|Overall Study||75
10107974|NCT02462291|11238363|FG000|NOT COMPLETED|Overall Study||5
10107975|NCT02462291|11238364|FG001|NOT COMPLETED|Overall Study||6
10107976|NCT02462382|11238374|FG000|STARTED|Overall Study||24
10107977|NCT02462382|11238375|FG001|STARTED|Overall Study||27
10107978|NCT02462382|11238374|FG000|COMPLETED|Overall Study||24
10107979|NCT02462382|11238375|FG001|COMPLETED|Overall Study||27
10107980|NCT02462382|11238374|FG000|NOT COMPLETED|Overall Study||0
10107981|NCT02462382|11238375|FG001|NOT COMPLETED|Overall Study||0
10107982|NCT02462473|11238381|FG000|STARTED|Overall Study||9
10107983|NCT02462473|11238381|FG000|COMPLETED|Overall Study||5
10107984|NCT02462473|11238381|FG000|NOT COMPLETED|Overall Study||4
10107985|NCT02462486|11238388|FG000|STARTED|Overall Study||316
10007703|NCT01752634|11129966|FG001|STARTED|Week 24 to Week 260||95
10107986|NCT02462486|11238389|FG001|STARTED|Overall Study||315
10107987|NCT02462486|11238390|FG002|STARTED|Overall Study||318
10107988|NCT02462486|11238388|FG000|COMPLETED|Overall Study||222
10107989|NCT02462486|11238389|FG001|COMPLETED|Overall Study||223
10107990|NCT02462486|11238390|FG002|COMPLETED|Overall Study||266
10107991|NCT02462486|11238388|FG000|NOT COMPLETED|Overall Study||94
9880106|NCT01025791|10994817|FG000|STARTED|Period 4||2
9880107|NCT01025791|10994818|FG001|STARTED|Period 4||2
10007704|NCT01752634|11129967|FG002|STARTED|Week 24 to Week 260||97
9880108|NCT01025791|10994819|FG002|STARTED|Period 4||2
9880109|NCT01025791|10994820|FG003|STARTED|Period 4||2
9880110|NCT01025791|10994821|FG004|STARTED|Period 4||2
9880111|NCT01025791|10994822|FG005|STARTED|Period 4||2
9880112|NCT01025791|10994823|FG006|STARTED|Period 4||2
9880113|NCT01025791|10994824|FG007|STARTED|Period 4||2
9880114|NCT01025791|10994825|FG008|STARTED|Period 4||2
9880115|NCT01025791|10994826|FG009|STARTED|Period 4||1
9880116|NCT01025791|10994827|FG010|STARTED|Period 4||2
9880117|NCT01025791|10994828|FG011|STARTED|Period 4||1
10107992|NCT02462486|11238389|FG001|NOT COMPLETED|Overall Study||92
9880118|NCT01025791|10994829|FG012|STARTED|Period 4||2
9880119|NCT01025791|10994830|FG013|STARTED|Period 4||1
9880120|NCT01025791|10994817|FG000|COMPLETED|Period 4||2
9880121|NCT01025791|10994818|FG001|COMPLETED|Period 4||2
9880122|NCT01025791|10994819|FG002|COMPLETED|Period 4||2
9880123|NCT01025791|10994820|FG003|COMPLETED|Period 4||2
9880124|NCT01025791|10994821|FG004|COMPLETED|Period 4||2
9880125|NCT01025791|10994822|FG005|COMPLETED|Period 4||2
9880126|NCT01025791|10994823|FG006|COMPLETED|Period 4||2
9880127|NCT01025791|10994824|FG007|COMPLETED|Period 4||2
9880128|NCT01025791|10994825|FG008|COMPLETED|Period 4||2
9880129|NCT01025791|10994826|FG009|COMPLETED|Period 4||1
9880130|NCT01025791|10994827|FG010|COMPLETED|Period 4||2
9880131|NCT01025791|10994828|FG011|COMPLETED|Period 4||1
9880132|NCT01025791|10994829|FG012|COMPLETED|Period 4||2
9880133|NCT01025791|10994830|FG013|COMPLETED|Period 4||1
9880134|NCT01025791|10994817|FG000|NOT COMPLETED|Period 4||0
9880135|NCT01025791|10994818|FG001|NOT COMPLETED|Period 4||0
9880136|NCT01025791|10994819|FG002|NOT COMPLETED|Period 4||0
9880137|NCT01025791|10994820|FG003|NOT COMPLETED|Period 4||0
9880138|NCT01025791|10994821|FG004|NOT COMPLETED|Period 4||0
9880139|NCT01025791|10994822|FG005|NOT COMPLETED|Period 4||0
9880140|NCT01025791|10994823|FG006|NOT COMPLETED|Period 4||0
9880141|NCT01025791|10994824|FG007|NOT COMPLETED|Period 4||0
9880142|NCT01025791|10994825|FG008|NOT COMPLETED|Period 4||0
9880143|NCT01025791|10994826|FG009|NOT COMPLETED|Period 4||0
9880144|NCT01025791|10994827|FG010|NOT COMPLETED|Period 4||0
9880145|NCT01025791|10994828|FG011|NOT COMPLETED|Period 4||0
9880146|NCT01025791|10994829|FG012|NOT COMPLETED|Period 4||0
9880147|NCT01025791|10994830|FG013|NOT COMPLETED|Period 4||0
9880148|NCT01025791|10994817|FG000|STARTED|Period 5||2
9880149|NCT01025791|10994818|FG001|STARTED|Period 5||2
9880150|NCT01025791|10994819|FG002|STARTED|Period 5||2
9880151|NCT01025791|10994820|FG003|STARTED|Period 5||2
9880152|NCT01025791|10994821|FG004|STARTED|Period 5||0
9880153|NCT01025791|10994822|FG005|STARTED|Period 5||0
9880154|NCT01025791|10994823|FG006|STARTED|Period 5||0
9880155|NCT01025791|10994824|FG007|STARTED|Period 5||0
9880156|NCT01025791|10994825|FG008|STARTED|Period 5||0
9880157|NCT01025791|10994826|FG009|STARTED|Period 5||0
9880158|NCT01025791|10994827|FG010|STARTED|Period 5||0
9880159|NCT01025791|10994828|FG011|STARTED|Period 5||0
10007705|NCT01752634|11129968|FG003|STARTED|Week 24 to Week 260||43
10007706|NCT01752634|11129969|FG004|STARTED|Week 24 to Week 260||45
10007707|NCT01752634|11129970|FG005|STARTED|Week 24 to Week 260||0
10007708|NCT01752634|11129965|FG000|COMPLETED|Week 24 to Week 260||59
10007709|NCT01752634|11129966|FG001|COMPLETED|Week 24 to Week 260||65
10007710|NCT01752634|11129967|FG002|COMPLETED|Week 24 to Week 260||64
10007711|NCT01752634|11129968|FG003|COMPLETED|Week 24 to Week 260||29
10007712|NCT01752634|11129969|FG004|COMPLETED|Week 24 to Week 260||31
10007713|NCT01752634|11129970|FG005|COMPLETED|Week 24 to Week 260||0
10007714|NCT01752634|11129965|FG000|NOT COMPLETED|Week 24 to Week 260||34
10007715|NCT01752634|11129966|FG001|NOT COMPLETED|Week 24 to Week 260||30
10007716|NCT01752634|11129967|FG002|NOT COMPLETED|Week 24 to Week 260||33
10007717|NCT01752634|11129968|FG003|NOT COMPLETED|Week 24 to Week 260||14
10007718|NCT01752634|11129969|FG004|NOT COMPLETED|Week 24 to Week 260||14
10007719|NCT01752634|11129970|FG005|NOT COMPLETED|Week 24 to Week 260||0
10007720|NCT01752712|11129982|FG000|STARTED|Overall Study||31
10007721|NCT01752712|11129983|FG001|STARTED|Overall Study||31
10007722|NCT01752712|11129982|FG000|COMPLETED|Overall Study||22
10007723|NCT01752712|11129983|FG001|COMPLETED|Overall Study||21
10007724|NCT01752712|11129982|FG000|NOT COMPLETED|Overall Study||9
10007725|NCT01752712|11129983|FG001|NOT COMPLETED|Overall Study||10
10007726|NCT01752842|11129991|FG000|STARTED|Overall Study||34
10007727|NCT01752842|11129992|FG001|STARTED|Overall Study||36
10007728|NCT01752842|11129991|FG000|COMPLETED|Overall Study||31
10007729|NCT01752842|11129992|FG001|COMPLETED|Overall Study||34
10007730|NCT01752842|11129991|FG000|NOT COMPLETED|Overall Study||3
10107993|NCT02462486|11238390|FG002|NOT COMPLETED|Overall Study||52
10107994|NCT02462720|11238398|FG000|STARTED|Part 1||18
10107995|NCT02462720|11238399|FG001|STARTED|Part 1||17
10107996|NCT02462720|11238398|FG000|COMPLETED|Part 1||18
10107997|NCT02462720|11238399|FG001|COMPLETED|Part 1||17
10107998|NCT02462720|11238398|FG000|NOT COMPLETED|Part 1||0
9880160|NCT01025791|10994829|FG012|STARTED|Period 5||0
9880161|NCT01025791|10994830|FG013|STARTED|Period 5||0
9880162|NCT01025791|10994817|FG000|COMPLETED|Period 5||2
9880163|NCT01025791|10994818|FG001|COMPLETED|Period 5||2
10007731|NCT01752842|11129992|FG001|NOT COMPLETED|Overall Study||2
9880164|NCT01025791|10994819|FG002|COMPLETED|Period 5||2
9880165|NCT01025791|10994820|FG003|COMPLETED|Period 5||2
9880166|NCT01025791|10994821|FG004|COMPLETED|Period 5||0
9880167|NCT01025791|10994822|FG005|COMPLETED|Period 5||0
9880168|NCT01025791|10994823|FG006|COMPLETED|Period 5||0
9880169|NCT01025791|10994824|FG007|COMPLETED|Period 5||0
9880170|NCT01025791|10994825|FG008|COMPLETED|Period 5||0
9880171|NCT01025791|10994826|FG009|COMPLETED|Period 5||0
9880172|NCT01025791|10994827|FG010|COMPLETED|Period 5||0
9880173|NCT01025791|10994828|FG011|COMPLETED|Period 5||0
9880174|NCT01025791|10994829|FG012|COMPLETED|Period 5||0
9880175|NCT01025791|10994830|FG013|COMPLETED|Period 5||0
9880176|NCT01025791|10994817|FG000|NOT COMPLETED|Period 5||0
9880177|NCT01025791|10994818|FG001|NOT COMPLETED|Period 5||0
10007732|NCT01752855|11130000|FG000|STARTED|Overall Study||44
10007733|NCT01752855|11130001|FG001|STARTED|Overall Study||44
10007734|NCT01752855|11130000|FG000|COMPLETED|Overall Study||43
10107999|NCT02462720|11238399|FG001|NOT COMPLETED|Part 1||0
10108000|NCT02462720|11238398|FG000|STARTED|Part 2||18
10108001|NCT02462720|11238399|FG001|STARTED|Part 2||17
10108002|NCT02462720|11238398|FG000|COMPLETED|Part 2||17
10108003|NCT02462720|11238399|FG001|COMPLETED|Part 2||16
10108004|NCT02462720|11238398|FG000|NOT COMPLETED|Part 2||1
10108005|NCT02462720|11238399|FG001|NOT COMPLETED|Part 2||1
10108006|NCT02462759|11238409|FG000|STARTED|Part 1: Double Blind||7
10108007|NCT02462759|11238410|FG001|STARTED|Part 1: Double Blind||14
10108008|NCT02462759|11238411|FG002|STARTED|Part 1: Double Blind||0
10108009|NCT02462759|11238409|FG000|COMPLETED|Part 1: Double Blind||6
10108010|NCT02462759|11238410|FG001|COMPLETED|Part 1: Double Blind||14
10108011|NCT02462759|11238411|FG002|COMPLETED|Part 1: Double Blind||0
10108012|NCT02462759|11238409|FG000|NOT COMPLETED|Part 1: Double Blind||1
10108013|NCT02462759|11238410|FG001|NOT COMPLETED|Part 1: Double Blind||0
10108014|NCT02462759|11238411|FG002|NOT COMPLETED|Part 1: Double Blind||0
10108015|NCT02462759|11238409|FG000|STARTED|Part 2: Open-Label Phase||0
10108016|NCT02462759|11238410|FG001|STARTED|Part 2: Open-Label Phase||0
10108017|NCT02462759|11238411|FG002|STARTED|Part 2: Open-Label Phase||20
10108018|NCT02462759|11238409|FG000|COMPLETED|Part 2: Open-Label Phase||0
10108019|NCT02462759|11238410|FG001|COMPLETED|Part 2: Open-Label Phase||0
10108020|NCT02462759|11238411|FG002|COMPLETED|Part 2: Open-Label Phase||20
10108021|NCT02462759|11238409|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0
10108022|NCT02462759|11238410|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0
10108023|NCT02462759|11238411|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0
10108024|NCT02462928|11238425|FG000|STARTED|Overall Study||314
10108025|NCT02462928|11238426|FG001|STARTED|Overall Study||313
10108026|NCT02462928|11238427|FG002|STARTED|Overall Study||312
10108027|NCT02462928|11238425|FG000|COMPLETED|Overall Study||224
10108028|NCT02462928|11238426|FG001|COMPLETED|Overall Study||221
10108029|NCT02462928|11238427|FG002|COMPLETED|Overall Study||255
10108030|NCT02462928|11238425|FG000|NOT COMPLETED|Overall Study||90
10108031|NCT02462928|11238426|FG001|NOT COMPLETED|Overall Study||92
10108032|NCT02462928|11238427|FG002|NOT COMPLETED|Overall Study||57
10108033|NCT02462967|11238438|FG000|STARTED|Overall Study||54
10108034|NCT02462967|11238439|FG001|STARTED|Overall Study||54
10108035|NCT02462967|11238440|FG002|STARTED|Overall Study||54
10007735|NCT01752855|11130001|FG001|COMPLETED|Overall Study||40
10007736|NCT01752855|11130000|FG000|NOT COMPLETED|Overall Study||1
10007737|NCT01752855|11130001|FG001|NOT COMPLETED|Overall Study||4
10007738|NCT01752907|11130009|FG000|STARTED|Overall Study||151
10007739|NCT01752907|11130010|FG001|STARTED|Overall Study||153
10007740|NCT01752907|11130009|FG000|Received Pegfilgrastim|Overall Study||149
10007741|NCT01752907|11130010|FG001|Received Pegfilgrastim|Overall Study||151
10007742|NCT01752907|11130009|FG000|COMPLETED|Overall Study||139
10007743|NCT01752907|11130010|FG001|COMPLETED|Overall Study||133
10108036|NCT02462967|11238438|FG000|COMPLETED|Overall Study||52
10108037|NCT02462967|11238439|FG001|COMPLETED|Overall Study||48
10108038|NCT02462967|11238440|FG002|COMPLETED|Overall Study||51
10108039|NCT02462967|11238438|FG000|NOT COMPLETED|Overall Study||2
10108040|NCT02462967|11238439|FG001|NOT COMPLETED|Overall Study||6
10108041|NCT02462967|11238440|FG002|NOT COMPLETED|Overall Study||3
10108042|NCT02463032|11238450|FG000|STARTED|Overall Study||72
10108043|NCT02463032|11238451|FG001|STARTED|Overall Study||64
10108044|NCT02463032|11238450|FG000|COMPLETED|Overall Study||1
10108045|NCT02463032|11238451|FG001|COMPLETED|Overall Study||0
10007744|NCT01752907|11130009|FG000|NOT COMPLETED|Overall Study||12
10007745|NCT01752907|11130010|FG001|NOT COMPLETED|Overall Study||20
10007746|NCT01752933|11130018|FG000|STARTED|Treatment|Includes all patients who received any treatment|4
10007747|NCT01752933|11130019|FG001|STARTED|Treatment|Includes all patients who received any treatment|46
10007748|NCT01752933|11130018|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0
10007749|NCT01752933|11130019|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0
10007750|NCT01752933|11130018|FG000|NOT COMPLETED|Treatment||4
10007751|NCT01752933|11130019|FG001|NOT COMPLETED|Treatment||46
10007752|NCT01752933|11130018|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
10007753|NCT01752933|11130019|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
10007754|NCT01752933|11130018|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
10007755|NCT01752933|11130019|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
10007756|NCT01752933|11130018|FG000|NOT COMPLETED|Overall Study and Follow-up||4
10007757|NCT01752933|11130019|FG001|NOT COMPLETED|Overall Study and Follow-up||46
10007758|NCT01752985|11130029|FG000|STARTED|Treatment Period||29
10007759|NCT01752985|11130030|FG001|STARTED|Treatment Period||30
10007760|NCT01752985|11130031|FG002|STARTED|Treatment Period||29
10007761|NCT01752985|11130029|FG000|COMPLETED|Treatment Period||25
10007762|NCT01752985|11130030|FG001|COMPLETED|Treatment Period||27
10007763|NCT01752985|11130031|FG002|COMPLETED|Treatment Period||24
10007764|NCT01752985|11130029|FG000|NOT COMPLETED|Treatment Period||4
10007765|NCT01752985|11130030|FG001|NOT COMPLETED|Treatment Period||3
10007766|NCT01752985|11130031|FG002|NOT COMPLETED|Treatment Period||5
10018974|NCT01826851|11142030|FG001|STARTED|Overall Study||41
10108046|NCT02463032|11238450|FG000|NOT COMPLETED|Overall Study||71
10108047|NCT02463032|11238451|FG001|NOT COMPLETED|Overall Study||64
10108048|NCT02463071|11238460|FG000|STARTED|Overall Study||152
10108049|NCT02463071|11238461|FG001|STARTED|Overall Study||154
10108050|NCT02463071|11238462|FG002|STARTED|Overall Study||77
10108051|NCT02463071|11238460|FG000|COMPLETED|Overall Study||140
10007767|NCT01752985|11130029|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
10007768|NCT01752985|11130030|FG001|STARTED|Follow-up Period||27
10007769|NCT01752985|11130031|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
10007770|NCT01752985|11130029|FG000|COMPLETED|Follow-up Period||28
10007771|NCT01752985|11130030|FG001|COMPLETED|Follow-up Period||27
10007772|NCT01752985|11130031|FG002|COMPLETED|Follow-up Period||26
10007773|NCT01752985|11130029|FG000|NOT COMPLETED|Follow-up Period||0
10108052|NCT02463071|11238461|FG001|COMPLETED|Overall Study||138
10108053|NCT02463071|11238462|FG002|COMPLETED|Overall Study||71
10108054|NCT02463071|11238460|FG000|NOT COMPLETED|Overall Study||12
10007774|NCT01752985|11130030|FG001|NOT COMPLETED|Follow-up Period||0
10007775|NCT01752985|11130031|FG002|NOT COMPLETED|Follow-up Period||0
10007776|NCT01753076|11130041|FG000|STARTED|Overall Study||151
10007777|NCT01753076|11130042|FG001|STARTED|Overall Study||152
10007778|NCT01753076|11130041|FG000|COMPLETED|Overall Study||110
10007779|NCT01753076|11130042|FG001|COMPLETED|Overall Study||106
10007780|NCT01753076|11130041|FG000|NOT COMPLETED|Overall Study||41
10007781|NCT01753076|11130042|FG001|NOT COMPLETED|Overall Study||46
10007782|NCT01753115|11130053|FG000|STARTED|Overall Study||44
10007783|NCT01753115|11130054|FG001|STARTED|Overall Study||40
10007784|NCT01753115|11130055|FG002|STARTED|Overall Study||70
10007785|NCT01753115|11130053|FG000|Treated|Overall Study||38
10007786|NCT01753115|11130054|FG001|Treated|Overall Study||39
10108055|NCT02463071|11238461|FG001|NOT COMPLETED|Overall Study||16
10108056|NCT02463071|11238462|FG002|NOT COMPLETED|Overall Study||6
10108057|NCT02463097|11238470|FG000|STARTED|Overall Study||124
10108058|NCT02463097|11238470|FG000|COMPLETED|Overall Study||123
10108059|NCT02463097|11238470|FG000|NOT COMPLETED|Overall Study||1
10108060|NCT02463227|11238474|FG000|STARTED|Overall Study||14
10108061|NCT02463227|11238474|FG000|COMPLETED|Overall Study||14
10108062|NCT02463227|11238474|FG000|NOT COMPLETED|Overall Study||0
10108063|NCT02463331|11238480|FG000|STARTED|Overall Study||26
10108064|NCT02463331|11238481|FG001|STARTED|Overall Study||31
9880178|NCT01025791|10994819|FG002|NOT COMPLETED|Period 5||0
9880179|NCT01025791|10994820|FG003|NOT COMPLETED|Period 5||0
9880180|NCT01025791|10994821|FG004|NOT COMPLETED|Period 5||0
9880181|NCT01025791|10994822|FG005|NOT COMPLETED|Period 5||0
9880182|NCT01025791|10994823|FG006|NOT COMPLETED|Period 5||0
9880183|NCT01025791|10994824|FG007|NOT COMPLETED|Period 5||0
10108065|NCT02463331|11238480|FG000|COMPLETED|Overall Study||10
10108066|NCT02463331|11238481|FG001|COMPLETED|Overall Study||25
10108067|NCT02463331|11238480|FG000|NOT COMPLETED|Overall Study||16
10108068|NCT02463331|11238481|FG001|NOT COMPLETED|Overall Study||6
10108069|NCT02463357|11238492|FG000|STARTED|Overall Study||20
10108070|NCT02463357|11238493|FG001|STARTED|Overall Study||20
10108071|NCT02463357|11238494|FG002|STARTED|Overall Study||20
10108072|NCT02463357|11238495|FG003|STARTED|Overall Study||19
10108073|NCT02463357|11238496|FG004|STARTED|Overall Study||20
10108074|NCT02463357|11238492|FG000|COMPLETED|Overall Study||19
10108075|NCT02463357|11238493|FG001|COMPLETED|Overall Study||20
10108076|NCT02463357|11238494|FG002|COMPLETED|Overall Study||20
10108077|NCT02463357|11238495|FG003|COMPLETED|Overall Study||19
10108078|NCT02463357|11238496|FG004|COMPLETED|Overall Study||19
10108079|NCT02463357|11238492|FG000|NOT COMPLETED|Overall Study||1
10108080|NCT02463357|11238493|FG001|NOT COMPLETED|Overall Study||0
10108081|NCT02463357|11238494|FG002|NOT COMPLETED|Overall Study||0
10108082|NCT02463357|11238495|FG003|NOT COMPLETED|Overall Study||0
10108083|NCT02463357|11238496|FG004|NOT COMPLETED|Overall Study||1
10108084|NCT02463409|11238508|FG000|STARTED|Overall Study||6
10108085|NCT02463409|11238508|FG000|COMPLETED|Overall Study||4
10108086|NCT02463409|11238508|FG000|NOT COMPLETED|Overall Study||2
10108087|NCT02463487|11238514|FG000|STARTED|Overall Study||75
10108088|NCT02463487|11238515|FG001|STARTED|Overall Study||75
10108089|NCT02463487|11238514|FG000|COMPLETED|Overall Study||65
10108090|NCT02463487|11238515|FG001|COMPLETED|Overall Study||65
10108091|NCT02463487|11238514|FG000|NOT COMPLETED|Overall Study||10
10108092|NCT02463487|11238515|FG001|NOT COMPLETED|Overall Study||10
10108093|NCT02463799|11238523|FG000|STARTED|Overall Study||16
10108094|NCT02463799|11238524|FG001|STARTED|Overall Study||16
10108095|NCT02463799|11238523|FG000|COMPLETED|Overall Study||16
10108096|NCT02463799|11238524|FG001|COMPLETED|Overall Study||16
10108097|NCT02463799|11238523|FG000|NOT COMPLETED|Overall Study||0
10108098|NCT02463799|11238524|FG001|NOT COMPLETED|Overall Study||0
9880184|NCT01025791|10994825|FG008|NOT COMPLETED|Period 5||0
9880185|NCT01025791|10994826|FG009|NOT COMPLETED|Period 5||0
9880186|NCT01025791|10994827|FG010|NOT COMPLETED|Period 5||0
9880187|NCT01025791|10994828|FG011|NOT COMPLETED|Period 5||0
9880188|NCT01025791|10994829|FG012|NOT COMPLETED|Period 5||0
9880189|NCT01025791|10994830|FG013|NOT COMPLETED|Period 5||0
9880190|NCT01025817|10994883|FG000|STARTED|Completed Study Medication||309
9880191|NCT01025817|10994884|FG001|STARTED|Completed Study Medication||304
9880192|NCT01025817|10994883|FG000|COMPLETED|Completed Study Medication||204
9880193|NCT01025817|10994884|FG001|COMPLETED|Completed Study Medication||232
9880194|NCT01025817|10994883|FG000|NOT COMPLETED|Completed Study Medication||105
9880195|NCT01025817|10994884|FG001|NOT COMPLETED|Completed Study Medication||72
9880196|NCT01025817|10994883|FG000|STARTED|Completed Study||309
10108099|NCT02464033|11238530|FG000|STARTED|Overall Study||20
10108100|NCT02464033|11238530|FG000|COMPLETED|Overall Study||20
10108101|NCT02464033|11238530|FG000|NOT COMPLETED|Overall Study||0
10108102|NCT02464059|11238535|FG000|STARTED|Overall Study||23
10108103|NCT02464059|11238535|FG000|COMPLETED|Overall Study||17
9880197|NCT01025817|10994884|FG001|STARTED|Completed Study||304
9880198|NCT01025817|10994883|FG000|COMPLETED|Completed Study|Completed study phase|293
9880199|NCT01025817|10994884|FG001|COMPLETED|Completed Study|Completed study phase|282
9880200|NCT01025817|10994883|FG000|NOT COMPLETED|Completed Study||16
9880201|NCT01025817|10994884|FG001|NOT COMPLETED|Completed Study||22
9880202|NCT01025830|10994890|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
9880203|NCT01025830|10994891|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
9880204|NCT01025830|10994890|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
9880205|NCT01025830|10994891|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
9880206|NCT01025830|10994890|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
9880207|NCT01025830|10994891|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
9880208|NCT01025830|10994890|FG000|STARTED|Washout Period of 30 Days||8
9880209|NCT01025830|10994891|FG001|STARTED|Washout Period of 30 Days||12
9880210|NCT01025830|10994890|FG000|COMPLETED|Washout Period of 30 Days||8
9880211|NCT01025830|10994891|FG001|COMPLETED|Washout Period of 30 Days||12
9880212|NCT01025830|10994890|FG000|NOT COMPLETED|Washout Period of 30 Days||0
9880213|NCT01025830|10994891|FG001|NOT COMPLETED|Washout Period of 30 Days||0
10108104|NCT02464059|11238535|FG000|NOT COMPLETED|Overall Study||6
10108105|NCT02464163|11238543|FG000|STARTED|Overall Study||102
10108106|NCT02464163|11238544|FG001|STARTED|Overall Study||102
10108107|NCT02464163|11238545|FG002|STARTED|Overall Study||102
10108108|NCT02464163|11238546|FG003|STARTED|Overall Study||101
10108109|NCT02464163|11238543|FG000|COMPLETED|Overall Study||99
10108110|NCT02464163|11238544|FG001|COMPLETED|Overall Study||94
10108111|NCT02464163|11238545|FG002|COMPLETED|Overall Study||97
10108112|NCT02464163|11238546|FG003|COMPLETED|Overall Study||96
10108113|NCT02464163|11238543|FG000|NOT COMPLETED|Overall Study||3
10108114|NCT02464163|11238544|FG001|NOT COMPLETED|Overall Study||8
10108115|NCT02464163|11238545|FG002|NOT COMPLETED|Overall Study||5
10108116|NCT02464163|11238546|FG003|NOT COMPLETED|Overall Study||5
10108117|NCT02464176|11238559|FG000|STARTED|Overall Study||50
10108118|NCT02464176|11238560|FG001|STARTED|Overall Study||50
10108119|NCT02464176|11238561|FG002|STARTED|Overall Study||15
10108120|NCT02464176|11238559|FG000|COMPLETED|Overall Study||50
10108121|NCT02464176|11238560|FG001|COMPLETED|Overall Study||50
10108122|NCT02464176|11238561|FG002|COMPLETED|Overall Study||15
10108123|NCT02464176|11238559|FG000|NOT COMPLETED|Overall Study||0
10108124|NCT02464176|11238560|FG001|NOT COMPLETED|Overall Study||0
10108125|NCT02464176|11238561|FG002|NOT COMPLETED|Overall Study||0
10108126|NCT02464449|11238571|FG000|STARTED|Overall Study||166
10108127|NCT02464449|11238572|FG001|STARTED|Overall Study||112
10108128|NCT02464449|11238571|FG000|COMPLETED|Overall Study||151
10108129|NCT02464449|11238572|FG001|COMPLETED|Overall Study||100
10108130|NCT02464449|11238571|FG000|NOT COMPLETED|Overall Study||15
10108131|NCT02464449|11238572|FG001|NOT COMPLETED|Overall Study||12
10108132|NCT02464540|11238578|FG000|STARTED|Overall Study||11
10108133|NCT02464540|11238579|FG001|STARTED|Overall Study||11
10108134|NCT02464540|11238578|FG000|COMPLETED|Overall Study||11
10108135|NCT02464540|11238579|FG001|COMPLETED|Overall Study||11
10108136|NCT02464540|11238578|FG000|NOT COMPLETED|Overall Study||0
10108137|NCT02464540|11238579|FG001|NOT COMPLETED|Overall Study||0
10108138|NCT02464657|11238588|FG000|STARTED|Overall Study||3
10108139|NCT02464657|11238589|FG001|STARTED|Overall Study||2
10108140|NCT02464657|11238590|FG002|STARTED|Overall Study||39
10108141|NCT02464657|11238588|FG000|COMPLETED|Overall Study||3
10108142|NCT02464657|11238589|FG001|COMPLETED|Overall Study||2
10108143|NCT02464657|11238590|FG002|COMPLETED|Overall Study||39
10108144|NCT02464657|11238588|FG000|NOT COMPLETED|Overall Study||0
10108145|NCT02464657|11238589|FG001|NOT COMPLETED|Overall Study||0
10108146|NCT02464657|11238590|FG002|NOT COMPLETED|Overall Study||0
10108147|NCT02464917|11238601|FG000|STARTED|Overall Study||35
9880214|NCT01025830|10994890|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
9880215|NCT01025830|10994891|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
9880216|NCT01025830|10994890|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
9880217|NCT01025830|10994891|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
9880218|NCT01025830|10994890|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
9880219|NCT01025830|10994891|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
9880220|NCT01025843|10994912|FG000|STARTED|Period 1||2
9880221|NCT01025843|10994913|FG001|STARTED|Period 1||2
9880222|NCT01025843|10994914|FG002|STARTED|Period 1||2
9880223|NCT01025843|10994915|FG003|STARTED|Period 1||2
9880224|NCT01025843|10994916|FG004|STARTED|Period 1||2
9880225|NCT01025843|10994917|FG005|STARTED|Period 1||2
9880226|NCT01025843|10994918|FG006|STARTED|Period 1||2
9880227|NCT01025843|10994919|FG007|STARTED|Period 1||2
10108148|NCT02464917|11238602|FG001|STARTED|Overall Study||35
10108149|NCT02464917|11238601|FG000|COMPLETED|Overall Study||35
10108150|NCT02464917|11238602|FG001|COMPLETED|Overall Study||35
10108151|NCT02464917|11238601|FG000|NOT COMPLETED|Overall Study||0
10108152|NCT02464917|11238602|FG001|NOT COMPLETED|Overall Study||0
9880228|NCT01025843|10994920|FG008|STARTED|Period 1||2
9880229|NCT01025843|10994921|FG009|STARTED|Period 1||2
9880230|NCT01025843|10994912|FG000|COMPLETED|Period 1||2
9880231|NCT01025843|10994913|FG001|COMPLETED|Period 1||2
9880232|NCT01025843|10994914|FG002|COMPLETED|Period 1||2
9880233|NCT01025843|10994915|FG003|COMPLETED|Period 1||2
10108153|NCT02465034|11238610|FG000|STARTED|Overall Study||19
10108154|NCT02465034|11238611|FG001|STARTED|Overall Study||26
9880234|NCT01025843|10994916|FG004|COMPLETED|Period 1||2
10007787|NCT01753115|11130055|FG002|Treated|Overall Study||67
10007788|NCT01753115|11130053|FG000|COMPLETED|Overall Study||32
10007789|NCT01753115|11130054|FG001|COMPLETED|Overall Study||25
9880235|NCT01025843|10994917|FG005|COMPLETED|Period 1||2
9880236|NCT01025843|10994918|FG006|COMPLETED|Period 1||2
9880237|NCT01025843|10994919|FG007|COMPLETED|Period 1||2
9880238|NCT01025843|10994920|FG008|COMPLETED|Period 1||2
9880239|NCT01025843|10994921|FG009|COMPLETED|Period 1||2
9880240|NCT01025843|10994912|FG000|NOT COMPLETED|Period 1||0
9880241|NCT01025843|10994913|FG001|NOT COMPLETED|Period 1||0
9880242|NCT01025843|10994914|FG002|NOT COMPLETED|Period 1||0
9880243|NCT01025843|10994915|FG003|NOT COMPLETED|Period 1||0
9880244|NCT01025843|10994916|FG004|NOT COMPLETED|Period 1||0
9880245|NCT01025843|10994917|FG005|NOT COMPLETED|Period 1||0
9880246|NCT01025843|10994918|FG006|NOT COMPLETED|Period 1||0
9880247|NCT01025843|10994919|FG007|NOT COMPLETED|Period 1||0
9880248|NCT01025843|10994920|FG008|NOT COMPLETED|Period 1||0
9880249|NCT01025843|10994921|FG009|NOT COMPLETED|Period 1||0
9880250|NCT01025843|10994912|FG000|STARTED|Washout 1||2
9880251|NCT01025843|10994913|FG001|STARTED|Washout 1||2
9880252|NCT01025843|10994914|FG002|STARTED|Washout 1||2
9880253|NCT01025843|10994915|FG003|STARTED|Washout 1||2
9880254|NCT01025843|10994916|FG004|STARTED|Washout 1||2
9880255|NCT01025843|10994917|FG005|STARTED|Washout 1||2
9880256|NCT01025843|10994918|FG006|STARTED|Washout 1||2
9880257|NCT01025843|10994919|FG007|STARTED|Washout 1||2
9880258|NCT01025843|10994920|FG008|STARTED|Washout 1||2
9880259|NCT01025843|10994921|FG009|STARTED|Washout 1||2
9880260|NCT01025843|10994912|FG000|COMPLETED|Washout 1||2
9880261|NCT01025843|10994913|FG001|COMPLETED|Washout 1||2
9880262|NCT01025843|10994914|FG002|COMPLETED|Washout 1||2
10108155|NCT02465034|11238610|FG000|Started PAS|Overall Study||12
10108156|NCT02465034|11238611|FG001|Started PAS|Overall Study||21
10108157|NCT02465034|11238610|FG000|Completed PAS|Overall Study||9
10108158|NCT02465034|11238611|FG001|Completed PAS|Overall Study||20
10108159|NCT02465034|11238610|FG000|Started CC-PAS|Overall Study||16
10108160|NCT02465034|11238611|FG001|Started CC-PAS|Overall Study||0
10108161|NCT02465034|11238610|FG000|Completed CC-PAS|Overall Study||16
10108162|NCT02465034|11238611|FG001|Completed CC-PAS|Overall Study||0
10108163|NCT02465034|11238610|FG000|COMPLETED|Overall Study||16
10108164|NCT02465034|11238611|FG001|COMPLETED|Overall Study||20
10108165|NCT02465034|11238610|FG000|NOT COMPLETED|Overall Study||3
10108166|NCT02465034|11238611|FG001|NOT COMPLETED|Overall Study||6
10108167|NCT02465073|11238628|FG000|STARTED|Overall Study||17
10108168|NCT02465073|11238629|FG001|STARTED|Overall Study||16
9880263|NCT01025843|10994915|FG003|COMPLETED|Washout 1||2
9880264|NCT01025843|10994916|FG004|COMPLETED|Washout 1||2
9880265|NCT01025843|10994917|FG005|COMPLETED|Washout 1||2
10007790|NCT01753115|11130055|FG002|COMPLETED|Overall Study||56
10007791|NCT01753115|11130053|FG000|NOT COMPLETED|Overall Study||12
10007792|NCT01753115|11130054|FG001|NOT COMPLETED|Overall Study||15
10007793|NCT01753115|11130055|FG002|NOT COMPLETED|Overall Study||14
10007794|NCT01753193|11130063|FG000|STARTED|Overall Study||218
10007795|NCT01753193|11130063|FG000|COMPLETED|Overall Study||172
10007796|NCT01753193|11130063|FG000|NOT COMPLETED|Overall Study||46
10007797|NCT01753297|11130069|FG000|STARTED|Overall Study||117
10007798|NCT01753297|11130070|FG001|STARTED|Overall Study||109
10007799|NCT01753297|11130069|FG000|Received Triptorelin Treatment|Overall Study||0
10007800|NCT01753297|11130070|FG001|Received Triptorelin Treatment|Overall Study||105
10007801|NCT01753297|11130069|FG000|COMPLETED|Overall Study||76
10007802|NCT01753297|11130070|FG001|COMPLETED|Overall Study||73
10007803|NCT01753297|11130069|FG000|NOT COMPLETED|Overall Study||41
10007804|NCT01753297|11130070|FG001|NOT COMPLETED|Overall Study||36
10007805|NCT01753310|11130080|FG000|STARTED|Overall Study||89
10007806|NCT01753310|11130081|FG001|STARTED|Overall Study||45
9880266|NCT01025843|10994918|FG006|COMPLETED|Washout 1||2
10007807|NCT01753310|11130080|FG000|COMPLETED|Overall Study||57
10007808|NCT01753310|11130081|FG001|COMPLETED|Overall Study||21
10007809|NCT01753310|11130080|FG000|NOT COMPLETED|Overall Study||32
10007810|NCT01753310|11130081|FG001|NOT COMPLETED|Overall Study||24
10007811|NCT01753323|11130090|FG000|STARTED|Overall Study||11
10007812|NCT01753323|11130091|FG001|STARTED|Overall Study||10
10007813|NCT01753323|11130092|FG002|STARTED|Overall Study||22
10007814|NCT01753323|11130090|FG000|Pharmacodynamic (PD) Set|Overall Study||10
10108169|NCT02465073|11238630|FG002|STARTED|Overall Study||16
10108170|NCT02465073|11238628|FG000|COMPLETED|Overall Study||15
9880267|NCT01025843|10994919|FG007|COMPLETED|Washout 1||2
9880268|NCT01025843|10994920|FG008|COMPLETED|Washout 1||2
9880269|NCT01025843|10994921|FG009|COMPLETED|Washout 1||2
9880270|NCT01025843|10994912|FG000|NOT COMPLETED|Washout 1||0
9880271|NCT01025843|10994913|FG001|NOT COMPLETED|Washout 1||0
9880272|NCT01025843|10994914|FG002|NOT COMPLETED|Washout 1||0
10007815|NCT01753323|11130091|FG001|Pharmacodynamic (PD) Set|Overall Study||10
10007816|NCT01753323|11130092|FG002|Pharmacodynamic (PD) Set|Overall Study||21
10007817|NCT01753323|11130090|FG000|Pharmacokinetic(PK) Set|Overall Study||10
10007818|NCT01753323|11130091|FG001|Pharmacokinetic(PK) Set|Overall Study||10
10007819|NCT01753323|11130092|FG002|Pharmacokinetic(PK) Set|Overall Study||21
10007820|NCT01753323|11130090|FG000|Safety Set|Overall Study||11
10007821|NCT01753323|11130091|FG001|Safety Set|Overall Study||10
10007822|NCT01753323|11130092|FG002|Safety Set|Overall Study||22
9880273|NCT01025843|10994915|FG003|NOT COMPLETED|Washout 1||0
9880274|NCT01025843|10994916|FG004|NOT COMPLETED|Washout 1||0
9880275|NCT01025843|10994917|FG005|NOT COMPLETED|Washout 1||0
9880276|NCT01025843|10994918|FG006|NOT COMPLETED|Washout 1||0
9880277|NCT01025843|10994919|FG007|NOT COMPLETED|Washout 1||0
9880278|NCT01025843|10994920|FG008|NOT COMPLETED|Washout 1||0
9880279|NCT01025843|10994921|FG009|NOT COMPLETED|Washout 1||0
9880280|NCT01025843|10994912|FG000|STARTED|Period 2||2
9880281|NCT01025843|10994913|FG001|STARTED|Period 2||2
9880282|NCT01025843|10994914|FG002|STARTED|Period 2||2
9880283|NCT01025843|10994915|FG003|STARTED|Period 2||2
9880284|NCT01025843|10994916|FG004|STARTED|Period 2||2
10108171|NCT02465073|11238629|FG001|COMPLETED|Overall Study||15
10108172|NCT02465073|11238630|FG002|COMPLETED|Overall Study||15
10108173|NCT02465073|11238628|FG000|NOT COMPLETED|Overall Study||2
10108174|NCT02465073|11238629|FG001|NOT COMPLETED|Overall Study||1
10108175|NCT02465073|11238630|FG002|NOT COMPLETED|Overall Study||1
10108176|NCT02465099|11238640|FG000|STARTED|Overall Study||45
10108177|NCT02465099|11238641|FG001|STARTED|Overall Study||19
10108178|NCT02465099|11238640|FG000|COMPLETED|Overall Study||45
10108179|NCT02465099|11238641|FG001|COMPLETED|Overall Study||19
10108180|NCT02465099|11238640|FG000|NOT COMPLETED|Overall Study||0
10108181|NCT02465099|11238641|FG001|NOT COMPLETED|Overall Study||0
10108182|NCT02465203|11238650|FG000|STARTED|Overall Study||56
10108183|NCT02465203|11238651|FG001|STARTED|Overall Study||36
10108184|NCT02465203|11238652|FG002|STARTED|Overall Study||13
10108185|NCT02465203|11238650|FG000|COMPLETED|Overall Study||0
10108186|NCT02465203|11238651|FG001|COMPLETED|Overall Study||0
10108187|NCT02465203|11238652|FG002|COMPLETED|Overall Study||0
10108188|NCT02465203|11238650|FG000|NOT COMPLETED|Overall Study||56
10108189|NCT02465203|11238651|FG001|NOT COMPLETED|Overall Study||36
10108190|NCT02465203|11238652|FG002|NOT COMPLETED|Overall Study||13
10108191|NCT02465216|11238664|FG000|STARTED|Overall Study||15
10108192|NCT02465216|11238665|FG001|STARTED|Overall Study||5
10108193|NCT02465216|11238666|FG002|STARTED|Overall Study||14
10108194|NCT02465216|11238667|FG003|STARTED|Overall Study||14
10108195|NCT02465216|11238668|FG004|STARTED|Overall Study||12
10108196|NCT02465216|11238664|FG000|COMPLETED|Overall Study||12
10108197|NCT02465216|11238665|FG001|COMPLETED|Overall Study||5
10108198|NCT02465216|11238666|FG002|COMPLETED|Overall Study||13
10108199|NCT02465216|11238667|FG003|COMPLETED|Overall Study||12
10108200|NCT02465216|11238668|FG004|COMPLETED|Overall Study||9
10108201|NCT02465216|11238664|FG000|NOT COMPLETED|Overall Study||3
10108202|NCT02465216|11238665|FG001|NOT COMPLETED|Overall Study||0
10108203|NCT02465216|11238666|FG002|NOT COMPLETED|Overall Study||1
10108204|NCT02465216|11238667|FG003|NOT COMPLETED|Overall Study||2
10108205|NCT02465216|11238668|FG004|NOT COMPLETED|Overall Study||3
10108206|NCT02465372|11238682|FG000|STARTED|Overall Study||349
10108207|NCT02465372|11238683|FG001|STARTED|Overall Study||250
10108208|NCT02465372|11238682|FG000|COMPLETED|Overall Study||227
10108209|NCT02465372|11238683|FG001|COMPLETED|Overall Study||153
10108210|NCT02465372|11238682|FG000|NOT COMPLETED|Overall Study||122
10108211|NCT02465372|11238683|FG001|NOT COMPLETED|Overall Study||97
10108212|NCT02465437|11238693|FG000|STARTED|Overall Study||9
10108213|NCT02465437|11238694|FG001|STARTED|Overall Study||9
10108214|NCT02465437|11238695|FG002|STARTED|Overall Study||9
10108215|NCT02465437|11238696|FG003|STARTED|Overall Study||15
10108216|NCT02465437|11238693|FG000|COMPLETED|Overall Study||8
10108217|NCT02465437|11238694|FG001|COMPLETED|Overall Study||8
10108218|NCT02465437|11238695|FG002|COMPLETED|Overall Study||8
10108219|NCT02465437|11238696|FG003|COMPLETED|Overall Study||14
10108220|NCT02465437|11238693|FG000|NOT COMPLETED|Overall Study||1
10108221|NCT02465437|11238694|FG001|NOT COMPLETED|Overall Study||1
9880285|NCT01025843|10994917|FG005|STARTED|Period 2||2
9880286|NCT01025843|10994918|FG006|STARTED|Period 2||2
9880287|NCT01025843|10994919|FG007|STARTED|Period 2||2
9880288|NCT01025843|10994920|FG008|STARTED|Period 2||2
9880289|NCT01025843|10994921|FG009|STARTED|Period 2||2
9880290|NCT01025843|10994912|FG000|COMPLETED|Period 2||2
9880291|NCT01025843|10994913|FG001|COMPLETED|Period 2||2
9880292|NCT01025843|10994914|FG002|COMPLETED|Period 2||2
9880293|NCT01025843|10994915|FG003|COMPLETED|Period 2||2
10108222|NCT02465437|11238695|FG002|NOT COMPLETED|Overall Study||1
10108223|NCT02465437|11238696|FG003|NOT COMPLETED|Overall Study||1
10108224|NCT02465450|11238707|FG000|STARTED|Treatment Period 1||26
10108225|NCT02465450|11238708|FG001|STARTED|Treatment Period 1||24
10108226|NCT02465450|11238709|FG002|STARTED|Treatment Period 1||35
10108227|NCT02465450|11238710|FG003|STARTED|Treatment Period 1||0
10108228|NCT02465450|11238711|FG004|STARTED|Treatment Period 1||0
10108229|NCT02465450|11238712|FG005|STARTED|Treatment Period 1||0
10108230|NCT02465450|11238707|FG000|COMPLETED|Treatment Period 1||24
10108231|NCT02465450|11238708|FG001|COMPLETED|Treatment Period 1||23
10108232|NCT02465450|11238709|FG002|COMPLETED|Treatment Period 1||34
10108233|NCT02465450|11238710|FG003|COMPLETED|Treatment Period 1||0
10108234|NCT02465450|11238711|FG004|COMPLETED|Treatment Period 1||0
9880294|NCT01025843|10994916|FG004|COMPLETED|Period 2||2
9880295|NCT01025843|10994917|FG005|COMPLETED|Period 2||2
9880296|NCT01025843|10994918|FG006|COMPLETED|Period 2||2
10108235|NCT02465450|11238712|FG005|COMPLETED|Treatment Period 1||0
10108236|NCT02465450|11238707|FG000|NOT COMPLETED|Treatment Period 1||2
10108237|NCT02465450|11238708|FG001|NOT COMPLETED|Treatment Period 1||1
10108238|NCT02465450|11238709|FG002|NOT COMPLETED|Treatment Period 1||1
10108239|NCT02465450|11238710|FG003|NOT COMPLETED|Treatment Period 1||0
10108240|NCT02465450|11238711|FG004|NOT COMPLETED|Treatment Period 1||0
9880297|NCT01025843|10994919|FG007|COMPLETED|Period 2||2
9880298|NCT01025843|10994920|FG008|COMPLETED|Period 2||2
9880299|NCT01025843|10994921|FG009|COMPLETED|Period 2||2
9880300|NCT01025843|10994912|FG000|NOT COMPLETED|Period 2||0
9880301|NCT01025843|10994913|FG001|NOT COMPLETED|Period 2||0
9880302|NCT01025843|10994914|FG002|NOT COMPLETED|Period 2||0
9880303|NCT01025843|10994915|FG003|NOT COMPLETED|Period 2||0
9880304|NCT01025843|10994916|FG004|NOT COMPLETED|Period 2||0
10007823|NCT01753323|11130090|FG000|Intent-to-treat Analysis Set|Overall Study||11
10007824|NCT01753323|11130091|FG001|Intent-to-treat Analysis Set|Overall Study||10
10007825|NCT01753323|11130092|FG002|Intent-to-treat Analysis Set|Overall Study||22
10007826|NCT01753323|11130090|FG000|COMPLETED|Overall Study||10
10007827|NCT01753323|11130091|FG001|COMPLETED|Overall Study||10
10108241|NCT02465450|11238712|FG005|NOT COMPLETED|Treatment Period 1||0
9880305|NCT01025843|10994917|FG005|NOT COMPLETED|Period 2||0
9880306|NCT01025843|10994918|FG006|NOT COMPLETED|Period 2||0
9880307|NCT01025843|10994919|FG007|NOT COMPLETED|Period 2||0
9880308|NCT01025843|10994920|FG008|NOT COMPLETED|Period 2||0
9880309|NCT01025843|10994921|FG009|NOT COMPLETED|Period 2||0
9880310|NCT01025843|10994912|FG000|STARTED|Washout 2||2
9880311|NCT01025843|10994913|FG001|STARTED|Washout 2||2
10007828|NCT01753323|11130092|FG002|COMPLETED|Overall Study||13
10108242|NCT02465450|11238707|FG000|STARTED|Treatment Period 2||0
10108243|NCT02465450|11238708|FG001|STARTED|Treatment Period 2||0
10108244|NCT02465450|11238709|FG002|STARTED|Treatment Period 2||0
10108245|NCT02465450|11238710|FG003|STARTED|Treatment Period 2||30
10108246|NCT02465450|11238711|FG004|STARTED|Treatment Period 2||28
10108247|NCT02465450|11238712|FG005|STARTED|Treatment Period 2||23
10108248|NCT02465450|11238707|FG000|COMPLETED|Treatment Period 2||0
10108249|NCT02465450|11238708|FG001|COMPLETED|Treatment Period 2||0
10108250|NCT02465450|11238709|FG002|COMPLETED|Treatment Period 2||0
10108251|NCT02465450|11238710|FG003|COMPLETED|Treatment Period 2||27
10108252|NCT02465450|11238711|FG004|COMPLETED|Treatment Period 2||24
10108253|NCT02465450|11238712|FG005|COMPLETED|Treatment Period 2||23
10108254|NCT02465450|11238707|FG000|NOT COMPLETED|Treatment Period 2||0
10108255|NCT02465450|11238708|FG001|NOT COMPLETED|Treatment Period 2||0
10108256|NCT02465450|11238709|FG002|NOT COMPLETED|Treatment Period 2||0
10108257|NCT02465450|11238710|FG003|NOT COMPLETED|Treatment Period 2||3
10108258|NCT02465450|11238711|FG004|NOT COMPLETED|Treatment Period 2||4
10108259|NCT02465450|11238712|FG005|NOT COMPLETED|Treatment Period 2||0
10108260|NCT02465463|11238732|FG000|STARTED|Overall Study||8
10108261|NCT02465463|11238733|FG001|STARTED|Overall Study||5
10108262|NCT02465463|11238732|FG000|COMPLETED|Overall Study||4
10108263|NCT02465463|11238733|FG001|COMPLETED|Overall Study||4
10108264|NCT02465463|11238732|FG000|NOT COMPLETED|Overall Study||4
10108265|NCT02465463|11238733|FG001|NOT COMPLETED|Overall Study||1
10108266|NCT02465489|11238740|FG000|STARTED|Overall Study||20
10108267|NCT02465489|11238740|FG000|COMPLETED|Overall Study||15
10108268|NCT02465489|11238740|FG000|NOT COMPLETED|Overall Study||5
10108269|NCT02465515|11238754|FG000|STARTED|Overall Study||4732
10108270|NCT02465515|11238755|FG001|STARTED|Overall Study||4731
10108271|NCT02465515|11238754|FG000|COMPLETED|Overall Study||4578
10108272|NCT02465515|11238755|FG001|COMPLETED|Overall Study||4620
10108273|NCT02465515|11238754|FG000|NOT COMPLETED|Overall Study||154
10108274|NCT02465515|11238755|FG001|NOT COMPLETED|Overall Study||111
10108275|NCT02465528|11238765|FG000|STARTED|Overall Study||1
10108276|NCT02465528|11238766|FG001|STARTED|Overall Study||4
10108277|NCT02465528|11238767|FG002|STARTED|Overall Study||12
10108278|NCT02465528|11238768|FG003|STARTED|Overall Study||5
10108279|NCT02465528|11238765|FG000|COMPLETED|Overall Study||0
10108280|NCT02465528|11238766|FG001|COMPLETED|Overall Study||0
10108281|NCT02465528|11238767|FG002|COMPLETED|Overall Study||0
10108282|NCT02465528|11238768|FG003|COMPLETED|Overall Study||0
9880312|NCT01025843|10994914|FG002|STARTED|Washout 2||2
9880313|NCT01025843|10994915|FG003|STARTED|Washout 2||2
9880314|NCT01025843|10994916|FG004|STARTED|Washout 2||2
9880315|NCT01025843|10994917|FG005|STARTED|Washout 2||2
9880316|NCT01025843|10994918|FG006|STARTED|Washout 2||2
9880317|NCT01025843|10994919|FG007|STARTED|Washout 2||2
9880318|NCT01025843|10994920|FG008|STARTED|Washout 2||2
9880319|NCT01025843|10994921|FG009|STARTED|Washout 2||2
9880320|NCT01025843|10994912|FG000|COMPLETED|Washout 2||2
9880321|NCT01025843|10994913|FG001|COMPLETED|Washout 2||2
9880322|NCT01025843|10994914|FG002|COMPLETED|Washout 2||2
9880323|NCT01025843|10994915|FG003|COMPLETED|Washout 2||2
10007829|NCT01753323|11130090|FG000|NOT COMPLETED|Overall Study||1
10007830|NCT01753323|11130091|FG001|NOT COMPLETED|Overall Study||0
10007831|NCT01753323|11130092|FG002|NOT COMPLETED|Overall Study||9
10007832|NCT01753336|11130101|FG000|STARTED|Overall Study||112
10007833|NCT01753336|11130101|FG000|Cycle 1|Overall Study||112
10108283|NCT02465528|11238765|FG000|NOT COMPLETED|Overall Study||1
10108284|NCT02465528|11238766|FG001|NOT COMPLETED|Overall Study||4
10108285|NCT02465528|11238767|FG002|NOT COMPLETED|Overall Study||12
10108286|NCT02465528|11238768|FG003|NOT COMPLETED|Overall Study||5
9880324|NCT01025843|10994916|FG004|COMPLETED|Washout 2||2
9880325|NCT01025843|10994917|FG005|COMPLETED|Washout 2||2
10108287|NCT02465567|11238784|FG000|STARTED|Overall Study||2157
10108288|NCT02465567|11238785|FG001|STARTED|Overall Study||2137
10108289|NCT02465567|11238786|FG002|STARTED|Overall Study||2143
10108290|NCT02465567|11238787|FG003|STARTED|Overall Study||2151
10108291|NCT02465567|11238784|FG000|COMPLETED|Overall Study||1708
10108292|NCT02465567|11238785|FG001|COMPLETED|Overall Study||1713
10108293|NCT02465567|11238786|FG002|COMPLETED|Overall Study||1580
10108294|NCT02465567|11238787|FG003|COMPLETED|Overall Study||1643
9880326|NCT01025843|10994918|FG006|COMPLETED|Washout 2||2
9880327|NCT01025843|10994919|FG007|COMPLETED|Washout 2||2
9880328|NCT01025843|10994920|FG008|COMPLETED|Washout 2||2
9880329|NCT01025843|10994921|FG009|COMPLETED|Washout 2||2
9880330|NCT01025843|10994912|FG000|NOT COMPLETED|Washout 2||0
9880331|NCT01025843|10994913|FG001|NOT COMPLETED|Washout 2||0
9880332|NCT01025843|10994914|FG002|NOT COMPLETED|Washout 2||0
9880333|NCT01025843|10994915|FG003|NOT COMPLETED|Washout 2||0
9880334|NCT01025843|10994916|FG004|NOT COMPLETED|Washout 2||0
9880335|NCT01025843|10994917|FG005|NOT COMPLETED|Washout 2||0
9880336|NCT01025843|10994918|FG006|NOT COMPLETED|Washout 2||0
9880337|NCT01025843|10994919|FG007|NOT COMPLETED|Washout 2||0
9880338|NCT01025843|10994920|FG008|NOT COMPLETED|Washout 2||0
9880339|NCT01025843|10994921|FG009|NOT COMPLETED|Washout 2||0
9880340|NCT01025843|10994912|FG000|STARTED|Period 3||2
9880341|NCT01025843|10994913|FG001|STARTED|Period 3||2
9880342|NCT01025843|10994914|FG002|STARTED|Period 3||2
9880343|NCT01025843|10994915|FG003|STARTED|Period 3||2
10108295|NCT02465567|11238784|FG000|NOT COMPLETED|Overall Study||449
10108296|NCT02465567|11238785|FG001|NOT COMPLETED|Overall Study||424
10108297|NCT02465567|11238786|FG002|NOT COMPLETED|Overall Study||563
10108298|NCT02465567|11238787|FG003|NOT COMPLETED|Overall Study||508
10108299|NCT02465632|11238800|FG000|STARTED|Overall Study||440
10108300|NCT02465632|11238801|FG001|STARTED|Overall Study||440
10108301|NCT02465632|11238802|FG002|STARTED|Overall Study||220
10108302|NCT02465632|11238800|FG000|COMPLETED|Overall Study||409
10108303|NCT02465632|11238801|FG001|COMPLETED|Overall Study||417
10108304|NCT02465632|11238802|FG002|COMPLETED|Overall Study||203
10108305|NCT02465632|11238800|FG000|NOT COMPLETED|Overall Study||31
10108306|NCT02465632|11238801|FG001|NOT COMPLETED|Overall Study||23
10108307|NCT02465632|11238802|FG002|NOT COMPLETED|Overall Study||17
10108308|NCT02465866|11238811|FG000|STARTED|Period 1||5
10108309|NCT02465866|11238812|FG001|STARTED|Period 1||5
10108310|NCT02465866|11238813|FG002|STARTED|Period 1||5
10108311|NCT02465866|11238814|FG003|STARTED|Period 1||5
10108312|NCT02465866|11238811|FG000|COMPLETED|Period 1||5
10108313|NCT02465866|11238812|FG001|COMPLETED|Period 1||5
10108314|NCT02465866|11238813|FG002|COMPLETED|Period 1||5
10108315|NCT02465866|11238814|FG003|COMPLETED|Period 1||5
10108316|NCT02465866|11238811|FG000|NOT COMPLETED|Period 1||0
10108317|NCT02465866|11238812|FG001|NOT COMPLETED|Period 1||0
10108318|NCT02465866|11238813|FG002|NOT COMPLETED|Period 1||0
10108319|NCT02465866|11238814|FG003|NOT COMPLETED|Period 1||0
10108320|NCT02465866|11238811|FG000|STARTED|Period 1: Washout (14 Days)||5
10108321|NCT02465866|11238812|FG001|STARTED|Period 1: Washout (14 Days)||5
10108322|NCT02465866|11238813|FG002|STARTED|Period 1: Washout (14 Days)||5
10108323|NCT02465866|11238814|FG003|STARTED|Period 1: Washout (14 Days)||5
10108324|NCT02465866|11238811|FG000|COMPLETED|Period 1: Washout (14 Days)||5
10108325|NCT02465866|11238812|FG001|COMPLETED|Period 1: Washout (14 Days)||5
10108326|NCT02465866|11238813|FG002|COMPLETED|Period 1: Washout (14 Days)||5
10108327|NCT02465866|11238814|FG003|COMPLETED|Period 1: Washout (14 Days)||5
10108328|NCT02465866|11238811|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0
10108329|NCT02465866|11238812|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0
10108330|NCT02465866|11238813|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0
10108331|NCT02465866|11238814|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0
10108332|NCT02465866|11238811|FG000|STARTED|Period 2||5
10108333|NCT02465866|11238812|FG001|STARTED|Period 2||5
10108334|NCT02465866|11238813|FG002|STARTED|Period 2||5
10108335|NCT02465866|11238814|FG003|STARTED|Period 2||5
10108336|NCT02465866|11238811|FG000|COMPLETED|Period 2||5
10108337|NCT02465866|11238812|FG001|COMPLETED|Period 2||5
10108338|NCT02465866|11238813|FG002|COMPLETED|Period 2||5
10108339|NCT02465866|11238814|FG003|COMPLETED|Period 2||5
10108340|NCT02465866|11238811|FG000|NOT COMPLETED|Period 2||0
10108341|NCT02465866|11238812|FG001|NOT COMPLETED|Period 2||0
10108342|NCT02465866|11238813|FG002|NOT COMPLETED|Period 2||0
10108343|NCT02465866|11238814|FG003|NOT COMPLETED|Period 2||0
10108344|NCT02465866|11238811|FG000|STARTED|Period 2: Washout (14 Days)||5
10108345|NCT02465866|11238812|FG001|STARTED|Period 2: Washout (14 Days)||5
10108346|NCT02465866|11238813|FG002|STARTED|Period 2: Washout (14 Days)||5
10108347|NCT02465866|11238814|FG003|STARTED|Period 2: Washout (14 Days)||5
10108348|NCT02465866|11238811|FG000|COMPLETED|Period 2: Washout (14 Days)||5
10108349|NCT02465866|11238812|FG001|COMPLETED|Period 2: Washout (14 Days)||5
10108350|NCT02465866|11238813|FG002|COMPLETED|Period 2: Washout (14 Days)||5
9880344|NCT01025843|10994916|FG004|STARTED|Period 3||2
10108351|NCT02465866|11238814|FG003|COMPLETED|Period 2: Washout (14 Days)||5
10108352|NCT02465866|11238811|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0
10108353|NCT02465866|11238812|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0
10108354|NCT02465866|11238813|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0
10108355|NCT02465866|11238814|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0
10108356|NCT02465866|11238811|FG000|STARTED|Period 3||5
10108357|NCT02465866|11238812|FG001|STARTED|Period 3||5
10108358|NCT02465866|11238813|FG002|STARTED|Period 3||5
10108359|NCT02465866|11238814|FG003|STARTED|Period 3||5
9880345|NCT01025843|10994917|FG005|STARTED|Period 3||2
9880346|NCT01025843|10994918|FG006|STARTED|Period 3||2
9880347|NCT01025843|10994919|FG007|STARTED|Period 3||2
9880348|NCT01025843|10994920|FG008|STARTED|Period 3||2
10108360|NCT02465866|11238811|FG000|COMPLETED|Period 3||5
10108361|NCT02465866|11238812|FG001|COMPLETED|Period 3||4
10108362|NCT02465866|11238813|FG002|COMPLETED|Period 3||5
10108363|NCT02465866|11238814|FG003|COMPLETED|Period 3||5
10108364|NCT02465866|11238811|FG000|NOT COMPLETED|Period 3||0
9880349|NCT01025843|10994921|FG009|STARTED|Period 3||2
9880350|NCT01025843|10994912|FG000|COMPLETED|Period 3||2
9880351|NCT01025843|10994913|FG001|COMPLETED|Period 3||2
9880352|NCT01025843|10994914|FG002|COMPLETED|Period 3||2
9880353|NCT01025843|10994915|FG003|COMPLETED|Period 3||2
9880354|NCT01025843|10994916|FG004|COMPLETED|Period 3||2
9880355|NCT01025843|10994917|FG005|COMPLETED|Period 3||2
9880356|NCT01025843|10994918|FG006|COMPLETED|Period 3||2
9880357|NCT01025843|10994919|FG007|COMPLETED|Period 3||2
9880358|NCT01025843|10994920|FG008|COMPLETED|Period 3||2
9880359|NCT01025843|10994921|FG009|COMPLETED|Period 3||2
9880360|NCT01025843|10994912|FG000|NOT COMPLETED|Period 3||0
10108365|NCT02465866|11238812|FG001|NOT COMPLETED|Period 3||1
10108366|NCT02465866|11238813|FG002|NOT COMPLETED|Period 3||0
10108367|NCT02465866|11238814|FG003|NOT COMPLETED|Period 3||0
10108368|NCT02465866|11238811|FG000|STARTED|Period 3: Washout (14 Days)||5
10108369|NCT02465866|11238812|FG001|STARTED|Period 3: Washout (14 Days)||4
10108370|NCT02465866|11238813|FG002|STARTED|Period 3: Washout (14 Days)||5
10108371|NCT02465866|11238814|FG003|STARTED|Period 3: Washout (14 Days)||5
10108372|NCT02465866|11238811|FG000|COMPLETED|Period 3: Washout (14 Days)||5
10108373|NCT02465866|11238812|FG001|COMPLETED|Period 3: Washout (14 Days)||4
10108374|NCT02465866|11238813|FG002|COMPLETED|Period 3: Washout (14 Days)||5
10108375|NCT02465866|11238814|FG003|COMPLETED|Period 3: Washout (14 Days)||5
10108376|NCT02465866|11238811|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0
10108377|NCT02465866|11238812|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0
10108378|NCT02465866|11238813|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0
10108379|NCT02465866|11238814|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0
10108380|NCT02465866|11238811|FG000|STARTED|Period 4||5
10108381|NCT02465866|11238812|FG001|STARTED|Period 4||4
10108382|NCT02465866|11238813|FG002|STARTED|Period 4||5
10108383|NCT02465866|11238814|FG003|STARTED|Period 4||5
10108384|NCT02465866|11238811|FG000|COMPLETED|Period 4||5
10108385|NCT02465866|11238812|FG001|COMPLETED|Period 4||4
10108386|NCT02465866|11238813|FG002|COMPLETED|Period 4||5
10108387|NCT02465866|11238814|FG003|COMPLETED|Period 4||5
10108388|NCT02465866|11238811|FG000|NOT COMPLETED|Period 4||0
10108389|NCT02465866|11238812|FG001|NOT COMPLETED|Period 4||0
10108390|NCT02465866|11238813|FG002|NOT COMPLETED|Period 4||0
10108391|NCT02465866|11238814|FG003|NOT COMPLETED|Period 4||0
10108392|NCT02465866|11238811|FG000|STARTED|Period 4: Washout (14 Days)||5
10108393|NCT02465866|11238812|FG001|STARTED|Period 4: Washout (14 Days)||4
10108394|NCT02465866|11238813|FG002|STARTED|Period 4: Washout (14 Days)||5
10108395|NCT02465866|11238814|FG003|STARTED|Period 4: Washout (14 Days)||5
10108396|NCT02465866|11238811|FG000|COMPLETED|Period 4: Washout (14 Days)||5
10108397|NCT02465866|11238812|FG001|COMPLETED|Period 4: Washout (14 Days)||4
10108398|NCT02465866|11238813|FG002|COMPLETED|Period 4: Washout (14 Days)||5
10108399|NCT02465866|11238814|FG003|COMPLETED|Period 4: Washout (14 Days)||5
10108400|NCT02465866|11238811|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0
10108401|NCT02465866|11238812|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0
10108402|NCT02465866|11238813|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0
10108403|NCT02465866|11238814|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0
10108404|NCT02465931|11238826|FG000|STARTED|Overall Study||55
10108405|NCT02465931|11238827|FG001|STARTED|Overall Study||56
10108406|NCT02465931|11238826|FG000|COMPLETED|Overall Study||44
10108407|NCT02465931|11238827|FG001|COMPLETED|Overall Study||45
10108408|NCT02465931|11238826|FG000|NOT COMPLETED|Overall Study||11
10108409|NCT02465931|11238827|FG001|NOT COMPLETED|Overall Study||11
10108410|NCT02466009|11238833|FG000|STARTED|Overall Study||27
10108411|NCT02466009|11238833|FG000|COMPLETED|Overall Study||27
10108412|NCT02466009|11238833|FG000|NOT COMPLETED|Overall Study||0
10108413|NCT02466087|11238837|FG000|STARTED|First Intervention: Weeks 1-6||62
10108414|NCT02466087|11238838|FG001|STARTED|First Intervention: Weeks 1-6||64
10108415|NCT02466087|11238837|FG000|COMPLETED|First Intervention: Weeks 1-6||55
10108416|NCT02466087|11238838|FG001|COMPLETED|First Intervention: Weeks 1-6||57
10108417|NCT02466087|11238837|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7
10108418|NCT02466087|11238838|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7
10108419|NCT02466087|11238837|FG000|STARTED|Second Intervention: Weeks 7-12||55
10108420|NCT02466087|11238838|FG001|STARTED|Second Intervention: Weeks 7-12||57
10108421|NCT02466087|11238837|FG000|COMPLETED|Second Intervention: Weeks 7-12||55
10108422|NCT02466087|11238838|FG001|COMPLETED|Second Intervention: Weeks 7-12||57
10108423|NCT02466087|11238837|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0
10108424|NCT02466087|11238838|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0
10108425|NCT02466126|11238847|FG000|STARTED|Baseline||109
10108426|NCT02466126|11238848|FG001|STARTED|Baseline||80
10108427|NCT02466126|11238847|FG000|COMPLETED|Baseline||109
10108428|NCT02466126|11238848|FG001|COMPLETED|Baseline||80
10108429|NCT02466126|11238847|FG000|NOT COMPLETED|Baseline||0
10108430|NCT02466126|11238848|FG001|NOT COMPLETED|Baseline||0
10108431|NCT02466126|11238847|FG000|STARTED|4 Month Assessment||109
10108432|NCT02466126|11238848|FG001|STARTED|4 Month Assessment||80
10108433|NCT02466126|11238847|FG000|COMPLETED|4 Month Assessment||93
10108434|NCT02466126|11238848|FG001|COMPLETED|4 Month Assessment||71
10108435|NCT02466126|11238847|FG000|NOT COMPLETED|4 Month Assessment||16
9880361|NCT01025843|10994913|FG001|NOT COMPLETED|Period 3||0
9880362|NCT01025843|10994914|FG002|NOT COMPLETED|Period 3||0
9880363|NCT01025843|10994915|FG003|NOT COMPLETED|Period 3||0
9880364|NCT01025843|10994916|FG004|NOT COMPLETED|Period 3||0
9880365|NCT01025843|10994917|FG005|NOT COMPLETED|Period 3||0
9880366|NCT01025843|10994918|FG006|NOT COMPLETED|Period 3||0
9880367|NCT01025843|10994919|FG007|NOT COMPLETED|Period 3||0
9880368|NCT01025843|10994920|FG008|NOT COMPLETED|Period 3||0
9880369|NCT01025843|10994921|FG009|NOT COMPLETED|Period 3||0
9880370|NCT01025843|10994912|FG000|STARTED|Washout 3||2
9880371|NCT01025843|10994913|FG001|STARTED|Washout 3||2
9880372|NCT01025843|10994914|FG002|STARTED|Washout 3||2
9880373|NCT01025843|10994915|FG003|STARTED|Washout 3||2
9880374|NCT01025843|10994916|FG004|STARTED|Washout 3||2
9880375|NCT01025843|10994917|FG005|STARTED|Washout 3||2
9880376|NCT01025843|10994918|FG006|STARTED|Washout 3||2
9880377|NCT01025843|10994919|FG007|STARTED|Washout 3||2
9880378|NCT01025843|10994920|FG008|STARTED|Washout 3||2
9880379|NCT01025843|10994921|FG009|STARTED|Washout 3||2
9880380|NCT01025843|10994912|FG000|COMPLETED|Washout 3||2
9880381|NCT01025843|10994913|FG001|COMPLETED|Washout 3||2
9880382|NCT01025843|10994914|FG002|COMPLETED|Washout 3||2
9880383|NCT01025843|10994915|FG003|COMPLETED|Washout 3||2
9880384|NCT01025843|10994916|FG004|COMPLETED|Washout 3||2
9880385|NCT01025843|10994917|FG005|COMPLETED|Washout 3||2
10108436|NCT02466126|11238848|FG001|NOT COMPLETED|4 Month Assessment||9
10108437|NCT02466126|11238847|FG000|STARTED|8 Month Assessment||93
10108438|NCT02466126|11238848|FG001|STARTED|8 Month Assessment||71
10108439|NCT02466126|11238847|FG000|COMPLETED|8 Month Assessment||86
10108440|NCT02466126|11238848|FG001|COMPLETED|8 Month Assessment||68
10108441|NCT02466126|11238847|FG000|NOT COMPLETED|8 Month Assessment||7
10108442|NCT02466126|11238848|FG001|NOT COMPLETED|8 Month Assessment||3
10108443|NCT02466126|11238847|FG000|STARTED|12 Month Assessment||86
10108444|NCT02466126|11238848|FG001|STARTED|12 Month Assessment||68
10108445|NCT02466126|11238847|FG000|COMPLETED|12 Month Assessment||85
10108446|NCT02466126|11238848|FG001|COMPLETED|12 Month Assessment||66
10108447|NCT02466126|11238847|FG000|NOT COMPLETED|12 Month Assessment||1
10108448|NCT02466126|11238848|FG001|NOT COMPLETED|12 Month Assessment||2
10108449|NCT02466230|11238854|FG000|STARTED|Overall Study||28
10108450|NCT02466230|11238854|FG000|COMPLETED|Overall Study||28
10108451|NCT02466230|11238854|FG000|NOT COMPLETED|Overall Study||0
10108452|NCT02466386|11238858|FG000|STARTED|Overall Study||113
10108453|NCT02466386|11238858|FG000|COMPLETED|Overall Study||69
10108454|NCT02466386|11238858|FG000|NOT COMPLETED|Overall Study||44
10108455|NCT02466399|11238864|FG000|STARTED|Overall Study||53
10108456|NCT02466399|11238865|FG001|STARTED|Overall Study||27
10108457|NCT02466399|11238864|FG000|COMPLETED|Overall Study||51
10108458|NCT02466399|11238865|FG001|COMPLETED|Overall Study||27
10108459|NCT02466399|11238864|FG000|NOT COMPLETED|Overall Study||2
10108460|NCT02466399|11238865|FG001|NOT COMPLETED|Overall Study||0
10108461|NCT02466412|11238873|FG000|STARTED|Washout Period of 1 Day (Day -1)||24
10108462|NCT02466412|11238874|FG001|STARTED|Washout Period of 1 Day (Day -1)||24
10108463|NCT02466412|11238873|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24
10108464|NCT02466412|11238874|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24
10108465|NCT02466412|11238873|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
10108466|NCT02466412|11238874|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
10108467|NCT02466412|11238873|FG000|STARTED|First Intervention (Day 1)||24
10108468|NCT02466412|11238874|FG001|STARTED|First Intervention (Day 1)||24
10108469|NCT02466412|11238873|FG000|COMPLETED|First Intervention (Day 1)||24
10108470|NCT02466412|11238874|FG001|COMPLETED|First Intervention (Day 1)||24
10108471|NCT02466412|11238873|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10108472|NCT02466412|11238874|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10108473|NCT02466412|11238873|FG000|STARTED|Washout Period of 1 Day (Day 2)||24
10108474|NCT02466412|11238874|FG001|STARTED|Washout Period of 1 Day (Day 2)||24
10108475|NCT02466412|11238873|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24
10108476|NCT02466412|11238874|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24
10108477|NCT02466412|11238873|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10108478|NCT02466412|11238874|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10108479|NCT02466412|11238873|FG000|STARTED|Second Intervention (Day 3)||24
10108480|NCT02466412|11238874|FG001|STARTED|Second Intervention (Day 3)||24
10108481|NCT02466412|11238873|FG000|COMPLETED|Second Intervention (Day 3)||24
10108482|NCT02466412|11238874|FG001|COMPLETED|Second Intervention (Day 3)||24
10108483|NCT02466412|11238873|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10108484|NCT02466412|11238874|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10113355|NCT02509117|11244191|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113356|NCT02509117|11244192|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113357|NCT02509117|11244193|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113358|NCT02509117|11244194|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113359|NCT02509117|11244195|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113360|NCT02509117|11244196|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113361|NCT02509117|11244197|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113362|NCT02509117|11244198|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113363|NCT02509117|11244199|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10113364|NCT02509117|11244190|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2
10113365|NCT02509117|11244191|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2
10113366|NCT02509117|11244192|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2
10113367|NCT02509117|11244193|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2
10113368|NCT02509117|11244194|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0
10113369|NCT02509117|11244195|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0
9880386|NCT01025843|10994918|FG006|COMPLETED|Washout 3||2
9880387|NCT01025843|10994919|FG007|COMPLETED|Washout 3||2
9880388|NCT01025843|10994920|FG008|COMPLETED|Washout 3||2
9880389|NCT01025843|10994921|FG009|COMPLETED|Washout 3||2
9880390|NCT01025843|10994912|FG000|NOT COMPLETED|Washout 3||0
9880391|NCT01025843|10994913|FG001|NOT COMPLETED|Washout 3||0
9880392|NCT01025843|10994914|FG002|NOT COMPLETED|Washout 3||0
9880393|NCT01025843|10994915|FG003|NOT COMPLETED|Washout 3||0
9880394|NCT01025843|10994916|FG004|NOT COMPLETED|Washout 3||0
10007834|NCT01753336|11130101|FG000|Cycle 2|Overall Study||98
10007835|NCT01753336|11130101|FG000|Cycle 3|Overall Study||93
10007836|NCT01753336|11130101|FG000|COMPLETED|Overall Study||92
10007837|NCT01753336|11130101|FG000|NOT COMPLETED|Overall Study||20
10007838|NCT01753362|11130107|FG000|STARTED|Overall Study||36
10007839|NCT01753362|11130108|FG001|STARTED|Overall Study||48
10007840|NCT01753362|11130107|FG000|COMPLETED|Overall Study||26
10007841|NCT01753362|11130108|FG001|COMPLETED|Overall Study||40
10007842|NCT01753362|11130107|FG000|NOT COMPLETED|Overall Study||10
10007843|NCT01753362|11130108|FG001|NOT COMPLETED|Overall Study||8
9880395|NCT01025843|10994917|FG005|NOT COMPLETED|Washout 3||0
9880396|NCT01025843|10994918|FG006|NOT COMPLETED|Washout 3||0
9880397|NCT01025843|10994919|FG007|NOT COMPLETED|Washout 3||0
9880398|NCT01025843|10994920|FG008|NOT COMPLETED|Washout 3||0
9880399|NCT01025843|10994921|FG009|NOT COMPLETED|Washout 3||0
9880400|NCT01025843|10994912|FG000|STARTED|Period 4||2
9880401|NCT01025843|10994913|FG001|STARTED|Period 4||2
9880402|NCT01025843|10994914|FG002|STARTED|Period 4||2
9880403|NCT01025843|10994915|FG003|STARTED|Period 4||2
9880404|NCT01025843|10994916|FG004|STARTED|Period 4||2
9880405|NCT01025843|10994917|FG005|STARTED|Period 4||2
9880406|NCT01025843|10994918|FG006|STARTED|Period 4||2
9880407|NCT01025843|10994919|FG007|STARTED|Period 4||2
9880408|NCT01025843|10994920|FG008|STARTED|Period 4||2
9880409|NCT01025843|10994921|FG009|STARTED|Period 4||2
9880410|NCT01025843|10994912|FG000|COMPLETED|Period 4||2
9880411|NCT01025843|10994913|FG001|COMPLETED|Period 4||2
9880412|NCT01025843|10994914|FG002|COMPLETED|Period 4||2
9880413|NCT01025843|10994915|FG003|COMPLETED|Period 4||2
9880414|NCT01025843|10994916|FG004|COMPLETED|Period 4||2
9880415|NCT01025843|10994917|FG005|COMPLETED|Period 4||2
9880416|NCT01025843|10994918|FG006|COMPLETED|Period 4||2
9880417|NCT01025843|10994919|FG007|COMPLETED|Period 4||2
9880418|NCT01025843|10994920|FG008|COMPLETED|Period 4||2
9880419|NCT01025843|10994921|FG009|COMPLETED|Period 4||2
9880420|NCT01025843|10994912|FG000|NOT COMPLETED|Period 4||0
9880421|NCT01025843|10994913|FG001|NOT COMPLETED|Period 4||0
9880422|NCT01025843|10994914|FG002|NOT COMPLETED|Period 4||0
9880423|NCT01025843|10994915|FG003|NOT COMPLETED|Period 4||0
10108485|NCT02466425|11238883|FG000|STARTED|Overall Study||132
10108486|NCT02466425|11238884|FG001|STARTED|Overall Study||132
10108487|NCT02466425|11238883|FG000|Treated|Overall Study||131
10108488|NCT02466425|11238884|FG001|Treated|Overall Study||132
10108489|NCT02466425|11238883|FG000|COMPLETED|Overall Study||118
10108490|NCT02466425|11238884|FG001|COMPLETED|Overall Study||116
10108491|NCT02466425|11238883|FG000|NOT COMPLETED|Overall Study||14
10108492|NCT02466425|11238884|FG001|NOT COMPLETED|Overall Study||16
10108493|NCT02466516|11238895|FG000|STARTED|Overall Study||20
10108494|NCT02466516|11238896|FG001|STARTED|Overall Study||22
10108495|NCT02466516|11238897|FG002|STARTED|Overall Study||10
10108496|NCT02466516|11238898|FG003|STARTED|Overall Study||10
10108497|NCT02466516|11238899|FG004|STARTED|Overall Study||10
10108498|NCT02466516|11238895|FG000|COMPLETED|Overall Study||16
10108499|NCT02466516|11238896|FG001|COMPLETED|Overall Study||21
10108500|NCT02466516|11238897|FG002|COMPLETED|Overall Study||9
10108501|NCT02466516|11238898|FG003|COMPLETED|Overall Study||10
10108502|NCT02466516|11238899|FG004|COMPLETED|Overall Study||10
10108503|NCT02466516|11238895|FG000|NOT COMPLETED|Overall Study||4
10108504|NCT02466516|11238896|FG001|NOT COMPLETED|Overall Study||1
10108505|NCT02466516|11238897|FG002|NOT COMPLETED|Overall Study||1
10108506|NCT02466516|11238898|FG003|NOT COMPLETED|Overall Study||0
10108507|NCT02466516|11238899|FG004|NOT COMPLETED|Overall Study||0
10108508|NCT02466555|11238911|FG000|STARTED|Overall Study||30
10108509|NCT02466555|11238911|FG000|COMPLETED|Overall Study||28
10108510|NCT02466555|11238911|FG000|NOT COMPLETED|Overall Study||2
10108511|NCT02466646|11238919|FG000|STARTED|Overall Study||14
10108512|NCT02466646|11238920|FG001|STARTED|Overall Study||14
10108513|NCT02466646|11238921|FG002|STARTED|Overall Study||14
10108514|NCT02466646|11238919|FG000|COMPLETED|Overall Study||14
10108515|NCT02466646|11238920|FG001|COMPLETED|Overall Study||14
10108516|NCT02466646|11238921|FG002|COMPLETED|Overall Study||14
10108517|NCT02466646|11238919|FG000|NOT COMPLETED|Overall Study||0
10108518|NCT02466646|11238920|FG001|NOT COMPLETED|Overall Study||0
9880424|NCT01025843|10994916|FG004|NOT COMPLETED|Period 4||0
10007844|NCT01753401|11130116|FG000|STARTED|Double-blind Period (8 Weeks)||12
10108519|NCT02466646|11238921|FG002|NOT COMPLETED|Overall Study||0
10108520|NCT02466659|11238934|FG000|STARTED|Overall Study||5
9880425|NCT01025843|10994917|FG005|NOT COMPLETED|Period 4||0
9880426|NCT01025843|10994918|FG006|NOT COMPLETED|Period 4||0
9880427|NCT01025843|10994919|FG007|NOT COMPLETED|Period 4||0
9880428|NCT01025843|10994920|FG008|NOT COMPLETED|Period 4||0
9880429|NCT01025843|10994921|FG009|NOT COMPLETED|Period 4||0
9880430|NCT01025843|10994912|FG000|STARTED|Washout 4||2
9880431|NCT01025843|10994913|FG001|STARTED|Washout 4||2
9880432|NCT01025843|10994914|FG002|STARTED|Washout 4||2
10007845|NCT01753401|11130117|FG001|STARTED|Double-blind Period (8 Weeks)||26
10018975|NCT01826851|11142029|FG000|COMPLETED|Overall Study||38
10108521|NCT02466659|11238935|FG001|STARTED|Overall Study||3
10108522|NCT02466659|11238934|FG000|COMPLETED|Overall Study||0
9880433|NCT01025843|10994915|FG003|STARTED|Washout 4||2
9880434|NCT01025843|10994916|FG004|STARTED|Washout 4||2
10108523|NCT02466659|11238935|FG001|COMPLETED|Overall Study||1
9880435|NCT01025843|10994917|FG005|STARTED|Washout 4||2
9880436|NCT01025843|10994918|FG006|STARTED|Washout 4||2
9880437|NCT01025843|10994919|FG007|STARTED|Washout 4||2
9880438|NCT01025843|10994920|FG008|STARTED|Washout 4||2
9880439|NCT01025843|10994921|FG009|STARTED|Washout 4||2
9880440|NCT01025843|10994912|FG000|COMPLETED|Washout 4||2
9880441|NCT01025843|10994913|FG001|COMPLETED|Washout 4||2
9880442|NCT01025843|10994914|FG002|COMPLETED|Washout 4||1
9880443|NCT01025843|10994915|FG003|COMPLETED|Washout 4||1
10007846|NCT01753401|11130118|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
10007847|NCT01753401|11130119|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
10007848|NCT01753401|11130116|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
10007849|NCT01753401|11130117|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
10007850|NCT01753401|11130118|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
10007851|NCT01753401|11130119|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
10007852|NCT01753401|11130116|FG000|COMPLETED|Double-blind Period (8 Weeks)||11
10007853|NCT01753401|11130117|FG001|COMPLETED|Double-blind Period (8 Weeks)||22
10007854|NCT01753401|11130118|FG002|COMPLETED|Double-blind Period (8 Weeks)||0
10007855|NCT01753401|11130119|FG003|COMPLETED|Double-blind Period (8 Weeks)||0
10018976|NCT01826851|11142030|FG001|COMPLETED|Overall Study||41
9880444|NCT01025843|10994916|FG004|COMPLETED|Washout 4||2
9880445|NCT01025843|10994917|FG005|COMPLETED|Washout 4||2
9880446|NCT01025843|10994918|FG006|COMPLETED|Washout 4||2
9880447|NCT01025843|10994919|FG007|COMPLETED|Washout 4||2
9880448|NCT01025843|10994920|FG008|COMPLETED|Washout 4||2
9880449|NCT01025843|10994921|FG009|COMPLETED|Washout 4||2
9880450|NCT01025843|10994912|FG000|NOT COMPLETED|Washout 4||0
9880451|NCT01025843|10994913|FG001|NOT COMPLETED|Washout 4||0
9880452|NCT01025843|10994914|FG002|NOT COMPLETED|Washout 4||1
9880453|NCT01025843|10994915|FG003|NOT COMPLETED|Washout 4||1
9880454|NCT01025843|10994916|FG004|NOT COMPLETED|Washout 4||0
9880455|NCT01025843|10994917|FG005|NOT COMPLETED|Washout 4||0
9880456|NCT01025843|10994918|FG006|NOT COMPLETED|Washout 4||0
9880457|NCT01025843|10994919|FG007|NOT COMPLETED|Washout 4||0
9880458|NCT01025843|10994920|FG008|NOT COMPLETED|Washout 4||0
9880459|NCT01025843|10994921|FG009|NOT COMPLETED|Washout 4||0
9880460|NCT01025843|10994912|FG000|STARTED|Period 5||2
9880461|NCT01025843|10994913|FG001|STARTED|Period 5||2
9880462|NCT01025843|10994914|FG002|STARTED|Period 5||1
9880463|NCT01025843|10994915|FG003|STARTED|Period 5||1
9880464|NCT01025843|10994916|FG004|STARTED|Period 5||2
9880465|NCT01025843|10994917|FG005|STARTED|Period 5||2
9880466|NCT01025843|10994918|FG006|STARTED|Period 5||2
9880467|NCT01025843|10994919|FG007|STARTED|Period 5||2
9880468|NCT01025843|10994920|FG008|STARTED|Period 5||2
9880469|NCT01025843|10994921|FG009|STARTED|Period 5||2
9880470|NCT01025843|10994912|FG000|COMPLETED|Period 5||2
9880471|NCT01025843|10994913|FG001|COMPLETED|Period 5||2
9880472|NCT01025843|10994914|FG002|COMPLETED|Period 5||1
9880473|NCT01025843|10994915|FG003|COMPLETED|Period 5||1
9880474|NCT01025843|10994916|FG004|COMPLETED|Period 5||2
9880475|NCT01025843|10994917|FG005|COMPLETED|Period 5||2
9880476|NCT01025843|10994918|FG006|COMPLETED|Period 5||2
9880477|NCT01025843|10994919|FG007|COMPLETED|Period 5||2
9880478|NCT01025843|10994920|FG008|COMPLETED|Period 5||2
9880479|NCT01025843|10994921|FG009|COMPLETED|Period 5||2
9880480|NCT01025843|10994912|FG000|NOT COMPLETED|Period 5||0
9880481|NCT01025843|10994913|FG001|NOT COMPLETED|Period 5||0
9880482|NCT01025843|10994914|FG002|NOT COMPLETED|Period 5||0
9880483|NCT01025843|10994915|FG003|NOT COMPLETED|Period 5||0
9880484|NCT01025843|10994916|FG004|NOT COMPLETED|Period 5||0
9880485|NCT01025843|10994917|FG005|NOT COMPLETED|Period 5||0
9880486|NCT01025843|10994918|FG006|NOT COMPLETED|Period 5||0
9880487|NCT01025843|10994919|FG007|NOT COMPLETED|Period 5||0
9880488|NCT01025843|10994920|FG008|NOT COMPLETED|Period 5||0
9880489|NCT01025843|10994921|FG009|NOT COMPLETED|Period 5||0
9880490|NCT01026012|10994949|FG000|STARTED|Overall Study||40
9880491|NCT01026012|10994949|FG000|COMPLETED|Overall Study||40
9880492|NCT01026012|10994949|FG000|NOT COMPLETED|Overall Study||0
9880493|NCT01026038|10994956|FG000|STARTED|Overall Study||130
9880494|NCT01026038|10994957|FG001|STARTED|Overall Study||65
9880495|NCT01026038|10994958|FG002|STARTED|Overall Study||67
9880496|NCT01026038|10994956|FG000|COMPLETED|Overall Study||129
9880497|NCT01026038|10994957|FG001|COMPLETED|Overall Study||64
9880498|NCT01026038|10994958|FG002|COMPLETED|Overall Study||67
9880499|NCT01026038|10994956|FG000|NOT COMPLETED|Overall Study||1
9880500|NCT01026038|10994957|FG001|NOT COMPLETED|Overall Study||1
9880501|NCT01026038|10994958|FG002|NOT COMPLETED|Overall Study||0
9880502|NCT01026103|10994966|FG000|STARTED|Overall Study||30
9880503|NCT01026103|10994966|FG000|Consented|Overall Study||30
9880504|NCT01026103|10994966|FG000|COMPLETED|Overall Study||28
9880505|NCT01026103|10994966|FG000|NOT COMPLETED|Overall Study||2
9880506|NCT01026142|10994972|FG000|STARTED|Overall Study||224
9880507|NCT01026142|10994973|FG001|STARTED|Overall Study||228
9880508|NCT01026142|10994972|FG000|COMPLETED|Overall Study||52
9880509|NCT01026142|10994973|FG001|COMPLETED|Overall Study||65
9880510|NCT01026142|10994972|FG000|NOT COMPLETED|Overall Study||172
9880511|NCT01026142|10994973|FG001|NOT COMPLETED|Overall Study||163
9880512|NCT01026181|10994982|FG000|STARTED|Overall Study||51
9880513|NCT01026181|10994983|FG001|STARTED|Overall Study||51
9880514|NCT01026181|10994984|FG002|STARTED|Overall Study||48
9880515|NCT01026181|10994982|FG000|COMPLETED|Overall Study||51
9880516|NCT01026181|10994983|FG001|COMPLETED|Overall Study||51
10007856|NCT01753401|11130116|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1
9880517|NCT01026181|10994984|FG002|COMPLETED|Overall Study||48
9880518|NCT01026181|10994982|FG000|NOT COMPLETED|Overall Study||0
9880519|NCT01026181|10994983|FG001|NOT COMPLETED|Overall Study||0
9880520|NCT01026181|10994984|FG002|NOT COMPLETED|Overall Study||0
9880521|NCT01026194|10994994|FG000|STARTED|Period 1：Double Blind Period||101
9880522|NCT01026194|10994995|FG001|STARTED|Period 1：Double Blind Period||103
9880523|NCT01026194|10994994|FG000|COMPLETED|Period 1：Double Blind Period||98
9880524|NCT01026194|10994995|FG001|COMPLETED|Period 1：Double Blind Period||98
9880525|NCT01026194|10994994|FG000|NOT COMPLETED|Period 1：Double Blind Period||3
9880526|NCT01026194|10994995|FG001|NOT COMPLETED|Period 1：Double Blind Period||5
9880527|NCT01026194|10994994|FG000|STARTED|Period 2：Open-label Period||98
9880528|NCT01026194|10994995|FG001|STARTED|Period 2：Open-label Period||98
9880529|NCT01026194|10994994|FG000|COMPLETED|Period 2：Open-label Period||91
9880530|NCT01026194|10994995|FG001|COMPLETED|Period 2：Open-label Period||88
9880531|NCT01026194|10994994|FG000|NOT COMPLETED|Period 2：Open-label Period||7
9880532|NCT01026194|10994995|FG001|NOT COMPLETED|Period 2：Open-label Period||10
9880533|NCT01026324|10995006|FG000|STARTED|Treatment Allocation||5
9880534|NCT01026324|10995007|FG001|STARTED|Treatment Allocation||3
9880535|NCT01026324|10995008|FG002|STARTED|Treatment Allocation||4
9880536|NCT01026324|10995006|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1
9880537|NCT01026324|10995007|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0
9880538|NCT01026324|10995008|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0
9880539|NCT01026324|10995006|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3
9880540|NCT01026324|10995007|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3
9880541|NCT01026324|10995008|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4
9880542|NCT01026324|10995006|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1
9880543|NCT01026324|10995007|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0
9880544|NCT01026324|10995008|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0
9880545|NCT01026324|10995006|FG000|COMPLETED|Treatment Allocation||5
9880546|NCT01026324|10995007|FG001|COMPLETED|Treatment Allocation||3
9880547|NCT01026324|10995008|FG002|COMPLETED|Treatment Allocation||4
9880548|NCT01026324|10995006|FG000|NOT COMPLETED|Treatment Allocation||0
9880549|NCT01026324|10995007|FG001|NOT COMPLETED|Treatment Allocation||0
9880550|NCT01026324|10995008|FG002|NOT COMPLETED|Treatment Allocation||0
9880551|NCT01026324|10995006|FG000|STARTED|Follow up/Survival||5
9880552|NCT01026324|10995007|FG001|STARTED|Follow up/Survival||3
9880553|NCT01026324|10995008|FG002|STARTED|Follow up/Survival||4
9880554|NCT01026324|10995006|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4
9880555|NCT01026324|10995007|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3
9880556|NCT01026324|10995008|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4
9880557|NCT01026324|10995006|FG000|COMPLETED|Follow up/Survival||4
9880558|NCT01026324|10995007|FG001|COMPLETED|Follow up/Survival||3
9880559|NCT01026324|10995008|FG002|COMPLETED|Follow up/Survival||4
9880560|NCT01026324|10995006|FG000|NOT COMPLETED|Follow up/Survival||1
9880561|NCT01026324|10995007|FG001|NOT COMPLETED|Follow up/Survival||0
9880562|NCT01026324|10995008|FG002|NOT COMPLETED|Follow up/Survival||0
9880563|NCT01026389|10995019|FG000|STARTED|Overall Study||93
9880564|NCT01026389|10995020|FG001|STARTED|Overall Study||93
9880565|NCT01026389|10995019|FG000|COMPLETED|Overall Study||88
9880566|NCT01026389|10995020|FG001|COMPLETED|Overall Study||88
9880567|NCT01026389|10995019|FG000|NOT COMPLETED|Overall Study||5
9880568|NCT01026389|10995020|FG001|NOT COMPLETED|Overall Study||5
9880569|NCT01026402|10995043|FG000|STARTED|Overall Study||6
9880570|NCT01026402|10995044|FG001|STARTED|Overall Study||8
9880571|NCT01026402|10995045|FG002|STARTED|Overall Study||33
9880572|NCT01026402|10995046|FG003|STARTED|Overall Study||18
9880573|NCT01026402|10995047|FG004|STARTED|Overall Study||3
9880574|NCT01026402|10995048|FG005|STARTED|Overall Study||5
9880575|NCT01026402|10995049|FG006|STARTED|Overall Study||8
9880576|NCT01026402|10995050|FG007|STARTED|Overall Study||3
9880577|NCT01026402|10995051|FG008|STARTED|Overall Study||7
9880578|NCT01026402|10995052|FG009|STARTED|Overall Study||3
9880579|NCT01026402|10995053|FG010|STARTED|Overall Study||7
9880580|NCT01026402|10995054|FG011|STARTED|Overall Study||8
9880581|NCT01026402|10995055|FG012|STARTED|Overall Study||8
9880582|NCT01026402|10995056|FG013|STARTED|Overall Study||6
9880583|NCT01026402|10995057|FG014|STARTED|Overall Study||3
9880584|NCT01026402|10995058|FG015|STARTED|Overall Study||5
9880585|NCT01026402|10995059|FG016|STARTED|Overall Study||4
9880586|NCT01026402|10995043|FG000|COMPLETED|Overall Study||6
10007857|NCT01753401|11130117|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4
9880587|NCT01026402|10995044|FG001|COMPLETED|Overall Study||8
9880588|NCT01026402|10995045|FG002|COMPLETED|Overall Study||33
9880589|NCT01026402|10995046|FG003|COMPLETED|Overall Study||18
9880590|NCT01026402|10995047|FG004|COMPLETED|Overall Study||3
9880591|NCT01026402|10995048|FG005|COMPLETED|Overall Study||5
9880592|NCT01026402|10995049|FG006|COMPLETED|Overall Study||8
9880593|NCT01026402|10995050|FG007|COMPLETED|Overall Study||3
9880594|NCT01026402|10995051|FG008|COMPLETED|Overall Study||7
9880595|NCT01026402|10995052|FG009|COMPLETED|Overall Study||3
9880596|NCT01026402|10995053|FG010|COMPLETED|Overall Study||7
9880597|NCT01026402|10995054|FG011|COMPLETED|Overall Study||8
9880598|NCT01026402|10995055|FG012|COMPLETED|Overall Study||8
9880599|NCT01026402|10995056|FG013|COMPLETED|Overall Study||6
9880600|NCT01026402|10995057|FG014|COMPLETED|Overall Study||3
9880601|NCT01026402|10995058|FG015|COMPLETED|Overall Study||5
9880602|NCT01026402|10995059|FG016|COMPLETED|Overall Study||4
9880603|NCT01026402|10995043|FG000|NOT COMPLETED|Overall Study||0
9880604|NCT01026402|10995044|FG001|NOT COMPLETED|Overall Study||0
9880605|NCT01026402|10995045|FG002|NOT COMPLETED|Overall Study||0
9880606|NCT01026402|10995046|FG003|NOT COMPLETED|Overall Study||0
9880607|NCT01026402|10995047|FG004|NOT COMPLETED|Overall Study||0
9880608|NCT01026402|10995048|FG005|NOT COMPLETED|Overall Study||0
9880609|NCT01026402|10995049|FG006|NOT COMPLETED|Overall Study||0
9880610|NCT01026402|10995050|FG007|NOT COMPLETED|Overall Study||0
9880611|NCT01026402|10995051|FG008|NOT COMPLETED|Overall Study||0
9880612|NCT01026402|10995052|FG009|NOT COMPLETED|Overall Study||0
9880613|NCT01026402|10995053|FG010|NOT COMPLETED|Overall Study||0
10007858|NCT01753401|11130118|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0
10007859|NCT01753401|11130119|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0
10007860|NCT01753401|11130116|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
10007861|NCT01753401|11130117|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
10007862|NCT01753401|11130118|FG002|STARTED|Open Label Period (44 Weeks)||11
10007863|NCT01753401|11130119|FG003|STARTED|Open Label Period (44 Weeks)||22
10108524|NCT02466659|11238934|FG000|NOT COMPLETED|Overall Study||5
10108525|NCT02466659|11238935|FG001|NOT COMPLETED|Overall Study||2
10108526|NCT02466958|11238943|FG000|STARTED|Overall Study||17
10108527|NCT02466958|11238944|FG001|STARTED|Overall Study||12
10108528|NCT02466958|11238943|FG000|COMPLETED|Overall Study||7
10108529|NCT02466958|11238944|FG001|COMPLETED|Overall Study||9
10108530|NCT02466958|11238943|FG000|NOT COMPLETED|Overall Study||10
10108531|NCT02466958|11238944|FG001|NOT COMPLETED|Overall Study||3
10108532|NCT02467075|11238952|FG000|STARTED|Initial CT Scan||0
10108533|NCT02467075|11238953|FG001|STARTED|Initial CT Scan||1
10108534|NCT02467075|11238952|FG000|COMPLETED|Initial CT Scan||0
10108535|NCT02467075|11238953|FG001|COMPLETED|Initial CT Scan||1
10108536|NCT02467075|11238952|FG000|NOT COMPLETED|Initial CT Scan||0
10108537|NCT02467075|11238953|FG001|NOT COMPLETED|Initial CT Scan||0
10108538|NCT02467075|11238952|FG000|STARTED|48 Hour Follow-up||0
10108539|NCT02467075|11238953|FG001|STARTED|48 Hour Follow-up||1
10108540|NCT02467075|11238952|FG000|COMPLETED|48 Hour Follow-up||0
10108541|NCT02467075|11238953|FG001|COMPLETED|48 Hour Follow-up||1
10108542|NCT02467075|11238952|FG000|NOT COMPLETED|48 Hour Follow-up||0
10108543|NCT02467075|11238953|FG001|NOT COMPLETED|48 Hour Follow-up||0
10108544|NCT02467075|11238952|FG000|STARTED|72 Hour Follow-up||0
10108545|NCT02467075|11238953|FG001|STARTED|72 Hour Follow-up||1
10108546|NCT02467075|11238952|FG000|COMPLETED|72 Hour Follow-up||0
10108547|NCT02467075|11238953|FG001|COMPLETED|72 Hour Follow-up||1
10108548|NCT02467075|11238952|FG000|NOT COMPLETED|72 Hour Follow-up||0
10108549|NCT02467075|11238953|FG001|NOT COMPLETED|72 Hour Follow-up||0
10108550|NCT02467075|11238952|FG000|STARTED|30 Day Follow-up||0
10108551|NCT02467075|11238953|FG001|STARTED|30 Day Follow-up||1
10108552|NCT02467075|11238952|FG000|COMPLETED|30 Day Follow-up||0
10108553|NCT02467075|11238953|FG001|COMPLETED|30 Day Follow-up||1
10108554|NCT02467075|11238952|FG000|NOT COMPLETED|30 Day Follow-up||0
10108555|NCT02467075|11238953|FG001|NOT COMPLETED|30 Day Follow-up||0
10108556|NCT02467166|11238961|FG000|STARTED|Overall Study||36
10108557|NCT02467166|11238961|FG000|COMPLETED|Overall Study||36
10108558|NCT02467166|11238961|FG000|NOT COMPLETED|Overall Study||0
10108559|NCT02467179|11238967|FG000|STARTED|Overall Study||25
10108560|NCT02467179|11238968|FG001|STARTED|Overall Study||25
10108561|NCT02467179|11238967|FG000|COMPLETED|Overall Study||25
10108562|NCT02467179|11238968|FG001|COMPLETED|Overall Study||25
10108563|NCT02467179|11238967|FG000|NOT COMPLETED|Overall Study||0
10108564|NCT02467179|11238968|FG001|NOT COMPLETED|Overall Study||0
10108565|NCT02467192|11238974|FG000|STARTED|Overall Study||203
10108566|NCT02467192|11238974|FG000|COMPLETED|Overall Study||200
10108567|NCT02467192|11238974|FG000|NOT COMPLETED|Overall Study||3
10108568|NCT02467387|11238982|FG000|STARTED|First Intervention||11
10108569|NCT02467387|11238983|FG001|STARTED|First Intervention||12
10108570|NCT02467387|11238982|FG000|Received Treatment as Randomized|First Intervention||10
10108571|NCT02467387|11238983|FG001|Received Treatment as Randomized|First Intervention||12
9880614|NCT01026402|10995054|FG011|NOT COMPLETED|Overall Study||0
10007864|NCT01753401|11130116|FG000|mITT|Open Label Period (44 Weeks)||0
10007865|NCT01753401|11130117|FG001|mITT|Open Label Period (44 Weeks)||0
10007866|NCT01753401|11130118|FG002|mITT|Open Label Period (44 Weeks)||11
10007867|NCT01753401|11130119|FG003|mITT|Open Label Period (44 Weeks)||22
10108572|NCT02467387|11238982|FG000|COMPLETED|First Intervention||10
10108573|NCT02467387|11238983|FG001|COMPLETED|First Intervention||12
10108574|NCT02467387|11238982|FG000|NOT COMPLETED|First Intervention||1
10108575|NCT02467387|11238983|FG001|NOT COMPLETED|First Intervention||0
10108576|NCT02467387|11238982|FG000|STARTED|Second Intervention||10
10108577|NCT02467387|11238983|FG001|STARTED|Second Intervention||12
10108578|NCT02467387|11238982|FG000|COMPLETED|Second Intervention||7
10108579|NCT02467387|11238983|FG001|COMPLETED|Second Intervention||12
10108580|NCT02467387|11238982|FG000|NOT COMPLETED|Second Intervention||3
10108581|NCT02467387|11238983|FG001|NOT COMPLETED|Second Intervention||0
10108582|NCT02467465|11238993|FG000|STARTED|Overall Study||15
10108583|NCT02467465|11238994|FG001|STARTED|Overall Study||15
9880615|NCT01026402|10995055|FG012|NOT COMPLETED|Overall Study||0
9880616|NCT01026402|10995056|FG013|NOT COMPLETED|Overall Study||0
10108584|NCT02467465|11238993|FG000|COMPLETED|Overall Study||15
9880617|NCT01026402|10995057|FG014|NOT COMPLETED|Overall Study||0
9880618|NCT01026402|10995058|FG015|NOT COMPLETED|Overall Study||0
9880619|NCT01026402|10995059|FG016|NOT COMPLETED|Overall Study||0
9880620|NCT01026454|10995100|FG000|STARTED|First Intervention||18
9880621|NCT01026454|10995101|FG001|STARTED|First Intervention||14
9880622|NCT01026454|10995100|FG000|COMPLETED|First Intervention||18
9880623|NCT01026454|10995101|FG001|COMPLETED|First Intervention||14
9880624|NCT01026454|10995100|FG000|NOT COMPLETED|First Intervention||0
9880625|NCT01026454|10995101|FG001|NOT COMPLETED|First Intervention||0
9880626|NCT01026454|10995100|FG000|STARTED|Washout||18
9880627|NCT01026454|10995101|FG001|STARTED|Washout||14
9880628|NCT01026454|10995100|FG000|COMPLETED|Washout||18
9880629|NCT01026454|10995101|FG001|COMPLETED|Washout||14
9880630|NCT01026454|10995100|FG000|NOT COMPLETED|Washout||0
9880631|NCT01026454|10995101|FG001|NOT COMPLETED|Washout||0
9880632|NCT01026454|10995100|FG000|STARTED|Second Intervention||17
9880633|NCT01026454|10995101|FG001|STARTED|Second Intervention||14
9880634|NCT01026454|10995100|FG000|COMPLETED|Second Intervention||16
9880635|NCT01026454|10995101|FG001|COMPLETED|Second Intervention||13
9880636|NCT01026454|10995100|FG000|NOT COMPLETED|Second Intervention||1
9880637|NCT01026454|10995101|FG001|NOT COMPLETED|Second Intervention||1
9880638|NCT01026493|10995115|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
10108585|NCT02467465|11238994|FG001|COMPLETED|Overall Study||15
10108586|NCT02467465|11238993|FG000|NOT COMPLETED|Overall Study||0
10108587|NCT02467465|11238994|FG001|NOT COMPLETED|Overall Study||0
10108588|NCT02467491|11239002|FG000|STARTED|Overall Study||12
10108589|NCT02467491|11239002|FG000|COMPLETED|Overall Study||12
10108590|NCT02467491|11239002|FG000|NOT COMPLETED|Overall Study||0
10108591|NCT02467504|11239008|FG000|STARTED|Overall Study||23
10108592|NCT02467504|11239009|FG001|STARTED|Overall Study||24
10108593|NCT02467504|11239008|FG000|COMPLETED|Overall Study||17
10108594|NCT02467504|11239009|FG001|COMPLETED|Overall Study||23
10108595|NCT02467504|11239008|FG000|NOT COMPLETED|Overall Study||6
10108596|NCT02467504|11239009|FG001|NOT COMPLETED|Overall Study||1
10108597|NCT02467621|11239017|FG000|STARTED|Overall Study||1645
10108598|NCT02467621|11239018|FG001|STARTED|Overall Study||1653
10108599|NCT02467621|11239017|FG000|COMPLETED|Overall Study||1644
10108600|NCT02467621|11239018|FG001|COMPLETED|Overall Study||1647
10108601|NCT02467621|11239017|FG000|NOT COMPLETED|Overall Study||1
10108602|NCT02467621|11239018|FG001|NOT COMPLETED|Overall Study||6
10108603|NCT02467777|11239026|FG000|STARTED|Overall Study||23
10108604|NCT02467777|11239027|FG001|STARTED|Overall Study||27
10108605|NCT02467777|11239026|FG000|COMPLETED|Overall Study||23
10108606|NCT02467777|11239027|FG001|COMPLETED|Overall Study||27
10108607|NCT02467777|11239026|FG000|NOT COMPLETED|Overall Study||0
10108608|NCT02467777|11239027|FG001|NOT COMPLETED|Overall Study||0
10108609|NCT02467842|11239036|FG000|STARTED|Overall Study||752
10108610|NCT02467842|11239037|FG001|STARTED|Overall Study||373
10108611|NCT02467842|11239038|FG002|STARTED|Overall Study||378
10108612|NCT02467842|11239036|FG000|COMPLETED|Overall Study||752
10108613|NCT02467842|11239037|FG001|COMPLETED|Overall Study||373
10108614|NCT02467842|11239038|FG002|COMPLETED|Overall Study||378
10108615|NCT02467842|11239036|FG000|NOT COMPLETED|Overall Study||0
10108616|NCT02467842|11239037|FG001|NOT COMPLETED|Overall Study||0
10108617|NCT02467842|11239038|FG002|NOT COMPLETED|Overall Study||0
10108618|NCT02468154|11239050|FG000|STARTED|Overall Study||29
10108619|NCT02468154|11239051|FG001|STARTED|Overall Study||28
10108620|NCT02468154|11239050|FG000|COMPLETED|Overall Study||29
10108621|NCT02468154|11239051|FG001|COMPLETED|Overall Study||28
10108622|NCT02468154|11239050|FG000|NOT COMPLETED|Overall Study||0
10108623|NCT02468154|11239051|FG001|NOT COMPLETED|Overall Study||0
10108624|NCT02468193|11239057|FG000|STARTED|Overall Study||9
10108625|NCT02468193|11239057|FG000|Completed Week-12 (Study Period I)|Overall Study||7
10108626|NCT02468193|11239057|FG000|Discontinued at or Prior to Week-12|Overall Study||2
10108627|NCT02468193|11239057|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3
10202767|NCT03449446|11329877|FG000|NOT COMPLETED|Overall Study||36
10202768|NCT03449446|11329878|FG001|NOT COMPLETED|Overall Study||7
10202769|NCT03449446|11329879|FG002|NOT COMPLETED|Overall Study||7
10202770|NCT03449446|11329880|FG003|NOT COMPLETED|Overall Study||9
10202771|NCT03449446|11329881|FG004|NOT COMPLETED|Overall Study||12
10202772|NCT03449446|11329882|FG005|NOT COMPLETED|Overall Study||9
9880639|NCT01026493|10995116|FG001|STARTED|Overall Study||7
9880640|NCT01026493|10995117|FG002|STARTED|Overall Study||9
10202773|NCT03449446|11329883|FG006|NOT COMPLETED|Overall Study||1
9880641|NCT01026493|10995118|FG003|STARTED|Overall Study||8
9880642|NCT01026493|10995119|FG004|STARTED|Overall Study||75
9880643|NCT01026493|10995120|FG005|STARTED|Overall Study||76
9880644|NCT01026493|10995121|FG006|STARTED|Overall Study||36
9880645|NCT01026493|10995122|FG007|STARTED|Overall Study||38
10108628|NCT02468193|11239057|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4
10108629|NCT02468193|11239057|FG000|Completed Week-48 (Study Period II)|Overall Study||2
10108630|NCT02468193|11239057|FG000|Discontinued at or Prior to Week48|Overall Study||2
10108631|NCT02468193|11239057|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
10108632|NCT02468193|11239057|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
10108633|NCT02468193|11239057|FG000|Completed Optional Extension Period|Overall Study||0
10108634|NCT02468193|11239057|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2
10108635|NCT02468193|11239057|FG000|COMPLETED|Overall Study||3
10108636|NCT02468193|11239057|FG000|NOT COMPLETED|Overall Study||6
10108637|NCT02468557|11239077|FG000|STARTED|Overall Study||16
10108638|NCT02468557|11239077|FG000|COMPLETED|Overall Study||0
9880646|NCT01026493|10995115|FG000|COMPLETED|Overall Study||8
9880647|NCT01026493|10995116|FG001|COMPLETED|Overall Study||6
9880648|NCT01026493|10995117|FG002|COMPLETED|Overall Study||9
9880649|NCT01026493|10995118|FG003|COMPLETED|Overall Study||8
9880650|NCT01026493|10995119|FG004|COMPLETED|Overall Study||73
9880651|NCT01026493|10995120|FG005|COMPLETED|Overall Study||73
9880652|NCT01026493|10995121|FG006|COMPLETED|Overall Study||32
9880653|NCT01026493|10995122|FG007|COMPLETED|Overall Study||37
9880654|NCT01026493|10995115|FG000|NOT COMPLETED|Overall Study||0
9880655|NCT01026493|10995116|FG001|NOT COMPLETED|Overall Study||1
9880656|NCT01026493|10995117|FG002|NOT COMPLETED|Overall Study||0
9880657|NCT01026493|10995118|FG003|NOT COMPLETED|Overall Study||0
9880658|NCT01026493|10995119|FG004|NOT COMPLETED|Overall Study||2
9880659|NCT01026493|10995120|FG005|NOT COMPLETED|Overall Study||3
9880660|NCT01026493|10995121|FG006|NOT COMPLETED|Overall Study||4
9880661|NCT01026493|10995122|FG007|NOT COMPLETED|Overall Study||1
9880662|NCT01026623|10995143|FG000|STARTED|Overall Study||6
9880663|NCT01026623|10995144|FG001|STARTED|Overall Study||5
10007868|NCT01753401|11130116|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0
10007869|NCT01753401|11130117|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0
10007870|NCT01753401|11130118|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11
10108639|NCT02468557|11239077|FG000|NOT COMPLETED|Overall Study||16
10108640|NCT02468570|11239087|FG000|STARTED|Overall Study||6
10108641|NCT02468570|11239088|FG001|STARTED|Overall Study||3
10108642|NCT02468570|11239087|FG000|COMPLETED|Overall Study||6
10108643|NCT02468570|11239088|FG001|COMPLETED|Overall Study||3
10108644|NCT02468570|11239087|FG000|NOT COMPLETED|Overall Study||0
10108645|NCT02468570|11239088|FG001|NOT COMPLETED|Overall Study||0
10108646|NCT02468648|11239094|FG000|STARTED|Overall Study||72
10108647|NCT02468648|11239094|FG000|COMPLETED|Overall Study||71
10108648|NCT02468648|11239094|FG000|NOT COMPLETED|Overall Study||1
10108649|NCT02468674|11239107|FG000|STARTED|Overall Study||5
10108650|NCT02468674|11239108|FG001|STARTED|Overall Study||5
10108651|NCT02468674|11239109|FG002|STARTED|Overall Study||5
10108652|NCT02468674|11239110|FG003|STARTED|Overall Study||4
10108653|NCT02468674|11239111|FG004|STARTED|Overall Study||7
10108654|NCT02468674|11239112|FG005|STARTED|Overall Study||7
10108655|NCT02468674|11239113|FG006|STARTED|Overall Study||15
10108656|NCT02468674|11239114|FG007|STARTED|Overall Study||69
10108657|NCT02468674|11239115|FG008|STARTED|Overall Study||43
10108658|NCT02468674|11239107|FG000|COMPLETED|Overall Study||4
10108659|NCT02468674|11239108|FG001|COMPLETED|Overall Study||5
10108660|NCT02468674|11239109|FG002|COMPLETED|Overall Study||5
10108661|NCT02468674|11239110|FG003|COMPLETED|Overall Study||3
10108662|NCT02468674|11239111|FG004|COMPLETED|Overall Study||6
10108663|NCT02468674|11239112|FG005|COMPLETED|Overall Study||6
10108664|NCT02468674|11239113|FG006|COMPLETED|Overall Study||14
10108665|NCT02468674|11239114|FG007|COMPLETED|Overall Study||65
10108666|NCT02468674|11239115|FG008|COMPLETED|Overall Study||40
10108667|NCT02468674|11239107|FG000|NOT COMPLETED|Overall Study||1
10108668|NCT02468674|11239108|FG001|NOT COMPLETED|Overall Study||0
10108669|NCT02468674|11239109|FG002|NOT COMPLETED|Overall Study||0
10108670|NCT02468674|11239110|FG003|NOT COMPLETED|Overall Study||1
10108671|NCT02468674|11239111|FG004|NOT COMPLETED|Overall Study||1
10108672|NCT02468674|11239112|FG005|NOT COMPLETED|Overall Study||1
10108673|NCT02468674|11239113|FG006|NOT COMPLETED|Overall Study||1
10108674|NCT02468674|11239114|FG007|NOT COMPLETED|Overall Study||4
10108675|NCT02468674|11239115|FG008|NOT COMPLETED|Overall Study||3
10108676|NCT02468700|11239137|FG000|STARTED|Overall Study||22
9880664|NCT01026623|10995145|FG002|STARTED|Overall Study||5
9880665|NCT01026623|10995143|FG000|COMPLETED|Overall Study||6
10007871|NCT01753401|11130119|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22
10007872|NCT01753401|11130116|FG000|COMPLETED|Open Label Period (44 Weeks)||0
10007873|NCT01753401|11130117|FG001|COMPLETED|Open Label Period (44 Weeks)||0
10007874|NCT01753401|11130118|FG002|COMPLETED|Open Label Period (44 Weeks)||7
10007875|NCT01753401|11130119|FG003|COMPLETED|Open Label Period (44 Weeks)||13
10108677|NCT02468700|11239138|FG001|STARTED|Overall Study||21
10108678|NCT02468700|11239137|FG000|COMPLETED|Overall Study||20
10108679|NCT02468700|11239138|FG001|COMPLETED|Overall Study||19
10108680|NCT02468700|11239137|FG000|NOT COMPLETED|Overall Study||2
10108681|NCT02468700|11239138|FG001|NOT COMPLETED|Overall Study||2
10108682|NCT02468804|11239146|FG000|STARTED|Overall Study||37
10108683|NCT02468804|11239147|FG001|STARTED|Overall Study||58
10108684|NCT02468804|11239146|FG000|COMPLETED|Overall Study||36
10108685|NCT02468804|11239147|FG001|COMPLETED|Overall Study||50
10108686|NCT02468804|11239146|FG000|NOT COMPLETED|Overall Study||1
10108687|NCT02468804|11239147|FG001|NOT COMPLETED|Overall Study||8
10108688|NCT02468830|11239153|FG000|STARTED|Overall Study||58
10108689|NCT02468830|11239153|FG000|COMPLETED|Overall Study||55
10108690|NCT02468830|11239153|FG000|NOT COMPLETED|Overall Study||3
10108691|NCT02468934|11239157|FG000|STARTED|Overall Study||27
10108692|NCT02468934|11239157|FG000|Enrolled/Received Leads|Overall Study||24
10108693|NCT02468934|11239157|FG000|Underwent Total Knee Arthroplasty|Overall Study||20
10108694|NCT02468934|11239157|FG000|COMPLETED|Overall Study||20
10108695|NCT02468934|11239157|FG000|NOT COMPLETED|Overall Study||7
10108696|NCT02469038|11239165|FG000|STARTED|Overall Study||26
9880666|NCT01026623|10995144|FG001|COMPLETED|Overall Study||5
9880667|NCT01026623|10995145|FG002|COMPLETED|Overall Study||5
9880668|NCT01026623|10995143|FG000|NOT COMPLETED|Overall Study||0
10108697|NCT02469038|11239166|FG001|STARTED|Overall Study||24
10108698|NCT02469038|11239165|FG000|COMPLETED|Overall Study||22
10108699|NCT02469038|11239166|FG001|COMPLETED|Overall Study||19
10007876|NCT01753401|11130116|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0
10007877|NCT01753401|11130117|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0
10007878|NCT01753401|11130118|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4
10007879|NCT01753401|11130119|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9
10007880|NCT01753518|11130131|FG000|STARTED|Intention-to-Treat Analysis||110
10007881|NCT01753518|11130132|FG001|STARTED|Intention-to-Treat Analysis||110
10007882|NCT01753518|11130131|FG000|COMPLETED|Intention-to-Treat Analysis||103
10007883|NCT01753518|11130132|FG001|COMPLETED|Intention-to-Treat Analysis||103
10007884|NCT01753518|11130131|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7
10007885|NCT01753518|11130132|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7
10007886|NCT01753518|11130131|FG000|STARTED|Postpartum Follow-up||103
10007887|NCT01753518|11130132|FG001|STARTED|Postpartum Follow-up||103
9880669|NCT01026623|10995144|FG001|NOT COMPLETED|Overall Study||0
9880670|NCT01026623|10995145|FG002|NOT COMPLETED|Overall Study||0
9880671|NCT01026792|10995154|FG000|STARTED|Overall Study||38
9880672|NCT01026792|10995154|FG000|COMPLETED|Overall Study||37
9880673|NCT01026792|10995154|FG000|NOT COMPLETED|Overall Study||1
9880674|NCT01026805|10995158|FG000|STARTED|Overall Study||11
9880675|NCT01026805|10995158|FG000|COMPLETED|Overall Study||11
9880676|NCT01026805|10995158|FG000|NOT COMPLETED|Overall Study||0
9880677|NCT01026818|10995165|FG000|STARTED|Screening Period||583
9880678|NCT01026818|10995166|FG001|STARTED|Screening Period||0
9880679|NCT01026818|10995167|FG002|STARTED|Screening Period||0
9880680|NCT01026818|10995168|FG003|STARTED|Screening Period||0
9880681|NCT01026818|10995165|FG000|COMPLETED|Screening Period||423
9880682|NCT01026818|10995166|FG001|COMPLETED|Screening Period||0
9880683|NCT01026818|10995167|FG002|COMPLETED|Screening Period||0
9880684|NCT01026818|10995168|FG003|COMPLETED|Screening Period||0
9880685|NCT01026818|10995165|FG000|NOT COMPLETED|Screening Period||160
9880686|NCT01026818|10995166|FG001|NOT COMPLETED|Screening Period||0
9880687|NCT01026818|10995167|FG002|NOT COMPLETED|Screening Period||0
9880688|NCT01026818|10995168|FG003|NOT COMPLETED|Screening Period||0
9880689|NCT01026818|10995165|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0
9880690|NCT01026818|10995166|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139
9880691|NCT01026818|10995167|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143
9880692|NCT01026818|10995168|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141
9880693|NCT01026818|10995165|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
9880694|NCT01026818|10995166|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
9880695|NCT01026818|10995167|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
9880696|NCT01026818|10995168|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
9880697|NCT01026818|10995165|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0
9880698|NCT01026818|10995166|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114
9880699|NCT01026818|10995167|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122
9880700|NCT01026818|10995168|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115
9880701|NCT01026818|10995165|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
9880702|NCT01026818|10995166|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
9880703|NCT01026818|10995167|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
9880704|NCT01026818|10995168|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
9880705|NCT01026818|10995165|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
9880706|NCT01026818|10995166|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
9880707|NCT01026818|10995167|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
9880708|NCT01026818|10995168|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
9880709|NCT01026818|10995165|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
9880710|NCT01026818|10995166|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
9880711|NCT01026818|10995167|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
9880712|NCT01026818|10995168|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
9880713|NCT01026818|10995165|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
9880714|NCT01026818|10995166|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
9880715|NCT01026818|10995167|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
9880716|NCT01026818|10995168|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
9880717|NCT01026818|10995165|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0
9880718|NCT01026818|10995166|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105
9880719|NCT01026818|10995167|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117
9880720|NCT01026818|10995168|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108
10007888|NCT01753518|11130131|FG000|COMPLETED|Postpartum Follow-up||81
10007889|NCT01753518|11130132|FG001|COMPLETED|Postpartum Follow-up||88
10007890|NCT01753518|11130131|FG000|NOT COMPLETED|Postpartum Follow-up||22
10007891|NCT01753518|11130132|FG001|NOT COMPLETED|Postpartum Follow-up||15
10007892|NCT01753557|11130140|FG000|STARTED|Overall Study||35
10007893|NCT01753557|11130141|FG001|STARTED|Overall Study||19
10007894|NCT01753557|11130140|FG000|COMPLETED|Overall Study||35
10007895|NCT01753557|11130141|FG001|COMPLETED|Overall Study||19
9880721|NCT01026818|10995165|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0
9880722|NCT01026818|10995166|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98
9880723|NCT01026818|10995167|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112
9880724|NCT01026818|10995168|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105
9880725|NCT01026818|10995165|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
9880726|NCT01026818|10995166|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
9880727|NCT01026818|10995167|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
9880728|NCT01026818|10995168|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
9880729|NCT01026831|10995182|FG000|STARTED|Overall Study|randomized|320
9880730|NCT01026831|10995183|FG001|STARTED|Overall Study|randomized|323
9880731|NCT01026831|10995182|FG000|COMPLETED|Overall Study||306
10007896|NCT01753557|11130140|FG000|NOT COMPLETED|Overall Study||0
10007897|NCT01753557|11130141|FG001|NOT COMPLETED|Overall Study||0
10007898|NCT01753570|11130151|FG000|STARTED|Overall Study||30
10007899|NCT01753570|11130152|FG001|STARTED|Overall Study||30
10007900|NCT01753570|11130153|FG002|STARTED|Overall Study||14
10007901|NCT01753570|11130151|FG000|COMPLETED|Overall Study||28
10007902|NCT01753570|11130152|FG001|COMPLETED|Overall Study||25
10108700|NCT02469038|11239165|FG000|NOT COMPLETED|Overall Study||4
10108701|NCT02469038|11239166|FG001|NOT COMPLETED|Overall Study||5
10108702|NCT02469064|11239174|FG000|STARTED|Overall Study||64
10108703|NCT02469064|11239175|FG001|STARTED|Overall Study||62
10108704|NCT02469064|11239174|FG000|COMPLETED|Overall Study||63
10108705|NCT02469064|11239175|FG001|COMPLETED|Overall Study||59
10108706|NCT02469064|11239174|FG000|NOT COMPLETED|Overall Study||1
10108707|NCT02469064|11239175|FG001|NOT COMPLETED|Overall Study||3
10108708|NCT02469077|11239183|FG000|STARTED|Pre Randomization - Pre Intervention||44
10108709|NCT02469077|11239184|FG001|STARTED|Pre Randomization - Pre Intervention||49
10108710|NCT02469077|11239183|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
10108711|NCT02469077|11239184|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
10108712|NCT02469077|11239183|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
10108713|NCT02469077|11239184|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
10108714|NCT02469077|11239183|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
10108715|NCT02469077|11239184|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
10108716|NCT02469077|11239183|FG000|COMPLETED|Pre Randomization - Pre Intervention||44
10108717|NCT02469077|11239184|FG001|COMPLETED|Pre Randomization - Pre Intervention||49
10108718|NCT02469077|11239183|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0
10108719|NCT02469077|11239184|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0
10108720|NCT02469077|11239183|FG000|STARTED|Post Randomization/Intervention Period||44
10108721|NCT02469077|11239184|FG001|STARTED|Post Randomization/Intervention Period||49
10108722|NCT02469077|11239183|FG000|COMPLETED|Post Randomization/Intervention Period||40
10108723|NCT02469077|11239184|FG001|COMPLETED|Post Randomization/Intervention Period||45
10108724|NCT02469077|11239183|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4
10108725|NCT02469077|11239184|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4
10108726|NCT02469077|11239183|FG000|STARTED|Post Intervention /Followup||40
10108727|NCT02469077|11239184|FG001|STARTED|Post Intervention /Followup||45
10108728|NCT02469077|11239183|FG000|Post Intervention Placebo|Post Intervention /Followup||39
10108729|NCT02469077|11239184|FG001|Post Intervention Placebo|Post Intervention /Followup||45
10108730|NCT02469077|11239183|FG000|Post Intervention Morphine|Post Intervention /Followup||40
10108731|NCT02469077|11239184|FG001|Post Intervention Morphine|Post Intervention /Followup||45
10108732|NCT02469077|11239183|FG000|Post Intervention Naloxone|Post Intervention /Followup||39
10108733|NCT02469077|11239184|FG001|Post Intervention Naloxone|Post Intervention /Followup||44
10202774|NCT03449979|11329903|FG000|STARTED|Overall Study||21
10202775|NCT03449979|11329904|FG001|STARTED|Overall Study||20
10202776|NCT03449979|11329905|FG002|STARTED|Overall Study||21
10202777|NCT03449979|11329906|FG003|STARTED|Overall Study||22
10202778|NCT03449979|11329903|FG000|COMPLETED|Overall Study||21
10202779|NCT03449979|11329904|FG001|COMPLETED|Overall Study||20
10202780|NCT03449979|11329905|FG002|COMPLETED|Overall Study||21
10202781|NCT03449979|11329906|FG003|COMPLETED|Overall Study||21
10202782|NCT03449979|11329903|FG000|NOT COMPLETED|Overall Study||0
10202783|NCT03449979|11329904|FG001|NOT COMPLETED|Overall Study||0
10202784|NCT03449979|11329905|FG002|NOT COMPLETED|Overall Study||0
10202785|NCT03449979|11329906|FG003|NOT COMPLETED|Overall Study||1
10202786|NCT03450070|11329916|FG000|STARTED|Overall Study||118
10202787|NCT03450070|11329916|FG000|COMPLETED|Overall Study||110
10202788|NCT03450070|11329916|FG000|NOT COMPLETED|Overall Study||8
10202789|NCT03450083|11329922|FG000|STARTED|Overall Study||12
10202790|NCT03450083|11329923|FG001|STARTED|Overall Study||12
10202791|NCT03450083|11329922|FG000|COMPLETED|Overall Study||12
10202792|NCT03450083|11329923|FG001|COMPLETED|Overall Study||12
10202793|NCT03450083|11329922|FG000|NOT COMPLETED|Overall Study||0
10202794|NCT03450083|11329923|FG001|NOT COMPLETED|Overall Study||0
10007903|NCT01753570|11130153|FG002|COMPLETED|Overall Study||13
10007904|NCT01753570|11130151|FG000|NOT COMPLETED|Overall Study||2
10007905|NCT01753570|11130152|FG001|NOT COMPLETED|Overall Study||5
10007906|NCT01753570|11130153|FG002|NOT COMPLETED|Overall Study||1
10202795|NCT03450369|11329931|FG000|STARTED|Overall Study||5
10202796|NCT03450369|11329932|FG001|STARTED|Overall Study||5
10202797|NCT03450369|11329931|FG000|COMPLETED|Overall Study||5
10202798|NCT03450369|11329932|FG001|COMPLETED|Overall Study||5
9880732|NCT01026831|10995183|FG001|COMPLETED|Overall Study||312
10007907|NCT01753713|11130164|FG000|STARTED|Overall Study||14
10108734|NCT02469077|11239183|FG000|COMPLETED|Post Intervention /Followup||38
10202799|NCT03450369|11329931|FG000|NOT COMPLETED|Overall Study||0
10202800|NCT03450369|11329932|FG001|NOT COMPLETED|Overall Study||0
10202801|NCT03450915|11329940|FG000|STARTED|Overall Study||6230
10202802|NCT03450915|11329941|FG001|STARTED|Overall Study||6230
10202803|NCT03450915|11329940|FG000|COMPLETED|Overall Study||5827
10202804|NCT03450915|11329941|FG001|COMPLETED|Overall Study||5855
10007908|NCT01753713|11130165|FG001|STARTED|Overall Study||19
10007909|NCT01753713|11130164|FG000|COMPLETED|Overall Study||14
10202805|NCT03450915|11329940|FG000|NOT COMPLETED|Overall Study||403
9880733|NCT01026831|10995182|FG000|NOT COMPLETED|Overall Study||14
9880734|NCT01026831|10995183|FG001|NOT COMPLETED|Overall Study||11
9880735|NCT01026844|10995191|FG000|STARTED|Overall Study||19
9880736|NCT01026844|10995192|FG001|STARTED|Overall Study||8
9880737|NCT01026844|10995191|FG000|COMPLETED|Overall Study||19
9880738|NCT01026844|10995192|FG001|COMPLETED|Overall Study||8
9880739|NCT01026844|10995191|FG000|NOT COMPLETED|Overall Study||0
9880740|NCT01026844|10995192|FG001|NOT COMPLETED|Overall Study||0
9880741|NCT01026909|10995200|FG000|STARTED|Overall Study||1
9880742|NCT01026909|10995201|FG001|STARTED|Overall Study||2
10108735|NCT02469077|11239184|FG001|COMPLETED|Post Intervention /Followup||44
10108736|NCT02469077|11239183|FG000|NOT COMPLETED|Post Intervention /Followup||2
10108737|NCT02469077|11239184|FG001|NOT COMPLETED|Post Intervention /Followup||1
10108738|NCT02469090|11239196|FG000|STARTED|Period 1: Dose Titration Phase||141
10108739|NCT02469090|11239197|FG001|STARTED|Period 1: Dose Titration Phase||0
10108740|NCT02469090|11239198|FG002|STARTED|Period 1: Dose Titration Phase||0
10108741|NCT02469090|11239196|FG000|COMPLETED|Period 1: Dose Titration Phase||109
10108742|NCT02469090|11239197|FG001|COMPLETED|Period 1: Dose Titration Phase||0
10108743|NCT02469090|11239198|FG002|COMPLETED|Period 1: Dose Titration Phase||0
10108744|NCT02469090|11239196|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32
10108745|NCT02469090|11239197|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0
10108746|NCT02469090|11239198|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0
10108747|NCT02469090|11239196|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
10108748|NCT02469090|11239197|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
10108749|NCT02469090|11239198|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
10108750|NCT02469090|11239196|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0
10108751|NCT02469090|11239197|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46
10108752|NCT02469090|11239198|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34
10108753|NCT02469090|11239196|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
10108754|NCT02469090|11239197|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
10108755|NCT02469090|11239198|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
10108756|NCT02469116|11239205|FG000|STARTED|Overall Study||18
10108757|NCT02469116|11239205|FG000|COMPLETED|Overall Study||18
10108758|NCT02469116|11239205|FG000|NOT COMPLETED|Overall Study||0
10108759|NCT02469168|11239211|FG000|STARTED|Overall Study||1
10108760|NCT02469168|11239212|FG001|STARTED|Overall Study||0
10108761|NCT02469168|11239211|FG000|COMPLETED|Overall Study||0
10108762|NCT02469168|11239212|FG001|COMPLETED|Overall Study||0
10108763|NCT02469168|11239211|FG000|NOT COMPLETED|Overall Study||1
10108764|NCT02469168|11239212|FG001|NOT COMPLETED|Overall Study||0
10108765|NCT02469246|11239220|FG000|STARTED|Double-Blind Phase||285
10108766|NCT02469246|11239221|FG001|STARTED|Double-Blind Phase||282
10108767|NCT02469246|11239220|FG000|COMPLETED|Double-Blind Phase||218
10108768|NCT02469246|11239221|FG001|COMPLETED|Double-Blind Phase||226
10108769|NCT02469246|11239220|FG000|NOT COMPLETED|Double-Blind Phase||67
10108770|NCT02469246|11239221|FG001|NOT COMPLETED|Double-Blind Phase||56
10108771|NCT02469246|11239220|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
10108772|NCT02469246|11239221|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
10108773|NCT02469246|11239220|FG000|COMPLETED|Open-Label Extension (OLE)||6
10108774|NCT02469246|11239221|FG001|COMPLETED|Open-Label Extension (OLE)||5
10108775|NCT02469246|11239220|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0
10108776|NCT02469246|11239221|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0
10108777|NCT02469298|11239233|FG000|STARTED|Overall Study||15
10108778|NCT02469298|11239234|FG001|STARTED|Overall Study||7
10108779|NCT02469298|11239235|FG002|STARTED|Overall Study||16
10108780|NCT02469298|11239236|FG003|STARTED|Overall Study||7
10108781|NCT02469298|11239233|FG000|COMPLETED|Overall Study||14
10108782|NCT02469298|11239234|FG001|COMPLETED|Overall Study||6
10108783|NCT02469298|11239235|FG002|COMPLETED|Overall Study||14
10108784|NCT02469298|11239236|FG003|COMPLETED|Overall Study||5
10108785|NCT02469298|11239233|FG000|NOT COMPLETED|Overall Study||1
10108786|NCT02469298|11239234|FG001|NOT COMPLETED|Overall Study||1
10108787|NCT02469298|11239235|FG002|NOT COMPLETED|Overall Study||2
10108788|NCT02469298|11239236|FG003|NOT COMPLETED|Overall Study||2
10108789|NCT02469389|11239255|FG000|STARTED|Overall Study||53
10108790|NCT02469389|11239256|FG001|STARTED|Overall Study||52
10108791|NCT02469389|11239255|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
10108792|NCT02469389|11239256|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
10108793|NCT02469389|11239255|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
10108794|NCT02469389|11239256|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
10108795|NCT02469389|11239255|FG000|COMPLETED|Overall Study||37
10108796|NCT02469389|11239256|FG001|COMPLETED|Overall Study||44
10108797|NCT02469389|11239255|FG000|NOT COMPLETED|Overall Study||16
10108798|NCT02469389|11239256|FG001|NOT COMPLETED|Overall Study||8
10108799|NCT02469597|11239264|FG000|STARTED|Overall Study||22
10108800|NCT02469597|11239265|FG001|STARTED|Overall Study||24
9880743|NCT01026909|10995200|FG000|COMPLETED|Overall Study||1
9880744|NCT01026909|10995201|FG001|COMPLETED|Overall Study||2
9880745|NCT01026909|10995200|FG000|NOT COMPLETED|Overall Study||0
9880746|NCT01026909|10995201|FG001|NOT COMPLETED|Overall Study||0
9880747|NCT01026948|10995207|FG000|STARTED|Overall Study||70
9880748|NCT01026948|10995207|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
10108801|NCT02469597|11239264|FG000|COMPLETED|Overall Study||22
10108802|NCT02469597|11239265|FG001|COMPLETED|Overall Study||24
10108803|NCT02469597|11239264|FG000|NOT COMPLETED|Overall Study||0
10108804|NCT02469597|11239265|FG001|NOT COMPLETED|Overall Study||0
10108805|NCT02469610|11239273|FG000|STARTED|Overall Study||34
10108806|NCT02469610|11239274|FG001|STARTED|Overall Study||31
10108807|NCT02469610|11239273|FG000|COMPLETED|Overall Study||30
10108808|NCT02469610|11239274|FG001|COMPLETED|Overall Study||30
10108809|NCT02469610|11239273|FG000|NOT COMPLETED|Overall Study||4
10108810|NCT02469610|11239274|FG001|NOT COMPLETED|Overall Study||1
10108811|NCT02469623|11239280|FG000|STARTED|Overall Study||85
10108812|NCT02469623|11239280|FG000|COMPLETED|Overall Study||72
10108813|NCT02469623|11239280|FG000|NOT COMPLETED|Overall Study||13
10108814|NCT02469701|11239285|FG000|STARTED|Overall Study||10
10108815|NCT02469701|11239285|FG000|COMPLETED|Overall Study||10
10108816|NCT02469701|11239285|FG000|NOT COMPLETED|Overall Study||0
10108817|NCT02469714|11239291|FG000|STARTED|Overall Study||55
10108818|NCT02469714|11239292|FG001|STARTED|Overall Study||55
10108819|NCT02469714|11239291|FG000|4 Month Follow-Up|Overall Study||50
10108820|NCT02469714|11239292|FG001|4 Month Follow-Up|Overall Study||51
10108821|NCT02469714|11239291|FG000|8 Month Follow-Up|Overall Study||49
10108822|NCT02469714|11239292|FG001|8 Month Follow-Up|Overall Study||50
10108823|NCT02469714|11239291|FG000|COMPLETED|Overall Study||47
10108824|NCT02469714|11239292|FG001|COMPLETED|Overall Study||50
10108825|NCT02469714|11239291|FG000|NOT COMPLETED|Overall Study||8
10108826|NCT02469714|11239292|FG001|NOT COMPLETED|Overall Study||5
10108827|NCT02469857|11239300|FG000|STARTED|Overall Study||143
10108828|NCT02469857|11239301|FG001|STARTED|Overall Study||147
10108829|NCT02469857|11239300|FG000|COMPLETED|Overall Study||118
10108830|NCT02469857|11239301|FG001|COMPLETED|Overall Study||115
10108831|NCT02469857|11239300|FG000|NOT COMPLETED|Overall Study||25
10108832|NCT02469857|11239301|FG001|NOT COMPLETED|Overall Study||32
10108833|NCT02469870|11239311|FG000|STARTED|Overall Study||77
10108834|NCT02469870|11239312|FG001|STARTED|Overall Study||79
10108835|NCT02469870|11239311|FG000|COMPLETED|Overall Study||73
10108836|NCT02469870|11239312|FG001|COMPLETED|Overall Study||72
10108837|NCT02469870|11239311|FG000|NOT COMPLETED|Overall Study||4
10108838|NCT02469870|11239312|FG001|NOT COMPLETED|Overall Study||7
10108839|NCT02469896|11239323|FG000|STARTED|Overall Study||8
10108840|NCT02469896|11239324|FG001|STARTED|Overall Study||14
10108841|NCT02469896|11239323|FG000|COMPLETED|Overall Study||6
10108842|NCT02469896|11239324|FG001|COMPLETED|Overall Study||14
10108843|NCT02469896|11239323|FG000|NOT COMPLETED|Overall Study||2
10108844|NCT02469896|11239324|FG001|NOT COMPLETED|Overall Study||0
10108845|NCT02469961|11239336|FG000|STARTED|Overall Study||25
10108846|NCT02469961|11239337|FG001|STARTED|Overall Study||25
10108847|NCT02469961|11239336|FG000|COMPLETED|Overall Study||21
10108848|NCT02469961|11239337|FG001|COMPLETED|Overall Study||24
10108849|NCT02469961|11239336|FG000|NOT COMPLETED|Overall Study||4
10108850|NCT02469961|11239337|FG001|NOT COMPLETED|Overall Study||1
10108851|NCT02470234|11239351|FG000|STARTED|Overall Study||5
10108852|NCT02470234|11239352|FG001|STARTED|Overall Study||3
10108853|NCT02470234|11239353|FG002|STARTED|Overall Study||2
10108854|NCT02470234|11239351|FG000|COMPLETED|Overall Study||5
10108855|NCT02470234|11239352|FG001|COMPLETED|Overall Study||3
10108856|NCT02470234|11239353|FG002|COMPLETED|Overall Study||2
10108857|NCT02470234|11239351|FG000|NOT COMPLETED|Overall Study||0
10108858|NCT02470234|11239352|FG001|NOT COMPLETED|Overall Study||0
10108859|NCT02470234|11239353|FG002|NOT COMPLETED|Overall Study||0
10108860|NCT02470312|11239368|FG000|STARTED|Overall Study||147
10108861|NCT02470312|11239369|FG001|STARTED|Overall Study||431
10108862|NCT02470312|11239368|FG000|COMPLETED|Overall Study||142
10108863|NCT02470312|11239369|FG001|COMPLETED|Overall Study||419
10108864|NCT02470312|11239368|FG000|NOT COMPLETED|Overall Study||5
10108865|NCT02470312|11239369|FG001|NOT COMPLETED|Overall Study||12
10108866|NCT02470390|11239377|FG000|STARTED|Overall Study||6
9760394|NCT00380692|10864026|FG000|COMPLETED|Study Period III - Open Label||36
9760395|NCT00380692|10864027|FG001|COMPLETED|Study Period III - Open Label||34
9760396|NCT00380692|10864026|FG000|NOT COMPLETED|Study Period III - Open Label||6
9760397|NCT00380692|10864027|FG001|NOT COMPLETED|Study Period III - Open Label||12
9760398|NCT00380718|10864033|FG000|STARTED|Overall Study||33
9760399|NCT00380718|10864033|FG000|Received at Least One Dose of Study Drug|Overall Study||33
9880749|NCT01026948|10995207|FG000|NOT COMPLETED|Overall Study||8
10108867|NCT02470390|11239378|FG001|STARTED|Overall Study||7
10108868|NCT02470390|11239377|FG000|COMPLETED|Overall Study||6
10108869|NCT02470390|11239378|FG001|COMPLETED|Overall Study||6
10108870|NCT02470390|11239377|FG000|NOT COMPLETED|Overall Study||0
10108871|NCT02470390|11239378|FG001|NOT COMPLETED|Overall Study||1
10108872|NCT02470403|11239391|FG000|STARTED|Overall Study||44
10108873|NCT02470403|11239392|FG001|STARTED|Overall Study||44
10108874|NCT02470403|11239393|FG002|STARTED|Overall Study||40
10108875|NCT02470403|11239394|FG003|STARTED|Overall Study||43
10108876|NCT02470403|11239395|FG004|STARTED|Overall Study||10
10108877|NCT02470403|11239391|FG000|Dysglycemic|Overall Study||24
10108878|NCT02470403|11239392|FG001|Dysglycemic|Overall Study||24
10108879|NCT02470403|11239393|FG002|Dysglycemic|Overall Study||20
10108880|NCT02470403|11239394|FG003|Dysglycemic|Overall Study||20
10108881|NCT02470403|11239395|FG004|Dysglycemic|Overall Study||5
10108882|NCT02470403|11239391|FG000|Normoglycemic|Overall Study||20
10108883|NCT02470403|11239392|FG001|Normoglycemic|Overall Study||20
9880750|NCT01026974|10995216|FG000|STARTED|Overall Study||16
9880751|NCT01026974|10995217|FG001|STARTED|Overall Study||14
9880752|NCT01026974|10995218|FG002|STARTED|Overall Study||41
9880753|NCT01026974|10995219|FG003|STARTED|Overall Study||49
9880754|NCT01026974|10995216|FG000|COMPLETED|Overall Study||15
9880755|NCT01026974|10995217|FG001|COMPLETED|Overall Study||12
9880756|NCT01026974|10995218|FG002|COMPLETED|Overall Study||29
9880757|NCT01026974|10995219|FG003|COMPLETED|Overall Study||46
9880758|NCT01026974|10995216|FG000|NOT COMPLETED|Overall Study||1
9880759|NCT01026974|10995217|FG001|NOT COMPLETED|Overall Study||2
9880760|NCT01026974|10995218|FG002|NOT COMPLETED|Overall Study||12
9880761|NCT01026974|10995219|FG003|NOT COMPLETED|Overall Study||3
9880762|NCT01027000|10995234|FG000|STARTED|Overall Study||68
9880763|NCT01027000|10995234|FG000|COMPLETED|Overall Study||68
9880764|NCT01027000|10995234|FG000|NOT COMPLETED|Overall Study||0
9880765|NCT01027195|10995240|FG000|STARTED|Overall Study||71
9880766|NCT01027195|10995241|FG001|STARTED|Overall Study||69
9880767|NCT01027195|10995240|FG000|COMPLETED|Overall Study||71
9880768|NCT01027195|10995241|FG001|COMPLETED|Overall Study||69
9880769|NCT01027195|10995240|FG000|NOT COMPLETED|Overall Study||0
9880770|NCT01027195|10995241|FG001|NOT COMPLETED|Overall Study||0
9880771|NCT01027273|10995249|FG000|STARTED|Overall Study||301
9880772|NCT01027273|10995250|FG001|STARTED|Overall Study||299
9880773|NCT01027273|10995249|FG000|COMPLETED|Overall Study||242
9880774|NCT01027273|10995250|FG001|COMPLETED|Overall Study||266
9880775|NCT01027273|10995249|FG000|NOT COMPLETED|Overall Study||59
9880776|NCT01027273|10995250|FG001|NOT COMPLETED|Overall Study||33
9880777|NCT01027286|10995258|FG000|STARTED|Overall Study||50
9880778|NCT01027286|10995259|FG001|STARTED|Overall Study||50
9880779|NCT01027286|10995258|FG000|Preoperative|Overall Study||50
9880780|NCT01027286|10995259|FG001|Preoperative|Overall Study||50
9880781|NCT01027286|10995258|FG000|Day of Surgery|Overall Study||50
9880782|NCT01027286|10995259|FG001|Day of Surgery|Overall Study||50
9880783|NCT01027286|10995258|FG000|4 Week Postoperative|Overall Study||49
9880784|NCT01027286|10995259|FG001|4 Week Postoperative|Overall Study||50
9880785|NCT01027286|10995258|FG000|12 Week Postoperative|Overall Study||49
9880786|NCT01027286|10995259|FG001|12 Week Postoperative|Overall Study||49
9880787|NCT01027286|10995258|FG000|COMPLETED|Overall Study||49
9880788|NCT01027286|10995259|FG001|COMPLETED|Overall Study||49
9880789|NCT01027286|10995258|FG000|NOT COMPLETED|Overall Study||1
9880790|NCT01027286|10995259|FG001|NOT COMPLETED|Overall Study||1
9880791|NCT01027351|10995271|FG000|STARTED|Overall Study||29
9880792|NCT01027351|10995272|FG001|STARTED|Overall Study||19
9880793|NCT01027351|10995273|FG002|STARTED|Overall Study||14
9880794|NCT01027351|10995274|FG003|STARTED|Overall Study||8
9880795|NCT01027351|10995275|FG004|STARTED|Overall Study||43
9880796|NCT01027351|10995276|FG005|STARTED|Overall Study||50
9880797|NCT01027351|10995271|FG000|COMPLETED|Overall Study||26
9880798|NCT01027351|10995272|FG001|COMPLETED|Overall Study||18
9880799|NCT01027351|10995273|FG002|COMPLETED|Overall Study||13
9880800|NCT01027351|10995274|FG003|COMPLETED|Overall Study||6
9880801|NCT01027351|10995275|FG004|COMPLETED|Overall Study||32
9880802|NCT01027351|10995276|FG005|COMPLETED|Overall Study||45
9880803|NCT01027351|10995271|FG000|NOT COMPLETED|Overall Study||3
9880804|NCT01027351|10995272|FG001|NOT COMPLETED|Overall Study||1
9880805|NCT01027351|10995273|FG002|NOT COMPLETED|Overall Study||1
9880806|NCT01027351|10995274|FG003|NOT COMPLETED|Overall Study||2
9880807|NCT01027351|10995275|FG004|NOT COMPLETED|Overall Study||11
9880808|NCT01027351|10995276|FG005|NOT COMPLETED|Overall Study||5
9880809|NCT01027364|10995301|FG000|STARTED|Overall Study||63
9880810|NCT01027364|10995302|FG001|STARTED|Overall Study||29
9880811|NCT01027364|10995303|FG002|STARTED|Overall Study||27
9880812|NCT01027364|10995304|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
9880813|NCT01027364|10995301|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22
9880814|NCT01027364|10995302|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0
9880815|NCT01027364|10995303|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0
9880816|NCT01027364|10995304|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0
9880817|NCT01027364|10995301|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5
9880818|NCT01027364|10995302|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0
9880819|NCT01027364|10995303|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1
9880820|NCT01027364|10995304|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0
9880821|NCT01027364|10995301|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2
9880822|NCT01027364|10995302|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0
9880823|NCT01027364|10995303|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0
9880824|NCT01027364|10995304|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0
9880825|NCT01027364|10995301|FG000|COMPLETED|Overall Study||59
9880826|NCT01027364|10995302|FG001|COMPLETED|Overall Study||27
9880827|NCT01027364|10995303|FG002|COMPLETED|Overall Study||26
9880828|NCT01027364|10995304|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
9880829|NCT01027364|10995301|FG000|NOT COMPLETED|Overall Study||4
9880830|NCT01027364|10995302|FG001|NOT COMPLETED|Overall Study||2
9880831|NCT01027364|10995303|FG002|NOT COMPLETED|Overall Study||1
9880832|NCT01027364|10995304|FG003|NOT COMPLETED|Overall Study||1
9880833|NCT01027416|10995332|FG000|STARTED|Overall Study||31
9880834|NCT01027416|10995333|FG001|STARTED|Overall Study||28
9880835|NCT01027416|10995332|FG000|COMPLETED|Overall Study||30
9880836|NCT01027416|10995333|FG001|COMPLETED|Overall Study||23
9880837|NCT01027416|10995332|FG000|NOT COMPLETED|Overall Study||1
9880838|NCT01027416|10995333|FG001|NOT COMPLETED|Overall Study||5
9880839|NCT01027468|10995339|FG000|STARTED|Overall Study||160
9880840|NCT01027468|10995339|FG000|COMPLETED|Overall Study||160
9880841|NCT01027468|10995339|FG000|NOT COMPLETED|Overall Study||0
9880842|NCT01027559|10995346|FG000|STARTED|Overall Study||26
9880843|NCT01027559|10995347|FG001|STARTED|Overall Study||34
9880844|NCT01027559|10995348|FG002|STARTED|Overall Study||31
9880845|NCT01027559|10995346|FG000|COMPLETED|Overall Study||20
9880846|NCT01027559|10995347|FG001|COMPLETED|Overall Study||26
9880847|NCT01027559|10995348|FG002|COMPLETED|Overall Study||22
9880848|NCT01027559|10995346|FG000|NOT COMPLETED|Overall Study||6
9880849|NCT01027559|10995347|FG001|NOT COMPLETED|Overall Study||8
9880850|NCT01027559|10995348|FG002|NOT COMPLETED|Overall Study||9
9880851|NCT01027598|10995359|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134
9880852|NCT01027598|10995360|FG001|STARTED|Overall Study||67
9880853|NCT01027598|10995359|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
9880854|NCT01027598|10995360|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
9880855|NCT01027598|10995359|FG000|NOT COMPLETED|Overall Study||134
9880856|NCT01027598|10995360|FG001|NOT COMPLETED|Overall Study||67
9880857|NCT01027650|10995374|FG000|STARTED|Overall Study||6
9880858|NCT01027650|10995375|FG001|STARTED|Overall Study||6
9880859|NCT01027650|10995376|FG002|STARTED|Overall Study||6
9880860|NCT01027650|10995377|FG003|STARTED|Overall Study||3
9880861|NCT01027650|10995378|FG004|STARTED|Overall Study||25
9880862|NCT01027650|10995379|FG005|STARTED|Overall Study||26
9880863|NCT01027650|10995380|FG006|STARTED|Overall Study||25
9880864|NCT01027650|10995381|FG007|STARTED|Overall Study||24
9880865|NCT01027650|10995374|FG000|COMPLETED|Overall Study||6
9880866|NCT01027650|10995375|FG001|COMPLETED|Overall Study||6
9880867|NCT01027650|10995376|FG002|COMPLETED|Overall Study||6
9880868|NCT01027650|10995377|FG003|COMPLETED|Overall Study||3
9880869|NCT01027650|10995378|FG004|COMPLETED|Overall Study||23
9760400|NCT00380718|10864033|FG000|Received Escalated Dose in Cycle 2|Overall Study||25
9760401|NCT00380718|10864033|FG000|COMPLETED|Overall Study||15
9880870|NCT01027650|10995379|FG005|COMPLETED|Overall Study||24
9880871|NCT01027650|10995380|FG006|COMPLETED|Overall Study||24
10007910|NCT01753713|11130165|FG001|COMPLETED|Overall Study||19
10007911|NCT01753713|11130164|FG000|NOT COMPLETED|Overall Study||0
10007912|NCT01753713|11130165|FG001|NOT COMPLETED|Overall Study||0
10007913|NCT01753739|11130176|FG000|STARTED|Overall Study||124
9880872|NCT01027650|10995381|FG007|COMPLETED|Overall Study||24
9880873|NCT01027650|10995374|FG000|NOT COMPLETED|Overall Study||0
9880874|NCT01027650|10995375|FG001|NOT COMPLETED|Overall Study||0
9880875|NCT01027650|10995376|FG002|NOT COMPLETED|Overall Study||0
9880876|NCT01027650|10995377|FG003|NOT COMPLETED|Overall Study||0
9880877|NCT01027650|10995378|FG004|NOT COMPLETED|Overall Study||2
9880878|NCT01027650|10995379|FG005|NOT COMPLETED|Overall Study||2
9880879|NCT01027650|10995380|FG006|NOT COMPLETED|Overall Study||1
9880880|NCT01027650|10995381|FG007|NOT COMPLETED|Overall Study||0
9880881|NCT01027754|10995401|FG000|STARTED|Overall Study||57
9880882|NCT01027754|10995402|FG001|STARTED|Overall Study||55
9880883|NCT01027754|10995401|FG000|COMPLETED|Overall Study||55
9880884|NCT01027754|10995402|FG001|COMPLETED|Overall Study||47
9880885|NCT01027754|10995401|FG000|NOT COMPLETED|Overall Study||2
9880886|NCT01027754|10995402|FG001|NOT COMPLETED|Overall Study||8
9880887|NCT01027780|10995410|FG000|STARTED|Overall Study||105
9880888|NCT01027780|10995411|FG001|STARTED|Overall Study||103
9880889|NCT01027780|10995410|FG000|COMPLETED|Overall Study||105
9880890|NCT01027780|10995411|FG001|COMPLETED|Overall Study||102
9880891|NCT01027780|10995410|FG000|NOT COMPLETED|Overall Study||0
10007914|NCT01753739|11130177|FG001|STARTED|Overall Study||123
10007915|NCT01753739|11130178|FG002|STARTED|Overall Study||123
10007916|NCT01753739|11130179|FG003|STARTED|Overall Study||124
10007917|NCT01753739|11130180|FG004|STARTED|Overall Study||123
10007918|NCT01753739|11130176|FG000|COMPLETED|Overall Study||120
10007919|NCT01753739|11130177|FG001|COMPLETED|Overall Study||118
10007920|NCT01753739|11130178|FG002|COMPLETED|Overall Study||118
10007921|NCT01753739|11130179|FG003|COMPLETED|Overall Study||117
10007922|NCT01753739|11130180|FG004|COMPLETED|Overall Study||120
10007923|NCT01753739|11130176|FG000|NOT COMPLETED|Overall Study||4
9760402|NCT00380718|10864033|FG000|NOT COMPLETED|Overall Study||18
10108884|NCT02470403|11239393|FG002|Normoglycemic|Overall Study||20
9880892|NCT01027780|10995411|FG001|NOT COMPLETED|Overall Study||1
9880893|NCT01027793|10995420|FG000|STARTED|Overall Study||17
9880894|NCT01027793|10995421|FG001|STARTED|Overall Study||15
9880895|NCT01027793|10995420|FG000|COMPLETED|Overall Study||10
9880896|NCT01027793|10995421|FG001|COMPLETED|Overall Study||12
9880897|NCT01027793|10995420|FG000|NOT COMPLETED|Overall Study||7
9880898|NCT01027793|10995421|FG001|NOT COMPLETED|Overall Study||3
9880899|NCT01027806|10995429|FG000|STARTED|Overall Study||32
10108885|NCT02470403|11239394|FG003|Normoglycemic|Overall Study||23
9880900|NCT01027806|10995430|FG001|STARTED|Overall Study||32
9880901|NCT01027806|10995429|FG000|COMPLETED|Overall Study||28
9880902|NCT01027806|10995430|FG001|COMPLETED|Overall Study||29
9880903|NCT01027806|10995429|FG000|NOT COMPLETED|Overall Study||4
10007924|NCT01753739|11130177|FG001|NOT COMPLETED|Overall Study||5
10007925|NCT01753739|11130178|FG002|NOT COMPLETED|Overall Study||5
10007926|NCT01753739|11130179|FG003|NOT COMPLETED|Overall Study||7
10108886|NCT02470403|11239395|FG004|Normoglycemic|Overall Study||5
9880904|NCT01027806|10995430|FG001|NOT COMPLETED|Overall Study||3
9880905|NCT01027819|10995438|FG000|STARTED|Overall Study||40
9880906|NCT01027819|10995439|FG001|STARTED|Overall Study||40
9880907|NCT01027819|10995438|FG000|COMPLETED|Overall Study||40
9880908|NCT01027819|10995439|FG001|COMPLETED|Overall Study||40
9880909|NCT01027819|10995438|FG000|NOT COMPLETED|Overall Study||0
9880910|NCT01027819|10995439|FG001|NOT COMPLETED|Overall Study||0
9880911|NCT01027845|10995447|FG000|STARTED|Primary Vaccination Phase||237
9880912|NCT01027845|10995448|FG001|STARTED|Primary Vaccination Phase||123
9880913|NCT01027845|10995449|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
9880914|NCT01027845|10995450|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
9880915|NCT01027845|10995447|FG000|COMPLETED|Primary Vaccination Phase||233
9880916|NCT01027845|10995448|FG001|COMPLETED|Primary Vaccination Phase||122
9880917|NCT01027845|10995449|FG002|COMPLETED|Primary Vaccination Phase||0
9880918|NCT01027845|10995450|FG003|COMPLETED|Primary Vaccination Phase||0
9880919|NCT01027845|10995447|FG000|NOT COMPLETED|Primary Vaccination Phase||4
9880920|NCT01027845|10995448|FG001|NOT COMPLETED|Primary Vaccination Phase||1
9880921|NCT01027845|10995449|FG002|NOT COMPLETED|Primary Vaccination Phase||0
9880922|NCT01027845|10995450|FG003|NOT COMPLETED|Primary Vaccination Phase||0
9880923|NCT01027845|10995447|FG000|STARTED|Booster Vaccination Phase||228
9880924|NCT01027845|10995448|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
9880925|NCT01027845|10995449|FG002|STARTED|Booster Vaccination Phase||119
9880926|NCT01027845|10995450|FG003|STARTED|Booster Vaccination Phase||1
9880927|NCT01027845|10995447|FG000|COMPLETED|Booster Vaccination Phase||226
9880928|NCT01027845|10995448|FG001|COMPLETED|Booster Vaccination Phase||0
9880929|NCT01027845|10995449|FG002|COMPLETED|Booster Vaccination Phase||119
9880930|NCT01027845|10995450|FG003|COMPLETED|Booster Vaccination Phase||1
9880931|NCT01027845|10995447|FG000|NOT COMPLETED|Booster Vaccination Phase||2
9880932|NCT01027845|10995448|FG001|NOT COMPLETED|Booster Vaccination Phase||0
9880933|NCT01027845|10995449|FG002|NOT COMPLETED|Booster Vaccination Phase||0
9880934|NCT01027845|10995450|FG003|NOT COMPLETED|Booster Vaccination Phase||0
9880935|NCT01027871|10995462|FG000|STARTED|Overall Study||93
9880936|NCT01027871|10995463|FG001|STARTED|Overall Study||98
9880937|NCT01027871|10995464|FG002|STARTED|Overall Study||98
9880938|NCT01027871|10995462|FG000|Received at Least One Dose of Study Drug|Overall Study||93
9880939|NCT01027871|10995463|FG001|Received at Least One Dose of Study Drug|Overall Study||98
9880940|NCT01027871|10995464|FG002|Received at Least One Dose of Study Drug|Overall Study||97
9880941|NCT01027871|10995462|FG000|COMPLETED|Overall Study||91
9880942|NCT01027871|10995463|FG001|COMPLETED|Overall Study||85
9880943|NCT01027871|10995464|FG002|COMPLETED|Overall Study||91
9880944|NCT01027871|10995462|FG000|NOT COMPLETED|Overall Study||2
9880945|NCT01027871|10995463|FG001|NOT COMPLETED|Overall Study||13
9880946|NCT01027871|10995464|FG002|NOT COMPLETED|Overall Study||7
9880947|NCT01027884|10995479|FG000|STARTED|Overall Study||34
9880948|NCT01027884|10995480|FG001|STARTED|Overall Study||32
9880949|NCT01027884|10995479|FG000|COMPLETED|Overall Study||30
9880950|NCT01027884|10995480|FG001|COMPLETED|Overall Study||25
9880951|NCT01027884|10995479|FG000|NOT COMPLETED|Overall Study||4
9880952|NCT01027884|10995480|FG001|NOT COMPLETED|Overall Study||7
9880953|NCT01027897|10995488|FG000|STARTED|Overall Study||30
9880954|NCT01027897|10995488|FG000|COMPLETED|Overall Study||28
9880955|NCT01027897|10995488|FG000|NOT COMPLETED|Overall Study||2
9880956|NCT01027910|10995494|FG000|STARTED|Overall Study||6
9880957|NCT01027910|10995495|FG001|STARTED|Overall Study||14
9880958|NCT01027910|10995494|FG000|COMPLETED|Overall Study||6
9880959|NCT01027910|10995495|FG001|COMPLETED|Overall Study||14
9880960|NCT01027910|10995494|FG000|NOT COMPLETED|Overall Study||0
9880961|NCT01027910|10995495|FG001|NOT COMPLETED|Overall Study||0
9880962|NCT01027949|10995503|FG000|STARTED|Overall Study||894
9880963|NCT01027949|10995503|FG000|COMPLETED|Overall Study||208
9880964|NCT01027949|10995503|FG000|NOT COMPLETED|Overall Study||686
9880965|NCT01028014|10995513|FG000|STARTED|Overall Study||10
9880966|NCT01028014|10995514|FG001|STARTED|Overall Study||10
9880967|NCT01028014|10995515|FG002|STARTED|Overall Study||10
9880968|NCT01028014|10995516|FG003|STARTED|Overall Study||10
9880969|NCT01028014|10995517|FG004|STARTED|Overall Study||10
9880970|NCT01028014|10995518|FG005|STARTED|Overall Study||6
9880971|NCT01028014|10995513|FG000|COMPLETED|Overall Study||9
9880972|NCT01028014|10995514|FG001|COMPLETED|Overall Study||8
9880973|NCT01028014|10995515|FG002|COMPLETED|Overall Study||10
9880974|NCT01028014|10995516|FG003|COMPLETED|Overall Study||9
9880975|NCT01028014|10995517|FG004|COMPLETED|Overall Study||9
9880976|NCT01028014|10995518|FG005|COMPLETED|Overall Study||4
9880977|NCT01028014|10995513|FG000|NOT COMPLETED|Overall Study||1
9880978|NCT01028014|10995514|FG001|NOT COMPLETED|Overall Study||2
9880979|NCT01028014|10995515|FG002|NOT COMPLETED|Overall Study||0
9880980|NCT01028014|10995516|FG003|NOT COMPLETED|Overall Study||1
9880981|NCT01028014|10995517|FG004|NOT COMPLETED|Overall Study||1
9880982|NCT01028014|10995518|FG005|NOT COMPLETED|Overall Study||2
9880983|NCT01028027|10995534|FG000|STARTED|Overall Study||180
9880984|NCT01028027|10995535|FG001|STARTED|Overall Study||177
9880985|NCT01028027|10995534|FG000|COMPLETED|Overall Study||164
9880986|NCT01028027|10995535|FG001|COMPLETED|Overall Study||164
9880987|NCT01028027|10995534|FG000|NOT COMPLETED|Overall Study||16
9880988|NCT01028027|10995535|FG001|NOT COMPLETED|Overall Study||13
9880989|NCT01028053|10995541|FG000|STARTED|Overall Study||365
9880990|NCT01028053|10995541|FG000|COMPLETED|Overall Study||232
9880991|NCT01028053|10995541|FG000|NOT COMPLETED|Overall Study||133
9880992|NCT01028131|10995551|FG000|STARTED|Overall Study||26
9880993|NCT01028131|10995552|FG001|STARTED|Overall Study||26
9880994|NCT01028131|10995553|FG002|STARTED|Overall Study||28
9880995|NCT01028131|10995554|FG003|STARTED|Overall Study||30
9880996|NCT01028131|10995551|FG000|Completed Intervention/Control Session|Overall Study||26
9880997|NCT01028131|10995552|FG001|Completed Intervention/Control Session|Overall Study||26
9880998|NCT01028131|10995553|FG002|Completed Intervention/Control Session|Overall Study||28
9880999|NCT01028131|10995554|FG003|Completed Intervention/Control Session|Overall Study||30
9881000|NCT01028131|10995551|FG000|COMPLETED|Overall Study||23
9881001|NCT01028131|10995552|FG001|COMPLETED|Overall Study||23
9881002|NCT01028131|10995553|FG002|COMPLETED|Overall Study||22
9881003|NCT01028131|10995554|FG003|COMPLETED|Overall Study||26
9881004|NCT01028131|10995551|FG000|NOT COMPLETED|Overall Study||3
9881005|NCT01028131|10995552|FG001|NOT COMPLETED|Overall Study||3
9881006|NCT01028131|10995553|FG002|NOT COMPLETED|Overall Study||6
9881007|NCT01028131|10995554|FG003|NOT COMPLETED|Overall Study||4
9881008|NCT01028222|10995566|FG000|STARTED|Overall Study||42
9881009|NCT01028222|10995567|FG001|STARTED|Overall Study||13
9881010|NCT01028222|10995566|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0
9881011|NCT01028222|10995567|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10
9881012|NCT01028222|10995566|FG000|COMPLETED|Overall Study||4
9881013|NCT01028222|10995567|FG001|COMPLETED|Overall Study||0
9881014|NCT01028222|10995566|FG000|NOT COMPLETED|Overall Study||38
9881015|NCT01028222|10995567|FG001|NOT COMPLETED|Overall Study||13
9881016|NCT01028352|10995574|FG000|STARTED|Overall Study||35
9881017|NCT01028352|10995574|FG000|COMPLETED|Overall Study||29
9881018|NCT01028352|10995574|FG000|NOT COMPLETED|Overall Study||6
9881019|NCT01028378|10995578|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
9881020|NCT01028378|10995578|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
9881021|NCT01028378|10995578|FG000|NOT COMPLETED|Overall Study||17
9881022|NCT01028391|10995584|FG000|STARTED|Overall Study||164
9881023|NCT01028391|10995585|FG001|STARTED|Overall Study||153
9881024|NCT01028391|10995584|FG000|COMPLETED|Overall Study||150
9881025|NCT01028391|10995585|FG001|COMPLETED|Overall Study||142
9881026|NCT01028391|10995584|FG000|NOT COMPLETED|Overall Study||14
9881027|NCT01028391|10995585|FG001|NOT COMPLETED|Overall Study||11
9881028|NCT01028560|10995593|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
9881029|NCT01028560|10995594|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
9881030|NCT01028560|10995593|FG000|Started Study Protocol|Overall Study||23
9881031|NCT01028560|10995594|FG001|Started Study Protocol|Overall Study||27
9881032|NCT01028560|10995593|FG000|COMPLETED|Overall Study||17
9881033|NCT01028560|10995594|FG001|COMPLETED|Overall Study||13
9881034|NCT01028560|10995593|FG000|NOT COMPLETED|Overall Study||10
10007927|NCT01753739|11130180|FG004|NOT COMPLETED|Overall Study||3
10007928|NCT01753830|11130194|FG000|STARTED|Overall Study||37
10007929|NCT01753830|11130195|FG001|STARTED|Overall Study||38
10007930|NCT01753830|11130194|FG000|COMPLETED|Overall Study||30
10007931|NCT01753830|11130195|FG001|COMPLETED|Overall Study||35
10007932|NCT01753830|11130194|FG000|NOT COMPLETED|Overall Study||7
10007933|NCT01753830|11130195|FG001|NOT COMPLETED|Overall Study||3
10007934|NCT01753856|11130203|FG000|STARTED|Overall Study||33
10007935|NCT01753856|11130204|FG001|STARTED|Overall Study||36
10007936|NCT01753856|11130203|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
10007937|NCT01753856|11130204|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
10007938|NCT01753856|11130203|FG000|Completed 3-Month Bone Biopsy|Overall Study||31
10007939|NCT01753856|11130204|FG001|Completed 3-Month Bone Biopsy|Overall Study||35
10007940|NCT01753856|11130203|FG000|COMPLETED|Overall Study||30
10007941|NCT01753856|11130204|FG001|COMPLETED|Overall Study||34
9881035|NCT01028560|10995594|FG001|NOT COMPLETED|Overall Study||18
9881036|NCT01028651|10995601|FG000|STARTED|Overall Study||13
9881037|NCT01028651|10995601|FG000|COMPLETED|Overall Study||10
9881038|NCT01028651|10995601|FG000|NOT COMPLETED|Overall Study||3
9881039|NCT01028677|10995609|FG000|STARTED|Overall Study||10
9881040|NCT01028677|10995610|FG001|STARTED|Overall Study||7
9881041|NCT01028677|10995609|FG000|COMPLETED|Overall Study||8
9881042|NCT01028677|10995610|FG001|COMPLETED|Overall Study||6
9881043|NCT01028677|10995609|FG000|NOT COMPLETED|Overall Study||2
9881044|NCT01028677|10995610|FG001|NOT COMPLETED|Overall Study||1
9881045|NCT01028820|10995616|FG000|STARTED|Overall Study||13
9881046|NCT01028820|10995616|FG000|COMPLETED|Overall Study||12
9881047|NCT01028820|10995616|FG000|NOT COMPLETED|Overall Study||1
9881048|NCT01028911|10995623|FG000|STARTED|Overall Study||7
9881049|NCT01028911|10995624|FG001|STARTED|Overall Study||2
9881050|NCT01028911|10995623|FG000|COMPLETED|Overall Study||7
9881051|NCT01028911|10995624|FG001|COMPLETED|Overall Study||2
9881052|NCT01028911|10995623|FG000|NOT COMPLETED|Overall Study||0
10007942|NCT01753856|11130203|FG000|NOT COMPLETED|Overall Study||3
10007943|NCT01753856|11130204|FG001|NOT COMPLETED|Overall Study||2
10007944|NCT01753999|11130213|FG000|STARTED|Period 1 - Initial Assignment||155
10007945|NCT01753999|11130214|FG001|STARTED|Period 1 - Initial Assignment||162
9881053|NCT01028911|10995624|FG001|NOT COMPLETED|Overall Study||0
9881054|NCT01028937|10995630|FG000|STARTED|Overall Study||6
9881055|NCT01028937|10995630|FG000|COMPLETED|Overall Study||6
10007946|NCT01753999|11130213|FG000|Received Intervention|Period 1 - Initial Assignment||144
9881056|NCT01028937|10995630|FG000|NOT COMPLETED|Overall Study||0
9881057|NCT01029054|10995634|FG000|STARTED|Phase I||4
9881058|NCT01029054|10995635|FG001|STARTED|Phase I||13
9881059|NCT01029054|10995636|FG002|STARTED|Phase I||18
9881060|NCT01029054|10995634|FG000|COMPLETED|Phase I||4
9881061|NCT01029054|10995635|FG001|COMPLETED|Phase I||13
9881062|NCT01029054|10995636|FG002|COMPLETED|Phase I||18
9881063|NCT01029054|10995634|FG000|NOT COMPLETED|Phase I||0
9881064|NCT01029054|10995635|FG001|NOT COMPLETED|Phase I||0
9881065|NCT01029054|10995636|FG002|NOT COMPLETED|Phase I||0
9881066|NCT01029054|10995634|FG000|STARTED|Phase II||0
9881067|NCT01029054|10995635|FG001|STARTED|Phase II||0
9881068|NCT01029054|10995636|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
9881069|NCT01029054|10995634|FG000|COMPLETED|Phase II||0
9881070|NCT01029054|10995635|FG001|COMPLETED|Phase II||0
9881071|NCT01029054|10995636|FG002|COMPLETED|Phase II||18
9881072|NCT01029054|10995634|FG000|NOT COMPLETED|Phase II||0
9881073|NCT01029054|10995635|FG001|NOT COMPLETED|Phase II||0
9881074|NCT01029054|10995636|FG002|NOT COMPLETED|Phase II||0
9881075|NCT01029262|10995642|FG000|STARTED|Overall Study||79
9881076|NCT01029262|10995643|FG001|STARTED|Overall Study||160
9881077|NCT01029262|10995642|FG000|COMPLETED|Overall Study||0
9881078|NCT01029262|10995643|FG001|COMPLETED|Overall Study||0
9881079|NCT01029262|10995642|FG000|NOT COMPLETED|Overall Study||79
9881080|NCT01029262|10995643|FG001|NOT COMPLETED|Overall Study||160
9881081|NCT01029340|10995659|FG000|STARTED|Part A Treatment Period||14
9881082|NCT01029340|10995660|FG001|STARTED|Part A Treatment Period||14
9881083|NCT01029340|10995661|FG002|STARTED|Part A Treatment Period||0
9881084|NCT01029340|10995662|FG003|STARTED|Part A Treatment Period||0
9881085|NCT01029340|10995663|FG004|STARTED|Part A Treatment Period||0
9881086|NCT01029340|10995664|FG005|STARTED|Part A Treatment Period||0
9881087|NCT01029340|10995659|FG000|Participants Received Treatment|Part A Treatment Period||14
9881088|NCT01029340|10995660|FG001|Participants Received Treatment|Part A Treatment Period||14
9881089|NCT01029340|10995661|FG002|Participants Received Treatment|Part A Treatment Period||0
9881090|NCT01029340|10995662|FG003|Participants Received Treatment|Part A Treatment Period||0
9881091|NCT01029340|10995663|FG004|Participants Received Treatment|Part A Treatment Period||0
9881092|NCT01029340|10995664|FG005|Participants Received Treatment|Part A Treatment Period||0
9881093|NCT01029340|10995659|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
9881094|NCT01029340|10995660|FG001|Safety Population|Part A Treatment Period||14
9881095|NCT01029340|10995661|FG002|Safety Population|Part A Treatment Period||0
9881096|NCT01029340|10995662|FG003|Safety Population|Part A Treatment Period||0
9881097|NCT01029340|10995663|FG004|Safety Population|Part A Treatment Period||0
9881098|NCT01029340|10995664|FG005|Safety Population|Part A Treatment Period||0
9881099|NCT01029340|10995659|FG000|COMPLETED|Part A Treatment Period||14
9881100|NCT01029340|10995660|FG001|COMPLETED|Part A Treatment Period||14
9881101|NCT01029340|10995661|FG002|COMPLETED|Part A Treatment Period||0
9881102|NCT01029340|10995662|FG003|COMPLETED|Part A Treatment Period||0
9881103|NCT01029340|10995663|FG004|COMPLETED|Part A Treatment Period||0
9881104|NCT01029340|10995664|FG005|COMPLETED|Part A Treatment Period||0
9881105|NCT01029340|10995659|FG000|NOT COMPLETED|Part A Treatment Period||0
9881106|NCT01029340|10995660|FG001|NOT COMPLETED|Part A Treatment Period||0
9881107|NCT01029340|10995661|FG002|NOT COMPLETED|Part A Treatment Period||0
9881108|NCT01029340|10995662|FG003|NOT COMPLETED|Part A Treatment Period||0
9881109|NCT01029340|10995663|FG004|NOT COMPLETED|Part A Treatment Period||0
9881110|NCT01029340|10995664|FG005|NOT COMPLETED|Part A Treatment Period||0
9881111|NCT01029340|10995659|FG000|STARTED|Part A Follow up Period||14
9881112|NCT01029340|10995660|FG001|STARTED|Part A Follow up Period||14
9881113|NCT01029340|10995661|FG002|STARTED|Part A Follow up Period||0
9881114|NCT01029340|10995662|FG003|STARTED|Part A Follow up Period||0
9881115|NCT01029340|10995663|FG004|STARTED|Part A Follow up Period||0
9881116|NCT01029340|10995664|FG005|STARTED|Part A Follow up Period||0
9881117|NCT01029340|10995659|FG000|COMPLETED|Part A Follow up Period||14
9881118|NCT01029340|10995660|FG001|COMPLETED|Part A Follow up Period||14
9881119|NCT01029340|10995661|FG002|COMPLETED|Part A Follow up Period||0
9881120|NCT01029340|10995662|FG003|COMPLETED|Part A Follow up Period||0
9881121|NCT01029340|10995663|FG004|COMPLETED|Part A Follow up Period||0
9881122|NCT01029340|10995664|FG005|COMPLETED|Part A Follow up Period||0
9881123|NCT01029340|10995659|FG000|NOT COMPLETED|Part A Follow up Period||0
9881124|NCT01029340|10995660|FG001|NOT COMPLETED|Part A Follow up Period||0
9881125|NCT01029340|10995661|FG002|NOT COMPLETED|Part A Follow up Period||0
9881126|NCT01029340|10995662|FG003|NOT COMPLETED|Part A Follow up Period||0
9881127|NCT01029340|10995663|FG004|NOT COMPLETED|Part A Follow up Period||0
9881128|NCT01029340|10995664|FG005|NOT COMPLETED|Part A Follow up Period||0
9881129|NCT01029340|10995659|FG000|STARTED|Part B Treatment Period||0
9881130|NCT01029340|10995660|FG001|STARTED|Part B Treatment Period||0
9881131|NCT01029340|10995661|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
9881132|NCT01029340|10995662|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
9881133|NCT01029340|10995663|FG004|STARTED|Part B Treatment Period||0
9881134|NCT01029340|10995664|FG005|STARTED|Part B Treatment Period||0
9881135|NCT01029340|10995659|FG000|Participants Received Treatment|Part B Treatment Period||0
9881136|NCT01029340|10995660|FG001|Participants Received Treatment|Part B Treatment Period||0
9881137|NCT01029340|10995661|FG002|Participants Received Treatment|Part B Treatment Period||30
9881138|NCT01029340|10995662|FG003|Participants Received Treatment|Part B Treatment Period||32
9881139|NCT01029340|10995663|FG004|Participants Received Treatment|Part B Treatment Period||0
9881140|NCT01029340|10995664|FG005|Participants Received Treatment|Part B Treatment Period||0
9881141|NCT01029340|10995659|FG000|COMPLETED|Part B Treatment Period||0
9881142|NCT01029340|10995660|FG001|COMPLETED|Part B Treatment Period||0
9881143|NCT01029340|10995661|FG002|COMPLETED|Part B Treatment Period||29
9881144|NCT01029340|10995662|FG003|COMPLETED|Part B Treatment Period||32
9881145|NCT01029340|10995663|FG004|COMPLETED|Part B Treatment Period||0
9881146|NCT01029340|10995664|FG005|COMPLETED|Part B Treatment Period||0
9881147|NCT01029340|10995659|FG000|NOT COMPLETED|Part B Treatment Period||0
9881148|NCT01029340|10995660|FG001|NOT COMPLETED|Part B Treatment Period||0
9881149|NCT01029340|10995661|FG002|NOT COMPLETED|Part B Treatment Period||2
9881150|NCT01029340|10995662|FG003|NOT COMPLETED|Part B Treatment Period||0
9881151|NCT01029340|10995663|FG004|NOT COMPLETED|Part B Treatment Period||0
9881152|NCT01029340|10995664|FG005|NOT COMPLETED|Part B Treatment Period||0
9881153|NCT01029340|10995659|FG000|STARTED|Part B Follow up Period||0
9881154|NCT01029340|10995660|FG001|STARTED|Part B Follow up Period||0
9881155|NCT01029340|10995661|FG002|STARTED|Part B Follow up Period||29
9881156|NCT01029340|10995662|FG003|STARTED|Part B Follow up Period||32
9881157|NCT01029340|10995663|FG004|STARTED|Part B Follow up Period||0
9881158|NCT01029340|10995664|FG005|STARTED|Part B Follow up Period||0
9881159|NCT01029340|10995659|FG000|COMPLETED|Part B Follow up Period||0
9881160|NCT01029340|10995660|FG001|COMPLETED|Part B Follow up Period||0
9881161|NCT01029340|10995661|FG002|COMPLETED|Part B Follow up Period||29
9881162|NCT01029340|10995662|FG003|COMPLETED|Part B Follow up Period||32
9881163|NCT01029340|10995663|FG004|COMPLETED|Part B Follow up Period||0
9881164|NCT01029340|10995664|FG005|COMPLETED|Part B Follow up Period||0
9881165|NCT01029340|10995659|FG000|NOT COMPLETED|Part B Follow up Period||0
9881166|NCT01029340|10995660|FG001|NOT COMPLETED|Part B Follow up Period||0
9881167|NCT01029340|10995661|FG002|NOT COMPLETED|Part B Follow up Period||0
9881168|NCT01029340|10995662|FG003|NOT COMPLETED|Part B Follow up Period||0
9881169|NCT01029340|10995663|FG004|NOT COMPLETED|Part B Follow up Period||0
9881170|NCT01029340|10995664|FG005|NOT COMPLETED|Part B Follow up Period||0
9881171|NCT01029340|10995659|FG000|STARTED|Extension Period||0
9881172|NCT01029340|10995660|FG001|STARTED|Extension Period||0
9881173|NCT01029340|10995661|FG002|STARTED|Extension Period||0
9881174|NCT01029340|10995662|FG003|STARTED|Extension Period||0
9881175|NCT01029340|10995663|FG004|STARTED|Extension Period||0
9881176|NCT01029340|10995664|FG005|STARTED|Extension Period||55
9881177|NCT01029340|10995659|FG000|COMPLETED|Extension Period||0
9881178|NCT01029340|10995660|FG001|COMPLETED|Extension Period||0
9881179|NCT01029340|10995661|FG002|COMPLETED|Extension Period||0
9881180|NCT01029340|10995662|FG003|COMPLETED|Extension Period||0
9881181|NCT01029340|10995663|FG004|COMPLETED|Extension Period||0
9881182|NCT01029340|10995664|FG005|COMPLETED|Extension Period||43
9881183|NCT01029340|10995659|FG000|NOT COMPLETED|Extension Period||0
9881184|NCT01029340|10995660|FG001|NOT COMPLETED|Extension Period||0
9881185|NCT01029340|10995661|FG002|NOT COMPLETED|Extension Period||0
9881186|NCT01029340|10995662|FG003|NOT COMPLETED|Extension Period||0
9881187|NCT01029340|10995663|FG004|NOT COMPLETED|Extension Period||0
10018977|NCT01826851|11142029|FG000|NOT COMPLETED|Overall Study||0
9881188|NCT01029340|10995664|FG005|NOT COMPLETED|Extension Period||12
9881189|NCT01029340|10995659|FG000|STARTED|Part C Treatment Period||0
9881190|NCT01029340|10995660|FG001|STARTED|Part C Treatment Period||0
9881191|NCT01029340|10995661|FG002|STARTED|Part C Treatment Period||0
9881192|NCT01029340|10995662|FG003|STARTED|Part C Treatment Period||0
9881193|NCT01029340|10995663|FG004|STARTED|Part C Treatment Period||5
9881194|NCT01029340|10995664|FG005|STARTED|Part C Treatment Period||0
9881195|NCT01029340|10995659|FG000|Participants Received Treatment|Part C Treatment Period||0
9881196|NCT01029340|10995660|FG001|Participants Received Treatment|Part C Treatment Period||0
9881197|NCT01029340|10995661|FG002|Participants Received Treatment|Part C Treatment Period||0
9881198|NCT01029340|10995662|FG003|Participants Received Treatment|Part C Treatment Period||0
9881199|NCT01029340|10995663|FG004|Participants Received Treatment|Part C Treatment Period||5
9881200|NCT01029340|10995664|FG005|Participants Received Treatment|Part C Treatment Period||0
9881201|NCT01029340|10995659|FG000|COMPLETED|Part C Treatment Period||0
9881202|NCT01029340|10995660|FG001|COMPLETED|Part C Treatment Period||0
9881203|NCT01029340|10995661|FG002|COMPLETED|Part C Treatment Period||0
9881204|NCT01029340|10995662|FG003|COMPLETED|Part C Treatment Period||0
9881205|NCT01029340|10995663|FG004|COMPLETED|Part C Treatment Period||5
9881206|NCT01029340|10995664|FG005|COMPLETED|Part C Treatment Period||0
9881207|NCT01029340|10995659|FG000|NOT COMPLETED|Part C Treatment Period||0
9881208|NCT01029340|10995660|FG001|NOT COMPLETED|Part C Treatment Period||0
9881209|NCT01029340|10995661|FG002|NOT COMPLETED|Part C Treatment Period||0
9881210|NCT01029340|10995662|FG003|NOT COMPLETED|Part C Treatment Period||0
9881211|NCT01029340|10995663|FG004|NOT COMPLETED|Part C Treatment Period||0
9881212|NCT01029340|10995664|FG005|NOT COMPLETED|Part C Treatment Period||0
9881213|NCT01029340|10995659|FG000|STARTED|Part C Follow up Period||0
9881214|NCT01029340|10995660|FG001|STARTED|Part C Follow up Period||0
9881215|NCT01029340|10995661|FG002|STARTED|Part C Follow up Period||0
9881216|NCT01029340|10995662|FG003|STARTED|Part C Follow up Period||0
9881217|NCT01029340|10995663|FG004|STARTED|Part C Follow up Period||5
9881218|NCT01029340|10995664|FG005|STARTED|Part C Follow up Period||0
9881219|NCT01029340|10995659|FG000|COMPLETED|Part C Follow up Period||0
9881220|NCT01029340|10995660|FG001|COMPLETED|Part C Follow up Period||0
9881221|NCT01029340|10995661|FG002|COMPLETED|Part C Follow up Period||0
9881222|NCT01029340|10995662|FG003|COMPLETED|Part C Follow up Period||0
9881223|NCT01029340|10995663|FG004|COMPLETED|Part C Follow up Period||5
9881224|NCT01029340|10995664|FG005|COMPLETED|Part C Follow up Period||0
9881225|NCT01029340|10995659|FG000|NOT COMPLETED|Part C Follow up Period||0
9881226|NCT01029340|10995660|FG001|NOT COMPLETED|Part C Follow up Period||0
9881227|NCT01029340|10995661|FG002|NOT COMPLETED|Part C Follow up Period||0
9881228|NCT01029340|10995662|FG003|NOT COMPLETED|Part C Follow up Period||0
9881229|NCT01029340|10995663|FG004|NOT COMPLETED|Part C Follow up Period||0
9881230|NCT01029340|10995664|FG005|NOT COMPLETED|Part C Follow up Period||0
9881231|NCT01029353|10995681|FG000|STARTED|Overall Study||148
9881232|NCT01029353|10995682|FG001|STARTED|Overall Study||162
9881233|NCT01029353|10995683|FG002|STARTED|Overall Study||100
9881234|NCT01029353|10995684|FG003|STARTED|Overall Study||119
9881235|NCT01029353|10995681|FG000|Included in ITT Analysis|Overall Study||146
9881236|NCT01029353|10995682|FG001|Included in ITT Analysis|Overall Study||162
9881237|NCT01029353|10995683|FG002|Included in ITT Analysis|Overall Study||100
9881238|NCT01029353|10995684|FG003|Included in ITT Analysis|Overall Study||119
9881239|NCT01029353|10995681|FG000|Reached Network Status|Overall Study||146
9881240|NCT01029353|10995682|FG001|Reached Network Status|Overall Study||162
9881241|NCT01029353|10995683|FG002|Reached Network Status|Overall Study||100
9881242|NCT01029353|10995684|FG003|Reached Network Status|Overall Study||119
9881243|NCT01029353|10995681|FG000|COMPLETED|Overall Study||141
9881244|NCT01029353|10995682|FG001|COMPLETED|Overall Study||154
9881245|NCT01029353|10995683|FG002|COMPLETED|Overall Study||93
9881246|NCT01029353|10995684|FG003|COMPLETED|Overall Study||115
9881247|NCT01029353|10995681|FG000|NOT COMPLETED|Overall Study||7
9881248|NCT01029353|10995682|FG001|NOT COMPLETED|Overall Study||8
9881249|NCT01029353|10995683|FG002|NOT COMPLETED|Overall Study||7
9881250|NCT01029353|10995684|FG003|NOT COMPLETED|Overall Study||4
9881251|NCT01029366|10995696|FG000|STARTED|Overall Study||18
9881252|NCT01029366|10995697|FG001|STARTED|Overall Study||8
9881253|NCT01029366|10995696|FG000|COMPLETED|Overall Study||14
9881254|NCT01029366|10995697|FG001|COMPLETED|Overall Study||6
9881255|NCT01029366|10995696|FG000|NOT COMPLETED|Overall Study||4
9881256|NCT01029366|10995697|FG001|NOT COMPLETED|Overall Study||2
9881257|NCT01029392|10995706|FG000|STARTED|Overall Study||37
9881258|NCT01029392|10995707|FG001|STARTED|Overall Study||38
9881259|NCT01029392|10995706|FG000|COMPLETED|Overall Study||17
9881260|NCT01029392|10995707|FG001|COMPLETED|Overall Study||27
9881261|NCT01029392|10995706|FG000|NOT COMPLETED|Overall Study||20
9881262|NCT01029392|10995707|FG001|NOT COMPLETED|Overall Study||11
9881263|NCT01029405|10995719|FG000|STARTED|Overall Study||36
9881264|NCT01029405|10995720|FG001|STARTED|Overall Study||37
9881265|NCT01029405|10995721|FG002|STARTED|Overall Study||35
9881266|NCT01029405|10995722|FG003|STARTED|Overall Study||37
9881267|NCT01029405|10995719|FG000|COMPLETED|Overall Study||34
9881268|NCT01029405|10995720|FG001|COMPLETED|Overall Study||34
9881269|NCT01029405|10995721|FG002|COMPLETED|Overall Study||31
10007947|NCT01753999|11130214|FG001|Received Intervention|Period 1 - Initial Assignment||146
10007948|NCT01753999|11130213|FG000|COMPLETED|Period 1 - Initial Assignment||116
10007949|NCT01753999|11130214|FG001|COMPLETED|Period 1 - Initial Assignment||112
10007950|NCT01753999|11130213|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39
10007951|NCT01753999|11130214|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50
10007952|NCT01753999|11130213|FG000|STARTED|Period 2 -Cross to Alternate Arm||116
10007953|NCT01753999|11130214|FG001|STARTED|Period 2 -Cross to Alternate Arm||112
10007954|NCT01753999|11130213|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103
10007955|NCT01753999|11130214|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95
10007956|NCT01753999|11130213|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99
10007957|NCT01753999|11130214|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89
10007958|NCT01753999|11130213|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
10007959|NCT01753999|11130214|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
10007960|NCT01754129|11130225|FG000|STARTED|Overall Study||148
10007961|NCT01754129|11130225|FG000|Visit 1 (Enrollment Day)|Overall Study||145
9881270|NCT01029405|10995722|FG003|COMPLETED|Overall Study||32
9881271|NCT01029405|10995719|FG000|NOT COMPLETED|Overall Study||2
9881272|NCT01029405|10995720|FG001|NOT COMPLETED|Overall Study||3
9881273|NCT01029405|10995721|FG002|NOT COMPLETED|Overall Study||4
9881274|NCT01029405|10995722|FG003|NOT COMPLETED|Overall Study||5
9881275|NCT01029535|10995732|FG000|STARTED|Overall Study||103
9881276|NCT01029535|10995732|FG000|COMPLETED|Overall Study||72
9881277|NCT01029535|10995732|FG000|NOT COMPLETED|Overall Study||31
9881278|NCT01029587|10995737|FG000|STARTED|Overall Study||1
9881279|NCT01029587|10995737|FG000|COMPLETED|Overall Study||1
9881280|NCT01029587|10995737|FG000|NOT COMPLETED|Overall Study||0
9881281|NCT01029652|10995743|FG000|STARTED|Core Study (0-12 Weeks)||115
9881282|NCT01029652|10995744|FG001|STARTED|Core Study (0-12 Weeks)||115
9881283|NCT01029652|10995743|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
9881284|NCT01029652|10995744|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
9881285|NCT01029652|10995743|FG000|COMPLETED|Core Study (0-12 Weeks)||109
9881286|NCT01029652|10995744|FG001|COMPLETED|Core Study (0-12 Weeks)||105
10007962|NCT01754129|11130225|FG000|Visit 2 (Year 1)|Overall Study||129
9881287|NCT01029652|10995743|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6
9881288|NCT01029652|10995744|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10
9881289|NCT01029652|10995743|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90
9881290|NCT01029652|10995744|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85
10007963|NCT01754129|11130225|FG000|Visit 3 (Year 2)|Overall Study||115
9881291|NCT01029652|10995743|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87
9881292|NCT01029652|10995744|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80
9881293|NCT01029652|10995743|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
9881294|NCT01029652|10995744|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
9881295|NCT01029652|10995743|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69
9881296|NCT01029652|10995744|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66
9881297|NCT01029652|10995743|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
9881298|NCT01029652|10995744|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
9881299|NCT01029652|10995743|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68
9881300|NCT01029652|10995744|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63
9881301|NCT01029652|10995743|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
9881302|NCT01029652|10995744|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
10007964|NCT01754129|11130225|FG000|COMPLETED|Overall Study||115
10007965|NCT01754129|11130225|FG000|NOT COMPLETED|Overall Study||33
10007966|NCT01754194|11130238|FG000|STARTED|Overall Study||169
10007967|NCT01754194|11130239|FG001|STARTED|Overall Study||124
10007968|NCT01754194|11130238|FG000|COMPLETED|Overall Study||117
10007969|NCT01754194|11130239|FG001|COMPLETED|Overall Study||97
9881303|NCT01029691|10995771|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20
9881304|NCT01029691|10995772|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
9881305|NCT01029691|10995773|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77
9881306|NCT01029691|10995771|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
9881307|NCT01029691|10995772|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
9881308|NCT01029691|10995773|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
9881309|NCT01029691|10995771|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
9881310|NCT01029691|10995772|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
9881311|NCT01029691|10995773|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
9881312|NCT01029691|10995771|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20
9881313|NCT01029691|10995772|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16
9881314|NCT01029691|10995773|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77
10007970|NCT01754194|11130238|FG000|NOT COMPLETED|Overall Study||52
10007971|NCT01754194|11130239|FG001|NOT COMPLETED|Overall Study||27
10007972|NCT01754207|11130247|FG000|STARTED|Overall Study||20
10108887|NCT02470403|11239391|FG000|COMPLETED|Overall Study||42
9881315|NCT01029691|10995771|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
9881316|NCT01029691|10995772|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
9881317|NCT01029691|10995773|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
9881318|NCT01029691|10995771|FG000|STARTED|Continued APAP to Delivery||20
9881319|NCT01029691|10995772|FG001|STARTED|Continued APAP to Delivery||16
9881320|NCT01029691|10995773|FG002|STARTED|Continued APAP to Delivery||77
9881321|NCT01029691|10995771|FG000|COMPLETED|Continued APAP to Delivery||20
9881322|NCT01029691|10995772|FG001|COMPLETED|Continued APAP to Delivery||16
9881323|NCT01029691|10995773|FG002|COMPLETED|Continued APAP to Delivery||76
9881324|NCT01029691|10995771|FG000|NOT COMPLETED|Continued APAP to Delivery||0
9881325|NCT01029691|10995772|FG001|NOT COMPLETED|Continued APAP to Delivery||0
9881326|NCT01029691|10995773|FG002|NOT COMPLETED|Continued APAP to Delivery||1
9881327|NCT01029704|10995791|FG000|STARTED|Overall Study||5
9881328|NCT01029704|10995792|FG001|STARTED|Overall Study||5
9881329|NCT01029704|10995793|FG002|STARTED|Overall Study||5
9881330|NCT01029704|10995794|FG003|STARTED|Overall Study||5
9881331|NCT01029704|10995795|FG004|STARTED|Overall Study||28
9881332|NCT01029704|10995796|FG005|STARTED|Overall Study||24
9881333|NCT01029704|10995797|FG006|STARTED|Overall Study||23
9881334|NCT01029704|10995798|FG007|STARTED|Overall Study||28
9881335|NCT01029704|10995799|FG008|STARTED|Overall Study||26
9881336|NCT01029704|10995791|FG000|COMPLETED|Overall Study||5
9881337|NCT01029704|10995792|FG001|COMPLETED|Overall Study||5
9881338|NCT01029704|10995793|FG002|COMPLETED|Overall Study||5
9881339|NCT01029704|10995794|FG003|COMPLETED|Overall Study||5
9881340|NCT01029704|10995795|FG004|COMPLETED|Overall Study||23
9881341|NCT01029704|10995796|FG005|COMPLETED|Overall Study||20
9881342|NCT01029704|10995797|FG006|COMPLETED|Overall Study||19
9881343|NCT01029704|10995798|FG007|COMPLETED|Overall Study||22
9881344|NCT01029704|10995799|FG008|COMPLETED|Overall Study||25
9881345|NCT01029704|10995791|FG000|NOT COMPLETED|Overall Study||0
9881346|NCT01029704|10995792|FG001|NOT COMPLETED|Overall Study||0
9881347|NCT01029704|10995793|FG002|NOT COMPLETED|Overall Study||0
9881348|NCT01029704|10995794|FG003|NOT COMPLETED|Overall Study||0
9881349|NCT01029704|10995795|FG004|NOT COMPLETED|Overall Study||5
9881350|NCT01029704|10995796|FG005|NOT COMPLETED|Overall Study||4
9881351|NCT01029704|10995797|FG006|NOT COMPLETED|Overall Study||4
10007973|NCT01754207|11130247|FG000|COMPLETED|Overall Study||17
10007974|NCT01754207|11130247|FG000|NOT COMPLETED|Overall Study||3
10108888|NCT02470403|11239392|FG001|COMPLETED|Overall Study||43
10108889|NCT02470403|11239393|FG002|COMPLETED|Overall Study||40
10108890|NCT02470403|11239394|FG003|COMPLETED|Overall Study||39
10108891|NCT02470403|11239395|FG004|COMPLETED|Overall Study||10
10108892|NCT02470403|11239391|FG000|NOT COMPLETED|Overall Study||2
10108893|NCT02470403|11239392|FG001|NOT COMPLETED|Overall Study||1
10108894|NCT02470403|11239393|FG002|NOT COMPLETED|Overall Study||0
10108895|NCT02470403|11239394|FG003|NOT COMPLETED|Overall Study||4
10108896|NCT02470403|11239395|FG004|NOT COMPLETED|Overall Study||0
10108897|NCT02470429|11239412|FG000|STARTED|Overall Study||50
10108898|NCT02470429|11239413|FG001|STARTED|Overall Study||49
10108899|NCT02470429|11239412|FG000|COMPLETED|Overall Study||48
10108900|NCT02470429|11239413|FG001|COMPLETED|Overall Study||49
10108901|NCT02470429|11239412|FG000|NOT COMPLETED|Overall Study||2
10007975|NCT01754259|11130253|FG000|STARTED|Overall Study||23
10007976|NCT01754259|11130254|FG001|STARTED|Overall Study||24
10007977|NCT01754259|11130253|FG000|COMPLETED|Overall Study||18
10007978|NCT01754259|11130254|FG001|COMPLETED|Overall Study||18
10007979|NCT01754259|11130253|FG000|NOT COMPLETED|Overall Study||5
10007980|NCT01754259|11130254|FG001|NOT COMPLETED|Overall Study||6
10007981|NCT01754350|11130262|FG000|STARTED|Overall Study||25
10007982|NCT01754350|11130263|FG001|STARTED|Overall Study||25
10007983|NCT01754350|11130262|FG000|COMPLETED|Overall Study||20
10007984|NCT01754350|11130263|FG001|COMPLETED|Overall Study||22
10108902|NCT02470429|11239413|FG001|NOT COMPLETED|Overall Study||0
10108903|NCT02470494|11239420|FG000|STARTED|Overall Study||46
9881352|NCT01029704|10995798|FG007|NOT COMPLETED|Overall Study||6
9881353|NCT01029704|10995799|FG008|NOT COMPLETED|Overall Study||1
9881354|NCT01029730|10995819|FG000|STARTED|Combination Therapy||55
9881355|NCT01029730|10995819|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
9881356|NCT01029730|10995819|FG000|NOT COMPLETED|Combination Therapy||16
9881357|NCT01029730|10995819|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
9881358|NCT01029730|10995819|FG000|COMPLETED|Maintenance Therapy||14
9881359|NCT01029730|10995819|FG000|NOT COMPLETED|Maintenance Therapy||23
9881360|NCT01029782|10995825|FG000|STARTED|Overall Study||102
9881361|NCT01029782|10995826|FG001|STARTED|Overall Study||104
9881362|NCT01029782|10995825|FG000|COMPLETED|Overall Study||99
9881363|NCT01029782|10995826|FG001|COMPLETED|Overall Study||96
9881364|NCT01029782|10995825|FG000|NOT COMPLETED|Overall Study||3
9881365|NCT01029782|10995826|FG001|NOT COMPLETED|Overall Study||8
9881366|NCT01029795|10995834|FG000|STARTED|Overall Study||16
9881367|NCT01029795|10995835|FG001|STARTED|Overall Study||22
9881368|NCT01029795|10995834|FG000|COMPLETED|Overall Study||0
9881369|NCT01029795|10995835|FG001|COMPLETED|Overall Study||0
9881370|NCT01029795|10995834|FG000|NOT COMPLETED|Overall Study||16
9881371|NCT01029795|10995835|FG001|NOT COMPLETED|Overall Study||22
9881372|NCT01029886|10995843|FG000|STARTED|Overall Study||461
9881373|NCT01029886|10995844|FG001|STARTED|Overall Study||451
9881374|NCT01029886|10995843|FG000|Intent to Treat (ITT)|Overall Study||461
9881375|NCT01029886|10995844|FG001|Intent to Treat (ITT)|Overall Study||450
9881376|NCT01029886|10995843|FG000|COMPLETED|Overall Study||400
9881377|NCT01029886|10995844|FG001|COMPLETED|Overall Study||391
9881378|NCT01029886|10995843|FG000|NOT COMPLETED|Overall Study||61
9881379|NCT01029886|10995844|FG001|NOT COMPLETED|Overall Study||60
9881380|NCT01029912|10995856|FG000|STARTED|Overall Study||14
9881381|NCT01029912|10995857|FG001|STARTED|Overall Study||12
9881382|NCT01029912|10995856|FG000|COMPLETED|Overall Study||12
9881383|NCT01029912|10995857|FG001|COMPLETED|Overall Study||12
9881384|NCT01029912|10995856|FG000|NOT COMPLETED|Overall Study||2
9881385|NCT01029912|10995857|FG001|NOT COMPLETED|Overall Study||0
9881386|NCT01029925|10995863|FG000|STARTED|Completion of Cycle 1 (28 Days)||7
9881387|NCT01029925|10995863|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3
10007985|NCT01754350|11130262|FG000|NOT COMPLETED|Overall Study||5
10007986|NCT01754350|11130263|FG001|NOT COMPLETED|Overall Study||3
10007987|NCT01754376|11130269|FG000|STARTED|Overall Study||6
10007988|NCT01754376|11130269|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6
10007989|NCT01754376|11130269|FG000|COMPLETED|Overall Study||3
10007990|NCT01754376|11130269|FG000|NOT COMPLETED|Overall Study||3
9881388|NCT01029925|10995863|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
9881389|NCT01029925|10995863|FG000|STARTED|Completion of Cycle 2 (56 Days)||3
9881390|NCT01029925|10995863|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2
9881391|NCT01029925|10995863|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
9881392|NCT01030133|10995869|FG000|STARTED|Overall Study||14
9881393|NCT01030133|10995870|FG001|STARTED|Overall Study||14
9881394|NCT01030133|10995869|FG000|COMPLETED|Overall Study||12
9881395|NCT01030133|10995870|FG001|COMPLETED|Overall Study||12
9881396|NCT01030133|10995869|FG000|NOT COMPLETED|Overall Study||2
9881397|NCT01030133|10995870|FG001|NOT COMPLETED|Overall Study||2
9881398|NCT01030289|10995880|FG000|STARTED|Overall Study||9
9881399|NCT01030289|10995881|FG001|STARTED|Overall Study||10
9881400|NCT01030289|10995880|FG000|COMPLETED|Overall Study||9
9881401|NCT01030289|10995881|FG001|COMPLETED|Overall Study||10
9881402|NCT01030289|10995880|FG000|NOT COMPLETED|Overall Study||0
9881403|NCT01030289|10995881|FG001|NOT COMPLETED|Overall Study||0
10007991|NCT01754389|11130277|FG000|STARTED|Overall Study||46
10007992|NCT01754389|11130278|FG001|STARTED|Overall Study||45
10007993|NCT01754389|11130279|FG002|STARTED|Overall Study||47
10007994|NCT01754389|11130277|FG000|COMPLETED|Overall Study||46
10007995|NCT01754389|11130278|FG001|COMPLETED|Overall Study||45
10007996|NCT01754389|11130279|FG002|COMPLETED|Overall Study||47
10007997|NCT01754389|11130277|FG000|NOT COMPLETED|Overall Study||0
10007998|NCT01754389|11130278|FG001|NOT COMPLETED|Overall Study||0
10007999|NCT01754389|11130279|FG002|NOT COMPLETED|Overall Study||0
10008000|NCT01754402|11130290|FG000|STARTED|Overall Study||6
10108904|NCT02470494|11239420|FG000|COMPLETED|Overall Study||41
10108905|NCT02470494|11239420|FG000|NOT COMPLETED|Overall Study||5
10108906|NCT02470741|11239426|FG000|STARTED|Overall Study||6
9881404|NCT01030406|10995893|FG000|STARTED|Overall Study||10
9881405|NCT01030406|10995894|FG001|STARTED|Overall Study||10
9881406|NCT01030406|10995895|FG002|STARTED|Overall Study||10
9881407|NCT01030406|10995896|FG003|STARTED|Overall Study||10
9881408|NCT01030406|10995897|FG004|STARTED|Overall Study||9
9881409|NCT01030406|10995893|FG000|COMPLETED|Overall Study||10
9881410|NCT01030406|10995894|FG001|COMPLETED|Overall Study||10
9881411|NCT01030406|10995895|FG002|COMPLETED|Overall Study||9
9881412|NCT01030406|10995896|FG003|COMPLETED|Overall Study||9
9881413|NCT01030406|10995897|FG004|COMPLETED|Overall Study||9
9881414|NCT01030406|10995893|FG000|NOT COMPLETED|Overall Study||0
9881415|NCT01030406|10995894|FG001|NOT COMPLETED|Overall Study||0
9881416|NCT01030406|10995895|FG002|NOT COMPLETED|Overall Study||1
9881417|NCT01030406|10995896|FG003|NOT COMPLETED|Overall Study||1
9881418|NCT01030406|10995897|FG004|NOT COMPLETED|Overall Study||0
9881419|NCT01030458|10995911|FG000|STARTED|Overall Study||94
9881420|NCT01030458|10995912|FG001|STARTED|Overall Study||89
9881421|NCT01030458|10995911|FG000|COMPLETED|Overall Study||67
9881422|NCT01030458|10995912|FG001|COMPLETED|Overall Study||57
9881423|NCT01030458|10995911|FG000|NOT COMPLETED|Overall Study||27
9881424|NCT01030458|10995912|FG001|NOT COMPLETED|Overall Study||32
9881425|NCT01030523|10995920|FG000|STARTED|Overall Study||50
9881426|NCT01030523|10995921|FG001|STARTED|Overall Study||51
9881427|NCT01030523|10995920|FG000|COMPLETED|Overall Study||44
9881428|NCT01030523|10995921|FG001|COMPLETED|Overall Study||46
9881429|NCT01030523|10995920|FG000|NOT COMPLETED|Overall Study||6
9881430|NCT01030523|10995921|FG001|NOT COMPLETED|Overall Study||5
9881431|NCT01030536|10995932|FG000|STARTED|Overall Study||7
9881432|NCT01030536|10995933|FG001|STARTED|Overall Study||6
9881433|NCT01030536|10995934|FG002|STARTED|Overall Study||6
9881434|NCT01030536|10995935|FG003|STARTED|Overall Study||3
9881435|NCT01030536|10995936|FG004|STARTED|Overall Study||1
9881436|NCT01030536|10995932|FG000|COMPLETED|Overall Study||0
9881437|NCT01030536|10995933|FG001|COMPLETED|Overall Study||0
9881438|NCT01030536|10995934|FG002|COMPLETED|Overall Study||0
9881439|NCT01030536|10995935|FG003|COMPLETED|Overall Study||0
9881440|NCT01030536|10995936|FG004|COMPLETED|Overall Study||0
9881441|NCT01030536|10995932|FG000|NOT COMPLETED|Overall Study||7
9881442|NCT01030536|10995933|FG001|NOT COMPLETED|Overall Study||6
9881443|NCT01030536|10995934|FG002|NOT COMPLETED|Overall Study||6
9881444|NCT01030536|10995935|FG003|NOT COMPLETED|Overall Study||3
9881445|NCT01030536|10995936|FG004|NOT COMPLETED|Overall Study||1
9881446|NCT01030653|10995954|FG000|STARTED|Loading Dose & First Maintenance Regimen||4
9881447|NCT01030653|10995955|FG001|STARTED|Loading Dose & First Maintenance Regimen||4
9881448|NCT01030653|10995954|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4
9881449|NCT01030653|10995955|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4
9881450|NCT01030653|10995954|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
9881451|NCT01030653|10995955|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
9881452|NCT01030653|10995954|FG000|STARTED|7-Day Washout Period||4
9881453|NCT01030653|10995955|FG001|STARTED|7-Day Washout Period||4
9881454|NCT01030653|10995954|FG000|COMPLETED|7-Day Washout Period||4
9881455|NCT01030653|10995955|FG001|COMPLETED|7-Day Washout Period||4
9881456|NCT01030653|10995954|FG000|NOT COMPLETED|7-Day Washout Period||0
9881457|NCT01030653|10995955|FG001|NOT COMPLETED|7-Day Washout Period||0
9881458|NCT01030653|10995954|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4
9881459|NCT01030653|10995955|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4
9881460|NCT01030653|10995954|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
9881461|NCT01030653|10995955|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
9881462|NCT01030653|10995954|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
9881463|NCT01030653|10995955|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
9881464|NCT01030666|10995964|FG000|STARTED|Overall Study||28
9881465|NCT01030666|10995965|FG001|STARTED|Overall Study||33
9881466|NCT01030666|10995964|FG000|COMPLETED|Overall Study||25
9881467|NCT01030666|10995965|FG001|COMPLETED|Overall Study||31
9881468|NCT01030666|10995964|FG000|NOT COMPLETED|Overall Study||3
9881469|NCT01030666|10995965|FG001|NOT COMPLETED|Overall Study||2
9881470|NCT01030718|10995975|FG000|STARTED|Studies CA180-031 and -036 Combined||30
9881471|NCT01030718|10995976|FG001|STARTED|Studies CA180-031 and -036 Combined||11
9881472|NCT01030718|10995977|FG002|STARTED|Studies CA180-031 and -036 Combined||13
9881473|NCT01030718|10995975|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26
9881474|NCT01030718|10995976|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2
9881475|NCT01030718|10995977|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1
9881476|NCT01030718|10995975|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
9881477|NCT01030718|10995976|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
9881478|NCT01030718|10995977|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
9881479|NCT01030718|10995975|FG000|STARTED|Study CA180-036 Only||29
9881480|NCT01030718|10995976|FG001|STARTED|Study CA180-036 Only||9
9881481|NCT01030718|10995977|FG002|STARTED|Study CA180-036 Only||6
9881482|NCT01030718|10995975|FG000|COMPLETED|Study CA180-036 Only||26
9881483|NCT01030718|10995976|FG001|COMPLETED|Study CA180-036 Only||2
9881484|NCT01030718|10995977|FG002|COMPLETED|Study CA180-036 Only||1
9881485|NCT01030718|10995975|FG000|NOT COMPLETED|Study CA180-036 Only||3
9881486|NCT01030718|10995976|FG001|NOT COMPLETED|Study CA180-036 Only||7
9881487|NCT01030718|10995977|FG002|NOT COMPLETED|Study CA180-036 Only||5
9881488|NCT01030783|10995997|FG000|STARTED|Overall Study||260
9881489|NCT01030783|10995998|FG001|STARTED|Overall Study||257
9881490|NCT01030783|10995997|FG000|COMPLETED|Overall Study||211
9881491|NCT01030783|10995998|FG001|COMPLETED|Overall Study||231
9881492|NCT01030783|10995997|FG000|NOT COMPLETED|Overall Study||49
9881493|NCT01030783|10995998|FG001|NOT COMPLETED|Overall Study||26
9881494|NCT01030822|10996007|FG000|STARTED|Overall Study||100
9881495|NCT01030822|10996008|FG001|STARTED|Overall Study||95
9881496|NCT01030822|10996009|FG002|STARTED|Overall Study||87
9881497|NCT01030822|10996007|FG000|COMPLETED|Overall Study||69
9881498|NCT01030822|10996008|FG001|COMPLETED|Overall Study||71
9881499|NCT01030822|10996009|FG002|COMPLETED|Overall Study||61
9881500|NCT01030822|10996007|FG000|NOT COMPLETED|Overall Study||31
9881501|NCT01030822|10996008|FG001|NOT COMPLETED|Overall Study||24
9881502|NCT01030822|10996009|FG002|NOT COMPLETED|Overall Study||26
9881503|NCT01030861|10996020|FG000|STARTED|Overall Study||44
9881504|NCT01030861|10996021|FG001|STARTED|Overall Study||32
9881505|NCT01030861|10996020|FG000|COMPLETED|Overall Study||44
9881506|NCT01030861|10996021|FG001|COMPLETED|Overall Study||32
9881507|NCT01030861|10996020|FG000|NOT COMPLETED|Overall Study||0
9881508|NCT01030861|10996021|FG001|NOT COMPLETED|Overall Study||0
9954132|NCT01430403|11072845|FG000|COMPLETED|Overall Study||242
9954133|NCT01430403|11072846|FG001|COMPLETED|Overall Study||121
9954134|NCT01430403|11072847|FG002|COMPLETED|Overall Study||81
9954135|NCT01430403|11072845|FG000|NOT COMPLETED|Overall Study||17
9954136|NCT01430403|11072846|FG001|NOT COMPLETED|Overall Study||9
9954137|NCT01430403|11072847|FG002|NOT COMPLETED|Overall Study||8
9954138|NCT01430442|11072868|FG000|STARTED|Overall Study||85
9954139|NCT01430442|11072869|FG001|STARTED|Overall Study||68
9954140|NCT01430442|11072870|FG002|STARTED|Overall Study||91
9954141|NCT01430442|11072871|FG003|STARTED|Overall Study||90
9954142|NCT01430442|11072872|FG004|STARTED|Overall Study||121
9954143|NCT01430442|11072873|FG005|STARTED|Overall Study||92
9954144|NCT01430442|11072874|FG006|STARTED|Overall Study||229
9954145|NCT01430442|11072875|FG007|STARTED|Overall Study||109
9954146|NCT01430442|11072868|FG000|COMPLETED|Overall Study||72
9954147|NCT01430442|11072869|FG001|COMPLETED|Overall Study||62
9954148|NCT01430442|11072870|FG002|COMPLETED|Overall Study||86
9954149|NCT01430442|11072871|FG003|COMPLETED|Overall Study||86
9954150|NCT01430442|11072872|FG004|COMPLETED|Overall Study||112
9954151|NCT01430442|11072873|FG005|COMPLETED|Overall Study||84
9954152|NCT01430442|11072874|FG006|COMPLETED|Overall Study||210
9954153|NCT01430442|11072875|FG007|COMPLETED|Overall Study||100
9954154|NCT01430442|11072868|FG000|NOT COMPLETED|Overall Study||13
9954155|NCT01430442|11072869|FG001|NOT COMPLETED|Overall Study||6
9954156|NCT01430442|11072870|FG002|NOT COMPLETED|Overall Study||5
9954157|NCT01430442|11072871|FG003|NOT COMPLETED|Overall Study||4
9954158|NCT01430442|11072872|FG004|NOT COMPLETED|Overall Study||9
9954159|NCT01430442|11072873|FG005|NOT COMPLETED|Overall Study||8
9954160|NCT01430442|11072874|FG006|NOT COMPLETED|Overall Study||19
9954161|NCT01430442|11072875|FG007|NOT COMPLETED|Overall Study||9
9954162|NCT01430455|11072893|FG000|STARTED|Overall Study||7
9954163|NCT01430455|11072893|FG000|COMPLETED|Overall Study||5
9954164|NCT01430455|11072893|FG000|NOT COMPLETED|Overall Study||2
9954165|NCT01430468|11072899|FG000|STARTED|Overall Study||22
9954166|NCT01430468|11072900|FG001|STARTED|Overall Study||22
9954167|NCT01430468|11072899|FG000|COMPLETED|Overall Study||15
9954168|NCT01430468|11072900|FG001|COMPLETED|Overall Study||16
9954169|NCT01430468|11072899|FG000|NOT COMPLETED|Overall Study||7
9954170|NCT01430468|11072900|FG001|NOT COMPLETED|Overall Study||6
9954171|NCT01430559|11072908|FG000|STARTED|Overall Study||146
9954172|NCT01430559|11072909|FG001|STARTED|Overall Study||147
9954173|NCT01430559|11072908|FG000|Treated|Overall Study||143
9954174|NCT01430559|11072909|FG001|Treated|Overall Study||144
9954175|NCT01430559|11072908|FG000|COMPLETED|Overall Study||126
9954176|NCT01430559|11072909|FG001|COMPLETED|Overall Study||135
9954177|NCT01430559|11072908|FG000|NOT COMPLETED|Overall Study||20
9954178|NCT01430559|11072909|FG001|NOT COMPLETED|Overall Study||12
9954179|NCT01430585|11072920|FG000|STARTED|Overall Study||14
9954180|NCT01430585|11072920|FG000|COMPLETED|Overall Study||0
9954181|NCT01430585|11072920|FG000|NOT COMPLETED|Overall Study||14
9954182|NCT01430611|11072932|FG000|STARTED|Overall Study||332
9954183|NCT01430611|11072933|FG001|STARTED|Overall Study||333
9954184|NCT01430611|11072932|FG000|COMPLETED|Overall Study||315
9954185|NCT01430611|11072933|FG001|COMPLETED|Overall Study||318
9954186|NCT01430611|11072932|FG000|NOT COMPLETED|Overall Study||17
9954187|NCT01430611|11072933|FG001|NOT COMPLETED|Overall Study||15
9954188|NCT01430624|11072942|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82
9954189|NCT01430624|11072943|FG001|STARTED|Overall Study||82
9954190|NCT01430624|11072944|FG002|STARTED|Overall Study||81
9954191|NCT01430624|11072942|FG000|Eligible Baseline Completes|Overall Study||77
9954192|NCT01430624|11072943|FG001|Eligible Baseline Completes|Overall Study||77
9954193|NCT01430624|11072944|FG002|Eligible Baseline Completes|Overall Study||79
9954194|NCT01430624|11072942|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54
9954195|NCT01430624|11072943|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48
9954196|NCT01430624|11072944|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52
9954197|NCT01430624|11072942|FG000|NOT COMPLETED|Overall Study||28
9954198|NCT01430624|11072943|FG001|NOT COMPLETED|Overall Study||34
9954199|NCT01430624|11072944|FG002|NOT COMPLETED|Overall Study||29
9954200|NCT01430741|11072960|FG000|STARTED|Overall Study||22
9954201|NCT01430741|11072961|FG001|STARTED|Overall Study||87
9954202|NCT01430741|11072962|FG002|STARTED|Overall Study||47
9954203|NCT01430741|11072963|FG003|STARTED|Overall Study||81
9881509|NCT01030874|10996029|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178
9881510|NCT01030874|10996030|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178
9881511|NCT01030874|10996029|FG000|COMPLETED|Overall Study||160
9881512|NCT01030874|10996030|FG001|COMPLETED|Overall Study||162
9881513|NCT01030874|10996029|FG000|NOT COMPLETED|Overall Study||18
9881514|NCT01030874|10996030|FG001|NOT COMPLETED|Overall Study||16
9881515|NCT01030952|10996038|FG000|STARTED|Overall Study||51
9881516|NCT01030952|10996039|FG001|STARTED|Overall Study||52
9881517|NCT01030952|10996038|FG000|COMPLETED|Overall Study||49
9881518|NCT01030952|10996039|FG001|COMPLETED|Overall Study||49
9881519|NCT01030952|10996038|FG000|NOT COMPLETED|Overall Study||2
9881520|NCT01030952|10996039|FG001|NOT COMPLETED|Overall Study||3
9881521|NCT01030965|10996051|FG000|STARTED|Overall Study||71
9881522|NCT01030965|10996052|FG001|STARTED|Overall Study||71
9881523|NCT01030965|10996053|FG002|STARTED|Overall Study||72
9881524|NCT01030965|10996054|FG003|STARTED|Overall Study||71
9881525|NCT01030965|10996051|FG000|COMPLETED|Overall Study||67
9881526|NCT01030965|10996052|FG001|COMPLETED|Overall Study||65
9881527|NCT01030965|10996053|FG002|COMPLETED|Overall Study||68
10008001|NCT01754402|11130291|FG001|STARTED|Overall Study||2
10008002|NCT01754402|11130292|FG002|STARTED|Overall Study||30
10008003|NCT01754402|11130290|FG000|COMPLETED|Overall Study||4
10008004|NCT01754402|11130291|FG001|COMPLETED|Overall Study||0
10008005|NCT01754402|11130292|FG002|COMPLETED|Overall Study||26
10008006|NCT01754402|11130290|FG000|NOT COMPLETED|Overall Study||2
10008007|NCT01754402|11130291|FG001|NOT COMPLETED|Overall Study||2
10008008|NCT01754402|11130292|FG002|NOT COMPLETED|Overall Study||4
10008009|NCT01754467|11130301|FG000|STARTED|Overall Study||9
10008010|NCT01754467|11130301|FG000|COMPLETED|Overall Study||8
10008011|NCT01754467|11130301|FG000|NOT COMPLETED|Overall Study||1
10008012|NCT01754480|11130307|FG000|STARTED|Part I + Part II (Overall Study)||163
9881528|NCT01030965|10996054|FG003|COMPLETED|Overall Study||64
9881529|NCT01030965|10996051|FG000|NOT COMPLETED|Overall Study||4
9881530|NCT01030965|10996052|FG001|NOT COMPLETED|Overall Study||6
9881531|NCT01030965|10996053|FG002|NOT COMPLETED|Overall Study||4
9881532|NCT01030965|10996054|FG003|NOT COMPLETED|Overall Study||7
9881533|NCT01031004|10996066|FG000|STARTED|Overall Study||25
9881534|NCT01031004|10996067|FG001|STARTED|Overall Study||25
9881535|NCT01031004|10996066|FG000|COMPLETED|Overall Study||24
9881536|NCT01031004|10996067|FG001|COMPLETED|Overall Study||24
9881537|NCT01031004|10996066|FG000|NOT COMPLETED|Overall Study||1
9881538|NCT01031004|10996067|FG001|NOT COMPLETED|Overall Study||1
10008013|NCT01754480|11130308|FG001|STARTED|Part I + Part II (Overall Study)||162
10008014|NCT01754480|11130307|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
10108907|NCT02470741|11239427|FG001|STARTED|Overall Study||6
9881539|NCT01031043|10996073|FG000|STARTED|Overall Study||5
9881540|NCT01031043|10996073|FG000|COMPLETED|Overall Study||4
9881541|NCT01031043|10996073|FG000|NOT COMPLETED|Overall Study||1
9881542|NCT01031069|10996081|FG000|STARTED|Overall Study||129
9881543|NCT01031069|10996082|FG001|STARTED|Overall Study||128
9881544|NCT01031069|10996083|FG002|STARTED|Overall Study||144
9881545|NCT01031069|10996084|FG003|STARTED|Overall Study||145
9881546|NCT01031069|10996081|FG000|COMPLETED|Overall Study||117
9881547|NCT01031069|10996082|FG001|COMPLETED|Overall Study||117
9881548|NCT01031069|10996083|FG002|COMPLETED|Overall Study||103
9881549|NCT01031069|10996084|FG003|COMPLETED|Overall Study||111
9881550|NCT01031069|10996081|FG000|NOT COMPLETED|Overall Study||12
9881551|NCT01031069|10996082|FG001|NOT COMPLETED|Overall Study||11
9881552|NCT01031069|10996083|FG002|NOT COMPLETED|Overall Study||41
9881553|NCT01031069|10996084|FG003|NOT COMPLETED|Overall Study||34
9881554|NCT01031095|10996098|FG000|STARTED|Overall Study||100
9881555|NCT01031095|10996099|FG001|STARTED|Overall Study||100
9881556|NCT01031095|10996098|FG000|COMPLETED|Overall Study||100
9881557|NCT01031095|10996099|FG001|COMPLETED|Overall Study||100
9881558|NCT01031095|10996098|FG000|NOT COMPLETED|Overall Study||0
9881559|NCT01031095|10996099|FG001|NOT COMPLETED|Overall Study||0
9881560|NCT01031134|10996107|FG000|STARTED|Overall Study||114
9881561|NCT01031134|10996108|FG001|STARTED|Overall Study||88
9881562|NCT01031134|10996107|FG000|COMPLETED|Overall Study||103
9881563|NCT01031134|10996108|FG001|COMPLETED|Overall Study||78
9881564|NCT01031134|10996107|FG000|NOT COMPLETED|Overall Study||11
9881565|NCT01031134|10996108|FG001|NOT COMPLETED|Overall Study||10
9881566|NCT01031381|10996114|FG000|STARTED|Overall Study||59
9881567|NCT01031381|10996114|FG000|COMPLETED|Overall Study||50
9881568|NCT01031381|10996114|FG000|NOT COMPLETED|Overall Study||9
9881569|NCT01031420|10996119|FG000|STARTED|Overall Study||54
9881570|NCT01031420|10996119|FG000|COMPLETED|Overall Study||44
9881571|NCT01031420|10996119|FG000|NOT COMPLETED|Overall Study||10
9881572|NCT01031446|10996123|FG000|STARTED|Overall Study||55
9881573|NCT01031446|10996123|FG000|COMPLETED|Overall Study||0
9881574|NCT01031446|10996123|FG000|NOT COMPLETED|Overall Study||55
9881575|NCT01031498|10996132|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
9881576|NCT01031498|10996133|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
9881577|NCT01031498|10996134|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
9881578|NCT01031498|10996132|FG000|COMPLETED|Overall Study||47
10008015|NCT01754480|11130308|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
10008016|NCT01754480|11130307|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
9881579|NCT01031498|10996133|FG001|COMPLETED|Overall Study||48
9881580|NCT01031498|10996134|FG002|COMPLETED|Overall Study||48
9881581|NCT01031498|10996132|FG000|NOT COMPLETED|Overall Study||2
9881582|NCT01031498|10996133|FG001|NOT COMPLETED|Overall Study||3
9881583|NCT01031498|10996134|FG002|NOT COMPLETED|Overall Study||2
9881584|NCT01031537|10996142|FG000|STARTED|Overall Study||66
9881585|NCT01031537|10996142|FG000|COMPLETED|Overall Study||34
9881586|NCT01031537|10996142|FG000|NOT COMPLETED|Overall Study||32
9881587|NCT01031680|10996148|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
9881588|NCT01031680|10996149|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
9881589|NCT01031680|10996148|FG000|COMPLETED|Overall Study||403
9881590|NCT01031680|10996149|FG001|COMPLETED|Overall Study||404
9881591|NCT01031680|10996148|FG000|NOT COMPLETED|Overall Study||57
9881592|NCT01031680|10996149|FG001|NOT COMPLETED|Overall Study||58
9881593|NCT01031706|10996157|FG000|STARTED|Overall Study||14
9881594|NCT01031706|10996158|FG001|STARTED|Overall Study||9
9881595|NCT01031706|10996157|FG000|COMPLETED|Overall Study||12
9881596|NCT01031706|10996158|FG001|COMPLETED|Overall Study||8
9881597|NCT01031706|10996157|FG000|NOT COMPLETED|Overall Study||2
9881598|NCT01031706|10996158|FG001|NOT COMPLETED|Overall Study||1
9881599|NCT01031810|10996164|FG000|STARTED|Overall Study||13
9881600|NCT01031810|10996164|FG000|COMPLETED|Overall Study||9
9881601|NCT01031810|10996164|FG000|NOT COMPLETED|Overall Study||4
9881602|NCT01031836|10996176|FG000|STARTED|Stage I||5
9881603|NCT01031836|10996177|FG001|STARTED|Stage I||5
9881604|NCT01031836|10996178|FG002|STARTED|Stage I||5
9881605|NCT01031836|10996179|FG003|STARTED|Stage I||5
9881606|NCT01031836|10996180|FG004|STARTED|Stage I||5
9881607|NCT01031836|10996181|FG005|STARTED|Stage I||5
9881608|NCT01031836|10996176|FG000|COMPLETED|Stage I||4
9881609|NCT01031836|10996177|FG001|COMPLETED|Stage I||3
9881610|NCT01031836|10996178|FG002|COMPLETED|Stage I||5
10008017|NCT01754480|11130308|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
10008018|NCT01754480|11130307|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25
10008019|NCT01754480|11130308|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23
9881611|NCT01031836|10996179|FG003|COMPLETED|Stage I||5
9881612|NCT01031836|10996180|FG004|COMPLETED|Stage I||5
9881613|NCT01031836|10996181|FG005|COMPLETED|Stage I||4
9881614|NCT01031836|10996176|FG000|NOT COMPLETED|Stage I||1
9881615|NCT01031836|10996177|FG001|NOT COMPLETED|Stage I||2
9881616|NCT01031836|10996178|FG002|NOT COMPLETED|Stage I||0
9881617|NCT01031836|10996179|FG003|NOT COMPLETED|Stage I||0
9881618|NCT01031836|10996180|FG004|NOT COMPLETED|Stage I||0
9881619|NCT01031836|10996181|FG005|NOT COMPLETED|Stage I||1
9881620|NCT01031836|10996176|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
9881621|NCT01031836|10996177|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
9881622|NCT01031836|10996178|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
9881623|NCT01031836|10996179|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
9881624|NCT01031836|10996180|FG004|STARTED|Stage II||5
9881625|NCT01031836|10996181|FG005|STARTED|Stage II||4
9881626|NCT01031836|10996176|FG000|COMPLETED|Stage II||1
9881627|NCT01031836|10996177|FG001|COMPLETED|Stage II||1
9881628|NCT01031836|10996178|FG002|COMPLETED|Stage II||2
9881629|NCT01031836|10996179|FG003|COMPLETED|Stage II||1
9881630|NCT01031836|10996180|FG004|COMPLETED|Stage II||3
9881631|NCT01031836|10996181|FG005|COMPLETED|Stage II||3
9881632|NCT01031836|10996176|FG000|NOT COMPLETED|Stage II||2
9881633|NCT01031836|10996177|FG001|NOT COMPLETED|Stage II||0
9881634|NCT01031836|10996178|FG002|NOT COMPLETED|Stage II||2
9881635|NCT01031836|10996179|FG003|NOT COMPLETED|Stage II||3
9881636|NCT01031836|10996180|FG004|NOT COMPLETED|Stage II||2
9881637|NCT01031836|10996181|FG005|NOT COMPLETED|Stage II||1
9881638|NCT01031914|10996195|FG000|STARTED|Overall Study||36
9881639|NCT01031914|10996195|FG000|COMPLETED|Overall Study||36
9881640|NCT01031914|10996195|FG000|NOT COMPLETED|Overall Study||0
9881641|NCT01031953|10996199|FG000|STARTED|Overall Study||11
9881642|NCT01031953|10996199|FG000|COMPLETED|Overall Study||11
9881643|NCT01031953|10996199|FG000|NOT COMPLETED|Overall Study||0
9881644|NCT01031979|10996211|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
9881645|NCT01031979|10996212|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
9881646|NCT01031979|10996211|FG000|Completed Primary Outcome Measure|Overall Study||12
9881647|NCT01031979|10996212|FG001|Completed Primary Outcome Measure|Overall Study||12
9881648|NCT01031979|10996211|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
9881649|NCT01031979|10996212|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
9881650|NCT01031979|10996211|FG000|NOT COMPLETED|Overall Study||5
9881651|NCT01031979|10996212|FG001|NOT COMPLETED|Overall Study||4
9881652|NCT01032018|10996220|FG000|STARTED|Overall Study||77
9881653|NCT01032018|10996221|FG001|STARTED|Overall Study||73
9881654|NCT01032018|10996220|FG000|COMPLETED|Overall Study||71
9881655|NCT01032018|10996221|FG001|COMPLETED|Overall Study||67
9881656|NCT01032018|10996220|FG000|NOT COMPLETED|Overall Study||6
9881657|NCT01032018|10996221|FG001|NOT COMPLETED|Overall Study||6
9881658|NCT01032044|10996229|FG000|STARTED|Overall Study||82
9881659|NCT01032044|10996230|FG001|STARTED|Overall Study||82
9881660|NCT01032044|10996229|FG000|Procedure|Overall Study||74
9881661|NCT01032044|10996230|FG001|Procedure|Overall Study||75
9881662|NCT01032044|10996229|FG000|COMPLETED|Overall Study||57
9881663|NCT01032044|10996230|FG001|COMPLETED|Overall Study||62
9881664|NCT01032044|10996229|FG000|NOT COMPLETED|Overall Study||25
9881665|NCT01032044|10996230|FG001|NOT COMPLETED|Overall Study||20
9881666|NCT01032070|10996238|FG000|STARTED|Overall Study||13
9881667|NCT01032070|10996239|FG001|STARTED|Overall Study||12
9881668|NCT01032070|10996238|FG000|COMPLETED|Overall Study||0
9881669|NCT01032070|10996239|FG001|COMPLETED|Overall Study||0
9881670|NCT01032070|10996238|FG000|NOT COMPLETED|Overall Study||13
9881671|NCT01032070|10996239|FG001|NOT COMPLETED|Overall Study||12
9881672|NCT01032135|10996250|FG000|STARTED|2 Week Randomization||311
9881673|NCT01032135|10996251|FG001|STARTED|2 Week Randomization||93
9881674|NCT01032135|10996252|FG002|STARTED|2 Week Randomization||96
9881675|NCT01032135|10996253|FG003|STARTED|2 Week Randomization||0
9881676|NCT01032135|10996254|FG004|STARTED|2 Week Randomization||0
9881677|NCT01032135|10996255|FG005|STARTED|2 Week Randomization||0
9881678|NCT01032135|10996256|FG006|STARTED|2 Week Randomization||0
9881679|NCT01032135|10996250|FG000|COMPLETED|2 Week Randomization||311
9881680|NCT01032135|10996251|FG001|COMPLETED|2 Week Randomization||93
9881681|NCT01032135|10996252|FG002|COMPLETED|2 Week Randomization||96
9881682|NCT01032135|10996253|FG003|COMPLETED|2 Week Randomization||0
9881683|NCT01032135|10996254|FG004|COMPLETED|2 Week Randomization||0
9881684|NCT01032135|10996255|FG005|COMPLETED|2 Week Randomization||0
9881685|NCT01032135|10996256|FG006|COMPLETED|2 Week Randomization||0
9881686|NCT01032135|10996250|FG000|NOT COMPLETED|2 Week Randomization||0
10008020|NCT01754480|11130307|FG000|STARTED|Primary Part II||111
10008021|NCT01754480|11130308|FG001|STARTED|Primary Part II||113
10008022|NCT01754480|11130307|FG000|Completed Study up to Week 6|Primary Part II||100
10008023|NCT01754480|11130308|FG001|Completed Study up to Week 6|Primary Part II||108
10018978|NCT01826851|11142030|FG001|NOT COMPLETED|Overall Study||0
9881687|NCT01032135|10996251|FG001|NOT COMPLETED|2 Week Randomization||0
9881688|NCT01032135|10996252|FG002|NOT COMPLETED|2 Week Randomization||0
9881689|NCT01032135|10996253|FG003|NOT COMPLETED|2 Week Randomization||0
9881690|NCT01032135|10996254|FG004|NOT COMPLETED|2 Week Randomization||0
9881691|NCT01032135|10996255|FG005|NOT COMPLETED|2 Week Randomization||0
9881692|NCT01032135|10996256|FG006|NOT COMPLETED|2 Week Randomization||0
9881693|NCT01032135|10996250|FG000|STARTED|8 Week Randomization||227
9881694|NCT01032135|10996251|FG001|STARTED|8 Week Randomization||0
9881695|NCT01032135|10996252|FG002|STARTED|8 Week Randomization||0
9881696|NCT01032135|10996253|FG003|STARTED|8 Week Randomization||41
9881697|NCT01032135|10996254|FG004|STARTED|8 Week Randomization||43
9881698|NCT01032135|10996255|FG005|STARTED|8 Week Randomization||48
9881699|NCT01032135|10996256|FG006|STARTED|8 Week Randomization||54
9881700|NCT01032135|10996250|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
9881701|NCT01032135|10996251|FG001|12 Week Follow up|8 Week Randomization||0
9881702|NCT01032135|10996252|FG002|12 Week Follow up|8 Week Randomization||0
9881703|NCT01032135|10996253|FG003|12 Week Follow up|8 Week Randomization||34
9881704|NCT01032135|10996254|FG004|12 Week Follow up|8 Week Randomization||38
9881705|NCT01032135|10996255|FG005|12 Week Follow up|8 Week Randomization||36
9881706|NCT01032135|10996256|FG006|12 Week Follow up|8 Week Randomization||41
9881707|NCT01032135|10996250|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
9881708|NCT01032135|10996251|FG001|COMPLETED|8 Week Randomization||0
9881709|NCT01032135|10996252|FG002|COMPLETED|8 Week Randomization||0
9881710|NCT01032135|10996253|FG003|COMPLETED|8 Week Randomization||30
9881711|NCT01032135|10996254|FG004|COMPLETED|8 Week Randomization||34
9881712|NCT01032135|10996255|FG005|COMPLETED|8 Week Randomization||31
9881713|NCT01032135|10996256|FG006|COMPLETED|8 Week Randomization||36
9881714|NCT01032135|10996250|FG000|NOT COMPLETED|8 Week Randomization||26
9881715|NCT01032135|10996251|FG001|NOT COMPLETED|8 Week Randomization||0
9881716|NCT01032135|10996252|FG002|NOT COMPLETED|8 Week Randomization||0
9881717|NCT01032135|10996253|FG003|NOT COMPLETED|8 Week Randomization||11
9881718|NCT01032135|10996254|FG004|NOT COMPLETED|8 Week Randomization||9
9881719|NCT01032135|10996255|FG005|NOT COMPLETED|8 Week Randomization||17
9881720|NCT01032135|10996256|FG006|NOT COMPLETED|8 Week Randomization||18
9881721|NCT01032174|10996272|FG000|STARTED|Overall Study||63
9881722|NCT01032174|10996273|FG001|STARTED|Overall Study||60
9881723|NCT01032174|10996272|FG000|COMPLETED|Overall Study||63
9881724|NCT01032174|10996273|FG001|COMPLETED|Overall Study||59
9881725|NCT01032174|10996272|FG000|NOT COMPLETED|Overall Study||0
9881726|NCT01032174|10996273|FG001|NOT COMPLETED|Overall Study||1
9881727|NCT01032200|10996281|FG000|STARTED|Overall Study||26
9881728|NCT01032200|10996282|FG001|STARTED|Overall Study||28
9881729|NCT01032200|10996281|FG000|COMPLETED|Overall Study||22
9881730|NCT01032200|10996282|FG001|COMPLETED|Overall Study||21
9881731|NCT01032200|10996281|FG000|NOT COMPLETED|Overall Study||4
9881732|NCT01032200|10996282|FG001|NOT COMPLETED|Overall Study||7
9881733|NCT01032239|10996290|FG000|STARTED|Overall Study|randomized to ITB arm|31
9881734|NCT01032239|10996291|FG001|STARTED|Overall Study|randomized to BMT arm|29
9881735|NCT01032239|10996290|FG000|Implant|Overall Study|implanted|25
9881736|NCT01032239|10996291|FG001|Implant|Overall Study||0
9881737|NCT01032239|10996290|FG000|COMPLETED|Overall Study||24
9881738|NCT01032239|10996291|FG001|COMPLETED|Overall Study||24
9881739|NCT01032239|10996290|FG000|NOT COMPLETED|Overall Study||7
9881740|NCT01032239|10996291|FG001|NOT COMPLETED|Overall Study||5
9881741|NCT01032291|10996300|FG000|STARTED|Safety Lead-in||8
9881742|NCT01032291|10996301|FG001|STARTED|Safety Lead-in||0
9881743|NCT01032291|10996302|FG002|STARTED|Safety Lead-in||0
9881744|NCT01032291|10996300|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6
9881745|NCT01032291|10996301|FG001|COMPLETED|Safety Lead-in||0
9881746|NCT01032291|10996302|FG002|COMPLETED|Safety Lead-in||0
9881747|NCT01032291|10996300|FG000|NOT COMPLETED|Safety Lead-in||2
9881748|NCT01032291|10996301|FG001|NOT COMPLETED|Safety Lead-in||0
9881749|NCT01032291|10996302|FG002|NOT COMPLETED|Safety Lead-in||0
9881750|NCT01032291|10996300|FG000|STARTED|Proof of Concept||0
9881751|NCT01032291|10996301|FG001|STARTED|Proof of Concept||22
9881752|NCT01032291|10996302|FG002|STARTED|Proof of Concept||21
9881753|NCT01032291|10996300|FG000|Intent to Treat and Safety Populations|Proof of Concept||0
9881754|NCT01032291|10996301|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
9881755|NCT01032291|10996302|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
9881756|NCT01032291|10996300|FG000|COMPLETED|Proof of Concept||0
9881757|NCT01032291|10996301|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14
9881758|NCT01032291|10996302|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18
9881759|NCT01032291|10996300|FG000|NOT COMPLETED|Proof of Concept||0
9881760|NCT01032291|10996301|FG001|NOT COMPLETED|Proof of Concept||8
9881761|NCT01032291|10996302|FG002|NOT COMPLETED|Proof of Concept||3
9881762|NCT01032330|10996317|FG000|STARTED|Overall Study||183
9881763|NCT01032330|10996318|FG001|STARTED|Overall Study||175
9881764|NCT01032330|10996319|FG002|STARTED|Overall Study||97
9881765|NCT01032330|10996320|FG003|STARTED|Overall Study||104
9881766|NCT01032330|10996317|FG000|COMPLETED|Overall Study||165
9881767|NCT01032330|10996318|FG001|COMPLETED|Overall Study||151
9881768|NCT01032330|10996319|FG002|COMPLETED|Overall Study||87
9881769|NCT01032330|10996320|FG003|COMPLETED|Overall Study||90
9881770|NCT01032330|10996317|FG000|NOT COMPLETED|Overall Study||18
9881771|NCT01032330|10996318|FG001|NOT COMPLETED|Overall Study||24
9881772|NCT01032330|10996319|FG002|NOT COMPLETED|Overall Study||10
9881773|NCT01032330|10996320|FG003|NOT COMPLETED|Overall Study||14
9881774|NCT01032382|10996340|FG000|STARTED|Overall Study||16
9881775|NCT01032382|10996341|FG001|STARTED|Overall Study||14
10108908|NCT02470741|11239426|FG000|COMPLETED|Overall Study||3
10108909|NCT02470741|11239427|FG001|COMPLETED|Overall Study||4
10108910|NCT02470741|11239426|FG000|NOT COMPLETED|Overall Study||3
10108911|NCT02470741|11239427|FG001|NOT COMPLETED|Overall Study||2
10108912|NCT02470754|11239433|FG000|STARTED|Overall Study||19
10108913|NCT02470754|11239434|FG001|STARTED|Overall Study||19
10108914|NCT02470754|11239433|FG000|COMPLETED|Overall Study||17
10108915|NCT02470754|11239434|FG001|COMPLETED|Overall Study||19
10108916|NCT02470754|11239433|FG000|NOT COMPLETED|Overall Study||2
10108917|NCT02470754|11239434|FG001|NOT COMPLETED|Overall Study||0
10108918|NCT02470806|11239442|FG000|STARTED|Overall Study||80
9881776|NCT01032382|10996340|FG000|COMPLETED|Overall Study||11
9881777|NCT01032382|10996341|FG001|COMPLETED|Overall Study||9
9881778|NCT01032382|10996340|FG000|NOT COMPLETED|Overall Study||5
9881779|NCT01032382|10996341|FG001|NOT COMPLETED|Overall Study||5
9881780|NCT01032538|10996347|FG000|STARTED|Overall Study|Knees|99
9881781|NCT01032538|10996347|FG000|COMPLETED|Overall Study|Knees|99
9881782|NCT01032538|10996347|FG000|NOT COMPLETED|Overall Study||0
9881783|NCT01032629|10996356|FG000|STARTED|Overall Study||1442
9881784|NCT01032629|10996357|FG001|STARTED|Overall Study||1445
9881785|NCT01032629|10996358|FG002|STARTED|Overall Study||1443
9881786|NCT01032629|10996356|FG000|Treated|Overall Study||1441
9881787|NCT01032629|10996357|FG001|Treated|Overall Study||1445
9881788|NCT01032629|10996358|FG002|Treated|Overall Study||1441
9881789|NCT01032629|10996356|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
9881790|NCT01032629|10996357|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
9881791|NCT01032629|10996358|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
9881792|NCT01032629|10996356|FG000|NOT COMPLETED|Overall Study||145
9881793|NCT01032629|10996357|FG001|NOT COMPLETED|Overall Study||101
9881794|NCT01032629|10996358|FG002|NOT COMPLETED|Overall Study||88
9881795|NCT01032694|10996369|FG000|STARTED|Overall Study||20
9881796|NCT01032694|10996370|FG001|STARTED|Overall Study||10
9881797|NCT01032694|10996369|FG000|COMPLETED|Overall Study||20
9881798|NCT01032694|10996370|FG001|COMPLETED|Overall Study||10
9881799|NCT01032694|10996369|FG000|NOT COMPLETED|Overall Study||0
9881800|NCT01032694|10996370|FG001|NOT COMPLETED|Overall Study||0
9881801|NCT01032733|10996378|FG000|STARTED|Overall Study||17
9881802|NCT01032733|10996379|FG001|STARTED|Overall Study||17
9881803|NCT01032733|10996378|FG000|COMPLETED|Overall Study||16
9881804|NCT01032733|10996379|FG001|COMPLETED|Overall Study||16
9881805|NCT01032733|10996378|FG000|NOT COMPLETED|Overall Study||1
9881806|NCT01032733|10996379|FG001|NOT COMPLETED|Overall Study||1
9881807|NCT01032759|10996388|FG000|STARTED|Overall Study||32
9881808|NCT01032759|10996389|FG001|STARTED|Overall Study||31
9881809|NCT01032759|10996388|FG000|Completed 24 Hour Assessment|Overall Study||32
9881810|NCT01032759|10996389|FG001|Completed 24 Hour Assessment|Overall Study||30
10108919|NCT02470806|11239443|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
9881811|NCT01032759|10996388|FG000|Completed 48 Hour Assessment|Overall Study||31
9881812|NCT01032759|10996389|FG001|Completed 48 Hour Assessment|Overall Study||28
9881813|NCT01032759|10996388|FG000|COMPLETED|Overall Study||31
9881814|NCT01032759|10996389|FG001|COMPLETED|Overall Study||28
9881815|NCT01032759|10996388|FG000|NOT COMPLETED|Overall Study||1
9881816|NCT01032759|10996389|FG001|NOT COMPLETED|Overall Study||3
9881817|NCT01032837|10996399|FG000|STARTED|Overall Study||26
9881818|NCT01032837|10996400|FG001|STARTED|Overall Study||26
9881819|NCT01032837|10996401|FG002|STARTED|Overall Study||25
9881820|NCT01032837|10996402|FG003|STARTED|Overall Study||25
9881821|NCT01032837|10996399|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
9881822|NCT01032837|10996400|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
9881823|NCT01032837|10996401|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
9881824|NCT01032837|10996402|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
9881825|NCT01032837|10996399|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26
9881826|NCT01032837|10996400|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23
9881827|NCT01032837|10996401|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24
9881828|NCT01032837|10996402|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22
9881829|NCT01032837|10996399|FG000|NOT COMPLETED|Overall Study||0
9881830|NCT01032837|10996400|FG001|NOT COMPLETED|Overall Study||3
9881831|NCT01032837|10996401|FG002|NOT COMPLETED|Overall Study||1
9881832|NCT01032837|10996402|FG003|NOT COMPLETED|Overall Study||3
9881833|NCT01032850|10996412|FG000|STARTED|Overall Study||15
9881834|NCT01032850|10996412|FG000|COMPLETED|Overall Study||13
9881835|NCT01032850|10996412|FG000|NOT COMPLETED|Overall Study||2
9881836|NCT01032889|10996419|FG000|STARTED|Overall Study||41
9881837|NCT01032889|10996420|FG001|STARTED|Overall Study||43
9881838|NCT01032889|10996421|FG002|STARTED|Overall Study||45
9881839|NCT01032889|10996419|FG000|Received Treatment|Overall Study||41
9881840|NCT01032889|10996420|FG001|Received Treatment|Overall Study||43
9881841|NCT01032889|10996421|FG002|Received Treatment|Overall Study||45
9881842|NCT01032889|10996419|FG000|COMPLETED|Overall Study||33
9881843|NCT01032889|10996420|FG001|COMPLETED|Overall Study||28
9881844|NCT01032889|10996421|FG002|COMPLETED|Overall Study||42
9881845|NCT01032889|10996419|FG000|NOT COMPLETED|Overall Study||8
9881846|NCT01032889|10996420|FG001|NOT COMPLETED|Overall Study||15
9881847|NCT01032889|10996421|FG002|NOT COMPLETED|Overall Study||3
9881848|NCT01032915|10996433|FG000|STARTED|Overall Study||29
9881849|NCT01032915|10996434|FG001|STARTED|Overall Study||31
9881850|NCT01032915|10996435|FG002|STARTED|Overall Study||31
9881851|NCT01032915|10996436|FG003|STARTED|Overall Study||34
9881852|NCT01032915|10996433|FG000|COMPLETED|Overall Study||21
9881853|NCT01032915|10996434|FG001|COMPLETED|Overall Study||20
9881854|NCT01032915|10996435|FG002|COMPLETED|Overall Study||24
9881855|NCT01032915|10996436|FG003|COMPLETED|Overall Study||27
9881856|NCT01032915|10996433|FG000|NOT COMPLETED|Overall Study||8
9881857|NCT01032915|10996434|FG001|NOT COMPLETED|Overall Study||11
9881858|NCT01032915|10996435|FG002|NOT COMPLETED|Overall Study||7
9881859|NCT01032915|10996436|FG003|NOT COMPLETED|Overall Study||7
9881860|NCT01032928|10996446|FG000|STARTED|Overall Study||30
9881861|NCT01032928|10996446|FG000|COMPLETED|Overall Study||30
9881862|NCT01032928|10996446|FG000|NOT COMPLETED|Overall Study||0
9881863|NCT01032954|10996457|FG000|STARTED|Overall Study||30
9881864|NCT01032954|10996458|FG001|STARTED|Overall Study||30
9881865|NCT01032954|10996459|FG002|STARTED|Overall Study||30
9881866|NCT01032954|10996457|FG000|COMPLETED|Overall Study||26
10108920|NCT02470806|11239442|FG000|COMPLETED|Overall Study||62
10108921|NCT02470806|11239443|FG001|COMPLETED|Overall Study||42
10108922|NCT02470806|11239442|FG000|NOT COMPLETED|Overall Study||18
10108923|NCT02470806|11239443|FG001|NOT COMPLETED|Overall Study||42
9881867|NCT01032954|10996458|FG001|COMPLETED|Overall Study||29
9881868|NCT01032954|10996459|FG002|COMPLETED|Overall Study||30
9881869|NCT01032954|10996457|FG000|NOT COMPLETED|Overall Study||4
9881870|NCT01032954|10996458|FG001|NOT COMPLETED|Overall Study||1
9881871|NCT01032954|10996459|FG002|NOT COMPLETED|Overall Study||0
9881872|NCT01032993|10996469|FG000|STARTED|Overall Study||19
9881873|NCT01032993|10996470|FG001|STARTED|Overall Study||20
9881874|NCT01032993|10996469|FG000|COMPLETED|Overall Study||19
9881875|NCT01032993|10996470|FG001|COMPLETED|Overall Study||20
9881876|NCT01032993|10996469|FG000|NOT COMPLETED|Overall Study||0
9881877|NCT01032993|10996470|FG001|NOT COMPLETED|Overall Study||0
9881878|NCT01033019|10996478|FG000|STARTED|Overall Study||16
9881879|NCT01033019|10996479|FG001|STARTED|Overall Study||8
9881880|NCT01033019|10996478|FG000|COMPLETED|Overall Study||15
9881881|NCT01033019|10996479|FG001|COMPLETED|Overall Study||8
9881882|NCT01033019|10996478|FG000|NOT COMPLETED|Overall Study||1
9881883|NCT01033019|10996479|FG001|NOT COMPLETED|Overall Study||0
9881884|NCT01033071|10996489|FG000|STARTED|Overall Study||355
9881885|NCT01033071|10996490|FG001|STARTED|Overall Study||352
9881886|NCT01033071|10996491|FG002|STARTED|Overall Study||364
9881887|NCT01033071|10996489|FG000|COMPLETED|Overall Study||300
9881888|NCT01033071|10996490|FG001|COMPLETED|Overall Study||275
9881889|NCT01033071|10996491|FG002|COMPLETED|Overall Study||317
9881890|NCT01033071|10996489|FG000|NOT COMPLETED|Overall Study||55
9881891|NCT01033071|10996490|FG001|NOT COMPLETED|Overall Study||77
10108924|NCT02470910|11239449|FG000|STARTED|Overall Study||15
10108925|NCT02470910|11239449|FG000|COMPLETED|Overall Study||15
9881892|NCT01033071|10996491|FG002|NOT COMPLETED|Overall Study||47
9881893|NCT01033136|10996501|FG000|STARTED|Baseline Assessment||36
9881894|NCT01033136|10996502|FG001|STARTED|Baseline Assessment||32
9881895|NCT01033136|10996501|FG000|COMPLETED|Baseline Assessment||30
9881896|NCT01033136|10996502|FG001|COMPLETED|Baseline Assessment||26
9881897|NCT01033136|10996501|FG000|NOT COMPLETED|Baseline Assessment||6
9881898|NCT01033136|10996502|FG001|NOT COMPLETED|Baseline Assessment||6
9881899|NCT01033136|10996501|FG000|STARTED|Post-Treatment (1 Week)||30
9881900|NCT01033136|10996502|FG001|STARTED|Post-Treatment (1 Week)||26
9881901|NCT01033136|10996501|FG000|COMPLETED|Post-Treatment (1 Week)||16
9881902|NCT01033136|10996502|FG001|COMPLETED|Post-Treatment (1 Week)||15
9881903|NCT01033136|10996501|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14
9881904|NCT01033136|10996502|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11
9881905|NCT01033136|10996501|FG000|STARTED|Follow-Up (3 Month)||16
9881906|NCT01033136|10996502|FG001|STARTED|Follow-Up (3 Month)||15
9881907|NCT01033136|10996501|FG000|COMPLETED|Follow-Up (3 Month)||14
9881908|NCT01033136|10996502|FG001|COMPLETED|Follow-Up (3 Month)||13
9881909|NCT01033136|10996501|FG000|NOT COMPLETED|Follow-Up (3 Month)||2
9881910|NCT01033136|10996502|FG001|NOT COMPLETED|Follow-Up (3 Month)||2
9881911|NCT01033227|10996512|FG000|STARTED|Overall Study||3
9881912|NCT01033227|10996513|FG001|STARTED|Overall Study||2
9881913|NCT01033227|10996512|FG000|COMPLETED|Overall Study||3
9881914|NCT01033227|10996513|FG001|COMPLETED|Overall Study||2
9881915|NCT01033227|10996512|FG000|NOT COMPLETED|Overall Study||0
9881916|NCT01033227|10996513|FG001|NOT COMPLETED|Overall Study||0
9881917|NCT01033240|10996524|FG000|STARTED|Overall Study||55
9881918|NCT01033240|10996525|FG001|STARTED|Overall Study||53
10108926|NCT02470910|11239449|FG000|NOT COMPLETED|Overall Study||0
10108927|NCT02470949|11239456|FG000|STARTED|First Intervention||4
10108928|NCT02470949|11239457|FG001|STARTED|First Intervention||5
9881919|NCT01033240|10996526|FG002|STARTED|Overall Study||55
9881920|NCT01033240|10996524|FG000|COMPLETED|Overall Study||6
9881921|NCT01033240|10996525|FG001|COMPLETED|Overall Study||3
9881922|NCT01033240|10996526|FG002|COMPLETED|Overall Study||2
9881923|NCT01033240|10996524|FG000|NOT COMPLETED|Overall Study||49
9881924|NCT01033240|10996525|FG001|NOT COMPLETED|Overall Study||50
9881925|NCT01033240|10996526|FG002|NOT COMPLETED|Overall Study||53
9881926|NCT01033383|10996538|FG000|STARTED|Overall Study||20
9881927|NCT01033383|10996539|FG001|STARTED|Overall Study||20
9881928|NCT01033383|10996540|FG002|STARTED|Overall Study||20
9881929|NCT01033383|10996541|FG003|STARTED|Overall Study||20
9881930|NCT01033383|10996538|FG000|COMPLETED|Overall Study||20
9881931|NCT01033383|10996539|FG001|COMPLETED|Overall Study||20
9881932|NCT01033383|10996540|FG002|COMPLETED|Overall Study||20
9881933|NCT01033383|10996541|FG003|COMPLETED|Overall Study||20
9881934|NCT01033383|10996538|FG000|NOT COMPLETED|Overall Study||0
10108929|NCT02470949|11239456|FG000|COMPLETED|First Intervention||4
10108930|NCT02470949|11239457|FG001|COMPLETED|First Intervention||5
9881935|NCT01033383|10996539|FG001|NOT COMPLETED|Overall Study||0
9881936|NCT01033383|10996540|FG002|NOT COMPLETED|Overall Study||0
9881937|NCT01033383|10996541|FG003|NOT COMPLETED|Overall Study||0
9881938|NCT01033422|10996554|FG000|STARTED|Overall Study||34
9881939|NCT01033422|10996555|FG001|STARTED|Overall Study||32
9881940|NCT01033422|10996556|FG002|STARTED|Overall Study||23
9881941|NCT01033422|10996554|FG000|COMPLETED|Overall Study||33
9881942|NCT01033422|10996555|FG001|COMPLETED|Overall Study||28
9881943|NCT01033422|10996556|FG002|COMPLETED|Overall Study||22
9881944|NCT01033422|10996554|FG000|NOT COMPLETED|Overall Study||1
9881945|NCT01033422|10996555|FG001|NOT COMPLETED|Overall Study||4
9881946|NCT01033422|10996556|FG002|NOT COMPLETED|Overall Study||1
9881947|NCT01033448|10996564|FG000|STARTED|Overall Study||59
9881948|NCT01033448|10996564|FG000|COMPLETED|Overall Study||47
9881949|NCT01033448|10996564|FG000|NOT COMPLETED|Overall Study||12
9881950|NCT01033487|10996570|FG000|STARTED|First Intervention Period||2
9881951|NCT01033487|10996571|FG001|STARTED|First Intervention Period||3
9881952|NCT01033487|10996572|FG002|STARTED|First Intervention Period||2
9881953|NCT01033487|10996573|FG003|STARTED|First Intervention Period||2
9881954|NCT01033487|10996574|FG004|STARTED|First Intervention Period||2
9881955|NCT01033487|10996575|FG005|STARTED|First Intervention Period||2
9881956|NCT01033487|10996576|FG006|STARTED|First Intervention Period||2
9881957|NCT01033487|10996577|FG007|STARTED|First Intervention Period||3
9881958|NCT01033487|10996578|FG008|STARTED|First Intervention Period||2
9881959|NCT01033487|10996579|FG009|STARTED|First Intervention Period||2
9881960|NCT01033487|10996570|FG000|COMPLETED|First Intervention Period||2
9881961|NCT01033487|10996571|FG001|COMPLETED|First Intervention Period||3
9881962|NCT01033487|10996572|FG002|COMPLETED|First Intervention Period||2
9881963|NCT01033487|10996573|FG003|COMPLETED|First Intervention Period||2
9881964|NCT01033487|10996574|FG004|COMPLETED|First Intervention Period||2
9881965|NCT01033487|10996575|FG005|COMPLETED|First Intervention Period||2
9881966|NCT01033487|10996576|FG006|COMPLETED|First Intervention Period||2
9881967|NCT01033487|10996577|FG007|COMPLETED|First Intervention Period||3
10108931|NCT02470949|11239456|FG000|NOT COMPLETED|First Intervention||0
10108932|NCT02470949|11239457|FG001|NOT COMPLETED|First Intervention||0
10108933|NCT02470949|11239456|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4
9881968|NCT01033487|10996578|FG008|COMPLETED|First Intervention Period||2
9881969|NCT01033487|10996579|FG009|COMPLETED|First Intervention Period||2
9881970|NCT01033487|10996570|FG000|NOT COMPLETED|First Intervention Period||0
9881971|NCT01033487|10996571|FG001|NOT COMPLETED|First Intervention Period||0
9881972|NCT01033487|10996572|FG002|NOT COMPLETED|First Intervention Period||0
9881973|NCT01033487|10996573|FG003|NOT COMPLETED|First Intervention Period||0
9881974|NCT01033487|10996574|FG004|NOT COMPLETED|First Intervention Period||0
9881975|NCT01033487|10996575|FG005|NOT COMPLETED|First Intervention Period||0
9881976|NCT01033487|10996576|FG006|NOT COMPLETED|First Intervention Period||0
9881977|NCT01033487|10996577|FG007|NOT COMPLETED|First Intervention Period||0
9881978|NCT01033487|10996578|FG008|NOT COMPLETED|First Intervention Period||0
9881979|NCT01033487|10996579|FG009|NOT COMPLETED|First Intervention Period||0
9881980|NCT01033487|10996570|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881981|NCT01033487|10996571|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
9881982|NCT01033487|10996572|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881983|NCT01033487|10996573|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881984|NCT01033487|10996574|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881985|NCT01033487|10996575|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881986|NCT01033487|10996576|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881987|NCT01033487|10996577|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
9881988|NCT01033487|10996578|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881989|NCT01033487|10996579|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
9881990|NCT01033487|10996570|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9881991|NCT01033487|10996571|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
9881992|NCT01033487|10996572|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9881993|NCT01033487|10996573|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9881994|NCT01033487|10996574|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9881995|NCT01033487|10996575|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9881996|NCT01033487|10996576|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9881997|NCT01033487|10996577|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
9881998|NCT01033487|10996578|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9881999|NCT01033487|10996579|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
9882000|NCT01033487|10996570|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882001|NCT01033487|10996571|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882002|NCT01033487|10996572|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882003|NCT01033487|10996573|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882004|NCT01033487|10996574|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882005|NCT01033487|10996575|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882006|NCT01033487|10996576|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882007|NCT01033487|10996577|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882008|NCT01033487|10996578|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882009|NCT01033487|10996579|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
9882010|NCT01033487|10996570|FG000|STARTED|Second Intervention Period||2
9882011|NCT01033487|10996571|FG001|STARTED|Second Intervention Period||3
9882012|NCT01033487|10996572|FG002|STARTED|Second Intervention Period||2
9882013|NCT01033487|10996573|FG003|STARTED|Second Intervention Period||2
9882014|NCT01033487|10996574|FG004|STARTED|Second Intervention Period||2
9882015|NCT01033487|10996575|FG005|STARTED|Second Intervention Period||2
9882016|NCT01033487|10996576|FG006|STARTED|Second Intervention Period||2
9882017|NCT01033487|10996577|FG007|STARTED|Second Intervention Period||3
9882018|NCT01033487|10996578|FG008|STARTED|Second Intervention Period||2
9882019|NCT01033487|10996579|FG009|STARTED|Second Intervention Period||2
9882020|NCT01033487|10996570|FG000|COMPLETED|Second Intervention Period||2
9882021|NCT01033487|10996571|FG001|COMPLETED|Second Intervention Period||3
9882022|NCT01033487|10996572|FG002|COMPLETED|Second Intervention Period||2
9882023|NCT01033487|10996573|FG003|COMPLETED|Second Intervention Period||2
9882024|NCT01033487|10996574|FG004|COMPLETED|Second Intervention Period||2
9882025|NCT01033487|10996575|FG005|COMPLETED|Second Intervention Period||2
9882026|NCT01033487|10996576|FG006|COMPLETED|Second Intervention Period||2
9882027|NCT01033487|10996577|FG007|COMPLETED|Second Intervention Period||3
9882028|NCT01033487|10996578|FG008|COMPLETED|Second Intervention Period||2
9882029|NCT01033487|10996579|FG009|COMPLETED|Second Intervention Period||2
9882030|NCT01033487|10996570|FG000|NOT COMPLETED|Second Intervention Period||0
9882031|NCT01033487|10996571|FG001|NOT COMPLETED|Second Intervention Period||0
9882032|NCT01033487|10996572|FG002|NOT COMPLETED|Second Intervention Period||0
9882033|NCT01033487|10996573|FG003|NOT COMPLETED|Second Intervention Period||0
9882034|NCT01033487|10996574|FG004|NOT COMPLETED|Second Intervention Period||0
9882035|NCT01033487|10996575|FG005|NOT COMPLETED|Second Intervention Period||0
9882036|NCT01033487|10996576|FG006|NOT COMPLETED|Second Intervention Period||0
9882037|NCT01033487|10996577|FG007|NOT COMPLETED|Second Intervention Period||0
9882038|NCT01033487|10996578|FG008|NOT COMPLETED|Second Intervention Period||0
9882039|NCT01033487|10996579|FG009|NOT COMPLETED|Second Intervention Period||0
9882040|NCT01033487|10996570|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882041|NCT01033487|10996571|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
9882042|NCT01033487|10996572|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882043|NCT01033487|10996573|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882044|NCT01033487|10996574|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882045|NCT01033487|10996575|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882046|NCT01033487|10996576|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882047|NCT01033487|10996577|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
9882048|NCT01033487|10996578|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882049|NCT01033487|10996579|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
9882050|NCT01033487|10996570|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882051|NCT01033487|10996571|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
9882052|NCT01033487|10996572|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882053|NCT01033487|10996573|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882054|NCT01033487|10996574|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882055|NCT01033487|10996575|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882056|NCT01033487|10996576|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882057|NCT01033487|10996577|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
9882058|NCT01033487|10996578|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882059|NCT01033487|10996579|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
9882060|NCT01033487|10996570|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882061|NCT01033487|10996571|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882062|NCT01033487|10996572|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882063|NCT01033487|10996573|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882064|NCT01033487|10996574|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882065|NCT01033487|10996575|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882066|NCT01033487|10996576|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882067|NCT01033487|10996577|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882068|NCT01033487|10996578|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882069|NCT01033487|10996579|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
9882070|NCT01033487|10996570|FG000|STARTED|Third Intervention Period||2
9882071|NCT01033487|10996571|FG001|STARTED|Third Intervention Period||3
9882072|NCT01033487|10996572|FG002|STARTED|Third Intervention Period||2
9882073|NCT01033487|10996573|FG003|STARTED|Third Intervention Period||2
9882074|NCT01033487|10996574|FG004|STARTED|Third Intervention Period||2
9882075|NCT01033487|10996575|FG005|STARTED|Third Intervention Period||2
9882076|NCT01033487|10996576|FG006|STARTED|Third Intervention Period||2
9882077|NCT01033487|10996577|FG007|STARTED|Third Intervention Period||3
9882078|NCT01033487|10996578|FG008|STARTED|Third Intervention Period||2
9882079|NCT01033487|10996579|FG009|STARTED|Third Intervention Period||2
9882080|NCT01033487|10996570|FG000|COMPLETED|Third Intervention Period||2
9882081|NCT01033487|10996571|FG001|COMPLETED|Third Intervention Period||3
9882082|NCT01033487|10996572|FG002|COMPLETED|Third Intervention Period||2
9882083|NCT01033487|10996573|FG003|COMPLETED|Third Intervention Period||2
9882084|NCT01033487|10996574|FG004|COMPLETED|Third Intervention Period||2
9882085|NCT01033487|10996575|FG005|COMPLETED|Third Intervention Period||2
9882086|NCT01033487|10996576|FG006|COMPLETED|Third Intervention Period||2
9882087|NCT01033487|10996577|FG007|COMPLETED|Third Intervention Period||3
9882088|NCT01033487|10996578|FG008|COMPLETED|Third Intervention Period||2
9882089|NCT01033487|10996579|FG009|COMPLETED|Third Intervention Period||2
9882090|NCT01033487|10996570|FG000|NOT COMPLETED|Third Intervention Period||0
9882091|NCT01033487|10996571|FG001|NOT COMPLETED|Third Intervention Period||0
10108934|NCT02470949|11239457|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5
10108935|NCT02470949|11239456|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
10108936|NCT02470949|11239457|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
10108937|NCT02470949|11239456|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
10108938|NCT02470949|11239457|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
10108939|NCT02470949|11239456|FG000|STARTED|Second Intervention||4
10108940|NCT02470949|11239457|FG001|STARTED|Second Intervention||2
10108941|NCT02470949|11239456|FG000|COMPLETED|Second Intervention||4
10108942|NCT02470949|11239457|FG001|COMPLETED|Second Intervention||2
10108943|NCT02470949|11239456|FG000|NOT COMPLETED|Second Intervention||0
10108944|NCT02470949|11239457|FG001|NOT COMPLETED|Second Intervention||0
9882092|NCT01033487|10996572|FG002|NOT COMPLETED|Third Intervention Period||0
9882093|NCT01033487|10996573|FG003|NOT COMPLETED|Third Intervention Period||0
9882094|NCT01033487|10996574|FG004|NOT COMPLETED|Third Intervention Period||0
9882095|NCT01033487|10996575|FG005|NOT COMPLETED|Third Intervention Period||0
9882096|NCT01033487|10996576|FG006|NOT COMPLETED|Third Intervention Period||0
9882097|NCT01033487|10996577|FG007|NOT COMPLETED|Third Intervention Period||0
9882098|NCT01033487|10996578|FG008|NOT COMPLETED|Third Intervention Period||0
9882099|NCT01033487|10996579|FG009|NOT COMPLETED|Third Intervention Period||0
9882100|NCT01033487|10996570|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882101|NCT01033487|10996571|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
9882102|NCT01033487|10996572|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882103|NCT01033487|10996573|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882104|NCT01033487|10996574|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882105|NCT01033487|10996575|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882106|NCT01033487|10996576|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882107|NCT01033487|10996577|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
9882108|NCT01033487|10996578|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882109|NCT01033487|10996579|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
9882110|NCT01033487|10996570|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
9882111|NCT01033487|10996571|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
9882112|NCT01033487|10996572|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10108945|NCT02471014|11239467|FG000|STARTED|Overall Study||25
10108946|NCT02471014|11239468|FG001|STARTED|Overall Study||25
9882113|NCT01033487|10996573|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
9882114|NCT01033487|10996574|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
9882115|NCT01033487|10996575|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
9882116|NCT01033487|10996576|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
9882117|NCT01033487|10996577|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
9882118|NCT01033487|10996578|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
9882119|NCT01033487|10996579|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
9882120|NCT01033487|10996570|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882121|NCT01033487|10996571|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882122|NCT01033487|10996572|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882123|NCT01033487|10996573|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882124|NCT01033487|10996574|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882125|NCT01033487|10996575|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882126|NCT01033487|10996576|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882127|NCT01033487|10996577|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882128|NCT01033487|10996578|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882129|NCT01033487|10996579|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
9882130|NCT01033487|10996570|FG000|STARTED|Fourth Intervention Period||2
9882131|NCT01033487|10996571|FG001|STARTED|Fourth Intervention Period||3
9882132|NCT01033487|10996572|FG002|STARTED|Fourth Intervention Period||2
10108947|NCT02471014|11239467|FG000|COMPLETED|Overall Study||23
10108948|NCT02471014|11239468|FG001|COMPLETED|Overall Study||23
10108949|NCT02471014|11239467|FG000|NOT COMPLETED|Overall Study||2
10108950|NCT02471014|11239468|FG001|NOT COMPLETED|Overall Study||2
10108951|NCT02471183|11239474|FG000|STARTED|Main Treatment Period||34
10108952|NCT02471183|11239474|FG000|COMPLETED|Main Treatment Period||32
10108953|NCT02471183|11239474|FG000|NOT COMPLETED|Main Treatment Period||2
10108954|NCT02471183|11239474|FG000|STARTED|Extended Treatment Period||32
10108955|NCT02471183|11239474|FG000|COMPLETED|Extended Treatment Period||31
9882133|NCT01033487|10996573|FG003|STARTED|Fourth Intervention Period||2
9882134|NCT01033487|10996574|FG004|STARTED|Fourth Intervention Period||2
9882135|NCT01033487|10996575|FG005|STARTED|Fourth Intervention Period||2
9882136|NCT01033487|10996576|FG006|STARTED|Fourth Intervention Period||2
9882137|NCT01033487|10996577|FG007|STARTED|Fourth Intervention Period||3
9882138|NCT01033487|10996578|FG008|STARTED|Fourth Intervention Period||2
9882139|NCT01033487|10996579|FG009|STARTED|Fourth Intervention Period||2
9882140|NCT01033487|10996570|FG000|COMPLETED|Fourth Intervention Period||2
9882141|NCT01033487|10996571|FG001|COMPLETED|Fourth Intervention Period||3
9882142|NCT01033487|10996572|FG002|COMPLETED|Fourth Intervention Period||2
9882143|NCT01033487|10996573|FG003|COMPLETED|Fourth Intervention Period||2
9882144|NCT01033487|10996574|FG004|COMPLETED|Fourth Intervention Period||2
9882145|NCT01033487|10996575|FG005|COMPLETED|Fourth Intervention Period||2
9882146|NCT01033487|10996576|FG006|COMPLETED|Fourth Intervention Period||2
9882147|NCT01033487|10996577|FG007|COMPLETED|Fourth Intervention Period||3
9882148|NCT01033487|10996578|FG008|COMPLETED|Fourth Intervention Period||1
9882149|NCT01033487|10996579|FG009|COMPLETED|Fourth Intervention Period||2
9882150|NCT01033487|10996570|FG000|NOT COMPLETED|Fourth Intervention Period||0
9882151|NCT01033487|10996571|FG001|NOT COMPLETED|Fourth Intervention Period||0
9882152|NCT01033487|10996572|FG002|NOT COMPLETED|Fourth Intervention Period||0
9882153|NCT01033487|10996573|FG003|NOT COMPLETED|Fourth Intervention Period||0
9882154|NCT01033487|10996574|FG004|NOT COMPLETED|Fourth Intervention Period||0
9882155|NCT01033487|10996575|FG005|NOT COMPLETED|Fourth Intervention Period||0
9882156|NCT01033487|10996576|FG006|NOT COMPLETED|Fourth Intervention Period||0
9882157|NCT01033487|10996577|FG007|NOT COMPLETED|Fourth Intervention Period||0
9882158|NCT01033487|10996578|FG008|NOT COMPLETED|Fourth Intervention Period||1
9882159|NCT01033487|10996579|FG009|NOT COMPLETED|Fourth Intervention Period||0
9882160|NCT01033487|10996570|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
9882161|NCT01033487|10996571|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
9882162|NCT01033487|10996572|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
9882163|NCT01033487|10996573|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
9882164|NCT01033487|10996574|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
9882165|NCT01033487|10996575|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
9882166|NCT01033487|10996576|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
9882167|NCT01033487|10996577|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
9882168|NCT01033487|10996578|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
9882169|NCT01033487|10996579|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
9882170|NCT01033487|10996570|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
9882171|NCT01033487|10996571|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
9882172|NCT01033487|10996572|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
9882173|NCT01033487|10996573|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
9882174|NCT01033487|10996574|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
9882175|NCT01033487|10996575|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
9882176|NCT01033487|10996576|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10108956|NCT02471183|11239474|FG000|NOT COMPLETED|Extended Treatment Period||1
10108957|NCT02471313|11239478|FG000|STARTED|Overall Study||3
10108958|NCT02471313|11239478|FG000|COMPLETED|Overall Study||3
10108959|NCT02471313|11239478|FG000|NOT COMPLETED|Overall Study||0
9882177|NCT01033487|10996577|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
9882178|NCT01033487|10996578|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
9882179|NCT01033487|10996579|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
9882180|NCT01033487|10996570|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882181|NCT01033487|10996571|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882182|NCT01033487|10996572|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882183|NCT01033487|10996573|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882184|NCT01033487|10996574|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882185|NCT01033487|10996575|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882186|NCT01033487|10996576|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882187|NCT01033487|10996577|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882188|NCT01033487|10996578|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882189|NCT01033487|10996579|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
9882190|NCT01033487|10996570|FG000|STARTED|Fifth Intervention Period||2
9882191|NCT01033487|10996571|FG001|STARTED|Fifth Intervention Period||3
9882192|NCT01033487|10996572|FG002|STARTED|Fifth Intervention Period||2
9882193|NCT01033487|10996573|FG003|STARTED|Fifth Intervention Period||2
9882194|NCT01033487|10996574|FG004|STARTED|Fifth Intervention Period||2
9882195|NCT01033487|10996575|FG005|STARTED|Fifth Intervention Period||2
9882196|NCT01033487|10996576|FG006|STARTED|Fifth Intervention Period||2
9882197|NCT01033487|10996577|FG007|STARTED|Fifth Intervention Period||3
9882198|NCT01033487|10996578|FG008|STARTED|Fifth Intervention Period||1
9882199|NCT01033487|10996579|FG009|STARTED|Fifth Intervention Period||2
9882200|NCT01033487|10996570|FG000|COMPLETED|Fifth Intervention Period||2
9882201|NCT01033487|10996571|FG001|COMPLETED|Fifth Intervention Period||3
9882202|NCT01033487|10996572|FG002|COMPLETED|Fifth Intervention Period||2
9882203|NCT01033487|10996573|FG003|COMPLETED|Fifth Intervention Period||2
9882204|NCT01033487|10996574|FG004|COMPLETED|Fifth Intervention Period||2
9882205|NCT01033487|10996575|FG005|COMPLETED|Fifth Intervention Period||2
9882206|NCT01033487|10996576|FG006|COMPLETED|Fifth Intervention Period||2
9882207|NCT01033487|10996577|FG007|COMPLETED|Fifth Intervention Period||3
9882208|NCT01033487|10996578|FG008|COMPLETED|Fifth Intervention Period||1
9882209|NCT01033487|10996579|FG009|COMPLETED|Fifth Intervention Period||2
9882210|NCT01033487|10996570|FG000|NOT COMPLETED|Fifth Intervention Period||0
9882211|NCT01033487|10996571|FG001|NOT COMPLETED|Fifth Intervention Period||0
9882212|NCT01033487|10996572|FG002|NOT COMPLETED|Fifth Intervention Period||0
9882213|NCT01033487|10996573|FG003|NOT COMPLETED|Fifth Intervention Period||0
9882214|NCT01033487|10996574|FG004|NOT COMPLETED|Fifth Intervention Period||0
9882215|NCT01033487|10996575|FG005|NOT COMPLETED|Fifth Intervention Period||0
10202806|NCT03450915|11329941|FG001|NOT COMPLETED|Overall Study||375
10202807|NCT03451071|11329947|FG000|STARTED|First Vaccine||56
10202808|NCT03451071|11329947|FG000|COMPLETED|First Vaccine||55
10202809|NCT03451071|11329947|FG000|NOT COMPLETED|First Vaccine||1
10202810|NCT03451071|11329947|FG000|STARTED|Second Vaccine||55
10202811|NCT03451071|11329947|FG000|COMPLETED|Second Vaccine||36
10202812|NCT03451071|11329947|FG000|NOT COMPLETED|Second Vaccine||19
10202813|NCT03451071|11329947|FG000|STARTED|Third Vaccine||36
9882216|NCT01033487|10996576|FG006|NOT COMPLETED|Fifth Intervention Period||0
9882217|NCT01033487|10996577|FG007|NOT COMPLETED|Fifth Intervention Period||0
9882218|NCT01033487|10996578|FG008|NOT COMPLETED|Fifth Intervention Period||0
9882219|NCT01033487|10996579|FG009|NOT COMPLETED|Fifth Intervention Period||0
9882220|NCT01033565|10996593|FG000|STARTED|Overall Study||1
9882221|NCT01033565|10996593|FG000|COMPLETED|Overall Study||1
9882222|NCT01033565|10996593|FG000|NOT COMPLETED|Overall Study||0
9882223|NCT01033643|10996602|FG000|STARTED|Overall Study||6
9882224|NCT01033643|10996603|FG001|STARTED|Overall Study||6
9882225|NCT01033643|10996604|FG002|STARTED|Overall Study||6
9882226|NCT01033643|10996605|FG003|STARTED|Overall Study||4
9882227|NCT01033643|10996606|FG004|STARTED|Overall Study||0
9882228|NCT01033643|10996607|FG005|STARTED|Overall Study||8
9882229|NCT01033643|10996602|FG000|COMPLETED|Overall Study||6
9882230|NCT01033643|10996603|FG001|COMPLETED|Overall Study||3
9882231|NCT01033643|10996604|FG002|COMPLETED|Overall Study||6
9882232|NCT01033643|10996605|FG003|COMPLETED|Overall Study||4
9882233|NCT01033643|10996606|FG004|COMPLETED|Overall Study||0
9882234|NCT01033643|10996607|FG005|COMPLETED|Overall Study||7
9882235|NCT01033643|10996602|FG000|NOT COMPLETED|Overall Study||0
9882236|NCT01033643|10996603|FG001|NOT COMPLETED|Overall Study||3
9882237|NCT01033643|10996604|FG002|NOT COMPLETED|Overall Study||0
9882238|NCT01033643|10996605|FG003|NOT COMPLETED|Overall Study||0
9882239|NCT01033643|10996606|FG004|NOT COMPLETED|Overall Study||0
9882240|NCT01033643|10996607|FG005|NOT COMPLETED|Overall Study||1
9882241|NCT01033734|10996621|FG000|STARTED|Overall Study||8
9882242|NCT01033734|10996621|FG000|COMPLETED|Overall Study||7
10008024|NCT01754480|11130307|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
10008025|NCT01754480|11130308|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
10008026|NCT01754480|11130307|FG000|NOT COMPLETED|Primary Part II||15
10008027|NCT01754480|11130308|FG001|NOT COMPLETED|Primary Part II||11
10202814|NCT03451071|11329947|FG000|COMPLETED|Third Vaccine||14
9882243|NCT01033734|10996621|FG000|NOT COMPLETED|Overall Study||1
10202815|NCT03451071|11329947|FG000|NOT COMPLETED|Third Vaccine||22
10202816|NCT03451071|11329947|FG000|STARTED|Final Questionnaire and Blood Draw||14
10008028|NCT01754493|11130315|FG000|STARTED|Overall Study||17
10008029|NCT01754493|11130315|FG000|COMPLETED|Overall Study||10
10008030|NCT01754493|11130315|FG000|NOT COMPLETED|Overall Study||7
10008031|NCT01754519|11130319|FG000|STARTED|Overall Study||1
10008032|NCT01754519|11130319|FG000|COMPLETED|Overall Study||1
10008033|NCT01754519|11130319|FG000|NOT COMPLETED|Overall Study||0
10008034|NCT01754623|11130323|FG000|STARTED|Overall Study||9
10008035|NCT01754623|11130323|FG000|COMPLETED|Overall Study||9
10008036|NCT01754623|11130323|FG000|NOT COMPLETED|Overall Study||0
10008037|NCT01754688|11130329|FG000|STARTED|Overall Study||624
10008038|NCT01754688|11130329|FG000|COMPLETED|Overall Study||624
10008039|NCT01754688|11130329|FG000|NOT COMPLETED|Overall Study||0
10008040|NCT01754714|11130338|FG000|STARTED|Overall Study||27
10008041|NCT01754714|11130339|FG001|STARTED|Overall Study||27
10008042|NCT01754714|11130340|FG002|STARTED|Overall Study||26
10008043|NCT01754714|11130341|FG003|STARTED|Overall Study||28
10008044|NCT01754714|11130338|FG000|COMPLETED|Overall Study||27
10008045|NCT01754714|11130339|FG001|COMPLETED|Overall Study||26
10008046|NCT01754714|11130340|FG002|COMPLETED|Overall Study||24
10008047|NCT01754714|11130341|FG003|COMPLETED|Overall Study||27
10008048|NCT01754714|11130338|FG000|NOT COMPLETED|Overall Study||0
10008049|NCT01754714|11130339|FG001|NOT COMPLETED|Overall Study||1
10008050|NCT01754714|11130340|FG002|NOT COMPLETED|Overall Study||2
10008051|NCT01754714|11130341|FG003|NOT COMPLETED|Overall Study||1
9882244|NCT01033747|10996636|FG000|STARTED|Overall Study||51
9882245|NCT01033747|10996637|FG001|STARTED|Overall Study||19
9882246|NCT01033747|10996636|FG000|COMPLETED|Overall Study||14
9882247|NCT01033747|10996637|FG001|COMPLETED|Overall Study||4
9882248|NCT01033747|10996636|FG000|NOT COMPLETED|Overall Study||37
9882249|NCT01033747|10996637|FG001|NOT COMPLETED|Overall Study||15
9882250|NCT01033773|10996643|FG000|STARTED|Overall Study||86
9882251|NCT01033773|10996643|FG000|COMPLETED|Overall Study||51
9882252|NCT01033773|10996643|FG000|NOT COMPLETED|Overall Study||35
9882253|NCT01033825|10996654|FG000|STARTED|Overall Study||51
9882254|NCT01033825|10996655|FG001|STARTED|Overall Study||60
9882255|NCT01033825|10996656|FG002|STARTED|Overall Study||57
9882256|NCT01033825|10996657|FG003|STARTED|Overall Study||48
9882257|NCT01033825|10996658|FG004|STARTED|Overall Study||58
9882258|NCT01033825|10996659|FG005|STARTED|Overall Study||18
9882259|NCT01033825|10996660|FG006|STARTED|Overall Study||18
9882260|NCT01033825|10996654|FG000|COMPLETED|Overall Study||48
9882261|NCT01033825|10996655|FG001|COMPLETED|Overall Study||57
9882262|NCT01033825|10996656|FG002|COMPLETED|Overall Study||55
9882263|NCT01033825|10996657|FG003|COMPLETED|Overall Study||46
9882264|NCT01033825|10996658|FG004|COMPLETED|Overall Study||56
9882265|NCT01033825|10996659|FG005|COMPLETED|Overall Study||18
9882266|NCT01033825|10996660|FG006|COMPLETED|Overall Study||18
9882267|NCT01033825|10996654|FG000|NOT COMPLETED|Overall Study||3
9882268|NCT01033825|10996655|FG001|NOT COMPLETED|Overall Study||3
9882269|NCT01033825|10996656|FG002|NOT COMPLETED|Overall Study||2
9882270|NCT01033825|10996657|FG003|NOT COMPLETED|Overall Study||2
9882271|NCT01033825|10996658|FG004|NOT COMPLETED|Overall Study||2
9882272|NCT01033825|10996659|FG005|NOT COMPLETED|Overall Study||0
9882273|NCT01033825|10996660|FG006|NOT COMPLETED|Overall Study||0
9882274|NCT01033851|10996680|FG000|STARTED|Overall Study||48
9882275|NCT01033851|10996681|FG001|STARTED|Overall Study||41
9882276|NCT01033851|10996680|FG000|COMPLETED|Overall Study||45
9882277|NCT01033851|10996681|FG001|COMPLETED|Overall Study||34
9882278|NCT01033851|10996680|FG000|NOT COMPLETED|Overall Study||3
9882279|NCT01033851|10996681|FG001|NOT COMPLETED|Overall Study||7
9882280|NCT01033864|10996689|FG000|STARTED|Overall Study||12
9882281|NCT01033864|10996690|FG001|STARTED|Overall Study||11
9882282|NCT01033864|10996689|FG000|COMPLETED|Overall Study||12
9882283|NCT01033864|10996690|FG001|COMPLETED|Overall Study||11
9882284|NCT01033864|10996689|FG000|NOT COMPLETED|Overall Study||0
9882285|NCT01033864|10996690|FG001|NOT COMPLETED|Overall Study||0
9882286|NCT01033942|10996699|FG000|STARTED|Overall Study||20
9882287|NCT01033942|10996700|FG001|STARTED|Overall Study||19
9882288|NCT01033942|10996701|FG002|STARTED|Overall Study||19
9882289|NCT01033942|10996699|FG000|COMPLETED|Overall Study||18
9882290|NCT01033942|10996700|FG001|COMPLETED|Overall Study||15
9882291|NCT01033942|10996701|FG002|COMPLETED|Overall Study||18
9882292|NCT01033942|10996699|FG000|NOT COMPLETED|Overall Study||2
9882293|NCT01033942|10996700|FG001|NOT COMPLETED|Overall Study||4
9882294|NCT01033942|10996701|FG002|NOT COMPLETED|Overall Study||1
9882295|NCT01034111|10996711|FG000|STARTED|Overall Study||30
10008052|NCT01754727|11130352|FG000|STARTED|Overall Study||452
10008053|NCT01754727|11130352|FG000|COMPLETED|Overall Study||450
9882296|NCT01034111|10996711|FG000|COMPLETED|Overall Study||30
9882297|NCT01034111|10996711|FG000|NOT COMPLETED|Overall Study||0
9882298|NCT01034137|10996718|FG000|STARTED|Overall Study||106
9882299|NCT01034137|10996719|FG001|STARTED|Overall Study||103
9882300|NCT01034137|10996720|FG002|STARTED|Overall Study||108
9882301|NCT01034137|10996718|FG000|COMPLETED|Overall Study||78
9882302|NCT01034137|10996719|FG001|COMPLETED|Overall Study||81
10008054|NCT01754727|11130352|FG000|NOT COMPLETED|Overall Study||2
10008055|NCT01754753|11130358|FG000|STARTED|Overall Study||78
10008056|NCT01754753|11130359|FG001|STARTED|Overall Study||79
10008057|NCT01754753|11130358|FG000|COMPLETED|Overall Study||26
10008058|NCT01754753|11130359|FG001|COMPLETED|Overall Study||30
9882303|NCT01034137|10996720|FG002|COMPLETED|Overall Study||78
9882304|NCT01034137|10996718|FG000|NOT COMPLETED|Overall Study||28
9882305|NCT01034137|10996719|FG001|NOT COMPLETED|Overall Study||22
9882306|NCT01034137|10996720|FG002|NOT COMPLETED|Overall Study||30
9882307|NCT01034163|10996731|FG000|STARTED|Overall Study||27
9882308|NCT01034163|10996732|FG001|STARTED|Overall Study||14
9882309|NCT01034163|10996731|FG000|Untreated (Not in Safety Set)|Overall Study||1
9882310|NCT01034163|10996732|FG001|Untreated (Not in Safety Set)|Overall Study||2
9882311|NCT01034163|10996731|FG000|Safety Set|Overall Study||26
9882312|NCT01034163|10996732|FG001|Safety Set|Overall Study||12
9882313|NCT01034163|10996731|FG000|In Open Label Phase After Unblinding|Overall Study||5
9882314|NCT01034163|10996732|FG001|In Open Label Phase After Unblinding|Overall Study||0
9882315|NCT01034163|10996731|FG000|COMPLETED|Overall Study||0
9882316|NCT01034163|10996732|FG001|COMPLETED|Overall Study||0
9882317|NCT01034163|10996731|FG000|NOT COMPLETED|Overall Study||27
9882318|NCT01034163|10996732|FG001|NOT COMPLETED|Overall Study||14
9882319|NCT01034176|10996740|FG000|STARTED|Overall Study||22
9882320|NCT01034176|10996741|FG001|STARTED|Overall Study||21
9882321|NCT01034176|10996740|FG000|COMPLETED|Overall Study||20
9882322|NCT01034176|10996741|FG001|COMPLETED|Overall Study||19
9882323|NCT01034176|10996740|FG000|NOT COMPLETED|Overall Study||2
9882324|NCT01034176|10996741|FG001|NOT COMPLETED|Overall Study||2
9882325|NCT01034358|10996747|FG000|STARTED|Overall Study||15
9882326|NCT01034358|10996747|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
9882327|NCT01034358|10996747|FG000|NOT COMPLETED|Overall Study||2
9882328|NCT01034397|10996753|FG000|STARTED|Overall Study||35
9882329|NCT01034397|10996754|FG001|STARTED|Overall Study||19
9882330|NCT01034397|10996753|FG000|COMPLETED|Overall Study||28
9882331|NCT01034397|10996754|FG001|COMPLETED|Overall Study||17
9882332|NCT01034397|10996753|FG000|NOT COMPLETED|Overall Study||7
9882333|NCT01034397|10996754|FG001|NOT COMPLETED|Overall Study||2
9882334|NCT01034462|10996771|FG000|STARTED|Overall Study||217
9882335|NCT01034462|10996772|FG001|STARTED|Overall Study||217
9882336|NCT01034462|10996771|FG000|COMPLETED|Overall Study||172
9882337|NCT01034462|10996772|FG001|COMPLETED|Overall Study||163
9882338|NCT01034462|10996771|FG000|NOT COMPLETED|Overall Study||45
9882339|NCT01034462|10996772|FG001|NOT COMPLETED|Overall Study||54
9882340|NCT01034527|10996782|FG000|STARTED|Overall Study||307
9882341|NCT01034527|10996783|FG001|STARTED|Overall Study||216
9882342|NCT01034527|10996782|FG000|COMPLETED|Overall Study||307
9882343|NCT01034527|10996783|FG001|COMPLETED|Overall Study||216
9882344|NCT01034527|10996782|FG000|NOT COMPLETED|Overall Study||0
9882345|NCT01034527|10996783|FG001|NOT COMPLETED|Overall Study||0
9882346|NCT01034540|10996791|FG000|STARTED|Overall Study||11
9882347|NCT01034540|10996792|FG001|STARTED|Overall Study||12
9882348|NCT01034540|10996791|FG000|Completed 1st Treatment Intervention|Overall Study||11
9882349|NCT01034540|10996792|FG001|Completed 1st Treatment Intervention|Overall Study||11
9882350|NCT01034540|10996791|FG000|COMPLETED|Overall Study||11
9882351|NCT01034540|10996792|FG001|COMPLETED|Overall Study||11
9882352|NCT01034540|10996791|FG000|NOT COMPLETED|Overall Study||0
9882353|NCT01034540|10996792|FG001|NOT COMPLETED|Overall Study||1
9882354|NCT01034553|10996800|FG000|STARTED|Overall Study||3
9882355|NCT01034553|10996801|FG001|STARTED|Overall Study||4
9882356|NCT01034553|10996802|FG002|STARTED|Overall Study||3
9882357|NCT01034553|10996803|FG003|STARTED|Overall Study||3
9882358|NCT01034553|10996804|FG004|STARTED|Overall Study||6
9882359|NCT01034553|10996805|FG005|STARTED|Overall Study||7
9882360|NCT01034553|10996800|FG000|COMPLETED|Overall Study||3
9882361|NCT01034553|10996801|FG001|COMPLETED|Overall Study||4
9882362|NCT01034553|10996802|FG002|COMPLETED|Overall Study||3
9882363|NCT01034553|10996803|FG003|COMPLETED|Overall Study||3
10108960|NCT02471326|11239482|FG000|STARTED|Overall Study||10
9882364|NCT01034553|10996804|FG004|COMPLETED|Overall Study||6
9882365|NCT01034553|10996805|FG005|COMPLETED|Overall Study||7
9882366|NCT01034553|10996800|FG000|NOT COMPLETED|Overall Study||0
9882367|NCT01034553|10996801|FG001|NOT COMPLETED|Overall Study||0
9882368|NCT01034553|10996802|FG002|NOT COMPLETED|Overall Study||0
9882369|NCT01034553|10996803|FG003|NOT COMPLETED|Overall Study||0
9882370|NCT01034553|10996804|FG004|NOT COMPLETED|Overall Study||0
9882371|NCT01034553|10996805|FG005|NOT COMPLETED|Overall Study||0
9882372|NCT01034579|10996821|FG000|STARTED|Overall Study||158
9882373|NCT01034579|10996822|FG001|STARTED|Overall Study||166
9882374|NCT01034579|10996821|FG000|COMPLETED|Overall Study||158
9882375|NCT01034579|10996822|FG001|COMPLETED|Overall Study||166
9882376|NCT01034579|10996821|FG000|NOT COMPLETED|Overall Study||0
9882377|NCT01034579|10996822|FG001|NOT COMPLETED|Overall Study||0
9882378|NCT01034592|10996828|FG000|STARTED|Overall Study||2
9882379|NCT01034592|10996828|FG000|COMPLETED|Overall Study||2
9882380|NCT01034592|10996828|FG000|NOT COMPLETED|Overall Study||0
9882381|NCT01034631|10996836|FG000|STARTED|Phase I||15
9882382|NCT01034631|10996837|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
9882383|NCT01034631|10996838|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
9882384|NCT01034631|10996836|FG000|COMPLETED|Phase I||12
9882385|NCT01034631|10996837|FG001|COMPLETED|Phase I||0
9882386|NCT01034631|10996838|FG002|COMPLETED|Phase I||0
9882387|NCT01034631|10996836|FG000|NOT COMPLETED|Phase I||3
9882388|NCT01034631|10996837|FG001|NOT COMPLETED|Phase I||0
10108961|NCT02471326|11239482|FG000|COMPLETED|Overall Study||9
9882389|NCT01034631|10996838|FG002|NOT COMPLETED|Phase I||0
9882390|NCT01034631|10996836|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
9882391|NCT01034631|10996837|FG001|STARTED|Phase II||70
9882392|NCT01034631|10996838|FG002|STARTED|Phase II||69
9882393|NCT01034631|10996836|FG000|COMPLETED|Phase II||0
9882394|NCT01034631|10996837|FG001|COMPLETED|Phase II||69
9882395|NCT01034631|10996838|FG002|COMPLETED|Phase II||67
9882396|NCT01034631|10996836|FG000|NOT COMPLETED|Phase II||0
9882397|NCT01034631|10996837|FG001|NOT COMPLETED|Phase II||1
9882398|NCT01034631|10996838|FG002|NOT COMPLETED|Phase II||2
9882399|NCT01034657|10996848|FG000|STARTED|Core Phase||34
9882400|NCT01034657|10996849|FG001|STARTED|Core Phase||0
9882401|NCT01034657|10996850|FG002|STARTED|Core Phase||0
9882402|NCT01034657|10996848|FG000|COMPLETED|Core Phase||20
9882403|NCT01034657|10996849|FG001|COMPLETED|Core Phase||0
9882404|NCT01034657|10996850|FG002|COMPLETED|Core Phase||0
9882405|NCT01034657|10996848|FG000|NOT COMPLETED|Core Phase||14
9882406|NCT01034657|10996849|FG001|NOT COMPLETED|Core Phase||0
9882407|NCT01034657|10996850|FG002|NOT COMPLETED|Core Phase||0
9882408|NCT01034657|10996848|FG000|STARTED|Randomized Phase||6
9882409|NCT01034657|10996849|FG001|STARTED|Randomized Phase||6
9882410|NCT01034657|10996850|FG002|STARTED|Randomized Phase||1
9882411|NCT01034657|10996848|FG000|COMPLETED|Randomized Phase||1
9882412|NCT01034657|10996849|FG001|COMPLETED|Randomized Phase||0
9882413|NCT01034657|10996850|FG002|COMPLETED|Randomized Phase||0
9882414|NCT01034657|10996848|FG000|NOT COMPLETED|Randomized Phase||5
9882415|NCT01034657|10996849|FG001|NOT COMPLETED|Randomized Phase||6
9882416|NCT01034657|10996850|FG002|NOT COMPLETED|Randomized Phase||1
9882417|NCT01034709|10996862|FG000|STARTED|Overall Study||53
9882418|NCT01034709|10996863|FG001|STARTED|Overall Study||58
9882419|NCT01034709|10996862|FG000|COMPLETED|Overall Study||44
9882420|NCT01034709|10996863|FG001|COMPLETED|Overall Study||42
9882421|NCT01034709|10996862|FG000|NOT COMPLETED|Overall Study||9
9882422|NCT01034709|10996863|FG001|NOT COMPLETED|Overall Study||16
9882423|NCT01035047|10996871|FG000|STARTED|Overall Study||52
9882424|NCT01035047|10996872|FG001|STARTED|Overall Study||53
9882425|NCT01035047|10996871|FG000|COMPLETED|Overall Study||52
9882426|NCT01035047|10996872|FG001|COMPLETED|Overall Study||53
9882427|NCT01035047|10996871|FG000|NOT COMPLETED|Overall Study||0
9882428|NCT01035047|10996872|FG001|NOT COMPLETED|Overall Study||0
9882429|NCT01035060|10996880|FG000|STARTED|Overall Study||39
9882430|NCT01035060|10996881|FG001|STARTED|Overall Study||29
9882431|NCT01035060|10996880|FG000|COMPLETED|Overall Study||15
9882432|NCT01035060|10996881|FG001|COMPLETED|Overall Study||15
9882433|NCT01035060|10996880|FG000|NOT COMPLETED|Overall Study||24
9882434|NCT01035060|10996881|FG001|NOT COMPLETED|Overall Study||14
9882435|NCT01035099|10996889|FG000|STARTED|Overall Study||18
9882436|NCT01035099|10996890|FG001|STARTED|Overall Study||22
9882437|NCT01035099|10996889|FG000|COMPLETED|Overall Study||18
9882438|NCT01035099|10996890|FG001|COMPLETED|Overall Study||22
9882439|NCT01035099|10996889|FG000|NOT COMPLETED|Overall Study||0
9882440|NCT01035099|10996890|FG001|NOT COMPLETED|Overall Study||0
9882441|NCT01035138|10996900|FG000|STARTED|Overall Study||73
9882442|NCT01035138|10996901|FG001|STARTED|Overall Study||60
9882443|NCT01035138|10996902|FG002|STARTED|Overall Study||47
9882444|NCT01035138|10996900|FG000|COMPLETED|Overall Study||0
9882445|NCT01035138|10996901|FG001|COMPLETED|Overall Study||0
9882446|NCT01035138|10996902|FG002|COMPLETED|Overall Study||0
9882447|NCT01035138|10996900|FG000|NOT COMPLETED|Overall Study||73
9882448|NCT01035138|10996901|FG001|NOT COMPLETED|Overall Study||60
9882449|NCT01035138|10996902|FG002|NOT COMPLETED|Overall Study||47
9882450|NCT01035151|10996914|FG000|STARTED|Overall Study||209
9882451|NCT01035151|10996915|FG001|STARTED|Overall Study||200
9882452|NCT01035151|10996914|FG000|COMPLETED|Overall Study||188
9882453|NCT01035151|10996915|FG001|COMPLETED|Overall Study||185
9882454|NCT01035151|10996914|FG000|NOT COMPLETED|Overall Study||21
9882455|NCT01035151|10996915|FG001|NOT COMPLETED|Overall Study||15
9882456|NCT01035229|10996923|FG000|STARTED|Overall Study||362
9882457|NCT01035229|10996924|FG001|STARTED|Overall Study||184
9882458|NCT01035229|10996923|FG000|COMPLETED|Overall Study||0
9882459|NCT01035229|10996924|FG001|COMPLETED|Overall Study||0
9882460|NCT01035229|10996923|FG000|NOT COMPLETED|Overall Study||362
10008059|NCT01754753|11130358|FG000|NOT COMPLETED|Overall Study||52
10008060|NCT01754753|11130359|FG001|NOT COMPLETED|Overall Study||49
10008061|NCT01754766|11130368|FG000|STARTED|Overall Study||31
10008062|NCT01754766|11130369|FG001|STARTED|Overall Study||29
10008063|NCT01754766|11130370|FG002|STARTED|Overall Study||30
10008064|NCT01754766|11130368|FG000|COMPLETED|Overall Study||30
9882461|NCT01035229|10996924|FG001|NOT COMPLETED|Overall Study||184
9882462|NCT01035255|10996934|FG000|STARTED|Overall Study||4209
10008065|NCT01754766|11130369|FG001|COMPLETED|Overall Study||28
10008066|NCT01754766|11130370|FG002|COMPLETED|Overall Study||30
10008067|NCT01754766|11130368|FG000|NOT COMPLETED|Overall Study||1
9882463|NCT01035255|10996935|FG001|STARTED|Overall Study||4233
9882464|NCT01035255|10996934|FG000|GCP Violations|Overall Study||18
9882465|NCT01035255|10996935|FG001|GCP Violations|Overall Study||19
9882466|NCT01035255|10996934|FG000|Mis-randomized|Overall Study||4
9882467|NCT01035255|10996935|FG001|Mis-randomized|Overall Study||2
9882468|NCT01035255|10996934|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
9882469|NCT01035255|10996935|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
9882470|NCT01035255|10996934|FG000|COMPLETED|Overall Study||3468
9882471|NCT01035255|10996935|FG001|COMPLETED|Overall Study||3371
9882472|NCT01035255|10996934|FG000|NOT COMPLETED|Overall Study||741
9882473|NCT01035255|10996935|FG001|NOT COMPLETED|Overall Study||862
9882474|NCT01035333|10996941|FG000|STARTED|Overall Study||19
9882475|NCT01035333|10996941|FG000|COMPLETED|Overall Study||9
9882476|NCT01035333|10996941|FG000|NOT COMPLETED|Overall Study||10
9882477|NCT01035346|10996947|FG000|STARTED|Overall Study||7
9882478|NCT01035346|10996948|FG001|STARTED|Overall Study||9
9882479|NCT01035346|10996947|FG000|COMPLETED|Overall Study||7
9882480|NCT01035346|10996948|FG001|COMPLETED|Overall Study||9
9882481|NCT01035346|10996947|FG000|NOT COMPLETED|Overall Study||0
9882482|NCT01035346|10996948|FG001|NOT COMPLETED|Overall Study||0
9882483|NCT01035463|10996956|FG000|STARTED|Overall Study||6
9882484|NCT01035463|10996957|FG001|STARTED|Overall Study||3
9882485|NCT01035463|10996958|FG002|STARTED|Overall Study||6
9882486|NCT01035463|10996959|FG003|STARTED|Overall Study||4
9882487|NCT01035463|10996960|FG004|STARTED|Overall Study||7
9882488|NCT01035463|10996961|FG005|STARTED|Overall Study||33
9882489|NCT01035463|10996956|FG000|COMPLETED|Overall Study||6
9882490|NCT01035463|10996957|FG001|COMPLETED|Overall Study||1
9882491|NCT01035463|10996958|FG002|COMPLETED|Overall Study||1
9882492|NCT01035463|10996959|FG003|COMPLETED|Overall Study||2
9882493|NCT01035463|10996960|FG004|COMPLETED|Overall Study||1
9882494|NCT01035463|10996961|FG005|COMPLETED|Overall Study||15
9882495|NCT01035463|10996956|FG000|NOT COMPLETED|Overall Study||0
9882496|NCT01035463|10996957|FG001|NOT COMPLETED|Overall Study||2
9882497|NCT01035463|10996958|FG002|NOT COMPLETED|Overall Study||5
9882498|NCT01035463|10996959|FG003|NOT COMPLETED|Overall Study||2
9882499|NCT01035463|10996960|FG004|NOT COMPLETED|Overall Study||6
9882500|NCT01035463|10996961|FG005|NOT COMPLETED|Overall Study||18
9882501|NCT01035606|10996971|FG000|STARTED|Overall Study||19
9882502|NCT01035606|10996972|FG001|STARTED|Overall Study||19
9882503|NCT01035606|10996973|FG002|STARTED|Overall Study||11
9882504|NCT01035606|10996971|FG000|COMPLETED|Overall Study||16
9882505|NCT01035606|10996972|FG001|COMPLETED|Overall Study||16
9882506|NCT01035606|10996973|FG002|COMPLETED|Overall Study||7
9882507|NCT01035606|10996971|FG000|NOT COMPLETED|Overall Study||3
9882508|NCT01035606|10996972|FG001|NOT COMPLETED|Overall Study||3
9882509|NCT01035606|10996973|FG002|NOT COMPLETED|Overall Study||4
9882510|NCT01035658|10996985|FG000|STARTED|Overall Study||5
9882511|NCT01035658|10996986|FG001|STARTED|Overall Study||8
9882512|NCT01035658|10996987|FG002|STARTED|Overall Study||3
9882513|NCT01035658|10996988|FG003|STARTED|Overall Study||6
9882514|NCT01035658|10996985|FG000|COMPLETED|Overall Study||5
9882515|NCT01035658|10996986|FG001|COMPLETED|Overall Study||8
9882516|NCT01035658|10996987|FG002|COMPLETED|Overall Study||3
9882517|NCT01035658|10996988|FG003|COMPLETED|Overall Study||6
9882518|NCT01035658|10996985|FG000|NOT COMPLETED|Overall Study||0
9882519|NCT01035658|10996986|FG001|NOT COMPLETED|Overall Study||0
9882520|NCT01035658|10996987|FG002|NOT COMPLETED|Overall Study||0
9882521|NCT01035658|10996988|FG003|NOT COMPLETED|Overall Study||0
9882522|NCT01035749|10997005|FG000|STARTED|Overall Study||66
9882523|NCT01035749|10997006|FG001|STARTED|Overall Study||66
9882524|NCT01035749|10997007|FG002|STARTED|Overall Study||68
9882525|NCT01035749|10997008|FG003|STARTED|Overall Study||110
9882526|NCT01035749|10997005|FG000|COMPLETED|Overall Study||66
9882527|NCT01035749|10997006|FG001|COMPLETED|Overall Study||66
9882528|NCT01035749|10997007|FG002|COMPLETED|Overall Study||68
9882529|NCT01035749|10997008|FG003|COMPLETED|Overall Study||110
9882530|NCT01035749|10997005|FG000|NOT COMPLETED|Overall Study||0
9882531|NCT01035749|10997006|FG001|NOT COMPLETED|Overall Study||0
9882532|NCT01035749|10997007|FG002|NOT COMPLETED|Overall Study||0
9882533|NCT01035749|10997008|FG003|NOT COMPLETED|Overall Study||0
9882534|NCT01035788|10997020|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
9882535|NCT01035788|10997021|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
9882536|NCT01035788|10997020|FG000|COMPLETED|Overall Study||17
9882537|NCT01035788|10997021|FG001|COMPLETED|Overall Study||9
9882538|NCT01035788|10997020|FG000|NOT COMPLETED|Overall Study||6
9882539|NCT01035788|10997021|FG001|NOT COMPLETED|Overall Study||14
9882540|NCT01035905|10997029|FG000|STARTED|Overall Study||32
9882541|NCT01035905|10997030|FG001|STARTED|Overall Study||31
10008068|NCT01754766|11130369|FG001|NOT COMPLETED|Overall Study||1
10008069|NCT01754766|11130370|FG002|NOT COMPLETED|Overall Study||0
10008070|NCT01754909|11130380|FG000|STARTED|Overall Study||20
10008071|NCT01754909|11130381|FG001|STARTED|Overall Study||23
10008072|NCT01754909|11130380|FG000|COMPLETED|Overall Study||20
10008073|NCT01754909|11130381|FG001|COMPLETED|Overall Study||23
10008074|NCT01754909|11130380|FG000|NOT COMPLETED|Overall Study||0
9882542|NCT01035905|10997029|FG000|COMPLETED|Overall Study||31
9882543|NCT01035905|10997030|FG001|COMPLETED|Overall Study||30
9882544|NCT01035905|10997029|FG000|NOT COMPLETED|Overall Study||1
9882545|NCT01035905|10997030|FG001|NOT COMPLETED|Overall Study||1
9882546|NCT01036009|10997038|FG000|STARTED|Overall Study||17
9882547|NCT01036009|10997039|FG001|STARTED|Overall Study||26
9882548|NCT01036009|10997038|FG000|COMPLETED|Overall Study||17
9882549|NCT01036009|10997039|FG001|COMPLETED|Overall Study||26
9882550|NCT01036009|10997038|FG000|NOT COMPLETED|Overall Study||0
9882551|NCT01036009|10997039|FG001|NOT COMPLETED|Overall Study||0
9882552|NCT01036022|10997052|FG000|STARTED|Overall Study||15
9882553|NCT01036022|10997053|FG001|STARTED|Overall Study||11
9882554|NCT01036022|10997054|FG002|STARTED|Overall Study||12
9882555|NCT01036022|10997055|FG003|STARTED|Overall Study||12
9882556|NCT01036022|10997056|FG004|STARTED|Overall Study||12
9882557|NCT01036022|10997057|FG005|STARTED|Overall Study||16
9882558|NCT01036022|10997052|FG000|COMPLETED|Overall Study||13
10008075|NCT01754909|11130381|FG001|NOT COMPLETED|Overall Study||0
10008076|NCT01754922|11130389|FG000|STARTED|Overall Study||32
10008077|NCT01754922|11130390|FG001|STARTED|Overall Study||18
10008078|NCT01754922|11130389|FG000|COMPLETED|Overall Study||32
10108962|NCT02471326|11239482|FG000|NOT COMPLETED|Overall Study||1
10108963|NCT02471404|11239489|FG000|STARTED|Overall Study||314
10108964|NCT02471404|11239490|FG001|STARTED|Overall Study||312
9882559|NCT01036022|10997053|FG001|COMPLETED|Overall Study||7
9882560|NCT01036022|10997054|FG002|COMPLETED|Overall Study||8
9882561|NCT01036022|10997055|FG003|COMPLETED|Overall Study||10
9882562|NCT01036022|10997056|FG004|COMPLETED|Overall Study||9
9882563|NCT01036022|10997057|FG005|COMPLETED|Overall Study||13
9882564|NCT01036022|10997052|FG000|NOT COMPLETED|Overall Study||2
9882565|NCT01036022|10997053|FG001|NOT COMPLETED|Overall Study||4
9882566|NCT01036022|10997054|FG002|NOT COMPLETED|Overall Study||4
9882567|NCT01036022|10997055|FG003|NOT COMPLETED|Overall Study||2
9882568|NCT01036022|10997056|FG004|NOT COMPLETED|Overall Study||3
9882569|NCT01036022|10997057|FG005|NOT COMPLETED|Overall Study||3
9882570|NCT01036165|10997079|FG000|STARTED|Overall Study||103
9882571|NCT01036165|10997079|FG000|COMPLETED|Overall Study||88
9882572|NCT01036165|10997079|FG000|NOT COMPLETED|Overall Study||15
9882573|NCT01036321|10997085|FG000|STARTED|Overall Study||36
9882574|NCT01036321|10997086|FG001|STARTED|Overall Study||35
9882575|NCT01036321|10997085|FG000|COMPLETED|Overall Study||31
9882576|NCT01036321|10997086|FG001|COMPLETED|Overall Study||31
9882577|NCT01036321|10997085|FG000|NOT COMPLETED|Overall Study||5
9882578|NCT01036321|10997086|FG001|NOT COMPLETED|Overall Study||4
9882579|NCT01036438|10997094|FG000|STARTED|Overall Study||101
9882580|NCT01036438|10997095|FG001|STARTED|Overall Study||100
9882581|NCT01036438|10997094|FG000|COMPLETED|Overall Study||91
9882582|NCT01036438|10997095|FG001|COMPLETED|Overall Study||90
9882583|NCT01036438|10997094|FG000|NOT COMPLETED|Overall Study||10
9882584|NCT01036438|10997095|FG001|NOT COMPLETED|Overall Study||10
9882585|NCT01036490|10997103|FG000|STARTED|Overall Study||18
9882586|NCT01036490|10997104|FG001|STARTED|Overall Study||18
9882587|NCT01036490|10997103|FG000|COMPLETED|Overall Study||14
9882588|NCT01036490|10997104|FG001|COMPLETED|Overall Study||18
9882589|NCT01036490|10997103|FG000|NOT COMPLETED|Overall Study||4
9882590|NCT01036490|10997104|FG001|NOT COMPLETED|Overall Study||0
9882591|NCT01036529|10997112|FG000|STARTED|Overall Study||13
9882592|NCT01036529|10997113|FG001|STARTED|Overall Study||15
9882593|NCT01036529|10997112|FG000|Baseline Visit|Overall Study||10
9882594|NCT01036529|10997113|FG001|Baseline Visit|Overall Study||13
9882595|NCT01036529|10997112|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
9882596|NCT01036529|10997113|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11
9882597|NCT01036529|10997112|FG000|3 Month Follow-up|Overall Study||7
9882598|NCT01036529|10997113|FG001|3 Month Follow-up|Overall Study||9
9882599|NCT01036529|10997112|FG000|6 Month Follow-up|Overall Study||6
9882600|NCT01036529|10997113|FG001|6 Month Follow-up|Overall Study||7
9882601|NCT01036529|10997112|FG000|12 Month Follow-up|Overall Study||4
9882602|NCT01036529|10997113|FG001|12 Month Follow-up|Overall Study||3
9882603|NCT01036529|10997112|FG000|Requested Crossover|Overall Study||1
9882604|NCT01036529|10997113|FG001|Requested Crossover|Overall Study||2
9882605|NCT01036529|10997112|FG000|Crossover to Other Group|Overall Study||1
9882606|NCT01036529|10997113|FG001|Crossover to Other Group|Overall Study||1
9882607|NCT01036529|10997112|FG000|COMPLETED|Overall Study||0
9882608|NCT01036529|10997113|FG001|COMPLETED|Overall Study||0
9882609|NCT01036529|10997112|FG000|NOT COMPLETED|Overall Study||13
9882610|NCT01036529|10997113|FG001|NOT COMPLETED|Overall Study||15
9882611|NCT01036594|10997119|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32
9882612|NCT01036594|10997120|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
10008079|NCT01754922|11130390|FG001|COMPLETED|Overall Study||17
10008080|NCT01754922|11130389|FG000|NOT COMPLETED|Overall Study||0
10008081|NCT01754922|11130390|FG001|NOT COMPLETED|Overall Study||1
10108965|NCT02471404|11239491|FG002|STARTED|Overall Study||313
10108966|NCT02471404|11239489|FG000|COMPLETED|Overall Study||281
10108967|NCT02471404|11239490|FG001|COMPLETED|Overall Study||298
10108968|NCT02471404|11239491|FG002|COMPLETED|Overall Study||288
10008082|NCT01755026|11130399|FG000|STARTED|Overall Study||11
10008083|NCT01755026|11130400|FG001|STARTED|Overall Study||12
10008084|NCT01755026|11130399|FG000|COMPLETED|Overall Study||9
10008085|NCT01755026|11130400|FG001|COMPLETED|Overall Study||11
10008086|NCT01755026|11130399|FG000|NOT COMPLETED|Overall Study||2
10008087|NCT01755026|11130400|FG001|NOT COMPLETED|Overall Study||1
10008088|NCT01755091|11130409|FG000|STARTED|Overall Study||26
10008089|NCT01755091|11130410|FG001|STARTED|Overall Study||22
10008090|NCT01755091|11130411|FG002|STARTED|Overall Study||27
10008091|NCT01755091|11130409|FG000|COMPLETED|Overall Study||17
10008092|NCT01755091|11130410|FG001|COMPLETED|Overall Study||19
10008093|NCT01755091|11130411|FG002|COMPLETED|Overall Study||20
10008094|NCT01755091|11130409|FG000|NOT COMPLETED|Overall Study||9
10108969|NCT02471404|11239489|FG000|NOT COMPLETED|Overall Study||33
10108970|NCT02471404|11239490|FG001|NOT COMPLETED|Overall Study||14
9882613|NCT01036594|10997119|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
9882614|NCT01036594|10997120|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
9882615|NCT01036594|10997119|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
9882616|NCT01036594|10997120|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
10008095|NCT01755091|11130410|FG001|NOT COMPLETED|Overall Study||3
10008096|NCT01755091|11130411|FG002|NOT COMPLETED|Overall Study||7
10108971|NCT02471404|11239491|FG002|NOT COMPLETED|Overall Study||25
10008097|NCT01755143|11130421|FG000|STARTED|Overall Study||177
10008098|NCT01755143|11130422|FG001|STARTED|Overall Study||89
10008099|NCT01755143|11130421|FG000|COMPLETED|Overall Study||166
10008100|NCT01755143|11130422|FG001|COMPLETED|Overall Study||86
10008101|NCT01755143|11130421|FG000|NOT COMPLETED|Overall Study||11
10008102|NCT01755143|11130422|FG001|NOT COMPLETED|Overall Study||3
9882617|NCT01036594|10997119|FG000|STARTED|First Treatment Regimen||31
9882618|NCT01036594|10997120|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
9882619|NCT01036594|10997119|FG000|COMPLETED|First Treatment Regimen||30
9882620|NCT01036594|10997120|FG001|COMPLETED|First Treatment Regimen||0
9882621|NCT01036594|10997119|FG000|NOT COMPLETED|First Treatment Regimen||1
9882622|NCT01036594|10997120|FG001|NOT COMPLETED|First Treatment Regimen||0
9882623|NCT01036594|10997119|FG000|STARTED|Week 12 Evaluation||30
9882624|NCT01036594|10997120|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
9882625|NCT01036594|10997119|FG000|COMPLETED|Week 12 Evaluation||24
9882626|NCT01036594|10997120|FG001|COMPLETED|Week 12 Evaluation||0
9882627|NCT01036594|10997119|FG000|NOT COMPLETED|Week 12 Evaluation||6
9882628|NCT01036594|10997120|FG001|NOT COMPLETED|Week 12 Evaluation||0
9882629|NCT01036594|10997119|FG000|STARTED|Treatment Regiments Post Week 12||15
9882630|NCT01036594|10997120|FG001|STARTED|Treatment Regiments Post Week 12||9
9882631|NCT01036594|10997119|FG000|COMPLETED|Treatment Regiments Post Week 12||13
9882632|NCT01036594|10997120|FG001|COMPLETED|Treatment Regiments Post Week 12||5
9882633|NCT01036594|10997119|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2
9882634|NCT01036594|10997120|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
9882635|NCT01036724|10997128|FG000|STARTED|Overall Study||52
9882636|NCT01036724|10997129|FG001|STARTED|Overall Study||55
9882637|NCT01036724|10997128|FG000|COMPLETED|Overall Study||46
9882638|NCT01036724|10997129|FG001|COMPLETED|Overall Study||47
9882639|NCT01036724|10997128|FG000|NOT COMPLETED|Overall Study||6
9882640|NCT01036724|10997129|FG001|NOT COMPLETED|Overall Study||8
9882641|NCT01036763|10997135|FG000|STARTED|Overall Study||1264
9882642|NCT01036763|10997135|FG000|COMPLETED|Overall Study||1171
9882643|NCT01036763|10997135|FG000|NOT COMPLETED|Overall Study||93
9954204|NCT01430741|11072960|FG000|COMPLETED|Overall Study||22
9954205|NCT01430741|11072961|FG001|COMPLETED|Overall Study||87
9954206|NCT01430741|11072962|FG002|COMPLETED|Overall Study||37
9954207|NCT01430741|11072963|FG003|COMPLETED|Overall Study||81
9954208|NCT01430741|11072960|FG000|NOT COMPLETED|Overall Study||0
9954209|NCT01430741|11072961|FG001|NOT COMPLETED|Overall Study||0
9954210|NCT01430741|11072962|FG002|NOT COMPLETED|Overall Study||10
9954211|NCT01430741|11072963|FG003|NOT COMPLETED|Overall Study||0
9954212|NCT01430754|11072976|FG000|STARTED|Run-In Phase||57
9954213|NCT01430754|11072977|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
9954214|NCT01430754|11072976|FG000|Entrained - After Run-In Phase|Run-In Phase||24
9954215|NCT01430754|11072977|FG001|Entrained - After Run-In Phase|Run-In Phase||0
9954216|NCT01430754|11072976|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
9954217|NCT01430754|11072977|FG001|COMPLETED|Run-In Phase||0
9954218|NCT01430754|11072976|FG000|NOT COMPLETED|Run-In Phase||37
9954219|NCT01430754|11072977|FG001|NOT COMPLETED|Run-In Phase||0
9954220|NCT01430754|11072976|FG000|STARTED|Randomized Phase||10
9954221|NCT01430754|11072977|FG001|STARTED|Randomized Phase||10
9954222|NCT01430754|11072976|FG000|COMPLETED|Randomized Phase||10
9954223|NCT01430754|11072977|FG001|COMPLETED|Randomized Phase||10
9954224|NCT01430754|11072976|FG000|NOT COMPLETED|Randomized Phase||0
9954225|NCT01430754|11072977|FG001|NOT COMPLETED|Randomized Phase||0
9954226|NCT01430819|11072987|FG000|STARTED|Overall Study||150
9954227|NCT01430819|11072988|FG001|STARTED|Overall Study||150
9954228|NCT01430819|11072987|FG000|COMPLETED|Overall Study||150
9954229|NCT01430819|11072988|FG001|COMPLETED|Overall Study||150
9954230|NCT01430819|11072987|FG000|NOT COMPLETED|Overall Study||0
9954231|NCT01430819|11072988|FG001|NOT COMPLETED|Overall Study||0
9954232|NCT01431014|11072996|FG000|STARTED|Overall Study||34
9954233|NCT01431014|11072997|FG001|STARTED|Overall Study||34
9954234|NCT01431014|11072996|FG000|COMPLETED|Overall Study||31
9954235|NCT01431014|11072997|FG001|COMPLETED|Overall Study||25
9954236|NCT01431014|11072996|FG000|NOT COMPLETED|Overall Study||3
9954237|NCT01431014|11072997|FG001|NOT COMPLETED|Overall Study||9
9954238|NCT01431079|11073005|FG000|STARTED|Overall Study||45
9954239|NCT01431079|11073006|FG001|STARTED|Overall Study||45
9954240|NCT01431079|11073005|FG000|Post-test|Overall Study||45
9954241|NCT01431079|11073006|FG001|Post-test|Overall Study||45
9954242|NCT01431079|11073005|FG000|COMPLETED|Overall Study||10
9954243|NCT01431079|11073006|FG001|COMPLETED|Overall Study||6
9954244|NCT01431079|11073005|FG000|NOT COMPLETED|Overall Study||35
9954245|NCT01431079|11073006|FG001|NOT COMPLETED|Overall Study||39
9954246|NCT01431105|11073036|FG000|STARTED|Overall Study||34
9954247|NCT01431105|11073036|FG000|COMPLETED|Overall Study||34
10008103|NCT01755156|11130430|FG000|STARTED|Phase A (Weeks 0-24)||201
10008104|NCT01755156|11130431|FG001|STARTED|Phase A (Weeks 0-24)||201
9954248|NCT01431105|11073036|FG000|NOT COMPLETED|Overall Study||0
9954249|NCT01431131|11073042|FG000|STARTED|Overall Study||12
10008105|NCT01755156|11130430|FG000|COMPLETED|Phase A (Weeks 0-24)||184
10008106|NCT01755156|11130431|FG001|COMPLETED|Phase A (Weeks 0-24)||177
10008107|NCT01755156|11130430|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17
10008108|NCT01755156|11130431|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24
9954250|NCT01431131|11073043|FG001|STARTED|Overall Study||12
9882644|NCT01036802|10997141|FG000|STARTED|Overall Study||2
9882645|NCT01036802|10997142|FG001|STARTED|Overall Study||1
9882646|NCT01036802|10997141|FG000|COMPLETED|Overall Study||2
9882647|NCT01036802|10997142|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
9882648|NCT01036802|10997141|FG000|NOT COMPLETED|Overall Study||0
9882649|NCT01036802|10997142|FG001|NOT COMPLETED|Overall Study||0
9882650|NCT01037088|10997149|FG000|STARTED|Overall Study||39
9882651|NCT01037088|10997149|FG000|Received 3.53% THC|Overall Study||36
9882652|NCT01037088|10997149|FG000|Received 1.29% THC|Overall Study||37
9882653|NCT01037088|10997149|FG000|Received Placebo|Overall Study||38
9882654|NCT01037088|10997149|FG000|COMPLETED|Overall Study||36
9882655|NCT01037088|10997149|FG000|NOT COMPLETED|Overall Study||3
9882656|NCT01037114|10997158|FG000|STARTED|Year 16||49
9882657|NCT01037114|10997158|FG000|COMPLETED|Year 16||49
9882658|NCT01037114|10997158|FG000|NOT COMPLETED|Year 16||0
9882659|NCT01037114|10997158|FG000|STARTED|Year 17||48
9882660|NCT01037114|10997158|FG000|COMPLETED|Year 17||48
9882661|NCT01037114|10997158|FG000|NOT COMPLETED|Year 17||0
9882662|NCT01037114|10997158|FG000|STARTED|Year 18||44
9882663|NCT01037114|10997158|FG000|COMPLETED|Year 18||44
9882664|NCT01037114|10997158|FG000|NOT COMPLETED|Year 18||0
9882665|NCT01037114|10997158|FG000|STARTED|Year 19||45
9882666|NCT01037114|10997158|FG000|COMPLETED|Year 19||45
9882667|NCT01037114|10997158|FG000|NOT COMPLETED|Year 19||0
9882668|NCT01037114|10997158|FG000|STARTED|Year 20||45
9882669|NCT01037114|10997158|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
9882670|NCT01037114|10997158|FG000|NOT COMPLETED|Year 20||1
9882671|NCT01037127|10997164|FG000|STARTED|Overall Study||40
9882672|NCT01037127|10997165|FG001|STARTED|Overall Study||57
9882673|NCT01037127|10997164|FG000|COMPLETED|Overall Study||35
9882674|NCT01037127|10997165|FG001|COMPLETED|Overall Study||36
9882675|NCT01037127|10997164|FG000|NOT COMPLETED|Overall Study||5
9882676|NCT01037127|10997165|FG001|NOT COMPLETED|Overall Study||21
9882677|NCT01037192|10997183|FG000|STARTED|Overall Study||3
9882678|NCT01037192|10997184|FG001|STARTED|Overall Study||1
9882679|NCT01037192|10997183|FG000|COMPLETED|Overall Study||3
9882680|NCT01037192|10997184|FG001|COMPLETED|Overall Study||1
9882681|NCT01037192|10997183|FG000|NOT COMPLETED|Overall Study||0
9882682|NCT01037192|10997184|FG001|NOT COMPLETED|Overall Study||0
9882683|NCT01037218|10997196|FG000|STARTED|Overall Study||147
9882684|NCT01037218|10997197|FG001|STARTED|Overall Study||149
9882685|NCT01037218|10997198|FG002|STARTED|Overall Study||155
9882686|NCT01037218|10997199|FG003|STARTED|Overall Study||150
9882687|NCT01037218|10997196|FG000|Safety Population|Overall Study||147
9882688|NCT01037218|10997197|FG001|Safety Population|Overall Study||148
9882689|NCT01037218|10997198|FG002|Safety Population|Overall Study||154
9882690|NCT01037218|10997199|FG003|Safety Population|Overall Study||150
9882691|NCT01037218|10997196|FG000|mITT Population|Overall Study||141
9882692|NCT01037218|10997197|FG001|mITT Population|Overall Study||140
9882693|NCT01037218|10997198|FG002|mITT Population|Overall Study||147
9882694|NCT01037218|10997199|FG003|mITT Population|Overall Study||141
9882695|NCT01037218|10997196|FG000|COMPLETED|Overall Study||131
9882696|NCT01037218|10997197|FG001|COMPLETED|Overall Study||128
9882697|NCT01037218|10997198|FG002|COMPLETED|Overall Study||134
9882698|NCT01037218|10997199|FG003|COMPLETED|Overall Study||134
9882699|NCT01037218|10997196|FG000|NOT COMPLETED|Overall Study||16
9882700|NCT01037218|10997197|FG001|NOT COMPLETED|Overall Study||21
9882701|NCT01037218|10997198|FG002|NOT COMPLETED|Overall Study||21
9882702|NCT01037218|10997199|FG003|NOT COMPLETED|Overall Study||16
9882703|NCT01037244|10997213|FG000|STARTED|Overall Study||154
9882704|NCT01037244|10997214|FG001|STARTED|Overall Study||152
9882705|NCT01037244|10997215|FG002|STARTED|Overall Study||158
9882706|NCT01037244|10997216|FG003|STARTED|Overall Study||154
9882707|NCT01037244|10997213|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150
9882708|NCT01037244|10997214|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148
9882709|NCT01037244|10997215|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154
9882710|NCT01037244|10997216|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153
9882711|NCT01037244|10997213|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
9882712|NCT01037244|10997214|FG001|Safety Population|Overall Study||150
9882713|NCT01037244|10997215|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
9882714|NCT01037244|10997216|FG003|Safety Population|Overall Study||152
9882715|NCT01037244|10997213|FG000|COMPLETED|Overall Study||141
9882716|NCT01037244|10997214|FG001|COMPLETED|Overall Study||138
9882717|NCT01037244|10997215|FG002|COMPLETED|Overall Study||144
9882718|NCT01037244|10997216|FG003|COMPLETED|Overall Study||140
9882719|NCT01037244|10997213|FG000|NOT COMPLETED|Overall Study||13
9882720|NCT01037244|10997214|FG001|NOT COMPLETED|Overall Study||14
9882721|NCT01037244|10997215|FG002|NOT COMPLETED|Overall Study||14
9882722|NCT01037244|10997216|FG003|NOT COMPLETED|Overall Study||14
9882723|NCT01037309|10997232|FG000|STARTED|Subcutaneous Cohort 1 - 6||3
9882724|NCT01037309|10997233|FG001|STARTED|Subcutaneous Cohort 1 - 6||3
9882725|NCT01037309|10997234|FG002|STARTED|Subcutaneous Cohort 1 - 6||3
9882726|NCT01037309|10997235|FG003|STARTED|Subcutaneous Cohort 1 - 6||3
9882727|NCT01037309|10997236|FG004|STARTED|Subcutaneous Cohort 1 - 6||3
9882728|NCT01037309|10997237|FG005|STARTED|Subcutaneous Cohort 1 - 6||3
9882729|NCT01037309|10997238|FG006|STARTED|Subcutaneous Cohort 1 - 6||0
9882730|NCT01037309|10997239|FG007|STARTED|Subcutaneous Cohort 1 - 6||0
9882731|NCT01037309|10997240|FG008|STARTED|Subcutaneous Cohort 1 - 6||0
9882732|NCT01037309|10997232|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3
9882733|NCT01037309|10997233|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3
9882734|NCT01037309|10997234|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3
9882735|NCT01037309|10997235|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3
9882736|NCT01037309|10997236|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3
9882737|NCT01037309|10997237|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3
9882738|NCT01037309|10997238|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0
9882739|NCT01037309|10997239|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0
9882740|NCT01037309|10997240|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0
9882741|NCT01037309|10997232|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882742|NCT01037309|10997233|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882743|NCT01037309|10997234|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882744|NCT01037309|10997235|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882745|NCT01037309|10997236|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882746|NCT01037309|10997237|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882747|NCT01037309|10997238|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882748|NCT01037309|10997239|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882749|NCT01037309|10997240|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
9882750|NCT01037309|10997232|FG000|STARTED|Intravenous Period 7 - 9||0
9882751|NCT01037309|10997233|FG001|STARTED|Intravenous Period 7 - 9||0
9882752|NCT01037309|10997234|FG002|STARTED|Intravenous Period 7 - 9||0
9882753|NCT01037309|10997235|FG003|STARTED|Intravenous Period 7 - 9||0
9882754|NCT01037309|10997236|FG004|STARTED|Intravenous Period 7 - 9||0
9882755|NCT01037309|10997237|FG005|STARTED|Intravenous Period 7 - 9||0
9882756|NCT01037309|10997238|FG006|STARTED|Intravenous Period 7 - 9||3
9882757|NCT01037309|10997239|FG007|STARTED|Intravenous Period 7 - 9||3
9882758|NCT01037309|10997240|FG008|STARTED|Intravenous Period 7 - 9||3
9882759|NCT01037309|10997232|FG000|COMPLETED|Intravenous Period 7 - 9||0
9882760|NCT01037309|10997233|FG001|COMPLETED|Intravenous Period 7 - 9||0
9882761|NCT01037309|10997234|FG002|COMPLETED|Intravenous Period 7 - 9||0
9882762|NCT01037309|10997235|FG003|COMPLETED|Intravenous Period 7 - 9||0
9882763|NCT01037309|10997236|FG004|COMPLETED|Intravenous Period 7 - 9||0
9882764|NCT01037309|10997237|FG005|COMPLETED|Intravenous Period 7 - 9||0
9882765|NCT01037309|10997238|FG006|COMPLETED|Intravenous Period 7 - 9||3
9882766|NCT01037309|10997239|FG007|COMPLETED|Intravenous Period 7 - 9||3
9882767|NCT01037309|10997240|FG008|COMPLETED|Intravenous Period 7 - 9||3
9882768|NCT01037309|10997232|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0
9882769|NCT01037309|10997233|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0
9882770|NCT01037309|10997234|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0
9882771|NCT01037309|10997235|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0
9882772|NCT01037309|10997236|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0
9882773|NCT01037309|10997237|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0
9882774|NCT01037309|10997238|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0
9882775|NCT01037309|10997239|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0
9882776|NCT01037309|10997240|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0
9882777|NCT01037413|10997263|FG000|STARTED|Part A: Skin Testing||25
9882778|NCT01037413|10997264|FG001|STARTED|Part A: Skin Testing||0
9882779|NCT01037413|10997263|FG000|COMPLETED|Part A: Skin Testing||23
9882780|NCT01037413|10997264|FG001|COMPLETED|Part A: Skin Testing||0
9882781|NCT01037413|10997263|FG000|NOT COMPLETED|Part A: Skin Testing||2
9882782|NCT01037413|10997264|FG001|NOT COMPLETED|Part A: Skin Testing||0
9882783|NCT01037413|10997263|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
9882784|NCT01037413|10997264|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
9882785|NCT01037413|10997263|FG000|Treated|Part B: Scar Revision||0
9882786|NCT01037413|10997264|FG001|Treated|Part B: Scar Revision||22
9882787|NCT01037413|10997263|FG000|COMPLETED|Part B: Scar Revision||0
9882788|NCT01037413|10997264|FG001|COMPLETED|Part B: Scar Revision||21
9882789|NCT01037413|10997263|FG000|NOT COMPLETED|Part B: Scar Revision||0
9882790|NCT01037413|10997264|FG001|NOT COMPLETED|Part B: Scar Revision||2
9882791|NCT01037452|10997281|FG000|STARTED|Overall Study||30
9882792|NCT01037452|10997282|FG001|STARTED|Overall Study||30
9882793|NCT01037452|10997283|FG002|STARTED|Overall Study||30
9882794|NCT01037452|10997284|FG003|STARTED|Overall Study||30
9882795|NCT01037452|10997281|FG000|COMPLETED|Overall Study||30
9882796|NCT01037452|10997282|FG001|COMPLETED|Overall Study||30
9882797|NCT01037452|10997283|FG002|COMPLETED|Overall Study||30
9882798|NCT01037452|10997284|FG003|COMPLETED|Overall Study||30
9882799|NCT01037452|10997281|FG000|NOT COMPLETED|Overall Study||0
9882800|NCT01037452|10997282|FG001|NOT COMPLETED|Overall Study||0
9882801|NCT01037452|10997283|FG002|NOT COMPLETED|Overall Study||0
9882802|NCT01037452|10997284|FG003|NOT COMPLETED|Overall Study||0
9882803|NCT01037790|10997299|FG000|STARTED|Overall Study||63
9882804|NCT01037790|10997300|FG001|STARTED|Overall Study||18
9882805|NCT01037790|10997301|FG002|STARTED|Overall Study||19
9882806|NCT01037790|10997302|FG003|STARTED|Overall Study||30
9882807|NCT01037790|10997303|FG004|STARTED|Overall Study||11
9882808|NCT01037790|10997299|FG000|COMPLETED|Overall Study||63
9882809|NCT01037790|10997300|FG001|COMPLETED|Overall Study||18
9882810|NCT01037790|10997301|FG002|COMPLETED|Overall Study||19
9882811|NCT01037790|10997302|FG003|COMPLETED|Overall Study||30
9882812|NCT01037790|10997303|FG004|COMPLETED|Overall Study||11
9882813|NCT01037790|10997299|FG000|NOT COMPLETED|Overall Study||0
9882814|NCT01037790|10997300|FG001|NOT COMPLETED|Overall Study||0
9882815|NCT01037790|10997301|FG002|NOT COMPLETED|Overall Study||0
9882816|NCT01037790|10997302|FG003|NOT COMPLETED|Overall Study||0
9882817|NCT01037790|10997303|FG004|NOT COMPLETED|Overall Study||0
9882818|NCT01037881|10997322|FG000|STARTED|Overall Study||25
9882819|NCT01037881|10997323|FG001|STARTED|Overall Study||24
9882820|NCT01037881|10997324|FG002|STARTED|Overall Study||25
9882821|NCT01037881|10997325|FG003|STARTED|Overall Study||25
9882822|NCT01037881|10997326|FG004|STARTED|Overall Study||29
9882823|NCT01037881|10997327|FG005|STARTED|Overall Study||30
9882824|NCT01037881|10997328|FG006|STARTED|Overall Study||25
9882825|NCT01037881|10997322|FG000|COMPLETED|Overall Study||19
9882826|NCT01037881|10997323|FG001|COMPLETED|Overall Study||22
9882827|NCT01037881|10997324|FG002|COMPLETED|Overall Study||22
9882828|NCT01037881|10997325|FG003|COMPLETED|Overall Study||24
9882829|NCT01037881|10997326|FG004|COMPLETED|Overall Study||26
9882830|NCT01037881|10997327|FG005|COMPLETED|Overall Study||27
9882831|NCT01037881|10997328|FG006|COMPLETED|Overall Study||23
9882832|NCT01037881|10997322|FG000|NOT COMPLETED|Overall Study||6
9882833|NCT01037881|10997323|FG001|NOT COMPLETED|Overall Study||2
9882834|NCT01037881|10997324|FG002|NOT COMPLETED|Overall Study||3
9882835|NCT01037881|10997325|FG003|NOT COMPLETED|Overall Study||1
9882836|NCT01037881|10997326|FG004|NOT COMPLETED|Overall Study||3
9882837|NCT01037881|10997327|FG005|NOT COMPLETED|Overall Study||3
9882838|NCT01037881|10997328|FG006|NOT COMPLETED|Overall Study||2
9882839|NCT01037985|10997353|FG000|STARTED|Part A: Skin Testing (50 Days)||41
9882840|NCT01037985|10997354|FG001|STARTED|Part A: Skin Testing (50 Days)||0
9882841|NCT01037985|10997353|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37
9882842|NCT01037985|10997354|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0
9882843|NCT01037985|10997353|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
9882844|NCT01037985|10997354|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
9882845|NCT01037985|10997353|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
9882846|NCT01037985|10997354|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
9882847|NCT01037985|10997353|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
9882848|NCT01037985|10997354|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
9882849|NCT01037985|10997353|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
9882850|NCT01037985|10997354|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
9882851|NCT01037985|10997353|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
9882852|NCT01037985|10997354|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
9882853|NCT01038128|10997364|FG000|STARTED|Overall Study||5
9882854|NCT01038128|10997364|FG000|Baseline Visit|Overall Study||3
10108972|NCT02471521|11239501|FG000|STARTED|Overall Study||60
10108973|NCT02471521|11239502|FG001|STARTED|Overall Study||60
10108974|NCT02471521|11239501|FG000|COMPLETED|Overall Study||60
10108975|NCT02471521|11239502|FG001|COMPLETED|Overall Study||52
10108976|NCT02471521|11239501|FG000|NOT COMPLETED|Overall Study||0
10108977|NCT02471521|11239502|FG001|NOT COMPLETED|Overall Study||8
10108978|NCT02471586|11239511|FG000|STARTED|Overall Study||158
10108979|NCT02471586|11239512|FG001|STARTED|Overall Study||146
10108980|NCT02471586|11239513|FG002|STARTED|Overall Study||146
9882855|NCT01038128|10997364|FG000|COMPLETED|Overall Study||1
9882856|NCT01038128|10997364|FG000|NOT COMPLETED|Overall Study||4
9882857|NCT01038297|10997373|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10
9882858|NCT01038297|10997374|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10
9882859|NCT01038297|10997375|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10
9882860|NCT01038297|10997373|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9
9882861|NCT01038297|10997374|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
9882862|NCT01038297|10997375|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
9882863|NCT01038297|10997373|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1
9882864|NCT01038297|10997374|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
9882865|NCT01038297|10997375|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
9882866|NCT01038297|10997373|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9
9882867|NCT01038297|10997374|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
9882868|NCT01038297|10997375|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
9882869|NCT01038297|10997373|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9
9882870|NCT01038297|10997374|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
9882871|NCT01038297|10997375|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
9882872|NCT01038297|10997373|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
9882873|NCT01038297|10997374|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
9882874|NCT01038297|10997375|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
9882875|NCT01038323|10997395|FG000|STARTED|Overall Study||20
9882876|NCT01038323|10997396|FG001|STARTED|Overall Study||19
9882877|NCT01038323|10997397|FG002|STARTED|Overall Study||19
9882878|NCT01038323|10997395|FG000|COMPLETED|Overall Study||17
9882879|NCT01038323|10997396|FG001|COMPLETED|Overall Study||17
9882880|NCT01038323|10997397|FG002|COMPLETED|Overall Study||15
9882881|NCT01038323|10997395|FG000|NOT COMPLETED|Overall Study||3
9882882|NCT01038323|10997396|FG001|NOT COMPLETED|Overall Study||2
9882883|NCT01038323|10997397|FG002|NOT COMPLETED|Overall Study||4
9882884|NCT01038336|10997408|FG000|STARTED|Overall Study||43
10108981|NCT02471586|11239511|FG000|COMPLETED|Overall Study||153
10108982|NCT02471586|11239512|FG001|COMPLETED|Overall Study||136
9882885|NCT01038336|10997409|FG001|STARTED|Overall Study||42
10108983|NCT02471586|11239513|FG002|COMPLETED|Overall Study||142
10108984|NCT02471586|11239511|FG000|NOT COMPLETED|Overall Study||5
9882886|NCT01038336|10997410|FG002|STARTED|Overall Study||44
9882887|NCT01038336|10997408|FG000|COMPLETED|Overall Study||43
9882888|NCT01038336|10997409|FG001|COMPLETED|Overall Study||42
9882889|NCT01038336|10997410|FG002|COMPLETED|Overall Study||44
9882890|NCT01038336|10997408|FG000|NOT COMPLETED|Overall Study||0
9882891|NCT01038336|10997409|FG001|NOT COMPLETED|Overall Study||0
9882892|NCT01038336|10997410|FG002|NOT COMPLETED|Overall Study||0
9882893|NCT01038427|10997426|FG000|STARTED|Overall Study||317
9882894|NCT01038427|10997427|FG001|STARTED|Overall Study||320
9882895|NCT01038427|10997428|FG002|STARTED|Overall Study||158
9882896|NCT01038427|10997426|FG000|Per-Protocol (PPP) Population|Overall Study||306
9882897|NCT01038427|10997427|FG001|Per-Protocol (PPP) Population|Overall Study||307
9882898|NCT01038427|10997428|FG002|Per-Protocol (PPP) Population|Overall Study||150
9882899|NCT01038427|10997426|FG000|Intent-to-Treat (ITT) Population|Overall Study||314
9882900|NCT01038427|10997427|FG001|Intent-to-Treat (ITT) Population|Overall Study||314
9882901|NCT01038427|10997428|FG002|Intent-to-Treat (ITT) Population|Overall Study||156
9882902|NCT01038427|10997426|FG000|COMPLETED|Overall Study||314
9882903|NCT01038427|10997427|FG001|COMPLETED|Overall Study||314
9882904|NCT01038427|10997428|FG002|COMPLETED|Overall Study||154
9882905|NCT01038427|10997426|FG000|NOT COMPLETED|Overall Study||3
9882906|NCT01038427|10997427|FG001|NOT COMPLETED|Overall Study||6
9882907|NCT01038427|10997428|FG002|NOT COMPLETED|Overall Study||4
9882908|NCT01038557|10997439|FG000|STARTED|Overall Study||82
9882909|NCT01038557|10997440|FG001|STARTED|Overall Study||86
9882910|NCT01038557|10997441|FG002|STARTED|Overall Study||86
9882911|NCT01038557|10997439|FG000|COMPLETED|Overall Study||82
9882912|NCT01038557|10997440|FG001|COMPLETED|Overall Study||86
9882913|NCT01038557|10997441|FG002|COMPLETED|Overall Study||86
9882914|NCT01038557|10997439|FG000|NOT COMPLETED|Overall Study||0
9882915|NCT01038557|10997440|FG001|NOT COMPLETED|Overall Study||0
9882916|NCT01038557|10997441|FG002|NOT COMPLETED|Overall Study||0
9882917|NCT01038609|10997454|FG000|STARTED|Overall Study||50
9882918|NCT01038609|10997455|FG001|STARTED|Overall Study||52
9882919|NCT01038609|10997456|FG002|STARTED|Overall Study||49
9882920|NCT01038609|10997457|FG003|STARTED|Overall Study||48
9882921|NCT01038609|10997458|FG004|STARTED|Overall Study||51
9882922|NCT01038609|10997454|FG000|COMPLETED|Overall Study||49
9882923|NCT01038609|10997455|FG001|COMPLETED|Overall Study||51
9882924|NCT01038609|10997456|FG002|COMPLETED|Overall Study||48
9882925|NCT01038609|10997457|FG003|COMPLETED|Overall Study||47
9882926|NCT01038609|10997458|FG004|COMPLETED|Overall Study||50
9882927|NCT01038609|10997454|FG000|NOT COMPLETED|Overall Study||1
9882928|NCT01038609|10997455|FG001|NOT COMPLETED|Overall Study||1
9882929|NCT01038609|10997456|FG002|NOT COMPLETED|Overall Study||1
9882930|NCT01038609|10997457|FG003|NOT COMPLETED|Overall Study||1
9882931|NCT01038609|10997458|FG004|NOT COMPLETED|Overall Study||1
9882932|NCT01038635|10997479|FG000|STARTED|Overall Study||5
9882933|NCT01038635|10997480|FG001|STARTED|Overall Study||3
9882934|NCT01038635|10997481|FG002|STARTED|Overall Study||3
9882935|NCT01038635|10997482|FG003|STARTED|Overall Study||3
9882936|NCT01038635|10997483|FG004|STARTED|Overall Study||4
9882937|NCT01038635|10997484|FG005|STARTED|Overall Study||3
9882938|NCT01038635|10997485|FG006|STARTED|Overall Study||7
9882939|NCT01038635|10997486|FG007|STARTED|Overall Study||20
9882940|NCT01038635|10997487|FG008|STARTED|Overall Study||40
9882941|NCT01038635|10997479|FG000|COMPLETED|Overall Study||3
9882942|NCT01038635|10997480|FG001|COMPLETED|Overall Study||3
9882943|NCT01038635|10997481|FG002|COMPLETED|Overall Study||3
9882944|NCT01038635|10997482|FG003|COMPLETED|Overall Study||3
9882945|NCT01038635|10997483|FG004|COMPLETED|Overall Study||3
10108985|NCT02471586|11239512|FG001|NOT COMPLETED|Overall Study||10
10108986|NCT02471586|11239513|FG002|NOT COMPLETED|Overall Study||4
10108987|NCT02471612|11239523|FG000|STARTED|Overall Study||159
9882946|NCT01038635|10997484|FG005|COMPLETED|Overall Study||3
9882947|NCT01038635|10997485|FG006|COMPLETED|Overall Study||5
9882948|NCT01038635|10997486|FG007|COMPLETED|Overall Study||15
9882949|NCT01038635|10997487|FG008|COMPLETED|Overall Study||38
9882950|NCT01038635|10997479|FG000|NOT COMPLETED|Overall Study||2
9882951|NCT01038635|10997480|FG001|NOT COMPLETED|Overall Study||0
9882952|NCT01038635|10997481|FG002|NOT COMPLETED|Overall Study||0
9882953|NCT01038635|10997482|FG003|NOT COMPLETED|Overall Study||0
9882954|NCT01038635|10997483|FG004|NOT COMPLETED|Overall Study||1
9882955|NCT01038635|10997484|FG005|NOT COMPLETED|Overall Study||0
9882956|NCT01038635|10997485|FG006|NOT COMPLETED|Overall Study||2
9882957|NCT01038635|10997486|FG007|NOT COMPLETED|Overall Study||5
9882958|NCT01038635|10997487|FG008|NOT COMPLETED|Overall Study||2
9882959|NCT01038687|10997511|FG000|STARTED|Overall Study||12
9882960|NCT01038687|10997512|FG001|STARTED|Overall Study||11
9882961|NCT01038687|10997513|FG002|STARTED|Overall Study||13
9882962|NCT01038687|10997511|FG000|COMPLETED|Overall Study||12
9882963|NCT01038687|10997512|FG001|COMPLETED|Overall Study||9
9882964|NCT01038687|10997513|FG002|COMPLETED|Overall Study||12
9882965|NCT01038687|10997511|FG000|NOT COMPLETED|Overall Study||0
9882966|NCT01038687|10997512|FG001|NOT COMPLETED|Overall Study||2
9882967|NCT01038687|10997513|FG002|NOT COMPLETED|Overall Study||1
9882968|NCT01038713|10997524|FG000|STARTED|Overall Study||26
9882969|NCT01038713|10997525|FG001|STARTED|Overall Study||20
9882970|NCT01038713|10997526|FG002|STARTED|Overall Study||17
9882971|NCT01038713|10997524|FG000|COMPLETED|Overall Study||21
9882972|NCT01038713|10997525|FG001|COMPLETED|Overall Study||17
9882973|NCT01038713|10997526|FG002|COMPLETED|Overall Study||16
10108988|NCT02471612|11239523|FG000|COMPLETED|Overall Study||157
9882974|NCT01038713|10997524|FG000|NOT COMPLETED|Overall Study||5
9882975|NCT01038713|10997525|FG001|NOT COMPLETED|Overall Study||3
9882976|NCT01038713|10997526|FG002|NOT COMPLETED|Overall Study||1
9882977|NCT01038856|10997534|FG000|STARTED|Overall Study||5
9882978|NCT01038856|10997534|FG000|COMPLETED|Overall Study||3
9882979|NCT01038856|10997534|FG000|NOT COMPLETED|Overall Study||2
9882980|NCT01038869|10997540|FG000|STARTED|Overall Study||20
9882981|NCT01038869|10997540|FG000|COMPLETED|Overall Study||13
9882982|NCT01038869|10997540|FG000|NOT COMPLETED|Overall Study||7
9882983|NCT01038921|10997550|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
9882984|NCT01038921|10997551|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
9882985|NCT01038921|10997550|FG000|COMPLETED|Overall Study|2 subjects withdrew|17
9882986|NCT01038921|10997551|FG001|COMPLETED|Overall Study||20
9882987|NCT01038921|10997550|FG000|NOT COMPLETED|Overall Study||2
9882988|NCT01038921|10997551|FG001|NOT COMPLETED|Overall Study||0
9882989|NCT01039207|10997557|FG000|STARTED|Overall Study||31
9882990|NCT01039207|10997557|FG000|COMPLETED|Overall Study||31
9882991|NCT01039207|10997557|FG000|NOT COMPLETED|Overall Study||0
10008109|NCT01755156|11130430|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
9882992|NCT01039376|10997563|FG000|STARTED|Overall Study||240
9882993|NCT01039376|10997564|FG001|STARTED|Overall Study||240
9882994|NCT01039376|10997563|FG000|COMPLETED|Overall Study||110
9882995|NCT01039376|10997564|FG001|COMPLETED|Overall Study||114
9882996|NCT01039376|10997563|FG000|NOT COMPLETED|Overall Study||130
9882997|NCT01039376|10997564|FG001|NOT COMPLETED|Overall Study||126
9882998|NCT01039428|10997573|FG000|STARTED|Overall Study||35
9882999|NCT01039428|10997574|FG001|STARTED|Overall Study||28
9883000|NCT01039428|10997573|FG000|COMPLETED|Overall Study||33
9883001|NCT01039428|10997574|FG001|COMPLETED|Overall Study||28
9883002|NCT01039428|10997573|FG000|NOT COMPLETED|Overall Study||2
9883003|NCT01039428|10997574|FG001|NOT COMPLETED|Overall Study||0
9883004|NCT01039467|10997582|FG000|STARTED|Overall Study||196
9883005|NCT01039467|10997583|FG001|STARTED|Overall Study||189
9883006|NCT01039467|10997582|FG000|COMPLETED|Overall Study||156
9883007|NCT01039467|10997583|FG001|COMPLETED|Overall Study||140
9883008|NCT01039467|10997582|FG000|NOT COMPLETED|Overall Study||40
9883009|NCT01039467|10997583|FG001|NOT COMPLETED|Overall Study||49
9883010|NCT01039519|10997591|FG000|STARTED|Treatment||27
9883011|NCT01039519|10997591|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
9883012|NCT01039519|10997591|FG000|NOT COMPLETED|Treatment||27
9883013|NCT01039519|10997591|FG000|STARTED|Survival Follow-up||27
9883014|NCT01039519|10997591|FG000|COMPLETED|Survival Follow-up||0
9883015|NCT01039519|10997591|FG000|NOT COMPLETED|Survival Follow-up||27
9883016|NCT01039584|10997598|FG000|STARTED|Overall Study||246
9883017|NCT01039584|10997599|FG001|STARTED|Overall Study||243
9883018|NCT01039584|10997600|FG002|STARTED|Overall Study||122
9883019|NCT01039584|10997598|FG000|COMPLETED|Overall Study||143
9883020|NCT01039584|10997599|FG001|COMPLETED|Overall Study||146
9883021|NCT01039584|10997600|FG002|COMPLETED|Overall Study||65
9883022|NCT01039584|10997598|FG000|NOT COMPLETED|Overall Study||103
9883023|NCT01039584|10997599|FG001|NOT COMPLETED|Overall Study||97
9883024|NCT01039584|10997600|FG002|NOT COMPLETED|Overall Study||57
9883025|NCT01039675|10997610|FG000|STARTED|Overall Study||9
9883026|NCT01039675|10997611|FG001|STARTED|Overall Study||42
9883027|NCT01039675|10997610|FG000|COMPLETED|Overall Study||9
9883028|NCT01039675|10997611|FG001|COMPLETED|Overall Study||35
9883029|NCT01039675|10997610|FG000|NOT COMPLETED|Overall Study||0
9883030|NCT01039675|10997611|FG001|NOT COMPLETED|Overall Study||7
9883031|NCT01039688|10997620|FG000|STARTED|Overall Study||373
9883032|NCT01039688|10997621|FG001|STARTED|Overall Study||397
9883033|NCT01039688|10997622|FG002|STARTED|Overall Study||186
9883034|NCT01039688|10997620|FG000|COMPLETED|Overall Study||266
9883035|NCT01039688|10997621|FG001|COMPLETED|Overall Study||286
9883036|NCT01039688|10997622|FG002|COMPLETED|Overall Study||106
9883037|NCT01039688|10997620|FG000|NOT COMPLETED|Overall Study||107
9883038|NCT01039688|10997621|FG001|NOT COMPLETED|Overall Study||111
9883039|NCT01039688|10997622|FG002|NOT COMPLETED|Overall Study||80
9883040|NCT01039792|10997635|FG000|STARTED|Overall Study||29
9883041|NCT01039792|10997636|FG001|STARTED|Overall Study||28
9883042|NCT01039792|10997635|FG000|COMPLETED|Overall Study||23
9883043|NCT01039792|10997636|FG001|COMPLETED|Overall Study||27
9883044|NCT01039792|10997635|FG000|NOT COMPLETED|Overall Study||6
9883045|NCT01039792|10997636|FG001|NOT COMPLETED|Overall Study||1
9883046|NCT01040052|10997642|FG000|STARTED|Overall Study||30
9883047|NCT01040052|10997642|FG000|COMPLETED|Overall Study||30
9883048|NCT01040052|10997642|FG000|NOT COMPLETED|Overall Study||0
9883049|NCT01040130|10997646|FG000|STARTED|Overall Study|Number of patients entered and treated|25
9883050|NCT01040130|10997647|FG001|STARTED|Overall Study||25
9883051|NCT01040130|10997648|FG002|STARTED|Overall Study||25
9883052|NCT01040130|10997649|FG003|STARTED|Overall Study||25
9883053|NCT01040130|10997650|FG004|STARTED|Overall Study||25
9883054|NCT01040130|10997651|FG005|STARTED|Overall Study||26
9883055|NCT01040130|10997646|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
9883056|NCT01040130|10997647|FG001|COMPLETED|Overall Study||22
9883057|NCT01040130|10997648|FG002|COMPLETED|Overall Study||23
9883058|NCT01040130|10997649|FG003|COMPLETED|Overall Study||20
9883059|NCT01040130|10997650|FG004|COMPLETED|Overall Study||25
9883060|NCT01040130|10997651|FG005|COMPLETED|Overall Study||22
9883061|NCT01040130|10997646|FG000|NOT COMPLETED|Overall Study||3
9883062|NCT01040130|10997647|FG001|NOT COMPLETED|Overall Study||3
9883063|NCT01040130|10997648|FG002|NOT COMPLETED|Overall Study||2
9883064|NCT01040130|10997649|FG003|NOT COMPLETED|Overall Study||5
9883065|NCT01040130|10997650|FG004|NOT COMPLETED|Overall Study||0
9883066|NCT01040130|10997651|FG005|NOT COMPLETED|Overall Study||4
9883067|NCT01040169|10997663|FG000|STARTED|Overall Study||35
9883068|NCT01040169|10997664|FG001|STARTED|Overall Study||44
9883069|NCT01040169|10997663|FG000|COMPLETED|Overall Study||32
9883070|NCT01040169|10997664|FG001|COMPLETED|Overall Study||36
9883071|NCT01040169|10997663|FG000|NOT COMPLETED|Overall Study||3
9883072|NCT01040169|10997664|FG001|NOT COMPLETED|Overall Study||8
9883073|NCT01040208|10997673|FG000|STARTED|Overall Study||45
9883074|NCT01040208|10997674|FG001|STARTED|Overall Study||28
9883075|NCT01040208|10997675|FG002|STARTED|Overall Study||38
9883076|NCT01040208|10997673|FG000|COMPLETED|Overall Study||39
9883077|NCT01040208|10997674|FG001|COMPLETED|Overall Study||15
9883078|NCT01040208|10997675|FG002|COMPLETED|Overall Study||35
9883079|NCT01040208|10997673|FG000|NOT COMPLETED|Overall Study||6
9883080|NCT01040208|10997674|FG001|NOT COMPLETED|Overall Study||13
9883081|NCT01040208|10997675|FG002|NOT COMPLETED|Overall Study||3
9883082|NCT01040260|10997690|FG000|STARTED|Overall Study||53
9883083|NCT01040260|10997691|FG001|STARTED|Overall Study||50
9883084|NCT01040260|10997690|FG000|COMPLETED|Overall Study||38
9883085|NCT01040260|10997691|FG001|COMPLETED|Overall Study||39
9883086|NCT01040260|10997690|FG000|NOT COMPLETED|Overall Study||15
9883087|NCT01040260|10997691|FG001|NOT COMPLETED|Overall Study||11
9883088|NCT01040351|10997699|FG000|STARTED|Overall Study|October 2006|55
9883089|NCT01040351|10997700|FG001|STARTED|Overall Study|October 2006|55
9883090|NCT01040351|10997699|FG000|COMPLETED|Overall Study|May 2010|54
10008110|NCT01755156|11130431|FG001|STARTED|Phase B (Weeks 24-104)||177
10008111|NCT01755156|11130430|FG000|COMPLETED|Phase B (Weeks 24-104)||144
10008112|NCT01755156|11130431|FG001|COMPLETED|Phase B (Weeks 24-104)||141
10008113|NCT01755156|11130430|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39
10008114|NCT01755156|11130431|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36
10008115|NCT01755169|11130445|FG000|STARTED|Overall Study||2
10008116|NCT01755169|11130446|FG001|STARTED|Overall Study||1
10008117|NCT01755169|11130447|FG002|STARTED|Overall Study||0
10108989|NCT02471612|11239523|FG000|NOT COMPLETED|Overall Study||2
10108990|NCT02471651|11239542|FG000|STARTED|Overall Study||20
10108991|NCT02471651|11239543|FG001|STARTED|Overall Study||20
10108992|NCT02471651|11239542|FG000|COMPLETED|Overall Study||15
9883091|NCT01040351|10997700|FG001|COMPLETED|Overall Study|May 2010|53
9883092|NCT01040351|10997699|FG000|NOT COMPLETED|Overall Study||1
9883093|NCT01040351|10997700|FG001|NOT COMPLETED|Overall Study||2
9883094|NCT01040403|10997706|FG000|STARTED|Overall Study||233
9883095|NCT01040403|10997706|FG000|Completed Olo 5|Overall Study||106
9883096|NCT01040403|10997706|FG000|Completed T+O 1.25/5|Overall Study||105
9883097|NCT01040403|10997706|FG000|Completed T+O 2.5/5|Overall Study||111
9883098|NCT01040403|10997706|FG000|Completed T+O 5/5|Overall Study||106
9883099|NCT01040403|10997706|FG000|Completed Olo 10|Overall Study||109
9883100|NCT01040403|10997706|FG000|Completed T+O 1.25/10|Overall Study||106
9883101|NCT01040403|10997706|FG000|Completed T+O 2.5/10|Overall Study||110
9883102|NCT01040403|10997706|FG000|Completed T+O 5/10|Overall Study||107
9883103|NCT01040403|10997706|FG000|COMPLETED|Overall Study|All treatment periods|213
9883104|NCT01040403|10997706|FG000|NOT COMPLETED|Overall Study||20
9883105|NCT01040689|10997725|FG000|STARTED|Overall Study||27
9883106|NCT01040689|10997726|FG001|STARTED|Overall Study||27
9883107|NCT01040689|10997727|FG002|STARTED|Overall Study||27
10108993|NCT02471651|11239543|FG001|COMPLETED|Overall Study||15
9883108|NCT01040689|10997728|FG003|STARTED|Overall Study||27
9883109|NCT01040689|10997725|FG000|COMPLETED|Overall Study||24
9883110|NCT01040689|10997726|FG001|COMPLETED|Overall Study||25
9883111|NCT01040689|10997727|FG002|COMPLETED|Overall Study||23
9883112|NCT01040689|10997728|FG003|COMPLETED|Overall Study||23
10008118|NCT01755169|11130448|FG003|STARTED|Overall Study||1
10108994|NCT02471651|11239542|FG000|NOT COMPLETED|Overall Study||5
10108995|NCT02471651|11239543|FG001|NOT COMPLETED|Overall Study||5
10108996|NCT02471716|11239554|FG000|STARTED|Overall Study||3
10108997|NCT02471716|11239555|FG001|STARTED|Overall Study||3
10108998|NCT02471716|11239556|FG002|STARTED|Overall Study||3
10108999|NCT02471716|11239557|FG003|STARTED|Overall Study||33
9883113|NCT01040689|10997725|FG000|NOT COMPLETED|Overall Study||3
9883114|NCT01040689|10997726|FG001|NOT COMPLETED|Overall Study||2
9883115|NCT01040689|10997727|FG002|NOT COMPLETED|Overall Study||4
9883116|NCT01040689|10997728|FG003|NOT COMPLETED|Overall Study||4
9883117|NCT01040728|10997743|FG000|STARTED|Overall Study||31
9883118|NCT01040728|10997744|FG001|STARTED|Overall Study||30
9883119|NCT01040728|10997745|FG002|STARTED|Overall Study||31
9883120|NCT01040728|10997746|FG003|STARTED|Overall Study||30
9883121|NCT01040728|10997743|FG000|COMPLETED|Overall Study||27
9883122|NCT01040728|10997744|FG001|COMPLETED|Overall Study||19
9883123|NCT01040728|10997745|FG002|COMPLETED|Overall Study||30
9883124|NCT01040728|10997746|FG003|COMPLETED|Overall Study||24
9883125|NCT01040728|10997743|FG000|NOT COMPLETED|Overall Study||4
9883126|NCT01040728|10997744|FG001|NOT COMPLETED|Overall Study||11
9883127|NCT01040728|10997745|FG002|NOT COMPLETED|Overall Study||1
9883128|NCT01040728|10997746|FG003|NOT COMPLETED|Overall Study||6
9883129|NCT01040780|10997764|FG000|STARTED|Overall Study||200
9883130|NCT01040780|10997765|FG001|STARTED|Overall Study||199
9883131|NCT01040780|10997764|FG000|COMPLETED|Overall Study||199
9883132|NCT01040780|10997765|FG001|COMPLETED|Overall Study||196
9883133|NCT01040780|10997764|FG000|NOT COMPLETED|Overall Study||1
9883134|NCT01040780|10997765|FG001|NOT COMPLETED|Overall Study||3
9883135|NCT01040793|10997774|FG000|STARTED|Overall Study|Entered and treated|26
9883136|NCT01040793|10997775|FG001|STARTED|Overall Study||26
9883137|NCT01040793|10997776|FG002|STARTED|Overall Study||26
9883138|NCT01040793|10997777|FG003|STARTED|Overall Study||26
9883139|NCT01040793|10997778|FG004|STARTED|Overall Study||26
9883140|NCT01040793|10997779|FG005|STARTED|Overall Study||27
9883141|NCT01040793|10997774|FG000|COMPLETED|Overall Study||20
9883142|NCT01040793|10997775|FG001|COMPLETED|Overall Study||21
9883143|NCT01040793|10997776|FG002|COMPLETED|Overall Study||23
9883144|NCT01040793|10997777|FG003|COMPLETED|Overall Study||22
9883145|NCT01040793|10997778|FG004|COMPLETED|Overall Study||22
9883146|NCT01040793|10997779|FG005|COMPLETED|Overall Study||26
9883147|NCT01040793|10997774|FG000|NOT COMPLETED|Overall Study||6
9883148|NCT01040793|10997775|FG001|NOT COMPLETED|Overall Study||5
9883149|NCT01040793|10997776|FG002|NOT COMPLETED|Overall Study||3
9883150|NCT01040793|10997777|FG003|NOT COMPLETED|Overall Study||4
9883151|NCT01040793|10997778|FG004|NOT COMPLETED|Overall Study||4
9883152|NCT01040793|10997779|FG005|NOT COMPLETED|Overall Study||1
9883153|NCT01040819|10997791|FG000|STARTED|Overall Study||13
9883154|NCT01040819|10997792|FG001|STARTED|Overall Study||12
9883155|NCT01040819|10997791|FG000|COMPLETED|Overall Study||13
9883156|NCT01040819|10997792|FG001|COMPLETED|Overall Study||12
9883157|NCT01040819|10997791|FG000|NOT COMPLETED|Overall Study||0
9883158|NCT01040819|10997792|FG001|NOT COMPLETED|Overall Study||0
9883159|NCT01040832|10997800|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
9883160|NCT01040832|10997801|FG001|STARTED|Overall Study||53
9883161|NCT01040832|10997800|FG000|COMPLETED|Overall Study||8
9883162|NCT01040832|10997801|FG001|COMPLETED|Overall Study||16
9883163|NCT01040832|10997800|FG000|NOT COMPLETED|Overall Study||46
9883164|NCT01040832|10997801|FG001|NOT COMPLETED|Overall Study||37
9883165|NCT01040845|10997809|FG000|STARTED|Overall Study||15
9883166|NCT01040845|10997810|FG001|STARTED|Overall Study||15
9883167|NCT01040845|10997809|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
9883168|NCT01040845|10997810|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
9883169|NCT01040845|10997809|FG000|NOT COMPLETED|Overall Study||2
9883170|NCT01040845|10997810|FG001|NOT COMPLETED|Overall Study||1
9883171|NCT01040858|10997820|FG000|STARTED|Overall Study||59
9883172|NCT01040858|10997821|FG001|STARTED|Overall Study||69
9883173|NCT01040858|10997820|FG000|COMPLETED|Overall Study||50
9883174|NCT01040858|10997821|FG001|COMPLETED|Overall Study||69
9883175|NCT01040858|10997820|FG000|NOT COMPLETED|Overall Study||9
9883176|NCT01040858|10997821|FG001|NOT COMPLETED|Overall Study||0
9883177|NCT01040871|10997832|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84
9883178|NCT01040871|10997833|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80
9883179|NCT01040871|10997832|FG000|COMPLETED|Overall Study||71
9883180|NCT01040871|10997833|FG001|COMPLETED|Overall Study||73
9883181|NCT01040871|10997832|FG000|NOT COMPLETED|Overall Study||13
9883182|NCT01040871|10997833|FG001|NOT COMPLETED|Overall Study||7
9883183|NCT01041209|10997841|FG000|STARTED|Overall Study||60
9883184|NCT01041209|10997842|FG001|STARTED|Overall Study||60
9883185|NCT01041209|10997841|FG000|COMPLETED|Overall Study||60
9883186|NCT01041209|10997842|FG001|COMPLETED|Overall Study||60
9883187|NCT01041209|10997841|FG000|NOT COMPLETED|Overall Study||0
9883188|NCT01041209|10997842|FG001|NOT COMPLETED|Overall Study||0
9883189|NCT01041248|10997849|FG000|STARTED|Overall Study|January 2010|1
9883190|NCT01041248|10997849|FG000|COMPLETED|Overall Study||1
9883191|NCT01041248|10997849|FG000|NOT COMPLETED|Overall Study||0
9883192|NCT01041274|10997856|FG000|STARTED|Overall Study||49
9883193|NCT01041274|10997857|FG001|STARTED|Overall Study||46
9883194|NCT01041274|10997856|FG000|COMPLETED|Overall Study||26
9883195|NCT01041274|10997857|FG001|COMPLETED|Overall Study||25
9883196|NCT01041274|10997856|FG000|NOT COMPLETED|Overall Study||23
9883197|NCT01041274|10997857|FG001|NOT COMPLETED|Overall Study||21
9883198|NCT01041287|10997865|FG000|STARTED|Treatment Period 1 (3 Months)||19
9883199|NCT01041287|10997866|FG001|STARTED|Treatment Period 1 (3 Months)||19
9883200|NCT01041287|10997865|FG000|COMPLETED|Treatment Period 1 (3 Months)||19
9883201|NCT01041287|10997866|FG001|COMPLETED|Treatment Period 1 (3 Months)||19
9883202|NCT01041287|10997865|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0
9883203|NCT01041287|10997866|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0
9883204|NCT01041287|10997865|FG000|STARTED|Treatment Period 2 (3 Months)||19
9883205|NCT01041287|10997866|FG001|STARTED|Treatment Period 2 (3 Months)||19
9883206|NCT01041287|10997865|FG000|COMPLETED|Treatment Period 2 (3 Months)||16
9883207|NCT01041287|10997866|FG001|COMPLETED|Treatment Period 2 (3 Months)||14
9883208|NCT01041287|10997865|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3
9883209|NCT01041287|10997866|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5
9883210|NCT01041404|10997874|FG000|STARTED|Overall Study||290
9883211|NCT01041404|10997875|FG001|STARTED|Overall Study||294
9883212|NCT01041404|10997874|FG000|Entered Follow-Up|Overall Study||251
9883213|NCT01041404|10997875|FG001|Entered Follow-Up|Overall Study||251
9883214|NCT01041404|10997874|FG000|Died in Follow-up|Overall Study||199
9883215|NCT01041404|10997875|FG001|Died in Follow-up|Overall Study||200
9883216|NCT01041404|10997874|FG000|Lost to Follow-up|Overall Study||12
9883217|NCT01041404|10997875|FG001|Lost to Follow-up|Overall Study||10
9883218|NCT01041404|10997874|FG000|Alive in Follow-up|Overall Study||40
9883219|NCT01041404|10997875|FG001|Alive in Follow-up|Overall Study||41
9883220|NCT01041404|10997874|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
9883221|NCT01041404|10997875|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
9883222|NCT01041404|10997874|FG000|NOT COMPLETED|Overall Study||290
9883223|NCT01041404|10997875|FG001|NOT COMPLETED|Overall Study||294
9883224|NCT01041417|10997886|FG000|STARTED|Overall Study||80
9883225|NCT01041417|10997887|FG001|STARTED|Overall Study||79
9883226|NCT01041417|10997886|FG000|COMPLETED|Overall Study||73
9883227|NCT01041417|10997887|FG001|COMPLETED|Overall Study||76
9883228|NCT01041417|10997886|FG000|NOT COMPLETED|Overall Study||7
9883229|NCT01041417|10997887|FG001|NOT COMPLETED|Overall Study||3
9883230|NCT01041495|10997897|FG000|STARTED|Overall Study||16
9883231|NCT01041495|10997898|FG001|STARTED|Overall Study||12
9883232|NCT01041495|10997897|FG000|COMPLETED|Overall Study||12
9883233|NCT01041495|10997898|FG001|COMPLETED|Overall Study||5
9883234|NCT01041495|10997897|FG000|NOT COMPLETED|Overall Study||4
9883235|NCT01041495|10997898|FG001|NOT COMPLETED|Overall Study||7
9883236|NCT01041521|10997906|FG000|STARTED|Overall Study||61
9883237|NCT01041521|10997907|FG001|STARTED|Overall Study||56
9883238|NCT01041521|10997906|FG000|COMPLETED|Overall Study||44
9883239|NCT01041521|10997907|FG001|COMPLETED|Overall Study||40
9883240|NCT01041521|10997906|FG000|NOT COMPLETED|Overall Study||17
9883241|NCT01041521|10997907|FG001|NOT COMPLETED|Overall Study||16
9883242|NCT01041573|10997917|FG000|STARTED|Overall Study||540
9883243|NCT01041573|10997918|FG001|STARTED|Overall Study||871
9883244|NCT01041573|10997919|FG002|STARTED|Overall Study||394
9883245|NCT01041573|10997920|FG003|STARTED|Overall Study||64
9883246|NCT01041573|10997917|FG000|COMPLETED|Overall Study||535
9883247|NCT01041573|10997918|FG001|COMPLETED|Overall Study||858
9883248|NCT01041573|10997919|FG002|COMPLETED|Overall Study||387
9883249|NCT01041573|10997920|FG003|COMPLETED|Overall Study||62
9883250|NCT01041573|10997917|FG000|NOT COMPLETED|Overall Study||5
9883251|NCT01041573|10997918|FG001|NOT COMPLETED|Overall Study||13
9883252|NCT01041573|10997919|FG002|NOT COMPLETED|Overall Study||7
9883253|NCT01041573|10997920|FG003|NOT COMPLETED|Overall Study||2
9883254|NCT01041638|10997939|FG000|STARTED|Overall Study||105
9883255|NCT01041638|10997939|FG000|COMPLETED|Overall Study||78
9883256|NCT01041638|10997939|FG000|NOT COMPLETED|Overall Study||27
9883257|NCT01041781|10997945|FG000|STARTED|Overall Study||154
9883258|NCT01041781|10997946|FG001|STARTED|Overall Study||158
9883259|NCT01041781|10997945|FG000|COMPLETED|Overall Study||154
9883260|NCT01041781|10997946|FG001|COMPLETED|Overall Study||158
9883261|NCT01041781|10997945|FG000|NOT COMPLETED|Overall Study||0
9883262|NCT01041781|10997946|FG001|NOT COMPLETED|Overall Study||0
9883263|NCT01041859|10997962|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
9883264|NCT01041859|10997963|FG001|STARTED|Open-Label Titration||0
9883265|NCT01041859|10997964|FG002|STARTED|Open-Label Titration||0
10008119|NCT01755169|11130445|FG000|COMPLETED|Overall Study||2
10008120|NCT01755169|11130446|FG001|COMPLETED|Overall Study||1
10008121|NCT01755169|11130447|FG002|COMPLETED|Overall Study||0
10008122|NCT01755169|11130448|FG003|COMPLETED|Overall Study||1
10008123|NCT01755169|11130445|FG000|NOT COMPLETED|Overall Study||0
10008124|NCT01755169|11130446|FG001|NOT COMPLETED|Overall Study||0
10008125|NCT01755169|11130447|FG002|NOT COMPLETED|Overall Study||0
10008126|NCT01755169|11130448|FG003|NOT COMPLETED|Overall Study||0
9883266|NCT01041859|10997962|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
9883267|NCT01041859|10997963|FG001|COMPLETED|Open-Label Titration||0
9883268|NCT01041859|10997964|FG002|COMPLETED|Open-Label Titration||0
9883269|NCT01041859|10997962|FG000|NOT COMPLETED|Open-Label Titration||101
9883270|NCT01041859|10997963|FG001|NOT COMPLETED|Open-Label Titration||0
9883271|NCT01041859|10997964|FG002|NOT COMPLETED|Open-Label Titration||0
9883272|NCT01041859|10997962|FG000|STARTED|Double-Blind Maintenance||0
9883273|NCT01041859|10997963|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
9883274|NCT01041859|10997964|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
9883275|NCT01041859|10997962|FG000|COMPLETED|Double-Blind Maintenance||0
9883276|NCT01041859|10997963|FG001|COMPLETED|Double-Blind Maintenance||120
9883277|NCT01041859|10997964|FG002|COMPLETED|Double-Blind Maintenance||107
9883278|NCT01041859|10997962|FG000|NOT COMPLETED|Double-Blind Maintenance||0
9883279|NCT01041859|10997963|FG001|NOT COMPLETED|Double-Blind Maintenance||46
9883280|NCT01041859|10997964|FG002|NOT COMPLETED|Double-Blind Maintenance||45
9883281|NCT01041976|10997973|FG000|STARTED|Overall Study||42
9883282|NCT01041976|10997974|FG001|STARTED|Overall Study||42
9883283|NCT01041976|10997973|FG000|6 Month Follow-up|Overall Study||39
9883284|NCT01041976|10997974|FG001|6 Month Follow-up|Overall Study||41
9883285|NCT01041976|10997973|FG000|12 Month Follow-up|Overall Study||37
9883286|NCT01041976|10997974|FG001|12 Month Follow-up|Overall Study||38
9883287|NCT01041976|10997973|FG000|18 Month Follow-up|Overall Study||37
9883288|NCT01041976|10997974|FG001|18 Month Follow-up|Overall Study||38
9883289|NCT01041976|10997973|FG000|COMPLETED|Overall Study||37
9883290|NCT01041976|10997974|FG001|COMPLETED|Overall Study||38
9883291|NCT01041976|10997973|FG000|NOT COMPLETED|Overall Study||5
9883292|NCT01041976|10997974|FG001|NOT COMPLETED|Overall Study||4
10008127|NCT01755195|11130458|FG000|STARTED|Overall Study||55
9883293|NCT01042093|10997984|FG000|STARTED|Overall Study||40
9883294|NCT01042093|10997985|FG001|STARTED|Overall Study||40
9883295|NCT01042093|10997986|FG002|STARTED|Overall Study||40
9883296|NCT01042093|10997987|FG003|STARTED|Overall Study||40
9883297|NCT01042093|10997984|FG000|COMPLETED|Overall Study||38
9883298|NCT01042093|10997985|FG001|COMPLETED|Overall Study||38
9883299|NCT01042093|10997986|FG002|COMPLETED|Overall Study||38
9883300|NCT01042093|10997987|FG003|COMPLETED|Overall Study||36
9883301|NCT01042093|10997984|FG000|NOT COMPLETED|Overall Study||2
9883302|NCT01042093|10997985|FG001|NOT COMPLETED|Overall Study||2
9883303|NCT01042093|10997986|FG002|NOT COMPLETED|Overall Study||2
9883304|NCT01042093|10997987|FG003|NOT COMPLETED|Overall Study||4
9883305|NCT01042145|10998002|FG000|STARTED|Overall Study||41
9883306|NCT01042145|10998003|FG001|STARTED|Overall Study||46
9883307|NCT01042145|10998002|FG000|COMPLETED|Overall Study||40
9883308|NCT01042145|10998003|FG001|COMPLETED|Overall Study||45
9883309|NCT01042145|10998002|FG000|NOT COMPLETED|Overall Study||1
9883310|NCT01042145|10998003|FG001|NOT COMPLETED|Overall Study||1
9883311|NCT01042158|10998009|FG000|STARTED|Overall Study||25
9883312|NCT01042158|10998009|FG000|COMPLETED|Overall Study||24
9883313|NCT01042158|10998009|FG000|NOT COMPLETED|Overall Study||1
9883314|NCT01042236|10998013|FG000|STARTED|Treatment Period 1||3
9883315|NCT01042236|10998014|FG001|STARTED|Treatment Period 1||4
9883316|NCT01042236|10998015|FG002|STARTED|Treatment Period 1||3
9883317|NCT01042236|10998016|FG003|STARTED|Treatment Period 1||5
9883318|NCT01042236|10998017|FG004|STARTED|Treatment Period 1||4
9883319|NCT01042236|10998018|FG005|STARTED|Treatment Period 1||3
9883320|NCT01042236|10998013|FG000|COMPLETED|Treatment Period 1||3
9883321|NCT01042236|10998014|FG001|COMPLETED|Treatment Period 1||3
9883322|NCT01042236|10998015|FG002|COMPLETED|Treatment Period 1||3
9883323|NCT01042236|10998016|FG003|COMPLETED|Treatment Period 1||5
9883324|NCT01042236|10998017|FG004|COMPLETED|Treatment Period 1||3
9883325|NCT01042236|10998018|FG005|COMPLETED|Treatment Period 1||3
9883326|NCT01042236|10998013|FG000|NOT COMPLETED|Treatment Period 1||0
9883327|NCT01042236|10998014|FG001|NOT COMPLETED|Treatment Period 1||1
9883328|NCT01042236|10998015|FG002|NOT COMPLETED|Treatment Period 1||0
9883329|NCT01042236|10998016|FG003|NOT COMPLETED|Treatment Period 1||0
9883330|NCT01042236|10998017|FG004|NOT COMPLETED|Treatment Period 1||1
9883331|NCT01042236|10998018|FG005|NOT COMPLETED|Treatment Period 1||0
9883332|NCT01042236|10998013|FG000|STARTED|Treatment Period 2||3
9883333|NCT01042236|10998014|FG001|STARTED|Treatment Period 2||3
9883334|NCT01042236|10998015|FG002|STARTED|Treatment Period 2||3
9883335|NCT01042236|10998016|FG003|STARTED|Treatment Period 2||5
9883336|NCT01042236|10998017|FG004|STARTED|Treatment Period 2||3
9883337|NCT01042236|10998018|FG005|STARTED|Treatment Period 2||3
9883338|NCT01042236|10998013|FG000|COMPLETED|Treatment Period 2||3
9883339|NCT01042236|10998014|FG001|COMPLETED|Treatment Period 2||3
9883340|NCT01042236|10998015|FG002|COMPLETED|Treatment Period 2||3
9883341|NCT01042236|10998016|FG003|COMPLETED|Treatment Period 2||5
9883342|NCT01042236|10998017|FG004|COMPLETED|Treatment Period 2||3
9883343|NCT01042236|10998018|FG005|COMPLETED|Treatment Period 2||3
9883344|NCT01042236|10998013|FG000|NOT COMPLETED|Treatment Period 2||0
9883345|NCT01042236|10998014|FG001|NOT COMPLETED|Treatment Period 2||0
9883346|NCT01042236|10998015|FG002|NOT COMPLETED|Treatment Period 2||0
9883347|NCT01042236|10998016|FG003|NOT COMPLETED|Treatment Period 2||0
9883348|NCT01042236|10998017|FG004|NOT COMPLETED|Treatment Period 2||0
9883349|NCT01042236|10998018|FG005|NOT COMPLETED|Treatment Period 2||0
9883350|NCT01042236|10998013|FG000|STARTED|Treatment Period 3||3
9883351|NCT01042236|10998014|FG001|STARTED|Treatment Period 3||3
9883352|NCT01042236|10998015|FG002|STARTED|Treatment Period 3||3
9883353|NCT01042236|10998016|FG003|STARTED|Treatment Period 3||5
10109000|NCT02471716|11239558|FG004|STARTED|Overall Study||24
10109001|NCT02471716|11239554|FG000|COMPLETED|Overall Study||3
10109002|NCT02471716|11239555|FG001|COMPLETED|Overall Study||2
10109003|NCT02471716|11239556|FG002|COMPLETED|Overall Study||3
9883354|NCT01042236|10998017|FG004|STARTED|Treatment Period 3||3
9883355|NCT01042236|10998018|FG005|STARTED|Treatment Period 3||3
9883356|NCT01042236|10998013|FG000|COMPLETED|Treatment Period 3||3
9883357|NCT01042236|10998014|FG001|COMPLETED|Treatment Period 3||3
9883358|NCT01042236|10998015|FG002|COMPLETED|Treatment Period 3||3
9883359|NCT01042236|10998016|FG003|COMPLETED|Treatment Period 3||3
9883360|NCT01042236|10998017|FG004|COMPLETED|Treatment Period 3||3
9883361|NCT01042236|10998018|FG005|COMPLETED|Treatment Period 3||3
9883362|NCT01042236|10998013|FG000|NOT COMPLETED|Treatment Period 3||0
9883363|NCT01042236|10998014|FG001|NOT COMPLETED|Treatment Period 3||0
9883364|NCT01042236|10998015|FG002|NOT COMPLETED|Treatment Period 3||0
9883365|NCT01042236|10998016|FG003|NOT COMPLETED|Treatment Period 3||2
9883366|NCT01042236|10998017|FG004|NOT COMPLETED|Treatment Period 3||0
9883367|NCT01042236|10998018|FG005|NOT COMPLETED|Treatment Period 3||0
9883368|NCT01042288|10998026|FG000|STARTED|Overall Study||69
9883369|NCT01042288|10998026|FG000|Maintenance|Overall Study||27
9883370|NCT01042288|10998026|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
9883371|NCT01042288|10998026|FG000|NOT COMPLETED|Overall Study||69
10109004|NCT02471716|11239557|FG003|COMPLETED|Overall Study||18
9883372|NCT01042366|10998033|FG000|STARTED|Overall Study||5
9883373|NCT01042366|10998034|FG001|STARTED|Overall Study||6
9883374|NCT01042366|10998035|FG002|STARTED|Overall Study||4
9883375|NCT01042366|10998033|FG000|COMPLETED|Overall Study||5
10109005|NCT02471716|11239558|FG004|COMPLETED|Overall Study||8
9883376|NCT01042366|10998034|FG001|COMPLETED|Overall Study||6
9883377|NCT01042366|10998035|FG002|COMPLETED|Overall Study||4
10109006|NCT02471716|11239554|FG000|NOT COMPLETED|Overall Study||0
10109007|NCT02471716|11239555|FG001|NOT COMPLETED|Overall Study||1
10109008|NCT02471716|11239556|FG002|NOT COMPLETED|Overall Study||0
9883378|NCT01042366|10998033|FG000|NOT COMPLETED|Overall Study||0
9883379|NCT01042366|10998034|FG001|NOT COMPLETED|Overall Study||0
9883380|NCT01042366|10998035|FG002|NOT COMPLETED|Overall Study||0
9883381|NCT01042392|10998043|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257
9883382|NCT01042392|10998044|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
9883383|NCT01042392|10998045|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249
9883384|NCT01042392|10998046|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
9883385|NCT01042392|10998043|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
9883386|NCT01042392|10998044|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
9883387|NCT01042392|10998045|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
9883388|NCT01042392|10998046|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
9883389|NCT01042392|10998043|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
9883390|NCT01042392|10998044|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
9883391|NCT01042392|10998045|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
9883392|NCT01042392|10998046|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
9883393|NCT01042392|10998043|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
9883394|NCT01042392|10998044|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
9883395|NCT01042392|10998045|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
9883396|NCT01042392|10998046|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
9883397|NCT01042392|10998043|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
9883398|NCT01042392|10998044|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
9883399|NCT01042392|10998045|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
9883400|NCT01042392|10998046|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
9883401|NCT01042392|10998043|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
9883402|NCT01042392|10998044|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
9883403|NCT01042392|10998045|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
9883404|NCT01042392|10998046|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
9883405|NCT01042392|10998043|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
9883406|NCT01042392|10998044|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
9883407|NCT01042392|10998045|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
9883408|NCT01042392|10998046|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
9883409|NCT01042392|10998043|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
9883410|NCT01042392|10998044|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
9883411|NCT01042392|10998045|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
9883412|NCT01042392|10998046|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
9883413|NCT01042496|10998060|FG000|STARTED|Overall Study||29
9883414|NCT01042496|10998061|FG001|STARTED|Overall Study||33
9883415|NCT01042496|10998060|FG000|COMPLETED|Overall Study||29
9883416|NCT01042496|10998061|FG001|COMPLETED|Overall Study||33
9883417|NCT01042496|10998060|FG000|NOT COMPLETED|Overall Study||0
9883418|NCT01042496|10998061|FG001|NOT COMPLETED|Overall Study||0
9883419|NCT01042509|10998071|FG000|STARTED|Overall Study||15
9883420|NCT01042509|10998071|FG000|COMPLETED|Overall Study||15
9883421|NCT01042509|10998071|FG000|NOT COMPLETED|Overall Study||0
9883422|NCT01042535|10998075|FG000|STARTED|Overall Study||44
9883423|NCT01042535|10998075|FG000|COMPLETED|Overall Study||36
9883424|NCT01042535|10998075|FG000|NOT COMPLETED|Overall Study||8
9883425|NCT01042600|10998081|FG000|STARTED|Overall Study||31
9883426|NCT01042600|10998082|FG001|STARTED|Overall Study||30
9883427|NCT01042600|10998081|FG000|COMPLETED|Overall Study||30
9883428|NCT01042600|10998082|FG001|COMPLETED|Overall Study||30
9883429|NCT01042600|10998081|FG000|NOT COMPLETED|Overall Study||1
9883430|NCT01042600|10998082|FG001|NOT COMPLETED|Overall Study||0
9883431|NCT01042613|10998091|FG000|STARTED|Overall Study||72
10008128|NCT01755195|11130458|FG000|COMPLETED|Overall Study||42
10008129|NCT01755195|11130458|FG000|NOT COMPLETED|Overall Study||13
9883432|NCT01042613|10998092|FG001|STARTED|Overall Study||74
9883433|NCT01042613|10998091|FG000|COMPLETED|Overall Study||72
9883434|NCT01042613|10998092|FG001|COMPLETED|Overall Study||74
9883435|NCT01042613|10998091|FG000|NOT COMPLETED|Overall Study||0
9883436|NCT01042613|10998092|FG001|NOT COMPLETED|Overall Study||0
9883437|NCT01042678|10998101|FG000|STARTED|Overall Study||6
9883438|NCT01042678|10998102|FG001|STARTED|Overall Study||6
9883439|NCT01042678|10998103|FG002|STARTED|Overall Study||6
9883440|NCT01042678|10998104|FG003|STARTED|Overall Study||0
9883441|NCT01042678|10998105|FG004|STARTED|Overall Study||0
9883442|NCT01042678|10998106|FG005|STARTED|Overall Study||0
9883443|NCT01042678|10998101|FG000|COMPLETED|Overall Study||5
9883444|NCT01042678|10998102|FG001|COMPLETED|Overall Study||6
9883445|NCT01042678|10998103|FG002|COMPLETED|Overall Study||6
10008130|NCT01755234|11130464|FG000|STARTED|Overall Study||45
10008131|NCT01755234|11130465|FG001|STARTED|Overall Study||45
10008132|NCT01755234|11130464|FG000|COMPLETED|Overall Study||30
10008133|NCT01755234|11130465|FG001|COMPLETED|Overall Study||37
10008134|NCT01755234|11130464|FG000|NOT COMPLETED|Overall Study||15
9883446|NCT01042678|10998104|FG003|COMPLETED|Overall Study||0
9883447|NCT01042678|10998105|FG004|COMPLETED|Overall Study||0
9883448|NCT01042678|10998106|FG005|COMPLETED|Overall Study||0
9883449|NCT01042678|10998101|FG000|NOT COMPLETED|Overall Study||1
9883450|NCT01042678|10998102|FG001|NOT COMPLETED|Overall Study||0
9883451|NCT01042678|10998103|FG002|NOT COMPLETED|Overall Study||0
9883452|NCT01042678|10998104|FG003|NOT COMPLETED|Overall Study||0
9883453|NCT01042678|10998105|FG004|NOT COMPLETED|Overall Study||0
9883454|NCT01042678|10998106|FG005|NOT COMPLETED|Overall Study||0
9883455|NCT01042795|10998114|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
9883456|NCT01042795|10998114|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
9883457|NCT01042795|10998114|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
9883458|NCT01042795|10998114|FG000|STARTED|Follow up - 22 Months After Drug Start||2
9883459|NCT01042795|10998114|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0
9883460|NCT01042795|10998114|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
9883461|NCT01042938|10998120|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
9883462|NCT01042938|10998121|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
9883463|NCT01042938|10998120|FG000|COMPLETED|Overall Study||14
9883464|NCT01042938|10998121|FG001|COMPLETED|Overall Study||16
9883465|NCT01042938|10998120|FG000|NOT COMPLETED|Overall Study||3
9883466|NCT01042938|10998121|FG001|NOT COMPLETED|Overall Study||2
9883467|NCT01042977|10998131|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
9883468|NCT01042977|10998132|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
9883469|NCT01042977|10998131|FG000|COMPLETED|Overall Study||441
9883470|NCT01042977|10998132|FG001|COMPLETED|Overall Study||428
9883471|NCT01042977|10998131|FG000|NOT COMPLETED|Overall Study||41
9883472|NCT01042977|10998132|FG001|NOT COMPLETED|Overall Study||55
9883473|NCT01043094|10998140|FG000|STARTED|Overall Study||8
9883474|NCT01043094|10998141|FG001|STARTED|Overall Study||8
9883475|NCT01043094|10998140|FG000|COMPLETED|Overall Study||8
9883476|NCT01043094|10998141|FG001|COMPLETED|Overall Study||8
9883477|NCT01043094|10998140|FG000|NOT COMPLETED|Overall Study||0
9883478|NCT01043094|10998141|FG001|NOT COMPLETED|Overall Study||0
9883479|NCT01043133|10998149|FG000|STARTED|Overall Study||75
9883480|NCT01043133|10998150|FG001|STARTED|Overall Study||80
9883481|NCT01043133|10998149|FG000|COMPLETED|Overall Study||74
9883482|NCT01043133|10998150|FG001|COMPLETED|Overall Study||78
9883483|NCT01043133|10998149|FG000|NOT COMPLETED|Overall Study||1
9883484|NCT01043133|10998150|FG001|NOT COMPLETED|Overall Study||2
9883485|NCT01043146|10998162|FG000|STARTED|Overall Study||10
9883486|NCT01043146|10998163|FG001|STARTED|Overall Study||8
9883487|NCT01043146|10998164|FG002|STARTED|Overall Study||8
9883488|NCT01043146|10998165|FG003|STARTED|Overall Study||8
9883489|NCT01043146|10998166|FG004|STARTED|Overall Study||8
9883490|NCT01043146|10998167|FG005|STARTED|Overall Study||8
9883491|NCT01043146|10998162|FG000|COMPLETED|Overall Study||10
9883492|NCT01043146|10998163|FG001|COMPLETED|Overall Study||8
9883493|NCT01043146|10998164|FG002|COMPLETED|Overall Study||8
9883494|NCT01043146|10998165|FG003|COMPLETED|Overall Study||8
9883495|NCT01043146|10998166|FG004|COMPLETED|Overall Study||8
9883496|NCT01043146|10998167|FG005|COMPLETED|Overall Study||8
9883497|NCT01043146|10998162|FG000|NOT COMPLETED|Overall Study||0
9883498|NCT01043146|10998163|FG001|NOT COMPLETED|Overall Study||0
9883499|NCT01043146|10998164|FG002|NOT COMPLETED|Overall Study||0
9883500|NCT01043146|10998165|FG003|NOT COMPLETED|Overall Study||0
9883501|NCT01043146|10998166|FG004|NOT COMPLETED|Overall Study||0
9883502|NCT01043146|10998167|FG005|NOT COMPLETED|Overall Study||0
9883503|NCT01043185|10998181|FG000|STARTED|Period 1 - First Intervention||3
9883504|NCT01043185|10998182|FG001|STARTED|Period 1 - First Intervention||2
9883505|NCT01043185|10998183|FG002|STARTED|Period 1 - First Intervention||3
9883506|NCT01043185|10998184|FG003|STARTED|Period 1 - First Intervention||2
9883507|NCT01043185|10998185|FG004|STARTED|Period 1 - First Intervention||2
9883508|NCT01043185|10998186|FG005|STARTED|Period 1 - First Intervention||3
9883509|NCT01043185|10998187|FG006|STARTED|Period 1 - First Intervention||3
9883510|NCT01043185|10998188|FG007|STARTED|Period 1 - First Intervention||3
9883511|NCT01043185|10998189|FG008|STARTED|Period 1 - First Intervention||3
9883512|NCT01043185|10998190|FG009|STARTED|Period 1 - First Intervention||3
9883513|NCT01043185|10998181|FG000|COMPLETED|Period 1 - First Intervention||3
9883514|NCT01043185|10998182|FG001|COMPLETED|Period 1 - First Intervention||2
9883515|NCT01043185|10998183|FG002|COMPLETED|Period 1 - First Intervention||3
9883516|NCT01043185|10998184|FG003|COMPLETED|Period 1 - First Intervention||2
9883517|NCT01043185|10998185|FG004|COMPLETED|Period 1 - First Intervention||2
9883518|NCT01043185|10998186|FG005|COMPLETED|Period 1 - First Intervention||3
9883519|NCT01043185|10998187|FG006|COMPLETED|Period 1 - First Intervention||3
9883520|NCT01043185|10998188|FG007|COMPLETED|Period 1 - First Intervention||3
9883521|NCT01043185|10998189|FG008|COMPLETED|Period 1 - First Intervention||3
9883522|NCT01043185|10998190|FG009|COMPLETED|Period 1 - First Intervention||3
9883523|NCT01043185|10998181|FG000|NOT COMPLETED|Period 1 - First Intervention||0
9883524|NCT01043185|10998182|FG001|NOT COMPLETED|Period 1 - First Intervention||0
9883525|NCT01043185|10998183|FG002|NOT COMPLETED|Period 1 - First Intervention||0
9883526|NCT01043185|10998184|FG003|NOT COMPLETED|Period 1 - First Intervention||0
9883527|NCT01043185|10998185|FG004|NOT COMPLETED|Period 1 - First Intervention||0
9883528|NCT01043185|10998186|FG005|NOT COMPLETED|Period 1 - First Intervention||0
9883529|NCT01043185|10998187|FG006|NOT COMPLETED|Period 1 - First Intervention||0
9883530|NCT01043185|10998188|FG007|NOT COMPLETED|Period 1 - First Intervention||0
9883531|NCT01043185|10998189|FG008|NOT COMPLETED|Period 1 - First Intervention||0
9883532|NCT01043185|10998190|FG009|NOT COMPLETED|Period 1 - First Intervention||0
9883533|NCT01043185|10998181|FG000|STARTED|Period 2 - First Washout Period||3
9883534|NCT01043185|10998182|FG001|STARTED|Period 2 - First Washout Period||2
9883535|NCT01043185|10998183|FG002|STARTED|Period 2 - First Washout Period||3
9883536|NCT01043185|10998184|FG003|STARTED|Period 2 - First Washout Period||2
9883537|NCT01043185|10998185|FG004|STARTED|Period 2 - First Washout Period||2
9883538|NCT01043185|10998186|FG005|STARTED|Period 2 - First Washout Period||3
9883539|NCT01043185|10998187|FG006|STARTED|Period 2 - First Washout Period||3
9883540|NCT01043185|10998188|FG007|STARTED|Period 2 - First Washout Period||3
9883541|NCT01043185|10998189|FG008|STARTED|Period 2 - First Washout Period||3
9883542|NCT01043185|10998190|FG009|STARTED|Period 2 - First Washout Period||3
9883543|NCT01043185|10998181|FG000|COMPLETED|Period 2 - First Washout Period||3
9883544|NCT01043185|10998182|FG001|COMPLETED|Period 2 - First Washout Period||2
9883545|NCT01043185|10998183|FG002|COMPLETED|Period 2 - First Washout Period||3
9883546|NCT01043185|10998184|FG003|COMPLETED|Period 2 - First Washout Period||2
9883547|NCT01043185|10998185|FG004|COMPLETED|Period 2 - First Washout Period||2
9883548|NCT01043185|10998186|FG005|COMPLETED|Period 2 - First Washout Period||3
9883549|NCT01043185|10998187|FG006|COMPLETED|Period 2 - First Washout Period||3
9883550|NCT01043185|10998188|FG007|COMPLETED|Period 2 - First Washout Period||3
9883551|NCT01043185|10998189|FG008|COMPLETED|Period 2 - First Washout Period||3
9883552|NCT01043185|10998190|FG009|COMPLETED|Period 2 - First Washout Period||3
9883553|NCT01043185|10998181|FG000|NOT COMPLETED|Period 2 - First Washout Period||0
9883554|NCT01043185|10998182|FG001|NOT COMPLETED|Period 2 - First Washout Period||0
9883555|NCT01043185|10998183|FG002|NOT COMPLETED|Period 2 - First Washout Period||0
10109009|NCT02471716|11239557|FG003|NOT COMPLETED|Overall Study||15
10109010|NCT02471716|11239558|FG004|NOT COMPLETED|Overall Study||16
10109011|NCT02471755|11239574|FG000|STARTED|Overall Study||45
10109012|NCT02471755|11239575|FG001|STARTED|Overall Study||45
10109013|NCT02471755|11239574|FG000|COMPLETED|Overall Study||44
10109014|NCT02471755|11239575|FG001|COMPLETED|Overall Study||44
10109015|NCT02471755|11239574|FG000|NOT COMPLETED|Overall Study||1
10109016|NCT02471755|11239575|FG001|NOT COMPLETED|Overall Study||1
10109017|NCT02472145|11239584|FG000|STARTED|Overall Study||10
10109018|NCT02472145|11239585|FG001|STARTED|Overall Study||159
10109019|NCT02472145|11239586|FG002|STARTED|Overall Study||157
10109020|NCT02472145|11239584|FG000|Treated|Overall Study||10
10109021|NCT02472145|11239585|FG001|Treated|Overall Study||156
10109022|NCT02472145|11239586|FG002|Treated|Overall Study||156
10109023|NCT02472145|11239584|FG000|Safety|Overall Study||10
10109024|NCT02472145|11239585|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
10109025|NCT02472145|11239586|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
10109026|NCT02472145|11239584|FG000|COMPLETED|Overall Study||0
10109027|NCT02472145|11239585|FG001|COMPLETED|Overall Study||0
9883556|NCT01043185|10998184|FG003|NOT COMPLETED|Period 2 - First Washout Period||0
9883557|NCT01043185|10998185|FG004|NOT COMPLETED|Period 2 - First Washout Period||0
9883558|NCT01043185|10998186|FG005|NOT COMPLETED|Period 2 - First Washout Period||0
9883559|NCT01043185|10998187|FG006|NOT COMPLETED|Period 2 - First Washout Period||0
9883560|NCT01043185|10998188|FG007|NOT COMPLETED|Period 2 - First Washout Period||0
9883561|NCT01043185|10998189|FG008|NOT COMPLETED|Period 2 - First Washout Period||0
9883562|NCT01043185|10998190|FG009|NOT COMPLETED|Period 2 - First Washout Period||0
9883563|NCT01043185|10998181|FG000|STARTED|Period 3 - Second Intervention||3
9883564|NCT01043185|10998182|FG001|STARTED|Period 3 - Second Intervention||2
9883565|NCT01043185|10998183|FG002|STARTED|Period 3 - Second Intervention||3
9883566|NCT01043185|10998184|FG003|STARTED|Period 3 - Second Intervention||2
9883567|NCT01043185|10998185|FG004|STARTED|Period 3 - Second Intervention||2
9883568|NCT01043185|10998186|FG005|STARTED|Period 3 - Second Intervention||3
9883569|NCT01043185|10998187|FG006|STARTED|Period 3 - Second Intervention||3
9883570|NCT01043185|10998188|FG007|STARTED|Period 3 - Second Intervention||3
9883571|NCT01043185|10998189|FG008|STARTED|Period 3 - Second Intervention||3
9883572|NCT01043185|10998190|FG009|STARTED|Period 3 - Second Intervention||3
9883573|NCT01043185|10998181|FG000|COMPLETED|Period 3 - Second Intervention||3
9883574|NCT01043185|10998182|FG001|COMPLETED|Period 3 - Second Intervention||2
9883575|NCT01043185|10998183|FG002|COMPLETED|Period 3 - Second Intervention||3
9883576|NCT01043185|10998184|FG003|COMPLETED|Period 3 - Second Intervention||2
9883577|NCT01043185|10998185|FG004|COMPLETED|Period 3 - Second Intervention||2
9883578|NCT01043185|10998186|FG005|COMPLETED|Period 3 - Second Intervention||3
9883579|NCT01043185|10998187|FG006|COMPLETED|Period 3 - Second Intervention||3
9883580|NCT01043185|10998188|FG007|COMPLETED|Period 3 - Second Intervention||3
9883581|NCT01043185|10998189|FG008|COMPLETED|Period 3 - Second Intervention||3
9883582|NCT01043185|10998190|FG009|COMPLETED|Period 3 - Second Intervention||3
9883583|NCT01043185|10998181|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
9883584|NCT01043185|10998182|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
10109028|NCT02472145|11239586|FG002|COMPLETED|Overall Study||0
10109029|NCT02472145|11239584|FG000|NOT COMPLETED|Overall Study||10
10109030|NCT02472145|11239585|FG001|NOT COMPLETED|Overall Study||159
10109031|NCT02472145|11239586|FG002|NOT COMPLETED|Overall Study||157
10109032|NCT02472223|11239595|FG000|STARTED|Overall Study||16
10109033|NCT02472223|11239596|FG001|STARTED|Overall Study||12
9883585|NCT01043185|10998183|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
9883586|NCT01043185|10998184|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
9883587|NCT01043185|10998185|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
9883588|NCT01043185|10998186|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
9883589|NCT01043185|10998187|FG006|NOT COMPLETED|Period 3 - Second Intervention||0
9883590|NCT01043185|10998188|FG007|NOT COMPLETED|Period 3 - Second Intervention||0
9883591|NCT01043185|10998189|FG008|NOT COMPLETED|Period 3 - Second Intervention||0
9883592|NCT01043185|10998190|FG009|NOT COMPLETED|Period 3 - Second Intervention||0
9883593|NCT01043185|10998181|FG000|STARTED|Period 4 - Second Washout Period||3
9883594|NCT01043185|10998182|FG001|STARTED|Period 4 - Second Washout Period||2
9883595|NCT01043185|10998183|FG002|STARTED|Period 4 - Second Washout Period||3
9883596|NCT01043185|10998184|FG003|STARTED|Period 4 - Second Washout Period||2
9883597|NCT01043185|10998185|FG004|STARTED|Period 4 - Second Washout Period||2
9883598|NCT01043185|10998186|FG005|STARTED|Period 4 - Second Washout Period||3
9883599|NCT01043185|10998187|FG006|STARTED|Period 4 - Second Washout Period||3
9883600|NCT01043185|10998188|FG007|STARTED|Period 4 - Second Washout Period||3
9883601|NCT01043185|10998189|FG008|STARTED|Period 4 - Second Washout Period||3
9883602|NCT01043185|10998190|FG009|STARTED|Period 4 - Second Washout Period||3
9883603|NCT01043185|10998181|FG000|COMPLETED|Period 4 - Second Washout Period||3
9883604|NCT01043185|10998182|FG001|COMPLETED|Period 4 - Second Washout Period||2
9883605|NCT01043185|10998183|FG002|COMPLETED|Period 4 - Second Washout Period||3
9883606|NCT01043185|10998184|FG003|COMPLETED|Period 4 - Second Washout Period||2
9883607|NCT01043185|10998185|FG004|COMPLETED|Period 4 - Second Washout Period||2
9883608|NCT01043185|10998186|FG005|COMPLETED|Period 4 - Second Washout Period||3
9883609|NCT01043185|10998187|FG006|COMPLETED|Period 4 - Second Washout Period||3
9883610|NCT01043185|10998188|FG007|COMPLETED|Period 4 - Second Washout Period||3
9883611|NCT01043185|10998189|FG008|COMPLETED|Period 4 - Second Washout Period||3
9883612|NCT01043185|10998190|FG009|COMPLETED|Period 4 - Second Washout Period||3
9883613|NCT01043185|10998181|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0
9883614|NCT01043185|10998182|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0
9883615|NCT01043185|10998183|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0
9883616|NCT01043185|10998184|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0
9883617|NCT01043185|10998185|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0
9883618|NCT01043185|10998186|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0
9883619|NCT01043185|10998187|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0
9883620|NCT01043185|10998188|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0
9883621|NCT01043185|10998189|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0
9883622|NCT01043185|10998190|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0
9883623|NCT01043185|10998181|FG000|STARTED|Period 5 - Third Intervention||3
9883624|NCT01043185|10998182|FG001|STARTED|Period 5 - Third Intervention||2
9883625|NCT01043185|10998183|FG002|STARTED|Period 5 - Third Intervention||3
9883626|NCT01043185|10998184|FG003|STARTED|Period 5 - Third Intervention||2
9883627|NCT01043185|10998185|FG004|STARTED|Period 5 - Third Intervention||2
9883628|NCT01043185|10998186|FG005|STARTED|Period 5 - Third Intervention||3
9883629|NCT01043185|10998187|FG006|STARTED|Period 5 - Third Intervention||3
9883630|NCT01043185|10998188|FG007|STARTED|Period 5 - Third Intervention||3
9883631|NCT01043185|10998189|FG008|STARTED|Period 5 - Third Intervention||3
9883632|NCT01043185|10998190|FG009|STARTED|Period 5 - Third Intervention||3
9883633|NCT01043185|10998181|FG000|COMPLETED|Period 5 - Third Intervention||3
9883634|NCT01043185|10998182|FG001|COMPLETED|Period 5 - Third Intervention||2
9883635|NCT01043185|10998183|FG002|COMPLETED|Period 5 - Third Intervention||3
9883636|NCT01043185|10998184|FG003|COMPLETED|Period 5 - Third Intervention||2
9883637|NCT01043185|10998185|FG004|COMPLETED|Period 5 - Third Intervention||2
9883638|NCT01043185|10998186|FG005|COMPLETED|Period 5 - Third Intervention||3
9883639|NCT01043185|10998187|FG006|COMPLETED|Period 5 - Third Intervention||3
9883640|NCT01043185|10998188|FG007|COMPLETED|Period 5 - Third Intervention||3
9883641|NCT01043185|10998189|FG008|COMPLETED|Period 5 - Third Intervention||3
9883642|NCT01043185|10998190|FG009|COMPLETED|Period 5 - Third Intervention||3
9883643|NCT01043185|10998181|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
9883644|NCT01043185|10998182|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
9883645|NCT01043185|10998183|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
9883646|NCT01043185|10998184|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
9883647|NCT01043185|10998185|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
9883648|NCT01043185|10998186|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
9883649|NCT01043185|10998187|FG006|NOT COMPLETED|Period 5 - Third Intervention||0
9883650|NCT01043185|10998188|FG007|NOT COMPLETED|Period 5 - Third Intervention||0
9883651|NCT01043185|10998189|FG008|NOT COMPLETED|Period 5 - Third Intervention||0
9883652|NCT01043185|10998190|FG009|NOT COMPLETED|Period 5 - Third Intervention||0
9883653|NCT01043185|10998181|FG000|STARTED|Period 6 - Third Washout Period||3
9883654|NCT01043185|10998182|FG001|STARTED|Period 6 - Third Washout Period||2
9883655|NCT01043185|10998183|FG002|STARTED|Period 6 - Third Washout Period||3
9883656|NCT01043185|10998184|FG003|STARTED|Period 6 - Third Washout Period||2
9883657|NCT01043185|10998185|FG004|STARTED|Period 6 - Third Washout Period||2
9883658|NCT01043185|10998186|FG005|STARTED|Period 6 - Third Washout Period||3
9883659|NCT01043185|10998187|FG006|STARTED|Period 6 - Third Washout Period||3
9883660|NCT01043185|10998188|FG007|STARTED|Period 6 - Third Washout Period||3
9883661|NCT01043185|10998189|FG008|STARTED|Period 6 - Third Washout Period||3
9883662|NCT01043185|10998190|FG009|STARTED|Period 6 - Third Washout Period||3
9883663|NCT01043185|10998181|FG000|COMPLETED|Period 6 - Third Washout Period||3
9883664|NCT01043185|10998182|FG001|COMPLETED|Period 6 - Third Washout Period||2
9883665|NCT01043185|10998183|FG002|COMPLETED|Period 6 - Third Washout Period||3
9883666|NCT01043185|10998184|FG003|COMPLETED|Period 6 - Third Washout Period||2
9883667|NCT01043185|10998185|FG004|COMPLETED|Period 6 - Third Washout Period||2
9883668|NCT01043185|10998186|FG005|COMPLETED|Period 6 - Third Washout Period||3
9883669|NCT01043185|10998187|FG006|COMPLETED|Period 6 - Third Washout Period||3
9883670|NCT01043185|10998188|FG007|COMPLETED|Period 6 - Third Washout Period||3
9883671|NCT01043185|10998189|FG008|COMPLETED|Period 6 - Third Washout Period||2
9883672|NCT01043185|10998190|FG009|COMPLETED|Period 6 - Third Washout Period||3
9883673|NCT01043185|10998181|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0
9883674|NCT01043185|10998182|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0
9883675|NCT01043185|10998183|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0
9883676|NCT01043185|10998184|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0
9883677|NCT01043185|10998185|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0
9883678|NCT01043185|10998186|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0
9883679|NCT01043185|10998187|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0
9883680|NCT01043185|10998188|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0
9883681|NCT01043185|10998189|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1
9883682|NCT01043185|10998190|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0
9883683|NCT01043185|10998181|FG000|STARTED|Period 7 - Fourth Intervention||3
9883684|NCT01043185|10998182|FG001|STARTED|Period 7 - Fourth Intervention||2
9883685|NCT01043185|10998183|FG002|STARTED|Period 7 - Fourth Intervention||3
9883686|NCT01043185|10998184|FG003|STARTED|Period 7 - Fourth Intervention||2
9883687|NCT01043185|10998185|FG004|STARTED|Period 7 - Fourth Intervention||2
9883688|NCT01043185|10998186|FG005|STARTED|Period 7 - Fourth Intervention||3
9883689|NCT01043185|10998187|FG006|STARTED|Period 7 - Fourth Intervention||3
9883690|NCT01043185|10998188|FG007|STARTED|Period 7 - Fourth Intervention||3
9883691|NCT01043185|10998189|FG008|STARTED|Period 7 - Fourth Intervention||2
9883692|NCT01043185|10998190|FG009|STARTED|Period 7 - Fourth Intervention||3
9883693|NCT01043185|10998181|FG000|COMPLETED|Period 7 - Fourth Intervention||3
9883694|NCT01043185|10998182|FG001|COMPLETED|Period 7 - Fourth Intervention||2
9883695|NCT01043185|10998183|FG002|COMPLETED|Period 7 - Fourth Intervention||3
9883696|NCT01043185|10998184|FG003|COMPLETED|Period 7 - Fourth Intervention||2
9883697|NCT01043185|10998185|FG004|COMPLETED|Period 7 - Fourth Intervention||2
9883698|NCT01043185|10998186|FG005|COMPLETED|Period 7 - Fourth Intervention||3
9883699|NCT01043185|10998187|FG006|COMPLETED|Period 7 - Fourth Intervention||3
9883700|NCT01043185|10998188|FG007|COMPLETED|Period 7 - Fourth Intervention||3
9883701|NCT01043185|10998189|FG008|COMPLETED|Period 7 - Fourth Intervention||2
9883702|NCT01043185|10998190|FG009|COMPLETED|Period 7 - Fourth Intervention||3
9883703|NCT01043185|10998181|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883704|NCT01043185|10998182|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883705|NCT01043185|10998183|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883706|NCT01043185|10998184|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883707|NCT01043185|10998185|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883708|NCT01043185|10998186|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883709|NCT01043185|10998187|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883710|NCT01043185|10998188|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883711|NCT01043185|10998189|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883712|NCT01043185|10998190|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0
9883713|NCT01043393|10998204|FG000|STARTED|Overall Study||12
9883714|NCT01043393|10998205|FG001|STARTED|Overall Study||12
9883715|NCT01043393|10998204|FG000|COMPLETED|Overall Study||12
9883716|NCT01043393|10998205|FG001|COMPLETED|Overall Study||12
9883717|NCT01043393|10998204|FG000|NOT COMPLETED|Overall Study||0
9883718|NCT01043393|10998205|FG001|NOT COMPLETED|Overall Study||0
9883719|NCT01043432|10998215|FG000|STARTED|Overall Study||22
9883720|NCT01043432|10998216|FG001|STARTED|Overall Study||51
9883721|NCT01043432|10998217|FG002|STARTED|Overall Study||12
9883722|NCT01043432|10998218|FG003|STARTED|Overall Study||48
9883723|NCT01043432|10998215|FG000|COMPLETED|Overall Study||22
9883724|NCT01043432|10998216|FG001|COMPLETED|Overall Study||51
9883725|NCT01043432|10998217|FG002|COMPLETED|Overall Study||12
9883726|NCT01043432|10998218|FG003|COMPLETED|Overall Study||48
9883727|NCT01043432|10998215|FG000|NOT COMPLETED|Overall Study||0
9883728|NCT01043432|10998216|FG001|NOT COMPLETED|Overall Study||0
9883729|NCT01043432|10998217|FG002|NOT COMPLETED|Overall Study||0
9883730|NCT01043432|10998218|FG003|NOT COMPLETED|Overall Study||0
9883731|NCT01043523|10998225|FG000|STARTED|Overall Study||52
9883732|NCT01043523|10998225|FG000|Participants With Unenhanced Images|Overall Study||51
9883733|NCT01043523|10998225|FG000|COMPLETED|Overall Study||52
9883734|NCT01043523|10998225|FG000|NOT COMPLETED|Overall Study||0
9883735|NCT01043562|10998233|FG000|STARTED|Overall Study||20
9883736|NCT01043562|10998233|FG000|COMPLETED|Overall Study||20
9883737|NCT01043562|10998233|FG000|NOT COMPLETED|Overall Study||0
9883738|NCT01043640|10998240|FG000|STARTED|Overall Study||46
9883739|NCT01043640|10998240|FG000|COMPLETED|Overall Study||46
9883740|NCT01043640|10998240|FG000|NOT COMPLETED|Overall Study||0
9883741|NCT01043653|10998244|FG000|STARTED|Overall Study||250
9883742|NCT01043653|10998244|FG000|COMPLETED|Overall Study||186
9883743|NCT01043653|10998244|FG000|NOT COMPLETED|Overall Study||64
9883744|NCT01043705|10998251|FG000|STARTED|Overall Study||459
9883745|NCT01043705|10998252|FG001|STARTED|Overall Study||578
9883746|NCT01043705|10998253|FG002|STARTED|Overall Study||578
9883747|NCT01043705|10998251|FG000|COMPLETED|Overall Study||352
9883748|NCT01043705|10998252|FG001|COMPLETED|Overall Study||447
9883749|NCT01043705|10998253|FG002|COMPLETED|Overall Study||498
9883750|NCT01043705|10998251|FG000|NOT COMPLETED|Overall Study||107
9883751|NCT01043705|10998252|FG001|NOT COMPLETED|Overall Study||131
9883752|NCT01043705|10998253|FG002|NOT COMPLETED|Overall Study||80
9883753|NCT01043874|10998261|FG000|STARTED|Overall Study||45
9883754|NCT01043874|10998261|FG000|COMPLETED|Overall Study||39
9883755|NCT01043874|10998261|FG000|NOT COMPLETED|Overall Study||6
9883756|NCT01043926|10998267|FG000|STARTED|Overall Study||8
9883757|NCT01043926|10998268|FG001|STARTED|Overall Study||8
9883758|NCT01043926|10998269|FG002|STARTED|Overall Study||0
9883759|NCT01043926|10998270|FG003|STARTED|Overall Study||0
9883760|NCT01043926|10998267|FG000|COMPLETED|Overall Study||8
9883761|NCT01043926|10998268|FG001|COMPLETED|Overall Study||8
9883762|NCT01043926|10998269|FG002|COMPLETED|Overall Study||0
9883763|NCT01043926|10998270|FG003|COMPLETED|Overall Study||0
9883764|NCT01043926|10998267|FG000|NOT COMPLETED|Overall Study||0
9883765|NCT01043926|10998268|FG001|NOT COMPLETED|Overall Study||0
9883766|NCT01043926|10998269|FG002|NOT COMPLETED|Overall Study||0
9883767|NCT01043926|10998270|FG003|NOT COMPLETED|Overall Study||0
9883768|NCT01043939|10998278|FG000|STARTED|First Intervention||12
9883769|NCT01043939|10998279|FG001|STARTED|First Intervention||12
9883770|NCT01043939|10998278|FG000|COMPLETED|First Intervention||12
9883771|NCT01043939|10998279|FG001|COMPLETED|First Intervention||12
9883772|NCT01043939|10998278|FG000|NOT COMPLETED|First Intervention||0
9883773|NCT01043939|10998279|FG001|NOT COMPLETED|First Intervention||0
9883774|NCT01043939|10998278|FG000|STARTED|Washout Period||12
9883775|NCT01043939|10998279|FG001|STARTED|Washout Period||12
9883776|NCT01043939|10998278|FG000|COMPLETED|Washout Period||12
9883777|NCT01043939|10998279|FG001|COMPLETED|Washout Period||12
9883778|NCT01043939|10998278|FG000|NOT COMPLETED|Washout Period||0
9883779|NCT01043939|10998279|FG001|NOT COMPLETED|Washout Period||0
9883780|NCT01043939|10998278|FG000|STARTED|Second Intervention||12
9883781|NCT01043939|10998279|FG001|STARTED|Second Intervention||12
9883782|NCT01043939|10998278|FG000|COMPLETED|Second Intervention||12
9883783|NCT01043939|10998279|FG001|COMPLETED|Second Intervention||12
9883784|NCT01043939|10998278|FG000|NOT COMPLETED|Second Intervention||0
9883785|NCT01043939|10998279|FG001|NOT COMPLETED|Second Intervention||0
9883786|NCT01044030|10998288|FG000|STARTED|Overall Study||160
9883787|NCT01044030|10998289|FG001|STARTED|Overall Study||166
9883788|NCT01044030|10998288|FG000|COMPLETED|Overall Study||141
9883789|NCT01044030|10998289|FG001|COMPLETED|Overall Study||146
9883790|NCT01044030|10998288|FG000|NOT COMPLETED|Overall Study||19
9883791|NCT01044030|10998289|FG001|NOT COMPLETED|Overall Study||20
9883792|NCT01044212|10998297|FG000|STARTED|Overall Study||35
9883793|NCT01044212|10998298|FG001|STARTED|Overall Study||37
9883794|NCT01044212|10998297|FG000|COMPLETED|Overall Study||30
9883795|NCT01044212|10998298|FG001|COMPLETED|Overall Study||30
9883796|NCT01044212|10998297|FG000|NOT COMPLETED|Overall Study||5
9883797|NCT01044212|10998298|FG001|NOT COMPLETED|Overall Study||7
9883798|NCT01044264|10998307|FG000|STARTED|Overall Study||200
9883799|NCT01044264|10998308|FG001|STARTED|Overall Study||202
9883800|NCT01044264|10998309|FG002|STARTED|Overall Study||200
9883801|NCT01044264|10998307|FG000|COMPLETED|Overall Study||110
9883802|NCT01044264|10998308|FG001|COMPLETED|Overall Study||108
9883803|NCT01044264|10998309|FG002|COMPLETED|Overall Study||108
9883804|NCT01044264|10998307|FG000|NOT COMPLETED|Overall Study||90
9883805|NCT01044264|10998308|FG001|NOT COMPLETED|Overall Study||94
9883806|NCT01044264|10998309|FG002|NOT COMPLETED|Overall Study||92
9883807|NCT01044290|10998320|FG000|STARTED|Randomization||75
9883808|NCT01044290|10998321|FG001|STARTED|Randomization||74
9883809|NCT01044290|10998322|FG002|STARTED|Randomization||72
9883810|NCT01044290|10998320|FG000|Randomized|Randomization||75
9883811|NCT01044290|10998321|FG001|Randomized|Randomization||74
9883812|NCT01044290|10998322|FG002|Randomized|Randomization||72
9883813|NCT01044290|10998320|FG000|COMPLETED|Randomization||75
9883814|NCT01044290|10998321|FG001|COMPLETED|Randomization||74
9883815|NCT01044290|10998322|FG002|COMPLETED|Randomization||72
9883816|NCT01044290|10998320|FG000|NOT COMPLETED|Randomization||0
9883817|NCT01044290|10998321|FG001|NOT COMPLETED|Randomization||0
9883818|NCT01044290|10998322|FG002|NOT COMPLETED|Randomization||0
9883819|NCT01044290|10998320|FG000|STARTED|Follow-up 1||75
9883820|NCT01044290|10998321|FG001|STARTED|Follow-up 1||74
9883821|NCT01044290|10998322|FG002|STARTED|Follow-up 1||72
9883822|NCT01044290|10998320|FG000|Completed F1 Interview|Follow-up 1||61
9883823|NCT01044290|10998321|FG001|Completed F1 Interview|Follow-up 1||60
9883824|NCT01044290|10998322|FG002|Completed F1 Interview|Follow-up 1||61
9883825|NCT01044290|10998320|FG000|COMPLETED|Follow-up 1||70
9883826|NCT01044290|10998321|FG001|COMPLETED|Follow-up 1||69
9883827|NCT01044290|10998322|FG002|COMPLETED|Follow-up 1||71
9883828|NCT01044290|10998320|FG000|NOT COMPLETED|Follow-up 1||5
9883829|NCT01044290|10998321|FG001|NOT COMPLETED|Follow-up 1||5
9883830|NCT01044290|10998322|FG002|NOT COMPLETED|Follow-up 1||1
9883831|NCT01044290|10998320|FG000|STARTED|Follow-Up 2||70
9883832|NCT01044290|10998321|FG001|STARTED|Follow-Up 2||69
9883833|NCT01044290|10998322|FG002|STARTED|Follow-Up 2||71
9883834|NCT01044290|10998320|FG000|Completed F2 Interview|Follow-Up 2||64
9883835|NCT01044290|10998321|FG001|Completed F2 Interview|Follow-Up 2||57
9883836|NCT01044290|10998322|FG002|Completed F2 Interview|Follow-Up 2||64
9883837|NCT01044290|10998320|FG000|COMPLETED|Follow-Up 2||70
9883838|NCT01044290|10998321|FG001|COMPLETED|Follow-Up 2||67
9883839|NCT01044290|10998322|FG002|COMPLETED|Follow-Up 2||69
9883840|NCT01044290|10998320|FG000|NOT COMPLETED|Follow-Up 2||0
9883841|NCT01044290|10998321|FG001|NOT COMPLETED|Follow-Up 2||2
9883842|NCT01044290|10998322|FG002|NOT COMPLETED|Follow-Up 2||2
9883843|NCT01044303|10998340|FG000|STARTED|Overall Study||32
9883844|NCT01044303|10998340|FG000|COMPLETED|Overall Study||30
9883845|NCT01044303|10998340|FG000|NOT COMPLETED|Overall Study||2
9883846|NCT01044433|10998347|FG000|STARTED|Overall Study||44
9883847|NCT01044433|10998347|FG000|COMPLETED|Overall Study||38
9883848|NCT01044433|10998347|FG000|NOT COMPLETED|Overall Study||6
9954251|NCT01431131|11073042|FG000|COMPLETED|Overall Study||12
9954252|NCT01431131|11073043|FG001|COMPLETED|Overall Study||12
9954253|NCT01431131|11073042|FG000|NOT COMPLETED|Overall Study||0
9954254|NCT01431131|11073043|FG001|NOT COMPLETED|Overall Study||0
9954255|NCT01431144|11073051|FG000|STARTED|Overall Study||13
9954256|NCT01431144|11073052|FG001|STARTED|Overall Study||14
10109034|NCT02472223|11239595|FG000|COMPLETED|Overall Study||10
10109035|NCT02472223|11239596|FG001|COMPLETED|Overall Study||7
10109036|NCT02472223|11239595|FG000|NOT COMPLETED|Overall Study||6
10109037|NCT02472223|11239596|FG001|NOT COMPLETED|Overall Study||5
10109038|NCT02472262|11239605|FG000|STARTED|Overall Study||117
10109039|NCT02472262|11239606|FG001|STARTED|Overall Study||120
9954257|NCT01431144|11073051|FG000|COMPLETED|Overall Study||11
9954258|NCT01431144|11073052|FG001|COMPLETED|Overall Study||14
9954259|NCT01431144|11073051|FG000|NOT COMPLETED|Overall Study||2
9954260|NCT01431144|11073052|FG001|NOT COMPLETED|Overall Study||0
9954261|NCT01431170|11073060|FG000|STARTED|Overall Study||12
9954262|NCT01431170|11073061|FG001|STARTED|Overall Study||12
9954263|NCT01431170|11073060|FG000|COMPLETED|Overall Study||9
9954264|NCT01431170|11073061|FG001|COMPLETED|Overall Study||11
9954265|NCT01431170|11073060|FG000|NOT COMPLETED|Overall Study||3
9954266|NCT01431170|11073061|FG001|NOT COMPLETED|Overall Study||1
9954267|NCT01431209|11073079|FG000|STARTED|Overall Study||47
9954268|NCT01431209|11073080|FG001|STARTED|Overall Study||13
9954269|NCT01431209|11073079|FG000|COMPLETED|Overall Study||43
9954270|NCT01431209|11073080|FG001|COMPLETED|Overall Study||12
9954271|NCT01431209|11073079|FG000|NOT COMPLETED|Overall Study||4
10109040|NCT02472262|11239607|FG002|STARTED|Overall Study||118
10109041|NCT02472262|11239605|FG000|COMPLETED|Overall Study||99
10109042|NCT02472262|11239606|FG001|COMPLETED|Overall Study||99
9954272|NCT01431209|11073080|FG001|NOT COMPLETED|Overall Study||1
9954273|NCT01431274|11073091|FG000|STARTED|Overall Study||528
9954274|NCT01431274|11073092|FG001|STARTED|Overall Study||525
10109043|NCT02472262|11239607|FG002|COMPLETED|Overall Study||93
10109044|NCT02472262|11239605|FG000|NOT COMPLETED|Overall Study||18
10109045|NCT02472262|11239606|FG001|NOT COMPLETED|Overall Study||21
9954275|NCT01431274|11073093|FG002|STARTED|Overall Study||527
9954276|NCT01431274|11073094|FG003|STARTED|Overall Study||522
9954277|NCT01431274|11073095|FG004|STARTED|Overall Study||522
9954278|NCT01431274|11073091|FG000|COMPLETED|Overall Study||431
9954279|NCT01431274|11073092|FG001|COMPLETED|Overall Study||448
9954280|NCT01431274|11073093|FG002|COMPLETED|Overall Study||455
9954281|NCT01431274|11073094|FG003|COMPLETED|Overall Study||462
9954282|NCT01431274|11073095|FG004|COMPLETED|Overall Study||466
9954283|NCT01431274|11073091|FG000|NOT COMPLETED|Overall Study||97
9954284|NCT01431274|11073092|FG001|NOT COMPLETED|Overall Study||77
9954285|NCT01431274|11073093|FG002|NOT COMPLETED|Overall Study||72
9954286|NCT01431274|11073094|FG003|NOT COMPLETED|Overall Study||60
9954287|NCT01431274|11073095|FG004|NOT COMPLETED|Overall Study||56
9954288|NCT01431287|11073112|FG000|STARTED|Overall Study|started are actually the randomized|510
9954289|NCT01431287|11073113|FG001|STARTED|Overall Study||507
9954290|NCT01431287|11073114|FG002|STARTED|Overall Study||507
9954291|NCT01431287|11073115|FG003|STARTED|Overall Study||508
9954292|NCT01431287|11073116|FG004|STARTED|Overall Study||507
9954293|NCT01431287|11073112|FG000|COMPLETED|Overall Study||412
9954294|NCT01431287|11073113|FG001|COMPLETED|Overall Study||409
9954295|NCT01431287|11073114|FG002|COMPLETED|Overall Study||410
9954296|NCT01431287|11073115|FG003|COMPLETED|Overall Study||445
9954297|NCT01431287|11073116|FG004|COMPLETED|Overall Study||430
9954298|NCT01431287|11073112|FG000|NOT COMPLETED|Overall Study||98
9954299|NCT01431287|11073113|FG001|NOT COMPLETED|Overall Study||98
9954300|NCT01431287|11073114|FG002|NOT COMPLETED|Overall Study||97
10109046|NCT02472262|11239607|FG002|NOT COMPLETED|Overall Study||25
10109047|NCT02472314|11239617|FG000|STARTED|Overall Study||34
10109048|NCT02472314|11239618|FG001|STARTED|Overall Study||36
9954301|NCT01431287|11073115|FG003|NOT COMPLETED|Overall Study||63
9954302|NCT01431287|11073116|FG004|NOT COMPLETED|Overall Study||77
9954303|NCT01431300|11073131|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
9954304|NCT01431300|11073132|FG001|STARTED|Overall Study||10
9954305|NCT01431300|11073133|FG002|STARTED|Overall Study||10
9954306|NCT01431300|11073131|FG000|COMPLETED|Overall Study||10
9954307|NCT01431300|11073132|FG001|COMPLETED|Overall Study||10
9954308|NCT01431300|11073133|FG002|COMPLETED|Overall Study||10
9954309|NCT01431300|11073131|FG000|NOT COMPLETED|Overall Study||1
9954310|NCT01431300|11073132|FG001|NOT COMPLETED|Overall Study||0
9954311|NCT01431300|11073133|FG002|NOT COMPLETED|Overall Study||0
9954312|NCT01431313|11073144|FG000|STARTED|Overall Study||20
9954313|NCT01431313|11073145|FG001|STARTED|Overall Study||20
9954314|NCT01431313|11073146|FG002|STARTED|Overall Study||8
9954315|NCT01431313|11073144|FG000|COMPLETED|Overall Study||20
9954316|NCT01431313|11073145|FG001|COMPLETED|Overall Study||20
10109049|NCT02472314|11239617|FG000|COMPLETED|Overall Study||34
10109050|NCT02472314|11239618|FG001|COMPLETED|Overall Study||36
9883849|NCT01044459|10998354|FG000|STARTED|Overall Study||312
9883850|NCT01044459|10998355|FG001|STARTED|Overall Study||293
9883851|NCT01044459|10998354|FG000|COMPLETED|Overall Study||179
9883852|NCT01044459|10998355|FG001|COMPLETED|Overall Study||162
9883853|NCT01044459|10998354|FG000|NOT COMPLETED|Overall Study||133
9883854|NCT01044459|10998355|FG001|NOT COMPLETED|Overall Study||131
9883855|NCT01044498|10998363|FG000|STARTED|Overall Study||23
9883856|NCT01044498|10998364|FG001|STARTED|Overall Study||23
9883857|NCT01044498|10998363|FG000|COMPLETED|Overall Study||20
9883858|NCT01044498|10998364|FG001|COMPLETED|Overall Study||21
9883859|NCT01044498|10998363|FG000|NOT COMPLETED|Overall Study||3
9883860|NCT01044498|10998364|FG001|NOT COMPLETED|Overall Study||2
9883861|NCT01044537|10998377|FG000|STARTED|Overall Study||6
9883862|NCT01044537|10998378|FG001|STARTED|Overall Study||6
9883863|NCT01044537|10998379|FG002|STARTED|Overall Study||6
9883864|NCT01044537|10998380|FG003|STARTED|Overall Study||6
9883865|NCT01044537|10998381|FG004|STARTED|Overall Study||5
9883866|NCT01044537|10998382|FG005|STARTED|Overall Study||5
9883867|NCT01044537|10998383|FG006|STARTED|Overall Study||16
9883868|NCT01044537|10998377|FG000|COMPLETED|Overall Study||6
9883869|NCT01044537|10998378|FG001|COMPLETED|Overall Study||6
9883870|NCT01044537|10998379|FG002|COMPLETED|Overall Study||6
9883871|NCT01044537|10998380|FG003|COMPLETED|Overall Study||6
9883872|NCT01044537|10998381|FG004|COMPLETED|Overall Study||5
9883873|NCT01044537|10998382|FG005|COMPLETED|Overall Study||5
9883874|NCT01044537|10998383|FG006|COMPLETED|Overall Study||16
9883875|NCT01044537|10998377|FG000|NOT COMPLETED|Overall Study||0
9883876|NCT01044537|10998378|FG001|NOT COMPLETED|Overall Study||0
9883877|NCT01044537|10998379|FG002|NOT COMPLETED|Overall Study||0
9883878|NCT01044537|10998380|FG003|NOT COMPLETED|Overall Study||0
9883879|NCT01044537|10998381|FG004|NOT COMPLETED|Overall Study||0
9883880|NCT01044537|10998382|FG005|NOT COMPLETED|Overall Study||0
9883881|NCT01044537|10998383|FG006|NOT COMPLETED|Overall Study||0
9883882|NCT01044576|10998399|FG000|STARTED|Overall Study||200
9883883|NCT01044576|10998399|FG000|COMPLETED|Overall Study||200
9883884|NCT01044576|10998399|FG000|NOT COMPLETED|Overall Study||0
10008135|NCT01755234|11130465|FG001|NOT COMPLETED|Overall Study||8
10008136|NCT01755416|11130471|FG000|STARTED|First Intervention ( Upto 2 Days)||9
10008137|NCT01755416|11130472|FG001|STARTED|First Intervention ( Upto 2 Days)||9
10008138|NCT01755416|11130471|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8
10008139|NCT01755416|11130472|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7
10008140|NCT01755416|11130471|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
10008141|NCT01755416|11130472|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
10008142|NCT01755416|11130471|FG000|STARTED|Second Intervention (Upto 2 Days)||8
10008143|NCT01755416|11130472|FG001|STARTED|Second Intervention (Upto 2 Days)||7
10008144|NCT01755416|11130471|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8
10008145|NCT01755416|11130472|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7
10008146|NCT01755416|11130471|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
10008147|NCT01755416|11130472|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
10008148|NCT01755455|11130478|FG000|STARTED|First Intervention (6 Weeks)||11
10008149|NCT01755455|11130479|FG001|STARTED|First Intervention (6 Weeks)||11
10008150|NCT01755455|11130478|FG000|COMPLETED|First Intervention (6 Weeks)||11
10008151|NCT01755455|11130479|FG001|COMPLETED|First Intervention (6 Weeks)||11
10008152|NCT01755455|11130478|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10008153|NCT01755455|11130479|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10008154|NCT01755455|11130478|FG000|STARTED|Washout (4 Weeks)||11
10008155|NCT01755455|11130479|FG001|STARTED|Washout (4 Weeks)||11
10008156|NCT01755455|11130478|FG000|COMPLETED|Washout (4 Weeks)||11
10008157|NCT01755455|11130479|FG001|COMPLETED|Washout (4 Weeks)||11
10008158|NCT01755455|11130478|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9883885|NCT01044589|10998405|FG000|STARTED|Overall Study||6
9883886|NCT01044589|10998406|FG001|STARTED|Overall Study||7
9883887|NCT01044589|10998405|FG000|COMPLETED|Overall Study||3
9883888|NCT01044589|10998406|FG001|COMPLETED|Overall Study||2
9883889|NCT01044589|10998405|FG000|NOT COMPLETED|Overall Study||3
9883890|NCT01044589|10998406|FG001|NOT COMPLETED|Overall Study||5
9883891|NCT01044693|10998412|FG000|STARTED|Overall Study||3
9883892|NCT01044693|10998413|FG001|STARTED|Overall Study||1
9883893|NCT01044693|10998414|FG002|STARTED|Overall Study||1
9883894|NCT01044693|10998415|FG003|STARTED|Overall Study||1
9883895|NCT01044693|10998416|FG004|STARTED|Overall Study||1
9883896|NCT01044693|10998417|FG005|STARTED|Overall Study||2
9883897|NCT01044693|10998418|FG006|STARTED|Overall Study||1
9883898|NCT01044693|10998419|FG007|STARTED|Overall Study||1
9883899|NCT01044693|10998420|FG008|STARTED|Overall Study||1
9883900|NCT01044693|10998421|FG009|STARTED|Overall Study||1
9883901|NCT01044693|10998422|FG010|STARTED|Overall Study||1
9883902|NCT01044693|10998423|FG011|STARTED|Overall Study||1
9883903|NCT01044693|10998424|FG012|STARTED|Overall Study||2
9883904|NCT01044693|10998425|FG013|STARTED|Overall Study||1
9883905|NCT01044693|10998426|FG014|STARTED|Overall Study||1
9883906|NCT01044693|10998427|FG015|STARTED|Overall Study||1
9883907|NCT01044693|10998412|FG000|COMPLETED|Overall Study||3
9883908|NCT01044693|10998413|FG001|COMPLETED|Overall Study||1
9883909|NCT01044693|10998414|FG002|COMPLETED|Overall Study||1
9883910|NCT01044693|10998415|FG003|COMPLETED|Overall Study||1
9883911|NCT01044693|10998416|FG004|COMPLETED|Overall Study||1
9883912|NCT01044693|10998417|FG005|COMPLETED|Overall Study||2
9883913|NCT01044693|10998418|FG006|COMPLETED|Overall Study||1
10008159|NCT01755455|11130479|FG001|NOT COMPLETED|Washout (4 Weeks)||0
9883914|NCT01044693|10998419|FG007|COMPLETED|Overall Study||1
9883915|NCT01044693|10998420|FG008|COMPLETED|Overall Study||1
9883916|NCT01044693|10998421|FG009|COMPLETED|Overall Study||1
9883917|NCT01044693|10998422|FG010|COMPLETED|Overall Study||1
9883918|NCT01044693|10998423|FG011|COMPLETED|Overall Study||1
9883919|NCT01044693|10998424|FG012|COMPLETED|Overall Study||2
9883920|NCT01044693|10998425|FG013|COMPLETED|Overall Study||1
9883921|NCT01044693|10998426|FG014|COMPLETED|Overall Study||1
9883922|NCT01044693|10998427|FG015|COMPLETED|Overall Study||1
9883923|NCT01044693|10998412|FG000|NOT COMPLETED|Overall Study||0
9883924|NCT01044693|10998413|FG001|NOT COMPLETED|Overall Study||0
9883925|NCT01044693|10998414|FG002|NOT COMPLETED|Overall Study||0
9883926|NCT01044693|10998415|FG003|NOT COMPLETED|Overall Study||0
9883927|NCT01044693|10998416|FG004|NOT COMPLETED|Overall Study||0
9883928|NCT01044693|10998417|FG005|NOT COMPLETED|Overall Study||0
9883929|NCT01044693|10998418|FG006|NOT COMPLETED|Overall Study||0
9883930|NCT01044693|10998419|FG007|NOT COMPLETED|Overall Study||0
9883931|NCT01044693|10998420|FG008|NOT COMPLETED|Overall Study||0
9883932|NCT01044693|10998421|FG009|NOT COMPLETED|Overall Study||0
9883933|NCT01044693|10998422|FG010|NOT COMPLETED|Overall Study||0
9883934|NCT01044693|10998423|FG011|NOT COMPLETED|Overall Study||0
9883935|NCT01044693|10998424|FG012|NOT COMPLETED|Overall Study||0
9883936|NCT01044693|10998425|FG013|NOT COMPLETED|Overall Study||0
9883937|NCT01044693|10998426|FG014|NOT COMPLETED|Overall Study||0
9883938|NCT01044693|10998427|FG015|NOT COMPLETED|Overall Study||0
9883939|NCT01044706|10998439|FG000|STARTED|Overall Study||30
9883940|NCT01044706|10998440|FG001|STARTED|Overall Study||30
9883941|NCT01044706|10998439|FG000|COMPLETED|Overall Study||30
9883942|NCT01044706|10998440|FG001|COMPLETED|Overall Study||30
9883943|NCT01044706|10998439|FG000|NOT COMPLETED|Overall Study||0
9883944|NCT01044706|10998440|FG001|NOT COMPLETED|Overall Study||0
9883945|NCT01044732|10998448|FG000|STARTED|Overall Study||222
9883946|NCT01044732|10998449|FG001|STARTED|Overall Study||226
9883947|NCT01044732|10998448|FG000|COMPLETED|Overall Study||173
9883948|NCT01044732|10998449|FG001|COMPLETED|Overall Study||176
9883949|NCT01044732|10998448|FG000|NOT COMPLETED|Overall Study||49
9883950|NCT01044732|10998449|FG001|NOT COMPLETED|Overall Study||50
9883951|NCT01044745|10998457|FG000|STARTED|Overall Study||20
9883952|NCT01044745|10998457|FG000|COMPLETED|Overall Study||18
9883953|NCT01044745|10998457|FG000|NOT COMPLETED|Overall Study||2
9883954|NCT01044758|10998469|FG000|STARTED|Overall Study||12
9883955|NCT01044758|10998470|FG001|STARTED|Overall Study||12
9883956|NCT01044758|10998471|FG002|STARTED|Overall Study||11
9883957|NCT01044758|10998472|FG003|STARTED|Overall Study||12
9883958|NCT01044758|10998473|FG004|STARTED|Overall Study||11
9883959|NCT01044758|10998474|FG005|STARTED|Overall Study||11
9883960|NCT01044758|10998475|FG006|STARTED|Overall Study||27
9883961|NCT01044758|10998469|FG000|COMPLETED|Overall Study||8
9883962|NCT01044758|10998470|FG001|COMPLETED|Overall Study||12
9883963|NCT01044758|10998471|FG002|COMPLETED|Overall Study||7
9883964|NCT01044758|10998472|FG003|COMPLETED|Overall Study||10
9883965|NCT01044758|10998473|FG004|COMPLETED|Overall Study||9
9883966|NCT01044758|10998474|FG005|COMPLETED|Overall Study||8
9883967|NCT01044758|10998475|FG006|COMPLETED|Overall Study||17
9883968|NCT01044758|10998469|FG000|NOT COMPLETED|Overall Study||4
9883969|NCT01044758|10998470|FG001|NOT COMPLETED|Overall Study||0
9883970|NCT01044758|10998471|FG002|NOT COMPLETED|Overall Study||4
9883971|NCT01044758|10998472|FG003|NOT COMPLETED|Overall Study||2
9883972|NCT01044758|10998473|FG004|NOT COMPLETED|Overall Study||2
9883973|NCT01044758|10998474|FG005|NOT COMPLETED|Overall Study||3
9883974|NCT01044758|10998475|FG006|NOT COMPLETED|Overall Study||10
9883975|NCT01044771|10998494|FG000|STARTED|Overall Study||20
9883976|NCT01044771|10998494|FG000|COMPLETED|Overall Study||20
9883977|NCT01044771|10998494|FG000|NOT COMPLETED|Overall Study||0
9883978|NCT01044862|10998502|FG000|STARTED|Overall Study||299
9883979|NCT01044862|10998503|FG001|STARTED|Overall Study||300
9883980|NCT01044862|10998504|FG002|STARTED|Overall Study||301
9883981|NCT01044862|10998502|FG000|COMPLETED|Overall Study||246
9883982|NCT01044862|10998503|FG001|COMPLETED|Overall Study||251
9883983|NCT01044862|10998504|FG002|COMPLETED|Overall Study||249
9883984|NCT01044862|10998502|FG000|NOT COMPLETED|Overall Study||53
9883985|NCT01044862|10998503|FG001|NOT COMPLETED|Overall Study||49
9883986|NCT01044862|10998504|FG002|NOT COMPLETED|Overall Study||52
9883987|NCT01044966|10998512|FG000|STARTED|Induction Phase||12
9883988|NCT01044966|10998512|FG000|COMPLETED|Induction Phase||12
9883989|NCT01044966|10998512|FG000|NOT COMPLETED|Induction Phase||0
9883990|NCT01044966|10998512|FG000|STARTED|Consolidation Phase||12
9883991|NCT01044966|10998512|FG000|COMPLETED|Consolidation Phase||2
9883992|NCT01044966|10998512|FG000|NOT COMPLETED|Consolidation Phase||10
9883993|NCT01045031|10998519|FG000|STARTED|Overall Study||58
9883994|NCT01045031|10998520|FG001|STARTED|Overall Study||56
9883995|NCT01045031|10998519|FG000|COMPLETED|Overall Study||49
9883996|NCT01045031|10998520|FG001|COMPLETED|Overall Study||50
9883997|NCT01045031|10998519|FG000|NOT COMPLETED|Overall Study||9
9883998|NCT01045031|10998520|FG001|NOT COMPLETED|Overall Study||6
9883999|NCT01045057|10998530|FG000|STARTED|Overall Study||27
9884000|NCT01045057|10998530|FG000|COMPLETED|Overall Study||27
9884001|NCT01045057|10998530|FG000|NOT COMPLETED|Overall Study||0
9884002|NCT01045096|10998539|FG000|STARTED|Overall Study||12
9884003|NCT01045096|10998540|FG001|STARTED|Overall Study||12
9884004|NCT01045096|10998541|FG002|STARTED|Overall Study||12
9884005|NCT01045096|10998539|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
9884006|NCT01045096|10998540|FG001|Pharmacokinetic Set|Overall Study||11
9884007|NCT01045096|10998541|FG002|Pharmacokinetic Set|Overall Study||11
9884008|NCT01045096|10998539|FG000|COMPLETED|Overall Study||9
9884009|NCT01045096|10998540|FG001|COMPLETED|Overall Study||12
9884010|NCT01045096|10998541|FG002|COMPLETED|Overall Study||12
9884011|NCT01045096|10998539|FG000|NOT COMPLETED|Overall Study||3
9884012|NCT01045096|10998540|FG001|NOT COMPLETED|Overall Study||0
9884013|NCT01045096|10998541|FG002|NOT COMPLETED|Overall Study||0
9884014|NCT01045122|10998549|FG000|STARTED|Dexmedetomidine Then Propofol||5
9884015|NCT01045122|10998550|FG001|STARTED|Dexmedetomidine Then Propofol||6
9884016|NCT01045122|10998549|FG000|COMPLETED|Dexmedetomidine Then Propofol||5
9884017|NCT01045122|10998550|FG001|COMPLETED|Dexmedetomidine Then Propofol||6
9884018|NCT01045122|10998549|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0
9884019|NCT01045122|10998550|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0
9884020|NCT01045122|10998549|FG000|STARTED|Propofol Then Dexmedetomidine||5
9884021|NCT01045122|10998550|FG001|STARTED|Propofol Then Dexmedetomidine||6
9884022|NCT01045122|10998549|FG000|COMPLETED|Propofol Then Dexmedetomidine||5
9884023|NCT01045122|10998550|FG001|COMPLETED|Propofol Then Dexmedetomidine||6
9884024|NCT01045122|10998549|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0
9884025|NCT01045122|10998550|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0
9884026|NCT01045135|10998556|FG000|STARTED|Overall Study||300
9884027|NCT01045135|10998556|FG000|COMPLETED|Overall Study||274
9884028|NCT01045135|10998556|FG000|NOT COMPLETED|Overall Study||26
9884029|NCT01045161|10998565|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182
9884030|NCT01045161|10998566|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184
9884031|NCT01045161|10998567|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178
9884032|NCT01045161|10998565|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
9884033|NCT01045161|10998566|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
9884034|NCT01045161|10998567|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
9884035|NCT01045161|10998565|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
9884036|NCT01045161|10998566|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
9884037|NCT01045161|10998567|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
9884038|NCT01045161|10998565|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147
9884039|NCT01045161|10998566|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154
9884040|NCT01045161|10998567|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147
9884041|NCT01045161|10998565|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111
9884042|NCT01045161|10998566|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118
9884043|NCT01045161|10998567|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115
9884044|NCT01045161|10998565|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
9884045|NCT01045161|10998566|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
9884046|NCT01045161|10998567|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
9884047|NCT01045174|10998586|FG000|STARTED|Overall Study||90
9884048|NCT01045174|10998587|FG001|STARTED|Overall Study||90
9884049|NCT01045174|10998586|FG000|COMPLETED|Overall Study||90
9884050|NCT01045174|10998587|FG001|COMPLETED|Overall Study||90
9884051|NCT01045174|10998586|FG000|NOT COMPLETED|Overall Study||0
9884052|NCT01045174|10998587|FG001|NOT COMPLETED|Overall Study||0
9884053|NCT01045187|10998593|FG000|STARTED|Overall Study||15
9884054|NCT01045187|10998593|FG000|COMPLETED|Overall Study||15
9884055|NCT01045187|10998593|FG000|NOT COMPLETED|Overall Study||0
9884056|NCT01045265|10998597|FG000|STARTED|Overall Study||16
9884057|NCT01045265|10998597|FG000|COMPLETED|Overall Study||16
9884058|NCT01045265|10998597|FG000|NOT COMPLETED|Overall Study||0
9884059|NCT01045421|10998607|FG000|STARTED|Phase 1||1
9884060|NCT01045421|10998608|FG001|STARTED|Phase 1||3
9884061|NCT01045421|10998609|FG002|STARTED|Phase 1||4
9884062|NCT01045421|10998610|FG003|STARTED|Phase 1||12
9884063|NCT01045421|10998611|FG004|STARTED|Phase 1||3
9884064|NCT01045421|10998612|FG005|STARTED|Phase 1||1
9884065|NCT01045421|10998613|FG006|STARTED|Phase 1||0
9884066|NCT01045421|10998614|FG007|STARTED|Phase 1||0
9884067|NCT01045421|10998615|FG008|STARTED|Phase 1||0
9884068|NCT01045421|10998616|FG009|STARTED|Phase 1||0
9884069|NCT01045421|10998617|FG010|STARTED|Phase 1||0
9884070|NCT01045421|10998607|FG000|COMPLETED|Phase 1||1
9884071|NCT01045421|10998608|FG001|COMPLETED|Phase 1||3
9884072|NCT01045421|10998609|FG002|COMPLETED|Phase 1||4
10008160|NCT01755455|11130478|FG000|STARTED|Second Intervention (6 Weeks)||11
9884073|NCT01045421|10998610|FG003|COMPLETED|Phase 1||11
9884074|NCT01045421|10998611|FG004|COMPLETED|Phase 1||2
9884075|NCT01045421|10998612|FG005|COMPLETED|Phase 1||1
9884076|NCT01045421|10998613|FG006|COMPLETED|Phase 1||0
9884077|NCT01045421|10998614|FG007|COMPLETED|Phase 1||0
9884078|NCT01045421|10998615|FG008|COMPLETED|Phase 1||0
9884079|NCT01045421|10998616|FG009|COMPLETED|Phase 1||0
9884080|NCT01045421|10998617|FG010|COMPLETED|Phase 1||0
9884081|NCT01045421|10998607|FG000|NOT COMPLETED|Phase 1||0
9884082|NCT01045421|10998608|FG001|NOT COMPLETED|Phase 1||0
9884083|NCT01045421|10998609|FG002|NOT COMPLETED|Phase 1||0
9884084|NCT01045421|10998610|FG003|NOT COMPLETED|Phase 1||1
9884085|NCT01045421|10998611|FG004|NOT COMPLETED|Phase 1||1
9884086|NCT01045421|10998612|FG005|NOT COMPLETED|Phase 1||0
9884087|NCT01045421|10998613|FG006|NOT COMPLETED|Phase 1||0
9884088|NCT01045421|10998614|FG007|NOT COMPLETED|Phase 1||0
9884089|NCT01045421|10998615|FG008|NOT COMPLETED|Phase 1||0
9884090|NCT01045421|10998616|FG009|NOT COMPLETED|Phase 1||0
9884091|NCT01045421|10998617|FG010|NOT COMPLETED|Phase 1||0
9884092|NCT01045421|10998607|FG000|STARTED|Phase 2||0
9884093|NCT01045421|10998608|FG001|STARTED|Phase 2||0
9884094|NCT01045421|10998609|FG002|STARTED|Phase 2||0
9884095|NCT01045421|10998610|FG003|STARTED|Phase 2||0
9884096|NCT01045421|10998611|FG004|STARTED|Phase 2||0
9884097|NCT01045421|10998612|FG005|STARTED|Phase 2||0
9884098|NCT01045421|10998613|FG006|STARTED|Phase 2||53
9884099|NCT01045421|10998614|FG007|STARTED|Phase 2||55
9884100|NCT01045421|10998615|FG008|STARTED|Phase 2||55
9884101|NCT01045421|10998616|FG009|STARTED|Phase 2||26
9884102|NCT01045421|10998617|FG010|STARTED|Phase 2||60
9884103|NCT01045421|10998607|FG000|COMPLETED|Phase 2||0
9884104|NCT01045421|10998608|FG001|COMPLETED|Phase 2||0
9884105|NCT01045421|10998609|FG002|COMPLETED|Phase 2||0
9884106|NCT01045421|10998610|FG003|COMPLETED|Phase 2||0
9884107|NCT01045421|10998611|FG004|COMPLETED|Phase 2||0
9884108|NCT01045421|10998612|FG005|COMPLETED|Phase 2||0
9884109|NCT01045421|10998613|FG006|COMPLETED|Phase 2||53
9884110|NCT01045421|10998614|FG007|COMPLETED|Phase 2||50
9884111|NCT01045421|10998615|FG008|COMPLETED|Phase 2||53
9884112|NCT01045421|10998616|FG009|COMPLETED|Phase 2||23
9884113|NCT01045421|10998617|FG010|COMPLETED|Phase 2||58
9884114|NCT01045421|10998607|FG000|NOT COMPLETED|Phase 2||0
9884115|NCT01045421|10998608|FG001|NOT COMPLETED|Phase 2||0
9884116|NCT01045421|10998609|FG002|NOT COMPLETED|Phase 2||0
9884117|NCT01045421|10998610|FG003|NOT COMPLETED|Phase 2||0
9884118|NCT01045421|10998611|FG004|NOT COMPLETED|Phase 2||0
9884119|NCT01045421|10998612|FG005|NOT COMPLETED|Phase 2||0
9884120|NCT01045421|10998613|FG006|NOT COMPLETED|Phase 2||0
9884121|NCT01045421|10998614|FG007|NOT COMPLETED|Phase 2||5
9884122|NCT01045421|10998615|FG008|NOT COMPLETED|Phase 2||2
9884123|NCT01045421|10998616|FG009|NOT COMPLETED|Phase 2||3
9884124|NCT01045421|10998617|FG010|NOT COMPLETED|Phase 2||2
9884125|NCT01045447|10998640|FG000|STARTED|Overall Study||232
9884126|NCT01045447|10998641|FG001|STARTED|Overall Study||233
9884127|NCT01045447|10998640|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
9884128|NCT01045447|10998641|FG001|Exposed|Overall Study||233
9884129|NCT01045447|10998640|FG000|COMPLETED|Overall Study||196
9884130|NCT01045447|10998641|FG001|COMPLETED|Overall Study||205
9884131|NCT01045447|10998640|FG000|NOT COMPLETED|Overall Study||36
9884132|NCT01045447|10998641|FG001|NOT COMPLETED|Overall Study||28
9884133|NCT01045460|10998649|FG000|STARTED|Overall Study||17
9884134|NCT01045460|10998650|FG001|STARTED|Overall Study||18
9884135|NCT01045460|10998649|FG000|COMPLETED|Overall Study||11
9884136|NCT01045460|10998650|FG001|COMPLETED|Overall Study||15
9884137|NCT01045460|10998649|FG000|NOT COMPLETED|Overall Study||6
9884138|NCT01045460|10998650|FG001|NOT COMPLETED|Overall Study||3
10008161|NCT01755455|11130479|FG001|STARTED|Second Intervention (6 Weeks)||11
9884139|NCT01045499|10998658|FG000|STARTED|Overall Study||137
9884140|NCT01045499|10998658|FG000|COMPLETED|Overall Study||127
9884141|NCT01045499|10998658|FG000|NOT COMPLETED|Overall Study||10
9884142|NCT01045551|10998662|FG000|STARTED|Overall Study||10
9884143|NCT01045551|10998662|FG000|COMPLETED|Overall Study||10
9884144|NCT01045551|10998662|FG000|NOT COMPLETED|Overall Study||0
9884145|NCT01045707|10998669|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
9884146|NCT01045707|10998670|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
9884147|NCT01045707|10998669|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
9884148|NCT01045707|10998670|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
9884149|NCT01045707|10998669|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
9884150|NCT01045707|10998670|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
9884151|NCT01045707|10998669|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
9884152|NCT01045707|10998670|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
9884153|NCT01045707|10998669|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
9884154|NCT01045707|10998670|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
9884155|NCT01045707|10998669|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
9884156|NCT01045707|10998670|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
9884157|NCT01045707|10998669|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
9884158|NCT01045707|10998670|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
9884159|NCT01045798|10998678|FG000|STARTED|Overall Study||6
9884160|NCT01045798|10998679|FG001|STARTED|Overall Study||9
9884161|NCT01045798|10998678|FG000|COMPLETED|Overall Study||4
9884162|NCT01045798|10998679|FG001|COMPLETED|Overall Study||5
9884163|NCT01045798|10998678|FG000|NOT COMPLETED|Overall Study||2
9884164|NCT01045798|10998679|FG001|NOT COMPLETED|Overall Study||4
9884165|NCT01045967|10998687|FG000|STARTED|First Intervention||28
9884166|NCT01045967|10998688|FG001|STARTED|First Intervention||28
9884167|NCT01045967|10998687|FG000|COMPLETED|First Intervention||28
9884168|NCT01045967|10998688|FG001|COMPLETED|First Intervention||28
9884169|NCT01045967|10998687|FG000|NOT COMPLETED|First Intervention||0
9884170|NCT01045967|10998688|FG001|NOT COMPLETED|First Intervention||0
9884171|NCT01045967|10998687|FG000|STARTED|Washout of 7 Days||28
9884172|NCT01045967|10998688|FG001|STARTED|Washout of 7 Days||28
9884173|NCT01045967|10998687|FG000|COMPLETED|Washout of 7 Days||28
9884174|NCT01045967|10998688|FG001|COMPLETED|Washout of 7 Days||28
9884175|NCT01045967|10998687|FG000|NOT COMPLETED|Washout of 7 Days||0
9884176|NCT01045967|10998688|FG001|NOT COMPLETED|Washout of 7 Days||0
9884177|NCT01045967|10998687|FG000|STARTED|Second Intervention||28
9884178|NCT01045967|10998688|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
9884179|NCT01045967|10998687|FG000|COMPLETED|Second Intervention||28
9884180|NCT01045967|10998688|FG001|COMPLETED|Second Intervention||27
9884181|NCT01045967|10998687|FG000|NOT COMPLETED|Second Intervention||0
9884182|NCT01045967|10998688|FG001|NOT COMPLETED|Second Intervention||1
9884183|NCT01045993|10998698|FG000|STARTED|Overall Study||26
9884184|NCT01045993|10998699|FG001|STARTED|Overall Study||5
9884185|NCT01045993|10998700|FG002|STARTED|Overall Study||5
9884186|NCT01045993|10998701|FG003|STARTED|Overall Study||25
9884187|NCT01045993|10998698|FG000|COMPLETED|Overall Study||26
9884188|NCT01045993|10998699|FG001|COMPLETED|Overall Study||4
9884189|NCT01045993|10998700|FG002|COMPLETED|Overall Study||5
9884190|NCT01045993|10998701|FG003|COMPLETED|Overall Study||25
10008162|NCT01755455|11130478|FG000|COMPLETED|Second Intervention (6 Weeks)||11
10008163|NCT01755455|11130479|FG001|COMPLETED|Second Intervention (6 Weeks)||11
10008164|NCT01755455|11130478|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10008165|NCT01755455|11130479|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10008166|NCT01755546|11130485|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304
10008167|NCT01755546|11130485|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
10008168|NCT01755546|11130485|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
10008169|NCT01755546|11130485|FG000|STARTED|Titration Phase||294
10008170|NCT01755546|11130485|FG000|COMPLETED|Titration Phase||224
9884191|NCT01045993|10998698|FG000|NOT COMPLETED|Overall Study||0
9884192|NCT01045993|10998699|FG001|NOT COMPLETED|Overall Study||1
9884193|NCT01045993|10998700|FG002|NOT COMPLETED|Overall Study||0
9884194|NCT01045993|10998701|FG003|NOT COMPLETED|Overall Study||0
9884195|NCT01046084|10998713|FG000|STARTED|First Intervention||25
9884196|NCT01046084|10998714|FG001|STARTED|First Intervention||25
9884197|NCT01046084|10998713|FG000|COMPLETED|First Intervention||25
9884198|NCT01046084|10998714|FG001|COMPLETED|First Intervention||25
9884199|NCT01046084|10998713|FG000|NOT COMPLETED|First Intervention||0
9884200|NCT01046084|10998714|FG001|NOT COMPLETED|First Intervention||0
9884201|NCT01046084|10998713|FG000|STARTED|First Washout of 7 Days||25
9884202|NCT01046084|10998714|FG001|STARTED|First Washout of 7 Days||25
9884203|NCT01046084|10998713|FG000|COMPLETED|First Washout of 7 Days||25
9884204|NCT01046084|10998714|FG001|COMPLETED|First Washout of 7 Days||25
9884205|NCT01046084|10998713|FG000|NOT COMPLETED|First Washout of 7 Days||0
9884206|NCT01046084|10998714|FG001|NOT COMPLETED|First Washout of 7 Days||0
9884207|NCT01046084|10998713|FG000|STARTED|Second Intervention||25
9884208|NCT01046084|10998714|FG001|STARTED|Second Intervention||25
9884209|NCT01046084|10998713|FG000|COMPLETED|Second Intervention||25
9884210|NCT01046084|10998714|FG001|COMPLETED|Second Intervention||25
9884211|NCT01046084|10998713|FG000|NOT COMPLETED|Second Intervention||0
9884212|NCT01046084|10998714|FG001|NOT COMPLETED|Second Intervention||0
9884213|NCT01046084|10998713|FG000|STARTED|Second Washout of 7 Days||25
9884214|NCT01046084|10998714|FG001|STARTED|Second Washout of 7 Days||25
9884215|NCT01046084|10998713|FG000|COMPLETED|Second Washout of 7 Days||25
9884216|NCT01046084|10998714|FG001|COMPLETED|Second Washout of 7 Days||25
10008171|NCT01755546|11130485|FG000|NOT COMPLETED|Titration Phase||70
10008172|NCT01755546|11130485|FG000|STARTED|Long Term Treatment||224
9884217|NCT01046084|10998713|FG000|NOT COMPLETED|Second Washout of 7 Days||0
9884218|NCT01046084|10998714|FG001|NOT COMPLETED|Second Washout of 7 Days||0
9884219|NCT01046084|10998713|FG000|STARTED|Third Intervention||25
9884220|NCT01046084|10998714|FG001|STARTED|Third Intervention||25
9884221|NCT01046084|10998713|FG000|COMPLETED|Third Intervention||25
9884222|NCT01046084|10998714|FG001|COMPLETED|Third Intervention||25
9884223|NCT01046084|10998713|FG000|NOT COMPLETED|Third Intervention||0
9884224|NCT01046084|10998714|FG001|NOT COMPLETED|Third Intervention||0
9884225|NCT01046084|10998713|FG000|STARTED|Third Washout of 7 Days||25
9884226|NCT01046084|10998714|FG001|STARTED|Third Washout of 7 Days||25
9884227|NCT01046084|10998713|FG000|COMPLETED|Third Washout of 7 Days||23
9884228|NCT01046084|10998714|FG001|COMPLETED|Third Washout of 7 Days||25
9884229|NCT01046084|10998713|FG000|NOT COMPLETED|Third Washout of 7 Days||2
9884230|NCT01046084|10998714|FG001|NOT COMPLETED|Third Washout of 7 Days||0
9884231|NCT01046084|10998713|FG000|STARTED|Fourth Intervention||23
9884232|NCT01046084|10998714|FG001|STARTED|Fourth Intervention||25
9884233|NCT01046084|10998713|FG000|COMPLETED|Fourth Intervention||23
9884234|NCT01046084|10998714|FG001|COMPLETED|Fourth Intervention||25
9884235|NCT01046084|10998713|FG000|NOT COMPLETED|Fourth Intervention||0
9884236|NCT01046084|10998714|FG001|NOT COMPLETED|Fourth Intervention||0
9884237|NCT01046110|10998722|FG000|STARTED|Overall Study||229
9884238|NCT01046110|10998723|FG001|STARTED|Overall Study||229
9884239|NCT01046110|10998722|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
9884240|NCT01046110|10998723|FG001|Exposed|Overall Study|1 subject was randomised in error|228
9884241|NCT01046110|10998722|FG000|COMPLETED|Overall Study||174
9884242|NCT01046110|10998723|FG001|COMPLETED|Overall Study||174
9884243|NCT01046110|10998722|FG000|NOT COMPLETED|Overall Study||55
9884244|NCT01046110|10998723|FG001|NOT COMPLETED|Overall Study||55
9884245|NCT01046136|10998731|FG000|STARTED|Overall Study||188
9884246|NCT01046136|10998732|FG001|STARTED|Overall Study||190
9884247|NCT01046136|10998731|FG000|COMPLETED|Overall Study||184
9884248|NCT01046136|10998732|FG001|COMPLETED|Overall Study||182
9884249|NCT01046136|10998731|FG000|NOT COMPLETED|Overall Study||4
9884250|NCT01046136|10998732|FG001|NOT COMPLETED|Overall Study||8
9884251|NCT01046253|10998742|FG000|STARTED|First Intervention||25
9884252|NCT01046253|10998743|FG001|STARTED|First Intervention||25
9884253|NCT01046253|10998742|FG000|COMPLETED|First Intervention||25
9884254|NCT01046253|10998743|FG001|COMPLETED|First Intervention||25
9884255|NCT01046253|10998742|FG000|NOT COMPLETED|First Intervention||0
9884256|NCT01046253|10998743|FG001|NOT COMPLETED|First Intervention||0
9884257|NCT01046253|10998742|FG000|STARTED|First Washout of 7 Days||25
9884258|NCT01046253|10998743|FG001|STARTED|First Washout of 7 Days||25
9884259|NCT01046253|10998742|FG000|COMPLETED|First Washout of 7 Days||25
9884260|NCT01046253|10998743|FG001|COMPLETED|First Washout of 7 Days||25
9884261|NCT01046253|10998742|FG000|NOT COMPLETED|First Washout of 7 Days||0
9884262|NCT01046253|10998743|FG001|NOT COMPLETED|First Washout of 7 Days||0
9884263|NCT01046253|10998742|FG000|STARTED|Second Intervention||25
9884264|NCT01046253|10998743|FG001|STARTED|Second Intervention||25
9884265|NCT01046253|10998742|FG000|COMPLETED|Second Intervention||25
9884266|NCT01046253|10998743|FG001|COMPLETED|Second Intervention||23
9884267|NCT01046253|10998742|FG000|NOT COMPLETED|Second Intervention||0
9884268|NCT01046253|10998743|FG001|NOT COMPLETED|Second Intervention||2
9884269|NCT01046253|10998742|FG000|STARTED|Second Washout of 7 Days||25
9884270|NCT01046253|10998743|FG001|STARTED|Second Washout of 7 Days||23
9884271|NCT01046253|10998742|FG000|COMPLETED|Second Washout of 7 Days||25
9884272|NCT01046253|10998743|FG001|COMPLETED|Second Washout of 7 Days||23
9884273|NCT01046253|10998742|FG000|NOT COMPLETED|Second Washout of 7 Days||0
9884274|NCT01046253|10998743|FG001|NOT COMPLETED|Second Washout of 7 Days||0
9884275|NCT01046253|10998742|FG000|STARTED|Third Intervention||25
9884276|NCT01046253|10998743|FG001|STARTED|Third Intervention||23
9884277|NCT01046253|10998742|FG000|COMPLETED|Third Intervention||25
9884278|NCT01046253|10998743|FG001|COMPLETED|Third Intervention||23
9884279|NCT01046253|10998742|FG000|NOT COMPLETED|Third Intervention||0
9884280|NCT01046253|10998743|FG001|NOT COMPLETED|Third Intervention||0
9884281|NCT01046253|10998742|FG000|STARTED|Third Washout of 7 Days||25
9884282|NCT01046253|10998743|FG001|STARTED|Third Washout of 7 Days||23
9884283|NCT01046253|10998742|FG000|COMPLETED|Third Washout of 7 Days||25
9884284|NCT01046253|10998743|FG001|COMPLETED|Third Washout of 7 Days||23
9884285|NCT01046253|10998742|FG000|NOT COMPLETED|Third Washout of 7 Days||0
9884286|NCT01046253|10998743|FG001|NOT COMPLETED|Third Washout of 7 Days||0
9884287|NCT01046253|10998742|FG000|STARTED|Fourth Intervention||25
9884288|NCT01046253|10998743|FG001|STARTED|Fourth Intervention||23
9884289|NCT01046253|10998742|FG000|COMPLETED|Fourth Intervention||25
9884290|NCT01046253|10998743|FG001|COMPLETED|Fourth Intervention||23
9884291|NCT01046253|10998742|FG000|NOT COMPLETED|Fourth Intervention||0
9884292|NCT01046253|10998743|FG001|NOT COMPLETED|Fourth Intervention||0
9884293|NCT01046396|10998749|FG000|STARTED|Overall Study||69
9884294|NCT01046396|10998749|FG000|COMPLETED|Overall Study||64
9884295|NCT01046396|10998749|FG000|NOT COMPLETED|Overall Study||5
9884296|NCT01046565|10998756|FG000|STARTED|Overall Study||75
9884297|NCT01046565|10998756|FG000|COMPLETED|Overall Study||66
9884298|NCT01046565|10998756|FG000|NOT COMPLETED|Overall Study||9
9884299|NCT01046643|10998767|FG000|STARTED|First Period Treatment or Placebo||9
9884300|NCT01046643|10998768|FG001|STARTED|First Period Treatment or Placebo||7
9884301|NCT01046643|10998769|FG002|STARTED|First Period Treatment or Placebo||7
9884302|NCT01046643|10998770|FG003|STARTED|First Period Treatment or Placebo||7
9884303|NCT01046643|10998767|FG000|COMPLETED|First Period Treatment or Placebo||9
9884304|NCT01046643|10998768|FG001|COMPLETED|First Period Treatment or Placebo||6
9884305|NCT01046643|10998769|FG002|COMPLETED|First Period Treatment or Placebo||7
9884306|NCT01046643|10998770|FG003|COMPLETED|First Period Treatment or Placebo||7
9884307|NCT01046643|10998767|FG000|NOT COMPLETED|First Period Treatment or Placebo||0
9884308|NCT01046643|10998768|FG001|NOT COMPLETED|First Period Treatment or Placebo||1
9884309|NCT01046643|10998769|FG002|NOT COMPLETED|First Period Treatment or Placebo||0
9884310|NCT01046643|10998770|FG003|NOT COMPLETED|First Period Treatment or Placebo||0
9884311|NCT01046643|10998767|FG000|STARTED|Washout Period||9
9884312|NCT01046643|10998768|FG001|STARTED|Washout Period||6
9884313|NCT01046643|10998769|FG002|STARTED|Washout Period||7
9884314|NCT01046643|10998770|FG003|STARTED|Washout Period||7
9884315|NCT01046643|10998767|FG000|COMPLETED|Washout Period||9
9884316|NCT01046643|10998768|FG001|COMPLETED|Washout Period||6
9884317|NCT01046643|10998769|FG002|COMPLETED|Washout Period||7
9884318|NCT01046643|10998770|FG003|COMPLETED|Washout Period||7
10008173|NCT01755546|11130485|FG000|COMPLETED|Long Term Treatment||103
10008174|NCT01755546|11130485|FG000|NOT COMPLETED|Long Term Treatment||121
10008175|NCT01755598|11130491|FG000|STARTED|Overall Study||1786
10008176|NCT01755598|11130492|FG001|STARTED|Overall Study||1787
10008177|NCT01755598|11130491|FG000|COMPLETED|Overall Study||1521
10008178|NCT01755598|11130492|FG001|COMPLETED|Overall Study||1504
9884319|NCT01046643|10998767|FG000|NOT COMPLETED|Washout Period||0
9884320|NCT01046643|10998768|FG001|NOT COMPLETED|Washout Period||0
9884321|NCT01046643|10998769|FG002|NOT COMPLETED|Washout Period||0
9884322|NCT01046643|10998770|FG003|NOT COMPLETED|Washout Period||0
9884323|NCT01046643|10998767|FG000|STARTED|Second Period Treatment or Placebo||9
9884324|NCT01046643|10998768|FG001|STARTED|Second Period Treatment or Placebo||6
9884325|NCT01046643|10998769|FG002|STARTED|Second Period Treatment or Placebo||7
9884326|NCT01046643|10998770|FG003|STARTED|Second Period Treatment or Placebo||7
9884327|NCT01046643|10998767|FG000|COMPLETED|Second Period Treatment or Placebo||9
9884328|NCT01046643|10998768|FG001|COMPLETED|Second Period Treatment or Placebo||6
9884329|NCT01046643|10998769|FG002|COMPLETED|Second Period Treatment or Placebo||7
9884330|NCT01046643|10998770|FG003|COMPLETED|Second Period Treatment or Placebo||7
9884331|NCT01046643|10998767|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0
9884332|NCT01046643|10998768|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0
9884333|NCT01046643|10998769|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0
9884334|NCT01046643|10998770|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0
9884335|NCT01046669|10998782|FG000|STARTED|Overall Study||226
9884336|NCT01046669|10998783|FG001|STARTED|Overall Study||224
9884337|NCT01046669|10998782|FG000|COMPLETED|Overall Study||226
9884338|NCT01046669|10998783|FG001|COMPLETED|Overall Study||223
9884339|NCT01046669|10998782|FG000|NOT COMPLETED|Overall Study||0
9884340|NCT01046669|10998783|FG001|NOT COMPLETED|Overall Study||1
9884341|NCT01046682|10998791|FG000|STARTED|Overall Study||20
9884342|NCT01046682|10998792|FG001|STARTED|Overall Study||20
9884343|NCT01046682|10998791|FG000|COMPLETED|Overall Study||18
9884344|NCT01046682|10998792|FG001|COMPLETED|Overall Study||20
9884345|NCT01046682|10998791|FG000|NOT COMPLETED|Overall Study||2
9884346|NCT01046682|10998792|FG001|NOT COMPLETED|Overall Study||0
9884347|NCT01046695|10998800|FG000|STARTED|Overall Study||20
9884348|NCT01046695|10998801|FG001|STARTED|Overall Study||22
9884349|NCT01046695|10998800|FG000|COMPLETED|Overall Study||20
9884350|NCT01046695|10998801|FG001|COMPLETED|Overall Study||20
9884351|NCT01046695|10998800|FG000|NOT COMPLETED|Overall Study||0
9884352|NCT01046695|10998801|FG001|NOT COMPLETED|Overall Study||2
9884353|NCT01046877|10998807|FG000|STARTED|Overall Study||25
9884354|NCT01046877|10998807|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
9884355|NCT01046877|10998807|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
9884356|NCT01046877|10998807|FG000|COMPLETED|Overall Study||7
9884357|NCT01046877|10998807|FG000|NOT COMPLETED|Overall Study||18
9884358|NCT01046903|10998811|FG000|STARTED|Overall Study||503
9884359|NCT01046903|10998811|FG000|COMPLETED|Overall Study||475
9884360|NCT01046903|10998811|FG000|NOT COMPLETED|Overall Study||28
9884361|NCT01047007|10998819|FG000|STARTED|Overall Study||3
9884362|NCT01047007|10998820|FG001|STARTED|Overall Study||6
9884363|NCT01047007|10998821|FG002|STARTED|Overall Study||2
9884364|NCT01047007|10998822|FG003|STARTED|Overall Study||0
9884365|NCT01047007|10998819|FG000|Treated|Overall Study||3
9884366|NCT01047007|10998820|FG001|Treated|Overall Study||6
9884367|NCT01047007|10998821|FG002|Treated|Overall Study||2
9884368|NCT01047007|10998822|FG003|Treated|Overall Study||0
9884369|NCT01047007|10998819|FG000|COMPLETED|Overall Study||1
9884370|NCT01047007|10998820|FG001|COMPLETED|Overall Study||0
9884371|NCT01047007|10998821|FG002|COMPLETED|Overall Study||0
9884372|NCT01047007|10998822|FG003|COMPLETED|Overall Study||0
9884373|NCT01047007|10998819|FG000|NOT COMPLETED|Overall Study||2
9884374|NCT01047007|10998820|FG001|NOT COMPLETED|Overall Study||6
10008179|NCT01755598|11130491|FG000|NOT COMPLETED|Overall Study||265
10008180|NCT01755598|11130492|FG001|NOT COMPLETED|Overall Study||283
10008181|NCT01755637|11130498|FG000|STARTED|Period 1||28
10008182|NCT01755637|11130499|FG001|STARTED|Period 1||28
9884375|NCT01047007|10998821|FG002|NOT COMPLETED|Overall Study||2
9884376|NCT01047007|10998822|FG003|NOT COMPLETED|Overall Study||0
9884377|NCT01047189|10998834|FG000|STARTED|Overall Study||13
9884378|NCT01047189|10998835|FG001|STARTED|Overall Study||13
9884379|NCT01047189|10998834|FG000|COMPLETED|Overall Study||9
9884380|NCT01047189|10998835|FG001|COMPLETED|Overall Study||13
9884381|NCT01047189|10998834|FG000|NOT COMPLETED|Overall Study||4
9884382|NCT01047189|10998835|FG001|NOT COMPLETED|Overall Study||0
9884383|NCT01047241|10998841|FG000|STARTED|Overall Study||50
9884384|NCT01047241|10998841|FG000|COMPLETED|Overall Study||50
9884385|NCT01047241|10998841|FG000|NOT COMPLETED|Overall Study||0
9884386|NCT01047293|10998848|FG000|STARTED|Overall Study||4
9884387|NCT01047293|10998849|FG001|STARTED|Overall Study||8
9884388|NCT01047293|10998850|FG002|STARTED|Overall Study||9
9884389|NCT01047293|10998851|FG003|STARTED|Overall Study||26
9884390|NCT01047293|10998848|FG000|COMPLETED|Overall Study||3
9884391|NCT01047293|10998849|FG001|COMPLETED|Overall Study||7
10008183|NCT01755637|11130498|FG000|COMPLETED|Period 1||28
9884392|NCT01047293|10998850|FG002|COMPLETED|Overall Study||9
10008184|NCT01755637|11130499|FG001|COMPLETED|Period 1||27
9884393|NCT01047293|10998851|FG003|COMPLETED|Overall Study||26
9884394|NCT01047293|10998848|FG000|NOT COMPLETED|Overall Study||1
9884395|NCT01047293|10998849|FG001|NOT COMPLETED|Overall Study||1
9884396|NCT01047293|10998850|FG002|NOT COMPLETED|Overall Study||0
9884397|NCT01047293|10998851|FG003|NOT COMPLETED|Overall Study||0
9884398|NCT01047306|10998860|FG000|STARTED|Overall Study||19
9884399|NCT01047306|10998861|FG001|STARTED|Overall Study||6
9884400|NCT01047306|10998860|FG000|Discontinued From the Study|Overall Study||3
9884401|NCT01047306|10998861|FG001|Discontinued From the Study|Overall Study||0
9884402|NCT01047306|10998860|FG000|COMPLETED|Overall Study||16
9884403|NCT01047306|10998861|FG001|COMPLETED|Overall Study||6
9884404|NCT01047306|10998860|FG000|NOT COMPLETED|Overall Study||3
9884405|NCT01047306|10998861|FG001|NOT COMPLETED|Overall Study||0
9884406|NCT01047332|10998871|FG000|STARTED|Overall Study||61
9884407|NCT01047332|10998872|FG001|STARTED|Overall Study||68
9884408|NCT01047332|10998871|FG000|COMPLETED|Overall Study|Alive at final follow-up|4
9884409|NCT01047332|10998872|FG001|COMPLETED|Overall Study|Alive at final follow-up|4
9884410|NCT01047332|10998871|FG000|NOT COMPLETED|Overall Study||57
9884411|NCT01047332|10998872|FG001|NOT COMPLETED|Overall Study||64
9884412|NCT01047345|10998880|FG000|STARTED|Base Study||618
9884413|NCT01047345|10998881|FG001|STARTED|Base Study||306
9884414|NCT01047345|10998882|FG002|STARTED|Base Study||0
9884415|NCT01047345|10998880|FG000|Vaccination 1|Base Study||615
9884416|NCT01047345|10998881|FG001|Vaccination 1|Base Study||306
9884417|NCT01047345|10998882|FG002|Vaccination 1|Base Study||0
9884418|NCT01047345|10998880|FG000|Vaccination 2|Base Study||604
9884419|NCT01047345|10998881|FG001|Vaccination 2|Base Study||304
9884420|NCT01047345|10998882|FG002|Vaccination 2|Base Study||0
9884421|NCT01047345|10998880|FG000|Vaccination 3|Base Study||597
9884422|NCT01047345|10998881|FG001|Vaccination 3|Base Study||300
9884423|NCT01047345|10998882|FG002|Vaccination 3|Base Study||0
9884424|NCT01047345|10998880|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
9884425|NCT01047345|10998881|FG001|COMPLETED|Base Study||300
9884426|NCT01047345|10998882|FG002|COMPLETED|Base Study||0
9884427|NCT01047345|10998880|FG000|NOT COMPLETED|Base Study||22
9884428|NCT01047345|10998881|FG001|NOT COMPLETED|Base Study||6
9884429|NCT01047345|10998882|FG002|NOT COMPLETED|Base Study||0
9884430|NCT01047345|10998880|FG000|STARTED|Extension||0
9884431|NCT01047345|10998881|FG001|STARTED|Extension||0
9884432|NCT01047345|10998882|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102
9884433|NCT01047345|10998880|FG000|Vaccination 4|Extension||0
9884434|NCT01047345|10998881|FG001|Vaccination 4|Extension||0
9884435|NCT01047345|10998882|FG002|Vaccination 4|Extension||102
9884436|NCT01047345|10998880|FG000|Vaccination 5|Extension||0
9884437|NCT01047345|10998881|FG001|Vaccination 5|Extension||0
9884438|NCT01047345|10998882|FG002|Vaccination 5|Extension||99
9884439|NCT01047345|10998880|FG000|Vaccination 6|Extension||0
9884440|NCT01047345|10998881|FG001|Vaccination 6|Extension||0
9884441|NCT01047345|10998882|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
9884442|NCT01047345|10998880|FG000|COMPLETED|Extension||0
9884443|NCT01047345|10998881|FG001|COMPLETED|Extension||0
9884444|NCT01047345|10998882|FG002|COMPLETED|Extension||96
9884445|NCT01047345|10998880|FG000|NOT COMPLETED|Extension||0
9884446|NCT01047345|10998881|FG001|NOT COMPLETED|Extension||0
9884447|NCT01047345|10998882|FG002|NOT COMPLETED|Extension||6
9884448|NCT01047358|10998890|FG000|STARTED|Overall Study||206
9884449|NCT01047358|10998890|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
9884450|NCT01047358|10998890|FG000|NOT COMPLETED|Overall Study||0
9884451|NCT01047436|10998897|FG000|STARTED|Overall Study||16
9884452|NCT01047436|10998898|FG001|STARTED|Overall Study||15
9884453|NCT01047436|10998897|FG000|COMPLETED|Overall Study||15
9884454|NCT01047436|10998898|FG001|COMPLETED|Overall Study||15
9884455|NCT01047436|10998897|FG000|NOT COMPLETED|Overall Study||1
9884456|NCT01047436|10998898|FG001|NOT COMPLETED|Overall Study||0
9884457|NCT01047475|10998906|FG000|STARTED|Overall Study||34
9884458|NCT01047475|10998907|FG001|STARTED|Overall Study||38
9884459|NCT01047475|10998906|FG000|COMPLETED|Overall Study||29
9884460|NCT01047475|10998907|FG001|COMPLETED|Overall Study||31
9884461|NCT01047475|10998906|FG000|NOT COMPLETED|Overall Study||5
9884462|NCT01047475|10998907|FG001|NOT COMPLETED|Overall Study||7
9884463|NCT01047527|10998916|FG000|STARTED|Overall Study||180
9884464|NCT01047527|10998917|FG001|STARTED|Overall Study||173
9884465|NCT01047527|10998918|FG002|STARTED|Overall Study||172
9884466|NCT01047527|10998916|FG000|8 Weeks|Overall Study||148
9884467|NCT01047527|10998917|FG001|8 Weeks|Overall Study||142
9884468|NCT01047527|10998918|FG002|8 Weeks|Overall Study||138
9884469|NCT01047527|10998916|FG000|24 Weeks|Overall Study||111
9884470|NCT01047527|10998917|FG001|24 Weeks|Overall Study||123
9884471|NCT01047527|10998918|FG002|24 Weeks|Overall Study||119
9884472|NCT01047527|10998916|FG000|COMPLETED|Overall Study||95
9884473|NCT01047527|10998917|FG001|COMPLETED|Overall Study||112
9884474|NCT01047527|10998918|FG002|COMPLETED|Overall Study||107
9884475|NCT01047527|10998916|FG000|NOT COMPLETED|Overall Study||85
9884476|NCT01047527|10998917|FG001|NOT COMPLETED|Overall Study||61
9884477|NCT01047527|10998918|FG002|NOT COMPLETED|Overall Study||65
9884478|NCT01047553|10998929|FG000|STARTED|Overall Study||125
9884479|NCT01047553|10998930|FG001|STARTED|Overall Study||126
9884480|NCT01047553|10998929|FG000|COMPLETED|Overall Study||108
9884481|NCT01047553|10998930|FG001|COMPLETED|Overall Study||117
9884482|NCT01047553|10998929|FG000|NOT COMPLETED|Overall Study||17
9884483|NCT01047553|10998930|FG001|NOT COMPLETED|Overall Study||9
9884484|NCT01047709|10998936|FG000|STARTED|Positional Therapy (1 Night)||9
9884485|NCT01047709|10998937|FG001|STARTED|Positional Therapy (1 Night)||9
9884486|NCT01047709|10998936|FG000|COMPLETED|Positional Therapy (1 Night)||9
9884487|NCT01047709|10998937|FG001|COMPLETED|Positional Therapy (1 Night)||9
9884488|NCT01047709|10998936|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0
9884489|NCT01047709|10998937|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0
9884490|NCT01047709|10998936|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9
9884491|NCT01047709|10998937|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9
9884492|NCT01047709|10998936|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9
9884493|NCT01047709|10998937|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9
9884494|NCT01047709|10998936|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
9884495|NCT01047709|10998937|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
9884496|NCT01047839|10998946|FG000|STARTED|Overall Study||12
9884497|NCT01047839|10998947|FG001|STARTED|Overall Study||29
9884498|NCT01047839|10998948|FG002|STARTED|Overall Study||59
9884499|NCT01047839|10998946|FG000|COMPLETED|Overall Study||10
9884500|NCT01047839|10998947|FG001|COMPLETED|Overall Study||29
9884501|NCT01047839|10998948|FG002|COMPLETED|Overall Study||53
9884502|NCT01047839|10998946|FG000|NOT COMPLETED|Overall Study||2
9884503|NCT01047839|10998947|FG001|NOT COMPLETED|Overall Study||0
10008185|NCT01755637|11130498|FG000|NOT COMPLETED|Period 1||0
10008186|NCT01755637|11130499|FG001|NOT COMPLETED|Period 1||1
10008187|NCT01755637|11130498|FG000|STARTED|Period 2||28
10008188|NCT01755637|11130499|FG001|STARTED|Period 2||27
10008189|NCT01755637|11130498|FG000|COMPLETED|Period 2||28
10008190|NCT01755637|11130499|FG001|COMPLETED|Period 2||27
10008191|NCT01755637|11130498|FG000|NOT COMPLETED|Period 2||0
10008192|NCT01755637|11130499|FG001|NOT COMPLETED|Period 2||0
9884504|NCT01047839|10998948|FG002|NOT COMPLETED|Overall Study||6
9884505|NCT01048099|10998963|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
9884506|NCT01048099|10998963|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
9884507|NCT01048099|10998963|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57
9884508|NCT01048099|10998963|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
9884509|NCT01048099|10998963|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
9884510|NCT01048099|10998963|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
9884511|NCT01048099|10998963|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
9884512|NCT01048099|10998963|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
9884513|NCT01048099|10998963|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
9884514|NCT01048099|10998963|FG000|STARTED|Treatment Per Protocol||14
9884515|NCT01048099|10998963|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
9884516|NCT01048099|10998963|FG000|NOT COMPLETED|Treatment Per Protocol||14
9884517|NCT01048242|10998971|FG000|STARTED|Overall Study||12
9884518|NCT01048242|10998972|FG001|STARTED|Overall Study||15
9884519|NCT01048242|10998971|FG000|COMPLETED|Overall Study||8
9884520|NCT01048242|10998972|FG001|COMPLETED|Overall Study||13
9884521|NCT01048242|10998971|FG000|NOT COMPLETED|Overall Study||4
9884522|NCT01048242|10998972|FG001|NOT COMPLETED|Overall Study||2
9884523|NCT01048333|10998978|FG000|STARTED|Treatment Period 1||21
9884524|NCT01048333|10998979|FG001|STARTED|Treatment Period 1||19
9884525|NCT01048333|10998980|FG002|STARTED|Treatment Period 1||16
9884526|NCT01048333|10998981|FG003|STARTED|Treatment Period 1||18
9884527|NCT01048333|10998982|FG004|STARTED|Treatment Period 1||17
9884528|NCT01048333|10998983|FG005|STARTED|Treatment Period 1||18
9884529|NCT01048333|10998978|FG000|COMPLETED|Treatment Period 1||21
9884530|NCT01048333|10998979|FG001|COMPLETED|Treatment Period 1||19
9884531|NCT01048333|10998980|FG002|COMPLETED|Treatment Period 1||16
9884532|NCT01048333|10998981|FG003|COMPLETED|Treatment Period 1||18
9884533|NCT01048333|10998982|FG004|COMPLETED|Treatment Period 1||17
9884534|NCT01048333|10998983|FG005|COMPLETED|Treatment Period 1||18
9884535|NCT01048333|10998978|FG000|NOT COMPLETED|Treatment Period 1||0
9884536|NCT01048333|10998979|FG001|NOT COMPLETED|Treatment Period 1||0
9884537|NCT01048333|10998980|FG002|NOT COMPLETED|Treatment Period 1||0
9884538|NCT01048333|10998981|FG003|NOT COMPLETED|Treatment Period 1||0
9884539|NCT01048333|10998982|FG004|NOT COMPLETED|Treatment Period 1||0
9884540|NCT01048333|10998983|FG005|NOT COMPLETED|Treatment Period 1||0
9884541|NCT01048333|10998978|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
9884542|NCT01048333|10998979|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
9884543|NCT01048333|10998980|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
9884544|NCT01048333|10998981|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
10008193|NCT01755702|11130511|FG000|STARTED|Period I||66
10008194|NCT01755702|11130511|FG000|Received Paracetamol|Period I||16
10008195|NCT01755702|11130511|FG000|Received Placebo|Period I||17
10008196|NCT01755702|11130511|FG000|Received Ibuprofen|Period I||16
9884545|NCT01048333|10998982|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
9884546|NCT01048333|10998983|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
9884547|NCT01048333|10998978|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
9884548|NCT01048333|10998979|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
9884549|NCT01048333|10998980|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
9884550|NCT01048333|10998981|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
9884551|NCT01048333|10998982|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
10008197|NCT01755702|11130511|FG000|Received Paracetamol/Caffeine|Period I||17
9884552|NCT01048333|10998983|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
9884553|NCT01048333|10998978|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
9884554|NCT01048333|10998979|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
9884555|NCT01048333|10998980|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
9884556|NCT01048333|10998981|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
9884557|NCT01048333|10998982|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
9884558|NCT01048333|10998983|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
9884559|NCT01048333|10998978|FG000|STARTED|Treatment Period 2||21
9884560|NCT01048333|10998979|FG001|STARTED|Treatment Period 2||19
9884561|NCT01048333|10998980|FG002|STARTED|Treatment Period 2||16
9884562|NCT01048333|10998981|FG003|STARTED|Treatment Period 2||18
9884563|NCT01048333|10998982|FG004|STARTED|Treatment Period 2||17
9884564|NCT01048333|10998983|FG005|STARTED|Treatment Period 2||18
9884565|NCT01048333|10998978|FG000|COMPLETED|Treatment Period 2||21
10008198|NCT01755702|11130511|FG000|COMPLETED|Period I||66
10008199|NCT01755702|11130511|FG000|NOT COMPLETED|Period I||0
10008200|NCT01755702|11130511|FG000|STARTED|Wash Out Period I||66
10008201|NCT01755702|11130511|FG000|COMPLETED|Wash Out Period I||63
10008202|NCT01755702|11130511|FG000|NOT COMPLETED|Wash Out Period I||3
10008203|NCT01755702|11130511|FG000|STARTED|Period II||63
9884566|NCT01048333|10998979|FG001|COMPLETED|Treatment Period 2||19
9884567|NCT01048333|10998980|FG002|COMPLETED|Treatment Period 2||16
9884568|NCT01048333|10998981|FG003|COMPLETED|Treatment Period 2||18
9884569|NCT01048333|10998982|FG004|COMPLETED|Treatment Period 2||17
9884570|NCT01048333|10998983|FG005|COMPLETED|Treatment Period 2||18
9884571|NCT01048333|10998978|FG000|NOT COMPLETED|Treatment Period 2||0
9884572|NCT01048333|10998979|FG001|NOT COMPLETED|Treatment Period 2||0
9884573|NCT01048333|10998980|FG002|NOT COMPLETED|Treatment Period 2||0
9884574|NCT01048333|10998981|FG003|NOT COMPLETED|Treatment Period 2||0
9884575|NCT01048333|10998982|FG004|NOT COMPLETED|Treatment Period 2||0
9884576|NCT01048333|10998983|FG005|NOT COMPLETED|Treatment Period 2||0
9884577|NCT01048333|10998978|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
9884578|NCT01048333|10998979|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
9884579|NCT01048333|10998980|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
9884580|NCT01048333|10998981|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
9884581|NCT01048333|10998982|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
9884582|NCT01048333|10998983|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
9884583|NCT01048333|10998978|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
9884584|NCT01048333|10998979|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
9884585|NCT01048333|10998980|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
9884586|NCT01048333|10998981|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
10008204|NCT01755702|11130511|FG000|Received Ibuprofen|Period II||11
10008205|NCT01755702|11130511|FG000|Received Placebo|Period II||15
10008206|NCT01755702|11130511|FG000|Received Paracetamol/Caffeine|Period II||20
9884587|NCT01048333|10998982|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
9884588|NCT01048333|10998983|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
9884589|NCT01048333|10998978|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
9884590|NCT01048333|10998979|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
9884591|NCT01048333|10998980|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
9884592|NCT01048333|10998981|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
9884593|NCT01048333|10998982|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
9884594|NCT01048333|10998983|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
9884595|NCT01048333|10998978|FG000|STARTED|Treatment Period 3||21
9884596|NCT01048333|10998979|FG001|STARTED|Treatment Period 3||18
9884597|NCT01048333|10998980|FG002|STARTED|Treatment Period 3||16
9884598|NCT01048333|10998981|FG003|STARTED|Treatment Period 3||18
9884599|NCT01048333|10998982|FG004|STARTED|Treatment Period 3||17
9884600|NCT01048333|10998983|FG005|STARTED|Treatment Period 3||18
9884601|NCT01048333|10998978|FG000|COMPLETED|Treatment Period 3||21
9884602|NCT01048333|10998979|FG001|COMPLETED|Treatment Period 3||18
9884603|NCT01048333|10998980|FG002|COMPLETED|Treatment Period 3||16
9884604|NCT01048333|10998981|FG003|COMPLETED|Treatment Period 3||18
9884605|NCT01048333|10998982|FG004|COMPLETED|Treatment Period 3||17
9884606|NCT01048333|10998983|FG005|COMPLETED|Treatment Period 3||18
9884607|NCT01048333|10998978|FG000|NOT COMPLETED|Treatment Period 3||0
9884608|NCT01048333|10998979|FG001|NOT COMPLETED|Treatment Period 3||0
10008207|NCT01755702|11130511|FG000|Received Paracetamol|Period II||17
10008208|NCT01755702|11130511|FG000|COMPLETED|Period II||63
10008209|NCT01755702|11130511|FG000|NOT COMPLETED|Period II||0
10008210|NCT01755702|11130511|FG000|STARTED|Washout Period II||63
10008211|NCT01755702|11130511|FG000|COMPLETED|Washout Period II||58
9884609|NCT01048333|10998980|FG002|NOT COMPLETED|Treatment Period 3||0
9884610|NCT01048333|10998981|FG003|NOT COMPLETED|Treatment Period 3||0
9884611|NCT01048333|10998982|FG004|NOT COMPLETED|Treatment Period 3||0
9884612|NCT01048333|10998983|FG005|NOT COMPLETED|Treatment Period 3||0
9884613|NCT01048424|10998993|FG000|STARTED|Overall Study||10
9884614|NCT01048424|10998994|FG001|STARTED|Overall Study||10
9884615|NCT01048424|10998993|FG000|COMPLETED|Overall Study||8
9884616|NCT01048424|10998994|FG001|COMPLETED|Overall Study||10
9884617|NCT01048424|10998993|FG000|NOT COMPLETED|Overall Study||2
9884618|NCT01048424|10998994|FG001|NOT COMPLETED|Overall Study||0
9884619|NCT01048502|10999005|FG000|STARTED|Overall Study||24
9884620|NCT01048502|10999006|FG001|STARTED|Overall Study||23
9884621|NCT01048502|10999007|FG002|STARTED|Overall Study||28
9884622|NCT01048502|10999008|FG003|STARTED|Overall Study||25
9884623|NCT01048502|10999005|FG000|COMPLETED|Overall Study||20
9884624|NCT01048502|10999006|FG001|COMPLETED|Overall Study||16
9884625|NCT01048502|10999007|FG002|COMPLETED|Overall Study||23
9884626|NCT01048502|10999008|FG003|COMPLETED|Overall Study||21
9884627|NCT01048502|10999005|FG000|NOT COMPLETED|Overall Study||4
9884628|NCT01048502|10999006|FG001|NOT COMPLETED|Overall Study||7
9884629|NCT01048502|10999007|FG002|NOT COMPLETED|Overall Study||5
9884630|NCT01048502|10999008|FG003|NOT COMPLETED|Overall Study||4
9884631|NCT01048541|10999019|FG000|STARTED|Overall Study||18
9884632|NCT01048541|10999020|FG001|STARTED|Overall Study||19
9884633|NCT01048541|10999019|FG000|COMPLETED|Overall Study||17
9884634|NCT01048541|10999020|FG001|COMPLETED|Overall Study||19
9884635|NCT01048541|10999019|FG000|NOT COMPLETED|Overall Study||1
9884636|NCT01048541|10999020|FG001|NOT COMPLETED|Overall Study||0
9884637|NCT01048593|10999029|FG000|STARTED|Overall Study||3
9884638|NCT01048593|10999030|FG001|STARTED|Overall Study||2
9884639|NCT01048593|10999031|FG002|STARTED|Overall Study||1
9884640|NCT01048593|10999029|FG000|COMPLETED|Overall Study||3
9884641|NCT01048593|10999030|FG001|COMPLETED|Overall Study||2
9884642|NCT01048593|10999031|FG002|COMPLETED|Overall Study||1
9884643|NCT01048593|10999029|FG000|NOT COMPLETED|Overall Study||0
9884644|NCT01048593|10999030|FG001|NOT COMPLETED|Overall Study||0
9884645|NCT01048593|10999031|FG002|NOT COMPLETED|Overall Study||0
9884646|NCT01048606|10999043|FG000|STARTED|Overall Study||28
9884647|NCT01048606|10999044|FG001|STARTED|Overall Study||15
9884648|NCT01048606|10999045|FG002|STARTED|Overall Study||26
9884649|NCT01048606|10999046|FG003|STARTED|Overall Study||10
9884650|NCT01048606|10999043|FG000|COMPLETED|Overall Study||16
9884651|NCT01048606|10999044|FG001|COMPLETED|Overall Study||8
9884652|NCT01048606|10999045|FG002|COMPLETED|Overall Study||16
9884653|NCT01048606|10999046|FG003|COMPLETED|Overall Study||5
9884654|NCT01048606|10999043|FG000|NOT COMPLETED|Overall Study||12
9884655|NCT01048606|10999044|FG001|NOT COMPLETED|Overall Study||7
9884656|NCT01048606|10999045|FG002|NOT COMPLETED|Overall Study||10
9884657|NCT01048606|10999046|FG003|NOT COMPLETED|Overall Study||5
9884658|NCT01048658|10999058|FG000|STARTED|Overall Study||80
9884659|NCT01048658|10999059|FG001|STARTED|Overall Study||80
9884660|NCT01048658|10999058|FG000|COMPLETED|Overall Study||80
9884661|NCT01048658|10999059|FG001|COMPLETED|Overall Study||80
9884662|NCT01048658|10999058|FG000|NOT COMPLETED|Overall Study||0
9884663|NCT01048658|10999059|FG001|NOT COMPLETED|Overall Study||0
9884664|NCT01048671|10999068|FG000|STARTED|Overall Study||66
9884665|NCT01048671|10999069|FG001|STARTED|Overall Study||264
9884666|NCT01048671|10999070|FG002|STARTED|Overall Study||152
9884667|NCT01048671|10999068|FG000|COMPLETED|Overall Study||66
9884668|NCT01048671|10999069|FG001|COMPLETED|Overall Study||263
10008212|NCT01755702|11130511|FG000|NOT COMPLETED|Washout Period II||5
10008213|NCT01755702|11130511|FG000|STARTED|Period III||58
10008214|NCT01755702|11130511|FG000|Received Paracetamol|Period III||17
10008215|NCT01755702|11130511|FG000|Received Placebo|Period III||13
10008216|NCT01755702|11130511|FG000|Received Paracetamol/Caffeine|Period III||10
10008217|NCT01755702|11130511|FG000|Received Ibuprofen|Period III||18
10008218|NCT01755702|11130511|FG000|COMPLETED|Period III||58
10008219|NCT01755702|11130511|FG000|NOT COMPLETED|Period III||0
10008220|NCT01755767|11130525|FG000|STARTED|Overall Study||28
10109051|NCT02472314|11239617|FG000|NOT COMPLETED|Overall Study||0
9884669|NCT01048671|10999070|FG002|COMPLETED|Overall Study||151
10109052|NCT02472314|11239618|FG001|NOT COMPLETED|Overall Study||0
10109053|NCT02472353|11239626|FG000|STARTED|Overall Study||14
10109054|NCT02472353|11239627|FG001|STARTED|Overall Study||16
10109055|NCT02472353|11239626|FG000|COMPLETED|Overall Study||10
10109056|NCT02472353|11239627|FG001|COMPLETED|Overall Study||10
9884670|NCT01048671|10999068|FG000|NOT COMPLETED|Overall Study||0
9884671|NCT01048671|10999069|FG001|NOT COMPLETED|Overall Study||1
9884672|NCT01048671|10999070|FG002|NOT COMPLETED|Overall Study||1
9884673|NCT01048697|10999078|FG000|STARTED|Overall Study||18
9884674|NCT01048697|10999078|FG000|COMPLETED|Overall Study||18
9884675|NCT01048697|10999078|FG000|NOT COMPLETED|Overall Study||0
9884676|NCT01048788|10999085|FG000|STARTED|Overall Study||8
9884677|NCT01048788|10999086|FG001|STARTED|Overall Study||30
9884678|NCT01048788|10999087|FG002|STARTED|Overall Study||13
9884679|NCT01048788|10999085|FG000|COMPLETED|Overall Study||3
10008221|NCT01755767|11130526|FG001|STARTED|Overall Study||15
10008222|NCT01755767|11130527|FG002|STARTED|Overall Study||226
9884680|NCT01048788|10999086|FG001|COMPLETED|Overall Study||28
9884681|NCT01048788|10999087|FG002|COMPLETED|Overall Study||11
9884682|NCT01048788|10999085|FG000|NOT COMPLETED|Overall Study||5
9884683|NCT01048788|10999086|FG001|NOT COMPLETED|Overall Study||2
9884684|NCT01048788|10999087|FG002|NOT COMPLETED|Overall Study||2
9884685|NCT01048866|10999097|FG000|STARTED|Overall Study||101
9884686|NCT01048866|10999098|FG001|STARTED|Overall Study||97
9884687|NCT01048866|10999097|FG000|COMPLETED|Overall Study||97
9884688|NCT01048866|10999098|FG001|COMPLETED|Overall Study||92
9884689|NCT01048866|10999097|FG000|NOT COMPLETED|Overall Study||4
9884690|NCT01048866|10999098|FG001|NOT COMPLETED|Overall Study||5
9884691|NCT01048879|10999107|FG000|STARTED|Overall Study||1
9884692|NCT01048879|10999108|FG001|STARTED|Overall Study||9
9884693|NCT01048879|10999109|FG002|STARTED|Overall Study||5
9884694|NCT01048879|10999107|FG000|COMPLETED|Overall Study||1
9884695|NCT01048879|10999108|FG001|COMPLETED|Overall Study||9
9884696|NCT01048879|10999109|FG002|COMPLETED|Overall Study||5
9884697|NCT01048879|10999107|FG000|NOT COMPLETED|Overall Study||0
10008223|NCT01755767|11130528|FG003|STARTED|Overall Study||114
10109057|NCT02472353|11239626|FG000|NOT COMPLETED|Overall Study||4
9884698|NCT01048879|10999108|FG001|NOT COMPLETED|Overall Study||0
9884699|NCT01048879|10999109|FG002|NOT COMPLETED|Overall Study||0
9884700|NCT01048905|10999117|FG000|STARTED|Overall Study||13
9884701|NCT01048905|10999117|FG000|COMPLETED|Overall Study||12
9884702|NCT01048905|10999117|FG000|NOT COMPLETED|Overall Study||1
9884703|NCT01048944|10999125|FG000|STARTED|Overall Study||32
9884704|NCT01048944|10999126|FG001|STARTED|Overall Study||38
9884705|NCT01048944|10999127|FG002|STARTED|Overall Study||35
9884706|NCT01048944|10999128|FG003|STARTED|Overall Study||21
9884707|NCT01048944|10999125|FG000|COMPLETED|Overall Study||24
9884708|NCT01048944|10999126|FG001|COMPLETED|Overall Study||28
9884709|NCT01048944|10999127|FG002|COMPLETED|Overall Study||25
9884710|NCT01048944|10999128|FG003|COMPLETED|Overall Study||19
9884711|NCT01048944|10999125|FG000|NOT COMPLETED|Overall Study||8
9884712|NCT01048944|10999126|FG001|NOT COMPLETED|Overall Study||10
9884713|NCT01048944|10999127|FG002|NOT COMPLETED|Overall Study||10
9884714|NCT01048944|10999128|FG003|NOT COMPLETED|Overall Study||2
9884715|NCT01049009|10999140|FG000|STARTED|Treatment Period 1 (12 Weeks)||23
9884716|NCT01049009|10999141|FG001|STARTED|Treatment Period 1 (12 Weeks)||21
9884717|NCT01049009|10999140|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21
9884718|NCT01049009|10999141|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18
9884719|NCT01049009|10999140|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
9884720|NCT01049009|10999141|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
9884721|NCT01049009|10999140|FG000|STARTED|Treatment Period 2 (12 Weeks)||21
9884722|NCT01049009|10999141|FG001|STARTED|Treatment Period 2 (12 Weeks)||18
9884723|NCT01049009|10999140|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11
9884724|NCT01049009|10999141|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8
9884725|NCT01049009|10999140|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
9884726|NCT01049009|10999141|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
9884727|NCT01049217|10999149|FG000|STARTED|Overall Study||183
9884728|NCT01049217|10999150|FG001|STARTED|Overall Study||194
9884729|NCT01049217|10999149|FG000|Treated|Overall Study||183
9884730|NCT01049217|10999150|FG001|Treated|Overall Study||192
9884731|NCT01049217|10999149|FG000|COMPLETED|Overall Study||127
9884732|NCT01049217|10999150|FG001|COMPLETED|Overall Study||131
9884733|NCT01049217|10999149|FG000|NOT COMPLETED|Overall Study||56
9884734|NCT01049217|10999150|FG001|NOT COMPLETED|Overall Study||63
9884735|NCT01049243|10999156|FG000|STARTED|Overall Study||20
9884736|NCT01049243|10999156|FG000|COMPLETED|Overall Study||18
9884737|NCT01049243|10999156|FG000|NOT COMPLETED|Overall Study||2
9884738|NCT01049308|10999161|FG000|STARTED|Evaluation of Cognitive Impairment||251
9884739|NCT01049308|10999161|FG000|COMPLETED|Evaluation of Cognitive Impairment||251
9884740|NCT01049308|10999161|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0
9884741|NCT01049308|10999161|FG000|STARTED|Pill Counts||251
9884742|NCT01049308|10999161|FG000|COMPLETED|Pill Counts||168
9884743|NCT01049308|10999161|FG000|NOT COMPLETED|Pill Counts||83
9884744|NCT01049334|10999170|FG000|STARTED|Overall Study||102
9884745|NCT01049334|10999171|FG001|STARTED|Overall Study||102
9884746|NCT01049334|10999170|FG000|COMPLETED|Overall Study||93
9884747|NCT01049334|10999171|FG001|COMPLETED|Overall Study||95
9884748|NCT01049334|10999170|FG000|NOT COMPLETED|Overall Study||9
9884749|NCT01049334|10999171|FG001|NOT COMPLETED|Overall Study||7
9884750|NCT01049360|10999177|FG000|STARTED|Period 1||6
9884751|NCT01049360|10999178|FG001|STARTED|Period 1||6
9884752|NCT01049360|10999179|FG002|STARTED|Period 1||7
9884753|NCT01049360|10999180|FG003|STARTED|Period 1||7
9884754|NCT01049360|10999181|FG004|STARTED|Period 1||7
9884755|NCT01049360|10999182|FG005|STARTED|Period 1||6
9884756|NCT01049360|10999183|FG006|STARTED|Period 1||6
9884757|NCT01049360|10999184|FG007|STARTED|Period 1||6
9884758|NCT01049360|10999185|FG008|STARTED|Period 1||7
9884759|NCT01049360|10999186|FG009|STARTED|Period 1||6
9884760|NCT01049360|10999187|FG010|STARTED|Period 1||6
9884761|NCT01049360|10999188|FG011|STARTED|Period 1||6
9884762|NCT01049360|10999189|FG012|STARTED|Period 1||6
9884763|NCT01049360|10999190|FG013|STARTED|Period 1||7
9884764|NCT01049360|10999191|FG014|STARTED|Period 1||7
9884765|NCT01049360|10999192|FG015|STARTED|Period 1||7
9884766|NCT01049360|10999193|FG016|STARTED|Period 1||6
9884767|NCT01049360|10999194|FG017|STARTED|Period 1||6
9884768|NCT01049360|10999195|FG018|STARTED|Period 1||6
9884769|NCT01049360|10999196|FG019|STARTED|Period 1||7
9884770|NCT01049360|10999177|FG000|COMPLETED|Period 1||6
9884771|NCT01049360|10999178|FG001|COMPLETED|Period 1||5
9884772|NCT01049360|10999179|FG002|COMPLETED|Period 1||7
9884773|NCT01049360|10999180|FG003|COMPLETED|Period 1||6
9884774|NCT01049360|10999181|FG004|COMPLETED|Period 1||7
9884775|NCT01049360|10999182|FG005|COMPLETED|Period 1||6
9884776|NCT01049360|10999183|FG006|COMPLETED|Period 1||6
9884777|NCT01049360|10999184|FG007|COMPLETED|Period 1||4
9884778|NCT01049360|10999185|FG008|COMPLETED|Period 1||5
9884779|NCT01049360|10999186|FG009|COMPLETED|Period 1||6
9884780|NCT01049360|10999187|FG010|COMPLETED|Period 1||5
9884781|NCT01049360|10999188|FG011|COMPLETED|Period 1||6
9884782|NCT01049360|10999189|FG012|COMPLETED|Period 1||4
9884783|NCT01049360|10999190|FG013|COMPLETED|Period 1||6
9884784|NCT01049360|10999191|FG014|COMPLETED|Period 1||7
9884785|NCT01049360|10999192|FG015|COMPLETED|Period 1||7
9884786|NCT01049360|10999193|FG016|COMPLETED|Period 1||5
9884787|NCT01049360|10999194|FG017|COMPLETED|Period 1||6
9884788|NCT01049360|10999195|FG018|COMPLETED|Period 1||5
9884789|NCT01049360|10999196|FG019|COMPLETED|Period 1||7
9884790|NCT01049360|10999177|FG000|NOT COMPLETED|Period 1||0
9884791|NCT01049360|10999178|FG001|NOT COMPLETED|Period 1||1
9884792|NCT01049360|10999179|FG002|NOT COMPLETED|Period 1||0
9884793|NCT01049360|10999180|FG003|NOT COMPLETED|Period 1||1
9884794|NCT01049360|10999181|FG004|NOT COMPLETED|Period 1||0
9884795|NCT01049360|10999182|FG005|NOT COMPLETED|Period 1||0
9884796|NCT01049360|10999183|FG006|NOT COMPLETED|Period 1||0
9884797|NCT01049360|10999184|FG007|NOT COMPLETED|Period 1||2
9884798|NCT01049360|10999185|FG008|NOT COMPLETED|Period 1||2
9884799|NCT01049360|10999186|FG009|NOT COMPLETED|Period 1||0
9884800|NCT01049360|10999187|FG010|NOT COMPLETED|Period 1||1
9884801|NCT01049360|10999188|FG011|NOT COMPLETED|Period 1||0
9884802|NCT01049360|10999189|FG012|NOT COMPLETED|Period 1||2
9884803|NCT01049360|10999190|FG013|NOT COMPLETED|Period 1||1
9884804|NCT01049360|10999191|FG014|NOT COMPLETED|Period 1||0
9884805|NCT01049360|10999192|FG015|NOT COMPLETED|Period 1||0
9884806|NCT01049360|10999193|FG016|NOT COMPLETED|Period 1||1
9884807|NCT01049360|10999194|FG017|NOT COMPLETED|Period 1||0
9884808|NCT01049360|10999195|FG018|NOT COMPLETED|Period 1||1
9884809|NCT01049360|10999196|FG019|NOT COMPLETED|Period 1||0
9884810|NCT01049360|10999177|FG000|STARTED|Period 2||6
9884811|NCT01049360|10999178|FG001|STARTED|Period 2||5
9884812|NCT01049360|10999179|FG002|STARTED|Period 2||7
9884813|NCT01049360|10999180|FG003|STARTED|Period 2||6
9884814|NCT01049360|10999181|FG004|STARTED|Period 2||7
9884815|NCT01049360|10999182|FG005|STARTED|Period 2||6
9884816|NCT01049360|10999183|FG006|STARTED|Period 2||6
9884817|NCT01049360|10999184|FG007|STARTED|Period 2||4
9884818|NCT01049360|10999185|FG008|STARTED|Period 2||5
9884819|NCT01049360|10999186|FG009|STARTED|Period 2||6
9884820|NCT01049360|10999187|FG010|STARTED|Period 2||5
9884821|NCT01049360|10999188|FG011|STARTED|Period 2||6
9884822|NCT01049360|10999189|FG012|STARTED|Period 2||4
9884823|NCT01049360|10999190|FG013|STARTED|Period 2||6
9884824|NCT01049360|10999191|FG014|STARTED|Period 2||7
9884825|NCT01049360|10999192|FG015|STARTED|Period 2||7
9884826|NCT01049360|10999193|FG016|STARTED|Period 2||5
9884827|NCT01049360|10999194|FG017|STARTED|Period 2||6
9884828|NCT01049360|10999195|FG018|STARTED|Period 2||5
9884829|NCT01049360|10999196|FG019|STARTED|Period 2||7
9884830|NCT01049360|10999177|FG000|COMPLETED|Period 2||6
9884831|NCT01049360|10999178|FG001|COMPLETED|Period 2||4
9884832|NCT01049360|10999179|FG002|COMPLETED|Period 2||7
9884833|NCT01049360|10999180|FG003|COMPLETED|Period 2||4
9884834|NCT01049360|10999181|FG004|COMPLETED|Period 2||7
9884835|NCT01049360|10999182|FG005|COMPLETED|Period 2||5
9884836|NCT01049360|10999183|FG006|COMPLETED|Period 2||6
9884837|NCT01049360|10999184|FG007|COMPLETED|Period 2||4
9884838|NCT01049360|10999185|FG008|COMPLETED|Period 2||4
9884839|NCT01049360|10999186|FG009|COMPLETED|Period 2||6
9884840|NCT01049360|10999187|FG010|COMPLETED|Period 2||5
9884841|NCT01049360|10999188|FG011|COMPLETED|Period 2||6
9884842|NCT01049360|10999189|FG012|COMPLETED|Period 2||4
9884843|NCT01049360|10999190|FG013|COMPLETED|Period 2||6
9884844|NCT01049360|10999191|FG014|COMPLETED|Period 2||5
9884845|NCT01049360|10999192|FG015|COMPLETED|Period 2||6
9884846|NCT01049360|10999193|FG016|COMPLETED|Period 2||5
9884847|NCT01049360|10999194|FG017|COMPLETED|Period 2||6
9884848|NCT01049360|10999195|FG018|COMPLETED|Period 2||5
9884849|NCT01049360|10999196|FG019|COMPLETED|Period 2||5
9884850|NCT01049360|10999177|FG000|NOT COMPLETED|Period 2||0
9884851|NCT01049360|10999178|FG001|NOT COMPLETED|Period 2||1
9884852|NCT01049360|10999179|FG002|NOT COMPLETED|Period 2||0
9884853|NCT01049360|10999180|FG003|NOT COMPLETED|Period 2||2
9884854|NCT01049360|10999181|FG004|NOT COMPLETED|Period 2||0
9884855|NCT01049360|10999182|FG005|NOT COMPLETED|Period 2||1
9884856|NCT01049360|10999183|FG006|NOT COMPLETED|Period 2||0
9884857|NCT01049360|10999184|FG007|NOT COMPLETED|Period 2||0
9884858|NCT01049360|10999185|FG008|NOT COMPLETED|Period 2||1
9884859|NCT01049360|10999186|FG009|NOT COMPLETED|Period 2||0
9884860|NCT01049360|10999187|FG010|NOT COMPLETED|Period 2||0
9884861|NCT01049360|10999188|FG011|NOT COMPLETED|Period 2||0
9884862|NCT01049360|10999189|FG012|NOT COMPLETED|Period 2||0
9884863|NCT01049360|10999190|FG013|NOT COMPLETED|Period 2||0
9884864|NCT01049360|10999191|FG014|NOT COMPLETED|Period 2||2
9884865|NCT01049360|10999192|FG015|NOT COMPLETED|Period 2||1
9884866|NCT01049360|10999193|FG016|NOT COMPLETED|Period 2||0
9884867|NCT01049360|10999194|FG017|NOT COMPLETED|Period 2||0
9884868|NCT01049360|10999195|FG018|NOT COMPLETED|Period 2||0
9884869|NCT01049360|10999196|FG019|NOT COMPLETED|Period 2||2
9884870|NCT01049360|10999177|FG000|STARTED|Period 3||6
9884871|NCT01049360|10999178|FG001|STARTED|Period 3||4
9884872|NCT01049360|10999179|FG002|STARTED|Period 3||7
9884873|NCT01049360|10999180|FG003|STARTED|Period 3||4
9884874|NCT01049360|10999181|FG004|STARTED|Period 3||7
9884875|NCT01049360|10999182|FG005|STARTED|Period 3||5
9884876|NCT01049360|10999183|FG006|STARTED|Period 3||6
9884877|NCT01049360|10999184|FG007|STARTED|Period 3||4
9884878|NCT01049360|10999185|FG008|STARTED|Period 3||4
9884879|NCT01049360|10999186|FG009|STARTED|Period 3||6
9884880|NCT01049360|10999187|FG010|STARTED|Period 3||5
9884881|NCT01049360|10999188|FG011|STARTED|Period 3||6
9884882|NCT01049360|10999189|FG012|STARTED|Period 3||4
9884883|NCT01049360|10999190|FG013|STARTED|Period 3||6
9884884|NCT01049360|10999191|FG014|STARTED|Period 3||5
9884885|NCT01049360|10999192|FG015|STARTED|Period 3||6
9884886|NCT01049360|10999193|FG016|STARTED|Period 3||5
9884887|NCT01049360|10999194|FG017|STARTED|Period 3||6
9884888|NCT01049360|10999195|FG018|STARTED|Period 3||5
9884889|NCT01049360|10999196|FG019|STARTED|Period 3||5
9884890|NCT01049360|10999177|FG000|COMPLETED|Period 3||6
9884891|NCT01049360|10999178|FG001|COMPLETED|Period 3||4
9884892|NCT01049360|10999179|FG002|COMPLETED|Period 3||7
9884893|NCT01049360|10999180|FG003|COMPLETED|Period 3||4
9884894|NCT01049360|10999181|FG004|COMPLETED|Period 3||7
9884895|NCT01049360|10999182|FG005|COMPLETED|Period 3||5
9884896|NCT01049360|10999183|FG006|COMPLETED|Period 3||6
9884897|NCT01049360|10999184|FG007|COMPLETED|Period 3||4
9884898|NCT01049360|10999185|FG008|COMPLETED|Period 3||4
9884899|NCT01049360|10999186|FG009|COMPLETED|Period 3||6
9884900|NCT01049360|10999187|FG010|COMPLETED|Period 3||5
9884901|NCT01049360|10999188|FG011|COMPLETED|Period 3||6
9884902|NCT01049360|10999189|FG012|COMPLETED|Period 3||4
9884903|NCT01049360|10999190|FG013|COMPLETED|Period 3||6
9884904|NCT01049360|10999191|FG014|COMPLETED|Period 3||5
9884905|NCT01049360|10999192|FG015|COMPLETED|Period 3||6
9884906|NCT01049360|10999193|FG016|COMPLETED|Period 3||5
9884907|NCT01049360|10999194|FG017|COMPLETED|Period 3||6
9884908|NCT01049360|10999195|FG018|COMPLETED|Period 3||5
9884909|NCT01049360|10999196|FG019|COMPLETED|Period 3||5
9884910|NCT01049360|10999177|FG000|NOT COMPLETED|Period 3||0
9884911|NCT01049360|10999178|FG001|NOT COMPLETED|Period 3||0
9884912|NCT01049360|10999179|FG002|NOT COMPLETED|Period 3||0
9884913|NCT01049360|10999180|FG003|NOT COMPLETED|Period 3||0
9884914|NCT01049360|10999181|FG004|NOT COMPLETED|Period 3||0
9884915|NCT01049360|10999182|FG005|NOT COMPLETED|Period 3||0
9884916|NCT01049360|10999183|FG006|NOT COMPLETED|Period 3||0
9884917|NCT01049360|10999184|FG007|NOT COMPLETED|Period 3||0
9884918|NCT01049360|10999185|FG008|NOT COMPLETED|Period 3||0
9884919|NCT01049360|10999186|FG009|NOT COMPLETED|Period 3||0
9884920|NCT01049360|10999187|FG010|NOT COMPLETED|Period 3||0
9884921|NCT01049360|10999188|FG011|NOT COMPLETED|Period 3||0
9884922|NCT01049360|10999189|FG012|NOT COMPLETED|Period 3||0
9884923|NCT01049360|10999190|FG013|NOT COMPLETED|Period 3||0
9884924|NCT01049360|10999191|FG014|NOT COMPLETED|Period 3||0
9884925|NCT01049360|10999192|FG015|NOT COMPLETED|Period 3||0
9884926|NCT01049360|10999193|FG016|NOT COMPLETED|Period 3||0
9884927|NCT01049360|10999194|FG017|NOT COMPLETED|Period 3||0
9884928|NCT01049360|10999195|FG018|NOT COMPLETED|Period 3||0
9884929|NCT01049360|10999196|FG019|NOT COMPLETED|Period 3||0
9884930|NCT01049360|10999177|FG000|STARTED|Period 4||6
9884931|NCT01049360|10999178|FG001|STARTED|Period 4||4
9884932|NCT01049360|10999179|FG002|STARTED|Period 4||7
9884933|NCT01049360|10999180|FG003|STARTED|Period 4||4
9884934|NCT01049360|10999181|FG004|STARTED|Period 4||7
9884935|NCT01049360|10999182|FG005|STARTED|Period 4||5
9884936|NCT01049360|10999183|FG006|STARTED|Period 4||6
9884937|NCT01049360|10999184|FG007|STARTED|Period 4||4
9884938|NCT01049360|10999185|FG008|STARTED|Period 4||4
9884939|NCT01049360|10999186|FG009|STARTED|Period 4||6
9884940|NCT01049360|10999187|FG010|STARTED|Period 4||5
9884941|NCT01049360|10999188|FG011|STARTED|Period 4||6
9884942|NCT01049360|10999189|FG012|STARTED|Period 4||4
9884943|NCT01049360|10999190|FG013|STARTED|Period 4||6
9884944|NCT01049360|10999191|FG014|STARTED|Period 4||5
9884945|NCT01049360|10999192|FG015|STARTED|Period 4||6
9884946|NCT01049360|10999193|FG016|STARTED|Period 4||5
9884947|NCT01049360|10999194|FG017|STARTED|Period 4||6
9884948|NCT01049360|10999195|FG018|STARTED|Period 4||5
9884949|NCT01049360|10999196|FG019|STARTED|Period 4||5
9884950|NCT01049360|10999177|FG000|COMPLETED|Period 4||6
9884951|NCT01049360|10999178|FG001|COMPLETED|Period 4||4
9884952|NCT01049360|10999179|FG002|COMPLETED|Period 4||7
9884953|NCT01049360|10999180|FG003|COMPLETED|Period 4||3
9884954|NCT01049360|10999181|FG004|COMPLETED|Period 4||7
9884955|NCT01049360|10999182|FG005|COMPLETED|Period 4||5
9884956|NCT01049360|10999183|FG006|COMPLETED|Period 4||6
9884957|NCT01049360|10999184|FG007|COMPLETED|Period 4||4
9884958|NCT01049360|10999185|FG008|COMPLETED|Period 4||4
9884959|NCT01049360|10999186|FG009|COMPLETED|Period 4||6
9884960|NCT01049360|10999187|FG010|COMPLETED|Period 4||5
9884961|NCT01049360|10999188|FG011|COMPLETED|Period 4||6
9884962|NCT01049360|10999189|FG012|COMPLETED|Period 4||4
9884963|NCT01049360|10999190|FG013|COMPLETED|Period 4||6
9884964|NCT01049360|10999191|FG014|COMPLETED|Period 4||5
9884965|NCT01049360|10999192|FG015|COMPLETED|Period 4||6
9884966|NCT01049360|10999193|FG016|COMPLETED|Period 4||5
9884967|NCT01049360|10999194|FG017|COMPLETED|Period 4||5
9884968|NCT01049360|10999195|FG018|COMPLETED|Period 4||5
9884969|NCT01049360|10999196|FG019|COMPLETED|Period 4||5
9884970|NCT01049360|10999177|FG000|NOT COMPLETED|Period 4||0
9884971|NCT01049360|10999178|FG001|NOT COMPLETED|Period 4||0
9884972|NCT01049360|10999179|FG002|NOT COMPLETED|Period 4||0
9884973|NCT01049360|10999180|FG003|NOT COMPLETED|Period 4||1
9884974|NCT01049360|10999181|FG004|NOT COMPLETED|Period 4||0
9884975|NCT01049360|10999182|FG005|NOT COMPLETED|Period 4||0
9884976|NCT01049360|10999183|FG006|NOT COMPLETED|Period 4||0
9884977|NCT01049360|10999184|FG007|NOT COMPLETED|Period 4||0
9884978|NCT01049360|10999185|FG008|NOT COMPLETED|Period 4||0
9884979|NCT01049360|10999186|FG009|NOT COMPLETED|Period 4||0
9884980|NCT01049360|10999187|FG010|NOT COMPLETED|Period 4||0
9884981|NCT01049360|10999188|FG011|NOT COMPLETED|Period 4||0
9884982|NCT01049360|10999189|FG012|NOT COMPLETED|Period 4||0
9884983|NCT01049360|10999190|FG013|NOT COMPLETED|Period 4||0
9884984|NCT01049360|10999191|FG014|NOT COMPLETED|Period 4||0
9884985|NCT01049360|10999192|FG015|NOT COMPLETED|Period 4||0
9884986|NCT01049360|10999193|FG016|NOT COMPLETED|Period 4||0
9884987|NCT01049360|10999194|FG017|NOT COMPLETED|Period 4||1
9884988|NCT01049360|10999195|FG018|NOT COMPLETED|Period 4||0
9884989|NCT01049360|10999196|FG019|NOT COMPLETED|Period 4||0
9884990|NCT01049373|10999210|FG000|STARTED|Overall Study||112
9884991|NCT01049373|10999211|FG001|STARTED|Overall Study||109
9884992|NCT01049373|10999210|FG000|COMPLETED|Overall Study||73
9884993|NCT01049373|10999211|FG001|COMPLETED|Overall Study||65
9884994|NCT01049373|10999210|FG000|NOT COMPLETED|Overall Study||39
9884995|NCT01049373|10999211|FG001|NOT COMPLETED|Overall Study||44
9884996|NCT01049412|10999221|FG000|STARTED|Period I||70
9884997|NCT01049412|10999222|FG001|STARTED|Period I||68
9884998|NCT01049412|10999221|FG000|Took at Least One Dose of Study Drug|Period I||69
9884999|NCT01049412|10999222|FG001|Took at Least One Dose of Study Drug|Period I||68
9885000|NCT01049412|10999221|FG000|COMPLETED|Period I||62
9885001|NCT01049412|10999222|FG001|COMPLETED|Period I||55
9885002|NCT01049412|10999221|FG000|NOT COMPLETED|Period I||8
9885003|NCT01049412|10999222|FG001|NOT COMPLETED|Period I||13
9885004|NCT01049412|10999221|FG000|STARTED|Period II||62
9885005|NCT01049412|10999222|FG001|STARTED|Period II||55
9885006|NCT01049412|10999221|FG000|COMPLETED|Period II||58
9885007|NCT01049412|10999222|FG001|COMPLETED|Period II||52
9885008|NCT01049412|10999221|FG000|NOT COMPLETED|Period II||4
9885009|NCT01049412|10999222|FG001|NOT COMPLETED|Period II||3
9885010|NCT01049503|10999236|FG000|STARTED|Overall Study||52
9885011|NCT01049503|10999237|FG001|STARTED|Overall Study||48
9885012|NCT01049503|10999238|FG002|STARTED|Overall Study||56
9885013|NCT01049503|10999239|FG003|STARTED|Overall Study||55
9885014|NCT01049503|10999240|FG004|STARTED|Overall Study||56
9885015|NCT01049503|10999241|FG005|STARTED|Overall Study||48
9885016|NCT01049503|10999236|FG000|COMPLETED|Overall Study||41
9885017|NCT01049503|10999237|FG001|COMPLETED|Overall Study||36
9885018|NCT01049503|10999238|FG002|COMPLETED|Overall Study||32
9885019|NCT01049503|10999239|FG003|COMPLETED|Overall Study||29
9885020|NCT01049503|10999240|FG004|COMPLETED|Overall Study||29
9885021|NCT01049503|10999241|FG005|COMPLETED|Overall Study||40
9885022|NCT01049503|10999236|FG000|NOT COMPLETED|Overall Study||11
9885023|NCT01049503|10999237|FG001|NOT COMPLETED|Overall Study||12
9885024|NCT01049503|10999238|FG002|NOT COMPLETED|Overall Study||24
9885025|NCT01049503|10999239|FG003|NOT COMPLETED|Overall Study||26
9885026|NCT01049503|10999240|FG004|NOT COMPLETED|Overall Study||27
9885027|NCT01049503|10999241|FG005|NOT COMPLETED|Overall Study||8
9885028|NCT01049581|10999266|FG000|STARTED|Overall Study||13
9885029|NCT01049581|10999267|FG001|STARTED|Overall Study||14
9885030|NCT01049581|10999266|FG000|COMPLETED|Overall Study||11
9885031|NCT01049581|10999267|FG001|COMPLETED|Overall Study||13
9885032|NCT01049581|10999266|FG000|NOT COMPLETED|Overall Study||2
9885033|NCT01049581|10999267|FG001|NOT COMPLETED|Overall Study||1
9885034|NCT01049776|10999276|FG000|STARTED|Overall Study||32
9885035|NCT01049776|10999276|FG000|COMPLETED|Overall Study||12
9885036|NCT01049776|10999276|FG000|NOT COMPLETED|Overall Study||20
9885037|NCT01049802|10999282|FG000|STARTED|Overall Study||20
9885038|NCT01049802|10999283|FG001|STARTED|Overall Study||10
9885039|NCT01049802|10999282|FG000|COMPLETED|Overall Study||20
9885040|NCT01049802|10999283|FG001|COMPLETED|Overall Study||10
9885041|NCT01049802|10999282|FG000|NOT COMPLETED|Overall Study||0
9885042|NCT01049802|10999283|FG001|NOT COMPLETED|Overall Study||0
9885043|NCT01049919|10999291|FG000|STARTED|Overall Study||117
9885044|NCT01049919|10999292|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
9885045|NCT01049919|10999291|FG000|COMPLETED|Overall Study||65
9885046|NCT01049919|10999292|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
9885047|NCT01049919|10999291|FG000|NOT COMPLETED|Overall Study||52
9885048|NCT01049919|10999292|FG001|NOT COMPLETED|Overall Study||17
9885049|NCT01049945|10999300|FG000|STARTED|Overall Study||3
9885050|NCT01049945|10999301|FG001|STARTED|Overall Study||6
9885051|NCT01049945|10999302|FG002|STARTED|Overall Study||3
9885052|NCT01049945|10999303|FG003|STARTED|Overall Study||6
9885053|NCT01049945|10999304|FG004|STARTED|Overall Study||3
9885054|NCT01049945|10999305|FG005|STARTED|Overall Study||49
9885055|NCT01049945|10999300|FG000|COMPLETED|Overall Study||3
9885056|NCT01049945|10999301|FG001|COMPLETED|Overall Study||6
9885057|NCT01049945|10999302|FG002|COMPLETED|Overall Study||3
9885058|NCT01049945|10999303|FG003|COMPLETED|Overall Study||6
9885059|NCT01049945|10999304|FG004|COMPLETED|Overall Study||3
9885060|NCT01049945|10999305|FG005|COMPLETED|Overall Study||49
9885061|NCT01049945|10999300|FG000|NOT COMPLETED|Overall Study||0
9885062|NCT01049945|10999301|FG001|NOT COMPLETED|Overall Study||0
9885063|NCT01049945|10999302|FG002|NOT COMPLETED|Overall Study||0
9885064|NCT01049945|10999303|FG003|NOT COMPLETED|Overall Study||0
9885065|NCT01049945|10999304|FG004|NOT COMPLETED|Overall Study||0
9885066|NCT01049945|10999305|FG005|NOT COMPLETED|Overall Study||0
9885067|NCT01049984|10999321|FG000|STARTED|Overall Study||163
9885068|NCT01049984|10999322|FG001|STARTED|Overall Study||165
9885069|NCT01049984|10999321|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
9885070|NCT01049984|10999322|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
9885071|NCT01049984|10999321|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
9885072|NCT01049984|10999322|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
9885073|NCT01049984|10999321|FG000|COMPLETED|Overall Study||144
9885074|NCT01049984|10999322|FG001|COMPLETED|Overall Study||146
9885075|NCT01049984|10999321|FG000|NOT COMPLETED|Overall Study||19
9885076|NCT01049984|10999322|FG001|NOT COMPLETED|Overall Study||19
9885077|NCT01050062|10999330|FG000|STARTED|Overall Study||1070
9885078|NCT01050062|10999331|FG001|STARTED|Overall Study||355
10109058|NCT02472353|11239627|FG001|NOT COMPLETED|Overall Study||6
10109059|NCT02472366|11239635|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
10109060|NCT02472366|11239636|FG001|STARTED|Overall Study||10
10109061|NCT02472366|11239635|FG000|COMPLETED|Overall Study||5
10109062|NCT02472366|11239636|FG001|COMPLETED|Overall Study||10
10109063|NCT02472366|11239635|FG000|NOT COMPLETED|Overall Study||1
10109064|NCT02472366|11239636|FG001|NOT COMPLETED|Overall Study||0
10109065|NCT02472405|11239642|FG000|STARTED|Overall Study||18
10109066|NCT02472405|11239642|FG000|COMPLETED|Overall Study||8
10109067|NCT02472405|11239642|FG000|NOT COMPLETED|Overall Study||10
10109068|NCT02472457|11239650|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
10109069|NCT02472457|11239651|FG001|STARTED|Overall Study||11
10109070|NCT02472457|11239650|FG000|COMPLETED|Overall Study||8
10109071|NCT02472457|11239651|FG001|COMPLETED|Overall Study||10
10109072|NCT02472457|11239650|FG000|NOT COMPLETED|Overall Study||0
10109073|NCT02472457|11239651|FG001|NOT COMPLETED|Overall Study||1
10109074|NCT02472522|11239659|FG000|STARTED|Overall Study||50
10109075|NCT02472522|11239660|FG001|STARTED|Overall Study||50
10109076|NCT02472522|11239659|FG000|COMPLETED|Overall Study||50
10109077|NCT02472522|11239660|FG001|COMPLETED|Overall Study||50
10109078|NCT02472522|11239659|FG000|NOT COMPLETED|Overall Study||0
10109079|NCT02472522|11239660|FG001|NOT COMPLETED|Overall Study||0
10109080|NCT02472652|11239668|FG000|STARTED|Overall Study||2
10109081|NCT02472652|11239668|FG000|COMPLETED|Overall Study||1
10109082|NCT02472652|11239668|FG000|NOT COMPLETED|Overall Study||1
10109083|NCT02472730|11239674|FG000|STARTED|Overall Study||110
10109084|NCT02472730|11239675|FG001|STARTED|Overall Study||109
10109085|NCT02472730|11239674|FG000|COMPLETED|Overall Study||101
10109086|NCT02472730|11239675|FG001|COMPLETED|Overall Study||102
10109087|NCT02472730|11239674|FG000|NOT COMPLETED|Overall Study||9
10109088|NCT02472730|11239675|FG001|NOT COMPLETED|Overall Study||7
10109089|NCT02472756|11239681|FG000|STARTED|Induction (Approximately 6 Months)||41
10109090|NCT02472756|11239681|FG000|Treated|Induction (Approximately 6 Months)||40
10109091|NCT02472756|11239681|FG000|COMPLETED|Induction (Approximately 6 Months)||39
10109092|NCT02472756|11239681|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2
10109093|NCT02472756|11239681|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
10109094|NCT02472756|11239681|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10
10109095|NCT02472756|11239681|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
10109096|NCT02472795|11239690|FG000|STARTED|Overall Study||12
10109097|NCT02472795|11239691|FG001|STARTED|Overall Study||12
10109098|NCT02472795|11239692|FG002|STARTED|Overall Study||13
10109099|NCT02472795|11239693|FG003|STARTED|Overall Study||13
10109100|NCT02472795|11239694|FG004|STARTED|Overall Study||17
10109101|NCT02472795|11239690|FG000|Pharmacodynamic Set|Overall Study||12
10109102|NCT02472795|11239691|FG001|Pharmacodynamic Set|Overall Study||10
10109103|NCT02472795|11239692|FG002|Pharmacodynamic Set|Overall Study||13
10109104|NCT02472795|11239693|FG003|Pharmacodynamic Set|Overall Study||13
10109105|NCT02472795|11239694|FG004|Pharmacodynamic Set|Overall Study||16
10109106|NCT02472795|11239690|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12
10109107|NCT02472795|11239691|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10
10109108|NCT02472795|11239692|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13
10109109|NCT02472795|11239693|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9
10109110|NCT02472795|11239694|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16
10109111|NCT02472795|11239690|FG000|COMPLETED|Overall Study||12
10109112|NCT02472795|11239691|FG001|COMPLETED|Overall Study||11
10109113|NCT02472795|11239692|FG002|COMPLETED|Overall Study||13
10109114|NCT02472795|11239693|FG003|COMPLETED|Overall Study||13
10109115|NCT02472795|11239694|FG004|COMPLETED|Overall Study||14
10109116|NCT02472795|11239690|FG000|NOT COMPLETED|Overall Study||0
9885079|NCT01050062|10999330|FG000|COMPLETED|Overall Study||799
10109117|NCT02472795|11239691|FG001|NOT COMPLETED|Overall Study||1
10109118|NCT02472795|11239692|FG002|NOT COMPLETED|Overall Study||0
9885080|NCT01050062|10999331|FG001|COMPLETED|Overall Study||243
9885081|NCT01050062|10999330|FG000|NOT COMPLETED|Overall Study||271
9885082|NCT01050062|10999331|FG001|NOT COMPLETED|Overall Study||112
9885083|NCT01050153|10999341|FG000|STARTED|Overall Study||25
9885084|NCT01050153|10999342|FG001|STARTED|Overall Study||25
9885085|NCT01050153|10999341|FG000|COMPLETED|Overall Study||25
10109119|NCT02472795|11239693|FG003|NOT COMPLETED|Overall Study||0
10109120|NCT02472795|11239694|FG004|NOT COMPLETED|Overall Study||3
10109121|NCT02472847|11239708|FG000|STARTED|Overall Study||24
10109122|NCT02472847|11239709|FG001|STARTED|Overall Study||26
10109123|NCT02472847|11239708|FG000|COMPLETED|Overall Study||23
10109124|NCT02472847|11239709|FG001|COMPLETED|Overall Study||21
10109125|NCT02472847|11239708|FG000|NOT COMPLETED|Overall Study||1
10109126|NCT02472847|11239709|FG001|NOT COMPLETED|Overall Study||5
10109127|NCT02472886|11239718|FG000|STARTED|Overall Study||67
9885086|NCT01050153|10999342|FG001|COMPLETED|Overall Study||25
10109128|NCT02472886|11239719|FG001|STARTED|Overall Study||59
10109129|NCT02472886|11239720|FG002|STARTED|Overall Study||27
10109130|NCT02472886|11239718|FG000|COMPLETED|Overall Study||67
10109131|NCT02472886|11239719|FG001|COMPLETED|Overall Study||57
9885087|NCT01050153|10999341|FG000|NOT COMPLETED|Overall Study||0
9885088|NCT01050153|10999342|FG001|NOT COMPLETED|Overall Study||0
9885089|NCT01050205|10999350|FG000|STARTED|Overall Study||148
9885090|NCT01050205|10999351|FG001|STARTED|Overall Study||75
9885091|NCT01050205|10999350|FG000|COMPLETED|Overall Study||137
9885092|NCT01050205|10999351|FG001|COMPLETED|Overall Study||71
9885093|NCT01050205|10999350|FG000|NOT COMPLETED|Overall Study||11
9885094|NCT01050205|10999351|FG001|NOT COMPLETED|Overall Study||4
9885095|NCT01050231|10999359|FG000|STARTED|Overall Study||10
9885096|NCT01050231|10999360|FG001|STARTED|Overall Study||10
9885097|NCT01050231|10999359|FG000|COMPLETED|Overall Study||10
9885098|NCT01050231|10999360|FG001|COMPLETED|Overall Study||10
9885099|NCT01050231|10999359|FG000|NOT COMPLETED|Overall Study||0
9885100|NCT01050231|10999360|FG001|NOT COMPLETED|Overall Study||0
9885101|NCT01050257|10999369|FG000|STARTED|Overall Study||50
9885102|NCT01050257|10999370|FG001|STARTED|Overall Study||53
9885103|NCT01050257|10999371|FG002|STARTED|Overall Study||15
9885104|NCT01050257|10999369|FG000|Received Treatment|Overall Study||49
9885105|NCT01050257|10999370|FG001|Received Treatment|Overall Study||50
9885106|NCT01050257|10999371|FG002|Received Treatment|Overall Study||14
9885107|NCT01050257|10999369|FG000|Safety Population: Actual Dose Received|Overall Study||48
9885108|NCT01050257|10999370|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
9885109|NCT01050257|10999371|FG002|Safety Population: Actual Dose Received|Overall Study||14
9885110|NCT01050257|10999369|FG000|Intent-to-treat Infected Confirmed|Overall Study||30
9885111|NCT01050257|10999370|FG001|Intent-to-treat Infected Confirmed|Overall Study||32
9885112|NCT01050257|10999371|FG002|Intent-to-treat Infected Confirmed|Overall Study||10
9885113|NCT01050257|10999369|FG000|Switched to Oral Treatment|Overall Study||28
9885114|NCT01050257|10999370|FG001|Switched to Oral Treatment|Overall Study||31
9885115|NCT01050257|10999371|FG002|Switched to Oral Treatment|Overall Study||3
9885116|NCT01050257|10999369|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
9885117|NCT01050257|10999370|FG001|COMPLETED|Overall Study||40
9885118|NCT01050257|10999371|FG002|COMPLETED|Overall Study||8
9885119|NCT01050257|10999369|FG000|NOT COMPLETED|Overall Study||11
9885120|NCT01050257|10999370|FG001|NOT COMPLETED|Overall Study||13
9885121|NCT01050257|10999371|FG002|NOT COMPLETED|Overall Study||7
9885122|NCT01050530|10999381|FG000|STARTED|Overall Study||82
9885123|NCT01050530|10999382|FG001|STARTED|Overall Study||80
9885124|NCT01050530|10999381|FG000|COMPLETED|Overall Study||74
9885125|NCT01050530|10999382|FG001|COMPLETED|Overall Study||70
9885126|NCT01050530|10999381|FG000|NOT COMPLETED|Overall Study||8
9885127|NCT01050530|10999382|FG001|NOT COMPLETED|Overall Study||10
9885128|NCT01050543|10999390|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
9885129|NCT01050543|10999391|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
9885130|NCT01050543|10999390|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
9885131|NCT01050543|10999391|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
9885132|NCT01050543|10999390|FG000|NOT COMPLETED|Overall Study||4
9885133|NCT01050543|10999391|FG001|NOT COMPLETED|Overall Study||4
9885134|NCT01050569|10999400|FG000|STARTED|Overall Study||79
9885135|NCT01050569|10999401|FG001|STARTED|Overall Study||76
9885136|NCT01050569|10999402|FG002|STARTED|Overall Study||80
9885137|NCT01050569|10999400|FG000|COMPLETED|Overall Study||41
9885138|NCT01050569|10999401|FG001|COMPLETED|Overall Study||52
9885139|NCT01050569|10999402|FG002|COMPLETED|Overall Study||47
9885140|NCT01050569|10999400|FG000|NOT COMPLETED|Overall Study||38
9885141|NCT01050569|10999401|FG001|NOT COMPLETED|Overall Study||24
9885142|NCT01050569|10999402|FG002|NOT COMPLETED|Overall Study||33
9885143|NCT01050582|10999416|FG000|STARTED|Overall Study||133
9885144|NCT01050582|10999417|FG001|STARTED|Overall Study||51
9885145|NCT01050582|10999416|FG000|COMPLETED|Overall Study||133
9885146|NCT01050582|10999417|FG001|COMPLETED|Overall Study||51
9885147|NCT01050582|10999416|FG000|NOT COMPLETED|Overall Study||0
9885148|NCT01050582|10999417|FG001|NOT COMPLETED|Overall Study||0
9885149|NCT01050634|10999423|FG000|STARTED|Overall Study||980
9885150|NCT01050634|10999423|FG000|Received Treatment|Overall Study||924
9885151|NCT01050634|10999423|FG000|COMPLETED|Overall Study||852
9885152|NCT01050634|10999423|FG000|NOT COMPLETED|Overall Study||128
9885153|NCT01050647|10999429|FG000|STARTED|Overall Study||10
9885154|NCT01050647|10999430|FG001|STARTED|Overall Study||11
9885155|NCT01050647|10999429|FG000|COMPLETED|Overall Study||10
9885156|NCT01050647|10999430|FG001|COMPLETED|Overall Study||11
9885157|NCT01050647|10999429|FG000|NOT COMPLETED|Overall Study||0
9885158|NCT01050647|10999430|FG001|NOT COMPLETED|Overall Study||0
9885159|NCT01050660|10999438|FG000|STARTED|Overall Study||67
9885160|NCT01050660|10999439|FG001|STARTED|Overall Study||69
9885161|NCT01050660|10999438|FG000|COMPLETED|Overall Study||67
9885162|NCT01050660|10999439|FG001|COMPLETED|Overall Study||69
9885163|NCT01050660|10999438|FG000|NOT COMPLETED|Overall Study||0
9885164|NCT01050660|10999439|FG001|NOT COMPLETED|Overall Study||0
9954317|NCT01431313|11073146|FG002|COMPLETED|Overall Study||8
9954318|NCT01431313|11073144|FG000|NOT COMPLETED|Overall Study||0
9954319|NCT01431313|11073145|FG001|NOT COMPLETED|Overall Study||0
9954320|NCT01431313|11073146|FG002|NOT COMPLETED|Overall Study||0
9954321|NCT01431339|11073157|FG000|STARTED|Overall Study||371
9954322|NCT01431339|11073158|FG001|STARTED|Overall Study||368
9954323|NCT01431339|11073157|FG000|Safety Population|Overall Study||368
9954324|NCT01431339|11073158|FG001|Safety Population|Overall Study||367
9954325|NCT01431339|11073157|FG000|COMPLETED|Overall Study||332
9954326|NCT01431339|11073158|FG001|COMPLETED|Overall Study||333
9954327|NCT01431339|11073157|FG000|NOT COMPLETED|Overall Study||39
9954328|NCT01431339|11073158|FG001|NOT COMPLETED|Overall Study||35
9954329|NCT01431391|11073166|FG000|STARTED|Overall Study||34
9954330|NCT01431391|11073167|FG001|STARTED|Overall Study||34
9954331|NCT01431391|11073166|FG000|Received ≥1 Leaukapheresis|Overall Study||34
9954332|NCT01431391|11073167|FG001|Received ≥1 Leaukapheresis|Overall Study||34
9954333|NCT01431391|11073166|FG000|COMPLETED|Overall Study||26
9954334|NCT01431391|11073167|FG001|COMPLETED|Overall Study||30
9954335|NCT01431391|11073166|FG000|NOT COMPLETED|Overall Study||8
9954336|NCT01431391|11073167|FG001|NOT COMPLETED|Overall Study||4
9954337|NCT01431521|11073178|FG000|STARTED|Overall Study||10
9954338|NCT01431521|11073179|FG001|STARTED|Overall Study||5
9954339|NCT01431521|11073180|FG002|STARTED|Overall Study||11
9954340|NCT01431521|11073181|FG003|STARTED|Overall Study||5
9954341|NCT01431521|11073178|FG000|Treated|Overall Study||10
9954342|NCT01431521|11073179|FG001|Treated|Overall Study||5
9954343|NCT01431521|11073180|FG002|Treated|Overall Study||10
9954344|NCT01431521|11073181|FG003|Treated|Overall Study||5
9954345|NCT01431521|11073178|FG000|COMPLETED|Overall Study||10
9954346|NCT01431521|11073179|FG001|COMPLETED|Overall Study||5
9954347|NCT01431521|11073180|FG002|COMPLETED|Overall Study||10
9954348|NCT01431521|11073181|FG003|COMPLETED|Overall Study||5
9954349|NCT01431521|11073178|FG000|NOT COMPLETED|Overall Study||0
9954350|NCT01431521|11073179|FG001|NOT COMPLETED|Overall Study||0
9954351|NCT01431521|11073180|FG002|NOT COMPLETED|Overall Study||1
9954352|NCT01431521|11073181|FG003|NOT COMPLETED|Overall Study||0
9954353|NCT01431534|11073193|FG000|STARTED|Treatment Phase||4
9954354|NCT01431534|11073194|FG001|STARTED|Treatment Phase||3
9954355|NCT01431534|11073195|FG002|STARTED|Treatment Phase||13
9954356|NCT01431534|11073193|FG000|COMPLETED|Treatment Phase||0
9954357|NCT01431534|11073194|FG001|COMPLETED|Treatment Phase||0
9954358|NCT01431534|11073195|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
9954359|NCT01431534|11073193|FG000|NOT COMPLETED|Treatment Phase||4
9954360|NCT01431534|11073194|FG001|NOT COMPLETED|Treatment Phase||3
9954361|NCT01431534|11073195|FG002|NOT COMPLETED|Treatment Phase||11
9954362|NCT01431534|11073193|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0
9954363|NCT01431534|11073194|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0
9954364|NCT01431534|11073195|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
9954365|NCT01431534|11073193|FG000|COMPLETED|Extension Phase||0
9954366|NCT01431534|11073194|FG001|COMPLETED|Extension Phase||0
9954367|NCT01431534|11073195|FG002|COMPLETED|Extension Phase||2
9954368|NCT01431534|11073193|FG000|NOT COMPLETED|Extension Phase||0
9954369|NCT01431534|11073194|FG001|NOT COMPLETED|Extension Phase||0
9954370|NCT01431534|11073195|FG002|NOT COMPLETED|Extension Phase||0
9954371|NCT01431573|11073203|FG000|STARTED|Overall Study||8
9954372|NCT01431573|11073203|FG000|COMPLETED|Overall Study||8
9954373|NCT01431573|11073203|FG000|NOT COMPLETED|Overall Study||0
9954374|NCT01431638|11073210|FG000|STARTED|Overall Study||133
9954375|NCT01431638|11073211|FG001|STARTED|Overall Study||132
9954376|NCT01431638|11073212|FG002|STARTED|Overall Study||132
9954377|NCT01431638|11073210|FG000|Completed Core Study|Overall Study||124
9954378|NCT01431638|11073211|FG001|Completed Core Study|Overall Study||117
9954379|NCT01431638|11073212|FG002|Completed Core Study|Overall Study||108
9954380|NCT01431638|11073210|FG000|Entered Extension 1 Study|Overall Study||85
9954381|NCT01431638|11073211|FG001|Entered Extension 1 Study|Overall Study||71
9954382|NCT01431638|11073212|FG002|Entered Extension 1 Study|Overall Study||76
9954383|NCT01431638|11073210|FG000|COMPLETED|Overall Study||67
9954384|NCT01431638|11073211|FG001|COMPLETED|Overall Study||61
9954385|NCT01431638|11073212|FG002|COMPLETED|Overall Study||70
9954386|NCT01431638|11073210|FG000|NOT COMPLETED|Overall Study||66
9954387|NCT01431638|11073211|FG001|NOT COMPLETED|Overall Study||71
9954388|NCT01431638|11073212|FG002|NOT COMPLETED|Overall Study||62
9954389|NCT01431703|11073220|FG000|STARTED|Overall Study||326
9954390|NCT01431703|11073220|FG000|COMPLETED|Overall Study||326
9954391|NCT01431703|11073220|FG000|NOT COMPLETED|Overall Study||0
9954392|NCT01431716|11073224|FG000|STARTED|Overall Study||42
9954393|NCT01431716|11073224|FG000|COMPLETED|Overall Study||41
9954394|NCT01431716|11073224|FG000|NOT COMPLETED|Overall Study||1
9954395|NCT01431755|11073228|FG000|STARTED|Overall Study||54
9954396|NCT01431755|11073228|FG000|COMPLETED|Overall Study||49
9954397|NCT01431755|11073228|FG000|NOT COMPLETED|Overall Study||5
9954398|NCT01431794|11073239|FG000|STARTED|Overall Study||13
9954399|NCT01431794|11073240|FG001|STARTED|Overall Study|not started due to early study's termination|0
9954400|NCT01431794|11073241|FG002|STARTED|Overall Study|not started due to early study's termination|0
9954401|NCT01431794|11073242|FG003|STARTED|Overall Study|not started due to early study's termination|0
9954402|NCT01431794|11073243|FG004|STARTED|Overall Study|not started due to early study's termination|0
9885165|NCT01050673|10999447|FG000|STARTED|Overall Study||21
9885166|NCT01050673|10999448|FG001|STARTED|Overall Study||19
9885167|NCT01050673|10999447|FG000|COMPLETED|Overall Study||17
9885168|NCT01050673|10999448|FG001|COMPLETED|Overall Study||14
9885169|NCT01050673|10999447|FG000|NOT COMPLETED|Overall Study||4
9885170|NCT01050673|10999448|FG001|NOT COMPLETED|Overall Study||5
9885171|NCT01050764|10999454|FG000|STARTED|Overall Study||10
9885172|NCT01050764|10999454|FG000|Received HSCT Graft|Overall Study||8
9885173|NCT01050764|10999454|FG000|Received Infusion of T-reg Cells|Overall Study||7
9885174|NCT01050764|10999454|FG000|Received Infusion of T-con Cells|Overall Study||7
9885175|NCT01050764|10999454|FG000|COMPLETED|Overall Study||7
9885176|NCT01050764|10999454|FG000|NOT COMPLETED|Overall Study||3
9885177|NCT01050790|10999458|FG000|STARTED|Overall Study||17
10109132|NCT02472886|11239720|FG002|COMPLETED|Overall Study||26
10109133|NCT02472886|11239718|FG000|NOT COMPLETED|Overall Study||0
10109134|NCT02472886|11239719|FG001|NOT COMPLETED|Overall Study||2
10109135|NCT02472886|11239720|FG002|NOT COMPLETED|Overall Study||1
10109136|NCT02472977|11239736|FG000|STARTED|Overall Study||6
10109137|NCT02472977|11239737|FG001|STARTED|Overall Study||27
10109138|NCT02472977|11239738|FG002|STARTED|Overall Study||8
10109139|NCT02472977|11239736|FG000|COMPLETED|Overall Study||0
10109140|NCT02472977|11239737|FG001|COMPLETED|Overall Study||0
10109141|NCT02472977|11239738|FG002|COMPLETED|Overall Study||0
10109142|NCT02472977|11239736|FG000|NOT COMPLETED|Overall Study||6
10109143|NCT02472977|11239737|FG001|NOT COMPLETED|Overall Study||27
10109144|NCT02472977|11239738|FG002|NOT COMPLETED|Overall Study||8
10109145|NCT02473250|11239746|FG000|STARTED|Overall Study||40
10109146|NCT02473250|11239746|FG000|COMPLETED|Overall Study||20
10109147|NCT02473250|11239746|FG000|NOT COMPLETED|Overall Study||20
10109148|NCT02473289|11239753|FG000|STARTED|Overall Study||99
10109149|NCT02473289|11239754|FG001|STARTED|Overall Study||94
10109150|NCT02473289|11239753|FG000|COMPLETED|Overall Study||88
10109151|NCT02473289|11239754|FG001|COMPLETED|Overall Study||81
10109152|NCT02473289|11239753|FG000|NOT COMPLETED|Overall Study||11
10109153|NCT02473289|11239754|FG001|NOT COMPLETED|Overall Study||13
10109154|NCT02473367|11239760|FG000|STARTED|Period 1||20
10109155|NCT02473367|11239760|FG000|COMPLETED|Period 1||20
10109156|NCT02473367|11239760|FG000|NOT COMPLETED|Period 1||0
10109157|NCT02473367|11239760|FG000|STARTED|Wait 1||20
10109158|NCT02473367|11239760|FG000|COMPLETED|Wait 1||19
10109159|NCT02473367|11239760|FG000|NOT COMPLETED|Wait 1||1
10109160|NCT02473367|11239760|FG000|STARTED|Period 2||19
10109161|NCT02473367|11239760|FG000|COMPLETED|Period 2||19
10109162|NCT02473367|11239760|FG000|NOT COMPLETED|Period 2||0
10109163|NCT02473367|11239760|FG000|STARTED|Wait 2||19
10109164|NCT02473367|11239760|FG000|COMPLETED|Wait 2||19
10109165|NCT02473367|11239760|FG000|NOT COMPLETED|Wait 2||0
10109166|NCT02473367|11239760|FG000|STARTED|Period 3||19
10109167|NCT02473367|11239760|FG000|COMPLETED|Period 3||19
10109168|NCT02473367|11239760|FG000|NOT COMPLETED|Period 3||0
10109169|NCT02473367|11239760|FG000|STARTED|Wait 3||19
10109170|NCT02473367|11239760|FG000|COMPLETED|Wait 3||19
10109171|NCT02473367|11239760|FG000|NOT COMPLETED|Wait 3||0
10109172|NCT02473367|11239760|FG000|STARTED|Period 4||19
10109173|NCT02473367|11239760|FG000|COMPLETED|Period 4||18
10109174|NCT02473367|11239760|FG000|NOT COMPLETED|Period 4||1
10109175|NCT02473393|11239774|FG000|STARTED|Overall Study||5
10109176|NCT02473393|11239775|FG001|STARTED|Overall Study||12
10109177|NCT02473393|11239776|FG002|STARTED|Overall Study||13
10109178|NCT02473393|11239777|FG003|STARTED|Overall Study||13
9885178|NCT01050790|10999458|FG000|COMPLETED|Overall Study||16
9885179|NCT01050790|10999458|FG000|NOT COMPLETED|Overall Study||1
9885180|NCT01050816|10999463|FG000|STARTED|Overall Study||30
9885181|NCT01050816|10999463|FG000|COMPLETED|Overall Study||26
9885182|NCT01050816|10999463|FG000|NOT COMPLETED|Overall Study||4
9885183|NCT01050907|10999467|FG000|STARTED|Overall Study||4
9885184|NCT01050907|10999467|FG000|COMPLETED|Overall Study||4
9885185|NCT01050907|10999467|FG000|NOT COMPLETED|Overall Study||0
9885186|NCT01050946|10999471|FG000|STARTED|Overall Study||1
9885187|NCT01050946|10999471|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
9885188|NCT01050946|10999471|FG000|NOT COMPLETED|Overall Study||0
9885189|NCT01050998|10999481|FG000|STARTED|Overall Study||48
9885190|NCT01050998|10999482|FG001|STARTED|Overall Study||49
9885191|NCT01050998|10999483|FG002|STARTED|Overall Study||49
9885192|NCT01050998|10999484|FG003|STARTED|Overall Study||48
9885193|NCT01050998|10999485|FG004|STARTED|Overall Study||96
9885194|NCT01050998|10999481|FG000|COMPLETED|Overall Study||44
9885195|NCT01050998|10999482|FG001|COMPLETED|Overall Study||47
9885196|NCT01050998|10999483|FG002|COMPLETED|Overall Study||46
9885197|NCT01050998|10999484|FG003|COMPLETED|Overall Study||45
9885198|NCT01050998|10999485|FG004|COMPLETED|Overall Study||82
9885199|NCT01050998|10999481|FG000|NOT COMPLETED|Overall Study||4
9885200|NCT01050998|10999482|FG001|NOT COMPLETED|Overall Study||2
9885201|NCT01050998|10999483|FG002|NOT COMPLETED|Overall Study||3
9885202|NCT01050998|10999484|FG003|NOT COMPLETED|Overall Study||3
9885203|NCT01050998|10999485|FG004|NOT COMPLETED|Overall Study||14
10109179|NCT02473393|11239774|FG000|COMPLETED|Overall Study||5
10109180|NCT02473393|11239775|FG001|COMPLETED|Overall Study||12
10109181|NCT02473393|11239776|FG002|COMPLETED|Overall Study||11
10109182|NCT02473393|11239777|FG003|COMPLETED|Overall Study||12
10109183|NCT02473393|11239774|FG000|NOT COMPLETED|Overall Study||0
10109184|NCT02473393|11239775|FG001|NOT COMPLETED|Overall Study||0
10109185|NCT02473393|11239776|FG002|NOT COMPLETED|Overall Study||2
9885204|NCT01051063|10999503|FG000|STARTED|Overall Study||12
9885205|NCT01051063|10999504|FG001|STARTED|Overall Study||5
9885206|NCT01051063|10999503|FG000|COMPLETED|Overall Study||2
9885207|NCT01051063|10999504|FG001|COMPLETED|Overall Study||1
9885208|NCT01051063|10999503|FG000|NOT COMPLETED|Overall Study||10
9885209|NCT01051063|10999504|FG001|NOT COMPLETED|Overall Study||4
9885210|NCT01051310|10999511|FG000|STARTED|Overall Study||18
9885211|NCT01051310|10999511|FG000|COMPLETED|Overall Study||13
9885212|NCT01051310|10999511|FG000|NOT COMPLETED|Overall Study||5
9885213|NCT01051323|10999517|FG000|STARTED|Overall Study||1580
9885214|NCT01051323|10999517|FG000|Received at Least One Dose|Overall Study||1547
9885215|NCT01051323|10999517|FG000|COMPLETED|Overall Study||1041
9885216|NCT01051323|10999517|FG000|NOT COMPLETED|Overall Study||539
9885217|NCT01051349|10999525|FG000|STARTED|Overall Study||410
9885218|NCT01051349|10999525|FG000|COMPLETED|Overall Study||237
9885219|NCT01051349|10999525|FG000|NOT COMPLETED|Overall Study||173
9885220|NCT01051440|10999534|FG000|STARTED|Overall Study||1
9885221|NCT01051440|10999535|FG001|STARTED|Overall Study||1
9885222|NCT01051440|10999534|FG000|COMPLETED|Overall Study||1
9885223|NCT01051440|10999535|FG001|COMPLETED|Overall Study||1
9885224|NCT01051440|10999534|FG000|NOT COMPLETED|Overall Study||0
9885225|NCT01051440|10999535|FG001|NOT COMPLETED|Overall Study||0
9885226|NCT01051466|10999543|FG000|STARTED|Overall Study||32
9885227|NCT01051466|10999544|FG001|STARTED|Overall Study||28
9885228|NCT01051466|10999543|FG000|COMPLETED|Overall Study||24
9885229|NCT01051466|10999544|FG001|COMPLETED|Overall Study||23
9885230|NCT01051466|10999543|FG000|NOT COMPLETED|Overall Study||8
9885231|NCT01051466|10999544|FG001|NOT COMPLETED|Overall Study||5
9885232|NCT01051518|10999554|FG000|STARTED|Overall Study||126
9885233|NCT01051518|10999554|FG000|COMPLETED|Overall Study||53
9885234|NCT01051518|10999554|FG000|NOT COMPLETED|Overall Study||73
9885235|NCT01051557|10999570|FG000|STARTED|Overall Study||4
9885236|NCT01051557|10999571|FG001|STARTED|Overall Study||3
9885237|NCT01051557|10999572|FG002|STARTED|Overall Study||6
9885238|NCT01051557|10999573|FG003|STARTED|Overall Study||3
9885239|NCT01051557|10999574|FG004|STARTED|Overall Study||8
9885240|NCT01051557|10999575|FG005|STARTED|Overall Study||6
9885241|NCT01051557|10999576|FG006|STARTED|Overall Study||6
9885242|NCT01051557|10999570|FG000|COMPLETED|Overall Study||0
9885243|NCT01051557|10999571|FG001|COMPLETED|Overall Study||0
10008224|NCT01755767|11130525|FG000|COMPLETED|Overall Study||0
10008225|NCT01755767|11130526|FG001|COMPLETED|Overall Study||0
10008226|NCT01755767|11130527|FG002|COMPLETED|Overall Study||0
10008227|NCT01755767|11130528|FG003|COMPLETED|Overall Study||0
10008228|NCT01755767|11130525|FG000|NOT COMPLETED|Overall Study||28
10008229|NCT01755767|11130526|FG001|NOT COMPLETED|Overall Study||15
10008230|NCT01755767|11130527|FG002|NOT COMPLETED|Overall Study||226
10008231|NCT01755767|11130528|FG003|NOT COMPLETED|Overall Study||114
10008232|NCT01755858|11130540|FG000|STARTED|Overall Study||7
9885244|NCT01051557|10999572|FG002|COMPLETED|Overall Study||0
9885245|NCT01051557|10999573|FG003|COMPLETED|Overall Study||0
9885246|NCT01051557|10999574|FG004|COMPLETED|Overall Study||1
9885247|NCT01051557|10999575|FG005|COMPLETED|Overall Study||0
9885248|NCT01051557|10999576|FG006|COMPLETED|Overall Study||0
9885249|NCT01051557|10999570|FG000|NOT COMPLETED|Overall Study||4
9885250|NCT01051557|10999571|FG001|NOT COMPLETED|Overall Study||3
9885251|NCT01051557|10999572|FG002|NOT COMPLETED|Overall Study||6
9885252|NCT01051557|10999573|FG003|NOT COMPLETED|Overall Study||3
9885253|NCT01051557|10999574|FG004|NOT COMPLETED|Overall Study||7
9885254|NCT01051557|10999575|FG005|NOT COMPLETED|Overall Study||6
9885255|NCT01051557|10999576|FG006|NOT COMPLETED|Overall Study||6
9885256|NCT01051570|10999593|FG000|STARTED|Overall Study||26
9885257|NCT01051570|10999593|FG000|COMPLETED|Overall Study||26
9885258|NCT01051570|10999593|FG000|NOT COMPLETED|Overall Study||0
9885259|NCT01051596|10999597|FG000|STARTED|Overall Study||75
9885260|NCT01051596|10999597|FG000|COMPLETED|Overall Study||75
9885261|NCT01051596|10999597|FG000|NOT COMPLETED|Overall Study||0
9885262|NCT01051661|10999607|FG000|STARTED|Overall Study||610
9885263|NCT01051661|10999608|FG001|STARTED|Overall Study||1438
9885264|NCT01051661|10999609|FG002|STARTED|Overall Study||612
9885265|NCT01051661|10999610|FG003|STARTED|Overall Study||1436
9885266|NCT01051661|10999611|FG004|STARTED|Overall Study||613
9885267|NCT01051661|10999612|FG005|STARTED|Overall Study||1436
9885268|NCT01051661|10999607|FG000|COMPLETED|Overall Study||576
10008233|NCT01755858|11130541|FG001|STARTED|Overall Study||9
9885269|NCT01051661|10999608|FG001|COMPLETED|Overall Study||1375
9885270|NCT01051661|10999609|FG002|COMPLETED|Overall Study||573
9885271|NCT01051661|10999610|FG003|COMPLETED|Overall Study||1380
9885272|NCT01051661|10999611|FG004|COMPLETED|Overall Study||578
9885273|NCT01051661|10999612|FG005|COMPLETED|Overall Study||1369
9885274|NCT01051661|10999607|FG000|NOT COMPLETED|Overall Study||34
9885275|NCT01051661|10999608|FG001|NOT COMPLETED|Overall Study||63
9885276|NCT01051661|10999609|FG002|NOT COMPLETED|Overall Study||39
9885277|NCT01051661|10999610|FG003|NOT COMPLETED|Overall Study||56
9885278|NCT01051661|10999611|FG004|NOT COMPLETED|Overall Study||35
9885279|NCT01051661|10999612|FG005|NOT COMPLETED|Overall Study||67
9885280|NCT01051739|10999649|FG000|STARTED|Overall Study||120
9885281|NCT01051739|10999650|FG001|STARTED|Overall Study||60
9885282|NCT01051739|10999649|FG000|COMPLETED|Overall Study||92
9885283|NCT01051739|10999650|FG001|COMPLETED|Overall Study||47
9885284|NCT01051739|10999649|FG000|NOT COMPLETED|Overall Study||28
9885285|NCT01051739|10999650|FG001|NOT COMPLETED|Overall Study||13
9885286|NCT01051778|10999658|FG000|STARTED|Overall Study|June 2006|30
10008234|NCT01755858|11130540|FG000|COMPLETED|Overall Study||6
9885287|NCT01051778|10999659|FG001|STARTED|Overall Study|June 2006|30
9885288|NCT01051778|10999658|FG000|COMPLETED|Overall Study|November 2009|30
9885289|NCT01051778|10999659|FG001|COMPLETED|Overall Study|November 2009|30
9885290|NCT01051778|10999658|FG000|NOT COMPLETED|Overall Study||0
9885291|NCT01051778|10999659|FG001|NOT COMPLETED|Overall Study||0
9885292|NCT01051791|10999665|FG000|STARTED|Overall Study||13
9885293|NCT01051791|10999665|FG000|COMPLETED|Overall Study||9
9885294|NCT01051791|10999665|FG000|NOT COMPLETED|Overall Study||4
9885295|NCT01051817|10999672|FG000|STARTED|Overall Study||38
9885296|NCT01051817|10999673|FG001|STARTED|Overall Study||35
9885297|NCT01051817|10999672|FG000|COMPLETED|Overall Study||35
9885298|NCT01051817|10999673|FG001|COMPLETED|Overall Study||26
9885299|NCT01051817|10999672|FG000|NOT COMPLETED|Overall Study||3
9885300|NCT01051817|10999673|FG001|NOT COMPLETED|Overall Study||9
9885301|NCT01051856|10999681|FG000|STARTED|Overall Study||33
9885302|NCT01051856|10999682|FG001|STARTED|Overall Study||35
9885303|NCT01051856|10999681|FG000|COMPLETED|Overall Study||32
9885304|NCT01051856|10999682|FG001|COMPLETED|Overall Study||35
9885305|NCT01051856|10999681|FG000|NOT COMPLETED|Overall Study||1
9885306|NCT01051856|10999682|FG001|NOT COMPLETED|Overall Study||0
9885307|NCT01051960|10999688|FG000|STARTED|Overall Study||12
9885308|NCT01051960|10999688|FG000|COMPLETED|Overall Study||11
9885309|NCT01051960|10999688|FG000|NOT COMPLETED|Overall Study||1
9885310|NCT01051986|10999694|FG000|STARTED|Overall Study||112
9885311|NCT01051986|10999695|FG001|STARTED|Overall Study||112
9885312|NCT01051986|10999694|FG000|COMPLETED|Overall Study||107
9885313|NCT01051986|10999695|FG001|COMPLETED|Overall Study||108
9885314|NCT01051986|10999694|FG000|NOT COMPLETED|Overall Study||5
9885315|NCT01051986|10999695|FG001|NOT COMPLETED|Overall Study||4
9885316|NCT01052012|10999707|FG000|STARTED|Overall Study||32
9885317|NCT01052012|10999708|FG001|STARTED|Overall Study||23
9885318|NCT01052012|10999709|FG002|STARTED|Overall Study||30
9885319|NCT01052012|10999710|FG003|STARTED|Overall Study||20
9885320|NCT01052012|10999711|FG004|STARTED|Overall Study||140
9885321|NCT01052012|10999712|FG005|STARTED|Overall Study||86
9885322|NCT01052012|10999707|FG000|COMPLETED|Overall Study||28
9885323|NCT01052012|10999708|FG001|COMPLETED|Overall Study||17
9885324|NCT01052012|10999709|FG002|COMPLETED|Overall Study||30
9885325|NCT01052012|10999710|FG003|COMPLETED|Overall Study||19
9885326|NCT01052012|10999711|FG004|COMPLETED|Overall Study||124
9885327|NCT01052012|10999712|FG005|COMPLETED|Overall Study||76
9885328|NCT01052012|10999707|FG000|NOT COMPLETED|Overall Study||4
9885329|NCT01052012|10999708|FG001|NOT COMPLETED|Overall Study||6
9885330|NCT01052012|10999709|FG002|NOT COMPLETED|Overall Study||0
9885331|NCT01052012|10999710|FG003|NOT COMPLETED|Overall Study||1
9885332|NCT01052012|10999711|FG004|NOT COMPLETED|Overall Study||16
9885333|NCT01052012|10999712|FG005|NOT COMPLETED|Overall Study||10
9885334|NCT01052038|10999729|FG000|STARTED|Overall Study||40
9885335|NCT01052038|10999730|FG001|STARTED|Overall Study||40
9885336|NCT01052038|10999731|FG002|STARTED|Overall Study||40
9885337|NCT01052038|10999729|FG000|COMPLETED|Overall Study||36
9885338|NCT01052038|10999730|FG001|COMPLETED|Overall Study||34
9885339|NCT01052038|10999731|FG002|COMPLETED|Overall Study||36
9885340|NCT01052038|10999729|FG000|NOT COMPLETED|Overall Study||4
9885341|NCT01052038|10999730|FG001|NOT COMPLETED|Overall Study||6
9885342|NCT01052038|10999731|FG002|NOT COMPLETED|Overall Study||4
9885343|NCT01052077|10999741|FG000|STARTED|Phase A||769
9885344|NCT01052077|10999742|FG001|STARTED|Phase A||0
9885345|NCT01052077|10999743|FG002|STARTED|Phase A||0
9885346|NCT01052077|10999744|FG003|STARTED|Phase A||0
9885347|NCT01052077|10999741|FG000|COMPLETED|Phase A||623
9885348|NCT01052077|10999742|FG001|COMPLETED|Phase A||0
10008235|NCT01755858|11130541|FG001|COMPLETED|Overall Study||8
10008236|NCT01755858|11130540|FG000|NOT COMPLETED|Overall Study||1
10008237|NCT01755858|11130541|FG001|NOT COMPLETED|Overall Study||1
10008238|NCT01755949|11130555|FG000|STARTED|Overall Study||5
10008239|NCT01755949|11130556|FG001|STARTED|Overall Study||5
9885349|NCT01052077|10999743|FG002|COMPLETED|Phase A||0
9885350|NCT01052077|10999744|FG003|COMPLETED|Phase A||0
9885351|NCT01052077|10999741|FG000|NOT COMPLETED|Phase A||146
9885352|NCT01052077|10999742|FG001|NOT COMPLETED|Phase A||0
9885353|NCT01052077|10999743|FG002|NOT COMPLETED|Phase A||0
9885354|NCT01052077|10999744|FG003|NOT COMPLETED|Phase A||0
9885355|NCT01052077|10999741|FG000|STARTED|Phase B||0
9885356|NCT01052077|10999742|FG001|STARTED|Phase B||185
9885357|NCT01052077|10999743|FG002|STARTED|Phase B||187
9885358|NCT01052077|10999744|FG003|STARTED|Phase B||0
10008240|NCT01755949|11130557|FG002|STARTED|Overall Study||4
10008241|NCT01755949|11130558|FG003|STARTED|Overall Study||5
9885359|NCT01052077|10999741|FG000|COMPLETED|Phase B||0
9885360|NCT01052077|10999742|FG001|COMPLETED|Phase B||167
9885361|NCT01052077|10999743|FG002|COMPLETED|Phase B||171
9885362|NCT01052077|10999744|FG003|COMPLETED|Phase B||0
9885363|NCT01052077|10999741|FG000|NOT COMPLETED|Phase B||0
9885364|NCT01052077|10999742|FG001|NOT COMPLETED|Phase B||18
9885365|NCT01052077|10999743|FG002|NOT COMPLETED|Phase B||16
9885366|NCT01052077|10999744|FG003|NOT COMPLETED|Phase B||0
9885367|NCT01052077|10999741|FG000|STARTED|Phase A+||0
9885368|NCT01052077|10999742|FG001|STARTED|Phase A+||0
9885369|NCT01052077|10999743|FG002|STARTED|Phase A+||0
9885370|NCT01052077|10999744|FG003|STARTED|Phase A+||251
9885371|NCT01052077|10999741|FG000|COMPLETED|Phase A+||0
9885372|NCT01052077|10999742|FG001|COMPLETED|Phase A+||0
9885373|NCT01052077|10999743|FG002|COMPLETED|Phase A+||0
9885374|NCT01052077|10999744|FG003|COMPLETED|Phase A+||230
9885375|NCT01052077|10999741|FG000|NOT COMPLETED|Phase A+||0
9885376|NCT01052077|10999742|FG001|NOT COMPLETED|Phase A+||0
9885377|NCT01052077|10999743|FG002|NOT COMPLETED|Phase A+||0
9885378|NCT01052077|10999744|FG003|NOT COMPLETED|Phase A+||21
9885379|NCT01052103|10999752|FG000|STARTED|Overall Study||84
9885380|NCT01052103|10999753|FG001|STARTED|Overall Study||83
9885381|NCT01052103|10999752|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
9885382|NCT01052103|10999753|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
9885383|NCT01052103|10999752|FG000|COMPLETED|Overall Study||50
9885384|NCT01052103|10999753|FG001|COMPLETED|Overall Study||60
9885385|NCT01052103|10999752|FG000|NOT COMPLETED|Overall Study||34
9885386|NCT01052103|10999753|FG001|NOT COMPLETED|Overall Study||23
9885387|NCT01052116|10999762|FG000|STARTED|Overall Study||193
9885388|NCT01052116|10999763|FG001|STARTED|Overall Study||193
9885389|NCT01052116|10999762|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
9885390|NCT01052116|10999763|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
9885391|NCT01052116|10999762|FG000|NOT COMPLETED|Overall Study||14
9885392|NCT01052116|10999763|FG001|NOT COMPLETED|Overall Study||27
9885393|NCT01052207|10999771|FG000|STARTED|Overall Study||60
9885394|NCT01052207|10999772|FG001|STARTED|Overall Study||42
9885395|NCT01052207|10999771|FG000|COMPLETED|Overall Study||60
9885396|NCT01052207|10999772|FG001|COMPLETED|Overall Study||42
9885397|NCT01052207|10999771|FG000|NOT COMPLETED|Overall Study||0
9885398|NCT01052207|10999772|FG001|NOT COMPLETED|Overall Study||0
9885399|NCT01052272|10999782|FG000|STARTED|Overall Study||18
9885400|NCT01052272|10999783|FG001|STARTED|Overall Study||18
9885401|NCT01052272|10999784|FG002|STARTED|Overall Study||18
9885402|NCT01052272|10999785|FG003|STARTED|Overall Study||18
9885403|NCT01052272|10999782|FG000|COMPLETED|Overall Study||13
9885404|NCT01052272|10999783|FG001|COMPLETED|Overall Study||11
9885405|NCT01052272|10999784|FG002|COMPLETED|Overall Study||10
9885406|NCT01052272|10999785|FG003|COMPLETED|Overall Study||11
9885407|NCT01052272|10999782|FG000|NOT COMPLETED|Overall Study||5
9885408|NCT01052272|10999783|FG001|NOT COMPLETED|Overall Study||7
9885409|NCT01052272|10999784|FG002|NOT COMPLETED|Overall Study||8
9885410|NCT01052272|10999785|FG003|NOT COMPLETED|Overall Study||7
9885411|NCT01052428|10999797|FG000|STARTED|Overall Study||19
9885412|NCT01052428|10999798|FG001|STARTED|Overall Study||19
9885413|NCT01052428|10999797|FG000|COMPLETED|Overall Study||18
9885414|NCT01052428|10999798|FG001|COMPLETED|Overall Study||18
9885415|NCT01052428|10999797|FG000|NOT COMPLETED|Overall Study||1
9885416|NCT01052428|10999798|FG001|NOT COMPLETED|Overall Study||1
9885417|NCT01052480|10999806|FG000|STARTED|Overall Study||49
9885418|NCT01052480|10999807|FG001|STARTED|Overall Study||49
9885419|NCT01052480|10999806|FG000|COMPLETED|Overall Study||41
9885420|NCT01052480|10999807|FG001|COMPLETED|Overall Study||32
9885421|NCT01052480|10999806|FG000|NOT COMPLETED|Overall Study||8
9885422|NCT01052480|10999807|FG001|NOT COMPLETED|Overall Study||17
9885423|NCT01052493|10999813|FG000|STARTED|Intervention 1 (Up to 10 Days)||4
9885424|NCT01052493|10999814|FG001|STARTED|Intervention 1 (Up to 10 Days)||4
9885425|NCT01052493|10999815|FG002|STARTED|Intervention 1 (Up to 10 Days)||4
9885426|NCT01052493|10999813|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3
9885427|NCT01052493|10999814|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4
9885428|NCT01052493|10999815|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4
9885429|NCT01052493|10999813|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
9885430|NCT01052493|10999814|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
9885431|NCT01052493|10999815|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
9885432|NCT01052493|10999813|FG000|STARTED|Washout Period 1 (up to 5 Days)||3
9885433|NCT01052493|10999814|FG001|STARTED|Washout Period 1 (up to 5 Days)||4
9885434|NCT01052493|10999815|FG002|STARTED|Washout Period 1 (up to 5 Days)||4
9885435|NCT01052493|10999813|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3
9885436|NCT01052493|10999814|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4
9885437|NCT01052493|10999815|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4
9885438|NCT01052493|10999813|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
9885439|NCT01052493|10999814|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
9885440|NCT01052493|10999815|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
9885441|NCT01052493|10999813|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
9885442|NCT01052493|10999814|FG001|STARTED|Intervention 2 (up to 10 Days)||4
9885443|NCT01052493|10999815|FG002|STARTED|Intervention 2 (up to 10 Days)||4
9885444|NCT01052493|10999813|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4
9885445|NCT01052493|10999814|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4
9885446|NCT01052493|10999815|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4
9885447|NCT01052493|10999813|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
9885448|NCT01052493|10999814|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
9885449|NCT01052493|10999815|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
9885450|NCT01052493|10999813|FG000|STARTED|Washout Period 2 (up to 5 Days)||4
9885451|NCT01052493|10999814|FG001|STARTED|Washout Period 2 (up to 5 Days)||4
9885452|NCT01052493|10999815|FG002|STARTED|Washout Period 2 (up to 5 Days)||4
9885453|NCT01052493|10999813|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4
9885454|NCT01052493|10999814|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4
9885455|NCT01052493|10999815|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4
9885456|NCT01052493|10999813|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
9885457|NCT01052493|10999814|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
9885458|NCT01052493|10999815|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
9885459|NCT01052493|10999813|FG000|STARTED|Intervention 3 (up to 10 Days)||4
9885460|NCT01052493|10999814|FG001|STARTED|Intervention 3 (up to 10 Days)||4
9885461|NCT01052493|10999815|FG002|STARTED|Intervention 3 (up to 10 Days)||4
9885462|NCT01052493|10999813|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4
9885463|NCT01052493|10999814|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4
10202817|NCT03451071|11329947|FG000|COMPLETED|Final Questionnaire and Blood Draw||10
10202818|NCT03451071|11329947|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4
10202819|NCT03451084|11329955|FG000|STARTED|Overall Study||6
10202820|NCT03451084|11329956|FG001|STARTED|Overall Study||6
10202821|NCT03451084|11329957|FG002|STARTED|Overall Study||6
10202822|NCT03451084|11329958|FG003|STARTED|Overall Study||6
10202823|NCT03451084|11329955|FG000|COMPLETED|Overall Study||0
10202824|NCT03451084|11329956|FG001|COMPLETED|Overall Study||0
9885464|NCT01052493|10999815|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4
9885465|NCT01052493|10999813|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
9885466|NCT01052493|10999814|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
9885467|NCT01052493|10999815|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
9885468|NCT01052545|10999830|FG000|STARTED|Overall Study||867
9885469|NCT01052545|10999831|FG001|STARTED|Overall Study||731
9885470|NCT01052545|10999830|FG000|COMPLETED|Overall Study||867
9885471|NCT01052545|10999831|FG001|COMPLETED|Overall Study||731
9885472|NCT01052545|10999830|FG000|NOT COMPLETED|Overall Study||0
9885473|NCT01052545|10999831|FG001|NOT COMPLETED|Overall Study||0
9885474|NCT01052662|10999852|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
9885475|NCT01052662|10999853|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
9885476|NCT01052662|10999854|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
9885477|NCT01052662|10999852|FG000|Stabilization Phase|Overall Study||21
9885478|NCT01052662|10999853|FG001|Stabilization Phase|Overall Study||21
9885479|NCT01052662|10999854|FG002|Stabilization Phase|Overall Study||26
9885480|NCT01052662|10999852|FG000|Discontinuation Phase|Overall Study||6
9885481|NCT01052662|10999853|FG001|Discontinuation Phase|Overall Study||5
9885482|NCT01052662|10999854|FG002|Discontinuation Phase|Overall Study||10
9885483|NCT01052662|10999852|FG000|COMPLETED|Overall Study||6
9885484|NCT01052662|10999853|FG001|COMPLETED|Overall Study||5
9885485|NCT01052662|10999854|FG002|COMPLETED|Overall Study||10
9885486|NCT01052662|10999852|FG000|NOT COMPLETED|Overall Study||22
9885487|NCT01052662|10999853|FG001|NOT COMPLETED|Overall Study||22
9885488|NCT01052662|10999854|FG002|NOT COMPLETED|Overall Study||22
9885489|NCT01052701|10999864|FG000|STARTED|Overall Study||14
9885490|NCT01052701|10999865|FG001|STARTED|Overall Study||12
9885491|NCT01052701|10999864|FG000|COMPLETED|Overall Study||14
9885492|NCT01052701|10999865|FG001|COMPLETED|Overall Study||12
9885493|NCT01052701|10999864|FG000|NOT COMPLETED|Overall Study||0
9885494|NCT01052701|10999865|FG001|NOT COMPLETED|Overall Study||0
9885495|NCT01052714|10999873|FG000|STARTED|Overall Study||42
9885496|NCT01052714|10999874|FG001|STARTED|Overall Study||62
9885497|NCT01052714|10999875|FG002|STARTED|Overall Study||17
9885498|NCT01052714|10999873|FG000|COMPLETED|Overall Study||17
9885499|NCT01052714|10999874|FG001|COMPLETED|Overall Study||33
9885500|NCT01052714|10999875|FG002|COMPLETED|Overall Study||15
9885501|NCT01052714|10999873|FG000|NOT COMPLETED|Overall Study||25
9885502|NCT01052714|10999874|FG001|NOT COMPLETED|Overall Study||29
9885503|NCT01052714|10999875|FG002|NOT COMPLETED|Overall Study||2
9885504|NCT01052779|10999883|FG000|STARTED|Overall Study||80
9885505|NCT01052779|10999884|FG001|STARTED|Overall Study||82
9885506|NCT01052779|10999883|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
9885507|NCT01052779|10999884|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
9885508|NCT01052779|10999883|FG000|COMPLETED|Overall Study||75
9885509|NCT01052779|10999884|FG001|COMPLETED|Overall Study||73
9885510|NCT01052779|10999883|FG000|NOT COMPLETED|Overall Study||5
9885511|NCT01052779|10999884|FG001|NOT COMPLETED|Overall Study||9
9885512|NCT01052831|10999892|FG000|STARTED|Overall Study||26
9885513|NCT01052831|10999893|FG001|STARTED|Overall Study||24
9885514|NCT01052831|10999892|FG000|COMPLETED|Overall Study||22
9885515|NCT01052831|10999893|FG001|COMPLETED|Overall Study||23
9885516|NCT01052831|10999892|FG000|NOT COMPLETED|Overall Study||4
9885517|NCT01052831|10999893|FG001|NOT COMPLETED|Overall Study||1
9885518|NCT01052844|10999901|FG000|STARTED|Overall Study||40
9885519|NCT01052844|10999902|FG001|STARTED|Overall Study||40
9885520|NCT01052844|10999901|FG000|COMPLETED|Overall Study||40
9885521|NCT01052844|10999902|FG001|COMPLETED|Overall Study||39
9885522|NCT01052844|10999901|FG000|NOT COMPLETED|Overall Study||0
9885523|NCT01052844|10999902|FG001|NOT COMPLETED|Overall Study||1
9885524|NCT01052948|10999912|FG000|STARTED|Overall Study||27812
9885525|NCT01052948|10999913|FG001|STARTED|Overall Study||14669
10202825|NCT03451084|11329957|FG002|COMPLETED|Overall Study||0
9885526|NCT01052948|10999914|FG002|STARTED|Overall Study||15147
9885527|NCT01052948|10999915|FG003|STARTED|Overall Study||29311
9885528|NCT01052948|10999912|FG000|COMPLETED|Overall Study||27812
9885529|NCT01052948|10999913|FG001|COMPLETED|Overall Study||14669
9885530|NCT01052948|10999914|FG002|COMPLETED|Overall Study||15147
9885531|NCT01052948|10999915|FG003|COMPLETED|Overall Study||29311
9885532|NCT01052948|10999912|FG000|NOT COMPLETED|Overall Study||0
9885533|NCT01052948|10999913|FG001|NOT COMPLETED|Overall Study||0
9885534|NCT01052948|10999914|FG002|NOT COMPLETED|Overall Study||0
9885535|NCT01052948|10999915|FG003|NOT COMPLETED|Overall Study||0
10202826|NCT03451084|11329958|FG003|COMPLETED|Overall Study||0
10202827|NCT03451084|11329955|FG000|NOT COMPLETED|Overall Study||6
9885536|NCT01053000|10999925|FG000|STARTED|Overall Study||5
9885537|NCT01053000|10999926|FG001|STARTED|Overall Study||5
9885538|NCT01053000|10999925|FG000|COMPLETED|Overall Study||5
9885539|NCT01053000|10999926|FG001|COMPLETED|Overall Study||5
9885540|NCT01053000|10999925|FG000|NOT COMPLETED|Overall Study||0
9885541|NCT01053000|10999926|FG001|NOT COMPLETED|Overall Study||0
9885542|NCT01053013|10999934|FG000|STARTED|Overall Study||24
9885543|NCT01053013|10999935|FG001|STARTED|Overall Study||34
9885544|NCT01053013|10999934|FG000|COMPLETED|Overall Study||24
9885545|NCT01053013|10999935|FG001|COMPLETED|Overall Study||34
9885546|NCT01053013|10999934|FG000|NOT COMPLETED|Overall Study||0
9885547|NCT01053013|10999935|FG001|NOT COMPLETED|Overall Study||0
9885548|NCT01053078|11000039|FG000|STARTED|Overall Study||14
9885549|NCT01053078|11000040|FG001|STARTED|Overall Study||15
9885550|NCT01053078|11000039|FG000|COMPLETED|Overall Study||10
9885551|NCT01053078|11000040|FG001|COMPLETED|Overall Study||12
9885552|NCT01053078|11000039|FG000|NOT COMPLETED|Overall Study||4
9885553|NCT01053078|11000040|FG001|NOT COMPLETED|Overall Study||3
9885554|NCT01053156|11000050|FG000|STARTED|First Intervention (Week 1-12)||33
9885555|NCT01053156|11000051|FG001|STARTED|First Intervention (Week 1-12)||33
9885556|NCT01053156|11000050|FG000|COMPLETED|First Intervention (Week 1-12)||28
9885557|NCT01053156|11000051|FG001|COMPLETED|First Intervention (Week 1-12)||27
9885558|NCT01053156|11000050|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5
9885559|NCT01053156|11000051|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6
9885560|NCT01053156|11000050|FG000|STARTED|Second Intervention (Week 13-24)||28
9885561|NCT01053156|11000051|FG001|STARTED|Second Intervention (Week 13-24)||27
9885562|NCT01053156|11000050|FG000|COMPLETED|Second Intervention (Week 13-24)||26
9885563|NCT01053156|11000051|FG001|COMPLETED|Second Intervention (Week 13-24)||22
9885564|NCT01053156|11000050|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2
9885565|NCT01053156|11000051|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5
9885566|NCT01053247|11000063|FG000|STARTED|Overall Study||269
9885567|NCT01053247|11000064|FG001|STARTED|Overall Study||260
9885568|NCT01053247|11000065|FG002|STARTED|Overall Study||264
9885569|NCT01053247|11000063|FG000|COMPLETED|Overall Study||249
9885570|NCT01053247|11000064|FG001|COMPLETED|Overall Study||241
9885571|NCT01053247|11000065|FG002|COMPLETED|Overall Study||236
9885572|NCT01053247|11000063|FG000|NOT COMPLETED|Overall Study||20
9885573|NCT01053247|11000064|FG001|NOT COMPLETED|Overall Study||19
9885574|NCT01053247|11000065|FG002|NOT COMPLETED|Overall Study||28
9885575|NCT01053312|11000073|FG000|STARTED|Overall Study||7
9885576|NCT01053312|11000073|FG000|COMPLETED|Overall Study||7
9885577|NCT01053312|11000073|FG000|NOT COMPLETED|Overall Study||0
9885578|NCT01053429|11000091|FG000|STARTED|Overall Study||3391
9885579|NCT01053429|11000091|FG000|COMPLETED|Overall Study||3018
9885580|NCT01053429|11000091|FG000|NOT COMPLETED|Overall Study||373
9885581|NCT01053507|11000097|FG000|STARTED|Overall Study||11
9885582|NCT01053507|11000098|FG001|STARTED|Overall Study||12
9885583|NCT01053507|11000097|FG000|COMPLETED|Overall Study||8
9885584|NCT01053507|11000098|FG001|COMPLETED|Overall Study||11
9885585|NCT01053507|11000097|FG000|NOT COMPLETED|Overall Study||3
9885586|NCT01053507|11000098|FG001|NOT COMPLETED|Overall Study||1
9885587|NCT01053663|11000107|FG000|STARTED|Overall Study||9
9885588|NCT01053663|11000107|FG000|COMPLETED|Overall Study||3
9885589|NCT01053663|11000107|FG000|NOT COMPLETED|Overall Study||6
9885590|NCT01053741|11000119|FG000|STARTED|1st Intervention||5
9885591|NCT01053741|11000120|FG001|STARTED|1st Intervention||6
9885592|NCT01053741|11000119|FG000|COMPLETED|1st Intervention||5
9885593|NCT01053741|11000120|FG001|COMPLETED|1st Intervention||6
9885594|NCT01053741|11000119|FG000|NOT COMPLETED|1st Intervention||0
9885595|NCT01053741|11000120|FG001|NOT COMPLETED|1st Intervention||0
9885596|NCT01053741|11000119|FG000|STARTED|14 Day Washout||5
9885597|NCT01053741|11000120|FG001|STARTED|14 Day Washout||6
9885598|NCT01053741|11000119|FG000|COMPLETED|14 Day Washout||5
9885599|NCT01053741|11000120|FG001|COMPLETED|14 Day Washout||6
9885600|NCT01053741|11000119|FG000|NOT COMPLETED|14 Day Washout||0
9885601|NCT01053741|11000120|FG001|NOT COMPLETED|14 Day Washout||0
9885602|NCT01053741|11000119|FG000|STARTED|2nd Study Intervention||5
9885603|NCT01053741|11000120|FG001|STARTED|2nd Study Intervention||6
9885604|NCT01053741|11000119|FG000|COMPLETED|2nd Study Intervention||5
9885605|NCT01053741|11000120|FG001|COMPLETED|2nd Study Intervention||5
9885606|NCT01053741|11000119|FG000|NOT COMPLETED|2nd Study Intervention||0
9885607|NCT01053741|11000120|FG001|NOT COMPLETED|2nd Study Intervention||1
9885608|NCT01053819|11000126|FG000|STARTED|Overall Study||6
9885609|NCT01053819|11000126|FG000|COMPLETED|Overall Study||6
9885610|NCT01053819|11000126|FG000|NOT COMPLETED|Overall Study||0
9885611|NCT01053897|11000131|FG000|STARTED|Overall Study||5
9885612|NCT01053897|11000131|FG000|COMPLETED|Overall Study||5
9885613|NCT01053897|11000131|FG000|NOT COMPLETED|Overall Study||0
9885614|NCT01053962|11000146|FG000|STARTED|Pretreatment Period||14
9885615|NCT01053962|11000147|FG001|STARTED|Pretreatment Period||15
9885616|NCT01053962|11000148|FG002|STARTED|Pretreatment Period||16
9885617|NCT01053962|11000149|FG003|STARTED|Pretreatment Period||17
9885618|NCT01053962|11000150|FG004|STARTED|Pretreatment Period||22
9885619|NCT01053962|11000146|FG000|COMPLETED|Pretreatment Period||14
9885620|NCT01053962|11000147|FG001|COMPLETED|Pretreatment Period||14
9885621|NCT01053962|11000148|FG002|COMPLETED|Pretreatment Period||15
9885622|NCT01053962|11000149|FG003|COMPLETED|Pretreatment Period||15
9885623|NCT01053962|11000150|FG004|COMPLETED|Pretreatment Period||20
9885624|NCT01053962|11000146|FG000|NOT COMPLETED|Pretreatment Period||0
9885625|NCT01053962|11000147|FG001|NOT COMPLETED|Pretreatment Period||1
9885626|NCT01053962|11000148|FG002|NOT COMPLETED|Pretreatment Period||1
9885627|NCT01053962|11000149|FG003|NOT COMPLETED|Pretreatment Period||2
9885628|NCT01053962|11000150|FG004|NOT COMPLETED|Pretreatment Period||2
9885629|NCT01053962|11000146|FG000|STARTED|Treatment Period||14
9885630|NCT01053962|11000147|FG001|STARTED|Treatment Period||14
9885631|NCT01053962|11000148|FG002|STARTED|Treatment Period||15
9885632|NCT01053962|11000149|FG003|STARTED|Treatment Period||15
9885633|NCT01053962|11000150|FG004|STARTED|Treatment Period||20
9885634|NCT01053962|11000146|FG000|COMPLETED|Treatment Period||13
9885635|NCT01053962|11000147|FG001|COMPLETED|Treatment Period||14
9885636|NCT01053962|11000148|FG002|COMPLETED|Treatment Period||15
9885637|NCT01053962|11000149|FG003|COMPLETED|Treatment Period||15
9885638|NCT01053962|11000150|FG004|COMPLETED|Treatment Period||17
9885639|NCT01053962|11000146|FG000|NOT COMPLETED|Treatment Period||1
9885640|NCT01053962|11000147|FG001|NOT COMPLETED|Treatment Period||0
9885641|NCT01053962|11000148|FG002|NOT COMPLETED|Treatment Period||0
9885642|NCT01053962|11000149|FG003|NOT COMPLETED|Treatment Period||0
9885643|NCT01053962|11000150|FG004|NOT COMPLETED|Treatment Period||3
9885644|NCT01053962|11000146|FG000|STARTED|Follow-up Period||13
9885645|NCT01053962|11000147|FG001|STARTED|Follow-up Period||14
9885646|NCT01053962|11000148|FG002|STARTED|Follow-up Period||15
9885647|NCT01053962|11000149|FG003|STARTED|Follow-up Period||15
9885648|NCT01053962|11000150|FG004|STARTED|Follow-up Period||17
9885649|NCT01053962|11000146|FG000|COMPLETED|Follow-up Period||13
9885650|NCT01053962|11000147|FG001|COMPLETED|Follow-up Period||14
9885651|NCT01053962|11000148|FG002|COMPLETED|Follow-up Period||15
9885652|NCT01053962|11000149|FG003|COMPLETED|Follow-up Period||15
9885653|NCT01053962|11000150|FG004|COMPLETED|Follow-up Period||17
9885654|NCT01053962|11000146|FG000|NOT COMPLETED|Follow-up Period||0
9885655|NCT01053962|11000147|FG001|NOT COMPLETED|Follow-up Period||0
9885656|NCT01053962|11000148|FG002|NOT COMPLETED|Follow-up Period||0
9885657|NCT01053962|11000149|FG003|NOT COMPLETED|Follow-up Period||0
9885658|NCT01053962|11000150|FG004|NOT COMPLETED|Follow-up Period||0
9885659|NCT01053988|11000172|FG000|STARTED|2-week, Single-blind Run-In Period||1390
9885660|NCT01053988|11000173|FG001|STARTED|2-week, Single-blind Run-In Period||0
9885661|NCT01053988|11000174|FG002|STARTED|2-week, Single-blind Run-In Period||0
9885662|NCT01053988|11000175|FG003|STARTED|2-week, Single-blind Run-In Period||0
9885663|NCT01053988|11000176|FG004|STARTED|2-week, Single-blind Run-In Period||0
9885664|NCT01053988|11000177|FG005|STARTED|2-week, Single-blind Run-In Period||0
9885665|NCT01053988|11000172|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030
9885666|NCT01053988|11000173|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
9885667|NCT01053988|11000174|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
9885668|NCT01053988|11000175|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
9885669|NCT01053988|11000176|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
9885670|NCT01053988|11000177|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
9885671|NCT01053988|11000172|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360
9885672|NCT01053988|11000173|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885673|NCT01053988|11000174|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885674|NCT01053988|11000175|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885675|NCT01053988|11000176|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885676|NCT01053988|11000177|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885677|NCT01053988|11000172|FG000|STARTED|24-week, Double-blind Treatment Period||0
9885678|NCT01053988|11000173|FG001|STARTED|24-week, Double-blind Treatment Period||207
9885679|NCT01053988|11000174|FG002|STARTED|24-week, Double-blind Treatment Period||206
9885680|NCT01053988|11000175|FG003|STARTED|24-week, Double-blind Treatment Period||205
9885681|NCT01053988|11000176|FG004|STARTED|24-week, Double-blind Treatment Period||206
9885682|NCT01053988|11000177|FG005|STARTED|24-week, Double-blind Treatment Period||206
9885683|NCT01053988|11000172|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
9885684|NCT01053988|11000173|FG001|COMPLETED|24-week, Double-blind Treatment Period||138
9885685|NCT01053988|11000174|FG002|COMPLETED|24-week, Double-blind Treatment Period||145
9885686|NCT01053988|11000175|FG003|COMPLETED|24-week, Double-blind Treatment Period||142
9885687|NCT01053988|11000176|FG004|COMPLETED|24-week, Double-blind Treatment Period||147
9885688|NCT01053988|11000177|FG005|COMPLETED|24-week, Double-blind Treatment Period||151
9885689|NCT01053988|11000172|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
9885690|NCT01053988|11000173|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69
9885691|NCT01053988|11000174|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61
9885692|NCT01053988|11000175|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63
9885693|NCT01053988|11000176|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59
9885694|NCT01053988|11000177|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55
9885695|NCT01054079|11000189|FG000|STARTED|Overall Study||20
9885696|NCT01054079|11000189|FG000|# Recieved Proper PSA Testing|Overall Study||10
9885697|NCT01054079|11000189|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
9885698|NCT01054079|11000189|FG000|NOT COMPLETED|Overall Study||0
9885699|NCT01054144|11000193|FG000|STARTED|Overall Study||27
9885700|NCT01054144|11000193|FG000|COMPLETED|Overall Study||25
9885701|NCT01054144|11000193|FG000|NOT COMPLETED|Overall Study||2
9885702|NCT01054170|11000202|FG000|STARTED|Overall Study||25
9885703|NCT01054170|11000203|FG001|STARTED|Overall Study||27
9885704|NCT01054170|11000202|FG000|COMPLETED|Overall Study||21
9885705|NCT01054170|11000203|FG001|COMPLETED|Overall Study||21
9885706|NCT01054170|11000202|FG000|NOT COMPLETED|Overall Study||4
9885707|NCT01054170|11000203|FG001|NOT COMPLETED|Overall Study||6
9885708|NCT01054183|11000211|FG000|STARTED|Overall Study||10
9885709|NCT01054183|11000212|FG001|STARTED|Overall Study||12
9885710|NCT01054183|11000211|FG000|COMPLETED|Overall Study||10
9885711|NCT01054183|11000212|FG001|COMPLETED|Overall Study||12
9885712|NCT01054183|11000211|FG000|NOT COMPLETED|Overall Study||0
9885713|NCT01054183|11000212|FG001|NOT COMPLETED|Overall Study||0
9885714|NCT01054209|11000220|FG000|STARTED|Overall Study||58
9885715|NCT01054209|11000221|FG001|STARTED|Overall Study||58
9885716|NCT01054209|11000220|FG000|COMPLETED|Overall Study||58
9885717|NCT01054209|11000221|FG001|COMPLETED|Overall Study||58
9885718|NCT01054209|11000220|FG000|NOT COMPLETED|Overall Study||0
9885719|NCT01054209|11000221|FG001|NOT COMPLETED|Overall Study||0
9885720|NCT01054222|11000227|FG000|STARTED|Overall Study||31
9885721|NCT01054222|11000227|FG000|COMPLETED|Overall Study||20
9885722|NCT01054222|11000227|FG000|NOT COMPLETED|Overall Study||11
9885723|NCT01054300|11000233|FG000|STARTED|Period 1||13
9885724|NCT01054300|11000234|FG001|STARTED|Period 1||13
9885725|NCT01054300|11000235|FG002|STARTED|Period 1||13
9885726|NCT01054300|11000236|FG003|STARTED|Period 1||13
9885727|NCT01054300|11000233|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
10109186|NCT02473393|11239777|FG003|NOT COMPLETED|Overall Study||1
10109187|NCT02473471|11239787|FG000|STARTED|Overall Study||35
10109188|NCT02473471|11239787|FG000|Received Allocated Intervention|Overall Study||33
9885728|NCT01054300|11000234|FG001|COMPLETED|Period 1||13
9885729|NCT01054300|11000235|FG002|COMPLETED|Period 1||13
9885730|NCT01054300|11000236|FG003|COMPLETED|Period 1||13
9885731|NCT01054300|11000233|FG000|NOT COMPLETED|Period 1||1
9885732|NCT01054300|11000234|FG001|NOT COMPLETED|Period 1||0
9885733|NCT01054300|11000235|FG002|NOT COMPLETED|Period 1||0
9885734|NCT01054300|11000236|FG003|NOT COMPLETED|Period 1||0
9885735|NCT01054300|11000233|FG000|STARTED|Period 2||12
9885736|NCT01054300|11000234|FG001|STARTED|Period 2||13
9885737|NCT01054300|11000235|FG002|STARTED|Period 2||13
9885738|NCT01054300|11000236|FG003|STARTED|Period 2||13
9885739|NCT01054300|11000233|FG000|COMPLETED|Period 2||12
9885740|NCT01054300|11000234|FG001|COMPLETED|Period 2||13
9885741|NCT01054300|11000235|FG002|COMPLETED|Period 2||12
9885742|NCT01054300|11000236|FG003|COMPLETED|Period 2||13
9885743|NCT01054300|11000233|FG000|NOT COMPLETED|Period 2||0
9885744|NCT01054300|11000234|FG001|NOT COMPLETED|Period 2||0
9885745|NCT01054300|11000235|FG002|NOT COMPLETED|Period 2||1
9885746|NCT01054300|11000236|FG003|NOT COMPLETED|Period 2||0
9885747|NCT01054339|11000249|FG000|STARTED|Overall Study||3
9885748|NCT01054339|11000250|FG001|STARTED|Overall Study||3
9885749|NCT01054339|11000251|FG002|STARTED|Overall Study||3
9885750|NCT01054339|11000249|FG000|COMPLETED|Overall Study||3
9885751|NCT01054339|11000250|FG001|COMPLETED|Overall Study||3
9885752|NCT01054339|11000251|FG002|COMPLETED|Overall Study||3
9885753|NCT01054339|11000249|FG000|NOT COMPLETED|Overall Study||0
9885754|NCT01054339|11000250|FG001|NOT COMPLETED|Overall Study||0
9885755|NCT01054339|11000251|FG002|NOT COMPLETED|Overall Study||0
9885756|NCT01054404|11000263|FG000|STARTED|Overall Study||10
9885757|NCT01054404|11000264|FG001|STARTED|Overall Study||13
9885758|NCT01054404|11000263|FG000|COMPLETED|Overall Study||10
9885759|NCT01054404|11000264|FG001|COMPLETED|Overall Study||13
9885760|NCT01054404|11000263|FG000|NOT COMPLETED|Overall Study||0
9885761|NCT01054404|11000264|FG001|NOT COMPLETED|Overall Study||0
9885762|NCT01054443|11000274|FG000|STARTED|Overall Study||5
9885763|NCT01054443|11000275|FG001|STARTED|Overall Study||5
9885764|NCT01054443|11000276|FG002|STARTED|Overall Study||5
9885765|NCT01054443|11000277|FG003|STARTED|Overall Study||5
9885766|NCT01054443|11000274|FG000|COMPLETED|Overall Study||5
9885767|NCT01054443|11000275|FG001|COMPLETED|Overall Study||5
9885768|NCT01054443|11000276|FG002|COMPLETED|Overall Study||5
9885769|NCT01054443|11000277|FG003|COMPLETED|Overall Study||4
9885770|NCT01054443|11000274|FG000|NOT COMPLETED|Overall Study||0
9885771|NCT01054443|11000275|FG001|NOT COMPLETED|Overall Study||0
9885772|NCT01054443|11000276|FG002|NOT COMPLETED|Overall Study||0
9885773|NCT01054443|11000277|FG003|NOT COMPLETED|Overall Study||1
9885774|NCT01054456|11000290|FG000|STARTED|Overall Study||36
9885775|NCT01054456|11000290|FG000|COMPLETED|Overall Study||35
9885776|NCT01054456|11000290|FG000|NOT COMPLETED|Overall Study||1
9885777|NCT01054560|11000296|FG000|STARTED|Overall Study||58
9885778|NCT01054560|11000297|FG001|STARTED|Overall Study||55
10109189|NCT02473471|11239787|FG000|Randomized Not Treated|Overall Study||2
10109190|NCT02473471|11239787|FG000|COMPLETED|Overall Study||32
9885779|NCT01054560|11000296|FG000|COMPLETED|Overall Study||45
9885780|NCT01054560|11000297|FG001|COMPLETED|Overall Study||27
9885781|NCT01054560|11000296|FG000|NOT COMPLETED|Overall Study||13
9885782|NCT01054560|11000297|FG001|NOT COMPLETED|Overall Study||28
9885783|NCT01054573|11000309|FG000|STARTED|Overall Study||9
9885784|NCT01054573|11000310|FG001|STARTED|Overall Study||32
9885785|NCT01054573|11000311|FG002|STARTED|Overall Study||22
9885786|NCT01054573|11000312|FG003|STARTED|Overall Study||27
9885787|NCT01054573|11000309|FG000|COMPLETED|Overall Study||8
9885788|NCT01054573|11000310|FG001|COMPLETED|Overall Study||28
9885789|NCT01054573|11000311|FG002|COMPLETED|Overall Study||19
9885790|NCT01054573|11000312|FG003|COMPLETED|Overall Study||25
9885791|NCT01054573|11000309|FG000|NOT COMPLETED|Overall Study||1
9885792|NCT01054573|11000310|FG001|NOT COMPLETED|Overall Study||4
9885793|NCT01054573|11000311|FG002|NOT COMPLETED|Overall Study||3
9885794|NCT01054573|11000312|FG003|NOT COMPLETED|Overall Study||2
9885795|NCT01054586|11000335|FG000|STARTED|Overall Study||43
9885796|NCT01054586|11000336|FG001|STARTED|Overall Study||15
9885797|NCT01054586|11000337|FG002|STARTED|Overall Study||8
9885798|NCT01054586|11000338|FG003|STARTED|Overall Study||101
9885799|NCT01054586|11000335|FG000|COMPLETED|Overall Study||43
9885800|NCT01054586|11000336|FG001|COMPLETED|Overall Study||15
9885801|NCT01054586|11000337|FG002|COMPLETED|Overall Study||8
9885802|NCT01054586|11000338|FG003|COMPLETED|Overall Study||101
9885803|NCT01054586|11000335|FG000|NOT COMPLETED|Overall Study||0
9885804|NCT01054586|11000336|FG001|NOT COMPLETED|Overall Study||0
9885805|NCT01054586|11000337|FG002|NOT COMPLETED|Overall Study||0
9885806|NCT01054586|11000338|FG003|NOT COMPLETED|Overall Study||0
9885807|NCT01054599|11000360|FG000|STARTED|Overall Study||13
9885808|NCT01054599|11000361|FG001|STARTED|Overall Study||16
9885809|NCT01054599|11000360|FG000|COMPLETED|Overall Study||9
9885810|NCT01054599|11000361|FG001|COMPLETED|Overall Study||9
9885811|NCT01054599|11000360|FG000|NOT COMPLETED|Overall Study||4
9885812|NCT01054599|11000361|FG001|NOT COMPLETED|Overall Study||7
9885813|NCT01054625|11000370|FG000|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
9885814|NCT01054625|11000371|FG001|STARTED|Overall Study||12
9885815|NCT01054625|11000372|FG002|STARTED|Overall Study||10
9885816|NCT01054625|11000370|FG000|COMPLETED|Overall Study||6
9885817|NCT01054625|11000371|FG001|COMPLETED|Overall Study||9
9885818|NCT01054625|11000372|FG002|COMPLETED|Overall Study||9
9885819|NCT01054625|11000370|FG000|NOT COMPLETED|Overall Study||2
9885820|NCT01054625|11000371|FG001|NOT COMPLETED|Overall Study||3
9885821|NCT01054625|11000372|FG002|NOT COMPLETED|Overall Study||1
9885822|NCT01054703|11000380|FG000|STARTED|Overall Study||14
9885823|NCT01054703|11000380|FG000|COMPLETED|Overall Study||14
9885824|NCT01054703|11000380|FG000|NOT COMPLETED|Overall Study||0
9885825|NCT01054729|11000388|FG000|STARTED|Overall Study||16
9885826|NCT01054729|11000389|FG001|STARTED|Overall Study||19
9885827|NCT01054729|11000390|FG002|STARTED|Overall Study||15
9885828|NCT01054729|11000391|FG003|STARTED|Overall Study||14
9885829|NCT01054729|11000388|FG000|Randomized and Treated|Overall Study||16
9885830|NCT01054729|11000389|FG001|Randomized and Treated|Overall Study||18
9885831|NCT01054729|11000390|FG002|Randomized and Treated|Overall Study||15
9885832|NCT01054729|11000391|FG003|Randomized and Treated|Overall Study||14
9885833|NCT01054729|11000388|FG000|COMPLETED|Overall Study||12
9885834|NCT01054729|11000389|FG001|COMPLETED|Overall Study||14
9885835|NCT01054729|11000390|FG002|COMPLETED|Overall Study||9
9885836|NCT01054729|11000391|FG003|COMPLETED|Overall Study||11
9885837|NCT01054729|11000388|FG000|NOT COMPLETED|Overall Study||4
9885838|NCT01054729|11000389|FG001|NOT COMPLETED|Overall Study||5
9885839|NCT01054729|11000390|FG002|NOT COMPLETED|Overall Study||6
9885840|NCT01054729|11000391|FG003|NOT COMPLETED|Overall Study||3
9885841|NCT01054742|11000401|FG000|STARTED|Overall Study||2
9885842|NCT01054742|11000401|FG000|COMPLETED|Overall Study||2
9885843|NCT01054742|11000401|FG000|NOT COMPLETED|Overall Study||0
9885844|NCT01054768|11000407|FG000|STARTED|Overall Study||17
9885845|NCT01054768|11000408|FG001|STARTED|Overall Study||20
9885846|NCT01054768|11000407|FG000|COMPLETED|Overall Study||9
9885847|NCT01054768|11000408|FG001|COMPLETED|Overall Study||17
9885848|NCT01054768|11000407|FG000|NOT COMPLETED|Overall Study||8
9885849|NCT01054768|11000408|FG001|NOT COMPLETED|Overall Study||3
9885850|NCT01054820|11000414|FG000|STARTED|Overall Study||123
9885851|NCT01054820|11000414|FG000|COMPLETED|Overall Study||121
9885852|NCT01054820|11000414|FG000|NOT COMPLETED|Overall Study||2
9885853|NCT01054846|11000420|FG000|STARTED|Overall Study||322
9885854|NCT01054846|11000421|FG001|STARTED|Overall Study||68
9885855|NCT01054846|11000420|FG000|COMPLETED|Overall Study||246
9885856|NCT01054846|11000421|FG001|COMPLETED|Overall Study||51
9885857|NCT01054846|11000420|FG000|NOT COMPLETED|Overall Study||76
9885858|NCT01054846|11000421|FG001|NOT COMPLETED|Overall Study||17
9885859|NCT01054885|11000432|FG000|STARTED|2-week, Single-blind Run-In Period||1577
9885860|NCT01054885|11000433|FG001|STARTED|2-week, Single-blind Run-In Period||0
9885861|NCT01054885|11000434|FG002|STARTED|2-week, Single-blind Run-In Period||0
9885862|NCT01054885|11000435|FG003|STARTED|2-week, Single-blind Run-In Period||0
9885863|NCT01054885|11000436|FG004|STARTED|2-week, Single-blind Run-In Period||0
9885864|NCT01054885|11000437|FG005|STARTED|2-week, Single-blind Run-In Period||0
9885865|NCT01054885|11000438|FG006|STARTED|2-week, Single-blind Run-In Period||0
9885866|NCT01054885|11000432|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226
9885867|NCT01054885|11000433|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
9885868|NCT01054885|11000434|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
9885869|NCT01054885|11000435|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
9885870|NCT01054885|11000436|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
9885871|NCT01054885|11000437|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
9885872|NCT01054885|11000438|FG006|COMPLETED|2-week, Single-blind Run-In Period||0
9885873|NCT01054885|11000432|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351
9885874|NCT01054885|11000433|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885875|NCT01054885|11000434|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885876|NCT01054885|11000435|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885877|NCT01054885|11000436|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885878|NCT01054885|11000437|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885879|NCT01054885|11000438|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9885880|NCT01054885|11000432|FG000|STARTED|24-week, Double-blind Treatment Period||0
9885881|NCT01054885|11000433|FG001|STARTED|24-week, Double-blind Treatment Period||205
9885882|NCT01054885|11000434|FG002|STARTED|24-week, Double-blind Treatment Period||204
9885883|NCT01054885|11000435|FG003|STARTED|24-week, Double-blind Treatment Period||203
9885884|NCT01054885|11000436|FG004|STARTED|24-week, Double-blind Treatment Period||203
9885885|NCT01054885|11000437|FG005|STARTED|24-week, Double-blind Treatment Period||204
9885886|NCT01054885|11000438|FG006|STARTED|24-week, Double-blind Treatment Period||205
9885887|NCT01054885|11000432|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
9885888|NCT01054885|11000433|FG001|COMPLETED|24-week, Double-blind Treatment Period||146
9885889|NCT01054885|11000434|FG002|COMPLETED|24-week, Double-blind Treatment Period||155
9885890|NCT01054885|11000435|FG003|COMPLETED|24-week, Double-blind Treatment Period||160
9885891|NCT01054885|11000436|FG004|COMPLETED|24-week, Double-blind Treatment Period||161
9885892|NCT01054885|11000437|FG005|COMPLETED|24-week, Double-blind Treatment Period||144
9885893|NCT01054885|11000438|FG006|COMPLETED|24-week, Double-blind Treatment Period||158
9885894|NCT01054885|11000432|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
9885895|NCT01054885|11000433|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59
9885896|NCT01054885|11000434|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49
9885897|NCT01054885|11000435|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43
9885898|NCT01054885|11000436|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42
9885899|NCT01054885|11000437|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60
9885900|NCT01054885|11000438|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47
9885901|NCT01054911|11000453|FG000|STARTED|Overall Study||5
9885902|NCT01054911|11000453|FG000|COMPLETED|Overall Study||5
9885903|NCT01054911|11000453|FG000|NOT COMPLETED|Overall Study||0
9885904|NCT01054976|11000459|FG000|STARTED|Overall Study||92
9885905|NCT01054976|11000459|FG000|COMPLETED|Overall Study||57
9885906|NCT01054976|11000459|FG000|NOT COMPLETED|Overall Study||35
9885907|NCT01055028|11000465|FG000|STARTED|Screening||9
9885908|NCT01055028|11000466|FG001|STARTED|Screening||9
9885909|NCT01055028|11000465|FG000|COMPLETED|Screening||8
9885910|NCT01055028|11000466|FG001|COMPLETED|Screening||8
9885911|NCT01055028|11000465|FG000|NOT COMPLETED|Screening||1
9885912|NCT01055028|11000466|FG001|NOT COMPLETED|Screening||1
9885913|NCT01055028|11000465|FG000|STARTED|Treatment Cycles 1 to 3||8
9885914|NCT01055028|11000466|FG001|STARTED|Treatment Cycles 1 to 3||8
9885915|NCT01055028|11000465|FG000|COMPLETED|Treatment Cycles 1 to 3||6
10109191|NCT02473471|11239787|FG000|NOT COMPLETED|Overall Study||3
10109192|NCT02473510|11239799|FG000|STARTED|Overall Study||60
9885916|NCT01055028|11000466|FG001|COMPLETED|Treatment Cycles 1 to 3||5
9885917|NCT01055028|11000465|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2
9885918|NCT01055028|11000466|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3
9885919|NCT01055028|11000465|FG000|STARTED|Inter-treatment Period||6
9885920|NCT01055028|11000466|FG001|STARTED|Inter-treatment Period||5
9885921|NCT01055028|11000465|FG000|COMPLETED|Inter-treatment Period||6
9885922|NCT01055028|11000466|FG001|COMPLETED|Inter-treatment Period||2
9885923|NCT01055028|11000465|FG000|NOT COMPLETED|Inter-treatment Period||0
9885924|NCT01055028|11000466|FG001|NOT COMPLETED|Inter-treatment Period||3
9885925|NCT01055028|11000465|FG000|STARTED|Treatment Cycles 4 to 6||6
9885926|NCT01055028|11000466|FG001|STARTED|Treatment Cycles 4 to 6||2
9885927|NCT01055028|11000465|FG000|COMPLETED|Treatment Cycles 4 to 6||6
9885928|NCT01055028|11000466|FG001|COMPLETED|Treatment Cycles 4 to 6||2
9885929|NCT01055028|11000465|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0
9885930|NCT01055028|11000466|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0
9885931|NCT01055067|11000476|FG000|STARTED|Overall Study||27
9885932|NCT01055067|11000476|FG000|COMPLETED|Overall Study||27
9885933|NCT01055067|11000476|FG000|NOT COMPLETED|Overall Study||0
9885934|NCT01055132|11000482|FG000|STARTED|Period 1 (5-9 Days)||36
9885935|NCT01055132|11000483|FG001|STARTED|Period 1 (5-9 Days)||33
9885936|NCT01055132|11000482|FG000|COMPLETED|Period 1 (5-9 Days)||35
9885937|NCT01055132|11000483|FG001|COMPLETED|Period 1 (5-9 Days)||33
9885938|NCT01055132|11000482|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1
9885939|NCT01055132|11000483|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0
9885940|NCT01055132|11000482|FG000|STARTED|Period 2 (5-9 Days)||35
9885941|NCT01055132|11000483|FG001|STARTED|Period 2 (5-9 Days)||33
9885942|NCT01055132|11000482|FG000|COMPLETED|Period 2 (5-9 Days)||35
9885943|NCT01055132|11000483|FG001|COMPLETED|Period 2 (5-9 Days)||32
9885944|NCT01055132|11000482|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0
9885945|NCT01055132|11000483|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1
10008242|NCT01755949|11130559|FG004|STARTED|Overall Study||4
10008243|NCT01755949|11130560|FG005|STARTED|Overall Study||3
10008244|NCT01755949|11130555|FG000|COMPLETED|Overall Study||5
10008245|NCT01755949|11130556|FG001|COMPLETED|Overall Study||5
10008246|NCT01755949|11130557|FG002|COMPLETED|Overall Study||4
10008247|NCT01755949|11130558|FG003|COMPLETED|Overall Study||5
10008248|NCT01755949|11130559|FG004|COMPLETED|Overall Study||4
10008249|NCT01755949|11130560|FG005|COMPLETED|Overall Study||3
10008250|NCT01755949|11130555|FG000|NOT COMPLETED|Overall Study||0
10008251|NCT01755949|11130556|FG001|NOT COMPLETED|Overall Study||0
10008252|NCT01755949|11130557|FG002|NOT COMPLETED|Overall Study||0
10008253|NCT01755949|11130558|FG003|NOT COMPLETED|Overall Study||0
10008254|NCT01755949|11130559|FG004|NOT COMPLETED|Overall Study||0
9885946|NCT01055171|11000495|FG000|STARTED|Overall Study|Randomized to receive medication.|29
9885947|NCT01055171|11000496|FG001|STARTED|Overall Study|Randomized to receive placebo.|28
9885948|NCT01055171|11000495|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
10008255|NCT01755949|11130560|FG005|NOT COMPLETED|Overall Study||0
10109193|NCT02473510|11239800|FG001|STARTED|Overall Study||240
9885949|NCT01055171|11000496|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
9885950|NCT01055171|11000495|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
9885951|NCT01055171|11000496|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
9885952|NCT01055171|11000495|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
9885953|NCT01055171|11000496|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
9885954|NCT01055171|11000495|FG000|NOT COMPLETED|Overall Study||11
9885955|NCT01055171|11000496|FG001|NOT COMPLETED|Overall Study||7
9885956|NCT01055184|11000502|FG000|STARTED|Overall Study||34
9885957|NCT01055184|11000502|FG000|COMPLETED|Overall Study||34
9885958|NCT01055184|11000502|FG000|NOT COMPLETED|Overall Study||0
9885959|NCT01055197|11000508|FG000|STARTED|Overall Study||51
9885960|NCT01055197|11000509|FG001|STARTED|Overall Study||46
9885961|NCT01055197|11000508|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
9885962|NCT01055197|11000509|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
9885963|NCT01055197|11000508|FG000|NOT COMPLETED|Overall Study||9
9885964|NCT01055197|11000509|FG001|NOT COMPLETED|Overall Study||2
9885965|NCT01055223|11000515|FG000|STARTED|Overall Study||98483
9885966|NCT01055223|11000515|FG000|COMPLETED|Overall Study||98483
9885967|NCT01055223|11000515|FG000|NOT COMPLETED|Overall Study||0
9885968|NCT01055262|11000528|FG000|STARTED|Overall Study||169
9885969|NCT01055262|11000528|FG000|COMPLETED|Overall Study||160
9885970|NCT01055262|11000528|FG000|NOT COMPLETED|Overall Study||9
9885971|NCT01055314|11000534|FG000|STARTED|Overall Study||100
9885972|NCT01055314|11000535|FG001|STARTED|Overall Study||75
9885973|NCT01055314|11000534|FG000|COMPLETED|Overall Study||55
9885974|NCT01055314|11000535|FG001|COMPLETED|Overall Study||37
9885975|NCT01055314|11000534|FG000|NOT COMPLETED|Overall Study||45
9885976|NCT01055314|11000535|FG001|NOT COMPLETED|Overall Study||38
9885977|NCT01055457|11000552|FG000|STARTED|Overall Study||40
9885978|NCT01055457|11000553|FG001|STARTED|Overall Study||40
9885979|NCT01055457|11000554|FG002|STARTED|Overall Study||38
9885980|NCT01055457|11000555|FG003|STARTED|Overall Study||40
9885981|NCT01055457|11000556|FG004|STARTED|Overall Study||41
9885982|NCT01055457|11000557|FG005|STARTED|Overall Study||18
9885983|NCT01055457|11000558|FG006|STARTED|Overall Study||19
9885984|NCT01055457|11000559|FG007|STARTED|Overall Study||19
9885985|NCT01055457|11000560|FG008|STARTED|Overall Study||20
9885986|NCT01055457|11000561|FG009|STARTED|Overall Study||20
9885987|NCT01055457|11000552|FG000|COMPLETED|Overall Study||39
9885988|NCT01055457|11000553|FG001|COMPLETED|Overall Study||39
9885989|NCT01055457|11000554|FG002|COMPLETED|Overall Study||36
9885990|NCT01055457|11000555|FG003|COMPLETED|Overall Study||37
9885991|NCT01055457|11000556|FG004|COMPLETED|Overall Study||38
9885992|NCT01055457|11000557|FG005|COMPLETED|Overall Study||15
10008256|NCT01756053|11130574|FG000|STARTED|Period 1 (10 Days)||8
10008257|NCT01756053|11130575|FG001|STARTED|Period 1 (10 Days)||9
10008258|NCT01756053|11130574|FG000|COMPLETED|Period 1 (10 Days)||7
10008259|NCT01756053|11130575|FG001|COMPLETED|Period 1 (10 Days)||8
10008260|NCT01756053|11130574|FG000|NOT COMPLETED|Period 1 (10 Days)||1
9885993|NCT01055457|11000558|FG006|COMPLETED|Overall Study||18
9885994|NCT01055457|11000559|FG007|COMPLETED|Overall Study||18
9885995|NCT01055457|11000560|FG008|COMPLETED|Overall Study||20
9885996|NCT01055457|11000561|FG009|COMPLETED|Overall Study||19
9885997|NCT01055457|11000552|FG000|NOT COMPLETED|Overall Study||1
9885998|NCT01055457|11000553|FG001|NOT COMPLETED|Overall Study||1
9885999|NCT01055457|11000554|FG002|NOT COMPLETED|Overall Study||2
9886000|NCT01055457|11000555|FG003|NOT COMPLETED|Overall Study||3
9886001|NCT01055457|11000556|FG004|NOT COMPLETED|Overall Study||3
9886002|NCT01055457|11000557|FG005|NOT COMPLETED|Overall Study||3
9886003|NCT01055457|11000558|FG006|NOT COMPLETED|Overall Study||1
9886004|NCT01055457|11000559|FG007|NOT COMPLETED|Overall Study||1
9886005|NCT01055457|11000560|FG008|NOT COMPLETED|Overall Study||0
9886006|NCT01055457|11000561|FG009|NOT COMPLETED|Overall Study||1
9886007|NCT01055496|11000585|FG000|STARTED|Overall Study||48
9886008|NCT01055496|11000586|FG001|STARTED|Overall Study||55
9886009|NCT01055496|11000585|FG000|COMPLETED|Overall Study||33
9886010|NCT01055496|11000586|FG001|COMPLETED|Overall Study||25
9886011|NCT01055496|11000585|FG000|NOT COMPLETED|Overall Study||15
9886012|NCT01055496|11000586|FG001|NOT COMPLETED|Overall Study||30
9886013|NCT01055613|11000615|FG000|STARTED|Overall Study||200
9886014|NCT01055613|11000616|FG001|STARTED|Overall Study||100
9886015|NCT01055613|11000615|FG000|COMPLETED|Overall Study||191
9886016|NCT01055613|11000616|FG001|COMPLETED|Overall Study||96
9886017|NCT01055613|11000615|FG000|NOT COMPLETED|Overall Study||9
9886018|NCT01055613|11000616|FG001|NOT COMPLETED|Overall Study||4
9886019|NCT01055639|11000624|FG000|STARTED|Overall Study||66
9886020|NCT01055639|11000625|FG001|STARTED|Overall Study||60
9886021|NCT01055639|11000624|FG000|COMPLETED|Overall Study||45
9886022|NCT01055639|11000625|FG001|COMPLETED|Overall Study||31
9886023|NCT01055639|11000624|FG000|NOT COMPLETED|Overall Study||21
9886024|NCT01055639|11000625|FG001|NOT COMPLETED|Overall Study||29
10008261|NCT01756053|11130575|FG001|NOT COMPLETED|Period 1 (10 Days)||1
10008262|NCT01756053|11130574|FG000|STARTED|Washout Period (~21 Days)||7
10008263|NCT01756053|11130575|FG001|STARTED|Washout Period (~21 Days)||8
10008264|NCT01756053|11130574|FG000|COMPLETED|Washout Period (~21 Days)||7
9886025|NCT01055704|11000635|FG000|STARTED|Overall Study||16
9886026|NCT01055704|11000636|FG001|STARTED|Overall Study||8
9886027|NCT01055704|11000637|FG002|STARTED|Overall Study||16
9886028|NCT01055704|11000638|FG003|STARTED|Overall Study||8
9886029|NCT01055704|11000635|FG000|COMPLETED|Overall Study||16
9886030|NCT01055704|11000636|FG001|COMPLETED|Overall Study||8
9886031|NCT01055704|11000637|FG002|COMPLETED|Overall Study||16
9886032|NCT01055704|11000638|FG003|COMPLETED|Overall Study||8
9886033|NCT01055704|11000635|FG000|NOT COMPLETED|Overall Study||0
9886034|NCT01055704|11000636|FG001|NOT COMPLETED|Overall Study||0
9886035|NCT01055704|11000637|FG002|NOT COMPLETED|Overall Study||0
9886036|NCT01055704|11000638|FG003|NOT COMPLETED|Overall Study||0
9886037|NCT01055769|11000648|FG000|STARTED|First Intervention||10
9886038|NCT01055769|11000649|FG001|STARTED|First Intervention||10
9886039|NCT01055769|11000648|FG000|COMPLETED|First Intervention||10
9886040|NCT01055769|11000649|FG001|COMPLETED|First Intervention||10
9886041|NCT01055769|11000648|FG000|NOT COMPLETED|First Intervention||0
9886042|NCT01055769|11000649|FG001|NOT COMPLETED|First Intervention||0
9886043|NCT01055769|11000648|FG000|STARTED|Washout Period of Atleast 4 Days||10
9886044|NCT01055769|11000649|FG001|STARTED|Washout Period of Atleast 4 Days||10
9886045|NCT01055769|11000648|FG000|COMPLETED|Washout Period of Atleast 4 Days||10
9886046|NCT01055769|11000649|FG001|COMPLETED|Washout Period of Atleast 4 Days||10
9886047|NCT01055769|11000648|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0
9886048|NCT01055769|11000649|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0
9886049|NCT01055769|11000648|FG000|STARTED|Second Intervention||10
9886050|NCT01055769|11000649|FG001|STARTED|Second Intervention||10
9886051|NCT01055769|11000648|FG000|COMPLETED|Second Intervention||10
9886052|NCT01055769|11000649|FG001|COMPLETED|Second Intervention||10
9886053|NCT01055769|11000648|FG000|NOT COMPLETED|Second Intervention||0
9886054|NCT01055769|11000649|FG001|NOT COMPLETED|Second Intervention||0
9886055|NCT01055782|11000658|FG000|STARTED|Overall Study||555
9886056|NCT01055782|11000659|FG001|STARTED|Overall Study||449
9886057|NCT01055782|11000658|FG000|COMPLETED|Overall Study||555
9886058|NCT01055782|11000659|FG001|COMPLETED|Overall Study||449
9886059|NCT01055782|11000658|FG000|NOT COMPLETED|Overall Study||0
9886060|NCT01055782|11000659|FG001|NOT COMPLETED|Overall Study||0
9886061|NCT01055834|11000669|FG000|STARTED|Treatment Period I||21
9886062|NCT01055834|11000670|FG001|STARTED|Treatment Period I||21
9886063|NCT01055834|11000669|FG000|COMPLETED|Treatment Period I||20
9886064|NCT01055834|11000670|FG001|COMPLETED|Treatment Period I||21
9886065|NCT01055834|11000669|FG000|NOT COMPLETED|Treatment Period I||1
9886066|NCT01055834|11000670|FG001|NOT COMPLETED|Treatment Period I||0
9886067|NCT01055834|11000669|FG000|STARTED|Treatment Period II||20
9886068|NCT01055834|11000670|FG001|STARTED|Treatment Period II||21
9886069|NCT01055834|11000669|FG000|COMPLETED|Treatment Period II||20
9886070|NCT01055834|11000670|FG001|COMPLETED|Treatment Period II||21
9886071|NCT01055834|11000669|FG000|NOT COMPLETED|Treatment Period II||0
9886072|NCT01055834|11000670|FG001|NOT COMPLETED|Treatment Period II||0
9886073|NCT01055834|11000669|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
9886074|NCT01055834|11000670|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
9886075|NCT01055834|11000669|FG000|COMPLETED|Treatment Period III||0
9886076|NCT01055834|11000670|FG001|COMPLETED|Treatment Period III||14
9886077|NCT01055834|11000669|FG000|NOT COMPLETED|Treatment Period III||0
9886078|NCT01055834|11000670|FG001|NOT COMPLETED|Treatment Period III||0
9886079|NCT01055886|11000681|FG000|STARTED|Overall Study||33
9886080|NCT01055886|11000682|FG001|STARTED|Overall Study||32
9886081|NCT01055886|11000681|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
9886082|NCT01055886|11000682|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31
9886083|NCT01055886|11000681|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
9886084|NCT01055886|11000682|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
9886085|NCT01055886|11000681|FG000|NOT COMPLETED|Overall Study||5
9886086|NCT01055886|11000682|FG001|NOT COMPLETED|Overall Study||11
9954403|NCT01431794|11073239|FG000|COMPLETED|Overall Study||13
9954404|NCT01431794|11073240|FG001|COMPLETED|Overall Study|not started due to early study's termination|0
9954405|NCT01431794|11073241|FG002|COMPLETED|Overall Study|not started due to early study's termination|0
9954406|NCT01431794|11073242|FG003|COMPLETED|Overall Study|not started due to early study's termination|0
9954407|NCT01431794|11073243|FG004|COMPLETED|Overall Study|not started due to early study's termination|0
9954408|NCT01431794|11073239|FG000|NOT COMPLETED|Overall Study||0
9954409|NCT01431794|11073240|FG001|NOT COMPLETED|Overall Study||0
9954410|NCT01431794|11073241|FG002|NOT COMPLETED|Overall Study||0
9954411|NCT01431794|11073242|FG003|NOT COMPLETED|Overall Study||0
9954412|NCT01431794|11073243|FG004|NOT COMPLETED|Overall Study||0
9954413|NCT01431846|11073258|FG000|STARTED|Overall Study||8
9954414|NCT01431846|11073259|FG001|STARTED|Overall Study||3
9954415|NCT01431846|11073260|FG002|STARTED|Overall Study||8
9954416|NCT01431846|11073258|FG000|COMPLETED|Overall Study||8
9954417|NCT01431846|11073259|FG001|COMPLETED|Overall Study||3
9954418|NCT01431846|11073260|FG002|COMPLETED|Overall Study||8
9954419|NCT01431846|11073258|FG000|NOT COMPLETED|Overall Study||0
9954420|NCT01431846|11073259|FG001|NOT COMPLETED|Overall Study||0
9954421|NCT01431846|11073260|FG002|NOT COMPLETED|Overall Study||0
9954422|NCT01431950|11073270|FG000|STARTED|Overall Study||119
9954423|NCT01431950|11073271|FG001|STARTED|Overall Study||119
9954424|NCT01431950|11073270|FG000|COMPLETED|Overall Study||100
9886087|NCT01056016|11000690|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
9886088|NCT01056016|11000691|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
9886089|NCT01056016|11000690|FG000|COMPLETED|Overall Study||20
9886090|NCT01056016|11000691|FG001|COMPLETED|Overall Study||26
9886091|NCT01056016|11000690|FG000|NOT COMPLETED|Overall Study||2
9886092|NCT01056016|11000691|FG001|NOT COMPLETED|Overall Study||1
9886093|NCT01056107|11000701|FG000|STARTED|Overall Study||11
9886094|NCT01056107|11000702|FG001|STARTED|Overall Study||11
9886095|NCT01056107|11000703|FG002|STARTED|Overall Study||12
9886096|NCT01056107|11000704|FG003|STARTED|Overall Study||12
9886097|NCT01056107|11000701|FG000|COMPLETED|Overall Study||11
10008265|NCT01756053|11130575|FG001|COMPLETED|Washout Period (~21 Days)||8
10008266|NCT01756053|11130574|FG000|NOT COMPLETED|Washout Period (~21 Days)||0
10008267|NCT01756053|11130575|FG001|NOT COMPLETED|Washout Period (~21 Days)||0
10008268|NCT01756053|11130574|FG000|STARTED|Period 2 (10 Days)||7
10109194|NCT02473510|11239799|FG000|COMPLETED|Overall Study||59
10109195|NCT02473510|11239800|FG001|COMPLETED|Overall Study||238
9886098|NCT01056107|11000702|FG001|COMPLETED|Overall Study||10
9886099|NCT01056107|11000703|FG002|COMPLETED|Overall Study||9
9886100|NCT01056107|11000704|FG003|COMPLETED|Overall Study||12
9886101|NCT01056107|11000701|FG000|NOT COMPLETED|Overall Study||0
9886102|NCT01056107|11000702|FG001|NOT COMPLETED|Overall Study||1
9886103|NCT01056107|11000703|FG002|NOT COMPLETED|Overall Study||3
9886104|NCT01056107|11000704|FG003|NOT COMPLETED|Overall Study||0
9886105|NCT01056198|11000716|FG000|STARTED|Overall Study||24
9886106|NCT01056198|11000717|FG001|STARTED|Overall Study||24
9886107|NCT01056198|11000716|FG000|COMPLETED|Overall Study||24
9886108|NCT01056198|11000717|FG001|COMPLETED|Overall Study||24
9886109|NCT01056198|11000716|FG000|NOT COMPLETED|Overall Study||0
9886110|NCT01056198|11000717|FG001|NOT COMPLETED|Overall Study||0
9886111|NCT01056263|11000725|FG000|STARTED|Overall Study||52
9886112|NCT01056263|11000725|FG000|COMPLETED|Overall Study||0
9886113|NCT01056263|11000725|FG000|NOT COMPLETED|Overall Study||52
9886114|NCT01056276|11000731|FG000|STARTED|Treatment Period-Cycles 1-8||18
9886115|NCT01056276|11000732|FG001|STARTED|Treatment Period-Cycles 1-8||41
9886116|NCT01056276|11000731|FG000|COMPLETED|Treatment Period-Cycles 1-8||5
9886117|NCT01056276|11000732|FG001|COMPLETED|Treatment Period-Cycles 1-8||33
9886118|NCT01056276|11000731|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13
9886119|NCT01056276|11000732|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8
9886120|NCT01056276|11000731|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
9886121|NCT01056276|11000732|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
9886122|NCT01056276|11000731|FG000|COMPLETED|Maintenance Therapy||0
9886123|NCT01056276|11000732|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
9886124|NCT01056276|11000731|FG000|NOT COMPLETED|Maintenance Therapy||0
9886125|NCT01056276|11000732|FG001|NOT COMPLETED|Maintenance Therapy||28
9886126|NCT01056289|11000743|FG000|STARTED|Open-label Phase||480
9886127|NCT01056289|11000744|FG001|STARTED|Open-label Phase||0
9886128|NCT01056289|11000745|FG002|STARTED|Open-label Phase||0
9886129|NCT01056289|11000746|FG003|STARTED|Open-label Phase||0
9886130|NCT01056289|11000743|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
9886131|NCT01056289|11000744|FG001|COMPLETED|Open-label Phase||0
9886132|NCT01056289|11000745|FG002|COMPLETED|Open-label Phase||0
9886133|NCT01056289|11000746|FG003|COMPLETED|Open-label Phase||0
9886134|NCT01056289|11000743|FG000|NOT COMPLETED|Open-label Phase||119
9886135|NCT01056289|11000744|FG001|NOT COMPLETED|Open-label Phase||0
9886136|NCT01056289|11000745|FG002|NOT COMPLETED|Open-label Phase||0
9886137|NCT01056289|11000746|FG003|NOT COMPLETED|Open-label Phase||0
9886138|NCT01056289|11000743|FG000|STARTED|Double-blind Phase||0
9886139|NCT01056289|11000744|FG001|STARTED|Double-blind Phase||73
9886140|NCT01056289|11000745|FG002|STARTED|Double-blind Phase||140
9886141|NCT01056289|11000746|FG003|STARTED|Double-blind Phase||148
9886142|NCT01056289|11000743|FG000|COMPLETED|Double-blind Phase||0
9886143|NCT01056289|11000744|FG001|COMPLETED|Double-blind Phase||69
9886144|NCT01056289|11000745|FG002|COMPLETED|Double-blind Phase||127
9886145|NCT01056289|11000746|FG003|COMPLETED|Double-blind Phase||138
10008269|NCT01756053|11130575|FG001|STARTED|Period 2 (10 Days)||8
9886146|NCT01056289|11000743|FG000|NOT COMPLETED|Double-blind Phase||0
9886147|NCT01056289|11000744|FG001|NOT COMPLETED|Double-blind Phase||4
9886148|NCT01056289|11000745|FG002|NOT COMPLETED|Double-blind Phase||13
9886149|NCT01056289|11000746|FG003|NOT COMPLETED|Double-blind Phase||10
9886150|NCT01056302|11000756|FG000|STARTED|Overall Study||3
9886151|NCT01056302|11000756|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
10008270|NCT01756053|11130574|FG000|COMPLETED|Period 2 (10 Days)||7
9886152|NCT01056302|11000756|FG000|NOT COMPLETED|Overall Study||0
9886153|NCT01056328|11000763|FG000|STARTED|Overall Study||164
9886154|NCT01056328|11000764|FG001|STARTED|Overall Study||160
9886155|NCT01056328|11000763|FG000|COMPLETED|Overall Study||147
9886156|NCT01056328|11000764|FG001|COMPLETED|Overall Study||144
10008271|NCT01756053|11130575|FG001|COMPLETED|Period 2 (10 Days)||6
10008272|NCT01756053|11130574|FG000|NOT COMPLETED|Period 2 (10 Days)||0
9886157|NCT01056328|11000763|FG000|NOT COMPLETED|Overall Study||17
9886158|NCT01056328|11000764|FG001|NOT COMPLETED|Overall Study||16
9886159|NCT01056341|11000778|FG000|STARTED|Overall Study||55
10008273|NCT01756053|11130575|FG001|NOT COMPLETED|Period 2 (10 Days)||2
10008274|NCT01756079|11130581|FG000|STARTED|Lead-in: Day 0 to Week 4||58
9886160|NCT01056341|11000779|FG001|STARTED|Overall Study||99
9886161|NCT01056341|11000780|FG002|STARTED|Overall Study||103
9886162|NCT01056341|11000781|FG003|STARTED|Overall Study||101
9886163|NCT01056341|11000782|FG004|STARTED|Overall Study||102
9886164|NCT01056341|11000778|FG000|Interim Analysis|Overall Study||25
9886165|NCT01056341|11000779|FG001|Interim Analysis|Overall Study||41
9886166|NCT01056341|11000780|FG002|Interim Analysis|Overall Study||41
9886167|NCT01056341|11000781|FG003|Interim Analysis|Overall Study||40
9886168|NCT01056341|11000782|FG004|Interim Analysis|Overall Study||43
10008275|NCT01756079|11130581|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58
10008276|NCT01756079|11130581|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
10008277|NCT01756079|11130581|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
10008278|NCT01756079|11130581|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
10008279|NCT01756079|11130581|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
10008280|NCT01756079|11130581|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
9886169|NCT01056341|11000778|FG000|COMPLETED|Overall Study||19
9886170|NCT01056341|11000779|FG001|COMPLETED|Overall Study||63
9886171|NCT01056341|11000780|FG002|COMPLETED|Overall Study||88
9886172|NCT01056341|11000781|FG003|COMPLETED|Overall Study||65
9886173|NCT01056341|11000782|FG004|COMPLETED|Overall Study||88
9886174|NCT01056341|11000778|FG000|NOT COMPLETED|Overall Study||36
9886175|NCT01056341|11000779|FG001|NOT COMPLETED|Overall Study||36
9886176|NCT01056341|11000780|FG002|NOT COMPLETED|Overall Study||15
9886177|NCT01056341|11000781|FG003|NOT COMPLETED|Overall Study||36
9886178|NCT01056341|11000782|FG004|NOT COMPLETED|Overall Study||14
9886179|NCT01056380|11000802|FG000|STARTED|Overall Study||37
9886180|NCT01056380|11000803|FG001|STARTED|Overall Study||42
9886181|NCT01056380|11000802|FG000|COMPLETED|Overall Study||35
9886182|NCT01056380|11000803|FG001|COMPLETED|Overall Study||39
9886183|NCT01056380|11000802|FG000|NOT COMPLETED|Overall Study||2
9886184|NCT01056380|11000803|FG001|NOT COMPLETED|Overall Study||3
9886185|NCT01056484|11000813|FG000|STARTED|Randomized Controlled Trial||64
9886186|NCT01056484|11000814|FG001|STARTED|Randomized Controlled Trial||59
9886187|NCT01056484|11000813|FG000|COMPLETED|Randomized Controlled Trial||57
9886188|NCT01056484|11000814|FG001|COMPLETED|Randomized Controlled Trial||58
9886189|NCT01056484|11000813|FG000|NOT COMPLETED|Randomized Controlled Trial||7
9886190|NCT01056484|11000814|FG001|NOT COMPLETED|Randomized Controlled Trial||1
9886191|NCT01056484|11000813|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
9886192|NCT01056484|11000814|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
9886193|NCT01056484|11000813|FG000|COMPLETED|Follow up - Non-randomized||57
9886194|NCT01056484|11000814|FG001|COMPLETED|Follow up - Non-randomized||56
9886195|NCT01056484|11000813|FG000|NOT COMPLETED|Follow up - Non-randomized||0
9886196|NCT01056484|11000814|FG001|NOT COMPLETED|Follow up - Non-randomized||2
9886197|NCT01056510|11000823|FG000|STARTED|Overall Study||178
9886198|NCT01056510|11000824|FG001|STARTED|Overall Study||179
9886199|NCT01056510|11000823|FG000|COMPLETED|Overall Study||124
9886200|NCT01056510|11000824|FG001|COMPLETED|Overall Study||115
9886201|NCT01056510|11000823|FG000|NOT COMPLETED|Overall Study||54
9886202|NCT01056510|11000824|FG001|NOT COMPLETED|Overall Study||64
9886203|NCT01056523|11000830|FG000|STARTED|Overall Study||4
9886204|NCT01056523|11000831|FG001|STARTED|Overall Study||3
9886205|NCT01056523|11000832|FG002|STARTED|Overall Study||5
9886206|NCT01056523|11000833|FG003|STARTED|Overall Study||6
9886207|NCT01056523|11000834|FG004|STARTED|Overall Study||3
9886208|NCT01056523|11000835|FG005|STARTED|Overall Study||3
9886209|NCT01056523|11000836|FG006|STARTED|Overall Study||5
9886210|NCT01056523|11000830|FG000|COMPLETED|Overall Study||3
9886211|NCT01056523|11000831|FG001|COMPLETED|Overall Study||3
9886212|NCT01056523|11000832|FG002|COMPLETED|Overall Study||3
9886213|NCT01056523|11000833|FG003|COMPLETED|Overall Study||3
9886214|NCT01056523|11000834|FG004|COMPLETED|Overall Study||3
9886215|NCT01056523|11000835|FG005|COMPLETED|Overall Study||3
9886216|NCT01056523|11000836|FG006|COMPLETED|Overall Study||4
9886217|NCT01056523|11000830|FG000|NOT COMPLETED|Overall Study||1
9886218|NCT01056523|11000831|FG001|NOT COMPLETED|Overall Study||0
9886219|NCT01056523|11000832|FG002|NOT COMPLETED|Overall Study||2
9886220|NCT01056523|11000833|FG003|NOT COMPLETED|Overall Study||3
9886221|NCT01056523|11000834|FG004|NOT COMPLETED|Overall Study||0
9886222|NCT01056523|11000835|FG005|NOT COMPLETED|Overall Study||0
9886223|NCT01056523|11000836|FG006|NOT COMPLETED|Overall Study||1
9886224|NCT01056536|11000844|FG000|STARTED|Overall Study||596
9886225|NCT01056536|11000845|FG001|STARTED|Overall Study||356
9886226|NCT01056536|11000846|FG002|STARTED|Overall Study||729
9886227|NCT01056536|11000844|FG000|COMPLETED|Overall Study||394
9886228|NCT01056536|11000845|FG001|COMPLETED|Overall Study||240
9886229|NCT01056536|11000846|FG002|COMPLETED|Overall Study||481
9886230|NCT01056536|11000844|FG000|NOT COMPLETED|Overall Study||202
9886231|NCT01056536|11000845|FG001|NOT COMPLETED|Overall Study||116
9886232|NCT01056536|11000846|FG002|NOT COMPLETED|Overall Study||248
9886233|NCT01056601|11000854|FG000|STARTED|Overall Study||7
9886234|NCT01056601|11000854|FG000|COMPLETED|Overall Study||7
9886235|NCT01056601|11000854|FG000|NOT COMPLETED|Overall Study||0
9886236|NCT01056640|11000860|FG000|STARTED|Overall Study||102
9886237|NCT01056640|11000861|FG001|STARTED|Overall Study||103
9886238|NCT01056640|11000860|FG000|COMPLETED|Overall Study||76
9886239|NCT01056640|11000861|FG001|COMPLETED|Overall Study||91
9886240|NCT01056640|11000860|FG000|NOT COMPLETED|Overall Study||26
9886241|NCT01056640|11000861|FG001|NOT COMPLETED|Overall Study||12
9886242|NCT01056653|11000870|FG000|STARTED|Overall Study||46
9886243|NCT01056653|11000871|FG001|STARTED|Overall Study||23
9886244|NCT01056653|11000872|FG002|STARTED|Overall Study||44
9886245|NCT01056653|11000870|FG000|COMPLETED|Overall Study||46
9886246|NCT01056653|11000871|FG001|COMPLETED|Overall Study||23
9886247|NCT01056653|11000872|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
9886248|NCT01056653|11000870|FG000|NOT COMPLETED|Overall Study||0
9886249|NCT01056653|11000871|FG001|NOT COMPLETED|Overall Study||0
9886250|NCT01056653|11000872|FG002|NOT COMPLETED|Overall Study||2
9886251|NCT01056718|11000881|FG000|STARTED|Overall Study||53
9886252|NCT01056718|11000881|FG000|COMPLETED|Overall Study||50
9886253|NCT01056718|11000881|FG000|NOT COMPLETED|Overall Study||3
9886254|NCT01056822|11000888|FG000|STARTED|Overall Study||47
9886255|NCT01056822|11000889|FG001|STARTED|Overall Study||42
9886256|NCT01056822|11000888|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43
9886257|NCT01056822|11000889|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38
9886258|NCT01056822|11000888|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4
9886259|NCT01056822|11000889|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4
9886260|NCT01056822|11000888|FG000|Per-protocol (PP) Population: YES|Overall Study||29
9886261|NCT01056822|11000889|FG001|Per-protocol (PP) Population: YES|Overall Study||25
9886262|NCT01056822|11000888|FG000|Per-protocol (PP) Population: NO|Overall Study||18
9886263|NCT01056822|11000889|FG001|Per-protocol (PP) Population: NO|Overall Study||17
9886264|NCT01056822|11000888|FG000|Safety (SAF) Population: YES|Overall Study||46
9886265|NCT01056822|11000889|FG001|Safety (SAF) Population: YES|Overall Study||40
9886266|NCT01056822|11000888|FG000|Safety (SAF) Population: NO|Overall Study||1
9886267|NCT01056822|11000889|FG001|Safety (SAF) Population: NO|Overall Study||2
9886268|NCT01056822|11000888|FG000|COMPLETED|Overall Study||39
9886269|NCT01056822|11000889|FG001|COMPLETED|Overall Study||35
9886270|NCT01056822|11000888|FG000|NOT COMPLETED|Overall Study||8
9886271|NCT01056822|11000889|FG001|NOT COMPLETED|Overall Study||7
9886272|NCT01056913|11000896|FG000|STARTED|Overall Study||62
9886273|NCT01056913|11000896|FG000|COMPLETED|Overall Study||62
9886274|NCT01056913|11000896|FG000|NOT COMPLETED|Overall Study||0
9886275|NCT01057017|11000900|FG000|STARTED|Overall Study||5
9886276|NCT01057017|11000900|FG000|COMPLETED|Overall Study||5
9886277|NCT01057017|11000900|FG000|NOT COMPLETED|Overall Study||0
9886278|NCT01057225|11000904|FG000|STARTED|Overall Study||3
9886279|NCT01057225|11000905|FG001|STARTED|Overall Study||3
9886280|NCT01057225|11000906|FG002|STARTED|Overall Study||6
9886281|NCT01057225|11000907|FG003|STARTED|Overall Study||7
9886282|NCT01057225|11000908|FG004|STARTED|Overall Study||22
9886283|NCT01057225|11000909|FG005|STARTED|Overall Study||23
9886284|NCT01057225|11000904|FG000|COMPLETED|Overall Study||3
9886285|NCT01057225|11000905|FG001|COMPLETED|Overall Study||3
9886286|NCT01057225|11000906|FG002|COMPLETED|Overall Study||6
9886287|NCT01057225|11000907|FG003|COMPLETED|Overall Study||7
10008281|NCT01756157|11130586|FG000|STARTED|First Intervention Period||23
10008282|NCT01756157|11130587|FG001|STARTED|First Intervention Period||24
10008283|NCT01756157|11130586|FG000|COMPLETED|First Intervention Period||22
10008284|NCT01756157|11130587|FG001|COMPLETED|First Intervention Period||22
10008285|NCT01756157|11130586|FG000|NOT COMPLETED|First Intervention Period||1
10008286|NCT01756157|11130587|FG001|NOT COMPLETED|First Intervention Period||2
9886288|NCT01057225|11000908|FG004|COMPLETED|Overall Study||22
9886289|NCT01057225|11000909|FG005|COMPLETED|Overall Study||23
9886290|NCT01057225|11000904|FG000|NOT COMPLETED|Overall Study||0
9886291|NCT01057225|11000905|FG001|NOT COMPLETED|Overall Study||0
9886292|NCT01057225|11000906|FG002|NOT COMPLETED|Overall Study||0
9886293|NCT01057225|11000907|FG003|NOT COMPLETED|Overall Study||0
9886294|NCT01057225|11000908|FG004|NOT COMPLETED|Overall Study||0
9886295|NCT01057225|11000909|FG005|NOT COMPLETED|Overall Study||0
9886296|NCT01057251|11000924|FG000|STARTED|Overall Study||290
9886297|NCT01057251|11000925|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
9886298|NCT01057251|11000924|FG000|COMPLETED|Overall Study||262
9886299|NCT01057251|11000925|FG001|COMPLETED|Overall Study||114
9886300|NCT01057251|11000924|FG000|NOT COMPLETED|Overall Study||28
9886301|NCT01057251|11000925|FG001|NOT COMPLETED|Overall Study||29
9886302|NCT01057277|11000931|FG000|STARTED|Overall Study||3
9886303|NCT01057277|11000931|FG000|COMPLETED|Overall Study||3
10008287|NCT01756157|11130586|FG000|STARTED|Washout Period (at Least 7 Days)||22
10008288|NCT01756157|11130587|FG001|STARTED|Washout Period (at Least 7 Days)||22
10008289|NCT01756157|11130586|FG000|COMPLETED|Washout Period (at Least 7 Days)||22
10008290|NCT01756157|11130587|FG001|COMPLETED|Washout Period (at Least 7 Days)||22
10008291|NCT01756157|11130586|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10008292|NCT01756157|11130587|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10008293|NCT01756157|11130586|FG000|STARTED|Second Intervention Period||22
9886304|NCT01057277|11000931|FG000|NOT COMPLETED|Overall Study||0
9886305|NCT01057381|11000939|FG000|STARTED|Overall Study||26
9886306|NCT01057381|11000940|FG001|STARTED|Overall Study||27
9886307|NCT01057381|11000941|FG002|STARTED|Overall Study||30
9886308|NCT01057381|11000942|FG003|STARTED|Overall Study||26
9886309|NCT01057381|11000939|FG000|COMPLETED|Overall Study||26
9886310|NCT01057381|11000940|FG001|COMPLETED|Overall Study||27
9886311|NCT01057381|11000941|FG002|COMPLETED|Overall Study||30
9886312|NCT01057381|11000942|FG003|COMPLETED|Overall Study||26
9886313|NCT01057381|11000939|FG000|NOT COMPLETED|Overall Study||0
9886314|NCT01057381|11000940|FG001|NOT COMPLETED|Overall Study||0
9886315|NCT01057381|11000941|FG002|NOT COMPLETED|Overall Study||0
9886316|NCT01057381|11000942|FG003|NOT COMPLETED|Overall Study||0
9886317|NCT01057394|11000952|FG000|STARTED|Overall Study||0
9886318|NCT01057394|11000953|FG001|STARTED|Overall Study|21 enrolled participants|21
9886319|NCT01057394|11000952|FG000|COMPLETED|Overall Study||0
9886320|NCT01057394|11000953|FG001|COMPLETED|Overall Study|19 treated participants|19
9886321|NCT01057394|11000952|FG000|NOT COMPLETED|Overall Study||0
9886322|NCT01057394|11000953|FG001|NOT COMPLETED|Overall Study||2
9886323|NCT01057433|11000957|FG000|STARTED|Overall Study||24
9886324|NCT01057433|11000957|FG000|COMPLETED|Overall Study||23
9886325|NCT01057433|11000957|FG000|NOT COMPLETED|Overall Study||1
9886326|NCT01057589|11000961|FG000|STARTED|Overall Study||66
9886327|NCT01057589|11000961|FG000|COMPLETED|Overall Study||0
9886328|NCT01057589|11000961|FG000|NOT COMPLETED|Overall Study||66
9886329|NCT01057693|11000965|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665
9886330|NCT01057693|11000966|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0
9886331|NCT01057693|11000967|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0
9886332|NCT01057693|11000965|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566
9886333|NCT01057693|11000966|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0
9886334|NCT01057693|11000967|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0
9886335|NCT01057693|11000965|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
9886336|NCT01057693|11000966|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
9886337|NCT01057693|11000967|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
9886338|NCT01057693|11000965|FG000|STARTED|Between Single-Blind and Double-Blind||566
9886339|NCT01057693|11000966|FG001|STARTED|Between Single-Blind and Double-Blind||0
9886340|NCT01057693|11000967|FG002|STARTED|Between Single-Blind and Double-Blind||0
9886341|NCT01057693|11000965|FG000|COMPLETED|Between Single-Blind and Double-Blind||296
9886342|NCT01057693|11000966|FG001|COMPLETED|Between Single-Blind and Double-Blind||0
9886343|NCT01057693|11000967|FG002|COMPLETED|Between Single-Blind and Double-Blind||0
9886344|NCT01057693|11000965|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270
9886345|NCT01057693|11000966|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0
9886346|NCT01057693|11000967|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0
9886347|NCT01057693|11000965|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
9886348|NCT01057693|11000966|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
9886349|NCT01057693|11000967|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
9886350|NCT01057693|11000965|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0
9886351|NCT01057693|11000966|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147
9886352|NCT01057693|11000967|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147
9886353|NCT01057693|11000965|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
9886354|NCT01057693|11000966|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
9886355|NCT01057693|11000967|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
9886356|NCT01057693|11000965|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
10008294|NCT01756157|11130587|FG001|STARTED|Second Intervention Period||22
10008295|NCT01756157|11130586|FG000|COMPLETED|Second Intervention Period||22
10008296|NCT01756157|11130587|FG001|COMPLETED|Second Intervention Period||22
10008297|NCT01756157|11130586|FG000|NOT COMPLETED|Second Intervention Period||0
10008298|NCT01756157|11130587|FG001|NOT COMPLETED|Second Intervention Period||0
10008299|NCT01756209|11130597|FG000|STARTED|Overall Study||40
9886357|NCT01057693|11000966|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
9886358|NCT01057693|11000967|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
9886359|NCT01057810|11000977|FG000|STARTED|Overall Study||199
9886360|NCT01057810|11000978|FG001|STARTED|Overall Study||399
9886361|NCT01057810|11000977|FG000|COMPLETED|Overall Study||1
9886362|NCT01057810|11000978|FG001|COMPLETED|Overall Study||1
9886363|NCT01057810|11000977|FG000|NOT COMPLETED|Overall Study||198
9886364|NCT01057810|11000978|FG001|NOT COMPLETED|Overall Study||398
9886365|NCT01057862|11000986|FG000|STARTED|Overall Study||5
9886366|NCT01057862|11000987|FG001|STARTED|Overall Study||4
9886367|NCT01057862|11000986|FG000|COMPLETED|Overall Study||4
9886368|NCT01057862|11000987|FG001|COMPLETED|Overall Study||2
9886369|NCT01057862|11000986|FG000|NOT COMPLETED|Overall Study||1
9886370|NCT01057862|11000987|FG001|NOT COMPLETED|Overall Study||2
9886371|NCT01057888|11000996|FG000|STARTED|Overall Study||2504
9886372|NCT01057888|11000997|FG001|STARTED|Overall Study||2406
9886373|NCT01057888|11000998|FG002|STARTED|Overall Study||2494
9886374|NCT01057888|11000996|FG000|COMPLETED|Overall Study||2504
9886375|NCT01057888|11000997|FG001|COMPLETED|Overall Study||2406
9886376|NCT01057888|11000998|FG002|COMPLETED|Overall Study||2494
9886377|NCT01057888|11000996|FG000|NOT COMPLETED|Overall Study||0
9886378|NCT01057888|11000997|FG001|NOT COMPLETED|Overall Study||0
9886379|NCT01057888|11000998|FG002|NOT COMPLETED|Overall Study||0
9886380|NCT01057901|11001006|FG000|STARTED|Overall Study||376
9886381|NCT01057901|11001007|FG001|STARTED|Overall Study||372
9886382|NCT01057901|11001006|FG000|COMPLETED|Overall Study||116
9886383|NCT01057901|11001007|FG001|COMPLETED|Overall Study||126
9886384|NCT01057901|11001006|FG000|NOT COMPLETED|Overall Study||260
9886385|NCT01057901|11001007|FG001|NOT COMPLETED|Overall Study||246
9886386|NCT01058005|11001016|FG000|STARTED|Overall Study||38
9886387|NCT01058005|11001017|FG001|STARTED|Overall Study||25
9886388|NCT01058005|11001018|FG002|STARTED|Overall Study||21
9886389|NCT01058005|11001016|FG000|Dosed With Study Treatment|Overall Study||36
9886390|NCT01058005|11001017|FG001|Dosed With Study Treatment|Overall Study||22
10008300|NCT01756209|11130598|FG001|STARTED|Overall Study||40
9886391|NCT01058005|11001018|FG002|Dosed With Study Treatment|Overall Study||17
9886392|NCT01058005|11001016|FG000|COMPLETED|Overall Study||0
9886393|NCT01058005|11001017|FG001|COMPLETED|Overall Study||0
9886394|NCT01058005|11001018|FG002|COMPLETED|Overall Study||1
9886395|NCT01058005|11001016|FG000|NOT COMPLETED|Overall Study||38
9886396|NCT01058005|11001017|FG001|NOT COMPLETED|Overall Study||25
9886397|NCT01058005|11001018|FG002|NOT COMPLETED|Overall Study||20
9886398|NCT01058070|11001026|FG000|STARTED|Overall Study||44
9886399|NCT01058070|11001026|FG000|COMPLETED|Overall Study||33
9886400|NCT01058070|11001026|FG000|NOT COMPLETED|Overall Study||11
9886401|NCT01058096|11001033|FG000|STARTED|Double-blind Treatment Phase||154
9886402|NCT01058096|11001034|FG001|STARTED|Double-blind Treatment Phase||158
9886403|NCT01058096|11001033|FG000|COMPLETED|Double-blind Treatment Phase||106
9886404|NCT01058096|11001034|FG001|COMPLETED|Double-blind Treatment Phase||108
9886405|NCT01058096|11001033|FG000|NOT COMPLETED|Double-blind Treatment Phase||48
9886406|NCT01058096|11001034|FG001|NOT COMPLETED|Double-blind Treatment Phase||50
9886407|NCT01058096|11001033|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
9886408|NCT01058096|11001034|FG001|STARTED|Safety Follow-up||134
9886409|NCT01058096|11001033|FG000|COMPLETED|Safety Follow-up||129
9886410|NCT01058096|11001034|FG001|COMPLETED|Safety Follow-up||130
9886411|NCT01058096|11001033|FG000|NOT COMPLETED|Safety Follow-up||4
9886412|NCT01058096|11001034|FG001|NOT COMPLETED|Safety Follow-up||4
9886413|NCT01058239|11001040|FG000|STARTED|Overall Study||7
9886414|NCT01058239|11001040|FG000|COMPLETED|Overall Study||7
9886415|NCT01058239|11001040|FG000|NOT COMPLETED|Overall Study||0
9886416|NCT01058265|11001046|FG000|STARTED|Overall Study||22
9886417|NCT01058265|11001047|FG001|STARTED|Overall Study||25
9886418|NCT01058265|11001046|FG000|COMPLETED|Overall Study||11
9886419|NCT01058265|11001047|FG001|COMPLETED|Overall Study||13
9886420|NCT01058265|11001046|FG000|NOT COMPLETED|Overall Study||11
9886421|NCT01058265|11001047|FG001|NOT COMPLETED|Overall Study||12
9886422|NCT01058304|11001055|FG000|STARTED|Overall Study||159
9886423|NCT01058304|11001056|FG001|STARTED|Overall Study||161
9886424|NCT01058304|11001055|FG000|COMPLETED|Overall Study||132
9886425|NCT01058304|11001056|FG001|COMPLETED|Overall Study||128
9886426|NCT01058304|11001055|FG000|NOT COMPLETED|Overall Study||27
9886427|NCT01058304|11001056|FG001|NOT COMPLETED|Overall Study||33
9886428|NCT01058356|11001062|FG000|STARTED|Overall Study||214
9886429|NCT01058356|11001062|FG000|COMPLETED|Overall Study||172
9886430|NCT01058356|11001062|FG000|NOT COMPLETED|Overall Study||42
9886431|NCT01058395|11001068|FG000|STARTED|Overall Study||7
9886432|NCT01058395|11001069|FG001|STARTED|Overall Study||8
9886433|NCT01058395|11001068|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
9886434|NCT01058395|11001069|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
9886435|NCT01058395|11001068|FG000|NOT COMPLETED|Overall Study||3
9886436|NCT01058395|11001069|FG001|NOT COMPLETED|Overall Study||1
9886437|NCT01058421|11001077|FG000|STARTED|1 Month Outcomes||59
9886438|NCT01058421|11001078|FG001|STARTED|1 Month Outcomes||61
9886439|NCT01058421|11001077|FG000|COMPLETED|1 Month Outcomes||20
9886440|NCT01058421|11001078|FG001|COMPLETED|1 Month Outcomes||19
9886441|NCT01058421|11001077|FG000|NOT COMPLETED|1 Month Outcomes||39
9886442|NCT01058421|11001078|FG001|NOT COMPLETED|1 Month Outcomes||42
9886443|NCT01058421|11001077|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
9886444|NCT01058421|11001078|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
9886445|NCT01058421|11001077|FG000|COMPLETED|3 Month Outcomes||29
9886446|NCT01058421|11001078|FG001|COMPLETED|3 Month Outcomes||29
9886447|NCT01058421|11001077|FG000|NOT COMPLETED|3 Month Outcomes||20
9886448|NCT01058421|11001078|FG001|NOT COMPLETED|3 Month Outcomes||26
9886449|NCT01058421|11001077|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
9886450|NCT01058421|11001078|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
9886451|NCT01058421|11001077|FG000|COMPLETED|6 Month Outcomes||27
9886452|NCT01058421|11001078|FG001|COMPLETED|6 Month Outcomes||24
9886453|NCT01058421|11001077|FG000|NOT COMPLETED|6 Month Outcomes||19
9886454|NCT01058421|11001078|FG001|NOT COMPLETED|6 Month Outcomes||26
9886455|NCT01058655|11001088|FG000|STARTED|Overall Study||3
9886456|NCT01058655|11001089|FG001|STARTED|Overall Study||3
9886457|NCT01058655|11001090|FG002|STARTED|Overall Study||8
9886458|NCT01058655|11001091|FG003|STARTED|Overall Study||42
9886459|NCT01058655|11001088|FG000|Evaluable|Overall Study||3
9886460|NCT01058655|11001089|FG001|Evaluable|Overall Study||3
9886461|NCT01058655|11001090|FG002|Evaluable|Overall Study||6
9886462|NCT01058655|11001091|FG003|Evaluable|Overall Study||40
9886463|NCT01058655|11001088|FG000|COMPLETED|Overall Study||0
9886464|NCT01058655|11001089|FG001|COMPLETED|Overall Study||0
9886465|NCT01058655|11001090|FG002|COMPLETED|Overall Study||0
9886466|NCT01058655|11001091|FG003|COMPLETED|Overall Study||0
9886467|NCT01058655|11001088|FG000|NOT COMPLETED|Overall Study||3
9886468|NCT01058655|11001089|FG001|NOT COMPLETED|Overall Study||3
9886469|NCT01058655|11001090|FG002|NOT COMPLETED|Overall Study||8
9886470|NCT01058655|11001091|FG003|NOT COMPLETED|Overall Study||42
9886471|NCT01058668|11001105|FG000|STARTED|Double-blind Treatment Phase||161
9886472|NCT01058668|11001106|FG001|STARTED|Double-blind Treatment Phase||167
9886473|NCT01058668|11001107|FG002|STARTED|Double-blind Treatment Phase||169
9886474|NCT01058668|11001105|FG000|COMPLETED|Double-blind Treatment Phase||122
9886475|NCT01058668|11001106|FG001|COMPLETED|Double-blind Treatment Phase||129
9886476|NCT01058668|11001107|FG002|COMPLETED|Double-blind Treatment Phase||119
9886477|NCT01058668|11001105|FG000|NOT COMPLETED|Double-blind Treatment Phase||39
9886478|NCT01058668|11001106|FG001|NOT COMPLETED|Double-blind Treatment Phase||38
9886479|NCT01058668|11001107|FG002|NOT COMPLETED|Double-blind Treatment Phase||50
9886480|NCT01058668|11001105|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
9886481|NCT01058668|11001106|FG001|STARTED|Safety Follow-up||146
9886482|NCT01058668|11001107|FG002|STARTED|Safety Follow-up||148
9886483|NCT01058668|11001105|FG000|COMPLETED|Safety Follow-up||139
9886484|NCT01058668|11001106|FG001|COMPLETED|Safety Follow-up||146
9886485|NCT01058668|11001107|FG002|COMPLETED|Safety Follow-up||141
9886486|NCT01058668|11001105|FG000|NOT COMPLETED|Safety Follow-up||5
9886487|NCT01058668|11001106|FG001|NOT COMPLETED|Safety Follow-up||0
9886488|NCT01058668|11001107|FG002|NOT COMPLETED|Safety Follow-up||7
9886489|NCT01058707|11001122|FG000|STARTED|Overall Study||31
9886490|NCT01058707|11001123|FG001|STARTED|Overall Study||30
9886491|NCT01058707|11001124|FG002|STARTED|Overall Study||33
9886492|NCT01058707|11001125|FG003|STARTED|Overall Study||22
9886493|NCT01058707|11001126|FG004|STARTED|Overall Study||39
9886494|NCT01058707|11001127|FG005|STARTED|Overall Study||17
9886495|NCT01058707|11001128|FG006|STARTED|Overall Study||26
9886496|NCT01058707|11001122|FG000|COMPLETED|Overall Study||0
9886497|NCT01058707|11001123|FG001|COMPLETED|Overall Study||0
9886498|NCT01058707|11001124|FG002|COMPLETED|Overall Study||0
9886499|NCT01058707|11001125|FG003|COMPLETED|Overall Study||0
9886500|NCT01058707|11001126|FG004|COMPLETED|Overall Study||0
9886501|NCT01058707|11001127|FG005|COMPLETED|Overall Study||0
9886502|NCT01058707|11001128|FG006|COMPLETED|Overall Study||0
9886503|NCT01058707|11001122|FG000|NOT COMPLETED|Overall Study||31
9886504|NCT01058707|11001123|FG001|NOT COMPLETED|Overall Study||30
9886505|NCT01058707|11001124|FG002|NOT COMPLETED|Overall Study||33
9886506|NCT01058707|11001125|FG003|NOT COMPLETED|Overall Study||22
9886507|NCT01058707|11001126|FG004|NOT COMPLETED|Overall Study||39
9886508|NCT01058707|11001127|FG005|NOT COMPLETED|Overall Study||17
9886509|NCT01058707|11001128|FG006|NOT COMPLETED|Overall Study||26
9886510|NCT01058863|11001166|FG000|STARTED|Overall Study||72
9886511|NCT01058863|11001166|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
9886512|NCT01058863|11001166|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
9886513|NCT01058863|11001166|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
9886514|NCT01058863|11001166|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70
9886515|NCT01058863|11001166|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68
9886516|NCT01058863|11001166|FG000|Treated With Placebo Inhaler|Overall Study||69
9886517|NCT01058863|11001166|FG000|COMPLETED|Overall Study||68
9886518|NCT01058863|11001166|FG000|NOT COMPLETED|Overall Study||4
9886519|NCT01058941|11001181|FG000|STARTED|Overall Study||34
9886520|NCT01058941|11001182|FG001|STARTED|Overall Study||33
9886521|NCT01058941|11001181|FG000|COMPLETED|Overall Study||25
9886522|NCT01058941|11001182|FG001|COMPLETED|Overall Study||22
9886523|NCT01058941|11001181|FG000|NOT COMPLETED|Overall Study||9
9886524|NCT01058941|11001182|FG001|NOT COMPLETED|Overall Study||11
9886525|NCT01058993|11001188|FG000|STARTED|Overall Study||6
9886526|NCT01058993|11001188|FG000|COMPLETED|Overall Study||6
9886527|NCT01058993|11001188|FG000|NOT COMPLETED|Overall Study||0
9886528|NCT01059175|11001194|FG000|STARTED|Overall Study||43
9886529|NCT01059175|11001195|FG001|STARTED|Overall Study||41
9886530|NCT01059175|11001194|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
9886531|NCT01059175|11001195|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
9886532|NCT01059175|11001194|FG000|NOT COMPLETED|Overall Study||21
9886533|NCT01059175|11001195|FG001|NOT COMPLETED|Overall Study||20
9886534|NCT01059305|11001201|FG000|STARTED|Overall Study||10
9886535|NCT01059305|11001201|FG000|COMPLETED|Overall Study||10
9886536|NCT01059305|11001201|FG000|NOT COMPLETED|Overall Study||0
9886537|NCT01059318|11001205|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
9886538|NCT01059318|11001205|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
9886539|NCT01059318|11001205|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
9886540|NCT01059318|11001205|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
10008301|NCT01756209|11130599|FG002|STARTED|Overall Study||40
10008302|NCT01756209|11130600|FG003|STARTED|Overall Study||40
10008303|NCT01756209|11130597|FG000|COMPLETED|Overall Study||40
10008304|NCT01756209|11130598|FG001|COMPLETED|Overall Study||40
10008305|NCT01756209|11130599|FG002|COMPLETED|Overall Study||40
10008306|NCT01756209|11130600|FG003|COMPLETED|Overall Study||40
10008307|NCT01756209|11130597|FG000|NOT COMPLETED|Overall Study||0
10008308|NCT01756209|11130598|FG001|NOT COMPLETED|Overall Study||0
10008309|NCT01756209|11130599|FG002|NOT COMPLETED|Overall Study||0
10109196|NCT02473510|11239799|FG000|NOT COMPLETED|Overall Study||1
10109197|NCT02473510|11239800|FG001|NOT COMPLETED|Overall Study||2
9886541|NCT01059318|11001205|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
9886542|NCT01059318|11001205|FG000|COMPLETED|Core Study (26 Week)||20
9886543|NCT01059318|11001205|FG000|NOT COMPLETED|Core Study (26 Week)||4
9886544|NCT01059318|11001205|FG000|STARTED|Extension (36 Week)||20
9886545|NCT01059318|11001205|FG000|COMPLETED|Extension (36 Week)||17
10008310|NCT01756209|11130600|FG003|NOT COMPLETED|Overall Study||0
10008311|NCT01756235|11130610|FG000|STARTED|Overall Study||462
9886546|NCT01059318|11001205|FG000|NOT COMPLETED|Extension (36 Week)||3
9886547|NCT01059344|11001214|FG000|STARTED|Overall Study||140
9886548|NCT01059344|11001215|FG001|STARTED|Overall Study||141
9886549|NCT01059344|11001214|FG000|COMPLETED|Overall Study||118
9886550|NCT01059344|11001215|FG001|COMPLETED|Overall Study||95
9886551|NCT01059344|11001214|FG000|NOT COMPLETED|Overall Study||22
9886552|NCT01059344|11001215|FG001|NOT COMPLETED|Overall Study||46
9886553|NCT01059357|11001223|FG000|STARTED|Overall Study||58
9886554|NCT01059357|11001223|FG000|COMPLETED|Overall Study||54
9886555|NCT01059357|11001223|FG000|NOT COMPLETED|Overall Study||4
9886556|NCT01059435|11001237|FG000|STARTED|Overall Study||14
9886557|NCT01059435|11001238|FG001|STARTED|Overall Study||6
9886558|NCT01059435|11001239|FG002|STARTED|Overall Study||8
9886559|NCT01059435|11001240|FG003|STARTED|Overall Study||9
9886560|NCT01059435|11001241|FG004|STARTED|Overall Study||6
9886561|NCT01059435|11001242|FG005|STARTED|Overall Study||9
9886562|NCT01059435|11001243|FG006|STARTED|Overall Study||6
9886563|NCT01059435|11001244|FG007|STARTED|Overall Study||4
9886564|NCT01059435|11001245|FG008|STARTED|Overall Study||6
9886565|NCT01059435|11001246|FG009|STARTED|Overall Study||6
9886566|NCT01059435|11001237|FG000|Received Study Drug|Overall Study||14
9886567|NCT01059435|11001238|FG001|Received Study Drug|Overall Study||6
9886568|NCT01059435|11001239|FG002|Received Study Drug|Overall Study||6
9886569|NCT01059435|11001240|FG003|Received Study Drug|Overall Study||9
9886570|NCT01059435|11001241|FG004|Received Study Drug|Overall Study||6
9886571|NCT01059435|11001242|FG005|Received Study Drug|Overall Study||9
9886572|NCT01059435|11001243|FG006|Received Study Drug|Overall Study||6
9886573|NCT01059435|11001244|FG007|Received Study Drug|Overall Study||4
9886574|NCT01059435|11001245|FG008|Received Study Drug|Overall Study||6
9886575|NCT01059435|11001246|FG009|Received Study Drug|Overall Study||6
10008312|NCT01756235|11130610|FG000|COMPLETED|Overall Study||460
10008313|NCT01756235|11130610|FG000|NOT COMPLETED|Overall Study||2
10008314|NCT01756274|11130614|FG000|STARTED|Overall Study||162
10008315|NCT01756274|11130614|FG000|COMPLETED|Overall Study||159
10008316|NCT01756274|11130614|FG000|NOT COMPLETED|Overall Study||3
10008317|NCT01756300|11130619|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
10008318|NCT01756300|11130619|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
10008319|NCT01756300|11130619|FG000|NOT COMPLETED|Overall Study||2
10008320|NCT01756352|11130640|FG000|STARTED|Overall Study||13
10008321|NCT01756352|11130640|FG000|COMPLETED|Overall Study||12
10008322|NCT01756352|11130640|FG000|NOT COMPLETED|Overall Study||1
10008323|NCT01756391|11130644|FG000|STARTED|Overall Study||351
10008324|NCT01756391|11130644|FG000|COMPLETED|Overall Study||319
10008325|NCT01756391|11130644|FG000|NOT COMPLETED|Overall Study||32
10008326|NCT01756456|11130654|FG000|STARTED|Treatment Period: Phase I/II||7
10008327|NCT01756456|11130655|FG001|STARTED|Treatment Period: Phase I/II||7
9886576|NCT01059435|11001237|FG000|COMPLETED|Overall Study||14
9886577|NCT01059435|11001238|FG001|COMPLETED|Overall Study||6
9886578|NCT01059435|11001239|FG002|COMPLETED|Overall Study||6
9886579|NCT01059435|11001240|FG003|COMPLETED|Overall Study||9
9886580|NCT01059435|11001241|FG004|COMPLETED|Overall Study||6
9886581|NCT01059435|11001242|FG005|COMPLETED|Overall Study||9
9886582|NCT01059435|11001243|FG006|COMPLETED|Overall Study||6
9886583|NCT01059435|11001244|FG007|COMPLETED|Overall Study||4
9886584|NCT01059435|11001245|FG008|COMPLETED|Overall Study||6
9886585|NCT01059435|11001246|FG009|COMPLETED|Overall Study||6
9886586|NCT01059435|11001237|FG000|NOT COMPLETED|Overall Study||0
9886587|NCT01059435|11001238|FG001|NOT COMPLETED|Overall Study||0
9886588|NCT01059435|11001239|FG002|NOT COMPLETED|Overall Study||2
9886589|NCT01059435|11001240|FG003|NOT COMPLETED|Overall Study||0
9886590|NCT01059435|11001241|FG004|NOT COMPLETED|Overall Study||0
9886591|NCT01059435|11001242|FG005|NOT COMPLETED|Overall Study||0
9886592|NCT01059435|11001243|FG006|NOT COMPLETED|Overall Study||0
9886593|NCT01059435|11001244|FG007|NOT COMPLETED|Overall Study||0
9886594|NCT01059435|11001245|FG008|NOT COMPLETED|Overall Study||0
9886595|NCT01059435|11001246|FG009|NOT COMPLETED|Overall Study||0
9886596|NCT01059526|11001280|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
9886597|NCT01059526|11001281|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
9886598|NCT01059526|11001280|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
9886599|NCT01059526|11001281|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
9886600|NCT01059526|11001280|FG000|COMPLETED|Overall Study||11
9886601|NCT01059526|11001281|FG001|COMPLETED|Overall Study||18
9886602|NCT01059526|11001280|FG000|NOT COMPLETED|Overall Study||30
9886603|NCT01059526|11001281|FG001|NOT COMPLETED|Overall Study||22
9886604|NCT01059539|11001287|FG000|STARTED|Overall Study||403
9886605|NCT01059539|11001287|FG000|COMPLETED|Overall Study||132
10008328|NCT01756456|11130656|FG002|STARTED|Treatment Period: Phase I/II||4
10008329|NCT01756456|11130657|FG003|STARTED|Treatment Period: Phase I/II||52
9886606|NCT01059539|11001287|FG000|NOT COMPLETED|Overall Study||271
9886607|NCT01059565|11001293|FG000|STARTED|24-Week Randomized Phase||49
9886608|NCT01059565|11001294|FG001|STARTED|24-Week Randomized Phase||52
9886609|NCT01059565|11001293|FG000|Randomized and Treated|24-Week Randomized Phase||48
10008330|NCT01756456|11130658|FG004|STARTED|Treatment Period: Phase I/II||52
10008331|NCT01756456|11130659|FG005|STARTED|Treatment Period: Phase I/II||52
10008332|NCT01756456|11130654|FG000|COMPLETED|Treatment Period: Phase I/II||6
9886610|NCT01059565|11001294|FG001|Randomized and Treated|24-Week Randomized Phase||52
9886611|NCT01059565|11001293|FG000|COMPLETED|24-Week Randomized Phase||39
9886612|NCT01059565|11001294|FG001|COMPLETED|24-Week Randomized Phase||45
9886613|NCT01059565|11001293|FG000|NOT COMPLETED|24-Week Randomized Phase||10
9886614|NCT01059565|11001294|FG001|NOT COMPLETED|24-Week Randomized Phase||7
9886615|NCT01059565|11001293|FG000|STARTED|24-Week Open-Label Phase||39
9886616|NCT01059565|11001294|FG001|STARTED|24-Week Open-Label Phase||45
9886617|NCT01059565|11001293|FG000|COMPLETED|24-Week Open-Label Phase||34
9886618|NCT01059565|11001294|FG001|COMPLETED|24-Week Open-Label Phase||42
9886619|NCT01059565|11001293|FG000|NOT COMPLETED|24-Week Open-Label Phase||5
9886620|NCT01059565|11001294|FG001|NOT COMPLETED|24-Week Open-Label Phase||3
9886621|NCT01059617|11001306|FG000|STARTED|Overall Study||33
9886622|NCT01059617|11001307|FG001|STARTED|Overall Study||34
9886623|NCT01059617|11001308|FG002|STARTED|Overall Study||33
9886624|NCT01059617|11001309|FG003|STARTED|Overall Study||33
9886625|NCT01059617|11001306|FG000|COMPLETED|Overall Study||26
9886626|NCT01059617|11001307|FG001|COMPLETED|Overall Study||33
9886627|NCT01059617|11001308|FG002|COMPLETED|Overall Study||25
9886628|NCT01059617|11001309|FG003|COMPLETED|Overall Study||27
9886629|NCT01059617|11001306|FG000|NOT COMPLETED|Overall Study||7
9886630|NCT01059617|11001307|FG001|NOT COMPLETED|Overall Study||1
9886631|NCT01059617|11001308|FG002|NOT COMPLETED|Overall Study||8
9886632|NCT01059617|11001309|FG003|NOT COMPLETED|Overall Study||6
9886633|NCT01059630|11001329|FG000|STARTED|Overall Study||209
9886634|NCT01059630|11001330|FG001|STARTED|Overall Study||204
9886635|NCT01059630|11001329|FG000|COMPLETED|Overall Study||82
9886636|NCT01059630|11001330|FG001|COMPLETED|Overall Study||101
9886637|NCT01059630|11001329|FG000|NOT COMPLETED|Overall Study||127
9886638|NCT01059630|11001330|FG001|NOT COMPLETED|Overall Study||103
9886639|NCT01059643|11001336|FG000|STARTED|Overall Study||103
9886640|NCT01059643|11001336|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103
9886641|NCT01059643|11001336|FG000|COMPLETED|Overall Study||97
9886642|NCT01059643|11001336|FG000|NOT COMPLETED|Overall Study||6
9886643|NCT01059682|11001345|FG000|STARTED|Overall Study||474
9886644|NCT01059682|11001346|FG001|STARTED|Overall Study||462
9886645|NCT01059682|11001345|FG000|COMPLETED|Overall Study||464
9886646|NCT01059682|11001346|FG001|COMPLETED|Overall Study||444
9886647|NCT01059682|11001345|FG000|NOT COMPLETED|Overall Study||10
9886648|NCT01059682|11001346|FG001|NOT COMPLETED|Overall Study||18
9886649|NCT01059760|11001354|FG000|STARTED|Overall Study||16
9886650|NCT01059760|11001355|FG001|STARTED|Overall Study||14
9886651|NCT01059760|11001354|FG000|COMPLETED|Overall Study||16
9886652|NCT01059760|11001355|FG001|COMPLETED|Overall Study||14
9886653|NCT01059760|11001354|FG000|NOT COMPLETED|Overall Study||0
9886654|NCT01059760|11001355|FG001|NOT COMPLETED|Overall Study||0
9886655|NCT01059773|11001364|FG000|STARTED|Overall Study||244
9886656|NCT01059773|11001365|FG001|STARTED|Overall Study||245
9886657|NCT01059773|11001364|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
9886658|NCT01059773|11001365|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
9886659|NCT01059773|11001364|FG000|NOT COMPLETED|Overall Study||20
9886660|NCT01059773|11001365|FG001|NOT COMPLETED|Overall Study||24
9886661|NCT01059799|11001378|FG000|STARTED|Overall Study||289
9886662|NCT01059799|11001379|FG001|STARTED|Overall Study||146
9886663|NCT01059799|11001378|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
9886664|NCT01059799|11001379|FG001|Exposed|Overall Study||146
10008333|NCT01756456|11130655|FG001|COMPLETED|Treatment Period: Phase I/II||6
9886665|NCT01059799|11001378|FG000|COMPLETED|Overall Study||258
9886666|NCT01059799|11001379|FG001|COMPLETED|Overall Study||136
9886667|NCT01059799|11001378|FG000|NOT COMPLETED|Overall Study||31
9886668|NCT01059799|11001379|FG001|NOT COMPLETED|Overall Study||10
9886669|NCT01059812|11001387|FG000|STARTED|Overall Study||282
9886670|NCT01059812|11001388|FG001|STARTED|Overall Study||142
9886671|NCT01059812|11001387|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
9886672|NCT01059812|11001388|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
9886673|NCT01059812|11001387|FG000|COMPLETED|Overall Study||245
9886674|NCT01059812|11001388|FG001|COMPLETED|Overall Study||126
9886675|NCT01059812|11001387|FG000|NOT COMPLETED|Overall Study||37
9886676|NCT01059812|11001388|FG001|NOT COMPLETED|Overall Study||16
9886677|NCT01059825|11001400|FG000|STARTED|Enrolled, Run-in Period||0
9886678|NCT01059825|11001401|FG001|STARTED|Enrolled, Run-in Period||0
9886679|NCT01059825|11001402|FG002|STARTED|Enrolled, Run-in Period||0
9886680|NCT01059825|11001403|FG003|STARTED|Enrolled, Run-in Period||0
9886681|NCT01059825|11001404|FG004|STARTED|Enrolled, Run-in Period||0
9886682|NCT01059825|11001405|FG005|STARTED|Enrolled, Run-in Period||0
9886683|NCT01059825|11001406|FG006|STARTED|Enrolled, Run-in Period||375
9886684|NCT01059825|11001400|FG000|COMPLETED|Enrolled, Run-in Period||0
9886685|NCT01059825|11001401|FG001|COMPLETED|Enrolled, Run-in Period||0
9886686|NCT01059825|11001402|FG002|COMPLETED|Enrolled, Run-in Period||0
9886687|NCT01059825|11001403|FG003|COMPLETED|Enrolled, Run-in Period||0
9886688|NCT01059825|11001404|FG004|COMPLETED|Enrolled, Run-in Period||0
9886689|NCT01059825|11001405|FG005|COMPLETED|Enrolled, Run-in Period||0
9886690|NCT01059825|11001406|FG006|COMPLETED|Enrolled, Run-in Period||328
9886691|NCT01059825|11001400|FG000|NOT COMPLETED|Enrolled, Run-in Period||0
9886692|NCT01059825|11001401|FG001|NOT COMPLETED|Enrolled, Run-in Period||0
9886693|NCT01059825|11001402|FG002|NOT COMPLETED|Enrolled, Run-in Period||0
10008334|NCT01756456|11130656|FG002|COMPLETED|Treatment Period: Phase I/II||2
9886694|NCT01059825|11001403|FG003|NOT COMPLETED|Enrolled, Run-in Period||0
9886695|NCT01059825|11001404|FG004|NOT COMPLETED|Enrolled, Run-in Period||0
9886696|NCT01059825|11001405|FG005|NOT COMPLETED|Enrolled, Run-in Period||0
9886697|NCT01059825|11001406|FG006|NOT COMPLETED|Enrolled, Run-in Period||47
9886698|NCT01059825|11001400|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
9886699|NCT01059825|11001401|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
9886700|NCT01059825|11001402|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
9886701|NCT01059825|11001403|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
9886702|NCT01059825|11001404|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
9886703|NCT01059825|11001405|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
9886704|NCT01059825|11001406|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
9886705|NCT01059825|11001400|FG000|COMPLETED|Treatment Period||44
9886706|NCT01059825|11001401|FG001|COMPLETED|Treatment Period||50
9886707|NCT01059825|11001402|FG002|COMPLETED|Treatment Period||49
9886708|NCT01059825|11001403|FG003|COMPLETED|Treatment Period||44
9886709|NCT01059825|11001404|FG004|COMPLETED|Treatment Period||47
9886710|NCT01059825|11001405|FG005|COMPLETED|Treatment Period||52
9886711|NCT01059825|11001406|FG006|COMPLETED|Treatment Period||0
9886712|NCT01059825|11001400|FG000|NOT COMPLETED|Treatment Period||10
9886713|NCT01059825|11001401|FG001|NOT COMPLETED|Treatment Period||4
10008335|NCT01756456|11130657|FG003|COMPLETED|Treatment Period: Phase I/II||45
10008336|NCT01756456|11130658|FG004|COMPLETED|Treatment Period: Phase I/II||39
10008337|NCT01756456|11130659|FG005|COMPLETED|Treatment Period: Phase I/II||48
9886714|NCT01059825|11001402|FG002|NOT COMPLETED|Treatment Period||6
9886715|NCT01059825|11001403|FG003|NOT COMPLETED|Treatment Period||11
9886716|NCT01059825|11001404|FG004|NOT COMPLETED|Treatment Period||8
9886717|NCT01059825|11001405|FG005|NOT COMPLETED|Treatment Period||3
9886718|NCT01059825|11001406|FG006|NOT COMPLETED|Treatment Period||0
9886719|NCT01059851|11001424|FG000|STARTED|Overall Study||8
9886720|NCT01059851|11001425|FG001|STARTED|Overall Study||8
9886721|NCT01059851|11001426|FG002|STARTED|Overall Study||0
9886722|NCT01059851|11001427|FG003|STARTED|Overall Study||0
9886723|NCT01059851|11001428|FG004|STARTED|Overall Study||0
9886724|NCT01059851|11001429|FG005|STARTED|Overall Study||0
9886725|NCT01059851|11001424|FG000|COMPLETED|Overall Study||8
9886726|NCT01059851|11001425|FG001|COMPLETED|Overall Study||8
9886727|NCT01059851|11001426|FG002|COMPLETED|Overall Study||0
9886728|NCT01059851|11001427|FG003|COMPLETED|Overall Study||0
9886729|NCT01059851|11001428|FG004|COMPLETED|Overall Study||0
9886730|NCT01059851|11001429|FG005|COMPLETED|Overall Study||0
9886731|NCT01059851|11001424|FG000|NOT COMPLETED|Overall Study||0
9886732|NCT01059851|11001425|FG001|NOT COMPLETED|Overall Study||0
9886733|NCT01059851|11001426|FG002|NOT COMPLETED|Overall Study||0
9886734|NCT01059851|11001427|FG003|NOT COMPLETED|Overall Study||0
9886735|NCT01059851|11001428|FG004|NOT COMPLETED|Overall Study||0
9886736|NCT01059851|11001429|FG005|NOT COMPLETED|Overall Study||0
9886737|NCT01059864|11001439|FG000|STARTED|Open-Label Run-In Phase||111
9886738|NCT01059864|11001440|FG001|STARTED|Open-Label Run-In Phase||0
9886739|NCT01059864|11001441|FG002|STARTED|Open-Label Run-In Phase||0
9886740|NCT01059864|11001439|FG000|COMPLETED|Open-Label Run-In Phase||98
9886741|NCT01059864|11001440|FG001|COMPLETED|Open-Label Run-In Phase||0
9886742|NCT01059864|11001441|FG002|COMPLETED|Open-Label Run-In Phase||0
9886743|NCT01059864|11001439|FG000|NOT COMPLETED|Open-Label Run-In Phase||13
9886744|NCT01059864|11001440|FG001|NOT COMPLETED|Open-Label Run-In Phase||0
9886745|NCT01059864|11001441|FG002|NOT COMPLETED|Open-Label Run-In Phase||0
9886746|NCT01059864|11001439|FG000|STARTED|Double-Blind Treatment Phase||0
9886747|NCT01059864|11001440|FG001|STARTED|Double-Blind Treatment Phase||50
9886748|NCT01059864|11001441|FG002|STARTED|Double-Blind Treatment Phase||48
9886749|NCT01059864|11001439|FG000|Treated|Double-Blind Treatment Phase||0
9886750|NCT01059864|11001440|FG001|Treated|Double-Blind Treatment Phase||50
9886751|NCT01059864|11001441|FG002|Treated|Double-Blind Treatment Phase||47
9886752|NCT01059864|11001439|FG000|COMPLETED|Double-Blind Treatment Phase||0
10008338|NCT01756456|11130654|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1
10008339|NCT01756456|11130655|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1
10008340|NCT01756456|11130656|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2
10008341|NCT01756456|11130657|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7
9886753|NCT01059864|11001440|FG001|COMPLETED|Double-Blind Treatment Phase||47
9886754|NCT01059864|11001441|FG002|COMPLETED|Double-Blind Treatment Phase||45
9886755|NCT01059864|11001439|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
9886756|NCT01059864|11001440|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
9886757|NCT01059864|11001441|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
9886758|NCT01059877|11001450|FG000|STARTED|Overall Study||6
9886759|NCT01059877|11001451|FG001|STARTED|Overall Study||5
10008342|NCT01756456|11130658|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13
10008343|NCT01756456|11130659|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4
10008344|NCT01756456|11130654|FG000|STARTED|Follow Up Period Phase I/II||6
9886760|NCT01059877|11001450|FG000|COMPLETED|Overall Study||6
9886761|NCT01059877|11001451|FG001|COMPLETED|Overall Study||3
9886762|NCT01059877|11001450|FG000|NOT COMPLETED|Overall Study||0
9886763|NCT01059877|11001451|FG001|NOT COMPLETED|Overall Study||2
9886764|NCT01059903|11001459|FG000|STARTED|Period 1: First Intervention- 24 Hours||25
9886765|NCT01059903|11001460|FG001|STARTED|Period 1: First Intervention- 24 Hours||25
9886766|NCT01059903|11001459|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24
9886767|NCT01059903|11001460|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24
9886768|NCT01059903|11001459|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
9886769|NCT01059903|11001460|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
9886770|NCT01059903|11001459|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24
9886771|NCT01059903|11001460|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24
9886772|NCT01059903|11001459|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
9886773|NCT01059903|11001460|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
9886774|NCT01059903|11001459|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
9886775|NCT01059903|11001460|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
9886776|NCT01059903|11001459|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24
9886777|NCT01059903|11001460|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24
9886778|NCT01059903|11001459|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
9886779|NCT01059903|11001460|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
10008345|NCT01756456|11130655|FG001|STARTED|Follow Up Period Phase I/II||6
10008346|NCT01756456|11130656|FG002|STARTED|Follow Up Period Phase I/II||2
10008347|NCT01756456|11130657|FG003|STARTED|Follow Up Period Phase I/II||45
9886780|NCT01059903|11001459|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24
9886781|NCT01059903|11001460|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24
9886782|NCT01059903|11001459|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
9886783|NCT01059903|11001460|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
9886784|NCT01059929|11001468|FG000|STARTED|Overall Study||20
9886785|NCT01059929|11001469|FG001|STARTED|Overall Study||21
9886786|NCT01059929|11001468|FG000|COMPLETED|Overall Study||20
9886787|NCT01059929|11001469|FG001|COMPLETED|Overall Study||21
9886788|NCT01059929|11001468|FG000|NOT COMPLETED|Overall Study||0
9886789|NCT01059929|11001469|FG001|NOT COMPLETED|Overall Study||0
9886790|NCT01059994|11001479|FG000|STARTED|Overall Study||3
9886791|NCT01059994|11001480|FG001|STARTED|Overall Study||2
9886792|NCT01059994|11001481|FG002|STARTED|Overall Study||3
9886793|NCT01059994|11001482|FG003|STARTED|Overall Study||4
9886794|NCT01059994|11001479|FG000|COMPLETED|Overall Study||3
9886795|NCT01059994|11001480|FG001|COMPLETED|Overall Study||2
9886796|NCT01059994|11001481|FG002|COMPLETED|Overall Study||3
9886797|NCT01059994|11001482|FG003|COMPLETED|Overall Study||3
9886798|NCT01059994|11001479|FG000|NOT COMPLETED|Overall Study||0
9886799|NCT01059994|11001480|FG001|NOT COMPLETED|Overall Study||0
9886800|NCT01059994|11001481|FG002|NOT COMPLETED|Overall Study||0
9886801|NCT01059994|11001482|FG003|NOT COMPLETED|Overall Study||1
9886802|NCT01060007|11001492|FG000|STARTED|Overall Study||80
9886803|NCT01060007|11001492|FG000|COMPLETED|Overall Study||76
9886804|NCT01060007|11001492|FG000|NOT COMPLETED|Overall Study||4
9886805|NCT01060020|11001499|FG000|STARTED|Overall Study||20
9886806|NCT01060020|11001499|FG000|COMPLETED|Overall Study||20
9886807|NCT01060020|11001499|FG000|NOT COMPLETED|Overall Study||0
9886808|NCT01060059|11001506|FG000|STARTED|Overall Study||444
9886809|NCT01060059|11001507|FG001|STARTED|Overall Study||438
9886810|NCT01060059|11001506|FG000|COMPLETED|Overall Study||377
9886811|NCT01060059|11001507|FG001|COMPLETED|Overall Study||371
9886812|NCT01060059|11001506|FG000|NOT COMPLETED|Overall Study||67
9886813|NCT01060059|11001507|FG001|NOT COMPLETED|Overall Study||67
9886814|NCT01060072|11001517|FG000|STARTED|Overall Study||206
9886815|NCT01060072|11001518|FG001|STARTED|Overall Study||201
9886816|NCT01060072|11001517|FG000|COMPLETED|Overall Study||204
9886817|NCT01060072|11001518|FG001|COMPLETED|Overall Study||196
9886818|NCT01060072|11001517|FG000|NOT COMPLETED|Overall Study||2
9886819|NCT01060072|11001518|FG001|NOT COMPLETED|Overall Study||5
9886820|NCT01060098|11001527|FG000|STARTED|Overall Study||25
9886821|NCT01060098|11001528|FG001|STARTED|Overall Study||15
9886822|NCT01060098|11001529|FG002|STARTED|Overall Study||8
9886823|NCT01060098|11001527|FG000|COMPLETED|Overall Study||25
9886824|NCT01060098|11001528|FG001|COMPLETED|Overall Study||15
9886825|NCT01060098|11001529|FG002|COMPLETED|Overall Study||8
9886826|NCT01060098|11001527|FG000|NOT COMPLETED|Overall Study||0
9886827|NCT01060098|11001528|FG001|NOT COMPLETED|Overall Study||0
9886828|NCT01060098|11001529|FG002|NOT COMPLETED|Overall Study||0
9886829|NCT01060111|11001540|FG000|STARTED|Overall Study||81
9886830|NCT01060111|11001541|FG001|STARTED|Overall Study||84
9886831|NCT01060111|11001542|FG002|STARTED|Overall Study||80
9886832|NCT01060111|11001540|FG000|Treated|Overall Study||81
9886833|NCT01060111|11001541|FG001|Treated|Overall Study||83
9886834|NCT01060111|11001542|FG002|Treated|Overall Study||79
9886835|NCT01060111|11001540|FG000|COMPLETED|Overall Study||54
9886836|NCT01060111|11001541|FG001|COMPLETED|Overall Study||61
9886837|NCT01060111|11001542|FG002|COMPLETED|Overall Study||45
9886838|NCT01060111|11001540|FG000|NOT COMPLETED|Overall Study||27
9886839|NCT01060111|11001541|FG001|NOT COMPLETED|Overall Study||23
9886840|NCT01060111|11001542|FG002|NOT COMPLETED|Overall Study||35
10008348|NCT01756456|11130658|FG004|STARTED|Follow Up Period Phase I/II||39
9886841|NCT01060124|11001553|FG000|STARTED|Overall Study||103
9886842|NCT01060124|11001553|FG000|COMPLETED|Overall Study||66
9886843|NCT01060124|11001553|FG000|NOT COMPLETED|Overall Study||37
9886844|NCT01060150|11001557|FG000|STARTED|Overall Study||115
9886845|NCT01060150|11001557|FG000|Treated|Overall Study||113
9886846|NCT01060150|11001557|FG000|COMPLETED|Overall Study||92
9886847|NCT01060150|11001557|FG000|NOT COMPLETED|Overall Study||23
9886848|NCT01060345|11001561|FG000|STARTED|Overall Study||20
9886849|NCT01060345|11001561|FG000|COMPLETED|Overall Study||20
9886850|NCT01060345|11001561|FG000|NOT COMPLETED|Overall Study||0
9886851|NCT01060384|11001565|FG000|STARTED|Overall Study||6
9886852|NCT01060384|11001566|FG001|STARTED|Overall Study||4
9886853|NCT01060384|11001567|FG002|STARTED|Overall Study||0
9886854|NCT01060384|11001568|FG003|STARTED|Overall Study||0
9886855|NCT01060384|11001569|FG004|STARTED|Overall Study||36
9886856|NCT01060384|11001565|FG000|COMPLETED|Overall Study||6
9886857|NCT01060384|11001566|FG001|COMPLETED|Overall Study||3
9886858|NCT01060384|11001567|FG002|COMPLETED|Overall Study||0
9886859|NCT01060384|11001568|FG003|COMPLETED|Overall Study||0
9886860|NCT01060384|11001569|FG004|COMPLETED|Overall Study||34
9886861|NCT01060384|11001565|FG000|NOT COMPLETED|Overall Study||0
9886862|NCT01060384|11001566|FG001|NOT COMPLETED|Overall Study||1
9886863|NCT01060384|11001567|FG002|NOT COMPLETED|Overall Study||0
9886864|NCT01060384|11001568|FG003|NOT COMPLETED|Overall Study||0
9886865|NCT01060384|11001569|FG004|NOT COMPLETED|Overall Study||2
9886866|NCT01060540|11001580|FG000|STARTED|Overall Study||303
9886867|NCT01060540|11001581|FG001|STARTED|Overall Study||298
9886868|NCT01060540|11001580|FG000|COMPLETED|Overall Study||239
9886869|NCT01060540|11001581|FG001|COMPLETED|Overall Study||233
9886870|NCT01060540|11001580|FG000|NOT COMPLETED|Overall Study||64
9886871|NCT01060540|11001581|FG001|NOT COMPLETED|Overall Study||65
9886872|NCT01060553|11001589|FG000|STARTED|Overall Study||15
9886873|NCT01060553|11001590|FG001|STARTED|Overall Study||15
9886874|NCT01060553|11001589|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
9886875|NCT01060553|11001590|FG001|COMPLETED|Overall Study||5
9886876|NCT01060553|11001589|FG000|NOT COMPLETED|Overall Study||9
9886877|NCT01060553|11001590|FG001|NOT COMPLETED|Overall Study||10
9886878|NCT01060592|11001597|FG000|STARTED|4-6w||35
9886879|NCT01060592|11001598|FG001|STARTED|4-6w||49
9886880|NCT01060592|11001597|FG000|COMPLETED|4-6w||23
9886881|NCT01060592|11001598|FG001|COMPLETED|4-6w||39
9886882|NCT01060592|11001597|FG000|NOT COMPLETED|4-6w||12
9886883|NCT01060592|11001598|FG001|NOT COMPLETED|4-6w||10
9886884|NCT01060592|11001597|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
9886885|NCT01060592|11001598|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
9886886|NCT01060592|11001597|FG000|COMPLETED|12m||35
9886887|NCT01060592|11001598|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
9886888|NCT01060592|11001597|FG000|NOT COMPLETED|12m||0
9886889|NCT01060592|11001598|FG001|NOT COMPLETED|12m||18
9886890|NCT01060670|11001606|FG000|STARTED|Run In||0
9886891|NCT01060670|11001607|FG001|STARTED|Run In||545
9886892|NCT01060670|11001606|FG000|COMPLETED|Run In||0
9886893|NCT01060670|11001607|FG001|COMPLETED|Run In||307
9886894|NCT01060670|11001606|FG000|NOT COMPLETED|Run In||0
9886895|NCT01060670|11001607|FG001|NOT COMPLETED|Run In||238
9886896|NCT01060670|11001606|FG000|STARTED|Treatment Phase||154
9886897|NCT01060670|11001607|FG001|STARTED|Treatment Phase||153
9886898|NCT01060670|11001606|FG000|Healed at End of Treatment Phase|Treatment Phase||79
9886899|NCT01060670|11001607|FG001|Healed at End of Treatment Phase|Treatment Phase||49
9886900|NCT01060670|11001606|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49
9886901|NCT01060670|11001607|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68
9886902|NCT01060670|11001606|FG000|Withdrew From Treatment|Treatment Phase||26
9886903|NCT01060670|11001607|FG001|Withdrew From Treatment|Treatment Phase||36
9886904|NCT01060670|11001606|FG000|COMPLETED|Treatment Phase||128
9886905|NCT01060670|11001607|FG001|COMPLETED|Treatment Phase||117
9886906|NCT01060670|11001606|FG000|NOT COMPLETED|Treatment Phase||26
9886907|NCT01060670|11001607|FG001|NOT COMPLETED|Treatment Phase||36
9886908|NCT01060670|11001606|FG000|STARTED|Follow up Phase||128
9886909|NCT01060670|11001607|FG001|STARTED|Follow up Phase||117
9886910|NCT01060670|11001606|FG000|Recurrence|Follow up Phase||14
9886911|NCT01060670|11001607|FG001|Recurrence|Follow up Phase||9
9886912|NCT01060670|11001606|FG000|Withdrew From Follow up Phase|Follow up Phase||22
9886913|NCT01060670|11001607|FG001|Withdrew From Follow up Phase|Follow up Phase||35
9886914|NCT01060670|11001606|FG000|COMPLETED|Follow up Phase||106
10109198|NCT02473614|11239806|FG000|STARTED|First Intervention (3 Weeks)||6
10109199|NCT02473614|11239807|FG001|STARTED|First Intervention (3 Weeks)||5
10109200|NCT02473614|11239806|FG000|COMPLETED|First Intervention (3 Weeks)||5
10109201|NCT02473614|11239807|FG001|COMPLETED|First Intervention (3 Weeks)||5
10109202|NCT02473614|11239806|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
10109203|NCT02473614|11239807|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10109204|NCT02473614|11239806|FG000|STARTED|Wash Out Period (3 Weeks)||5
9886915|NCT01060670|11001607|FG001|COMPLETED|Follow up Phase||82
9886916|NCT01060670|11001606|FG000|NOT COMPLETED|Follow up Phase||22
9886917|NCT01060670|11001607|FG001|NOT COMPLETED|Follow up Phase||35
9886918|NCT01061008|11001617|FG000|STARTED|Overall Study||16
9886919|NCT01061008|11001618|FG001|STARTED|Overall Study||15
9886920|NCT01061008|11001617|FG000|COMPLETED|Overall Study||10
9886921|NCT01061008|11001618|FG001|COMPLETED|Overall Study||9
9886922|NCT01061008|11001617|FG000|NOT COMPLETED|Overall Study||6
9886923|NCT01061008|11001618|FG001|NOT COMPLETED|Overall Study||6
9886924|NCT01061034|11001624|FG000|STARTED|Aspirin||9
9886925|NCT01061034|11001624|FG000|COMPLETED|Aspirin||9
9886926|NCT01061034|11001624|FG000|NOT COMPLETED|Aspirin||0
9886927|NCT01061034|11001624|FG000|STARTED|Aspirin Plus Omeprazole||9
9886928|NCT01061034|11001624|FG000|COMPLETED|Aspirin Plus Omeprazole||9
9886929|NCT01061034|11001624|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0
9886930|NCT01061177|11001628|FG000|STARTED|Overall Study||1089
9886931|NCT01061177|11001628|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
9886932|NCT01061177|11001628|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983
9886933|NCT01061177|11001628|FG000|COMPLETED|Overall Study||881
9886934|NCT01061177|11001628|FG000|NOT COMPLETED|Overall Study||208
9886935|NCT01061333|11001632|FG000|STARTED|Period 1: Placebo Run-in||8
9886936|NCT01061333|11001633|FG001|STARTED|Period 1: Placebo Run-in||8
9886937|NCT01061333|11001632|FG000|COMPLETED|Period 1: Placebo Run-in||8
9886938|NCT01061333|11001633|FG001|COMPLETED|Period 1: Placebo Run-in||8
9886939|NCT01061333|11001632|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
9886940|NCT01061333|11001633|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
9886941|NCT01061333|11001632|FG000|STARTED|Period 2: 20-day Washout||8
9886942|NCT01061333|11001633|FG001|STARTED|Period 2: 20-day Washout||8
9886943|NCT01061333|11001632|FG000|COMPLETED|Period 2: 20-day Washout||8
9886944|NCT01061333|11001633|FG001|COMPLETED|Period 2: 20-day Washout||8
9886945|NCT01061333|11001632|FG000|NOT COMPLETED|Period 2: 20-day Washout||0
9886946|NCT01061333|11001633|FG001|NOT COMPLETED|Period 2: 20-day Washout||0
9886947|NCT01061333|11001632|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8
9886948|NCT01061333|11001633|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8
9886949|NCT01061333|11001632|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
9886950|NCT01061333|11001633|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
9886951|NCT01061333|11001632|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
9886952|NCT01061333|11001633|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
9886953|NCT01061333|11001632|FG000|STARTED|Period 4: 20-day Washout||8
9886954|NCT01061333|11001633|FG001|STARTED|Period 4: 20-day Washout||8
9886955|NCT01061333|11001632|FG000|COMPLETED|Period 4: 20-day Washout||8
10008349|NCT01756456|11130659|FG005|STARTED|Follow Up Period Phase I/II||48
10008350|NCT01756456|11130654|FG000|COMPLETED|Follow Up Period Phase I/II||5
10008351|NCT01756456|11130655|FG001|COMPLETED|Follow Up Period Phase I/II||5
10008352|NCT01756456|11130656|FG002|COMPLETED|Follow Up Period Phase I/II||1
10008353|NCT01756456|11130657|FG003|COMPLETED|Follow Up Period Phase I/II||12
9886956|NCT01061333|11001633|FG001|COMPLETED|Period 4: 20-day Washout||7
9886957|NCT01061333|11001632|FG000|NOT COMPLETED|Period 4: 20-day Washout||0
9886958|NCT01061333|11001633|FG001|NOT COMPLETED|Period 4: 20-day Washout||1
9886959|NCT01061333|11001632|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8
9886960|NCT01061333|11001633|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7
9886961|NCT01061333|11001632|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
9886962|NCT01061333|11001633|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
9886963|NCT01061333|11001632|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
9886964|NCT01061333|11001633|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
9886965|NCT01061333|11001632|FG000|STARTED|Period 6: 20-day Washout||8
9886966|NCT01061333|11001633|FG001|STARTED|Period 6: 20-day Washout||7
9886967|NCT01061333|11001632|FG000|COMPLETED|Period 6: 20-day Washout||8
9886968|NCT01061333|11001633|FG001|COMPLETED|Period 6: 20-day Washout||7
9886969|NCT01061333|11001632|FG000|NOT COMPLETED|Period 6: 20-day Washout||0
9886970|NCT01061333|11001633|FG001|NOT COMPLETED|Period 6: 20-day Washout||0
9886971|NCT01061333|11001632|FG000|STARTED|Period 7: Mometasone||8
9886972|NCT01061333|11001633|FG001|STARTED|Period 7: Mometasone||7
9886973|NCT01061333|11001632|FG000|COMPLETED|Period 7: Mometasone||8
9886974|NCT01061333|11001633|FG001|COMPLETED|Period 7: Mometasone||7
9886975|NCT01061333|11001632|FG000|NOT COMPLETED|Period 7: Mometasone||0
9886976|NCT01061333|11001633|FG001|NOT COMPLETED|Period 7: Mometasone||0
9886977|NCT01061359|11001644|FG000|STARTED|Overall Study||1972
9886978|NCT01061359|11001644|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
9886979|NCT01061359|11001644|FG000|NOT COMPLETED|Overall Study||1302
9886980|NCT01061385|11001650|FG000|STARTED|Overall Study||21
9886981|NCT01061385|11001651|FG001|STARTED|Overall Study||9
9886982|NCT01061385|11001650|FG000|COMPLETED|Overall Study||20
9886983|NCT01061385|11001651|FG001|COMPLETED|Overall Study||8
9886984|NCT01061385|11001650|FG000|NOT COMPLETED|Overall Study||1
9886985|NCT01061385|11001651|FG001|NOT COMPLETED|Overall Study||1
9886986|NCT01061476|11001658|FG000|STARTED|Overall Study||12
9886987|NCT01061476|11001658|FG000|COMPLETED|Overall Study||12
9886988|NCT01061476|11001658|FG000|NOT COMPLETED|Overall Study||0
9886989|NCT01061528|11001664|FG000|STARTED|Overall Study||62
9886990|NCT01061528|11001665|FG001|STARTED|Overall Study||54
9886991|NCT01061528|11001664|FG000|COMPLETED|Overall Study||59
9886992|NCT01061528|11001665|FG001|COMPLETED|Overall Study||52
9886993|NCT01061528|11001664|FG000|NOT COMPLETED|Overall Study||3
9886994|NCT01061528|11001665|FG001|NOT COMPLETED|Overall Study||2
9886995|NCT01061567|11001671|FG000|STARTED|Overall Study||1814
9886996|NCT01061567|11001671|FG000|COMPLETED|Overall Study||1738
9886997|NCT01061567|11001671|FG000|NOT COMPLETED|Overall Study||76
9886998|NCT01061606|11001675|FG000|STARTED|Overall Study||8
9886999|NCT01061606|11001675|FG000|COMPLETED|Overall Study||0
9887000|NCT01061606|11001675|FG000|NOT COMPLETED|Overall Study||8
9887001|NCT01061671|11001681|FG000|STARTED|Overall Study||433
9887002|NCT01061671|11001682|FG001|STARTED|Overall Study||452
9887003|NCT01061671|11001681|FG000|COMPLETED|Overall Study||386
9887004|NCT01061671|11001682|FG001|COMPLETED|Overall Study||397
9887005|NCT01061671|11001681|FG000|NOT COMPLETED|Overall Study||47
9887006|NCT01061671|11001682|FG001|NOT COMPLETED|Overall Study||55
9887007|NCT01061710|11001688|FG000|STARTED|Overall Study||20
9887008|NCT01061710|11001688|FG000|COMPLETED|Overall Study||6
9887009|NCT01061710|11001688|FG000|NOT COMPLETED|Overall Study||14
9887010|NCT01061723|11001698|FG000|STARTED|Overall Study||50
9887011|NCT01061723|11001699|FG001|STARTED|Overall Study||49
9887012|NCT01061723|11001700|FG002|STARTED|Overall Study||50
9887013|NCT01061723|11001701|FG003|STARTED|Overall Study||52
9887014|NCT01061723|11001702|FG004|STARTED|Overall Study||50
9887015|NCT01061723|11001703|FG005|STARTED|Overall Study||50
9887016|NCT01061723|11001698|FG000|Treated|Overall Study||50
9887017|NCT01061723|11001699|FG001|Treated|Overall Study||49
9887018|NCT01061723|11001700|FG002|Treated|Overall Study||50
9887019|NCT01061723|11001701|FG003|Treated|Overall Study||52
9887020|NCT01061723|11001702|FG004|Treated|Overall Study||50
9887021|NCT01061723|11001703|FG005|Treated|Overall Study||49
9887022|NCT01061723|11001698|FG000|COMPLETED|Overall Study||46
9887023|NCT01061723|11001699|FG001|COMPLETED|Overall Study||43
9887024|NCT01061723|11001700|FG002|COMPLETED|Overall Study||40
9887025|NCT01061723|11001701|FG003|COMPLETED|Overall Study||44
9887026|NCT01061723|11001702|FG004|COMPLETED|Overall Study||47
9887027|NCT01061723|11001703|FG005|COMPLETED|Overall Study||41
9887028|NCT01061723|11001698|FG000|NOT COMPLETED|Overall Study||4
9887029|NCT01061723|11001699|FG001|NOT COMPLETED|Overall Study||6
9887030|NCT01061723|11001700|FG002|NOT COMPLETED|Overall Study||10
9887031|NCT01061723|11001701|FG003|NOT COMPLETED|Overall Study||8
9887032|NCT01061723|11001702|FG004|NOT COMPLETED|Overall Study||3
9887033|NCT01061723|11001703|FG005|NOT COMPLETED|Overall Study||9
9887034|NCT01061736|11001732|FG000|STARTED|Overall Study||50
9887035|NCT01061736|11001733|FG001|STARTED|Overall Study||50
9887036|NCT01061736|11001734|FG002|STARTED|Overall Study||51
9887037|NCT01061736|11001735|FG003|STARTED|Overall Study||51
9887038|NCT01061736|11001736|FG004|STARTED|Overall Study||52
9887039|NCT01061736|11001737|FG005|STARTED|Overall Study||52
9887040|NCT01061736|11001738|FG006|STARTED|Overall Study||84
9887041|NCT01061736|11001739|FG007|STARTED|Overall Study||430
9887042|NCT01061736|11001740|FG008|STARTED|Overall Study||427
9887043|NCT01061736|11001741|FG009|STARTED|Overall Study||428
9887044|NCT01061736|11001732|FG000|Treated|Overall Study||50
9887045|NCT01061736|11001733|FG001|Treated|Overall Study||50
9887046|NCT01061736|11001734|FG002|Treated|Overall Study||51
9887047|NCT01061736|11001735|FG003|Treated|Overall Study||51
9887048|NCT01061736|11001736|FG004|Treated|Overall Study||51
9887049|NCT01061736|11001737|FG005|Treated|Overall Study||52
9887050|NCT01061736|11001738|FG006|Treated|Overall Study||84
9887051|NCT01061736|11001739|FG007|Treated|Overall Study||428
9887052|NCT01061736|11001740|FG008|Treated|Overall Study||426
9887053|NCT01061736|11001741|FG009|Treated|Overall Study||428
9887054|NCT01061736|11001732|FG000|Rescued|Overall Study||0
9887055|NCT01061736|11001733|FG001|Rescued|Overall Study||0
9887056|NCT01061736|11001734|FG002|Rescued|Overall Study||0
9887057|NCT01061736|11001735|FG003|Rescued|Overall Study||0
10109205|NCT02473614|11239807|FG001|STARTED|Wash Out Period (3 Weeks)||5
10109206|NCT02473614|11239806|FG000|COMPLETED|Wash Out Period (3 Weeks)||5
9887058|NCT01061736|11001736|FG004|Rescued|Overall Study||0
9887059|NCT01061736|11001737|FG005|Rescued|Overall Study||0
9887060|NCT01061736|11001738|FG006|Rescued|Overall Study||0
9887061|NCT01061736|11001739|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
9887062|NCT01061736|11001740|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
9887063|NCT01061736|11001741|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
9887064|NCT01061736|11001732|FG000|COMPLETED|Overall Study||37
9887065|NCT01061736|11001733|FG001|COMPLETED|Overall Study||46
9887066|NCT01061736|11001734|FG002|COMPLETED|Overall Study||45
9887067|NCT01061736|11001735|FG003|COMPLETED|Overall Study||48
9887068|NCT01061736|11001736|FG004|COMPLETED|Overall Study||45
9887069|NCT01061736|11001737|FG005|COMPLETED|Overall Study||49
9887070|NCT01061736|11001738|FG006|COMPLETED|Overall Study||0
9887071|NCT01061736|11001739|FG007|COMPLETED|Overall Study||336
9887072|NCT01061736|11001740|FG008|COMPLETED|Overall Study||330
9887073|NCT01061736|11001741|FG009|COMPLETED|Overall Study||354
9887074|NCT01061736|11001732|FG000|NOT COMPLETED|Overall Study||13
9887075|NCT01061736|11001733|FG001|NOT COMPLETED|Overall Study||4
9887076|NCT01061736|11001734|FG002|NOT COMPLETED|Overall Study||6
10008354|NCT01756456|11130658|FG004|COMPLETED|Follow Up Period Phase I/II||13
9887077|NCT01061736|11001735|FG003|NOT COMPLETED|Overall Study||3
9887078|NCT01061736|11001736|FG004|NOT COMPLETED|Overall Study||7
9887079|NCT01061736|11001737|FG005|NOT COMPLETED|Overall Study||3
9887080|NCT01061736|11001738|FG006|NOT COMPLETED|Overall Study||84
9887081|NCT01061736|11001739|FG007|NOT COMPLETED|Overall Study||94
9887082|NCT01061736|11001740|FG008|NOT COMPLETED|Overall Study||97
9887083|NCT01061736|11001741|FG009|NOT COMPLETED|Overall Study||74
9954425|NCT01431950|11073271|FG001|COMPLETED|Overall Study||104
9954426|NCT01431950|11073270|FG000|NOT COMPLETED|Overall Study||19
9954427|NCT01431950|11073271|FG001|NOT COMPLETED|Overall Study||15
9954428|NCT01431963|11073277|FG000|STARTED|Overall Study||67
9954429|NCT01431963|11073277|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
9954430|NCT01431963|11073277|FG000|Received Treatment|Overall Study||65
9954431|NCT01431963|11073277|FG000|Complete EP (6 Weeks)|Overall Study||52
9954432|NCT01431963|11073277|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
9887084|NCT01061775|11001766|FG000|STARTED|Overall Study||19
9887085|NCT01061775|11001766|FG000|COMPLETED|Overall Study||16
9887086|NCT01061775|11001766|FG000|NOT COMPLETED|Overall Study||3
9887087|NCT01061866|11001771|FG000|STARTED|Overall Study||7
9887088|NCT01061866|11001771|FG000|COMPLETED|Overall Study||5
9887089|NCT01061866|11001771|FG000|NOT COMPLETED|Overall Study||2
9887090|NCT01062009|11001779|FG000|STARTED|Overall Study||7
9887091|NCT01062009|11001780|FG001|STARTED|Overall Study||6
9887092|NCT01062009|11001781|FG002|STARTED|Overall Study||6
9887093|NCT01062009|11001782|FG003|STARTED|Overall Study||6
9887094|NCT01062009|11001779|FG000|COMPLETED|Overall Study||6
9887095|NCT01062009|11001780|FG001|COMPLETED|Overall Study||6
10008355|NCT01756456|11130659|FG005|COMPLETED|Follow Up Period Phase I/II||15
10008356|NCT01756456|11130654|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1
10008357|NCT01756456|11130655|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1
10008358|NCT01756456|11130656|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1
10008359|NCT01756456|11130657|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33
10008360|NCT01756456|11130658|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26
10008361|NCT01756456|11130659|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33
9887096|NCT01062009|11001781|FG002|COMPLETED|Overall Study||6
9887097|NCT01062009|11001782|FG003|COMPLETED|Overall Study||6
9887098|NCT01062009|11001779|FG000|NOT COMPLETED|Overall Study||1
9887099|NCT01062009|11001780|FG001|NOT COMPLETED|Overall Study||0
9887100|NCT01062009|11001781|FG002|NOT COMPLETED|Overall Study||0
9887101|NCT01062009|11001782|FG003|NOT COMPLETED|Overall Study||0
9887102|NCT01062061|11001792|FG000|STARTED|Overall Study||754
9887103|NCT01062061|11001792|FG000|COMPLETED|Overall Study||727
9887104|NCT01062061|11001792|FG000|NOT COMPLETED|Overall Study||27
9887105|NCT01062074|11001800|FG000|STARTED|Overall Study||3605
9887106|NCT01062074|11001800|FG000|COMPLETED|Overall Study||3605
9887107|NCT01062074|11001800|FG000|NOT COMPLETED|Overall Study||0
9887108|NCT01062113|11001807|FG000|STARTED|Overall Study||133
9887109|NCT01062113|11001808|FG001|STARTED|Overall Study||64
9887110|NCT01062113|11001809|FG002|STARTED|Overall Study||58
9887111|NCT01062113|11001807|FG000|COMPLETED|Overall Study||93
9887112|NCT01062113|11001808|FG001|COMPLETED|Overall Study||42
9887113|NCT01062113|11001809|FG002|COMPLETED|Overall Study||27
9887114|NCT01062113|11001807|FG000|NOT COMPLETED|Overall Study||40
9887115|NCT01062113|11001808|FG001|NOT COMPLETED|Overall Study||22
9887116|NCT01062113|11001809|FG002|NOT COMPLETED|Overall Study||31
9887117|NCT01062126|11001817|FG000|STARTED|Overall Study||3389
9887118|NCT01062126|11001817|FG000|COMPLETED|Overall Study||2856
9887119|NCT01062126|11001817|FG000|NOT COMPLETED|Overall Study||533
9887120|NCT01062165|11001821|FG000|STARTED|Overall Study||18
9887121|NCT01062165|11001821|FG000|COMPLETED|Overall Study||18
9887122|NCT01062165|11001821|FG000|NOT COMPLETED|Overall Study||0
9887123|NCT01062230|11001825|FG000|STARTED|Overall Study||6
9887124|NCT01062230|11001825|FG000|COMPLETED|Overall Study||6
9887125|NCT01062230|11001825|FG000|NOT COMPLETED|Overall Study||0
9887126|NCT01062256|11001832|FG000|STARTED|Overall Study||55
9887127|NCT01062256|11001833|FG001|STARTED|Overall Study||103
9887128|NCT01062256|11001834|FG002|STARTED|Overall Study||107
9887129|NCT01062256|11001832|FG000|COMPLETED|Overall Study||52
9887130|NCT01062256|11001833|FG001|COMPLETED|Overall Study||96
9887131|NCT01062256|11001834|FG002|COMPLETED|Overall Study||103
9887132|NCT01062256|11001832|FG000|NOT COMPLETED|Overall Study||3
9887133|NCT01062256|11001833|FG001|NOT COMPLETED|Overall Study||7
9887134|NCT01062256|11001834|FG002|NOT COMPLETED|Overall Study||4
9887135|NCT01062269|11001842|FG000|STARTED|Overall Study||42
9887136|NCT01062269|11001842|FG000|COMPLETED|Overall Study||42
9887137|NCT01062269|11001842|FG000|NOT COMPLETED|Overall Study||0
9887138|NCT01062308|11001852|FG000|STARTED|Overall Study||80
9887139|NCT01062308|11001853|FG001|STARTED|Overall Study||82
9887140|NCT01062308|11001852|FG000|COMPLETED|Overall Study||64
9887141|NCT01062308|11001853|FG001|COMPLETED|Overall Study||72
9887142|NCT01062308|11001852|FG000|NOT COMPLETED|Overall Study||16
9887143|NCT01062308|11001853|FG001|NOT COMPLETED|Overall Study||10
9887144|NCT01062555|11001861|FG000|STARTED|Phase 1||266
9887145|NCT01062555|11001862|FG001|STARTED|Phase 1||261
9887146|NCT01062555|11001863|FG002|STARTED|Phase 1||0
10008362|NCT01756833|11130684|FG000|STARTED|Overall Study||133
9887147|NCT01062555|11001864|FG003|STARTED|Phase 1||0
9887148|NCT01062555|11001861|FG000|COMPLETED|Phase 1||243
9887149|NCT01062555|11001862|FG001|COMPLETED|Phase 1||235
9887150|NCT01062555|11001863|FG002|COMPLETED|Phase 1||0
9887151|NCT01062555|11001864|FG003|COMPLETED|Phase 1||0
9887152|NCT01062555|11001861|FG000|NOT COMPLETED|Phase 1||23
9887153|NCT01062555|11001862|FG001|NOT COMPLETED|Phase 1||26
9887154|NCT01062555|11001863|FG002|NOT COMPLETED|Phase 1||0
9887155|NCT01062555|11001864|FG003|NOT COMPLETED|Phase 1||0
9887156|NCT01062555|11001861|FG000|STARTED|Phase 2||0
9887157|NCT01062555|11001862|FG001|STARTED|Phase 2||0
9887158|NCT01062555|11001863|FG002|STARTED|Phase 2||86
9887159|NCT01062555|11001864|FG003|STARTED|Phase 2||87
9887160|NCT01062555|11001861|FG000|COMPLETED|Phase 2||0
9887161|NCT01062555|11001862|FG001|COMPLETED|Phase 2||0
9887162|NCT01062555|11001863|FG002|COMPLETED|Phase 2||71
9887163|NCT01062555|11001864|FG003|COMPLETED|Phase 2||53
9887164|NCT01062555|11001861|FG000|NOT COMPLETED|Phase 2||0
9887165|NCT01062555|11001862|FG001|NOT COMPLETED|Phase 2||0
9887166|NCT01062555|11001863|FG002|NOT COMPLETED|Phase 2||15
9887167|NCT01062555|11001864|FG003|NOT COMPLETED|Phase 2||34
9887168|NCT01062568|11001876|FG000|STARTED|Overall Study||10
9887169|NCT01062568|11001877|FG001|STARTED|Overall Study||40
9887170|NCT01062568|11001876|FG000|COMPLETED|Overall Study||10
9887171|NCT01062568|11001877|FG001|COMPLETED|Overall Study||40
9887172|NCT01062568|11001876|FG000|NOT COMPLETED|Overall Study||0
9887173|NCT01062568|11001877|FG001|NOT COMPLETED|Overall Study||0
9887174|NCT01062763|11001890|FG000|STARTED|Overall Study|119 randomized.|58
9887175|NCT01062763|11001891|FG001|STARTED|Overall Study||61
9887176|NCT01062763|11001890|FG000|COMPLETED|Overall Study||55
9887177|NCT01062763|11001891|FG001|COMPLETED|Overall Study||57
9887178|NCT01062763|11001890|FG000|NOT COMPLETED|Overall Study||3
9887179|NCT01062763|11001891|FG001|NOT COMPLETED|Overall Study||4
9887180|NCT01062841|11001899|FG000|STARTED|Overall Study||203
9887181|NCT01062841|11001900|FG001|STARTED|Overall Study||215
9887182|NCT01062841|11001899|FG000|COMPLETED|Overall Study||154
9887183|NCT01062841|11001900|FG001|COMPLETED|Overall Study||162
9887184|NCT01062841|11001899|FG000|NOT COMPLETED|Overall Study||49
9887185|NCT01062841|11001900|FG001|NOT COMPLETED|Overall Study||53
9887186|NCT01062893|11001908|FG000|STARTED|Overall Study||41
9887187|NCT01062893|11001909|FG001|STARTED|Overall Study||41
9887188|NCT01062893|11001908|FG000|COMPLETED|Overall Study||27
9887189|NCT01062893|11001909|FG001|COMPLETED|Overall Study||28
9887190|NCT01062893|11001908|FG000|NOT COMPLETED|Overall Study||14
9887191|NCT01062893|11001909|FG001|NOT COMPLETED|Overall Study||13
9887192|NCT01062971|11001917|FG000|STARTED|Overall Study||60
9887193|NCT01062971|11001918|FG001|STARTED|Overall Study||63
9887194|NCT01062971|11001917|FG000|COMPLETED|Overall Study||56
9887195|NCT01062971|11001918|FG001|COMPLETED|Overall Study||56
9887196|NCT01062971|11001917|FG000|NOT COMPLETED|Overall Study||4
9887197|NCT01062971|11001918|FG001|NOT COMPLETED|Overall Study||7
9887198|NCT01063036|11001924|FG000|STARTED|Participants Treated With Study Drug||92
9887199|NCT01063036|11001924|FG000|COMPLETED|Participants Treated With Study Drug||86
9887200|NCT01063036|11001924|FG000|NOT COMPLETED|Participants Treated With Study Drug||6
9887201|NCT01063036|11001924|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
9887202|NCT01063036|11001924|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
9887203|NCT01063036|11001924|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
9887204|NCT01063049|11001931|FG000|STARTED|Overall Study||200
9887205|NCT01063049|11001932|FG001|STARTED|Overall Study||200
9887206|NCT01063049|11001933|FG002|STARTED|Overall Study||200
9887207|NCT01063049|11001931|FG000|COMPLETED|Overall Study||200
9887208|NCT01063049|11001932|FG001|COMPLETED|Overall Study||200
9887209|NCT01063049|11001933|FG002|COMPLETED|Overall Study||200
9887210|NCT01063049|11001931|FG000|NOT COMPLETED|Overall Study||0
9887211|NCT01063049|11001932|FG001|NOT COMPLETED|Overall Study||0
9887212|NCT01063049|11001933|FG002|NOT COMPLETED|Overall Study||0
9887213|NCT01063062|11001943|FG000|STARTED|Overall Study||30
9887214|NCT01063062|11001944|FG001|STARTED|Overall Study||77
9887215|NCT01063062|11001943|FG000|Received Study Drug|Overall Study||29
9887216|NCT01063062|11001944|FG001|Received Study Drug|Overall Study||76
9887217|NCT01063062|11001943|FG000|COMPLETED|Overall Study||22
9887218|NCT01063062|11001944|FG001|COMPLETED|Overall Study||65
9887219|NCT01063062|11001943|FG000|NOT COMPLETED|Overall Study||8
9887220|NCT01063062|11001944|FG001|NOT COMPLETED|Overall Study||12
9887221|NCT01063075|11001951|FG000|STARTED|Overall Study||2
9887222|NCT01063075|11001952|FG001|STARTED|Overall Study||3
9887223|NCT01063075|11001953|FG002|STARTED|Overall Study||14
9887224|NCT01063075|11001954|FG003|STARTED|Overall Study||15
9887225|NCT01063075|11001951|FG000|COMPLETED|Overall Study||1
9887226|NCT01063075|11001952|FG001|COMPLETED|Overall Study||1
9887227|NCT01063075|11001953|FG002|COMPLETED|Overall Study||9
9887228|NCT01063075|11001954|FG003|COMPLETED|Overall Study||14
9887229|NCT01063075|11001951|FG000|NOT COMPLETED|Overall Study||1
9887230|NCT01063075|11001952|FG001|NOT COMPLETED|Overall Study||2
9887231|NCT01063075|11001953|FG002|NOT COMPLETED|Overall Study||5
9887232|NCT01063075|11001954|FG003|NOT COMPLETED|Overall Study||1
9887233|NCT01063153|11001966|FG000|STARTED|Overall Study||33
9887234|NCT01063153|11001967|FG001|STARTED|Overall Study||38
9887235|NCT01063153|11001966|FG000|COMPLETED|Overall Study||31
9887236|NCT01063153|11001967|FG001|COMPLETED|Overall Study||26
9887237|NCT01063153|11001966|FG000|NOT COMPLETED|Overall Study||2
9887238|NCT01063153|11001967|FG001|NOT COMPLETED|Overall Study||12
9887239|NCT01063283|11001979|FG000|STARTED|Cycle 1||20
9887240|NCT01063283|11001980|FG001|STARTED|Cycle 1||0
9887241|NCT01063283|11001981|FG002|STARTED|Cycle 1||0
9887242|NCT01063283|11001979|FG000|COMPLETED|Cycle 1||17
9887243|NCT01063283|11001980|FG001|COMPLETED|Cycle 1||0
9887244|NCT01063283|11001981|FG002|COMPLETED|Cycle 1||0
9887245|NCT01063283|11001979|FG000|NOT COMPLETED|Cycle 1||3
9887246|NCT01063283|11001980|FG001|NOT COMPLETED|Cycle 1||0
9887247|NCT01063283|11001981|FG002|NOT COMPLETED|Cycle 1||0
9887248|NCT01063283|11001979|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
9887249|NCT01063283|11001980|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
9887250|NCT01063283|11001981|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
9887251|NCT01063283|11001979|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
9887252|NCT01063283|11001980|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
9887253|NCT01063283|11001981|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
9887254|NCT01063283|11001979|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
9887255|NCT01063283|11001980|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
9887256|NCT01063283|11001981|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
9887257|NCT01063348|11001989|FG000|STARTED|Overall Study||35
9887258|NCT01063348|11001990|FG001|STARTED|Overall Study||31
9887259|NCT01063348|11001989|FG000|COMPLETED|Overall Study||32
9887260|NCT01063348|11001990|FG001|COMPLETED|Overall Study||21
9887261|NCT01063348|11001989|FG000|NOT COMPLETED|Overall Study||3
9887262|NCT01063348|11001990|FG001|NOT COMPLETED|Overall Study||10
9887263|NCT01063595|11001996|FG000|STARTED|Enrolled in Study and Randomized||32
9887264|NCT01063595|11001997|FG001|STARTED|Enrolled in Study and Randomized||31
9887265|NCT01063595|11001996|FG000|Received Treatment|Enrolled in Study and Randomized||31
9887266|NCT01063595|11001997|FG001|Received Treatment|Enrolled in Study and Randomized||29
9887267|NCT01063595|11001996|FG000|COMPLETED|Enrolled in Study and Randomized||31
9887268|NCT01063595|11001997|FG001|COMPLETED|Enrolled in Study and Randomized||29
9887269|NCT01063595|11001996|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1
9887270|NCT01063595|11001997|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2
9887271|NCT01063595|11001996|FG000|STARTED|First Intervention||31
9887272|NCT01063595|11001997|FG001|STARTED|First Intervention||29
9887273|NCT01063595|11001996|FG000|COMPLETED|First Intervention||29
9887274|NCT01063595|11001997|FG001|COMPLETED|First Intervention||24
9887275|NCT01063595|11001996|FG000|NOT COMPLETED|First Intervention||2
9887276|NCT01063595|11001997|FG001|NOT COMPLETED|First Intervention||5
9887277|NCT01063595|11001996|FG000|STARTED|Second Intervention||29
9887278|NCT01063595|11001997|FG001|STARTED|Second Intervention||24
9887279|NCT01063595|11001996|FG000|COMPLETED|Second Intervention||29
9887280|NCT01063595|11001997|FG001|COMPLETED|Second Intervention||24
9887281|NCT01063595|11001996|FG000|NOT COMPLETED|Second Intervention||0
9887282|NCT01063595|11001997|FG001|NOT COMPLETED|Second Intervention||0
9887283|NCT01063712|11002003|FG000|STARTED|Overall Study||29
9887284|NCT01063712|11002003|FG000|COMPLETED|Overall Study||29
9887285|NCT01063712|11002003|FG000|NOT COMPLETED|Overall Study||0
9887286|NCT01063764|11002008|FG000|STARTED|1st Period (From Week 8 to Week 22)||73
9887287|NCT01063764|11002008|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
9887288|NCT01063764|11002008|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
9887289|NCT01063764|11002008|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
9887290|NCT01063764|11002008|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35
9887291|NCT01063764|11002008|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
9887292|NCT01063829|11002016|FG000|STARTED|Overall Study||33
9887293|NCT01063829|11002017|FG001|STARTED|Overall Study||31
9887294|NCT01063829|11002018|FG002|STARTED|Overall Study||34
9887295|NCT01063829|11002019|FG003|STARTED|Overall Study||33
9887296|NCT01063829|11002016|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
9887297|NCT01063829|11002017|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
9887298|NCT01063829|11002018|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
9887299|NCT01063829|11002019|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
9887300|NCT01063829|11002016|FG000|NOT COMPLETED|Overall Study||16
9887301|NCT01063829|11002017|FG001|NOT COMPLETED|Overall Study||10
9887302|NCT01063829|11002018|FG002|NOT COMPLETED|Overall Study||10
9887303|NCT01063829|11002019|FG003|NOT COMPLETED|Overall Study||21
9887304|NCT01063855|11002031|FG000|STARTED|Overall Study||245
9887305|NCT01063855|11002032|FG001|STARTED|Overall Study||250
9887306|NCT01063855|11002031|FG000|COMPLETED|Overall Study||208
9887307|NCT01063855|11002032|FG001|COMPLETED|Overall Study||221
9887308|NCT01063855|11002031|FG000|NOT COMPLETED|Overall Study||37
9887309|NCT01063855|11002032|FG001|NOT COMPLETED|Overall Study||29
9887310|NCT01063868|11002044|FG000|STARTED|Overall Study||35
9887311|NCT01063868|11002045|FG001|STARTED|Overall Study||12
10008363|NCT01756833|11130685|FG001|STARTED|Overall Study||128
10008364|NCT01756833|11130684|FG000|COMPLETED|Overall Study||129
10008365|NCT01756833|11130685|FG001|COMPLETED|Overall Study||125
10008366|NCT01756833|11130684|FG000|NOT COMPLETED|Overall Study||4
10008367|NCT01756833|11130685|FG001|NOT COMPLETED|Overall Study||3
10008368|NCT01756846|11130693|FG000|STARTED|Overall Study||1833
10008369|NCT01756846|11130694|FG001|STARTED|Overall Study||1833
10008370|NCT01756846|11130693|FG000|COMPLETED|Overall Study||1827
10008371|NCT01756846|11130694|FG001|COMPLETED|Overall Study||1821
10008372|NCT01756846|11130693|FG000|NOT COMPLETED|Overall Study||6
10008373|NCT01756846|11130694|FG001|NOT COMPLETED|Overall Study||12
10008374|NCT01756885|11130702|FG000|STARTED|Overall Study||102
10008375|NCT01756885|11130703|FG001|STARTED|Overall Study||105
10008376|NCT01756885|11130702|FG000|COMPLETED|Overall Study||79
10008377|NCT01756885|11130703|FG001|COMPLETED|Overall Study||79
10008378|NCT01756885|11130702|FG000|NOT COMPLETED|Overall Study||23
9887312|NCT01063868|11002044|FG000|COMPLETED|Overall Study||0
9887313|NCT01063868|11002045|FG001|COMPLETED|Overall Study||0
9887314|NCT01063868|11002044|FG000|NOT COMPLETED|Overall Study||35
9887315|NCT01063868|11002045|FG001|NOT COMPLETED|Overall Study||12
9887316|NCT01063881|11002054|FG000|STARTED|Overall Study||147
9887317|NCT01063881|11002055|FG001|STARTED|Overall Study||125
9887318|NCT01063881|11002056|FG002|STARTED|Overall Study||13
9887319|NCT01063881|11002054|FG000|COMPLETED|Overall Study||92
9887320|NCT01063881|11002055|FG001|COMPLETED|Overall Study||114
9887321|NCT01063881|11002056|FG002|COMPLETED|Overall Study||12
9887322|NCT01063881|11002054|FG000|NOT COMPLETED|Overall Study||55
9887323|NCT01063881|11002055|FG001|NOT COMPLETED|Overall Study||11
9887324|NCT01063881|11002056|FG002|NOT COMPLETED|Overall Study||1
9887325|NCT01063907|11002071|FG000|STARTED|Overall Study||15
9887326|NCT01063907|11002072|FG001|STARTED|Overall Study||80
10008379|NCT01756885|11130703|FG001|NOT COMPLETED|Overall Study||26
10008380|NCT01756898|11130713|FG000|STARTED|Overall Study||92
10008381|NCT01756898|11130714|FG001|STARTED|Overall Study||92
10008382|NCT01756898|11130715|FG002|STARTED|Overall Study||93
10008383|NCT01756898|11130716|FG003|STARTED|Overall Study||93
10008384|NCT01756898|11130713|FG000|COMPLETED|Overall Study||73
10008385|NCT01756898|11130714|FG001|COMPLETED|Overall Study||73
10008386|NCT01756898|11130715|FG002|COMPLETED|Overall Study||76
10008387|NCT01756898|11130716|FG003|COMPLETED|Overall Study||77
10008388|NCT01756898|11130713|FG000|NOT COMPLETED|Overall Study||19
10008389|NCT01756898|11130714|FG001|NOT COMPLETED|Overall Study||19
10008390|NCT01756898|11130715|FG002|NOT COMPLETED|Overall Study||17
10008391|NCT01756898|11130716|FG003|NOT COMPLETED|Overall Study||16
10008392|NCT01756976|11130731|FG000|STARTED|Overall Study||76
10008393|NCT01756976|11130732|FG001|STARTED|Overall Study||8
10008394|NCT01756976|11130731|FG000|COMPLETED|Overall Study||73
10008395|NCT01756976|11130732|FG001|COMPLETED|Overall Study||8
10008396|NCT01756976|11130731|FG000|NOT COMPLETED|Overall Study||3
10008397|NCT01756976|11130732|FG001|NOT COMPLETED|Overall Study||0
10008398|NCT01757067|11130740|FG000|STARTED|Overall Study||2
10008399|NCT01757067|11130741|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1
10008400|NCT01757067|11130740|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
10008401|NCT01757067|11130741|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
10008402|NCT01757067|11130740|FG000|NOT COMPLETED|Overall Study||0
10008403|NCT01757067|11130741|FG001|NOT COMPLETED|Overall Study||0
10008404|NCT01757171|11130749|FG000|STARTED|Overall Study||61
10008405|NCT01757171|11130750|FG001|STARTED|Overall Study||24
10008406|NCT01757171|11130749|FG000|COMPLETED|Overall Study||53
10008407|NCT01757171|11130750|FG001|COMPLETED|Overall Study||23
10008408|NCT01757171|11130749|FG000|NOT COMPLETED|Overall Study||8
10008409|NCT01757171|11130750|FG001|NOT COMPLETED|Overall Study||1
10008410|NCT01757184|11130758|FG000|STARTED|Double-blind Period||36
10008411|NCT01757184|11130759|FG001|STARTED|Double-blind Period||30
10008412|NCT01757184|11130760|FG002|STARTED|Double-blind Period||0
10008413|NCT01757184|11130761|FG003|STARTED|Double-blind Period||0
10008414|NCT01757184|11130758|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36
10008415|NCT01757184|11130759|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30
10008416|NCT01757184|11130760|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0
10008417|NCT01757184|11130761|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0
10008418|NCT01757184|11130758|FG000|COMPLETED|Double-blind Period||35
10008419|NCT01757184|11130759|FG001|COMPLETED|Double-blind Period||30
10008420|NCT01757184|11130760|FG002|COMPLETED|Double-blind Period||0
10008421|NCT01757184|11130761|FG003|COMPLETED|Double-blind Period||0
10008422|NCT01757184|11130758|FG000|NOT COMPLETED|Double-blind Period||1
10008423|NCT01757184|11130759|FG001|NOT COMPLETED|Double-blind Period||0
10008424|NCT01757184|11130760|FG002|NOT COMPLETED|Double-blind Period||0
10008425|NCT01757184|11130761|FG003|NOT COMPLETED|Double-blind Period||0
10008426|NCT01757184|11130758|FG000|STARTED|Open-label Period||0
10008427|NCT01757184|11130759|FG001|STARTED|Open-label Period||0
10008428|NCT01757184|11130760|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
10008429|NCT01757184|11130761|FG003|STARTED|Open-label Period||30
10008430|NCT01757184|11130758|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0
9887327|NCT01063907|11002071|FG000|COMPLETED|Overall Study||15
9887328|NCT01063907|11002072|FG001|COMPLETED|Overall Study||80
9887329|NCT01063907|11002071|FG000|NOT COMPLETED|Overall Study||0
9887330|NCT01063907|11002072|FG001|NOT COMPLETED|Overall Study||0
9887331|NCT01063972|11002096|FG000|STARTED|Overall Study||310
9887332|NCT01063972|11002097|FG001|STARTED|Overall Study||296
9887333|NCT01063972|11002096|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
9887334|NCT01063972|11002097|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
9887335|NCT01063972|11002096|FG000|NOT COMPLETED|Overall Study||14
9887336|NCT01063972|11002097|FG001|NOT COMPLETED|Overall Study||12
9887337|NCT01064076|11002103|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
9887338|NCT01064076|11002103|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
9887339|NCT01064076|11002103|FG000|NOT COMPLETED|Overall Study||18
9887340|NCT01064167|11002110|FG000|STARTED|Overall Study||130
9887341|NCT01064167|11002111|FG001|STARTED|Overall Study||130
9887342|NCT01064167|11002110|FG000|COMPLETED|Overall Study||116
9887343|NCT01064167|11002111|FG001|COMPLETED|Overall Study||115
10008431|NCT01757184|11130759|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0
10008432|NCT01757184|11130760|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36
10008433|NCT01757184|11130761|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30
10008434|NCT01757184|11130758|FG000|COMPLETED|Open-label Period||0
10008435|NCT01757184|11130759|FG001|COMPLETED|Open-label Period||0
10008436|NCT01757184|11130760|FG002|COMPLETED|Open-label Period||32
9887344|NCT01064167|11002110|FG000|NOT COMPLETED|Overall Study||14
9887345|NCT01064167|11002111|FG001|NOT COMPLETED|Overall Study||15
9887346|NCT01064284|11002119|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125
10008437|NCT01757184|11130761|FG003|COMPLETED|Open-label Period||27
10008438|NCT01757184|11130758|FG000|NOT COMPLETED|Open-label Period||0
10008439|NCT01757184|11130759|FG001|NOT COMPLETED|Open-label Period||0
10008440|NCT01757184|11130760|FG002|NOT COMPLETED|Open-label Period||4
10008441|NCT01757184|11130761|FG003|NOT COMPLETED|Open-label Period||3
10008442|NCT01757197|11130775|FG000|STARTED|Overall Study||2
10008443|NCT01757197|11130775|FG000|COMPLETED|Overall Study||0
9887347|NCT01064284|11002120|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126
9887348|NCT01064284|11002119|FG000|COMPLETED|Overall Study||107
9887349|NCT01064284|11002120|FG001|COMPLETED|Overall Study||109
9887350|NCT01064284|11002119|FG000|NOT COMPLETED|Overall Study||18
9887351|NCT01064284|11002120|FG001|NOT COMPLETED|Overall Study||17
9887352|NCT01064297|11002130|FG000|STARTED|Overall Study||2567
9887353|NCT01064297|11002131|FG001|STARTED|Overall Study||219
9887354|NCT01064297|11002132|FG002|STARTED|Overall Study||630
9887355|NCT01064297|11002130|FG000|COMPLETED|Overall Study||1776
9887356|NCT01064297|11002131|FG001|COMPLETED|Overall Study||171
9887357|NCT01064297|11002132|FG002|COMPLETED|Overall Study||497
9887358|NCT01064297|11002130|FG000|NOT COMPLETED|Overall Study||791
9887359|NCT01064297|11002131|FG001|NOT COMPLETED|Overall Study||48
9887360|NCT01064297|11002132|FG002|NOT COMPLETED|Overall Study||133
9887361|NCT01064310|11002149|FG000|STARTED|Period 1||82
9887362|NCT01064310|11002150|FG001|STARTED|Period 1||86
9887363|NCT01064310|11002151|FG002|STARTED|Period 1||0
9887364|NCT01064310|11002149|FG000|COMPLETED|Period 1||68
9887365|NCT01064310|11002150|FG001|COMPLETED|Period 1||68
9887366|NCT01064310|11002151|FG002|COMPLETED|Period 1||0
9887367|NCT01064310|11002149|FG000|NOT COMPLETED|Period 1||14
9887368|NCT01064310|11002150|FG001|NOT COMPLETED|Period 1||18
9887369|NCT01064310|11002151|FG002|NOT COMPLETED|Period 1||0
9887370|NCT01064310|11002149|FG000|STARTED|Period 2||68
9887371|NCT01064310|11002150|FG001|STARTED|Period 2||68
9887372|NCT01064310|11002151|FG002|STARTED|Period 2||0
9887373|NCT01064310|11002149|FG000|COMPLETED|Period 2||64
9887374|NCT01064310|11002150|FG001|COMPLETED|Period 2||62
9887375|NCT01064310|11002151|FG002|COMPLETED|Period 2||0
9887376|NCT01064310|11002149|FG000|NOT COMPLETED|Period 2||4
9887377|NCT01064310|11002150|FG001|NOT COMPLETED|Period 2||6
9887378|NCT01064310|11002151|FG002|NOT COMPLETED|Period 2||0
9887379|NCT01064310|11002149|FG000|STARTED|Open Label Pazopinib||0
9887380|NCT01064310|11002150|FG001|STARTED|Open Label Pazopinib||0
9887381|NCT01064310|11002151|FG002|STARTED|Open Label Pazopinib||84
9887382|NCT01064310|11002149|FG000|COMPLETED|Open Label Pazopinib||0
9887383|NCT01064310|11002150|FG001|COMPLETED|Open Label Pazopinib||0
9887384|NCT01064310|11002151|FG002|COMPLETED|Open Label Pazopinib||0
9887385|NCT01064310|11002149|FG000|NOT COMPLETED|Open Label Pazopinib||0
9887386|NCT01064310|11002150|FG001|NOT COMPLETED|Open Label Pazopinib||0
9887387|NCT01064310|11002151|FG002|NOT COMPLETED|Open Label Pazopinib||84
9887388|NCT01064323|11002160|FG000|STARTED|Overall Study||10
9887389|NCT01064323|11002160|FG000|COMPLETED|Overall Study||10
9887390|NCT01064323|11002160|FG000|NOT COMPLETED|Overall Study||0
9887391|NCT01064362|11002166|FG000|STARTED|Overall Study||1559
9887392|NCT01064362|11002167|FG001|STARTED|Overall Study||11883
9887393|NCT01064362|11002166|FG000|COMPLETED|Overall Study||1559
9887394|NCT01064362|11002167|FG001|COMPLETED|Overall Study||11883
9887395|NCT01064362|11002166|FG000|NOT COMPLETED|Overall Study||0
9887396|NCT01064362|11002167|FG001|NOT COMPLETED|Overall Study||0
9887397|NCT01064401|11002175|FG000|STARTED|Overall Study||922
9887398|NCT01064401|11002176|FG001|STARTED|Overall Study||919
9887399|NCT01064401|11002175|FG000|COMPLETED|Overall Study||694
9887400|NCT01064401|11002176|FG001|COMPLETED|Overall Study||724
9887401|NCT01064401|11002175|FG000|NOT COMPLETED|Overall Study||228
10109207|NCT02473614|11239807|FG001|COMPLETED|Wash Out Period (3 Weeks)||5
10109208|NCT02473614|11239806|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0
10109209|NCT02473614|11239807|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0
10109210|NCT02473614|11239806|FG000|STARTED|Second Intervention (3 Weeks)||5
10109211|NCT02473614|11239807|FG001|STARTED|Second Intervention (3 Weeks)||5
10109212|NCT02473614|11239806|FG000|COMPLETED|Second Intervention (3 Weeks)||5
10109213|NCT02473614|11239807|FG001|COMPLETED|Second Intervention (3 Weeks)||5
10109214|NCT02473614|11239806|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
9887402|NCT01064401|11002176|FG001|NOT COMPLETED|Overall Study||195
9887403|NCT01064414|11002186|FG000|STARTED|Core Period: Baseline to Week 26||90
9887404|NCT01064414|11002187|FG001|STARTED|Core Period: Baseline to Week 26||90
9887405|NCT01064414|11002188|FG002|STARTED|Core Period: Baseline to Week 26||89
9887406|NCT01064414|11002186|FG000|COMPLETED|Core Period: Baseline to Week 26||77
9887407|NCT01064414|11002187|FG001|COMPLETED|Core Period: Baseline to Week 26||75
9887408|NCT01064414|11002188|FG002|COMPLETED|Core Period: Baseline to Week 26||82
9887409|NCT01064414|11002186|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13
9887410|NCT01064414|11002187|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15
9887411|NCT01064414|11002188|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7
9887412|NCT01064414|11002186|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
9887413|NCT01064414|11002187|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
9887414|NCT01064414|11002188|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
9887415|NCT01064414|11002186|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64
10109215|NCT02473614|11239807|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9887416|NCT01064414|11002187|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67
9887417|NCT01064414|11002188|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76
9887418|NCT01064414|11002186|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
9887419|NCT01064414|11002187|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
9887420|NCT01064414|11002188|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
9887421|NCT01064531|11002201|FG000|STARTED|Overall Study||21
9887422|NCT01064531|11002202|FG001|STARTED|Overall Study||20
9887423|NCT01064531|11002201|FG000|COMPLETED|Overall Study||18
9887424|NCT01064531|11002202|FG001|COMPLETED|Overall Study||13
9887425|NCT01064531|11002201|FG000|NOT COMPLETED|Overall Study||3
9887426|NCT01064531|11002202|FG001|NOT COMPLETED|Overall Study||7
9887427|NCT01064622|11002211|FG000|STARTED|Lead-in Phase I||0
9887428|NCT01064622|11002212|FG001|STARTED|Lead-in Phase I||7
9887429|NCT01064622|11002211|FG000|COMPLETED|Lead-in Phase I||0
9887430|NCT01064622|11002212|FG001|COMPLETED|Lead-in Phase I||7
9887431|NCT01064622|11002211|FG000|NOT COMPLETED|Lead-in Phase I||0
9887432|NCT01064622|11002212|FG001|NOT COMPLETED|Lead-in Phase I||0
9887433|NCT01064622|11002211|FG000|STARTED|Randomized Phase II||55
9887434|NCT01064622|11002212|FG001|STARTED|Randomized Phase II||56
9887435|NCT01064622|11002211|FG000|COMPLETED|Randomized Phase II||53
9887436|NCT01064622|11002212|FG001|COMPLETED|Randomized Phase II||53
9887437|NCT01064622|11002211|FG000|NOT COMPLETED|Randomized Phase II||2
9887438|NCT01064622|11002212|FG001|NOT COMPLETED|Randomized Phase II||3
9887439|NCT01064622|11002211|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
9887440|NCT01064622|11002212|FG001|STARTED|Crossover of Arm I||0
9887441|NCT01064622|11002211|FG000|COMPLETED|Crossover of Arm I||22
9887442|NCT01064622|11002212|FG001|COMPLETED|Crossover of Arm I||0
9887443|NCT01064622|11002211|FG000|NOT COMPLETED|Crossover of Arm I||0
9887444|NCT01064622|11002212|FG001|NOT COMPLETED|Crossover of Arm I||0
9887445|NCT01064687|11002225|FG000|STARTED|Overall Study||279
9887446|NCT01064687|11002226|FG001|STARTED|Overall Study||280
9887447|NCT01064687|11002227|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
9887448|NCT01064687|11002228|FG003|STARTED|Overall Study||141
9887449|NCT01064687|11002225|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279
9887450|NCT01064687|11002226|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280
9887451|NCT01064687|11002227|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276
9887452|NCT01064687|11002228|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141
9887453|NCT01064687|11002225|FG000|Completed 26 Weeks|Overall Study||260
9887454|NCT01064687|11002226|FG001|Completed 26 Weeks|Overall Study||263
9887455|NCT01064687|11002227|FG002|Completed 26 Weeks|Overall Study||252
9887456|NCT01064687|11002228|FG003|Completed 26 Weeks|Overall Study||124
9887457|NCT01064687|11002225|FG000|COMPLETED|Overall Study||245
9887458|NCT01064687|11002226|FG001|COMPLETED|Overall Study||254
9887459|NCT01064687|11002227|FG002|COMPLETED|Overall Study||237
9887460|NCT01064687|11002228|FG003|COMPLETED|Overall Study||124
9887461|NCT01064687|11002225|FG000|NOT COMPLETED|Overall Study||34
9887462|NCT01064687|11002226|FG001|NOT COMPLETED|Overall Study||26
9887463|NCT01064687|11002227|FG002|NOT COMPLETED|Overall Study||41
9887464|NCT01064687|11002228|FG003|NOT COMPLETED|Overall Study||17
9887465|NCT01064713|11002251|FG000|STARTED|Overall Study||13
9887466|NCT01064713|11002252|FG001|STARTED|Overall Study||4
9887467|NCT01064713|11002251|FG000|COMPLETED|Overall Study||13
9887468|NCT01064713|11002252|FG001|COMPLETED|Overall Study||4
9887469|NCT01064713|11002251|FG000|NOT COMPLETED|Overall Study||0
9887470|NCT01064713|11002252|FG001|NOT COMPLETED|Overall Study||0
9887471|NCT01064739|11002258|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
9887472|NCT01064739|11002258|FG000|COMPLETED|Fixed Sodium Study Diet||14
9887473|NCT01064739|11002258|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0
9887474|NCT01064739|11002258|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14
9887475|NCT01064739|11002258|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
9887476|NCT01064739|11002258|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
9887477|NCT01064830|11002270|FG000|STARTED|Overall Study||10
9887478|NCT01064830|11002271|FG001|STARTED|Overall Study||11
9887479|NCT01064830|11002270|FG000|COMPLETED|Overall Study||8
9887480|NCT01064830|11002271|FG001|COMPLETED|Overall Study||7
9887481|NCT01064830|11002270|FG000|NOT COMPLETED|Overall Study||2
9887482|NCT01064830|11002271|FG001|NOT COMPLETED|Overall Study||4
9887483|NCT01064856|11002281|FG000|STARTED|Double-blind (DB) Period||84
9887484|NCT01064856|11002282|FG001|STARTED|Double-blind (DB) Period||81
9887485|NCT01064856|11002283|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
9887486|NCT01064856|11002284|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
9887487|NCT01064856|11002281|FG000|COMPLETED|Double-blind (DB) Period||82
9887488|NCT01064856|11002282|FG001|COMPLETED|Double-blind (DB) Period||81
9887489|NCT01064856|11002283|FG002|COMPLETED|Double-blind (DB) Period||0
9887490|NCT01064856|11002284|FG003|COMPLETED|Double-blind (DB) Period||0
9887491|NCT01064856|11002281|FG000|NOT COMPLETED|Double-blind (DB) Period||2
9887492|NCT01064856|11002282|FG001|NOT COMPLETED|Double-blind (DB) Period||0
9887493|NCT01064856|11002283|FG002|NOT COMPLETED|Double-blind (DB) Period||0
9887494|NCT01064856|11002284|FG003|NOT COMPLETED|Double-blind (DB) Period||0
9887495|NCT01064856|11002281|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
9887496|NCT01064856|11002282|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
9887497|NCT01064856|11002283|FG002|STARTED|Open-label (OL) Period||82
9887498|NCT01064856|11002284|FG003|STARTED|Open-label (OL) Period||81
9887499|NCT01064856|11002281|FG000|COMPLETED|Open-label (OL) Period||0
9887500|NCT01064856|11002282|FG001|COMPLETED|Open-label (OL) Period||0
9887501|NCT01064856|11002283|FG002|COMPLETED|Open-label (OL) Period||56
9887502|NCT01064856|11002284|FG003|COMPLETED|Open-label (OL) Period||61
9887503|NCT01064856|11002281|FG000|NOT COMPLETED|Open-label (OL) Period||0
9887504|NCT01064856|11002282|FG001|NOT COMPLETED|Open-label (OL) Period||0
9887505|NCT01064856|11002283|FG002|NOT COMPLETED|Open-label (OL) Period||26
9887506|NCT01064856|11002284|FG003|NOT COMPLETED|Open-label (OL) Period||20
9887507|NCT01064882|11002294|FG000|STARTED|Overall Study||36
9887508|NCT01064882|11002295|FG001|STARTED|Overall Study||34
9887509|NCT01064882|11002296|FG002|STARTED|Overall Study||34
9887510|NCT01064882|11002294|FG000|COMPLETED|Overall Study||34
9887511|NCT01064882|11002295|FG001|COMPLETED|Overall Study||32
9887512|NCT01064882|11002296|FG002|COMPLETED|Overall Study||32
9887513|NCT01064882|11002294|FG000|NOT COMPLETED|Overall Study||2
9887514|NCT01064882|11002295|FG001|NOT COMPLETED|Overall Study||2
9887515|NCT01064882|11002296|FG002|NOT COMPLETED|Overall Study||2
9887516|NCT01064947|11002304|FG000|STARTED|Overall Study||70
9887517|NCT01064947|11002304|FG000|COMPLETED|Overall Study||29
9887518|NCT01064947|11002304|FG000|NOT COMPLETED|Overall Study||41
9887519|NCT01065350|11002314|FG000|STARTED|Overall Study||43
9887520|NCT01065350|11002315|FG001|STARTED|Overall Study||42
9887521|NCT01065350|11002314|FG000|COMPLETED|Overall Study||43
9887522|NCT01065350|11002315|FG001|COMPLETED|Overall Study||41
9887523|NCT01065350|11002314|FG000|NOT COMPLETED|Overall Study||0
9887524|NCT01065350|11002315|FG001|NOT COMPLETED|Overall Study||1
9887525|NCT01065428|11002323|FG000|STARTED|Overall Study||17
9887526|NCT01065428|11002324|FG001|STARTED|Overall Study||35
9887527|NCT01065428|11002323|FG000|COMPLETED|Overall Study||17
9887528|NCT01065428|11002324|FG001|COMPLETED|Overall Study||35
9887529|NCT01065428|11002323|FG000|NOT COMPLETED|Overall Study||0
9887530|NCT01065428|11002324|FG001|NOT COMPLETED|Overall Study||0
9887531|NCT01065480|11002332|FG000|STARTED|Overall Study||48
9887532|NCT01065480|11002333|FG001|STARTED|Overall Study||43
9887533|NCT01065480|11002332|FG000|COMPLETED|Overall Study||48
9887534|NCT01065480|11002333|FG001|COMPLETED|Overall Study||43
9887535|NCT01065480|11002332|FG000|NOT COMPLETED|Overall Study||0
9887536|NCT01065480|11002333|FG001|NOT COMPLETED|Overall Study||0
9887537|NCT01065506|11002341|FG000|STARTED|Overall Study||64
9887538|NCT01065506|11002342|FG001|STARTED|Overall Study||72
9887539|NCT01065506|11002341|FG000|End of Treatment|Overall Study||44
9887540|NCT01065506|11002342|FG001|End of Treatment|Overall Study||37
9887541|NCT01065506|11002341|FG000|4-Month Follow-Up|Overall Study||35
9887542|NCT01065506|11002342|FG001|4-Month Follow-Up|Overall Study||34
9887543|NCT01065506|11002341|FG000|COMPLETED|Overall Study||32
9887544|NCT01065506|11002342|FG001|COMPLETED|Overall Study||34
9887545|NCT01065506|11002341|FG000|NOT COMPLETED|Overall Study||32
9887546|NCT01065506|11002342|FG001|NOT COMPLETED|Overall Study||38
9887547|NCT01065558|11002348|FG000|STARTED|Overall Study||5
9887548|NCT01065558|11002348|FG000|COMPLETED|Overall Study||5
9887549|NCT01065558|11002348|FG000|NOT COMPLETED|Overall Study||0
9887550|NCT01065571|11002354|FG000|STARTED|Overall Study||10
9887551|NCT01065571|11002355|FG001|STARTED|Overall Study||5
9887552|NCT01065571|11002354|FG000|COMPLETED|Overall Study||7
9887553|NCT01065571|11002355|FG001|COMPLETED|Overall Study||5
9887554|NCT01065571|11002354|FG000|NOT COMPLETED|Overall Study||3
9887555|NCT01065571|11002355|FG001|NOT COMPLETED|Overall Study||0
9887556|NCT01065597|11002363|FG000|STARTED|Overall Study||13
9887557|NCT01065597|11002363|FG000|COMPLETED|Overall Study||12
9887558|NCT01065597|11002363|FG000|NOT COMPLETED|Overall Study||1
9887559|NCT01065714|11002367|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
9887560|NCT01065714|11002367|FG000|COMPLETED|Overall Study||20
9887561|NCT01065714|11002367|FG000|NOT COMPLETED|Overall Study||0
9887562|NCT01065766|11002374|FG000|STARTED|Overall Study||4065
9887563|NCT01065766|11002374|FG000|COMPLETED|Overall Study||4033
9887564|NCT01065766|11002374|FG000|NOT COMPLETED|Overall Study||32
9887565|NCT01065844|11002378|FG000|STARTED|Overall Study||15
9887566|NCT01065844|11002378|FG000|COMPLETED|Overall Study||10
9887567|NCT01065844|11002378|FG000|NOT COMPLETED|Overall Study||5
9887568|NCT01066000|11002382|FG000|STARTED|Overall Study||33
9887569|NCT01066000|11002382|FG000|COMPLETED|Overall Study||24
9887570|NCT01066000|11002382|FG000|NOT COMPLETED|Overall Study||9
9887571|NCT01066026|11002386|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
9887572|NCT01066026|11002386|FG000|COMPLETED|Overall Study||23
9887573|NCT01066026|11002386|FG000|NOT COMPLETED|Overall Study||2
9887574|NCT01066039|11002392|FG000|STARTED|Overall Study||202
9887575|NCT01066039|11002392|FG000|Treated|Overall Study||200
9887576|NCT01066039|11002392|FG000|COMPLETED|Overall Study||158
9887577|NCT01066039|11002392|FG000|NOT COMPLETED|Overall Study||44
9887578|NCT01066052|11002398|FG000|STARTED|Overall Study||64
9887579|NCT01066052|11002399|FG001|STARTED|Overall Study||51
9887580|NCT01066052|11002398|FG000|Treated|Overall Study||61
9887581|NCT01066052|11002399|FG001|Treated|Overall Study||0
9887582|NCT01066052|11002398|FG000|COMPLETED|Overall Study||61
9887583|NCT01066052|11002399|FG001|COMPLETED|Overall Study||51
9887584|NCT01066052|11002398|FG000|NOT COMPLETED|Overall Study||3
9887585|NCT01066052|11002399|FG001|NOT COMPLETED|Overall Study||0
9887586|NCT01066104|11002406|FG000|STARTED|Overall Study||14
9887587|NCT01066104|11002407|FG001|STARTED|Overall Study||13
9887588|NCT01066104|11002406|FG000|COMPLETED|Overall Study||12
9887589|NCT01066104|11002407|FG001|COMPLETED|Overall Study||12
9887590|NCT01066104|11002406|FG000|NOT COMPLETED|Overall Study||2
9887591|NCT01066104|11002407|FG001|NOT COMPLETED|Overall Study||1
9887592|NCT01066143|11002413|FG000|STARTED|Overall Study||8
9887593|NCT01066143|11002413|FG000|COMPLETED|Overall Study||0
9887594|NCT01066143|11002413|FG000|NOT COMPLETED|Overall Study||8
9887595|NCT01066156|11002417|FG000|STARTED|Overall Study||34
9887596|NCT01066156|11002417|FG000|COMPLETED|Overall Study||24
9887597|NCT01066156|11002417|FG000|NOT COMPLETED|Overall Study||10
9887598|NCT01066364|11002423|FG000|STARTED|Overall Study||25
9887599|NCT01066364|11002424|FG001|STARTED|Overall Study||25
9887600|NCT01066364|11002423|FG000|COMPLETED|Overall Study||22
9887601|NCT01066364|11002424|FG001|COMPLETED|Overall Study||23
9887602|NCT01066364|11002423|FG000|NOT COMPLETED|Overall Study||3
9887603|NCT01066364|11002424|FG001|NOT COMPLETED|Overall Study||2
9887604|NCT01066520|11002433|FG000|STARTED|Overall Study||143
9887605|NCT01066520|11002434|FG001|STARTED|Overall Study||140
9887606|NCT01066520|11002435|FG002|STARTED|Overall Study||137
9887607|NCT01066520|11002433|FG000|COMPLETED|Overall Study||143
9887608|NCT01066520|11002434|FG001|COMPLETED|Overall Study||140
9887609|NCT01066520|11002435|FG002|COMPLETED|Overall Study||137
9887610|NCT01066520|11002433|FG000|NOT COMPLETED|Overall Study||0
9887611|NCT01066520|11002434|FG001|NOT COMPLETED|Overall Study||0
9887612|NCT01066520|11002435|FG002|NOT COMPLETED|Overall Study||0
9887613|NCT01066546|11002443|FG000|STARTED|Overall Study||5
9887614|NCT01066546|11002443|FG000|COMPLETED|Overall Study||0
9887615|NCT01066546|11002443|FG000|NOT COMPLETED|Overall Study||5
9887616|NCT01066585|11002449|FG000|STARTED|Overall Study||211
9887617|NCT01066585|11002450|FG001|STARTED|Overall Study||199
9887618|NCT01066585|11002449|FG000|COMPLETED|Overall Study||210
9887619|NCT01066585|11002450|FG001|COMPLETED|Overall Study||196
9887620|NCT01066585|11002449|FG000|NOT COMPLETED|Overall Study||1
9887621|NCT01066585|11002450|FG001|NOT COMPLETED|Overall Study||3
9887622|NCT01066624|11002459|FG000|STARTED|Overall Study||38
9887623|NCT01066624|11002460|FG001|STARTED|Overall Study||40
9887624|NCT01066624|11002461|FG002|STARTED|Overall Study||39
9887625|NCT01066624|11002459|FG000|COMPLETED|Overall Study||38
9887626|NCT01066624|11002460|FG001|COMPLETED|Overall Study||40
9887627|NCT01066624|11002461|FG002|COMPLETED|Overall Study||39
9887628|NCT01066624|11002459|FG000|NOT COMPLETED|Overall Study||0
9887629|NCT01066624|11002460|FG001|NOT COMPLETED|Overall Study||0
9887630|NCT01066624|11002461|FG002|NOT COMPLETED|Overall Study||0
9887631|NCT01066780|11002469|FG000|STARTED|Overall Study||24
9887632|NCT01066780|11002470|FG001|STARTED|Overall Study||24
9887633|NCT01066780|11002469|FG000|COMPLETED|Overall Study||23
9887634|NCT01066780|11002470|FG001|COMPLETED|Overall Study||23
9887635|NCT01066780|11002469|FG000|NOT COMPLETED|Overall Study||1
9887636|NCT01066780|11002470|FG001|NOT COMPLETED|Overall Study||1
9887637|NCT01066793|11002480|FG000|STARTED|Overall Study||1128
9887638|NCT01066793|11002481|FG001|STARTED|Overall Study||572
9887639|NCT01066793|11002482|FG002|STARTED|Overall Study||484
9887640|NCT01066793|11002483|FG003|STARTED|Overall Study||143
9887641|NCT01066793|11002484|FG004|STARTED|Overall Study||11
9887642|NCT01066793|11002485|FG005|STARTED|Overall Study||5
9887643|NCT01066793|11002480|FG000|COMPLETED|Overall Study||754
9887644|NCT01066793|11002481|FG001|COMPLETED|Overall Study||495
9887645|NCT01066793|11002482|FG002|COMPLETED|Overall Study||369
9887646|NCT01066793|11002483|FG003|COMPLETED|Overall Study||94
9887647|NCT01066793|11002484|FG004|COMPLETED|Overall Study||11
9887648|NCT01066793|11002485|FG005|COMPLETED|Overall Study||4
9887649|NCT01066793|11002480|FG000|NOT COMPLETED|Overall Study||374
9887650|NCT01066793|11002481|FG001|NOT COMPLETED|Overall Study||77
9887651|NCT01066793|11002482|FG002|NOT COMPLETED|Overall Study||115
9887652|NCT01066793|11002483|FG003|NOT COMPLETED|Overall Study||49
10008444|NCT01757197|11130775|FG000|NOT COMPLETED|Overall Study||2
10008445|NCT01757275|11130781|FG000|STARTED|Overall Study||111
10008446|NCT01757275|11130782|FG001|STARTED|Overall Study||111
10008447|NCT01757275|11130781|FG000|COMPLETED|Overall Study||102
10008448|NCT01757275|11130782|FG001|COMPLETED|Overall Study||98
10008449|NCT01757275|11130781|FG000|NOT COMPLETED|Overall Study||9
10008450|NCT01757275|11130782|FG001|NOT COMPLETED|Overall Study||13
10008451|NCT01757288|11130791|FG000|STARTED|Overall Study||6
10008452|NCT01757288|11130792|FG001|STARTED|Overall Study||46
9887653|NCT01066793|11002484|FG004|NOT COMPLETED|Overall Study||0
9887654|NCT01066793|11002485|FG005|NOT COMPLETED|Overall Study||1
9887655|NCT01066819|11002506|FG000|STARTED|Overall Study||1006
9887656|NCT01066819|11002507|FG001|STARTED|Overall Study||348
9887657|NCT01066819|11002508|FG002|STARTED|Overall Study||257
9887658|NCT01066819|11002509|FG003|STARTED|Overall Study||25
9887659|NCT01066819|11002510|FG004|STARTED|Overall Study||7
9887660|NCT01066819|11002511|FG005|STARTED|Overall Study||13
9887661|NCT01066819|11002506|FG000|COMPLETED|Overall Study||317
9887662|NCT01066819|11002507|FG001|COMPLETED|Overall Study||177
9887663|NCT01066819|11002508|FG002|COMPLETED|Overall Study||111
9887664|NCT01066819|11002509|FG003|COMPLETED|Overall Study||8
9887665|NCT01066819|11002510|FG004|COMPLETED|Overall Study||3
9887666|NCT01066819|11002511|FG005|COMPLETED|Overall Study||7
9887667|NCT01066819|11002506|FG000|NOT COMPLETED|Overall Study||689
9887668|NCT01066819|11002507|FG001|NOT COMPLETED|Overall Study||171
9887669|NCT01066819|11002508|FG002|NOT COMPLETED|Overall Study||146
9887670|NCT01066819|11002509|FG003|NOT COMPLETED|Overall Study||17
9887671|NCT01066819|11002510|FG004|NOT COMPLETED|Overall Study||4
9887672|NCT01066819|11002511|FG005|NOT COMPLETED|Overall Study||6
9887673|NCT01066871|11002527|FG000|STARTED|Overall Study||20
9887674|NCT01066871|11002528|FG001|STARTED|Overall Study||18
9887675|NCT01066871|11002529|FG002|STARTED|Overall Study||18
10008453|NCT01757288|11130793|FG002|STARTED|Overall Study||46
10008454|NCT01757288|11130791|FG000|COMPLETED|Overall Study||6
10008455|NCT01757288|11130792|FG001|COMPLETED|Overall Study||38
9887676|NCT01066871|11002530|FG003|STARTED|Overall Study||18
9887677|NCT01066871|11002527|FG000|COMPLETED|Overall Study||16
9887678|NCT01066871|11002528|FG001|COMPLETED|Overall Study||13
9887679|NCT01066871|11002529|FG002|COMPLETED|Overall Study||12
9887680|NCT01066871|11002530|FG003|COMPLETED|Overall Study||13
9887681|NCT01066871|11002527|FG000|NOT COMPLETED|Overall Study||4
9887682|NCT01066871|11002528|FG001|NOT COMPLETED|Overall Study||5
9887683|NCT01066871|11002529|FG002|NOT COMPLETED|Overall Study||6
9887684|NCT01066871|11002530|FG003|NOT COMPLETED|Overall Study||5
9887685|NCT01066897|11002547|FG000|STARTED|Overall Study||7
9887686|NCT01066897|11002548|FG001|STARTED|Overall Study||9
9887687|NCT01066897|11002547|FG000|COMPLETED|Overall Study||5
9887688|NCT01066897|11002548|FG001|COMPLETED|Overall Study||9
9887689|NCT01066897|11002547|FG000|NOT COMPLETED|Overall Study||2
9887690|NCT01066897|11002548|FG001|NOT COMPLETED|Overall Study||0
9887691|NCT01066923|11002559|FG000|STARTED|Overall Study||28
9887692|NCT01066923|11002560|FG001|STARTED|Overall Study||32
9887693|NCT01066923|11002561|FG002|STARTED|Overall Study||33
9887694|NCT01066923|11002562|FG003|STARTED|Overall Study||31
9887695|NCT01066923|11002559|FG000|Platelet Closure Time|Overall Study||25
9887696|NCT01066923|11002560|FG001|Platelet Closure Time|Overall Study||29
9887697|NCT01066923|11002561|FG002|Platelet Closure Time|Overall Study||25
9887698|NCT01066923|11002562|FG003|Platelet Closure Time|Overall Study||23
9887699|NCT01066923|11002559|FG000|Vascular Function|Overall Study||13
9887700|NCT01066923|11002560|FG001|Vascular Function|Overall Study||14
9887701|NCT01066923|11002561|FG002|Vascular Function|Overall Study||12
9887702|NCT01066923|11002562|FG003|Vascular Function|Overall Study||13
9887703|NCT01066923|11002559|FG000|Activation of Coagulation|Overall Study||0
9887704|NCT01066923|11002560|FG001|Activation of Coagulation|Overall Study||0
9887705|NCT01066923|11002561|FG002|Activation of Coagulation|Overall Study||0
9887706|NCT01066923|11002562|FG003|Activation of Coagulation|Overall Study||0
9887707|NCT01066923|11002559|FG000|Retinal Imaging|Overall Study||0
9887708|NCT01066923|11002560|FG001|Retinal Imaging|Overall Study||0
9887709|NCT01066923|11002561|FG002|Retinal Imaging|Overall Study||0
9887710|NCT01066923|11002562|FG003|Retinal Imaging|Overall Study||0
9887711|NCT01066923|11002559|FG000|COMPLETED|Overall Study||25
9887712|NCT01066923|11002560|FG001|COMPLETED|Overall Study||29
9887713|NCT01066923|11002561|FG002|COMPLETED|Overall Study||25
9887714|NCT01066923|11002562|FG003|COMPLETED|Overall Study||23
9887715|NCT01066923|11002559|FG000|NOT COMPLETED|Overall Study||3
9887716|NCT01066923|11002560|FG001|NOT COMPLETED|Overall Study||3
9887717|NCT01066923|11002561|FG002|NOT COMPLETED|Overall Study||8
9887718|NCT01066923|11002562|FG003|NOT COMPLETED|Overall Study||8
9887719|NCT01066936|11002572|FG000|STARTED|Overall Study||20
9887720|NCT01066936|11002572|FG000|COMPLETED|Overall Study||10
9887721|NCT01066936|11002572|FG000|NOT COMPLETED|Overall Study||10
9887722|NCT01067105|11002578|FG000|STARTED|Overall Study||824
9887723|NCT01067105|11002578|FG000|COMPLETED|Overall Study||683
9887724|NCT01067105|11002578|FG000|NOT COMPLETED|Overall Study||141
9887725|NCT01067326|11002584|FG000|STARTED|Overall Study||14
9887726|NCT01067326|11002585|FG001|STARTED|Overall Study||8
9887727|NCT01067326|11002584|FG000|COMPLETED|Overall Study||12
9887728|NCT01067326|11002585|FG001|COMPLETED|Overall Study||5
9887729|NCT01067326|11002584|FG000|NOT COMPLETED|Overall Study||2
9887730|NCT01067326|11002585|FG001|NOT COMPLETED|Overall Study||3
9887731|NCT01067339|11002593|FG000|STARTED|Overall Study||31
9887732|NCT01067339|11002594|FG001|STARTED|Overall Study||34
9887733|NCT01067339|11002593|FG000|COMPLETED|Overall Study||25
9887734|NCT01067339|11002594|FG001|COMPLETED|Overall Study||29
9887735|NCT01067339|11002593|FG000|NOT COMPLETED|Overall Study||6
9887736|NCT01067339|11002594|FG001|NOT COMPLETED|Overall Study||5
9887737|NCT01067352|11002603|FG000|STARTED|Overall Study||9
9887738|NCT01067352|11002604|FG001|STARTED|Overall Study||6
9887739|NCT01067352|11002605|FG002|STARTED|Overall Study||10
9887740|NCT01067352|11002603|FG000|COMPLETED|Overall Study||8
9887741|NCT01067352|11002604|FG001|COMPLETED|Overall Study||3
9887742|NCT01067352|11002605|FG002|COMPLETED|Overall Study||9
9887743|NCT01067352|11002603|FG000|NOT COMPLETED|Overall Study||1
9887744|NCT01067352|11002604|FG001|NOT COMPLETED|Overall Study||3
9887745|NCT01067352|11002605|FG002|NOT COMPLETED|Overall Study||1
9887746|NCT01067456|11002615|FG000|STARTED|Overall Study||30
9887747|NCT01067456|11002616|FG001|STARTED|Overall Study||29
9887748|NCT01067456|11002615|FG000|COMPLETED|Overall Study||30
9887749|NCT01067456|11002616|FG001|COMPLETED|Overall Study||29
9887750|NCT01067456|11002615|FG000|NOT COMPLETED|Overall Study||0
9887751|NCT01067456|11002616|FG001|NOT COMPLETED|Overall Study||0
9887752|NCT01067469|11002626|FG000|STARTED|Overall Study||36
9887753|NCT01067469|11002627|FG001|STARTED|Overall Study||35
9887754|NCT01067469|11002626|FG000|90 mg/m^2|Overall Study||0
9887755|NCT01067469|11002627|FG001|90 mg/m^2|Overall Study||12
9887756|NCT01067469|11002626|FG000|75 mg/m^2|Overall Study||0
9887757|NCT01067469|11002627|FG001|75 mg/m^2|Overall Study||21
9887758|NCT01067469|11002626|FG000|COMPLETED|Overall Study||36
9887759|NCT01067469|11002627|FG001|COMPLETED|Overall Study||33
9887760|NCT01067469|11002626|FG000|NOT COMPLETED|Overall Study||0
9887761|NCT01067469|11002627|FG001|NOT COMPLETED|Overall Study||2
9887762|NCT01067508|11002635|FG000|STARTED|Overall Study||10
9887763|NCT01067508|11002636|FG001|STARTED|Overall Study||9
9887764|NCT01067508|11002635|FG000|COMPLETED|Overall Study||10
9887765|NCT01067508|11002636|FG001|COMPLETED|Overall Study||7
9887766|NCT01067508|11002635|FG000|NOT COMPLETED|Overall Study||0
9887767|NCT01067508|11002636|FG001|NOT COMPLETED|Overall Study||2
9887768|NCT01067716|11002645|FG000|STARTED|Overall Study|110 eyes|57
9887769|NCT01067716|11002646|FG001|STARTED|Overall Study|25 eyes|13
9887770|NCT01067716|11002647|FG002|STARTED|Overall Study|15 eyes|9
9887771|NCT01067716|11002645|FG000|COMPLETED|Overall Study|110 eyes|57
9887772|NCT01067716|11002646|FG001|COMPLETED|Overall Study|25 eyes|13
9887773|NCT01067716|11002647|FG002|COMPLETED|Overall Study|15 eyes|9
9887774|NCT01067716|11002645|FG000|NOT COMPLETED|Overall Study||0
9887775|NCT01067716|11002646|FG001|NOT COMPLETED|Overall Study||0
9887776|NCT01067716|11002647|FG002|NOT COMPLETED|Overall Study||0
9887777|NCT01067768|11002657|FG000|STARTED|Overall Study||604
9887778|NCT01067768|11002658|FG001|STARTED|Overall Study||605
9887779|NCT01067768|11002657|FG000|COMPLETED|Overall Study||604
9887780|NCT01067768|11002658|FG001|COMPLETED|Overall Study||605
9887781|NCT01067768|11002657|FG000|NOT COMPLETED|Overall Study||0
9887782|NCT01067768|11002658|FG001|NOT COMPLETED|Overall Study||0
9887783|NCT01067781|11002668|FG000|STARTED|Up to Day 180||203
9887784|NCT01067781|11002669|FG001|STARTED|Up to Day 180||199
9887785|NCT01067781|11002670|FG002|STARTED|Up to Day 180||97
9887786|NCT01067781|11002671|FG003|STARTED|Up to Day 180||101
9887787|NCT01067781|11002668|FG000|COMPLETED|Up to Day 180||173
9887788|NCT01067781|11002669|FG001|COMPLETED|Up to Day 180||168
9887789|NCT01067781|11002670|FG002|COMPLETED|Up to Day 180||89
9887790|NCT01067781|11002671|FG003|COMPLETED|Up to Day 180||89
9887791|NCT01067781|11002668|FG000|NOT COMPLETED|Up to Day 180||30
9887792|NCT01067781|11002669|FG001|NOT COMPLETED|Up to Day 180||31
9887793|NCT01067781|11002670|FG002|NOT COMPLETED|Up to Day 180||8
9887794|NCT01067781|11002671|FG003|NOT COMPLETED|Up to Day 180||12
9887795|NCT01067781|11002668|FG000|STARTED|180 to Day 720||173
9887796|NCT01067781|11002669|FG001|STARTED|180 to Day 720||168
9887797|NCT01067781|11002670|FG002|STARTED|180 to Day 720||89
9887798|NCT01067781|11002671|FG003|STARTED|180 to Day 720||89
9887799|NCT01067781|11002668|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
9887800|NCT01067781|11002669|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
9887801|NCT01067781|11002670|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
9887802|NCT01067781|11002671|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
9887803|NCT01067781|11002668|FG000|NOT COMPLETED|180 to Day 720||170
9887804|NCT01067781|11002669|FG001|NOT COMPLETED|180 to Day 720||164
9887805|NCT01067781|11002670|FG002|NOT COMPLETED|180 to Day 720||89
9887806|NCT01067781|11002671|FG003|NOT COMPLETED|180 to Day 720||89
9887807|NCT01067846|11002685|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
9887808|NCT01067846|11002686|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
9887809|NCT01067846|11002685|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
9887810|NCT01067846|11002686|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
9887811|NCT01067846|11002685|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
9887812|NCT01067846|11002686|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
9887813|NCT01067846|11002685|FG000|NOT COMPLETED|Overall Study||19
9887814|NCT01067846|11002686|FG001|NOT COMPLETED|Overall Study||19
9887815|NCT01067976|11002692|FG000|STARTED|Overall Study|screened and enrolled|446
10008456|NCT01757288|11130793|FG002|COMPLETED|Overall Study||37
10008457|NCT01757288|11130791|FG000|NOT COMPLETED|Overall Study||0
10008458|NCT01757288|11130792|FG001|NOT COMPLETED|Overall Study||8
10008459|NCT01757288|11130793|FG002|NOT COMPLETED|Overall Study||9
9887816|NCT01067976|11002692|FG000|Received Treatment|Overall Study|treatment started|426
9887817|NCT01067976|11002692|FG000|Fulfilled Requirements of FAS Population|Overall Study||390
9887818|NCT01067976|11002692|FG000|COMPLETED|Overall Study|study course completed|424
9887819|NCT01067976|11002692|FG000|NOT COMPLETED|Overall Study||22
9887820|NCT01068158|11002712|FG000|STARTED|Overall Study||169
9887821|NCT01068158|11002713|FG001|STARTED|Overall Study||202
9887822|NCT01068158|11002712|FG000|COMPLETED|Overall Study||161
9887823|NCT01068158|11002713|FG001|COMPLETED|Overall Study||198
9887824|NCT01068158|11002712|FG000|NOT COMPLETED|Overall Study||8
9887825|NCT01068158|11002713|FG001|NOT COMPLETED|Overall Study||4
9887826|NCT01068262|11002723|FG000|STARTED|Overall Study||23
9887827|NCT01068262|11002724|FG001|STARTED|Overall Study||9
9887828|NCT01068262|11002725|FG002|STARTED|Overall Study||10
9887829|NCT01068262|11002726|FG003|STARTED|Overall Study||2
9887830|NCT01068262|11002723|FG000|COMPLETED|Overall Study||20
9887831|NCT01068262|11002724|FG001|COMPLETED|Overall Study||8
9887832|NCT01068262|11002725|FG002|COMPLETED|Overall Study||9
9887833|NCT01068262|11002726|FG003|COMPLETED|Overall Study||2
9887834|NCT01068262|11002723|FG000|NOT COMPLETED|Overall Study||3
9760403|NCT00380744|10864044|FG000|STARTED|Overall Study||20
9760404|NCT00380744|10864045|FG001|STARTED|Overall Study||4
9760405|NCT00380744|10864046|FG002|STARTED|Overall Study||20
9760406|NCT00380744|10864047|FG003|STARTED|Overall Study||4
9887835|NCT01068262|11002724|FG001|NOT COMPLETED|Overall Study||1
9887836|NCT01068262|11002725|FG002|NOT COMPLETED|Overall Study||1
9887837|NCT01068262|11002726|FG003|NOT COMPLETED|Overall Study||0
9887838|NCT01068418|11002739|FG000|STARTED|Overall Study|26 participants found to be eligible|26
10008460|NCT01757301|11130804|FG000|STARTED|Overall Study||147
9760407|NCT00380744|10864048|FG004|STARTED|Overall Study||23
9887839|NCT01068418|11002739|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
9887840|NCT01068418|11002739|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14
9887841|NCT01068418|11002739|FG000|NOT COMPLETED|Overall Study||12
9887842|NCT01068509|11002746|FG000|STARTED|Overall Study||7
9887843|NCT01068509|11002747|FG001|STARTED|Overall Study||29
9887844|NCT01068509|11002748|FG002|STARTED|Overall Study||27
9887845|NCT01068509|11002746|FG000|COMPLETED|Overall Study||1
9887846|NCT01068509|11002747|FG001|COMPLETED|Overall Study||7
9887847|NCT01068509|11002748|FG002|COMPLETED|Overall Study||6
9887848|NCT01068509|11002746|FG000|NOT COMPLETED|Overall Study||6
9887849|NCT01068509|11002747|FG001|NOT COMPLETED|Overall Study||22
9887850|NCT01068509|11002748|FG002|NOT COMPLETED|Overall Study||21
9887851|NCT01068548|11002757|FG000|STARTED|Overall Study||66
9887852|NCT01068548|11002758|FG001|STARTED|Overall Study||63
9887853|NCT01068548|11002757|FG000|COMPLETED|Overall Study||66
9887854|NCT01068548|11002758|FG001|COMPLETED|Overall Study||63
9887855|NCT01068548|11002757|FG000|NOT COMPLETED|Overall Study||0
9887856|NCT01068548|11002758|FG001|NOT COMPLETED|Overall Study||0
9887857|NCT01068600|11002767|FG000|STARTED|Overall Study||159
9887858|NCT01068600|11002768|FG001|STARTED|Overall Study||159
9887859|NCT01068600|11002767|FG000|COMPLETED|Overall Study||148
9887860|NCT01068600|11002768|FG001|COMPLETED|Overall Study||142
9887861|NCT01068600|11002767|FG000|NOT COMPLETED|Overall Study||11
9887862|NCT01068600|11002768|FG001|NOT COMPLETED|Overall Study||17
9887863|NCT01068626|11002776|FG000|STARTED|Overall Study||30
9887864|NCT01068626|11002777|FG001|STARTED|Overall Study||29
9887865|NCT01068626|11002776|FG000|COMPLETED|Overall Study||27
9887866|NCT01068626|11002777|FG001|COMPLETED|Overall Study||27
9887867|NCT01068626|11002776|FG000|NOT COMPLETED|Overall Study||3
9887868|NCT01068626|11002777|FG001|NOT COMPLETED|Overall Study||2
9954433|NCT01431963|11073277|FG000|Complete MP (24 Weeks)|Overall Study||42
9954434|NCT01431963|11073277|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
9954435|NCT01431963|11073277|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
9954436|NCT01431963|11073277|FG000|COMPLETED|Overall Study||32
9954437|NCT01431963|11073277|FG000|NOT COMPLETED|Overall Study||35
9954438|NCT01431976|11073281|FG000|STARTED|Overall Study||20
9954439|NCT01431976|11073281|FG000|COMPLETED|Overall Study||6
9954440|NCT01431976|11073281|FG000|NOT COMPLETED|Overall Study||14
9954441|NCT01431989|11073285|FG000|STARTED|Period 1||14
9954442|NCT01431989|11073286|FG001|STARTED|Period 1||14
9954443|NCT01431989|11073285|FG000|COMPLETED|Period 1||14
9954444|NCT01431989|11073286|FG001|COMPLETED|Period 1||14
9954445|NCT01431989|11073285|FG000|NOT COMPLETED|Period 1||0
9954446|NCT01431989|11073286|FG001|NOT COMPLETED|Period 1||0
9954447|NCT01431989|11073285|FG000|STARTED|14-Day Washout Period||14
9954448|NCT01431989|11073286|FG001|STARTED|14-Day Washout Period||14
9954449|NCT01431989|11073285|FG000|COMPLETED|14-Day Washout Period||14
9954450|NCT01431989|11073286|FG001|COMPLETED|14-Day Washout Period||14
9954451|NCT01431989|11073285|FG000|NOT COMPLETED|14-Day Washout Period||0
9954452|NCT01431989|11073286|FG001|NOT COMPLETED|14-Day Washout Period||0
9954453|NCT01431989|11073285|FG000|STARTED|Period 2||14
9954454|NCT01431989|11073286|FG001|STARTED|Period 2||14
9954455|NCT01431989|11073285|FG000|COMPLETED|Period 2||14
9954456|NCT01431989|11073286|FG001|COMPLETED|Period 2||14
9954457|NCT01431989|11073285|FG000|NOT COMPLETED|Period 2||0
9954458|NCT01431989|11073286|FG001|NOT COMPLETED|Period 2||0
9954459|NCT01432015|11073294|FG000|STARTED|Overall Study||10
9954460|NCT01432015|11073295|FG001|STARTED|Overall Study||10
9954461|NCT01432015|11073294|FG000|COMPLETED|Overall Study||10
9954462|NCT01432015|11073295|FG001|COMPLETED|Overall Study||10
9954463|NCT01432015|11073294|FG000|NOT COMPLETED|Overall Study||0
9954464|NCT01432015|11073295|FG001|NOT COMPLETED|Overall Study||0
9954465|NCT01432145|11073301|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
9954466|NCT01432145|11073301|FG000|COMPLETED|Overall Study||67
9954467|NCT01432145|11073301|FG000|NOT COMPLETED|Overall Study||7
9954468|NCT01432171|11073307|FG000|STARTED|Overall Study||18
9954469|NCT01432171|11073308|FG001|STARTED|Overall Study||19
9954470|NCT01432171|11073307|FG000|COMPLETED|Overall Study||4
9954471|NCT01432171|11073308|FG001|COMPLETED|Overall Study||8
9954472|NCT01432171|11073307|FG000|NOT COMPLETED|Overall Study||14
9954473|NCT01432171|11073308|FG001|NOT COMPLETED|Overall Study||11
9954474|NCT01432236|11073316|FG000|STARTED|Overall Study||96
9954475|NCT01432236|11073317|FG001|STARTED|Overall Study||97
9954476|NCT01432236|11073316|FG000|COMPLETED|Overall Study||70
9954477|NCT01432236|11073317|FG001|COMPLETED|Overall Study||79
9954478|NCT01432236|11073316|FG000|NOT COMPLETED|Overall Study||26
9954479|NCT01432236|11073317|FG001|NOT COMPLETED|Overall Study||18
9954480|NCT01432262|11073332|FG000|STARTED|Overall Study||162
9954481|NCT01432262|11073333|FG001|STARTED|Overall Study||162
9954482|NCT01432262|11073332|FG000|Vaccinated|Overall Study||162
9954483|NCT01432262|11073333|FG001|Vaccinated|Overall Study||161
10008461|NCT01757301|11130805|FG001|STARTED|Overall Study||147
10008462|NCT01757301|11130804|FG000|COMPLETED|Overall Study||134
10008463|NCT01757301|11130805|FG001|COMPLETED|Overall Study||133
9954484|NCT01432262|11073332|FG000|COMPLETED|Overall Study||160
9954485|NCT01432262|11073333|FG001|COMPLETED|Overall Study||161
9954486|NCT01432262|11073332|FG000|NOT COMPLETED|Overall Study||2
9954487|NCT01432262|11073333|FG001|NOT COMPLETED|Overall Study||1
10008464|NCT01757301|11130804|FG000|NOT COMPLETED|Overall Study||13
9887869|NCT01068652|11002785|FG000|STARTED|Overall Study||200
9887870|NCT01068652|11002786|FG001|STARTED|Overall Study||203
9887871|NCT01068652|11002785|FG000|COMPLETED|Overall Study||182
9887872|NCT01068652|11002786|FG001|COMPLETED|Overall Study||188
9887873|NCT01068652|11002785|FG000|NOT COMPLETED|Overall Study||18
9887874|NCT01068652|11002786|FG001|NOT COMPLETED|Overall Study||15
9887875|NCT01068665|11002794|FG000|STARTED|Overall Study||230
9887876|NCT01068665|11002795|FG001|STARTED|Overall Study||230
9887877|NCT01068665|11002794|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
9887878|NCT01068665|11002795|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
9887879|NCT01068665|11002794|FG000|Exposed|Overall Study||228
9887880|NCT01068665|11002795|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
9887881|NCT01068665|11002794|FG000|COMPLETED|Overall Study||200
9887882|NCT01068665|11002795|FG001|COMPLETED|Overall Study||201
9887883|NCT01068665|11002794|FG000|NOT COMPLETED|Overall Study||30
9887884|NCT01068665|11002795|FG001|NOT COMPLETED|Overall Study||29
9887885|NCT01068678|11002803|FG000|STARTED|Overall Study||230
9887886|NCT01068678|11002804|FG001|STARTED|Overall Study||230
9887887|NCT01068678|11002803|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
9887888|NCT01068678|11002804|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
9887889|NCT01068678|11002803|FG000|COMPLETED|Overall Study||192
9887890|NCT01068678|11002804|FG001|COMPLETED|Overall Study||206
9887891|NCT01068678|11002803|FG000|NOT COMPLETED|Overall Study||38
9887892|NCT01068678|11002804|FG001|NOT COMPLETED|Overall Study||24
9887893|NCT01068717|11002810|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7
9887894|NCT01068717|11002811|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6
9887895|NCT01068717|11002812|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7
9887896|NCT01068717|11002813|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7
9887897|NCT01068717|11002810|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
9887898|NCT01068717|11002811|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6
9887899|NCT01068717|11002812|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7
9887900|NCT01068717|11002813|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7
9887901|NCT01068717|11002810|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
9887902|NCT01068717|11002811|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
9887903|NCT01068717|11002812|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
9887904|NCT01068717|11002813|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
9887905|NCT01068717|11002810|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6
9887906|NCT01068717|11002811|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6
9887907|NCT01068717|11002812|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7
9887908|NCT01068717|11002813|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7
9887909|NCT01068717|11002810|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6
9887910|NCT01068717|11002811|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6
9887911|NCT01068717|11002812|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7
9887912|NCT01068717|11002813|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7
9887913|NCT01068717|11002810|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
9887914|NCT01068717|11002811|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
9887915|NCT01068717|11002812|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
9887916|NCT01068717|11002813|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
9887917|NCT01068717|11002810|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
9887918|NCT01068717|11002811|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6
9887919|NCT01068717|11002812|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7
9887920|NCT01068717|11002813|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7
9887921|NCT01068717|11002810|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7
9887922|NCT01068717|11002811|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6
9887923|NCT01068717|11002812|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7
9887924|NCT01068717|11002813|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7
9887925|NCT01068717|11002810|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
9887926|NCT01068717|11002811|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
9887927|NCT01068717|11002812|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
9887928|NCT01068717|11002813|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
9887929|NCT01068717|11002810|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
9887930|NCT01068717|11002811|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6
10008465|NCT01757301|11130805|FG001|NOT COMPLETED|Overall Study||14
10008466|NCT01757392|11130813|FG000|STARTED|Overall Study||39
10008467|NCT01757392|11130813|FG000|COMPLETED|Overall Study||35
10008468|NCT01757392|11130813|FG000|NOT COMPLETED|Overall Study||4
9887931|NCT01068717|11002812|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7
9887932|NCT01068717|11002813|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7
9887933|NCT01068717|11002810|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7
9887934|NCT01068717|11002811|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6
9887935|NCT01068717|11002812|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7
9887936|NCT01068717|11002813|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7
9887937|NCT01068717|11002810|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
10008469|NCT01757405|11130819|FG000|STARTED|Overall Study||18
9887938|NCT01068717|11002811|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
9887939|NCT01068717|11002812|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
9887940|NCT01068717|11002813|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
9887941|NCT01068730|11002827|FG000|STARTED|Period 1||7
9887942|NCT01068730|11002828|FG001|STARTED|Period 1||7
9887943|NCT01068730|11002829|FG002|STARTED|Period 1||7
9887944|NCT01068730|11002830|FG003|STARTED|Period 1||7
10008470|NCT01757405|11130820|FG001|STARTED|Overall Study||20
10008471|NCT01757405|11130819|FG000|COMPLETED|Overall Study||17
9887945|NCT01068730|11002827|FG000|COMPLETED|Period 1||7
9887946|NCT01068730|11002828|FG001|COMPLETED|Period 1||7
9887947|NCT01068730|11002829|FG002|COMPLETED|Period 1||7
9887948|NCT01068730|11002830|FG003|COMPLETED|Period 1||7
9887949|NCT01068730|11002827|FG000|NOT COMPLETED|Period 1||0
9887950|NCT01068730|11002828|FG001|NOT COMPLETED|Period 1||0
9887951|NCT01068730|11002829|FG002|NOT COMPLETED|Period 1||0
9887952|NCT01068730|11002830|FG003|NOT COMPLETED|Period 1||0
9887953|NCT01068730|11002827|FG000|STARTED|Period 2||7
9887954|NCT01068730|11002828|FG001|STARTED|Period 2||7
9887955|NCT01068730|11002829|FG002|STARTED|Period 2||7
9887956|NCT01068730|11002830|FG003|STARTED|Period 2||7
9887957|NCT01068730|11002827|FG000|COMPLETED|Period 2||7
9887958|NCT01068730|11002828|FG001|COMPLETED|Period 2||7
9887959|NCT01068730|11002829|FG002|COMPLETED|Period 2||7
9887960|NCT01068730|11002830|FG003|COMPLETED|Period 2||7
9887961|NCT01068730|11002827|FG000|NOT COMPLETED|Period 2||0
9887962|NCT01068730|11002828|FG001|NOT COMPLETED|Period 2||0
9887963|NCT01068730|11002829|FG002|NOT COMPLETED|Period 2||0
9887964|NCT01068730|11002830|FG003|NOT COMPLETED|Period 2||0
9887965|NCT01068730|11002827|FG000|STARTED|Period 3||7
9887966|NCT01068730|11002828|FG001|STARTED|Period 3||7
9887967|NCT01068730|11002829|FG002|STARTED|Period 3||7
9887968|NCT01068730|11002830|FG003|STARTED|Period 3||7
9887969|NCT01068730|11002827|FG000|COMPLETED|Period 3||6
9887970|NCT01068730|11002828|FG001|COMPLETED|Period 3||7
9887971|NCT01068730|11002829|FG002|COMPLETED|Period 3||7
9887972|NCT01068730|11002830|FG003|COMPLETED|Period 3||7
9887973|NCT01068730|11002827|FG000|NOT COMPLETED|Period 3||1
9887974|NCT01068730|11002828|FG001|NOT COMPLETED|Period 3||0
9887975|NCT01068730|11002829|FG002|NOT COMPLETED|Period 3||0
9887976|NCT01068730|11002830|FG003|NOT COMPLETED|Period 3||0
9887977|NCT01068730|11002827|FG000|STARTED|Period 4||6
9887978|NCT01068730|11002828|FG001|STARTED|Period 4||7
9887979|NCT01068730|11002829|FG002|STARTED|Period 4||7
9887980|NCT01068730|11002830|FG003|STARTED|Period 4||7
9887981|NCT01068730|11002827|FG000|COMPLETED|Period 4||6
9887982|NCT01068730|11002828|FG001|COMPLETED|Period 4||6
9887983|NCT01068730|11002829|FG002|COMPLETED|Period 4||7
9887984|NCT01068730|11002830|FG003|COMPLETED|Period 4||7
9887985|NCT01068730|11002827|FG000|NOT COMPLETED|Period 4||0
9887986|NCT01068730|11002828|FG001|NOT COMPLETED|Period 4||1
9887987|NCT01068730|11002829|FG002|NOT COMPLETED|Period 4||0
9887988|NCT01068730|11002830|FG003|NOT COMPLETED|Period 4||0
9887989|NCT01068743|11002847|FG000|STARTED|Period 1||6
9887990|NCT01068743|11002848|FG001|STARTED|Period 1||6
9887991|NCT01068743|11002849|FG002|STARTED|Period 1||6
9887992|NCT01068743|11002850|FG003|STARTED|Period 1||6
9887993|NCT01068743|11002847|FG000|COMPLETED|Period 1||6
9887994|NCT01068743|11002848|FG001|COMPLETED|Period 1||6
9887995|NCT01068743|11002849|FG002|COMPLETED|Period 1||6
9887996|NCT01068743|11002850|FG003|COMPLETED|Period 1||6
9887997|NCT01068743|11002847|FG000|NOT COMPLETED|Period 1||0
9887998|NCT01068743|11002848|FG001|NOT COMPLETED|Period 1||0
9887999|NCT01068743|11002849|FG002|NOT COMPLETED|Period 1||0
9888000|NCT01068743|11002850|FG003|NOT COMPLETED|Period 1||0
9888001|NCT01068743|11002847|FG000|STARTED|Period 2||6
9888002|NCT01068743|11002848|FG001|STARTED|Period 2||6
9888003|NCT01068743|11002849|FG002|STARTED|Period 2||6
9888004|NCT01068743|11002850|FG003|STARTED|Period 2||6
9888005|NCT01068743|11002847|FG000|COMPLETED|Period 2||6
9888006|NCT01068743|11002848|FG001|COMPLETED|Period 2||6
9888007|NCT01068743|11002849|FG002|COMPLETED|Period 2||6
9888008|NCT01068743|11002850|FG003|COMPLETED|Period 2||6
9888009|NCT01068743|11002847|FG000|NOT COMPLETED|Period 2||0
9888010|NCT01068743|11002848|FG001|NOT COMPLETED|Period 2||0
9888011|NCT01068743|11002849|FG002|NOT COMPLETED|Period 2||0
9888012|NCT01068743|11002850|FG003|NOT COMPLETED|Period 2||0
9888013|NCT01068743|11002847|FG000|STARTED|Period 3||6
9888014|NCT01068743|11002848|FG001|STARTED|Period 3||6
9888015|NCT01068743|11002849|FG002|STARTED|Period 3||6
9888016|NCT01068743|11002850|FG003|STARTED|Period 3||6
9888017|NCT01068743|11002847|FG000|COMPLETED|Period 3||6
9888018|NCT01068743|11002848|FG001|COMPLETED|Period 3||5
9888019|NCT01068743|11002849|FG002|COMPLETED|Period 3||6
9888020|NCT01068743|11002850|FG003|COMPLETED|Period 3||6
9888021|NCT01068743|11002847|FG000|NOT COMPLETED|Period 3||0
9888022|NCT01068743|11002848|FG001|NOT COMPLETED|Period 3||1
9888023|NCT01068743|11002849|FG002|NOT COMPLETED|Period 3||0
9888024|NCT01068743|11002850|FG003|NOT COMPLETED|Period 3||0
9888025|NCT01068743|11002847|FG000|STARTED|Period 4||6
9888026|NCT01068743|11002848|FG001|STARTED|Period 4||5
9888027|NCT01068743|11002849|FG002|STARTED|Period 4||6
9888028|NCT01068743|11002850|FG003|STARTED|Period 4||6
9888029|NCT01068743|11002847|FG000|COMPLETED|Period 4||6
9888030|NCT01068743|11002848|FG001|COMPLETED|Period 4||5
9888031|NCT01068743|11002849|FG002|COMPLETED|Period 4||6
9888032|NCT01068743|11002850|FG003|COMPLETED|Period 4||6
9888033|NCT01068743|11002847|FG000|NOT COMPLETED|Period 4||0
10008472|NCT01757405|11130820|FG001|COMPLETED|Overall Study||18
9888034|NCT01068743|11002848|FG001|NOT COMPLETED|Period 4||0
9888035|NCT01068743|11002849|FG002|NOT COMPLETED|Period 4||0
9888036|NCT01068743|11002850|FG003|NOT COMPLETED|Period 4||0
9888037|NCT01068769|11002863|FG000|STARTED|Overall Study||34
9888038|NCT01068769|11002863|FG000|COMPLETED|Overall Study||33
9888039|NCT01068769|11002863|FG000|NOT COMPLETED|Overall Study||1
9888040|NCT01068821|11002869|FG000|STARTED|Overall Study||31
9888041|NCT01068821|11002870|FG001|STARTED|Overall Study||29
9888042|NCT01068821|11002869|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
9888043|NCT01068821|11002870|FG001|COMPLETED|Overall Study||29
9888044|NCT01068821|11002869|FG000|NOT COMPLETED|Overall Study||1
9888045|NCT01068821|11002870|FG001|NOT COMPLETED|Overall Study||0
9888046|NCT01068860|11002886|FG000|STARTED|Overall Study||33
9888047|NCT01068860|11002887|FG001|STARTED|Overall Study||17
9888048|NCT01068860|11002888|FG002|STARTED|Overall Study||33
9888049|NCT01068860|11002889|FG003|STARTED|Overall Study||17
9888050|NCT01068860|11002890|FG004|STARTED|Overall Study||32
9888051|NCT01068860|11002891|FG005|STARTED|Overall Study||16
9888052|NCT01068860|11002892|FG006|STARTED|Overall Study||28
9888053|NCT01068860|11002893|FG007|STARTED|Overall Study||15
9888054|NCT01068860|11002894|FG008|STARTED|Overall Study||28
9888055|NCT01068860|11002895|FG009|STARTED|Overall Study||27
9888056|NCT01068860|11002886|FG000|COMPLETED|Overall Study||33
9888057|NCT01068860|11002887|FG001|COMPLETED|Overall Study||16
9888058|NCT01068860|11002888|FG002|COMPLETED|Overall Study||33
9888059|NCT01068860|11002889|FG003|COMPLETED|Overall Study||16
9888060|NCT01068860|11002890|FG004|COMPLETED|Overall Study||32
9888061|NCT01068860|11002891|FG005|COMPLETED|Overall Study||14
9888062|NCT01068860|11002892|FG006|COMPLETED|Overall Study||28
9888063|NCT01068860|11002893|FG007|COMPLETED|Overall Study||15
9888064|NCT01068860|11002894|FG008|COMPLETED|Overall Study||28
9888065|NCT01068860|11002895|FG009|COMPLETED|Overall Study||23
9888066|NCT01068860|11002886|FG000|NOT COMPLETED|Overall Study||0
9888067|NCT01068860|11002887|FG001|NOT COMPLETED|Overall Study||1
9888068|NCT01068860|11002888|FG002|NOT COMPLETED|Overall Study||0
9888069|NCT01068860|11002889|FG003|NOT COMPLETED|Overall Study||1
9888070|NCT01068860|11002890|FG004|NOT COMPLETED|Overall Study||0
9888071|NCT01068860|11002891|FG005|NOT COMPLETED|Overall Study||2
9888072|NCT01068860|11002892|FG006|NOT COMPLETED|Overall Study||0
9888073|NCT01068860|11002893|FG007|NOT COMPLETED|Overall Study||0
9888074|NCT01068860|11002894|FG008|NOT COMPLETED|Overall Study||0
9888075|NCT01068860|11002895|FG009|NOT COMPLETED|Overall Study||4
9888076|NCT01068873|11002917|FG000|STARTED|Overall Study||1
9888077|NCT01068873|11002917|FG000|COMPLETED|Overall Study||1
9888078|NCT01068873|11002917|FG000|NOT COMPLETED|Overall Study||0
9888079|NCT01068912|11002924|FG000|STARTED|Overall Study||134
9888080|NCT01068912|11002925|FG001|STARTED|Overall Study||195
9888081|NCT01068912|11002926|FG002|STARTED|Overall Study||201
9888082|NCT01068912|11002924|FG000|COMPLETED|Overall Study||123
9888083|NCT01068912|11002925|FG001|COMPLETED|Overall Study||173
9888084|NCT01068912|11002926|FG002|COMPLETED|Overall Study||186
9888085|NCT01068912|11002924|FG000|NOT COMPLETED|Overall Study||11
9888086|NCT01068912|11002925|FG001|NOT COMPLETED|Overall Study||22
9888087|NCT01068912|11002926|FG002|NOT COMPLETED|Overall Study||15
9888088|NCT01068964|11002936|FG000|STARTED|Overall Study||121
9888089|NCT01068964|11002937|FG001|STARTED|Overall Study||114
9888090|NCT01068964|11002936|FG000|COMPLETED|Overall Study||113
9888091|NCT01068964|11002937|FG001|COMPLETED|Overall Study||104
9888092|NCT01068964|11002936|FG000|NOT COMPLETED|Overall Study||8
9888093|NCT01068964|11002937|FG001|NOT COMPLETED|Overall Study||10
9888094|NCT01069003|11002946|FG000|STARTED|Overall Study||399
9888095|NCT01069003|11002947|FG001|STARTED|Overall Study||412
9888096|NCT01069003|11002948|FG002|STARTED|Overall Study||1451
9888097|NCT01069003|11002946|FG000|COMPLETED|Overall Study||353
9888098|NCT01069003|11002947|FG001|COMPLETED|Overall Study||358
9888099|NCT01069003|11002948|FG002|COMPLETED|Overall Study||976
9888100|NCT01069003|11002946|FG000|NOT COMPLETED|Overall Study||46
9888101|NCT01069003|11002947|FG001|NOT COMPLETED|Overall Study||54
9888102|NCT01069003|11002948|FG002|NOT COMPLETED|Overall Study||475
9888103|NCT01069172|11002958|FG000|STARTED|Overall Study|30 eyes|30
9888104|NCT01069172|11002959|FG001|STARTED|Overall Study|30 eyes|30
9888105|NCT01069172|11002958|FG000|COMPLETED|Overall Study|29 eyes|29
9888106|NCT01069172|11002959|FG001|COMPLETED|Overall Study|30 eyes|30
9888107|NCT01069172|11002958|FG000|NOT COMPLETED|Overall Study||1
9888108|NCT01069172|11002959|FG001|NOT COMPLETED|Overall Study||0
9888109|NCT01069185|11002968|FG000|STARTED|Overall Study||47
9888110|NCT01069185|11002969|FG001|STARTED|Overall Study||45
9888111|NCT01069185|11002968|FG000|COMPLETED|Overall Study||47
9888112|NCT01069185|11002969|FG001|COMPLETED|Overall Study||45
9888113|NCT01069185|11002968|FG000|NOT COMPLETED|Overall Study||0
9888114|NCT01069185|11002969|FG001|NOT COMPLETED|Overall Study||0
9888115|NCT01069289|11002977|FG000|STARTED|Overall Study||636
9888116|NCT01069289|11002978|FG001|STARTED|Overall Study||657
9888117|NCT01069289|11002977|FG000|COMPLETED|Overall Study||594
9888118|NCT01069289|11002978|FG001|COMPLETED|Overall Study||601
9888119|NCT01069289|11002977|FG000|NOT COMPLETED|Overall Study||42
9888120|NCT01069289|11002978|FG001|NOT COMPLETED|Overall Study||56
9888121|NCT01069315|11002988|FG000|STARTED|Overall Study||27
9888122|NCT01069315|11002989|FG001|STARTED|Overall Study||30
9888123|NCT01069315|11002990|FG002|STARTED|Overall Study||28
9888124|NCT01069315|11002991|FG003|STARTED|Overall Study||26
9888125|NCT01069315|11002988|FG000|COMPLETED|Overall Study||23
9888126|NCT01069315|11002989|FG001|COMPLETED|Overall Study||24
9888127|NCT01069315|11002990|FG002|COMPLETED|Overall Study||23
9888128|NCT01069315|11002991|FG003|COMPLETED|Overall Study||19
9888129|NCT01069315|11002988|FG000|NOT COMPLETED|Overall Study||4
9888130|NCT01069315|11002989|FG001|NOT COMPLETED|Overall Study||6
9888131|NCT01069315|11002990|FG002|NOT COMPLETED|Overall Study||5
9888132|NCT01069315|11002991|FG003|NOT COMPLETED|Overall Study||7
9888133|NCT01069341|11003005|FG000|STARTED|Overall Study||4
9888134|NCT01069341|11003005|FG000|COMPLETED|Overall Study||3
9888135|NCT01069341|11003005|FG000|NOT COMPLETED|Overall Study||1
9888136|NCT01069354|11003009|FG000|STARTED|Overall Study||102
9888137|NCT01069354|11003009|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
9888138|NCT01069354|11003009|FG000|NOT COMPLETED|Overall Study||1
9888139|NCT01069419|11003017|FG000|STARTED|Overall Study||1117
9888140|NCT01069419|11003017|FG000|Safety Set|Overall Study||1111
9888141|NCT01069419|11003017|FG000|Full Analysis Set|Overall Study||851
9888142|NCT01069419|11003017|FG000|COMPLETED|Overall Study||402
9888143|NCT01069419|11003017|FG000|NOT COMPLETED|Overall Study||715
9888144|NCT01069484|11003023|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
9888145|NCT01069484|11003024|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
9888146|NCT01069484|11003023|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
9888147|NCT01069484|11003024|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
9888148|NCT01069484|11003023|FG000|NOT COMPLETED|Overall Study||12
9888149|NCT01069484|11003024|FG001|NOT COMPLETED|Overall Study||3
9888150|NCT01069510|11003033|FG000|STARTED|Overall Study||8
9888151|NCT01069510|11003034|FG001|STARTED|Overall Study||7
9888152|NCT01069510|11003033|FG000|COMPLETED|Overall Study||8
9888153|NCT01069510|11003034|FG001|COMPLETED|Overall Study||7
9888154|NCT01069510|11003033|FG000|NOT COMPLETED|Overall Study||0
9888155|NCT01069510|11003034|FG001|NOT COMPLETED|Overall Study||0
9888156|NCT01069523|11003042|FG000|STARTED|Overall Study||13
9888157|NCT01069523|11003043|FG001|STARTED|Overall Study||16
9888158|NCT01069523|11003042|FG000|COMPLETED|Overall Study||9
9888159|NCT01069523|11003043|FG001|COMPLETED|Overall Study||9
9888160|NCT01069523|11003042|FG000|NOT COMPLETED|Overall Study||4
9888161|NCT01069523|11003043|FG001|NOT COMPLETED|Overall Study||7
9888162|NCT01069562|11003053|FG000|STARTED|Overall Study||20
9888163|NCT01069562|11003054|FG001|STARTED|Overall Study||20
9888164|NCT01069562|11003053|FG000|COMPLETED|Overall Study||20
9888165|NCT01069562|11003054|FG001|COMPLETED|Overall Study||20
9888166|NCT01069562|11003053|FG000|NOT COMPLETED|Overall Study||0
9888167|NCT01069562|11003054|FG001|NOT COMPLETED|Overall Study||0
9888168|NCT01069627|11003060|FG000|STARTED|Overall Study||20
9888169|NCT01069627|11003060|FG000|COMPLETED|Overall Study||0
9888170|NCT01069627|11003060|FG000|NOT COMPLETED|Overall Study||20
9888171|NCT01069705|11003064|FG000|STARTED|Overall Study||49
9888172|NCT01069705|11003064|FG000|COMPLETED|Overall Study||46
9888173|NCT01069705|11003064|FG000|NOT COMPLETED|Overall Study||3
9888174|NCT01069900|11003070|FG000|STARTED|Overall Study||305
9888175|NCT01069900|11003071|FG001|STARTED|Overall Study||153
9888176|NCT01069900|11003070|FG000|Treated|Overall Study||301
9888177|NCT01069900|11003071|FG001|Treated|Overall Study||150
9888178|NCT01069900|11003070|FG000|COMPLETED|Overall Study||287
9888179|NCT01069900|11003071|FG001|COMPLETED|Overall Study||149
9888180|NCT01069900|11003070|FG000|NOT COMPLETED|Overall Study||18
9888181|NCT01069900|11003071|FG001|NOT COMPLETED|Overall Study||4
9888182|NCT01069939|11003079|FG000|STARTED|Randomised and Included in the Analyses||213
9888183|NCT01069939|11003080|FG001|STARTED|Randomised and Included in the Analyses||214
9888184|NCT01069939|11003079|FG000|COMPLETED|Randomised and Included in the Analyses||164
9888185|NCT01069939|11003080|FG001|COMPLETED|Randomised and Included in the Analyses||137
9888186|NCT01069939|11003079|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49
9888187|NCT01069939|11003080|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77
9888188|NCT01069939|11003079|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213
9888189|NCT01069939|11003080|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214
9888190|NCT01069939|11003079|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
9888191|NCT01069939|11003080|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
9888192|NCT01069939|11003079|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
9888193|NCT01069939|11003080|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
9888194|NCT01070043|11003088|FG000|STARTED|Run-In Phase||60
9888195|NCT01070043|11003089|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
9888196|NCT01070043|11003090|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
9888197|NCT01070043|11003088|FG000|COMPLETED|Run-In Phase||42
9888198|NCT01070043|11003089|FG001|COMPLETED|Run-In Phase||0
9888199|NCT01070043|11003090|FG002|COMPLETED|Run-In Phase||0
9888200|NCT01070043|11003088|FG000|NOT COMPLETED|Run-In Phase||18
9888201|NCT01070043|11003089|FG001|NOT COMPLETED|Run-In Phase||0
9888202|NCT01070043|11003090|FG002|NOT COMPLETED|Run-In Phase||0
9888203|NCT01070043|11003088|FG000|STARTED|Double-Blind Treatment||0
9888204|NCT01070043|11003089|FG001|STARTED|Double-Blind Treatment||21
9888205|NCT01070043|11003090|FG002|STARTED|Double-Blind Treatment||21
9888206|NCT01070043|11003088|FG000|COMPLETED|Double-Blind Treatment||0
9888207|NCT01070043|11003089|FG001|COMPLETED|Double-Blind Treatment||21
9888208|NCT01070043|11003090|FG002|COMPLETED|Double-Blind Treatment||19
9888209|NCT01070043|11003088|FG000|NOT COMPLETED|Double-Blind Treatment||0
9888210|NCT01070043|11003089|FG001|NOT COMPLETED|Double-Blind Treatment||0
9888211|NCT01070043|11003090|FG002|NOT COMPLETED|Double-Blind Treatment||2
9888212|NCT01070095|11003096|FG000|STARTED|Baseline Period||19
9888213|NCT01070095|11003097|FG001|STARTED|Baseline Period||830
9888214|NCT01070095|11003096|FG000|COMPLETED|Baseline Period||18
9888215|NCT01070095|11003097|FG001|COMPLETED|Baseline Period||830
9888216|NCT01070095|11003096|FG000|NOT COMPLETED|Baseline Period||1
9888217|NCT01070095|11003097|FG001|NOT COMPLETED|Baseline Period||0
9888218|NCT01070095|11003096|FG000|STARTED|Intervention Period||18
9888219|NCT01070095|11003097|FG001|STARTED|Intervention Period||890
9888220|NCT01070095|11003096|FG000|COMPLETED|Intervention Period||18
9888221|NCT01070095|11003097|FG001|COMPLETED|Intervention Period||890
9888222|NCT01070095|11003096|FG000|NOT COMPLETED|Intervention Period||0
9888223|NCT01070095|11003097|FG001|NOT COMPLETED|Intervention Period||0
9888224|NCT01070173|11003107|FG000|STARTED|Overall Study||33
9888225|NCT01070173|11003108|FG001|STARTED|Overall Study||8
9888226|NCT01070173|11003109|FG002|STARTED|Overall Study||11
9888227|NCT01070173|11003107|FG000|COMPLETED|Overall Study||33
9888228|NCT01070173|11003108|FG001|COMPLETED|Overall Study||8
9888229|NCT01070173|11003109|FG002|COMPLETED|Overall Study||11
9888230|NCT01070173|11003107|FG000|NOT COMPLETED|Overall Study||0
9888231|NCT01070173|11003108|FG001|NOT COMPLETED|Overall Study||0
9888232|NCT01070173|11003109|FG002|NOT COMPLETED|Overall Study||0
9888233|NCT01070303|11003119|FG000|STARTED|Overall Study||177
9888234|NCT01070303|11003119|FG000|COMPLETED|Overall Study||88
9888235|NCT01070303|11003119|FG000|NOT COMPLETED|Overall Study||89
9888236|NCT01070316|11003129|FG000|STARTED|Main Phase||20
9888237|NCT01070316|11003129|FG000|COMPLETED|Main Phase||20
9888238|NCT01070316|11003129|FG000|NOT COMPLETED|Main Phase||0
9888239|NCT01070316|11003129|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
9888240|NCT01070316|11003129|FG000|COMPLETED|Extension Phase||14
9888241|NCT01070316|11003129|FG000|NOT COMPLETED|Extension Phase||4
10109216|NCT02473640|11239814|FG000|STARTED|Treatment Period 1||15
10109217|NCT02473640|11239814|FG000|COMPLETED|Treatment Period 1||14
10109218|NCT02473640|11239814|FG000|NOT COMPLETED|Treatment Period 1||1
9888242|NCT01070329|11003135|FG000|STARTED|Overall Study||261
9888243|NCT01070329|11003136|FG001|STARTED|Overall Study||266
9888244|NCT01070329|11003135|FG000|COMPLETED|Overall Study||209
9888245|NCT01070329|11003136|FG001|COMPLETED|Overall Study||217
9888246|NCT01070329|11003135|FG000|NOT COMPLETED|Overall Study||52
9888247|NCT01070329|11003136|FG001|NOT COMPLETED|Overall Study||49
9888248|NCT01070381|11003142|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
9888249|NCT01070381|11003143|FG001|STARTED|Period 1, 1 Week of Wear||107
9888250|NCT01070381|11003142|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
9888251|NCT01070381|11003143|FG001|COMPLETED|Period 1, 1 Week of Wear||107
9888252|NCT01070381|11003142|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
9888253|NCT01070381|11003143|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0
9888254|NCT01070381|11003142|FG000|STARTED|Period 2, 1 Week of Wear||109
9888255|NCT01070381|11003143|FG001|STARTED|Period 2, 1 Week of Wear||107
9888256|NCT01070381|11003142|FG000|COMPLETED|Period 2, 1 Week of Wear||108
9888257|NCT01070381|11003143|FG001|COMPLETED|Period 2, 1 Week of Wear||106
9888258|NCT01070381|11003142|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1
9888259|NCT01070381|11003143|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
9888260|NCT01070394|11003149|FG000|STARTED|Overall Study||40
9888261|NCT01070394|11003149|FG000|COMPLETED|Overall Study||33
9888262|NCT01070394|11003149|FG000|NOT COMPLETED|Overall Study||7
9888263|NCT01070550|11003161|FG000|STARTED|Overall Study||3356
9888264|NCT01070550|11003162|FG001|STARTED|Overall Study||316
9888265|NCT01070550|11003163|FG002|STARTED|Overall Study||744
9888266|NCT01070550|11003164|FG003|STARTED|Overall Study||201
9888267|NCT01070550|11003165|FG004|STARTED|Overall Study||21
9888268|NCT01070550|11003166|FG005|STARTED|Overall Study||42
9888269|NCT01070550|11003161|FG000|COMPLETED|Overall Study||2071
9888270|NCT01070550|11003162|FG001|COMPLETED|Overall Study||254
9888271|NCT01070550|11003163|FG002|COMPLETED|Overall Study||528
9888272|NCT01070550|11003164|FG003|COMPLETED|Overall Study||124
9888273|NCT01070550|11003165|FG004|COMPLETED|Overall Study||20
9888274|NCT01070550|11003166|FG005|COMPLETED|Overall Study||35
9888275|NCT01070550|11003161|FG000|NOT COMPLETED|Overall Study||1285
9888276|NCT01070550|11003162|FG001|NOT COMPLETED|Overall Study||62
9888277|NCT01070550|11003163|FG002|NOT COMPLETED|Overall Study||216
9888278|NCT01070550|11003164|FG003|NOT COMPLETED|Overall Study||77
9888279|NCT01070550|11003165|FG004|NOT COMPLETED|Overall Study||1
9888280|NCT01070550|11003166|FG005|NOT COMPLETED|Overall Study||7
9888281|NCT01070693|11003183|FG000|STARTED|Overall Study||150
9888282|NCT01070693|11003184|FG001|STARTED|Overall Study||149
9888283|NCT01070693|11003183|FG000|COMPLETED|Overall Study||122
9888284|NCT01070693|11003184|FG001|COMPLETED|Overall Study||110
9888285|NCT01070693|11003183|FG000|NOT COMPLETED|Overall Study||28
9888286|NCT01070693|11003184|FG001|NOT COMPLETED|Overall Study||39
9888287|NCT01070771|11003190|FG000|STARTED|Overall Study|September 2008|203
9888288|NCT01070771|11003190|FG000|COMPLETED|Overall Study|August 2012|200
10109219|NCT02473640|11239814|FG000|STARTED|Run-in Phase||14
9888289|NCT01070771|11003190|FG000|NOT COMPLETED|Overall Study||3
9888290|NCT01070784|11003197|FG000|STARTED|Overall Study||130
9888291|NCT01070784|11003198|FG001|STARTED|Overall Study||130
10109220|NCT02473640|11239814|FG000|COMPLETED|Run-in Phase||14
9888292|NCT01070784|11003197|FG000|COMPLETED|Overall Study||110
9888293|NCT01070784|11003198|FG001|COMPLETED|Overall Study||112
9888294|NCT01070784|11003197|FG000|NOT COMPLETED|Overall Study||20
9888295|NCT01070784|11003198|FG001|NOT COMPLETED|Overall Study||18
9888296|NCT01070810|11003206|FG000|STARTED|Overall Study||45
9888297|NCT01070810|11003207|FG001|STARTED|Overall Study||43
9888298|NCT01070810|11003206|FG000|COMPLETED|Overall Study||45
9888299|NCT01070810|11003207|FG001|COMPLETED|Overall Study||43
9888300|NCT01070810|11003206|FG000|NOT COMPLETED|Overall Study||0
9888301|NCT01070810|11003207|FG001|NOT COMPLETED|Overall Study||0
9888302|NCT01070888|11003217|FG000|STARTED|First Intervention (14 Days)||2
9888303|NCT01070888|11003218|FG001|STARTED|First Intervention (14 Days)||4
9888304|NCT01070888|11003217|FG000|COMPLETED|First Intervention (14 Days)||2
9888305|NCT01070888|11003218|FG001|COMPLETED|First Intervention (14 Days)||2
9888306|NCT01070888|11003217|FG000|NOT COMPLETED|First Intervention (14 Days)||0
9888307|NCT01070888|11003218|FG001|NOT COMPLETED|First Intervention (14 Days)||2
9888308|NCT01070888|11003217|FG000|STARTED|Washout (14 Days)||2
9888309|NCT01070888|11003218|FG001|STARTED|Washout (14 Days)||2
9888310|NCT01070888|11003217|FG000|COMPLETED|Washout (14 Days)||1
9888311|NCT01070888|11003218|FG001|COMPLETED|Washout (14 Days)||2
9888312|NCT01070888|11003217|FG000|NOT COMPLETED|Washout (14 Days)||1
9888313|NCT01070888|11003218|FG001|NOT COMPLETED|Washout (14 Days)||0
9888314|NCT01070888|11003217|FG000|STARTED|Second Intervention (14 Days)||1
9888315|NCT01070888|11003218|FG001|STARTED|Second Intervention (14 Days)||2
9888316|NCT01070888|11003217|FG000|COMPLETED|Second Intervention (14 Days)||1
9888317|NCT01070888|11003218|FG001|COMPLETED|Second Intervention (14 Days)||2
9888318|NCT01070888|11003217|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
9888319|NCT01070888|11003218|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
9888320|NCT01070979|11003227|FG000|STARTED|Overall Study||79
9888321|NCT01070979|11003228|FG001|STARTED|Overall Study||85
9888322|NCT01070979|11003229|FG002|STARTED|Overall Study||85
9888323|NCT01070979|11003227|FG000|COMPLETED|Overall Study||68
9888324|NCT01070979|11003228|FG001|COMPLETED|Overall Study||73
9888325|NCT01070979|11003229|FG002|COMPLETED|Overall Study||72
9888326|NCT01070979|11003227|FG000|NOT COMPLETED|Overall Study||11
9888327|NCT01070979|11003228|FG001|NOT COMPLETED|Overall Study||12
9888328|NCT01070979|11003229|FG002|NOT COMPLETED|Overall Study||13
9888329|NCT01071044|11003239|FG000|STARTED|Overall Study||15
9888330|NCT01071044|11003240|FG001|STARTED|Overall Study||11
9888331|NCT01071044|11003239|FG000|COMPLETED|Overall Study||13
9888332|NCT01071044|11003240|FG001|COMPLETED|Overall Study||11
9888333|NCT01071044|11003239|FG000|NOT COMPLETED|Overall Study||2
9888334|NCT01071044|11003240|FG001|NOT COMPLETED|Overall Study||0
9888335|NCT01071070|11003251|FG000|STARTED|Overall Study||108
9888336|NCT01071070|11003252|FG001|STARTED|Overall Study||108
9888337|NCT01071070|11003251|FG000|COMPLETED|Overall Study||104
9888338|NCT01071070|11003252|FG001|COMPLETED|Overall Study||105
9888339|NCT01071070|11003251|FG000|NOT COMPLETED|Overall Study||4
9888340|NCT01071070|11003252|FG001|NOT COMPLETED|Overall Study||3
9888341|NCT01071083|11003263|FG000|STARTED|Overall Study||42
9888342|NCT01071083|11003264|FG001|STARTED|Overall Study||45
9888343|NCT01071083|11003265|FG002|STARTED|Overall Study||17
9888344|NCT01071083|11003266|FG003|STARTED|Overall Study||17
9888345|NCT01071083|11003267|FG004|STARTED|Overall Study||54
9888346|NCT01071083|11003263|FG000|COMPLETED|Overall Study||35
9888347|NCT01071083|11003264|FG001|COMPLETED|Overall Study||43
9888348|NCT01071083|11003265|FG002|COMPLETED|Overall Study||12
9888349|NCT01071083|11003266|FG003|COMPLETED|Overall Study||15
9888350|NCT01071083|11003267|FG004|COMPLETED|Overall Study||46
9888351|NCT01071083|11003263|FG000|NOT COMPLETED|Overall Study||7
9888352|NCT01071083|11003264|FG001|NOT COMPLETED|Overall Study||2
9888353|NCT01071083|11003265|FG002|NOT COMPLETED|Overall Study||5
9888354|NCT01071083|11003266|FG003|NOT COMPLETED|Overall Study||2
9888355|NCT01071083|11003267|FG004|NOT COMPLETED|Overall Study||8
9888356|NCT01071096|11003279|FG000|STARTED|First Intervention (90 Days)||10
9888357|NCT01071096|11003280|FG001|STARTED|First Intervention (90 Days)||10
9888358|NCT01071096|11003279|FG000|COMPLETED|First Intervention (90 Days)||9
9888359|NCT01071096|11003280|FG001|COMPLETED|First Intervention (90 Days)||10
9888360|NCT01071096|11003279|FG000|NOT COMPLETED|First Intervention (90 Days)||1
9888361|NCT01071096|11003280|FG001|NOT COMPLETED|First Intervention (90 Days)||0
9888362|NCT01071096|11003279|FG000|STARTED|Washout Period (30 Days)||9
9888363|NCT01071096|11003280|FG001|STARTED|Washout Period (30 Days)||10
9888364|NCT01071096|11003279|FG000|COMPLETED|Washout Period (30 Days)||9
10109221|NCT02473640|11239814|FG000|NOT COMPLETED|Run-in Phase||0
10109222|NCT02473640|11239814|FG000|STARTED|Treatment Period 2||14
9888365|NCT01071096|11003280|FG001|COMPLETED|Washout Period (30 Days)||10
9888366|NCT01071096|11003279|FG000|NOT COMPLETED|Washout Period (30 Days)||0
9888367|NCT01071096|11003280|FG001|NOT COMPLETED|Washout Period (30 Days)||0
9888368|NCT01071096|11003279|FG000|STARTED|Second Intervention (90 Days)||9
9888369|NCT01071096|11003280|FG001|STARTED|Second Intervention (90 Days)||10
9888370|NCT01071096|11003279|FG000|COMPLETED|Second Intervention (90 Days)||9
9888371|NCT01071096|11003280|FG001|COMPLETED|Second Intervention (90 Days)||10
9888372|NCT01071096|11003279|FG000|NOT COMPLETED|Second Intervention (90 Days)||0
9888373|NCT01071096|11003280|FG001|NOT COMPLETED|Second Intervention (90 Days)||0
9888374|NCT01071200|11003299|FG000|STARTED|Overall Study||67
9888375|NCT01071200|11003300|FG001|STARTED|Overall Study||66
9888376|NCT01071200|11003299|FG000|COMPLETED|Overall Study||60
9888377|NCT01071200|11003300|FG001|COMPLETED|Overall Study||63
9888378|NCT01071200|11003299|FG000|NOT COMPLETED|Overall Study||7
9888379|NCT01071200|11003300|FG001|NOT COMPLETED|Overall Study||3
9888380|NCT01071252|11003311|FG000|STARTED|Overall Study||29
9888381|NCT01071252|11003312|FG001|STARTED|Overall Study||26
9888382|NCT01071252|11003313|FG002|STARTED|Overall Study||21
9888383|NCT01071252|11003314|FG003|STARTED|Overall Study||27
9888384|NCT01071252|11003315|FG004|STARTED|Overall Study||22
9888385|NCT01071252|11003311|FG000|COMPLETED|Overall Study||14
9888386|NCT01071252|11003312|FG001|COMPLETED|Overall Study||16
9888387|NCT01071252|11003313|FG002|COMPLETED|Overall Study||17
9888388|NCT01071252|11003314|FG003|COMPLETED|Overall Study||20
9888389|NCT01071252|11003315|FG004|COMPLETED|Overall Study||11
9888390|NCT01071252|11003311|FG000|NOT COMPLETED|Overall Study||15
9888391|NCT01071252|11003312|FG001|NOT COMPLETED|Overall Study||10
9888392|NCT01071252|11003313|FG002|NOT COMPLETED|Overall Study||4
9888393|NCT01071252|11003314|FG003|NOT COMPLETED|Overall Study||7
9888394|NCT01071252|11003315|FG004|NOT COMPLETED|Overall Study||11
9888395|NCT01071278|11003327|FG000|STARTED|Overall Study||2390
9888396|NCT01071278|11003327|FG000|COMPLETED|Overall Study||1677
9888397|NCT01071278|11003327|FG000|NOT COMPLETED|Overall Study||713
9888398|NCT01071317|11003335|FG000|STARTED|Overall Study||25
9888399|NCT01071317|11003336|FG001|STARTED|Overall Study||25
9888400|NCT01071317|11003335|FG000|COMPLETED|Overall Study||23
9888401|NCT01071317|11003336|FG001|COMPLETED|Overall Study||23
9888402|NCT01071317|11003335|FG000|NOT COMPLETED|Overall Study||2
9888403|NCT01071317|11003336|FG001|NOT COMPLETED|Overall Study||2
9888404|NCT01071356|11003344|FG000|STARTED|Overall Study||111
9888405|NCT01071356|11003345|FG001|STARTED|Overall Study||106
9888406|NCT01071356|11003344|FG000|COMPLETED|Overall Study||104
9888407|NCT01071356|11003345|FG001|COMPLETED|Overall Study||97
9888408|NCT01071356|11003344|FG000|NOT COMPLETED|Overall Study||7
9888409|NCT01071356|11003345|FG001|NOT COMPLETED|Overall Study||9
9888410|NCT01071395|11003353|FG000|STARTED|Overall Study||36
9888411|NCT01071395|11003354|FG001|STARTED|Overall Study||32
9888412|NCT01071395|11003353|FG000|COMPLETED|Overall Study||31
9888413|NCT01071395|11003354|FG001|COMPLETED|Overall Study||30
9888414|NCT01071395|11003353|FG000|NOT COMPLETED|Overall Study||5
9888415|NCT01071395|11003354|FG001|NOT COMPLETED|Overall Study||2
9888416|NCT01071512|11003360|FG000|STARTED|Overall Study||20
9888417|NCT01071512|11003360|FG000|COMPLETED|Overall Study||15
9888418|NCT01071512|11003360|FG000|NOT COMPLETED|Overall Study||5
9888419|NCT01071538|11003364|FG000|STARTED|Overall Study||15
9888420|NCT01071538|11003364|FG000|COMPLETED|Overall Study||13
9888421|NCT01071538|11003364|FG000|NOT COMPLETED|Overall Study||2
9888422|NCT01071798|11003368|FG000|STARTED|Participants Who Received One Cycle||1653
9888423|NCT01071798|11003368|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
9888424|NCT01071798|11003368|FG000|COMPLETED|Participants Who Received One Cycle||1588
9888425|NCT01071798|11003368|FG000|NOT COMPLETED|Participants Who Received One Cycle||65
9888426|NCT01071798|11003368|FG000|STARTED|Subpopulation Who Received Two Cycles||820
9888427|NCT01071798|11003368|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
9888428|NCT01071798|11003368|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805
9888429|NCT01071798|11003368|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
9888430|NCT01071915|11003382|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157
9888431|NCT01071915|11003382|FG000|Full Analysis Set (FAS)|Overall Study||155
9888432|NCT01071915|11003382|FG000|Safety Analysis Set|Overall Study||156
9888433|NCT01071915|11003382|FG000|COMPLETED|Overall Study||148
9888434|NCT01071915|11003382|FG000|NOT COMPLETED|Overall Study||9
9888435|NCT01071954|11003386|FG000|STARTED|Overall Study||66
9888436|NCT01071954|11003386|FG000|Received Treatment|Overall Study||65
9888437|NCT01071954|11003386|FG000|COMPLETED|Overall Study||39
9888438|NCT01071954|11003386|FG000|NOT COMPLETED|Overall Study||27
9888439|NCT01072006|11003394|FG000|STARTED|Overall Study||14
9888440|NCT01072006|11003395|FG001|STARTED|Overall Study||5
9888441|NCT01072006|11003396|FG002|STARTED|Overall Study||0
9888442|NCT01072006|11003397|FG003|STARTED|Overall Study||11
9888443|NCT01072006|11003394|FG000|COMPLETED|Overall Study||14
9888444|NCT01072006|11003395|FG001|COMPLETED|Overall Study||5
9888445|NCT01072006|11003396|FG002|COMPLETED|Overall Study||0
9888446|NCT01072006|11003397|FG003|COMPLETED|Overall Study||11
9888447|NCT01072006|11003394|FG000|NOT COMPLETED|Overall Study||0
9888448|NCT01072006|11003395|FG001|NOT COMPLETED|Overall Study||0
9888449|NCT01072006|11003396|FG002|NOT COMPLETED|Overall Study||0
9888450|NCT01072006|11003397|FG003|NOT COMPLETED|Overall Study||0
9888451|NCT01072032|11003410|FG000|STARTED|Overall Study||13
9888452|NCT01072032|11003411|FG001|STARTED|Overall Study||14
9888453|NCT01072032|11003410|FG000|COMPLETED|Overall Study||5
9888454|NCT01072032|11003411|FG001|COMPLETED|Overall Study||5
9888455|NCT01072032|11003410|FG000|NOT COMPLETED|Overall Study||8
9888456|NCT01072032|11003411|FG001|NOT COMPLETED|Overall Study||9
9888457|NCT01072136|11003420|FG000|STARTED|Overall Study||44
9888458|NCT01072136|11003421|FG001|STARTED|Overall Study||43
9888459|NCT01072136|11003420|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
9888460|NCT01072136|11003421|FG001|Met All Enrollment Criteria|Overall Study||25
9888461|NCT01072136|11003420|FG000|COMPLETED|Overall Study||21
9888462|NCT01072136|11003421|FG001|COMPLETED|Overall Study||12
9888463|NCT01072136|11003420|FG000|NOT COMPLETED|Overall Study||23
9888464|NCT01072136|11003421|FG001|NOT COMPLETED|Overall Study||31
9888465|NCT01072149|11003430|FG000|STARTED|Treatment Period 1 (28 Days)||3
9888466|NCT01072149|11003431|FG001|STARTED|Treatment Period 1 (28 Days)||3
9888467|NCT01072149|11003432|FG002|STARTED|Treatment Period 1 (28 Days)||3
9888468|NCT01072149|11003433|FG003|STARTED|Treatment Period 1 (28 Days)||3
9888469|NCT01072149|11003434|FG004|STARTED|Treatment Period 1 (28 Days)||3
9888470|NCT01072149|11003435|FG005|STARTED|Treatment Period 1 (28 Days)||3
9888471|NCT01072149|11003436|FG006|STARTED|Treatment Period 1 (28 Days)||3
9888472|NCT01072149|11003437|FG007|STARTED|Treatment Period 1 (28 Days)||3
9888473|NCT01072149|11003438|FG008|STARTED|Treatment Period 1 (28 Days)||3
9888474|NCT01072149|11003439|FG009|STARTED|Treatment Period 1 (28 Days)||3
9888475|NCT01072149|11003440|FG010|STARTED|Treatment Period 1 (28 Days)||3
9888476|NCT01072149|11003441|FG011|STARTED|Treatment Period 1 (28 Days)||3
9888477|NCT01072149|11003442|FG012|STARTED|Treatment Period 1 (28 Days)||3
9888478|NCT01072149|11003443|FG013|STARTED|Treatment Period 1 (28 Days)||3
9888479|NCT01072149|11003444|FG014|STARTED|Treatment Period 1 (28 Days)||3
9888480|NCT01072149|11003445|FG015|STARTED|Treatment Period 1 (28 Days)||3
9888481|NCT01072149|11003446|FG016|STARTED|Treatment Period 1 (28 Days)||3
9888482|NCT01072149|11003447|FG017|STARTED|Treatment Period 1 (28 Days)||3
9888483|NCT01072149|11003430|FG000|COMPLETED|Treatment Period 1 (28 Days)||3
9888484|NCT01072149|11003431|FG001|COMPLETED|Treatment Period 1 (28 Days)||3
9888485|NCT01072149|11003432|FG002|COMPLETED|Treatment Period 1 (28 Days)||2
9888486|NCT01072149|11003433|FG003|COMPLETED|Treatment Period 1 (28 Days)||3
9888487|NCT01072149|11003434|FG004|COMPLETED|Treatment Period 1 (28 Days)||3
9888488|NCT01072149|11003435|FG005|COMPLETED|Treatment Period 1 (28 Days)||3
9888489|NCT01072149|11003436|FG006|COMPLETED|Treatment Period 1 (28 Days)||3
9888490|NCT01072149|11003437|FG007|COMPLETED|Treatment Period 1 (28 Days)||3
10008473|NCT01757405|11130819|FG000|NOT COMPLETED|Overall Study||1
10008474|NCT01757405|11130820|FG001|NOT COMPLETED|Overall Study||2
10008475|NCT01757561|11130830|FG000|STARTED|Overall Study||38
10008476|NCT01757561|11130831|FG001|STARTED|Overall Study||34
10008477|NCT01757561|11130832|FG002|STARTED|Overall Study||38
10008478|NCT01757561|11130833|FG003|STARTED|Overall Study||34
10008479|NCT01757561|11130830|FG000|COMPLETED|Overall Study||32
10008480|NCT01757561|11130831|FG001|COMPLETED|Overall Study||28
10008481|NCT01757561|11130832|FG002|COMPLETED|Overall Study||31
9888491|NCT01072149|11003438|FG008|COMPLETED|Treatment Period 1 (28 Days)||3
9888492|NCT01072149|11003439|FG009|COMPLETED|Treatment Period 1 (28 Days)||3
9888493|NCT01072149|11003440|FG010|COMPLETED|Treatment Period 1 (28 Days)||2
9888494|NCT01072149|11003441|FG011|COMPLETED|Treatment Period 1 (28 Days)||3
9888495|NCT01072149|11003442|FG012|COMPLETED|Treatment Period 1 (28 Days)||3
9888496|NCT01072149|11003443|FG013|COMPLETED|Treatment Period 1 (28 Days)||3
9888497|NCT01072149|11003444|FG014|COMPLETED|Treatment Period 1 (28 Days)||3
9888498|NCT01072149|11003445|FG015|COMPLETED|Treatment Period 1 (28 Days)||3
9888499|NCT01072149|11003446|FG016|COMPLETED|Treatment Period 1 (28 Days)||3
9888500|NCT01072149|11003447|FG017|COMPLETED|Treatment Period 1 (28 Days)||2
9888501|NCT01072149|11003430|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888502|NCT01072149|11003431|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888503|NCT01072149|11003432|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
9888504|NCT01072149|11003433|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888505|NCT01072149|11003434|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888506|NCT01072149|11003435|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888507|NCT01072149|11003436|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888508|NCT01072149|11003437|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888509|NCT01072149|11003438|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888510|NCT01072149|11003439|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888511|NCT01072149|11003440|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1
9888512|NCT01072149|11003441|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888513|NCT01072149|11003442|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888514|NCT01072149|11003443|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888515|NCT01072149|11003444|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888516|NCT01072149|11003445|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888517|NCT01072149|11003446|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9888518|NCT01072149|11003447|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1
9888519|NCT01072149|11003430|FG000|STARTED|Washout Period 1 (14 Days)||3
9888520|NCT01072149|11003431|FG001|STARTED|Washout Period 1 (14 Days)||3
9888521|NCT01072149|11003432|FG002|STARTED|Washout Period 1 (14 Days)||2
9888522|NCT01072149|11003433|FG003|STARTED|Washout Period 1 (14 Days)||3
9888523|NCT01072149|11003434|FG004|STARTED|Washout Period 1 (14 Days)||3
9888524|NCT01072149|11003435|FG005|STARTED|Washout Period 1 (14 Days)||3
9888525|NCT01072149|11003436|FG006|STARTED|Washout Period 1 (14 Days)||3
10008482|NCT01757561|11130833|FG003|COMPLETED|Overall Study||25
9888526|NCT01072149|11003437|FG007|STARTED|Washout Period 1 (14 Days)||3
10008483|NCT01757561|11130830|FG000|NOT COMPLETED|Overall Study||6
10008484|NCT01757561|11130831|FG001|NOT COMPLETED|Overall Study||6
10008485|NCT01757561|11130832|FG002|NOT COMPLETED|Overall Study||7
9888527|NCT01072149|11003438|FG008|STARTED|Washout Period 1 (14 Days)||3
9888528|NCT01072149|11003439|FG009|STARTED|Washout Period 1 (14 Days)||3
9888529|NCT01072149|11003440|FG010|STARTED|Washout Period 1 (14 Days)||2
10008486|NCT01757561|11130833|FG003|NOT COMPLETED|Overall Study||9
10008487|NCT01757678|11130843|FG000|STARTED|Overall Study||276
10008488|NCT01757678|11130843|FG000|COMPLETED|Overall Study||276
10008489|NCT01757678|11130843|FG000|NOT COMPLETED|Overall Study||0
9888530|NCT01072149|11003441|FG011|STARTED|Washout Period 1 (14 Days)||3
9888531|NCT01072149|11003442|FG012|STARTED|Washout Period 1 (14 Days)||3
9888532|NCT01072149|11003443|FG013|STARTED|Washout Period 1 (14 Days)||3
9888533|NCT01072149|11003444|FG014|STARTED|Washout Period 1 (14 Days)||3
9888534|NCT01072149|11003445|FG015|STARTED|Washout Period 1 (14 Days)||3
9888535|NCT01072149|11003446|FG016|STARTED|Washout Period 1 (14 Days)||3
9888536|NCT01072149|11003447|FG017|STARTED|Washout Period 1 (14 Days)||2
9888537|NCT01072149|11003430|FG000|COMPLETED|Washout Period 1 (14 Days)||3
9888538|NCT01072149|11003431|FG001|COMPLETED|Washout Period 1 (14 Days)||3
9888539|NCT01072149|11003432|FG002|COMPLETED|Washout Period 1 (14 Days)||2
9888540|NCT01072149|11003433|FG003|COMPLETED|Washout Period 1 (14 Days)||3
9888541|NCT01072149|11003434|FG004|COMPLETED|Washout Period 1 (14 Days)||3
9888542|NCT01072149|11003435|FG005|COMPLETED|Washout Period 1 (14 Days)||3
9888543|NCT01072149|11003436|FG006|COMPLETED|Washout Period 1 (14 Days)||3
9888544|NCT01072149|11003437|FG007|COMPLETED|Washout Period 1 (14 Days)||3
9888545|NCT01072149|11003438|FG008|COMPLETED|Washout Period 1 (14 Days)||3
9888546|NCT01072149|11003439|FG009|COMPLETED|Washout Period 1 (14 Days)||3
9888547|NCT01072149|11003440|FG010|COMPLETED|Washout Period 1 (14 Days)||2
9888548|NCT01072149|11003441|FG011|COMPLETED|Washout Period 1 (14 Days)||3
9888549|NCT01072149|11003442|FG012|COMPLETED|Washout Period 1 (14 Days)||3
9888550|NCT01072149|11003443|FG013|COMPLETED|Washout Period 1 (14 Days)||3
9888551|NCT01072149|11003444|FG014|COMPLETED|Washout Period 1 (14 Days)||3
9888552|NCT01072149|11003445|FG015|COMPLETED|Washout Period 1 (14 Days)||3
9888553|NCT01072149|11003446|FG016|COMPLETED|Washout Period 1 (14 Days)||3
9888554|NCT01072149|11003447|FG017|COMPLETED|Washout Period 1 (14 Days)||2
9888555|NCT01072149|11003430|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888556|NCT01072149|11003431|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888557|NCT01072149|11003432|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888558|NCT01072149|11003433|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888559|NCT01072149|11003434|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888560|NCT01072149|11003435|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888561|NCT01072149|11003436|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888562|NCT01072149|11003437|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888563|NCT01072149|11003438|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888564|NCT01072149|11003439|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888565|NCT01072149|11003440|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888566|NCT01072149|11003441|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888567|NCT01072149|11003442|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888568|NCT01072149|11003443|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888569|NCT01072149|11003444|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888570|NCT01072149|11003445|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888571|NCT01072149|11003446|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888572|NCT01072149|11003447|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0
9888573|NCT01072149|11003430|FG000|STARTED|Treatment Period 2 (28 Days)||3
9888574|NCT01072149|11003431|FG001|STARTED|Treatment Period 2 (28 Days)||3
9888575|NCT01072149|11003432|FG002|STARTED|Treatment Period 2 (28 Days)||2
9888576|NCT01072149|11003433|FG003|STARTED|Treatment Period 2 (28 Days)||3
9888577|NCT01072149|11003434|FG004|STARTED|Treatment Period 2 (28 Days)||3
9888578|NCT01072149|11003435|FG005|STARTED|Treatment Period 2 (28 Days)||3
9888579|NCT01072149|11003436|FG006|STARTED|Treatment Period 2 (28 Days)||3
9888580|NCT01072149|11003437|FG007|STARTED|Treatment Period 2 (28 Days)||3
9888581|NCT01072149|11003438|FG008|STARTED|Treatment Period 2 (28 Days)||3
9888582|NCT01072149|11003439|FG009|STARTED|Treatment Period 2 (28 Days)||3
9888583|NCT01072149|11003440|FG010|STARTED|Treatment Period 2 (28 Days)||2
9888584|NCT01072149|11003441|FG011|STARTED|Treatment Period 2 (28 Days)||3
9888585|NCT01072149|11003442|FG012|STARTED|Treatment Period 2 (28 Days)||3
9888586|NCT01072149|11003443|FG013|STARTED|Treatment Period 2 (28 Days)||3
9888587|NCT01072149|11003444|FG014|STARTED|Treatment Period 2 (28 Days)||3
9888588|NCT01072149|11003445|FG015|STARTED|Treatment Period 2 (28 Days)||3
9888589|NCT01072149|11003446|FG016|STARTED|Treatment Period 2 (28 Days)||3
9888590|NCT01072149|11003447|FG017|STARTED|Treatment Period 2 (28 Days)||2
9888591|NCT01072149|11003430|FG000|COMPLETED|Treatment Period 2 (28 Days)||3
9888592|NCT01072149|11003431|FG001|COMPLETED|Treatment Period 2 (28 Days)||2
9888593|NCT01072149|11003432|FG002|COMPLETED|Treatment Period 2 (28 Days)||1
9888594|NCT01072149|11003433|FG003|COMPLETED|Treatment Period 2 (28 Days)||3
9888595|NCT01072149|11003434|FG004|COMPLETED|Treatment Period 2 (28 Days)||3
9888596|NCT01072149|11003435|FG005|COMPLETED|Treatment Period 2 (28 Days)||3
9888597|NCT01072149|11003436|FG006|COMPLETED|Treatment Period 2 (28 Days)||3
9888598|NCT01072149|11003437|FG007|COMPLETED|Treatment Period 2 (28 Days)||2
9888599|NCT01072149|11003438|FG008|COMPLETED|Treatment Period 2 (28 Days)||3
9888600|NCT01072149|11003439|FG009|COMPLETED|Treatment Period 2 (28 Days)||3
9888601|NCT01072149|11003440|FG010|COMPLETED|Treatment Period 2 (28 Days)||2
9888602|NCT01072149|11003441|FG011|COMPLETED|Treatment Period 2 (28 Days)||3
9888603|NCT01072149|11003442|FG012|COMPLETED|Treatment Period 2 (28 Days)||3
9888604|NCT01072149|11003443|FG013|COMPLETED|Treatment Period 2 (28 Days)||3
9888605|NCT01072149|11003444|FG014|COMPLETED|Treatment Period 2 (28 Days)||3
9888606|NCT01072149|11003445|FG015|COMPLETED|Treatment Period 2 (28 Days)||3
9888607|NCT01072149|11003446|FG016|COMPLETED|Treatment Period 2 (28 Days)||3
9888608|NCT01072149|11003447|FG017|COMPLETED|Treatment Period 2 (28 Days)||2
9888609|NCT01072149|11003430|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888610|NCT01072149|11003431|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
9888611|NCT01072149|11003432|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
9888612|NCT01072149|11003433|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888613|NCT01072149|11003434|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888614|NCT01072149|11003435|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888615|NCT01072149|11003436|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888616|NCT01072149|11003437|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1
9888617|NCT01072149|11003438|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888618|NCT01072149|11003439|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888619|NCT01072149|11003440|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888620|NCT01072149|11003441|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888621|NCT01072149|11003442|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888622|NCT01072149|11003443|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888623|NCT01072149|11003444|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888624|NCT01072149|11003445|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888625|NCT01072149|11003446|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888626|NCT01072149|11003447|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9888627|NCT01072149|11003430|FG000|STARTED|Washout Period 2 (14 Days)||3
9888628|NCT01072149|11003431|FG001|STARTED|Washout Period 2 (14 Days)||2
9888629|NCT01072149|11003432|FG002|STARTED|Washout Period 2 (14 Days)||1
9888630|NCT01072149|11003433|FG003|STARTED|Washout Period 2 (14 Days)||3
9888631|NCT01072149|11003434|FG004|STARTED|Washout Period 2 (14 Days)||3
9888632|NCT01072149|11003435|FG005|STARTED|Washout Period 2 (14 Days)||3
9888633|NCT01072149|11003436|FG006|STARTED|Washout Period 2 (14 Days)||3
9888634|NCT01072149|11003437|FG007|STARTED|Washout Period 2 (14 Days)||2
9888635|NCT01072149|11003438|FG008|STARTED|Washout Period 2 (14 Days)||3
9888636|NCT01072149|11003439|FG009|STARTED|Washout Period 2 (14 Days)||3
9888637|NCT01072149|11003440|FG010|STARTED|Washout Period 2 (14 Days)||2
9888638|NCT01072149|11003441|FG011|STARTED|Washout Period 2 (14 Days)||3
10109223|NCT02473640|11239814|FG000|COMPLETED|Treatment Period 2||14
10109224|NCT02473640|11239814|FG000|NOT COMPLETED|Treatment Period 2||0
10109225|NCT02473718|11239823|FG000|STARTED|Overall Study||41
10109226|NCT02473718|11239824|FG001|STARTED|Overall Study||41
10109227|NCT02473718|11239823|FG000|COMPLETED|Overall Study||41
9888639|NCT01072149|11003442|FG012|STARTED|Washout Period 2 (14 Days)||3
9888640|NCT01072149|11003443|FG013|STARTED|Washout Period 2 (14 Days)||3
9888641|NCT01072149|11003444|FG014|STARTED|Washout Period 2 (14 Days)||3
9888642|NCT01072149|11003445|FG015|STARTED|Washout Period 2 (14 Days)||3
9888643|NCT01072149|11003446|FG016|STARTED|Washout Period 2 (14 Days)||3
9888644|NCT01072149|11003447|FG017|STARTED|Washout Period 2 (14 Days)||2
9888645|NCT01072149|11003430|FG000|COMPLETED|Washout Period 2 (14 Days)||2
9888646|NCT01072149|11003431|FG001|COMPLETED|Washout Period 2 (14 Days)||2
9888647|NCT01072149|11003432|FG002|COMPLETED|Washout Period 2 (14 Days)||1
9888648|NCT01072149|11003433|FG003|COMPLETED|Washout Period 2 (14 Days)||3
9888649|NCT01072149|11003434|FG004|COMPLETED|Washout Period 2 (14 Days)||3
9888650|NCT01072149|11003435|FG005|COMPLETED|Washout Period 2 (14 Days)||3
9888651|NCT01072149|11003436|FG006|COMPLETED|Washout Period 2 (14 Days)||3
9888652|NCT01072149|11003437|FG007|COMPLETED|Washout Period 2 (14 Days)||2
9888653|NCT01072149|11003438|FG008|COMPLETED|Washout Period 2 (14 Days)||3
9888654|NCT01072149|11003439|FG009|COMPLETED|Washout Period 2 (14 Days)||3
9888655|NCT01072149|11003440|FG010|COMPLETED|Washout Period 2 (14 Days)||2
9888656|NCT01072149|11003441|FG011|COMPLETED|Washout Period 2 (14 Days)||3
9888657|NCT01072149|11003442|FG012|COMPLETED|Washout Period 2 (14 Days)||2
9888658|NCT01072149|11003443|FG013|COMPLETED|Washout Period 2 (14 Days)||3
9888659|NCT01072149|11003444|FG014|COMPLETED|Washout Period 2 (14 Days)||3
9888660|NCT01072149|11003445|FG015|COMPLETED|Washout Period 2 (14 Days)||1
9888661|NCT01072149|11003446|FG016|COMPLETED|Washout Period 2 (14 Days)||3
9888662|NCT01072149|11003447|FG017|COMPLETED|Washout Period 2 (14 Days)||2
9888663|NCT01072149|11003430|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1
9888664|NCT01072149|11003431|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888665|NCT01072149|11003432|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888666|NCT01072149|11003433|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888667|NCT01072149|11003434|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888668|NCT01072149|11003435|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888669|NCT01072149|11003436|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888670|NCT01072149|11003437|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888671|NCT01072149|11003438|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888672|NCT01072149|11003439|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888673|NCT01072149|11003440|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888674|NCT01072149|11003441|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888675|NCT01072149|11003442|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1
10109228|NCT02473718|11239824|FG001|COMPLETED|Overall Study||41
10109229|NCT02473718|11239823|FG000|NOT COMPLETED|Overall Study||0
9888676|NCT01072149|11003443|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888677|NCT01072149|11003444|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888678|NCT01072149|11003445|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2
9888679|NCT01072149|11003446|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888680|NCT01072149|11003447|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0
9888681|NCT01072149|11003430|FG000|STARTED|Treatment Period 3 (28 Days)||2
9888682|NCT01072149|11003431|FG001|STARTED|Treatment Period 3 (28 Days)||2
9888683|NCT01072149|11003432|FG002|STARTED|Treatment Period 3 (28 Days)||1
9888684|NCT01072149|11003433|FG003|STARTED|Treatment Period 3 (28 Days)||3
9888685|NCT01072149|11003434|FG004|STARTED|Treatment Period 3 (28 Days)||3
9888686|NCT01072149|11003435|FG005|STARTED|Treatment Period 3 (28 Days)||3
9888687|NCT01072149|11003436|FG006|STARTED|Treatment Period 3 (28 Days)||3
9888688|NCT01072149|11003437|FG007|STARTED|Treatment Period 3 (28 Days)||2
9888689|NCT01072149|11003438|FG008|STARTED|Treatment Period 3 (28 Days)||3
9888690|NCT01072149|11003439|FG009|STARTED|Treatment Period 3 (28 Days)||3
9888691|NCT01072149|11003440|FG010|STARTED|Treatment Period 3 (28 Days)||2
9888692|NCT01072149|11003441|FG011|STARTED|Treatment Period 3 (28 Days)||3
9888693|NCT01072149|11003442|FG012|STARTED|Treatment Period 3 (28 Days)||2
9888694|NCT01072149|11003443|FG013|STARTED|Treatment Period 3 (28 Days)||3
9888695|NCT01072149|11003444|FG014|STARTED|Treatment Period 3 (28 Days)||3
9888696|NCT01072149|11003445|FG015|STARTED|Treatment Period 3 (28 Days)||1
9888697|NCT01072149|11003446|FG016|STARTED|Treatment Period 3 (28 Days)||3
9888698|NCT01072149|11003447|FG017|STARTED|Treatment Period 3 (28 Days)||2
9888699|NCT01072149|11003430|FG000|COMPLETED|Treatment Period 3 (28 Days)||2
9888700|NCT01072149|11003431|FG001|COMPLETED|Treatment Period 3 (28 Days)||2
9888701|NCT01072149|11003432|FG002|COMPLETED|Treatment Period 3 (28 Days)||0
9888702|NCT01072149|11003433|FG003|COMPLETED|Treatment Period 3 (28 Days)||3
9888703|NCT01072149|11003434|FG004|COMPLETED|Treatment Period 3 (28 Days)||3
9888704|NCT01072149|11003435|FG005|COMPLETED|Treatment Period 3 (28 Days)||3
9888705|NCT01072149|11003436|FG006|COMPLETED|Treatment Period 3 (28 Days)||3
9888706|NCT01072149|11003437|FG007|COMPLETED|Treatment Period 3 (28 Days)||2
9888707|NCT01072149|11003438|FG008|COMPLETED|Treatment Period 3 (28 Days)||3
9888708|NCT01072149|11003439|FG009|COMPLETED|Treatment Period 3 (28 Days)||3
9888709|NCT01072149|11003440|FG010|COMPLETED|Treatment Period 3 (28 Days)||2
9888710|NCT01072149|11003441|FG011|COMPLETED|Treatment Period 3 (28 Days)||3
9888711|NCT01072149|11003442|FG012|COMPLETED|Treatment Period 3 (28 Days)||2
9888712|NCT01072149|11003443|FG013|COMPLETED|Treatment Period 3 (28 Days)||2
9888713|NCT01072149|11003444|FG014|COMPLETED|Treatment Period 3 (28 Days)||3
9888714|NCT01072149|11003445|FG015|COMPLETED|Treatment Period 3 (28 Days)||1
9888715|NCT01072149|11003446|FG016|COMPLETED|Treatment Period 3 (28 Days)||3
9888716|NCT01072149|11003447|FG017|COMPLETED|Treatment Period 3 (28 Days)||2
9888717|NCT01072149|11003430|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888718|NCT01072149|11003431|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888719|NCT01072149|11003432|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1
9888720|NCT01072149|11003433|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888721|NCT01072149|11003434|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888722|NCT01072149|11003435|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888723|NCT01072149|11003436|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888724|NCT01072149|11003437|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888725|NCT01072149|11003438|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888726|NCT01072149|11003439|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888727|NCT01072149|11003440|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888728|NCT01072149|11003441|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888729|NCT01072149|11003442|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888730|NCT01072149|11003443|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1
9888731|NCT01072149|11003444|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888732|NCT01072149|11003445|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9888733|NCT01072149|11003446|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10109230|NCT02473718|11239824|FG001|NOT COMPLETED|Overall Study||0
10109231|NCT02473783|11239832|FG000|STARTED|Overall Study||20
10109232|NCT02473783|11239833|FG001|STARTED|Overall Study||17
10109233|NCT02473783|11239832|FG000|COMPLETED|Overall Study||20
10109234|NCT02473783|11239833|FG001|COMPLETED|Overall Study||17
10109235|NCT02473783|11239832|FG000|NOT COMPLETED|Overall Study||0
10109236|NCT02473783|11239833|FG001|NOT COMPLETED|Overall Study||0
10109237|NCT02473913|11239842|FG000|STARTED|Overall Study||11
10109238|NCT02473913|11239843|FG001|STARTED|Overall Study||11
10109239|NCT02473913|11239842|FG000|COMPLETED|Overall Study||8
10109240|NCT02473913|11239843|FG001|COMPLETED|Overall Study||8
10109241|NCT02473913|11239842|FG000|NOT COMPLETED|Overall Study||3
10109242|NCT02473913|11239843|FG001|NOT COMPLETED|Overall Study||3
10109243|NCT02473952|11239851|FG000|STARTED|Overall Study||30
10109244|NCT02473952|11239852|FG001|STARTED|Overall Study||32
10109245|NCT02473952|11239851|FG000|COMPLETED|Overall Study||28
10109246|NCT02473952|11239852|FG001|COMPLETED|Overall Study||24
10109247|NCT02473952|11239851|FG000|NOT COMPLETED|Overall Study||2
10109248|NCT02473952|11239852|FG001|NOT COMPLETED|Overall Study||8
10109249|NCT02473965|11239860|FG000|STARTED|Overall Study||30
10109250|NCT02473965|11239861|FG001|STARTED|Overall Study||30
10109251|NCT02473965|11239860|FG000|COMPLETED|Overall Study||18
10109252|NCT02473965|11239861|FG001|COMPLETED|Overall Study||20
10109253|NCT02473965|11239860|FG000|NOT COMPLETED|Overall Study||12
10109254|NCT02473965|11239861|FG001|NOT COMPLETED|Overall Study||10
9888734|NCT01072149|11003447|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10109255|NCT02473991|11239867|FG000|STARTED|Overall Study||395
10109256|NCT02473991|11239867|FG000|COMPLETED|Overall Study||395
10109257|NCT02473991|11239867|FG000|NOT COMPLETED|Overall Study||0
10109258|NCT02474069|11239871|FG000|STARTED|Selection Phase (SP)||772
10109259|NCT02474069|11239872|FG001|STARTED|Selection Phase (SP)||0
10109260|NCT02474069|11239873|FG002|STARTED|Selection Phase (SP)||0
9888735|NCT01072188|11003459|FG000|STARTED|Overall Study||22
9888736|NCT01072188|11003460|FG001|STARTED|Overall Study||23
9888737|NCT01072188|11003459|FG000|COMPLETED|Overall Study||22
9888738|NCT01072188|11003460|FG001|COMPLETED|Overall Study||23
9888739|NCT01072188|11003459|FG000|NOT COMPLETED|Overall Study||0
9888740|NCT01072188|11003460|FG001|NOT COMPLETED|Overall Study||0
9888741|NCT01072201|11003468|FG000|STARTED|Overall Study||30
9888742|NCT01072201|11003469|FG001|STARTED|Overall Study||30
9888743|NCT01072201|11003468|FG000|COMPLETED|Overall Study||30
9888744|NCT01072201|11003469|FG001|COMPLETED|Overall Study||29
9888745|NCT01072201|11003468|FG000|NOT COMPLETED|Overall Study||0
9888746|NCT01072201|11003469|FG001|NOT COMPLETED|Overall Study||1
9888747|NCT01072331|11003478|FG000|STARTED|Overall Study||34
9888748|NCT01072331|11003479|FG001|STARTED|Overall Study||33
9888749|NCT01072331|11003480|FG002|STARTED|Overall Study||32
9888750|NCT01072331|11003478|FG000|COMPLETED|Overall Study||34
9888751|NCT01072331|11003479|FG001|COMPLETED|Overall Study||33
9888752|NCT01072331|11003480|FG002|COMPLETED|Overall Study||32
9888753|NCT01072331|11003478|FG000|NOT COMPLETED|Overall Study||0
9888754|NCT01072331|11003479|FG001|NOT COMPLETED|Overall Study||0
9888755|NCT01072331|11003480|FG002|NOT COMPLETED|Overall Study||0
9888756|NCT01072344|11003490|FG000|STARTED|Overall Study||46
9888757|NCT01072344|11003491|FG001|STARTED|Overall Study||47
9888758|NCT01072344|11003490|FG000|COMPLETED|Overall Study||35
9888759|NCT01072344|11003491|FG001|COMPLETED|Overall Study||29
9888760|NCT01072344|11003490|FG000|NOT COMPLETED|Overall Study||11
9888761|NCT01072344|11003491|FG001|NOT COMPLETED|Overall Study||18
9888762|NCT01072357|11003499|FG000|STARTED|Overall Study||15
9888763|NCT01072357|11003500|FG001|STARTED|Overall Study||15
9888764|NCT01072357|11003499|FG000|COMPLETED|Overall Study||15
9888765|NCT01072357|11003500|FG001|COMPLETED|Overall Study||14
9888766|NCT01072357|11003499|FG000|NOT COMPLETED|Overall Study||0
9888767|NCT01072357|11003500|FG001|NOT COMPLETED|Overall Study||1
9888768|NCT01072396|11003508|FG000|STARTED|Period One||63
9888769|NCT01072396|11003509|FG001|STARTED|Period One||63
9888770|NCT01072396|11003508|FG000|COMPLETED|Period One||58
9888771|NCT01072396|11003509|FG001|COMPLETED|Period One||61
9888772|NCT01072396|11003508|FG000|NOT COMPLETED|Period One||5
9888773|NCT01072396|11003509|FG001|NOT COMPLETED|Period One||2
9888774|NCT01072396|11003508|FG000|STARTED|Washout Period||58
9888775|NCT01072396|11003509|FG001|STARTED|Washout Period||61
9888776|NCT01072396|11003508|FG000|COMPLETED|Washout Period||58
9888777|NCT01072396|11003509|FG001|COMPLETED|Washout Period||60
9888778|NCT01072396|11003508|FG000|NOT COMPLETED|Washout Period||0
9888779|NCT01072396|11003509|FG001|NOT COMPLETED|Washout Period||1
9888780|NCT01072396|11003508|FG000|STARTED|Period Two||58
9888781|NCT01072396|11003509|FG001|STARTED|Period Two||60
9888782|NCT01072396|11003508|FG000|COMPLETED|Period Two||57
9888783|NCT01072396|11003509|FG001|COMPLETED|Period Two||57
9888784|NCT01072396|11003508|FG000|NOT COMPLETED|Period Two||1
9888785|NCT01072396|11003509|FG001|NOT COMPLETED|Period Two||3
9888786|NCT01072409|11003515|FG000|STARTED|Overall Study||45
9888787|NCT01072409|11003515|FG000|COMPLETED|Overall Study||38
9888788|NCT01072409|11003515|FG000|NOT COMPLETED|Overall Study||7
9888789|NCT01072448|11003521|FG000|STARTED|Overall Study||163
9888790|NCT01072448|11003522|FG001|STARTED|Overall Study||160
9888791|NCT01072448|11003521|FG000|COMPLETED|Overall Study||144
9888792|NCT01072448|11003522|FG001|COMPLETED|Overall Study||130
9888793|NCT01072448|11003521|FG000|NOT COMPLETED|Overall Study||19
9888794|NCT01072448|11003522|FG001|NOT COMPLETED|Overall Study||30
9888795|NCT01072500|11003530|FG000|STARTED|Overall Study||818
9888796|NCT01072500|11003531|FG001|STARTED|Overall Study||817
9888797|NCT01072500|11003530|FG000|COMPLETED|Overall Study||794
9888798|NCT01072500|11003531|FG001|COMPLETED|Overall Study||803
9888799|NCT01072500|11003530|FG000|NOT COMPLETED|Overall Study||24
9888800|NCT01072500|11003531|FG001|NOT COMPLETED|Overall Study||14
9888801|NCT01072539|11003539|FG000|STARTED|Overall Study||3172
9888802|NCT01072539|11003539|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
9888803|NCT01072539|11003539|FG000|NOT COMPLETED|Overall Study||3
9888804|NCT01072617|11003543|FG000|STARTED|Overall Study||8
9888805|NCT01072617|11003543|FG000|COMPLETED|Overall Study||8
9888806|NCT01072617|11003543|FG000|NOT COMPLETED|Overall Study||0
9888807|NCT01072630|11003551|FG000|STARTED|Overall Study||230
9888808|NCT01072630|11003552|FG001|STARTED|Overall Study||232
9888809|NCT01072630|11003553|FG002|STARTED|Overall Study||30
9888810|NCT01072630|11003551|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
9888811|NCT01072630|11003552|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
9888812|NCT01072630|11003553|FG002|Safety Population|Overall Study|Treated participants.|30
9888813|NCT01072630|11003551|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
9888814|NCT01072630|11003552|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
9888815|NCT01072630|11003553|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
9888816|NCT01072630|11003551|FG000|COMPLETED|Overall Study||175
9888817|NCT01072630|11003552|FG001|COMPLETED|Overall Study||172
9888818|NCT01072630|11003553|FG002|COMPLETED|Overall Study||17
9888819|NCT01072630|11003551|FG000|NOT COMPLETED|Overall Study||55
9888820|NCT01072630|11003552|FG001|NOT COMPLETED|Overall Study||60
9888821|NCT01072630|11003553|FG002|NOT COMPLETED|Overall Study||13
9888822|NCT01072643|11003562|FG000|STARTED|Overall Study||4
9888823|NCT01072643|11003562|FG000|COMPLETED|Overall Study||4
9888824|NCT01072643|11003562|FG000|NOT COMPLETED|Overall Study||0
9888825|NCT01072656|11003587|FG000|STARTED|First Intervention||5
9888826|NCT01072656|11003588|FG001|STARTED|First Intervention||4
9888827|NCT01072656|11003587|FG000|COMPLETED|First Intervention||5
9888828|NCT01072656|11003588|FG001|COMPLETED|First Intervention||4
9888829|NCT01072656|11003587|FG000|NOT COMPLETED|First Intervention||0
9888830|NCT01072656|11003588|FG001|NOT COMPLETED|First Intervention||0
9888831|NCT01072656|11003587|FG000|STARTED|Second Intervention||5
9888832|NCT01072656|11003588|FG001|STARTED|Second Intervention||4
9888833|NCT01072656|11003587|FG000|COMPLETED|Second Intervention||5
9888834|NCT01072656|11003588|FG001|COMPLETED|Second Intervention||4
9888835|NCT01072656|11003587|FG000|NOT COMPLETED|Second Intervention||0
9888836|NCT01072656|11003588|FG001|NOT COMPLETED|Second Intervention||0
9888837|NCT01072669|11003597|FG000|STARTED|Overall Study||15
9888838|NCT01072669|11003598|FG001|STARTED|Overall Study||5
9888839|NCT01072669|11003597|FG000|COMPLETED|Overall Study||15
9888840|NCT01072669|11003598|FG001|COMPLETED|Overall Study||5
9888841|NCT01072669|11003597|FG000|NOT COMPLETED|Overall Study||0
9888842|NCT01072669|11003598|FG001|NOT COMPLETED|Overall Study||0
9888843|NCT01072773|11003604|FG000|STARTED|Overall Study||2
9888844|NCT01072773|11003604|FG000|COMPLETED|Overall Study||2
9888845|NCT01072773|11003604|FG000|NOT COMPLETED|Overall Study||0
9888846|NCT01072877|11003613|FG000|STARTED|Overall Study||56
9888847|NCT01072877|11003614|FG001|STARTED|Overall Study||57
9888848|NCT01072877|11003615|FG002|STARTED|Overall Study||51
9888849|NCT01072877|11003616|FG003|STARTED|Overall Study||52
9888850|NCT01072877|11003617|FG004|STARTED|Overall Study||63
9888851|NCT01072877|11003613|FG000|COMPLETED|Overall Study||55
9888852|NCT01072877|11003614|FG001|COMPLETED|Overall Study||56
9888853|NCT01072877|11003615|FG002|COMPLETED|Overall Study||51
9888854|NCT01072877|11003616|FG003|COMPLETED|Overall Study||50
10008490|NCT01757691|11130851|FG000|STARTED|Overall Study||2
10008491|NCT01757691|11130852|FG001|STARTED|Overall Study||0
10008492|NCT01757691|11130851|FG000|COMPLETED|Overall Study||0
10008493|NCT01757691|11130852|FG001|COMPLETED|Overall Study||0
10008494|NCT01757691|11130851|FG000|NOT COMPLETED|Overall Study||2
10008495|NCT01757691|11130852|FG001|NOT COMPLETED|Overall Study||0
10018979|NCT01826981|11142051|FG000|STARTED|Overall Study||19
10018980|NCT01826981|11142052|FG001|STARTED|Overall Study||10
10109261|NCT02474069|11239871|FG000|COMPLETED|Selection Phase (SP)||749
10109262|NCT02474069|11239872|FG001|COMPLETED|Selection Phase (SP)||0
10109263|NCT02474069|11239873|FG002|COMPLETED|Selection Phase (SP)||0
10109264|NCT02474069|11239871|FG000|NOT COMPLETED|Selection Phase (SP)||23
10109265|NCT02474069|11239872|FG001|NOT COMPLETED|Selection Phase (SP)||0
10109266|NCT02474069|11239873|FG002|NOT COMPLETED|Selection Phase (SP)||0
10109267|NCT02474069|11239871|FG000|STARTED|Comparative Dosing Phase (CDP)||0
10109268|NCT02474069|11239872|FG001|STARTED|Comparative Dosing Phase (CDP)||162
10109269|NCT02474069|11239873|FG002|STARTED|Comparative Dosing Phase (CDP)||163
9888855|NCT01072877|11003617|FG004|COMPLETED|Overall Study||63
9888856|NCT01072877|11003613|FG000|NOT COMPLETED|Overall Study||1
9888857|NCT01072877|11003614|FG001|NOT COMPLETED|Overall Study||1
9888858|NCT01072877|11003615|FG002|NOT COMPLETED|Overall Study||0
9888859|NCT01072877|11003616|FG003|NOT COMPLETED|Overall Study||2
9888860|NCT01072877|11003617|FG004|NOT COMPLETED|Overall Study||0
9888861|NCT01072929|11003634|FG000|STARTED|Overall Study||199
9888862|NCT01072929|11003635|FG001|STARTED|Overall Study||201
9888863|NCT01072929|11003636|FG002|STARTED|Overall Study||33
9888864|NCT01072929|11003634|FG000|Safety Population|Overall Study|Treated participants|199
9888865|NCT01072929|11003635|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
9888866|NCT01072929|11003636|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
9888867|NCT01072929|11003634|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
10018981|NCT01826981|11142053|FG002|STARTED|Overall Study||25
10018982|NCT01826981|11142054|FG003|STARTED|Overall Study||26
10018983|NCT01826981|11142055|FG004|STARTED|Overall Study||25
10018984|NCT01826981|11142056|FG005|STARTED|Overall Study||26
10018985|NCT01826981|11142057|FG006|STARTED|Overall Study||25
10018986|NCT01826981|11142058|FG007|STARTED|Overall Study||51
10018987|NCT01826981|11142059|FG008|STARTED|Overall Study||20
10018988|NCT01826981|11142060|FG009|STARTED|Overall Study||27
10018989|NCT01826981|11142061|FG010|STARTED|Overall Study||24
9888868|NCT01072929|11003635|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
9888869|NCT01072929|11003636|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
10018990|NCT01826981|11142062|FG011|STARTED|Overall Study||27
10018991|NCT01826981|11142063|FG012|STARTED|Overall Study||26
10018992|NCT01826981|11142064|FG013|STARTED|Overall Study||20
10018993|NCT01826981|11142065|FG014|STARTED|Overall Study||8
10018994|NCT01826981|11142051|FG000|COMPLETED|Overall Study||19
10018995|NCT01826981|11142052|FG001|COMPLETED|Overall Study||9
10018996|NCT01826981|11142053|FG002|COMPLETED|Overall Study||25
10018997|NCT01826981|11142054|FG003|COMPLETED|Overall Study||26
10018998|NCT01826981|11142055|FG004|COMPLETED|Overall Study||18
10018999|NCT01826981|11142056|FG005|COMPLETED|Overall Study||25
10019000|NCT01826981|11142057|FG006|COMPLETED|Overall Study||24
10109270|NCT02474069|11239871|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0
10109271|NCT02474069|11239872|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153
9888870|NCT01072929|11003634|FG000|COMPLETED|Overall Study||155
9888871|NCT01072929|11003635|FG001|COMPLETED|Overall Study||150
9888872|NCT01072929|11003636|FG002|COMPLETED|Overall Study||24
9888873|NCT01072929|11003634|FG000|NOT COMPLETED|Overall Study||44
9888874|NCT01072929|11003635|FG001|NOT COMPLETED|Overall Study||51
9888875|NCT01072929|11003636|FG002|NOT COMPLETED|Overall Study||9
9888876|NCT01073020|11003649|FG000|STARTED|Overall Study||23
9888877|NCT01073020|11003650|FG001|STARTED|Overall Study||22
9888878|NCT01073020|11003651|FG002|STARTED|Overall Study||22
9888879|NCT01073020|11003652|FG003|STARTED|Overall Study||21
9888880|NCT01073020|11003649|FG000|COMPLETED|Overall Study||16
9888881|NCT01073020|11003650|FG001|COMPLETED|Overall Study||17
9888882|NCT01073020|11003651|FG002|COMPLETED|Overall Study||19
9888883|NCT01073020|11003652|FG003|COMPLETED|Overall Study||19
9888884|NCT01073020|11003649|FG000|NOT COMPLETED|Overall Study||7
9888885|NCT01073020|11003650|FG001|NOT COMPLETED|Overall Study||5
9888886|NCT01073020|11003651|FG002|NOT COMPLETED|Overall Study||3
9888887|NCT01073020|11003652|FG003|NOT COMPLETED|Overall Study||2
9888888|NCT01073163|11003662|FG000|STARTED|Overall Study||54
9888889|NCT01073163|11003662|FG000|Enrolled But Not Treated|Overall Study||1
9888890|NCT01073163|11003662|FG000|Treated With <6 Cycles|Overall Study||4
9888891|NCT01073163|11003662|FG000|Treated With >=6 Cycles|Overall Study||49
9888892|NCT01073163|11003662|FG000|COMPLETED|Overall Study|Patients completed study|51
9888893|NCT01073163|11003662|FG000|NOT COMPLETED|Overall Study||3
9888894|NCT01073267|11003670|FG000|STARTED|Overall Study||4
9888895|NCT01073267|11003670|FG000|COMPLETED|Overall Study||1
9888896|NCT01073267|11003670|FG000|NOT COMPLETED|Overall Study||3
9888897|NCT01073293|11003676|FG000|STARTED|Overall Study||526
9888898|NCT01073293|11003677|FG001|STARTED|Overall Study||528
9888899|NCT01073293|11003676|FG000|COMPLETED|Overall Study||521
9888900|NCT01073293|11003677|FG001|COMPLETED|Overall Study||517
9888901|NCT01073293|11003676|FG000|NOT COMPLETED|Overall Study||5
9888902|NCT01073293|11003677|FG001|NOT COMPLETED|Overall Study||11
9888903|NCT01073449|11003683|FG000|STARTED|Overall Study||3362
9888904|NCT01073449|11003683|FG000|COMPLETED|Overall Study||3362
9888905|NCT01073449|11003683|FG000|NOT COMPLETED|Overall Study||0
9888906|NCT01073462|11003687|FG000|STARTED|Overall Study||67
9888907|NCT01073462|11003687|FG000|COMPLETED|Overall Study||26
9888908|NCT01073462|11003687|FG000|NOT COMPLETED|Overall Study||41
9888909|NCT01073566|11003693|FG000|STARTED|Period 1 (6 Weeks)||19
9888910|NCT01073566|11003694|FG001|STARTED|Period 1 (6 Weeks)||19
9888911|NCT01073566|11003693|FG000|COMPLETED|Period 1 (6 Weeks)||19
9888912|NCT01073566|11003694|FG001|COMPLETED|Period 1 (6 Weeks)||19
9888913|NCT01073566|11003693|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
9888914|NCT01073566|11003694|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
9888915|NCT01073566|11003693|FG000|STARTED|Period 2 (6 Weeks)||19
9888916|NCT01073566|11003694|FG001|STARTED|Period 2 (6 Weeks)||19
9888917|NCT01073566|11003693|FG000|COMPLETED|Period 2 (6 Weeks)||18
9888918|NCT01073566|11003694|FG001|COMPLETED|Period 2 (6 Weeks)||19
9888919|NCT01073566|11003693|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1
9888920|NCT01073566|11003694|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
9888921|NCT01073605|11003703|FG000|STARTED|Overall Study||68
9888922|NCT01073605|11003704|FG001|STARTED|Overall Study||71
9888923|NCT01073605|11003705|FG002|STARTED|Overall Study||69
9888924|NCT01073605|11003703|FG000|Received Treatment|Overall Study||68
9888925|NCT01073605|11003704|FG001|Received Treatment|Overall Study||70
9888926|NCT01073605|11003705|FG002|Received Treatment|Overall Study||68
9888927|NCT01073605|11003703|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
9888928|NCT01073605|11003704|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
9888929|NCT01073605|11003705|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
9888930|NCT01073605|11003703|FG000|NOT COMPLETED|Overall Study||62
9888931|NCT01073605|11003704|FG001|NOT COMPLETED|Overall Study||67
9888932|NCT01073605|11003705|FG002|NOT COMPLETED|Overall Study||61
9888933|NCT01073618|11003713|FG000|STARTED|Overall Study||692
9888934|NCT01073618|11003713|FG000|COMPLETED|Overall Study||385
9888935|NCT01073618|11003713|FG000|NOT COMPLETED|Overall Study||307
9888936|NCT01073631|11003717|FG000|STARTED|Overall Study||543
9888937|NCT01073631|11003717|FG000|COMPLETED|Overall Study||374
9888938|NCT01073631|11003717|FG000|NOT COMPLETED|Overall Study||169
9888939|NCT01073657|11003723|FG000|STARTED|Overall Study||17
9888940|NCT01073657|11003724|FG001|STARTED|Overall Study||16
9888941|NCT01073657|11003723|FG000|COMPLETED|Overall Study||17
9888942|NCT01073657|11003724|FG001|COMPLETED|Overall Study||16
9888943|NCT01073657|11003723|FG000|NOT COMPLETED|Overall Study||0
9888944|NCT01073657|11003724|FG001|NOT COMPLETED|Overall Study||0
9888945|NCT01073865|11003732|FG000|STARTED|Overall Study|Number of patients randomised|109
9888946|NCT01073865|11003733|FG001|STARTED|Overall Study|Number of patients randomised|113
9888947|NCT01073865|11003732|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
9888948|NCT01073865|11003733|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
9888949|NCT01073865|11003732|FG000|COMPLETED|Overall Study|Number of patients completed the study|81
9888950|NCT01073865|11003733|FG001|COMPLETED|Overall Study|Number of patients completed the study|74
9888951|NCT01073865|11003732|FG000|NOT COMPLETED|Overall Study||28
9888952|NCT01073865|11003733|FG001|NOT COMPLETED|Overall Study||39
9888953|NCT01073930|11003741|FG000|STARTED|Overall Study||307
9888954|NCT01073930|11003742|FG001|STARTED|Overall Study||301
9888955|NCT01073930|11003741|FG000|Safety Population (Treated)|Overall Study||305
9888956|NCT01073930|11003742|FG001|Safety Population (Treated)|Overall Study||298
9888957|NCT01073930|11003741|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
9888958|NCT01073930|11003742|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
9888959|NCT01073930|11003741|FG000|COMPLETED|Overall Study||304
9888960|NCT01073930|11003742|FG001|COMPLETED|Overall Study||295
9888961|NCT01073930|11003741|FG000|NOT COMPLETED|Overall Study||3
9888962|NCT01073930|11003742|FG001|NOT COMPLETED|Overall Study||6
9888963|NCT01073943|11003750|FG000|STARTED|Overall Study||300
9888964|NCT01073943|11003751|FG001|STARTED|Overall Study||303
9888965|NCT01073943|11003750|FG000|Safety Population (Treated)|Overall Study||296
9888966|NCT01073943|11003751|FG001|Safety Population (Treated)|Overall Study||302
9888967|NCT01073943|11003750|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
9888968|NCT01073943|11003751|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
9888969|NCT01073943|11003750|FG000|COMPLETED|Overall Study||287
9888970|NCT01073943|11003751|FG001|COMPLETED|Overall Study||295
9888971|NCT01073943|11003750|FG000|NOT COMPLETED|Overall Study||13
9888972|NCT01073943|11003751|FG001|NOT COMPLETED|Overall Study||8
9888973|NCT01074008|11003766|FG000|STARTED|Overall Study||8
9888974|NCT01074008|11003767|FG001|STARTED|Overall Study||8
9888975|NCT01074008|11003768|FG002|STARTED|Overall Study||8
9888976|NCT01074008|11003769|FG003|STARTED|Overall Study||8
9888977|NCT01074008|11003770|FG004|STARTED|Overall Study||8
9888978|NCT01074008|11003771|FG005|STARTED|Overall Study||7
9888979|NCT01074008|11003772|FG006|STARTED|Overall Study||8
9888980|NCT01074008|11003773|FG007|STARTED|Overall Study||8
9888981|NCT01074008|11003774|FG008|STARTED|Overall Study||11
9888982|NCT01074008|11003766|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8
9888983|NCT01074008|11003767|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7
9888984|NCT01074008|11003768|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7
9888985|NCT01074008|11003769|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8
9888986|NCT01074008|11003770|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8
9888987|NCT01074008|11003771|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5
9888988|NCT01074008|11003772|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8
9888989|NCT01074008|11003773|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7
9888990|NCT01074008|11003774|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5
9888991|NCT01074008|11003766|FG000|COMPLETED|Overall Study||7
9888992|NCT01074008|11003767|FG001|COMPLETED|Overall Study||5
9888993|NCT01074008|11003768|FG002|COMPLETED|Overall Study||6
9888994|NCT01074008|11003769|FG003|COMPLETED|Overall Study||7
9888995|NCT01074008|11003770|FG004|COMPLETED|Overall Study||6
9888996|NCT01074008|11003771|FG005|COMPLETED|Overall Study||7
9888997|NCT01074008|11003772|FG006|COMPLETED|Overall Study||7
9888998|NCT01074008|11003773|FG007|COMPLETED|Overall Study||8
9888999|NCT01074008|11003774|FG008|COMPLETED|Overall Study||7
9889000|NCT01074008|11003766|FG000|NOT COMPLETED|Overall Study||1
9889001|NCT01074008|11003767|FG001|NOT COMPLETED|Overall Study||3
9889002|NCT01074008|11003768|FG002|NOT COMPLETED|Overall Study||2
9889003|NCT01074008|11003769|FG003|NOT COMPLETED|Overall Study||1
9889004|NCT01074008|11003770|FG004|NOT COMPLETED|Overall Study||2
9889005|NCT01074008|11003771|FG005|NOT COMPLETED|Overall Study||0
9889006|NCT01074008|11003772|FG006|NOT COMPLETED|Overall Study||1
9889007|NCT01074008|11003773|FG007|NOT COMPLETED|Overall Study||0
9889008|NCT01074008|11003774|FG008|NOT COMPLETED|Overall Study||4
9889009|NCT01074034|11003803|FG000|STARTED|Overall Study||211
9889010|NCT01074034|11003803|FG000|COMPLETED|Overall Study||205
9889011|NCT01074034|11003803|FG000|NOT COMPLETED|Overall Study||6
9889012|NCT01074047|11003810|FG000|STARTED|Treatment Phase||241
9889013|NCT01074047|11003811|FG001|STARTED|Treatment Phase||247
9889014|NCT01074047|11003810|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
9889015|NCT01074047|11003811|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
9889016|NCT01074047|11003810|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
9889017|NCT01074047|11003811|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
9889018|NCT01074047|11003810|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
9889019|NCT01074047|11003811|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
9889020|NCT01074047|11003810|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
9889021|NCT01074047|11003811|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
9889022|NCT01074047|11003810|FG000|NOT COMPLETED|Treatment Phase||217
9889023|NCT01074047|11003811|FG001|NOT COMPLETED|Treatment Phase||234
9889024|NCT01074047|11003810|FG000|STARTED|Survival Follow-Up Phase||140
9889025|NCT01074047|11003811|FG001|STARTED|Survival Follow-Up Phase||163
9889026|NCT01074047|11003810|FG000|COMPLETED|Survival Follow-Up Phase||16
9889027|NCT01074047|11003811|FG001|COMPLETED|Survival Follow-Up Phase||27
9889028|NCT01074047|11003810|FG000|NOT COMPLETED|Survival Follow-Up Phase||124
9889029|NCT01074047|11003811|FG001|NOT COMPLETED|Survival Follow-Up Phase||136
9889030|NCT01074047|11003810|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
9889031|NCT01074047|11003811|FG001|STARTED|Extension Phase||0
9954488|NCT01432275|11073339|FG000|STARTED|First BG Meter System (7 Days)||90
10109272|NCT02474069|11239873|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157
10109273|NCT02474069|11239871|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
10109274|NCT02474069|11239872|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
10109275|NCT02474069|11239873|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
10109276|NCT02474082|11239885|FG000|STARTED|Overall Study||105
10109277|NCT02474082|11239886|FG001|STARTED|Overall Study||97
9889032|NCT01074047|11003810|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
9889033|NCT01074047|11003811|FG001|Safety Population|Extension Phase||0
9889034|NCT01074047|11003810|FG000|COMPLETED|Extension Phase||0
9889035|NCT01074047|11003811|FG001|COMPLETED|Extension Phase||0
9889036|NCT01074047|11003810|FG000|NOT COMPLETED|Extension Phase||22
9889037|NCT01074047|11003811|FG001|NOT COMPLETED|Extension Phase||0
9889038|NCT01074099|11003826|FG000|STARTED|Overall Study||2
9889039|NCT01074099|11003827|FG001|STARTED|Overall Study||3
9889040|NCT01074099|11003826|FG000|COMPLETED|Overall Study||2
9889041|NCT01074099|11003827|FG001|COMPLETED|Overall Study||3
9889042|NCT01074099|11003826|FG000|NOT COMPLETED|Overall Study||0
9889043|NCT01074099|11003827|FG001|NOT COMPLETED|Overall Study||0
9889044|NCT01074125|11003836|FG000|STARTED|Overall Study||51
9889045|NCT01074125|11003837|FG001|STARTED|Overall Study||52
9889046|NCT01074125|11003838|FG002|STARTED|Overall Study||48
9889047|NCT01074125|11003836|FG000|COMPLETED|Overall Study||39
9889048|NCT01074125|11003837|FG001|COMPLETED|Overall Study||47
9889049|NCT01074125|11003838|FG002|COMPLETED|Overall Study||36
9889050|NCT01074125|11003836|FG000|NOT COMPLETED|Overall Study||12
9889051|NCT01074125|11003837|FG001|NOT COMPLETED|Overall Study||5
9889052|NCT01074125|11003838|FG002|NOT COMPLETED|Overall Study||12
9889053|NCT01074164|11003851|FG000|STARTED|Overall Study||7
9889054|NCT01074164|11003852|FG001|STARTED|Overall Study||8
9889055|NCT01074164|11003851|FG000|COMPLETED|Overall Study||4
9889056|NCT01074164|11003852|FG001|COMPLETED|Overall Study||7
9889057|NCT01074164|11003851|FG000|NOT COMPLETED|Overall Study||3
9889058|NCT01074164|11003852|FG001|NOT COMPLETED|Overall Study||1
9954489|NCT01432275|11073340|FG001|STARTED|First BG Meter System (7 Days)||87
9954490|NCT01432275|11073339|FG000|COMPLETED|First BG Meter System (7 Days)||90
9954491|NCT01432275|11073340|FG001|COMPLETED|First BG Meter System (7 Days)||84
9954492|NCT01432275|11073339|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0
9954493|NCT01432275|11073340|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3
9954494|NCT01432275|11073339|FG000|STARTED|Second BG Meter System (7 Days)||90
9954495|NCT01432275|11073340|FG001|STARTED|Second BG Meter System (7 Days)||84
9954496|NCT01432275|11073339|FG000|COMPLETED|Second BG Meter System (7 Days)||88
9954497|NCT01432275|11073340|FG001|COMPLETED|Second BG Meter System (7 Days)||81
9954498|NCT01432275|11073339|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2
9954499|NCT01432275|11073340|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3
9954500|NCT01432275|11073339|FG000|STARTED|ADC With Calculator (10 Days)||88
9954501|NCT01432275|11073340|FG001|STARTED|ADC With Calculator (10 Days)||81
9954502|NCT01432275|11073339|FG000|COMPLETED|ADC With Calculator (10 Days)||85
9954503|NCT01432275|11073340|FG001|COMPLETED|ADC With Calculator (10 Days)||79
9954504|NCT01432275|11073339|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3
9954505|NCT01432275|11073340|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2
9954506|NCT01432327|11073350|FG000|STARTED|Baseline||56
9954507|NCT01432327|11073351|FG001|STARTED|Baseline||57
9954508|NCT01432327|11073352|FG002|STARTED|Baseline||57
9954509|NCT01432327|11073353|FG003|STARTED|Baseline||57
9954510|NCT01432327|11073350|FG000|COMPLETED|Baseline||56
9954511|NCT01432327|11073351|FG001|COMPLETED|Baseline||57
9954512|NCT01432327|11073352|FG002|COMPLETED|Baseline||57
9954513|NCT01432327|11073353|FG003|COMPLETED|Baseline||57
9954514|NCT01432327|11073350|FG000|NOT COMPLETED|Baseline||0
9954515|NCT01432327|11073351|FG001|NOT COMPLETED|Baseline||0
9954516|NCT01432327|11073352|FG002|NOT COMPLETED|Baseline||0
9954517|NCT01432327|11073353|FG003|NOT COMPLETED|Baseline||0
9954518|NCT01432327|11073350|FG000|STARTED|Posttest 3 Months||56
9954519|NCT01432327|11073351|FG001|STARTED|Posttest 3 Months||57
9954520|NCT01432327|11073352|FG002|STARTED|Posttest 3 Months||57
9954521|NCT01432327|11073353|FG003|STARTED|Posttest 3 Months||57
9954522|NCT01432327|11073350|FG000|COMPLETED|Posttest 3 Months||52
9954523|NCT01432327|11073351|FG001|COMPLETED|Posttest 3 Months||55
9954524|NCT01432327|11073352|FG002|COMPLETED|Posttest 3 Months||55
9954525|NCT01432327|11073353|FG003|COMPLETED|Posttest 3 Months||56
9954526|NCT01432327|11073350|FG000|NOT COMPLETED|Posttest 3 Months||4
9954527|NCT01432327|11073351|FG001|NOT COMPLETED|Posttest 3 Months||2
9954528|NCT01432327|11073352|FG002|NOT COMPLETED|Posttest 3 Months||2
9954529|NCT01432327|11073353|FG003|NOT COMPLETED|Posttest 3 Months||1
9954530|NCT01432327|11073350|FG000|STARTED|Posttest 6 Months||52
9954531|NCT01432327|11073351|FG001|STARTED|Posttest 6 Months||55
9954532|NCT01432327|11073352|FG002|STARTED|Posttest 6 Months||55
10109278|NCT02474082|11239885|FG000|Full Analysis Set (FAS)|Overall Study||105
10109279|NCT02474082|11239886|FG001|Full Analysis Set (FAS)|Overall Study||95
10109280|NCT02474082|11239885|FG000|COMPLETED|Overall Study||99
10109281|NCT02474082|11239886|FG001|COMPLETED|Overall Study||43
10109282|NCT02474082|11239885|FG000|NOT COMPLETED|Overall Study||6
9954533|NCT01432327|11073353|FG003|STARTED|Posttest 6 Months||56
9954534|NCT01432327|11073350|FG000|COMPLETED|Posttest 6 Months||52
9954535|NCT01432327|11073351|FG001|COMPLETED|Posttest 6 Months||55
9954536|NCT01432327|11073352|FG002|COMPLETED|Posttest 6 Months||50
9954537|NCT01432327|11073353|FG003|COMPLETED|Posttest 6 Months||54
9954538|NCT01432327|11073350|FG000|NOT COMPLETED|Posttest 6 Months||0
9889059|NCT01074177|11003858|FG000|STARTED|Overall Study||24
9889060|NCT01074177|11003858|FG000|COMPLETED|Overall Study||24
9889061|NCT01074177|11003858|FG000|NOT COMPLETED|Overall Study||0
9889062|NCT01074216|11003862|FG000|STARTED|Overall Study||54
9889063|NCT01074216|11003862|FG000|COMPLETED|Overall Study||41
9889064|NCT01074216|11003862|FG000|NOT COMPLETED|Overall Study||13
9889065|NCT01074229|11003869|FG000|STARTED|Overall Study||25
9889066|NCT01074229|11003870|FG001|STARTED|Overall Study||25
9889067|NCT01074229|11003871|FG002|STARTED|Overall Study||25
9889068|NCT01074229|11003869|FG000|COMPLETED|Overall Study||23
9889069|NCT01074229|11003870|FG001|COMPLETED|Overall Study||22
9889070|NCT01074229|11003871|FG002|COMPLETED|Overall Study||21
9889071|NCT01074229|11003869|FG000|NOT COMPLETED|Overall Study||2
9889072|NCT01074229|11003870|FG001|NOT COMPLETED|Overall Study||3
9889073|NCT01074229|11003871|FG002|NOT COMPLETED|Overall Study||4
9889074|NCT01074242|11003881|FG000|STARTED|Overall Study||3798
9889075|NCT01074242|11003881|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395
9889076|NCT01074242|11003881|FG000|COMPLETED|Overall Study||3395
9889077|NCT01074242|11003881|FG000|NOT COMPLETED|Overall Study||403
9889078|NCT01074255|11003885|FG000|STARTED|Overall Study||3141
9889079|NCT01074255|11003885|FG000|Treated|Overall Study||3139
9889080|NCT01074255|11003885|FG000|COMPLETED|Overall Study||3139
9889081|NCT01074255|11003885|FG000|NOT COMPLETED|Overall Study||2
9889082|NCT01074268|11003891|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
9889083|NCT01074268|11003892|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
9889084|NCT01074268|11003891|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
9889085|NCT01074268|11003892|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
9889086|NCT01074268|11003891|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
9889087|NCT01074268|11003892|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
9889088|NCT01074268|11003891|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
9889089|NCT01074268|11003892|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
9889090|NCT01074268|11003891|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
9889091|NCT01074268|11003892|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
9889092|NCT01074268|11003891|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
9889093|NCT01074268|11003892|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
9889094|NCT01074268|11003891|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
9889095|NCT01074268|11003892|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
9889096|NCT01074268|11003891|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
9889097|NCT01074268|11003892|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
9889098|NCT01074307|11003900|FG000|STARTED|Overall Study||66
9889099|NCT01074307|11003901|FG001|STARTED|Overall Study||114
9889100|NCT01074307|11003900|FG000|COMPLETED|Overall Study||44
9889101|NCT01074307|11003901|FG001|COMPLETED|Overall Study||102
9889102|NCT01074307|11003900|FG000|NOT COMPLETED|Overall Study||22
9889103|NCT01074307|11003901|FG001|NOT COMPLETED|Overall Study||12
9889104|NCT01074450|11003909|FG000|STARTED|First Intervention||12
9889105|NCT01074450|11003910|FG001|STARTED|First Intervention||12
9889106|NCT01074450|11003909|FG000|COMPLETED|First Intervention||12
9889107|NCT01074450|11003910|FG001|COMPLETED|First Intervention||10
9889108|NCT01074450|11003909|FG000|NOT COMPLETED|First Intervention||0
9889109|NCT01074450|11003910|FG001|NOT COMPLETED|First Intervention||2
9889110|NCT01074450|11003909|FG000|STARTED|Washout of 7 Days||12
9889111|NCT01074450|11003910|FG001|STARTED|Washout of 7 Days||10
9889112|NCT01074450|11003909|FG000|COMPLETED|Washout of 7 Days||12
9889113|NCT01074450|11003910|FG001|COMPLETED|Washout of 7 Days||10
9889114|NCT01074450|11003909|FG000|NOT COMPLETED|Washout of 7 Days||0
9889115|NCT01074450|11003910|FG001|NOT COMPLETED|Washout of 7 Days||0
9889116|NCT01074450|11003909|FG000|STARTED|Second Intervention||12
9889117|NCT01074450|11003910|FG001|STARTED|Second Intervention||10
9889118|NCT01074450|11003909|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
9889119|NCT01074450|11003910|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
9889120|NCT01074450|11003909|FG000|NOT COMPLETED|Second Intervention||1
9889121|NCT01074450|11003910|FG001|NOT COMPLETED|Second Intervention||1
9889122|NCT01074463|11003918|FG000|STARTED|First Intervention||12
9889123|NCT01074463|11003919|FG001|STARTED|First Intervention||12
9889124|NCT01074463|11003918|FG000|COMPLETED|First Intervention||12
9889125|NCT01074463|11003919|FG001|COMPLETED|First Intervention||12
9889126|NCT01074463|11003918|FG000|NOT COMPLETED|First Intervention||0
9889127|NCT01074463|11003919|FG001|NOT COMPLETED|First Intervention||0
9889128|NCT01074463|11003918|FG000|STARTED|Washout of 7 Days||12
9889129|NCT01074463|11003919|FG001|STARTED|Washout of 7 Days||12
9889130|NCT01074463|11003918|FG000|COMPLETED|Washout of 7 Days||12
9889131|NCT01074463|11003919|FG001|COMPLETED|Washout of 7 Days||12
9889132|NCT01074463|11003918|FG000|NOT COMPLETED|Washout of 7 Days||0
9889133|NCT01074463|11003919|FG001|NOT COMPLETED|Washout of 7 Days||0
9889134|NCT01074463|11003918|FG000|STARTED|Second Intervention||12
9889135|NCT01074463|11003919|FG001|STARTED|Second Intervention||12
9889136|NCT01074463|11003918|FG000|COMPLETED|Second Intervention||12
9889137|NCT01074463|11003919|FG001|COMPLETED|Second Intervention||12
9889138|NCT01074463|11003918|FG000|NOT COMPLETED|Second Intervention||0
9889139|NCT01074463|11003919|FG001|NOT COMPLETED|Second Intervention||0
9889140|NCT01074554|11003927|FG000|STARTED|Overall Study||14
9889141|NCT01074554|11003928|FG001|STARTED|Overall Study||15
9889142|NCT01074554|11003927|FG000|COMPLETED|Overall Study||11
9889143|NCT01074554|11003928|FG001|COMPLETED|Overall Study||11
9889144|NCT01074554|11003927|FG000|NOT COMPLETED|Overall Study||3
9889145|NCT01074554|11003928|FG001|NOT COMPLETED|Overall Study||4
9889146|NCT01074658|11003934|FG000|STARTED|Overall Study||1015
9889147|NCT01074658|11003934|FG000|Attempted Implant|Overall Study||996
9889148|NCT01074658|11003934|FG000|COMPLETED|Overall Study||996
9889149|NCT01074658|11003934|FG000|NOT COMPLETED|Overall Study||19
9889150|NCT01074931|11003938|FG000|STARTED|Overall Study||98
9889151|NCT01074931|11003938|FG000|COMPLETED|Overall Study||92
9889152|NCT01074931|11003938|FG000|NOT COMPLETED|Overall Study||6
9889153|NCT01074944|11003946|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
9889154|NCT01074944|11003947|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0
9889155|NCT01074944|11003948|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0
9889156|NCT01074944|11003949|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0
9889157|NCT01074944|11003950|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0
9889158|NCT01074944|11003946|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157
9889159|NCT01074944|11003947|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889160|NCT01074944|11003948|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889161|NCT01074944|11003949|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889162|NCT01074944|11003950|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889163|NCT01074944|11003946|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
9889164|NCT01074944|11003947|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889165|NCT01074944|11003948|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889166|NCT01074944|11003949|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889167|NCT01074944|11003950|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
9889168|NCT01074944|11003946|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0
9889169|NCT01074944|11003947|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
9889170|NCT01074944|11003948|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
9889171|NCT01074944|11003949|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0
9889172|NCT01074944|11003950|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0
9889173|NCT01074944|11003946|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
9889174|NCT01074944|11003947|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
9889175|NCT01074944|11003948|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
9889176|NCT01074944|11003949|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
9889177|NCT01074944|11003950|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
9889178|NCT01074944|11003946|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
9889179|NCT01074944|11003947|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
9889180|NCT01074944|11003948|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
9889181|NCT01074944|11003949|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
9889182|NCT01074944|11003950|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
9889183|NCT01074944|11003946|FG000|STARTED|Long Term Treatment||0
9889184|NCT01074944|11003947|FG001|STARTED|Long Term Treatment||0
9889185|NCT01074944|11003948|FG002|STARTED|Long Term Treatment||0
9889186|NCT01074944|11003949|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
9889187|NCT01074944|11003950|FG004|STARTED|Long Term Treatment||0
9889188|NCT01074944|11003946|FG000|COMPLETED|Long Term Treatment||0
9889189|NCT01074944|11003947|FG001|COMPLETED|Long Term Treatment||0
9889190|NCT01074944|11003948|FG002|COMPLETED|Long Term Treatment||0
9889191|NCT01074944|11003949|FG003|COMPLETED|Long Term Treatment||95
9889192|NCT01074944|11003950|FG004|COMPLETED|Long Term Treatment||0
9889193|NCT01074944|11003946|FG000|NOT COMPLETED|Long Term Treatment||0
9889194|NCT01074944|11003947|FG001|NOT COMPLETED|Long Term Treatment||0
9889195|NCT01074944|11003948|FG002|NOT COMPLETED|Long Term Treatment||0
9889196|NCT01074944|11003949|FG003|NOT COMPLETED|Long Term Treatment||26
9889197|NCT01074944|11003950|FG004|NOT COMPLETED|Long Term Treatment||0
9889198|NCT01074944|11003946|FG000|STARTED|Extended Treatment (up to 42 Months)||0
9889199|NCT01074944|11003947|FG001|STARTED|Extended Treatment (up to 42 Months)||0
9889200|NCT01074944|11003948|FG002|STARTED|Extended Treatment (up to 42 Months)||0
9889201|NCT01074944|11003949|FG003|STARTED|Extended Treatment (up to 42 Months)||0
9889202|NCT01074944|11003950|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
9889203|NCT01074944|11003946|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0
9889204|NCT01074944|11003947|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0
9889205|NCT01074944|11003948|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0
9889206|NCT01074944|11003949|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0
9889207|NCT01074944|11003950|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20
9889208|NCT01074944|11003946|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
9889209|NCT01074944|11003947|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
10008496|NCT01757704|11130860|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
10008497|NCT01757704|11130861|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
10008498|NCT01757704|11130860|FG000|COMPLETED|Overall Study||10
10008499|NCT01757704|11130861|FG001|COMPLETED|Overall Study||10
10008500|NCT01757704|11130860|FG000|NOT COMPLETED|Overall Study||1
9889210|NCT01074944|11003948|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
9889211|NCT01074944|11003949|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
9889212|NCT01074944|11003950|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
9889213|NCT01075048|11003961|FG000|STARTED|Overall Study||9
9889214|NCT01075048|11003962|FG001|STARTED|Overall Study||60
9889215|NCT01075048|11003963|FG002|STARTED|Overall Study||62
9889216|NCT01075048|11003961|FG000|Did Not Receive Treatment|Overall Study||0
9889217|NCT01075048|11003962|FG001|Did Not Receive Treatment|Overall Study||1
9889218|NCT01075048|11003963|FG002|Did Not Receive Treatment|Overall Study||0
9889219|NCT01075048|11003961|FG000|COMPLETED|Overall Study||0
9889220|NCT01075048|11003962|FG001|COMPLETED|Overall Study||0
9889221|NCT01075048|11003963|FG002|COMPLETED|Overall Study||0
9889222|NCT01075048|11003961|FG000|NOT COMPLETED|Overall Study||9
9889223|NCT01075048|11003962|FG001|NOT COMPLETED|Overall Study||60
9889224|NCT01075048|11003963|FG002|NOT COMPLETED|Overall Study||62
9889225|NCT01075074|11003977|FG000|STARTED|Overall Study||25
9889226|NCT01075074|11003978|FG001|STARTED|Overall Study||25
9889227|NCT01075074|11003979|FG002|STARTED|Overall Study||25
9889228|NCT01075074|11003977|FG000|COMPLETED|Overall Study||24
9889229|NCT01075074|11003978|FG001|COMPLETED|Overall Study||23
9889230|NCT01075074|11003979|FG002|COMPLETED|Overall Study||23
9889231|NCT01075074|11003977|FG000|NOT COMPLETED|Overall Study||1
9889232|NCT01075074|11003978|FG001|NOT COMPLETED|Overall Study||2
9889233|NCT01075074|11003979|FG002|NOT COMPLETED|Overall Study||2
9889234|NCT01075087|11003993|FG000|STARTED|Overall Study||9
9889235|NCT01075087|11003994|FG001|STARTED|Overall Study||10
9889236|NCT01075087|11003993|FG000|COMPLETED|Overall Study||9
9889237|NCT01075087|11003994|FG001|COMPLETED|Overall Study||10
9889238|NCT01075087|11003993|FG000|NOT COMPLETED|Overall Study||0
9889239|NCT01075087|11003994|FG001|NOT COMPLETED|Overall Study||0
9889240|NCT01075100|11004002|FG000|STARTED|Overall Study||49
9889241|NCT01075100|11004003|FG001|STARTED|Overall Study||54
9889242|NCT01075100|11004002|FG000|COMPLETED|Overall Study||0
9889243|NCT01075100|11004003|FG001|COMPLETED|Overall Study||1
9889244|NCT01075100|11004002|FG000|NOT COMPLETED|Overall Study||49
9889245|NCT01075100|11004003|FG001|NOT COMPLETED|Overall Study||53
9889246|NCT01075152|11004013|FG000|STARTED|Overall Study|randomized|88
9889247|NCT01075152|11004014|FG001|STARTED|Overall Study|randomized|89
9889248|NCT01075152|11004013|FG000|COMPLETED|Overall Study||87
9889249|NCT01075152|11004014|FG001|COMPLETED|Overall Study||89
9889250|NCT01075152|11004013|FG000|NOT COMPLETED|Overall Study||1
9889251|NCT01075152|11004014|FG001|NOT COMPLETED|Overall Study||0
9889252|NCT01075178|11004024|FG000|STARTED|Subject Matching|eligible for matching|1148
9889253|NCT01075178|11004025|FG001|STARTED|Subject Matching|eligible for matching|1421
9889254|NCT01075178|11004024|FG000|COMPLETED|Subject Matching|subjects matched|1018
9889255|NCT01075178|11004025|FG001|COMPLETED|Subject Matching|subjects matched|1018
9889256|NCT01075178|11004024|FG000|NOT COMPLETED|Subject Matching||130
9889257|NCT01075178|11004025|FG001|NOT COMPLETED|Subject Matching||403
9889258|NCT01075178|11004024|FG000|STARTED|Subject Chart Review|subjects matched|1018
9889259|NCT01075178|11004025|FG001|STARTED|Subject Chart Review|subjects matched|1018
9889260|NCT01075178|11004024|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
9889261|NCT01075178|11004025|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
9889262|NCT01075178|11004024|FG000|NOT COMPLETED|Subject Chart Review||9
9889263|NCT01075178|11004025|FG001|NOT COMPLETED|Subject Chart Review||9
9889264|NCT01075191|11004031|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
9889265|NCT01075191|11004031|FG000|Discontinued Year 1|Overall Study||7
9889266|NCT01075191|11004031|FG000|Discontinued Year 2|Overall Study||6
9889267|NCT01075191|11004031|FG000|Discontinued Year 3|Overall Study||5
9889268|NCT01075191|11004031|FG000|COMPLETED|Overall Study||42
9889269|NCT01075191|11004031|FG000|NOT COMPLETED|Overall Study||18
9889270|NCT01075204|11004035|FG000|STARTED|Overall Study||335
9889271|NCT01075204|11004035|FG000|COMPLETED|Overall Study||335
9889272|NCT01075204|11004035|FG000|NOT COMPLETED|Overall Study||0
9889273|NCT01075217|11004041|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
9889274|NCT01075217|11004042|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
9889275|NCT01075217|11004041|FG000|COMPLETED|Overall Study||82
9889276|NCT01075217|11004042|FG001|COMPLETED|Overall Study||84
9889277|NCT01075217|11004041|FG000|NOT COMPLETED|Overall Study||2
9889278|NCT01075217|11004042|FG001|NOT COMPLETED|Overall Study||1
9889279|NCT01075243|11004059|FG000|STARTED|Overall Study||163
9889280|NCT01075243|11004060|FG001|STARTED|Overall Study||158
9889281|NCT01075243|11004061|FG002|STARTED|Overall Study||80
9889282|NCT01075243|11004059|FG000|COMPLETED|Overall Study||157
9889283|NCT01075243|11004060|FG001|COMPLETED|Overall Study||155
9889284|NCT01075243|11004061|FG002|COMPLETED|Overall Study||80
9889285|NCT01075243|11004059|FG000|NOT COMPLETED|Overall Study||6
10008501|NCT01757704|11130861|FG001|NOT COMPLETED|Overall Study||3
10008502|NCT01757717|11130867|FG000|STARTED|Overall Study||3
10008503|NCT01757717|11130867|FG000|COMPLETED|Overall Study||3
10008504|NCT01757717|11130867|FG000|NOT COMPLETED|Overall Study||0
10008505|NCT01757821|11130871|FG000|STARTED|Overall Study|11 subjects|11
9889286|NCT01075243|11004060|FG001|NOT COMPLETED|Overall Study||3
10008506|NCT01757821|11130871|FG000|COMPLETED|Overall Study|10 subjects|10
10008507|NCT01757821|11130871|FG000|NOT COMPLETED|Overall Study||1
10008508|NCT01757847|11130881|FG000|STARTED|Overall Study||44
10008509|NCT01757847|11130882|FG001|STARTED|Overall Study||46
10008510|NCT01757847|11130881|FG000|COMPLETED|Overall Study||41
10008511|NCT01757847|11130882|FG001|COMPLETED|Overall Study||42
10008512|NCT01757847|11130881|FG000|NOT COMPLETED|Overall Study||3
10008513|NCT01757847|11130882|FG001|NOT COMPLETED|Overall Study||4
10008514|NCT01757964|11130890|FG000|STARTED|Overall Study||9
10008515|NCT01757964|11130891|FG001|STARTED|Overall Study||4
10008516|NCT01757964|11130890|FG000|COMPLETED|Overall Study||9
9889287|NCT01075243|11004061|FG002|NOT COMPLETED|Overall Study||0
9889288|NCT01075256|11004074|FG000|STARTED|Overall Study||64
9889289|NCT01075256|11004075|FG001|STARTED|Overall Study||66
9889290|NCT01075256|11004076|FG002|STARTED|Overall Study||65
9889291|NCT01075256|11004074|FG000|COMPLETED|Overall Study||63
9889292|NCT01075256|11004075|FG001|COMPLETED|Overall Study||66
9889293|NCT01075256|11004076|FG002|COMPLETED|Overall Study||65
9889294|NCT01075256|11004074|FG000|NOT COMPLETED|Overall Study||1
9889295|NCT01075256|11004075|FG001|NOT COMPLETED|Overall Study||0
9889296|NCT01075256|11004076|FG002|NOT COMPLETED|Overall Study||0
9889297|NCT01075282|11004092|FG000|STARTED|Overall Study||273
9889298|NCT01075282|11004093|FG001|STARTED|Overall Study||272
9889299|NCT01075282|11004094|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
9889300|NCT01075282|11004092|FG000|Received at Least One Dose of Study Drug|Overall Study||273
9889301|NCT01075282|11004093|FG001|Received at Least One Dose of Study Drug|Overall Study||272
9889302|NCT01075282|11004094|FG002|Received at Least One Dose of Study Drug|Overall Study||262
9889303|NCT01075282|11004092|FG000|COMPLETED|Overall Study||242
9889304|NCT01075282|11004093|FG001|COMPLETED|Overall Study||243
9889305|NCT01075282|11004094|FG002|COMPLETED|Overall Study||238
9889306|NCT01075282|11004092|FG000|NOT COMPLETED|Overall Study||31
9889307|NCT01075282|11004093|FG001|NOT COMPLETED|Overall Study||29
9889308|NCT01075282|11004094|FG002|NOT COMPLETED|Overall Study||27
9889309|NCT01075321|11004103|FG000|STARTED|Overall Study||7
9889310|NCT01075321|11004104|FG001|STARTED|Overall Study||9
9889311|NCT01075321|11004105|FG002|STARTED|Overall Study||9
9889312|NCT01075321|11004106|FG003|STARTED|Overall Study||33
9889313|NCT01075321|11004103|FG000|COMPLETED|Overall Study||6
9889314|NCT01075321|11004104|FG001|COMPLETED|Overall Study||9
9889315|NCT01075321|11004105|FG002|COMPLETED|Overall Study||7
9889316|NCT01075321|11004106|FG003|COMPLETED|Overall Study||31
9889317|NCT01075321|11004103|FG000|NOT COMPLETED|Overall Study||1
9889318|NCT01075321|11004104|FG001|NOT COMPLETED|Overall Study||0
9889319|NCT01075321|11004105|FG002|NOT COMPLETED|Overall Study||2
9889320|NCT01075321|11004106|FG003|NOT COMPLETED|Overall Study||2
9889321|NCT01075347|11004120|FG000|STARTED|Overall Study||82
9889322|NCT01075347|11004121|FG001|STARTED|Overall Study||83
9889323|NCT01075347|11004120|FG000|COMPLETED|Overall Study||82
9889324|NCT01075347|11004121|FG001|COMPLETED|Overall Study||83
9889325|NCT01075347|11004120|FG000|NOT COMPLETED|Overall Study||0
9889326|NCT01075347|11004121|FG001|NOT COMPLETED|Overall Study||0
9889327|NCT01075399|11004127|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
9889328|NCT01075399|11004127|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
9889329|NCT01075399|11004127|FG000|NOT COMPLETED|Overall Study||8
9889330|NCT01075412|11004133|FG000|STARTED|Overall Study||4
9889331|NCT01075412|11004134|FG001|STARTED|Overall Study||2
9889332|NCT01075412|11004133|FG000|COMPLETED|Overall Study||4
9889333|NCT01075412|11004134|FG001|COMPLETED|Overall Study||1
9889334|NCT01075412|11004133|FG000|NOT COMPLETED|Overall Study||0
9889335|NCT01075412|11004134|FG001|NOT COMPLETED|Overall Study||1
9889336|NCT01075516|11004141|FG000|STARTED|Overall Study||107
9889337|NCT01075516|11004142|FG001|STARTED|Overall Study||102
9889338|NCT01075516|11004141|FG000|COMPLETED|Overall Study||89
9889339|NCT01075516|11004142|FG001|COMPLETED|Overall Study||86
9889340|NCT01075516|11004141|FG000|NOT COMPLETED|Overall Study||18
9889341|NCT01075516|11004142|FG001|NOT COMPLETED|Overall Study||16
9889342|NCT01075646|11004152|FG000|STARTED|Overall Study||33
9889343|NCT01075646|11004153|FG001|STARTED|Overall Study||34
9889344|NCT01075646|11004154|FG002|STARTED|Overall Study||53
9889345|NCT01075646|11004155|FG003|STARTED|Overall Study||46
9889346|NCT01075646|11004152|FG000|COMPLETED|Overall Study||29
9889347|NCT01075646|11004153|FG001|COMPLETED|Overall Study||31
9889348|NCT01075646|11004154|FG002|COMPLETED|Overall Study||52
9889349|NCT01075646|11004155|FG003|COMPLETED|Overall Study||44
9889350|NCT01075646|11004152|FG000|NOT COMPLETED|Overall Study||4
9889351|NCT01075646|11004153|FG001|NOT COMPLETED|Overall Study||3
9889352|NCT01075646|11004154|FG002|NOT COMPLETED|Overall Study||1
9889353|NCT01075646|11004155|FG003|NOT COMPLETED|Overall Study||2
9889354|NCT01075685|11004167|FG000|STARTED|Overall Study||743
9889355|NCT01075685|11004168|FG001|STARTED|Overall Study||414
9889356|NCT01075685|11004167|FG000|Met Inclusion Criteria|Overall Study||734
9889357|NCT01075685|11004168|FG001|Met Inclusion Criteria|Overall Study||413
9889358|NCT01075685|11004167|FG000|Completed Baseline Measures|Overall Study||225
9889359|NCT01075685|11004168|FG001|Completed Baseline Measures|Overall Study||263
9889360|NCT01075685|11004167|FG000|COMPLETED|Overall Study||151
10008517|NCT01757964|11130891|FG001|COMPLETED|Overall Study||4
9889361|NCT01075685|11004168|FG001|COMPLETED|Overall Study||188
9889362|NCT01075685|11004167|FG000|NOT COMPLETED|Overall Study||592
9889363|NCT01075685|11004168|FG001|NOT COMPLETED|Overall Study||226
9889364|NCT01075763|11004176|FG000|STARTED|Overall Study||23
9889365|NCT01075763|11004177|FG001|STARTED|Overall Study||19
10008518|NCT01757964|11130890|FG000|NOT COMPLETED|Overall Study||0
9889366|NCT01075763|11004176|FG000|COMPLETED|Overall Study||19
9889367|NCT01075763|11004177|FG001|COMPLETED|Overall Study||15
9889368|NCT01075763|11004176|FG000|NOT COMPLETED|Overall Study||4
9889369|NCT01075763|11004177|FG001|NOT COMPLETED|Overall Study||4
9889370|NCT01075815|11004185|FG000|STARTED|Overall Study|Number of participants treated.|40
9889371|NCT01075815|11004186|FG001|STARTED|Overall Study|Number of participants treated.|35
9889372|NCT01075815|11004185|FG000|COMPLETED|Overall Study||30
9889373|NCT01075815|11004186|FG001|COMPLETED|Overall Study||31
9889374|NCT01075815|11004185|FG000|NOT COMPLETED|Overall Study||10
9889375|NCT01075815|11004186|FG001|NOT COMPLETED|Overall Study||4
9889376|NCT01075958|11004192|FG000|STARTED|Overall Study||283
9889377|NCT01075958|11004192|FG000|COMPLETED|Overall Study||239
9889378|NCT01075958|11004192|FG000|NOT COMPLETED|Overall Study||44
9889379|NCT01075971|11004196|FG000|STARTED|Overall Study||52
9889380|NCT01075971|11004196|FG000|COMPLETED|Overall Study||52
9889381|NCT01075971|11004196|FG000|NOT COMPLETED|Overall Study||0
9889382|NCT01075984|11004205|FG000|STARTED|Treatment Phase||10
9889383|NCT01075984|11004206|FG001|STARTED|Treatment Phase||11
9889384|NCT01075984|11004207|FG002|STARTED|Treatment Phase||21
9889385|NCT01075984|11004208|FG003|STARTED|Treatment Phase||24
9889386|NCT01075984|11004209|FG004|STARTED|Treatment Phase||213
9889387|NCT01075984|11004205|FG000|COMPLETED|Treatment Phase||10
9889388|NCT01075984|11004206|FG001|COMPLETED|Treatment Phase||10
9889389|NCT01075984|11004207|FG002|COMPLETED|Treatment Phase||14
9889390|NCT01075984|11004208|FG003|COMPLETED|Treatment Phase||17
9889391|NCT01075984|11004209|FG004|COMPLETED|Treatment Phase||153
9889392|NCT01075984|11004205|FG000|NOT COMPLETED|Treatment Phase||0
9889393|NCT01075984|11004206|FG001|NOT COMPLETED|Treatment Phase||1
9889394|NCT01075984|11004207|FG002|NOT COMPLETED|Treatment Phase||7
9889395|NCT01075984|11004208|FG003|NOT COMPLETED|Treatment Phase||7
9889396|NCT01075984|11004209|FG004|NOT COMPLETED|Treatment Phase||60
9889397|NCT01075984|11004205|FG000|STARTED|Follow-up Phase||10
9889398|NCT01075984|11004206|FG001|STARTED|Follow-up Phase||10
9889399|NCT01075984|11004207|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
9889400|NCT01075984|11004208|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
9889401|NCT01075984|11004209|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
9889402|NCT01075984|11004205|FG000|COMPLETED|Follow-up Phase||10
9889403|NCT01075984|11004206|FG001|COMPLETED|Follow-up Phase||10
9889404|NCT01075984|11004207|FG002|COMPLETED|Follow-up Phase||19
9889405|NCT01075984|11004208|FG003|COMPLETED|Follow-up Phase||19
9889406|NCT01075984|11004209|FG004|COMPLETED|Follow-up Phase||165
9889407|NCT01075984|11004205|FG000|NOT COMPLETED|Follow-up Phase||0
9889408|NCT01075984|11004206|FG001|NOT COMPLETED|Follow-up Phase||0
9889409|NCT01075984|11004207|FG002|NOT COMPLETED|Follow-up Phase||1
9889410|NCT01075984|11004208|FG003|NOT COMPLETED|Follow-up Phase||2
9889411|NCT01075984|11004209|FG004|NOT COMPLETED|Follow-up Phase||47
9889412|NCT01076010|11004224|FG000|STARTED|Overall Study||161
9889413|NCT01076010|11004225|FG001|STARTED|Overall Study||88
9889414|NCT01076010|11004226|FG002|STARTED|Overall Study||28
9889415|NCT01076010|11004224|FG000|COMPLETED|Overall Study||36
9889416|NCT01076010|11004225|FG001|COMPLETED|Overall Study||49
9889417|NCT01076010|11004226|FG002|COMPLETED|Overall Study||26
9889418|NCT01076010|11004224|FG000|NOT COMPLETED|Overall Study||125
9889419|NCT01076010|11004225|FG001|NOT COMPLETED|Overall Study||39
9889420|NCT01076010|11004226|FG002|NOT COMPLETED|Overall Study||2
9889421|NCT01076036|11004234|FG000|STARTED|Overall Study||10
9889422|NCT01076036|11004234|FG000|# of Procedures|Overall Study||8
9889423|NCT01076036|11004234|FG000|Complete CorPath Procedures|Overall Study||8
9889424|NCT01076036|11004234|FG000|COMPLETED|Overall Study||8
9889425|NCT01076036|11004234|FG000|NOT COMPLETED|Overall Study||2
9889426|NCT01076049|11004241|FG000|STARTED|Overall Study||52
9889427|NCT01076049|11004242|FG001|STARTED|Overall Study||55
9889428|NCT01076049|11004243|FG002|STARTED|Overall Study||1
9889429|NCT01076049|11004241|FG000|COMPLETED|Overall Study||45
9889430|NCT01076049|11004242|FG001|COMPLETED|Overall Study||52
9889431|NCT01076049|11004243|FG002|COMPLETED|Overall Study||1
9889432|NCT01076049|11004241|FG000|NOT COMPLETED|Overall Study||7
9889433|NCT01076049|11004242|FG001|NOT COMPLETED|Overall Study||3
9889434|NCT01076049|11004243|FG002|NOT COMPLETED|Overall Study||0
9889435|NCT01076075|11004255|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
9889436|NCT01076075|11004256|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
9889437|NCT01076075|11004255|FG000|Completed Phase A|Overall Study||199
9889438|NCT01076075|11004256|FG001|Completed Phase A|Overall Study||189
9889439|NCT01076075|11004255|FG000|COMPLETED|Overall Study||172
9889440|NCT01076075|11004256|FG001|COMPLETED|Overall Study||167
9889441|NCT01076075|11004255|FG000|NOT COMPLETED|Overall Study||41
9889442|NCT01076075|11004256|FG001|NOT COMPLETED|Overall Study||47
9889443|NCT01076088|11004271|FG000|STARTED|Overall Study||122
9889444|NCT01076088|11004272|FG001|STARTED|Overall Study||125
9889445|NCT01076088|11004273|FG002|STARTED|Overall Study||126
9889446|NCT01076088|11004274|FG003|STARTED|Overall Study||124
9889447|NCT01076088|11004275|FG004|STARTED|Overall Study||120
9889448|NCT01076088|11004276|FG005|STARTED|Overall Study||127
9889449|NCT01076088|11004271|FG000|COMPLETED|Overall Study||111
9889450|NCT01076088|11004272|FG001|COMPLETED|Overall Study||107
9889451|NCT01076088|11004273|FG002|COMPLETED|Overall Study||109
9889452|NCT01076088|11004274|FG003|COMPLETED|Overall Study||109
9889453|NCT01076088|11004275|FG004|COMPLETED|Overall Study||104
9889454|NCT01076088|11004276|FG005|COMPLETED|Overall Study||104
9889455|NCT01076088|11004271|FG000|NOT COMPLETED|Overall Study||11
9889456|NCT01076088|11004272|FG001|NOT COMPLETED|Overall Study||18
9889457|NCT01076088|11004273|FG002|NOT COMPLETED|Overall Study||17
9889458|NCT01076088|11004274|FG003|NOT COMPLETED|Overall Study||15
9889459|NCT01076088|11004275|FG004|NOT COMPLETED|Overall Study||16
9889460|NCT01076088|11004276|FG005|NOT COMPLETED|Overall Study||23
9889461|NCT01076153|11004291|FG000|STARTED|Overall Study||760
9889462|NCT01076153|11004291|FG000|COMPLETED|Overall Study||749
9889463|NCT01076153|11004291|FG000|NOT COMPLETED|Overall Study||11
9889464|NCT01076166|11004299|FG000|STARTED|Overall Study||337
9889465|NCT01076166|11004299|FG000|COMPLETED|Overall Study||328
9889466|NCT01076166|11004299|FG000|NOT COMPLETED|Overall Study||9
9889467|NCT01076179|11004306|FG000|STARTED|Overall Study||502
9889468|NCT01076179|11004306|FG000|COMPLETED|Overall Study||501
9889469|NCT01076179|11004306|FG000|NOT COMPLETED|Overall Study||1
9889470|NCT01076192|11004311|FG000|STARTED|Overall Study||547
9889471|NCT01076192|11004311|FG000|COMPLETED|Overall Study||350
9889472|NCT01076192|11004311|FG000|NOT COMPLETED|Overall Study||197
9889473|NCT01076205|11004316|FG000|STARTED|Overall Study||7229
9889474|NCT01076205|11004316|FG000|COMPLETED|Overall Study||1210
9889475|NCT01076205|11004316|FG000|NOT COMPLETED|Overall Study||6019
9889476|NCT01076231|11004336|FG000|STARTED|Overall Study||34
9889477|NCT01076231|11004336|FG000|COMPLETED|Overall Study||0
9889478|NCT01076231|11004336|FG000|NOT COMPLETED|Overall Study||34
9889479|NCT01076244|11004340|FG000|STARTED|Overall Study||46
9889480|NCT01076244|11004340|FG000|COMPLETED|Overall Study||42
9889481|NCT01076244|11004340|FG000|NOT COMPLETED|Overall Study||4
9889482|NCT01076270|11004344|FG000|STARTED|Overall Study||1
9889483|NCT01076270|11004344|FG000|COMPLETED|Overall Study||1
9889484|NCT01076270|11004344|FG000|NOT COMPLETED|Overall Study||0
9889485|NCT01076283|11004350|FG000|STARTED|Overall Study||7
9889486|NCT01076283|11004351|FG001|STARTED|Overall Study||7
9889487|NCT01076283|11004350|FG000|COMPLETED|Overall Study||6
9889488|NCT01076283|11004351|FG001|COMPLETED|Overall Study||7
9889489|NCT01076283|11004350|FG000|NOT COMPLETED|Overall Study||1
9889490|NCT01076283|11004351|FG001|NOT COMPLETED|Overall Study||0
9889491|NCT01076296|11004357|FG000|STARTED|Overall Study||54
9889492|NCT01076296|11004358|FG001|STARTED|Overall Study||196
9889493|NCT01076296|11004359|FG002|STARTED|Overall Study||51
9889494|NCT01076296|11004360|FG003|STARTED|Overall Study||199
9889495|NCT01076296|11004361|FG004|STARTED|Overall Study||59
9889496|NCT01076296|11004362|FG005|STARTED|Overall Study||191
9889497|NCT01076296|11004363|FG006|STARTED|Overall Study||51
9889498|NCT01076296|11004364|FG007|STARTED|Overall Study||199
9889499|NCT01076296|11004357|FG000|COMPLETED|Overall Study||54
9889500|NCT01076296|11004358|FG001|COMPLETED|Overall Study||196
9889501|NCT01076296|11004359|FG002|COMPLETED|Overall Study||51
9889502|NCT01076296|11004360|FG003|COMPLETED|Overall Study||199
9889503|NCT01076296|11004361|FG004|COMPLETED|Overall Study||59
9889504|NCT01076296|11004362|FG005|COMPLETED|Overall Study||191
9889505|NCT01076296|11004363|FG006|COMPLETED|Overall Study||51
9889506|NCT01076296|11004364|FG007|COMPLETED|Overall Study||199
9889507|NCT01076296|11004357|FG000|NOT COMPLETED|Overall Study||0
9889508|NCT01076296|11004358|FG001|NOT COMPLETED|Overall Study||0
9889509|NCT01076296|11004359|FG002|NOT COMPLETED|Overall Study||0
9889510|NCT01076296|11004360|FG003|NOT COMPLETED|Overall Study||0
9889511|NCT01076296|11004361|FG004|NOT COMPLETED|Overall Study||0
9889512|NCT01076296|11004362|FG005|NOT COMPLETED|Overall Study||0
9889513|NCT01076296|11004363|FG006|NOT COMPLETED|Overall Study||0
9889514|NCT01076296|11004364|FG007|NOT COMPLETED|Overall Study||0
9889515|NCT01076335|11004382|FG000|STARTED|Overall Study||40
9889516|NCT01076335|11004382|FG000|COMPLETED|Overall Study||36
9889517|NCT01076335|11004382|FG000|NOT COMPLETED|Overall Study||4
9889518|NCT01076348|11004386|FG000|STARTED|Overall Study||73
9889519|NCT01076348|11004386|FG000|COMPLETED|Overall Study||51
9889520|NCT01076348|11004386|FG000|NOT COMPLETED|Overall Study||22
9889521|NCT01076361|11004390|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
9889522|NCT01076361|11004390|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
9889523|NCT01076361|11004390|FG000|NOT COMPLETED|Overall Study||21
9889524|NCT01076400|11004394|FG000|STARTED|Overall Study||7
9889525|NCT01076400|11004395|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
9889526|NCT01076400|11004396|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
9889527|NCT01076400|11004394|FG000|COMPLETED|Overall Study||0
9889528|NCT01076400|11004395|FG001|COMPLETED|Overall Study||0
9889529|NCT01076400|11004396|FG002|COMPLETED|Overall Study||0
9889530|NCT01076400|11004394|FG000|NOT COMPLETED|Overall Study||7
9889531|NCT01076400|11004395|FG001|NOT COMPLETED|Overall Study||0
9889532|NCT01076400|11004396|FG002|NOT COMPLETED|Overall Study||0
9889533|NCT01076452|11004402|FG000|STARTED|Overall Study||147
9889534|NCT01076452|11004403|FG001|STARTED|Overall Study||152
9889535|NCT01076452|11004402|FG000|COMPLETED|Overall Study||123
9889536|NCT01076452|11004403|FG001|COMPLETED|Overall Study||138
9889537|NCT01076452|11004402|FG000|NOT COMPLETED|Overall Study||24
9889538|NCT01076452|11004403|FG001|NOT COMPLETED|Overall Study||14
9889539|NCT01076504|11004409|FG000|STARTED|Overall Study||80
9889540|NCT01076504|11004409|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
9889541|NCT01076504|11004409|FG000|NOT COMPLETED|Overall Study||80
9889542|NCT01076543|11004419|FG000|STARTED|Overall Study||8
9889543|NCT01076543|11004420|FG001|STARTED|Overall Study||3
9889544|NCT01076543|11004421|FG002|STARTED|Overall Study||6
9889545|NCT01076543|11004422|FG003|STARTED|Overall Study||39
9889546|NCT01076543|11004423|FG004|STARTED|Overall Study||15
9889547|NCT01076543|11004424|FG005|STARTED|Overall Study||39
9889548|NCT01076543|11004419|FG000|COMPLETED|Overall Study||6
9889549|NCT01076543|11004420|FG001|COMPLETED|Overall Study||3
9889550|NCT01076543|11004421|FG002|COMPLETED|Overall Study||6
9889551|NCT01076543|11004422|FG003|COMPLETED|Overall Study||39
9889552|NCT01076543|11004423|FG004|COMPLETED|Overall Study||15
9889553|NCT01076543|11004424|FG005|COMPLETED|Overall Study||39
9889554|NCT01076543|11004419|FG000|NOT COMPLETED|Overall Study||2
9889555|NCT01076543|11004420|FG001|NOT COMPLETED|Overall Study||0
9889556|NCT01076543|11004421|FG002|NOT COMPLETED|Overall Study||0
9889557|NCT01076543|11004422|FG003|NOT COMPLETED|Overall Study||0
9889558|NCT01076543|11004423|FG004|NOT COMPLETED|Overall Study||0
9889559|NCT01076543|11004424|FG005|NOT COMPLETED|Overall Study||0
9889560|NCT01076647|11004441|FG000|STARTED|Overall Study||233
9889561|NCT01076647|11004442|FG001|STARTED|Overall Study||234
9889562|NCT01076647|11004441|FG000|COMPLETED|Overall Study||208
9889563|NCT01076647|11004442|FG001|COMPLETED|Overall Study||209
9889564|NCT01076647|11004441|FG000|NOT COMPLETED|Overall Study||25
9889565|NCT01076647|11004442|FG001|NOT COMPLETED|Overall Study||25
9889566|NCT01076686|11004452|FG000|STARTED|Overall Study||17
9889567|NCT01076686|11004453|FG001|STARTED|Overall Study||14
9889568|NCT01076686|11004454|FG002|STARTED|Overall Study||32
9889569|NCT01076686|11004455|FG003|STARTED|Overall Study||31
9889570|NCT01076686|11004452|FG000|COMPLETED|Overall Study||17
9889571|NCT01076686|11004453|FG001|COMPLETED|Overall Study||14
9889572|NCT01076686|11004454|FG002|COMPLETED|Overall Study||32
9889573|NCT01076686|11004455|FG003|COMPLETED|Overall Study||31
9889574|NCT01076686|11004452|FG000|NOT COMPLETED|Overall Study||0
9889575|NCT01076686|11004453|FG001|NOT COMPLETED|Overall Study||0
9889576|NCT01076686|11004454|FG002|NOT COMPLETED|Overall Study||0
9889577|NCT01076686|11004455|FG003|NOT COMPLETED|Overall Study||0
9889578|NCT01076959|11004465|FG000|STARTED|Overall Study||7740
9889579|NCT01076959|11004465|FG000|COMPLETED|Overall Study||5490
9889580|NCT01076959|11004465|FG000|NOT COMPLETED|Overall Study||2250
9889581|NCT01076972|11004482|FG000|STARTED|Overall Study||1184
9889582|NCT01076972|11004482|FG000|COMPLETED|Overall Study||1184
9889583|NCT01076972|11004482|FG000|NOT COMPLETED|Overall Study||0
9889584|NCT01076985|11004496|FG000|STARTED|Overall Study||24
9889585|NCT01076985|11004496|FG000|COMPLETED|Overall Study||24
9889586|NCT01076985|11004496|FG000|NOT COMPLETED|Overall Study||0
9889587|NCT01077024|11004504|FG000|STARTED|Overall Study||267
9889588|NCT01077024|11004505|FG001|STARTED|Overall Study||271
9889589|NCT01077024|11004504|FG000|COMPLETED|Overall Study||236
9889590|NCT01077024|11004505|FG001|COMPLETED|Overall Study||243
9889591|NCT01077024|11004504|FG000|NOT COMPLETED|Overall Study||31
10109283|NCT02474082|11239886|FG001|NOT COMPLETED|Overall Study||54
10109284|NCT02474199|11239894|FG000|STARTED|Overall Study||5
10109285|NCT02474199|11239895|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
9889592|NCT01077024|11004505|FG001|NOT COMPLETED|Overall Study||28
9889593|NCT01077050|11004511|FG000|STARTED|Overall Study||1951
9889594|NCT01077050|11004511|FG000|COMPLETED|Overall Study||1942
9889595|NCT01077050|11004511|FG000|NOT COMPLETED|Overall Study||9
9889596|NCT01077063|11004517|FG000|STARTED|Overall Study||4
9889597|NCT01077063|11004518|FG001|STARTED|Overall Study||3
9889598|NCT01077063|11004517|FG000|COMPLETED|Overall Study||0
9889599|NCT01077063|11004518|FG001|COMPLETED|Overall Study||0
9889600|NCT01077063|11004517|FG000|NOT COMPLETED|Overall Study||4
9889601|NCT01077063|11004518|FG001|NOT COMPLETED|Overall Study||3
9889602|NCT01077076|11004524|FG000|STARTED|First Intervention||5
9889603|NCT01077076|11004525|FG001|STARTED|First Intervention||5
9889604|NCT01077076|11004526|FG002|STARTED|First Intervention||5
9889605|NCT01077076|11004527|FG003|STARTED|First Intervention||5
9889606|NCT01077076|11004528|FG004|STARTED|First Intervention||5
9889607|NCT01077076|11004529|FG005|STARTED|First Intervention||5
9889608|NCT01077076|11004524|FG000|COMPLETED|First Intervention||4
9889609|NCT01077076|11004525|FG001|COMPLETED|First Intervention||5
9889610|NCT01077076|11004526|FG002|COMPLETED|First Intervention||5
9889611|NCT01077076|11004527|FG003|COMPLETED|First Intervention||5
9889612|NCT01077076|11004528|FG004|COMPLETED|First Intervention||5
10109286|NCT02474199|11239896|FG002|STARTED|Overall Study||2
10109287|NCT02474199|11239897|FG003|STARTED|Overall Study||3
10109288|NCT02474199|11239894|FG000|COMPLETED|Overall Study||3
10109289|NCT02474199|11239895|FG001|COMPLETED|Overall Study||2
9889613|NCT01077076|11004529|FG005|COMPLETED|First Intervention||5
9889614|NCT01077076|11004524|FG000|NOT COMPLETED|First Intervention||1
9889615|NCT01077076|11004525|FG001|NOT COMPLETED|First Intervention||0
9889616|NCT01077076|11004526|FG002|NOT COMPLETED|First Intervention||0
9889617|NCT01077076|11004527|FG003|NOT COMPLETED|First Intervention||0
9889618|NCT01077076|11004528|FG004|NOT COMPLETED|First Intervention||0
9889619|NCT01077076|11004529|FG005|NOT COMPLETED|First Intervention||0
9889620|NCT01077076|11004524|FG000|STARTED|Washout Period of 2 Weeks||4
9889621|NCT01077076|11004525|FG001|STARTED|Washout Period of 2 Weeks||5
9889622|NCT01077076|11004526|FG002|STARTED|Washout Period of 2 Weeks||5
9889623|NCT01077076|11004527|FG003|STARTED|Washout Period of 2 Weeks||5
9889624|NCT01077076|11004528|FG004|STARTED|Washout Period of 2 Weeks||5
9889625|NCT01077076|11004529|FG005|STARTED|Washout Period of 2 Weeks||5
9889626|NCT01077076|11004524|FG000|COMPLETED|Washout Period of 2 Weeks||4
9889627|NCT01077076|11004525|FG001|COMPLETED|Washout Period of 2 Weeks||5
9889628|NCT01077076|11004526|FG002|COMPLETED|Washout Period of 2 Weeks||5
9889629|NCT01077076|11004527|FG003|COMPLETED|Washout Period of 2 Weeks||5
9889630|NCT01077076|11004528|FG004|COMPLETED|Washout Period of 2 Weeks||5
9889631|NCT01077076|11004529|FG005|COMPLETED|Washout Period of 2 Weeks||5
9889632|NCT01077076|11004524|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9889633|NCT01077076|11004525|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10109290|NCT02474199|11239896|FG002|COMPLETED|Overall Study||0
10109291|NCT02474199|11239897|FG003|COMPLETED|Overall Study||0
10109292|NCT02474199|11239894|FG000|NOT COMPLETED|Overall Study||2
9889634|NCT01077076|11004526|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
9889635|NCT01077076|11004527|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
9889636|NCT01077076|11004528|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
9889637|NCT01077076|11004529|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
9889638|NCT01077076|11004524|FG000|STARTED|Second Intervention||4
9889639|NCT01077076|11004525|FG001|STARTED|Second Intervention||5
9889640|NCT01077076|11004526|FG002|STARTED|Second Intervention||5
9889641|NCT01077076|11004527|FG003|STARTED|Second Intervention||5
9889642|NCT01077076|11004528|FG004|STARTED|Second Intervention||5
9889643|NCT01077076|11004529|FG005|STARTED|Second Intervention||5
9889644|NCT01077076|11004524|FG000|COMPLETED|Second Intervention||4
9889645|NCT01077076|11004525|FG001|COMPLETED|Second Intervention||5
9889646|NCT01077076|11004526|FG002|COMPLETED|Second Intervention||5
9889647|NCT01077076|11004527|FG003|COMPLETED|Second Intervention||5
9889648|NCT01077076|11004528|FG004|COMPLETED|Second Intervention||5
9889649|NCT01077076|11004529|FG005|COMPLETED|Second Intervention||5
9889650|NCT01077076|11004524|FG000|NOT COMPLETED|Second Intervention||0
10109293|NCT02474199|11239895|FG001|NOT COMPLETED|Overall Study||3
10109294|NCT02474199|11239896|FG002|NOT COMPLETED|Overall Study||2
10109295|NCT02474199|11239897|FG003|NOT COMPLETED|Overall Study||3
10113370|NCT02509117|11244196|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0
10113371|NCT02509117|11244197|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0
10113372|NCT02509117|11244198|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0
10113373|NCT02509117|11244199|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0
10113374|NCT02509117|11244190|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10113375|NCT02509117|11244191|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10113376|NCT02509117|11244192|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10113377|NCT02509117|11244193|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10113378|NCT02509117|11244194|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113379|NCT02509117|11244195|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113380|NCT02509117|11244196|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113381|NCT02509117|11244197|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113382|NCT02509117|11244198|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113383|NCT02509117|11244199|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113384|NCT02509117|11244190|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113385|NCT02509117|11244191|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113386|NCT02509117|11244192|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113387|NCT02509117|11244193|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113388|NCT02509117|11244194|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113389|NCT02509117|11244195|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113390|NCT02509117|11244196|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113391|NCT02509117|11244197|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10113392|NCT02509117|11244198|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
9889651|NCT01077076|11004525|FG001|NOT COMPLETED|Second Intervention||0
9889652|NCT01077076|11004526|FG002|NOT COMPLETED|Second Intervention||0
9889653|NCT01077076|11004527|FG003|NOT COMPLETED|Second Intervention||0
9889654|NCT01077076|11004528|FG004|NOT COMPLETED|Second Intervention||0
9889655|NCT01077076|11004529|FG005|NOT COMPLETED|Second Intervention||0
9889656|NCT01077076|11004524|FG000|STARTED|Washout Period of 2 Weeks||4
9889657|NCT01077076|11004525|FG001|STARTED|Washout Period of 2 Weeks||5
9889658|NCT01077076|11004526|FG002|STARTED|Washout Period of 2 Weeks||5
9889659|NCT01077076|11004527|FG003|STARTED|Washout Period of 2 Weeks||5
9889660|NCT01077076|11004528|FG004|STARTED|Washout Period of 2 Weeks||5
9889661|NCT01077076|11004529|FG005|STARTED|Washout Period of 2 Weeks||5
9889662|NCT01077076|11004524|FG000|COMPLETED|Washout Period of 2 Weeks||4
9889663|NCT01077076|11004525|FG001|COMPLETED|Washout Period of 2 Weeks||5
9889664|NCT01077076|11004526|FG002|COMPLETED|Washout Period of 2 Weeks||5
9889665|NCT01077076|11004527|FG003|COMPLETED|Washout Period of 2 Weeks||5
10113393|NCT02509117|11244199|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
9889666|NCT01077076|11004528|FG004|COMPLETED|Washout Period of 2 Weeks||5
9889667|NCT01077076|11004529|FG005|COMPLETED|Washout Period of 2 Weeks||5
9889668|NCT01077076|11004524|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9889669|NCT01077076|11004525|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9889670|NCT01077076|11004526|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
9889671|NCT01077076|11004527|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
9889672|NCT01077076|11004528|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
9889673|NCT01077076|11004529|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
9889674|NCT01077076|11004524|FG000|STARTED|Third Intervention||4
9889675|NCT01077076|11004525|FG001|STARTED|Third Intervention||5
9889676|NCT01077076|11004526|FG002|STARTED|Third Intervention||5
9889677|NCT01077076|11004527|FG003|STARTED|Third Intervention||5
9889678|NCT01077076|11004528|FG004|STARTED|Third Intervention||5
10008519|NCT01757964|11130891|FG001|NOT COMPLETED|Overall Study||0
10008520|NCT01758289|11130895|FG000|STARTED|Overall Study||105
10008521|NCT01758289|11130895|FG000|COMPLETED|Overall Study||52
10008522|NCT01758289|11130895|FG000|NOT COMPLETED|Overall Study||53
10008523|NCT01758432|11130910|FG000|STARTED|Overall Study||18
10109296|NCT02474355|11239904|FG000|STARTED|Overall Study||3014
10109297|NCT02474355|11239904|FG000|COMPLETED|Overall Study||1386
10109298|NCT02474355|11239904|FG000|NOT COMPLETED|Overall Study||1628
9889679|NCT01077076|11004529|FG005|STARTED|Third Intervention||5
9889680|NCT01077076|11004524|FG000|COMPLETED|Third Intervention||4
9889681|NCT01077076|11004525|FG001|COMPLETED|Third Intervention||5
9889682|NCT01077076|11004526|FG002|COMPLETED|Third Intervention||5
9889683|NCT01077076|11004527|FG003|COMPLETED|Third Intervention||5
9889684|NCT01077076|11004528|FG004|COMPLETED|Third Intervention||5
9889685|NCT01077076|11004529|FG005|COMPLETED|Third Intervention||4
10008524|NCT01758432|11130911|FG001|STARTED|Overall Study||6
10008525|NCT01758432|11130912|FG002|STARTED|Overall Study||6
10008526|NCT01758432|11130913|FG003|STARTED|Overall Study||6
10008527|NCT01758432|11130914|FG004|STARTED|Overall Study||6
10008528|NCT01758432|11130915|FG005|STARTED|Overall Study||6
10008529|NCT01758432|11130916|FG006|STARTED|Overall Study||6
10109299|NCT02474407|11239908|FG000|STARTED|First Intervention (14 Days)||39
9889686|NCT01077076|11004524|FG000|NOT COMPLETED|Third Intervention||0
9889687|NCT01077076|11004525|FG001|NOT COMPLETED|Third Intervention||0
9889688|NCT01077076|11004526|FG002|NOT COMPLETED|Third Intervention||0
9889689|NCT01077076|11004527|FG003|NOT COMPLETED|Third Intervention||0
9889690|NCT01077076|11004528|FG004|NOT COMPLETED|Third Intervention||0
9889691|NCT01077076|11004529|FG005|NOT COMPLETED|Third Intervention||1
9889692|NCT01077128|11004537|FG000|STARTED|Overall Study||500
9889693|NCT01077128|11004537|FG000|COMPLETED|Overall Study||433
9889694|NCT01077128|11004537|FG000|NOT COMPLETED|Overall Study||67
9889695|NCT01077154|11004593|FG000|STARTED|Overall Study||2253
9889696|NCT01077154|11004594|FG001|STARTED|Overall Study||2256
9889697|NCT01077154|11004593|FG000|Received Study Drug|Overall Study||2229
9889698|NCT01077154|11004594|FG001|Received Study Drug|Overall Study||2230
9889699|NCT01077154|11004593|FG000|COMPLETED|Overall Study||27
9889700|NCT01077154|11004594|FG001|COMPLETED|Overall Study||28
9889701|NCT01077154|11004593|FG000|NOT COMPLETED|Overall Study||2226
9889702|NCT01077154|11004594|FG001|NOT COMPLETED|Overall Study||2228
9889703|NCT01077193|11004600|FG000|STARTED|Overall Study||44
9889704|NCT01077193|11004600|FG000|COMPLETED|Overall Study||0
9889705|NCT01077193|11004600|FG000|NOT COMPLETED|Overall Study||44
9889706|NCT01077258|11004604|FG000|STARTED|Overall Study||4208
9889707|NCT01077258|11004604|FG000|COMPLETED|Overall Study||1640
9889708|NCT01077258|11004604|FG000|NOT COMPLETED|Overall Study||2568
9889709|NCT01077271|11004621|FG000|STARTED|Overall Study||124
9889710|NCT01077271|11004621|FG000|Participants Treated With Palivizumab|Overall Study||120
9889711|NCT01077271|11004621|FG000|Number of Participants Analyzed|Overall Study||120
9889712|NCT01077271|11004621|FG000|COMPLETED|Overall Study||102
9889713|NCT01077271|11004621|FG000|NOT COMPLETED|Overall Study||22
9889714|NCT01077284|11004636|FG000|STARTED|Overall Study||33
9889715|NCT01077284|11004637|FG001|STARTED|Overall Study||33
9889716|NCT01077284|11004638|FG002|STARTED|Overall Study||33
9889717|NCT01077284|11004636|FG000|COMPLETED|Overall Study||28
9889718|NCT01077284|11004637|FG001|COMPLETED|Overall Study||28
9889719|NCT01077284|11004638|FG002|COMPLETED|Overall Study||30
9889720|NCT01077284|11004636|FG000|NOT COMPLETED|Overall Study||5
9889721|NCT01077284|11004637|FG001|NOT COMPLETED|Overall Study||5
9889722|NCT01077284|11004638|FG002|NOT COMPLETED|Overall Study||3
9889723|NCT01077310|11004648|FG000|STARTED|Overall Study||67
9889724|NCT01077310|11004649|FG001|STARTED|Overall Study||33
9889725|NCT01077310|11004648|FG000|COMPLETED|Overall Study||67
9889726|NCT01077310|11004649|FG001|COMPLETED|Overall Study||33
9889727|NCT01077310|11004648|FG000|NOT COMPLETED|Overall Study||0
9889728|NCT01077310|11004649|FG001|NOT COMPLETED|Overall Study||0
9889729|NCT01077323|11004663|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
9889730|NCT01077323|11004664|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
9889731|NCT01077323|11004665|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
9954539|NCT01432327|11073351|FG001|NOT COMPLETED|Posttest 6 Months||0
9954540|NCT01432327|11073352|FG002|NOT COMPLETED|Posttest 6 Months||5
9954541|NCT01432327|11073353|FG003|NOT COMPLETED|Posttest 6 Months||2
9954542|NCT01432327|11073350|FG000|STARTED|Posttest 1 Year||52
9954543|NCT01432327|11073351|FG001|STARTED|Posttest 1 Year||55
9889732|NCT01077323|11004663|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
9889733|NCT01077323|11004664|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
9889734|NCT01077323|11004665|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
9889735|NCT01077323|11004663|FG000|NOT COMPLETED|Overall Study||11378
9889736|NCT01077323|11004664|FG001|NOT COMPLETED|Overall Study||386263
9889737|NCT01077323|11004665|FG002|NOT COMPLETED|Overall Study||11912089
9889738|NCT01077362|11004676|FG000|STARTED|Overall Study||104
9889739|NCT01077362|11004677|FG001|STARTED|Overall Study||103
9889740|NCT01077362|11004678|FG002|STARTED|Overall Study||105
9889741|NCT01077362|11004676|FG000|COMPLETED|Overall Study||73
9889742|NCT01077362|11004677|FG001|COMPLETED|Overall Study||84
9889743|NCT01077362|11004678|FG002|COMPLETED|Overall Study||81
9889744|NCT01077362|11004676|FG000|NOT COMPLETED|Overall Study||31
9889745|NCT01077362|11004677|FG001|NOT COMPLETED|Overall Study||19
9889746|NCT01077362|11004678|FG002|NOT COMPLETED|Overall Study||24
9889747|NCT01077375|11004693|FG000|STARTED|Overall Study||21
9889748|NCT01077375|11004694|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
9889749|NCT01077375|11004693|FG000|COMPLETED|Overall Study||11
9889750|NCT01077375|11004694|FG001|COMPLETED|Overall Study||51
9889751|NCT01077375|11004693|FG000|NOT COMPLETED|Overall Study||10
9889752|NCT01077375|11004694|FG001|NOT COMPLETED|Overall Study||35
9889753|NCT01077401|11004704|FG000|STARTED|Overall Study||77
9889754|NCT01077401|11004705|FG001|STARTED|Overall Study||75
9889755|NCT01077401|11004704|FG000|COMPLETED|Overall Study||59
9889756|NCT01077401|11004705|FG001|COMPLETED|Overall Study||54
9889757|NCT01077401|11004704|FG000|NOT COMPLETED|Overall Study||18
9889758|NCT01077401|11004705|FG001|NOT COMPLETED|Overall Study||21
9889759|NCT01077518|11004713|FG000|STARTED|Treatment Phase - no Optional Ofa||173
9889760|NCT01077518|11004714|FG001|STARTED|Treatment Phase - no Optional Ofa||173
9889761|NCT01077518|11004715|FG002|STARTED|Treatment Phase - no Optional Ofa||0
9889762|NCT01077518|11004713|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
9889763|NCT01077518|11004714|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
9889764|NCT01077518|11004715|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
9889765|NCT01077518|11004713|FG000|Safety Population|Treatment Phase - no Optional Ofa||172
9889766|NCT01077518|11004714|FG001|Safety Population|Treatment Phase - no Optional Ofa||170
9889767|NCT01077518|11004715|FG002|Safety Population|Treatment Phase - no Optional Ofa||0
9889768|NCT01077518|11004713|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95
9889769|NCT01077518|11004714|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108
9889770|NCT01077518|11004715|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0
9889771|NCT01077518|11004713|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
9889772|NCT01077518|11004714|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
9889773|NCT01077518|11004715|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
9889774|NCT01077518|11004713|FG000|STARTED|Optional Ofa Phase||0
9889775|NCT01077518|11004714|FG001|STARTED|Optional Ofa Phase||0
9889776|NCT01077518|11004715|FG002|STARTED|Optional Ofa Phase||32
9889777|NCT01077518|11004713|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0
9889778|NCT01077518|11004714|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0
9889779|NCT01077518|11004715|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12
9889780|NCT01077518|11004713|FG000|COMPLETED|Optional Ofa Phase||0
9889781|NCT01077518|11004714|FG001|COMPLETED|Optional Ofa Phase||0
9760408|NCT00380744|10864049|FG005|STARTED|Overall Study||25
9760409|NCT00380744|10864050|FG006|STARTED|Overall Study||25
9760410|NCT00380744|10864044|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
9760411|NCT00380744|10864045|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
9760412|NCT00380744|10864046|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
9760413|NCT00380744|10864047|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
9760414|NCT00380744|10864048|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23
9760415|NCT00380744|10864049|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
9760416|NCT00380744|10864050|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25
9760417|NCT00380744|10864044|FG000|COMPLETED|Overall Study||19
9760418|NCT00380744|10864045|FG001|COMPLETED|Overall Study||4
9889782|NCT01077518|11004715|FG002|COMPLETED|Optional Ofa Phase||16
9889783|NCT01077518|11004713|FG000|NOT COMPLETED|Optional Ofa Phase||0
9889784|NCT01077518|11004714|FG001|NOT COMPLETED|Optional Ofa Phase||0
9889785|NCT01077518|11004715|FG002|NOT COMPLETED|Optional Ofa Phase||16
9889786|NCT01077544|11004726|FG000|STARTED|Overall Study||8
9889787|NCT01077544|11004727|FG001|STARTED|Overall Study||7
9889788|NCT01077544|11004726|FG000|COMPLETED|Overall Study||5
9889789|NCT01077544|11004727|FG001|COMPLETED|Overall Study||2
9889790|NCT01077544|11004726|FG000|NOT COMPLETED|Overall Study||3
9889791|NCT01077544|11004727|FG001|NOT COMPLETED|Overall Study||5
9889792|NCT01077596|11004745|FG000|STARTED|Overall Study||350
9889793|NCT01077596|11004746|FG001|STARTED|Overall Study||1050
9889794|NCT01077596|11004747|FG002|STARTED|Overall Study||457
9889795|NCT01077596|11004748|FG003|STARTED|Overall Study||1370
9889796|NCT01077596|11004749|FG004|STARTED|Overall Study||294
9889797|NCT01077596|11004750|FG005|STARTED|Overall Study||882
9889798|NCT01077596|11004751|FG006|STARTED|Overall Study||308
9889799|NCT01077596|11004752|FG007|STARTED|Overall Study||837
9889800|NCT01077596|11004753|FG008|STARTED|Overall Study||2842
9889801|NCT01077596|11004754|FG009|STARTED|Overall Study||28420
9889802|NCT01077596|11004755|FG010|STARTED|Overall Study||2215
9889803|NCT01077596|11004756|FG011|STARTED|Overall Study||22150
9889804|NCT01077596|11004745|FG000|COMPLETED|Overall Study||350
9889805|NCT01077596|11004746|FG001|COMPLETED|Overall Study||1050
9889806|NCT01077596|11004747|FG002|COMPLETED|Overall Study||457
9889807|NCT01077596|11004748|FG003|COMPLETED|Overall Study||1370
9889808|NCT01077596|11004749|FG004|COMPLETED|Overall Study||294
9889809|NCT01077596|11004750|FG005|COMPLETED|Overall Study||882
9889810|NCT01077596|11004751|FG006|COMPLETED|Overall Study||308
9889811|NCT01077596|11004752|FG007|COMPLETED|Overall Study||837
9889812|NCT01077596|11004753|FG008|COMPLETED|Overall Study||2842
9889813|NCT01077596|11004754|FG009|COMPLETED|Overall Study||28420
9889814|NCT01077596|11004755|FG010|COMPLETED|Overall Study||2215
9889815|NCT01077596|11004756|FG011|COMPLETED|Overall Study||22150
9889816|NCT01077596|11004745|FG000|NOT COMPLETED|Overall Study||0
9889817|NCT01077596|11004746|FG001|NOT COMPLETED|Overall Study||0
9889818|NCT01077596|11004747|FG002|NOT COMPLETED|Overall Study||0
9889819|NCT01077596|11004748|FG003|NOT COMPLETED|Overall Study||0
9889820|NCT01077596|11004749|FG004|NOT COMPLETED|Overall Study||0
9889821|NCT01077596|11004750|FG005|NOT COMPLETED|Overall Study||0
9889822|NCT01077596|11004751|FG006|NOT COMPLETED|Overall Study||0
9889823|NCT01077596|11004752|FG007|NOT COMPLETED|Overall Study||0
9889824|NCT01077596|11004753|FG008|NOT COMPLETED|Overall Study||0
9889825|NCT01077596|11004754|FG009|NOT COMPLETED|Overall Study||0
9889826|NCT01077596|11004755|FG010|NOT COMPLETED|Overall Study||0
9889827|NCT01077596|11004756|FG011|NOT COMPLETED|Overall Study||0
9889828|NCT01077622|11004777|FG000|STARTED|Overall Study||10
9889829|NCT01077622|11004777|FG000|COMPLETED|Overall Study||7
9889830|NCT01077622|11004777|FG000|NOT COMPLETED|Overall Study||3
9889831|NCT01077713|11004783|FG000|STARTED|Overall Study||44
9889832|NCT01077713|11004784|FG001|STARTED|Overall Study||42
9889833|NCT01077713|11004783|FG000|COMPLETED|Overall Study||8
9889834|NCT01077713|11004784|FG001|COMPLETED|Overall Study||6
9889835|NCT01077713|11004783|FG000|NOT COMPLETED|Overall Study||36
9889836|NCT01077713|11004784|FG001|NOT COMPLETED|Overall Study||36
9889837|NCT01077739|11004792|FG000|STARTED|Overall Study||25
9889838|NCT01077739|11004793|FG001|STARTED|Overall Study||50
9889839|NCT01077739|11004792|FG000|COMPLETED|Overall Study||20
9889840|NCT01077739|11004793|FG001|COMPLETED|Overall Study||40
9889841|NCT01077739|11004792|FG000|NOT COMPLETED|Overall Study||5
9889842|NCT01077739|11004793|FG001|NOT COMPLETED|Overall Study||10
9889843|NCT01077804|11004799|FG000|STARTED|Overall Study||7585
9889844|NCT01077804|11004799|FG000|COMPLETED|Overall Study||7386
9889845|NCT01077804|11004799|FG000|NOT COMPLETED|Overall Study||199
9889846|NCT01077856|11004806|FG000|STARTED|Overall Study||22199
9889847|NCT01077856|11004807|FG001|STARTED|Overall Study||16604
9889848|NCT01077856|11004808|FG002|STARTED|Overall Study||15713
9889849|NCT01077856|11004806|FG000|COMPLETED|Overall Study||22199
9889850|NCT01077856|11004807|FG001|COMPLETED|Overall Study||16604
9889851|NCT01077856|11004808|FG002|COMPLETED|Overall Study||15713
9889852|NCT01077856|11004806|FG000|NOT COMPLETED|Overall Study||0
9889853|NCT01077856|11004807|FG001|NOT COMPLETED|Overall Study||0
9889854|NCT01077856|11004808|FG002|NOT COMPLETED|Overall Study||0
9889855|NCT01077921|11004850|FG000|STARTED|First Intervention||14
9889856|NCT01077921|11004851|FG001|STARTED|First Intervention||13
9889857|NCT01077921|11004850|FG000|COMPLETED|First Intervention||13
9889858|NCT01077921|11004851|FG001|COMPLETED|First Intervention||12
9889859|NCT01077921|11004850|FG000|NOT COMPLETED|First Intervention||1
9889860|NCT01077921|11004851|FG001|NOT COMPLETED|First Intervention||1
9889861|NCT01077921|11004850|FG000|STARTED|Washout||13
9889862|NCT01077921|11004851|FG001|STARTED|Washout||12
9889863|NCT01077921|11004850|FG000|COMPLETED|Washout||13
9889864|NCT01077921|11004851|FG001|COMPLETED|Washout||10
9889865|NCT01077921|11004850|FG000|NOT COMPLETED|Washout||0
9889866|NCT01077921|11004851|FG001|NOT COMPLETED|Washout||2
9889867|NCT01077921|11004850|FG000|STARTED|Second Intervention||13
9889868|NCT01077921|11004851|FG001|STARTED|Second Intervention||10
9889869|NCT01077921|11004850|FG000|COMPLETED|Second Intervention||13
9889870|NCT01077921|11004851|FG001|COMPLETED|Second Intervention||9
9889871|NCT01077921|11004850|FG000|NOT COMPLETED|Second Intervention||0
9889872|NCT01077921|11004851|FG001|NOT COMPLETED|Second Intervention||1
9889873|NCT01077960|11004858|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
9889874|NCT01077960|11004858|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
9889875|NCT01077960|11004858|FG000|NOT COMPLETED|Overall Study||16
9889876|NCT01077973|11004865|FG000|STARTED|Overall Study||41
9889877|NCT01077973|11004866|FG001|STARTED|Overall Study||79
9889878|NCT01077973|11004867|FG002|STARTED|Overall Study||80
9889879|NCT01077973|11004865|FG000|COMPLETED|Overall Study||41
9889880|NCT01077973|11004866|FG001|COMPLETED|Overall Study||79
9889881|NCT01077973|11004867|FG002|COMPLETED|Overall Study||80
9889882|NCT01077973|11004865|FG000|NOT COMPLETED|Overall Study||0
9889883|NCT01077973|11004866|FG001|NOT COMPLETED|Overall Study||0
9889884|NCT01077973|11004867|FG002|NOT COMPLETED|Overall Study||0
9889885|NCT01078090|11004877|FG000|STARTED|Overall Study||5745
9889886|NCT01078090|11004877|FG000|COMPLETED|Overall Study||1152
9889887|NCT01078090|11004877|FG000|NOT COMPLETED|Overall Study||4593
9889888|NCT01078116|11004895|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
9889889|NCT01078116|11004895|FG000|COMPLETED|Overall Study||76
9889890|NCT01078116|11004895|FG000|NOT COMPLETED|Overall Study||48
9889891|NCT01078155|11004899|FG000|STARTED|Overall Study||131
9889892|NCT01078155|11004899|FG000|COMPLETED|Overall Study||87
9889893|NCT01078155|11004899|FG000|NOT COMPLETED|Overall Study||44
9889894|NCT01078168|11004905|FG000|STARTED|Overall Study||11
9889895|NCT01078168|11004906|FG001|STARTED|Overall Study||11
9889896|NCT01078168|11004905|FG000|COMPLETED|Overall Study||11
9889897|NCT01078168|11004906|FG001|COMPLETED|Overall Study||10
9889898|NCT01078168|11004905|FG000|NOT COMPLETED|Overall Study||0
9889899|NCT01078168|11004906|FG001|NOT COMPLETED|Overall Study||1
9889900|NCT01078207|11004912|FG000|STARTED|Overall Study||100
9889901|NCT01078207|11004912|FG000|COMPLETED|Overall Study||100
9889902|NCT01078207|11004912|FG000|NOT COMPLETED|Overall Study||0
9889903|NCT01078220|11004916|FG000|STARTED|Overall Study||189629
9889904|NCT01078220|11004916|FG000|COMPLETED|Overall Study||189629
9889905|NCT01078220|11004916|FG000|NOT COMPLETED|Overall Study||0
9889906|NCT01078233|11004929|FG000|STARTED|Overall Study||656
9889907|NCT01078233|11004930|FG001|STARTED|Overall Study||296
9889908|NCT01078233|11004931|FG002|STARTED|Overall Study||1681
9889909|NCT01078233|11004932|FG003|STARTED|Overall Study||631
9889910|NCT01078233|11004933|FG004|STARTED|Overall Study||3199
9889911|NCT01078233|11004934|FG005|STARTED|Overall Study||154
9889912|NCT01078233|11004929|FG000|COMPLETED|Overall Study||656
9889913|NCT01078233|11004930|FG001|COMPLETED|Overall Study||296
9889914|NCT01078233|11004931|FG002|COMPLETED|Overall Study||1681
9889915|NCT01078233|11004932|FG003|COMPLETED|Overall Study||631
9889916|NCT01078233|11004933|FG004|COMPLETED|Overall Study||3199
9889917|NCT01078233|11004934|FG005|COMPLETED|Overall Study||154
9889918|NCT01078233|11004929|FG000|NOT COMPLETED|Overall Study||0
9889919|NCT01078233|11004930|FG001|NOT COMPLETED|Overall Study||0
9889920|NCT01078233|11004931|FG002|NOT COMPLETED|Overall Study||0
9889921|NCT01078233|11004932|FG003|NOT COMPLETED|Overall Study||0
9889922|NCT01078233|11004933|FG004|NOT COMPLETED|Overall Study||0
9889923|NCT01078233|11004934|FG005|NOT COMPLETED|Overall Study||0
9889924|NCT01078246|11004949|FG000|STARTED|Overall Study||1041
9889925|NCT01078246|11004950|FG001|STARTED|Overall Study||405
9889926|NCT01078246|11004951|FG002|STARTED|Overall Study||1963
9889927|NCT01078246|11004952|FG003|STARTED|Overall Study||152
9889928|NCT01078246|11004953|FG004|STARTED|Overall Study||3310
9889929|NCT01078246|11004954|FG005|STARTED|Overall Study||231
9889930|NCT01078246|11004955|FG006|STARTED|Overall Study||22
9889931|NCT01078246|11004949|FG000|COMPLETED|Overall Study||1041
9889932|NCT01078246|11004950|FG001|COMPLETED|Overall Study||405
9889933|NCT01078246|11004951|FG002|COMPLETED|Overall Study||1963
9889934|NCT01078246|11004952|FG003|COMPLETED|Overall Study||152
9889935|NCT01078246|11004953|FG004|COMPLETED|Overall Study||3310
9889936|NCT01078246|11004954|FG005|COMPLETED|Overall Study||231
9889937|NCT01078246|11004955|FG006|COMPLETED|Overall Study||22
9889938|NCT01078246|11004949|FG000|NOT COMPLETED|Overall Study||0
9889939|NCT01078246|11004950|FG001|NOT COMPLETED|Overall Study||0
9889940|NCT01078246|11004951|FG002|NOT COMPLETED|Overall Study||0
9889941|NCT01078246|11004952|FG003|NOT COMPLETED|Overall Study||0
9889942|NCT01078246|11004953|FG004|NOT COMPLETED|Overall Study||0
9889943|NCT01078246|11004954|FG005|NOT COMPLETED|Overall Study||0
9889944|NCT01078246|11004955|FG006|NOT COMPLETED|Overall Study||0
9889945|NCT01078298|11004965|FG000|STARTED|Overall Study||256
9889946|NCT01078298|11004966|FG001|STARTED|Overall Study||269
9889947|NCT01078298|11004965|FG000|COMPLETED|Overall Study||175
9889948|NCT01078298|11004966|FG001|COMPLETED|Overall Study||179
9889949|NCT01078298|11004965|FG000|NOT COMPLETED|Overall Study||81
9889950|NCT01078298|11004966|FG001|NOT COMPLETED|Overall Study||90
9889951|NCT01078363|11004974|FG000|STARTED|Overall Study||47
9889952|NCT01078363|11004975|FG001|STARTED|Overall Study||49
9889953|NCT01078363|11004974|FG000|COMPLETED|Overall Study||47
9889954|NCT01078363|11004975|FG001|COMPLETED|Overall Study||49
9889955|NCT01078363|11004974|FG000|NOT COMPLETED|Overall Study||0
9889956|NCT01078363|11004975|FG001|NOT COMPLETED|Overall Study||0
9954544|NCT01432327|11073352|FG002|STARTED|Posttest 1 Year||50
9954545|NCT01432327|11073353|FG003|STARTED|Posttest 1 Year||54
9954546|NCT01432327|11073350|FG000|COMPLETED|Posttest 1 Year||28
9954547|NCT01432327|11073351|FG001|COMPLETED|Posttest 1 Year||27
9954548|NCT01432327|11073352|FG002|COMPLETED|Posttest 1 Year||30
9954549|NCT01432327|11073353|FG003|COMPLETED|Posttest 1 Year||31
9954550|NCT01432327|11073350|FG000|NOT COMPLETED|Posttest 1 Year||24
9954551|NCT01432327|11073351|FG001|NOT COMPLETED|Posttest 1 Year||28
9954552|NCT01432327|11073352|FG002|NOT COMPLETED|Posttest 1 Year||20
9954553|NCT01432327|11073353|FG003|NOT COMPLETED|Posttest 1 Year||23
9954554|NCT01432366|11073363|FG000|STARTED|Overall Study||460
9954555|NCT01432366|11073363|FG000|COMPLETED|Overall Study||392
9954556|NCT01432366|11073363|FG000|NOT COMPLETED|Overall Study||68
9954557|NCT01432379|11073367|FG000|STARTED|Overall Study||1168
9954558|NCT01432379|11073367|FG000|COMPLETED|Overall Study||783
9954559|NCT01432379|11073367|FG000|NOT COMPLETED|Overall Study||385
9956996|NCT01448824|11076141|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9956997|NCT01448824|11076142|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9956998|NCT01448824|11076143|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9956999|NCT01448824|11076144|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9957000|NCT01448824|11076145|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9957001|NCT01448824|11076146|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9957002|NCT01448824|11076147|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
9957003|NCT01448824|11076140|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9957004|NCT01448824|11076141|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9957005|NCT01448824|11076142|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9957090|NCT01449370|11076240|FG005|NOT COMPLETED|Overall Study||3
9889957|NCT01078376|11004987|FG000|STARTED|Overall Study||9
9889958|NCT01078376|11004988|FG001|STARTED|Overall Study||9
9889959|NCT01078376|11004989|FG002|STARTED|Overall Study||8
9889960|NCT01078376|11004990|FG003|STARTED|Overall Study||3
9889961|NCT01078376|11004987|FG000|COMPLETED|Overall Study||9
9889962|NCT01078376|11004988|FG001|COMPLETED|Overall Study||9
9889963|NCT01078376|11004989|FG002|COMPLETED|Overall Study||8
9889964|NCT01078376|11004990|FG003|COMPLETED|Overall Study||3
9889965|NCT01078376|11004987|FG000|NOT COMPLETED|Overall Study||0
9889966|NCT01078376|11004988|FG001|NOT COMPLETED|Overall Study||0
9889967|NCT01078376|11004989|FG002|NOT COMPLETED|Overall Study||0
9889968|NCT01078376|11004990|FG003|NOT COMPLETED|Overall Study||0
9889969|NCT01078389|11005005|FG000|STARTED|Overall Study||157
9889970|NCT01078389|11005006|FG001|STARTED|Overall Study||157
9889971|NCT01078389|11005005|FG000|COMPLETED|Overall Study||93
9889972|NCT01078389|11005006|FG001|COMPLETED|Overall Study||90
9889973|NCT01078389|11005005|FG000|NOT COMPLETED|Overall Study||64
9889974|NCT01078389|11005006|FG001|NOT COMPLETED|Overall Study||67
9889975|NCT01078402|11005015|FG000|STARTED|Overall Study||431
9889976|NCT01078402|11005016|FG001|STARTED|Overall Study||124
9889977|NCT01078402|11005017|FG002|STARTED|Overall Study||234
9889978|NCT01078402|11005015|FG000|COMPLETED|Overall Study||324
9889979|NCT01078402|11005016|FG001|COMPLETED|Overall Study||95
9889980|NCT01078402|11005017|FG002|COMPLETED|Overall Study||166
9889981|NCT01078402|11005015|FG000|NOT COMPLETED|Overall Study||107
9889982|NCT01078402|11005016|FG001|NOT COMPLETED|Overall Study||29
9889983|NCT01078402|11005017|FG002|NOT COMPLETED|Overall Study||68
9889984|NCT01078441|11005029|FG000|STARTED|Overall Study||2
9889985|NCT01078441|11005029|FG000|COMPLETED|Overall Study||1
9889986|NCT01078441|11005029|FG000|NOT COMPLETED|Overall Study||1
9889987|NCT01078545|11005033|FG000|STARTED|Overall Study||729
9889988|NCT01078545|11005033|FG000|Intent-to-treat Population|Overall Study||729
9889989|NCT01078545|11005033|FG000|Per Protocol Population|Overall Study||661
9889990|NCT01078545|11005033|FG000|COMPLETED|Overall Study||703
9889991|NCT01078545|11005033|FG000|NOT COMPLETED|Overall Study||26
9889992|NCT01078558|11005040|FG000|STARTED|Overall Study||2836
9889993|NCT01078558|11005041|FG001|STARTED|Overall Study||1127
9889994|NCT01078558|11005042|FG002|STARTED|Overall Study||1957
9889995|NCT01078558|11005040|FG000|Oligoarticular PsA|Overall Study||0
9889996|NCT01078558|11005041|FG001|Oligoarticular PsA|Overall Study||197
10109300|NCT02474407|11239909|FG001|STARTED|First Intervention (14 Days)||39
10109301|NCT02474407|11239908|FG000|COMPLETED|First Intervention (14 Days)||39
10109302|NCT02474407|11239909|FG001|COMPLETED|First Intervention (14 Days)||39
10109303|NCT02474407|11239908|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10109304|NCT02474407|11239909|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10109305|NCT02474407|11239908|FG000|STARTED|Washout (14 Days)||39
10109306|NCT02474407|11239909|FG001|STARTED|Washout (14 Days)||39
10109307|NCT02474407|11239908|FG000|COMPLETED|Washout (14 Days)||39
10109308|NCT02474407|11239909|FG001|COMPLETED|Washout (14 Days)||39
10109309|NCT02474407|11239908|FG000|NOT COMPLETED|Washout (14 Days)||0
10109310|NCT02474407|11239909|FG001|NOT COMPLETED|Washout (14 Days)||0
10109311|NCT02474407|11239908|FG000|STARTED|Second Intervention (14 Days)||39
10109312|NCT02474407|11239909|FG001|STARTED|Second Intervention (14 Days)||39
10109313|NCT02474407|11239908|FG000|COMPLETED|Second Intervention (14 Days)||39
10109314|NCT02474407|11239909|FG001|COMPLETED|Second Intervention (14 Days)||39
10109315|NCT02474407|11239908|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10109316|NCT02474407|11239909|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10109317|NCT02474498|11239938|FG000|STARTED|Overall Study||13
10109318|NCT02474498|11239939|FG001|STARTED|Overall Study||14
10109319|NCT02474498|11239940|FG002|STARTED|Overall Study||14
10109320|NCT02474498|11239938|FG000|COMPLETED|Overall Study||13
10109321|NCT02474498|11239939|FG001|COMPLETED|Overall Study||14
10109322|NCT02474498|11239940|FG002|COMPLETED|Overall Study||14
10109323|NCT02474498|11239938|FG000|NOT COMPLETED|Overall Study||0
10109324|NCT02474498|11239939|FG001|NOT COMPLETED|Overall Study||0
10109325|NCT02474498|11239940|FG002|NOT COMPLETED|Overall Study||0
10109326|NCT02474589|11239954|FG000|STARTED|Overall Study||359
10109327|NCT02474589|11239955|FG001|STARTED|Overall Study||90
10109328|NCT02474589|11239954|FG000|COMPLETED|Overall Study||334
10109329|NCT02474589|11239955|FG001|COMPLETED|Overall Study||85
10109330|NCT02474589|11239954|FG000|NOT COMPLETED|Overall Study||25
10109331|NCT02474589|11239955|FG001|NOT COMPLETED|Overall Study||5
10109332|NCT02474901|11239963|FG000|STARTED|Overall Study||45
10109333|NCT02474901|11239964|FG001|STARTED|Overall Study||56
10109334|NCT02474901|11239963|FG000|COMPLETED|Overall Study||44
10109335|NCT02474901|11239964|FG001|COMPLETED|Overall Study||56
10109336|NCT02474901|11239963|FG000|NOT COMPLETED|Overall Study||1
9889997|NCT01078558|11005042|FG002|Oligoarticular PsA|Overall Study||0
9889998|NCT01078558|11005040|FG000|COMPLETED|Overall Study||818
9889999|NCT01078558|11005041|FG001|COMPLETED|Overall Study||372
9890000|NCT01078558|11005042|FG002|COMPLETED|Overall Study||596
9890001|NCT01078558|11005040|FG000|NOT COMPLETED|Overall Study||2018
9890002|NCT01078558|11005041|FG001|NOT COMPLETED|Overall Study||755
9890003|NCT01078558|11005042|FG002|NOT COMPLETED|Overall Study||1361
9890004|NCT01078571|11005050|FG000|STARTED|Overall Study||705
9890005|NCT01078571|11005050|FG000|Safety Population|Overall Study||675
9954560|NCT01432405|11073373|FG000|STARTED|Overall Study||12
10109337|NCT02474901|11239964|FG001|NOT COMPLETED|Overall Study||0
10109338|NCT02475031|11239972|FG000|STARTED|Overall Study||35
10109339|NCT02475031|11239973|FG001|STARTED|Overall Study||35
10109340|NCT02475031|11239972|FG000|COMPLETED|Overall Study||35
9890006|NCT01078571|11005050|FG000|Intent-to-treat (ITT) Population|Overall Study||591
9890007|NCT01078571|11005050|FG000|COMPLETED|Overall Study||590
9890008|NCT01078571|11005050|FG000|NOT COMPLETED|Overall Study||115
9890009|NCT01078584|11005059|FG000|STARTED|Overall Study||7993
10008530|NCT01758432|11130910|FG000|COMPLETED|Overall Study||18
10109341|NCT02475031|11239973|FG001|COMPLETED|Overall Study||35
10109342|NCT02475031|11239972|FG000|NOT COMPLETED|Overall Study||0
9890010|NCT01078584|11005059|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125
9890011|NCT01078584|11005059|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833
9890012|NCT01078584|11005059|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983
9890013|NCT01078584|11005059|FG000|COMPLETED|Overall Study||4983
9890014|NCT01078584|11005059|FG000|NOT COMPLETED|Overall Study||3010
9890015|NCT01078623|11005076|FG000|STARTED|Treatment Period 1||6
9890016|NCT01078623|11005077|FG001|STARTED|Treatment Period 1||6
9890017|NCT01078623|11005078|FG002|STARTED|Treatment Period 1||7
9890018|NCT01078623|11005079|FG003|STARTED|Treatment Period 1||6
9890019|NCT01078623|11005080|FG004|STARTED|Treatment Period 1||7
9890020|NCT01078623|11005081|FG005|STARTED|Treatment Period 1||6
9890021|NCT01078623|11005082|FG006|STARTED|Treatment Period 1||7
9890022|NCT01078623|11005083|FG007|STARTED|Treatment Period 1||7
9890023|NCT01078623|11005084|FG008|STARTED|Treatment Period 1||6
9890024|NCT01078623|11005085|FG009|STARTED|Treatment Period 1||7
9890025|NCT01078623|11005086|FG010|STARTED|Treatment Period 1||7
9890026|NCT01078623|11005087|FG011|STARTED|Treatment Period 1||7
9890027|NCT01078623|11005088|FG012|STARTED|Treatment Period 1||7
9890028|NCT01078623|11005089|FG013|STARTED|Treatment Period 1||7
9890029|NCT01078623|11005090|FG014|STARTED|Treatment Period 1||7
9890030|NCT01078623|11005091|FG015|STARTED|Treatment Period 1||7
9890031|NCT01078623|11005092|FG016|STARTED|Treatment Period 1||7
9890032|NCT01078623|11005093|FG017|STARTED|Treatment Period 1||7
9890033|NCT01078623|11005094|FG018|STARTED|Treatment Period 1||7
9890034|NCT01078623|11005095|FG019|STARTED|Treatment Period 1||7
9890035|NCT01078623|11005076|FG000|COMPLETED|Treatment Period 1||5
9890036|NCT01078623|11005077|FG001|COMPLETED|Treatment Period 1||5
9890037|NCT01078623|11005078|FG002|COMPLETED|Treatment Period 1||6
9890038|NCT01078623|11005079|FG003|COMPLETED|Treatment Period 1||6
9890039|NCT01078623|11005080|FG004|COMPLETED|Treatment Period 1||7
9890040|NCT01078623|11005081|FG005|COMPLETED|Treatment Period 1||5
9890041|NCT01078623|11005082|FG006|COMPLETED|Treatment Period 1||6
9890042|NCT01078623|11005083|FG007|COMPLETED|Treatment Period 1||6
9890043|NCT01078623|11005084|FG008|COMPLETED|Treatment Period 1||5
9890044|NCT01078623|11005085|FG009|COMPLETED|Treatment Period 1||6
9890045|NCT01078623|11005086|FG010|COMPLETED|Treatment Period 1||6
9890046|NCT01078623|11005087|FG011|COMPLETED|Treatment Period 1||7
10109343|NCT02475031|11239973|FG001|NOT COMPLETED|Overall Study||0
10109344|NCT02475070|11239983|FG000|STARTED|Overall Study||17
10109345|NCT02475070|11239984|FG001|STARTED|Overall Study||11
10109346|NCT02475070|11239983|FG000|COMPLETED|Overall Study||17
10109347|NCT02475070|11239984|FG001|COMPLETED|Overall Study||11
10109348|NCT02475070|11239983|FG000|NOT COMPLETED|Overall Study||0
10109349|NCT02475070|11239984|FG001|NOT COMPLETED|Overall Study||0
10109350|NCT02475265|11239991|FG000|STARTED|Overall Study||11
10109351|NCT02475265|11239991|FG000|COMPLETED|Overall Study||8
10109352|NCT02475265|11239991|FG000|NOT COMPLETED|Overall Study||3
10109353|NCT02475278|11239995|FG000|STARTED|Overall Study||50
10109354|NCT02475278|11239995|FG000|COMPLETED|Overall Study||48
10109355|NCT02475278|11239995|FG000|NOT COMPLETED|Overall Study||2
9890047|NCT01078623|11005088|FG012|COMPLETED|Treatment Period 1||7
9890048|NCT01078623|11005089|FG013|COMPLETED|Treatment Period 1||7
9890049|NCT01078623|11005090|FG014|COMPLETED|Treatment Period 1||7
9890050|NCT01078623|11005091|FG015|COMPLETED|Treatment Period 1||7
9890051|NCT01078623|11005092|FG016|COMPLETED|Treatment Period 1||7
9890052|NCT01078623|11005093|FG017|COMPLETED|Treatment Period 1||7
10008531|NCT01758432|11130911|FG001|COMPLETED|Overall Study||6
10008532|NCT01758432|11130912|FG002|COMPLETED|Overall Study||6
10008533|NCT01758432|11130913|FG003|COMPLETED|Overall Study||6
10008534|NCT01758432|11130914|FG004|COMPLETED|Overall Study||6
10008535|NCT01758432|11130915|FG005|COMPLETED|Overall Study||6
10008536|NCT01758432|11130916|FG006|COMPLETED|Overall Study||6
10008537|NCT01758432|11130910|FG000|NOT COMPLETED|Overall Study||0
10008538|NCT01758432|11130911|FG001|NOT COMPLETED|Overall Study||0
10008539|NCT01758432|11130912|FG002|NOT COMPLETED|Overall Study||0
10008540|NCT01758432|11130913|FG003|NOT COMPLETED|Overall Study||0
10008541|NCT01758432|11130914|FG004|NOT COMPLETED|Overall Study||0
10008542|NCT01758432|11130915|FG005|NOT COMPLETED|Overall Study||0
10008543|NCT01758432|11130916|FG006|NOT COMPLETED|Overall Study||0
10008544|NCT01758523|11130934|FG000|STARTED|Overall Study||74
10008545|NCT01758523|11130935|FG001|STARTED|Overall Study||68
10008546|NCT01758523|11130934|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68
10008547|NCT01758523|11130935|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67
10008548|NCT01758523|11130934|FG000|COMPLETED|Overall Study||53
10008549|NCT01758523|11130935|FG001|COMPLETED|Overall Study||54
10008550|NCT01758523|11130934|FG000|NOT COMPLETED|Overall Study||21
10008551|NCT01758523|11130935|FG001|NOT COMPLETED|Overall Study||14
10008552|NCT01758588|11130947|FG000|STARTED|Overall Study||5
10008553|NCT01758588|11130948|FG001|STARTED|Overall Study||3
10008554|NCT01758588|11130947|FG000|COMPLETED|Overall Study||5
9890053|NCT01078623|11005094|FG018|COMPLETED|Treatment Period 1||7
9890054|NCT01078623|11005095|FG019|COMPLETED|Treatment Period 1||7
9890055|NCT01078623|11005076|FG000|NOT COMPLETED|Treatment Period 1||1
9890056|NCT01078623|11005077|FG001|NOT COMPLETED|Treatment Period 1||1
9890057|NCT01078623|11005078|FG002|NOT COMPLETED|Treatment Period 1||1
9890058|NCT01078623|11005079|FG003|NOT COMPLETED|Treatment Period 1||0
9890059|NCT01078623|11005080|FG004|NOT COMPLETED|Treatment Period 1||0
9890060|NCT01078623|11005081|FG005|NOT COMPLETED|Treatment Period 1||1
9890061|NCT01078623|11005082|FG006|NOT COMPLETED|Treatment Period 1||1
9890062|NCT01078623|11005083|FG007|NOT COMPLETED|Treatment Period 1||1
9890063|NCT01078623|11005084|FG008|NOT COMPLETED|Treatment Period 1||1
9890064|NCT01078623|11005085|FG009|NOT COMPLETED|Treatment Period 1||1
9890065|NCT01078623|11005086|FG010|NOT COMPLETED|Treatment Period 1||1
9890066|NCT01078623|11005087|FG011|NOT COMPLETED|Treatment Period 1||0
9890067|NCT01078623|11005088|FG012|NOT COMPLETED|Treatment Period 1||0
9890068|NCT01078623|11005089|FG013|NOT COMPLETED|Treatment Period 1||0
9890069|NCT01078623|11005090|FG014|NOT COMPLETED|Treatment Period 1||0
9890070|NCT01078623|11005091|FG015|NOT COMPLETED|Treatment Period 1||0
9890071|NCT01078623|11005092|FG016|NOT COMPLETED|Treatment Period 1||0
9890072|NCT01078623|11005093|FG017|NOT COMPLETED|Treatment Period 1||0
9890073|NCT01078623|11005094|FG018|NOT COMPLETED|Treatment Period 1||0
9890074|NCT01078623|11005095|FG019|NOT COMPLETED|Treatment Period 1||0
9890075|NCT01078623|11005076|FG000|STARTED|Treatment Period 2||5
9890076|NCT01078623|11005077|FG001|STARTED|Treatment Period 2||5
9890077|NCT01078623|11005078|FG002|STARTED|Treatment Period 2||6
9890078|NCT01078623|11005079|FG003|STARTED|Treatment Period 2||6
9890079|NCT01078623|11005080|FG004|STARTED|Treatment Period 2||7
9890080|NCT01078623|11005081|FG005|STARTED|Treatment Period 2||5
9890081|NCT01078623|11005082|FG006|STARTED|Treatment Period 2||6
9890082|NCT01078623|11005083|FG007|STARTED|Treatment Period 2||6
9890083|NCT01078623|11005084|FG008|STARTED|Treatment Period 2||5
9890084|NCT01078623|11005085|FG009|STARTED|Treatment Period 2||6
9890085|NCT01078623|11005086|FG010|STARTED|Treatment Period 2||6
9890086|NCT01078623|11005087|FG011|STARTED|Treatment Period 2||7
9890087|NCT01078623|11005088|FG012|STARTED|Treatment Period 2||7
9890088|NCT01078623|11005089|FG013|STARTED|Treatment Period 2||7
9890089|NCT01078623|11005090|FG014|STARTED|Treatment Period 2||7
9890090|NCT01078623|11005091|FG015|STARTED|Treatment Period 2||7
9890091|NCT01078623|11005092|FG016|STARTED|Treatment Period 2||7
9890092|NCT01078623|11005093|FG017|STARTED|Treatment Period 2||7
9890093|NCT01078623|11005094|FG018|STARTED|Treatment Period 2||7
9890094|NCT01078623|11005095|FG019|STARTED|Treatment Period 2||7
9890095|NCT01078623|11005076|FG000|COMPLETED|Treatment Period 2||5
9890096|NCT01078623|11005077|FG001|COMPLETED|Treatment Period 2||5
9890097|NCT01078623|11005078|FG002|COMPLETED|Treatment Period 2||6
9890098|NCT01078623|11005079|FG003|COMPLETED|Treatment Period 2||6
9890099|NCT01078623|11005080|FG004|COMPLETED|Treatment Period 2||7
9890100|NCT01078623|11005081|FG005|COMPLETED|Treatment Period 2||4
9890101|NCT01078623|11005082|FG006|COMPLETED|Treatment Period 2||5
9890102|NCT01078623|11005083|FG007|COMPLETED|Treatment Period 2||6
9890103|NCT01078623|11005084|FG008|COMPLETED|Treatment Period 2||5
9890104|NCT01078623|11005085|FG009|COMPLETED|Treatment Period 2||6
9890105|NCT01078623|11005086|FG010|COMPLETED|Treatment Period 2||6
9890106|NCT01078623|11005087|FG011|COMPLETED|Treatment Period 2||7
9890107|NCT01078623|11005088|FG012|COMPLETED|Treatment Period 2||7
9890108|NCT01078623|11005089|FG013|COMPLETED|Treatment Period 2||7
9890109|NCT01078623|11005090|FG014|COMPLETED|Treatment Period 2||7
9890110|NCT01078623|11005091|FG015|COMPLETED|Treatment Period 2||7
9890111|NCT01078623|11005092|FG016|COMPLETED|Treatment Period 2||7
9890112|NCT01078623|11005093|FG017|COMPLETED|Treatment Period 2||7
9890113|NCT01078623|11005094|FG018|COMPLETED|Treatment Period 2||6
9890114|NCT01078623|11005095|FG019|COMPLETED|Treatment Period 2||7
9890115|NCT01078623|11005076|FG000|NOT COMPLETED|Treatment Period 2||0
9890116|NCT01078623|11005077|FG001|NOT COMPLETED|Treatment Period 2||0
9890117|NCT01078623|11005078|FG002|NOT COMPLETED|Treatment Period 2||0
9890118|NCT01078623|11005079|FG003|NOT COMPLETED|Treatment Period 2||0
9890119|NCT01078623|11005080|FG004|NOT COMPLETED|Treatment Period 2||0
9890120|NCT01078623|11005081|FG005|NOT COMPLETED|Treatment Period 2||1
9890121|NCT01078623|11005082|FG006|NOT COMPLETED|Treatment Period 2||1
9890122|NCT01078623|11005083|FG007|NOT COMPLETED|Treatment Period 2||0
9890123|NCT01078623|11005084|FG008|NOT COMPLETED|Treatment Period 2||0
9890124|NCT01078623|11005085|FG009|NOT COMPLETED|Treatment Period 2||0
9890125|NCT01078623|11005086|FG010|NOT COMPLETED|Treatment Period 2||0
9890126|NCT01078623|11005087|FG011|NOT COMPLETED|Treatment Period 2||0
9890127|NCT01078623|11005088|FG012|NOT COMPLETED|Treatment Period 2||0
9890128|NCT01078623|11005089|FG013|NOT COMPLETED|Treatment Period 2||0
9890129|NCT01078623|11005090|FG014|NOT COMPLETED|Treatment Period 2||0
9890130|NCT01078623|11005091|FG015|NOT COMPLETED|Treatment Period 2||0
9890131|NCT01078623|11005092|FG016|NOT COMPLETED|Treatment Period 2||0
9890132|NCT01078623|11005093|FG017|NOT COMPLETED|Treatment Period 2||0
9890133|NCT01078623|11005094|FG018|NOT COMPLETED|Treatment Period 2||1
9890134|NCT01078623|11005095|FG019|NOT COMPLETED|Treatment Period 2||0
9890135|NCT01078623|11005076|FG000|STARTED|Treatment Period 3||5
9890136|NCT01078623|11005077|FG001|STARTED|Treatment Period 3||5
9890137|NCT01078623|11005078|FG002|STARTED|Treatment Period 3||6
9890138|NCT01078623|11005079|FG003|STARTED|Treatment Period 3||6
9890139|NCT01078623|11005080|FG004|STARTED|Treatment Period 3||7
9890140|NCT01078623|11005081|FG005|STARTED|Treatment Period 3||4
9890141|NCT01078623|11005082|FG006|STARTED|Treatment Period 3||5
9890142|NCT01078623|11005083|FG007|STARTED|Treatment Period 3||6
9890143|NCT01078623|11005084|FG008|STARTED|Treatment Period 3||5
9890144|NCT01078623|11005085|FG009|STARTED|Treatment Period 3||6
9890145|NCT01078623|11005086|FG010|STARTED|Treatment Period 3||6
9890146|NCT01078623|11005087|FG011|STARTED|Treatment Period 3||7
9890147|NCT01078623|11005088|FG012|STARTED|Treatment Period 3||7
9890148|NCT01078623|11005089|FG013|STARTED|Treatment Period 3||7
9890149|NCT01078623|11005090|FG014|STARTED|Treatment Period 3||7
9890150|NCT01078623|11005091|FG015|STARTED|Treatment Period 3||7
9890151|NCT01078623|11005092|FG016|STARTED|Treatment Period 3||7
9890152|NCT01078623|11005093|FG017|STARTED|Treatment Period 3||7
9890153|NCT01078623|11005094|FG018|STARTED|Treatment Period 3||6
9890154|NCT01078623|11005095|FG019|STARTED|Treatment Period 3||7
9890155|NCT01078623|11005076|FG000|COMPLETED|Treatment Period 3||5
9890156|NCT01078623|11005077|FG001|COMPLETED|Treatment Period 3||5
9890157|NCT01078623|11005078|FG002|COMPLETED|Treatment Period 3||6
9890158|NCT01078623|11005079|FG003|COMPLETED|Treatment Period 3||6
9890159|NCT01078623|11005080|FG004|COMPLETED|Treatment Period 3||6
9890160|NCT01078623|11005081|FG005|COMPLETED|Treatment Period 3||4
9890161|NCT01078623|11005082|FG006|COMPLETED|Treatment Period 3||5
9890162|NCT01078623|11005083|FG007|COMPLETED|Treatment Period 3||6
9890163|NCT01078623|11005084|FG008|COMPLETED|Treatment Period 3||5
9890164|NCT01078623|11005085|FG009|COMPLETED|Treatment Period 3||6
9890165|NCT01078623|11005086|FG010|COMPLETED|Treatment Period 3||6
9890166|NCT01078623|11005087|FG011|COMPLETED|Treatment Period 3||7
9890167|NCT01078623|11005088|FG012|COMPLETED|Treatment Period 3||7
9890168|NCT01078623|11005089|FG013|COMPLETED|Treatment Period 3||6
9890169|NCT01078623|11005090|FG014|COMPLETED|Treatment Period 3||7
9890170|NCT01078623|11005091|FG015|COMPLETED|Treatment Period 3||7
9890171|NCT01078623|11005092|FG016|COMPLETED|Treatment Period 3||7
10109356|NCT02475369|11239999|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10
10109357|NCT02475369|11240000|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11
10109358|NCT02475369|11239999|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3
10109359|NCT02475369|11240000|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9
10109360|NCT02475369|11239999|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
10109361|NCT02475369|11240000|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
10109362|NCT02475369|11239999|FG000|STARTED|Treatment Period #1 (10 Days)||3
10109363|NCT02475369|11240000|FG001|STARTED|Treatment Period #1 (10 Days)||9
10109364|NCT02475369|11239999|FG000|COMPLETED|Treatment Period #1 (10 Days)||3
10109365|NCT02475369|11240000|FG001|COMPLETED|Treatment Period #1 (10 Days)||9
10109366|NCT02475369|11239999|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0
10109367|NCT02475369|11240000|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0
10109368|NCT02475369|11239999|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3
10109369|NCT02475369|11240000|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9
10202828|NCT03451084|11329956|FG001|NOT COMPLETED|Overall Study||6
10202829|NCT03451084|11329957|FG002|NOT COMPLETED|Overall Study||6
10202830|NCT03451084|11329958|FG003|NOT COMPLETED|Overall Study||6
10202831|NCT03451721|11329968|FG000|STARTED|Overall Study||20
10202832|NCT03451721|11329968|FG000|COMPLETED|Overall Study||19
10202833|NCT03451721|11329968|FG000|NOT COMPLETED|Overall Study||1
10202834|NCT03451773|11329974|FG000|STARTED|Overall Study||1
10202835|NCT03451773|11329975|FG001|STARTED|Overall Study||6
10202836|NCT03451773|11329974|FG000|COMPLETED|Overall Study||0
10202837|NCT03451773|11329975|FG001|COMPLETED|Overall Study||0
10202838|NCT03451773|11329974|FG000|NOT COMPLETED|Overall Study||1
10202839|NCT03451773|11329975|FG001|NOT COMPLETED|Overall Study||6
10202840|NCT03452033|11329986|FG000|STARTED|Overall Study||21
10202841|NCT03452033|11329987|FG001|STARTED|Overall Study||22
10202842|NCT03452033|11329988|FG002|STARTED|Overall Study||22
10202843|NCT03452033|11329989|FG003|STARTED|Overall Study||22
10202844|NCT03452033|11329986|FG000|COMPLETED|Overall Study||21
10202845|NCT03452033|11329987|FG001|COMPLETED|Overall Study||22
10202846|NCT03452033|11329988|FG002|COMPLETED|Overall Study||22
10202847|NCT03452033|11329989|FG003|COMPLETED|Overall Study||22
10202848|NCT03452033|11329986|FG000|NOT COMPLETED|Overall Study||0
10202849|NCT03452033|11329987|FG001|NOT COMPLETED|Overall Study||0
10202850|NCT03452033|11329988|FG002|NOT COMPLETED|Overall Study||0
10202851|NCT03452033|11329989|FG003|NOT COMPLETED|Overall Study||0
10202852|NCT03452176|11330004|FG000|STARTED|Overall Study||11
10202853|NCT03452176|11330005|FG001|STARTED|Overall Study||11
10202854|NCT03452176|11330004|FG000|COMPLETED|Overall Study||11
10202855|NCT03452176|11330005|FG001|COMPLETED|Overall Study||11
10202856|NCT03452176|11330004|FG000|NOT COMPLETED|Overall Study||0
10202857|NCT03452176|11330005|FG001|NOT COMPLETED|Overall Study||0
10202858|NCT03452189|11330019|FG000|STARTED|First Intervention (3 Months)||10
10202859|NCT03452189|11330020|FG001|STARTED|First Intervention (3 Months)||5
10202860|NCT03452189|11330019|FG000|COMPLETED|First Intervention (3 Months)||5
10202861|NCT03452189|11330020|FG001|COMPLETED|First Intervention (3 Months)||5
10202862|NCT03452189|11330019|FG000|NOT COMPLETED|First Intervention (3 Months)||5
10202863|NCT03452189|11330020|FG001|NOT COMPLETED|First Intervention (3 Months)||0
9890172|NCT01078623|11005093|FG017|COMPLETED|Treatment Period 3||7
10113394|NCT02509117|11244190|FG000|STARTED|Period 3 -Part A: 4 Days||2
10202864|NCT03452189|11330019|FG000|STARTED|Intervention 2 (3 Months)||5
10202865|NCT03452189|11330020|FG001|STARTED|Intervention 2 (3 Months)||5
10202866|NCT03452189|11330019|FG000|COMPLETED|Intervention 2 (3 Months)||5
10202867|NCT03452189|11330020|FG001|COMPLETED|Intervention 2 (3 Months)||5
10202868|NCT03452189|11330019|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0
9890173|NCT01078623|11005094|FG018|COMPLETED|Treatment Period 3||6
9890174|NCT01078623|11005095|FG019|COMPLETED|Treatment Period 3||7
9890175|NCT01078623|11005076|FG000|NOT COMPLETED|Treatment Period 3||0
9890176|NCT01078623|11005077|FG001|NOT COMPLETED|Treatment Period 3||0
9890177|NCT01078623|11005078|FG002|NOT COMPLETED|Treatment Period 3||0
9890178|NCT01078623|11005079|FG003|NOT COMPLETED|Treatment Period 3||0
9890179|NCT01078623|11005080|FG004|NOT COMPLETED|Treatment Period 3||1
9890180|NCT01078623|11005081|FG005|NOT COMPLETED|Treatment Period 3||0
9890181|NCT01078623|11005082|FG006|NOT COMPLETED|Treatment Period 3||0
9890182|NCT01078623|11005083|FG007|NOT COMPLETED|Treatment Period 3||0
9890183|NCT01078623|11005084|FG008|NOT COMPLETED|Treatment Period 3||0
9890184|NCT01078623|11005085|FG009|NOT COMPLETED|Treatment Period 3||0
9890185|NCT01078623|11005086|FG010|NOT COMPLETED|Treatment Period 3||0
9890186|NCT01078623|11005087|FG011|NOT COMPLETED|Treatment Period 3||0
9890187|NCT01078623|11005088|FG012|NOT COMPLETED|Treatment Period 3||0
9890188|NCT01078623|11005089|FG013|NOT COMPLETED|Treatment Period 3||1
9890189|NCT01078623|11005090|FG014|NOT COMPLETED|Treatment Period 3||0
9890190|NCT01078623|11005091|FG015|NOT COMPLETED|Treatment Period 3||0
9890191|NCT01078623|11005092|FG016|NOT COMPLETED|Treatment Period 3||0
9890192|NCT01078623|11005093|FG017|NOT COMPLETED|Treatment Period 3||0
9890193|NCT01078623|11005094|FG018|NOT COMPLETED|Treatment Period 3||0
9890194|NCT01078623|11005095|FG019|NOT COMPLETED|Treatment Period 3||0
9890195|NCT01078623|11005076|FG000|STARTED|Treatment Period 4||5
9890196|NCT01078623|11005077|FG001|STARTED|Treatment Period 4||5
9890197|NCT01078623|11005078|FG002|STARTED|Treatment Period 4||6
9890198|NCT01078623|11005079|FG003|STARTED|Treatment Period 4||6
9890199|NCT01078623|11005080|FG004|STARTED|Treatment Period 4||6
9890200|NCT01078623|11005081|FG005|STARTED|Treatment Period 4||4
9890201|NCT01078623|11005082|FG006|STARTED|Treatment Period 4||5
9890202|NCT01078623|11005083|FG007|STARTED|Treatment Period 4||6
9890203|NCT01078623|11005084|FG008|STARTED|Treatment Period 4||5
9890204|NCT01078623|11005085|FG009|STARTED|Treatment Period 4||6
9890205|NCT01078623|11005086|FG010|STARTED|Treatment Period 4||6
9890206|NCT01078623|11005087|FG011|STARTED|Treatment Period 4||7
9890207|NCT01078623|11005088|FG012|STARTED|Treatment Period 4||7
9890208|NCT01078623|11005089|FG013|STARTED|Treatment Period 4||6
9890209|NCT01078623|11005090|FG014|STARTED|Treatment Period 4||7
9890210|NCT01078623|11005091|FG015|STARTED|Treatment Period 4||7
9890211|NCT01078623|11005092|FG016|STARTED|Treatment Period 4||7
9890212|NCT01078623|11005093|FG017|STARTED|Treatment Period 4||7
9890213|NCT01078623|11005094|FG018|STARTED|Treatment Period 4||6
9890214|NCT01078623|11005095|FG019|STARTED|Treatment Period 4||7
9890215|NCT01078623|11005076|FG000|COMPLETED|Treatment Period 4||5
9890216|NCT01078623|11005077|FG001|COMPLETED|Treatment Period 4||5
9890217|NCT01078623|11005078|FG002|COMPLETED|Treatment Period 4||5
9890218|NCT01078623|11005079|FG003|COMPLETED|Treatment Period 4||6
9890219|NCT01078623|11005080|FG004|COMPLETED|Treatment Period 4||6
9890220|NCT01078623|11005081|FG005|COMPLETED|Treatment Period 4||4
9890221|NCT01078623|11005082|FG006|COMPLETED|Treatment Period 4||5
9890222|NCT01078623|11005083|FG007|COMPLETED|Treatment Period 4||6
9890223|NCT01078623|11005084|FG008|COMPLETED|Treatment Period 4||5
9890224|NCT01078623|11005085|FG009|COMPLETED|Treatment Period 4||6
9890225|NCT01078623|11005086|FG010|COMPLETED|Treatment Period 4||6
9890226|NCT01078623|11005087|FG011|COMPLETED|Treatment Period 4||7
9890227|NCT01078623|11005088|FG012|COMPLETED|Treatment Period 4||7
9890228|NCT01078623|11005089|FG013|COMPLETED|Treatment Period 4||6
9890229|NCT01078623|11005090|FG014|COMPLETED|Treatment Period 4||7
9890230|NCT01078623|11005091|FG015|COMPLETED|Treatment Period 4||6
9890231|NCT01078623|11005092|FG016|COMPLETED|Treatment Period 4||7
9890232|NCT01078623|11005093|FG017|COMPLETED|Treatment Period 4||7
9890233|NCT01078623|11005094|FG018|COMPLETED|Treatment Period 4||6
9890234|NCT01078623|11005095|FG019|COMPLETED|Treatment Period 4||7
9890235|NCT01078623|11005076|FG000|NOT COMPLETED|Treatment Period 4||0
9890236|NCT01078623|11005077|FG001|NOT COMPLETED|Treatment Period 4||0
9890237|NCT01078623|11005078|FG002|NOT COMPLETED|Treatment Period 4||1
9890238|NCT01078623|11005079|FG003|NOT COMPLETED|Treatment Period 4||0
9890239|NCT01078623|11005080|FG004|NOT COMPLETED|Treatment Period 4||0
10109370|NCT02475369|11239999|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3
10109371|NCT02475369|11240000|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9
10109372|NCT02475369|11239999|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
10109373|NCT02475369|11240000|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
10109374|NCT02475369|11239999|FG000|STARTED|Treatment Period #2 (10 Days)||3
10109375|NCT02475369|11240000|FG001|STARTED|Treatment Period #2 (10 Days)||9
10109376|NCT02475369|11239999|FG000|COMPLETED|Treatment Period #2 (10 Days)||3
10109377|NCT02475369|11240000|FG001|COMPLETED|Treatment Period #2 (10 Days)||9
10109378|NCT02475369|11239999|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0
10109379|NCT02475369|11240000|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0
10109380|NCT02475395|11240013|FG000|STARTED|Overall Study||258
9890240|NCT01078623|11005081|FG005|NOT COMPLETED|Treatment Period 4||0
9890241|NCT01078623|11005082|FG006|NOT COMPLETED|Treatment Period 4||0
9890242|NCT01078623|11005083|FG007|NOT COMPLETED|Treatment Period 4||0
9890243|NCT01078623|11005084|FG008|NOT COMPLETED|Treatment Period 4||0
9890244|NCT01078623|11005085|FG009|NOT COMPLETED|Treatment Period 4||0
9890245|NCT01078623|11005086|FG010|NOT COMPLETED|Treatment Period 4||0
9890246|NCT01078623|11005087|FG011|NOT COMPLETED|Treatment Period 4||0
9890247|NCT01078623|11005088|FG012|NOT COMPLETED|Treatment Period 4||0
10109381|NCT02475395|11240014|FG001|STARTED|Overall Study||14
9890248|NCT01078623|11005089|FG013|NOT COMPLETED|Treatment Period 4||0
9890249|NCT01078623|11005090|FG014|NOT COMPLETED|Treatment Period 4||0
9890250|NCT01078623|11005091|FG015|NOT COMPLETED|Treatment Period 4||1
9890251|NCT01078623|11005092|FG016|NOT COMPLETED|Treatment Period 4||0
9890252|NCT01078623|11005093|FG017|NOT COMPLETED|Treatment Period 4||0
9890253|NCT01078623|11005094|FG018|NOT COMPLETED|Treatment Period 4||0
9890254|NCT01078623|11005095|FG019|NOT COMPLETED|Treatment Period 4||0
9890255|NCT01078675|11005109|FG000|STARTED|Overall Study||250
9890256|NCT01078675|11005110|FG001|STARTED|Overall Study||65
9890257|NCT01078675|11005109|FG000|Patients Treated|Overall Study||198
9890258|NCT01078675|11005110|FG001|Patients Treated|Overall Study||0
9890259|NCT01078675|11005109|FG000|COMPLETED|Overall Study||182
9890260|NCT01078675|11005110|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
9890261|NCT01078675|11005109|FG000|NOT COMPLETED|Overall Study||68
9890262|NCT01078675|11005110|FG001|NOT COMPLETED|Overall Study||6
9890263|NCT01078753|11005118|FG000|STARTED|Treatment Period I||45
9890264|NCT01078753|11005119|FG001|STARTED|Treatment Period I||44
9890265|NCT01078753|11005118|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
9890266|NCT01078753|11005119|FG001|Full Analysis Set|Treatment Period I||44
9890267|NCT01078753|11005118|FG000|COMPLETED|Treatment Period I||45
9890268|NCT01078753|11005119|FG001|COMPLETED|Treatment Period I||44
9890269|NCT01078753|11005118|FG000|NOT COMPLETED|Treatment Period I||0
9890270|NCT01078753|11005119|FG001|NOT COMPLETED|Treatment Period I||0
9890271|NCT01078753|11005118|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
9890272|NCT01078753|11005119|FG001|STARTED|Treatment Period II||44
9890273|NCT01078753|11005118|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
9890274|NCT01078753|11005119|FG001|Full Analysis Set|Treatment Period II||44
9890275|NCT01078753|11005118|FG000|COMPLETED|Treatment Period II||45
9890276|NCT01078753|11005119|FG001|COMPLETED|Treatment Period II||44
9890277|NCT01078753|11005118|FG000|NOT COMPLETED|Treatment Period II||0
9890278|NCT01078753|11005119|FG001|NOT COMPLETED|Treatment Period II||0
9890279|NCT01078805|11005125|FG000|STARTED|Overall Study||4167
9890280|NCT01078805|11005125|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085
9890281|NCT01078805|11005125|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
9890282|NCT01078805|11005125|FG000|COMPLETED|Overall Study||2117
9890283|NCT01078805|11005125|FG000|NOT COMPLETED|Overall Study||2050
9890284|NCT01078909|11005134|FG000|STARTED|Overall Study||25
9890285|NCT01078909|11005135|FG001|STARTED|Overall Study||25
9890286|NCT01078909|11005136|FG002|STARTED|Overall Study||25
10109382|NCT02475395|11240013|FG000|COMPLETED|Overall Study||228
10109383|NCT02475395|11240014|FG001|COMPLETED|Overall Study||11
10109384|NCT02475395|11240013|FG000|NOT COMPLETED|Overall Study||30
10109385|NCT02475395|11240014|FG001|NOT COMPLETED|Overall Study||3
10109386|NCT02475564|11240022|FG000|STARTED|Overall Study||22
10109387|NCT02475564|11240023|FG001|STARTED|Overall Study||22
10109388|NCT02475564|11240022|FG000|COMPLETED|Overall Study||18
10109389|NCT02475564|11240023|FG001|COMPLETED|Overall Study||21
10109390|NCT02475564|11240022|FG000|NOT COMPLETED|Overall Study||4
10109391|NCT02475564|11240023|FG001|NOT COMPLETED|Overall Study||1
10109392|NCT02475629|11240029|FG000|STARTED|Overall Study||40
10109393|NCT02475629|11240029|FG000|COMPLETED|Overall Study||31
10109394|NCT02475629|11240029|FG000|NOT COMPLETED|Overall Study||9
10109395|NCT02475655|11240035|FG000|STARTED|Overall Study||40
10109396|NCT02475655|11240036|FG001|STARTED|Overall Study||20
10109397|NCT02475655|11240035|FG000|COMPLETED|Overall Study||40
10109398|NCT02475655|11240036|FG001|COMPLETED|Overall Study||19
10109399|NCT02475655|11240035|FG000|NOT COMPLETED|Overall Study||0
10109400|NCT02475655|11240036|FG001|NOT COMPLETED|Overall Study||1
10109401|NCT02475733|11240044|FG000|STARTED|Overall Study||61
10109402|NCT02475733|11240045|FG001|STARTED|Overall Study||22
10109403|NCT02475733|11240044|FG000|COMPLETED|Overall Study||59
10109404|NCT02475733|11240045|FG001|COMPLETED|Overall Study||22
10109405|NCT02475733|11240044|FG000|NOT COMPLETED|Overall Study||2
10109406|NCT02475733|11240045|FG001|NOT COMPLETED|Overall Study||0
10109407|NCT02475837|11240053|FG000|STARTED|Overall Study||6
10109408|NCT02475837|11240054|FG001|STARTED|Overall Study||7
10109409|NCT02475837|11240053|FG000|COMPLETED|Overall Study||6
10109410|NCT02475837|11240054|FG001|COMPLETED|Overall Study||7
10109411|NCT02475837|11240053|FG000|NOT COMPLETED|Overall Study||0
10109412|NCT02475837|11240054|FG001|NOT COMPLETED|Overall Study||0
10109413|NCT02475850|11240062|FG000|STARTED|Overall Study||2802
10109414|NCT02475850|11240063|FG001|STARTED|Overall Study||2649
10109415|NCT02475850|11240062|FG000|COMPLETED|Overall Study||2209
9890287|NCT01078909|11005137|FG003|STARTED|Overall Study||25
9890288|NCT01078909|11005138|FG004|STARTED|Overall Study||25
9890289|NCT01078909|11005134|FG000|COMPLETED|Overall Study||23
9890290|NCT01078909|11005135|FG001|COMPLETED|Overall Study||21
9890291|NCT01078909|11005136|FG002|COMPLETED|Overall Study||24
9890292|NCT01078909|11005137|FG003|COMPLETED|Overall Study||24
10109416|NCT02475850|11240063|FG001|COMPLETED|Overall Study||2165
10109417|NCT02475850|11240062|FG000|NOT COMPLETED|Overall Study||593
10109418|NCT02475850|11240063|FG001|NOT COMPLETED|Overall Study||484
10109419|NCT02475954|11240072|FG000|STARTED|Overall Study||87
10109420|NCT02475954|11240073|FG001|STARTED|Overall Study||87
10109421|NCT02475954|11240072|FG000|COMPLETED|Overall Study||73
10109422|NCT02475954|11240073|FG001|COMPLETED|Overall Study||75
10008555|NCT01758588|11130948|FG001|COMPLETED|Overall Study||3
10008556|NCT01758588|11130947|FG000|NOT COMPLETED|Overall Study||0
10008557|NCT01758588|11130948|FG001|NOT COMPLETED|Overall Study||0
10008558|NCT01758731|11130956|FG000|STARTED|Overall Study||17
10008559|NCT01758731|11130956|FG000|COMPLETED|Overall Study||16
10008560|NCT01758731|11130956|FG000|NOT COMPLETED|Overall Study||1
10008561|NCT01758900|11130962|FG000|STARTED|Overall Study||106
10109423|NCT02475954|11240072|FG000|NOT COMPLETED|Overall Study||14
9890293|NCT01078909|11005138|FG004|COMPLETED|Overall Study||23
9890294|NCT01078909|11005134|FG000|NOT COMPLETED|Overall Study||2
9890295|NCT01078909|11005135|FG001|NOT COMPLETED|Overall Study||4
9890296|NCT01078909|11005136|FG002|NOT COMPLETED|Overall Study||1
9890297|NCT01078909|11005137|FG003|NOT COMPLETED|Overall Study||1
9890298|NCT01078909|11005138|FG004|NOT COMPLETED|Overall Study||2
9890299|NCT01078922|11005150|FG000|STARTED|Overall Study||11
9890300|NCT01078922|11005150|FG000|COMPLETED|Overall Study||10
9890301|NCT01078922|11005150|FG000|NOT COMPLETED|Overall Study||1
9890302|NCT01078974|11005155|FG000|STARTED|Overall Study||7
9890303|NCT01078974|11005155|FG000|COMPLETED|Overall Study||4
9890304|NCT01078974|11005155|FG000|NOT COMPLETED|Overall Study||3
9890305|NCT01079130|11005165|FG000|STARTED|Overall Study||85
9890306|NCT01079130|11005166|FG001|STARTED|Overall Study||85
9890307|NCT01079130|11005167|FG002|STARTED|Overall Study||84
9890308|NCT01079130|11005168|FG003|STARTED|Overall Study||86
9890309|NCT01079130|11005169|FG004|STARTED|Overall Study||86
9890310|NCT01079130|11005170|FG005|STARTED|Overall Study||85
9890311|NCT01079130|11005165|FG000|Safety Set: Received Study Drug|Overall Study||84
9890312|NCT01079130|11005166|FG001|Safety Set: Received Study Drug|Overall Study||81
9890313|NCT01079130|11005167|FG002|Safety Set: Received Study Drug|Overall Study||84
9890314|NCT01079130|11005168|FG003|Safety Set: Received Study Drug|Overall Study||85
9890315|NCT01079130|11005169|FG004|Safety Set: Received Study Drug|Overall Study||84
9890316|NCT01079130|11005170|FG005|Safety Set: Received Study Drug|Overall Study||84
9890317|NCT01079130|11005165|FG000|Full Analysis Set (FAS)|Overall Study||84
9890318|NCT01079130|11005166|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
9890319|NCT01079130|11005167|FG002|Full Analysis Set (FAS)|Overall Study||83
9890320|NCT01079130|11005168|FG003|Full Analysis Set (FAS)|Overall Study||85
9890321|NCT01079130|11005169|FG004|Full Analysis Set (FAS)|Overall Study||84
9890322|NCT01079130|11005170|FG005|Full Analysis Set (FAS)|Overall Study||84
9890323|NCT01079130|11005165|FG000|COMPLETED|Overall Study||83
9890324|NCT01079130|11005166|FG001|COMPLETED|Overall Study||78
9890325|NCT01079130|11005167|FG002|COMPLETED|Overall Study||83
9890326|NCT01079130|11005168|FG003|COMPLETED|Overall Study||81
9890327|NCT01079130|11005169|FG004|COMPLETED|Overall Study||78
9890328|NCT01079130|11005170|FG005|COMPLETED|Overall Study||80
9890329|NCT01079130|11005165|FG000|NOT COMPLETED|Overall Study||2
9890330|NCT01079130|11005166|FG001|NOT COMPLETED|Overall Study||7
9890331|NCT01079130|11005167|FG002|NOT COMPLETED|Overall Study||1
9890332|NCT01079130|11005168|FG003|NOT COMPLETED|Overall Study||5
9890333|NCT01079130|11005169|FG004|NOT COMPLETED|Overall Study||8
9890334|NCT01079130|11005170|FG005|NOT COMPLETED|Overall Study||5
9890335|NCT01079143|11005188|FG000|STARTED|Overall Study||36
9890336|NCT01079143|11005189|FG001|STARTED|Overall Study||60
9890337|NCT01079143|11005190|FG002|STARTED|Overall Study||39
9890338|NCT01079143|11005191|FG003|STARTED|Overall Study||59
9890339|NCT01079143|11005188|FG000|Exposed|Overall Study||36
9890340|NCT01079143|11005189|FG001|Exposed|Overall Study||60
9890341|NCT01079143|11005190|FG002|Exposed|Overall Study||39
9890342|NCT01079143|11005191|FG003|Exposed|Overall Study||59
9890343|NCT01079143|11005188|FG000|Month 3 (M3) Biopsies|Overall Study||36
9890344|NCT01079143|11005189|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
9890345|NCT01079143|11005190|FG002|Month 3 (M3) Biopsies|Overall Study||39
9890346|NCT01079143|11005191|FG003|Month 3 (M3) Biopsies|Overall Study||59
9890347|NCT01079143|11005188|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
9890348|NCT01079143|11005189|FG001|Month 12 (M12) Biopsies|Overall Study||43
9890349|NCT01079143|11005190|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
9890350|NCT01079143|11005191|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
9890351|NCT01079143|11005188|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
9890352|NCT01079143|11005189|FG001|M3 and M12 Biopsies|Overall Study||43
9890353|NCT01079143|11005190|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
9890354|NCT01079143|11005191|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
9890355|NCT01079143|11005188|FG000|COMPLETED|Overall Study||27
9890356|NCT01079143|11005189|FG001|COMPLETED|Overall Study||43
9890357|NCT01079143|11005190|FG002|COMPLETED|Overall Study||34
9890358|NCT01079143|11005191|FG003|COMPLETED|Overall Study||54
9890359|NCT01079143|11005188|FG000|NOT COMPLETED|Overall Study||9
10008562|NCT01758900|11130963|FG001|STARTED|Overall Study||108
10008563|NCT01758900|11130962|FG000|COMPLETED|Overall Study||99
10008564|NCT01758900|11130963|FG001|COMPLETED|Overall Study||100
10008565|NCT01758900|11130962|FG000|NOT COMPLETED|Overall Study||7
10008566|NCT01758900|11130963|FG001|NOT COMPLETED|Overall Study||8
9890360|NCT01079143|11005189|FG001|NOT COMPLETED|Overall Study||17
9890361|NCT01079143|11005190|FG002|NOT COMPLETED|Overall Study||5
9890362|NCT01079143|11005191|FG003|NOT COMPLETED|Overall Study||5
9890363|NCT01079182|11005205|FG000|STARTED|Overall Study||4681
9890364|NCT01079182|11005205|FG000|COMPLETED|Overall Study||1962
9890365|NCT01079182|11005205|FG000|NOT COMPLETED|Overall Study||2719
9890366|NCT01079195|11005209|FG000|STARTED|Overall Study||15873
9890367|NCT01079195|11005209|FG000|COMPLETED|Overall Study||14442
9890368|NCT01079195|11005209|FG000|NOT COMPLETED|Overall Study||1431
9890369|NCT01079234|11005216|FG000|STARTED|Main: Week 0 to 26||164
9890370|NCT01079234|11005217|FG001|STARTED|Main: Week 0 to 26||165
9890371|NCT01079234|11005218|FG002|STARTED|Main: Week 0 to 26||164
9890372|NCT01079234|11005219|FG003|STARTED|Main: Week 0 to 26||0
9890373|NCT01079234|11005216|FG000|Exposed|Main: Week 0 to 26||164
9890374|NCT01079234|11005217|FG001|Exposed|Main: Week 0 to 26||165
9890375|NCT01079234|11005218|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
9890376|NCT01079234|11005219|FG003|Exposed|Main: Week 0 to 26||0
9890377|NCT01079234|11005216|FG000|COMPLETED|Main: Week 0 to 26||138
9890378|NCT01079234|11005217|FG001|COMPLETED|Main: Week 0 to 26||139
9890379|NCT01079234|11005218|FG002|COMPLETED|Main: Week 0 to 26||152
9890380|NCT01079234|11005219|FG003|COMPLETED|Main: Week 0 to 26||0
9890381|NCT01079234|11005216|FG000|NOT COMPLETED|Main: Week 0 to 26||26
9890382|NCT01079234|11005217|FG001|NOT COMPLETED|Main: Week 0 to 26||26
9890383|NCT01079234|11005218|FG002|NOT COMPLETED|Main: Week 0 to 26||12
9890384|NCT01079234|11005219|FG003|NOT COMPLETED|Main: Week 0 to 26||0
9890385|NCT01079234|11005216|FG000|STARTED|Extension: Week 27 to 52||0
9890386|NCT01079234|11005217|FG001|STARTED|Extension: Week 27 to 52||0
9890387|NCT01079234|11005218|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
9890388|NCT01079234|11005219|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
9890389|NCT01079234|11005216|FG000|COMPLETED|Extension: Week 27 to 52||0
9890390|NCT01079234|11005217|FG001|COMPLETED|Extension: Week 27 to 52||0
9890391|NCT01079234|11005218|FG002|COMPLETED|Extension: Week 27 to 52||122
9890392|NCT01079234|11005219|FG003|COMPLETED|Extension: Week 27 to 52||223
9890393|NCT01079234|11005216|FG000|NOT COMPLETED|Extension: Week 27 to 52||0
9890394|NCT01079234|11005217|FG001|NOT COMPLETED|Extension: Week 27 to 52||0
9890395|NCT01079234|11005218|FG002|NOT COMPLETED|Extension: Week 27 to 52||11
9890396|NCT01079234|11005219|FG003|NOT COMPLETED|Extension: Week 27 to 52||16
10109424|NCT02475954|11240073|FG001|NOT COMPLETED|Overall Study||12
10109425|NCT02475980|11240080|FG000|STARTED|Overall Study||13
10109426|NCT02475980|11240080|FG000|COMPLETED|Overall Study||8
10109427|NCT02475980|11240080|FG000|NOT COMPLETED|Overall Study||5
10109428|NCT02476032|11240087|FG000|STARTED|Overall Study||20
10109429|NCT02476032|11240088|FG001|STARTED|Overall Study||20
10109430|NCT02476032|11240089|FG002|STARTED|Overall Study||20
10109431|NCT02476032|11240087|FG000|COMPLETED|Overall Study||20
10109432|NCT02476032|11240088|FG001|COMPLETED|Overall Study||19
10109433|NCT02476032|11240089|FG002|COMPLETED|Overall Study||19
10109434|NCT02476032|11240087|FG000|NOT COMPLETED|Overall Study||0
10109435|NCT02476032|11240088|FG001|NOT COMPLETED|Overall Study||1
10109436|NCT02476032|11240089|FG002|NOT COMPLETED|Overall Study||1
10109437|NCT02476175|11240100|FG000|STARTED|Overall Study||35
10109438|NCT02476175|11240100|FG000|COMPLETED|Overall Study||33
10109439|NCT02476175|11240100|FG000|NOT COMPLETED|Overall Study||2
10109440|NCT02476357|11240106|FG000|STARTED|Overall Study||40
10109441|NCT02476357|11240107|FG001|STARTED|Overall Study||40
10109442|NCT02476357|11240106|FG000|COMPLETED|Overall Study||40
10109443|NCT02476357|11240107|FG001|COMPLETED|Overall Study||40
10109444|NCT02476357|11240106|FG000|NOT COMPLETED|Overall Study||0
10109445|NCT02476357|11240107|FG001|NOT COMPLETED|Overall Study||0
10109446|NCT02476422|11240117|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
10109447|NCT02476422|11240118|FG001|STARTED|Overall Study||162
10109448|NCT02476422|11240117|FG000|COMPLETED|Overall Study||166
10109449|NCT02476422|11240118|FG001|COMPLETED|Overall Study||161
10109450|NCT02476422|11240117|FG000|NOT COMPLETED|Overall Study||0
10109451|NCT02476422|11240118|FG001|NOT COMPLETED|Overall Study||1
10109452|NCT02476448|11240128|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
10109453|NCT02476448|11240129|FG001|STARTED|Overall Study||44
10109454|NCT02476448|11240130|FG002|STARTED|Overall Study||44
10109455|NCT02476448|11240131|FG003|STARTED|Overall Study||44
10109456|NCT02476448|11240128|FG000|COMPLETED|Overall Study||44
10109457|NCT02476448|11240129|FG001|COMPLETED|Overall Study||44
10109458|NCT02476448|11240130|FG002|COMPLETED|Overall Study||44
10109459|NCT02476448|11240131|FG003|COMPLETED|Overall Study||44
10109460|NCT02476448|11240128|FG000|NOT COMPLETED|Overall Study||0
10109461|NCT02476448|11240129|FG001|NOT COMPLETED|Overall Study||0
10109462|NCT02476448|11240130|FG002|NOT COMPLETED|Overall Study||0
10109463|NCT02476448|11240131|FG003|NOT COMPLETED|Overall Study||0
10109464|NCT02476565|11240143|FG000|STARTED|Overall Study||20
10109465|NCT02476565|11240144|FG001|STARTED|Overall Study||19
10109466|NCT02476565|11240143|FG000|COMPLETED|Overall Study||20
10109467|NCT02476565|11240144|FG001|COMPLETED|Overall Study||19
9890397|NCT01079299|11005230|FG000|STARTED|Overall Study||27
9890398|NCT01079299|11005231|FG001|STARTED|Overall Study||25
10109468|NCT02476565|11240143|FG000|NOT COMPLETED|Overall Study||0
10109469|NCT02476565|11240144|FG001|NOT COMPLETED|Overall Study||0
10109470|NCT02476578|11240152|FG000|STARTED|Overall Study||4310
9890399|NCT01079299|11005230|FG000|COMPLETED|Overall Study||27
10008567|NCT01759160|11130971|FG000|STARTED|Overall Study||30
10008568|NCT01759160|11130972|FG001|STARTED|Overall Study||30
10008569|NCT01759160|11130971|FG000|COMPLETED|Overall Study||30
9890400|NCT01079299|11005231|FG001|COMPLETED|Overall Study||25
9890401|NCT01079299|11005230|FG000|NOT COMPLETED|Overall Study||0
9890402|NCT01079299|11005231|FG001|NOT COMPLETED|Overall Study||0
9890403|NCT01079390|11005240|FG000|STARTED|Overall Study||15
9890404|NCT01079390|11005241|FG001|STARTED|Overall Study||15
9890405|NCT01079390|11005242|FG002|STARTED|Overall Study||14
9890406|NCT01079390|11005240|FG000|COMPLETED|Overall Study||10
9890407|NCT01079390|11005241|FG001|COMPLETED|Overall Study||10
9890408|NCT01079390|11005242|FG002|COMPLETED|Overall Study||10
9890409|NCT01079390|11005240|FG000|NOT COMPLETED|Overall Study||5
9890410|NCT01079390|11005241|FG001|NOT COMPLETED|Overall Study||5
9890411|NCT01079390|11005242|FG002|NOT COMPLETED|Overall Study||4
9890412|NCT01079663|11005254|FG000|STARTED|Overall Study||30
9890413|NCT01079663|11005255|FG001|STARTED|Overall Study||30
9890414|NCT01079663|11005254|FG000|COMPLETED|Overall Study||30
9890415|NCT01079663|11005255|FG001|COMPLETED|Overall Study||26
9890416|NCT01079663|11005254|FG000|NOT COMPLETED|Overall Study||0
9890417|NCT01079663|11005255|FG001|NOT COMPLETED|Overall Study||4
9890418|NCT01079741|11005266|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
9890419|NCT01079741|11005267|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890420|NCT01079741|11005268|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890421|NCT01079741|11005269|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890422|NCT01079741|11005270|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890423|NCT01079741|11005266|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
9890424|NCT01079741|11005267|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890425|NCT01079741|11005268|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890426|NCT01079741|11005269|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890427|NCT01079741|11005270|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890428|NCT01079741|11005266|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890429|NCT01079741|11005267|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890430|NCT01079741|11005268|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890431|NCT01079741|11005269|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890432|NCT01079741|11005270|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
9890433|NCT01079741|11005266|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890434|NCT01079741|11005267|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
9890435|NCT01079741|11005268|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890436|NCT01079741|11005269|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890437|NCT01079741|11005270|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890438|NCT01079741|11005266|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890439|NCT01079741|11005267|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
9890440|NCT01079741|11005268|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890441|NCT01079741|11005269|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890442|NCT01079741|11005270|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890443|NCT01079741|11005266|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890444|NCT01079741|11005267|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
9890445|NCT01079741|11005268|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890446|NCT01079741|11005269|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890447|NCT01079741|11005270|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
9890448|NCT01079741|11005266|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890449|NCT01079741|11005267|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890450|NCT01079741|11005268|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
9890451|NCT01079741|11005269|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890452|NCT01079741|11005270|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890453|NCT01079741|11005266|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890454|NCT01079741|11005267|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890455|NCT01079741|11005268|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890456|NCT01079741|11005269|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890457|NCT01079741|11005270|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890458|NCT01079741|11005266|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890459|NCT01079741|11005267|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890460|NCT01079741|11005268|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
9890461|NCT01079741|11005269|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
9890462|NCT01079741|11005270|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10008570|NCT01759160|11130972|FG001|COMPLETED|Overall Study||30
10008571|NCT01759160|11130971|FG000|NOT COMPLETED|Overall Study||0
10008572|NCT01759160|11130972|FG001|NOT COMPLETED|Overall Study||0
10008573|NCT01759251|11130978|FG000|STARTED|30 Days Treatment Period||309
10008574|NCT01759251|11130978|FG000|COMPLETED|30 Days Treatment Period||305
10008575|NCT01759251|11130978|FG000|NOT COMPLETED|30 Days Treatment Period||4
10008576|NCT01759251|11130978|FG000|STARTED|60 Days Treatment Period||305
10008577|NCT01759251|11130978|FG000|COMPLETED|60 Days Treatment Period||305
10008578|NCT01759251|11130978|FG000|NOT COMPLETED|60 Days Treatment Period||0
10008579|NCT01759251|11130978|FG000|STARTED|Follow-up Period||305
10008580|NCT01759251|11130978|FG000|COMPLETED|Follow-up Period||305
10008581|NCT01759251|11130978|FG000|NOT COMPLETED|Follow-up Period||0
10008582|NCT01759264|11130982|FG000|STARTED|Overall Study||101
10008583|NCT01759264|11130982|FG000|COMPLETED|Overall Study||91
10008584|NCT01759264|11130982|FG000|NOT COMPLETED|Overall Study||10
10008585|NCT01759277|11130989|FG000|STARTED|Overall Study||41
10008586|NCT01759277|11130990|FG001|STARTED|Overall Study||39
10008587|NCT01759277|11130989|FG000|COMPLETED|Overall Study||41
10008588|NCT01759277|11130990|FG001|COMPLETED|Overall Study||39
10008589|NCT01759277|11130989|FG000|NOT COMPLETED|Overall Study||0
10008590|NCT01759277|11130990|FG001|NOT COMPLETED|Overall Study||0
10109471|NCT02476578|11240153|FG001|STARTED|Overall Study||4274
10109472|NCT02476578|11240152|FG000|Died Before Email Was Sent|Overall Study||35
9890463|NCT01079741|11005266|FG000|STARTED|Phase 2 (Weeks 37-48)||0
9890464|NCT01079741|11005267|FG001|STARTED|Phase 2 (Weeks 37-48)||0
9890465|NCT01079741|11005268|FG002|STARTED|Phase 2 (Weeks 37-48)||0
9890466|NCT01079741|11005269|FG003|STARTED|Phase 2 (Weeks 37-48)||12
9890467|NCT01079741|11005270|FG004|STARTED|Phase 2 (Weeks 37-48)||12
9890468|NCT01079741|11005266|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0
9890469|NCT01079741|11005267|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0
9890470|NCT01079741|11005268|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0
9890471|NCT01079741|11005269|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12
9890472|NCT01079741|11005270|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9
9890473|NCT01079741|11005266|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
9890474|NCT01079741|11005267|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
9890475|NCT01079741|11005268|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
9890476|NCT01079741|11005269|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
9890477|NCT01079741|11005270|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
9890478|NCT01079806|11005284|FG000|STARTED|Day 1 to Week 96||120
9890479|NCT01079806|11005285|FG001|STARTED|Day 1 to Week 96||60
9890480|NCT01079806|11005284|FG000|Received Treatment|Day 1 to Week 96||120
9890481|NCT01079806|11005285|FG001|Received Treatment|Day 1 to Week 96||60
9890482|NCT01079806|11005284|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82
9890483|NCT01079806|11005285|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41
9890484|NCT01079806|11005284|FG000|COMPLETED|Day 1 to Week 96||113
9890485|NCT01079806|11005285|FG001|COMPLETED|Day 1 to Week 96||53
9890486|NCT01079806|11005284|FG000|NOT COMPLETED|Day 1 to Week 96||7
9890487|NCT01079806|11005285|FG001|NOT COMPLETED|Day 1 to Week 96||7
9890488|NCT01079806|11005284|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111
9890489|NCT01079806|11005285|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58
9890490|NCT01079806|11005284|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
9890491|NCT01079806|11005285|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
9890492|NCT01079806|11005284|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
9890493|NCT01079806|11005285|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
9890494|NCT01079832|11005293|FG000|STARTED|Overall Study||50
9890495|NCT01079832|11005293|FG000|COMPLETED|Overall Study||49
9890496|NCT01079832|11005293|FG000|NOT COMPLETED|Overall Study||1
9890497|NCT01079936|11005301|FG000|STARTED|Phase I: MTD||16
9890498|NCT01079936|11005302|FG001|STARTED|Phase I: MTD||0
9890499|NCT01079936|11005303|FG002|STARTED|Phase I: MTD||0
9890500|NCT01079936|11005304|FG003|STARTED|Phase I: MTD||0
9890501|NCT01079936|11005305|FG004|STARTED|Phase I: MTD||0
9890502|NCT01079936|11005301|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
9890503|NCT01079936|11005302|FG001|COMPLETED|Phase I: MTD||0
9890504|NCT01079936|11005303|FG002|COMPLETED|Phase I: MTD||0
9890505|NCT01079936|11005304|FG003|COMPLETED|Phase I: MTD||0
9890506|NCT01079936|11005305|FG004|COMPLETED|Phase I: MTD||0
9890507|NCT01079936|11005301|FG000|NOT COMPLETED|Phase I: MTD||4
9890508|NCT01079936|11005302|FG001|NOT COMPLETED|Phase I: MTD||0
9890509|NCT01079936|11005303|FG002|NOT COMPLETED|Phase I: MTD||0
9890510|NCT01079936|11005304|FG003|NOT COMPLETED|Phase I: MTD||0
9890511|NCT01079936|11005305|FG004|NOT COMPLETED|Phase I: MTD||0
9890512|NCT01079936|11005301|FG000|STARTED|Phase II||0
9890513|NCT01079936|11005302|FG001|STARTED|Phase II||3
9890514|NCT01079936|11005303|FG002|STARTED|Phase II||6
9890515|NCT01079936|11005304|FG003|STARTED|Phase II||24
9890516|NCT01079936|11005305|FG004|STARTED|Phase II||26
9890517|NCT01079936|11005301|FG000|COMPLETED|Phase II||0
9890518|NCT01079936|11005302|FG001|COMPLETED|Phase II||3
9890519|NCT01079936|11005303|FG002|COMPLETED|Phase II||5
9890520|NCT01079936|11005304|FG003|COMPLETED|Phase II||24
9890521|NCT01079936|11005305|FG004|COMPLETED|Phase II||25
9890522|NCT01079936|11005301|FG000|NOT COMPLETED|Phase II||0
9890523|NCT01079936|11005302|FG001|NOT COMPLETED|Phase II||0
9890524|NCT01079936|11005303|FG002|NOT COMPLETED|Phase II||1
9890525|NCT01079936|11005304|FG003|NOT COMPLETED|Phase II||0
10008591|NCT01759290|11130998|FG000|STARTED|Overall Study||1800
10008592|NCT01759290|11130998|FG000|COMPLETED|Overall Study||1719
10008593|NCT01759290|11130998|FG000|NOT COMPLETED|Overall Study||81
10008594|NCT01759368|11131004|FG000|STARTED|Overall Study||47
10008595|NCT01759368|11131005|FG001|STARTED|Overall Study||47
10008596|NCT01759368|11131004|FG000|COMPLETED|Overall Study||46
10008597|NCT01759368|11131005|FG001|COMPLETED|Overall Study||47
9890526|NCT01079936|11005305|FG004|NOT COMPLETED|Phase II||1
9890527|NCT01079949|11005318|FG000|STARTED|Overall Study||46
9890528|NCT01079949|11005319|FG001|STARTED|Overall Study||47
9890529|NCT01079949|11005318|FG000|COMPLETED|Overall Study||31
9890530|NCT01079949|11005319|FG001|COMPLETED|Overall Study||34
9890531|NCT01079949|11005318|FG000|NOT COMPLETED|Overall Study||15
9890532|NCT01079949|11005319|FG001|NOT COMPLETED|Overall Study||13
9890533|NCT01079962|11005327|FG000|STARTED|Overall Study||105
9890534|NCT01079962|11005328|FG001|STARTED|Overall Study||104
10008598|NCT01759368|11131004|FG000|NOT COMPLETED|Overall Study||1
9890535|NCT01079962|11005327|FG000|COMPLETED|Overall Study||90
9890536|NCT01079962|11005328|FG001|COMPLETED|Overall Study||89
9890537|NCT01079962|11005327|FG000|NOT COMPLETED|Overall Study||15
9890538|NCT01079962|11005328|FG001|NOT COMPLETED|Overall Study||15
9890539|NCT01079988|11005339|FG000|STARTED|Overall Study||10
9890540|NCT01079988|11005340|FG001|STARTED|Overall Study||1
9890541|NCT01079988|11005341|FG002|STARTED|Overall Study||8
9890542|NCT01079988|11005342|FG003|STARTED|Overall Study||20
9890543|NCT01079988|11005343|FG004|STARTED|Overall Study||2
9890544|NCT01079988|11005339|FG000|COMPLETED|Overall Study||9
9890545|NCT01079988|11005340|FG001|COMPLETED|Overall Study||1
9890546|NCT01079988|11005341|FG002|COMPLETED|Overall Study||8
9890547|NCT01079988|11005342|FG003|COMPLETED|Overall Study||17
9890548|NCT01079988|11005343|FG004|COMPLETED|Overall Study||1
9890549|NCT01079988|11005339|FG000|NOT COMPLETED|Overall Study||1
9890550|NCT01079988|11005340|FG001|NOT COMPLETED|Overall Study||0
9890551|NCT01079988|11005341|FG002|NOT COMPLETED|Overall Study||0
9890552|NCT01079988|11005342|FG003|NOT COMPLETED|Overall Study||3
9890553|NCT01079988|11005343|FG004|NOT COMPLETED|Overall Study||1
9890554|NCT01080118|11005357|FG000|STARTED|Overall Study||15
9890555|NCT01080118|11005358|FG001|STARTED|Overall Study||15
9890556|NCT01080118|11005359|FG002|STARTED|Overall Study||30
9890557|NCT01080118|11005360|FG003|STARTED|Overall Study||30
9890558|NCT01080118|11005357|FG000|COMPLETED|Overall Study||15
9890559|NCT01080118|11005358|FG001|COMPLETED|Overall Study||15
9890560|NCT01080118|11005359|FG002|COMPLETED|Overall Study||30
9890561|NCT01080118|11005360|FG003|COMPLETED|Overall Study||30
9890562|NCT01080118|11005357|FG000|NOT COMPLETED|Overall Study||0
9890563|NCT01080118|11005358|FG001|NOT COMPLETED|Overall Study||0
9890564|NCT01080118|11005359|FG002|NOT COMPLETED|Overall Study||0
9890565|NCT01080118|11005360|FG003|NOT COMPLETED|Overall Study||0
9890566|NCT01080131|11005368|FG000|STARTED|Core Study (0- 12 Weeks)||112
9890567|NCT01080131|11005369|FG001|STARTED|Core Study (0- 12 Weeks)||114
9890568|NCT01080131|11005368|FG000|COMPLETED|Core Study (0- 12 Weeks)||99
9890569|NCT01080131|11005369|FG001|COMPLETED|Core Study (0- 12 Weeks)||103
9890570|NCT01080131|11005368|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13
9890571|NCT01080131|11005369|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11
9890572|NCT01080131|11005368|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84
9890573|NCT01080131|11005369|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76
9890574|NCT01080131|11005368|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
10008599|NCT01759368|11131005|FG001|NOT COMPLETED|Overall Study||0
10109473|NCT02476578|11240153|FG001|Died Before Email Was Sent|Overall Study||43
10109474|NCT02476578|11240152|FG000|Left Before End of Trial|Overall Study||6
10109475|NCT02476578|11240153|FG001|Left Before End of Trial|Overall Study||13
9890575|NCT01080131|11005369|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
9890576|NCT01080131|11005368|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
10008600|NCT01759381|11131015|FG000|STARTED|Overall Study||8
10008601|NCT01759381|11131016|FG001|STARTED|Overall Study||11
10008602|NCT01759381|11131015|FG000|COMPLETED|Overall Study||7
10008603|NCT01759381|11131016|FG001|COMPLETED|Overall Study||11
10008604|NCT01759381|11131015|FG000|NOT COMPLETED|Overall Study||1
10008605|NCT01759381|11131016|FG001|NOT COMPLETED|Overall Study||0
10008606|NCT01759407|11131024|FG000|STARTED|Overall Study||10
10008607|NCT01759407|11131025|FG001|STARTED|Overall Study||9
10008608|NCT01759407|11131024|FG000|COMPLETED|Overall Study||10
10008609|NCT01759407|11131025|FG001|COMPLETED|Overall Study||7
10008610|NCT01759407|11131024|FG000|NOT COMPLETED|Overall Study||0
10008611|NCT01759407|11131025|FG001|NOT COMPLETED|Overall Study||2
10008612|NCT01759420|11131031|FG000|STARTED|Overall Study||28
10008613|NCT01759420|11131031|FG000|COMPLETED|Overall Study||22
10008614|NCT01759420|11131031|FG000|NOT COMPLETED|Overall Study||6
10008615|NCT01759446|11131040|FG000|STARTED|Overall Study||9
10008616|NCT01759446|11131041|FG001|STARTED|Overall Study||9
10008617|NCT01759446|11131042|FG002|STARTED|Overall Study||9
10008618|NCT01759446|11131043|FG003|STARTED|Overall Study||9
10008619|NCT01759446|11131044|FG004|STARTED|Overall Study||8
10008620|NCT01759446|11131040|FG000|COMPLETED|Overall Study||8
10008621|NCT01759446|11131041|FG001|COMPLETED|Overall Study||8
10008622|NCT01759446|11131042|FG002|COMPLETED|Overall Study||8
10008623|NCT01759446|11131043|FG003|COMPLETED|Overall Study||8
10008624|NCT01759446|11131044|FG004|COMPLETED|Overall Study||8
10008625|NCT01759446|11131040|FG000|NOT COMPLETED|Overall Study||1
10008626|NCT01759446|11131041|FG001|NOT COMPLETED|Overall Study||1
10008627|NCT01759446|11131042|FG002|NOT COMPLETED|Overall Study||1
10008628|NCT01759446|11131043|FG003|NOT COMPLETED|Overall Study||1
10008629|NCT01759446|11131044|FG004|NOT COMPLETED|Overall Study||0
9890577|NCT01080131|11005369|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
10008630|NCT01759511|11131056|FG000|STARTED|Overall Study||34
10008631|NCT01759511|11131056|FG000|COMPLETED|Overall Study||0
10008632|NCT01759511|11131056|FG000|NOT COMPLETED|Overall Study||34
10008633|NCT01759602|11131060|FG000|STARTED|Overall Study||10
9890578|NCT01080131|11005368|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72
9890579|NCT01080131|11005369|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65
9954561|NCT01432405|11073374|FG001|STARTED|Overall Study||12
9954562|NCT01432405|11073373|FG000|COMPLETED|Overall Study||11
9954563|NCT01432405|11073374|FG001|COMPLETED|Overall Study||10
9954564|NCT01432405|11073373|FG000|NOT COMPLETED|Overall Study||1
9954565|NCT01432405|11073374|FG001|NOT COMPLETED|Overall Study||2
9954566|NCT01432444|11073380|FG000|STARTED|Tolerability/Cross-titration Phase||325
10008634|NCT01759602|11131060|FG000|COMPLETED|Overall Study||10
10008635|NCT01759602|11131060|FG000|NOT COMPLETED|Overall Study||0
9890580|NCT01080131|11005368|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
9890581|NCT01080131|11005369|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
9890582|NCT01080131|11005368|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64
9890583|NCT01080131|11005369|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54
9890584|NCT01080131|11005368|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
9890585|NCT01080131|11005369|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
9890586|NCT01080209|11005400|FG000|STARTED|Overall Study||28
9890587|NCT01080209|11005401|FG001|STARTED|Overall Study||53
9890588|NCT01080209|11005402|FG002|STARTED|Overall Study||33
9890589|NCT01080209|11005403|FG003|STARTED|Overall Study||42
9890590|NCT01080209|11005404|FG004|STARTED|Overall Study||6
9890591|NCT01080209|11005405|FG005|STARTED|Overall Study||2
9890592|NCT01080209|11005406|FG006|STARTED|Overall Study||51
9890593|NCT01080209|11005400|FG000|COMPLETED|Overall Study||22
9890594|NCT01080209|11005401|FG001|COMPLETED|Overall Study||42
9890595|NCT01080209|11005402|FG002|COMPLETED|Overall Study||28
9890596|NCT01080209|11005403|FG003|COMPLETED|Overall Study||37
9890597|NCT01080209|11005404|FG004|COMPLETED|Overall Study||6
9890598|NCT01080209|11005405|FG005|COMPLETED|Overall Study||2
9890599|NCT01080209|11005406|FG006|COMPLETED|Overall Study||44
9890600|NCT01080209|11005400|FG000|NOT COMPLETED|Overall Study||6
9890601|NCT01080209|11005401|FG001|NOT COMPLETED|Overall Study||11
9890602|NCT01080209|11005402|FG002|NOT COMPLETED|Overall Study||5
9890603|NCT01080209|11005403|FG003|NOT COMPLETED|Overall Study||5
9890604|NCT01080209|11005404|FG004|NOT COMPLETED|Overall Study||0
9890605|NCT01080209|11005405|FG005|NOT COMPLETED|Overall Study||0
9890606|NCT01080209|11005406|FG006|NOT COMPLETED|Overall Study||7
9890607|NCT01080248|11005422|FG000|STARTED|Overall Study||2
9890608|NCT01080248|11005422|FG000|COMPLETED|Overall Study||2
9890609|NCT01080248|11005422|FG000|NOT COMPLETED|Overall Study||0
9890610|NCT01080261|11005426|FG000|STARTED|Overall Study||60
9890611|NCT01080261|11005426|FG000|COMPLETED|Overall Study||60
9890612|NCT01080261|11005426|FG000|NOT COMPLETED|Overall Study||0
9890613|NCT01080300|11005432|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
9890614|NCT01080300|11005433|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
9890615|NCT01080300|11005432|FG000|COMPLETED|Overall Study||206
9890616|NCT01080300|11005433|FG001|COMPLETED|Overall Study||191
9890617|NCT01080300|11005432|FG000|NOT COMPLETED|Overall Study||94
9890618|NCT01080300|11005433|FG001|NOT COMPLETED|Overall Study||104
9890619|NCT01080326|11005441|FG000|STARTED|Overall Study||7
9890620|NCT01080326|11005441|FG000|COMPLETED|Overall Study||3
9890621|NCT01080326|11005441|FG000|NOT COMPLETED|Overall Study||4
9890622|NCT01080391|11005447|FG000|STARTED|Overall Study||396
9890623|NCT01080391|11005448|FG001|STARTED|Overall Study||396
9890624|NCT01080391|11005447|FG000|Treated|Overall Study||389
9890625|NCT01080391|11005448|FG001|Treated|Overall Study||392
9890626|NCT01080391|11005447|FG000|COMPLETED|Overall Study||389
9890627|NCT01080391|11005448|FG001|COMPLETED|Overall Study||392
10008636|NCT01759862|11131066|FG000|STARTED|Overall Study||23
10008637|NCT01759862|11131067|FG001|STARTED|Overall Study||27
10008638|NCT01759862|11131066|FG000|COMPLETED|Overall Study||20
10008639|NCT01759862|11131067|FG001|COMPLETED|Overall Study||25
10008640|NCT01759862|11131066|FG000|NOT COMPLETED|Overall Study||3
10008641|NCT01759862|11131067|FG001|NOT COMPLETED|Overall Study||2
10008642|NCT01760187|11131083|FG000|STARTED|Overall Study||20
10008643|NCT01760187|11131084|FG001|STARTED|Overall Study||12
10109476|NCT02476578|11240152|FG000|COMPLETED|Overall Study||4269
9890628|NCT01080391|11005447|FG000|NOT COMPLETED|Overall Study||7
10008644|NCT01760187|11131085|FG002|STARTED|Overall Study||12
10008645|NCT01760187|11131086|FG003|STARTED|Overall Study||12
10008646|NCT01760187|11131087|FG004|STARTED|Overall Study||16
10008647|NCT01760187|11131083|FG000|COMPLETED|Overall Study||19
10008648|NCT01760187|11131084|FG001|COMPLETED|Overall Study||12
10008649|NCT01760187|11131085|FG002|COMPLETED|Overall Study||12
10008650|NCT01760187|11131086|FG003|COMPLETED|Overall Study||10
10008651|NCT01760187|11131087|FG004|COMPLETED|Overall Study||16
10008652|NCT01760187|11131083|FG000|NOT COMPLETED|Overall Study||1
10008653|NCT01760187|11131084|FG001|NOT COMPLETED|Overall Study||0
10008654|NCT01760187|11131085|FG002|NOT COMPLETED|Overall Study||0
10008655|NCT01760187|11131086|FG003|NOT COMPLETED|Overall Study||2
10008656|NCT01760187|11131087|FG004|NOT COMPLETED|Overall Study||0
10008657|NCT01760239|11131109|FG000|STARTED|Overall Study||17037
10008658|NCT01760239|11131110|FG001|STARTED|Overall Study||14542
10008659|NCT01760239|11131109|FG000|COMPLETED|Overall Study||296
9890629|NCT01080391|11005448|FG001|NOT COMPLETED|Overall Study||4
9890630|NCT01080625|11005457|FG000|STARTED|Overall Study||31
9890631|NCT01080625|11005458|FG001|STARTED|Overall Study||33
9890632|NCT01080625|11005459|FG002|STARTED|Overall Study||32
9890633|NCT01080625|11005457|FG000|COMPLETED|Overall Study||31
9890634|NCT01080625|11005458|FG001|COMPLETED|Overall Study||31
9890635|NCT01080625|11005459|FG002|COMPLETED|Overall Study||31
9890636|NCT01080625|11005457|FG000|NOT COMPLETED|Overall Study||0
9890637|NCT01080625|11005458|FG001|NOT COMPLETED|Overall Study||2
10008660|NCT01760239|11131110|FG001|COMPLETED|Overall Study||226
10008661|NCT01760239|11131109|FG000|NOT COMPLETED|Overall Study||16741
9890638|NCT01080625|11005459|FG002|NOT COMPLETED|Overall Study||1
9890639|NCT01080677|11005470|FG000|STARTED|Overall Study||20
9890640|NCT01080677|11005471|FG001|STARTED|Overall Study||20
9890641|NCT01080677|11005472|FG002|STARTED|Overall Study||20
9890642|NCT01080677|11005470|FG000|COMPLETED|Overall Study||20
9890643|NCT01080677|11005471|FG001|COMPLETED|Overall Study||20
9890644|NCT01080677|11005472|FG002|COMPLETED|Overall Study||20
9890645|NCT01080677|11005470|FG000|NOT COMPLETED|Overall Study||0
9890646|NCT01080677|11005471|FG001|NOT COMPLETED|Overall Study||0
9890647|NCT01080677|11005472|FG002|NOT COMPLETED|Overall Study||0
9890648|NCT01080716|11005484|FG000|STARTED|Part 1||14
9890649|NCT01080716|11005485|FG001|STARTED|Part 1||6
9890650|NCT01080716|11005486|FG002|STARTED|Part 1||0
9890651|NCT01080716|11005487|FG003|STARTED|Part 1||0
9890652|NCT01080716|11005484|FG000|COMPLETED|Part 1||13
9890653|NCT01080716|11005485|FG001|COMPLETED|Part 1||6
9890654|NCT01080716|11005486|FG002|COMPLETED|Part 1||0
9890655|NCT01080716|11005487|FG003|COMPLETED|Part 1||0
9890656|NCT01080716|11005484|FG000|NOT COMPLETED|Part 1||1
9890657|NCT01080716|11005485|FG001|NOT COMPLETED|Part 1||0
9890658|NCT01080716|11005486|FG002|NOT COMPLETED|Part 1||0
9890659|NCT01080716|11005487|FG003|NOT COMPLETED|Part 1||0
9890660|NCT01080716|11005484|FG000|STARTED|Part 2||0
9890661|NCT01080716|11005485|FG001|STARTED|Part 2||0
9890662|NCT01080716|11005486|FG002|STARTED|Part 2||10
9890663|NCT01080716|11005487|FG003|STARTED|Part 2||10
9890664|NCT01080716|11005484|FG000|COMPLETED|Part 2||0
9890665|NCT01080716|11005485|FG001|COMPLETED|Part 2||0
9890666|NCT01080716|11005486|FG002|COMPLETED|Part 2||10
9890667|NCT01080716|11005487|FG003|COMPLETED|Part 2||10
9890668|NCT01080716|11005484|FG000|NOT COMPLETED|Part 2||0
9890669|NCT01080716|11005485|FG001|NOT COMPLETED|Part 2||0
9890670|NCT01080716|11005486|FG002|NOT COMPLETED|Part 2||0
9890671|NCT01080716|11005487|FG003|NOT COMPLETED|Part 2||0
9890672|NCT01080794|11005505|FG000|STARTED|Overall Study||20
9890673|NCT01080794|11005506|FG001|STARTED|Overall Study||14
9890674|NCT01080794|11005507|FG002|STARTED|Overall Study||12
9890675|NCT01080794|11005508|FG003|STARTED|Overall Study||15
9890676|NCT01080794|11005505|FG000|COMPLETED|Overall Study||15
9890677|NCT01080794|11005506|FG001|COMPLETED|Overall Study||12
9890678|NCT01080794|11005507|FG002|COMPLETED|Overall Study||10
9890679|NCT01080794|11005508|FG003|COMPLETED|Overall Study||13
9890680|NCT01080794|11005505|FG000|NOT COMPLETED|Overall Study||5
9890681|NCT01080794|11005506|FG001|NOT COMPLETED|Overall Study||2
9890682|NCT01080794|11005507|FG002|NOT COMPLETED|Overall Study||2
9890683|NCT01080794|11005508|FG003|NOT COMPLETED|Overall Study||2
9890684|NCT01080807|11005520|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
9890685|NCT01080807|11005521|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
9890686|NCT01080807|11005520|FG000|COMPLETED|Overall Study||158
9890687|NCT01080807|11005521|FG001|COMPLETED|Overall Study||167
9890688|NCT01080807|11005520|FG000|NOT COMPLETED|Overall Study||35
9890689|NCT01080807|11005521|FG001|NOT COMPLETED|Overall Study||23
9890690|NCT01080976|11005529|FG000|STARTED|Overall Study||5
9890691|NCT01080976|11005530|FG001|STARTED|Overall Study||5
9890692|NCT01080976|11005529|FG000|COMPLETED|Overall Study||5
9890693|NCT01080976|11005530|FG001|COMPLETED|Overall Study||5
10008662|NCT01760239|11131110|FG001|NOT COMPLETED|Overall Study||14316
10008663|NCT01760304|11131119|FG000|STARTED|Overall Study||2
10008664|NCT01760304|11131120|FG001|STARTED|Overall Study||3
10008665|NCT01760304|11131119|FG000|COMPLETED|Overall Study||2
10008666|NCT01760304|11131120|FG001|COMPLETED|Overall Study||3
10008667|NCT01760304|11131119|FG000|NOT COMPLETED|Overall Study||0
10008668|NCT01760304|11131120|FG001|NOT COMPLETED|Overall Study||0
10008669|NCT01760447|11131134|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
10008670|NCT01760447|11131135|FG001|STARTED|Weeks 0-20||62
10008671|NCT01760447|11131136|FG002|STARTED|Weeks 0-20||47
10109477|NCT02476578|11240153|FG001|COMPLETED|Overall Study||4218
10109478|NCT02476578|11240152|FG000|NOT COMPLETED|Overall Study||41
10008672|NCT01760447|11131137|FG003|STARTED|Weeks 0-20||51
10008673|NCT01760447|11131134|FG000|Treated|Weeks 0-20||62
10109479|NCT02476578|11240153|FG001|NOT COMPLETED|Overall Study||56
10109480|NCT02476617|11240159|FG000|STARTED|Overall Study||25
10109481|NCT02476617|11240159|FG000|COMPLETED|Overall Study||23
10109482|NCT02476617|11240159|FG000|NOT COMPLETED|Overall Study||2
10109483|NCT02476890|11240167|FG000|STARTED|Overall Study|Crossover study|6
9890694|NCT01080976|11005529|FG000|NOT COMPLETED|Overall Study||0
9890695|NCT01080976|11005530|FG001|NOT COMPLETED|Overall Study||0
9890696|NCT01081041|11005539|FG000|STARTED|Overall Study||33
9890697|NCT01081041|11005540|FG001|STARTED|Overall Study||81
9890698|NCT01081041|11005541|FG002|STARTED|Overall Study||73
9890699|NCT01081041|11005539|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
9890700|NCT01081041|11005540|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77
9890701|NCT01081041|11005541|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
9890702|NCT01081041|11005539|FG000|COMPLETED|Overall Study||33
9890703|NCT01081041|11005540|FG001|COMPLETED|Overall Study||77
9890704|NCT01081041|11005541|FG002|COMPLETED|Overall Study||71
9890705|NCT01081041|11005539|FG000|NOT COMPLETED|Overall Study||0
10008674|NCT01760447|11131135|FG001|Treated|Weeks 0-20||62
10008675|NCT01760447|11131136|FG002|Treated|Weeks 0-20||45
10008676|NCT01760447|11131137|FG003|Treated|Weeks 0-20||51
9890706|NCT01081041|11005540|FG001|NOT COMPLETED|Overall Study||4
9890707|NCT01081041|11005541|FG002|NOT COMPLETED|Overall Study||2
10202869|NCT03452189|11330020|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0
10202870|NCT03452371|11330028|FG000|STARTED|Overall Study||21
10202871|NCT03452371|11330029|FG001|STARTED|Overall Study||23
10202872|NCT03452371|11330028|FG000|COMPLETED|Overall Study||21
10202873|NCT03452371|11330029|FG001|COMPLETED|Overall Study||23
10202874|NCT03452371|11330028|FG000|NOT COMPLETED|Overall Study||0
10202875|NCT03452371|11330029|FG001|NOT COMPLETED|Overall Study||0
10202876|NCT03452527|11330037|FG000|STARTED|Overall Study||7
10202877|NCT03452527|11330038|FG001|STARTED|Overall Study||8
10202878|NCT03452527|11330037|FG000|COMPLETED|Overall Study||4
10202879|NCT03452527|11330038|FG001|COMPLETED|Overall Study||4
10202880|NCT03452527|11330037|FG000|NOT COMPLETED|Overall Study||3
9890708|NCT01081132|11005556|FG000|STARTED|Overall Study||157
9890709|NCT01081132|11005557|FG001|STARTED|Overall Study||157
9890710|NCT01081132|11005556|FG000|COMPLETED|Overall Study||102
9890711|NCT01081132|11005557|FG001|COMPLETED|Overall Study||105
9890712|NCT01081132|11005556|FG000|NOT COMPLETED|Overall Study||55
9890713|NCT01081132|11005557|FG001|NOT COMPLETED|Overall Study||52
9890714|NCT01081145|11005563|FG000|STARTED|Open-Label Phase||528
9890715|NCT01081145|11005564|FG001|STARTED|Open-Label Phase||0
9890716|NCT01081145|11005563|FG000|COMPLETED|Open-Label Phase||316
9890717|NCT01081145|11005564|FG001|COMPLETED|Open-Label Phase||0
9890718|NCT01081145|11005563|FG000|NOT COMPLETED|Open-Label Phase||212
9890719|NCT01081145|11005564|FG001|NOT COMPLETED|Open-Label Phase||0
9890720|NCT01081145|11005563|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157
9890721|NCT01081145|11005564|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159
9890722|NCT01081145|11005563|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
9890723|NCT01081145|11005564|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
9890724|NCT01081145|11005563|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
9890725|NCT01081145|11005564|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
9890726|NCT01081249|11005572|FG000|STARTED|Overall Study||11
9890727|NCT01081249|11005573|FG001|STARTED|Overall Study||7
9890728|NCT01081249|11005572|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11
9890729|NCT01081249|11005573|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6
9890730|NCT01081249|11005572|FG000|Washout (5-10 Days)|Overall Study||11
9890731|NCT01081249|11005573|FG001|Washout (5-10 Days)|Overall Study||6
9890732|NCT01081249|11005572|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11
9890733|NCT01081249|11005573|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6
9890734|NCT01081249|11005572|FG000|COMPLETED|Overall Study||11
9890735|NCT01081249|11005573|FG001|COMPLETED|Overall Study||6
9890736|NCT01081249|11005572|FG000|NOT COMPLETED|Overall Study||0
9890737|NCT01081249|11005573|FG001|NOT COMPLETED|Overall Study||1
9890738|NCT01081301|11005579|FG000|STARTED|Overall Study||36
9890739|NCT01081301|11005579|FG000|COMPLETED|Overall Study||22
9890740|NCT01081301|11005579|FG000|NOT COMPLETED|Overall Study||14
9890741|NCT01081626|11005602|FG000|STARTED|Overall Study||155
9890742|NCT01081626|11005603|FG001|STARTED|Overall Study||155
9890743|NCT01081626|11005602|FG000|Assessed for Efficacy|Overall Study||122
9890744|NCT01081626|11005603|FG001|Assessed for Efficacy|Overall Study||125
9890745|NCT01081626|11005602|FG000|COMPLETED|Overall Study||95
9890746|NCT01081626|11005603|FG001|COMPLETED|Overall Study||94
9890747|NCT01081626|11005602|FG000|NOT COMPLETED|Overall Study||60
9890748|NCT01081626|11005603|FG001|NOT COMPLETED|Overall Study||61
9890749|NCT01081665|11005609|FG000|STARTED|Overall Study||237
9890750|NCT01081665|11005609|FG000|Full Analysis Set|Overall Study||237
9890751|NCT01081665|11005609|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
9890752|NCT01081665|11005609|FG000|COMPLETED|Overall Study||142
9890753|NCT01081665|11005609|FG000|NOT COMPLETED|Overall Study||95
9890754|NCT01081678|11005617|FG000|STARTED|Overall Study||89
9890755|NCT01081678|11005618|FG001|STARTED|Overall Study||60
9890756|NCT01081678|11005619|FG002|STARTED|Overall Study||93
9890757|NCT01081678|11005620|FG003|STARTED|Overall Study||90
9890758|NCT01081678|11005617|FG000|Received Study Drug|Overall Study||87
9890759|NCT01081678|11005618|FG001|Received Study Drug|Overall Study||60
9890760|NCT01081678|11005619|FG002|Received Study Drug|Overall Study||89
9890761|NCT01081678|11005620|FG003|Received Study Drug|Overall Study||89
9890762|NCT01081678|11005617|FG000|Completed 24 Weeks of Study|Overall Study||73
9890763|NCT01081678|11005618|FG001|Completed 24 Weeks of Study|Overall Study||50
9890764|NCT01081678|11005619|FG002|Completed 24 Weeks of Study|Overall Study||72
9890765|NCT01081678|11005620|FG003|Completed 24 Weeks of Study|Overall Study||68
9890766|NCT01081678|11005617|FG000|COMPLETED|Overall Study||62
10202881|NCT03452527|11330038|FG001|NOT COMPLETED|Overall Study||4
10202882|NCT03452943|11330046|FG000|STARTED|Titration Period (7 Weeks)||59
10202883|NCT03452943|11330047|FG001|STARTED|Titration Period (7 Weeks)||60
9890767|NCT01081678|11005618|FG001|COMPLETED|Overall Study||44
9890768|NCT01081678|11005619|FG002|COMPLETED|Overall Study||62
9890769|NCT01081678|11005620|FG003|COMPLETED|Overall Study||61
9890770|NCT01081678|11005617|FG000|NOT COMPLETED|Overall Study||27
9890771|NCT01081678|11005618|FG001|NOT COMPLETED|Overall Study||16
9890772|NCT01081678|11005619|FG002|NOT COMPLETED|Overall Study||31
9890773|NCT01081678|11005620|FG003|NOT COMPLETED|Overall Study||29
9890774|NCT01081769|11005632|FG000|STARTED|Whole Intent-to-Treat||376
9890775|NCT01081769|11005633|FG001|STARTED|Whole Intent-to-Treat||388
9890776|NCT01081769|11005632|FG000|COMPLETED|Whole Intent-to-Treat||352
9890777|NCT01081769|11005633|FG001|COMPLETED|Whole Intent-to-Treat||363
10202884|NCT03452943|11330046|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58
9890778|NCT01081769|11005632|FG000|NOT COMPLETED|Whole Intent-to-Treat||24
9890779|NCT01081769|11005633|FG001|NOT COMPLETED|Whole Intent-to-Treat||25
9890780|NCT01081769|11005632|FG000|STARTED|CORE Intent-To-Treat||352
9890781|NCT01081769|11005633|FG001|STARTED|CORE Intent-To-Treat||363
9890782|NCT01081769|11005632|FG000|COMPLETED|CORE Intent-To-Treat||272
9890783|NCT01081769|11005633|FG001|COMPLETED|CORE Intent-To-Treat||266
9890784|NCT01081769|11005632|FG000|NOT COMPLETED|CORE Intent-To-Treat||80
9890785|NCT01081769|11005633|FG001|NOT COMPLETED|CORE Intent-To-Treat||97
9890786|NCT01081795|11005642|FG000|STARTED|Overall Study||130
9890787|NCT01081795|11005643|FG001|STARTED|Overall Study||130
9890788|NCT01081795|11005644|FG002|STARTED|Overall Study||127
9890789|NCT01081795|11005642|FG000|COMPLETED|Overall Study||97
9890790|NCT01081795|11005643|FG001|COMPLETED|Overall Study||95
9890791|NCT01081795|11005644|FG002|COMPLETED|Overall Study||97
9890792|NCT01081795|11005642|FG000|NOT COMPLETED|Overall Study||33
9890793|NCT01081795|11005643|FG001|NOT COMPLETED|Overall Study||35
9890794|NCT01081795|11005644|FG002|NOT COMPLETED|Overall Study||30
9890795|NCT01081834|11005657|FG000|STARTED|Core Period: Baseline to Week 26||192
9890796|NCT01081834|11005658|FG001|STARTED|Core Period: Baseline to Week 26||195
9890797|NCT01081834|11005659|FG002|STARTED|Core Period: Baseline to Week 26||197
9890798|NCT01081834|11005660|FG003|STARTED|Core Period: Baseline to Week 26||47
9890799|NCT01081834|11005661|FG004|STARTED|Core Period: Baseline to Week 26||44
9890800|NCT01081834|11005657|FG000|COMPLETED|Core Period: Baseline to Week 26||160
9890801|NCT01081834|11005658|FG001|COMPLETED|Core Period: Baseline to Week 26||172
9890802|NCT01081834|11005659|FG002|COMPLETED|Core Period: Baseline to Week 26||175
9890803|NCT01081834|11005660|FG003|COMPLETED|Core Period: Baseline to Week 26||40
9890804|NCT01081834|11005661|FG004|COMPLETED|Core Period: Baseline to Week 26||40
9890805|NCT01081834|11005657|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32
9890806|NCT01081834|11005658|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23
9890807|NCT01081834|11005659|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22
9890808|NCT01081834|11005660|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7
9890809|NCT01081834|11005661|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4
9890810|NCT01081834|11005657|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
9890811|NCT01081834|11005658|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
9890812|NCT01081834|11005659|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
9890813|NCT01081834|11005660|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
9890814|NCT01081834|11005661|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
9890815|NCT01081834|11005657|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135
9890816|NCT01081834|11005658|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152
9890817|NCT01081834|11005659|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165
9890818|NCT01081834|11005660|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0
10008677|NCT01760447|11131134|FG000|COMPLETED|Weeks 0-20||59
10008678|NCT01760447|11131135|FG001|COMPLETED|Weeks 0-20||62
10008679|NCT01760447|11131136|FG002|COMPLETED|Weeks 0-20||42
10008680|NCT01760447|11131137|FG003|COMPLETED|Weeks 0-20||47
10008681|NCT01760447|11131134|FG000|NOT COMPLETED|Weeks 0-20||3
9890819|NCT01081834|11005661|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0
9890820|NCT01081834|11005657|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
9890821|NCT01081834|11005658|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
9890822|NCT01081834|11005659|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
9890823|NCT01081834|11005660|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
9890824|NCT01081834|11005661|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
9890825|NCT01081873|11005680|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
9890826|NCT01081873|11005680|FG000|COMPLETED|Overall Study||2416
9890827|NCT01081873|11005680|FG000|NOT COMPLETED|Overall Study||298
9890828|NCT01081912|11005709|FG000|STARTED|Conversion/Titration||510
9890829|NCT01081912|11005710|FG001|STARTED|Conversion/Titration||0
9890830|NCT01081912|11005711|FG002|STARTED|Conversion/Titration||0
9890831|NCT01081912|11005709|FG000|COMPLETED|Conversion/Titration||302
9890832|NCT01081912|11005710|FG001|COMPLETED|Conversion/Titration||0
9890833|NCT01081912|11005711|FG002|COMPLETED|Conversion/Titration||0
9890834|NCT01081912|11005709|FG000|NOT COMPLETED|Conversion/Titration||208
9890835|NCT01081912|11005710|FG001|NOT COMPLETED|Conversion/Titration||0
9890836|NCT01081912|11005711|FG002|NOT COMPLETED|Conversion/Titration||0
9890837|NCT01081912|11005709|FG000|STARTED|Maintenance Treatment||0
9890838|NCT01081912|11005710|FG001|STARTED|Maintenance Treatment||151
9890839|NCT01081912|11005711|FG002|STARTED|Maintenance Treatment||151
9890840|NCT01081912|11005709|FG000|COMPLETED|Maintenance Treatment||0
9890841|NCT01081912|11005710|FG001|COMPLETED|Maintenance Treatment||124
9890842|NCT01081912|11005711|FG002|COMPLETED|Maintenance Treatment||59
9890843|NCT01081912|11005709|FG000|NOT COMPLETED|Maintenance Treatment||0
9890844|NCT01081912|11005710|FG001|NOT COMPLETED|Maintenance Treatment||27
9890845|NCT01081912|11005711|FG002|NOT COMPLETED|Maintenance Treatment||92
9890846|NCT01082081|11005721|FG000|STARTED|Overall Study||121
9890847|NCT01082081|11005722|FG001|STARTED|Overall Study||119
9890848|NCT01082081|11005723|FG002|STARTED|Overall Study||60
10008682|NCT01760447|11131135|FG001|NOT COMPLETED|Weeks 0-20||0
9890849|NCT01082081|11005721|FG000|COMPLETED|Overall Study||121
9890850|NCT01082081|11005722|FG001|COMPLETED|Overall Study||118
9890851|NCT01082081|11005723|FG002|COMPLETED|Overall Study||58
9890852|NCT01082081|11005721|FG000|NOT COMPLETED|Overall Study||0
9890853|NCT01082081|11005722|FG001|NOT COMPLETED|Overall Study||1
9890854|NCT01082081|11005723|FG002|NOT COMPLETED|Overall Study||2
9890855|NCT01082159|11005731|FG000|STARTED|Overall Study||55
9890856|NCT01082159|11005731|FG000|COMPLETED|Overall Study||46
9890857|NCT01082159|11005731|FG000|NOT COMPLETED|Overall Study||9
9890858|NCT01082328|11005736|FG000|STARTED|Overall Study||59
9890859|NCT01082328|11005736|FG000|COMPLETED|Overall Study||58
9890860|NCT01082328|11005736|FG000|NOT COMPLETED|Overall Study||1
9890861|NCT01082367|11005742|FG000|STARTED|Double-blind Period||26
9890862|NCT01082367|11005743|FG001|STARTED|Double-blind Period||25
9890863|NCT01082367|11005742|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
9890864|NCT01082367|11005743|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
9890865|NCT01082367|11005742|FG000|Stage 2:no tx|Double-blind Period||0
9890866|NCT01082367|11005743|FG001|Stage 2:no tx|Double-blind Period||0
9890867|NCT01082367|11005742|FG000|Entered OL TOBI|Double-blind Period||4
9890868|NCT01082367|11005743|FG001|Entered OL TOBI|Double-blind Period||18
9890869|NCT01082367|11005742|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
9890870|NCT01082367|11005743|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
9890871|NCT01082367|11005742|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13
9890872|NCT01082367|11005743|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6
9890873|NCT01082367|11005742|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0
9890874|NCT01082367|11005743|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0
9890875|NCT01082367|11005742|FG000|COMPLETED|Double-blind Period||21
9890876|NCT01082367|11005743|FG001|COMPLETED|Double-blind Period||12
9890877|NCT01082367|11005742|FG000|NOT COMPLETED|Double-blind Period||5
9890878|NCT01082367|11005743|FG001|NOT COMPLETED|Double-blind Period||13
9890879|NCT01082367|11005742|FG000|STARTED|Follow-up (F-U) Period||19
9890880|NCT01082367|11005743|FG001|STARTED|Follow-up (F-U) Period||10
9890881|NCT01082367|11005742|FG000|Treated in F-U|Follow-up (F-U) Period||5
9890882|NCT01082367|11005743|FG001|Treated in F-U|Follow-up (F-U) Period||5
9890883|NCT01082367|11005742|FG000|COMPLETED|Follow-up (F-U) Period||17
9890884|NCT01082367|11005743|FG001|COMPLETED|Follow-up (F-U) Period||9
9890885|NCT01082367|11005742|FG000|NOT COMPLETED|Follow-up (F-U) Period||2
9890886|NCT01082367|11005743|FG001|NOT COMPLETED|Follow-up (F-U) Period||1
9890887|NCT01082380|11005753|FG000|STARTED|Overall Study||6
9890888|NCT01082380|11005753|FG000|COMPLETED|Overall Study||6
9890889|NCT01082380|11005753|FG000|NOT COMPLETED|Overall Study||0
9890890|NCT01082575|11005757|FG000|STARTED|Overall Study||100
9890891|NCT01082575|11005757|FG000|COMPLETED|Overall Study||100
9890892|NCT01082575|11005757|FG000|NOT COMPLETED|Overall Study||0
9890893|NCT01082588|11005763|FG000|STARTED|Overall Study||30
9890894|NCT01082588|11005764|FG001|STARTED|Overall Study||30
9890895|NCT01082588|11005763|FG000|COMPLETED|Overall Study||24
9890896|NCT01082588|11005764|FG001|COMPLETED|Overall Study||25
9890897|NCT01082588|11005763|FG000|NOT COMPLETED|Overall Study||6
9890898|NCT01082588|11005764|FG001|NOT COMPLETED|Overall Study||5
10109484|NCT02476890|11240168|FG001|STARTED|Overall Study|Crossover study|6
10109485|NCT02476890|11240169|FG002|STARTED|Overall Study|Crossover study|12
10109486|NCT02476890|11240170|FG003|STARTED|Overall Study|Crossover study|12
10109487|NCT02476890|11240167|FG000|Washout|Overall Study||6
10109488|NCT02476890|11240168|FG001|Washout|Overall Study||6
10109489|NCT02476890|11240169|FG002|Washout|Overall Study||12
10109490|NCT02476890|11240170|FG003|Washout|Overall Study||12
10109491|NCT02476890|11240167|FG000|COMPLETED|Overall Study||6
10109492|NCT02476890|11240168|FG001|COMPLETED|Overall Study||6
10109493|NCT02476890|11240169|FG002|COMPLETED|Overall Study||12
10109494|NCT02476890|11240170|FG003|COMPLETED|Overall Study||12
10109495|NCT02476890|11240167|FG000|NOT COMPLETED|Overall Study||0
10109496|NCT02476890|11240168|FG001|NOT COMPLETED|Overall Study||0
10109497|NCT02476890|11240169|FG002|NOT COMPLETED|Overall Study||0
10109498|NCT02476890|11240170|FG003|NOT COMPLETED|Overall Study||0
10109499|NCT02477020|11240184|FG000|STARTED|Overall Study||81
10109500|NCT02477020|11240185|FG001|STARTED|Overall Study||83
10109501|NCT02477020|11240184|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
10109502|NCT02477020|11240185|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
10109503|NCT02477020|11240184|FG000|NOT COMPLETED|Overall Study||30
10109504|NCT02477020|11240185|FG001|NOT COMPLETED|Overall Study||28
10109505|NCT02477111|11240191|FG000|STARTED|Overall Study||150
10109506|NCT02477111|11240191|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139
10109507|NCT02477111|11240191|FG000|NOT COMPLETED|Overall Study||11
10109508|NCT02477215|11240201|FG000|STARTED|Dose Escalation Phase||4
10109509|NCT02477215|11240202|FG001|STARTED|Dose Escalation Phase||8
10109510|NCT02477215|11240203|FG002|STARTED|Dose Escalation Phase||6
9890899|NCT01082614|11005772|FG000|STARTED|Overall Study||23
10109511|NCT02477215|11240201|FG000|COMPLETED|Dose Escalation Phase||3
10109512|NCT02477215|11240202|FG001|COMPLETED|Dose Escalation Phase||6
9890900|NCT01082614|11005773|FG001|STARTED|Overall Study||23
9890901|NCT01082614|11005772|FG000|COMPLETED|Overall Study||20
9890902|NCT01082614|11005773|FG001|COMPLETED|Overall Study||18
9890903|NCT01082614|11005772|FG000|NOT COMPLETED|Overall Study||3
10109513|NCT02477215|11240203|FG002|COMPLETED|Dose Escalation Phase||6
10109514|NCT02477215|11240201|FG000|NOT COMPLETED|Dose Escalation Phase||1
9890904|NCT01082614|11005773|FG001|NOT COMPLETED|Overall Study||5
9890905|NCT01082640|11005782|FG000|STARTED|Overall Study||32
9890906|NCT01082640|11005783|FG001|STARTED|Overall Study||32
9890907|NCT01082640|11005784|FG002|STARTED|Overall Study||32
9890908|NCT01082640|11005782|FG000|COMPLETED|Overall Study||15
9890909|NCT01082640|11005783|FG001|COMPLETED|Overall Study||17
9890910|NCT01082640|11005784|FG002|COMPLETED|Overall Study||24
9890911|NCT01082640|11005782|FG000|NOT COMPLETED|Overall Study||17
9890912|NCT01082640|11005783|FG001|NOT COMPLETED|Overall Study||15
9890913|NCT01082640|11005784|FG002|NOT COMPLETED|Overall Study||8
9890914|NCT01082874|11005799|FG000|STARTED|Overall Study||2499
10109515|NCT02477215|11240202|FG001|NOT COMPLETED|Dose Escalation Phase||2
10109516|NCT02477215|11240203|FG002|NOT COMPLETED|Dose Escalation Phase||0
10109517|NCT02477215|11240201|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
10109518|NCT02477215|11240202|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
10109519|NCT02477215|11240203|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
10109520|NCT02477215|11240201|FG000|COMPLETED|Fixed Dose Phase||0
10109521|NCT02477215|11240202|FG001|COMPLETED|Fixed Dose Phase||13
10109522|NCT02477215|11240203|FG002|COMPLETED|Fixed Dose Phase||0
10109523|NCT02477215|11240201|FG000|NOT COMPLETED|Fixed Dose Phase||0
10109524|NCT02477215|11240202|FG001|NOT COMPLETED|Fixed Dose Phase||7
10109525|NCT02477215|11240203|FG002|NOT COMPLETED|Fixed Dose Phase||0
10109526|NCT02477319|11240218|FG000|STARTED|Overall Study||55
10109527|NCT02477319|11240219|FG001|STARTED|Overall Study||40
10109528|NCT02477319|11240220|FG002|STARTED|Overall Study||164
10109529|NCT02477319|11240221|FG003|STARTED|Overall Study||193
10109530|NCT02477319|11240218|FG000|COMPLETED|Overall Study||55
10109531|NCT02477319|11240219|FG001|COMPLETED|Overall Study||37
10109532|NCT02477319|11240220|FG002|COMPLETED|Overall Study||149
10109533|NCT02477319|11240221|FG003|COMPLETED|Overall Study||171
10109534|NCT02477319|11240218|FG000|NOT COMPLETED|Overall Study||0
10109535|NCT02477319|11240219|FG001|NOT COMPLETED|Overall Study||3
10109536|NCT02477319|11240220|FG002|NOT COMPLETED|Overall Study||15
10109537|NCT02477319|11240221|FG003|NOT COMPLETED|Overall Study||22
10109538|NCT02477332|11240234|FG000|STARTED|Overall Study||43
10109539|NCT02477332|11240235|FG001|STARTED|Overall Study||84
10109540|NCT02477332|11240236|FG002|STARTED|Overall Study||85
10109541|NCT02477332|11240237|FG003|STARTED|Overall Study||85
10109542|NCT02477332|11240238|FG004|STARTED|Overall Study||43
10109543|NCT02477332|11240239|FG005|STARTED|Overall Study||42
10109544|NCT02477332|11240234|FG000|COMPLETED|Overall Study||40
10109545|NCT02477332|11240235|FG001|COMPLETED|Overall Study||77
10109546|NCT02477332|11240236|FG002|COMPLETED|Overall Study||73
10109547|NCT02477332|11240237|FG003|COMPLETED|Overall Study||72
10109548|NCT02477332|11240238|FG004|COMPLETED|Overall Study||39
10109549|NCT02477332|11240239|FG005|COMPLETED|Overall Study||37
10109550|NCT02477332|11240234|FG000|NOT COMPLETED|Overall Study||3
10109551|NCT02477332|11240235|FG001|NOT COMPLETED|Overall Study||7
10109552|NCT02477332|11240236|FG002|NOT COMPLETED|Overall Study||12
10109553|NCT02477332|11240237|FG003|NOT COMPLETED|Overall Study||13
10109554|NCT02477332|11240238|FG004|NOT COMPLETED|Overall Study||4
10109555|NCT02477332|11240239|FG005|NOT COMPLETED|Overall Study||5
10109556|NCT02477423|11240257|FG000|STARTED|Overall Study||12
10109557|NCT02477423|11240258|FG001|STARTED|Overall Study||15
10109558|NCT02477423|11240257|FG000|COMPLETED|Overall Study||11
10109559|NCT02477423|11240258|FG001|COMPLETED|Overall Study||11
10109560|NCT02477423|11240257|FG000|NOT COMPLETED|Overall Study||1
10109561|NCT02477423|11240258|FG001|NOT COMPLETED|Overall Study||4
10109562|NCT02477527|11240264|FG000|STARTED|Overall Study||27
10109563|NCT02477527|11240264|FG000|COMPLETED|Overall Study||21
10109564|NCT02477527|11240264|FG000|NOT COMPLETED|Overall Study||6
10109565|NCT02477553|11240270|FG000|STARTED|Overall Study||364
10109566|NCT02477553|11240271|FG001|STARTED|Overall Study||364
10109567|NCT02477553|11240270|FG000|COMPLETED|Overall Study||344
10109568|NCT02477553|11240271|FG001|COMPLETED|Overall Study||344
10109569|NCT02477553|11240270|FG000|NOT COMPLETED|Overall Study||20
10109570|NCT02477553|11240271|FG001|NOT COMPLETED|Overall Study||20
10109571|NCT02477605|11240279|FG000|STARTED|Overall Study||68
10109572|NCT02477605|11240280|FG001|STARTED|Overall Study||68
10109573|NCT02477605|11240279|FG000|Randomized and Treated|Overall Study||67
10109574|NCT02477605|11240280|FG001|Randomized and Treated|Overall Study||68
10109575|NCT02477605|11240279|FG000|COMPLETED|Overall Study||67
10109576|NCT02477605|11240280|FG001|COMPLETED|Overall Study||64
10109577|NCT02477605|11240279|FG000|NOT COMPLETED|Overall Study||1
10109578|NCT02477605|11240280|FG001|NOT COMPLETED|Overall Study||4
10109579|NCT02477670|11240292|FG000|STARTED|Stage 1||47
10109580|NCT02477670|11240293|FG001|STARTED|Stage 1||80
10109581|NCT02477670|11240294|FG002|STARTED|Stage 1||0
10109582|NCT02477670|11240295|FG003|STARTED|Stage 1||0
10109583|NCT02477670|11240296|FG004|STARTED|Stage 1||0
10109584|NCT02477670|11240297|FG005|STARTED|Stage 1||0
10109585|NCT02477670|11240298|FG006|STARTED|Stage 1||0
9890915|NCT01082874|11005800|FG001|STARTED|Overall Study||2510
10109586|NCT02477670|11240292|FG000|COMPLETED|Stage 1||43
10109587|NCT02477670|11240293|FG001|COMPLETED|Stage 1||67
10109588|NCT02477670|11240294|FG002|COMPLETED|Stage 1||0
10109589|NCT02477670|11240295|FG003|COMPLETED|Stage 1||0
10109590|NCT02477670|11240296|FG004|COMPLETED|Stage 1||0
10109591|NCT02477670|11240297|FG005|COMPLETED|Stage 1||0
9890916|NCT01082874|11005801|FG002|STARTED|Overall Study||2499
9890917|NCT01082874|11005802|FG003|STARTED|Overall Study||2502
9890918|NCT01082874|11005799|FG000|COMPLETED|Overall Study||2488
9890919|NCT01082874|11005800|FG001|COMPLETED|Overall Study||2498
9890920|NCT01082874|11005801|FG002|COMPLETED|Overall Study||2488
9890921|NCT01082874|11005802|FG003|COMPLETED|Overall Study||2489
9890922|NCT01082874|11005799|FG000|NOT COMPLETED|Overall Study||11
9890923|NCT01082874|11005800|FG001|NOT COMPLETED|Overall Study||12
9890924|NCT01082874|11005801|FG002|NOT COMPLETED|Overall Study||11
9890925|NCT01082874|11005802|FG003|NOT COMPLETED|Overall Study||13
9890926|NCT01082939|11005812|FG000|STARTED|Overall Study||80
9890927|NCT01082939|11005812|FG000|COMPLETED|Overall Study||80
9890928|NCT01082939|11005812|FG000|NOT COMPLETED|Overall Study||0
9890929|NCT01082952|11005818|FG000|STARTED|Overall Study||6
9890930|NCT01082952|11005819|FG001|STARTED|Overall Study||6
9890931|NCT01082952|11005818|FG000|COMPLETED|Overall Study||6
9890932|NCT01082952|11005819|FG001|COMPLETED|Overall Study||6
9890933|NCT01082952|11005818|FG000|NOT COMPLETED|Overall Study||0
9890934|NCT01082952|11005819|FG001|NOT COMPLETED|Overall Study||0
9890935|NCT01082965|11005827|FG000|STARTED|Overall Study||10
9890936|NCT01082965|11005828|FG001|STARTED|Overall Study||8
9890937|NCT01082965|11005827|FG000|COMPLETED|Overall Study||9
9890938|NCT01082965|11005828|FG001|COMPLETED|Overall Study||6
9890939|NCT01082965|11005827|FG000|NOT COMPLETED|Overall Study||1
9890940|NCT01082965|11005828|FG001|NOT COMPLETED|Overall Study||2
9890941|NCT01083121|11005834|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779
9890942|NCT01083121|11005834|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698
9890943|NCT01083121|11005834|FG000|NOT COMPLETED|Overall Study||81
9890944|NCT01083160|11005842|FG000|STARTED|Overall Study||82
9890945|NCT01083160|11005842|FG000|Evaluable Population|Overall Study||71
9890946|NCT01083160|11005842|FG000|COMPLETED|Overall Study||81
9890947|NCT01083160|11005842|FG000|NOT COMPLETED|Overall Study||1
9890948|NCT01083173|11005846|FG000|STARTED|Main Surveillance: Safety Group||595
9890949|NCT01083173|11005847|FG001|STARTED|Main Surveillance: Safety Group||0
9890950|NCT01083173|11005846|FG000|COMPLETED|Main Surveillance: Safety Group||580
9890951|NCT01083173|11005847|FG001|COMPLETED|Main Surveillance: Safety Group||0
9890952|NCT01083173|11005846|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15
10008683|NCT01760447|11131136|FG002|NOT COMPLETED|Weeks 0-20||5
10008684|NCT01760447|11131137|FG003|NOT COMPLETED|Weeks 0-20||4
10109592|NCT02477670|11240298|FG006|COMPLETED|Stage 1||0
9890953|NCT01083173|11005847|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0
9890954|NCT01083173|11005846|FG000|STARTED|Main Surveillance: Effectiveness Group||580
9890955|NCT01083173|11005847|FG001|STARTED|Main Surveillance: Effectiveness Group||0
9890956|NCT01083173|11005846|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198
9890957|NCT01083173|11005847|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0
9890958|NCT01083173|11005846|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
9890959|NCT01083173|11005847|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
9890960|NCT01083173|11005846|FG000|STARTED|Long-term Surveillance: Safety Group||0
9890961|NCT01083173|11005847|FG001|STARTED|Long-term Surveillance: Safety Group||595
9890962|NCT01083173|11005846|FG000|COMPLETED|Long-term Surveillance: Safety Group||0
9890963|NCT01083173|11005847|FG001|COMPLETED|Long-term Surveillance: Safety Group||479
9890964|NCT01083173|11005846|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0
9890965|NCT01083173|11005847|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116
9890966|NCT01083173|11005846|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0
9890967|NCT01083173|11005847|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479
9890968|NCT01083173|11005846|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
9890969|NCT01083173|11005847|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
9890970|NCT01083173|11005846|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
9890971|NCT01083173|11005847|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
9890972|NCT01083186|11005856|FG000|STARTED|Overall Study||500
9890973|NCT01083186|11005856|FG000|COMPLETED|Overall Study||406
9890974|NCT01083186|11005856|FG000|NOT COMPLETED|Overall Study||94
9890975|NCT01083199|11005880|FG000|STARTED|Overall Study||10
10008685|NCT01760447|11131134|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
10008686|NCT01760447|11131135|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
10008687|NCT01760447|11131136|FG002|STARTED|Weeks 20-54||42
10109593|NCT02477670|11240292|FG000|NOT COMPLETED|Stage 1||4
10109594|NCT02477670|11240293|FG001|NOT COMPLETED|Stage 1||13
10109595|NCT02477670|11240294|FG002|NOT COMPLETED|Stage 1||0
10008688|NCT01760447|11131137|FG003|STARTED|Weeks 20-54||47
10008689|NCT01760447|11131134|FG000|COMPLETED|Weeks 20-54||25
10008690|NCT01760447|11131135|FG001|COMPLETED|Weeks 20-54||28
10008691|NCT01760447|11131136|FG002|COMPLETED|Weeks 20-54||39
10008692|NCT01760447|11131137|FG003|COMPLETED|Weeks 20-54||43
10008693|NCT01760447|11131134|FG000|NOT COMPLETED|Weeks 20-54||3
10008694|NCT01760447|11131135|FG001|NOT COMPLETED|Weeks 20-54||2
10008695|NCT01760447|11131136|FG002|NOT COMPLETED|Weeks 20-54||3
10008696|NCT01760447|11131137|FG003|NOT COMPLETED|Weeks 20-54||4
10008697|NCT01760473|11131153|FG000|STARTED|Overall Study||27
10008698|NCT01760473|11131153|FG000|COMPLETED|Overall Study||12
10008699|NCT01760473|11131153|FG000|NOT COMPLETED|Overall Study||15
10008700|NCT01760733|11131165|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289
10008701|NCT01760733|11131165|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217
10008702|NCT01760733|11131165|FG000|NOT COMPLETED|Waiting List||72
10109596|NCT02477670|11240295|FG003|NOT COMPLETED|Stage 1||0
10109597|NCT02477670|11240296|FG004|NOT COMPLETED|Stage 1||0
9890976|NCT01083199|11005880|FG000|COMPLETED|Overall Study||10
9890977|NCT01083199|11005880|FG000|NOT COMPLETED|Overall Study||0
9890978|NCT01083316|11005885|FG000|STARTED|Overall Study||35
9890979|NCT01083316|11005885|FG000|COMPLETED|Overall Study||32
9890980|NCT01083316|11005885|FG000|NOT COMPLETED|Overall Study||3
9890981|NCT01083368|11005892|FG000|STARTED|Dose Escalation Weeks 1-4||0
9890982|NCT01083368|11005893|FG001|STARTED|Dose Escalation Weeks 1-4||0
9890983|NCT01083368|11005894|FG002|STARTED|Dose Escalation Weeks 1-4||4
9890984|NCT01083368|11005895|FG003|STARTED|Dose Escalation Weeks 1-4||0
9890985|NCT01083368|11005892|FG000|Disease Progression|Dose Escalation Weeks 1-4||0
9890986|NCT01083368|11005893|FG001|Disease Progression|Dose Escalation Weeks 1-4||0
9890987|NCT01083368|11005894|FG002|Disease Progression|Dose Escalation Weeks 1-4||1
9890988|NCT01083368|11005895|FG003|Disease Progression|Dose Escalation Weeks 1-4||0
9890989|NCT01083368|11005892|FG000|COMPLETED|Dose Escalation Weeks 1-4||0
9890990|NCT01083368|11005893|FG001|COMPLETED|Dose Escalation Weeks 1-4||0
9890991|NCT01083368|11005894|FG002|COMPLETED|Dose Escalation Weeks 1-4||4
9890992|NCT01083368|11005895|FG003|COMPLETED|Dose Escalation Weeks 1-4||0
9890993|NCT01083368|11005892|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0
9890994|NCT01083368|11005893|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0
9890995|NCT01083368|11005894|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0
9890996|NCT01083368|11005895|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0
9890997|NCT01083368|11005892|FG000|STARTED|Dose Escalation Weeks 5-9||0
9890998|NCT01083368|11005893|FG001|STARTED|Dose Escalation Weeks 5-9||0
9890999|NCT01083368|11005894|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
9891000|NCT01083368|11005895|FG003|STARTED|Dose Escalation Weeks 5-9||6
9891001|NCT01083368|11005892|FG000|COMPLETED|Dose Escalation Weeks 5-9||0
10109598|NCT02477670|11240297|FG005|NOT COMPLETED|Stage 1||0
10109599|NCT02477670|11240298|FG006|NOT COMPLETED|Stage 1||0
10109600|NCT02477670|11240292|FG000|STARTED|Stage 2||0
10109601|NCT02477670|11240293|FG001|STARTED|Stage 2||0
10109602|NCT02477670|11240294|FG002|STARTED|Stage 2||30
10109603|NCT02477670|11240295|FG003|STARTED|Stage 2||33
10109604|NCT02477670|11240296|FG004|STARTED|Stage 2||2
10109605|NCT02477670|11240297|FG005|STARTED|Stage 2||1
10109606|NCT02477670|11240298|FG006|STARTED|Stage 2||42
10109607|NCT02477670|11240292|FG000|COMPLETED|Stage 2||0
10109608|NCT02477670|11240293|FG001|COMPLETED|Stage 2||0
10109609|NCT02477670|11240294|FG002|COMPLETED|Stage 2||28
10109610|NCT02477670|11240295|FG003|COMPLETED|Stage 2||32
10109611|NCT02477670|11240296|FG004|COMPLETED|Stage 2||2
10109612|NCT02477670|11240297|FG005|COMPLETED|Stage 2||1
10109613|NCT02477670|11240298|FG006|COMPLETED|Stage 2||42
10109614|NCT02477670|11240292|FG000|NOT COMPLETED|Stage 2||0
10109615|NCT02477670|11240293|FG001|NOT COMPLETED|Stage 2||0
10109616|NCT02477670|11240294|FG002|NOT COMPLETED|Stage 2||2
10109617|NCT02477670|11240295|FG003|NOT COMPLETED|Stage 2||1
10109618|NCT02477670|11240296|FG004|NOT COMPLETED|Stage 2||0
10109619|NCT02477670|11240297|FG005|NOT COMPLETED|Stage 2||0
10109620|NCT02477670|11240298|FG006|NOT COMPLETED|Stage 2||0
10109621|NCT02477709|11240309|FG000|STARTED|Overall Study||6
10109622|NCT02477709|11240309|FG000|COMPLETED|Overall Study||6
10109623|NCT02477709|11240309|FG000|NOT COMPLETED|Overall Study||0
10109624|NCT02477800|11240316|FG000|STARTED|Placebo-Controlled Period||545
10109625|NCT02477800|11240317|FG001|STARTED|Placebo-Controlled Period||547
10109626|NCT02477800|11240318|FG002|STARTED|Placebo-Controlled Period||555
10109627|NCT02477800|11240319|FG003|STARTED|Placebo-Controlled Period||0
10109628|NCT02477800|11240320|FG004|STARTED|Placebo-Controlled Period||0
9891002|NCT01083368|11005893|FG001|COMPLETED|Dose Escalation Weeks 5-9||0
9891003|NCT01083368|11005894|FG002|COMPLETED|Dose Escalation Weeks 5-9||1
9891004|NCT01083368|11005895|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
9891005|NCT01083368|11005892|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0
9891006|NCT01083368|11005893|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0
9891007|NCT01083368|11005894|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0
9891008|NCT01083368|11005895|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0
9891009|NCT01083368|11005892|FG000|STARTED|Phase II - Efficacy/Safety||0
9891010|NCT01083368|11005893|FG001|STARTED|Phase II - Efficacy/Safety||0
9891011|NCT01083368|11005894|FG002|STARTED|Phase II - Efficacy/Safety||0
9891012|NCT01083368|11005895|FG003|STARTED|Phase II - Efficacy/Safety||20
10109629|NCT02477800|11240321|FG005|STARTED|Placebo-Controlled Period||0
10109630|NCT02477800|11240322|FG006|STARTED|Placebo-Controlled Period||0
10109631|NCT02477800|11240316|FG000|COMPLETED|Placebo-Controlled Period||325
10109632|NCT02477800|11240317|FG001|COMPLETED|Placebo-Controlled Period||325
10109633|NCT02477800|11240318|FG002|COMPLETED|Placebo-Controlled Period||288
10109634|NCT02477800|11240319|FG003|COMPLETED|Placebo-Controlled Period||0
10109635|NCT02477800|11240320|FG004|COMPLETED|Placebo-Controlled Period||0
10109636|NCT02477800|11240321|FG005|COMPLETED|Placebo-Controlled Period||0
9891013|NCT01083368|11005892|FG000|COMPLETED|Phase II - Efficacy/Safety||0
9891014|NCT01083368|11005893|FG001|COMPLETED|Phase II - Efficacy/Safety||0
9891015|NCT01083368|11005894|FG002|COMPLETED|Phase II - Efficacy/Safety||0
10109637|NCT02477800|11240322|FG006|COMPLETED|Placebo-Controlled Period||0
10109638|NCT02477800|11240316|FG000|NOT COMPLETED|Placebo-Controlled Period||220
10109639|NCT02477800|11240317|FG001|NOT COMPLETED|Placebo-Controlled Period||222
10109640|NCT02477800|11240318|FG002|NOT COMPLETED|Placebo-Controlled Period||267
10109641|NCT02477800|11240319|FG003|NOT COMPLETED|Placebo-Controlled Period||0
10109642|NCT02477800|11240320|FG004|NOT COMPLETED|Placebo-Controlled Period||0
10109643|NCT02477800|11240321|FG005|NOT COMPLETED|Placebo-Controlled Period||0
9891016|NCT01083368|11005895|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
9891017|NCT01083368|11005892|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0
9891018|NCT01083368|11005893|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0
9891019|NCT01083368|11005894|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0
9891020|NCT01083368|11005895|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0
9891021|NCT01083485|11005905|FG000|STARTED|Overall Study||70
9891022|NCT01083485|11005906|FG001|STARTED|Overall Study||67
9891023|NCT01083485|11005905|FG000|COMPLETED|Overall Study||63
9891024|NCT01083485|11005906|FG001|COMPLETED|Overall Study||64
9891025|NCT01083485|11005905|FG000|NOT COMPLETED|Overall Study||7
9891026|NCT01083485|11005906|FG001|NOT COMPLETED|Overall Study||3
9891027|NCT01083576|11005916|FG000|STARTED|Overall Study||15
9891028|NCT01083576|11005917|FG001|STARTED|Overall Study||15
9891029|NCT01083576|11005916|FG000|COMPLETED|Overall Study||9
9891030|NCT01083576|11005917|FG001|COMPLETED|Overall Study||14
9891031|NCT01083576|11005916|FG000|NOT COMPLETED|Overall Study||6
9891032|NCT01083576|11005917|FG001|NOT COMPLETED|Overall Study||1
9891033|NCT01083602|11005924|FG000|STARTED|Overall Study||55
9891034|NCT01083602|11005924|FG000|COMPLETED|Overall Study||0
9891035|NCT01083602|11005924|FG000|NOT COMPLETED|Overall Study||55
9891036|NCT01083628|11005930|FG000|STARTED|Overall Study||45
9891037|NCT01083628|11005931|FG001|STARTED|Overall Study||40
9891038|NCT01083628|11005930|FG000|COMPLETED|Overall Study||45
9891039|NCT01083628|11005931|FG001|COMPLETED|Overall Study||40
9891040|NCT01083628|11005930|FG000|NOT COMPLETED|Overall Study||0
9891041|NCT01083628|11005931|FG001|NOT COMPLETED|Overall Study||0
9891042|NCT01083641|11005937|FG000|STARTED|Overall Study||17
9891043|NCT01083641|11005937|FG000|COMPLETED|Overall Study||15
9891044|NCT01083641|11005937|FG000|NOT COMPLETED|Overall Study||2
9891045|NCT01083654|11005943|FG000|STARTED|Overall Study||53
9891046|NCT01083654|11005944|FG001|STARTED|Overall Study||50
9891047|NCT01083654|11005943|FG000|COMPLETED|Overall Study||53
9891048|NCT01083654|11005944|FG001|COMPLETED|Overall Study||50
9891049|NCT01083654|11005943|FG000|NOT COMPLETED|Overall Study||0
9891050|NCT01083654|11005944|FG001|NOT COMPLETED|Overall Study||0
9891051|NCT01083667|11005950|FG000|STARTED|Overall Study|enrolled|32
9891052|NCT01083667|11005950|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
9891053|NCT01083667|11005950|FG000|NOT COMPLETED|Overall Study||10
9891054|NCT01083680|11005954|FG000|STARTED|Overall Study||4107
9891055|NCT01083680|11005954|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621
9891056|NCT01083680|11005954|FG000|COMPLETED|Overall Study||263
9891057|NCT01083680|11005954|FG000|NOT COMPLETED|Overall Study||3844
9891058|NCT01083693|11005961|FG000|STARTED|Overall Study||93
9891059|NCT01083693|11005962|FG001|STARTED|Overall Study||28
9891060|NCT01083693|11005963|FG002|STARTED|Overall Study||40
9891061|NCT01083693|11005961|FG000|COMPLETED|Overall Study||73
9891062|NCT01083693|11005962|FG001|COMPLETED|Overall Study||22
9891063|NCT01083693|11005963|FG002|COMPLETED|Overall Study||33
9891064|NCT01083693|11005961|FG000|NOT COMPLETED|Overall Study||20
9891065|NCT01083693|11005962|FG001|NOT COMPLETED|Overall Study||6
9891066|NCT01083693|11005963|FG002|NOT COMPLETED|Overall Study||7
9891067|NCT01083706|11005975|FG000|STARTED|Overall Study||39
9891068|NCT01083706|11005975|FG000|COMPLETED|Overall Study||39
9891069|NCT01083706|11005975|FG000|NOT COMPLETED|Overall Study||0
9891070|NCT01083732|11005982|FG000|STARTED|Overall Study||6
9891071|NCT01083732|11005983|FG001|STARTED|Overall Study||9
9891072|NCT01083732|11005984|FG002|STARTED|Overall Study||3
9891073|NCT01083732|11005982|FG000|COMPLETED|Overall Study||6
9891074|NCT01083732|11005983|FG001|COMPLETED|Overall Study||9
9891075|NCT01083732|11005984|FG002|COMPLETED|Overall Study||3
9891076|NCT01083732|11005982|FG000|NOT COMPLETED|Overall Study||0
9891077|NCT01083732|11005983|FG001|NOT COMPLETED|Overall Study||0
9891078|NCT01083732|11005984|FG002|NOT COMPLETED|Overall Study||0
9891079|NCT01083758|11005995|FG000|STARTED|Overall Study||31
9891080|NCT01083758|11005995|FG000|COMPLETED|Overall Study||29
9891081|NCT01083758|11005995|FG000|NOT COMPLETED|Overall Study||2
9891082|NCT01083810|11006002|FG000|STARTED|Overall Study||137
9891083|NCT01083810|11006003|FG001|STARTED|Overall Study||92
10109644|NCT02477800|11240322|FG006|NOT COMPLETED|Placebo-Controlled Period||0
10109645|NCT02477800|11240316|FG000|STARTED|Long Term Extension Period||0
10109646|NCT02477800|11240317|FG001|STARTED|Long Term Extension Period||0
10109647|NCT02477800|11240318|FG002|STARTED|Long Term Extension Period||0
10109648|NCT02477800|11240319|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150
10109649|NCT02477800|11240320|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152
10109650|NCT02477800|11240321|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299
10109651|NCT02477800|11240322|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251
9891084|NCT01083810|11006004|FG002|STARTED|Overall Study||55
9891085|NCT01083810|11006002|FG000|COMPLETED|Overall Study||72
9891086|NCT01083810|11006003|FG001|COMPLETED|Overall Study||47
9891087|NCT01083810|11006004|FG002|COMPLETED|Overall Study||35
9891088|NCT01083810|11006002|FG000|NOT COMPLETED|Overall Study||65
9891089|NCT01083810|11006003|FG001|NOT COMPLETED|Overall Study||45
9891090|NCT01083810|11006004|FG002|NOT COMPLETED|Overall Study||20
9891091|NCT01083849|11006012|FG000|STARTED|Overall Study||121
9891092|NCT01083849|11006013|FG001|STARTED|Overall Study||638
9891093|NCT01083849|11006012|FG000|COMPLETED|Overall Study||61
9891094|NCT01083849|11006013|FG001|COMPLETED|Overall Study||527
9891095|NCT01083849|11006012|FG000|NOT COMPLETED|Overall Study||60
10109652|NCT02477800|11240316|FG000|COMPLETED|Long Term Extension Period||0
9891096|NCT01083849|11006013|FG001|NOT COMPLETED|Overall Study||111
9891097|NCT01083901|11006025|FG000|STARTED|Overall Study||13
9891098|NCT01083901|11006026|FG001|STARTED|Overall Study||8
9891099|NCT01083901|11006027|FG002|STARTED|Overall Study||13
9891100|NCT01083901|11006025|FG000|COMPLETED|Overall Study||12
9891101|NCT01083901|11006026|FG001|COMPLETED|Overall Study||6
9891102|NCT01083901|11006027|FG002|COMPLETED|Overall Study||11
9891103|NCT01083901|11006025|FG000|NOT COMPLETED|Overall Study||1
9891104|NCT01083901|11006026|FG001|NOT COMPLETED|Overall Study||2
10008703|NCT01760733|11131165|FG000|STARTED|Transplanted||217
10008704|NCT01760733|11131165|FG000|COMPLETED|Transplanted||0
10008705|NCT01760733|11131165|FG000|NOT COMPLETED|Transplanted||217
10008706|NCT01760785|11131172|FG000|STARTED|Overall Study||23
10008707|NCT01760785|11131173|FG001|STARTED|Overall Study||27
10008708|NCT01760785|11131172|FG000|COMPLETED|Overall Study||23
10008709|NCT01760785|11131173|FG001|COMPLETED|Overall Study||27
10008710|NCT01760785|11131172|FG000|NOT COMPLETED|Overall Study||0
10008711|NCT01760785|11131173|FG001|NOT COMPLETED|Overall Study||0
10008712|NCT01760876|11131179|FG000|STARTED|Overall Study||106
10109653|NCT02477800|11240317|FG001|COMPLETED|Long Term Extension Period||0
10109654|NCT02477800|11240318|FG002|COMPLETED|Long Term Extension Period||0
10109655|NCT02477800|11240319|FG003|COMPLETED|Long Term Extension Period||0
10109656|NCT02477800|11240320|FG004|COMPLETED|Long Term Extension Period||0
10109657|NCT02477800|11240321|FG005|COMPLETED|Long Term Extension Period||0
10109658|NCT02477800|11240322|FG006|COMPLETED|Long Term Extension Period||0
10109659|NCT02477800|11240316|FG000|NOT COMPLETED|Long Term Extension Period||0
10109660|NCT02477800|11240317|FG001|NOT COMPLETED|Long Term Extension Period||0
10109661|NCT02477800|11240318|FG002|NOT COMPLETED|Long Term Extension Period||0
10109662|NCT02477800|11240319|FG003|NOT COMPLETED|Long Term Extension Period||150
10109663|NCT02477800|11240320|FG004|NOT COMPLETED|Long Term Extension Period||152
10109664|NCT02477800|11240321|FG005|NOT COMPLETED|Long Term Extension Period||299
10109665|NCT02477800|11240322|FG006|NOT COMPLETED|Long Term Extension Period||251
10109666|NCT02477839|11240336|FG000|STARTED|Overall Study||127
10109667|NCT02477839|11240337|FG001|STARTED|Overall Study||128
10109668|NCT02477839|11240336|FG000|Completed Transition Period|Overall Study||124
10109669|NCT02477839|11240337|FG001|Completed Transition Period|Overall Study||117
10109670|NCT02477839|11240336|FG000|Completed Taper After Maintenance|Overall Study||0
10109671|NCT02477839|11240337|FG001|Completed Taper After Maintenance|Overall Study||1
10109672|NCT02477839|11240336|FG000|COMPLETED|Overall Study||124
10109673|NCT02477839|11240337|FG001|COMPLETED|Overall Study||118
10109674|NCT02477839|11240336|FG000|NOT COMPLETED|Overall Study||3
10109675|NCT02477839|11240337|FG001|NOT COMPLETED|Overall Study||10
10109676|NCT02478164|11240345|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
10109677|NCT02478164|11240345|FG000|COMPLETED|Overall Study||0
10109678|NCT02478164|11240345|FG000|NOT COMPLETED|Overall Study||15
10109679|NCT02478359|11240351|FG000|STARTED|Overall Study||1349
10109680|NCT02478359|11240352|FG001|STARTED|Overall Study||1358
10109681|NCT02478359|11240351|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
10109682|NCT02478359|11240352|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
10109683|NCT02478359|11240351|FG000|COMPLETED|Overall Study||1243
10109684|NCT02478359|11240352|FG001|COMPLETED|Overall Study||1293
10109685|NCT02478359|11240351|FG000|NOT COMPLETED|Overall Study||106
10109686|NCT02478359|11240352|FG001|NOT COMPLETED|Overall Study||65
10109687|NCT02478372|11240362|FG000|STARTED|Overall Study||121
10109688|NCT02478372|11240363|FG001|STARTED|Overall Study||121
10109689|NCT02478372|11240362|FG000|Recieved Allocation Intervention|Overall Study||109
10109690|NCT02478372|11240363|FG001|Recieved Allocation Intervention|Overall Study||113
10109691|NCT02478372|11240362|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
10109692|NCT02478372|11240363|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
10109693|NCT02478372|11240362|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108
10109694|NCT02478372|11240363|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
10109695|NCT02478372|11240362|FG000|COMPLETED|Overall Study||108
10109696|NCT02478372|11240363|FG001|COMPLETED|Overall Study||107
10109697|NCT02478372|11240362|FG000|NOT COMPLETED|Overall Study||13
10109698|NCT02478372|11240363|FG001|NOT COMPLETED|Overall Study||14
10109699|NCT02478398|11240371|FG000|STARTED|Overall Study||513
10109700|NCT02478398|11240372|FG001|STARTED|Overall Study||512
9891105|NCT01083901|11006027|FG002|NOT COMPLETED|Overall Study||2
10008713|NCT01760876|11131179|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
10109701|NCT02478398|11240371|FG000|Treated|Overall Study||512
10109702|NCT02478398|11240372|FG001|Treated|Overall Study||510
10109703|NCT02478398|11240371|FG000|COMPLETED|Overall Study||461
10109704|NCT02478398|11240372|FG001|COMPLETED|Overall Study||491
10109705|NCT02478398|11240371|FG000|NOT COMPLETED|Overall Study||52
10109706|NCT02478398|11240372|FG001|NOT COMPLETED|Overall Study||21
10109707|NCT02478463|11240379|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19
10109708|NCT02478463|11240379|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18
9891106|NCT01083979|11006035|FG000|STARTED|Overall Study||1
9891107|NCT01083979|11006035|FG000|COMPLETED|Overall Study||1
9891108|NCT01083979|11006035|FG000|NOT COMPLETED|Overall Study||0
10008714|NCT01760876|11131179|FG000|NOT COMPLETED|Overall Study||6
10008715|NCT01760954|11131187|FG000|STARTED|Treatment Period (6 Months)||149
10008716|NCT01760954|11131188|FG001|STARTED|Treatment Period (6 Months)||138
9891109|NCT01084005|11006041|FG000|STARTED|Overall Study||79
9891110|NCT01084005|11006042|FG001|STARTED|Overall Study||162
9891111|NCT01084005|11006041|FG000|COMPLETED|Overall Study||74
9891112|NCT01084005|11006042|FG001|COMPLETED|Overall Study||146
9891113|NCT01084005|11006041|FG000|NOT COMPLETED|Overall Study||5
9891114|NCT01084005|11006042|FG001|NOT COMPLETED|Overall Study||16
9891115|NCT01084083|11006048|FG000|STARTED|Overall Study||90
9891116|NCT01084083|11006048|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
9891117|NCT01084083|11006048|FG000|Eligible|Overall Study||81
9891118|NCT01084083|11006048|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
9891119|NCT01084083|11006048|FG000|CR to Induction Therapy|Overall Study||56
9891120|NCT01084083|11006048|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
9891121|NCT01084083|11006048|FG000|COMPLETED|Overall Study||78
9891122|NCT01084083|11006048|FG000|NOT COMPLETED|Overall Study||12
9891123|NCT01084135|11006057|FG000|STARTED|12 Week||4
9891124|NCT01084135|11006058|FG001|STARTED|12 Week||4
9891125|NCT01084135|11006057|FG000|COMPLETED|12 Week||4
9891126|NCT01084135|11006058|FG001|COMPLETED|12 Week||4
9891127|NCT01084135|11006057|FG000|NOT COMPLETED|12 Week||0
9891128|NCT01084135|11006058|FG001|NOT COMPLETED|12 Week||0
9891129|NCT01084135|11006057|FG000|STARTED|20 Week||12
9891130|NCT01084135|11006058|FG001|STARTED|20 Week||11
9891131|NCT01084135|11006057|FG000|COMPLETED|20 Week||12
9891132|NCT01084135|11006058|FG001|COMPLETED|20 Week||10
9891133|NCT01084135|11006057|FG000|NOT COMPLETED|20 Week||0
9891134|NCT01084135|11006058|FG001|NOT COMPLETED|20 Week||1
9891135|NCT01084148|11006068|FG000|STARTED|Overall Study||118
9891136|NCT01084148|11006069|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
9891137|NCT01084148|11006068|FG000|Treated Patients|Overall Study||118
9891138|NCT01084148|11006069|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117
9891139|NCT01084148|11006068|FG000|COMPLETED|Overall Study||88
9891140|NCT01084148|11006069|FG001|COMPLETED|Overall Study||102
9891141|NCT01084148|11006068|FG000|NOT COMPLETED|Overall Study||30
9891142|NCT01084148|11006069|FG001|NOT COMPLETED|Overall Study||16
9891143|NCT01084174|11006079|FG000|STARTED|Overall Study||10
9891144|NCT01084174|11006080|FG001|STARTED|Overall Study||11
9891145|NCT01084174|11006079|FG000|COMPLETED|Overall Study||9
9891146|NCT01084174|11006080|FG001|COMPLETED|Overall Study||7
9891147|NCT01084174|11006079|FG000|NOT COMPLETED|Overall Study||1
9891148|NCT01084174|11006080|FG001|NOT COMPLETED|Overall Study||4
9891149|NCT01084239|11006088|FG000|STARTED|Randomization - Index Hospitalization||501
9891150|NCT01084239|11006089|FG001|STARTED|Randomization - Index Hospitalization||499
9891151|NCT01084239|11006088|FG000|COMPLETED|Randomization - Index Hospitalization||501
9891152|NCT01084239|11006089|FG001|COMPLETED|Randomization - Index Hospitalization||499
9891153|NCT01084239|11006088|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0
9891154|NCT01084239|11006089|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0
9891155|NCT01084239|11006088|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
9891156|NCT01084239|11006089|FG001|STARTED|28-Day Follow-up||499
9891157|NCT01084239|11006088|FG000|COMPLETED|28-Day Follow-up||497
9891158|NCT01084239|11006089|FG001|COMPLETED|28-Day Follow-up||490
9891159|NCT01084239|11006088|FG000|NOT COMPLETED|28-Day Follow-up||4
9891160|NCT01084239|11006089|FG001|NOT COMPLETED|28-Day Follow-up||9
9891161|NCT01084265|11006097|FG000|STARTED|Overall Study||31
9891162|NCT01084265|11006097|FG000|COMPLETED|Overall Study||31
9891163|NCT01084265|11006097|FG000|NOT COMPLETED|Overall Study||0
9954567|NCT01432444|11073381|FG001|STARTED|Tolerability/Cross-titration Phase||0
9954568|NCT01432444|11073382|FG002|STARTED|Tolerability/Cross-titration Phase||0
9954569|NCT01432444|11073380|FG000|COMPLETED|Tolerability/Cross-titration Phase||265
9954570|NCT01432444|11073381|FG001|COMPLETED|Tolerability/Cross-titration Phase||0
9954571|NCT01432444|11073382|FG002|COMPLETED|Tolerability/Cross-titration Phase||0
9954572|NCT01432444|11073380|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60
9954573|NCT01432444|11073381|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0
9954574|NCT01432444|11073382|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0
9954575|NCT01432444|11073380|FG000|STARTED|Treatment Phase||0
9954576|NCT01432444|11073381|FG001|STARTED|Treatment Phase||433
9954577|NCT01432444|11073382|FG002|STARTED|Treatment Phase||0
9954578|NCT01432444|11073380|FG000|COMPLETED|Treatment Phase||0
9954579|NCT01432444|11073381|FG001|COMPLETED|Treatment Phase||293
9954580|NCT01432444|11073382|FG002|COMPLETED|Treatment Phase||0
9954581|NCT01432444|11073380|FG000|NOT COMPLETED|Treatment Phase||0
9954582|NCT01432444|11073381|FG001|NOT COMPLETED|Treatment Phase||140
9954583|NCT01432444|11073382|FG002|NOT COMPLETED|Treatment Phase||0
9954584|NCT01432444|11073380|FG000|STARTED|Extension Phase||0
9954585|NCT01432444|11073381|FG001|STARTED|Extension Phase||0
9954586|NCT01432444|11073382|FG002|STARTED|Extension Phase||192
9954587|NCT01432444|11073380|FG000|COMPLETED|Extension Phase||0
9954588|NCT01432444|11073381|FG001|COMPLETED|Extension Phase||0
9954589|NCT01432444|11073382|FG002|COMPLETED|Extension Phase||0
9954590|NCT01432444|11073380|FG000|NOT COMPLETED|Extension Phase||0
9954591|NCT01432444|11073381|FG001|NOT COMPLETED|Extension Phase||0
9954592|NCT01432444|11073382|FG002|NOT COMPLETED|Extension Phase||192
9954593|NCT01432457|11073390|FG000|STARTED|Overall Study||306
9954594|NCT01432457|11073391|FG001|STARTED|Overall Study||306
9954595|NCT01432457|11073392|FG002|STARTED|Overall Study||312
9954596|NCT01432457|11073390|FG000|COMPLETED|Overall Study||269
9891164|NCT01084278|11006106|FG000|STARTED|Overall Study||8
9891165|NCT01084278|11006107|FG001|STARTED|Overall Study||8
9891166|NCT01084278|11006108|FG002|STARTED|Overall Study||8
9891167|NCT01084278|11006109|FG003|STARTED|Overall Study||8
9891168|NCT01084278|11006110|FG004|STARTED|Overall Study||8
9891169|NCT01084278|11006106|FG000|COMPLETED|Overall Study||8
9891170|NCT01084278|11006107|FG001|COMPLETED|Overall Study||8
9891171|NCT01084278|11006108|FG002|COMPLETED|Overall Study||8
9891172|NCT01084278|11006109|FG003|COMPLETED|Overall Study||8
9891173|NCT01084278|11006110|FG004|COMPLETED|Overall Study||8
9891174|NCT01084278|11006106|FG000|NOT COMPLETED|Overall Study||0
9891175|NCT01084278|11006107|FG001|NOT COMPLETED|Overall Study||0
9891176|NCT01084278|11006108|FG002|NOT COMPLETED|Overall Study||0
9891177|NCT01084278|11006109|FG003|NOT COMPLETED|Overall Study||0
9891178|NCT01084278|11006110|FG004|NOT COMPLETED|Overall Study||0
9891179|NCT01084499|11006126|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
9891180|NCT01084499|11006127|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
9891181|NCT01084499|11006126|FG000|Washout (5 Weeks)|Overall Study||13
9891182|NCT01084499|11006127|FG001|Washout (5 Weeks)|Overall Study||13
9891183|NCT01084499|11006126|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
9891184|NCT01084499|11006127|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
9891185|NCT01084499|11006126|FG000|NOT COMPLETED|Overall Study||0
9891186|NCT01084499|11006127|FG001|NOT COMPLETED|Overall Study||0
9891187|NCT01084538|11006133|FG000|STARTED|Overall Study||181
9891188|NCT01084538|11006133|FG000|COMPLETED|Overall Study||113
9891189|NCT01084538|11006133|FG000|NOT COMPLETED|Overall Study||68
9891190|NCT01084551|11006140|FG000|STARTED|Overall Study||95
9891191|NCT01084551|11006141|FG001|STARTED|Overall Study||95
9891192|NCT01084551|11006142|FG002|STARTED|Overall Study||94
9891193|NCT01084551|11006140|FG000|COMPLETED|Overall Study||86
9891194|NCT01084551|11006141|FG001|COMPLETED|Overall Study||81
9891195|NCT01084551|11006142|FG002|COMPLETED|Overall Study||86
9891196|NCT01084551|11006140|FG000|NOT COMPLETED|Overall Study||9
9891197|NCT01084551|11006141|FG001|NOT COMPLETED|Overall Study||14
9891198|NCT01084551|11006142|FG002|NOT COMPLETED|Overall Study||8
9891199|NCT01084603|11006150|FG000|STARTED|Baseline||45
9891200|NCT01084603|11006150|FG000|COMPLETED|Baseline||43
9891201|NCT01084603|11006150|FG000|NOT COMPLETED|Baseline||2
9891202|NCT01084603|11006150|FG000|STARTED|NiQuitinTM Lozenge||43
9891203|NCT01084603|11006150|FG000|COMPLETED|NiQuitinTM Lozenge||42
9891204|NCT01084603|11006150|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1
9891205|NCT01084603|11006150|FG000|STARTED|Washout Period 1||42
9891206|NCT01084603|11006150|FG000|COMPLETED|Washout Period 1||42
9891207|NCT01084603|11006150|FG000|NOT COMPLETED|Washout Period 1||0
9891208|NCT01084603|11006150|FG000|STARTED|Nicorette® Gum||42
9891209|NCT01084603|11006150|FG000|COMPLETED|Nicorette® Gum||41
9891210|NCT01084603|11006150|FG000|NOT COMPLETED|Nicorette® Gum||1
9891211|NCT01084603|11006150|FG000|STARTED|Washout Period 2||41
9891212|NCT01084603|11006150|FG000|COMPLETED|Washout Period 2||41
9891213|NCT01084603|11006150|FG000|NOT COMPLETED|Washout Period 2||0
9891214|NCT01084603|11006150|FG000|STARTED|Oral Nicotine 1||41
9891215|NCT01084603|11006150|FG000|COMPLETED|Oral Nicotine 1||40
9891216|NCT01084603|11006150|FG000|NOT COMPLETED|Oral Nicotine 1||1
9891217|NCT01084603|11006150|FG000|STARTED|Washout Period 3||40
9891218|NCT01084603|11006150|FG000|COMPLETED|Washout Period 3||40
9891219|NCT01084603|11006150|FG000|NOT COMPLETED|Washout Period 3||0
9891220|NCT01084603|11006150|FG000|STARTED|Oral Nicotine 2||40
9891221|NCT01084603|11006150|FG000|COMPLETED|Oral Nicotine 2||40
9891222|NCT01084603|11006150|FG000|NOT COMPLETED|Oral Nicotine 2||0
9891223|NCT01084603|11006150|FG000|STARTED|Washout Period 4||40
9891224|NCT01084603|11006150|FG000|COMPLETED|Washout Period 4||39
9891225|NCT01084603|11006150|FG000|NOT COMPLETED|Washout Period 4||1
9891226|NCT01084603|11006150|FG000|STARTED|Oral Nicotine 4||39
9891227|NCT01084603|11006150|FG000|COMPLETED|Oral Nicotine 4||39
9891228|NCT01084603|11006150|FG000|NOT COMPLETED|Oral Nicotine 4||0
9891229|NCT01084655|11006166|FG000|STARTED|Overall Study||6
9891230|NCT01084655|11006167|FG001|STARTED|Overall Study||8
9891231|NCT01084655|11006168|FG002|STARTED|Overall Study||24
9891232|NCT01084655|11006166|FG000|Treated|Overall Study||6
9891233|NCT01084655|11006167|FG001|Treated|Overall Study||8
9891234|NCT01084655|11006168|FG002|Treated|Overall Study||23
9891235|NCT01084655|11006166|FG000|COMPLETED|Overall Study||0
9891236|NCT01084655|11006167|FG001|COMPLETED|Overall Study||2
9891237|NCT01084655|11006168|FG002|COMPLETED|Overall Study||5
9891238|NCT01084655|11006166|FG000|NOT COMPLETED|Overall Study||6
9891239|NCT01084655|11006167|FG001|NOT COMPLETED|Overall Study||6
9891240|NCT01084655|11006168|FG002|NOT COMPLETED|Overall Study||19
9891241|NCT01084668|11006180|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
9891242|NCT01084668|11006180|FG000|COMPLETED|Overall Study||33
9891243|NCT01084668|11006180|FG000|NOT COMPLETED|Overall Study||9
9891244|NCT01084694|11006188|FG000|STARTED|Overall Study||50
9891245|NCT01084694|11006189|FG001|STARTED|Overall Study||50
9891246|NCT01084694|11006188|FG000|COMPLETED|Overall Study||44
9891247|NCT01084694|11006189|FG001|COMPLETED|Overall Study||30
9891248|NCT01084694|11006188|FG000|NOT COMPLETED|Overall Study||6
9891249|NCT01084694|11006189|FG001|NOT COMPLETED|Overall Study||20
9891250|NCT01084707|11006203|FG000|STARTED|Overall Study||40
9891251|NCT01084707|11006203|FG000|COMPLETED|Overall Study||34
9891252|NCT01084707|11006203|FG000|NOT COMPLETED|Overall Study||6
9891253|NCT01084759|11006215|FG000|STARTED|Overall Study||16
9891254|NCT01084759|11006215|FG000|COMPLETED|Overall Study||14
9891255|NCT01084759|11006215|FG000|NOT COMPLETED|Overall Study||2
9891256|NCT01084772|11006221|FG000|STARTED|Baseline||68
9891257|NCT01084772|11006222|FG001|STARTED|Baseline||66
9891258|NCT01084772|11006221|FG000|COMPLETED|Baseline||61
9891259|NCT01084772|11006222|FG001|COMPLETED|Baseline||60
9891260|NCT01084772|11006221|FG000|NOT COMPLETED|Baseline||7
9891261|NCT01084772|11006222|FG001|NOT COMPLETED|Baseline||6
9891262|NCT01084772|11006221|FG000|STARTED|3 Months||61
9891263|NCT01084772|11006222|FG001|STARTED|3 Months||60
9891264|NCT01084772|11006221|FG000|COMPLETED|3 Months||58
9891265|NCT01084772|11006222|FG001|COMPLETED|3 Months||58
9891266|NCT01084772|11006221|FG000|NOT COMPLETED|3 Months||3
9891267|NCT01084772|11006222|FG001|NOT COMPLETED|3 Months||2
9891268|NCT01084772|11006221|FG000|STARTED|1 Year||58
9891269|NCT01084772|11006222|FG001|STARTED|1 Year||58
9891270|NCT01084772|11006221|FG000|COMPLETED|1 Year||55
9891271|NCT01084772|11006222|FG001|COMPLETED|1 Year||50
9891272|NCT01084772|11006221|FG000|NOT COMPLETED|1 Year||3
9891273|NCT01084772|11006222|FG001|NOT COMPLETED|1 Year||8
9891274|NCT01084772|11006221|FG000|STARTED|2 Years||55
9891275|NCT01084772|11006222|FG001|STARTED|2 Years||50
9891276|NCT01084772|11006221|FG000|COMPLETED|2 Years||46
9891277|NCT01084772|11006222|FG001|COMPLETED|2 Years||46
9891278|NCT01084772|11006221|FG000|NOT COMPLETED|2 Years||9
9891279|NCT01084772|11006222|FG001|NOT COMPLETED|2 Years||4
9891280|NCT01085006|11006230|FG000|STARTED|Overall Study||50
9891281|NCT01085006|11006231|FG001|STARTED|Overall Study||50
9891282|NCT01085006|11006230|FG000|COMPLETED|Overall Study||50
9891283|NCT01085006|11006231|FG001|COMPLETED|Overall Study||50
9891284|NCT01085006|11006230|FG000|NOT COMPLETED|Overall Study||0
9891285|NCT01085006|11006231|FG001|NOT COMPLETED|Overall Study||0
9891286|NCT01085045|11006237|FG000|STARTED|Part A||122
9891287|NCT01085045|11006237|FG000|GFF MDI 72/9.6mcg|Part A||40
9891288|NCT01085045|11006237|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42
9891289|NCT01085045|11006237|FG000|GP MDI 36 µg (PT001)|Part A||40
9891290|NCT01085045|11006237|FG000|Spiriva 18 µg|Part A||58
9891291|NCT01085045|11006237|FG000|FF MDI 9.6 µg (PT005)|Part A||20
9891292|NCT01085045|11006237|FG000|FF MDI 7.2 µg (PT005)|Part A||21
9891293|NCT01085045|11006237|FG000|Placebo MDI|Part A||5
9891294|NCT01085045|11006237|FG000|Foradil 12 µg|Part A||14
9891295|NCT01085045|11006237|FG000|COMPLETED|Part A||104
9891296|NCT01085045|11006237|FG000|NOT COMPLETED|Part A||18
9891297|NCT01085045|11006237|FG000|STARTED|Part B||104
9891298|NCT01085045|11006237|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0
9891299|NCT01085045|11006237|FG000|GFF MDI 36/9.6 µg|Part B||0
9891300|NCT01085045|11006237|FG000|Spiriva 18 µg|Part B||0
9891301|NCT01085045|11006237|FG000|FF MDI 9.6 µg (PT005)|Part B||43
9891302|NCT01085045|11006237|FG000|FF MDI 7.2 µg (PT005)|Part B||43
9891303|NCT01085045|11006237|FG000|Placebo MDI|Part B||47
9891304|NCT01085045|11006237|FG000|Foradil 12 µg|Part B||41
9891305|NCT01085045|11006237|FG000|GP MDI 36 µg (PT001)|Part B||0
9891306|NCT01085045|11006237|FG000|COMPLETED|Part B||89
9891307|NCT01085045|11006237|FG000|NOT COMPLETED|Part B||15
9891308|NCT01085136|11006257|FG000|STARTED|Part A||1154
9891309|NCT01085136|11006258|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
9891310|NCT01085136|11006259|FG002|STARTED|Part A||0
9891311|NCT01085136|11006257|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
9891312|NCT01085136|11006258|FG001|Randomized to Part B|Part A||0
9891313|NCT01085136|11006259|FG002|Randomized to Part B|Part A||0
9891314|NCT01085136|11006257|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
9891315|NCT01085136|11006258|FG001|COMPLETED|Part A||0
9891316|NCT01085136|11006259|FG002|COMPLETED|Part A||0
9891317|NCT01085136|11006257|FG000|NOT COMPLETED|Part A||323
9891318|NCT01085136|11006258|FG001|NOT COMPLETED|Part A||0
9891319|NCT01085136|11006259|FG002|NOT COMPLETED|Part A||0
9891320|NCT01085136|11006257|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
9891321|NCT01085136|11006258|FG001|STARTED|Part B||138
9891322|NCT01085136|11006259|FG002|STARTED|Part B||68
9891323|NCT01085136|11006257|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
9891324|NCT01085136|11006258|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
9891325|NCT01085136|11006259|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
9891326|NCT01085136|11006257|FG000|NOT COMPLETED|Part B||0
9891327|NCT01085136|11006258|FG001|NOT COMPLETED|Part B||51
9891328|NCT01085136|11006259|FG002|NOT COMPLETED|Part B||26
9891329|NCT01085201|11006274|FG000|STARTED|Overall Study||18
9891330|NCT01085201|11006275|FG001|STARTED|Overall Study||7
9891331|NCT01085201|11006276|FG002|STARTED|Overall Study||5
9891332|NCT01085201|11006277|FG003|STARTED|Overall Study||6
9891333|NCT01085201|11006278|FG004|STARTED|Overall Study||3
9891334|NCT01085201|11006274|FG000|COMPLETED|Overall Study||15
9891335|NCT01085201|11006275|FG001|COMPLETED|Overall Study||6
9891336|NCT01085201|11006276|FG002|COMPLETED|Overall Study||3
9891337|NCT01085201|11006277|FG003|COMPLETED|Overall Study||6
9891338|NCT01085201|11006278|FG004|COMPLETED|Overall Study||3
9891339|NCT01085201|11006274|FG000|NOT COMPLETED|Overall Study||3
9891340|NCT01085201|11006275|FG001|NOT COMPLETED|Overall Study||1
9891341|NCT01085201|11006276|FG002|NOT COMPLETED|Overall Study||2
9891342|NCT01085201|11006277|FG003|NOT COMPLETED|Overall Study||0
9891343|NCT01085201|11006278|FG004|NOT COMPLETED|Overall Study||0
9891344|NCT01085214|11006295|FG000|STARTED|Overall Study||37
9891345|NCT01085214|11006295|FG000|COMPLETED|Overall Study||36
9891346|NCT01085214|11006295|FG000|NOT COMPLETED|Overall Study||1
9891347|NCT01085318|11006301|FG000|STARTED|Overall Study||23
9891348|NCT01085318|11006302|FG001|STARTED|Overall Study||15
9891349|NCT01085318|11006301|FG000|COMPLETED|Overall Study||21
9891350|NCT01085318|11006302|FG001|COMPLETED|Overall Study||15
9891351|NCT01085318|11006301|FG000|NOT COMPLETED|Overall Study||2
9891352|NCT01085318|11006302|FG001|NOT COMPLETED|Overall Study||0
9891353|NCT01085331|11006310|FG000|STARTED|Overall Study||10
9891354|NCT01085331|11006311|FG001|STARTED|Overall Study||6
9891355|NCT01085331|11006310|FG000|COMPLETED|Overall Study||10
9891356|NCT01085331|11006311|FG001|COMPLETED|Overall Study||6
9891357|NCT01085331|11006310|FG000|NOT COMPLETED|Overall Study||0
9891358|NCT01085331|11006311|FG001|NOT COMPLETED|Overall Study||0
9891359|NCT01085344|11006321|FG000|STARTED|Overall Study||56
9891360|NCT01085344|11006321|FG000|COMPLETED|Overall Study||50
9891361|NCT01085344|11006321|FG000|NOT COMPLETED|Overall Study||6
9891362|NCT01085357|11006327|FG000|STARTED|Overall Study||374
9891363|NCT01085357|11006328|FG001|STARTED|Overall Study||131
9891364|NCT01085357|11006327|FG000|COMPLETED|Overall Study||355
9891365|NCT01085357|11006328|FG001|COMPLETED|Overall Study||125
9891366|NCT01085357|11006327|FG000|NOT COMPLETED|Overall Study||19
9891367|NCT01085357|11006328|FG001|NOT COMPLETED|Overall Study||6
9891368|NCT01085500|11006336|FG000|STARTED|Overall Study||26
9891369|NCT01085500|11006337|FG001|STARTED|Overall Study||24
9891370|NCT01085500|11006336|FG000|COMPLETED|Overall Study||26
9891371|NCT01085500|11006337|FG001|COMPLETED|Overall Study||24
9891372|NCT01085500|11006336|FG000|NOT COMPLETED|Overall Study||0
9891373|NCT01085500|11006337|FG001|NOT COMPLETED|Overall Study||0
9891374|NCT01085513|11006345|FG000|STARTED|Phase I - Development Phase||54
9891375|NCT01085513|11006346|FG001|STARTED|Phase I - Development Phase||52
9891376|NCT01085513|11006345|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
9891377|NCT01085513|11006346|FG001|COMPLETED|Phase I - Development Phase||52
9891378|NCT01085513|11006345|FG000|NOT COMPLETED|Phase I - Development Phase||0
9891379|NCT01085513|11006346|FG001|NOT COMPLETED|Phase I - Development Phase||0
9891380|NCT01085513|11006345|FG000|STARTED|Phase II - Validation Phase||21
9891381|NCT01085513|11006346|FG001|STARTED|Phase II - Validation Phase||16
9891382|NCT01085513|11006345|FG000|COMPLETED|Phase II - Validation Phase||21
9891383|NCT01085513|11006346|FG001|COMPLETED|Phase II - Validation Phase||16
9891384|NCT01085513|11006345|FG000|NOT COMPLETED|Phase II - Validation Phase||0
9891385|NCT01085513|11006346|FG001|NOT COMPLETED|Phase II - Validation Phase||0
9891386|NCT01085539|11006352|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50
9891387|NCT01085539|11006352|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
9891388|NCT01085539|11006352|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
9891389|NCT01085539|11006352|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
9891390|NCT01085539|11006352|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
9891391|NCT01085539|11006352|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
9891392|NCT01085539|11006352|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
9891393|NCT01085539|11006352|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
9891394|NCT01085539|11006352|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
9891395|NCT01085539|11006352|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
10109709|NCT02478463|11240379|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
10109710|NCT02478463|11240379|FG000|STARTED|Washout Period (Up to 42 Days)||18
10008717|NCT01760954|11131189|FG002|STARTED|Treatment Period (6 Months)||108
10008718|NCT01760954|11131190|FG003|STARTED|Treatment Period (6 Months)||109
10008719|NCT01760954|11131187|FG000|COMPLETED|Treatment Period (6 Months)||116
9891396|NCT01085539|11006352|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
9891397|NCT01085539|11006352|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
9891398|NCT01085539|11006352|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
9891399|NCT01085539|11006352|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
9891400|NCT01085539|11006352|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
9891401|NCT01085591|11006359|FG000|STARTED|Overall Study||69
9891402|NCT01085591|11006360|FG001|STARTED|Overall Study||71
9891403|NCT01085591|11006361|FG002|STARTED|Overall Study||70
9891404|NCT01085591|11006359|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
9891405|NCT01085591|11006360|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69
9891406|NCT01085591|11006361|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
9891407|NCT01085591|11006359|FG000|COMPLETED|Overall Study||66
9891408|NCT01085591|11006360|FG001|COMPLETED|Overall Study||65
9891409|NCT01085591|11006361|FG002|COMPLETED|Overall Study||63
9891410|NCT01085591|11006359|FG000|NOT COMPLETED|Overall Study||3
9891411|NCT01085591|11006360|FG001|NOT COMPLETED|Overall Study||6
9891412|NCT01085591|11006361|FG002|NOT COMPLETED|Overall Study||7
9891413|NCT01085630|11006372|FG000|STARTED|Overall Study||26
10008720|NCT01760954|11131188|FG001|COMPLETED|Treatment Period (6 Months)||110
10008721|NCT01760954|11131189|FG002|COMPLETED|Treatment Period (6 Months)||87
10008722|NCT01760954|11131190|FG003|COMPLETED|Treatment Period (6 Months)||83
10008723|NCT01760954|11131187|FG000|NOT COMPLETED|Treatment Period (6 Months)||33
10008724|NCT01760954|11131188|FG001|NOT COMPLETED|Treatment Period (6 Months)||28
10008725|NCT01760954|11131189|FG002|NOT COMPLETED|Treatment Period (6 Months)||21
9891414|NCT01085630|11006373|FG001|STARTED|Overall Study||27
9891415|NCT01085630|11006372|FG000|COMPLETED|Overall Study||22
9891416|NCT01085630|11006373|FG001|COMPLETED|Overall Study||27
9891417|NCT01085630|11006372|FG000|NOT COMPLETED|Overall Study||4
10008726|NCT01760954|11131190|FG003|NOT COMPLETED|Treatment Period (6 Months)||26
9891418|NCT01085630|11006373|FG001|NOT COMPLETED|Overall Study||0
9891419|NCT01085682|11006381|FG000|STARTED|Overall Study||31
9891420|NCT01085682|11006382|FG001|STARTED|Overall Study||28
9891421|NCT01085682|11006381|FG000|COMPLETED|Overall Study||6
9891422|NCT01085682|11006382|FG001|COMPLETED|Overall Study||3
9891423|NCT01085682|11006381|FG000|NOT COMPLETED|Overall Study||25
9891424|NCT01085682|11006382|FG001|NOT COMPLETED|Overall Study||25
9891425|NCT01085734|11006390|FG000|STARTED|Overall Study||15
9891426|NCT01085734|11006391|FG001|STARTED|Overall Study||15
9891427|NCT01085734|11006390|FG000|COMPLETED|Overall Study||14
9891428|NCT01085734|11006391|FG001|COMPLETED|Overall Study||11
9891429|NCT01085734|11006390|FG000|NOT COMPLETED|Overall Study||1
9891430|NCT01085734|11006391|FG001|NOT COMPLETED|Overall Study||4
9891431|NCT01085760|11006402|FG000|STARTED|Overall Study||8
9891432|NCT01085760|11006403|FG001|STARTED|Overall Study||9
9891433|NCT01085760|11006404|FG002|STARTED|Overall Study||9
9891434|NCT01085760|11006405|FG003|STARTED|Overall Study||9
9891435|NCT01085760|11006402|FG000|COMPLETED|Overall Study||7
9891436|NCT01085760|11006403|FG001|COMPLETED|Overall Study||8
9891437|NCT01085760|11006404|FG002|COMPLETED|Overall Study||7
9891438|NCT01085760|11006405|FG003|COMPLETED|Overall Study||6
9891439|NCT01085760|11006402|FG000|NOT COMPLETED|Overall Study||1
9891440|NCT01085760|11006403|FG001|NOT COMPLETED|Overall Study||1
9891441|NCT01085760|11006404|FG002|NOT COMPLETED|Overall Study||2
9891442|NCT01085760|11006405|FG003|NOT COMPLETED|Overall Study||3
9891443|NCT01085786|11006417|FG000|STARTED|Overall Study||123
9891444|NCT01085786|11006418|FG001|STARTED|Overall Study||117
9891445|NCT01085786|11006417|FG000|COMPLETED|Overall Study||123
9891446|NCT01085786|11006418|FG001|COMPLETED|Overall Study||117
9891447|NCT01085786|11006417|FG000|NOT COMPLETED|Overall Study||0
9891448|NCT01085786|11006418|FG001|NOT COMPLETED|Overall Study||0
9891449|NCT01085812|11006424|FG000|STARTED|Open-Label Period||0
9891450|NCT01085812|11006425|FG001|STARTED|Open-Label Period||734
9891451|NCT01085812|11006424|FG000|COMPLETED|Open-Label Period||0
9891452|NCT01085812|11006425|FG001|COMPLETED|Open-Label Period||494
9891453|NCT01085812|11006424|FG000|NOT COMPLETED|Open-Label Period||0
9891454|NCT01085812|11006425|FG001|NOT COMPLETED|Open-Label Period||240
9891455|NCT01085812|11006424|FG000|STARTED|Double-Blind Period||113
9891456|NCT01085812|11006425|FG001|STARTED|Double-Blind Period||235
9891457|NCT01085812|11006424|FG000|COMPLETED|Double-Blind Period||92
9891458|NCT01085812|11006425|FG001|COMPLETED|Double-Blind Period||177
9891459|NCT01085812|11006424|FG000|NOT COMPLETED|Double-Blind Period||21
9891460|NCT01085812|11006425|FG001|NOT COMPLETED|Double-Blind Period||58
10109711|NCT02478463|11240379|FG000|COMPLETED|Washout Period (Up to 42 Days)||17
10109712|NCT02478463|11240379|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1
10109713|NCT02478463|11240379|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
10109714|NCT02478463|11240379|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
10109715|NCT02478463|11240379|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
10109716|NCT02478489|11240387|FG000|STARTED|Overall Study||123
10109717|NCT02478489|11240388|FG001|STARTED|Overall Study||125
10109718|NCT02478489|11240387|FG000|COMPLETED|Overall Study||108
10109719|NCT02478489|11240388|FG001|COMPLETED|Overall Study||109
10109720|NCT02478489|11240387|FG000|NOT COMPLETED|Overall Study||15
10109721|NCT02478489|11240388|FG001|NOT COMPLETED|Overall Study||16
10109722|NCT02478580|11240396|FG000|STARTED|Overall Study||34
10109723|NCT02478580|11240397|FG001|STARTED|Overall Study||33
10109724|NCT02478580|11240396|FG000|COMPLETED|Overall Study||34
10109725|NCT02478580|11240397|FG001|COMPLETED|Overall Study||33
10109726|NCT02478580|11240396|FG000|NOT COMPLETED|Overall Study||0
10109727|NCT02478580|11240397|FG001|NOT COMPLETED|Overall Study||0
10109728|NCT02478632|11240407|FG000|STARTED|Early Switch Phase (Up to Week 52)||53
10109729|NCT02478632|11240408|FG001|STARTED|Early Switch Phase (Up to Week 52)||49
10109730|NCT02478632|11240407|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49
10109731|NCT02478632|11240408|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44
10109732|NCT02478632|11240407|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
10109733|NCT02478632|11240408|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
10109734|NCT02478632|11240407|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49
10109735|NCT02478632|11240408|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44
10109736|NCT02478632|11240407|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
10109737|NCT02478632|11240408|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
10109738|NCT02478632|11240407|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
10109739|NCT02478632|11240408|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
10109740|NCT02478671|11240417|FG000|STARTED|Overall Study||4
10109741|NCT02478671|11240417|FG000|COMPLETED|Overall Study||4
10109742|NCT02478671|11240417|FG000|NOT COMPLETED|Overall Study||0
9891461|NCT01085812|11006424|FG000|STARTED|Double-blind Intent-to-treat Population||112
9891462|NCT01085812|11006425|FG001|STARTED|Double-blind Intent-to-treat Population||230
9891463|NCT01085812|11006424|FG000|COMPLETED|Double-blind Intent-to-treat Population||92
9891464|NCT01085812|11006425|FG001|COMPLETED|Double-blind Intent-to-treat Population||174
9891465|NCT01085812|11006424|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20
9891466|NCT01085812|11006425|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56
9891467|NCT01085825|11006434|FG000|STARTED|Overall Study|1st participant enrolled|252
9891468|NCT01085825|11006435|FG001|STARTED|Overall Study||248
9891469|NCT01085825|11006434|FG000|COMPLETED|Overall Study||251
9891470|NCT01085825|11006435|FG001|COMPLETED|Overall Study||247
9891471|NCT01085825|11006434|FG000|NOT COMPLETED|Overall Study||1
10109743|NCT02479139|11240428|FG000|STARTED|Overall Study||27
9891472|NCT01085825|11006435|FG001|NOT COMPLETED|Overall Study||1
9891473|NCT01085903|11006443|FG000|STARTED|Overall Study||21
9891474|NCT01085903|11006444|FG001|STARTED|Overall Study||4
9891475|NCT01085903|11006445|FG002|STARTED|Overall Study||3
9891476|NCT01085903|11006443|FG000|COMPLETED|Overall Study||21
9891477|NCT01085903|11006444|FG001|COMPLETED|Overall Study||4
9891478|NCT01085903|11006445|FG002|COMPLETED|Overall Study||3
10008727|NCT01760954|11131187|FG000|STARTED|Post-treatment Follow-up (12 Months)||126
10008728|NCT01760954|11131188|FG001|STARTED|Post-treatment Follow-up (12 Months)||118
10008729|NCT01760954|11131189|FG002|STARTED|Post-treatment Follow-up (12 Months)||86
10109744|NCT02479139|11240429|FG001|STARTED|Overall Study||22
10109745|NCT02479139|11240430|FG002|STARTED|Overall Study||28
10109746|NCT02479139|11240431|FG003|STARTED|Overall Study||21
9891479|NCT01085903|11006443|FG000|NOT COMPLETED|Overall Study||0
9891480|NCT01085903|11006444|FG001|NOT COMPLETED|Overall Study||0
9891481|NCT01085903|11006445|FG002|NOT COMPLETED|Overall Study||0
9891482|NCT01085968|11006466|FG000|STARTED|Overall Study||29
9891483|NCT01085968|11006467|FG001|STARTED|Overall Study||25
9891484|NCT01085968|11006466|FG000|COMPLETED|Overall Study||19
9891485|NCT01085968|11006467|FG001|COMPLETED|Overall Study||21
9891486|NCT01085968|11006466|FG000|NOT COMPLETED|Overall Study||10
9891487|NCT01085968|11006467|FG001|NOT COMPLETED|Overall Study||4
10109747|NCT02479139|11240432|FG004|STARTED|Overall Study||22
10109748|NCT02479139|11240433|FG005|STARTED|Overall Study||25
10109749|NCT02479139|11240428|FG000|COMPLETED|Overall Study||19
10109750|NCT02479139|11240429|FG001|COMPLETED|Overall Study||12
10109751|NCT02479139|11240430|FG002|COMPLETED|Overall Study||21
10109752|NCT02479139|11240431|FG003|COMPLETED|Overall Study||14
10109753|NCT02479139|11240432|FG004|COMPLETED|Overall Study||17
10109754|NCT02479139|11240433|FG005|COMPLETED|Overall Study||19
10109755|NCT02479139|11240428|FG000|NOT COMPLETED|Overall Study||8
10109756|NCT02479139|11240429|FG001|NOT COMPLETED|Overall Study||10
10109757|NCT02479139|11240430|FG002|NOT COMPLETED|Overall Study||7
10109758|NCT02479139|11240431|FG003|NOT COMPLETED|Overall Study||7
10109759|NCT02479139|11240432|FG004|NOT COMPLETED|Overall Study||5
10109760|NCT02479139|11240433|FG005|NOT COMPLETED|Overall Study||6
10109761|NCT02479412|11240456|FG000|STARTED|Overall Study||6
10109762|NCT02479412|11240457|FG001|STARTED|Overall Study||6
10109763|NCT02479412|11240458|FG002|STARTED|Overall Study||6
10109764|NCT02479412|11240459|FG003|STARTED|Overall Study||7
10109765|NCT02479412|11240460|FG004|STARTED|Overall Study||6
10109766|NCT02479412|11240461|FG005|STARTED|Overall Study||5
10109767|NCT02479412|11240462|FG006|STARTED|Overall Study||6
10109768|NCT02479412|11240463|FG007|STARTED|Overall Study||5
10109769|NCT02479412|11240464|FG008|STARTED|Overall Study||7
10109770|NCT02479412|11240456|FG000|COMPLETED|Overall Study||6
10109771|NCT02479412|11240457|FG001|COMPLETED|Overall Study||6
10109772|NCT02479412|11240458|FG002|COMPLETED|Overall Study||4
10109773|NCT02479412|11240459|FG003|COMPLETED|Overall Study||6
10109774|NCT02479412|11240460|FG004|COMPLETED|Overall Study||5
10109775|NCT02479412|11240461|FG005|COMPLETED|Overall Study||5
10109776|NCT02479412|11240462|FG006|COMPLETED|Overall Study||6
10109777|NCT02479412|11240463|FG007|COMPLETED|Overall Study||4
10109778|NCT02479412|11240464|FG008|COMPLETED|Overall Study||6
10109779|NCT02479412|11240456|FG000|NOT COMPLETED|Overall Study||0
10109780|NCT02479412|11240457|FG001|NOT COMPLETED|Overall Study||0
10109781|NCT02479412|11240458|FG002|NOT COMPLETED|Overall Study||2
9891488|NCT01086033|11006473|FG000|STARTED|Overall Study||566
9891489|NCT01086033|11006473|FG000|COMPLETED|Overall Study||262
10008730|NCT01760954|11131190|FG003|STARTED|Post-treatment Follow-up (12 Months)||87
10008731|NCT01760954|11131187|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96
10008732|NCT01760954|11131188|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83
10008733|NCT01760954|11131189|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65
10008734|NCT01760954|11131190|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67
10008735|NCT01760954|11131187|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
10008736|NCT01760954|11131188|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
10008737|NCT01760954|11131189|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
10008738|NCT01760954|11131190|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
10008739|NCT01761019|11131200|FG000|STARTED|Overall Study||8
10008740|NCT01761019|11131200|FG000|COMPLETED|Overall Study||8
10008741|NCT01761019|11131200|FG000|NOT COMPLETED|Overall Study||0
10008742|NCT01761084|11131206|FG000|STARTED|Overall Study||71
10008743|NCT01761084|11131207|FG001|STARTED|Overall Study||70
10008744|NCT01761084|11131206|FG000|COMPLETED|Overall Study||66
10109782|NCT02479412|11240459|FG003|NOT COMPLETED|Overall Study||1
10109783|NCT02479412|11240460|FG004|NOT COMPLETED|Overall Study||1
10109784|NCT02479412|11240461|FG005|NOT COMPLETED|Overall Study||0
10109785|NCT02479412|11240462|FG006|NOT COMPLETED|Overall Study||0
10109786|NCT02479412|11240463|FG007|NOT COMPLETED|Overall Study||1
10109787|NCT02479412|11240464|FG008|NOT COMPLETED|Overall Study||1
9891490|NCT01086033|11006473|FG000|NOT COMPLETED|Overall Study||304
10008745|NCT01761084|11131207|FG001|COMPLETED|Overall Study||64
10109788|NCT02479763|11240482|FG000|STARTED|Overall Study||53
10109789|NCT02479763|11240483|FG001|STARTED|Overall Study||53
10109790|NCT02479763|11240482|FG000|COMPLETED|Overall Study||50
10109791|NCT02479763|11240483|FG001|COMPLETED|Overall Study||50
10109792|NCT02479763|11240482|FG000|NOT COMPLETED|Overall Study||3
10109793|NCT02479763|11240483|FG001|NOT COMPLETED|Overall Study||3
9891491|NCT01086150|11006483|FG000|STARTED|Overall Study||11
10109794|NCT02479802|11240489|FG000|STARTED|Overall Study||13
10008746|NCT01761084|11131206|FG000|NOT COMPLETED|Overall Study||5
10008747|NCT01761084|11131207|FG001|NOT COMPLETED|Overall Study||6
10109795|NCT02479802|11240489|FG000|COMPLETED|Overall Study||11
10109796|NCT02479802|11240489|FG000|NOT COMPLETED|Overall Study||2
9891492|NCT01086150|11006484|FG001|STARTED|Overall Study||27
9891493|NCT01086150|11006485|FG002|STARTED|Overall Study||13
9891494|NCT01086150|11006483|FG000|COMPLETED|Overall Study||11
9891495|NCT01086150|11006484|FG001|COMPLETED|Overall Study||21
10202885|NCT03452943|11330047|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59
10202886|NCT03452943|11330046|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
10202887|NCT03452943|11330047|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
10202888|NCT03452943|11330046|FG000|COMPLETED|Titration Period (7 Weeks)||54
10202889|NCT03452943|11330047|FG001|COMPLETED|Titration Period (7 Weeks)||56
9891496|NCT01086150|11006485|FG002|COMPLETED|Overall Study||12
9891497|NCT01086150|11006483|FG000|NOT COMPLETED|Overall Study||0
9891498|NCT01086150|11006484|FG001|NOT COMPLETED|Overall Study||6
9891499|NCT01086150|11006485|FG002|NOT COMPLETED|Overall Study||1
10008748|NCT01761162|11131214|FG000|STARTED|Overall Study||229
10109797|NCT02479880|11240495|FG000|STARTED|Overall Study||15
10109798|NCT02479880|11240496|FG001|STARTED|Overall Study||15
10109799|NCT02479880|11240495|FG000|COMPLETED|Overall Study||2
10109800|NCT02479880|11240496|FG001|COMPLETED|Overall Study||2
10109801|NCT02479880|11240495|FG000|NOT COMPLETED|Overall Study||13
10109802|NCT02479880|11240496|FG001|NOT COMPLETED|Overall Study||13
10109803|NCT02480010|11240504|FG000|STARTED|Overall Study||35
10109804|NCT02480010|11240505|FG001|STARTED|Overall Study||33
10109805|NCT02480010|11240504|FG000|COMPLETED|Overall Study||0
10109806|NCT02480010|11240505|FG001|COMPLETED|Overall Study||0
10109807|NCT02480010|11240504|FG000|NOT COMPLETED|Overall Study||35
10109808|NCT02480010|11240505|FG001|NOT COMPLETED|Overall Study||33
10109809|NCT02480114|11240513|FG000|STARTED|Overall Study||41
10109810|NCT02480114|11240514|FG001|STARTED|Overall Study||38
10109811|NCT02480114|11240513|FG000|COMPLETED|Overall Study||32
10109812|NCT02480114|11240514|FG001|COMPLETED|Overall Study||30
9891500|NCT01086215|11006497|FG000|STARTED|Overall Study||212
9891501|NCT01086215|11006498|FG001|STARTED|Overall Study||201
10008749|NCT01761162|11131214|FG000|COMPLETED|Overall Study||226
10008750|NCT01761162|11131214|FG000|NOT COMPLETED|Overall Study||3
10008751|NCT01761175|11131220|FG000|STARTED|Overall Study||112
10008752|NCT01761175|11131221|FG001|STARTED|Overall Study||112
10008753|NCT01761175|11131220|FG000|COMPLETED|Overall Study||112
10008754|NCT01761175|11131221|FG001|COMPLETED|Overall Study||112
10008755|NCT01761175|11131220|FG000|NOT COMPLETED|Overall Study||0
10008756|NCT01761175|11131221|FG001|NOT COMPLETED|Overall Study||0
10008757|NCT01761279|11131228|FG000|STARTED|Overall Study||84
10008758|NCT01761279|11131228|FG000|COMPLETED|Overall Study||84
10008759|NCT01761279|11131228|FG000|NOT COMPLETED|Overall Study||0
10008760|NCT01761292|11131236|FG000|STARTED|Part 1||20
10008761|NCT01761292|11131236|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
10008762|NCT01761292|11131236|FG000|COMPLETED|Part 1||18
10008763|NCT01761292|11131236|FG000|NOT COMPLETED|Part 1||2
10008764|NCT01761292|11131236|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
10008765|NCT01761292|11131236|FG000|COMPLETED|Part 2||19
10008766|NCT01761292|11131236|FG000|NOT COMPLETED|Part 2||0
10008767|NCT01761292|11131236|FG000|STARTED|Extension 1||19
10008768|NCT01761292|11131236|FG000|COMPLETED|Extension 1||18
10008769|NCT01761292|11131236|FG000|NOT COMPLETED|Extension 1||1
10008770|NCT01761292|11131236|FG000|STARTED|Extension 2||18
10008771|NCT01761292|11131236|FG000|COMPLETED|Extension 2||18
10008772|NCT01761292|11131236|FG000|NOT COMPLETED|Extension 2||0
10008773|NCT01761292|11131236|FG000|STARTED|Extension 3||18
10008774|NCT01761292|11131236|FG000|COMPLETED|Extension 3||18
10008775|NCT01761292|11131236|FG000|NOT COMPLETED|Extension 3||0
10008776|NCT01761565|11131247|FG000|STARTED|Single Dose of SUF NT 15 mcg||40
10008777|NCT01761565|11131247|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40
10008778|NCT01761565|11131247|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
10008779|NCT01761565|11131247|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
10008780|NCT01761565|11131247|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
10008781|NCT01761565|11131247|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
10008782|NCT01761643|11131257|FG000|STARTED|Overall Study||198
10008783|NCT01761643|11131258|FG001|STARTED|Overall Study||200
10008784|NCT01761643|11131257|FG000|COMPLETED|Overall Study||166
10008785|NCT01761643|11131258|FG001|COMPLETED|Overall Study||158
10008786|NCT01761643|11131257|FG000|NOT COMPLETED|Overall Study||32
10008787|NCT01761643|11131258|FG001|NOT COMPLETED|Overall Study||42
10008788|NCT01761747|11131264|FG000|STARTED|Overall Study||3
10008789|NCT01761747|11131264|FG000|COMPLETED|Overall Study||2
10008790|NCT01761747|11131264|FG000|NOT COMPLETED|Overall Study||1
10008791|NCT01762059|11131268|FG000|STARTED|Overall Study||20
10008792|NCT01762059|11131268|FG000|COMPLETED|Overall Study||20
10008793|NCT01762059|11131268|FG000|NOT COMPLETED|Overall Study||0
10008794|NCT01762345|11131277|FG000|STARTED|Overall Study||83
10109813|NCT02480114|11240513|FG000|NOT COMPLETED|Overall Study||9
10109814|NCT02480114|11240514|FG001|NOT COMPLETED|Overall Study||8
10109815|NCT02480153|11240522|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
10109816|NCT02480153|11240523|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
9891502|NCT01086215|11006499|FG002|STARTED|Overall Study||73
9891503|NCT01086215|11006500|FG003|STARTED|Overall Study||14
9891504|NCT01086215|11006497|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
9891505|NCT01086215|11006498|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
9891506|NCT01086215|11006499|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
9891507|NCT01086215|11006500|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
9891508|NCT01086215|11006497|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
9891509|NCT01086215|11006498|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
10109817|NCT02480153|11240524|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
10109818|NCT02480153|11240522|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
10109819|NCT02480153|11240523|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
10109820|NCT02480153|11240524|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
10109821|NCT02480153|11240522|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
10109822|NCT02480153|11240523|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
10109823|NCT02480153|11240524|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
10109824|NCT02480153|11240522|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
10109825|NCT02480153|11240523|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
10109826|NCT02480153|11240524|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
10109827|NCT02480153|11240522|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
10109828|NCT02480153|11240523|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
10109829|NCT02480153|11240524|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
10109830|NCT02480153|11240522|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
10109831|NCT02480153|11240523|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
10109832|NCT02480153|11240524|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
10109833|NCT02480153|11240522|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
10109834|NCT02480153|11240523|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
10109835|NCT02480153|11240524|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
10109836|NCT02480153|11240522|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
10109837|NCT02480153|11240523|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
10109838|NCT02480153|11240524|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
10109839|NCT02480153|11240522|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259
10109840|NCT02480153|11240523|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121
10109841|NCT02480153|11240524|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127
10109842|NCT02480153|11240522|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
10109843|NCT02480153|11240523|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
10109844|NCT02480153|11240524|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
10109845|NCT02480153|11240522|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
10109846|NCT02480153|11240523|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
10109847|NCT02480153|11240524|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
10109848|NCT02480153|11240522|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
10109849|NCT02480153|11240523|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
10109850|NCT02480153|11240524|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
10109851|NCT02480166|11240550|FG000|STARTED|Overall Study||20
10109852|NCT02480166|11240551|FG001|STARTED|Overall Study||36
10109853|NCT02480166|11240552|FG002|STARTED|Overall Study||4
10109854|NCT02480166|11240550|FG000|COMPLETED|Overall Study||20
10109855|NCT02480166|11240551|FG001|COMPLETED|Overall Study||36
10109856|NCT02480166|11240552|FG002|COMPLETED|Overall Study||4
10109857|NCT02480166|11240550|FG000|NOT COMPLETED|Overall Study||0
10109858|NCT02480166|11240551|FG001|NOT COMPLETED|Overall Study||0
10109859|NCT02480166|11240552|FG002|NOT COMPLETED|Overall Study||0
10109860|NCT02480439|11240564|FG000|STARTED|Treatment Period 1||8
10109861|NCT02480439|11240565|FG001|STARTED|Treatment Period 1||8
10109862|NCT02480439|11240566|FG002|STARTED|Treatment Period 1||8
10109863|NCT02480439|11240564|FG000|COMPLETED|Treatment Period 1||8
10109864|NCT02480439|11240565|FG001|COMPLETED|Treatment Period 1||8
10109865|NCT02480439|11240566|FG002|COMPLETED|Treatment Period 1||8
10109866|NCT02480439|11240564|FG000|NOT COMPLETED|Treatment Period 1||0
10109867|NCT02480439|11240565|FG001|NOT COMPLETED|Treatment Period 1||0
10109868|NCT02480439|11240566|FG002|NOT COMPLETED|Treatment Period 1||0
10109869|NCT02480439|11240564|FG000|STARTED|Treatment Period 2||8
10109870|NCT02480439|11240565|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
10109871|NCT02480439|11240566|FG002|STARTED|Treatment Period 2||8
10109872|NCT02480439|11240564|FG000|COMPLETED|Treatment Period 2||8
10109873|NCT02480439|11240565|FG001|COMPLETED|Treatment Period 2||7
10109874|NCT02480439|11240566|FG002|COMPLETED|Treatment Period 2||8
10109875|NCT02480439|11240564|FG000|NOT COMPLETED|Treatment Period 2||0
10109876|NCT02480439|11240565|FG001|NOT COMPLETED|Treatment Period 2||0
10109877|NCT02480439|11240566|FG002|NOT COMPLETED|Treatment Period 2||0
10109878|NCT02480439|11240564|FG000|STARTED|Treatment Period 3||8
10109879|NCT02480439|11240565|FG001|STARTED|Treatment Period 3||7
10109880|NCT02480439|11240566|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
10109881|NCT02480439|11240564|FG000|COMPLETED|Treatment Period 3||8
10109882|NCT02480439|11240565|FG001|COMPLETED|Treatment Period 3||7
10109883|NCT02480439|11240566|FG002|COMPLETED|Treatment Period 3||7
10109884|NCT02480439|11240564|FG000|NOT COMPLETED|Treatment Period 3||0
9891510|NCT01086215|11006499|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
9891511|NCT01086215|11006500|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
9891512|NCT01086215|11006497|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
9891513|NCT01086215|11006498|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
9891514|NCT01086215|11006499|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
9891515|NCT01086215|11006500|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
10008795|NCT01762345|11131277|FG000|COMPLETED|Overall Study||76
10008796|NCT01762345|11131277|FG000|NOT COMPLETED|Overall Study||7
10008797|NCT01762501|11131284|FG000|STARTED|Overall Study||359
10008798|NCT01762501|11131285|FG001|STARTED|Overall Study||359
10008799|NCT01762501|11131284|FG000|COMPLETED|Overall Study||332
10109885|NCT02480439|11240565|FG001|NOT COMPLETED|Treatment Period 3||0
10109886|NCT02480439|11240566|FG002|NOT COMPLETED|Treatment Period 3||0
10109887|NCT02480582|11240574|FG000|STARTED|Overall Study||7
10109888|NCT02480582|11240575|FG001|STARTED|Overall Study||7
10109889|NCT02480582|11240576|FG002|STARTED|Overall Study||7
10109890|NCT02480582|11240577|FG003|STARTED|Overall Study||7
10109891|NCT02480582|11240578|FG004|STARTED|Overall Study||7
10109892|NCT02480582|11240579|FG005|STARTED|Overall Study||7
10109893|NCT02480582|11240574|FG000|COMPLETED|Overall Study||7
10109894|NCT02480582|11240575|FG001|COMPLETED|Overall Study||7
10109895|NCT02480582|11240576|FG002|COMPLETED|Overall Study||7
10109896|NCT02480582|11240577|FG003|COMPLETED|Overall Study||7
10109897|NCT02480582|11240578|FG004|COMPLETED|Overall Study||7
10109898|NCT02480582|11240579|FG005|COMPLETED|Overall Study||7
10109899|NCT02480582|11240574|FG000|NOT COMPLETED|Overall Study||0
10109900|NCT02480582|11240575|FG001|NOT COMPLETED|Overall Study||0
10109901|NCT02480582|11240576|FG002|NOT COMPLETED|Overall Study||0
10109902|NCT02480582|11240577|FG003|NOT COMPLETED|Overall Study||0
10109903|NCT02480582|11240578|FG004|NOT COMPLETED|Overall Study||0
10109904|NCT02480582|11240579|FG005|NOT COMPLETED|Overall Study||0
10109905|NCT02480621|11240594|FG000|STARTED|Randomization||44
10109906|NCT02480621|11240595|FG001|STARTED|Randomization||40
10109907|NCT02480621|11240594|FG000|COMPLETED|Randomization||43
10109908|NCT02480621|11240595|FG001|COMPLETED|Randomization||39
10109909|NCT02480621|11240594|FG000|NOT COMPLETED|Randomization||1
10109910|NCT02480621|11240595|FG001|NOT COMPLETED|Randomization||1
10109911|NCT02480621|11240594|FG000|STARTED|Follow Up||43
10109912|NCT02480621|11240595|FG001|STARTED|Follow Up||39
10109913|NCT02480621|11240594|FG000|COMPLETED|Follow Up||39
10109914|NCT02480621|11240595|FG001|COMPLETED|Follow Up||37
10109915|NCT02480621|11240594|FG000|NOT COMPLETED|Follow Up||4
10109916|NCT02480621|11240595|FG001|NOT COMPLETED|Follow Up||2
10109917|NCT02480712|11240601|FG000|STARTED|Overall Study||107
10109918|NCT02480712|11240601|FG000|COMPLETED|Overall Study||96
10109919|NCT02480712|11240601|FG000|NOT COMPLETED|Overall Study||11
10109920|NCT02480764|11240614|FG000|STARTED|Overall Study||199
10109921|NCT02480764|11240615|FG001|STARTED|Overall Study||209
10109922|NCT02480764|11240616|FG002|STARTED|Overall Study||204
10109923|NCT02480764|11240614|FG000|COMPLETED|Overall Study||189
10109924|NCT02480764|11240615|FG001|COMPLETED|Overall Study||189
10109925|NCT02480764|11240616|FG002|COMPLETED|Overall Study||183
9891516|NCT01086215|11006497|FG000|COMPLETED|Overall Study||176
9891517|NCT01086215|11006498|FG001|COMPLETED|Overall Study||154
9891518|NCT01086215|11006499|FG002|COMPLETED|Overall Study||47
9891519|NCT01086215|11006500|FG003|COMPLETED|Overall Study||11
9891520|NCT01086215|11006497|FG000|NOT COMPLETED|Overall Study||36
9891521|NCT01086215|11006498|FG001|NOT COMPLETED|Overall Study||47
10008800|NCT01762501|11131285|FG001|COMPLETED|Overall Study||336
10008801|NCT01762501|11131284|FG000|NOT COMPLETED|Overall Study||27
10008802|NCT01762501|11131285|FG001|NOT COMPLETED|Overall Study||23
10008803|NCT01762631|11131293|FG000|STARTED|Overall Study||53
10008804|NCT01762631|11131294|FG001|STARTED|Overall Study||22
10008805|NCT01762631|11131293|FG000|COMPLETED|Overall Study||53
10008806|NCT01762631|11131294|FG001|COMPLETED|Overall Study||22
10008807|NCT01762631|11131293|FG000|NOT COMPLETED|Overall Study||0
10008808|NCT01762631|11131294|FG001|NOT COMPLETED|Overall Study||0
10008809|NCT01762722|11131302|FG000|STARTED|Overall Study||12
10008810|NCT01762722|11131303|FG001|STARTED|Overall Study||11
10008811|NCT01762722|11131302|FG000|COMPLETED|Overall Study||12
10008812|NCT01762722|11131303|FG001|COMPLETED|Overall Study||11
10008813|NCT01762722|11131302|FG000|NOT COMPLETED|Overall Study||0
10008814|NCT01762722|11131303|FG001|NOT COMPLETED|Overall Study||0
10008815|NCT01762800|11131311|FG000|STARTED|Overall Study||202
10008816|NCT01762800|11131312|FG001|STARTED|Overall Study||204
10008817|NCT01762800|11131311|FG000|COMPLETED|Overall Study||183
10008818|NCT01762800|11131312|FG001|COMPLETED|Overall Study||183
10008819|NCT01762800|11131311|FG000|NOT COMPLETED|Overall Study||19
10008820|NCT01762800|11131312|FG001|NOT COMPLETED|Overall Study||21
10008821|NCT01762904|11131324|FG000|STARTED|Overall Study|January, 2013|135
10008822|NCT01762904|11131324|FG000|COMPLETED|Overall Study|October, 2013|135
10008823|NCT01762904|11131324|FG000|NOT COMPLETED|Overall Study||0
10008824|NCT01762943|11131333|FG000|STARTED|Overall Study||19
10008825|NCT01762943|11131334|FG001|STARTED|Overall Study||17
10008826|NCT01762943|11131333|FG000|Hypogonadism|Overall Study||18
10008827|NCT01762943|11131334|FG001|Hypogonadism|Overall Study||15
10008828|NCT01762943|11131333|FG000|Addback|Overall Study||16
10008829|NCT01762943|11131334|FG001|Addback|Overall Study||15
10008830|NCT01762943|11131333|FG000|Withdrawal|Overall Study||15
10008831|NCT01762943|11131334|FG001|Withdrawal|Overall Study||15
10008832|NCT01762943|11131333|FG000|COMPLETED|Overall Study||15
10008833|NCT01762943|11131334|FG001|COMPLETED|Overall Study||15
10008834|NCT01762943|11131333|FG000|NOT COMPLETED|Overall Study||4
9891522|NCT01086215|11006499|FG002|NOT COMPLETED|Overall Study||26
9891523|NCT01086215|11006500|FG003|NOT COMPLETED|Overall Study||3
9891524|NCT01086228|11006510|FG000|STARTED|8 Month Follow-up|Analysis population|2009
9891525|NCT01086228|11006510|FG000|COMPLETED|8 Month Follow-up||1938
9891526|NCT01086228|11006510|FG000|NOT COMPLETED|8 Month Follow-up||71
9891527|NCT01086228|11006510|FG000|STARTED|1-year Follow-up||1938
9891528|NCT01086228|11006510|FG000|COMPLETED|1-year Follow-up||1894
9891529|NCT01086228|11006510|FG000|NOT COMPLETED|1-year Follow-up||44
10109926|NCT02480764|11240614|FG000|NOT COMPLETED|Overall Study||10
10109927|NCT02480764|11240615|FG001|NOT COMPLETED|Overall Study||20
10109928|NCT02480764|11240616|FG002|NOT COMPLETED|Overall Study||21
10109929|NCT02480920|11240624|FG000|STARTED|Overall Study||2738
10109930|NCT02480920|11240624|FG000|COMPLETED|Overall Study||2738
10109931|NCT02480920|11240624|FG000|NOT COMPLETED|Overall Study||0
10109932|NCT02480998|11240630|FG000|STARTED|Overall Study||56
10109933|NCT02480998|11240631|FG001|STARTED|Overall Study||28
10109934|NCT02480998|11240630|FG000|COMPLETED|Overall Study||56
10109935|NCT02480998|11240631|FG001|COMPLETED|Overall Study||28
10109936|NCT02480998|11240630|FG000|NOT COMPLETED|Overall Study||0
10109937|NCT02480998|11240631|FG001|NOT COMPLETED|Overall Study||0
10109938|NCT02481050|11240639|FG000|STARTED|Overall Study||58
10109939|NCT02481050|11240639|FG000|COMPLETED|Overall Study||0
10109940|NCT02481050|11240639|FG000|NOT COMPLETED|Overall Study||58
10109941|NCT02481141|11240645|FG000|STARTED|Overall Study||35
10109942|NCT02481141|11240646|FG001|STARTED|Overall Study||18
10109943|NCT02481141|11240645|FG000|COMPLETED|Overall Study||26
10109944|NCT02481141|11240646|FG001|COMPLETED|Overall Study||13
10109945|NCT02481141|11240645|FG000|NOT COMPLETED|Overall Study||9
10109946|NCT02481141|11240646|FG001|NOT COMPLETED|Overall Study||5
10109947|NCT02481206|11240675|FG000|STARTED|Overall Study||34
10109948|NCT02481206|11240676|FG001|STARTED|Overall Study||32
10109949|NCT02481206|11240675|FG000|COMPLETED|Overall Study||29
10109950|NCT02481206|11240676|FG001|COMPLETED|Overall Study||31
10109951|NCT02481206|11240675|FG000|NOT COMPLETED|Overall Study||5
10109952|NCT02481206|11240676|FG001|NOT COMPLETED|Overall Study||1
10109953|NCT02481219|11240686|FG000|STARTED|Overall Study||60
10109954|NCT02481219|11240687|FG001|STARTED|Overall Study||62
10109955|NCT02481219|11240686|FG000|COMPLETED|Overall Study||58
10109956|NCT02481219|11240687|FG001|COMPLETED|Overall Study||61
10109957|NCT02481219|11240686|FG000|NOT COMPLETED|Overall Study||2
10109958|NCT02481219|11240687|FG001|NOT COMPLETED|Overall Study||1
10109959|NCT02481258|11240699|FG000|STARTED|Overall Study||12
10109960|NCT02481258|11240700|FG001|STARTED|Overall Study||11
10109961|NCT02481258|11240699|FG000|COMPLETED|Overall Study||12
10109962|NCT02481258|11240700|FG001|COMPLETED|Overall Study||11
10109963|NCT02481258|11240699|FG000|NOT COMPLETED|Overall Study||0
10109964|NCT02481258|11240700|FG001|NOT COMPLETED|Overall Study||0
10109965|NCT02481297|11240710|FG000|STARTED|Overall Study||1
10109966|NCT02481297|11240711|FG001|STARTED|Overall Study||6
10109967|NCT02481297|11240710|FG000|COMPLETED|Overall Study||1
10109968|NCT02481297|11240711|FG001|COMPLETED|Overall Study||6
10109969|NCT02481297|11240710|FG000|NOT COMPLETED|Overall Study||0
10109970|NCT02481297|11240711|FG001|NOT COMPLETED|Overall Study||0
10109971|NCT02481375|11240721|FG000|STARTED|Overall Study||206
10109972|NCT02481375|11240722|FG001|STARTED|Overall Study||202
10109973|NCT02481375|11240723|FG002|STARTED|Overall Study||201
10109974|NCT02481375|11240724|FG003|STARTED|Overall Study||200
10109975|NCT02481375|11240721|FG000|COMPLETED|Overall Study||192
10109976|NCT02481375|11240722|FG001|COMPLETED|Overall Study||191
10109977|NCT02481375|11240723|FG002|COMPLETED|Overall Study||191
10109978|NCT02481375|11240724|FG003|COMPLETED|Overall Study||186
10109979|NCT02481375|11240721|FG000|NOT COMPLETED|Overall Study||14
10109980|NCT02481375|11240722|FG001|NOT COMPLETED|Overall Study||11
10109981|NCT02481375|11240723|FG002|NOT COMPLETED|Overall Study||10
10109982|NCT02481375|11240724|FG003|NOT COMPLETED|Overall Study||14
10109983|NCT02481440|11240734|FG000|STARTED|Overall Study||102
10109984|NCT02481440|11240734|FG000|COMPLETED|Overall Study||41
10109985|NCT02481440|11240734|FG000|NOT COMPLETED|Overall Study||61
10109986|NCT02481505|11240741|FG000|STARTED|Overall Study||15
10109987|NCT02481505|11240742|FG001|STARTED|Overall Study||15
10109988|NCT02481505|11240743|FG002|STARTED|Overall Study||15
10109989|NCT02481505|11240741|FG000|COMPLETED|Overall Study||15
10109990|NCT02481505|11240742|FG001|COMPLETED|Overall Study||15
10109991|NCT02481505|11240743|FG002|COMPLETED|Overall Study||15
10109992|NCT02481505|11240741|FG000|NOT COMPLETED|Overall Study||0
10109993|NCT02481505|11240742|FG001|NOT COMPLETED|Overall Study||0
10109994|NCT02481505|11240743|FG002|NOT COMPLETED|Overall Study||0
10109995|NCT02481557|11240753|FG000|STARTED|Overall Study||17
10109996|NCT02481557|11240754|FG001|STARTED|Overall Study||19
10109997|NCT02481557|11240753|FG000|COMPLETED|Overall Study||17
10109998|NCT02481557|11240754|FG001|COMPLETED|Overall Study||19
10109999|NCT02481557|11240753|FG000|NOT COMPLETED|Overall Study||0
10110000|NCT02481557|11240754|FG001|NOT COMPLETED|Overall Study||0
9891530|NCT01086228|11006510|FG000|STARTED|2-year Follow-up||1894
9891531|NCT01086228|11006510|FG000|COMPLETED|2-year Follow-up||1834
9891532|NCT01086228|11006510|FG000|NOT COMPLETED|2-year Follow-up||60
9891533|NCT01086228|11006510|FG000|STARTED|3-year Follow-up||1834
10110001|NCT02481596|11240763|FG000|STARTED|Overall Study||126
10110002|NCT02481596|11240764|FG001|STARTED|Overall Study||127
10110003|NCT02481596|11240765|FG002|STARTED|Overall Study||253
10110004|NCT02481596|11240763|FG000|COMPLETED|Overall Study||123
10110005|NCT02481596|11240764|FG001|COMPLETED|Overall Study||126
10110006|NCT02481596|11240765|FG002|COMPLETED|Overall Study||245
9891534|NCT01086228|11006510|FG000|COMPLETED|3-year Follow-up||1767
9891535|NCT01086228|11006510|FG000|NOT COMPLETED|3-year Follow-up||67
9891536|NCT01086228|11006510|FG000|STARTED|4-year Follow-up||1767
9891537|NCT01086228|11006510|FG000|COMPLETED|4-year Follow-up||1664
9891538|NCT01086228|11006510|FG000|NOT COMPLETED|4-year Follow-up||103
9891539|NCT01086228|11006510|FG000|STARTED|5-year Follow-up||1664
9891540|NCT01086228|11006510|FG000|COMPLETED|5-year Follow-up||1012
9891541|NCT01086228|11006510|FG000|NOT COMPLETED|5-year Follow-up||652
9891542|NCT01086358|11006514|FG000|STARTED|First Intervention|30 subjects enrolled.|30
9891543|NCT01086358|11006515|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
9891544|NCT01086358|11006514|FG000|COMPLETED|First Intervention||21
9891545|NCT01086358|11006515|FG001|COMPLETED|First Intervention||24
9891546|NCT01086358|11006514|FG000|NOT COMPLETED|First Intervention||9
9891547|NCT01086358|11006515|FG001|NOT COMPLETED|First Intervention||5
9891548|NCT01086358|11006514|FG000|STARTED|Second Intervention||21
9891549|NCT01086358|11006515|FG001|STARTED|Second Intervention||24
9891550|NCT01086358|11006514|FG000|COMPLETED|Second Intervention||17
9891551|NCT01086358|11006515|FG001|COMPLETED|Second Intervention||20
9891552|NCT01086358|11006514|FG000|NOT COMPLETED|Second Intervention||4
9891553|NCT01086358|11006515|FG001|NOT COMPLETED|Second Intervention||4
10008835|NCT01762943|11131334|FG001|NOT COMPLETED|Overall Study||2
10008836|NCT01762982|11131340|FG000|STARTED|Overall Study||36
9891554|NCT01086384|11006523|FG000|STARTED|2-week Run-in Period||2183
9891555|NCT01086384|11006524|FG001|STARTED|2-week Run-in Period||0
9891556|NCT01086384|11006525|FG002|STARTED|2-week Run-in Period||0
9891557|NCT01086384|11006523|FG000|COMPLETED|2-week Run-in Period||2020
9891558|NCT01086384|11006524|FG001|COMPLETED|2-week Run-in Period||0
9891559|NCT01086384|11006525|FG002|COMPLETED|2-week Run-in Period||0
9891560|NCT01086384|11006523|FG000|NOT COMPLETED|2-week Run-in Period||163
9891561|NCT01086384|11006524|FG001|NOT COMPLETED|2-week Run-in Period||0
9891562|NCT01086384|11006525|FG002|NOT COMPLETED|2-week Run-in Period||0
9891563|NCT01086384|11006523|FG000|STARTED|Treatment Period||0
9891564|NCT01086384|11006524|FG001|STARTED|Treatment Period||1011
9891565|NCT01086384|11006525|FG002|STARTED|Treatment Period||1009
9891566|NCT01086384|11006523|FG000|COMPLETED|Treatment Period||0
9891567|NCT01086384|11006524|FG001|COMPLETED|Treatment Period||863
9891568|NCT01086384|11006525|FG002|COMPLETED|Treatment Period||885
9891569|NCT01086384|11006523|FG000|NOT COMPLETED|Treatment Period||0
9891570|NCT01086384|11006524|FG001|NOT COMPLETED|Treatment Period||148
9891571|NCT01086384|11006525|FG002|NOT COMPLETED|Treatment Period||124
9891572|NCT01086410|11006535|FG000|STARTED|Overall Study||58
9891573|NCT01086410|11006536|FG001|STARTED|Overall Study||56
9891574|NCT01086410|11006537|FG002|STARTED|Overall Study||56
9891575|NCT01086410|11006538|FG003|STARTED|Overall Study||15
9891576|NCT01086410|11006535|FG000|COMPLETED|Overall Study||55
9891577|NCT01086410|11006536|FG001|COMPLETED|Overall Study||54
9891578|NCT01086410|11006537|FG002|COMPLETED|Overall Study||55
9891579|NCT01086410|11006538|FG003|COMPLETED|Overall Study||13
9891580|NCT01086410|11006535|FG000|NOT COMPLETED|Overall Study||3
9891581|NCT01086410|11006536|FG001|NOT COMPLETED|Overall Study||2
9891582|NCT01086410|11006537|FG002|NOT COMPLETED|Overall Study||1
9891583|NCT01086410|11006538|FG003|NOT COMPLETED|Overall Study||2
9891584|NCT01086423|11006551|FG000|STARTED|Overall Study||330
9891585|NCT01086423|11006552|FG001|STARTED|Overall Study||324
9891586|NCT01086423|11006553|FG002|STARTED|Overall Study||330
9891587|NCT01086423|11006551|FG000|COMPLETED|Overall Study||320
9891588|NCT01086423|11006552|FG001|COMPLETED|Overall Study||321
9891589|NCT01086423|11006553|FG002|COMPLETED|Overall Study||321
9891590|NCT01086423|11006551|FG000|NOT COMPLETED|Overall Study||10
9891591|NCT01086423|11006552|FG001|NOT COMPLETED|Overall Study||3
9891592|NCT01086423|11006553|FG002|NOT COMPLETED|Overall Study||9
9891593|NCT01086475|11006563|FG000|STARTED|Overall Study||34
9891594|NCT01086475|11006564|FG001|STARTED|Overall Study||33
9891595|NCT01086475|11006563|FG000|COMPLETED|Overall Study||34
9891596|NCT01086475|11006564|FG001|COMPLETED|Overall Study||33
9891597|NCT01086475|11006563|FG000|NOT COMPLETED|Overall Study||0
9891598|NCT01086475|11006564|FG001|NOT COMPLETED|Overall Study||0
9891599|NCT01086540|11006572|FG000|STARTED|Overall Study||29
9891600|NCT01086540|11006573|FG001|STARTED|Overall Study||28
9891601|NCT01086540|11006572|FG000|COMPLETED|Overall Study||23
9891602|NCT01086540|11006573|FG001|COMPLETED|Overall Study||26
9891603|NCT01086540|11006572|FG000|NOT COMPLETED|Overall Study||6
9891604|NCT01086540|11006573|FG001|NOT COMPLETED|Overall Study||2
9891605|NCT01086605|11006581|FG000|STARTED|Overall Study||24
9891606|NCT01086605|11006582|FG001|STARTED|Overall Study||22
9891607|NCT01086605|11006581|FG000|COMPLETED|Overall Study||24
9891608|NCT01086605|11006582|FG001|COMPLETED|Overall Study||22
9891609|NCT01086605|11006581|FG000|NOT COMPLETED|Overall Study||0
9891610|NCT01086605|11006582|FG001|NOT COMPLETED|Overall Study||0
9891611|NCT01086761|11006594|FG000|STARTED|Overall Study||9
9891612|NCT01086761|11006595|FG001|STARTED|Overall Study||7
9891613|NCT01086761|11006596|FG002|STARTED|Overall Study||6
9891614|NCT01086761|11006597|FG003|STARTED|Overall Study||6
9891615|NCT01086761|11006598|FG004|STARTED|Overall Study||4
9891616|NCT01086761|11006599|FG005|STARTED|Overall Study||0
9891617|NCT01086761|11006594|FG000|COMPLETED|Overall Study||9
9891618|NCT01086761|11006595|FG001|COMPLETED|Overall Study||7
9891619|NCT01086761|11006596|FG002|COMPLETED|Overall Study||6
9891620|NCT01086761|11006597|FG003|COMPLETED|Overall Study||6
10008837|NCT01762982|11131340|FG000|Received Saline Water|Overall Study||36
9891621|NCT01086761|11006598|FG004|COMPLETED|Overall Study||4
9891622|NCT01086761|11006599|FG005|COMPLETED|Overall Study||0
9891623|NCT01086761|11006594|FG000|NOT COMPLETED|Overall Study||0
9891624|NCT01086761|11006595|FG001|NOT COMPLETED|Overall Study||0
9891625|NCT01086761|11006596|FG002|NOT COMPLETED|Overall Study||0
9891626|NCT01086761|11006597|FG003|NOT COMPLETED|Overall Study||0
10110007|NCT02481596|11240763|FG000|NOT COMPLETED|Overall Study||3
10110008|NCT02481596|11240764|FG001|NOT COMPLETED|Overall Study||1
10110009|NCT02481596|11240765|FG002|NOT COMPLETED|Overall Study||8
10110010|NCT02481713|11240775|FG000|STARTED|Overall Study||56
10110011|NCT02481713|11240776|FG001|STARTED|Overall Study||58
10110012|NCT02481713|11240775|FG000|COMPLETED|Overall Study||40
10110013|NCT02481713|11240776|FG001|COMPLETED|Overall Study||42
10110014|NCT02481713|11240775|FG000|NOT COMPLETED|Overall Study||16
10110015|NCT02481713|11240776|FG001|NOT COMPLETED|Overall Study||16
10110016|NCT02481869|11240784|FG000|STARTED|Overall Study||5
10110017|NCT02481869|11240785|FG001|STARTED|Overall Study||6
10110018|NCT02481869|11240784|FG000|COMPLETED|Overall Study||0
10110019|NCT02481869|11240785|FG001|COMPLETED|Overall Study||2
10110020|NCT02481869|11240784|FG000|NOT COMPLETED|Overall Study||5
10110021|NCT02481869|11240785|FG001|NOT COMPLETED|Overall Study||4
10110022|NCT02481934|11240792|FG000|STARTED|Overall Study||5
10110023|NCT02481934|11240792|FG000|COMPLETED|Overall Study||3
10110024|NCT02481934|11240792|FG000|NOT COMPLETED|Overall Study||2
10110025|NCT02481947|11240798|FG000|STARTED|Overall Study||230
10110026|NCT02481947|11240799|FG001|STARTED|Overall Study||229
10110027|NCT02481947|11240798|FG000|COMPLETED|Overall Study||184
10110028|NCT02481947|11240799|FG001|COMPLETED|Overall Study||193
10110029|NCT02481947|11240798|FG000|NOT COMPLETED|Overall Study||46
10110030|NCT02481947|11240799|FG001|NOT COMPLETED|Overall Study||36
10110031|NCT02482025|11240807|FG000|STARTED|Overall Study||122
10110032|NCT02482025|11240808|FG001|STARTED|Overall Study||118
10110033|NCT02482025|11240807|FG000|COMPLETED|Overall Study||122
10110034|NCT02482025|11240808|FG001|COMPLETED|Overall Study||118
10110035|NCT02482025|11240807|FG000|NOT COMPLETED|Overall Study||0
10110036|NCT02482025|11240808|FG001|NOT COMPLETED|Overall Study||0
10110037|NCT02482129|11240816|FG000|STARTED|Overall Study||32
10110038|NCT02482129|11240817|FG001|STARTED|Overall Study||11
10110039|NCT02482129|11240816|FG000|Treated, as Randomized|Overall Study||30
10110040|NCT02482129|11240817|FG001|Treated, as Randomized|Overall Study||9
10110041|NCT02482129|11240816|FG000|COMPLETED|Overall Study||26
10110042|NCT02482129|11240817|FG001|COMPLETED|Overall Study||9
10110043|NCT02482129|11240816|FG000|NOT COMPLETED|Overall Study||6
10110044|NCT02482129|11240817|FG001|NOT COMPLETED|Overall Study||2
10110045|NCT02482298|11240828|FG000|STARTED|Overall Study||30
10110046|NCT02482298|11240829|FG001|STARTED|Overall Study||27
10110047|NCT02482298|11240830|FG002|STARTED|Overall Study||30
10110048|NCT02482298|11240828|FG000|COMPLETED|Overall Study||28
10110049|NCT02482298|11240829|FG001|COMPLETED|Overall Study||24
10110050|NCT02482298|11240830|FG002|COMPLETED|Overall Study||27
10110051|NCT02482298|11240828|FG000|NOT COMPLETED|Overall Study||2
10110052|NCT02482298|11240829|FG001|NOT COMPLETED|Overall Study||3
10110053|NCT02482298|11240830|FG002|NOT COMPLETED|Overall Study||3
10110054|NCT02482428|11240843|FG000|STARTED|Overall Study||24
10110055|NCT02482428|11240844|FG001|STARTED|Overall Study||22
10110056|NCT02482428|11240845|FG002|STARTED|Overall Study||10
10110057|NCT02482428|11240846|FG003|STARTED|Overall Study||10
10110058|NCT02482428|11240847|FG004|STARTED|Overall Study||22
10110059|NCT02482428|11240843|FG000|COMPLETED|Overall Study||15
10110060|NCT02482428|11240844|FG001|COMPLETED|Overall Study||10
10110061|NCT02482428|11240845|FG002|COMPLETED|Overall Study||9
10110062|NCT02482428|11240846|FG003|COMPLETED|Overall Study||8
10110063|NCT02482428|11240847|FG004|COMPLETED|Overall Study||15
10110064|NCT02482428|11240843|FG000|NOT COMPLETED|Overall Study||9
10110065|NCT02482428|11240844|FG001|NOT COMPLETED|Overall Study||12
10110066|NCT02482428|11240845|FG002|NOT COMPLETED|Overall Study||1
10110067|NCT02482428|11240846|FG003|NOT COMPLETED|Overall Study||2
10110068|NCT02482428|11240847|FG004|NOT COMPLETED|Overall Study||7
10110069|NCT02482571|11240861|FG000|STARTED|Overall Study||25
10110070|NCT02482571|11240861|FG000|COMPLETED|Overall Study||17
10110071|NCT02482571|11240861|FG000|NOT COMPLETED|Overall Study||8
10110072|NCT02482610|11240866|FG000|STARTED|Overall Study||4
10110073|NCT02482610|11240867|FG001|STARTED|Overall Study||5
10110074|NCT02482610|11240868|FG002|STARTED|Overall Study||2
10110075|NCT02482610|11240869|FG003|STARTED|Overall Study||3
10110076|NCT02482610|11240870|FG004|STARTED|Overall Study||3
10110077|NCT02482610|11240871|FG005|STARTED|Overall Study||5
10110078|NCT02482610|11240866|FG000|COMPLETED|Overall Study||4
10110079|NCT02482610|11240867|FG001|COMPLETED|Overall Study||5
10110080|NCT02482610|11240868|FG002|COMPLETED|Overall Study||2
9891627|NCT01086761|11006598|FG004|NOT COMPLETED|Overall Study||0
9891628|NCT01086761|11006599|FG005|NOT COMPLETED|Overall Study||0
9891629|NCT01086852|11006612|FG000|STARTED|Overall Study||4
9891630|NCT01086852|11006612|FG000|COMPLETED|Overall Study||4
10110081|NCT02482610|11240869|FG003|COMPLETED|Overall Study||3
10110082|NCT02482610|11240870|FG004|COMPLETED|Overall Study||3
10110083|NCT02482610|11240871|FG005|COMPLETED|Overall Study||5
10110084|NCT02482610|11240866|FG000|NOT COMPLETED|Overall Study||0
10110085|NCT02482610|11240867|FG001|NOT COMPLETED|Overall Study||0
10110086|NCT02482610|11240868|FG002|NOT COMPLETED|Overall Study||0
10110087|NCT02482610|11240869|FG003|NOT COMPLETED|Overall Study||0
9891631|NCT01086852|11006612|FG000|NOT COMPLETED|Overall Study||0
9891632|NCT01086969|11006620|FG000|STARTED|Overall Study||100
9891633|NCT01086969|11006621|FG001|STARTED|Overall Study||100
9891634|NCT01086969|11006622|FG002|STARTED|Overall Study||100
9891635|NCT01086969|11006620|FG000|COMPLETED|Overall Study||99
9891636|NCT01086969|11006621|FG001|COMPLETED|Overall Study||98
9891637|NCT01086969|11006622|FG002|COMPLETED|Overall Study||100
9891638|NCT01086969|11006620|FG000|NOT COMPLETED|Overall Study||1
9891639|NCT01086969|11006621|FG001|NOT COMPLETED|Overall Study||2
9891640|NCT01086969|11006622|FG002|NOT COMPLETED|Overall Study||0
9891641|NCT01087489|11006630|FG000|STARTED|Overall Study||19
9891642|NCT01087489|11006631|FG001|STARTED|Overall Study||34
9891643|NCT01087489|11006630|FG000|COMPLETED|Overall Study||19
9891644|NCT01087489|11006631|FG001|COMPLETED|Overall Study||31
9891645|NCT01087489|11006630|FG000|NOT COMPLETED|Overall Study||0
9891646|NCT01087489|11006631|FG001|NOT COMPLETED|Overall Study||3
9891647|NCT01087502|11006639|FG000|STARTED|Up to Interim Analysis (Week 12)||123
9891648|NCT01087502|11006640|FG001|STARTED|Up to Interim Analysis (Week 12)||118
9891649|NCT01087502|11006639|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114
9891650|NCT01087502|11006640|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110
9891651|NCT01087502|11006639|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
9891652|NCT01087502|11006640|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
9891653|NCT01087502|11006639|FG000|STARTED|Up to Final Analysis (Week 52)||123
9891654|NCT01087502|11006640|FG001|STARTED|Up to Final Analysis (Week 52)||118
9891655|NCT01087502|11006639|FG000|COMPLETED|Up to Final Analysis (Week 52)||90
9891656|NCT01087502|11006640|FG001|COMPLETED|Up to Final Analysis (Week 52)||95
9891657|NCT01087502|11006639|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33
9891658|NCT01087502|11006640|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23
9891659|NCT01087528|11006648|FG000|STARTED|Overall Study||51
9891660|NCT01087528|11006648|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
9891661|NCT01087528|11006648|FG000|NOT COMPLETED|Overall Study||7
9891662|NCT01087541|11006656|FG000|STARTED|Overall Study||3307
9891663|NCT01087541|11006657|FG001|STARTED|Overall Study||3523
9891664|NCT01087541|11006656|FG000|COMPLETED|Overall Study||3307
9891665|NCT01087541|11006657|FG001|COMPLETED|Overall Study||3523
9891666|NCT01087541|11006656|FG000|NOT COMPLETED|Overall Study||0
9891667|NCT01087541|11006657|FG001|NOT COMPLETED|Overall Study||0
9891668|NCT01087723|11006665|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
9891669|NCT01087723|11006666|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
9891670|NCT01087723|11006665|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
9891671|NCT01087723|11006666|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
9891672|NCT01087723|11006665|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
9891673|NCT01087723|11006666|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
9891674|NCT01087723|11006665|FG000|NOT COMPLETED|Overall Study||14
9891675|NCT01087723|11006666|FG001|NOT COMPLETED|Overall Study||20
9891676|NCT01087736|11006674|FG000|STARTED|Overall Study||14
9891677|NCT01087736|11006675|FG001|STARTED|Overall Study||16
9891678|NCT01087736|11006674|FG000|COMPLETED|Overall Study||13
9891679|NCT01087736|11006675|FG001|COMPLETED|Overall Study||14
9891680|NCT01087736|11006674|FG000|NOT COMPLETED|Overall Study||1
9891681|NCT01087736|11006675|FG001|NOT COMPLETED|Overall Study||2
9891682|NCT01087762|11006684|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
9891683|NCT01087762|11006685|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
9891684|NCT01087762|11006686|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
9891685|NCT01087762|11006687|FG003|STARTED|Double Blind Period (Weeks 0-24)||0
9891686|NCT01087762|11006688|FG004|STARTED|Double Blind Period (Weeks 0-24)||0
10110088|NCT02482610|11240870|FG004|NOT COMPLETED|Overall Study||0
10110089|NCT02482610|11240871|FG005|NOT COMPLETED|Overall Study||0
10110090|NCT02482675|11240882|FG000|STARTED|Overall Study||1
10110091|NCT02482675|11240883|FG001|STARTED|Overall Study||1
10110092|NCT02482675|11240884|FG002|STARTED|Overall Study||1
10110093|NCT02482675|11240885|FG003|STARTED|Overall Study||1
9891687|NCT01087762|11006684|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95
9891688|NCT01087762|11006685|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105
9891689|NCT01087762|11006686|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98
9891690|NCT01087762|11006687|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0
9891691|NCT01087762|11006688|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0
9891692|NCT01087762|11006684|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
10110094|NCT02482675|11240886|FG004|STARTED|Overall Study||1
10110095|NCT02482675|11240887|FG005|STARTED|Overall Study||1
10110096|NCT02482675|11240888|FG006|STARTED|Overall Study||1
9891693|NCT01087762|11006685|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
9891694|NCT01087762|11006686|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
9891695|NCT01087762|11006687|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
9891696|NCT01087762|11006688|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
9891697|NCT01087762|11006684|FG000|STARTED|Open-Label Period (Weeks 48-204)||0
9891698|NCT01087762|11006685|FG001|STARTED|Open-Label Period (Weeks 48-204)||0
9891699|NCT01087762|11006686|FG002|STARTED|Open-Label Period (Weeks 48-204)||0
9891700|NCT01087762|11006687|FG003|STARTED|Open-Label Period (Weeks 48-204)||158
9891701|NCT01087762|11006688|FG004|STARTED|Open-Label Period (Weeks 48-204)||157
9891702|NCT01087762|11006684|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0
9891703|NCT01087762|11006685|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0
9891704|NCT01087762|11006686|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0
9891705|NCT01087762|11006687|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99
9891706|NCT01087762|11006688|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100
9891707|NCT01087762|11006684|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
9891708|NCT01087762|11006685|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
9891709|NCT01087762|11006686|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
9891710|NCT01087762|11006687|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
9891711|NCT01087762|11006688|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
9891712|NCT01087775|11006698|FG000|STARTED|Overall Study||25
9891713|NCT01087775|11006698|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
9891714|NCT01087775|11006698|FG000|NOT COMPLETED|Overall Study||2
9891715|NCT01087788|11006706|FG000|STARTED|24-weeks Double-blind Period||136
9891716|NCT01087788|11006707|FG001|STARTED|24-weeks Double-blind Period||138
9891717|NCT01087788|11006708|FG002|STARTED|24-weeks Double-blind Period||135
9891718|NCT01087788|11006706|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
9891719|NCT01087788|11006707|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
9891720|NCT01087788|11006708|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
9891721|NCT01087788|11006706|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
9891722|NCT01087788|11006707|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
9891723|NCT01087788|11006708|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
9891724|NCT01087788|11006706|FG000|COMPLETED|24-weeks Double-blind Period||120
9891725|NCT01087788|11006707|FG001|COMPLETED|24-weeks Double-blind Period||128
9891726|NCT01087788|11006708|FG002|COMPLETED|24-weeks Double-blind Period||120
9891727|NCT01087788|11006706|FG000|NOT COMPLETED|24-weeks Double-blind Period||16
9891728|NCT01087788|11006707|FG001|NOT COMPLETED|24-weeks Double-blind Period||10
9891729|NCT01087788|11006708|FG002|NOT COMPLETED|24-weeks Double-blind Period||15
9891730|NCT01087788|11006706|FG000|STARTED|24-weeks Dose-blind Period||120
9891731|NCT01087788|11006707|FG001|STARTED|24-weeks Dose-blind Period||128
9891732|NCT01087788|11006708|FG002|STARTED|24-weeks Dose-blind Period||120
9891733|NCT01087788|11006706|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
9891734|NCT01087788|11006707|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
9891735|NCT01087788|11006708|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
9891736|NCT01087788|11006706|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
9891737|NCT01087788|11006707|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
9891738|NCT01087788|11006708|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
9891739|NCT01087788|11006706|FG000|COMPLETED|24-weeks Dose-blind Period||113
9891740|NCT01087788|11006707|FG001|COMPLETED|24-weeks Dose-blind Period||123
9891741|NCT01087788|11006708|FG002|COMPLETED|24-weeks Dose-blind Period||114
9891742|NCT01087788|11006706|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7
9891743|NCT01087788|11006707|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5
9891744|NCT01087788|11006708|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6
9891745|NCT01087788|11006706|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
9891746|NCT01087788|11006707|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
9891747|NCT01087788|11006708|FG002|STARTED|Open-Label Period (OL-P)||114
9891748|NCT01087788|11006706|FG000|COMPLETED|Open-Label Period (OL-P)||81
9891749|NCT01087788|11006707|FG001|COMPLETED|Open-Label Period (OL-P)||97
9891750|NCT01087788|11006708|FG002|COMPLETED|Open-Label Period (OL-P)||86
9891751|NCT01087788|11006706|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30
9891752|NCT01087788|11006707|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24
9891753|NCT01087788|11006708|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28
9891754|NCT01087801|11006719|FG000|STARTED|Overall Study||30
9891755|NCT01087801|11006720|FG001|STARTED|Overall Study||34
9891756|NCT01087801|11006719|FG000|COMPLETED|Overall Study||26
9891757|NCT01087801|11006720|FG001|COMPLETED|Overall Study||29
9891758|NCT01087801|11006719|FG000|NOT COMPLETED|Overall Study||4
9891759|NCT01087801|11006720|FG001|NOT COMPLETED|Overall Study||5
9891760|NCT01087814|11006728|FG000|STARTED|First Intervention (5 Days)||8
9891761|NCT01087814|11006729|FG001|STARTED|First Intervention (5 Days)||7
9891762|NCT01087814|11006728|FG000|COMPLETED|First Intervention (5 Days)||5
9891763|NCT01087814|11006729|FG001|COMPLETED|First Intervention (5 Days)||6
10110097|NCT02482675|11240889|FG007|STARTED|Overall Study||1
10110098|NCT02482675|11240890|FG008|STARTED|Overall Study||1
10110099|NCT02482675|11240891|FG009|STARTED|Overall Study||1
10110100|NCT02482675|11240892|FG010|STARTED|Overall Study||1
10110101|NCT02482675|11240893|FG011|STARTED|Overall Study||1
10110102|NCT02482675|11240894|FG012|STARTED|Overall Study||1
10110103|NCT02482675|11240895|FG013|STARTED|Overall Study||1
9891764|NCT01087814|11006728|FG000|NOT COMPLETED|First Intervention (5 Days)||3
9891765|NCT01087814|11006729|FG001|NOT COMPLETED|First Intervention (5 Days)||1
9891766|NCT01087814|11006728|FG000|STARTED|Second Intervention (5 Days)||5
9891767|NCT01087814|11006729|FG001|STARTED|Second Intervention (5 Days)||6
9891768|NCT01087814|11006728|FG000|COMPLETED|Second Intervention (5 Days)||4
9891769|NCT01087814|11006729|FG001|COMPLETED|Second Intervention (5 Days)||6
9891770|NCT01087814|11006728|FG000|NOT COMPLETED|Second Intervention (5 Days)||1
9891771|NCT01087814|11006729|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
9891772|NCT01087905|11006743|FG000|STARTED|Overall Study||119
9891773|NCT01087905|11006744|FG001|STARTED|Overall Study||126
9891774|NCT01087905|11006745|FG002|STARTED|Overall Study||123
9891775|NCT01087905|11006746|FG003|STARTED|Overall Study||122
9891776|NCT01087905|11006747|FG004|STARTED|Overall Study||122
9891777|NCT01087905|11006748|FG005|STARTED|Overall Study||127
9891778|NCT01087905|11006749|FG006|STARTED|Overall Study||121
9891779|NCT01087905|11006750|FG007|STARTED|Overall Study||127
9891780|NCT01087905|11006743|FG000|COMPLETED|Overall Study||90
9891781|NCT01087905|11006744|FG001|COMPLETED|Overall Study||94
9891782|NCT01087905|11006745|FG002|COMPLETED|Overall Study||101
9891783|NCT01087905|11006746|FG003|COMPLETED|Overall Study||86
9891784|NCT01087905|11006747|FG004|COMPLETED|Overall Study||91
9891785|NCT01087905|11006748|FG005|COMPLETED|Overall Study||99
9891786|NCT01087905|11006749|FG006|COMPLETED|Overall Study||98
9891787|NCT01087905|11006750|FG007|COMPLETED|Overall Study||98
9891788|NCT01087905|11006743|FG000|NOT COMPLETED|Overall Study||29
9891789|NCT01087905|11006744|FG001|NOT COMPLETED|Overall Study||32
9891790|NCT01087905|11006745|FG002|NOT COMPLETED|Overall Study||22
9891791|NCT01087905|11006746|FG003|NOT COMPLETED|Overall Study||36
9891792|NCT01087905|11006747|FG004|NOT COMPLETED|Overall Study||31
9891793|NCT01087905|11006748|FG005|NOT COMPLETED|Overall Study||28
9891794|NCT01087905|11006749|FG006|NOT COMPLETED|Overall Study||23
9891795|NCT01087905|11006750|FG007|NOT COMPLETED|Overall Study||29
9891796|NCT01087918|11006768|FG000|STARTED|Overall Study||5
9891797|NCT01087918|11006769|FG001|STARTED|Overall Study||4
9891798|NCT01087918|11006768|FG000|COMPLETED|Overall Study||5
9891799|NCT01087918|11006769|FG001|COMPLETED|Overall Study||4
9891800|NCT01087918|11006768|FG000|NOT COMPLETED|Overall Study||0
9891801|NCT01087918|11006769|FG001|NOT COMPLETED|Overall Study||0
9891802|NCT01087931|11006781|FG000|STARTED|Overall Study||20
9891803|NCT01087931|11006782|FG001|STARTED|Overall Study||20
9891804|NCT01087931|11006781|FG000|1st Follow up|Overall Study||20
9891805|NCT01087931|11006782|FG001|1st Follow up|Overall Study||19
9891806|NCT01087931|11006781|FG000|Final Follow up|Overall Study||19
9891807|NCT01087931|11006782|FG001|Final Follow up|Overall Study||17
9891808|NCT01087931|11006781|FG000|COMPLETED|Overall Study||20
9891809|NCT01087931|11006782|FG001|COMPLETED|Overall Study||20
9891810|NCT01087931|11006781|FG000|NOT COMPLETED|Overall Study||0
9891811|NCT01087931|11006782|FG001|NOT COMPLETED|Overall Study||0
9891812|NCT01087944|11006788|FG000|STARTED|Period 1 (Week 1-3)||30
9891813|NCT01087944|11006789|FG001|STARTED|Period 1 (Week 1-3)||30
9891814|NCT01087944|11006788|FG000|COMPLETED|Period 1 (Week 1-3)||29
9891815|NCT01087944|11006789|FG001|COMPLETED|Period 1 (Week 1-3)||30
9891816|NCT01087944|11006788|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1
9891817|NCT01087944|11006789|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0
9891818|NCT01087944|11006788|FG000|STARTED|Period 2 (Week 4-6)||29
9891819|NCT01087944|11006789|FG001|STARTED|Period 2 (Week 4-6)||30
9891820|NCT01087944|11006788|FG000|COMPLETED|Period 2 (Week 4-6)||29
9891821|NCT01087944|11006789|FG001|COMPLETED|Period 2 (Week 4-6)||28
9891822|NCT01087944|11006788|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0
9891823|NCT01087944|11006789|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2
9891824|NCT01087957|11006797|FG000|STARTED|Overall Study||253
9891825|NCT01087957|11006798|FG001|STARTED|Overall Study||242
9891826|NCT01087957|11006797|FG000|COMPLETED|Overall Study||212
9891827|NCT01087957|11006798|FG001|COMPLETED|Overall Study||187
9891828|NCT01087957|11006797|FG000|NOT COMPLETED|Overall Study||41
9891829|NCT01087957|11006798|FG001|NOT COMPLETED|Overall Study||55
9891830|NCT01087970|11006804|FG000|STARTED|Overall Study||69
9891831|NCT01087970|11006804|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69
9891832|NCT01087970|11006804|FG000|Completed 6 Cycles|Overall Study||69
9891833|NCT01087970|11006804|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
9891834|NCT01087970|11006804|FG000|Received Carboplatin|Overall Study||63
9891835|NCT01087970|11006804|FG000|COMPLETED|Overall Study||67
9891836|NCT01087970|11006804|FG000|NOT COMPLETED|Overall Study||2
9891837|NCT01087996|11006811|FG000|STARTED|Overall Study||15
9891838|NCT01087996|11006812|FG001|STARTED|Overall Study||15
9891839|NCT01087996|11006811|FG000|COMPLETED|Overall Study||15
9891840|NCT01087996|11006812|FG001|COMPLETED|Overall Study||15
9891841|NCT01087996|11006811|FG000|NOT COMPLETED|Overall Study||0
9891842|NCT01087996|11006812|FG001|NOT COMPLETED|Overall Study||0
9891843|NCT01088048|11006828|FG000|STARTED|Overall Study||51
9891844|NCT01088048|11006829|FG001|STARTED|Overall Study||51
9891845|NCT01088048|11006830|FG002|STARTED|Overall Study||18
9891846|NCT01088048|11006831|FG003|STARTED|Overall Study||18
9891847|NCT01088048|11006832|FG004|STARTED|Overall Study||33
9891848|NCT01088048|11006833|FG005|STARTED|Overall Study||21
9891849|NCT01088048|11006834|FG006|STARTED|Overall Study||12
9891850|NCT01088048|11006835|FG007|STARTED|Overall Study||15
9891851|NCT01088048|11006836|FG008|STARTED|Overall Study||15
9891852|NCT01088048|11006837|FG009|STARTED|Overall Study||7
9891853|NCT01088048|11006828|FG000|Participants With CLL|Overall Study||19
9891854|NCT01088048|11006829|FG001|Participants With CLL|Overall Study||18
9891855|NCT01088048|11006830|FG002|Participants With CLL|Overall Study||0
9891856|NCT01088048|11006831|FG003|Participants With CLL|Overall Study||0
9891857|NCT01088048|11006832|FG004|Participants With CLL|Overall Study||15
9891858|NCT01088048|11006833|FG005|Participants With CLL|Overall Study||21
9891859|NCT01088048|11006834|FG006|Participants With CLL|Overall Study||12
9891860|NCT01088048|11006835|FG007|Participants With CLL|Overall Study||15
9891861|NCT01088048|11006836|FG008|Participants With CLL|Overall Study||14
9891862|NCT01088048|11006837|FG009|Participants With CLL|Overall Study||1
9891863|NCT01088048|11006828|FG000|Participants With Indolent NHL|Overall Study||32
9891864|NCT01088048|11006829|FG001|Participants With Indolent NHL|Overall Study||33
9891865|NCT01088048|11006830|FG002|Participants With Indolent NHL|Overall Study||0
9891866|NCT01088048|11006831|FG003|Participants With Indolent NHL|Overall Study||0
9891867|NCT01088048|11006832|FG004|Participants With Indolent NHL|Overall Study||14
9891868|NCT01088048|11006833|FG005|Participants With Indolent NHL|Overall Study||0
9891869|NCT01088048|11006834|FG006|Participants With Indolent NHL|Overall Study||0
9891870|NCT01088048|11006835|FG007|Participants With Indolent NHL|Overall Study||0
9891871|NCT01088048|11006836|FG008|Participants With Indolent NHL|Overall Study||1
9891872|NCT01088048|11006837|FG009|Participants With Indolent NHL|Overall Study||6
9891873|NCT01088048|11006828|FG000|Participants With MCL|Overall Study||0
9891874|NCT01088048|11006829|FG001|Participants With MCL|Overall Study||0
9891875|NCT01088048|11006830|FG002|Participants With MCL|Overall Study||18
9891876|NCT01088048|11006831|FG003|Participants With MCL|Overall Study||18
9891877|NCT01088048|11006832|FG004|Participants With MCL|Overall Study||4
9891878|NCT01088048|11006833|FG005|Participants With MCL|Overall Study||0
9891879|NCT01088048|11006834|FG006|Participants With MCL|Overall Study||0
9891880|NCT01088048|11006835|FG007|Participants With MCL|Overall Study||0
9891881|NCT01088048|11006836|FG008|Participants With MCL|Overall Study||0
9891882|NCT01088048|11006837|FG009|Participants With MCL|Overall Study||0
9891883|NCT01088048|11006828|FG000|COMPLETED|Overall Study||29
9891884|NCT01088048|11006829|FG001|COMPLETED|Overall Study||24
9891885|NCT01088048|11006830|FG002|COMPLETED|Overall Study||4
9891886|NCT01088048|11006831|FG003|COMPLETED|Overall Study||4
9891887|NCT01088048|11006832|FG004|COMPLETED|Overall Study||16
9891888|NCT01088048|11006833|FG005|COMPLETED|Overall Study||10
9891889|NCT01088048|11006834|FG006|COMPLETED|Overall Study||6
9891890|NCT01088048|11006835|FG007|COMPLETED|Overall Study||10
9891891|NCT01088048|11006836|FG008|COMPLETED|Overall Study||8
9891892|NCT01088048|11006837|FG009|COMPLETED|Overall Study||3
9891893|NCT01088048|11006828|FG000|NOT COMPLETED|Overall Study||22
9891894|NCT01088048|11006829|FG001|NOT COMPLETED|Overall Study||27
9891895|NCT01088048|11006830|FG002|NOT COMPLETED|Overall Study||14
9891896|NCT01088048|11006831|FG003|NOT COMPLETED|Overall Study||14
9891897|NCT01088048|11006832|FG004|NOT COMPLETED|Overall Study||17
9891898|NCT01088048|11006833|FG005|NOT COMPLETED|Overall Study||11
9891899|NCT01088048|11006834|FG006|NOT COMPLETED|Overall Study||6
9891900|NCT01088048|11006835|FG007|NOT COMPLETED|Overall Study||5
9891901|NCT01088048|11006836|FG008|NOT COMPLETED|Overall Study||7
9891902|NCT01088048|11006837|FG009|NOT COMPLETED|Overall Study||4
9891903|NCT01088243|11006872|FG000|STARTED|Overall Study||13
9891904|NCT01088243|11006873|FG001|STARTED|Overall Study||5
9891905|NCT01088243|11006872|FG000|COMPLETED|Overall Study||12
9891906|NCT01088243|11006873|FG001|COMPLETED|Overall Study||5
9891907|NCT01088243|11006872|FG000|NOT COMPLETED|Overall Study||1
9891908|NCT01088243|11006873|FG001|NOT COMPLETED|Overall Study||0
9891909|NCT01088295|11006879|FG000|STARTED|Overall Study||36
9891910|NCT01088295|11006879|FG000|COMPLETED|Overall Study||35
9891911|NCT01088295|11006879|FG000|NOT COMPLETED|Overall Study||1
9891912|NCT01088399|11006886|FG000|STARTED|Overall Study||8716
9891913|NCT01088399|11006887|FG001|STARTED|Overall Study||1655
9891914|NCT01088399|11006888|FG002|STARTED|Overall Study||302
9891915|NCT01088399|11006886|FG000|COMPLETED|Overall Study||1595
9891916|NCT01088399|11006887|FG001|COMPLETED|Overall Study||308
9891917|NCT01088399|11006888|FG002|COMPLETED|Overall Study||21
9891918|NCT01088399|11006886|FG000|NOT COMPLETED|Overall Study||7121
9891919|NCT01088399|11006887|FG001|NOT COMPLETED|Overall Study||1347
9891920|NCT01088399|11006888|FG002|NOT COMPLETED|Overall Study||281
9891921|NCT01088412|11006899|FG000|STARTED|Overall Study||22311
9891922|NCT01088412|11006900|FG001|STARTED|Overall Study||457
9891923|NCT01088412|11006901|FG002|STARTED|Overall Study||77
9891924|NCT01088412|11006899|FG000|Safety Modified Evaluable (SME)|Overall Study||22294
9891925|NCT01088412|11006900|FG001|Safety Modified Evaluable (SME)|Overall Study||456
9891926|NCT01088412|11006901|FG002|Safety Modified Evaluable (SME)|Overall Study||0
9891927|NCT01088412|11006899|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178
9891928|NCT01088412|11006900|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306
9891929|NCT01088412|11006901|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0
9891930|NCT01088412|11006899|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
9891931|NCT01088412|11006900|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306
9891932|NCT01088412|11006901|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40
9891933|NCT01088412|11006899|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
9891934|NCT01088412|11006900|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
9891935|NCT01088412|11006901|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
9891936|NCT01088412|11006899|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622
9891937|NCT01088412|11006900|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114
9891938|NCT01088412|11006901|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0
9891939|NCT01088412|11006899|FG000|COMPLETED|Overall Study||4294
9891940|NCT01088412|11006900|FG001|COMPLETED|Overall Study||21
9891941|NCT01088412|11006901|FG002|COMPLETED|Overall Study||5
9891942|NCT01088412|11006899|FG000|NOT COMPLETED|Overall Study||18017
9891943|NCT01088412|11006900|FG001|NOT COMPLETED|Overall Study||436
9891944|NCT01088412|11006901|FG002|NOT COMPLETED|Overall Study||72
9891945|NCT01088438|11006914|FG000|STARTED|Overall Study||94
9891946|NCT01088438|11006915|FG001|STARTED|Overall Study||95
10019001|NCT01826981|11142058|FG007|COMPLETED|Overall Study||40
9891947|NCT01088438|11006914|FG000|COMPLETED|Overall Study||65
9891948|NCT01088438|11006915|FG001|COMPLETED|Overall Study||59
9891949|NCT01088438|11006914|FG000|NOT COMPLETED|Overall Study||29
9891950|NCT01088438|11006915|FG001|NOT COMPLETED|Overall Study||36
9891951|NCT01088464|11006924|FG000|STARTED|Overall Study||3
9891952|NCT01088464|11006925|FG001|STARTED|Overall Study||6
9891953|NCT01088464|11006926|FG002|STARTED|Overall Study||6
9891954|NCT01088464|11006924|FG000|Received Any Quantity of Study Drug|Overall Study||3
9891955|NCT01088464|11006925|FG001|Received Any Quantity of Study Drug|Overall Study||6
9891956|NCT01088464|11006926|FG002|Received Any Quantity of Study Drug|Overall Study||6
9891957|NCT01088464|11006924|FG000|COMPLETED|Overall Study||3
9891958|NCT01088464|11006925|FG001|COMPLETED|Overall Study||6
9891959|NCT01088464|11006926|FG002|COMPLETED|Overall Study||6
9891960|NCT01088464|11006924|FG000|NOT COMPLETED|Overall Study||0
9891961|NCT01088464|11006925|FG001|NOT COMPLETED|Overall Study||0
9891962|NCT01088464|11006926|FG002|NOT COMPLETED|Overall Study||0
9891963|NCT01088503|11006937|FG000|STARTED|Overall Study||3123
9891964|NCT01088503|11006938|FG001|STARTED|Overall Study||8846
9891965|NCT01088503|11006939|FG002|STARTED|Overall Study||258
9891966|NCT01088503|11006937|FG000|COMPLETED|Overall Study||2941
9891967|NCT01088503|11006938|FG001|COMPLETED|Overall Study||8161
9891968|NCT01088503|11006939|FG002|COMPLETED|Overall Study||241
9891969|NCT01088503|11006937|FG000|NOT COMPLETED|Overall Study||182
9891970|NCT01088503|11006938|FG001|NOT COMPLETED|Overall Study||685
9891971|NCT01088503|11006939|FG002|NOT COMPLETED|Overall Study||17
9891972|NCT01088529|11006947|FG000|STARTED|Overall Study||44
9891973|NCT01088529|11006948|FG001|STARTED|Overall Study||22
9891974|NCT01088529|11006947|FG000|Received Treatment|Overall Study||44
9891975|NCT01088529|11006948|FG001|Received Treatment|Overall Study||21
9891976|NCT01088529|11006947|FG000|COMPLETED|Overall Study||44
9891977|NCT01088529|11006948|FG001|COMPLETED|Overall Study||21
9891978|NCT01088529|11006947|FG000|NOT COMPLETED|Overall Study||0
9891979|NCT01088529|11006948|FG001|NOT COMPLETED|Overall Study||1
9891980|NCT01088646|11006954|FG000|STARTED|Overall Study||25
9891981|NCT01088646|11006954|FG000|COMPLETED|Overall Study||25
9891982|NCT01088646|11006954|FG000|NOT COMPLETED|Overall Study||0
9891983|NCT01088672|11006959|FG000|STARTED|Overall Study||60
9891984|NCT01088672|11006959|FG000|COMPLETED|Overall Study||60
9891985|NCT01088672|11006959|FG000|NOT COMPLETED|Overall Study||0
9891986|NCT01088711|11006967|FG000|STARTED|Overall Study||18
9891987|NCT01088711|11006968|FG001|STARTED|Overall Study||6
9891988|NCT01088711|11006969|FG002|STARTED|Overall Study||6
9891989|NCT01088711|11006970|FG003|STARTED|Overall Study||2
9891990|NCT01088711|11006967|FG000|COMPLETED|Overall Study||18
9891991|NCT01088711|11006968|FG001|COMPLETED|Overall Study||6
9891992|NCT01088711|11006969|FG002|COMPLETED|Overall Study||6
9891993|NCT01088711|11006970|FG003|COMPLETED|Overall Study||2
9891994|NCT01088711|11006967|FG000|NOT COMPLETED|Overall Study||0
9891995|NCT01088711|11006968|FG001|NOT COMPLETED|Overall Study||0
9891996|NCT01088711|11006969|FG002|NOT COMPLETED|Overall Study||0
9891997|NCT01088711|11006970|FG003|NOT COMPLETED|Overall Study||0
9891998|NCT01088984|11006984|FG000|STARTED|Phase 1||5
9891999|NCT01088984|11006985|FG001|STARTED|Phase 1||6
9892000|NCT01088984|11006984|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
9892001|NCT01088984|11006985|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
9892002|NCT01088984|11006984|FG000|NOT COMPLETED|Phase 1||5
9892003|NCT01088984|11006985|FG001|NOT COMPLETED|Phase 1||6
9892004|NCT01088984|11006984|FG000|STARTED|Phase 2||0
9892005|NCT01088984|11006985|FG001|STARTED|Phase 2||32
9892006|NCT01088984|11006984|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
9892007|NCT01088984|11006985|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
9892008|NCT01088984|11006984|FG000|NOT COMPLETED|Phase 2||0
9892009|NCT01088984|11006985|FG001|NOT COMPLETED|Phase 2||32
9892010|NCT01088997|11006996|FG000|STARTED|Overall Study||7
9892011|NCT01088997|11006997|FG001|STARTED|Overall Study||5
9892012|NCT01088997|11006996|FG000|COMPLETED|Overall Study||4
9892013|NCT01088997|11006997|FG001|COMPLETED|Overall Study||2
9892014|NCT01088997|11006996|FG000|NOT COMPLETED|Overall Study||3
9892015|NCT01088997|11006997|FG001|NOT COMPLETED|Overall Study||3
9892016|NCT01089023|11007006|FG000|STARTED|Overall Study||95
9892017|NCT01089023|11007006|FG000|COMPLETED|Overall Study||88
9892018|NCT01089023|11007006|FG000|NOT COMPLETED|Overall Study||7
9892019|NCT01089062|11007016|FG000|STARTED|Visit 2 (Randomization)||4
9892020|NCT01089062|11007017|FG001|STARTED|Visit 2 (Randomization)||4
9892021|NCT01089062|11007018|FG002|STARTED|Visit 2 (Randomization)||4
9892022|NCT01089062|11007019|FG003|STARTED|Visit 2 (Randomization)||4
9892023|NCT01089062|11007020|FG004|STARTED|Visit 2 (Randomization)||4
9892024|NCT01089062|11007021|FG005|STARTED|Visit 2 (Randomization)||4
9892025|NCT01089062|11007016|FG000|COMPLETED|Visit 2 (Randomization)||3
9892026|NCT01089062|11007017|FG001|COMPLETED|Visit 2 (Randomization)||3
9892027|NCT01089062|11007018|FG002|COMPLETED|Visit 2 (Randomization)||3
9892028|NCT01089062|11007019|FG003|COMPLETED|Visit 2 (Randomization)||4
9892029|NCT01089062|11007020|FG004|COMPLETED|Visit 2 (Randomization)||3
9892030|NCT01089062|11007021|FG005|COMPLETED|Visit 2 (Randomization)||3
9892031|NCT01089062|11007016|FG000|NOT COMPLETED|Visit 2 (Randomization)||1
9892032|NCT01089062|11007017|FG001|NOT COMPLETED|Visit 2 (Randomization)||1
9892033|NCT01089062|11007018|FG002|NOT COMPLETED|Visit 2 (Randomization)||1
9892034|NCT01089062|11007019|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
9892035|NCT01089062|11007020|FG004|NOT COMPLETED|Visit 2 (Randomization)||1
9892036|NCT01089062|11007021|FG005|NOT COMPLETED|Visit 2 (Randomization)||1
9892037|NCT01089062|11007016|FG000|STARTED|Visit 3||3
9892038|NCT01089062|11007017|FG001|STARTED|Visit 3||3
9892039|NCT01089062|11007018|FG002|STARTED|Visit 3||3
9892040|NCT01089062|11007019|FG003|STARTED|Visit 3||4
9892041|NCT01089062|11007020|FG004|STARTED|Visit 3||3
9892042|NCT01089062|11007021|FG005|STARTED|Visit 3||3
9892043|NCT01089062|11007016|FG000|COMPLETED|Visit 3||3
9892044|NCT01089062|11007017|FG001|COMPLETED|Visit 3||3
9892045|NCT01089062|11007018|FG002|COMPLETED|Visit 3||3
9892046|NCT01089062|11007019|FG003|COMPLETED|Visit 3||3
9892047|NCT01089062|11007020|FG004|COMPLETED|Visit 3||3
9892048|NCT01089062|11007021|FG005|COMPLETED|Visit 3||3
9892049|NCT01089062|11007016|FG000|NOT COMPLETED|Visit 3||0
9892050|NCT01089062|11007017|FG001|NOT COMPLETED|Visit 3||0
9892051|NCT01089062|11007018|FG002|NOT COMPLETED|Visit 3||0
9892052|NCT01089062|11007019|FG003|NOT COMPLETED|Visit 3||1
9892053|NCT01089062|11007020|FG004|NOT COMPLETED|Visit 3||0
9892054|NCT01089062|11007021|FG005|NOT COMPLETED|Visit 3||0
9892055|NCT01089062|11007016|FG000|STARTED|Visit 4||3
9892056|NCT01089062|11007017|FG001|STARTED|Visit 4||3
9892057|NCT01089062|11007018|FG002|STARTED|Visit 4||3
9892058|NCT01089062|11007019|FG003|STARTED|Visit 4||3
9892059|NCT01089062|11007020|FG004|STARTED|Visit 4||3
9892060|NCT01089062|11007021|FG005|STARTED|Visit 4||3
9892061|NCT01089062|11007016|FG000|COMPLETED|Visit 4||3
9892062|NCT01089062|11007017|FG001|COMPLETED|Visit 4||3
9892063|NCT01089062|11007018|FG002|COMPLETED|Visit 4||3
9892064|NCT01089062|11007019|FG003|COMPLETED|Visit 4||3
9892065|NCT01089062|11007020|FG004|COMPLETED|Visit 4||3
9892066|NCT01089062|11007021|FG005|COMPLETED|Visit 4||3
9892067|NCT01089062|11007016|FG000|NOT COMPLETED|Visit 4||0
9892068|NCT01089062|11007017|FG001|NOT COMPLETED|Visit 4||0
9892069|NCT01089062|11007018|FG002|NOT COMPLETED|Visit 4||0
9892070|NCT01089062|11007019|FG003|NOT COMPLETED|Visit 4||0
9892071|NCT01089062|11007020|FG004|NOT COMPLETED|Visit 4||0
9892072|NCT01089062|11007021|FG005|NOT COMPLETED|Visit 4||0
9892073|NCT01089062|11007016|FG000|STARTED|Follow-up Visit (Final Visit)||3
9892074|NCT01089062|11007017|FG001|STARTED|Follow-up Visit (Final Visit)||3
9892075|NCT01089062|11007018|FG002|STARTED|Follow-up Visit (Final Visit)||3
9892076|NCT01089062|11007019|FG003|STARTED|Follow-up Visit (Final Visit)||3
9892077|NCT01089062|11007020|FG004|STARTED|Follow-up Visit (Final Visit)||3
9892078|NCT01089062|11007021|FG005|STARTED|Follow-up Visit (Final Visit)||3
9892079|NCT01089062|11007016|FG000|COMPLETED|Follow-up Visit (Final Visit)||3
9892080|NCT01089062|11007017|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
9892081|NCT01089062|11007018|FG002|COMPLETED|Follow-up Visit (Final Visit)||3
9892082|NCT01089062|11007019|FG003|COMPLETED|Follow-up Visit (Final Visit)||3
9892083|NCT01089062|11007020|FG004|COMPLETED|Follow-up Visit (Final Visit)||3
9892084|NCT01089062|11007021|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
9892085|NCT01089062|11007016|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9892086|NCT01089062|11007017|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9892087|NCT01089062|11007018|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9892088|NCT01089062|11007019|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9892089|NCT01089062|11007020|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9892090|NCT01089062|11007021|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
9892091|NCT01089127|11007036|FG000|STARTED|Overall Study||92
9892092|NCT01089127|11007037|FG001|STARTED|Overall Study||91
9892093|NCT01089127|11007038|FG002|STARTED|Overall Study||94
9892094|NCT01089127|11007039|FG003|STARTED|Overall Study||92
9892095|NCT01089127|11007040|FG004|STARTED|Overall Study||92
9892096|NCT01089127|11007041|FG005|STARTED|Overall Study||91
9892097|NCT01089127|11007036|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
9892098|NCT01089127|11007037|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
9892099|NCT01089127|11007038|FG002|Exposed to Study Drug|Overall Study||94
9892100|NCT01089127|11007039|FG003|Exposed to Study Drug|Overall Study||92
9892101|NCT01089127|11007040|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
9892102|NCT01089127|11007041|FG005|Exposed to Study Drug|Overall Study||91
9892103|NCT01089127|11007036|FG000|COMPLETED|Overall Study||84
9892104|NCT01089127|11007037|FG001|COMPLETED|Overall Study||86
9892105|NCT01089127|11007038|FG002|COMPLETED|Overall Study||92
9892106|NCT01089127|11007039|FG003|COMPLETED|Overall Study||91
9892107|NCT01089127|11007040|FG004|COMPLETED|Overall Study||90
9892108|NCT01089127|11007041|FG005|COMPLETED|Overall Study||88
9892109|NCT01089127|11007036|FG000|NOT COMPLETED|Overall Study||8
9892110|NCT01089127|11007037|FG001|NOT COMPLETED|Overall Study||5
9892111|NCT01089127|11007038|FG002|NOT COMPLETED|Overall Study||2
9892112|NCT01089127|11007039|FG003|NOT COMPLETED|Overall Study||1
9892113|NCT01089127|11007040|FG004|NOT COMPLETED|Overall Study||2
9892114|NCT01089127|11007041|FG005|NOT COMPLETED|Overall Study||3
9892115|NCT01089231|11007059|FG000|STARTED|Overall Study||10
9892116|NCT01089231|11007060|FG001|STARTED|Overall Study||10
9892117|NCT01089231|11007061|FG002|STARTED|Overall Study||10
9892118|NCT01089231|11007062|FG003|STARTED|Overall Study||10
10008838|NCT01762982|11131340|FG000|Received Benzalkonium Chloride|Overall Study||36
10008839|NCT01762982|11131340|FG000|Received SLS|Overall Study||36
10008840|NCT01762982|11131340|FG000|Received Empty Finn Chamber|Overall Study||36
10008841|NCT01762982|11131340|FG000|COMPLETED|Overall Study||36
10008842|NCT01762982|11131340|FG000|NOT COMPLETED|Overall Study||0
10008843|NCT01763047|11131350|FG000|STARTED|Period 1||139
10008844|NCT01763047|11131351|FG001|STARTED|Period 1||137
10008845|NCT01763047|11131350|FG000|Myopes|Period 1||77
10008846|NCT01763047|11131351|FG001|Myopes|Period 1||76
10008847|NCT01763047|11131350|FG000|Hyperopes|Period 1||62
10008848|NCT01763047|11131351|FG001|Hyperopes|Period 1||61
10008849|NCT01763047|11131350|FG000|COMPLETED|Period 1||130
9892119|NCT01089231|11007059|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
9892120|NCT01089231|11007060|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
9892121|NCT01089231|11007061|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
9892122|NCT01089231|11007062|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
9892123|NCT01089231|11007059|FG000|NOT COMPLETED|Overall Study||4
9892124|NCT01089231|11007060|FG001|NOT COMPLETED|Overall Study||2
9892125|NCT01089231|11007061|FG002|NOT COMPLETED|Overall Study||2
9892126|NCT01089231|11007062|FG003|NOT COMPLETED|Overall Study||1
9892127|NCT01089361|11007074|FG000|STARTED|Overall Study||9
9892128|NCT01089361|11007075|FG001|STARTED|Overall Study||10
9892129|NCT01089361|11007074|FG000|COMPLETED|Overall Study||8
9892130|NCT01089361|11007075|FG001|COMPLETED|Overall Study||10
9892131|NCT01089361|11007074|FG000|NOT COMPLETED|Overall Study||1
9892132|NCT01089361|11007075|FG001|NOT COMPLETED|Overall Study||0
9892133|NCT01089413|11007086|FG000|STARTED|Overall Study||201
9892134|NCT01089413|11007086|FG000|Received Bevacizumab in First Line|Overall Study||199
9892135|NCT01089413|11007086|FG000|COMPLETED|Overall Study||0
9892136|NCT01089413|11007086|FG000|NOT COMPLETED|Overall Study||201
9892137|NCT01089504|11007098|FG000|STARTED|Overall Study||8
9892138|NCT01089504|11007099|FG001|STARTED|Overall Study||5
9892139|NCT01089504|11007098|FG000|COMPLETED|Overall Study||5
9892140|NCT01089504|11007099|FG001|COMPLETED|Overall Study||4
9892141|NCT01089504|11007098|FG000|NOT COMPLETED|Overall Study||3
9892142|NCT01089504|11007099|FG001|NOT COMPLETED|Overall Study||1
9892143|NCT01089517|11007108|FG000|STARTED|Overall Study||148
9892144|NCT01089517|11007109|FG001|STARTED|Overall Study||149
9892145|NCT01089517|11007110|FG002|STARTED|Overall Study||152
9892146|NCT01089517|11007108|FG000|COMPLETED|Overall Study||144
9892147|NCT01089517|11007109|FG001|COMPLETED|Overall Study||144
9892148|NCT01089517|11007110|FG002|COMPLETED|Overall Study||147
9892149|NCT01089517|11007108|FG000|NOT COMPLETED|Overall Study||4
9892150|NCT01089517|11007109|FG001|NOT COMPLETED|Overall Study||5
9892151|NCT01089517|11007110|FG002|NOT COMPLETED|Overall Study||5
9892152|NCT01089543|11007122|FG000|STARTED|Overall Study||84
9892153|NCT01089543|11007123|FG001|STARTED|Overall Study||85
9892154|NCT01089543|11007124|FG002|STARTED|Overall Study||84
9892155|NCT01089543|11007125|FG003|STARTED|Overall Study||85
9892156|NCT01089543|11007122|FG000|COMPLETED|Overall Study||81
9892157|NCT01089543|11007123|FG001|COMPLETED|Overall Study||81
9892158|NCT01089543|11007124|FG002|COMPLETED|Overall Study||81
9892159|NCT01089543|11007125|FG003|COMPLETED|Overall Study||83
9892160|NCT01089543|11007122|FG000|NOT COMPLETED|Overall Study||3
9892161|NCT01089543|11007123|FG001|NOT COMPLETED|Overall Study||4
9892162|NCT01089543|11007124|FG002|NOT COMPLETED|Overall Study||3
9892163|NCT01089543|11007125|FG003|NOT COMPLETED|Overall Study||2
9892164|NCT01089556|11007137|FG000|STARTED|Study Period II (Weeks 1-8)||404
9892165|NCT01089556|11007138|FG001|STARTED|Study Period II (Weeks 1-8)||407
9892166|NCT01089556|11007139|FG002|STARTED|Study Period II (Weeks 1-8)||0
9892167|NCT01089556|11007140|FG003|STARTED|Study Period II (Weeks 1-8)||0
9892168|NCT01089556|11007141|FG004|STARTED|Study Period II (Weeks 1-8)||0
9892169|NCT01089556|11007142|FG005|STARTED|Study Period II (Weeks 1-8)||0
9892170|NCT01089556|11007137|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
9892171|NCT01089556|11007138|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
9892172|NCT01089556|11007139|FG002|Safety Population|Study Period II (Weeks 1-8)||0
9892173|NCT01089556|11007140|FG003|Safety Population|Study Period II (Weeks 1-8)||0
9892174|NCT01089556|11007141|FG004|Safety Population|Study Period II (Weeks 1-8)||0
9892175|NCT01089556|11007142|FG005|Safety Population|Study Period II (Weeks 1-8)||0
9892176|NCT01089556|11007137|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
9892177|NCT01089556|11007138|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
9892178|NCT01089556|11007139|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
9892179|NCT01089556|11007140|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
9892180|NCT01089556|11007141|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
9892181|NCT01089556|11007142|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
10008850|NCT01763047|11131351|FG001|COMPLETED|Period 1||126
10008851|NCT01763047|11131350|FG000|NOT COMPLETED|Period 1||9
10008852|NCT01763047|11131351|FG001|NOT COMPLETED|Period 1||11
10008853|NCT01763047|11131350|FG000|STARTED|Period 2||130
10008854|NCT01763047|11131351|FG001|STARTED|Period 2||126
10008855|NCT01763047|11131350|FG000|Myopes|Period 2||74
10008856|NCT01763047|11131351|FG001|Myopes|Period 2||72
10008857|NCT01763047|11131350|FG000|Hyperopes|Period 2||56
9892182|NCT01089556|11007137|FG000|COMPLETED|Study Period II (Weeks 1-8)||333
9892183|NCT01089556|11007138|FG001|COMPLETED|Study Period II (Weeks 1-8)||333
9892184|NCT01089556|11007139|FG002|COMPLETED|Study Period II (Weeks 1-8)||0
9892185|NCT01089556|11007140|FG003|COMPLETED|Study Period II (Weeks 1-8)||0
9892186|NCT01089556|11007141|FG004|COMPLETED|Study Period II (Weeks 1-8)||0
9892187|NCT01089556|11007142|FG005|COMPLETED|Study Period II (Weeks 1-8)||0
9892188|NCT01089556|11007137|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71
9892189|NCT01089556|11007138|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74
9892190|NCT01089556|11007139|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0
9892191|NCT01089556|11007140|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0
9892192|NCT01089556|11007141|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0
9892193|NCT01089556|11007142|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0
9892194|NCT01089556|11007137|FG000|STARTED|Study Period III (Weeks 9-16)||0
9892195|NCT01089556|11007138|FG001|STARTED|Study Period III (Weeks 9-16)||0
9892196|NCT01089556|11007139|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
9892197|NCT01089556|11007140|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
9892198|NCT01089556|11007141|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
9892199|NCT01089556|11007142|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
9892200|NCT01089556|11007137|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
9892201|NCT01089556|11007138|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
9892202|NCT01089556|11007139|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
9892203|NCT01089556|11007140|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
9892204|NCT01089556|11007141|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
9892205|NCT01089556|11007142|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
9892206|NCT01089556|11007137|FG000|COMPLETED|Study Period III (Weeks 9-16)||0
9892207|NCT01089556|11007138|FG001|COMPLETED|Study Period III (Weeks 9-16)||0
9892208|NCT01089556|11007139|FG002|COMPLETED|Study Period III (Weeks 9-16)||60
9892209|NCT01089556|11007140|FG003|COMPLETED|Study Period III (Weeks 9-16)||66
9892210|NCT01089556|11007141|FG004|COMPLETED|Study Period III (Weeks 9-16)||83
9892211|NCT01089556|11007142|FG005|COMPLETED|Study Period III (Weeks 9-16)||92
9892212|NCT01089556|11007137|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0
9892213|NCT01089556|11007138|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0
9892214|NCT01089556|11007139|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14
9892215|NCT01089556|11007140|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9
9892216|NCT01089556|11007141|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12
9892217|NCT01089556|11007142|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7
9892218|NCT01089569|11007157|FG000|STARTED|Overall Study||20
9892219|NCT01089569|11007158|FG001|STARTED|Overall Study||20
9892220|NCT01089569|11007159|FG002|STARTED|Overall Study||20
9892221|NCT01089569|11007157|FG000|COMPLETED|Overall Study||16
9892222|NCT01089569|11007158|FG001|COMPLETED|Overall Study||17
9892223|NCT01089569|11007159|FG002|COMPLETED|Overall Study||16
9892224|NCT01089569|11007157|FG000|NOT COMPLETED|Overall Study||4
9892225|NCT01089569|11007158|FG001|NOT COMPLETED|Overall Study||3
9892226|NCT01089569|11007159|FG002|NOT COMPLETED|Overall Study||4
9892227|NCT01089582|11007167|FG000|STARTED|Overall Study||603
9892228|NCT01089582|11007167|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
9892229|NCT01089582|11007167|FG000|NOT COMPLETED|Overall Study||30
9892230|NCT01089595|11007173|FG000|STARTED|Overall Study||2
9892231|NCT01089595|11007174|FG001|STARTED|Overall Study||3
9892232|NCT01089595|11007173|FG000|COMPLETED|Overall Study||2
9892233|NCT01089595|11007174|FG001|COMPLETED|Overall Study||3
9892234|NCT01089595|11007173|FG000|NOT COMPLETED|Overall Study||0
9892235|NCT01089595|11007174|FG001|NOT COMPLETED|Overall Study||0
9892236|NCT01089608|11007184|FG000|STARTED|Overall Study||43
9892237|NCT01089608|11007185|FG001|STARTED|Overall Study||50
9892238|NCT01089608|11007184|FG000|COMPLETED|Overall Study||43
9892239|NCT01089608|11007185|FG001|COMPLETED|Overall Study||44
9892240|NCT01089608|11007184|FG000|NOT COMPLETED|Overall Study||0
9892241|NCT01089608|11007185|FG001|NOT COMPLETED|Overall Study||6
9892242|NCT01089647|11007193|FG000|STARTED|Overall Study||17
9892243|NCT01089647|11007194|FG001|STARTED|Overall Study||17
9892244|NCT01089647|11007193|FG000|COMPLETED|Overall Study||13
9892245|NCT01089647|11007194|FG001|COMPLETED|Overall Study||13
9892246|NCT01089647|11007193|FG000|NOT COMPLETED|Overall Study||4
9892247|NCT01089647|11007194|FG001|NOT COMPLETED|Overall Study||4
9892248|NCT01089725|11007205|FG000|STARTED|Overall Study||72
9892249|NCT01089725|11007206|FG001|STARTED|Overall Study||75
9892250|NCT01089725|11007207|FG002|STARTED|Overall Study||65
9892251|NCT01089725|11007208|FG003|STARTED|Overall Study||87
9892252|NCT01089725|11007209|FG004|STARTED|Overall Study||86
10008858|NCT01763047|11131351|FG001|Hyperopes|Period 2||54
10008859|NCT01763047|11131350|FG000|COMPLETED|Period 2||126
9892253|NCT01089725|11007205|FG000|Treated|Overall Study||72
9892254|NCT01089725|11007206|FG001|Treated|Overall Study||74
9892255|NCT01089725|11007207|FG002|Treated|Overall Study||63
9892256|NCT01089725|11007208|FG003|Treated|Overall Study||86
9892257|NCT01089725|11007209|FG004|Treated|Overall Study||84
9892258|NCT01089725|11007205|FG000|COMPLETED|Overall Study||6
9892259|NCT01089725|11007206|FG001|COMPLETED|Overall Study||7
9892260|NCT01089725|11007207|FG002|COMPLETED|Overall Study||4
9892261|NCT01089725|11007208|FG003|COMPLETED|Overall Study||8
9892262|NCT01089725|11007209|FG004|COMPLETED|Overall Study||6
9892263|NCT01089725|11007205|FG000|NOT COMPLETED|Overall Study||66
9892264|NCT01089725|11007206|FG001|NOT COMPLETED|Overall Study||68
9892265|NCT01089725|11007207|FG002|NOT COMPLETED|Overall Study||61
9892266|NCT01089725|11007208|FG003|NOT COMPLETED|Overall Study||79
9892267|NCT01089725|11007209|FG004|NOT COMPLETED|Overall Study||80
9892268|NCT01089751|11007227|FG000|STARTED|Overall Study||163
9892269|NCT01089751|11007228|FG001|STARTED|Overall Study||159
9892270|NCT01089751|11007227|FG000|COMPLETED|Overall Study||129
9892271|NCT01089751|11007228|FG001|COMPLETED|Overall Study||132
9892272|NCT01089751|11007227|FG000|NOT COMPLETED|Overall Study||34
9892273|NCT01089751|11007228|FG001|NOT COMPLETED|Overall Study||27
9892274|NCT01090011|11007234|FG000|STARTED|Overall Study||171
9892275|NCT01090011|11007234|FG000|COMPLETED|Overall Study||0
9892276|NCT01090011|11007234|FG000|NOT COMPLETED|Overall Study||171
10110104|NCT02482675|11240896|FG014|STARTED|Overall Study||1
10110105|NCT02482675|11240897|FG015|STARTED|Overall Study||1
10110106|NCT02482675|11240898|FG016|STARTED|Overall Study||1
10110107|NCT02482675|11240899|FG017|STARTED|Overall Study||1
10110108|NCT02482675|11240900|FG018|STARTED|Overall Study||1
10110109|NCT02482675|11240901|FG019|STARTED|Overall Study||1
10110110|NCT02482675|11240902|FG020|STARTED|Overall Study||1
10110111|NCT02482675|11240903|FG021|STARTED|Overall Study||1
10110112|NCT02482675|11240904|FG022|STARTED|Overall Study||1
9892277|NCT01090050|11007248|FG000|STARTED|Overall Study||16
9892278|NCT01090050|11007249|FG001|STARTED|Overall Study||12
9892279|NCT01090050|11007248|FG000|COMPLETED|Overall Study||15
9892280|NCT01090050|11007249|FG001|COMPLETED|Overall Study||5
9892281|NCT01090050|11007248|FG000|NOT COMPLETED|Overall Study||1
9892282|NCT01090050|11007249|FG001|NOT COMPLETED|Overall Study||7
10110113|NCT02482675|11240882|FG000|COMPLETED|Overall Study||1
10110114|NCT02482675|11240883|FG001|COMPLETED|Overall Study||1
10110115|NCT02482675|11240884|FG002|COMPLETED|Overall Study||1
10110116|NCT02482675|11240885|FG003|COMPLETED|Overall Study||1
10110117|NCT02482675|11240886|FG004|COMPLETED|Overall Study||1
10110118|NCT02482675|11240887|FG005|COMPLETED|Overall Study||1
10110119|NCT02482675|11240888|FG006|COMPLETED|Overall Study||1
10110120|NCT02482675|11240889|FG007|COMPLETED|Overall Study||1
10202890|NCT03452943|11330046|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5
10202891|NCT03452943|11330047|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4
10202892|NCT03452943|11330046|FG000|STARTED|Maintenance Period (5 Weeks)||54
9892283|NCT01090063|11007259|FG000|STARTED|Screen||28
9892284|NCT01090063|11007259|FG000|COMPLETED|Screen||24
9892285|NCT01090063|11007259|FG000|NOT COMPLETED|Screen||4
9892286|NCT01090063|11007259|FG000|STARTED|Treatment||24
9892287|NCT01090063|11007259|FG000|COMPLETED|Treatment||20
9892288|NCT01090063|11007259|FG000|NOT COMPLETED|Treatment||4
9892289|NCT01090076|11007275|FG000|STARTED|Overall Study||12
9892290|NCT01090076|11007276|FG001|STARTED|Overall Study||14
9892291|NCT01090076|11007275|FG000|COMPLETED|Overall Study||11
9892292|NCT01090076|11007276|FG001|COMPLETED|Overall Study||12
9892293|NCT01090076|11007275|FG000|NOT COMPLETED|Overall Study||1
9892294|NCT01090076|11007276|FG001|NOT COMPLETED|Overall Study||2
9954597|NCT01432457|11073391|FG001|COMPLETED|Overall Study||258
9954598|NCT01432457|11073392|FG002|COMPLETED|Overall Study||253
9954599|NCT01432457|11073390|FG000|NOT COMPLETED|Overall Study||37
9954600|NCT01432457|11073391|FG001|NOT COMPLETED|Overall Study||48
9954601|NCT01432457|11073392|FG002|NOT COMPLETED|Overall Study||59
9954602|NCT01432535|11073403|FG000|STARTED|Overall Study||12
9954603|NCT01432535|11073404|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
9954604|NCT01432535|11073405|FG002|STARTED|Overall Study||6
9954605|NCT01432535|11073403|FG000|COMPLETED|Overall Study||12
9954606|NCT01432535|11073404|FG001|COMPLETED|Overall Study||7
9954607|NCT01432535|11073405|FG002|COMPLETED|Overall Study||6
9954608|NCT01432535|11073403|FG000|NOT COMPLETED|Overall Study||0
9954609|NCT01432535|11073404|FG001|NOT COMPLETED|Overall Study||0
9954610|NCT01432535|11073405|FG002|NOT COMPLETED|Overall Study||0
9954611|NCT01432561|11073413|FG000|STARTED|Overall Study||8
10110121|NCT02482675|11240890|FG008|COMPLETED|Overall Study||1
10110122|NCT02482675|11240891|FG009|COMPLETED|Overall Study||1
10202893|NCT03452943|11330047|FG001|STARTED|Maintenance Period (5 Weeks)||56
10110123|NCT02482675|11240892|FG010|COMPLETED|Overall Study||1
10110124|NCT02482675|11240893|FG011|COMPLETED|Overall Study||1
10110125|NCT02482675|11240894|FG012|COMPLETED|Overall Study||1
9954612|NCT01432561|11073413|FG000|COMPLETED|Overall Study||8
9954613|NCT01432561|11073413|FG000|NOT COMPLETED|Overall Study||0
9954614|NCT01432574|11073417|FG000|STARTED|Overall Study||150
9954615|NCT01432574|11073417|FG000|COMPLETED|Overall Study||147
9954616|NCT01432574|11073417|FG000|NOT COMPLETED|Overall Study||3
9954617|NCT01432600|11073426|FG000|STARTED|Overall Study||10
9954618|NCT01432600|11073427|FG001|STARTED|Overall Study||36
10110126|NCT02482675|11240895|FG013|COMPLETED|Overall Study||1
10110127|NCT02482675|11240896|FG014|COMPLETED|Overall Study||1
10110128|NCT02482675|11240897|FG015|COMPLETED|Overall Study||1
9892295|NCT01090102|11007286|FG000|STARTED|First 12 Weeks||15
9892296|NCT01090102|11007287|FG001|STARTED|First 12 Weeks||18
9892297|NCT01090102|11007286|FG000|COMPLETED|First 12 Weeks||11
9892298|NCT01090102|11007287|FG001|COMPLETED|First 12 Weeks||16
9892299|NCT01090102|11007286|FG000|NOT COMPLETED|First 12 Weeks||4
9892300|NCT01090102|11007287|FG001|NOT COMPLETED|First 12 Weeks||2
9892301|NCT01090102|11007286|FG000|STARTED|Second 12 Weeks||11
9892302|NCT01090102|11007287|FG001|STARTED|Second 12 Weeks||16
9892303|NCT01090102|11007286|FG000|COMPLETED|Second 12 Weeks||11
9892304|NCT01090102|11007287|FG001|COMPLETED|Second 12 Weeks||15
9892305|NCT01090102|11007286|FG000|NOT COMPLETED|Second 12 Weeks||0
9892306|NCT01090102|11007287|FG001|NOT COMPLETED|Second 12 Weeks||1
9892307|NCT01090180|11007295|FG000|STARTED|Overall Study||33
9892308|NCT01090180|11007296|FG001|STARTED|Overall Study||29
9892309|NCT01090180|11007295|FG000|COMPLETED|Overall Study||22
9892310|NCT01090180|11007296|FG001|COMPLETED|Overall Study||21
9892311|NCT01090180|11007295|FG000|NOT COMPLETED|Overall Study||11
9892312|NCT01090180|11007296|FG001|NOT COMPLETED|Overall Study||8
9892313|NCT01090310|11007306|FG000|STARTED|Core Study||29
9892314|NCT01090310|11007307|FG001|STARTED|Core Study||31
9892315|NCT01090310|11007308|FG002|STARTED|Core Study||31
9892316|NCT01090310|11007309|FG003|STARTED|Core Study||34
9892317|NCT01090310|11007306|FG000|COMPLETED|Core Study||21
9892318|NCT01090310|11007307|FG001|COMPLETED|Core Study||20
9892319|NCT01090310|11007308|FG002|COMPLETED|Core Study||24
9892320|NCT01090310|11007309|FG003|COMPLETED|Core Study||27
9892321|NCT01090310|11007306|FG000|NOT COMPLETED|Core Study||8
9892322|NCT01090310|11007307|FG001|NOT COMPLETED|Core Study||11
9892323|NCT01090310|11007308|FG002|NOT COMPLETED|Core Study||7
9892324|NCT01090310|11007309|FG003|NOT COMPLETED|Core Study||7
9892325|NCT01090310|11007306|FG000|STARTED|Extension Study||17
9892326|NCT01090310|11007307|FG001|STARTED|Extension Study||16
9892327|NCT01090310|11007308|FG002|STARTED|Extension Study||16
9892328|NCT01090310|11007309|FG003|STARTED|Extension Study||21
9892329|NCT01090310|11007306|FG000|COMPLETED|Extension Study||3
9892330|NCT01090310|11007307|FG001|COMPLETED|Extension Study||0
9892331|NCT01090310|11007308|FG002|COMPLETED|Extension Study||1
9892332|NCT01090310|11007309|FG003|COMPLETED|Extension Study||1
9892333|NCT01090310|11007306|FG000|NOT COMPLETED|Extension Study||14
9892334|NCT01090310|11007307|FG001|NOT COMPLETED|Extension Study||16
9892335|NCT01090310|11007308|FG002|NOT COMPLETED|Extension Study||15
9892336|NCT01090310|11007309|FG003|NOT COMPLETED|Extension Study||20
9892337|NCT01090323|11007321|FG000|STARTED|Overall Study||132
9892338|NCT01090323|11007322|FG001|STARTED|Overall Study||53
9892339|NCT01090323|11007321|FG000|COMPLETED|Overall Study||43
9892340|NCT01090323|11007322|FG001|COMPLETED|Overall Study||19
9892341|NCT01090323|11007321|FG000|NOT COMPLETED|Overall Study||89
9892342|NCT01090323|11007322|FG001|NOT COMPLETED|Overall Study||34
9892343|NCT01090414|11007332|FG000|STARTED|Parent Studies||191
9892344|NCT01090414|11007333|FG001|STARTED|Parent Studies||241
9892345|NCT01090414|11007334|FG002|STARTED|Parent Studies||64
9892346|NCT01090414|11007335|FG003|STARTED|Parent Studies||18
9892347|NCT01090414|11007332|FG000|COMPLETED|Parent Studies||50
9892348|NCT01090414|11007333|FG001|COMPLETED|Parent Studies||114
9892349|NCT01090414|11007334|FG002|COMPLETED|Parent Studies||43
9892350|NCT01090414|11007335|FG003|COMPLETED|Parent Studies||5
9892351|NCT01090414|11007332|FG000|NOT COMPLETED|Parent Studies||141
9892352|NCT01090414|11007333|FG001|NOT COMPLETED|Parent Studies||127
9892353|NCT01090414|11007334|FG002|NOT COMPLETED|Parent Studies||21
9892354|NCT01090414|11007335|FG003|NOT COMPLETED|Parent Studies||13
9892355|NCT01090414|11007332|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
9892356|NCT01090414|11007333|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
9892357|NCT01090414|11007334|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
9892358|NCT01090414|11007335|FG003|STARTED|Study 101-99||5
9892359|NCT01090414|11007332|FG000|COMPLETED|Study 101-99||0
9892360|NCT01090414|11007333|FG001|COMPLETED|Study 101-99||0
9892361|NCT01090414|11007334|FG002|COMPLETED|Study 101-99||0
9892362|NCT01090414|11007335|FG003|COMPLETED|Study 101-99||0
9892363|NCT01090414|11007332|FG000|NOT COMPLETED|Study 101-99||48
9892364|NCT01090414|11007333|FG001|NOT COMPLETED|Study 101-99||108
9892365|NCT01090414|11007334|FG002|NOT COMPLETED|Study 101-99||41
9892366|NCT01090414|11007335|FG003|NOT COMPLETED|Study 101-99||5
10008860|NCT01763047|11131351|FG001|COMPLETED|Period 2||121
10008861|NCT01763047|11131350|FG000|NOT COMPLETED|Period 2||4
10008862|NCT01763047|11131351|FG001|NOT COMPLETED|Period 2||5
9892367|NCT01090427|11007360|FG000|STARTED|Controlled Period||37
9892368|NCT01090427|11007361|FG001|STARTED|Controlled Period||37
9892369|NCT01090427|11007362|FG002|STARTED|Controlled Period||36
9892370|NCT01090427|11007363|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9892371|NCT01090427|11007364|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9892372|NCT01090427|11007365|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9892373|NCT01090427|11007366|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9892374|NCT01090427|11007360|FG000|COMPLETED|Controlled Period||37
9892375|NCT01090427|11007361|FG001|COMPLETED|Controlled Period||37
9892376|NCT01090427|11007362|FG002|COMPLETED|Controlled Period||36
10008863|NCT01763164|11131362|FG000|STARTED|Treatment Phase||269
10008864|NCT01763164|11131363|FG001|STARTED|Treatment Phase||133
9892377|NCT01090427|11007363|FG003|COMPLETED|Controlled Period||0
9892378|NCT01090427|11007364|FG004|COMPLETED|Controlled Period||0
9892379|NCT01090427|11007365|FG005|COMPLETED|Controlled Period||0
9892380|NCT01090427|11007366|FG006|COMPLETED|Controlled Period||0
9892381|NCT01090427|11007360|FG000|NOT COMPLETED|Controlled Period||0
9892382|NCT01090427|11007361|FG001|NOT COMPLETED|Controlled Period||0
9892383|NCT01090427|11007362|FG002|NOT COMPLETED|Controlled Period||0
9892384|NCT01090427|11007363|FG003|NOT COMPLETED|Controlled Period||0
9892385|NCT01090427|11007364|FG004|NOT COMPLETED|Controlled Period||0
9892386|NCT01090427|11007365|FG005|NOT COMPLETED|Controlled Period||0
9892387|NCT01090427|11007366|FG006|NOT COMPLETED|Controlled Period||0
9892388|NCT01090427|11007360|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9892389|NCT01090427|11007361|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9892390|NCT01090427|11007362|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9892391|NCT01090427|11007363|FG003|STARTED|After Controlled Period||19
9892392|NCT01090427|11007364|FG004|STARTED|After Controlled Period||18
9892393|NCT01090427|11007365|FG005|STARTED|After Controlled Period||37
9892394|NCT01090427|11007366|FG006|STARTED|After Controlled Period||36
9892395|NCT01090427|11007360|FG000|COMPLETED|After Controlled Period||0
9892396|NCT01090427|11007361|FG001|COMPLETED|After Controlled Period||0
9892397|NCT01090427|11007362|FG002|COMPLETED|After Controlled Period||0
9892398|NCT01090427|11007363|FG003|COMPLETED|After Controlled Period||17
9892399|NCT01090427|11007364|FG004|COMPLETED|After Controlled Period||18
9892400|NCT01090427|11007365|FG005|COMPLETED|After Controlled Period||32
9892401|NCT01090427|11007366|FG006|COMPLETED|After Controlled Period||34
9892402|NCT01090427|11007360|FG000|NOT COMPLETED|After Controlled Period||0
9892403|NCT01090427|11007361|FG001|NOT COMPLETED|After Controlled Period||0
9892404|NCT01090427|11007362|FG002|NOT COMPLETED|After Controlled Period||0
9892405|NCT01090427|11007363|FG003|NOT COMPLETED|After Controlled Period||2
9892406|NCT01090427|11007364|FG004|NOT COMPLETED|After Controlled Period||0
9892407|NCT01090427|11007365|FG005|NOT COMPLETED|After Controlled Period||5
9892408|NCT01090427|11007366|FG006|NOT COMPLETED|After Controlled Period||2
9892409|NCT01090453|11007380|FG000|STARTED|Overall Study||238
9892410|NCT01090453|11007381|FG001|STARTED|Overall Study||242
9892411|NCT01090453|11007380|FG000|COMPLETED|Overall Study||225
9892412|NCT01090453|11007381|FG001|COMPLETED|Overall Study||228
9892413|NCT01090453|11007380|FG000|NOT COMPLETED|Overall Study||13
9892414|NCT01090453|11007381|FG001|NOT COMPLETED|Overall Study||14
9892415|NCT01090479|11007389|FG000|STARTED|Overall Study||50
9892416|NCT01090479|11007390|FG001|STARTED|Overall Study||50
9892417|NCT01090479|11007389|FG000|COMPLETED|Overall Study||50
9892418|NCT01090479|11007390|FG001|COMPLETED|Overall Study||50
9892419|NCT01090479|11007389|FG000|NOT COMPLETED|Overall Study||0
9892420|NCT01090479|11007390|FG001|NOT COMPLETED|Overall Study||0
9892421|NCT01090492|11007404|FG000|STARTED|First Intervention Period (4 Weeks)||27
9892422|NCT01090492|11007405|FG001|STARTED|First Intervention Period (4 Weeks)||29
9892423|NCT01090492|11007406|FG002|STARTED|First Intervention Period (4 Weeks)||29
9892424|NCT01090492|11007407|FG003|STARTED|First Intervention Period (4 Weeks)||28
9892425|NCT01090492|11007408|FG004|STARTED|First Intervention Period (4 Weeks)||33
9892426|NCT01090492|11007409|FG005|STARTED|First Intervention Period (4 Weeks)||32
9892427|NCT01090492|11007410|FG006|STARTED|First Intervention Period (4 Weeks)||32
9892428|NCT01090492|11007411|FG007|STARTED|First Intervention Period (4 Weeks)||33
9892429|NCT01090492|11007404|FG000|COMPLETED|First Intervention Period (4 Weeks)||26
9892430|NCT01090492|11007405|FG001|COMPLETED|First Intervention Period (4 Weeks)||24
10202894|NCT03452943|11330046|FG000|COMPLETED|Maintenance Period (5 Weeks)||51
10202895|NCT03452943|11330047|FG001|COMPLETED|Maintenance Period (5 Weeks)||56
10202896|NCT03452943|11330046|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3
9892431|NCT01090492|11007406|FG002|COMPLETED|First Intervention Period (4 Weeks)||26
9892432|NCT01090492|11007407|FG003|COMPLETED|First Intervention Period (4 Weeks)||22
9892433|NCT01090492|11007408|FG004|COMPLETED|First Intervention Period (4 Weeks)||29
9892434|NCT01090492|11007409|FG005|COMPLETED|First Intervention Period (4 Weeks)||30
9892435|NCT01090492|11007410|FG006|COMPLETED|First Intervention Period (4 Weeks)||31
9892436|NCT01090492|11007411|FG007|COMPLETED|First Intervention Period (4 Weeks)||27
9892437|NCT01090492|11007404|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1
9892438|NCT01090492|11007405|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5
9892439|NCT01090492|11007406|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3
9892440|NCT01090492|11007407|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6
9892441|NCT01090492|11007408|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4
9892442|NCT01090492|11007409|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2
9892443|NCT01090492|11007410|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1
9892444|NCT01090492|11007411|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6
9892445|NCT01090492|11007404|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26
9892446|NCT01090492|11007405|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24
9892447|NCT01090492|11007406|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26
9892448|NCT01090492|11007407|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22
9892449|NCT01090492|11007408|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29
9892450|NCT01090492|11007409|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30
9892451|NCT01090492|11007410|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31
9892452|NCT01090492|11007411|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27
10202897|NCT03452943|11330047|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0
9892453|NCT01090492|11007404|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
9892454|NCT01090492|11007405|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
9892455|NCT01090492|11007406|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
9892456|NCT01090492|11007407|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
9892457|NCT01090492|11007408|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
9892458|NCT01090492|11007409|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
9892459|NCT01090492|11007410|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
9892460|NCT01090492|11007411|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
9892461|NCT01090492|11007404|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892462|NCT01090492|11007405|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892463|NCT01090492|11007406|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892464|NCT01090492|11007407|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892465|NCT01090492|11007408|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892466|NCT01090492|11007409|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892467|NCT01090492|11007410|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892468|NCT01090492|11007411|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
9892469|NCT01090492|11007404|FG000|STARTED|Second Intervention Period (4 Weeks)||26
9892470|NCT01090492|11007405|FG001|STARTED|Second Intervention Period (4 Weeks)||24
9892471|NCT01090492|11007406|FG002|STARTED|Second Intervention Period (4 Weeks)||26
9892472|NCT01090492|11007407|FG003|STARTED|Second Intervention Period (4 Weeks)||22
9892473|NCT01090492|11007408|FG004|STARTED|Second Intervention Period (4 Weeks)||29
9892474|NCT01090492|11007409|FG005|STARTED|Second Intervention Period (4 Weeks)||30
9892475|NCT01090492|11007410|FG006|STARTED|Second Intervention Period (4 Weeks)||31
9892476|NCT01090492|11007411|FG007|STARTED|Second Intervention Period (4 Weeks)||27
9892477|NCT01090492|11007404|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25
9892478|NCT01090492|11007405|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22
9892479|NCT01090492|11007406|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24
10008865|NCT01763164|11131362|FG000|Treated/Safety Set|Treatment Phase||269
10008866|NCT01763164|11131363|FG001|Treated/Safety Set|Treatment Phase||114
10008867|NCT01763164|11131362|FG000|Full Analysis Set|Treatment Phase||269
10008868|NCT01763164|11131363|FG001|Full Analysis Set|Treatment Phase||133
9892480|NCT01090492|11007407|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22
9892481|NCT01090492|11007408|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27
9892482|NCT01090492|11007409|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29
9892483|NCT01090492|11007410|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22
9892484|NCT01090492|11007411|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25
9892485|NCT01090492|11007404|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
9892486|NCT01090492|11007405|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
9892487|NCT01090492|11007406|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
9892488|NCT01090492|11007407|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
9892489|NCT01090492|11007408|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
9892490|NCT01090492|11007409|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
9892491|NCT01090492|11007410|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
9892492|NCT01090492|11007411|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
9892493|NCT01090739|11007430|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
9892494|NCT01090739|11007430|FG000|COMPLETED|Enrollment||152
9892495|NCT01090739|11007430|FG000|NOT COMPLETED|Enrollment||55
9892496|NCT01090739|11007430|FG000|STARTED|12 Month Follow-up||152
9892497|NCT01090739|11007430|FG000|COMPLETED|12 Month Follow-up||147
9892498|NCT01090739|11007430|FG000|NOT COMPLETED|12 Month Follow-up||5
9892499|NCT01090739|11007430|FG000|STARTED|24 Month Follow-up||147
9892500|NCT01090739|11007430|FG000|COMPLETED|24 Month Follow-up||138
9892501|NCT01090739|11007430|FG000|NOT COMPLETED|24 Month Follow-up||9
9892502|NCT01090739|11007430|FG000|STARTED|36 Month Follow-up||138
9892503|NCT01090739|11007430|FG000|COMPLETED|36 Month Follow-up||115
9892504|NCT01090739|11007430|FG000|NOT COMPLETED|36 Month Follow-up||23
9892505|NCT01090752|11007437|FG000|STARTED|Overall Study||8
9892506|NCT01090752|11007438|FG001|STARTED|Overall Study||8
9892507|NCT01090752|11007437|FG000|COMPLETED|Overall Study||8
9892508|NCT01090752|11007438|FG001|COMPLETED|Overall Study||8
9892509|NCT01090752|11007437|FG000|NOT COMPLETED|Overall Study||0
9892510|NCT01090752|11007438|FG001|NOT COMPLETED|Overall Study||0
9892511|NCT01090765|11007450|FG000|STARTED|Overall Study||3
9892512|NCT01090765|11007451|FG001|STARTED|Overall Study||3
9892513|NCT01090765|11007452|FG002|STARTED|Overall Study||3
9892514|NCT01090765|11007453|FG003|STARTED|Overall Study||2
9892515|NCT01090765|11007454|FG004|STARTED|Overall Study||6
9892516|NCT01090765|11007455|FG005|STARTED|Overall Study||4
9892517|NCT01090765|11007450|FG000|COMPLETED|Overall Study||3
9892518|NCT01090765|11007451|FG001|COMPLETED|Overall Study||3
9892519|NCT01090765|11007452|FG002|COMPLETED|Overall Study||3
9892520|NCT01090765|11007453|FG003|COMPLETED|Overall Study||1
9892521|NCT01090765|11007454|FG004|COMPLETED|Overall Study||4
9892522|NCT01090765|11007455|FG005|COMPLETED|Overall Study||3
9892523|NCT01090765|11007450|FG000|NOT COMPLETED|Overall Study||0
9892524|NCT01090765|11007451|FG001|NOT COMPLETED|Overall Study||0
9892525|NCT01090765|11007452|FG002|NOT COMPLETED|Overall Study||0
9892526|NCT01090765|11007453|FG003|NOT COMPLETED|Overall Study||1
9892527|NCT01090765|11007454|FG004|NOT COMPLETED|Overall Study||2
9892528|NCT01090765|11007455|FG005|NOT COMPLETED|Overall Study||1
9892529|NCT01090921|11007470|FG000|STARTED|Overall Study||50
9892530|NCT01090921|11007470|FG000|COMPLETED|Overall Study||23
9892531|NCT01090921|11007470|FG000|NOT COMPLETED|Overall Study||27
9892532|NCT01090973|11007474|FG000|STARTED|Overall Study||1
9892533|NCT01090973|11007474|FG000|COMPLETED|Overall Study||0
9892534|NCT01090973|11007474|FG000|NOT COMPLETED|Overall Study||1
9892535|NCT01091103|11007478|FG000|STARTED|Overall Study||60
9892536|NCT01091103|11007478|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
9892537|NCT01091103|11007478|FG000|NOT COMPLETED|Overall Study||4
9892538|NCT01091116|11007489|FG000|STARTED|Overall Study||83
9892539|NCT01091116|11007490|FG001|STARTED|Overall Study||88
9892540|NCT01091116|11007491|FG002|STARTED|Overall Study||84
9892541|NCT01091116|11007492|FG003|STARTED|Overall Study||84
9892542|NCT01091116|11007493|FG004|STARTED|Overall Study||84
9892543|NCT01091116|11007489|FG000|COMPLETED|Overall Study||77
9892544|NCT01091116|11007490|FG001|COMPLETED|Overall Study||80
9892545|NCT01091116|11007491|FG002|COMPLETED|Overall Study||73
9892546|NCT01091116|11007492|FG003|COMPLETED|Overall Study||80
9892547|NCT01091116|11007493|FG004|COMPLETED|Overall Study||73
9892548|NCT01091116|11007489|FG000|NOT COMPLETED|Overall Study||6
9892549|NCT01091116|11007490|FG001|NOT COMPLETED|Overall Study||8
9892550|NCT01091116|11007491|FG002|NOT COMPLETED|Overall Study||11
9892551|NCT01091116|11007492|FG003|NOT COMPLETED|Overall Study||4
9892552|NCT01091116|11007493|FG004|NOT COMPLETED|Overall Study||11
9892553|NCT01091155|11007505|FG000|STARTED|Overall Study||288
9892554|NCT01091155|11007505|FG000|COMPLETED|Overall Study||279
9892555|NCT01091155|11007505|FG000|NOT COMPLETED|Overall Study||9
9892556|NCT01091168|11007511|FG000|STARTED|Overall Study||298
9892557|NCT01091168|11007512|FG001|STARTED|Overall Study||296
9892558|NCT01091168|11007511|FG000|COMPLETED|Overall Study||0
9892559|NCT01091168|11007512|FG001|COMPLETED|Overall Study||0
9892560|NCT01091168|11007511|FG000|NOT COMPLETED|Overall Study||298
9892561|NCT01091168|11007512|FG001|NOT COMPLETED|Overall Study||296
9892562|NCT01091246|11007521|FG000|STARTED|Overall Study||1385
9892563|NCT01091246|11007522|FG001|STARTED|Overall Study||464
9892564|NCT01091246|11007523|FG002|STARTED|Overall Study||463
9892565|NCT01091246|11007521|FG000|COMPLETED|Overall Study||1350
9892566|NCT01091246|11007522|FG001|COMPLETED|Overall Study||448
9892567|NCT01091246|11007523|FG002|COMPLETED|Overall Study||450
9892568|NCT01091246|11007521|FG000|NOT COMPLETED|Overall Study||35
9892569|NCT01091246|11007522|FG001|NOT COMPLETED|Overall Study||16
9892570|NCT01091246|11007523|FG002|NOT COMPLETED|Overall Study||13
9892571|NCT01091259|11007533|FG000|STARTED|Overall Study||29
9892572|NCT01091259|11007533|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
9892573|NCT01091259|11007533|FG000|NOT COMPLETED|Overall Study||5
9892574|NCT01091363|11007539|FG000|STARTED|Overall Study||55
9892575|NCT01091363|11007540|FG001|STARTED|Overall Study||54
9892576|NCT01091363|11007539|FG000|COMPLETED|Overall Study||42
9892577|NCT01091363|11007540|FG001|COMPLETED|Overall Study||37
9892578|NCT01091363|11007539|FG000|NOT COMPLETED|Overall Study||13
9892579|NCT01091363|11007540|FG001|NOT COMPLETED|Overall Study||17
9892580|NCT01091428|11007550|FG000|STARTED|Phase 1||38
9892581|NCT01091428|11007551|FG001|STARTED|Phase 1||11
9892582|NCT01091428|11007552|FG002|STARTED|Phase 1||0
9892583|NCT01091428|11007553|FG003|STARTED|Phase 1||0
9892584|NCT01091428|11007550|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
9892585|NCT01091428|11007551|FG001|COMPLETED|Phase 1||0
9892586|NCT01091428|11007552|FG002|COMPLETED|Phase 1||0
9892587|NCT01091428|11007553|FG003|COMPLETED|Phase 1||0
9892588|NCT01091428|11007550|FG000|NOT COMPLETED|Phase 1||38
9892589|NCT01091428|11007551|FG001|NOT COMPLETED|Phase 1||11
9892590|NCT01091428|11007552|FG002|NOT COMPLETED|Phase 1||0
9892591|NCT01091428|11007553|FG003|NOT COMPLETED|Phase 1||0
9892592|NCT01091428|11007550|FG000|STARTED|Phase 2||0
9892593|NCT01091428|11007551|FG001|STARTED|Phase 2||0
9892594|NCT01091428|11007552|FG002|STARTED|Phase 2||73
9892595|NCT01091428|11007553|FG003|STARTED|Phase 2||69
9892596|NCT01091428|11007550|FG000|COMPLETED|Phase 2||0
10110129|NCT02482675|11240898|FG016|COMPLETED|Overall Study||1
10110130|NCT02482675|11240899|FG017|COMPLETED|Overall Study||1
10110131|NCT02482675|11240900|FG018|COMPLETED|Overall Study||1
10110132|NCT02482675|11240901|FG019|COMPLETED|Overall Study||1
10110133|NCT02482675|11240902|FG020|COMPLETED|Overall Study||1
9892597|NCT01091428|11007551|FG001|COMPLETED|Phase 2||0
9892598|NCT01091428|11007552|FG002|COMPLETED|Phase 2||0
9892599|NCT01091428|11007553|FG003|COMPLETED|Phase 2||0
9892600|NCT01091428|11007550|FG000|NOT COMPLETED|Phase 2||0
9892601|NCT01091428|11007551|FG001|NOT COMPLETED|Phase 2||0
9892602|NCT01091428|11007552|FG002|NOT COMPLETED|Phase 2||73
9892603|NCT01091428|11007553|FG003|NOT COMPLETED|Phase 2||69
9892604|NCT01091454|11007572|FG000|STARTED|Overall Study||48
9892605|NCT01091454|11007572|FG000|COMPLETED|Overall Study||47
9892606|NCT01091454|11007572|FG000|NOT COMPLETED|Overall Study||1
9892607|NCT01091519|11007578|FG000|STARTED|Overall Study||346
9892608|NCT01091519|11007579|FG001|STARTED|Overall Study||435
9892609|NCT01091519|11007578|FG000|Treated|Overall Study||342
9892610|NCT01091519|11007579|FG001|Treated|Overall Study||431
9892611|NCT01091519|11007578|FG000|COMPLETED|Overall Study||291
9892612|NCT01091519|11007579|FG001|COMPLETED|Overall Study||362
9892613|NCT01091519|11007578|FG000|NOT COMPLETED|Overall Study||55
9892614|NCT01091519|11007579|FG001|NOT COMPLETED|Overall Study||73
9892615|NCT01091662|11007587|FG000|STARTED|Overall Study||58
9892616|NCT01091662|11007588|FG001|STARTED|Overall Study||114
9892617|NCT01091662|11007587|FG000|COMPLETED|Overall Study||41
10110134|NCT02482675|11240903|FG021|COMPLETED|Overall Study||1
9892618|NCT01091662|11007588|FG001|COMPLETED|Overall Study||80
9892619|NCT01091662|11007587|FG000|NOT COMPLETED|Overall Study||17
9892620|NCT01091662|11007588|FG001|NOT COMPLETED|Overall Study||34
9892621|NCT01091675|11007599|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
9892622|NCT01091675|11007599|FG000|COMPLETED|Overall Study||23
9892623|NCT01091675|11007599|FG000|NOT COMPLETED|Overall Study||34
9892624|NCT01091948|11007605|FG000|STARTED|Overall Study||37
9892625|NCT01091948|11007606|FG001|STARTED|Overall Study||38
9892626|NCT01091948|11007605|FG000|COMPLETED|Overall Study||37
9892627|NCT01091948|11007606|FG001|COMPLETED|Overall Study||38
9892628|NCT01091948|11007605|FG000|NOT COMPLETED|Overall Study||0
9892629|NCT01091948|11007606|FG001|NOT COMPLETED|Overall Study||0
9892630|NCT01091974|11007617|FG000|STARTED|Overall Study||24
9892631|NCT01091974|11007618|FG001|STARTED|Overall Study||23
9892632|NCT01091974|11007619|FG002|STARTED|Overall Study||25
9892633|NCT01091974|11007620|FG003|STARTED|Overall Study||24
9892634|NCT01091974|11007617|FG000|COMPLETED|Overall Study||19
9892635|NCT01091974|11007618|FG001|COMPLETED|Overall Study||18
9892636|NCT01091974|11007619|FG002|COMPLETED|Overall Study||19
9892637|NCT01091974|11007620|FG003|COMPLETED|Overall Study||17
9892638|NCT01091974|11007617|FG000|NOT COMPLETED|Overall Study||5
9892639|NCT01091974|11007618|FG001|NOT COMPLETED|Overall Study||5
9892640|NCT01091974|11007619|FG002|NOT COMPLETED|Overall Study||6
9892641|NCT01091974|11007620|FG003|NOT COMPLETED|Overall Study||7
9892642|NCT01092182|11007633|FG000|STARTED|Overall Study||15
9892643|NCT01092182|11007634|FG001|STARTED|Overall Study||98
9892644|NCT01092182|11007635|FG002|STARTED|Overall Study||81
9892645|NCT01092182|11007633|FG000|COMPLETED|Overall Study||14
9892646|NCT01092182|11007634|FG001|COMPLETED|Overall Study||80
9892647|NCT01092182|11007635|FG002|COMPLETED|Overall Study||53
9892648|NCT01092182|11007633|FG000|NOT COMPLETED|Overall Study||1
9892649|NCT01092182|11007634|FG001|NOT COMPLETED|Overall Study||18
9892650|NCT01092182|11007635|FG002|NOT COMPLETED|Overall Study||28
9892651|NCT01092195|11007646|FG000|STARTED|Overall Study||23
9892652|NCT01092195|11007647|FG001|STARTED|Overall Study||21
9892653|NCT01092195|11007648|FG002|STARTED|Overall Study||20
9892654|NCT01092195|11007646|FG000|COMPLETED|Overall Study||23
9892655|NCT01092195|11007647|FG001|COMPLETED|Overall Study||21
9892656|NCT01092195|11007648|FG002|COMPLETED|Overall Study||20
9892657|NCT01092195|11007646|FG000|NOT COMPLETED|Overall Study||0
9892658|NCT01092195|11007647|FG001|NOT COMPLETED|Overall Study||0
9892659|NCT01092195|11007648|FG002|NOT COMPLETED|Overall Study||0
9892660|NCT01092338|11007658|FG000|STARTED|Overall Study||22
9892661|NCT01092338|11007659|FG001|STARTED|Overall Study||22
9892662|NCT01092338|11007658|FG000|COMPLETED|Overall Study||21
9892663|NCT01092338|11007659|FG001|COMPLETED|Overall Study||21
9892664|NCT01092338|11007658|FG000|NOT COMPLETED|Overall Study||1
9892665|NCT01092338|11007659|FG001|NOT COMPLETED|Overall Study||1
9892666|NCT01092364|11007668|FG000|STARTED|Overall Study||122
9892667|NCT01092364|11007669|FG001|STARTED|Overall Study||120
9892668|NCT01092364|11007670|FG002|STARTED|Overall Study||123
9892669|NCT01092364|11007668|FG000|COMPLETED|Overall Study||104
9892670|NCT01092364|11007669|FG001|COMPLETED|Overall Study||104
9892671|NCT01092364|11007670|FG002|COMPLETED|Overall Study||105
9892672|NCT01092364|11007668|FG000|NOT COMPLETED|Overall Study||18
9892673|NCT01092364|11007669|FG001|NOT COMPLETED|Overall Study||16
9892674|NCT01092364|11007670|FG002|NOT COMPLETED|Overall Study||18
9892675|NCT01092416|11007678|FG000|STARTED|Enrollment||443
9892676|NCT01092416|11007678|FG000|COMPLETED|Enrollment||440
9892677|NCT01092416|11007678|FG000|NOT COMPLETED|Enrollment||3
9892678|NCT01092416|11007678|FG000|STARTED|30-Day Follow-up||440
9892679|NCT01092416|11007678|FG000|COMPLETED|30-Day Follow-up||430
10008869|NCT01763164|11131362|FG000|COMPLETED|Treatment Phase||0
10008870|NCT01763164|11131363|FG001|COMPLETED|Treatment Phase||0
10008871|NCT01763164|11131362|FG000|NOT COMPLETED|Treatment Phase||269
10008872|NCT01763164|11131363|FG001|NOT COMPLETED|Treatment Phase||133
9892680|NCT01092416|11007678|FG000|NOT COMPLETED|30-Day Follow-up||10
9892681|NCT01092416|11007678|FG000|STARTED|12-Month Follow-up||438
9892682|NCT01092416|11007678|FG000|COMPLETED|12-Month Follow-up||413
9892683|NCT01092416|11007678|FG000|NOT COMPLETED|12-Month Follow-up||25
9892684|NCT01092442|11007687|FG000|STARTED|Overall Study||80
9892685|NCT01092442|11007688|FG001|STARTED|Overall Study||60
9892686|NCT01092442|11007687|FG000|COMPLETED|Overall Study||80
9892687|NCT01092442|11007688|FG001|COMPLETED|Overall Study||60
9892688|NCT01092442|11007687|FG000|NOT COMPLETED|Overall Study||0
9892689|NCT01092442|11007688|FG001|NOT COMPLETED|Overall Study||0
10008873|NCT01763164|11131362|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
9892690|NCT01092507|11007701|FG000|STARTED|Overall Study||149
9892691|NCT01092507|11007702|FG001|STARTED|Overall Study||150
9892692|NCT01092507|11007701|FG000|COMPLETED|Overall Study||147
9892693|NCT01092507|11007702|FG001|COMPLETED|Overall Study||150
9892694|NCT01092507|11007701|FG000|NOT COMPLETED|Overall Study||2
9892695|NCT01092507|11007702|FG001|NOT COMPLETED|Overall Study||0
9892696|NCT01092546|11007708|FG000|STARTED|Overall Study||16
9892697|NCT01092546|11007708|FG000|COMPLETED|Overall Study||12
9892698|NCT01092546|11007708|FG000|NOT COMPLETED|Overall Study||4
9892699|NCT01092559|11007712|FG000|STARTED|Overall Study||10
9892700|NCT01092559|11007712|FG000|COMPLETED|Overall Study||10
9892701|NCT01092559|11007712|FG000|NOT COMPLETED|Overall Study||0
9892702|NCT01092637|11007718|FG000|STARTED|Overall Study||145
9892703|NCT01092637|11007719|FG001|STARTED|Overall Study||135
9892704|NCT01092637|11007718|FG000|COMPLETED|Overall Study||98
9892705|NCT01092637|11007719|FG001|COMPLETED|Overall Study||86
9892706|NCT01092637|11007718|FG000|NOT COMPLETED|Overall Study||47
9892707|NCT01092637|11007719|FG001|NOT COMPLETED|Overall Study||49
9892708|NCT01092663|11007728|FG000|STARTED|Overall Study||31
9892709|NCT01092663|11007729|FG001|STARTED|Overall Study||30
9892710|NCT01092663|11007728|FG000|COMPLETED|Overall Study||24
9892711|NCT01092663|11007729|FG001|COMPLETED|Overall Study||26
9892712|NCT01092663|11007728|FG000|NOT COMPLETED|Overall Study||7
9892713|NCT01092663|11007729|FG001|NOT COMPLETED|Overall Study||4
9892714|NCT01092676|11007742|FG000|STARTED|Overall Study||50
9892715|NCT01092676|11007743|FG001|STARTED|Overall Study||49
9892716|NCT01092676|11007742|FG000|COMPLETED|Overall Study||50
9892717|NCT01092676|11007743|FG001|COMPLETED|Overall Study||49
9892718|NCT01092676|11007742|FG000|NOT COMPLETED|Overall Study||0
9892719|NCT01092676|11007743|FG001|NOT COMPLETED|Overall Study||0
9892720|NCT01092702|11007749|FG000|STARTED|Overall Study||32
9892721|NCT01092702|11007749|FG000|COMPLETED|Overall Study||23
9892722|NCT01092702|11007749|FG000|NOT COMPLETED|Overall Study||9
9892723|NCT01092728|11007755|FG000|STARTED|Overall Study||4
9892724|NCT01092728|11007756|FG001|STARTED|Overall Study||14
9892725|NCT01092728|11007755|FG000|COMPLETED|Overall Study||0
9892726|NCT01092728|11007756|FG001|COMPLETED|Overall Study||0
9892727|NCT01092728|11007755|FG000|NOT COMPLETED|Overall Study||4
9892728|NCT01092728|11007756|FG001|NOT COMPLETED|Overall Study||14
9892729|NCT01092767|11007762|FG000|STARTED|Overall Study||50
9892730|NCT01092767|11007762|FG000|COMPLETED|Overall Study||45
9892731|NCT01092767|11007762|FG000|NOT COMPLETED|Overall Study||5
9892732|NCT01092780|11007766|FG000|STARTED|Treatment Period 1||14
9892733|NCT01092780|11007767|FG001|STARTED|Treatment Period 1||15
9892734|NCT01092780|11007768|FG002|STARTED|Treatment Period 1||14
9892735|NCT01092780|11007769|FG003|STARTED|Treatment Period 1||13
9892736|NCT01092780|11007766|FG000|COMPLETED|Treatment Period 1||14
9892737|NCT01092780|11007767|FG001|COMPLETED|Treatment Period 1||15
9892738|NCT01092780|11007768|FG002|COMPLETED|Treatment Period 1||14
9892739|NCT01092780|11007769|FG003|COMPLETED|Treatment Period 1||13
9892740|NCT01092780|11007766|FG000|NOT COMPLETED|Treatment Period 1||0
9892741|NCT01092780|11007767|FG001|NOT COMPLETED|Treatment Period 1||0
9892742|NCT01092780|11007768|FG002|NOT COMPLETED|Treatment Period 1||0
9892743|NCT01092780|11007769|FG003|NOT COMPLETED|Treatment Period 1||0
9892744|NCT01092780|11007766|FG000|STARTED|Washout Period 1||14
9892745|NCT01092780|11007767|FG001|STARTED|Washout Period 1||15
9892746|NCT01092780|11007768|FG002|STARTED|Washout Period 1||14
9892747|NCT01092780|11007769|FG003|STARTED|Washout Period 1||13
9892748|NCT01092780|11007766|FG000|COMPLETED|Washout Period 1||13
9892749|NCT01092780|11007767|FG001|COMPLETED|Washout Period 1||14
9892750|NCT01092780|11007768|FG002|COMPLETED|Washout Period 1||14
9892751|NCT01092780|11007769|FG003|COMPLETED|Washout Period 1||13
9892752|NCT01092780|11007766|FG000|NOT COMPLETED|Washout Period 1||1
9892753|NCT01092780|11007767|FG001|NOT COMPLETED|Washout Period 1||1
9892754|NCT01092780|11007768|FG002|NOT COMPLETED|Washout Period 1||0
9892755|NCT01092780|11007769|FG003|NOT COMPLETED|Washout Period 1||0
9892756|NCT01092780|11007766|FG000|STARTED|Treatment Period 2||13
9892757|NCT01092780|11007767|FG001|STARTED|Treatment Period 2||14
9892758|NCT01092780|11007768|FG002|STARTED|Treatment Period 2||14
9892759|NCT01092780|11007769|FG003|STARTED|Treatment Period 2||13
9892760|NCT01092780|11007766|FG000|COMPLETED|Treatment Period 2||13
9892761|NCT01092780|11007767|FG001|COMPLETED|Treatment Period 2||14
9892762|NCT01092780|11007768|FG002|COMPLETED|Treatment Period 2||14
9892763|NCT01092780|11007769|FG003|COMPLETED|Treatment Period 2||13
9892764|NCT01092780|11007766|FG000|NOT COMPLETED|Treatment Period 2||0
9892765|NCT01092780|11007767|FG001|NOT COMPLETED|Treatment Period 2||0
9892766|NCT01092780|11007768|FG002|NOT COMPLETED|Treatment Period 2||0
9892767|NCT01092780|11007769|FG003|NOT COMPLETED|Treatment Period 2||0
9892768|NCT01092780|11007766|FG000|STARTED|Washout Period 2||13
9892769|NCT01092780|11007767|FG001|STARTED|Washout Period 2||14
9892770|NCT01092780|11007768|FG002|STARTED|Washout Period 2||14
9892771|NCT01092780|11007769|FG003|STARTED|Washout Period 2||13
9892772|NCT01092780|11007766|FG000|COMPLETED|Washout Period 2||13
9892773|NCT01092780|11007767|FG001|COMPLETED|Washout Period 2||13
9892774|NCT01092780|11007768|FG002|COMPLETED|Washout Period 2||13
9892775|NCT01092780|11007769|FG003|COMPLETED|Washout Period 2||13
9892776|NCT01092780|11007766|FG000|NOT COMPLETED|Washout Period 2||0
9892777|NCT01092780|11007767|FG001|NOT COMPLETED|Washout Period 2||1
9892778|NCT01092780|11007768|FG002|NOT COMPLETED|Washout Period 2||1
9892779|NCT01092780|11007769|FG003|NOT COMPLETED|Washout Period 2||0
9892780|NCT01092780|11007766|FG000|STARTED|Treatment Period 3||13
9892781|NCT01092780|11007767|FG001|STARTED|Treatment Period 3||13
9892782|NCT01092780|11007768|FG002|STARTED|Treatment Period 3||13
9892783|NCT01092780|11007769|FG003|STARTED|Treatment Period 3||13
9892784|NCT01092780|11007766|FG000|COMPLETED|Treatment Period 3||13
9892785|NCT01092780|11007767|FG001|COMPLETED|Treatment Period 3||13
9892786|NCT01092780|11007768|FG002|COMPLETED|Treatment Period 3||13
9892787|NCT01092780|11007769|FG003|COMPLETED|Treatment Period 3||13
9892788|NCT01092780|11007766|FG000|NOT COMPLETED|Treatment Period 3||0
9892789|NCT01092780|11007767|FG001|NOT COMPLETED|Treatment Period 3||0
9892790|NCT01092780|11007768|FG002|NOT COMPLETED|Treatment Period 3||0
9892791|NCT01092780|11007769|FG003|NOT COMPLETED|Treatment Period 3||0
9892792|NCT01092780|11007766|FG000|STARTED|Washout Period 3||13
9892793|NCT01092780|11007767|FG001|STARTED|Washout Period 3||13
9892794|NCT01092780|11007768|FG002|STARTED|Washout Period 3||13
9892795|NCT01092780|11007769|FG003|STARTED|Washout Period 3||13
9892796|NCT01092780|11007766|FG000|COMPLETED|Washout Period 3||13
9892797|NCT01092780|11007767|FG001|COMPLETED|Washout Period 3||13
9892798|NCT01092780|11007768|FG002|COMPLETED|Washout Period 3||13
9892799|NCT01092780|11007769|FG003|COMPLETED|Washout Period 3||13
9892800|NCT01092780|11007766|FG000|NOT COMPLETED|Washout Period 3||0
10110135|NCT02482675|11240904|FG022|COMPLETED|Overall Study||1
10110136|NCT02482675|11240882|FG000|NOT COMPLETED|Overall Study||0
10110137|NCT02482675|11240883|FG001|NOT COMPLETED|Overall Study||0
9892801|NCT01092780|11007767|FG001|NOT COMPLETED|Washout Period 3||0
9892802|NCT01092780|11007768|FG002|NOT COMPLETED|Washout Period 3||0
9892803|NCT01092780|11007769|FG003|NOT COMPLETED|Washout Period 3||0
9892804|NCT01092780|11007766|FG000|STARTED|Treatment Period 4||13
9892805|NCT01092780|11007767|FG001|STARTED|Treatment Period 4||13
9892806|NCT01092780|11007768|FG002|STARTED|Treatment Period 4||13
9892807|NCT01092780|11007769|FG003|STARTED|Treatment Period 4||13
9892808|NCT01092780|11007766|FG000|COMPLETED|Treatment Period 4||13
9892809|NCT01092780|11007767|FG001|COMPLETED|Treatment Period 4||13
9892810|NCT01092780|11007768|FG002|COMPLETED|Treatment Period 4||13
9892811|NCT01092780|11007769|FG003|COMPLETED|Treatment Period 4||13
9892812|NCT01092780|11007766|FG000|NOT COMPLETED|Treatment Period 4||0
9892813|NCT01092780|11007767|FG001|NOT COMPLETED|Treatment Period 4||0
9892814|NCT01092780|11007768|FG002|NOT COMPLETED|Treatment Period 4||0
9892815|NCT01092780|11007769|FG003|NOT COMPLETED|Treatment Period 4||0
9892816|NCT01092832|11007781|FG000|STARTED|Overall Study||14
9892817|NCT01092832|11007782|FG001|STARTED|Overall Study||8
9892818|NCT01092832|11007781|FG000|COMPLETED|Overall Study||13
9892819|NCT01092832|11007782|FG001|COMPLETED|Overall Study||8
9892820|NCT01092832|11007781|FG000|NOT COMPLETED|Overall Study||1
9892821|NCT01092832|11007782|FG001|NOT COMPLETED|Overall Study||0
9892822|NCT01092910|11007788|FG000|STARTED|Overall Study||57
9892823|NCT01092910|11007788|FG000|4 Month Follow-up|Overall Study||54
9892824|NCT01092910|11007788|FG000|10 Month Follow-up|Overall Study||52
9892825|NCT01092910|11007788|FG000|COMPLETED|Overall Study||52
9892826|NCT01092910|11007788|FG000|NOT COMPLETED|Overall Study||5
9892827|NCT01092923|11007795|FG000|STARTED|Overall Study||10
9892828|NCT01092923|11007796|FG001|STARTED|Overall Study||10
9892829|NCT01092923|11007795|FG000|COMPLETED|Overall Study||10
9892830|NCT01092923|11007796|FG001|COMPLETED|Overall Study||10
9892831|NCT01092923|11007795|FG000|NOT COMPLETED|Overall Study||0
9892832|NCT01092923|11007796|FG001|NOT COMPLETED|Overall Study||0
9892833|NCT01093014|11007806|FG000|STARTED|Overall Study||12
9892834|NCT01093014|11007807|FG001|STARTED|Overall Study||9
9892835|NCT01093014|11007808|FG002|STARTED|Overall Study||12
9892836|NCT01093014|11007806|FG000|COMPLETED|Overall Study||12
9892837|NCT01093014|11007807|FG001|COMPLETED|Overall Study||9
9892838|NCT01093014|11007808|FG002|COMPLETED|Overall Study||12
9892839|NCT01093014|11007806|FG000|NOT COMPLETED|Overall Study||0
9892840|NCT01093014|11007807|FG001|NOT COMPLETED|Overall Study||0
9892841|NCT01093014|11007808|FG002|NOT COMPLETED|Overall Study||0
9892842|NCT01093027|11007821|FG000|STARTED|Visit 1||10
9892843|NCT01093027|11007822|FG001|STARTED|Visit 1||10
9892844|NCT01093027|11007821|FG000|COMPLETED|Visit 1||10
9892845|NCT01093027|11007822|FG001|COMPLETED|Visit 1||10
9892846|NCT01093027|11007821|FG000|NOT COMPLETED|Visit 1||0
9892847|NCT01093027|11007822|FG001|NOT COMPLETED|Visit 1||0
9892848|NCT01093027|11007821|FG000|STARTED|Visit 2||10
9892849|NCT01093027|11007822|FG001|STARTED|Visit 2||10
9892850|NCT01093027|11007821|FG000|COMPLETED|Visit 2||10
9892851|NCT01093027|11007822|FG001|COMPLETED|Visit 2||10
9892852|NCT01093027|11007821|FG000|NOT COMPLETED|Visit 2||0
9892853|NCT01093027|11007822|FG001|NOT COMPLETED|Visit 2||0
9892854|NCT01093183|11007828|FG000|STARTED|Overall Study||19
9892855|NCT01093183|11007829|FG001|STARTED|Overall Study||6
9892856|NCT01093183|11007828|FG000|COMPLETED|Overall Study||18
9892857|NCT01093183|11007829|FG001|COMPLETED|Overall Study||4
9892858|NCT01093183|11007828|FG000|NOT COMPLETED|Overall Study||1
9892859|NCT01093183|11007829|FG001|NOT COMPLETED|Overall Study||2
9892860|NCT01093222|11007833|FG000|STARTED|Overall Study||40
9892861|NCT01093222|11007833|FG000|Eligible and Began Protocol Therapy|Overall Study||34
9892862|NCT01093222|11007833|FG000|COMPLETED|Overall Study||0
9892863|NCT01093222|11007833|FG000|NOT COMPLETED|Overall Study||40
9892864|NCT01093417|11007839|FG000|STARTED|Overall Study||15
9892865|NCT01093417|11007840|FG001|STARTED|Overall Study||30
9892866|NCT01093417|11007839|FG000|COMPLETED|Overall Study||15
9892867|NCT01093417|11007840|FG001|COMPLETED|Overall Study||29
9892868|NCT01093417|11007839|FG000|NOT COMPLETED|Overall Study||0
9892869|NCT01093417|11007840|FG001|NOT COMPLETED|Overall Study||1
9892870|NCT01093469|11007849|FG000|STARTED|Overall Study||13
9892871|NCT01093469|11007850|FG001|STARTED|Overall Study||13
9892872|NCT01093469|11007851|FG002|STARTED|Overall Study||13
9892873|NCT01093469|11007849|FG000|COMPLETED|Overall Study||13
9892874|NCT01093469|11007850|FG001|COMPLETED|Overall Study||13
9892875|NCT01093469|11007851|FG002|COMPLETED|Overall Study||12
10110138|NCT02482675|11240884|FG002|NOT COMPLETED|Overall Study||0
9892876|NCT01093469|11007849|FG000|NOT COMPLETED|Overall Study||0
9892877|NCT01093469|11007850|FG001|NOT COMPLETED|Overall Study||0
9892878|NCT01093469|11007851|FG002|NOT COMPLETED|Overall Study||1
9892879|NCT01093482|11007859|FG000|STARTED|Overall Study||8151
9892880|NCT01093482|11007859|FG000|COMPLETED|Overall Study||8151
10110139|NCT02482675|11240885|FG003|NOT COMPLETED|Overall Study||0
9892881|NCT01093482|11007859|FG000|NOT COMPLETED|Overall Study||0
9892882|NCT01093521|11007863|FG000|STARTED|Overall Study||20
9892883|NCT01093521|11007863|FG000|COMPLETED|Overall Study||20
9892884|NCT01093521|11007863|FG000|NOT COMPLETED|Overall Study||0
9892885|NCT01093534|11007872|FG000|STARTED|Overall Study||186
9892886|NCT01093534|11007873|FG001|STARTED|Overall Study||183
9892887|NCT01093534|11007874|FG002|STARTED|Overall Study||178
9892888|NCT01093534|11007872|FG000|Received Study Treatment|Overall Study||186
9892889|NCT01093534|11007873|FG001|Received Study Treatment|Overall Study||182
9892890|NCT01093534|11007874|FG002|Received Study Treatment|Overall Study||175
9892891|NCT01093534|11007872|FG000|COMPLETED|Overall Study||176
9892892|NCT01093534|11007873|FG001|COMPLETED|Overall Study||167
9892893|NCT01093534|11007874|FG002|COMPLETED|Overall Study||169
9892894|NCT01093534|11007872|FG000|NOT COMPLETED|Overall Study||10
9892895|NCT01093534|11007873|FG001|NOT COMPLETED|Overall Study||16
9892896|NCT01093534|11007874|FG002|NOT COMPLETED|Overall Study||9
9892906|NCT01093586|11007899|FG000|STARTED|Overall Study||14
9892907|NCT01093586|11007899|FG000|COMPLETED|Overall Study||11
9892908|NCT01093586|11007899|FG000|NOT COMPLETED|Overall Study||3
9892909|NCT01093599|11007905|FG000|STARTED|Overall Study||91
9892910|NCT01093599|11007906|FG001|STARTED|Overall Study||105
9892911|NCT01093599|11007905|FG000|COMPLETED|Overall Study||59
9892912|NCT01093599|11007906|FG001|COMPLETED|Overall Study||59
9892913|NCT01093599|11007905|FG000|NOT COMPLETED|Overall Study||32
9892914|NCT01093599|11007906|FG001|NOT COMPLETED|Overall Study||46
9892915|NCT01093625|11007914|FG000|STARTED|Baseline and Dispensed||49
9892916|NCT01093625|11007915|FG001|STARTED|Baseline and Dispensed||49
9892917|NCT01093625|11007914|FG000|COMPLETED|Baseline and Dispensed||47
9892918|NCT01093625|11007915|FG001|COMPLETED|Baseline and Dispensed||49
9892919|NCT01093625|11007914|FG000|NOT COMPLETED|Baseline and Dispensed||2
9892920|NCT01093625|11007915|FG001|NOT COMPLETED|Baseline and Dispensed||0
9892921|NCT01093625|11007914|FG000|STARTED|2-Week Visit||47
9892922|NCT01093625|11007915|FG001|STARTED|2-Week Visit||49
9892923|NCT01093625|11007914|FG000|COMPLETED|2-Week Visit||46
9892924|NCT01093625|11007915|FG001|COMPLETED|2-Week Visit||49
9892925|NCT01093625|11007914|FG000|NOT COMPLETED|2-Week Visit||1
9892926|NCT01093625|11007915|FG001|NOT COMPLETED|2-Week Visit||0
9892927|NCT01093625|11007914|FG000|STARTED|1-Month Visit||46
9892928|NCT01093625|11007915|FG001|STARTED|1-Month Visit||49
9892929|NCT01093625|11007914|FG000|COMPLETED|1-Month Visit||44
9892930|NCT01093625|11007915|FG001|COMPLETED|1-Month Visit||49
9892931|NCT01093625|11007914|FG000|NOT COMPLETED|1-Month Visit||2
9892932|NCT01093625|11007915|FG001|NOT COMPLETED|1-Month Visit||0
9892933|NCT01093625|11007914|FG000|STARTED|3-Month Visit||44
9892934|NCT01093625|11007915|FG001|STARTED|3-Month Visit||49
9892935|NCT01093625|11007914|FG000|COMPLETED|3-Month Visit||42
9892936|NCT01093625|11007915|FG001|COMPLETED|3-Month Visit||49
9892937|NCT01093625|11007914|FG000|NOT COMPLETED|3-Month Visit||2
9892938|NCT01093625|11007915|FG001|NOT COMPLETED|3-Month Visit||0
9892939|NCT01093625|11007914|FG000|STARTED|6-Month Visit||42
9892940|NCT01093625|11007915|FG001|STARTED|6-Month Visit||49
9892941|NCT01093625|11007914|FG000|COMPLETED|6-Month Visit||34
9892942|NCT01093625|11007915|FG001|COMPLETED|6-Month Visit||40
9892943|NCT01093625|11007914|FG000|NOT COMPLETED|6-Month Visit||8
9892944|NCT01093625|11007915|FG001|NOT COMPLETED|6-Month Visit||9
9892945|NCT01093625|11007914|FG000|STARTED|1-Year Visit||34
9892946|NCT01093625|11007915|FG001|STARTED|1-Year Visit||40
9892947|NCT01093625|11007914|FG000|COMPLETED|1-Year Visit||29
9892948|NCT01093625|11007915|FG001|COMPLETED|1-Year Visit||37
9892949|NCT01093625|11007914|FG000|NOT COMPLETED|1-Year Visit||5
9892950|NCT01093625|11007915|FG001|NOT COMPLETED|1-Year Visit||3
9892951|NCT01093651|11007923|FG000|STARTED|Overall Study||10
9892952|NCT01093651|11007924|FG001|STARTED|Overall Study||10
9892953|NCT01093651|11007923|FG000|COMPLETED|Overall Study||10
9892954|NCT01093651|11007924|FG001|COMPLETED|Overall Study||10
9892955|NCT01093651|11007923|FG000|NOT COMPLETED|Overall Study||0
9892956|NCT01093651|11007924|FG001|NOT COMPLETED|Overall Study||0
9892957|NCT01093690|11007932|FG000|STARTED|Overall Study||83
9892958|NCT01093690|11007933|FG001|STARTED|Overall Study||79
9892959|NCT01093690|11007932|FG000|COMPLETED|Overall Study||83
9892960|NCT01093690|11007933|FG001|COMPLETED|Overall Study||79
9892961|NCT01093690|11007932|FG000|NOT COMPLETED|Overall Study||0
9892962|NCT01093690|11007933|FG001|NOT COMPLETED|Overall Study||0
9892963|NCT01093755|11007941|FG000|STARTED|Overall Study||16
9892964|NCT01093755|11007942|FG001|STARTED|Overall Study||14
9892965|NCT01093755|11007941|FG000|COMPLETED|Overall Study||13
9892966|NCT01093755|11007942|FG001|COMPLETED|Overall Study||10
9892967|NCT01093755|11007941|FG000|NOT COMPLETED|Overall Study||3
9892968|NCT01093755|11007942|FG001|NOT COMPLETED|Overall Study||4
9892969|NCT01093794|11007948|FG000|STARTED|Treatment Period 1||7
9892970|NCT01093794|11007949|FG001|STARTED|Treatment Period 1||7
9892971|NCT01093794|11007950|FG002|STARTED|Treatment Period 1||7
9892972|NCT01093794|11007951|FG003|STARTED|Treatment Period 1||7
9892973|NCT01093794|11007948|FG000|COMPLETED|Treatment Period 1||7
9892974|NCT01093794|11007949|FG001|COMPLETED|Treatment Period 1||7
9892975|NCT01093794|11007950|FG002|COMPLETED|Treatment Period 1||7
9892976|NCT01093794|11007951|FG003|COMPLETED|Treatment Period 1||7
9892977|NCT01093794|11007948|FG000|NOT COMPLETED|Treatment Period 1||0
9892978|NCT01093794|11007949|FG001|NOT COMPLETED|Treatment Period 1||0
9892979|NCT01093794|11007950|FG002|NOT COMPLETED|Treatment Period 1||0
9892980|NCT01093794|11007951|FG003|NOT COMPLETED|Treatment Period 1||0
9892981|NCT01093794|11007948|FG000|STARTED|Treatment Period 2||7
9892982|NCT01093794|11007949|FG001|STARTED|Treatment Period 2||7
9892983|NCT01093794|11007950|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
9892984|NCT01093794|11007951|FG003|STARTED|Treatment Period 2||7
9892985|NCT01093794|11007948|FG000|COMPLETED|Treatment Period 2||7
9892986|NCT01093794|11007949|FG001|COMPLETED|Treatment Period 2||7
9892987|NCT01093794|11007950|FG002|COMPLETED|Treatment Period 2||6
9892988|NCT01093794|11007951|FG003|COMPLETED|Treatment Period 2||7
9892989|NCT01093794|11007948|FG000|NOT COMPLETED|Treatment Period 2||0
9892990|NCT01093794|11007949|FG001|NOT COMPLETED|Treatment Period 2||0
9892991|NCT01093794|11007950|FG002|NOT COMPLETED|Treatment Period 2||0
9892992|NCT01093794|11007951|FG003|NOT COMPLETED|Treatment Period 2||0
9892993|NCT01093794|11007948|FG000|STARTED|Treatment Period 3||7
9892994|NCT01093794|11007949|FG001|STARTED|Treatment Period 3||7
9892995|NCT01093794|11007950|FG002|STARTED|Treatment Period 3||6
9892996|NCT01093794|11007951|FG003|STARTED|Treatment Period 3||7
9892997|NCT01093794|11007948|FG000|COMPLETED|Treatment Period 3||7
9892998|NCT01093794|11007949|FG001|COMPLETED|Treatment Period 3||7
9892999|NCT01093794|11007950|FG002|COMPLETED|Treatment Period 3||6
9893000|NCT01093794|11007951|FG003|COMPLETED|Treatment Period 3||7
9893001|NCT01093794|11007948|FG000|NOT COMPLETED|Treatment Period 3||0
9893002|NCT01093794|11007949|FG001|NOT COMPLETED|Treatment Period 3||0
9893003|NCT01093794|11007950|FG002|NOT COMPLETED|Treatment Period 3||0
9893004|NCT01093794|11007951|FG003|NOT COMPLETED|Treatment Period 3||0
9893005|NCT01093794|11007948|FG000|STARTED|Treatment Period 4||7
9893006|NCT01093794|11007949|FG001|STARTED|Treatment Period 4||7
9893007|NCT01093794|11007950|FG002|STARTED|Treatment Period 4||6
9893008|NCT01093794|11007951|FG003|STARTED|Treatment Period 4||7
9893009|NCT01093794|11007948|FG000|COMPLETED|Treatment Period 4||7
9893010|NCT01093794|11007949|FG001|COMPLETED|Treatment Period 4||7
9893011|NCT01093794|11007950|FG002|COMPLETED|Treatment Period 4||6
9893012|NCT01093794|11007951|FG003|COMPLETED|Treatment Period 4||7
9893013|NCT01093794|11007948|FG000|NOT COMPLETED|Treatment Period 4||0
9893014|NCT01093794|11007949|FG001|NOT COMPLETED|Treatment Period 4||0
9893015|NCT01093794|11007950|FG002|NOT COMPLETED|Treatment Period 4||0
9893016|NCT01093794|11007951|FG003|NOT COMPLETED|Treatment Period 4||0
9893017|NCT01093885|11007961|FG000|STARTED|Overall Study||15
9893018|NCT01093885|11007961|FG000|COMPLETED|Overall Study||10
9893019|NCT01093885|11007961|FG000|NOT COMPLETED|Overall Study||5
9893020|NCT01093976|11007966|FG000|STARTED|Overall Study||14
9893021|NCT01093976|11007966|FG000|COMPLETED|Overall Study||14
9893022|NCT01093976|11007966|FG000|NOT COMPLETED|Overall Study||0
9893023|NCT01094106|11007972|FG000|STARTED|Overall Study||33
9893024|NCT01094106|11007973|FG001|STARTED|Overall Study||34
9893025|NCT01094106|11007972|FG000|COMPLETED|Overall Study||33
9893026|NCT01094106|11007973|FG001|COMPLETED|Overall Study||34
9893027|NCT01094106|11007972|FG000|NOT COMPLETED|Overall Study||0
9893028|NCT01094106|11007973|FG001|NOT COMPLETED|Overall Study||0
9893029|NCT01094119|11007981|FG000|STARTED|Overall Study||34
9893030|NCT01094119|11007982|FG001|STARTED|Overall Study||36
9893031|NCT01094119|11007981|FG000|COMPLETED|Overall Study||32
9893032|NCT01094119|11007982|FG001|COMPLETED|Overall Study||32
9893033|NCT01094119|11007981|FG000|NOT COMPLETED|Overall Study||2
9893034|NCT01094119|11007982|FG001|NOT COMPLETED|Overall Study||4
9893035|NCT01094171|11007988|FG000|STARTED|Overall Study||400
9893036|NCT01094171|11007988|FG000|COMPLETED|Overall Study||390
9893037|NCT01094171|11007988|FG000|NOT COMPLETED|Overall Study||10
9893038|NCT01094184|11007994|FG000|STARTED|Overall Study||36
9893039|NCT01094184|11007995|FG001|STARTED|Overall Study||13
9893040|NCT01094184|11007994|FG000|COMPLETED|Overall Study||1
9893041|NCT01094184|11007995|FG001|COMPLETED|Overall Study||2
9893042|NCT01094184|11007994|FG000|NOT COMPLETED|Overall Study||35
9893043|NCT01094184|11007995|FG001|NOT COMPLETED|Overall Study||11
9893044|NCT01094288|11008009|FG000|STARTED|Overall Study||6
9893045|NCT01094288|11008010|FG001|STARTED|Overall Study||15
9893046|NCT01094288|11008011|FG002|STARTED|Overall Study||5
9893047|NCT01094288|11008012|FG003|STARTED|Overall Study||3
9893048|NCT01094288|11008013|FG004|STARTED|Overall Study||2
9893049|NCT01094288|11008014|FG005|STARTED|Overall Study||4
9893050|NCT01094288|11008015|FG006|STARTED|Overall Study||2
9893051|NCT01094288|11008016|FG007|STARTED|Overall Study||4
9893052|NCT01094288|11008009|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4
9893053|NCT01094288|11008010|FG001|COMPLETED|Overall Study||5
9893054|NCT01094288|11008011|FG002|COMPLETED|Overall Study||1
9893055|NCT01094288|11008012|FG003|COMPLETED|Overall Study||1
9893056|NCT01094288|11008013|FG004|COMPLETED|Overall Study||2
9893057|NCT01094288|11008014|FG005|COMPLETED|Overall Study||4
9893058|NCT01094288|11008015|FG006|COMPLETED|Overall Study||2
9893059|NCT01094288|11008016|FG007|COMPLETED|Overall Study||2
9893060|NCT01094288|11008009|FG000|NOT COMPLETED|Overall Study||2
9893061|NCT01094288|11008010|FG001|NOT COMPLETED|Overall Study||10
9893062|NCT01094288|11008011|FG002|NOT COMPLETED|Overall Study||4
9893063|NCT01094288|11008012|FG003|NOT COMPLETED|Overall Study||2
9893064|NCT01094288|11008013|FG004|NOT COMPLETED|Overall Study||0
9893065|NCT01094288|11008014|FG005|NOT COMPLETED|Overall Study||0
9893066|NCT01094288|11008015|FG006|NOT COMPLETED|Overall Study||0
9893067|NCT01094288|11008016|FG007|NOT COMPLETED|Overall Study||2
9893068|NCT01094301|11008038|FG000|STARTED|Trial Stage||28
9893069|NCT01094301|11008038|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28
9893070|NCT01094301|11008038|FG000|COMPLETED|Trial Stage||27
9893071|NCT01094301|11008038|FG000|NOT COMPLETED|Trial Stage||1
9893072|NCT01094301|11008038|FG000|STARTED|Implant Stage||13
9893073|NCT01094301|11008038|FG000|Met Criteria for Implant Stage|Implant Stage||7
9893074|NCT01094301|11008038|FG000|Subjects Who Received SPR IPG|Implant Stage||5
9893075|NCT01094301|11008038|FG000|COMPLETED|Implant Stage||5
9893076|NCT01094301|11008038|FG000|NOT COMPLETED|Implant Stage||8
9893077|NCT01094522|11008046|FG000|STARTED|Overall Study||20
9893078|NCT01094522|11008047|FG001|STARTED|Overall Study||20
9893079|NCT01094522|11008046|FG000|COMPLETED|Overall Study||20
9893080|NCT01094522|11008047|FG001|COMPLETED|Overall Study||20
9893081|NCT01094522|11008046|FG000|NOT COMPLETED|Overall Study||0
9893082|NCT01094522|11008047|FG001|NOT COMPLETED|Overall Study||0
9893083|NCT01094548|11008056|FG000|STARTED|Overall Study||17
9893084|NCT01094548|11008057|FG001|STARTED|Overall Study||17
9893085|NCT01094548|11008056|FG000|COMPLETED|Overall Study||17
9893086|NCT01094548|11008057|FG001|COMPLETED|Overall Study||17
9893087|NCT01094548|11008056|FG000|NOT COMPLETED|Overall Study||0
9893088|NCT01094548|11008057|FG001|NOT COMPLETED|Overall Study||0
9893089|NCT01094574|11008071|FG000|STARTED|Overall Study||1
9893090|NCT01094574|11008072|FG001|STARTED|Overall Study||1
9893091|NCT01094574|11008073|FG002|STARTED|Overall Study||2
9893092|NCT01094574|11008074|FG003|STARTED|Overall Study||2
9893093|NCT01094574|11008075|FG004|STARTED|Overall Study||2
9893094|NCT01094574|11008076|FG005|STARTED|Overall Study||2
9893095|NCT01094574|11008071|FG000|COMPLETED|Overall Study||1
9893096|NCT01094574|11008072|FG001|COMPLETED|Overall Study||1
9893097|NCT01094574|11008073|FG002|COMPLETED|Overall Study||2
9893098|NCT01094574|11008074|FG003|COMPLETED|Overall Study||2
9893099|NCT01094574|11008075|FG004|COMPLETED|Overall Study||2
9893100|NCT01094574|11008076|FG005|COMPLETED|Overall Study||2
9893101|NCT01094574|11008071|FG000|NOT COMPLETED|Overall Study||0
9893102|NCT01094574|11008072|FG001|NOT COMPLETED|Overall Study||0
9893103|NCT01094574|11008073|FG002|NOT COMPLETED|Overall Study||0
9893104|NCT01094574|11008074|FG003|NOT COMPLETED|Overall Study||0
9893105|NCT01094574|11008075|FG004|NOT COMPLETED|Overall Study||0
9893106|NCT01094574|11008076|FG005|NOT COMPLETED|Overall Study||0
9893107|NCT01094704|11008089|FG000|STARTED|Overall Study||8
9893108|NCT01094704|11008090|FG001|STARTED|Overall Study||8
9893109|NCT01094704|11008089|FG000|COMPLETED|Overall Study||8
9893110|NCT01094704|11008090|FG001|COMPLETED|Overall Study||8
9893111|NCT01094704|11008089|FG000|NOT COMPLETED|Overall Study||0
9893112|NCT01094704|11008090|FG001|NOT COMPLETED|Overall Study||0
9893113|NCT01094717|11008098|FG000|STARTED|Overall Study||3
9893114|NCT01094717|11008099|FG001|STARTED|Overall Study||10
9893115|NCT01094717|11008098|FG000|COMPLETED|Overall Study||3
9893116|NCT01094717|11008099|FG001|COMPLETED|Overall Study||10
9893117|NCT01094717|11008098|FG000|NOT COMPLETED|Overall Study||0
9893118|NCT01094717|11008099|FG001|NOT COMPLETED|Overall Study||0
9893119|NCT01094730|11008115|FG000|STARTED|Period 1 (14 Days)||92
9893120|NCT01094730|11008116|FG001|STARTED|Period 1 (14 Days)||88
9893121|NCT01094730|11008115|FG000|COMPLETED|Period 1 (14 Days)||90
9893122|NCT01094730|11008116|FG001|COMPLETED|Period 1 (14 Days)||86
9893123|NCT01094730|11008115|FG000|NOT COMPLETED|Period 1 (14 Days)||2
9893124|NCT01094730|11008116|FG001|NOT COMPLETED|Period 1 (14 Days)||2
9893125|NCT01094730|11008115|FG000|STARTED|Period 2 (14 Days)||90
9893126|NCT01094730|11008116|FG001|STARTED|Period 2 (14 Days)||86
9893127|NCT01094730|11008115|FG000|COMPLETED|Period 2 (14 Days)||87
9893128|NCT01094730|11008116|FG001|COMPLETED|Period 2 (14 Days)||84
9893129|NCT01094730|11008115|FG000|NOT COMPLETED|Period 2 (14 Days)||3
9893130|NCT01094730|11008116|FG001|NOT COMPLETED|Period 2 (14 Days)||2
9893131|NCT01094743|11008123|FG000|STARTED|Period 1||52
9893132|NCT01094743|11008123|FG000|COMPLETED|Period 1||50
9893133|NCT01094743|11008123|FG000|NOT COMPLETED|Period 1||2
9893134|NCT01094743|11008123|FG000|STARTED|Period 2||50
9893135|NCT01094743|11008123|FG000|COMPLETED|Period 2||50
9893136|NCT01094743|11008123|FG000|NOT COMPLETED|Period 2||0
9893137|NCT01094808|11008131|FG000|STARTED|Overall Study||21
9893138|NCT01094808|11008132|FG001|STARTED|Overall Study||20
9893139|NCT01094808|11008133|FG002|STARTED|Overall Study||21
9893140|NCT01094808|11008131|FG000|COMPLETED|Overall Study||20
9893141|NCT01094808|11008132|FG001|COMPLETED|Overall Study||19
9893142|NCT01094808|11008133|FG002|COMPLETED|Overall Study||21
9893143|NCT01094808|11008131|FG000|NOT COMPLETED|Overall Study||1
9893144|NCT01094808|11008132|FG001|NOT COMPLETED|Overall Study||1
9893145|NCT01094808|11008133|FG002|NOT COMPLETED|Overall Study||0
9893146|NCT01094886|11008141|FG000|STARTED|Overall Study||53
9893147|NCT01094886|11008141|FG000|COMPLETED|Overall Study||46
9893148|NCT01094886|11008141|FG000|NOT COMPLETED|Overall Study||7
9893149|NCT01095094|11008145|FG000|STARTED|Overall Study||19
9893150|NCT01095094|11008145|FG000|COMPLETED|Overall Study||16
9893151|NCT01095094|11008145|FG000|NOT COMPLETED|Overall Study||3
9893152|NCT01095497|11008151|FG000|STARTED|Intravenous CINRYZE||14
9893153|NCT01095497|11008152|FG001|STARTED|Intravenous CINRYZE||12
9893154|NCT01095497|11008151|FG000|COMPLETED|Intravenous CINRYZE||13
9893155|NCT01095497|11008152|FG001|COMPLETED|Intravenous CINRYZE||12
9893156|NCT01095497|11008151|FG000|NOT COMPLETED|Intravenous CINRYZE||1
9893157|NCT01095497|11008152|FG001|NOT COMPLETED|Intravenous CINRYZE||0
9893158|NCT01095497|11008151|FG000|STARTED|Subcutaneous CINRYZE||13
9893159|NCT01095497|11008152|FG001|STARTED|Subcutaneous CINRYZE||12
9893160|NCT01095497|11008151|FG000|COMPLETED|Subcutaneous CINRYZE||12
9893161|NCT01095497|11008152|FG001|COMPLETED|Subcutaneous CINRYZE||12
9893162|NCT01095497|11008151|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1
9893163|NCT01095497|11008152|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0
9893164|NCT01095510|11008166|FG000|STARTED|Overall Study||3
9893165|NCT01095510|11008167|FG001|STARTED|Overall Study||0
9893166|NCT01095510|11008168|FG002|STARTED|Overall Study||3
9893167|NCT01095510|11008169|FG003|STARTED|Overall Study||3
9893168|NCT01095510|11008166|FG000|COMPLETED|Overall Study||3
9893169|NCT01095510|11008167|FG001|COMPLETED|Overall Study||0
9893170|NCT01095510|11008168|FG002|COMPLETED|Overall Study||3
9893171|NCT01095510|11008169|FG003|COMPLETED|Overall Study||3
9893172|NCT01095510|11008166|FG000|NOT COMPLETED|Overall Study||0
9893173|NCT01095510|11008167|FG001|NOT COMPLETED|Overall Study||0
9893174|NCT01095510|11008168|FG002|NOT COMPLETED|Overall Study||0
9893175|NCT01095510|11008169|FG003|NOT COMPLETED|Overall Study||0
9893176|NCT01095653|11008180|FG000|STARTED|Overall Study||132
9893177|NCT01095653|11008181|FG001|STARTED|Overall Study||128
9893178|NCT01095653|11008182|FG002|STARTED|Overall Study||133
9893179|NCT01095653|11008180|FG000|COMPLETED|Overall Study||113
9893180|NCT01095653|11008181|FG001|COMPLETED|Overall Study||113
9893181|NCT01095653|11008182|FG002|COMPLETED|Overall Study||117
9893182|NCT01095653|11008180|FG000|NOT COMPLETED|Overall Study||19
9893183|NCT01095653|11008181|FG001|NOT COMPLETED|Overall Study||15
9893184|NCT01095653|11008182|FG002|NOT COMPLETED|Overall Study||16
9893185|NCT01095666|11008193|FG000|STARTED|Overall Study||145
9893186|NCT01095666|11008194|FG001|STARTED|Overall Study||147
9893187|NCT01095666|11008195|FG002|STARTED|Overall Study||152
9893188|NCT01095666|11008193|FG000|COMPLETED|Overall Study||128
9893189|NCT01095666|11008194|FG001|COMPLETED|Overall Study||136
9893190|NCT01095666|11008195|FG002|COMPLETED|Overall Study||145
9893191|NCT01095666|11008193|FG000|NOT COMPLETED|Overall Study||17
9893192|NCT01095666|11008194|FG001|NOT COMPLETED|Overall Study||11
9893193|NCT01095666|11008195|FG002|NOT COMPLETED|Overall Study||7
9893194|NCT01095757|11008203|FG000|STARTED|Overall Study||45
9893195|NCT01095757|11008203|FG000|COMPLETED|Overall Study||45
9893196|NCT01095757|11008203|FG000|NOT COMPLETED|Overall Study||0
9893197|NCT01095796|11008210|FG000|STARTED|Overall Study||353
9893198|NCT01095796|11008211|FG001|STARTED|Overall Study||354
9893199|NCT01095796|11008210|FG000|COMPLETED|Overall Study||58
9893200|NCT01095796|11008211|FG001|COMPLETED|Overall Study||65
9893201|NCT01095796|11008210|FG000|NOT COMPLETED|Overall Study||295
9893202|NCT01095796|11008211|FG001|NOT COMPLETED|Overall Study||289
9893203|NCT01095835|11008220|FG000|STARTED|Overall Study||51
9893204|NCT01095835|11008221|FG001|STARTED|Overall Study||52
9893205|NCT01095835|11008222|FG002|STARTED|Overall Study||25
9893206|NCT01095835|11008220|FG000|COMPLETED|Overall Study||41
9893207|NCT01095835|11008221|FG001|COMPLETED|Overall Study||40
9893208|NCT01095835|11008222|FG002|COMPLETED|Overall Study||17
9893209|NCT01095835|11008220|FG000|NOT COMPLETED|Overall Study||10
9893210|NCT01095835|11008221|FG001|NOT COMPLETED|Overall Study||12
9893211|NCT01095835|11008222|FG002|NOT COMPLETED|Overall Study||8
9893212|NCT01095887|11008231|FG000|STARTED|Overall Study||6
9893213|NCT01095887|11008231|FG000|COMPLETED|Overall Study||6
9893214|NCT01095887|11008231|FG000|NOT COMPLETED|Overall Study||0
9893215|NCT01095978|11008235|FG000|STARTED|Overall Study||2822
9893216|NCT01095978|11008235|FG000|COMPLETED|Overall Study||2819
9893217|NCT01095978|11008235|FG000|NOT COMPLETED|Overall Study||3
9893218|NCT01096017|11008241|FG000|STARTED|Treatment Period 1||12
9893219|NCT01096017|11008242|FG001|STARTED|Treatment Period 1||12
9893220|NCT01096017|11008241|FG000|COMPLETED|Treatment Period 1||12
9893221|NCT01096017|11008242|FG001|COMPLETED|Treatment Period 1||12
9893222|NCT01096017|11008241|FG000|NOT COMPLETED|Treatment Period 1||0
9893223|NCT01096017|11008242|FG001|NOT COMPLETED|Treatment Period 1||0
9893224|NCT01096017|11008241|FG000|STARTED|Washout 1 - 14 Days||12
9893225|NCT01096017|11008242|FG001|STARTED|Washout 1 - 14 Days||12
9893226|NCT01096017|11008241|FG000|COMPLETED|Washout 1 - 14 Days||12
9893227|NCT01096017|11008242|FG001|COMPLETED|Washout 1 - 14 Days||12
9893228|NCT01096017|11008241|FG000|NOT COMPLETED|Washout 1 - 14 Days||0
9893229|NCT01096017|11008242|FG001|NOT COMPLETED|Washout 1 - 14 Days||0
9893230|NCT01096017|11008241|FG000|STARTED|Treatment Period 2||12
9893231|NCT01096017|11008242|FG001|STARTED|Treatment Period 2||12
9893232|NCT01096017|11008241|FG000|COMPLETED|Treatment Period 2||11
9893233|NCT01096017|11008242|FG001|COMPLETED|Treatment Period 2||11
9893234|NCT01096017|11008241|FG000|NOT COMPLETED|Treatment Period 2||1
9893235|NCT01096017|11008242|FG001|NOT COMPLETED|Treatment Period 2||1
9893236|NCT01096056|11008250|FG000|STARTED|Overall Study||20
9893237|NCT01096056|11008251|FG001|STARTED|Overall Study||20
9893238|NCT01096056|11008250|FG000|Completed at Day 42|Overall Study||20
9893239|NCT01096056|11008251|FG001|Completed at Day 42|Overall Study||20
9893240|NCT01096056|11008250|FG000|COMPLETED|Overall Study||20
9893241|NCT01096056|11008251|FG001|COMPLETED|Overall Study||19
9893242|NCT01096056|11008250|FG000|NOT COMPLETED|Overall Study||0
9893243|NCT01096056|11008251|FG001|NOT COMPLETED|Overall Study||1
9893244|NCT01096160|11008267|FG000|STARTED|Overall Study||6
9893245|NCT01096160|11008268|FG001|STARTED|Overall Study||2
9893246|NCT01096160|11008269|FG002|STARTED|Overall Study||6
9893247|NCT01096160|11008270|FG003|STARTED|Overall Study||2
9893248|NCT01096160|11008271|FG004|STARTED|Overall Study||6
9893249|NCT01096160|11008272|FG005|STARTED|Overall Study||2
9893250|NCT01096160|11008273|FG006|STARTED|Overall Study||6
9893251|NCT01096160|11008274|FG007|STARTED|Overall Study||2
9893252|NCT01096160|11008275|FG008|STARTED|Overall Study||6
9893253|NCT01096160|11008276|FG009|STARTED|Overall Study||2
9893254|NCT01096160|11008267|FG000|COMPLETED|Overall Study||6
9893255|NCT01096160|11008268|FG001|COMPLETED|Overall Study||2
9893256|NCT01096160|11008269|FG002|COMPLETED|Overall Study||5
9893257|NCT01096160|11008270|FG003|COMPLETED|Overall Study||2
9893258|NCT01096160|11008271|FG004|COMPLETED|Overall Study||5
9893259|NCT01096160|11008272|FG005|COMPLETED|Overall Study||2
9893260|NCT01096160|11008273|FG006|COMPLETED|Overall Study||4
9893261|NCT01096160|11008274|FG007|COMPLETED|Overall Study||2
9893262|NCT01096160|11008275|FG008|COMPLETED|Overall Study||4
9893263|NCT01096160|11008276|FG009|COMPLETED|Overall Study||1
9893264|NCT01096160|11008267|FG000|NOT COMPLETED|Overall Study||0
9893265|NCT01096160|11008268|FG001|NOT COMPLETED|Overall Study||0
9893266|NCT01096160|11008269|FG002|NOT COMPLETED|Overall Study||1
9893267|NCT01096160|11008270|FG003|NOT COMPLETED|Overall Study||0
9893268|NCT01096160|11008271|FG004|NOT COMPLETED|Overall Study||1
9893269|NCT01096160|11008272|FG005|NOT COMPLETED|Overall Study||0
9893270|NCT01096160|11008273|FG006|NOT COMPLETED|Overall Study||2
9893271|NCT01096160|11008274|FG007|NOT COMPLETED|Overall Study||0
9893272|NCT01096160|11008275|FG008|NOT COMPLETED|Overall Study||2
9893273|NCT01096160|11008276|FG009|NOT COMPLETED|Overall Study||1
9893274|NCT01096186|11008311|FG000|STARTED|Overall Study||617
9893275|NCT01096186|11008311|FG000|COMPLETED|Overall Study||567
9893276|NCT01096186|11008311|FG000|NOT COMPLETED|Overall Study||50
9893277|NCT01096290|11008317|FG000|STARTED|Overall Study||9
9893278|NCT01096290|11008318|FG001|STARTED|Overall Study||14
9893279|NCT01096290|11008317|FG000|COMPLETED|Overall Study||9
9893280|NCT01096290|11008318|FG001|COMPLETED|Overall Study||14
9893281|NCT01096290|11008317|FG000|NOT COMPLETED|Overall Study||0
9893282|NCT01096290|11008318|FG001|NOT COMPLETED|Overall Study||0
9893283|NCT01096316|11008326|FG000|STARTED|Overall Study||102
9893284|NCT01096316|11008327|FG001|STARTED|Overall Study||103
9893285|NCT01096316|11008326|FG000|COMPLETED|Overall Study||87
9893286|NCT01096316|11008327|FG001|COMPLETED|Overall Study||94
9893287|NCT01096316|11008326|FG000|NOT COMPLETED|Overall Study||15
9893288|NCT01096316|11008327|FG001|NOT COMPLETED|Overall Study||9
10008874|NCT01763164|11131363|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
10008875|NCT01763164|11131362|FG000|COMPLETED|Follow up Phase||3
10008876|NCT01763164|11131363|FG001|COMPLETED|Follow up Phase||3
10008877|NCT01763164|11131362|FG000|NOT COMPLETED|Follow up Phase||197
10008878|NCT01763164|11131363|FG001|NOT COMPLETED|Follow up Phase||75
10008879|NCT01763203|11131371|FG000|STARTED|Overall Study||241
9893289|NCT01096342|11008333|FG000|STARTED|Overall Study||16
9893290|NCT01096342|11008333|FG000|COMPLETED|Overall Study||15
9893291|NCT01096342|11008333|FG000|NOT COMPLETED|Overall Study||1
9893292|NCT01096446|11008339|FG000|STARTED|Overall Study||12
9893293|NCT01096446|11008340|FG001|STARTED|Overall Study||10
9893294|NCT01096446|11008339|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
9893295|NCT01096446|11008340|FG001|COMPLETED|Overall Study||10
9893296|NCT01096446|11008339|FG000|NOT COMPLETED|Overall Study||3
9893297|NCT01096446|11008340|FG001|NOT COMPLETED|Overall Study||0
9893298|NCT01096550|11008347|FG000|STARTED|Overall Study||170
9893299|NCT01096550|11008348|FG001|STARTED|Overall Study||175
9893300|NCT01096550|11008347|FG000|COMPLETED|Overall Study||133
9893301|NCT01096550|11008348|FG001|COMPLETED|Overall Study||146
9893302|NCT01096550|11008347|FG000|NOT COMPLETED|Overall Study||37
9893303|NCT01096550|11008348|FG001|NOT COMPLETED|Overall Study||29
9954619|NCT01432600|11073428|FG002|STARTED|Overall Study||34
9954620|NCT01432600|11073426|FG000|COMPLETED|Overall Study||10
9954621|NCT01432600|11073427|FG001|COMPLETED|Overall Study||35
9954622|NCT01432600|11073428|FG002|COMPLETED|Overall Study||33
9954623|NCT01432600|11073426|FG000|NOT COMPLETED|Overall Study||0
9954624|NCT01432600|11073427|FG001|NOT COMPLETED|Overall Study||1
9954625|NCT01432600|11073428|FG002|NOT COMPLETED|Overall Study||1
9954626|NCT01432626|11073438|FG000|STARTED|Overall Study||10
9954627|NCT01432626|11073438|FG000|COMPLETED|Overall Study|Completed both images|3
9954628|NCT01432626|11073438|FG000|NOT COMPLETED|Overall Study||7
9954629|NCT01432730|11073442|FG000|STARTED|Period 1||12
9954630|NCT01432730|11073443|FG001|STARTED|Period 1||12
9954631|NCT01432730|11073442|FG000|COMPLETED|Period 1||10
9954632|NCT01432730|11073443|FG001|COMPLETED|Period 1||12
9954633|NCT01432730|11073442|FG000|NOT COMPLETED|Period 1||2
9954634|NCT01432730|11073443|FG001|NOT COMPLETED|Period 1||0
9954635|NCT01432730|11073442|FG000|STARTED|Period 2||10
9954636|NCT01432730|11073443|FG001|STARTED|Period 2||12
9954637|NCT01432730|11073442|FG000|COMPLETED|Period 2||10
9954638|NCT01432730|11073443|FG001|COMPLETED|Period 2||8
9954639|NCT01432730|11073442|FG000|NOT COMPLETED|Period 2||0
9954640|NCT01432730|11073443|FG001|NOT COMPLETED|Period 2||4
9954641|NCT01432756|11073453|FG000|STARTED|Overall Study||32
9954642|NCT01432756|11073454|FG001|STARTED|Overall Study||34
9954643|NCT01432756|11073455|FG002|STARTED|Overall Study||32
9954644|NCT01432756|11073456|FG003|STARTED|Overall Study||34
9954645|NCT01432756|11073453|FG000|COMPLETED|Overall Study||31
9954646|NCT01432756|11073454|FG001|COMPLETED|Overall Study||34
9954647|NCT01432756|11073455|FG002|COMPLETED|Overall Study||30
9954648|NCT01432756|11073456|FG003|COMPLETED|Overall Study||33
9954649|NCT01432756|11073453|FG000|NOT COMPLETED|Overall Study||1
9893304|NCT01096589|11008358|FG000|STARTED|Overall Study||22
9893305|NCT01096589|11008359|FG001|STARTED|Overall Study||20
9893306|NCT01096589|11008360|FG002|STARTED|Overall Study||22
9893307|NCT01096589|11008361|FG003|STARTED|Overall Study||18
9893308|NCT01096589|11008358|FG000|COMPLETED|Overall Study||18
9893309|NCT01096589|11008359|FG001|COMPLETED|Overall Study||18
9893310|NCT01096589|11008360|FG002|COMPLETED|Overall Study||18
9893311|NCT01096589|11008361|FG003|COMPLETED|Overall Study||15
9893312|NCT01096589|11008358|FG000|NOT COMPLETED|Overall Study||4
10110140|NCT02482675|11240886|FG004|NOT COMPLETED|Overall Study||0
10110141|NCT02482675|11240887|FG005|NOT COMPLETED|Overall Study||0
10110142|NCT02482675|11240888|FG006|NOT COMPLETED|Overall Study||0
10110143|NCT02482675|11240889|FG007|NOT COMPLETED|Overall Study||0
10110144|NCT02482675|11240890|FG008|NOT COMPLETED|Overall Study||0
9893313|NCT01096589|11008359|FG001|NOT COMPLETED|Overall Study||2
9893314|NCT01096589|11008360|FG002|NOT COMPLETED|Overall Study||4
9893315|NCT01096589|11008361|FG003|NOT COMPLETED|Overall Study||3
9893316|NCT01096667|11008380|FG000|STARTED|Overall Study||39
9893317|NCT01096667|11008381|FG001|STARTED|Overall Study||39
9893318|NCT01096667|11008382|FG002|STARTED|Overall Study||38
9893319|NCT01096667|11008383|FG003|STARTED|Overall Study||39
9893320|NCT01096667|11008384|FG004|STARTED|Overall Study||39
9893321|NCT01096667|11008380|FG000|Treated|Overall Study||38
9893322|NCT01096667|11008381|FG001|Treated|Overall Study||39
9893323|NCT01096667|11008382|FG002|Treated|Overall Study||38
9893324|NCT01096667|11008383|FG003|Treated|Overall Study||39
9893325|NCT01096667|11008384|FG004|Treated|Overall Study||39
9893326|NCT01096667|11008380|FG000|COMPLETED|Overall Study||36
9893327|NCT01096667|11008381|FG001|COMPLETED|Overall Study||37
9893328|NCT01096667|11008382|FG002|COMPLETED|Overall Study||36
9893329|NCT01096667|11008383|FG003|COMPLETED|Overall Study||36
9893330|NCT01096667|11008384|FG004|COMPLETED|Overall Study||39
9893331|NCT01096667|11008380|FG000|NOT COMPLETED|Overall Study||3
9893332|NCT01096667|11008381|FG001|NOT COMPLETED|Overall Study||2
9893333|NCT01096667|11008382|FG002|NOT COMPLETED|Overall Study||2
9893334|NCT01096667|11008383|FG003|NOT COMPLETED|Overall Study||3
9893335|NCT01096667|11008384|FG004|NOT COMPLETED|Overall Study||0
9893336|NCT01096680|11008402|FG000|STARTED|Overall Study||27
9893337|NCT01096680|11008403|FG001|STARTED|Overall Study||27
9893338|NCT01096680|11008404|FG002|STARTED|Overall Study||27
9893339|NCT01096680|11008405|FG003|STARTED|Overall Study||27
9893340|NCT01096680|11008406|FG004|STARTED|Overall Study||27
9893341|NCT01096680|11008402|FG000|COMPLETED|Overall Study||27
9893342|NCT01096680|11008403|FG001|COMPLETED|Overall Study||27
9893343|NCT01096680|11008404|FG002|COMPLETED|Overall Study||27
9893344|NCT01096680|11008405|FG003|COMPLETED|Overall Study||27
9893345|NCT01096680|11008406|FG004|COMPLETED|Overall Study||27
9893346|NCT01096680|11008402|FG000|NOT COMPLETED|Overall Study||0
9893347|NCT01096680|11008403|FG001|NOT COMPLETED|Overall Study||0
9893348|NCT01096680|11008404|FG002|NOT COMPLETED|Overall Study||0
9893349|NCT01096680|11008405|FG003|NOT COMPLETED|Overall Study||0
9893350|NCT01096680|11008406|FG004|NOT COMPLETED|Overall Study||0
9893351|NCT01096771|11008420|FG000|STARTED|Overall Study||7
9893352|NCT01096771|11008421|FG001|STARTED|Overall Study||7
9893353|NCT01096771|11008420|FG000|COMPLETED|Overall Study||7
9893354|NCT01096771|11008421|FG001|COMPLETED|Overall Study||7
9893355|NCT01096771|11008420|FG000|NOT COMPLETED|Overall Study||0
9893356|NCT01096771|11008421|FG001|NOT COMPLETED|Overall Study||0
9893357|NCT01096784|11008429|FG000|STARTED|Overall Study||61
9893358|NCT01096784|11008430|FG001|STARTED|Overall Study||60
9893359|NCT01096784|11008429|FG000|COMPLETED|Overall Study||46
9893360|NCT01096784|11008430|FG001|COMPLETED|Overall Study||46
9893361|NCT01096784|11008429|FG000|NOT COMPLETED|Overall Study||15
9893362|NCT01096784|11008430|FG001|NOT COMPLETED|Overall Study||14
9893363|NCT01096810|11008438|FG000|STARTED|Overall Study||20
9893364|NCT01096810|11008438|FG000|COMPLETED|Overall Study||20
9893365|NCT01096810|11008438|FG000|NOT COMPLETED|Overall Study||0
9893366|NCT01096823|11008444|FG000|STARTED|Overall Study||14
9893367|NCT01096823|11008445|FG001|STARTED|Overall Study||16
9893368|NCT01096823|11008444|FG000|COMPLETED|Overall Study||11
9893369|NCT01096823|11008445|FG001|COMPLETED|Overall Study||15
9893370|NCT01096823|11008444|FG000|NOT COMPLETED|Overall Study||3
9893371|NCT01096823|11008445|FG001|NOT COMPLETED|Overall Study||1
9893372|NCT01096849|11008454|FG000|STARTED|Overall Study||22
9893373|NCT01096849|11008455|FG001|STARTED|Overall Study||76
9893374|NCT01096849|11008456|FG002|STARTED|Overall Study||47
9893375|NCT01096849|11008454|FG000|COMPLETED|Overall Study||20
9893376|NCT01096849|11008455|FG001|COMPLETED|Overall Study||64
9893377|NCT01096849|11008456|FG002|COMPLETED|Overall Study||41
9893378|NCT01096849|11008454|FG000|NOT COMPLETED|Overall Study||2
9893379|NCT01096849|11008455|FG001|NOT COMPLETED|Overall Study||12
10110145|NCT02482675|11240891|FG009|NOT COMPLETED|Overall Study||0
9893380|NCT01096849|11008456|FG002|NOT COMPLETED|Overall Study||6
9893381|NCT01096875|11008466|FG000|STARTED|Overall Study||30
9893382|NCT01096875|11008467|FG001|STARTED|Overall Study||30
9893383|NCT01096875|11008466|FG000|COMPLETED|Overall Study||30
9893384|NCT01096875|11008467|FG001|COMPLETED|Overall Study||29
9893385|NCT01096875|11008466|FG000|NOT COMPLETED|Overall Study||0
9893386|NCT01096875|11008467|FG001|NOT COMPLETED|Overall Study||1
9893387|NCT01096992|11008480|FG000|STARTED|Overall Study||6
9893388|NCT01096992|11008481|FG001|STARTED|Overall Study||3
9893389|NCT01096992|11008482|FG002|STARTED|Overall Study||6
9893390|NCT01096992|11008483|FG003|STARTED|Overall Study||6
9893391|NCT01096992|11008484|FG004|STARTED|Overall Study||30
9893392|NCT01096992|11008480|FG000|COMPLETED|Overall Study||6
9893393|NCT01096992|11008481|FG001|COMPLETED|Overall Study||3
9893394|NCT01096992|11008482|FG002|COMPLETED|Overall Study||6
9893395|NCT01096992|11008483|FG003|COMPLETED|Overall Study||6
9893396|NCT01096992|11008484|FG004|COMPLETED|Overall Study||30
9893397|NCT01096992|11008480|FG000|NOT COMPLETED|Overall Study||0
9893398|NCT01096992|11008481|FG001|NOT COMPLETED|Overall Study||0
9893399|NCT01096992|11008482|FG002|NOT COMPLETED|Overall Study||0
9893400|NCT01096992|11008483|FG003|NOT COMPLETED|Overall Study||0
9893401|NCT01096992|11008484|FG004|NOT COMPLETED|Overall Study||0
9893402|NCT01097044|11008499|FG000|STARTED|Overall Study||39
9893403|NCT01097044|11008500|FG001|STARTED|Overall Study||38
9893404|NCT01097044|11008499|FG000|COMPLETED|Overall Study||34
9893405|NCT01097044|11008500|FG001|COMPLETED|Overall Study||33
9893406|NCT01097044|11008499|FG000|NOT COMPLETED|Overall Study||5
9893407|NCT01097044|11008500|FG001|NOT COMPLETED|Overall Study||5
9893408|NCT01097057|11008508|FG000|STARTED|Overall Study||20
9893409|NCT01097057|11008508|FG000|COMPLETED|Overall Study||17
9893410|NCT01097057|11008508|FG000|NOT COMPLETED|Overall Study||3
9893411|NCT01097304|11008512|FG000|STARTED|Overall Study||36
9893412|NCT01097304|11008512|FG000|COMPLETED|Overall Study||29
9893413|NCT01097304|11008512|FG000|NOT COMPLETED|Overall Study||7
9893414|NCT01097330|11008519|FG000|STARTED|Overall Study||7
9893415|NCT01097330|11008520|FG001|STARTED|Overall Study||5
9893416|NCT01097330|11008519|FG000|COMPLETED|Overall Study||0
9893417|NCT01097330|11008520|FG001|COMPLETED|Overall Study||0
9893418|NCT01097330|11008519|FG000|NOT COMPLETED|Overall Study||7
9893419|NCT01097330|11008520|FG001|NOT COMPLETED|Overall Study||5
9893420|NCT01097343|11008526|FG000|STARTED|First Intervention- 30 Days||25
10008880|NCT01763203|11131372|FG001|STARTED|Overall Study||246
10008881|NCT01763203|11131371|FG000|COMPLETED|Overall Study||208
10008882|NCT01763203|11131372|FG001|COMPLETED|Overall Study||204
10008883|NCT01763203|11131371|FG000|NOT COMPLETED|Overall Study||33
10008884|NCT01763203|11131372|FG001|NOT COMPLETED|Overall Study||42
10008885|NCT01763333|11131392|FG000|STARTED|Overall Study||6
10008886|NCT01763333|11131393|FG001|STARTED|Overall Study||6
10008887|NCT01763333|11131394|FG002|STARTED|Overall Study||6
10008888|NCT01763333|11131395|FG003|STARTED|Overall Study||6
10008889|NCT01763333|11131396|FG004|STARTED|Overall Study||4
10008890|NCT01763333|11131397|FG005|STARTED|Overall Study||6
9893421|NCT01097343|11008527|FG001|STARTED|First Intervention- 30 Days||25
9893422|NCT01097343|11008526|FG000|COMPLETED|First Intervention- 30 Days||25
9893423|NCT01097343|11008527|FG001|COMPLETED|First Intervention- 30 Days||25
9893424|NCT01097343|11008526|FG000|NOT COMPLETED|First Intervention- 30 Days||0
9893425|NCT01097343|11008527|FG001|NOT COMPLETED|First Intervention- 30 Days||0
9893426|NCT01097343|11008526|FG000|STARTED|Second Intervention- 30 Days||25
9893427|NCT01097343|11008527|FG001|STARTED|Second Intervention- 30 Days||25
9893428|NCT01097343|11008526|FG000|COMPLETED|Second Intervention- 30 Days||25
9893429|NCT01097343|11008527|FG001|COMPLETED|Second Intervention- 30 Days||25
9893430|NCT01097343|11008526|FG000|NOT COMPLETED|Second Intervention- 30 Days||0
9893431|NCT01097343|11008527|FG001|NOT COMPLETED|Second Intervention- 30 Days||0
9893432|NCT01097395|11008535|FG000|STARTED|Overall Study||17
9893433|NCT01097395|11008536|FG001|STARTED|Overall Study||18
9893434|NCT01097395|11008535|FG000|COMPLETED|Overall Study||14
9893435|NCT01097395|11008536|FG001|COMPLETED|Overall Study||14
9893436|NCT01097395|11008535|FG000|NOT COMPLETED|Overall Study||3
9893437|NCT01097395|11008536|FG001|NOT COMPLETED|Overall Study||4
9893438|NCT01097421|11008542|FG000|STARTED|Overall Study||328
9893439|NCT01097421|11008542|FG000|COMPLETED|Overall Study||314
9893440|NCT01097421|11008542|FG000|NOT COMPLETED|Overall Study||14
9893441|NCT01097460|11008546|FG000|STARTED|Overall Study||16
9893442|NCT01097460|11008546|FG000|COMPLETED|Overall Study||16
9893443|NCT01097460|11008546|FG000|NOT COMPLETED|Overall Study||0
9893444|NCT01097577|11008552|FG000|STARTED|Overall Study||67
9893445|NCT01097577|11008553|FG001|STARTED|Overall Study||63
9893446|NCT01097577|11008552|FG000|COMPLETED|Overall Study||67
9893447|NCT01097577|11008553|FG001|COMPLETED|Overall Study||62
9893448|NCT01097577|11008552|FG000|NOT COMPLETED|Overall Study||0
9893449|NCT01097577|11008553|FG001|NOT COMPLETED|Overall Study||1
9893450|NCT01097616|11008562|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
9893451|NCT01097616|11008563|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
9893452|NCT01097616|11008564|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
9893453|NCT01097616|11008565|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893454|NCT01097616|11008566|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893455|NCT01097616|11008567|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893456|NCT01097616|11008568|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893457|NCT01097616|11008569|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893458|NCT01097616|11008562|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
9893459|NCT01097616|11008563|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
9893460|NCT01097616|11008564|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
9893461|NCT01097616|11008565|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893462|NCT01097616|11008566|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10008891|NCT01763333|11131398|FG006|STARTED|Overall Study||5
10008892|NCT01763333|11131399|FG007|STARTED|Overall Study||6
10008893|NCT01763333|11131400|FG008|STARTED|Overall Study||5
10008894|NCT01763333|11131401|FG009|STARTED|Overall Study||18
10008895|NCT01763333|11131402|FG010|STARTED|Overall Study||3
10008896|NCT01763333|11131403|FG011|STARTED|Overall Study||3
9893463|NCT01097616|11008567|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893464|NCT01097616|11008568|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893465|NCT01097616|11008569|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893466|NCT01097616|11008562|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
9893467|NCT01097616|11008563|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
9893468|NCT01097616|11008564|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
9893469|NCT01097616|11008565|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893470|NCT01097616|11008566|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893471|NCT01097616|11008567|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893472|NCT01097616|11008568|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893473|NCT01097616|11008569|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893474|NCT01097616|11008562|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
9893475|NCT01097616|11008563|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
9893476|NCT01097616|11008564|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
9893477|NCT01097616|11008565|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893478|NCT01097616|11008566|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893479|NCT01097616|11008567|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893480|NCT01097616|11008568|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893481|NCT01097616|11008569|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893482|NCT01097616|11008562|FG000|STARTED|Optional DB EXT Phase||100
9893483|NCT01097616|11008563|FG001|STARTED|Optional DB EXT Phase||172
9893484|NCT01097616|11008564|FG002|STARTED|Optional DB EXT Phase||151
9893485|NCT01097616|11008565|FG003|STARTED|Optional DB EXT Phase||0
9893486|NCT01097616|11008566|FG004|STARTED|Optional DB EXT Phase||0
9893487|NCT01097616|11008567|FG005|STARTED|Optional DB EXT Phase||0
9893488|NCT01097616|11008568|FG006|STARTED|Optional DB EXT Phase||0
9893489|NCT01097616|11008569|FG007|STARTED|Optional DB EXT Phase||0
9893490|NCT01097616|11008562|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
9893491|NCT01097616|11008563|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
9893492|NCT01097616|11008564|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
9893493|NCT01097616|11008565|FG003|COMPLETED|Optional DB EXT Phase||0
9893494|NCT01097616|11008566|FG004|COMPLETED|Optional DB EXT Phase||0
9893495|NCT01097616|11008567|FG005|COMPLETED|Optional DB EXT Phase||0
9893496|NCT01097616|11008568|FG006|COMPLETED|Optional DB EXT Phase||0
9893497|NCT01097616|11008569|FG007|COMPLETED|Optional DB EXT Phase||0
9893498|NCT01097616|11008562|FG000|NOT COMPLETED|Optional DB EXT Phase||15
9893499|NCT01097616|11008563|FG001|NOT COMPLETED|Optional DB EXT Phase||21
9893500|NCT01097616|11008564|FG002|NOT COMPLETED|Optional DB EXT Phase||10
10008897|NCT01763333|11131404|FG012|STARTED|Overall Study||3
10008898|NCT01763333|11131405|FG013|STARTED|Overall Study||3
9893501|NCT01097616|11008565|FG003|NOT COMPLETED|Optional DB EXT Phase||0
9893502|NCT01097616|11008566|FG004|NOT COMPLETED|Optional DB EXT Phase||0
9893503|NCT01097616|11008567|FG005|NOT COMPLETED|Optional DB EXT Phase||0
9893504|NCT01097616|11008568|FG006|NOT COMPLETED|Optional DB EXT Phase||0
9893505|NCT01097616|11008569|FG007|NOT COMPLETED|Optional DB EXT Phase||0
9893506|NCT01097616|11008562|FG000|STARTED|DB RO Phase||0
9893507|NCT01097616|11008563|FG001|STARTED|DB RO Phase||0
9893508|NCT01097616|11008564|FG002|STARTED|DB RO Phase||0
9893509|NCT01097616|11008565|FG003|STARTED|DB RO Phase||101
9893510|NCT01097616|11008566|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
9893511|NCT01097616|11008567|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
9893512|NCT01097616|11008568|FG006|STARTED|DB RO Phase||162
9893513|NCT01097616|11008569|FG007|STARTED|DB RO Phase||327
9893514|NCT01097616|11008562|FG000|COMPLETED|DB RO Phase||0
9893515|NCT01097616|11008563|FG001|COMPLETED|DB RO Phase||0
9893516|NCT01097616|11008564|FG002|COMPLETED|DB RO Phase||0
9893517|NCT01097616|11008565|FG003|COMPLETED|DB RO Phase||100
9893518|NCT01097616|11008566|FG004|COMPLETED|DB RO Phase||111
9893519|NCT01097616|11008567|FG005|COMPLETED|DB RO Phase||159
9893520|NCT01097616|11008568|FG006|COMPLETED|DB RO Phase||161
9893521|NCT01097616|11008569|FG007|COMPLETED|DB RO Phase||326
9893522|NCT01097616|11008562|FG000|NOT COMPLETED|DB RO Phase||0
9893523|NCT01097616|11008563|FG001|NOT COMPLETED|DB RO Phase||0
9893524|NCT01097616|11008564|FG002|NOT COMPLETED|DB RO Phase||0
9893525|NCT01097616|11008565|FG003|NOT COMPLETED|DB RO Phase||1
9893526|NCT01097616|11008566|FG004|NOT COMPLETED|DB RO Phase||1
9893527|NCT01097616|11008567|FG005|NOT COMPLETED|DB RO Phase||2
9893528|NCT01097616|11008568|FG006|NOT COMPLETED|DB RO Phase||1
9893529|NCT01097616|11008569|FG007|NOT COMPLETED|DB RO Phase||1
9893530|NCT01097629|11008598|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
9893531|NCT01097629|11008599|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
9893532|NCT01097629|11008600|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
9893533|NCT01097629|11008601|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893534|NCT01097629|11008602|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10008899|NCT01763333|11131392|FG000|COMPLETED|Overall Study||6
9893535|NCT01097629|11008603|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893536|NCT01097629|11008604|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
9893537|NCT01097629|11008605|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10008900|NCT01763333|11131393|FG001|COMPLETED|Overall Study||6
9893538|NCT01097629|11008598|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
9893539|NCT01097629|11008599|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
9893540|NCT01097629|11008600|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
9893541|NCT01097629|11008601|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893542|NCT01097629|11008602|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893543|NCT01097629|11008603|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893544|NCT01097629|11008604|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893545|NCT01097629|11008605|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
9893546|NCT01097629|11008598|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
9893547|NCT01097629|11008599|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
9893548|NCT01097629|11008600|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
9893549|NCT01097629|11008601|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893550|NCT01097629|11008602|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893551|NCT01097629|11008603|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893552|NCT01097629|11008604|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10008901|NCT01763333|11131394|FG002|COMPLETED|Overall Study||6
10008902|NCT01763333|11131395|FG003|COMPLETED|Overall Study||6
10008903|NCT01763333|11131396|FG004|COMPLETED|Overall Study||4
10008904|NCT01763333|11131397|FG005|COMPLETED|Overall Study||6
10008905|NCT01763333|11131398|FG006|COMPLETED|Overall Study||5
10008906|NCT01763333|11131399|FG007|COMPLETED|Overall Study||6
9893553|NCT01097629|11008605|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893554|NCT01097629|11008598|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
9893555|NCT01097629|11008599|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
9893556|NCT01097629|11008600|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
9893557|NCT01097629|11008601|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893558|NCT01097629|11008602|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893559|NCT01097629|11008603|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893560|NCT01097629|11008604|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893561|NCT01097629|11008605|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
9893562|NCT01097629|11008598|FG000|STARTED|DB RO Phase||0
9893563|NCT01097629|11008599|FG001|STARTED|DB RO Phase||0
9893564|NCT01097629|11008600|FG002|STARTED|DB RO Phase||0
9893565|NCT01097629|11008601|FG003|STARTED|DB RO Phase||97
9893566|NCT01097629|11008602|FG004|STARTED|DB RO Phase||108
9893567|NCT01097629|11008603|FG005|STARTED|DB RO Phase||173
9893568|NCT01097629|11008604|FG006|STARTED|DB RO Phase||171
9893569|NCT01097629|11008605|FG007|STARTED|DB RO Phase||327
9893570|NCT01097629|11008598|FG000|COMPLETED|DB RO Phase||0
9893571|NCT01097629|11008599|FG001|COMPLETED|DB RO Phase||0
9893572|NCT01097629|11008600|FG002|COMPLETED|DB RO Phase||0
9893573|NCT01097629|11008601|FG003|COMPLETED|DB RO Phase||96
9893574|NCT01097629|11008602|FG004|COMPLETED|DB RO Phase||108
9893575|NCT01097629|11008603|FG005|COMPLETED|DB RO Phase||172
9893576|NCT01097629|11008604|FG006|COMPLETED|DB RO Phase||168
9893577|NCT01097629|11008605|FG007|COMPLETED|DB RO Phase||326
9893578|NCT01097629|11008598|FG000|NOT COMPLETED|DB RO Phase||0
9893579|NCT01097629|11008599|FG001|NOT COMPLETED|DB RO Phase||0
9893580|NCT01097629|11008600|FG002|NOT COMPLETED|DB RO Phase||0
9893581|NCT01097629|11008601|FG003|NOT COMPLETED|DB RO Phase||1
9893582|NCT01097629|11008602|FG004|NOT COMPLETED|DB RO Phase||0
9893583|NCT01097629|11008603|FG005|NOT COMPLETED|DB RO Phase||1
9893584|NCT01097629|11008604|FG006|NOT COMPLETED|DB RO Phase||3
9893585|NCT01097629|11008605|FG007|NOT COMPLETED|DB RO Phase||1
9893586|NCT01097642|11008630|FG000|STARTED|Overall Study||15
9893587|NCT01097642|11008631|FG001|STARTED|Overall Study||25
9893588|NCT01097642|11008630|FG000|COMPLETED|Overall Study||15
9893589|NCT01097642|11008631|FG001|COMPLETED|Overall Study||25
9893590|NCT01097642|11008630|FG000|NOT COMPLETED|Overall Study||0
9893591|NCT01097642|11008631|FG001|NOT COMPLETED|Overall Study||0
9893592|NCT01097655|11008637|FG000|STARTED|Overall Study||3049
9893593|NCT01097655|11008637|FG000|COMPLETED|Overall Study|participants included for analysis|3039
9893594|NCT01097655|11008637|FG000|NOT COMPLETED|Overall Study||10
9893595|NCT01097668|11008643|FG000|STARTED|Overall Study||21
9893596|NCT01097668|11008644|FG001|STARTED|Overall Study||22
9893597|NCT01097668|11008643|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21
10008907|NCT01763333|11131400|FG008|COMPLETED|Overall Study||5
10008908|NCT01763333|11131401|FG009|COMPLETED|Overall Study||18
10008909|NCT01763333|11131402|FG010|COMPLETED|Overall Study||3
10008910|NCT01763333|11131403|FG011|COMPLETED|Overall Study||3
10008911|NCT01763333|11131404|FG012|COMPLETED|Overall Study||3
9893598|NCT01097668|11008644|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22
9893599|NCT01097668|11008643|FG000|Week 48|Overall Study||19
9893600|NCT01097668|11008644|FG001|Week 48|Overall Study||20
9893601|NCT01097668|11008643|FG000|COMPLETED|Overall Study||19
9893602|NCT01097668|11008644|FG001|COMPLETED|Overall Study||20
9893603|NCT01097668|11008643|FG000|NOT COMPLETED|Overall Study||2
9893604|NCT01097668|11008644|FG001|NOT COMPLETED|Overall Study||2
9893605|NCT01097694|11008656|FG000|STARTED|Overall Study||32
9893606|NCT01097694|11008657|FG001|STARTED|Overall Study||30
9893607|NCT01097694|11008656|FG000|COMPLETED|Overall Study||24
10008912|NCT01763333|11131405|FG013|COMPLETED|Overall Study||3
10008913|NCT01763333|11131392|FG000|NOT COMPLETED|Overall Study||0
10008914|NCT01763333|11131393|FG001|NOT COMPLETED|Overall Study||0
10008915|NCT01763333|11131394|FG002|NOT COMPLETED|Overall Study||0
10008916|NCT01763333|11131395|FG003|NOT COMPLETED|Overall Study||0
9893608|NCT01097694|11008657|FG001|COMPLETED|Overall Study||26
9893609|NCT01097694|11008656|FG000|NOT COMPLETED|Overall Study||8
9893610|NCT01097694|11008657|FG001|NOT COMPLETED|Overall Study||4
9893611|NCT01097707|11008668|FG000|STARTED|Overall Study||83
9893612|NCT01097707|11008669|FG001|STARTED|Overall Study||80
9893613|NCT01097707|11008670|FG002|STARTED|Overall Study||82
9893614|NCT01097707|11008671|FG003|STARTED|Overall Study||84
9893615|NCT01097707|11008672|FG004|STARTED|Overall Study||85
9893616|NCT01097707|11008668|FG000|COMPLETED|Overall Study||39
9893617|NCT01097707|11008669|FG001|COMPLETED|Overall Study||37
9893618|NCT01097707|11008670|FG002|COMPLETED|Overall Study||37
9893619|NCT01097707|11008671|FG003|COMPLETED|Overall Study||40
9893620|NCT01097707|11008672|FG004|COMPLETED|Overall Study||35
9893621|NCT01097707|11008668|FG000|NOT COMPLETED|Overall Study||44
9893622|NCT01097707|11008669|FG001|NOT COMPLETED|Overall Study||43
9893623|NCT01097707|11008670|FG002|NOT COMPLETED|Overall Study||45
9893624|NCT01097707|11008671|FG003|NOT COMPLETED|Overall Study||44
9893625|NCT01097707|11008672|FG004|NOT COMPLETED|Overall Study||50
9893626|NCT01097785|11008686|FG000|STARTED|Cycle 1 (30 Days)||6
9893627|NCT01097785|11008687|FG001|STARTED|Cycle 1 (30 Days)||6
9893628|NCT01097785|11008686|FG000|COMPLETED|Cycle 1 (30 Days)||6
9893629|NCT01097785|11008687|FG001|COMPLETED|Cycle 1 (30 Days)||6
9893630|NCT01097785|11008686|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0
9893631|NCT01097785|11008687|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0
9893632|NCT01097785|11008686|FG000|STARTED|Washout (2 Weeks)||6
9893633|NCT01097785|11008687|FG001|STARTED|Washout (2 Weeks)||6
9893634|NCT01097785|11008686|FG000|COMPLETED|Washout (2 Weeks)||6
9893635|NCT01097785|11008687|FG001|COMPLETED|Washout (2 Weeks)||6
9893636|NCT01097785|11008686|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9893637|NCT01097785|11008687|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9893638|NCT01097785|11008686|FG000|STARTED|Cycle 3 (30 Days)||6
9893639|NCT01097785|11008687|FG001|STARTED|Cycle 3 (30 Days)||6
9893640|NCT01097785|11008686|FG000|COMPLETED|Cycle 3 (30 Days)||6
9893641|NCT01097785|11008687|FG001|COMPLETED|Cycle 3 (30 Days)||6
9893642|NCT01097785|11008686|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0
9893643|NCT01097785|11008687|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0
9893644|NCT01097863|11008697|FG000|STARTED|Overall Study||90
9893645|NCT01097863|11008698|FG001|STARTED|Overall Study||98
9893646|NCT01097863|11008699|FG002|STARTED|Overall Study||91
9893647|NCT01097863|11008697|FG000|COMPLETED|Overall Study||89
9893648|NCT01097863|11008698|FG001|COMPLETED|Overall Study||98
9893649|NCT01097863|11008699|FG002|COMPLETED|Overall Study||89
9893650|NCT01097863|11008697|FG000|NOT COMPLETED|Overall Study||1
9893651|NCT01097863|11008698|FG001|NOT COMPLETED|Overall Study||0
10110146|NCT02482675|11240892|FG010|NOT COMPLETED|Overall Study||0
9893652|NCT01097863|11008699|FG002|NOT COMPLETED|Overall Study||2
9893653|NCT01097915|11008710|FG000|STARTED|Overall Study||50
9893654|NCT01097915|11008711|FG001|STARTED|Overall Study||70
9893655|NCT01097915|11008712|FG002|STARTED|Overall Study||50
9893656|NCT01097915|11008710|FG000|COMPLETED|Overall Study||27
9893657|NCT01097915|11008711|FG001|COMPLETED|Overall Study||28
9893658|NCT01097915|11008712|FG002|COMPLETED|Overall Study||20
9893659|NCT01097915|11008710|FG000|NOT COMPLETED|Overall Study||23
9893660|NCT01097915|11008711|FG001|NOT COMPLETED|Overall Study||42
9893661|NCT01097915|11008712|FG002|NOT COMPLETED|Overall Study||30
9893662|NCT01098006|11008731|FG000|STARTED|Overall Study||7
9893663|NCT01098006|11008732|FG001|STARTED|Overall Study||11
9893664|NCT01098006|11008733|FG002|STARTED|Overall Study||60
9893665|NCT01098006|11008734|FG003|STARTED|Overall Study||21
9893666|NCT01098006|11008731|FG000|COMPLETED|Overall Study||7
9893667|NCT01098006|11008732|FG001|COMPLETED|Overall Study||11
9893668|NCT01098006|11008733|FG002|COMPLETED|Overall Study||60
9893669|NCT01098006|11008734|FG003|COMPLETED|Overall Study||21
9893670|NCT01098006|11008731|FG000|NOT COMPLETED|Overall Study||0
9893671|NCT01098006|11008732|FG001|NOT COMPLETED|Overall Study||0
9893672|NCT01098006|11008733|FG002|NOT COMPLETED|Overall Study||0
9893673|NCT01098006|11008734|FG003|NOT COMPLETED|Overall Study||0
9893674|NCT01098097|11008744|FG000|STARTED|Overall Study||963
9893675|NCT01098097|11008744|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
9893676|NCT01098097|11008744|FG000|NOT COMPLETED|Overall Study||82
9893677|NCT01098162|11008748|FG000|STARTED|Overall Study||573
9893678|NCT01098162|11008748|FG000|COMPLETED|Overall Study||461
9893679|NCT01098162|11008748|FG000|NOT COMPLETED|Overall Study||112
9893680|NCT01098240|11008752|FG000|STARTED|Open-Label Phase||297
9893681|NCT01098240|11008753|FG001|STARTED|Open-Label Phase||0
9893682|NCT01098240|11008754|FG002|STARTED|Open-Label Phase||0
10110147|NCT02482675|11240893|FG011|NOT COMPLETED|Overall Study||0
9893683|NCT01098240|11008752|FG000|COMPLETED|Open-Label Phase||162
9893684|NCT01098240|11008753|FG001|COMPLETED|Open-Label Phase||0
9893685|NCT01098240|11008754|FG002|COMPLETED|Open-Label Phase||0
9893686|NCT01098240|11008752|FG000|NOT COMPLETED|Open-Label Phase||135
9893687|NCT01098240|11008753|FG001|NOT COMPLETED|Open-Label Phase||0
9893688|NCT01098240|11008754|FG002|NOT COMPLETED|Open-Label Phase||0
9893689|NCT01098240|11008752|FG000|STARTED|Double-Blind Phase||0
10110148|NCT02482675|11240894|FG012|NOT COMPLETED|Overall Study||0
10110149|NCT02482675|11240895|FG013|NOT COMPLETED|Overall Study||0
9893690|NCT01098240|11008753|FG001|STARTED|Double-Blind Phase||77
9893691|NCT01098240|11008754|FG002|STARTED|Double-Blind Phase||85
9893692|NCT01098240|11008752|FG000|COMPLETED|Double-Blind Phase||0
9893693|NCT01098240|11008753|FG001|COMPLETED|Double-Blind Phase||60
9893694|NCT01098240|11008754|FG002|COMPLETED|Double-Blind Phase||63
9893695|NCT01098240|11008752|FG000|NOT COMPLETED|Double-Blind Phase||0
9893696|NCT01098240|11008753|FG001|NOT COMPLETED|Double-Blind Phase||17
9893697|NCT01098240|11008754|FG002|NOT COMPLETED|Double-Blind Phase||22
9893698|NCT01098253|11008763|FG000|STARTED|Overall Study||94
9893699|NCT01098253|11008764|FG001|STARTED|Overall Study||88
9893700|NCT01098253|11008763|FG000|COMPLETED|Overall Study||92
9893701|NCT01098253|11008764|FG001|COMPLETED|Overall Study||88
9893702|NCT01098253|11008763|FG000|NOT COMPLETED|Overall Study||2
9893703|NCT01098253|11008764|FG001|NOT COMPLETED|Overall Study||0
9893704|NCT01098266|11008772|FG000|STARTED|Overall Study||200
9893705|NCT01098266|11008773|FG001|STARTED|Overall Study||200
9893706|NCT01098266|11008772|FG000|COMPLETED|Overall Study||193
9893707|NCT01098266|11008773|FG001|COMPLETED|Overall Study||193
9893708|NCT01098266|11008772|FG000|NOT COMPLETED|Overall Study||7
9893709|NCT01098266|11008773|FG001|NOT COMPLETED|Overall Study||7
9893710|NCT01098305|11008781|FG000|STARTED|Overall Study||119
9893711|NCT01098305|11008782|FG001|STARTED|Overall Study||118
9893712|NCT01098305|11008781|FG000|COMPLETED|Overall Study||88
9893713|NCT01098305|11008782|FG001|COMPLETED|Overall Study||85
9893714|NCT01098305|11008781|FG000|NOT COMPLETED|Overall Study||31
9893715|NCT01098305|11008782|FG001|NOT COMPLETED|Overall Study||33
9893716|NCT01098318|11008791|FG000|STARTED|Overall Study||20
9893717|NCT01098318|11008792|FG001|STARTED|Overall Study||19
9893718|NCT01098318|11008793|FG002|STARTED|Overall Study||18
9893719|NCT01098318|11008791|FG000|COMPLETED|Overall Study||17
9893720|NCT01098318|11008792|FG001|COMPLETED|Overall Study||12
9893721|NCT01098318|11008793|FG002|COMPLETED|Overall Study||15
9893722|NCT01098318|11008791|FG000|NOT COMPLETED|Overall Study||3
9893723|NCT01098318|11008792|FG001|NOT COMPLETED|Overall Study||7
9893724|NCT01098318|11008793|FG002|NOT COMPLETED|Overall Study||3
9893725|NCT01098422|11008801|FG000|STARTED|Overall Study||10
9893726|NCT01098422|11008801|FG000|COMPLETED|Overall Study||9
9893727|NCT01098422|11008801|FG000|NOT COMPLETED|Overall Study||1
9893728|NCT01098461|11008809|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53
9893729|NCT01098461|11008810|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52
9893730|NCT01098461|11008811|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54
9893731|NCT01098461|11008812|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53
9893732|NCT01098461|11008809|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41
9893733|NCT01098461|11008810|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45
9893734|NCT01098461|11008811|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53
9893735|NCT01098461|11008812|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50
9893736|NCT01098461|11008809|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
9893737|NCT01098461|11008810|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
9893738|NCT01098461|11008811|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
9893739|NCT01098461|11008812|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
9893740|NCT01098461|11008809|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
9893741|NCT01098461|11008810|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52
9893742|NCT01098461|11008811|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
9893743|NCT01098461|11008812|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
9893744|NCT01098461|11008809|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
9893745|NCT01098461|11008810|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
9893746|NCT01098461|11008811|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
9893747|NCT01098461|11008812|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
9893748|NCT01098461|11008809|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
9893749|NCT01098461|11008810|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
9893750|NCT01098461|11008811|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
9893751|NCT01098461|11008812|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
9893752|NCT01098474|11008829|FG000|STARTED|Active Phase||50
9893753|NCT01098474|11008830|FG001|STARTED|Active Phase||50
9893754|NCT01098474|11008831|FG002|STARTED|Active Phase||50
9893755|NCT01098474|11008832|FG003|STARTED|Active Phase||49
9893756|NCT01098474|11008833|FG004|STARTED|Active Phase||52
9893757|NCT01098474|11008834|FG005|STARTED|Active Phase||49
9893758|NCT01098474|11008829|FG000|COMPLETED|Active Phase||48
9893759|NCT01098474|11008830|FG001|COMPLETED|Active Phase||49
9893760|NCT01098474|11008831|FG002|COMPLETED|Active Phase||45
9893761|NCT01098474|11008832|FG003|COMPLETED|Active Phase||49
9893762|NCT01098474|11008833|FG004|COMPLETED|Active Phase||52
9893763|NCT01098474|11008834|FG005|COMPLETED|Active Phase||49
9893764|NCT01098474|11008829|FG000|NOT COMPLETED|Active Phase||2
9893765|NCT01098474|11008830|FG001|NOT COMPLETED|Active Phase||1
9893766|NCT01098474|11008831|FG002|NOT COMPLETED|Active Phase||5
9893767|NCT01098474|11008832|FG003|NOT COMPLETED|Active Phase||0
9893768|NCT01098474|11008833|FG004|NOT COMPLETED|Active Phase||0
9893769|NCT01098474|11008834|FG005|NOT COMPLETED|Active Phase||0
9893770|NCT01098474|11008829|FG000|STARTED|Follow Up Phase||48
9893771|NCT01098474|11008830|FG001|STARTED|Follow Up Phase||49
9893772|NCT01098474|11008831|FG002|STARTED|Follow Up Phase||45
9893773|NCT01098474|11008832|FG003|STARTED|Follow Up Phase||49
9893774|NCT01098474|11008833|FG004|STARTED|Follow Up Phase||52
9893775|NCT01098474|11008834|FG005|STARTED|Follow Up Phase||49
9893776|NCT01098474|11008829|FG000|COMPLETED|Follow Up Phase||48
9893777|NCT01098474|11008830|FG001|COMPLETED|Follow Up Phase||49
9893778|NCT01098474|11008831|FG002|COMPLETED|Follow Up Phase||45
9893779|NCT01098474|11008832|FG003|COMPLETED|Follow Up Phase||47
9893780|NCT01098474|11008833|FG004|COMPLETED|Follow Up Phase||50
9893781|NCT01098474|11008834|FG005|COMPLETED|Follow Up Phase||44
9893782|NCT01098474|11008829|FG000|NOT COMPLETED|Follow Up Phase||0
9893783|NCT01098474|11008830|FG001|NOT COMPLETED|Follow Up Phase||0
9893784|NCT01098474|11008831|FG002|NOT COMPLETED|Follow Up Phase||0
9893785|NCT01098474|11008832|FG003|NOT COMPLETED|Follow Up Phase||2
9893786|NCT01098474|11008833|FG004|NOT COMPLETED|Follow Up Phase||2
9893787|NCT01098474|11008834|FG005|NOT COMPLETED|Follow Up Phase||5
9893788|NCT01098487|11008858|FG000|STARTED|Overall Study||162
9893789|NCT01098487|11008858|FG000|COMPLETED|Overall Study||118
9893790|NCT01098487|11008858|FG000|NOT COMPLETED|Overall Study||44
9893791|NCT01098500|11008862|FG000|STARTED|Overall Study||3800
9893792|NCT01098500|11008862|FG000|COMPLETED|Overall Study||3800
9893793|NCT01098500|11008862|FG000|NOT COMPLETED|Overall Study||0
9893794|NCT01098539|11008868|FG000|STARTED|Overall Study||249
9893795|NCT01098539|11008869|FG001|STARTED|Overall Study||246
9893796|NCT01098539|11008868|FG000|COMPLETED|Overall Study||198
9893797|NCT01098539|11008869|FG001|COMPLETED|Overall Study||178
9893798|NCT01098539|11008868|FG000|NOT COMPLETED|Overall Study||51
9893799|NCT01098539|11008869|FG001|NOT COMPLETED|Overall Study||68
9893800|NCT01098578|11008875|FG000|STARTED|Overall Study||20
9893801|NCT01098578|11008875|FG000|COMPLETED|Overall Study||20
9893802|NCT01098578|11008875|FG000|NOT COMPLETED|Overall Study||0
9893803|NCT01098747|11008885|FG000|STARTED|Overall Study||48
9893804|NCT01098747|11008886|FG001|STARTED|Overall Study||95
9893805|NCT01098747|11008887|FG002|STARTED|Overall Study||86
9893806|NCT01098747|11008888|FG003|STARTED|Overall Study||87
9893807|NCT01098747|11008885|FG000|COMPLETED|Overall Study||48
9893808|NCT01098747|11008886|FG001|COMPLETED|Overall Study||95
9893809|NCT01098747|11008887|FG002|COMPLETED|Overall Study||86
9893810|NCT01098747|11008888|FG003|COMPLETED|Overall Study||87
9893811|NCT01098747|11008885|FG000|NOT COMPLETED|Overall Study||0
9893812|NCT01098747|11008886|FG001|NOT COMPLETED|Overall Study||0
9893813|NCT01098747|11008887|FG002|NOT COMPLETED|Overall Study||0
9893814|NCT01098747|11008888|FG003|NOT COMPLETED|Overall Study||0
9893815|NCT01098812|11008900|FG000|STARTED|Overall Study||95
9893816|NCT01098812|11008901|FG001|STARTED|Overall Study||102
9893817|NCT01098812|11008902|FG002|STARTED|Overall Study||72
9893818|NCT01098812|11008900|FG000|COMPLETED|Overall Study||93
9893819|NCT01098812|11008901|FG001|COMPLETED|Overall Study||101
9893820|NCT01098812|11008902|FG002|COMPLETED|Overall Study||71
9893821|NCT01098812|11008900|FG000|NOT COMPLETED|Overall Study||2
9893822|NCT01098812|11008901|FG001|NOT COMPLETED|Overall Study||1
9893823|NCT01098812|11008902|FG002|NOT COMPLETED|Overall Study||1
9893824|NCT01098851|11008911|FG000|STARTED|Overall Study||11
9893825|NCT01098851|11008912|FG001|STARTED|Overall Study||10
9893826|NCT01098851|11008911|FG000|COMPLETED|Overall Study||10
9893827|NCT01098851|11008912|FG001|COMPLETED|Overall Study||10
9893828|NCT01098851|11008911|FG000|NOT COMPLETED|Overall Study||1
9893829|NCT01098851|11008912|FG001|NOT COMPLETED|Overall Study||0
9893830|NCT01099111|11008923|FG000|STARTED|Overall Study||50
9893831|NCT01099111|11008924|FG001|STARTED|Overall Study||50
9893832|NCT01099111|11008925|FG002|STARTED|Overall Study||46
9893833|NCT01099111|11008926|FG003|STARTED|Overall Study||29
9893834|NCT01099111|11008927|FG004|STARTED|Overall Study||50
9893835|NCT01099111|11008923|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
9893836|NCT01099111|11008924|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
9893837|NCT01099111|11008925|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
9893838|NCT01099111|11008926|FG003|COMPLETED|Overall Study||29
9893839|NCT01099111|11008927|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
9893840|NCT01099111|11008923|FG000|NOT COMPLETED|Overall Study||0
9893841|NCT01099111|11008924|FG001|NOT COMPLETED|Overall Study||0
9893842|NCT01099111|11008925|FG002|NOT COMPLETED|Overall Study||0
9893843|NCT01099111|11008926|FG003|NOT COMPLETED|Overall Study||0
9893844|NCT01099111|11008927|FG004|NOT COMPLETED|Overall Study||0
9893845|NCT01099202|11008941|FG000|STARTED|Overall Study||55
9893846|NCT01099202|11008942|FG001|STARTED|Overall Study||54
9893847|NCT01099202|11008941|FG000|COMPLETED|Overall Study||55
9893848|NCT01099202|11008942|FG001|COMPLETED|Overall Study||54
9893849|NCT01099202|11008941|FG000|NOT COMPLETED|Overall Study||0
9893850|NCT01099202|11008942|FG001|NOT COMPLETED|Overall Study||0
9893851|NCT01099215|11008951|FG000|STARTED|Overall Study||11
9893852|NCT01099215|11008952|FG001|STARTED|Overall Study||10
9893853|NCT01099215|11008951|FG000|COMPLETED|Overall Study||10
9893854|NCT01099215|11008952|FG001|COMPLETED|Overall Study||9
9893855|NCT01099215|11008951|FG000|NOT COMPLETED|Overall Study||1
9893856|NCT01099215|11008952|FG001|NOT COMPLETED|Overall Study||1
9893857|NCT01099267|11008958|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
9893858|NCT01099267|11008958|FG000|COMPLETED|MDS-003 Study||24
9893859|NCT01099267|11008958|FG000|NOT COMPLETED|MDS-003 Study||124
9893860|NCT01099267|11008958|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
9893861|NCT01099267|11008958|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33
9893862|NCT01099267|11008958|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
9893863|NCT01099267|11008958|FG000|COMPLETED|MDS-009 Extension Follow-up||54
9893864|NCT01099267|11008958|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0
9893865|NCT01099358|11008962|FG000|STARTED|Overall Study||4
9893866|NCT01099358|11008963|FG001|STARTED|Overall Study||6
9893867|NCT01099358|11008964|FG002|STARTED|Overall Study||21
9893868|NCT01099358|11008965|FG003|STARTED|Overall Study||16
9893869|NCT01099358|11008962|FG000|Received at Least One Dose of Study Drug|Overall Study||3
9893870|NCT01099358|11008963|FG001|Received at Least One Dose of Study Drug|Overall Study||6
9893871|NCT01099358|11008964|FG002|Received at Least One Dose of Study Drug|Overall Study||20
9893872|NCT01099358|11008965|FG003|Received at Least One Dose of Study Drug|Overall Study||15
9893873|NCT01099358|11008962|FG000|COMPLETED|Overall Study||1
9893874|NCT01099358|11008963|FG001|COMPLETED|Overall Study||5
9893875|NCT01099358|11008964|FG002|COMPLETED|Overall Study||13
9893876|NCT01099358|11008965|FG003|COMPLETED|Overall Study||12
9893877|NCT01099358|11008962|FG000|NOT COMPLETED|Overall Study||3
9893878|NCT01099358|11008963|FG001|NOT COMPLETED|Overall Study||1
9893879|NCT01099358|11008964|FG002|NOT COMPLETED|Overall Study||8
9893880|NCT01099358|11008965|FG003|NOT COMPLETED|Overall Study||4
9893881|NCT01099397|11008976|FG000|STARTED|Overall Study||39
9893882|NCT01099397|11008976|FG000|COMPLETED|Overall Study||26
9893883|NCT01099397|11008976|FG000|NOT COMPLETED|Overall Study||13
9893884|NCT01099449|11008984|FG000|STARTED|Overall Study||118
9893885|NCT01099449|11008985|FG001|STARTED|Overall Study||119
9893886|NCT01099449|11008986|FG002|STARTED|Overall Study||116
9893887|NCT01099449|11008984|FG000|COMPLETED|Overall Study||118
9893888|NCT01099449|11008985|FG001|COMPLETED|Overall Study||119
9893889|NCT01099449|11008986|FG002|COMPLETED|Overall Study||116
9893890|NCT01099449|11008984|FG000|NOT COMPLETED|Overall Study||0
9893891|NCT01099449|11008985|FG001|NOT COMPLETED|Overall Study||0
9893892|NCT01099449|11008986|FG002|NOT COMPLETED|Overall Study||0
9893893|NCT01099475|11009009|FG000|STARTED|Overall Study||10
9893894|NCT01099475|11009010|FG001|STARTED|Overall Study||10
9893895|NCT01099475|11009009|FG000|COMPLETED|Overall Study||10
9893896|NCT01099475|11009010|FG001|COMPLETED|Overall Study||10
9893897|NCT01099475|11009009|FG000|NOT COMPLETED|Overall Study||0
9893898|NCT01099475|11009010|FG001|NOT COMPLETED|Overall Study||0
9893899|NCT01099579|11009019|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21
9893900|NCT01099579|11009020|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19
9893901|NCT01099579|11009021|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16
9893902|NCT01099579|11009019|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
9893903|NCT01099579|11009020|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
9893904|NCT01099579|11009021|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
9893905|NCT01099579|11009019|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
9893906|NCT01099579|11009020|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
9893907|NCT01099579|11009021|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
9893908|NCT01099579|11009019|FG000|STARTED|Stage 2 (ATV Capsule)||16
9893909|NCT01099579|11009020|FG001|STARTED|Stage 2 (ATV Capsule)||14
9893910|NCT01099579|11009021|FG002|STARTED|Stage 2 (ATV Capsule)||15
10008917|NCT01763333|11131396|FG004|NOT COMPLETED|Overall Study||0
10008918|NCT01763333|11131397|FG005|NOT COMPLETED|Overall Study||0
10202898|NCT03453060|11330058|FG000|STARTED|Overall Study||4
10202899|NCT03453060|11330059|FG001|STARTED|Overall Study||4
9893911|NCT01099579|11009019|FG000|COMPLETED|Stage 2 (ATV Capsule)||10
10008919|NCT01763333|11131398|FG006|NOT COMPLETED|Overall Study||0
9893912|NCT01099579|11009020|FG001|COMPLETED|Stage 2 (ATV Capsule)||9
9893913|NCT01099579|11009021|FG002|COMPLETED|Stage 2 (ATV Capsule)||9
9893914|NCT01099579|11009019|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6
9893915|NCT01099579|11009020|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5
9893916|NCT01099579|11009021|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6
9893917|NCT01099618|11009034|FG000|STARTED|Overall Study||17
10008920|NCT01763333|11131399|FG007|NOT COMPLETED|Overall Study||0
10008921|NCT01763333|11131400|FG008|NOT COMPLETED|Overall Study||0
10008922|NCT01763333|11131401|FG009|NOT COMPLETED|Overall Study||0
9893918|NCT01099618|11009035|FG001|STARTED|Overall Study||16
9893919|NCT01099618|11009036|FG002|STARTED|Overall Study||15
9893920|NCT01099618|11009034|FG000|COMPLETED|Overall Study||17
9893921|NCT01099618|11009035|FG001|COMPLETED|Overall Study||16
9893922|NCT01099618|11009036|FG002|COMPLETED|Overall Study||15
9893923|NCT01099618|11009034|FG000|NOT COMPLETED|Overall Study||0
9893924|NCT01099618|11009035|FG001|NOT COMPLETED|Overall Study||0
9893925|NCT01099618|11009036|FG002|NOT COMPLETED|Overall Study||0
9893926|NCT01099631|11009050|FG000|STARTED|Overall Study||6
9893927|NCT01099631|11009051|FG001|STARTED|Overall Study||3
9893928|NCT01099631|11009052|FG002|STARTED|Overall Study||3
9893929|NCT01099631|11009053|FG003|STARTED|Overall Study||3
10008923|NCT01763333|11131402|FG010|NOT COMPLETED|Overall Study||0
10008924|NCT01763333|11131403|FG011|NOT COMPLETED|Overall Study||0
9893930|NCT01099631|11009054|FG004|STARTED|Overall Study||3
9893931|NCT01099631|11009055|FG005|STARTED|Overall Study||4
9893932|NCT01099631|11009050|FG000|COMPLETED|Overall Study||6
9893933|NCT01099631|11009051|FG001|COMPLETED|Overall Study||3
9893934|NCT01099631|11009052|FG002|COMPLETED|Overall Study||3
9893935|NCT01099631|11009053|FG003|COMPLETED|Overall Study||3
9893936|NCT01099631|11009054|FG004|COMPLETED|Overall Study||3
9893937|NCT01099631|11009055|FG005|COMPLETED|Overall Study||4
9893938|NCT01099631|11009050|FG000|NOT COMPLETED|Overall Study||0
9893939|NCT01099631|11009051|FG001|NOT COMPLETED|Overall Study||0
9893940|NCT01099631|11009052|FG002|NOT COMPLETED|Overall Study||0
10202900|NCT03453060|11330060|FG002|STARTED|Overall Study||4
9893941|NCT01099631|11009053|FG003|NOT COMPLETED|Overall Study||0
9893942|NCT01099631|11009054|FG004|NOT COMPLETED|Overall Study||0
9893943|NCT01099631|11009055|FG005|NOT COMPLETED|Overall Study||0
9893944|NCT01099709|11009075|FG000|STARTED|Period 1||42
9893945|NCT01099709|11009076|FG001|STARTED|Period 1||43
9893946|NCT01099709|11009075|FG000|COMPLETED|Period 1||41
9893947|NCT01099709|11009076|FG001|COMPLETED|Period 1||41
9893948|NCT01099709|11009075|FG000|NOT COMPLETED|Period 1||1
9893949|NCT01099709|11009076|FG001|NOT COMPLETED|Period 1||2
9893950|NCT01099709|11009075|FG000|STARTED|Period 2||41
9893951|NCT01099709|11009076|FG001|STARTED|Period 2||41
9893952|NCT01099709|11009075|FG000|COMPLETED|Period 2||41
9893953|NCT01099709|11009076|FG001|COMPLETED|Period 2||41
9893954|NCT01099709|11009075|FG000|NOT COMPLETED|Period 2||0
9893955|NCT01099709|11009076|FG001|NOT COMPLETED|Period 2||0
9893956|NCT01099761|11009087|FG000|STARTED|Overall Study||9
9893957|NCT01099761|11009088|FG001|STARTED|Overall Study||9
9893958|NCT01099761|11009089|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
9893959|NCT01099761|11009090|FG003|STARTED|Overall Study||6
9893960|NCT01099761|11009087|FG000|COMPLETED|Overall Study||9
9893961|NCT01099761|11009088|FG001|COMPLETED|Overall Study||9
9893962|NCT01099761|11009089|FG002|COMPLETED|Overall Study||0
9893963|NCT01099761|11009090|FG003|COMPLETED|Overall Study||6
9893964|NCT01099761|11009087|FG000|NOT COMPLETED|Overall Study||0
9893965|NCT01099761|11009088|FG001|NOT COMPLETED|Overall Study||0
9893966|NCT01099761|11009089|FG002|NOT COMPLETED|Overall Study||0
9893967|NCT01099761|11009090|FG003|NOT COMPLETED|Overall Study||0
9893968|NCT01099774|11009101|FG000|STARTED|Overall Study||302
9893969|NCT01099774|11009102|FG001|STARTED|Overall Study||295
9893970|NCT01099774|11009101|FG000|COMPLETED|Overall Study||296
9893971|NCT01099774|11009102|FG001|COMPLETED|Overall Study||289
9893972|NCT01099774|11009101|FG000|NOT COMPLETED|Overall Study||6
9893973|NCT01099774|11009102|FG001|NOT COMPLETED|Overall Study||6
9893974|NCT01099917|11009108|FG000|STARTED|Overall Study||45
9893975|NCT01099917|11009108|FG000|COMPLETED|Overall Study||18
9893976|NCT01099917|11009108|FG000|NOT COMPLETED|Overall Study||27
9893977|NCT01099969|11009116|FG000|STARTED|Overall Study||15
9893978|NCT01099969|11009117|FG001|STARTED|Overall Study||15
9893979|NCT01099969|11009118|FG002|STARTED|Overall Study||15
9893980|NCT01099969|11009119|FG003|STARTED|Overall Study||15
9893981|NCT01099969|11009116|FG000|COMPLETED|Overall Study||15
9893982|NCT01099969|11009117|FG001|COMPLETED|Overall Study||15
9893983|NCT01099969|11009118|FG002|COMPLETED|Overall Study||15
9893984|NCT01099969|11009119|FG003|COMPLETED|Overall Study||15
9893985|NCT01099969|11009116|FG000|NOT COMPLETED|Overall Study||0
9893986|NCT01099969|11009117|FG001|NOT COMPLETED|Overall Study||0
9893987|NCT01099969|11009118|FG002|NOT COMPLETED|Overall Study||0
9893988|NCT01099969|11009119|FG003|NOT COMPLETED|Overall Study||0
9893989|NCT01100034|11009129|FG000|STARTED|Overall Study||72
9893990|NCT01100034|11009129|FG000|COMPLETED|Overall Study||29
9893991|NCT01100034|11009129|FG000|NOT COMPLETED|Overall Study||43
9893992|NCT01100073|11009133|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699
9893993|NCT01100073|11009133|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599
9893994|NCT01100073|11009133|FG000|NOT COMPLETED|Overall Study||100
9893995|NCT01100086|11009137|FG000|STARTED|Period 1||43
9893996|NCT01100086|11009138|FG001|STARTED|Period 1||41
9893997|NCT01100086|11009137|FG000|COMPLETED|Period 1||42
9893998|NCT01100086|11009138|FG001|COMPLETED|Period 1||41
9893999|NCT01100086|11009137|FG000|NOT COMPLETED|Period 1||1
9894000|NCT01100086|11009138|FG001|NOT COMPLETED|Period 1||0
9894001|NCT01100086|11009137|FG000|STARTED|Period 2||42
9894002|NCT01100086|11009138|FG001|STARTED|Period 2||41
9894003|NCT01100086|11009137|FG000|COMPLETED|Period 2||42
9894004|NCT01100086|11009138|FG001|COMPLETED|Period 2||41
9894005|NCT01100086|11009137|FG000|NOT COMPLETED|Period 2||0
9894006|NCT01100086|11009138|FG001|NOT COMPLETED|Period 2||0
9894007|NCT01100112|11009144|FG000|STARTED|Overall Study||60
9894008|NCT01100112|11009144|FG000|COMPLETED|Overall Study||52
9894009|NCT01100112|11009144|FG000|NOT COMPLETED|Overall Study||8
9894010|NCT01100242|11009148|FG000|STARTED|Overall Study||17
9894011|NCT01100242|11009148|FG000|COMPLETED|Overall Study||17
9894012|NCT01100242|11009148|FG000|NOT COMPLETED|Overall Study||0
9894013|NCT01100255|11009154|FG000|STARTED|Overall Study||8
9894014|NCT01100255|11009155|FG001|STARTED|Overall Study||7
9894015|NCT01100255|11009154|FG000|COMPLETED|Overall Study||8
9894016|NCT01100255|11009155|FG001|COMPLETED|Overall Study||7
9894017|NCT01100255|11009154|FG000|NOT COMPLETED|Overall Study||0
9894018|NCT01100255|11009155|FG001|NOT COMPLETED|Overall Study||0
9894019|NCT01100268|11009161|FG000|STARTED|Overall Study||4
9894020|NCT01100268|11009161|FG000|COMPLETED|Overall Study||4
9894021|NCT01100268|11009161|FG000|NOT COMPLETED|Overall Study||0
9894022|NCT01100307|11009167|FG000|STARTED|Double Masked Phase (Up to Week 24)||123
9894023|NCT01100307|11009168|FG001|STARTED|Double Masked Phase (Up to Week 24)||120
9894024|NCT01100307|11009167|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117
9894025|NCT01100307|11009168|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116
9894026|NCT01100307|11009167|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
9894027|NCT01100307|11009168|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
9894028|NCT01100307|11009167|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
9894029|NCT01100307|11009168|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
9954650|NCT01432756|11073454|FG001|NOT COMPLETED|Overall Study||0
9894030|NCT01100307|11009167|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110
9894031|NCT01100307|11009168|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99
9894032|NCT01100307|11009167|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
9894033|NCT01100307|11009168|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
9894034|NCT01100320|11009176|FG000|STARTED|Period 1||43
9894035|NCT01100320|11009177|FG001|STARTED|Period 1||45
9894036|NCT01100320|11009176|FG000|COMPLETED|Period 1||38
9894037|NCT01100320|11009177|FG001|COMPLETED|Period 1||38
9894038|NCT01100320|11009176|FG000|NOT COMPLETED|Period 1||5
9894039|NCT01100320|11009177|FG001|NOT COMPLETED|Period 1||7
9894040|NCT01100320|11009176|FG000|STARTED|Period 2||38
9894041|NCT01100320|11009177|FG001|STARTED|Period 2||38
9894042|NCT01100320|11009176|FG000|COMPLETED|Period 2||37
9894043|NCT01100320|11009177|FG001|COMPLETED|Period 2||37
9894044|NCT01100320|11009176|FG000|NOT COMPLETED|Period 2||1
9894045|NCT01100320|11009177|FG001|NOT COMPLETED|Period 2||1
9894046|NCT01100437|11009183|FG000|STARTED|Screening||4
9894047|NCT01100437|11009184|FG001|STARTED|Screening||2
9894048|NCT01100437|11009185|FG002|STARTED|Screening||8
9894049|NCT01100437|11009183|FG000|COMPLETED|Screening||4
9894050|NCT01100437|11009184|FG001|COMPLETED|Screening||2
9894051|NCT01100437|11009185|FG002|COMPLETED|Screening||8
9894052|NCT01100437|11009183|FG000|NOT COMPLETED|Screening||0
9894053|NCT01100437|11009184|FG001|NOT COMPLETED|Screening||0
9894054|NCT01100437|11009185|FG002|NOT COMPLETED|Screening||0
9894055|NCT01100437|11009183|FG000|STARTED|Titration/Stabilization||4
9894056|NCT01100437|11009184|FG001|STARTED|Titration/Stabilization||2
9894057|NCT01100437|11009185|FG002|STARTED|Titration/Stabilization||8
9894058|NCT01100437|11009183|FG000|COMPLETED|Titration/Stabilization||4
9894059|NCT01100437|11009184|FG001|COMPLETED|Titration/Stabilization||2
9894060|NCT01100437|11009185|FG002|COMPLETED|Titration/Stabilization||2
9894061|NCT01100437|11009183|FG000|NOT COMPLETED|Titration/Stabilization||0
9894062|NCT01100437|11009184|FG001|NOT COMPLETED|Titration/Stabilization||0
9894063|NCT01100437|11009185|FG002|NOT COMPLETED|Titration/Stabilization||6
9894064|NCT01100437|11009183|FG000|STARTED|Maintenance||4
9894065|NCT01100437|11009184|FG001|STARTED|Maintenance||2
9894066|NCT01100437|11009185|FG002|STARTED|Maintenance||2
9894067|NCT01100437|11009183|FG000|COMPLETED|Maintenance||4
9894068|NCT01100437|11009184|FG001|COMPLETED|Maintenance||2
9894069|NCT01100437|11009185|FG002|COMPLETED|Maintenance||0
9894070|NCT01100437|11009183|FG000|NOT COMPLETED|Maintenance||0
9894071|NCT01100437|11009184|FG001|NOT COMPLETED|Maintenance||0
9894072|NCT01100437|11009185|FG002|NOT COMPLETED|Maintenance||2
9894073|NCT01100437|11009183|FG000|STARTED|Treatment 1||4
9894074|NCT01100437|11009184|FG001|STARTED|Treatment 1||2
9894075|NCT01100437|11009185|FG002|STARTED|Treatment 1||0
9894076|NCT01100437|11009183|FG000|COMPLETED|Treatment 1||4
9894077|NCT01100437|11009184|FG001|COMPLETED|Treatment 1||2
9894078|NCT01100437|11009185|FG002|COMPLETED|Treatment 1||0
9894079|NCT01100437|11009183|FG000|NOT COMPLETED|Treatment 1||0
9894080|NCT01100437|11009184|FG001|NOT COMPLETED|Treatment 1||0
9894081|NCT01100437|11009185|FG002|NOT COMPLETED|Treatment 1||0
9894082|NCT01100437|11009183|FG000|STARTED|Washout (4 Days)||4
9894083|NCT01100437|11009184|FG001|STARTED|Washout (4 Days)||2
9894084|NCT01100437|11009185|FG002|STARTED|Washout (4 Days)||0
9894085|NCT01100437|11009183|FG000|COMPLETED|Washout (4 Days)||4
9894086|NCT01100437|11009184|FG001|COMPLETED|Washout (4 Days)||2
9894087|NCT01100437|11009185|FG002|COMPLETED|Washout (4 Days)||0
9894088|NCT01100437|11009183|FG000|NOT COMPLETED|Washout (4 Days)||0
9894089|NCT01100437|11009184|FG001|NOT COMPLETED|Washout (4 Days)||0
9894090|NCT01100437|11009185|FG002|NOT COMPLETED|Washout (4 Days)||0
9894091|NCT01100437|11009183|FG000|STARTED|Treatment 2||4
9894092|NCT01100437|11009184|FG001|STARTED|Treatment 2||2
9894093|NCT01100437|11009185|FG002|STARTED|Treatment 2||0
9894094|NCT01100437|11009183|FG000|COMPLETED|Treatment 2||4
9894095|NCT01100437|11009184|FG001|COMPLETED|Treatment 2||2
9894096|NCT01100437|11009185|FG002|COMPLETED|Treatment 2||0
9894097|NCT01100437|11009183|FG000|NOT COMPLETED|Treatment 2||0
9894098|NCT01100437|11009184|FG001|NOT COMPLETED|Treatment 2||0
9894099|NCT01100437|11009185|FG002|NOT COMPLETED|Treatment 2||0
9894100|NCT01100502|11009196|FG000|STARTED|Overall Study||165
9894101|NCT01100502|11009197|FG001|STARTED|Overall Study||164
9894102|NCT01100502|11009196|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
9894103|NCT01100502|11009197|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
9894104|NCT01100502|11009196|FG000|NOT COMPLETED|Overall Study||76
9894105|NCT01100502|11009197|FG001|NOT COMPLETED|Overall Study||94
9894106|NCT01100528|11009203|FG000|STARTED|Overall Study||38
9894107|NCT01100528|11009203|FG000|COMPLETED|Overall Study||35
9894108|NCT01100528|11009203|FG000|NOT COMPLETED|Overall Study||3
9894109|NCT01100567|11009209|FG000|STARTED|Overall Study||50
9894110|NCT01100567|11009210|FG001|STARTED|Overall Study||51
9894111|NCT01100567|11009209|FG000|COMPLETED|Overall Study||38
9894112|NCT01100567|11009210|FG001|COMPLETED|Overall Study||35
9894113|NCT01100567|11009209|FG000|NOT COMPLETED|Overall Study||12
9894114|NCT01100567|11009210|FG001|NOT COMPLETED|Overall Study||16
9894115|NCT01100606|11009216|FG000|STARTED|First Treatment Period||8
9894116|NCT01100606|11009217|FG001|STARTED|First Treatment Period||7
9894117|NCT01100606|11009216|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
9894118|NCT01100606|11009217|FG001|COMPLETED|First Treatment Period||7
9894119|NCT01100606|11009216|FG000|NOT COMPLETED|First Treatment Period||0
9894120|NCT01100606|11009217|FG001|NOT COMPLETED|First Treatment Period||0
9894121|NCT01100606|11009216|FG000|STARTED|Second Treatment Period||8
9894122|NCT01100606|11009217|FG001|STARTED|Second Treatment Period||7
9894123|NCT01100606|11009216|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
9894124|NCT01100606|11009217|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
9894125|NCT01100606|11009216|FG000|NOT COMPLETED|Second Treatment Period||0
9894126|NCT01100606|11009217|FG001|NOT COMPLETED|Second Treatment Period||0
9894127|NCT01100723|11009227|FG000|STARTED|Overall Study||92
9894128|NCT01100723|11009227|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
9894129|NCT01100723|11009227|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
9894130|NCT01100723|11009227|FG000|NOT COMPLETED|Overall Study||14
9894131|NCT01100762|11009232|FG000|STARTED|Overall Study||10
9894132|NCT01100762|11009232|FG000|COMPLETED|Overall Study||10
9894133|NCT01100762|11009232|FG000|NOT COMPLETED|Overall Study||0
9894134|NCT01100853|11009240|FG000|STARTED|Overall Study||51
9894135|NCT01100853|11009241|FG001|STARTED|Overall Study||49
9894136|NCT01100853|11009240|FG000|COMPLETED|Overall Study||24
9894137|NCT01100853|11009241|FG001|COMPLETED|Overall Study||26
9894138|NCT01100853|11009240|FG000|NOT COMPLETED|Overall Study||27
9894139|NCT01100853|11009241|FG001|NOT COMPLETED|Overall Study||23
9894140|NCT01100931|11009249|FG000|STARTED|Phase I||22
9894141|NCT01100931|11009250|FG001|STARTED|Phase I||0
9894142|NCT01100931|11009249|FG000|COMPLETED|Phase I||22
9894143|NCT01100931|11009250|FG001|COMPLETED|Phase I||0
9894144|NCT01100931|11009249|FG000|NOT COMPLETED|Phase I||0
9894145|NCT01100931|11009250|FG001|NOT COMPLETED|Phase I||0
9894146|NCT01100931|11009249|FG000|STARTED|Phase II||0
9894147|NCT01100931|11009250|FG001|STARTED|Phase II||19
9894148|NCT01100931|11009249|FG000|COMPLETED|Phase II||0
9894149|NCT01100931|11009250|FG001|COMPLETED|Phase II||19
9894150|NCT01100931|11009249|FG000|NOT COMPLETED|Phase II||0
9894151|NCT01100931|11009250|FG001|NOT COMPLETED|Phase II||0
9894152|NCT01100944|11009257|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6
9894153|NCT01100944|11009258|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0
9894154|NCT01100944|11009259|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0
9894155|NCT01100944|11009257|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
9894156|NCT01100944|11009258|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
9894157|NCT01100944|11009259|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
9894158|NCT01100944|11009257|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
9894159|NCT01100944|11009258|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
9894160|NCT01100944|11009259|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
9894161|NCT01100944|11009257|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0
9894162|NCT01100944|11009258|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2
9894163|NCT01100944|11009259|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0
9894164|NCT01100944|11009257|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
9894165|NCT01100944|11009258|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
9894166|NCT01100944|11009259|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
9894167|NCT01100944|11009257|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
9894168|NCT01100944|11009258|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
9894169|NCT01100944|11009259|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
9894170|NCT01100944|11009257|FG000|STARTED|Expansion Phase - Phase 2||0
9894171|NCT01100944|11009258|FG001|STARTED|Expansion Phase - Phase 2||0
9894172|NCT01100944|11009259|FG002|STARTED|Expansion Phase - Phase 2||18
9894173|NCT01100944|11009257|FG000|COMPLETED|Expansion Phase - Phase 2||0
9894174|NCT01100944|11009258|FG001|COMPLETED|Expansion Phase - Phase 2||0
9894175|NCT01100944|11009259|FG002|COMPLETED|Expansion Phase - Phase 2||18
9894176|NCT01100944|11009257|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0
9894177|NCT01100944|11009258|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0
9894178|NCT01100944|11009259|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0
9894179|NCT01101022|11009282|FG000|STARTED|Overall Study||79
9894180|NCT01101022|11009283|FG001|STARTED|Overall Study||80
9894181|NCT01101022|11009282|FG000|COMPLETED|Overall Study||62
9894182|NCT01101022|11009283|FG001|COMPLETED|Overall Study||53
9894183|NCT01101022|11009282|FG000|NOT COMPLETED|Overall Study||17
9894184|NCT01101022|11009283|FG001|NOT COMPLETED|Overall Study||27
9894185|NCT01101035|11009291|FG000|STARTED|Overall Study||3101
9894186|NCT01101035|11009292|FG001|STARTED|Overall Study||3097
9894187|NCT01101035|11009291|FG000|COMPLETED|Overall Study||1704
9894188|NCT01101035|11009292|FG001|COMPLETED|Overall Study||1706
9894189|NCT01101035|11009291|FG000|NOT COMPLETED|Overall Study||1397
9894190|NCT01101035|11009292|FG001|NOT COMPLETED|Overall Study||1391
9894191|NCT01101061|11009304|FG000|STARTED|Overall Study||6
10008925|NCT01763333|11131404|FG012|NOT COMPLETED|Overall Study||0
10008926|NCT01763333|11131405|FG013|NOT COMPLETED|Overall Study||0
10008927|NCT01763346|11131441|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
10008928|NCT01763346|11131442|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
9894192|NCT01101061|11009305|FG001|STARTED|Overall Study||6
9894193|NCT01101061|11009306|FG002|STARTED|Overall Study||7
9894194|NCT01101061|11009307|FG003|STARTED|Overall Study||6
9894195|NCT01101061|11009308|FG004|STARTED|Overall Study||2
9894196|NCT01101061|11009309|FG005|STARTED|Overall Study||4
9894197|NCT01101061|11009304|FG000|Received Study Drug|Overall Study||6
9894198|NCT01101061|11009305|FG001|Received Study Drug|Overall Study||6
9894199|NCT01101061|11009306|FG002|Received Study Drug|Overall Study||6
9894200|NCT01101061|11009307|FG003|Received Study Drug|Overall Study||6
9894201|NCT01101061|11009308|FG004|Received Study Drug|Overall Study||2
9894202|NCT01101061|11009309|FG005|Received Study Drug|Overall Study||4
9894203|NCT01101061|11009304|FG000|COMPLETED|Overall Study||6
9894204|NCT01101061|11009305|FG001|COMPLETED|Overall Study||6
9894205|NCT01101061|11009306|FG002|COMPLETED|Overall Study||6
9894206|NCT01101061|11009307|FG003|COMPLETED|Overall Study||6
9894207|NCT01101061|11009308|FG004|COMPLETED|Overall Study||2
9894208|NCT01101061|11009309|FG005|COMPLETED|Overall Study||4
9894209|NCT01101061|11009304|FG000|NOT COMPLETED|Overall Study||0
9894210|NCT01101061|11009305|FG001|NOT COMPLETED|Overall Study||0
9894211|NCT01101061|11009306|FG002|NOT COMPLETED|Overall Study||1
9894212|NCT01101061|11009307|FG003|NOT COMPLETED|Overall Study||0
9894213|NCT01101061|11009308|FG004|NOT COMPLETED|Overall Study||0
9894214|NCT01101061|11009309|FG005|NOT COMPLETED|Overall Study||0
9894215|NCT01101100|11009327|FG000|STARTED|Overall Study||181
9894216|NCT01101100|11009327|FG000|COMPLETED|Overall Study||126
9894217|NCT01101100|11009327|FG000|NOT COMPLETED|Overall Study||55
9894218|NCT01101165|11009332|FG000|STARTED|Period 1||47
9894219|NCT01101165|11009333|FG001|STARTED|Period 1||45
9894220|NCT01101165|11009332|FG000|COMPLETED|Period 1||45
9894221|NCT01101165|11009333|FG001|COMPLETED|Period 1||40
9894222|NCT01101165|11009332|FG000|NOT COMPLETED|Period 1||2
9894223|NCT01101165|11009333|FG001|NOT COMPLETED|Period 1||5
9894224|NCT01101165|11009332|FG000|STARTED|Period 2||45
9894225|NCT01101165|11009333|FG001|STARTED|Period 2||40
9894226|NCT01101165|11009332|FG000|COMPLETED|Period 2||41
9894227|NCT01101165|11009333|FG001|COMPLETED|Period 2||39
9894228|NCT01101165|11009332|FG000|NOT COMPLETED|Period 2||4
9894229|NCT01101165|11009333|FG001|NOT COMPLETED|Period 2||1
9894230|NCT01101178|11009339|FG000|STARTED|Period 1||40
9894231|NCT01101178|11009340|FG001|STARTED|Period 1||39
9894232|NCT01101178|11009339|FG000|COMPLETED|Period 1||36
9894233|NCT01101178|11009340|FG001|COMPLETED|Period 1||35
9894234|NCT01101178|11009339|FG000|NOT COMPLETED|Period 1||4
9894235|NCT01101178|11009340|FG001|NOT COMPLETED|Period 1||4
9894236|NCT01101178|11009339|FG000|STARTED|Period 2||36
9894237|NCT01101178|11009340|FG001|STARTED|Period 2||35
9894238|NCT01101178|11009339|FG000|COMPLETED|Period 2||36
9894239|NCT01101178|11009340|FG001|COMPLETED|Period 2||34
9894240|NCT01101178|11009339|FG000|NOT COMPLETED|Period 2||0
9894241|NCT01101178|11009340|FG001|NOT COMPLETED|Period 2||1
9894242|NCT01101191|11009347|FG000|STARTED|Period 1||42
9894243|NCT01101191|11009348|FG001|STARTED|Period 1||42
9894244|NCT01101191|11009347|FG000|COMPLETED|Period 1||40
9894245|NCT01101191|11009348|FG001|COMPLETED|Period 1||40
9894246|NCT01101191|11009347|FG000|NOT COMPLETED|Period 1||2
9894247|NCT01101191|11009348|FG001|NOT COMPLETED|Period 1||2
9894248|NCT01101191|11009347|FG000|STARTED|Period 2||40
9894249|NCT01101191|11009348|FG001|STARTED|Period 2||40
9894250|NCT01101191|11009347|FG000|COMPLETED|Period 2||40
9894251|NCT01101191|11009348|FG001|COMPLETED|Period 2||40
9894252|NCT01101191|11009347|FG000|NOT COMPLETED|Period 2||0
9894253|NCT01101191|11009348|FG001|NOT COMPLETED|Period 2||0
9894254|NCT01101308|11009355|FG000|STARTED|Period 1||27
9894255|NCT01101308|11009356|FG001|STARTED|Period 1||28
9894256|NCT01101308|11009355|FG000|COMPLETED|Period 1||24
9894257|NCT01101308|11009356|FG001|COMPLETED|Period 1||27
9894258|NCT01101308|11009355|FG000|NOT COMPLETED|Period 1||3
9894259|NCT01101308|11009356|FG001|NOT COMPLETED|Period 1||1
9894260|NCT01101308|11009355|FG000|STARTED|Period 2||24
9894261|NCT01101308|11009356|FG001|STARTED|Period 2||27
9894262|NCT01101308|11009355|FG000|COMPLETED|Period 2||24
9894263|NCT01101308|11009356|FG001|COMPLETED|Period 2||27
9894264|NCT01101308|11009355|FG000|NOT COMPLETED|Period 2||0
9894265|NCT01101308|11009356|FG001|NOT COMPLETED|Period 2||0
9894266|NCT01101321|11009363|FG000|STARTED|Period 1||30
9894267|NCT01101321|11009364|FG001|STARTED|Period 1||28
9894268|NCT01101321|11009363|FG000|COMPLETED|Period 1||26
9894269|NCT01101321|11009364|FG001|COMPLETED|Period 1||24
9894270|NCT01101321|11009363|FG000|NOT COMPLETED|Period 1||4
9894271|NCT01101321|11009364|FG001|NOT COMPLETED|Period 1||4
10008929|NCT01763346|11131441|FG000|Received Intervention|Overall Study||39
9894272|NCT01101321|11009363|FG000|STARTED|Period 2||26
9894273|NCT01101321|11009364|FG001|STARTED|Period 2||24
9894274|NCT01101321|11009363|FG000|COMPLETED|Period 2||26
9894275|NCT01101321|11009364|FG001|COMPLETED|Period 2||24
9894276|NCT01101321|11009363|FG000|NOT COMPLETED|Period 2||0
9894277|NCT01101321|11009364|FG001|NOT COMPLETED|Period 2||0
9894278|NCT01101334|11009372|FG000|STARTED|Overall Study||45
9894279|NCT01101334|11009373|FG001|STARTED|Overall Study||45
9894280|NCT01101334|11009372|FG000|Received Study Treatment|Overall Study||44
9894281|NCT01101334|11009373|FG001|Received Study Treatment|Overall Study||45
9894282|NCT01101334|11009372|FG000|COMPLETED|Overall Study||0
9894283|NCT01101334|11009373|FG001|COMPLETED|Overall Study||0
9894284|NCT01101334|11009372|FG000|NOT COMPLETED|Overall Study||45
9894285|NCT01101334|11009373|FG001|NOT COMPLETED|Overall Study||45
9894286|NCT01101477|11009382|FG000|STARTED|Overall Study||49
9894287|NCT01101477|11009383|FG001|STARTED|Overall Study||49
9894288|NCT01101477|11009384|FG002|STARTED|Overall Study||46
9894289|NCT01101477|11009382|FG000|COMPLETED|Overall Study||44
9894290|NCT01101477|11009383|FG001|COMPLETED|Overall Study||46
9894291|NCT01101477|11009384|FG002|COMPLETED|Overall Study||45
9894292|NCT01101477|11009382|FG000|NOT COMPLETED|Overall Study||5
9894293|NCT01101477|11009383|FG001|NOT COMPLETED|Overall Study||3
9894294|NCT01101477|11009384|FG002|NOT COMPLETED|Overall Study||1
9894295|NCT01101542|11009392|FG000|STARTED|Year 3 Surveillance Period||105
9894296|NCT01101542|11009392|FG000|COMPLETED|Year 3 Surveillance Period||94
9894297|NCT01101542|11009392|FG000|NOT COMPLETED|Year 3 Surveillance Period||11
9894298|NCT01101542|11009392|FG000|STARTED|Year 4 Surveillance Period||569
9894299|NCT01101542|11009392|FG000|COMPLETED|Year 4 Surveillance Period||282
9894300|NCT01101542|11009392|FG000|NOT COMPLETED|Year 4 Surveillance Period||287
9894301|NCT01101542|11009392|FG000|STARTED|Year 5 Surveillance Period||809
9894302|NCT01101542|11009392|FG000|COMPLETED|Year 5 Surveillance Period||668
9894303|NCT01101542|11009392|FG000|NOT COMPLETED|Year 5 Surveillance Period||141
9894304|NCT01101542|11009392|FG000|STARTED|Year 6 Surveillance Period||3091
9894305|NCT01101542|11009392|FG000|COMPLETED|Year 6 Surveillance Period||2100
9894306|NCT01101542|11009392|FG000|NOT COMPLETED|Year 6 Surveillance Period||991
9894307|NCT01101750|11009396|FG000|STARTED|Overall Study||25
9894308|NCT01101750|11009396|FG000|COMPLETED|Overall Study||9
9894309|NCT01101750|11009396|FG000|NOT COMPLETED|Overall Study||16
9894310|NCT01101841|11009402|FG000|STARTED|Overall Study||285
9894311|NCT01101841|11009403|FG001|STARTED|Overall Study||285
9894312|NCT01101841|11009402|FG000|COMPLETED|Overall Study||235
9894313|NCT01101841|11009403|FG001|COMPLETED|Overall Study||218
9894314|NCT01101841|11009402|FG000|NOT COMPLETED|Overall Study||50
9894315|NCT01101841|11009403|FG001|NOT COMPLETED|Overall Study||67
9894316|NCT01101867|11009412|FG000|STARTED|Overall Study||63
9894317|NCT01101867|11009413|FG001|STARTED|Overall Study||63
9894318|NCT01101867|11009412|FG000|COMPLETED|Overall Study||62
9894319|NCT01101867|11009413|FG001|COMPLETED|Overall Study||59
9894320|NCT01101867|11009412|FG000|NOT COMPLETED|Overall Study||1
9760419|NCT00380744|10864046|FG002|COMPLETED|Overall Study||20
9760420|NCT00380744|10864047|FG003|COMPLETED|Overall Study||4
9760421|NCT00380744|10864048|FG004|COMPLETED|Overall Study||23
9760422|NCT00380744|10864049|FG005|COMPLETED|Overall Study||25
9760423|NCT00380744|10864050|FG006|COMPLETED|Overall Study||24
9760424|NCT00380744|10864044|FG000|NOT COMPLETED|Overall Study||1
9894321|NCT01101867|11009413|FG001|NOT COMPLETED|Overall Study||4
9894322|NCT01101880|11009423|FG000|STARTED|Overall Study||50
9894323|NCT01101880|11009423|FG000|COMPLETED|Overall Study||50
9894324|NCT01101880|11009423|FG000|NOT COMPLETED|Overall Study||0
9894325|NCT01101958|11009429|FG000|STARTED|Overall Study||62
9894326|NCT01101958|11009430|FG001|STARTED|Overall Study||34
9894327|NCT01101958|11009429|FG000|COMPLETED|Overall Study||51
9894328|NCT01101958|11009430|FG001|COMPLETED|Overall Study||29
9894329|NCT01101958|11009429|FG000|NOT COMPLETED|Overall Study||11
9894330|NCT01101958|11009430|FG001|NOT COMPLETED|Overall Study||5
9894331|NCT01101971|11009436|FG000|STARTED|Overall Study||45
9894332|NCT01101971|11009436|FG000|COMPLETED|Overall Study||45
9894333|NCT01101971|11009436|FG000|NOT COMPLETED|Overall Study||0
9954651|NCT01432756|11073455|FG002|NOT COMPLETED|Overall Study||2
9954652|NCT01432756|11073456|FG003|NOT COMPLETED|Overall Study||1
9954653|NCT01432886|11073466|FG000|STARTED|Overall Study||6
9954654|NCT01432886|11073467|FG001|STARTED|Overall Study||6
9954655|NCT01432886|11073466|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
9954656|NCT01432886|11073467|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
9954657|NCT01432886|11073466|FG000|NOT COMPLETED|Overall Study||0
9954658|NCT01432886|11073467|FG001|NOT COMPLETED|Overall Study||0
9954659|NCT01432938|11073474|FG000|STARTED|First Intervention||14
9954660|NCT01432938|11073475|FG001|STARTED|First Intervention||14
9954661|NCT01432938|11073474|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14
9954662|NCT01432938|11073475|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14
9954663|NCT01432938|11073474|FG000|COMPLETED|First Intervention||12
9954664|NCT01432938|11073475|FG001|COMPLETED|First Intervention||14
9954665|NCT01432938|11073474|FG000|NOT COMPLETED|First Intervention||2
9954666|NCT01432938|11073475|FG001|NOT COMPLETED|First Intervention||0
9954667|NCT01432938|11073474|FG000|STARTED|Washout Period of at Least 24 Days||12
9954668|NCT01432938|11073475|FG001|STARTED|Washout Period of at Least 24 Days||14
9954669|NCT01432938|11073474|FG000|COMPLETED|Washout Period of at Least 24 Days||12
9954670|NCT01432938|11073475|FG001|COMPLETED|Washout Period of at Least 24 Days||14
9954671|NCT01432938|11073474|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0
9954672|NCT01432938|11073475|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0
9954673|NCT01432938|11073474|FG000|STARTED|Second Intervention||12
9954674|NCT01432938|11073475|FG001|STARTED|Second Intervention||14
9954675|NCT01432938|11073474|FG000|COMPLETED|Second Intervention||11
9954676|NCT01432938|11073475|FG001|COMPLETED|Second Intervention||14
9954677|NCT01432938|11073474|FG000|NOT COMPLETED|Second Intervention||1
9954678|NCT01432938|11073475|FG001|NOT COMPLETED|Second Intervention||0
9954679|NCT01432951|11073482|FG000|STARTED|Treatment Phase (Day 1 to 30)||26
9954680|NCT01432951|11073482|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
9954681|NCT01432951|11073482|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
9954682|NCT01432951|11073482|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10
9954683|NCT01432951|11073482|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25
9954684|NCT01432951|11073482|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
9954685|NCT01432951|11073482|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
9954686|NCT01432951|11073482|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15
9954687|NCT01432951|11073482|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
9894334|NCT01101997|11009440|FG000|STARTED|Overall Study||60
9894335|NCT01101997|11009440|FG000|COMPLETED|Overall Study||58
9894336|NCT01101997|11009440|FG000|NOT COMPLETED|Overall Study||2
9894337|NCT01102218|11009448|FG000|STARTED|Overall Study||24
9894338|NCT01102218|11009449|FG001|STARTED|Overall Study||24
9894339|NCT01102218|11009448|FG000|COMPLETED|Overall Study||13
9894340|NCT01102218|11009449|FG001|COMPLETED|Overall Study||14
9894341|NCT01102218|11009448|FG000|NOT COMPLETED|Overall Study||11
9894342|NCT01102218|11009449|FG001|NOT COMPLETED|Overall Study||10
9894343|NCT01102231|11009455|FG000|STARTED|Overall Study||106
9894344|NCT01102231|11009455|FG000|COMPLETED|Overall Study||91
9894345|NCT01102231|11009455|FG000|NOT COMPLETED|Overall Study||15
9894346|NCT01102257|11009462|FG000|STARTED|Overall Study||9
9894347|NCT01102257|11009463|FG001|STARTED|Overall Study||9
9894348|NCT01102257|11009462|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
9894349|NCT01102257|11009463|FG001|COMPLETED|Overall Study||9
9894350|NCT01102257|11009462|FG000|NOT COMPLETED|Overall Study||2
9894351|NCT01102257|11009463|FG001|NOT COMPLETED|Overall Study||0
9894352|NCT01102270|11009469|FG000|STARTED|Overall Study||8
9894353|NCT01102270|11009470|FG001|STARTED|Overall Study||9
9894354|NCT01102270|11009469|FG000|COMPLETED|Overall Study||8
9894355|NCT01102270|11009470|FG001|COMPLETED|Overall Study||9
9894356|NCT01102270|11009469|FG000|NOT COMPLETED|Overall Study||0
9894357|NCT01102270|11009470|FG001|NOT COMPLETED|Overall Study||0
9894358|NCT01102374|11009478|FG000|STARTED|Overall Study||55
9894359|NCT01102374|11009479|FG001|STARTED|Overall Study||52
9894360|NCT01102374|11009478|FG000|COMPLETED|Overall Study||39
9894361|NCT01102374|11009479|FG001|COMPLETED|Overall Study||33
9894362|NCT01102374|11009478|FG000|NOT COMPLETED|Overall Study||16
9894363|NCT01102374|11009479|FG001|NOT COMPLETED|Overall Study||19
9894364|NCT01102413|11009487|FG000|STARTED|Overall Study||233
9894365|NCT01102413|11009488|FG001|STARTED|Overall Study||118
9894366|NCT01102413|11009487|FG000|COMPLETED|Overall Study||208
9894367|NCT01102413|11009488|FG001|COMPLETED|Overall Study||106
9894368|NCT01102413|11009487|FG000|NOT COMPLETED|Overall Study||25
9894369|NCT01102413|11009488|FG001|NOT COMPLETED|Overall Study||12
9894370|NCT01102426|11009496|FG000|STARTED|Overall Study||171
9894371|NCT01102426|11009497|FG001|STARTED|Overall Study||84
9894372|NCT01102426|11009496|FG000|COMPLETED|Overall Study||6
9894373|NCT01102426|11009497|FG001|COMPLETED|Overall Study||3
9894374|NCT01102426|11009496|FG000|NOT COMPLETED|Overall Study||165
9894375|NCT01102426|11009497|FG001|NOT COMPLETED|Overall Study||81
9894376|NCT01102491|11009505|FG000|STARTED|Overall Study||71
9894377|NCT01102491|11009506|FG001|STARTED|Overall Study||71
9894378|NCT01102491|11009505|FG000|COMPLETED|Overall Study|11 patient excluded|60
9894379|NCT01102491|11009506|FG001|COMPLETED|Overall Study|12 patients were excluded|59
9894380|NCT01102491|11009505|FG000|NOT COMPLETED|Overall Study||11
9894381|NCT01102491|11009506|FG001|NOT COMPLETED|Overall Study||12
9894382|NCT01102738|11009512|FG000|STARTED|Overall Study||369
9894383|NCT01102738|11009512|FG000|COMPLETED|Overall Study||369
9894384|NCT01102738|11009512|FG000|NOT COMPLETED|Overall Study||0
9894385|NCT01102764|11009518|FG000|STARTED|Overall Study||64
9894386|NCT01102764|11009519|FG001|STARTED|Overall Study||68
9894387|NCT01102764|11009518|FG000|COMPLETED|Overall Study||43
9894388|NCT01102764|11009519|FG001|COMPLETED|Overall Study||55
9894389|NCT01102764|11009518|FG000|NOT COMPLETED|Overall Study||21
9894390|NCT01102764|11009519|FG001|NOT COMPLETED|Overall Study||13
9894391|NCT01102777|11009527|FG000|STARTED|Overall Study||84
9894392|NCT01102777|11009528|FG001|STARTED|Overall Study||155
9894393|NCT01102777|11009527|FG000|COMPLETED|Overall Study||75
9894394|NCT01102777|11009528|FG001|COMPLETED|Overall Study||139
9894395|NCT01102777|11009527|FG000|NOT COMPLETED|Overall Study||9
9894396|NCT01102777|11009528|FG001|NOT COMPLETED|Overall Study||16
9894397|NCT01102803|11009537|FG000|STARTED|Baseline to Post-Treatment||14
9894398|NCT01102803|11009538|FG001|STARTED|Baseline to Post-Treatment||15
9894399|NCT01102803|11009537|FG000|COMPLETED|Baseline to Post-Treatment||11
9894400|NCT01102803|11009538|FG001|COMPLETED|Baseline to Post-Treatment||15
9894401|NCT01102803|11009537|FG000|NOT COMPLETED|Baseline to Post-Treatment||3
9894402|NCT01102803|11009538|FG001|NOT COMPLETED|Baseline to Post-Treatment||0
9894403|NCT01102803|11009537|FG000|STARTED|Post to Follow-Up||11
9894404|NCT01102803|11009538|FG001|STARTED|Post to Follow-Up||15
9894405|NCT01102803|11009537|FG000|COMPLETED|Post to Follow-Up||10
9894406|NCT01102803|11009538|FG001|COMPLETED|Post to Follow-Up||12
9894407|NCT01102803|11009537|FG000|NOT COMPLETED|Post to Follow-Up||1
9894408|NCT01102803|11009538|FG001|NOT COMPLETED|Post to Follow-Up||3
9894409|NCT01102894|11009546|FG000|STARTED|Overall Study||10
9894410|NCT01102894|11009546|FG000|COMPLETED|Overall Study||10
9894411|NCT01102894|11009546|FG000|NOT COMPLETED|Overall Study||0
9894412|NCT01102972|11009554|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
9894413|NCT01102972|11009555|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
9894414|NCT01102972|11009554|FG000|Completed Week 24|Overall Study||180
9894415|NCT01102972|11009555|FG001|Completed Week 24|Overall Study||88
9894416|NCT01102972|11009554|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170
9894417|NCT01102972|11009555|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83
9894418|NCT01102972|11009554|FG000|NOT COMPLETED|Overall Study||29
9894419|NCT01102972|11009555|FG001|NOT COMPLETED|Overall Study||14
9894420|NCT01103063|11009563|FG000|STARTED|Overall Study||1446
9894421|NCT01103063|11009564|FG001|STARTED|Overall Study||1445
9894422|NCT01103063|11009563|FG000|COMPLETED|Overall Study||969
9894423|NCT01103063|11009564|FG001|COMPLETED|Overall Study||1024
9894424|NCT01103063|11009563|FG000|NOT COMPLETED|Overall Study||477
9894425|NCT01103063|11009564|FG001|NOT COMPLETED|Overall Study||421
9894426|NCT01103141|11009574|FG000|STARTED|Overall Study||67
9894427|NCT01103141|11009575|FG001|STARTED|Overall Study||76
9894428|NCT01103141|11009574|FG000|COMPLETED|Overall Study||65
9894429|NCT01103141|11009575|FG001|COMPLETED|Overall Study||74
9894430|NCT01103141|11009574|FG000|NOT COMPLETED|Overall Study||2
9894431|NCT01103141|11009575|FG001|NOT COMPLETED|Overall Study||2
9894432|NCT01103232|11009583|FG000|STARTED|Overall Study||13
9894433|NCT01103232|11009584|FG001|STARTED|Overall Study||13
9894434|NCT01103232|11009583|FG000|COMPLETED|Overall Study||12
9894435|NCT01103232|11009584|FG001|COMPLETED|Overall Study||11
9894436|NCT01103232|11009583|FG000|NOT COMPLETED|Overall Study||1
9894437|NCT01103232|11009584|FG001|NOT COMPLETED|Overall Study||2
9894438|NCT01103245|11009594|FG000|STARTED|Overall Study||13
9894439|NCT01103245|11009595|FG001|STARTED|Overall Study||7
9894440|NCT01103245|11009596|FG002|STARTED|Overall Study||12
9894441|NCT01103245|11009597|FG003|STARTED|Overall Study||6
9894442|NCT01103245|11009594|FG000|COMPLETED|Overall Study||10
9894443|NCT01103245|11009595|FG001|COMPLETED|Overall Study||5
9894444|NCT01103245|11009596|FG002|COMPLETED|Overall Study||8
9894445|NCT01103245|11009597|FG003|COMPLETED|Overall Study||6
9894446|NCT01103245|11009594|FG000|NOT COMPLETED|Overall Study||3
9894447|NCT01103245|11009595|FG001|NOT COMPLETED|Overall Study||2
9894448|NCT01103245|11009596|FG002|NOT COMPLETED|Overall Study||4
9894449|NCT01103245|11009597|FG003|NOT COMPLETED|Overall Study||0
9894450|NCT01103271|11009609|FG000|STARTED|Overall Study||11
9894451|NCT01103271|11009610|FG001|STARTED|Overall Study||9
9894452|NCT01103271|11009609|FG000|COMPLETED|Overall Study||10
9894453|NCT01103271|11009610|FG001|COMPLETED|Overall Study||5
9894454|NCT01103271|11009609|FG000|NOT COMPLETED|Overall Study||1
9894455|NCT01103271|11009610|FG001|NOT COMPLETED|Overall Study||4
9894456|NCT01103284|11009619|FG000|STARTED|Overall Study||236
9894457|NCT01103284|11009620|FG001|STARTED|Overall Study||239
9894458|NCT01103284|11009619|FG000|Treated|Overall Study||236
9894459|NCT01103284|11009620|FG001|Treated|Overall Study||238
9894460|NCT01103284|11009619|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
9894461|NCT01103284|11009620|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
9894462|NCT01103284|11009619|FG000|COMPLETED|Overall Study||194
9894463|NCT01103284|11009620|FG001|COMPLETED|Overall Study||195
9894464|NCT01103284|11009619|FG000|NOT COMPLETED|Overall Study||42
9894465|NCT01103284|11009620|FG001|NOT COMPLETED|Overall Study||44
9894466|NCT01103323|11009628|FG000|STARTED|Without/Before Drug Switch||505
9894467|NCT01103323|11009629|FG001|STARTED|Without/Before Drug Switch||255
9894468|NCT01103323|11009628|FG000|Participants Received Treatment|Without/Before Drug Switch||500
9894469|NCT01103323|11009629|FG001|Participants Received Treatment|Without/Before Drug Switch||253
9894470|NCT01103323|11009628|FG000|COMPLETED|Without/Before Drug Switch||429
9894471|NCT01103323|11009629|FG001|COMPLETED|Without/Before Drug Switch||237
9894472|NCT01103323|11009628|FG000|NOT COMPLETED|Without/Before Drug Switch||76
9894473|NCT01103323|11009629|FG001|NOT COMPLETED|Without/Before Drug Switch||18
9894474|NCT01103323|11009628|FG000|STARTED|Switched From Placebo to Regorafenib||0
9894475|NCT01103323|11009629|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
9894476|NCT01103323|11009628|FG000|COMPLETED|Switched From Placebo to Regorafenib||0
9894477|NCT01103323|11009629|FG001|COMPLETED|Switched From Placebo to Regorafenib||3
9894478|NCT01103323|11009628|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0
9894479|NCT01103323|11009629|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1
9894480|NCT01103362|11009636|FG000|STARTED|Overall Study||596
9894481|NCT01103362|11009636|FG000|COMPLETED|Overall Study||0
9894482|NCT01103362|11009636|FG000|NOT COMPLETED|Overall Study||596
9894483|NCT01103414|11009645|FG000|STARTED|Overall Study||72
9894484|NCT01103414|11009646|FG001|STARTED|Overall Study||71
9894485|NCT01103414|11009647|FG002|STARTED|Overall Study||71
9894486|NCT01103414|11009648|FG003|STARTED|Overall Study||71
9894487|NCT01103414|11009649|FG004|STARTED|Overall Study||71
9894488|NCT01103414|11009645|FG000|COMPLETED|Overall Study||59
9894489|NCT01103414|11009646|FG001|COMPLETED|Overall Study||62
9894490|NCT01103414|11009647|FG002|COMPLETED|Overall Study||56
9894491|NCT01103414|11009648|FG003|COMPLETED|Overall Study||64
9894492|NCT01103414|11009649|FG004|COMPLETED|Overall Study||56
9894493|NCT01103414|11009645|FG000|NOT COMPLETED|Overall Study||13
9894494|NCT01103414|11009646|FG001|NOT COMPLETED|Overall Study||9
9894495|NCT01103414|11009647|FG002|NOT COMPLETED|Overall Study||15
9894496|NCT01103414|11009648|FG003|NOT COMPLETED|Overall Study||7
9894497|NCT01103414|11009649|FG004|NOT COMPLETED|Overall Study||15
9894498|NCT01103440|11009663|FG000|STARTED|Overall Study||18
9894499|NCT01103440|11009664|FG001|STARTED|Overall Study||18
9894500|NCT01103440|11009663|FG000|COMPLETED|Overall Study||18
9894501|NCT01103440|11009664|FG001|COMPLETED|Overall Study||18
9894502|NCT01103440|11009663|FG000|NOT COMPLETED|Overall Study||0
9894503|NCT01103440|11009664|FG001|NOT COMPLETED|Overall Study||0
9894504|NCT01103466|11009670|FG000|STARTED|First Period (14 +/- 3 Days)||12
9894505|NCT01103466|11009671|FG001|STARTED|First Period (14 +/- 3 Days)||12
9894506|NCT01103466|11009672|FG002|STARTED|First Period (14 +/- 3 Days)||13
9894507|NCT01103466|11009670|FG000|COMPLETED|First Period (14 +/- 3 Days)||10
9894508|NCT01103466|11009671|FG001|COMPLETED|First Period (14 +/- 3 Days)||12
9894509|NCT01103466|11009672|FG002|COMPLETED|First Period (14 +/- 3 Days)||13
9894510|NCT01103466|11009670|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2
9894511|NCT01103466|11009671|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0
9894512|NCT01103466|11009672|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0
9894513|NCT01103466|11009670|FG000|STARTED|Second Period (14 +/- 3 Days)||15
9894514|NCT01103466|11009671|FG001|STARTED|Second Period (14 +/- 3 Days)||13
9894515|NCT01103466|11009672|FG002|STARTED|Second Period (14 +/- 3 Days)||7
9894516|NCT01103466|11009670|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13
9894517|NCT01103466|11009671|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11
9894518|NCT01103466|11009672|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6
9894519|NCT01103466|11009670|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
9894520|NCT01103466|11009671|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
9894521|NCT01103466|11009672|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
9894522|NCT01103466|11009670|FG000|STARTED|Third Period (14 +/- 3 Days)||8
9894523|NCT01103466|11009671|FG001|STARTED|Third Period (14 +/- 3 Days)||8
9894524|NCT01103466|11009672|FG002|STARTED|Third Period (14 +/- 3 Days)||14
9894525|NCT01103466|11009670|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6
9894526|NCT01103466|11009671|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8
9894527|NCT01103466|11009672|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13
9894528|NCT01103466|11009670|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
9894529|NCT01103466|11009671|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
9894530|NCT01103466|11009672|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
9894531|NCT01103479|11009683|FG000|STARTED|Overall Study||168
9894532|NCT01103479|11009684|FG001|STARTED|Overall Study||210
9894533|NCT01103479|11009685|FG002|STARTED|Overall Study||188
9894534|NCT01103479|11009683|FG000|COMPLETED|Overall Study||163
9894535|NCT01103479|11009684|FG001|COMPLETED|Overall Study||201
9894536|NCT01103479|11009685|FG002|COMPLETED|Overall Study||174
9894537|NCT01103479|11009683|FG000|NOT COMPLETED|Overall Study||5
9894538|NCT01103479|11009684|FG001|NOT COMPLETED|Overall Study||9
9894539|NCT01103479|11009685|FG002|NOT COMPLETED|Overall Study||14
9894540|NCT01103492|11009694|FG000|STARTED|Overall Study||1
9894541|NCT01103492|11009694|FG000|COMPLETED|Overall Study||1
9894542|NCT01103492|11009694|FG000|NOT COMPLETED|Overall Study||0
9894543|NCT01103505|11009700|FG000|STARTED|Overall Study||763
9894544|NCT01103505|11009701|FG001|STARTED|Overall Study||757
9894545|NCT01103505|11009700|FG000|COMPLETED|Overall Study||739
9894546|NCT01103505|11009701|FG001|COMPLETED|Overall Study||737
9894547|NCT01103505|11009700|FG000|NOT COMPLETED|Overall Study||24
9894548|NCT01103505|11009701|FG001|NOT COMPLETED|Overall Study||20
9894549|NCT01103713|11009715|FG000|STARTED|Overall Study||168
9894550|NCT01103713|11009715|FG000|COMPLETED|Overall Study||155
9894551|NCT01103713|11009715|FG000|NOT COMPLETED|Overall Study||13
9894552|NCT01103778|11009722|FG000|STARTED|Overall Study||11
9894553|NCT01103778|11009722|FG000|COMPLETED|Overall Study||8
9894554|NCT01103778|11009722|FG000|NOT COMPLETED|Overall Study||3
9894555|NCT01103934|11009730|FG000|STARTED|Overall Study||17
9894556|NCT01103934|11009731|FG001|STARTED|Overall Study||18
9894557|NCT01103934|11009730|FG000|COMPLETED|Overall Study||17
9894558|NCT01103934|11009731|FG001|COMPLETED|Overall Study||18
9894559|NCT01103934|11009730|FG000|NOT COMPLETED|Overall Study||0
9894560|NCT01103934|11009731|FG001|NOT COMPLETED|Overall Study||0
9894561|NCT01103960|11009739|FG000|STARTED|Overall Study|Randomised and treated.|164
9894562|NCT01103960|11009740|FG001|STARTED|Overall Study|Randomised and treated.|160
9894563|NCT01103960|11009739|FG000|COMPLETED|Overall Study|Completed study medication.|159
9894564|NCT01103960|11009740|FG001|COMPLETED|Overall Study|Completed study medication.|158
9894565|NCT01103960|11009739|FG000|NOT COMPLETED|Overall Study||5
9894566|NCT01103960|11009740|FG001|NOT COMPLETED|Overall Study||2
9894567|NCT01103973|11009748|FG000|STARTED|Overall Study||51
9894568|NCT01103973|11009749|FG001|STARTED|Overall Study||46
9894569|NCT01103973|11009748|FG000|COMPLETED|Overall Study||51
9894570|NCT01103973|11009749|FG001|COMPLETED|Overall Study||46
9894571|NCT01103973|11009748|FG000|NOT COMPLETED|Overall Study||0
9894572|NCT01103973|11009749|FG001|NOT COMPLETED|Overall Study||0
9894573|NCT01104025|11009755|FG000|STARTED|Treatment Period||31
9894574|NCT01104025|11009755|FG000|COMPLETED|Treatment Period||25
9894575|NCT01104025|11009755|FG000|NOT COMPLETED|Treatment Period||6
9894576|NCT01104025|11009755|FG000|STARTED|Follow up Until BMT OR 6 Months||25
9894577|NCT01104025|11009755|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22
9894578|NCT01104025|11009755|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
9894579|NCT01104025|11009755|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
9894580|NCT01104025|11009755|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9
9894581|NCT01104025|11009755|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
9894582|NCT01104090|11009761|FG000|STARTED|Overall Study||25
9894583|NCT01104090|11009762|FG001|STARTED|Overall Study||25
9894584|NCT01104090|11009761|FG000|COMPLETED|Overall Study||25
9894585|NCT01104090|11009762|FG001|COMPLETED|Overall Study||25
9894586|NCT01104090|11009761|FG000|NOT COMPLETED|Overall Study||0
9894587|NCT01104090|11009762|FG001|NOT COMPLETED|Overall Study||0
9894588|NCT01104103|11009772|FG000|STARTED|Overall Study||243
9894589|NCT01104103|11009773|FG001|STARTED|Overall Study||224
9894590|NCT01104103|11009772|FG000|COMPLETED|Overall Study||243
9894591|NCT01104103|11009773|FG001|COMPLETED|Overall Study||224
9894592|NCT01104103|11009772|FG000|NOT COMPLETED|Overall Study||0
9894593|NCT01104103|11009773|FG001|NOT COMPLETED|Overall Study||0
9894594|NCT01104155|11009781|FG000|STARTED|Overall Study||63
9894595|NCT01104155|11009782|FG001|STARTED|Overall Study||60
9894596|NCT01104155|11009781|FG000|COMPLETED|Overall Study||38
9894597|NCT01104155|11009782|FG001|COMPLETED|Overall Study||42
9894598|NCT01104155|11009781|FG000|NOT COMPLETED|Overall Study||25
9894599|NCT01104155|11009782|FG001|NOT COMPLETED|Overall Study||18
9894600|NCT01104207|11009790|FG000|STARTED|Overall Study||35
9894601|NCT01104207|11009791|FG001|STARTED|Overall Study||35
9894602|NCT01104207|11009790|FG000|COMPLETED|Overall Study||32
9894603|NCT01104207|11009791|FG001|COMPLETED|Overall Study||32
9894604|NCT01104207|11009790|FG000|NOT COMPLETED|Overall Study||3
9894605|NCT01104207|11009791|FG001|NOT COMPLETED|Overall Study||3
9894606|NCT01104246|11009797|FG000|STARTED|Overall Study||40
9894607|NCT01104246|11009797|FG000|Baseline Characteristics Measured|Overall Study||35
9894608|NCT01104246|11009797|FG000|COMPLETED|Overall Study||35
9894609|NCT01104246|11009797|FG000|NOT COMPLETED|Overall Study||5
9894610|NCT01104285|11009803|FG000|STARTED|Overall Study||112
9894611|NCT01104285|11009804|FG001|STARTED|Overall Study||86
9894612|NCT01104285|11009803|FG000|COMPLETED|Overall Study||112
9894613|NCT01104285|11009804|FG001|COMPLETED|Overall Study||86
9894614|NCT01104285|11009803|FG000|NOT COMPLETED|Overall Study||0
9894615|NCT01104285|11009804|FG001|NOT COMPLETED|Overall Study||0
9894616|NCT01104311|11009812|FG000|STARTED|Overall Study||66
9894617|NCT01104311|11009813|FG001|STARTED|Overall Study||66
9894618|NCT01104311|11009812|FG000|COMPLETED|Overall Study||56
9894619|NCT01104311|11009813|FG001|COMPLETED|Overall Study||54
9894620|NCT01104311|11009812|FG000|NOT COMPLETED|Overall Study||10
9894621|NCT01104311|11009813|FG001|NOT COMPLETED|Overall Study||12
9894622|NCT01104376|11009823|FG000|STARTED|Overall Study||89
9894623|NCT01104376|11009823|FG000|COMPLETED|Overall Study||61
9894624|NCT01104376|11009823|FG000|NOT COMPLETED|Overall Study||28
9894625|NCT01104402|11009829|FG000|STARTED|Overall Study||132
9894626|NCT01104402|11009830|FG001|STARTED|Overall Study||135
9894627|NCT01104402|11009829|FG000|COMPLETED|Overall Study||111
9894628|NCT01104402|11009830|FG001|COMPLETED|Overall Study||102
9894629|NCT01104402|11009829|FG000|NOT COMPLETED|Overall Study||21
9894630|NCT01104402|11009830|FG001|NOT COMPLETED|Overall Study||33
9894631|NCT01104415|11009836|FG000|STARTED|Core Phase||15
9894632|NCT01104415|11009837|FG001|STARTED|Core Phase||0
9894633|NCT01104415|11009836|FG000|COMPLETED|Core Phase||14
9894634|NCT01104415|11009837|FG001|COMPLETED|Core Phase||0
9894635|NCT01104415|11009836|FG000|NOT COMPLETED|Core Phase||1
9894636|NCT01104415|11009837|FG001|NOT COMPLETED|Core Phase||0
9894637|NCT01104415|11009836|FG000|STARTED|Extension Period||0
9894638|NCT01104415|11009837|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
9894639|NCT01104415|11009836|FG000|COMPLETED|Extension Period||0
9894640|NCT01104415|11009837|FG001|COMPLETED|Extension Period||0
9894641|NCT01104415|11009836|FG000|NOT COMPLETED|Extension Period||0
9894642|NCT01104415|11009837|FG001|NOT COMPLETED|Extension Period||11
9894643|NCT01104493|11009846|FG000|STARTED|Overall Study||240
9894644|NCT01104493|11009847|FG001|STARTED|Overall Study||60
9894645|NCT01104493|11009846|FG000|COMPLETED|Overall Study||240
9894646|NCT01104493|11009847|FG001|COMPLETED|Overall Study||58
9894647|NCT01104493|11009846|FG000|NOT COMPLETED|Overall Study||0
9894648|NCT01104493|11009847|FG001|NOT COMPLETED|Overall Study||2
9894649|NCT01104545|11009856|FG000|STARTED|Overall Study||8
9894650|NCT01104545|11009857|FG001|STARTED|Overall Study||8
9894651|NCT01104545|11009858|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
9894652|NCT01104545|11009856|FG000|COMPLETED|Overall Study||8
9894653|NCT01104545|11009857|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
9894654|NCT01104545|11009858|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
9894655|NCT01104545|11009856|FG000|NOT COMPLETED|Overall Study||0
9894656|NCT01104545|11009857|FG001|NOT COMPLETED|Overall Study||1
9894657|NCT01104545|11009858|FG002|NOT COMPLETED|Overall Study||2
9894658|NCT01104558|11009903|FG000|STARTED|Overall Study||100
9894659|NCT01104558|11009903|FG000|COMPLETED|Overall Study||83
9894660|NCT01104558|11009903|FG000|NOT COMPLETED|Overall Study||17
9894661|NCT01104584|11009907|FG000|STARTED|Overall Study|screened and enrolled|460
9894662|NCT01104584|11009907|FG000|Received Treatment|Overall Study|treatment started|439
9894663|NCT01104584|11009907|FG000|Fulfilled Requirements of FAS Population|Overall Study||397
9894664|NCT01104584|11009907|FG000|COMPLETED|Overall Study|study course completed|437
9894665|NCT01104584|11009907|FG000|NOT COMPLETED|Overall Study||23
9894666|NCT01104636|11009929|FG000|STARTED|Overall Study||1177
9894667|NCT01104636|11009929|FG000|COMPLETED|Overall Study||999
9894668|NCT01104636|11009929|FG000|NOT COMPLETED|Overall Study||178
9894669|NCT01104662|11009941|FG000|STARTED|Overall Study||20
9894670|NCT01104662|11009942|FG001|STARTED|Overall Study||21
9894671|NCT01104662|11009943|FG002|STARTED|Overall Study||5
9894672|NCT01104662|11009944|FG003|STARTED|Overall Study||4
9894673|NCT01104662|11009945|FG004|STARTED|Overall Study||15
9894674|NCT01104662|11009946|FG005|STARTED|Overall Study||16
9894675|NCT01104662|11009947|FG006|STARTED|Overall Study||5
9894676|NCT01104662|11009948|FG007|STARTED|Overall Study||6
9894677|NCT01104662|11009941|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17
9894678|NCT01104662|11009942|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
9894679|NCT01104662|11009943|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
9894680|NCT01104662|11009944|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
9894681|NCT01104662|11009945|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15
9894682|NCT01104662|11009946|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15
9894683|NCT01104662|11009947|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
9894684|NCT01104662|11009948|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
9894685|NCT01104662|11009941|FG000|COMPLETED|Overall Study||10
9894686|NCT01104662|11009942|FG001|COMPLETED|Overall Study||11
9894687|NCT01104662|11009943|FG002|COMPLETED|Overall Study||4
9894688|NCT01104662|11009944|FG003|COMPLETED|Overall Study||3
9894689|NCT01104662|11009945|FG004|COMPLETED|Overall Study||14
9894690|NCT01104662|11009946|FG005|COMPLETED|Overall Study||12
9894691|NCT01104662|11009947|FG006|COMPLETED|Overall Study||5
9894692|NCT01104662|11009948|FG007|COMPLETED|Overall Study||6
9894693|NCT01104662|11009941|FG000|NOT COMPLETED|Overall Study||10
9894694|NCT01104662|11009942|FG001|NOT COMPLETED|Overall Study||10
9894695|NCT01104662|11009943|FG002|NOT COMPLETED|Overall Study||1
9894696|NCT01104662|11009944|FG003|NOT COMPLETED|Overall Study||1
9894697|NCT01104662|11009945|FG004|NOT COMPLETED|Overall Study||1
9894698|NCT01104662|11009946|FG005|NOT COMPLETED|Overall Study||4
9894699|NCT01104662|11009947|FG006|NOT COMPLETED|Overall Study||0
9894700|NCT01104662|11009948|FG007|NOT COMPLETED|Overall Study||0
9894701|NCT01104701|11009971|FG000|STARTED|Overall Study||30
9894702|NCT01104701|11009972|FG001|STARTED|Overall Study||30
9894703|NCT01104701|11009973|FG002|STARTED|Overall Study||31
9894704|NCT01104701|11009974|FG003|STARTED|Overall Study||30
9894705|NCT01104701|11009971|FG000|COMPLETED|Overall Study||30
9894706|NCT01104701|11009972|FG001|COMPLETED|Overall Study||27
9894707|NCT01104701|11009973|FG002|COMPLETED|Overall Study||29
9894708|NCT01104701|11009974|FG003|COMPLETED|Overall Study||28
9894709|NCT01104701|11009971|FG000|NOT COMPLETED|Overall Study||0
9894710|NCT01104701|11009972|FG001|NOT COMPLETED|Overall Study||3
9894711|NCT01104701|11009973|FG002|NOT COMPLETED|Overall Study||2
9894712|NCT01104701|11009974|FG003|NOT COMPLETED|Overall Study||2
9894713|NCT01104766|11009988|FG000|STARTED|Overall Study||153
9894714|NCT01104766|11009989|FG001|STARTED|Overall Study||155
9894715|NCT01104766|11009990|FG002|STARTED|Overall Study||157
9894716|NCT01104766|11009991|FG003|STARTED|Overall Study||152
9894717|NCT01104766|11009988|FG000|COMPLETED|Overall Study||95
9894718|NCT01104766|11009989|FG001|COMPLETED|Overall Study||104
9894719|NCT01104766|11009990|FG002|COMPLETED|Overall Study||97
9894720|NCT01104766|11009991|FG003|COMPLETED|Overall Study||114
9894721|NCT01104766|11009988|FG000|NOT COMPLETED|Overall Study||58
9894722|NCT01104766|11009989|FG001|NOT COMPLETED|Overall Study||51
9894723|NCT01104766|11009990|FG002|NOT COMPLETED|Overall Study||60
9894724|NCT01104766|11009991|FG003|NOT COMPLETED|Overall Study||38
9894725|NCT01104779|11010004|FG000|STARTED|Overall Study||147
9894726|NCT01104779|11010005|FG001|STARTED|Overall Study||151
9894727|NCT01104779|11010006|FG002|STARTED|Overall Study||148
9894728|NCT01104779|11010004|FG000|COMPLETED|Overall Study||88
9894729|NCT01104779|11010005|FG001|COMPLETED|Overall Study||96
9894730|NCT01104779|11010006|FG002|COMPLETED|Overall Study||86
9894731|NCT01104779|11010004|FG000|NOT COMPLETED|Overall Study||59
9894732|NCT01104779|11010005|FG001|NOT COMPLETED|Overall Study||55
9894733|NCT01104779|11010006|FG002|NOT COMPLETED|Overall Study||62
9894734|NCT01104792|11010014|FG000|STARTED|Overall Study||752
9894735|NCT01104792|11010014|FG000|COMPLETED|Overall Study||226
9894736|NCT01104792|11010014|FG000|NOT COMPLETED|Overall Study||526
9894737|NCT01104870|11010021|FG000|STARTED|Overall Study||11
9894738|NCT01104870|11010022|FG001|STARTED|Overall Study||19
9894739|NCT01104870|11010023|FG002|STARTED|Overall Study||20
9894740|NCT01104870|11010021|FG000|COMPLETED|Overall Study||10
9894741|NCT01104870|11010022|FG001|COMPLETED|Overall Study||18
9894742|NCT01104870|11010023|FG002|COMPLETED|Overall Study||18
9894743|NCT01104870|11010021|FG000|NOT COMPLETED|Overall Study||1
9894744|NCT01104870|11010022|FG001|NOT COMPLETED|Overall Study||1
9894745|NCT01104870|11010023|FG002|NOT COMPLETED|Overall Study||2
9894746|NCT01105065|11010031|FG000|STARTED|Overall Study||23
9894747|NCT01105065|11010031|FG000|COMPLETED|Overall Study||17
9894748|NCT01105065|11010031|FG000|NOT COMPLETED|Overall Study||6
9894749|NCT01105091|11010039|FG000|STARTED|Overall Study||20
9894750|NCT01105091|11010040|FG001|STARTED|Overall Study||10
9894751|NCT01105091|11010039|FG000|COMPLETED|Overall Study||18
9894752|NCT01105091|11010040|FG001|COMPLETED|Overall Study||10
9894753|NCT01105091|11010039|FG000|NOT COMPLETED|Overall Study||2
9894754|NCT01105091|11010040|FG001|NOT COMPLETED|Overall Study||0
9894755|NCT01105117|11010050|FG000|STARTED|Overall Study||1
9894756|NCT01105117|11010051|FG001|STARTED|Overall Study||1
9894757|NCT01105117|11010050|FG000|COMPLETED|Overall Study||1
9894758|NCT01105117|11010051|FG001|COMPLETED|Overall Study||1
9894759|NCT01105117|11010050|FG000|NOT COMPLETED|Overall Study||0
9894760|NCT01105117|11010051|FG001|NOT COMPLETED|Overall Study||0
9894761|NCT01105130|11010060|FG000|STARTED|Overall Study||48
9894762|NCT01105130|11010061|FG001|STARTED|Overall Study||45
9894763|NCT01105130|11010062|FG002|STARTED|Overall Study||47
9894764|NCT01105130|11010060|FG000|COMPLETED|Overall Study||38
9894765|NCT01105130|11010061|FG001|COMPLETED|Overall Study||34
9894766|NCT01105130|11010062|FG002|COMPLETED|Overall Study||37
9894767|NCT01105130|11010060|FG000|NOT COMPLETED|Overall Study||10
9894768|NCT01105130|11010061|FG001|NOT COMPLETED|Overall Study||11
9894769|NCT01105130|11010062|FG002|NOT COMPLETED|Overall Study||10
9894770|NCT01105247|11010072|FG000|STARTED|Overall Study||116
9894771|NCT01105247|11010073|FG001|STARTED|Overall Study||16
9894772|NCT01105247|11010072|FG000|COMPLETED|Overall Study||79
9894773|NCT01105247|11010073|FG001|COMPLETED|Overall Study||16
9894774|NCT01105247|11010072|FG000|NOT COMPLETED|Overall Study||37
9894775|NCT01105247|11010073|FG001|NOT COMPLETED|Overall Study||0
9894776|NCT01105312|11010087|FG000|STARTED|Overall Study||16
9894777|NCT01105312|11010088|FG001|STARTED|Overall Study||6
9894778|NCT01105312|11010089|FG002|STARTED|Overall Study||6
9894779|NCT01105312|11010087|FG000|COMPLETED|Overall Study||13
9894780|NCT01105312|11010088|FG001|COMPLETED|Overall Study||6
9894781|NCT01105312|11010089|FG002|COMPLETED|Overall Study||6
9894782|NCT01105312|11010087|FG000|NOT COMPLETED|Overall Study||3
9894783|NCT01105312|11010088|FG001|NOT COMPLETED|Overall Study||0
9894784|NCT01105312|11010089|FG002|NOT COMPLETED|Overall Study||0
9894785|NCT01105377|11010099|FG000|STARTED|Overall Study||24
9894786|NCT01105377|11010100|FG001|STARTED|Overall Study||23
9894787|NCT01105377|11010099|FG000|COMPLETED|Overall Study||24
9894788|NCT01105377|11010100|FG001|COMPLETED|Overall Study||22
9894789|NCT01105377|11010099|FG000|NOT COMPLETED|Overall Study||0
9894790|NCT01105377|11010100|FG001|NOT COMPLETED|Overall Study||1
9894791|NCT01105533|11010106|FG000|STARTED|Overall Study||1
9894792|NCT01105533|11010107|FG001|STARTED|Overall Study||1
9894793|NCT01105533|11010108|FG002|STARTED|Overall Study||3
9894794|NCT01105533|11010109|FG003|STARTED|Overall Study||3
9894795|NCT01105533|11010110|FG004|STARTED|Overall Study||7
9894796|NCT01105533|11010111|FG005|STARTED|Overall Study||7
9894797|NCT01105533|11010112|FG006|STARTED|Overall Study||8
9894798|NCT01105533|11010113|FG007|STARTED|Overall Study||4
9894799|NCT01105533|11010114|FG008|STARTED|Overall Study||12
9894800|NCT01105533|11010106|FG000|COMPLETED|Overall Study||0
9894801|NCT01105533|11010107|FG001|COMPLETED|Overall Study||0
9894802|NCT01105533|11010108|FG002|COMPLETED|Overall Study||0
9894803|NCT01105533|11010109|FG003|COMPLETED|Overall Study||0
9894804|NCT01105533|11010110|FG004|COMPLETED|Overall Study||0
9894805|NCT01105533|11010111|FG005|COMPLETED|Overall Study||0
9894806|NCT01105533|11010112|FG006|COMPLETED|Overall Study||0
9894807|NCT01105533|11010113|FG007|COMPLETED|Overall Study||0
9894808|NCT01105533|11010114|FG008|COMPLETED|Overall Study||0
9894809|NCT01105533|11010106|FG000|NOT COMPLETED|Overall Study||1
9894810|NCT01105533|11010107|FG001|NOT COMPLETED|Overall Study||1
9894811|NCT01105533|11010108|FG002|NOT COMPLETED|Overall Study||3
9894812|NCT01105533|11010109|FG003|NOT COMPLETED|Overall Study||3
9894813|NCT01105533|11010110|FG004|NOT COMPLETED|Overall Study||7
9894814|NCT01105533|11010111|FG005|NOT COMPLETED|Overall Study||7
9894815|NCT01105533|11010112|FG006|NOT COMPLETED|Overall Study||8
9894816|NCT01105533|11010113|FG007|NOT COMPLETED|Overall Study||4
9894817|NCT01105533|11010114|FG008|NOT COMPLETED|Overall Study||12
9894818|NCT01105650|11010130|FG000|STARTED|Overall Study||3
9894819|NCT01105650|11010131|FG001|STARTED|Overall Study||3
9894820|NCT01105650|11010132|FG002|STARTED|Overall Study||7
9894821|NCT01105650|11010133|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
9894822|NCT01105650|11010130|FG000|COMPLETED|Overall Study||3
9894823|NCT01105650|11010131|FG001|COMPLETED|Overall Study||3
9894824|NCT01105650|11010132|FG002|COMPLETED|Overall Study||7
9894825|NCT01105650|11010133|FG003|COMPLETED|Overall Study||0
9894826|NCT01105650|11010130|FG000|NOT COMPLETED|Overall Study||0
9894827|NCT01105650|11010131|FG001|NOT COMPLETED|Overall Study||0
9894828|NCT01105650|11010132|FG002|NOT COMPLETED|Overall Study||0
9894829|NCT01105650|11010133|FG003|NOT COMPLETED|Overall Study||0
9894830|NCT01105702|11010141|FG000|STARTED|Overall Study||28
9894831|NCT01105702|11010141|FG000|COMPLETED|Overall Study||10
9894832|NCT01105702|11010141|FG000|NOT COMPLETED|Overall Study||18
9894833|NCT01105754|11010149|FG000|STARTED|Overall Study||319
9894834|NCT01105754|11010150|FG001|STARTED|Overall Study||319
9894835|NCT01105754|11010149|FG000|COMPLETED|Overall Study||304
9894836|NCT01105754|11010150|FG001|COMPLETED|Overall Study||307
9894837|NCT01105754|11010149|FG000|NOT COMPLETED|Overall Study||15
9894838|NCT01105754|11010150|FG001|NOT COMPLETED|Overall Study||12
9894839|NCT01105767|11010159|FG000|STARTED|Overall Study||9315
9894840|NCT01105767|11010160|FG001|STARTED|Overall Study||10864
9894841|NCT01105767|11010161|FG002|STARTED|Overall Study||10030
9894842|NCT01105767|11010159|FG000|COMPLETED|Overall Study||8155
9894843|NCT01105767|11010160|FG001|COMPLETED|Overall Study||9250
10008930|NCT01763346|11131442|FG001|Received Intervention|Overall Study||38
10008931|NCT01763346|11131441|FG000|COMPLETED|Overall Study||34
10008932|NCT01763346|11131442|FG001|COMPLETED|Overall Study||36
10008933|NCT01763346|11131441|FG000|NOT COMPLETED|Overall Study||10
10008934|NCT01763346|11131442|FG001|NOT COMPLETED|Overall Study||8
10008935|NCT01763567|11131448|FG000|STARTED|Overall Study||19
9894844|NCT01105767|11010161|FG002|COMPLETED|Overall Study||8846
9894845|NCT01105767|11010159|FG000|NOT COMPLETED|Overall Study||1160
10008936|NCT01763567|11131448|FG000|COMPLETED|Overall Study||19
9894846|NCT01105767|11010160|FG001|NOT COMPLETED|Overall Study||1614
9894847|NCT01105767|11010161|FG002|NOT COMPLETED|Overall Study||1184
9894848|NCT01105936|11010169|FG000|STARTED|Period 1||8
9894849|NCT01105936|11010170|FG001|STARTED|Period 1||8
9894850|NCT01105936|11010171|FG002|STARTED|Period 1||7
9894851|NCT01105936|11010172|FG003|STARTED|Period 1||8
9894852|NCT01105936|11010169|FG000|COMPLETED|Period 1||8
9894853|NCT01105936|11010170|FG001|COMPLETED|Period 1||8
9894854|NCT01105936|11010171|FG002|COMPLETED|Period 1||7
10008937|NCT01763567|11131448|FG000|NOT COMPLETED|Overall Study||0
10008938|NCT01763606|11131454|FG000|STARTED|Overall Study||10
10008939|NCT01763606|11131455|FG001|STARTED|Overall Study||10
10008940|NCT01763606|11131454|FG000|COMPLETED|Overall Study||10
10008941|NCT01763606|11131455|FG001|COMPLETED|Overall Study||10
10008942|NCT01763606|11131454|FG000|NOT COMPLETED|Overall Study||0
10008943|NCT01763606|11131455|FG001|NOT COMPLETED|Overall Study||0
10008944|NCT01763645|11131464|FG000|STARTED|Overall Study||69
10008945|NCT01763645|11131465|FG001|STARTED|Overall Study||69
10008946|NCT01763645|11131464|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
10008947|NCT01763645|11131465|FG001|Received at Least 1 Dose of Study Drug|Overall Study||66
10008948|NCT01763645|11131464|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|43
10008949|NCT01763645|11131465|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|45
10008950|NCT01763645|11131464|FG000|NOT COMPLETED|Overall Study||26
10008951|NCT01763645|11131465|FG001|NOT COMPLETED|Overall Study||24
10008952|NCT01763684|11131474|FG000|STARTED|Overall Study||133
10008953|NCT01763684|11131475|FG001|STARTED|Overall Study||133
10008954|NCT01763684|11131474|FG000|Completed Surgery|Overall Study||126
10008955|NCT01763684|11131475|FG001|Completed Surgery|Overall Study||127
10008956|NCT01763684|11131474|FG000|COMPLETED|Overall Study||0
10008957|NCT01763684|11131475|FG001|COMPLETED|Overall Study||0
10008958|NCT01763684|11131474|FG000|NOT COMPLETED|Overall Study||133
10008959|NCT01763684|11131475|FG001|NOT COMPLETED|Overall Study||133
10008960|NCT01763827|11131487|FG000|STARTED|Overall Study||77
10008961|NCT01763827|11131488|FG001|STARTED|Overall Study||78
10008962|NCT01763827|11131489|FG002|STARTED|Overall Study||77
10008963|NCT01763827|11131490|FG003|STARTED|Overall Study||77
10008964|NCT01763827|11131491|FG004|STARTED|Overall Study||153
10008965|NCT01763827|11131492|FG005|STARTED|Overall Study||153
10110150|NCT02482675|11240896|FG014|NOT COMPLETED|Overall Study||0
10110151|NCT02482675|11240897|FG015|NOT COMPLETED|Overall Study||0
10110152|NCT02482675|11240898|FG016|NOT COMPLETED|Overall Study||0
10110153|NCT02482675|11240899|FG017|NOT COMPLETED|Overall Study||0
10110154|NCT02482675|11240900|FG018|NOT COMPLETED|Overall Study||0
10110155|NCT02482675|11240901|FG019|NOT COMPLETED|Overall Study||0
10110156|NCT02482675|11240902|FG020|NOT COMPLETED|Overall Study||0
10110157|NCT02482675|11240903|FG021|NOT COMPLETED|Overall Study||0
9894855|NCT01105936|11010172|FG003|COMPLETED|Period 1||7
9894856|NCT01105936|11010169|FG000|NOT COMPLETED|Period 1||0
9894857|NCT01105936|11010170|FG001|NOT COMPLETED|Period 1||0
9894858|NCT01105936|11010171|FG002|NOT COMPLETED|Period 1||0
9894859|NCT01105936|11010172|FG003|NOT COMPLETED|Period 1||1
9894860|NCT01105936|11010169|FG000|STARTED|Wash-out Period 1||8
10110158|NCT02482675|11240904|FG022|NOT COMPLETED|Overall Study||0
10110159|NCT02482805|11240917|FG000|STARTED|Overall Study||26
10110160|NCT02482805|11240918|FG001|STARTED|Overall Study||27
10110161|NCT02482805|11240919|FG002|STARTED|Overall Study||20
10110162|NCT02482805|11240917|FG000|COMPLETED|Overall Study||22
10110163|NCT02482805|11240918|FG001|COMPLETED|Overall Study||23
10110164|NCT02482805|11240919|FG002|COMPLETED|Overall Study||20
10110165|NCT02482805|11240917|FG000|NOT COMPLETED|Overall Study||4
10110166|NCT02482805|11240918|FG001|NOT COMPLETED|Overall Study||4
10110167|NCT02482805|11240919|FG002|NOT COMPLETED|Overall Study||0
10110168|NCT02482870|11240927|FG000|STARTED|Period 1 - First 60 Patients||30
9894861|NCT01105936|11010170|FG001|STARTED|Wash-out Period 1||8
9894862|NCT01105936|11010171|FG002|STARTED|Wash-out Period 1||7
9894863|NCT01105936|11010172|FG003|STARTED|Wash-out Period 1||7
9894864|NCT01105936|11010169|FG000|COMPLETED|Wash-out Period 1||8
9894865|NCT01105936|11010170|FG001|COMPLETED|Wash-out Period 1||8
9894866|NCT01105936|11010171|FG002|COMPLETED|Wash-out Period 1||7
9894867|NCT01105936|11010172|FG003|COMPLETED|Wash-out Period 1||7
9894868|NCT01105936|11010169|FG000|NOT COMPLETED|Wash-out Period 1||0
9894869|NCT01105936|11010170|FG001|NOT COMPLETED|Wash-out Period 1||0
9894870|NCT01105936|11010171|FG002|NOT COMPLETED|Wash-out Period 1||0
9894871|NCT01105936|11010172|FG003|NOT COMPLETED|Wash-out Period 1||0
9894872|NCT01105936|11010169|FG000|STARTED|Period 2||8
9894873|NCT01105936|11010170|FG001|STARTED|Period 2||8
9894874|NCT01105936|11010171|FG002|STARTED|Period 2||7
9894875|NCT01105936|11010172|FG003|STARTED|Period 2||7
9894876|NCT01105936|11010169|FG000|COMPLETED|Period 2||7
9894877|NCT01105936|11010170|FG001|COMPLETED|Period 2||8
9894878|NCT01105936|11010171|FG002|COMPLETED|Period 2||7
9894879|NCT01105936|11010172|FG003|COMPLETED|Period 2||7
9894880|NCT01105936|11010169|FG000|NOT COMPLETED|Period 2||1
9894881|NCT01105936|11010170|FG001|NOT COMPLETED|Period 2||0
9894882|NCT01105936|11010171|FG002|NOT COMPLETED|Period 2||0
9894883|NCT01105936|11010172|FG003|NOT COMPLETED|Period 2||0
9894884|NCT01105936|11010169|FG000|STARTED|Wash-out Period 2||7
9894885|NCT01105936|11010170|FG001|STARTED|Wash-out Period 2||8
9894886|NCT01105936|11010171|FG002|STARTED|Wash-out Period 2||7
9894887|NCT01105936|11010172|FG003|STARTED|Wash-out Period 2||7
9894888|NCT01105936|11010169|FG000|COMPLETED|Wash-out Period 2||7
9894889|NCT01105936|11010170|FG001|COMPLETED|Wash-out Period 2||8
9894890|NCT01105936|11010171|FG002|COMPLETED|Wash-out Period 2||7
9894891|NCT01105936|11010172|FG003|COMPLETED|Wash-out Period 2||7
10008966|NCT01763827|11131487|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
10008967|NCT01763827|11131488|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
10008968|NCT01763827|11131489|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77
10008969|NCT01763827|11131490|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77
10008970|NCT01763827|11131491|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153
10110169|NCT02482870|11240928|FG001|STARTED|Period 1 - First 60 Patients||30
9894892|NCT01105936|11010169|FG000|NOT COMPLETED|Wash-out Period 2||0
9894893|NCT01105936|11010170|FG001|NOT COMPLETED|Wash-out Period 2||0
9894894|NCT01105936|11010171|FG002|NOT COMPLETED|Wash-out Period 2||0
9894895|NCT01105936|11010172|FG003|NOT COMPLETED|Wash-out Period 2||0
9894896|NCT01105936|11010169|FG000|STARTED|Period 3||7
9894897|NCT01105936|11010170|FG001|STARTED|Period 3||8
9894898|NCT01105936|11010171|FG002|STARTED|Period 3||7
9894899|NCT01105936|11010172|FG003|STARTED|Period 3||7
9894900|NCT01105936|11010169|FG000|COMPLETED|Period 3||7
9894901|NCT01105936|11010170|FG001|COMPLETED|Period 3||6
9894902|NCT01105936|11010171|FG002|COMPLETED|Period 3||7
9894903|NCT01105936|11010172|FG003|COMPLETED|Period 3||7
9894904|NCT01105936|11010169|FG000|NOT COMPLETED|Period 3||0
9894905|NCT01105936|11010170|FG001|NOT COMPLETED|Period 3||2
9894906|NCT01105936|11010171|FG002|NOT COMPLETED|Period 3||0
9894907|NCT01105936|11010172|FG003|NOT COMPLETED|Period 3||0
9894908|NCT01105975|11010191|FG000|STARTED|Overall Study||40
9894909|NCT01105975|11010192|FG001|STARTED|Overall Study||39
9894910|NCT01105975|11010193|FG002|STARTED|Overall Study||42
9894911|NCT01105975|11010194|FG003|STARTED|Overall Study||38
9894912|NCT01105975|11010195|FG004|STARTED|Overall Study||41
9894913|NCT01105975|11010196|FG005|STARTED|Overall Study||35
9894914|NCT01105975|11010197|FG006|STARTED|Overall Study||42
9894915|NCT01105975|11010198|FG007|STARTED|Overall Study||40
9894916|NCT01105975|11010199|FG008|STARTED|Overall Study||40
9894917|NCT01105975|11010200|FG009|STARTED|Overall Study||41
9894918|NCT01105975|11010191|FG000|Took at Least One Dose of Study Drug|Overall Study||40
9894919|NCT01105975|11010192|FG001|Took at Least One Dose of Study Drug|Overall Study||38
9894920|NCT01105975|11010193|FG002|Took at Least One Dose of Study Drug|Overall Study||40
9894921|NCT01105975|11010194|FG003|Took at Least One Dose of Study Drug|Overall Study||38
9894922|NCT01105975|11010195|FG004|Took at Least One Dose of Study Drug|Overall Study||41
9894923|NCT01105975|11010196|FG005|Took at Least One Dose of Study Drug|Overall Study||35
9894924|NCT01105975|11010197|FG006|Took at Least One Dose of Study Drug|Overall Study||41
9894925|NCT01105975|11010198|FG007|Took at Least One Dose of Study Drug|Overall Study||40
9894926|NCT01105975|11010199|FG008|Took at Least One Dose of Study Drug|Overall Study||39
9894927|NCT01105975|11010200|FG009|Took at Least One Dose of Study Drug|Overall Study||41
9894928|NCT01105975|11010191|FG000|COMPLETED|Overall Study||35
9894929|NCT01105975|11010192|FG001|COMPLETED|Overall Study||34
9894930|NCT01105975|11010193|FG002|COMPLETED|Overall Study||32
9894931|NCT01105975|11010194|FG003|COMPLETED|Overall Study||36
9894932|NCT01105975|11010195|FG004|COMPLETED|Overall Study||35
9894933|NCT01105975|11010196|FG005|COMPLETED|Overall Study||30
9894934|NCT01105975|11010197|FG006|COMPLETED|Overall Study||34
9894935|NCT01105975|11010198|FG007|COMPLETED|Overall Study||33
9894936|NCT01105975|11010199|FG008|COMPLETED|Overall Study||34
9894937|NCT01105975|11010200|FG009|COMPLETED|Overall Study||32
9894938|NCT01105975|11010191|FG000|NOT COMPLETED|Overall Study||5
9894939|NCT01105975|11010192|FG001|NOT COMPLETED|Overall Study||5
9894940|NCT01105975|11010193|FG002|NOT COMPLETED|Overall Study||10
9894941|NCT01105975|11010194|FG003|NOT COMPLETED|Overall Study||2
9894942|NCT01105975|11010195|FG004|NOT COMPLETED|Overall Study||6
9894943|NCT01105975|11010196|FG005|NOT COMPLETED|Overall Study||5
9894944|NCT01105975|11010197|FG006|NOT COMPLETED|Overall Study||8
9894945|NCT01105975|11010198|FG007|NOT COMPLETED|Overall Study||7
9894946|NCT01105975|11010199|FG008|NOT COMPLETED|Overall Study||6
9894947|NCT01105975|11010200|FG009|NOT COMPLETED|Overall Study||9
9894948|NCT01106014|11010243|FG000|STARTED|Overall Study||574
9894949|NCT01106014|11010244|FG001|STARTED|Overall Study||582
9894950|NCT01106014|11010243|FG000|COMPLETED|Overall Study||289
9894951|NCT01106014|11010244|FG001|COMPLETED|Overall Study||252
9894952|NCT01106014|11010243|FG000|NOT COMPLETED|Overall Study||285
9894953|NCT01106014|11010244|FG001|NOT COMPLETED|Overall Study||330
9894954|NCT01106027|11010250|FG000|STARTED|Overall Study||2
9894955|NCT01106027|11010250|FG000|COMPLETED|Overall Study||1
9894956|NCT01106027|11010250|FG000|NOT COMPLETED|Overall Study||1
9894957|NCT01106040|11010254|FG000|STARTED|Overall Study||163
9894958|NCT01106040|11010254|FG000|COMPLETED|Overall Study||152
9894959|NCT01106040|11010254|FG000|NOT COMPLETED|Overall Study||11
9894960|NCT01106092|11010263|FG000|STARTED|Overall Study||78
9894961|NCT01106092|11010264|FG001|STARTED|Overall Study||78
9894962|NCT01106092|11010265|FG002|STARTED|Overall Study||78
9894963|NCT01106092|11010266|FG003|STARTED|Overall Study||78
10110170|NCT02482870|11240927|FG000|COMPLETED|Period 1 - First 60 Patients||30
10110171|NCT02482870|11240928|FG001|COMPLETED|Period 1 - First 60 Patients||30
10110172|NCT02482870|11240927|FG000|NOT COMPLETED|Period 1 - First 60 Patients||0
10110173|NCT02482870|11240928|FG001|NOT COMPLETED|Period 1 - First 60 Patients||0
9894964|NCT01106092|11010263|FG000|COMPLETED|Overall Study||78
9894965|NCT01106092|11010264|FG001|COMPLETED|Overall Study||78
9894966|NCT01106092|11010265|FG002|COMPLETED|Overall Study||78
9894967|NCT01106092|11010266|FG003|COMPLETED|Overall Study||77
9894968|NCT01106092|11010263|FG000|NOT COMPLETED|Overall Study||0
9894969|NCT01106092|11010264|FG001|NOT COMPLETED|Overall Study||0
9894970|NCT01106092|11010265|FG002|NOT COMPLETED|Overall Study||0
9894971|NCT01106092|11010266|FG003|NOT COMPLETED|Overall Study||1
9894972|NCT01106157|11010278|FG000|STARTED|Overall Study||17
9894973|NCT01106157|11010279|FG001|STARTED|Overall Study||8
9894974|NCT01106157|11010278|FG000|COMPLETED|Overall Study||16
9894975|NCT01106157|11010279|FG001|COMPLETED|Overall Study||8
9894976|NCT01106157|11010278|FG000|NOT COMPLETED|Overall Study||1
9894977|NCT01106157|11010279|FG001|NOT COMPLETED|Overall Study||0
9894978|NCT01106248|11010285|FG000|STARTED|Overall Study||26
9894979|NCT01106248|11010285|FG000|COMPLETED|Overall Study||23
9894980|NCT01106248|11010285|FG000|NOT COMPLETED|Overall Study||3
9894981|NCT01106287|11010293|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
9894982|NCT01106287|11010294|FG001|STARTED|Overall Study||3
9894983|NCT01106287|11010295|FG002|STARTED|Overall Study||3
9894984|NCT01106287|11010296|FG003|STARTED|Overall Study||3
9894985|NCT01106287|11010293|FG000|COMPLETED|Overall Study||3
9894986|NCT01106287|11010294|FG001|COMPLETED|Overall Study||3
9894987|NCT01106287|11010295|FG002|COMPLETED|Overall Study||3
9894988|NCT01106287|11010296|FG003|COMPLETED|Overall Study||3
9894989|NCT01106287|11010293|FG000|NOT COMPLETED|Overall Study||1
9894990|NCT01106287|11010294|FG001|NOT COMPLETED|Overall Study||0
9894991|NCT01106287|11010295|FG002|NOT COMPLETED|Overall Study||0
9894992|NCT01106287|11010296|FG003|NOT COMPLETED|Overall Study||0
9894993|NCT01106326|11010310|FG000|STARTED|Overall Study||30
9894994|NCT01106326|11010310|FG000|COMPLETED|Overall Study||28
9894995|NCT01106326|11010310|FG000|NOT COMPLETED|Overall Study||2
9894996|NCT01106352|11010321|FG000|STARTED|Overall Study||7
9894997|NCT01106352|11010322|FG001|STARTED|Overall Study||3
9894998|NCT01106352|11010323|FG002|STARTED|Overall Study||7
9894999|NCT01106352|11010324|FG003|STARTED|Overall Study||36
9895000|NCT01106352|11010325|FG004|STARTED|Overall Study||17
9895001|NCT01106352|11010321|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
9895002|NCT01106352|11010322|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
9895003|NCT01106352|11010323|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
9895004|NCT01106352|11010324|FG003|Started Dose Escalation|Overall Study||0
9895005|NCT01106352|11010325|FG004|Started Dose Escalation|Overall Study||0
9895006|NCT01106352|11010321|FG000|Completed Dose Escalation|Overall Study||6
9895007|NCT01106352|11010322|FG001|Completed Dose Escalation|Overall Study||3
10110174|NCT02482870|11240927|FG000|STARTED|Period 2 - Rest of the Study||186
10110175|NCT02482870|11240928|FG001|STARTED|Period 2 - Rest of the Study||202
10110176|NCT02482870|11240927|FG000|COMPLETED|Period 2 - Rest of the Study||186
10110177|NCT02482870|11240928|FG001|COMPLETED|Period 2 - Rest of the Study||202
9895008|NCT01106352|11010323|FG002|Completed Dose Escalation|Overall Study||5
9895009|NCT01106352|11010324|FG003|Completed Dose Escalation|Overall Study||0
9895010|NCT01106352|11010325|FG004|Completed Dose Escalation|Overall Study||0
9895011|NCT01106352|11010321|FG000|Started Safety Cohort|Overall Study||0
9895012|NCT01106352|11010322|FG001|Started Safety Cohort|Overall Study||0
9895013|NCT01106352|11010323|FG002|Started Safety Cohort|Overall Study||0
9895014|NCT01106352|11010324|FG003|Started Safety Cohort|Overall Study||36
9895015|NCT01106352|11010325|FG004|Started Safety Cohort|Overall Study||17
9895016|NCT01106352|11010321|FG000|Treated Safety Cohort|Overall Study||0
9895017|NCT01106352|11010322|FG001|Treated Safety Cohort|Overall Study||0
9895018|NCT01106352|11010323|FG002|Treated Safety Cohort|Overall Study||0
9895019|NCT01106352|11010324|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
9895020|NCT01106352|11010325|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
9895021|NCT01106352|11010321|FG000|Completed Safety Cohort|Overall Study||0
9895022|NCT01106352|11010322|FG001|Completed Safety Cohort|Overall Study||0
9895023|NCT01106352|11010323|FG002|Completed Safety Cohort|Overall Study||0
9895024|NCT01106352|11010324|FG003|Completed Safety Cohort|Overall Study||23
10008971|NCT01763827|11131492|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153
10008972|NCT01763827|11131487|FG000|COMPLETED|Overall Study||74
10008973|NCT01763827|11131488|FG001|COMPLETED|Overall Study||77
10008974|NCT01763827|11131489|FG002|COMPLETED|Overall Study||73
10008975|NCT01763827|11131490|FG003|COMPLETED|Overall Study||76
10008976|NCT01763827|11131491|FG004|COMPLETED|Overall Study||147
9895025|NCT01106352|11010325|FG004|Completed Safety Cohort|Overall Study||9
9895026|NCT01106352|11010321|FG000|COMPLETED|Overall Study||6
9895027|NCT01106352|11010322|FG001|COMPLETED|Overall Study||3
9895028|NCT01106352|11010323|FG002|COMPLETED|Overall Study||5
9895029|NCT01106352|11010324|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
9895030|NCT01106352|11010325|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
9895031|NCT01106352|11010321|FG000|NOT COMPLETED|Overall Study||1
9895032|NCT01106352|11010322|FG001|NOT COMPLETED|Overall Study||0
9895033|NCT01106352|11010323|FG002|NOT COMPLETED|Overall Study||2
9895034|NCT01106352|11010324|FG003|NOT COMPLETED|Overall Study||13
9895035|NCT01106352|11010325|FG004|NOT COMPLETED|Overall Study||8
9895036|NCT01106391|11010341|FG000|STARTED|Overall Study||60
9895037|NCT01106391|11010341|FG000|COMPLETED|Overall Study||60
9895038|NCT01106391|11010341|FG000|NOT COMPLETED|Overall Study||0
9895039|NCT01106404|11010347|FG000|STARTED|Period I (First 6 Weeks)||36
9895040|NCT01106404|11010348|FG001|STARTED|Period I (First 6 Weeks)||40
9895041|NCT01106404|11010347|FG000|COMPLETED|Period I (First 6 Weeks)||33
9895042|NCT01106404|11010348|FG001|COMPLETED|Period I (First 6 Weeks)||38
9895043|NCT01106404|11010347|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3
10110178|NCT02482870|11240927|FG000|NOT COMPLETED|Period 2 - Rest of the Study||0
10008977|NCT01763827|11131492|FG005|COMPLETED|Overall Study||151
10008978|NCT01763827|11131487|FG000|NOT COMPLETED|Overall Study||3
10008979|NCT01763827|11131488|FG001|NOT COMPLETED|Overall Study||1
10008980|NCT01763827|11131489|FG002|NOT COMPLETED|Overall Study||4
10008981|NCT01763827|11131490|FG003|NOT COMPLETED|Overall Study||1
10110179|NCT02482870|11240928|FG001|NOT COMPLETED|Period 2 - Rest of the Study||0
9895044|NCT01106404|11010348|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2
9895045|NCT01106404|11010347|FG000|STARTED|Period II (Second 6 Weeks)||33
9895046|NCT01106404|11010348|FG001|STARTED|Period II (Second 6 Weeks)||38
9895047|NCT01106404|11010347|FG000|COMPLETED|Period II (Second 6 Weeks)||33
9895048|NCT01106404|11010348|FG001|COMPLETED|Period II (Second 6 Weeks)||38
9895049|NCT01106404|11010347|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0
9895050|NCT01106404|11010348|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0
9895051|NCT01106430|11010362|FG000|STARTED|Overall Study||133
9895052|NCT01106430|11010363|FG001|STARTED|Overall Study||134
9895053|NCT01106430|11010362|FG000|COMPLETED|Overall Study||100
9895054|NCT01106430|11010363|FG001|COMPLETED|Overall Study||101
9895055|NCT01106430|11010362|FG000|NOT COMPLETED|Overall Study||33
9895056|NCT01106430|11010363|FG001|NOT COMPLETED|Overall Study||33
9895057|NCT01106456|11010371|FG000|STARTED|Overall Study||243
9895058|NCT01106456|11010372|FG001|STARTED|Overall Study||220
9895059|NCT01106456|11010371|FG000|COMPLETED|Overall Study||140
9895060|NCT01106456|11010372|FG001|COMPLETED|Overall Study||96
9895061|NCT01106456|11010371|FG000|NOT COMPLETED|Overall Study||103
9895062|NCT01106456|11010372|FG001|NOT COMPLETED|Overall Study||124
9895063|NCT01106586|11010380|FG000|STARTED|Overall Study||353
9895064|NCT01106586|11010381|FG001|STARTED|Overall Study||355
9895065|NCT01106586|11010380|FG000|COMPLETED|Overall Study||68
9895066|NCT01106586|11010381|FG001|COMPLETED|Overall Study||70
9895067|NCT01106586|11010380|FG000|NOT COMPLETED|Overall Study||285
9895068|NCT01106586|11010381|FG001|NOT COMPLETED|Overall Study||285
9895069|NCT01106625|11010390|FG000|STARTED|Core Period: Baseline to Week 26||156
9895070|NCT01106625|11010391|FG001|STARTED|Core Period: Baseline to Week 26||157
9895071|NCT01106625|11010392|FG002|STARTED|Core Period: Baseline to Week 26||156
9895072|NCT01106625|11010390|FG000|COMPLETED|Core Period: Baseline to Week 26||123
9895073|NCT01106625|11010391|FG001|COMPLETED|Core Period: Baseline to Week 26||129
9895074|NCT01106625|11010392|FG002|COMPLETED|Core Period: Baseline to Week 26||129
9895075|NCT01106625|11010390|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33
9895076|NCT01106625|11010391|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28
9895077|NCT01106625|11010392|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27
9895078|NCT01106625|11010390|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
9895079|NCT01106625|11010391|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
9895080|NCT01106625|11010392|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
9895081|NCT01106625|11010390|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90
9895082|NCT01106625|11010391|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109
9895083|NCT01106625|11010392|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111
10008982|NCT01763827|11131491|FG004|NOT COMPLETED|Overall Study||6
10008983|NCT01763827|11131492|FG005|NOT COMPLETED|Overall Study||2
10008984|NCT01763866|11131530|FG000|STARTED|Overall Study||56
10008985|NCT01763866|11131531|FG001|STARTED|Overall Study||55
10008986|NCT01763866|11131532|FG002|STARTED|Overall Study||56
10008987|NCT01763866|11131533|FG003|STARTED|Overall Study||55
9895084|NCT01106625|11010390|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
9895085|NCT01106625|11010391|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
9895086|NCT01106625|11010392|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
9895087|NCT01106651|11010406|FG000|STARTED|Overall Study||237
9895088|NCT01106651|11010407|FG001|STARTED|Overall Study||241
9895089|NCT01106651|11010408|FG002|STARTED|Overall Study||236
9895090|NCT01106651|11010406|FG000|COMPLETED|Overall Study||158
9895091|NCT01106651|11010407|FG001|COMPLETED|Overall Study||184
9895092|NCT01106651|11010408|FG002|COMPLETED|Overall Study||178
9895093|NCT01106651|11010406|FG000|NOT COMPLETED|Overall Study||79
9895094|NCT01106651|11010407|FG001|NOT COMPLETED|Overall Study||57
9895095|NCT01106651|11010408|FG002|NOT COMPLETED|Overall Study||58
9895096|NCT01106677|11010423|FG000|STARTED|Core Period: Baseline to Week 26||183
9895097|NCT01106677|11010424|FG001|STARTED|Core Period: Baseline to Week 26||368
9895098|NCT01106677|11010425|FG002|STARTED|Core Period: Baseline to Week 26||367
9895099|NCT01106677|11010426|FG003|STARTED|Core Period: Baseline to Week 26||366
9895100|NCT01106677|11010423|FG000|COMPLETED|Core Period: Baseline to Week 26||155
9895101|NCT01106677|11010424|FG001|COMPLETED|Core Period: Baseline to Week 26||322
9895102|NCT01106677|11010425|FG002|COMPLETED|Core Period: Baseline to Week 26||323
9895103|NCT01106677|11010426|FG003|COMPLETED|Core Period: Baseline to Week 26||319
9895104|NCT01106677|11010423|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28
9895105|NCT01106677|11010424|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46
9895106|NCT01106677|11010425|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44
9895107|NCT01106677|11010426|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47
9895108|NCT01106677|11010423|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
9895109|NCT01106677|11010424|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
9954688|NCT01433016|11073487|FG000|STARTED|Overall Study||20
10008988|NCT01763866|11131534|FG004|STARTED|Overall Study||110
10008989|NCT01763866|11131535|FG005|STARTED|Overall Study||110
10008990|NCT01763866|11131536|FG006|STARTED|Overall Study||55
10008991|NCT01763866|11131537|FG007|STARTED|Overall Study||55
10008992|NCT01763866|11131538|FG008|STARTED|Overall Study||56
10008993|NCT01763866|11131539|FG009|STARTED|Overall Study||54
10008994|NCT01763866|11131540|FG010|STARTED|Overall Study||110
9895110|NCT01106677|11010425|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
9895111|NCT01106677|11010426|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
9895112|NCT01106677|11010423|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138
9895113|NCT01106677|11010424|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298
9895114|NCT01106677|11010425|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299
9895115|NCT01106677|11010426|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285
9895116|NCT01106677|11010423|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
9895117|NCT01106677|11010424|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
9895118|NCT01106677|11010425|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
9895119|NCT01106677|11010426|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
9895120|NCT01106690|11010446|FG000|STARTED|Core Period: Baseline to Week 26||115
9895121|NCT01106690|11010447|FG001|STARTED|Core Period: Baseline to Week 26||113
9895122|NCT01106690|11010448|FG002|STARTED|Core Period: Baseline to Week 26||114
9895123|NCT01106690|11010446|FG000|COMPLETED|Core Period: Baseline to Week 26||91
9895124|NCT01106690|11010447|FG001|COMPLETED|Core Period: Baseline to Week 26||104
9895125|NCT01106690|11010448|FG002|COMPLETED|Core Period: Baseline to Week 26||101
9895126|NCT01106690|11010446|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24
9895127|NCT01106690|11010447|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9
9895128|NCT01106690|11010448|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13
9895129|NCT01106690|11010446|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
9895130|NCT01106690|11010447|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
9895131|NCT01106690|11010448|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
9895132|NCT01106690|11010446|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78
9895133|NCT01106690|11010447|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96
9895134|NCT01106690|11010448|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89
9895135|NCT01106690|11010446|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
9895136|NCT01106690|11010447|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
9895137|NCT01106690|11010448|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
9895138|NCT01106833|11010461|FG000|STARTED|Overall Study||74
9895139|NCT01106833|11010462|FG001|STARTED|Overall Study||77
9895140|NCT01106833|11010461|FG000|COMPLETED|Overall Study||74
9895141|NCT01106833|11010462|FG001|COMPLETED|Overall Study||77
9895142|NCT01106833|11010461|FG000|NOT COMPLETED|Overall Study||0
9895143|NCT01106833|11010462|FG001|NOT COMPLETED|Overall Study||0
9895144|NCT01106846|11010470|FG000|STARTED|Overall Study||12
9895145|NCT01106846|11010471|FG001|STARTED|Overall Study||10
9895146|NCT01106846|11010470|FG000|COMPLETED|Overall Study||12
9895147|NCT01106846|11010471|FG001|COMPLETED|Overall Study||9
9895148|NCT01106846|11010470|FG000|NOT COMPLETED|Overall Study||0
9895149|NCT01106846|11010471|FG001|NOT COMPLETED|Overall Study||1
9895150|NCT01106859|11010477|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
9895151|NCT01106859|11010477|FG000|COMPLETED|Overall Study||40
9895152|NCT01106859|11010477|FG000|NOT COMPLETED|Overall Study||0
9895153|NCT01106898|11010488|FG000|STARTED|Overall Study||100
9895154|NCT01106898|11010488|FG000|COMPLETED|Overall Study||94
9895155|NCT01106898|11010488|FG000|NOT COMPLETED|Overall Study||6
9895156|NCT01106911|11010492|FG000|STARTED|Overall Study||1085
9895157|NCT01106911|11010492|FG000|COMPLETED|Overall Study||1080
9895158|NCT01106911|11010492|FG000|NOT COMPLETED|Overall Study||5
9895159|NCT01106950|11010496|FG000|STARTED|Overall Study||15
9895160|NCT01106950|11010496|FG000|COMPLETED|Overall Study||15
9895161|NCT01106950|11010496|FG000|NOT COMPLETED|Overall Study||0
9895162|NCT01106976|11010502|FG000|STARTED|Overall Study||67
9895163|NCT01106976|11010502|FG000|COMPLETED|Overall Study||59
9895164|NCT01106976|11010502|FG000|NOT COMPLETED|Overall Study||8
9895165|NCT01107015|11010510|FG000|STARTED|Overall Study||62
9895166|NCT01107015|11010511|FG001|STARTED|Overall Study||38
9895167|NCT01107015|11010512|FG002|STARTED|Overall Study||33
9895168|NCT01107015|11010513|FG003|STARTED|Overall Study||80
9895169|NCT01107015|11010510|FG000|COMPLETED|Overall Study||56
9895170|NCT01107015|11010511|FG001|COMPLETED|Overall Study||23
9895171|NCT01107015|11010512|FG002|COMPLETED|Overall Study||22
9895172|NCT01107015|11010513|FG003|COMPLETED|Overall Study||62
9895173|NCT01107015|11010510|FG000|NOT COMPLETED|Overall Study||6
9895174|NCT01107015|11010511|FG001|NOT COMPLETED|Overall Study||15
9895175|NCT01107015|11010512|FG002|NOT COMPLETED|Overall Study||11
9895176|NCT01107015|11010513|FG003|NOT COMPLETED|Overall Study||18
9895177|NCT01107197|11010525|FG000|STARTED|Overall Study||99
9895178|NCT01107197|11010526|FG001|STARTED|Overall Study||101
9895179|NCT01107197|11010525|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
9895180|NCT01107197|11010526|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
9895181|NCT01107197|11010525|FG000|NOT COMPLETED|Overall Study||20
9895182|NCT01107197|11010526|FG001|NOT COMPLETED|Overall Study||23
9895183|NCT01107353|11010534|FG000|STARTED|Overall Study||20
9895184|NCT01107353|11010535|FG001|STARTED|Overall Study||20
9895185|NCT01107353|11010534|FG000|COMPLETED|Overall Study||19
9895186|NCT01107353|11010535|FG001|COMPLETED|Overall Study||20
9895187|NCT01107353|11010534|FG000|NOT COMPLETED|Overall Study||1
9895188|NCT01107353|11010535|FG001|NOT COMPLETED|Overall Study||0
9895189|NCT01107379|11010541|FG000|STARTED|Overall Study||203
9895190|NCT01107379|11010541|FG000|COMPLETED|Overall Study||182
9895191|NCT01107379|11010541|FG000|NOT COMPLETED|Overall Study||21
9895192|NCT01107392|11010547|FG000|STARTED|Overall Study||158
9895193|NCT01107392|11010548|FG001|STARTED|Overall Study||157
9895194|NCT01107392|11010547|FG000|COMPLETED|Overall Study||153
9895195|NCT01107392|11010548|FG001|COMPLETED|Overall Study||154
9895196|NCT01107392|11010547|FG000|NOT COMPLETED|Overall Study||5
9895197|NCT01107392|11010548|FG001|NOT COMPLETED|Overall Study||3
9954689|NCT01433016|11073487|FG000|COMPLETED|Overall Study||20
9954690|NCT01433016|11073487|FG000|NOT COMPLETED|Overall Study||0
9954691|NCT01433042|11073491|FG000|STARTED|Overall Study||225
9954692|NCT01433042|11073491|FG000|COMPLETED|Overall Study||224
9954693|NCT01433042|11073491|FG000|NOT COMPLETED|Overall Study||1
9954694|NCT01433055|11073497|FG000|STARTED|Overall Study||29
9954695|NCT01433055|11073498|FG001|STARTED|Overall Study||23
9954696|NCT01433055|11073497|FG000|COMPLETED|Overall Study||27
9954697|NCT01433055|11073498|FG001|COMPLETED|Overall Study||23
9954698|NCT01433055|11073497|FG000|NOT COMPLETED|Overall Study||2
9954699|NCT01433055|11073498|FG001|NOT COMPLETED|Overall Study||0
9954700|NCT01433081|11073506|FG000|STARTED|Overall Study||25
9954701|NCT01433081|11073507|FG001|STARTED|Overall Study||25
9954702|NCT01433081|11073506|FG000|COMPLETED|Overall Study||23
9954703|NCT01433081|11073507|FG001|COMPLETED|Overall Study||23
9954704|NCT01433081|11073506|FG000|NOT COMPLETED|Overall Study||2
9954705|NCT01433081|11073507|FG001|NOT COMPLETED|Overall Study||2
9954706|NCT01433107|11073516|FG000|STARTED|Overall Study||145
9954707|NCT01433107|11073517|FG001|STARTED|Overall Study||145
9954708|NCT01433107|11073516|FG000|COMPLETED|Overall Study||118
9954709|NCT01433107|11073517|FG001|COMPLETED|Overall Study||128
9954710|NCT01433107|11073516|FG000|NOT COMPLETED|Overall Study||27
9954711|NCT01433107|11073517|FG001|NOT COMPLETED|Overall Study||17
9954712|NCT01433159|11073525|FG000|STARTED|Overall Study||9
9954713|NCT01433159|11073526|FG001|STARTED|Overall Study||10
9954714|NCT01433159|11073525|FG000|COMPLETED|Overall Study||7
9954715|NCT01433159|11073526|FG001|COMPLETED|Overall Study||9
9954716|NCT01433159|11073525|FG000|NOT COMPLETED|Overall Study||2
9954717|NCT01433159|11073526|FG001|NOT COMPLETED|Overall Study||1
9954718|NCT01433172|11073535|FG000|STARTED|Overall Study||3
9954719|NCT01433172|11073536|FG001|STARTED|Overall Study||37
9954720|NCT01433172|11073537|FG002|STARTED|Overall Study||33
9954721|NCT01433172|11073535|FG000|COMPLETED|Overall Study||3
9954722|NCT01433172|11073536|FG001|COMPLETED|Overall Study||34
9954723|NCT01433172|11073537|FG002|COMPLETED|Overall Study||32
9954724|NCT01433172|11073535|FG000|NOT COMPLETED|Overall Study||0
9954725|NCT01433172|11073536|FG001|NOT COMPLETED|Overall Study||3
9954726|NCT01433172|11073537|FG002|NOT COMPLETED|Overall Study||1
9954727|NCT01433250|11073547|FG000|STARTED|Overall Study||22
9954728|NCT01433250|11073548|FG001|STARTED|Overall Study||17
9954729|NCT01433250|11073547|FG000|COMPLETED|Overall Study||19
9954730|NCT01433250|11073548|FG001|COMPLETED|Overall Study||14
9954731|NCT01433250|11073547|FG000|NOT COMPLETED|Overall Study||3
9954732|NCT01433250|11073548|FG001|NOT COMPLETED|Overall Study||3
9954733|NCT01433263|11073556|FG000|STARTED|Overall Study||29
9954734|NCT01433263|11073557|FG001|STARTED|Overall Study||28
9954735|NCT01433263|11073556|FG000|COMPLETED|Overall Study||10
9954736|NCT01433263|11073557|FG001|COMPLETED|Overall Study||16
9954737|NCT01433263|11073556|FG000|NOT COMPLETED|Overall Study||19
9954738|NCT01433263|11073557|FG001|NOT COMPLETED|Overall Study||12
9954739|NCT01433354|11073566|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
9954740|NCT01433354|11073566|FG000|COMPLETED|Overall Study||0
9954741|NCT01433354|11073566|FG000|NOT COMPLETED|Overall Study||119
9954742|NCT01433549|11073580|FG000|STARTED|Phase 1: First Study Product||12
9954743|NCT01433549|11073581|FG001|STARTED|Phase 1: First Study Product||13
9954744|NCT01433549|11073580|FG000|COMPLETED|Phase 1: First Study Product||12
9954745|NCT01433549|11073581|FG001|COMPLETED|Phase 1: First Study Product||13
9954746|NCT01433549|11073580|FG000|NOT COMPLETED|Phase 1: First Study Product||0
9954747|NCT01433549|11073581|FG001|NOT COMPLETED|Phase 1: First Study Product||0
9954748|NCT01433549|11073580|FG000|STARTED|Phase 2: Second Study Product||12
9954749|NCT01433549|11073581|FG001|STARTED|Phase 2: Second Study Product||13
9954750|NCT01433549|11073580|FG000|COMPLETED|Phase 2: Second Study Product||12
9954751|NCT01433549|11073581|FG001|COMPLETED|Phase 2: Second Study Product||12
9954752|NCT01433549|11073580|FG000|NOT COMPLETED|Phase 2: Second Study Product||0
9954753|NCT01433549|11073581|FG001|NOT COMPLETED|Phase 2: Second Study Product||1
9954754|NCT01433731|11073591|FG000|STARTED|Overall Study||3
9954755|NCT01433731|11073592|FG001|STARTED|Overall Study||5
9954756|NCT01433731|11073593|FG002|STARTED|Overall Study||5
9954757|NCT01433731|11073594|FG003|STARTED|Overall Study||5
9954758|NCT01433731|11073591|FG000|COMPLETED|Overall Study||3
9954759|NCT01433731|11073592|FG001|COMPLETED|Overall Study||5
9954760|NCT01433731|11073593|FG002|COMPLETED|Overall Study||5
9954761|NCT01433731|11073594|FG003|COMPLETED|Overall Study||5
9954762|NCT01433731|11073591|FG000|NOT COMPLETED|Overall Study||0
9954763|NCT01433731|11073592|FG001|NOT COMPLETED|Overall Study||0
9954764|NCT01433731|11073593|FG002|NOT COMPLETED|Overall Study||0
9954765|NCT01433731|11073594|FG003|NOT COMPLETED|Overall Study||0
9954766|NCT01433913|11073604|FG000|STARTED|Overall Study||10
9954767|NCT01433913|11073605|FG001|STARTED|Overall Study||10
9954768|NCT01433913|11073604|FG000|COMPLETED|Overall Study||9
9895198|NCT01107405|11010559|FG000|STARTED|Overall Study||21
9895199|NCT01107405|11010560|FG001|STARTED|Overall Study||20
9895200|NCT01107405|11010561|FG002|STARTED|Overall Study||20
9895201|NCT01107405|11010562|FG003|STARTED|Overall Study||20
9895202|NCT01107405|11010563|FG004|STARTED|Overall Study||20
9895203|NCT01107405|11010559|FG000|COMPLETED|Overall Study||19
9895204|NCT01107405|11010560|FG001|COMPLETED|Overall Study||19
9895205|NCT01107405|11010561|FG002|COMPLETED|Overall Study||18
9895206|NCT01107405|11010562|FG003|COMPLETED|Overall Study||17
9895207|NCT01107405|11010563|FG004|COMPLETED|Overall Study||17
9895208|NCT01107405|11010559|FG000|NOT COMPLETED|Overall Study||2
9895209|NCT01107405|11010560|FG001|NOT COMPLETED|Overall Study||1
9895210|NCT01107405|11010561|FG002|NOT COMPLETED|Overall Study||2
9895211|NCT01107405|11010562|FG003|NOT COMPLETED|Overall Study||3
9895212|NCT01107405|11010563|FG004|NOT COMPLETED|Overall Study||3
9895213|NCT01107418|11010579|FG000|STARTED|Overall Study||52
9895214|NCT01107418|11010579|FG000|COMPLETED|Overall Study||0
9895215|NCT01107418|11010579|FG000|NOT COMPLETED|Overall Study||52
9895216|NCT01107444|11010596|FG000|STARTED|Overall Study||120
9895217|NCT01107444|11010597|FG001|STARTED|Overall Study||60
9895218|NCT01107444|11010596|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114
9895219|NCT01107444|11010597|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48
9895220|NCT01107444|11010596|FG000|COMPLETED|Overall Study||112
9895221|NCT01107444|11010597|FG001|COMPLETED|Overall Study||47
9895222|NCT01107444|11010596|FG000|NOT COMPLETED|Overall Study||8
9895223|NCT01107444|11010597|FG001|NOT COMPLETED|Overall Study||13
9895224|NCT01107457|11010611|FG000|STARTED|Part A||27
9895225|NCT01107457|11010612|FG001|STARTED|Part A||28
9895226|NCT01107457|11010613|FG002|STARTED|Part A||30
9895227|NCT01107457|11010614|FG003|STARTED|Part A||29
9895228|NCT01107457|11010615|FG004|STARTED|Part A||28
9895229|NCT01107457|11010616|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
9895230|NCT01107457|11010611|FG000|Received at Least 1 Dose of Study Drug|Part A||27
9895231|NCT01107457|11010612|FG001|Received at Least 1 Dose of Study Drug|Part A||28
9895232|NCT01107457|11010613|FG002|Received at Least 1 Dose of Study Drug|Part A||30
9895233|NCT01107457|11010614|FG003|Received at Least 1 Dose of Study Drug|Part A||29
9895234|NCT01107457|11010615|FG004|Received at Least 1 Dose of Study Drug|Part A||28
9895235|NCT01107457|11010616|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
9895236|NCT01107457|11010611|FG000|COMPLETED|Part A||22
9895237|NCT01107457|11010612|FG001|COMPLETED|Part A||21
9895238|NCT01107457|11010613|FG002|COMPLETED|Part A||29
9895239|NCT01107457|11010614|FG003|COMPLETED|Part A||26
9895240|NCT01107457|11010615|FG004|COMPLETED|Part A||27
9895241|NCT01107457|11010616|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
9895242|NCT01107457|11010611|FG000|NOT COMPLETED|Part A||5
9895243|NCT01107457|11010612|FG001|NOT COMPLETED|Part A||7
9895244|NCT01107457|11010613|FG002|NOT COMPLETED|Part A||1
9895245|NCT01107457|11010614|FG003|NOT COMPLETED|Part A||3
9895246|NCT01107457|11010615|FG004|NOT COMPLETED|Part A||1
10008995|NCT01763866|11131541|FG011|STARTED|Overall Study||110
10008996|NCT01763866|11131542|FG012|STARTED|Overall Study||58
10008997|NCT01763866|11131543|FG013|STARTED|Overall Study||57
10008998|NCT01763866|11131544|FG014|STARTED|Overall Study||114
10008999|NCT01763866|11131545|FG015|STARTED|Overall Study||115
10009000|NCT01763866|11131546|FG016|STARTED|Overall Study||56
9895247|NCT01107457|11010616|FG005|NOT COMPLETED|Part A||0
9895248|NCT01107457|11010611|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
9895249|NCT01107457|11010612|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
9895250|NCT01107457|11010613|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
9895251|NCT01107457|11010614|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
9895252|NCT01107457|11010615|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
9895253|NCT01107457|11010616|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
9895254|NCT01107457|11010611|FG000|Completed Part B (Week 240)|Part B and C||0
9895255|NCT01107457|11010612|FG001|Completed Part B (Week 240)|Part B and C||0
9895256|NCT01107457|11010613|FG002|Completed Part B (Week 240)|Part B and C||0
9895257|NCT01107457|11010614|FG003|Completed Part B (Week 240)|Part B and C||0
9895258|NCT01107457|11010615|FG004|Completed Part B (Week 240)|Part B and C||0
9895259|NCT01107457|11010616|FG005|Completed Part B (Week 240)|Part B and C||74
9895260|NCT01107457|11010611|FG000|Completed Part C|Part B and C||0
9895261|NCT01107457|11010612|FG001|Completed Part C|Part B and C||0
9895262|NCT01107457|11010613|FG002|Completed Part C|Part B and C||0
9895263|NCT01107457|11010614|FG003|Completed Part C|Part B and C||0
9895264|NCT01107457|11010615|FG004|Completed Part C|Part B and C||0
9895265|NCT01107457|11010616|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
9895266|NCT01107457|11010611|FG000|Post Treatment Safety Visits|Part B and C||0
10009001|NCT01763866|11131547|FG017|STARTED|Overall Study||56
9895267|NCT01107457|11010612|FG001|Post Treatment Safety Visits|Part B and C||0
9895268|NCT01107457|11010613|FG002|Post Treatment Safety Visits|Part B and C||0
9895269|NCT01107457|11010614|FG003|Post Treatment Safety Visits|Part B and C||0
10009002|NCT01763866|11131548|FG018|STARTED|Overall Study||111
10009003|NCT01763866|11131549|FG019|STARTED|Overall Study||112
10009004|NCT01763866|11131550|FG020|STARTED|Overall Study||56
10009005|NCT01763866|11131551|FG021|STARTED|Overall Study||55
9895270|NCT01107457|11010615|FG004|Post Treatment Safety Visits|Part B and C||0
9895271|NCT01107457|11010616|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
9895272|NCT01107457|11010611|FG000|COMPLETED|Part B and C||0
9895273|NCT01107457|11010612|FG001|COMPLETED|Part B and C||0
9895274|NCT01107457|11010613|FG002|COMPLETED|Part B and C||0
9895275|NCT01107457|11010614|FG003|COMPLETED|Part B and C||0
9895276|NCT01107457|11010615|FG004|COMPLETED|Part B and C||0
9895277|NCT01107457|11010616|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
9895278|NCT01107457|11010611|FG000|NOT COMPLETED|Part B and C||0
9895279|NCT01107457|11010612|FG001|NOT COMPLETED|Part B and C||0
9895280|NCT01107457|11010613|FG002|NOT COMPLETED|Part B and C||0
9895281|NCT01107457|11010614|FG003|NOT COMPLETED|Part B and C||0
9895282|NCT01107457|11010615|FG004|NOT COMPLETED|Part B and C||0
9895283|NCT01107457|11010616|FG005|NOT COMPLETED|Part B and C||120
9895284|NCT01107535|11010634|FG000|STARTED|Overall Study||82
9895285|NCT01107535|11010634|FG000|Number of Participants Analyzed|Overall Study||82
9895286|NCT01107535|11010634|FG000|COMPLETED|Overall Study||77
9895287|NCT01107535|11010634|FG000|NOT COMPLETED|Overall Study||5
9895288|NCT01107626|11010642|FG000|STARTED|Step 1: Induction Therapy||642
9895289|NCT01107626|11010643|FG001|STARTED|Step 1: Induction Therapy||287
9895290|NCT01107626|11010644|FG002|STARTED|Step 1: Induction Therapy||294
9895291|NCT01107626|11010645|FG003|STARTED|Step 1: Induction Therapy||293
9895292|NCT01107626|11010642|FG000|COMPLETED|Step 1: Induction Therapy||65
9895293|NCT01107626|11010643|FG001|COMPLETED|Step 1: Induction Therapy||287
9895294|NCT01107626|11010644|FG002|COMPLETED|Step 1: Induction Therapy||294
9895295|NCT01107626|11010645|FG003|COMPLETED|Step 1: Induction Therapy||293
9895296|NCT01107626|11010642|FG000|NOT COMPLETED|Step 1: Induction Therapy||577
9895297|NCT01107626|11010643|FG001|NOT COMPLETED|Step 1: Induction Therapy||0
9895298|NCT01107626|11010644|FG002|NOT COMPLETED|Step 1: Induction Therapy||0
9895299|NCT01107626|11010645|FG003|NOT COMPLETED|Step 1: Induction Therapy||0
9895300|NCT01107626|11010642|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
9895301|NCT01107626|11010643|FG001|STARTED|Step 2: Maintenance Therapy||287
9895302|NCT01107626|11010644|FG002|STARTED|Step 2: Maintenance Therapy||294
9895303|NCT01107626|11010645|FG003|STARTED|Step 2: Maintenance Therapy||293
9895304|NCT01107626|11010642|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
9895305|NCT01107626|11010643|FG001|COMPLETED|Step 2: Maintenance Therapy||1
9895306|NCT01107626|11010644|FG002|COMPLETED|Step 2: Maintenance Therapy||0
9895307|NCT01107626|11010645|FG003|COMPLETED|Step 2: Maintenance Therapy||1
9895308|NCT01107626|11010642|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0
9895309|NCT01107626|11010643|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286
9895310|NCT01107626|11010644|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294
9895311|NCT01107626|11010645|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292
9895312|NCT01107665|11010654|FG000|STARTED|Overall Study||60
9895313|NCT01107665|11010654|FG000|COMPLETED|Overall Study||11
9895314|NCT01107665|11010654|FG000|NOT COMPLETED|Overall Study||49
9895315|NCT01107730|11010663|FG000|STARTED|Overall Study||11
9895316|NCT01107730|11010664|FG001|STARTED|Overall Study||11
9895317|NCT01107730|11010665|FG002|STARTED|Overall Study||11
9895318|NCT01107730|11010663|FG000|COMPLETED|Overall Study||11
9895319|NCT01107730|11010664|FG001|COMPLETED|Overall Study||11
9895320|NCT01107730|11010665|FG002|COMPLETED|Overall Study||11
9895321|NCT01107730|11010663|FG000|NOT COMPLETED|Overall Study||0
9895322|NCT01107730|11010664|FG001|NOT COMPLETED|Overall Study||0
9895323|NCT01107730|11010665|FG002|NOT COMPLETED|Overall Study||0
9895324|NCT01107743|11010673|FG000|STARTED|Overall Study||1291
9895325|NCT01107743|11010673|FG000|COMPLETED|Overall Study||1245
9895326|NCT01107743|11010673|FG000|NOT COMPLETED|Overall Study||46
9895327|NCT01107834|11010724|FG000|STARTED|Overall Study||30
9895328|NCT01107834|11010725|FG001|STARTED|Overall Study||30
9895329|NCT01107834|11010724|FG000|COMPLETED|Overall Study||30
9895330|NCT01107834|11010725|FG001|COMPLETED|Overall Study||30
9895331|NCT01107834|11010724|FG000|NOT COMPLETED|Overall Study||0
9895332|NCT01107834|11010725|FG001|NOT COMPLETED|Overall Study||0
9895333|NCT01107886|11010733|FG000|STARTED|Overall Study|Randomized subjects|8280
9895334|NCT01107886|11010734|FG001|STARTED|Overall Study|Randomized subjects|8212
9895335|NCT01107886|11010733|FG000|COMPLETED|Overall Study|Completed subjects|8078
9895336|NCT01107886|11010734|FG001|COMPLETED|Overall Study|Completed subjects|7998
9895337|NCT01107886|11010733|FG000|NOT COMPLETED|Overall Study||202
9895338|NCT01107886|11010734|FG001|NOT COMPLETED|Overall Study||214
9895339|NCT01107899|11010743|FG000|STARTED|Overall Study||10
9895340|NCT01107899|11010744|FG001|STARTED|Overall Study||10
9895341|NCT01107899|11010745|FG002|STARTED|Overall Study||9
9895342|NCT01107899|11010743|FG000|Received at Least One Dose of Study Drug|Overall Study||10
9895343|NCT01107899|11010744|FG001|Received at Least One Dose of Study Drug|Overall Study||10
9895344|NCT01107899|11010745|FG002|Received at Least One Dose of Study Drug|Overall Study||8
9895345|NCT01107899|11010743|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
9895346|NCT01107899|11010744|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
9895347|NCT01107899|11010745|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
9895348|NCT01107899|11010743|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
9895349|NCT01107899|11010744|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
9895350|NCT01107899|11010745|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
9895351|NCT01107899|11010743|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
9895352|NCT01107899|11010744|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
9895353|NCT01107899|11010745|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
9895354|NCT01107899|11010743|FG000|COMPLETED|Overall Study||5
9895355|NCT01107899|11010744|FG001|COMPLETED|Overall Study||10
9895356|NCT01107899|11010745|FG002|COMPLETED|Overall Study||5
9895357|NCT01107899|11010743|FG000|NOT COMPLETED|Overall Study||5
9895358|NCT01107899|11010744|FG001|NOT COMPLETED|Overall Study||0
9895359|NCT01107899|11010745|FG002|NOT COMPLETED|Overall Study||4
9895360|NCT01107912|11010760|FG000|STARTED|Period 1||73
9895361|NCT01107912|11010761|FG001|STARTED|Period 1||0
9895362|NCT01107912|11010762|FG002|STARTED|Period 1||0
9895363|NCT01107912|11010763|FG003|STARTED|Period 1||0
9895364|NCT01107912|11010764|FG004|STARTED|Period 1||82
9895365|NCT01107912|11010765|FG005|STARTED|Period 1||0
9895366|NCT01107912|11010760|FG000|Received at Least 1 Dose of Study Drug|Period 1||73
9895367|NCT01107912|11010761|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
9895368|NCT01107912|11010762|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
9895369|NCT01107912|11010763|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
9895370|NCT01107912|11010764|FG004|Received at Least 1 Dose of Study Drug|Period 1||82
9895371|NCT01107912|11010765|FG005|Received at Least 1 Dose of Study Drug|Period 1||0
9895372|NCT01107912|11010760|FG000|COMPLETED|Period 1||72
9895373|NCT01107912|11010761|FG001|COMPLETED|Period 1||0
9895374|NCT01107912|11010762|FG002|COMPLETED|Period 1||0
9895375|NCT01107912|11010763|FG003|COMPLETED|Period 1||0
9895376|NCT01107912|11010764|FG004|COMPLETED|Period 1||79
9895377|NCT01107912|11010765|FG005|COMPLETED|Period 1||0
9895378|NCT01107912|11010760|FG000|NOT COMPLETED|Period 1||1
9895379|NCT01107912|11010761|FG001|NOT COMPLETED|Period 1||0
9895380|NCT01107912|11010762|FG002|NOT COMPLETED|Period 1||0
9895381|NCT01107912|11010763|FG003|NOT COMPLETED|Period 1||0
9895382|NCT01107912|11010764|FG004|NOT COMPLETED|Period 1||3
9895383|NCT01107912|11010765|FG005|NOT COMPLETED|Period 1||0
9895384|NCT01107912|11010760|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
9895385|NCT01107912|11010761|FG001|STARTED|Period 2||36
9895386|NCT01107912|11010762|FG002|STARTED|Period 2||36
9895387|NCT01107912|11010763|FG003|STARTED|Period 2||41
9895388|NCT01107912|11010764|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
9895389|NCT01107912|11010765|FG005|STARTED|Period 2||38
9895390|NCT01107912|11010760|FG000|COMPLETED|Period 2||0
9895391|NCT01107912|11010761|FG001|COMPLETED|Period 2||36
9895392|NCT01107912|11010762|FG002|COMPLETED|Period 2||35
9895393|NCT01107912|11010763|FG003|COMPLETED|Period 2||41
9895394|NCT01107912|11010764|FG004|COMPLETED|Period 2||0
9895395|NCT01107912|11010765|FG005|COMPLETED|Period 2||38
9895396|NCT01107912|11010760|FG000|NOT COMPLETED|Period 2||0
9895397|NCT01107912|11010761|FG001|NOT COMPLETED|Period 2||0
9895398|NCT01107912|11010762|FG002|NOT COMPLETED|Period 2||1
9895399|NCT01107912|11010763|FG003|NOT COMPLETED|Period 2||0
9895400|NCT01107912|11010764|FG004|NOT COMPLETED|Period 2||0
9895401|NCT01107912|11010765|FG005|NOT COMPLETED|Period 2||0
9895402|NCT01107912|11010760|FG000|STARTED|Period 3||0
9895403|NCT01107912|11010761|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
9895404|NCT01107912|11010762|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
9895405|NCT01107912|11010763|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
9895406|NCT01107912|11010764|FG004|STARTED|Period 3||0
9895407|NCT01107912|11010765|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
9895408|NCT01107912|11010760|FG000|COMPLETED|Period 3||0
9895409|NCT01107912|11010761|FG001|COMPLETED|Period 3||34
9895410|NCT01107912|11010762|FG002|COMPLETED|Period 3||35
9895411|NCT01107912|11010763|FG003|COMPLETED|Period 3||37
9895412|NCT01107912|11010764|FG004|COMPLETED|Period 3||0
9895413|NCT01107912|11010765|FG005|COMPLETED|Period 3||41
9895414|NCT01107912|11010760|FG000|NOT COMPLETED|Period 3||0
9895415|NCT01107912|11010761|FG001|NOT COMPLETED|Period 3||1
9895416|NCT01107912|11010762|FG002|NOT COMPLETED|Period 3||1
9895417|NCT01107912|11010763|FG003|NOT COMPLETED|Period 3||1
9895418|NCT01107912|11010764|FG004|NOT COMPLETED|Period 3||0
9895419|NCT01107912|11010765|FG005|NOT COMPLETED|Period 3||0
9895420|NCT01107925|11010784|FG000|STARTED|Period 1-Randomization up Through Day 12||34
9895421|NCT01107925|11010785|FG001|STARTED|Period 1-Randomization up Through Day 12||0
9895422|NCT01107925|11010786|FG002|STARTED|Period 1-Randomization up Through Day 12||0
9895423|NCT01107925|11010787|FG003|STARTED|Period 1-Randomization up Through Day 12||0
9895424|NCT01107925|11010788|FG004|STARTED|Period 1-Randomization up Through Day 12||38
9895425|NCT01107925|11010789|FG005|STARTED|Period 1-Randomization up Through Day 12||0
9895426|NCT01107925|11010784|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
9895427|NCT01107925|11010785|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
9895428|NCT01107925|11010786|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
9895429|NCT01107925|11010787|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
9895430|NCT01107925|11010788|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
9895431|NCT01107925|11010789|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
9895432|NCT01107925|11010784|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33
9895433|NCT01107925|11010785|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0
9895434|NCT01107925|11010786|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0
9895435|NCT01107925|11010787|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0
9895436|NCT01107925|11010788|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37
9895437|NCT01107925|11010789|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0
9895438|NCT01107925|11010784|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
9895439|NCT01107925|11010785|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
9895440|NCT01107925|11010786|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
9895441|NCT01107925|11010787|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
9895442|NCT01107925|11010788|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
9895443|NCT01107925|11010789|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
9895444|NCT01107925|11010784|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
9895445|NCT01107925|11010785|FG001|STARTED|Period 2||16
9895446|NCT01107925|11010786|FG002|STARTED|Period 2||17
9895447|NCT01107925|11010787|FG003|STARTED|Period 2||20
9895448|NCT01107925|11010788|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
9895449|NCT01107925|11010789|FG005|STARTED|Period 2||17
9895450|NCT01107925|11010784|FG000|Took at Least 1 Dose of Study Drug|Period 2||0
9895451|NCT01107925|11010785|FG001|Took at Least 1 Dose of Study Drug|Period 2||16
9895452|NCT01107925|11010786|FG002|Took at Least 1 Dose of Study Drug|Period 2||17
9895453|NCT01107925|11010787|FG003|Took at Least 1 Dose of Study Drug|Period 2||20
9895454|NCT01107925|11010788|FG004|Took at Least 1 Dose of Study Drug|Period 2||0
9895455|NCT01107925|11010789|FG005|Took at Least 1 Dose of Study Drug|Period 2||17
9895456|NCT01107925|11010784|FG000|COMPLETED|Period 2||0
9895457|NCT01107925|11010785|FG001|COMPLETED|Period 2||15
9895458|NCT01107925|11010786|FG002|COMPLETED|Period 2||17
9895459|NCT01107925|11010787|FG003|COMPLETED|Period 2||20
9895460|NCT01107925|11010788|FG004|COMPLETED|Period 2||0
9895461|NCT01107925|11010789|FG005|COMPLETED|Period 2||16
9895462|NCT01107925|11010784|FG000|NOT COMPLETED|Period 2||0
9895463|NCT01107925|11010785|FG001|NOT COMPLETED|Period 2||1
9895464|NCT01107925|11010786|FG002|NOT COMPLETED|Period 2||0
9895465|NCT01107925|11010787|FG003|NOT COMPLETED|Period 2||0
9895466|NCT01107925|11010788|FG004|NOT COMPLETED|Period 2||0
9895467|NCT01107925|11010789|FG005|NOT COMPLETED|Period 2||1
9895468|NCT01107925|11010784|FG000|STARTED|Period 3||0
9895469|NCT01107925|11010785|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
9895470|NCT01107925|11010786|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
9895471|NCT01107925|11010787|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
9895472|NCT01107925|11010788|FG004|STARTED|Period 3||0
9895473|NCT01107925|11010789|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
9895474|NCT01107925|11010784|FG000|Took at Least 1 Dose of Study Drug|Period 3||0
9895475|NCT01107925|11010785|FG001|Took at Least 1 Dose of Study Drug|Period 3||17
9895476|NCT01107925|11010786|FG002|Took at Least 1 Dose of Study Drug|Period 3||15
9895477|NCT01107925|11010787|FG003|Took at Least 1 Dose of Study Drug|Period 3||16
9895478|NCT01107925|11010788|FG004|Took at Least 1 Dose of Study Drug|Period 3||0
9895479|NCT01107925|11010789|FG005|Took at Least 1 Dose of Study Drug|Period 3||20
9895480|NCT01107925|11010784|FG000|COMPLETED|Period 3||0
9895481|NCT01107925|11010785|FG001|COMPLETED|Period 3||17
9895482|NCT01107925|11010786|FG002|COMPLETED|Period 3||15
9895483|NCT01107925|11010787|FG003|COMPLETED|Period 3||16
9895484|NCT01107925|11010788|FG004|COMPLETED|Period 3||0
9895485|NCT01107925|11010789|FG005|COMPLETED|Period 3||20
9895486|NCT01107925|11010784|FG000|NOT COMPLETED|Period 3||0
9895487|NCT01107925|11010785|FG001|NOT COMPLETED|Period 3||0
9895488|NCT01107925|11010786|FG002|NOT COMPLETED|Period 3||0
9895489|NCT01107925|11010787|FG003|NOT COMPLETED|Period 3||0
9895490|NCT01107925|11010788|FG004|NOT COMPLETED|Period 3||0
9895491|NCT01107925|11010789|FG005|NOT COMPLETED|Period 3||0
9895492|NCT01107964|11010819|FG000|STARTED|Overall Study||13
9895493|NCT01107964|11010820|FG001|STARTED|Overall Study||14
9895494|NCT01107964|11010819|FG000|COMPLETED|Overall Study||12
9895495|NCT01107964|11010820|FG001|COMPLETED|Overall Study||13
9895496|NCT01107964|11010819|FG000|NOT COMPLETED|Overall Study||1
9895497|NCT01107964|11010820|FG001|NOT COMPLETED|Overall Study||1
9895498|NCT01108003|11010828|FG000|STARTED|Overall Study||4
9895499|NCT01108003|11010829|FG001|STARTED|Overall Study||3
9895500|NCT01108003|11010828|FG000|COMPLETED|Overall Study||4
9895501|NCT01108003|11010829|FG001|COMPLETED|Overall Study||3
9895502|NCT01108003|11010828|FG000|NOT COMPLETED|Overall Study||0
9895503|NCT01108003|11010829|FG001|NOT COMPLETED|Overall Study||0
9895504|NCT01108068|11010837|FG000|STARTED|Overall Study||10
9895505|NCT01108068|11010838|FG001|STARTED|Overall Study||16
9895506|NCT01108068|11010837|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
9895507|NCT01108068|11010838|FG001|COMPLETED|Overall Study||16
9895508|NCT01108068|11010837|FG000|NOT COMPLETED|Overall Study||6
9895509|NCT01108068|11010838|FG001|NOT COMPLETED|Overall Study||0
9895510|NCT01108081|11010849|FG000|STARTED|Overall Study||46
9895511|NCT01108081|11010850|FG001|STARTED|Overall Study||42
9895512|NCT01108081|11010851|FG002|STARTED|Overall Study||38
9895513|NCT01108081|11010852|FG003|STARTED|Overall Study||43
9895514|NCT01108081|11010849|FG000|COMPLETED|Overall Study||44
9895515|NCT01108081|11010850|FG001|COMPLETED|Overall Study||40
9895516|NCT01108081|11010851|FG002|COMPLETED|Overall Study||38
9895517|NCT01108081|11010852|FG003|COMPLETED|Overall Study||39
9895518|NCT01108081|11010849|FG000|NOT COMPLETED|Overall Study||2
9895519|NCT01108081|11010850|FG001|NOT COMPLETED|Overall Study||2
9895520|NCT01108081|11010851|FG002|NOT COMPLETED|Overall Study||0
9895521|NCT01108081|11010852|FG003|NOT COMPLETED|Overall Study||4
9895522|NCT01108094|11010866|FG000|STARTED|Overall Study||12
9895523|NCT01108094|11010867|FG001|STARTED|Overall Study||3
9895524|NCT01108094|11010868|FG002|STARTED|Overall Study||4
9895525|NCT01108094|11010869|FG003|STARTED|Overall Study||10
9895526|NCT01108094|11010866|FG000|COMPLETED|Overall Study||9
9895527|NCT01108094|11010867|FG001|COMPLETED|Overall Study||3
9895528|NCT01108094|11010868|FG002|COMPLETED|Overall Study||4
9895529|NCT01108094|11010869|FG003|COMPLETED|Overall Study||10
9895530|NCT01108094|11010866|FG000|NOT COMPLETED|Overall Study||3
9895531|NCT01108094|11010867|FG001|NOT COMPLETED|Overall Study||0
9895532|NCT01108094|11010868|FG002|NOT COMPLETED|Overall Study||0
9895533|NCT01108094|11010869|FG003|NOT COMPLETED|Overall Study||0
9895534|NCT01108185|11010882|FG000|STARTED|Overall Study||3181
9895535|NCT01108185|11010882|FG000|Per Protocol Population|Overall Study||3181
9895536|NCT01108185|11010882|FG000|COMPLETED|Overall Study||3154
9895537|NCT01108185|11010882|FG000|NOT COMPLETED|Overall Study||27
9895538|NCT01108237|11010888|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
9895539|NCT01108237|11010889|FG001|STARTED|Overall Study||101
9895540|NCT01108237|11010888|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
9895541|NCT01108237|11010889|FG001|COMPLETED|Overall Study||84
9895542|NCT01108237|11010888|FG000|NOT COMPLETED|Overall Study||9
9895543|NCT01108237|11010889|FG001|NOT COMPLETED|Overall Study||17
9895544|NCT01108263|11010897|FG000|STARTED|Overall Study||2
9895545|NCT01108263|11010898|FG001|STARTED|Overall Study||3
9895546|NCT01108263|11010897|FG000|COMPLETED|Overall Study||2
9895547|NCT01108263|11010898|FG001|COMPLETED|Overall Study||2
9895548|NCT01108263|11010897|FG000|NOT COMPLETED|Overall Study||0
9895549|NCT01108263|11010898|FG001|NOT COMPLETED|Overall Study||1
9895550|NCT01108341|11010904|FG000|STARTED|Overall Study||50
9895551|NCT01108341|11010904|FG000|Safety Set (Enrolled and Treated)|Overall Study||49
9895552|NCT01108341|11010904|FG000|COMPLETED|Overall Study||45
9895553|NCT01108341|11010904|FG000|NOT COMPLETED|Overall Study||5
9895554|NCT01108406|11010908|FG000|STARTED|Overall Study||22
9895555|NCT01108406|11010908|FG000|COMPLETED|Overall Study||22
9895556|NCT01108406|11010908|FG000|NOT COMPLETED|Overall Study||0
9895557|NCT01108445|11010916|FG000|STARTED|Overall Study||57
9895558|NCT01108445|11010917|FG001|STARTED|Overall Study||51
9895559|NCT01108445|11010916|FG000|COMPLETED|Overall Study||1
9895560|NCT01108445|11010917|FG001|COMPLETED|Overall Study||2
9895561|NCT01108445|11010916|FG000|NOT COMPLETED|Overall Study||56
9895562|NCT01108445|11010917|FG001|NOT COMPLETED|Overall Study||49
9895563|NCT01108458|11010923|FG000|STARTED|Overall Study||1
9895564|NCT01108458|11010923|FG000|COMPLETED|Overall Study||0
9895565|NCT01108458|11010923|FG000|NOT COMPLETED|Overall Study||1
9895566|NCT01108510|11010929|FG000|STARTED|Overall Study||349
9895567|NCT01108510|11010930|FG001|STARTED|Overall Study||349
9895568|NCT01108510|11010929|FG000|COMPLETED|Overall Study||70
9895569|NCT01108510|11010930|FG001|COMPLETED|Overall Study||81
9895570|NCT01108510|11010929|FG000|NOT COMPLETED|Overall Study||279
9895571|NCT01108510|11010930|FG001|NOT COMPLETED|Overall Study||268
9954769|NCT01433913|11073605|FG001|COMPLETED|Overall Study||10
9895572|NCT01108718|11010938|FG000|STARTED|Received First Intervention (2 Months)||5
9895573|NCT01108718|11010939|FG001|STARTED|Received First Intervention (2 Months)||7
9895574|NCT01108718|11010938|FG000|COMPLETED|Received First Intervention (2 Months)||5
9895575|NCT01108718|11010939|FG001|COMPLETED|Received First Intervention (2 Months)||7
9895576|NCT01108718|11010938|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0
9895577|NCT01108718|11010939|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0
9895578|NCT01108718|11010938|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
9895579|NCT01108718|11010939|FG001|STARTED|Received Second Intervention (2 Months)||7
9895580|NCT01108718|11010938|FG000|COMPLETED|Received Second Intervention (2 Months)||4
9895581|NCT01108718|11010939|FG001|COMPLETED|Received Second Intervention (2 Months)||7
9895582|NCT01108718|11010938|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1
9895583|NCT01108718|11010939|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0
9895584|NCT01108731|11010946|FG000|STARTED|Overall Study||17
9895585|NCT01108731|11010947|FG001|STARTED|Overall Study||17
9895586|NCT01108731|11010946|FG000|COMPLETED|Overall Study||13
9895587|NCT01108731|11010947|FG001|COMPLETED|Overall Study||13
9895588|NCT01108731|11010946|FG000|NOT COMPLETED|Overall Study||4
9895589|NCT01108731|11010947|FG001|NOT COMPLETED|Overall Study||4
9895590|NCT01108757|11010955|FG000|STARTED|Overall Study||26
9895591|NCT01108757|11010956|FG001|STARTED|Overall Study||26
9895592|NCT01108757|11010955|FG000|COMPLETED|Overall Study||26
9895593|NCT01108757|11010956|FG001|COMPLETED|Overall Study||26
9895594|NCT01108757|11010955|FG000|NOT COMPLETED|Overall Study||0
9895595|NCT01108757|11010956|FG001|NOT COMPLETED|Overall Study||0
9895596|NCT01108796|11010966|FG000|STARTED|Overall Study||774
9895597|NCT01108796|11010967|FG001|STARTED|Overall Study||1067
9895598|NCT01108796|11010966|FG000|COMPLETED|Overall Study||767
9895599|NCT01108796|11010967|FG001|COMPLETED|Overall Study||1060
9895600|NCT01108796|11010966|FG000|NOT COMPLETED|Overall Study||7
9895601|NCT01108796|11010967|FG001|NOT COMPLETED|Overall Study||7
9895602|NCT01108809|11010975|FG000|STARTED|Overall Study||295
9895603|NCT01108809|11010975|FG000|COMPLETED|Overall Study||291
9895604|NCT01108809|11010975|FG000|NOT COMPLETED|Overall Study||4
9895605|NCT01108835|11010982|FG000|STARTED|Overall Study||90
9895606|NCT01108835|11010983|FG001|STARTED|Overall Study||90
9895607|NCT01108835|11010982|FG000|COMPLETED|Overall Study||73
9895608|NCT01108835|11010983|FG001|COMPLETED|Overall Study||69
9895609|NCT01108835|11010982|FG000|NOT COMPLETED|Overall Study||17
9895610|NCT01108835|11010983|FG001|NOT COMPLETED|Overall Study||21
9895611|NCT01109056|11010992|FG000|STARTED|Overall Study||57
9895612|NCT01109056|11010993|FG001|STARTED|Overall Study||58
9895613|NCT01109056|11010992|FG000|COMPLETED|Overall Study||50
9895614|NCT01109056|11010993|FG001|COMPLETED|Overall Study||53
9895615|NCT01109056|11010992|FG000|NOT COMPLETED|Overall Study||7
9895616|NCT01109056|11010993|FG001|NOT COMPLETED|Overall Study||5
9895617|NCT01109069|11010999|FG000|STARTED|Overall Study||199
9895618|NCT01109069|11010999|FG000|COMPLETED|Overall Study||106
9895619|NCT01109069|11010999|FG000|NOT COMPLETED|Overall Study||93
9895620|NCT01109108|11011006|FG000|STARTED|Overall Study||4035
9895621|NCT01109108|11011007|FG001|STARTED|Overall Study||4755
9895622|NCT01109108|11011006|FG000|COMPLETED|Overall Study||4035
9895623|NCT01109108|11011007|FG001|COMPLETED|Overall Study||4755
9895624|NCT01109108|11011006|FG000|NOT COMPLETED|Overall Study||0
9895625|NCT01109108|11011007|FG001|NOT COMPLETED|Overall Study||0
10009006|NCT01763866|11131552|FG022|STARTED|Overall Study||112
10009007|NCT01763866|11131553|FG023|STARTED|Overall Study||115
10009008|NCT01763866|11131530|FG000|Received Treatment|Overall Study||56
10009009|NCT01763866|11131531|FG001|Received Treatment|Overall Study||55
10009010|NCT01763866|11131532|FG002|Received Treatment|Overall Study||56
10009011|NCT01763866|11131533|FG003|Received Treatment|Overall Study||55
9895626|NCT01109147|11011016|FG000|STARTED|Overall Study||17
9895627|NCT01109147|11011017|FG001|STARTED|Overall Study||14
9895628|NCT01109147|11011018|FG002|STARTED|Overall Study||36
9895629|NCT01109147|11011016|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15
9895630|NCT01109147|11011017|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11
9895631|NCT01109147|11011018|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26
9895632|NCT01109147|11011016|FG000|NOT COMPLETED|Overall Study||2
9895633|NCT01109147|11011017|FG001|NOT COMPLETED|Overall Study||3
9895634|NCT01109147|11011018|FG002|NOT COMPLETED|Overall Study||10
9895635|NCT01109173|11011030|FG000|STARTED|Overall Study||851
9895636|NCT01109173|11011031|FG001|STARTED|Overall Study||845
9895637|NCT01109173|11011032|FG002|STARTED|Overall Study||211
9895638|NCT01109173|11011033|FG003|STARTED|Overall Study||213
9895639|NCT01109173|11011030|FG000|COMPLETED|Overall Study||763
9895640|NCT01109173|11011031|FG001|COMPLETED|Overall Study||759
9895641|NCT01109173|11011032|FG002|COMPLETED|Overall Study||110
9895642|NCT01109173|11011033|FG003|COMPLETED|Overall Study||120
9895643|NCT01109173|11011030|FG000|NOT COMPLETED|Overall Study||88
9895644|NCT01109173|11011031|FG001|NOT COMPLETED|Overall Study||86
9895645|NCT01109173|11011032|FG002|NOT COMPLETED|Overall Study||101
10009012|NCT01763866|11131534|FG004|Received Treatment|Overall Study||110
9895646|NCT01109173|11011033|FG003|NOT COMPLETED|Overall Study||93
9895647|NCT01109316|11011049|FG000|STARTED|Study Period 1||22
9895648|NCT01109316|11011050|FG001|STARTED|Study Period 1||22
9895649|NCT01109316|11011051|FG002|STARTED|Study Period 1||22
9895650|NCT01109316|11011052|FG003|STARTED|Study Period 1||22
9895651|NCT01109316|11011053|FG004|STARTED|Study Period 1||22
9895652|NCT01109316|11011054|FG005|STARTED|Study Period 1||22
9895653|NCT01109316|11011049|FG000|Received at Least One Dose of Study Drug|Study Period 1||22
9895654|NCT01109316|11011050|FG001|Received at Least One Dose of Study Drug|Study Period 1||22
10009013|NCT01763866|11131535|FG005|Received Treatment|Overall Study||110
10009014|NCT01763866|11131536|FG006|Received Treatment|Overall Study||55
10009015|NCT01763866|11131537|FG007|Received Treatment|Overall Study||55
9895655|NCT01109316|11011051|FG002|Received at Least One Dose of Study Drug|Study Period 1||22
9895656|NCT01109316|11011052|FG003|Received at Least One Dose of Study Drug|Study Period 1||22
9895657|NCT01109316|11011053|FG004|Received at Least One Dose of Study Drug|Study Period 1||22
9895658|NCT01109316|11011054|FG005|Received at Least One Dose of Study Drug|Study Period 1||20
9895659|NCT01109316|11011049|FG000|COMPLETED|Study Period 1||22
9895660|NCT01109316|11011050|FG001|COMPLETED|Study Period 1||22
9895661|NCT01109316|11011051|FG002|COMPLETED|Study Period 1||19
9895662|NCT01109316|11011052|FG003|COMPLETED|Study Period 1||21
9895663|NCT01109316|11011053|FG004|COMPLETED|Study Period 1||20
9895664|NCT01109316|11011054|FG005|COMPLETED|Study Period 1||20
9895665|NCT01109316|11011049|FG000|NOT COMPLETED|Study Period 1||0
9895666|NCT01109316|11011050|FG001|NOT COMPLETED|Study Period 1||0
9895667|NCT01109316|11011051|FG002|NOT COMPLETED|Study Period 1||3
9895668|NCT01109316|11011052|FG003|NOT COMPLETED|Study Period 1||1
9895669|NCT01109316|11011053|FG004|NOT COMPLETED|Study Period 1||2
9895670|NCT01109316|11011054|FG005|NOT COMPLETED|Study Period 1||2
9895671|NCT01109316|11011049|FG000|STARTED|Study Period 2||22
9895672|NCT01109316|11011050|FG001|STARTED|Study Period 2||22
9895673|NCT01109316|11011051|FG002|STARTED|Study Period 2||19
9895674|NCT01109316|11011052|FG003|STARTED|Study Period 2||21
9895675|NCT01109316|11011053|FG004|STARTED|Study Period 2||20
9895676|NCT01109316|11011054|FG005|STARTED|Study Period 2||20
9895677|NCT01109316|11011049|FG000|COMPLETED|Study Period 2||21
9895678|NCT01109316|11011050|FG001|COMPLETED|Study Period 2||21
9895679|NCT01109316|11011051|FG002|COMPLETED|Study Period 2||18
9895680|NCT01109316|11011052|FG003|COMPLETED|Study Period 2||20
9895681|NCT01109316|11011053|FG004|COMPLETED|Study Period 2||20
9895682|NCT01109316|11011054|FG005|COMPLETED|Study Period 2||19
9895683|NCT01109316|11011049|FG000|NOT COMPLETED|Study Period 2||1
9895684|NCT01109316|11011050|FG001|NOT COMPLETED|Study Period 2||1
9895685|NCT01109316|11011051|FG002|NOT COMPLETED|Study Period 2||1
9895686|NCT01109316|11011052|FG003|NOT COMPLETED|Study Period 2||1
9895687|NCT01109316|11011053|FG004|NOT COMPLETED|Study Period 2||0
9895688|NCT01109316|11011054|FG005|NOT COMPLETED|Study Period 2||1
9895689|NCT01109316|11011049|FG000|STARTED|Study Period 3||21
9895690|NCT01109316|11011050|FG001|STARTED|Study Period 3||21
9895691|NCT01109316|11011051|FG002|STARTED|Study Period 3||18
9895692|NCT01109316|11011052|FG003|STARTED|Study Period 3||20
9895693|NCT01109316|11011053|FG004|STARTED|Study Period 3||20
9895694|NCT01109316|11011054|FG005|STARTED|Study Period 3||19
9895695|NCT01109316|11011049|FG000|COMPLETED|Study Period 3||20
9895696|NCT01109316|11011050|FG001|COMPLETED|Study Period 3||21
9895697|NCT01109316|11011051|FG002|COMPLETED|Study Period 3||18
9895698|NCT01109316|11011052|FG003|COMPLETED|Study Period 3||20
9895699|NCT01109316|11011053|FG004|COMPLETED|Study Period 3||18
9895700|NCT01109316|11011054|FG005|COMPLETED|Study Period 3||19
9895701|NCT01109316|11011049|FG000|NOT COMPLETED|Study Period 3||1
9895702|NCT01109316|11011050|FG001|NOT COMPLETED|Study Period 3||0
9895703|NCT01109316|11011051|FG002|NOT COMPLETED|Study Period 3||0
9895704|NCT01109316|11011052|FG003|NOT COMPLETED|Study Period 3||0
9895705|NCT01109316|11011053|FG004|NOT COMPLETED|Study Period 3||2
9895706|NCT01109316|11011054|FG005|NOT COMPLETED|Study Period 3||0
9895707|NCT01109381|11011062|FG000|STARTED|Overall Study||33
9895708|NCT01109381|11011062|FG000|COMPLETED|Overall Study||31
9895709|NCT01109381|11011062|FG000|NOT COMPLETED|Overall Study||2
9895710|NCT01109524|11011068|FG000|STARTED|Overall Study||60
9895711|NCT01109524|11011068|FG000|COMPLETED|Overall Study||3
9895712|NCT01109524|11011068|FG000|NOT COMPLETED|Overall Study||57
9895713|NCT01109576|11011072|FG000|STARTED|Overall Study||13
9895714|NCT01109576|11011072|FG000|COMPLETED|Overall Study||12
9895715|NCT01109576|11011072|FG000|NOT COMPLETED|Overall Study||1
9895716|NCT01109602|11011079|FG000|STARTED|Overall Study||14
9895717|NCT01109602|11011080|FG001|STARTED|Overall Study||23
9895718|NCT01109602|11011081|FG002|STARTED|Overall Study||10
9895719|NCT01109602|11011079|FG000|COMPLETED|Overall Study||13
9895720|NCT01109602|11011080|FG001|COMPLETED|Overall Study||21
9895721|NCT01109602|11011081|FG002|COMPLETED|Overall Study||9
9895722|NCT01109602|11011079|FG000|NOT COMPLETED|Overall Study||1
9895723|NCT01109602|11011080|FG001|NOT COMPLETED|Overall Study||2
9895724|NCT01109602|11011081|FG002|NOT COMPLETED|Overall Study||1
9895725|NCT01109849|11011090|FG000|STARTED|Initial Randomization: ADHD Treatment||50
9895726|NCT01109849|11011091|FG001|STARTED|Initial Randomization: ADHD Treatment||180
9895727|NCT01109849|11011092|FG002|STARTED|Initial Randomization: ADHD Treatment||0
9895728|NCT01109849|11011093|FG003|STARTED|Initial Randomization: ADHD Treatment||0
10009016|NCT01763866|11131538|FG008|Received Treatment|Overall Study||56
10009017|NCT01763866|11131539|FG009|Received Treatment|Overall Study||54
10009018|NCT01763866|11131540|FG010|Received Treatment|Overall Study||109
9895729|NCT01109849|11011094|FG004|STARTED|Initial Randomization: ADHD Treatment||0
9895730|NCT01109849|11011090|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32
9895731|NCT01109849|11011091|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131
9895732|NCT01109849|11011092|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0
9895733|NCT01109849|11011093|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0
9895734|NCT01109849|11011094|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0
9895735|NCT01109849|11011090|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
9895736|NCT01109849|11011091|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
9895737|NCT01109849|11011092|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
9895738|NCT01109849|11011093|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
9895739|NCT01109849|11011094|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
9895740|NCT01109849|11011090|FG000|STARTED|Adaptive Randomization: Weight Recovery||0
9895741|NCT01109849|11011091|FG001|STARTED|Adaptive Randomization: Weight Recovery||0
9895742|NCT01109849|11011092|FG002|STARTED|Adaptive Randomization: Weight Recovery||24
9895743|NCT01109849|11011093|FG003|STARTED|Adaptive Randomization: Weight Recovery||23
9895744|NCT01109849|11011094|FG004|STARTED|Adaptive Randomization: Weight Recovery||25
9895745|NCT01109849|11011090|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0
9895746|NCT01109849|11011091|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0
9895747|NCT01109849|11011092|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23
9895748|NCT01109849|11011093|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20
9895749|NCT01109849|11011094|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24
9895750|NCT01109849|11011090|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
9895751|NCT01109849|11011091|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
9895752|NCT01109849|11011092|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
9895753|NCT01109849|11011093|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
9895754|NCT01109849|11011094|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
9895755|NCT01109940|11011118|FG000|STARTED|Overall Study||21
9895756|NCT01109940|11011119|FG001|STARTED|Overall Study||8
9895757|NCT01109940|11011120|FG002|STARTED|Overall Study||7
9895758|NCT01109940|11011121|FG003|STARTED|Overall Study||3
9895759|NCT01109940|11011118|FG000|COMPLETED|Overall Study||13
9895760|NCT01109940|11011119|FG001|COMPLETED|Overall Study||6
9895761|NCT01109940|11011120|FG002|COMPLETED|Overall Study||6
9895762|NCT01109940|11011121|FG003|COMPLETED|Overall Study||3
9895763|NCT01109940|11011118|FG000|NOT COMPLETED|Overall Study||8
9895764|NCT01109940|11011119|FG001|NOT COMPLETED|Overall Study||2
9895765|NCT01109940|11011120|FG002|NOT COMPLETED|Overall Study||1
9895766|NCT01109940|11011121|FG003|NOT COMPLETED|Overall Study||0
9895767|NCT01109979|11011133|FG000|STARTED|Overall Study||12
9895768|NCT01109979|11011134|FG001|STARTED|Overall Study||12
9895769|NCT01109979|11011133|FG000|COMPLETED|Overall Study||10
9895770|NCT01109979|11011134|FG001|COMPLETED|Overall Study||11
9895771|NCT01109979|11011133|FG000|NOT COMPLETED|Overall Study||2
9895772|NCT01109979|11011134|FG001|NOT COMPLETED|Overall Study||1
9895773|NCT01109992|11011142|FG000|STARTED|Overall Study||11
9895774|NCT01109992|11011143|FG001|STARTED|Overall Study||32
9895775|NCT01109992|11011142|FG000|Subjects Enrolled|Overall Study||11
9895776|NCT01109992|11011143|FG001|Subjects Enrolled|Overall Study||32
9895777|NCT01109992|11011142|FG000|COMPLETED|Overall Study||11
9895778|NCT01109992|11011143|FG001|COMPLETED|Overall Study||30
9895779|NCT01109992|11011142|FG000|NOT COMPLETED|Overall Study||0
9895780|NCT01109992|11011143|FG001|NOT COMPLETED|Overall Study||2
9895781|NCT01110005|11011154|FG000|STARTED|Overall Study||157
9895782|NCT01110005|11011155|FG001|STARTED|Overall Study||161
9895783|NCT01110005|11011154|FG000|COMPLETED|Overall Study||153
9895784|NCT01110005|11011155|FG001|COMPLETED|Overall Study||156
9895785|NCT01110005|11011154|FG000|NOT COMPLETED|Overall Study||4
9895786|NCT01110005|11011155|FG001|NOT COMPLETED|Overall Study||5
9895787|NCT01110135|11011161|FG000|STARTED|Overall Study||43
9895788|NCT01110135|11011161|FG000|COMPLETED|Overall Study||34
9895789|NCT01110135|11011161|FG000|NOT COMPLETED|Overall Study||9
9895790|NCT01110187|11011167|FG000|STARTED|Overall Study||7
9895791|NCT01110187|11011168|FG001|STARTED|Overall Study||4
9895792|NCT01110187|11011167|FG000|COMPLETED|Overall Study|completed 7 day treatment|7
9895793|NCT01110187|11011168|FG001|COMPLETED|Overall Study|completed 7 day treatment|4
9895794|NCT01110187|11011167|FG000|NOT COMPLETED|Overall Study||0
9895795|NCT01110187|11011168|FG001|NOT COMPLETED|Overall Study||0
9895796|NCT01110200|11011178|FG000|STARTED|Overall Study||314
9895797|NCT01110200|11011179|FG001|STARTED|Overall Study||325
9895798|NCT01110200|11011178|FG000|COMPLETED|Overall Study||208
9895799|NCT01110200|11011179|FG001|COMPLETED|Overall Study||204
9895800|NCT01110200|11011178|FG000|NOT COMPLETED|Overall Study||106
9895801|NCT01110200|11011179|FG001|NOT COMPLETED|Overall Study||121
9895802|NCT01110239|11011189|FG000|STARTED|Sham Preconditioning||7
9895803|NCT01110239|11011190|FG001|STARTED|Sham Preconditioning||14
9895804|NCT01110239|11011191|FG002|STARTED|Sham Preconditioning||7
9895805|NCT01110239|11011192|FG003|STARTED|Sham Preconditioning||6
9895806|NCT01110239|11011189|FG000|COMPLETED|Sham Preconditioning||7
9895807|NCT01110239|11011190|FG001|COMPLETED|Sham Preconditioning||14
9895808|NCT01110239|11011191|FG002|COMPLETED|Sham Preconditioning||6
9895809|NCT01110239|11011192|FG003|COMPLETED|Sham Preconditioning||6
9895810|NCT01110239|11011189|FG000|NOT COMPLETED|Sham Preconditioning||0
9895811|NCT01110239|11011190|FG001|NOT COMPLETED|Sham Preconditioning||0
9895812|NCT01110239|11011191|FG002|NOT COMPLETED|Sham Preconditioning||1
9895813|NCT01110239|11011192|FG003|NOT COMPLETED|Sham Preconditioning||0
9895814|NCT01110239|11011189|FG000|STARTED|5 Min Ischemia||0
9895815|NCT01110239|11011190|FG001|STARTED|5 Min Ischemia||14
9895816|NCT01110239|11011191|FG002|STARTED|5 Min Ischemia||0
9895817|NCT01110239|11011192|FG003|STARTED|5 Min Ischemia||0
9895818|NCT01110239|11011189|FG000|COMPLETED|5 Min Ischemia||0
9895819|NCT01110239|11011190|FG001|COMPLETED|5 Min Ischemia||0
9895820|NCT01110239|11011191|FG002|COMPLETED|5 Min Ischemia||0
9895821|NCT01110239|11011192|FG003|COMPLETED|5 Min Ischemia||0
9895822|NCT01110239|11011189|FG000|NOT COMPLETED|5 Min Ischemia||0
9895823|NCT01110239|11011190|FG001|NOT COMPLETED|5 Min Ischemia||14
9895824|NCT01110239|11011191|FG002|NOT COMPLETED|5 Min Ischemia||0
9895825|NCT01110239|11011192|FG003|NOT COMPLETED|5 Min Ischemia||0
9895826|NCT01110239|11011189|FG000|STARTED|7.5 Min Ischemia||0
9895827|NCT01110239|11011190|FG001|STARTED|7.5 Min Ischemia||0
9895828|NCT01110239|11011191|FG002|STARTED|7.5 Min Ischemia||7
9895829|NCT01110239|11011192|FG003|STARTED|7.5 Min Ischemia||0
9895830|NCT01110239|11011189|FG000|COMPLETED|7.5 Min Ischemia||0
9895831|NCT01110239|11011190|FG001|COMPLETED|7.5 Min Ischemia||0
9895832|NCT01110239|11011191|FG002|COMPLETED|7.5 Min Ischemia||6
9895833|NCT01110239|11011192|FG003|COMPLETED|7.5 Min Ischemia||0
9895834|NCT01110239|11011189|FG000|NOT COMPLETED|7.5 Min Ischemia||0
9895835|NCT01110239|11011190|FG001|NOT COMPLETED|7.5 Min Ischemia||0
9895836|NCT01110239|11011191|FG002|NOT COMPLETED|7.5 Min Ischemia||1
9895837|NCT01110239|11011192|FG003|NOT COMPLETED|7.5 Min Ischemia||0
9895838|NCT01110239|11011189|FG000|STARTED|10 Min Ischemia||0
9895839|NCT01110239|11011190|FG001|STARTED|10 Min Ischemia||0
9895840|NCT01110239|11011191|FG002|STARTED|10 Min Ischemia||0
9895841|NCT01110239|11011192|FG003|STARTED|10 Min Ischemia||6
9895842|NCT01110239|11011189|FG000|COMPLETED|10 Min Ischemia||0
9895843|NCT01110239|11011190|FG001|COMPLETED|10 Min Ischemia||0
9895844|NCT01110239|11011191|FG002|COMPLETED|10 Min Ischemia||0
9895845|NCT01110239|11011192|FG003|COMPLETED|10 Min Ischemia||6
9895846|NCT01110239|11011189|FG000|NOT COMPLETED|10 Min Ischemia||0
9895847|NCT01110239|11011190|FG001|NOT COMPLETED|10 Min Ischemia||0
9895848|NCT01110239|11011191|FG002|NOT COMPLETED|10 Min Ischemia||0
9895849|NCT01110239|11011192|FG003|NOT COMPLETED|10 Min Ischemia||0
9895850|NCT01110252|11011203|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4
9895851|NCT01110252|11011203|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
9895852|NCT01110252|11011203|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
9895853|NCT01110252|11011203|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4
9895854|NCT01110252|11011203|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4
9895855|NCT01110252|11011203|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
9895856|NCT01110330|11011211|FG000|STARTED|Overall Study||119
9895857|NCT01110330|11011212|FG001|STARTED|Overall Study||230
9895858|NCT01110330|11011213|FG002|STARTED|Overall Study||234
9895859|NCT01110330|11011211|FG000|Positive Baseline Culture Set|Overall Study||56
9895860|NCT01110330|11011212|FG001|Positive Baseline Culture Set|Overall Study||111
9895861|NCT01110330|11011213|FG002|Positive Baseline Culture Set|Overall Study||114
9895862|NCT01110330|11011211|FG000|COMPLETED|Overall Study||104
9895863|NCT01110330|11011212|FG001|COMPLETED|Overall Study||207
9895864|NCT01110330|11011213|FG002|COMPLETED|Overall Study||208
9895865|NCT01110330|11011211|FG000|NOT COMPLETED|Overall Study||15
9895866|NCT01110330|11011212|FG001|NOT COMPLETED|Overall Study||23
9895867|NCT01110330|11011213|FG002|NOT COMPLETED|Overall Study||26
9895868|NCT01110382|11011223|FG000|STARTED|Overall Study||31
9895869|NCT01110382|11011224|FG001|STARTED|Overall Study||10
9895870|NCT01110382|11011223|FG000|COMPLETED|Overall Study||31
9895871|NCT01110382|11011224|FG001|COMPLETED|Overall Study||8
9895872|NCT01110382|11011223|FG000|NOT COMPLETED|Overall Study||0
9895873|NCT01110382|11011224|FG001|NOT COMPLETED|Overall Study||2
9895874|NCT01110395|11011230|FG000|STARTED|Overall Study||15
9895875|NCT01110395|11011230|FG000|COMPLETED|Overall Study||15
9895876|NCT01110395|11011230|FG000|NOT COMPLETED|Overall Study||0
9895877|NCT01110408|11011236|FG000|STARTED|Overall Study||31
9895878|NCT01110408|11011237|FG001|STARTED|Overall Study||10
9895879|NCT01110408|11011236|FG000|COMPLETED|Overall Study||30
9895880|NCT01110408|11011237|FG001|COMPLETED|Overall Study||10
9895881|NCT01110408|11011236|FG000|NOT COMPLETED|Overall Study||1
9895882|NCT01110408|11011237|FG001|NOT COMPLETED|Overall Study||0
9895883|NCT01110421|11011245|FG000|STARTED|Overall Study||5
9895884|NCT01110421|11011246|FG001|STARTED|Overall Study||2
9895885|NCT01110421|11011245|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
9895886|NCT01110421|11011246|FG001|COMPLETED|Overall Study||2
9895887|NCT01110421|11011245|FG000|NOT COMPLETED|Overall Study||0
9895888|NCT01110421|11011246|FG001|NOT COMPLETED|Overall Study||0
9895889|NCT01110434|11011254|FG000|STARTED|Overall Study||40
9895890|NCT01110434|11011255|FG001|STARTED|Overall Study||26
9895891|NCT01110434|11011254|FG000|COMPLETED|Overall Study||29
9895892|NCT01110434|11011255|FG001|COMPLETED|Overall Study||20
9895893|NCT01110434|11011254|FG000|NOT COMPLETED|Overall Study||11
9895894|NCT01110434|11011255|FG001|NOT COMPLETED|Overall Study||6
9895895|NCT01110499|11011269|FG000|STARTED|Overall Study||14
9895896|NCT01110499|11011270|FG001|STARTED|Overall Study||14
9895897|NCT01110499|11011271|FG002|STARTED|Overall Study||14
9895898|NCT01110499|11011272|FG003|STARTED|Overall Study||14
9895899|NCT01110499|11011273|FG004|STARTED|Overall Study||14
9895900|NCT01110499|11011274|FG005|STARTED|Overall Study||14
9895901|NCT01110499|11011275|FG006|STARTED|Overall Study||39
9895902|NCT01110499|11011276|FG007|STARTED|Overall Study||40
9895903|NCT01110499|11011269|FG000|COMPLETED|Overall Study||14
9895904|NCT01110499|11011270|FG001|COMPLETED|Overall Study||14
9895905|NCT01110499|11011271|FG002|COMPLETED|Overall Study||14
9895906|NCT01110499|11011272|FG003|COMPLETED|Overall Study||14
9895907|NCT01110499|11011273|FG004|COMPLETED|Overall Study||14
9895908|NCT01110499|11011274|FG005|COMPLETED|Overall Study||14
9895909|NCT01110499|11011275|FG006|COMPLETED|Overall Study||39
9895910|NCT01110499|11011276|FG007|COMPLETED|Overall Study||40
9895911|NCT01110499|11011269|FG000|NOT COMPLETED|Overall Study||0
9895912|NCT01110499|11011270|FG001|NOT COMPLETED|Overall Study||0
9895913|NCT01110499|11011271|FG002|NOT COMPLETED|Overall Study||0
9895914|NCT01110499|11011272|FG003|NOT COMPLETED|Overall Study||0
9895915|NCT01110499|11011273|FG004|NOT COMPLETED|Overall Study||0
9895916|NCT01110499|11011274|FG005|NOT COMPLETED|Overall Study||0
9895917|NCT01110499|11011275|FG006|NOT COMPLETED|Overall Study||0
9895918|NCT01110499|11011276|FG007|NOT COMPLETED|Overall Study||0
9895919|NCT01110681|11011296|FG000|STARTED|Overall Study||115
9895920|NCT01110681|11011296|FG000|COMPLETED|Overall Study||83
9895921|NCT01110681|11011296|FG000|NOT COMPLETED|Overall Study||32
9895922|NCT01110707|11011302|FG000|STARTED|Overall Study||63
9895923|NCT01110707|11011303|FG001|STARTED|Overall Study||68
9895924|NCT01110707|11011302|FG000|COMPLETED|Overall Study||63
9895925|NCT01110707|11011303|FG001|COMPLETED|Overall Study||65
9895926|NCT01110707|11011302|FG000|NOT COMPLETED|Overall Study||0
9895927|NCT01110707|11011303|FG001|NOT COMPLETED|Overall Study||3
9895928|NCT01110876|11011312|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
9895929|NCT01110876|11011313|FG001|STARTED|Overall Study||5
9895930|NCT01110876|11011312|FG000|COMPLETED|Overall Study||13
9895931|NCT01110876|11011313|FG001|COMPLETED|Overall Study||5
9895932|NCT01110876|11011312|FG000|NOT COMPLETED|Overall Study||0
9895933|NCT01110876|11011313|FG001|NOT COMPLETED|Overall Study||0
9895934|NCT01110915|11011322|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
9895935|NCT01110915|11011323|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86
9895936|NCT01110915|11011322|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
9895937|NCT01110915|11011323|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
9895938|NCT01110915|11011322|FG000|NOT COMPLETED|Overall Study||10
9895939|NCT01110915|11011323|FG001|NOT COMPLETED|Overall Study||2
9895940|NCT01110967|11011330|FG000|STARTED|Overall Study||40
9895941|NCT01110967|11011330|FG000|Surgery|Overall Study||40
9895942|NCT01110967|11011330|FG000|1 Month Follow up|Overall Study||26
9895943|NCT01110967|11011330|FG000|3 Months Follow up|Overall Study||28
9895944|NCT01110967|11011330|FG000|6 Months Follow up|Overall Study||24
9895945|NCT01110967|11011330|FG000|12 Months Follow up|Overall Study||31
9895946|NCT01110967|11011330|FG000|COMPLETED|Overall Study||31
9895947|NCT01110967|11011330|FG000|NOT COMPLETED|Overall Study||9
9895948|NCT01111058|11011336|FG000|STARTED|Overall Study||28
9895949|NCT01111058|11011337|FG001|STARTED|Overall Study||24
9895950|NCT01111058|11011336|FG000|COMPLETED|Overall Study||28
9895951|NCT01111058|11011337|FG001|COMPLETED|Overall Study||24
9895952|NCT01111058|11011336|FG000|NOT COMPLETED|Overall Study||0
9895953|NCT01111058|11011337|FG001|NOT COMPLETED|Overall Study||0
9895954|NCT01111123|11011345|FG000|STARTED|Open- Label Phase||55
9895955|NCT01111123|11011346|FG001|STARTED|Open- Label Phase||0
9895956|NCT01111123|11011345|FG000|COMPLETED|Open- Label Phase||41
9895957|NCT01111123|11011346|FG001|COMPLETED|Open- Label Phase||0
9895958|NCT01111123|11011345|FG000|NOT COMPLETED|Open- Label Phase||14
9895959|NCT01111123|11011346|FG001|NOT COMPLETED|Open- Label Phase||0
10110180|NCT02482935|11240942|FG000|STARTED|Period 1||15
10110181|NCT02482935|11240943|FG001|STARTED|Period 1||15
10110182|NCT02482935|11240942|FG000|Received Abemaciclib|Period 1||15
10110183|NCT02482935|11240943|FG001|Received Abemaciclib|Period 1||15
10110184|NCT02482935|11240942|FG000|Washout|Period 1||15
10110185|NCT02482935|11240943|FG001|Washout|Period 1||15
10110186|NCT02482935|11240942|FG000|COMPLETED|Period 1||14
10110187|NCT02482935|11240943|FG001|COMPLETED|Period 1||15
10110188|NCT02482935|11240942|FG000|NOT COMPLETED|Period 1||1
10110189|NCT02482935|11240943|FG001|NOT COMPLETED|Period 1||0
10110190|NCT02482935|11240942|FG000|STARTED|Period 2||14
10110191|NCT02482935|11240943|FG001|STARTED|Period 2||15
10110192|NCT02482935|11240942|FG000|Received Abemaciclib|Period 2||14
9895960|NCT01111123|11011345|FG000|STARTED|Maintenance Phase||21
9895961|NCT01111123|11011346|FG001|STARTED|Maintenance Phase||20
9895962|NCT01111123|11011345|FG000|COMPLETED|Maintenance Phase||21
9895963|NCT01111123|11011346|FG001|COMPLETED|Maintenance Phase||18
9895964|NCT01111123|11011345|FG000|NOT COMPLETED|Maintenance Phase||0
9895965|NCT01111123|11011346|FG001|NOT COMPLETED|Maintenance Phase||2
9895966|NCT01111149|11011357|FG000|STARTED|Overall Study||9
9895967|NCT01111149|11011358|FG001|STARTED|Overall Study||6
9895968|NCT01111149|11011359|FG002|STARTED|Overall Study||9
9895969|NCT01111149|11011357|FG000|COMPLETED|Overall Study||7
9895970|NCT01111149|11011358|FG001|COMPLETED|Overall Study||5
9895971|NCT01111149|11011359|FG002|COMPLETED|Overall Study||5
9895972|NCT01111149|11011357|FG000|NOT COMPLETED|Overall Study||2
9895973|NCT01111149|11011358|FG001|NOT COMPLETED|Overall Study||1
9895974|NCT01111149|11011359|FG002|NOT COMPLETED|Overall Study||4
9895975|NCT01111162|11011367|FG000|STARTED|Overall Study||120
9895976|NCT01111162|11011367|FG000|COMPLETED|Overall Study||120
9895977|NCT01111162|11011367|FG000|NOT COMPLETED|Overall Study||0
9895978|NCT01111240|11011372|FG000|STARTED|Overall Study||4635
9895979|NCT01111240|11011372|FG000|COMPLETED|Overall Study||3569
9895980|NCT01111240|11011372|FG000|NOT COMPLETED|Overall Study||1066
9895981|NCT01111292|11011378|FG000|STARTED|Randomization||3
10110193|NCT02482935|11240943|FG001|Received Abemaciclib|Period 2||15
10110194|NCT02482935|11240942|FG000|Follow-up|Period 2||14
10110195|NCT02482935|11240943|FG001|Follow-up|Period 2||15
10110196|NCT02482935|11240942|FG000|COMPLETED|Period 2||14
9895982|NCT01111292|11011379|FG001|STARTED|Randomization||2
9895983|NCT01111292|11011378|FG000|COMPLETED|Randomization||3
9895984|NCT01111292|11011379|FG001|COMPLETED|Randomization||2
9895985|NCT01111292|11011378|FG000|NOT COMPLETED|Randomization||0
9895986|NCT01111292|11011379|FG001|NOT COMPLETED|Randomization||0
9895987|NCT01111292|11011378|FG000|STARTED|Treatment||3
9895988|NCT01111292|11011379|FG001|STARTED|Treatment||2
9895989|NCT01111292|11011378|FG000|COMPLETED|Treatment||2
9895990|NCT01111292|11011379|FG001|COMPLETED|Treatment||1
9895991|NCT01111292|11011378|FG000|NOT COMPLETED|Treatment||1
9895992|NCT01111292|11011379|FG001|NOT COMPLETED|Treatment||1
9895993|NCT01111292|11011378|FG000|STARTED|Post Treatment Biopsy||2
9895994|NCT01111292|11011379|FG001|STARTED|Post Treatment Biopsy||1
9895995|NCT01111292|11011378|FG000|COMPLETED|Post Treatment Biopsy||2
9895996|NCT01111292|11011379|FG001|COMPLETED|Post Treatment Biopsy||1
9895997|NCT01111292|11011378|FG000|NOT COMPLETED|Post Treatment Biopsy||0
9895998|NCT01111292|11011379|FG001|NOT COMPLETED|Post Treatment Biopsy||0
10009019|NCT01763866|11131541|FG011|Received Treatment|Overall Study||110
10009020|NCT01763866|11131542|FG012|Received Treatment|Overall Study||58
9895999|NCT01111292|11011378|FG000|STARTED|Follow-Up||2
9896000|NCT01111292|11011379|FG001|STARTED|Follow-Up||1
9896001|NCT01111292|11011378|FG000|COMPLETED|Follow-Up||2
9896002|NCT01111292|11011379|FG001|COMPLETED|Follow-Up||1
9896003|NCT01111292|11011378|FG000|NOT COMPLETED|Follow-Up||0
9896004|NCT01111292|11011379|FG001|NOT COMPLETED|Follow-Up||0
9896005|NCT01111318|11011389|FG000|STARTED|Overall Study||12
9896006|NCT01111318|11011390|FG001|STARTED|Overall Study||8
9896007|NCT01111318|11011391|FG002|STARTED|Overall Study||8
9896008|NCT01111318|11011392|FG003|STARTED|Overall Study||8
9896009|NCT01111318|11011389|FG000|COMPLETED|Overall Study||12
9896010|NCT01111318|11011390|FG001|COMPLETED|Overall Study||8
9896011|NCT01111318|11011391|FG002|COMPLETED|Overall Study||8
9896012|NCT01111318|11011392|FG003|COMPLETED|Overall Study||8
9896013|NCT01111318|11011389|FG000|NOT COMPLETED|Overall Study||0
9896014|NCT01111318|11011390|FG001|NOT COMPLETED|Overall Study||0
9896015|NCT01111318|11011391|FG002|NOT COMPLETED|Overall Study||0
9896016|NCT01111318|11011392|FG003|NOT COMPLETED|Overall Study||0
9896017|NCT01111331|11011402|FG000|STARTED|Overall Study||9
9896018|NCT01111331|11011403|FG001|STARTED|Overall Study||9
9896019|NCT01111331|11011402|FG000|COMPLETED|Overall Study||9
9896020|NCT01111331|11011403|FG001|COMPLETED|Overall Study||9
9896021|NCT01111331|11011402|FG000|NOT COMPLETED|Overall Study||0
9896022|NCT01111331|11011403|FG001|NOT COMPLETED|Overall Study||0
9896023|NCT01111370|11011413|FG000|STARTED|Overall Study||60
9896024|NCT01111370|11011413|FG000|COMPLETED|Overall Study||58
9896025|NCT01111370|11011413|FG000|NOT COMPLETED|Overall Study||2
9896026|NCT01111461|11011417|FG000|STARTED|Overall Study||133
9896027|NCT01111461|11011417|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
9760425|NCT00380744|10864045|FG001|NOT COMPLETED|Overall Study||0
9760426|NCT00380744|10864046|FG002|NOT COMPLETED|Overall Study||0
9760427|NCT00380744|10864047|FG003|NOT COMPLETED|Overall Study||0
9760428|NCT00380744|10864048|FG004|NOT COMPLETED|Overall Study||0
9760429|NCT00380744|10864049|FG005|NOT COMPLETED|Overall Study||0
9760430|NCT00380744|10864050|FG006|NOT COMPLETED|Overall Study||1
9896028|NCT01111461|11011417|FG000|NOT COMPLETED|Overall Study||51
9896029|NCT01111474|11011421|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
9896030|NCT01111474|11011421|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
9896031|NCT01111474|11011421|FG000|NOT COMPLETED|Overall Study||12
9896032|NCT01111526|11011427|FG000|STARTED|Overall Study||4
9896033|NCT01111526|11011428|FG001|STARTED|Overall Study||8
9896034|NCT01111526|11011429|FG002|STARTED|Overall Study||10
9896035|NCT01111526|11011427|FG000|COMPLETED|Overall Study||4
9896036|NCT01111526|11011428|FG001|COMPLETED|Overall Study||7
9896037|NCT01111526|11011429|FG002|COMPLETED|Overall Study||8
9896038|NCT01111526|11011427|FG000|NOT COMPLETED|Overall Study||0
9896039|NCT01111526|11011428|FG001|NOT COMPLETED|Overall Study||1
9896040|NCT01111526|11011429|FG002|NOT COMPLETED|Overall Study||2
9896041|NCT01111539|11011433|FG000|STARTED|Phase B (Day 1 to Week 8)||211
9896042|NCT01111539|11011434|FG001|STARTED|Phase B (Day 1 to Week 8)||0
9896043|NCT01111539|11011435|FG002|STARTED|Phase B (Day 1 to Week 8)||0
9896044|NCT01111539|11011436|FG003|STARTED|Phase B (Day 1 to Week 8)||0
9896045|NCT01111539|11011437|FG004|STARTED|Phase B (Day 1 to Week 8)||0
9896046|NCT01111539|11011433|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129
9896047|NCT01111539|11011434|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
9896048|NCT01111539|11011435|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
9896049|NCT01111539|11011436|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
9896050|NCT01111539|11011437|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
9760431|NCT00380861|10864069|FG000|STARTED|Overall Study||93
9760432|NCT00380861|10864070|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
9760433|NCT00380861|10864069|FG000|COMPLETED|Overall Study||75
9896051|NCT01111539|11011433|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82
9896052|NCT01111539|11011434|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10009021|NCT01763866|11131543|FG013|Received Treatment|Overall Study||57
9896053|NCT01111539|11011435|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
9896054|NCT01111539|11011436|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
9896055|NCT01111539|11011437|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
9896056|NCT01111539|11011433|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
9760434|NCT00380861|10864070|FG001|COMPLETED|Overall Study||74
9896057|NCT01111539|11011434|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45
9896058|NCT01111539|11011435|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
9896059|NCT01111539|11011436|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
9896060|NCT01111539|11011437|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
9896061|NCT01111539|11011433|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
9896062|NCT01111539|11011434|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
9896063|NCT01111539|11011435|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
9896064|NCT01111539|11011436|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
9896065|NCT01111539|11011437|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
9896066|NCT01111539|11011433|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
9896067|NCT01111539|11011434|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
9896068|NCT01111539|11011435|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
9896069|NCT01111539|11011436|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
9896070|NCT01111539|11011437|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
9896071|NCT01111539|11011433|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
9896072|NCT01111539|11011434|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38
9896073|NCT01111539|11011435|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22
9896074|NCT01111539|11011436|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20
9896075|NCT01111539|11011437|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
9896076|NCT01111539|11011433|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
9896077|NCT01111539|11011434|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7
9896078|NCT01111539|11011435|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6
9896079|NCT01111539|11011436|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8
9896080|NCT01111539|11011437|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10
9896081|NCT01111552|11011447|FG000|STARTED|Phase B (Day 1 to Week 8)||237
9896082|NCT01111552|11011448|FG001|STARTED|Phase B (Day 1 to Week 8)||0
9896083|NCT01111552|11011449|FG002|STARTED|Phase B (Day 1 to Week 8)||0
9896084|NCT01111552|11011450|FG003|STARTED|Phase B (Day 1 to Week 8)||0
9896085|NCT01111552|11011451|FG004|STARTED|Phase B (Day 1 to Week 8)||0
9896086|NCT01111552|11011447|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120
9896087|NCT01111552|11011448|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
9896088|NCT01111552|11011449|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
9896089|NCT01111552|11011450|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
9896090|NCT01111552|11011451|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
9896091|NCT01111552|11011447|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117
9896092|NCT01111552|11011448|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
9896093|NCT01111552|11011449|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
9896094|NCT01111552|11011450|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
9896095|NCT01111552|11011451|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
9896096|NCT01111552|11011447|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
9896097|NCT01111552|11011448|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54
9896098|NCT01111552|11011449|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22
9896099|NCT01111552|11011450|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21
9896100|NCT01111552|11011451|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23
9896101|NCT01111552|11011447|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
9896102|NCT01111552|11011448|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45
9896103|NCT01111552|11011449|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
9896104|NCT01111552|11011450|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
9896105|NCT01111552|11011451|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
9896106|NCT01111552|11011447|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
9896107|NCT01111552|11011448|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9
9896108|NCT01111552|11011449|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
9896109|NCT01111552|11011450|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4
9896110|NCT01111552|11011451|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
9896111|NCT01111604|11011464|FG000|STARTED|Overall Study||54
9896112|NCT01111604|11011465|FG001|STARTED|Overall Study||52
9896113|NCT01111604|11011466|FG002|STARTED|Overall Study||52
9896114|NCT01111604|11011464|FG000|Received at Least One Dose of Study Drug|Overall Study||49
9896115|NCT01111604|11011465|FG001|Received at Least One Dose of Study Drug|Overall Study||52
9896116|NCT01111604|11011466|FG002|Received at Least One Dose of Study Drug|Overall Study||52
9896117|NCT01111604|11011464|FG000|COMPLETED|Overall Study||46
9896118|NCT01111604|11011465|FG001|COMPLETED|Overall Study||52
9896119|NCT01111604|11011466|FG002|COMPLETED|Overall Study||49
9896120|NCT01111604|11011464|FG000|NOT COMPLETED|Overall Study||8
9896121|NCT01111604|11011465|FG001|NOT COMPLETED|Overall Study||0
9896122|NCT01111604|11011466|FG002|NOT COMPLETED|Overall Study||3
9896123|NCT01111825|11011496|FG000|STARTED|Overall Study||8
9896124|NCT01111825|11011497|FG001|STARTED|Overall Study||6
9896125|NCT01111825|11011498|FG002|STARTED|Overall Study||37
9896126|NCT01111825|11011499|FG003|STARTED|Overall Study||48
9896127|NCT01111825|11011496|FG000|COMPLETED|Overall Study||5
9896128|NCT01111825|11011497|FG001|COMPLETED|Overall Study||5
9896129|NCT01111825|11011498|FG002|COMPLETED|Overall Study||29
9896130|NCT01111825|11011499|FG003|COMPLETED|Overall Study||27
9896131|NCT01111825|11011496|FG000|NOT COMPLETED|Overall Study||3
9896132|NCT01111825|11011497|FG001|NOT COMPLETED|Overall Study||1
9896133|NCT01111825|11011498|FG002|NOT COMPLETED|Overall Study||8
9896134|NCT01111825|11011499|FG003|NOT COMPLETED|Overall Study||21
9896135|NCT01111838|11011509|FG000|STARTED|Overall Study||22
9896136|NCT01111838|11011509|FG000|COMPLETED|Overall Study||15
9896137|NCT01111838|11011509|FG000|NOT COMPLETED|Overall Study||7
9896138|NCT01111851|11011515|FG000|STARTED|Overall Study||8
9896139|NCT01111851|11011516|FG001|STARTED|Overall Study||8
9896140|NCT01111851|11011515|FG000|COMPLETED|Overall Study||6
9896141|NCT01111851|11011516|FG001|COMPLETED|Overall Study||8
9896142|NCT01111851|11011515|FG000|NOT COMPLETED|Overall Study||2
9896143|NCT01111851|11011516|FG001|NOT COMPLETED|Overall Study||0
9896144|NCT01112059|11011524|FG000|STARTED|Overall Study||20
9896145|NCT01112059|11011525|FG001|STARTED|Overall Study||20
9896146|NCT01112059|11011524|FG000|COMPLETED|Overall Study||19
9896147|NCT01112059|11011525|FG001|COMPLETED|Overall Study||20
9896148|NCT01112059|11011524|FG000|NOT COMPLETED|Overall Study||1
9896149|NCT01112059|11011525|FG001|NOT COMPLETED|Overall Study||0
9896150|NCT01112228|11011534|FG000|STARTED|Overall Study||600
9896151|NCT01112228|11011534|FG000|COMPLETED|Overall Study||600
9896152|NCT01112228|11011534|FG000|NOT COMPLETED|Overall Study||0
9896153|NCT01112241|11011540|FG000|STARTED|Overall Study||17
9896154|NCT01112241|11011540|FG000|COMPLETED|Overall Study||17
9896155|NCT01112241|11011540|FG000|NOT COMPLETED|Overall Study||0
9896156|NCT01112267|11011546|FG000|STARTED|Overall Study||126
9896157|NCT01112267|11011547|FG001|STARTED|Overall Study||122
9896158|NCT01112267|11011546|FG000|Treated|Overall Study||125
9896159|NCT01112267|11011547|FG001|Treated|Overall Study||120
9896160|NCT01112267|11011546|FG000|COMPLETED|Overall Study||92
9896161|NCT01112267|11011547|FG001|COMPLETED|Overall Study||104
9896162|NCT01112267|11011546|FG000|NOT COMPLETED|Overall Study||34
9896163|NCT01112267|11011547|FG001|NOT COMPLETED|Overall Study||18
9896164|NCT01112293|11011553|FG000|STARTED|Overall Study||14
9896165|NCT01112293|11011553|FG000|COMPLETED|Overall Study||14
9896166|NCT01112293|11011553|FG000|NOT COMPLETED|Overall Study||0
9896167|NCT01112358|11011559|FG000|STARTED|Overall Study||25
9896168|NCT01112358|11011560|FG001|STARTED|Overall Study||33
9896169|NCT01112358|11011559|FG000|COMPLETED|Overall Study||25
9896170|NCT01112358|11011560|FG001|COMPLETED|Overall Study||33
9896171|NCT01112358|11011559|FG000|NOT COMPLETED|Overall Study||0
9896172|NCT01112358|11011560|FG001|NOT COMPLETED|Overall Study||0
9896173|NCT01112514|11011566|FG000|STARTED|Overall Study||4
9896174|NCT01112514|11011566|FG000|COMPLETED|Overall Study||3
9896175|NCT01112514|11011566|FG000|NOT COMPLETED|Overall Study||1
9896176|NCT01112579|11011572|FG000|STARTED|Overall Study||42
9896177|NCT01112579|11011573|FG001|STARTED|Overall Study||24
9896178|NCT01112579|11011572|FG000|COMPLETED|Overall Study||41
9896179|NCT01112579|11011573|FG001|COMPLETED|Overall Study||21
9896180|NCT01112579|11011572|FG000|NOT COMPLETED|Overall Study||1
9896181|NCT01112579|11011573|FG001|NOT COMPLETED|Overall Study||3
9896182|NCT01112670|11011579|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
9896183|NCT01112670|11011580|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896184|NCT01112670|11011581|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
9896185|NCT01112670|11011582|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896186|NCT01112670|11011583|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
9896187|NCT01112670|11011584|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896188|NCT01112670|11011579|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
9896189|NCT01112670|11011580|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896190|NCT01112670|11011581|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
9896191|NCT01112670|11011582|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896192|NCT01112670|11011583|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
9896193|NCT01112670|11011584|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896194|NCT01112670|11011579|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
9896195|NCT01112670|11011580|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896196|NCT01112670|11011581|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
9896197|NCT01112670|11011582|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896198|NCT01112670|11011583|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
9896199|NCT01112670|11011584|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
9896200|NCT01112670|11011579|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896201|NCT01112670|11011580|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
9896202|NCT01112670|11011581|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896203|NCT01112670|11011582|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
9896204|NCT01112670|11011583|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896205|NCT01112670|11011584|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
9896206|NCT01112670|11011579|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896207|NCT01112670|11011580|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
9896208|NCT01112670|11011581|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896209|NCT01112670|11011582|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
9896210|NCT01112670|11011583|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896211|NCT01112670|11011584|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
9896212|NCT01112670|11011579|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896213|NCT01112670|11011580|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896214|NCT01112670|11011581|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896215|NCT01112670|11011582|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896216|NCT01112670|11011583|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896217|NCT01112670|11011584|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
9896218|NCT01112683|11011593|FG000|STARTED|Overall Study||19
9896219|NCT01112683|11011594|FG001|STARTED|Overall Study||20
9896220|NCT01112683|11011593|FG000|COMPLETED|Overall Study||18
9896221|NCT01112683|11011594|FG001|COMPLETED|Overall Study||19
9896222|NCT01112683|11011593|FG000|NOT COMPLETED|Overall Study||1
9896223|NCT01112683|11011594|FG001|NOT COMPLETED|Overall Study||1
9896224|NCT01112696|11011600|FG000|STARTED|Overall Study||100
9896225|NCT01112696|11011600|FG000|COMPLETED|Overall Study||98
9896226|NCT01112696|11011600|FG000|NOT COMPLETED|Overall Study||2
9896227|NCT01112735|11011607|FG000|STARTED|Overall Study||20
9896228|NCT01112735|11011608|FG001|STARTED|Overall Study||20
9896229|NCT01112735|11011607|FG000|COMPLETED|Overall Study||20
9896230|NCT01112735|11011608|FG001|COMPLETED|Overall Study||20
9896231|NCT01112735|11011607|FG000|NOT COMPLETED|Overall Study||0
9896232|NCT01112735|11011608|FG001|NOT COMPLETED|Overall Study||0
9896233|NCT01112865|11011614|FG000|STARTED|First Intervention||59
9896234|NCT01112865|11011615|FG001|STARTED|First Intervention||61
9896235|NCT01112865|11011614|FG000|COMPLETED|First Intervention||59
9896236|NCT01112865|11011615|FG001|COMPLETED|First Intervention||61
9896237|NCT01112865|11011614|FG000|NOT COMPLETED|First Intervention||0
9896238|NCT01112865|11011615|FG001|NOT COMPLETED|First Intervention||0
9896239|NCT01112865|11011614|FG000|STARTED|Second Intervention||59
9896240|NCT01112865|11011615|FG001|STARTED|Second Intervention||61
9896241|NCT01112865|11011614|FG000|COMPLETED|Second Intervention||59
9896242|NCT01112865|11011615|FG001|COMPLETED|Second Intervention||61
9896243|NCT01112865|11011614|FG000|NOT COMPLETED|Second Intervention||0
9896244|NCT01112865|11011615|FG001|NOT COMPLETED|Second Intervention||0
9896245|NCT01112917|11011621|FG000|STARTED|Overall Study||96
9896246|NCT01112917|11011622|FG001|STARTED|Overall Study||53
9896247|NCT01112917|11011621|FG000|COMPLETED|Overall Study||89
9896248|NCT01112917|11011622|FG001|COMPLETED|Overall Study||38
9896249|NCT01112917|11011621|FG000|NOT COMPLETED|Overall Study||7
9896250|NCT01112917|11011622|FG001|NOT COMPLETED|Overall Study||15
10110197|NCT02482935|11240943|FG001|COMPLETED|Period 2||15
10110198|NCT02482935|11240942|FG000|NOT COMPLETED|Period 2||0
10110199|NCT02482935|11240943|FG001|NOT COMPLETED|Period 2||0
10110200|NCT02483000|11240949|FG000|STARTED|Overall Study||3
10110201|NCT02483000|11240949|FG000|COMPLETED|Overall Study||3
10110202|NCT02483000|11240949|FG000|NOT COMPLETED|Overall Study||0
10110203|NCT02483416|11240958|FG000|STARTED|Overall Study||21
10110204|NCT02483416|11240959|FG001|STARTED|Overall Study||7
10110205|NCT02483416|11240958|FG000|COMPLETED|Overall Study||18
10110206|NCT02483416|11240959|FG001|COMPLETED|Overall Study||6
9896251|NCT01112982|11011626|FG000|STARTED|Overall Study||74
9896252|NCT01112982|11011626|FG000|COMPLETED|Overall Study||72
9896253|NCT01112982|11011626|FG000|NOT COMPLETED|Overall Study||2
9896254|NCT01113008|11011635|FG000|STARTED|Overall Study||133
9896255|NCT01113008|11011636|FG001|STARTED|Overall Study||133
9896256|NCT01113008|11011635|FG000|COMPLETED|Overall Study||133
9896257|NCT01113008|11011636|FG001|COMPLETED|Overall Study||133
9896258|NCT01113008|11011635|FG000|NOT COMPLETED|Overall Study||0
9896259|NCT01113008|11011636|FG001|NOT COMPLETED|Overall Study||0
9896260|NCT01113385|11011642|FG000|STARTED|Overall Study||7
9896261|NCT01113385|11011642|FG000|COMPLETED|Overall Study||7
9896262|NCT01113385|11011642|FG000|NOT COMPLETED|Overall Study||0
9954770|NCT01433913|11073604|FG000|NOT COMPLETED|Overall Study||1
9954771|NCT01433913|11073605|FG001|NOT COMPLETED|Overall Study||0
9954772|NCT01433978|11073614|FG000|STARTED|Core Study||11
9954773|NCT01433978|11073615|FG001|STARTED|Core Study||12
9954774|NCT01433978|11073616|FG002|STARTED|Core Study||0
9954775|NCT01433978|11073614|FG000|COMPLETED|Core Study||0
9954776|NCT01433978|11073615|FG001|COMPLETED|Core Study||1
9954777|NCT01433978|11073616|FG002|COMPLETED|Core Study||0
9954778|NCT01433978|11073614|FG000|NOT COMPLETED|Core Study||11
9954779|NCT01433978|11073615|FG001|NOT COMPLETED|Core Study||11
9954780|NCT01433978|11073616|FG002|NOT COMPLETED|Core Study||0
9954781|NCT01433978|11073614|FG000|STARTED|Extension Phase||0
9954782|NCT01433978|11073615|FG001|STARTED|Extension Phase||0
9954783|NCT01433978|11073616|FG002|STARTED|Extension Phase||6
9954784|NCT01433978|11073614|FG000|COMPLETED|Extension Phase||0
9954785|NCT01433978|11073615|FG001|COMPLETED|Extension Phase||0
9954786|NCT01433978|11073616|FG002|COMPLETED|Extension Phase||0
9954787|NCT01433978|11073614|FG000|NOT COMPLETED|Extension Phase||0
9954788|NCT01433978|11073615|FG001|NOT COMPLETED|Extension Phase||0
9954789|NCT01433978|11073616|FG002|NOT COMPLETED|Extension Phase||6
9954790|NCT01433991|11073627|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5
9954791|NCT01433991|11073628|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3
9954792|NCT01433991|11073629|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14
9954793|NCT01433991|11073630|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8
9954794|NCT01433991|11073627|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
9954795|NCT01433991|11073628|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
9954796|NCT01433991|11073629|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
9954797|NCT01433991|11073630|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
10110207|NCT02483416|11240958|FG000|NOT COMPLETED|Overall Study||3
10110208|NCT02483416|11240959|FG001|NOT COMPLETED|Overall Study||1
10110209|NCT02483520|11240968|FG000|STARTED|Overall Study||92
10110210|NCT02483520|11240969|FG001|STARTED|Overall Study||97
10110211|NCT02483520|11240968|FG000|Caregivers|Overall Study||50
10110212|NCT02483520|11240969|FG001|Caregivers|Overall Study||56
9896263|NCT01113398|11011646|FG000|STARTED|Overall Study||36
9896264|NCT01113398|11011646|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
9896265|NCT01113398|11011646|FG000|NOT COMPLETED|Overall Study||0
9896266|NCT01113463|11011650|FG000|STARTED|Overall Study||17
9896267|NCT01113463|11011650|FG000|COMPLETED|Overall Study||12
9896268|NCT01113463|11011650|FG000|NOT COMPLETED|Overall Study||5
9896269|NCT01113502|11011659|FG000|STARTED|Overall Study||4
9896270|NCT01113502|11011660|FG001|STARTED|Overall Study||3
9896271|NCT01113502|11011661|FG002|STARTED|Overall Study||7
9896272|NCT01113502|11011662|FG003|STARTED|Overall Study||9
9896273|NCT01113502|11011663|FG004|STARTED|Overall Study||21
9896274|NCT01113502|11011659|FG000|COMPLETED|Overall Study||3
9896275|NCT01113502|11011660|FG001|COMPLETED|Overall Study||3
9896276|NCT01113502|11011661|FG002|COMPLETED|Overall Study||3
9896277|NCT01113502|11011662|FG003|COMPLETED|Overall Study||6
9896278|NCT01113502|11011663|FG004|COMPLETED|Overall Study||21
9896279|NCT01113502|11011659|FG000|NOT COMPLETED|Overall Study||1
9896280|NCT01113502|11011660|FG001|NOT COMPLETED|Overall Study||0
9896281|NCT01113502|11011661|FG002|NOT COMPLETED|Overall Study||4
9896282|NCT01113502|11011662|FG003|NOT COMPLETED|Overall Study||3
9896283|NCT01113502|11011663|FG004|NOT COMPLETED|Overall Study||0
9896284|NCT01113541|11011676|FG000|STARTED|Overall Study||13
9896285|NCT01113541|11011676|FG000|COMPLETED|Overall Study||0
9896286|NCT01113541|11011676|FG000|NOT COMPLETED|Overall Study||13
9896287|NCT01113580|11011682|FG000|STARTED|Overall Study||60
9896288|NCT01113580|11011683|FG001|STARTED|Overall Study||60
9896289|NCT01113580|11011682|FG000|COMPLETED|Overall Study||59
9896290|NCT01113580|11011683|FG001|COMPLETED|Overall Study||60
9896291|NCT01113580|11011682|FG000|NOT COMPLETED|Overall Study||1
9896292|NCT01113580|11011683|FG001|NOT COMPLETED|Overall Study||0
9896293|NCT01113632|11011691|FG000|STARTED|Overall Study||33
9896294|NCT01113632|11011692|FG001|STARTED|Overall Study||44
9896295|NCT01113632|11011691|FG000|COMPLETED|Overall Study||2
9896296|NCT01113632|11011692|FG001|COMPLETED|Overall Study||19
9896297|NCT01113632|11011691|FG000|NOT COMPLETED|Overall Study||31
9896298|NCT01113632|11011692|FG001|NOT COMPLETED|Overall Study||25
9896299|NCT01113710|11011698|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
9896300|NCT01113710|11011698|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
9896301|NCT01113710|11011698|FG000|NOT COMPLETED|Overall Study||269
9896302|NCT01113723|11011704|FG000|STARTED|Overall Study||70
9896303|NCT01113723|11011705|FG001|STARTED|Overall Study||70
9896304|NCT01113723|11011704|FG000|COMPLETED|Overall Study||70
9896305|NCT01113723|11011705|FG001|COMPLETED|Overall Study||70
9896306|NCT01113723|11011704|FG000|NOT COMPLETED|Overall Study||0
9896307|NCT01113723|11011705|FG001|NOT COMPLETED|Overall Study||0
9896308|NCT01113749|11011715|FG000|STARTED|Overall Study||127
9896309|NCT01113749|11011716|FG001|STARTED|Overall Study||129
9896310|NCT01113749|11011715|FG000|COMPLETED|Overall Study||126
9896311|NCT01113749|11011716|FG001|COMPLETED|Overall Study||127
9896312|NCT01113749|11011715|FG000|NOT COMPLETED|Overall Study||1
9896313|NCT01113749|11011716|FG001|NOT COMPLETED|Overall Study||2
9896314|NCT01113801|11011726|FG000|STARTED|Overall Study||103
9896315|NCT01113801|11011727|FG001|STARTED|Overall Study||105
9896316|NCT01113801|11011728|FG002|STARTED|Overall Study||103
9896317|NCT01113801|11011729|FG003|STARTED|Overall Study||106
9896318|NCT01113801|11011726|FG000|Received at Least One Dose of Drug|Overall Study||103
9896319|NCT01113801|11011727|FG001|Received at Least One Dose of Drug|Overall Study||105
9896320|NCT01113801|11011728|FG002|Received at Least One Dose of Drug|Overall Study||103
9896321|NCT01113801|11011729|FG003|Received at Least One Dose of Drug|Overall Study||105
9896322|NCT01113801|11011726|FG000|COMPLETED|Overall Study||62
9896323|NCT01113801|11011727|FG001|COMPLETED|Overall Study||65
9896324|NCT01113801|11011728|FG002|COMPLETED|Overall Study||66
9896325|NCT01113801|11011729|FG003|COMPLETED|Overall Study||65
9896326|NCT01113801|11011726|FG000|NOT COMPLETED|Overall Study||41
9896327|NCT01113801|11011727|FG001|NOT COMPLETED|Overall Study||40
9896328|NCT01113801|11011728|FG002|NOT COMPLETED|Overall Study||37
9896329|NCT01113801|11011729|FG003|NOT COMPLETED|Overall Study||41
9896330|NCT01113879|11011741|FG000|STARTED|Period 1: Block 1||7
9896331|NCT01113879|11011742|FG001|STARTED|Period 1: Block 1||2
9896332|NCT01113879|11011741|FG000|COMPLETED|Period 1: Block 1||5
9896333|NCT01113879|11011742|FG001|COMPLETED|Period 1: Block 1||2
9896334|NCT01113879|11011741|FG000|NOT COMPLETED|Period 1: Block 1||2
9896335|NCT01113879|11011742|FG001|NOT COMPLETED|Period 1: Block 1||0
9896336|NCT01113879|11011741|FG000|STARTED|Period 2: Block 2||5
9896337|NCT01113879|11011742|FG001|STARTED|Period 2: Block 2||2
9896338|NCT01113879|11011741|FG000|COMPLETED|Period 2: Block 2||5
9896339|NCT01113879|11011742|FG001|COMPLETED|Period 2: Block 2||2
9896340|NCT01113879|11011741|FG000|NOT COMPLETED|Period 2: Block 2||0
9896341|NCT01113879|11011742|FG001|NOT COMPLETED|Period 2: Block 2||0
9896342|NCT01113892|11011752|FG000|STARTED|Overall Study||101
9896343|NCT01113892|11011753|FG001|STARTED|Overall Study||106
9896344|NCT01113892|11011752|FG000|COMPLETED|Overall Study||87
9896345|NCT01113892|11011753|FG001|COMPLETED|Overall Study||90
9896346|NCT01113892|11011752|FG000|NOT COMPLETED|Overall Study||14
9896347|NCT01113892|11011753|FG001|NOT COMPLETED|Overall Study||16
9896348|NCT01113931|11011761|FG000|STARTED|Overall Study||247
9896349|NCT01113931|11011762|FG001|STARTED|Overall Study||248
9896350|NCT01113931|11011761|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246
9896351|NCT01113931|11011762|FG001|Safety Population|Overall Study||248
9896352|NCT01113931|11011761|FG000|mITT Population|Overall Study||188
9896353|NCT01113931|11011762|FG001|mITT Population|Overall Study||190
9896354|NCT01113931|11011761|FG000|COMPLETED|Overall Study||228
9896355|NCT01113931|11011762|FG001|COMPLETED|Overall Study||231
9896356|NCT01113931|11011761|FG000|NOT COMPLETED|Overall Study||19
9896357|NCT01113931|11011762|FG001|NOT COMPLETED|Overall Study||17
9896358|NCT01113983|11011770|FG000|STARTED|Overall Study||37
9896359|NCT01113983|11011771|FG001|STARTED|Overall Study||27
9896360|NCT01113983|11011770|FG000|COMPLETED|Overall Study||12
9896361|NCT01113983|11011771|FG001|COMPLETED|Overall Study||10
9896362|NCT01113983|11011770|FG000|NOT COMPLETED|Overall Study||25
9896363|NCT01113983|11011771|FG001|NOT COMPLETED|Overall Study||17
9896364|NCT01114334|11011779|FG000|STARTED|Overall Study||88
9896365|NCT01114334|11011780|FG001|STARTED|Overall Study||80
9896366|NCT01114334|11011779|FG000|COMPLETED|Overall Study||67
9896367|NCT01114334|11011780|FG001|COMPLETED|Overall Study||58
9896368|NCT01114334|11011779|FG000|NOT COMPLETED|Overall Study||21
9896369|NCT01114334|11011780|FG001|NOT COMPLETED|Overall Study||22
9896370|NCT01114360|11011787|FG000|STARTED|Intervention 1 (4 Weeks)||18
9896371|NCT01114360|11011788|FG001|STARTED|Intervention 1 (4 Weeks)||19
9896372|NCT01114360|11011787|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
9896373|NCT01114360|11011788|FG001|COMPLETED|Intervention 1 (4 Weeks)||18
9896374|NCT01114360|11011787|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0
9896375|NCT01114360|11011788|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1
9896376|NCT01114360|11011787|FG000|STARTED|Intervention 2 (4 Weeks)||18
9896377|NCT01114360|11011788|FG001|STARTED|Intervention 2 (4 Weeks)||18
9896378|NCT01114360|11011787|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
9896379|NCT01114360|11011788|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
9896380|NCT01114360|11011787|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
9896381|NCT01114360|11011788|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0
9896382|NCT01114373|11011808|FG000|STARTED|Intervention 1 (4 Weeks)||21
9896383|NCT01114373|11011809|FG001|STARTED|Intervention 1 (4 Weeks)||19
9896384|NCT01114373|11011808|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
9896385|NCT01114373|11011809|FG001|COMPLETED|Intervention 1 (4 Weeks)||19
9896386|NCT01114373|11011808|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3
9896387|NCT01114373|11011809|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0
9896388|NCT01114373|11011808|FG000|STARTED|Intervention 2 (4 Weeks)||18
9896389|NCT01114373|11011809|FG001|STARTED|Intervention 2 (4 Weeks)||19
9896390|NCT01114373|11011808|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
9896391|NCT01114373|11011809|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
9896392|NCT01114373|11011808|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
9896393|NCT01114373|11011809|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1
9896394|NCT01114438|11011819|FG000|STARTED|Overall Study||45
9896395|NCT01114438|11011819|FG000|COMPLETED|Overall Study||31
9896396|NCT01114438|11011819|FG000|NOT COMPLETED|Overall Study||14
9896397|NCT01114503|11011828|FG000|STARTED|Overall Study||2
9896398|NCT01114503|11011828|FG000|COMPLETED|Overall Study||2
9896399|NCT01114503|11011828|FG000|NOT COMPLETED|Overall Study||0
9896400|NCT01114516|11011834|FG000|STARTED|Overall Study||26
9896401|NCT01114516|11011835|FG001|STARTED|Overall Study||27
9896402|NCT01114516|11011834|FG000|COMPLETED|Overall Study||24
9896403|NCT01114516|11011835|FG001|COMPLETED|Overall Study||26
9896404|NCT01114516|11011834|FG000|NOT COMPLETED|Overall Study||2
9896405|NCT01114516|11011835|FG001|NOT COMPLETED|Overall Study||1
9896406|NCT01114529|11011844|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
9896407|NCT01114529|11011845|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
9896408|NCT01114529|11011846|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
9896409|NCT01114529|11011844|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
9896410|NCT01114529|11011845|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
9896411|NCT01114529|11011846|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
9896412|NCT01114529|11011844|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124
9896413|NCT01114529|11011845|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41
9896414|NCT01114529|11011846|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32
9896415|NCT01114529|11011844|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
9896416|NCT01114529|11011845|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
9896417|NCT01114529|11011846|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
9896418|NCT01114529|11011844|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313
9896419|NCT01114529|11011845|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215
9896420|NCT01114529|11011846|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111
9896421|NCT01114529|11011844|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40
9896422|NCT01114529|11011845|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16
9896423|NCT01114529|11011846|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14
9896424|NCT01114555|11011856|FG000|STARTED|Overall Study||34
9896425|NCT01114555|11011856|FG000|COMPLETED|Overall Study||34
9896426|NCT01114555|11011856|FG000|NOT COMPLETED|Overall Study||0
9896427|NCT01114581|11011862|FG000|STARTED|Overall Study||19
9896428|NCT01114581|11011863|FG001|STARTED|Overall Study||19
9896429|NCT01114581|11011862|FG000|COMPLETED|Overall Study||19
9896430|NCT01114581|11011863|FG001|COMPLETED|Overall Study||19
9896431|NCT01114581|11011862|FG000|NOT COMPLETED|Overall Study||0
9896432|NCT01114581|11011863|FG001|NOT COMPLETED|Overall Study||0
9896433|NCT01114620|11011869|FG000|STARTED|Overall Study||50
9896434|NCT01114620|11011869|FG000|COMPLETED|Overall Study||50
9896435|NCT01114620|11011869|FG000|NOT COMPLETED|Overall Study||0
9896436|NCT01114646|11011875|FG000|STARTED|Overall Study||66
9896437|NCT01114646|11011876|FG001|STARTED|Overall Study||64
9896438|NCT01114646|11011875|FG000|COMPLETED|Overall Study||63
9896439|NCT01114646|11011876|FG001|COMPLETED|Overall Study||62
9896440|NCT01114646|11011875|FG000|NOT COMPLETED|Overall Study||3
9896441|NCT01114646|11011876|FG001|NOT COMPLETED|Overall Study||2
9896442|NCT01114672|11011884|FG000|STARTED|Overall Study||25
9896443|NCT01114672|11011885|FG001|STARTED|Overall Study||25
9896444|NCT01114672|11011884|FG000|COMPLETED|Overall Study||21
9896445|NCT01114672|11011885|FG001|COMPLETED|Overall Study||23
9896446|NCT01114672|11011884|FG000|NOT COMPLETED|Overall Study||4
9896447|NCT01114672|11011885|FG001|NOT COMPLETED|Overall Study||2
9896448|NCT01114724|11011891|FG000|STARTED|Overall Study||50
9896449|NCT01114724|11011891|FG000|COMPLETED|Overall Study||40
9896450|NCT01114724|11011891|FG000|NOT COMPLETED|Overall Study||10
9896451|NCT01114737|11011898|FG000|STARTED|Randomized Treatment Period||108
9896452|NCT01114737|11011899|FG001|STARTED|Randomized Treatment Period||98
9896453|NCT01114737|11011898|FG000|COMPLETED|Randomized Treatment Period||105
9896454|NCT01114737|11011899|FG001|COMPLETED|Randomized Treatment Period||97
9896455|NCT01114737|11011898|FG000|NOT COMPLETED|Randomized Treatment Period||3
9896456|NCT01114737|11011899|FG001|NOT COMPLETED|Randomized Treatment Period||1
9896457|NCT01114737|11011898|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
9896458|NCT01114737|11011899|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
9896459|NCT01114737|11011898|FG000|COMPLETED|Open-Label Treatment Period||100
9896460|NCT01114737|11011899|FG001|COMPLETED|Open-Label Treatment Period||95
9896461|NCT01114737|11011898|FG000|NOT COMPLETED|Open-Label Treatment Period||5
9896462|NCT01114737|11011899|FG001|NOT COMPLETED|Open-Label Treatment Period||2
9896463|NCT01114828|11011918|FG000|STARTED|Overall Study||19
9896464|NCT01114828|11011919|FG001|STARTED|Overall Study||21
9896465|NCT01114828|11011918|FG000|COMPLETED|Overall Study||16
9896466|NCT01114828|11011919|FG001|COMPLETED|Overall Study||17
9896467|NCT01114828|11011918|FG000|NOT COMPLETED|Overall Study||3
9896468|NCT01114828|11011919|FG001|NOT COMPLETED|Overall Study||4
9896469|NCT01114880|11011927|FG000|STARTED|Period 1 (Week 0 to Week 12)||229
9896470|NCT01114880|11011928|FG001|STARTED|Period 1 (Week 0 to Week 12)||115
9896471|NCT01114880|11011927|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224
9896472|NCT01114880|11011928|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113
9896473|NCT01114880|11011927|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
9896474|NCT01114880|11011928|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
9896475|NCT01114880|11011927|FG000|STARTED|Period 2 (Week 12 to Week 24)||224
9896476|NCT01114880|11011928|FG001|STARTED|Period 2 (Week 12 to Week 24)||113
9896477|NCT01114880|11011927|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221
9896478|NCT01114880|11011928|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111
9896479|NCT01114880|11011927|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
9896480|NCT01114880|11011928|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
9896481|NCT01114893|11011941|FG000|STARTED|Overall Study||14
9896482|NCT01114893|11011942|FG001|STARTED|Overall Study||14
9896483|NCT01114893|11011943|FG002|STARTED|Overall Study||14
9896484|NCT01114893|11011944|FG003|STARTED|Overall Study||13
9896485|NCT01114893|11011945|FG004|STARTED|Overall Study||12
9896486|NCT01114893|11011941|FG000|COMPLETED|Overall Study||14
9896487|NCT01114893|11011942|FG001|COMPLETED|Overall Study||14
9896488|NCT01114893|11011943|FG002|COMPLETED|Overall Study||14
9896489|NCT01114893|11011944|FG003|COMPLETED|Overall Study||13
9896490|NCT01114893|11011945|FG004|COMPLETED|Overall Study||12
9896491|NCT01114893|11011941|FG000|NOT COMPLETED|Overall Study||0
9896492|NCT01114893|11011942|FG001|NOT COMPLETED|Overall Study||0
9896493|NCT01114893|11011943|FG002|NOT COMPLETED|Overall Study||0
9896494|NCT01114893|11011944|FG003|NOT COMPLETED|Overall Study||0
9896495|NCT01114893|11011945|FG004|NOT COMPLETED|Overall Study||0
9896496|NCT01114945|11011961|FG000|STARTED|Overall Study||30
9896497|NCT01114945|11011962|FG001|STARTED|Overall Study||30
9896498|NCT01114945|11011963|FG002|STARTED|Overall Study||30
9896499|NCT01114945|11011964|FG003|STARTED|Overall Study||31
9896500|NCT01114945|11011961|FG000|COMPLETED|Overall Study||30
9896501|NCT01114945|11011962|FG001|COMPLETED|Overall Study||30
9896502|NCT01114945|11011963|FG002|COMPLETED|Overall Study||30
9896503|NCT01114945|11011964|FG003|COMPLETED|Overall Study||31
9896504|NCT01114945|11011961|FG000|NOT COMPLETED|Overall Study||0
9896505|NCT01114945|11011962|FG001|NOT COMPLETED|Overall Study||0
9896506|NCT01114945|11011963|FG002|NOT COMPLETED|Overall Study||0
9896507|NCT01114945|11011964|FG003|NOT COMPLETED|Overall Study||0
9896508|NCT01114971|11011978|FG000|STARTED|Overall Study||25
9896509|NCT01114971|11011979|FG001|STARTED|Overall Study||25
9896510|NCT01114971|11011980|FG002|STARTED|Overall Study||25
9896511|NCT01114971|11011978|FG000|COMPLETED|Overall Study||25
9896512|NCT01114971|11011979|FG001|COMPLETED|Overall Study||25
9896513|NCT01114971|11011980|FG002|COMPLETED|Overall Study||25
9896514|NCT01114971|11011978|FG000|NOT COMPLETED|Overall Study||0
9896515|NCT01114971|11011979|FG001|NOT COMPLETED|Overall Study||0
9896516|NCT01114971|11011980|FG002|NOT COMPLETED|Overall Study||0
9896517|NCT01114997|11011991|FG000|STARTED|Overall Study||11
9896518|NCT01114997|11011992|FG001|STARTED|Overall Study||10
9896519|NCT01114997|11011993|FG002|STARTED|Overall Study||11
9896520|NCT01114997|11011991|FG000|COMPLETED|Overall Study||11
10110213|NCT02483520|11240968|FG000|Persons With Dementia|Overall Study||42
10110214|NCT02483520|11240969|FG001|Persons With Dementia|Overall Study||41
10110215|NCT02483520|11240968|FG000|COMPLETED|Overall Study||81
10110216|NCT02483520|11240969|FG001|COMPLETED|Overall Study||73
10110217|NCT02483520|11240968|FG000|NOT COMPLETED|Overall Study||11
10110218|NCT02483520|11240969|FG001|NOT COMPLETED|Overall Study||24
10110219|NCT02483572|11240977|FG000|STARTED|Overall Study||2
10110220|NCT02483572|11240978|FG001|STARTED|Overall Study||2
10110221|NCT02483572|11240977|FG000|COMPLETED|Overall Study||0
9896521|NCT01114997|11011992|FG001|COMPLETED|Overall Study||10
9896522|NCT01114997|11011993|FG002|COMPLETED|Overall Study||11
9896523|NCT01114997|11011991|FG000|NOT COMPLETED|Overall Study||0
9896524|NCT01114997|11011992|FG001|NOT COMPLETED|Overall Study||0
9896525|NCT01114997|11011993|FG002|NOT COMPLETED|Overall Study||0
9896526|NCT01115101|11012004|FG000|STARTED|Overall Study||113
9896527|NCT01115101|11012005|FG001|STARTED|Overall Study||126
9896528|NCT01115101|11012004|FG000|COMPLETED|Overall Study||113
9896529|NCT01115101|11012005|FG001|COMPLETED|Overall Study||126
9896530|NCT01115101|11012004|FG000|NOT COMPLETED|Overall Study||0
9896531|NCT01115101|11012005|FG001|NOT COMPLETED|Overall Study||0
9896532|NCT01115166|11012011|FG000|STARTED|Overall Study||10
10110222|NCT02483572|11240978|FG001|COMPLETED|Overall Study||1
10110223|NCT02483572|11240977|FG000|NOT COMPLETED|Overall Study||2
10110224|NCT02483572|11240978|FG001|NOT COMPLETED|Overall Study||1
10110225|NCT02483611|11240987|FG000|STARTED|Overall Study||16
10110226|NCT02483611|11240988|FG001|STARTED|Overall Study||16
10110227|NCT02483611|11240989|FG002|STARTED|Overall Study||16
10110228|NCT02483611|11240987|FG000|COMPLETED|Overall Study||16
10110229|NCT02483611|11240988|FG001|COMPLETED|Overall Study||16
10110230|NCT02483611|11240989|FG002|COMPLETED|Overall Study|One patient required decurarization|15
10110231|NCT02483611|11240987|FG000|NOT COMPLETED|Overall Study||0
10110232|NCT02483611|11240988|FG001|NOT COMPLETED|Overall Study||0
10110233|NCT02483611|11240989|FG002|NOT COMPLETED|Overall Study||1
9896533|NCT01115166|11012011|FG000|COMPLETED|Overall Study||10
9896534|NCT01115166|11012011|FG000|NOT COMPLETED|Overall Study||0
9896535|NCT01115231|11012017|FG000|STARTED|Overall Study||133
9896536|NCT01115231|11012018|FG001|STARTED|Overall Study||90
9896537|NCT01115231|11012017|FG000|COMPLETED|Overall Study||133
9896538|NCT01115231|11012018|FG001|COMPLETED|Overall Study||90
9896539|NCT01115231|11012017|FG000|NOT COMPLETED|Overall Study||0
9896540|NCT01115231|11012018|FG001|NOT COMPLETED|Overall Study||0
9896541|NCT01115309|11012025|FG000|STARTED|Procedure Safety (1-Month)||175
9896542|NCT01115309|11012025|FG000|COMPLETED|Procedure Safety (1-Month)||172
9896543|NCT01115309|11012025|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3
10110234|NCT02483676|11240999|FG000|STARTED|Overall Study||23
10110235|NCT02483676|11241000|FG001|STARTED|Overall Study||22
9896544|NCT01115309|11012025|FG000|STARTED|Long-term Follow-up||50
9896545|NCT01115309|11012025|FG000|6-Month Follow-up|Long-term Follow-up||46
9896546|NCT01115309|11012025|FG000|12-Month Follow-up|Long-term Follow-up||44
9896547|NCT01115309|11012025|FG000|COMPLETED|Long-term Follow-up||44
9896548|NCT01115309|11012025|FG000|NOT COMPLETED|Long-term Follow-up||6
9896549|NCT01115452|11012030|FG000|STARTED|Overall Study||32
9896550|NCT01115452|11012030|FG000|COMPLETED|Overall Study||32
9896551|NCT01115452|11012030|FG000|NOT COMPLETED|Overall Study||0
9896552|NCT01115491|11012038|FG000|STARTED|Overall Study||32
9896553|NCT01115491|11012038|FG000|COMPLETED|Overall Study||2
9896554|NCT01115491|11012038|FG000|NOT COMPLETED|Overall Study||30
9896555|NCT01115517|11012044|FG000|STARTED|Overall Study||18
9896556|NCT01115517|11012045|FG001|STARTED|Overall Study||21
9896557|NCT01115517|11012044|FG000|COMPLETED|Overall Study||14
9896558|NCT01115517|11012045|FG001|COMPLETED|Overall Study||16
9896559|NCT01115517|11012044|FG000|NOT COMPLETED|Overall Study||4
9896560|NCT01115517|11012045|FG001|NOT COMPLETED|Overall Study||5
9896561|NCT01115556|11012053|FG000|STARTED|Overall Study||7
9896562|NCT01115556|11012054|FG001|STARTED|Overall Study||2
9896563|NCT01115556|11012053|FG000|COMPLETED|Overall Study||7
9896564|NCT01115556|11012054|FG001|COMPLETED|Overall Study||2
9896565|NCT01115556|11012053|FG000|NOT COMPLETED|Overall Study||0
9896566|NCT01115556|11012054|FG001|NOT COMPLETED|Overall Study||0
9896567|NCT01115569|11012062|FG000|STARTED|Conversion/Titration Phase||638
9896568|NCT01115569|11012063|FG001|STARTED|Conversion/Titration Phase||0
9896569|NCT01115569|11012062|FG000|COMPLETED|Conversion/Titration Phase||424
9896570|NCT01115569|11012063|FG001|COMPLETED|Conversion/Titration Phase||0
9896571|NCT01115569|11012062|FG000|NOT COMPLETED|Conversion/Titration Phase||214
9896572|NCT01115569|11012063|FG001|NOT COMPLETED|Conversion/Titration Phase||0
9896573|NCT01115569|11012062|FG000|STARTED|Maintenance Phase||0
9896574|NCT01115569|11012063|FG001|STARTED|Maintenance Phase||424
9896575|NCT01115569|11012062|FG000|COMPLETED|Maintenance Phase||0
9896576|NCT01115569|11012063|FG001|COMPLETED|Maintenance Phase||285
9896577|NCT01115569|11012062|FG000|NOT COMPLETED|Maintenance Phase||0
9896578|NCT01115569|11012063|FG001|NOT COMPLETED|Maintenance Phase||139
10110236|NCT02483676|11240999|FG000|COMPLETED|Overall Study||17
10110237|NCT02483676|11241000|FG001|COMPLETED|Overall Study||17
10110238|NCT02483676|11240999|FG000|NOT COMPLETED|Overall Study||6
10110239|NCT02483676|11241000|FG001|NOT COMPLETED|Overall Study||5
10110240|NCT02483975|11241008|FG000|STARTED|Overall Study||56
10110241|NCT02483975|11241009|FG001|STARTED|Overall Study||55
10110242|NCT02483975|11241008|FG000|COMPLETED|Overall Study||54
10113395|NCT02509117|11244191|FG001|STARTED|Period 3 -Part A: 4 Days||2
9896579|NCT01115582|11012068|FG000|STARTED|Overall Study||16
9896580|NCT01115582|11012068|FG000|COMPLETED|Overall Study||16
9896581|NCT01115582|11012068|FG000|NOT COMPLETED|Overall Study||0
9896582|NCT01115660|11012074|FG000|STARTED|Overall Study||20
9896583|NCT01115660|11012075|FG001|STARTED|Overall Study||10
9896584|NCT01115660|11012074|FG000|COMPLETED|Overall Study||19
9896585|NCT01115660|11012075|FG001|COMPLETED|Overall Study||10
9896586|NCT01115660|11012074|FG000|NOT COMPLETED|Overall Study||1
9896587|NCT01115660|11012075|FG001|NOT COMPLETED|Overall Study||0
9896588|NCT01115673|11012084|FG000|STARTED|Overall Study||239
9896589|NCT01115673|11012085|FG001|STARTED|Overall Study||241
9896590|NCT01115673|11012086|FG002|STARTED|Overall Study||60
9896591|NCT01115673|11012084|FG000|COMPLETED|Overall Study||239
9896592|NCT01115673|11012085|FG001|COMPLETED|Overall Study||241
9896593|NCT01115673|11012086|FG002|COMPLETED|Overall Study||60
9896594|NCT01115673|11012084|FG000|NOT COMPLETED|Overall Study||0
9896595|NCT01115673|11012085|FG001|NOT COMPLETED|Overall Study||0
9896596|NCT01115673|11012086|FG002|NOT COMPLETED|Overall Study||0
9896597|NCT01115738|11012097|FG000|STARTED|Overall Study||110
9896598|NCT01115738|11012098|FG001|STARTED|Overall Study||83
9896599|NCT01115738|11012099|FG002|STARTED|Overall Study||89
9896600|NCT01115738|11012097|FG000|Received Any Treatment|Overall Study||109
9896601|NCT01115738|11012098|FG001|Received Any Treatment|Overall Study||79
9896602|NCT01115738|11012099|FG002|Received Any Treatment|Overall Study||88
9896603|NCT01115738|11012097|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
9896604|NCT01115738|11012098|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
9896605|NCT01115738|11012099|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
9896606|NCT01115738|11012097|FG000|COMPLETED|Overall Study||85
9896607|NCT01115738|11012098|FG001|COMPLETED|Overall Study||62
9896608|NCT01115738|11012099|FG002|COMPLETED|Overall Study||62
9896609|NCT01115738|11012097|FG000|NOT COMPLETED|Overall Study||25
9896610|NCT01115738|11012098|FG001|NOT COMPLETED|Overall Study||21
9896611|NCT01115738|11012099|FG002|NOT COMPLETED|Overall Study||27
9896612|NCT01115803|11012122|FG000|STARTED|Overall Study||4
9896613|NCT01115803|11012123|FG001|STARTED|Overall Study||5
9896614|NCT01115803|11012124|FG002|STARTED|Overall Study||3
9896615|NCT01115803|11012125|FG003|STARTED|Overall Study||5
9896616|NCT01115803|11012126|FG004|STARTED|Overall Study||3
9896617|NCT01115803|11012127|FG005|STARTED|Overall Study||3
9896618|NCT01115803|11012128|FG006|STARTED|Overall Study||6
9896619|NCT01115803|11012122|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
9896620|NCT01115803|11012123|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
9896621|NCT01115803|11012124|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9896622|NCT01115803|11012125|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
9896623|NCT01115803|11012126|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
9896624|NCT01115803|11012127|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
9896625|NCT01115803|11012128|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
9896626|NCT01115803|11012122|FG000|COMPLETED|Overall Study||4
9896627|NCT01115803|11012123|FG001|COMPLETED|Overall Study||5
9896628|NCT01115803|11012124|FG002|COMPLETED|Overall Study||2
9896629|NCT01115803|11012125|FG003|COMPLETED|Overall Study||5
9896630|NCT01115803|11012126|FG004|COMPLETED|Overall Study||3
9896631|NCT01115803|11012127|FG005|COMPLETED|Overall Study||3
9896632|NCT01115803|11012128|FG006|COMPLETED|Overall Study||4
9896633|NCT01115803|11012122|FG000|NOT COMPLETED|Overall Study||0
9896634|NCT01115803|11012123|FG001|NOT COMPLETED|Overall Study||0
9896635|NCT01115803|11012124|FG002|NOT COMPLETED|Overall Study||1
9896636|NCT01115803|11012125|FG003|NOT COMPLETED|Overall Study||0
9896637|NCT01115803|11012126|FG004|NOT COMPLETED|Overall Study||0
9896638|NCT01115803|11012127|FG005|NOT COMPLETED|Overall Study||0
9896639|NCT01115803|11012128|FG006|NOT COMPLETED|Overall Study||2
9896640|NCT01115855|11012151|FG000|STARTED|Overall Study||111
9896641|NCT01115855|11012152|FG001|STARTED|Overall Study||110
9896642|NCT01115855|11012151|FG000|COMPLETED|Overall Study||75
9896643|NCT01115855|11012152|FG001|COMPLETED|Overall Study||74
9896644|NCT01115855|11012151|FG000|NOT COMPLETED|Overall Study||36
9896645|NCT01115855|11012152|FG001|NOT COMPLETED|Overall Study||36
9896646|NCT01115933|11012158|FG000|STARTED|Overall Study||65
9896647|NCT01115933|11012158|FG000|COMPLETED|Overall Study||64
9896648|NCT01115933|11012158|FG000|NOT COMPLETED|Overall Study||1
9896649|NCT01115998|11012217|FG000|STARTED|Overall Study||17
9896650|NCT01115998|11012218|FG001|STARTED|Overall Study||17
9896651|NCT01115998|11012217|FG000|COMPLETED|Overall Study||11
9896652|NCT01115998|11012218|FG001|COMPLETED|Overall Study||11
9896653|NCT01115998|11012217|FG000|NOT COMPLETED|Overall Study||6
9896654|NCT01115998|11012218|FG001|NOT COMPLETED|Overall Study||6
9896655|NCT01116024|11012224|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
9896656|NCT01116024|11012224|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96
9896657|NCT01116024|11012224|FG000|NOT COMPLETED|Overall Study||52
9896658|NCT01116037|11012250|FG000|STARTED|Overall Study||26
9896659|NCT01116037|11012250|FG000|COMPLETED|Overall Study||1
9896660|NCT01116037|11012250|FG000|NOT COMPLETED|Overall Study||25
9896661|NCT01116102|11012262|FG000|STARTED|Overall Study||2
9896662|NCT01116102|11012263|FG001|STARTED|Overall Study||3
9896663|NCT01116102|11012264|FG002|STARTED|Overall Study||3
9896664|NCT01116102|11012265|FG003|STARTED|Overall Study||3
9896665|NCT01116102|11012266|FG004|STARTED|Overall Study||2
9896666|NCT01116102|11012267|FG005|STARTED|Overall Study||2
9896667|NCT01116102|11012268|FG006|STARTED|Overall Study||2
9896668|NCT01116102|11012269|FG007|STARTED|Overall Study||3
9896669|NCT01116102|11012262|FG000|COMPLETED|Overall Study||2
9896670|NCT01116102|11012263|FG001|COMPLETED|Overall Study||3
9896671|NCT01116102|11012264|FG002|COMPLETED|Overall Study||3
9896672|NCT01116102|11012265|FG003|COMPLETED|Overall Study||3
9896673|NCT01116102|11012266|FG004|COMPLETED|Overall Study||2
9896674|NCT01116102|11012267|FG005|COMPLETED|Overall Study||2
9896675|NCT01116102|11012268|FG006|COMPLETED|Overall Study||2
9896676|NCT01116102|11012269|FG007|COMPLETED|Overall Study||3
9896677|NCT01116102|11012262|FG000|NOT COMPLETED|Overall Study||0
9896678|NCT01116102|11012263|FG001|NOT COMPLETED|Overall Study||0
9896679|NCT01116102|11012264|FG002|NOT COMPLETED|Overall Study||0
9896680|NCT01116102|11012265|FG003|NOT COMPLETED|Overall Study||0
9896681|NCT01116102|11012266|FG004|NOT COMPLETED|Overall Study||0
9896682|NCT01116102|11012267|FG005|NOT COMPLETED|Overall Study||0
9896683|NCT01116102|11012268|FG006|NOT COMPLETED|Overall Study||0
9896684|NCT01116102|11012269|FG007|NOT COMPLETED|Overall Study||0
9896685|NCT01116401|11012287|FG000|STARTED|Overall Study||29
9896686|NCT01116401|11012287|FG000|COMPLETED|Overall Study||29
9896687|NCT01116401|11012287|FG000|NOT COMPLETED|Overall Study||0
9896688|NCT01116427|11012293|FG000|STARTED|Core Phase||44
9896689|NCT01116427|11012294|FG001|STARTED|Core Phase||21
9896690|NCT01116427|11012293|FG000|COMPLETED|Core Phase||39
9896691|NCT01116427|11012294|FG001|COMPLETED|Core Phase||20
9896692|NCT01116427|11012293|FG000|NOT COMPLETED|Core Phase||5
9896693|NCT01116427|11012294|FG001|NOT COMPLETED|Core Phase||1
9896694|NCT01116427|11012293|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
9896695|NCT01116427|11012294|FG001|STARTED|Extension Phase||20
9896696|NCT01116427|11012293|FG000|COMPLETED|Extension Phase||29
9896697|NCT01116427|11012294|FG001|COMPLETED|Extension Phase||18
9896698|NCT01116427|11012293|FG000|NOT COMPLETED|Extension Phase||9
9896699|NCT01116427|11012294|FG001|NOT COMPLETED|Extension Phase||2
9896700|NCT01116440|11012306|FG000|STARTED|Treatment||11
9896701|NCT01116440|11012307|FG001|STARTED|Treatment||16
9896702|NCT01116440|11012306|FG000|COMPLETED|Treatment||8
9896703|NCT01116440|11012307|FG001|COMPLETED|Treatment||9
9896704|NCT01116440|11012306|FG000|NOT COMPLETED|Treatment||3
9896705|NCT01116440|11012307|FG001|NOT COMPLETED|Treatment||7
9896706|NCT01116440|11012306|FG000|STARTED|Withdrawal||8
9896707|NCT01116440|11012307|FG001|STARTED|Withdrawal||9
9896708|NCT01116440|11012306|FG000|COMPLETED|Withdrawal||8
9896709|NCT01116440|11012307|FG001|COMPLETED|Withdrawal||7
9896710|NCT01116440|11012306|FG000|NOT COMPLETED|Withdrawal||0
9896711|NCT01116440|11012307|FG001|NOT COMPLETED|Withdrawal||2
9896712|NCT01116440|11012306|FG000|STARTED|Follow-up||8
9896713|NCT01116440|11012307|FG001|STARTED|Follow-up||7
9896714|NCT01116440|11012306|FG000|COMPLETED|Follow-up||8
9896715|NCT01116440|11012307|FG001|COMPLETED|Follow-up||5
9896716|NCT01116440|11012306|FG000|NOT COMPLETED|Follow-up||0
9896717|NCT01116440|11012307|FG001|NOT COMPLETED|Follow-up||2
9896718|NCT01116466|11012315|FG000|STARTED|Overall Study||5
9896719|NCT01116466|11012315|FG000|COMPLETED|Overall Study||5
9896720|NCT01116466|11012315|FG000|NOT COMPLETED|Overall Study||0
9896721|NCT01116544|11012322|FG000|STARTED|Overall Study||23
9896722|NCT01116544|11012323|FG001|STARTED|Overall Study||23
9896723|NCT01116544|11012322|FG000|COMPLETED|Overall Study||21
9896724|NCT01116544|11012323|FG001|COMPLETED|Overall Study||22
9896725|NCT01116544|11012322|FG000|NOT COMPLETED|Overall Study||2
9896726|NCT01116544|11012323|FG001|NOT COMPLETED|Overall Study||1
9954798|NCT01433991|11073627|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
9954799|NCT01433991|11073628|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
9954800|NCT01433991|11073629|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
9954801|NCT01433991|11073630|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
9954802|NCT01433991|11073627|FG000|STARTED|Treatment Phase (Combination Agent)||3
9954803|NCT01433991|11073628|FG001|STARTED|Treatment Phase (Combination Agent)||3
9954804|NCT01433991|11073629|FG002|STARTED|Treatment Phase (Combination Agent)||14
9954805|NCT01433991|11073630|FG003|STARTED|Treatment Phase (Combination Agent)||8
9954806|NCT01433991|11073627|FG000|COMPLETED|Treatment Phase (Combination Agent)||1
9954807|NCT01433991|11073628|FG001|COMPLETED|Treatment Phase (Combination Agent)||2
9954808|NCT01433991|11073629|FG002|COMPLETED|Treatment Phase (Combination Agent)||8
9954809|NCT01433991|11073630|FG003|COMPLETED|Treatment Phase (Combination Agent)||2
9954810|NCT01433991|11073627|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2
9954811|NCT01433991|11073628|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1
9954812|NCT01433991|11073629|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6
9954813|NCT01433991|11073630|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6
9954814|NCT01434030|11073646|FG000|STARTED|Overall Study||57
9954815|NCT01434030|11073646|FG000|COMPLETED|Overall Study||56
9954816|NCT01434030|11073646|FG000|NOT COMPLETED|Overall Study||1
9954817|NCT01434121|11073654|FG000|STARTED|Overall Study||8
9954818|NCT01434121|11073655|FG001|STARTED|Overall Study||8
9954819|NCT01434121|11073656|FG002|STARTED|Overall Study||8
9954820|NCT01434121|11073654|FG000|COMPLETED|Overall Study||8
9954821|NCT01434121|11073655|FG001|COMPLETED|Overall Study||8
9954822|NCT01434121|11073656|FG002|COMPLETED|Overall Study||8
9954823|NCT01434121|11073654|FG000|NOT COMPLETED|Overall Study||0
9896727|NCT01116661|11012329|FG000|STARTED|Overall Study||199
10009022|NCT01763866|11131544|FG014|Received Treatment|Overall Study||113
10009023|NCT01763866|11131545|FG015|Received Treatment|Overall Study||115
9896728|NCT01116661|11012329|FG000|COMPLETED|Overall Study||197
9896729|NCT01116661|11012329|FG000|NOT COMPLETED|Overall Study||2
9896730|NCT01116687|11012333|FG000|STARTED|Overall Study||37
9896731|NCT01116687|11012333|FG000|COMPLETED|Overall Study||33
9896732|NCT01116687|11012333|FG000|NOT COMPLETED|Overall Study||4
9896733|NCT01116739|11012339|FG000|STARTED|Overall Study||1056
9896734|NCT01116739|11012340|FG001|STARTED|Overall Study||1004
9896735|NCT01116739|11012339|FG000|COMPLETED|Overall Study||926
9896736|NCT01116739|11012340|FG001|COMPLETED|Overall Study||868
9896737|NCT01116739|11012339|FG000|NOT COMPLETED|Overall Study||130
9896738|NCT01116739|11012340|FG001|NOT COMPLETED|Overall Study||136
9896739|NCT01116882|11012348|FG000|STARTED|30-day||2774
9896740|NCT01116882|11012349|FG001|STARTED|30-day||917
9896741|NCT01116882|11012348|FG000|COMPLETED|30-day||2706
9896742|NCT01116882|11012349|FG001|COMPLETED|30-day||886
9896743|NCT01116882|11012348|FG000|NOT COMPLETED|30-day||68
9896744|NCT01116882|11012349|FG001|NOT COMPLETED|30-day||31
9896745|NCT01116882|11012348|FG000|STARTED|12-month||2706
9896746|NCT01116882|11012349|FG001|STARTED|12-month||886
9896747|NCT01116882|11012348|FG000|COMPLETED|12-month||2439
9896748|NCT01116882|11012349|FG001|COMPLETED|12-month||787
9896749|NCT01116882|11012348|FG000|NOT COMPLETED|12-month||267
9896750|NCT01116882|11012349|FG001|NOT COMPLETED|12-month||99
9896751|NCT01116895|11012362|FG000|STARTED|Overall Study||16
9896752|NCT01116895|11012363|FG001|STARTED|Overall Study||15
9896753|NCT01116895|11012364|FG002|STARTED|Overall Study||18
9896754|NCT01116895|11012365|FG003|STARTED|Overall Study||14
9896755|NCT01116895|11012362|FG000|COMPLETED|Overall Study||12
9896756|NCT01116895|11012363|FG001|COMPLETED|Overall Study||8
9896757|NCT01116895|11012364|FG002|COMPLETED|Overall Study||14
9896758|NCT01116895|11012365|FG003|COMPLETED|Overall Study||11
9896759|NCT01116895|11012362|FG000|NOT COMPLETED|Overall Study||4
9896760|NCT01116895|11012363|FG001|NOT COMPLETED|Overall Study||7
9896761|NCT01116895|11012364|FG002|NOT COMPLETED|Overall Study||4
9896762|NCT01116895|11012365|FG003|NOT COMPLETED|Overall Study||3
9896763|NCT01116921|11012377|FG000|STARTED|Overall Study||53
9896764|NCT01116921|11012378|FG001|STARTED|Overall Study||50
9896765|NCT01116921|11012377|FG000|COMPLETED|Overall Study||53
9896766|NCT01116921|11012378|FG001|COMPLETED|Overall Study||50
9896767|NCT01116921|11012377|FG000|NOT COMPLETED|Overall Study||0
9896768|NCT01116921|11012378|FG001|NOT COMPLETED|Overall Study||0
9896769|NCT01116934|11012386|FG000|STARTED|Overall Study||8
9896770|NCT01116934|11012387|FG001|STARTED|Overall Study||9
9896771|NCT01116934|11012386|FG000|COMPLETED|Overall Study||8
9896772|NCT01116934|11012387|FG001|COMPLETED|Overall Study||9
9896773|NCT01116934|11012386|FG000|NOT COMPLETED|Overall Study||0
9896774|NCT01116934|11012387|FG001|NOT COMPLETED|Overall Study||0
9896775|NCT01116986|11012425|FG000|STARTED|Overall Study||24
9896776|NCT01116986|11012426|FG001|STARTED|Overall Study||19
9896777|NCT01116986|11012427|FG002|STARTED|Overall Study||18
9896778|NCT01116986|11012428|FG003|STARTED|Overall Study||22
9896779|NCT01116986|11012429|FG004|STARTED|Overall Study||24
9896780|NCT01116986|11012430|FG005|STARTED|Overall Study||22
9896781|NCT01116986|11012431|FG006|STARTED|Overall Study||22
9896782|NCT01116986|11012432|FG007|STARTED|Overall Study||22
9896783|NCT01116986|11012433|FG008|STARTED|Overall Study||20
9896784|NCT01116986|11012434|FG009|STARTED|Overall Study||23
9896785|NCT01116986|11012435|FG010|STARTED|Overall Study||19
9896786|NCT01116986|11012436|FG011|STARTED|Overall Study||20
9896787|NCT01116986|11012437|FG012|STARTED|Overall Study||17
9896788|NCT01116986|11012438|FG013|STARTED|Overall Study||19
9896789|NCT01116986|11012439|FG014|STARTED|Overall Study||17
9896790|NCT01116986|11012440|FG015|STARTED|Overall Study||21
9896791|NCT01116986|11012441|FG016|STARTED|Overall Study||16
9896792|NCT01116986|11012442|FG017|STARTED|Overall Study||24
9896793|NCT01116986|11012443|FG018|STARTED|Overall Study||23
9896794|NCT01116986|11012444|FG019|STARTED|Overall Study||15
9896795|NCT01116986|11012445|FG020|STARTED|Overall Study||24
9896796|NCT01116986|11012446|FG021|STARTED|Overall Study||20
9896797|NCT01116986|11012447|FG022|STARTED|Overall Study||23
9896798|NCT01116986|11012448|FG023|STARTED|Overall Study||21
9896799|NCT01116986|11012449|FG024|STARTED|Overall Study||18
9896800|NCT01116986|11012450|FG025|STARTED|Overall Study||19
9896801|NCT01116986|11012451|FG026|STARTED|Overall Study||18
9896802|NCT01116986|11012452|FG027|STARTED|Overall Study||19
9896803|NCT01116986|11012453|FG028|STARTED|Overall Study||17
9896804|NCT01116986|11012454|FG029|STARTED|Overall Study||17
9896805|NCT01116986|11012455|FG030|STARTED|Overall Study||17
9896806|NCT01116986|11012456|FG031|STARTED|Overall Study||17
10009024|NCT01763866|11131546|FG016|Received Treatment|Overall Study||56
10009025|NCT01763866|11131547|FG017|Received Treatment|Overall Study||55
9896807|NCT01116986|11012425|FG000|COMPLETED|Overall Study||22
9896808|NCT01116986|11012426|FG001|COMPLETED|Overall Study||16
10009026|NCT01763866|11131548|FG018|Received Treatment|Overall Study||111
9896809|NCT01116986|11012427|FG002|COMPLETED|Overall Study||16
9896810|NCT01116986|11012428|FG003|COMPLETED|Overall Study||20
9896811|NCT01116986|11012429|FG004|COMPLETED|Overall Study||20
9896812|NCT01116986|11012430|FG005|COMPLETED|Overall Study||20
9896813|NCT01116986|11012431|FG006|COMPLETED|Overall Study||20
9896814|NCT01116986|11012432|FG007|COMPLETED|Overall Study||20
9896815|NCT01116986|11012433|FG008|COMPLETED|Overall Study||19
9896816|NCT01116986|11012434|FG009|COMPLETED|Overall Study||19
9896817|NCT01116986|11012435|FG010|COMPLETED|Overall Study||18
9896818|NCT01116986|11012436|FG011|COMPLETED|Overall Study||20
9896819|NCT01116986|11012437|FG012|COMPLETED|Overall Study||16
9896820|NCT01116986|11012438|FG013|COMPLETED|Overall Study||16
9896821|NCT01116986|11012439|FG014|COMPLETED|Overall Study||17
9896822|NCT01116986|11012440|FG015|COMPLETED|Overall Study||15
9896823|NCT01116986|11012441|FG016|COMPLETED|Overall Study||13
9896824|NCT01116986|11012442|FG017|COMPLETED|Overall Study||19
9896825|NCT01116986|11012443|FG018|COMPLETED|Overall Study||20
9896826|NCT01116986|11012444|FG019|COMPLETED|Overall Study||13
9896827|NCT01116986|11012445|FG020|COMPLETED|Overall Study||22
9896828|NCT01116986|11012446|FG021|COMPLETED|Overall Study||18
9896829|NCT01116986|11012447|FG022|COMPLETED|Overall Study||19
9896830|NCT01116986|11012448|FG023|COMPLETED|Overall Study||19
9896831|NCT01116986|11012449|FG024|COMPLETED|Overall Study||15
9896832|NCT01116986|11012450|FG025|COMPLETED|Overall Study||19
9896833|NCT01116986|11012451|FG026|COMPLETED|Overall Study||14
9896834|NCT01116986|11012452|FG027|COMPLETED|Overall Study||18
9896835|NCT01116986|11012453|FG028|COMPLETED|Overall Study||17
9896836|NCT01116986|11012454|FG029|COMPLETED|Overall Study||17
9896837|NCT01116986|11012455|FG030|COMPLETED|Overall Study||16
9896838|NCT01116986|11012456|FG031|COMPLETED|Overall Study||14
9896839|NCT01116986|11012425|FG000|NOT COMPLETED|Overall Study||2
9896840|NCT01116986|11012426|FG001|NOT COMPLETED|Overall Study||3
9896841|NCT01116986|11012427|FG002|NOT COMPLETED|Overall Study||2
9896842|NCT01116986|11012428|FG003|NOT COMPLETED|Overall Study||2
9896843|NCT01116986|11012429|FG004|NOT COMPLETED|Overall Study||4
9896844|NCT01116986|11012430|FG005|NOT COMPLETED|Overall Study||2
9896845|NCT01116986|11012431|FG006|NOT COMPLETED|Overall Study||2
9896846|NCT01116986|11012432|FG007|NOT COMPLETED|Overall Study||2
9896847|NCT01116986|11012433|FG008|NOT COMPLETED|Overall Study||1
9896848|NCT01116986|11012434|FG009|NOT COMPLETED|Overall Study||4
9896849|NCT01116986|11012435|FG010|NOT COMPLETED|Overall Study||1
9896850|NCT01116986|11012436|FG011|NOT COMPLETED|Overall Study||0
9896851|NCT01116986|11012437|FG012|NOT COMPLETED|Overall Study||1
9896852|NCT01116986|11012438|FG013|NOT COMPLETED|Overall Study||3
9896853|NCT01116986|11012439|FG014|NOT COMPLETED|Overall Study||0
9896854|NCT01116986|11012440|FG015|NOT COMPLETED|Overall Study||6
9896855|NCT01116986|11012441|FG016|NOT COMPLETED|Overall Study||3
9896856|NCT01116986|11012442|FG017|NOT COMPLETED|Overall Study||5
9896857|NCT01116986|11012443|FG018|NOT COMPLETED|Overall Study||3
9896858|NCT01116986|11012444|FG019|NOT COMPLETED|Overall Study||2
9896859|NCT01116986|11012445|FG020|NOT COMPLETED|Overall Study||2
9896860|NCT01116986|11012446|FG021|NOT COMPLETED|Overall Study||2
9896861|NCT01116986|11012447|FG022|NOT COMPLETED|Overall Study||4
9896862|NCT01116986|11012448|FG023|NOT COMPLETED|Overall Study||2
9896863|NCT01116986|11012449|FG024|NOT COMPLETED|Overall Study||3
9896864|NCT01116986|11012450|FG025|NOT COMPLETED|Overall Study||0
9896865|NCT01116986|11012451|FG026|NOT COMPLETED|Overall Study||4
9896866|NCT01116986|11012452|FG027|NOT COMPLETED|Overall Study||1
9896867|NCT01116986|11012453|FG028|NOT COMPLETED|Overall Study||0
9896868|NCT01116986|11012454|FG029|NOT COMPLETED|Overall Study||0
9896869|NCT01116986|11012455|FG030|NOT COMPLETED|Overall Study||1
9896870|NCT01116986|11012456|FG031|NOT COMPLETED|Overall Study||3
9896871|NCT01117012|11012478|FG000|STARTED|Overall Study||89
9896872|NCT01117012|11012479|FG001|STARTED|Overall Study||103
9896873|NCT01117012|11012478|FG000|COMPLETED|Overall Study||81
9896874|NCT01117012|11012479|FG001|COMPLETED|Overall Study||98
9896875|NCT01117012|11012478|FG000|NOT COMPLETED|Overall Study||8
9896876|NCT01117012|11012479|FG001|NOT COMPLETED|Overall Study||5
9896877|NCT01117051|11012487|FG000|STARTED|Overall Study||86
9896878|NCT01117051|11012488|FG001|STARTED|Overall Study||88
9896879|NCT01117051|11012487|FG000|COMPLETED|Overall Study||73
9896880|NCT01117051|11012488|FG001|COMPLETED|Overall Study||77
9896881|NCT01117051|11012487|FG000|NOT COMPLETED|Overall Study||13
9896882|NCT01117051|11012488|FG001|NOT COMPLETED|Overall Study||11
9896883|NCT01117090|11012495|FG000|STARTED|Overall Study||47
9896884|NCT01117090|11012495|FG000|COMPLETED|Overall Study||47
9896885|NCT01117090|11012495|FG000|NOT COMPLETED|Overall Study||0
9896886|NCT01117181|11012508|FG000|STARTED|Overall Study||29
9896887|NCT01117181|11012509|FG001|STARTED|Overall Study||31
9896888|NCT01117181|11012508|FG000|COMPLETED|Overall Study||28
9896889|NCT01117181|11012509|FG001|COMPLETED|Overall Study||29
9896890|NCT01117181|11012508|FG000|NOT COMPLETED|Overall Study||1
9896891|NCT01117181|11012509|FG001|NOT COMPLETED|Overall Study||2
9896892|NCT01117311|11012517|FG000|STARTED|Lead-in Mixed Meal 1||3
9896893|NCT01117311|11012518|FG001|STARTED|Lead-in Mixed Meal 1||4
9896894|NCT01117311|11012517|FG000|COMPLETED|Lead-in Mixed Meal 1||3
9896895|NCT01117311|11012518|FG001|COMPLETED|Lead-in Mixed Meal 1||4
9896896|NCT01117311|11012517|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0
9896897|NCT01117311|11012518|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0
9896898|NCT01117311|11012517|FG000|STARTED|First Intervention - Mixed Meal 2||3
9896899|NCT01117311|11012518|FG001|STARTED|First Intervention - Mixed Meal 2||4
9896900|NCT01117311|11012517|FG000|COMPLETED|First Intervention - Mixed Meal 2||3
9896901|NCT01117311|11012518|FG001|COMPLETED|First Intervention - Mixed Meal 2||4
9896902|NCT01117311|11012517|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0
9896903|NCT01117311|11012518|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0
9896904|NCT01117311|11012517|FG000|STARTED|Second Intervention - Mixed Meal 3||3
9896905|NCT01117311|11012518|FG001|STARTED|Second Intervention - Mixed Meal 3||4
9896906|NCT01117311|11012517|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3
9896907|NCT01117311|11012518|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4
9896908|NCT01117311|11012517|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
9896909|NCT01117311|11012518|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
9896910|NCT01117337|11012526|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
9896911|NCT01117337|11012527|FG001|STARTED|Overall Study||52
9896912|NCT01117337|11012526|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52
9896913|NCT01117337|11012527|FG001|Underwent Surgery|Overall Study||52
9896914|NCT01117337|11012526|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
9896915|NCT01117337|11012527|FG001|COMPLETED|Overall Study||52
10009027|NCT01763866|11131549|FG019|Received Treatment|Overall Study||112
10009028|NCT01763866|11131550|FG020|Received Treatment|Overall Study||56
10009029|NCT01763866|11131551|FG021|Received Treatment|Overall Study||55
10009030|NCT01763866|11131552|FG022|Received Treatment|Overall Study||112
10009031|NCT01763866|11131553|FG023|Received Treatment|Overall Study||115
10009032|NCT01763866|11131530|FG000|COMPLETED|Overall Study||54
10009033|NCT01763866|11131531|FG001|COMPLETED|Overall Study||54
10009034|NCT01763866|11131532|FG002|COMPLETED|Overall Study||51
10009035|NCT01763866|11131533|FG003|COMPLETED|Overall Study||55
10009036|NCT01763866|11131534|FG004|COMPLETED|Overall Study||108
10009037|NCT01763866|11131535|FG005|COMPLETED|Overall Study||107
9896916|NCT01117337|11012526|FG000|NOT COMPLETED|Overall Study||4
9896917|NCT01117337|11012527|FG001|NOT COMPLETED|Overall Study||0
9896918|NCT01117350|11012535|FG000|STARTED|Comparative Period|STARTED: randomized|489
9896919|NCT01117350|11012536|FG001|STARTED|Comparative Period||489
9896920|NCT01117350|11012535|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
9896921|NCT01117350|11012536|FG001|TREATED = Safety Population|Comparative Period||481
9896922|NCT01117350|11012535|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
9896923|NCT01117350|11012536|FG001|mITT Population|Comparative Period||470
9896924|NCT01117350|11012535|FG000|COMPLETED|Comparative Period||447
9896925|NCT01117350|11012536|FG001|COMPLETED|Comparative Period||414
9896926|NCT01117350|11012535|FG000|NOT COMPLETED|Comparative Period||42
9896927|NCT01117350|11012536|FG001|NOT COMPLETED|Comparative Period||75
9896928|NCT01117350|11012535|FG000|STARTED|Extension Period||0
9896929|NCT01117350|11012536|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
9896930|NCT01117350|11012535|FG000|TREATED = Safety Population (Extension)|Extension Period||0
9896931|NCT01117350|11012536|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
9896932|NCT01117350|11012535|FG000|mITT Population (Extension)|Extension Period||0
9896933|NCT01117350|11012536|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
9896934|NCT01117350|11012535|FG000|COMPLETED|Extension Period||0
9896935|NCT01117350|11012536|FG001|COMPLETED|Extension Period||147
9896936|NCT01117350|11012535|FG000|NOT COMPLETED|Extension Period||0
9896937|NCT01117350|11012536|FG001|NOT COMPLETED|Extension Period||63
9896938|NCT01117428|11012551|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
9896939|NCT01117428|11012552|FG001|STARTED|Overall Study||29
9896940|NCT01117428|11012553|FG002|STARTED|Overall Study||13
9896941|NCT01117428|11012554|FG003|STARTED|Overall Study||12
9896942|NCT01117428|11012555|FG004|STARTED|Overall Study||17
9896943|NCT01117428|11012556|FG005|STARTED|Overall Study||20
9896944|NCT01117428|11012551|FG000|COMPLETED|Overall Study||0
9896945|NCT01117428|11012552|FG001|COMPLETED|Overall Study||0
9896946|NCT01117428|11012553|FG002|COMPLETED|Overall Study||0
9896947|NCT01117428|11012554|FG003|COMPLETED|Overall Study||0
9896948|NCT01117428|11012555|FG004|COMPLETED|Overall Study||0
9896949|NCT01117428|11012556|FG005|COMPLETED|Overall Study||0
9896950|NCT01117428|11012551|FG000|NOT COMPLETED|Overall Study||20
9896951|NCT01117428|11012552|FG001|NOT COMPLETED|Overall Study||29
9896952|NCT01117428|11012553|FG002|NOT COMPLETED|Overall Study||13
9896953|NCT01117428|11012554|FG003|NOT COMPLETED|Overall Study||12
9896954|NCT01117428|11012555|FG004|NOT COMPLETED|Overall Study||17
9896955|NCT01117428|11012556|FG005|NOT COMPLETED|Overall Study||20
9896956|NCT01117454|11012574|FG000|STARTED|Overall Study||6
9896957|NCT01117454|11012575|FG001|STARTED|Overall Study||8
9896958|NCT01117454|11012574|FG000|COMPLETED|Overall Study||6
9896959|NCT01117454|11012575|FG001|COMPLETED|Overall Study||7
9896960|NCT01117454|11012574|FG000|NOT COMPLETED|Overall Study||0
9896961|NCT01117454|11012575|FG001|NOT COMPLETED|Overall Study||1
9896962|NCT01117480|11012581|FG000|STARTED|Overall Study||1013
9896963|NCT01117480|11012581|FG000|COMPLETED|Overall Study||985
9896964|NCT01117480|11012581|FG000|NOT COMPLETED|Overall Study||28
9896965|NCT01117623|11012593|FG000|STARTED|Overall Study||3
9896966|NCT01117623|11012594|FG001|STARTED|Overall Study||8
9896967|NCT01117623|11012595|FG002|STARTED|Overall Study||11
9896968|NCT01117623|11012596|FG003|STARTED|Overall Study||6
9896969|NCT01117623|11012597|FG004|STARTED|Overall Study||10
9896970|NCT01117623|11012598|FG005|STARTED|Overall Study||16
9896971|NCT01117623|11012599|FG006|STARTED|Overall Study||6
9896972|NCT01117623|11012600|FG007|STARTED|Overall Study||26
9896973|NCT01117623|11012593|FG000|ITT Efficacy Analysis Population|Overall Study||3
10009038|NCT01763866|11131536|FG006|COMPLETED|Overall Study||48
10009039|NCT01763866|11131537|FG007|COMPLETED|Overall Study||55
10009040|NCT01763866|11131538|FG008|COMPLETED|Overall Study||53
9896974|NCT01117623|11012594|FG001|ITT Efficacy Analysis Population|Overall Study||8
9896975|NCT01117623|11012595|FG002|ITT Efficacy Analysis Population|Overall Study||11
9896976|NCT01117623|11012596|FG003|ITT Efficacy Analysis Population|Overall Study||5
9896977|NCT01117623|11012597|FG004|ITT Efficacy Analysis Population|Overall Study||10
9896978|NCT01117623|11012598|FG005|ITT Efficacy Analysis Population|Overall Study||16
9896979|NCT01117623|11012599|FG006|ITT Efficacy Analysis Population|Overall Study||6
9896980|NCT01117623|11012600|FG007|ITT Efficacy Analysis Population|Overall Study||22
9896981|NCT01117623|11012593|FG000|PK Population|Overall Study||3
9896982|NCT01117623|11012594|FG001|PK Population|Overall Study||8
9896983|NCT01117623|11012595|FG002|PK Population|Overall Study||10
9896984|NCT01117623|11012596|FG003|PK Population|Overall Study||6
9896985|NCT01117623|11012597|FG004|PK Population|Overall Study||10
9896986|NCT01117623|11012598|FG005|PK Population|Overall Study||14
9896987|NCT01117623|11012599|FG006|PK Population|Overall Study||6
9896988|NCT01117623|11012600|FG007|PK Population|Overall Study||24
9896989|NCT01117623|11012593|FG000|COMPLETED|Overall Study||0
9896990|NCT01117623|11012594|FG001|COMPLETED|Overall Study||0
9896991|NCT01117623|11012595|FG002|COMPLETED|Overall Study||0
9896992|NCT01117623|11012596|FG003|COMPLETED|Overall Study||0
9896993|NCT01117623|11012597|FG004|COMPLETED|Overall Study||0
9896994|NCT01117623|11012598|FG005|COMPLETED|Overall Study||0
9896995|NCT01117623|11012599|FG006|COMPLETED|Overall Study||0
9896996|NCT01117623|11012600|FG007|COMPLETED|Overall Study||0
9896997|NCT01117623|11012593|FG000|NOT COMPLETED|Overall Study||3
9896998|NCT01117623|11012594|FG001|NOT COMPLETED|Overall Study||8
9896999|NCT01117623|11012595|FG002|NOT COMPLETED|Overall Study||11
9897000|NCT01117623|11012596|FG003|NOT COMPLETED|Overall Study||6
9897001|NCT01117623|11012597|FG004|NOT COMPLETED|Overall Study||10
9897002|NCT01117623|11012598|FG005|NOT COMPLETED|Overall Study||16
9897003|NCT01117623|11012599|FG006|NOT COMPLETED|Overall Study||6
9897004|NCT01117623|11012600|FG007|NOT COMPLETED|Overall Study||26
9897005|NCT01117727|11012620|FG000|STARTED|Overall Study||1
9897006|NCT01117727|11012620|FG000|COMPLETED|Overall Study||1
9897007|NCT01117727|11012620|FG000|NOT COMPLETED|Overall Study||0
9897008|NCT01117766|11012625|FG000|STARTED|First Intervention||14
9897009|NCT01117766|11012626|FG001|STARTED|First Intervention||17
9897010|NCT01117766|11012625|FG000|Received Treatment|First Intervention||14
9897011|NCT01117766|11012626|FG001|Received Treatment|First Intervention||17
9897012|NCT01117766|11012625|FG000|COMPLETED|First Intervention||13
9897013|NCT01117766|11012626|FG001|COMPLETED|First Intervention||16
9897014|NCT01117766|11012625|FG000|NOT COMPLETED|First Intervention||1
9897015|NCT01117766|11012626|FG001|NOT COMPLETED|First Intervention||1
9897016|NCT01117766|11012625|FG000|STARTED|Washout Period||13
9897017|NCT01117766|11012626|FG001|STARTED|Washout Period||16
9897018|NCT01117766|11012625|FG000|COMPLETED|Washout Period||13
9897019|NCT01117766|11012626|FG001|COMPLETED|Washout Period||14
9897020|NCT01117766|11012625|FG000|NOT COMPLETED|Washout Period||0
9897021|NCT01117766|11012626|FG001|NOT COMPLETED|Washout Period||2
9897022|NCT01117766|11012625|FG000|STARTED|Second Intervention||13
9897023|NCT01117766|11012626|FG001|STARTED|Second Intervention||14
9897024|NCT01117766|11012625|FG000|COMPLETED|Second Intervention||11
9897025|NCT01117766|11012626|FG001|COMPLETED|Second Intervention||9
9897026|NCT01117766|11012625|FG000|NOT COMPLETED|Second Intervention||2
9897027|NCT01117766|11012626|FG001|NOT COMPLETED|Second Intervention||5
9897028|NCT01117792|11012632|FG000|STARTED|Overall Study||55
9897029|NCT01117792|11012632|FG000|COMPLETED|Overall Study||51
9897030|NCT01117792|11012632|FG000|NOT COMPLETED|Overall Study||4
9897031|NCT01117857|11012636|FG000|STARTED|Overall Study||22
9897032|NCT01117857|11012636|FG000|COMPLETED|Overall Study||13
9897033|NCT01117857|11012636|FG000|NOT COMPLETED|Overall Study||9
9897034|NCT01117870|11012642|FG000|STARTED|Overall Study||15
9897035|NCT01117870|11012643|FG001|STARTED|Overall Study||16
9897036|NCT01117870|11012642|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
9897037|NCT01117870|11012643|FG001|COMPLETED|Overall Study||16
9897038|NCT01117870|11012642|FG000|NOT COMPLETED|Overall Study||1
9897039|NCT01117870|11012643|FG001|NOT COMPLETED|Overall Study||0
9897040|NCT01117948|11012655|FG000|STARTED|Double Blind||111
9897041|NCT01117948|11012656|FG001|STARTED|Double Blind||108
9897042|NCT01117948|11012655|FG000|COMPLETED|Double Blind||93
9897043|NCT01117948|11012656|FG001|COMPLETED|Double Blind||98
9897044|NCT01117948|11012655|FG000|NOT COMPLETED|Double Blind||18
9897045|NCT01117948|11012656|FG001|NOT COMPLETED|Double Blind||10
9897046|NCT01117948|11012655|FG000|STARTED|Open Label||93
9897047|NCT01117948|11012656|FG001|STARTED|Open Label||98
9897048|NCT01117948|11012655|FG000|COMPLETED|Open Label||41
9897049|NCT01117948|11012656|FG001|COMPLETED|Open Label||51
9897050|NCT01117948|11012655|FG000|NOT COMPLETED|Open Label||52
9897051|NCT01117948|11012656|FG001|NOT COMPLETED|Open Label||47
9897052|NCT01117987|11012664|FG000|STARTED|Overall Study||66
9897053|NCT01117987|11012665|FG001|STARTED|Overall Study||78
9897054|NCT01117987|11012664|FG000|COMPLETED|Overall Study||5
9897055|NCT01117987|11012665|FG001|COMPLETED|Overall Study||4
9897056|NCT01117987|11012664|FG000|NOT COMPLETED|Overall Study||61
9897057|NCT01117987|11012665|FG001|NOT COMPLETED|Overall Study||74
9897058|NCT01118052|11012671|FG000|STARTED|Overall Study||22
9897059|NCT01118052|11012671|FG000|COMPLETED|Overall Study||20
9897060|NCT01118052|11012671|FG000|NOT COMPLETED|Overall Study||2
9897061|NCT01118091|11012683|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
9897062|NCT01118091|11012684|FG001|STARTED|Overall Study||5
9897063|NCT01118091|11012683|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
9897064|NCT01118091|11012684|FG001|COMPLETED|Overall Study||5
9897065|NCT01118091|11012683|FG000|NOT COMPLETED|Overall Study||0
9897066|NCT01118091|11012684|FG001|NOT COMPLETED|Overall Study||0
9897067|NCT01118117|11012692|FG000|STARTED|Overall Study||261
9897068|NCT01118117|11012693|FG001|STARTED|Overall Study||15
9897069|NCT01118117|11012692|FG000|COMPLETED|Overall Study||240
9897070|NCT01118117|11012693|FG001|COMPLETED|Overall Study||15
9897071|NCT01118117|11012692|FG000|NOT COMPLETED|Overall Study||21
9897072|NCT01118117|11012693|FG001|NOT COMPLETED|Overall Study||0
9897073|NCT01118143|11012701|FG000|STARTED|Overall Study||64
9897074|NCT01118143|11012702|FG001|STARTED|Overall Study||69
9897075|NCT01118143|11012701|FG000|COMPLETED|Overall Study||62
9897076|NCT01118143|11012702|FG001|COMPLETED|Overall Study||64
9897077|NCT01118143|11012701|FG000|NOT COMPLETED|Overall Study||2
9897078|NCT01118143|11012702|FG001|NOT COMPLETED|Overall Study||5
9897079|NCT01118221|11012712|FG000|STARTED|Overall Study||14
9897080|NCT01118221|11012713|FG001|STARTED|Overall Study||11
9897081|NCT01118221|11012712|FG000|COMPLETED|Overall Study||11
9897082|NCT01118221|11012713|FG001|COMPLETED|Overall Study||10
9897083|NCT01118221|11012712|FG000|NOT COMPLETED|Overall Study||3
9897084|NCT01118221|11012713|FG001|NOT COMPLETED|Overall Study||1
9897085|NCT01118273|11012729|FG000|STARTED|Overall Study||27
9897086|NCT01118273|11012730|FG001|STARTED|Overall Study||27
9897087|NCT01118273|11012731|FG002|STARTED|Overall Study||27
9897088|NCT01118273|11012732|FG003|STARTED|Overall Study||27
9897089|NCT01118273|11012733|FG004|STARTED|Overall Study||27
9897090|NCT01118273|11012734|FG005|STARTED|Overall Study||27
9897091|NCT01118273|11012729|FG000|COMPLETED|Overall Study||27
9897092|NCT01118273|11012730|FG001|COMPLETED|Overall Study||27
9897093|NCT01118273|11012731|FG002|COMPLETED|Overall Study||27
9897094|NCT01118273|11012732|FG003|COMPLETED|Overall Study||27
9897095|NCT01118273|11012733|FG004|COMPLETED|Overall Study||27
9897096|NCT01118273|11012734|FG005|COMPLETED|Overall Study||27
9897097|NCT01118273|11012729|FG000|NOT COMPLETED|Overall Study||0
9897098|NCT01118273|11012730|FG001|NOT COMPLETED|Overall Study||0
9897099|NCT01118273|11012731|FG002|NOT COMPLETED|Overall Study||0
9897100|NCT01118273|11012732|FG003|NOT COMPLETED|Overall Study||0
9897101|NCT01118273|11012733|FG004|NOT COMPLETED|Overall Study||0
9897102|NCT01118273|11012734|FG005|NOT COMPLETED|Overall Study||0
9897103|NCT01118299|11012750|FG000|STARTED|Overall Study||68
9897104|NCT01118299|11012751|FG001|STARTED|Overall Study||29
9897105|NCT01118299|11012750|FG000|COMPLETED|Overall Study||45
9897106|NCT01118299|11012751|FG001|COMPLETED|Overall Study||0
9897107|NCT01118299|11012750|FG000|NOT COMPLETED|Overall Study||23
9897108|NCT01118299|11012751|FG001|NOT COMPLETED|Overall Study||29
9897109|NCT01118312|11012758|FG000|STARTED|Overall Study||189
9897110|NCT01118312|11012759|FG001|STARTED|Overall Study||199
9897111|NCT01118312|11012758|FG000|COMPLETED|Overall Study||155
9897112|NCT01118312|11012759|FG001|COMPLETED|Overall Study||164
9897113|NCT01118312|11012758|FG000|NOT COMPLETED|Overall Study||34
9897114|NCT01118312|11012759|FG001|NOT COMPLETED|Overall Study||35
9897115|NCT01118325|11012768|FG000|STARTED|Overall Study||50
9897116|NCT01118325|11012769|FG001|STARTED|Overall Study||43
9897117|NCT01118325|11012770|FG002|STARTED|Overall Study||46
9897118|NCT01118325|11012768|FG000|COMPLETED|Overall Study||49
9897119|NCT01118325|11012769|FG001|COMPLETED|Overall Study||43
9897120|NCT01118325|11012770|FG002|COMPLETED|Overall Study||45
9897121|NCT01118325|11012768|FG000|NOT COMPLETED|Overall Study||1
9897122|NCT01118325|11012769|FG001|NOT COMPLETED|Overall Study||0
9897123|NCT01118325|11012770|FG002|NOT COMPLETED|Overall Study||1
9897124|NCT01118338|11012793|FG000|STARTED|Overall Study||185
9897125|NCT01118338|11012794|FG001|STARTED|Overall Study||183
9897126|NCT01118338|11012793|FG000|COMPLETED|Overall Study||182
9897127|NCT01118338|11012794|FG001|COMPLETED|Overall Study||174
9897128|NCT01118338|11012793|FG000|NOT COMPLETED|Overall Study||3
9897129|NCT01118338|11012794|FG001|NOT COMPLETED|Overall Study||9
9897130|NCT01118351|11012800|FG000|STARTED|Overall Study||19
9897131|NCT01118351|11012800|FG000|COMPLETED|Overall Study||15
9897132|NCT01118351|11012800|FG000|NOT COMPLETED|Overall Study||4
9897133|NCT01118377|11012804|FG000|STARTED|Overall Study||45
9897134|NCT01118377|11012804|FG000|COMPLETED|Overall Study||3
9897135|NCT01118377|11012804|FG000|NOT COMPLETED|Overall Study||42
9897136|NCT01118455|11012810|FG000|STARTED|Baseline [Visits 1 & 2]||66
9897137|NCT01118455|11012811|FG001|STARTED|Baseline [Visits 1 & 2]||69
9897138|NCT01118455|11012810|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65
9897139|NCT01118455|11012811|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69
9897140|NCT01118455|11012810|FG000|COMPLETED|Baseline [Visits 1 & 2]||65
9897141|NCT01118455|11012811|FG001|COMPLETED|Baseline [Visits 1 & 2]||69
9897142|NCT01118455|11012810|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1
9897143|NCT01118455|11012811|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0
9897144|NCT01118455|11012810|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
9897145|NCT01118455|11012811|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
9897146|NCT01118455|11012810|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
9897147|NCT01118455|11012811|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
9897148|NCT01118455|11012810|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
9897149|NCT01118455|11012811|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
9897150|NCT01118520|11012828|FG000|STARTED|Overall Study||73
9897151|NCT01118520|11012829|FG001|STARTED|Overall Study||72
9897152|NCT01118520|11012830|FG002|STARTED|Overall Study||79
9897153|NCT01118520|11012828|FG000|COMPLETED|Overall Study||53
9897154|NCT01118520|11012829|FG001|COMPLETED|Overall Study||49
9897155|NCT01118520|11012830|FG002|COMPLETED|Overall Study||59
9897156|NCT01118520|11012828|FG000|NOT COMPLETED|Overall Study||20
9897157|NCT01118520|11012829|FG001|NOT COMPLETED|Overall Study||23
9897158|NCT01118520|11012830|FG002|NOT COMPLETED|Overall Study||20
9897159|NCT01118624|11012838|FG000|STARTED|Overall Study||22
9897160|NCT01118624|11012838|FG000|COMPLETED|Overall Study||0
9897161|NCT01118624|11012838|FG000|NOT COMPLETED|Overall Study||22
9954824|NCT01434121|11073655|FG001|NOT COMPLETED|Overall Study||0
9954825|NCT01434121|11073656|FG002|NOT COMPLETED|Overall Study||0
9954826|NCT01434186|11073669|FG000|STARTED|Overall Study||2
9954827|NCT01434186|11073670|FG001|STARTED|Overall Study||4
9954828|NCT01434186|11073669|FG000|COMPLETED|Overall Study||2
9954829|NCT01434186|11073670|FG001|COMPLETED|Overall Study||4
9954830|NCT01434186|11073669|FG000|NOT COMPLETED|Overall Study||0
9954831|NCT01434186|11073670|FG001|NOT COMPLETED|Overall Study||0
9954832|NCT01434342|11073678|FG000|STARTED|Overall Study||98
9954833|NCT01434342|11073679|FG001|STARTED|Overall Study||48
9954834|NCT01434342|11073678|FG000|COMPLETED|Overall Study||50
9954835|NCT01434342|11073679|FG001|COMPLETED|Overall Study||31
9954836|NCT01434342|11073678|FG000|NOT COMPLETED|Overall Study||48
9954837|NCT01434342|11073679|FG001|NOT COMPLETED|Overall Study||17
9954838|NCT01434472|11073685|FG000|STARTED|Overall Study||20
9954839|NCT01434472|11073685|FG000|COMPLETED|Overall Study||20
9954840|NCT01434472|11073685|FG000|NOT COMPLETED|Overall Study||0
9954841|NCT01434641|11073689|FG000|STARTED|Overall Study||102
9954842|NCT01434641|11073689|FG000|COMPLETED|Overall Study||102
9954843|NCT01434641|11073689|FG000|NOT COMPLETED|Overall Study||0
9954844|NCT01434654|11073695|FG000|STARTED|Overall Study||7
9954845|NCT01434654|11073696|FG001|STARTED|Overall Study||12
9954846|NCT01434654|11073695|FG000|COMPLETED|Overall Study||5
9954847|NCT01434654|11073696|FG001|COMPLETED|Overall Study||12
9954848|NCT01434654|11073695|FG000|NOT COMPLETED|Overall Study||2
9954849|NCT01434654|11073696|FG001|NOT COMPLETED|Overall Study||0
9954850|NCT01434667|11073706|FG000|STARTED|Overall Study||39
9954851|NCT01434667|11073707|FG001|STARTED|Overall Study||75
9954852|NCT01434667|11073706|FG000|COMPLETED|Overall Study||34
9954853|NCT01434667|11073707|FG001|COMPLETED|Overall Study||65
9954854|NCT01434667|11073706|FG000|NOT COMPLETED|Overall Study||5
9954855|NCT01434667|11073707|FG001|NOT COMPLETED|Overall Study||10
9954856|NCT01434680|11073717|FG000|STARTED|Overall Study||299
9954857|NCT01434680|11073718|FG001|STARTED|Overall Study||268
9954858|NCT01434680|11073719|FG002|STARTED|Overall Study||306
9954859|NCT01434680|11073720|FG003|STARTED|Overall Study||119
9954860|NCT01434680|11073717|FG000|COMPLETED|Overall Study||296
9954861|NCT01434680|11073718|FG001|COMPLETED|Overall Study||266
9954862|NCT01434680|11073719|FG002|COMPLETED|Overall Study||304
9954863|NCT01434680|11073720|FG003|COMPLETED|Overall Study||119
9954864|NCT01434680|11073717|FG000|NOT COMPLETED|Overall Study||3
9954865|NCT01434680|11073718|FG001|NOT COMPLETED|Overall Study||2
9954866|NCT01434680|11073719|FG002|NOT COMPLETED|Overall Study||2
10009041|NCT01763866|11131539|FG009|COMPLETED|Overall Study||53
10009042|NCT01763866|11131540|FG010|COMPLETED|Overall Study||102
10009043|NCT01763866|11131541|FG011|COMPLETED|Overall Study||108
10009044|NCT01763866|11131542|FG012|COMPLETED|Overall Study||54
10009045|NCT01763866|11131543|FG013|COMPLETED|Overall Study||57
10009046|NCT01763866|11131544|FG014|COMPLETED|Overall Study||102
10009047|NCT01763866|11131545|FG015|COMPLETED|Overall Study||112
10009048|NCT01763866|11131546|FG016|COMPLETED|Overall Study||55
10009049|NCT01763866|11131547|FG017|COMPLETED|Overall Study||55
10009050|NCT01763866|11131548|FG018|COMPLETED|Overall Study||105
10009051|NCT01763866|11131549|FG019|COMPLETED|Overall Study||110
10009052|NCT01763866|11131550|FG020|COMPLETED|Overall Study||52
10009053|NCT01763866|11131551|FG021|COMPLETED|Overall Study||54
10009054|NCT01763866|11131552|FG022|COMPLETED|Overall Study||109
10009055|NCT01763866|11131553|FG023|COMPLETED|Overall Study||113
10009056|NCT01763866|11131530|FG000|NOT COMPLETED|Overall Study||2
10009057|NCT01763866|11131531|FG001|NOT COMPLETED|Overall Study||1
10009058|NCT01763866|11131532|FG002|NOT COMPLETED|Overall Study||5
10009059|NCT01763866|11131533|FG003|NOT COMPLETED|Overall Study||0
10009060|NCT01763866|11131534|FG004|NOT COMPLETED|Overall Study||2
9954867|NCT01434680|11073720|FG003|NOT COMPLETED|Overall Study||0
9954868|NCT01434693|11073734|FG000|STARTED|Overall Study||9
9954869|NCT01434693|11073735|FG001|STARTED|Overall Study||9
9954870|NCT01434693|11073736|FG002|STARTED|Overall Study||9
9954871|NCT01434693|11073737|FG003|STARTED|Overall Study||9
9954872|NCT01434693|11073734|FG000|COMPLETED|Overall Study||6
9954873|NCT01434693|11073735|FG001|COMPLETED|Overall Study||9
9954874|NCT01434693|11073736|FG002|COMPLETED|Overall Study||8
9954875|NCT01434693|11073737|FG003|COMPLETED|Overall Study||8
9954876|NCT01434693|11073734|FG000|NOT COMPLETED|Overall Study||3
9954877|NCT01434693|11073735|FG001|NOT COMPLETED|Overall Study||0
9954878|NCT01434693|11073736|FG002|NOT COMPLETED|Overall Study||1
10009061|NCT01763866|11131535|FG005|NOT COMPLETED|Overall Study||3
10009062|NCT01763866|11131536|FG006|NOT COMPLETED|Overall Study||7
10009063|NCT01763866|11131537|FG007|NOT COMPLETED|Overall Study||0
10009064|NCT01763866|11131538|FG008|NOT COMPLETED|Overall Study||3
9954879|NCT01434693|11073737|FG003|NOT COMPLETED|Overall Study||1
9954880|NCT01434810|11073749|FG000|STARTED|Overall Study||224
9954881|NCT01434810|11073750|FG001|STARTED|Overall Study||223
9954882|NCT01434810|11073749|FG000|COMPLETED|Overall Study||201
9954883|NCT01434810|11073750|FG001|COMPLETED|Overall Study||213
9897162|NCT01118663|11012844|FG000|STARTED|Overall Study||7
9897163|NCT01118663|11012845|FG001|STARTED|Overall Study||10
9897164|NCT01118663|11012844|FG000|COMPLETED|Overall Study||5
9897165|NCT01118663|11012845|FG001|COMPLETED|Overall Study||8
9897166|NCT01118663|11012844|FG000|NOT COMPLETED|Overall Study||2
9897167|NCT01118663|11012845|FG001|NOT COMPLETED|Overall Study||2
9897168|NCT01118715|11012853|FG000|STARTED|Overall Study||68
9897169|NCT01118715|11012854|FG001|STARTED|Overall Study||60
9897170|NCT01118715|11012853|FG000|COMPLETED|Overall Study||68
9897171|NCT01118715|11012854|FG001|COMPLETED|Overall Study||60
9897172|NCT01118715|11012853|FG000|NOT COMPLETED|Overall Study||0
9897173|NCT01118715|11012854|FG001|NOT COMPLETED|Overall Study||0
9897174|NCT01118728|11012881|FG000|STARTED|Overall Study||223
9897175|NCT01118728|11012881|FG000|COMPLETED|Overall Study||0
9897176|NCT01118728|11012881|FG000|NOT COMPLETED|Overall Study||223
9897177|NCT01118741|11012887|FG000|STARTED|Overall Study||9
9897178|NCT01118741|11012888|FG001|STARTED|Overall Study||10
9897179|NCT01118741|11012887|FG000|COMPLETED|Overall Study||9
9897180|NCT01118741|11012888|FG001|COMPLETED|Overall Study||10
9897181|NCT01118741|11012887|FG000|NOT COMPLETED|Overall Study||0
9897182|NCT01118741|11012888|FG001|NOT COMPLETED|Overall Study||0
9897183|NCT01118780|11012898|FG000|STARTED|Overall Study||151
9897184|NCT01118780|11012899|FG001|STARTED|Overall Study||140
9897185|NCT01118780|11012898|FG000|COMPLETED|Overall Study||115
9897186|NCT01118780|11012899|FG001|COMPLETED|Overall Study||105
9897187|NCT01118780|11012898|FG000|NOT COMPLETED|Overall Study||36
9897188|NCT01118780|11012899|FG001|NOT COMPLETED|Overall Study||35
9897189|NCT01118845|11012908|FG000|STARTED|Overall Study||59
9897190|NCT01118845|11012908|FG000|COMPLETED|Overall Study||17
9897191|NCT01118845|11012908|FG000|NOT COMPLETED|Overall Study||42
9897192|NCT01118949|11012912|FG000|STARTED|Overall Study||49
9897193|NCT01118949|11012912|FG000|COMPLETED|Overall Study||40
9897194|NCT01118949|11012912|FG000|NOT COMPLETED|Overall Study||9
9897195|NCT01118962|11012916|FG000|STARTED|Overall Study||39
9897196|NCT01118962|11012916|FG000|COMPLETED|Overall Study||29
9897197|NCT01118962|11012916|FG000|NOT COMPLETED|Overall Study||10
9897198|NCT01118975|11012922|FG000|STARTED|Overall Study||9
9897199|NCT01118975|11012923|FG001|STARTED|Overall Study||3
9897200|NCT01118975|11012922|FG000|COMPLETED|Overall Study||9
9897201|NCT01118975|11012923|FG001|COMPLETED|Overall Study||2
9897202|NCT01118975|11012922|FG000|NOT COMPLETED|Overall Study||0
9897203|NCT01118975|11012923|FG001|NOT COMPLETED|Overall Study||1
10110243|NCT02483975|11241009|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
10110244|NCT02483975|11241008|FG000|NOT COMPLETED|Overall Study||2
10110245|NCT02483975|11241009|FG001|NOT COMPLETED|Overall Study||2
10110246|NCT02484092|11241018|FG000|STARTED|Overall Study||15
10110247|NCT02484092|11241018|FG000|COMPLETED|Overall Study||15
10110248|NCT02484092|11241018|FG000|NOT COMPLETED|Overall Study||0
10110249|NCT02484222|11241022|FG000|STARTED|Overall Study||80
10110250|NCT02484222|11241022|FG000|COMPLETED|Overall Study||77
10110251|NCT02484222|11241022|FG000|NOT COMPLETED|Overall Study||3
10113396|NCT02509117|11244192|FG002|STARTED|Period 3 -Part A: 4 Days||2
10113397|NCT02509117|11244193|FG003|STARTED|Period 3 -Part A: 4 Days||2
10113398|NCT02509117|11244194|FG004|STARTED|Period 3 -Part A: 4 Days||0
10113399|NCT02509117|11244195|FG005|STARTED|Period 3 -Part A: 4 Days||0
10113400|NCT02509117|11244196|FG006|STARTED|Period 3 -Part A: 4 Days||0
10113401|NCT02509117|11244197|FG007|STARTED|Period 3 -Part A: 4 Days||0
10113402|NCT02509117|11244198|FG008|STARTED|Period 3 -Part A: 4 Days||0
9897204|NCT01118988|11012932|FG000|STARTED|Overall Study||16
9897205|NCT01118988|11012933|FG001|STARTED|Overall Study||4
9897206|NCT01118988|11012934|FG002|STARTED|Overall Study||7
9897207|NCT01118988|11012932|FG000|COMPLETED|Overall Study||11
9897208|NCT01118988|11012933|FG001|COMPLETED|Overall Study||3
9897209|NCT01118988|11012934|FG002|COMPLETED|Overall Study||3
9897210|NCT01118988|11012932|FG000|NOT COMPLETED|Overall Study||5
9897211|NCT01118988|11012933|FG001|NOT COMPLETED|Overall Study||1
9897212|NCT01118988|11012934|FG002|NOT COMPLETED|Overall Study||4
9897213|NCT01119001|11012941|FG000|STARTED|Overall Study||13
9897214|NCT01119001|11012941|FG000|COMPLETED|Overall Study||11
9897215|NCT01119001|11012941|FG000|NOT COMPLETED|Overall Study||2
9897216|NCT01119040|11012947|FG000|STARTED|Overall Study||1
9897217|NCT01119040|11012947|FG000|COMPLETED|Overall Study||0
9897218|NCT01119040|11012947|FG000|NOT COMPLETED|Overall Study||1
9897219|NCT01119105|11012954|FG000|STARTED|Overall Study||70
9897220|NCT01119105|11012955|FG001|STARTED|Overall Study||72
9897221|NCT01119105|11012956|FG002|STARTED|Overall Study||68
9897222|NCT01119105|11012954|FG000|COMPLETED|Overall Study||66
9897223|NCT01119105|11012955|FG001|COMPLETED|Overall Study||66
9897224|NCT01119105|11012956|FG002|COMPLETED|Overall Study||60
9897225|NCT01119105|11012954|FG000|NOT COMPLETED|Overall Study||4
9897226|NCT01119105|11012955|FG001|NOT COMPLETED|Overall Study||6
9897227|NCT01119105|11012956|FG002|NOT COMPLETED|Overall Study||8
9897228|NCT01119118|11012964|FG000|STARTED|Overall Study||6
9897229|NCT01119118|11012964|FG000|COMPLETED|Overall Study||5
9897230|NCT01119118|11012964|FG000|NOT COMPLETED|Overall Study||1
9897231|NCT01119131|11012971|FG000|STARTED|Overall Study||10
9897232|NCT01119131|11012972|FG001|STARTED|Overall Study||28
9897233|NCT01119131|11012973|FG002|STARTED|Overall Study||30
9897234|NCT01119131|11012971|FG000|COMPLETED|Overall Study||8
10113403|NCT02509117|11244199|FG009|STARTED|Period 3 -Part A: 4 Days||0
10113404|NCT02509117|11244190|FG000|COMPLETED|Period 3 -Part A: 4 Days||2
10113405|NCT02509117|11244191|FG001|COMPLETED|Period 3 -Part A: 4 Days||2
9897235|NCT01119131|11012972|FG001|COMPLETED|Overall Study||27
9897236|NCT01119131|11012973|FG002|COMPLETED|Overall Study||24
9897237|NCT01119131|11012971|FG000|NOT COMPLETED|Overall Study||2
9897238|NCT01119131|11012972|FG001|NOT COMPLETED|Overall Study||1
9897239|NCT01119131|11012973|FG002|NOT COMPLETED|Overall Study||6
9897240|NCT01119222|11012981|FG000|STARTED|Overall Study||5
9897241|NCT01119222|11012982|FG001|STARTED|Overall Study||5
9897242|NCT01119222|11012983|FG002|STARTED|Overall Study||5
9897243|NCT01119222|11012984|FG003|STARTED|Overall Study||4
9897244|NCT01119222|11012981|FG000|COMPLETED|Overall Study||5
9897245|NCT01119222|11012982|FG001|COMPLETED|Overall Study||5
9897246|NCT01119222|11012983|FG002|COMPLETED|Overall Study||5
9897247|NCT01119222|11012984|FG003|COMPLETED|Overall Study||4
9897248|NCT01119222|11012981|FG000|NOT COMPLETED|Overall Study||0
9897249|NCT01119222|11012982|FG001|NOT COMPLETED|Overall Study||0
9897250|NCT01119222|11012983|FG002|NOT COMPLETED|Overall Study||0
9897251|NCT01119222|11012984|FG003|NOT COMPLETED|Overall Study||0
9897252|NCT01119248|11012997|FG000|STARTED|Overall Study||120
9897253|NCT01119248|11012997|FG000|COMPLETED|Overall Study||115
9897254|NCT01119248|11012997|FG000|NOT COMPLETED|Overall Study||5
9897255|NCT01119287|11013008|FG000|STARTED|Overall Study||26
9897256|NCT01119287|11013009|FG001|STARTED|Overall Study||24
9897257|NCT01119287|11013010|FG002|STARTED|Overall Study||26
9897258|NCT01119287|11013011|FG003|STARTED|Overall Study||31
9897259|NCT01119287|11013012|FG004|STARTED|Overall Study||31
9897260|NCT01119287|11013013|FG005|STARTED|Overall Study||32
9897261|NCT01119287|11013008|FG000|COMPLETED|Overall Study||26
9897262|NCT01119287|11013009|FG001|COMPLETED|Overall Study||24
9897263|NCT01119287|11013010|FG002|COMPLETED|Overall Study||24
9897264|NCT01119287|11013011|FG003|COMPLETED|Overall Study||29
9897265|NCT01119287|11013012|FG004|COMPLETED|Overall Study||30
9897266|NCT01119287|11013013|FG005|COMPLETED|Overall Study||32
9897267|NCT01119287|11013008|FG000|NOT COMPLETED|Overall Study||0
9897268|NCT01119287|11013009|FG001|NOT COMPLETED|Overall Study||0
9897269|NCT01119287|11013010|FG002|NOT COMPLETED|Overall Study||2
9897270|NCT01119287|11013011|FG003|NOT COMPLETED|Overall Study||2
9897271|NCT01119287|11013012|FG004|NOT COMPLETED|Overall Study||1
9897272|NCT01119287|11013013|FG005|NOT COMPLETED|Overall Study||0
9897273|NCT01119443|11013027|FG000|STARTED|Up-titration Period (10 Days)||14
9897274|NCT01119443|11013028|FG001|STARTED|Up-titration Period (10 Days)||14
9897275|NCT01119443|11013027|FG000|COMPLETED|Up-titration Period (10 Days)||14
9897276|NCT01119443|11013028|FG001|COMPLETED|Up-titration Period (10 Days)||14
9897277|NCT01119443|11013027|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0
9897278|NCT01119443|11013028|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0
9897279|NCT01119443|11013027|FG000|STARTED|Crossover Period 1 (5 Days)||14
9897280|NCT01119443|11013028|FG001|STARTED|Crossover Period 1 (5 Days)||14
9897281|NCT01119443|11013027|FG000|COMPLETED|Crossover Period 1 (5 Days)||14
9897282|NCT01119443|11013028|FG001|COMPLETED|Crossover Period 1 (5 Days)||13
9897283|NCT01119443|11013027|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0
9897284|NCT01119443|11013028|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1
9897285|NCT01119443|11013027|FG000|STARTED|Crossover Period 2 (5 Days)||14
9897286|NCT01119443|11013028|FG001|STARTED|Crossover Period 2 (5 Days)||13
9897287|NCT01119443|11013027|FG000|COMPLETED|Crossover Period 2 (5 Days)||14
9897288|NCT01119443|11013028|FG001|COMPLETED|Crossover Period 2 (5 Days)||13
9897289|NCT01119443|11013027|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0
9897290|NCT01119443|11013028|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0
9897291|NCT01119443|11013027|FG000|STARTED|Crossover Period 3 (5 Days)||14
9897292|NCT01119443|11013028|FG001|STARTED|Crossover Period 3 (5 Days)||13
9897293|NCT01119443|11013027|FG000|COMPLETED|Crossover Period 3 (5 Days)||14
9897294|NCT01119443|11013028|FG001|COMPLETED|Crossover Period 3 (5 Days)||13
9897295|NCT01119443|11013027|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0
9897296|NCT01119443|11013028|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0
9897297|NCT01119443|11013027|FG000|STARTED|Crossover Period 4 (5 Days)||14
9897298|NCT01119443|11013028|FG001|STARTED|Crossover Period 4 (5 Days)||13
9897299|NCT01119443|11013027|FG000|COMPLETED|Crossover Period 4 (5 Days)||14
9897300|NCT01119443|11013028|FG001|COMPLETED|Crossover Period 4 (5 Days)||13
9897301|NCT01119443|11013027|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0
9897302|NCT01119443|11013028|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0
9897303|NCT01119443|11013027|FG000|STARTED|Down-titration Period (1 Day)||14
9897304|NCT01119443|11013028|FG001|STARTED|Down-titration Period (1 Day)||13
9897305|NCT01119443|11013027|FG000|COMPLETED|Down-titration Period (1 Day)||14
9897306|NCT01119443|11013028|FG001|COMPLETED|Down-titration Period (1 Day)||13
9897307|NCT01119443|11013027|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0
9897308|NCT01119443|11013028|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0
9897309|NCT01119443|11013027|FG000|STARTED|End of Study (All Patients)||14
9897310|NCT01119443|11013028|FG001|STARTED|End of Study (All Patients)||14
9897311|NCT01119443|11013027|FG000|COMPLETED|End of Study (All Patients)||14
9897312|NCT01119443|11013028|FG001|COMPLETED|End of Study (All Patients)||14
9897313|NCT01119443|11013027|FG000|NOT COMPLETED|End of Study (All Patients)||0
9897314|NCT01119443|11013028|FG001|NOT COMPLETED|End of Study (All Patients)||0
9897315|NCT01119456|11013045|FG000|STARTED|Overall Study||7
9897316|NCT01119456|11013046|FG001|STARTED|Overall Study||3
9897317|NCT01119456|11013047|FG002|STARTED|Overall Study||3
9897318|NCT01119456|11013048|FG003|STARTED|Overall Study||13
9897319|NCT01119456|11013049|FG004|STARTED|Overall Study||4
9897320|NCT01119456|11013050|FG005|STARTED|Overall Study||3
9897321|NCT01119456|11013051|FG006|STARTED|Overall Study||3
9897322|NCT01119456|11013052|FG007|STARTED|Overall Study||3
9897323|NCT01119456|11013045|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
9897324|NCT01119456|11013046|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9897325|NCT01119456|11013047|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9897326|NCT01119456|11013048|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13
9897327|NCT01119456|11013049|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4
9897328|NCT01119456|11013050|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
9897329|NCT01119456|11013051|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
9897330|NCT01119456|11013052|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
9897331|NCT01119456|11013045|FG000|COMPLETED|Overall Study||7
9897332|NCT01119456|11013046|FG001|COMPLETED|Overall Study||3
9897333|NCT01119456|11013047|FG002|COMPLETED|Overall Study||3
9897334|NCT01119456|11013048|FG003|COMPLETED|Overall Study||13
9897335|NCT01119456|11013049|FG004|COMPLETED|Overall Study||4
9897336|NCT01119456|11013050|FG005|COMPLETED|Overall Study||3
9897337|NCT01119456|11013051|FG006|COMPLETED|Overall Study||3
9897338|NCT01119456|11013052|FG007|COMPLETED|Overall Study||3
9897339|NCT01119456|11013045|FG000|NOT COMPLETED|Overall Study||0
9897340|NCT01119456|11013046|FG001|NOT COMPLETED|Overall Study||0
9897341|NCT01119456|11013047|FG002|NOT COMPLETED|Overall Study||0
9897342|NCT01119456|11013048|FG003|NOT COMPLETED|Overall Study||0
9897343|NCT01119456|11013049|FG004|NOT COMPLETED|Overall Study||0
9897344|NCT01119456|11013050|FG005|NOT COMPLETED|Overall Study||0
9897345|NCT01119456|11013051|FG006|NOT COMPLETED|Overall Study||0
9897346|NCT01119456|11013052|FG007|NOT COMPLETED|Overall Study||0
9897347|NCT01119508|11013077|FG000|STARTED|Overall Study||64
9897348|NCT01119508|11013077|FG000|Received Four Induction Doses|Overall Study||45
9897349|NCT01119508|11013077|FG000|Received Fifth Consolidation Dose week12|Overall Study||32
9897350|NCT01119508|11013077|FG000|COMPLETED|Overall Study||5
9897351|NCT01119508|11013077|FG000|NOT COMPLETED|Overall Study||59
9897352|NCT01119625|11013083|FG000|STARTED|Overall Study||118
9897353|NCT01119625|11013084|FG001|STARTED|Overall Study||120
9897354|NCT01119625|11013083|FG000|COMPLETED|Overall Study||115
9897355|NCT01119625|11013084|FG001|COMPLETED|Overall Study||116
9897356|NCT01119625|11013083|FG000|NOT COMPLETED|Overall Study||3
9897357|NCT01119625|11013084|FG001|NOT COMPLETED|Overall Study||4
9897358|NCT01119703|11013092|FG000|STARTED|Overall Study||30
9897359|NCT01119703|11013093|FG001|STARTED|Overall Study||144
9897360|NCT01119703|11013092|FG000|COMPLETED|Overall Study||30
9897361|NCT01119703|11013093|FG001|COMPLETED|Overall Study||143
9897362|NCT01119703|11013092|FG000|NOT COMPLETED|Overall Study||0
9897363|NCT01119703|11013093|FG001|NOT COMPLETED|Overall Study||1
9897364|NCT01119716|11013098|FG000|STARTED|Overall Study||4658
9897365|NCT01119716|11013098|FG000|COMPLETED|Overall Study||4658
9897366|NCT01119716|11013098|FG000|NOT COMPLETED|Overall Study||0
9897367|NCT01119755|11013106|FG000|STARTED|Overall Study||80
9897368|NCT01119755|11013106|FG000|COMPLETED|Overall Study||80
9897369|NCT01119755|11013106|FG000|NOT COMPLETED|Overall Study||0
9897370|NCT01119768|11013112|FG000|STARTED|Treatment Period||154
9897371|NCT01119768|11013113|FG001|STARTED|Treatment Period||151
9897372|NCT01119768|11013112|FG000|COMPLETED|Treatment Period||136
9897373|NCT01119768|11013113|FG001|COMPLETED|Treatment Period||126
9897374|NCT01119768|11013112|FG000|NOT COMPLETED|Treatment Period||18
9897375|NCT01119768|11013113|FG001|NOT COMPLETED|Treatment Period||25
9897376|NCT01119768|11013112|FG000|STARTED|Follow-up||136
9897377|NCT01119768|11013113|FG001|STARTED|Follow-up||124
9897378|NCT01119768|11013112|FG000|COMPLETED|Follow-up||135
9897379|NCT01119768|11013113|FG001|COMPLETED|Follow-up||122
9897380|NCT01119768|11013112|FG000|NOT COMPLETED|Follow-up||1
9897381|NCT01119768|11013113|FG001|NOT COMPLETED|Follow-up||2
9897382|NCT01119794|11013119|FG000|STARTED|Overall Study||10
9897383|NCT01119794|11013119|FG000|COMPLETED|Overall Study||10
9897384|NCT01119794|11013119|FG000|NOT COMPLETED|Overall Study||0
9897385|NCT01119846|11013126|FG000|STARTED|Overall Study||13
9897386|NCT01119846|11013127|FG001|STARTED|Overall Study||4
9897387|NCT01119846|11013128|FG002|STARTED|Overall Study||83
9897388|NCT01119846|11013126|FG000|COMPLETED|Overall Study||11
9897389|NCT01119846|11013127|FG001|COMPLETED|Overall Study||4
9897390|NCT01119846|11013128|FG002|COMPLETED|Overall Study||72
9897391|NCT01119846|11013126|FG000|NOT COMPLETED|Overall Study||2
10009065|NCT01763866|11131539|FG009|NOT COMPLETED|Overall Study||1
10009066|NCT01763866|11131540|FG010|NOT COMPLETED|Overall Study||8
10009067|NCT01763866|11131541|FG011|NOT COMPLETED|Overall Study||2
10009068|NCT01763866|11131542|FG012|NOT COMPLETED|Overall Study||4
10009069|NCT01763866|11131543|FG013|NOT COMPLETED|Overall Study||0
10009070|NCT01763866|11131544|FG014|NOT COMPLETED|Overall Study||12
9897392|NCT01119846|11013127|FG001|NOT COMPLETED|Overall Study||0
9897393|NCT01119846|11013128|FG002|NOT COMPLETED|Overall Study||11
9897394|NCT01119859|11013165|FG000|STARTED|Overall Study||163
9897395|NCT01119859|11013166|FG001|STARTED|Overall Study||163
9897396|NCT01119859|11013165|FG000|COMPLETED|Overall Study||139
9897397|NCT01119859|11013166|FG001|COMPLETED|Overall Study||133
9897398|NCT01119859|11013165|FG000|NOT COMPLETED|Overall Study||24
9897399|NCT01119859|11013166|FG001|NOT COMPLETED|Overall Study||30
9897400|NCT01119898|11013174|FG000|STARTED|Overall Study||131
9897401|NCT01119898|11013175|FG001|STARTED|Overall Study||129
9897402|NCT01119898|11013174|FG000|Received Study Drug (mITT)|Overall Study||130
9897403|NCT01119898|11013175|FG001|Received Study Drug (mITT)|Overall Study||129
9897404|NCT01119898|11013174|FG000|COMPLETED|Overall Study||123
9897405|NCT01119898|11013175|FG001|COMPLETED|Overall Study||117
9897406|NCT01119898|11013174|FG000|NOT COMPLETED|Overall Study||8
9897407|NCT01119898|11013175|FG001|NOT COMPLETED|Overall Study||12
9897408|NCT01119937|11013183|FG000|STARTED|Overall Study||123
9897409|NCT01119937|11013184|FG001|STARTED|Overall Study||40
9897410|NCT01119937|11013183|FG000|COMPLETED|Overall Study||104
9897411|NCT01119937|11013184|FG001|COMPLETED|Overall Study||33
9897412|NCT01119937|11013183|FG000|NOT COMPLETED|Overall Study||19
9897413|NCT01119937|11013184|FG001|NOT COMPLETED|Overall Study||7
9897414|NCT01119950|11013190|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
9897415|NCT01119950|11013190|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
9897416|NCT01119950|11013190|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
9897417|NCT01119950|11013190|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
9897418|NCT01119950|11013190|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
9897419|NCT01119950|11013190|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
9897420|NCT01119950|11013190|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
9897421|NCT01119950|11013190|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
9897422|NCT01119950|11013190|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
9897423|NCT01119950|11013190|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
9897424|NCT01119950|11013190|FG000|NOT COMPLETED|Overall Study||47
9897425|NCT01119963|11013218|FG000|STARTED|Overall Study||74
9897426|NCT01119963|11013219|FG001|STARTED|Overall Study||78
9897427|NCT01119963|11013218|FG000|COMPLETED|Overall Study||73
9897428|NCT01119963|11013219|FG001|COMPLETED|Overall Study||77
9897429|NCT01119963|11013218|FG000|NOT COMPLETED|Overall Study||1
9897430|NCT01119963|11013219|FG001|NOT COMPLETED|Overall Study||1
9897431|NCT01120028|11013231|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426
9897432|NCT01120028|11013232|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426
9897433|NCT01120028|11013233|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0
9897434|NCT01120028|11013234|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0
9897435|NCT01120028|11013231|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
9897436|NCT01120028|11013232|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
9897437|NCT01120028|11013233|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
9897438|NCT01120028|11013234|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
9897439|NCT01120028|11013231|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
9897440|NCT01120028|11013232|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
9897441|NCT01120028|11013233|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
9897442|NCT01120028|11013234|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
9897443|NCT01120028|11013231|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0
9897444|NCT01120028|11013232|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0
9897445|NCT01120028|11013233|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197
9897446|NCT01120028|11013234|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197
9897447|NCT01120028|11013231|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
9897448|NCT01120028|11013232|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
9897449|NCT01120028|11013233|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
9897450|NCT01120028|11013234|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
9897451|NCT01120028|11013231|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
9897452|NCT01120028|11013232|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
9897453|NCT01120028|11013233|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
9897454|NCT01120028|11013234|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
9897455|NCT01120067|11013247|FG000|STARTED|Overall Study||12
9897456|NCT01120067|11013248|FG001|STARTED|Overall Study||11
9897457|NCT01120067|11013247|FG000|COMPLETED|Overall Study||7
9897458|NCT01120067|11013248|FG001|COMPLETED|Overall Study||10
9897459|NCT01120067|11013247|FG000|NOT COMPLETED|Overall Study||5
9897460|NCT01120067|11013248|FG001|NOT COMPLETED|Overall Study||1
9897461|NCT01120093|11013254|FG000|STARTED|Treatment Period 1||18
9897462|NCT01120093|11013255|FG001|STARTED|Treatment Period 1||14
9897463|NCT01120093|11013256|FG002|STARTED|Treatment Period 1||17
9897464|NCT01120093|11013257|FG003|STARTED|Treatment Period 1||14
9897465|NCT01120093|11013258|FG004|STARTED|Treatment Period 1||16
9897466|NCT01120093|11013254|FG000|COMPLETED|Treatment Period 1||18
9897467|NCT01120093|11013255|FG001|COMPLETED|Treatment Period 1||13
9897468|NCT01120093|11013256|FG002|COMPLETED|Treatment Period 1||16
9897469|NCT01120093|11013257|FG003|COMPLETED|Treatment Period 1||14
9897470|NCT01120093|11013258|FG004|COMPLETED|Treatment Period 1||15
9897471|NCT01120093|11013254|FG000|NOT COMPLETED|Treatment Period 1||0
9897472|NCT01120093|11013255|FG001|NOT COMPLETED|Treatment Period 1||1
9897473|NCT01120093|11013256|FG002|NOT COMPLETED|Treatment Period 1||1
9897474|NCT01120093|11013257|FG003|NOT COMPLETED|Treatment Period 1||0
9897475|NCT01120093|11013258|FG004|NOT COMPLETED|Treatment Period 1||1
9897476|NCT01120093|11013254|FG000|STARTED|Treatment Period 2||18
9897477|NCT01120093|11013255|FG001|STARTED|Treatment Period 2||13
9897478|NCT01120093|11013256|FG002|STARTED|Treatment Period 2||16
9897479|NCT01120093|11013257|FG003|STARTED|Treatment Period 2||14
9897480|NCT01120093|11013258|FG004|STARTED|Treatment Period 2||15
9897481|NCT01120093|11013254|FG000|COMPLETED|Treatment Period 2||18
9897482|NCT01120093|11013255|FG001|COMPLETED|Treatment Period 2||13
9897483|NCT01120093|11013256|FG002|COMPLETED|Treatment Period 2||16
9897484|NCT01120093|11013257|FG003|COMPLETED|Treatment Period 2||13
9897485|NCT01120093|11013258|FG004|COMPLETED|Treatment Period 2||14
9897486|NCT01120093|11013254|FG000|NOT COMPLETED|Treatment Period 2||0
9897487|NCT01120093|11013255|FG001|NOT COMPLETED|Treatment Period 2||0
9897488|NCT01120093|11013256|FG002|NOT COMPLETED|Treatment Period 2||0
9897489|NCT01120093|11013257|FG003|NOT COMPLETED|Treatment Period 2||1
9897490|NCT01120093|11013258|FG004|NOT COMPLETED|Treatment Period 2||1
9897491|NCT01120093|11013254|FG000|STARTED|Treatment Period 3||18
9897492|NCT01120093|11013255|FG001|STARTED|Treatment Period 3||13
9897493|NCT01120093|11013256|FG002|STARTED|Treatment Period 3||16
9897494|NCT01120093|11013257|FG003|STARTED|Treatment Period 3||13
9897495|NCT01120093|11013258|FG004|STARTED|Treatment Period 3||14
9897496|NCT01120093|11013254|FG000|COMPLETED|Treatment Period 3||18
9897497|NCT01120093|11013255|FG001|COMPLETED|Treatment Period 3||13
9897498|NCT01120093|11013256|FG002|COMPLETED|Treatment Period 3||15
9897499|NCT01120093|11013257|FG003|COMPLETED|Treatment Period 3||12
9897500|NCT01120093|11013258|FG004|COMPLETED|Treatment Period 3||13
9897501|NCT01120093|11013254|FG000|NOT COMPLETED|Treatment Period 3||0
9897502|NCT01120093|11013255|FG001|NOT COMPLETED|Treatment Period 3||0
9897503|NCT01120093|11013256|FG002|NOT COMPLETED|Treatment Period 3||1
9897504|NCT01120093|11013257|FG003|NOT COMPLETED|Treatment Period 3||1
9897505|NCT01120093|11013258|FG004|NOT COMPLETED|Treatment Period 3||1
9897506|NCT01120093|11013254|FG000|STARTED|Treatment Period 4||18
9897507|NCT01120093|11013255|FG001|STARTED|Treatment Period 4||13
9897508|NCT01120093|11013256|FG002|STARTED|Treatment Period 4||15
9897509|NCT01120093|11013257|FG003|STARTED|Treatment Period 4||12
9897510|NCT01120093|11013258|FG004|STARTED|Treatment Period 4||13
9897511|NCT01120093|11013254|FG000|COMPLETED|Treatment Period 4||17
9897512|NCT01120093|11013255|FG001|COMPLETED|Treatment Period 4||13
9897513|NCT01120093|11013256|FG002|COMPLETED|Treatment Period 4||15
9897514|NCT01120093|11013257|FG003|COMPLETED|Treatment Period 4||12
9897515|NCT01120093|11013258|FG004|COMPLETED|Treatment Period 4||13
9897516|NCT01120093|11013254|FG000|NOT COMPLETED|Treatment Period 4||1
9897517|NCT01120093|11013255|FG001|NOT COMPLETED|Treatment Period 4||0
9897518|NCT01120093|11013256|FG002|NOT COMPLETED|Treatment Period 4||0
9897519|NCT01120093|11013257|FG003|NOT COMPLETED|Treatment Period 4||0
9897520|NCT01120093|11013258|FG004|NOT COMPLETED|Treatment Period 4||0
9897521|NCT01120093|11013254|FG000|STARTED|Treatment Period 5||17
9897522|NCT01120093|11013255|FG001|STARTED|Treatment Period 5||13
9897523|NCT01120093|11013256|FG002|STARTED|Treatment Period 5||15
9897524|NCT01120093|11013257|FG003|STARTED|Treatment Period 5||12
9897525|NCT01120093|11013258|FG004|STARTED|Treatment Period 5||13
9897526|NCT01120093|11013254|FG000|COMPLETED|Treatment Period 5||17
9897527|NCT01120093|11013255|FG001|COMPLETED|Treatment Period 5||12
9897528|NCT01120093|11013256|FG002|COMPLETED|Treatment Period 5||15
9897529|NCT01120093|11013257|FG003|COMPLETED|Treatment Period 5||11
9897530|NCT01120093|11013258|FG004|COMPLETED|Treatment Period 5||13
9897531|NCT01120093|11013254|FG000|NOT COMPLETED|Treatment Period 5||0
9897532|NCT01120093|11013255|FG001|NOT COMPLETED|Treatment Period 5||1
9897533|NCT01120093|11013256|FG002|NOT COMPLETED|Treatment Period 5||0
9897534|NCT01120093|11013257|FG003|NOT COMPLETED|Treatment Period 5||1
9897535|NCT01120093|11013258|FG004|NOT COMPLETED|Treatment Period 5||0
9897536|NCT01120184|11013273|FG000|STARTED|Overall Study||365
9897537|NCT01120184|11013274|FG001|STARTED|Overall Study||367
9897538|NCT01120184|11013275|FG002|STARTED|Overall Study||363
9897539|NCT01120184|11013273|FG000|Treated|Overall Study||355
9897540|NCT01120184|11013274|FG001|Treated|Overall Study||365
9897541|NCT01120184|11013275|FG002|Treated|Overall Study||360
9897542|NCT01120184|11013273|FG000|COMPLETED|Overall Study||0
10009071|NCT01763866|11131545|FG015|NOT COMPLETED|Overall Study||3
10009072|NCT01763866|11131546|FG016|NOT COMPLETED|Overall Study||1
10009073|NCT01763866|11131547|FG017|NOT COMPLETED|Overall Study||1
10009074|NCT01763866|11131548|FG018|NOT COMPLETED|Overall Study||6
10009075|NCT01763866|11131549|FG019|NOT COMPLETED|Overall Study||2
10009076|NCT01763866|11131550|FG020|NOT COMPLETED|Overall Study||4
9897543|NCT01120184|11013274|FG001|COMPLETED|Overall Study||0
9897544|NCT01120184|11013275|FG002|COMPLETED|Overall Study||0
9897545|NCT01120184|11013273|FG000|NOT COMPLETED|Overall Study||365
10009077|NCT01763866|11131551|FG021|NOT COMPLETED|Overall Study||1
10110252|NCT02484547|11241031|FG000|STARTED|Placebo-Controlled Period||548
9897546|NCT01120184|11013274|FG001|NOT COMPLETED|Overall Study||367
9897547|NCT01120184|11013275|FG002|NOT COMPLETED|Overall Study||363
9897548|NCT01120197|11013285|FG000|STARTED|Overall Study||47
9897549|NCT01120197|11013286|FG001|STARTED|Overall Study||42
9897550|NCT01120197|11013285|FG000|COMPLETED|Overall Study||38
9897551|NCT01120197|11013286|FG001|COMPLETED|Overall Study||32
9897552|NCT01120197|11013285|FG000|NOT COMPLETED|Overall Study||9
9897553|NCT01120197|11013286|FG001|NOT COMPLETED|Overall Study||10
10009078|NCT01763866|11131552|FG022|NOT COMPLETED|Overall Study||3
9897554|NCT01120210|11013295|FG000|STARTED|MAIN INFUSION||16
9897555|NCT01120210|11013296|FG001|STARTED|MAIN INFUSION||46
9897556|NCT01120210|11013295|FG000|COMPLETED|MAIN INFUSION||15
9897557|NCT01120210|11013296|FG001|COMPLETED|MAIN INFUSION||45
9897558|NCT01120210|11013295|FG000|NOT COMPLETED|MAIN INFUSION||1
9897559|NCT01120210|11013296|FG001|NOT COMPLETED|MAIN INFUSION||1
9897560|NCT01120210|11013295|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
9897561|NCT01120210|11013296|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
9897562|NCT01120210|11013295|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
9897563|NCT01120210|11013296|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
9897564|NCT01120210|11013295|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
9897565|NCT01120210|11013296|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
9897566|NCT01120223|11013302|FG000|STARTED|Overall Study||78
9897567|NCT01120223|11013302|FG000|COMPLETED|Overall Study||74
9897568|NCT01120223|11013302|FG000|NOT COMPLETED|Overall Study||4
9897569|NCT01120236|11013308|FG000|STARTED|Overall Study||105
9897570|NCT01120236|11013309|FG001|STARTED|Overall Study||106
9897571|NCT01120236|11013308|FG000|Ineligble|Overall Study||0
9897572|NCT01120236|11013309|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
9897573|NCT01120236|11013308|FG000|COMPLETED|Overall Study||105
9897574|NCT01120236|11013309|FG001|COMPLETED|Overall Study||105
9897575|NCT01120236|11013308|FG000|NOT COMPLETED|Overall Study||0
9897576|NCT01120236|11013309|FG001|NOT COMPLETED|Overall Study||1
9897577|NCT01120275|11013323|FG000|STARTED|Overall Study||36
9897578|NCT01120275|11013323|FG000|Eligible and Treated|Overall Study||32
9897579|NCT01120275|11013323|FG000|COMPLETED|Overall Study||0
9897580|NCT01120275|11013323|FG000|NOT COMPLETED|Overall Study||36
10009079|NCT01763866|11131553|FG023|NOT COMPLETED|Overall Study||2
10009080|NCT01763905|11131607|FG000|STARTED|Overall Study||51
10009081|NCT01763905|11131608|FG001|STARTED|Overall Study||51
10009082|NCT01763905|11131609|FG002|STARTED|Overall Study||103
10009083|NCT01763905|11131610|FG003|STARTED|Overall Study||102
10009084|NCT01763905|11131607|FG000|COMPLETED|Overall Study||45
10009085|NCT01763905|11131608|FG001|COMPLETED|Overall Study||50
10009086|NCT01763905|11131609|FG002|COMPLETED|Overall Study||94
10110253|NCT02484547|11241032|FG001|STARTED|Placebo-Controlled Period||543
10110254|NCT02484547|11241033|FG002|STARTED|Placebo-Controlled Period||547
10110255|NCT02484547|11241034|FG003|STARTED|Placebo-Controlled Period||0
10110256|NCT02484547|11241035|FG004|STARTED|Placebo-Controlled Period||0
10110257|NCT02484547|11241036|FG005|STARTED|Placebo-Controlled Period||0
10110258|NCT02484547|11241037|FG006|STARTED|Placebo-Controlled Period||0
10110259|NCT02484547|11241031|FG000|COMPLETED|Placebo-Controlled Period||288
10110260|NCT02484547|11241032|FG001|COMPLETED|Placebo-Controlled Period||291
10110261|NCT02484547|11241033|FG002|COMPLETED|Placebo-Controlled Period||295
10110262|NCT02484547|11241034|FG003|COMPLETED|Placebo-Controlled Period||0
10110263|NCT02484547|11241035|FG004|COMPLETED|Placebo-Controlled Period||0
10110264|NCT02484547|11241036|FG005|COMPLETED|Placebo-Controlled Period||0
10110265|NCT02484547|11241037|FG006|COMPLETED|Placebo-Controlled Period||0
10110266|NCT02484547|11241031|FG000|NOT COMPLETED|Placebo-Controlled Period||260
10110267|NCT02484547|11241032|FG001|NOT COMPLETED|Placebo-Controlled Period||252
10110268|NCT02484547|11241033|FG002|NOT COMPLETED|Placebo-Controlled Period||252
10110269|NCT02484547|11241034|FG003|NOT COMPLETED|Placebo-Controlled Period||0
10110270|NCT02484547|11241035|FG004|NOT COMPLETED|Placebo-Controlled Period||0
10110271|NCT02484547|11241036|FG005|NOT COMPLETED|Placebo-Controlled Period||0
10110272|NCT02484547|11241037|FG006|NOT COMPLETED|Placebo-Controlled Period||0
10110273|NCT02484547|11241031|FG000|STARTED|Long-Term Extension Period||0
10110274|NCT02484547|11241032|FG001|STARTED|Long-Term Extension Period||0
10110275|NCT02484547|11241033|FG002|STARTED|Long-Term Extension Period||0
9897581|NCT01120379|11013328|FG000|STARTED|One Year Timepoint||5020
9897582|NCT01120379|11013328|FG000|COMPLETED|One Year Timepoint||4742
9897583|NCT01120379|11013328|FG000|NOT COMPLETED|One Year Timepoint||278
9897584|NCT01120379|11013328|FG000|STARTED|Two Year Timepoint||4742
9897585|NCT01120379|11013328|FG000|COMPLETED|Two Year Timepoint||4505
9897586|NCT01120379|11013328|FG000|NOT COMPLETED|Two Year Timepoint||237
9897587|NCT01120379|11013328|FG000|STARTED|Three Year Timepoint||4505
9897588|NCT01120379|11013328|FG000|COMPLETED|Three Year Timepoint||4291
9897589|NCT01120379|11013328|FG000|NOT COMPLETED|Three Year Timepoint||214
9897590|NCT01120379|11013328|FG000|STARTED|Four Year Timepoint||4291
9897591|NCT01120379|11013328|FG000|COMPLETED|Four Year Timepoint||3923
9897592|NCT01120379|11013328|FG000|NOT COMPLETED|Four Year Timepoint||368
9897593|NCT01120405|11013334|FG000|STARTED|Overall Study||298
9897594|NCT01120405|11013335|FG001|STARTED|Overall Study||302
9897595|NCT01120405|11013334|FG000|COMPLETED|Overall Study||271
9897596|NCT01120405|11013335|FG001|COMPLETED|Overall Study||269
9897597|NCT01120405|11013334|FG000|NOT COMPLETED|Overall Study||27
9897598|NCT01120405|11013335|FG001|NOT COMPLETED|Overall Study||33
9897599|NCT01120600|11013345|FG000|STARTED|Overall Study||147
9897600|NCT01120600|11013346|FG001|STARTED|Overall Study||147
10009087|NCT01763905|11131610|FG003|COMPLETED|Overall Study||101
10009088|NCT01763905|11131607|FG000|NOT COMPLETED|Overall Study||6
10110276|NCT02484547|11241034|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131
10110277|NCT02484547|11241035|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132
9897601|NCT01120600|11013345|FG000|Treated|Overall Study||146
9897602|NCT01120600|11013346|FG001|Treated|Overall Study||146
9897603|NCT01120600|11013345|FG000|COMPLETED|Overall Study||128
9897604|NCT01120600|11013346|FG001|COMPLETED|Overall Study||115
9897605|NCT01120600|11013345|FG000|NOT COMPLETED|Overall Study||19
9897606|NCT01120600|11013346|FG001|NOT COMPLETED|Overall Study||32
9897607|NCT01120626|11013354|FG000|STARTED|Overall Study||20
9897608|NCT01120626|11013355|FG001|STARTED|Overall Study||22
10009089|NCT01763905|11131608|FG001|NOT COMPLETED|Overall Study||1
9897609|NCT01120626|11013354|FG000|COMPLETED|Overall Study||19
9897610|NCT01120626|11013355|FG001|COMPLETED|Overall Study||22
9897611|NCT01120626|11013354|FG000|NOT COMPLETED|Overall Study||1
9897612|NCT01120626|11013355|FG001|NOT COMPLETED|Overall Study||0
9897613|NCT01120639|11013365|FG000|STARTED|Overall Study||6
9897614|NCT01120639|11013366|FG001|STARTED|Overall Study||6
9897615|NCT01120639|11013367|FG002|STARTED|Overall Study||6
9897616|NCT01120639|11013368|FG003|STARTED|Overall Study||12
9897617|NCT01120639|11013365|FG000|COMPLETED|Overall Study||6
9897618|NCT01120639|11013366|FG001|COMPLETED|Overall Study||6
9897619|NCT01120639|11013367|FG002|COMPLETED|Overall Study||6
9897620|NCT01120639|11013368|FG003|COMPLETED|Overall Study||12
9897621|NCT01120639|11013365|FG000|NOT COMPLETED|Overall Study||0
9897622|NCT01120639|11013366|FG001|NOT COMPLETED|Overall Study||0
9897623|NCT01120639|11013367|FG002|NOT COMPLETED|Overall Study||0
9897624|NCT01120639|11013368|FG003|NOT COMPLETED|Overall Study||0
9897625|NCT01120691|11013381|FG000|STARTED|Overall Study||741
9897626|NCT01120691|11013382|FG001|STARTED|Overall Study||741
9897627|NCT01120691|11013383|FG002|STARTED|Overall Study||742
9897628|NCT01120691|11013381|FG000|Full Analysis Set (FAS)|Overall Study||736
9897629|NCT01120691|11013382|FG001|Full Analysis Set (FAS)|Overall Study||739
9897630|NCT01120691|11013383|FG002|Full Analysis Set (FAS)|Overall Study||739
9897631|NCT01120691|11013381|FG000|Safety Set (SAF)|Overall Study||736
9897632|NCT01120691|11013382|FG001|Safety Set (SAF)|Overall Study||740
9897633|NCT01120691|11013383|FG002|Safety Set (SAF)|Overall Study||739
9897634|NCT01120691|11013381|FG000|Modified Safety Set (mSAF)|Overall Study||729
9897635|NCT01120691|11013382|FG001|Modified Safety Set (mSAF)|Overall Study||740
9897636|NCT01120691|11013383|FG002|Modified Safety Set (mSAF)|Overall Study||737
9897637|NCT01120691|11013381|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729
9897638|NCT01120691|11013382|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739
9897639|NCT01120691|11013383|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737
9897640|NCT01120691|11013381|FG000|COMPLETED|Overall Study||570
9897641|NCT01120691|11013382|FG001|COMPLETED|Overall Study||538
9897642|NCT01120691|11013383|FG002|COMPLETED|Overall Study||559
9897643|NCT01120691|11013381|FG000|NOT COMPLETED|Overall Study||171
9897644|NCT01120691|11013382|FG001|NOT COMPLETED|Overall Study||203
9897645|NCT01120691|11013383|FG002|NOT COMPLETED|Overall Study||183
9897646|NCT01120704|11013427|FG000|STARTED|Overall Study||13
9897647|NCT01120704|11013428|FG001|STARTED|Overall Study||17
9897648|NCT01120704|11013429|FG002|STARTED|Overall Study||14
9897649|NCT01120704|11013430|FG003|STARTED|Overall Study||19
9897650|NCT01120704|11013431|FG004|STARTED|Overall Study||16
9897651|NCT01120704|11013432|FG005|STARTED|Overall Study||19
9897652|NCT01120704|11013433|FG006|STARTED|Overall Study||15
9897653|NCT01120704|11013434|FG007|STARTED|Overall Study||15
9897654|NCT01120704|11013435|FG008|STARTED|Overall Study||22
9897655|NCT01120704|11013436|FG009|STARTED|Overall Study||20
9897656|NCT01120704|11013437|FG010|STARTED|Overall Study||17
9897657|NCT01120704|11013438|FG011|STARTED|Overall Study||16
9897658|NCT01120704|11013439|FG012|STARTED|Overall Study||17
9897659|NCT01120704|11013440|FG013|STARTED|Overall Study||19
9897660|NCT01120704|11013441|FG014|STARTED|Overall Study||18
9897661|NCT01120704|11013442|FG015|STARTED|Overall Study||18
9897662|NCT01120704|11013443|FG016|STARTED|Overall Study||14
9897663|NCT01120704|11013444|FG017|STARTED|Overall Study||16
9897664|NCT01120704|11013445|FG018|STARTED|Overall Study||17
9897665|NCT01120704|11013446|FG019|STARTED|Overall Study||18
9897666|NCT01120704|11013447|FG020|STARTED|Overall Study||17
9897667|NCT01120704|11013448|FG021|STARTED|Overall Study||16
9897668|NCT01120704|11013449|FG022|STARTED|Overall Study||21
9897669|NCT01120704|11013450|FG023|STARTED|Overall Study||16
9897670|NCT01120704|11013451|FG024|STARTED|Overall Study||18
9897671|NCT01120704|11013452|FG025|STARTED|Overall Study||14
9897672|NCT01120704|11013453|FG026|STARTED|Overall Study||18
9897673|NCT01120704|11013454|FG027|STARTED|Overall Study||18
9897674|NCT01120704|11013455|FG028|STARTED|Overall Study||19
9897675|NCT01120704|11013456|FG029|STARTED|Overall Study||15
9897676|NCT01120704|11013457|FG030|STARTED|Overall Study||14
9897677|NCT01120704|11013458|FG031|STARTED|Overall Study||18
9897678|NCT01120704|11013427|FG000|COMPLETED|Overall Study||10
10009090|NCT01763905|11131609|FG002|NOT COMPLETED|Overall Study||9
10009091|NCT01763905|11131610|FG003|NOT COMPLETED|Overall Study||1
10009092|NCT01763918|11131624|FG000|STARTED|Overall Study||55
10009093|NCT01763918|11131625|FG001|STARTED|Overall Study||55
10009094|NCT01763918|11131626|FG002|STARTED|Overall Study||111
9897679|NCT01120704|11013428|FG001|COMPLETED|Overall Study||13
9897680|NCT01120704|11013429|FG002|COMPLETED|Overall Study||13
9897681|NCT01120704|11013430|FG003|COMPLETED|Overall Study||15
9897682|NCT01120704|11013431|FG004|COMPLETED|Overall Study||14
9897683|NCT01120704|11013432|FG005|COMPLETED|Overall Study||18
10009095|NCT01763918|11131627|FG003|STARTED|Overall Study||110
9897684|NCT01120704|11013433|FG006|COMPLETED|Overall Study||12
9897685|NCT01120704|11013434|FG007|COMPLETED|Overall Study||13
9897686|NCT01120704|11013435|FG008|COMPLETED|Overall Study||19
9897687|NCT01120704|11013436|FG009|COMPLETED|Overall Study||19
9897688|NCT01120704|11013437|FG010|COMPLETED|Overall Study||16
9897689|NCT01120704|11013438|FG011|COMPLETED|Overall Study||14
9897690|NCT01120704|11013439|FG012|COMPLETED|Overall Study||14
9897691|NCT01120704|11013440|FG013|COMPLETED|Overall Study||15
9897692|NCT01120704|11013441|FG014|COMPLETED|Overall Study||17
9897693|NCT01120704|11013442|FG015|COMPLETED|Overall Study||16
9897694|NCT01120704|11013443|FG016|COMPLETED|Overall Study||13
9897695|NCT01120704|11013444|FG017|COMPLETED|Overall Study||16
9897696|NCT01120704|11013445|FG018|COMPLETED|Overall Study||15
9897697|NCT01120704|11013446|FG019|COMPLETED|Overall Study||15
9897698|NCT01120704|11013447|FG020|COMPLETED|Overall Study||14
9897699|NCT01120704|11013448|FG021|COMPLETED|Overall Study||16
9897700|NCT01120704|11013449|FG022|COMPLETED|Overall Study||17
9897701|NCT01120704|11013450|FG023|COMPLETED|Overall Study||13
9897702|NCT01120704|11013451|FG024|COMPLETED|Overall Study||16
9897703|NCT01120704|11013452|FG025|COMPLETED|Overall Study||14
9897704|NCT01120704|11013453|FG026|COMPLETED|Overall Study||15
9897705|NCT01120704|11013454|FG027|COMPLETED|Overall Study||16
9897706|NCT01120704|11013455|FG028|COMPLETED|Overall Study||14
9897707|NCT01120704|11013456|FG029|COMPLETED|Overall Study||12
9897708|NCT01120704|11013457|FG030|COMPLETED|Overall Study||12
9897709|NCT01120704|11013458|FG031|COMPLETED|Overall Study||17
9897710|NCT01120704|11013427|FG000|NOT COMPLETED|Overall Study||3
9897711|NCT01120704|11013428|FG001|NOT COMPLETED|Overall Study||4
9897712|NCT01120704|11013429|FG002|NOT COMPLETED|Overall Study||1
9897713|NCT01120704|11013430|FG003|NOT COMPLETED|Overall Study||4
9897714|NCT01120704|11013431|FG004|NOT COMPLETED|Overall Study||2
9897715|NCT01120704|11013432|FG005|NOT COMPLETED|Overall Study||1
9897716|NCT01120704|11013433|FG006|NOT COMPLETED|Overall Study||3
9897717|NCT01120704|11013434|FG007|NOT COMPLETED|Overall Study||2
9897718|NCT01120704|11013435|FG008|NOT COMPLETED|Overall Study||3
9897719|NCT01120704|11013436|FG009|NOT COMPLETED|Overall Study||1
9897720|NCT01120704|11013437|FG010|NOT COMPLETED|Overall Study||1
9897721|NCT01120704|11013438|FG011|NOT COMPLETED|Overall Study||2
9897722|NCT01120704|11013439|FG012|NOT COMPLETED|Overall Study||3
10009096|NCT01763918|11131624|FG000|Received Treatment|Overall Study||54
10009097|NCT01763918|11131625|FG001|Received Treatment|Overall Study||55
10009098|NCT01763918|11131626|FG002|Received Treatment|Overall Study||110
10009099|NCT01763918|11131627|FG003|Received Treatment|Overall Study||110
10009100|NCT01763918|11131624|FG000|COMPLETED|Overall Study||49
10009101|NCT01763918|11131625|FG001|COMPLETED|Overall Study||54
10009102|NCT01763918|11131626|FG002|COMPLETED|Overall Study||101
10009103|NCT01763918|11131627|FG003|COMPLETED|Overall Study||108
9897723|NCT01120704|11013440|FG013|NOT COMPLETED|Overall Study||4
9897724|NCT01120704|11013441|FG014|NOT COMPLETED|Overall Study||1
9897725|NCT01120704|11013442|FG015|NOT COMPLETED|Overall Study||2
9897726|NCT01120704|11013443|FG016|NOT COMPLETED|Overall Study||1
9897727|NCT01120704|11013444|FG017|NOT COMPLETED|Overall Study||0
9897728|NCT01120704|11013445|FG018|NOT COMPLETED|Overall Study||2
9897729|NCT01120704|11013446|FG019|NOT COMPLETED|Overall Study||3
9897730|NCT01120704|11013447|FG020|NOT COMPLETED|Overall Study||3
9897731|NCT01120704|11013448|FG021|NOT COMPLETED|Overall Study||0
9897732|NCT01120704|11013449|FG022|NOT COMPLETED|Overall Study||4
9897733|NCT01120704|11013450|FG023|NOT COMPLETED|Overall Study||3
9897734|NCT01120704|11013451|FG024|NOT COMPLETED|Overall Study||2
9897735|NCT01120704|11013452|FG025|NOT COMPLETED|Overall Study||0
9897736|NCT01120704|11013453|FG026|NOT COMPLETED|Overall Study||3
9897737|NCT01120704|11013454|FG027|NOT COMPLETED|Overall Study||2
9897738|NCT01120704|11013455|FG028|NOT COMPLETED|Overall Study||5
9897739|NCT01120704|11013456|FG029|NOT COMPLETED|Overall Study||3
9897740|NCT01120704|11013457|FG030|NOT COMPLETED|Overall Study||2
9897741|NCT01120704|11013458|FG031|NOT COMPLETED|Overall Study||1
9897742|NCT01120717|11013474|FG000|STARTED|Overall Study||226
9897743|NCT01120717|11013475|FG001|STARTED|Overall Study||113
9897744|NCT01120717|11013474|FG000|Safety Population: Received Study Drug|Overall Study||225
9897745|NCT01120717|11013475|FG001|Safety Population: Received Study Drug|Overall Study||113
9897746|NCT01120717|11013474|FG000|COMPLETED|Overall Study||194
9897747|NCT01120717|11013475|FG001|COMPLETED|Overall Study||89
9897748|NCT01120717|11013474|FG000|NOT COMPLETED|Overall Study||32
9897749|NCT01120717|11013475|FG001|NOT COMPLETED|Overall Study||24
9897750|NCT01120756|11013483|FG000|STARTED|Overall Study||21
9897751|NCT01120756|11013484|FG001|STARTED|Overall Study||14
9897752|NCT01120756|11013483|FG000|COMPLETED|Overall Study||20
9897753|NCT01120756|11013484|FG001|COMPLETED|Overall Study||13
9897754|NCT01120756|11013483|FG000|NOT COMPLETED|Overall Study||1
9897755|NCT01120756|11013484|FG001|NOT COMPLETED|Overall Study||1
9897756|NCT01120782|11013490|FG000|STARTED|Overall Study||45
9897757|NCT01120782|11013490|FG000|COMPLETED|Overall Study||34
9897758|NCT01120782|11013490|FG000|NOT COMPLETED|Overall Study||11
9897759|NCT01120808|11013494|FG000|STARTED|Overall Study||136
9897760|NCT01120808|11013494|FG000|COMPLETED|Overall Study||90
9897761|NCT01120808|11013494|FG000|NOT COMPLETED|Overall Study||46
9897762|NCT01120834|11013498|FG000|STARTED|Overall Study||18
9897763|NCT01120834|11013498|FG000|COMPLETED|Overall Study||18
9897764|NCT01120834|11013498|FG000|NOT COMPLETED|Overall Study||0
9897765|NCT01120899|11013502|FG000|STARTED|Overall Study||6
9897766|NCT01120899|11013502|FG000|Month 6|Overall Study||5
9897767|NCT01120899|11013502|FG000|Month 12|Overall Study||3
9897768|NCT01120899|11013502|FG000|Month 18|Overall Study||3
9897769|NCT01120899|11013502|FG000|COMPLETED|Overall Study||3
9897770|NCT01120899|11013502|FG000|NOT COMPLETED|Overall Study||3
9897771|NCT01120990|11013506|FG000|STARTED|Overall Study||51
9897772|NCT01120990|11013506|FG000|COMPLETED|Overall Study||51
9897773|NCT01120990|11013506|FG000|NOT COMPLETED|Overall Study||0
9897774|NCT01121146|11013512|FG000|STARTED|Overall Study||116
9897775|NCT01121146|11013513|FG001|STARTED|Overall Study||114
10009104|NCT01763918|11131624|FG000|NOT COMPLETED|Overall Study||6
9954884|NCT01434810|11073749|FG000|NOT COMPLETED|Overall Study||23
10009105|NCT01763918|11131625|FG001|NOT COMPLETED|Overall Study||1
9897776|NCT01121146|11013512|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
9897777|NCT01121146|11013513|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
9897778|NCT01121146|11013512|FG000|NOT COMPLETED|Overall Study||26
9897779|NCT01121146|11013513|FG001|NOT COMPLETED|Overall Study||42
9897780|NCT01121172|11013522|FG000|STARTED|Overall Study||90
9897781|NCT01121172|11013523|FG001|STARTED|Overall Study||90
9897782|NCT01121172|11013522|FG000|COMPLETED|Overall Study||90
9897783|NCT01121172|11013523|FG001|COMPLETED|Overall Study||90
9897784|NCT01121172|11013522|FG000|NOT COMPLETED|Overall Study||0
9897785|NCT01121172|11013523|FG001|NOT COMPLETED|Overall Study||0
9897786|NCT01121185|11013532|FG000|STARTED|Overall Study||7
9897787|NCT01121185|11013533|FG001|STARTED|Overall Study||6
9897788|NCT01121185|11013532|FG000|Infused|Overall Study||7
9897789|NCT01121185|11013533|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
9897790|NCT01121185|11013532|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
9897791|NCT01121185|11013533|FG001|Transplanted|Overall Study||5
9897792|NCT01121185|11013532|FG000|COMPLETED|Overall Study||6
9897793|NCT01121185|11013533|FG001|COMPLETED|Overall Study||5
9897794|NCT01121185|11013532|FG000|NOT COMPLETED|Overall Study||1
9897795|NCT01121185|11013533|FG001|NOT COMPLETED|Overall Study||1
9897796|NCT01121211|11013541|FG000|STARTED|Overall Study||43
9897797|NCT01121211|11013542|FG001|STARTED|Overall Study||47
9897798|NCT01121211|11013541|FG000|COMPLETED|Overall Study||32
9897799|NCT01121211|11013542|FG001|COMPLETED|Overall Study||35
9897800|NCT01121211|11013541|FG000|NOT COMPLETED|Overall Study||11
9897801|NCT01121211|11013542|FG001|NOT COMPLETED|Overall Study||12
9897802|NCT01121224|11013550|FG000|STARTED|Overall Study||305
9897803|NCT01121224|11013551|FG001|STARTED|Overall Study||292
9897804|NCT01121224|11013550|FG000|COMPLETED|Overall Study||280
9897805|NCT01121224|11013551|FG001|COMPLETED|Overall Study||275
9897806|NCT01121224|11013550|FG000|NOT COMPLETED|Overall Study||25
9897807|NCT01121224|11013551|FG001|NOT COMPLETED|Overall Study||17
9897808|NCT01121250|11013562|FG000|STARTED|Overall Study||76
9897809|NCT01121250|11013563|FG001|STARTED|Overall Study||76
9897810|NCT01121250|11013564|FG002|STARTED|Overall Study||76
9897811|NCT01121250|11013562|FG000|COMPLETED|Overall Study||76
9897812|NCT01121250|11013563|FG001|COMPLETED|Overall Study||76
9897813|NCT01121250|11013564|FG002|COMPLETED|Overall Study||75
9897814|NCT01121250|11013562|FG000|NOT COMPLETED|Overall Study||0
9897815|NCT01121250|11013563|FG001|NOT COMPLETED|Overall Study||0
9897816|NCT01121250|11013564|FG002|NOT COMPLETED|Overall Study||1
9897817|NCT01121263|11013574|FG000|STARTED|Overall Study||200
9897818|NCT01121263|11013575|FG001|STARTED|Overall Study||98
9897819|NCT01121263|11013574|FG000|COMPLETED|Overall Study||175
9897820|NCT01121263|11013575|FG001|COMPLETED|Overall Study||83
9897821|NCT01121263|11013574|FG000|NOT COMPLETED|Overall Study||25
9897822|NCT01121263|11013575|FG001|NOT COMPLETED|Overall Study||15
9897823|NCT01121393|11013585|FG000|STARTED|Overall Study|Randomised|242
9897824|NCT01121393|11013586|FG001|STARTED|Overall Study|Randomised|122
9897825|NCT01121393|11013585|FG000|Treated|Overall Study|Treated|239
9897826|NCT01121393|11013586|FG001|Treated|Overall Study|Treated|113
9897827|NCT01121393|11013585|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
9897828|NCT01121393|11013586|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
9897829|NCT01121393|11013585|FG000|NOT COMPLETED|Overall Study||242
9897830|NCT01121393|11013586|FG001|NOT COMPLETED|Overall Study||84
9897831|NCT01121406|11013600|FG000|STARTED|Overall Study||55
9897832|NCT01121406|11013601|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
9897833|NCT01121406|11013600|FG000|COMPLETED|Overall Study||0
9897834|NCT01121406|11013601|FG001|COMPLETED|Overall Study||0
9897835|NCT01121406|11013600|FG000|NOT COMPLETED|Overall Study||55
9897836|NCT01121406|11013601|FG001|NOT COMPLETED|Overall Study||55
9897837|NCT01121484|11013612|FG000|STARTED|Overall Study||218
9897838|NCT01121484|11013613|FG001|STARTED|Overall Study||221
9897839|NCT01121484|11013612|FG000|Treated|Overall Study||217
9897840|NCT01121484|11013613|FG001|Treated|Overall Study||217
9897841|NCT01121484|11013612|FG000|COMPLETED|Overall Study||185
9897842|NCT01121484|11013613|FG001|COMPLETED|Overall Study||178
9897843|NCT01121484|11013612|FG000|NOT COMPLETED|Overall Study||33
9897844|NCT01121484|11013613|FG001|NOT COMPLETED|Overall Study||43
9897845|NCT01121536|11013619|FG000|STARTED|Overall Study||867
9897846|NCT01121536|11013619|FG000|Safety Population|Overall Study|Participants treated|863
9897847|NCT01121536|11013619|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
9897848|NCT01121536|11013619|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
9897849|NCT01121536|11013619|FG000|NOT COMPLETED|Overall Study||361
9897850|NCT01121549|11013623|FG000|STARTED|Overall Study||378
9897851|NCT01121549|11013623|FG000|COMPLETED|Overall Study||31
9897852|NCT01121549|11013623|FG000|NOT COMPLETED|Overall Study||347
10110278|NCT02484547|11241036|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251
10110279|NCT02484547|11241037|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257
10110280|NCT02484547|11241031|FG000|COMPLETED|Long-Term Extension Period||0
9897853|NCT01121562|11013627|FG000|STARTED|Overall Study||12
9897854|NCT01121562|11013627|FG000|COMPLETED|Overall Study||0
10009106|NCT01763918|11131626|FG002|NOT COMPLETED|Overall Study||10
10110281|NCT02484547|11241032|FG001|COMPLETED|Long-Term Extension Period||0
9897855|NCT01121562|11013627|FG000|NOT COMPLETED|Overall Study||12
9897856|NCT01121575|11013637|FG000|STARTED|Overall Study||14
9897857|NCT01121575|11013638|FG001|STARTED|Overall Study||6
9897858|NCT01121575|11013639|FG002|STARTED|Overall Study||7
9897859|NCT01121575|11013640|FG003|STARTED|Overall Study||6
9897860|NCT01121575|11013641|FG004|STARTED|Overall Study||25
9897861|NCT01121575|11013642|FG005|STARTED|Overall Study||12
9897862|NCT01121575|11013637|FG000|Treated|Overall Study||14
10009107|NCT01763918|11131627|FG003|NOT COMPLETED|Overall Study||2
9897863|NCT01121575|11013638|FG001|Treated|Overall Study||6
9897864|NCT01121575|11013639|FG002|Treated|Overall Study||7
9897865|NCT01121575|11013640|FG003|Treated|Overall Study||6
9897866|NCT01121575|11013641|FG004|Treated|Overall Study||25
9897867|NCT01121575|11013642|FG005|Treated|Overall Study||12
9897868|NCT01121575|11013637|FG000|COMPLETED|Overall Study||0
9897869|NCT01121575|11013638|FG001|COMPLETED|Overall Study||0
9897870|NCT01121575|11013639|FG002|COMPLETED|Overall Study||0
9897871|NCT01121575|11013640|FG003|COMPLETED|Overall Study||0
9897872|NCT01121575|11013641|FG004|COMPLETED|Overall Study||0
9897873|NCT01121575|11013642|FG005|COMPLETED|Overall Study||0
9897874|NCT01121575|11013637|FG000|NOT COMPLETED|Overall Study||14
9897875|NCT01121575|11013638|FG001|NOT COMPLETED|Overall Study||6
9897876|NCT01121575|11013639|FG002|NOT COMPLETED|Overall Study||7
9897877|NCT01121575|11013640|FG003|NOT COMPLETED|Overall Study||6
9897878|NCT01121575|11013641|FG004|NOT COMPLETED|Overall Study||25
9897879|NCT01121575|11013642|FG005|NOT COMPLETED|Overall Study||12
9897880|NCT01121666|11013663|FG000|STARTED|Overall Study||249
9897881|NCT01121666|11013664|FG001|STARTED|Overall Study||123
9897882|NCT01121666|11013663|FG000|COMPLETED|Overall Study||220
9897883|NCT01121666|11013664|FG001|COMPLETED|Overall Study||113
9897884|NCT01121666|11013663|FG000|NOT COMPLETED|Overall Study||29
9897885|NCT01121666|11013664|FG001|NOT COMPLETED|Overall Study||10
9897886|NCT01121757|11013672|FG000|STARTED|First Drug||6
9897887|NCT01121757|11013673|FG001|STARTED|First Drug||3
9897888|NCT01121757|11013672|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
9897889|NCT01121757|11013673|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
9897890|NCT01121757|11013672|FG000|NOT COMPLETED|First Drug||1
9897891|NCT01121757|11013673|FG001|NOT COMPLETED|First Drug||2
9897892|NCT01121757|11013672|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
9897893|NCT01121757|11013673|FG001|STARTED|Second Drug||1
9897894|NCT01121757|11013672|FG000|COMPLETED|Second Drug||4
9897895|NCT01121757|11013673|FG001|COMPLETED|Second Drug||1
9897896|NCT01121757|11013672|FG000|NOT COMPLETED|Second Drug||0
9897897|NCT01121757|11013673|FG001|NOT COMPLETED|Second Drug||0
9897898|NCT01121757|11013672|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
9897899|NCT01121757|11013673|FG001|STARTED|Combination||1
9897900|NCT01121757|11013672|FG000|COMPLETED|Combination||0
9897901|NCT01121757|11013673|FG001|COMPLETED|Combination||0
9897902|NCT01121757|11013672|FG000|NOT COMPLETED|Combination||2
9897903|NCT01121757|11013673|FG001|NOT COMPLETED|Combination||1
9897904|NCT01121900|11013681|FG000|STARTED|First Intervention Period||13
9897905|NCT01121900|11013682|FG001|STARTED|First Intervention Period||13
9897906|NCT01121900|11013681|FG000|COMPLETED|First Intervention Period||12
9897907|NCT01121900|11013682|FG001|COMPLETED|First Intervention Period||12
9897908|NCT01121900|11013681|FG000|NOT COMPLETED|First Intervention Period||1
9897909|NCT01121900|11013682|FG001|NOT COMPLETED|First Intervention Period||1
9897910|NCT01121900|11013681|FG000|STARTED|Washout Period of 7 Days||12
9897911|NCT01121900|11013682|FG001|STARTED|Washout Period of 7 Days||12
9897912|NCT01121900|11013681|FG000|COMPLETED|Washout Period of 7 Days||12
9897913|NCT01121900|11013682|FG001|COMPLETED|Washout Period of 7 Days||11
9897914|NCT01121900|11013681|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9897915|NCT01121900|11013682|FG001|NOT COMPLETED|Washout Period of 7 Days||1
9897916|NCT01121900|11013681|FG000|STARTED|Second Intervention Period||12
9897917|NCT01121900|11013682|FG001|STARTED|Second Intervention Period||11
9897918|NCT01121900|11013681|FG000|COMPLETED|Second Intervention Period||12
9897919|NCT01121900|11013682|FG001|COMPLETED|Second Intervention Period||11
9897920|NCT01121900|11013681|FG000|NOT COMPLETED|Second Intervention Period||0
9897921|NCT01121900|11013682|FG001|NOT COMPLETED|Second Intervention Period||0
9897922|NCT01121913|11013688|FG000|STARTED|First Intervention Period||6
9897923|NCT01121913|11013689|FG001|STARTED|First Intervention Period||6
9897924|NCT01121913|11013690|FG002|STARTED|First Intervention Period||6
9897925|NCT01121913|11013691|FG003|STARTED|First Intervention Period||6
9897926|NCT01121913|11013688|FG000|COMPLETED|First Intervention Period||6
9897927|NCT01121913|11013689|FG001|COMPLETED|First Intervention Period||6
9897928|NCT01121913|11013690|FG002|COMPLETED|First Intervention Period||5
9897929|NCT01121913|11013691|FG003|COMPLETED|First Intervention Period||6
10009108|NCT01763931|11131639|FG000|STARTED|Overall Study||2
10009109|NCT01763931|11131640|FG001|STARTED|Overall Study||4
10009110|NCT01763931|11131639|FG000|COMPLETED|Overall Study||2
10009111|NCT01763931|11131640|FG001|COMPLETED|Overall Study||3
9897930|NCT01121913|11013688|FG000|NOT COMPLETED|First Intervention Period||0
9897931|NCT01121913|11013689|FG001|NOT COMPLETED|First Intervention Period||0
9897932|NCT01121913|11013690|FG002|NOT COMPLETED|First Intervention Period||1
9897933|NCT01121913|11013691|FG003|NOT COMPLETED|First Intervention Period||0
9897934|NCT01121913|11013688|FG000|STARTED|First Washout Period||6
9897935|NCT01121913|11013689|FG001|STARTED|First Washout Period||6
9897936|NCT01121913|11013690|FG002|STARTED|First Washout Period||5
9897937|NCT01121913|11013691|FG003|STARTED|First Washout Period||6
9897938|NCT01121913|11013688|FG000|COMPLETED|First Washout Period||5
9897939|NCT01121913|11013689|FG001|COMPLETED|First Washout Period||6
9897940|NCT01121913|11013690|FG002|COMPLETED|First Washout Period||5
9897941|NCT01121913|11013691|FG003|COMPLETED|First Washout Period||6
9897942|NCT01121913|11013688|FG000|NOT COMPLETED|First Washout Period||1
9897943|NCT01121913|11013689|FG001|NOT COMPLETED|First Washout Period||0
9897944|NCT01121913|11013690|FG002|NOT COMPLETED|First Washout Period||0
9897945|NCT01121913|11013691|FG003|NOT COMPLETED|First Washout Period||0
9897946|NCT01121913|11013688|FG000|STARTED|Second Intervention Period||5
9897947|NCT01121913|11013689|FG001|STARTED|Second Intervention Period||6
9897948|NCT01121913|11013690|FG002|STARTED|Second Intervention Period||5
9897949|NCT01121913|11013691|FG003|STARTED|Second Intervention Period||6
9897950|NCT01121913|11013688|FG000|COMPLETED|Second Intervention Period||5
9897951|NCT01121913|11013689|FG001|COMPLETED|Second Intervention Period||6
9897952|NCT01121913|11013690|FG002|COMPLETED|Second Intervention Period||4
9897953|NCT01121913|11013691|FG003|COMPLETED|Second Intervention Period||6
9897954|NCT01121913|11013688|FG000|NOT COMPLETED|Second Intervention Period||0
9897955|NCT01121913|11013689|FG001|NOT COMPLETED|Second Intervention Period||0
9897956|NCT01121913|11013690|FG002|NOT COMPLETED|Second Intervention Period||1
9897957|NCT01121913|11013691|FG003|NOT COMPLETED|Second Intervention Period||0
9897958|NCT01121913|11013688|FG000|STARTED|Second Washout Period||5
9897959|NCT01121913|11013689|FG001|STARTED|Second Washout Period||6
9897960|NCT01121913|11013690|FG002|STARTED|Second Washout Period||4
9897961|NCT01121913|11013691|FG003|STARTED|Second Washout Period||6
9897962|NCT01121913|11013688|FG000|COMPLETED|Second Washout Period||5
9897963|NCT01121913|11013689|FG001|COMPLETED|Second Washout Period||6
9897964|NCT01121913|11013690|FG002|COMPLETED|Second Washout Period||3
9897965|NCT01121913|11013691|FG003|COMPLETED|Second Washout Period||6
9897966|NCT01121913|11013688|FG000|NOT COMPLETED|Second Washout Period||0
9897967|NCT01121913|11013689|FG001|NOT COMPLETED|Second Washout Period||0
9897968|NCT01121913|11013690|FG002|NOT COMPLETED|Second Washout Period||1
9897969|NCT01121913|11013691|FG003|NOT COMPLETED|Second Washout Period||0
9897970|NCT01121913|11013688|FG000|STARTED|Third Intervention Period||5
9897971|NCT01121913|11013689|FG001|STARTED|Third Intervention Period||6
9897972|NCT01121913|11013690|FG002|STARTED|Third Intervention Period||3
9897973|NCT01121913|11013691|FG003|STARTED|Third Intervention Period||6
9897974|NCT01121913|11013688|FG000|COMPLETED|Third Intervention Period||5
9897975|NCT01121913|11013689|FG001|COMPLETED|Third Intervention Period||6
9897976|NCT01121913|11013690|FG002|COMPLETED|Third Intervention Period||3
9897977|NCT01121913|11013691|FG003|COMPLETED|Third Intervention Period||6
9897978|NCT01121913|11013688|FG000|NOT COMPLETED|Third Intervention Period||0
9897979|NCT01121913|11013689|FG001|NOT COMPLETED|Third Intervention Period||0
9897980|NCT01121913|11013690|FG002|NOT COMPLETED|Third Intervention Period||0
9897981|NCT01121913|11013691|FG003|NOT COMPLETED|Third Intervention Period||0
9897982|NCT01121913|11013688|FG000|STARTED|Third Washout Period||5
9897983|NCT01121913|11013689|FG001|STARTED|Third Washout Period||6
9897984|NCT01121913|11013690|FG002|STARTED|Third Washout Period||3
9897985|NCT01121913|11013691|FG003|STARTED|Third Washout Period||6
9897986|NCT01121913|11013688|FG000|COMPLETED|Third Washout Period||4
9897987|NCT01121913|11013689|FG001|COMPLETED|Third Washout Period||6
9897988|NCT01121913|11013690|FG002|COMPLETED|Third Washout Period||3
9897989|NCT01121913|11013691|FG003|COMPLETED|Third Washout Period||6
9897990|NCT01121913|11013688|FG000|NOT COMPLETED|Third Washout Period||1
9897991|NCT01121913|11013689|FG001|NOT COMPLETED|Third Washout Period||0
9897992|NCT01121913|11013690|FG002|NOT COMPLETED|Third Washout Period||0
9897993|NCT01121913|11013691|FG003|NOT COMPLETED|Third Washout Period||0
9897994|NCT01121913|11013688|FG000|STARTED|Fourth Intervention Period||4
9897995|NCT01121913|11013689|FG001|STARTED|Fourth Intervention Period||6
9897996|NCT01121913|11013690|FG002|STARTED|Fourth Intervention Period||3
9897997|NCT01121913|11013691|FG003|STARTED|Fourth Intervention Period||6
9897998|NCT01121913|11013688|FG000|COMPLETED|Fourth Intervention Period||4
9897999|NCT01121913|11013689|FG001|COMPLETED|Fourth Intervention Period||6
9898000|NCT01121913|11013690|FG002|COMPLETED|Fourth Intervention Period||3
9898001|NCT01121913|11013691|FG003|COMPLETED|Fourth Intervention Period||6
9898002|NCT01121913|11013688|FG000|NOT COMPLETED|Fourth Intervention Period||0
9898003|NCT01121913|11013689|FG001|NOT COMPLETED|Fourth Intervention Period||0
9898004|NCT01121913|11013690|FG002|NOT COMPLETED|Fourth Intervention Period||0
9898005|NCT01121913|11013691|FG003|NOT COMPLETED|Fourth Intervention Period||0
9898006|NCT01121926|11013701|FG000|STARTED|First Intervention Period||15
9898007|NCT01121926|11013702|FG001|STARTED|First Intervention Period||15
9898008|NCT01121926|11013701|FG000|COMPLETED|First Intervention Period||14
9898009|NCT01121926|11013702|FG001|COMPLETED|First Intervention Period||15
9898010|NCT01121926|11013701|FG000|NOT COMPLETED|First Intervention Period||1
10009112|NCT01763931|11131639|FG000|NOT COMPLETED|Overall Study||0
10009113|NCT01763931|11131640|FG001|NOT COMPLETED|Overall Study||1
10009114|NCT01763970|11131646|FG000|STARTED|Overall Study||14
10009115|NCT01763970|11131646|FG000|COMPLETED|Overall Study||14
10009116|NCT01763970|11131646|FG000|NOT COMPLETED|Overall Study||0
10009117|NCT01763996|11131653|FG000|STARTED|Treatment Period 1||15
10009118|NCT01763996|11131654|FG001|STARTED|Treatment Period 1||15
10009119|NCT01763996|11131653|FG000|COMPLETED|Treatment Period 1||15
10110282|NCT02484547|11241033|FG002|COMPLETED|Long-Term Extension Period||0
9898011|NCT01121926|11013702|FG001|NOT COMPLETED|First Intervention Period||0
9898012|NCT01121926|11013701|FG000|STARTED|Washout Period||14
9898013|NCT01121926|11013702|FG001|STARTED|Washout Period||15
9898014|NCT01121926|11013701|FG000|COMPLETED|Washout Period||14
9898015|NCT01121926|11013702|FG001|COMPLETED|Washout Period||13
9898016|NCT01121926|11013701|FG000|NOT COMPLETED|Washout Period||0
9898017|NCT01121926|11013702|FG001|NOT COMPLETED|Washout Period||2
9898018|NCT01121926|11013701|FG000|STARTED|Second Intervention Period||14
9898019|NCT01121926|11013702|FG001|STARTED|Second Intervention Period||13
9898020|NCT01121926|11013701|FG000|COMPLETED|Second Intervention Period||14
9898021|NCT01121926|11013702|FG001|COMPLETED|Second Intervention Period||13
9898022|NCT01121926|11013701|FG000|NOT COMPLETED|Second Intervention Period||0
9898023|NCT01121926|11013702|FG001|NOT COMPLETED|Second Intervention Period||0
9898024|NCT01121939|11013708|FG000|STARTED|Overall Study||43
9898025|NCT01121939|11013708|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
9898026|NCT01121939|11013708|FG000|NOT COMPLETED|Overall Study||43
9898027|NCT01121991|11013715|FG000|STARTED|Overall Study|Number of participants treated|52
9898028|NCT01121991|11013715|FG000|COMPLETED|Overall Study||46
9898029|NCT01121991|11013715|FG000|NOT COMPLETED|Overall Study||6
9898030|NCT01122030|11013726|FG000|STARTED|Overall Study||18
9898031|NCT01122030|11013727|FG001|STARTED|Overall Study||9
9898032|NCT01122030|11013728|FG002|STARTED|Overall Study||9
9898033|NCT01122030|11013729|FG003|STARTED|Overall Study||9
9898034|NCT01122030|11013730|FG004|STARTED|Overall Study||9
9898035|NCT01122030|11013731|FG005|STARTED|Overall Study||9
9898036|NCT01122030|11013732|FG006|STARTED|Overall Study||9
9898037|NCT01122030|11013726|FG000|Received Treatment|Overall Study||18
9898038|NCT01122030|11013727|FG001|Received Treatment|Overall Study||9
9898039|NCT01122030|11013728|FG002|Received Treatment|Overall Study||9
9898040|NCT01122030|11013729|FG003|Received Treatment|Overall Study||9
9898041|NCT01122030|11013730|FG004|Received Treatment|Overall Study||9
9898042|NCT01122030|11013731|FG005|Received Treatment|Overall Study||9
9898043|NCT01122030|11013732|FG006|Received Treatment|Overall Study||9
9898044|NCT01122030|11013726|FG000|COMPLETED|Overall Study||18
9898045|NCT01122030|11013727|FG001|COMPLETED|Overall Study||9
9898046|NCT01122030|11013728|FG002|COMPLETED|Overall Study||9
9898047|NCT01122030|11013729|FG003|COMPLETED|Overall Study||9
9898048|NCT01122030|11013730|FG004|COMPLETED|Overall Study||9
9898049|NCT01122030|11013731|FG005|COMPLETED|Overall Study||9
9898050|NCT01122030|11013732|FG006|COMPLETED|Overall Study||9
9898051|NCT01122030|11013726|FG000|NOT COMPLETED|Overall Study||0
9898052|NCT01122030|11013727|FG001|NOT COMPLETED|Overall Study||0
9898053|NCT01122030|11013728|FG002|NOT COMPLETED|Overall Study||0
9898054|NCT01122030|11013729|FG003|NOT COMPLETED|Overall Study||0
9898055|NCT01122030|11013730|FG004|NOT COMPLETED|Overall Study||0
9898056|NCT01122030|11013731|FG005|NOT COMPLETED|Overall Study||0
9898057|NCT01122030|11013732|FG006|NOT COMPLETED|Overall Study||0
9898058|NCT01122108|11013754|FG000|STARTED|Overall Study||21
9898059|NCT01122108|11013755|FG001|STARTED|Overall Study||21
9898060|NCT01122108|11013754|FG000|COMPLETED|Overall Study||21
9898061|NCT01122108|11013755|FG001|COMPLETED|Overall Study||21
9898062|NCT01122108|11013754|FG000|NOT COMPLETED|Overall Study||0
9898063|NCT01122108|11013755|FG001|NOT COMPLETED|Overall Study||0
9898064|NCT01122160|11013763|FG000|STARTED|First Intervention (7 Days)||6
9898065|NCT01122160|11013764|FG001|STARTED|First Intervention (7 Days)||5
9898066|NCT01122160|11013763|FG000|COMPLETED|First Intervention (7 Days)||6
9898067|NCT01122160|11013764|FG001|COMPLETED|First Intervention (7 Days)||5
9898068|NCT01122160|11013763|FG000|NOT COMPLETED|First Intervention (7 Days)||0
9898069|NCT01122160|11013764|FG001|NOT COMPLETED|First Intervention (7 Days)||0
9898070|NCT01122160|11013763|FG000|STARTED|Washout (7-14 Days)||6
9898071|NCT01122160|11013764|FG001|STARTED|Washout (7-14 Days)||5
9898072|NCT01122160|11013763|FG000|COMPLETED|Washout (7-14 Days)||6
9898073|NCT01122160|11013764|FG001|COMPLETED|Washout (7-14 Days)||5
9898074|NCT01122160|11013763|FG000|NOT COMPLETED|Washout (7-14 Days)||0
9898075|NCT01122160|11013764|FG001|NOT COMPLETED|Washout (7-14 Days)||0
9898076|NCT01122160|11013763|FG000|STARTED|Second Intervention (7 Days)||6
10110283|NCT02484547|11241034|FG003|COMPLETED|Long-Term Extension Period||0
10110284|NCT02484547|11241035|FG004|COMPLETED|Long-Term Extension Period||0
10110285|NCT02484547|11241036|FG005|COMPLETED|Long-Term Extension Period||0
10110286|NCT02484547|11241037|FG006|COMPLETED|Long-Term Extension Period||0
9898077|NCT01122160|11013764|FG001|STARTED|Second Intervention (7 Days)||5
9898078|NCT01122160|11013763|FG000|COMPLETED|Second Intervention (7 Days)||6
9898079|NCT01122160|11013764|FG001|COMPLETED|Second Intervention (7 Days)||5
9898080|NCT01122160|11013763|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
9898081|NCT01122160|11013764|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
9898082|NCT01122173|11013770|FG000|STARTED|Overall Study||150
9898083|NCT01122173|11013770|FG000|COMPLETED|Overall Study||141
9898084|NCT01122173|11013770|FG000|NOT COMPLETED|Overall Study||9
9898085|NCT01122238|11013791|FG000|STARTED|Overall Study||30
9898086|NCT01122238|11013792|FG001|STARTED|Overall Study||37
10110287|NCT02484547|11241031|FG000|NOT COMPLETED|Long-Term Extension Period||0
10110288|NCT02484547|11241032|FG001|NOT COMPLETED|Long-Term Extension Period||0
9898087|NCT01122238|11013793|FG002|STARTED|Overall Study||33
9898088|NCT01122238|11013794|FG003|STARTED|Overall Study||33
9898089|NCT01122238|11013795|FG004|STARTED|Overall Study||33
9898090|NCT01122238|11013796|FG005|STARTED|Overall Study||32
9898091|NCT01122238|11013797|FG006|STARTED|Overall Study||35
9898092|NCT01122238|11013798|FG007|STARTED|Overall Study||32
9898093|NCT01122238|11013799|FG008|STARTED|Overall Study||32
9898094|NCT01122238|11013800|FG009|STARTED|Overall Study||34
9898095|NCT01122238|11013801|FG010|STARTED|Overall Study||32
9898096|NCT01122238|11013802|FG011|STARTED|Overall Study||33
9898097|NCT01122238|11013803|FG012|STARTED|Overall Study||30
9898098|NCT01122238|11013804|FG013|STARTED|Overall Study||32
9898099|NCT01122238|11013805|FG014|STARTED|Overall Study||28
9898100|NCT01122238|11013806|FG015|STARTED|Overall Study||31
9898101|NCT01122238|11013791|FG000|COMPLETED|Overall Study||28
9898102|NCT01122238|11013792|FG001|COMPLETED|Overall Study||36
9898103|NCT01122238|11013793|FG002|COMPLETED|Overall Study||28
9898104|NCT01122238|11013794|FG003|COMPLETED|Overall Study||33
9898105|NCT01122238|11013795|FG004|COMPLETED|Overall Study||33
9898106|NCT01122238|11013796|FG005|COMPLETED|Overall Study||31
9898107|NCT01122238|11013797|FG006|COMPLETED|Overall Study||34
9898108|NCT01122238|11013798|FG007|COMPLETED|Overall Study||32
9898109|NCT01122238|11013799|FG008|COMPLETED|Overall Study||31
9898110|NCT01122238|11013800|FG009|COMPLETED|Overall Study||33
9898111|NCT01122238|11013801|FG010|COMPLETED|Overall Study||32
9898112|NCT01122238|11013802|FG011|COMPLETED|Overall Study||31
9898113|NCT01122238|11013803|FG012|COMPLETED|Overall Study||28
9898114|NCT01122238|11013804|FG013|COMPLETED|Overall Study||31
9898115|NCT01122238|11013805|FG014|COMPLETED|Overall Study||28
9898116|NCT01122238|11013806|FG015|COMPLETED|Overall Study||31
9898117|NCT01122238|11013791|FG000|NOT COMPLETED|Overall Study||2
9898118|NCT01122238|11013792|FG001|NOT COMPLETED|Overall Study||1
9898119|NCT01122238|11013793|FG002|NOT COMPLETED|Overall Study||5
9898120|NCT01122238|11013794|FG003|NOT COMPLETED|Overall Study||0
9898121|NCT01122238|11013795|FG004|NOT COMPLETED|Overall Study||0
9898122|NCT01122238|11013796|FG005|NOT COMPLETED|Overall Study||1
9898123|NCT01122238|11013797|FG006|NOT COMPLETED|Overall Study||1
9898124|NCT01122238|11013798|FG007|NOT COMPLETED|Overall Study||0
9898125|NCT01122238|11013799|FG008|NOT COMPLETED|Overall Study||1
9898126|NCT01122238|11013800|FG009|NOT COMPLETED|Overall Study||1
9898127|NCT01122238|11013801|FG010|NOT COMPLETED|Overall Study||0
9898128|NCT01122238|11013802|FG011|NOT COMPLETED|Overall Study||2
9898129|NCT01122238|11013803|FG012|NOT COMPLETED|Overall Study||2
9898130|NCT01122238|11013804|FG013|NOT COMPLETED|Overall Study||1
9898131|NCT01122238|11013805|FG014|NOT COMPLETED|Overall Study||0
9898132|NCT01122238|11013806|FG015|NOT COMPLETED|Overall Study||0
9898133|NCT01122264|11013823|FG000|STARTED|Overall Study||252
9898134|NCT01122264|11013824|FG001|STARTED|Overall Study||257
9898135|NCT01122264|11013825|FG002|STARTED|Overall Study||261
9898136|NCT01122264|11013823|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250
9898137|NCT01122264|11013824|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257
9898138|NCT01122264|11013825|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260
9898139|NCT01122264|11013823|FG000|COMPLETED|Overall Study||220
9898140|NCT01122264|11013824|FG001|COMPLETED|Overall Study||228
9898141|NCT01122264|11013825|FG002|COMPLETED|Overall Study||214
9898142|NCT01122264|11013823|FG000|NOT COMPLETED|Overall Study||32
9898143|NCT01122264|11013824|FG001|NOT COMPLETED|Overall Study||29
9898144|NCT01122264|11013825|FG002|NOT COMPLETED|Overall Study||47
9898145|NCT01122316|11013837|FG000|STARTED|Overall Study||10
9898146|NCT01122316|11013837|FG000|COMPLETED|Overall Study||8
9898147|NCT01122316|11013837|FG000|NOT COMPLETED|Overall Study||2
9898148|NCT01122394|11013843|FG000|STARTED|Overall Study||66
9898149|NCT01122394|11013844|FG001|STARTED|Overall Study||74
9898150|NCT01122394|11013843|FG000|COMPLETED|Overall Study||63
9898151|NCT01122394|11013844|FG001|COMPLETED|Overall Study||70
9898152|NCT01122394|11013843|FG000|NOT COMPLETED|Overall Study||3
9898153|NCT01122394|11013844|FG001|NOT COMPLETED|Overall Study||4
9898154|NCT01122446|11013854|FG000|STARTED|Overall Study||25
9898155|NCT01122446|11013855|FG001|STARTED|Overall Study||25
9898156|NCT01122446|11013854|FG000|COMPLETED|Overall Study||25
9898157|NCT01122446|11013855|FG001|COMPLETED|Overall Study||25
9898158|NCT01122446|11013854|FG000|NOT COMPLETED|Overall Study||0
9898159|NCT01122446|11013855|FG001|NOT COMPLETED|Overall Study||0
9898160|NCT01122576|11013864|FG000|STARTED|Pre-Cataract Surgery||26
9898161|NCT01122576|11013865|FG001|STARTED|Pre-Cataract Surgery||26
9898162|NCT01122576|11013866|FG002|STARTED|Pre-Cataract Surgery||26
9898163|NCT01122576|11013864|FG000|COMPLETED|Pre-Cataract Surgery||26
9898164|NCT01122576|11013865|FG001|COMPLETED|Pre-Cataract Surgery||25
9898165|NCT01122576|11013866|FG002|COMPLETED|Pre-Cataract Surgery||24
9898166|NCT01122576|11013864|FG000|NOT COMPLETED|Pre-Cataract Surgery||0
9898167|NCT01122576|11013865|FG001|NOT COMPLETED|Pre-Cataract Surgery||1
9898168|NCT01122576|11013866|FG002|NOT COMPLETED|Pre-Cataract Surgery||2
9898169|NCT01122576|11013864|FG000|STARTED|Post-Cataract Surgery||26
9898170|NCT01122576|11013865|FG001|STARTED|Post-Cataract Surgery||25
9898171|NCT01122576|11013866|FG002|STARTED|Post-Cataract Surgery||24
9898172|NCT01122576|11013864|FG000|COMPLETED|Post-Cataract Surgery||26
9898173|NCT01122576|11013865|FG001|COMPLETED|Post-Cataract Surgery||25
9898174|NCT01122576|11013866|FG002|COMPLETED|Post-Cataract Surgery||22
9898175|NCT01122576|11013864|FG000|NOT COMPLETED|Post-Cataract Surgery||0
9898176|NCT01122576|11013865|FG001|NOT COMPLETED|Post-Cataract Surgery||0
9898177|NCT01122576|11013866|FG002|NOT COMPLETED|Post-Cataract Surgery||2
9898178|NCT01122680|11013877|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
9898179|NCT01122680|11013878|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
9898180|NCT01122680|11013879|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
9898181|NCT01122680|11013880|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
9898182|NCT01122680|11013877|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
9898183|NCT01122680|11013878|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
9898184|NCT01122680|11013879|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
9898185|NCT01122680|11013880|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
9898186|NCT01122680|11013877|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3
9898187|NCT01122680|11013878|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
9898188|NCT01122680|11013879|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
9898189|NCT01122680|11013880|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
9898190|NCT01122680|11013877|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
9898191|NCT01122680|11013878|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
9898192|NCT01122680|11013879|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
9898193|NCT01122680|11013880|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
9898194|NCT01122680|11013877|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
9898195|NCT01122680|11013878|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
9898196|NCT01122680|11013879|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
9898197|NCT01122680|11013880|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
9898198|NCT01122680|11013877|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1
9898199|NCT01122680|11013878|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
9898200|NCT01122680|11013879|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
9898201|NCT01122680|11013880|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1
9898202|NCT01122680|11013877|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
9898203|NCT01122680|11013878|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
9898204|NCT01122680|11013879|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
9898205|NCT01122680|11013880|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
9898206|NCT01122680|11013877|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
9898207|NCT01122680|11013878|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
9898208|NCT01122680|11013879|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
9898209|NCT01122680|11013880|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
9898210|NCT01122680|11013877|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1
9898211|NCT01122680|11013878|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1
9898212|NCT01122680|11013879|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
9898213|NCT01122680|11013880|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
9898214|NCT01122849|11013893|FG000|STARTED|Overall Study||20
9898215|NCT01122849|11013894|FG001|STARTED|Overall Study||21
9898216|NCT01122849|11013895|FG002|STARTED|Overall Study||20
9898217|NCT01122849|11013893|FG000|COMPLETED|Overall Study||20
9898218|NCT01122849|11013894|FG001|COMPLETED|Overall Study||21
9898219|NCT01122849|11013895|FG002|COMPLETED|Overall Study||20
9898220|NCT01122849|11013893|FG000|NOT COMPLETED|Overall Study||0
9898221|NCT01122849|11013894|FG001|NOT COMPLETED|Overall Study||0
9898222|NCT01122849|11013895|FG002|NOT COMPLETED|Overall Study||0
9898223|NCT01122862|11013913|FG000|STARTED|Period 1||8
9898224|NCT01122862|11013914|FG001|STARTED|Period 1||8
9898225|NCT01122862|11013915|FG002|STARTED|Period 1||7
9898226|NCT01122862|11013913|FG000|COMPLETED|Period 1||8
9898227|NCT01122862|11013914|FG001|COMPLETED|Period 1||7
9898228|NCT01122862|11013915|FG002|COMPLETED|Period 1||7
9898229|NCT01122862|11013913|FG000|NOT COMPLETED|Period 1||0
9898230|NCT01122862|11013914|FG001|NOT COMPLETED|Period 1||1
9898231|NCT01122862|11013915|FG002|NOT COMPLETED|Period 1||0
9898232|NCT01122862|11013913|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
9898233|NCT01122862|11013914|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
9898234|NCT01122862|11013915|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
9898235|NCT01122862|11013913|FG000|COMPLETED|Period 2||8
9898236|NCT01122862|11013914|FG001|COMPLETED|Period 2||7
9898237|NCT01122862|11013915|FG002|COMPLETED|Period 2||6
9898238|NCT01122862|11013913|FG000|NOT COMPLETED|Period 2||0
9898239|NCT01122862|11013914|FG001|NOT COMPLETED|Period 2||0
9898240|NCT01122862|11013915|FG002|NOT COMPLETED|Period 2||1
9898241|NCT01122862|11013913|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
9898242|NCT01122862|11013914|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
9898243|NCT01122862|11013915|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
9898244|NCT01122862|11013913|FG000|COMPLETED|Period 3||6
9898245|NCT01122862|11013914|FG001|COMPLETED|Period 3||7
9898246|NCT01122862|11013915|FG002|COMPLETED|Period 3||8
9898247|NCT01122862|11013913|FG000|NOT COMPLETED|Period 3||0
9898248|NCT01122862|11013914|FG001|NOT COMPLETED|Period 3||0
9898249|NCT01122862|11013915|FG002|NOT COMPLETED|Period 3||0
9898250|NCT01122901|11013926|FG000|STARTED|Overall Study||40
9898251|NCT01122901|11013927|FG001|STARTED|Overall Study||7
9898252|NCT01122901|11013926|FG000|COMPLETED|Overall Study||40
9898253|NCT01122901|11013927|FG001|COMPLETED|Overall Study||7
9898254|NCT01122901|11013926|FG000|NOT COMPLETED|Overall Study||0
9898255|NCT01122901|11013927|FG001|NOT COMPLETED|Overall Study||0
9898256|NCT01122927|11013938|FG000|STARTED|Period 1 - Conversion Phase||297
9898257|NCT01122927|11013939|FG001|STARTED|Period 1 - Conversion Phase||0
9898258|NCT01122927|11013938|FG000|COMPLETED|Period 1 - Conversion Phase||283
9898259|NCT01122927|11013939|FG001|COMPLETED|Period 1 - Conversion Phase||0
9898260|NCT01122927|11013938|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14
9898261|NCT01122927|11013939|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
9898262|NCT01122927|11013938|FG000|STARTED|Period 2- Open-label Treatment Phase||0
9898263|NCT01122927|11013939|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
9898264|NCT01122927|11013938|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0
9898265|NCT01122927|11013939|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
9898266|NCT01122927|11013938|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
9898267|NCT01122927|11013939|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
9898268|NCT01123070|11013953|FG000|STARTED|Part A Cohort 1 Open Label Period||3
9898269|NCT01123070|11013954|FG001|STARTED|Part A Cohort 1 Open Label Period||0
9898270|NCT01123070|11013955|FG002|STARTED|Part A Cohort 1 Open Label Period||0
9898271|NCT01123070|11013956|FG003|STARTED|Part A Cohort 1 Open Label Period||0
9898272|NCT01123070|11013953|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3
9898273|NCT01123070|11013954|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0
9898274|NCT01123070|11013955|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0
9898275|NCT01123070|11013956|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0
9898276|NCT01123070|11013953|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
9898277|NCT01123070|11013954|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
9898278|NCT01123070|11013955|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
9898279|NCT01123070|11013956|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
9898280|NCT01123070|11013953|FG000|STARTED|Part A Cohort 2 Open Label Period||0
9898281|NCT01123070|11013954|FG001|STARTED|Part A Cohort 2 Open Label Period||3
9898282|NCT01123070|11013955|FG002|STARTED|Part A Cohort 2 Open Label Period||0
9898283|NCT01123070|11013956|FG003|STARTED|Part A Cohort 2 Open Label Period||0
9898284|NCT01123070|11013953|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0
9898285|NCT01123070|11013954|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3
9898286|NCT01123070|11013955|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0
9898287|NCT01123070|11013956|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0
10009120|NCT01763996|11131654|FG001|COMPLETED|Treatment Period 1||15
10009121|NCT01763996|11131653|FG000|NOT COMPLETED|Treatment Period 1||0
10009122|NCT01763996|11131654|FG001|NOT COMPLETED|Treatment Period 1||0
10009123|NCT01763996|11131653|FG000|STARTED|Treatment Period 2||15
10009124|NCT01763996|11131654|FG001|STARTED|Treatment Period 2||15
10009125|NCT01763996|11131653|FG000|COMPLETED|Treatment Period 2||15
10009126|NCT01763996|11131654|FG001|COMPLETED|Treatment Period 2||14
10009127|NCT01763996|11131653|FG000|NOT COMPLETED|Treatment Period 2||0
10009128|NCT01763996|11131654|FG001|NOT COMPLETED|Treatment Period 2||1
10009129|NCT01764022|11131662|FG000|STARTED|Overall Study||115
10009130|NCT01764022|11131663|FG001|STARTED|Overall Study||110
10009131|NCT01764022|11131662|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
10009132|NCT01764022|11131663|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110
10009133|NCT01764022|11131662|FG000|COMPLETED|Overall Study||107
10009134|NCT01764022|11131663|FG001|COMPLETED|Overall Study||96
10009135|NCT01764022|11131662|FG000|NOT COMPLETED|Overall Study||8
10009136|NCT01764022|11131663|FG001|NOT COMPLETED|Overall Study||14
10009137|NCT01764256|11131675|FG000|STARTED|Received All Vaccinations||12
9898288|NCT01123070|11013953|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
9898289|NCT01123070|11013954|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
9898290|NCT01123070|11013955|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
9898291|NCT01123070|11013956|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
9898292|NCT01123070|11013953|FG000|STARTED|Part B Double Blind Period||0
9898293|NCT01123070|11013954|FG001|STARTED|Part B Double Blind Period||0
9898294|NCT01123070|11013955|FG002|STARTED|Part B Double Blind Period||25
9898295|NCT01123070|11013956|FG003|STARTED|Part B Double Blind Period||23
9898296|NCT01123070|11013953|FG000|COMPLETED|Part B Double Blind Period||0
9898297|NCT01123070|11013954|FG001|COMPLETED|Part B Double Blind Period||0
9898298|NCT01123070|11013955|FG002|COMPLETED|Part B Double Blind Period||21
10009138|NCT01764256|11131676|FG001|STARTED|Received All Vaccinations||12
9898299|NCT01123070|11013956|FG003|COMPLETED|Part B Double Blind Period||20
9898300|NCT01123070|11013953|FG000|NOT COMPLETED|Part B Double Blind Period||0
9898301|NCT01123070|11013954|FG001|NOT COMPLETED|Part B Double Blind Period||0
9898302|NCT01123070|11013955|FG002|NOT COMPLETED|Part B Double Blind Period||4
9898303|NCT01123070|11013956|FG003|NOT COMPLETED|Part B Double Blind Period||3
9898304|NCT01123083|11013969|FG000|STARTED|Overall Study||61
9898305|NCT01123083|11013970|FG001|STARTED|Overall Study||118
9898306|NCT01123083|11013969|FG000|COMPLETED|Overall Study||50
9898307|NCT01123083|11013970|FG001|COMPLETED|Overall Study||103
9898308|NCT01123083|11013969|FG000|NOT COMPLETED|Overall Study||11
9898309|NCT01123083|11013970|FG001|NOT COMPLETED|Overall Study||15
9898310|NCT01123148|11013976|FG000|STARTED|Overall Study||14
9898311|NCT01123148|11013976|FG000|BCI Calibration >50% Accuracy|Overall Study||13
9898312|NCT01123148|11013976|FG000|COMPLETED|Overall Study||12
9898313|NCT01123148|11013976|FG000|NOT COMPLETED|Overall Study||2
9898314|NCT01123161|11013982|FG000|STARTED|Overall Study||57
10009139|NCT01764256|11131677|FG002|STARTED|Received All Vaccinations||12
10110289|NCT02484547|11241033|FG002|NOT COMPLETED|Long-Term Extension Period||0
9898315|NCT01123161|11013983|FG001|STARTED|Overall Study||63
10110290|NCT02484547|11241034|FG003|NOT COMPLETED|Long-Term Extension Period||131
10110291|NCT02484547|11241035|FG004|NOT COMPLETED|Long-Term Extension Period||132
10110292|NCT02484547|11241036|FG005|NOT COMPLETED|Long-Term Extension Period||251
10110293|NCT02484547|11241037|FG006|NOT COMPLETED|Long-Term Extension Period||257
9898316|NCT01123161|11013982|FG000|COMPLETED|Overall Study||55
9898317|NCT01123161|11013983|FG001|COMPLETED|Overall Study||63
9898318|NCT01123161|11013982|FG000|NOT COMPLETED|Overall Study||2
9898319|NCT01123161|11013983|FG001|NOT COMPLETED|Overall Study||0
9898320|NCT01123200|11013992|FG000|STARTED|Overall Study||1
9898321|NCT01123200|11013992|FG000|COMPLETED|Overall Study||0
9898322|NCT01123200|11013992|FG000|NOT COMPLETED|Overall Study||1
9898323|NCT01123356|11013996|FG000|STARTED|Overall Study||21
9898324|NCT01123356|11013996|FG000|COMPLETED|Overall Study||14
9898325|NCT01123356|11013996|FG000|NOT COMPLETED|Overall Study||7
9898326|NCT01123382|11014003|FG000|STARTED|Overall Study||13
9898327|NCT01123382|11014004|FG001|STARTED|Overall Study||12
9898328|NCT01123382|11014003|FG000|Received Intervention|Overall Study||12
9898329|NCT01123382|11014004|FG001|Received Intervention|Overall Study||10
9898330|NCT01123382|11014003|FG000|COMPLETED|Overall Study||11
9898331|NCT01123382|11014004|FG001|COMPLETED|Overall Study||6
9898332|NCT01123382|11014003|FG000|NOT COMPLETED|Overall Study||2
9898333|NCT01123382|11014004|FG001|NOT COMPLETED|Overall Study||6
9898334|NCT01123395|11014010|FG000|STARTED|Period 1||8
9898335|NCT01123395|11014011|FG001|STARTED|Period 1||8
9898336|NCT01123395|11014010|FG000|COMPLETED|Period 1||8
9898337|NCT01123395|11014011|FG001|COMPLETED|Period 1||8
9898338|NCT01123395|11014010|FG000|NOT COMPLETED|Period 1||0
9898339|NCT01123395|11014011|FG001|NOT COMPLETED|Period 1||0
9898340|NCT01123395|11014010|FG000|STARTED|Washout Period of 14 Days||8
9898341|NCT01123395|11014011|FG001|STARTED|Washout Period of 14 Days||8
9898342|NCT01123395|11014010|FG000|COMPLETED|Washout Period of 14 Days||8
9898343|NCT01123395|11014011|FG001|COMPLETED|Washout Period of 14 Days||7
9898344|NCT01123395|11014010|FG000|NOT COMPLETED|Washout Period of 14 Days||0
9898345|NCT01123395|11014011|FG001|NOT COMPLETED|Washout Period of 14 Days||1
9898346|NCT01123395|11014010|FG000|STARTED|Period 2||8
9898347|NCT01123395|11014011|FG001|STARTED|Period 2||7
9898348|NCT01123395|11014010|FG000|COMPLETED|Period 2||8
9898349|NCT01123395|11014011|FG001|COMPLETED|Period 2||7
10009140|NCT01764256|11131678|FG003|STARTED|Received All Vaccinations||12
10009141|NCT01764256|11131675|FG000|COMPLETED|Received All Vaccinations||10
10009142|NCT01764256|11131676|FG001|COMPLETED|Received All Vaccinations||11
10009143|NCT01764256|11131677|FG002|COMPLETED|Received All Vaccinations||11
9898350|NCT01123395|11014010|FG000|NOT COMPLETED|Period 2||0
9898351|NCT01123395|11014011|FG001|NOT COMPLETED|Period 2||0
9954885|NCT01434810|11073750|FG001|NOT COMPLETED|Overall Study||10
9954886|NCT01434823|11073758|FG000|STARTED|Overall Study||824
9954887|NCT01434823|11073759|FG001|STARTED|Overall Study||785
9954888|NCT01434823|11073758|FG000|COMPLETED|Overall Study||820
9954889|NCT01434823|11073759|FG001|COMPLETED|Overall Study||778
9954890|NCT01434823|11073758|FG000|NOT COMPLETED|Overall Study||4
9954891|NCT01434823|11073759|FG001|NOT COMPLETED|Overall Study||7
9954892|NCT01435018|11073769|FG000|STARTED|Overall Study||135
9954893|NCT01435018|11073770|FG001|STARTED|Overall Study||60
9954894|NCT01435018|11073771|FG002|STARTED|Overall Study||139
9954895|NCT01435018|11073769|FG000|COMPLETED|Overall Study||88
9954896|NCT01435018|11073770|FG001|COMPLETED|Overall Study||26
9954897|NCT01435018|11073771|FG002|COMPLETED|Overall Study||98
9954898|NCT01435018|11073769|FG000|NOT COMPLETED|Overall Study||47
9954899|NCT01435018|11073770|FG001|NOT COMPLETED|Overall Study||34
9954900|NCT01435018|11073771|FG002|NOT COMPLETED|Overall Study||41
9954901|NCT01435031|11073781|FG000|STARTED|ITT at 1 Month|ITT population|222
9954902|NCT01435031|11073781|FG000|COMPLETED|ITT at 1 Month||216
9954903|NCT01435031|11073781|FG000|NOT COMPLETED|ITT at 1 Month||6
9954904|NCT01435031|11073781|FG000|STARTED|ITT at 6 Months||216
9954905|NCT01435031|11073781|FG000|COMPLETED|ITT at 6 Months||211
9954906|NCT01435031|11073781|FG000|NOT COMPLETED|ITT at 6 Months||5
9954907|NCT01435031|11073781|FG000|STARTED|ITT at 1 Year||211
9954908|NCT01435031|11073781|FG000|COMPLETED|ITT at 1 Year||202
9954909|NCT01435031|11073781|FG000|NOT COMPLETED|ITT at 1 Year||9
9954910|NCT01435031|11073781|FG000|STARTED|ITT at 2 Years||202
9954911|NCT01435031|11073781|FG000|COMPLETED|ITT at 2 Years||189
9954912|NCT01435031|11073781|FG000|NOT COMPLETED|ITT at 2 Years||13
10009144|NCT01764256|11131678|FG003|COMPLETED|Received All Vaccinations||12
10009145|NCT01764256|11131675|FG000|NOT COMPLETED|Received All Vaccinations||2
10009146|NCT01764256|11131676|FG001|NOT COMPLETED|Received All Vaccinations||1
9954913|NCT01435031|11073781|FG000|STARTED|ITT at 3 Years||189
9954914|NCT01435031|11073781|FG000|COMPLETED|ITT at 3 Years||178
9954915|NCT01435031|11073781|FG000|NOT COMPLETED|ITT at 3 Years||11
9954916|NCT01435031|11073781|FG000|STARTED|ITT at 4 Years||178
9954917|NCT01435031|11073781|FG000|COMPLETED|ITT at 4 Years||171
9954918|NCT01435031|11073781|FG000|NOT COMPLETED|ITT at 4 Years||7
9954919|NCT01435122|11073785|FG000|STARTED|Overall Study||30
9954920|NCT01435122|11073785|FG000|COMPLETED|Overall Study||22
9954921|NCT01435122|11073785|FG000|NOT COMPLETED|Overall Study||8
9954922|NCT01435174|11073789|FG000|STARTED|Overall Study||17
9954923|NCT01435174|11073789|FG000|COMPLETED|Overall Study||8
9954924|NCT01435174|11073789|FG000|NOT COMPLETED|Overall Study||9
9954925|NCT01435265|11073795|FG000|STARTED|Overall Study||3
9954926|NCT01435265|11073796|FG001|STARTED|Overall Study||4
10009147|NCT01764256|11131677|FG002|NOT COMPLETED|Received All Vaccinations||1
10009148|NCT01764256|11131678|FG003|NOT COMPLETED|Received All Vaccinations||0
9898352|NCT01123512|11014019|FG000|STARTED|Overall Study||153
9898353|NCT01123512|11014020|FG001|STARTED|Overall Study||147
9898354|NCT01123512|11014019|FG000|COMPLETED|Overall Study||127
9898355|NCT01123512|11014020|FG001|COMPLETED|Overall Study||126
9898356|NCT01123512|11014019|FG000|NOT COMPLETED|Overall Study||26
9898357|NCT01123512|11014020|FG001|NOT COMPLETED|Overall Study||21
9898358|NCT01123642|11014026|FG000|STARTED|Overall Study||345
9898359|NCT01123642|11014026|FG000|COMPLETED|Overall Study||277
9898360|NCT01123642|11014026|FG000|NOT COMPLETED|Overall Study||68
9898361|NCT01123655|11014033|FG000|STARTED|Overall Study||10
9898362|NCT01123655|11014034|FG001|STARTED|Overall Study||4
9898363|NCT01123655|11014035|FG002|STARTED|Overall Study||8
9898364|NCT01123655|11014033|FG000|COMPLETED|Overall Study||9
9898365|NCT01123655|11014034|FG001|COMPLETED|Overall Study||3
9898366|NCT01123655|11014035|FG002|COMPLETED|Overall Study||7
9898367|NCT01123655|11014033|FG000|NOT COMPLETED|Overall Study||1
9898368|NCT01123655|11014034|FG001|NOT COMPLETED|Overall Study||1
9898369|NCT01123655|11014035|FG002|NOT COMPLETED|Overall Study||1
9898370|NCT01123889|11014043|FG000|STARTED|Overall Study||5
9898371|NCT01123889|11014044|FG001|STARTED|Overall Study||7
9898372|NCT01123889|11014043|FG000|COMPLETED|Overall Study||2
9898373|NCT01123889|11014044|FG001|COMPLETED|Overall Study||6
9898374|NCT01123889|11014043|FG000|NOT COMPLETED|Overall Study||3
9898375|NCT01123889|11014044|FG001|NOT COMPLETED|Overall Study||1
9898376|NCT01123928|11014052|FG000|STARTED|Overall Study||212
9898377|NCT01123928|11014053|FG001|STARTED|Overall Study||222
9898378|NCT01123928|11014052|FG000|COMPLETED|Overall Study||212
9898379|NCT01123928|11014053|FG001|COMPLETED|Overall Study||222
9898380|NCT01123928|11014052|FG000|NOT COMPLETED|Overall Study||0
9898381|NCT01123928|11014053|FG001|NOT COMPLETED|Overall Study||0
9898382|NCT01123941|11014061|FG000|STARTED|Overall Study||25
9898383|NCT01123941|11014062|FG001|STARTED|Overall Study||25
9898384|NCT01123941|11014061|FG000|COMPLETED|Overall Study||23
9898385|NCT01123941|11014062|FG001|COMPLETED|Overall Study||24
9898386|NCT01123941|11014061|FG000|NOT COMPLETED|Overall Study||2
9898387|NCT01123941|11014062|FG001|NOT COMPLETED|Overall Study||1
9898388|NCT01123980|11014070|FG000|STARTED|Overall Study||261
9898389|NCT01123980|11014071|FG001|STARTED|Overall Study||260
9898390|NCT01123980|11014070|FG000|COMPLETED|Overall Study||242
9898391|NCT01123980|11014071|FG001|COMPLETED|Overall Study||236
9898392|NCT01123980|11014070|FG000|NOT COMPLETED|Overall Study||19
9898393|NCT01123980|11014071|FG001|NOT COMPLETED|Overall Study||24
9898394|NCT01124006|11014080|FG000|STARTED|Overall Study||10
9898395|NCT01124006|11014081|FG001|STARTED|Overall Study||10
9898396|NCT01124006|11014082|FG002|STARTED|Overall Study||4
9898397|NCT01124006|11014080|FG000|COMPLETED|Overall Study||7
9898398|NCT01124006|11014081|FG001|COMPLETED|Overall Study||8
9898399|NCT01124006|11014082|FG002|COMPLETED|Overall Study||2
9898400|NCT01124006|11014080|FG000|NOT COMPLETED|Overall Study||3
9898401|NCT01124006|11014081|FG001|NOT COMPLETED|Overall Study||2
10110294|NCT02484651|11241051|FG000|STARTED|Overall Study|35 patients were randomized|35
10110295|NCT02484651|11241052|FG001|STARTED|Overall Study|35 patients were randomized|35
10110296|NCT02484651|11241051|FG000|End of Clinical Study|Overall Study||35
10110297|NCT02484651|11241052|FG001|End of Clinical Study|Overall Study||35
10110298|NCT02484651|11241051|FG000|Data Analysis|Overall Study||32
10110299|NCT02484651|11241052|FG001|Data Analysis|Overall Study||31
10110300|NCT02484651|11241051|FG000|COMPLETED|Overall Study||32
10110301|NCT02484651|11241052|FG001|COMPLETED|Overall Study||31
10110302|NCT02484651|11241051|FG000|NOT COMPLETED|Overall Study||3
10110303|NCT02484651|11241052|FG001|NOT COMPLETED|Overall Study||4
10110304|NCT02484690|11241064|FG000|STARTED|Overall Study||68
10110305|NCT02484690|11241065|FG001|STARTED|Overall Study||46
10110306|NCT02484690|11241066|FG002|STARTED|Overall Study||39
10110307|NCT02484690|11241067|FG003|STARTED|Overall Study||46
10110308|NCT02484690|11241068|FG004|STARTED|Overall Study||64
9898402|NCT01124006|11014082|FG002|NOT COMPLETED|Overall Study||2
9898403|NCT01124045|11014092|FG000|STARTED|Overall Study||39
9898404|NCT01124045|11014093|FG001|STARTED|Overall Study||40
9898405|NCT01124045|11014092|FG000|COMPLETED|Overall Study||39
9898406|NCT01124045|11014093|FG001|COMPLETED|Overall Study||37
9898407|NCT01124045|11014092|FG000|NOT COMPLETED|Overall Study||0
9898408|NCT01124045|11014093|FG001|NOT COMPLETED|Overall Study||3
9898409|NCT01124097|11014103|FG000|STARTED|Overall Study||60
9898410|NCT01124097|11014104|FG001|STARTED|Overall Study||60
10110309|NCT02484690|11241064|FG000|Received at Least One Dose of Study Drug|Overall Study||67
9898411|NCT01124097|11014105|FG002|STARTED|Overall Study||60
10110310|NCT02484690|11241065|FG001|Received at Least One Dose of Study Drug|Overall Study||46
9898412|NCT01124097|11014106|FG003|STARTED|Overall Study||60
9898413|NCT01124097|11014103|FG000|Safety Population|Overall Study||60
10110311|NCT02484690|11241066|FG002|Received at Least One Dose of Study Drug|Overall Study||39
10110312|NCT02484690|11241067|FG003|Received at Least One Dose of Study Drug|Overall Study||46
9898414|NCT01124097|11014104|FG001|Safety Population|Overall Study||60
9898415|NCT01124097|11014105|FG002|Safety Population|Overall Study||60
9898416|NCT01124097|11014106|FG003|Safety Population|Overall Study||60
9898417|NCT01124097|11014103|FG000|Efficacy Population|Overall Study||52
9898418|NCT01124097|11014104|FG001|Efficacy Population|Overall Study||53
9898419|NCT01124097|11014105|FG002|Efficacy Population|Overall Study||53
9898420|NCT01124097|11014106|FG003|Efficacy Population|Overall Study||51
9898421|NCT01124097|11014103|FG000|COMPLETED|Overall Study||26
9898422|NCT01124097|11014104|FG001|COMPLETED|Overall Study||38
10110313|NCT02484690|11241068|FG004|Received at Least One Dose of Study Drug|Overall Study||64
9898423|NCT01124097|11014105|FG002|COMPLETED|Overall Study||40
9898424|NCT01124097|11014106|FG003|COMPLETED|Overall Study||46
9898425|NCT01124097|11014103|FG000|NOT COMPLETED|Overall Study||34
9898426|NCT01124097|11014104|FG001|NOT COMPLETED|Overall Study||22
9898427|NCT01124097|11014105|FG002|NOT COMPLETED|Overall Study||20
9898428|NCT01124097|11014106|FG003|NOT COMPLETED|Overall Study||14
9898429|NCT01124149|11014116|FG000|STARTED|Acute Phase||722
9898430|NCT01124149|11014116|FG000|COMPLETED|Acute Phase||639
9898431|NCT01124149|11014116|FG000|NOT COMPLETED|Acute Phase||83
9898432|NCT01124149|11014116|FG000|STARTED|Maintenance Phase||469
9898433|NCT01124149|11014116|FG000|COMPLETED|Maintenance Phase||373
9898434|NCT01124149|11014116|FG000|NOT COMPLETED|Maintenance Phase||96
9898435|NCT01124162|11014125|FG000|STARTED|First Intervention||40
9898436|NCT01124162|11014126|FG001|STARTED|First Intervention||40
9898437|NCT01124162|11014125|FG000|COMPLETED|First Intervention||38
9898438|NCT01124162|11014126|FG001|COMPLETED|First Intervention||40
9898439|NCT01124162|11014125|FG000|NOT COMPLETED|First Intervention||2
9898440|NCT01124162|11014126|FG001|NOT COMPLETED|First Intervention||0
9898441|NCT01124162|11014125|FG000|STARTED|Washout of 7 Days||38
9898442|NCT01124162|11014126|FG001|STARTED|Washout of 7 Days||40
9898443|NCT01124162|11014125|FG000|COMPLETED|Washout of 7 Days||37
9898444|NCT01124162|11014126|FG001|COMPLETED|Washout of 7 Days||40
9898445|NCT01124162|11014125|FG000|NOT COMPLETED|Washout of 7 Days||1
9898446|NCT01124162|11014126|FG001|NOT COMPLETED|Washout of 7 Days||0
9898447|NCT01124162|11014125|FG000|STARTED|Second Intervention||37
9898448|NCT01124162|11014126|FG001|STARTED|Second Intervention||40
9898449|NCT01124162|11014125|FG000|COMPLETED|Second Intervention||37
9898450|NCT01124162|11014126|FG001|COMPLETED|Second Intervention||40
9898451|NCT01124162|11014125|FG000|NOT COMPLETED|Second Intervention||0
9898452|NCT01124162|11014126|FG001|NOT COMPLETED|Second Intervention||0
9898453|NCT01124175|11014134|FG000|STARTED|First Intervention||40
9898454|NCT01124175|11014135|FG001|STARTED|First Intervention||40
9898455|NCT01124175|11014134|FG000|COMPLETED|First Intervention||40
9898456|NCT01124175|11014135|FG001|COMPLETED|First Intervention||40
9898457|NCT01124175|11014134|FG000|NOT COMPLETED|First Intervention||0
9898458|NCT01124175|11014135|FG001|NOT COMPLETED|First Intervention||0
9898459|NCT01124175|11014134|FG000|STARTED|Washout of 7 Days||40
9898460|NCT01124175|11014135|FG001|STARTED|Washout of 7 Days||40
9898461|NCT01124175|11014134|FG000|COMPLETED|Washout of 7 Days||40
9898462|NCT01124175|11014135|FG001|COMPLETED|Washout of 7 Days||38
9898463|NCT01124175|11014134|FG000|NOT COMPLETED|Washout of 7 Days||0
10009149|NCT01764256|11131675|FG000|STARTED|Completed Study||10
9898464|NCT01124175|11014135|FG001|NOT COMPLETED|Washout of 7 Days||2
9898465|NCT01124175|11014134|FG000|STARTED|Second Intervention||40
9898466|NCT01124175|11014135|FG001|STARTED|Second Intervention||38
9898467|NCT01124175|11014134|FG000|COMPLETED|Second Intervention||40
9898468|NCT01124175|11014135|FG001|COMPLETED|Second Intervention||38
9898469|NCT01124175|11014134|FG000|NOT COMPLETED|Second Intervention||0
9898470|NCT01124175|11014135|FG001|NOT COMPLETED|Second Intervention||0
9898471|NCT01124188|11014143|FG000|STARTED|Overall Study||68
9898472|NCT01124188|11014144|FG001|STARTED|Overall Study||71
9898473|NCT01124188|11014143|FG000|COMPLETED|Overall Study||60
9898474|NCT01124188|11014144|FG001|COMPLETED|Overall Study||65
9898475|NCT01124188|11014143|FG000|NOT COMPLETED|Overall Study||8
9898476|NCT01124188|11014144|FG001|NOT COMPLETED|Overall Study||6
9898477|NCT01124292|11014153|FG000|STARTED|Overall Study||16
9898478|NCT01124292|11014154|FG001|STARTED|Overall Study||24
9898479|NCT01124292|11014155|FG002|STARTED|Overall Study||21
10009150|NCT01764256|11131676|FG001|STARTED|Completed Study||11
10009151|NCT01764256|11131677|FG002|STARTED|Completed Study||11
10009152|NCT01764256|11131678|FG003|STARTED|Completed Study||12
10009153|NCT01764256|11131675|FG000|COMPLETED|Completed Study||10
10009154|NCT01764256|11131676|FG001|COMPLETED|Completed Study||11
10009155|NCT01764256|11131677|FG002|COMPLETED|Completed Study||11
9898480|NCT01124292|11014153|FG000|COMPLETED|Overall Study||14
9898481|NCT01124292|11014154|FG001|COMPLETED|Overall Study||9
9898482|NCT01124292|11014155|FG002|COMPLETED|Overall Study||11
9898483|NCT01124292|11014153|FG000|NOT COMPLETED|Overall Study||2
9898484|NCT01124292|11014154|FG001|NOT COMPLETED|Overall Study||15
9898485|NCT01124292|11014155|FG002|NOT COMPLETED|Overall Study||10
9898486|NCT01124305|11014168|FG000|STARTED|Overall Study||34
9898487|NCT01124305|11014169|FG001|STARTED|Overall Study||36
9898488|NCT01124305|11014168|FG000|COMPLETED|Overall Study||26
9898489|NCT01124305|11014169|FG001|COMPLETED|Overall Study||26
9898490|NCT01124305|11014168|FG000|NOT COMPLETED|Overall Study||8
9898491|NCT01124305|11014169|FG001|NOT COMPLETED|Overall Study||10
9898492|NCT01124370|11014175|FG000|STARTED|Overall Study|Underwent implant attempt|57
9898493|NCT01124370|11014175|FG000|Successfully Implanted|Overall Study||50
9898494|NCT01124370|11014175|FG000|Therapy Initiated|Overall Study||48
9898495|NCT01124370|11014175|FG000|3 Month Visit|Overall Study|Defines evaluable population|47
9898496|NCT01124370|11014175|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
9898497|NCT01124370|11014175|FG000|NOT COMPLETED|Overall Study||20
9898498|NCT01124422|11014181|FG000|STARTED|4-Week Open-label Run-in Phase||338
9898499|NCT01124422|11014182|FG001|STARTED|4-Week Open-label Run-in Phase||0
9898500|NCT01124422|11014183|FG002|STARTED|4-Week Open-label Run-in Phase||0
9898501|NCT01124422|11014181|FG000|COMPLETED|4-Week Open-label Run-in Phase||255
9898502|NCT01124422|11014182|FG001|COMPLETED|4-Week Open-label Run-in Phase||0
9898503|NCT01124422|11014183|FG002|COMPLETED|4-Week Open-label Run-in Phase||0
9898504|NCT01124422|11014181|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83
9898505|NCT01124422|11014182|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0
9898506|NCT01124422|11014183|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0
9898507|NCT01124422|11014181|FG000|STARTED|4-Week Double-blind Treatment Phase||0
9898508|NCT01124422|11014182|FG001|STARTED|4-Week Double-blind Treatment Phase||131
9898509|NCT01124422|11014183|FG002|STARTED|4-Week Double-blind Treatment Phase||124
9898510|NCT01124422|11014181|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0
9898511|NCT01124422|11014182|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120
9898512|NCT01124422|11014183|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115
9898513|NCT01124422|11014181|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
9898514|NCT01124422|11014182|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
9898515|NCT01124422|11014183|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
9898516|NCT01124448|11014192|FG000|STARTED|Overall Study||25
9898517|NCT01124448|11014193|FG001|STARTED|Overall Study||15
9898518|NCT01124448|11014192|FG000|COMPLETED|Overall Study||23
9898519|NCT01124448|11014193|FG001|COMPLETED|Overall Study||12
9898520|NCT01124448|11014192|FG000|NOT COMPLETED|Overall Study||2
9898521|NCT01124448|11014193|FG001|NOT COMPLETED|Overall Study||3
9898522|NCT01124604|11014201|FG000|STARTED|Overall Study||60
9898523|NCT01124604|11014202|FG001|STARTED|Overall Study||31
9898524|NCT01124604|11014201|FG000|COMPLETED|Overall Study||45
9898525|NCT01124604|11014202|FG001|COMPLETED|Overall Study||29
9898526|NCT01124604|11014201|FG000|NOT COMPLETED|Overall Study||15
9898527|NCT01124604|11014202|FG001|NOT COMPLETED|Overall Study||2
9898528|NCT01124617|11014210|FG000|STARTED|Overall Study||60
9898529|NCT01124617|11014211|FG001|STARTED|Overall Study||31
9898530|NCT01124617|11014210|FG000|COMPLETED|Overall Study||41
9898531|NCT01124617|11014211|FG001|COMPLETED|Overall Study||25
9898532|NCT01124617|11014210|FG000|NOT COMPLETED|Overall Study||19
9898533|NCT01124617|11014211|FG001|NOT COMPLETED|Overall Study||6
9898534|NCT01124643|11014217|FG000|STARTED|Overall Study||35
9898535|NCT01124643|11014217|FG000|COMPLETED|Overall Study||34
9898536|NCT01124643|11014217|FG000|NOT COMPLETED|Overall Study||1
9898537|NCT01124734|11014221|FG000|STARTED|Overall Study||17
9898538|NCT01124734|11014221|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
9898539|NCT01124734|11014221|FG000|Initiation of Course 1 Cycle 2|Overall Study||17
9898540|NCT01124734|11014221|FG000|COMPLETED|Overall Study|Closed to accrual|0
9898541|NCT01124734|11014221|FG000|NOT COMPLETED|Overall Study||17
9898542|NCT01124786|11014232|FG000|STARTED|Overall Study||182
9898543|NCT01124786|11014233|FG001|STARTED|Overall Study||185
9898544|NCT01124786|11014232|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
9898545|NCT01124786|11014233|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
9898546|NCT01124786|11014232|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
9898547|NCT01124786|11014233|FG001|Safety Population|Overall Study||181
9898548|NCT01124786|11014232|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
9898549|NCT01124786|11014233|FG001|Tumor Evaluable Population|Overall Study||180
9898550|NCT01124786|11014232|FG000|COMPLETED|Overall Study||178
9898551|NCT01124786|11014233|FG001|COMPLETED|Overall Study||180
9898552|NCT01124786|11014232|FG000|NOT COMPLETED|Overall Study||4
9898553|NCT01124786|11014233|FG001|NOT COMPLETED|Overall Study||5
9898554|NCT01124838|11014241|FG000|STARTED|Overall Study||130
9898555|NCT01124838|11014242|FG001|STARTED|Overall Study||131
9898556|NCT01124838|11014241|FG000|Enrolled in Main Study|Overall Study||114
9898557|NCT01124838|11014242|FG001|Enrolled in Main Study|Overall Study||115
9898558|NCT01124838|11014241|FG000|Enrolled in Japan Sub-study|Overall Study||16
9898559|NCT01124838|11014242|FG001|Enrolled in Japan Sub-study|Overall Study||16
9898560|NCT01124838|11014241|FG000|COMPLETED|Overall Study||112
9898561|NCT01124838|11014242|FG001|COMPLETED|Overall Study||116
9898562|NCT01124838|11014241|FG000|NOT COMPLETED|Overall Study||18
9898563|NCT01124838|11014242|FG001|NOT COMPLETED|Overall Study||15
9898564|NCT01124864|11014256|FG000|STARTED|Overall Study||28
9898565|NCT01124864|11014257|FG001|STARTED|Overall Study||35
9898566|NCT01124864|11014258|FG002|STARTED|Overall Study||34
9898567|NCT01124864|11014259|FG003|STARTED|Overall Study||22
9898568|NCT01124864|11014260|FG004|STARTED|Overall Study||31
9898569|NCT01124864|11014261|FG005|STARTED|Overall Study||3
9898570|NCT01124864|11014256|FG000|COMPLETED|Overall Study||0
9898571|NCT01124864|11014257|FG001|COMPLETED|Overall Study||0
9898572|NCT01124864|11014258|FG002|COMPLETED|Overall Study||0
9898573|NCT01124864|11014259|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
9898574|NCT01124864|11014260|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
9898575|NCT01124864|11014261|FG005|COMPLETED|Overall Study||0
9898576|NCT01124864|11014256|FG000|NOT COMPLETED|Overall Study||28
9898577|NCT01124864|11014257|FG001|NOT COMPLETED|Overall Study||35
9898578|NCT01124864|11014258|FG002|NOT COMPLETED|Overall Study||34
9898579|NCT01124864|11014259|FG003|NOT COMPLETED|Overall Study||21
9898580|NCT01124864|11014260|FG004|NOT COMPLETED|Overall Study||30
9898581|NCT01124864|11014261|FG005|NOT COMPLETED|Overall Study||3
9898582|NCT01124916|11014279|FG000|STARTED|Overall Study||38
9898583|NCT01124916|11014280|FG001|STARTED|Overall Study||40
9898584|NCT01124916|11014279|FG000|COMPLETED|Overall Study||35
9898585|NCT01124916|11014280|FG001|COMPLETED|Overall Study||38
9898586|NCT01124916|11014279|FG000|NOT COMPLETED|Overall Study||3
9898587|NCT01124916|11014280|FG001|NOT COMPLETED|Overall Study||2
9898588|NCT01124955|11014288|FG000|STARTED|Overall Study||40
9898589|NCT01124955|11014289|FG001|STARTED|Overall Study||40
9898590|NCT01124955|11014288|FG000|COMPLETED|Overall Study||40
9898591|NCT01124955|11014289|FG001|COMPLETED|Overall Study||40
9898592|NCT01124955|11014288|FG000|NOT COMPLETED|Overall Study||0
9898593|NCT01124955|11014289|FG001|NOT COMPLETED|Overall Study||0
9898594|NCT01125046|11014295|FG000|STARTED|First 6 Months of Treatment||50
9898595|NCT01125046|11014295|FG000|COMPLETED|First 6 Months of Treatment||36
9898596|NCT01125046|11014295|FG000|NOT COMPLETED|First 6 Months of Treatment||14
9898597|NCT01125046|11014295|FG000|STARTED|Continued Treatment After 6 Months||36
9898598|NCT01125046|11014295|FG000|COMPLETED|Continued Treatment After 6 Months||33
9898599|NCT01125046|11014295|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3
9898600|NCT01125046|11014295|FG000|STARTED|Follow-up/Data Cut Off Point||49
9898601|NCT01125046|11014295|FG000|COMPLETED|Follow-up/Data Cut Off Point||16
9898602|NCT01125046|11014295|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33
9898603|NCT01125098|11014301|FG000|STARTED|Overall Study||91
9898604|NCT01125098|11014302|FG001|STARTED|Overall Study||90
9898605|NCT01125098|11014301|FG000|COMPLETED|Overall Study||88
9898606|NCT01125098|11014302|FG001|COMPLETED|Overall Study||90
9898607|NCT01125098|11014301|FG000|NOT COMPLETED|Overall Study||3
9898608|NCT01125098|11014302|FG001|NOT COMPLETED|Overall Study||0
9898609|NCT01125163|11014310|FG000|STARTED|Overall Study||76
9898610|NCT01125163|11014311|FG001|STARTED|Overall Study||74
9898611|NCT01125163|11014310|FG000|COMPLETED|Overall Study||76
9898612|NCT01125163|11014311|FG001|COMPLETED|Overall Study||74
9898613|NCT01125163|11014310|FG000|NOT COMPLETED|Overall Study||0
9898614|NCT01125163|11014311|FG001|NOT COMPLETED|Overall Study||0
9898615|NCT01125189|11014321|FG000|STARTED|Treatment Period||159
9898616|NCT01125189|11014322|FG001|STARTED|Treatment Period||158
9898617|NCT01125189|11014323|FG002|STARTED|Treatment Period||78
9898618|NCT01125189|11014321|FG000|COMPLETED|Treatment Period||128
9898619|NCT01125189|11014322|FG001|COMPLETED|Treatment Period||123
9898620|NCT01125189|11014323|FG002|COMPLETED|Treatment Period||37
9898621|NCT01125189|11014321|FG000|NOT COMPLETED|Treatment Period||31
9898622|NCT01125189|11014322|FG001|NOT COMPLETED|Treatment Period||35
9898623|NCT01125189|11014323|FG002|NOT COMPLETED|Treatment Period||41
9898624|NCT01125189|11014321|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
9898625|NCT01125189|11014322|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
9898626|NCT01125189|11014323|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
9898627|NCT01125189|11014321|FG000|COMPLETED|Follow up Period||132
9898628|NCT01125189|11014322|FG001|COMPLETED|Follow up Period||138
9898629|NCT01125189|11014323|FG002|COMPLETED|Follow up Period||58
9898630|NCT01125189|11014321|FG000|NOT COMPLETED|Follow up Period||20
9898631|NCT01125189|11014322|FG001|NOT COMPLETED|Follow up Period||15
9898632|NCT01125189|11014323|FG002|NOT COMPLETED|Follow up Period||16
9898633|NCT01125202|11014336|FG000|STARTED|Overall Study||93
9898634|NCT01125202|11014337|FG001|STARTED|Overall Study||86
9898635|NCT01125202|11014336|FG000|COMPLETED|Overall Study||81
9898636|NCT01125202|11014337|FG001|COMPLETED|Overall Study||79
9898637|NCT01125202|11014336|FG000|NOT COMPLETED|Overall Study||12
9898638|NCT01125202|11014337|FG001|NOT COMPLETED|Overall Study||7
9898639|NCT01125293|11014349|FG000|STARTED|Overall Study||3
9898640|NCT01125293|11014350|FG001|STARTED|Overall Study||3
9898641|NCT01125293|11014351|FG002|STARTED|Overall Study||4
9898642|NCT01125293|11014352|FG003|STARTED|Overall Study||3
9898643|NCT01125293|11014353|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
9898644|NCT01125293|11014354|FG005|STARTED|Overall Study||23
9898645|NCT01125293|11014349|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
9898646|NCT01125293|11014350|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
9898647|NCT01125293|11014351|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
9898648|NCT01125293|11014352|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
9898649|NCT01125293|11014353|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
9898650|NCT01125293|11014354|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
9898651|NCT01125293|11014349|FG000|COMPLETED|Overall Study||0
9898652|NCT01125293|11014350|FG001|COMPLETED|Overall Study||0
9898653|NCT01125293|11014351|FG002|COMPLETED|Overall Study||0
9898654|NCT01125293|11014352|FG003|COMPLETED|Overall Study||0
9898655|NCT01125293|11014353|FG004|COMPLETED|Overall Study||0
9898656|NCT01125293|11014354|FG005|COMPLETED|Overall Study||0
9898657|NCT01125293|11014349|FG000|NOT COMPLETED|Overall Study||3
9898658|NCT01125293|11014350|FG001|NOT COMPLETED|Overall Study||3
9898659|NCT01125293|11014351|FG002|NOT COMPLETED|Overall Study||4
9898660|NCT01125293|11014352|FG003|NOT COMPLETED|Overall Study||3
9898661|NCT01125293|11014353|FG004|NOT COMPLETED|Overall Study||10
9898662|NCT01125293|11014354|FG005|NOT COMPLETED|Overall Study||23
9898663|NCT01125358|11014375|FG000|STARTED|Overall Study||21
9898664|NCT01125358|11014376|FG001|STARTED|Overall Study||21
9898665|NCT01125358|11014377|FG002|STARTED|Overall Study||20
9898666|NCT01125358|11014378|FG003|STARTED|Overall Study||20
9898667|NCT01125358|11014375|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
9898668|NCT01125358|11014376|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
9898669|NCT01125358|11014377|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
9898670|NCT01125358|11014378|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20
9898671|NCT01125358|11014375|FG000|Placebo Responder|Overall Study||1
9898672|NCT01125358|11014376|FG001|Placebo Responder|Overall Study||0
9898673|NCT01125358|11014377|FG002|Placebo Responder|Overall Study||0
9898674|NCT01125358|11014378|FG003|Placebo Responder|Overall Study||0
9898675|NCT01125358|11014375|FG000|COMPLETED|Overall Study||9
9898676|NCT01125358|11014376|FG001|COMPLETED|Overall Study||17
9898677|NCT01125358|11014377|FG002|COMPLETED|Overall Study||11
9898678|NCT01125358|11014378|FG003|COMPLETED|Overall Study||12
9898679|NCT01125358|11014375|FG000|NOT COMPLETED|Overall Study||12
9898680|NCT01125358|11014376|FG001|NOT COMPLETED|Overall Study||4
9898681|NCT01125358|11014377|FG002|NOT COMPLETED|Overall Study||9
9898682|NCT01125358|11014378|FG003|NOT COMPLETED|Overall Study||8
9954927|NCT01435265|11073795|FG000|COMPLETED|Overall Study||3
9954928|NCT01435265|11073796|FG001|COMPLETED|Overall Study||3
9954929|NCT01435265|11073795|FG000|NOT COMPLETED|Overall Study||0
9954930|NCT01435265|11073796|FG001|NOT COMPLETED|Overall Study||1
9954931|NCT01435304|11073804|FG000|STARTED|Overall Study||50
9954932|NCT01435304|11073805|FG001|STARTED|Overall Study||50
9954933|NCT01435304|11073804|FG000|COMPLETED|Overall Study||50
9954934|NCT01435304|11073805|FG001|COMPLETED|Overall Study||50
9954935|NCT01435304|11073804|FG000|NOT COMPLETED|Overall Study||0
9954936|NCT01435304|11073805|FG001|NOT COMPLETED|Overall Study||0
9954937|NCT01435356|11073813|FG000|STARTED|Overall Study||48
9954938|NCT01435356|11073814|FG001|STARTED|Overall Study||29
9954939|NCT01435356|11073813|FG000|COMPLETED|Overall Study||16
9954940|NCT01435356|11073814|FG001|COMPLETED|Overall Study||5
9954941|NCT01435356|11073813|FG000|NOT COMPLETED|Overall Study||32
9954942|NCT01435356|11073814|FG001|NOT COMPLETED|Overall Study||24
9954943|NCT01435382|11073824|FG000|STARTED|Overall Study||12
9954944|NCT01435382|11073825|FG001|STARTED|Overall Study||13
9954945|NCT01435382|11073826|FG002|STARTED|Overall Study||13
9954946|NCT01435382|11073827|FG003|STARTED|Overall Study||11
9954947|NCT01435382|11073824|FG000|COMPLETED|Overall Study||11
9954948|NCT01435382|11073825|FG001|COMPLETED|Overall Study||11
9954949|NCT01435382|11073826|FG002|COMPLETED|Overall Study||12
9954950|NCT01435382|11073827|FG003|COMPLETED|Overall Study||10
9954951|NCT01435382|11073824|FG000|NOT COMPLETED|Overall Study||1
9954952|NCT01435382|11073825|FG001|NOT COMPLETED|Overall Study||2
9954953|NCT01435382|11073826|FG002|NOT COMPLETED|Overall Study||1
9954954|NCT01435382|11073827|FG003|NOT COMPLETED|Overall Study||1
9954955|NCT01435460|11073845|FG000|STARTED|Overall Study||151
9954956|NCT01435460|11073846|FG001|STARTED|Overall Study||149
9954957|NCT01435460|11073845|FG000|COMPLETED|Overall Study||140
9954958|NCT01435460|11073846|FG001|COMPLETED|Overall Study||143
9954959|NCT01435460|11073845|FG000|NOT COMPLETED|Overall Study||11
10009156|NCT01764256|11131678|FG003|COMPLETED|Completed Study||11
10009157|NCT01764256|11131675|FG000|NOT COMPLETED|Completed Study||0
9954960|NCT01435460|11073846|FG001|NOT COMPLETED|Overall Study||6
9954961|NCT01435512|11073854|FG000|STARTED|Overall Study||67
9954962|NCT01435512|11073855|FG001|STARTED|Overall Study||68
9954963|NCT01435512|11073854|FG000|COMPLETED|Overall Study||67
9954964|NCT01435512|11073855|FG001|COMPLETED|Overall Study||68
9954965|NCT01435512|11073854|FG000|NOT COMPLETED|Overall Study||0
9954966|NCT01435512|11073855|FG001|NOT COMPLETED|Overall Study||0
9954967|NCT01435577|11073863|FG000|STARTED|Overall Study||64
9954968|NCT01435577|11073864|FG001|STARTED|Overall Study||65
9954969|NCT01435577|11073863|FG000|COMPLETED|Overall Study||47
9954970|NCT01435577|11073864|FG001|COMPLETED|Overall Study||13
9954971|NCT01435577|11073863|FG000|NOT COMPLETED|Overall Study||17
9954972|NCT01435577|11073864|FG001|NOT COMPLETED|Overall Study||52
9954973|NCT01435603|11073876|FG000|STARTED|Overall Study||167
9954974|NCT01435603|11073877|FG001|STARTED|Overall Study||164
9954975|NCT01435603|11073876|FG000|COMPLETED|Overall Study||128
9954976|NCT01435603|11073877|FG001|COMPLETED|Overall Study||129
9954977|NCT01435603|11073876|FG000|NOT COMPLETED|Overall Study||39
9954978|NCT01435603|11073877|FG001|NOT COMPLETED|Overall Study||35
9954979|NCT01435616|11073885|FG000|STARTED|Overall Study||1003
9954980|NCT01435616|11073886|FG001|STARTED|Overall Study||535
9954981|NCT01435616|11073885|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003
9954982|NCT01435616|11073886|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535
9954983|NCT01435616|11073885|FG000|COMPLETED|Overall Study||832
9954984|NCT01435616|11073886|FG001|COMPLETED|Overall Study||455
9954985|NCT01435616|11073885|FG000|NOT COMPLETED|Overall Study||171
9954986|NCT01435616|11073886|FG001|NOT COMPLETED|Overall Study||80
9954987|NCT01435655|11073894|FG000|STARTED|Overall Study||10
9954988|NCT01435655|11073894|FG000|COMPLETED|Overall Study||7
9954989|NCT01435655|11073894|FG000|NOT COMPLETED|Overall Study||3
9954990|NCT01435759|11073903|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
9954991|NCT01435759|11073904|FG001|STARTED|Antidepressant Lead-in Phase||0
10009158|NCT01764256|11131676|FG001|NOT COMPLETED|Completed Study||0
10009159|NCT01764256|11131677|FG002|NOT COMPLETED|Completed Study||0
9954992|NCT01435759|11073905|FG002|STARTED|Antidepressant Lead-in Phase||0
9954993|NCT01435759|11073906|FG003|STARTED|Antidepressant Lead-in Phase||0
9954994|NCT01435759|11073907|FG004|STARTED|Antidepressant Lead-in Phase||0
9954995|NCT01435759|11073908|FG005|STARTED|Antidepressant Lead-in Phase||0
9954996|NCT01435759|11073903|FG000|COMPLETED|Antidepressant Lead-in Phase||855
9954997|NCT01435759|11073904|FG001|COMPLETED|Antidepressant Lead-in Phase||0
9954998|NCT01435759|11073905|FG002|COMPLETED|Antidepressant Lead-in Phase||0
9954999|NCT01435759|11073906|FG003|COMPLETED|Antidepressant Lead-in Phase||0
9898683|NCT04733664|11014388|FG000|STARTED|Overall Study||10
9898684|NCT04733664|11014388|FG000|COMPLETED|Overall Study||10
9898685|NCT04733664|11014388|FG000|NOT COMPLETED|Overall Study||0
9898686|NCT04573322|11014396|FG000|STARTED|Overall Study||6
9898687|NCT04573322|11014397|FG001|STARTED|Overall Study||6
9898688|NCT04573322|11014398|FG002|STARTED|Overall Study||7
9898689|NCT04573322|11014399|FG003|STARTED|Overall Study||6
9898690|NCT04573322|11014396|FG000|COMPLETED|Overall Study||5
9898691|NCT04573322|11014397|FG001|COMPLETED|Overall Study||4
9898692|NCT04573322|11014398|FG002|COMPLETED|Overall Study||5
9898693|NCT04573322|11014399|FG003|COMPLETED|Overall Study||3
9898694|NCT04573322|11014396|FG000|NOT COMPLETED|Overall Study||1
9898695|NCT04573322|11014397|FG001|NOT COMPLETED|Overall Study||2
9898696|NCT04573322|11014398|FG002|NOT COMPLETED|Overall Study||2
9898697|NCT04573322|11014399|FG003|NOT COMPLETED|Overall Study||3
9898698|NCT04516746|11014411|FG000|STARTED|Overall Study||21635
9898699|NCT04516746|11014412|FG001|STARTED|Overall Study||10816
9898700|NCT04516746|11014411|FG000|Participants Who Received First Dose|Overall Study||21583
9898701|NCT04516746|11014412|FG001|Participants Who Received First Dose|Overall Study||10796
9898702|NCT04516746|11014411|FG000|Participants Who Received Second Dose|Overall Study||20769
9898703|NCT04516746|11014412|FG001|Participants Who Received Second Dose|Overall Study||9951
9898704|NCT04516746|11014411|FG000|COMPLETED|Overall Study||0
9898705|NCT04516746|11014412|FG001|COMPLETED|Overall Study||0
9898706|NCT04516746|11014411|FG000|NOT COMPLETED|Overall Study||21635
9898707|NCT04516746|11014412|FG001|NOT COMPLETED|Overall Study||10816
9898708|NCT04374565|11014418|FG000|STARTED|Overall Study||29
9898709|NCT04374565|11014418|FG000|COMPLETED|Overall Study||29
9898710|NCT04374565|11014418|FG000|NOT COMPLETED|Overall Study||0
9898711|NCT04364737|11014424|FG000|STARTED|Overall Study||468
9898712|NCT04364737|11014425|FG001|STARTED|Overall Study||473
9898713|NCT04364737|11014424|FG000|COMPLETED|Overall Study||463
9898714|NCT04364737|11014425|FG001|COMPLETED|Overall Study||463
9898715|NCT04364737|11014424|FG000|NOT COMPLETED|Overall Study||5
9898716|NCT04364737|11014425|FG001|NOT COMPLETED|Overall Study||10
9898717|NCT04354155|11014431|FG000|STARTED|Overall Study||40
9898718|NCT04354155|11014431|FG000|COMPLETED|Overall Study||38
9898719|NCT04354155|11014431|FG000|NOT COMPLETED|Overall Study||2
9898720|NCT04085367|11014437|FG000|STARTED|Overall Study||364
9898721|NCT04085367|11014438|FG001|STARTED|Overall Study||193
9898722|NCT04085367|11014437|FG000|COMPLETED|Overall Study||344
9898723|NCT04085367|11014438|FG001|COMPLETED|Overall Study||185
9898724|NCT04085367|11014437|FG000|NOT COMPLETED|Overall Study||20
9898725|NCT04085367|11014438|FG001|NOT COMPLETED|Overall Study||8
9898726|NCT03884270|11014444|FG000|STARTED|Overall Study||23
9898727|NCT03884270|11014444|FG000|COMPLETED|Overall Study||22
9898728|NCT03884270|11014444|FG000|NOT COMPLETED|Overall Study||1
9898729|NCT03621696|11014452|FG000|STARTED|Overall Study||21
9898730|NCT03621696|11014453|FG001|STARTED|Overall Study||31
9898731|NCT03621696|11014454|FG002|STARTED|Overall Study||6
9898732|NCT03621696|11014455|FG003|STARTED|Overall Study||5
9898733|NCT03621696|11014452|FG000|COMPLETED|Overall Study||20
9898734|NCT03621696|11014453|FG001|COMPLETED|Overall Study||30
9898735|NCT03621696|11014454|FG002|COMPLETED|Overall Study||4
9898736|NCT03621696|11014455|FG003|COMPLETED|Overall Study||0
9898737|NCT03621696|11014452|FG000|NOT COMPLETED|Overall Study||1
9898738|NCT03621696|11014453|FG001|NOT COMPLETED|Overall Study||1
9898739|NCT03621696|11014454|FG002|NOT COMPLETED|Overall Study||2
9898740|NCT03621696|11014455|FG003|NOT COMPLETED|Overall Study||5
9898741|NCT03544268|11014465|FG000|STARTED|Overall Study||5
9898742|NCT03544268|11014466|FG001|STARTED|Overall Study||15
9898743|NCT03544268|11014465|FG000|COMPLETED|Overall Study||3
9898744|NCT03544268|11014466|FG001|COMPLETED|Overall Study||15
9898745|NCT03544268|11014465|FG000|NOT COMPLETED|Overall Study||2
9898746|NCT03544268|11014466|FG001|NOT COMPLETED|Overall Study||0
9898747|NCT03421197|11014476|FG000|STARTED|Overall Study||105
9898748|NCT03421197|11014477|FG001|STARTED|Overall Study||107
9898749|NCT03421197|11014478|FG002|STARTED|Overall Study||107
9898750|NCT03421197|11014479|FG003|STARTED|Overall Study||107
9898751|NCT03421197|11014476|FG000|COMPLETED|Overall Study||67
9898752|NCT03421197|11014477|FG001|COMPLETED|Overall Study||68
9898753|NCT03421197|11014478|FG002|COMPLETED|Overall Study||56
9898754|NCT03421197|11014479|FG003|COMPLETED|Overall Study||62
9898755|NCT03421197|11014476|FG000|NOT COMPLETED|Overall Study||38
9898756|NCT03421197|11014477|FG001|NOT COMPLETED|Overall Study||39
9898757|NCT03421197|11014478|FG002|NOT COMPLETED|Overall Study||51
9898758|NCT03421197|11014479|FG003|NOT COMPLETED|Overall Study||45
9898759|NCT03371108|11014491|FG000|STARTED|Safety Analysis Set||284
9898760|NCT03371108|11014492|FG001|STARTED|Safety Analysis Set||283
9898761|NCT03371108|11014491|FG000|COMPLETED|Safety Analysis Set||281
9898762|NCT03371108|11014492|FG001|COMPLETED|Safety Analysis Set||282
9898763|NCT03371108|11014491|FG000|NOT COMPLETED|Safety Analysis Set||3
9898764|NCT03371108|11014492|FG001|NOT COMPLETED|Safety Analysis Set||1
9898765|NCT03371108|11014491|FG000|STARTED|Completers||281
9898766|NCT03371108|11014492|FG001|STARTED|Completers||282
9898767|NCT03371108|11014491|FG000|COMPLETED|Completers||259
9898768|NCT03371108|11014492|FG001|COMPLETED|Completers||256
9898769|NCT03371108|11014491|FG000|NOT COMPLETED|Completers||22
9898770|NCT03371108|11014492|FG001|NOT COMPLETED|Completers||26
9898771|NCT03112993|11014500|FG000|STARTED|Overall Study||19
9898772|NCT03112993|11014501|FG001|STARTED|Overall Study||21
9898773|NCT03112993|11014500|FG000|COMPLETED|Overall Study||19
9898774|NCT03112993|11014501|FG001|COMPLETED|Overall Study||21
9898775|NCT03112993|11014500|FG000|NOT COMPLETED|Overall Study||0
9898776|NCT03112993|11014501|FG001|NOT COMPLETED|Overall Study||0
9898777|NCT03088137|11014511|FG000|STARTED|Overall Study||55
9898778|NCT03088137|11014512|FG001|STARTED|Overall Study||55
9898779|NCT03088137|11014511|FG000|COMPLETED|Overall Study||55
9898780|NCT03088137|11014512|FG001|COMPLETED|Overall Study||55
9898781|NCT03088137|11014511|FG000|NOT COMPLETED|Overall Study||0
9898782|NCT03088137|11014512|FG001|NOT COMPLETED|Overall Study||0
9898783|NCT03038438|11014518|FG000|STARTED|Overall Study||200
9898784|NCT03038438|11014518|FG000|30-Day Follow-Up|Overall Study||198
9898785|NCT03038438|11014518|FG000|6-Month Follow-up|Overall Study||193
9898786|NCT03038438|11014518|FG000|12-Month Follow-up|Overall Study||191
9898787|NCT03038438|11014518|FG000|24-Month Follow-up|Overall Study||148
9898788|NCT03038438|11014518|FG000|COMPLETED|Overall Study||148
9898789|NCT03038438|11014518|FG000|NOT COMPLETED|Overall Study||52
9898790|NCT02951481|11014524|FG000|STARTED|Overall Study||231
9898791|NCT02951481|11014525|FG001|STARTED|Overall Study||172
9898792|NCT02951481|11014524|FG000|COMPLETED|Overall Study||231
9898793|NCT02951481|11014525|FG001|COMPLETED|Overall Study||172
9898794|NCT02951481|11014524|FG000|NOT COMPLETED|Overall Study||0
9898795|NCT02951481|11014525|FG001|NOT COMPLETED|Overall Study||0
9898796|NCT02451943|11014533|FG000|STARTED|Overall Study||258
9898797|NCT02451943|11014534|FG001|STARTED|Overall Study||251
9898798|NCT02451943|11014533|FG000|Received at Least One Dose of Study Drug|Overall Study||257
9898799|NCT02451943|11014534|FG001|Received at Least One Dose of Study Drug|Overall Study||249
9898800|NCT02451943|11014533|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119
10009160|NCT01764256|11131678|FG003|NOT COMPLETED|Completed Study||1
10009161|NCT01764386|11131694|FG000|STARTED|Controlled Treatment Period (CTP)||153
10009162|NCT01764386|11131695|FG001|STARTED|Controlled Treatment Period (CTP)||89
9898801|NCT02451943|11014534|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115
9898802|NCT02451943|11014533|FG000|COMPLETED|Overall Study||238
9898803|NCT02451943|11014534|FG001|COMPLETED|Overall Study||227
9898804|NCT02451943|11014533|FG000|NOT COMPLETED|Overall Study||20
9898805|NCT02451943|11014534|FG001|NOT COMPLETED|Overall Study||24
9955000|NCT01435759|11073907|FG004|COMPLETED|Antidepressant Lead-in Phase||0
9955001|NCT01435759|11073908|FG005|COMPLETED|Antidepressant Lead-in Phase||0
9955002|NCT01435759|11073903|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342
9955003|NCT01435759|11073904|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
9955004|NCT01435759|11073905|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
9955005|NCT01435759|11073906|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0
9955006|NCT01435759|11073907|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0
9955007|NCT01435759|11073908|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0
9955008|NCT01435759|11073903|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
9955009|NCT01435759|11073904|FG001|STARTED|Double-blind Phase||78
9955010|NCT01435759|11073905|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78
9955011|NCT01435759|11073906|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78
9955012|NCT01435759|11073907|FG004|STARTED|Double-blind Phase||78
9955013|NCT01435759|11073908|FG005|STARTED|Double-blind Phase||80
9955014|NCT01435759|11073903|FG000|COMPLETED|Double-blind Phase||397
9955015|NCT01435759|11073904|FG001|COMPLETED|Double-blind Phase||71
9955016|NCT01435759|11073905|FG002|COMPLETED|Double-blind Phase||71
9955017|NCT01435759|11073906|FG003|COMPLETED|Double-blind Phase||69
9955018|NCT01435759|11073907|FG004|COMPLETED|Double-blind Phase||69
9955019|NCT01435759|11073908|FG005|COMPLETED|Double-blind Phase||71
9955020|NCT01435759|11073903|FG000|NOT COMPLETED|Double-blind Phase||66
9955021|NCT01435759|11073904|FG001|NOT COMPLETED|Double-blind Phase||7
9955022|NCT01435759|11073905|FG002|NOT COMPLETED|Double-blind Phase||7
9955023|NCT01435759|11073906|FG003|NOT COMPLETED|Double-blind Phase||9
10009163|NCT01764386|11131694|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
10009164|NCT01764386|11131695|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
10009165|NCT01764386|11131694|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82
10009166|NCT01764386|11131695|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7
10110314|NCT02484690|11241064|FG000|COMPLETED|Overall Study||64
10110315|NCT02484690|11241065|FG001|COMPLETED|Overall Study||40
10110316|NCT02484690|11241066|FG002|COMPLETED|Overall Study||36
10110317|NCT02484690|11241067|FG003|COMPLETED|Overall Study||44
10110318|NCT02484690|11241068|FG004|COMPLETED|Overall Study||58
10110319|NCT02484690|11241064|FG000|NOT COMPLETED|Overall Study||4
10110320|NCT02484690|11241065|FG001|NOT COMPLETED|Overall Study||6
10110321|NCT02484690|11241066|FG002|NOT COMPLETED|Overall Study||3
10110322|NCT02484690|11241067|FG003|NOT COMPLETED|Overall Study||2
10110323|NCT02484690|11241068|FG004|NOT COMPLETED|Overall Study||6
10110324|NCT02484729|11241091|FG000|STARTED|Overall Study||16
10110325|NCT02484729|11241092|FG001|STARTED|Overall Study||6
10009167|NCT01764386|11131694|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71
10009168|NCT01764386|11131695|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
10009169|NCT01764386|11131694|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
10110326|NCT02484729|11241093|FG002|STARTED|Overall Study||6
10110327|NCT02484729|11241094|FG003|STARTED|Overall Study||6
10110328|NCT02484729|11241095|FG004|STARTED|Overall Study||5
9955024|NCT01435759|11073907|FG004|NOT COMPLETED|Double-blind Phase||9
9955025|NCT01435759|11073908|FG005|NOT COMPLETED|Double-blind Phase||9
10110329|NCT02484729|11241096|FG005|STARTED|Overall Study||6
9898818|NCT02198794|11014555|FG000|STARTED|Part A: Open-Label (158 Weeks)||337
9898819|NCT02198794|11014556|FG001|STARTED|Part A: Open-Label (158 Weeks)||0
9898820|NCT02198794|11014557|FG002|STARTED|Part A: Open-Label (158 Weeks)||0
9898821|NCT02198794|11014558|FG003|STARTED|Part A: Open-Label (158 Weeks)||0
9898822|NCT02198794|11014555|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
9898823|NCT02198794|11014556|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
9898824|NCT02198794|11014557|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
9898825|NCT02198794|11014558|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
9898826|NCT02198794|11014555|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
9898827|NCT02198794|11014556|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
9898828|NCT02198794|11014557|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
9898829|NCT02198794|11014558|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
9898830|NCT02198794|11014555|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
9898831|NCT02198794|11014556|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
9898832|NCT02198794|11014557|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
9898833|NCT02198794|11014558|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
9898834|NCT02198794|11014555|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
9898835|NCT02198794|11014556|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
9898836|NCT02198794|11014557|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
9898837|NCT02198794|11014558|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
9898838|NCT02198794|11014555|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32
9898839|NCT02198794|11014556|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0
9898840|NCT02198794|11014557|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0
9898841|NCT02198794|11014558|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0
9898842|NCT02198794|11014555|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
9898843|NCT02198794|11014556|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
9898844|NCT02198794|11014557|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
9898845|NCT02198794|11014558|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
9898846|NCT02198794|11014555|FG000|STARTED|Part B: Randomized (13 Weeks)||0
9898847|NCT02198794|11014556|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
9898848|NCT02198794|11014557|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
9898849|NCT02198794|11014558|FG003|STARTED|Part B: Randomized (13 Weeks)||0
9898850|NCT02198794|11014555|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
9898851|NCT02198794|11014556|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
9898852|NCT02198794|11014557|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
9898853|NCT02198794|11014558|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
9898854|NCT02198794|11014555|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0
9898855|NCT02198794|11014556|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66
9898856|NCT02198794|11014557|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68
9898857|NCT02198794|11014558|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0
9898858|NCT02198794|11014555|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
9898859|NCT02198794|11014556|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
9898860|NCT02198794|11014557|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
9898861|NCT02198794|11014558|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
9898862|NCT02198794|11014555|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0
9898863|NCT02198794|11014556|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0
9898864|NCT02198794|11014557|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0
9898865|NCT02198794|11014558|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80
9898866|NCT02198794|11014555|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
9898867|NCT02198794|11014556|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
9898868|NCT02198794|11014557|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
9898869|NCT02198794|11014558|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73
9898870|NCT02198794|11014555|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
9898871|NCT02198794|11014556|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
9898872|NCT02198794|11014557|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
9898873|NCT02198794|11014558|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7
9898874|NCT01877655|11014569|FG000|STARTED|Overall Study||263
9898875|NCT01877655|11014570|FG001|STARTED|Overall Study||251
9898876|NCT01877655|11014569|FG000|Received Treatment|Overall Study||255
9898877|NCT01877655|11014570|FG001|Received Treatment|Overall Study||246
9898878|NCT01877655|11014569|FG000|COMPLETED|Overall Study||165
9898879|NCT01877655|11014570|FG001|COMPLETED|Overall Study||154
9898880|NCT01877655|11014569|FG000|NOT COMPLETED|Overall Study||98
9898881|NCT01877655|11014570|FG001|NOT COMPLETED|Overall Study||97
9898882|NCT00308685|11014578|FG000|STARTED|Overall Study||50
9898883|NCT00308685|11014579|FG001|STARTED|Overall Study||45
9898884|NCT00308685|11014578|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
9898885|NCT00308685|11014579|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
9898886|NCT00308685|11014578|FG000|COMPLETED|Overall Study||47
9898887|NCT00308685|11014579|FG001|COMPLETED|Overall Study||40
9898888|NCT00308685|11014578|FG000|NOT COMPLETED|Overall Study||3
9898889|NCT00308685|11014579|FG001|NOT COMPLETED|Overall Study||5
9898890|NCT01125514|11014585|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
9898891|NCT01125514|11014585|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
9898892|NCT01125514|11014585|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
9898893|NCT01125514|11014585|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
9898894|NCT01125514|11014585|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
9898895|NCT01125514|11014585|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
9898896|NCT01125514|11014585|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
9898897|NCT01125514|11014585|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
9898898|NCT01125514|11014585|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
9898899|NCT01125514|11014585|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
9898900|NCT01125514|11014585|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
9898901|NCT01125566|11014601|FG000|STARTED|Patients Before the Switch (26Apr2013)||339
9898902|NCT01125566|11014602|FG001|STARTED|Patients Before the Switch (26Apr2013)||169
9898903|NCT01125566|11014603|FG002|STARTED|Patients Before the Switch (26Apr2013)||0
9898904|NCT01125566|11014601|FG000|Treated|Patients Before the Switch (26Apr2013)||337
9898905|NCT01125566|11014602|FG001|Treated|Patients Before the Switch (26Apr2013)||169
9898906|NCT01125566|11014603|FG002|Treated|Patients Before the Switch (26Apr2013)||0
9898907|NCT01125566|11014601|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74
9898908|NCT01125566|11014602|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0
9898909|NCT01125566|11014603|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0
9898910|NCT01125566|11014601|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
9898911|NCT01125566|11014602|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
9898912|NCT01125566|11014603|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
9898913|NCT01125566|11014601|FG000|STARTED|Patients Who Switched From AV to TV||0
9898914|NCT01125566|11014602|FG001|STARTED|Patients Who Switched From AV to TV||0
9898915|NCT01125566|11014603|FG002|STARTED|Patients Who Switched From AV to TV||75
9898916|NCT01125566|11014601|FG000|COMPLETED|Patients Who Switched From AV to TV||0
9898917|NCT01125566|11014602|FG001|COMPLETED|Patients Who Switched From AV to TV||0
9898918|NCT01125566|11014603|FG002|COMPLETED|Patients Who Switched From AV to TV||2
9898919|NCT01125566|11014601|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0
9898920|NCT01125566|11014602|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0
10009170|NCT01764386|11131695|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
10009171|NCT01764386|11131694|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
10009172|NCT01764386|11131695|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
10009173|NCT01764386|11131694|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
10009174|NCT01764386|11131695|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
10009175|NCT01764464|11131704|FG000|STARTED|First Intervention|Started Gralise|16
10009176|NCT01764464|11131705|FG001|STARTED|First Intervention|Started Placebo|16
10009177|NCT01764464|11131704|FG000|COMPLETED|First Intervention|Completed Gralise|14
9898921|NCT01125566|11014603|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73
9898922|NCT01125605|11014610|FG000|STARTED|Overall Study|started = had baseline values|325
9898923|NCT01125605|11014610|FG000|Safety|Overall Study|1 patient was only analysed for safety|326
9898924|NCT01125605|11014610|FG000|COMPLETED|Overall Study||325
9898925|NCT01125605|11014610|FG000|NOT COMPLETED|Overall Study||0
9898926|NCT01125722|11014629|FG000|STARTED|Overall Study||37
9898927|NCT01125722|11014630|FG001|STARTED|Overall Study||37
10009178|NCT01764464|11131705|FG001|COMPLETED|First Intervention|Completed Placebo|13
10009179|NCT01764464|11131704|FG000|NOT COMPLETED|First Intervention||2
10009180|NCT01764464|11131705|FG001|NOT COMPLETED|First Intervention||3
10009181|NCT01764464|11131704|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14
10009182|NCT01764464|11131705|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13
10009183|NCT01764464|11131704|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
9898928|NCT01125722|11014629|FG000|COMPLETED|Overall Study||34
9898929|NCT01125722|11014630|FG001|COMPLETED|Overall Study||36
9898930|NCT01125722|11014629|FG000|NOT COMPLETED|Overall Study||3
9898931|NCT01125722|11014630|FG001|NOT COMPLETED|Overall Study||1
9898932|NCT01125748|11014638|FG000|STARTED|Overall Study||88
9898933|NCT01125748|11014639|FG001|STARTED|Overall Study||88
9898934|NCT01125748|11014638|FG000|COMPLETED|Overall Study||78
9898935|NCT01125748|11014639|FG001|COMPLETED|Overall Study||74
9898936|NCT01125748|11014638|FG000|NOT COMPLETED|Overall Study||10
9898937|NCT01125748|11014639|FG001|NOT COMPLETED|Overall Study||14
9898938|NCT01125774|11014647|FG000|STARTED|Overall Study|Randomized|3018
9898939|NCT01125774|11014648|FG001|STARTED|Overall Study|Randomized|1502
9898940|NCT01125774|11014649|FG002|STARTED|Overall Study|Unique participants randomized|22
9898941|NCT01125774|11014650|FG003|STARTED|Overall Study|Unique participants randomized|6
9898942|NCT01125774|11014647|FG000|Treated|Overall Study||2638
9898943|NCT01125774|11014648|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
9898944|NCT01125774|11014649|FG002|Treated|Overall Study|Received telcagepant|21
9898945|NCT01125774|11014650|FG003|Treated|Overall Study||5
9898946|NCT01125774|11014647|FG000|COMPLETED|Overall Study||1893
9898947|NCT01125774|11014648|FG001|COMPLETED|Overall Study||948
9898948|NCT01125774|11014649|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
9898949|NCT01125774|11014650|FG003|COMPLETED|Overall Study|Completed study at least once|3
9898950|NCT01125774|11014647|FG000|NOT COMPLETED|Overall Study||1125
9898951|NCT01125774|11014648|FG001|NOT COMPLETED|Overall Study||554
9898952|NCT01125774|11014649|FG002|NOT COMPLETED|Overall Study||9
9898953|NCT01125774|11014650|FG003|NOT COMPLETED|Overall Study||3
9898954|NCT01125800|11014661|FG000|STARTED|Phase I||11
9898955|NCT01125800|11014662|FG001|STARTED|Phase I||16
9898956|NCT01125800|11014663|FG002|STARTED|Phase I||11
9898957|NCT01125800|11014664|FG003|STARTED|Phase I||21
9898958|NCT01125800|11014665|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
9898959|NCT01125800|11014661|FG000|COMPLETED|Phase I||3
9898960|NCT01125800|11014662|FG001|COMPLETED|Phase I||7
9898961|NCT01125800|11014663|FG002|COMPLETED|Phase I||7
9898962|NCT01125800|11014664|FG003|COMPLETED|Phase I||10
9898963|NCT01125800|11014665|FG004|COMPLETED|Phase I||0
9898964|NCT01125800|11014661|FG000|NOT COMPLETED|Phase I||8
9898965|NCT01125800|11014662|FG001|NOT COMPLETED|Phase I||9
9898966|NCT01125800|11014663|FG002|NOT COMPLETED|Phase I||4
9898967|NCT01125800|11014664|FG003|NOT COMPLETED|Phase I||11
9898968|NCT01125800|11014665|FG004|NOT COMPLETED|Phase I||0
9898969|NCT01125800|11014661|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
9898970|NCT01125800|11014662|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
9898971|NCT01125800|11014663|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
9898972|NCT01125800|11014664|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
9898973|NCT01125800|11014665|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
9898974|NCT01125800|11014661|FG000|COMPLETED|Phase II||0
9898975|NCT01125800|11014662|FG001|COMPLETED|Phase II||0
9898976|NCT01125800|11014663|FG002|COMPLETED|Phase II||0
9898977|NCT01125800|11014664|FG003|COMPLETED|Phase II||0
9898978|NCT01125800|11014665|FG004|COMPLETED|Phase II||5
9898979|NCT01125800|11014661|FG000|NOT COMPLETED|Phase II||0
9898980|NCT01125800|11014662|FG001|NOT COMPLETED|Phase II||0
9898981|NCT01125800|11014663|FG002|NOT COMPLETED|Phase II||0
9898982|NCT01125800|11014664|FG003|NOT COMPLETED|Phase II||1
9898983|NCT01125800|11014665|FG004|NOT COMPLETED|Phase II||11
9898984|NCT01125813|11014680|FG000|STARTED|Overall Study||36
9898985|NCT01125813|11014680|FG000|COMPLETED|Overall Study||30
9898986|NCT01125813|11014680|FG000|NOT COMPLETED|Overall Study||6
9898987|NCT01125917|11014684|FG000|STARTED|Overall Study||354
9898988|NCT01125917|11014684|FG000|COMPLETED|Overall Study||15
9898989|NCT01125917|11014684|FG000|NOT COMPLETED|Overall Study||339
9898990|NCT01125930|11014690|FG000|STARTED|Overall Study||22
9898991|NCT01125930|11014691|FG001|STARTED|Overall Study||46
9898992|NCT01125930|11014690|FG000|COMPLETED|Overall Study||21
9898993|NCT01125930|11014691|FG001|COMPLETED|Overall Study||36
9898994|NCT01125930|11014690|FG000|NOT COMPLETED|Overall Study||1
9898995|NCT01125930|11014691|FG001|NOT COMPLETED|Overall Study||10
9898996|NCT01126060|11014715|FG000|STARTED|Overall Study||40
9898997|NCT01126060|11014716|FG001|STARTED|Overall Study||40
9898998|NCT01126060|11014715|FG000|COMPLETED|Overall Study||40
9898999|NCT01126060|11014716|FG001|COMPLETED|Overall Study||38
9899000|NCT01126060|11014715|FG000|NOT COMPLETED|Overall Study||0
9899001|NCT01126060|11014716|FG001|NOT COMPLETED|Overall Study||2
9899002|NCT01126099|11014724|FG000|STARTED|Double Blind Phase||11
9899003|NCT01126099|11014725|FG001|STARTED|Double Blind Phase||9
9899004|NCT01126099|11014724|FG000|COMPLETED|Double Blind Phase||7
9899005|NCT01126099|11014725|FG001|COMPLETED|Double Blind Phase||7
9899006|NCT01126099|11014724|FG000|NOT COMPLETED|Double Blind Phase||4
9899007|NCT01126099|11014725|FG001|NOT COMPLETED|Double Blind Phase||2
9899008|NCT01126099|11014724|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
9899009|NCT01126099|11014725|FG001|STARTED|Open-label Extension||7
9899010|NCT01126099|11014724|FG000|COMPLETED|Open-label Extension||4
9899011|NCT01126099|11014725|FG001|COMPLETED|Open-label Extension||6
9899012|NCT01126099|11014724|FG000|NOT COMPLETED|Open-label Extension||1
9899013|NCT01126099|11014725|FG001|NOT COMPLETED|Open-label Extension||1
9899014|NCT01126268|11014731|FG000|STARTED|Overall Study||38
9899015|NCT01126268|11014731|FG000|COMPLETED|Overall Study||37
9899016|NCT01126268|11014731|FG000|NOT COMPLETED|Overall Study||1
9899017|NCT01126359|11014735|FG000|STARTED|First Intervention (20-minutes)||5
9899018|NCT01126359|11014736|FG001|STARTED|First Intervention (20-minutes)||6
9899019|NCT01126359|11014735|FG000|COMPLETED|First Intervention (20-minutes)||5
9899020|NCT01126359|11014736|FG001|COMPLETED|First Intervention (20-minutes)||5
9899021|NCT01126359|11014735|FG000|NOT COMPLETED|First Intervention (20-minutes)||0
9899022|NCT01126359|11014736|FG001|NOT COMPLETED|First Intervention (20-minutes)||1
9899023|NCT01126359|11014735|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5
9899024|NCT01126359|11014736|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5
9899025|NCT01126359|11014735|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5
9899026|NCT01126359|11014736|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5
9899027|NCT01126359|11014735|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
9899028|NCT01126359|11014736|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
9899029|NCT01126359|11014735|FG000|STARTED|Second Intervention (20-minutes)||5
9899030|NCT01126359|11014736|FG001|STARTED|Second Intervention (20-minutes)||5
9899031|NCT01126359|11014735|FG000|COMPLETED|Second Intervention (20-minutes)||5
9899032|NCT01126359|11014736|FG001|COMPLETED|Second Intervention (20-minutes)||5
9899033|NCT01126359|11014735|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0
9899034|NCT01126359|11014736|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0
9899035|NCT01126424|11014752|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
9899036|NCT01126424|11014753|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
9899037|NCT01126424|11014754|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
9899038|NCT01126424|11014755|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
9899039|NCT01126424|11014756|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
9899040|NCT01126424|11014757|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
9899041|NCT01126424|11014752|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
9760435|NCT00380861|10864069|FG000|NOT COMPLETED|Overall Study||18
9760436|NCT00380861|10864070|FG001|NOT COMPLETED|Overall Study||17
9760437|NCT00380874|10864078|FG000|STARTED|Overall Study||32
9899042|NCT01126424|11014753|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
9899043|NCT01126424|11014754|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
9899044|NCT01126424|11014755|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
9899045|NCT01126424|11014756|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
9899046|NCT01126424|11014757|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
9899047|NCT01126424|11014752|FG000|COMPLETED|Overall Study||3
10009184|NCT01764464|11131705|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
10009185|NCT01764464|11131704|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2
10009186|NCT01764464|11131705|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0
10009187|NCT01764607|11131711|FG000|STARTED|Overall Study||1
10009188|NCT01764607|11131711|FG000|COMPLETED|Overall Study||1
10009189|NCT01764607|11131711|FG000|NOT COMPLETED|Overall Study||0
10009190|NCT01764633|11131717|FG000|STARTED|Overall Study||13780
10009191|NCT01764633|11131718|FG001|STARTED|Overall Study||13784
10009192|NCT01764633|11131717|FG000|Received Treatment|Overall Study||13756
9899048|NCT01126424|11014753|FG001|COMPLETED|Overall Study||4
9899049|NCT01126424|11014754|FG002|COMPLETED|Overall Study||4
9899050|NCT01126424|11014755|FG003|COMPLETED|Overall Study||3
9899051|NCT01126424|11014756|FG004|COMPLETED|Overall Study||2
9899052|NCT01126424|11014757|FG005|COMPLETED|Overall Study||4
9899053|NCT01126424|11014752|FG000|NOT COMPLETED|Overall Study||0
9899054|NCT01126424|11014753|FG001|NOT COMPLETED|Overall Study||0
9899055|NCT01126424|11014754|FG002|NOT COMPLETED|Overall Study||1
9899056|NCT01126424|11014755|FG003|NOT COMPLETED|Overall Study||3
9899057|NCT01126424|11014756|FG004|NOT COMPLETED|Overall Study||2
9899058|NCT01126424|11014757|FG005|NOT COMPLETED|Overall Study||0
9899059|NCT01126437|11014768|FG000|STARTED|Overall Study||5741
9899060|NCT01126437|11014769|FG001|STARTED|Overall Study||5729
9899061|NCT01126437|11014770|FG002|STARTED|Overall Study||5713
9899062|NCT01126437|11014768|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
9899063|NCT01126437|11014769|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
9899064|NCT01126437|11014770|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
9899065|NCT01126437|11014768|FG000|NOT COMPLETED|Overall Study||1341
9899066|NCT01126437|11014769|FG001|NOT COMPLETED|Overall Study||1330
9899067|NCT01126437|11014770|FG002|NOT COMPLETED|Overall Study||1313
9899068|NCT01126541|11014781|FG000|STARTED|Overall Study||70
9899069|NCT01126541|11014782|FG001|STARTED|Overall Study||73
9899070|NCT01126541|11014783|FG002|STARTED|Overall Study||81
9899071|NCT01126541|11014781|FG000|COMPLETED|Overall Study||60
9899072|NCT01126541|11014782|FG001|COMPLETED|Overall Study||61
9899073|NCT01126541|11014783|FG002|COMPLETED|Overall Study||55
9899074|NCT01126541|11014781|FG000|NOT COMPLETED|Overall Study||10
9899075|NCT01126541|11014782|FG001|NOT COMPLETED|Overall Study||12
9899076|NCT01126541|11014783|FG002|NOT COMPLETED|Overall Study||26
9899077|NCT01126580|11014796|FG000|STARTED|Overall Study||269
9899078|NCT01126580|11014797|FG001|STARTED|Overall Study||270
9899079|NCT01126580|11014798|FG002|STARTED|Overall Study||268
10009193|NCT01764633|11131718|FG001|Received Treatment|Overall Study||13769
10009194|NCT01764633|11131717|FG000|COMPLETED|Overall Study||13662
10009195|NCT01764633|11131718|FG001|COMPLETED|Overall Study||13691
10009196|NCT01764633|11131717|FG000|NOT COMPLETED|Overall Study||118
10009197|NCT01764633|11131718|FG001|NOT COMPLETED|Overall Study||93
10009198|NCT01764659|11131724|FG000|STARTED|Overall Study||14
10009199|NCT01764659|11131724|FG000|COMPLETED|Overall Study||12
10009200|NCT01764659|11131724|FG000|NOT COMPLETED|Overall Study||2
10009201|NCT01764685|11131732|FG000|STARTED|Overall Study||0
9899080|NCT01126580|11014796|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269
9899081|NCT01126580|11014797|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270
9899082|NCT01126580|11014798|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268
9899083|NCT01126580|11014796|FG000|Completed 26 Weeks|Overall Study||233
9899084|NCT01126580|11014797|FG001|Completed 26 Weeks|Overall Study||242
9899085|NCT01126580|11014798|FG002|Completed 26 Weeks|Overall Study||226
9899086|NCT01126580|11014796|FG000|COMPLETED|Overall Study||220
9899087|NCT01126580|11014797|FG001|COMPLETED|Overall Study||218
9899088|NCT01126580|11014798|FG002|COMPLETED|Overall Study||213
9899089|NCT01126580|11014796|FG000|NOT COMPLETED|Overall Study||49
9899090|NCT01126580|11014797|FG001|NOT COMPLETED|Overall Study||52
9899091|NCT01126580|11014798|FG002|NOT COMPLETED|Overall Study||55
9899092|NCT01126593|11014810|FG000|STARTED|Overall Study||33
9899093|NCT01126593|11014811|FG001|STARTED|Overall Study||29
9899094|NCT01126593|11014812|FG002|STARTED|Overall Study||34
9899095|NCT01126593|11014810|FG000|COMPLETED|Overall Study||29
9899096|NCT01126593|11014811|FG001|COMPLETED|Overall Study||27
9899097|NCT01126593|11014812|FG002|COMPLETED|Overall Study||32
9899098|NCT01126593|11014810|FG000|NOT COMPLETED|Overall Study||4
9899099|NCT01126593|11014811|FG001|NOT COMPLETED|Overall Study||2
9899100|NCT01126593|11014812|FG002|NOT COMPLETED|Overall Study||2
9899101|NCT01126619|11014820|FG000|STARTED|Overall Study||103
9899102|NCT01126619|11014820|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
9899103|NCT01126619|11014820|FG000|NOT COMPLETED|Overall Study||17
9899104|NCT01126671|11014828|FG000|STARTED|Overall Study||26
9899105|NCT01126671|11014829|FG001|STARTED|Overall Study||30
9899106|NCT01126671|11014828|FG000|COMPLETED|Overall Study||24
9899107|NCT01126671|11014829|FG001|COMPLETED|Overall Study||29
9899108|NCT01126671|11014828|FG000|NOT COMPLETED|Overall Study||2
9899109|NCT01126671|11014829|FG001|NOT COMPLETED|Overall Study||1
9899110|NCT01126723|11014839|FG000|STARTED|Overall Study||35
9899111|NCT01126723|11014840|FG001|STARTED|Overall Study||31
9899112|NCT01126723|11014839|FG000|COMPLETED|Overall Study||29
9899113|NCT01126723|11014840|FG001|COMPLETED|Overall Study||28
9899114|NCT01126723|11014839|FG000|NOT COMPLETED|Overall Study||6
9899115|NCT01126723|11014840|FG001|NOT COMPLETED|Overall Study||3
9899116|NCT01127061|11014848|FG000|STARTED|Overall Study||67
9899117|NCT01127061|11014849|FG001|STARTED|Overall Study||69
9899118|NCT01127061|11014848|FG000|COMPLETED|Overall Study||57
9899119|NCT01127061|11014849|FG001|COMPLETED|Overall Study||56
9899120|NCT01127061|11014848|FG000|NOT COMPLETED|Overall Study||10
9899121|NCT01127061|11014849|FG001|NOT COMPLETED|Overall Study||13
9899122|NCT01127087|11014857|FG000|STARTED|Overall Study||8
9899123|NCT01127087|11014858|FG001|STARTED|Overall Study||2
9899124|NCT01127087|11014857|FG000|COMPLETED|Overall Study||8
9899125|NCT01127087|11014858|FG001|COMPLETED|Overall Study||2
9899126|NCT01127087|11014857|FG000|NOT COMPLETED|Overall Study||0
9899127|NCT01127087|11014858|FG001|NOT COMPLETED|Overall Study||0
9899128|NCT01127139|11014866|FG000|STARTED|Overall Study||3828
9899129|NCT01127139|11014866|FG000|Number of Participants Analyzed|Overall Study||3828
9899130|NCT01127139|11014866|FG000|COMPLETED|Overall Study||3771
9899131|NCT01127139|11014866|FG000|NOT COMPLETED|Overall Study||57
9899132|NCT01127165|11014875|FG000|STARTED|Overall Study||65
9899133|NCT01127165|11014876|FG001|STARTED|Overall Study||60
9899134|NCT01127165|11014875|FG000|COMPLETED|Overall Study||49
9899135|NCT01127165|11014876|FG001|COMPLETED|Overall Study||41
9899136|NCT01127165|11014875|FG000|NOT COMPLETED|Overall Study||16
9899137|NCT01127165|11014876|FG001|NOT COMPLETED|Overall Study||19
9899138|NCT01127321|11014887|FG000|STARTED|Overall Study||3
9899139|NCT01127321|11014888|FG001|STARTED|Overall Study||1
9899140|NCT01127321|11014889|FG002|STARTED|Overall Study||1
9899141|NCT01127321|11014890|FG003|STARTED|Overall Study||7
9899142|NCT01127321|11014891|FG004|STARTED|Overall Study||5
9899143|NCT01127321|11014887|FG000|COMPLETED|Overall Study||3
9899144|NCT01127321|11014888|FG001|COMPLETED|Overall Study||1
9899145|NCT01127321|11014889|FG002|COMPLETED|Overall Study||1
9899146|NCT01127321|11014890|FG003|COMPLETED|Overall Study||7
9899147|NCT01127321|11014891|FG004|COMPLETED|Overall Study||5
9899148|NCT01127321|11014887|FG000|NOT COMPLETED|Overall Study||0
9899149|NCT01127321|11014888|FG001|NOT COMPLETED|Overall Study||0
9899150|NCT01127321|11014889|FG002|NOT COMPLETED|Overall Study||0
9899151|NCT01127321|11014890|FG003|NOT COMPLETED|Overall Study||0
9899152|NCT01127321|11014891|FG004|NOT COMPLETED|Overall Study||0
9899153|NCT01127373|11014903|FG000|STARTED|Overall Study||116
9899154|NCT01127373|11014903|FG000|COMPLETED|Overall Study||104
9899155|NCT01127373|11014903|FG000|NOT COMPLETED|Overall Study||12
9899156|NCT01127438|11014913|FG000|STARTED|Overall Study||25
9899157|NCT01127438|11014914|FG001|STARTED|Overall Study||25
9899158|NCT01127438|11014915|FG002|STARTED|Overall Study||26
9899159|NCT01127438|11014916|FG003|STARTED|Overall Study||24
9899160|NCT01127438|11014917|FG004|STARTED|Overall Study||28
9899161|NCT01127438|11014918|FG005|STARTED|Overall Study||25
9899162|NCT01127438|11014913|FG000|COMPLETED|Overall Study||25
9899163|NCT01127438|11014914|FG001|COMPLETED|Overall Study||25
9899164|NCT01127438|11014915|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
9899165|NCT01127438|11014916|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
9899166|NCT01127438|11014917|FG004|COMPLETED|Overall Study||28
9899167|NCT01127438|11014918|FG005|COMPLETED|Overall Study||25
9899168|NCT01127438|11014913|FG000|NOT COMPLETED|Overall Study||0
9899169|NCT01127438|11014914|FG001|NOT COMPLETED|Overall Study||0
9899170|NCT01127438|11014915|FG002|NOT COMPLETED|Overall Study||0
9899171|NCT01127438|11014916|FG003|NOT COMPLETED|Overall Study||0
9899172|NCT01127438|11014917|FG004|NOT COMPLETED|Overall Study||0
9899173|NCT01127438|11014918|FG005|NOT COMPLETED|Overall Study||0
9899174|NCT01127581|11014930|FG000|STARTED|Overall Study||678
9899175|NCT01127581|11014931|FG001|STARTED|Overall Study||680
9899176|NCT01127581|11014930|FG000|COMPLETED|Overall Study||678
9899177|NCT01127581|11014931|FG001|COMPLETED|Overall Study||680
9899178|NCT01127581|11014930|FG000|NOT COMPLETED|Overall Study||0
9899179|NCT01127581|11014931|FG001|NOT COMPLETED|Overall Study||0
9899180|NCT01127607|11014939|FG000|STARTED|Phase I (Within Subjects)||14
9899181|NCT01127607|11014940|FG001|STARTED|Phase I (Within Subjects)||13
9899182|NCT01127607|11014939|FG000|COMPLETED|Phase I (Within Subjects)||14
9899183|NCT01127607|11014940|FG001|COMPLETED|Phase I (Within Subjects)||13
9899184|NCT01127607|11014939|FG000|NOT COMPLETED|Phase I (Within Subjects)||0
9899185|NCT01127607|11014940|FG001|NOT COMPLETED|Phase I (Within Subjects)||0
9899186|NCT01127607|11014939|FG000|STARTED|Phase II (Between Subjects)||14
9899187|NCT01127607|11014940|FG001|STARTED|Phase II (Between Subjects)||13
9899188|NCT01127607|11014939|FG000|COMPLETED|Phase II (Between Subjects)||13
9899189|NCT01127607|11014940|FG001|COMPLETED|Phase II (Between Subjects)||11
9899190|NCT01127607|11014939|FG000|NOT COMPLETED|Phase II (Between Subjects)||1
9899191|NCT01127607|11014940|FG001|NOT COMPLETED|Phase II (Between Subjects)||2
9899192|NCT01127633|11014965|FG000|STARTED|Overall Study||723
9899193|NCT01127633|11014966|FG001|STARTED|Overall Study||734
9899194|NCT01127633|11014965|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723
9899195|NCT01127633|11014966|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734
9899196|NCT01127633|11014965|FG000|COMPLETED|Overall Study||70
9899197|NCT01127633|11014966|FG001|COMPLETED|Overall Study||61
9899198|NCT01127633|11014965|FG000|NOT COMPLETED|Overall Study||653
9899199|NCT01127633|11014966|FG001|NOT COMPLETED|Overall Study||673
9899200|NCT01127646|11014974|FG000|STARTED|Overall Study||15
9899201|NCT01127646|11014975|FG001|STARTED|Overall Study||8
9899202|NCT01127646|11014974|FG000|COMPLETED|Overall Study||14
9899203|NCT01127646|11014975|FG001|COMPLETED|Overall Study||7
9899204|NCT01127646|11014974|FG000|NOT COMPLETED|Overall Study||1
9899205|NCT01127646|11014975|FG001|NOT COMPLETED|Overall Study||1
9899206|NCT01127659|11014989|FG000|STARTED|Overall Study||22
9899207|NCT01127659|11014990|FG001|STARTED|Overall Study||22
9899208|NCT01127659|11014991|FG002|STARTED|Overall Study||12
9899209|NCT01127659|11014992|FG003|STARTED|Overall Study||10
9899210|NCT01127659|11014993|FG004|STARTED|Overall Study||50
9899211|NCT01127659|11014994|FG005|STARTED|Overall Study||21
9899212|NCT01127659|11014989|FG000|COMPLETED|Overall Study||20
9899213|NCT01127659|11014990|FG001|COMPLETED|Overall Study||14
9899214|NCT01127659|11014991|FG002|COMPLETED|Overall Study||10
9899215|NCT01127659|11014992|FG003|COMPLETED|Overall Study||6
9899216|NCT01127659|11014993|FG004|COMPLETED|Overall Study||50
9899217|NCT01127659|11014994|FG005|COMPLETED|Overall Study||21
9899218|NCT01127659|11014989|FG000|NOT COMPLETED|Overall Study||2
9899219|NCT01127659|11014990|FG001|NOT COMPLETED|Overall Study||8
9899220|NCT01127659|11014991|FG002|NOT COMPLETED|Overall Study||2
9899221|NCT01127659|11014992|FG003|NOT COMPLETED|Overall Study||4
9899222|NCT01127659|11014993|FG004|NOT COMPLETED|Overall Study||0
9899223|NCT01127659|11014994|FG005|NOT COMPLETED|Overall Study||0
9899224|NCT01127737|11015010|FG000|STARTED|Overall Study||37
9899225|NCT01127737|11015011|FG001|STARTED|Overall Study||38
9899226|NCT01127737|11015010|FG000|COMPLETED|Overall Study||37
9899227|NCT01127737|11015011|FG001|COMPLETED|Overall Study||38
9899228|NCT01127737|11015010|FG000|NOT COMPLETED|Overall Study||0
9899229|NCT01127737|11015011|FG001|NOT COMPLETED|Overall Study||0
9899230|NCT01127763|11015017|FG000|STARTED|Overall Study||25
9899231|NCT01127763|11015017|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
9899232|NCT01127763|11015017|FG000|NOT COMPLETED|Overall Study||5
9899233|NCT01127893|11015025|FG000|STARTED|Overall Study||1
9899234|NCT01127893|11015025|FG000|COMPLETED|Overall Study||0
9899235|NCT01127893|11015025|FG000|NOT COMPLETED|Overall Study||1
9899236|NCT01128049|11015032|FG000|STARTED|Overall Study||5
9899237|NCT01128049|11015033|FG001|STARTED|Overall Study||5
9899238|NCT01128049|11015034|FG002|STARTED|Overall Study||5
9899239|NCT01128049|11015032|FG000|COMPLETED|Overall Study||5
9899240|NCT01128049|11015033|FG001|COMPLETED|Overall Study||5
9899241|NCT01128049|11015034|FG002|COMPLETED|Overall Study||5
9899242|NCT01128049|11015032|FG000|NOT COMPLETED|Overall Study||0
9899243|NCT01128049|11015033|FG001|NOT COMPLETED|Overall Study||0
9899244|NCT01128049|11015034|FG002|NOT COMPLETED|Overall Study||0
9899245|NCT01128153|11015044|FG000|STARTED|Overall Study|Randomised|129
9899246|NCT01128153|11015045|FG001|STARTED|Overall Study|Randomised|128
9899247|NCT01128153|11015044|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
9899248|NCT01128153|11015045|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
9899249|NCT01128153|11015044|FG000|COMPLETED|Overall Study|Completed 24 weeks|113
9899250|NCT01128153|11015045|FG001|COMPLETED|Overall Study|Completed 24 weeks|113
9899251|NCT01128153|11015044|FG000|NOT COMPLETED|Overall Study||16
9899252|NCT01128153|11015045|FG001|NOT COMPLETED|Overall Study||15
9899253|NCT01128179|11015053|FG000|STARTED|Overall Study||23
9899254|NCT01128179|11015054|FG001|STARTED|Overall Study||12
9899255|NCT01128179|11015053|FG000|COMPLETED|Overall Study||21
9899256|NCT01128179|11015054|FG001|COMPLETED|Overall Study||12
9899257|NCT01128179|11015053|FG000|NOT COMPLETED|Overall Study||2
9899258|NCT01128179|11015054|FG001|NOT COMPLETED|Overall Study||0
9899259|NCT01128192|11015062|FG000|STARTED|Overall Study||19
9899260|NCT01128192|11015063|FG001|STARTED|Overall Study||19
9899261|NCT01128192|11015064|FG002|STARTED|Overall Study||7
9899262|NCT01128192|11015062|FG000|COMPLETED|Overall Study||19
9899263|NCT01128192|11015063|FG001|COMPLETED|Overall Study||19
9899264|NCT01128192|11015064|FG002|COMPLETED|Overall Study||7
9899265|NCT01128192|11015062|FG000|NOT COMPLETED|Overall Study||0
9899266|NCT01128192|11015063|FG001|NOT COMPLETED|Overall Study||0
9899267|NCT01128192|11015064|FG002|NOT COMPLETED|Overall Study||0
9899268|NCT01128244|11015075|FG000|STARTED|Overall Study||13
9899269|NCT01128244|11015075|FG000|COMPLETED|Overall Study||10
9899270|NCT01128244|11015075|FG000|NOT COMPLETED|Overall Study||3
9899271|NCT01128270|11015083|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7
9899272|NCT01128270|11015083|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
9899273|NCT01128270|11015083|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
9899274|NCT01128270|11015083|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
9899275|NCT01128270|11015083|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8
9899276|NCT01128270|11015083|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
9899277|NCT01128270|11015083|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
9899278|NCT01128270|11015083|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
9899279|NCT01128270|11015083|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
9899280|NCT01128270|11015083|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8
9899281|NCT01128270|11015083|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
9899282|NCT01128270|11015083|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
9899283|NCT01128296|11015095|FG000|STARTED|Overall Study||1
9899284|NCT01128296|11015096|FG001|STARTED|Overall Study||1
9899285|NCT01128296|11015097|FG002|STARTED|Overall Study||1
9899286|NCT01128296|11015098|FG003|STARTED|Overall Study||1
9899287|NCT01128296|11015099|FG004|STARTED|Overall Study||1
9899288|NCT01128296|11015100|FG005|STARTED|Overall Study||26
9899289|NCT01128296|11015095|FG000|COMPLETED|Overall Study||1
9899290|NCT01128296|11015096|FG001|COMPLETED|Overall Study||1
9899291|NCT01128296|11015097|FG002|COMPLETED|Overall Study||1
9899292|NCT01128296|11015098|FG003|COMPLETED|Overall Study||1
9899293|NCT01128296|11015099|FG004|COMPLETED|Overall Study||1
9899294|NCT01128296|11015100|FG005|COMPLETED|Overall Study||21
9899295|NCT01128296|11015095|FG000|NOT COMPLETED|Overall Study||0
9899296|NCT01128296|11015096|FG001|NOT COMPLETED|Overall Study||0
9899297|NCT01128296|11015097|FG002|NOT COMPLETED|Overall Study||0
9899298|NCT01128296|11015098|FG003|NOT COMPLETED|Overall Study||0
9899299|NCT01128296|11015099|FG004|NOT COMPLETED|Overall Study||0
9899300|NCT01128296|11015100|FG005|NOT COMPLETED|Overall Study||5
9899301|NCT01128361|11015113|FG000|STARTED|Overall Study||39
9899302|NCT01128361|11015114|FG001|STARTED|Overall Study||37
9899303|NCT01128361|11015113|FG000|COMPLETED|Overall Study||34
9899304|NCT01128361|11015114|FG001|COMPLETED|Overall Study||34
9899305|NCT01128361|11015113|FG000|NOT COMPLETED|Overall Study||5
9899306|NCT01128361|11015114|FG001|NOT COMPLETED|Overall Study||3
9899307|NCT01128387|11015122|FG000|STARTED|Overall Study||5
9899308|NCT01128387|11015123|FG001|STARTED|Overall Study||6
9899309|NCT01128387|11015122|FG000|COMPLETED|Overall Study||5
9899310|NCT01128387|11015123|FG001|COMPLETED|Overall Study||5
9899311|NCT01128387|11015122|FG000|NOT COMPLETED|Overall Study||0
9899312|NCT01128387|11015123|FG001|NOT COMPLETED|Overall Study||1
9899313|NCT01128400|11015132|FG000|STARTED|Overall Study||8
9899314|NCT01128400|11015133|FG001|STARTED|Overall Study||9
9899315|NCT01128400|11015134|FG002|STARTED|Overall Study||23
9899316|NCT01128400|11015132|FG000|COMPLETED|Overall Study||6
9899317|NCT01128400|11015133|FG001|COMPLETED|Overall Study||8
9899318|NCT01128400|11015134|FG002|COMPLETED|Overall Study||7
9899319|NCT01128400|11015132|FG000|NOT COMPLETED|Overall Study||2
9899320|NCT01128400|11015133|FG001|NOT COMPLETED|Overall Study||1
9899321|NCT01128400|11015134|FG002|NOT COMPLETED|Overall Study||16
9899322|NCT01128413|11015144|FG000|STARTED|Overall Study||11
9899323|NCT01128413|11015145|FG001|STARTED|Overall Study||11
10009202|NCT01764685|11131733|FG001|STARTED|Overall Study||4
10009203|NCT01764685|11131732|FG000|COMPLETED|Overall Study||0
10009204|NCT01764685|11131733|FG001|COMPLETED|Overall Study||3
10009205|NCT01764685|11131732|FG000|NOT COMPLETED|Overall Study||0
9899324|NCT01128413|11015144|FG000|COMPLETED|Overall Study||7
9899325|NCT01128413|11015145|FG001|COMPLETED|Overall Study||10
9899326|NCT01128413|11015144|FG000|NOT COMPLETED|Overall Study||4
9899327|NCT01128413|11015145|FG001|NOT COMPLETED|Overall Study||1
9899328|NCT01128426|11015151|FG000|STARTED|Overall Study||53902
9899329|NCT01128426|11015151|FG000|COMPLETED|Overall Study||53902
9899330|NCT01128426|11015151|FG000|NOT COMPLETED|Overall Study||0
9899331|NCT01128543|11015157|FG000|STARTED|Overall Study||29
10009206|NCT01764685|11131733|FG001|NOT COMPLETED|Overall Study||1
9899332|NCT01128543|11015157|FG000|COMPLETED|Overall Study||25
9899333|NCT01128543|11015157|FG000|NOT COMPLETED|Overall Study||4
9899334|NCT01128569|11015161|FG000|STARTED|Treatment Period 1||9
9899335|NCT01128569|11015162|FG001|STARTED|Treatment Period 1||8
9899336|NCT01128569|11015163|FG002|STARTED|Treatment Period 1||9
9899337|NCT01128569|11015164|FG003|STARTED|Treatment Period 1||8
9899338|NCT01128569|11015165|FG004|STARTED|Treatment Period 1||9
10009207|NCT01764841|11131743|FG000|STARTED|Overall Study||141
9899339|NCT01128569|11015166|FG005|STARTED|Treatment Period 1||9
9899340|NCT01128569|11015161|FG000|COMPLETED|Treatment Period 1||9
9899341|NCT01128569|11015162|FG001|COMPLETED|Treatment Period 1||8
9899342|NCT01128569|11015163|FG002|COMPLETED|Treatment Period 1||9
9899343|NCT01128569|11015164|FG003|COMPLETED|Treatment Period 1||8
9899344|NCT01128569|11015165|FG004|COMPLETED|Treatment Period 1||9
9899345|NCT01128569|11015166|FG005|COMPLETED|Treatment Period 1||9
9899346|NCT01128569|11015161|FG000|NOT COMPLETED|Treatment Period 1||0
9899347|NCT01128569|11015162|FG001|NOT COMPLETED|Treatment Period 1||0
9899348|NCT01128569|11015163|FG002|NOT COMPLETED|Treatment Period 1||0
9899349|NCT01128569|11015164|FG003|NOT COMPLETED|Treatment Period 1||0
9899350|NCT01128569|11015165|FG004|NOT COMPLETED|Treatment Period 1||0
9899351|NCT01128569|11015166|FG005|NOT COMPLETED|Treatment Period 1||0
9899352|NCT01128569|11015161|FG000|STARTED|Washout Period 1||9
9899353|NCT01128569|11015162|FG001|STARTED|Washout Period 1||8
9899354|NCT01128569|11015163|FG002|STARTED|Washout Period 1||9
9899355|NCT01128569|11015164|FG003|STARTED|Washout Period 1||8
9899356|NCT01128569|11015165|FG004|STARTED|Washout Period 1||9
9899357|NCT01128569|11015166|FG005|STARTED|Washout Period 1||9
9899358|NCT01128569|11015161|FG000|COMPLETED|Washout Period 1||9
9899359|NCT01128569|11015162|FG001|COMPLETED|Washout Period 1||8
9899360|NCT01128569|11015163|FG002|COMPLETED|Washout Period 1||8
9899361|NCT01128569|11015164|FG003|COMPLETED|Washout Period 1||8
9899362|NCT01128569|11015165|FG004|COMPLETED|Washout Period 1||9
9899363|NCT01128569|11015166|FG005|COMPLETED|Washout Period 1||9
9899364|NCT01128569|11015161|FG000|NOT COMPLETED|Washout Period 1||0
9899365|NCT01128569|11015162|FG001|NOT COMPLETED|Washout Period 1||0
9899366|NCT01128569|11015163|FG002|NOT COMPLETED|Washout Period 1||1
9899367|NCT01128569|11015164|FG003|NOT COMPLETED|Washout Period 1||0
9899368|NCT01128569|11015165|FG004|NOT COMPLETED|Washout Period 1||0
9899369|NCT01128569|11015166|FG005|NOT COMPLETED|Washout Period 1||0
9899370|NCT01128569|11015161|FG000|STARTED|Treatment Period 2||9
9899371|NCT01128569|11015162|FG001|STARTED|Treatment Period 2||8
9899372|NCT01128569|11015163|FG002|STARTED|Treatment Period 2||8
9899373|NCT01128569|11015164|FG003|STARTED|Treatment Period 2||8
9899374|NCT01128569|11015165|FG004|STARTED|Treatment Period 2||9
9899375|NCT01128569|11015166|FG005|STARTED|Treatment Period 2||9
9899376|NCT01128569|11015161|FG000|COMPLETED|Treatment Period 2||9
9899377|NCT01128569|11015162|FG001|COMPLETED|Treatment Period 2||7
9899378|NCT01128569|11015163|FG002|COMPLETED|Treatment Period 2||8
9899379|NCT01128569|11015164|FG003|COMPLETED|Treatment Period 2||8
9899380|NCT01128569|11015165|FG004|COMPLETED|Treatment Period 2||9
9899381|NCT01128569|11015166|FG005|COMPLETED|Treatment Period 2||9
9899382|NCT01128569|11015161|FG000|NOT COMPLETED|Treatment Period 2||0
9899383|NCT01128569|11015162|FG001|NOT COMPLETED|Treatment Period 2||1
9899384|NCT01128569|11015163|FG002|NOT COMPLETED|Treatment Period 2||0
9899385|NCT01128569|11015164|FG003|NOT COMPLETED|Treatment Period 2||0
9899386|NCT01128569|11015165|FG004|NOT COMPLETED|Treatment Period 2||0
9899387|NCT01128569|11015166|FG005|NOT COMPLETED|Treatment Period 2||0
9899388|NCT01128569|11015161|FG000|STARTED|Washout Period 2||9
9899389|NCT01128569|11015162|FG001|STARTED|Washout Period 2||7
9899390|NCT01128569|11015163|FG002|STARTED|Washout Period 2||8
9899391|NCT01128569|11015164|FG003|STARTED|Washout Period 2||8
9899392|NCT01128569|11015165|FG004|STARTED|Washout Period 2||9
9899393|NCT01128569|11015166|FG005|STARTED|Washout Period 2||9
9899394|NCT01128569|11015161|FG000|COMPLETED|Washout Period 2||9
9899395|NCT01128569|11015162|FG001|COMPLETED|Washout Period 2||7
9899396|NCT01128569|11015163|FG002|COMPLETED|Washout Period 2||8
9899397|NCT01128569|11015164|FG003|COMPLETED|Washout Period 2||8
9899398|NCT01128569|11015165|FG004|COMPLETED|Washout Period 2||9
9899399|NCT01128569|11015166|FG005|COMPLETED|Washout Period 2||9
9899400|NCT01128569|11015161|FG000|NOT COMPLETED|Washout Period 2||0
9899401|NCT01128569|11015162|FG001|NOT COMPLETED|Washout Period 2||0
9899402|NCT01128569|11015163|FG002|NOT COMPLETED|Washout Period 2||0
9899403|NCT01128569|11015164|FG003|NOT COMPLETED|Washout Period 2||0
9899404|NCT01128569|11015165|FG004|NOT COMPLETED|Washout Period 2||0
9899405|NCT01128569|11015166|FG005|NOT COMPLETED|Washout Period 2||0
9899406|NCT01128569|11015161|FG000|STARTED|Treatment Period 3||9
9899407|NCT01128569|11015162|FG001|STARTED|Treatment Period 3||7
9899408|NCT01128569|11015163|FG002|STARTED|Treatment Period 3||8
9899409|NCT01128569|11015164|FG003|STARTED|Treatment Period 3||8
9899410|NCT01128569|11015165|FG004|STARTED|Treatment Period 3||9
9899411|NCT01128569|11015166|FG005|STARTED|Treatment Period 3||9
9899412|NCT01128569|11015161|FG000|COMPLETED|Treatment Period 3||9
9899413|NCT01128569|11015162|FG001|COMPLETED|Treatment Period 3||7
9899414|NCT01128569|11015163|FG002|COMPLETED|Treatment Period 3||8
9899415|NCT01128569|11015164|FG003|COMPLETED|Treatment Period 3||8
9899416|NCT01128569|11015165|FG004|COMPLETED|Treatment Period 3||9
9899417|NCT01128569|11015166|FG005|COMPLETED|Treatment Period 3||9
9899418|NCT01128569|11015161|FG000|NOT COMPLETED|Treatment Period 3||0
9899419|NCT01128569|11015162|FG001|NOT COMPLETED|Treatment Period 3||0
9899420|NCT01128569|11015163|FG002|NOT COMPLETED|Treatment Period 3||0
9899421|NCT01128569|11015164|FG003|NOT COMPLETED|Treatment Period 3||0
9899422|NCT01128569|11015165|FG004|NOT COMPLETED|Treatment Period 3||0
9899423|NCT01128569|11015166|FG005|NOT COMPLETED|Treatment Period 3||0
9899424|NCT01128595|11015174|FG000|STARTED|Treatment Period 1||7
9899425|NCT01128595|11015175|FG001|STARTED|Treatment Period 1||6
9899426|NCT01128595|11015176|FG002|STARTED|Treatment Period 1||7
9899427|NCT01128595|11015177|FG003|STARTED|Treatment Period 1||7
9899428|NCT01128595|11015174|FG000|COMPLETED|Treatment Period 1||7
9899429|NCT01128595|11015175|FG001|COMPLETED|Treatment Period 1||6
9899430|NCT01128595|11015176|FG002|COMPLETED|Treatment Period 1||7
9899431|NCT01128595|11015177|FG003|COMPLETED|Treatment Period 1||7
9899432|NCT01128595|11015174|FG000|NOT COMPLETED|Treatment Period 1||0
9899433|NCT01128595|11015175|FG001|NOT COMPLETED|Treatment Period 1||0
9899434|NCT01128595|11015176|FG002|NOT COMPLETED|Treatment Period 1||0
9899435|NCT01128595|11015177|FG003|NOT COMPLETED|Treatment Period 1||0
9899436|NCT01128595|11015174|FG000|STARTED|Washout Period 1||7
9899437|NCT01128595|11015175|FG001|STARTED|Washout Period 1||6
9899438|NCT01128595|11015176|FG002|STARTED|Washout Period 1||7
9899439|NCT01128595|11015177|FG003|STARTED|Washout Period 1||7
9899440|NCT01128595|11015174|FG000|COMPLETED|Washout Period 1||7
9899441|NCT01128595|11015175|FG001|COMPLETED|Washout Period 1||6
9899442|NCT01128595|11015176|FG002|COMPLETED|Washout Period 1||7
9899443|NCT01128595|11015177|FG003|COMPLETED|Washout Period 1||7
9899444|NCT01128595|11015174|FG000|NOT COMPLETED|Washout Period 1||0
9899445|NCT01128595|11015175|FG001|NOT COMPLETED|Washout Period 1||0
9899446|NCT01128595|11015176|FG002|NOT COMPLETED|Washout Period 1||0
9899447|NCT01128595|11015177|FG003|NOT COMPLETED|Washout Period 1||0
9899448|NCT01128595|11015174|FG000|STARTED|Treatment Period 2||7
9899449|NCT01128595|11015175|FG001|STARTED|Treatment Period 2||6
9899450|NCT01128595|11015176|FG002|STARTED|Treatment Period 2||7
9899451|NCT01128595|11015177|FG003|STARTED|Treatment Period 2||7
9899452|NCT01128595|11015174|FG000|COMPLETED|Treatment Period 2||7
9899453|NCT01128595|11015175|FG001|COMPLETED|Treatment Period 2||6
9899454|NCT01128595|11015176|FG002|COMPLETED|Treatment Period 2||7
9899455|NCT01128595|11015177|FG003|COMPLETED|Treatment Period 2||7
9899456|NCT01128595|11015174|FG000|NOT COMPLETED|Treatment Period 2||0
9899457|NCT01128595|11015175|FG001|NOT COMPLETED|Treatment Period 2||0
9899458|NCT01128595|11015176|FG002|NOT COMPLETED|Treatment Period 2||0
9899459|NCT01128595|11015177|FG003|NOT COMPLETED|Treatment Period 2||0
9899460|NCT01128595|11015174|FG000|STARTED|Washout Period 2||7
9899461|NCT01128595|11015175|FG001|STARTED|Washout Period 2||6
9899462|NCT01128595|11015176|FG002|STARTED|Washout Period 2||7
9899463|NCT01128595|11015177|FG003|STARTED|Washout Period 2||7
9899464|NCT01128595|11015174|FG000|COMPLETED|Washout Period 2||7
9899465|NCT01128595|11015175|FG001|COMPLETED|Washout Period 2||6
9899466|NCT01128595|11015176|FG002|COMPLETED|Washout Period 2||7
9899467|NCT01128595|11015177|FG003|COMPLETED|Washout Period 2||7
9899468|NCT01128595|11015174|FG000|NOT COMPLETED|Washout Period 2||0
9899469|NCT01128595|11015175|FG001|NOT COMPLETED|Washout Period 2||0
9899470|NCT01128595|11015176|FG002|NOT COMPLETED|Washout Period 2||0
9899471|NCT01128595|11015177|FG003|NOT COMPLETED|Washout Period 2||0
9899472|NCT01128595|11015174|FG000|STARTED|Treatment Period 3||7
9899473|NCT01128595|11015175|FG001|STARTED|Treatment Period 3||6
9899474|NCT01128595|11015176|FG002|STARTED|Treatment Period 3||7
9899475|NCT01128595|11015177|FG003|STARTED|Treatment Period 3||7
9899476|NCT01128595|11015174|FG000|COMPLETED|Treatment Period 3||7
9899477|NCT01128595|11015175|FG001|COMPLETED|Treatment Period 3||5
9899478|NCT01128595|11015176|FG002|COMPLETED|Treatment Period 3||7
9899479|NCT01128595|11015177|FG003|COMPLETED|Treatment Period 3||7
9899480|NCT01128595|11015174|FG000|NOT COMPLETED|Treatment Period 3||0
9899481|NCT01128595|11015175|FG001|NOT COMPLETED|Treatment Period 3||1
9899482|NCT01128595|11015176|FG002|NOT COMPLETED|Treatment Period 3||0
9899483|NCT01128595|11015177|FG003|NOT COMPLETED|Treatment Period 3||0
9899484|NCT01128595|11015174|FG000|STARTED|Washout Period 3||7
9899485|NCT01128595|11015175|FG001|STARTED|Washout Period 3||5
9899486|NCT01128595|11015176|FG002|STARTED|Washout Period 3||7
9899487|NCT01128595|11015177|FG003|STARTED|Washout Period 3||7
9899488|NCT01128595|11015174|FG000|COMPLETED|Washout Period 3||7
9899489|NCT01128595|11015175|FG001|COMPLETED|Washout Period 3||5
9899490|NCT01128595|11015176|FG002|COMPLETED|Washout Period 3||7
9899491|NCT01128595|11015177|FG003|COMPLETED|Washout Period 3||7
9899492|NCT01128595|11015174|FG000|NOT COMPLETED|Washout Period 3||0
9899493|NCT01128595|11015175|FG001|NOT COMPLETED|Washout Period 3||0
9899494|NCT01128595|11015176|FG002|NOT COMPLETED|Washout Period 3||0
9899495|NCT01128595|11015177|FG003|NOT COMPLETED|Washout Period 3||0
9899496|NCT01128595|11015174|FG000|STARTED|Treatment Period 4||7
9899497|NCT01128595|11015175|FG001|STARTED|Treatment Period 4||5
9899498|NCT01128595|11015176|FG002|STARTED|Treatment Period 4||7
9899499|NCT01128595|11015177|FG003|STARTED|Treatment Period 4||7
9899500|NCT01128595|11015174|FG000|COMPLETED|Treatment Period 4||7
9899501|NCT01128595|11015175|FG001|COMPLETED|Treatment Period 4||5
9899502|NCT01128595|11015176|FG002|COMPLETED|Treatment Period 4||7
9899503|NCT01128595|11015177|FG003|COMPLETED|Treatment Period 4||7
9899504|NCT01128595|11015174|FG000|NOT COMPLETED|Treatment Period 4||0
9899505|NCT01128595|11015175|FG001|NOT COMPLETED|Treatment Period 4||0
9899506|NCT01128595|11015176|FG002|NOT COMPLETED|Treatment Period 4||0
9899507|NCT01128595|11015177|FG003|NOT COMPLETED|Treatment Period 4||0
9899508|NCT01128621|11015190|FG000|STARTED|Part A: GSK1292263 300 mg||6
9899509|NCT01128621|11015191|FG001|STARTED|Part A: GSK1292263 300 mg||0
9899510|NCT01128621|11015190|FG000|COMPLETED|Part A: GSK1292263 300 mg||6
9899511|NCT01128621|11015191|FG001|COMPLETED|Part A: GSK1292263 300 mg||0
9899512|NCT01128621|11015190|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0
9899513|NCT01128621|11015191|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0
9899514|NCT01128621|11015190|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
9899515|NCT01128621|11015191|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
9899516|NCT01128621|11015190|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
9899517|NCT01128621|11015191|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
9899518|NCT01128621|11015190|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
9899519|NCT01128621|11015191|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
9899520|NCT01128738|11015215|FG000|STARTED|First Treatment Phase (TP)||78
9899521|NCT01128738|11015216|FG001|STARTED|First Treatment Phase (TP)||74
9899522|NCT01128738|11015215|FG000|COMPLETED|First Treatment Phase (TP)||74
9899523|NCT01128738|11015216|FG001|COMPLETED|First Treatment Phase (TP)||73
9899524|NCT01128738|11015215|FG000|NOT COMPLETED|First Treatment Phase (TP)||4
9899525|NCT01128738|11015216|FG001|NOT COMPLETED|First Treatment Phase (TP)||1
9899526|NCT01128738|11015215|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
9899527|NCT01128738|11015216|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
9899528|NCT01128738|11015215|FG000|COMPLETED|Second TP||34
9899529|NCT01128738|11015216|FG001|COMPLETED|Second TP||63
9899530|NCT01128738|11015215|FG000|NOT COMPLETED|Second TP||0
9899531|NCT01128738|11015216|FG001|NOT COMPLETED|Second TP||3
9899532|NCT01128829|11015223|FG000|STARTED|Overall Study||6
9899533|NCT01128829|11015224|FG001|STARTED|Overall Study||11
9899534|NCT01128829|11015223|FG000|COMPLETED|Overall Study||6
9899535|NCT01128829|11015224|FG001|COMPLETED|Overall Study||11
9899536|NCT01128829|11015223|FG000|NOT COMPLETED|Overall Study||0
9899537|NCT01128829|11015224|FG001|NOT COMPLETED|Overall Study||0
9899538|NCT01128842|11015228|FG000|STARTED|Overall Study||7
9899539|NCT01128842|11015228|FG000|COMPLETED|Overall Study||0
9899540|NCT01128842|11015228|FG000|NOT COMPLETED|Overall Study||7
9899541|NCT01128894|11015235|FG000|STARTED|Overall Study||404
10009208|NCT01764841|11131744|FG001|STARTED|Overall Study||137
10009209|NCT01764841|11131745|FG002|STARTED|Overall Study||70
10009210|NCT01764841|11131746|FG003|STARTED|Overall Study||68
10009211|NCT01764841|11131743|FG000|Participants Received Treatment|Overall Study|safety population|141
10009212|NCT01764841|11131744|FG001|Participants Received Treatment|Overall Study|safety population|136
10009213|NCT01764841|11131745|FG002|Participants Received Treatment|Overall Study|safety population|69
10009214|NCT01764841|11131746|FG003|Participants Received Treatment|Overall Study|safety population|68
10009215|NCT01764841|11131743|FG000|COMPLETED|Overall Study||118
10009216|NCT01764841|11131744|FG001|COMPLETED|Overall Study||111
9899542|NCT01128894|11015236|FG001|STARTED|Overall Study||408
9899543|NCT01128894|11015235|FG000|COMPLETED|Overall Study||346
9899544|NCT01128894|11015236|FG001|COMPLETED|Overall Study||340
9899545|NCT01128894|11015235|FG000|NOT COMPLETED|Overall Study||58
9899546|NCT01128894|11015236|FG001|NOT COMPLETED|Overall Study||68
9899547|NCT01128946|11015242|FG000|STARTED|Period I||20
9899548|NCT01128946|11015243|FG001|STARTED|Period I||21
9899549|NCT01128946|11015244|FG002|STARTED|Period I||21
9899550|NCT01128946|11015245|FG003|STARTED|Period I||21
9899551|NCT01128946|11015242|FG000|COMPLETED|Period I||20
9899552|NCT01128946|11015243|FG001|COMPLETED|Period I||20
9899553|NCT01128946|11015244|FG002|COMPLETED|Period I||20
9899554|NCT01128946|11015245|FG003|COMPLETED|Period I||20
9899555|NCT01128946|11015242|FG000|NOT COMPLETED|Period I||0
9899556|NCT01128946|11015243|FG001|NOT COMPLETED|Period I||1
9899557|NCT01128946|11015244|FG002|NOT COMPLETED|Period I||1
9899558|NCT01128946|11015245|FG003|NOT COMPLETED|Period I||1
9899559|NCT01128946|11015242|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
9899560|NCT01128946|11015243|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
9899561|NCT01128946|11015244|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
9899562|NCT01128946|11015245|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
9899563|NCT01128946|11015242|FG000|COMPLETED|Period II||20
9899564|NCT01128946|11015243|FG001|COMPLETED|Period II||19
9899565|NCT01128946|11015244|FG002|COMPLETED|Period II||20
9899566|NCT01128946|11015245|FG003|COMPLETED|Period II||19
9899567|NCT01128946|11015242|FG000|NOT COMPLETED|Period II||0
9899568|NCT01128946|11015243|FG001|NOT COMPLETED|Period II||1
9899569|NCT01128946|11015244|FG002|NOT COMPLETED|Period II||0
9899570|NCT01128946|11015245|FG003|NOT COMPLETED|Period II||1
9899571|NCT01128946|11015242|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
9899572|NCT01128946|11015243|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
9899573|NCT01128946|11015244|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
9899574|NCT01128946|11015245|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
9899575|NCT01128946|11015242|FG000|COMPLETED|Period III||19
9899576|NCT01128946|11015243|FG001|COMPLETED|Period III||19
9899577|NCT01128946|11015244|FG002|COMPLETED|Period III||20
9899578|NCT01128946|11015245|FG003|COMPLETED|Period III||19
9899579|NCT01128946|11015242|FG000|NOT COMPLETED|Period III||1
10009217|NCT01764841|11131745|FG002|COMPLETED|Overall Study||56
10009218|NCT01764841|11131746|FG003|COMPLETED|Overall Study||49
10009219|NCT01764841|11131743|FG000|NOT COMPLETED|Overall Study||23
10009220|NCT01764841|11131744|FG001|NOT COMPLETED|Overall Study||26
9899580|NCT01128946|11015243|FG001|NOT COMPLETED|Period III||0
9899581|NCT01128946|11015244|FG002|NOT COMPLETED|Period III||0
9899582|NCT01128946|11015245|FG003|NOT COMPLETED|Period III||0
9899583|NCT01128946|11015242|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
9899584|NCT01128946|11015243|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
9899585|NCT01128946|11015244|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
9899586|NCT01128946|11015245|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
9899587|NCT01128946|11015242|FG000|COMPLETED|Period IV||19
9899588|NCT01128946|11015243|FG001|COMPLETED|Period IV||20
9899589|NCT01128946|11015244|FG002|COMPLETED|Period IV||19
9899590|NCT01128946|11015245|FG003|COMPLETED|Period IV||19
9899591|NCT01128946|11015242|FG000|NOT COMPLETED|Period IV||0
9899592|NCT01128946|11015243|FG001|NOT COMPLETED|Period IV||0
9899593|NCT01128946|11015244|FG002|NOT COMPLETED|Period IV||0
9899594|NCT01128946|11015245|FG003|NOT COMPLETED|Period IV||0
9899595|NCT01128959|11015256|FG000|STARTED|Lead in Period||108
9899596|NCT01128959|11015256|FG000|COMPLETED|Lead in Period||105
9899597|NCT01128959|11015256|FG000|NOT COMPLETED|Lead in Period||3
9899598|NCT01128959|11015256|FG000|STARTED|Treatment Period||105
9899599|NCT01128959|11015256|FG000|COMPLETED|Treatment Period||101
9899600|NCT01128959|11015256|FG000|NOT COMPLETED|Treatment Period||4
9899601|NCT01128972|11015262|FG000|STARTED|Period I||7
9899602|NCT01128972|11015263|FG001|STARTED|Period I||7
9899603|NCT01128972|11015264|FG002|STARTED|Period I||7
9899604|NCT01128972|11015265|FG003|STARTED|Period I||7
9899605|NCT01128972|11015266|FG004|STARTED|Period I||8
9899606|NCT01128972|11015262|FG000|COMPLETED|Period I||7
9899607|NCT01128972|11015263|FG001|COMPLETED|Period I||7
9899608|NCT01128972|11015264|FG002|COMPLETED|Period I||7
9899609|NCT01128972|11015265|FG003|COMPLETED|Period I||7
9899610|NCT01128972|11015266|FG004|COMPLETED|Period I||8
9899611|NCT01128972|11015262|FG000|NOT COMPLETED|Period I||0
9899612|NCT01128972|11015263|FG001|NOT COMPLETED|Period I||0
9899613|NCT01128972|11015264|FG002|NOT COMPLETED|Period I||0
9899614|NCT01128972|11015265|FG003|NOT COMPLETED|Period I||0
9899615|NCT01128972|11015266|FG004|NOT COMPLETED|Period I||0
9899616|NCT01128972|11015262|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
9899617|NCT01128972|11015263|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
9899618|NCT01128972|11015264|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
9899619|NCT01128972|11015265|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
9899620|NCT01128972|11015266|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
9899621|NCT01128972|11015262|FG000|COMPLETED|Period II||7
9899622|NCT01128972|11015263|FG001|COMPLETED|Period II||7
9899623|NCT01128972|11015264|FG002|COMPLETED|Period II||7
9899624|NCT01128972|11015265|FG003|COMPLETED|Period II||8
9899625|NCT01128972|11015266|FG004|COMPLETED|Period II||7
9899626|NCT01128972|11015262|FG000|NOT COMPLETED|Period II||0
9899627|NCT01128972|11015263|FG001|NOT COMPLETED|Period II||0
9899628|NCT01128972|11015264|FG002|NOT COMPLETED|Period II||0
9899629|NCT01128972|11015265|FG003|NOT COMPLETED|Period II||0
9899630|NCT01128972|11015266|FG004|NOT COMPLETED|Period II||0
9899631|NCT01128972|11015262|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
9899632|NCT01128972|11015263|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
9899633|NCT01128972|11015264|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
9899634|NCT01128972|11015265|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
9899635|NCT01128972|11015266|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
9899636|NCT01128972|11015262|FG000|COMPLETED|Period III||7
9899637|NCT01128972|11015263|FG001|COMPLETED|Period III||7
9899638|NCT01128972|11015264|FG002|COMPLETED|Period III||8
9899639|NCT01128972|11015265|FG003|COMPLETED|Period III||7
9899640|NCT01128972|11015266|FG004|COMPLETED|Period III||7
9899641|NCT01128972|11015262|FG000|NOT COMPLETED|Period III||0
9899642|NCT01128972|11015263|FG001|NOT COMPLETED|Period III||0
9899643|NCT01128972|11015264|FG002|NOT COMPLETED|Period III||0
9899644|NCT01128972|11015265|FG003|NOT COMPLETED|Period III||0
9899645|NCT01128972|11015266|FG004|NOT COMPLETED|Period III||0
9899646|NCT01128972|11015262|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
9899647|NCT01128972|11015263|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
9899648|NCT01128972|11015264|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
9899649|NCT01128972|11015265|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
9899650|NCT01128972|11015266|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
9899651|NCT01128972|11015262|FG000|COMPLETED|Period IV||7
9899652|NCT01128972|11015263|FG001|COMPLETED|Period IV||8
9899653|NCT01128972|11015264|FG002|COMPLETED|Period IV||7
9899654|NCT01128972|11015265|FG003|COMPLETED|Period IV||7
9899655|NCT01128972|11015266|FG004|COMPLETED|Period IV||7
9899656|NCT01128972|11015262|FG000|NOT COMPLETED|Period IV||0
9899657|NCT01128972|11015263|FG001|NOT COMPLETED|Period IV||0
9899658|NCT01128972|11015264|FG002|NOT COMPLETED|Period IV||0
9899659|NCT01128972|11015265|FG003|NOT COMPLETED|Period IV||0
9899660|NCT01128972|11015266|FG004|NOT COMPLETED|Period IV||0
9899661|NCT01128972|11015262|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
9899662|NCT01128972|11015263|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
9899663|NCT01128972|11015264|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
9899664|NCT01128972|11015265|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
9899665|NCT01128972|11015266|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
9899666|NCT01128972|11015262|FG000|COMPLETED|Period V||8
9899667|NCT01128972|11015263|FG001|COMPLETED|Period V||7
9899668|NCT01128972|11015264|FG002|COMPLETED|Period V||7
9899669|NCT01128972|11015265|FG003|COMPLETED|Period V||7
9899670|NCT01128972|11015266|FG004|COMPLETED|Period V||7
9899671|NCT01128972|11015262|FG000|NOT COMPLETED|Period V||0
9899672|NCT01128972|11015263|FG001|NOT COMPLETED|Period V||0
9899673|NCT01128972|11015264|FG002|NOT COMPLETED|Period V||0
9899674|NCT01128972|11015265|FG003|NOT COMPLETED|Period V||0
9899675|NCT01128972|11015266|FG004|NOT COMPLETED|Period V||0
9899676|NCT01129024|11015284|FG000|STARTED|Overall Study||19
9899677|NCT01129024|11015284|FG000|COMPLETED|Overall Study||0
9899678|NCT01129024|11015284|FG000|NOT COMPLETED|Overall Study||19
9899679|NCT01129102|11015291|FG000|STARTED|Overall Study||110
9899680|NCT01129102|11015292|FG001|STARTED|Overall Study||50
9899681|NCT01129102|11015293|FG002|STARTED|Overall Study||55
9899682|NCT01129102|11015291|FG000|COMPLETED|Overall Study||102
9899683|NCT01129102|11015292|FG001|COMPLETED|Overall Study||44
9899684|NCT01129102|11015293|FG002|COMPLETED|Overall Study||48
9899685|NCT01129102|11015291|FG000|NOT COMPLETED|Overall Study||8
9899686|NCT01129102|11015292|FG001|NOT COMPLETED|Overall Study||6
9899687|NCT01129102|11015293|FG002|NOT COMPLETED|Overall Study||7
9899688|NCT01129115|11015304|FG000|STARTED|Overall Study||25
9899689|NCT01129115|11015305|FG001|STARTED|Overall Study||25
9899690|NCT01129115|11015306|FG002|STARTED|Overall Study||27
9899691|NCT01129115|11015307|FG003|STARTED|Overall Study||24
9899692|NCT01129115|11015304|FG000|COMPLETED|Overall Study||23
9899693|NCT01129115|11015305|FG001|COMPLETED|Overall Study||18
9899694|NCT01129115|11015306|FG002|COMPLETED|Overall Study||21
9899695|NCT01129115|11015307|FG003|COMPLETED|Overall Study||15
9899696|NCT01129115|11015304|FG000|NOT COMPLETED|Overall Study||2
9899697|NCT01129115|11015305|FG001|NOT COMPLETED|Overall Study||7
9899698|NCT01129115|11015306|FG002|NOT COMPLETED|Overall Study||6
9899699|NCT01129115|11015307|FG003|NOT COMPLETED|Overall Study||9
9899700|NCT01129128|11015320|FG000|STARTED|Overall Study||22
9899701|NCT01129128|11015321|FG001|STARTED|Overall Study||22
9899702|NCT01129128|11015322|FG002|STARTED|Overall Study||23
9899703|NCT01129128|11015320|FG000|COMPLETED|Overall Study||19
9899704|NCT01129128|11015321|FG001|COMPLETED|Overall Study||18
9899705|NCT01129128|11015322|FG002|COMPLETED|Overall Study||19
9899706|NCT01129128|11015320|FG000|NOT COMPLETED|Overall Study||3
9899707|NCT01129128|11015321|FG001|NOT COMPLETED|Overall Study||4
9899708|NCT01129128|11015322|FG002|NOT COMPLETED|Overall Study||4
9899709|NCT01129141|11015332|FG000|STARTED|Overall Study||101
9899710|NCT01129141|11015333|FG001|STARTED|Overall Study||104
9899711|NCT01129141|11015332|FG000|COMPLETED|Overall Study||86
9899712|NCT01129141|11015333|FG001|COMPLETED|Overall Study||91
9899713|NCT01129141|11015332|FG000|NOT COMPLETED|Overall Study||15
9899714|NCT01129141|11015333|FG001|NOT COMPLETED|Overall Study||13
9899715|NCT01129206|11015339|FG000|STARTED|Overall Study||6
9899716|NCT01129206|11015339|FG000|COMPLETED|Overall Study||6
9899717|NCT01129206|11015339|FG000|NOT COMPLETED|Overall Study||0
9899718|NCT01129245|11015348|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10
9899719|NCT01129245|11015349|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10
9899720|NCT01129245|11015348|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
9899721|NCT01129245|11015349|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
9899722|NCT01129245|11015348|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
9899723|NCT01129245|11015349|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
9899724|NCT01129245|11015348|FG000|STARTED|Treatment Cycle 1||10
9899725|NCT01129245|11015349|FG001|STARTED|Treatment Cycle 1||10
9899726|NCT01129245|11015348|FG000|COMPLETED|Treatment Cycle 1||10
9899727|NCT01129245|11015349|FG001|COMPLETED|Treatment Cycle 1||10
9899728|NCT01129245|11015348|FG000|NOT COMPLETED|Treatment Cycle 1||0
9899729|NCT01129245|11015349|FG001|NOT COMPLETED|Treatment Cycle 1||0
9899730|NCT01129245|11015348|FG000|STARTED|Washout Cycle||10
9899731|NCT01129245|11015349|FG001|STARTED|Washout Cycle||10
9899732|NCT01129245|11015348|FG000|COMPLETED|Washout Cycle||10
9899733|NCT01129245|11015349|FG001|COMPLETED|Washout Cycle||10
9899734|NCT01129245|11015348|FG000|NOT COMPLETED|Washout Cycle||0
9899735|NCT01129245|11015349|FG001|NOT COMPLETED|Washout Cycle||0
9899736|NCT01129245|11015348|FG000|STARTED|Treatment Cycle 2||10
9899737|NCT01129245|11015349|FG001|STARTED|Treatment Cycle 2||10
9899738|NCT01129245|11015348|FG000|COMPLETED|Treatment Cycle 2||10
9899739|NCT01129245|11015349|FG001|COMPLETED|Treatment Cycle 2||10
9899740|NCT01129245|11015348|FG000|NOT COMPLETED|Treatment Cycle 2||0
9899741|NCT01129245|11015349|FG001|NOT COMPLETED|Treatment Cycle 2||0
9899742|NCT01129284|11015361|FG000|STARTED|Overall Study||5
9899743|NCT01129284|11015362|FG001|STARTED|Overall Study||5
9899744|NCT01129284|11015363|FG002|STARTED|Overall Study||5
9899745|NCT01129284|11015361|FG000|COMPLETED|Overall Study||3
9899746|NCT01129284|11015362|FG001|COMPLETED|Overall Study||5
9899747|NCT01129284|11015363|FG002|COMPLETED|Overall Study||4
9899748|NCT01129284|11015361|FG000|NOT COMPLETED|Overall Study||2
9899749|NCT01129284|11015362|FG001|NOT COMPLETED|Overall Study||0
9899750|NCT01129284|11015363|FG002|NOT COMPLETED|Overall Study||1
9899751|NCT01129336|11015373|FG000|STARTED|Overall Study||15
9899752|NCT01129336|11015374|FG001|STARTED|Overall Study||29
9899753|NCT01129336|11015373|FG000|Completed Treatment|Overall Study||1
9899754|NCT01129336|11015374|FG001|Completed Treatment|Overall Study||3
9899755|NCT01129336|11015373|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
9899756|NCT01129336|11015374|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
9899757|NCT01129336|11015373|FG000|NOT COMPLETED|Overall Study||12
9899758|NCT01129336|11015374|FG001|NOT COMPLETED|Overall Study||16
9899759|NCT01129440|11015382|FG000|STARTED|Overall Study||297
9899760|NCT01129440|11015383|FG001|STARTED|Overall Study||300
9899761|NCT01129440|11015382|FG000|12 Month Follow-up|Overall Study||249
9899762|NCT01129440|11015383|FG001|12 Month Follow-up|Overall Study||256
9899763|NCT01129440|11015382|FG000|24 Month Follow-up|Overall Study||239
9899764|NCT01129440|11015383|FG001|24 Month Follow-up|Overall Study||258
9899765|NCT01129440|11015382|FG000|COMPLETED|Overall Study||246
9899766|NCT01129440|11015383|FG001|COMPLETED|Overall Study||258
9899767|NCT01129440|11015382|FG000|NOT COMPLETED|Overall Study||51
9899768|NCT01129440|11015383|FG001|NOT COMPLETED|Overall Study||42
9899769|NCT01129531|11015393|FG000|STARTED|Treatment Cycle 1||84
9899770|NCT01129531|11015394|FG001|STARTED|Treatment Cycle 1||84
9899771|NCT01129531|11015395|FG002|STARTED|Treatment Cycle 1||126
9899772|NCT01129531|11015393|FG000|COMPLETED|Treatment Cycle 1||80
9899773|NCT01129531|11015394|FG001|COMPLETED|Treatment Cycle 1||78
9899774|NCT01129531|11015395|FG002|COMPLETED|Treatment Cycle 1||110
9899775|NCT01129531|11015393|FG000|NOT COMPLETED|Treatment Cycle 1||4
9899776|NCT01129531|11015394|FG001|NOT COMPLETED|Treatment Cycle 1||6
9899777|NCT01129531|11015395|FG002|NOT COMPLETED|Treatment Cycle 1||16
9899778|NCT01129531|11015393|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
9899779|NCT01129531|11015394|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
9899780|NCT01129531|11015395|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
9899781|NCT01129531|11015393|FG000|COMPLETED|Treatment Cycle 2||88
9899782|NCT01129531|11015394|FG001|COMPLETED|Treatment Cycle 2||92
9899783|NCT01129531|11015395|FG002|COMPLETED|Treatment Cycle 2||74
9899784|NCT01129531|11015393|FG000|NOT COMPLETED|Treatment Cycle 2||6
9899785|NCT01129531|11015394|FG001|NOT COMPLETED|Treatment Cycle 2||3
9899786|NCT01129531|11015395|FG002|NOT COMPLETED|Treatment Cycle 2||5
9899787|NCT01129557|11015410|FG000|STARTED|Overall Study||15
9899788|NCT01129557|11015411|FG001|STARTED|Overall Study||17
9899789|NCT01129557|11015412|FG002|STARTED|Overall Study||14
9899790|NCT01129557|11015410|FG000|COMPLETED|Overall Study||11
9899791|NCT01129557|11015411|FG001|COMPLETED|Overall Study||12
9899792|NCT01129557|11015412|FG002|COMPLETED|Overall Study||10
9899793|NCT01129557|11015410|FG000|NOT COMPLETED|Overall Study||4
9899794|NCT01129557|11015411|FG001|NOT COMPLETED|Overall Study||5
9899795|NCT01129557|11015412|FG002|NOT COMPLETED|Overall Study||4
9899796|NCT01129583|11015433|FG000|STARTED|Overall Study||9
9899797|NCT01129583|11015434|FG001|STARTED|Overall Study||9
9899798|NCT01129583|11015433|FG000|COMPLETED|Overall Study||6
9899799|NCT01129583|11015434|FG001|COMPLETED|Overall Study||7
9899800|NCT01129583|11015433|FG000|NOT COMPLETED|Overall Study||3
9899801|NCT01129583|11015434|FG001|NOT COMPLETED|Overall Study||2
9899802|NCT01129609|11015440|FG000|STARTED|Overall Study||20
9899803|NCT01129609|11015440|FG000|COMPLETED|Overall Study||18
9899804|NCT01129609|11015440|FG000|NOT COMPLETED|Overall Study||2
9899805|NCT01129622|11015444|FG000|STARTED|Overall Study||16
9899806|NCT01129622|11015444|FG000|COMPLETED|Overall Study||14
9899807|NCT01129622|11015444|FG000|NOT COMPLETED|Overall Study||2
9955026|NCT01435772|11073923|FG000|STARTED|Overall Study||3
9955027|NCT01435772|11073924|FG001|STARTED|Overall Study||3
9955028|NCT01435772|11073925|FG002|STARTED|Overall Study||15
9955029|NCT01435772|11073923|FG000|COMPLETED|Overall Study||0
9955030|NCT01435772|11073924|FG001|COMPLETED|Overall Study||0
9955031|NCT01435772|11073925|FG002|COMPLETED|Overall Study||0
9955032|NCT01435772|11073923|FG000|NOT COMPLETED|Overall Study||3
9955033|NCT01435772|11073924|FG001|NOT COMPLETED|Overall Study||3
9955034|NCT01435772|11073925|FG002|NOT COMPLETED|Overall Study||15
9955035|NCT01435798|11073934|FG000|STARTED|Overall Study|Crossover design|26
9955036|NCT01435798|11073934|FG000|0% MTD|Overall Study||25
9955037|NCT01435798|11073934|FG000|25% MTD|Overall Study||26
9955038|NCT01435798|11073934|FG000|50% MTD|Overall Study||25
9955039|NCT01435798|11073934|FG000|100% MTD|Overall Study||25
9955040|NCT01435798|11073934|FG000|COMPLETED|Overall Study|Crossover design|25
9955041|NCT01435798|11073934|FG000|NOT COMPLETED|Overall Study||1
9955042|NCT01435824|11073944|FG000|STARTED|First Intervention||8
9955043|NCT01435824|11073945|FG001|STARTED|First Intervention||8
9955044|NCT01435824|11073944|FG000|COMPLETED|First Intervention||8
9955045|NCT01435824|11073945|FG001|COMPLETED|First Intervention||8
9955046|NCT01435824|11073944|FG000|NOT COMPLETED|First Intervention||0
9955047|NCT01435824|11073945|FG001|NOT COMPLETED|First Intervention||0
9899808|NCT01129765|11015449|FG000|STARTED|Overall Study||30
9899809|NCT01129765|11015449|FG000|COMPLETED|Overall Study||30
9899810|NCT01129765|11015449|FG000|NOT COMPLETED|Overall Study||0
9899811|NCT01129778|11015453|FG000|STARTED|Overall Study||22
9899812|NCT01129778|11015453|FG000|COMPLETED|Overall Study||15
9899813|NCT01129778|11015453|FG000|NOT COMPLETED|Overall Study||7
10009221|NCT01764841|11131745|FG002|NOT COMPLETED|Overall Study||14
10009222|NCT01764841|11131746|FG003|NOT COMPLETED|Overall Study||19
10009223|NCT01764854|11131760|FG000|STARTED|Overall Study||8
10009224|NCT01764854|11131761|FG001|STARTED|Overall Study||8
10009225|NCT01764854|11131762|FG002|STARTED|Overall Study||37
10009226|NCT01764854|11131763|FG003|STARTED|Overall Study||35
10009227|NCT01764854|11131760|FG000|COMPLETED|Overall Study||8
9899814|NCT01129804|11015459|FG000|STARTED|Overall Study||96
9899815|NCT01129804|11015460|FG001|STARTED|Overall Study||97
9899816|NCT01129804|11015459|FG000|COMPLETED|Overall Study||64
9899817|NCT01129804|11015460|FG001|COMPLETED|Overall Study||66
9899818|NCT01129804|11015459|FG000|NOT COMPLETED|Overall Study||32
9899819|NCT01129804|11015460|FG001|NOT COMPLETED|Overall Study||31
9899820|NCT01129882|11015466|FG000|STARTED|Overall Study||709
10110330|NCT02484729|11241097|FG006|STARTED|Overall Study||5
10110331|NCT02484729|11241098|FG007|STARTED|Overall Study||6
10110332|NCT02484729|11241099|FG008|STARTED|Overall Study||6
10110333|NCT02484729|11241100|FG009|STARTED|Overall Study||8
10110334|NCT02484729|11241091|FG000|COMPLETED|Overall Study||16
10110335|NCT02484729|11241092|FG001|COMPLETED|Overall Study||6
9899821|NCT01129882|11015466|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709
9899822|NCT01129882|11015466|FG000|COMPLETED|Overall Study||431
9899823|NCT01129882|11015466|FG000|NOT COMPLETED|Overall Study||278
9899824|NCT01129921|11015472|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
9899825|NCT01129921|11015473|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
9899826|NCT01129921|11015472|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
9899827|NCT01129921|11015473|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
9899828|NCT01129921|11015472|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
9899829|NCT01129921|11015473|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
9899830|NCT01129921|11015472|FG000|STARTED|After Sham Cross-over to Mild, One Year||20
9899831|NCT01129921|11015473|FG001|STARTED|After Sham Cross-over to Mild, One Year||20
9899832|NCT01129921|11015472|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
9899833|NCT01129921|11015473|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
9899834|NCT01129921|11015472|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
9899835|NCT01129921|11015473|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
9899836|NCT01129960|11015487|FG000|STARTED|Overall Study||84
9899837|NCT01129960|11015488|FG001|STARTED|Overall Study||83
9899838|NCT01129960|11015489|FG002|STARTED|Overall Study||82
9899839|NCT01129960|11015490|FG003|STARTED|Overall Study||83
9899840|NCT01129960|11015487|FG000|Safety|Overall Study||84
9899841|NCT01129960|11015488|FG001|Safety|Overall Study||83
9899842|NCT01129960|11015489|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
9899843|NCT01129960|11015490|FG003|Safety|Overall Study||82
9899844|NCT01129960|11015487|FG000|Intent-to-Treat|Overall Study||84
9899845|NCT01129960|11015488|FG001|Intent-to-Treat|Overall Study||83
9899846|NCT01129960|11015489|FG002|Intent-to-Treat|Overall Study||82
9899847|NCT01129960|11015490|FG003|Intent-to-Treat|Overall Study||83
9899848|NCT01129960|11015487|FG000|Per-Protocol|Overall Study||34
9899849|NCT01129960|11015488|FG001|Per-Protocol|Overall Study||52
9899850|NCT01129960|11015489|FG002|Per-Protocol|Overall Study||49
9899851|NCT01129960|11015490|FG003|Per-Protocol|Overall Study||55
9899852|NCT01129960|11015487|FG000|Full Analysis Set (FAS|Overall Study||71
9899853|NCT01129960|11015488|FG001|Full Analysis Set (FAS|Overall Study||67
9899854|NCT01129960|11015489|FG002|Full Analysis Set (FAS|Overall Study||68
9899855|NCT01129960|11015490|FG003|Full Analysis Set (FAS|Overall Study||71
9899856|NCT01129960|11015487|FG000|COMPLETED|Overall Study||54
9899857|NCT01129960|11015488|FG001|COMPLETED|Overall Study||61
9899858|NCT01129960|11015489|FG002|COMPLETED|Overall Study||56
9899859|NCT01129960|11015490|FG003|COMPLETED|Overall Study||70
9899860|NCT01129960|11015487|FG000|NOT COMPLETED|Overall Study||30
9899861|NCT01129960|11015488|FG001|NOT COMPLETED|Overall Study||22
9899862|NCT01129960|11015489|FG002|NOT COMPLETED|Overall Study||26
9899863|NCT01129960|11015490|FG003|NOT COMPLETED|Overall Study||13
9899864|NCT01130051|11015500|FG000|STARTED|Period 1||8
9899865|NCT01130051|11015501|FG001|STARTED|Period 1||8
9899866|NCT01130051|11015500|FG000|COMPLETED|Period 1||8
9899867|NCT01130051|11015501|FG001|COMPLETED|Period 1||8
9899868|NCT01130051|11015500|FG000|NOT COMPLETED|Period 1||0
9899869|NCT01130051|11015501|FG001|NOT COMPLETED|Period 1||0
9899870|NCT01130051|11015500|FG000|STARTED|Washout Period of 14 Days||8
9899871|NCT01130051|11015501|FG001|STARTED|Washout Period of 14 Days||8
9899872|NCT01130051|11015500|FG000|COMPLETED|Washout Period of 14 Days||7
10009228|NCT01764854|11131761|FG001|COMPLETED|Overall Study||8
10009229|NCT01764854|11131762|FG002|COMPLETED|Overall Study||31
10009230|NCT01764854|11131763|FG003|COMPLETED|Overall Study||33
10009231|NCT01764854|11131760|FG000|NOT COMPLETED|Overall Study||0
10110336|NCT02484729|11241093|FG002|COMPLETED|Overall Study||6
10009232|NCT01764854|11131761|FG001|NOT COMPLETED|Overall Study||0
10110337|NCT02484729|11241094|FG003|COMPLETED|Overall Study||6
10110338|NCT02484729|11241095|FG004|COMPLETED|Overall Study||5
9899873|NCT01130051|11015501|FG001|COMPLETED|Washout Period of 14 Days||6
9899874|NCT01130051|11015500|FG000|NOT COMPLETED|Washout Period of 14 Days||1
9899875|NCT01130051|11015501|FG001|NOT COMPLETED|Washout Period of 14 Days||2
9899876|NCT01130051|11015500|FG000|STARTED|Period 2||7
9899877|NCT01130051|11015501|FG001|STARTED|Period 2||6
9899878|NCT01130051|11015500|FG000|COMPLETED|Period 2||7
9899879|NCT01130051|11015501|FG001|COMPLETED|Period 2||6
9899880|NCT01130051|11015500|FG000|NOT COMPLETED|Period 2||0
9899881|NCT01130051|11015501|FG001|NOT COMPLETED|Period 2||0
9899882|NCT01130103|11015509|FG000|STARTED|Randomized Treatment||19
9899883|NCT01130103|11015510|FG001|STARTED|Randomized Treatment||18
9899884|NCT01130103|11015509|FG000|COMPLETED|Randomized Treatment||13
9899885|NCT01130103|11015510|FG001|COMPLETED|Randomized Treatment||13
9899886|NCT01130103|11015509|FG000|NOT COMPLETED|Randomized Treatment||6
9899887|NCT01130103|11015510|FG001|NOT COMPLETED|Randomized Treatment||5
9899888|NCT01130103|11015509|FG000|STARTED|Maintenance Treatment||13
9899889|NCT01130103|11015510|FG001|STARTED|Maintenance Treatment||13
9899890|NCT01130103|11015509|FG000|COMPLETED|Maintenance Treatment||11
9899891|NCT01130103|11015510|FG001|COMPLETED|Maintenance Treatment||11
9899892|NCT01130103|11015509|FG000|NOT COMPLETED|Maintenance Treatment||2
9899893|NCT01130103|11015510|FG001|NOT COMPLETED|Maintenance Treatment||2
9899894|NCT01130168|11015516|FG000|STARTED|Period 1||6
9899895|NCT01130168|11015517|FG001|STARTED|Period 1||7
9899896|NCT01130168|11015518|FG002|STARTED|Period 1||6
9899897|NCT01130168|11015519|FG003|STARTED|Period 1||8
9899898|NCT01130168|11015520|FG004|STARTED|Period 1||5
9899899|NCT01130168|11015521|FG005|STARTED|Period 1||6
9899900|NCT01130168|11015516|FG000|COMPLETED|Period 1||6
9899901|NCT01130168|11015517|FG001|COMPLETED|Period 1||6
9899902|NCT01130168|11015518|FG002|COMPLETED|Period 1||5
9899903|NCT01130168|11015519|FG003|COMPLETED|Period 1||5
9899904|NCT01130168|11015520|FG004|COMPLETED|Period 1||5
9899905|NCT01130168|11015521|FG005|COMPLETED|Period 1||6
9899906|NCT01130168|11015516|FG000|NOT COMPLETED|Period 1||0
9899907|NCT01130168|11015517|FG001|NOT COMPLETED|Period 1||1
9899908|NCT01130168|11015518|FG002|NOT COMPLETED|Period 1||1
9899909|NCT01130168|11015519|FG003|NOT COMPLETED|Period 1||3
9899910|NCT01130168|11015520|FG004|NOT COMPLETED|Period 1||0
9899911|NCT01130168|11015521|FG005|NOT COMPLETED|Period 1||0
9899912|NCT01130168|11015516|FG000|STARTED|Period 2||6
9899913|NCT01130168|11015517|FG001|STARTED|Period 2||6
9899914|NCT01130168|11015518|FG002|STARTED|Period 2||5
9899915|NCT01130168|11015519|FG003|STARTED|Period 2||5
9899916|NCT01130168|11015520|FG004|STARTED|Period 2||5
9899917|NCT01130168|11015521|FG005|STARTED|Period 2||6
9899918|NCT01130168|11015516|FG000|COMPLETED|Period 2||6
9899919|NCT01130168|11015517|FG001|COMPLETED|Period 2||6
9899920|NCT01130168|11015518|FG002|COMPLETED|Period 2||5
9899921|NCT01130168|11015519|FG003|COMPLETED|Period 2||5
9899922|NCT01130168|11015520|FG004|COMPLETED|Period 2||5
9899923|NCT01130168|11015521|FG005|COMPLETED|Period 2||6
9899924|NCT01130168|11015516|FG000|NOT COMPLETED|Period 2||0
9899925|NCT01130168|11015517|FG001|NOT COMPLETED|Period 2||0
9899926|NCT01130168|11015518|FG002|NOT COMPLETED|Period 2||0
9899927|NCT01130168|11015519|FG003|NOT COMPLETED|Period 2||0
9899928|NCT01130168|11015520|FG004|NOT COMPLETED|Period 2||0
9899929|NCT01130168|11015521|FG005|NOT COMPLETED|Period 2||0
9899930|NCT01130168|11015516|FG000|STARTED|Period 3||6
9899931|NCT01130168|11015517|FG001|STARTED|Period 3||6
9899932|NCT01130168|11015518|FG002|STARTED|Period 3||5
9899933|NCT01130168|11015519|FG003|STARTED|Period 3||5
9899934|NCT01130168|11015520|FG004|STARTED|Period 3||5
9899935|NCT01130168|11015521|FG005|STARTED|Period 3||6
9899936|NCT01130168|11015516|FG000|COMPLETED|Period 3||6
9899937|NCT01130168|11015517|FG001|COMPLETED|Period 3||6
9899938|NCT01130168|11015518|FG002|COMPLETED|Period 3||5
9899939|NCT01130168|11015519|FG003|COMPLETED|Period 3||5
9899940|NCT01130168|11015520|FG004|COMPLETED|Period 3||5
9899941|NCT01130168|11015521|FG005|COMPLETED|Period 3||6
9899942|NCT01130168|11015516|FG000|NOT COMPLETED|Period 3||0
9899943|NCT01130168|11015517|FG001|NOT COMPLETED|Period 3||0
9899944|NCT01130168|11015518|FG002|NOT COMPLETED|Period 3||0
9899945|NCT01130168|11015519|FG003|NOT COMPLETED|Period 3||0
9899946|NCT01130168|11015520|FG004|NOT COMPLETED|Period 3||0
9899947|NCT01130168|11015521|FG005|NOT COMPLETED|Period 3||0
9899948|NCT01130272|11015535|FG000|STARTED|Overall Study||107
9899949|NCT01130272|11015536|FG001|STARTED|Overall Study||173
9899950|NCT01130272|11015537|FG002|STARTED|Overall Study||169
9899951|NCT01130272|11015538|FG003|STARTED|Overall Study||171
9899952|NCT01130272|11015539|FG004|STARTED|Overall Study||169
9899953|NCT01130272|11015535|FG000|Safety Analysis Set: as Randomized|Overall Study||105
9899954|NCT01130272|11015536|FG001|Safety Analysis Set: as Randomized|Overall Study||171
9899955|NCT01130272|11015537|FG002|Safety Analysis Set: as Randomized|Overall Study||166
9899956|NCT01130272|11015538|FG003|Safety Analysis Set: as Randomized|Overall Study||167
9899957|NCT01130272|11015539|FG004|Safety Analysis Set: as Randomized|Overall Study||162
9899958|NCT01130272|11015535|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
9899959|NCT01130272|11015536|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
9899960|NCT01130272|11015537|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
9899961|NCT01130272|11015538|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
9899962|NCT01130272|11015539|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
9899963|NCT01130272|11015535|FG000|COMPLETED|Overall Study||48
9899964|NCT01130272|11015536|FG001|COMPLETED|Overall Study||131
9899965|NCT01130272|11015537|FG002|COMPLETED|Overall Study||121
9899966|NCT01130272|11015538|FG003|COMPLETED|Overall Study||103
9899967|NCT01130272|11015539|FG004|COMPLETED|Overall Study||117
9899968|NCT01130272|11015535|FG000|NOT COMPLETED|Overall Study||59
9899969|NCT01130272|11015536|FG001|NOT COMPLETED|Overall Study||42
9899970|NCT01130272|11015537|FG002|NOT COMPLETED|Overall Study||48
9899971|NCT01130272|11015538|FG003|NOT COMPLETED|Overall Study||68
9899972|NCT01130272|11015539|FG004|NOT COMPLETED|Overall Study||52
9899973|NCT01130337|11015551|FG000|STARTED|Overall Study||36
9899974|NCT01130337|11015551|FG000|COMPLETED|Overall Study||22
9899975|NCT01130337|11015551|FG000|NOT COMPLETED|Overall Study||14
9899976|NCT01130493|11015555|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
9899977|NCT01130493|11015556|FG001|STARTED|Open-label Dose Conversion to IPX066||0
9899978|NCT01130493|11015557|FG002|STARTED|Open-label Dose Conversion to IPX066||0
9899979|NCT01130493|11015555|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91
9899980|NCT01130493|11015556|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0
10009233|NCT01764854|11131762|FG002|NOT COMPLETED|Overall Study||6
10009234|NCT01764854|11131763|FG003|NOT COMPLETED|Overall Study||2
10009235|NCT01764919|11131773|FG000|STARTED|Overall Study||4
9899981|NCT01130493|11015557|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0
9899982|NCT01130493|11015555|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
9899983|NCT01130493|11015556|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
9899984|NCT01130493|11015557|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
9899985|NCT01130493|11015555|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
9899986|NCT01130493|11015556|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
9899987|NCT01130493|11015557|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
9899988|NCT01130493|11015555|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0
9899989|NCT01130493|11015556|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46
9899990|NCT01130493|11015557|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43
9899991|NCT01130493|11015555|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
9899992|NCT01130493|11015556|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
9899993|NCT01130493|11015557|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
9899994|NCT01130493|11015555|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0
9899995|NCT01130493|11015556|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46
9899996|NCT01130493|11015557|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43
9899997|NCT01130493|11015555|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0
9899998|NCT01130493|11015556|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45
9899999|NCT01130493|11015557|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41
9900000|NCT01130493|11015555|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
9900001|NCT01130493|11015556|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
9900002|NCT01130493|11015557|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
9900003|NCT01130493|11015555|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0
9900004|NCT01130493|11015556|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45
9900005|NCT01130493|11015557|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41
9900006|NCT01130493|11015555|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0
9900007|NCT01130493|11015556|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45
9900008|NCT01130493|11015557|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39
9900009|NCT01130493|11015555|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
9900010|NCT01130493|11015556|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
9900011|NCT01130493|11015557|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
9900012|NCT01130493|11015555|FG000|STARTED|Part 2: OLE||0
9900013|NCT01130493|11015556|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
9900014|NCT01130493|11015557|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
9900015|NCT01130493|11015555|FG000|COMPLETED|Part 2: OLE||0
9900016|NCT01130493|11015556|FG001|COMPLETED|Part 2: OLE||36
9900017|NCT01130493|11015557|FG002|COMPLETED|Part 2: OLE||30
9900018|NCT01130493|11015555|FG000|NOT COMPLETED|Part 2: OLE||0
9900019|NCT01130493|11015556|FG001|NOT COMPLETED|Part 2: OLE||3
9900020|NCT01130493|11015557|FG002|NOT COMPLETED|Part 2: OLE||5
9900021|NCT01130532|11015571|FG000|STARTED|Period III (Weeks 0-12)||207
9900022|NCT01130532|11015572|FG001|STARTED|Period III (Weeks 0-12)||207
9900023|NCT01130532|11015573|FG002|STARTED|Period III (Weeks 0-12)||209
9900024|NCT01130532|11015574|FG003|STARTED|Period III (Weeks 0-12)||0
9900025|NCT01130532|11015571|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
9900026|NCT01130532|11015572|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
9900027|NCT01130532|11015573|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
9900028|NCT01130532|11015574|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
9900029|NCT01130532|11015571|FG000|COMPLETED|Period III (Weeks 0-12)||186
10009236|NCT01764919|11131773|FG000|COMPLETED|Overall Study||4
10009237|NCT01764919|11131773|FG000|NOT COMPLETED|Overall Study||0
10009238|NCT01764945|11131785|FG000|STARTED|Overall Study||5
10009239|NCT01764945|11131786|FG001|STARTED|Overall Study||5
10009240|NCT01764945|11131787|FG002|STARTED|Overall Study||5
9900030|NCT01130532|11015572|FG001|COMPLETED|Period III (Weeks 0-12)||189
9900031|NCT01130532|11015573|FG002|COMPLETED|Period III (Weeks 0-12)||190
9900032|NCT01130532|11015574|FG003|COMPLETED|Period III (Weeks 0-12)||0
9900033|NCT01130532|11015571|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21
9900034|NCT01130532|11015572|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18
9900035|NCT01130532|11015573|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19
9900036|NCT01130532|11015574|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0
9900037|NCT01130532|11015571|FG000|STARTED|Period IV (Weeks 13-16)||0
9900038|NCT01130532|11015572|FG001|STARTED|Period IV (Weeks 13-16)||0
9900039|NCT01130532|11015573|FG002|STARTED|Period IV (Weeks 13-16)||0
9900040|NCT01130532|11015574|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
9900041|NCT01130532|11015571|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
9900042|NCT01130532|11015572|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
9900043|NCT01130532|11015573|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
9900044|NCT01130532|11015574|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
9900045|NCT01130532|11015571|FG000|COMPLETED|Period IV (Weeks 13-16)||0
9900046|NCT01130532|11015572|FG001|COMPLETED|Period IV (Weeks 13-16)||0
9900047|NCT01130532|11015573|FG002|COMPLETED|Period IV (Weeks 13-16)||0
9900048|NCT01130532|11015574|FG003|COMPLETED|Period IV (Weeks 13-16)||552
9900049|NCT01130532|11015571|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0
9900050|NCT01130532|11015572|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0
9900051|NCT01130532|11015573|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0
9900052|NCT01130532|11015574|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10
9900053|NCT01130597|11015586|FG000|STARTED|Overall Study||63
9900054|NCT01130597|11015586|FG000|COMPLETED|Overall Study||56
9900055|NCT01130597|11015586|FG000|NOT COMPLETED|Overall Study||7
9900056|NCT01130740|11015592|FG000|STARTED|Overall Study||149
9900057|NCT01130740|11015593|FG001|STARTED|Overall Study||151
9900058|NCT01130740|11015592|FG000|COMPLETED|Overall Study||137
9900059|NCT01130740|11015593|FG001|COMPLETED|Overall Study||136
9900060|NCT01130740|11015592|FG000|NOT COMPLETED|Overall Study||12
9900061|NCT01130740|11015593|FG001|NOT COMPLETED|Overall Study||15
9900062|NCT01130831|11015599|FG000|STARTED|Overall Study||66
9900063|NCT01130831|11015599|FG000|COMPLETED|Overall Study||52
9900064|NCT01130831|11015599|FG000|NOT COMPLETED|Overall Study||14
9900065|NCT01130844|11015618|FG000|STARTED|Overall Study||21
9900066|NCT01130844|11015619|FG001|STARTED|Overall Study||22
9900067|NCT01130844|11015620|FG002|STARTED|Overall Study||9
9900068|NCT01130844|11015618|FG000|COMPLETED|Overall Study||21
9900069|NCT01130844|11015619|FG001|COMPLETED|Overall Study||22
9900070|NCT01130844|11015620|FG002|COMPLETED|Overall Study||9
9900071|NCT01130844|11015618|FG000|NOT COMPLETED|Overall Study||0
9900072|NCT01130844|11015619|FG001|NOT COMPLETED|Overall Study||0
9900073|NCT01130844|11015620|FG002|NOT COMPLETED|Overall Study||0
9900074|NCT01130883|11015631|FG000|STARTED|Overall Study||3130
9900075|NCT01130883|11015631|FG000|Participants Analyzed|Overall Study||3128
9900076|NCT01130883|11015631|FG000|COMPLETED|Overall Study||3120
9900077|NCT01130883|11015631|FG000|NOT COMPLETED|Overall Study||10
9900078|NCT01130896|11015635|FG000|STARTED|Overall Study||1509
9900079|NCT01130896|11015635|FG000|COMPLETED|Overall Study||1509
9900080|NCT01130896|11015635|FG000|NOT COMPLETED|Overall Study||0
9900081|NCT01130974|11015641|FG000|STARTED|Overall Study||100
9900082|NCT01130974|11015642|FG001|STARTED|Overall Study||100
9900083|NCT01130974|11015641|FG000|COMPLETED|Overall Study||85
9900084|NCT01130974|11015642|FG001|COMPLETED|Overall Study||87
9900085|NCT01130974|11015641|FG000|NOT COMPLETED|Overall Study||15
9900086|NCT01130974|11015642|FG001|NOT COMPLETED|Overall Study||13
9900087|NCT01131052|11015651|FG000|STARTED|Overall Study||75
9900088|NCT01131052|11015652|FG001|STARTED|Overall Study||75
9900089|NCT01131052|11015651|FG000|COMPLETED|Overall Study||75
9900090|NCT01131052|11015652|FG001|COMPLETED|Overall Study||75
9900091|NCT01131052|11015651|FG000|NOT COMPLETED|Overall Study||0
9900092|NCT01131052|11015652|FG001|NOT COMPLETED|Overall Study||0
9900093|NCT01131065|11015658|FG000|STARTED|Overall Study||15
9900094|NCT01131065|11015658|FG000|COMPLETED|Overall Study||15
9900095|NCT01131065|11015658|FG000|NOT COMPLETED|Overall Study||0
9900096|NCT01131078|11015665|FG000|STARTED|Overall Study||101
9900097|NCT01131078|11015666|FG001|STARTED|Overall Study||102
9900098|NCT01131078|11015667|FG002|STARTED|Overall Study||103
9900099|NCT01131078|11015665|FG000|COMPLETED|Overall Study||0
9900100|NCT01131078|11015666|FG001|COMPLETED|Overall Study||1
9900101|NCT01131078|11015667|FG002|COMPLETED|Overall Study||1
9900102|NCT01131078|11015665|FG000|NOT COMPLETED|Overall Study||101
9900103|NCT01131078|11015666|FG001|NOT COMPLETED|Overall Study||101
9900104|NCT01131078|11015667|FG002|NOT COMPLETED|Overall Study||102
9900105|NCT01131104|11015677|FG000|STARTED|Overall Study||345
9900106|NCT01131104|11015677|FG000|Study Set|Overall Study||344
9900107|NCT01131104|11015677|FG000|Adjudication-Confirmed NAION Set|Overall Study||279
9900108|NCT01131104|11015677|FG000|30-Day Analysis Set|Overall Study||24
9900109|NCT01131104|11015677|FG000|42-Day Analysis Set|Overall Study||28
9900110|NCT01131104|11015677|FG000|12-Month Analysis Set|Overall Study||26
9900111|NCT01131104|11015677|FG000|COMPLETED|Overall Study||332
9900112|NCT01131104|11015677|FG000|NOT COMPLETED|Overall Study||13
9900113|NCT01131130|11015681|FG000|STARTED|Period 1 - Baseline||118
9900114|NCT01131130|11015681|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
9900115|NCT01131130|11015681|FG000|NOT COMPLETED|Period 1 - Baseline||1
9900116|NCT01131130|11015681|FG000|STARTED|Period 2 - Crossover||117
9900117|NCT01131130|11015681|FG000|COMPLETED|Period 2 - Crossover||117
9900118|NCT01131130|11015681|FG000|NOT COMPLETED|Period 2 - Crossover||0
9900119|NCT01131130|11015681|FG000|STARTED|Period 3- Crossover||117
9900120|NCT01131130|11015681|FG000|COMPLETED|Period 3- Crossover||116
9900121|NCT01131130|11015681|FG000|NOT COMPLETED|Period 3- Crossover||1
9900122|NCT01131182|11015691|FG000|STARTED|Overall Study||529
9900123|NCT01131182|11015692|FG001|STARTED|Overall Study||537
9900124|NCT01131182|11015691|FG000|COMPLETED|Overall Study||513
9900125|NCT01131182|11015692|FG001|COMPLETED|Overall Study||521
9900126|NCT01131182|11015691|FG000|NOT COMPLETED|Overall Study||16
9900127|NCT01131182|11015692|FG001|NOT COMPLETED|Overall Study||16
9900128|NCT01131260|11015700|FG000|STARTED|Overall Study||5532
9900129|NCT01131260|11015701|FG001|STARTED|Overall Study||5576
9900130|NCT01131260|11015700|FG000|COMPLETED|Overall Study||5488
9900131|NCT01131260|11015701|FG001|COMPLETED|Overall Study||5529
9900132|NCT01131260|11015700|FG000|NOT COMPLETED|Overall Study||44
9900133|NCT01131260|11015701|FG001|NOT COMPLETED|Overall Study||47
9900134|NCT01131299|11015709|FG000|STARTED|Overall Study||42
9900135|NCT01131299|11015710|FG001|STARTED|Overall Study||44
9900136|NCT01131299|11015709|FG000|COMPLETED|Overall Study||38
9900137|NCT01131299|11015710|FG001|COMPLETED|Overall Study||37
9900138|NCT01131299|11015709|FG000|NOT COMPLETED|Overall Study||4
9900139|NCT01131299|11015710|FG001|NOT COMPLETED|Overall Study||7
9900140|NCT01131312|11015718|FG000|STARTED|Overall Study||1839
9900141|NCT01131312|11015719|FG001|STARTED|Overall Study||1385
9900142|NCT01131312|11015720|FG002|STARTED|Overall Study||1836
9900143|NCT01131312|11015718|FG000|COMPLETED|Overall Study||1414
9900144|NCT01131312|11015719|FG001|COMPLETED|Overall Study||1156
9900145|NCT01131312|11015720|FG002|COMPLETED|Overall Study||1485
9900146|NCT01131312|11015718|FG000|NOT COMPLETED|Overall Study||425
9900147|NCT01131312|11015719|FG001|NOT COMPLETED|Overall Study||229
9900148|NCT01131312|11015720|FG002|NOT COMPLETED|Overall Study||351
9900149|NCT01131325|11015728|FG000|STARTED|Overall Study||3
9900150|NCT01131325|11015728|FG000|COMPLETED|Overall Study||0
9900151|NCT01131325|11015728|FG000|NOT COMPLETED|Overall Study||3
9900152|NCT01131351|11015734|FG000|STARTED|Overall Study||5
9900153|NCT01131351|11015735|FG001|STARTED|Overall Study||5
9900154|NCT01131351|11015734|FG000|COMPLETED|Overall Study||5
9900155|NCT01131351|11015735|FG001|COMPLETED|Overall Study||2
9900156|NCT01131351|11015734|FG000|NOT COMPLETED|Overall Study||0
9900157|NCT01131351|11015735|FG001|NOT COMPLETED|Overall Study||3
9900158|NCT01131494|11015741|FG000|STARTED|Overall Study||17
9900159|NCT01131494|11015741|FG000|COMPLETED|Overall Study||15
9900160|NCT01131494|11015741|FG000|NOT COMPLETED|Overall Study||2
9900161|NCT01131507|11015746|FG000|STARTED|Overall Study||15
9900162|NCT01131507|11015746|FG000|COMPLETED|Overall Study||12
9900163|NCT01131507|11015746|FG000|NOT COMPLETED|Overall Study||3
9900164|NCT01131520|11015752|FG000|STARTED|Overall Study||180
9900165|NCT01131520|11015753|FG001|STARTED|Overall Study||180
9900166|NCT01131520|11015752|FG000|COMPLETED|Overall Study||179
9900167|NCT01131520|11015753|FG001|COMPLETED|Overall Study||176
9900168|NCT01131520|11015752|FG000|NOT COMPLETED|Overall Study||1
9900169|NCT01131520|11015753|FG001|NOT COMPLETED|Overall Study||4
9900170|NCT01131585|11015761|FG000|STARTED|Overall Study||85
9900171|NCT01131585|11015762|FG001|STARTED|Overall Study||43
9900172|NCT01131585|11015761|FG000|COMPLETED|Overall Study||0
9900173|NCT01131585|11015762|FG001|COMPLETED|Overall Study||0
9900174|NCT01131585|11015761|FG000|NOT COMPLETED|Overall Study||85
9900175|NCT01131585|11015762|FG001|NOT COMPLETED|Overall Study||43
9900176|NCT01131676|11015771|FG000|STARTED|Discontinuation From Treatment|Randomised|2337
9900177|NCT01131676|11015772|FG001|STARTED|Discontinuation From Treatment|Randomised|2347
9900178|NCT01131676|11015773|FG002|STARTED|Discontinuation From Treatment|Randomised|2344
9900179|NCT01131676|11015771|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
9900180|NCT01131676|11015772|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
9900181|NCT01131676|11015773|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
9900182|NCT01131676|11015771|FG000|NOT COMPLETED|Discontinuation From Treatment||687
9900183|NCT01131676|11015772|FG001|NOT COMPLETED|Discontinuation From Treatment||557
9900184|NCT01131676|11015773|FG002|NOT COMPLETED|Discontinuation From Treatment||544
9900185|NCT01131676|11015771|FG000|STARTED|Discontinuation From Study (Treated Set)||2333
9900186|NCT01131676|11015772|FG001|STARTED|Discontinuation From Study (Treated Set)||2345
9900187|NCT01131676|11015773|FG002|STARTED|Discontinuation From Study (Treated Set)||2342
10009241|NCT01764945|11131788|FG003|STARTED|Overall Study||5
10009242|NCT01764945|11131789|FG004|STARTED|Overall Study||10
10009243|NCT01764945|11131790|FG005|STARTED|Overall Study||8
10009244|NCT01764945|11131791|FG006|STARTED|Overall Study||9
9900188|NCT01131676|11015771|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
9900189|NCT01131676|11015772|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
9900190|NCT01131676|11015773|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
9900191|NCT01131676|11015771|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
9900192|NCT01131676|11015772|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
9955048|NCT01435824|11073944|FG000|STARTED|Washout of 1-2 Weeks||8
10009245|NCT01764945|11131792|FG007|STARTED|Overall Study||9
10009246|NCT01764945|11131785|FG000|COMPLETED|Overall Study||5
10009247|NCT01764945|11131786|FG001|COMPLETED|Overall Study||4
10009248|NCT01764945|11131787|FG002|COMPLETED|Overall Study||5
9900193|NCT01131676|11015773|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
9900194|NCT01131676|11015771|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
9900195|NCT01131676|11015772|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
9900196|NCT01131676|11015773|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
9900197|NCT01132118|11015784|FG000|STARTED|First Intervention (8 Weeks)||15
9900198|NCT01132118|11015785|FG001|STARTED|First Intervention (8 Weeks)||15
9900199|NCT01132118|11015784|FG000|COMPLETED|First Intervention (8 Weeks)||12
9900200|NCT01132118|11015785|FG001|COMPLETED|First Intervention (8 Weeks)||12
9900201|NCT01132118|11015784|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3
9900202|NCT01132118|11015785|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3
9900203|NCT01132118|11015784|FG000|STARTED|Second Intervention (8 Weeks)||12
9900204|NCT01132118|11015785|FG001|STARTED|Second Intervention (8 Weeks)||12
9900205|NCT01132118|11015784|FG000|COMPLETED|Second Intervention (8 Weeks)||12
9900206|NCT01132118|11015785|FG001|COMPLETED|Second Intervention (8 Weeks)||11
9900207|NCT01132118|11015784|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
9900208|NCT01132118|11015785|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1
9900209|NCT01132144|11015793|FG000|STARTED|Overall Study||79
9900210|NCT01132144|11015794|FG001|STARTED|Overall Study||79
9900211|NCT01132144|11015793|FG000|COMPLETED|Overall Study||79
9900212|NCT01132144|11015794|FG001|COMPLETED|Overall Study||79
9900213|NCT01132144|11015793|FG000|NOT COMPLETED|Overall Study||0
9900214|NCT01132144|11015794|FG001|NOT COMPLETED|Overall Study||0
9900215|NCT01132313|11015814|FG000|STARTED|Overall Study||17
9900216|NCT01132313|11015815|FG001|STARTED|Overall Study||17
9900217|NCT01132313|11015816|FG002|STARTED|Overall Study||81
9900218|NCT01132313|11015817|FG003|STARTED|Overall Study||80
9900219|NCT01132313|11015818|FG004|STARTED|Overall Study||79
9900220|NCT01132313|11015819|FG005|STARTED|Overall Study||79
9900221|NCT01132313|11015820|FG006|STARTED|Overall Study||49
9900222|NCT01132313|11015821|FG007|STARTED|Overall Study||32
9900223|NCT01132313|11015822|FG008|STARTED|Overall Study||26
9900224|NCT01132313|11015823|FG009|STARTED|Overall Study||25
9900225|NCT01132313|11015824|FG010|STARTED|Overall Study||1
9900226|NCT01132313|11015825|FG011|STARTED|Overall Study||2
9900227|NCT01132313|11015814|FG000|COMPLETED|Overall Study||14
9900228|NCT01132313|11015815|FG001|COMPLETED|Overall Study||17
9900229|NCT01132313|11015816|FG002|COMPLETED|Overall Study||61
9900230|NCT01132313|11015817|FG003|COMPLETED|Overall Study||48
9900231|NCT01132313|11015818|FG004|COMPLETED|Overall Study||34
9900232|NCT01132313|11015819|FG005|COMPLETED|Overall Study||54
9900233|NCT01132313|11015820|FG006|COMPLETED|Overall Study||19
9900234|NCT01132313|11015821|FG007|COMPLETED|Overall Study||24
9900235|NCT01132313|11015822|FG008|COMPLETED|Overall Study||5
9900236|NCT01132313|11015823|FG009|COMPLETED|Overall Study||5
9900237|NCT01132313|11015824|FG010|COMPLETED|Overall Study||0
9900238|NCT01132313|11015825|FG011|COMPLETED|Overall Study||2
9900239|NCT01132313|11015814|FG000|NOT COMPLETED|Overall Study||3
9900240|NCT01132313|11015815|FG001|NOT COMPLETED|Overall Study||0
9900241|NCT01132313|11015816|FG002|NOT COMPLETED|Overall Study||20
9900242|NCT01132313|11015817|FG003|NOT COMPLETED|Overall Study||32
9900243|NCT01132313|11015818|FG004|NOT COMPLETED|Overall Study||45
9900244|NCT01132313|11015819|FG005|NOT COMPLETED|Overall Study||25
9900245|NCT01132313|11015820|FG006|NOT COMPLETED|Overall Study||30
9900246|NCT01132313|11015821|FG007|NOT COMPLETED|Overall Study||8
9900247|NCT01132313|11015822|FG008|NOT COMPLETED|Overall Study||21
9900248|NCT01132313|11015823|FG009|NOT COMPLETED|Overall Study||20
9900249|NCT01132313|11015824|FG010|NOT COMPLETED|Overall Study||1
9900250|NCT01132313|11015825|FG011|NOT COMPLETED|Overall Study||0
9900251|NCT01132326|11015856|FG000|STARTED|Overall Study||350
9900252|NCT01132326|11015856|FG000|COMPLETED|Overall Study||132
9900253|NCT01132326|11015856|FG000|NOT COMPLETED|Overall Study||218
9900254|NCT01132378|11015860|FG000|STARTED|Overall Study||40
9900255|NCT01132378|11015860|FG000|COMPLETED|Overall Study||40
9900256|NCT01132378|11015860|FG000|NOT COMPLETED|Overall Study||0
9900257|NCT01132482|11015867|FG000|STARTED|Overall Study||13
9900258|NCT01132482|11015868|FG001|STARTED|Overall Study||6
9900259|NCT01132482|11015867|FG000|COMPLETED|Overall Study||12
9900260|NCT01132482|11015868|FG001|COMPLETED|Overall Study||6
9900261|NCT01132482|11015867|FG000|NOT COMPLETED|Overall Study||1
9900262|NCT01132482|11015868|FG001|NOT COMPLETED|Overall Study||0
9900263|NCT01132495|11015878|FG000|STARTED|Overall Study||447
9900264|NCT01132495|11015879|FG001|STARTED|Overall Study||441
9900265|NCT01132495|11015880|FG002|STARTED|Overall Study||166
9900266|NCT01132495|11015881|FG003|STARTED|Overall Study||116
9900267|NCT01132495|11015878|FG000|COMPLETED|Overall Study||407
9900268|NCT01132495|11015879|FG001|COMPLETED|Overall Study||403
9900269|NCT01132495|11015880|FG002|COMPLETED|Overall Study||146
9900270|NCT01132495|11015881|FG003|COMPLETED|Overall Study||104
9900271|NCT01132495|11015878|FG000|NOT COMPLETED|Overall Study||40
9900272|NCT01132495|11015879|FG001|NOT COMPLETED|Overall Study||38
9900273|NCT01132495|11015880|FG002|NOT COMPLETED|Overall Study||20
9900274|NCT01132495|11015881|FG003|NOT COMPLETED|Overall Study||12
9900275|NCT01132508|11015892|FG000|STARTED|Overall Study||33
9900276|NCT01132508|11015892|FG000|Treated at Baseline|Overall Study||33
9900277|NCT01132508|11015892|FG000|6 Weeks|Overall Study||33
9900278|NCT01132508|11015892|FG000|12 Weeks|Overall Study||33
9900279|NCT01132508|11015892|FG000|26 Weeks|Overall Study||33
9900280|NCT01132508|11015892|FG000|52 Weeks|Overall Study||30
9900281|NCT01132508|11015892|FG000|78 Weeks|Overall Study||28
9900282|NCT01132508|11015892|FG000|104 Weeks|Overall Study||27
9900283|NCT01132508|11015892|FG000|COMPLETED|Overall Study||24
9900284|NCT01132508|11015892|FG000|NOT COMPLETED|Overall Study||9
9900285|NCT01132547|11015898|FG000|STARTED|Overall Study||9
9900286|NCT01132547|11015899|FG001|STARTED|Overall Study||13
9900287|NCT01132547|11015898|FG000|COMPLETED|Overall Study||5
9900288|NCT01132547|11015899|FG001|COMPLETED|Overall Study||12
9900289|NCT01132547|11015898|FG000|NOT COMPLETED|Overall Study||4
9900290|NCT01132547|11015899|FG001|NOT COMPLETED|Overall Study||1
9900291|NCT01132612|11015908|FG000|STARTED|Overall Study||46
9900292|NCT01132612|11015909|FG001|STARTED|Overall Study||42
9900293|NCT01132612|11015910|FG002|STARTED|Overall Study||187
9900294|NCT01132612|11015908|FG000|COMPLETED|Overall Study||6
9900295|NCT01132612|11015909|FG001|COMPLETED|Overall Study||7
9900296|NCT01132612|11015910|FG002|COMPLETED|Overall Study||17
9900297|NCT01132612|11015908|FG000|NOT COMPLETED|Overall Study||40
9900298|NCT01132612|11015909|FG001|NOT COMPLETED|Overall Study||35
9900299|NCT01132612|11015910|FG002|NOT COMPLETED|Overall Study||170
9900300|NCT01132651|11015920|FG000|STARTED|Overall Study||4
9900301|NCT01132651|11015921|FG001|STARTED|Overall Study||5
9900302|NCT01132651|11015920|FG000|COMPLETED|Overall Study||3
9900303|NCT01132651|11015921|FG001|COMPLETED|Overall Study||4
9900304|NCT01132651|11015920|FG000|NOT COMPLETED|Overall Study||1
9900305|NCT01132651|11015921|FG001|NOT COMPLETED|Overall Study||1
9900306|NCT01132664|11015932|FG000|STARTED|Phase lb||5
9900307|NCT01132664|11015933|FG001|STARTED|Phase lb||12
9900308|NCT01132664|11015934|FG002|STARTED|Phase lb||0
9900309|NCT01132664|11015935|FG003|STARTED|Phase lb||0
9900310|NCT01132664|11015936|FG004|STARTED|Phase lb||0
9900311|NCT01132664|11015932|FG000|COMPLETED|Phase lb||0
9900312|NCT01132664|11015933|FG001|COMPLETED|Phase lb||0
9900313|NCT01132664|11015934|FG002|COMPLETED|Phase lb||0
9900314|NCT01132664|11015935|FG003|COMPLETED|Phase lb||0
9900315|NCT01132664|11015936|FG004|COMPLETED|Phase lb||0
9900316|NCT01132664|11015932|FG000|NOT COMPLETED|Phase lb||5
9900317|NCT01132664|11015933|FG001|NOT COMPLETED|Phase lb||12
9900318|NCT01132664|11015934|FG002|NOT COMPLETED|Phase lb||0
9900319|NCT01132664|11015935|FG003|NOT COMPLETED|Phase lb||0
9900320|NCT01132664|11015936|FG004|NOT COMPLETED|Phase lb||0
9900321|NCT01132664|11015932|FG000|STARTED|Phase ll||0
9900322|NCT01132664|11015933|FG001|STARTED|Phase ll||0
9900323|NCT01132664|11015934|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
9900324|NCT01132664|11015935|FG003|STARTED|Phase ll||0
9900325|NCT01132664|11015936|FG004|STARTED|Phase ll||0
9900326|NCT01132664|11015932|FG000|COMPLETED|Phase ll||0
9900327|NCT01132664|11015933|FG001|COMPLETED|Phase ll||0
9900328|NCT01132664|11015934|FG002|COMPLETED|Phase ll||0
9900329|NCT01132664|11015935|FG003|COMPLETED|Phase ll||0
9900330|NCT01132664|11015936|FG004|COMPLETED|Phase ll||0
9900331|NCT01132664|11015932|FG000|NOT COMPLETED|Phase ll||0
9900332|NCT01132664|11015933|FG001|NOT COMPLETED|Phase ll||0
9900333|NCT01132664|11015934|FG002|NOT COMPLETED|Phase ll||50
9900334|NCT01132664|11015935|FG003|NOT COMPLETED|Phase ll||0
9900335|NCT01132664|11015936|FG004|NOT COMPLETED|Phase ll||0
9900336|NCT01132664|11015932|FG000|STARTED|BM Cohort||0
9900337|NCT01132664|11015933|FG001|STARTED|BM Cohort||0
9900338|NCT01132664|11015934|FG002|STARTED|BM Cohort||0
9900339|NCT01132664|11015935|FG003|STARTED|BM Cohort||3
9900340|NCT01132664|11015936|FG004|STARTED|BM Cohort||6
9900341|NCT01132664|11015932|FG000|COMPLETED|BM Cohort||0
9900342|NCT01132664|11015933|FG001|COMPLETED|BM Cohort||0
9900343|NCT01132664|11015934|FG002|COMPLETED|BM Cohort||0
9900344|NCT01132664|11015935|FG003|COMPLETED|BM Cohort||0
9900345|NCT01132664|11015936|FG004|COMPLETED|BM Cohort||0
10009249|NCT01764945|11131788|FG003|COMPLETED|Overall Study||5
10009250|NCT01764945|11131789|FG004|COMPLETED|Overall Study||10
10009251|NCT01764945|11131790|FG005|COMPLETED|Overall Study||8
10009252|NCT01764945|11131791|FG006|COMPLETED|Overall Study||8
9900346|NCT01132664|11015932|FG000|NOT COMPLETED|BM Cohort||0
9900347|NCT01132664|11015933|FG001|NOT COMPLETED|BM Cohort||0
9900348|NCT01132664|11015934|FG002|NOT COMPLETED|BM Cohort||0
9900349|NCT01132664|11015935|FG003|NOT COMPLETED|BM Cohort||3
9900350|NCT01132664|11015936|FG004|NOT COMPLETED|BM Cohort||6
9900351|NCT01132690|11015950|FG000|STARTED|Overall Study||6
9900352|NCT01132690|11015951|FG001|STARTED|Overall Study||5
9900353|NCT01132690|11015950|FG000|COMPLETED|Overall Study||6
9900354|NCT01132690|11015951|FG001|COMPLETED|Overall Study||5
9900355|NCT01132690|11015950|FG000|NOT COMPLETED|Overall Study||0
9900356|NCT01132690|11015951|FG001|NOT COMPLETED|Overall Study||0
9900357|NCT01132755|11015957|FG000|STARTED|Overall Study||112
9900358|NCT01132755|11015957|FG000|COMPLETED|Overall Study||70
9900359|NCT01132755|11015957|FG000|NOT COMPLETED|Overall Study||42
9900360|NCT01132807|11015961|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15
9900361|NCT01132807|11015962|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135
9900362|NCT01132807|11015963|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14
10009253|NCT01764945|11131792|FG007|COMPLETED|Overall Study||9
10009254|NCT01764945|11131785|FG000|NOT COMPLETED|Overall Study||0
9900363|NCT01132807|11015961|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
9900364|NCT01132807|11015962|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
9900365|NCT01132807|11015963|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
9900366|NCT01132807|11015961|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
9900367|NCT01132807|11015962|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
9900368|NCT01132807|11015963|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
10009255|NCT01764945|11131786|FG001|NOT COMPLETED|Overall Study||1
10009256|NCT01764945|11131787|FG002|NOT COMPLETED|Overall Study||0
9900369|NCT01132807|11015961|FG000|STARTED|Post-Cycle 2 PET Assessment||0
9900370|NCT01132807|11015962|FG001|STARTED|Post-Cycle 2 PET Assessment||135
9900371|NCT01132807|11015963|FG002|STARTED|Post-Cycle 2 PET Assessment||14
9900372|NCT01132807|11015961|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0
9900373|NCT01132807|11015962|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135
9900374|NCT01132807|11015963|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14
9900375|NCT01132807|11015961|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
9900376|NCT01132807|11015962|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
9900377|NCT01132807|11015963|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
9900378|NCT01132820|11015971|FG000|STARTED|Overall Study||53
9900379|NCT01132820|11015971|FG000|COMPLETED|Overall Study||48
9900380|NCT01132820|11015971|FG000|NOT COMPLETED|Overall Study||5
9900381|NCT01132846|11015978|FG000|STARTED|Overall Study||122
9900382|NCT01132846|11015979|FG001|STARTED|Overall Study||119
9900383|NCT01132846|11015980|FG002|STARTED|Overall Study||119
9900384|NCT01132846|11015978|FG000|COMPLETED|Overall Study||106
9900385|NCT01132846|11015979|FG001|COMPLETED|Overall Study||101
9900386|NCT01132846|11015980|FG002|COMPLETED|Overall Study||108
9900387|NCT01132846|11015978|FG000|NOT COMPLETED|Overall Study||16
9900388|NCT01132846|11015979|FG001|NOT COMPLETED|Overall Study||18
9900389|NCT01132846|11015980|FG002|NOT COMPLETED|Overall Study||11
9900390|NCT01133067|11015990|FG000|STARTED|Overall Study||200
9900391|NCT01133067|11015990|FG000|COMPLETED|Overall Study||61
9900392|NCT01133067|11015990|FG000|NOT COMPLETED|Overall Study||139
9900393|NCT01133158|11015994|FG000|STARTED|Overall Study||60
9900394|NCT01133158|11015994|FG000|COMPLETED|Overall Study||43
9900395|NCT01133158|11015994|FG000|NOT COMPLETED|Overall Study||17
9900396|NCT01133171|11016003|FG000|STARTED|Overall Study||25
9900397|NCT01133171|11016004|FG001|STARTED|Overall Study||27
9900398|NCT01133171|11016005|FG002|STARTED|Overall Study||25
9900399|NCT01133171|11016003|FG000|COMPLETED|Overall Study||24
9900400|NCT01133171|11016004|FG001|COMPLETED|Overall Study||25
9900401|NCT01133171|11016005|FG002|COMPLETED|Overall Study||25
9900402|NCT01133171|11016003|FG000|NOT COMPLETED|Overall Study||1
9900403|NCT01133171|11016004|FG001|NOT COMPLETED|Overall Study||2
9900404|NCT01133171|11016005|FG002|NOT COMPLETED|Overall Study||0
9900405|NCT01133275|11016013|FG000|STARTED|Overall Study||28
9900406|NCT01133275|11016013|FG000|COMPLETED|Overall Study||26
9900407|NCT01133275|11016013|FG000|NOT COMPLETED|Overall Study||2
9900408|NCT01133379|11016020|FG000|STARTED|Overall Study||58
9900409|NCT01133379|11016021|FG001|STARTED|Overall Study||58
9900410|NCT01133379|11016022|FG002|STARTED|Overall Study||58
9900411|NCT01133379|11016020|FG000|COMPLETED|Overall Study||57
9900412|NCT01133379|11016021|FG001|COMPLETED|Overall Study||56
9900413|NCT01133379|11016022|FG002|COMPLETED|Overall Study||56
9900414|NCT01133379|11016020|FG000|NOT COMPLETED|Overall Study||1
9900415|NCT01133379|11016021|FG001|NOT COMPLETED|Overall Study||2
9900416|NCT01133379|11016022|FG002|NOT COMPLETED|Overall Study||2
9900417|NCT01133392|11016032|FG000|STARTED|First Intervention (1 Day )||20
9900418|NCT01133392|11016033|FG001|STARTED|First Intervention (1 Day )||18
9900419|NCT01133392|11016032|FG000|COMPLETED|First Intervention (1 Day )||20
9900420|NCT01133392|11016033|FG001|COMPLETED|First Intervention (1 Day )||18
9900421|NCT01133392|11016032|FG000|NOT COMPLETED|First Intervention (1 Day )||0
9900422|NCT01133392|11016033|FG001|NOT COMPLETED|First Intervention (1 Day )||0
9900423|NCT01133392|11016032|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
9900424|NCT01133392|11016033|FG001|STARTED|Interval Between Dosing (4-7 Days)||18
9900425|NCT01133392|11016032|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
9900426|NCT01133392|11016033|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
9900427|NCT01133392|11016032|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
9900428|NCT01133392|11016033|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
9900429|NCT01133392|11016032|FG000|STARTED|Second Intervention (1 Day)||20
9900430|NCT01133392|11016033|FG001|STARTED|Second Intervention (1 Day)||17
9900431|NCT01133392|11016032|FG000|COMPLETED|Second Intervention (1 Day)||20
9900432|NCT01133392|11016033|FG001|COMPLETED|Second Intervention (1 Day)||17
9900433|NCT01133392|11016032|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9900434|NCT01133392|11016033|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9900435|NCT01133392|11016032|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
9900436|NCT01133392|11016033|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
9900437|NCT01133392|11016032|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
9900438|NCT01133392|11016033|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
9900439|NCT01133392|11016032|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
9900440|NCT01133392|11016033|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
9900441|NCT01133392|11016032|FG000|STARTED|Third Intervention (1 Day)||20
10110339|NCT02484729|11241096|FG005|COMPLETED|Overall Study||6
9900442|NCT01133392|11016033|FG001|STARTED|Third Intervention (1 Day)||17
9900443|NCT01133392|11016032|FG000|COMPLETED|Third Intervention (1 Day)||20
9900444|NCT01133392|11016033|FG001|COMPLETED|Third Intervention (1 Day)||17
10110340|NCT02484729|11241097|FG006|COMPLETED|Overall Study||5
10110341|NCT02484729|11241098|FG007|COMPLETED|Overall Study||6
9900445|NCT01133392|11016032|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9900446|NCT01133392|11016033|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9900447|NCT01133392|11016032|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
9900448|NCT01133392|11016033|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
9900449|NCT01133392|11016032|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
9900450|NCT01133392|11016033|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16
9900451|NCT01133392|11016032|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
9900452|NCT01133392|11016033|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
9900453|NCT01133392|11016032|FG000|STARTED|Fourth Intervention (1 Day)||20
9900454|NCT01133392|11016033|FG001|STARTED|Fourth Intervention (1 Day)||16
9900455|NCT01133392|11016032|FG000|COMPLETED|Fourth Intervention (1 Day)||20
9900456|NCT01133392|11016033|FG001|COMPLETED|Fourth Intervention (1 Day)||16
9900457|NCT01133392|11016032|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
9900458|NCT01133392|11016033|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
9900459|NCT01133405|11016049|FG000|STARTED|Period 1||3
9900460|NCT01133405|11016050|FG001|STARTED|Period 1||6
9900461|NCT01133405|11016051|FG002|STARTED|Period 1||5
9900462|NCT01133405|11016052|FG003|STARTED|Period 1||5
9900463|NCT01133405|11016053|FG004|STARTED|Period 1||3
9900464|NCT01133405|11016054|FG005|STARTED|Period 1||5
9900465|NCT01133405|11016055|FG006|STARTED|Period 1||5
9900466|NCT01133405|11016056|FG007|STARTED|Period 1||2
9900467|NCT01133405|11016057|FG008|STARTED|Period 1||4
9900468|NCT01133405|11016058|FG009|STARTED|Period 1||2
9900469|NCT01133405|11016049|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
9900470|NCT01133405|11016050|FG001|Safety Analysis Population|Period 1||6
9900471|NCT01133405|11016051|FG002|Safety Analysis Population|Period 1||5
9900472|NCT01133405|11016052|FG003|Safety Analysis Population|Period 1||5
9900473|NCT01133405|11016053|FG004|Safety Analysis Population|Period 1||3
9900474|NCT01133405|11016054|FG005|Safety Analysis Population|Period 1||5
9900475|NCT01133405|11016055|FG006|Safety Analysis Population|Period 1||5
9900476|NCT01133405|11016056|FG007|Safety Analysis Population|Period 1||2
9900477|NCT01133405|11016057|FG008|Safety Analysis Population|Period 1||4
9900478|NCT01133405|11016058|FG009|Safety Analysis Population|Period 1||2
9900479|NCT01133405|11016049|FG000|Received at Least 1 Dose of Drug|Period 1||2
9900480|NCT01133405|11016050|FG001|Received at Least 1 Dose of Drug|Period 1||4
9900481|NCT01133405|11016051|FG002|Received at Least 1 Dose of Drug|Period 1||4
9900482|NCT01133405|11016052|FG003|Received at Least 1 Dose of Drug|Period 1||3
9900483|NCT01133405|11016053|FG004|Received at Least 1 Dose of Drug|Period 1||3
9900484|NCT01133405|11016054|FG005|Received at Least 1 Dose of Drug|Period 1||4
9900485|NCT01133405|11016055|FG006|Received at Least 1 Dose of Drug|Period 1||4
9900486|NCT01133405|11016056|FG007|Received at Least 1 Dose of Drug|Period 1||2
9900487|NCT01133405|11016057|FG008|Received at Least 1 Dose of Drug|Period 1||4
9900488|NCT01133405|11016058|FG009|Received at Least 1 Dose of Drug|Period 1||2
9900489|NCT01133405|11016049|FG000|COMPLETED|Period 1||2
9900490|NCT01133405|11016050|FG001|COMPLETED|Period 1||3
9900491|NCT01133405|11016051|FG002|COMPLETED|Period 1||4
9900492|NCT01133405|11016052|FG003|COMPLETED|Period 1||1
9900493|NCT01133405|11016053|FG004|COMPLETED|Period 1||3
9900494|NCT01133405|11016054|FG005|COMPLETED|Period 1||3
9900495|NCT01133405|11016055|FG006|COMPLETED|Period 1||4
9900496|NCT01133405|11016056|FG007|COMPLETED|Period 1||2
9900497|NCT01133405|11016057|FG008|COMPLETED|Period 1||4
9900498|NCT01133405|11016058|FG009|COMPLETED|Period 1||2
9900499|NCT01133405|11016049|FG000|NOT COMPLETED|Period 1||1
9900500|NCT01133405|11016050|FG001|NOT COMPLETED|Period 1||3
9900501|NCT01133405|11016051|FG002|NOT COMPLETED|Period 1||1
9900502|NCT01133405|11016052|FG003|NOT COMPLETED|Period 1||4
9900503|NCT01133405|11016053|FG004|NOT COMPLETED|Period 1||0
9900504|NCT01133405|11016054|FG005|NOT COMPLETED|Period 1||2
9900505|NCT01133405|11016055|FG006|NOT COMPLETED|Period 1||1
9900506|NCT01133405|11016056|FG007|NOT COMPLETED|Period 1||0
9900507|NCT01133405|11016057|FG008|NOT COMPLETED|Period 1||0
9900508|NCT01133405|11016058|FG009|NOT COMPLETED|Period 1||0
9900509|NCT01133405|11016049|FG000|STARTED|Period 2||2
9900510|NCT01133405|11016050|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
9900511|NCT01133405|11016051|FG002|STARTED|Period 2||4
9900512|NCT01133405|11016052|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
9900513|NCT01133405|11016053|FG004|STARTED|Period 2||3
9900514|NCT01133405|11016054|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
9900515|NCT01133405|11016055|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0
9900516|NCT01133405|11016056|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0
9900517|NCT01133405|11016057|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0
9900518|NCT01133405|11016058|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0
9900519|NCT01133405|11016049|FG000|Received at Least 1 Dose of Study Drug|Period 2||2
9900520|NCT01133405|11016050|FG001|Received at Least 1 Dose of Study Drug|Period 2||4
9900521|NCT01133405|11016051|FG002|Received at Least 1 Dose of Study Drug|Period 2||4
9900522|NCT01133405|11016052|FG003|Received at Least 1 Dose of Study Drug|Period 2||3
9900523|NCT01133405|11016053|FG004|Received at Least 1 Dose of Study Drug|Period 2||3
9900524|NCT01133405|11016054|FG005|Received at Least 1 Dose of Study Drug|Period 2||4
9900525|NCT01133405|11016055|FG006|Received at Least 1 Dose of Study Drug|Period 2||0
9900526|NCT01133405|11016056|FG007|Received at Least 1 Dose of Study Drug|Period 2||0
9900527|NCT01133405|11016057|FG008|Received at Least 1 Dose of Study Drug|Period 2||0
9900528|NCT01133405|11016058|FG009|Received at Least 1 Dose of Study Drug|Period 2||0
9900529|NCT01133405|11016049|FG000|COMPLETED|Period 2||2
9900530|NCT01133405|11016050|FG001|COMPLETED|Period 2||3
9900531|NCT01133405|11016051|FG002|COMPLETED|Period 2||3
9900532|NCT01133405|11016052|FG003|COMPLETED|Period 2||2
9900533|NCT01133405|11016053|FG004|COMPLETED|Period 2||3
9900534|NCT01133405|11016054|FG005|COMPLETED|Period 2||2
9900535|NCT01133405|11016055|FG006|COMPLETED|Period 2||0
9900536|NCT01133405|11016056|FG007|COMPLETED|Period 2||0
9900537|NCT01133405|11016057|FG008|COMPLETED|Period 2||0
9900538|NCT01133405|11016058|FG009|COMPLETED|Period 2||0
9900539|NCT01133405|11016049|FG000|NOT COMPLETED|Period 2||0
9900540|NCT01133405|11016050|FG001|NOT COMPLETED|Period 2||1
9900541|NCT01133405|11016051|FG002|NOT COMPLETED|Period 2||1
9900542|NCT01133405|11016052|FG003|NOT COMPLETED|Period 2||1
9900543|NCT01133405|11016053|FG004|NOT COMPLETED|Period 2||0
9900544|NCT01133405|11016054|FG005|NOT COMPLETED|Period 2||2
9900545|NCT01133405|11016055|FG006|NOT COMPLETED|Period 2||0
9900546|NCT01133405|11016056|FG007|NOT COMPLETED|Period 2||0
9900547|NCT01133405|11016057|FG008|NOT COMPLETED|Period 2||0
9900548|NCT01133405|11016058|FG009|NOT COMPLETED|Period 2||0
9900549|NCT01133405|11016049|FG000|STARTED|Period 3||2
9900550|NCT01133405|11016050|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4
9900551|NCT01133405|11016051|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
9900552|NCT01133405|11016052|FG003|STARTED|Period 3||2
9900553|NCT01133405|11016053|FG004|STARTED|Period 3||3
9900554|NCT01133405|11016054|FG005|STARTED|Period 3||2
9900555|NCT01133405|11016055|FG006|STARTED|Period 3||0
9900556|NCT01133405|11016056|FG007|STARTED|Period 3||0
9900557|NCT01133405|11016057|FG008|STARTED|Period 3||0
9900558|NCT01133405|11016058|FG009|STARTED|Period 3||0
9900559|NCT01133405|11016049|FG000|Received at Least 1 Dose of Study Drug|Period 3||2
9900560|NCT01133405|11016050|FG001|Received at Least 1 Dose of Study Drug|Period 3||4
9900561|NCT01133405|11016051|FG002|Received at Least 1 Dose of Study Drug|Period 3||4
9900562|NCT01133405|11016052|FG003|Received at Least 1 Dose of Study Drug|Period 3||2
9900563|NCT01133405|11016053|FG004|Received at Least 1 Dose of Study Drug|Period 3||3
9900564|NCT01133405|11016054|FG005|Received at Least 1 Dose of Study Drug|Period 3||2
9900565|NCT01133405|11016055|FG006|Received at Least 1 Dose of Study Drug|Period 3||0
9900566|NCT01133405|11016056|FG007|Received at Least 1 Dose of Study Drug|Period 3||0
9900567|NCT01133405|11016057|FG008|Received at Least 1 Dose of Study Drug|Period 3||0
9900568|NCT01133405|11016058|FG009|Received at Least 1 Dose of Study Drug|Period 3||0
9900569|NCT01133405|11016049|FG000|COMPLETED|Period 3||2
9900570|NCT01133405|11016050|FG001|COMPLETED|Period 3||4
9900571|NCT01133405|11016051|FG002|COMPLETED|Period 3||4
9900572|NCT01133405|11016052|FG003|COMPLETED|Period 3||2
9900573|NCT01133405|11016053|FG004|COMPLETED|Period 3||3
9900574|NCT01133405|11016054|FG005|COMPLETED|Period 3||2
10009257|NCT01764945|11131788|FG003|NOT COMPLETED|Overall Study||0
10009258|NCT01764945|11131789|FG004|NOT COMPLETED|Overall Study||0
10009259|NCT01764945|11131790|FG005|NOT COMPLETED|Overall Study||0
10009260|NCT01764945|11131791|FG006|NOT COMPLETED|Overall Study||1
9900575|NCT01133405|11016055|FG006|COMPLETED|Period 3||0
9900576|NCT01133405|11016056|FG007|COMPLETED|Period 3||0
9900577|NCT01133405|11016057|FG008|COMPLETED|Period 3||0
9900578|NCT01133405|11016058|FG009|COMPLETED|Period 3||0
9900579|NCT01133405|11016049|FG000|NOT COMPLETED|Period 3||0
9900580|NCT01133405|11016050|FG001|NOT COMPLETED|Period 3||0
9900581|NCT01133405|11016051|FG002|NOT COMPLETED|Period 3||0
9900582|NCT01133405|11016052|FG003|NOT COMPLETED|Period 3||0
9900583|NCT01133405|11016053|FG004|NOT COMPLETED|Period 3||0
9900584|NCT01133405|11016054|FG005|NOT COMPLETED|Period 3||0
9900585|NCT01133405|11016055|FG006|NOT COMPLETED|Period 3||0
9900586|NCT01133405|11016056|FG007|NOT COMPLETED|Period 3||0
9900587|NCT01133405|11016057|FG008|NOT COMPLETED|Period 3||0
9900588|NCT01133405|11016058|FG009|NOT COMPLETED|Period 3||0
9900589|NCT01133418|11016090|FG000|STARTED|Overall Study||34
9900590|NCT01133418|11016091|FG001|STARTED|Overall Study||38
9900591|NCT01133418|11016090|FG000|COMPLETED|Overall Study||29
9900592|NCT01133418|11016091|FG001|COMPLETED|Overall Study||32
9900593|NCT01133418|11016090|FG000|NOT COMPLETED|Overall Study||5
9900594|NCT01133418|11016091|FG001|NOT COMPLETED|Overall Study||6
9900595|NCT01133522|11016107|FG000|STARTED|Overall Study||10
9900596|NCT01133522|11016108|FG001|STARTED|Overall Study||7
9900597|NCT01133522|11016109|FG002|STARTED|Overall Study||6
9900598|NCT01133522|11016110|FG003|STARTED|Overall Study||7
9900599|NCT01133522|11016111|FG004|STARTED|Overall Study||7
9900600|NCT01133522|11016112|FG005|STARTED|Overall Study||6
9900601|NCT01133522|11016113|FG006|STARTED|Overall Study||2
9900602|NCT01133522|11016114|FG007|STARTED|Overall Study||9
9900603|NCT01133522|11016115|FG008|STARTED|Overall Study||2
9900604|NCT01133522|11016116|FG009|STARTED|Overall Study||4
9900605|NCT01133522|11016107|FG000|Received Treatment|Overall Study||10
9900606|NCT01133522|11016108|FG001|Received Treatment|Overall Study||6
9900607|NCT01133522|11016109|FG002|Received Treatment|Overall Study||6
9900608|NCT01133522|11016110|FG003|Received Treatment|Overall Study||6
9900609|NCT01133522|11016111|FG004|Received Treatment|Overall Study||6
9900610|NCT01133522|11016112|FG005|Received Treatment|Overall Study||6
10009261|NCT01764945|11131792|FG007|NOT COMPLETED|Overall Study||0
9900611|NCT01133522|11016113|FG006|Received Treatment|Overall Study||2
9900612|NCT01133522|11016114|FG007|Received Treatment|Overall Study||9
9900613|NCT01133522|11016115|FG008|Received Treatment|Overall Study||2
9900614|NCT01133522|11016116|FG009|Received Treatment|Overall Study||4
9900615|NCT01133522|11016107|FG000|COMPLETED|Overall Study||10
9900616|NCT01133522|11016108|FG001|COMPLETED|Overall Study||6
9900617|NCT01133522|11016109|FG002|COMPLETED|Overall Study||6
9900618|NCT01133522|11016110|FG003|COMPLETED|Overall Study||6
9900619|NCT01133522|11016111|FG004|COMPLETED|Overall Study||6
9900620|NCT01133522|11016112|FG005|COMPLETED|Overall Study||6
10009262|NCT01765153|11131812|FG000|STARTED|Training Phase 1||10
9900621|NCT01133522|11016113|FG006|COMPLETED|Overall Study||2
10110342|NCT02484729|11241099|FG008|COMPLETED|Overall Study||6
10110343|NCT02484729|11241100|FG009|COMPLETED|Overall Study||7
10110344|NCT02484729|11241091|FG000|NOT COMPLETED|Overall Study||0
9900622|NCT01133522|11016114|FG007|COMPLETED|Overall Study||9
9900623|NCT01133522|11016115|FG008|COMPLETED|Overall Study||2
10110345|NCT02484729|11241092|FG001|NOT COMPLETED|Overall Study||0
10110346|NCT02484729|11241093|FG002|NOT COMPLETED|Overall Study||0
10110347|NCT02484729|11241094|FG003|NOT COMPLETED|Overall Study||0
10110348|NCT02484729|11241095|FG004|NOT COMPLETED|Overall Study||0
10110349|NCT02484729|11241096|FG005|NOT COMPLETED|Overall Study||0
10110350|NCT02484729|11241097|FG006|NOT COMPLETED|Overall Study||0
9900624|NCT01133522|11016116|FG009|COMPLETED|Overall Study||4
9900625|NCT01133522|11016107|FG000|NOT COMPLETED|Overall Study||0
9900626|NCT01133522|11016108|FG001|NOT COMPLETED|Overall Study||1
10110351|NCT02484729|11241098|FG007|NOT COMPLETED|Overall Study||0
10110352|NCT02484729|11241099|FG008|NOT COMPLETED|Overall Study||0
9900627|NCT01133522|11016109|FG002|NOT COMPLETED|Overall Study||0
9900628|NCT01133522|11016110|FG003|NOT COMPLETED|Overall Study||1
9900629|NCT01133522|11016111|FG004|NOT COMPLETED|Overall Study||1
9900630|NCT01133522|11016112|FG005|NOT COMPLETED|Overall Study||0
9900631|NCT01133522|11016113|FG006|NOT COMPLETED|Overall Study||0
9900632|NCT01133522|11016114|FG007|NOT COMPLETED|Overall Study||0
9900633|NCT01133522|11016115|FG008|NOT COMPLETED|Overall Study||0
9900634|NCT01133522|11016116|FG009|NOT COMPLETED|Overall Study||0
9900635|NCT01133626|11016148|FG000|STARTED|Overall Study||50
9900636|NCT01133626|11016149|FG001|STARTED|Overall Study||46
9900637|NCT01133626|11016150|FG002|STARTED|Overall Study||11
9900638|NCT01133626|11016148|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
9900639|NCT01133626|11016149|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
9900640|NCT01133626|11016150|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
9900641|NCT01133626|11016148|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
9900642|NCT01133626|11016149|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
9900643|NCT01133626|11016150|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
9900644|NCT01133626|11016148|FG000|COMPLETED|Overall Study||49
9900645|NCT01133626|11016149|FG001|COMPLETED|Overall Study||41
9900646|NCT01133626|11016150|FG002|COMPLETED|Overall Study||9
9900647|NCT01133626|11016148|FG000|NOT COMPLETED|Overall Study||1
9900648|NCT01133626|11016149|FG001|NOT COMPLETED|Overall Study||5
9900649|NCT01133626|11016150|FG002|NOT COMPLETED|Overall Study||2
9900650|NCT01133665|11016158|FG000|STARTED|Overall Study||42
9900651|NCT01133665|11016158|FG000|COMPLETED|Overall Study||40
9900652|NCT01133665|11016158|FG000|NOT COMPLETED|Overall Study||2
9900653|NCT01133678|11016164|FG000|STARTED|Overall Study||25
9900654|NCT01133678|11016165|FG001|STARTED|Overall Study||25
9900655|NCT01133678|11016164|FG000|COMPLETED|Overall Study||24
9900656|NCT01133678|11016165|FG001|COMPLETED|Overall Study||24
9900657|NCT01133678|11016164|FG000|NOT COMPLETED|Overall Study||1
9900658|NCT01133678|11016165|FG001|NOT COMPLETED|Overall Study||1
9900659|NCT01133704|11016173|FG000|STARTED|Overall Study||65
9900660|NCT01133704|11016174|FG001|STARTED|Overall Study||33
9900661|NCT01133704|11016173|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16
9900662|NCT01133704|11016174|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7
9900663|NCT01133704|11016173|FG000|NOT COMPLETED|Overall Study||49
9900664|NCT01133704|11016174|FG001|NOT COMPLETED|Overall Study||26
9900665|NCT01133756|11016183|FG000|STARTED|Overall Study||2
9900666|NCT01133756|11016184|FG001|STARTED|Overall Study||3
9900667|NCT01133756|11016185|FG002|STARTED|Overall Study||2
9900668|NCT01133756|11016183|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
9900669|NCT01133756|11016184|FG001|Completed 6 Cycles|Overall Study||0
9900670|NCT01133756|11016185|FG002|Completed 6 Cycles|Overall Study||0
9900671|NCT01133756|11016183|FG000|COMPLETED|Overall Study||0
9900672|NCT01133756|11016184|FG001|COMPLETED|Overall Study||0
9900673|NCT01133756|11016185|FG002|COMPLETED|Overall Study||0
9900674|NCT01133756|11016183|FG000|NOT COMPLETED|Overall Study||2
9900675|NCT01133756|11016184|FG001|NOT COMPLETED|Overall Study||3
9900676|NCT01133756|11016185|FG002|NOT COMPLETED|Overall Study||2
9900677|NCT01133821|11016195|FG000|STARTED|Overall Study||45
9900678|NCT01133821|11016196|FG001|STARTED|Overall Study||47
9900679|NCT01133821|11016195|FG000|COMPLETED|Overall Study||27
9900680|NCT01133821|11016196|FG001|COMPLETED|Overall Study||28
9900681|NCT01133821|11016195|FG000|NOT COMPLETED|Overall Study||18
9900682|NCT01133821|11016196|FG001|NOT COMPLETED|Overall Study||19
10110353|NCT02484729|11241100|FG009|NOT COMPLETED|Overall Study||1
10110354|NCT02484807|11241140|FG000|STARTED|Overall Study||39
10110355|NCT02484807|11241141|FG001|STARTED|Overall Study||7
10110356|NCT02484807|11241142|FG002|STARTED|Overall Study||19
9900683|NCT01133847|11016205|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78
9900684|NCT01133847|11016206|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74
9900685|NCT01133847|11016207|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70
9900686|NCT01133847|11016205|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
9900687|NCT01133847|11016206|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
9900688|NCT01133847|11016207|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
9900689|NCT01133847|11016205|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
9900690|NCT01133847|11016206|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
9900691|NCT01133847|11016207|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
9900692|NCT01133847|11016205|FG000|STARTED|Follow-Up Phase||73
9900693|NCT01133847|11016206|FG001|STARTED|Follow-Up Phase||73
9900694|NCT01133847|11016207|FG002|STARTED|Follow-Up Phase||67
9900695|NCT01133847|11016205|FG000|COMPLETED|Follow-Up Phase||72
9900696|NCT01133847|11016206|FG001|COMPLETED|Follow-Up Phase||70
9900697|NCT01133847|11016207|FG002|COMPLETED|Follow-Up Phase||60
9900698|NCT01133847|11016205|FG000|NOT COMPLETED|Follow-Up Phase||1
10110357|NCT02484807|11241143|FG003|STARTED|Overall Study||21
10110358|NCT02484807|11241144|FG004|STARTED|Overall Study||33
10110359|NCT02484807|11241145|FG005|STARTED|Overall Study||6
10110360|NCT02484807|11241140|FG000|COMPLETED|Overall Study||39
10110361|NCT02484807|11241141|FG001|COMPLETED|Overall Study||7
10110362|NCT02484807|11241142|FG002|COMPLETED|Overall Study||19
10110363|NCT02484807|11241143|FG003|COMPLETED|Overall Study||21
10110364|NCT02484807|11241144|FG004|COMPLETED|Overall Study||33
9900699|NCT01133847|11016206|FG001|NOT COMPLETED|Follow-Up Phase||3
9900700|NCT01133847|11016207|FG002|NOT COMPLETED|Follow-Up Phase||7
9900701|NCT01133860|11016216|FG000|STARTED|Overall Study||12
9900702|NCT01133860|11016216|FG000|COMPLETED|Overall Study||12
9900703|NCT01133860|11016216|FG000|NOT COMPLETED|Overall Study||0
9900704|NCT01133977|11016226|FG000|STARTED|Overall Study|Treated|3
9900705|NCT01133977|11016227|FG001|STARTED|Overall Study|Treated|7
9900706|NCT01133977|11016228|FG002|STARTED|Overall Study|Treated|6
9900707|NCT01133977|11016229|FG003|STARTED|Overall Study|Treated|42
9900708|NCT01133977|11016230|FG004|STARTED|Overall Study|Treated|39
9900709|NCT01133977|11016226|FG000|COMPLETED|Overall Study||0
9900710|NCT01133977|11016227|FG001|COMPLETED|Overall Study||0
9900711|NCT01133977|11016228|FG002|COMPLETED|Overall Study||0
9900712|NCT01133977|11016229|FG003|COMPLETED|Overall Study||3
9900713|NCT01133977|11016230|FG004|COMPLETED|Overall Study||1
9900714|NCT01133977|11016226|FG000|NOT COMPLETED|Overall Study||3
9900715|NCT01133977|11016227|FG001|NOT COMPLETED|Overall Study||7
9900716|NCT01133977|11016228|FG002|NOT COMPLETED|Overall Study||6
9900717|NCT01133977|11016229|FG003|NOT COMPLETED|Overall Study||39
9900718|NCT01133977|11016230|FG004|NOT COMPLETED|Overall Study||38
9900719|NCT01134016|11016245|FG000|STARTED|Overall Study||13
9900720|NCT01134016|11016245|FG000|COMPLETED|Overall Study||10
9900721|NCT01134016|11016245|FG000|NOT COMPLETED|Overall Study||3
9900722|NCT01134042|11016281|FG000|STARTED|Overall Study||194
9900723|NCT01134042|11016282|FG001|STARTED|Overall Study||197
9900724|NCT01134042|11016283|FG002|STARTED|Overall Study||195
9900725|NCT01134042|11016281|FG000|COMPLETED|Overall Study||146
9900726|NCT01134042|11016282|FG001|COMPLETED|Overall Study||169
9900727|NCT01134042|11016283|FG002|COMPLETED|Overall Study||161
9900728|NCT01134042|11016281|FG000|NOT COMPLETED|Overall Study||48
9900729|NCT01134042|11016282|FG001|NOT COMPLETED|Overall Study||28
9900730|NCT01134042|11016283|FG002|NOT COMPLETED|Overall Study||34
9900731|NCT01134055|11016299|FG000|STARTED|Overall Study||73
9900732|NCT01134055|11016300|FG001|STARTED|Overall Study||72
9900733|NCT01134055|11016301|FG002|STARTED|Overall Study||74
9900734|NCT01134055|11016302|FG003|STARTED|Overall Study||73
9900735|NCT01134055|11016303|FG004|STARTED|Overall Study||73
9900736|NCT01134055|11016304|FG005|STARTED|Overall Study||72
9900737|NCT01134055|11016305|FG006|STARTED|Overall Study||73
9900738|NCT01134055|11016299|FG000|COMPLETED|Overall Study||65
9900739|NCT01134055|11016300|FG001|COMPLETED|Overall Study||66
9900740|NCT01134055|11016301|FG002|COMPLETED|Overall Study||71
9900741|NCT01134055|11016302|FG003|COMPLETED|Overall Study||67
9900742|NCT01134055|11016303|FG004|COMPLETED|Overall Study||67
9900743|NCT01134055|11016304|FG005|COMPLETED|Overall Study||65
9900744|NCT01134055|11016305|FG006|COMPLETED|Overall Study||62
9900745|NCT01134055|11016299|FG000|NOT COMPLETED|Overall Study||8
9900746|NCT01134055|11016300|FG001|NOT COMPLETED|Overall Study||6
9900747|NCT01134055|11016301|FG002|NOT COMPLETED|Overall Study||3
9900748|NCT01134055|11016302|FG003|NOT COMPLETED|Overall Study||6
9900749|NCT01134055|11016303|FG004|NOT COMPLETED|Overall Study||6
9900750|NCT01134055|11016304|FG005|NOT COMPLETED|Overall Study||7
9900751|NCT01134055|11016305|FG006|NOT COMPLETED|Overall Study||11
9900752|NCT01134081|11016327|FG000|STARTED|Overall Study||44
9900753|NCT01134081|11016327|FG000|COMPLETED|Overall Study||44
9900754|NCT01134081|11016327|FG000|NOT COMPLETED|Overall Study||0
9900755|NCT01134107|11016337|FG000|STARTED|Period 1-First Treatment Intervention||67
9900756|NCT01134107|11016338|FG001|STARTED|Period 1-First Treatment Intervention||66
10110365|NCT02484807|11241145|FG005|COMPLETED|Overall Study||6
10110366|NCT02484807|11241140|FG000|NOT COMPLETED|Overall Study||0
9900757|NCT01134107|11016337|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
9900758|NCT01134107|11016338|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
9900759|NCT01134107|11016337|FG000|COMPLETED|Period 1-First Treatment Intervention||61
9900760|NCT01134107|11016338|FG001|COMPLETED|Period 1-First Treatment Intervention||61
9900761|NCT01134107|11016337|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6
10110367|NCT02484807|11241141|FG001|NOT COMPLETED|Overall Study||0
9900762|NCT01134107|11016338|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5
9900763|NCT01134107|11016337|FG000|STARTED|Period 2-Second Treatment Intervention||61
9900764|NCT01134107|11016338|FG001|STARTED|Period 2-Second Treatment Intervention||61
9900765|NCT01134107|11016337|FG000|COMPLETED|Period 2-Second Treatment Intervention||57
9955049|NCT01435824|11073945|FG001|STARTED|Washout of 1-2 Weeks||8
9900766|NCT01134107|11016338|FG001|COMPLETED|Period 2-Second Treatment Intervention||61
9900767|NCT01134107|11016337|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4
9900768|NCT01134107|11016338|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0
9900769|NCT01134198|11016346|FG000|STARTED|Phase 1||16
9900770|NCT01134198|11016347|FG001|STARTED|Phase 1||13
9900771|NCT01134198|11016346|FG000|COMPLETED|Phase 1||9
9900772|NCT01134198|11016347|FG001|COMPLETED|Phase 1||11
9900773|NCT01134198|11016346|FG000|NOT COMPLETED|Phase 1||7
9900774|NCT01134198|11016347|FG001|NOT COMPLETED|Phase 1||2
9900775|NCT01134198|11016346|FG000|STARTED|Phase 2||9
9900776|NCT01134198|11016347|FG001|STARTED|Phase 2||11
9900777|NCT01134198|11016346|FG000|COMPLETED|Phase 2||9
9900778|NCT01134198|11016347|FG001|COMPLETED|Phase 2||7
9900779|NCT01134198|11016346|FG000|NOT COMPLETED|Phase 2||0
9900780|NCT01134198|11016347|FG001|NOT COMPLETED|Phase 2||4
9900781|NCT01134263|11016358|FG000|STARTED|Overall Study||164
9900782|NCT01134263|11016359|FG001|STARTED|Overall Study||163
9900783|NCT01134263|11016360|FG002|STARTED|Overall Study||163
9900784|NCT01134263|11016361|FG003|STARTED|Overall Study||168
9900785|NCT01134263|11016362|FG004|STARTED|Overall Study||57
10009263|NCT01765153|11131813|FG001|STARTED|Training Phase 1||11
10009264|NCT01765153|11131812|FG000|COMPLETED|Training Phase 1||9
10009265|NCT01765153|11131813|FG001|COMPLETED|Training Phase 1||10
9900786|NCT01134263|11016358|FG000|Received Vaccination 1|Overall Study||163
9900787|NCT01134263|11016359|FG001|Received Vaccination 1|Overall Study||162
9900788|NCT01134263|11016360|FG002|Received Vaccination 1|Overall Study||163
9900789|NCT01134263|11016361|FG003|Received Vaccination 1|Overall Study||167
9900790|NCT01134263|11016362|FG004|Received Vaccination 1|Overall Study||57
9900791|NCT01134263|11016358|FG000|Received Vaccination 2|Overall Study||151
9900792|NCT01134263|11016359|FG001|Received Vaccination 2|Overall Study||152
9900793|NCT01134263|11016360|FG002|Received Vaccination 2|Overall Study||139
9900794|NCT01134263|11016361|FG003|Received Vaccination 2|Overall Study||154
9900795|NCT01134263|11016362|FG004|Received Vaccination 2|Overall Study||53
9900796|NCT01134263|11016358|FG000|Received Vaccination 3|Overall Study||140
9900797|NCT01134263|11016359|FG001|Received Vaccination 3|Overall Study||145
9900798|NCT01134263|11016360|FG002|Received Vaccination 3|Overall Study||134
9900799|NCT01134263|11016361|FG003|Received Vaccination 3|Overall Study||151
9900800|NCT01134263|11016362|FG004|Received Vaccination 3|Overall Study||49
9900801|NCT01134263|11016358|FG000|Safety Population|Overall Study||163
9900802|NCT01134263|11016359|FG001|Safety Population|Overall Study||161
9900803|NCT01134263|11016360|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
9900804|NCT01134263|11016361|FG003|Safety Population|Overall Study||167
9900805|NCT01134263|11016362|FG004|Safety Population|Overall Study||57
9900806|NCT01134263|11016358|FG000|COMPLETED|Overall Study||140
9900807|NCT01134263|11016359|FG001|COMPLETED|Overall Study||143
9900808|NCT01134263|11016360|FG002|COMPLETED|Overall Study||134
9900809|NCT01134263|11016361|FG003|COMPLETED|Overall Study||149
9900810|NCT01134263|11016362|FG004|COMPLETED|Overall Study||48
9900811|NCT01134263|11016358|FG000|NOT COMPLETED|Overall Study||24
9900812|NCT01134263|11016359|FG001|NOT COMPLETED|Overall Study||20
9900813|NCT01134263|11016360|FG002|NOT COMPLETED|Overall Study||29
9900814|NCT01134263|11016361|FG003|NOT COMPLETED|Overall Study||19
9900815|NCT01134263|11016362|FG004|NOT COMPLETED|Overall Study||9
9900816|NCT01134276|11016382|FG000|STARTED|Overall Study||104
9900817|NCT01134276|11016383|FG001|STARTED|Overall Study||107
9900818|NCT01134276|11016382|FG000|COMPLETED|Overall Study||104
9900819|NCT01134276|11016383|FG001|COMPLETED|Overall Study||107
9900820|NCT01134276|11016382|FG000|NOT COMPLETED|Overall Study||0
9900821|NCT01134276|11016383|FG001|NOT COMPLETED|Overall Study||0
9900822|NCT01134315|11016394|FG000|STARTED|Overall Study||21
9900823|NCT01134315|11016395|FG001|STARTED|Overall Study||40
9900824|NCT01134315|11016394|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
9900825|NCT01134315|11016395|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
9900826|NCT01134315|11016394|FG000|NOT COMPLETED|Overall Study||9
9900827|NCT01134315|11016395|FG001|NOT COMPLETED|Overall Study||19
9900828|NCT01134328|11016405|FG000|STARTED|Overall Study||21
9900829|NCT01134328|11016406|FG001|STARTED|Overall Study||21
9900830|NCT01134328|11016407|FG002|STARTED|Overall Study||20
9900831|NCT01134328|11016408|FG003|STARTED|Overall Study||21
9900832|NCT01134328|11016405|FG000|COMPLETED|Overall Study||19
10009266|NCT01765153|11131812|FG000|NOT COMPLETED|Training Phase 1||1
10009267|NCT01765153|11131813|FG001|NOT COMPLETED|Training Phase 1||1
10009268|NCT01765153|11131812|FG000|STARTED|Rest Phase 1||9
10009269|NCT01765153|11131813|FG001|STARTED|Rest Phase 1||10
10009270|NCT01765153|11131812|FG000|COMPLETED|Rest Phase 1||9
10009271|NCT01765153|11131813|FG001|COMPLETED|Rest Phase 1||9
9900833|NCT01134328|11016406|FG001|COMPLETED|Overall Study||18
9900834|NCT01134328|11016407|FG002|COMPLETED|Overall Study||17
9900835|NCT01134328|11016408|FG003|COMPLETED|Overall Study||17
9900836|NCT01134328|11016405|FG000|NOT COMPLETED|Overall Study||2
9900837|NCT01134328|11016406|FG001|NOT COMPLETED|Overall Study||3
9900838|NCT01134328|11016407|FG002|NOT COMPLETED|Overall Study||3
9900839|NCT01134328|11016408|FG003|NOT COMPLETED|Overall Study||4
9900840|NCT01134393|11016418|FG000|STARTED|Overall Study|Entered and treated.|501
9900841|NCT01134393|11016418|FG000|COMPLETED|Overall Study|Completed trial medication.|449
10009272|NCT01765153|11131812|FG000|NOT COMPLETED|Rest Phase 1||0
10009273|NCT01765153|11131813|FG001|NOT COMPLETED|Rest Phase 1||1
9900842|NCT01134393|11016418|FG000|NOT COMPLETED|Overall Study||52
9900843|NCT01134510|11016425|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
9900844|NCT01134510|11016426|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
9900845|NCT01134510|11016425|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
9900846|NCT01134510|11016426|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
9900847|NCT01134510|11016425|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
9900848|NCT01134510|11016426|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
9900849|NCT01134510|11016425|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
9900850|NCT01134510|11016426|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
9900851|NCT01134510|11016425|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
9900852|NCT01134510|11016426|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
9900853|NCT01134510|11016425|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
9900854|NCT01134510|11016426|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
9900855|NCT01134510|11016425|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
9900856|NCT01134510|11016426|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
9900857|NCT01134510|11016425|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
9900858|NCT01134510|11016426|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
9900859|NCT01134510|11016425|FG000|Month 1|Overall Study||10
9900860|NCT01134510|11016426|FG001|Month 1|Overall Study||10
9900861|NCT01134510|11016425|FG000|Month 3|Overall Study||10
9900862|NCT01134510|11016426|FG001|Month 3|Overall Study||9
9900863|NCT01134510|11016425|FG000|COMPLETED|Overall Study||10
9900864|NCT01134510|11016426|FG001|COMPLETED|Overall Study||9
9900865|NCT01134510|11016425|FG000|NOT COMPLETED|Overall Study||0
9900866|NCT01134510|11016426|FG001|NOT COMPLETED|Overall Study||1
9900867|NCT01129011|11016437|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210
9900868|NCT01129011|11016438|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210
9900869|NCT01129011|11016437|FG000|COMPLETED|Overall Study||151
9900870|NCT01129011|11016438|FG001|COMPLETED|Overall Study||153
9900871|NCT01129011|11016437|FG000|NOT COMPLETED|Overall Study||59
9900872|NCT01129011|11016438|FG001|NOT COMPLETED|Overall Study||57
9900873|NCT01134549|11016449|FG000|STARTED|Overall Study||8
9900874|NCT01134549|11016450|FG001|STARTED|Overall Study||6
9900875|NCT01134549|11016451|FG002|STARTED|Overall Study||6
9900876|NCT01134549|11016452|FG003|STARTED|Overall Study||6
9900877|NCT01134549|11016453|FG004|STARTED|Overall Study||6
9900878|NCT01134549|11016449|FG000|COMPLETED|Overall Study||8
9900879|NCT01134549|11016450|FG001|COMPLETED|Overall Study||6
9900880|NCT01134549|11016451|FG002|COMPLETED|Overall Study||6
9900881|NCT01134549|11016452|FG003|COMPLETED|Overall Study||6
9900882|NCT01134549|11016453|FG004|COMPLETED|Overall Study||6
9900883|NCT01134549|11016449|FG000|NOT COMPLETED|Overall Study||0
9900884|NCT01134549|11016450|FG001|NOT COMPLETED|Overall Study||0
9900885|NCT01134549|11016451|FG002|NOT COMPLETED|Overall Study||0
9900886|NCT01134549|11016452|FG003|NOT COMPLETED|Overall Study||0
9900887|NCT01134549|11016453|FG004|NOT COMPLETED|Overall Study||0
9900888|NCT01134562|11016475|FG000|STARTED|Overall Study||4
9900889|NCT01134562|11016476|FG001|STARTED|Overall Study||4
9900890|NCT01134562|11016477|FG002|STARTED|Overall Study||4
9900891|NCT01134562|11016478|FG003|STARTED|Overall Study||8
9900892|NCT01134562|11016479|FG004|STARTED|Overall Study||8
9900893|NCT01134562|11016475|FG000|COMPLETED|Overall Study||4
9900894|NCT01134562|11016476|FG001|COMPLETED|Overall Study||3
9900895|NCT01134562|11016477|FG002|COMPLETED|Overall Study||4
9900896|NCT01134562|11016478|FG003|COMPLETED|Overall Study||8
9900897|NCT01134562|11016479|FG004|COMPLETED|Overall Study||8
9900898|NCT01134562|11016475|FG000|NOT COMPLETED|Overall Study||0
9900899|NCT01134562|11016476|FG001|NOT COMPLETED|Overall Study||1
9900900|NCT01134562|11016477|FG002|NOT COMPLETED|Overall Study||0
9900901|NCT01134562|11016478|FG003|NOT COMPLETED|Overall Study||0
9900902|NCT01134562|11016479|FG004|NOT COMPLETED|Overall Study||0
9900903|NCT01134575|11016502|FG000|STARTED|Overall Study||3
9900904|NCT01134575|11016503|FG001|STARTED|Overall Study||45
9900905|NCT01134575|11016504|FG002|STARTED|Overall Study||42
9900906|NCT01134575|11016502|FG000|COMPLETED|Overall Study||3
9900907|NCT01134575|11016503|FG001|COMPLETED|Overall Study||45
9900908|NCT01134575|11016504|FG002|COMPLETED|Overall Study||42
9900909|NCT01134575|11016502|FG000|NOT COMPLETED|Overall Study||0
9900910|NCT01134575|11016503|FG001|NOT COMPLETED|Overall Study||0
9900911|NCT01134575|11016504|FG002|NOT COMPLETED|Overall Study||0
9900912|NCT01134627|11016514|FG000|STARTED|Overall Study|Number of participants treated.|149
9900913|NCT01134627|11016515|FG001|STARTED|Overall Study|Number of participants treated.|155
9900914|NCT01134627|11016514|FG000|COMPLETED|Overall Study||80
9900915|NCT01134627|11016515|FG001|COMPLETED|Overall Study||88
9900916|NCT01134627|11016514|FG000|NOT COMPLETED|Overall Study||69
9900917|NCT01134627|11016515|FG001|NOT COMPLETED|Overall Study||67
9900918|NCT01134705|11016523|FG000|STARTED|Overall Study||236
9900919|NCT01134705|11016524|FG001|STARTED|Overall Study||238
9900920|NCT01134705|11016523|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
9900921|NCT01134705|11016524|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
9900922|NCT01134705|11016523|FG000|COMPLETED|Overall Study||221
9900923|NCT01134705|11016524|FG001|COMPLETED|Overall Study||216
9900924|NCT01134705|11016523|FG000|NOT COMPLETED|Overall Study||15
9900925|NCT01134705|11016524|FG001|NOT COMPLETED|Overall Study||22
9900926|NCT01134731|11016533|FG000|STARTED|Overall Study||23
9900927|NCT01134731|11016534|FG001|STARTED|Overall Study||21
9900928|NCT01134731|11016535|FG002|STARTED|Overall Study||10
9900929|NCT01134731|11016533|FG000|COMPLETED|Overall Study||10
9900930|NCT01134731|11016534|FG001|COMPLETED|Overall Study||10
9900931|NCT01134731|11016535|FG002|COMPLETED|Overall Study||2
9900932|NCT01134731|11016533|FG000|NOT COMPLETED|Overall Study||13
9900933|NCT01134731|11016534|FG001|NOT COMPLETED|Overall Study||11
9900934|NCT01134731|11016535|FG002|NOT COMPLETED|Overall Study||8
9900935|NCT01134783|11016546|FG000|STARTED|Overall Study||224
9900936|NCT01134783|11016547|FG001|STARTED|Overall Study||217
9900937|NCT01134783|11016546|FG000|COMPLETED|Overall Study||188
9900938|NCT01134783|11016547|FG001|COMPLETED|Overall Study||180
9900939|NCT01134783|11016546|FG000|NOT COMPLETED|Overall Study||36
9900940|NCT01134783|11016547|FG001|NOT COMPLETED|Overall Study||37
9900941|NCT01134887|11016561|FG000|STARTED|Overall Study||9
9900942|NCT01134887|11016562|FG001|STARTED|Overall Study||11
9900943|NCT01134887|11016563|FG002|STARTED|Overall Study||5
9900944|NCT01134887|11016564|FG003|STARTED|Overall Study||5
9900945|NCT01134887|11016561|FG000|COMPLETED|Overall Study||9
9900946|NCT01134887|11016562|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
9900947|NCT01134887|11016563|FG002|COMPLETED|Overall Study||5
9900948|NCT01134887|11016564|FG003|COMPLETED|Overall Study||5
9900949|NCT01134887|11016561|FG000|NOT COMPLETED|Overall Study||0
9900950|NCT01134887|11016562|FG001|NOT COMPLETED|Overall Study||4
9900951|NCT01134887|11016563|FG002|NOT COMPLETED|Overall Study||0
9900952|NCT01134887|11016564|FG003|NOT COMPLETED|Overall Study||0
9900953|NCT01134900|11016574|FG000|STARTED|Overall Study||200
9900954|NCT01134900|11016575|FG001|STARTED|Overall Study||196
9900955|NCT01134900|11016574|FG000|COMPLETED|Overall Study||200
9900956|NCT01134900|11016575|FG001|COMPLETED|Overall Study||196
9900957|NCT01134900|11016574|FG000|NOT COMPLETED|Overall Study||0
9900958|NCT01134900|11016575|FG001|NOT COMPLETED|Overall Study||0
9900959|NCT01134939|11016589|FG000|STARTED|Overall Study||59
9900960|NCT01134939|11016590|FG001|STARTED|Overall Study||42
9900961|NCT01134939|11016591|FG002|STARTED|Overall Study||51
9900962|NCT01134939|11016592|FG003|STARTED|Overall Study||46
9900963|NCT01134939|11016593|FG004|STARTED|Overall Study||33
9900964|NCT01134939|11016594|FG005|STARTED|Overall Study||14
9900965|NCT01134939|11016595|FG006|STARTED|Overall Study||19
9900966|NCT01134939|11016596|FG007|STARTED|Overall Study||1
9900967|NCT01134939|11016589|FG000|COMPLETED|Overall Study||42
9900968|NCT01134939|11016590|FG001|COMPLETED|Overall Study||24
9900969|NCT01134939|11016591|FG002|COMPLETED|Overall Study||41
9900970|NCT01134939|11016592|FG003|COMPLETED|Overall Study||32
9900971|NCT01134939|11016593|FG004|COMPLETED|Overall Study||23
9900972|NCT01134939|11016594|FG005|COMPLETED|Overall Study||5
9900973|NCT01134939|11016595|FG006|COMPLETED|Overall Study||10
9900974|NCT01134939|11016596|FG007|COMPLETED|Overall Study||1
9900975|NCT01134939|11016589|FG000|NOT COMPLETED|Overall Study||17
9900976|NCT01134939|11016590|FG001|NOT COMPLETED|Overall Study||18
9900977|NCT01134939|11016591|FG002|NOT COMPLETED|Overall Study||10
9900978|NCT01134939|11016592|FG003|NOT COMPLETED|Overall Study||14
9900979|NCT01134939|11016593|FG004|NOT COMPLETED|Overall Study||10
9900980|NCT01134939|11016594|FG005|NOT COMPLETED|Overall Study||9
9900981|NCT01134939|11016595|FG006|NOT COMPLETED|Overall Study||9
9900982|NCT01134939|11016596|FG007|NOT COMPLETED|Overall Study||0
9900983|NCT01134952|11016610|FG000|STARTED|Overall Study||11
9900984|NCT01134952|11016610|FG000|COMPLETED|Overall Study||11
9900985|NCT01134952|11016610|FG000|NOT COMPLETED|Overall Study||0
9900986|NCT01135017|11016620|FG000|STARTED|Overall Study||55
9900987|NCT01135017|11016621|FG001|STARTED|Overall Study||57
9900988|NCT01135017|11016620|FG000|Treated|Overall Study||55
9900989|NCT01135017|11016621|FG001|Treated|Overall Study||57
9900990|NCT01135017|11016620|FG000|Evaluable for Efficacy|Overall Study||55
9900991|NCT01135017|11016621|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
9900992|NCT01135017|11016620|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
9900993|NCT01135017|11016621|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
9900994|NCT01135017|11016620|FG000|NOT COMPLETED|Overall Study||6
9900995|NCT01135017|11016621|FG001|NOT COMPLETED|Overall Study||12
9900996|NCT01135069|11016630|FG000|STARTED|Overall Study||205
9900997|NCT01135069|11016631|FG001|STARTED|Overall Study||209
9900998|NCT01135069|11016632|FG002|STARTED|Overall Study||66
9900999|NCT01135069|11016630|FG000|COMPLETED|Overall Study||169
9901000|NCT01135069|11016631|FG001|COMPLETED|Overall Study||177
9901001|NCT01135069|11016632|FG002|COMPLETED|Overall Study||56
9901002|NCT01135069|11016630|FG000|NOT COMPLETED|Overall Study||36
9901003|NCT01135069|11016631|FG001|NOT COMPLETED|Overall Study||32
9901004|NCT01135069|11016632|FG002|NOT COMPLETED|Overall Study||10
9901005|NCT01135095|11016640|FG000|STARTED|Overall Study||101
9901006|NCT01135095|11016640|FG000|COMPLETED|Overall Study||101
9901007|NCT01135095|11016640|FG000|NOT COMPLETED|Overall Study||0
9901008|NCT01135186|11016644|FG000|STARTED|Overall Study||9
9901009|NCT01135186|11016644|FG000|COMPLETED|Overall Study||9
9901010|NCT01135186|11016644|FG000|NOT COMPLETED|Overall Study||0
9901011|NCT01135329|11016650|FG000|STARTED|Overall Study||15
9901012|NCT01135329|11016650|FG000|COMPLETED|Overall Study||15
9901013|NCT01135329|11016650|FG000|NOT COMPLETED|Overall Study||0
9955050|NCT01435824|11073944|FG000|COMPLETED|Washout of 1-2 Weeks||8
9955051|NCT01435824|11073945|FG001|COMPLETED|Washout of 1-2 Weeks||8
9955052|NCT01435824|11073944|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0
9955053|NCT01435824|11073945|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0
9955054|NCT01435824|11073944|FG000|STARTED|Second Intervention||8
9955055|NCT01435824|11073945|FG001|STARTED|Second Intervention||8
9955056|NCT01435824|11073944|FG000|COMPLETED|Second Intervention||8
9955057|NCT01435824|11073945|FG001|COMPLETED|Second Intervention||8
9955058|NCT01435824|11073944|FG000|NOT COMPLETED|Second Intervention||0
9955059|NCT01435824|11073945|FG001|NOT COMPLETED|Second Intervention||0
9955060|NCT01435928|11073953|FG000|STARTED|Open Label Phase - up to 24 Weeks||676
9955061|NCT01435928|11073954|FG001|STARTED|Open Label Phase - up to 24 Weeks||0
9955062|NCT01435928|11073955|FG002|STARTED|Open Label Phase - up to 24 Weeks||0
9955063|NCT01435928|11073953|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287
9955064|NCT01435928|11073954|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0
9955065|NCT01435928|11073955|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0
9955066|NCT01435928|11073953|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
9955067|NCT01435928|11073954|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
9955068|NCT01435928|11073955|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
9955069|NCT01435928|11073953|FG000|STARTED|Double Blind Phase - 28 Weeks||0
9955070|NCT01435928|11073954|FG001|STARTED|Double Blind Phase - 28 Weeks||144
9955071|NCT01435928|11073955|FG002|STARTED|Double Blind Phase - 28 Weeks||141
9955072|NCT01435928|11073953|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0
9955073|NCT01435928|11073954|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28
9955074|NCT01435928|11073955|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20
9955075|NCT01435928|11073953|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
9955076|NCT01435928|11073954|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
9955077|NCT01435928|11073955|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
9955078|NCT01436006|11073962|FG000|STARTED|Overall Study||6700
9955079|NCT01436006|11073962|FG000|COMPLETED|Overall Study||6663
9955080|NCT01436006|11073962|FG000|NOT COMPLETED|Overall Study||37
9955081|NCT01436045|11073974|FG000|STARTED|Overall Study||6
9955082|NCT01436045|11073975|FG001|STARTED|Overall Study||6
9955083|NCT01436045|11073974|FG000|COMPLETED|Overall Study||6
9955084|NCT01436045|11073975|FG001|COMPLETED|Overall Study||6
9955085|NCT01436045|11073974|FG000|NOT COMPLETED|Overall Study||0
9955086|NCT01436045|11073975|FG001|NOT COMPLETED|Overall Study||0
9955087|NCT01436071|11073983|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124
9955088|NCT01436071|11073984|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124
9955089|NCT01436071|11073983|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
9955090|NCT01436071|11073984|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
9955091|NCT01436071|11073983|FG000|COMPLETED|Overall Study||98
9955092|NCT01436071|11073984|FG001|COMPLETED|Overall Study||110
9955093|NCT01436071|11073983|FG000|NOT COMPLETED|Overall Study||26
9955094|NCT01436071|11073984|FG001|NOT COMPLETED|Overall Study||14
9955095|NCT01436110|11073993|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116
10110368|NCT02484807|11241142|FG002|NOT COMPLETED|Overall Study||0
9955096|NCT01436110|11073994|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117
9955097|NCT01436110|11073995|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118
9955098|NCT01436110|11073993|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
9955099|NCT01436110|11073994|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
9955100|NCT01436110|11073995|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
9955101|NCT01436110|11073993|FG000|COMPLETED|Overall Study||77
9955102|NCT01436110|11073994|FG001|COMPLETED|Overall Study||91
9955103|NCT01436110|11073995|FG002|COMPLETED|Overall Study||95
9955104|NCT01436110|11073993|FG000|NOT COMPLETED|Overall Study||39
9955105|NCT01436110|11073994|FG001|NOT COMPLETED|Overall Study||26
9955106|NCT01436110|11073995|FG002|NOT COMPLETED|Overall Study||23
9955107|NCT01436149|11074005|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
9955108|NCT01436149|11074006|FG001|STARTED|Antidepressant Lead-in Phase||0
9955109|NCT01436149|11074007|FG002|STARTED|Antidepressant Lead-in Phase||0
9955110|NCT01436149|11074005|FG000|COMPLETED|Antidepressant Lead-in Phase||896
9955111|NCT01436149|11074006|FG001|COMPLETED|Antidepressant Lead-in Phase||0
9955112|NCT01436149|11074007|FG002|COMPLETED|Antidepressant Lead-in Phase||0
9955113|NCT01436149|11074005|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366
9955114|NCT01436149|11074006|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
9955115|NCT01436149|11074007|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
9955116|NCT01436149|11074005|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
9955117|NCT01436149|11074006|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
9955118|NCT01436149|11074007|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
9955119|NCT01436149|11074005|FG000|COMPLETED|Randomized Phase||415
10110369|NCT02484807|11241143|FG003|NOT COMPLETED|Overall Study||0
9901014|NCT01135368|11016655|FG000|STARTED|Overall Study||506
9901015|NCT01135368|11016655|FG000|COMPLETED|Overall Study||255
9901016|NCT01135368|11016655|FG000|NOT COMPLETED|Overall Study||251
9901017|NCT01135381|11016697|FG000|STARTED|Overall Study||189
9901018|NCT01135381|11016698|FG001|STARTED|Overall Study||185
9901019|NCT01135381|11016699|FG002|STARTED|Overall Study||69
9901020|NCT01135381|11016700|FG003|STARTED|Overall Study||68
9901021|NCT01135381|11016697|FG000|COMPLETED|Overall Study||168
9901022|NCT01135381|11016698|FG001|COMPLETED|Overall Study||178
9901023|NCT01135381|11016699|FG002|COMPLETED|Overall Study||65
9901024|NCT01135381|11016700|FG003|COMPLETED|Overall Study||67
9901025|NCT01135381|11016697|FG000|NOT COMPLETED|Overall Study||21
9901026|NCT01135381|11016698|FG001|NOT COMPLETED|Overall Study||7
9901027|NCT01135381|11016699|FG002|NOT COMPLETED|Overall Study||4
9901028|NCT01135381|11016700|FG003|NOT COMPLETED|Overall Study||1
9901029|NCT01135394|11016710|FG000|STARTED|Screening||114
9901030|NCT01135394|11016710|FG000|COMPLETED|Screening||81
9901031|NCT01135394|11016710|FG000|NOT COMPLETED|Screening||33
9901032|NCT01135394|11016710|FG000|STARTED|Baseline Assessment||81
9901033|NCT01135394|11016710|FG000|COMPLETED|Baseline Assessment||66
9901034|NCT01135394|11016710|FG000|NOT COMPLETED|Baseline Assessment||15
9901035|NCT01135394|11016710|FG000|STARTED|Study Treatment||66
9901036|NCT01135394|11016710|FG000|COMPLETED|Study Treatment||62
9901037|NCT01135394|11016710|FG000|NOT COMPLETED|Study Treatment||4
9901038|NCT01135420|11016716|FG000|STARTED|Overall Study||199
9901039|NCT01135420|11016717|FG001|STARTED|Overall Study||207
9901040|NCT01135420|11016716|FG000|COMPLETED|Overall Study||155
9901041|NCT01135420|11016717|FG001|COMPLETED|Overall Study||175
9901042|NCT01135420|11016716|FG000|NOT COMPLETED|Overall Study||44
9901043|NCT01135420|11016717|FG001|NOT COMPLETED|Overall Study||32
9901044|NCT01135498|11016723|FG000|STARTED|Overall Study||90
9901045|NCT01135498|11016723|FG000|COMPLETED|Overall Study||0
9901046|NCT01135498|11016723|FG000|NOT COMPLETED|Overall Study||90
9901047|NCT01135511|11016737|FG000|STARTED|Overall Study||41
9901048|NCT01135511|11016738|FG001|STARTED|Overall Study||42
9901049|NCT01135511|11016739|FG002|STARTED|Overall Study||41
9901050|NCT01135511|11016740|FG003|STARTED|Overall Study||40
9901051|NCT01135511|11016741|FG004|STARTED|Overall Study||39
9901052|NCT01135511|11016742|FG005|STARTED|Overall Study||21
9901053|NCT01135511|11016743|FG006|STARTED|Overall Study||19
9901054|NCT01135511|11016744|FG007|STARTED|Overall Study||21
9901055|NCT01135511|11016745|FG008|STARTED|Overall Study||21
9901056|NCT01135511|11016737|FG000|COMPLETED|Overall Study||41
9901057|NCT01135511|11016738|FG001|COMPLETED|Overall Study||39
9901058|NCT01135511|11016739|FG002|COMPLETED|Overall Study||33
9901059|NCT01135511|11016740|FG003|COMPLETED|Overall Study||37
9901060|NCT01135511|11016741|FG004|COMPLETED|Overall Study||38
9901061|NCT01135511|11016742|FG005|COMPLETED|Overall Study||20
9901062|NCT01135511|11016743|FG006|COMPLETED|Overall Study||18
9901063|NCT01135511|11016744|FG007|COMPLETED|Overall Study||20
9901064|NCT01135511|11016745|FG008|COMPLETED|Overall Study||20
9901065|NCT01135511|11016737|FG000|NOT COMPLETED|Overall Study||0
9901066|NCT01135511|11016738|FG001|NOT COMPLETED|Overall Study||3
9901067|NCT01135511|11016739|FG002|NOT COMPLETED|Overall Study||8
9901068|NCT01135511|11016740|FG003|NOT COMPLETED|Overall Study||3
9901069|NCT01135511|11016741|FG004|NOT COMPLETED|Overall Study||1
9901070|NCT01135511|11016742|FG005|NOT COMPLETED|Overall Study||1
9901071|NCT01135511|11016743|FG006|NOT COMPLETED|Overall Study||1
9901072|NCT01135511|11016744|FG007|NOT COMPLETED|Overall Study||1
9901073|NCT01135511|11016745|FG008|NOT COMPLETED|Overall Study||1
9901074|NCT01135524|11016765|FG000|STARTED|Overall Study||196
9901075|NCT01135524|11016765|FG000|COMPLETED|Overall Study||0
9901076|NCT01135524|11016765|FG000|NOT COMPLETED|Overall Study||196
9901077|NCT01135537|11016769|FG000|STARTED|Overall Study||30
9901078|NCT01135537|11016769|FG000|COMPLETED|Overall Study||17
9901079|NCT01135537|11016769|FG000|NOT COMPLETED|Overall Study||13
9901080|NCT01135914|11016776|FG000|STARTED|Overall Study||78
9901081|NCT01135914|11016777|FG001|STARTED|Overall Study||80
9901082|NCT01135914|11016778|FG002|STARTED|Overall Study||81
9901083|NCT01135914|11016776|FG000|Intent to Treat (ITT) Population|Overall Study||73
9901084|NCT01135914|11016777|FG001|Intent to Treat (ITT) Population|Overall Study||75
9901085|NCT01135914|11016778|FG002|Intent to Treat (ITT) Population|Overall Study||72
9901086|NCT01135914|11016776|FG000|Safety Population|Overall Study||73
9901087|NCT01135914|11016777|FG001|Safety Population|Overall Study||75
9901088|NCT01135914|11016778|FG002|Safety Population|Overall Study||74
9901089|NCT01135914|11016776|FG000|COMPLETED|Overall Study||74
9901090|NCT01135914|11016777|FG001|COMPLETED|Overall Study||75
9901091|NCT01135914|11016778|FG002|COMPLETED|Overall Study||59
9901092|NCT01135914|11016776|FG000|NOT COMPLETED|Overall Study||4
9901093|NCT01135914|11016777|FG001|NOT COMPLETED|Overall Study||5
9901094|NCT01135914|11016778|FG002|NOT COMPLETED|Overall Study||22
9901095|NCT01135992|11016786|FG000|STARTED|Overall Study||143
9901096|NCT01135992|11016786|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
9901097|NCT01135992|11016786|FG000|Full Analysis Set|Overall Study||129
9901098|NCT01135992|11016786|FG000|COMPLETED|Overall Study||122
9901099|NCT01135992|11016786|FG000|NOT COMPLETED|Overall Study||21
9901100|NCT01136174|11016794|FG000|STARTED|Overall Study||12
9901101|NCT01136174|11016795|FG001|STARTED|Overall Study||6
9901102|NCT01136174|11016796|FG002|STARTED|Overall Study||8
9901103|NCT01136174|11016797|FG003|STARTED|Overall Study||24
9901104|NCT01136174|11016794|FG000|COMPLETED|Overall Study||12
9901105|NCT01136174|11016795|FG001|COMPLETED|Overall Study||6
9901106|NCT01136174|11016796|FG002|COMPLETED|Overall Study||8
9901107|NCT01136174|11016797|FG003|COMPLETED|Overall Study||20
9901108|NCT01136174|11016794|FG000|NOT COMPLETED|Overall Study||0
9901109|NCT01136174|11016795|FG001|NOT COMPLETED|Overall Study||0
9901110|NCT01136174|11016796|FG002|NOT COMPLETED|Overall Study||0
9901111|NCT01136174|11016797|FG003|NOT COMPLETED|Overall Study||4
9901112|NCT01136226|11016816|FG000|STARTED|Overall Study||42
9901113|NCT01136226|11016816|FG000|COMPLETED|Overall Study||29
9901114|NCT01136226|11016816|FG000|NOT COMPLETED|Overall Study||13
9901115|NCT01136291|11016823|FG000|STARTED|Overall Study||40
9901116|NCT01136291|11016824|FG001|STARTED|Overall Study||42
9901117|NCT01136291|11016823|FG000|Follow|Overall Study||40
9901118|NCT01136291|11016824|FG001|Follow|Overall Study||42
9901119|NCT01136291|11016823|FG000|COMPLETED|Overall Study||39
9901120|NCT01136291|11016824|FG001|COMPLETED|Overall Study||41
9901121|NCT01136291|11016823|FG000|NOT COMPLETED|Overall Study||1
9901122|NCT01136291|11016824|FG001|NOT COMPLETED|Overall Study||1
9901123|NCT01136356|11016830|FG000|STARTED|First Intervention||6
9901124|NCT01136356|11016831|FG001|STARTED|First Intervention||6
9901125|NCT01136356|11016830|FG000|COMPLETED|First Intervention||6
9901126|NCT01136356|11016831|FG001|COMPLETED|First Intervention||6
9901127|NCT01136356|11016830|FG000|NOT COMPLETED|First Intervention||0
9901128|NCT01136356|11016831|FG001|NOT COMPLETED|First Intervention||0
9901129|NCT01136356|11016830|FG000|STARTED|First 18-day Withdrawal||6
9901130|NCT01136356|11016831|FG001|STARTED|First 18-day Withdrawal||6
9901131|NCT01136356|11016830|FG000|COMPLETED|First 18-day Withdrawal||2
9901132|NCT01136356|11016831|FG001|COMPLETED|First 18-day Withdrawal||6
9901133|NCT01136356|11016830|FG000|NOT COMPLETED|First 18-day Withdrawal||4
9901134|NCT01136356|11016831|FG001|NOT COMPLETED|First 18-day Withdrawal||0
9901135|NCT01136356|11016830|FG000|STARTED|Second Intervention||2
9901136|NCT01136356|11016831|FG001|STARTED|Second Intervention||6
9901137|NCT01136356|11016830|FG000|COMPLETED|Second Intervention||2
9901138|NCT01136356|11016831|FG001|COMPLETED|Second Intervention||6
10009274|NCT01765153|11131812|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
10009275|NCT01765153|11131813|FG001|STARTED|Training Phase 2||9
10009276|NCT01765153|11131812|FG000|COMPLETED|Training Phase 2||10
10009277|NCT01765153|11131813|FG001|COMPLETED|Training Phase 2||8
10009278|NCT01765153|11131812|FG000|NOT COMPLETED|Training Phase 2||0
10009279|NCT01765153|11131813|FG001|NOT COMPLETED|Training Phase 2||1
10009280|NCT01765153|11131812|FG000|STARTED|Rest Phase 2||10
10009281|NCT01765153|11131813|FG001|STARTED|Rest Phase 2||8
10110370|NCT02484807|11241144|FG004|NOT COMPLETED|Overall Study||0
10110371|NCT02484807|11241145|FG005|NOT COMPLETED|Overall Study||0
10110372|NCT02484859|11241162|FG000|STARTED|Overall Study||44
10110373|NCT02484859|11241163|FG001|STARTED|Overall Study||44
9901139|NCT01136356|11016830|FG000|NOT COMPLETED|Second Intervention||0
9901140|NCT01136356|11016831|FG001|NOT COMPLETED|Second Intervention||0
9901141|NCT01136356|11016830|FG000|STARTED|Second 18-day Withdrawal||2
9901142|NCT01136356|11016831|FG001|STARTED|Second 18-day Withdrawal||6
9901143|NCT01136356|11016830|FG000|COMPLETED|Second 18-day Withdrawal||2
9901144|NCT01136356|11016831|FG001|COMPLETED|Second 18-day Withdrawal||5
9901145|NCT01136356|11016830|FG000|NOT COMPLETED|Second 18-day Withdrawal||0
9901146|NCT01136356|11016831|FG001|NOT COMPLETED|Second 18-day Withdrawal||1
9901147|NCT01136382|11016838|FG000|STARTED|Overall Study||152
9901148|NCT01136382|11016839|FG001|STARTED|Overall Study||152
9901149|NCT01136382|11016838|FG000|COMPLETED|Overall Study||92
9901150|NCT01136382|11016839|FG001|COMPLETED|Overall Study||121
9901151|NCT01136382|11016838|FG000|NOT COMPLETED|Overall Study||60
9901152|NCT01136382|11016839|FG001|NOT COMPLETED|Overall Study||31
9901153|NCT01136408|11016848|FG000|STARTED|Overall Study||46
9901154|NCT01136408|11016849|FG001|STARTED|Overall Study||58
9901155|NCT01136408|11016850|FG002|STARTED|Overall Study||62
9901156|NCT01136408|11016848|FG000|COMPLETED|Overall Study||41
9901157|NCT01136408|11016849|FG001|COMPLETED|Overall Study||49
10009282|NCT01765153|11131812|FG000|COMPLETED|Rest Phase 2||8
10110374|NCT02484859|11241162|FG000|COMPLETED|Overall Study||44
10110375|NCT02484859|11241163|FG001|COMPLETED|Overall Study||44
10110376|NCT02484859|11241162|FG000|NOT COMPLETED|Overall Study||0
10110377|NCT02484859|11241163|FG001|NOT COMPLETED|Overall Study||0
10110378|NCT02484898|11241171|FG000|STARTED|Overall Study||200
9901158|NCT01136408|11016850|FG002|COMPLETED|Overall Study||57
9901159|NCT01136408|11016848|FG000|NOT COMPLETED|Overall Study||5
9901160|NCT01136408|11016849|FG001|NOT COMPLETED|Overall Study||9
9901161|NCT01136408|11016850|FG002|NOT COMPLETED|Overall Study||5
9901162|NCT01136486|11016862|FG000|STARTED|Overall Study||56
9901163|NCT01136486|11016862|FG000|COMPLETED|Overall Study||56
9901164|NCT01136486|11016862|FG000|NOT COMPLETED|Overall Study||0
9901165|NCT01136655|11016866|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54
9901166|NCT01136655|11016866|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
10009283|NCT01765153|11131813|FG001|COMPLETED|Rest Phase 2||7
9901167|NCT01136655|11016866|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
9955120|NCT01436149|11074006|FG001|COMPLETED|Randomized Phase||164
10009284|NCT01765153|11131812|FG000|NOT COMPLETED|Rest Phase 2||2
10110379|NCT02484898|11241171|FG000|COMPLETED|Overall Study||182
10110380|NCT02484898|11241171|FG000|NOT COMPLETED|Overall Study||18
10110381|NCT02484911|11241177|FG000|STARTED|Overall Study||60
10110382|NCT02484911|11241178|FG001|STARTED|Overall Study||60
10110383|NCT02484911|11241177|FG000|COMPLETED|Overall Study||56
9901168|NCT01136655|11016866|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
9901169|NCT01136655|11016866|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
9901170|NCT01136655|11016866|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
9901171|NCT01136655|11016866|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53
9901172|NCT01136655|11016866|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
9901173|NCT01136655|11016866|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
9901174|NCT01136655|11016866|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
9901175|NCT01136655|11016866|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
9901176|NCT01136655|11016866|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
9901177|NCT01136655|11016866|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53
9901178|NCT01136655|11016866|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
9901179|NCT01136655|11016866|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
9901180|NCT01136655|11016866|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
9901181|NCT01136655|11016866|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
9901182|NCT01136655|11016866|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
9901183|NCT01136655|11016866|FG000|STARTED|BUD 160 (1 Dose)||51
9901184|NCT01136655|11016866|FG000|COMPLETED|BUD 160 (1 Dose)||51
9901185|NCT01136655|11016866|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0
9901186|NCT01136655|11016866|FG000|STARTED|Washout After BUD 160 (7 Days)||51
9901187|NCT01136655|11016866|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51
9901188|NCT01136655|11016866|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
9901189|NCT01136655|11016866|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
9901190|NCT01136655|11016866|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
9901191|NCT01136655|11016866|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
9901192|NCT01136655|11016866|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
9901193|NCT01136655|11016866|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
9901194|NCT01136655|11016866|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
9901195|NCT01136733|11016886|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
9901196|NCT01136733|11016887|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
9901197|NCT01136733|11016888|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
9901198|NCT01136733|11016889|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
9901199|NCT01136733|11016890|FG004|STARTED|Phase 1b||0
9901200|NCT01136733|11016891|FG005|STARTED|Phase 1b||0
9901201|NCT01136733|11016892|FG006|STARTED|Phase 1b||0
9901202|NCT01136733|11016886|FG000|COMPLETED|Phase 1b||6
9901203|NCT01136733|11016887|FG001|COMPLETED|Phase 1b||6
9901204|NCT01136733|11016888|FG002|COMPLETED|Phase 1b||0
9901205|NCT01136733|11016889|FG003|COMPLETED|Phase 1b||0
9901206|NCT01136733|11016890|FG004|COMPLETED|Phase 1b||0
9901207|NCT01136733|11016891|FG005|COMPLETED|Phase 1b||0
9901208|NCT01136733|11016892|FG006|COMPLETED|Phase 1b||0
9901209|NCT01136733|11016886|FG000|NOT COMPLETED|Phase 1b||1
9901210|NCT01136733|11016887|FG001|NOT COMPLETED|Phase 1b||5
9901211|NCT01136733|11016888|FG002|NOT COMPLETED|Phase 1b||2
9901212|NCT01136733|11016889|FG003|NOT COMPLETED|Phase 1b||0
9901213|NCT01136733|11016890|FG004|NOT COMPLETED|Phase 1b||0
9901214|NCT01136733|11016891|FG005|NOT COMPLETED|Phase 1b||0
9901215|NCT01136733|11016892|FG006|NOT COMPLETED|Phase 1b||0
9901216|NCT01136733|11016886|FG000|STARTED|Phase 2||0
9901217|NCT01136733|11016887|FG001|STARTED|Phase 2||0
9901218|NCT01136733|11016888|FG002|STARTED|Phase 2||0
9901219|NCT01136733|11016889|FG003|STARTED|Phase 2||0
9901220|NCT01136733|11016890|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
9901221|NCT01136733|11016891|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
9901222|NCT01136733|11016892|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
9901223|NCT01136733|11016886|FG000|COMPLETED|Phase 2||0
9901224|NCT01136733|11016887|FG001|COMPLETED|Phase 2||0
9901225|NCT01136733|11016888|FG002|COMPLETED|Phase 2||0
9901226|NCT01136733|11016889|FG003|COMPLETED|Phase 2||0
9901227|NCT01136733|11016890|FG004|COMPLETED|Phase 2||0
9901228|NCT01136733|11016891|FG005|COMPLETED|Phase 2||0
9901229|NCT01136733|11016892|FG006|COMPLETED|Phase 2||0
9901230|NCT01136733|11016886|FG000|NOT COMPLETED|Phase 2||0
9901231|NCT01136733|11016887|FG001|NOT COMPLETED|Phase 2||0
9901232|NCT01136733|11016888|FG002|NOT COMPLETED|Phase 2||0
9901233|NCT01136733|11016889|FG003|NOT COMPLETED|Phase 2||0
9901234|NCT01136733|11016890|FG004|NOT COMPLETED|Phase 2||51
9901235|NCT01136733|11016891|FG005|NOT COMPLETED|Phase 2||52
10009285|NCT01765153|11131813|FG001|NOT COMPLETED|Rest Phase 2||1
10009286|NCT01765179|11131823|FG000|STARTED|Overall Study||144
9901236|NCT01136733|11016892|FG006|NOT COMPLETED|Phase 2||50
9901237|NCT01136746|11016924|FG000|STARTED|Overall Study||9
9901238|NCT01136746|11016925|FG001|STARTED|Overall Study||7
9901239|NCT01136746|11016924|FG000|COMPLETED|Overall Study||6
9901240|NCT01136746|11016925|FG001|COMPLETED|Overall Study||4
9901241|NCT01136746|11016924|FG000|NOT COMPLETED|Overall Study||3
9901242|NCT01136746|11016925|FG001|NOT COMPLETED|Overall Study||3
9901243|NCT01136772|11016933|FG000|STARTED|Overall Study||157
9901244|NCT01136772|11016934|FG001|STARTED|Overall Study||154
9901245|NCT01136772|11016933|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
9901246|NCT01136772|11016934|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
9901247|NCT01136772|11016933|FG000|COMPLETED|Overall Study||41
9901248|NCT01136772|11016934|FG001|COMPLETED|Overall Study||44
9901249|NCT01136772|11016933|FG000|NOT COMPLETED|Overall Study||116
10009287|NCT01765179|11131823|FG000|COMPLETED|Overall Study||117
9901250|NCT01136772|11016934|FG001|NOT COMPLETED|Overall Study||110
9901251|NCT01136785|11016942|FG000|STARTED|Overall Study||15
9901252|NCT01136785|11016943|FG001|STARTED|Overall Study||7
9901253|NCT01136785|11016942|FG000|COMPLETED|Overall Study||13
9901254|NCT01136785|11016943|FG001|COMPLETED|Overall Study||6
9901255|NCT01136785|11016942|FG000|NOT COMPLETED|Overall Study||2
9901256|NCT01136785|11016943|FG001|NOT COMPLETED|Overall Study||1
9901257|NCT01136798|11016955|FG000|STARTED|Overall Study||10
9901258|NCT01136798|11016956|FG001|STARTED|Overall Study||8
9901259|NCT01136798|11016955|FG000|COMPLETED|Overall Study||10
9901260|NCT01136798|11016956|FG001|COMPLETED|Overall Study||8
9901261|NCT01136798|11016955|FG000|NOT COMPLETED|Overall Study||0
9901262|NCT01136798|11016956|FG001|NOT COMPLETED|Overall Study||0
9901263|NCT01136876|11016964|FG000|STARTED|Overall Study||28
9901264|NCT01136876|11016965|FG001|STARTED|Overall Study||29
9901265|NCT01136876|11016964|FG000|COMPLETED|Overall Study||23
9901266|NCT01136876|11016965|FG001|COMPLETED|Overall Study||18
9901267|NCT01136876|11016964|FG000|NOT COMPLETED|Overall Study||5
9901268|NCT01136876|11016965|FG001|NOT COMPLETED|Overall Study||11
9901269|NCT01136915|11016975|FG000|STARTED|Overall Study||8
9901270|NCT01136915|11016976|FG001|STARTED|Overall Study||7
9901271|NCT01136915|11016975|FG000|COMPLETED|Overall Study||6
9901272|NCT01136915|11016976|FG001|COMPLETED|Overall Study||6
9901273|NCT01136915|11016975|FG000|NOT COMPLETED|Overall Study||2
9901274|NCT01136915|11016976|FG001|NOT COMPLETED|Overall Study||1
9901275|NCT01136954|11016986|FG000|STARTED|Overall Study||72
9901276|NCT01136954|11016987|FG001|STARTED|Overall Study||72
9901277|NCT01136954|11016986|FG000|COMPLETED|Overall Study||48
9901278|NCT01136954|11016987|FG001|COMPLETED|Overall Study||51
9901279|NCT01136954|11016986|FG000|NOT COMPLETED|Overall Study||24
9901280|NCT01136954|11016987|FG001|NOT COMPLETED|Overall Study||21
9901281|NCT01137006|11017001|FG000|STARTED|Overall Study||3
9901282|NCT01137006|11017002|FG001|STARTED|Overall Study||3
9901283|NCT01137006|11017003|FG002|STARTED|Overall Study||8
9901284|NCT01137006|11017004|FG003|STARTED|Overall Study||3
9901285|NCT01137006|11017005|FG004|STARTED|Overall Study||3
9901286|NCT01137006|11017006|FG005|STARTED|Overall Study||4
9901287|NCT01137006|11017007|FG006|STARTED|Overall Study||3
9901288|NCT01137006|11017001|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3
9901289|NCT01137006|11017002|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3
9901290|NCT01137006|11017003|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8
9901291|NCT01137006|11017004|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3
9901292|NCT01137006|11017005|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3
9901293|NCT01137006|11017006|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4
9901294|NCT01137006|11017007|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3
9901295|NCT01137006|11017001|FG000|COMPLETED|Overall Study||3
9901296|NCT01137006|11017002|FG001|COMPLETED|Overall Study||3
9901297|NCT01137006|11017003|FG002|COMPLETED|Overall Study||8
9901298|NCT01137006|11017004|FG003|COMPLETED|Overall Study||3
9901299|NCT01137006|11017005|FG004|COMPLETED|Overall Study||3
9901300|NCT01137006|11017006|FG005|COMPLETED|Overall Study||4
9901301|NCT01137006|11017007|FG006|COMPLETED|Overall Study||3
9901302|NCT01137006|11017001|FG000|NOT COMPLETED|Overall Study||0
9901303|NCT01137006|11017002|FG001|NOT COMPLETED|Overall Study||0
9901304|NCT01137006|11017003|FG002|NOT COMPLETED|Overall Study||0
9901305|NCT01137006|11017004|FG003|NOT COMPLETED|Overall Study||0
9901306|NCT01137006|11017005|FG004|NOT COMPLETED|Overall Study||0
9901307|NCT01137006|11017006|FG005|NOT COMPLETED|Overall Study||0
9901308|NCT01137006|11017007|FG006|NOT COMPLETED|Overall Study||0
9901309|NCT01137032|11017024|FG000|STARTED|Overall Study||19
9901310|NCT01137032|11017024|FG000|COMPLETED|Overall Study||19
9901311|NCT01137032|11017024|FG000|NOT COMPLETED|Overall Study||0
9901312|NCT01137071|11017028|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29
9901313|NCT01137071|11017028|FG000|COMPLETED|Overall Study|Of the eligible patients|15
9901314|NCT01137071|11017028|FG000|NOT COMPLETED|Overall Study||14
9901315|NCT01137110|11017039|FG000|STARTED|Overall Study||35
9901316|NCT01137110|11017040|FG001|STARTED|Overall Study||49
9901317|NCT01137110|11017039|FG000|COMPLETED|Overall Study||34
9901318|NCT01137110|11017040|FG001|COMPLETED|Overall Study||49
9901319|NCT01137110|11017039|FG000|NOT COMPLETED|Overall Study||1
9901320|NCT01137110|11017040|FG001|NOT COMPLETED|Overall Study||0
9901321|NCT01137292|11017046|FG000|STARTED|Overall Study||177
9901322|NCT01137292|11017046|FG000|COMPLETED|Overall Study||123
9901323|NCT01137292|11017046|FG000|NOT COMPLETED|Overall Study||54
9901324|NCT01137370|11017052|FG000|STARTED|Overall Study||116
9901325|NCT01137370|11017053|FG001|STARTED|Overall Study||87
9901326|NCT01137370|11017052|FG000|COMPLETED|Overall Study||116
9901327|NCT01137370|11017053|FG001|COMPLETED|Overall Study||87
9901328|NCT01137370|11017052|FG000|NOT COMPLETED|Overall Study||0
9901329|NCT01137370|11017053|FG001|NOT COMPLETED|Overall Study||0
9901330|NCT01137396|11017061|FG000|STARTED|Overall Study||30
9901331|NCT01137396|11017062|FG001|STARTED|Overall Study||27
9901332|NCT01137396|11017061|FG000|COMPLETED|Overall Study||22
9901333|NCT01137396|11017062|FG001|COMPLETED|Overall Study||25
9901334|NCT01137396|11017061|FG000|NOT COMPLETED|Overall Study||8
9901335|NCT01137396|11017062|FG001|NOT COMPLETED|Overall Study||2
9901336|NCT01137474|11017072|FG000|STARTED|Overall Study||311
9901337|NCT01137474|11017073|FG001|STARTED|Overall Study||166
9901338|NCT01137474|11017074|FG002|STARTED|Overall Study||165
9901339|NCT01137474|11017075|FG003|STARTED|Overall Study||302
9901340|NCT01137474|11017072|FG000|Received Treatment|Overall Study||311
9901341|NCT01137474|11017073|FG001|Received Treatment|Overall Study||166
9901342|NCT01137474|11017074|FG002|Received Treatment|Overall Study||165
9901343|NCT01137474|11017075|FG003|Received Treatment|Overall Study||302
9901344|NCT01137474|11017072|FG000|COMPLETED|Overall Study||287
9901345|NCT01137474|11017073|FG001|COMPLETED|Overall Study||154
9901346|NCT01137474|11017074|FG002|COMPLETED|Overall Study||158
9901347|NCT01137474|11017075|FG003|COMPLETED|Overall Study||281
9901348|NCT01137474|11017072|FG000|NOT COMPLETED|Overall Study||24
9901349|NCT01137474|11017073|FG001|NOT COMPLETED|Overall Study||12
9901350|NCT01137474|11017074|FG002|NOT COMPLETED|Overall Study||7
9901351|NCT01137474|11017075|FG003|NOT COMPLETED|Overall Study||21
9901352|NCT01137539|11017085|FG000|STARTED|Overall Study||50
9901353|NCT01137539|11017085|FG000|COMPLETED|Overall Study||50
9901354|NCT01137539|11017085|FG000|NOT COMPLETED|Overall Study||0
9901355|NCT01137578|11017089|FG000|STARTED|Overall Study||77
9901356|NCT01137578|11017090|FG001|STARTED|Overall Study||14
9901357|NCT01137578|11017091|FG002|STARTED|Overall Study||43
9901358|NCT01137578|11017089|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
9901359|NCT01137578|11017090|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
9901360|NCT01137578|11017091|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
9901361|NCT01137578|11017089|FG000|NOT COMPLETED|Overall Study||16
9901362|NCT01137578|11017090|FG001|NOT COMPLETED|Overall Study||2
9901363|NCT01137578|11017091|FG002|NOT COMPLETED|Overall Study||6
9901364|NCT01137604|11017123|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
9901365|NCT01137604|11017124|FG001|STARTED|Overall Study||42
9901366|NCT01137604|11017125|FG002|STARTED|Overall Study||39
9901367|NCT01137604|11017126|FG003|STARTED|Overall Study||32
9901368|NCT01137604|11017123|FG000|Disease Progression|Overall Study||34
9901369|NCT01137604|11017124|FG001|Disease Progression|Overall Study||29
9901370|NCT01137604|11017125|FG002|Disease Progression|Overall Study||25
9901371|NCT01137604|11017126|FG003|Disease Progression|Overall Study||21
9901372|NCT01137604|11017123|FG000|Treatment Ongoing at Data Cutoff|Overall Study||2
9901373|NCT01137604|11017124|FG001|Treatment Ongoing at Data Cutoff|Overall Study||3
9901374|NCT01137604|11017125|FG002|Treatment Ongoing at Data Cutoff|Overall Study||1
9901375|NCT01137604|11017126|FG003|Treatment Ongoing at Data Cutoff|Overall Study||0
9901376|NCT01137604|11017123|FG000|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
9901377|NCT01137604|11017124|FG001|COMPLETED|Overall Study||32
9901378|NCT01137604|11017125|FG002|COMPLETED|Overall Study||26
9901379|NCT01137604|11017126|FG003|COMPLETED|Overall Study||21
9901380|NCT01137604|11017123|FG000|NOT COMPLETED|Overall Study||2
9901381|NCT01137604|11017124|FG001|NOT COMPLETED|Overall Study||10
9901382|NCT01137604|11017125|FG002|NOT COMPLETED|Overall Study||13
9901383|NCT01137604|11017126|FG003|NOT COMPLETED|Overall Study||11
9901384|NCT01137682|11017139|FG000|STARTED|Overall Study||65
9901385|NCT01137682|11017140|FG001|STARTED|Overall Study||65
9901386|NCT01137682|11017141|FG002|STARTED|Overall Study||68
9901387|NCT01137682|11017139|FG000|Not Treated|Overall Study||2
9901388|NCT01137682|11017140|FG001|Not Treated|Overall Study||2
9901389|NCT01137682|11017141|FG002|Not Treated|Overall Study||1
9901390|NCT01137682|11017139|FG000|Treated|Overall Study||63
9901391|NCT01137682|11017140|FG001|Treated|Overall Study||63
9901392|NCT01137682|11017141|FG002|Treated|Overall Study||67
9901393|NCT01137682|11017139|FG000|Completed 24-Week Core Phase|Overall Study||59
9901394|NCT01137682|11017140|FG001|Completed 24-Week Core Phase|Overall Study||57
9901395|NCT01137682|11017141|FG002|Completed 24-Week Core Phase|Overall Study||65
9901396|NCT01137682|11017139|FG000|Not Continuing Into Extension|Overall Study||2
9901397|NCT01137682|11017140|FG001|Not Continuing Into Extension|Overall Study||3
9901398|NCT01137682|11017141|FG002|Not Continuing Into Extension|Overall Study||2
9901399|NCT01137682|11017139|FG000|Continuing Into Extension|Overall Study||57
9901400|NCT01137682|11017140|FG001|Continuing Into Extension|Overall Study||54
9901401|NCT01137682|11017141|FG002|Continuing Into Extension|Overall Study||63
9901402|NCT01137682|11017139|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63
9901403|NCT01137682|11017140|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
9901404|NCT01137682|11017141|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66
9901405|NCT01137682|11017139|FG000|Safety Set - Extension|Overall Study||57
9901406|NCT01137682|11017140|FG001|Safety Set - Extension|Overall Study||54
9901407|NCT01137682|11017141|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
9901408|NCT01137682|11017139|FG000|COMPLETED|Overall Study||28
9901409|NCT01137682|11017140|FG001|COMPLETED|Overall Study||25
9901410|NCT01137682|11017141|FG002|COMPLETED|Overall Study||34
9901411|NCT01137682|11017139|FG000|NOT COMPLETED|Overall Study||37
9901412|NCT01137682|11017140|FG001|NOT COMPLETED|Overall Study||40
9901413|NCT01137682|11017141|FG002|NOT COMPLETED|Overall Study||34
9901414|NCT01137786|11017155|FG000|STARTED|Overall Study||25
9901415|NCT01137786|11017156|FG001|STARTED|Overall Study||24
9901416|NCT01137786|11017155|FG000|COMPLETED|Overall Study||24
9901417|NCT01137786|11017156|FG001|COMPLETED|Overall Study||21
9901418|NCT01137786|11017155|FG000|NOT COMPLETED|Overall Study||1
9901419|NCT01137786|11017156|FG001|NOT COMPLETED|Overall Study||3
9901420|NCT01137812|11017166|FG000|STARTED|Overall Study||377
9901421|NCT01137812|11017167|FG001|STARTED|Overall Study||378
9901422|NCT01137812|11017166|FG000|COMPLETED|Overall Study||254
9901423|NCT01137812|11017167|FG001|COMPLETED|Overall Study||210
9901424|NCT01137812|11017166|FG000|NOT COMPLETED|Overall Study||123
10110384|NCT02484911|11241178|FG001|COMPLETED|Overall Study||58
10110385|NCT02484911|11241177|FG000|NOT COMPLETED|Overall Study||4
10110386|NCT02484911|11241178|FG001|NOT COMPLETED|Overall Study||2
10110387|NCT02485158|11241185|FG000|STARTED|Overall Study||28
10110388|NCT02485158|11241185|FG000|COMPLETED|Overall Study||24
10110389|NCT02485158|11241185|FG000|NOT COMPLETED|Overall Study||4
9901425|NCT01137812|11017167|FG001|NOT COMPLETED|Overall Study||168
9901426|NCT01137890|11017175|FG000|STARTED|Overall Study||14
9901427|NCT01137890|11017176|FG001|STARTED|Overall Study||5
9901428|NCT01137890|11017175|FG000|COMPLETED|Overall Study||8
9901429|NCT01137890|11017176|FG001|COMPLETED|Overall Study||2
9901430|NCT01137890|11017175|FG000|NOT COMPLETED|Overall Study||6
9901431|NCT01137890|11017176|FG001|NOT COMPLETED|Overall Study||3
9901432|NCT01138007|11017231|FG000|STARTED|Overall Study||187
9901433|NCT01138007|11017232|FG001|STARTED|Overall Study||190
9901434|NCT01138007|11017233|FG002|STARTED|Overall Study||192
9901435|NCT01138007|11017231|FG000|COMPLETED|Overall Study||165
9901436|NCT01138007|11017232|FG001|COMPLETED|Overall Study||160
9901437|NCT01138007|11017233|FG002|COMPLETED|Overall Study||144
9901438|NCT01138007|11017231|FG000|NOT COMPLETED|Overall Study||22
9901439|NCT01138007|11017232|FG001|NOT COMPLETED|Overall Study||30
9901440|NCT01138007|11017233|FG002|NOT COMPLETED|Overall Study||48
9901441|NCT01138046|11017243|FG000|STARTED|Overall Study||12
9901442|NCT01138046|11017243|FG000|COMPLETED|Overall Study||6
9901443|NCT01138046|11017243|FG000|NOT COMPLETED|Overall Study||6
9901444|NCT01138098|11017249|FG000|STARTED|Overall Study||95
9901445|NCT01138098|11017250|FG001|STARTED|Overall Study||90
9901446|NCT01138098|11017249|FG000|COMPLETED|Overall Study||95
9901447|NCT01138098|11017250|FG001|COMPLETED|Overall Study||90
9901448|NCT01138098|11017249|FG000|NOT COMPLETED|Overall Study||0
9901449|NCT01138098|11017250|FG001|NOT COMPLETED|Overall Study||0
9901450|NCT01138111|11017256|FG000|STARTED|Overall Study||45
9901451|NCT01138111|11017256|FG000|COMPLETED|Overall Study||36
9901452|NCT01138111|11017256|FG000|NOT COMPLETED|Overall Study||9
9901453|NCT01138124|11017289|FG000|STARTED|Overall Study||3149
9901454|NCT01138124|11017290|FG001|STARTED|Overall Study||30026
9901455|NCT01138124|11017291|FG002|STARTED|Overall Study||1981
9901456|NCT01138124|11017292|FG003|STARTED|Overall Study||19046
9901457|NCT01138124|11017289|FG000|COMPLETED|Overall Study||3149
9901458|NCT01138124|11017290|FG001|COMPLETED|Overall Study||30026
9901459|NCT01138124|11017291|FG002|COMPLETED|Overall Study||1981
9901460|NCT01138124|11017292|FG003|COMPLETED|Overall Study||19046
9901461|NCT01138124|11017289|FG000|NOT COMPLETED|Overall Study||0
9901462|NCT01138124|11017290|FG001|NOT COMPLETED|Overall Study||0
9901463|NCT01138124|11017291|FG002|NOT COMPLETED|Overall Study||0
9901464|NCT01138124|11017292|FG003|NOT COMPLETED|Overall Study||0
9901465|NCT01138150|11017302|FG000|STARTED|Overall Study||18
9901466|NCT01138150|11017303|FG001|STARTED|Overall Study||18
9901467|NCT01138150|11017302|FG000|COMPLETED|Overall Study||17
9901468|NCT01138150|11017303|FG001|COMPLETED|Overall Study||17
9901469|NCT01138150|11017302|FG000|NOT COMPLETED|Overall Study||1
9901470|NCT01138150|11017303|FG001|NOT COMPLETED|Overall Study||1
9901471|NCT01138475|11017322|FG000|STARTED|Overall Study||16
9901472|NCT01138475|11017323|FG001|STARTED|Overall Study||16
9901473|NCT01138475|11017324|FG002|STARTED|Overall Study||17
9901474|NCT01138475|11017322|FG000|COMPLETED|Overall Study||16
9901475|NCT01138475|11017323|FG001|COMPLETED|Overall Study||16
9901476|NCT01138475|11017324|FG002|COMPLETED|Overall Study||17
9901477|NCT01138475|11017322|FG000|NOT COMPLETED|Overall Study||0
9901478|NCT01138475|11017323|FG001|NOT COMPLETED|Overall Study||0
9901479|NCT01138475|11017324|FG002|NOT COMPLETED|Overall Study||0
9901480|NCT01138501|11017338|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
9901481|NCT01138501|11017338|FG000|Exposed|Overall Study||63
10202901|NCT03453060|11330061|FG003|STARTED|Overall Study||4
9901482|NCT01138501|11017338|FG000|COMPLETED|Overall Study||60
9901483|NCT01138501|11017338|FG000|NOT COMPLETED|Overall Study||5
9901484|NCT01138514|11017345|FG000|STARTED|Overall Study||522
9901485|NCT01138514|11017346|FG001|STARTED|Overall Study||516
9901486|NCT01138514|11017347|FG002|STARTED|Overall Study||517
9901487|NCT01138514|11017345|FG000|COMPLETED|Overall Study||474
9901488|NCT01138514|11017346|FG001|COMPLETED|Overall Study||463
10110390|NCT02485301|11241196|FG000|STARTED|Overall Study||1509
10110391|NCT02485301|11241197|FG001|STARTED|Overall Study||1504
10110392|NCT02485301|11241196|FG000|COMPLETED|Overall Study||1471
10110393|NCT02485301|11241197|FG001|COMPLETED|Overall Study||1455
10110394|NCT02485301|11241196|FG000|NOT COMPLETED|Overall Study||38
10110395|NCT02485301|11241197|FG001|NOT COMPLETED|Overall Study||49
9901489|NCT01138514|11017347|FG002|COMPLETED|Overall Study||424
9901490|NCT01138514|11017345|FG000|NOT COMPLETED|Overall Study||48
9901491|NCT01138514|11017346|FG001|NOT COMPLETED|Overall Study||53
9901492|NCT01138514|11017347|FG002|NOT COMPLETED|Overall Study||93
9901493|NCT01138657|11017358|FG000|STARTED|Overall Study||120
9901494|NCT01138657|11017359|FG001|STARTED|Overall Study||119
9901495|NCT01138657|11017358|FG000|Enrolled in Main Study|Overall Study||112
9901496|NCT01138657|11017359|FG001|Enrolled in Main Study|Overall Study||111
9901497|NCT01138657|11017358|FG000|Enrolled in Japan Sub-study|Overall Study||8
9901498|NCT01138657|11017359|FG001|Enrolled in Japan Sub-study|Overall Study||8
9901499|NCT01138657|11017358|FG000|COMPLETED|Overall Study||112
9901500|NCT01138657|11017359|FG001|COMPLETED|Overall Study||101
9901501|NCT01138657|11017358|FG000|NOT COMPLETED|Overall Study||8
9901502|NCT01138657|11017359|FG001|NOT COMPLETED|Overall Study||18
9901503|NCT01138735|11017369|FG000|STARTED|Overall Study||142
9901504|NCT01138735|11017370|FG001|STARTED|Overall Study||143
9901505|NCT01138735|11017369|FG000|COMPLETED|Overall Study||134
9901506|NCT01138735|11017370|FG001|COMPLETED|Overall Study||126
9901507|NCT01138735|11017369|FG000|NOT COMPLETED|Overall Study||8
9901508|NCT01138735|11017370|FG001|NOT COMPLETED|Overall Study||17
9901509|NCT01138826|11017376|FG000|STARTED|First Intervention Period||3
9901510|NCT01138826|11017377|FG001|STARTED|First Intervention Period||3
9901511|NCT01138826|11017378|FG002|STARTED|First Intervention Period||3
9901512|NCT01138826|11017379|FG003|STARTED|First Intervention Period||3
9901513|NCT01138826|11017380|FG004|STARTED|First Intervention Period||3
9901514|NCT01138826|11017381|FG005|STARTED|First Intervention Period||3
9901515|NCT01138826|11017376|FG000|COMPLETED|First Intervention Period||3
9901516|NCT01138826|11017377|FG001|COMPLETED|First Intervention Period||3
9901517|NCT01138826|11017378|FG002|COMPLETED|First Intervention Period||3
9901518|NCT01138826|11017379|FG003|COMPLETED|First Intervention Period||3
9901519|NCT01138826|11017380|FG004|COMPLETED|First Intervention Period||3
9901520|NCT01138826|11017381|FG005|COMPLETED|First Intervention Period||3
9901521|NCT01138826|11017376|FG000|NOT COMPLETED|First Intervention Period||0
9901522|NCT01138826|11017377|FG001|NOT COMPLETED|First Intervention Period||0
9901523|NCT01138826|11017378|FG002|NOT COMPLETED|First Intervention Period||0
9901524|NCT01138826|11017379|FG003|NOT COMPLETED|First Intervention Period||0
9901525|NCT01138826|11017380|FG004|NOT COMPLETED|First Intervention Period||0
9901526|NCT01138826|11017381|FG005|NOT COMPLETED|First Intervention Period||0
9901527|NCT01138826|11017376|FG000|STARTED|Washout Period I (of 16 Days)||3
9901528|NCT01138826|11017377|FG001|STARTED|Washout Period I (of 16 Days)||3
9901529|NCT01138826|11017378|FG002|STARTED|Washout Period I (of 16 Days)||3
9901530|NCT01138826|11017379|FG003|STARTED|Washout Period I (of 16 Days)||3
9901531|NCT01138826|11017380|FG004|STARTED|Washout Period I (of 16 Days)||3
9901532|NCT01138826|11017381|FG005|STARTED|Washout Period I (of 16 Days)||3
9901533|NCT01138826|11017376|FG000|COMPLETED|Washout Period I (of 16 Days)||2
9901534|NCT01138826|11017377|FG001|COMPLETED|Washout Period I (of 16 Days)||2
9901535|NCT01138826|11017378|FG002|COMPLETED|Washout Period I (of 16 Days)||3
9901536|NCT01138826|11017379|FG003|COMPLETED|Washout Period I (of 16 Days)||3
9901537|NCT01138826|11017380|FG004|COMPLETED|Washout Period I (of 16 Days)||2
9901538|NCT01138826|11017381|FG005|COMPLETED|Washout Period I (of 16 Days)||3
9901539|NCT01138826|11017376|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1
9901540|NCT01138826|11017377|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1
9901541|NCT01138826|11017378|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0
9901542|NCT01138826|11017379|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0
9901543|NCT01138826|11017380|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1
9901544|NCT01138826|11017381|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0
9901545|NCT01138826|11017376|FG000|STARTED|Second Intervention Period||2
9760438|NCT00380874|10864079|FG001|STARTED|Overall Study||29
9760439|NCT00380874|10864078|FG000|COMPLETED|Overall Study||19
9760440|NCT00380874|10864079|FG001|COMPLETED|Overall Study||19
9760441|NCT00380874|10864078|FG000|NOT COMPLETED|Overall Study||13
9760442|NCT00380874|10864079|FG001|NOT COMPLETED|Overall Study||10
9760443|NCT00380978|10864087|FG000|STARTED|Overall Study||408
9760444|NCT00380978|10864088|FG001|STARTED|Overall Study||410
9760445|NCT00380978|10864087|FG000|COMPLETED|Overall Study||406
9760446|NCT00380978|10864088|FG001|COMPLETED|Overall Study||400
9760447|NCT00380978|10864087|FG000|NOT COMPLETED|Overall Study||2
9760448|NCT00380978|10864088|FG001|NOT COMPLETED|Overall Study||10
9760449|NCT00381004|10864094|FG000|STARTED|Overall Study||60
9901546|NCT01138826|11017377|FG001|STARTED|Second Intervention Period||2
9901547|NCT01138826|11017378|FG002|STARTED|Second Intervention Period||3
9901548|NCT01138826|11017379|FG003|STARTED|Second Intervention Period||3
9901549|NCT01138826|11017380|FG004|STARTED|Second Intervention Period||2
9901550|NCT01138826|11017381|FG005|STARTED|Second Intervention Period||3
9901551|NCT01138826|11017376|FG000|COMPLETED|Second Intervention Period||2
9901552|NCT01138826|11017377|FG001|COMPLETED|Second Intervention Period||2
9901553|NCT01138826|11017378|FG002|COMPLETED|Second Intervention Period||3
9901554|NCT01138826|11017379|FG003|COMPLETED|Second Intervention Period||3
9901555|NCT01138826|11017380|FG004|COMPLETED|Second Intervention Period||2
9901556|NCT01138826|11017381|FG005|COMPLETED|Second Intervention Period||3
9901557|NCT01138826|11017376|FG000|NOT COMPLETED|Second Intervention Period||0
9901558|NCT01138826|11017377|FG001|NOT COMPLETED|Second Intervention Period||0
9901559|NCT01138826|11017378|FG002|NOT COMPLETED|Second Intervention Period||0
9901560|NCT01138826|11017379|FG003|NOT COMPLETED|Second Intervention Period||0
9901561|NCT01138826|11017380|FG004|NOT COMPLETED|Second Intervention Period||0
9901562|NCT01138826|11017381|FG005|NOT COMPLETED|Second Intervention Period||0
9901563|NCT01138826|11017376|FG000|STARTED|Washout Period II (of 16 Days)||2
9901564|NCT01138826|11017377|FG001|STARTED|Washout Period II (of 16 Days)||2
9901565|NCT01138826|11017378|FG002|STARTED|Washout Period II (of 16 Days)||3
9901566|NCT01138826|11017379|FG003|STARTED|Washout Period II (of 16 Days)||3
9901567|NCT01138826|11017380|FG004|STARTED|Washout Period II (of 16 Days)||2
9901568|NCT01138826|11017381|FG005|STARTED|Washout Period II (of 16 Days)||3
9760450|NCT00381004|10864094|FG000|COMPLETED|Overall Study||60
9901569|NCT01138826|11017376|FG000|COMPLETED|Washout Period II (of 16 Days)||2
9901570|NCT01138826|11017377|FG001|COMPLETED|Washout Period II (of 16 Days)||2
9901571|NCT01138826|11017378|FG002|COMPLETED|Washout Period II (of 16 Days)||3
9901572|NCT01138826|11017379|FG003|COMPLETED|Washout Period II (of 16 Days)||3
9901573|NCT01138826|11017380|FG004|COMPLETED|Washout Period II (of 16 Days)||2
9901574|NCT01138826|11017381|FG005|COMPLETED|Washout Period II (of 16 Days)||3
9901575|NCT01138826|11017376|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0
9901576|NCT01138826|11017377|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0
9901577|NCT01138826|11017378|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0
9901578|NCT01138826|11017379|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0
9901579|NCT01138826|11017380|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0
9901580|NCT01138826|11017381|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0
9901581|NCT01138826|11017376|FG000|STARTED|Third Intervention Period||2
9901582|NCT01138826|11017377|FG001|STARTED|Third Intervention Period||2
9901583|NCT01138826|11017378|FG002|STARTED|Third Intervention Period||3
9901584|NCT01138826|11017379|FG003|STARTED|Third Intervention Period||3
9901585|NCT01138826|11017380|FG004|STARTED|Third Intervention Period||2
9901586|NCT01138826|11017381|FG005|STARTED|Third Intervention Period||3
9901587|NCT01138826|11017376|FG000|COMPLETED|Third Intervention Period||2
9901588|NCT01138826|11017377|FG001|COMPLETED|Third Intervention Period||2
9901589|NCT01138826|11017378|FG002|COMPLETED|Third Intervention Period||3
9901590|NCT01138826|11017379|FG003|COMPLETED|Third Intervention Period||3
9901591|NCT01138826|11017380|FG004|COMPLETED|Third Intervention Period||2
9901592|NCT01138826|11017381|FG005|COMPLETED|Third Intervention Period||3
9901593|NCT01138826|11017376|FG000|NOT COMPLETED|Third Intervention Period||0
9901594|NCT01138826|11017377|FG001|NOT COMPLETED|Third Intervention Period||0
9901595|NCT01138826|11017378|FG002|NOT COMPLETED|Third Intervention Period||0
9901596|NCT01138826|11017379|FG003|NOT COMPLETED|Third Intervention Period||0
9901597|NCT01138826|11017380|FG004|NOT COMPLETED|Third Intervention Period||0
9901598|NCT01138826|11017381|FG005|NOT COMPLETED|Third Intervention Period||0
9901599|NCT01138917|11017389|FG000|STARTED|Overall Study||101
9901600|NCT01138917|11017389|FG000|COMPLETED|Overall Study||77
9901601|NCT01138917|11017389|FG000|NOT COMPLETED|Overall Study||24
9901602|NCT01138969|11017399|FG000|STARTED|Overall Study||83
9901603|NCT01138969|11017400|FG001|STARTED|Overall Study||82
9901604|NCT01138969|11017399|FG000|COMPLETED|Overall Study||83
9901605|NCT01138969|11017400|FG001|COMPLETED|Overall Study||82
9901606|NCT01138969|11017399|FG000|NOT COMPLETED|Overall Study||0
9901607|NCT01138969|11017400|FG001|NOT COMPLETED|Overall Study||0
9901608|NCT01138995|11017408|FG000|STARTED|Overall Study||98
9901609|NCT01138995|11017409|FG001|STARTED|Overall Study||99
9901610|NCT01138995|11017408|FG000|COMPLETED|Overall Study||88
9901611|NCT01138995|11017409|FG001|COMPLETED|Overall Study||74
9901612|NCT01138995|11017408|FG000|NOT COMPLETED|Overall Study||10
9901613|NCT01138995|11017409|FG001|NOT COMPLETED|Overall Study||25
9901614|NCT01139008|11017416|FG000|STARTED|Overall Study||80
9901615|NCT01139008|11017416|FG000|COMPLETED|Overall Study||74
9901616|NCT01139008|11017416|FG000|NOT COMPLETED|Overall Study||6
10110396|NCT02485353|11241203|FG000|STARTED|Overall Study||2
10110397|NCT02485353|11241203|FG000|COMPLETED|Overall Study||0
10110398|NCT02485353|11241203|FG000|NOT COMPLETED|Overall Study||2
10110399|NCT02485483|11241209|FG000|STARTED|Overall Study||277
10110400|NCT02485483|11241210|FG001|STARTED|Overall Study||1015
10110401|NCT02485483|11241209|FG000|COMPLETED|Overall Study||223
10110402|NCT02485483|11241210|FG001|COMPLETED|Overall Study||1015
10110403|NCT02485483|11241209|FG000|NOT COMPLETED|Overall Study||54
10110404|NCT02485483|11241210|FG001|NOT COMPLETED|Overall Study||0
10110405|NCT02485561|11241219|FG000|STARTED|Overall Study||161
10110406|NCT02485561|11241220|FG001|STARTED|Overall Study||157
10110407|NCT02485561|11241221|FG002|STARTED|Overall Study||159
10110408|NCT02485561|11241219|FG000|Completed 1 mo Survey|Overall Study||145
10110409|NCT02485561|11241220|FG001|Completed 1 mo Survey|Overall Study||138
10110410|NCT02485561|11241221|FG002|Completed 1 mo Survey|Overall Study||144
10110411|NCT02485561|11241219|FG000|COMPLETED|Overall Study||133
10110412|NCT02485561|11241220|FG001|COMPLETED|Overall Study||118
10110413|NCT02485561|11241221|FG002|COMPLETED|Overall Study||136
10110414|NCT02485561|11241219|FG000|NOT COMPLETED|Overall Study||28
10110415|NCT02485561|11241220|FG001|NOT COMPLETED|Overall Study||39
10110416|NCT02485561|11241221|FG002|NOT COMPLETED|Overall Study||23
10110417|NCT02485704|11241231|FG000|STARTED|Overall Study||154
10110418|NCT02485704|11241232|FG001|STARTED|Overall Study||126
10110419|NCT02485704|11241231|FG000|COMPLETED|Overall Study||149
10110420|NCT02485704|11241232|FG001|COMPLETED|Overall Study||118
10110421|NCT02485704|11241231|FG000|NOT COMPLETED|Overall Study||5
10110422|NCT02485704|11241232|FG001|NOT COMPLETED|Overall Study||8
9901617|NCT01139021|11017429|FG000|STARTED|Overall Study||152
9901618|NCT01139021|11017430|FG001|STARTED|Overall Study||153
9901619|NCT01139021|11017431|FG002|STARTED|Overall Study||67
9901620|NCT01139021|11017432|FG003|STARTED|Overall Study||19
9901621|NCT01139021|11017433|FG004|STARTED|Overall Study||116
10110423|NCT02485717|11241241|FG000|STARTED|Overall Study||142
9901622|NCT01139021|11017434|FG005|STARTED|Overall Study||1
9901623|NCT01139021|11017429|FG000|COMPLETED|Overall Study||151
9901624|NCT01139021|11017430|FG001|COMPLETED|Overall Study||153
9901625|NCT01139021|11017431|FG002|COMPLETED|Overall Study||67
9901626|NCT01139021|11017432|FG003|COMPLETED|Overall Study||18
9901627|NCT01139021|11017433|FG004|COMPLETED|Overall Study||107
10110424|NCT02485717|11241242|FG001|STARTED|Overall Study||129
10110425|NCT02485717|11241243|FG002|STARTED|Overall Study||20
10110426|NCT02485717|11241241|FG000|COMPLETED|Overall Study||136
10110427|NCT02485717|11241242|FG001|COMPLETED|Overall Study||127
9901628|NCT01139021|11017434|FG005|COMPLETED|Overall Study||1
9901629|NCT01139021|11017429|FG000|NOT COMPLETED|Overall Study||1
9901630|NCT01139021|11017430|FG001|NOT COMPLETED|Overall Study||0
9901631|NCT01139021|11017431|FG002|NOT COMPLETED|Overall Study||0
9901632|NCT01139021|11017432|FG003|NOT COMPLETED|Overall Study||1
9901633|NCT01139021|11017433|FG004|NOT COMPLETED|Overall Study||9
9901634|NCT01139021|11017434|FG005|NOT COMPLETED|Overall Study||0
9901635|NCT01139047|11017449|FG000|STARTED|Overall Study||77
9901636|NCT01139047|11017449|FG000|COMPLETED|Overall Study||76
9901637|NCT01139047|11017449|FG000|NOT COMPLETED|Overall Study||1
9901638|NCT01139164|11017459|FG000|STARTED|Overall Study||4
9901639|NCT01139164|11017460|FG001|STARTED|Overall Study||67
9901640|NCT01139164|11017461|FG002|STARTED|Overall Study||7
9901641|NCT01139164|11017459|FG000|COMPLETED|Overall Study||4
9901642|NCT01139164|11017460|FG001|COMPLETED|Overall Study||65
9901643|NCT01139164|11017461|FG002|COMPLETED|Overall Study||7
9901644|NCT01139164|11017459|FG000|NOT COMPLETED|Overall Study||0
9901645|NCT01139164|11017460|FG001|NOT COMPLETED|Overall Study||2
9901646|NCT01139164|11017461|FG002|NOT COMPLETED|Overall Study||0
9901647|NCT01139190|11017471|FG000|STARTED|Overall Study||38
9901648|NCT01139190|11017472|FG001|STARTED|Overall Study||39
9901649|NCT01139190|11017471|FG000|COMPLETED|Overall Study||38
9901650|NCT01139190|11017472|FG001|COMPLETED|Overall Study||38
9901651|NCT01139190|11017471|FG000|NOT COMPLETED|Overall Study||0
9901652|NCT01139190|11017472|FG001|NOT COMPLETED|Overall Study||1
9901653|NCT01139411|11017480|FG000|STARTED|Overall Study||26
9901654|NCT01139411|11017481|FG001|STARTED|Overall Study||23
9901655|NCT01139411|11017480|FG000|COMPLETED|Overall Study||24
9901656|NCT01139411|11017481|FG001|COMPLETED|Overall Study||19
9901657|NCT01139411|11017480|FG000|NOT COMPLETED|Overall Study||2
9901658|NCT01139411|11017481|FG001|NOT COMPLETED|Overall Study||4
9901659|NCT01139450|11017492|FG000|STARTED|Overall Study||302
9901660|NCT01139450|11017493|FG001|STARTED|Overall Study||297
9901661|NCT01139450|11017494|FG002|STARTED|Overall Study||300
9901662|NCT01139450|11017492|FG000|COMPLETED|Overall Study||275
9901663|NCT01139450|11017493|FG001|COMPLETED|Overall Study||272
9901664|NCT01139450|11017494|FG002|COMPLETED|Overall Study||262
9901665|NCT01139450|11017492|FG000|NOT COMPLETED|Overall Study||27
9901666|NCT01139450|11017493|FG001|NOT COMPLETED|Overall Study||25
9901667|NCT01139450|11017494|FG002|NOT COMPLETED|Overall Study||38
9901668|NCT01139515|11017502|FG000|STARTED|First Intervention Period||4
9901669|NCT01139515|11017503|FG001|STARTED|First Intervention Period||4
9901670|NCT01139515|11017504|FG002|STARTED|First Intervention Period||4
9901671|NCT01139515|11017505|FG003|STARTED|First Intervention Period||4
9901672|NCT01139515|11017502|FG000|COMPLETED|First Intervention Period||4
9901673|NCT01139515|11017503|FG001|COMPLETED|First Intervention Period||4
9901674|NCT01139515|11017504|FG002|COMPLETED|First Intervention Period||4
9901675|NCT01139515|11017505|FG003|COMPLETED|First Intervention Period||4
9901676|NCT01139515|11017502|FG000|NOT COMPLETED|First Intervention Period||0
9901677|NCT01139515|11017503|FG001|NOT COMPLETED|First Intervention Period||0
9901678|NCT01139515|11017504|FG002|NOT COMPLETED|First Intervention Period||0
9901679|NCT01139515|11017505|FG003|NOT COMPLETED|First Intervention Period||0
9901680|NCT01139515|11017502|FG000|STARTED|Washout Period I (46hrs)||4
9901681|NCT01139515|11017503|FG001|STARTED|Washout Period I (46hrs)||4
9901682|NCT01139515|11017504|FG002|STARTED|Washout Period I (46hrs)||4
9901683|NCT01139515|11017505|FG003|STARTED|Washout Period I (46hrs)||4
9901684|NCT01139515|11017502|FG000|COMPLETED|Washout Period I (46hrs)||4
9901685|NCT01139515|11017503|FG001|COMPLETED|Washout Period I (46hrs)||4
9901686|NCT01139515|11017504|FG002|COMPLETED|Washout Period I (46hrs)||4
9901687|NCT01139515|11017505|FG003|COMPLETED|Washout Period I (46hrs)||4
9901688|NCT01139515|11017502|FG000|NOT COMPLETED|Washout Period I (46hrs)||0
9901689|NCT01139515|11017503|FG001|NOT COMPLETED|Washout Period I (46hrs)||0
9901690|NCT01139515|11017504|FG002|NOT COMPLETED|Washout Period I (46hrs)||0
9901691|NCT01139515|11017505|FG003|NOT COMPLETED|Washout Period I (46hrs)||0
9901692|NCT01139515|11017502|FG000|STARTED|Second Intervention Period||4
9901693|NCT01139515|11017503|FG001|STARTED|Second Intervention Period||4
9901694|NCT01139515|11017504|FG002|STARTED|Second Intervention Period||4
9901695|NCT01139515|11017505|FG003|STARTED|Second Intervention Period||4
9901696|NCT01139515|11017502|FG000|COMPLETED|Second Intervention Period||4
9901697|NCT01139515|11017503|FG001|COMPLETED|Second Intervention Period||4
9901698|NCT01139515|11017504|FG002|COMPLETED|Second Intervention Period||4
9901699|NCT01139515|11017505|FG003|COMPLETED|Second Intervention Period||4
9901700|NCT01139515|11017502|FG000|NOT COMPLETED|Second Intervention Period||0
9901701|NCT01139515|11017503|FG001|NOT COMPLETED|Second Intervention Period||0
9901702|NCT01139515|11017504|FG002|NOT COMPLETED|Second Intervention Period||0
9901703|NCT01139515|11017505|FG003|NOT COMPLETED|Second Intervention Period||0
9901704|NCT01139515|11017502|FG000|STARTED|Washout Period 2 (46 Hrs)||4
9901705|NCT01139515|11017503|FG001|STARTED|Washout Period 2 (46 Hrs)||4
9901706|NCT01139515|11017504|FG002|STARTED|Washout Period 2 (46 Hrs)||4
9901707|NCT01139515|11017505|FG003|STARTED|Washout Period 2 (46 Hrs)||4
9901708|NCT01139515|11017502|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4
9901709|NCT01139515|11017503|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4
9901710|NCT01139515|11017504|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4
9901711|NCT01139515|11017505|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4
9901712|NCT01139515|11017502|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
9901713|NCT01139515|11017503|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
9901714|NCT01139515|11017504|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
9901715|NCT01139515|11017505|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
9901716|NCT01139515|11017502|FG000|STARTED|Third Intervention Period||4
9901717|NCT01139515|11017503|FG001|STARTED|Third Intervention Period||4
9901718|NCT01139515|11017504|FG002|STARTED|Third Intervention Period||4
9901719|NCT01139515|11017505|FG003|STARTED|Third Intervention Period||4
9901720|NCT01139515|11017502|FG000|COMPLETED|Third Intervention Period||4
9901721|NCT01139515|11017503|FG001|COMPLETED|Third Intervention Period||4
9901722|NCT01139515|11017504|FG002|COMPLETED|Third Intervention Period||4
9901723|NCT01139515|11017505|FG003|COMPLETED|Third Intervention Period||4
9901724|NCT01139515|11017502|FG000|NOT COMPLETED|Third Intervention Period||0
9901725|NCT01139515|11017503|FG001|NOT COMPLETED|Third Intervention Period||0
9901726|NCT01139515|11017504|FG002|NOT COMPLETED|Third Intervention Period||0
9901727|NCT01139515|11017505|FG003|NOT COMPLETED|Third Intervention Period||0
9901728|NCT01139515|11017502|FG000|STARTED|Washout Period 3 (46 Hrs)||4
9901729|NCT01139515|11017503|FG001|STARTED|Washout Period 3 (46 Hrs)||4
9901730|NCT01139515|11017504|FG002|STARTED|Washout Period 3 (46 Hrs)||4
9901731|NCT01139515|11017505|FG003|STARTED|Washout Period 3 (46 Hrs)||4
9901732|NCT01139515|11017502|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4
9901733|NCT01139515|11017503|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4
9901734|NCT01139515|11017504|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4
9901735|NCT01139515|11017505|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4
9901736|NCT01139515|11017502|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
9901737|NCT01139515|11017503|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
9901738|NCT01139515|11017504|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
9901739|NCT01139515|11017505|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
9901740|NCT01139515|11017502|FG000|STARTED|Fourth Intervention Period||4
9901741|NCT01139515|11017503|FG001|STARTED|Fourth Intervention Period||4
9901742|NCT01139515|11017504|FG002|STARTED|Fourth Intervention Period||4
9901743|NCT01139515|11017505|FG003|STARTED|Fourth Intervention Period||4
9901744|NCT01139515|11017502|FG000|COMPLETED|Fourth Intervention Period||4
9901745|NCT01139515|11017503|FG001|COMPLETED|Fourth Intervention Period||4
9901746|NCT01139515|11017504|FG002|COMPLETED|Fourth Intervention Period||4
9901747|NCT01139515|11017505|FG003|COMPLETED|Fourth Intervention Period||4
9901748|NCT01139515|11017502|FG000|NOT COMPLETED|Fourth Intervention Period||0
9901749|NCT01139515|11017503|FG001|NOT COMPLETED|Fourth Intervention Period||0
9901750|NCT01139515|11017504|FG002|NOT COMPLETED|Fourth Intervention Period||0
9901751|NCT01139515|11017505|FG003|NOT COMPLETED|Fourth Intervention Period||0
9901752|NCT01139580|11017517|FG000|STARTED|Overall Study||181
9901753|NCT01139580|11017518|FG001|STARTED|Overall Study||182
9901754|NCT01139580|11017517|FG000|COMPLETED|Overall Study||158
9901755|NCT01139580|11017518|FG001|COMPLETED|Overall Study||164
9901756|NCT01139580|11017517|FG000|NOT COMPLETED|Overall Study||23
9901757|NCT01139580|11017518|FG001|NOT COMPLETED|Overall Study||18
9901758|NCT01139658|11017526|FG000|STARTED|Overall Study||747
9901759|NCT01139658|11017527|FG001|STARTED|Overall Study||929
10110428|NCT02485717|11241243|FG002|COMPLETED|Overall Study||19
10110429|NCT02485717|11241241|FG000|NOT COMPLETED|Overall Study||6
10110430|NCT02485717|11241242|FG001|NOT COMPLETED|Overall Study||2
10110431|NCT02485717|11241243|FG002|NOT COMPLETED|Overall Study||1
10110432|NCT02485834|11241251|FG000|STARTED|Overall Study||3
10110433|NCT02485834|11241252|FG001|STARTED|Overall Study||2
10110434|NCT02485834|11241251|FG000|COMPLETED|Overall Study||3
10110435|NCT02485834|11241252|FG001|COMPLETED|Overall Study||2
10110436|NCT02485834|11241251|FG000|NOT COMPLETED|Overall Study||0
10110437|NCT02485834|11241252|FG001|NOT COMPLETED|Overall Study||0
10110438|NCT02485912|11241259|FG000|STARTED|Overall Study||20
10110439|NCT02485912|11241260|FG001|STARTED|Overall Study||20
10110440|NCT02485912|11241259|FG000|COMPLETED|Overall Study||20
10110441|NCT02485912|11241260|FG001|COMPLETED|Overall Study||20
10110442|NCT02485912|11241259|FG000|NOT COMPLETED|Overall Study||0
10110443|NCT02485912|11241260|FG001|NOT COMPLETED|Overall Study||0
10110444|NCT02485925|11241266|FG000|STARTED|Overall Study||200
10110445|NCT02485925|11241266|FG000|Safety Population|Overall Study||200
10110446|NCT02485925|11241266|FG000|Intent to Treat (ITT) Population|Overall Study||193
10110447|NCT02485925|11241266|FG000|Per-Protocol Population|Overall Study||166
10110448|NCT02485925|11241266|FG000|COMPLETED|Overall Study||185
10110449|NCT02485925|11241266|FG000|NOT COMPLETED|Overall Study||15
10110450|NCT02485964|11241270|FG000|STARTED|Overall Study||10
10110451|NCT02485964|11241270|FG000|COMPLETED|Overall Study||10
10110452|NCT02485964|11241270|FG000|NOT COMPLETED|Overall Study||0
10110453|NCT02486016|11241274|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
10110454|NCT02486016|11241274|FG000|COMPLETED|Overall Study||10
10110455|NCT02486016|11241274|FG000|NOT COMPLETED|Overall Study||0
10110456|NCT02486211|11241284|FG000|STARTED|Overall Study||7
10110457|NCT02486211|11241285|FG001|STARTED|Overall Study||7
10110458|NCT02486211|11241284|FG000|COMPLETED|Overall Study||6
10110459|NCT02486211|11241285|FG001|COMPLETED|Overall Study||7
10110460|NCT02486211|11241284|FG000|NOT COMPLETED|Overall Study||1
10110461|NCT02486211|11241285|FG001|NOT COMPLETED|Overall Study||0
9901760|NCT01139658|11017526|FG000|COMPLETED|Overall Study||691
9901761|NCT01139658|11017527|FG001|COMPLETED|Overall Study||816
9901762|NCT01139658|11017526|FG000|NOT COMPLETED|Overall Study||56
9901763|NCT01139658|11017527|FG001|NOT COMPLETED|Overall Study||113
9901764|NCT01139762|11017535|FG000|STARTED|Washout and Placebo Lead-In Period||1070
9901765|NCT01139762|11017536|FG001|STARTED|Washout and Placebo Lead-In Period||0
9901766|NCT01139762|11017537|FG002|STARTED|Washout and Placebo Lead-In Period||0
9901767|NCT01139762|11017535|FG000|COMPLETED|Washout and Placebo Lead-In Period||696
9901768|NCT01139762|11017536|FG001|COMPLETED|Washout and Placebo Lead-In Period||0
9901769|NCT01139762|11017537|FG002|COMPLETED|Washout and Placebo Lead-In Period||0
9901770|NCT01139762|11017535|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374
9901771|NCT01139762|11017536|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0
9901772|NCT01139762|11017537|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0
9901773|NCT01139762|11017535|FG000|STARTED|Double-Blind Randomized Active Treatment||0
9901774|NCT01139762|11017536|FG001|STARTED|Double-Blind Randomized Active Treatment||346
9901775|NCT01139762|11017537|FG002|STARTED|Double-Blind Randomized Active Treatment||350
9901776|NCT01139762|11017535|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
9901777|NCT01139762|11017536|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
9901778|NCT01139762|11017537|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
9901779|NCT01139762|11017535|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0
9901780|NCT01139762|11017536|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306
9901781|NCT01139762|11017537|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286
9901782|NCT01139762|11017535|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
9901783|NCT01139762|11017536|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
9901784|NCT01139762|11017537|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
9901785|NCT01139775|11017547|FG000|STARTED|Overall Study||14
9901786|NCT01139775|11017548|FG001|STARTED|Overall Study||39
9901787|NCT01139775|11017549|FG002|STARTED|Overall Study||23
9901788|NCT01139775|11017547|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
9901789|NCT01139775|11017548|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
9901790|NCT01139775|11017549|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22
9901791|NCT01139775|11017547|FG000|COMPLETED|Overall Study||13
9901792|NCT01139775|11017548|FG001|COMPLETED|Overall Study||26
9901793|NCT01139775|11017549|FG002|COMPLETED|Overall Study||17
9901794|NCT01139775|11017547|FG000|NOT COMPLETED|Overall Study||1
9901795|NCT01139775|11017548|FG001|NOT COMPLETED|Overall Study||13
9901796|NCT01139775|11017549|FG002|NOT COMPLETED|Overall Study||6
9901797|NCT01139801|11017561|FG000|STARTED|Overall Study||25
9901798|NCT01139801|11017562|FG001|STARTED|Overall Study||25
9901799|NCT01139801|11017561|FG000|COMPLETED|Overall Study||25
9901800|NCT01139801|11017562|FG001|COMPLETED|Overall Study||25
9901801|NCT01139801|11017561|FG000|NOT COMPLETED|Overall Study||0
9901802|NCT01139801|11017562|FG001|NOT COMPLETED|Overall Study||0
9901803|NCT01139814|11017568|FG000|STARTED|Overall Study||181
9901804|NCT01139814|11017568|FG000|COMPLETED|Overall Study||181
9901805|NCT01139814|11017568|FG000|NOT COMPLETED|Overall Study||0
9901806|NCT01139879|11017573|FG000|STARTED|Overall Study||10
9901807|NCT01139879|11017573|FG000|COMPLETED|Overall Study||10
9901808|NCT01139879|11017573|FG000|NOT COMPLETED|Overall Study||0
9901809|NCT01140061|11017589|FG000|STARTED|Part I|Includes 1 replacement participant|7
9901810|NCT01140061|11017590|FG001|STARTED|Part I||2
9901811|NCT01140061|11017591|FG002|STARTED|Part I||0
9901812|NCT01140061|11017592|FG003|STARTED|Part I||0
9901813|NCT01140061|11017593|FG004|STARTED|Part I||0
9901814|NCT01140061|11017594|FG005|STARTED|Part I||0
9901815|NCT01140061|11017595|FG006|STARTED|Part I||0
9901816|NCT01140061|11017596|FG007|STARTED|Part I||0
9901817|NCT01140061|11017597|FG008|STARTED|Part I||0
9901818|NCT01140061|11017598|FG009|STARTED|Part I||0
9901819|NCT01140061|11017589|FG000|COMPLETED|Part I||6
9901820|NCT01140061|11017590|FG001|COMPLETED|Part I||2
9901821|NCT01140061|11017591|FG002|COMPLETED|Part I||0
9901822|NCT01140061|11017592|FG003|COMPLETED|Part I||0
9901823|NCT01140061|11017593|FG004|COMPLETED|Part I||0
9901824|NCT01140061|11017594|FG005|COMPLETED|Part I||0
9901825|NCT01140061|11017595|FG006|COMPLETED|Part I||0
9901826|NCT01140061|11017596|FG007|COMPLETED|Part I||0
10110462|NCT02486263|11241294|FG000|STARTED|Overall Study||40
10110463|NCT02486263|11241295|FG001|STARTED|Overall Study||36
10110464|NCT02486263|11241294|FG000|COMPLETED|Overall Study||37
10110465|NCT02486263|11241295|FG001|COMPLETED|Overall Study||35
10110466|NCT02486263|11241294|FG000|NOT COMPLETED|Overall Study||3
10110467|NCT02486263|11241295|FG001|NOT COMPLETED|Overall Study||1
10110468|NCT02486302|11241303|FG000|STARTED|Overall Study||1534
10110469|NCT02486302|11241303|FG000|Treated|Overall Study||1523
10110470|NCT02486302|11241303|FG000|COMPLETED|Overall Study||858
10110471|NCT02486302|11241303|FG000|NOT COMPLETED|Overall Study||676
10110472|NCT02486328|11241318|FG000|STARTED|Overall Study||52
10110473|NCT02486328|11241319|FG001|STARTED|Overall Study||51
10110474|NCT02486328|11241318|FG000|COMPLETED|Overall Study||50
10110475|NCT02486328|11241319|FG001|COMPLETED|Overall Study||50
10110476|NCT02486328|11241318|FG000|NOT COMPLETED|Overall Study||2
10110477|NCT02486328|11241319|FG001|NOT COMPLETED|Overall Study||1
10110478|NCT02486406|11241329|FG000|STARTED|Overall Study||12
10110479|NCT02486406|11241330|FG001|STARTED|Overall Study||26
9901827|NCT01140061|11017597|FG008|COMPLETED|Part I||0
9901828|NCT01140061|11017598|FG009|COMPLETED|Part I||0
10110480|NCT02486406|11241331|FG002|STARTED|Overall Study||12
10110481|NCT02486406|11241332|FG003|STARTED|Overall Study||14
10110482|NCT02486406|11241329|FG000|COMPLETED|Overall Study||10
9901829|NCT01140061|11017589|FG000|NOT COMPLETED|Part I||1
9901830|NCT01140061|11017590|FG001|NOT COMPLETED|Part I||0
9901831|NCT01140061|11017591|FG002|NOT COMPLETED|Part I||0
9901832|NCT01140061|11017592|FG003|NOT COMPLETED|Part I||0
10110483|NCT02486406|11241330|FG001|COMPLETED|Overall Study||23
10110484|NCT02486406|11241331|FG002|COMPLETED|Overall Study||10
9901833|NCT01140061|11017593|FG004|NOT COMPLETED|Part I||0
9901834|NCT01140061|11017594|FG005|NOT COMPLETED|Part I||0
9901835|NCT01140061|11017595|FG006|NOT COMPLETED|Part I||0
9901836|NCT01140061|11017596|FG007|NOT COMPLETED|Part I||0
9901837|NCT01140061|11017597|FG008|NOT COMPLETED|Part I||0
9901838|NCT01140061|11017598|FG009|NOT COMPLETED|Part I||0
9901839|NCT01140061|11017589|FG000|STARTED|Part II||0
9901840|NCT01140061|11017590|FG001|STARTED|Part II||0
9901841|NCT01140061|11017591|FG002|STARTED|Part II||6
9901842|NCT01140061|11017592|FG003|STARTED|Part II||2
9901843|NCT01140061|11017593|FG004|STARTED|Part II||6
9901844|NCT01140061|11017594|FG005|STARTED|Part II||2
9901845|NCT01140061|11017595|FG006|STARTED|Part II||6
9901846|NCT01140061|11017596|FG007|STARTED|Part II||2
9901847|NCT01140061|11017597|FG008|STARTED|Part II||0
9901848|NCT01140061|11017598|FG009|STARTED|Part II||0
9901849|NCT01140061|11017589|FG000|COMPLETED|Part II||0
9901850|NCT01140061|11017590|FG001|COMPLETED|Part II||0
9901851|NCT01140061|11017591|FG002|COMPLETED|Part II||6
9901852|NCT01140061|11017592|FG003|COMPLETED|Part II||2
9901853|NCT01140061|11017593|FG004|COMPLETED|Part II||6
9901854|NCT01140061|11017594|FG005|COMPLETED|Part II||2
9901855|NCT01140061|11017595|FG006|COMPLETED|Part II||6
9901856|NCT01140061|11017596|FG007|COMPLETED|Part II||2
9901857|NCT01140061|11017597|FG008|COMPLETED|Part II||0
9901858|NCT01140061|11017598|FG009|COMPLETED|Part II||0
9901859|NCT01140061|11017589|FG000|NOT COMPLETED|Part II||0
9901860|NCT01140061|11017590|FG001|NOT COMPLETED|Part II||0
9901861|NCT01140061|11017591|FG002|NOT COMPLETED|Part II||0
9901862|NCT01140061|11017592|FG003|NOT COMPLETED|Part II||0
9901863|NCT01140061|11017593|FG004|NOT COMPLETED|Part II||0
9901864|NCT01140061|11017594|FG005|NOT COMPLETED|Part II||0
9901865|NCT01140061|11017595|FG006|NOT COMPLETED|Part II||0
9901866|NCT01140061|11017596|FG007|NOT COMPLETED|Part II||0
9901867|NCT01140061|11017597|FG008|NOT COMPLETED|Part II||0
9901868|NCT01140061|11017598|FG009|NOT COMPLETED|Part II||0
9901869|NCT01140061|11017589|FG000|STARTED|Part III||0
9901870|NCT01140061|11017590|FG001|STARTED|Part III||0
9901871|NCT01140061|11017591|FG002|STARTED|Part III||0
9901872|NCT01140061|11017592|FG003|STARTED|Part III||0
9901873|NCT01140061|11017593|FG004|STARTED|Part III||0
9901874|NCT01140061|11017594|FG005|STARTED|Part III||0
9901875|NCT01140061|11017595|FG006|STARTED|Part III||0
9901876|NCT01140061|11017596|FG007|STARTED|Part III||0
9901877|NCT01140061|11017597|FG008|STARTED|Part III||7
9901878|NCT01140061|11017598|FG009|STARTED|Part III|Includes 1 replacement participant|2
9901879|NCT01140061|11017589|FG000|COMPLETED|Part III||0
9901880|NCT01140061|11017590|FG001|COMPLETED|Part III||0
9901881|NCT01140061|11017591|FG002|COMPLETED|Part III||0
9901882|NCT01140061|11017592|FG003|COMPLETED|Part III||0
9901883|NCT01140061|11017593|FG004|COMPLETED|Part III||0
9901884|NCT01140061|11017594|FG005|COMPLETED|Part III||0
9901885|NCT01140061|11017595|FG006|COMPLETED|Part III||0
9901886|NCT01140061|11017596|FG007|COMPLETED|Part III||0
9901887|NCT01140061|11017597|FG008|COMPLETED|Part III||7
9901888|NCT01140061|11017598|FG009|COMPLETED|Part III||2
9901889|NCT01140061|11017589|FG000|NOT COMPLETED|Part III||0
9901890|NCT01140061|11017590|FG001|NOT COMPLETED|Part III||0
9901891|NCT01140061|11017591|FG002|NOT COMPLETED|Part III||0
9901892|NCT01140061|11017592|FG003|NOT COMPLETED|Part III||0
9901893|NCT01140061|11017593|FG004|NOT COMPLETED|Part III||0
9901894|NCT01140061|11017594|FG005|NOT COMPLETED|Part III||0
9901895|NCT01140061|11017595|FG006|NOT COMPLETED|Part III||0
9901896|NCT01140061|11017596|FG007|NOT COMPLETED|Part III||0
9901897|NCT01140061|11017597|FG008|NOT COMPLETED|Part III||0
9901898|NCT01140061|11017598|FG009|NOT COMPLETED|Part III||0
9901899|NCT01140061|11017589|FG000|STARTED|Extension||0
9901900|NCT01140061|11017590|FG001|STARTED|Extension||0
9901901|NCT01140061|11017591|FG002|STARTED|Extension||0
9901902|NCT01140061|11017592|FG003|STARTED|Extension||0
9901903|NCT01140061|11017593|FG004|STARTED|Extension||0
9901904|NCT01140061|11017594|FG005|STARTED|Extension||0
9901905|NCT01140061|11017595|FG006|STARTED|Extension||0
9901906|NCT01140061|11017596|FG007|STARTED|Extension||0
9901907|NCT01140061|11017597|FG008|STARTED|Extension||7
9901908|NCT01140061|11017598|FG009|STARTED|Extension||2
9901909|NCT01140061|11017589|FG000|COMPLETED|Extension||0
9901910|NCT01140061|11017590|FG001|COMPLETED|Extension||0
9901911|NCT01140061|11017591|FG002|COMPLETED|Extension||0
9901912|NCT01140061|11017592|FG003|COMPLETED|Extension||0
9901913|NCT01140061|11017593|FG004|COMPLETED|Extension||0
9901914|NCT01140061|11017594|FG005|COMPLETED|Extension||0
9901915|NCT01140061|11017595|FG006|COMPLETED|Extension||0
9901916|NCT01140061|11017596|FG007|COMPLETED|Extension||0
9901917|NCT01140061|11017597|FG008|COMPLETED|Extension||7
9901918|NCT01140061|11017598|FG009|COMPLETED|Extension||1
9901919|NCT01140061|11017589|FG000|NOT COMPLETED|Extension||0
9901920|NCT01140061|11017590|FG001|NOT COMPLETED|Extension||0
9901921|NCT01140061|11017591|FG002|NOT COMPLETED|Extension||0
9901922|NCT01140061|11017592|FG003|NOT COMPLETED|Extension||0
9901923|NCT01140061|11017593|FG004|NOT COMPLETED|Extension||0
9901924|NCT01140061|11017594|FG005|NOT COMPLETED|Extension||0
9901925|NCT01140061|11017595|FG006|NOT COMPLETED|Extension||0
9901926|NCT01140061|11017596|FG007|NOT COMPLETED|Extension||0
9901927|NCT01140061|11017597|FG008|NOT COMPLETED|Extension||0
9901928|NCT01140061|11017598|FG009|NOT COMPLETED|Extension||1
9901929|NCT01140191|11017613|FG000|STARTED|Overall Study||1
9901930|NCT01140191|11017613|FG000|COMPLETED|Overall Study||1
9901931|NCT01140191|11017613|FG000|NOT COMPLETED|Overall Study||0
9901932|NCT01140295|11017619|FG000|STARTED|Overall Study||17
9901933|NCT01140295|11017620|FG001|STARTED|Overall Study||16
9901934|NCT01140295|11017619|FG000|COMPLETED|Overall Study||16
9901935|NCT01140295|11017620|FG001|COMPLETED|Overall Study||14
9901936|NCT01140295|11017619|FG000|NOT COMPLETED|Overall Study||1
9901937|NCT01140295|11017620|FG001|NOT COMPLETED|Overall Study||2
9901938|NCT01140347|11017630|FG000|STARTED|Overall Study||283
9901939|NCT01140347|11017631|FG001|STARTED|Overall Study||282
9901940|NCT01140347|11017630|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277
9901941|NCT01140347|11017631|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276
9901942|NCT01140347|11017630|FG000|COMPLETED|Overall Study||265
9901943|NCT01140347|11017631|FG001|COMPLETED|Overall Study||268
9901944|NCT01140347|11017630|FG000|NOT COMPLETED|Overall Study||18
9901945|NCT01140347|11017631|FG001|NOT COMPLETED|Overall Study||14
9901946|NCT01140360|11017637|FG000|STARTED|Overall Study||21
9901947|NCT01140360|11017637|FG000|COMPLETED|Overall Study||15
9901948|NCT01140360|11017637|FG000|NOT COMPLETED|Overall Study||6
9901949|NCT01140477|11017643|FG000|STARTED|Overall Study||153
9901950|NCT01140477|11017644|FG001|STARTED|Overall Study||76
9901951|NCT01140477|11017643|FG000|COMPLETED|Overall Study||145
9901952|NCT01140477|11017644|FG001|COMPLETED|Overall Study||70
9901953|NCT01140477|11017643|FG000|NOT COMPLETED|Overall Study||8
9901954|NCT01140477|11017644|FG001|NOT COMPLETED|Overall Study||6
9901955|NCT01140503|11017650|FG000|STARTED|Overall Study||5
9901956|NCT01140503|11017650|FG000|COMPLETED|Overall Study||4
9901957|NCT01140503|11017650|FG000|NOT COMPLETED|Overall Study||1
9901958|NCT01140568|11017654|FG000|STARTED|Overall Study||38
9901959|NCT01140568|11017654|FG000|Screen Fail|Overall Study||4
9901960|NCT01140568|11017654|FG000|Treated With Study Drug|Overall Study||34
9901961|NCT01140568|11017654|FG000|COMPLETED|Overall Study||2
9901962|NCT01140568|11017654|FG000|NOT COMPLETED|Overall Study||36
9901963|NCT01140646|11017658|FG000|STARTED|Overall Study||43
9901964|NCT01140646|11017658|FG000|COMPLETED|Overall Study||34
9901965|NCT01140646|11017658|FG000|NOT COMPLETED|Overall Study||9
9901966|NCT01140815|11017664|FG000|STARTED|Overall Study||25
9901967|NCT01140815|11017665|FG001|STARTED|Overall Study||25
9901968|NCT01140815|11017664|FG000|COMPLETED|Overall Study||25
9901969|NCT01140815|11017665|FG001|COMPLETED|Overall Study||25
9901970|NCT01140815|11017664|FG000|NOT COMPLETED|Overall Study||0
9901971|NCT01140815|11017665|FG001|NOT COMPLETED|Overall Study||0
9901972|NCT01140880|11017675|FG000|STARTED|Overall Study||70
9901973|NCT01140880|11017676|FG001|STARTED|Overall Study||100
9901974|NCT01140880|11017675|FG000|COMPLETED|Overall Study||56
9901975|NCT01140880|11017676|FG001|COMPLETED|Overall Study||56
9901976|NCT01140880|11017675|FG000|NOT COMPLETED|Overall Study||14
9901977|NCT01140880|11017676|FG001|NOT COMPLETED|Overall Study||44
9901978|NCT01140906|11017686|FG000|STARTED|Overall Study||158
9901979|NCT01140906|11017687|FG001|STARTED|Overall Study||151
9901980|NCT01140906|11017688|FG002|STARTED|Overall Study||151
9901981|NCT01140906|11017689|FG003|STARTED|Overall Study||147
9901982|NCT01140906|11017686|FG000|COMPLETED|Overall Study||133
9901983|NCT01140906|11017687|FG001|COMPLETED|Overall Study||117
9901984|NCT01140906|11017688|FG002|COMPLETED|Overall Study||125
9901985|NCT01140906|11017689|FG003|COMPLETED|Overall Study||131
9901986|NCT01140906|11017686|FG000|NOT COMPLETED|Overall Study||25
9901987|NCT01140906|11017687|FG001|NOT COMPLETED|Overall Study||34
9901988|NCT01140906|11017688|FG002|NOT COMPLETED|Overall Study||26
9901989|NCT01140906|11017689|FG003|NOT COMPLETED|Overall Study||16
9901990|NCT01141049|11017701|FG000|STARTED|Overall Study||19
9901991|NCT01141049|11017702|FG001|STARTED|Overall Study||21
9901992|NCT01141049|11017701|FG000|COMPLETED|Overall Study||14
9901993|NCT01141049|11017702|FG001|COMPLETED|Overall Study||13
9901994|NCT01141049|11017701|FG000|NOT COMPLETED|Overall Study||5
9901995|NCT01141049|11017702|FG001|NOT COMPLETED|Overall Study||8
9901996|NCT01141075|11017708|FG000|STARTED|Cycle 1||11
9901997|NCT01141075|11017708|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11
9901998|NCT01141075|11017708|FG000|COMPLETED|Cycle 1||11
9901999|NCT01141075|11017708|FG000|NOT COMPLETED|Cycle 1||0
9902000|NCT01141075|11017708|FG000|STARTED|Cycle 2||11
9902001|NCT01141075|11017708|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11
9902002|NCT01141075|11017708|FG000|COMPLETED|Cycle 2||11
9902003|NCT01141075|11017708|FG000|NOT COMPLETED|Cycle 2||0
9902004|NCT01141205|11017714|FG000|STARTED|Overall Study||18
9902005|NCT01141205|11017715|FG001|STARTED|Overall Study||5
9902006|NCT01141205|11017714|FG000|COMPLETED|Overall Study||15
9902007|NCT01141205|11017715|FG001|COMPLETED|Overall Study||3
9902008|NCT01141205|11017714|FG000|NOT COMPLETED|Overall Study||3
10009288|NCT01765179|11131823|FG000|NOT COMPLETED|Overall Study||27
10009289|NCT01765192|11131829|FG000|STARTED|Treatment Period 1||32
9902009|NCT01141205|11017715|FG001|NOT COMPLETED|Overall Study||2
9902010|NCT01141283|11017725|FG000|STARTED|Overall Study||290
9902011|NCT01141283|11017725|FG000|COMPLETED|Overall Study||202
9902012|NCT01141283|11017725|FG000|NOT COMPLETED|Overall Study||88
9902013|NCT01141374|11017732|FG000|STARTED|Overall Study||26
9902014|NCT01141374|11017733|FG001|STARTED|Overall Study||27
9902015|NCT01141374|11017734|FG002|STARTED|Overall Study||22
9902016|NCT01141374|11017732|FG000|COMPLETED|Overall Study||26
9902017|NCT01141374|11017733|FG001|COMPLETED|Overall Study||27
9902018|NCT01141374|11017734|FG002|COMPLETED|Overall Study||22
9902019|NCT01141374|11017732|FG000|NOT COMPLETED|Overall Study||0
9902020|NCT01141374|11017733|FG001|NOT COMPLETED|Overall Study||0
9902021|NCT01141374|11017734|FG002|NOT COMPLETED|Overall Study||0
9902022|NCT01141478|11017746|FG000|STARTED|Overall Study||4
10009290|NCT01765192|11131830|FG001|STARTED|Treatment Period 1||32
10009291|NCT01765192|11131829|FG000|COMPLETED|Treatment Period 1||32
10009292|NCT01765192|11131830|FG001|COMPLETED|Treatment Period 1||31
10009293|NCT01765192|11131829|FG000|NOT COMPLETED|Treatment Period 1||0
9902023|NCT01141478|11017747|FG001|STARTED|Overall Study||4
9902024|NCT01141478|11017746|FG000|COMPLETED|Overall Study||3
9902025|NCT01141478|11017747|FG001|COMPLETED|Overall Study||3
9902026|NCT01141478|11017746|FG000|NOT COMPLETED|Overall Study||1
9902027|NCT01141478|11017747|FG001|NOT COMPLETED|Overall Study||1
9902028|NCT01141491|11017755|FG000|STARTED|Overall Study||68
9902029|NCT01141491|11017756|FG001|STARTED|Overall Study||68
9902030|NCT01141491|11017755|FG000|COMPLETED|Overall Study||20
9902031|NCT01141491|11017756|FG001|COMPLETED|Overall Study||21
9902032|NCT01141491|11017755|FG000|NOT COMPLETED|Overall Study||48
9902033|NCT01141491|11017756|FG001|NOT COMPLETED|Overall Study||47
9902034|NCT01141569|11017762|FG000|STARTED|Overall Study||12
9902035|NCT01141569|11017762|FG000|COMPLETED|Overall Study||12
9902036|NCT01141569|11017762|FG000|NOT COMPLETED|Overall Study||0
9902037|NCT01141595|11017766|FG000|STARTED|Overall Study||10
9902038|NCT01141595|11017766|FG000|COMPLETED|Overall Study||8
9902039|NCT01141595|11017766|FG000|NOT COMPLETED|Overall Study||2
9902040|NCT01141608|11017772|FG000|STARTED|Overall Study||152
9902041|NCT01141608|11017773|FG001|STARTED|Overall Study||150
9902042|NCT01141608|11017772|FG000|COMPLETED|Overall Study||152
9902043|NCT01141608|11017773|FG001|COMPLETED|Overall Study||150
9902044|NCT01141608|11017772|FG000|NOT COMPLETED|Overall Study||0
9902045|NCT01141608|11017773|FG001|NOT COMPLETED|Overall Study||0
9902046|NCT01141647|11017779|FG000|STARTED|Overall Study||213
9902047|NCT01141647|11017779|FG000|COMPLETED|Overall Study||167
9902048|NCT01141647|11017779|FG000|NOT COMPLETED|Overall Study||46
9902049|NCT01141660|11017790|FG000|STARTED|Overall Study||71
9902050|NCT01141660|11017791|FG001|STARTED|Overall Study||60
9902051|NCT01141660|11017790|FG000|COMPLETED|Overall Study||71
9902052|NCT01141660|11017791|FG001|COMPLETED|Overall Study||48
9902053|NCT01141660|11017790|FG000|NOT COMPLETED|Overall Study||0
9902054|NCT01141660|11017791|FG001|NOT COMPLETED|Overall Study||12
9902055|NCT01141725|11017797|FG000|STARTED|Overall Study||3
9902056|NCT01141725|11017798|FG001|STARTED|Overall Study||33
9902057|NCT01141725|11017799|FG002|STARTED|Overall Study||3
9902058|NCT01141725|11017797|FG000|COMPLETED|Overall Study||3
9902059|NCT01141725|11017798|FG001|COMPLETED|Overall Study||33
9902060|NCT01141725|11017799|FG002|COMPLETED|Overall Study||3
9902061|NCT01141725|11017797|FG000|NOT COMPLETED|Overall Study||0
9902062|NCT01141725|11017798|FG001|NOT COMPLETED|Overall Study||0
9902063|NCT01141725|11017799|FG002|NOT COMPLETED|Overall Study||0
9902064|NCT01141907|11017808|FG000|STARTED|Overall Study||6
9902065|NCT01141907|11017809|FG001|STARTED|Overall Study||5
9902066|NCT01141907|11017808|FG000|COMPLETED|Overall Study||6
9902067|NCT01141907|11017809|FG001|COMPLETED|Overall Study||5
9902068|NCT01141907|11017808|FG000|NOT COMPLETED|Overall Study||0
9902069|NCT01141907|11017809|FG001|NOT COMPLETED|Overall Study||0
9902070|NCT01142089|11017817|FG000|STARTED|Overall Study||65
9902071|NCT01142089|11017818|FG001|STARTED|Overall Study||199
9902072|NCT01142089|11017817|FG000|COMPLETED|Overall Study||53
9902073|NCT01142089|11017818|FG001|COMPLETED|Overall Study||178
9902074|NCT01142089|11017817|FG000|NOT COMPLETED|Overall Study||12
9902075|NCT01142089|11017818|FG001|NOT COMPLETED|Overall Study||21
9902076|NCT01142115|11017824|FG000|STARTED|First Intervention||21
9902077|NCT01142115|11017825|FG001|STARTED|First Intervention||20
9902078|NCT01142115|11017824|FG000|COMPLETED|First Intervention||19
9902079|NCT01142115|11017825|FG001|COMPLETED|First Intervention||19
9902080|NCT01142115|11017824|FG000|NOT COMPLETED|First Intervention||2
9902081|NCT01142115|11017825|FG001|NOT COMPLETED|First Intervention||1
9902082|NCT01142115|11017824|FG000|STARTED|Second Intervention||19
9902083|NCT01142115|11017825|FG001|STARTED|Second Intervention||19
9902084|NCT01142115|11017824|FG000|COMPLETED|Second Intervention||19
9902085|NCT01142115|11017825|FG001|COMPLETED|Second Intervention||19
9902086|NCT01142115|11017824|FG000|NOT COMPLETED|Second Intervention||0
9902087|NCT01142115|11017825|FG001|NOT COMPLETED|Second Intervention||0
9902088|NCT01142193|11017832|FG000|STARTED|Overall Study||124
9902089|NCT01142193|11017833|FG001|STARTED|Overall Study||125
9902090|NCT01142193|11017832|FG000|COMPLETED|Overall Study||103
9902091|NCT01142193|11017833|FG001|COMPLETED|Overall Study||114
9902092|NCT01142193|11017832|FG000|NOT COMPLETED|Overall Study||21
9902093|NCT01142193|11017833|FG001|NOT COMPLETED|Overall Study||11
9955121|NCT01436149|11074007|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
9955122|NCT01436149|11074005|FG000|NOT COMPLETED|Randomized Phase||77
9955123|NCT01436149|11074006|FG001|NOT COMPLETED|Randomized Phase||38
9955124|NCT01436149|11074007|FG002|NOT COMPLETED|Randomized Phase||42
9955125|NCT01436162|11074015|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
9955126|NCT01436162|11074016|FG001|STARTED|Single-blind Lead-in Phase||0
9955127|NCT01436162|11074017|FG002|STARTED|Single-blind Lead-in Phase||0
9955128|NCT01436162|11074015|FG000|COMPLETED|Single-blind Lead-in Phase||823
9955129|NCT01436162|11074016|FG001|COMPLETED|Single-blind Lead-in Phase||0
9955130|NCT01436162|11074017|FG002|COMPLETED|Single-blind Lead-in Phase||0
9955131|NCT01436162|11074015|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282
9955132|NCT01436162|11074016|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0
9955133|NCT01436162|11074017|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0
9957006|NCT01448824|11076143|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10009294|NCT01765192|11131830|FG001|NOT COMPLETED|Treatment Period 1||1
9902094|NCT01142232|11017844|FG000|STARTED|Overall Study||3
9902095|NCT01142232|11017845|FG001|STARTED|Overall Study||4
10110485|NCT02486406|11241332|FG003|COMPLETED|Overall Study||10
10110486|NCT02486406|11241329|FG000|NOT COMPLETED|Overall Study||2
10110487|NCT02486406|11241330|FG001|NOT COMPLETED|Overall Study||3
10110488|NCT02486406|11241331|FG002|NOT COMPLETED|Overall Study||2
10110489|NCT02486406|11241332|FG003|NOT COMPLETED|Overall Study||4
9902096|NCT01142232|11017846|FG002|STARTED|Overall Study||3
9902097|NCT01142232|11017847|FG003|STARTED|Overall Study||6
9902098|NCT01142232|11017848|FG004|STARTED|Overall Study||44
9902099|NCT01142232|11017844|FG000|COMPLETED|Overall Study||0
9902100|NCT01142232|11017845|FG001|COMPLETED|Overall Study||0
9902101|NCT01142232|11017846|FG002|COMPLETED|Overall Study||0
9902102|NCT01142232|11017847|FG003|COMPLETED|Overall Study||1
9902103|NCT01142232|11017848|FG004|COMPLETED|Overall Study||10
9902104|NCT01142232|11017844|FG000|NOT COMPLETED|Overall Study||3
9902105|NCT01142232|11017845|FG001|NOT COMPLETED|Overall Study||4
9902106|NCT01142232|11017846|FG002|NOT COMPLETED|Overall Study||3
9902107|NCT01142232|11017847|FG003|NOT COMPLETED|Overall Study||5
9902108|NCT01142232|11017848|FG004|NOT COMPLETED|Overall Study||34
9902109|NCT01142297|11017860|FG000|STARTED|Overall Study||24
9902110|NCT01142297|11017860|FG000|COMPLETED|Overall Study||18
9902111|NCT01142297|11017860|FG000|NOT COMPLETED|Overall Study||6
9902112|NCT01142310|11017869|FG000|STARTED|Overall Study||26
9902113|NCT01142310|11017870|FG001|STARTED|Overall Study||28
9902114|NCT01142310|11017869|FG000|COMPLETED|Overall Study||17
9902115|NCT01142310|11017870|FG001|COMPLETED|Overall Study||16
9902116|NCT01142310|11017869|FG000|NOT COMPLETED|Overall Study||9
9902117|NCT01142310|11017870|FG001|NOT COMPLETED|Overall Study||12
10009295|NCT01765192|11131829|FG000|STARTED|Washout Period||32
10009296|NCT01765192|11131830|FG001|STARTED|Washout Period||31
10009297|NCT01765192|11131829|FG000|COMPLETED|Washout Period||30
10009298|NCT01765192|11131830|FG001|COMPLETED|Washout Period||30
10009299|NCT01765192|11131829|FG000|NOT COMPLETED|Washout Period||2
10009300|NCT01765192|11131830|FG001|NOT COMPLETED|Washout Period||1
10009301|NCT01765192|11131829|FG000|STARTED|Treatment Period 2||30
10009302|NCT01765192|11131830|FG001|STARTED|Treatment Period 2||30
10009303|NCT01765192|11131829|FG000|COMPLETED|Treatment Period 2||30
10009304|NCT01765192|11131830|FG001|COMPLETED|Treatment Period 2||28
10009305|NCT01765192|11131829|FG000|NOT COMPLETED|Treatment Period 2||0
10009306|NCT01765192|11131830|FG001|NOT COMPLETED|Treatment Period 2||2
9902118|NCT01142323|11017876|FG000|STARTED|Overall Study||8
9902119|NCT01142323|11017876|FG000|COMPLETED|Overall Study||8
9902120|NCT01142323|11017876|FG000|NOT COMPLETED|Overall Study||0
9902121|NCT01142336|11017884|FG000|STARTED|Overall Study||26
9902122|NCT01142336|11017885|FG001|STARTED|Overall Study||23
9902123|NCT01142336|11017884|FG000|COMPLETED|Overall Study||25
9902124|NCT01142336|11017885|FG001|COMPLETED|Overall Study||21
9902125|NCT01142336|11017884|FG000|NOT COMPLETED|Overall Study||1
9902126|NCT01142336|11017885|FG001|NOT COMPLETED|Overall Study||2
9902127|NCT01142466|11017896|FG000|STARTED|Overall Study||15
9902128|NCT01142466|11017897|FG001|STARTED|Overall Study||15
9902129|NCT01142466|11017896|FG000|COMPLETED|Overall Study||12
9902130|NCT01142466|11017897|FG001|COMPLETED|Overall Study||13
9902131|NCT01142466|11017896|FG000|NOT COMPLETED|Overall Study||3
9902132|NCT01142466|11017897|FG001|NOT COMPLETED|Overall Study||2
9902133|NCT01142661|11017903|FG000|STARTED|Overall Study||9
10009307|NCT01765192|11131829|FG000|STARTED|End of Treatment Period 2 to Final Visit||30
10009308|NCT01765192|11131830|FG001|STARTED|End of Treatment Period 2 to Final Visit||28
9902134|NCT01142661|11017903|FG000|COMPLETED|Overall Study||5
9902135|NCT01142661|11017903|FG000|NOT COMPLETED|Overall Study||4
9902136|NCT01142726|11017910|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119
9902137|NCT01142726|11017911|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116
9902138|NCT01142726|11017912|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116
9902139|NCT01142726|11017910|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
9902140|NCT01142726|11017911|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
9902141|NCT01142726|11017912|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
9902142|NCT01142726|11017910|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
9902143|NCT01142726|11017911|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
9902144|NCT01142726|11017912|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
9902145|NCT01142726|11017910|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84
9902146|NCT01142726|11017911|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66
9902147|NCT01142726|11017912|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75
10009309|NCT01765192|11131829|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30
10009310|NCT01765192|11131830|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27
10110490|NCT02486588|11241370|FG000|STARTED|Overall Study||1188
10110491|NCT02486588|11241371|FG001|STARTED|Overall Study||1252
10202902|NCT03453060|11330062|FG004|STARTED|Overall Study||5
9902148|NCT01142726|11017910|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
9902149|NCT01142726|11017911|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
9902150|NCT01142726|11017912|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
9902151|NCT01142726|11017910|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
9902152|NCT01142726|11017911|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
9902153|NCT01142726|11017912|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
10009311|NCT01765192|11131829|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
10110492|NCT02486588|11241372|FG002|STARTED|Overall Study||1220
9902154|NCT01142726|11017910|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55
9902155|NCT01142726|11017911|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48
9902156|NCT01142726|11017912|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43
9902157|NCT01142726|11017910|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
9902158|NCT01142726|11017911|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
9902159|NCT01142726|11017912|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
9902160|NCT01142726|11017910|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
9902161|NCT01142726|11017911|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
9902162|NCT01142726|11017912|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
9902163|NCT01142791|11017928|FG000|STARTED|Overall Study||115
9902164|NCT01142791|11017929|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
9902165|NCT01142791|11017928|FG000|Safety|Overall Study||115
9902166|NCT01142791|11017929|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
9902167|NCT01142791|11017928|FG000|COMPLETED|Overall Study||108
9902168|NCT01142791|11017929|FG001|COMPLETED|Overall Study||0
9902169|NCT01142791|11017928|FG000|NOT COMPLETED|Overall Study||7
9902170|NCT01142791|11017929|FG001|NOT COMPLETED|Overall Study||6
9902171|NCT01142908|11017935|FG000|STARTED|Overall Study||215
9902172|NCT01142908|11017936|FG001|STARTED|Overall Study||213
9902173|NCT01142908|11017935|FG000|6 Month f/u|Overall Study||188
9902174|NCT01142908|11017936|FG001|6 Month f/u|Overall Study||196
9902175|NCT01142908|11017935|FG000|COMPLETED|Overall Study||183
9902176|NCT01142908|11017936|FG001|COMPLETED|Overall Study||191
9902177|NCT01142908|11017935|FG000|NOT COMPLETED|Overall Study||32
9902178|NCT01142908|11017936|FG001|NOT COMPLETED|Overall Study||22
9902179|NCT01142947|11017942|FG000|STARTED|Overall Study||362
9902180|NCT01142947|11017942|FG000|COMPLETED|Overall Study||244
9902181|NCT01142947|11017942|FG000|NOT COMPLETED|Overall Study||118
9902182|NCT01143038|11017946|FG000|STARTED|Overall Study||75
9902183|NCT01143038|11017946|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
9902184|NCT01143038|11017946|FG000|NOT COMPLETED|Overall Study||16
9902185|NCT01143051|11017956|FG000|STARTED|Visit 1||4
9902186|NCT01143051|11017957|FG001|STARTED|Visit 1||4
9902187|NCT01143051|11017958|FG002|STARTED|Visit 1||4
9902188|NCT01143051|11017959|FG003|STARTED|Visit 1||4
9902189|NCT01143051|11017960|FG004|STARTED|Visit 1||4
9902190|NCT01143051|11017961|FG005|STARTED|Visit 1||4
9902191|NCT01143051|11017956|FG000|COMPLETED|Visit 1||4
9902192|NCT01143051|11017957|FG001|COMPLETED|Visit 1||4
9902193|NCT01143051|11017958|FG002|COMPLETED|Visit 1||4
9902194|NCT01143051|11017959|FG003|COMPLETED|Visit 1||4
9902195|NCT01143051|11017960|FG004|COMPLETED|Visit 1||4
9902196|NCT01143051|11017961|FG005|COMPLETED|Visit 1||4
9902197|NCT01143051|11017956|FG000|NOT COMPLETED|Visit 1||0
9902198|NCT01143051|11017957|FG001|NOT COMPLETED|Visit 1||0
9902199|NCT01143051|11017958|FG002|NOT COMPLETED|Visit 1||0
9902200|NCT01143051|11017959|FG003|NOT COMPLETED|Visit 1||0
10009312|NCT01765192|11131830|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
10009313|NCT01765270|11131838|FG000|STARTED|Overall Study||5
10009314|NCT01765270|11131839|FG001|STARTED|Overall Study||7
10009315|NCT01765270|11131838|FG000|COMPLETED|Overall Study||4
10009316|NCT01765270|11131839|FG001|COMPLETED|Overall Study||6
10009317|NCT01765270|11131838|FG000|NOT COMPLETED|Overall Study||1
10009318|NCT01765270|11131839|FG001|NOT COMPLETED|Overall Study||1
10009319|NCT01765426|11131850|FG000|STARTED|Overall Study||18
10009320|NCT01765426|11131851|FG001|STARTED|Overall Study||17
10009321|NCT01765426|11131852|FG002|STARTED|Overall Study||17
9902201|NCT01143051|11017960|FG004|NOT COMPLETED|Visit 1||0
9902202|NCT01143051|11017961|FG005|NOT COMPLETED|Visit 1||0
9902203|NCT01143051|11017956|FG000|STARTED|3-14 Day Washout||4
9902204|NCT01143051|11017957|FG001|STARTED|3-14 Day Washout||4
9902205|NCT01143051|11017958|FG002|STARTED|3-14 Day Washout||4
9902206|NCT01143051|11017959|FG003|STARTED|3-14 Day Washout||4
9902207|NCT01143051|11017960|FG004|STARTED|3-14 Day Washout||4
9902208|NCT01143051|11017961|FG005|STARTED|3-14 Day Washout||4
9902209|NCT01143051|11017956|FG000|COMPLETED|3-14 Day Washout||4
9902210|NCT01143051|11017957|FG001|COMPLETED|3-14 Day Washout||4
9902211|NCT01143051|11017958|FG002|COMPLETED|3-14 Day Washout||3
9902212|NCT01143051|11017959|FG003|COMPLETED|3-14 Day Washout||4
9902213|NCT01143051|11017960|FG004|COMPLETED|3-14 Day Washout||4
9902214|NCT01143051|11017961|FG005|COMPLETED|3-14 Day Washout||4
9902215|NCT01143051|11017956|FG000|NOT COMPLETED|3-14 Day Washout||0
9902216|NCT01143051|11017957|FG001|NOT COMPLETED|3-14 Day Washout||0
9902217|NCT01143051|11017958|FG002|NOT COMPLETED|3-14 Day Washout||1
9902218|NCT01143051|11017959|FG003|NOT COMPLETED|3-14 Day Washout||0
9902219|NCT01143051|11017960|FG004|NOT COMPLETED|3-14 Day Washout||0
9902220|NCT01143051|11017961|FG005|NOT COMPLETED|3-14 Day Washout||0
9902221|NCT01143051|11017956|FG000|STARTED|Visit 2||4
9902222|NCT01143051|11017957|FG001|STARTED|Visit 2||4
9902223|NCT01143051|11017958|FG002|STARTED|Visit 2||3
9902224|NCT01143051|11017959|FG003|STARTED|Visit 2||4
9902225|NCT01143051|11017960|FG004|STARTED|Visit 2||4
9902226|NCT01143051|11017961|FG005|STARTED|Visit 2||4
9902227|NCT01143051|11017956|FG000|COMPLETED|Visit 2||4
9902228|NCT01143051|11017957|FG001|COMPLETED|Visit 2||4
9902229|NCT01143051|11017958|FG002|COMPLETED|Visit 2||3
9902230|NCT01143051|11017959|FG003|COMPLETED|Visit 2||4
9902231|NCT01143051|11017960|FG004|COMPLETED|Visit 2||4
9902232|NCT01143051|11017961|FG005|COMPLETED|Visit 2||4
9902233|NCT01143051|11017956|FG000|NOT COMPLETED|Visit 2||0
10009322|NCT01765426|11131853|FG003|STARTED|Overall Study||15
9902234|NCT01143051|11017957|FG001|NOT COMPLETED|Visit 2||0
9902235|NCT01143051|11017958|FG002|NOT COMPLETED|Visit 2||0
9902236|NCT01143051|11017959|FG003|NOT COMPLETED|Visit 2||0
9902237|NCT01143051|11017960|FG004|NOT COMPLETED|Visit 2||0
9902238|NCT01143051|11017961|FG005|NOT COMPLETED|Visit 2||0
9902239|NCT01143051|11017956|FG000|STARTED|3-14 Day Washout||4
9902240|NCT01143051|11017957|FG001|STARTED|3-14 Day Washout||4
9902241|NCT01143051|11017958|FG002|STARTED|3-14 Day Washout||3
9902242|NCT01143051|11017959|FG003|STARTED|3-14 Day Washout||4
9902243|NCT01143051|11017960|FG004|STARTED|3-14 Day Washout||4
9902244|NCT01143051|11017961|FG005|STARTED|3-14 Day Washout||4
9902245|NCT01143051|11017956|FG000|COMPLETED|3-14 Day Washout||4
9902246|NCT01143051|11017957|FG001|COMPLETED|3-14 Day Washout||4
9902247|NCT01143051|11017958|FG002|COMPLETED|3-14 Day Washout||3
9902248|NCT01143051|11017959|FG003|COMPLETED|3-14 Day Washout||4
9902249|NCT01143051|11017960|FG004|COMPLETED|3-14 Day Washout||4
9902250|NCT01143051|11017961|FG005|COMPLETED|3-14 Day Washout||3
9902251|NCT01143051|11017956|FG000|NOT COMPLETED|3-14 Day Washout||0
9902252|NCT01143051|11017957|FG001|NOT COMPLETED|3-14 Day Washout||0
9902253|NCT01143051|11017958|FG002|NOT COMPLETED|3-14 Day Washout||0
9902254|NCT01143051|11017959|FG003|NOT COMPLETED|3-14 Day Washout||0
9902255|NCT01143051|11017960|FG004|NOT COMPLETED|3-14 Day Washout||0
9902256|NCT01143051|11017961|FG005|NOT COMPLETED|3-14 Day Washout||1
9902257|NCT01143051|11017956|FG000|STARTED|Visit 3||4
9902258|NCT01143051|11017957|FG001|STARTED|Visit 3||4
9902259|NCT01143051|11017958|FG002|STARTED|Visit 3||3
9902260|NCT01143051|11017959|FG003|STARTED|Visit 3||4
9902261|NCT01143051|11017960|FG004|STARTED|Visit 3||4
9902262|NCT01143051|11017961|FG005|STARTED|Visit 3||3
9902263|NCT01143051|11017956|FG000|COMPLETED|Visit 3||4
9902264|NCT01143051|11017957|FG001|COMPLETED|Visit 3||4
9902265|NCT01143051|11017958|FG002|COMPLETED|Visit 3||3
9902266|NCT01143051|11017959|FG003|COMPLETED|Visit 3||4
9902267|NCT01143051|11017960|FG004|COMPLETED|Visit 3||4
9902268|NCT01143051|11017961|FG005|COMPLETED|Visit 3||3
9902269|NCT01143051|11017956|FG000|NOT COMPLETED|Visit 3||0
9902270|NCT01143051|11017957|FG001|NOT COMPLETED|Visit 3||0
9902271|NCT01143051|11017958|FG002|NOT COMPLETED|Visit 3||0
9902272|NCT01143051|11017959|FG003|NOT COMPLETED|Visit 3||0
9902273|NCT01143051|11017960|FG004|NOT COMPLETED|Visit 3||0
9902274|NCT01143051|11017961|FG005|NOT COMPLETED|Visit 3||0
9902275|NCT01143077|11017974|FG000|STARTED|Overall Study||74
9902276|NCT01143077|11017975|FG001|STARTED|Overall Study||88
9902277|NCT01143077|11017976|FG002|STARTED|Overall Study||82
9902278|NCT01143077|11017974|FG000|COMPLETED|Overall Study||58
9902279|NCT01143077|11017975|FG001|COMPLETED|Overall Study||73
9902280|NCT01143077|11017976|FG002|COMPLETED|Overall Study||67
9902281|NCT01143077|11017974|FG000|NOT COMPLETED|Overall Study||16
9902282|NCT01143077|11017975|FG001|NOT COMPLETED|Overall Study||15
9902283|NCT01143077|11017976|FG002|NOT COMPLETED|Overall Study||15
9902284|NCT01143090|11017984|FG000|STARTED|Overall Study||149
9902285|NCT01143090|11017984|FG000|COMPLETED|Overall Study||98
9902286|NCT01143090|11017984|FG000|NOT COMPLETED|Overall Study||51
9902287|NCT01143142|11017990|FG000|STARTED|Overall Study||36
9902288|NCT01143142|11017991|FG001|STARTED|Overall Study||34
9902289|NCT01143142|11017990|FG000|COMPLETED|Overall Study||36
9902290|NCT01143142|11017991|FG001|COMPLETED|Overall Study||34
9902291|NCT01143142|11017990|FG000|NOT COMPLETED|Overall Study||0
9902292|NCT01143142|11017991|FG001|NOT COMPLETED|Overall Study||0
9902293|NCT01143181|11018001|FG000|STARTED|Overall Study||30
9902294|NCT01143181|11018002|FG001|STARTED|Overall Study||38
9902295|NCT01143181|11018003|FG002|STARTED|Overall Study||102
9902296|NCT01143181|11018004|FG003|STARTED|Overall Study||40
9902297|NCT01143181|11018001|FG000|COMPLETED|Overall Study||14
9902298|NCT01143181|11018002|FG001|COMPLETED|Overall Study||22
9902299|NCT01143181|11018003|FG002|COMPLETED|Overall Study||58
9902300|NCT01143181|11018004|FG003|COMPLETED|Overall Study||17
9902301|NCT01143181|11018001|FG000|NOT COMPLETED|Overall Study||16
9902302|NCT01143181|11018002|FG001|NOT COMPLETED|Overall Study||16
9902303|NCT01143181|11018003|FG002|NOT COMPLETED|Overall Study||44
9902304|NCT01143181|11018004|FG003|NOT COMPLETED|Overall Study||23
9902305|NCT01143207|11018014|FG000|STARTED|Overall Study||26
9902306|NCT01143207|11018014|FG000|COMPLETED|Overall Study||24
9902307|NCT01143207|11018014|FG000|NOT COMPLETED|Overall Study||2
9902308|NCT01143259|11018020|FG000|STARTED|Overall Study||136
9902309|NCT01143259|11018021|FG001|STARTED|Overall Study||138
9902310|NCT01143259|11018020|FG000|COMPLETED|Overall Study||113
9902311|NCT01143259|11018021|FG001|COMPLETED|Overall Study||118
9902312|NCT01143259|11018020|FG000|NOT COMPLETED|Overall Study||23
9902313|NCT01143259|11018021|FG001|NOT COMPLETED|Overall Study||20
9902314|NCT01143272|11018029|FG000|STARTED|Overall Study||246
9902315|NCT01143272|11018030|FG001|STARTED|Overall Study||231
9902316|NCT01143272|11018029|FG000|COMPLETED|Overall Study||246
9902317|NCT01143272|11018030|FG001|COMPLETED|Overall Study||231
9902318|NCT01143272|11018029|FG000|NOT COMPLETED|Overall Study||0
9902319|NCT01143272|11018030|FG001|NOT COMPLETED|Overall Study||0
9902320|NCT01143324|11018036|FG000|STARTED|Overall Study||252
9902321|NCT01143324|11018036|FG000|COMPLETED|Overall Study||233
9902322|NCT01143324|11018036|FG000|NOT COMPLETED|Overall Study||19
9902323|NCT01143337|11018042|FG000|STARTED|Overall Study||49
9902324|NCT01143337|11018043|FG001|STARTED|Overall Study||50
9902325|NCT01143337|11018044|FG002|STARTED|Overall Study||13
9902326|NCT01143337|11018042|FG000|COMPLETED|Overall Study||39
9902327|NCT01143337|11018043|FG001|COMPLETED|Overall Study||39
9957007|NCT01448824|11076144|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9902328|NCT01143337|11018044|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
9902329|NCT01143337|11018042|FG000|NOT COMPLETED|Overall Study||10
9902330|NCT01143337|11018043|FG001|NOT COMPLETED|Overall Study||11
9902331|NCT01143337|11018044|FG002|NOT COMPLETED|Overall Study||12
9902332|NCT01143389|11018052|FG000|STARTED|Overall Study||253
9902333|NCT01143389|11018053|FG001|STARTED|Overall Study||257
9902334|NCT01143389|11018052|FG000|COMPLETED|Overall Study||227
9902335|NCT01143389|11018053|FG001|COMPLETED|Overall Study||232
9902336|NCT01143389|11018052|FG000|NOT COMPLETED|Overall Study||26
9902337|NCT01143389|11018053|FG001|NOT COMPLETED|Overall Study||25
9902338|NCT01143402|11018062|FG000|STARTED|Overall Study||51
9902339|NCT01143402|11018063|FG001|STARTED|Overall Study||50
9902340|NCT01143402|11018064|FG002|STARTED|Overall Study||19
9902341|NCT01143402|11018062|FG000|COMPLETED|Overall Study||50
9902342|NCT01143402|11018063|FG001|COMPLETED|Overall Study||49
9902343|NCT01143402|11018064|FG002|COMPLETED|Overall Study||18
9902344|NCT01143402|11018062|FG000|NOT COMPLETED|Overall Study||1
9902345|NCT01143402|11018063|FG001|NOT COMPLETED|Overall Study||1
9902346|NCT01143402|11018064|FG002|NOT COMPLETED|Overall Study||1
9902347|NCT01143610|11018073|FG000|STARTED|Overall Study||7
9902348|NCT01143610|11018074|FG001|STARTED|Overall Study||8
9902349|NCT01143610|11018073|FG000|COMPLETED|Overall Study||7
9902350|NCT01143610|11018074|FG001|COMPLETED|Overall Study||8
9902351|NCT01143610|11018073|FG000|NOT COMPLETED|Overall Study||0
9902352|NCT01143610|11018074|FG001|NOT COMPLETED|Overall Study||0
9902353|NCT01143636|11018083|FG000|STARTED|Overall Study||6
9902354|NCT01143636|11018084|FG001|STARTED|Overall Study||5
9902355|NCT01143636|11018085|FG002|STARTED|Overall Study||8
9902356|NCT01143636|11018086|FG003|STARTED|Overall Study||7
9902357|NCT01143636|11018083|FG000|COMPLETED|Overall Study||5
9902358|NCT01143636|11018084|FG001|COMPLETED|Overall Study||4
9902359|NCT01143636|11018085|FG002|COMPLETED|Overall Study||8
9902360|NCT01143636|11018086|FG003|COMPLETED|Overall Study||7
9902361|NCT01143636|11018083|FG000|NOT COMPLETED|Overall Study||1
9902362|NCT01143636|11018084|FG001|NOT COMPLETED|Overall Study||1
9902363|NCT01143636|11018085|FG002|NOT COMPLETED|Overall Study||0
9902364|NCT01143636|11018086|FG003|NOT COMPLETED|Overall Study||0
9902365|NCT01143649|11018101|FG000|STARTED|Overall Study||7
9902366|NCT01143649|11018102|FG001|STARTED|Overall Study||7
9902367|NCT01143649|11018103|FG002|STARTED|Overall Study||10
9902368|NCT01143649|11018104|FG003|STARTED|Overall Study||10
9902369|NCT01143649|11018105|FG004|STARTED|Overall Study||5
9902370|NCT01143649|11018106|FG005|STARTED|Overall Study||5
9902371|NCT01143649|11018101|FG000|COMPLETED|Overall Study||7
9902372|NCT01143649|11018102|FG001|COMPLETED|Overall Study||7
9902373|NCT01143649|11018103|FG002|COMPLETED|Overall Study||10
9902374|NCT01143649|11018104|FG003|COMPLETED|Overall Study||10
9902375|NCT01143649|11018105|FG004|COMPLETED|Overall Study||4
9902376|NCT01143649|11018106|FG005|COMPLETED|Overall Study||3
9902377|NCT01143649|11018101|FG000|NOT COMPLETED|Overall Study||0
9902378|NCT01143649|11018102|FG001|NOT COMPLETED|Overall Study||0
9902379|NCT01143649|11018103|FG002|NOT COMPLETED|Overall Study||0
9902380|NCT01143649|11018104|FG003|NOT COMPLETED|Overall Study||0
9902381|NCT01143649|11018105|FG004|NOT COMPLETED|Overall Study||1
9902382|NCT01143649|11018106|FG005|NOT COMPLETED|Overall Study||2
9902383|NCT01143688|11018120|FG000|STARTED|Overall Study||39
9902384|NCT01143688|11018120|FG000|COMPLETED|Overall Study||39
9902385|NCT01143688|11018120|FG000|NOT COMPLETED|Overall Study||0
9902386|NCT01143701|11018132|FG000|STARTED|Overall Study||258
9902387|NCT01143701|11018133|FG001|STARTED|Overall Study||319
9902388|NCT01143701|11018132|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
9902389|NCT01143701|11018133|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
9902390|NCT01143701|11018132|FG000|NOT COMPLETED|Overall Study||23
9902391|NCT01143701|11018133|FG001|NOT COMPLETED|Overall Study||32
9902392|NCT01143714|11018141|FG000|STARTED|Overall Study||29
9902393|NCT01143714|11018142|FG001|STARTED|Overall Study||28
9902394|NCT01143714|11018141|FG000|COMPLETED|Overall Study||22
9902395|NCT01143714|11018142|FG001|COMPLETED|Overall Study||25
9902396|NCT01143714|11018141|FG000|NOT COMPLETED|Overall Study||7
9902397|NCT01143714|11018142|FG001|NOT COMPLETED|Overall Study||3
9902398|NCT01143727|11018150|FG000|STARTED|Overall Study||9
9902399|NCT01143727|11018151|FG001|STARTED|Overall Study||8
9902400|NCT01143727|11018150|FG000|COMPLETED|Overall Study||9
9902401|NCT01143727|11018151|FG001|COMPLETED|Overall Study||8
9902402|NCT01143727|11018150|FG000|NOT COMPLETED|Overall Study||0
9902403|NCT01143727|11018151|FG001|NOT COMPLETED|Overall Study||0
9902404|NCT01143766|11018159|FG000|STARTED|Overall Study||25
9902405|NCT01143766|11018160|FG001|STARTED|Overall Study||31
9902406|NCT01143766|11018159|FG000|COMPLETED|Overall Study||25
9902407|NCT01143766|11018160|FG001|COMPLETED|Overall Study||31
9902408|NCT01143766|11018159|FG000|NOT COMPLETED|Overall Study||0
9902409|NCT01143766|11018160|FG001|NOT COMPLETED|Overall Study||0
9902410|NCT01143792|11018171|FG000|STARTED|Overall Study||93
9902411|NCT01143792|11018172|FG001|STARTED|Overall Study||86
9902412|NCT01143792|11018173|FG002|STARTED|Overall Study||91
9902413|NCT01143792|11018171|FG000|COMPLETED|Overall Study||93
9902414|NCT01143792|11018172|FG001|COMPLETED|Overall Study||86
9902415|NCT01143792|11018173|FG002|COMPLETED|Overall Study||91
9902416|NCT01143792|11018171|FG000|NOT COMPLETED|Overall Study||0
9902417|NCT01143792|11018172|FG001|NOT COMPLETED|Overall Study||0
10009323|NCT01765426|11131850|FG000|Completed All Vaccinations|Overall Study||17
10009324|NCT01765426|11131851|FG001|Completed All Vaccinations|Overall Study||16
10110493|NCT02486588|11241373|FG003|STARTED|Overall Study||1206
9902418|NCT01143792|11018173|FG002|NOT COMPLETED|Overall Study||0
9902419|NCT01143818|11018192|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
9902420|NCT01143818|11018192|FG000|COMPLETED|Overall Study||799
9902421|NCT01143818|11018192|FG000|NOT COMPLETED|Overall Study||250
9902422|NCT01143870|11018199|FG000|STARTED|Overall Study||58
9902423|NCT01143870|11018200|FG001|STARTED|Overall Study||58
10110494|NCT02486588|11241374|FG004|STARTED|Overall Study||1243
10110495|NCT02486588|11241375|FG005|STARTED|Overall Study||1205
10110496|NCT02486588|11241370|FG000|COMPLETED|Overall Study||450
10110497|NCT02486588|11241371|FG001|COMPLETED|Overall Study||502
10110498|NCT02486588|11241372|FG002|COMPLETED|Overall Study||465
10110499|NCT02486588|11241373|FG003|COMPLETED|Overall Study||468
10110500|NCT02486588|11241374|FG004|COMPLETED|Overall Study||497
10110501|NCT02486588|11241375|FG005|COMPLETED|Overall Study||459
10110502|NCT02486588|11241370|FG000|NOT COMPLETED|Overall Study||738
9902424|NCT01143870|11018201|FG002|STARTED|Overall Study||61
9902425|NCT01143870|11018199|FG000|Post-intervention Survey|Overall Study||53
9902426|NCT01143870|11018200|FG001|Post-intervention Survey|Overall Study||50
9902427|NCT01143870|11018201|FG002|Post-intervention Survey|Overall Study||61
9902428|NCT01143870|11018199|FG000|Had Available 6-month A1C|Overall Study||27
9902429|NCT01143870|11018200|FG001|Had Available 6-month A1C|Overall Study||29
9902430|NCT01143870|11018201|FG002|Had Available 6-month A1C|Overall Study||31
9902431|NCT01143870|11018199|FG000|A1C Imputed|Overall Study||31
9902432|NCT01143870|11018200|FG001|A1C Imputed|Overall Study||29
9902433|NCT01143870|11018201|FG002|A1C Imputed|Overall Study||30
9902434|NCT01143870|11018199|FG000|COMPLETED|Overall Study||58
9902435|NCT01143870|11018200|FG001|COMPLETED|Overall Study||58
9902436|NCT01143870|11018201|FG002|COMPLETED|Overall Study||61
9902437|NCT01143870|11018199|FG000|NOT COMPLETED|Overall Study||0
9902438|NCT01143870|11018200|FG001|NOT COMPLETED|Overall Study||0
9902439|NCT01143870|11018201|FG002|NOT COMPLETED|Overall Study||0
9902440|NCT01143883|11018211|FG000|STARTED|Overall Study||55
9902441|NCT01143883|11018212|FG001|STARTED|Overall Study||55
9902442|NCT01143883|11018211|FG000|COMPLETED|Overall Study||55
9902443|NCT01143883|11018212|FG001|COMPLETED|Overall Study||55
9902444|NCT01143883|11018211|FG000|NOT COMPLETED|Overall Study||0
9902445|NCT01143883|11018212|FG001|NOT COMPLETED|Overall Study||0
9902446|NCT01143896|11018220|FG000|STARTED|Overall Study||156
9902447|NCT01143896|11018221|FG001|STARTED|Overall Study||153
9902448|NCT01143896|11018220|FG000|COMPLETED|Overall Study||114
9902449|NCT01143896|11018221|FG001|COMPLETED|Overall Study||128
9902450|NCT01143896|11018220|FG000|NOT COMPLETED|Overall Study||42
9902451|NCT01143896|11018221|FG001|NOT COMPLETED|Overall Study||25
9902452|NCT01144026|11018230|FG000|STARTED|Overall Study||10
9902453|NCT01144026|11018231|FG001|STARTED|Overall Study||5
9902454|NCT01144026|11018230|FG000|COMPLETED|Overall Study||10
9902455|NCT01144026|11018231|FG001|COMPLETED|Overall Study||5
9902456|NCT01144026|11018230|FG000|NOT COMPLETED|Overall Study||0
10110503|NCT02486588|11241371|FG001|NOT COMPLETED|Overall Study||750
10110504|NCT02486588|11241372|FG002|NOT COMPLETED|Overall Study||755
10110505|NCT02486588|11241373|FG003|NOT COMPLETED|Overall Study||738
10110506|NCT02486588|11241374|FG004|NOT COMPLETED|Overall Study||746
10110507|NCT02486588|11241375|FG005|NOT COMPLETED|Overall Study||746
10110508|NCT02486627|11241396|FG000|STARTED|Overall Study||306
10110509|NCT02486627|11241397|FG001|STARTED|Overall Study||303
10110510|NCT02486627|11241396|FG000|COMPLETED|Overall Study||299
10110511|NCT02486627|11241397|FG001|COMPLETED|Overall Study||294
10110512|NCT02486627|11241396|FG000|NOT COMPLETED|Overall Study||7
10110513|NCT02486627|11241397|FG001|NOT COMPLETED|Overall Study||9
10110514|NCT02486653|11241405|FG000|STARTED|Overall Study||76
10110515|NCT02486653|11241406|FG001|STARTED|Overall Study||75
10110516|NCT02486653|11241405|FG000|COMPLETED|Overall Study||70
10110517|NCT02486653|11241406|FG001|COMPLETED|Overall Study||71
10110518|NCT02486653|11241405|FG000|NOT COMPLETED|Overall Study||6
9902457|NCT01144026|11018231|FG001|NOT COMPLETED|Overall Study||0
9902458|NCT01144052|11018239|FG000|STARTED|Overall Study||10
9902459|NCT01144052|11018240|FG001|STARTED|Overall Study||9
10009325|NCT01765426|11131852|FG002|Completed All Vaccinations|Overall Study||17
10009326|NCT01765426|11131853|FG003|Completed All Vaccinations|Overall Study||15
10009327|NCT01765426|11131850|FG000|COMPLETED|Overall Study||18
10009328|NCT01765426|11131851|FG001|COMPLETED|Overall Study||16
10009329|NCT01765426|11131852|FG002|COMPLETED|Overall Study||17
10009330|NCT01765426|11131853|FG003|COMPLETED|Overall Study||15
10110519|NCT02486653|11241406|FG001|NOT COMPLETED|Overall Study||4
10110520|NCT02486692|11241414|FG000|STARTED|Overall Study||30
10110521|NCT02486692|11241415|FG001|STARTED|Overall Study||30
9902460|NCT01144052|11018239|FG000|COMPLETED|Overall Study||9
9902461|NCT01144052|11018240|FG001|COMPLETED|Overall Study||8
9902462|NCT01144052|11018239|FG000|NOT COMPLETED|Overall Study||1
9902463|NCT01144052|11018240|FG001|NOT COMPLETED|Overall Study||1
9902464|NCT01144143|11018251|FG000|STARTED|Overall Study||8
9902465|NCT01144143|11018252|FG001|STARTED|Overall Study||4
9902466|NCT01144143|11018253|FG002|STARTED|Overall Study||4
10009331|NCT01765426|11131850|FG000|NOT COMPLETED|Overall Study||0
10009332|NCT01765426|11131851|FG001|NOT COMPLETED|Overall Study||1
10110522|NCT02486692|11241414|FG000|COMPLETED|Overall Study||26
9902467|NCT01144143|11018251|FG000|COMPLETED|Overall Study||8
9902468|NCT01144143|11018252|FG001|COMPLETED|Overall Study||4
9902469|NCT01144143|11018253|FG002|COMPLETED|Overall Study||4
9902470|NCT01144143|11018251|FG000|NOT COMPLETED|Overall Study||0
9902471|NCT01144143|11018252|FG001|NOT COMPLETED|Overall Study||0
9902472|NCT01144143|11018253|FG002|NOT COMPLETED|Overall Study||0
9902473|NCT01144182|11018267|FG000|STARTED|Overall Study||68
9902474|NCT01144182|11018268|FG001|STARTED|Overall Study||68
9902475|NCT01144182|11018267|FG000|COMPLETED|Overall Study||51
9902476|NCT01144182|11018268|FG001|COMPLETED|Overall Study||47
9902477|NCT01144182|11018267|FG000|NOT COMPLETED|Overall Study||17
9902478|NCT01144182|11018268|FG001|NOT COMPLETED|Overall Study||21
9902479|NCT01144286|11018279|FG000|STARTED|Overall Study||57
9902480|NCT01144286|11018280|FG001|STARTED|Overall Study||58
9902481|NCT01144286|11018281|FG002|STARTED|Overall Study||58
9902482|NCT01144286|11018282|FG003|STARTED|Overall Study||56
9902483|NCT01144286|11018279|FG000|COMPLETED|Overall Study||57
9902484|NCT01144286|11018280|FG001|COMPLETED|Overall Study||58
9902485|NCT01144286|11018281|FG002|COMPLETED|Overall Study||58
9902486|NCT01144286|11018282|FG003|COMPLETED|Overall Study||56
9902487|NCT01144286|11018279|FG000|NOT COMPLETED|Overall Study||0
9902488|NCT01144286|11018280|FG001|NOT COMPLETED|Overall Study||0
9902489|NCT01144286|11018281|FG002|NOT COMPLETED|Overall Study||0
9902490|NCT01144286|11018282|FG003|NOT COMPLETED|Overall Study||0
10009333|NCT01765426|11131852|FG002|NOT COMPLETED|Overall Study||0
10009334|NCT01765426|11131853|FG003|NOT COMPLETED|Overall Study||0
10009335|NCT01765465|11131865|FG000|STARTED|Overall Study||71
10009336|NCT01765465|11131866|FG001|STARTED|Overall Study||67
10009337|NCT01765465|11131865|FG000|COMPLETED|Overall Study||64
10009338|NCT01765465|11131866|FG001|COMPLETED|Overall Study||63
9902491|NCT01144299|11018294|FG000|STARTED|Overall Study||60
9902492|NCT01144299|11018295|FG001|STARTED|Overall Study||54
9902493|NCT01144299|11018294|FG000|COMPLETED|Overall Study||58
9902494|NCT01144299|11018295|FG001|COMPLETED|Overall Study||54
9902495|NCT01144299|11018294|FG000|NOT COMPLETED|Overall Study||2
9902496|NCT01144299|11018295|FG001|NOT COMPLETED|Overall Study||0
9902497|NCT01144338|11018303|FG000|STARTED|Overall Study||7396
9902498|NCT01144338|11018304|FG001|STARTED|Overall Study||7356
9902499|NCT01144338|11018303|FG000|COMPLETED|Overall Study||7093
9902500|NCT01144338|11018304|FG001|COMPLETED|Overall Study||7094
9902501|NCT01144338|11018303|FG000|NOT COMPLETED|Overall Study||303
9902502|NCT01144338|11018304|FG001|NOT COMPLETED|Overall Study||262
9902503|NCT01144364|11018312|FG000|STARTED|Induction Phase||234
9902504|NCT01144364|11018313|FG001|STARTED|Induction Phase||0
9902505|NCT01144364|11018314|FG002|STARTED|Induction Phase||0
9902506|NCT01144364|11018312|FG000|COMPLETED|Induction Phase||202
9902507|NCT01144364|11018313|FG001|COMPLETED|Induction Phase||0
9902508|NCT01144364|11018314|FG002|COMPLETED|Induction Phase||0
9902509|NCT01144364|11018312|FG000|NOT COMPLETED|Induction Phase||32
9902510|NCT01144364|11018313|FG001|NOT COMPLETED|Induction Phase||0
9902511|NCT01144364|11018314|FG002|NOT COMPLETED|Induction Phase||0
9902512|NCT01144364|11018312|FG000|STARTED|Follow-Up/Maintenance Phase||0
9902513|NCT01144364|11018313|FG001|STARTED|Follow-Up/Maintenance Phase||101
9902514|NCT01144364|11018314|FG002|STARTED|Follow-Up/Maintenance Phase||101
9902515|NCT01144364|11018312|FG000|COMPLETED|Follow-Up/Maintenance Phase||0
9902516|NCT01144364|11018313|FG001|COMPLETED|Follow-Up/Maintenance Phase||66
9902517|NCT01144364|11018314|FG002|COMPLETED|Follow-Up/Maintenance Phase||60
9902518|NCT01144364|11018312|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0
9902519|NCT01144364|11018313|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35
9902520|NCT01144364|11018314|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41
9902521|NCT01144377|11018329|FG000|STARTED|52 Week Treatment Period||31
9902522|NCT01144377|11018330|FG001|STARTED|52 Week Treatment Period||30
9902523|NCT01144377|11018331|FG002|STARTED|52 Week Treatment Period||30
9902524|NCT01144377|11018332|FG003|STARTED|52 Week Treatment Period||26
9902525|NCT01144377|11018333|FG004|STARTED|52 Week Treatment Period||37
9902526|NCT01144377|11018329|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
9902527|NCT01144377|11018330|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
9902528|NCT01144377|11018331|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
9902529|NCT01144377|11018332|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
10009339|NCT01765465|11131865|FG000|NOT COMPLETED|Overall Study||7
10009340|NCT01765465|11131866|FG001|NOT COMPLETED|Overall Study||4
10009341|NCT01765530|11131876|FG000|STARTED|Overall Study||37
10009342|NCT01765530|11131877|FG001|STARTED|Overall Study||37
10110523|NCT02486692|11241415|FG001|COMPLETED|Overall Study||23
10110524|NCT02486692|11241414|FG000|NOT COMPLETED|Overall Study||4
10110525|NCT02486692|11241415|FG001|NOT COMPLETED|Overall Study||7
10110526|NCT02486757|11241421|FG000|STARTED|Overall Study||6
9902530|NCT01144377|11018333|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
9902531|NCT01144377|11018329|FG000|COMPLETED|52 Week Treatment Period||26
9902532|NCT01144377|11018330|FG001|COMPLETED|52 Week Treatment Period||29
9902533|NCT01144377|11018331|FG002|COMPLETED|52 Week Treatment Period||25
9902534|NCT01144377|11018332|FG003|COMPLETED|52 Week Treatment Period||22
9902535|NCT01144377|11018333|FG004|COMPLETED|52 Week Treatment Period||34
10110527|NCT02486757|11241421|FG000|COMPLETED|Overall Study||5
10110528|NCT02486757|11241421|FG000|NOT COMPLETED|Overall Study||1
10110529|NCT02486796|11241427|FG000|STARTED|Overall Study||3
9902536|NCT01144377|11018329|FG000|NOT COMPLETED|52 Week Treatment Period||5
10009343|NCT01765530|11131876|FG000|COMPLETED|Overall Study||36
10110530|NCT02486796|11241428|FG001|STARTED|Overall Study||2
9902537|NCT01144377|11018330|FG001|NOT COMPLETED|52 Week Treatment Period||1
9902538|NCT01144377|11018331|FG002|NOT COMPLETED|52 Week Treatment Period||5
9902539|NCT01144377|11018332|FG003|NOT COMPLETED|52 Week Treatment Period||4
9902540|NCT01144377|11018333|FG004|NOT COMPLETED|52 Week Treatment Period||3
9902541|NCT01144377|11018329|FG000|STARTED|12 Week Safety Follow-up Period||26
9902542|NCT01144377|11018330|FG001|STARTED|12 Week Safety Follow-up Period||29
9902543|NCT01144377|11018331|FG002|STARTED|12 Week Safety Follow-up Period||25
9902544|NCT01144377|11018332|FG003|STARTED|12 Week Safety Follow-up Period||22
9902545|NCT01144377|11018333|FG004|STARTED|12 Week Safety Follow-up Period||34
9902546|NCT01144377|11018329|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
9902547|NCT01144377|11018330|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
9902548|NCT01144377|11018331|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
9902549|NCT01144377|11018332|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
9902550|NCT01144377|11018333|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
9902551|NCT01144377|11018329|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0
9902552|NCT01144377|11018330|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0
9902553|NCT01144377|11018331|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0
9902554|NCT01144377|11018332|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0
9902555|NCT01144377|11018333|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0
9902556|NCT01144377|11018329|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22
9902557|NCT01144377|11018330|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25
9902558|NCT01144377|11018331|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23
9902559|NCT01144377|11018332|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3
9902560|NCT01144377|11018333|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23
9902561|NCT01144377|11018329|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21
9902562|NCT01144377|11018330|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24
9902563|NCT01144377|11018331|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23
9902564|NCT01144377|11018332|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3
9902565|NCT01144377|11018333|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21
9902566|NCT01144377|11018329|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
9902567|NCT01144377|11018330|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
9902568|NCT01144377|11018331|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
9902569|NCT01144377|11018332|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
9902570|NCT01144377|11018333|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
9902571|NCT01144403|11018347|FG000|STARTED|Overall Study||8
9902572|NCT01144403|11018347|FG000|COMPLETED|Overall Study||3
9902573|NCT01144403|11018347|FG000|NOT COMPLETED|Overall Study||5
9902574|NCT01144442|11018352|FG000|STARTED|Overall Study||10
9902575|NCT01144442|11018352|FG000|COMPLETED|Overall Study||10
9902576|NCT01144442|11018352|FG000|NOT COMPLETED|Overall Study||0
9902577|NCT01144455|11018359|FG000|STARTED|Overall Study||69
9902578|NCT01144455|11018360|FG001|STARTED|Overall Study||71
9902579|NCT01144455|11018361|FG002|STARTED|Overall Study||74
9902580|NCT01144455|11018359|FG000|COMPLETED|Overall Study||19
9902581|NCT01144455|11018360|FG001|COMPLETED|Overall Study||29
9902582|NCT01144455|11018361|FG002|COMPLETED|Overall Study||38
9902583|NCT01144455|11018359|FG000|NOT COMPLETED|Overall Study||50
9902584|NCT01144455|11018360|FG001|NOT COMPLETED|Overall Study||42
9902585|NCT01144455|11018361|FG002|NOT COMPLETED|Overall Study||36
9902586|NCT01144494|11018369|FG000|STARTED|Overall Study||15
9902587|NCT01144494|11018370|FG001|STARTED|Overall Study||18
9902588|NCT01144494|11018369|FG000|COMPLETED|Overall Study||15
9902589|NCT01144494|11018370|FG001|COMPLETED|Overall Study||14
9902590|NCT01144494|11018369|FG000|NOT COMPLETED|Overall Study||0
9902591|NCT01144494|11018370|FG001|NOT COMPLETED|Overall Study||4
9902592|NCT01144598|11018381|FG000|STARTED|Overall Study||356
9902593|NCT01144598|11018381|FG000|Analysis Population|Overall Study||356
9902594|NCT01144598|11018381|FG000|COMPLETED|Overall Study||356
9902595|NCT01144598|11018381|FG000|NOT COMPLETED|Overall Study||0
9902596|NCT01144624|11018388|FG000|STARTED|Overall Study||7
9902597|NCT01144624|11018389|FG001|STARTED|Overall Study||7
9902598|NCT01144624|11018390|FG002|STARTED|Overall Study||6
9902599|NCT01144624|11018388|FG000|Received Treatment|Overall Study||7
9902600|NCT01144624|11018389|FG001|Received Treatment|Overall Study||7
9902601|NCT01144624|11018390|FG002|Received Treatment|Overall Study||6
9902602|NCT01144624|11018388|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
9902603|NCT01144624|11018389|FG001|Completed Treatment|Overall Study||7
9902604|NCT01144624|11018390|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
9902605|NCT01144624|11018388|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
9902606|NCT01144624|11018389|FG001|COMPLETED|Overall Study||7
9902607|NCT01144624|11018390|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
9902608|NCT01144624|11018388|FG000|NOT COMPLETED|Overall Study||0
9902609|NCT01144624|11018389|FG001|NOT COMPLETED|Overall Study||0
9902610|NCT01144624|11018390|FG002|NOT COMPLETED|Overall Study||0
9902611|NCT01144637|11018402|FG000|STARTED|Overall Study||999
9902612|NCT01144637|11018403|FG001|STARTED|Overall Study||1005
9902613|NCT01144637|11018404|FG002|STARTED|Overall Study||999
9902614|NCT01144637|11018405|FG003|STARTED|Overall Study||1002
9902615|NCT01144637|11018402|FG000|COMPLETED|Overall Study||925
9902616|NCT01144637|11018403|FG001|COMPLETED|Overall Study||929
9902617|NCT01144637|11018404|FG002|COMPLETED|Overall Study||939
9902618|NCT01144637|11018405|FG003|COMPLETED|Overall Study||946
9902619|NCT01144637|11018402|FG000|NOT COMPLETED|Overall Study||74
9902620|NCT01144637|11018403|FG001|NOT COMPLETED|Overall Study||76
9902621|NCT01144637|11018404|FG002|NOT COMPLETED|Overall Study||60
9902622|NCT01144637|11018405|FG003|NOT COMPLETED|Overall Study||56
9902623|NCT01144663|11018419|FG000|STARTED|Primary Vaccination Phase||528
9902624|NCT01144663|11018420|FG001|STARTED|Primary Vaccination Phase||524
9902625|NCT01144663|11018421|FG002|STARTED|Primary Vaccination Phase||516
9902626|NCT01144663|11018422|FG003|STARTED|Primary Vaccination Phase||527
9902627|NCT01144663|11018419|FG000|COMPLETED|Primary Vaccination Phase||508
9902628|NCT01144663|11018420|FG001|COMPLETED|Primary Vaccination Phase||517
9902629|NCT01144663|11018421|FG002|COMPLETED|Primary Vaccination Phase||508
9902630|NCT01144663|11018422|FG003|COMPLETED|Primary Vaccination Phase||509
9902631|NCT01144663|11018419|FG000|NOT COMPLETED|Primary Vaccination Phase||20
9902632|NCT01144663|11018420|FG001|NOT COMPLETED|Primary Vaccination Phase||7
9902633|NCT01144663|11018421|FG002|NOT COMPLETED|Primary Vaccination Phase||8
9902634|NCT01144663|11018422|FG003|NOT COMPLETED|Primary Vaccination Phase||18
9902635|NCT01144663|11018419|FG000|STARTED|Booster Vaccination Phase||497
9902636|NCT01144663|11018420|FG001|STARTED|Booster Vaccination Phase||511
9902637|NCT01144663|11018421|FG002|STARTED|Booster Vaccination Phase||503
9902638|NCT01144663|11018422|FG003|STARTED|Booster Vaccination Phase||506
9902639|NCT01144663|11018419|FG000|COMPLETED|Booster Vaccination Phase||494
10110531|NCT02486796|11241427|FG000|COMPLETED|Overall Study||1
10110532|NCT02486796|11241428|FG001|COMPLETED|Overall Study||1
10110533|NCT02486796|11241427|FG000|NOT COMPLETED|Overall Study||2
10110534|NCT02486796|11241428|FG001|NOT COMPLETED|Overall Study||1
10110535|NCT02486939|11241436|FG000|STARTED|Overall Study||225
10110536|NCT02486939|11241437|FG001|STARTED|Overall Study||134
10110537|NCT02486939|11241436|FG000|COMPLETED|Overall Study||224
10110538|NCT02486939|11241437|FG001|COMPLETED|Overall Study||132
10110539|NCT02486939|11241436|FG000|NOT COMPLETED|Overall Study||1
10110540|NCT02486939|11241437|FG001|NOT COMPLETED|Overall Study||2
10110541|NCT02486952|11241443|FG000|STARTED|Overall Study||154
10110542|NCT02486952|11241443|FG000|Started Induction Therapy|Overall Study||151
10110543|NCT02486952|11241443|FG000|COMPLETED|Overall Study||104
10110544|NCT02486952|11241443|FG000|NOT COMPLETED|Overall Study||50
10110545|NCT02487030|11241454|FG000|STARTED|Overall Study||43
9902640|NCT01144663|11018420|FG001|COMPLETED|Booster Vaccination Phase||509
9902641|NCT01144663|11018421|FG002|COMPLETED|Booster Vaccination Phase||498
9902642|NCT01144663|11018422|FG003|COMPLETED|Booster Vaccination Phase||505
9902643|NCT01144663|11018419|FG000|NOT COMPLETED|Booster Vaccination Phase||3
9902644|NCT01144663|11018420|FG001|NOT COMPLETED|Booster Vaccination Phase||2
9902645|NCT01144663|11018421|FG002|NOT COMPLETED|Booster Vaccination Phase||5
9902646|NCT01144663|11018422|FG003|NOT COMPLETED|Booster Vaccination Phase||1
9902647|NCT01144663|11018419|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497
9902648|NCT01144663|11018420|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511
9902649|NCT01144663|11018421|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503
9902650|NCT01144663|11018422|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506
9902651|NCT01144663|11018419|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492
9902652|NCT01144663|11018420|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502
9902653|NCT01144663|11018421|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496
9902654|NCT01144663|11018422|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505
9902655|NCT01144663|11018419|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
10110546|NCT02487030|11241455|FG001|STARTED|Overall Study||42
10110547|NCT02487030|11241456|FG002|STARTED|Overall Study||43
10110548|NCT02487030|11241457|FG003|STARTED|Overall Study||42
10110549|NCT02487030|11241458|FG004|STARTED|Overall Study||36
10110550|NCT02487030|11241459|FG005|STARTED|Overall Study||38
10110551|NCT02487030|11241460|FG006|STARTED|Overall Study||11
10110552|NCT02487030|11241454|FG000|COMPLETED|Overall Study||41
10110553|NCT02487030|11241455|FG001|COMPLETED|Overall Study||38
10110554|NCT02487030|11241456|FG002|COMPLETED|Overall Study||41
10110555|NCT02487030|11241457|FG003|COMPLETED|Overall Study||40
10110556|NCT02487030|11241458|FG004|COMPLETED|Overall Study||34
9902656|NCT01144663|11018420|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
9902657|NCT01144663|11018421|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
9902658|NCT01144663|11018422|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
10110557|NCT02487030|11241459|FG005|COMPLETED|Overall Study||37
10110558|NCT02487030|11241460|FG006|COMPLETED|Overall Study||11
10110559|NCT02487030|11241454|FG000|NOT COMPLETED|Overall Study||2
9902659|NCT01144715|11018434|FG000|STARTED|Overall Study||51
9902660|NCT01144715|11018435|FG001|STARTED|Overall Study||48
9902661|NCT01144715|11018434|FG000|COMPLETED|Overall Study||47
9902662|NCT01144715|11018435|FG001|COMPLETED|Overall Study||45
9902663|NCT01144715|11018434|FG000|NOT COMPLETED|Overall Study||4
9902664|NCT01144715|11018435|FG001|NOT COMPLETED|Overall Study||3
9902665|NCT01144949|11018443|FG000|STARTED|Overall Study||119
9902666|NCT01144949|11018444|FG001|STARTED|Overall Study||120
9902667|NCT01144949|11018443|FG000|COMPLETED|Overall Study||108
9902668|NCT01144949|11018444|FG001|COMPLETED|Overall Study||106
10110560|NCT02487030|11241455|FG001|NOT COMPLETED|Overall Study||4
10110561|NCT02487030|11241456|FG002|NOT COMPLETED|Overall Study||2
9902669|NCT01144949|11018443|FG000|NOT COMPLETED|Overall Study||11
9902670|NCT01144949|11018444|FG001|NOT COMPLETED|Overall Study||14
9902671|NCT01145001|11018454|FG000|STARTED|Overall Study||36
9902672|NCT01145001|11018455|FG001|STARTED|Overall Study||37
9902673|NCT01145001|11018456|FG002|STARTED|Overall Study||44
9902674|NCT01145001|11018457|FG003|STARTED|Overall Study||37
9902675|NCT01145001|11018454|FG000|COMPLETED|Overall Study||28
9902676|NCT01145001|11018455|FG001|COMPLETED|Overall Study||31
9902677|NCT01145001|11018456|FG002|COMPLETED|Overall Study||39
9902678|NCT01145001|11018457|FG003|COMPLETED|Overall Study||31
9902679|NCT01145001|11018454|FG000|NOT COMPLETED|Overall Study||8
9902680|NCT01145001|11018455|FG001|NOT COMPLETED|Overall Study||6
9902681|NCT01145001|11018456|FG002|NOT COMPLETED|Overall Study||5
9902682|NCT01145001|11018457|FG003|NOT COMPLETED|Overall Study||6
9902683|NCT01145053|11018467|FG000|STARTED|Overall Study||341
9902684|NCT01145053|11018467|FG000|COMPLETED|Overall Study||248
9902685|NCT01145053|11018467|FG000|NOT COMPLETED|Overall Study||93
9902686|NCT01145066|11018474|FG000|STARTED|Overall Study||26
9902687|NCT01145066|11018475|FG001|STARTED|Overall Study||20
9902688|NCT01145066|11018476|FG002|STARTED|Overall Study||25
9902689|NCT01145066|11018474|FG000|COMPLETED|Overall Study||22
9902690|NCT01145066|11018475|FG001|COMPLETED|Overall Study||16
9902691|NCT01145066|11018476|FG002|COMPLETED|Overall Study||21
9902692|NCT01145066|11018474|FG000|NOT COMPLETED|Overall Study||4
9902693|NCT01145066|11018475|FG001|NOT COMPLETED|Overall Study||4
9902694|NCT01145066|11018476|FG002|NOT COMPLETED|Overall Study||4
9902695|NCT01145183|11018488|FG000|STARTED|Overall Study||21
9902696|NCT01145183|11018489|FG001|STARTED|Overall Study||26
9902697|NCT01145183|11018490|FG002|STARTED|Overall Study||19
9902698|NCT01145183|11018491|FG003|STARTED|Overall Study||10
9902699|NCT01145183|11018488|FG000|COMPLETED|Overall Study||21
9902700|NCT01145183|11018489|FG001|COMPLETED|Overall Study||26
9902701|NCT01145183|11018490|FG002|COMPLETED|Overall Study||19
9902702|NCT01145183|11018491|FG003|COMPLETED|Overall Study||10
9902703|NCT01145183|11018488|FG000|NOT COMPLETED|Overall Study||0
9902704|NCT01145183|11018489|FG001|NOT COMPLETED|Overall Study||0
9902705|NCT01145183|11018490|FG002|NOT COMPLETED|Overall Study||0
10009344|NCT01765530|11131877|FG001|COMPLETED|Overall Study||36
10009345|NCT01765530|11131876|FG000|NOT COMPLETED|Overall Study||1
10009346|NCT01765530|11131877|FG001|NOT COMPLETED|Overall Study||1
10009347|NCT01765543|11131883|FG000|STARTED|Overall Study||27
10009348|NCT01765543|11131883|FG000|COMPLETED|Overall Study||24
10009349|NCT01765543|11131883|FG000|NOT COMPLETED|Overall Study||3
10110562|NCT02487030|11241457|FG003|NOT COMPLETED|Overall Study||2
10110563|NCT02487030|11241458|FG004|NOT COMPLETED|Overall Study||2
10110564|NCT02487030|11241459|FG005|NOT COMPLETED|Overall Study||1
10110565|NCT02487030|11241460|FG006|NOT COMPLETED|Overall Study||0
10110566|NCT02487056|11241477|FG000|STARTED|Overall Study||1622
10110567|NCT02487056|11241477|FG000|COMPLETED|Overall Study||1606
10110568|NCT02487056|11241477|FG000|NOT COMPLETED|Overall Study||16
10110569|NCT02487199|11241484|FG000|STARTED|Overall Study||13
10110570|NCT02487199|11241485|FG001|STARTED|Overall Study||5
10110571|NCT02487199|11241484|FG000|COMPLETED|Overall Study||13
10110572|NCT02487199|11241485|FG001|COMPLETED|Overall Study||4
10110573|NCT02487199|11241484|FG000|NOT COMPLETED|Overall Study||0
10110574|NCT02487199|11241485|FG001|NOT COMPLETED|Overall Study||1
10110575|NCT02487225|11241493|FG000|STARTED|Overall Study||45
10110576|NCT02487225|11241494|FG001|STARTED|Overall Study||38
10110577|NCT02487225|11241493|FG000|COMPLETED|Overall Study||18
10110578|NCT02487225|11241494|FG001|COMPLETED|Overall Study||8
10110579|NCT02487225|11241493|FG000|NOT COMPLETED|Overall Study||27
10110580|NCT02487225|11241494|FG001|NOT COMPLETED|Overall Study||30
10110581|NCT02487303|11241503|FG000|STARTED|Overall Study||49
10110582|NCT02487303|11241504|FG001|STARTED|Overall Study||51
10110583|NCT02487303|11241505|FG002|STARTED|Overall Study||48
10110584|NCT02487303|11241503|FG000|COMPLETED|Overall Study||47
10110585|NCT02487303|11241504|FG001|COMPLETED|Overall Study||47
10110586|NCT02487303|11241505|FG002|COMPLETED|Overall Study||47
10110587|NCT02487303|11241503|FG000|NOT COMPLETED|Overall Study||2
10110588|NCT02487303|11241504|FG001|NOT COMPLETED|Overall Study||4
10009350|NCT01765569|11131891|FG000|STARTED|Period A||29
10009351|NCT01765569|11131891|FG000|COMPLETED|Period A||29
10009352|NCT01765569|11131891|FG000|NOT COMPLETED|Period A||0
10110589|NCT02487303|11241505|FG002|NOT COMPLETED|Overall Study||1
10110590|NCT02487446|11241516|FG000|STARTED|Period 1||178
10110591|NCT02487446|11241517|FG001|STARTED|Period 1||179
10110592|NCT02487446|11241516|FG000|COMPLETED|Period 1||165
10202903|NCT03453060|11330058|FG000|COMPLETED|Overall Study||4
10202904|NCT03453060|11330059|FG001|COMPLETED|Overall Study||4
9902706|NCT01145183|11018491|FG003|NOT COMPLETED|Overall Study||0
9902707|NCT01145222|11018505|FG000|STARTED|Overall Study||40
9902708|NCT01145222|11018506|FG001|STARTED|Overall Study||40
9902709|NCT01145222|11018507|FG002|STARTED|Overall Study||41
9902710|NCT01145222|11018508|FG003|STARTED|Overall Study||41
9902711|NCT01145222|11018505|FG000|Safety Population|Overall Study||40
9902712|NCT01145222|11018506|FG001|Safety Population|Overall Study||40
9902713|NCT01145222|11018507|FG002|Safety Population|Overall Study||40
9902714|NCT01145222|11018508|FG003|Safety Population|Overall Study||41
9902715|NCT01145222|11018505|FG000|Intention to Treat (ITT) Population|Overall Study||40
10009353|NCT01765569|11131891|FG000|STARTED|Period B||29
10009354|NCT01765569|11131891|FG000|COMPLETED|Period B||28
10009355|NCT01765569|11131891|FG000|NOT COMPLETED|Period B||1
10110593|NCT02487446|11241517|FG001|COMPLETED|Period 1||171
10202905|NCT03453060|11330060|FG002|COMPLETED|Overall Study||4
9902716|NCT01145222|11018506|FG001|Intention to Treat (ITT) Population|Overall Study||40
9902717|NCT01145222|11018507|FG002|Intention to Treat (ITT) Population|Overall Study||40
9902718|NCT01145222|11018508|FG003|Intention to Treat (ITT) Population|Overall Study||40
9902719|NCT01145222|11018505|FG000|COMPLETED|Overall Study||40
9902720|NCT01145222|11018506|FG001|COMPLETED|Overall Study||40
9902721|NCT01145222|11018507|FG002|COMPLETED|Overall Study||40
9902722|NCT01145222|11018508|FG003|COMPLETED|Overall Study||40
9902723|NCT01145222|11018505|FG000|NOT COMPLETED|Overall Study||0
9902724|NCT01145222|11018506|FG001|NOT COMPLETED|Overall Study||0
9902725|NCT01145222|11018507|FG002|NOT COMPLETED|Overall Study||1
9902726|NCT01145222|11018508|FG003|NOT COMPLETED|Overall Study||1
9902727|NCT01145352|11018518|FG000|STARTED|Overall Study||113
9902728|NCT01145352|11018518|FG000|COMPLETED|Overall Study||102
9902729|NCT01145352|11018518|FG000|NOT COMPLETED|Overall Study||11
9902730|NCT01145391|11018524|FG000|STARTED|Overall Study||293
9902731|NCT01145391|11018525|FG001|STARTED|Overall Study||298
9902732|NCT01145391|11018524|FG000|9 Months Post-randomization|Overall Study||293
9902733|NCT01145391|11018525|FG001|9 Months Post-randomization|Overall Study||298
9902734|NCT01145391|11018524|FG000|COMPLETED|Overall Study||293
9902735|NCT01145391|11018525|FG001|COMPLETED|Overall Study||298
9902736|NCT01145391|11018524|FG000|NOT COMPLETED|Overall Study||0
9902737|NCT01145391|11018525|FG001|NOT COMPLETED|Overall Study||0
9902738|NCT01145417|11018535|FG000|STARTED|Overall Study||108
9902739|NCT01145417|11018536|FG001|STARTED|Overall Study||109
9902740|NCT01145417|11018535|FG000|COMPLETED|Overall Study||67
9902741|NCT01145417|11018536|FG001|COMPLETED|Overall Study||62
9902742|NCT01145417|11018535|FG000|NOT COMPLETED|Overall Study||41
9902743|NCT01145417|11018536|FG001|NOT COMPLETED|Overall Study||47
9902744|NCT01145482|11018544|FG000|STARTED|First Intervention (1 Day)||6
10110594|NCT02487446|11241516|FG000|NOT COMPLETED|Period 1||13
10110595|NCT02487446|11241517|FG001|NOT COMPLETED|Period 1||8
10110596|NCT02487446|11241516|FG000|STARTED|Washout||165
10110597|NCT02487446|11241517|FG001|STARTED|Washout||171
10110598|NCT02487446|11241516|FG000|COMPLETED|Washout||162
10110599|NCT02487446|11241517|FG001|COMPLETED|Washout||163
10110600|NCT02487446|11241516|FG000|NOT COMPLETED|Washout||3
10110601|NCT02487446|11241517|FG001|NOT COMPLETED|Washout||8
9902745|NCT01145482|11018545|FG001|STARTED|First Intervention (1 Day)||6
9902746|NCT01145482|11018544|FG000|COMPLETED|First Intervention (1 Day)||6
9902747|NCT01145482|11018545|FG001|COMPLETED|First Intervention (1 Day)||5
9902748|NCT01145482|11018544|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9902749|NCT01145482|11018545|FG001|NOT COMPLETED|First Intervention (1 Day)||1
9902750|NCT01145482|11018544|FG000|STARTED|Second Intervention (1 Day)||5
9902751|NCT01145482|11018545|FG001|STARTED|Second Intervention (1 Day)||6
9902752|NCT01145482|11018544|FG000|COMPLETED|Second Intervention (1 Day)||5
9902753|NCT01145482|11018545|FG001|COMPLETED|Second Intervention (1 Day)||6
9902754|NCT01145482|11018544|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9902755|NCT01145482|11018545|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9902756|NCT01145508|11018553|FG000|STARTED|Overall Study||7
9902757|NCT01145508|11018554|FG001|STARTED|Overall Study||3
9902758|NCT01145508|11018553|FG000|Treated|Overall Study||6
9902759|NCT01145508|11018554|FG001|Treated|Overall Study||2
9902760|NCT01145508|11018553|FG000|COMPLETED|Overall Study||2
9902761|NCT01145508|11018554|FG001|COMPLETED|Overall Study||1
9902762|NCT01145508|11018553|FG000|NOT COMPLETED|Overall Study||5
9902763|NCT01145508|11018554|FG001|NOT COMPLETED|Overall Study||2
9902764|NCT01145547|11018560|FG000|STARTED|Overall Study||4
9902765|NCT01145547|11018561|FG001|STARTED|Overall Study||3
10202906|NCT03453060|11330061|FG003|COMPLETED|Overall Study||4
10202907|NCT03453060|11330062|FG004|COMPLETED|Overall Study||5
10202908|NCT03453060|11330058|FG000|NOT COMPLETED|Overall Study||0
10009356|NCT01765569|11131891|FG000|STARTED|Period C||28
10009357|NCT01765569|11131891|FG000|COMPLETED|Period C||27
10110602|NCT02487446|11241516|FG000|STARTED|Period 2||162
10110603|NCT02487446|11241517|FG001|STARTED|Period 2||163
10110604|NCT02487446|11241516|FG000|COMPLETED|Period 2||154
10110605|NCT02487446|11241517|FG001|COMPLETED|Period 2||158
10110606|NCT02487446|11241516|FG000|NOT COMPLETED|Period 2||8
10110607|NCT02487446|11241517|FG001|NOT COMPLETED|Period 2||5
9902766|NCT01145547|11018560|FG000|COMPLETED|Overall Study||4
9902767|NCT01145547|11018561|FG001|COMPLETED|Overall Study||3
9902768|NCT01145547|11018560|FG000|NOT COMPLETED|Overall Study||0
9902769|NCT01145547|11018561|FG001|NOT COMPLETED|Overall Study||0
10009358|NCT01765569|11131891|FG000|NOT COMPLETED|Period C||1
10009359|NCT01765582|11131901|FG000|STARTED|Overall Study||93
10009360|NCT01765582|11131902|FG001|STARTED|Overall Study||92
10009361|NCT01765582|11131903|FG002|STARTED|Overall Study||95
10009362|NCT01765582|11131901|FG000|COMPLETED|Overall Study||0
10009363|NCT01765582|11131902|FG001|COMPLETED|Overall Study||0
10009364|NCT01765582|11131903|FG002|COMPLETED|Overall Study||0
10009365|NCT01765582|11131901|FG000|NOT COMPLETED|Overall Study||93
10009366|NCT01765582|11131902|FG001|NOT COMPLETED|Overall Study||92
10009367|NCT01765582|11131903|FG002|NOT COMPLETED|Overall Study||95
9902770|NCT01145560|11018570|FG000|STARTED|Overall Study||100
9902771|NCT01145560|11018571|FG001|STARTED|Overall Study||100
9902772|NCT01145560|11018572|FG002|STARTED|Overall Study||100
9902773|NCT01145560|11018570|FG000|Received Treatment|Overall Study||99
9902774|NCT01145560|11018571|FG001|Received Treatment|Overall Study||98
10110608|NCT02487472|11241524|FG000|STARTED|Overall Study||101
10110609|NCT02487472|11241524|FG000|COMPLETED|Overall Study||90
10110610|NCT02487472|11241524|FG000|NOT COMPLETED|Overall Study||11
10202909|NCT03453060|11330059|FG001|NOT COMPLETED|Overall Study||0
9902775|NCT01145560|11018572|FG002|Received Treatment|Overall Study||99
9902776|NCT01145560|11018570|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
9902777|NCT01145560|11018571|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
9902778|NCT01145560|11018572|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
9902779|NCT01145560|11018570|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
9902780|NCT01145560|11018571|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
9902781|NCT01145560|11018572|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
9902782|NCT01145560|11018570|FG000|NOT COMPLETED|Overall Study||4
9902783|NCT01145560|11018571|FG001|NOT COMPLETED|Overall Study||4
9902784|NCT01145560|11018572|FG002|NOT COMPLETED|Overall Study||2
9902785|NCT01145625|11018582|FG000|STARTED|Overall Study||161
9902786|NCT01145625|11018583|FG001|STARTED|Overall Study||161
9902787|NCT01145625|11018582|FG000|COMPLETED|Overall Study||137
9902788|NCT01145625|11018583|FG001|COMPLETED|Overall Study||130
9902789|NCT01145625|11018582|FG000|NOT COMPLETED|Overall Study||24
9902790|NCT01145625|11018583|FG001|NOT COMPLETED|Overall Study||31
9902791|NCT01145638|11018591|FG000|STARTED|Overall Study||231
9902792|NCT01145638|11018592|FG001|STARTED|Overall Study||119
9902793|NCT01145638|11018591|FG000|COMPLETED|Overall Study||141
9902794|NCT01145638|11018592|FG001|COMPLETED|Overall Study||62
9902795|NCT01145638|11018591|FG000|NOT COMPLETED|Overall Study||90
9902796|NCT01145638|11018592|FG001|NOT COMPLETED|Overall Study||57
9902797|NCT01145755|11018601|FG000|STARTED|Overall Study||40
9902798|NCT01145755|11018602|FG001|STARTED|Overall Study||47
9902799|NCT01145755|11018603|FG002|STARTED|Overall Study||44
9902800|NCT01145755|11018601|FG000|COMPLETED|Overall Study||20
9902801|NCT01145755|11018602|FG001|COMPLETED|Overall Study||19
9902802|NCT01145755|11018603|FG002|COMPLETED|Overall Study||19
9902803|NCT01145755|11018601|FG000|NOT COMPLETED|Overall Study||20
9902804|NCT01145755|11018602|FG001|NOT COMPLETED|Overall Study||28
9902805|NCT01145755|11018603|FG002|NOT COMPLETED|Overall Study||25
10110611|NCT02487485|11241532|FG000|STARTED|Overall Study||12
10110612|NCT02487485|11241533|FG001|STARTED|Overall Study||11
10110613|NCT02487485|11241532|FG000|COMPLETED|Overall Study||9
10110614|NCT02487485|11241533|FG001|COMPLETED|Overall Study||8
10110615|NCT02487485|11241532|FG000|NOT COMPLETED|Overall Study||3
10110616|NCT02487485|11241533|FG001|NOT COMPLETED|Overall Study||3
10110617|NCT02487498|11241539|FG000|STARTED|Period: Period 1||178
10110618|NCT02487498|11241540|FG001|STARTED|Period: Period 1||177
10110619|NCT02487498|11241539|FG000|COMPLETED|Period: Period 1||172
10110620|NCT02487498|11241540|FG001|COMPLETED|Period: Period 1||166
10110621|NCT02487498|11241539|FG000|NOT COMPLETED|Period: Period 1||6
10110622|NCT02487498|11241540|FG001|NOT COMPLETED|Period: Period 1||11
10110623|NCT02487498|11241539|FG000|STARTED|Period: Washout||172
10110624|NCT02487498|11241540|FG001|STARTED|Period: Washout||166
10110625|NCT02487498|11241539|FG000|COMPLETED|Period: Washout||170
10110626|NCT02487498|11241540|FG001|COMPLETED|Period: Washout||159
10110627|NCT02487498|11241539|FG000|NOT COMPLETED|Period: Washout||2
10110628|NCT02487498|11241540|FG001|NOT COMPLETED|Period: Washout||7
10110629|NCT02487498|11241539|FG000|STARTED|Period: Period 2||170
10110630|NCT02487498|11241540|FG001|STARTED|Period: Period 2||159
10110631|NCT02487498|11241539|FG000|COMPLETED|Period: Period 2||164
10110632|NCT02487498|11241540|FG001|COMPLETED|Period: Period 2||154
10110633|NCT02487498|11241539|FG000|NOT COMPLETED|Period: Period 2||6
10110634|NCT02487498|11241540|FG001|NOT COMPLETED|Period: Period 2||5
10110635|NCT02487563|11241550|FG000|STARTED|Overall Study||32
10110636|NCT02487563|11241551|FG001|STARTED|Overall Study||33
10110637|NCT02487563|11241552|FG002|STARTED|Overall Study||32
10110638|NCT02487563|11241550|FG000|COMPLETED|Overall Study||30
10110639|NCT02487563|11241551|FG001|COMPLETED|Overall Study||30
10110640|NCT02487563|11241552|FG002|COMPLETED|Overall Study||31
10110641|NCT02487563|11241550|FG000|NOT COMPLETED|Overall Study||2
10110642|NCT02487563|11241551|FG001|NOT COMPLETED|Overall Study||3
10110643|NCT02487563|11241552|FG002|NOT COMPLETED|Overall Study||1
10110644|NCT02487771|11241565|FG000|STARTED|Overall Study||91
10110645|NCT02487771|11241566|FG001|STARTED|Overall Study||99
10110646|NCT02487771|11241565|FG000|COMPLETED|Overall Study||81
10110647|NCT02487771|11241566|FG001|COMPLETED|Overall Study||85
10110648|NCT02487771|11241565|FG000|NOT COMPLETED|Overall Study||10
10110649|NCT02487771|11241566|FG001|NOT COMPLETED|Overall Study||14
10110650|NCT02487810|11241574|FG000|STARTED|Overall Study||98
10110651|NCT02487810|11241575|FG001|STARTED|Overall Study||102
10110652|NCT02487810|11241574|FG000|COMPLETED|Overall Study||97
10110653|NCT02487810|11241575|FG001|COMPLETED|Overall Study||102
10110654|NCT02487810|11241574|FG000|NOT COMPLETED|Overall Study||1
10110655|NCT02487810|11241575|FG001|NOT COMPLETED|Overall Study||0
10110656|NCT02487966|11241585|FG000|STARTED|Overall Study||29
10110657|NCT02487966|11241586|FG001|STARTED|Overall Study||28
9902806|NCT01145833|11018613|FG000|STARTED|Overall Study||25
10110658|NCT02487966|11241587|FG002|STARTED|Overall Study||28
10110659|NCT02487966|11241588|FG003|STARTED|Overall Study||27
10110660|NCT02487966|11241585|FG000|COMPLETED|Overall Study||28
10110661|NCT02487966|11241586|FG001|COMPLETED|Overall Study||24
10110662|NCT02487966|11241587|FG002|COMPLETED|Overall Study||26
10110663|NCT02487966|11241588|FG003|COMPLETED|Overall Study||25
10110664|NCT02487966|11241585|FG000|NOT COMPLETED|Overall Study||1
9902807|NCT01145833|11018614|FG001|STARTED|Overall Study||25
9902808|NCT01145833|11018613|FG000|COMPLETED|Overall Study||22
9902809|NCT01145833|11018614|FG001|COMPLETED|Overall Study||25
9902810|NCT01145833|11018613|FG000|NOT COMPLETED|Overall Study||3
9902811|NCT01145833|11018614|FG001|NOT COMPLETED|Overall Study||0
9902812|NCT01145885|11018620|FG000|STARTED|Overall Study||7
9902813|NCT01145885|11018620|FG000|COMPLETED|Overall Study||0
9902814|NCT01145885|11018620|FG000|NOT COMPLETED|Overall Study||7
9902815|NCT01145898|11018632|FG000|STARTED|6-month Treatment||12
9902816|NCT01145898|11018633|FG001|STARTED|6-month Treatment||44
9902817|NCT01145898|11018632|FG000|COMPLETED|6-month Treatment||12
9902818|NCT01145898|11018633|FG001|COMPLETED|6-month Treatment||44
9902819|NCT01145898|11018632|FG000|NOT COMPLETED|6-month Treatment||0
9902820|NCT01145898|11018633|FG001|NOT COMPLETED|6-month Treatment||0
9902821|NCT01145898|11018632|FG000|STARTED|3-year Treatment||12
9902822|NCT01145898|11018633|FG001|STARTED|3-year Treatment||44
9902823|NCT01145898|11018632|FG000|COMPLETED|3-year Treatment||9
9902824|NCT01145898|11018633|FG001|COMPLETED|3-year Treatment||28
9902825|NCT01145898|11018632|FG000|NOT COMPLETED|3-year Treatment||3
9902826|NCT01145898|11018633|FG001|NOT COMPLETED|3-year Treatment||16
9902827|NCT01146054|11018638|FG000|STARTED|Overall Study||59
9902828|NCT01146054|11018638|FG000|COMPLETED|Overall Study||49
9902829|NCT01146054|11018638|FG000|NOT COMPLETED|Overall Study||10
9902830|NCT01146275|11018642|FG000|STARTED|Overall Study||6
9902831|NCT01146275|11018642|FG000|COMPLETED|Overall Study||6
9902832|NCT01146275|11018642|FG000|NOT COMPLETED|Overall Study||0
9902833|NCT01146288|11018649|FG000|STARTED|First Intervention(1 Day)||7
9902834|NCT01146288|11018650|FG001|STARTED|First Intervention(1 Day)||6
9902835|NCT01146288|11018649|FG000|COMPLETED|First Intervention(1 Day)||7
9902836|NCT01146288|11018650|FG001|COMPLETED|First Intervention(1 Day)||5
9902837|NCT01146288|11018649|FG000|NOT COMPLETED|First Intervention(1 Day)||0
9902838|NCT01146288|11018650|FG001|NOT COMPLETED|First Intervention(1 Day)||1
9902839|NCT01146288|11018649|FG000|STARTED|Second Intervention (1 Day)||7
9902840|NCT01146288|11018650|FG001|STARTED|Second Intervention (1 Day)||5
9902841|NCT01146288|11018649|FG000|COMPLETED|Second Intervention (1 Day)||7
9902842|NCT01146288|11018650|FG001|COMPLETED|Second Intervention (1 Day)||5
9902843|NCT01146288|11018649|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9902844|NCT01146288|11018650|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9902845|NCT01146379|11018661|FG000|STARTED|Overall Study||21
9902846|NCT01146379|11018662|FG001|STARTED|Overall Study||22
9902847|NCT01146379|11018663|FG002|STARTED|Overall Study||21
9902848|NCT01146379|11018664|FG003|STARTED|Overall Study||21
9902849|NCT01146379|11018661|FG000|COMPLETED|Overall Study||20
9902850|NCT01146379|11018662|FG001|COMPLETED|Overall Study||21
9902851|NCT01146379|11018663|FG002|COMPLETED|Overall Study||21
9902852|NCT01146379|11018664|FG003|COMPLETED|Overall Study||20
10009368|NCT01765647|11131912|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
10009369|NCT01765647|11131912|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
10009370|NCT01765647|11131912|FG000|NOT COMPLETED|Overall Study||0
10009371|NCT01765673|11131916|FG000|STARTED|Overall Study||12
10110665|NCT02487966|11241586|FG001|NOT COMPLETED|Overall Study||4
10110666|NCT02487966|11241587|FG002|NOT COMPLETED|Overall Study||2
10110667|NCT02487966|11241588|FG003|NOT COMPLETED|Overall Study||2
10110668|NCT02488005|11241598|FG000|STARTED|Overall Study||15
10202910|NCT03453060|11330060|FG002|NOT COMPLETED|Overall Study||0
10202911|NCT03453060|11330061|FG003|NOT COMPLETED|Overall Study||0
9902853|NCT01146379|11018661|FG000|NOT COMPLETED|Overall Study||1
9902854|NCT01146379|11018662|FG001|NOT COMPLETED|Overall Study||1
10009372|NCT01765673|11131916|FG000|COMPLETED|Overall Study||11
10009373|NCT01765673|11131916|FG000|NOT COMPLETED|Overall Study||1
10009374|NCT01765712|11131925|FG000|STARTED|Overall Study||27
10009375|NCT01765712|11131926|FG001|STARTED|Overall Study||23
10009376|NCT01765712|11131925|FG000|COMPLETED|Overall Study||27
10009377|NCT01765712|11131926|FG001|COMPLETED|Overall Study||23
10009378|NCT01765712|11131925|FG000|NOT COMPLETED|Overall Study||0
10009379|NCT01765712|11131926|FG001|NOT COMPLETED|Overall Study||0
10009380|NCT01765751|11131935|FG000|STARTED|Overall Study||16
10009381|NCT01765751|11131936|FG001|STARTED|Overall Study||16
10009382|NCT01765751|11131937|FG002|STARTED|Overall Study||16
10009383|NCT01765751|11131935|FG000|COMPLETED|Overall Study||16
10009384|NCT01765751|11131936|FG001|COMPLETED|Overall Study||14
10009385|NCT01765751|11131937|FG002|COMPLETED|Overall Study||15
10009386|NCT01765751|11131935|FG000|NOT COMPLETED|Overall Study||0
10009387|NCT01765751|11131936|FG001|NOT COMPLETED|Overall Study||2
10009388|NCT01765751|11131937|FG002|NOT COMPLETED|Overall Study||1
10009389|NCT01765764|11131951|FG000|STARTED|Treatment Period||118
9902855|NCT01146379|11018663|FG002|NOT COMPLETED|Overall Study||0
9902856|NCT01146379|11018664|FG003|NOT COMPLETED|Overall Study||1
9902857|NCT01146457|11018679|FG000|STARTED|Overall Study||19
9902858|NCT01146457|11018680|FG001|STARTED|Overall Study||17
9902859|NCT01146457|11018681|FG002|STARTED|Overall Study||21
9902860|NCT01146457|11018682|FG003|STARTED|Overall Study||13
9902861|NCT01146457|11018683|FG004|STARTED|Overall Study||13
9902862|NCT01146457|11018679|FG000|COMPLETED|Overall Study||19
9902863|NCT01146457|11018680|FG001|COMPLETED|Overall Study||17
9902864|NCT01146457|11018681|FG002|COMPLETED|Overall Study||20
10009390|NCT01765764|11131952|FG001|STARTED|Treatment Period||118
10009391|NCT01765764|11131953|FG002|STARTED|Treatment Period||121
10009392|NCT01765764|11131951|FG000|COMPLETED|Treatment Period||115
10110669|NCT02488005|11241598|FG000|COMPLETED|Overall Study||13
9902865|NCT01146457|11018682|FG003|COMPLETED|Overall Study||13
9902866|NCT01146457|11018683|FG004|COMPLETED|Overall Study||13
9902867|NCT01146457|11018679|FG000|NOT COMPLETED|Overall Study||0
9902868|NCT01146457|11018680|FG001|NOT COMPLETED|Overall Study||0
9902869|NCT01146457|11018681|FG002|NOT COMPLETED|Overall Study||1
9902870|NCT01146457|11018682|FG003|NOT COMPLETED|Overall Study||0
9902871|NCT01146457|11018683|FG004|NOT COMPLETED|Overall Study||0
9902872|NCT01146496|11018697|FG000|STARTED|Overall Study||114168
9902873|NCT01146496|11018698|FG001|STARTED|Overall Study||109693
9902874|NCT01146496|11018697|FG000|COMPLETED|Overall Study||114168
9902875|NCT01146496|11018698|FG001|COMPLETED|Overall Study||109693
9902876|NCT01146496|11018697|FG000|NOT COMPLETED|Overall Study||0
9902877|NCT01146496|11018698|FG001|NOT COMPLETED|Overall Study||0
9902878|NCT01146561|11018705|FG000|STARTED|Overall Study||2
9902879|NCT01146561|11018705|FG000|COMPLETED|Overall Study||0
9902880|NCT01146561|11018705|FG000|NOT COMPLETED|Overall Study||2
9902881|NCT01146600|11018711|FG000|STARTED|Period 1 (Weeks 1 & 2)||13
9902882|NCT01146600|11018712|FG001|STARTED|Period 1 (Weeks 1 & 2)||10
9902883|NCT01146600|11018711|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10
9902884|NCT01146600|11018712|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10
9902885|NCT01146600|11018711|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
9902886|NCT01146600|11018712|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
9902887|NCT01146600|11018711|FG000|STARTED|Washout (Week 3)||10
9902888|NCT01146600|11018712|FG001|STARTED|Washout (Week 3)||10
9902889|NCT01146600|11018711|FG000|COMPLETED|Washout (Week 3)||10
9902890|NCT01146600|11018712|FG001|COMPLETED|Washout (Week 3)||10
9902891|NCT01146600|11018711|FG000|NOT COMPLETED|Washout (Week 3)||0
9902892|NCT01146600|11018712|FG001|NOT COMPLETED|Washout (Week 3)||0
9902893|NCT01146600|11018711|FG000|STARTED|Period 2 (Weeks 4 & 5)||10
9902894|NCT01146600|11018712|FG001|STARTED|Period 2 (Weeks 4 & 5)||10
9902895|NCT01146600|11018711|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10
9902896|NCT01146600|11018712|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10
9902897|NCT01146600|11018711|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
9902898|NCT01146600|11018712|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
9902899|NCT01146613|11018721|FG000|STARTED|Overall Study||99
9902900|NCT01146613|11018722|FG001|STARTED|Overall Study||101
9902901|NCT01146613|11018721|FG000|COMPLETED|Overall Study||92
9902902|NCT01146613|11018722|FG001|COMPLETED|Overall Study||89
9902903|NCT01146613|11018721|FG000|NOT COMPLETED|Overall Study||7
9902904|NCT01146613|11018722|FG001|NOT COMPLETED|Overall Study||12
9902905|NCT01146665|11018730|FG000|STARTED|Overall Study||18
9902906|NCT01146665|11018731|FG001|STARTED|Overall Study||26
9902907|NCT01146665|11018730|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9
9902908|NCT01146665|11018731|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12
9902909|NCT01146665|11018730|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8
9902910|NCT01146665|11018731|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10
9902911|NCT01146665|11018730|FG000|COMPLETED|Overall Study||8
9902912|NCT01146665|11018731|FG001|COMPLETED|Overall Study||10
9902913|NCT01146665|11018730|FG000|NOT COMPLETED|Overall Study||10
9902914|NCT01146665|11018731|FG001|NOT COMPLETED|Overall Study||16
9902915|NCT01146704|11018748|FG000|STARTED|Overall Study||16
9902916|NCT01146704|11018749|FG001|STARTED|Overall Study||15
9902917|NCT01146704|11018748|FG000|COMPLETED|Overall Study||16
9902918|NCT01146704|11018749|FG001|COMPLETED|Overall Study||15
9902919|NCT01146704|11018748|FG000|NOT COMPLETED|Overall Study||0
9902920|NCT01146704|11018749|FG001|NOT COMPLETED|Overall Study||0
9902921|NCT01146782|11018755|FG000|STARTED|Screening Cohort||367
9902922|NCT01146782|11018755|FG000|COMPLETED|Screening Cohort||146
9902923|NCT01146782|11018755|FG000|NOT COMPLETED|Screening Cohort||221
9902924|NCT01146782|11018755|FG000|STARTED|Safety Cohort||146
9902925|NCT01146782|11018755|FG000|COMPLETED|Safety Cohort||63
9902926|NCT01146782|11018755|FG000|NOT COMPLETED|Safety Cohort||83
9902927|NCT01146782|11018755|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
9902928|NCT01146782|11018755|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
9902929|NCT01146782|11018755|FG000|NOT COMPLETED|Primary Endpoint Cohort||6
9902930|NCT01146795|11018760|FG000|STARTED|Overall Study||32
9902931|NCT01146795|11018760|FG000|COMPLETED|Overall Study||12
9902932|NCT01146795|11018760|FG000|NOT COMPLETED|Overall Study||20
9902933|NCT01146808|11018764|FG000|STARTED|Overall Study||16
9902934|NCT01146808|11018764|FG000|COMPLETED|Overall Study||16
9902935|NCT01146808|11018764|FG000|NOT COMPLETED|Overall Study||0
9902936|NCT01146834|11018773|FG000|STARTED|Overall Study||20
9902937|NCT01146834|11018774|FG001|STARTED|Overall Study||4
9902938|NCT01146834|11018775|FG002|STARTED|Overall Study||23
9902939|NCT01146834|11018776|FG003|STARTED|Overall Study||0
9902940|NCT01146834|11018777|FG004|STARTED|Overall Study||0
9902941|NCT01146834|11018773|FG000|COMPLETED|Overall Study||17
9902942|NCT01146834|11018774|FG001|COMPLETED|Overall Study||4
9902943|NCT01146834|11018775|FG002|COMPLETED|Overall Study||21
9902944|NCT01146834|11018776|FG003|COMPLETED|Overall Study||0
9902945|NCT01146834|11018777|FG004|COMPLETED|Overall Study||0
9902946|NCT01146834|11018773|FG000|NOT COMPLETED|Overall Study||3
9902947|NCT01146834|11018774|FG001|NOT COMPLETED|Overall Study||0
9902948|NCT01146834|11018775|FG002|NOT COMPLETED|Overall Study||2
9902949|NCT01146834|11018776|FG003|NOT COMPLETED|Overall Study||0
9902950|NCT01146834|11018777|FG004|NOT COMPLETED|Overall Study||0
9902951|NCT01146860|11018791|FG000|STARTED|Overall Study||194
9902952|NCT01146860|11018792|FG001|STARTED|Overall Study||192
9902953|NCT01146860|11018791|FG000|COMPLETED|Overall Study||194
9902954|NCT01146860|11018792|FG001|COMPLETED|Overall Study||191
10110670|NCT02488005|11241598|FG000|NOT COMPLETED|Overall Study||2
10110671|NCT02488018|11241602|FG000|STARTED|Overall Study||10
10110672|NCT02488018|11241602|FG000|COMPLETED|Overall Study||10
10110673|NCT02488018|11241602|FG000|NOT COMPLETED|Overall Study||0
10110674|NCT02488070|11241606|FG000|STARTED|Overall Study||10
10110675|NCT02488070|11241606|FG000|COMPLETED|Overall Study||10
10110676|NCT02488070|11241606|FG000|NOT COMPLETED|Overall Study||0
10110677|NCT02488109|11241613|FG000|STARTED|Treatment in Hospital||60
10110678|NCT02488109|11241614|FG001|STARTED|Treatment in Hospital||56
10110679|NCT02488109|11241613|FG000|Received Treatment|Treatment in Hospital||60
10110680|NCT02488109|11241614|FG001|Received Treatment|Treatment in Hospital||51
10110681|NCT02488109|11241613|FG000|Included in mITT Analysis|Treatment in Hospital||60
10110682|NCT02488109|11241614|FG001|Included in mITT Analysis|Treatment in Hospital||51
10110683|NCT02488109|11241613|FG000|COMPLETED|Treatment in Hospital||60
10110684|NCT02488109|11241614|FG001|COMPLETED|Treatment in Hospital||51
10110685|NCT02488109|11241613|FG000|NOT COMPLETED|Treatment in Hospital||0
10110686|NCT02488109|11241614|FG001|NOT COMPLETED|Treatment in Hospital||5
10110687|NCT02488109|11241613|FG000|STARTED|12-month Follow-Up||60
10110688|NCT02488109|11241614|FG001|STARTED|12-month Follow-Up||51
10110689|NCT02488109|11241613|FG000|Included in mITT Analysis|12-month Follow-Up||60
10110690|NCT02488109|11241614|FG001|Included in mITT Analysis|12-month Follow-Up||51
10110691|NCT02488109|11241613|FG000|COMPLETED|12-month Follow-Up||56
10110692|NCT02488109|11241614|FG001|COMPLETED|12-month Follow-Up||44
10110693|NCT02488109|11241613|FG000|NOT COMPLETED|12-month Follow-Up||4
10110694|NCT02488109|11241614|FG001|NOT COMPLETED|12-month Follow-Up||7
10110695|NCT02488239|11241622|FG000|STARTED|Overall Study||64
10110696|NCT02488239|11241622|FG000|COMPLETED|Overall Study||54
10110697|NCT02488239|11241622|FG000|NOT COMPLETED|Overall Study||10
10110698|NCT02488317|11241629|FG000|STARTED|Overall Study||117
10110699|NCT02488317|11241630|FG001|STARTED|Overall Study||117
10110700|NCT02488317|11241629|FG000|COMPLETED|Overall Study||63
10110701|NCT02488317|11241630|FG001|COMPLETED|Overall Study||70
10110702|NCT02488317|11241629|FG000|NOT COMPLETED|Overall Study||54
10110703|NCT02488317|11241630|FG001|NOT COMPLETED|Overall Study||47
10110704|NCT02488330|11241640|FG000|STARTED|Overall Study||12
10110705|NCT02488330|11241640|FG000|COMPLETED|Overall Study||0
10110706|NCT02488330|11241640|FG000|NOT COMPLETED|Overall Study||12
10110707|NCT02488681|11241644|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276
10110708|NCT02488681|11241644|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
10110709|NCT02488681|11241644|FG000|NOT COMPLETED|Overall Study||7
10110710|NCT02488824|11241650|FG000|STARTED|Overall Study||21
10110711|NCT02488824|11241651|FG001|STARTED|Overall Study||20
10110712|NCT02488824|11241650|FG000|COMPLETED|Overall Study||20
10110713|NCT02488824|11241651|FG001|COMPLETED|Overall Study||19
10110714|NCT02488824|11241650|FG000|NOT COMPLETED|Overall Study||1
10110715|NCT02488824|11241651|FG001|NOT COMPLETED|Overall Study||1
10110716|NCT02488915|11241657|FG000|STARTED|Overall Study||228
10110717|NCT02488915|11241657|FG000|COMPLETED|Overall Study||202
10110718|NCT02488915|11241657|FG000|NOT COMPLETED|Overall Study||26
10110719|NCT02488980|11241664|FG000|STARTED|Overall Study||104
10110720|NCT02488980|11241665|FG001|STARTED|Overall Study||101
10110721|NCT02488980|11241666|FG002|STARTED|Overall Study||101
10110722|NCT02488980|11241664|FG000|COMPLETED|Overall Study||102
10110723|NCT02488980|11241665|FG001|COMPLETED|Overall Study||99
10110724|NCT02488980|11241666|FG002|COMPLETED|Overall Study||99
10110725|NCT02488980|11241664|FG000|NOT COMPLETED|Overall Study||2
10110726|NCT02488980|11241665|FG001|NOT COMPLETED|Overall Study||2
9902955|NCT01146860|11018791|FG000|NOT COMPLETED|Overall Study||0
9902956|NCT01146860|11018792|FG001|NOT COMPLETED|Overall Study||1
9902957|NCT01146873|11018800|FG000|STARTED|Overall Study||148
9902958|NCT01146873|11018801|FG001|STARTED|Overall Study||150
9902959|NCT01146873|11018800|FG000|COMPLETED|Overall Study||148
9902960|NCT01146873|11018801|FG001|COMPLETED|Overall Study||144
9902961|NCT01146873|11018800|FG000|NOT COMPLETED|Overall Study||0
10110727|NCT02488980|11241666|FG002|NOT COMPLETED|Overall Study||2
10110728|NCT02489045|11241674|FG000|STARTED|Overall Study||178
10110729|NCT02489045|11241674|FG000|COMPLETED|Overall Study||125
10110730|NCT02489045|11241674|FG000|NOT COMPLETED|Overall Study||53
10110731|NCT02489045|11241674|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
10110732|NCT02489045|11241674|FG000|COMPLETED|Follow-up||11
10110733|NCT02489045|11241674|FG000|NOT COMPLETED|Follow-up||10
10110734|NCT02489110|11241680|FG000|STARTED|Overall Study||75
10110735|NCT02489110|11241681|FG001|STARTED|Overall Study||75
10110736|NCT02489110|11241680|FG000|COMPLETED|Overall Study||48
10110737|NCT02489110|11241681|FG001|COMPLETED|Overall Study||50
10110738|NCT02489110|11241680|FG000|NOT COMPLETED|Overall Study||27
10110739|NCT02489110|11241681|FG001|NOT COMPLETED|Overall Study||25
10110740|NCT02489123|11241687|FG000|STARTED|Overall Study||8
10110741|NCT02489123|11241687|FG000|COMPLETED|Overall Study||8
10110742|NCT02489123|11241687|FG000|NOT COMPLETED|Overall Study||0
10110743|NCT02489227|11241694|FG000|STARTED|Overall Study||274
10110744|NCT02489227|11241695|FG001|STARTED|Overall Study||135
10110745|NCT02489227|11241696|FG002|STARTED|Overall Study||136
9902962|NCT01146873|11018801|FG001|NOT COMPLETED|Overall Study||6
9902963|NCT01146912|11018814|FG000|STARTED|Overall Study||4607
9902964|NCT01146912|11018815|FG001|STARTED|Overall Study||4606
9902965|NCT01146912|11018816|FG002|STARTED|Overall Study||593
9902966|NCT01146912|11018817|FG003|STARTED|Overall Study||594
9902967|NCT01146912|11018818|FG004|STARTED|Overall Study||1821
9902968|NCT01146912|11018819|FG005|STARTED|Overall Study||1821
9902969|NCT01146912|11018820|FG006|STARTED|Overall Study||1820
9902970|NCT01146912|11018821|FG007|STARTED|Overall Study||14675
9902971|NCT01146912|11018814|FG000|COMPLETED|Overall Study||3790
9902972|NCT01146912|11018815|FG001|COMPLETED|Overall Study||3784
9902973|NCT01146912|11018816|FG002|COMPLETED|Overall Study||576
9902974|NCT01146912|11018817|FG003|COMPLETED|Overall Study||577
9902975|NCT01146912|11018818|FG004|COMPLETED|Overall Study||1780
9902976|NCT01146912|11018819|FG005|COMPLETED|Overall Study||1760
9902977|NCT01146912|11018820|FG006|COMPLETED|Overall Study||1764
9902978|NCT01146912|11018821|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
9902979|NCT01146912|11018814|FG000|NOT COMPLETED|Overall Study||817
9902980|NCT01146912|11018815|FG001|NOT COMPLETED|Overall Study||822
9902981|NCT01146912|11018816|FG002|NOT COMPLETED|Overall Study||17
9902982|NCT01146912|11018817|FG003|NOT COMPLETED|Overall Study||17
9902983|NCT01146912|11018818|FG004|NOT COMPLETED|Overall Study||41
10110746|NCT02489227|11241694|FG000|COMPLETED|Overall Study||220
10110747|NCT02489227|11241695|FG001|COMPLETED|Overall Study||101
10110748|NCT02489227|11241696|FG002|COMPLETED|Overall Study||117
10110749|NCT02489227|11241694|FG000|NOT COMPLETED|Overall Study||54
10110750|NCT02489227|11241695|FG001|NOT COMPLETED|Overall Study||34
10110751|NCT02489227|11241696|FG002|NOT COMPLETED|Overall Study||19
10110752|NCT02489279|11241708|FG000|STARTED|Overall Study||44
10110753|NCT02489279|11241709|FG001|STARTED|Overall Study||41
10110754|NCT02489279|11241708|FG000|COMPLETED|Overall Study||32
10110755|NCT02489279|11241709|FG001|COMPLETED|Overall Study||31
10110756|NCT02489279|11241708|FG000|NOT COMPLETED|Overall Study||12
10110757|NCT02489279|11241709|FG001|NOT COMPLETED|Overall Study||10
10110758|NCT02489344|11241715|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11
10110759|NCT02489344|11241715|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
10110760|NCT02489344|11241715|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
10110761|NCT02489344|11241715|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8
10110762|NCT02489344|11241715|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5
10110763|NCT02489344|11241715|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
10110764|NCT02489357|11241719|FG000|STARTED|Overall Study||12
10110765|NCT02489357|11241719|FG000|COMPLETED|Overall Study||12
10110766|NCT02489357|11241719|FG000|NOT COMPLETED|Overall Study||0
10110767|NCT02489500|11241725|FG000|STARTED|Overall Study||2
10110768|NCT02489500|11241726|FG001|STARTED|Overall Study||1
10110769|NCT02489500|11241725|FG000|COMPLETED|Overall Study||1
10110770|NCT02489500|11241726|FG001|COMPLETED|Overall Study||0
10110771|NCT02489500|11241725|FG000|NOT COMPLETED|Overall Study||1
10110772|NCT02489500|11241726|FG001|NOT COMPLETED|Overall Study||1
10110773|NCT02489630|11241734|FG000|STARTED|Overall Study||53
10110774|NCT02489630|11241735|FG001|STARTED|Overall Study||63
10110775|NCT02489630|11241734|FG000|COMPLETED|Overall Study||51
10110776|NCT02489630|11241735|FG001|COMPLETED|Overall Study||61
10110777|NCT02489630|11241734|FG000|NOT COMPLETED|Overall Study||2
10110778|NCT02489630|11241735|FG001|NOT COMPLETED|Overall Study||2
10110779|NCT02489734|11241743|FG000|STARTED|Overall Study||56
10110780|NCT02489734|11241744|FG001|STARTED|Overall Study||53
10110781|NCT02489734|11241743|FG000|COMPLETED|Overall Study||39
10110782|NCT02489734|11241744|FG001|COMPLETED|Overall Study||53
10110783|NCT02489734|11241743|FG000|NOT COMPLETED|Overall Study||17
10110784|NCT02489734|11241744|FG001|NOT COMPLETED|Overall Study||0
10110785|NCT02489773|11241752|FG000|STARTED|Overall Study||98
10110786|NCT02489773|11241753|FG001|STARTED|Overall Study||52
10110787|NCT02489773|11241752|FG000|COMPLETED|Overall Study||91
10110788|NCT02489773|11241753|FG001|COMPLETED|Overall Study||50
10110789|NCT02489773|11241752|FG000|NOT COMPLETED|Overall Study||7
10110790|NCT02489773|11241753|FG001|NOT COMPLETED|Overall Study||2
9902984|NCT01146912|11018819|FG005|NOT COMPLETED|Overall Study||61
10110791|NCT02489799|11241761|FG000|STARTED|Overall Study||45
10110792|NCT02489799|11241762|FG001|STARTED|Overall Study||47
10110793|NCT02489799|11241761|FG000|Presurgical Consent Visit (V2)|Overall Study||40
10110794|NCT02489799|11241762|FG001|Presurgical Consent Visit (V2)|Overall Study||39
10110795|NCT02489799|11241761|FG000|Postsurgical One Week Visit (V3)|Overall Study||40
9902985|NCT01146912|11018820|FG006|NOT COMPLETED|Overall Study||56
9902986|NCT01146912|11018821|FG007|NOT COMPLETED|Overall Study||0
9902987|NCT01146951|11018842|FG000|STARTED|Overall Study||29
9902988|NCT01146951|11018843|FG001|STARTED|Overall Study||30
9902989|NCT01146951|11018842|FG000|COMPLETED|Overall Study||25
9902990|NCT01146951|11018843|FG001|COMPLETED|Overall Study||29
10110796|NCT02489799|11241762|FG001|Postsurgical One Week Visit (V3)|Overall Study||39
10110797|NCT02489799|11241761|FG000|COMPLETED|Overall Study||36
10110798|NCT02489799|11241762|FG001|COMPLETED|Overall Study||38
9902991|NCT01146951|11018842|FG000|NOT COMPLETED|Overall Study||4
9902992|NCT01146951|11018843|FG001|NOT COMPLETED|Overall Study||1
9902993|NCT01147055|11018849|FG000|STARTED|First Intervention Period||15
9902994|NCT01147055|11018850|FG001|STARTED|First Intervention Period||0
9902995|NCT01147055|11018849|FG000|COMPLETED|First Intervention Period||14
9902996|NCT01147055|11018850|FG001|COMPLETED|First Intervention Period||0
9902997|NCT01147055|11018849|FG000|NOT COMPLETED|First Intervention Period||1
9902998|NCT01147055|11018850|FG001|NOT COMPLETED|First Intervention Period||0
9902999|NCT01147055|11018849|FG000|STARTED|Washout Period (at Least 14 Days)||14
9903000|NCT01147055|11018850|FG001|STARTED|Washout Period (at Least 14 Days)||0
9903001|NCT01147055|11018849|FG000|COMPLETED|Washout Period (at Least 14 Days)||14
9903002|NCT01147055|11018850|FG001|COMPLETED|Washout Period (at Least 14 Days)||0
9903003|NCT01147055|11018849|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9903004|NCT01147055|11018850|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9903005|NCT01147055|11018849|FG000|STARTED|Second Intervention Period||0
9903006|NCT01147055|11018850|FG001|STARTED|Second Intervention Period||14
9903007|NCT01147055|11018849|FG000|COMPLETED|Second Intervention Period||0
9903008|NCT01147055|11018850|FG001|COMPLETED|Second Intervention Period||14
9903009|NCT01147055|11018849|FG000|NOT COMPLETED|Second Intervention Period||0
9903010|NCT01147055|11018850|FG001|NOT COMPLETED|Second Intervention Period||0
9903011|NCT01147068|11018863|FG000|STARTED|Subjects That Received 1st Dose||60
9903012|NCT01147068|11018864|FG001|STARTED|Subjects That Received 1st Dose||57
9903013|NCT01147068|11018865|FG002|STARTED|Subjects That Received 1st Dose||55
9903014|NCT01147068|11018866|FG003|STARTED|Subjects That Received 1st Dose||56
9903015|NCT01147068|11018867|FG004|STARTED|Subjects That Received 1st Dose||56
9903016|NCT01147068|11018868|FG005|STARTED|Subjects That Received 1st Dose||53
9903017|NCT01147068|11018869|FG006|STARTED|Subjects That Received 1st Dose||55
9903018|NCT01147068|11018863|FG000|COMPLETED|Subjects That Received 1st Dose||60
9903019|NCT01147068|11018864|FG001|COMPLETED|Subjects That Received 1st Dose||57
9903020|NCT01147068|11018865|FG002|COMPLETED|Subjects That Received 1st Dose||55
9903021|NCT01147068|11018866|FG003|COMPLETED|Subjects That Received 1st Dose||56
9903022|NCT01147068|11018867|FG004|COMPLETED|Subjects That Received 1st Dose||56
9903023|NCT01147068|11018868|FG005|COMPLETED|Subjects That Received 1st Dose||53
9903024|NCT01147068|11018869|FG006|COMPLETED|Subjects That Received 1st Dose||55
9903025|NCT01147068|11018863|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0
9903026|NCT01147068|11018864|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0
9903027|NCT01147068|11018865|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0
9903028|NCT01147068|11018866|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0
9903029|NCT01147068|11018867|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0
9903030|NCT01147068|11018868|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0
9903031|NCT01147068|11018869|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0
10009393|NCT01765764|11131952|FG001|COMPLETED|Treatment Period||109
10009394|NCT01765764|11131953|FG002|COMPLETED|Treatment Period||115
10110799|NCT02489799|11241761|FG000|NOT COMPLETED|Overall Study||9
10110800|NCT02489799|11241762|FG001|NOT COMPLETED|Overall Study||9
10110801|NCT02489968|11241770|FG000|STARTED|Open-label Treatment Period||439
10110802|NCT02489968|11241771|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
10110803|NCT02489968|11241772|FG002|STARTED|Open-label Treatment Period||0
10110804|NCT02489968|11241773|FG003|STARTED|Open-label Treatment Period||0
10110805|NCT02489968|11241774|FG004|STARTED|Open-label Treatment Period||0
10110806|NCT02489968|11241775|FG005|STARTED|Open-label Treatment Period||0
10110807|NCT02489968|11241770|FG000|COMPLETED|Open-label Treatment Period||215
10110808|NCT02489968|11241771|FG001|COMPLETED|Open-label Treatment Period||232
10110809|NCT02489968|11241772|FG002|COMPLETED|Open-label Treatment Period||0
10110810|NCT02489968|11241773|FG003|COMPLETED|Open-label Treatment Period||0
10110811|NCT02489968|11241774|FG004|COMPLETED|Open-label Treatment Period||0
10110812|NCT02489968|11241775|FG005|COMPLETED|Open-label Treatment Period||0
10110813|NCT02489968|11241770|FG000|NOT COMPLETED|Open-label Treatment Period||224
10110814|NCT02489968|11241771|FG001|NOT COMPLETED|Open-label Treatment Period||208
10110815|NCT02489968|11241772|FG002|NOT COMPLETED|Open-label Treatment Period||0
10110816|NCT02489968|11241773|FG003|NOT COMPLETED|Open-label Treatment Period||0
10110817|NCT02489968|11241774|FG004|NOT COMPLETED|Open-label Treatment Period||0
9903032|NCT01147068|11018863|FG000|STARTED|Subjects That Received 2nd Dose||60
9903033|NCT01147068|11018864|FG001|STARTED|Subjects That Received 2nd Dose||57
9903034|NCT01147068|11018865|FG002|STARTED|Subjects That Received 2nd Dose||55
9903035|NCT01147068|11018866|FG003|STARTED|Subjects That Received 2nd Dose||56
9903036|NCT01147068|11018867|FG004|STARTED|Subjects That Received 2nd Dose||56
10009395|NCT01765764|11131951|FG000|NOT COMPLETED|Treatment Period||3
10009396|NCT01765764|11131952|FG001|NOT COMPLETED|Treatment Period||9
10009397|NCT01765764|11131953|FG002|NOT COMPLETED|Treatment Period||6
10009398|NCT01765764|11131951|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
10009399|NCT01765764|11131952|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
10019002|NCT01826981|11142059|FG008|COMPLETED|Overall Study||13
10110818|NCT02489968|11241775|FG005|NOT COMPLETED|Open-label Treatment Period||0
10110819|NCT02489968|11241770|FG000|STARTED|Double-blind Treatment Period||0
10110820|NCT02489968|11241771|FG001|STARTED|Double-blind Treatment Period||0
10110821|NCT02489968|11241772|FG002|STARTED|Double-blind Treatment Period||107
10110822|NCT02489968|11241773|FG003|STARTED|Double-blind Treatment Period||108
9903037|NCT01147068|11018868|FG005|STARTED|Subjects That Received 2nd Dose||53
9903038|NCT01147068|11018869|FG006|STARTED|Subjects That Received 2nd Dose||55
9903039|NCT01147068|11018863|FG000|COMPLETED|Subjects That Received 2nd Dose||59
9903040|NCT01147068|11018864|FG001|COMPLETED|Subjects That Received 2nd Dose||52
9903041|NCT01147068|11018865|FG002|COMPLETED|Subjects That Received 2nd Dose||52
9903042|NCT01147068|11018866|FG003|COMPLETED|Subjects That Received 2nd Dose||56
9903043|NCT01147068|11018867|FG004|COMPLETED|Subjects That Received 2nd Dose||55
9903044|NCT01147068|11018868|FG005|COMPLETED|Subjects That Received 2nd Dose||51
9903045|NCT01147068|11018869|FG006|COMPLETED|Subjects That Received 2nd Dose||55
9903046|NCT01147068|11018863|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1
9903047|NCT01147068|11018864|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5
9903048|NCT01147068|11018865|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3
9903049|NCT01147068|11018866|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0
9903050|NCT01147068|11018867|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1
9903051|NCT01147068|11018868|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2
9903052|NCT01147068|11018869|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0
9903053|NCT01147068|11018863|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
9903054|NCT01147068|11018864|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
9903055|NCT01147068|11018865|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
9903056|NCT01147068|11018866|FG003|STARTED|Subjects That Completed Safety Follow-up||56
9903057|NCT01147068|11018867|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
9903058|NCT01147068|11018868|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
9903059|NCT01147068|11018869|FG006|STARTED|Subjects That Completed Safety Follow-up||55
9903060|NCT01147068|11018863|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59
9903061|NCT01147068|11018864|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56
9903062|NCT01147068|11018865|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55
9903063|NCT01147068|11018866|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54
9903064|NCT01147068|11018867|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56
9903065|NCT01147068|11018868|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52
9903066|NCT01147068|11018869|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54
9903067|NCT01147068|11018863|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
9903068|NCT01147068|11018864|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
9903069|NCT01147068|11018865|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
9903070|NCT01147068|11018866|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
9903071|NCT01147068|11018867|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
9903072|NCT01147068|11018868|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
9903073|NCT01147068|11018869|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
9903074|NCT01147107|11018887|FG000|STARTED|Overall Study||39
9903075|NCT01147107|11018888|FG001|STARTED|Overall Study||41
9903076|NCT01147107|11018887|FG000|COMPLETED|Overall Study||33
9903077|NCT01147107|11018888|FG001|COMPLETED|Overall Study||40
9903078|NCT01147107|11018887|FG000|NOT COMPLETED|Overall Study||6
9903079|NCT01147107|11018888|FG001|NOT COMPLETED|Overall Study||1
9903080|NCT01147172|11018894|FG000|STARTED|Overall Study||100
9903081|NCT01147172|11018894|FG000|COMPLETED|Overall Study||96
9903082|NCT01147172|11018894|FG000|NOT COMPLETED|Overall Study||4
9903083|NCT01147250|11018902|FG000|STARTED|Overall Study||3034
9903084|NCT01147250|11018903|FG001|STARTED|Overall Study||3034
9903085|NCT01147250|11018902|FG000|Treated|Overall Study||3032
9903086|NCT01147250|11018903|FG001|Treated|Overall Study||3031
9903087|NCT01147250|11018902|FG000|COMPLETED|Overall Study||2924
9903088|NCT01147250|11018903|FG001|COMPLETED|Overall Study||2929
9903089|NCT01147250|11018902|FG000|NOT COMPLETED|Overall Study||110
9903090|NCT01147250|11018903|FG001|NOT COMPLETED|Overall Study||105
9903091|NCT01147302|11018911|FG000|STARTED|Overall Study||9
9903092|NCT01147302|11018912|FG001|STARTED|Overall Study||9
9903093|NCT01147302|11018911|FG000|COMPLETED|Overall Study||9
9903094|NCT01147302|11018912|FG001|COMPLETED|Overall Study||9
9903095|NCT01147302|11018911|FG000|NOT COMPLETED|Overall Study||0
9903096|NCT01147302|11018912|FG001|NOT COMPLETED|Overall Study||0
9903097|NCT01147341|11018920|FG000|STARTED|Double Blind Period||27
9903098|NCT01147341|11018921|FG001|STARTED|Double Blind Period||10
9903099|NCT01147341|11018920|FG000|COMPLETED|Double Blind Period||26
9903100|NCT01147341|11018921|FG001|COMPLETED|Double Blind Period||8
9903101|NCT01147341|11018920|FG000|NOT COMPLETED|Double Blind Period||1
9903102|NCT01147341|11018921|FG001|NOT COMPLETED|Double Blind Period||2
9903103|NCT01147341|11018920|FG000|STARTED|Open Label Period||26
9903104|NCT01147341|11018921|FG001|STARTED|Open Label Period||8
9903105|NCT01147341|11018920|FG000|COMPLETED|Open Label Period||22
9903106|NCT01147341|11018921|FG001|COMPLETED|Open Label Period||8
9903107|NCT01147341|11018920|FG000|NOT COMPLETED|Open Label Period||4
9903108|NCT01147341|11018921|FG001|NOT COMPLETED|Open Label Period||0
9955134|NCT01436162|11074015|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
9955135|NCT01436162|11074016|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
9957008|NCT01448824|11076145|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9903109|NCT01147380|11018929|FG000|STARTED|Overall Study||6
9903110|NCT01147380|11018930|FG001|STARTED|Overall Study||12
9903111|NCT01147380|11018929|FG000|COMPLETED|Overall Study||6
9903112|NCT01147380|11018930|FG001|COMPLETED|Overall Study||12
9903113|NCT01147380|11018929|FG000|NOT COMPLETED|Overall Study||0
9903114|NCT01147380|11018930|FG001|NOT COMPLETED|Overall Study||0
9903115|NCT01147406|11018944|FG000|STARTED|Overall Study||6
9903116|NCT01147406|11018945|FG001|STARTED|Overall Study||12
9903117|NCT01147406|11018946|FG002|STARTED|Overall Study||1
9903118|NCT01147406|11018947|FG003|STARTED|Overall Study||6
9903119|NCT01147406|11018948|FG004|STARTED|Overall Study||6
9903120|NCT01147406|11018949|FG005|STARTED|Overall Study||10
9903121|NCT01147406|11018944|FG000|COMPLETED|Overall Study||6
9903122|NCT01147406|11018945|FG001|COMPLETED|Overall Study||12
9903123|NCT01147406|11018946|FG002|COMPLETED|Overall Study||1
9903124|NCT01147406|11018947|FG003|COMPLETED|Overall Study||6
9903125|NCT01147406|11018948|FG004|COMPLETED|Overall Study||6
9903126|NCT01147406|11018949|FG005|COMPLETED|Overall Study||10
9903127|NCT01147406|11018944|FG000|NOT COMPLETED|Overall Study||0
9903128|NCT01147406|11018945|FG001|NOT COMPLETED|Overall Study||0
9903129|NCT01147406|11018946|FG002|NOT COMPLETED|Overall Study||0
9903130|NCT01147406|11018947|FG003|NOT COMPLETED|Overall Study||0
9903131|NCT01147406|11018948|FG004|NOT COMPLETED|Overall Study||0
9903132|NCT01147406|11018949|FG005|NOT COMPLETED|Overall Study||0
9903133|NCT01147458|11018964|FG000|STARTED|First Intervention||48
9903134|NCT01147458|11018965|FG001|STARTED|First Intervention||47
9903135|NCT01147458|11018966|FG002|STARTED|First Intervention||47
9903136|NCT01147458|11018967|FG003|STARTED|First Intervention||48
9903137|NCT01147458|11018964|FG000|COMPLETED|First Intervention||34
9903138|NCT01147458|11018965|FG001|COMPLETED|First Intervention||31
9903139|NCT01147458|11018966|FG002|COMPLETED|First Intervention||35
9903140|NCT01147458|11018967|FG003|COMPLETED|First Intervention||34
9903141|NCT01147458|11018964|FG000|NOT COMPLETED|First Intervention||14
9903142|NCT01147458|11018965|FG001|NOT COMPLETED|First Intervention||16
9903143|NCT01147458|11018966|FG002|NOT COMPLETED|First Intervention||12
9903144|NCT01147458|11018967|FG003|NOT COMPLETED|First Intervention||14
9903145|NCT01147458|11018964|FG000|STARTED|Washout Period of 2 Weeks||34
9903146|NCT01147458|11018965|FG001|STARTED|Washout Period of 2 Weeks||31
9903147|NCT01147458|11018966|FG002|STARTED|Washout Period of 2 Weeks||35
9903148|NCT01147458|11018967|FG003|STARTED|Washout Period of 2 Weeks||34
9903149|NCT01147458|11018964|FG000|COMPLETED|Washout Period of 2 Weeks||34
9903150|NCT01147458|11018965|FG001|COMPLETED|Washout Period of 2 Weeks||31
9903151|NCT01147458|11018966|FG002|COMPLETED|Washout Period of 2 Weeks||35
9903152|NCT01147458|11018967|FG003|COMPLETED|Washout Period of 2 Weeks||34
9903153|NCT01147458|11018964|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9903154|NCT01147458|11018965|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9903155|NCT01147458|11018966|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
9903156|NCT01147458|11018967|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
9903157|NCT01147458|11018964|FG000|STARTED|Second Intervention||34
9903158|NCT01147458|11018965|FG001|STARTED|Second Intervention||31
9903159|NCT01147458|11018966|FG002|STARTED|Second Intervention||35
9903160|NCT01147458|11018967|FG003|STARTED|Second Intervention||34
9903161|NCT01147458|11018964|FG000|COMPLETED|Second Intervention||25
9903162|NCT01147458|11018965|FG001|COMPLETED|Second Intervention||24
9903163|NCT01147458|11018966|FG002|COMPLETED|Second Intervention||27
9903164|NCT01147458|11018967|FG003|COMPLETED|Second Intervention||30
9903165|NCT01147458|11018964|FG000|NOT COMPLETED|Second Intervention||9
9903166|NCT01147458|11018965|FG001|NOT COMPLETED|Second Intervention||7
9903167|NCT01147458|11018966|FG002|NOT COMPLETED|Second Intervention||8
9903168|NCT01147458|11018967|FG003|NOT COMPLETED|Second Intervention||4
9903169|NCT01147471|11018981|FG000|STARTED|Through Initial Hospital Discharge||13
9903170|NCT01147471|11018982|FG001|STARTED|Through Initial Hospital Discharge||11
9903171|NCT01147471|11018981|FG000|COMPLETED|Through Initial Hospital Discharge||13
9903172|NCT01147471|11018982|FG001|COMPLETED|Through Initial Hospital Discharge||11
9903173|NCT01147471|11018981|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0
9903174|NCT01147471|11018982|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0
9903175|NCT01147471|11018981|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
9903176|NCT01147471|11018982|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
9903177|NCT01147471|11018981|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
9903178|NCT01147471|11018982|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
9903179|NCT01147471|11018981|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
9903180|NCT01147471|11018982|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
9903181|NCT01147471|11018981|FG000|STARTED|3 Month Follow Up||13
9903182|NCT01147471|11018982|FG001|STARTED|3 Month Follow Up||8
9903183|NCT01147471|11018981|FG000|COMPLETED|3 Month Follow Up||12
9903184|NCT01147471|11018982|FG001|COMPLETED|3 Month Follow Up||6
9903185|NCT01147471|11018981|FG000|NOT COMPLETED|3 Month Follow Up||1
9903186|NCT01147471|11018982|FG001|NOT COMPLETED|3 Month Follow Up||2
9903187|NCT01147471|11018981|FG000|STARTED|6 Month Follow Up||12
9903188|NCT01147471|11018982|FG001|STARTED|6 Month Follow Up||6
9903189|NCT01147471|11018981|FG000|COMPLETED|6 Month Follow Up||8
9903190|NCT01147471|11018982|FG001|COMPLETED|6 Month Follow Up||4
9903191|NCT01147471|11018981|FG000|NOT COMPLETED|6 Month Follow Up||4
9903192|NCT01147471|11018982|FG001|NOT COMPLETED|6 Month Follow Up||2
9903193|NCT01147497|11018990|FG000|STARTED|Overall Study||37
9903194|NCT01147497|11018991|FG001|STARTED|Overall Study||36
9903195|NCT01147497|11018990|FG000|COMPLETED|Overall Study||35
9903196|NCT01147497|11018991|FG001|COMPLETED|Overall Study||36
9903197|NCT01147497|11018990|FG000|NOT COMPLETED|Overall Study||2
9903198|NCT01147497|11018991|FG001|NOT COMPLETED|Overall Study||0
9903199|NCT01147601|11018999|FG000|STARTED|Overall Study||5
9903200|NCT01147601|11019000|FG001|STARTED|Overall Study||1
9903201|NCT01147601|11018999|FG000|COMPLETED|Overall Study||2
9903202|NCT01147601|11019000|FG001|COMPLETED|Overall Study||1
9903203|NCT01147601|11018999|FG000|NOT COMPLETED|Overall Study||3
9903204|NCT01147601|11019000|FG001|NOT COMPLETED|Overall Study||0
9903205|NCT01147627|11019009|FG000|STARTED|Overall Study||142
9903206|NCT01147627|11019010|FG001|STARTED|Overall Study||138
9903207|NCT01147627|11019011|FG002|STARTED|Overall Study||136
9903208|NCT01147627|11019009|FG000|COMPLETED|Overall Study||110
9903209|NCT01147627|11019010|FG001|COMPLETED|Overall Study||114
9903210|NCT01147627|11019011|FG002|COMPLETED|Overall Study||118
9903211|NCT01147627|11019009|FG000|NOT COMPLETED|Overall Study||32
9903212|NCT01147627|11019010|FG001|NOT COMPLETED|Overall Study||24
9903213|NCT01147627|11019011|FG002|NOT COMPLETED|Overall Study||18
9903214|NCT01147640|11019021|FG000|STARTED|Overall Study||83
9903215|NCT01147640|11019022|FG001|STARTED|Overall Study||39
10110823|NCT02489968|11241774|FG004|STARTED|Double-blind Treatment Period||116
10110824|NCT02489968|11241775|FG005|STARTED|Double-blind Treatment Period||116
10110825|NCT02489968|11241770|FG000|COMPLETED|Double-blind Treatment Period||0
10110826|NCT02489968|11241771|FG001|COMPLETED|Double-blind Treatment Period||0
10110827|NCT02489968|11241772|FG002|COMPLETED|Double-blind Treatment Period||105
10110828|NCT02489968|11241773|FG003|COMPLETED|Double-blind Treatment Period||100
10110829|NCT02489968|11241774|FG004|COMPLETED|Double-blind Treatment Period||110
10110830|NCT02489968|11241775|FG005|COMPLETED|Double-blind Treatment Period||108
10110831|NCT02489968|11241770|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10110832|NCT02489968|11241771|FG001|NOT COMPLETED|Double-blind Treatment Period||0
10110833|NCT02489968|11241772|FG002|NOT COMPLETED|Double-blind Treatment Period||2
10110834|NCT02489968|11241773|FG003|NOT COMPLETED|Double-blind Treatment Period||8
10110835|NCT02489968|11241774|FG004|NOT COMPLETED|Double-blind Treatment Period||6
10110836|NCT02489968|11241775|FG005|NOT COMPLETED|Double-blind Treatment Period||8
10110837|NCT02489981|11241787|FG000|STARTED|Overall Study||340
10110838|NCT02489981|11241787|FG000|COMPLETED|Overall Study||213
10110839|NCT02489981|11241787|FG000|NOT COMPLETED|Overall Study||127
10110840|NCT02490293|11241793|FG000|STARTED|Overall Study||96
10110841|NCT02490293|11241794|FG001|STARTED|Overall Study||102
10110842|NCT02490293|11241793|FG000|COMPLETED|Overall Study||94
10110843|NCT02490293|11241794|FG001|COMPLETED|Overall Study||99
10110844|NCT02490293|11241793|FG000|NOT COMPLETED|Overall Study||2
10110845|NCT02490293|11241794|FG001|NOT COMPLETED|Overall Study||3
10110846|NCT02490371|11241802|FG000|STARTED|Overall Study||12
10110847|NCT02490371|11241803|FG001|STARTED|Overall Study||12
10110848|NCT02490371|11241802|FG000|COMPLETED|Overall Study||11
10110849|NCT02490371|11241803|FG001|COMPLETED|Overall Study||11
10110850|NCT02490371|11241802|FG000|NOT COMPLETED|Overall Study||1
10110851|NCT02490371|11241803|FG001|NOT COMPLETED|Overall Study||1
10110852|NCT02490475|11241813|FG000|STARTED|Period 1: First 6 Cycles||6
10110853|NCT02490475|11241814|FG001|STARTED|Period 1: First 6 Cycles||2
10110854|NCT02490475|11241815|FG002|STARTED|Period 1: First 6 Cycles||6
10110855|NCT02490475|11241816|FG003|STARTED|Period 1: First 6 Cycles||5
10110856|NCT02490475|11241813|FG000|COMPLETED|Period 1: First 6 Cycles||0
10110857|NCT02490475|11241814|FG001|COMPLETED|Period 1: First 6 Cycles||0
10110858|NCT02490475|11241815|FG002|COMPLETED|Period 1: First 6 Cycles||0
10110859|NCT02490475|11241816|FG003|COMPLETED|Period 1: First 6 Cycles||0
10110860|NCT02490475|11241813|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6
10110861|NCT02490475|11241814|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2
10110862|NCT02490475|11241815|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6
10110863|NCT02490475|11241816|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5
10110864|NCT02490475|11241813|FG000|STARTED|Period 2: Extension Phase||1
10110865|NCT02490475|11241814|FG001|STARTED|Period 2: Extension Phase||0
10110866|NCT02490475|11241815|FG002|STARTED|Period 2: Extension Phase||3
10110867|NCT02490475|11241816|FG003|STARTED|Period 2: Extension Phase||1
10110868|NCT02490475|11241813|FG000|COMPLETED|Period 2: Extension Phase||0
10110869|NCT02490475|11241814|FG001|COMPLETED|Period 2: Extension Phase||0
10110870|NCT02490475|11241815|FG002|COMPLETED|Period 2: Extension Phase||0
9903216|NCT01147640|11019021|FG000|COMPLETED|Overall Study||78
9903217|NCT01147640|11019022|FG001|COMPLETED|Overall Study||38
9903218|NCT01147640|11019021|FG000|NOT COMPLETED|Overall Study||5
9903219|NCT01147640|11019022|FG001|NOT COMPLETED|Overall Study||1
9903220|NCT01147744|11019035|FG000|STARTED|Overall Study||100
10110871|NCT02490475|11241816|FG003|COMPLETED|Period 2: Extension Phase||0
10110872|NCT02490475|11241813|FG000|NOT COMPLETED|Period 2: Extension Phase||1
10110873|NCT02490475|11241814|FG001|NOT COMPLETED|Period 2: Extension Phase||0
10110874|NCT02490475|11241815|FG002|NOT COMPLETED|Period 2: Extension Phase||3
10110875|NCT02490475|11241816|FG003|NOT COMPLETED|Period 2: Extension Phase||1
10110876|NCT02490631|11241839|FG000|STARTED|Overall Study||79
10110877|NCT02490631|11241840|FG001|STARTED|Overall Study||78
10110878|NCT02490631|11241839|FG000|COMPLETED|Overall Study||76
10110879|NCT02490631|11241840|FG001|COMPLETED|Overall Study||75
10110880|NCT02490631|11241839|FG000|NOT COMPLETED|Overall Study||3
10110881|NCT02490631|11241840|FG001|NOT COMPLETED|Overall Study||3
10110882|NCT02490670|11241848|FG000|STARTED|Period 1 (19 Days)||14
10110883|NCT02490670|11241849|FG001|STARTED|Period 1 (19 Days)||14
10110884|NCT02490670|11241848|FG000|COMPLETED|Period 1 (19 Days)||14
10110885|NCT02490670|11241849|FG001|COMPLETED|Period 1 (19 Days)||14
9903221|NCT01147744|11019036|FG001|STARTED|Overall Study||99
9903222|NCT01147744|11019037|FG002|STARTED|Overall Study||100
9903223|NCT01147744|11019038|FG003|STARTED|Overall Study||100
9903224|NCT01147744|11019039|FG004|STARTED|Overall Study||101
9903225|NCT01147744|11019040|FG005|STARTED|Overall Study||103
9903226|NCT01147744|11019041|FG006|STARTED|Overall Study||97
9903227|NCT01147744|11019035|FG000|COMPLETED|Overall Study||71
9903228|NCT01147744|11019036|FG001|COMPLETED|Overall Study||76
9903229|NCT01147744|11019037|FG002|COMPLETED|Overall Study||82
9903230|NCT01147744|11019038|FG003|COMPLETED|Overall Study||82
9903231|NCT01147744|11019039|FG004|COMPLETED|Overall Study||76
9903232|NCT01147744|11019040|FG005|COMPLETED|Overall Study||83
9903233|NCT01147744|11019041|FG006|COMPLETED|Overall Study||78
9903234|NCT01147744|11019035|FG000|NOT COMPLETED|Overall Study||29
9903235|NCT01147744|11019036|FG001|NOT COMPLETED|Overall Study||23
9903236|NCT01147744|11019037|FG002|NOT COMPLETED|Overall Study||18
9903237|NCT01147744|11019038|FG003|NOT COMPLETED|Overall Study||18
9903238|NCT01147744|11019039|FG004|NOT COMPLETED|Overall Study||25
9903239|NCT01147744|11019040|FG005|NOT COMPLETED|Overall Study||20
9903240|NCT01147744|11019041|FG006|NOT COMPLETED|Overall Study||19
9903241|NCT01147809|11019069|FG000|STARTED|Phase I (168 Days)||3
9903242|NCT01147809|11019070|FG001|STARTED|Phase I (168 Days)||9
9903243|NCT01147809|11019071|FG002|STARTED|Phase I (168 Days)||4
9903244|NCT01147809|11019072|FG003|STARTED|Phase I (168 Days)||10
9903245|NCT01147809|11019073|FG004|STARTED|Phase I (168 Days)||0
9903246|NCT01147809|11019074|FG005|STARTED|Phase I (168 Days)||0
9903247|NCT01147809|11019069|FG000|COMPLETED|Phase I (168 Days)||2
9903248|NCT01147809|11019070|FG001|COMPLETED|Phase I (168 Days)||8
9903249|NCT01147809|11019071|FG002|COMPLETED|Phase I (168 Days)||2
9903250|NCT01147809|11019072|FG003|COMPLETED|Phase I (168 Days)||5
9903251|NCT01147809|11019073|FG004|COMPLETED|Phase I (168 Days)||0
9903252|NCT01147809|11019074|FG005|COMPLETED|Phase I (168 Days)||0
9903253|NCT01147809|11019069|FG000|NOT COMPLETED|Phase I (168 Days)||1
9903254|NCT01147809|11019070|FG001|NOT COMPLETED|Phase I (168 Days)||1
9903255|NCT01147809|11019071|FG002|NOT COMPLETED|Phase I (168 Days)||2
9903256|NCT01147809|11019072|FG003|NOT COMPLETED|Phase I (168 Days)||5
9903257|NCT01147809|11019073|FG004|NOT COMPLETED|Phase I (168 Days)||0
9903258|NCT01147809|11019074|FG005|NOT COMPLETED|Phase I (168 Days)||0
9903259|NCT01147809|11019069|FG000|STARTED|Phase II (168 Days)||0
9903260|NCT01147809|11019070|FG001|STARTED|Phase II (168 Days)||0
9903261|NCT01147809|11019071|FG002|STARTED|Phase II (168 Days)||0
9903262|NCT01147809|11019072|FG003|STARTED|Phase II (168 Days)||0
9903263|NCT01147809|11019073|FG004|STARTED|Phase II (168 Days)||23
9903264|NCT01147809|11019074|FG005|STARTED|Phase II (168 Days)||52
9903265|NCT01147809|11019069|FG000|Ongoing|Phase II (168 Days)||0
9903266|NCT01147809|11019070|FG001|Ongoing|Phase II (168 Days)||0
9903267|NCT01147809|11019071|FG002|Ongoing|Phase II (168 Days)||0
9903268|NCT01147809|11019072|FG003|Ongoing|Phase II (168 Days)||0
9903269|NCT01147809|11019073|FG004|Ongoing|Phase II (168 Days)||1
9903270|NCT01147809|11019074|FG005|Ongoing|Phase II (168 Days)||0
9903271|NCT01147809|11019069|FG000|COMPLETED|Phase II (168 Days)||0
9903272|NCT01147809|11019070|FG001|COMPLETED|Phase II (168 Days)||0
9903273|NCT01147809|11019071|FG002|COMPLETED|Phase II (168 Days)||0
9903274|NCT01147809|11019072|FG003|COMPLETED|Phase II (168 Days)||0
9903275|NCT01147809|11019073|FG004|COMPLETED|Phase II (168 Days)||7
9903276|NCT01147809|11019074|FG005|COMPLETED|Phase II (168 Days)||19
9903277|NCT01147809|11019069|FG000|NOT COMPLETED|Phase II (168 Days)||0
9903278|NCT01147809|11019070|FG001|NOT COMPLETED|Phase II (168 Days)||0
9903279|NCT01147809|11019071|FG002|NOT COMPLETED|Phase II (168 Days)||0
9903280|NCT01147809|11019072|FG003|NOT COMPLETED|Phase II (168 Days)||0
9903281|NCT01147809|11019073|FG004|NOT COMPLETED|Phase II (168 Days)||16
9903282|NCT01147809|11019074|FG005|NOT COMPLETED|Phase II (168 Days)||33
9903283|NCT01147848|11019091|FG000|STARTED|Run-in Period||1564
9903284|NCT01147848|11019092|FG001|STARTED|Run-in Period||0
9903285|NCT01147848|11019093|FG002|STARTED|Run-in Period||0
9903286|NCT01147848|11019091|FG000|COMPLETED|Run-in Period||806
9903287|NCT01147848|11019092|FG001|COMPLETED|Run-in Period||0
9903288|NCT01147848|11019093|FG002|COMPLETED|Run-in Period||0
9903289|NCT01147848|11019091|FG000|NOT COMPLETED|Run-in Period||758
9903290|NCT01147848|11019092|FG001|NOT COMPLETED|Run-in Period||0
9903291|NCT01147848|11019093|FG002|NOT COMPLETED|Run-in Period||0
9903292|NCT01147848|11019091|FG000|STARTED|Randomized Phase||0
9903293|NCT01147848|11019092|FG001|STARTED|Randomized Phase||403
9903294|NCT01147848|11019093|FG002|STARTED|Randomized Phase||403
9903295|NCT01147848|11019091|FG000|COMPLETED|Randomized Phase||0
9903296|NCT01147848|11019092|FG001|COMPLETED|Randomized Phase||358
9903297|NCT01147848|11019093|FG002|COMPLETED|Randomized Phase||357
9903298|NCT01147848|11019091|FG000|NOT COMPLETED|Randomized Phase||0
9903299|NCT01147848|11019092|FG001|NOT COMPLETED|Randomized Phase||45
9903300|NCT01147848|11019093|FG002|NOT COMPLETED|Randomized Phase||46
9903301|NCT01147874|11019100|FG000|STARTED|Overall Study||1013
9903302|NCT01147874|11019100|FG000|COMPLETED|Overall Study||946
9903303|NCT01147874|11019100|FG000|NOT COMPLETED|Overall Study||67
9903304|NCT01147900|11019107|FG000|STARTED|At Year 8.5||54
9903305|NCT01147900|11019108|FG001|STARTED|At Year 8.5||60
9903306|NCT01147900|11019109|FG002|STARTED|At Year 8.5||66
9903307|NCT01147900|11019107|FG000|COMPLETED|At Year 8.5||54
9903308|NCT01147900|11019108|FG001|COMPLETED|At Year 8.5||60
9903309|NCT01147900|11019109|FG002|COMPLETED|At Year 8.5||66
9903310|NCT01147900|11019107|FG000|NOT COMPLETED|At Year 8.5||0
9903311|NCT01147900|11019108|FG001|NOT COMPLETED|At Year 8.5||0
9903312|NCT01147900|11019109|FG002|NOT COMPLETED|At Year 8.5||0
9903313|NCT01147900|11019107|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
9903314|NCT01147900|11019108|FG001|STARTED|At Year 10||60
9903315|NCT01147900|11019109|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
9903316|NCT01147900|11019107|FG000|COMPLETED|At Year 10||55
9903317|NCT01147900|11019108|FG001|COMPLETED|At Year 10||59
9903318|NCT01147900|11019109|FG002|COMPLETED|At Year 10||62
9903319|NCT01147900|11019107|FG000|NOT COMPLETED|At Year 10||0
9903320|NCT01147900|11019108|FG001|NOT COMPLETED|At Year 10||1
9903321|NCT01147900|11019109|FG002|NOT COMPLETED|At Year 10||0
9903322|NCT01147926|11019119|FG000|STARTED|Overall Study||187
9903323|NCT01147926|11019120|FG001|STARTED|Overall Study||187
9903324|NCT01147926|11019119|FG000|COMPLETED|Overall Study||160
9903325|NCT01147926|11019120|FG001|COMPLETED|Overall Study||158
9903326|NCT01147926|11019119|FG000|NOT COMPLETED|Overall Study||27
9903327|NCT01147926|11019120|FG001|NOT COMPLETED|Overall Study||29
9903328|NCT01148017|11019130|FG000|STARTED|Overall Study||214
9903329|NCT01148017|11019131|FG001|STARTED|Overall Study||121
9903330|NCT01148017|11019132|FG002|STARTED|Overall Study||53
9903331|NCT01148017|11019133|FG003|STARTED|Overall Study||45
9903332|NCT01148017|11019130|FG000|COMPLETED|Overall Study||134
9903333|NCT01148017|11019131|FG001|COMPLETED|Overall Study||87
9903334|NCT01148017|11019132|FG002|COMPLETED|Overall Study||53
9903335|NCT01148017|11019133|FG003|COMPLETED|Overall Study||45
9903336|NCT01148017|11019130|FG000|NOT COMPLETED|Overall Study||80
9903337|NCT01148017|11019131|FG001|NOT COMPLETED|Overall Study||34
9903338|NCT01148017|11019132|FG002|NOT COMPLETED|Overall Study||0
9903339|NCT01148017|11019133|FG003|NOT COMPLETED|Overall Study||0
9903340|NCT01148225|11019144|FG000|STARTED|Overall Study||424
9903341|NCT01148225|11019144|FG000|COMPLETED|Overall Study||239
9903342|NCT01148225|11019144|FG000|NOT COMPLETED|Overall Study||185
9903343|NCT01148420|11019151|FG000|STARTED|Overall Study||48
9903344|NCT01148420|11019151|FG000|COMPLETED|Overall Study||48
9903345|NCT01148420|11019151|FG000|NOT COMPLETED|Overall Study||0
9903346|NCT01148459|11019158|FG000|STARTED|Overall Study||99
9903347|NCT01148459|11019159|FG001|STARTED|Overall Study||101
9903348|NCT01148459|11019158|FG000|COMPLETED|Overall Study||87
10110886|NCT02490670|11241848|FG000|NOT COMPLETED|Period 1 (19 Days)||0
10110887|NCT02490670|11241849|FG001|NOT COMPLETED|Period 1 (19 Days)||0
10110888|NCT02490670|11241848|FG000|STARTED|Washout Period (7 Days)||14
10110889|NCT02490670|11241849|FG001|STARTED|Washout Period (7 Days)||14
10110890|NCT02490670|11241848|FG000|COMPLETED|Washout Period (7 Days)||14
10110891|NCT02490670|11241849|FG001|COMPLETED|Washout Period (7 Days)||14
10110892|NCT02490670|11241848|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10110893|NCT02490670|11241849|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10110894|NCT02490670|11241848|FG000|STARTED|Period 2 (19 Days)||14
10110895|NCT02490670|11241849|FG001|STARTED|Period 2 (19 Days)||14
10110896|NCT02490670|11241848|FG000|COMPLETED|Period 2 (19 Days)||14
10110897|NCT02490670|11241849|FG001|COMPLETED|Period 2 (19 Days)||14
10110898|NCT02490670|11241848|FG000|NOT COMPLETED|Period 2 (19 Days)||0
10110899|NCT02490670|11241849|FG001|NOT COMPLETED|Period 2 (19 Days)||0
10110900|NCT02490878|11241857|FG000|STARTED|Overall Study||10
10110901|NCT02490878|11241858|FG001|STARTED|Overall Study||9
10110902|NCT02490878|11241857|FG000|Eligible Participants|Overall Study||10
10110903|NCT02490878|11241858|FG001|Eligible Participants|Overall Study||8
10110904|NCT02490878|11241857|FG000|COMPLETED|Overall Study||10
10110905|NCT02490878|11241858|FG001|COMPLETED|Overall Study||6
10110906|NCT02490878|11241857|FG000|NOT COMPLETED|Overall Study||0
10110907|NCT02490878|11241858|FG001|NOT COMPLETED|Overall Study||3
10110908|NCT02491073|11241866|FG000|STARTED|Overall Study||37
10110909|NCT02491073|11241867|FG001|STARTED|Overall Study||34
10110910|NCT02491073|11241866|FG000|COMPLETED|Overall Study||36
10110911|NCT02491073|11241867|FG001|COMPLETED|Overall Study||34
10110912|NCT02491073|11241866|FG000|NOT COMPLETED|Overall Study||1
10110913|NCT02491073|11241867|FG001|NOT COMPLETED|Overall Study||0
10110914|NCT02491359|11241889|FG000|STARTED|Overall Study||20
10110915|NCT02491359|11241889|FG000|COMPLETED|Overall Study||4
10110916|NCT02491359|11241889|FG000|NOT COMPLETED|Overall Study||16
10110917|NCT02491437|11241897|FG000|STARTED|Overall Study||520
10110918|NCT02491437|11241898|FG001|STARTED|Overall Study||514
10110919|NCT02491437|11241897|FG000|Safety Sample|Overall Study||518
10110920|NCT02491437|11241898|FG001|Safety Sample|Overall Study||512
10110921|NCT02491437|11241897|FG000|Full Analysis Sample|Overall Study||494
10110922|NCT02491437|11241898|FG001|Full Analysis Sample|Overall Study||489
10110923|NCT02491437|11241897|FG000|COMPLETED|Overall Study||168
10110924|NCT02491437|11241898|FG001|COMPLETED|Overall Study||157
10110925|NCT02491437|11241897|FG000|NOT COMPLETED|Overall Study||352
10110926|NCT02491437|11241898|FG001|NOT COMPLETED|Overall Study||357
10110927|NCT02491463|11241910|FG000|STARTED|Overall Study||7
10110928|NCT02491463|11241911|FG001|STARTED|Overall Study||31
9903349|NCT01148459|11019159|FG001|COMPLETED|Overall Study||90
9903350|NCT01148459|11019158|FG000|NOT COMPLETED|Overall Study||12
9903351|NCT01148459|11019159|FG001|NOT COMPLETED|Overall Study||11
9903352|NCT01148511|11019167|FG000|STARTED|Exposed to Study Drug||99
9903353|NCT01148511|11019168|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
9903354|NCT01148511|11019169|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
9903355|NCT01148511|11019167|FG000|COMPLETED|Exposed to Study Drug||93
9903356|NCT01148511|11019168|FG001|COMPLETED|Exposed to Study Drug||0
9903357|NCT01148511|11019169|FG002|COMPLETED|Exposed to Study Drug||0
9903358|NCT01148511|11019167|FG000|NOT COMPLETED|Exposed to Study Drug||6
9903359|NCT01148511|11019168|FG001|NOT COMPLETED|Exposed to Study Drug||0
9903360|NCT01148511|11019169|FG002|NOT COMPLETED|Exposed to Study Drug||0
9903361|NCT01148511|11019167|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
9903362|NCT01148511|11019168|FG001|STARTED|Randomized||48
9903363|NCT01148511|11019169|FG002|STARTED|Randomized||45
9903364|NCT01148511|11019167|FG000|COMPLETED|Randomized||0
9903365|NCT01148511|11019168|FG001|COMPLETED|Randomized||38
9903366|NCT01148511|11019169|FG002|COMPLETED|Randomized||39
9903367|NCT01148511|11019167|FG000|NOT COMPLETED|Randomized||0
9903368|NCT01148511|11019168|FG001|NOT COMPLETED|Randomized||10
9903369|NCT01148511|11019169|FG002|NOT COMPLETED|Randomized||6
9903370|NCT01148524|11019185|FG000|STARTED|Overall Study||49
9903371|NCT01148524|11019186|FG001|STARTED|Overall Study||95
9903372|NCT01148524|11019187|FG002|STARTED|Overall Study||53
9903373|NCT01148524|11019188|FG003|STARTED|Overall Study||102
9903374|NCT01148524|11019189|FG004|STARTED|Overall Study||57
9903375|NCT01148524|11019190|FG005|STARTED|Overall Study||106
9903376|NCT01148524|11019191|FG006|STARTED|Overall Study||153
9903377|NCT01148524|11019192|FG007|STARTED|Overall Study||51
9903378|NCT01148524|11019193|FG008|STARTED|Overall Study||151
9903379|NCT01148524|11019185|FG000|COMPLETED|Overall Study||49
9903380|NCT01148524|11019186|FG001|COMPLETED|Overall Study||95
9903381|NCT01148524|11019187|FG002|COMPLETED|Overall Study||53
9903382|NCT01148524|11019188|FG003|COMPLETED|Overall Study||102
9903383|NCT01148524|11019189|FG004|COMPLETED|Overall Study||57
9903384|NCT01148524|11019190|FG005|COMPLETED|Overall Study||106
9903385|NCT01148524|11019191|FG006|COMPLETED|Overall Study||153
9903386|NCT01148524|11019192|FG007|COMPLETED|Overall Study||51
9903387|NCT01148524|11019193|FG008|COMPLETED|Overall Study||151
9903388|NCT01148524|11019185|FG000|NOT COMPLETED|Overall Study||0
9903389|NCT01148524|11019186|FG001|NOT COMPLETED|Overall Study||0
9903390|NCT01148524|11019187|FG002|NOT COMPLETED|Overall Study||0
9903391|NCT01148524|11019188|FG003|NOT COMPLETED|Overall Study||0
9903392|NCT01148524|11019189|FG004|NOT COMPLETED|Overall Study||0
9903393|NCT01148524|11019190|FG005|NOT COMPLETED|Overall Study||0
9903394|NCT01148524|11019191|FG006|NOT COMPLETED|Overall Study||0
9903395|NCT01148524|11019192|FG007|NOT COMPLETED|Overall Study||0
9903396|NCT01148524|11019193|FG008|NOT COMPLETED|Overall Study||0
10110929|NCT02491463|11241912|FG002|STARTED|Overall Study||19
10110930|NCT02491463|11241913|FG003|STARTED|Overall Study||15
10110931|NCT02491463|11241910|FG000|COMPLETED|Overall Study||5
10110932|NCT02491463|11241911|FG001|COMPLETED|Overall Study||21
10110933|NCT02491463|11241912|FG002|COMPLETED|Overall Study||15
10110934|NCT02491463|11241913|FG003|COMPLETED|Overall Study||14
10110935|NCT02491463|11241910|FG000|NOT COMPLETED|Overall Study||2
10110936|NCT02491463|11241911|FG001|NOT COMPLETED|Overall Study||10
10110937|NCT02491463|11241912|FG002|NOT COMPLETED|Overall Study||4
10110938|NCT02491463|11241913|FG003|NOT COMPLETED|Overall Study||1
10110939|NCT02491671|11241925|FG000|STARTED|Overall Study||129
10110940|NCT02491671|11241926|FG001|STARTED|Overall Study||131
10110941|NCT02491671|11241925|FG000|COMPLETED|Overall Study||118
10110942|NCT02491671|11241926|FG001|COMPLETED|Overall Study||118
10110943|NCT02491671|11241925|FG000|NOT COMPLETED|Overall Study||11
10110944|NCT02491671|11241926|FG001|NOT COMPLETED|Overall Study||13
10110945|NCT02491684|11241934|FG000|STARTED|Pre-treatment Phase||61
10110946|NCT02491684|11241935|FG001|STARTED|Pre-treatment Phase||60
10110947|NCT02491684|11241934|FG000|COMPLETED|Pre-treatment Phase||61
10110948|NCT02491684|11241935|FG001|COMPLETED|Pre-treatment Phase||60
10110949|NCT02491684|11241934|FG000|NOT COMPLETED|Pre-treatment Phase||0
10110950|NCT02491684|11241935|FG001|NOT COMPLETED|Pre-treatment Phase||0
10110951|NCT02491684|11241934|FG000|STARTED|Treatment Phase||61
10110952|NCT02491684|11241935|FG001|STARTED|Treatment Phase||60
10110953|NCT02491684|11241934|FG000|COMPLETED|Treatment Phase||58
10110954|NCT02491684|11241935|FG001|COMPLETED|Treatment Phase||57
10110955|NCT02491684|11241934|FG000|NOT COMPLETED|Treatment Phase||3
10110956|NCT02491684|11241935|FG001|NOT COMPLETED|Treatment Phase||3
10110957|NCT02491788|11241943|FG000|STARTED|Overall Study||8
10110958|NCT02491788|11241944|FG001|STARTED|Overall Study||11
10110959|NCT02491788|11241943|FG000|COMPLETED|Overall Study||8
10110960|NCT02491788|11241944|FG001|COMPLETED|Overall Study||11
10110961|NCT02491788|11241943|FG000|NOT COMPLETED|Overall Study||0
10110962|NCT02491788|11241944|FG001|NOT COMPLETED|Overall Study||0
10110963|NCT02491892|11241952|FG000|STARTED|Overall Study||41
10110964|NCT02491892|11241953|FG001|STARTED|Overall Study||38
9903397|NCT01148537|11019216|FG000|STARTED|Overall Study||44
9903398|NCT01148537|11019217|FG001|STARTED|Overall Study||44
9903399|NCT01148537|11019218|FG002|STARTED|Overall Study||44
9903400|NCT01148537|11019216|FG000|COMPLETED|Overall Study||41
9903401|NCT01148537|11019217|FG001|COMPLETED|Overall Study||44
9903402|NCT01148537|11019218|FG002|COMPLETED|Overall Study||41
9903403|NCT01148537|11019216|FG000|NOT COMPLETED|Overall Study||3
9903404|NCT01148537|11019217|FG001|NOT COMPLETED|Overall Study||0
9903405|NCT01148537|11019218|FG002|NOT COMPLETED|Overall Study||3
9903406|NCT01148563|11019229|FG000|STARTED|Overall Study||69
9903407|NCT01148563|11019230|FG001|STARTED|Overall Study||67
10110965|NCT02491892|11241952|FG000|Treated|Overall Study||41
10110966|NCT02491892|11241953|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
10110967|NCT02491892|11241952|FG000|COMPLETED|Overall Study||0
9903408|NCT01148563|11019229|FG000|COMPLETED|Overall Study||40
9903409|NCT01148563|11019230|FG001|COMPLETED|Overall Study||37
9903410|NCT01148563|11019229|FG000|NOT COMPLETED|Overall Study||29
9903411|NCT01148563|11019230|FG001|NOT COMPLETED|Overall Study||30
9903412|NCT01148693|11019239|FG000|STARTED|Overall Study||70
9903413|NCT01148693|11019240|FG001|STARTED|Overall Study||67
9903414|NCT01148693|11019239|FG000|COMPLETED|Overall Study||57
9903415|NCT01148693|11019240|FG001|COMPLETED|Overall Study||57
9903416|NCT01148693|11019239|FG000|NOT COMPLETED|Overall Study||13
10009400|NCT01765764|11131953|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
10009401|NCT01765764|11131951|FG000|COMPLETED|Post-treatment Period||114
10009402|NCT01765764|11131952|FG001|COMPLETED|Post-treatment Period||107
10009403|NCT01765764|11131953|FG002|COMPLETED|Post-treatment Period||112
10110968|NCT02491892|11241953|FG001|COMPLETED|Overall Study||0
10110969|NCT02491892|11241952|FG000|NOT COMPLETED|Overall Study||41
9903417|NCT01148693|11019240|FG001|NOT COMPLETED|Overall Study||10
9903418|NCT01148745|11019246|FG000|STARTED|Overall Study||15
9903419|NCT01148745|11019246|FG000|COMPLETED|Overall Study||15
9903420|NCT01148745|11019246|FG000|NOT COMPLETED|Overall Study||0
9903421|NCT01148771|11019254|FG000|STARTED|First Intervention||6
9903422|NCT01148771|11019255|FG001|STARTED|First Intervention||6
9903423|NCT01148771|11019254|FG000|COMPLETED|First Intervention||6
9903424|NCT01148771|11019255|FG001|COMPLETED|First Intervention||6
9903425|NCT01148771|11019254|FG000|NOT COMPLETED|First Intervention||0
9903426|NCT01148771|11019255|FG001|NOT COMPLETED|First Intervention||0
9903427|NCT01148771|11019254|FG000|STARTED|Washout Period||6
9903428|NCT01148771|11019255|FG001|STARTED|Washout Period||6
9903429|NCT01148771|11019254|FG000|COMPLETED|Washout Period||6
10009404|NCT01765764|11131951|FG000|NOT COMPLETED|Post-treatment Period||0
10009405|NCT01765764|11131952|FG001|NOT COMPLETED|Post-treatment Period||0
10009406|NCT01765764|11131953|FG002|NOT COMPLETED|Post-treatment Period||0
10110970|NCT02491892|11241953|FG001|NOT COMPLETED|Overall Study||38
10110971|NCT02491944|11241959|FG000|STARTED|Overall Study||10
10110972|NCT02491944|11241959|FG000|COMPLETED|Overall Study||10
10110973|NCT02491944|11241959|FG000|NOT COMPLETED|Overall Study||0
10110974|NCT02492100|11241963|FG000|STARTED|Overall Study||47
10110975|NCT02492100|11241963|FG000|COMPLETED|Overall Study||46
10110976|NCT02492100|11241963|FG000|NOT COMPLETED|Overall Study||1
10110977|NCT02492451|11241971|FG000|STARTED|Overall Study||40
10110978|NCT02492451|11241972|FG001|STARTED|Overall Study||39
10110979|NCT02492451|11241973|FG002|STARTED|Overall Study||39
10110980|NCT02492451|11241971|FG000|COMPLETED|Overall Study||40
10110981|NCT02492451|11241972|FG001|COMPLETED|Overall Study||39
10110982|NCT02492451|11241973|FG002|COMPLETED|Overall Study||39
10110983|NCT02492451|11241971|FG000|NOT COMPLETED|Overall Study||0
10110984|NCT02492451|11241972|FG001|NOT COMPLETED|Overall Study||0
10110985|NCT02492451|11241973|FG002|NOT COMPLETED|Overall Study||0
10110986|NCT02492750|11241984|FG000|STARTED|Overall Study||4
10110987|NCT02492750|11241985|FG001|STARTED|Overall Study||4
10110988|NCT02492750|11241986|FG002|STARTED|Overall Study||6
10110989|NCT02492750|11241984|FG000|COMPLETED|Overall Study||4
10110990|NCT02492750|11241985|FG001|COMPLETED|Overall Study||4
10110991|NCT02492750|11241986|FG002|COMPLETED|Overall Study||6
10110992|NCT02492750|11241984|FG000|NOT COMPLETED|Overall Study||0
10110993|NCT02492750|11241985|FG001|NOT COMPLETED|Overall Study||0
10110994|NCT02492750|11241986|FG002|NOT COMPLETED|Overall Study||0
10110995|NCT02492763|11241998|FG000|STARTED|Overall Study||46
10110996|NCT02492763|11241999|FG001|STARTED|Overall Study||44
10110997|NCT02492763|11242000|FG002|STARTED|Overall Study||43
10202912|NCT03453060|11330062|FG004|NOT COMPLETED|Overall Study||0
10202913|NCT03453151|11330074|FG000|STARTED|Overall Study||19
10202914|NCT03453151|11330074|FG000|COMPLETED|Overall Study||15
10202915|NCT03453151|11330074|FG000|NOT COMPLETED|Overall Study||4
10202916|NCT03453515|11330080|FG000|STARTED|Overall Study||113
10202917|NCT03453515|11330081|FG001|STARTED|Overall Study||113
10202918|NCT03453515|11330080|FG000|COMPLETED|Overall Study||107
10202919|NCT03453515|11330081|FG001|COMPLETED|Overall Study||100
10202920|NCT03453515|11330080|FG000|NOT COMPLETED|Overall Study||6
10202921|NCT03453515|11330081|FG001|NOT COMPLETED|Overall Study||13
10202922|NCT03454048|11330091|FG000|STARTED|Overall Study||6
10202923|NCT03454048|11330092|FG001|STARTED|Overall Study||6
10009407|NCT01765803|11131961|FG000|STARTED|Overall Study||6
10009408|NCT01765803|11131961|FG000|COMPLETED|Overall Study||6
10009409|NCT01765803|11131961|FG000|NOT COMPLETED|Overall Study||0
10009410|NCT01765920|11131967|FG000|STARTED|Overall Study||169
10009411|NCT01765920|11131968|FG001|STARTED|Overall Study||173
10110998|NCT02492763|11242001|FG003|STARTED|Overall Study||43
10202924|NCT03454048|11330093|FG002|STARTED|Overall Study||6
10202925|NCT03454048|11330094|FG003|STARTED|Overall Study||6
9903430|NCT01148771|11019255|FG001|COMPLETED|Washout Period||5
9903431|NCT01148771|11019254|FG000|NOT COMPLETED|Washout Period||0
9903432|NCT01148771|11019255|FG001|NOT COMPLETED|Washout Period||1
9903433|NCT01148771|11019254|FG000|STARTED|Second Intervention||6
9903434|NCT01148771|11019255|FG001|STARTED|Second Intervention||5
9903435|NCT01148771|11019254|FG000|COMPLETED|Second Intervention||6
10009412|NCT01765920|11131967|FG000|COMPLETED|Overall Study||167
10009413|NCT01765920|11131968|FG001|COMPLETED|Overall Study||167
10110999|NCT02492763|11241998|FG000|Treated|Overall Study||46
10111000|NCT02492763|11241999|FG001|Treated|Overall Study||44
10111001|NCT02492763|11242000|FG002|Treated|Overall Study||43
10111002|NCT02492763|11242001|FG003|Treated|Overall Study||42
10202926|NCT03454048|11330091|FG000|COMPLETED|Overall Study||6
9903436|NCT01148771|11019255|FG001|COMPLETED|Second Intervention||5
9903437|NCT01148771|11019254|FG000|NOT COMPLETED|Second Intervention||0
9903438|NCT01148771|11019255|FG001|NOT COMPLETED|Second Intervention||0
9903439|NCT01148810|11019267|FG000|STARTED|Overall Study||8
9903440|NCT01148810|11019268|FG001|STARTED|Overall Study||10
9903441|NCT01148810|11019267|FG000|COMPLETED|Overall Study||7
9903442|NCT01148810|11019268|FG001|COMPLETED|Overall Study||5
9903443|NCT01148810|11019267|FG000|NOT COMPLETED|Overall Study||1
9903444|NCT01148810|11019268|FG001|NOT COMPLETED|Overall Study||5
9903445|NCT01148836|11019277|FG000|STARTED|Overall Study|Enrollment completed|8
9903446|NCT01148836|11019278|FG001|STARTED|Overall Study||10
9903447|NCT01148836|11019277|FG000|COMPLETED|Overall Study|Enrollment completed|7
9903448|NCT01148836|11019278|FG001|COMPLETED|Overall Study||8
9903449|NCT01148836|11019277|FG000|NOT COMPLETED|Overall Study||1
9903450|NCT01148836|11019278|FG001|NOT COMPLETED|Overall Study||2
9903451|NCT01148862|11019284|FG000|STARTED|First Intervention||25
9903452|NCT01148862|11019285|FG001|STARTED|First Intervention||25
9903453|NCT01148862|11019284|FG000|COMPLETED|First Intervention||25
9903454|NCT01148862|11019285|FG001|COMPLETED|First Intervention||25
9903455|NCT01148862|11019284|FG000|NOT COMPLETED|First Intervention||0
9903456|NCT01148862|11019285|FG001|NOT COMPLETED|First Intervention||0
9903457|NCT01148862|11019284|FG000|STARTED|Washout Period of 2 Weeks||25
9903458|NCT01148862|11019285|FG001|STARTED|Washout Period of 2 Weeks||25
9903459|NCT01148862|11019284|FG000|COMPLETED|Washout Period of 2 Weeks||25
9903460|NCT01148862|11019285|FG001|COMPLETED|Washout Period of 2 Weeks||25
9903461|NCT01148862|11019284|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9903462|NCT01148862|11019285|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9903463|NCT01148862|11019284|FG000|STARTED|Second Intervention||25
9903464|NCT01148862|11019285|FG001|STARTED|Second Intervention||25
9903465|NCT01148862|11019284|FG000|COMPLETED|Second Intervention||25
9903466|NCT01148862|11019285|FG001|COMPLETED|Second Intervention||23
9903467|NCT01148862|11019284|FG000|NOT COMPLETED|Second Intervention||0
9903468|NCT01148862|11019285|FG001|NOT COMPLETED|Second Intervention||2
9903469|NCT01148940|11019293|FG000|STARTED|Overall Study||7
9903470|NCT01148940|11019294|FG001|STARTED|Overall Study||27
10111003|NCT02492763|11241998|FG000|COMPLETED|Overall Study||30
10111004|NCT02492763|11241999|FG001|COMPLETED|Overall Study||29
10111005|NCT02492763|11242000|FG002|COMPLETED|Overall Study||33
10111006|NCT02492763|11242001|FG003|COMPLETED|Overall Study||30
10111007|NCT02492763|11241998|FG000|NOT COMPLETED|Overall Study||16
10111008|NCT02492763|11241999|FG001|NOT COMPLETED|Overall Study||15
10111009|NCT02492763|11242000|FG002|NOT COMPLETED|Overall Study||10
10111010|NCT02492763|11242001|FG003|NOT COMPLETED|Overall Study||13
10111011|NCT02492802|11242011|FG000|STARTED|Overall Study||64
10111012|NCT02492802|11242011|FG000|COMPLETED|Overall Study||64
10111013|NCT02492802|11242011|FG000|NOT COMPLETED|Overall Study||0
10111014|NCT02492841|11242018|FG000|STARTED|Overall Study||56
10111015|NCT02492841|11242019|FG001|STARTED|Overall Study||53
10111016|NCT02492841|11242020|FG002|STARTED|Overall Study||60
10111017|NCT02492841|11242018|FG000|COMPLETED|Overall Study||22
10111018|NCT02492841|11242019|FG001|COMPLETED|Overall Study||22
10111019|NCT02492841|11242020|FG002|COMPLETED|Overall Study||25
10111020|NCT02492841|11242018|FG000|NOT COMPLETED|Overall Study||34
10111021|NCT02492841|11242019|FG001|NOT COMPLETED|Overall Study||31
10111022|NCT02492841|11242020|FG002|NOT COMPLETED|Overall Study||35
10111023|NCT02492854|11242033|FG000|STARTED|Overall Study||5
10111024|NCT02492854|11242034|FG001|STARTED|Overall Study||3
10111025|NCT02492854|11242033|FG000|COMPLETED|Overall Study||5
10111026|NCT02492854|11242034|FG001|COMPLETED|Overall Study||3
10111027|NCT02492854|11242033|FG000|NOT COMPLETED|Overall Study||0
10111028|NCT02492854|11242034|FG001|NOT COMPLETED|Overall Study||0
10111029|NCT02492880|11242040|FG000|STARTED|Overall Study||15
10111030|NCT02492880|11242040|FG000|COMPLETED|Overall Study||13
10111031|NCT02492880|11242040|FG000|NOT COMPLETED|Overall Study||2
10111032|NCT02492958|11242048|FG000|STARTED|Overall Study||34
10111033|NCT02492958|11242049|FG001|STARTED|Overall Study||34
10111034|NCT02492958|11242050|FG002|STARTED|Overall Study||34
10111035|NCT02492958|11242051|FG003|STARTED|Overall Study||34
10111036|NCT02492958|11242048|FG000|COMPLETED|Overall Study||33
10111037|NCT02492958|11242049|FG001|COMPLETED|Overall Study||34
10111038|NCT02492958|11242050|FG002|COMPLETED|Overall Study||32
10111039|NCT02492958|11242051|FG003|COMPLETED|Overall Study||34
10111040|NCT02492958|11242048|FG000|NOT COMPLETED|Overall Study||1
10111041|NCT02492958|11242049|FG001|NOT COMPLETED|Overall Study||0
10111042|NCT02492958|11242050|FG002|NOT COMPLETED|Overall Study||2
10111043|NCT02492958|11242051|FG003|NOT COMPLETED|Overall Study||0
9903471|NCT01148940|11019295|FG002|STARTED|Overall Study||0
9903472|NCT01148940|11019293|FG000|COMPLETED|Overall Study||7
9903473|NCT01148940|11019294|FG001|COMPLETED|Overall Study||27
10111044|NCT02492984|11242063|FG000|STARTED|Overall Study||73
10111045|NCT02492984|11242064|FG001|STARTED|Overall Study||14
10111046|NCT02492984|11242063|FG000|COMPLETED|Overall Study||70
10111047|NCT02492984|11242064|FG001|COMPLETED|Overall Study||14
10111048|NCT02492984|11242063|FG000|NOT COMPLETED|Overall Study||3
10111049|NCT02492984|11242064|FG001|NOT COMPLETED|Overall Study||0
10111050|NCT02492997|11242075|FG000|STARTED|Overall Study||21
10111051|NCT02492997|11242076|FG001|STARTED|Overall Study||21
10111052|NCT02492997|11242075|FG000|COMPLETED|Overall Study||19
10111053|NCT02492997|11242076|FG001|COMPLETED|Overall Study||20
9903474|NCT01148940|11019295|FG002|COMPLETED|Overall Study||0
9903475|NCT01148940|11019293|FG000|NOT COMPLETED|Overall Study||0
9903476|NCT01148940|11019294|FG001|NOT COMPLETED|Overall Study||0
9903477|NCT01148940|11019295|FG002|NOT COMPLETED|Overall Study||0
9903478|NCT01148979|11019305|FG000|STARTED|Overall Study||13
9903479|NCT01148979|11019306|FG001|STARTED|Overall Study||16
9903480|NCT01148979|11019305|FG000|COMPLETED|Overall Study||13
9903481|NCT01148979|11019306|FG001|COMPLETED|Overall Study||15
9903482|NCT01148979|11019305|FG000|NOT COMPLETED|Overall Study||0
9903483|NCT01148979|11019306|FG001|NOT COMPLETED|Overall Study||1
9903484|NCT01149057|11019312|FG000|STARTED|Overall Study||145
9903485|NCT01149057|11019312|FG000|COMPLETED|Overall Study||88
9903486|NCT01149057|11019312|FG000|NOT COMPLETED|Overall Study||57
9903487|NCT01149096|11019318|FG000|STARTED|Overall Study||6
9903488|NCT01149096|11019319|FG001|STARTED|Overall Study||7
9903489|NCT01149096|11019318|FG000|COMPLETED|Overall Study||6
9903490|NCT01149096|11019319|FG001|COMPLETED|Overall Study||6
9903491|NCT01149096|11019318|FG000|NOT COMPLETED|Overall Study||0
9903492|NCT01149096|11019319|FG001|NOT COMPLETED|Overall Study||1
9903493|NCT01149148|11019328|FG000|STARTED|Overall Study||12
9903494|NCT01149148|11019329|FG001|STARTED|Overall Study||13
9903495|NCT01149148|11019328|FG000|COMPLETED|Overall Study||10
9903496|NCT01149148|11019329|FG001|COMPLETED|Overall Study||11
9903497|NCT01149148|11019328|FG000|NOT COMPLETED|Overall Study||2
9903498|NCT01149148|11019329|FG001|NOT COMPLETED|Overall Study||2
9903499|NCT01149343|11019340|FG000|STARTED|Overall Study||20
9903500|NCT01149343|11019341|FG001|STARTED|Overall Study||24
9903501|NCT01149343|11019342|FG002|STARTED|Overall Study||22
9903502|NCT01149343|11019343|FG003|STARTED|Overall Study||40
9903503|NCT01149343|11019340|FG000|COMPLETED|Overall Study||0
9903504|NCT01149343|11019341|FG001|COMPLETED|Overall Study||0
9903505|NCT01149343|11019342|FG002|COMPLETED|Overall Study||0
9903506|NCT01149343|11019343|FG003|COMPLETED|Overall Study||0
9903507|NCT01149343|11019340|FG000|NOT COMPLETED|Overall Study||20
9903508|NCT01149343|11019341|FG001|NOT COMPLETED|Overall Study||24
9903509|NCT01149343|11019342|FG002|NOT COMPLETED|Overall Study||22
10111054|NCT02492997|11242075|FG000|NOT COMPLETED|Overall Study||2
10111055|NCT02492997|11242076|FG001|NOT COMPLETED|Overall Study||1
10111056|NCT02493036|11242085|FG000|STARTED|Overall Study||17
10111057|NCT02493036|11242086|FG001|STARTED|Overall Study||20
10111058|NCT02493036|11242087|FG002|STARTED|Overall Study||17
10111059|NCT02493036|11242085|FG000|COMPLETED|Overall Study||16
10111060|NCT02493036|11242086|FG001|COMPLETED|Overall Study||18
10111061|NCT02493036|11242087|FG002|COMPLETED|Overall Study||15
10111062|NCT02493036|11242085|FG000|NOT COMPLETED|Overall Study||1
10111063|NCT02493036|11242086|FG001|NOT COMPLETED|Overall Study||2
10111064|NCT02493036|11242087|FG002|NOT COMPLETED|Overall Study||2
10111065|NCT02493062|11242095|FG000|STARTED|Overall Study||35
10111066|NCT02493062|11242095|FG000|COMPLETED|Overall Study||23
10111067|NCT02493062|11242095|FG000|NOT COMPLETED|Overall Study||12
10111068|NCT02493088|11242099|FG000|STARTED|Overall Study||11
10111069|NCT02493088|11242099|FG000|COMPLETED|Overall Study||11
10111070|NCT02493088|11242099|FG000|NOT COMPLETED|Overall Study||0
10113406|NCT02509117|11244192|FG002|COMPLETED|Period 3 -Part A: 4 Days||2
10113407|NCT02509117|11244193|FG003|COMPLETED|Period 3 -Part A: 4 Days||2
10113408|NCT02509117|11244194|FG004|COMPLETED|Period 3 -Part A: 4 Days||0
10113409|NCT02509117|11244195|FG005|COMPLETED|Period 3 -Part A: 4 Days||0
10113410|NCT02509117|11244196|FG006|COMPLETED|Period 3 -Part A: 4 Days||0
10113411|NCT02509117|11244197|FG007|COMPLETED|Period 3 -Part A: 4 Days||0
10113412|NCT02509117|11244198|FG008|COMPLETED|Period 3 -Part A: 4 Days||0
10113413|NCT02509117|11244199|FG009|COMPLETED|Period 3 -Part A: 4 Days||0
10113414|NCT02509117|11244190|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113415|NCT02509117|11244191|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113416|NCT02509117|11244192|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113417|NCT02509117|11244193|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113418|NCT02509117|11244194|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113419|NCT02509117|11244195|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113420|NCT02509117|11244196|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113421|NCT02509117|11244197|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113422|NCT02509117|11244198|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113423|NCT02509117|11244199|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10113424|NCT02509117|11244190|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2
9903510|NCT01149343|11019343|FG003|NOT COMPLETED|Overall Study||40
9903511|NCT01149369|11019359|FG000|STARTED|Overall Study||63
9903512|NCT01149369|11019360|FG001|STARTED|Overall Study||63
9903513|NCT01149369|11019359|FG000|COMPLETED|Overall Study||57
9903514|NCT01149369|11019360|FG001|COMPLETED|Overall Study||60
9903515|NCT01149369|11019359|FG000|NOT COMPLETED|Overall Study||6
9903516|NCT01149369|11019360|FG001|NOT COMPLETED|Overall Study||3
10113425|NCT02509117|11244191|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2
10113426|NCT02509117|11244192|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2
10113427|NCT02509117|11244193|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2
10113428|NCT02509117|11244194|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0
10113429|NCT02509117|11244195|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0
9903517|NCT01149421|11019369|FG000|STARTED|Overall Study||251
9903518|NCT01149421|11019370|FG001|STARTED|Overall Study||254
9903519|NCT01149421|11019371|FG002|STARTED|Overall Study||250
9903520|NCT01149421|11019369|FG000|Received at Least One Dose of Study Drug|Overall Study||251
9903521|NCT01149421|11019370|FG001|Received at Least One Dose of Study Drug|Overall Study||254
9903522|NCT01149421|11019371|FG002|Received at Least One Dose of Study Drug|Overall Study||250
9903523|NCT01149421|11019369|FG000|COMPLETED|Overall Study||199
9903524|NCT01149421|11019370|FG001|COMPLETED|Overall Study||225
9903525|NCT01149421|11019371|FG002|COMPLETED|Overall Study||206
9903526|NCT01149421|11019369|FG000|NOT COMPLETED|Overall Study||52
9903527|NCT01149421|11019370|FG001|NOT COMPLETED|Overall Study||29
9903528|NCT01149421|11019371|FG002|NOT COMPLETED|Overall Study||44
9903529|NCT01149434|11019381|FG000|STARTED|Overall Study||4
9903530|NCT01149434|11019382|FG001|STARTED|Overall Study||15
9903531|NCT01149434|11019381|FG000|COMPLETED|Overall Study||4
9903532|NCT01149434|11019382|FG001|COMPLETED|Overall Study||10
9903533|NCT01149434|11019381|FG000|NOT COMPLETED|Overall Study||0
9903534|NCT01149434|11019382|FG001|NOT COMPLETED|Overall Study||5
9903535|NCT01149460|11019391|FG000|STARTED|Overall Study||18
9903536|NCT01149460|11019392|FG001|STARTED|Overall Study||18
9903537|NCT01149460|11019391|FG000|COMPLETED|Overall Study||18
9903538|NCT01149460|11019392|FG001|COMPLETED|Overall Study||16
9903539|NCT01149460|11019391|FG000|NOT COMPLETED|Overall Study||0
9903540|NCT01149460|11019392|FG001|NOT COMPLETED|Overall Study||2
9903541|NCT01149473|11019400|FG000|STARTED|First Intervention||40
9903542|NCT01149473|11019401|FG001|STARTED|First Intervention||40
9903543|NCT01149473|11019400|FG000|COMPLETED|First Intervention||39
9903544|NCT01149473|11019401|FG001|COMPLETED|First Intervention||39
9903545|NCT01149473|11019400|FG000|NOT COMPLETED|First Intervention||1
9903546|NCT01149473|11019401|FG001|NOT COMPLETED|First Intervention||1
9903547|NCT01149473|11019400|FG000|STARTED|Washout of 7 Days||39
9903548|NCT01149473|11019401|FG001|STARTED|Washout of 7 Days||39
9903549|NCT01149473|11019400|FG000|COMPLETED|Washout of 7 Days||38
9903550|NCT01149473|11019401|FG001|COMPLETED|Washout of 7 Days||38
9903551|NCT01149473|11019400|FG000|NOT COMPLETED|Washout of 7 Days||1
9903552|NCT01149473|11019401|FG001|NOT COMPLETED|Washout of 7 Days||1
9903553|NCT01149473|11019400|FG000|STARTED|Second Intervention||38
9903554|NCT01149473|11019401|FG001|STARTED|Second Intervention||38
9903555|NCT01149473|11019400|FG000|COMPLETED|Second Intervention||38
9903556|NCT01149473|11019401|FG001|COMPLETED|Second Intervention||38
9903557|NCT01149473|11019400|FG000|NOT COMPLETED|Second Intervention||0
9903558|NCT01149473|11019401|FG001|NOT COMPLETED|Second Intervention||0
9903559|NCT01149486|11019409|FG000|STARTED|First Intervention||10
9903560|NCT01149486|11019410|FG001|STARTED|First Intervention||10
9903561|NCT01149486|11019409|FG000|COMPLETED|First Intervention||10
9903562|NCT01149486|11019410|FG001|COMPLETED|First Intervention||9
9903563|NCT01149486|11019409|FG000|NOT COMPLETED|First Intervention||0
9903564|NCT01149486|11019410|FG001|NOT COMPLETED|First Intervention||1
9903565|NCT01149486|11019409|FG000|STARTED|Washout of 7 Days||10
9903566|NCT01149486|11019410|FG001|STARTED|Washout of 7 Days||9
9903567|NCT01149486|11019409|FG000|COMPLETED|Washout of 7 Days||10
9903568|NCT01149486|11019410|FG001|COMPLETED|Washout of 7 Days||9
9903569|NCT01149486|11019409|FG000|NOT COMPLETED|Washout of 7 Days||0
9903570|NCT01149486|11019410|FG001|NOT COMPLETED|Washout of 7 Days||0
9903571|NCT01149486|11019409|FG000|STARTED|Second Intervention||10
9903572|NCT01149486|11019410|FG001|STARTED|Second Intervention||9
9903573|NCT01149486|11019409|FG000|COMPLETED|Second Intervention||10
9903574|NCT01149486|11019410|FG001|COMPLETED|Second Intervention||9
9903575|NCT01149486|11019409|FG000|NOT COMPLETED|Second Intervention||0
9903576|NCT01149486|11019410|FG001|NOT COMPLETED|Second Intervention||0
9903577|NCT01149512|11019416|FG000|STARTED|Overall Study||178
9903578|NCT01149512|11019416|FG000|COMPLETED|Overall Study||178
9903579|NCT01149512|11019416|FG000|NOT COMPLETED|Overall Study||0
9903580|NCT01149538|11019422|FG000|STARTED|Overall Study||31
9903581|NCT01149538|11019423|FG001|STARTED|Overall Study||29
9903582|NCT01149538|11019422|FG000|COMPLETED|Overall Study||26
9903583|NCT01149538|11019423|FG001|COMPLETED|Overall Study||25
9903584|NCT01149538|11019422|FG000|NOT COMPLETED|Overall Study||5
9903585|NCT01149538|11019423|FG001|NOT COMPLETED|Overall Study||4
9903586|NCT01149616|11019431|FG000|STARTED|Overall Study||41
9903587|NCT01149616|11019432|FG001|STARTED|Overall Study||41
9903588|NCT01149616|11019431|FG000|COMPLETED|Overall Study||41
9903589|NCT01149616|11019432|FG001|COMPLETED|Overall Study||41
9903590|NCT01149616|11019431|FG000|NOT COMPLETED|Overall Study||0
9903591|NCT01149616|11019432|FG001|NOT COMPLETED|Overall Study||0
9903592|NCT01149655|11019442|FG000|STARTED|Period 1 - Conversion Phase||186
9903593|NCT01149655|11019443|FG001|STARTED|Period 1 - Conversion Phase||0
9903594|NCT01149655|11019444|FG002|STARTED|Period 1 - Conversion Phase||0
9903595|NCT01149655|11019445|FG003|STARTED|Period 1 - Conversion Phase||0
9903596|NCT01149655|11019442|FG000|COMPLETED|Period 1 - Conversion Phase||168
9903597|NCT01149655|11019443|FG001|COMPLETED|Period 1 - Conversion Phase||0
9903598|NCT01149655|11019444|FG002|COMPLETED|Period 1 - Conversion Phase||0
10111071|NCT02493127|11242105|FG000|STARTED|Overall Study||61
10111072|NCT02493127|11242106|FG001|STARTED|Overall Study||61
10111073|NCT02493127|11242105|FG000|COMPLETED|Overall Study||60
10111074|NCT02493127|11242106|FG001|COMPLETED|Overall Study||60
9903599|NCT01149655|11019445|FG003|COMPLETED|Period 1 - Conversion Phase||0
9903600|NCT01149655|11019442|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18
9903601|NCT01149655|11019443|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
9903602|NCT01149655|11019444|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0
10111075|NCT02493127|11242105|FG000|NOT COMPLETED|Overall Study||1
9903603|NCT01149655|11019445|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0
9903604|NCT01149655|11019442|FG000|STARTED|Period 2-Stabilization Phase||0
10111076|NCT02493127|11242106|FG001|NOT COMPLETED|Overall Study||1
9903605|NCT01149655|11019443|FG001|STARTED|Period 2-Stabilization Phase||183
9903606|NCT01149655|11019444|FG002|STARTED|Period 2-Stabilization Phase||0
9903607|NCT01149655|11019445|FG003|STARTED|Period 2-Stabilization Phase||0
9903608|NCT01149655|11019442|FG000|COMPLETED|Period 2-Stabilization Phase||0
9903609|NCT01149655|11019443|FG001|COMPLETED|Period 2-Stabilization Phase||146
9903610|NCT01149655|11019444|FG002|COMPLETED|Period 2-Stabilization Phase||0
9903611|NCT01149655|11019445|FG003|COMPLETED|Period 2-Stabilization Phase||0
9903612|NCT01149655|11019442|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0
9903613|NCT01149655|11019443|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37
9903614|NCT01149655|11019444|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0
9903615|NCT01149655|11019445|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0
9903616|NCT01149655|11019442|FG000|STARTED|Period 3-DB Maintenance Phase||0
9903617|NCT01149655|11019443|FG001|STARTED|Period 3-DB Maintenance Phase||0
9903618|NCT01149655|11019444|FG002|STARTED|Period 3-DB Maintenance Phase||98
9903619|NCT01149655|11019445|FG003|STARTED|Period 3-DB Maintenance Phase||48
9903620|NCT01149655|11019442|FG000|COMPLETED|Period 3-DB Maintenance Phase||0
9903621|NCT01149655|11019443|FG001|COMPLETED|Period 3-DB Maintenance Phase||0
9903622|NCT01149655|11019444|FG002|COMPLETED|Period 3-DB Maintenance Phase||15
10111077|NCT02493257|11242116|FG000|STARTED|Overall Study||11
10111078|NCT02493257|11242117|FG001|STARTED|Overall Study||11
10111079|NCT02493257|11242116|FG000|4 Week Follow up|Overall Study||11
10111080|NCT02493257|11242117|FG001|4 Week Follow up|Overall Study||11
10111081|NCT02493257|11242116|FG000|12 Week Follow up|Overall Study||10
10111082|NCT02493257|11242117|FG001|12 Week Follow up|Overall Study||10
10111083|NCT02493257|11242116|FG000|COMPLETED|Overall Study||10
10111084|NCT02493257|11242117|FG001|COMPLETED|Overall Study||10
10111085|NCT02493257|11242116|FG000|NOT COMPLETED|Overall Study||1
10111086|NCT02493257|11242117|FG001|NOT COMPLETED|Overall Study||1
10111087|NCT02493361|11242123|FG000|STARTED|Overall Study||24
10111088|NCT02493361|11242123|FG000|Week 24 Assessment|Overall Study||21
10111089|NCT02493361|11242123|FG000|COMPLETED|Overall Study||21
10111090|NCT02493361|11242123|FG000|NOT COMPLETED|Overall Study||3
10111091|NCT02493452|11242130|FG000|STARTED|Overall Study||379
10111092|NCT02493452|11242131|FG001|STARTED|Overall Study||377
10111093|NCT02493452|11242132|FG002|STARTED|Overall Study||379
10111094|NCT02493452|11242130|FG000|COMPLETED|Overall Study||329
10111095|NCT02493452|11242131|FG001|COMPLETED|Overall Study||328
10111096|NCT02493452|11242132|FG002|COMPLETED|Overall Study||325
10111097|NCT02493452|11242130|FG000|NOT COMPLETED|Overall Study||50
10111098|NCT02493452|11242131|FG001|NOT COMPLETED|Overall Study||49
10111099|NCT02493452|11242132|FG002|NOT COMPLETED|Overall Study||54
10111100|NCT02493517|11242142|FG000|STARTED|Overall Study||64
10111101|NCT02493517|11242143|FG001|STARTED|Overall Study||64
10111102|NCT02493517|11242142|FG000|COMPLETED|Overall Study||62
10111103|NCT02493517|11242143|FG001|COMPLETED|Overall Study||57
10111104|NCT02493517|11242142|FG000|NOT COMPLETED|Overall Study||2
10111105|NCT02493517|11242143|FG001|NOT COMPLETED|Overall Study||7
10111106|NCT02493608|11242153|FG000|STARTED|Overall Study||48
10111107|NCT02493608|11242154|FG001|STARTED|Overall Study||48
10111108|NCT02493608|11242153|FG000|COMPLETED|Overall Study||48
10111109|NCT02493608|11242154|FG001|COMPLETED|Overall Study||48
10111110|NCT02493608|11242153|FG000|NOT COMPLETED|Overall Study||0
10111111|NCT02493608|11242154|FG001|NOT COMPLETED|Overall Study||0
10111112|NCT02493621|11242162|FG000|STARTED|Overall Study||58
10111113|NCT02493621|11242163|FG001|STARTED|Overall Study||58
10111114|NCT02493621|11242162|FG000|COMPLETED|Overall Study||58
10111115|NCT02493621|11242163|FG001|COMPLETED|Overall Study||58
10111116|NCT02493621|11242162|FG000|NOT COMPLETED|Overall Study||0
10111117|NCT02493621|11242163|FG001|NOT COMPLETED|Overall Study||0
10111118|NCT02493712|11242172|FG000|STARTED|Overall Study||16
10111119|NCT02493712|11242173|FG001|STARTED|Overall Study||18
10111120|NCT02493712|11242174|FG002|STARTED|Overall Study||17
10111121|NCT02493712|11242172|FG000|COMPLETED|Overall Study||14
10111122|NCT02493712|11242173|FG001|COMPLETED|Overall Study||12
10111123|NCT02493712|11242174|FG002|COMPLETED|Overall Study||11
10111124|NCT02493712|11242172|FG000|NOT COMPLETED|Overall Study||2
10111125|NCT02493712|11242173|FG001|NOT COMPLETED|Overall Study||6
10111126|NCT02493712|11242174|FG002|NOT COMPLETED|Overall Study||6
10111127|NCT02493764|11242184|FG000|STARTED|Overall Study||268
10111128|NCT02493764|11242185|FG001|STARTED|Overall Study||269
10111129|NCT02493764|11242184|FG000|COMPLETED|Overall Study||185
10111130|NCT02493764|11242185|FG001|COMPLETED|Overall Study||187
10111131|NCT02493764|11242184|FG000|NOT COMPLETED|Overall Study||83
10111132|NCT02493764|11242185|FG001|NOT COMPLETED|Overall Study||82
10111133|NCT02493777|11242193|FG000|STARTED|Overall Study||65
10111134|NCT02493777|11242194|FG001|STARTED|Overall Study||54
10111135|NCT02493777|11242193|FG000|COMPLETED|Overall Study||65
10111136|NCT02493777|11242194|FG001|COMPLETED|Overall Study||53
10111137|NCT02493777|11242193|FG000|NOT COMPLETED|Overall Study||0
10111138|NCT02493777|11242194|FG001|NOT COMPLETED|Overall Study||1
10111139|NCT02493855|11242203|FG000|STARTED|Overall Study||21
10111140|NCT02493855|11242204|FG001|STARTED|Overall Study||19
10111141|NCT02493855|11242205|FG002|STARTED|Overall Study||6
10111142|NCT02493855|11242203|FG000|COMPLETED|Overall Study||19
10111143|NCT02493855|11242204|FG001|COMPLETED|Overall Study||18
10111144|NCT02493855|11242205|FG002|COMPLETED|Overall Study||6
10111145|NCT02493855|11242203|FG000|NOT COMPLETED|Overall Study||2
10111146|NCT02493855|11242204|FG001|NOT COMPLETED|Overall Study||1
10111147|NCT02493855|11242205|FG002|NOT COMPLETED|Overall Study||0
10111148|NCT02493868|11242213|FG000|STARTED|Induction Phase: DE Participants||437
9903623|NCT01149655|11019445|FG003|COMPLETED|Period 3-DB Maintenance Phase||6
9903624|NCT01149655|11019442|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0
9903625|NCT01149655|11019443|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0
9903626|NCT01149655|11019444|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83
9903627|NCT01149655|11019445|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42
9903628|NCT01149681|11019453|FG000|STARTED|Overall Study||12
9903629|NCT01149681|11019453|FG000|COMPLETED|Overall Study||0
9903630|NCT01149681|11019453|FG000|NOT COMPLETED|Overall Study||12
9903631|NCT01149733|11019460|FG000|STARTED|Overall Study||16
9903632|NCT01149733|11019461|FG001|STARTED|Overall Study||16
9903633|NCT01149733|11019460|FG000|COMPLETED|Overall Study||16
9903634|NCT01149733|11019461|FG001|COMPLETED|Overall Study||16
10111149|NCT02493868|11242214|FG001|STARTED|Induction Phase: DE Participants||0
10111150|NCT02493868|11242213|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
10111151|NCT02493868|11242214|FG001|COMPLETED|Induction Phase: DE Participants||0
10111152|NCT02493868|11242213|FG000|NOT COMPLETED|Induction Phase: DE Participants||164
10111153|NCT02493868|11242214|FG001|NOT COMPLETED|Induction Phase: DE Participants||0
10111154|NCT02493868|11242213|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
10111155|NCT02493868|11242214|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
10111156|NCT02493868|11242213|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
10111157|NCT02493868|11242214|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
10111158|NCT02493868|11242213|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
10111159|NCT02493868|11242214|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
10111160|NCT02493868|11242213|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
10111161|NCT02493868|11242214|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
10111162|NCT02493868|11242213|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90
10111163|NCT02493868|11242214|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86
10111164|NCT02493868|11242213|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62
10202927|NCT03454048|11330092|FG001|COMPLETED|Overall Study||6
10202928|NCT03454048|11330093|FG002|COMPLETED|Overall Study||6
10202929|NCT03454048|11330094|FG003|COMPLETED|Overall Study||6
10202930|NCT03454048|11330091|FG000|NOT COMPLETED|Overall Study||0
10202931|NCT03454048|11330092|FG001|NOT COMPLETED|Overall Study||0
10202932|NCT03454048|11330093|FG002|NOT COMPLETED|Overall Study||0
10202933|NCT03454048|11330094|FG003|NOT COMPLETED|Overall Study||0
10202934|NCT03454412|11330106|FG000|STARTED|Baseline Assesment||44
10202935|NCT03454412|11330106|FG000|COMPLETED|Baseline Assesment||32
10202936|NCT03454412|11330106|FG000|NOT COMPLETED|Baseline Assesment||12
10202937|NCT03454412|11330106|FG000|STARTED|Treatment Course||32
10202938|NCT03454412|11330106|FG000|COMPLETED|Treatment Course||32
10202939|NCT03454412|11330106|FG000|NOT COMPLETED|Treatment Course||0
10202940|NCT03454412|11330106|FG000|STARTED|Final Assesment||32
10202941|NCT03454412|11330106|FG000|COMPLETED|Final Assesment||32
10202942|NCT03454412|11330106|FG000|NOT COMPLETED|Final Assesment||0
10202943|NCT03454581|11330113|FG000|STARTED|Overall Study||18
10202944|NCT03454581|11330114|FG001|STARTED|Overall Study||16
10202945|NCT03454581|11330115|FG002|STARTED|Overall Study||17
10202946|NCT03454581|11330113|FG000|COMPLETED|Overall Study||14
10202947|NCT03454581|11330114|FG001|COMPLETED|Overall Study||13
10202948|NCT03454581|11330115|FG002|COMPLETED|Overall Study||14
10202949|NCT03454581|11330113|FG000|NOT COMPLETED|Overall Study||4
10202950|NCT03454581|11330114|FG001|NOT COMPLETED|Overall Study||3
10202951|NCT03454581|11330115|FG002|NOT COMPLETED|Overall Study||3
10202952|NCT03455218|11330126|FG000|STARTED|Overall Study||18
10202953|NCT03455218|11330127|FG001|STARTED|Overall Study||22
10202954|NCT03455218|11330126|FG000|COMPLETED|Overall Study||18
10202955|NCT03455218|11330127|FG001|COMPLETED|Overall Study||22
10202956|NCT03455218|11330126|FG000|NOT COMPLETED|Overall Study||0
10202957|NCT03455218|11330127|FG001|NOT COMPLETED|Overall Study||0
10202958|NCT03455491|11330136|FG000|STARTED|Overall Study||40
10202959|NCT03455491|11330137|FG001|STARTED|Overall Study||40
10202960|NCT03455491|11330138|FG002|STARTED|Overall Study||40
10202961|NCT03455491|11330136|FG000|COMPLETED|Overall Study||40
10202962|NCT03455491|11330137|FG001|COMPLETED|Overall Study||40
10202963|NCT03455491|11330138|FG002|COMPLETED|Overall Study||40
10202964|NCT03455491|11330136|FG000|NOT COMPLETED|Overall Study||0
10202965|NCT03455491|11330137|FG001|NOT COMPLETED|Overall Study||0
10202966|NCT03455491|11330138|FG002|NOT COMPLETED|Overall Study||0
10202967|NCT03455543|11330148|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92
10202968|NCT03455543|11330149|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90
10202969|NCT03455543|11330150|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0
10202970|NCT03455543|11330148|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
10202971|NCT03455543|11330149|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
10202972|NCT03455543|11330150|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
10202973|NCT03455543|11330148|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
10202974|NCT03455543|11330149|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
10202975|NCT03455543|11330150|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
9903635|NCT01149733|11019460|FG000|NOT COMPLETED|Overall Study||0
9903636|NCT01149733|11019461|FG001|NOT COMPLETED|Overall Study||0
9903637|NCT01149759|11019467|FG000|STARTED|Overall Study||9
9903638|NCT01149759|11019467|FG000|COMPLETED|Overall Study||9
9903639|NCT01149759|11019467|FG000|NOT COMPLETED|Overall Study||0
9903640|NCT01149772|11019473|FG000|STARTED|Overall Study||180
9903641|NCT01149772|11019474|FG001|STARTED|Overall Study||122
9903642|NCT01149772|11019473|FG000|COMPLETED|Overall Study||132
9903643|NCT01149772|11019474|FG001|COMPLETED|Overall Study||101
9903644|NCT01149772|11019473|FG000|NOT COMPLETED|Overall Study||48
9903645|NCT01149772|11019474|FG001|NOT COMPLETED|Overall Study||21
9903646|NCT01149785|11019482|FG000|STARTED|First Intervention||15
9903647|NCT01149785|11019483|FG001|STARTED|First Intervention||0
9903648|NCT01149785|11019482|FG000|COMPLETED|First Intervention||15
9903649|NCT01149785|11019483|FG001|COMPLETED|First Intervention||0
9903650|NCT01149785|11019482|FG000|NOT COMPLETED|First Intervention||0
9903651|NCT01149785|11019483|FG001|NOT COMPLETED|First Intervention||0
9903652|NCT01149785|11019482|FG000|STARTED|Washout Period of at Least 14 Days||15
9903653|NCT01149785|11019483|FG001|STARTED|Washout Period of at Least 14 Days||0
9903654|NCT01149785|11019482|FG000|COMPLETED|Washout Period of at Least 14 Days||15
9903655|NCT01149785|11019483|FG001|COMPLETED|Washout Period of at Least 14 Days||0
9903656|NCT01149785|11019482|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
9903657|NCT01149785|11019483|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
9903658|NCT01149785|11019482|FG000|STARTED|Second Intervention||0
9903659|NCT01149785|11019483|FG001|STARTED|Second Intervention||15
9903660|NCT01149785|11019482|FG000|COMPLETED|Second Intervention||0
9903661|NCT01149785|11019483|FG001|COMPLETED|Second Intervention||15
9903662|NCT01149785|11019482|FG000|NOT COMPLETED|Second Intervention||0
9903663|NCT01149785|11019483|FG001|NOT COMPLETED|Second Intervention||0
9903664|NCT01149863|11019489|FG000|STARTED|Overall Study||34
9903665|NCT01149863|11019489|FG000|COMPLETED|Overall Study||31
9903666|NCT01149863|11019489|FG000|NOT COMPLETED|Overall Study||3
9903667|NCT01149876|11019497|FG000|STARTED|Overall Study||21
9903668|NCT01149876|11019498|FG001|STARTED|Overall Study||20
9903669|NCT01149876|11019499|FG002|STARTED|Overall Study||21
9903670|NCT01149876|11019500|FG003|STARTED|Overall Study||18
9903671|NCT01149876|11019497|FG000|COMPLETED|Overall Study||20
9903672|NCT01149876|11019498|FG001|COMPLETED|Overall Study||20
9903673|NCT01149876|11019499|FG002|COMPLETED|Overall Study||20
9903674|NCT01149876|11019500|FG003|COMPLETED|Overall Study||18
9903675|NCT01149876|11019497|FG000|NOT COMPLETED|Overall Study||1
9903676|NCT01149876|11019498|FG001|NOT COMPLETED|Overall Study||0
10202976|NCT03455543|11330148|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0
10202977|NCT03455543|11330149|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0
10202978|NCT03455543|11330150|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152
10202979|NCT03455543|11330148|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10202980|NCT03455543|11330149|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10202981|NCT03455543|11330150|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
10202982|NCT03455543|11330148|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10202983|NCT03455543|11330149|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10202984|NCT03455543|11330150|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
10202985|NCT03456245|11330158|FG000|STARTED|Overall Study||205
10202986|NCT03456245|11330158|FG000|COMPLETED|Overall Study||190
10202987|NCT03456245|11330158|FG000|NOT COMPLETED|Overall Study||15
10202988|NCT03456427|11330162|FG000|STARTED|Overall Study||36
10202989|NCT03456427|11330162|FG000|COMPLETED|Overall Study||33
10202990|NCT03456427|11330162|FG000|NOT COMPLETED|Overall Study||3
10202991|NCT03456856|11330167|FG000|STARTED|Overall Study||30
10202992|NCT03456856|11330167|FG000|COMPLETED|Overall Study||27
10202993|NCT03456856|11330167|FG000|NOT COMPLETED|Overall Study||3
10202994|NCT03456960|11330177|FG000|STARTED|Period 1 (1 Day)||12
10202995|NCT03456960|11330178|FG001|STARTED|Period 1 (1 Day)||12
10202996|NCT03456960|11330179|FG002|STARTED|Period 1 (1 Day)||120
10202997|NCT03456960|11330180|FG003|STARTED|Period 1 (1 Day)||120
10202998|NCT03456960|11330181|FG004|STARTED|Period 1 (1 Day)||6
10202999|NCT03456960|11330182|FG005|STARTED|Period 1 (1 Day)||6
10203000|NCT03456960|11330177|FG000|COMPLETED|Period 1 (1 Day)||12
10203001|NCT03456960|11330178|FG001|COMPLETED|Period 1 (1 Day)||12
10203002|NCT03456960|11330179|FG002|COMPLETED|Period 1 (1 Day)||120
10203003|NCT03456960|11330180|FG003|COMPLETED|Period 1 (1 Day)||120
10203004|NCT03456960|11330181|FG004|COMPLETED|Period 1 (1 Day)||6
10203005|NCT03456960|11330182|FG005|COMPLETED|Period 1 (1 Day)||6
10203006|NCT03456960|11330177|FG000|NOT COMPLETED|Period 1 (1 Day)||0
10203007|NCT03456960|11330178|FG001|NOT COMPLETED|Period 1 (1 Day)||0
10203008|NCT03456960|11330179|FG002|NOT COMPLETED|Period 1 (1 Day)||0
10203009|NCT03456960|11330180|FG003|NOT COMPLETED|Period 1 (1 Day)||0
10203010|NCT03456960|11330181|FG004|NOT COMPLETED|Period 1 (1 Day)||0
10203011|NCT03456960|11330182|FG005|NOT COMPLETED|Period 1 (1 Day)||0
10203012|NCT03456960|11330177|FG000|STARTED|Washout Period (at Least 14 Days)||12
10203013|NCT03456960|11330178|FG001|STARTED|Washout Period (at Least 14 Days)||12
10203014|NCT03456960|11330179|FG002|STARTED|Washout Period (at Least 14 Days)||120
9903677|NCT01149876|11019499|FG002|NOT COMPLETED|Overall Study||1
9903678|NCT01149876|11019500|FG003|NOT COMPLETED|Overall Study||0
9903679|NCT01150097|11019514|FG000|STARTED|Months 24 to 36 Post-transplantation||106
9903680|NCT01150097|11019515|FG001|STARTED|Months 24 to 36 Post-transplantation||51
9903681|NCT01150097|11019516|FG002|STARTED|Months 24 to 36 Post-transplantation||125
9903682|NCT01150097|11019514|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96
10203015|NCT03456960|11330180|FG003|STARTED|Washout Period (at Least 14 Days)||120
9903683|NCT01150097|11019515|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49
9903684|NCT01150097|11019516|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117
9903685|NCT01150097|11019514|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
9903686|NCT01150097|11019515|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
9903687|NCT01150097|11019516|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
9903688|NCT01150097|11019514|FG000|STARTED|Months 24 to 48 Post-transplantation||106
9903689|NCT01150097|11019515|FG001|STARTED|Months 24 to 48 Post-transplantation||51
9903690|NCT01150097|11019516|FG002|STARTED|Months 24 to 48 Post-transplantation||0
9903691|NCT01150097|11019514|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95
9903692|NCT01150097|11019515|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47
9903693|NCT01150097|11019516|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0
9903694|NCT01150097|11019514|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
9903695|NCT01150097|11019515|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
9903696|NCT01150097|11019516|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
9903697|NCT01150123|11019544|FG000|STARTED|Overall Study||40
9903698|NCT01150123|11019545|FG001|STARTED|Overall Study||40
9903699|NCT01150123|11019546|FG002|STARTED|Overall Study||39
9903700|NCT01150123|11019547|FG003|STARTED|Overall Study||40
9903701|NCT01150123|11019548|FG004|STARTED|Overall Study||40
9903702|NCT01150123|11019549|FG005|STARTED|Overall Study||40
9903703|NCT01150123|11019550|FG006|STARTED|Overall Study||39
9903704|NCT01150123|11019551|FG007|STARTED|Overall Study||40
9903705|NCT01150123|11019552|FG008|STARTED|Overall Study||20
9903706|NCT01150123|11019553|FG009|STARTED|Overall Study||40
9903707|NCT01150123|11019554|FG010|STARTED|Overall Study||40
9903708|NCT01150123|11019555|FG011|STARTED|Overall Study||40
9903709|NCT01150123|11019556|FG012|STARTED|Overall Study||40
10203016|NCT03456960|11330181|FG004|STARTED|Washout Period (at Least 14 Days)||6
10203017|NCT03456960|11330182|FG005|STARTED|Washout Period (at Least 14 Days)||6
10203018|NCT03456960|11330177|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
10203019|NCT03456960|11330178|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
10203020|NCT03456960|11330179|FG002|COMPLETED|Washout Period (at Least 14 Days)||119
10203021|NCT03456960|11330180|FG003|COMPLETED|Washout Period (at Least 14 Days)||118
10203022|NCT03456960|11330181|FG004|COMPLETED|Washout Period (at Least 14 Days)||6
10203023|NCT03456960|11330182|FG005|COMPLETED|Washout Period (at Least 14 Days)||6
10203024|NCT03456960|11330177|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10203025|NCT03456960|11330178|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10203026|NCT03456960|11330179|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1
10203027|NCT03456960|11330180|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2
10203028|NCT03456960|11330181|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10203029|NCT03456960|11330182|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10203030|NCT03456960|11330177|FG000|STARTED|Period 2 (1 Day)||12
10203031|NCT03456960|11330178|FG001|STARTED|Period 2 (1 Day)||12
10203032|NCT03456960|11330179|FG002|STARTED|Period 2 (1 Day)||119
10203033|NCT03456960|11330180|FG003|STARTED|Period 2 (1 Day)||118
10203034|NCT03456960|11330181|FG004|STARTED|Period 2 (1 Day)||6
10203035|NCT03456960|11330182|FG005|STARTED|Period 2 (1 Day)||6
10203036|NCT03456960|11330177|FG000|COMPLETED|Period 2 (1 Day)||11
10203037|NCT03456960|11330178|FG001|COMPLETED|Period 2 (1 Day)||12
10203038|NCT03456960|11330179|FG002|COMPLETED|Period 2 (1 Day)||119
10203039|NCT03456960|11330180|FG003|COMPLETED|Period 2 (1 Day)||117
10203040|NCT03456960|11330181|FG004|COMPLETED|Period 2 (1 Day)||6
10203041|NCT03456960|11330182|FG005|COMPLETED|Period 2 (1 Day)||6
10203042|NCT03456960|11330177|FG000|NOT COMPLETED|Period 2 (1 Day)||1
10203043|NCT03456960|11330178|FG001|NOT COMPLETED|Period 2 (1 Day)||0
10203044|NCT03456960|11330179|FG002|NOT COMPLETED|Period 2 (1 Day)||0
10203045|NCT03456960|11330180|FG003|NOT COMPLETED|Period 2 (1 Day)||1
10203046|NCT03456960|11330181|FG004|NOT COMPLETED|Period 2 (1 Day)||0
10203047|NCT03456960|11330182|FG005|NOT COMPLETED|Period 2 (1 Day)||0
10203048|NCT03457103|11330200|FG000|STARTED|Overall Study||22
10203049|NCT03457103|11330201|FG001|STARTED|Overall Study||9
10203050|NCT03457103|11330200|FG000|COMPLETED|Overall Study||14
10203051|NCT03457103|11330201|FG001|COMPLETED|Overall Study||3
10203052|NCT03457103|11330200|FG000|NOT COMPLETED|Overall Study||8
10203053|NCT03457103|11330201|FG001|NOT COMPLETED|Overall Study||6
10203054|NCT03457116|11330209|FG000|STARTED|Overall Study||41
10203055|NCT03457116|11330210|FG001|STARTED|Overall Study||29
10203056|NCT03457116|11330209|FG000|COMPLETED|Overall Study||41
10203057|NCT03457116|11330210|FG001|COMPLETED|Overall Study||29
10203058|NCT03457116|11330209|FG000|NOT COMPLETED|Overall Study||0
10203059|NCT03457116|11330210|FG001|NOT COMPLETED|Overall Study||0
10203060|NCT03457636|11330216|FG000|STARTED|Overall Study||22
10203061|NCT03457636|11330216|FG000|COMPLETED|Overall Study||20
10203062|NCT03457636|11330216|FG000|NOT COMPLETED|Overall Study||2
10203063|NCT03457727|11330224|FG000|STARTED|Part 1, Period 1 (1 Day)||8
10203064|NCT03457727|11330225|FG001|STARTED|Part 1, Period 1 (1 Day)||8
10203065|NCT03457727|11330226|FG002|STARTED|Part 1, Period 1 (1 Day)||0
10203066|NCT03457727|11330227|FG003|STARTED|Part 1, Period 1 (1 Day)||0
9903710|NCT01150123|11019557|FG013|STARTED|Overall Study||40
9903711|NCT01150123|11019558|FG014|STARTED|Overall Study||40
9903712|NCT01150123|11019559|FG015|STARTED|Overall Study||40
10203067|NCT03457727|11330224|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8
10203068|NCT03457727|11330225|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8
10203069|NCT03457727|11330226|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
10203070|NCT03457727|11330227|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
9903713|NCT01150123|11019560|FG016|STARTED|Overall Study||40
9903714|NCT01150123|11019561|FG017|STARTED|Overall Study||20
9903715|NCT01150123|11019544|FG000|COMPLETED|Overall Study||37
9903716|NCT01150123|11019545|FG001|COMPLETED|Overall Study||38
9903717|NCT01150123|11019546|FG002|COMPLETED|Overall Study||35
9903718|NCT01150123|11019547|FG003|COMPLETED|Overall Study||37
9903719|NCT01150123|11019548|FG004|COMPLETED|Overall Study||37
9903720|NCT01150123|11019549|FG005|COMPLETED|Overall Study||34
9903721|NCT01150123|11019550|FG006|COMPLETED|Overall Study||39
9903722|NCT01150123|11019551|FG007|COMPLETED|Overall Study||37
9903723|NCT01150123|11019552|FG008|COMPLETED|Overall Study||15
10203071|NCT03457727|11330224|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10203072|NCT03457727|11330225|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10203073|NCT03457727|11330226|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10203074|NCT03457727|11330227|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10203075|NCT03457727|11330224|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8
10203076|NCT03457727|11330225|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8
10203077|NCT03457727|11330226|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0
10203078|NCT03457727|11330227|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0
10203079|NCT03457727|11330224|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
10203080|NCT03457727|11330225|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
10203081|NCT03457727|11330226|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10203082|NCT03457727|11330227|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10203083|NCT03457727|11330224|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10203084|NCT03457727|11330225|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10203085|NCT03457727|11330226|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10203086|NCT03457727|11330227|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10203087|NCT03457727|11330224|FG000|STARTED|Part 1, Period 2 (1 Day)||8
10203088|NCT03457727|11330225|FG001|STARTED|Part 1, Period 2 (1 Day)||8
10203089|NCT03457727|11330226|FG002|STARTED|Part 1, Period 2 (1 Day)||0
10203090|NCT03457727|11330227|FG003|STARTED|Part 1, Period 2 (1 Day)||0
10203091|NCT03457727|11330224|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8
10203092|NCT03457727|11330225|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8
10203093|NCT03457727|11330226|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
10203094|NCT03457727|11330227|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
10203095|NCT03457727|11330224|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10203096|NCT03457727|11330225|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10203097|NCT03457727|11330226|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10203098|NCT03457727|11330227|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10203099|NCT03457727|11330224|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8
10203100|NCT03457727|11330225|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8
10203101|NCT03457727|11330226|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0
10203102|NCT03457727|11330227|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0
10203103|NCT03457727|11330224|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
10203104|NCT03457727|11330225|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
10203105|NCT03457727|11330226|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10203106|NCT03457727|11330227|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10203107|NCT03457727|11330224|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10203108|NCT03457727|11330225|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10203109|NCT03457727|11330226|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10203110|NCT03457727|11330227|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10203111|NCT03457727|11330224|FG000|STARTED|Part 1, Period 3 (1 Day)||8
10203112|NCT03457727|11330225|FG001|STARTED|Part 1, Period 3 (1 Day)||8
10203113|NCT03457727|11330226|FG002|STARTED|Part 1, Period 3 (1 Day)||0
10203114|NCT03457727|11330227|FG003|STARTED|Part 1, Period 3 (1 Day)||0
10203115|NCT03457727|11330224|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8
10203116|NCT03457727|11330225|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8
10203117|NCT03457727|11330226|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0
10203118|NCT03457727|11330227|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0
10203119|NCT03457727|11330224|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10203120|NCT03457727|11330225|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10203121|NCT03457727|11330226|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10203122|NCT03457727|11330227|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10203123|NCT03457727|11330224|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8
10203124|NCT03457727|11330225|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8
10203125|NCT03457727|11330226|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0
10203126|NCT03457727|11330227|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0
10203127|NCT03457727|11330224|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
10203128|NCT03457727|11330225|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
10203129|NCT03457727|11330226|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10203130|NCT03457727|11330227|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10203131|NCT03457727|11330224|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10203132|NCT03457727|11330225|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10203133|NCT03457727|11330226|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10203134|NCT03457727|11330227|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
9903724|NCT01150123|11019553|FG009|COMPLETED|Overall Study||39
9903725|NCT01150123|11019554|FG010|COMPLETED|Overall Study||38
9903726|NCT01150123|11019555|FG011|COMPLETED|Overall Study||39
9903727|NCT01150123|11019556|FG012|COMPLETED|Overall Study||37
9903728|NCT01150123|11019557|FG013|COMPLETED|Overall Study||40
9903729|NCT01150123|11019558|FG014|COMPLETED|Overall Study||40
9903730|NCT01150123|11019559|FG015|COMPLETED|Overall Study||39
9903731|NCT01150123|11019560|FG016|COMPLETED|Overall Study||40
9903732|NCT01150123|11019561|FG017|COMPLETED|Overall Study||19
9903733|NCT01150123|11019544|FG000|NOT COMPLETED|Overall Study||3
9903734|NCT01150123|11019545|FG001|NOT COMPLETED|Overall Study||2
9903735|NCT01150123|11019546|FG002|NOT COMPLETED|Overall Study||4
9903736|NCT01150123|11019547|FG003|NOT COMPLETED|Overall Study||3
9903737|NCT01150123|11019548|FG004|NOT COMPLETED|Overall Study||3
9903738|NCT01150123|11019549|FG005|NOT COMPLETED|Overall Study||6
9903739|NCT01150123|11019550|FG006|NOT COMPLETED|Overall Study||0
9903740|NCT01150123|11019551|FG007|NOT COMPLETED|Overall Study||3
9903741|NCT01150123|11019552|FG008|NOT COMPLETED|Overall Study||5
9903742|NCT01150123|11019553|FG009|NOT COMPLETED|Overall Study||1
9903743|NCT01150123|11019554|FG010|NOT COMPLETED|Overall Study||2
9903744|NCT01150123|11019555|FG011|NOT COMPLETED|Overall Study||1
9903745|NCT01150123|11019556|FG012|NOT COMPLETED|Overall Study||3
9903746|NCT01150123|11019557|FG013|NOT COMPLETED|Overall Study||0
9903747|NCT01150123|11019558|FG014|NOT COMPLETED|Overall Study||0
9903748|NCT01150123|11019559|FG015|NOT COMPLETED|Overall Study||1
9903749|NCT01150123|11019560|FG016|NOT COMPLETED|Overall Study||0
9903750|NCT01150123|11019561|FG017|NOT COMPLETED|Overall Study||1
9903751|NCT01150357|11019621|FG000|STARTED|Dose Response Phase (Phase 1)||108
9903752|NCT01150357|11019622|FG001|STARTED|Dose Response Phase (Phase 1)||54
9903753|NCT01150357|11019623|FG002|STARTED|Dose Response Phase (Phase 1)||105
9903754|NCT01150357|11019621|FG000|COMPLETED|Dose Response Phase (Phase 1)||107
9903755|NCT01150357|11019622|FG001|COMPLETED|Dose Response Phase (Phase 1)||51
9903756|NCT01150357|11019623|FG002|COMPLETED|Dose Response Phase (Phase 1)||102
9903757|NCT01150357|11019621|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1
9903758|NCT01150357|11019622|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3
9903759|NCT01150357|11019623|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3
9903760|NCT01150357|11019621|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
9903761|NCT01150357|11019622|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
10009414|NCT01765920|11131967|FG000|NOT COMPLETED|Overall Study||2
10009415|NCT01765920|11131968|FG001|NOT COMPLETED|Overall Study||6
10009416|NCT01765972|11131974|FG000|STARTED|Overall Study||6
10009417|NCT01765972|11131975|FG001|STARTED|Overall Study||6
10009418|NCT01765972|11131976|FG002|STARTED|Overall Study||6
10009419|NCT01765972|11131977|FG003|STARTED|Overall Study||6
10009420|NCT01765972|11131974|FG000|COMPLETED|Overall Study||6
10009421|NCT01765972|11131975|FG001|COMPLETED|Overall Study||6
10009422|NCT01765972|11131976|FG002|COMPLETED|Overall Study||6
10009423|NCT01765972|11131977|FG003|COMPLETED|Overall Study||6
10009424|NCT01765972|11131974|FG000|NOT COMPLETED|Overall Study||0
10009425|NCT01765972|11131975|FG001|NOT COMPLETED|Overall Study||0
10009426|NCT01765972|11131976|FG002|NOT COMPLETED|Overall Study||0
10009427|NCT01765972|11131977|FG003|NOT COMPLETED|Overall Study||0
10009428|NCT01766024|11131989|FG000|STARTED|Overall Study||16
10009429|NCT01766024|11131990|FG001|STARTED|Overall Study||16
10009430|NCT01766024|11131989|FG000|COMPLETED|Overall Study||16
10009431|NCT01766024|11131990|FG001|COMPLETED|Overall Study||16
9903762|NCT01150357|11019623|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
9903763|NCT01150357|11019621|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
9903764|NCT01150357|11019622|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
9903765|NCT01150357|11019623|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
9903766|NCT01150357|11019621|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
9903767|NCT01150357|11019622|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
9903768|NCT01150357|11019623|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
9903769|NCT01150357|11019621|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
9903770|NCT01150357|11019622|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
9903771|NCT01150357|11019623|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
9903772|NCT01150357|11019621|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
9903773|NCT01150357|11019622|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
9903774|NCT01150357|11019623|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
9903775|NCT01150357|11019621|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
9903776|NCT01150357|11019622|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
9903777|NCT01150357|11019623|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
9903778|NCT01150357|11019621|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
9903779|NCT01150357|11019622|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
9903780|NCT01150357|11019623|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
9903781|NCT01150461|11019645|FG000|STARTED|Overall Study||11
9903782|NCT01150461|11019646|FG001|STARTED|Overall Study||9
9903783|NCT01150461|11019645|FG000|COMPLETED|Overall Study||11
9903784|NCT01150461|11019646|FG001|COMPLETED|Overall Study||9
9903785|NCT01150461|11019645|FG000|NOT COMPLETED|Overall Study||0
10009432|NCT01766024|11131989|FG000|NOT COMPLETED|Overall Study||0
10009433|NCT01766024|11131990|FG001|NOT COMPLETED|Overall Study||0
10009434|NCT01766037|11132000|FG000|STARTED|Overall Study||111
10009435|NCT01766037|11132001|FG001|STARTED|Overall Study||60
10009436|NCT01766037|11132000|FG000|COMPLETED|Overall Study||82
10009437|NCT01766037|11132001|FG001|COMPLETED|Overall Study||31
9903786|NCT01150461|11019646|FG001|NOT COMPLETED|Overall Study||0
10009438|NCT01766037|11132000|FG000|NOT COMPLETED|Overall Study||29
10203135|NCT03457727|11330224|FG000|STARTED|Part 1, Period 4 (1 Day)||8
10203136|NCT03457727|11330225|FG001|STARTED|Part 1, Period 4 (1 Day)||8
10203137|NCT03457727|11330226|FG002|STARTED|Part 1, Period 4 (1 Day)||0
10203138|NCT03457727|11330227|FG003|STARTED|Part 1, Period 4 (1 Day)||0
9903787|NCT01150474|11019654|FG000|STARTED|Overall Study||51
9903788|NCT01150474|11019655|FG001|STARTED|Overall Study||52
9903789|NCT01150474|11019654|FG000|COMPLETED|Overall Study||41
9903790|NCT01150474|11019655|FG001|COMPLETED|Overall Study||49
9903791|NCT01150474|11019654|FG000|NOT COMPLETED|Overall Study||10
9903792|NCT01150474|11019655|FG001|NOT COMPLETED|Overall Study||3
9903793|NCT01150500|11019661|FG000|STARTED|Overall Study||65
9903794|NCT01150500|11019661|FG000|COMPLETED|Overall Study||0
9903795|NCT01150500|11019661|FG000|NOT COMPLETED|Overall Study||65
10203139|NCT03457727|11330224|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8
10203140|NCT03457727|11330225|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8
10203141|NCT03457727|11330226|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0
10203142|NCT03457727|11330227|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0
10203143|NCT03457727|11330224|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10203144|NCT03457727|11330225|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10203145|NCT03457727|11330226|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10203146|NCT03457727|11330227|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10203147|NCT03457727|11330224|FG000|STARTED|Part 2, Period 1 (1 Day)||0
10203148|NCT03457727|11330225|FG001|STARTED|Part 2, Period 1 (1 Day)||0
10203149|NCT03457727|11330226|FG002|STARTED|Part 2, Period 1 (1 Day)||12
10203150|NCT03457727|11330227|FG003|STARTED|Part 2, Period 1 (1 Day)||12
10203151|NCT03457727|11330224|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
10203152|NCT03457727|11330225|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
10203153|NCT03457727|11330226|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12
10203154|NCT03457727|11330227|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12
10203155|NCT03457727|11330224|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10203156|NCT03457727|11330225|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10203157|NCT03457727|11330226|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10203158|NCT03457727|11330227|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10203159|NCT03457727|11330224|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0
10203160|NCT03457727|11330225|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0
10203161|NCT03457727|11330226|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12
10203162|NCT03457727|11330227|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12
10203163|NCT03457727|11330224|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10203164|NCT03457727|11330225|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10203165|NCT03457727|11330226|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
10203166|NCT03457727|11330227|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
10203167|NCT03457727|11330224|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10203168|NCT03457727|11330225|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10203169|NCT03457727|11330226|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10203170|NCT03457727|11330227|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
10203171|NCT03457727|11330224|FG000|STARTED|Part 2, Period 2 (1 Day)||0
10203172|NCT03457727|11330225|FG001|STARTED|Part 2, Period 2 (1 Day)||0
10203173|NCT03457727|11330226|FG002|STARTED|Part 2, Period 2 (1 Day)||12
10203174|NCT03457727|11330227|FG003|STARTED|Part 2, Period 2 (1 Day)||11
10203175|NCT03457727|11330224|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
10203176|NCT03457727|11330225|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
10203177|NCT03457727|11330226|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12
10203178|NCT03457727|11330227|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11
10203179|NCT03457727|11330224|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10203180|NCT03457727|11330225|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10203181|NCT03457727|11330226|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10203182|NCT03457727|11330227|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10203183|NCT03457727|11330224|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0
10203184|NCT03457727|11330225|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0
10203185|NCT03457727|11330226|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12
10203186|NCT03457727|11330227|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11
10203187|NCT03457727|11330224|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10203188|NCT03457727|11330225|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10203189|NCT03457727|11330226|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
10203190|NCT03457727|11330227|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
10203191|NCT03457727|11330224|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10203192|NCT03457727|11330225|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10203193|NCT03457727|11330226|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10203194|NCT03457727|11330227|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10203195|NCT03457727|11330224|FG000|STARTED|Part 2, Period 3 (1 Day)||0
10203196|NCT03457727|11330225|FG001|STARTED|Part 2, Period 3 (1 Day)||0
10203197|NCT03457727|11330226|FG002|STARTED|Part 2, Period 3 (1 Day)||12
10203198|NCT03457727|11330227|FG003|STARTED|Part 2, Period 3 (1 Day)||11
10203199|NCT03457727|11330224|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0
10203200|NCT03457727|11330225|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0
10203201|NCT03457727|11330226|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12
9903796|NCT01150760|11019667|FG000|STARTED|Overall Study||3525
10203202|NCT03457727|11330227|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11
10203203|NCT03457727|11330224|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
10203204|NCT03457727|11330225|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
10203205|NCT03457727|11330226|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
9903797|NCT01150760|11019668|FG001|STARTED|Overall Study||3525
9903798|NCT01150760|11019667|FG000|COMPLETED|Overall Study||3525
9903799|NCT01150760|11019668|FG001|COMPLETED|Overall Study||3525
9903800|NCT01150760|11019667|FG000|NOT COMPLETED|Overall Study||0
9903801|NCT01150760|11019668|FG001|NOT COMPLETED|Overall Study||0
9903802|NCT01150838|11019679|FG000|STARTED|Overall Study||19
9903803|NCT01150838|11019680|FG001|STARTED|Overall Study||26
9903804|NCT01150838|11019681|FG002|STARTED|Overall Study||24
9903805|NCT01150838|11019682|FG003|STARTED|Overall Study||15
9903806|NCT01150838|11019683|FG004|STARTED|Overall Study||16
9903807|NCT01150838|11019684|FG005|STARTED|Overall Study||2
9903808|NCT01150838|11019679|FG000|COMPLETED|Overall Study||19
9903809|NCT01150838|11019680|FG001|COMPLETED|Overall Study||26
9903810|NCT01150838|11019681|FG002|COMPLETED|Overall Study||24
9903811|NCT01150838|11019682|FG003|COMPLETED|Overall Study||15
10203206|NCT03457727|11330227|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
10203207|NCT03457727|11330224|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0
10203208|NCT03457727|11330225|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0
10203209|NCT03457727|11330226|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12
10203210|NCT03457727|11330227|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11
10203211|NCT03457727|11330224|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10203212|NCT03457727|11330225|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10203213|NCT03457727|11330226|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
10203214|NCT03457727|11330227|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
10203215|NCT03457727|11330224|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10203216|NCT03457727|11330225|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10203217|NCT03457727|11330226|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10203218|NCT03457727|11330227|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10203219|NCT03457727|11330224|FG000|STARTED|Part 2, Period 4 (1 Day)||0
10203220|NCT03457727|11330225|FG001|STARTED|Part 2, Period 4 (1 Day)||0
10203221|NCT03457727|11330226|FG002|STARTED|Part 2, Period 4 (1 Day)||12
10203222|NCT03457727|11330227|FG003|STARTED|Part 2, Period 4 (1 Day)||0
10203223|NCT03457727|11330224|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0
10203224|NCT03457727|11330225|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0
10203225|NCT03457727|11330226|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12
10203226|NCT03457727|11330227|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0
10203227|NCT03457727|11330224|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10203228|NCT03457727|11330225|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10203229|NCT03457727|11330226|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10203230|NCT03457727|11330227|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10203231|NCT03457909|11330259|FG000|STARTED|Overall Study||25
10203232|NCT03457909|11330259|FG000|COMPLETED|Overall Study||25
10203233|NCT03457909|11330259|FG000|NOT COMPLETED|Overall Study||0
10203234|NCT03458702|11330263|FG000|STARTED|Study Condition A (Yoga or Rest)||28
10203235|NCT03458702|11330264|FG001|STARTED|Study Condition A (Yoga or Rest)||28
10203236|NCT03458702|11330263|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24
10203237|NCT03458702|11330264|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22
10203238|NCT03458702|11330263|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
10203239|NCT03458702|11330264|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
10203240|NCT03458702|11330263|FG000|STARTED|Study Condition B (Yoga or Rest)||24
10203241|NCT03458702|11330264|FG001|STARTED|Study Condition B (Yoga or Rest)||22
10203242|NCT03458702|11330263|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20
10203243|NCT03458702|11330264|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20
10203244|NCT03458702|11330263|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
10203245|NCT03458702|11330264|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
10203246|NCT03458702|11330263|FG000|STARTED|Picture Rating/Body Composition||20
10203247|NCT03458702|11330264|FG001|STARTED|Picture Rating/Body Composition||20
10203248|NCT03458702|11330263|FG000|COMPLETED|Picture Rating/Body Composition||20
10203249|NCT03458702|11330264|FG001|COMPLETED|Picture Rating/Body Composition||20
10203250|NCT03458702|11330263|FG000|NOT COMPLETED|Picture Rating/Body Composition||0
10203251|NCT03458702|11330264|FG001|NOT COMPLETED|Picture Rating/Body Composition||0
10203252|NCT03458871|11330270|FG000|STARTED|Overall Study||16
10203253|NCT03458871|11330270|FG000|COMPLETED|Overall Study||16
10203254|NCT03458871|11330270|FG000|NOT COMPLETED|Overall Study||0
10203255|NCT03459040|11330274|FG000|STARTED|Overall Study||30
10203256|NCT03459040|11330274|FG000|COMPLETED|Overall Study||21
10203257|NCT03459040|11330274|FG000|NOT COMPLETED|Overall Study||9
10203258|NCT03459131|11330279|FG000|STARTED|Period 1, First 7 Days of Wear||7
10203259|NCT03459131|11330280|FG001|STARTED|Period 1, First 7 Days of Wear||8
10203260|NCT03459131|11330279|FG000|COMPLETED|Period 1, First 7 Days of Wear||7
10203261|NCT03459131|11330280|FG001|COMPLETED|Period 1, First 7 Days of Wear||8
10203262|NCT03459131|11330279|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10203263|NCT03459131|11330280|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10203264|NCT03459131|11330279|FG000|STARTED|Period 2, Second 7 Days of Wear||7
10203265|NCT03459131|11330280|FG001|STARTED|Period 2, Second 7 Days of Wear||8
10203266|NCT03459131|11330279|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7
10203267|NCT03459131|11330280|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8
10203268|NCT03459131|11330279|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10203269|NCT03459131|11330280|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10203270|NCT03459196|11330286|FG000|STARTED|Overall Study||54
10203271|NCT03459196|11330286|FG000|COMPLETED|Overall Study||52
10203272|NCT03459196|11330286|FG000|NOT COMPLETED|Overall Study||2
9903812|NCT01150838|11019683|FG004|COMPLETED|Overall Study||16
10203273|NCT03459612|11330294|FG000|STARTED|Period 1||17
10203274|NCT03459612|11330295|FG001|STARTED|Period 1||17
9903813|NCT01150838|11019684|FG005|COMPLETED|Overall Study||2
9903814|NCT01150838|11019679|FG000|NOT COMPLETED|Overall Study||0
9903815|NCT01150838|11019680|FG001|NOT COMPLETED|Overall Study||0
9903816|NCT01150838|11019681|FG002|NOT COMPLETED|Overall Study||0
9903817|NCT01150838|11019682|FG003|NOT COMPLETED|Overall Study||0
9903818|NCT01150838|11019683|FG004|NOT COMPLETED|Overall Study||0
9903819|NCT01150838|11019684|FG005|NOT COMPLETED|Overall Study||0
9903820|NCT01150903|11019694|FG000|STARTED|Overall Study||24708
10009439|NCT01766037|11132001|FG001|NOT COMPLETED|Overall Study||29
10009440|NCT01766050|11132007|FG000|STARTED|Overall Study||22
10009441|NCT01766050|11132007|FG000|COMPLETED|Overall Study||18
10009442|NCT01766050|11132007|FG000|NOT COMPLETED|Overall Study||4
10019003|NCT01826981|11142060|FG009|COMPLETED|Overall Study||26
10019004|NCT01826981|11142061|FG010|COMPLETED|Overall Study||22
10203275|NCT03459612|11330296|FG002|STARTED|Period 1||17
10203276|NCT03459612|11330297|FG003|STARTED|Period 1||17
10203277|NCT03459612|11330294|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
10203278|NCT03459612|11330295|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
10203279|NCT03459612|11330296|FG002|Received at Least 1 Dose of Study Drug|Period 1||17
10203280|NCT03459612|11330297|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
10203281|NCT03459612|11330294|FG000|COMPLETED|Period 1||17
10203282|NCT03459612|11330295|FG001|COMPLETED|Period 1||17
10203283|NCT03459612|11330296|FG002|COMPLETED|Period 1||17
10203284|NCT03459612|11330297|FG003|COMPLETED|Period 1||17
10203285|NCT03459612|11330294|FG000|NOT COMPLETED|Period 1||0
10203286|NCT03459612|11330295|FG001|NOT COMPLETED|Period 1||0
10203287|NCT03459612|11330296|FG002|NOT COMPLETED|Period 1||0
10203288|NCT03459612|11330297|FG003|NOT COMPLETED|Period 1||0
10203289|NCT03459612|11330294|FG000|STARTED|Period 2||17
10019005|NCT01826981|11142062|FG011|COMPLETED|Overall Study||25
10019006|NCT01826981|11142063|FG012|COMPLETED|Overall Study||25
10019007|NCT01826981|11142064|FG013|COMPLETED|Overall Study||15
10019008|NCT01826981|11142065|FG014|COMPLETED|Overall Study||8
10019009|NCT01826981|11142051|FG000|NOT COMPLETED|Overall Study||0
10203290|NCT03459612|11330295|FG001|STARTED|Period 2||17
10203291|NCT03459612|11330296|FG002|STARTED|Period 2||17
10203292|NCT03459612|11330297|FG003|STARTED|Period 2||17
10203293|NCT03459612|11330294|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
10203294|NCT03459612|11330295|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
10203295|NCT03459612|11330296|FG002|Received at Least 1 Dose of Study Drug|Period 2||17
10203296|NCT03459612|11330297|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
10203297|NCT03459612|11330294|FG000|COMPLETED|Period 2||17
10203298|NCT03459612|11330295|FG001|COMPLETED|Period 2||17
10203299|NCT03459612|11330296|FG002|COMPLETED|Period 2||17
10203300|NCT03459612|11330297|FG003|COMPLETED|Period 2||17
10203301|NCT03459612|11330294|FG000|NOT COMPLETED|Period 2||0
10203302|NCT03459612|11330295|FG001|NOT COMPLETED|Period 2||0
10203303|NCT03459612|11330296|FG002|NOT COMPLETED|Period 2||0
10203304|NCT03459612|11330297|FG003|NOT COMPLETED|Period 2||0
10203305|NCT03459612|11330294|FG000|STARTED|Period 3||17
10203306|NCT03459612|11330295|FG001|STARTED|Period 3||17
10203307|NCT03459612|11330296|FG002|STARTED|Period 3||17
10203308|NCT03459612|11330297|FG003|STARTED|Period 3||17
10203309|NCT03459612|11330294|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
10203310|NCT03459612|11330295|FG001|Received at Least 1 Dose of Study Drug|Period 3||17
10203311|NCT03459612|11330296|FG002|Received at Least 1 Dose of Study Drug|Period 3||17
10203312|NCT03459612|11330297|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
10203313|NCT03459612|11330294|FG000|COMPLETED|Period 3||17
10203314|NCT03459612|11330295|FG001|COMPLETED|Period 3||17
10203315|NCT03459612|11330296|FG002|COMPLETED|Period 3||17
10203316|NCT03459612|11330297|FG003|COMPLETED|Period 3||17
10203317|NCT03459612|11330294|FG000|NOT COMPLETED|Period 3||0
10203318|NCT03459612|11330295|FG001|NOT COMPLETED|Period 3||0
10203319|NCT03459612|11330296|FG002|NOT COMPLETED|Period 3||0
10203320|NCT03459612|11330297|FG003|NOT COMPLETED|Period 3||0
10203321|NCT03459612|11330294|FG000|STARTED|Period 4||17
10203322|NCT03459612|11330295|FG001|STARTED|Period 4||17
10203323|NCT03459612|11330296|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
10203324|NCT03459612|11330297|FG003|STARTED|Period 4||17
10203325|NCT03459612|11330294|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
10203326|NCT03459612|11330295|FG001|Received at Least 1 Dose of Study Drug|Period 4||17
10203327|NCT03459612|11330296|FG002|Received at Least 1 Dose of Study Drug|Period 4||16
10203328|NCT03459612|11330297|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
10203329|NCT03459612|11330294|FG000|COMPLETED|Period 4||17
10203330|NCT03459612|11330295|FG001|COMPLETED|Period 4||17
10203331|NCT03459612|11330296|FG002|COMPLETED|Period 4||16
9903821|NCT01150903|11019695|FG001|STARTED|Overall Study||74124
9903822|NCT01150903|11019694|FG000|COMPLETED|Overall Study||24708
9903823|NCT01150903|11019695|FG001|COMPLETED|Overall Study||74124
9903824|NCT01150903|11019694|FG000|NOT COMPLETED|Overall Study||0
10019010|NCT01826981|11142052|FG001|NOT COMPLETED|Overall Study||1
10019011|NCT01826981|11142053|FG002|NOT COMPLETED|Overall Study||0
10019012|NCT01826981|11142054|FG003|NOT COMPLETED|Overall Study||0
10203332|NCT03459612|11330297|FG003|COMPLETED|Period 4||17
10203333|NCT03459612|11330294|FG000|NOT COMPLETED|Period 4||0
10203334|NCT03459612|11330295|FG001|NOT COMPLETED|Period 4||0
10203335|NCT03459612|11330296|FG002|NOT COMPLETED|Period 4||0
10203336|NCT03459612|11330297|FG003|NOT COMPLETED|Period 4||0
10238731|NCT00484718|11370189|FG002|COMPLETED|Washout Period (2 Weeks)||1
10238732|NCT00484718|11370190|FG003|COMPLETED|Washout Period (2 Weeks)||1
9903825|NCT01150903|11019695|FG001|NOT COMPLETED|Overall Study||0
9903826|NCT01150981|11019703|FG000|STARTED|Overall Study||20
9903827|NCT01150981|11019704|FG001|STARTED|Overall Study||15
9903828|NCT01150981|11019703|FG000|COMPLETED|Overall Study||16
9903829|NCT01150981|11019704|FG001|COMPLETED|Overall Study||13
9903830|NCT01150981|11019703|FG000|NOT COMPLETED|Overall Study||4
10203337|NCT03459794|11330312|FG000|STARTED|Overall Study||8
10203338|NCT03459794|11330313|FG001|STARTED|Overall Study||4
10203339|NCT03459794|11330312|FG000|COMPLETED|Overall Study||8
10203340|NCT03459794|11330313|FG001|COMPLETED|Overall Study||4
10203341|NCT03459794|11330312|FG000|NOT COMPLETED|Overall Study||0
10203342|NCT03459794|11330313|FG001|NOT COMPLETED|Overall Study||0
10203343|NCT03460587|11330325|FG000|STARTED|Overall Study||13
10203344|NCT03460587|11330325|FG000|COMPLETED|Overall Study||13
10203345|NCT03460587|11330325|FG000|NOT COMPLETED|Overall Study||0
10203346|NCT03460652|11330329|FG000|STARTED|Overall Study||282
10203347|NCT03460652|11330329|FG000|Entered Treatment Phase|Overall Study||238
10203348|NCT03460652|11330329|FG000|COMPLETED|Overall Study||155
10203349|NCT03460652|11330329|FG000|NOT COMPLETED|Overall Study||127
10203350|NCT03460899|11330334|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
10203351|NCT03460899|11330334|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
10203352|NCT03460899|11330334|FG000|NOT COMPLETED|Euglycaemic Clamp||0
10203353|NCT03460899|11330334|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
10203354|NCT03460899|11330334|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
10203355|NCT03460899|11330334|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
10203356|NCT03460990|11330340|FG000|STARTED|Overall Study||57
10203357|NCT03460990|11330341|FG001|STARTED|Overall Study||54
10203358|NCT03460990|11330340|FG000|COMPLETED|Overall Study||57
10203359|NCT03460990|11330341|FG001|COMPLETED|Overall Study||54
10203360|NCT03460990|11330340|FG000|NOT COMPLETED|Overall Study||0
10203361|NCT03460990|11330341|FG001|NOT COMPLETED|Overall Study||0
10203362|NCT03461146|11330347|FG000|STARTED|Overall Study||24
10203363|NCT03461146|11330347|FG000|COMPLETED|Overall Study||21
10203364|NCT03461146|11330347|FG000|NOT COMPLETED|Overall Study||3
10203365|NCT03461757|11330353|FG000|STARTED|Overall Study||732
10203366|NCT03461757|11330354|FG001|STARTED|Overall Study||734
10203367|NCT03461757|11330353|FG000|Treated|Overall Study||682
10203368|NCT03461757|11330354|FG001|Treated|Overall Study||693
10203369|NCT03461757|11330353|FG000|COMPLETED|Overall Study||679
10203370|NCT03461757|11330354|FG001|COMPLETED|Overall Study||689
10203371|NCT03461757|11330353|FG000|NOT COMPLETED|Overall Study||53
10203372|NCT03461757|11330354|FG001|NOT COMPLETED|Overall Study||45
10203373|NCT03461965|11330362|FG000|STARTED|Overall Study||42
10203374|NCT03461965|11330363|FG001|STARTED|Overall Study||40
10203375|NCT03461965|11330362|FG000|COMPLETED|Overall Study||42
10203376|NCT03461965|11330363|FG001|COMPLETED|Overall Study||40
10203377|NCT03461965|11330362|FG000|NOT COMPLETED|Overall Study||0
10203378|NCT03461965|11330363|FG001|NOT COMPLETED|Overall Study||0
10203379|NCT03462082|11330369|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3
10203380|NCT03462082|11330370|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4
10203381|NCT03462082|11330371|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4
10203382|NCT03462082|11330372|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3
10203383|NCT03462082|11330373|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3
10203384|NCT03462082|11330374|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5
10203385|NCT03462082|11330375|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0
10203386|NCT03462082|11330376|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0
10203387|NCT03462082|11330369|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3
10203388|NCT03462082|11330370|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4
10203389|NCT03462082|11330371|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4
10203390|NCT03462082|11330372|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3
10203391|NCT03462082|11330373|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3
10203392|NCT03462082|11330374|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5
10203393|NCT03462082|11330375|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203394|NCT03462082|11330376|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203395|NCT03462082|11330369|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203396|NCT03462082|11330370|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203397|NCT03462082|11330371|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203398|NCT03462082|11330372|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203399|NCT03462082|11330373|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203400|NCT03462082|11330374|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203401|NCT03462082|11330375|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10203402|NCT03462082|11330376|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
9903831|NCT01150981|11019704|FG001|NOT COMPLETED|Overall Study||2
9903832|NCT01151020|11019710|FG000|STARTED|Overall Study||110
10203403|NCT03462082|11330369|FG000|STARTED|Open Label Phase||0
10203404|NCT03462082|11330370|FG001|STARTED|Open Label Phase||0
10203405|NCT03462082|11330371|FG002|STARTED|Open Label Phase||0
10203406|NCT03462082|11330372|FG003|STARTED|Open Label Phase||0
10203407|NCT03462082|11330373|FG004|STARTED|Open Label Phase||0
10203408|NCT03462082|11330374|FG005|STARTED|Open Label Phase||0
10203409|NCT03462082|11330375|FG006|STARTED|Open Label Phase||7
10203410|NCT03462082|11330376|FG007|STARTED|Open Label Phase||10
9903833|NCT01151020|11019710|FG000|30-day|Overall Study||110
9903834|NCT01151020|11019710|FG000|COMPLETED|Overall Study||56
9903835|NCT01151020|11019710|FG000|NOT COMPLETED|Overall Study||54
9903836|NCT01151046|11019716|FG000|STARTED|Overall Study||59
9903837|NCT01151046|11019717|FG001|STARTED|Overall Study||59
9903838|NCT01151046|11019716|FG000|COMPLETED|Overall Study||56
10203411|NCT03462082|11330369|FG000|COMPLETED|Open Label Phase||0
10203412|NCT03462082|11330370|FG001|COMPLETED|Open Label Phase||0
10203413|NCT03462082|11330371|FG002|COMPLETED|Open Label Phase||0
10203414|NCT03462082|11330372|FG003|COMPLETED|Open Label Phase||0
10203415|NCT03462082|11330373|FG004|COMPLETED|Open Label Phase||0
10203416|NCT03462082|11330374|FG005|COMPLETED|Open Label Phase||0
10203417|NCT03462082|11330375|FG006|COMPLETED|Open Label Phase||6
10203418|NCT03462082|11330376|FG007|COMPLETED|Open Label Phase||8
10203419|NCT03462082|11330369|FG000|NOT COMPLETED|Open Label Phase||0
10203420|NCT03462082|11330370|FG001|NOT COMPLETED|Open Label Phase||0
10203421|NCT03462082|11330371|FG002|NOT COMPLETED|Open Label Phase||0
10203422|NCT03462082|11330372|FG003|NOT COMPLETED|Open Label Phase||0
10203423|NCT03462082|11330373|FG004|NOT COMPLETED|Open Label Phase||0
10203424|NCT03462082|11330374|FG005|NOT COMPLETED|Open Label Phase||0
10203425|NCT03462082|11330375|FG006|NOT COMPLETED|Open Label Phase||1
10203426|NCT03462082|11330376|FG007|NOT COMPLETED|Open Label Phase||2
10203427|NCT03462576|11330389|FG000|STARTED|Overall Study||46
10203428|NCT03462576|11330390|FG001|STARTED|Overall Study||48
10203429|NCT03462576|11330391|FG002|STARTED|Overall Study||45
10203430|NCT03462576|11330389|FG000|COMPLETED|Overall Study||41
10203431|NCT03462576|11330390|FG001|COMPLETED|Overall Study||37
10203432|NCT03462576|11330391|FG002|COMPLETED|Overall Study||37
10203433|NCT03462576|11330389|FG000|NOT COMPLETED|Overall Study||5
10203434|NCT03462576|11330390|FG001|NOT COMPLETED|Overall Study||11
10203435|NCT03462576|11330391|FG002|NOT COMPLETED|Overall Study||8
10203436|NCT03462680|11330401|FG000|STARTED|Overall Study||21
10203437|NCT03462680|11330402|FG001|STARTED|Overall Study||26
10203438|NCT03462680|11330401|FG000|COMPLETED|Overall Study||18
10203439|NCT03462680|11330402|FG001|COMPLETED|Overall Study||21
10203440|NCT03462680|11330401|FG000|NOT COMPLETED|Overall Study||3
10203441|NCT03462680|11330402|FG001|NOT COMPLETED|Overall Study||5
10203442|NCT03462745|11330410|FG000|STARTED|Overall Study||92
10203443|NCT03462745|11330411|FG001|STARTED|Overall Study||92
10203444|NCT03462745|11330410|FG000|COMPLETED|Overall Study||92
10203445|NCT03462745|11330411|FG001|COMPLETED|Overall Study||92
10203446|NCT03462745|11330410|FG000|NOT COMPLETED|Overall Study||0
10203447|NCT03462745|11330411|FG001|NOT COMPLETED|Overall Study||0
10203448|NCT03462927|11330419|FG000|STARTED|Overall Study||32
10203449|NCT03462927|11330420|FG001|STARTED|Overall Study||31
10203450|NCT03462927|11330419|FG000|COMPLETED|Overall Study||26
10203451|NCT03462927|11330420|FG001|COMPLETED|Overall Study||29
10203452|NCT03462927|11330419|FG000|NOT COMPLETED|Overall Study||6
10203453|NCT03462927|11330420|FG001|NOT COMPLETED|Overall Study||2
10203454|NCT03463031|11330430|FG000|STARTED|Overall Study||225
10203455|NCT03463031|11330431|FG001|STARTED|Overall Study||221
10203456|NCT03463031|11330430|FG000|COMPLETED|Overall Study||215
10203457|NCT03463031|11330431|FG001|COMPLETED|Overall Study||216
10203458|NCT03463031|11330430|FG000|NOT COMPLETED|Overall Study||10
10203459|NCT03463031|11330431|FG001|NOT COMPLETED|Overall Study||5
10203460|NCT03463161|11330437|FG000|STARTED|Overall Study||2
10203461|NCT03463161|11330437|FG000|COMPLETED|Overall Study||2
10203462|NCT03463161|11330437|FG000|NOT COMPLETED|Overall Study||0
10203463|NCT03463512|11330443|FG000|STARTED|Overall Study||62
10203464|NCT03463512|11330444|FG001|STARTED|Overall Study||62
10203465|NCT03463512|11330443|FG000|COMPLETED|Overall Study||62
10203466|NCT03463512|11330444|FG001|COMPLETED|Overall Study||62
10203467|NCT03463512|11330443|FG000|NOT COMPLETED|Overall Study||0
10203468|NCT03463512|11330444|FG001|NOT COMPLETED|Overall Study||0
10203469|NCT03463889|11330450|FG000|STARTED|Overall Study||12
10203470|NCT03463889|11330450|FG000|COMPLETED|Overall Study||12
10203471|NCT03463889|11330450|FG000|NOT COMPLETED|Overall Study||0
10203472|NCT03463915|11330456|FG000|STARTED|Overall Study||45
10203473|NCT03463915|11330457|FG001|STARTED|Overall Study||45
10203474|NCT03463915|11330456|FG000|COMPLETED|Overall Study||35
10203475|NCT03463915|11330457|FG001|COMPLETED|Overall Study||36
10203476|NCT03463915|11330456|FG000|NOT COMPLETED|Overall Study||10
10203477|NCT03463915|11330457|FG001|NOT COMPLETED|Overall Study||9
10203478|NCT03463941|11330465|FG000|STARTED|Overall Study||80
10203479|NCT03463941|11330465|FG000|COMPLETED|Overall Study||62
10203480|NCT03463941|11330465|FG000|NOT COMPLETED|Overall Study||18
10203481|NCT03464383|11330473|FG000|STARTED|Overall Study||3
10203482|NCT03464383|11330474|FG001|STARTED|Overall Study||3
10203483|NCT03464383|11330475|FG002|STARTED|Overall Study||63
10203484|NCT03464383|11330473|FG000|COMPLETED|Overall Study||2
10203485|NCT03464383|11330474|FG001|COMPLETED|Overall Study||2
10203486|NCT03464383|11330475|FG002|COMPLETED|Overall Study||63
10203487|NCT03464383|11330473|FG000|NOT COMPLETED|Overall Study||1
10203488|NCT03464383|11330474|FG001|NOT COMPLETED|Overall Study||1
10203489|NCT03464383|11330475|FG002|NOT COMPLETED|Overall Study||0
10203490|NCT03464422|11330484|FG000|STARTED|Overall Study||21
10203491|NCT03464422|11330484|FG000|COMPLETED|Overall Study||17
9903839|NCT01151046|11019717|FG001|COMPLETED|Overall Study||59
10203492|NCT03464422|11330484|FG000|NOT COMPLETED|Overall Study||4
10203493|NCT03465436|11330494|FG000|STARTED|Period 1||14
10203494|NCT03465436|11330495|FG001|STARTED|Period 1||14
10203495|NCT03465436|11330496|FG002|STARTED|Period 1||14
10203496|NCT03465436|11330497|FG003|STARTED|Period 1||14
9903840|NCT01151046|11019716|FG000|NOT COMPLETED|Overall Study||3
9903841|NCT01151046|11019717|FG001|NOT COMPLETED|Overall Study||0
9903842|NCT01151085|11019727|FG000|STARTED|Overall Study||1002
9903843|NCT01151085|11019727|FG000|COMPLETED|Overall Study||946
9903844|NCT01151085|11019727|FG000|NOT COMPLETED|Overall Study||56
9903845|NCT01151098|11019738|FG000|STARTED|Overall Study|Extension Safety Population|189
9903846|NCT01151098|11019738|FG000|COMPLETED|Overall Study||72
9903847|NCT01151098|11019738|FG000|NOT COMPLETED|Overall Study||117
9903848|NCT01151137|11019744|FG000|STARTED|Overall Study||1617
9903849|NCT01151137|11019745|FG001|STARTED|Overall Study||1619
9903850|NCT01151137|11019744|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
9903851|NCT01151137|11019745|FG001|Treated|Overall Study||1613
9903852|NCT01151137|11019744|FG000|Discontinued Treatment|Overall Study||171
9903853|NCT01151137|11019745|FG001|Discontinued Treatment|Overall Study||342
9903854|NCT01151137|11019744|FG000|COMPLETED|Overall Study||1601
9903855|NCT01151137|11019745|FG001|COMPLETED|Overall Study||1591
9903856|NCT01151137|11019744|FG000|NOT COMPLETED|Overall Study||16
9903857|NCT01151137|11019745|FG001|NOT COMPLETED|Overall Study||28
9903858|NCT01151189|11019753|FG000|STARTED|Overall Study||326
9903859|NCT01151189|11019754|FG001|STARTED|Overall Study||324
9903860|NCT01151189|11019753|FG000|Received Vaccine|Overall Study||325
9903861|NCT01151189|11019754|FG001|Received Vaccine|Overall Study||324
9903862|NCT01151189|11019753|FG000|COMPLETED|Overall Study||311
9903863|NCT01151189|11019754|FG001|COMPLETED|Overall Study||314
9903864|NCT01151189|11019753|FG000|NOT COMPLETED|Overall Study||15
9903865|NCT01151189|11019754|FG001|NOT COMPLETED|Overall Study||10
9903866|NCT01151215|11019763|FG000|STARTED|Overall Study||120
9903867|NCT01151215|11019764|FG001|STARTED|Overall Study||118
9903868|NCT01151215|11019765|FG002|STARTED|Overall Study||121
9903869|NCT01151215|11019763|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
9903870|NCT01151215|11019764|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
9903871|NCT01151215|11019765|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
9903872|NCT01151215|11019763|FG000|NOT COMPLETED|Overall Study||20
10009443|NCT01766076|11132027|FG000|STARTED|Overall Study||15
10009444|NCT01766076|11132028|FG001|STARTED|Overall Study||15
9903873|NCT01151215|11019764|FG001|NOT COMPLETED|Overall Study||23
9903874|NCT01151215|11019765|FG002|NOT COMPLETED|Overall Study||19
9903875|NCT01151280|11019773|FG000|STARTED|Overall Study||10
9903876|NCT01151280|11019773|FG000|COMPLETED|Overall Study||6
9903877|NCT01151280|11019773|FG000|NOT COMPLETED|Overall Study||4
9903878|NCT01151345|11019777|FG000|STARTED|First Intervention Period||13
9903879|NCT01151345|11019778|FG001|STARTED|First Intervention Period||13
9903880|NCT01151345|11019777|FG000|Treated|First Intervention Period||13
9903881|NCT01151345|11019778|FG001|Treated|First Intervention Period||12
9903882|NCT01151345|11019777|FG000|COMPLETED|First Intervention Period||13
9903883|NCT01151345|11019778|FG001|COMPLETED|First Intervention Period||12
9903884|NCT01151345|11019777|FG000|NOT COMPLETED|First Intervention Period||0
9903885|NCT01151345|11019778|FG001|NOT COMPLETED|First Intervention Period||1
9903886|NCT01151345|11019777|FG000|STARTED|Wash-out Period (7 Days)||13
9903887|NCT01151345|11019778|FG001|STARTED|Wash-out Period (7 Days)||12
9903888|NCT01151345|11019777|FG000|COMPLETED|Wash-out Period (7 Days)||13
9903889|NCT01151345|11019778|FG001|COMPLETED|Wash-out Period (7 Days)||12
9903890|NCT01151345|11019777|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
9903891|NCT01151345|11019778|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
9903892|NCT01151345|11019777|FG000|STARTED|Second Intervention Period||13
9903893|NCT01151345|11019778|FG001|STARTED|Second Intervention Period||12
9903894|NCT01151345|11019777|FG000|COMPLETED|Second Intervention Period||13
9903895|NCT01151345|11019778|FG001|COMPLETED|Second Intervention Period||12
9903896|NCT01151345|11019777|FG000|NOT COMPLETED|Second Intervention Period||0
9903897|NCT01151345|11019778|FG001|NOT COMPLETED|Second Intervention Period||0
9903898|NCT01151371|11019787|FG000|STARTED|Overall Study||149
9903899|NCT01151371|11019788|FG001|STARTED|Overall Study||150
9903900|NCT01151371|11019789|FG002|STARTED|Overall Study||153
9903901|NCT01151371|11019787|FG000|COMPLETED|Overall Study||144
9903902|NCT01151371|11019788|FG001|COMPLETED|Overall Study||149
9903903|NCT01151371|11019789|FG002|COMPLETED|Overall Study||146
9903904|NCT01151371|11019787|FG000|NOT COMPLETED|Overall Study||5
9903905|NCT01151371|11019788|FG001|NOT COMPLETED|Overall Study||1
9903906|NCT01151371|11019789|FG002|NOT COMPLETED|Overall Study||7
9903907|NCT01151410|11019799|FG000|STARTED|Overall Study||104
9903908|NCT01151410|11019800|FG001|STARTED|Overall Study||104
9903909|NCT01151410|11019799|FG000|Safety Set (SAF)|Overall Study||105
9903910|NCT01151410|11019800|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
9903911|NCT01151410|11019799|FG000|COMPLETED|Overall Study||93
9903912|NCT01151410|11019800|FG001|COMPLETED|Overall Study||89
9903913|NCT01151410|11019799|FG000|NOT COMPLETED|Overall Study||11
9903914|NCT01151410|11019800|FG001|NOT COMPLETED|Overall Study||15
9903915|NCT01151423|11019808|FG000|STARTED|Overall Study||36
9903916|NCT01151423|11019809|FG001|STARTED|Overall Study||39
9903917|NCT01151423|11019808|FG000|Received Study Drug|Overall Study||35
9903918|NCT01151423|11019809|FG001|Received Study Drug|Overall Study||37
9903919|NCT01151423|11019808|FG000|COMPLETED|Overall Study||20
9903920|NCT01151423|11019809|FG001|COMPLETED|Overall Study||21
9903921|NCT01151423|11019808|FG000|NOT COMPLETED|Overall Study||16
10009445|NCT01766076|11132027|FG000|COMPLETED|Overall Study||15
9903922|NCT01151423|11019809|FG001|NOT COMPLETED|Overall Study||18
9903923|NCT01151436|11019815|FG000|STARTED|Overall Study||77
9903924|NCT01151436|11019815|FG000|COMPLETED|Overall Study||76
9903925|NCT01151436|11019815|FG000|NOT COMPLETED|Overall Study||1
9903926|NCT01151449|11019819|FG000|STARTED|Overall Study||6
9903927|NCT01151449|11019819|FG000|COMPLETED|Overall Study||6
9903928|NCT01151449|11019819|FG000|NOT COMPLETED|Overall Study||0
9903929|NCT01151540|11019823|FG000|STARTED|Overall Study||54
9903930|NCT01151540|11019823|FG000|COMPLETED|Overall Study||41
9903931|NCT01151540|11019823|FG000|NOT COMPLETED|Overall Study||13
9903932|NCT01151579|11019829|FG000|STARTED|Overall Study||58
9903933|NCT01151579|11019830|FG001|STARTED|Overall Study||31
9903934|NCT01151579|11019829|FG000|COMPLETED|Overall Study||46
9903935|NCT01151579|11019830|FG001|COMPLETED|Overall Study||24
9903936|NCT01151579|11019829|FG000|NOT COMPLETED|Overall Study||12
9903937|NCT01151579|11019830|FG001|NOT COMPLETED|Overall Study||7
9903938|NCT01151618|11019836|FG000|STARTED|Overall Study||22
9903939|NCT01151618|11019836|FG000|COMPLETED|Overall Study||13
9903940|NCT01151618|11019836|FG000|NOT COMPLETED|Overall Study||9
9903941|NCT01151761|11019840|FG000|STARTED|Overall Study||2
9903942|NCT01151761|11019840|FG000|COMPLETED|Overall Study||2
9903943|NCT01151761|11019840|FG000|NOT COMPLETED|Overall Study||0
9903944|NCT01151813|11019844|FG000|STARTED|Period 1||8
9903945|NCT01151813|11019845|FG001|STARTED|Period 1||7
9903946|NCT01151813|11019844|FG000|COMPLETED|Period 1||8
9903947|NCT01151813|11019845|FG001|COMPLETED|Period 1||7
9903948|NCT01151813|11019844|FG000|NOT COMPLETED|Period 1||0
9903949|NCT01151813|11019845|FG001|NOT COMPLETED|Period 1||0
9903950|NCT01151813|11019844|FG000|STARTED|Period 2||8
9903951|NCT01151813|11019845|FG001|STARTED|Period 2||7
9903952|NCT01151813|11019844|FG000|COMPLETED|Period 2||8
9903953|NCT01151813|11019845|FG001|COMPLETED|Period 2||7
9903954|NCT01151813|11019844|FG000|NOT COMPLETED|Period 2||0
9903955|NCT01151813|11019845|FG001|NOT COMPLETED|Period 2||0
9903956|NCT01151852|11019854|FG000|STARTED|Overall Study||41
9903957|NCT01151852|11019855|FG001|STARTED|Overall Study||40
9903958|NCT01151852|11019854|FG000|COMPLETED|Overall Study||41
9903959|NCT01151852|11019855|FG001|COMPLETED|Overall Study||40
9903960|NCT01151852|11019854|FG000|NOT COMPLETED|Overall Study||0
9903961|NCT01151852|11019855|FG001|NOT COMPLETED|Overall Study||0
9903962|NCT01152021|11019863|FG000|STARTED|Overall Study||8
9903963|NCT01152021|11019864|FG001|STARTED|Overall Study||7
9903964|NCT01152021|11019863|FG000|COMPLETED|Overall Study||2
9903965|NCT01152021|11019864|FG001|COMPLETED|Overall Study||1
9903966|NCT01152021|11019863|FG000|NOT COMPLETED|Overall Study||6
9903967|NCT01152021|11019864|FG001|NOT COMPLETED|Overall Study||6
9903968|NCT01152112|11019874|FG000|STARTED|Overall Study||42
9903969|NCT01152112|11019875|FG001|STARTED|Overall Study||32
9903970|NCT01152112|11019874|FG000|COMPLETED|Overall Study||42
9903971|NCT01152112|11019875|FG001|COMPLETED|Overall Study||32
9903972|NCT01152112|11019874|FG000|NOT COMPLETED|Overall Study||0
9903973|NCT01152112|11019875|FG001|NOT COMPLETED|Overall Study||0
9903974|NCT01152190|11019883|FG000|STARTED|Overall Study||50
9903975|NCT01152190|11019884|FG001|STARTED|Overall Study||47
9903976|NCT01152190|11019883|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
9903977|NCT01152190|11019884|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47
9903978|NCT01152190|11019883|FG000|COMPLETED|Overall Study||45
9903979|NCT01152190|11019884|FG001|COMPLETED|Overall Study||39
9903980|NCT01152190|11019883|FG000|NOT COMPLETED|Overall Study||5
9903981|NCT01152190|11019884|FG001|NOT COMPLETED|Overall Study||8
9903982|NCT01152294|11019892|FG000|STARTED|Overall Study||213
9903983|NCT01152294|11019893|FG001|STARTED|Overall Study||188
9903984|NCT01152294|11019892|FG000|COMPLETED|Overall Study||213
9903985|NCT01152294|11019893|FG001|COMPLETED|Overall Study||188
9903986|NCT01152294|11019892|FG000|NOT COMPLETED|Overall Study||0
9903987|NCT01152294|11019893|FG001|NOT COMPLETED|Overall Study||0
9903988|NCT01152307|11019901|FG000|STARTED|Overall Study||191
9903989|NCT01152307|11019902|FG001|STARTED|Overall Study||214
9903990|NCT01152307|11019901|FG000|COMPLETED|Overall Study||191
9903991|NCT01152307|11019902|FG001|COMPLETED|Overall Study||214
9903992|NCT01152307|11019901|FG000|NOT COMPLETED|Overall Study||0
9903993|NCT01152307|11019902|FG001|NOT COMPLETED|Overall Study||0
9903994|NCT01152359|11019910|FG000|STARTED|Overall Study||105
9903995|NCT01152359|11019911|FG001|STARTED|Overall Study||102
9903996|NCT01152359|11019910|FG000|COMPLETED|Overall Study||81
9903997|NCT01152359|11019911|FG001|COMPLETED|Overall Study||80
9903998|NCT01152359|11019910|FG000|NOT COMPLETED|Overall Study||24
9903999|NCT01152359|11019911|FG001|NOT COMPLETED|Overall Study||22
9904000|NCT01152385|11019921|FG000|STARTED|Overall Study||55
9904001|NCT01152385|11019922|FG001|STARTED|Overall Study||58
9904002|NCT01152385|11019923|FG002|STARTED|Overall Study||56
9904003|NCT01152385|11019924|FG003|STARTED|Overall Study||55
9904004|NCT01152385|11019921|FG000|COMPLETED|Overall Study||46
9904005|NCT01152385|11019922|FG001|COMPLETED|Overall Study||52
9904006|NCT01152385|11019923|FG002|COMPLETED|Overall Study||51
9904007|NCT01152385|11019924|FG003|COMPLETED|Overall Study||50
9904008|NCT01152385|11019921|FG000|NOT COMPLETED|Overall Study||9
9904009|NCT01152385|11019922|FG001|NOT COMPLETED|Overall Study||6
9904010|NCT01152385|11019923|FG002|NOT COMPLETED|Overall Study||5
9904011|NCT01152385|11019924|FG003|NOT COMPLETED|Overall Study||5
9904012|NCT01152437|11019941|FG000|STARTED|Overall Study|randomised|36
9904013|NCT01152437|11019942|FG001|STARTED|Overall Study|randomised|15
9904014|NCT01152437|11019943|FG002|STARTED|Overall Study|entered|43
9904015|NCT01152437|11019941|FG000|COMPLETED|Overall Study||0
9904016|NCT01152437|11019942|FG001|COMPLETED|Overall Study||0
9904017|NCT01152437|11019943|FG002|COMPLETED|Overall Study||0
9904018|NCT01152437|11019941|FG000|NOT COMPLETED|Overall Study||36
9904019|NCT01152437|11019942|FG001|NOT COMPLETED|Overall Study||15
9904020|NCT01152437|11019943|FG002|NOT COMPLETED|Overall Study||43
9904021|NCT01152450|11019953|FG000|STARTED|Period 1 (4 Weeks)||15
9904022|NCT01152450|11019954|FG001|STARTED|Period 1 (4 Weeks)||16
9904023|NCT01152450|11019955|FG002|STARTED|Period 1 (4 Weeks)||17
9904024|NCT01152450|11019956|FG003|STARTED|Period 1 (4 Weeks)||15
9904025|NCT01152450|11019957|FG004|STARTED|Period 1 (4 Weeks)||18
9904026|NCT01152450|11019958|FG005|STARTED|Period 1 (4 Weeks)||13
9904027|NCT01152450|11019953|FG000|COMPLETED|Period 1 (4 Weeks)||15
9904028|NCT01152450|11019954|FG001|COMPLETED|Period 1 (4 Weeks)||15
9904029|NCT01152450|11019955|FG002|COMPLETED|Period 1 (4 Weeks)||16
9904030|NCT01152450|11019956|FG003|COMPLETED|Period 1 (4 Weeks)||15
9904031|NCT01152450|11019957|FG004|COMPLETED|Period 1 (4 Weeks)||16
9904032|NCT01152450|11019958|FG005|COMPLETED|Period 1 (4 Weeks)||12
9904033|NCT01152450|11019953|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0
9904034|NCT01152450|11019954|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
9904035|NCT01152450|11019955|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
9904036|NCT01152450|11019956|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
9904037|NCT01152450|11019957|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2
9904038|NCT01152450|11019958|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1
9904039|NCT01152450|11019953|FG000|STARTED|Period 2 (4 Weeks)||15
9904040|NCT01152450|11019954|FG001|STARTED|Period 2 (4 Weeks)||15
9904041|NCT01152450|11019955|FG002|STARTED|Period 2 (4 Weeks)||16
9904042|NCT01152450|11019956|FG003|STARTED|Period 2 (4 Weeks)||15
9904043|NCT01152450|11019957|FG004|STARTED|Period 2 (4 Weeks)||16
9904044|NCT01152450|11019958|FG005|STARTED|Period 2 (4 Weeks)||12
9904045|NCT01152450|11019953|FG000|COMPLETED|Period 2 (4 Weeks)||15
9904046|NCT01152450|11019954|FG001|COMPLETED|Period 2 (4 Weeks)||15
9904047|NCT01152450|11019955|FG002|COMPLETED|Period 2 (4 Weeks)||16
9904048|NCT01152450|11019956|FG003|COMPLETED|Period 2 (4 Weeks)||15
9904049|NCT01152450|11019957|FG004|COMPLETED|Period 2 (4 Weeks)||16
9904050|NCT01152450|11019958|FG005|COMPLETED|Period 2 (4 Weeks)||12
9904051|NCT01152450|11019953|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
9904052|NCT01152450|11019954|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
9904053|NCT01152450|11019955|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
9904054|NCT01152450|11019956|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
9904055|NCT01152450|11019957|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
9904056|NCT01152450|11019958|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0
9904057|NCT01152450|11019953|FG000|STARTED|Period 3 (4 Weeks)||15
9904058|NCT01152450|11019954|FG001|STARTED|Period 3 (4 Weeks)||15
9904059|NCT01152450|11019955|FG002|STARTED|Period 3 (4 Weeks)||16
9904060|NCT01152450|11019956|FG003|STARTED|Period 3 (4 Weeks)||15
9904061|NCT01152450|11019957|FG004|STARTED|Period 3 (4 Weeks)||16
9904062|NCT01152450|11019958|FG005|STARTED|Period 3 (4 Weeks)||12
9904063|NCT01152450|11019953|FG000|COMPLETED|Period 3 (4 Weeks)||15
10009446|NCT01766076|11132028|FG001|COMPLETED|Overall Study||15
9904064|NCT01152450|11019954|FG001|COMPLETED|Period 3 (4 Weeks)||15
9904065|NCT01152450|11019955|FG002|COMPLETED|Period 3 (4 Weeks)||16
9904066|NCT01152450|11019956|FG003|COMPLETED|Period 3 (4 Weeks)||15
9904067|NCT01152450|11019957|FG004|COMPLETED|Period 3 (4 Weeks)||16
9904068|NCT01152450|11019958|FG005|COMPLETED|Period 3 (4 Weeks)||12
9904069|NCT01152450|11019953|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
9904070|NCT01152450|11019954|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
9904071|NCT01152450|11019955|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
9904072|NCT01152450|11019956|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
9904073|NCT01152450|11019957|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
9904074|NCT01152450|11019958|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0
9904075|NCT01152515|11019968|FG000|STARTED|Overall Study||25
9904076|NCT01152515|11019969|FG001|STARTED|Overall Study||25
9904077|NCT01152515|11019968|FG000|COMPLETED|Overall Study||25
9904078|NCT01152515|11019969|FG001|COMPLETED|Overall Study||25
9904079|NCT01152515|11019968|FG000|NOT COMPLETED|Overall Study||0
9904080|NCT01152515|11019969|FG001|NOT COMPLETED|Overall Study||0
9904081|NCT01152554|11019977|FG000|STARTED|Overall Study||610
9904082|NCT01152554|11019978|FG001|STARTED|Overall Study||203
9904083|NCT01152554|11019977|FG000|Received Treatment|Overall Study||607
9904084|NCT01152554|11019978|FG001|Received Treatment|Overall Study||201
9904085|NCT01152554|11019977|FG000|COMPLETED|Overall Study||276
9904086|NCT01152554|11019978|FG001|COMPLETED|Overall Study||92
9904087|NCT01152554|11019977|FG000|NOT COMPLETED|Overall Study||334
9904088|NCT01152554|11019978|FG001|NOT COMPLETED|Overall Study||111
9904089|NCT01152580|11019986|FG000|STARTED|Overall Study||5
9904090|NCT01152580|11019987|FG001|STARTED|Overall Study||14
9904091|NCT01152580|11019986|FG000|COMPLETED|Overall Study||5
9904092|NCT01152580|11019987|FG001|COMPLETED|Overall Study||13
9904093|NCT01152580|11019986|FG000|NOT COMPLETED|Overall Study||0
9904094|NCT01152580|11019987|FG001|NOT COMPLETED|Overall Study||1
9904095|NCT01152697|11019993|FG000|STARTED|Overall Study||30
9904096|NCT01152697|11019993|FG000|COMPLETED|Overall Study||11
9904097|NCT01152697|11019993|FG000|NOT COMPLETED|Overall Study||19
9904098|NCT01152788|11019999|FG000|STARTED|Overall Study||32
9904099|NCT01152788|11020000|FG001|STARTED|Overall Study||32
9904100|NCT01152788|11019999|FG000|COMPLETED|Overall Study||32
10009447|NCT01766076|11132027|FG000|NOT COMPLETED|Overall Study||0
9904101|NCT01152788|11020000|FG001|COMPLETED|Overall Study||28
9904102|NCT01152788|11019999|FG000|NOT COMPLETED|Overall Study||0
9904103|NCT01152788|11020000|FG001|NOT COMPLETED|Overall Study||4
9904104|NCT01152814|11020006|FG000|STARTED|Overall Study||64
9904105|NCT01152814|11020006|FG000|COMPLETED|Overall Study||62
9904106|NCT01152814|11020006|FG000|NOT COMPLETED|Overall Study||2
9904107|NCT01152996|11020010|FG000|STARTED|Overall Study||1075
9904108|NCT01152996|11020010|FG000|Treated|Overall Study||1073
9904109|NCT01152996|11020010|FG000|COMPLETED|Overall Study||538
9904110|NCT01152996|11020010|FG000|NOT COMPLETED|Overall Study||537
9904111|NCT01153009|11020018|FG000|STARTED|Overall Study||161
9904112|NCT01153009|11020019|FG001|STARTED|Overall Study||147
9904113|NCT01153009|11020020|FG002|STARTED|Overall Study||154
9904114|NCT01153009|11020021|FG003|STARTED|Overall Study||152
9904115|NCT01153009|11020018|FG000|Treated|Overall Study||159
9904116|NCT01153009|11020019|FG001|Treated|Overall Study||147
9904117|NCT01153009|11020020|FG002|Treated|Overall Study||154
9904118|NCT01153009|11020021|FG003|Treated|Overall Study||150
9904119|NCT01153009|11020018|FG000|COMPLETED|Overall Study||129
9904120|NCT01153009|11020019|FG001|COMPLETED|Overall Study||113
9904121|NCT01153009|11020020|FG002|COMPLETED|Overall Study||113
9904122|NCT01153009|11020021|FG003|COMPLETED|Overall Study||115
9904123|NCT01153009|11020018|FG000|NOT COMPLETED|Overall Study||32
9904124|NCT01153009|11020019|FG001|NOT COMPLETED|Overall Study||34
9904125|NCT01153009|11020020|FG002|NOT COMPLETED|Overall Study||41
9904126|NCT01153009|11020021|FG003|NOT COMPLETED|Overall Study||37
9904127|NCT01153269|11020031|FG000|STARTED|Overall Study||33
9904128|NCT01153269|11020031|FG000|Participants Analyzed|Overall Study||33
9904129|NCT01153269|11020031|FG000|COMPLETED|Overall Study||31
9904130|NCT01153269|11020031|FG000|NOT COMPLETED|Overall Study||2
9904131|NCT01153321|11020040|FG000|STARTED|Overall Study||22
9904132|NCT01153321|11020041|FG001|STARTED|Overall Study||22
9904133|NCT01153321|11020040|FG000|COMPLETED|Overall Study||21
9904134|NCT01153321|11020041|FG001|COMPLETED|Overall Study||19
9904135|NCT01153321|11020040|FG000|NOT COMPLETED|Overall Study||1
9904136|NCT01153321|11020041|FG001|NOT COMPLETED|Overall Study||3
9955136|NCT01436162|11074017|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
9955137|NCT01436162|11074015|FG000|COMPLETED|Randomized Phase||353
9955138|NCT01436162|11074016|FG001|COMPLETED|Randomized Phase||181
9955139|NCT01436162|11074017|FG002|COMPLETED|Randomized Phase||189
9955140|NCT01436162|11074015|FG000|NOT COMPLETED|Randomized Phase||44
9955141|NCT01436162|11074016|FG001|NOT COMPLETED|Randomized Phase||31
9955142|NCT01436162|11074017|FG002|NOT COMPLETED|Randomized Phase||25
9957009|NCT01448824|11076146|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
9957010|NCT01448824|11076147|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
9957011|NCT01448850|11076177|FG000|STARTED|Overall Study||164
9957012|NCT01448850|11076178|FG001|STARTED|Overall Study||160
9957013|NCT01448850|11076177|FG000|COMPLETED|Overall Study||130
9957014|NCT01448850|11076178|FG001|COMPLETED|Overall Study||120
9957015|NCT01448850|11076177|FG000|NOT COMPLETED|Overall Study||34
9957016|NCT01448850|11076178|FG001|NOT COMPLETED|Overall Study||40
9957017|NCT01449006|11076187|FG000|STARTED|Overall Study||8
9957018|NCT01449006|11076188|FG001|STARTED|Overall Study||9
9957019|NCT01449006|11076187|FG000|COMPLETED|Overall Study||5
9957020|NCT01449006|11076188|FG001|COMPLETED|Overall Study||9
9957021|NCT01449006|11076187|FG000|NOT COMPLETED|Overall Study||3
9957022|NCT01449006|11076188|FG001|NOT COMPLETED|Overall Study||0
9957023|NCT01449240|11076194|FG000|STARTED|Overall Study||10
9957024|NCT01449240|11076194|FG000|COMPLETED|Overall Study||10
9957025|NCT01449240|11076194|FG000|NOT COMPLETED|Overall Study||0
9957026|NCT01449266|11076198|FG000|STARTED|Overall Study||10
9957027|NCT01449266|11076198|FG000|COMPLETED|Overall Study||10
9957028|NCT01449266|11076198|FG000|NOT COMPLETED|Overall Study||0
9957029|NCT01449279|11076202|FG000|STARTED|Overall Study||22
9957030|NCT01449279|11076202|FG000|COMPLETED|Overall Study||15
9957031|NCT01449279|11076202|FG000|NOT COMPLETED|Overall Study||7
9957032|NCT01449305|11076206|FG000|STARTED|Overall Study||44
9957033|NCT01449305|11076206|FG000|COMPLETED|Overall Study||42
9957034|NCT01449305|11076206|FG000|NOT COMPLETED|Overall Study||2
9957035|NCT01449370|11076235|FG000|STARTED|Overall Study||6
9957036|NCT01449370|11076236|FG001|STARTED|Overall Study||6
9957037|NCT01449370|11076237|FG002|STARTED|Overall Study||8
9957038|NCT01449370|11076238|FG003|STARTED|Overall Study||4
9957039|NCT01449370|11076239|FG004|STARTED|Overall Study||3
9957040|NCT01449370|11076240|FG005|STARTED|Overall Study||3
9957041|NCT01449370|11076241|FG006|STARTED|Overall Study||3
9957042|NCT01449370|11076242|FG007|STARTED|Overall Study||3
9957043|NCT01449370|11076243|FG008|STARTED|Overall Study||12
9957044|NCT01449370|11076244|FG009|STARTED|Overall Study||3
9957045|NCT01449370|11076245|FG010|STARTED|Overall Study||3
9957046|NCT01449370|11076246|FG011|STARTED|Overall Study||3
9957047|NCT01449370|11076247|FG012|STARTED|Overall Study||3
9957048|NCT01449370|11076248|FG013|STARTED|Overall Study||11
9957049|NCT01449370|11076249|FG014|STARTED|Overall Study||3
9957050|NCT01449370|11076250|FG015|STARTED|Overall Study||3
9957051|NCT01449370|11076251|FG016|STARTED|Overall Study||7
9957052|NCT01449370|11076252|FG017|STARTED|Overall Study||3
9957053|NCT01449370|11076253|FG018|STARTED|Overall Study||3
9957054|NCT01449370|11076254|FG019|STARTED|Overall Study||3
9957055|NCT01449370|11076255|FG020|STARTED|Overall Study||6
9957056|NCT01449370|11076256|FG021|STARTED|Overall Study||4
9957057|NCT01449370|11076257|FG022|STARTED|Overall Study||4
9957058|NCT01449370|11076258|FG023|STARTED|Overall Study||10
9957059|NCT01449370|11076259|FG024|STARTED|Overall Study||8
9904137|NCT01153347|11020051|FG000|STARTED|Overall Study||160
9904138|NCT01153347|11020052|FG001|STARTED|Overall Study||160
9904139|NCT01153347|11020053|FG002|STARTED|Overall Study||160
9904140|NCT01153347|11020054|FG003|STARTED|Overall Study||161
10009448|NCT01766076|11132028|FG001|NOT COMPLETED|Overall Study||0
10009449|NCT01766102|11132036|FG000|STARTED|Overall Study||36
10009450|NCT01766102|11132037|FG001|STARTED|Overall Study||36
10009451|NCT01766102|11132036|FG000|COMPLETED|Overall Study||36
10009452|NCT01766102|11132037|FG001|COMPLETED|Overall Study||36
10009453|NCT01766102|11132036|FG000|NOT COMPLETED|Overall Study||0
10009454|NCT01766102|11132037|FG001|NOT COMPLETED|Overall Study||0
10009455|NCT01766206|11132043|FG000|STARTED|Overall Study||3939
9904141|NCT01153347|11020051|FG000|Received Treatment|Overall Study||160
9904142|NCT01153347|11020052|FG001|Received Treatment|Overall Study||158
9904143|NCT01153347|11020053|FG002|Received Treatment|Overall Study||158
9904144|NCT01153347|11020054|FG003|Received Treatment|Overall Study||160
9904145|NCT01153347|11020051|FG000|COMPLETED|Overall Study||127
9904146|NCT01153347|11020052|FG001|COMPLETED|Overall Study||116
9904147|NCT01153347|11020053|FG002|COMPLETED|Overall Study||110
9904148|NCT01153347|11020054|FG003|COMPLETED|Overall Study||129
9904149|NCT01153347|11020051|FG000|NOT COMPLETED|Overall Study||33
9904150|NCT01153347|11020052|FG001|NOT COMPLETED|Overall Study||44
9904151|NCT01153347|11020053|FG002|NOT COMPLETED|Overall Study||50
9904152|NCT01153347|11020054|FG003|NOT COMPLETED|Overall Study||32
9904153|NCT01153425|11020066|FG000|STARTED|Overall Study||16
9904154|NCT01153425|11020067|FG001|STARTED|Overall Study||17
9904155|NCT01153425|11020066|FG000|COMPLETED|Overall Study||13
9904156|NCT01153425|11020067|FG001|COMPLETED|Overall Study||14
9904157|NCT01153425|11020066|FG000|NOT COMPLETED|Overall Study||3
9904158|NCT01153425|11020067|FG001|NOT COMPLETED|Overall Study||3
9904159|NCT01153503|11020077|FG000|STARTED|Overall Study||25
9904160|NCT01153503|11020078|FG001|STARTED|Overall Study||25
9904161|NCT01153503|11020079|FG002|STARTED|Overall Study||25
9904162|NCT01153503|11020077|FG000|COMPLETED|Overall Study||25
9904163|NCT01153503|11020078|FG001|COMPLETED|Overall Study||24
9904164|NCT01153503|11020079|FG002|COMPLETED|Overall Study||25
9904165|NCT01153503|11020077|FG000|NOT COMPLETED|Overall Study||0
9904166|NCT01153503|11020078|FG001|NOT COMPLETED|Overall Study||1
9904167|NCT01153503|11020079|FG002|NOT COMPLETED|Overall Study||0
9904168|NCT01153516|11020089|FG000|STARTED|Overall Study||12
9904169|NCT01153516|11020090|FG001|STARTED|Overall Study||10
9904170|NCT01153516|11020089|FG000|COMPLETED|Overall Study||10
9904171|NCT01153516|11020090|FG001|COMPLETED|Overall Study||10
9904172|NCT01153516|11020089|FG000|NOT COMPLETED|Overall Study||2
9904173|NCT01153516|11020090|FG001|NOT COMPLETED|Overall Study||0
9904174|NCT01153581|11020096|FG000|STARTED|Overall Study||109
9904175|NCT01153581|11020096|FG000|COMPLETED|Overall Study||109
9904176|NCT01153581|11020096|FG000|NOT COMPLETED|Overall Study||0
9904177|NCT01153620|11020108|FG000|STARTED|Overall Study||30
9904178|NCT01153620|11020109|FG001|STARTED|Overall Study|30 patients (31 wounds)|30
9904179|NCT01153620|11020108|FG000|COMPLETED|Overall Study||30
9904180|NCT01153620|11020109|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30
9904181|NCT01153620|11020108|FG000|NOT COMPLETED|Overall Study||0
9904182|NCT01153620|11020109|FG001|NOT COMPLETED|Overall Study||0
9904183|NCT01153633|11020117|FG000|STARTED|Overall Study||17
9904184|NCT01153633|11020118|FG001|STARTED|Overall Study||17
9904185|NCT01153633|11020117|FG000|COMPLETED|Overall Study||13
9904186|NCT01153633|11020118|FG001|COMPLETED|Overall Study||13
9904187|NCT01153633|11020117|FG000|NOT COMPLETED|Overall Study||4
9904188|NCT01153633|11020118|FG001|NOT COMPLETED|Overall Study||4
9904189|NCT01153672|11020126|FG000|STARTED|Overall Study||8
9904190|NCT01153672|11020126|FG000|COMPLETED|Overall Study||6
9904191|NCT01153672|11020126|FG000|NOT COMPLETED|Overall Study||2
9904192|NCT01153685|11020132|FG000|STARTED|Overall Study||50
9904193|NCT01153685|11020133|FG001|STARTED|Overall Study||70
9904194|NCT01153685|11020132|FG000|COMPLETED|Overall Study||50
9904195|NCT01153685|11020133|FG001|COMPLETED|Overall Study||70
9904196|NCT01153685|11020132|FG000|NOT COMPLETED|Overall Study||0
9904197|NCT01153685|11020133|FG001|NOT COMPLETED|Overall Study||0
9904198|NCT01153698|11020139|FG000|STARTED|Overall Study|Entered and treated.|168
9904199|NCT01153698|11020139|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
9904200|NCT01153698|11020139|FG000|NOT COMPLETED|Overall Study||29
9904201|NCT01153711|11020144|FG000|STARTED|Overall Study||32
9904202|NCT01153711|11020144|FG000|COMPLETED|Overall Study||32
9904203|NCT01153711|11020144|FG000|NOT COMPLETED|Overall Study||0
9904204|NCT01153724|11020150|FG000|STARTED|Treatment Period 1||35
9904205|NCT01153724|11020150|FG000|COMPLETED|Treatment Period 1||34
10009456|NCT01766206|11132043|FG000|COMPLETED|Overall Study||3888
10009457|NCT01766206|11132043|FG000|NOT COMPLETED|Overall Study||51
9904206|NCT01153724|11020150|FG000|NOT COMPLETED|Treatment Period 1||1
9904207|NCT01153724|11020150|FG000|STARTED|Treatment Period 2||34
9904208|NCT01153724|11020150|FG000|COMPLETED|Treatment Period 2||32
9904209|NCT01153724|11020150|FG000|NOT COMPLETED|Treatment Period 2||2
10009458|NCT01766219|11132050|FG000|STARTED|Overall Study||4
9904210|NCT01153763|11020156|FG000|STARTED|Overall Study||92
9904211|NCT01153763|11020156|FG000|COMPLETED|Overall Study||71
9904212|NCT01153763|11020156|FG000|NOT COMPLETED|Overall Study||21
9904213|NCT01153815|11020162|FG000|STARTED|Overall Study||83
9904214|NCT01153815|11020163|FG001|STARTED|Overall Study||87
9904215|NCT01153815|11020162|FG000|COMPLETED|Overall Study||74
9904216|NCT01153815|11020163|FG001|COMPLETED|Overall Study||82
9904217|NCT01153815|11020162|FG000|NOT COMPLETED|Overall Study||9
9904218|NCT01153815|11020163|FG001|NOT COMPLETED|Overall Study||5
9904219|NCT01153841|11020171|FG000|STARTED|Overall Study||199
9904220|NCT01153841|11020172|FG001|STARTED|Overall Study||99
9904221|NCT01153841|11020171|FG000|COMPLETED|Overall Study||193
9904222|NCT01153841|11020172|FG001|COMPLETED|Overall Study||99
9904223|NCT01153841|11020171|FG000|NOT COMPLETED|Overall Study||6
9904224|NCT01153841|11020172|FG001|NOT COMPLETED|Overall Study||0
9904225|NCT01153893|11020180|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
9904226|NCT01153893|11020181|FG001|STARTED|Overall Study||36
9904227|NCT01153893|11020180|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
9904228|NCT01153893|11020181|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
9904229|NCT01153893|11020180|FG000|NOT COMPLETED|Overall Study||1
9904230|NCT01153893|11020181|FG001|NOT COMPLETED|Overall Study||0
9904231|NCT01153958|11020189|FG000|STARTED|Overall Study||66
9904232|NCT01153958|11020190|FG001|STARTED|Overall Study||67
9904233|NCT01153958|11020189|FG000|COMPLETED|Overall Study||30
9904234|NCT01153958|11020190|FG001|COMPLETED|Overall Study||35
9904235|NCT01153958|11020189|FG000|NOT COMPLETED|Overall Study||36
9904236|NCT01153958|11020190|FG001|NOT COMPLETED|Overall Study||32
9904237|NCT01153971|11020196|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47
9904238|NCT01153971|11020196|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
9904239|NCT01153971|11020196|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
9904240|NCT01153971|11020196|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44
9904241|NCT01153971|11020196|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
9904242|NCT01153971|11020196|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
9904243|NCT01153971|11020196|FG000|STARTED|Follow-up (Months 17-40 of Study)||41
9904244|NCT01153971|11020196|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37
9904245|NCT01153971|11020196|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
9904246|NCT01153984|11020200|FG000|STARTED|Overall Study||23
9904247|NCT01153984|11020200|FG000|COMPLETED|Overall Study||21
9904248|NCT01153984|11020200|FG000|NOT COMPLETED|Overall Study||2
9904249|NCT01154010|11020206|FG000|STARTED|Overall Study||9
9904250|NCT01154010|11020207|FG001|STARTED|Overall Study||9
9904251|NCT01154010|11020206|FG000|COMPLETED|Overall Study||9
9904252|NCT01154010|11020207|FG001|COMPLETED|Overall Study||8
9904253|NCT01154010|11020206|FG000|NOT COMPLETED|Overall Study||0
9904254|NCT01154010|11020207|FG001|NOT COMPLETED|Overall Study||1
9904255|NCT01154088|11020216|FG000|STARTED|Overall Study||390
9904256|NCT01154088|11020217|FG001|STARTED|Overall Study||390
9904257|NCT01154088|11020218|FG002|STARTED|Overall Study||390
9904258|NCT01154088|11020216|FG000|COMPLETED|Overall Study||386
9904259|NCT01154088|11020217|FG001|COMPLETED|Overall Study||384
9904260|NCT01154088|11020218|FG002|COMPLETED|Overall Study||383
9904261|NCT01154088|11020216|FG000|NOT COMPLETED|Overall Study||4
9904262|NCT01154088|11020217|FG001|NOT COMPLETED|Overall Study||6
9904263|NCT01154088|11020218|FG002|NOT COMPLETED|Overall Study||7
9904264|NCT01154101|11020232|FG000|STARTED|Overall Study||7
9904265|NCT01154101|11020233|FG001|STARTED|Overall Study||9
9904266|NCT01154101|11020234|FG002|STARTED|Overall Study||12
9904267|NCT01154101|11020235|FG003|STARTED|Overall Study||11
9904268|NCT01154101|11020236|FG004|STARTED|Overall Study||1
9904269|NCT01154101|11020232|FG000|COMPLETED|Overall Study||7
9904270|NCT01154101|11020233|FG001|COMPLETED|Overall Study||5
9904271|NCT01154101|11020234|FG002|COMPLETED|Overall Study||9
9904272|NCT01154101|11020235|FG003|COMPLETED|Overall Study||9
9904273|NCT01154101|11020236|FG004|COMPLETED|Overall Study||0
9904274|NCT01154101|11020232|FG000|NOT COMPLETED|Overall Study||0
9904275|NCT01154101|11020233|FG001|NOT COMPLETED|Overall Study||4
9904276|NCT01154101|11020234|FG002|NOT COMPLETED|Overall Study||3
9904277|NCT01154101|11020235|FG003|NOT COMPLETED|Overall Study||2
9904278|NCT01154101|11020236|FG004|NOT COMPLETED|Overall Study||1
9904279|NCT01154127|11020255|FG000|STARTED|Period 1 (21 Days)||55
9904280|NCT01154127|11020256|FG001|STARTED|Period 1 (21 Days)||53
9904281|NCT01154127|11020255|FG000|COMPLETED|Period 1 (21 Days)||52
9904282|NCT01154127|11020256|FG001|COMPLETED|Period 1 (21 Days)||47
9904283|NCT01154127|11020255|FG000|NOT COMPLETED|Period 1 (21 Days)||3
9904284|NCT01154127|11020256|FG001|NOT COMPLETED|Period 1 (21 Days)||6
9904285|NCT01154127|11020255|FG000|STARTED|Washout (14 - 28 Days)||52
9904286|NCT01154127|11020256|FG001|STARTED|Washout (14 - 28 Days)||47
9904287|NCT01154127|11020255|FG000|COMPLETED|Washout (14 - 28 Days)||49
9904288|NCT01154127|11020256|FG001|COMPLETED|Washout (14 - 28 Days)||47
9904289|NCT01154127|11020255|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3
9904290|NCT01154127|11020256|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0
9904291|NCT01154127|11020255|FG000|STARTED|Period 2 (21 Days)||49
9904292|NCT01154127|11020256|FG001|STARTED|Period 2 (21 Days)||47
9904293|NCT01154127|11020255|FG000|COMPLETED|Period 2 (21 Days)||49
9904294|NCT01154127|11020256|FG001|COMPLETED|Period 2 (21 Days)||46
9904295|NCT01154127|11020255|FG000|NOT COMPLETED|Period 2 (21 Days)||0
9904296|NCT01154127|11020256|FG001|NOT COMPLETED|Period 2 (21 Days)||1
9904297|NCT01154140|11020264|FG000|STARTED|Overall Study||172
9904298|NCT01154140|11020265|FG001|STARTED|Overall Study||171
9904299|NCT01154140|11020264|FG000|Treated|Overall Study||171
9904300|NCT01154140|11020265|FG001|Treated|Overall Study||169
9904301|NCT01154140|11020264|FG000|COMPLETED|Overall Study||81
9904302|NCT01154140|11020265|FG001|COMPLETED|Overall Study||69
9904303|NCT01154140|11020264|FG000|NOT COMPLETED|Overall Study||91
9904304|NCT01154140|11020265|FG001|NOT COMPLETED|Overall Study||102
9904305|NCT01154153|11020273|FG000|STARTED|Overall Study||71
9904306|NCT01154153|11020274|FG001|STARTED|Overall Study||69
9904307|NCT01154153|11020273|FG000|COMPLETED|Overall Study||66
9904308|NCT01154153|11020274|FG001|COMPLETED|Overall Study||66
9904309|NCT01154153|11020273|FG000|NOT COMPLETED|Overall Study||5
9904310|NCT01154153|11020274|FG001|NOT COMPLETED|Overall Study||3
9904311|NCT01154166|11020282|FG000|STARTED|Overall Study||169
9904312|NCT01154166|11020283|FG001|STARTED|Overall Study||175
9904313|NCT01154166|11020282|FG000|COMPLETED|Overall Study||135
9904314|NCT01154166|11020283|FG001|COMPLETED|Overall Study||163
9904315|NCT01154166|11020282|FG000|NOT COMPLETED|Overall Study||34
9904316|NCT01154166|11020283|FG001|NOT COMPLETED|Overall Study||12
9904317|NCT01154192|11020292|FG000|STARTED|Overall Study||14
9904318|NCT01154192|11020293|FG001|STARTED|Overall Study||10
9904319|NCT01154192|11020294|FG002|STARTED|Overall Study||0
9904320|NCT01154192|11020292|FG000|COMPLETED|Overall Study||14
9904321|NCT01154192|11020293|FG001|COMPLETED|Overall Study||10
9904322|NCT01154192|11020294|FG002|COMPLETED|Overall Study||0
9904323|NCT01154192|11020292|FG000|NOT COMPLETED|Overall Study||0
9904324|NCT01154192|11020293|FG001|NOT COMPLETED|Overall Study||0
9904325|NCT01154192|11020294|FG002|NOT COMPLETED|Overall Study||0
9904326|NCT01154218|11020303|FG000|STARTED|First Intervention Period||9
9904327|NCT01154218|11020304|FG001|STARTED|First Intervention Period||9
9904328|NCT01154218|11020305|FG002|STARTED|First Intervention Period||9
9904329|NCT01154218|11020306|FG003|STARTED|First Intervention Period||9
9904330|NCT01154218|11020303|FG000|COMPLETED|First Intervention Period||9
9904331|NCT01154218|11020304|FG001|COMPLETED|First Intervention Period||9
9904332|NCT01154218|11020305|FG002|COMPLETED|First Intervention Period||9
9904333|NCT01154218|11020306|FG003|COMPLETED|First Intervention Period||9
9904334|NCT01154218|11020303|FG000|NOT COMPLETED|First Intervention Period||0
9904335|NCT01154218|11020304|FG001|NOT COMPLETED|First Intervention Period||0
9904336|NCT01154218|11020305|FG002|NOT COMPLETED|First Intervention Period||0
9904337|NCT01154218|11020306|FG003|NOT COMPLETED|First Intervention Period||0
9904338|NCT01154218|11020303|FG000|STARTED|Washout Period (at Least 14 Days)||9
9904339|NCT01154218|11020304|FG001|STARTED|Washout Period (at Least 14 Days)||9
9904340|NCT01154218|11020305|FG002|STARTED|Washout Period (at Least 14 Days)||9
9904341|NCT01154218|11020306|FG003|STARTED|Washout Period (at Least 14 Days)||9
9904342|NCT01154218|11020303|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
9904343|NCT01154218|11020304|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
9904344|NCT01154218|11020305|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
9904345|NCT01154218|11020306|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
9904346|NCT01154218|11020303|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10203497|NCT03465436|11330494|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
10203498|NCT03465436|11330495|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
10203499|NCT03465436|11330496|FG002|Received at Least 1 Dose of Study Drug|Period 1||14
10203500|NCT03465436|11330497|FG003|Received at Least 1 Dose of Study Drug|Period 1||14
10203501|NCT03465436|11330494|FG000|COMPLETED|Period 1||14
9904347|NCT01154218|11020304|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904348|NCT01154218|11020305|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904349|NCT01154218|11020306|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904350|NCT01154218|11020303|FG000|STARTED|Second Intervention Period||9
9904351|NCT01154218|11020304|FG001|STARTED|Second Intervention Period||9
9904352|NCT01154218|11020305|FG002|STARTED|Second Intervention Period||9
9904353|NCT01154218|11020306|FG003|STARTED|Second Intervention Period||9
9904354|NCT01154218|11020303|FG000|COMPLETED|Second Intervention Period||9
9904355|NCT01154218|11020304|FG001|COMPLETED|Second Intervention Period||9
9904356|NCT01154218|11020305|FG002|COMPLETED|Second Intervention Period||9
9904357|NCT01154218|11020306|FG003|COMPLETED|Second Intervention Period||9
9904358|NCT01154218|11020303|FG000|NOT COMPLETED|Second Intervention Period||0
9904359|NCT01154218|11020304|FG001|NOT COMPLETED|Second Intervention Period||0
9904360|NCT01154218|11020305|FG002|NOT COMPLETED|Second Intervention Period||0
9904361|NCT01154218|11020306|FG003|NOT COMPLETED|Second Intervention Period||0
9904362|NCT01154218|11020303|FG000|STARTED|Washout Period (at Least 14 Days)||9
9904363|NCT01154218|11020304|FG001|STARTED|Washout Period (at Least 14 Days)||9
9904364|NCT01154218|11020305|FG002|STARTED|Washout Period (at Least 14 Days)||9
9904365|NCT01154218|11020306|FG003|STARTED|Washout Period (at Least 14 Days)||9
9904366|NCT01154218|11020303|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
9904367|NCT01154218|11020304|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
9904368|NCT01154218|11020305|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
9904369|NCT01154218|11020306|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
9904370|NCT01154218|11020303|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904371|NCT01154218|11020304|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904372|NCT01154218|11020305|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904373|NCT01154218|11020306|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10203502|NCT03465436|11330495|FG001|COMPLETED|Period 1||14
9904374|NCT01154218|11020303|FG000|STARTED|Third Intervention Period||9
9904375|NCT01154218|11020304|FG001|STARTED|Third Intervention Period||9
9904376|NCT01154218|11020305|FG002|STARTED|Third Intervention Period||9
9904377|NCT01154218|11020306|FG003|STARTED|Third Intervention Period||9
9904378|NCT01154218|11020303|FG000|COMPLETED|Third Intervention Period||9
9904379|NCT01154218|11020304|FG001|COMPLETED|Third Intervention Period||8
9904380|NCT01154218|11020305|FG002|COMPLETED|Third Intervention Period||9
9904381|NCT01154218|11020306|FG003|COMPLETED|Third Intervention Period||9
10009459|NCT01766219|11132051|FG001|STARTED|Overall Study||2
10009460|NCT01766219|11132052|FG002|STARTED|Overall Study||11
10009461|NCT01766219|11132050|FG000|COMPLETED|Overall Study||4
9904382|NCT01154218|11020303|FG000|NOT COMPLETED|Third Intervention Period||0
9904383|NCT01154218|11020304|FG001|NOT COMPLETED|Third Intervention Period||1
9904384|NCT01154218|11020305|FG002|NOT COMPLETED|Third Intervention Period||0
9904385|NCT01154218|11020306|FG003|NOT COMPLETED|Third Intervention Period||0
9904386|NCT01154218|11020303|FG000|STARTED|Washout Period (at Least 14 Days)||9
9904387|NCT01154218|11020304|FG001|STARTED|Washout Period (at Least 14 Days)||8
9904388|NCT01154218|11020305|FG002|STARTED|Washout Period (at Least 14 Days)||9
9904389|NCT01154218|11020306|FG003|STARTED|Washout Period (at Least 14 Days)||9
9904390|NCT01154218|11020303|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
9904391|NCT01154218|11020304|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
9904392|NCT01154218|11020305|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
9904393|NCT01154218|11020306|FG003|COMPLETED|Washout Period (at Least 14 Days)||8
9904394|NCT01154218|11020303|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904395|NCT01154218|11020304|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904396|NCT01154218|11020305|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9904397|NCT01154218|11020306|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1
9904398|NCT01154218|11020303|FG000|STARTED|Fourth Intervention Period||9
9904399|NCT01154218|11020304|FG001|STARTED|Fourth Intervention Period||8
9904400|NCT01154218|11020305|FG002|STARTED|Fourth Intervention Period||9
9904401|NCT01154218|11020306|FG003|STARTED|Fourth Intervention Period||8
9904402|NCT01154218|11020303|FG000|COMPLETED|Fourth Intervention Period||8
9904403|NCT01154218|11020304|FG001|COMPLETED|Fourth Intervention Period||8
9904404|NCT01154218|11020305|FG002|COMPLETED|Fourth Intervention Period||9
9904405|NCT01154218|11020306|FG003|COMPLETED|Fourth Intervention Period||8
9904406|NCT01154218|11020303|FG000|NOT COMPLETED|Fourth Intervention Period||1
9904407|NCT01154218|11020304|FG001|NOT COMPLETED|Fourth Intervention Period||0
9904408|NCT01154218|11020305|FG002|NOT COMPLETED|Fourth Intervention Period||0
9904409|NCT01154218|11020306|FG003|NOT COMPLETED|Fourth Intervention Period||0
9904410|NCT01154231|11020316|FG000|STARTED|Overall Study||314
9904411|NCT01154231|11020316|FG000|COMPLETED|Overall Study||312
9904412|NCT01154231|11020316|FG000|NOT COMPLETED|Overall Study||2
9904413|NCT01154283|11020322|FG000|STARTED|0-6 Weeks||14
9904414|NCT01154283|11020323|FG001|STARTED|0-6 Weeks||14
9904415|NCT01154283|11020322|FG000|COMPLETED|0-6 Weeks||7
9904416|NCT01154283|11020323|FG001|COMPLETED|0-6 Weeks||11
9904417|NCT01154283|11020322|FG000|NOT COMPLETED|0-6 Weeks||7
9904418|NCT01154283|11020323|FG001|NOT COMPLETED|0-6 Weeks||3
9904419|NCT01154283|11020322|FG000|STARTED|7-12 Weeks||7
9904420|NCT01154283|11020323|FG001|STARTED|7-12 Weeks||11
9904421|NCT01154283|11020322|FG000|COMPLETED|7-12 Weeks||6
9904422|NCT01154283|11020323|FG001|COMPLETED|7-12 Weeks||10
9904423|NCT01154283|11020322|FG000|NOT COMPLETED|7-12 Weeks||1
9904424|NCT01154283|11020323|FG001|NOT COMPLETED|7-12 Weeks||1
9904425|NCT01154296|11020331|FG000|STARTED|Randomization and Intervention||2505
9904426|NCT01154296|11020332|FG001|STARTED|Randomization and Intervention||2507
9904427|NCT01154296|11020331|FG000|COMPLETED|Randomization and Intervention||2500
9904428|NCT01154296|11020332|FG001|COMPLETED|Randomization and Intervention||2505
9904429|NCT01154296|11020331|FG000|NOT COMPLETED|Randomization and Intervention||5
9904430|NCT01154296|11020332|FG001|NOT COMPLETED|Randomization and Intervention||2
9904431|NCT01154296|11020331|FG000|STARTED|6-month Follow-up||2505
9904432|NCT01154296|11020332|FG001|STARTED|6-month Follow-up||2507
9904433|NCT01154296|11020331|FG000|COMPLETED|6-month Follow-up||2177
9904434|NCT01154296|11020332|FG001|COMPLETED|6-month Follow-up||2179
9904435|NCT01154296|11020331|FG000|NOT COMPLETED|6-month Follow-up||328
9904436|NCT01154296|11020332|FG001|NOT COMPLETED|6-month Follow-up||328
9904437|NCT01154322|11020338|FG000|STARTED|Overall Study||16
9904438|NCT01154322|11020338|FG000|COMPLETED|Overall Study||14
9904439|NCT01154322|11020338|FG000|NOT COMPLETED|Overall Study||2
9904440|NCT01154452|11020347|FG000|STARTED|Phase Ib||6
9904441|NCT01154452|11020348|FG001|STARTED|Phase Ib||4
9904442|NCT01154452|11020349|FG002|STARTED|Phase Ib||0
9904443|NCT01154452|11020350|FG003|STARTED|Phase Ib||0
9904444|NCT01154452|11020347|FG000|COMPLETED|Phase Ib||3
9904445|NCT01154452|11020348|FG001|COMPLETED|Phase Ib||3
9904446|NCT01154452|11020349|FG002|COMPLETED|Phase Ib||0
9904447|NCT01154452|11020350|FG003|COMPLETED|Phase Ib||0
10203503|NCT03465436|11330496|FG002|COMPLETED|Period 1||13
10203504|NCT03465436|11330497|FG003|COMPLETED|Period 1||14
10203505|NCT03465436|11330494|FG000|NOT COMPLETED|Period 1||0
10203506|NCT03465436|11330495|FG001|NOT COMPLETED|Period 1||0
10203507|NCT03465436|11330496|FG002|NOT COMPLETED|Period 1||1
10203508|NCT03465436|11330497|FG003|NOT COMPLETED|Period 1||0
10203509|NCT03465436|11330494|FG000|STARTED|Period 2||14
9904448|NCT01154452|11020347|FG000|NOT COMPLETED|Phase Ib||3
9904449|NCT01154452|11020348|FG001|NOT COMPLETED|Phase Ib||1
10009462|NCT01766219|11132051|FG001|COMPLETED|Overall Study||2
10203510|NCT03465436|11330495|FG001|STARTED|Period 2||14
9904450|NCT01154452|11020349|FG002|NOT COMPLETED|Phase Ib||0
9904451|NCT01154452|11020350|FG003|NOT COMPLETED|Phase Ib||0
9904452|NCT01154452|11020347|FG000|STARTED|Phase II||0
9904453|NCT01154452|11020348|FG001|STARTED|Phase II||0
9904454|NCT01154452|11020349|FG002|STARTED|Phase II||35
9904455|NCT01154452|11020350|FG003|STARTED|Phase II||33
10009463|NCT01766219|11132052|FG002|COMPLETED|Overall Study||11
9904456|NCT01154452|11020347|FG000|COMPLETED|Phase II||0
9904457|NCT01154452|11020348|FG001|COMPLETED|Phase II||0
10203511|NCT03465436|11330496|FG002|STARTED|Period 2||13
9904458|NCT01154452|11020349|FG002|COMPLETED|Phase II||30
9904459|NCT01154452|11020350|FG003|COMPLETED|Phase II||27
9904460|NCT01154452|11020347|FG000|NOT COMPLETED|Phase II||0
9904461|NCT01154452|11020348|FG001|NOT COMPLETED|Phase II||0
9904462|NCT01154452|11020349|FG002|NOT COMPLETED|Phase II||5
9904463|NCT01154452|11020350|FG003|NOT COMPLETED|Phase II||6
9904464|NCT01154634|11020367|FG000|STARTED|Period 1 - First Intervention||4
9904465|NCT01154634|11020368|FG001|STARTED|Period 1 - First Intervention||7
9904466|NCT01154634|11020369|FG002|STARTED|Period 1 - First Intervention||4
9904467|NCT01154634|11020370|FG003|STARTED|Period 1 - First Intervention||5
9904468|NCT01154634|11020367|FG000|COMPLETED|Period 1 - First Intervention||4
9904469|NCT01154634|11020368|FG001|COMPLETED|Period 1 - First Intervention||7
9904470|NCT01154634|11020369|FG002|COMPLETED|Period 1 - First Intervention||4
9904471|NCT01154634|11020370|FG003|COMPLETED|Period 1 - First Intervention||5
9904472|NCT01154634|11020367|FG000|NOT COMPLETED|Period 1 - First Intervention||0
9904473|NCT01154634|11020368|FG001|NOT COMPLETED|Period 1 - First Intervention||0
9904474|NCT01154634|11020369|FG002|NOT COMPLETED|Period 1 - First Intervention||0
9904475|NCT01154634|11020370|FG003|NOT COMPLETED|Period 1 - First Intervention||0
9904476|NCT01154634|11020367|FG000|STARTED|Period 2 - Washout||4
9904477|NCT01154634|11020368|FG001|STARTED|Period 2 - Washout||7
9904478|NCT01154634|11020369|FG002|STARTED|Period 2 - Washout||4
9904479|NCT01154634|11020370|FG003|STARTED|Period 2 - Washout||5
9904480|NCT01154634|11020367|FG000|COMPLETED|Period 2 - Washout||4
9904481|NCT01154634|11020368|FG001|COMPLETED|Period 2 - Washout||7
9904482|NCT01154634|11020369|FG002|COMPLETED|Period 2 - Washout||4
9904483|NCT01154634|11020370|FG003|COMPLETED|Period 2 - Washout||5
9904484|NCT01154634|11020367|FG000|NOT COMPLETED|Period 2 - Washout||0
9904485|NCT01154634|11020368|FG001|NOT COMPLETED|Period 2 - Washout||0
9904486|NCT01154634|11020369|FG002|NOT COMPLETED|Period 2 - Washout||0
9904487|NCT01154634|11020370|FG003|NOT COMPLETED|Period 2 - Washout||0
9904488|NCT01154634|11020367|FG000|STARTED|Period 3- Second Intervention||4
9904489|NCT01154634|11020368|FG001|STARTED|Period 3- Second Intervention||7
9904490|NCT01154634|11020369|FG002|STARTED|Period 3- Second Intervention||4
9904491|NCT01154634|11020370|FG003|STARTED|Period 3- Second Intervention||5
9904492|NCT01154634|11020367|FG000|COMPLETED|Period 3- Second Intervention||4
9904493|NCT01154634|11020368|FG001|COMPLETED|Period 3- Second Intervention||7
9904494|NCT01154634|11020369|FG002|COMPLETED|Period 3- Second Intervention||4
9904495|NCT01154634|11020370|FG003|COMPLETED|Period 3- Second Intervention||5
9904496|NCT01154634|11020367|FG000|NOT COMPLETED|Period 3- Second Intervention||0
9904497|NCT01154634|11020368|FG001|NOT COMPLETED|Period 3- Second Intervention||0
9904498|NCT01154634|11020369|FG002|NOT COMPLETED|Period 3- Second Intervention||0
9904499|NCT01154634|11020370|FG003|NOT COMPLETED|Period 3- Second Intervention||0
9904500|NCT01154634|11020367|FG000|STARTED|Period 4 - Washout||4
9904501|NCT01154634|11020368|FG001|STARTED|Period 4 - Washout||7
9904502|NCT01154634|11020369|FG002|STARTED|Period 4 - Washout||4
9904503|NCT01154634|11020370|FG003|STARTED|Period 4 - Washout||5
9904504|NCT01154634|11020367|FG000|COMPLETED|Period 4 - Washout||4
9904505|NCT01154634|11020368|FG001|COMPLETED|Period 4 - Washout||7
9904506|NCT01154634|11020369|FG002|COMPLETED|Period 4 - Washout||4
9904507|NCT01154634|11020370|FG003|COMPLETED|Period 4 - Washout||5
9904508|NCT01154634|11020367|FG000|NOT COMPLETED|Period 4 - Washout||0
9904509|NCT01154634|11020368|FG001|NOT COMPLETED|Period 4 - Washout||0
9904510|NCT01154634|11020369|FG002|NOT COMPLETED|Period 4 - Washout||0
9904511|NCT01154634|11020370|FG003|NOT COMPLETED|Period 4 - Washout||0
9904512|NCT01154634|11020367|FG000|STARTED|Period 5 - Third Intervention||4
9904513|NCT01154634|11020368|FG001|STARTED|Period 5 - Third Intervention||7
9904514|NCT01154634|11020369|FG002|STARTED|Period 5 - Third Intervention||4
9904515|NCT01154634|11020370|FG003|STARTED|Period 5 - Third Intervention||5
9904516|NCT01154634|11020367|FG000|COMPLETED|Period 5 - Third Intervention||4
9904517|NCT01154634|11020368|FG001|COMPLETED|Period 5 - Third Intervention||7
9904518|NCT01154634|11020369|FG002|COMPLETED|Period 5 - Third Intervention||4
9904519|NCT01154634|11020370|FG003|COMPLETED|Period 5 - Third Intervention||5
9904520|NCT01154634|11020367|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
9904521|NCT01154634|11020368|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
9904522|NCT01154634|11020369|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
9904523|NCT01154634|11020370|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
9904524|NCT01154634|11020367|FG000|STARTED|Period 6 - Washout||4
9904525|NCT01154634|11020368|FG001|STARTED|Period 6 - Washout||7
9904526|NCT01154634|11020369|FG002|STARTED|Period 6 - Washout||4
9904527|NCT01154634|11020370|FG003|STARTED|Period 6 - Washout||5
9904528|NCT01154634|11020367|FG000|COMPLETED|Period 6 - Washout||4
9904529|NCT01154634|11020368|FG001|COMPLETED|Period 6 - Washout||7
9904530|NCT01154634|11020369|FG002|COMPLETED|Period 6 - Washout||4
9904531|NCT01154634|11020370|FG003|COMPLETED|Period 6 - Washout||5
9904532|NCT01154634|11020367|FG000|NOT COMPLETED|Period 6 - Washout||0
9904533|NCT01154634|11020368|FG001|NOT COMPLETED|Period 6 - Washout||0
9904534|NCT01154634|11020369|FG002|NOT COMPLETED|Period 6 - Washout||0
9904535|NCT01154634|11020370|FG003|NOT COMPLETED|Period 6 - Washout||0
9904536|NCT01154634|11020367|FG000|STARTED|Period 7 - Fourth Intervention||4
9904537|NCT01154634|11020368|FG001|STARTED|Period 7 - Fourth Intervention||7
9904538|NCT01154634|11020369|FG002|STARTED|Period 7 - Fourth Intervention||4
9904539|NCT01154634|11020370|FG003|STARTED|Period 7 - Fourth Intervention||5
9904540|NCT01154634|11020367|FG000|COMPLETED|Period 7 - Fourth Intervention||4
9904541|NCT01154634|11020368|FG001|COMPLETED|Period 7 - Fourth Intervention||7
9904542|NCT01154634|11020369|FG002|COMPLETED|Period 7 - Fourth Intervention||4
9904543|NCT01154634|11020370|FG003|COMPLETED|Period 7 - Fourth Intervention||5
9904544|NCT01154634|11020367|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
9904545|NCT01154634|11020368|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
9904546|NCT01154634|11020369|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
9904547|NCT01154634|11020370|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
9904548|NCT01154673|11020382|FG000|STARTED|Overall Study||16
9904549|NCT01154673|11020383|FG001|STARTED|Overall Study||16
9904550|NCT01154673|11020382|FG000|COMPLETED|Overall Study||14
9904551|NCT01154673|11020383|FG001|COMPLETED|Overall Study||16
9904552|NCT01154673|11020382|FG000|NOT COMPLETED|Overall Study||2
9904553|NCT01154673|11020383|FG001|NOT COMPLETED|Overall Study||0
9904554|NCT01154699|11020391|FG000|STARTED|First Intervention (4 Weeks)||13
9904555|NCT01154699|11020392|FG001|STARTED|First Intervention (4 Weeks)||8
9904556|NCT01154699|11020391|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7
9904557|NCT01154699|11020392|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6
9904558|NCT01154699|11020391|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
9904559|NCT01154699|11020392|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
9904560|NCT01154699|11020391|FG000|COMPLETED|First Intervention (4 Weeks)||13
9904561|NCT01154699|11020392|FG001|COMPLETED|First Intervention (4 Weeks)||8
9904562|NCT01154699|11020391|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
9904563|NCT01154699|11020392|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
9904564|NCT01154699|11020391|FG000|STARTED|Washout Period (4 Weeks)||13
9904565|NCT01154699|11020392|FG001|STARTED|Washout Period (4 Weeks)||8
9904566|NCT01154699|11020391|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7
9904567|NCT01154699|11020392|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6
9904568|NCT01154699|11020391|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
9904569|NCT01154699|11020392|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
9904570|NCT01154699|11020391|FG000|COMPLETED|Washout Period (4 Weeks)||13
9904571|NCT01154699|11020392|FG001|COMPLETED|Washout Period (4 Weeks)||8
9904572|NCT01154699|11020391|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
9904573|NCT01154699|11020392|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0
9904574|NCT01154699|11020391|FG000|STARTED|Second Intervention||13
10009464|NCT01766219|11132050|FG000|NOT COMPLETED|Overall Study||0
10009465|NCT01766219|11132051|FG001|NOT COMPLETED|Overall Study||0
10009466|NCT01766219|11132052|FG002|NOT COMPLETED|Overall Study||0
10009467|NCT01766310|11132063|FG000|STARTED|Overall Study||24
10009468|NCT01766310|11132064|FG001|STARTED|Overall Study||26
10009469|NCT01766310|11132063|FG000|COMPLETED|Overall Study||23
10009470|NCT01766310|11132064|FG001|COMPLETED|Overall Study||23
10009471|NCT01766310|11132063|FG000|NOT COMPLETED|Overall Study||1
10009472|NCT01766310|11132064|FG001|NOT COMPLETED|Overall Study||3
10009473|NCT01766336|11132072|FG000|STARTED|Overall Study||150
9904575|NCT01154699|11020392|FG001|STARTED|Second Intervention||8
9904576|NCT01154699|11020391|FG000|Subjects With Asthma Only|Second Intervention||7
9904577|NCT01154699|11020392|FG001|Subjects With Asthma Only|Second Intervention||6
9904578|NCT01154699|11020391|FG000|Subjects With Asthma + OSA|Second Intervention||6
9904579|NCT01154699|11020392|FG001|Subjects With Asthma + OSA|Second Intervention||2
9904580|NCT01154699|11020391|FG000|COMPLETED|Second Intervention||13
9904581|NCT01154699|11020392|FG001|COMPLETED|Second Intervention||8
9904582|NCT01154699|11020391|FG000|NOT COMPLETED|Second Intervention||0
9904583|NCT01154699|11020392|FG001|NOT COMPLETED|Second Intervention||0
9904584|NCT01154751|11020400|FG000|STARTED|6-month Follow-up||109
9904585|NCT01154751|11020400|FG000|COMPLETED|6-month Follow-up||98
9904586|NCT01154751|11020400|FG000|NOT COMPLETED|6-month Follow-up||11
9904587|NCT01154751|11020400|FG000|STARTED|1-year Follow-up||98
9904588|NCT01154751|11020400|FG000|COMPLETED|1-year Follow-up||93
9904589|NCT01154751|11020400|FG000|NOT COMPLETED|1-year Follow-up||5
9904590|NCT01154751|11020400|FG000|STARTED|2-year Follow-up||93
9904591|NCT01154751|11020400|FG000|COMPLETED|2-year Follow-up||83
9904592|NCT01154751|11020400|FG000|NOT COMPLETED|2-year Follow-up||10
9904593|NCT01154751|11020400|FG000|STARTED|3-year Follow-up||83
9904594|NCT01154751|11020400|FG000|COMPLETED|3-year Follow-up||34
9904595|NCT01154751|11020400|FG000|NOT COMPLETED|3-year Follow-up||49
9904596|NCT01154816|11020416|FG000|STARTED|Overall Study||20
9904597|NCT01154816|11020417|FG001|STARTED|Overall Study||12
9904598|NCT01154816|11020418|FG002|STARTED|Overall Study||10
9904599|NCT01154816|11020419|FG003|STARTED|Overall Study||10
9904600|NCT01154816|11020420|FG004|STARTED|Overall Study||10
9904601|NCT01154816|11020421|FG005|STARTED|Overall Study||8
9904602|NCT01154816|11020422|FG006|STARTED|Overall Study||6
9904603|NCT01154816|11020423|FG007|STARTED|Overall Study||7
9904604|NCT01154816|11020424|FG008|STARTED|Overall Study||10
9904605|NCT01154816|11020425|FG009|STARTED|Overall Study||10
9904606|NCT01154816|11020426|FG010|STARTED|Overall Study||11
9904607|NCT01154816|11020427|FG011|STARTED|Overall Study||4
9904608|NCT01154816|11020416|FG000|COMPLETED|Overall Study||0
9904609|NCT01154816|11020417|FG001|COMPLETED|Overall Study||2
10009474|NCT01766336|11132073|FG001|STARTED|Overall Study||146
10009475|NCT01766336|11132072|FG000|COMPLETED|Overall Study||60
9904610|NCT01154816|11020418|FG002|COMPLETED|Overall Study||0
9904611|NCT01154816|11020419|FG003|COMPLETED|Overall Study||0
9904612|NCT01154816|11020420|FG004|COMPLETED|Overall Study||0
9904613|NCT01154816|11020421|FG005|COMPLETED|Overall Study||0
9904614|NCT01154816|11020422|FG006|COMPLETED|Overall Study||0
9904615|NCT01154816|11020423|FG007|COMPLETED|Overall Study||0
9904616|NCT01154816|11020424|FG008|COMPLETED|Overall Study||1
9904617|NCT01154816|11020425|FG009|COMPLETED|Overall Study||0
9904618|NCT01154816|11020426|FG010|COMPLETED|Overall Study||0
9904619|NCT01154816|11020427|FG011|COMPLETED|Overall Study||0
9904620|NCT01154816|11020416|FG000|NOT COMPLETED|Overall Study||20
9904621|NCT01154816|11020417|FG001|NOT COMPLETED|Overall Study||10
9904622|NCT01154816|11020418|FG002|NOT COMPLETED|Overall Study||10
9904623|NCT01154816|11020419|FG003|NOT COMPLETED|Overall Study||10
9904624|NCT01154816|11020420|FG004|NOT COMPLETED|Overall Study||10
9904625|NCT01154816|11020421|FG005|NOT COMPLETED|Overall Study||8
9904626|NCT01154816|11020422|FG006|NOT COMPLETED|Overall Study||6
9904627|NCT01154816|11020423|FG007|NOT COMPLETED|Overall Study||7
9904628|NCT01154816|11020424|FG008|NOT COMPLETED|Overall Study||9
9904629|NCT01154816|11020425|FG009|NOT COMPLETED|Overall Study||10
9904630|NCT01154816|11020426|FG010|NOT COMPLETED|Overall Study||11
9904631|NCT01154816|11020427|FG011|NOT COMPLETED|Overall Study||4
9904632|NCT01154985|11020458|FG000|STARTED|Overall Study|Randomized|75
9904633|NCT01154985|11020459|FG001|STARTED|Overall Study|Randomized|82
9904634|NCT01154985|11020460|FG002|STARTED|Overall Study|Randomized|86
9904635|NCT01154985|11020458|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
9904636|NCT01154985|11020459|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
9904637|NCT01154985|11020460|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
9904638|NCT01154985|11020458|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
9904639|NCT01154985|11020459|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
9904640|NCT01154985|11020460|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
9904641|NCT01154985|11020458|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
9904642|NCT01154985|11020459|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
9904643|NCT01154985|11020460|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
9904644|NCT01154985|11020458|FG000|COMPLETED|Overall Study||58
9904645|NCT01154985|11020459|FG001|COMPLETED|Overall Study||55
9904646|NCT01154985|11020460|FG002|COMPLETED|Overall Study||68
9904647|NCT01154985|11020458|FG000|NOT COMPLETED|Overall Study||17
9904648|NCT01154985|11020459|FG001|NOT COMPLETED|Overall Study||27
9904649|NCT01154985|11020460|FG002|NOT COMPLETED|Overall Study||18
9904650|NCT01155011|11020470|FG000|STARTED|Baseline to 6 Months||151
9904651|NCT01155011|11020471|FG001|STARTED|Baseline to 6 Months||156
9904652|NCT01155011|11020470|FG000|COMPLETED|Baseline to 6 Months||129
9904653|NCT01155011|11020471|FG001|COMPLETED|Baseline to 6 Months||131
9904654|NCT01155011|11020470|FG000|NOT COMPLETED|Baseline to 6 Months||22
9904655|NCT01155011|11020471|FG001|NOT COMPLETED|Baseline to 6 Months||25
9904656|NCT01155011|11020470|FG000|STARTED|6 to 12 Months||129
9904657|NCT01155011|11020471|FG001|STARTED|6 to 12 Months||131
9904658|NCT01155011|11020470|FG000|COMPLETED|6 to 12 Months||120
9904659|NCT01155011|11020471|FG001|COMPLETED|6 to 12 Months||121
9904660|NCT01155011|11020470|FG000|NOT COMPLETED|6 to 12 Months||9
9904661|NCT01155011|11020471|FG001|NOT COMPLETED|6 to 12 Months||10
9904662|NCT01155024|11020481|FG000|STARTED|First Socket Intervention Fitting||5
9904663|NCT01155024|11020482|FG001|STARTED|First Socket Intervention Fitting||5
9904664|NCT01155024|11020481|FG000|COMPLETED|First Socket Intervention Fitting||5
9904665|NCT01155024|11020482|FG001|COMPLETED|First Socket Intervention Fitting||5
9904666|NCT01155024|11020481|FG000|NOT COMPLETED|First Socket Intervention Fitting||0
9904667|NCT01155024|11020482|FG001|NOT COMPLETED|First Socket Intervention Fitting||0
10009476|NCT01766336|11132073|FG001|COMPLETED|Overall Study||71
10203512|NCT03465436|11330497|FG003|STARTED|Period 2||14
10203513|NCT03465436|11330494|FG000|Received at Least 1 Dose of Study Drug|Period 2||14
9904668|NCT01155024|11020481|FG000|STARTED|Second Socket Intervention Fitting||5
9904669|NCT01155024|11020482|FG001|STARTED|Second Socket Intervention Fitting||5
9904670|NCT01155024|11020481|FG000|COMPLETED|Second Socket Intervention Fitting||5
9904671|NCT01155024|11020482|FG001|COMPLETED|Second Socket Intervention Fitting||5
9904672|NCT01155024|11020481|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0
9904673|NCT01155024|11020482|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0
9904674|NCT01155024|11020481|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0
9904675|NCT01155024|11020482|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10
9904676|NCT01155024|11020481|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
9904677|NCT01155024|11020482|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
9904678|NCT01155024|11020481|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
9904679|NCT01155024|11020482|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
9904680|NCT01155050|11020493|FG000|STARTED|Overall Study||50
9904681|NCT01155050|11020494|FG001|STARTED|Overall Study||51
9904682|NCT01155050|11020495|FG002|STARTED|Overall Study||52
9904683|NCT01155050|11020496|FG003|STARTED|Overall Study||49
9904684|NCT01155050|11020493|FG000|COMPLETED|Overall Study||35
9904685|NCT01155050|11020494|FG001|COMPLETED|Overall Study||31
9904686|NCT01155050|11020495|FG002|COMPLETED|Overall Study||33
9904687|NCT01155050|11020496|FG003|COMPLETED|Overall Study||27
9904688|NCT01155050|11020493|FG000|NOT COMPLETED|Overall Study||15
9904689|NCT01155050|11020494|FG001|NOT COMPLETED|Overall Study||20
9904690|NCT01155050|11020495|FG002|NOT COMPLETED|Overall Study||19
9904691|NCT01155050|11020496|FG003|NOT COMPLETED|Overall Study||22
9904692|NCT01155063|11020506|FG000|STARTED|Overall Study||89
9904693|NCT01155063|11020506|FG000|COMPLETED|Overall Study||0
9904694|NCT01155063|11020506|FG000|NOT COMPLETED|Overall Study||89
9904695|NCT01155141|11020510|FG000|STARTED|Overall Study||16
9904696|NCT01155141|11020510|FG000|COMPLETED|Overall Study||14
9904697|NCT01155141|11020510|FG000|NOT COMPLETED|Overall Study||2
9904698|NCT01155154|11020517|FG000|STARTED|Overall Study||25
9904699|NCT01155154|11020518|FG001|STARTED|Overall Study||24
9904700|NCT01155154|11020519|FG002|STARTED|Overall Study||24
9904701|NCT01155154|11020517|FG000|COMPLETED|Overall Study||25
9904702|NCT01155154|11020518|FG001|COMPLETED|Overall Study||24
9904703|NCT01155154|11020519|FG002|COMPLETED|Overall Study||24
9904704|NCT01155154|11020517|FG000|NOT COMPLETED|Overall Study||0
9904705|NCT01155154|11020518|FG001|NOT COMPLETED|Overall Study||0
9904706|NCT01155154|11020519|FG002|NOT COMPLETED|Overall Study||0
9904707|NCT01155167|11020529|FG000|STARTED|Overall Study||43
9904708|NCT01155167|11020530|FG001|STARTED|Overall Study||43
9904709|NCT01155167|11020529|FG000|COMPLETED|Overall Study||40
9904710|NCT01155167|11020530|FG001|COMPLETED|Overall Study||43
9904711|NCT01155167|11020529|FG000|NOT COMPLETED|Overall Study||3
9904712|NCT01155167|11020530|FG001|NOT COMPLETED|Overall Study||0
9904713|NCT01155180|11020538|FG000|STARTED|Overall Study||18
9904714|NCT01155180|11020539|FG001|STARTED|Overall Study||6
9904715|NCT01155180|11020538|FG000|COMPLETED|Overall Study||18
9904716|NCT01155180|11020539|FG001|COMPLETED|Overall Study||6
9904717|NCT01155180|11020538|FG000|NOT COMPLETED|Overall Study||0
9904718|NCT01155180|11020539|FG001|NOT COMPLETED|Overall Study||0
9904719|NCT01155193|11020549|FG000|STARTED|Overall Study||10924
9904720|NCT01155193|11020550|FG001|STARTED|Overall Study||3818
9904721|NCT01155193|11020551|FG002|STARTED|Overall Study||2260
9904722|NCT01155193|11020552|FG003|STARTED|Overall Study||13802
9904723|NCT01155193|11020549|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
9904724|NCT01155193|11020550|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
9904725|NCT01155193|11020551|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
9904726|NCT01155193|11020552|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
9904727|NCT01155193|11020549|FG000|NOT COMPLETED|Overall Study||238
9904728|NCT01155193|11020550|FG001|NOT COMPLETED|Overall Study||13
9904729|NCT01155193|11020551|FG002|NOT COMPLETED|Overall Study||12
9904730|NCT01155193|11020552|FG003|NOT COMPLETED|Overall Study||91
9904731|NCT01155219|11020569|FG000|STARTED|Overall Study||77
9904732|NCT01155219|11020570|FG001|STARTED|Overall Study||73
9904733|NCT01155219|11020569|FG000|COMPLETED|Overall Study||73
9904734|NCT01155219|11020570|FG001|COMPLETED|Overall Study||70
9904735|NCT01155219|11020569|FG000|NOT COMPLETED|Overall Study||4
10009477|NCT01766336|11132072|FG000|NOT COMPLETED|Overall Study||90
10009478|NCT01766336|11132073|FG001|NOT COMPLETED|Overall Study||75
10203514|NCT03465436|11330495|FG001|Received at Least 1 Dose of Study Drug|Period 2||13
10203515|NCT03465436|11330496|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
10203516|NCT03465436|11330497|FG003|Received at Least 1 Dose of Study Drug|Period 2||14
10203517|NCT03465436|11330494|FG000|COMPLETED|Period 2||14
10203518|NCT03465436|11330495|FG001|COMPLETED|Period 2||13
10203519|NCT03465436|11330496|FG002|COMPLETED|Period 2||13
10203520|NCT03465436|11330497|FG003|COMPLETED|Period 2||14
9904736|NCT01155219|11020570|FG001|NOT COMPLETED|Overall Study||3
9904737|NCT01155284|11020578|FG000|STARTED|Overall Study||47
9904738|NCT01155284|11020579|FG001|STARTED|Overall Study||23
9904739|NCT01155284|11020578|FG000|COMPLETED|Overall Study||40
9904740|NCT01155284|11020579|FG001|COMPLETED|Overall Study||18
9904741|NCT01155284|11020578|FG000|NOT COMPLETED|Overall Study||7
9904742|NCT01155284|11020579|FG001|NOT COMPLETED|Overall Study||5
9904743|NCT01155323|11020587|FG000|STARTED|First Intervention||60
9904744|NCT01155323|11020588|FG001|STARTED|First Intervention||58
9904745|NCT01155323|11020587|FG000|COMPLETED|First Intervention||59
9904746|NCT01155323|11020588|FG001|COMPLETED|First Intervention||57
9904747|NCT01155323|11020587|FG000|NOT COMPLETED|First Intervention||1
9904748|NCT01155323|11020588|FG001|NOT COMPLETED|First Intervention||1
9904749|NCT01155323|11020587|FG000|STARTED|Second Intervention||59
9904750|NCT01155323|11020588|FG001|STARTED|Second Intervention||57
9904751|NCT01155323|11020587|FG000|COMPLETED|Second Intervention||58
9904752|NCT01155323|11020588|FG001|COMPLETED|Second Intervention||56
9904753|NCT01155323|11020587|FG000|NOT COMPLETED|Second Intervention||1
9904754|NCT01155323|11020588|FG001|NOT COMPLETED|Second Intervention||1
9904755|NCT01155336|11020596|FG000|STARTED|Overall Study|We did not complete the study.|0
10203521|NCT03465436|11330494|FG000|NOT COMPLETED|Period 2||0
10203522|NCT03465436|11330495|FG001|NOT COMPLETED|Period 2||1
10203523|NCT03465436|11330496|FG002|NOT COMPLETED|Period 2||0
9904756|NCT01155336|11020597|FG001|STARTED|Overall Study|We did not complete the study.|4
9904757|NCT01155336|11020596|FG000|COMPLETED|Overall Study|We did not complete the study.|0
10009479|NCT01766401|11132081|FG000|STARTED|Overall Study||198
10203524|NCT03465436|11330497|FG003|NOT COMPLETED|Period 2||0
9904758|NCT01155336|11020597|FG001|COMPLETED|Overall Study|We did not complete the study.|4
9904759|NCT01155336|11020596|FG000|NOT COMPLETED|Overall Study||0
9904760|NCT01155336|11020597|FG001|NOT COMPLETED|Overall Study||0
9904761|NCT01155466|11020608|FG000|STARTED|Overall Study||156
9904762|NCT01155466|11020609|FG001|STARTED|Overall Study||155
10009480|NCT01766401|11132082|FG001|STARTED|Overall Study||200
10203525|NCT03465436|11330494|FG000|STARTED|Period 3||14
10009481|NCT01766401|11132081|FG000|COMPLETED|Overall Study||161
10009482|NCT01766401|11132082|FG001|COMPLETED|Overall Study||144
9904763|NCT01155466|11020610|FG002|STARTED|Overall Study||156
9904764|NCT01155466|11020611|FG003|STARTED|Overall Study||155
9904765|NCT01155466|11020612|FG004|STARTED|Overall Study||156
9904766|NCT01155466|11020608|FG000|Treated|Overall Study||154
9904767|NCT01155466|11020609|FG001|Treated|Overall Study||153
9904768|NCT01155466|11020610|FG002|Treated|Overall Study||153
9904769|NCT01155466|11020611|FG003|Treated|Overall Study||155
9904770|NCT01155466|11020612|FG004|Treated|Overall Study||154
9904771|NCT01155466|11020608|FG000|COMPLETED|Overall Study|Completed treatment phase|134
9904772|NCT01155466|11020609|FG001|COMPLETED|Overall Study|Completed treatment phase|130
9904773|NCT01155466|11020610|FG002|COMPLETED|Overall Study|Completed treatment phase|136
9904774|NCT01155466|11020611|FG003|COMPLETED|Overall Study|Completed treatment phase|134
9904775|NCT01155466|11020612|FG004|COMPLETED|Overall Study|Completed treatment phase|129
9904776|NCT01155466|11020608|FG000|NOT COMPLETED|Overall Study||22
9904777|NCT01155466|11020609|FG001|NOT COMPLETED|Overall Study||25
9904778|NCT01155466|11020610|FG002|NOT COMPLETED|Overall Study||20
9904779|NCT01155466|11020611|FG003|NOT COMPLETED|Overall Study||21
9904780|NCT01155466|11020612|FG004|NOT COMPLETED|Overall Study||27
9904781|NCT01155479|11020629|FG000|STARTED|Part I||204
9904782|NCT01155479|11020630|FG001|STARTED|Part I||204
9904783|NCT01155479|11020631|FG002|STARTED|Part I||206
9904784|NCT01155479|11020632|FG003|STARTED|Part I||204
9904785|NCT01155479|11020633|FG004|STARTED|Part I||204
9904786|NCT01155479|11020629|FG000|Treated|Part I||200
9904787|NCT01155479|11020630|FG001|Treated|Part I||202
9904788|NCT01155479|11020631|FG002|Treated|Part I||204
9904789|NCT01155479|11020632|FG003|Treated|Part I||198
9904790|NCT01155479|11020633|FG004|Treated|Part I||203
9904791|NCT01155479|11020629|FG000|COMPLETED|Part I||166
9904792|NCT01155479|11020630|FG001|COMPLETED|Part I||177
9904793|NCT01155479|11020631|FG002|COMPLETED|Part I||167
9904794|NCT01155479|11020632|FG003|COMPLETED|Part I||177
9904795|NCT01155479|11020633|FG004|COMPLETED|Part I||181
9904796|NCT01155479|11020629|FG000|NOT COMPLETED|Part I||38
9904797|NCT01155479|11020630|FG001|NOT COMPLETED|Part I||27
9904798|NCT01155479|11020631|FG002|NOT COMPLETED|Part I||39
9904799|NCT01155479|11020632|FG003|NOT COMPLETED|Part I||27
9904800|NCT01155479|11020633|FG004|NOT COMPLETED|Part I||23
9904801|NCT01155479|11020629|FG000|STARTED|Part II||166
9904802|NCT01155479|11020630|FG001|STARTED|Part II||177
9904803|NCT01155479|11020631|FG002|STARTED|Part II||167
9904804|NCT01155479|11020632|FG003|STARTED|Part II||177
9904805|NCT01155479|11020633|FG004|STARTED|Part II||181
9904806|NCT01155479|11020629|FG000|COMPLETED|Part II||107
9904807|NCT01155479|11020630|FG001|COMPLETED|Part II||116
10009483|NCT01766401|11132081|FG000|NOT COMPLETED|Overall Study||37
10009484|NCT01766401|11132082|FG001|NOT COMPLETED|Overall Study||56
10009485|NCT01766440|11132088|FG000|STARTED|Overall Study||18
9904808|NCT01155479|11020631|FG002|COMPLETED|Part II||109
9904809|NCT01155479|11020632|FG003|COMPLETED|Part II||127
9904810|NCT01155479|11020633|FG004|COMPLETED|Part II||126
9904811|NCT01155479|11020629|FG000|NOT COMPLETED|Part II||59
9904812|NCT01155479|11020630|FG001|NOT COMPLETED|Part II||61
9904813|NCT01155479|11020631|FG002|NOT COMPLETED|Part II||58
9904814|NCT01155479|11020632|FG003|NOT COMPLETED|Part II||50
9904815|NCT01155479|11020633|FG004|NOT COMPLETED|Part II||55
9904816|NCT01155531|11020665|FG000|STARTED|Overall Study||10
9904817|NCT01155531|11020666|FG001|STARTED|Overall Study||10
9904818|NCT01155531|11020667|FG002|STARTED|Overall Study||10
9904819|NCT01155531|11020668|FG003|STARTED|Overall Study||10
9904820|NCT01155531|11020665|FG000|COMPLETED|Overall Study||9
9904821|NCT01155531|11020666|FG001|COMPLETED|Overall Study||10
9904822|NCT01155531|11020667|FG002|COMPLETED|Overall Study||8
9904823|NCT01155531|11020668|FG003|COMPLETED|Overall Study||9
9904824|NCT01155531|11020665|FG000|NOT COMPLETED|Overall Study||1
9904825|NCT01155531|11020666|FG001|NOT COMPLETED|Overall Study||0
9904826|NCT01155531|11020667|FG002|NOT COMPLETED|Overall Study||2
9904827|NCT01155531|11020668|FG003|NOT COMPLETED|Overall Study||1
9904828|NCT01155570|11020678|FG000|STARTED|Overall Study|Safety Analysis Population|734
9904829|NCT01155570|11020678|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
9904830|NCT01155570|11020678|FG000|COMPLETED|Overall Study||592
9904831|NCT01155570|11020678|FG000|NOT COMPLETED|Overall Study||142
10009486|NCT01766440|11132088|FG000|COMPLETED|Overall Study||17
10009487|NCT01766440|11132088|FG000|NOT COMPLETED|Overall Study||1
10009488|NCT01766466|11132094|FG000|STARTED|Day 1||6
9904832|NCT01155583|11020693|FG000|STARTED|Phase I||3
9904833|NCT01155583|11020694|FG001|STARTED|Phase I||3
9904834|NCT01155583|11020695|FG002|STARTED|Phase I||4
9904835|NCT01155583|11020696|FG003|STARTED|Phase I||6
9904836|NCT01155583|11020697|FG004|STARTED|Phase I||7
9904837|NCT01155583|11020698|FG005|STARTED|Phase I||0
9904838|NCT01155583|11020699|FG006|STARTED|Phase I||3
9904839|NCT01155583|11020700|FG007|STARTED|Phase I||8
9904840|NCT01155583|11020701|FG008|STARTED|Phase I||0
9904841|NCT01155583|11020693|FG000|COMPLETED|Phase I||3
9904842|NCT01155583|11020694|FG001|COMPLETED|Phase I||3
9904843|NCT01155583|11020695|FG002|COMPLETED|Phase I||4
9904844|NCT01155583|11020696|FG003|COMPLETED|Phase I||6
9904845|NCT01155583|11020697|FG004|COMPLETED|Phase I||6
9904846|NCT01155583|11020698|FG005|COMPLETED|Phase I||0
9904847|NCT01155583|11020699|FG006|COMPLETED|Phase I||3
9904848|NCT01155583|11020700|FG007|COMPLETED|Phase I||5
9904849|NCT01155583|11020701|FG008|COMPLETED|Phase I||0
9904850|NCT01155583|11020693|FG000|NOT COMPLETED|Phase I||0
9904851|NCT01155583|11020694|FG001|NOT COMPLETED|Phase I||0
9904852|NCT01155583|11020695|FG002|NOT COMPLETED|Phase I||0
9904853|NCT01155583|11020696|FG003|NOT COMPLETED|Phase I||0
9904854|NCT01155583|11020697|FG004|NOT COMPLETED|Phase I||1
9904855|NCT01155583|11020698|FG005|NOT COMPLETED|Phase I||0
9904856|NCT01155583|11020699|FG006|NOT COMPLETED|Phase I||0
9904857|NCT01155583|11020700|FG007|NOT COMPLETED|Phase I||3
9904858|NCT01155583|11020701|FG008|NOT COMPLETED|Phase I||0
9904859|NCT01155583|11020693|FG000|STARTED|Phase II - Expansion Phase||0
9904860|NCT01155583|11020694|FG001|STARTED|Phase II - Expansion Phase||0
9904861|NCT01155583|11020695|FG002|STARTED|Phase II - Expansion Phase||0
9904862|NCT01155583|11020696|FG003|STARTED|Phase II - Expansion Phase||0
9904863|NCT01155583|11020697|FG004|STARTED|Phase II - Expansion Phase||0
9904864|NCT01155583|11020698|FG005|STARTED|Phase II - Expansion Phase||0
9904865|NCT01155583|11020699|FG006|STARTED|Phase II - Expansion Phase||0
9904866|NCT01155583|11020700|FG007|STARTED|Phase II - Expansion Phase||0
9904867|NCT01155583|11020701|FG008|STARTED|Phase II - Expansion Phase||11
9904868|NCT01155583|11020693|FG000|COMPLETED|Phase II - Expansion Phase||0
9904869|NCT01155583|11020694|FG001|COMPLETED|Phase II - Expansion Phase||0
9904870|NCT01155583|11020695|FG002|COMPLETED|Phase II - Expansion Phase||0
9904871|NCT01155583|11020696|FG003|COMPLETED|Phase II - Expansion Phase||0
9904872|NCT01155583|11020697|FG004|COMPLETED|Phase II - Expansion Phase||0
9904873|NCT01155583|11020698|FG005|COMPLETED|Phase II - Expansion Phase||0
9904874|NCT01155583|11020699|FG006|COMPLETED|Phase II - Expansion Phase||0
9904875|NCT01155583|11020700|FG007|COMPLETED|Phase II - Expansion Phase||0
9904876|NCT01155583|11020701|FG008|COMPLETED|Phase II - Expansion Phase||11
9904877|NCT01155583|11020693|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
9904878|NCT01155583|11020694|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
9904879|NCT01155583|11020695|FG002|NOT COMPLETED|Phase II - Expansion Phase||0
9904880|NCT01155583|11020696|FG003|NOT COMPLETED|Phase II - Expansion Phase||0
9904881|NCT01155583|11020697|FG004|NOT COMPLETED|Phase II - Expansion Phase||0
9904882|NCT01155583|11020698|FG005|NOT COMPLETED|Phase II - Expansion Phase||0
9904883|NCT01155583|11020699|FG006|NOT COMPLETED|Phase II - Expansion Phase||0
9904884|NCT01155583|11020700|FG007|NOT COMPLETED|Phase II - Expansion Phase||0
9904885|NCT01155583|11020701|FG008|NOT COMPLETED|Phase II - Expansion Phase||0
9904886|NCT01155661|11020717|FG000|STARTED|Overall Study||608
9904887|NCT01155661|11020717|FG000|COMPLETED|Overall Study||328
9904888|NCT01155661|11020717|FG000|NOT COMPLETED|Overall Study||280
9904889|NCT01155726|11020723|FG000|STARTED|Period 1, 3 Days (Masked)||24
9904890|NCT01155726|11020724|FG001|STARTED|Period 1, 3 Days (Masked)||20
9904891|NCT01155726|11020725|FG002|STARTED|Period 1, 3 Days (Masked)||30
9904892|NCT01155726|11020726|FG003|STARTED|Period 1, 3 Days (Masked)||25
9904893|NCT01155726|11020723|FG000|COMPLETED|Period 1, 3 Days (Masked)||23
9904894|NCT01155726|11020724|FG001|COMPLETED|Period 1, 3 Days (Masked)||20
9904895|NCT01155726|11020725|FG002|COMPLETED|Period 1, 3 Days (Masked)||28
9904896|NCT01155726|11020726|FG003|COMPLETED|Period 1, 3 Days (Masked)||25
9904897|NCT01155726|11020723|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1
9904898|NCT01155726|11020724|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0
9904899|NCT01155726|11020725|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2
9904900|NCT01155726|11020726|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0
9904901|NCT01155726|11020723|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
9904902|NCT01155726|11020724|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
9904903|NCT01155726|11020725|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
9904904|NCT01155726|11020726|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
9904905|NCT01155726|11020723|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
9904906|NCT01155726|11020724|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
9904907|NCT01155726|11020725|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
9904908|NCT01155726|11020726|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
9904909|NCT01155726|11020723|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
9904910|NCT01155726|11020724|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
9904911|NCT01155726|11020725|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
9904912|NCT01155726|11020726|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
9904913|NCT01155778|11020751|FG000|STARTED|Overall Study||4
9904914|NCT01155778|11020752|FG001|STARTED|Overall Study||4
9904915|NCT01155778|11020753|FG002|STARTED|Overall Study||4
9904916|NCT01155778|11020751|FG000|COMPLETED|Overall Study||4
9904917|NCT01155778|11020752|FG001|COMPLETED|Overall Study||4
9904918|NCT01155778|11020753|FG002|COMPLETED|Overall Study||4
9904919|NCT01155778|11020751|FG000|NOT COMPLETED|Overall Study||0
9904920|NCT01155778|11020752|FG001|NOT COMPLETED|Overall Study||0
9904921|NCT01155778|11020753|FG002|NOT COMPLETED|Overall Study||0
9904922|NCT01155830|11020764|FG000|STARTED|Overall Study||0
9904923|NCT01155830|11020765|FG001|STARTED|Overall Study||0
9760451|NCT00381004|10864094|FG000|NOT COMPLETED|Overall Study||0
9760452|NCT00381043|10864100|FG000|STARTED|Overall Study||51
9760453|NCT00381043|10864101|FG001|STARTED|Overall Study||49
9760454|NCT00381043|10864100|FG000|COMPLETED|Overall Study||39
9904924|NCT01155830|11020766|FG002|STARTED|Overall Study||21
9904925|NCT01155830|11020764|FG000|COMPLETED|Overall Study||0
9904926|NCT01155830|11020765|FG001|COMPLETED|Overall Study||0
9904927|NCT01155830|11020766|FG002|COMPLETED|Overall Study||21
9904928|NCT01155830|11020764|FG000|NOT COMPLETED|Overall Study||0
9904929|NCT01155830|11020765|FG001|NOT COMPLETED|Overall Study||0
9904930|NCT01155830|11020766|FG002|NOT COMPLETED|Overall Study||0
9904931|NCT01155869|11020776|FG000|STARTED|Overall Study||3
9760455|NCT00381043|10864101|FG001|COMPLETED|Overall Study||41
9904932|NCT01155869|11020777|FG001|STARTED|Overall Study||4
9904933|NCT01155869|11020776|FG000|COMPLETED|Overall Study||0
9904934|NCT01155869|11020777|FG001|COMPLETED|Overall Study||3
9904935|NCT01155869|11020776|FG000|NOT COMPLETED|Overall Study||3
9904936|NCT01155869|11020777|FG001|NOT COMPLETED|Overall Study||1
9904937|NCT01155999|11020785|FG000|STARTED|Overall Study||146
9904938|NCT01155999|11020786|FG001|STARTED|Overall Study||140
9904939|NCT01155999|11020785|FG000|COMPLETED|Overall Study||139
9904940|NCT01155999|11020786|FG001|COMPLETED|Overall Study||136
9904941|NCT01155999|11020785|FG000|NOT COMPLETED|Overall Study||7
9904942|NCT01155999|11020786|FG001|NOT COMPLETED|Overall Study||4
9904943|NCT01156012|11020794|FG000|STARTED|Overall Study||213
9904944|NCT01156012|11020795|FG001|STARTED|Overall Study||189
9904945|NCT01156012|11020794|FG000|COMPLETED|Overall Study||206
9904946|NCT01156012|11020795|FG001|COMPLETED|Overall Study||186
9904947|NCT01156012|11020794|FG000|NOT COMPLETED|Overall Study||7
9904948|NCT01156012|11020795|FG001|NOT COMPLETED|Overall Study||3
9904949|NCT01156051|11020803|FG000|STARTED|Overall Study||12
9904950|NCT01156051|11020804|FG001|STARTED|Overall Study||17
9904951|NCT01156051|11020803|FG000|COMPLETED|Overall Study||11
9904952|NCT01156051|11020804|FG001|COMPLETED|Overall Study||16
9904953|NCT01156051|11020803|FG000|NOT COMPLETED|Overall Study||1
9904954|NCT01156051|11020804|FG001|NOT COMPLETED|Overall Study||1
9904955|NCT01156116|11020812|FG000|STARTED|Overall Study||26
9904956|NCT01156116|11020813|FG001|STARTED|Overall Study||13
9904957|NCT01156116|11020812|FG000|COMPLETED|Overall Study||21
9904958|NCT01156116|11020813|FG001|COMPLETED|Overall Study||12
9904959|NCT01156116|11020812|FG000|NOT COMPLETED|Overall Study||5
9904960|NCT01156116|11020813|FG001|NOT COMPLETED|Overall Study||1
9904961|NCT01156142|11020821|FG000|STARTED|Overall Study||77
9904962|NCT01156142|11020822|FG001|STARTED|Overall Study||78
9904963|NCT01156142|11020821|FG000|COMPLETED|Overall Study||69
9904964|NCT01156142|11020822|FG001|COMPLETED|Overall Study||71
9904965|NCT01156142|11020821|FG000|NOT COMPLETED|Overall Study||8
9904966|NCT01156142|11020822|FG001|NOT COMPLETED|Overall Study||7
9904967|NCT01156311|11020830|FG000|STARTED|2-Month Monotherapy Period||59
9904968|NCT01156311|11020831|FG001|STARTED|2-Month Monotherapy Period||49
9904969|NCT01156311|11020832|FG002|STARTED|2-Month Monotherapy Period||0
9904970|NCT01156311|11020833|FG003|STARTED|2-Month Monotherapy Period||0
9904971|NCT01156311|11020830|FG000|COMPLETED|2-Month Monotherapy Period||57
9904972|NCT01156311|11020831|FG001|COMPLETED|2-Month Monotherapy Period||47
9904973|NCT01156311|11020832|FG002|COMPLETED|2-Month Monotherapy Period||0
9904974|NCT01156311|11020833|FG003|COMPLETED|2-Month Monotherapy Period||0
9904975|NCT01156311|11020830|FG000|NOT COMPLETED|2-Month Monotherapy Period||2
9904976|NCT01156311|11020831|FG001|NOT COMPLETED|2-Month Monotherapy Period||2
9904977|NCT01156311|11020832|FG002|NOT COMPLETED|2-Month Monotherapy Period||0
9904978|NCT01156311|11020833|FG003|NOT COMPLETED|2-Month Monotherapy Period||0
9904979|NCT01156311|11020830|FG000|STARTED|6-month Add-on Therapy Period||0
9904980|NCT01156311|11020831|FG001|STARTED|6-month Add-on Therapy Period||0
9904981|NCT01156311|11020832|FG002|STARTED|6-month Add-on Therapy Period||57
9904982|NCT01156311|11020833|FG003|STARTED|6-month Add-on Therapy Period||47
9904983|NCT01156311|11020830|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
9904984|NCT01156311|11020831|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
9904985|NCT01156311|11020832|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
9904986|NCT01156311|11020833|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
9904987|NCT01156311|11020830|FG000|COMPLETED|6-month Add-on Therapy Period||0
9904988|NCT01156311|11020831|FG001|COMPLETED|6-month Add-on Therapy Period||0
9904989|NCT01156311|11020832|FG002|COMPLETED|6-month Add-on Therapy Period||45
9904990|NCT01156311|11020833|FG003|COMPLETED|6-month Add-on Therapy Period||37
9904991|NCT01156311|11020830|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0
9904992|NCT01156311|11020831|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0
9904993|NCT01156311|11020832|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12
9904994|NCT01156311|11020833|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10
9904995|NCT01156363|11020844|FG000|STARTED|Overall Study||86
9904996|NCT01156363|11020844|FG000|COMPLETED|Overall Study||64
9904997|NCT01156363|11020844|FG000|NOT COMPLETED|Overall Study||22
9904998|NCT01156376|11020858|FG000|STARTED|Overall Study||27
9904999|NCT01156376|11020859|FG001|STARTED|Overall Study||26
9905000|NCT01156376|11020860|FG002|STARTED|Overall Study||27
9905001|NCT01156376|11020858|FG000|COMPLETED|Overall Study||26
9905002|NCT01156376|11020859|FG001|COMPLETED|Overall Study||26
9905003|NCT01156376|11020860|FG002|COMPLETED|Overall Study||23
9905004|NCT01156376|11020858|FG000|NOT COMPLETED|Overall Study||1
9905005|NCT01156376|11020859|FG001|NOT COMPLETED|Overall Study||0
9905006|NCT01156376|11020860|FG002|NOT COMPLETED|Overall Study||4
9905007|NCT01156480|11020870|FG000|STARTED|Overall Study||0
9905008|NCT01156480|11020871|FG001|STARTED|Overall Study||2
9905009|NCT01156480|11020870|FG000|COMPLETED|Overall Study||0
9905010|NCT01156480|11020871|FG001|COMPLETED|Overall Study||1
9905011|NCT01156480|11020870|FG000|NOT COMPLETED|Overall Study||0
9905012|NCT01156480|11020871|FG001|NOT COMPLETED|Overall Study||1
9905013|NCT01156532|11020879|FG000|STARTED|Overall Study||30
9905014|NCT01156532|11020879|FG000|COMPLETED|Overall Study||28
9905015|NCT01156532|11020879|FG000|NOT COMPLETED|Overall Study||2
9905016|NCT01156571|11020885|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
9905017|NCT01156571|11020886|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
9905018|NCT01156571|11020885|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
9905019|NCT01156571|11020886|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
9905020|NCT01156571|11020885|FG000|NOT COMPLETED|Overall Study||17
9905021|NCT01156571|11020886|FG001|NOT COMPLETED|Overall Study||19
9905022|NCT01156597|11020894|FG000|STARTED|Overall Study||16
9905023|NCT01156597|11020895|FG001|STARTED|Overall Study||14
9905024|NCT01156597|11020894|FG000|COMPLETED|Overall Study||13
9905025|NCT01156597|11020895|FG001|COMPLETED|Overall Study||13
9905026|NCT01156597|11020894|FG000|NOT COMPLETED|Overall Study||3
9905027|NCT01156597|11020895|FG001|NOT COMPLETED|Overall Study||1
9905028|NCT01156675|11020905|FG000|STARTED|Overall Study||107
9905029|NCT01156675|11020906|FG001|STARTED|Overall Study||106
9905030|NCT01156675|11020907|FG002|STARTED|Overall Study||2
9905031|NCT01156675|11020905|FG000|COMPLETED|Overall Study||73
9905032|NCT01156675|11020906|FG001|COMPLETED|Overall Study||81
9905033|NCT01156675|11020907|FG002|COMPLETED|Overall Study||0
9905034|NCT01156675|11020905|FG000|NOT COMPLETED|Overall Study||34
9905035|NCT01156675|11020906|FG001|NOT COMPLETED|Overall Study||25
9905036|NCT01156675|11020907|FG002|NOT COMPLETED|Overall Study||2
9905037|NCT01156701|11020916|FG000|STARTED|Overall Study||257
9905038|NCT01156701|11020917|FG001|STARTED|Overall Study||1007
9905039|NCT01156701|11020918|FG002|STARTED|Overall Study||163716
9905040|NCT01156701|11020919|FG003|STARTED|Overall Study||6725
9905041|NCT01156701|11020916|FG000|COMPLETED|Overall Study||257
9905042|NCT01156701|11020917|FG001|COMPLETED|Overall Study||1007
9905043|NCT01156701|11020918|FG002|COMPLETED|Overall Study||163716
9905044|NCT01156701|11020919|FG003|COMPLETED|Overall Study||6725
9905045|NCT01156701|11020916|FG000|NOT COMPLETED|Overall Study||0
9905046|NCT01156701|11020917|FG001|NOT COMPLETED|Overall Study||0
9905047|NCT01156701|11020918|FG002|NOT COMPLETED|Overall Study||0
9905048|NCT01156701|11020919|FG003|NOT COMPLETED|Overall Study||0
9905049|NCT01156714|11020932|FG000|STARTED|Overall Study||20
9905050|NCT01156714|11020933|FG001|STARTED|Overall Study||19
9905051|NCT01156714|11020934|FG002|STARTED|Overall Study||20
9905052|NCT01156714|11020932|FG000|COMPLETED|Overall Study||11
9905053|NCT01156714|11020933|FG001|COMPLETED|Overall Study||15
9905054|NCT01156714|11020934|FG002|COMPLETED|Overall Study||17
9905055|NCT01156714|11020932|FG000|NOT COMPLETED|Overall Study||9
9905056|NCT01156714|11020933|FG001|NOT COMPLETED|Overall Study||4
9905057|NCT01156714|11020934|FG002|NOT COMPLETED|Overall Study||3
9905058|NCT01156792|11020945|FG000|STARTED|Overall Study||162
9905059|NCT01156792|11020945|FG000|COMPLETED|Overall Study||93
9905060|NCT01156792|11020945|FG000|NOT COMPLETED|Overall Study||69
9905061|NCT01156805|11020962|FG000|STARTED|Overall Study||237
9905062|NCT01156805|11020963|FG001|STARTED|Overall Study||272
9905063|NCT01156805|11020962|FG000|COMPLETED|Overall Study||181
9905064|NCT01156805|11020963|FG001|COMPLETED|Overall Study||216
9905065|NCT01156805|11020962|FG000|NOT COMPLETED|Overall Study||56
9905066|NCT01156805|11020963|FG001|NOT COMPLETED|Overall Study||56
9905067|NCT01156844|11020973|FG000|STARTED|Overall Study|Randomized participants.|48
9905068|NCT01156844|11020974|FG001|STARTED|Overall Study||48
9905069|NCT01156844|11020975|FG002|STARTED|Overall Study||48
9905070|NCT01156844|11020976|FG003|STARTED|Overall Study||47
9905071|NCT01156844|11020973|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
9905072|NCT01156844|11020974|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47
9905073|NCT01156844|11020975|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48
9905074|NCT01156844|11020976|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46
9905075|NCT01156844|11020973|FG000|COMPLETED|Overall Study||46
9905076|NCT01156844|11020974|FG001|COMPLETED|Overall Study||46
9905077|NCT01156844|11020975|FG002|COMPLETED|Overall Study||42
9905078|NCT01156844|11020976|FG003|COMPLETED|Overall Study||41
9905079|NCT01156844|11020973|FG000|NOT COMPLETED|Overall Study||2
9905080|NCT01156844|11020974|FG001|NOT COMPLETED|Overall Study||2
9905081|NCT01156844|11020975|FG002|NOT COMPLETED|Overall Study||6
9905082|NCT01156844|11020976|FG003|NOT COMPLETED|Overall Study||6
9905083|NCT01156987|11020991|FG000|STARTED|Overall Study||8
9905084|NCT01156987|11020992|FG001|STARTED|Overall Study||23
9905085|NCT01156987|11020991|FG000|COMPLETED|Overall Study||8
9905086|NCT01156987|11020992|FG001|COMPLETED|Overall Study||12
9905087|NCT01156987|11020991|FG000|NOT COMPLETED|Overall Study||0
9905088|NCT01156987|11020992|FG001|NOT COMPLETED|Overall Study||11
9905089|NCT01157065|11021000|FG000|STARTED|Overall Study||38
9905090|NCT01157065|11021001|FG001|STARTED|Overall Study||11
9905091|NCT01157065|11021000|FG000|COMPLETED|Overall Study||38
9905092|NCT01157065|11021001|FG001|COMPLETED|Overall Study||10
9905093|NCT01157065|11021000|FG000|NOT COMPLETED|Overall Study||0
9905094|NCT01157065|11021001|FG001|NOT COMPLETED|Overall Study||1
9905095|NCT01157078|11021009|FG000|STARTED|Overall Study||159
9905096|NCT01157078|11021010|FG001|STARTED|Overall Study||160
9905097|NCT01157078|11021009|FG000|Received Treatment|Overall Study||157
9905098|NCT01157078|11021010|FG001|Received Treatment|Overall Study||159
9905099|NCT01157078|11021009|FG000|COMPLETED|Overall Study||124
9905100|NCT01157078|11021010|FG001|COMPLETED|Overall Study||124
9905101|NCT01157078|11021009|FG000|NOT COMPLETED|Overall Study||35
9905102|NCT01157078|11021010|FG001|NOT COMPLETED|Overall Study||36
9905103|NCT01157117|11021019|FG000|STARTED|Overall Study||28
9905104|NCT01157117|11021020|FG001|STARTED|Overall Study||29
9905105|NCT01157117|11021021|FG002|STARTED|Overall Study||20
9905106|NCT01157117|11021019|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27
9905107|NCT01157117|11021020|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28
9905108|NCT01157117|11021021|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0
9905109|NCT01157117|11021019|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27
9905110|NCT01157117|11021020|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28
9905111|NCT01157117|11021021|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0
9905112|NCT01157117|11021019|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26
9905113|NCT01157117|11021020|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26
9905114|NCT01157117|11021021|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0
9905115|NCT01157117|11021019|FG000|Unblinded at Month 16|Overall Study||26
9905116|NCT01157117|11021020|FG001|Unblinded at Month 16|Overall Study||26
9905117|NCT01157117|11021021|FG002|Unblinded at Month 16|Overall Study||0
9905118|NCT01157117|11021019|FG000|Completed Month 28 Desensitization OFC|Overall Study||26
9905119|NCT01157117|11021020|FG001|Completed Month 28 Desensitization OFC|Overall Study||24
9905120|NCT01157117|11021021|FG002|Completed Month 28 Desensitization OFC|Overall Study||0
9905121|NCT01157117|11021019|FG000|Discontinued Milk OIT at Month 30|Overall Study||24
9905122|NCT01157117|11021020|FG001|Discontinued Milk OIT at Month 30|Overall Study||20
9905123|NCT01157117|11021021|FG002|Discontinued Milk OIT at Month 30|Overall Study||0
9905124|NCT01157117|11021019|FG000|Completed Month 32 Tolerance OFC|Overall Study||24
9905125|NCT01157117|11021020|FG001|Completed Month 32 Tolerance OFC|Overall Study||20
9905126|NCT01157117|11021021|FG002|Completed Month 32 Tolerance OFC|Overall Study||0
9905127|NCT01157117|11021019|FG000|Completed Final Month 38 Study Visit|Overall Study||19
9905128|NCT01157117|11021020|FG001|Completed Final Month 38 Study Visit|Overall Study||18
9905129|NCT01157117|11021021|FG002|Completed Final Month 38 Study Visit|Overall Study||3
9905130|NCT01157117|11021019|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
10203526|NCT03465436|11330495|FG001|STARTED|Period 3||13
10203527|NCT03465436|11330496|FG002|STARTED|Period 3||13
10203528|NCT03465436|11330497|FG003|STARTED|Period 3||14
9905131|NCT01157117|11021020|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
9905132|NCT01157117|11021021|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
9905133|NCT01157117|11021019|FG000|NOT COMPLETED|Overall Study||9
9905134|NCT01157117|11021020|FG001|NOT COMPLETED|Overall Study||11
9905135|NCT01157117|11021021|FG002|NOT COMPLETED|Overall Study||15
9905136|NCT01157169|11021031|FG000|STARTED|First Intervention||20
9905137|NCT01157169|11021032|FG001|STARTED|First Intervention||20
9905138|NCT01157169|11021031|FG000|COMPLETED|First Intervention||16
9905139|NCT01157169|11021032|FG001|COMPLETED|First Intervention||18
9905140|NCT01157169|11021031|FG000|NOT COMPLETED|First Intervention||4
9905141|NCT01157169|11021032|FG001|NOT COMPLETED|First Intervention||2
9905142|NCT01157169|11021031|FG000|STARTED|Washout of 10 Days||16
9905143|NCT01157169|11021032|FG001|STARTED|Washout of 10 Days||18
9905144|NCT01157169|11021031|FG000|COMPLETED|Washout of 10 Days||16
9905145|NCT01157169|11021032|FG001|COMPLETED|Washout of 10 Days||18
9905146|NCT01157169|11021031|FG000|NOT COMPLETED|Washout of 10 Days||0
9905147|NCT01157169|11021032|FG001|NOT COMPLETED|Washout of 10 Days||0
9905148|NCT01157169|11021031|FG000|STARTED|Second Intervention||16
9905149|NCT01157169|11021032|FG001|STARTED|Second Intervention||18
9905150|NCT01157169|11021031|FG000|COMPLETED|Second Intervention||16
9905151|NCT01157169|11021032|FG001|COMPLETED|Second Intervention||17
9905152|NCT01157169|11021031|FG000|NOT COMPLETED|Second Intervention||0
9905153|NCT01157169|11021032|FG001|NOT COMPLETED|Second Intervention||1
9905154|NCT01157182|11021040|FG000|STARTED|First Intervention||18
9905155|NCT01157182|11021041|FG001|STARTED|First Intervention||18
9905156|NCT01157182|11021040|FG000|COMPLETED|First Intervention||18
9905157|NCT01157182|11021041|FG001|COMPLETED|First Intervention||18
9905158|NCT01157182|11021040|FG000|NOT COMPLETED|First Intervention||0
9905159|NCT01157182|11021041|FG001|NOT COMPLETED|First Intervention||0
9905160|NCT01157182|11021040|FG000|STARTED|Washout of 28 Days||18
9905161|NCT01157182|11021041|FG001|STARTED|Washout of 28 Days||18
9905162|NCT01157182|11021040|FG000|COMPLETED|Washout of 28 Days||16
9905163|NCT01157182|11021041|FG001|COMPLETED|Washout of 28 Days||18
9905164|NCT01157182|11021040|FG000|NOT COMPLETED|Washout of 28 Days||2
9905165|NCT01157182|11021041|FG001|NOT COMPLETED|Washout of 28 Days||0
9905166|NCT01157182|11021040|FG000|STARTED|Second Intervention||16
9905167|NCT01157182|11021041|FG001|STARTED|Second Intervention||18
9905168|NCT01157182|11021040|FG000|COMPLETED|Second Intervention||16
9905169|NCT01157182|11021041|FG001|COMPLETED|Second Intervention||18
9905170|NCT01157182|11021040|FG000|NOT COMPLETED|Second Intervention||0
9905171|NCT01157182|11021041|FG001|NOT COMPLETED|Second Intervention||0
9905172|NCT01157234|11021049|FG000|STARTED|Overall Study||15
9905173|NCT01157234|11021050|FG001|STARTED|Overall Study||15
9905174|NCT01157234|11021049|FG000|COMPLETED|Overall Study||14
9905175|NCT01157234|11021050|FG001|COMPLETED|Overall Study||15
9905176|NCT01157234|11021049|FG000|NOT COMPLETED|Overall Study||1
9905177|NCT01157234|11021050|FG001|NOT COMPLETED|Overall Study||0
9905178|NCT01157351|11021065|FG000|STARTED|Overall Study||230
9905179|NCT01157351|11021066|FG001|STARTED|Overall Study||220
9905180|NCT01157351|11021065|FG000|Treated|Overall Study||226
9905181|NCT01157351|11021066|FG001|Treated|Overall Study||218
9905182|NCT01157351|11021065|FG000|COMPLETED|Overall Study||93
9905183|NCT01157351|11021066|FG001|COMPLETED|Overall Study||88
9905184|NCT01157351|11021065|FG000|NOT COMPLETED|Overall Study||137
9905185|NCT01157351|11021066|FG001|NOT COMPLETED|Overall Study||132
9905186|NCT01157364|11021078|FG000|STARTED|Overall Study||15
9905187|NCT01157364|11021079|FG001|STARTED|Overall Study||21
9905188|NCT01157364|11021080|FG002|STARTED|Overall Study||21
9905189|NCT01157364|11021081|FG003|STARTED|Overall Study||18
9905190|NCT01157364|11021082|FG004|STARTED|Overall Study||11
9905191|NCT01157364|11021083|FG005|STARTED|Overall Study||23
9905192|NCT01157364|11021078|FG000|COMPLETED|Overall Study||13
9905193|NCT01157364|11021079|FG001|COMPLETED|Overall Study||17
9905194|NCT01157364|11021080|FG002|COMPLETED|Overall Study||17
9905195|NCT01157364|11021081|FG003|COMPLETED|Overall Study||16
9905196|NCT01157364|11021082|FG004|COMPLETED|Overall Study||9
9905197|NCT01157364|11021083|FG005|COMPLETED|Overall Study||22
9905198|NCT01157364|11021078|FG000|NOT COMPLETED|Overall Study||2
9905199|NCT01157364|11021079|FG001|NOT COMPLETED|Overall Study||4
9905200|NCT01157364|11021080|FG002|NOT COMPLETED|Overall Study||4
9905201|NCT01157364|11021081|FG003|NOT COMPLETED|Overall Study||2
9905202|NCT01157364|11021082|FG004|NOT COMPLETED|Overall Study||2
9905203|NCT01157364|11021083|FG005|NOT COMPLETED|Overall Study||1
9905204|NCT01157377|11021104|FG000|STARTED|Overall Study||23
9905205|NCT01157377|11021105|FG001|STARTED|Overall Study||23
9905206|NCT01157377|11021106|FG002|STARTED|Overall Study||27
9905207|NCT01157377|11021107|FG003|STARTED|Overall Study||15
9905208|NCT01157377|11021108|FG004|STARTED|Overall Study||20
9905209|NCT01157377|11021109|FG005|STARTED|Overall Study||19
9905210|NCT01157377|11021110|FG006|STARTED|Overall Study||29
9905211|NCT01157377|11021104|FG000|COMPLETED|Overall Study||21
9905212|NCT01157377|11021105|FG001|COMPLETED|Overall Study||20
9905213|NCT01157377|11021106|FG002|COMPLETED|Overall Study||26
9905214|NCT01157377|11021107|FG003|COMPLETED|Overall Study||14
9905215|NCT01157377|11021108|FG004|COMPLETED|Overall Study||18
9905216|NCT01157377|11021109|FG005|COMPLETED|Overall Study||16
9905217|NCT01157377|11021110|FG006|COMPLETED|Overall Study||27
9905218|NCT01157377|11021104|FG000|NOT COMPLETED|Overall Study||2
9905219|NCT01157377|11021105|FG001|NOT COMPLETED|Overall Study||3
9905220|NCT01157377|11021106|FG002|NOT COMPLETED|Overall Study||1
9905221|NCT01157377|11021107|FG003|NOT COMPLETED|Overall Study||1
9905222|NCT01157377|11021108|FG004|NOT COMPLETED|Overall Study||2
9905223|NCT01157377|11021109|FG005|NOT COMPLETED|Overall Study||3
9905224|NCT01157377|11021110|FG006|NOT COMPLETED|Overall Study||2
9905225|NCT01157416|11021128|FG000|STARTED|Overall Study||17
9905226|NCT01157416|11021129|FG001|STARTED|Overall Study||16
9905227|NCT01157416|11021128|FG000|COMPLETED|Overall Study||15
9905228|NCT01157416|11021129|FG001|COMPLETED|Overall Study||16
9905229|NCT01157416|11021128|FG000|NOT COMPLETED|Overall Study||2
9905230|NCT01157416|11021129|FG001|NOT COMPLETED|Overall Study||0
9905231|NCT01157429|11021137|FG000|STARTED|Overall Study||12
9905232|NCT01157429|11021138|FG001|STARTED|Overall Study||12
9905233|NCT01157429|11021137|FG000|COMPLETED|Overall Study||8
9905234|NCT01157429|11021138|FG001|COMPLETED|Overall Study||8
9905235|NCT01157429|11021137|FG000|NOT COMPLETED|Overall Study||4
9905236|NCT01157429|11021138|FG001|NOT COMPLETED|Overall Study||4
9905237|NCT01157676|11021146|FG000|STARTED|Enrollment||174
9905238|NCT01157676|11021147|FG001|STARTED|Enrollment||176
9905239|NCT01157676|11021146|FG000|COMPLETED|Enrollment||174
9905240|NCT01157676|11021147|FG001|COMPLETED|Enrollment||176
9905241|NCT01157676|11021146|FG000|NOT COMPLETED|Enrollment||0
9905242|NCT01157676|11021147|FG001|NOT COMPLETED|Enrollment||0
9905243|NCT01157676|11021146|FG000|STARTED|Randomization||174
9905244|NCT01157676|11021147|FG001|STARTED|Randomization||176
9905245|NCT01157676|11021146|FG000|COMPLETED|Randomization||153
9905246|NCT01157676|11021147|FG001|COMPLETED|Randomization||159
9905247|NCT01157676|11021146|FG000|NOT COMPLETED|Randomization||21
9905248|NCT01157676|11021147|FG001|NOT COMPLETED|Randomization||17
9905249|NCT01157676|11021146|FG000|STARTED|Surgery||153
9905250|NCT01157676|11021147|FG001|STARTED|Surgery||159
9905251|NCT01157676|11021146|FG000|COMPLETED|Surgery||152
9905252|NCT01157676|11021147|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
9905253|NCT01157676|11021146|FG000|NOT COMPLETED|Surgery||1
9905254|NCT01157676|11021147|FG001|NOT COMPLETED|Surgery||9
9905255|NCT01157845|11021159|FG000|STARTED|Overall Study||165
9905256|NCT01157845|11021159|FG000|COMPLETED|Overall Study||130
9905257|NCT01157845|11021159|FG000|NOT COMPLETED|Overall Study||35
9905258|NCT01157897|11021167|FG000|STARTED|Overall Study||10
9905259|NCT01157897|11021168|FG001|STARTED|Overall Study||10
9905260|NCT01157897|11021169|FG002|STARTED|Overall Study||10
9905261|NCT01157897|11021170|FG003|STARTED|Overall Study||6
9905262|NCT01157897|11021167|FG000|COMPLETED|Overall Study||8
9905263|NCT01157897|11021168|FG001|COMPLETED|Overall Study||8
9905264|NCT01157897|11021169|FG002|COMPLETED|Overall Study||10
9905265|NCT01157897|11021170|FG003|COMPLETED|Overall Study||5
9905266|NCT01157897|11021167|FG000|NOT COMPLETED|Overall Study||2
9905267|NCT01157897|11021168|FG001|NOT COMPLETED|Overall Study||2
9905268|NCT01157897|11021169|FG002|NOT COMPLETED|Overall Study||0
9905269|NCT01157897|11021170|FG003|NOT COMPLETED|Overall Study||1
9905270|NCT01158118|11021182|FG000|STARTED|Overall Study||24
9905271|NCT01158118|11021183|FG001|STARTED|Overall Study||24
9905272|NCT01158118|11021182|FG000|COMPLETED|Overall Study||23
9905273|NCT01158118|11021183|FG001|COMPLETED|Overall Study||21
9905274|NCT01158118|11021182|FG000|NOT COMPLETED|Overall Study||1
9905275|NCT01158118|11021183|FG001|NOT COMPLETED|Overall Study||3
9905276|NCT01158157|11021189|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
10009489|NCT01766466|11132095|FG001|STARTED|Day 1||0
10009490|NCT01766466|11132096|FG002|STARTED|Day 1||6
10009491|NCT01766466|11132097|FG003|STARTED|Day 1||0
10009492|NCT01766466|11132094|FG000|COMPLETED|Day 1||6
10009493|NCT01766466|11132095|FG001|COMPLETED|Day 1||0
10009494|NCT01766466|11132096|FG002|COMPLETED|Day 1||6
10009495|NCT01766466|11132097|FG003|COMPLETED|Day 1||0
10009496|NCT01766466|11132094|FG000|NOT COMPLETED|Day 1||0
10009497|NCT01766466|11132095|FG001|NOT COMPLETED|Day 1||0
10009498|NCT01766466|11132096|FG002|NOT COMPLETED|Day 1||0
10009499|NCT01766466|11132097|FG003|NOT COMPLETED|Day 1||0
10009500|NCT01766466|11132094|FG000|STARTED|Day 5||0
10009501|NCT01766466|11132095|FG001|STARTED|Day 5||6
9905277|NCT01158157|11021189|FG000|COMPLETED|Overall Study||25
9905278|NCT01158157|11021189|FG000|NOT COMPLETED|Overall Study||0
9905279|NCT01158222|11021193|FG000|STARTED|Overall Study||37
9905280|NCT01158222|11021193|FG000|COMPLETED|Overall Study||20
9905281|NCT01158222|11021193|FG000|NOT COMPLETED|Overall Study||17
9905282|NCT01158261|11021197|FG000|STARTED|Overall Study||300
9905283|NCT01158261|11021197|FG000|COMPLETED|Overall Study||283
9905284|NCT01158261|11021197|FG000|NOT COMPLETED|Overall Study||17
9905285|NCT01158378|11021203|FG000|STARTED|Overall Study||124
9905286|NCT01158378|11021204|FG001|STARTED|Overall Study||126
9905287|NCT01158378|11021203|FG000|COMPLETED|Overall Study||114
9905288|NCT01158378|11021204|FG001|COMPLETED|Overall Study||117
9905289|NCT01158378|11021203|FG000|NOT COMPLETED|Overall Study||10
9905290|NCT01158378|11021204|FG001|NOT COMPLETED|Overall Study||9
9955143|NCT01436175|11074025|FG000|STARTED|Overall Study||1570
9955144|NCT01436175|11074025|FG000|COMPLETED|Overall Study||300
9955145|NCT01436175|11074025|FG000|NOT COMPLETED|Overall Study||1270
9955146|NCT01436201|11074030|FG000|STARTED|Overall Study||24
9955147|NCT01436201|11074030|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
9955148|NCT01436201|11074030|FG000|COMPLETED|Overall Study||20
9955149|NCT01436201|11074030|FG000|NOT COMPLETED|Overall Study||4
9955150|NCT01436266|11074038|FG000|STARTED|Overall Study||1
9955151|NCT01436266|11074039|FG001|STARTED|Overall Study||1
9955152|NCT01436266|11074038|FG000|COMPLETED|Overall Study||1
9955153|NCT01436266|11074039|FG001|COMPLETED|Overall Study||1
9955154|NCT01436266|11074038|FG000|NOT COMPLETED|Overall Study||0
9955155|NCT01436266|11074039|FG001|NOT COMPLETED|Overall Study||0
9955156|NCT01436279|11074047|FG000|STARTED|Overall Study||30
9955157|NCT01436279|11074048|FG001|STARTED|Overall Study||20
9955158|NCT01436279|11074047|FG000|COMPLETED|Overall Study||30
9955159|NCT01436279|11074048|FG001|COMPLETED|Overall Study||20
9955160|NCT01436279|11074047|FG000|NOT COMPLETED|Overall Study||0
9955161|NCT01436279|11074048|FG001|NOT COMPLETED|Overall Study||0
9955162|NCT01436305|11074059|FG000|STARTED|Overall Study||6
9955163|NCT01436305|11074060|FG001|STARTED|Overall Study||6
9955164|NCT01436305|11074061|FG002|STARTED|Overall Study||7
9955165|NCT01436305|11074059|FG000|COMPLETED|Overall Study||4
9955166|NCT01436305|11074060|FG001|COMPLETED|Overall Study||2
9955167|NCT01436305|11074061|FG002|COMPLETED|Overall Study||7
9955168|NCT01436305|11074059|FG000|NOT COMPLETED|Overall Study||2
9955169|NCT01436305|11074060|FG001|NOT COMPLETED|Overall Study||4
9955170|NCT01436305|11074061|FG002|NOT COMPLETED|Overall Study||0
9955171|NCT01436357|11074071|FG000|STARTED|Overall Study||274
9955172|NCT01436357|11074072|FG001|STARTED|Overall Study||274
9955173|NCT01436357|11074071|FG000|Stage 1|Overall Study||49
9955174|NCT01436357|11074072|FG001|Stage 1|Overall Study||48
9955175|NCT01436357|11074071|FG000|Stage 2|Overall Study||225
9955176|NCT01436357|11074072|FG001|Stage 2|Overall Study||226
9955177|NCT01436357|11074071|FG000|COMPLETED|Overall Study||152
9955178|NCT01436357|11074072|FG001|COMPLETED|Overall Study||146
9955179|NCT01436357|11074071|FG000|NOT COMPLETED|Overall Study||122
9955180|NCT01436357|11074072|FG001|NOT COMPLETED|Overall Study||128
9955181|NCT01436370|11074086|FG000|STARTED|Overall Study||6
9955182|NCT01436370|11074087|FG001|STARTED|Overall Study||6
9955183|NCT01436370|11074088|FG002|STARTED|Overall Study||10
9955184|NCT01436370|11074089|FG003|STARTED|Overall Study||10
9955185|NCT01436370|11074090|FG004|STARTED|Overall Study||19
9955186|NCT01436370|11074091|FG005|STARTED|Overall Study||19
9955187|NCT01436370|11074092|FG006|STARTED|Overall Study||16
9955188|NCT01436370|11074093|FG007|STARTED|Overall Study||16
10009502|NCT01766466|11132096|FG002|STARTED|Day 5||0
10009503|NCT01766466|11132097|FG003|STARTED|Day 5||6
10009504|NCT01766466|11132094|FG000|COMPLETED|Day 5||0
9955189|NCT01436370|11074086|FG000|COMPLETED|Overall Study||6
9955190|NCT01436370|11074087|FG001|COMPLETED|Overall Study||6
9955191|NCT01436370|11074088|FG002|COMPLETED|Overall Study||10
9955192|NCT01436370|11074089|FG003|COMPLETED|Overall Study||10
9955193|NCT01436370|11074090|FG004|COMPLETED|Overall Study||18
10009505|NCT01766466|11132095|FG001|COMPLETED|Day 5||6
10009506|NCT01766466|11132096|FG002|COMPLETED|Day 5||0
9955194|NCT01436370|11074091|FG005|COMPLETED|Overall Study||19
9955195|NCT01436370|11074092|FG006|COMPLETED|Overall Study||16
9955196|NCT01436370|11074093|FG007|COMPLETED|Overall Study||16
9955197|NCT01436370|11074086|FG000|NOT COMPLETED|Overall Study||0
9955198|NCT01436370|11074087|FG001|NOT COMPLETED|Overall Study||0
9955199|NCT01436370|11074088|FG002|NOT COMPLETED|Overall Study||0
9955200|NCT01436370|11074089|FG003|NOT COMPLETED|Overall Study||0
10009507|NCT01766466|11132097|FG003|COMPLETED|Day 5||6
10009508|NCT01766466|11132094|FG000|NOT COMPLETED|Day 5||0
9955201|NCT01436370|11074090|FG004|NOT COMPLETED|Overall Study||1
9955202|NCT01436370|11074091|FG005|NOT COMPLETED|Overall Study||0
10009509|NCT01766466|11132095|FG001|NOT COMPLETED|Day 5||0
10009510|NCT01766466|11132096|FG002|NOT COMPLETED|Day 5||0
9905291|NCT01158404|11021219|FG000|STARTED|Overall Study||3
9905292|NCT01158404|11021220|FG001|STARTED|Overall Study||4
9905293|NCT01158404|11021221|FG002|STARTED|Overall Study||3
9905294|NCT01158404|11021222|FG003|STARTED|Overall Study||3
9905295|NCT01158404|11021223|FG004|STARTED|Overall Study||6
9905296|NCT01158404|11021224|FG005|STARTED|Overall Study||5
9905297|NCT01158404|11021225|FG006|STARTED|Overall Study||3
9905298|NCT01158404|11021226|FG007|STARTED|Overall Study||8
9905299|NCT01158404|11021219|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9905300|NCT01158404|11021220|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
9905301|NCT01158404|11021221|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9905302|NCT01158404|11021222|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
9905303|NCT01158404|11021223|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
9905304|NCT01158404|11021224|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
9905305|NCT01158404|11021225|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
9905306|NCT01158404|11021226|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8
9905307|NCT01158404|11021219|FG000|COMPLETED|Overall Study||3
9905308|NCT01158404|11021220|FG001|COMPLETED|Overall Study||3
9905309|NCT01158404|11021221|FG002|COMPLETED|Overall Study||3
9905310|NCT01158404|11021222|FG003|COMPLETED|Overall Study||3
9905311|NCT01158404|11021223|FG004|COMPLETED|Overall Study||3
9905312|NCT01158404|11021224|FG005|COMPLETED|Overall Study||4
9905313|NCT01158404|11021225|FG006|COMPLETED|Overall Study||2
9905314|NCT01158404|11021226|FG007|COMPLETED|Overall Study||6
10009511|NCT01766466|11132097|FG003|NOT COMPLETED|Day 5||0
10009512|NCT01766713|11132108|FG000|STARTED|Overall Study||25
10009513|NCT01766713|11132109|FG001|STARTED|Overall Study||25
10009514|NCT01766713|11132108|FG000|COMPLETED|Overall Study||23
10009515|NCT01766713|11132109|FG001|COMPLETED|Overall Study||22
10009516|NCT01766713|11132108|FG000|NOT COMPLETED|Overall Study||2
10009517|NCT01766713|11132109|FG001|NOT COMPLETED|Overall Study||3
10009518|NCT01766778|11132117|FG000|STARTED|Overall Study|Intent to treat population|56
10009519|NCT01766778|11132118|FG001|STARTED|Overall Study||61
10009520|NCT01766778|11132117|FG000|COMPLETED|Overall Study||51
10009521|NCT01766778|11132118|FG001|COMPLETED|Overall Study||57
10009522|NCT01766778|11132117|FG000|NOT COMPLETED|Overall Study||5
10009523|NCT01766778|11132118|FG001|NOT COMPLETED|Overall Study||4
10009524|NCT01766817|11132127|FG000|STARTED|Overall Study||48
10009525|NCT01766817|11132128|FG001|STARTED|Overall Study||48
10009526|NCT01766817|11132129|FG002|STARTED|Overall Study||47
10009527|NCT01766817|11132127|FG000|COMPLETED|Overall Study||37
10009528|NCT01766817|11132128|FG001|COMPLETED|Overall Study||37
10009529|NCT01766817|11132129|FG002|COMPLETED|Overall Study||34
10009530|NCT01766817|11132127|FG000|NOT COMPLETED|Overall Study||11
10009531|NCT01766817|11132128|FG001|NOT COMPLETED|Overall Study||11
10009532|NCT01766817|11132129|FG002|NOT COMPLETED|Overall Study||13
10009533|NCT01766921|11132139|FG000|STARTED|Overall Study||700
10009534|NCT01766921|11132140|FG001|STARTED|Overall Study||693
9905315|NCT01158404|11021219|FG000|NOT COMPLETED|Overall Study||0
9905316|NCT01158404|11021220|FG001|NOT COMPLETED|Overall Study||1
9905317|NCT01158404|11021221|FG002|NOT COMPLETED|Overall Study||0
9905318|NCT01158404|11021222|FG003|NOT COMPLETED|Overall Study||0
9905319|NCT01158404|11021223|FG004|NOT COMPLETED|Overall Study||3
9905320|NCT01158404|11021224|FG005|NOT COMPLETED|Overall Study||1
9905321|NCT01158404|11021225|FG006|NOT COMPLETED|Overall Study||1
9905322|NCT01158404|11021226|FG007|NOT COMPLETED|Overall Study||2
9905323|NCT01158521|11021246|FG000|STARTED|Overall Study||25
9905324|NCT01158521|11021246|FG000|COMPLETED|Overall Study||25
9905325|NCT01158521|11021246|FG000|NOT COMPLETED|Overall Study||0
9905326|NCT01158534|11021252|FG000|STARTED|Overall Study||17
9905327|NCT01158534|11021252|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
9905328|NCT01158534|11021252|FG000|NOT COMPLETED|Overall Study||3
9905329|NCT01158573|11021260|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
9905330|NCT01158573|11021261|FG001|STARTED|Overall Study||30
9905331|NCT01158573|11021262|FG002|STARTED|Overall Study||29
9905332|NCT01158573|11021263|FG003|STARTED|Overall Study||28
9905333|NCT01158573|11021260|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30
9905334|NCT01158573|11021261|FG001|COMPLETED|Overall Study||30
9905335|NCT01158573|11021262|FG002|COMPLETED|Overall Study||29
9905336|NCT01158573|11021263|FG003|COMPLETED|Overall Study||28
9905337|NCT01158573|11021260|FG000|NOT COMPLETED|Overall Study||0
9905338|NCT01158573|11021261|FG001|NOT COMPLETED|Overall Study||0
9905339|NCT01158573|11021262|FG002|NOT COMPLETED|Overall Study||0
9905340|NCT01158573|11021263|FG003|NOT COMPLETED|Overall Study||0
9905341|NCT01158651|11021273|FG000|STARTED|Overall Study||23
9905342|NCT01158651|11021273|FG000|COMPLETED|Overall Study||22
9905343|NCT01158651|11021273|FG000|NOT COMPLETED|Overall Study||1
9905344|NCT01158703|11021279|FG000|STARTED|Overall Study||12
9905345|NCT01158703|11021280|FG001|STARTED|Overall Study||8
9905346|NCT01158703|11021279|FG000|COMPLETED|Overall Study||12
9905347|NCT01158703|11021280|FG001|COMPLETED|Overall Study||8
9905348|NCT01158703|11021279|FG000|NOT COMPLETED|Overall Study||0
10009535|NCT01766921|11132139|FG000|COMPLETED|Overall Study||676
10009536|NCT01766921|11132140|FG001|COMPLETED|Overall Study||676
10009537|NCT01766921|11132139|FG000|NOT COMPLETED|Overall Study||24
10009538|NCT01766921|11132140|FG001|NOT COMPLETED|Overall Study||17
10009539|NCT01766986|11132150|FG000|STARTED|Overall Study||41
10009540|NCT01766986|11132151|FG001|STARTED|Overall Study||51
9905349|NCT01158703|11021280|FG001|NOT COMPLETED|Overall Study||0
9905350|NCT01158716|11021288|FG000|STARTED|Overall Study||48
9905351|NCT01158716|11021289|FG001|STARTED|Overall Study||48
9905352|NCT01158716|11021288|FG000|COMPLETED|Overall Study||47
9905353|NCT01158716|11021289|FG001|COMPLETED|Overall Study||47
9905354|NCT01158716|11021288|FG000|NOT COMPLETED|Overall Study||1
9905355|NCT01158716|11021289|FG001|NOT COMPLETED|Overall Study||1
9905356|NCT01158820|11021297|FG000|STARTED|Overall Study||25
9905357|NCT01158820|11021298|FG001|STARTED|Overall Study||25
9905358|NCT01158820|11021297|FG000|COMPLETED|Overall Study||25
9905359|NCT01158820|11021298|FG001|COMPLETED|Overall Study||25
9905360|NCT01158820|11021297|FG000|NOT COMPLETED|Overall Study||0
9905361|NCT01158820|11021298|FG001|NOT COMPLETED|Overall Study||0
9905362|NCT01158885|11021305|FG000|STARTED|Treatment Course 1||2
9905363|NCT01158885|11021305|FG000|COMPLETED|Treatment Course 1||2
9905364|NCT01158885|11021305|FG000|NOT COMPLETED|Treatment Course 1||0
9905365|NCT01158885|11021305|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0
9905366|NCT01158885|11021305|FG000|COMPLETED|Treatment Course 2||0
9905367|NCT01158885|11021305|FG000|NOT COMPLETED|Treatment Course 2||0
9905368|NCT01158924|11021311|FG000|STARTED|Overall Study||14
9905369|NCT01158924|11021312|FG001|STARTED|Overall Study||26
9905370|NCT01158924|11021311|FG000|COMPLETED|Overall Study||13
9905371|NCT01158924|11021312|FG001|COMPLETED|Overall Study||23
9905372|NCT01158924|11021311|FG000|NOT COMPLETED|Overall Study||1
9905373|NCT01158924|11021312|FG001|NOT COMPLETED|Overall Study||3
9905374|NCT01158950|11021318|FG000|STARTED|1st Intervention (1 Day)||13
9905375|NCT01158950|11021319|FG001|STARTED|1st Intervention (1 Day)||13
9905376|NCT01158950|11021318|FG000|Data Collected|1st Intervention (1 Day)||12
9905377|NCT01158950|11021319|FG001|Data Collected|1st Intervention (1 Day)||11
9905378|NCT01158950|11021318|FG000|COMPLETED|1st Intervention (1 Day)||12
9905379|NCT01158950|11021319|FG001|COMPLETED|1st Intervention (1 Day)||11
9905380|NCT01158950|11021318|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
9905381|NCT01158950|11021319|FG001|NOT COMPLETED|1st Intervention (1 Day)||2
9905382|NCT01158950|11021318|FG000|STARTED|Washout (1 Week)||12
9905383|NCT01158950|11021319|FG001|STARTED|Washout (1 Week)||11
9905384|NCT01158950|11021318|FG000|COMPLETED|Washout (1 Week)||12
9905385|NCT01158950|11021319|FG001|COMPLETED|Washout (1 Week)||11
9905386|NCT01158950|11021318|FG000|NOT COMPLETED|Washout (1 Week)||0
9905387|NCT01158950|11021319|FG001|NOT COMPLETED|Washout (1 Week)||0
9905388|NCT01158950|11021318|FG000|STARTED|2nd Intervention (1 Day)||12
9905389|NCT01158950|11021319|FG001|STARTED|2nd Intervention (1 Day)||11
9905390|NCT01158950|11021318|FG000|COMPLETED|2nd Intervention (1 Day)||12
9905391|NCT01158950|11021319|FG001|COMPLETED|2nd Intervention (1 Day)||11
9905392|NCT01158950|11021318|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
9905393|NCT01158950|11021319|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0
9905394|NCT01158976|11021326|FG000|STARTED|Overall Study||43
9905395|NCT01158976|11021327|FG001|STARTED|Overall Study||21
9905396|NCT01158976|11021326|FG000|COMPLETED|Overall Study||34
9905397|NCT01158976|11021327|FG001|COMPLETED|Overall Study||17
9905398|NCT01158976|11021326|FG000|NOT COMPLETED|Overall Study||9
9905399|NCT01158976|11021327|FG001|NOT COMPLETED|Overall Study||4
9905400|NCT01159015|11021335|FG000|STARTED|Overall Study||357
9905401|NCT01159015|11021336|FG001|STARTED|Overall Study||177
9905402|NCT01159015|11021335|FG000|COMPLETED|Overall Study||339
9905403|NCT01159015|11021336|FG001|COMPLETED|Overall Study||170
9905404|NCT01159015|11021335|FG000|NOT COMPLETED|Overall Study||18
9905405|NCT01159015|11021336|FG001|NOT COMPLETED|Overall Study||7
9905406|NCT01159054|11021342|FG000|STARTED|Overall Study||22
9905407|NCT01159054|11021342|FG000|COMPLETED|Overall Study||2
9905408|NCT01159054|11021342|FG000|NOT COMPLETED|Overall Study||20
9905409|NCT01159067|11021346|FG000|STARTED|Overall Study||1
9905410|NCT01159067|11021346|FG000|COMPLETED|Overall Study||1
9905411|NCT01159067|11021346|FG000|NOT COMPLETED|Overall Study||0
9905412|NCT01159171|11021350|FG000|STARTED|Overall Study||50
9905413|NCT01159171|11021350|FG000|COMPLETED|Overall Study||0
9905414|NCT01159171|11021350|FG000|NOT COMPLETED|Overall Study||50
9905415|NCT01159262|11021358|FG000|STARTED|Overall Study||14
9905416|NCT01159262|11021359|FG001|STARTED|Overall Study||14
9905417|NCT01159262|11021360|FG002|STARTED|Overall Study||8
9905418|NCT01159262|11021358|FG000|COMPLETED|Overall Study||14
9905419|NCT01159262|11021359|FG001|COMPLETED|Overall Study||14
9905420|NCT01159262|11021360|FG002|COMPLETED|Overall Study||8
9905421|NCT01159262|11021358|FG000|NOT COMPLETED|Overall Study||0
9905422|NCT01159262|11021359|FG001|NOT COMPLETED|Overall Study||0
9905423|NCT01159262|11021360|FG002|NOT COMPLETED|Overall Study||0
9905424|NCT01159431|11021370|FG000|STARTED|Overall Study||25
9905425|NCT01159431|11021371|FG001|STARTED|Overall Study||25
9905426|NCT01159431|11021370|FG000|COMPLETED|Overall Study||23
9905427|NCT01159431|11021371|FG001|COMPLETED|Overall Study||19
9905428|NCT01159431|11021370|FG000|NOT COMPLETED|Overall Study||2
9905429|NCT01159431|11021371|FG001|NOT COMPLETED|Overall Study||6
9905430|NCT01159535|11021387|FG000|STARTED|Overall Study||103
9905431|NCT01159535|11021388|FG001|STARTED|Overall Study||88
9905432|NCT01159535|11021389|FG002|STARTED|Overall Study||95
9905433|NCT01159535|11021387|FG000|COMPLETED|Overall Study||79
9905434|NCT01159535|11021388|FG001|COMPLETED|Overall Study||64
9905435|NCT01159535|11021389|FG002|COMPLETED|Overall Study||64
9905436|NCT01159535|11021387|FG000|NOT COMPLETED|Overall Study||24
9905437|NCT01159535|11021388|FG001|NOT COMPLETED|Overall Study||24
9905438|NCT01159535|11021389|FG002|NOT COMPLETED|Overall Study||31
9905439|NCT01159574|11021397|FG000|STARTED|Treatment Phase||121
9905440|NCT01159574|11021397|FG000|COMPLETED|Treatment Phase||100
9905441|NCT01159574|11021397|FG000|NOT COMPLETED|Treatment Phase||21
9905442|NCT01159574|11021397|FG000|STARTED|Follow Up Phase||112
9905443|NCT01159574|11021397|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
9905444|NCT01159574|11021397|FG000|NOT COMPLETED|Follow Up Phase||20
9905445|NCT01159600|11021409|FG000|STARTED|Overall Study||207
9905446|NCT01159600|11021410|FG001|STARTED|Overall Study||217
9905447|NCT01159600|11021411|FG002|STARTED|Overall Study||214
9905448|NCT01159600|11021412|FG003|STARTED|Overall Study||69
9905449|NCT01159600|11021413|FG004|STARTED|Overall Study||225
9905450|NCT01159600|11021414|FG005|STARTED|Overall Study||226
9905451|NCT01159600|11021415|FG006|STARTED|Overall Study||218
9905452|NCT01159600|11021416|FG007|STARTED|Overall Study||103
9905453|NCT01159600|11021409|FG000|COMPLETED|Overall Study||186
9905454|NCT01159600|11021410|FG001|COMPLETED|Overall Study||209
9905455|NCT01159600|11021411|FG002|COMPLETED|Overall Study||196
9905456|NCT01159600|11021412|FG003|COMPLETED|Overall Study||58
9905457|NCT01159600|11021413|FG004|COMPLETED|Overall Study||201
9905458|NCT01159600|11021414|FG005|COMPLETED|Overall Study||208
9905459|NCT01159600|11021415|FG006|COMPLETED|Overall Study||199
9905460|NCT01159600|11021416|FG007|COMPLETED|Overall Study||85
9905461|NCT01159600|11021409|FG000|NOT COMPLETED|Overall Study||21
9905462|NCT01159600|11021410|FG001|NOT COMPLETED|Overall Study||8
9905463|NCT01159600|11021411|FG002|NOT COMPLETED|Overall Study||18
9905464|NCT01159600|11021412|FG003|NOT COMPLETED|Overall Study||11
9905465|NCT01159600|11021413|FG004|NOT COMPLETED|Overall Study||24
9905466|NCT01159600|11021414|FG005|NOT COMPLETED|Overall Study||18
9905467|NCT01159600|11021415|FG006|NOT COMPLETED|Overall Study||19
9905468|NCT01159600|11021416|FG007|NOT COMPLETED|Overall Study||18
9905469|NCT01159665|11021441|FG000|STARTED|Overall Study||9
9905470|NCT01159665|11021442|FG001|STARTED|Overall Study||9
9905471|NCT01159665|11021443|FG002|STARTED|Overall Study||8
9905472|NCT01159665|11021444|FG003|STARTED|Overall Study||4
9905473|NCT01159665|11021445|FG004|STARTED|Overall Study||4
9905474|NCT01159665|11021446|FG005|STARTED|Overall Study||4
10203529|NCT03465436|11330494|FG000|Received at Least One Dose of Study Drug|Period 3||13
9905475|NCT01159665|11021441|FG000|COMPLETED|Overall Study||9
10009541|NCT01766986|11132152|FG002|STARTED|Overall Study||38
10009542|NCT01766986|11132150|FG000|COMPLETED|Overall Study||41
10009543|NCT01766986|11132151|FG001|COMPLETED|Overall Study||51
10009544|NCT01766986|11132152|FG002|COMPLETED|Overall Study||38
9905476|NCT01159665|11021442|FG001|COMPLETED|Overall Study||8
9905477|NCT01159665|11021443|FG002|COMPLETED|Overall Study||8
9905478|NCT01159665|11021444|FG003|COMPLETED|Overall Study||4
9905479|NCT01159665|11021445|FG004|COMPLETED|Overall Study||4
9905480|NCT01159665|11021446|FG005|COMPLETED|Overall Study||4
9905481|NCT01159665|11021441|FG000|NOT COMPLETED|Overall Study||0
9905482|NCT01159665|11021442|FG001|NOT COMPLETED|Overall Study||1
9905483|NCT01159665|11021443|FG002|NOT COMPLETED|Overall Study||0
9905484|NCT01159665|11021444|FG003|NOT COMPLETED|Overall Study||0
9905485|NCT01159665|11021445|FG004|NOT COMPLETED|Overall Study||0
9905486|NCT01159665|11021446|FG005|NOT COMPLETED|Overall Study||0
9905487|NCT01159691|11021460|FG000|STARTED|Overall Study||76
9905488|NCT01159691|11021460|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
9905489|NCT01159691|11021460|FG000|NOT COMPLETED|Overall Study||22
9905490|NCT01159743|11021466|FG000|STARTED|Overall Study||237
9905491|NCT01159743|11021467|FG001|STARTED|Overall Study||109
9905492|NCT01159743|11021466|FG000|COMPLETED|Overall Study||237
9905493|NCT01159743|11021467|FG001|COMPLETED|Overall Study||109
9905494|NCT01159743|11021466|FG000|NOT COMPLETED|Overall Study||0
9905495|NCT01159743|11021467|FG001|NOT COMPLETED|Overall Study||0
9905496|NCT01159769|11021473|FG000|STARTED|Overall Study||215
9905497|NCT01159769|11021473|FG000|COMPLETED|Overall Study||214
9905498|NCT01159769|11021473|FG000|NOT COMPLETED|Overall Study||1
9905499|NCT01159912|11021480|FG000|STARTED|Overall Study||115
9905500|NCT01159912|11021481|FG001|STARTED|Overall Study||114
9905501|NCT01159912|11021482|FG002|STARTED|Overall Study||114
9905502|NCT01159912|11021480|FG000|COMPLETED|Overall Study||75
9905503|NCT01159912|11021481|FG001|COMPLETED|Overall Study||92
9905504|NCT01159912|11021482|FG002|COMPLETED|Overall Study||88
9905505|NCT01159912|11021480|FG000|NOT COMPLETED|Overall Study||40
10009545|NCT01766986|11132150|FG000|NOT COMPLETED|Overall Study||0
10009546|NCT01766986|11132151|FG001|NOT COMPLETED|Overall Study||0
10009547|NCT01766986|11132152|FG002|NOT COMPLETED|Overall Study||0
9905506|NCT01159912|11021481|FG001|NOT COMPLETED|Overall Study||22
9905507|NCT01159912|11021482|FG002|NOT COMPLETED|Overall Study||26
9905508|NCT01159938|11021493|FG000|STARTED|First Study Period||26
9905509|NCT01159938|11021494|FG001|STARTED|First Study Period||11
9905510|NCT01159938|11021495|FG002|STARTED|First Study Period||11
9905511|NCT01159938|11021496|FG003|STARTED|First Study Period||12
9905512|NCT01159938|11021497|FG004|STARTED|First Study Period||12
9905513|NCT01159938|11021493|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0
9905514|NCT01159938|11021494|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11
9905515|NCT01159938|11021495|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11
9905516|NCT01159938|11021496|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12
9905517|NCT01159938|11021497|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12
9955203|NCT01436370|11074092|FG006|NOT COMPLETED|Overall Study||0
9955204|NCT01436370|11074093|FG007|NOT COMPLETED|Overall Study||0
9905518|NCT01159938|11021493|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
9905519|NCT01159938|11021494|FG001|Safety and Efficacy Analysis Population|First Study Period||11
9905520|NCT01159938|11021495|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
9905521|NCT01159938|11021496|FG003|Safety and Efficacy Analysis Population|First Study Period||12
9905522|NCT01159938|11021497|FG004|Safety and Efficacy Analysis Population|First Study Period||12
9905523|NCT01159938|11021493|FG000|COMPLETED|First Study Period||26
9905524|NCT01159938|11021494|FG001|COMPLETED|First Study Period||11
9905525|NCT01159938|11021495|FG002|COMPLETED|First Study Period||10
9905526|NCT01159938|11021496|FG003|COMPLETED|First Study Period||12
9905527|NCT01159938|11021497|FG004|COMPLETED|First Study Period||12
9905528|NCT01159938|11021493|FG000|NOT COMPLETED|First Study Period||0
9905529|NCT01159938|11021494|FG001|NOT COMPLETED|First Study Period||0
9905530|NCT01159938|11021495|FG002|NOT COMPLETED|First Study Period||1
9905531|NCT01159938|11021496|FG003|NOT COMPLETED|First Study Period||0
9905532|NCT01159938|11021497|FG004|NOT COMPLETED|First Study Period||0
9905533|NCT01159938|11021493|FG000|STARTED|Second Study Period||0
9905534|NCT01159938|11021494|FG001|STARTED|Second Study Period||11
9905535|NCT01159938|11021495|FG002|STARTED|Second Study Period||10
9905536|NCT01159938|11021496|FG003|STARTED|Second Study Period||12
9905537|NCT01159938|11021497|FG004|STARTED|Second Study Period||12
9905538|NCT01159938|11021493|FG000|COMPLETED|Second Study Period||0
9905539|NCT01159938|11021494|FG001|COMPLETED|Second Study Period||11
9905540|NCT01159938|11021495|FG002|COMPLETED|Second Study Period||10
9905541|NCT01159938|11021496|FG003|COMPLETED|Second Study Period||12
9905542|NCT01159938|11021497|FG004|COMPLETED|Second Study Period||12
9905543|NCT01159938|11021493|FG000|NOT COMPLETED|Second Study Period||0
9905544|NCT01159938|11021494|FG001|NOT COMPLETED|Second Study Period||0
9905545|NCT01159938|11021495|FG002|NOT COMPLETED|Second Study Period||0
9905546|NCT01159938|11021496|FG003|NOT COMPLETED|Second Study Period||0
9905547|NCT01159938|11021497|FG004|NOT COMPLETED|Second Study Period||0
9905548|NCT01160198|11021521|FG000|STARTED|Overall Study||89
9905549|NCT01160198|11021522|FG001|STARTED|Overall Study||91
9905550|NCT01160198|11021523|FG002|STARTED|Overall Study||90
9905551|NCT01160198|11021521|FG000|COMPLETED|Overall Study||87
9905552|NCT01160198|11021522|FG001|COMPLETED|Overall Study||88
9905553|NCT01160198|11021523|FG002|COMPLETED|Overall Study||89
9905554|NCT01160198|11021521|FG000|NOT COMPLETED|Overall Study||2
9905555|NCT01160198|11021522|FG001|NOT COMPLETED|Overall Study||3
9905556|NCT01160198|11021523|FG002|NOT COMPLETED|Overall Study||1
10203530|NCT03465436|11330495|FG001|Received at Least One Dose of Study Drug|Period 3||12
10203531|NCT03465436|11330496|FG002|Received at Least One Dose of Study Drug|Period 3||13
10203532|NCT03465436|11330497|FG003|Received at Least One Dose of Study Drug|Period 3||14
10203533|NCT03465436|11330494|FG000|COMPLETED|Period 3||13
10203534|NCT03465436|11330495|FG001|COMPLETED|Period 3||12
10203535|NCT03465436|11330496|FG002|COMPLETED|Period 3||13
10203536|NCT03465436|11330497|FG003|COMPLETED|Period 3||14
10203537|NCT03465436|11330494|FG000|NOT COMPLETED|Period 3||1
10203538|NCT03465436|11330495|FG001|NOT COMPLETED|Period 3||1
10203539|NCT03465436|11330496|FG002|NOT COMPLETED|Period 3||0
10203540|NCT03465436|11330497|FG003|NOT COMPLETED|Period 3||0
10203541|NCT03465436|11330494|FG000|STARTED|Period 4||13
10203542|NCT03465436|11330495|FG001|STARTED|Period 4||12
10203543|NCT03465436|11330496|FG002|STARTED|Period 4||13
10203544|NCT03465436|11330497|FG003|STARTED|Period 4||14
10203545|NCT03465436|11330494|FG000|Received at Least 1 Dose of Study Drug|Period 4||13
10203546|NCT03465436|11330495|FG001|Received at Least 1 Dose of Study Drug|Period 4||12
10203547|NCT03465436|11330496|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
10203548|NCT03465436|11330497|FG003|Received at Least 1 Dose of Study Drug|Period 4||14
10203549|NCT03465436|11330494|FG000|COMPLETED|Period 4||13
10203550|NCT03465436|11330495|FG001|COMPLETED|Period 4||12
10203551|NCT03465436|11330496|FG002|COMPLETED|Period 4||12
10203552|NCT03465436|11330497|FG003|COMPLETED|Period 4||14
10203553|NCT03465436|11330494|FG000|NOT COMPLETED|Period 4||0
10203554|NCT03465436|11330495|FG001|NOT COMPLETED|Period 4||0
10203555|NCT03465436|11330496|FG002|NOT COMPLETED|Period 4||1
10203556|NCT03465436|11330497|FG003|NOT COMPLETED|Period 4||0
10203557|NCT03465709|11330509|FG000|STARTED|Overall Study||17
10203558|NCT03465709|11330509|FG000|COMPLETED|Overall Study||0
10203559|NCT03465709|11330509|FG000|NOT COMPLETED|Overall Study||17
10203560|NCT03465722|11330517|FG000|STARTED|End of Treatment||240
10203561|NCT03465722|11330518|FG001|STARTED|End of Treatment||236
10203562|NCT03465722|11330517|FG000|COMPLETED|End of Treatment||0
10203563|NCT03465722|11330518|FG001|COMPLETED|End of Treatment||0
10203564|NCT03465722|11330517|FG000|NOT COMPLETED|End of Treatment||240
10203565|NCT03465722|11330518|FG001|NOT COMPLETED|End of Treatment||236
10203566|NCT03465722|11330517|FG000|STARTED|End of Study||240
10203567|NCT03465722|11330518|FG001|STARTED|End of Study||236
10203568|NCT03465722|11330517|FG000|COMPLETED|End of Study||0
9905569|NCT01160237|11021548|FG000|STARTED|Overall Study||4
9905570|NCT01160237|11021549|FG001|STARTED|Overall Study||3
9905571|NCT01160237|11021550|FG002|STARTED|Overall Study||0
9905572|NCT01160237|11021548|FG000|COMPLETED|Overall Study||4
9905573|NCT01160237|11021549|FG001|COMPLETED|Overall Study||3
9905574|NCT01160237|11021550|FG002|COMPLETED|Overall Study||0
9905575|NCT01160237|11021548|FG000|NOT COMPLETED|Overall Study||0
9905576|NCT01160237|11021549|FG001|NOT COMPLETED|Overall Study||0
9905577|NCT01160237|11021550|FG002|NOT COMPLETED|Overall Study||0
9905578|NCT01160289|11021563|FG000|STARTED|Screening, Washout, and Lead-In Period||894
9905579|NCT01160289|11021564|FG001|STARTED|Screening, Washout, and Lead-In Period||0
9905580|NCT01160289|11021565|FG002|STARTED|Screening, Washout, and Lead-In Period||0
9905581|NCT01160289|11021566|FG003|STARTED|Screening, Washout, and Lead-In Period||0
9905582|NCT01160289|11021567|FG004|STARTED|Screening, Washout, and Lead-In Period||0
9905583|NCT01160289|11021568|FG005|STARTED|Screening, Washout, and Lead-In Period||0
9905584|NCT01160289|11021563|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410
9905585|NCT01160289|11021564|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0
9905586|NCT01160289|11021565|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0
9905587|NCT01160289|11021566|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0
9905588|NCT01160289|11021567|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0
9905589|NCT01160289|11021568|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0
9905590|NCT01160289|11021563|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
9905591|NCT01160289|11021564|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
9905592|NCT01160289|11021565|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
9905593|NCT01160289|11021566|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
9905594|NCT01160289|11021567|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
9905595|NCT01160289|11021568|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
9905596|NCT01160289|11021563|FG000|STARTED|Post-Randomization Period||0
9905597|NCT01160289|11021564|FG001|STARTED|Post-Randomization Period||85
9905598|NCT01160289|11021565|FG002|STARTED|Post-Randomization Period||97
9905599|NCT01160289|11021566|FG003|STARTED|Post-Randomization Period||52
9905600|NCT01160289|11021567|FG004|STARTED|Post-Randomization Period||89
9905601|NCT01160289|11021568|FG005|STARTED|Post-Randomization Period||87
9905602|NCT01160289|11021563|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
9905603|NCT01160289|11021564|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
9905604|NCT01160289|11021565|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
9905605|NCT01160289|11021566|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
9905606|NCT01160289|11021567|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
9905607|NCT01160289|11021568|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
9905608|NCT01160289|11021563|FG000|COMPLETED|Post-Randomization Period||0
9905609|NCT01160289|11021564|FG001|COMPLETED|Post-Randomization Period||65
9905610|NCT01160289|11021565|FG002|COMPLETED|Post-Randomization Period||73
9905611|NCT01160289|11021566|FG003|COMPLETED|Post-Randomization Period||31
9905612|NCT01160289|11021567|FG004|COMPLETED|Post-Randomization Period||80
9905613|NCT01160289|11021568|FG005|COMPLETED|Post-Randomization Period||73
9905614|NCT01160289|11021563|FG000|NOT COMPLETED|Post-Randomization Period||0
9905615|NCT01160289|11021564|FG001|NOT COMPLETED|Post-Randomization Period||20
9905616|NCT01160289|11021565|FG002|NOT COMPLETED|Post-Randomization Period||24
9905617|NCT01160289|11021566|FG003|NOT COMPLETED|Post-Randomization Period||21
9905618|NCT01160289|11021567|FG004|NOT COMPLETED|Post-Randomization Period||9
9905619|NCT01160289|11021568|FG005|NOT COMPLETED|Post-Randomization Period||14
9905620|NCT01160354|11021584|FG000|STARTED|Overall Study||3
9905621|NCT01160354|11021585|FG001|STARTED|Overall Study||4
9905622|NCT01160354|11021586|FG002|STARTED|Overall Study||15
9905623|NCT01160354|11021584|FG000|COMPLETED|Overall Study||3
9905624|NCT01160354|11021585|FG001|COMPLETED|Overall Study||3
9905625|NCT01160354|11021586|FG002|COMPLETED|Overall Study||14
9905626|NCT01160354|11021584|FG000|NOT COMPLETED|Overall Study||0
9905627|NCT01160354|11021585|FG001|NOT COMPLETED|Overall Study||1
9905628|NCT01160354|11021586|FG002|NOT COMPLETED|Overall Study||1
9905629|NCT01160380|11021596|FG000|STARTED|Overall Study||25
9905630|NCT01160380|11021597|FG001|STARTED|Overall Study||25
9905631|NCT01160380|11021596|FG000|COMPLETED|Overall Study||17
9905632|NCT01160380|11021597|FG001|COMPLETED|Overall Study||20
9905633|NCT01160380|11021596|FG000|NOT COMPLETED|Overall Study||8
9905634|NCT01160380|11021597|FG001|NOT COMPLETED|Overall Study||5
9905635|NCT01160445|11021605|FG000|STARTED|Overall Study||7
9905636|NCT01160445|11021606|FG001|STARTED|Overall Study||2
9905637|NCT01160445|11021605|FG000|COMPLETED|Overall Study||7
9905638|NCT01160445|11021606|FG001|COMPLETED|Overall Study||2
9905639|NCT01160445|11021605|FG000|NOT COMPLETED|Overall Study||0
9905640|NCT01160445|11021606|FG001|NOT COMPLETED|Overall Study||0
9905641|NCT01160458|11021612|FG000|STARTED|Overall Study||20
9905642|NCT01160458|11021612|FG000|COMPLETED|Overall Study||20
9905643|NCT01160458|11021612|FG000|NOT COMPLETED|Overall Study||0
9905644|NCT01160484|11021616|FG000|STARTED|Overall Study||40
9905645|NCT01160484|11021616|FG000|COMPLETED|Overall Study||22
9905646|NCT01160484|11021616|FG000|NOT COMPLETED|Overall Study||18
9905647|NCT01160614|11021622|FG000|STARTED|Overall Study||5
9905648|NCT01160614|11021623|FG001|STARTED|Overall Study||25
9905649|NCT01160614|11021622|FG000|COMPLETED|Overall Study||5
9905650|NCT01160614|11021623|FG001|COMPLETED|Overall Study||23
10009548|NCT01767064|11132162|FG000|STARTED|Overall Study||7
10009549|NCT01767064|11132163|FG001|STARTED|Overall Study||7
10009550|NCT01767064|11132162|FG000|COMPLETED|Overall Study||7
10009551|NCT01767064|11132163|FG001|COMPLETED|Overall Study||7
10009552|NCT01767064|11132162|FG000|NOT COMPLETED|Overall Study||0
10009553|NCT01767064|11132163|FG001|NOT COMPLETED|Overall Study||0
10009554|NCT01767103|11132172|FG000|STARTED|Overall Study||7
10009555|NCT01767103|11132173|FG001|STARTED|Overall Study||7
10009556|NCT01767103|11132174|FG002|STARTED|Overall Study||7
10009557|NCT01767103|11132172|FG000|COMPLETED|Overall Study||7
9905651|NCT01160614|11021622|FG000|NOT COMPLETED|Overall Study||0
9905652|NCT01160614|11021623|FG001|NOT COMPLETED|Overall Study||2
9905653|NCT01160640|11021649|FG000|STARTED|Overall Study||117
9905654|NCT01160640|11021650|FG001|STARTED|Overall Study||116
9905655|NCT01160640|11021649|FG000|COMPLETED|Overall Study||113
9905656|NCT01160640|11021650|FG001|COMPLETED|Overall Study||110
9905657|NCT01160640|11021649|FG000|NOT COMPLETED|Overall Study||4
9905658|NCT01160640|11021650|FG001|NOT COMPLETED|Overall Study||6
9905659|NCT01160744|11021662|FG000|STARTED|Overall Study||71
10009558|NCT01767103|11132173|FG001|COMPLETED|Overall Study||7
10009559|NCT01767103|11132174|FG002|COMPLETED|Overall Study||7
10009560|NCT01767103|11132172|FG000|NOT COMPLETED|Overall Study||0
10009561|NCT01767103|11132173|FG001|NOT COMPLETED|Overall Study||0
10009562|NCT01767103|11132174|FG002|NOT COMPLETED|Overall Study||0
9905660|NCT01160744|11021663|FG001|STARTED|Overall Study||69
9905661|NCT01160744|11021664|FG002|STARTED|Overall Study||69
9905662|NCT01160744|11021665|FG003|STARTED|Overall Study||71
9905663|NCT01160744|11021662|FG000|Received Study Drug|Overall Study||69
9905664|NCT01160744|11021663|FG001|Received Study Drug|Overall Study||67
9905665|NCT01160744|11021664|FG002|Received Study Drug|Overall Study||63
9905666|NCT01160744|11021665|FG003|Received Study Drug|Overall Study||71
9905667|NCT01160744|11021662|FG000|COMPLETED|Overall Study||60
9905668|NCT01160744|11021663|FG001|COMPLETED|Overall Study||64
9905669|NCT01160744|11021664|FG002|COMPLETED|Overall Study||62
9905670|NCT01160744|11021665|FG003|COMPLETED|Overall Study||67
9905671|NCT01160744|11021662|FG000|NOT COMPLETED|Overall Study||11
9905672|NCT01160744|11021663|FG001|NOT COMPLETED|Overall Study||5
9905673|NCT01160744|11021664|FG002|NOT COMPLETED|Overall Study||7
9905674|NCT01160744|11021665|FG003|NOT COMPLETED|Overall Study||4
9905675|NCT01160770|11021677|FG000|STARTED|Overall Study||267
9905676|NCT01160770|11021677|FG000|COMPLETED|Overall Study||188
9905677|NCT01160770|11021677|FG000|NOT COMPLETED|Overall Study||79
9905678|NCT01160822|11021688|FG000|STARTED|Overall Study||6
9905679|NCT01160822|11021689|FG001|STARTED|Overall Study||7
9905680|NCT01160822|11021690|FG002|STARTED|Overall Study||6
9905681|NCT01160822|11021691|FG003|STARTED|Overall Study||5
9905682|NCT01160822|11021692|FG004|STARTED|Overall Study||45
9905683|NCT01160822|11021693|FG005|STARTED|Overall Study||47
9905684|NCT01160822|11021694|FG006|STARTED|Overall Study||53
10009563|NCT01767116|11132185|FG000|STARTED|Overall Study||210
10009564|NCT01767116|11132186|FG001|STARTED|Overall Study||209
10009565|NCT01767116|11132185|FG000|COMPLETED|Overall Study||208
10009566|NCT01767116|11132186|FG001|COMPLETED|Overall Study||207
10009567|NCT01767116|11132185|FG000|NOT COMPLETED|Overall Study||2
10009568|NCT01767116|11132186|FG001|NOT COMPLETED|Overall Study||2
10009569|NCT01767142|11132192|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
10009570|NCT01767142|11132192|FG000|COMPLETED|Overall Study||37
9905685|NCT01160822|11021688|FG000|COMPLETED|Overall Study||6
9905686|NCT01160822|11021689|FG001|COMPLETED|Overall Study||7
9905687|NCT01160822|11021690|FG002|COMPLETED|Overall Study||6
9905688|NCT01160822|11021691|FG003|COMPLETED|Overall Study||5
9905689|NCT01160822|11021692|FG004|COMPLETED|Overall Study||36
9905690|NCT01160822|11021693|FG005|COMPLETED|Overall Study||40
9905691|NCT01160822|11021694|FG006|COMPLETED|Overall Study||44
9905692|NCT01160822|11021688|FG000|NOT COMPLETED|Overall Study||0
9905693|NCT01160822|11021689|FG001|NOT COMPLETED|Overall Study||0
9905694|NCT01160822|11021690|FG002|NOT COMPLETED|Overall Study||0
9905695|NCT01160822|11021691|FG003|NOT COMPLETED|Overall Study||0
9905696|NCT01160822|11021692|FG004|NOT COMPLETED|Overall Study||9
9905697|NCT01160822|11021693|FG005|NOT COMPLETED|Overall Study||7
9905698|NCT01160822|11021694|FG006|NOT COMPLETED|Overall Study||9
9905699|NCT01160848|11021713|FG000|STARTED|Overall Study||12
10009571|NCT01767142|11132192|FG000|NOT COMPLETED|Overall Study||3
10009572|NCT01767155|11132198|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256
10009573|NCT01767155|11132199|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255
10009574|NCT01767155|11132198|FG000|Modified ITT (mITT)|Overall Study||252
10009575|NCT01767155|11132199|FG001|Modified ITT (mITT)|Overall Study||249
10009576|NCT01767155|11132198|FG000|Safety Population (SAF)|Overall Study||252
10009577|NCT01767155|11132199|FG001|Safety Population (SAF)|Overall Study||249
10009578|NCT01767155|11132198|FG000|COMPLETED|Overall Study||243
10009579|NCT01767155|11132199|FG001|COMPLETED|Overall Study||240
10009580|NCT01767155|11132198|FG000|NOT COMPLETED|Overall Study||13
10009581|NCT01767155|11132199|FG001|NOT COMPLETED|Overall Study||15
10009582|NCT01767285|11132207|FG000|STARTED|Overall Study||29
9905700|NCT01160848|11021714|FG001|STARTED|Overall Study||8
9905701|NCT01160848|11021713|FG000|COMPLETED|Overall Study||12
10009583|NCT01767285|11132208|FG001|STARTED|Overall Study||30
10009584|NCT01767285|11132207|FG000|COMPLETED|Overall Study||22
9905702|NCT01160848|11021714|FG001|COMPLETED|Overall Study||8
10009585|NCT01767285|11132208|FG001|COMPLETED|Overall Study||24
10009586|NCT01767285|11132207|FG000|NOT COMPLETED|Overall Study||7
10009587|NCT01767285|11132208|FG001|NOT COMPLETED|Overall Study||6
10009588|NCT01767376|11132217|FG000|STARTED|Overall Study||231
10009589|NCT01767376|11132218|FG001|STARTED|Overall Study||228
10009590|NCT01767376|11132219|FG002|STARTED|Overall Study||232
10203569|NCT03465722|11330518|FG001|COMPLETED|End of Study||0
10203570|NCT03465722|11330517|FG000|NOT COMPLETED|End of Study||240
10203571|NCT03465722|11330518|FG001|NOT COMPLETED|End of Study||236
10203572|NCT03465878|11330526|FG000|STARTED|Period 1-Part A First Intervention Day 1||21
10203573|NCT03465878|11330527|FG001|STARTED|Period 1-Part A First Intervention Day 1||21
10203574|NCT03465878|11330528|FG002|STARTED|Period 1-Part A First Intervention Day 1||0
10009591|NCT01767376|11132217|FG000|COMPLETED|Overall Study||227
9905703|NCT01160848|11021713|FG000|NOT COMPLETED|Overall Study||0
9905704|NCT01160848|11021714|FG001|NOT COMPLETED|Overall Study||0
9905705|NCT01161043|11021724|FG000|STARTED|Overall Study||83
9905706|NCT01161043|11021724|FG000|COMPLETED|Overall Study||80
9905707|NCT01161043|11021724|FG000|NOT COMPLETED|Overall Study||3
9905708|NCT01161121|11021728|FG000|STARTED|Overall Study||46
9905709|NCT01161121|11021728|FG000|COMPLETED|Overall Study||46
9905710|NCT01161121|11021728|FG000|NOT COMPLETED|Overall Study||0
9905711|NCT01161160|11021739|FG000|STARTED|Overall Study||76
9905712|NCT01161160|11021740|FG001|STARTED|Overall Study||75
9905713|NCT01161160|11021741|FG002|STARTED|Overall Study||58
9905714|NCT01161160|11021739|FG000|COMPLETED|Overall Study||76
9905715|NCT01161160|11021740|FG001|COMPLETED|Overall Study||75
9905716|NCT01161160|11021741|FG002|COMPLETED|Overall Study||58
9905717|NCT01161160|11021739|FG000|NOT COMPLETED|Overall Study||0
9905718|NCT01161160|11021740|FG001|NOT COMPLETED|Overall Study||0
9905719|NCT01161160|11021741|FG002|NOT COMPLETED|Overall Study||0
9905720|NCT01161173|11021749|FG000|STARTED|Overall Study||347
9905721|NCT01161173|11021749|FG000|COMPLETED|Overall Study||0
9905722|NCT01161173|11021749|FG000|NOT COMPLETED|Overall Study||347
9905723|NCT01161225|11021756|FG000|STARTED|Overall Study||59
9905724|NCT01161225|11021757|FG001|STARTED|Overall Study||53
9905725|NCT01161225|11021758|FG002|STARTED|Overall Study||14
9905726|NCT01161225|11021756|FG000|COMPLETED|Overall Study||45
9905727|NCT01161225|11021757|FG001|COMPLETED|Overall Study||44
9905728|NCT01161225|11021758|FG002|COMPLETED|Overall Study||12
9905729|NCT01161225|11021756|FG000|NOT COMPLETED|Overall Study||14
9905730|NCT01161225|11021757|FG001|NOT COMPLETED|Overall Study||9
9905731|NCT01161225|11021758|FG002|NOT COMPLETED|Overall Study||2
9905732|NCT01161329|11021772|FG000|STARTED|Overall Study||33
9905733|NCT01161329|11021773|FG001|STARTED|Overall Study||34
9905734|NCT01161329|11021772|FG000|COMPLETED|Overall Study||29
9905735|NCT01161329|11021773|FG001|COMPLETED|Overall Study||24
9905736|NCT01161329|11021772|FG000|NOT COMPLETED|Overall Study||4
9905737|NCT01161329|11021773|FG001|NOT COMPLETED|Overall Study||10
9905738|NCT01161407|11021782|FG000|STARTED|Overall Study||6
9905739|NCT01161407|11021783|FG001|STARTED|Overall Study||6
9905740|NCT01161407|11021782|FG000|COMPLETED|Overall Study||3
9905741|NCT01161407|11021783|FG001|COMPLETED|Overall Study||5
9905742|NCT01161407|11021782|FG000|NOT COMPLETED|Overall Study||3
9905743|NCT01161407|11021783|FG001|NOT COMPLETED|Overall Study||1
9905744|NCT01161420|11021789|FG000|STARTED|Inspire Therapy||126
9905745|NCT01161420|11021789|FG000|COMPLETED|Inspire Therapy||124
9905746|NCT01161420|11021789|FG000|NOT COMPLETED|Inspire Therapy||2
9905747|NCT01161420|11021789|FG000|STARTED|Withdrawal Study - Maintenance||23
9905748|NCT01161420|11021789|FG000|COMPLETED|Withdrawal Study - Maintenance||23
9905749|NCT01161420|11021789|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0
9905750|NCT01161420|11021789|FG000|STARTED|Withdrawal Study - Withdrawal||23
9905751|NCT01161420|11021789|FG000|COMPLETED|Withdrawal Study - Withdrawal||23
9905752|NCT01161420|11021789|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0
9905753|NCT01161446|11021801|FG000|STARTED|Overall Study||116
9905754|NCT01161446|11021802|FG001|STARTED|Overall Study||114
9905755|NCT01161446|11021801|FG000|COMPLETED|Overall Study||98
9905756|NCT01161446|11021802|FG001|COMPLETED|Overall Study||99
9905757|NCT01161446|11021801|FG000|NOT COMPLETED|Overall Study||18
9905758|NCT01161446|11021802|FG001|NOT COMPLETED|Overall Study||15
9905759|NCT01161472|11021808|FG000|STARTED|First Intervention Period||5
9905760|NCT01161472|11021809|FG001|STARTED|First Intervention Period||5
9905761|NCT01161472|11021810|FG002|STARTED|First Intervention Period||5
9905762|NCT01161472|11021811|FG003|STARTED|First Intervention Period||5
9905763|NCT01161472|11021808|FG000|Treated|First Intervention Period||5
9905764|NCT01161472|11021809|FG001|Treated|First Intervention Period||5
9905765|NCT01161472|11021810|FG002|Treated|First Intervention Period||5
9905766|NCT01161472|11021811|FG003|Treated|First Intervention Period||5
9905767|NCT01161472|11021808|FG000|COMPLETED|First Intervention Period||5
9905768|NCT01161472|11021809|FG001|COMPLETED|First Intervention Period||5
9905769|NCT01161472|11021810|FG002|COMPLETED|First Intervention Period||5
9905770|NCT01161472|11021811|FG003|COMPLETED|First Intervention Period||5
9905771|NCT01161472|11021808|FG000|NOT COMPLETED|First Intervention Period||0
9905772|NCT01161472|11021809|FG001|NOT COMPLETED|First Intervention Period||0
9905773|NCT01161472|11021810|FG002|NOT COMPLETED|First Intervention Period||0
9905774|NCT01161472|11021811|FG003|NOT COMPLETED|First Intervention Period||0
9905775|NCT01161472|11021808|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905776|NCT01161472|11021809|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905777|NCT01161472|11021810|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
10203575|NCT03465878|11330529|FG003|STARTED|Period 1-Part A First Intervention Day 1||0
9905778|NCT01161472|11021811|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905779|NCT01161472|11021808|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905780|NCT01161472|11021809|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905781|NCT01161472|11021810|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905782|NCT01161472|11021811|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905783|NCT01161472|11021808|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905784|NCT01161472|11021809|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905785|NCT01161472|11021810|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905786|NCT01161472|11021811|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905787|NCT01161472|11021808|FG000|STARTED|Second Intervention Period||5
9905788|NCT01161472|11021809|FG001|STARTED|Second Intervention Period||5
9905789|NCT01161472|11021810|FG002|STARTED|Second Intervention Period||5
9905790|NCT01161472|11021811|FG003|STARTED|Second Intervention Period||5
9905791|NCT01161472|11021808|FG000|COMPLETED|Second Intervention Period||5
9905792|NCT01161472|11021809|FG001|COMPLETED|Second Intervention Period||5
9905793|NCT01161472|11021810|FG002|COMPLETED|Second Intervention Period||5
9905794|NCT01161472|11021811|FG003|COMPLETED|Second Intervention Period||5
9905795|NCT01161472|11021808|FG000|NOT COMPLETED|Second Intervention Period||0
9905796|NCT01161472|11021809|FG001|NOT COMPLETED|Second Intervention Period||0
9905797|NCT01161472|11021810|FG002|NOT COMPLETED|Second Intervention Period||0
9905798|NCT01161472|11021811|FG003|NOT COMPLETED|Second Intervention Period||0
9905799|NCT01161472|11021808|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905800|NCT01161472|11021809|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905801|NCT01161472|11021810|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905802|NCT01161472|11021811|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905803|NCT01161472|11021808|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
9905804|NCT01161472|11021809|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905805|NCT01161472|11021810|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905806|NCT01161472|11021811|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905807|NCT01161472|11021808|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
9905808|NCT01161472|11021809|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905809|NCT01161472|11021810|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905810|NCT01161472|11021811|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905811|NCT01161472|11021808|FG000|STARTED|Third Intervention Period||4
9905812|NCT01161472|11021809|FG001|STARTED|Third Intervention Period||5
9905813|NCT01161472|11021810|FG002|STARTED|Third Intervention Period||5
9905814|NCT01161472|11021811|FG003|STARTED|Third Intervention Period||5
9905815|NCT01161472|11021808|FG000|COMPLETED|Third Intervention Period||4
9905816|NCT01161472|11021809|FG001|COMPLETED|Third Intervention Period||5
9905817|NCT01161472|11021810|FG002|COMPLETED|Third Intervention Period||5
9905818|NCT01161472|11021811|FG003|COMPLETED|Third Intervention Period||5
9905819|NCT01161472|11021808|FG000|NOT COMPLETED|Third Intervention Period||0
9905820|NCT01161472|11021809|FG001|NOT COMPLETED|Third Intervention Period||0
9905821|NCT01161472|11021810|FG002|NOT COMPLETED|Third Intervention Period||0
9905822|NCT01161472|11021811|FG003|NOT COMPLETED|Third Intervention Period||0
9905823|NCT01161472|11021808|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4
9905824|NCT01161472|11021809|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905825|NCT01161472|11021810|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905826|NCT01161472|11021811|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
9905827|NCT01161472|11021808|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
9905828|NCT01161472|11021809|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905829|NCT01161472|11021810|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905830|NCT01161472|11021811|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
9905831|NCT01161472|11021808|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905832|NCT01161472|11021809|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905833|NCT01161472|11021810|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905834|NCT01161472|11021811|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
9905835|NCT01161472|11021808|FG000|STARTED|Fourth Intervention Period||4
9905836|NCT01161472|11021809|FG001|STARTED|Fourth Intervention Period||5
9905837|NCT01161472|11021810|FG002|STARTED|Fourth Intervention Period||5
9905838|NCT01161472|11021811|FG003|STARTED|Fourth Intervention Period||5
9905839|NCT01161472|11021808|FG000|COMPLETED|Fourth Intervention Period||4
9905840|NCT01161472|11021809|FG001|COMPLETED|Fourth Intervention Period||5
9905841|NCT01161472|11021810|FG002|COMPLETED|Fourth Intervention Period||5
9905842|NCT01161472|11021811|FG003|COMPLETED|Fourth Intervention Period||5
9905843|NCT01161472|11021808|FG000|NOT COMPLETED|Fourth Intervention Period||0
9905844|NCT01161472|11021809|FG001|NOT COMPLETED|Fourth Intervention Period||0
9905845|NCT01161472|11021810|FG002|NOT COMPLETED|Fourth Intervention Period||0
9905846|NCT01161472|11021811|FG003|NOT COMPLETED|Fourth Intervention Period||0
9905847|NCT01161498|11021823|FG000|STARTED|Overall Study||3
9905848|NCT01161498|11021824|FG001|STARTED|Overall Study||2
9905849|NCT01161498|11021823|FG000|COMPLETED|Overall Study||3
9905850|NCT01161498|11021824|FG001|COMPLETED|Overall Study||1
9905851|NCT01161498|11021823|FG000|NOT COMPLETED|Overall Study||0
9905852|NCT01161498|11021824|FG001|NOT COMPLETED|Overall Study||1
9905853|NCT01161524|11021832|FG000|STARTED|Core Study (23 Weeks)||85
9905854|NCT01161524|11021833|FG001|STARTED|Core Study (23 Weeks)||48
9905855|NCT01161524|11021834|FG002|STARTED|Core Study (23 Weeks)||0
9905856|NCT01161524|11021832|FG000|COMPLETED|Core Study (23 Weeks)||76
9905857|NCT01161524|11021833|FG001|COMPLETED|Core Study (23 Weeks)||43
9905858|NCT01161524|11021834|FG002|COMPLETED|Core Study (23 Weeks)||0
9905859|NCT01161524|11021832|FG000|NOT COMPLETED|Core Study (23 Weeks)||9
9905860|NCT01161524|11021833|FG001|NOT COMPLETED|Core Study (23 Weeks)||5
9905861|NCT01161524|11021834|FG002|NOT COMPLETED|Core Study (23 Weeks)||0
9905862|NCT01161524|11021832|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0
9905863|NCT01161524|11021833|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0
9905864|NCT01161524|11021834|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114
9905865|NCT01161524|11021832|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
9905866|NCT01161524|11021833|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
9905867|NCT01161524|11021834|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
9905868|NCT01161524|11021832|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
9905869|NCT01161524|11021833|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
9905870|NCT01161524|11021834|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
9905871|NCT01161537|11021843|FG000|STARTED|Part A||8
9905872|NCT01161537|11021843|FG000|COMPLETED|Part A||8
9905873|NCT01161537|11021843|FG000|NOT COMPLETED|Part A||0
9905874|NCT01161537|11021843|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
9905875|NCT01161537|11021843|FG000|COMPLETED|Part B||7
9905876|NCT01161537|11021843|FG000|NOT COMPLETED|Part B||2
9905877|NCT01161563|11021854|FG000|STARTED|Overall Study||63
9905878|NCT01161563|11021855|FG001|STARTED|Overall Study||55
9905879|NCT01161563|11021854|FG000|COMPLETED|Overall Study||58
9905880|NCT01161563|11021855|FG001|COMPLETED|Overall Study||49
9905881|NCT01161563|11021854|FG000|NOT COMPLETED|Overall Study||5
9905882|NCT01161563|11021855|FG001|NOT COMPLETED|Overall Study||6
9905883|NCT01161628|11021861|FG000|STARTED|Overall Study||25
9905884|NCT01161628|11021861|FG000|COMPLETED|Overall Study||17
9905885|NCT01161628|11021861|FG000|NOT COMPLETED|Overall Study||8
9905886|NCT01161771|11021865|FG000|STARTED|Overall Study||32
9905887|NCT01161771|11021865|FG000|COMPLETED|Overall Study||32
9905888|NCT01161771|11021865|FG000|NOT COMPLETED|Overall Study||0
9905889|NCT01161862|11021871|FG000|STARTED|Overall Study||12
9905890|NCT01161862|11021872|FG001|STARTED|Overall Study||12
9905891|NCT01161862|11021871|FG000|COMPLETED|Overall Study||12
9905892|NCT01161862|11021872|FG001|COMPLETED|Overall Study||12
9905893|NCT01161862|11021871|FG000|NOT COMPLETED|Overall Study||0
9905894|NCT01161862|11021872|FG001|NOT COMPLETED|Overall Study||0
9905895|NCT01162005|11021883|FG000|STARTED|Overall Study||44
9905896|NCT01162005|11021884|FG001|STARTED|Overall Study||33
9905897|NCT01162005|11021883|FG000|COMPLETED|Overall Study||44
9905898|NCT01162005|11021884|FG001|COMPLETED|Overall Study||33
9905899|NCT01162005|11021883|FG000|NOT COMPLETED|Overall Study||0
9905900|NCT01162005|11021884|FG001|NOT COMPLETED|Overall Study||0
9905901|NCT01162096|11021892|FG000|STARTED|Overall Study||34
9905902|NCT01162096|11021892|FG000|COMPLETED|Overall Study||34
9905903|NCT01162096|11021892|FG000|NOT COMPLETED|Overall Study||0
9905904|NCT01162122|11021899|FG000|STARTED|Overall Study||3552
9905905|NCT01162122|11021900|FG001|STARTED|Overall Study||3552
9905906|NCT01162122|11021899|FG000|Vaccinated|Overall Study||3541
9905907|NCT01162122|11021900|FG001|Vaccinated|Overall Study||3541
9905908|NCT01162122|11021899|FG000|COMPLETED|Overall Study||3361
9905909|NCT01162122|11021900|FG001|COMPLETED|Overall Study||3356
9905910|NCT01162122|11021899|FG000|NOT COMPLETED|Overall Study||191
9905911|NCT01162122|11021900|FG001|NOT COMPLETED|Overall Study||196
9905912|NCT01162135|11021909|FG000|STARTED|Overall Study||16
9905913|NCT01162135|11021909|FG000|COMPLETED|Overall Study||13
9905914|NCT01162135|11021909|FG000|NOT COMPLETED|Overall Study||3
9905915|NCT01162239|11021917|FG000|STARTED|Treatment Phase||55
9905916|NCT01162239|11021918|FG001|STARTED|Treatment Phase||54
9905917|NCT01162239|11021919|FG002|STARTED|Treatment Phase||52
9905918|NCT01162239|11021920|FG003|STARTED|Treatment Phase||55
9905919|NCT01162239|11021917|FG000|Week 12|Treatment Phase||50
9905920|NCT01162239|11021918|FG001|Week 12|Treatment Phase||51
9905921|NCT01162239|11021919|FG002|Week 12|Treatment Phase||49
9905922|NCT01162239|11021920|FG003|Week 12|Treatment Phase||53
9905923|NCT01162239|11021917|FG000|Week 24|Treatment Phase||51
9905924|NCT01162239|11021918|FG001|Week 24|Treatment Phase||48
9905925|NCT01162239|11021919|FG002|Week 24|Treatment Phase||48
9905926|NCT01162239|11021920|FG003|Week 24|Treatment Phase||50
9905927|NCT01162239|11021917|FG000|Week 52|Treatment Phase||49
9905928|NCT01162239|11021918|FG001|Week 52|Treatment Phase||47
9905929|NCT01162239|11021919|FG002|Week 52|Treatment Phase||48
9905930|NCT01162239|11021920|FG003|Week 52|Treatment Phase||50
9905931|NCT01162239|11021917|FG000|COMPLETED|Treatment Phase||49
9905932|NCT01162239|11021918|FG001|COMPLETED|Treatment Phase||47
9905933|NCT01162239|11021919|FG002|COMPLETED|Treatment Phase||48
9905934|NCT01162239|11021920|FG003|COMPLETED|Treatment Phase||50
9905935|NCT01162239|11021917|FG000|NOT COMPLETED|Treatment Phase||6
9905936|NCT01162239|11021918|FG001|NOT COMPLETED|Treatment Phase||7
9905937|NCT01162239|11021919|FG002|NOT COMPLETED|Treatment Phase||4
9905938|NCT01162239|11021920|FG003|NOT COMPLETED|Treatment Phase||5
9905939|NCT01162239|11021917|FG000|STARTED|Extended Follow-up||47
9905940|NCT01162239|11021918|FG001|STARTED|Extended Follow-up||45
9905941|NCT01162239|11021919|FG002|STARTED|Extended Follow-up||45
9905942|NCT01162239|11021920|FG003|STARTED|Extended Follow-up||47
9905943|NCT01162239|11021917|FG000|COMPLETED|Extended Follow-up||39
9905944|NCT01162239|11021918|FG001|COMPLETED|Extended Follow-up||32
9905945|NCT01162239|11021919|FG002|COMPLETED|Extended Follow-up||37
9905946|NCT01162239|11021920|FG003|COMPLETED|Extended Follow-up||41
9905947|NCT01162239|11021917|FG000|NOT COMPLETED|Extended Follow-up||8
9905948|NCT01162239|11021918|FG001|NOT COMPLETED|Extended Follow-up||13
9905949|NCT01162239|11021919|FG002|NOT COMPLETED|Extended Follow-up||8
9905950|NCT01162239|11021920|FG003|NOT COMPLETED|Extended Follow-up||6
9905951|NCT01162317|11021933|FG000|STARTED|Overall Study||30
9905952|NCT01162317|11021934|FG001|STARTED|Overall Study||30
9905953|NCT01162317|11021933|FG000|COMPLETED|Overall Study||27
9905954|NCT01162317|11021934|FG001|COMPLETED|Overall Study||28
9905955|NCT01162317|11021933|FG000|NOT COMPLETED|Overall Study||3
9905956|NCT01162317|11021934|FG001|NOT COMPLETED|Overall Study||2
9905957|NCT01162343|11021940|FG000|STARTED|Overall Study||498
9905958|NCT01162343|11021940|FG000|COMPLETED|Overall Study||406
9905959|NCT01162343|11021940|FG000|NOT COMPLETED|Overall Study||92
9905960|NCT01162421|11021946|FG000|STARTED|Overall Study||37
9905961|NCT01162421|11021947|FG001|STARTED|Overall Study||40
9905962|NCT01162421|11021946|FG000|COMPLETED|Overall Study||29
9905963|NCT01162421|11021947|FG001|COMPLETED|Overall Study||27
9905964|NCT01162421|11021946|FG000|NOT COMPLETED|Overall Study||8
9905965|NCT01162421|11021947|FG001|NOT COMPLETED|Overall Study||13
9905966|NCT01162473|11021955|FG000|STARTED|Overall Study||8
9905967|NCT01162473|11021956|FG001|STARTED|Overall Study||17
9905968|NCT01162473|11021955|FG000|COMPLETED|Overall Study||6
9905969|NCT01162473|11021956|FG001|COMPLETED|Overall Study||12
9905970|NCT01162473|11021955|FG000|NOT COMPLETED|Overall Study||2
9905971|NCT01162473|11021956|FG001|NOT COMPLETED|Overall Study||5
9905972|NCT01162486|11021967|FG000|STARTED|Overall Study||8
9905973|NCT01162486|11021968|FG001|STARTED|Overall Study||6
9905974|NCT01162486|11021969|FG002|STARTED|Overall Study||6
9905975|NCT01162486|11021970|FG003|STARTED|Overall Study||7
9905976|NCT01162486|11021971|FG004|STARTED|Overall Study||6
9905977|NCT01162486|11021967|FG000|Took at Least One Dose Study Drug|Overall Study||8
9905978|NCT01162486|11021968|FG001|Took at Least One Dose Study Drug|Overall Study||6
9905979|NCT01162486|11021969|FG002|Took at Least One Dose Study Drug|Overall Study||6
9905980|NCT01162486|11021970|FG003|Took at Least One Dose Study Drug|Overall Study||7
9905981|NCT01162486|11021971|FG004|Took at Least One Dose Study Drug|Overall Study||6
9905982|NCT01162486|11021967|FG000|COMPLETED|Overall Study||6
9905983|NCT01162486|11021968|FG001|COMPLETED|Overall Study||6
9905984|NCT01162486|11021969|FG002|COMPLETED|Overall Study||5
9905985|NCT01162486|11021970|FG003|COMPLETED|Overall Study||6
9905986|NCT01162486|11021971|FG004|COMPLETED|Overall Study||6
9905987|NCT01162486|11021967|FG000|NOT COMPLETED|Overall Study||2
9905988|NCT01162486|11021968|FG001|NOT COMPLETED|Overall Study||0
9905989|NCT01162486|11021969|FG002|NOT COMPLETED|Overall Study||1
9905990|NCT01162486|11021970|FG003|NOT COMPLETED|Overall Study||1
9905991|NCT01162486|11021971|FG004|NOT COMPLETED|Overall Study||0
9905992|NCT01162499|11021987|FG000|STARTED|Intervention 1 (4 Hours)||3
9905993|NCT01162499|11021988|FG001|STARTED|Intervention 1 (4 Hours)||4
9905994|NCT01162499|11021987|FG000|Received Intervention|Intervention 1 (4 Hours)||3
9905995|NCT01162499|11021988|FG001|Received Intervention|Intervention 1 (4 Hours)||3
9905996|NCT01162499|11021987|FG000|COMPLETED|Intervention 1 (4 Hours)||3
9905997|NCT01162499|11021988|FG001|COMPLETED|Intervention 1 (4 Hours)||3
9905998|NCT01162499|11021987|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0
9905999|NCT01162499|11021988|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1
9906000|NCT01162499|11021987|FG000|STARTED|Intervention 2 (4 Hours)||3
9906001|NCT01162499|11021988|FG001|STARTED|Intervention 2 (4 Hours)||3
9906002|NCT01162499|11021987|FG000|COMPLETED|Intervention 2 (4 Hours)||3
9906003|NCT01162499|11021988|FG001|COMPLETED|Intervention 2 (4 Hours)||3
9906004|NCT01162499|11021987|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0
9906005|NCT01162499|11021988|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0
9906006|NCT01162551|11021996|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
9906007|NCT01162551|11021996|FG000|COMPLETED|Overall Study||3
9906008|NCT01162551|11021996|FG000|NOT COMPLETED|Overall Study||0
9906009|NCT01162733|11022002|FG000|STARTED|Overall Study||49
9906010|NCT01162733|11022003|FG001|STARTED|Overall Study||50
9906011|NCT01162733|11022002|FG000|COMPLETED|Overall Study||22
9906012|NCT01162733|11022003|FG001|COMPLETED|Overall Study||25
9906013|NCT01162733|11022002|FG000|NOT COMPLETED|Overall Study||27
9906014|NCT01162733|11022003|FG001|NOT COMPLETED|Overall Study||25
9906015|NCT01162863|11022012|FG000|STARTED|Overall Study||18
9906016|NCT01162863|11022013|FG001|STARTED|Overall Study||17
9906017|NCT01162863|11022014|FG002|STARTED|Overall Study||17
9906018|NCT01162863|11022012|FG000|COMPLETED|Overall Study||17
9906019|NCT01162863|11022013|FG001|COMPLETED|Overall Study||16
10009592|NCT01767376|11132218|FG001|COMPLETED|Overall Study||225
10009593|NCT01767376|11132219|FG002|COMPLETED|Overall Study||232
9906020|NCT01162863|11022014|FG002|COMPLETED|Overall Study||17
9906021|NCT01162863|11022012|FG000|NOT COMPLETED|Overall Study||1
10009594|NCT01767376|11132217|FG000|NOT COMPLETED|Overall Study||4
9906022|NCT01162863|11022013|FG001|NOT COMPLETED|Overall Study||1
9906023|NCT01162863|11022014|FG002|NOT COMPLETED|Overall Study||0
9906024|NCT01163032|11022025|FG000|STARTED|Randomization Phase||42
9906025|NCT01163032|11022026|FG001|STARTED|Randomization Phase||42
9906026|NCT01163032|11022027|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
9906027|NCT01163032|11022025|FG000|COMPLETED|Randomization Phase||32
9906028|NCT01163032|11022026|FG001|COMPLETED|Randomization Phase||30
9906029|NCT01163032|11022027|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
9906030|NCT01163032|11022025|FG000|NOT COMPLETED|Randomization Phase||10
9906031|NCT01163032|11022026|FG001|NOT COMPLETED|Randomization Phase||12
9906032|NCT01163032|11022027|FG002|NOT COMPLETED|Randomization Phase||0
9906033|NCT01163032|11022025|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
9906034|NCT01163032|11022026|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
9906035|NCT01163032|11022027|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
9906036|NCT01163032|11022025|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
9906037|NCT01163032|11022026|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
9906038|NCT01163032|11022027|FG002|COMPLETED|Open Label Extension Phase||39
9906039|NCT01163032|11022025|FG000|NOT COMPLETED|Open Label Extension Phase||0
9906040|NCT01163032|11022026|FG001|NOT COMPLETED|Open Label Extension Phase||0
9906041|NCT01163032|11022027|FG002|NOT COMPLETED|Open Label Extension Phase||16
9906042|NCT01163097|11022038|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
9906043|NCT01163097|11022039|FG001|STARTED|Overall Study||16
10009595|NCT01767376|11132218|FG001|NOT COMPLETED|Overall Study||3
10009596|NCT01767376|11132219|FG002|NOT COMPLETED|Overall Study||0
10009597|NCT01767415|11132229|FG000|STARTED|Overall Study||10
10009598|NCT01767415|11132229|FG000|COMPLETED|Overall Study||10
10009599|NCT01767415|11132229|FG000|NOT COMPLETED|Overall Study||0
9906044|NCT01163097|11022040|FG002|STARTED|Overall Study||8
9906045|NCT01163097|11022038|FG000|COMPLETED|Overall Study||14
9906046|NCT01163097|11022039|FG001|COMPLETED|Overall Study||16
9906047|NCT01163097|11022040|FG002|COMPLETED|Overall Study||8
9906048|NCT01163097|11022038|FG000|NOT COMPLETED|Overall Study||6
9906049|NCT01163097|11022039|FG001|NOT COMPLETED|Overall Study||0
9906050|NCT01163097|11022040|FG002|NOT COMPLETED|Overall Study||0
9906051|NCT01163149|11022053|FG000|STARTED|Primary Treatment Period||7
9906052|NCT01163149|11022054|FG001|STARTED|Primary Treatment Period||6
9906053|NCT01163149|11022055|FG002|STARTED|Primary Treatment Period||6
9906054|NCT01163149|11022053|FG000|COMPLETED|Primary Treatment Period||7
9906055|NCT01163149|11022054|FG001|COMPLETED|Primary Treatment Period||6
9906056|NCT01163149|11022055|FG002|COMPLETED|Primary Treatment Period||6
9906057|NCT01163149|11022053|FG000|NOT COMPLETED|Primary Treatment Period||0
9906058|NCT01163149|11022054|FG001|NOT COMPLETED|Primary Treatment Period||0
9906059|NCT01163149|11022055|FG002|NOT COMPLETED|Primary Treatment Period||0
9906060|NCT01163149|11022053|FG000|STARTED|Extension Treatment Period||7
9906061|NCT01163149|11022054|FG001|STARTED|Extension Treatment Period||6
9906062|NCT01163149|11022055|FG002|STARTED|Extension Treatment Period||6
9906063|NCT01163149|11022053|FG000|COMPLETED|Extension Treatment Period||5
9906064|NCT01163149|11022054|FG001|COMPLETED|Extension Treatment Period||5
9906065|NCT01163149|11022055|FG002|COMPLETED|Extension Treatment Period||4
9906066|NCT01163149|11022053|FG000|NOT COMPLETED|Extension Treatment Period||2
9906067|NCT01163149|11022054|FG001|NOT COMPLETED|Extension Treatment Period||1
9906068|NCT01163149|11022055|FG002|NOT COMPLETED|Extension Treatment Period||2
9906069|NCT01163162|11022077|FG000|STARTED|Overall Study||16
9906070|NCT01163162|11022077|FG000|COMPLETED|Overall Study||16
9906071|NCT01163162|11022077|FG000|NOT COMPLETED|Overall Study||0
9906072|NCT01163214|11022083|FG000|STARTED|Overall Study||79
9906073|NCT01163214|11022084|FG001|STARTED|Overall Study||81
9906074|NCT01163214|11022083|FG000|COMPLETED|Overall Study||79
9906075|NCT01163214|11022084|FG001|COMPLETED|Overall Study||81
9906076|NCT01163214|11022083|FG000|NOT COMPLETED|Overall Study||0
9906077|NCT01163214|11022084|FG001|NOT COMPLETED|Overall Study||0
9906078|NCT01163253|11022092|FG000|STARTED|Overall Study||2281
9906079|NCT01163253|11022093|FG001|STARTED|Overall Study||586
9906080|NCT01163253|11022092|FG000|COMPLETED|Overall Study||0
9906081|NCT01163253|11022093|FG001|COMPLETED|Overall Study||0
9906082|NCT01163253|11022092|FG000|NOT COMPLETED|Overall Study||2281
9906083|NCT01163253|11022093|FG001|NOT COMPLETED|Overall Study||586
9906084|NCT01163266|11022102|FG000|STARTED|Overall Study||157
9906085|NCT01163266|11022103|FG001|STARTED|Overall Study||155
9906086|NCT01163266|11022104|FG002|STARTED|Overall Study||150
9906087|NCT01163266|11022102|FG000|Treated|Overall Study||157
9906088|NCT01163266|11022103|FG001|Treated|Overall Study||155
9906089|NCT01163266|11022104|FG002|Treated|Overall Study||150
9906090|NCT01163266|11022102|FG000|COMPLETED|Overall Study||139
9906091|NCT01163266|11022103|FG001|COMPLETED|Overall Study||124
9906092|NCT01163266|11022104|FG002|COMPLETED|Overall Study||122
9906093|NCT01163266|11022102|FG000|NOT COMPLETED|Overall Study||18
9906094|NCT01163266|11022103|FG001|NOT COMPLETED|Overall Study||31
9906095|NCT01163266|11022104|FG002|NOT COMPLETED|Overall Study||28
9906096|NCT01163279|11022114|FG000|STARTED|Overall Study||10
9906097|NCT01163279|11022115|FG001|STARTED|Overall Study||9
9906098|NCT01163279|11022114|FG000|COMPLETED|Overall Study||8
9906099|NCT01163279|11022115|FG001|COMPLETED|Overall Study||9
9906100|NCT01163279|11022114|FG000|NOT COMPLETED|Overall Study||2
9906101|NCT01163279|11022115|FG001|NOT COMPLETED|Overall Study||0
9906102|NCT01163292|11022124|FG000|STARTED|Overall Study||106
9906103|NCT01163292|11022125|FG001|STARTED|Overall Study||114
9906104|NCT01163292|11022124|FG000|COMPLETED|Overall Study||65
9906105|NCT01163292|11022125|FG001|COMPLETED|Overall Study||92
9906106|NCT01163292|11022124|FG000|NOT COMPLETED|Overall Study||41
9906107|NCT01163292|11022125|FG001|NOT COMPLETED|Overall Study||22
9906108|NCT01163318|11022131|FG000|STARTED|Overall Study||552
9906109|NCT01163318|11022131|FG000|COMPLETED|Overall Study||284
9906110|NCT01163318|11022131|FG000|NOT COMPLETED|Overall Study||268
9906111|NCT01163461|11022135|FG000|STARTED|Overall Study||14
9906112|NCT01163461|11022136|FG001|STARTED|Overall Study||14
9906113|NCT01163461|11022135|FG000|COMPLETED|Overall Study||14
9906114|NCT01163461|11022136|FG001|COMPLETED|Overall Study||14
9906115|NCT01163461|11022135|FG000|NOT COMPLETED|Overall Study||0
9906116|NCT01163461|11022136|FG001|NOT COMPLETED|Overall Study||0
9906117|NCT01163474|11022140|FG000|STARTED|Overall Study||40
9906118|NCT01163474|11022140|FG000|COMPLETED|Overall Study||24
9906119|NCT01163474|11022140|FG000|NOT COMPLETED|Overall Study||16
9906120|NCT01163604|11022149|FG000|STARTED|Overall Study|August 2010|58
9906121|NCT01163604|11022150|FG001|STARTED|Overall Study|August 2010|56
9906122|NCT01163604|11022149|FG000|COMPLETED|Overall Study|August 2011|58
9906123|NCT01163604|11022150|FG001|COMPLETED|Overall Study|August 2011|56
9906124|NCT01163604|11022149|FG000|NOT COMPLETED|Overall Study||0
9906125|NCT01163604|11022150|FG001|NOT COMPLETED|Overall Study||0
9906126|NCT01163617|11022156|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19
9906127|NCT01163617|11022157|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23
9906128|NCT01163617|11022158|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21
9906129|NCT01163617|11022159|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21
9906130|NCT01163617|11022160|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0
9906131|NCT01163617|11022161|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0
9906132|NCT01163617|11022162|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0
9906133|NCT01163617|11022163|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0
9906134|NCT01163617|11022156|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
9906135|NCT01163617|11022157|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
9906136|NCT01163617|11022158|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
9906137|NCT01163617|11022159|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
9906138|NCT01163617|11022160|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906139|NCT01163617|11022161|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906140|NCT01163617|11022162|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906141|NCT01163617|11022163|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906142|NCT01163617|11022156|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906143|NCT01163617|11022157|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
9906144|NCT01163617|11022158|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
9906145|NCT01163617|11022159|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906146|NCT01163617|11022160|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906147|NCT01163617|11022161|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906148|NCT01163617|11022162|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906149|NCT01163617|11022163|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
9906150|NCT01163617|11022156|FG000|STARTED|Phase B (Injection Time), Week 4||0
9906151|NCT01163617|11022157|FG001|STARTED|Phase B (Injection Time), Week 4||0
9906152|NCT01163617|11022158|FG002|STARTED|Phase B (Injection Time), Week 4||0
10009600|NCT01767467|11132235|FG000|STARTED|Vaccination Phase (up to Month 2)||283
9906153|NCT01163617|11022159|FG003|STARTED|Phase B (Injection Time), Week 4||0
9906154|NCT01163617|11022160|FG004|STARTED|Phase B (Injection Time), Week 4||18
9906155|NCT01163617|11022161|FG005|STARTED|Phase B (Injection Time), Week 4||27
9906156|NCT01163617|11022162|FG006|STARTED|Phase B (Injection Time), Week 4||16
9906157|NCT01163617|11022163|FG007|STARTED|Phase B (Injection Time), Week 4||20
9906158|NCT01163617|11022156|FG000|COMPLETED|Phase B (Injection Time), Week 4||0
9906159|NCT01163617|11022157|FG001|COMPLETED|Phase B (Injection Time), Week 4||0
9906160|NCT01163617|11022158|FG002|COMPLETED|Phase B (Injection Time), Week 4||0
9906161|NCT01163617|11022159|FG003|COMPLETED|Phase B (Injection Time), Week 4||0
9906162|NCT01163617|11022160|FG004|COMPLETED|Phase B (Injection Time), Week 4||18
9906163|NCT01163617|11022161|FG005|COMPLETED|Phase B (Injection Time), Week 4||27
9906164|NCT01163617|11022162|FG006|COMPLETED|Phase B (Injection Time), Week 4||16
9906165|NCT01163617|11022163|FG007|COMPLETED|Phase B (Injection Time), Week 4||20
9906166|NCT01163617|11022156|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906167|NCT01163617|11022157|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906168|NCT01163617|11022158|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906169|NCT01163617|11022159|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906170|NCT01163617|11022160|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906171|NCT01163617|11022161|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906172|NCT01163617|11022162|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906173|NCT01163617|11022163|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0
9906174|NCT01163643|11022189|FG000|STARTED|Overall Study||68
9906175|NCT01163643|11022190|FG001|STARTED|Overall Study||37
9906176|NCT01163643|11022191|FG002|STARTED|Overall Study||35
9906177|NCT01163643|11022192|FG003|STARTED|Overall Study||74
9906178|NCT01163643|11022193|FG004|STARTED|Overall Study||69
9906179|NCT01163643|11022194|FG005|STARTED|Overall Study||73
9906180|NCT01163643|11022189|FG000|COMPLETED|Overall Study||62
9906181|NCT01163643|11022190|FG001|COMPLETED|Overall Study||35
9906182|NCT01163643|11022191|FG002|COMPLETED|Overall Study||33
9906183|NCT01163643|11022192|FG003|COMPLETED|Overall Study||69
9906184|NCT01163643|11022193|FG004|COMPLETED|Overall Study||61
9906185|NCT01163643|11022194|FG005|COMPLETED|Overall Study||66
9906186|NCT01163643|11022189|FG000|NOT COMPLETED|Overall Study||6
9906187|NCT01163643|11022190|FG001|NOT COMPLETED|Overall Study||2
9906188|NCT01163643|11022191|FG002|NOT COMPLETED|Overall Study||2
10009601|NCT01767467|11132236|FG001|STARTED|Vaccination Phase (up to Month 2)||279
9906189|NCT01163643|11022192|FG003|NOT COMPLETED|Overall Study||5
9906190|NCT01163643|11022193|FG004|NOT COMPLETED|Overall Study||8
9906191|NCT01163643|11022194|FG005|NOT COMPLETED|Overall Study||7
9906192|NCT01163656|11022210|FG000|STARTED|Overall Study||33
9906193|NCT01163656|11022211|FG001|STARTED|Overall Study||33
9906194|NCT01163656|11022210|FG000|COMPLETED|Overall Study||30
9906195|NCT01163656|11022211|FG001|COMPLETED|Overall Study||30
9906196|NCT01163656|11022210|FG000|NOT COMPLETED|Overall Study||3
9906197|NCT01163656|11022211|FG001|NOT COMPLETED|Overall Study||3
9906198|NCT01163721|11022219|FG000|STARTED|Overall Study||39
9906199|NCT01163721|11022220|FG001|STARTED|Overall Study||41
9906200|NCT01163721|11022219|FG000|COMPLETED|Overall Study||31
9906201|NCT01163721|11022220|FG001|COMPLETED|Overall Study||29
9906202|NCT01163721|11022219|FG000|NOT COMPLETED|Overall Study||8
9906203|NCT01163721|11022220|FG001|NOT COMPLETED|Overall Study||12
9906204|NCT01163747|11022228|FG000|STARTED|Overall Study||31
9906205|NCT01163747|11022229|FG001|STARTED|Overall Study||60
9906206|NCT01163747|11022228|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
9906207|NCT01163747|11022229|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
9906208|NCT01163747|11022228|FG000|COMPLETED|Overall Study||25
9906209|NCT01163747|11022229|FG001|COMPLETED|Overall Study||49
9906210|NCT01163747|11022228|FG000|NOT COMPLETED|Overall Study||6
9906211|NCT01163747|11022229|FG001|NOT COMPLETED|Overall Study||11
9906212|NCT01163760|11022235|FG000|STARTED|Period 1 (Fit)||12
10203576|NCT03465878|11330526|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
10203577|NCT03465878|11330527|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
10203578|NCT03465878|11330528|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
10203579|NCT03465878|11330529|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
10203580|NCT03465878|11330526|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
10203581|NCT03465878|11330527|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
9906213|NCT01163760|11022236|FG001|STARTED|Period 1 (Fit)||13
9906214|NCT01163760|11022237|FG002|STARTED|Period 1 (Fit)||13
9906215|NCT01163760|11022238|FG003|STARTED|Period 1 (Fit)||12
9906216|NCT01163760|11022235|FG000|COMPLETED|Period 1 (Fit)||12
9906217|NCT01163760|11022236|FG001|COMPLETED|Period 1 (Fit)||13
9906218|NCT01163760|11022237|FG002|COMPLETED|Period 1 (Fit)||13
9906219|NCT01163760|11022238|FG003|COMPLETED|Period 1 (Fit)||12
9906220|NCT01163760|11022235|FG000|NOT COMPLETED|Period 1 (Fit)||0
9906221|NCT01163760|11022236|FG001|NOT COMPLETED|Period 1 (Fit)||0
9906222|NCT01163760|11022237|FG002|NOT COMPLETED|Period 1 (Fit)||0
9906223|NCT01163760|11022238|FG003|NOT COMPLETED|Period 1 (Fit)||0
9906224|NCT01163760|11022235|FG000|STARTED|Period 2 (Follow-up)||12
9906225|NCT01163760|11022236|FG001|STARTED|Period 2 (Follow-up)||13
9906226|NCT01163760|11022237|FG002|STARTED|Period 2 (Follow-up)||13
9906227|NCT01163760|11022238|FG003|STARTED|Period 2 (Follow-up)||12
9906228|NCT01163760|11022235|FG000|COMPLETED|Period 2 (Follow-up)||12
9906229|NCT01163760|11022236|FG001|COMPLETED|Period 2 (Follow-up)||13
9906230|NCT01163760|11022237|FG002|COMPLETED|Period 2 (Follow-up)||13
9906231|NCT01163760|11022238|FG003|COMPLETED|Period 2 (Follow-up)||12
9906232|NCT01163760|11022235|FG000|NOT COMPLETED|Period 2 (Follow-up)||0
9906233|NCT01163760|11022236|FG001|NOT COMPLETED|Period 2 (Follow-up)||0
9906234|NCT01163760|11022237|FG002|NOT COMPLETED|Period 2 (Follow-up)||0
9906235|NCT01163760|11022238|FG003|NOT COMPLETED|Period 2 (Follow-up)||0
9906236|NCT01163760|11022235|FG000|STARTED|Period 3 (Fit)||12
9906237|NCT01163760|11022236|FG001|STARTED|Period 3 (Fit)||13
9906238|NCT01163760|11022237|FG002|STARTED|Period 3 (Fit)||13
9906239|NCT01163760|11022238|FG003|STARTED|Period 3 (Fit)||12
9906240|NCT01163760|11022235|FG000|COMPLETED|Period 3 (Fit)||12
9906241|NCT01163760|11022236|FG001|COMPLETED|Period 3 (Fit)||13
9906242|NCT01163760|11022237|FG002|COMPLETED|Period 3 (Fit)||13
9906243|NCT01163760|11022238|FG003|COMPLETED|Period 3 (Fit)||12
9906244|NCT01163760|11022235|FG000|NOT COMPLETED|Period 3 (Fit)||0
9906245|NCT01163760|11022236|FG001|NOT COMPLETED|Period 3 (Fit)||0
9906246|NCT01163760|11022237|FG002|NOT COMPLETED|Period 3 (Fit)||0
9906247|NCT01163760|11022238|FG003|NOT COMPLETED|Period 3 (Fit)||0
9906248|NCT01163760|11022235|FG000|STARTED|Period 4 (Follow-up)||12
9906249|NCT01163760|11022236|FG001|STARTED|Period 4 (Follow-up)||13
9906250|NCT01163760|11022237|FG002|STARTED|Period 4 (Follow-up)||13
9906251|NCT01163760|11022238|FG003|STARTED|Period 4 (Follow-up)||12
9906252|NCT01163760|11022235|FG000|COMPLETED|Period 4 (Follow-up)||12
9906253|NCT01163760|11022236|FG001|COMPLETED|Period 4 (Follow-up)||13
9906254|NCT01163760|11022237|FG002|COMPLETED|Period 4 (Follow-up)||13
9906255|NCT01163760|11022238|FG003|COMPLETED|Period 4 (Follow-up)||12
9906256|NCT01163760|11022235|FG000|NOT COMPLETED|Period 4 (Follow-up)||0
9906257|NCT01163760|11022236|FG001|NOT COMPLETED|Period 4 (Follow-up)||0
9906258|NCT01163760|11022237|FG002|NOT COMPLETED|Period 4 (Follow-up)||0
9906259|NCT01163760|11022238|FG003|NOT COMPLETED|Period 4 (Follow-up)||0
9906260|NCT01163786|11022246|FG000|STARTED|Treatment With Bortezomib||17
9906261|NCT01163786|11022246|FG000|Completed 1st Cycle|Treatment With Bortezomib||17
9906262|NCT01163786|11022246|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
9906263|NCT01163786|11022246|FG000|COMPLETED|Treatment With Bortezomib||14
9906264|NCT01163786|11022246|FG000|NOT COMPLETED|Treatment With Bortezomib||3
9906265|NCT01163786|11022246|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14
9906266|NCT01163786|11022246|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
9906267|NCT01163786|11022246|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
9906268|NCT01163786|11022246|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13
9906269|NCT01163786|11022246|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
9906270|NCT01163851|11022252|FG000|STARTED|Overall Study||13
9906271|NCT01163851|11022253|FG001|STARTED|Overall Study||12
9906272|NCT01163851|11022252|FG000|Treated|Overall Study||12
9906273|NCT01163851|11022253|FG001|Treated|Overall Study||12
9906274|NCT01163851|11022252|FG000|COMPLETED|Overall Study||12
9906275|NCT01163851|11022253|FG001|COMPLETED|Overall Study||11
9906276|NCT01163851|11022252|FG000|NOT COMPLETED|Overall Study||1
9906277|NCT01163851|11022253|FG001|NOT COMPLETED|Overall Study||1
9906278|NCT01163916|11022262|FG000|STARTED|Overall Study||126
9906279|NCT01163916|11022263|FG001|STARTED|Overall Study||35
9906280|NCT01163916|11022264|FG002|STARTED|Overall Study||91
9906281|NCT01163916|11022262|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
9906282|NCT01163916|11022263|FG001|Safety Population|Overall Study||35
9906283|NCT01163916|11022264|FG002|Safety Population|Overall Study||91
9906284|NCT01163916|11022262|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
9906285|NCT01163916|11022263|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
9906286|NCT01163916|11022264|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
9906287|NCT01163916|11022262|FG000|NOT COMPLETED|Overall Study||30
9906288|NCT01163916|11022263|FG001|NOT COMPLETED|Overall Study||4
9906289|NCT01163916|11022264|FG002|NOT COMPLETED|Overall Study||20
9906290|NCT01163955|11022279|FG000|STARTED|Overall Study||26
9906291|NCT01163955|11022280|FG001|STARTED|Overall Study||30
9906292|NCT01163955|11022279|FG000|COMPLETED|Overall Study||26
9906293|NCT01163955|11022280|FG001|COMPLETED|Overall Study||26
9906294|NCT01163955|11022279|FG000|NOT COMPLETED|Overall Study||0
9906295|NCT01163955|11022280|FG001|NOT COMPLETED|Overall Study||4
9906296|NCT01164007|11022286|FG000|STARTED|Overall Study||40
9906297|NCT01164007|11022286|FG000|Treated|Overall Study||37
9906298|NCT01164007|11022286|FG000|COMPLETED|Overall Study||0
9906299|NCT01164007|11022286|FG000|NOT COMPLETED|Overall Study||40
9906300|NCT01164098|11022292|FG000|STARTED|Overall Study||15
9906301|NCT01164098|11022293|FG001|STARTED|Overall Study||15
9906302|NCT01164098|11022292|FG000|COMPLETED|Overall Study||15
9906303|NCT01164098|11022293|FG001|COMPLETED|Overall Study||15
9906304|NCT01164098|11022292|FG000|NOT COMPLETED|Overall Study||0
9906305|NCT01164098|11022293|FG001|NOT COMPLETED|Overall Study||0
9906306|NCT01164137|11022301|FG000|STARTED|Overall Study||80
9906307|NCT01164137|11022302|FG001|STARTED|Overall Study||76
9906308|NCT01164137|11022301|FG000|COMPLETED|Overall Study||77
9906309|NCT01164137|11022302|FG001|COMPLETED|Overall Study||76
9906310|NCT01164137|11022301|FG000|NOT COMPLETED|Overall Study||3
9906311|NCT01164137|11022302|FG001|NOT COMPLETED|Overall Study||0
9906312|NCT01164475|11022310|FG000|STARTED|Overall Study||30
9906313|NCT01164475|11022311|FG001|STARTED|Overall Study||31
9906314|NCT01164475|11022310|FG000|COMPLETED|Overall Study||28
9906315|NCT01164475|11022311|FG001|COMPLETED|Overall Study||29
9906316|NCT01164475|11022310|FG000|NOT COMPLETED|Overall Study||2
9906317|NCT01164475|11022311|FG001|NOT COMPLETED|Overall Study||2
9955205|NCT01436435|11074119|FG000|STARTED|Overall Study||241
9955206|NCT01436435|11074119|FG000|COMPLETED|Overall Study||177
9955207|NCT01436435|11074119|FG000|NOT COMPLETED|Overall Study||64
9955208|NCT01436500|11074125|FG000|STARTED|Overall Study||12
9955209|NCT01436500|11074126|FG001|STARTED|Overall Study||12
9955210|NCT01436500|11074127|FG002|STARTED|Overall Study||12
9955211|NCT01436500|11074128|FG003|STARTED|Overall Study||6
9955212|NCT01436500|11074129|FG004|STARTED|Overall Study||13
9955213|NCT01436500|11074125|FG000|COMPLETED|Overall Study||9
9955214|NCT01436500|11074126|FG001|COMPLETED|Overall Study||9
9955215|NCT01436500|11074127|FG002|COMPLETED|Overall Study||7
9955216|NCT01436500|11074128|FG003|COMPLETED|Overall Study||5
9955217|NCT01436500|11074129|FG004|COMPLETED|Overall Study||9
9955218|NCT01436500|11074125|FG000|NOT COMPLETED|Overall Study||3
9955219|NCT01436500|11074126|FG001|NOT COMPLETED|Overall Study||3
9955220|NCT01436500|11074127|FG002|NOT COMPLETED|Overall Study||5
9955221|NCT01436500|11074128|FG003|NOT COMPLETED|Overall Study||1
9955222|NCT01436500|11074129|FG004|NOT COMPLETED|Overall Study||4
9955223|NCT01436526|11074144|FG000|STARTED|Period 1||14
9955224|NCT01436526|11074145|FG001|STARTED|Period 1||14
9955225|NCT01436526|11074144|FG000|Participants Received Treatment|Period 1||14
9955226|NCT01436526|11074145|FG001|Participants Received Treatment|Period 1||14
9955227|NCT01436526|11074144|FG000|COMPLETED|Period 1||14
9955228|NCT01436526|11074145|FG001|COMPLETED|Period 1||14
9955229|NCT01436526|11074144|FG000|NOT COMPLETED|Period 1||0
9955230|NCT01436526|11074145|FG001|NOT COMPLETED|Period 1||0
9955231|NCT01436526|11074144|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
9955232|NCT01436526|11074145|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
9955233|NCT01436526|11074144|FG000|Participants Received Treatment|Period 2||13
9955234|NCT01436526|11074145|FG001|Participants Received Treatment|Period 2||13
9955235|NCT01436526|11074144|FG000|COMPLETED|Period 2||13
9955236|NCT01436526|11074145|FG001|COMPLETED|Period 2||13
9955237|NCT01436526|11074144|FG000|NOT COMPLETED|Period 2||0
9955238|NCT01436526|11074145|FG001|NOT COMPLETED|Period 2||0
9955239|NCT01436643|11074154|FG000|STARTED|2-week Pre-treatment||0
9906318|NCT01164501|11022320|FG000|STARTED|Overall Study||321
9906319|NCT01164501|11022321|FG001|STARTED|Overall Study||98
9906320|NCT01164501|11022322|FG002|STARTED|Overall Study||322
9906321|NCT01164501|11022320|FG000|COMPLETED|Overall Study||278
9906322|NCT01164501|11022321|FG001|COMPLETED|Overall Study||88
9906323|NCT01164501|11022322|FG002|COMPLETED|Overall Study||280
9906324|NCT01164501|11022320|FG000|NOT COMPLETED|Overall Study||43
9906325|NCT01164501|11022321|FG001|NOT COMPLETED|Overall Study||10
9906326|NCT01164501|11022322|FG002|NOT COMPLETED|Overall Study||42
9906327|NCT01164579|11022335|FG000|STARTED|Overall Study||36
9906328|NCT01164579|11022336|FG001|STARTED|Overall Study||36
9906329|NCT01164579|11022337|FG002|STARTED|Overall Study||37
9906330|NCT01164579|11022335|FG000|COMPLETED|Overall Study||28
9906331|NCT01164579|11022336|FG001|COMPLETED|Overall Study||27
9906332|NCT01164579|11022337|FG002|COMPLETED|Overall Study||21
9906333|NCT01164579|11022335|FG000|NOT COMPLETED|Overall Study||8
9906334|NCT01164579|11022336|FG001|NOT COMPLETED|Overall Study||9
9906335|NCT01164579|11022337|FG002|NOT COMPLETED|Overall Study||16
9906336|NCT01164644|11022348|FG000|STARTED|Overall Study||12
9906337|NCT01164644|11022349|FG001|STARTED|Overall Study||14
9906338|NCT01164644|11022348|FG000|COMPLETED|Overall Study||9
9906339|NCT01164644|11022349|FG001|COMPLETED|Overall Study||13
9906340|NCT01164644|11022348|FG000|NOT COMPLETED|Overall Study||3
9906341|NCT01164644|11022349|FG001|NOT COMPLETED|Overall Study||1
9906342|NCT01164722|11022357|FG000|STARTED|Overall Study||60
9906343|NCT01164722|11022358|FG001|STARTED|Overall Study||60
9906344|NCT01164722|11022357|FG000|COMPLETED|Overall Study||42
9906345|NCT01164722|11022358|FG001|COMPLETED|Overall Study||45
9906346|NCT01164722|11022357|FG000|NOT COMPLETED|Overall Study||18
9906347|NCT01164722|11022358|FG001|NOT COMPLETED|Overall Study||15
9906348|NCT01164865|11022366|FG000|STARTED|Overall Study||39
9906349|NCT01164865|11022367|FG001|STARTED|Overall Study||39
9906350|NCT01164865|11022366|FG000|COMPLETED|Overall Study||37
9906351|NCT01164865|11022367|FG001|COMPLETED|Overall Study||38
9906352|NCT01164865|11022366|FG000|NOT COMPLETED|Overall Study||2
9906353|NCT01164865|11022367|FG001|NOT COMPLETED|Overall Study||1
9906354|NCT01164891|11022373|FG000|STARTED|Overall Study||7
9906355|NCT01164891|11022373|FG000|COMPLETED|Overall Study||1
9906356|NCT01164891|11022373|FG000|NOT COMPLETED|Overall Study||6
9906357|NCT01164956|11022378|FG000|STARTED|Overall Study||1
9906358|NCT01164956|11022379|FG001|STARTED|Overall Study||1
9906359|NCT01164956|11022380|FG002|STARTED|Overall Study||1
9906360|NCT01164956|11022378|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0
9906361|NCT01164956|11022379|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1
9906362|NCT01164956|11022380|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0
9906363|NCT01164956|11022378|FG000|COMPLETED|Overall Study||0
9906364|NCT01164956|11022379|FG001|COMPLETED|Overall Study||1
9906365|NCT01164956|11022380|FG002|COMPLETED|Overall Study||0
9906366|NCT01164956|11022378|FG000|NOT COMPLETED|Overall Study||1
9906367|NCT01164956|11022379|FG001|NOT COMPLETED|Overall Study||0
9906368|NCT01164956|11022380|FG002|NOT COMPLETED|Overall Study||1
9906369|NCT01165021|11022388|FG000|STARTED|Overall Study||19
9906370|NCT01165021|11022388|FG000|≥1 Dose Chemo|Overall Study||19
9906371|NCT01165021|11022388|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
9906372|NCT01165021|11022388|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15
9906373|NCT01165021|11022388|FG000|COMPLETED|Overall Study||18
9906374|NCT01165021|11022388|FG000|NOT COMPLETED|Overall Study||1
9906375|NCT01165047|11022392|FG000|STARTED|Overall Study||10
9906376|NCT01165047|11022392|FG000|COMPLETED|Overall Study||10
9906377|NCT01165047|11022392|FG000|NOT COMPLETED|Overall Study||0
9906378|NCT01165112|11022396|FG000|STARTED|Overall Study||48
9906379|NCT01165112|11022396|FG000|COMPLETED|Overall Study||48
9906380|NCT01165112|11022396|FG000|NOT COMPLETED|Overall Study||0
9906381|NCT01165138|11022403|FG000|STARTED|Overall Study||0
9906382|NCT01165138|11022404|FG001|STARTED|Overall Study||203
9906383|NCT01165138|11022405|FG002|STARTED|Overall Study||205
9906384|NCT01165138|11022406|FG003|STARTED|Overall Study||201
9906385|NCT01165138|11022403|FG000|COMPLETED|Overall Study||0
9906386|NCT01165138|11022404|FG001|COMPLETED|Overall Study||151
9906387|NCT01165138|11022405|FG002|COMPLETED|Overall Study||185
9906388|NCT01165138|11022406|FG003|COMPLETED|Overall Study||179
9906389|NCT01165138|11022403|FG000|NOT COMPLETED|Overall Study||0
9906390|NCT01165138|11022404|FG001|NOT COMPLETED|Overall Study||52
9906391|NCT01165138|11022405|FG002|NOT COMPLETED|Overall Study||20
9906392|NCT01165138|11022406|FG003|NOT COMPLETED|Overall Study||22
9906393|NCT01165177|11022416|FG000|STARTED|Overall Study||7695
9906394|NCT01165177|11022417|FG001|STARTED|Overall Study||7710
9906395|NCT01165177|11022416|FG000|COMPLETED|Overall Study||6773
9906396|NCT01165177|11022417|FG001|COMPLETED|Overall Study||6808
9906397|NCT01165177|11022416|FG000|NOT COMPLETED|Overall Study||922
9906398|NCT01165177|11022417|FG001|NOT COMPLETED|Overall Study||902
9906399|NCT01165203|11022433|FG000|STARTED|Active Phase||74
9906400|NCT01165203|11022434|FG001|STARTED|Active Phase||49
9906401|NCT01165203|11022433|FG000|COMPLETED|Active Phase||69
9906402|NCT01165203|11022434|FG001|COMPLETED|Active Phase||47
9906403|NCT01165203|11022433|FG000|NOT COMPLETED|Active Phase||5
9906404|NCT01165203|11022434|FG001|NOT COMPLETED|Active Phase||2
9906405|NCT01165203|11022433|FG000|STARTED|Extended Safety Follow-up Phase||74
9906406|NCT01165203|11022434|FG001|STARTED|Extended Safety Follow-up Phase||49
9906407|NCT01165203|11022433|FG000|COMPLETED|Extended Safety Follow-up Phase||67
9906408|NCT01165203|11022434|FG001|COMPLETED|Extended Safety Follow-up Phase||45
9906409|NCT01165203|11022433|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7
9906410|NCT01165203|11022434|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4
9906411|NCT01165216|11022449|FG000|STARTED|Overall Study|Participants who received any study drug|8
9906412|NCT01165216|11022450|FG001|STARTED|Overall Study|Participants who received any study drug|7
9906413|NCT01165216|11022449|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6
9906414|NCT01165216|11022450|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6
9906415|NCT01165216|11022449|FG000|COMPLETED|Overall Study|Completed=still on study drug|0
9906416|NCT01165216|11022450|FG001|COMPLETED|Overall Study|Completed=still on study drug|0
9906417|NCT01165216|11022449|FG000|NOT COMPLETED|Overall Study||8
9906418|NCT01165216|11022450|FG001|NOT COMPLETED|Overall Study||7
9906419|NCT01165229|11022460|FG000|STARTED|Overall Study||6950
9906420|NCT01165229|11022461|FG001|STARTED|Overall Study||6950
9906421|NCT01165229|11022460|FG000|COMPLETED|Overall Study||5770
9906422|NCT01165229|11022461|FG001|COMPLETED|Overall Study||5760
9906423|NCT01165229|11022460|FG000|NOT COMPLETED|Overall Study||1180
9906424|NCT01165229|11022461|FG001|NOT COMPLETED|Overall Study||1190
9906425|NCT01165242|11022500|FG000|STARTED|Overall Study||337
9906426|NCT01165242|11022501|FG001|STARTED|Overall Study||336
9906427|NCT01165242|11022502|FG002|STARTED|Overall Study||338
9906428|NCT01165242|11022500|FG000|COMPLETED|Overall Study||327
9906429|NCT01165242|11022501|FG001|COMPLETED|Overall Study||326
9906430|NCT01165242|11022502|FG002|COMPLETED|Overall Study||324
9906431|NCT01165242|11022500|FG000|NOT COMPLETED|Overall Study||10
9906432|NCT01165242|11022501|FG001|NOT COMPLETED|Overall Study||10
9906433|NCT01165242|11022502|FG002|NOT COMPLETED|Overall Study||14
9906434|NCT01165281|11022514|FG000|STARTED|Overall Study||168
9906435|NCT01165281|11022515|FG001|STARTED|Overall Study||172
10111165|NCT02493868|11242214|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59
10111166|NCT02493868|11242213|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139
10111167|NCT02493868|11242214|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177
10111168|NCT02493868|11242213|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
9906436|NCT01165281|11022514|FG000|COMPLETED|Overall Study||110
9906437|NCT01165281|11022515|FG001|COMPLETED|Overall Study||121
9906438|NCT01165281|11022514|FG000|NOT COMPLETED|Overall Study||58
9906439|NCT01165281|11022515|FG001|NOT COMPLETED|Overall Study||51
9906440|NCT01165307|11022523|FG000|STARTED|Overall Study||33
9906441|NCT01165307|11022524|FG001|STARTED|Overall Study||34
9906442|NCT01165307|11022523|FG000|COMPLETED|Overall Study||19
9906443|NCT01165307|11022524|FG001|COMPLETED|Overall Study||31
9906444|NCT01165307|11022523|FG000|NOT COMPLETED|Overall Study||14
9906445|NCT01165307|11022524|FG001|NOT COMPLETED|Overall Study||3
9906446|NCT01165320|11022532|FG000|STARTED|Overall Study||12
9906447|NCT01165320|11022533|FG001|STARTED|Overall Study||8
9906448|NCT01165320|11022534|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
9906449|NCT01165320|11022532|FG000|COMPLETED|Overall Study||9
9906450|NCT01165320|11022533|FG001|COMPLETED|Overall Study||4
9906451|NCT01165320|11022534|FG002|COMPLETED|Overall Study||0
9906452|NCT01165320|11022532|FG000|NOT COMPLETED|Overall Study||3
9906453|NCT01165320|11022533|FG001|NOT COMPLETED|Overall Study||4
9906454|NCT01165320|11022534|FG002|NOT COMPLETED|Overall Study||0
9906455|NCT01165541|11022540|FG000|STARTED|Quetiapine XR Monotherapy||20
9906456|NCT01165541|11022540|FG000|COMPLETED|Quetiapine XR Monotherapy||16
9906457|NCT01165541|11022540|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4
9906458|NCT01165541|11022540|FG000|STARTED|Quetiapine XR and Mirtazepine||16
9906459|NCT01165541|11022540|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11
9906460|NCT01165541|11022540|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
9906461|NCT01165554|11022546|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203
9906462|NCT01165554|11022546|FG000|COMPLETED|Overall Study||180
9906463|NCT01165554|11022546|FG000|NOT COMPLETED|Overall Study||23
9906464|NCT01165684|11022555|FG000|STARTED|Overall Study||201
9906465|NCT01165684|11022556|FG001|STARTED|Overall Study||200
9906466|NCT01165684|11022555|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
9906467|NCT01165684|11022556|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
9906468|NCT01165684|11022555|FG000|COMPLETED|Overall Study||173
9906469|NCT01165684|11022556|FG001|COMPLETED|Overall Study||148
10111169|NCT02493868|11242214|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
9906470|NCT01165684|11022555|FG000|NOT COMPLETED|Overall Study||28
9906471|NCT01165684|11022556|FG001|NOT COMPLETED|Overall Study||52
9906472|NCT01165775|11022562|FG000|STARTED|Overall Study||17
9906473|NCT01165775|11022562|FG000|COMPLETED|Overall Study||15
9906474|NCT01165775|11022562|FG000|NOT COMPLETED|Overall Study||2
9906475|NCT01165840|11022570|FG000|STARTED|Overall Study||36
9906476|NCT01165840|11022570|FG000|COMPLETED|Overall Study||36
9906477|NCT01165840|11022570|FG000|NOT COMPLETED|Overall Study||0
9906478|NCT01165983|11022576|FG000|STARTED|Overall Study||51
9906479|NCT01165983|11022577|FG001|STARTED|Overall Study||49
9906480|NCT01165983|11022576|FG000|COMPLETED|Overall Study||46
9906481|NCT01165983|11022577|FG001|COMPLETED|Overall Study||42
9906482|NCT01165983|11022576|FG000|NOT COMPLETED|Overall Study||5
9906483|NCT01165983|11022577|FG001|NOT COMPLETED|Overall Study||7
9906484|NCT01165996|11022585|FG000|STARTED|Overall Study||25
9906485|NCT01165996|11022585|FG000|Induction Phase|Overall Study||25
9906486|NCT01165996|11022585|FG000|Maintenance Phase|Overall Study||23
9906487|NCT01165996|11022585|FG000|COMPLETED|Overall Study||23
9906488|NCT01165996|11022585|FG000|NOT COMPLETED|Overall Study||2
9906489|NCT01166126|11022590|FG000|STARTED|Overall Study||4
9906490|NCT01166126|11022590|FG000|COMPLETED|Overall Study||4
9906491|NCT01166126|11022590|FG000|NOT COMPLETED|Overall Study||0
9906492|NCT01166139|11022594|FG000|STARTED|Overall Study||10
9906493|NCT01166139|11022594|FG000|COMPLETED|Overall Study||7
9906494|NCT01166139|11022594|FG000|NOT COMPLETED|Overall Study||3
9906495|NCT01166230|11022600|FG000|STARTED|Overall Study||280
9906496|NCT01166230|11022601|FG001|STARTED|Overall Study||271
9906497|NCT01166230|11022600|FG000|COMPLETED|Overall Study||261
9906498|NCT01166230|11022601|FG001|COMPLETED|Overall Study||255
9906499|NCT01166230|11022600|FG000|NOT COMPLETED|Overall Study||19
9906500|NCT01166230|11022601|FG001|NOT COMPLETED|Overall Study||16
9906501|NCT01166282|11022609|FG000|STARTED|Double-blind Period||15
9906502|NCT01166282|11022610|FG001|STARTED|Double-blind Period||31
9906503|NCT01166282|11022611|FG002|STARTED|Double-blind Period||0
9906504|NCT01166282|11022609|FG000|COMPLETED|Double-blind Period||15
9906505|NCT01166282|11022610|FG001|COMPLETED|Double-blind Period||31
9906506|NCT01166282|11022611|FG002|COMPLETED|Double-blind Period||0
9906507|NCT01166282|11022609|FG000|NOT COMPLETED|Double-blind Period||0
9906508|NCT01166282|11022610|FG001|NOT COMPLETED|Double-blind Period||0
9906509|NCT01166282|11022611|FG002|NOT COMPLETED|Double-blind Period||0
9906510|NCT01166282|11022609|FG000|STARTED|Open-label Period||0
9906511|NCT01166282|11022610|FG001|STARTED|Open-label Period||0
9906512|NCT01166282|11022611|FG002|STARTED|Open-label Period||46
9906513|NCT01166282|11022609|FG000|COMPLETED|Open-label Period||0
9906514|NCT01166282|11022610|FG001|COMPLETED|Open-label Period||0
9906515|NCT01166282|11022611|FG002|COMPLETED|Open-label Period||29
9906516|NCT01166282|11022609|FG000|NOT COMPLETED|Open-label Period||0
9906517|NCT01166282|11022610|FG001|NOT COMPLETED|Open-label Period||0
9906518|NCT01166282|11022611|FG002|NOT COMPLETED|Open-label Period||17
9906519|NCT01166347|11022621|FG000|STARTED|Overall Study||297
9906520|NCT01166347|11022622|FG001|STARTED|Overall Study||149
9906521|NCT01166347|11022621|FG000|COMPLETED|Overall Study||295
9906522|NCT01166347|11022622|FG001|COMPLETED|Overall Study||148
9906523|NCT01166347|11022621|FG000|NOT COMPLETED|Overall Study||2
9906524|NCT01166347|11022622|FG001|NOT COMPLETED|Overall Study||1
9906525|NCT01166373|11022632|FG000|STARTED|Overall Study||95
9906526|NCT01166373|11022633|FG001|STARTED|Overall Study||91
9906527|NCT01166373|11022634|FG002|STARTED|Overall Study||91
9906528|NCT01166373|11022635|FG003|STARTED|Overall Study||97
9906529|NCT01166373|11022632|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81
9906530|NCT01166373|11022633|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80
9906531|NCT01166373|11022634|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79
9906532|NCT01166373|11022635|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87
9906533|NCT01166373|11022632|FG000|Randomized to Video|Overall Study||32
9906534|NCT01166373|11022633|FG001|Randomized to Video|Overall Study||43
9906535|NCT01166373|11022634|FG002|Randomized to Video|Overall Study||38
9906536|NCT01166373|11022635|FG003|Randomized to Video|Overall Study||40
9906537|NCT01166373|11022632|FG000|Randomized to No Video|Overall Study||45
9906538|NCT01166373|11022633|FG001|Randomized to No Video|Overall Study||30
9906539|NCT01166373|11022634|FG002|Randomized to No Video|Overall Study||34
9906540|NCT01166373|11022635|FG003|Randomized to No Video|Overall Study||42
9906541|NCT01166373|11022632|FG000|Consented to Participate E-OPTIMAL|Overall Study||72
9906542|NCT01166373|11022633|FG001|Consented to Participate E-OPTIMAL|Overall Study||66
9906543|NCT01166373|11022634|FG002|Consented to Participate E-OPTIMAL|Overall Study||69
9906544|NCT01166373|11022635|FG003|Consented to Participate E-OPTIMAL|Overall Study||78
9906545|NCT01166373|11022632|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
9906546|NCT01166373|11022633|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
9906547|NCT01166373|11022634|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
9906548|NCT01166373|11022635|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
9906549|NCT01166373|11022632|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
9906550|NCT01166373|11022633|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
9906551|NCT01166373|11022634|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
9906552|NCT01166373|11022635|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
9906553|NCT01166373|11022632|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
9906554|NCT01166373|11022633|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
9906555|NCT01166373|11022634|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
9906556|NCT01166373|11022635|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
9906557|NCT01166373|11022632|FG000|COMPLETED|Overall Study||90
9906558|NCT01166373|11022633|FG001|COMPLETED|Overall Study||87
9906559|NCT01166373|11022634|FG002|COMPLETED|Overall Study||87
9906560|NCT01166373|11022635|FG003|COMPLETED|Overall Study||92
9906561|NCT01166373|11022632|FG000|NOT COMPLETED|Overall Study||5
9906562|NCT01166373|11022633|FG001|NOT COMPLETED|Overall Study||4
9906563|NCT01166373|11022634|FG002|NOT COMPLETED|Overall Study||4
9906564|NCT01166373|11022635|FG003|NOT COMPLETED|Overall Study||5
9906565|NCT01166438|11022649|FG000|STARTED|Double-blind Phase: 1st 6 Months||122
9906566|NCT01166438|11022650|FG001|STARTED|Double-blind Phase: 1st 6 Months||127
9906567|NCT01166438|11022649|FG000|Treated|Double-blind Phase: 1st 6 Months||121
9906568|NCT01166438|11022650|FG001|Treated|Double-blind Phase: 1st 6 Months||126
9906569|NCT01166438|11022649|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
9906570|NCT01166438|11022650|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
9906571|NCT01166438|11022649|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
9906572|NCT01166438|11022650|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
9906573|NCT01166438|11022649|FG000|STARTED|Off Treatment Follow-up Phase||85
9906574|NCT01166438|11022650|FG001|STARTED|Off Treatment Follow-up Phase||89
9906575|NCT01166438|11022649|FG000|COMPLETED|Off Treatment Follow-up Phase||51
9906576|NCT01166438|11022650|FG001|COMPLETED|Off Treatment Follow-up Phase||33
9906577|NCT01166438|11022649|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34
9906578|NCT01166438|11022650|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56
9906579|NCT01166568|11022660|FG000|STARTED|Deferred Implantation- Randomized||0
9906580|NCT01166568|11022661|FG001|STARTED|Deferred Implantation- Randomized||0
9906581|NCT01166568|11022662|FG002|STARTED|Deferred Implantation- Randomized||16
9906582|NCT01166568|11022660|FG000|COMPLETED|Deferred Implantation- Randomized||0
9906583|NCT01166568|11022661|FG001|COMPLETED|Deferred Implantation- Randomized||0
9906584|NCT01166568|11022662|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
9906585|NCT01166568|11022660|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0
9906586|NCT01166568|11022661|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0
9906587|NCT01166568|11022662|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1
9906588|NCT01166568|11022660|FG000|STARTED|Implantation- Nonrandomized & Randomized||288
9906589|NCT01166568|11022661|FG001|STARTED|Implantation- Nonrandomized & Randomized||33
9906590|NCT01166568|11022662|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
9906591|NCT01166568|11022660|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274
9906592|NCT01166568|11022661|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32
9906593|NCT01166568|11022662|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
9906594|NCT01166568|11022660|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
9906595|NCT01166568|11022661|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
9906596|NCT01166568|11022662|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
9906597|NCT01166646|11022670|FG000|STARTED|Overall Study||21
9906598|NCT01166646|11022671|FG001|STARTED|Overall Study||22
9906599|NCT01166646|11022670|FG000|COMPLETED|Overall Study||20
9906600|NCT01166646|11022671|FG001|COMPLETED|Overall Study||21
9906601|NCT01166646|11022670|FG000|NOT COMPLETED|Overall Study||1
9906602|NCT01166646|11022671|FG001|NOT COMPLETED|Overall Study||1
9906603|NCT01166659|11022677|FG000|STARTED|Overall Study||48
9906604|NCT01166659|11022677|FG000|COMPLETED|Overall Study||35
9906605|NCT01166659|11022677|FG000|NOT COMPLETED|Overall Study||13
9906606|NCT01166750|11022684|FG000|STARTED|Overall Study||10
9906607|NCT01166750|11022685|FG001|STARTED|Overall Study||13
9906608|NCT01166750|11022684|FG000|COMPLETED|Overall Study||9
9906609|NCT01166750|11022685|FG001|COMPLETED|Overall Study||13
9906610|NCT01166750|11022684|FG000|NOT COMPLETED|Overall Study||1
9906611|NCT01166750|11022685|FG001|NOT COMPLETED|Overall Study||0
9906612|NCT01166763|11022691|FG000|STARTED|Overall Study||30
9906613|NCT01166763|11022691|FG000|COMPLETED|Overall Study||27
9906614|NCT01166763|11022691|FG000|NOT COMPLETED|Overall Study||3
9906615|NCT01166945|11022697|FG000|STARTED|Randomized||51
9906616|NCT01166945|11022698|FG001|STARTED|Randomized||47
9906617|NCT01166945|11022697|FG000|COMPLETED|Randomized||47
9906618|NCT01166945|11022698|FG001|COMPLETED|Randomized||43
9906619|NCT01166945|11022697|FG000|NOT COMPLETED|Randomized||4
9906620|NCT01166945|11022698|FG001|NOT COMPLETED|Randomized||4
9906621|NCT01166945|11022697|FG000|STARTED|Day 5||47
9906622|NCT01166945|11022698|FG001|STARTED|Day 5||43
9906623|NCT01166945|11022697|FG000|COMPLETED|Day 5||47
9906624|NCT01166945|11022698|FG001|COMPLETED|Day 5||43
9906625|NCT01166945|11022697|FG000|NOT COMPLETED|Day 5||0
9906626|NCT01166945|11022698|FG001|NOT COMPLETED|Day 5||0
9906627|NCT01166945|11022697|FG000|STARTED|Day 10||47
9906628|NCT01166945|11022698|FG001|STARTED|Day 10||43
9906629|NCT01166945|11022697|FG000|COMPLETED|Day 10||44
9906630|NCT01166945|11022698|FG001|COMPLETED|Day 10||41
9906631|NCT01166945|11022697|FG000|NOT COMPLETED|Day 10||3
9906632|NCT01166945|11022698|FG001|NOT COMPLETED|Day 10||2
9906633|NCT01166945|11022697|FG000|STARTED|Day 15||44
9906634|NCT01166945|11022698|FG001|STARTED|Day 15||41
9906635|NCT01166945|11022697|FG000|COMPLETED|Day 15||42
9906636|NCT01166945|11022698|FG001|COMPLETED|Day 15||40
9906637|NCT01166945|11022697|FG000|NOT COMPLETED|Day 15||2
9906638|NCT01166945|11022698|FG001|NOT COMPLETED|Day 15||1
9906639|NCT01166945|11022697|FG000|STARTED|Day 20||42
9906640|NCT01166945|11022698|FG001|STARTED|Day 20||40
9906641|NCT01166945|11022697|FG000|COMPLETED|Day 20||42
9906642|NCT01166945|11022698|FG001|COMPLETED|Day 20||40
9906643|NCT01166945|11022697|FG000|NOT COMPLETED|Day 20||0
9906644|NCT01166945|11022698|FG001|NOT COMPLETED|Day 20||0
9906645|NCT01166945|11022697|FG000|STARTED|Day 30||42
9906646|NCT01166945|11022698|FG001|STARTED|Day 30||40
9906647|NCT01166945|11022697|FG000|COMPLETED|Day 30||38
9906648|NCT01166945|11022698|FG001|COMPLETED|Day 30||37
9906649|NCT01166945|11022697|FG000|NOT COMPLETED|Day 30||4
9906650|NCT01166945|11022698|FG001|NOT COMPLETED|Day 30||3
9906651|NCT01166958|11022708|FG000|STARTED|Overall Study||13
9906652|NCT01166958|11022709|FG001|STARTED|Overall Study||13
9906653|NCT01166958|11022708|FG000|COMPLETED|Overall Study||12
9906654|NCT01166958|11022709|FG001|COMPLETED|Overall Study||13
9906655|NCT01166958|11022708|FG000|NOT COMPLETED|Overall Study||1
9906656|NCT01166958|11022709|FG001|NOT COMPLETED|Overall Study||0
9906657|NCT01166971|11022717|FG000|STARTED|Overall Study||33
9906658|NCT01166971|11022718|FG001|STARTED|Overall Study||31
9906659|NCT01166971|11022717|FG000|COMPLETED|Overall Study||32
9906660|NCT01166971|11022718|FG001|COMPLETED|Overall Study||30
9906661|NCT01166971|11022717|FG000|NOT COMPLETED|Overall Study||1
9906662|NCT01166971|11022718|FG001|NOT COMPLETED|Overall Study||1
9906663|NCT01166984|11022729|FG000|STARTED|Overall Study||5
9906664|NCT01166984|11022730|FG001|STARTED|Overall Study||5
9906665|NCT01166984|11022731|FG002|STARTED|Overall Study||5
9906666|NCT01166984|11022732|FG003|STARTED|Overall Study||5
9906667|NCT01166984|11022733|FG004|STARTED|Overall Study||5
9906668|NCT01166984|11022729|FG000|COMPLETED|Overall Study||5
9906669|NCT01166984|11022730|FG001|COMPLETED|Overall Study||5
9906670|NCT01166984|11022731|FG002|COMPLETED|Overall Study||5
9906671|NCT01166984|11022732|FG003|COMPLETED|Overall Study||5
9906672|NCT01166984|11022733|FG004|COMPLETED|Overall Study||5
9906673|NCT01166984|11022729|FG000|NOT COMPLETED|Overall Study||0
9906674|NCT01166984|11022730|FG001|NOT COMPLETED|Overall Study||0
9906675|NCT01166984|11022731|FG002|NOT COMPLETED|Overall Study||0
10203582|NCT03465878|11330528|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
10203583|NCT03465878|11330529|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
10203584|NCT03465878|11330526|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
10203585|NCT03465878|11330527|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
10203586|NCT03465878|11330528|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
10203587|NCT03465878|11330529|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
10203588|NCT03465878|11330526|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
10203589|NCT03465878|11330527|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
9906676|NCT01166984|11022732|FG003|NOT COMPLETED|Overall Study||0
9906677|NCT01166984|11022733|FG004|NOT COMPLETED|Overall Study||0
9906678|NCT01166997|11022757|FG000|STARTED|Overall Study||29
9906679|NCT01166997|11022758|FG001|STARTED|Overall Study||30
9906680|NCT01166997|11022757|FG000|COMPLETED|Overall Study||27
9906681|NCT01166997|11022758|FG001|COMPLETED|Overall Study||30
9906682|NCT01166997|11022757|FG000|NOT COMPLETED|Overall Study||2
9906683|NCT01166997|11022758|FG001|NOT COMPLETED|Overall Study||0
9906684|NCT01167023|11022768|FG000|STARTED|Overall Study||0
9906685|NCT01167023|11022769|FG001|STARTED|Overall Study||21
9906686|NCT01167023|11022770|FG002|STARTED|Overall Study||41
9906687|NCT01167023|11022768|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0
9906688|NCT01167023|11022769|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19
9906689|NCT01167023|11022770|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41
9906690|NCT01167023|11022768|FG000|COMPLETED|Overall Study||0
9906691|NCT01167023|11022769|FG001|COMPLETED|Overall Study||18
9906692|NCT01167023|11022770|FG002|COMPLETED|Overall Study||39
9906693|NCT01167023|11022768|FG000|NOT COMPLETED|Overall Study||0
9906694|NCT01167023|11022769|FG001|NOT COMPLETED|Overall Study||3
9906695|NCT01167023|11022770|FG002|NOT COMPLETED|Overall Study||2
9906696|NCT01167140|11022776|FG000|STARTED|Overall Study||42
9906697|NCT01167140|11022776|FG000|COMPLETED|Overall Study||41
9906698|NCT01167140|11022776|FG000|NOT COMPLETED|Overall Study||1
9906699|NCT01167153|11022782|FG000|STARTED|Overall Study||282
9906700|NCT01167153|11022783|FG001|STARTED|Overall Study||282
9906701|NCT01167153|11022782|FG000|Intention to Treat (ITT)|Overall Study||272
9906702|NCT01167153|11022783|FG001|Intention to Treat (ITT)|Overall Study||268
9906703|NCT01167153|11022782|FG000|COMPLETED|Overall Study||264
9906704|NCT01167153|11022783|FG001|COMPLETED|Overall Study||249
9906705|NCT01167153|11022782|FG000|NOT COMPLETED|Overall Study||18
9906706|NCT01167153|11022783|FG001|NOT COMPLETED|Overall Study||33
9906707|NCT01167179|11022791|FG000|STARTED|Overall Study||80
9906708|NCT01167179|11022792|FG001|STARTED|Overall Study||80
9906709|NCT01167179|11022791|FG000|COMPLETED|Overall Study||65
9906710|NCT01167179|11022792|FG001|COMPLETED|Overall Study||59
9906711|NCT01167179|11022791|FG000|NOT COMPLETED|Overall Study||15
9906712|NCT01167179|11022792|FG001|NOT COMPLETED|Overall Study||21
9906713|NCT01167192|11022798|FG000|STARTED|Overall Study||10
9906714|NCT01167192|11022798|FG000|COMPLETED|Overall Study||6
9906715|NCT01167192|11022798|FG000|NOT COMPLETED|Overall Study||4
9906716|NCT01167257|11022804|FG000|STARTED|Overall Study||31
9906717|NCT01167257|11022805|FG001|STARTED|Overall Study||31
9906718|NCT01167257|11022804|FG000|COMPLETED|Overall Study||28
9906719|NCT01167257|11022805|FG001|COMPLETED|Overall Study||28
9906720|NCT01167257|11022804|FG000|NOT COMPLETED|Overall Study||3
9906721|NCT01167257|11022805|FG001|NOT COMPLETED|Overall Study||3
9906722|NCT01167426|11022815|FG000|STARTED|Overall Study||148
9906723|NCT01167426|11022815|FG000|COMPLETED|Overall Study||138
9906724|NCT01167426|11022815|FG000|NOT COMPLETED|Overall Study||10
9906725|NCT01167452|11022820|FG000|STARTED|Overall Study||36
9906726|NCT01167452|11022820|FG000|COMPLETED|Overall Study||36
9906727|NCT01167452|11022820|FG000|NOT COMPLETED|Overall Study||0
9906728|NCT01167504|11022825|FG000|STARTED|Overall Study||15
9906729|NCT01167504|11022825|FG000|COMPLETED|Overall Study||12
9906730|NCT01167504|11022825|FG000|NOT COMPLETED|Overall Study||3
9906731|NCT01167569|11022831|FG000|STARTED|Overall Study||28
9906732|NCT01167569|11022832|FG001|STARTED|Overall Study||29
9906733|NCT01167569|11022831|FG000|COMPLETED|Overall Study||27
9906734|NCT01167569|11022832|FG001|COMPLETED|Overall Study||27
9906735|NCT01167569|11022831|FG000|NOT COMPLETED|Overall Study||1
9906736|NCT01167569|11022832|FG001|NOT COMPLETED|Overall Study||2
9906737|NCT01167582|11022842|FG000|STARTED|Overall Study||55
9906738|NCT01167582|11022843|FG001|STARTED|Overall Study||55
9906739|NCT01167582|11022842|FG000|COMPLETED|Overall Study||55
9906740|NCT01167582|11022843|FG001|COMPLETED|Overall Study||54
9906741|NCT01167582|11022842|FG000|NOT COMPLETED|Overall Study||0
9906742|NCT01167582|11022843|FG001|NOT COMPLETED|Overall Study||1
9906743|NCT01167595|11022851|FG000|STARTED|Overall Study||522
9906744|NCT01167595|11022852|FG001|STARTED|Overall Study||537
9906745|NCT01167595|11022851|FG000|COMPLETED|Overall Study||522
9906746|NCT01167595|11022852|FG001|COMPLETED|Overall Study||537
9906747|NCT01167595|11022851|FG000|NOT COMPLETED|Overall Study||0
9906748|NCT01167595|11022852|FG001|NOT COMPLETED|Overall Study||0
9906749|NCT01167608|11022858|FG000|STARTED|Overall Study||883
9906750|NCT01167608|11022858|FG000|COMPLETED|Overall Study||769
9906751|NCT01167608|11022858|FG000|NOT COMPLETED|Overall Study||114
9906752|NCT01167634|11022867|FG000|STARTED|Overall Study||33
9906753|NCT01167634|11022868|FG001|STARTED|Overall Study||33
9906754|NCT01167634|11022869|FG002|STARTED|Overall Study||33
9906755|NCT01167634|11022870|FG003|STARTED|Overall Study||33
9906756|NCT01167634|11022867|FG000|COMPLETED|Overall Study||31
9906757|NCT01167634|11022868|FG001|COMPLETED|Overall Study||29
9906758|NCT01167634|11022869|FG002|COMPLETED|Overall Study||30
9906759|NCT01167634|11022870|FG003|COMPLETED|Overall Study||29
9906760|NCT01167634|11022867|FG000|NOT COMPLETED|Overall Study||2
9906761|NCT01167634|11022868|FG001|NOT COMPLETED|Overall Study||4
9906762|NCT01167634|11022869|FG002|NOT COMPLETED|Overall Study||3
9906763|NCT01167634|11022870|FG003|NOT COMPLETED|Overall Study||4
10203590|NCT03465878|11330528|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
10203591|NCT03465878|11330529|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
9906764|NCT01167712|11022882|FG000|STARTED|Overall Study||346
9906765|NCT01167712|11022883|FG001|STARTED|Overall Study||346
9906766|NCT01167712|11022882|FG000|COMPLETED|Overall Study||346
9906767|NCT01167712|11022883|FG001|COMPLETED|Overall Study||346
9906768|NCT01167712|11022882|FG000|NOT COMPLETED|Overall Study||0
9906769|NCT01167712|11022883|FG001|NOT COMPLETED|Overall Study||0
9906770|NCT01167829|11022889|FG000|STARTED|Overall Study||12
9906771|NCT01167829|11022889|FG000|COMPLETED|Overall Study||12
9906772|NCT01167829|11022889|FG000|NOT COMPLETED|Overall Study||0
9906773|NCT01167881|11022897|FG000|STARTED|Overall Study||769
9906774|NCT01167881|11022898|FG001|STARTED|Overall Study||780
9906775|NCT01167881|11022897|FG000|Completed After 2 Years Treatment|Overall Study||95
9906776|NCT01167881|11022898|FG001|Completed After 2 Years Treatment|Overall Study||127
9906777|NCT01167881|11022897|FG000|Completed After 4 Years Treatment|Overall Study||515
9906778|NCT01167881|11022898|FG001|Completed After 4 Years Treatment|Overall Study||462
9906779|NCT01167881|11022897|FG000|COMPLETED|Overall Study||610
9906780|NCT01167881|11022898|FG001|COMPLETED|Overall Study||589
9906781|NCT01167881|11022897|FG000|NOT COMPLETED|Overall Study||159
9906782|NCT01167881|11022898|FG001|NOT COMPLETED|Overall Study||191
9906783|NCT01167907|11022906|FG000|STARTED|Overall Study||17
9906784|NCT01167907|11022907|FG001|STARTED|Overall Study||15
9906785|NCT01167907|11022906|FG000|COMPLETED|Overall Study||15
9906786|NCT01167907|11022907|FG001|COMPLETED|Overall Study||14
9906787|NCT01167907|11022906|FG000|NOT COMPLETED|Overall Study||2
9906788|NCT01167907|11022907|FG001|NOT COMPLETED|Overall Study||1
9906789|NCT01168024|11022915|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
9906790|NCT01168024|11022916|FG001|STARTED|Overall Study||3
9906791|NCT01168024|11022915|FG000|COMPLETED|Overall Study||13
9906792|NCT01168024|11022916|FG001|COMPLETED|Overall Study||3
9906793|NCT01168024|11022915|FG000|NOT COMPLETED|Overall Study||0
9906794|NCT01168024|11022916|FG001|NOT COMPLETED|Overall Study||0
9906795|NCT01168232|11022922|FG000|STARTED|Overall Study||42
9906796|NCT01168232|11022922|FG000|COMPLETED|Overall Study|Eligible and treated patients|34
9906797|NCT01168232|11022922|FG000|NOT COMPLETED|Overall Study||8
9906798|NCT01168349|11022926|FG000|STARTED|Overall Study||1055
9906799|NCT01168349|11022926|FG000|COMPLETED|Overall Study||754
9906800|NCT01168349|11022926|FG000|NOT COMPLETED|Overall Study||301
9906801|NCT01168401|11022957|FG000|STARTED|Overall Study||10
9906802|NCT01168401|11022958|FG001|STARTED|Overall Study||10
9906803|NCT01168401|11022959|FG002|STARTED|Overall Study||10
9906804|NCT01168401|11022960|FG003|STARTED|Overall Study||9
9906805|NCT01168401|11022961|FG004|STARTED|Overall Study||9
9906806|NCT01168401|11022962|FG005|STARTED|Overall Study||9
9906807|NCT01168401|11022963|FG006|STARTED|Overall Study||10
10238733|NCT00484718|11370191|FG004|COMPLETED|Washout Period (2 Weeks)||1
9906808|NCT01168401|11022964|FG007|STARTED|Overall Study||10
9906809|NCT01168401|11022965|FG008|STARTED|Overall Study||9
9906810|NCT01168401|11022966|FG009|STARTED|Overall Study||8
9906811|NCT01168401|11022967|FG010|STARTED|Overall Study||8
9906812|NCT01168401|11022957|FG000|COMPLETED|Overall Study||9
9906813|NCT01168401|11022958|FG001|COMPLETED|Overall Study||9
9906814|NCT01168401|11022959|FG002|COMPLETED|Overall Study||8
9906815|NCT01168401|11022960|FG003|COMPLETED|Overall Study||7
9906816|NCT01168401|11022961|FG004|COMPLETED|Overall Study||9
9906817|NCT01168401|11022962|FG005|COMPLETED|Overall Study||9
9906818|NCT01168401|11022963|FG006|COMPLETED|Overall Study||10
9906819|NCT01168401|11022964|FG007|COMPLETED|Overall Study||10
9906820|NCT01168401|11022965|FG008|COMPLETED|Overall Study||9
9906821|NCT01168401|11022966|FG009|COMPLETED|Overall Study||8
9906822|NCT01168401|11022967|FG010|COMPLETED|Overall Study||8
9906823|NCT01168401|11022957|FG000|NOT COMPLETED|Overall Study||1
9906824|NCT01168401|11022958|FG001|NOT COMPLETED|Overall Study||1
9906825|NCT01168401|11022959|FG002|NOT COMPLETED|Overall Study||2
9906826|NCT01168401|11022960|FG003|NOT COMPLETED|Overall Study||2
9906827|NCT01168401|11022961|FG004|NOT COMPLETED|Overall Study||0
9906828|NCT01168401|11022962|FG005|NOT COMPLETED|Overall Study||0
9906829|NCT01168401|11022963|FG006|NOT COMPLETED|Overall Study||0
9906830|NCT01168401|11022964|FG007|NOT COMPLETED|Overall Study||0
9906831|NCT01168401|11022965|FG008|NOT COMPLETED|Overall Study||0
9906832|NCT01168401|11022966|FG009|NOT COMPLETED|Overall Study||0
9906833|NCT01168401|11022967|FG010|NOT COMPLETED|Overall Study||0
9906834|NCT01168427|11022991|FG000|STARTED|Overall Study||66
9906835|NCT01168427|11022991|FG000|COMPLETED|Overall Study||65
9906836|NCT01168427|11022991|FG000|NOT COMPLETED|Overall Study||1
9906837|NCT01168596|11022997|FG000|STARTED|Overall Study||16
9906838|NCT01168596|11022998|FG001|STARTED|Overall Study||14
9906839|NCT01168596|11022997|FG000|COMPLETED|Overall Study||13
9906840|NCT01168596|11022998|FG001|COMPLETED|Overall Study||13
9906841|NCT01168596|11022997|FG000|NOT COMPLETED|Overall Study||3
9906842|NCT01168596|11022998|FG001|NOT COMPLETED|Overall Study||1
9906843|NCT01168674|11023004|FG000|STARTED|Overall Study||25
9906844|NCT01168674|11023005|FG001|STARTED|Overall Study||24
9906845|NCT01168674|11023004|FG000|COMPLETED|Overall Study||25
9906846|NCT01168674|11023005|FG001|COMPLETED|Overall Study||24
9906847|NCT01168674|11023004|FG000|NOT COMPLETED|Overall Study||0
9906848|NCT01168674|11023005|FG001|NOT COMPLETED|Overall Study||0
9906849|NCT01168687|11023014|FG000|STARTED|Overall Study||23
9906850|NCT01168687|11023015|FG001|STARTED|Overall Study||23
9906851|NCT01168687|11023014|FG000|COMPLETED|Overall Study||23
9906852|NCT01168687|11023015|FG001|COMPLETED|Overall Study||23
9906853|NCT01168687|11023014|FG000|NOT COMPLETED|Overall Study||0
9906854|NCT01168687|11023015|FG001|NOT COMPLETED|Overall Study||0
9906855|NCT01168726|11023024|FG000|STARTED|Overall Study||111
9906856|NCT01168726|11023025|FG001|STARTED|Overall Study||121
9906857|NCT01168726|11023026|FG002|STARTED|Overall Study||133
9906858|NCT01168726|11023024|FG000|COMPLETED|Overall Study||103
9906859|NCT01168726|11023025|FG001|COMPLETED|Overall Study||112
9906860|NCT01168726|11023026|FG002|COMPLETED|Overall Study||128
9906861|NCT01168726|11023024|FG000|NOT COMPLETED|Overall Study||8
9906862|NCT01168726|11023025|FG001|NOT COMPLETED|Overall Study||9
9906863|NCT01168726|11023026|FG002|NOT COMPLETED|Overall Study||5
9906864|NCT01168856|11023036|FG000|STARTED|Overall Study||176
9906865|NCT01168856|11023037|FG001|STARTED|Overall Study||558
9906866|NCT01168856|11023036|FG000|COMPLETED|Overall Study||158
9906867|NCT01168856|11023037|FG001|COMPLETED|Overall Study||215
9906868|NCT01168856|11023036|FG000|NOT COMPLETED|Overall Study||18
9906869|NCT01168856|11023037|FG001|NOT COMPLETED|Overall Study||343
9906870|NCT01168908|11023050|FG000|STARTED|Double Blind, Placebo Controlled||10
9906871|NCT01168908|11023051|FG001|STARTED|Double Blind, Placebo Controlled||10
9906872|NCT01168908|11023050|FG000|COMPLETED|Double Blind, Placebo Controlled||7
9906873|NCT01168908|11023051|FG001|COMPLETED|Double Blind, Placebo Controlled||8
9906874|NCT01168908|11023050|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3
9906875|NCT01168908|11023051|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2
9906876|NCT01168908|11023050|FG000|STARTED|Open Label||7
9906877|NCT01168908|11023051|FG001|STARTED|Open Label||8
9906878|NCT01168908|11023050|FG000|COMPLETED|Open Label||6
9906879|NCT01168908|11023051|FG001|COMPLETED|Open Label||7
9906880|NCT01168908|11023050|FG000|NOT COMPLETED|Open Label||1
9906881|NCT01168908|11023051|FG001|NOT COMPLETED|Open Label||1
9906882|NCT01168934|11023057|FG000|STARTED|First Intervention Period||7
9906883|NCT01168934|11023058|FG001|STARTED|First Intervention Period||7
9906884|NCT01168934|11023057|FG000|COMPLETED|First Intervention Period||7
9906885|NCT01168934|11023058|FG001|COMPLETED|First Intervention Period||7
9906886|NCT01168934|11023057|FG000|NOT COMPLETED|First Intervention Period||0
9906887|NCT01168934|11023058|FG001|NOT COMPLETED|First Intervention Period||0
9906888|NCT01168934|11023057|FG000|STARTED|Washout Period (at Least 14 Days)||7
9906889|NCT01168934|11023058|FG001|STARTED|Washout Period (at Least 14 Days)||7
9906890|NCT01168934|11023057|FG000|COMPLETED|Washout Period (at Least 14 Days)||7
9906891|NCT01168934|11023058|FG001|COMPLETED|Washout Period (at Least 14 Days)||7
9906892|NCT01168934|11023057|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9906893|NCT01168934|11023058|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9906894|NCT01168934|11023057|FG000|STARTED|Second Intervention Period||7
9906895|NCT01168934|11023058|FG001|STARTED|Second Intervention Period||7
9906896|NCT01168934|11023057|FG000|COMPLETED|Second Intervention Period||7
9906897|NCT01168934|11023058|FG001|COMPLETED|Second Intervention Period||7
9906898|NCT01168934|11023057|FG000|NOT COMPLETED|Second Intervention Period||0
9906899|NCT01168934|11023058|FG001|NOT COMPLETED|Second Intervention Period||0
9906900|NCT01168973|11023067|FG000|STARTED|Overall Study||628
9906901|NCT01168973|11023068|FG001|STARTED|Overall Study||625
9906902|NCT01168973|11023067|FG000|Received Any Quantity of Any Study Drug|Overall Study||624
9906903|NCT01168973|11023068|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
9906904|NCT01168973|11023067|FG000|COMPLETED|Overall Study||15
9906905|NCT01168973|11023068|FG001|COMPLETED|Overall Study||14
9906906|NCT01168973|11023067|FG000|NOT COMPLETED|Overall Study||613
9906907|NCT01168973|11023068|FG001|NOT COMPLETED|Overall Study||611
9906908|NCT01168986|11023077|FG000|STARTED|Overall Study||20
9906909|NCT01168986|11023078|FG001|STARTED|Overall Study||21
9906910|NCT01168986|11023079|FG002|STARTED|Overall Study||21
9906911|NCT01168986|11023077|FG000|COMPLETED|Overall Study||18
9906912|NCT01168986|11023078|FG001|COMPLETED|Overall Study||20
9906913|NCT01168986|11023079|FG002|COMPLETED|Overall Study||21
9906914|NCT01168986|11023077|FG000|NOT COMPLETED|Overall Study||2
9906915|NCT01168986|11023078|FG001|NOT COMPLETED|Overall Study||1
9906916|NCT01168986|11023079|FG002|NOT COMPLETED|Overall Study||0
9906917|NCT01168999|11023091|FG000|STARTED|Overall Study||28
9906918|NCT01168999|11023092|FG001|STARTED|Overall Study||27
9906919|NCT01168999|11023093|FG002|STARTED|Overall Study||27
9906920|NCT01168999|11023094|FG003|STARTED|Overall Study||28
9906921|NCT01168999|11023091|FG000|COMPLETED|Overall Study||26
9906922|NCT01168999|11023092|FG001|COMPLETED|Overall Study||26
9906923|NCT01168999|11023093|FG002|COMPLETED|Overall Study||27
9906924|NCT01168999|11023094|FG003|COMPLETED|Overall Study||28
9906925|NCT01168999|11023091|FG000|NOT COMPLETED|Overall Study||2
9906926|NCT01168999|11023092|FG001|NOT COMPLETED|Overall Study||1
9906927|NCT01168999|11023093|FG002|NOT COMPLETED|Overall Study||0
9906928|NCT01168999|11023094|FG003|NOT COMPLETED|Overall Study||0
9906929|NCT01169038|11023104|FG000|STARTED|Overall Study||15
9906930|NCT01169038|11023104|FG000|COMPLETED|Overall Study||8
9906931|NCT01169038|11023104|FG000|NOT COMPLETED|Overall Study||7
9906932|NCT01169064|11023110|FG000|STARTED|Overall Study||239
9906933|NCT01169064|11023111|FG001|STARTED|Overall Study||236
9906934|NCT01169064|11023110|FG000|COMPLETED|Overall Study||239
9906935|NCT01169064|11023111|FG001|COMPLETED|Overall Study||236
9906936|NCT01169064|11023110|FG000|NOT COMPLETED|Overall Study||0
9906937|NCT01169064|11023111|FG001|NOT COMPLETED|Overall Study||0
9906938|NCT01169103|11023121|FG000|STARTED|Overall Study||11
9906939|NCT01169103|11023122|FG001|STARTED|Overall Study||11
9906940|NCT01169103|11023121|FG000|COMPLETED|Overall Study||5
9906941|NCT01169103|11023122|FG001|COMPLETED|Overall Study||7
9906942|NCT01169103|11023121|FG000|NOT COMPLETED|Overall Study||6
9906943|NCT01169103|11023122|FG001|NOT COMPLETED|Overall Study||4
9906944|NCT01169311|11023128|FG000|STARTED|Overall Study||27
9906945|NCT01169311|11023128|FG000|COMPLETED|Overall Study||27
9906946|NCT01169311|11023128|FG000|NOT COMPLETED|Overall Study||0
9906947|NCT01169337|11023136|FG000|STARTED|Overall Study||44
9906948|NCT01169337|11023137|FG001|STARTED|Overall Study||90
9906949|NCT01169337|11023138|FG002|STARTED|Overall Study||92
9906950|NCT01169337|11023136|FG000|Received Treatment/Observation|Overall Study||44
9906951|NCT01169337|11023137|FG001|Received Treatment/Observation|Overall Study||88
9906952|NCT01169337|11023138|FG002|Received Treatment/Observation|Overall Study||86
9906953|NCT01169337|11023136|FG000|COMPLETED|Overall Study||0
9906954|NCT01169337|11023137|FG001|COMPLETED|Overall Study||0
9906955|NCT01169337|11023138|FG002|COMPLETED|Overall Study||86
9906956|NCT01169337|11023136|FG000|NOT COMPLETED|Overall Study||44
9906957|NCT01169337|11023137|FG001|NOT COMPLETED|Overall Study||90
9906958|NCT01169337|11023138|FG002|NOT COMPLETED|Overall Study||6
9906959|NCT01169350|11023146|FG000|STARTED|Overall Study||8
9906960|NCT01169350|11023146|FG000|COMPLETED|Overall Study||3
9906961|NCT01169350|11023146|FG000|NOT COMPLETED|Overall Study||5
9906962|NCT01169467|11023152|FG000|STARTED|Overall Study||44
9906963|NCT01169467|11023153|FG001|STARTED|Overall Study||40
9906964|NCT01169467|11023152|FG000|COMPLETED|Overall Study||37
9906965|NCT01169467|11023153|FG001|COMPLETED|Overall Study||36
9906966|NCT01169467|11023152|FG000|NOT COMPLETED|Overall Study||7
9906967|NCT01169467|11023153|FG001|NOT COMPLETED|Overall Study||4
9906968|NCT01169493|11023165|FG000|STARTED|Period 1 (6 Months)||2
9906969|NCT01169493|11023166|FG001|STARTED|Period 1 (6 Months)||4
9906970|NCT01169493|11023167|FG002|STARTED|Period 1 (6 Months)||5
9906971|NCT01169493|11023168|FG003|STARTED|Period 1 (6 Months)||0
9906972|NCT01169493|11023169|FG004|STARTED|Period 1 (6 Months)||0
9906973|NCT01169493|11023170|FG005|STARTED|Period 1 (6 Months)||5
9906974|NCT01169493|11023165|FG000|COMPLETED|Period 1 (6 Months)||2
9906975|NCT01169493|11023166|FG001|COMPLETED|Period 1 (6 Months)||3
9906976|NCT01169493|11023167|FG002|COMPLETED|Period 1 (6 Months)||3
9906977|NCT01169493|11023168|FG003|COMPLETED|Period 1 (6 Months)||0
9906978|NCT01169493|11023169|FG004|COMPLETED|Period 1 (6 Months)||0
9906979|NCT01169493|11023170|FG005|COMPLETED|Period 1 (6 Months)||2
9906980|NCT01169493|11023165|FG000|NOT COMPLETED|Period 1 (6 Months)||0
9906981|NCT01169493|11023166|FG001|NOT COMPLETED|Period 1 (6 Months)||1
9906982|NCT01169493|11023167|FG002|NOT COMPLETED|Period 1 (6 Months)||2
9906983|NCT01169493|11023168|FG003|NOT COMPLETED|Period 1 (6 Months)||0
9906984|NCT01169493|11023169|FG004|NOT COMPLETED|Period 1 (6 Months)||0
9906985|NCT01169493|11023170|FG005|NOT COMPLETED|Period 1 (6 Months)||3
9906986|NCT01169493|11023165|FG000|STARTED|Period 2 (6 Months)||2
9906987|NCT01169493|11023166|FG001|STARTED|Period 2 (6 Months)||3
9906988|NCT01169493|11023167|FG002|STARTED|Period 2 (6 Months)||3
9906989|NCT01169493|11023168|FG003|STARTED|Period 2 (6 Months)||0
9906990|NCT01169493|11023169|FG004|STARTED|Period 2 (6 Months)||0
9906991|NCT01169493|11023170|FG005|STARTED|Period 2 (6 Months)||2
9906992|NCT01169493|11023165|FG000|COMPLETED|Period 2 (6 Months)||2
9906993|NCT01169493|11023166|FG001|COMPLETED|Period 2 (6 Months)||3
9906994|NCT01169493|11023167|FG002|COMPLETED|Period 2 (6 Months)||3
9906995|NCT01169493|11023168|FG003|COMPLETED|Period 2 (6 Months)||0
9906996|NCT01169493|11023169|FG004|COMPLETED|Period 2 (6 Months)||0
9906997|NCT01169493|11023170|FG005|COMPLETED|Period 2 (6 Months)||2
9906998|NCT01169493|11023165|FG000|NOT COMPLETED|Period 2 (6 Months)||0
9906999|NCT01169493|11023166|FG001|NOT COMPLETED|Period 2 (6 Months)||0
9907000|NCT01169493|11023167|FG002|NOT COMPLETED|Period 2 (6 Months)||0
9907001|NCT01169493|11023168|FG003|NOT COMPLETED|Period 2 (6 Months)||0
9907002|NCT01169493|11023169|FG004|NOT COMPLETED|Period 2 (6 Months)||0
9907003|NCT01169493|11023170|FG005|NOT COMPLETED|Period 2 (6 Months)||0
9907004|NCT01169493|11023165|FG000|STARTED|Period 3 (6 Months)||2
9907005|NCT01169493|11023166|FG001|STARTED|Period 3 (6 Months)||3
9907006|NCT01169493|11023167|FG002|STARTED|Period 3 (6 Months)||3
9907007|NCT01169493|11023168|FG003|STARTED|Period 3 (6 Months)||0
9907008|NCT01169493|11023169|FG004|STARTED|Period 3 (6 Months)||0
9907009|NCT01169493|11023170|FG005|STARTED|Period 3 (6 Months)||2
9907010|NCT01169493|11023165|FG000|COMPLETED|Period 3 (6 Months)||2
9907011|NCT01169493|11023166|FG001|COMPLETED|Period 3 (6 Months)||1
9907012|NCT01169493|11023167|FG002|COMPLETED|Period 3 (6 Months)||2
9907013|NCT01169493|11023168|FG003|COMPLETED|Period 3 (6 Months)||0
9907014|NCT01169493|11023169|FG004|COMPLETED|Period 3 (6 Months)||0
9907015|NCT01169493|11023170|FG005|COMPLETED|Period 3 (6 Months)||2
9907016|NCT01169493|11023165|FG000|NOT COMPLETED|Period 3 (6 Months)||0
9907017|NCT01169493|11023166|FG001|NOT COMPLETED|Period 3 (6 Months)||2
9907018|NCT01169493|11023167|FG002|NOT COMPLETED|Period 3 (6 Months)||1
10203592|NCT03465878|11330526|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21
9907019|NCT01169493|11023168|FG003|NOT COMPLETED|Period 3 (6 Months)||0
9907020|NCT01169493|11023169|FG004|NOT COMPLETED|Period 3 (6 Months)||0
9907021|NCT01169493|11023170|FG005|NOT COMPLETED|Period 3 (6 Months)||0
9907022|NCT01169519|11023178|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
9907023|NCT01169519|11023178|FG000|COMPLETED|Overall Study||21
9907024|NCT01169519|11023178|FG000|NOT COMPLETED|Overall Study||0
9907025|NCT01169532|11023190|FG000|STARTED|Overall Study||16
9907026|NCT01169532|11023190|FG000|COMPLETED|Overall Study||15
9907027|NCT01169532|11023190|FG000|NOT COMPLETED|Overall Study||1
9907028|NCT01169558|11023194|FG000|STARTED|Overall Study||162
9907029|NCT01169558|11023194|FG000|COMPLETED|Overall Study||6
9907030|NCT01169558|11023194|FG000|NOT COMPLETED|Overall Study||156
9907031|NCT01169636|11023203|FG000|STARTED|Overall Study||3
9907032|NCT01169636|11023204|FG001|STARTED|Overall Study||6
9907033|NCT01169636|11023205|FG002|STARTED|Overall Study||20
9907034|NCT01169636|11023206|FG003|STARTED|Overall Study||13
9907035|NCT01169636|11023207|FG004|STARTED|Overall Study||14
9907036|NCT01169636|11023203|FG000|COMPLETED|Overall Study||3
9907037|NCT01169636|11023204|FG001|COMPLETED|Overall Study||6
9907038|NCT01169636|11023205|FG002|COMPLETED|Overall Study||17
9907039|NCT01169636|11023206|FG003|COMPLETED|Overall Study||12
9907040|NCT01169636|11023207|FG004|COMPLETED|Overall Study||11
9907041|NCT01169636|11023203|FG000|NOT COMPLETED|Overall Study||0
9907042|NCT01169636|11023204|FG001|NOT COMPLETED|Overall Study||0
9907043|NCT01169636|11023205|FG002|NOT COMPLETED|Overall Study||3
9907044|NCT01169636|11023206|FG003|NOT COMPLETED|Overall Study||1
9907045|NCT01169636|11023207|FG004|NOT COMPLETED|Overall Study||3
9907046|NCT01169649|11023217|FG000|STARTED|Overall Study||11
9907047|NCT01169649|11023217|FG000|COMPLETED|Overall Study||8
9907048|NCT01169649|11023217|FG000|NOT COMPLETED|Overall Study||3
9907049|NCT01169675|11023226|FG000|STARTED|Overall Study||20
9907050|NCT01169675|11023227|FG001|STARTED|Overall Study||3
9907051|NCT01169675|11023228|FG002|STARTED|Overall Study||7
9907052|NCT01169675|11023229|FG003|STARTED|Overall Study||17
9907053|NCT01169675|11023230|FG004|STARTED|Overall Study||6
9907054|NCT01169675|11023226|FG000|COMPLETED|Overall Study||0
9907055|NCT01169675|11023227|FG001|COMPLETED|Overall Study||0
9907056|NCT01169675|11023228|FG002|COMPLETED|Overall Study||0
9907057|NCT01169675|11023229|FG003|COMPLETED|Overall Study||0
9907058|NCT01169675|11023230|FG004|COMPLETED|Overall Study||0
9907059|NCT01169675|11023226|FG000|NOT COMPLETED|Overall Study||20
9907060|NCT01169675|11023227|FG001|NOT COMPLETED|Overall Study||3
9907061|NCT01169675|11023228|FG002|NOT COMPLETED|Overall Study||7
9907062|NCT01169675|11023229|FG003|NOT COMPLETED|Overall Study||17
9907063|NCT01169675|11023230|FG004|NOT COMPLETED|Overall Study||6
9907064|NCT01169701|11023244|FG000|STARTED|Overall Study||36
9907065|NCT01169701|11023245|FG001|STARTED|Overall Study||35
9907066|NCT01169701|11023244|FG000|Safety Set|Overall Study||36
9907067|NCT01169701|11023245|FG001|Safety Set|Overall Study||35
9907068|NCT01169701|11023244|FG000|Intent to Treat (ITT) Set|Overall Study||32
9907069|NCT01169701|11023245|FG001|Intent to Treat (ITT) Set|Overall Study||28
9907070|NCT01169701|11023244|FG000|COMPLETED|Overall Study||31
9907071|NCT01169701|11023245|FG001|COMPLETED|Overall Study||25
9907072|NCT01169701|11023244|FG000|NOT COMPLETED|Overall Study||5
9907073|NCT01169701|11023245|FG001|NOT COMPLETED|Overall Study||10
9907074|NCT01169779|11023253|FG000|STARTED|Overall Study|Randomized.|195
9907075|NCT01169779|11023254|FG001|STARTED|Overall Study||196
9907076|NCT01169779|11023253|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
9907077|NCT01169779|11023254|FG001|Treated/Safety Population|Overall Study||196
9907078|NCT01169779|11023253|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
10238734|NCT00484718|11370192|FG005|COMPLETED|Washout Period (2 Weeks)||1
9907079|NCT01169779|11023254|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195
9907080|NCT01169779|11023253|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
9907081|NCT01169779|11023254|FG001|Subgroup for Standardized Meal Test|Overall Study||121
9907082|NCT01169779|11023253|FG000|COMPLETED|Overall Study||184
9907083|NCT01169779|11023254|FG001|COMPLETED|Overall Study||179
9907084|NCT01169779|11023253|FG000|NOT COMPLETED|Overall Study||11
9907085|NCT01169779|11023254|FG001|NOT COMPLETED|Overall Study||17
9907086|NCT01169844|11023262|FG000|STARTED|Overall Study||19
9907087|NCT01169844|11023263|FG001|STARTED|Overall Study||9
9907088|NCT01169844|11023262|FG000|COMPLETED|Overall Study||14
9907089|NCT01169844|11023263|FG001|COMPLETED|Overall Study||8
9907090|NCT01169844|11023262|FG000|NOT COMPLETED|Overall Study||5
9907091|NCT01169844|11023263|FG001|NOT COMPLETED|Overall Study||1
9907092|NCT01169987|11023269|FG000|STARTED|Overall Study||191
9907093|NCT01169987|11023269|FG000|COMPLETED|Overall Study||160
9907094|NCT01169987|11023269|FG000|NOT COMPLETED|Overall Study||31
9907095|NCT01170039|11023281|FG000|STARTED|Overall Study||37
9907096|NCT01170039|11023282|FG001|STARTED|Overall Study||39
9907097|NCT01170039|11023281|FG000|COMPLETED|Overall Study||29
9907098|NCT01170039|11023282|FG001|COMPLETED|Overall Study||33
9907099|NCT01170039|11023281|FG000|NOT COMPLETED|Overall Study||8
9907100|NCT01170039|11023282|FG001|NOT COMPLETED|Overall Study||6
9907101|NCT01170065|11023291|FG000|STARTED|Overall Study||37
9907102|NCT01170065|11023292|FG001|STARTED|Overall Study||126
9907103|NCT01170065|11023293|FG002|STARTED|Overall Study||35
9907104|NCT01170065|11023291|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
9907105|NCT01170065|11023292|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
9907106|NCT01170065|11023293|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
9907107|NCT01170065|11023291|FG000|NOT COMPLETED|Overall Study||28
9907108|NCT01170065|11023292|FG001|NOT COMPLETED|Overall Study||92
9907109|NCT01170065|11023293|FG002|NOT COMPLETED|Overall Study||26
9907110|NCT01170091|11023301|FG000|STARTED|Overall Study||651
9907111|NCT01170091|11023301|FG000|COMPLETED|Overall Study||627
9907112|NCT01170091|11023301|FG000|NOT COMPLETED|Overall Study||24
9907113|NCT01170117|11023307|FG000|STARTED|Overall Study||77
9907114|NCT01170117|11023308|FG001|STARTED|Overall Study||75
9907115|NCT01170117|11023307|FG000|COMPLETED|Overall Study||47
9907116|NCT01170117|11023308|FG001|COMPLETED|Overall Study||55
9907117|NCT01170117|11023307|FG000|NOT COMPLETED|Overall Study||30
9907118|NCT01170117|11023308|FG001|NOT COMPLETED|Overall Study||20
9907119|NCT01170208|11023317|FG000|STARTED|Overall Study||20
9907120|NCT01170208|11023318|FG001|STARTED|Overall Study||20
9907121|NCT01170208|11023319|FG002|STARTED|Overall Study||6
9907122|NCT01170208|11023317|FG000|COMPLETED|Overall Study||14
9907123|NCT01170208|11023318|FG001|COMPLETED|Overall Study||20
9907124|NCT01170208|11023319|FG002|COMPLETED|Overall Study||4
9907125|NCT01170208|11023317|FG000|NOT COMPLETED|Overall Study||6
9907126|NCT01170208|11023318|FG001|NOT COMPLETED|Overall Study||0
9907127|NCT01170208|11023319|FG002|NOT COMPLETED|Overall Study||2
9907128|NCT01170221|11023332|FG000|STARTED|Overall Study||332
9907129|NCT01170221|11023333|FG001|STARTED|Overall Study||335
9907130|NCT01170221|11023332|FG000|COMPLETED|Overall Study||299
9907131|NCT01170221|11023333|FG001|COMPLETED|Overall Study||307
9907132|NCT01170221|11023332|FG000|NOT COMPLETED|Overall Study||33
9907133|NCT01170221|11023333|FG001|NOT COMPLETED|Overall Study||28
9955240|NCT01436643|11074155|FG001|STARTED|2-week Pre-treatment||0
9955241|NCT01436643|11074156|FG002|STARTED|2-week Pre-treatment||0
9955242|NCT01436643|11074157|FG003|STARTED|2-week Pre-treatment||54
9955243|NCT01436643|11074154|FG000|COMPLETED|2-week Pre-treatment||0
9955244|NCT01436643|11074155|FG001|COMPLETED|2-week Pre-treatment||0
9955245|NCT01436643|11074156|FG002|COMPLETED|2-week Pre-treatment||0
9955246|NCT01436643|11074157|FG003|COMPLETED|2-week Pre-treatment||44
9955247|NCT01436643|11074154|FG000|NOT COMPLETED|2-week Pre-treatment||0
9955248|NCT01436643|11074155|FG001|NOT COMPLETED|2-week Pre-treatment||0
9955249|NCT01436643|11074156|FG002|NOT COMPLETED|2-week Pre-treatment||0
9955250|NCT01436643|11074157|FG003|NOT COMPLETED|2-week Pre-treatment||10
9955251|NCT01436643|11074154|FG000|STARTED|Core Phase (16 Weeks)||17
9955252|NCT01436643|11074155|FG001|STARTED|Core Phase (16 Weeks)||15
9955253|NCT01436643|11074156|FG002|STARTED|Core Phase (16 Weeks)||20
9955254|NCT01436643|11074157|FG003|STARTED|Core Phase (16 Weeks)||0
9955255|NCT01436643|11074154|FG000|COMPLETED|Core Phase (16 Weeks)||16
9955256|NCT01436643|11074155|FG001|COMPLETED|Core Phase (16 Weeks)||11
9955257|NCT01436643|11074156|FG002|COMPLETED|Core Phase (16 Weeks)||17
9955258|NCT01436643|11074157|FG003|COMPLETED|Core Phase (16 Weeks)||0
9955259|NCT01436643|11074154|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1
9955260|NCT01436643|11074155|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4
9955261|NCT01436643|11074156|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3
9955262|NCT01436643|11074157|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0
9955263|NCT01436799|11074169|FG000|STARTED|Overall Study||20
9955264|NCT01436799|11074170|FG001|STARTED|Overall Study||20
9955265|NCT01436799|11074169|FG000|COMPLETED|Overall Study||20
9955266|NCT01436799|11074170|FG001|COMPLETED|Overall Study||20
9955267|NCT01436799|11074169|FG000|NOT COMPLETED|Overall Study||0
9955268|NCT01436799|11074170|FG001|NOT COMPLETED|Overall Study||0
9955269|NCT01437098|11074176|FG000|STARTED|Overall Study||55
9955270|NCT01437098|11074176|FG000|30 Days|Overall Study||51
9955271|NCT01437098|11074176|FG000|6 Months|Overall Study||47
9955272|NCT01437098|11074176|FG000|12 Months|Overall Study||45
9907134|NCT01170247|11023341|FG000|STARTED|Overall Study||2
9907135|NCT01170247|11023342|FG001|STARTED|Overall Study||1
9907136|NCT01170247|11023341|FG000|COMPLETED|Overall Study||2
9907137|NCT01170247|11023342|FG001|COMPLETED|Overall Study||1
9907138|NCT01170247|11023341|FG000|NOT COMPLETED|Overall Study||0
9907139|NCT01170247|11023342|FG001|NOT COMPLETED|Overall Study||0
9907140|NCT01170273|11023350|FG000|STARTED|Overall Study||64
9907141|NCT01170273|11023351|FG001|STARTED|Overall Study||66
9907142|NCT01170273|11023350|FG000|COMPLETED|Overall Study||56
9907143|NCT01170273|11023351|FG001|COMPLETED|Overall Study||57
9907144|NCT01170273|11023350|FG000|NOT COMPLETED|Overall Study||8
9907145|NCT01170273|11023351|FG001|NOT COMPLETED|Overall Study||9
9907146|NCT01170364|11023359|FG000|STARTED|Overall Study||8
9907147|NCT01170364|11023360|FG001|STARTED|Overall Study||6
9907148|NCT01170364|11023359|FG000|COMPLETED|Overall Study||4
9907149|NCT01170364|11023360|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
9907150|NCT01170364|11023359|FG000|NOT COMPLETED|Overall Study||4
9907151|NCT01170364|11023360|FG001|NOT COMPLETED|Overall Study||1
9907152|NCT01170390|11023368|FG000|STARTED|Oral Contraceptives||32
9907153|NCT01170390|11023369|FG001|STARTED|Oral Contraceptives||0
9907154|NCT01170390|11023370|FG002|STARTED|Oral Contraceptives||0
9907155|NCT01170390|11023368|FG000|COMPLETED|Oral Contraceptives||31
9907156|NCT01170390|11023369|FG001|COMPLETED|Oral Contraceptives||0
9907157|NCT01170390|11023370|FG002|COMPLETED|Oral Contraceptives||0
9907158|NCT01170390|11023368|FG000|NOT COMPLETED|Oral Contraceptives||1
9907159|NCT01170390|11023369|FG001|NOT COMPLETED|Oral Contraceptives||0
9907160|NCT01170390|11023370|FG002|NOT COMPLETED|Oral Contraceptives||0
9907161|NCT01170390|11023368|FG000|STARTED|Randomized Treatment||0
9907162|NCT01170390|11023369|FG001|STARTED|Randomized Treatment||17
9907163|NCT01170390|11023370|FG002|STARTED|Randomized Treatment||15
10203593|NCT03465878|11330527|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20
10203594|NCT03465878|11330528|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0
10203595|NCT03465878|11330529|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0
9907164|NCT01170390|11023368|FG000|COMPLETED|Randomized Treatment||0
9907165|NCT01170390|11023369|FG001|COMPLETED|Randomized Treatment||16
9907166|NCT01170390|11023370|FG002|COMPLETED|Randomized Treatment||15
9907167|NCT01170390|11023368|FG000|NOT COMPLETED|Randomized Treatment||0
9907168|NCT01170390|11023369|FG001|NOT COMPLETED|Randomized Treatment||1
9907169|NCT01170390|11023370|FG002|NOT COMPLETED|Randomized Treatment||0
9907170|NCT01170533|11023378|FG000|STARTED|Omeprazole Cross-over||20
9907171|NCT01170533|11023379|FG001|STARTED|Omeprazole Cross-over||0
9907172|NCT01170533|11023378|FG000|COMPLETED|Omeprazole Cross-over||20
9907173|NCT01170533|11023379|FG001|COMPLETED|Omeprazole Cross-over||0
9907174|NCT01170533|11023378|FG000|NOT COMPLETED|Omeprazole Cross-over||0
9907175|NCT01170533|11023379|FG001|NOT COMPLETED|Omeprazole Cross-over||0
9907176|NCT01170533|11023378|FG000|STARTED|Pantoprazole Cross-over||0
9907177|NCT01170533|11023379|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
9907178|NCT01170533|11023378|FG000|COMPLETED|Pantoprazole Cross-over||0
9907179|NCT01170533|11023379|FG001|COMPLETED|Pantoprazole Cross-over||20
9907180|NCT01170533|11023378|FG000|NOT COMPLETED|Pantoprazole Cross-over||0
9907181|NCT01170533|11023379|FG001|NOT COMPLETED|Pantoprazole Cross-over||0
9907182|NCT01170546|11023393|FG000|STARTED|Overall Study||7
9907183|NCT01170546|11023394|FG001|STARTED|Overall Study||7
9907184|NCT01170546|11023395|FG002|STARTED|Overall Study||6
9907185|NCT01170546|11023396|FG003|STARTED|Overall Study||8
9907186|NCT01170546|11023393|FG000|COMPLETED|Overall Study||7
9907187|NCT01170546|11023394|FG001|COMPLETED|Overall Study||7
9907188|NCT01170546|11023395|FG002|COMPLETED|Overall Study||6
9907189|NCT01170546|11023396|FG003|COMPLETED|Overall Study||8
9907190|NCT01170546|11023393|FG000|NOT COMPLETED|Overall Study||0
9907191|NCT01170546|11023394|FG001|NOT COMPLETED|Overall Study||0
9907192|NCT01170546|11023395|FG002|NOT COMPLETED|Overall Study||0
9907193|NCT01170546|11023396|FG003|NOT COMPLETED|Overall Study||0
9907194|NCT01170598|11023406|FG000|STARTED|Overall Study||35
9907195|NCT01170598|11023406|FG000|COMPLETED|Overall Study||29
9907196|NCT01170598|11023406|FG000|NOT COMPLETED|Overall Study||6
9907197|NCT01170663|11023412|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
9907198|NCT01170663|11023413|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
9907199|NCT01170663|11023412|FG000|Received Any Treatment (Safety Pop)|Overall Study||327
9907200|NCT01170663|11023413|FG001|Received Any Treatment (Safety Pop)|Overall Study||329
9907201|NCT01170663|11023412|FG000|COMPLETED|Overall Study||316
9907202|NCT01170663|11023413|FG001|COMPLETED|Overall Study||315
9907203|NCT01170663|11023412|FG000|NOT COMPLETED|Overall Study||14
9907204|NCT01170663|11023413|FG001|NOT COMPLETED|Overall Study||20
9907205|NCT01170715|11023419|FG000|STARTED|Overall Study||21
9907206|NCT01170715|11023419|FG000|COMPLETED|Overall Study||14
9907207|NCT01170715|11023419|FG000|NOT COMPLETED|Overall Study||7
9907208|NCT01170754|11023425|FG000|STARTED|Overall Study||66
9907209|NCT01170754|11023426|FG001|STARTED|Overall Study||70
9907210|NCT01170754|11023425|FG000|COMPLETED|Overall Study||66
9907211|NCT01170754|11023426|FG001|COMPLETED|Overall Study||70
9907212|NCT01170754|11023425|FG000|NOT COMPLETED|Overall Study||0
9907213|NCT01170754|11023426|FG001|NOT COMPLETED|Overall Study||0
9907214|NCT01170884|11023436|FG000|STARTED|Overall Study||59
10238735|NCT00484718|11370187|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
9907215|NCT01170884|11023437|FG001|STARTED|Overall Study||62
9907216|NCT01170884|11023436|FG000|COMPLETED|Overall Study||54
9907217|NCT01170884|11023437|FG001|COMPLETED|Overall Study||60
9907218|NCT01170884|11023436|FG000|NOT COMPLETED|Overall Study||5
9907219|NCT01170884|11023437|FG001|NOT COMPLETED|Overall Study||2
9907220|NCT01170949|11023445|FG000|STARTED|Overall Study||50
9907221|NCT01170949|11023446|FG001|STARTED|Overall Study||26
9907222|NCT01170949|11023445|FG000|COMPLETED|Overall Study||43
9907223|NCT01170949|11023446|FG001|COMPLETED|Overall Study||22
9907224|NCT01170949|11023445|FG000|NOT COMPLETED|Overall Study||7
9907225|NCT01170949|11023446|FG001|NOT COMPLETED|Overall Study||4
9907226|NCT01170962|11023455|FG000|STARTED|Treatment Period||203
9907227|NCT01170962|11023456|FG001|STARTED|Treatment Period||199
9907228|NCT01170962|11023457|FG002|STARTED|Treatment Period||17
9907229|NCT01170962|11023455|FG000|No PDR|Treatment Period||145
9907230|NCT01170962|11023456|FG001|No PDR|Treatment Period||127
9907231|NCT01170962|11023457|FG002|No PDR|Treatment Period||17
9907232|NCT01170962|11023455|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
9907233|NCT01170962|11023456|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
9907234|NCT01170962|11023457|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
9907235|NCT01170962|11023455|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
9907236|NCT01170962|11023456|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
9907237|NCT01170962|11023457|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
9907238|NCT01170962|11023455|FG000|COMPLETED|Treatment Period||76
9907239|NCT01170962|11023456|FG001|COMPLETED|Treatment Period||88
9907240|NCT01170962|11023457|FG002|COMPLETED|Treatment Period||5
9907241|NCT01170962|11023455|FG000|NOT COMPLETED|Treatment Period||127
9907242|NCT01170962|11023456|FG001|NOT COMPLETED|Treatment Period||111
9907243|NCT01170962|11023457|FG002|NOT COMPLETED|Treatment Period||12
9907244|NCT01170962|11023455|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
9907245|NCT01170962|11023456|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
9907246|NCT01170962|11023457|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
9907247|NCT01170962|11023455|FG000|COMPLETED|Follow up Period||159
9907248|NCT01170962|11023456|FG001|COMPLETED|Follow up Period||165
9907249|NCT01170962|11023457|FG002|COMPLETED|Follow up Period||9
9907250|NCT01170962|11023455|FG000|NOT COMPLETED|Follow up Period||39
9907251|NCT01170962|11023456|FG001|NOT COMPLETED|Follow up Period||27
9907252|NCT01170962|11023457|FG002|NOT COMPLETED|Follow up Period||6
9907253|NCT01171118|11023474|FG000|STARTED|Overall Study||10
9907254|NCT01171118|11023474|FG000|COMPLETED|Overall Study||10
9907255|NCT01171118|11023474|FG000|NOT COMPLETED|Overall Study||0
9907256|NCT01171183|11023486|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
9907257|NCT01171183|11023487|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
9907258|NCT01171183|11023486|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13
9907259|NCT01171183|11023487|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10
9907260|NCT01171183|11023486|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
9907261|NCT01171183|11023487|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
9907262|NCT01171183|11023486|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
9907263|NCT01171183|11023487|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
9907264|NCT01171183|11023486|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2
9907265|NCT01171183|11023487|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4
9907266|NCT01171183|11023486|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
9907267|NCT01171183|11023487|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
9907268|NCT01171521|11023493|FG000|STARTED|Overall Study||6
9907269|NCT01171521|11023493|FG000|COMPLETED|Overall Study||0
9907270|NCT01171521|11023493|FG000|NOT COMPLETED|Overall Study||6
9907271|NCT01171612|11023497|FG000|STARTED|Overall Study||483
9907272|NCT01171612|11023497|FG000|COMPLETED|Overall Study||432
9907273|NCT01171612|11023497|FG000|NOT COMPLETED|Overall Study||51
9907274|NCT01171625|11023504|FG000|STARTED|Overall Study||283
9907275|NCT01171625|11023504|FG000|Subjects Implanted With Device|Overall Study||258
9907276|NCT01171625|11023504|FG000|COMPLETED|Overall Study||103
9907277|NCT01171625|11023504|FG000|NOT COMPLETED|Overall Study||180
9907278|NCT01171677|11023518|FG000|STARTED|Overall Study||17
9907279|NCT01171677|11023519|FG001|STARTED|Overall Study||15
9907280|NCT01171677|11023518|FG000|COMPLETED|Overall Study||11
9907281|NCT01171677|11023519|FG001|COMPLETED|Overall Study||12
9907282|NCT01171677|11023518|FG000|NOT COMPLETED|Overall Study||6
9907283|NCT01171677|11023519|FG001|NOT COMPLETED|Overall Study||3
9907284|NCT01171690|11023527|FG000|STARTED|Overall Study||5
9907285|NCT01171690|11023528|FG001|STARTED|Overall Study||5
9907286|NCT01171690|11023527|FG000|COMPLETED|Overall Study||5
9907287|NCT01171690|11023528|FG001|COMPLETED|Overall Study||5
9907288|NCT01171690|11023527|FG000|NOT COMPLETED|Overall Study||0
9907289|NCT01171690|11023528|FG001|NOT COMPLETED|Overall Study||0
9907290|NCT01171794|11023536|FG000|STARTED|Overall Study||47
9907291|NCT01171794|11023537|FG001|STARTED|Overall Study||42
9907292|NCT01171794|11023536|FG000|COMPLETED|Overall Study||44
9907293|NCT01171794|11023537|FG001|COMPLETED|Overall Study||42
9907294|NCT01171794|11023536|FG000|NOT COMPLETED|Overall Study||3
9907295|NCT01171794|11023537|FG001|NOT COMPLETED|Overall Study||0
9907296|NCT01171820|11023545|FG000|STARTED|Overall Study||106
9907297|NCT01171820|11023546|FG001|STARTED|Overall Study||218
9907298|NCT01171820|11023545|FG000|COMPLETED|Overall Study||100
9907299|NCT01171820|11023546|FG001|COMPLETED|Overall Study||212
9907300|NCT01171820|11023545|FG000|NOT COMPLETED|Overall Study||6
9907301|NCT01171820|11023546|FG001|NOT COMPLETED|Overall Study||6
9907302|NCT01171924|11023554|FG000|STARTED|Overall Study||23
9907303|NCT01171924|11023555|FG001|STARTED|Overall Study||23
9907304|NCT01171924|11023554|FG000|COMPLETED|Overall Study||0
9907305|NCT01171924|11023555|FG001|COMPLETED|Overall Study||0
9907306|NCT01171924|11023554|FG000|NOT COMPLETED|Overall Study||23
9907307|NCT01171924|11023555|FG001|NOT COMPLETED|Overall Study||23
9907308|NCT01171963|11023563|FG000|STARTED|Overall Study||1666
9907309|NCT01171963|11023564|FG001|STARTED|Overall Study||1667
9907310|NCT01171963|11023563|FG000|COMPLETED|Overall Study||1518
9907311|NCT01171963|11023564|FG001|COMPLETED|Overall Study||1499
9907312|NCT01171963|11023563|FG000|NOT COMPLETED|Overall Study||148
9907313|NCT01171963|11023564|FG001|NOT COMPLETED|Overall Study||168
9907314|NCT01171976|11023576|FG000|STARTED|Overall Study||121
9907315|NCT01171976|11023577|FG001|STARTED|Overall Study||128
9907316|NCT01171976|11023578|FG002|STARTED|Overall Study||123
9907317|NCT01171976|11023576|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
9907318|NCT01171976|11023577|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
9907319|NCT01171976|11023578|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
9907320|NCT01171976|11023576|FG000|COMPLETED|Overall Study||107
9907321|NCT01171976|11023577|FG001|COMPLETED|Overall Study||117
9907322|NCT01171976|11023578|FG002|COMPLETED|Overall Study||108
9907323|NCT01171976|11023576|FG000|NOT COMPLETED|Overall Study||14
9907324|NCT01171976|11023577|FG001|NOT COMPLETED|Overall Study||11
9907325|NCT01171976|11023578|FG002|NOT COMPLETED|Overall Study||15
9907326|NCT01171989|11023589|FG000|STARTED|Overall Study||137
9907327|NCT01171989|11023590|FG001|STARTED|Overall Study||133
9907328|NCT01171989|11023591|FG002|STARTED|Overall Study||121
9907329|NCT01171989|11023589|FG000|COMPLETED|Overall Study||137
9907330|NCT01171989|11023590|FG001|COMPLETED|Overall Study||133
9907331|NCT01171989|11023591|FG002|COMPLETED|Overall Study||120
9907332|NCT01171989|11023589|FG000|NOT COMPLETED|Overall Study||0
9907333|NCT01171989|11023590|FG001|NOT COMPLETED|Overall Study||0
9907334|NCT01171989|11023591|FG002|NOT COMPLETED|Overall Study||1
9907335|NCT01172067|11023601|FG000|STARTED|Overall Study||200
9907336|NCT01172067|11023602|FG001|STARTED|Overall Study||200
9907337|NCT01172067|11023601|FG000|COMPLETED|Overall Study||153
9907338|NCT01172067|11023602|FG001|COMPLETED|Overall Study||163
9907339|NCT01172067|11023601|FG000|NOT COMPLETED|Overall Study||47
9907340|NCT01172067|11023602|FG001|NOT COMPLETED|Overall Study||37
9907341|NCT01172145|11023610|FG000|STARTED|Overall Study||11
9907342|NCT01172145|11023611|FG001|STARTED|Overall Study||11
9907343|NCT01172145|11023610|FG000|COMPLETED|Overall Study||11
9907344|NCT01172145|11023611|FG001|COMPLETED|Overall Study||11
9907345|NCT01172145|11023610|FG000|NOT COMPLETED|Overall Study||0
9907346|NCT01172145|11023611|FG001|NOT COMPLETED|Overall Study||0
9907347|NCT01172184|11023617|FG000|STARTED|Overall Study||111
9907348|NCT01172184|11023617|FG000|COMPLETED|Overall Study||111
9907349|NCT01172184|11023617|FG000|NOT COMPLETED|Overall Study||0
9907350|NCT01172197|11023623|FG000|STARTED|Overall Study||7
9907351|NCT01172197|11023624|FG001|STARTED|Overall Study||7
9907352|NCT01172197|11023623|FG000|COMPLETED|Overall Study||7
9907353|NCT01172197|11023624|FG001|COMPLETED|Overall Study||7
9907354|NCT01172197|11023623|FG000|NOT COMPLETED|Overall Study||0
9907355|NCT01172197|11023624|FG001|NOT COMPLETED|Overall Study||0
9907356|NCT01172275|11023632|FG000|STARTED|Overall Study||5
9907357|NCT01172275|11023633|FG001|STARTED|Overall Study||6
9907358|NCT01172275|11023632|FG000|COMPLETED|Overall Study||3
9907359|NCT01172275|11023633|FG001|COMPLETED|Overall Study||6
9907360|NCT01172275|11023632|FG000|NOT COMPLETED|Overall Study||2
9907361|NCT01172275|11023633|FG001|NOT COMPLETED|Overall Study||0
9907362|NCT01172288|11023641|FG000|STARTED|Overall Study||17
9907363|NCT01172288|11023642|FG001|STARTED|Overall Study||14
9907364|NCT01172288|11023641|FG000|COMPLETED|Overall Study||16
9907365|NCT01172288|11023642|FG001|COMPLETED|Overall Study||13
9907366|NCT01172288|11023641|FG000|NOT COMPLETED|Overall Study||1
9907367|NCT01172288|11023642|FG001|NOT COMPLETED|Overall Study||1
9907368|NCT01172353|11023650|FG000|STARTED|Overall Study||150
9907369|NCT01172353|11023651|FG001|STARTED|Overall Study||151
9907370|NCT01172353|11023650|FG000|COMPLETED|Overall Study||150
9907371|NCT01172353|11023651|FG001|COMPLETED|Overall Study||151
9907372|NCT01172353|11023650|FG000|NOT COMPLETED|Overall Study||0
9907373|NCT01172353|11023651|FG001|NOT COMPLETED|Overall Study||0
9907374|NCT01172418|11023659|FG000|STARTED|Overall Study||100
9907375|NCT01172418|11023660|FG001|STARTED|Overall Study||100
9907376|NCT01172418|11023659|FG000|COMPLETED|Overall Study||100
9907377|NCT01172418|11023660|FG001|COMPLETED|Overall Study||100
9907378|NCT01172418|11023659|FG000|NOT COMPLETED|Overall Study||0
9907379|NCT01172418|11023660|FG001|NOT COMPLETED|Overall Study||0
9907380|NCT01172522|11023670|FG000|STARTED|Overall Study||15
9907381|NCT01172522|11023671|FG001|STARTED|Overall Study||15
9907382|NCT01172522|11023670|FG000|COMPLETED|Overall Study||15
9907383|NCT01172522|11023671|FG001|COMPLETED|Overall Study||15
9907384|NCT01172522|11023670|FG000|NOT COMPLETED|Overall Study||0
10009602|NCT01767467|11132235|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266
10009603|NCT01767467|11132236|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259
10009604|NCT01767467|11132235|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
10009605|NCT01767467|11132236|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
10009606|NCT01767467|11132235|FG000|STARTED|End of Study Phase (up to Month 13)||283
10009607|NCT01767467|11132236|FG001|STARTED|End of Study Phase (up to Month 13)||279
10009608|NCT01767467|11132235|FG000|COMPLETED|End of Study Phase (up to Month 13)||236
10009609|NCT01767467|11132236|FG001|COMPLETED|End of Study Phase (up to Month 13)||216
10009610|NCT01767467|11132235|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47
10009611|NCT01767467|11132236|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63
10009612|NCT01767493|11132249|FG000|STARTED|Overall Study||19
10009613|NCT01767493|11132249|FG000|COMPLETED|Overall Study||16
10009614|NCT01767493|11132249|FG000|NOT COMPLETED|Overall Study||3
10009615|NCT01767506|11132255|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|
10009616|NCT01767506|11132256|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|
10009617|NCT01767506|11132255|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|
10009618|NCT01767506|11132256|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|
10009619|NCT01767506|11132255|FG000|NOT COMPLETED|Overall Study||
10009620|NCT01767506|11132256|FG001|NOT COMPLETED|Overall Study||
10009621|NCT01767519|11132265|FG000|STARTED|Overall Study||145
10009622|NCT01767519|11132266|FG001|STARTED|Overall Study||151
10009623|NCT01767519|11132267|FG002|STARTED|Overall Study||60
10009624|NCT01767519|11132265|FG000|COMPLETED|Overall Study||131
10009625|NCT01767519|11132266|FG001|COMPLETED|Overall Study||138
10009626|NCT01767519|11132267|FG002|COMPLETED|Overall Study||55
10009627|NCT01767519|11132265|FG000|NOT COMPLETED|Overall Study||14
10009628|NCT01767519|11132266|FG001|NOT COMPLETED|Overall Study||13
10009629|NCT01767519|11132267|FG002|NOT COMPLETED|Overall Study||5
10009630|NCT01767597|11132277|FG000|STARTED|Overall Study||500
10009631|NCT01767597|11132278|FG001|STARTED|Overall Study||500
9907385|NCT01172522|11023671|FG001|NOT COMPLETED|Overall Study||0
9907386|NCT01172535|11023676|FG000|STARTED|Overall Study||97
9907387|NCT01172535|11023676|FG000|COMPLETED|Overall Study||89
9907388|NCT01172535|11023676|FG000|NOT COMPLETED|Overall Study||8
9907389|NCT01172600|11023685|FG000|STARTED|Overall Study||39
9907390|NCT01172600|11023686|FG001|STARTED|Overall Study||39
9907391|NCT01172600|11023685|FG000|COMPLETED|Overall Study||39
9907392|NCT01172600|11023686|FG001|COMPLETED|Overall Study||39
9907393|NCT01172600|11023685|FG000|NOT COMPLETED|Overall Study||0
9907394|NCT01172600|11023686|FG001|NOT COMPLETED|Overall Study||0
9907395|NCT01172639|11023697|FG000|STARTED|Overall Study||98
9907396|NCT01172639|11023698|FG001|STARTED|Overall Study||98
9907397|NCT01172639|11023699|FG002|STARTED|Overall Study||93
9907398|NCT01172639|11023700|FG003|STARTED|Overall Study||43
9907399|NCT01172639|11023701|FG004|STARTED|Overall Study||47
9907400|NCT01172639|11023697|FG000|Week 16|Overall Study||94
9907401|NCT01172639|11023698|FG001|Week 16|Overall Study||96
9907402|NCT01172639|11023699|FG002|Week 16|Overall Study||91
9907403|NCT01172639|11023700|FG003|Week 16|Overall Study||39
9907404|NCT01172639|11023701|FG004|Week 16|Overall Study||47
9907405|NCT01172639|11023697|FG000|Week 52|Overall Study||89
9907406|NCT01172639|11023698|FG001|Week 52|Overall Study||89
9907407|NCT01172639|11023699|FG002|Week 52|Overall Study||88
9907408|NCT01172639|11023700|FG003|Week 52|Overall Study||38
9907409|NCT01172639|11023701|FG004|Week 52|Overall Study||45
9907410|NCT01172639|11023697|FG000|COMPLETED|Overall Study||85
9907411|NCT01172639|11023698|FG001|COMPLETED|Overall Study||87
9907412|NCT01172639|11023699|FG002|COMPLETED|Overall Study||77
9907413|NCT01172639|11023700|FG003|COMPLETED|Overall Study||32
9907414|NCT01172639|11023701|FG004|COMPLETED|Overall Study||41
9907415|NCT01172639|11023697|FG000|NOT COMPLETED|Overall Study||13
9907416|NCT01172639|11023698|FG001|NOT COMPLETED|Overall Study||11
9907417|NCT01172639|11023699|FG002|NOT COMPLETED|Overall Study||16
9907418|NCT01172639|11023700|FG003|NOT COMPLETED|Overall Study||11
10009632|NCT01767597|11132277|FG000|COMPLETED|Overall Study||496
9907419|NCT01172639|11023701|FG004|NOT COMPLETED|Overall Study||6
9907420|NCT01172808|11023717|FG000|STARTED|Overall Study|Entered and Treated|269
9907421|NCT01172808|11023718|FG001|STARTED|Overall Study|Entered and Treated|262
9907422|NCT01172808|11023719|FG002|STARTED|Overall Study|Entered and Treated|264
9907423|NCT01172808|11023720|FG003|STARTED|Overall Study|Entered and Treated|275
9907424|NCT01172808|11023717|FG000|COMPLETED|Overall Study||248
9907425|NCT01172808|11023718|FG001|COMPLETED|Overall Study||249
9907426|NCT01172808|11023719|FG002|COMPLETED|Overall Study||241
9907427|NCT01172808|11023720|FG003|COMPLETED|Overall Study||260
9907428|NCT01172808|11023717|FG000|NOT COMPLETED|Overall Study||21
9907429|NCT01172808|11023718|FG001|NOT COMPLETED|Overall Study||13
9907430|NCT01172808|11023719|FG002|NOT COMPLETED|Overall Study||23
9907431|NCT01172808|11023720|FG003|NOT COMPLETED|Overall Study||15
9907432|NCT01172821|11023734|FG000|STARTED|Overall Study|Entered and Treated|254
9907433|NCT01172821|11023735|FG001|STARTED|Overall Study|Entered and Treated|257
9907434|NCT01172821|11023736|FG002|STARTED|Overall Study|Entered and Treated|253
10009633|NCT01767597|11132278|FG001|COMPLETED|Overall Study||499
10009634|NCT01767597|11132277|FG000|NOT COMPLETED|Overall Study||4
9907435|NCT01172821|11023737|FG003|STARTED|Overall Study|Entered and Treated|266
9907436|NCT01172821|11023734|FG000|COMPLETED|Overall Study||240
9907437|NCT01172821|11023735|FG001|COMPLETED|Overall Study||245
9907438|NCT01172821|11023736|FG002|COMPLETED|Overall Study||240
9907439|NCT01172821|11023737|FG003|COMPLETED|Overall Study||249
9907440|NCT01172821|11023734|FG000|NOT COMPLETED|Overall Study||14
9907441|NCT01172821|11023735|FG001|NOT COMPLETED|Overall Study||12
9907442|NCT01172821|11023736|FG002|NOT COMPLETED|Overall Study||13
9907443|NCT01172821|11023737|FG003|NOT COMPLETED|Overall Study||17
9907444|NCT01172847|11023747|FG000|STARTED|Overall Study||24
9907445|NCT01172847|11023747|FG000|Oseltamivir|Overall Study||24
9907446|NCT01172847|11023747|FG000|Rimantadine|Overall Study||22
9907447|NCT01172847|11023747|FG000|Oseltamivir + Rimantadine|Overall Study||21
9907448|NCT01172847|11023747|FG000|COMPLETED|Overall Study||21
9907449|NCT01172847|11023747|FG000|NOT COMPLETED|Overall Study||3
9907450|NCT01172873|11023759|FG000|STARTED|Overall Study||11
9907451|NCT01172873|11023760|FG001|STARTED|Overall Study||5
9907452|NCT01172873|11023759|FG000|COMPLETED|Overall Study||8
9907453|NCT01172873|11023760|FG001|COMPLETED|Overall Study||3
10009635|NCT01767597|11132278|FG001|NOT COMPLETED|Overall Study||1
10009636|NCT01767636|11132284|FG000|STARTED|Overall Study||38
10009637|NCT01767636|11132284|FG000|COMPLETED|Overall Study||35
10009638|NCT01767636|11132284|FG000|NOT COMPLETED|Overall Study||3
10009639|NCT01767688|11132290|FG000|STARTED|Overall Study||8
10009640|NCT01767688|11132291|FG001|STARTED|Overall Study||8
9907454|NCT01172873|11023759|FG000|NOT COMPLETED|Overall Study||3
9907455|NCT01172873|11023760|FG001|NOT COMPLETED|Overall Study||2
9907456|NCT01172938|11023769|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168
9907457|NCT01172938|11023770|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168
9907458|NCT01172938|11023771|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168
10203596|NCT03465878|11330526|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
10203597|NCT03465878|11330527|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
10203598|NCT03465878|11330528|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
10203599|NCT03465878|11330529|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
10203600|NCT03465878|11330526|FG000|STARTED|Period2-Part A Second Intervention Day 1||21
10203601|NCT03465878|11330527|FG001|STARTED|Period2-Part A Second Intervention Day 1||20
10203602|NCT03465878|11330528|FG002|STARTED|Period2-Part A Second Intervention Day 1||0
10203603|NCT03465878|11330529|FG003|STARTED|Period2-Part A Second Intervention Day 1||0
10203604|NCT03465878|11330526|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
10203605|NCT03465878|11330527|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
9907459|NCT01172938|11023772|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
9907460|NCT01172938|11023773|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
9907461|NCT01172938|11023774|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
9907462|NCT01172938|11023775|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
9907463|NCT01172938|11023776|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
9907464|NCT01172938|11023777|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
9907465|NCT01172938|11023769|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
9907466|NCT01172938|11023770|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
9907467|NCT01172938|11023771|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
9907468|NCT01172938|11023772|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9907469|NCT01172938|11023773|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9907470|NCT01172938|11023774|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9907471|NCT01172938|11023775|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9907472|NCT01172938|11023776|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9907473|NCT01172938|11023777|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
9907474|NCT01172938|11023769|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
9907475|NCT01172938|11023770|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
9907476|NCT01172938|11023771|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
9907477|NCT01172938|11023772|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9907478|NCT01172938|11023773|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9907479|NCT01172938|11023774|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9907480|NCT01172938|11023775|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9907481|NCT01172938|11023776|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9907482|NCT01172938|11023777|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
9907483|NCT01172938|11023769|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
9907484|NCT01172938|11023770|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
9907485|NCT01172938|11023771|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
9907486|NCT01172938|11023772|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9907487|NCT01172938|11023773|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9907488|NCT01172938|11023774|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9907489|NCT01172938|11023775|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9907490|NCT01172938|11023776|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9907491|NCT01172938|11023777|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
9907492|NCT01172938|11023769|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
10009641|NCT01767688|11132290|FG000|COMPLETED|Overall Study||8
10009642|NCT01767688|11132291|FG001|COMPLETED|Overall Study||8
10203606|NCT03465878|11330528|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
9907493|NCT01172938|11023770|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
9907494|NCT01172938|11023771|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
9907495|NCT01172938|11023772|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907496|NCT01172938|11023773|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907497|NCT01172938|11023774|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907498|NCT01172938|11023775|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907499|NCT01172938|11023776|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907500|NCT01172938|11023777|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907501|NCT01172938|11023769|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
9907502|NCT01172938|11023770|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
9907503|NCT01172938|11023771|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
9907504|NCT01172938|11023772|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907505|NCT01172938|11023773|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907506|NCT01172938|11023774|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907507|NCT01172938|11023775|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907508|NCT01172938|11023776|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907509|NCT01172938|11023777|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
9907510|NCT01172938|11023769|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0
9907511|NCT01172938|11023770|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
9907512|NCT01172938|11023771|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
9907513|NCT01172938|11023772|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
9907514|NCT01172938|11023773|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23
9907515|NCT01172938|11023774|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
9907516|NCT01172938|11023775|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24
9907517|NCT01172938|11023776|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0
9907518|NCT01172938|11023777|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0
9907519|NCT01172938|11023769|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
9907520|NCT01172938|11023770|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
9907521|NCT01172938|11023771|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
9907522|NCT01172938|11023772|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
9907523|NCT01172938|11023773|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
9907524|NCT01172938|11023774|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
9907525|NCT01172938|11023775|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
9907526|NCT01172938|11023776|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
9907527|NCT01172938|11023777|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
9907528|NCT01172938|11023769|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
9907529|NCT01172938|11023770|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
9907530|NCT01172938|11023771|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
9907531|NCT01172938|11023772|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
9907532|NCT01172938|11023773|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
9907533|NCT01172938|11023774|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
9907534|NCT01172938|11023775|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
9907535|NCT01172938|11023776|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
9907536|NCT01172938|11023777|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
9907537|NCT01172938|11023769|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0
9907538|NCT01172938|11023770|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
9907539|NCT01172938|11023771|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
9907540|NCT01172938|11023772|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0
9907541|NCT01172938|11023773|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0
9907542|NCT01172938|11023774|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0
9907543|NCT01172938|11023775|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0
9907544|NCT01172938|11023776|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61
9907545|NCT01172938|11023777|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49
9907546|NCT01172938|11023769|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907547|NCT01172938|11023770|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
9907548|NCT01172938|11023771|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
9907549|NCT01172938|11023772|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907550|NCT01172938|11023773|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907551|NCT01172938|11023774|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907552|NCT01172938|11023775|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907553|NCT01172938|11023776|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
9907554|NCT01172938|11023777|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
9907555|NCT01172938|11023769|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907556|NCT01172938|11023770|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
9907557|NCT01172938|11023771|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
9907558|NCT01172938|11023772|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907559|NCT01172938|11023773|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9955273|NCT01437098|11074176|FG000|24 Months|Overall Study||42
10203607|NCT03465878|11330529|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
10203608|NCT03465878|11330526|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
10203609|NCT03465878|11330527|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
9907560|NCT01172938|11023774|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907561|NCT01172938|11023775|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
9907562|NCT01172938|11023776|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
9907563|NCT01172938|11023777|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
9907564|NCT01172938|11023769|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0
9907565|NCT01172938|11023770|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95
9907566|NCT01172938|11023771|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100
9907567|NCT01172938|11023772|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0
9907568|NCT01172938|11023773|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0
9907569|NCT01172938|11023774|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0
9907570|NCT01172938|11023775|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0
9907571|NCT01172938|11023776|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46
9907572|NCT01172938|11023777|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45
9907573|NCT01172938|11023769|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907574|NCT01172938|11023770|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
9907575|NCT01172938|11023771|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
9907576|NCT01172938|11023772|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907577|NCT01172938|11023773|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907578|NCT01172938|11023774|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907579|NCT01172938|11023775|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907580|NCT01172938|11023776|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
9907581|NCT01172938|11023777|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
9907582|NCT01172938|11023769|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907583|NCT01172938|11023770|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
9907584|NCT01172938|11023771|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
9907585|NCT01172938|11023772|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907586|NCT01172938|11023773|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907587|NCT01172938|11023774|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907588|NCT01172938|11023775|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
9907589|NCT01172938|11023776|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
9907590|NCT01172938|11023777|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
9907591|NCT01172938|11023769|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0
9907592|NCT01172938|11023770|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84
9907593|NCT01172938|11023771|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93
9907594|NCT01172938|11023772|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0
9907595|NCT01172938|11023773|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0
10203610|NCT03465878|11330528|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
10203611|NCT03465878|11330529|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
10203612|NCT03465878|11330526|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
10203613|NCT03465878|11330527|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
10203614|NCT03465878|11330528|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
10203615|NCT03465878|11330529|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
10203616|NCT03465878|11330526|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21
10203617|NCT03465878|11330527|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20
9907596|NCT01172938|11023774|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0
9907597|NCT01172938|11023775|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0
9907598|NCT01172938|11023776|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41
9907599|NCT01172938|11023777|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41
9907600|NCT01172938|11023769|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907601|NCT01172938|11023770|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
9907602|NCT01172938|11023771|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
9907603|NCT01172938|11023772|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907604|NCT01172938|11023773|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907605|NCT01172938|11023774|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907606|NCT01172938|11023775|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907607|NCT01172938|11023776|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
9907608|NCT01172938|11023777|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
9907609|NCT01172938|11023769|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907610|NCT01172938|11023770|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
9907611|NCT01172938|11023771|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
9907612|NCT01172938|11023772|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907613|NCT01172938|11023773|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907614|NCT01172938|11023774|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907615|NCT01172938|11023775|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
9907616|NCT01172938|11023776|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
10203618|NCT03465878|11330528|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0
9907617|NCT01172938|11023777|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
9907618|NCT01172938|11023769|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0
9907619|NCT01172938|11023770|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75
9907620|NCT01172938|11023771|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88
9907621|NCT01172938|11023772|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0
9907622|NCT01172938|11023773|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0
9907623|NCT01172938|11023774|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0
9907624|NCT01172938|11023775|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0
9907625|NCT01172938|11023776|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32
9907626|NCT01172938|11023777|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34
9907627|NCT01172938|11023769|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907628|NCT01172938|11023770|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907629|NCT01172938|11023771|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907630|NCT01172938|11023772|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907631|NCT01172938|11023773|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907632|NCT01172938|11023774|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907633|NCT01172938|11023775|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907634|NCT01172938|11023776|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
9907635|NCT01172938|11023777|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
9907636|NCT01172938|11023769|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907637|NCT01172938|11023770|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
9907638|NCT01172938|11023771|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
9907639|NCT01172938|11023772|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907640|NCT01172938|11023773|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907641|NCT01172938|11023774|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907642|NCT01172938|11023775|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907643|NCT01172938|11023776|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
9907644|NCT01172938|11023777|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
9907645|NCT01172938|11023769|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907646|NCT01172938|11023770|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
9907647|NCT01172938|11023771|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
9907648|NCT01172938|11023772|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907649|NCT01172938|11023773|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907650|NCT01172938|11023774|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
9907651|NCT01172938|11023775|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10009643|NCT01767688|11132290|FG000|NOT COMPLETED|Overall Study||0
10009644|NCT01767688|11132291|FG001|NOT COMPLETED|Overall Study||0
10009645|NCT01767701|11132297|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
10009646|NCT01767701|11132297|FG000|COMPLETED|Overall Study||20
10009647|NCT01767701|11132297|FG000|NOT COMPLETED|Overall Study||0
10009648|NCT01767792|11132302|FG000|STARTED|Overall Study||22
10009649|NCT01767792|11132302|FG000|COMPLETED|Overall Study||20
10009650|NCT01767792|11132302|FG000|NOT COMPLETED|Overall Study||2
10009651|NCT01767857|11132309|FG000|STARTED|Overall Study||430
10009652|NCT01767857|11132310|FG001|STARTED|Overall Study||213
10009653|NCT01767857|11132309|FG000|Treated|Overall Study||411
9907652|NCT01172938|11023776|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
9907653|NCT01172938|11023777|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
9907654|NCT01173016|11023795|FG000|STARTED|Overall Study||11
9907655|NCT01173016|11023795|FG000|COMPLETED|Overall Study||10
9907656|NCT01173016|11023795|FG000|NOT COMPLETED|Overall Study||1
9907657|NCT01173029|11023801|FG000|STARTED|Overall Study||61
9907658|NCT01173029|11023802|FG001|STARTED|Overall Study||31
9907659|NCT01173029|11023801|FG000|COMPLETED|Overall Study||61
9907660|NCT01173029|11023802|FG001|COMPLETED|Overall Study||31
9907661|NCT01173029|11023801|FG000|NOT COMPLETED|Overall Study||0
9907662|NCT01173029|11023802|FG001|NOT COMPLETED|Overall Study||0
9907663|NCT01173055|11023819|FG000|STARTED|Period 1 - Day 1 to 49||10
9907664|NCT01173055|11023820|FG001|STARTED|Period 1 - Day 1 to 49||12
9907665|NCT01173055|11023819|FG000|COMPLETED|Period 1 - Day 1 to 49||8
9907666|NCT01173055|11023820|FG001|COMPLETED|Period 1 - Day 1 to 49||10
9907667|NCT01173055|11023819|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2
9907668|NCT01173055|11023820|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2
9907669|NCT01173055|11023819|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8
9907670|NCT01173055|11023820|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10
9907671|NCT01173055|11023819|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8
9907672|NCT01173055|11023820|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10
9907673|NCT01173055|11023819|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
9907674|NCT01173055|11023820|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
9907675|NCT01173055|11023819|FG000|STARTED|Period 2 - Day 64 to 112||8
9907676|NCT01173055|11023820|FG001|STARTED|Period 2 - Day 64 to 112||10
9907677|NCT01173055|11023819|FG000|COMPLETED|Period 2 - Day 64 to 112||8
9907678|NCT01173055|11023820|FG001|COMPLETED|Period 2 - Day 64 to 112||9
9907679|NCT01173055|11023819|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0
9907680|NCT01173055|11023820|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1
9907681|NCT01173120|11023826|FG000|STARTED|Overall Study||62
9907682|NCT01173120|11023826|FG000|Switched Back to Main Study|Overall Study||57
10009654|NCT01767857|11132310|FG001|Treated|Overall Study||200
10009655|NCT01767857|11132309|FG000|COMPLETED|Overall Study||0
9907683|NCT01173120|11023826|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5
9907684|NCT01173120|11023826|FG000|COMPLETED|Overall Study||0
9907685|NCT01173120|11023826|FG000|NOT COMPLETED|Overall Study||62
9907686|NCT01173159|11023832|FG000|STARTED|Overall Study||10
9907687|NCT01173159|11023832|FG000|COMPLETED|Overall Study||10
9907688|NCT01173159|11023832|FG000|NOT COMPLETED|Overall Study||0
9907689|NCT01173211|11023842|FG000|STARTED|Overall Study||48
9907690|NCT01173211|11023843|FG001|STARTED|Overall Study||45
9907691|NCT01173211|11023844|FG002|STARTED|Overall Study||46
9907692|NCT01173211|11023845|FG003|STARTED|Overall Study||15
9907693|NCT01173211|11023846|FG004|STARTED|Overall Study||16
9907694|NCT01173211|11023847|FG005|STARTED|Overall Study||13
9907695|NCT01173211|11023842|FG000|COMPLETED|Overall Study||46
9907696|NCT01173211|11023843|FG001|COMPLETED|Overall Study||44
9907697|NCT01173211|11023844|FG002|COMPLETED|Overall Study||44
9907698|NCT01173211|11023845|FG003|COMPLETED|Overall Study||15
9907699|NCT01173211|11023846|FG004|COMPLETED|Overall Study||16
9907700|NCT01173211|11023847|FG005|COMPLETED|Overall Study||13
9907701|NCT01173211|11023842|FG000|NOT COMPLETED|Overall Study||2
9907702|NCT01173211|11023843|FG001|NOT COMPLETED|Overall Study||1
9907703|NCT01173211|11023844|FG002|NOT COMPLETED|Overall Study||2
9907704|NCT01173211|11023845|FG003|NOT COMPLETED|Overall Study||0
9907705|NCT01173211|11023846|FG004|NOT COMPLETED|Overall Study||0
9907706|NCT01173211|11023847|FG005|NOT COMPLETED|Overall Study||0
9907707|NCT01173471|11023865|FG000|STARTED|Overall Study|Randomized|6
9907708|NCT01173471|11023866|FG001|STARTED|Overall Study|Randomized|7
9907709|NCT01173471|11023867|FG002|STARTED|Overall Study|Randomized|18
9907710|NCT01173471|11023868|FG003|STARTED|Overall Study|Randomized|19
9907711|NCT01173471|11023865|FG000|Received Treatment|Overall Study||6
9907712|NCT01173471|11023866|FG001|Received Treatment|Overall Study||7
9907713|NCT01173471|11023867|FG002|Received Treatment|Overall Study||18
10009656|NCT01767857|11132310|FG001|COMPLETED|Overall Study||0
10009657|NCT01767857|11132309|FG000|NOT COMPLETED|Overall Study||430
10009658|NCT01767857|11132310|FG001|NOT COMPLETED|Overall Study||213
10009659|NCT01767909|11132319|FG000|STARTED|Overall Study||121
10009660|NCT01767909|11132320|FG001|STARTED|Overall Study||119
9907714|NCT01173471|11023868|FG003|Received Treatment|Overall Study||19
9907715|NCT01173471|11023865|FG000|Completed Treatment|Overall Study||4
9907716|NCT01173471|11023866|FG001|Completed Treatment|Overall Study||7
9907717|NCT01173471|11023867|FG002|Completed Treatment|Overall Study||15
9907718|NCT01173471|11023868|FG003|Completed Treatment|Overall Study||18
9907719|NCT01173471|11023865|FG000|COMPLETED|Overall Study|Completed study|4
9907720|NCT01173471|11023866|FG001|COMPLETED|Overall Study|Completed study|7
9907721|NCT01173471|11023867|FG002|COMPLETED|Overall Study|Completed study|15
9907722|NCT01173471|11023868|FG003|COMPLETED|Overall Study|Completed study|18
9907723|NCT01173471|11023865|FG000|NOT COMPLETED|Overall Study||2
9907724|NCT01173471|11023866|FG001|NOT COMPLETED|Overall Study||0
9907725|NCT01173471|11023867|FG002|NOT COMPLETED|Overall Study||3
9907726|NCT01173471|11023868|FG003|NOT COMPLETED|Overall Study||1
9907727|NCT01173523|11023880|FG000|STARTED|Overall Study||13
9907728|NCT01173523|11023881|FG001|STARTED|Overall Study||12
9907729|NCT01173523|11023880|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
9907730|NCT01173523|11023881|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
9907731|NCT01173523|11023880|FG000|NOT COMPLETED|Overall Study||13
9907732|NCT01173523|11023881|FG001|NOT COMPLETED|Overall Study||12
9907733|NCT01173601|11023891|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
9907734|NCT01173601|11023892|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9907735|NCT01173601|11023893|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9907736|NCT01173601|11023894|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9907737|NCT01173601|11023895|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9907738|NCT01173601|11023891|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
9907739|NCT01173601|11023892|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
9907740|NCT01173601|11023893|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
9907741|NCT01173601|11023894|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
9907742|NCT01173601|11023895|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
9907743|NCT01173601|11023891|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
9907744|NCT01173601|11023892|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907745|NCT01173601|11023893|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907746|NCT01173601|11023894|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907747|NCT01173601|11023895|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907748|NCT01173601|11023891|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
9907749|NCT01173601|11023892|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907750|NCT01173601|11023893|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907751|NCT01173601|11023894|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907752|NCT01173601|11023895|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9907753|NCT01173601|11023891|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9907754|NCT01173601|11023892|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
9907755|NCT01173601|11023893|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
9907756|NCT01173601|11023894|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
10009661|NCT01767909|11132319|FG000|COMPLETED|Overall Study||108
10009662|NCT01767909|11132320|FG001|COMPLETED|Overall Study||107
9907757|NCT01173601|11023895|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
9907758|NCT01173601|11023891|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9907759|NCT01173601|11023892|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
9907760|NCT01173601|11023893|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
9907761|NCT01173601|11023894|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9907762|NCT01173601|11023895|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9907763|NCT01173601|11023891|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9907764|NCT01173601|11023892|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
9907765|NCT01173601|11023893|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
9907766|NCT01173601|11023894|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
9907767|NCT01173601|11023895|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
9907768|NCT01173601|11023891|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9907769|NCT01173601|11023892|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
9907770|NCT01173601|11023893|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
9907771|NCT01173601|11023894|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
9907772|NCT01173601|11023895|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
9907773|NCT01173601|11023891|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9907774|NCT01173601|11023892|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
9907775|NCT01173601|11023893|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
9907776|NCT01173601|11023894|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
9907777|NCT01173601|11023895|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
9907778|NCT01173653|11023915|FG000|STARTED|Overall Study||109
9907779|NCT01173653|11023916|FG001|STARTED|Overall Study||90
9907780|NCT01173653|11023915|FG000|COMPLETED|Overall Study||56
9907781|NCT01173653|11023916|FG001|COMPLETED|Overall Study||49
9907782|NCT01173653|11023915|FG000|NOT COMPLETED|Overall Study||53
9907783|NCT01173653|11023916|FG001|NOT COMPLETED|Overall Study||41
9907784|NCT01173679|11023922|FG000|STARTED|Overall Study||10
9907785|NCT01173679|11023922|FG000|COMPLETED|Overall Study||9
9907786|NCT01173679|11023922|FG000|NOT COMPLETED|Overall Study||1
9907787|NCT01173692|11023929|FG000|STARTED|Overall Study||22
9907788|NCT01173692|11023930|FG001|STARTED|Overall Study||25
9907789|NCT01173692|11023929|FG000|COMPLETED|Overall Study||20
9907790|NCT01173692|11023930|FG001|COMPLETED|Overall Study||20
9907791|NCT01173692|11023929|FG000|NOT COMPLETED|Overall Study||2
9907792|NCT01173692|11023930|FG001|NOT COMPLETED|Overall Study||5
9907793|NCT01173718|11023936|FG000|STARTED|Overall Study||138
9907794|NCT01173718|11023936|FG000|COMPLETED|Overall Study||94
9907795|NCT01173718|11023936|FG000|NOT COMPLETED|Overall Study||44
9907796|NCT01173848|11023942|FG000|STARTED|Overall Study||8
9907797|NCT01173848|11023943|FG001|STARTED|Overall Study||11
9907798|NCT01173848|11023942|FG000|COMPLETED|Overall Study||4
9907799|NCT01173848|11023943|FG001|COMPLETED|Overall Study||3
9907800|NCT01173848|11023942|FG000|NOT COMPLETED|Overall Study||4
9907801|NCT01173848|11023943|FG001|NOT COMPLETED|Overall Study||8
9907802|NCT01173874|11023950|FG000|STARTED|Overall Study||56
9907803|NCT01173874|11023951|FG001|STARTED|Overall Study||64
9907804|NCT01173874|11023950|FG000|COMPLETED|Overall Study||33
9907805|NCT01173874|11023951|FG001|COMPLETED|Overall Study||41
9907806|NCT01173874|11023950|FG000|NOT COMPLETED|Overall Study||23
9907807|NCT01173874|11023951|FG001|NOT COMPLETED|Overall Study||23
9907808|NCT01174004|11023959|FG000|STARTED|Overall Study||94
9907809|NCT01174004|11023960|FG001|STARTED|Overall Study||105
9907810|NCT01174004|11023959|FG000|COMPLETED|Overall Study||87
9907811|NCT01174004|11023960|FG001|COMPLETED|Overall Study||89
9907812|NCT01174004|11023959|FG000|NOT COMPLETED|Overall Study||7
9907813|NCT01174004|11023960|FG001|NOT COMPLETED|Overall Study||16
9907814|NCT01174030|11023971|FG000|STARTED|Overall Study||53
9907815|NCT01174030|11023972|FG001|STARTED|Overall Study||54
9907816|NCT01174030|11023973|FG002|STARTED|Overall Study||54
9907817|NCT01174030|11023974|FG003|STARTED|Overall Study||55
9907818|NCT01174030|11023975|FG004|STARTED|Overall Study||53
9907819|NCT01174030|11023971|FG000|COMPLETED|Overall Study||51
9907820|NCT01174030|11023972|FG001|COMPLETED|Overall Study||52
9907821|NCT01174030|11023973|FG002|COMPLETED|Overall Study||52
9907822|NCT01174030|11023974|FG003|COMPLETED|Overall Study||53
9907823|NCT01174030|11023975|FG004|COMPLETED|Overall Study||52
9907824|NCT01174030|11023971|FG000|NOT COMPLETED|Overall Study||2
9907825|NCT01174030|11023972|FG001|NOT COMPLETED|Overall Study||2
9907826|NCT01174030|11023973|FG002|NOT COMPLETED|Overall Study||2
9907827|NCT01174030|11023974|FG003|NOT COMPLETED|Overall Study||2
9907828|NCT01174030|11023975|FG004|NOT COMPLETED|Overall Study||1
9907829|NCT01174043|11023987|FG000|STARTED|Overall Study||11
9907830|NCT01174043|11023987|FG000|COMPLETED|Overall Study||0
9907831|NCT01174043|11023987|FG000|NOT COMPLETED|Overall Study||11
9907832|NCT01174082|11023993|FG000|STARTED|Overall Study||1
9907833|NCT01174082|11023994|FG001|STARTED|Overall Study||1
9907834|NCT01174082|11023993|FG000|COMPLETED|Overall Study||1
9907835|NCT01174082|11023994|FG001|COMPLETED|Overall Study||1
9907836|NCT01174082|11023993|FG000|NOT COMPLETED|Overall Study||0
9907837|NCT01174082|11023994|FG001|NOT COMPLETED|Overall Study||0
9907838|NCT01174160|11024002|FG000|STARTED|Overall Study||61
9907839|NCT01174160|11024003|FG001|STARTED|Overall Study||62
9907840|NCT01174160|11024002|FG000|Discontinued Pre Dose|Overall Study||6
9907841|NCT01174160|11024003|FG001|Discontinued Pre Dose|Overall Study||6
9907842|NCT01174160|11024002|FG000|Dosed|Overall Study||55
9907843|NCT01174160|11024003|FG001|Dosed|Overall Study||56
9907844|NCT01174160|11024002|FG000|Discontinued Post Dose|Overall Study||2
9907845|NCT01174160|11024003|FG001|Discontinued Post Dose|Overall Study||0
9907846|NCT01174160|11024002|FG000|COMPLETED|Overall Study||53
9907847|NCT01174160|11024003|FG001|COMPLETED|Overall Study||56
9907848|NCT01174160|11024002|FG000|NOT COMPLETED|Overall Study||8
9907849|NCT01174160|11024003|FG001|NOT COMPLETED|Overall Study||6
9907850|NCT01174173|11024009|FG000|STARTED|Overall Study||11
10111170|NCT02493868|11242213|FG000|STARTED|Follow-up Phase||481
10111171|NCT02493868|11242214|FG001|STARTED|Follow-up Phase||64
10111172|NCT02493868|11242213|FG000|COMPLETED|Follow-up Phase||470
10111173|NCT02493868|11242214|FG001|COMPLETED|Follow-up Phase||62
10111174|NCT02493868|11242213|FG000|NOT COMPLETED|Follow-up Phase||11
9907851|NCT01174173|11024009|FG000|COMPLETED|Overall Study||10
9907852|NCT01174173|11024009|FG000|NOT COMPLETED|Overall Study||1
9907853|NCT01174186|11024016|FG000|STARTED|Overall Study|Patients were included over three years|15
9907854|NCT01174186|11024017|FG001|STARTED|Overall Study||15
9907855|NCT01174186|11024016|FG000|COMPLETED|Overall Study||15
9907856|NCT01174186|11024017|FG001|COMPLETED|Overall Study||12
9907857|NCT01174186|11024016|FG000|NOT COMPLETED|Overall Study||0
9907858|NCT01174186|11024017|FG001|NOT COMPLETED|Overall Study||3
9907859|NCT01174238|11024023|FG000|STARTED|Overall Study||38
10009663|NCT01767909|11132319|FG000|NOT COMPLETED|Overall Study||13
10009664|NCT01767909|11132320|FG001|NOT COMPLETED|Overall Study||12
10009665|NCT01767935|11132328|FG000|STARTED|Overall Study||1
9907860|NCT01174238|11024023|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6
9907861|NCT01174238|11024023|FG000|COMPLETED|Overall Study||36
9907862|NCT01174238|11024023|FG000|NOT COMPLETED|Overall Study||2
9907863|NCT01174264|11024033|FG000|STARTED|Single Dose Pharmacokinetics||23
9907864|NCT01174264|11024034|FG001|STARTED|Single Dose Pharmacokinetics||20
9907865|NCT01174264|11024035|FG002|STARTED|Single Dose Pharmacokinetics||20
9907866|NCT01174264|11024033|FG000|COMPLETED|Single Dose Pharmacokinetics||22
9907867|NCT01174264|11024034|FG001|COMPLETED|Single Dose Pharmacokinetics||20
9907868|NCT01174264|11024035|FG002|COMPLETED|Single Dose Pharmacokinetics||18
9907869|NCT01174264|11024033|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1
9907870|NCT01174264|11024034|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0
9907871|NCT01174264|11024035|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2
9907872|NCT01174264|11024033|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
9907873|NCT01174264|11024034|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
9907874|NCT01174264|11024035|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
9907875|NCT01174264|11024033|FG000|COMPLETED|Steady-state Pharmacokinetics||25
9907876|NCT01174264|11024034|FG001|COMPLETED|Steady-state Pharmacokinetics||0
9907877|NCT01174264|11024035|FG002|COMPLETED|Steady-state Pharmacokinetics||27
9907878|NCT01174264|11024033|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6
9907879|NCT01174264|11024034|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0
9907880|NCT01174264|11024035|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2
9907881|NCT01174342|11024043|FG000|STARTED|Overall Study||30
9907882|NCT01174342|11024043|FG000|COMPLETED|Overall Study||26
9907883|NCT01174342|11024043|FG000|NOT COMPLETED|Overall Study||4
9907884|NCT01174446|11024047|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14
9907885|NCT01174446|11024048|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14
9907886|NCT01174446|11024049|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0
9907887|NCT01174446|11024050|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0
9907888|NCT01174446|11024047|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
9907889|NCT01174446|11024048|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
9907890|NCT01174446|11024049|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
9907891|NCT01174446|11024050|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
9907892|NCT01174446|11024047|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
9907893|NCT01174446|11024048|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
9907894|NCT01174446|11024049|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
9907895|NCT01174446|11024050|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
9907896|NCT01174446|11024047|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
9955274|NCT01437098|11074176|FG000|36 Months|Overall Study||36
10009666|NCT01767935|11132328|FG000|COMPLETED|Overall Study||1
10009667|NCT01767935|11132328|FG000|NOT COMPLETED|Overall Study||0
10009668|NCT01767987|11132334|FG000|STARTED|Overall Study||4
10009669|NCT01767987|11132335|FG001|STARTED|Overall Study||2
10009670|NCT01767987|11132334|FG000|COMPLETED|Overall Study||0
10009671|NCT01767987|11132335|FG001|COMPLETED|Overall Study||1
10111175|NCT02493868|11242214|FG001|NOT COMPLETED|Follow-up Phase||2
10111176|NCT02493946|11242229|FG000|STARTED|DB Period||126
10111177|NCT02493946|11242230|FG001|STARTED|DB Period||64
9907897|NCT01174446|11024048|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
9907898|NCT01174446|11024049|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
9907899|NCT01174446|11024050|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
9907900|NCT01174446|11024047|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
9907901|NCT01174446|11024048|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
9907902|NCT01174446|11024049|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
9907903|NCT01174446|11024050|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
9907904|NCT01174446|11024047|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
9907905|NCT01174446|11024048|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
9907906|NCT01174446|11024049|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
9907907|NCT01174446|11024050|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
9907908|NCT01174446|11024047|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
9907909|NCT01174446|11024048|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
9907910|NCT01174446|11024049|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
9907911|NCT01174446|11024050|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
9907912|NCT01174446|11024047|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
9907913|NCT01174446|11024048|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
9907914|NCT01174446|11024049|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
9907915|NCT01174446|11024050|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
9907916|NCT01174446|11024047|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
9907917|NCT01174446|11024048|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
9907918|NCT01174446|11024049|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
9907919|NCT01174446|11024050|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
9907920|NCT01174459|11024097|FG000|STARTED|Overall Study|Registered patients|571
9907921|NCT01174459|11024097|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566
9907922|NCT01174459|11024097|FG000|NOT COMPLETED|Overall Study||5
9907923|NCT01174550|11024103|FG000|STARTED|Overall Study||5007
9907924|NCT01174550|11024104|FG001|STARTED|Overall Study||4996
9907925|NCT01174550|11024103|FG000|COMPLETED|Overall Study||3737
9907926|NCT01174550|11024104|FG001|COMPLETED|Overall Study||4123
9907927|NCT01174550|11024103|FG000|NOT COMPLETED|Overall Study||1270
9907928|NCT01174550|11024104|FG001|NOT COMPLETED|Overall Study||873
9907929|NCT01174576|11024110|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16
9907930|NCT01174576|11024110|FG000|COMPLETED|Overall Study||16
9907931|NCT01174576|11024110|FG000|NOT COMPLETED|Overall Study||0
9907932|NCT01174784|11024123|FG000|STARTED|Overall Study||88
9907933|NCT01174784|11024123|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
9907934|NCT01174784|11024123|FG000|NOT COMPLETED|Overall Study||4
9907935|NCT01174823|11024130|FG000|STARTED|Overall Study||122
9907936|NCT01174823|11024131|FG001|STARTED|Overall Study||123
9907937|NCT01174823|11024130|FG000|COMPLETED|Overall Study||115
9907938|NCT01174823|11024131|FG001|COMPLETED|Overall Study||119
9907939|NCT01174823|11024130|FG000|NOT COMPLETED|Overall Study||7
9907940|NCT01174823|11024131|FG001|NOT COMPLETED|Overall Study||4
9907941|NCT01175005|11024137|FG000|STARTED|Overall Study||62
9907942|NCT01175005|11024137|FG000|COMPLETED|Overall Study||62
9907943|NCT01175005|11024137|FG000|NOT COMPLETED|Overall Study||0
9907944|NCT01175018|11024144|FG000|STARTED|Overall Study||15
9907945|NCT01175018|11024145|FG001|STARTED|Overall Study||15
9907946|NCT01175018|11024144|FG000|COMPLETED|Overall Study||12
9907947|NCT01175018|11024145|FG001|COMPLETED|Overall Study||14
9907948|NCT01175018|11024144|FG000|NOT COMPLETED|Overall Study||3
9907949|NCT01175018|11024145|FG001|NOT COMPLETED|Overall Study||1
9907950|NCT01175031|11024153|FG000|STARTED|Overall Study||45
9907951|NCT01175031|11024153|FG000|COMPLETED|Overall Study||45
9907952|NCT01175031|11024153|FG000|NOT COMPLETED|Overall Study||0
9907953|NCT01175083|11024167|FG000|STARTED|Primary Epoch||50
9907954|NCT01175083|11024168|FG001|STARTED|Primary Epoch||50
9907955|NCT01175083|11024169|FG002|STARTED|Primary Epoch||50
9907956|NCT01175083|11024170|FG003|STARTED|Primary Epoch||50
9907957|NCT01175083|11024171|FG004|STARTED|Primary Epoch||50
9907958|NCT01175083|11024172|FG005|STARTED|Primary Epoch||50
9907959|NCT01175083|11024167|FG000|COMPLETED|Primary Epoch||50
9907960|NCT01175083|11024168|FG001|COMPLETED|Primary Epoch||50
9907961|NCT01175083|11024169|FG002|COMPLETED|Primary Epoch||50
9907962|NCT01175083|11024170|FG003|COMPLETED|Primary Epoch||50
9907963|NCT01175083|11024171|FG004|COMPLETED|Primary Epoch||50
9907964|NCT01175083|11024172|FG005|COMPLETED|Primary Epoch||47
9907965|NCT01175083|11024167|FG000|NOT COMPLETED|Primary Epoch||0
9907966|NCT01175083|11024168|FG001|NOT COMPLETED|Primary Epoch||0
9907967|NCT01175083|11024169|FG002|NOT COMPLETED|Primary Epoch||0
9907968|NCT01175083|11024170|FG003|NOT COMPLETED|Primary Epoch||0
9907969|NCT01175083|11024171|FG004|NOT COMPLETED|Primary Epoch||0
9907970|NCT01175083|11024172|FG005|NOT COMPLETED|Primary Epoch||3
9907971|NCT01175083|11024167|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
9907972|NCT01175083|11024168|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
9907973|NCT01175083|11024169|FG002|STARTED|Booster Epoch||50
9907974|NCT01175083|11024170|FG003|STARTED|Booster Epoch||50
9955275|NCT01437098|11074176|FG000|COMPLETED|Overall Study||42
9907975|NCT01175083|11024171|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
9907976|NCT01175083|11024172|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
9907977|NCT01175083|11024167|FG000|COMPLETED|Booster Epoch||49
9907978|NCT01175083|11024168|FG001|COMPLETED|Booster Epoch||49
9907979|NCT01175083|11024169|FG002|COMPLETED|Booster Epoch||49
9907980|NCT01175083|11024170|FG003|COMPLETED|Booster Epoch||49
9907981|NCT01175083|11024171|FG004|COMPLETED|Booster Epoch||0
9907982|NCT01175083|11024172|FG005|COMPLETED|Booster Epoch||0
9907983|NCT01175083|11024167|FG000|NOT COMPLETED|Booster Epoch||0
9907984|NCT01175083|11024168|FG001|NOT COMPLETED|Booster Epoch||0
9907985|NCT01175083|11024169|FG002|NOT COMPLETED|Booster Epoch||1
9907986|NCT01175083|11024170|FG003|NOT COMPLETED|Booster Epoch||1
9907987|NCT01175083|11024171|FG004|NOT COMPLETED|Booster Epoch||0
9907988|NCT01175083|11024172|FG005|NOT COMPLETED|Booster Epoch||0
9907989|NCT01175135|11024194|FG000|STARTED|Overall Study||74
9907990|NCT01175135|11024195|FG001|STARTED|Overall Study||74
9907991|NCT01175135|11024196|FG002|STARTED|Overall Study||37
9907992|NCT01175135|11024197|FG003|STARTED|Overall Study||74
9907993|NCT01175135|11024194|FG000|Treated|Overall Study||74
9907994|NCT01175135|11024195|FG001|Treated|Overall Study||74
9907995|NCT01175135|11024196|FG002|Treated|Overall Study||36
9907996|NCT01175135|11024197|FG003|Treated|Overall Study||74
9907997|NCT01175135|11024194|FG000|Analyzed for Efficacy|Overall Study||74
9907998|NCT01175135|11024195|FG001|Analyzed for Efficacy|Overall Study||73
9907999|NCT01175135|11024196|FG002|Analyzed for Efficacy|Overall Study||34
9908000|NCT01175135|11024197|FG003|Analyzed for Efficacy|Overall Study||73
9908001|NCT01175135|11024194|FG000|COMPLETED|Overall Study||58
9908002|NCT01175135|11024195|FG001|COMPLETED|Overall Study||52
9908003|NCT01175135|11024196|FG002|COMPLETED|Overall Study||25
9908004|NCT01175135|11024197|FG003|COMPLETED|Overall Study||60
9908005|NCT01175135|11024194|FG000|NOT COMPLETED|Overall Study||16
9908006|NCT01175135|11024195|FG001|NOT COMPLETED|Overall Study||22
9908007|NCT01175135|11024196|FG002|NOT COMPLETED|Overall Study||12
9908008|NCT01175135|11024197|FG003|NOT COMPLETED|Overall Study||14
9908009|NCT01175148|11024209|FG000|STARTED|Overall Study||30
9908010|NCT01175148|11024210|FG001|STARTED|Overall Study||30
9908011|NCT01175148|11024209|FG000|COMPLETED|Overall Study||30
9908012|NCT01175148|11024210|FG001|COMPLETED|Overall Study||30
9908013|NCT01175148|11024209|FG000|NOT COMPLETED|Overall Study||0
9908014|NCT01175148|11024210|FG001|NOT COMPLETED|Overall Study||0
9908015|NCT01175213|11024219|FG000|STARTED|IGSC, 10%/rHuPH20||63
9908016|NCT01175213|11024220|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
9908017|NCT01175213|11024219|FG000|COMPLETED|IGSC, 10%/rHuPH20||48
9908018|NCT01175213|11024220|FG001|COMPLETED|IGSC, 10%/rHuPH20||3
9908019|NCT01175213|11024219|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15
9908020|NCT01175213|11024220|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0
9908021|NCT01175213|11024219|FG000|STARTED|Safety Follow-up||48
9908022|NCT01175213|11024220|FG001|STARTED|Safety Follow-up||3
9908023|NCT01175213|11024219|FG000|COMPLETED|Safety Follow-up||47
9908024|NCT01175213|11024220|FG001|COMPLETED|Safety Follow-up||3
9908025|NCT01175213|11024219|FG000|NOT COMPLETED|Safety Follow-up||1
9908026|NCT01175213|11024220|FG001|NOT COMPLETED|Safety Follow-up||0
9908027|NCT01175226|11024231|FG000|STARTED|Overall Study||155
9908028|NCT01175226|11024232|FG001|STARTED|Overall Study||145
9908029|NCT01175226|11024231|FG000|COMPLETED|Overall Study||144
9908030|NCT01175226|11024232|FG001|COMPLETED|Overall Study||140
9908031|NCT01175226|11024231|FG000|NOT COMPLETED|Overall Study||11
9908032|NCT01175226|11024232|FG001|NOT COMPLETED|Overall Study||5
9908033|NCT01175317|11024240|FG000|STARTED|Overall Study||27
9908034|NCT01175317|11024241|FG001|STARTED|Overall Study||31
10203619|NCT03465878|11330529|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0
10203620|NCT03465878|11330526|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10203621|NCT03465878|11330527|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10203622|NCT03465878|11330528|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10203623|NCT03465878|11330529|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10203624|NCT03465878|11330526|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
9908035|NCT01175317|11024240|FG000|COMPLETED|Overall Study||27
9908036|NCT01175317|11024241|FG001|COMPLETED|Overall Study||31
9908037|NCT01175317|11024240|FG000|NOT COMPLETED|Overall Study||0
9908038|NCT01175317|11024241|FG001|NOT COMPLETED|Overall Study||0
9908039|NCT01175343|11024247|FG000|STARTED|Overall Study||44
9908040|NCT01175343|11024247|FG000|COMPLETED|Overall Study||44
9908041|NCT01175343|11024247|FG000|NOT COMPLETED|Overall Study||0
9908042|NCT01175369|11024253|FG000|STARTED|Overall Study||265
9908043|NCT01175369|11024254|FG001|STARTED|Overall Study||265
9908044|NCT01175369|11024253|FG000|COMPLETED|Overall Study||263
9908045|NCT01175369|11024254|FG001|COMPLETED|Overall Study||260
9908046|NCT01175369|11024253|FG000|NOT COMPLETED|Overall Study||2
9908047|NCT01175369|11024254|FG001|NOT COMPLETED|Overall Study||5
9908048|NCT01175382|11024263|FG000|STARTED|Overall Study||71
9908049|NCT01175382|11024264|FG001|STARTED|Overall Study||68
9908050|NCT01175382|11024265|FG002|STARTED|Overall Study||65
9908051|NCT01175382|11024263|FG000|COMPLETED|Overall Study||63
9908052|NCT01175382|11024264|FG001|COMPLETED|Overall Study||61
9908053|NCT01175382|11024265|FG002|COMPLETED|Overall Study||59
9908054|NCT01175382|11024263|FG000|NOT COMPLETED|Overall Study||8
9908055|NCT01175382|11024264|FG001|NOT COMPLETED|Overall Study||7
9908056|NCT01175382|11024265|FG002|NOT COMPLETED|Overall Study||6
9908057|NCT01175395|11024273|FG000|STARTED|Overall Study||10
9908058|NCT01175395|11024273|FG000|COMPLETED|Overall Study||10
9908059|NCT01175395|11024273|FG000|NOT COMPLETED|Overall Study||0
9908060|NCT01175434|11024279|FG000|STARTED|Overall Study||48
9908061|NCT01175434|11024280|FG001|STARTED|Overall Study||51
9908062|NCT01175434|11024279|FG000|COMPLETED|Overall Study||48
9908063|NCT01175434|11024280|FG001|COMPLETED|Overall Study||51
9908064|NCT01175434|11024279|FG000|NOT COMPLETED|Overall Study||0
9908065|NCT01175434|11024280|FG001|NOT COMPLETED|Overall Study||0
9908066|NCT01175473|11024288|FG000|STARTED|Overall Study|Randomized and treated.|77
9908067|NCT01175473|11024289|FG001|STARTED|Overall Study||71
9908068|NCT01175473|11024288|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
9908069|NCT01175473|11024289|FG001|Safety Population|Overall Study||71
9908070|NCT01175473|11024288|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
9908071|NCT01175473|11024289|FG001|Pharmacodynamic (PD) Population|Overall Study||68
9908072|NCT01175473|11024288|FG000|COMPLETED|Overall Study||75
9908073|NCT01175473|11024289|FG001|COMPLETED|Overall Study||69
9908074|NCT01175473|11024288|FG000|NOT COMPLETED|Overall Study||2
9908075|NCT01175473|11024289|FG001|NOT COMPLETED|Overall Study||2
9908076|NCT01175590|11024297|FG000|STARTED|Overall Study||347
9908077|NCT01175590|11024298|FG001|STARTED|Overall Study||171
9908078|NCT01175590|11024297|FG000|Modified Intent to Treat Population|Overall Study||212
9908079|NCT01175590|11024298|FG001|Modified Intent to Treat Population|Overall Study||87
9908080|NCT01175590|11024297|FG000|Safety Population|Overall Study||344
9908081|NCT01175590|11024298|FG001|Safety Population|Overall Study||170
9908082|NCT01175590|11024297|FG000|COMPLETED|Overall Study||335
9908083|NCT01175590|11024298|FG001|COMPLETED|Overall Study||161
9908084|NCT01175590|11024297|FG000|NOT COMPLETED|Overall Study||12
9908085|NCT01175590|11024298|FG001|NOT COMPLETED|Overall Study||10
9908086|NCT01175668|11024307|FG000|STARTED|Overall Study||34
9908087|NCT01175668|11024308|FG001|STARTED|Overall Study||34
9908088|NCT01175668|11024307|FG000|COMPLETED|Overall Study||32
9908089|NCT01175668|11024308|FG001|COMPLETED|Overall Study||34
9908090|NCT01175668|11024307|FG000|NOT COMPLETED|Overall Study||2
9908091|NCT01175668|11024308|FG001|NOT COMPLETED|Overall Study||0
9908092|NCT01175707|11024316|FG000|STARTED|Overall Study||40
9908093|NCT01175707|11024317|FG001|STARTED|Overall Study||40
9908094|NCT01175707|11024316|FG000|COMPLETED|Overall Study||36
9908095|NCT01175707|11024317|FG001|COMPLETED|Overall Study||34
9908096|NCT01175707|11024316|FG000|NOT COMPLETED|Overall Study||4
9908097|NCT01175707|11024317|FG001|NOT COMPLETED|Overall Study||6
9908098|NCT01175798|11024326|FG000|STARTED|Overall Study||34
9908099|NCT01175798|11024327|FG001|STARTED|Overall Study||62
9908100|NCT01175798|11024326|FG000|COMPLETED|Overall Study||27
9908101|NCT01175798|11024327|FG001|COMPLETED|Overall Study||41
9908102|NCT01175798|11024326|FG000|NOT COMPLETED|Overall Study||7
9908103|NCT01175798|11024327|FG001|NOT COMPLETED|Overall Study||21
9908104|NCT01175811|11024335|FG000|STARTED|Overall Study||199
9908105|NCT01175811|11024336|FG001|STARTED|Overall Study||203
9908106|NCT01175811|11024335|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197
9908107|NCT01175811|11024336|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
9908108|NCT01175811|11024335|FG000|COMPLETED|Overall Study||183
9908109|NCT01175811|11024336|FG001|COMPLETED|Overall Study||189
9908110|NCT01175811|11024335|FG000|NOT COMPLETED|Overall Study||16
9908111|NCT01175811|11024336|FG001|NOT COMPLETED|Overall Study||14
9908112|NCT01175824|11024344|FG000|STARTED|Overall Study||236
9908113|NCT01175824|11024345|FG001|STARTED|Overall Study||242
9908114|NCT01175824|11024344|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
9908115|NCT01175824|11024345|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240
9908116|NCT01175824|11024344|FG000|COMPLETED|Overall Study||220
9908117|NCT01175824|11024345|FG001|COMPLETED|Overall Study||220
9908118|NCT01175824|11024344|FG000|NOT COMPLETED|Overall Study||16
9908119|NCT01175824|11024345|FG001|NOT COMPLETED|Overall Study||22
9908120|NCT01175850|11024353|FG000|STARTED|IN.PACT SFA I Phase||99
9908121|NCT01175850|11024354|FG001|STARTED|IN.PACT SFA I Phase||51
9908122|NCT01175850|11024353|FG000|COMPLETED|IN.PACT SFA I Phase||88
9908123|NCT01175850|11024354|FG001|COMPLETED|IN.PACT SFA I Phase||49
9908124|NCT01175850|11024353|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
9908125|NCT01175850|11024354|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
9908126|NCT01175850|11024353|FG000|STARTED|IN.PACT SFA II Phase||121
9908127|NCT01175850|11024354|FG001|STARTED|IN.PACT SFA II Phase||60
9908128|NCT01175850|11024353|FG000|COMPLETED|IN.PACT SFA II Phase||109
9908129|NCT01175850|11024354|FG001|COMPLETED|IN.PACT SFA II Phase||55
9908130|NCT01175850|11024353|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
9908131|NCT01175850|11024354|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
9908132|NCT01175902|11024363|FG000|STARTED|Overall Study||22
9908133|NCT01175902|11024364|FG001|STARTED|Overall Study||22
9908134|NCT01175902|11024363|FG000|COMPLETED|Overall Study||22
9908135|NCT01175902|11024364|FG001|COMPLETED|Overall Study||22
9908136|NCT01175902|11024363|FG000|NOT COMPLETED|Overall Study||0
9908137|NCT01175902|11024364|FG001|NOT COMPLETED|Overall Study||0
9908138|NCT01175980|11024372|FG000|STARTED|Overall Study||30
9908139|NCT01175980|11024372|FG000|COMPLETED|Overall Study||30
9908140|NCT01175980|11024372|FG000|NOT COMPLETED|Overall Study||0
9908141|NCT01176032|11024378|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37
9908142|NCT01176032|11024379|FG001|STARTED|Overall Study||37
9908143|NCT01176032|11024378|FG000|Intention-to-treat (ITT) Population|Overall Study||32
9908144|NCT01176032|11024379|FG001|Intention-to-treat (ITT) Population|Overall Study||37
9908145|NCT01176032|11024378|FG000|COMPLETED|Overall Study||31
9908146|NCT01176032|11024379|FG001|COMPLETED|Overall Study||36
9908147|NCT01176032|11024378|FG000|NOT COMPLETED|Overall Study||6
9908148|NCT01176032|11024379|FG001|NOT COMPLETED|Overall Study||1
9908149|NCT01176058|11024392|FG000|STARTED|Overall Study||9
9908150|NCT01176058|11024393|FG001|STARTED|Overall Study||8
9908151|NCT01176058|11024392|FG000|COMPLETED|Overall Study||5
9908152|NCT01176058|11024393|FG001|COMPLETED|Overall Study||5
9908153|NCT01176058|11024392|FG000|NOT COMPLETED|Overall Study||4
9908154|NCT01176058|11024393|FG001|NOT COMPLETED|Overall Study||3
9955276|NCT01437098|11074176|FG000|NOT COMPLETED|Overall Study||13
9955277|NCT01437124|11074188|FG000|STARTED|Overall Study||83
9955278|NCT01437124|11074188|FG000|COMPLETED|Overall Study||83
9955279|NCT01437124|11074188|FG000|NOT COMPLETED|Overall Study||0
9955280|NCT01437267|11074198|FG000|STARTED|Overall Study||20
9955281|NCT01437267|11074199|FG001|STARTED|Overall Study||20
9955282|NCT01437267|11074200|FG002|STARTED|Overall Study||20
9955283|NCT01437267|11074201|FG003|STARTED|Overall Study||20
9955284|NCT01437267|11074202|FG004|STARTED|Overall Study||20
9955285|NCT01437267|11074203|FG005|STARTED|Overall Study||20
9955286|NCT01437267|11074198|FG000|COMPLETED|Overall Study||20
9955287|NCT01437267|11074199|FG001|COMPLETED|Overall Study||19
9955288|NCT01437267|11074200|FG002|COMPLETED|Overall Study||20
9955289|NCT01437267|11074201|FG003|COMPLETED|Overall Study||19
9955290|NCT01437267|11074202|FG004|COMPLETED|Overall Study||20
9955291|NCT01437267|11074203|FG005|COMPLETED|Overall Study||20
9955292|NCT01437267|11074198|FG000|NOT COMPLETED|Overall Study||0
9955293|NCT01437267|11074199|FG001|NOT COMPLETED|Overall Study||1
9955294|NCT01437267|11074200|FG002|NOT COMPLETED|Overall Study||0
9955295|NCT01437267|11074201|FG003|NOT COMPLETED|Overall Study||1
9955296|NCT01437267|11074202|FG004|NOT COMPLETED|Overall Study||0
9955297|NCT01437267|11074203|FG005|NOT COMPLETED|Overall Study||0
9955298|NCT01437319|11074217|FG000|STARTED|Phase I||282
9955299|NCT01437319|11074218|FG001|STARTED|Phase I||0
9955300|NCT01437319|11074219|FG002|STARTED|Phase I||0
9955301|NCT01437319|11074217|FG000|COMPLETED|Phase I||227
9955302|NCT01437319|11074218|FG001|COMPLETED|Phase I||0
9955303|NCT01437319|11074219|FG002|COMPLETED|Phase I||0
9955304|NCT01437319|11074217|FG000|NOT COMPLETED|Phase I||55
9955305|NCT01437319|11074218|FG001|NOT COMPLETED|Phase I||0
9955306|NCT01437319|11074219|FG002|NOT COMPLETED|Phase I||0
9955307|NCT01437319|11074217|FG000|STARTED|Phase II||0
9955308|NCT01437319|11074218|FG001|STARTED|Phase II||115
9955309|NCT01437319|11074219|FG002|STARTED|Phase II||112
9955310|NCT01437319|11074217|FG000|COMPLETED|Phase II||0
9955311|NCT01437319|11074218|FG001|COMPLETED|Phase II||71
9955312|NCT01437319|11074219|FG002|COMPLETED|Phase II||75
9955313|NCT01437319|11074217|FG000|NOT COMPLETED|Phase II||0
9955314|NCT01437319|11074218|FG001|NOT COMPLETED|Phase II||44
9955315|NCT01437319|11074219|FG002|NOT COMPLETED|Phase II||37
9955316|NCT01437397|11074233|FG000|STARTED|Overall Study||338
9955317|NCT01437397|11074234|FG001|STARTED|Overall Study||338
9955318|NCT01437397|11074235|FG002|STARTED|Overall Study||340
9955319|NCT01437397|11074236|FG003|STARTED|Overall Study||339
9955320|NCT01437397|11074237|FG004|STARTED|Overall Study||337
9955321|NCT01437397|11074233|FG000|COMPLETED|Overall Study||272
9955322|NCT01437397|11074234|FG001|COMPLETED|Overall Study||276
9955323|NCT01437397|11074235|FG002|COMPLETED|Overall Study||268
9955324|NCT01437397|11074236|FG003|COMPLETED|Overall Study||270
9955325|NCT01437397|11074237|FG004|COMPLETED|Overall Study||236
9955326|NCT01437397|11074233|FG000|NOT COMPLETED|Overall Study||66
9955327|NCT01437397|11074234|FG001|NOT COMPLETED|Overall Study||62
9955328|NCT01437397|11074235|FG002|NOT COMPLETED|Overall Study||72
9955329|NCT01437397|11074236|FG003|NOT COMPLETED|Overall Study||69
9955330|NCT01437397|11074237|FG004|NOT COMPLETED|Overall Study||101
9955331|NCT01437449|11074249|FG000|STARTED|Overall Study||27
9955332|NCT01437449|11074249|FG000|COMPLETED|Overall Study||27
9955333|NCT01437449|11074249|FG000|NOT COMPLETED|Overall Study||0
9955334|NCT01437488|11074253|FG000|STARTED|Overall Study||14
9955335|NCT01437488|11074253|FG000|COMPLETED|Overall Study||14
9955336|NCT01437488|11074253|FG000|NOT COMPLETED|Overall Study||0
9955337|NCT01437501|11074262|FG000|STARTED|Overall Study||148
9955338|NCT01437501|11074263|FG001|STARTED|Overall Study||143
9955339|NCT01437501|11074262|FG000|COMPLETED|Overall Study||135
9955340|NCT01437501|11074263|FG001|COMPLETED|Overall Study||132
9955341|NCT01437501|11074262|FG000|NOT COMPLETED|Overall Study||13
9955342|NCT01437501|11074263|FG001|NOT COMPLETED|Overall Study||11
9955343|NCT01437540|11074273|FG000|STARTED|Overall Study||392
9955344|NCT01437540|11074274|FG001|STARTED|Overall Study||198
9955345|NCT01437540|11074273|FG000|COMPLETED|Overall Study||265
9955346|NCT01437540|11074274|FG001|COMPLETED|Overall Study||133
9955347|NCT01437540|11074273|FG000|NOT COMPLETED|Overall Study||127
9955348|NCT01437540|11074274|FG001|NOT COMPLETED|Overall Study||65
9760456|NCT00381043|10864100|FG000|NOT COMPLETED|Overall Study||12
9760457|NCT00381043|10864101|FG001|NOT COMPLETED|Overall Study||8
9760458|NCT00381095|10864109|FG000|STARTED|Overall Study||72
9760459|NCT00381095|10864110|FG001|STARTED|Overall Study||80
9760460|NCT00381095|10864109|FG000|COMPLETED|Overall Study||59
9760461|NCT00381095|10864110|FG001|COMPLETED|Overall Study||59
9955349|NCT01437605|11074282|FG000|STARTED|Overall Study||9
9955350|NCT01437605|11074283|FG001|STARTED|Overall Study||5
9955351|NCT01437605|11074282|FG000|COMPLETED|Overall Study||9
9955352|NCT01437605|11074283|FG001|COMPLETED|Overall Study||5
10203625|NCT03465878|11330527|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
10203626|NCT03465878|11330528|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
10203627|NCT03465878|11330529|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
10238736|NCT00484718|11370188|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
9760462|NCT00381095|10864109|FG000|NOT COMPLETED|Overall Study||13
9760463|NCT00381095|10864110|FG001|NOT COMPLETED|Overall Study||21
9760464|NCT00381238|10864116|FG000|STARTED|Overall Study||33
9908155|NCT01176240|11024403|FG000|STARTED|Study 306A||24
9908156|NCT01176240|11024404|FG001|STARTED|Study 306A||27
9908157|NCT01176240|11024403|FG000|COMPLETED|Study 306A||21
9908158|NCT01176240|11024404|FG001|COMPLETED|Study 306A||24
9908159|NCT01176240|11024403|FG000|NOT COMPLETED|Study 306A||3
9908160|NCT01176240|11024404|FG001|NOT COMPLETED|Study 306A||3
9908161|NCT01176240|11024403|FG000|STARTED|Study 306B||89
9908162|NCT01176240|11024404|FG001|STARTED|Study 306B||85
9908163|NCT01176240|11024403|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
9908164|NCT01176240|11024404|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
9908165|NCT01176240|11024403|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69
9908166|NCT01176240|11024404|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78
9908167|NCT01176240|11024403|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68
9908168|NCT01176240|11024404|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75
9908169|NCT01176240|11024403|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67
9908170|NCT01176240|11024404|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73
9908171|NCT01176240|11024403|FG000|COMPLETED|Study 306B||63
9908172|NCT01176240|11024404|FG001|COMPLETED|Study 306B||68
9908173|NCT01176240|11024403|FG000|NOT COMPLETED|Study 306B||26
9908174|NCT01176240|11024404|FG001|NOT COMPLETED|Study 306B||17
9908175|NCT01176266|11024410|FG000|STARTED|Overall Study||69
9908176|NCT01176266|11024410|FG000|COMPLETED|Overall Study||60
9908177|NCT01176266|11024410|FG000|NOT COMPLETED|Overall Study||9
9908178|NCT01176292|11024420|FG000|STARTED|Overall Study||71
9908179|NCT01176292|11024421|FG001|STARTED|Overall Study||71
9908180|NCT01176292|11024420|FG000|COMPLETED|Overall Study||66
9908181|NCT01176292|11024421|FG001|COMPLETED|Overall Study||62
9908182|NCT01176292|11024420|FG000|NOT COMPLETED|Overall Study||5
9908183|NCT01176292|11024421|FG001|NOT COMPLETED|Overall Study||9
9760465|NCT00381238|10864116|FG000|COMPLETED|Overall Study||21
9760466|NCT00381238|10864116|FG000|NOT COMPLETED|Overall Study||12
9760467|NCT00381303|10864122|FG000|STARTED|Overall Study||287
9760468|NCT00381303|10864123|FG001|STARTED|Overall Study||142
9760469|NCT00381303|10864122|FG000|COMPLETED|Overall Study||193
9760470|NCT00381303|10864123|FG001|COMPLETED|Overall Study||109
9760471|NCT00381303|10864122|FG000|NOT COMPLETED|Overall Study||94
9760472|NCT00381303|10864123|FG001|NOT COMPLETED|Overall Study||33
9760473|NCT00381550|10864141|FG000|STARTED|Overall Study||35
9760474|NCT00381550|10864141|FG000|COMPLETED|Overall Study||35
9760475|NCT00381550|10864141|FG000|NOT COMPLETED|Overall Study||0
9760476|NCT00381563|10864147|FG000|STARTED|Overall Study||41
9760477|NCT00381563|10864148|FG001|STARTED|Overall Study||39
9760478|NCT00381563|10864147|FG000|COMPLETED|Overall Study||34
9760479|NCT00381563|10864148|FG001|COMPLETED|Overall Study||33
9760480|NCT00381563|10864147|FG000|NOT COMPLETED|Overall Study||7
9760481|NCT00381563|10864148|FG001|NOT COMPLETED|Overall Study||6
9760482|NCT00381615|10864157|FG000|STARTED|Overall Study||48
9908184|NCT01176435|11024430|FG000|STARTED|Overall Study||15
9908185|NCT01176435|11024431|FG001|STARTED|Overall Study||15
9908186|NCT01176435|11024432|FG002|STARTED|Overall Study||15
9908187|NCT01176435|11024430|FG000|COMPLETED|Overall Study||15
9908188|NCT01176435|11024431|FG001|COMPLETED|Overall Study||15
9908189|NCT01176435|11024432|FG002|COMPLETED|Overall Study||15
9908190|NCT01176435|11024430|FG000|NOT COMPLETED|Overall Study||0
9908191|NCT01176435|11024431|FG001|NOT COMPLETED|Overall Study||0
9908192|NCT01176435|11024432|FG002|NOT COMPLETED|Overall Study||0
9908193|NCT01176448|11024440|FG000|STARTED|Overall Study||6
9908194|NCT01176448|11024440|FG000|COMPLETED|Overall Study||6
9908195|NCT01176448|11024440|FG000|NOT COMPLETED|Overall Study||0
9908196|NCT01176565|11024450|FG000|STARTED|Overall Study||500
9908197|NCT01176565|11024451|FG001|STARTED|Overall Study||500
9908198|NCT01176565|11024450|FG000|COMPLETED|Overall Study||480
9908199|NCT01176565|11024451|FG001|COMPLETED|Overall Study||481
9908200|NCT01176565|11024450|FG000|NOT COMPLETED|Overall Study||20
9908201|NCT01176565|11024451|FG001|NOT COMPLETED|Overall Study||19
9908202|NCT01176591|11024459|FG000|STARTED|Session 1||10
9908203|NCT01176591|11024460|FG001|STARTED|Session 1||3
9908204|NCT01176591|11024459|FG000|COMPLETED|Session 1||10
9908205|NCT01176591|11024460|FG001|COMPLETED|Session 1||3
9908206|NCT01176591|11024459|FG000|NOT COMPLETED|Session 1||0
9908207|NCT01176591|11024460|FG001|NOT COMPLETED|Session 1||0
9908208|NCT01176591|11024459|FG000|STARTED|Session 2||10
9908209|NCT01176591|11024460|FG001|STARTED|Session 2||3
9908210|NCT01176591|11024459|FG000|COMPLETED|Session 2||10
9908211|NCT01176591|11024460|FG001|COMPLETED|Session 2||3
9908212|NCT01176591|11024459|FG000|NOT COMPLETED|Session 2||0
9760483|NCT00381615|10864158|FG001|STARTED|Overall Study||50
9760484|NCT00381615|10864159|FG002|STARTED|Overall Study||25
9760485|NCT00381615|10864160|FG003|STARTED|Overall Study||24
9760486|NCT00381615|10864157|FG000|COMPLETED|Overall Study||44
9760487|NCT00381615|10864158|FG001|COMPLETED|Overall Study||45
9908213|NCT01176591|11024460|FG001|NOT COMPLETED|Session 2||0
9908214|NCT01176617|11024470|FG000|STARTED|1 - 6 Months (Ron-randomized)||0
9908215|NCT01176617|11024471|FG001|STARTED|1 - 6 Months (Ron-randomized)||0
10009672|NCT01767987|11132334|FG000|NOT COMPLETED|Overall Study||4
10009673|NCT01767987|11132335|FG001|NOT COMPLETED|Overall Study||1
10009674|NCT01768000|11132345|FG000|STARTED|Overall Study||10
10009675|NCT01768000|11132346|FG001|STARTED|Overall Study||10
10009676|NCT01768000|11132347|FG002|STARTED|Overall Study||10
10009677|NCT01768000|11132348|FG003|STARTED|Overall Study||10
9908216|NCT01176617|11024472|FG002|STARTED|1 - 6 Months (Ron-randomized)||38
9908217|NCT01176617|11024470|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0
9908218|NCT01176617|11024471|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0
9908219|NCT01176617|11024472|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38
9908220|NCT01176617|11024470|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
9908221|NCT01176617|11024471|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
9908222|NCT01176617|11024472|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
9908223|NCT01176617|11024470|FG000|STARTED|6 - 12 Months (Randomized)||18
9908224|NCT01176617|11024471|FG001|STARTED|6 - 12 Months (Randomized)||20
9908225|NCT01176617|11024472|FG002|STARTED|6 - 12 Months (Randomized)||0
9908226|NCT01176617|11024470|FG000|COMPLETED|6 - 12 Months (Randomized)||13
9908227|NCT01176617|11024471|FG001|COMPLETED|6 - 12 Months (Randomized)||20
9908228|NCT01176617|11024472|FG002|COMPLETED|6 - 12 Months (Randomized)||0
9908229|NCT01176617|11024470|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5
9908230|NCT01176617|11024471|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0
9908231|NCT01176617|11024472|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0
9908232|NCT01176773|11024480|FG000|STARTED|Overall Study||62
9908233|NCT01176773|11024480|FG000|COMPLETED|Overall Study||59
9908234|NCT01176773|11024480|FG000|NOT COMPLETED|Overall Study||3
9908235|NCT01176877|11024485|FG000|STARTED|Overall Study||40
9908236|NCT01176877|11024485|FG000|COMPLETED|Overall Study||31
9908237|NCT01176877|11024485|FG000|NOT COMPLETED|Overall Study||9
9908238|NCT01176916|11024490|FG000|STARTED|Overall Study||564
9908239|NCT01176916|11024490|FG000|Treated|Overall Study||558
9908240|NCT01176916|11024490|FG000|Assigne But Not Treated|Overall Study||6
9908241|NCT01176916|11024490|FG000|COMPLETED|Overall Study||397
9908242|NCT01176916|11024490|FG000|NOT COMPLETED|Overall Study||167
9908243|NCT01176955|11024496|FG000|STARTED|Overall Study||10
9908244|NCT01176955|11024497|FG001|STARTED|Overall Study||10
9908245|NCT01176955|11024496|FG000|COMPLETED|Overall Study||7
9908246|NCT01176955|11024497|FG001|COMPLETED|Overall Study||8
9908247|NCT01176955|11024496|FG000|NOT COMPLETED|Overall Study||3
9908248|NCT01176955|11024497|FG001|NOT COMPLETED|Overall Study||2
9908249|NCT01176968|11024508|FG000|STARTED|Overall Study||506
9908250|NCT01176968|11024509|FG001|STARTED|Overall Study||506
9908251|NCT01176968|11024508|FG000|Treated|Overall Study||505
9908252|NCT01176968|11024509|FG001|Treated|Overall Study||505
9908253|NCT01176968|11024508|FG000|COMPLETED|Overall Study||422
9908254|NCT01176968|11024509|FG001|COMPLETED|Overall Study||424
9908255|NCT01176968|11024508|FG000|NOT COMPLETED|Overall Study||84
9908256|NCT01176968|11024509|FG001|NOT COMPLETED|Overall Study||82
9908257|NCT01176981|11024515|FG000|STARTED|Overall Study||6
9908258|NCT01176981|11024515|FG000|COMPLETED|Overall Study||6
9908259|NCT01176981|11024515|FG000|NOT COMPLETED|Overall Study||0
9908260|NCT01177007|11024519|FG000|STARTED|Overall Study||50
9908261|NCT01177007|11024519|FG000|Completed First Y90 Treatment|Overall Study||50
9908262|NCT01177007|11024519|FG000|Completed First Clinical and Imaging|Overall Study||43
9908263|NCT01177007|11024519|FG000|COMPLETED|Overall Study||12
9908264|NCT01177007|11024519|FG000|NOT COMPLETED|Overall Study||38
9908265|NCT01177059|11024525|FG000|STARTED|Overall Study||68
9908266|NCT01177059|11024525|FG000|COMPLETED|Overall Study||18
9908267|NCT01177059|11024525|FG000|NOT COMPLETED|Overall Study||50
9908268|NCT01177098|11024531|FG000|STARTED|Overall Study||278
9908269|NCT01177098|11024532|FG001|STARTED|Overall Study||283
9908270|NCT01177098|11024531|FG000|COMPLETED|Overall Study||269
9908271|NCT01177098|11024532|FG001|COMPLETED|Overall Study||271
9908272|NCT01177098|11024531|FG000|NOT COMPLETED|Overall Study||9
9908273|NCT01177098|11024532|FG001|NOT COMPLETED|Overall Study||12
9908274|NCT01177137|11024541|FG000|STARTED|Overall Study||51
9908275|NCT01177137|11024542|FG001|STARTED|Overall Study||51
9908276|NCT01177137|11024543|FG002|STARTED|Overall Study||49
9908277|NCT01177137|11024541|FG000|COMPLETED|Overall Study||41
9908278|NCT01177137|11024542|FG001|COMPLETED|Overall Study||41
9908279|NCT01177137|11024543|FG002|COMPLETED|Overall Study||47
9908280|NCT01177137|11024541|FG000|NOT COMPLETED|Overall Study||10
9908281|NCT01177137|11024542|FG001|NOT COMPLETED|Overall Study||10
9908282|NCT01177137|11024543|FG002|NOT COMPLETED|Overall Study||2
9908283|NCT01177189|11024556|FG000|STARTED|Overall Study||42
9908284|NCT01177189|11024557|FG001|STARTED|Overall Study||45
9908285|NCT01177189|11024556|FG000|COMPLETED|Overall Study||42
9908286|NCT01177189|11024557|FG001|COMPLETED|Overall Study||45
9908287|NCT01177189|11024556|FG000|NOT COMPLETED|Overall Study||0
10009678|NCT01768000|11132345|FG000|COMPLETED|Overall Study||9
10009679|NCT01768000|11132346|FG001|COMPLETED|Overall Study||8
9908288|NCT01177189|11024557|FG001|NOT COMPLETED|Overall Study||0
9908289|NCT01177228|11024567|FG000|STARTED|Overall Study||9
9908290|NCT01177228|11024568|FG001|STARTED|Overall Study||13
9908291|NCT01177228|11024569|FG002|STARTED|Overall Study||14
9908292|NCT01177228|11024570|FG003|STARTED|Overall Study||11
9908293|NCT01177228|11024567|FG000|Received Treatment|Overall Study||9
9908294|NCT01177228|11024568|FG001|Received Treatment|Overall Study||12
9908295|NCT01177228|11024569|FG002|Received Treatment|Overall Study||14
9908296|NCT01177228|11024570|FG003|Received Treatment|Overall Study||11
9908297|NCT01177228|11024567|FG000|COMPLETED|Overall Study||8
9908298|NCT01177228|11024568|FG001|COMPLETED|Overall Study||11
9908299|NCT01177228|11024569|FG002|COMPLETED|Overall Study||14
9908300|NCT01177228|11024570|FG003|COMPLETED|Overall Study||11
9908301|NCT01177228|11024567|FG000|NOT COMPLETED|Overall Study||1
9908302|NCT01177228|11024568|FG001|NOT COMPLETED|Overall Study||2
9908303|NCT01177228|11024569|FG002|NOT COMPLETED|Overall Study||0
9908304|NCT01177228|11024570|FG003|NOT COMPLETED|Overall Study||0
9908305|NCT01177293|11024585|FG000|STARTED|First Intervention Period||7
9908306|NCT01177293|11024586|FG001|STARTED|First Intervention Period||7
9908307|NCT01177293|11024585|FG000|COMPLETED|First Intervention Period||7
9908308|NCT01177293|11024586|FG001|COMPLETED|First Intervention Period||7
9908309|NCT01177293|11024585|FG000|NOT COMPLETED|First Intervention Period||0
9908310|NCT01177293|11024586|FG001|NOT COMPLETED|First Intervention Period||0
9908311|NCT01177293|11024585|FG000|STARTED|Washout Period (of 14 Days)||7
9908312|NCT01177293|11024586|FG001|STARTED|Washout Period (of 14 Days)||7
9908313|NCT01177293|11024585|FG000|COMPLETED|Washout Period (of 14 Days)||7
9908314|NCT01177293|11024586|FG001|COMPLETED|Washout Period (of 14 Days)||6
9908315|NCT01177293|11024585|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0
9908316|NCT01177293|11024586|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1
9908317|NCT01177293|11024585|FG000|STARTED|Second Intervention Period||7
9908318|NCT01177293|11024586|FG001|STARTED|Second Intervention Period||6
9908319|NCT01177293|11024585|FG000|COMPLETED|Second Intervention Period||7
9908320|NCT01177293|11024586|FG001|COMPLETED|Second Intervention Period||6
9908321|NCT01177293|11024585|FG000|NOT COMPLETED|Second Intervention Period||0
9908322|NCT01177293|11024586|FG001|NOT COMPLETED|Second Intervention Period||0
9908323|NCT01177384|11024594|FG000|STARTED|Overall Study||191
9908324|NCT01177384|11024595|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190
9908325|NCT01177384|11024594|FG000|COMPLETED|Overall Study||177
9908326|NCT01177384|11024595|FG001|COMPLETED|Overall Study||164
9908327|NCT01177384|11024594|FG000|NOT COMPLETED|Overall Study||14
9908328|NCT01177384|11024595|FG001|NOT COMPLETED|Overall Study||26
9908329|NCT01177410|11024604|FG000|STARTED|Overall Study||51
9908330|NCT01177410|11024605|FG001|STARTED|Overall Study||47
9908331|NCT01177410|11024606|FG002|STARTED|Overall Study||50
9908332|NCT01177410|11024604|FG000|COMPLETED|Overall Study||50
9908333|NCT01177410|11024605|FG001|COMPLETED|Overall Study||40
9908334|NCT01177410|11024606|FG002|COMPLETED|Overall Study||45
9908335|NCT01177410|11024604|FG000|NOT COMPLETED|Overall Study||1
9908336|NCT01177410|11024605|FG001|NOT COMPLETED|Overall Study||7
9908337|NCT01177410|11024606|FG002|NOT COMPLETED|Overall Study||5
9908338|NCT01177553|11024616|FG000|STARTED|Overall Study||3
9908339|NCT01177553|11024617|FG001|STARTED|Overall Study||2
9908340|NCT01177553|11024616|FG000|COMPLETED|Overall Study|data as of March 2009|2
9908341|NCT01177553|11024617|FG001|COMPLETED|Overall Study|data as of March 2009|2
9908342|NCT01177553|11024616|FG000|NOT COMPLETED|Overall Study||1
9908343|NCT01177553|11024617|FG001|NOT COMPLETED|Overall Study||0
9908344|NCT01177670|11024623|FG000|STARTED|Overall Study||169
9908345|NCT01177670|11024623|FG000|COMPLETED|Overall Study||0
9908346|NCT01177670|11024623|FG000|NOT COMPLETED|Overall Study||169
9908347|NCT01177709|11024627|FG000|STARTED|Overall Study||12
9908348|NCT01177709|11024627|FG000|COMPLETED|Overall Study||12
9908349|NCT01177709|11024627|FG000|NOT COMPLETED|Overall Study||0
9908350|NCT01177722|11024635|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
9908351|NCT01177722|11024636|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
9908352|NCT01177722|11024637|FG002|STARTED|Overall Study||342
9908353|NCT01177722|11024638|FG003|STARTED|Overall Study||345
9908354|NCT01177722|11024635|FG000|COMPLETED|Overall Study||331
9908355|NCT01177722|11024636|FG001|COMPLETED|Overall Study||334
9908356|NCT01177722|11024637|FG002|COMPLETED|Overall Study||333
9908357|NCT01177722|11024638|FG003|COMPLETED|Overall Study||338
10009680|NCT01768000|11132347|FG002|COMPLETED|Overall Study||9
10009681|NCT01768000|11132348|FG003|COMPLETED|Overall Study||8
10009682|NCT01768000|11132345|FG000|NOT COMPLETED|Overall Study||1
10009683|NCT01768000|11132346|FG001|NOT COMPLETED|Overall Study||2
10009684|NCT01768000|11132347|FG002|NOT COMPLETED|Overall Study||1
10009685|NCT01768000|11132348|FG003|NOT COMPLETED|Overall Study||2
9908358|NCT01177722|11024635|FG000|NOT COMPLETED|Overall Study||13
9908359|NCT01177722|11024636|FG001|NOT COMPLETED|Overall Study||10
9908360|NCT01177722|11024637|FG002|NOT COMPLETED|Overall Study||9
9908361|NCT01177722|11024638|FG003|NOT COMPLETED|Overall Study||7
9908362|NCT01177735|11024649|FG000|STARTED|Overall Study||71
10009686|NCT01768013|11132360|FG000|STARTED|Overall Study||13
9908363|NCT01177735|11024649|FG000|COMPLETED|Overall Study||0
9908364|NCT01177735|11024649|FG000|NOT COMPLETED|Overall Study||71
9908365|NCT01177787|11024653|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28
9908366|NCT01177787|11024653|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28
9908367|NCT01177787|11024653|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
9908368|NCT01177787|11024653|FG000|STARTED|Cryolipolysis on Thigh||28
9908369|NCT01177787|11024653|FG000|COMPLETED|Cryolipolysis on Thigh||14
9908370|NCT01177787|11024653|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14
9908371|NCT01177800|11024667|FG000|STARTED|Overall Study||84
10009687|NCT01768013|11132360|FG000|COMPLETED|Overall Study||13
10009688|NCT01768013|11132360|FG000|NOT COMPLETED|Overall Study||0
9908372|NCT01177800|11024668|FG001|STARTED|Overall Study||45
9908373|NCT01177800|11024667|FG000|COMPLETED|Overall Study||74
9908374|NCT01177800|11024668|FG001|COMPLETED|Overall Study||40
9908375|NCT01177800|11024667|FG000|NOT COMPLETED|Overall Study||10
9908376|NCT01177800|11024668|FG001|NOT COMPLETED|Overall Study||5
9908377|NCT01177813|11024679|FG000|STARTED|Overall Study||228
9908378|NCT01177813|11024680|FG001|STARTED|Overall Study||224
9908379|NCT01177813|11024681|FG002|STARTED|Overall Study||224
9908380|NCT01177813|11024682|FG003|STARTED|Overall Study||223
9908381|NCT01177813|11024683|FG004|STARTED|Overall Study||87
9908382|NCT01177813|11024679|FG000|COMPLETED|Overall Study||187
9908383|NCT01177813|11024680|FG001|COMPLETED|Overall Study||206
9908384|NCT01177813|11024681|FG002|COMPLETED|Overall Study||204
9908385|NCT01177813|11024682|FG003|COMPLETED|Overall Study||206
9908386|NCT01177813|11024683|FG004|COMPLETED|Overall Study||78
9908387|NCT01177813|11024679|FG000|NOT COMPLETED|Overall Study||41
9908388|NCT01177813|11024680|FG001|NOT COMPLETED|Overall Study||18
9908389|NCT01177813|11024681|FG002|NOT COMPLETED|Overall Study||20
9908390|NCT01177813|11024682|FG003|NOT COMPLETED|Overall Study||17
9908391|NCT01177813|11024683|FG004|NOT COMPLETED|Overall Study||9
9908392|NCT01177943|11024697|FG000|STARTED|First Intervention||21
9908393|NCT01177943|11024698|FG001|STARTED|First Intervention||21
9908394|NCT01177943|11024697|FG000|COMPLETED|First Intervention||19
9908395|NCT01177943|11024698|FG001|COMPLETED|First Intervention||21
9908396|NCT01177943|11024697|FG000|NOT COMPLETED|First Intervention||2
9908397|NCT01177943|11024698|FG001|NOT COMPLETED|First Intervention||0
9908398|NCT01177943|11024697|FG000|STARTED|Second Intervention||19
9908399|NCT01177943|11024698|FG001|STARTED|Second Intervention||21
9908400|NCT01177943|11024697|FG000|COMPLETED|Second Intervention||19
9908401|NCT01177943|11024698|FG001|COMPLETED|Second Intervention||21
9908402|NCT01177943|11024697|FG000|NOT COMPLETED|Second Intervention||0
9908403|NCT01177943|11024698|FG001|NOT COMPLETED|Second Intervention||0
9908404|NCT01177956|11024704|FG000|STARTED|Overall Study||68
9908405|NCT01177956|11024704|FG000|COMPLETED|Overall Study||68
9908406|NCT01177956|11024704|FG000|NOT COMPLETED|Overall Study||0
9908407|NCT01177969|11024711|FG000|STARTED|Overall Study||19
9908408|NCT01177969|11024712|FG001|STARTED|Overall Study||14
9908409|NCT01177969|11024711|FG000|COMPLETED|Overall Study||16
9908410|NCT01177969|11024712|FG001|COMPLETED|Overall Study||11
9908411|NCT01177969|11024711|FG000|NOT COMPLETED|Overall Study||3
9908412|NCT01177969|11024712|FG001|NOT COMPLETED|Overall Study||3
9908413|NCT01178073|11024721|FG000|STARTED|Overall Study||302
9908414|NCT01178073|11024722|FG001|STARTED|Overall Study||152
9908415|NCT01178073|11024723|FG002|STARTED|Overall Study||151
9908416|NCT01178073|11024721|FG000|COMPLETED|Overall Study||240
9908417|NCT01178073|11024722|FG001|COMPLETED|Overall Study||108
9908418|NCT01178073|11024723|FG002|COMPLETED|Overall Study||105
9908419|NCT01178073|11024721|FG000|NOT COMPLETED|Overall Study||62
9908420|NCT01178073|11024722|FG001|NOT COMPLETED|Overall Study||44
9908421|NCT01178073|11024723|FG002|NOT COMPLETED|Overall Study||46
9908422|NCT01178086|11024734|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
9908423|NCT01178086|11024734|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
9908424|NCT01178086|11024734|FG000|COMPLETED|Overall Study||349
9908425|NCT01178086|11024734|FG000|NOT COMPLETED|Overall Study||332
9908426|NCT01178099|11024744|FG000|STARTED|Overall Study||13
9908427|NCT01178099|11024745|FG001|STARTED|Overall Study||13
9908428|NCT01178099|11024744|FG000|COMPLETED|Overall Study||13
9908429|NCT01178099|11024745|FG001|COMPLETED|Overall Study||12
9908430|NCT01178099|11024744|FG000|NOT COMPLETED|Overall Study||0
9908431|NCT01178099|11024745|FG001|NOT COMPLETED|Overall Study||1
9908432|NCT01178125|11024755|FG000|STARTED|Overall Study|Number enrolled.|2858
9908433|NCT01178125|11024755|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
9908434|NCT01178125|11024755|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
9908435|NCT01178125|11024755|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
9908436|NCT01178125|11024755|FG000|COMPLETED|Overall Study||1680
9908437|NCT01178125|11024755|FG000|NOT COMPLETED|Overall Study||1178
9908438|NCT01178138|11024764|FG000|STARTED|Overall Study||24
9908439|NCT01178138|11024764|FG000|Completed 6 Sessions|Overall Study||1
9908440|NCT01178138|11024764|FG000|Completed 5 Sessions|Overall Study||1
9908441|NCT01178138|11024764|FG000|Completed 3 Sessions|Overall Study||1
9908442|NCT01178138|11024764|FG000|COMPLETED|Overall Study||1
9908443|NCT01178138|11024764|FG000|NOT COMPLETED|Overall Study||23
9908444|NCT01178216|11024773|FG000|STARTED|Overall Study||41
9908445|NCT01178216|11024773|FG000|COMPLETED|Overall Study||39
9908446|NCT01178216|11024773|FG000|NOT COMPLETED|Overall Study||2
9908447|NCT01178268|11024779|FG000|STARTED|Overall Study||367
9908448|NCT01178268|11024780|FG001|STARTED|Overall Study||121
9908449|NCT01178268|11024779|FG000|COMPLETED|Overall Study||360
9908450|NCT01178268|11024780|FG001|COMPLETED|Overall Study||120
9908451|NCT01178268|11024779|FG000|NOT COMPLETED|Overall Study||7
9908452|NCT01178268|11024780|FG001|NOT COMPLETED|Overall Study||1
9908453|NCT01178281|11024789|FG000|STARTED|Overall Study||168
9908454|NCT01178281|11024790|FG001|STARTED|Overall Study||84
9908455|NCT01178281|11024791|FG002|STARTED|Overall Study||15
9908456|NCT01178281|11024789|FG000|Received Study Drug|Overall Study||167
9908457|NCT01178281|11024790|FG001|Received Study Drug|Overall Study||83
9908458|NCT01178281|11024791|FG002|Received Study Drug|Overall Study||15
9908459|NCT01178281|11024789|FG000|COMPLETED|Overall Study||168
9908460|NCT01178281|11024790|FG001|COMPLETED|Overall Study||84
9908461|NCT01178281|11024791|FG002|COMPLETED|Overall Study||15
9908462|NCT01178281|11024789|FG000|NOT COMPLETED|Overall Study||0
9908463|NCT01178281|11024790|FG001|NOT COMPLETED|Overall Study||0
9908464|NCT01178281|11024791|FG002|NOT COMPLETED|Overall Study||0
9908465|NCT01178294|11024801|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
9908466|NCT01178294|11024801|FG000|COMPLETED|Overall Study||18
9908467|NCT01178294|11024801|FG000|NOT COMPLETED|Overall Study||11
9908468|NCT01178333|11024808|FG000|STARTED|Overall Study||71
9908469|NCT01178333|11024809|FG001|STARTED|Overall Study||284
9908470|NCT01178333|11024810|FG002|STARTED|Overall Study||87
9908471|NCT01178333|11024808|FG000|COMPLETED|Overall Study||71
9908472|NCT01178333|11024809|FG001|COMPLETED|Overall Study||284
9908473|NCT01178333|11024810|FG002|COMPLETED|Overall Study||87
9908474|NCT01178333|11024808|FG000|NOT COMPLETED|Overall Study||0
9908475|NCT01178333|11024809|FG001|NOT COMPLETED|Overall Study||0
9908476|NCT01178333|11024810|FG002|NOT COMPLETED|Overall Study||0
9908477|NCT01178385|11024822|FG000|STARTED|Overall Study||24
9908478|NCT01178385|11024823|FG001|STARTED|Overall Study||21
9908479|NCT01178385|11024822|FG000|COMPLETED|Overall Study||22
9908480|NCT01178385|11024823|FG001|COMPLETED|Overall Study||21
9908481|NCT01178385|11024822|FG000|NOT COMPLETED|Overall Study||2
9908482|NCT01178385|11024823|FG001|NOT COMPLETED|Overall Study||0
9908483|NCT01178411|11024829|FG000|STARTED|Overall Study||60
9908484|NCT01178411|11024829|FG000|COMPLETED|Overall Study||0
9908485|NCT01178411|11024829|FG000|NOT COMPLETED|Overall Study||60
9908486|NCT01178528|11024836|FG000|STARTED|Overall Study||41
9908487|NCT01178528|11024837|FG001|STARTED|Overall Study||38
9908488|NCT01178528|11024838|FG002|STARTED|Overall Study||42
9908489|NCT01178528|11024836|FG000|COMPLETED|Overall Study||41
9908490|NCT01178528|11024837|FG001|COMPLETED|Overall Study||38
9908491|NCT01178528|11024838|FG002|COMPLETED|Overall Study||42
9908492|NCT01178528|11024836|FG000|NOT COMPLETED|Overall Study||0
9908493|NCT01178528|11024837|FG001|NOT COMPLETED|Overall Study||0
9908494|NCT01178528|11024838|FG002|NOT COMPLETED|Overall Study||0
9908495|NCT01178671|11024849|FG000|STARTED|Overall Study||18
9908496|NCT01178671|11024850|FG001|STARTED|Overall Study||18
9908497|NCT01178671|11024849|FG000|COMPLETED|Overall Study||6
9908498|NCT01178671|11024850|FG001|COMPLETED|Overall Study||3
9908499|NCT01178671|11024849|FG000|NOT COMPLETED|Overall Study||12
9908500|NCT01178671|11024850|FG001|NOT COMPLETED|Overall Study||15
9908501|NCT01178762|11024856|FG000|STARTED|Overall Study||42
9908502|NCT01178762|11024856|FG000|COMPLETED|Overall Study||27
9908503|NCT01178762|11024856|FG000|NOT COMPLETED|Overall Study||15
9908504|NCT01178827|11024863|FG000|STARTED|Overall Study||6
9908505|NCT01178827|11024864|FG001|STARTED|Overall Study||10
9908506|NCT01178827|11024865|FG002|STARTED|Overall Study||4
9908507|NCT01178827|11024863|FG000|COMPLETED|Overall Study||6
9908508|NCT01178827|11024864|FG001|COMPLETED|Overall Study||10
9908509|NCT01178827|11024865|FG002|COMPLETED|Overall Study||4
9908510|NCT01178827|11024863|FG000|NOT COMPLETED|Overall Study||0
9908511|NCT01178827|11024864|FG001|NOT COMPLETED|Overall Study||0
9908512|NCT01178827|11024865|FG002|NOT COMPLETED|Overall Study||0
9908513|NCT01178853|11024875|FG000|STARTED|Period 1 (Warfarin Titration)||24
9908514|NCT01178853|11024876|FG001|STARTED|Period 1 (Warfarin Titration)||24
9908515|NCT01178853|11024875|FG000|COMPLETED|Period 1 (Warfarin Titration)||23
9908516|NCT01178853|11024876|FG001|COMPLETED|Period 1 (Warfarin Titration)||22
9908517|NCT01178853|11024875|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1
9908518|NCT01178853|11024876|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2
9908519|NCT01178853|11024875|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23
9908520|NCT01178853|11024876|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22
9908521|NCT01178853|11024875|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22
9908522|NCT01178853|11024876|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22
9908523|NCT01178853|11024875|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
9908524|NCT01178853|11024876|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
9908525|NCT01178853|11024875|FG000|STARTED|Period 3 (Warfarin Titration)||22
9908526|NCT01178853|11024876|FG001|STARTED|Period 3 (Warfarin Titration)||22
9908527|NCT01178853|11024875|FG000|COMPLETED|Period 3 (Warfarin Titration)||21
9908528|NCT01178853|11024876|FG001|COMPLETED|Period 3 (Warfarin Titration)||22
9908529|NCT01178853|11024875|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1
9908530|NCT01178853|11024876|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0
9908531|NCT01178853|11024875|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21
9908532|NCT01178853|11024876|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22
9908533|NCT01178853|11024875|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21
9908534|NCT01178853|11024876|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19
9908535|NCT01178853|11024875|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
9908536|NCT01178853|11024876|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
9908537|NCT01178944|11024882|FG000|STARTED|Overall Study||35
9908538|NCT01178944|11024882|FG000|COMPLETED|Overall Study||35
9908539|NCT01178944|11024882|FG000|NOT COMPLETED|Overall Study||0
9908540|NCT01179048|11024888|FG000|STARTED|Overall Study||4668
9908541|NCT01179048|11024889|FG001|STARTED|Overall Study||4672
9908542|NCT01179048|11024888|FG000|COMPLETED|Overall Study||4529
9908543|NCT01179048|11024889|FG001|COMPLETED|Overall Study||4513
9908544|NCT01179048|11024888|FG000|NOT COMPLETED|Overall Study||139
9908545|NCT01179048|11024889|FG001|NOT COMPLETED|Overall Study||159
9908546|NCT01179113|11024897|FG000|STARTED|Overall Study||17
9908547|NCT01179113|11024898|FG001|STARTED|Overall Study||16
9908548|NCT01179113|11024897|FG000|COMPLETED|Overall Study||17
9908549|NCT01179113|11024898|FG001|COMPLETED|Overall Study||16
9908550|NCT01179113|11024897|FG000|NOT COMPLETED|Overall Study||0
9908551|NCT01179113|11024898|FG001|NOT COMPLETED|Overall Study||0
9908552|NCT01179191|11024904|FG000|STARTED|Titration Phase (up to 6 Weeks)||684
9908553|NCT01179191|11024904|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351
9908554|NCT01179191|11024904|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
9908555|NCT01179191|11024904|FG000|STARTED|Maintenance Phase (8 Weeks)||351
9908556|NCT01179191|11024904|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234
9908557|NCT01179191|11024904|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
9908558|NCT01179217|11024910|FG000|STARTED|Overall Study||152
9908559|NCT01179217|11024911|FG001|STARTED|Overall Study||78
9908560|NCT01179217|11024910|FG000|COMPLETED|Overall Study||97
9908561|NCT01179217|11024911|FG001|COMPLETED|Overall Study||59
9908562|NCT01179217|11024910|FG000|NOT COMPLETED|Overall Study||55
9908563|NCT01179217|11024911|FG001|NOT COMPLETED|Overall Study||19
9908564|NCT01179334|11024921|FG000|STARTED|Treatment Period||12
9908565|NCT01179334|11024922|FG001|STARTED|Treatment Period||6
9908566|NCT01179334|11024921|FG000|Participants Received Treatment|Treatment Period||12
9908567|NCT01179334|11024922|FG001|Participants Received Treatment|Treatment Period||6
9908568|NCT01179334|11024921|FG000|COMPLETED|Treatment Period||11
9908569|NCT01179334|11024922|FG001|COMPLETED|Treatment Period||6
9908570|NCT01179334|11024921|FG000|NOT COMPLETED|Treatment Period||1
9908571|NCT01179334|11024922|FG001|NOT COMPLETED|Treatment Period||0
9908572|NCT01179334|11024921|FG000|STARTED|Long-term Extension (LTE) Period||11
9908573|NCT01179334|11024922|FG001|STARTED|Long-term Extension (LTE) Period||6
9908574|NCT01179334|11024921|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
9908575|NCT01179334|11024922|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
9908576|NCT01179334|11024921|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11
9908577|NCT01179334|11024922|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6
9908578|NCT01179347|11024930|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
9908579|NCT01179347|11024931|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
9908580|NCT01179347|11024930|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
9908581|NCT01179347|11024931|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
9908582|NCT01179347|11024930|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8
9908583|NCT01179347|11024931|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
9908584|NCT01179347|11024930|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
9908585|NCT01179347|11024931|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
9908586|NCT01179347|11024930|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
9908587|NCT01179347|11024931|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
9908588|NCT01179347|11024930|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15
9908589|NCT01179347|11024931|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16
9908590|NCT01179477|11024939|FG000|STARTED|Overall Study||1930
9908591|NCT01179477|11024939|FG000|COMPLETED|Overall Study||843
9908592|NCT01179477|11024939|FG000|NOT COMPLETED|Overall Study||1087
9908593|NCT01179490|11024943|FG000|STARTED|Overall Study||5
9908594|NCT01179490|11024943|FG000|COMPLETED|Overall Study||5
9908595|NCT01179490|11024943|FG000|NOT COMPLETED|Overall Study||0
9908596|NCT01179516|11024950|FG000|STARTED|Overall Study||160
9908597|NCT01179516|11024951|FG001|STARTED|Overall Study||157
9908598|NCT01179516|11024952|FG002|STARTED|Overall Study||152
9908599|NCT01179516|11024950|FG000|Treated|Overall Study||160
9908600|NCT01179516|11024951|FG001|Treated|Overall Study||154
9908601|NCT01179516|11024952|FG002|Treated|Overall Study||151
9908602|NCT01179516|11024950|FG000|COMPLETED|Overall Study||133
9908603|NCT01179516|11024951|FG001|COMPLETED|Overall Study||131
10203628|NCT03465878|11330526|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
10203629|NCT03465878|11330527|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
10203630|NCT03465878|11330528|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
9908604|NCT01179516|11024952|FG002|COMPLETED|Overall Study||121
9908605|NCT01179516|11024950|FG000|NOT COMPLETED|Overall Study||27
9908606|NCT01179516|11024951|FG001|NOT COMPLETED|Overall Study||26
9908607|NCT01179516|11024952|FG002|NOT COMPLETED|Overall Study||31
9908608|NCT01179568|11024964|FG000|STARTED|Overall Study||101
9908609|NCT01179568|11024965|FG001|STARTED|Overall Study||99
9908610|NCT01179568|11024966|FG002|STARTED|Overall Study||99
9908611|NCT01179568|11024967|FG003|STARTED|Overall Study||96
9908612|NCT01179568|11024964|FG000|Completed Week 12 Assessment|Overall Study||69
9908613|NCT01179568|11024965|FG001|Completed Week 12 Assessment|Overall Study||69
9908614|NCT01179568|11024966|FG002|Completed Week 12 Assessment|Overall Study||76
9908615|NCT01179568|11024967|FG003|Completed Week 12 Assessment|Overall Study||75
9908616|NCT01179568|11024964|FG000|COMPLETED|Overall Study||73
9908617|NCT01179568|11024965|FG001|COMPLETED|Overall Study||61
9908618|NCT01179568|11024966|FG002|COMPLETED|Overall Study||76
9908619|NCT01179568|11024967|FG003|COMPLETED|Overall Study||76
9908620|NCT01179568|11024964|FG000|NOT COMPLETED|Overall Study||28
9908621|NCT01179568|11024965|FG001|NOT COMPLETED|Overall Study||38
9908622|NCT01179568|11024966|FG002|NOT COMPLETED|Overall Study||23
9908623|NCT01179568|11024967|FG003|NOT COMPLETED|Overall Study||20
9908624|NCT01179672|11024982|FG000|STARTED|Overall Study||203
9908625|NCT01179672|11024983|FG001|STARTED|Overall Study||202
9908626|NCT01179672|11024982|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202
9908627|NCT01179672|11024983|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
9908628|NCT01179672|11024982|FG000|Entered Taper|Overall Study||181
9908629|NCT01179672|11024983|FG001|Entered Taper|Overall Study||177
9908630|NCT01179672|11024982|FG000|COMPLETED|Overall Study||173
9908631|NCT01179672|11024983|FG001|COMPLETED|Overall Study||176
9908632|NCT01179672|11024982|FG000|NOT COMPLETED|Overall Study||30
9908633|NCT01179672|11024983|FG001|NOT COMPLETED|Overall Study||26
9908634|NCT01179919|11024993|FG000|STARTED|Overall Study||21
9908635|NCT01179919|11024993|FG000|COMPLETED|Overall Study||19
9908636|NCT01179919|11024993|FG000|NOT COMPLETED|Overall Study||2
9908637|NCT01179984|11024997|FG000|STARTED|Overall Study||76
9908638|NCT01179984|11024997|FG000|COMPLETED|Overall Study||58
9908639|NCT01179984|11024997|FG000|NOT COMPLETED|Overall Study||18
9908640|NCT01180036|11025004|FG000|STARTED|Overall Study||65
9908641|NCT01180036|11025005|FG001|STARTED|Overall Study||65
9908642|NCT01180036|11025004|FG000|COMPLETED|Overall Study||65
9908643|NCT01180036|11025005|FG001|COMPLETED|Overall Study||65
9908644|NCT01180036|11025004|FG000|NOT COMPLETED|Overall Study||0
9908645|NCT01180036|11025005|FG001|NOT COMPLETED|Overall Study||0
9908646|NCT01180049|11025015|FG000|STARTED|Overall Study||53
9908647|NCT01180049|11025016|FG001|STARTED|Overall Study||48
9908648|NCT01180049|11025015|FG000|COMPLETED|Overall Study||0
9908649|NCT01180049|11025016|FG001|COMPLETED|Overall Study||0
9908650|NCT01180049|11025015|FG000|NOT COMPLETED|Overall Study||53
9908651|NCT01180049|11025016|FG001|NOT COMPLETED|Overall Study||48
9908652|NCT01180127|11025026|FG000|STARTED|Overall Study||10
9908653|NCT01180127|11025027|FG001|STARTED|Overall Study||11
9908654|NCT01180127|11025028|FG002|STARTED|Overall Study||10
9908655|NCT01180127|11025029|FG003|STARTED|Overall Study||10
9908656|NCT01180127|11025026|FG000|COMPLETED|Overall Study||8
9908657|NCT01180127|11025027|FG001|COMPLETED|Overall Study||11
9908658|NCT01180127|11025028|FG002|COMPLETED|Overall Study||9
9908659|NCT01180127|11025029|FG003|COMPLETED|Overall Study||9
9908660|NCT01180127|11025026|FG000|NOT COMPLETED|Overall Study||2
9908661|NCT01180127|11025027|FG001|NOT COMPLETED|Overall Study||0
9908662|NCT01180127|11025028|FG002|NOT COMPLETED|Overall Study||1
9908663|NCT01180127|11025029|FG003|NOT COMPLETED|Overall Study||1
9908664|NCT01180244|11025045|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
9908665|NCT01180244|11025046|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
9908666|NCT01180244|11025045|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
9908667|NCT01180244|11025046|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
9908668|NCT01180244|11025045|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
9908669|NCT01180244|11025046|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
9908670|NCT01180244|11025045|FG000|NOT COMPLETED|Overall Study||6
9908671|NCT01180244|11025046|FG001|NOT COMPLETED|Overall Study||8
9908672|NCT01180296|11025054|FG000|STARTED|Overall Study||20
9908673|NCT01180296|11025055|FG001|STARTED|Overall Study||16
9908674|NCT01180296|11025054|FG000|COMPLETED|Overall Study||19
9908675|NCT01180296|11025055|FG001|COMPLETED|Overall Study||14
9908676|NCT01180296|11025054|FG000|NOT COMPLETED|Overall Study||1
9908677|NCT01180296|11025055|FG001|NOT COMPLETED|Overall Study||2
9908678|NCT01180400|11025065|FG000|STARTED|Overall Study||147
9908679|NCT01180400|11025066|FG001|STARTED|Overall Study||148
9908680|NCT01180400|11025065|FG000|Received Treatment|Overall Study||147
9908681|NCT01180400|11025066|FG001|Received Treatment|Overall Study||146
9908682|NCT01180400|11025065|FG000|COMPLETED|Overall Study||122
9908683|NCT01180400|11025066|FG001|COMPLETED|Overall Study||121
9908684|NCT01180400|11025065|FG000|NOT COMPLETED|Overall Study||25
9908685|NCT01180400|11025066|FG001|NOT COMPLETED|Overall Study||27
9908686|NCT01180478|11025074|FG000|STARTED|Overall Study||484
9908687|NCT01180478|11025075|FG001|STARTED|Overall Study||481
9908688|NCT01180478|11025074|FG000|COMPLETED|Overall Study||303
9908689|NCT01180478|11025075|FG001|COMPLETED|Overall Study||293
9908690|NCT01180478|11025074|FG000|NOT COMPLETED|Overall Study||181
9908691|NCT01180478|11025075|FG001|NOT COMPLETED|Overall Study||188
9908692|NCT01180647|11025085|FG000|STARTED|Overall Study||17
9908693|NCT01180647|11025086|FG001|STARTED|Overall Study||17
9908694|NCT01180647|11025085|FG000|COMPLETED|Overall Study||12
9908695|NCT01180647|11025086|FG001|COMPLETED|Overall Study||11
9908696|NCT01180647|11025085|FG000|NOT COMPLETED|Overall Study||5
9908697|NCT01180647|11025086|FG001|NOT COMPLETED|Overall Study||6
9908698|NCT01180660|11025094|FG000|STARTED|Overall Study||25
9908699|NCT01180660|11025095|FG001|STARTED|Overall Study||26
9908700|NCT01180660|11025094|FG000|COMPLETED|Overall Study||24
9908701|NCT01180660|11025095|FG001|COMPLETED|Overall Study||26
9908702|NCT01180660|11025094|FG000|NOT COMPLETED|Overall Study||1
9908703|NCT01180660|11025095|FG001|NOT COMPLETED|Overall Study||0
9908704|NCT01180777|11025101|FG000|STARTED|Overall Study||92
9908705|NCT01180777|11025101|FG000|COMPLETED|Overall Study||80
9908706|NCT01180777|11025101|FG000|NOT COMPLETED|Overall Study||12
9908707|NCT01180790|11025114|FG000|STARTED|Overall Study||16
9908708|NCT01180790|11025115|FG001|STARTED|Overall Study||16
9908709|NCT01180790|11025116|FG002|STARTED|Overall Study||17
9908710|NCT01180790|11025117|FG003|STARTED|Overall Study||15
9908711|NCT01180790|11025118|FG004|STARTED|Overall Study||19
9908712|NCT01180790|11025119|FG005|STARTED|Overall Study||20
9908713|NCT01180790|11025120|FG006|STARTED|Overall Study||19
9908714|NCT01180790|11025114|FG000|COMPLETED|Overall Study||7
9908715|NCT01180790|11025115|FG001|COMPLETED|Overall Study||11
9908716|NCT01180790|11025116|FG002|COMPLETED|Overall Study||4
9908717|NCT01180790|11025117|FG003|COMPLETED|Overall Study||6
9908718|NCT01180790|11025118|FG004|COMPLETED|Overall Study||14
9908719|NCT01180790|11025119|FG005|COMPLETED|Overall Study||13
9908720|NCT01180790|11025120|FG006|COMPLETED|Overall Study||18
9908721|NCT01180790|11025114|FG000|NOT COMPLETED|Overall Study||9
9908722|NCT01180790|11025115|FG001|NOT COMPLETED|Overall Study||5
9908723|NCT01180790|11025116|FG002|NOT COMPLETED|Overall Study||13
9908724|NCT01180790|11025117|FG003|NOT COMPLETED|Overall Study||9
9908725|NCT01180790|11025118|FG004|NOT COMPLETED|Overall Study||5
9908726|NCT01180790|11025119|FG005|NOT COMPLETED|Overall Study||7
9908727|NCT01180790|11025120|FG006|NOT COMPLETED|Overall Study||1
9908728|NCT01180894|11025166|FG000|STARTED|Overall Study||75
9908729|NCT01180894|11025167|FG001|STARTED|Overall Study||75
9908730|NCT01180894|11025166|FG000|COMPLETED|Overall Study||75
9908731|NCT01180894|11025167|FG001|COMPLETED|Overall Study||75
9908732|NCT01180894|11025166|FG000|NOT COMPLETED|Overall Study||0
9908733|NCT01180894|11025167|FG001|NOT COMPLETED|Overall Study||0
9908734|NCT01180985|11025175|FG000|STARTED|Period 1 (7 +/- Days)||27
9908735|NCT01180985|11025176|FG001|STARTED|Period 1 (7 +/- Days)||26
9908736|NCT01180985|11025175|FG000|COMPLETED|Period 1 (7 +/- Days)||27
9908737|NCT01180985|11025176|FG001|COMPLETED|Period 1 (7 +/- Days)||26
9908738|NCT01180985|11025175|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0
9908739|NCT01180985|11025176|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0
9908740|NCT01180985|11025175|FG000|STARTED|Period 2 (7 +/- 1 Days)||27
9908741|NCT01180985|11025176|FG001|STARTED|Period 2 (7 +/- 1 Days)||26
9908742|NCT01180985|11025175|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26
9908743|NCT01180985|11025176|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26
9908744|NCT01180985|11025175|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
9908745|NCT01180985|11025176|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
9908746|NCT01180998|11025186|FG000|STARTED|Overall Study||67
9908747|NCT01180998|11025187|FG001|STARTED|Overall Study||72
9908748|NCT01180998|11025188|FG002|STARTED|Overall Study||61
9908749|NCT01180998|11025186|FG000|COMPLETED|Overall Study||63
9908750|NCT01180998|11025187|FG001|COMPLETED|Overall Study||68
9908751|NCT01180998|11025188|FG002|COMPLETED|Overall Study||51
9908752|NCT01180998|11025186|FG000|NOT COMPLETED|Overall Study||4
9908753|NCT01180998|11025187|FG001|NOT COMPLETED|Overall Study||4
9908754|NCT01180998|11025188|FG002|NOT COMPLETED|Overall Study||10
9908755|NCT01181011|11025197|FG000|STARTED|Overall Study||28
9908756|NCT01181011|11025197|FG000|Received Telmisartan 80mg|Overall Study||27
9908757|NCT01181011|11025197|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
9908758|NCT01181011|11025197|FG000|Received Amlodipine 5mg|Overall Study||26
9908759|NCT01181011|11025197|FG000|COMPLETED|Overall Study||25
9908760|NCT01181011|11025197|FG000|NOT COMPLETED|Overall Study||3
9908761|NCT01181050|11025208|FG000|STARTED|Overall Study||41
9908762|NCT01181050|11025209|FG001|STARTED|Overall Study||22
9908763|NCT01181050|11025208|FG000|COMPLETED|Overall Study||41
9908764|NCT01181050|11025209|FG001|COMPLETED|Overall Study||22
9908765|NCT01181050|11025208|FG000|NOT COMPLETED|Overall Study||0
9908766|NCT01181050|11025209|FG001|NOT COMPLETED|Overall Study||0
9908767|NCT01181076|11025217|FG000|STARTED|Overall Study||59
9908768|NCT01181076|11025218|FG001|STARTED|Overall Study||60
9908769|NCT01181076|11025217|FG000|COMPLETED|Overall Study||40
9908770|NCT01181076|11025218|FG001|COMPLETED|Overall Study|As determined|48
9908771|NCT01181076|11025217|FG000|NOT COMPLETED|Overall Study||19
9908772|NCT01181076|11025218|FG001|NOT COMPLETED|Overall Study||12
10009689|NCT01768117|11132364|FG000|STARTED|Overall Study||13
10009690|NCT01768117|11132364|FG000|COMPLETED|Overall Study||7
10009691|NCT01768117|11132364|FG000|NOT COMPLETED|Overall Study||6
9908773|NCT01181102|11025226|FG000|STARTED|Overall Study||360
9908774|NCT01181102|11025227|FG001|STARTED|Overall Study||356
9908775|NCT01181102|11025226|FG000|Safety Analysis Set|Overall Study||354
9908776|NCT01181102|11025227|FG001|Safety Analysis Set|Overall Study||349
9908777|NCT01181102|11025226|FG000|Efficacy Analysis Population|Overall Study||299
9908778|NCT01181102|11025227|FG001|Efficacy Analysis Population|Overall Study||295
9908779|NCT01181102|11025226|FG000|COMPLETED|Overall Study||309
9908780|NCT01181102|11025227|FG001|COMPLETED|Overall Study||310
9908781|NCT01181102|11025226|FG000|NOT COMPLETED|Overall Study||51
9908782|NCT01181102|11025227|FG001|NOT COMPLETED|Overall Study||46
9908783|NCT01181128|11025236|FG000|STARTED|Overall Study||118
9908784|NCT01181128|11025237|FG001|STARTED|Overall Study||24
9908785|NCT01181128|11025238|FG002|STARTED|Overall Study||23
9908786|NCT01181128|11025236|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30
10009692|NCT01768286|11132372|FG000|STARTED|Overall Study||109
9908787|NCT01181128|11025237|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0
9908788|NCT01181128|11025238|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0
9908789|NCT01181128|11025236|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
9908790|NCT01181128|11025237|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
9908791|NCT01181128|11025238|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
9908792|NCT01181128|11025236|FG000|COMPLETED|Overall Study||112
9908793|NCT01181128|11025237|FG001|COMPLETED|Overall Study||19
9908794|NCT01181128|11025238|FG002|COMPLETED|Overall Study||22
9908795|NCT01181128|11025236|FG000|NOT COMPLETED|Overall Study||6
9908796|NCT01181128|11025237|FG001|NOT COMPLETED|Overall Study||5
9908797|NCT01181128|11025238|FG002|NOT COMPLETED|Overall Study||1
9908798|NCT01181141|11025260|FG000|STARTED|Overall Study||62
9908799|NCT01181141|11025261|FG001|STARTED|Overall Study||30
9908800|NCT01181141|11025260|FG000|Safety Analysis Population|Overall Study||59
9908801|NCT01181141|11025261|FG001|Safety Analysis Population|Overall Study||29
9908802|NCT01181141|11025260|FG000|COMPLETED|Overall Study||50
9908803|NCT01181141|11025261|FG001|COMPLETED|Overall Study||26
9908804|NCT01181141|11025260|FG000|NOT COMPLETED|Overall Study||12
9908805|NCT01181141|11025261|FG001|NOT COMPLETED|Overall Study||4
9908806|NCT01181167|11025269|FG000|STARTED|Overall Study||307
9908807|NCT01181167|11025270|FG001|STARTED|Overall Study||303
9908808|NCT01181167|11025269|FG000|Efficacy Analysis Population|Overall Study||255
9908809|NCT01181167|11025270|FG001|Efficacy Analysis Population|Overall Study||248
9908810|NCT01181167|11025269|FG000|COMPLETED|Overall Study||284
9908811|NCT01181167|11025270|FG001|COMPLETED|Overall Study||271
9908812|NCT01181167|11025269|FG000|NOT COMPLETED|Overall Study||23
9908813|NCT01181167|11025270|FG001|NOT COMPLETED|Overall Study||32
9908814|NCT01181258|11025276|FG000|STARTED|Overall Study||16
9908815|NCT01181258|11025276|FG000|COMPLETED|Overall Study||16
9908816|NCT01181258|11025276|FG000|NOT COMPLETED|Overall Study||0
9908817|NCT01181271|11025280|FG000|STARTED|Autologous Transplant||42
10009693|NCT01768286|11132373|FG001|STARTED|Overall Study||111
10009694|NCT01768286|11132374|FG002|STARTED|Overall Study||110
10009695|NCT01768286|11132375|FG003|STARTED|Overall Study||111
10009696|NCT01768286|11132372|FG000|COMPLETED|Overall Study||102
10009697|NCT01768286|11132373|FG001|COMPLETED|Overall Study||107
10009698|NCT01768286|11132374|FG002|COMPLETED|Overall Study||108
10009699|NCT01768286|11132375|FG003|COMPLETED|Overall Study||110
10009700|NCT01768286|11132372|FG000|NOT COMPLETED|Overall Study||7
10009701|NCT01768286|11132373|FG001|NOT COMPLETED|Overall Study||4
10009702|NCT01768286|11132374|FG002|NOT COMPLETED|Overall Study||2
10009703|NCT01768286|11132375|FG003|NOT COMPLETED|Overall Study||1
10009704|NCT01768325|11132387|FG000|STARTED|Overall Study||37
10009705|NCT01768325|11132388|FG001|STARTED|Overall Study||41
10009706|NCT01768325|11132387|FG000|COMPLETED|Overall Study||37
10009707|NCT01768325|11132388|FG001|COMPLETED|Overall Study||41
10009708|NCT01768325|11132387|FG000|NOT COMPLETED|Overall Study||0
10009709|NCT01768325|11132388|FG001|NOT COMPLETED|Overall Study||0
10009710|NCT01768520|11132399|FG000|STARTED|Overall Study||152
10009711|NCT01768520|11132400|FG001|STARTED|Overall Study||147
10009712|NCT01768520|11132401|FG002|STARTED|Overall Study||39
10009713|NCT01768520|11132399|FG000|COMPLETED|Overall Study||120
10009714|NCT01768520|11132400|FG001|COMPLETED|Overall Study||121
10009715|NCT01768520|11132401|FG002|COMPLETED|Overall Study||30
10009716|NCT01768520|11132399|FG000|NOT COMPLETED|Overall Study||32
10009717|NCT01768520|11132400|FG001|NOT COMPLETED|Overall Study||26
10009718|NCT01768520|11132401|FG002|NOT COMPLETED|Overall Study||9
10009719|NCT01768559|11132412|FG000|STARTED|Overall Study||298
10009720|NCT01768559|11132413|FG001|STARTED|Overall Study||298
10009721|NCT01768559|11132414|FG002|STARTED|Overall Study||298
10009722|NCT01768559|11132412|FG000|Treated|Overall Study||298
10009723|NCT01768559|11132413|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
10009724|NCT01768559|11132414|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
10009725|NCT01768559|11132412|FG000|COMPLETED|Overall Study||268
10009726|NCT01768559|11132413|FG001|COMPLETED|Overall Study||281
10009727|NCT01768559|11132414|FG002|COMPLETED|Overall Study||285
10009728|NCT01768559|11132412|FG000|NOT COMPLETED|Overall Study||30
10009729|NCT01768559|11132413|FG001|NOT COMPLETED|Overall Study||17
10009730|NCT01768559|11132414|FG002|NOT COMPLETED|Overall Study||13
10009731|NCT01768572|11132429|FG000|STARTED|Overall Study||49
10009732|NCT01768572|11132430|FG001|STARTED|Overall Study||51
10009733|NCT01768572|11132431|FG002|STARTED|Overall Study||102
10009734|NCT01768572|11132429|FG000|COMPLETED|Overall Study||40
10009735|NCT01768572|11132430|FG001|COMPLETED|Overall Study||39
10009736|NCT01768572|11132431|FG002|COMPLETED|Overall Study||96
10009737|NCT01768572|11132429|FG000|NOT COMPLETED|Overall Study||9
10009738|NCT01768572|11132430|FG001|NOT COMPLETED|Overall Study||12
10009739|NCT01768572|11132431|FG002|NOT COMPLETED|Overall Study||6
10009740|NCT01768637|11132441|FG000|STARTED|Overall Study||29
10009741|NCT01768637|11132442|FG001|STARTED|Overall Study||19
10009742|NCT01768637|11132441|FG000|Completed Visit 1|Overall Study||28
10009743|NCT01768637|11132442|FG001|Completed Visit 1|Overall Study||16
10009744|NCT01768637|11132441|FG000|Completed Visit 2|Overall Study||26
9908818|NCT01181271|11025280|FG000|COMPLETED|Autologous Transplant||42
9908819|NCT01181271|11025280|FG000|NOT COMPLETED|Autologous Transplant||0
9908820|NCT01181271|11025280|FG000|STARTED|Evaluation for Allogeneic Transplant||42
9908821|NCT01181271|11025280|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29
9955353|NCT01437605|11074282|FG000|NOT COMPLETED|Overall Study||0
9908822|NCT01181271|11025280|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
9908823|NCT01181271|11025280|FG000|STARTED|Allogeneic Transplant||29
9908824|NCT01181271|11025280|FG000|COMPLETED|Allogeneic Transplant||29
9908825|NCT01181271|11025280|FG000|NOT COMPLETED|Allogeneic Transplant||0
9908826|NCT01181323|11025288|FG000|STARTED|Overall Study||124
9908827|NCT01181323|11025289|FG001|STARTED|Overall Study||124
9908828|NCT01181323|11025290|FG002|STARTED|Overall Study||124
9908829|NCT01181323|11025291|FG003|STARTED|Overall Study||125
9908830|NCT01181323|11025288|FG000|COMPLETED|Overall Study||123
9908831|NCT01181323|11025289|FG001|COMPLETED|Overall Study||121
9908832|NCT01181323|11025290|FG002|COMPLETED|Overall Study||123
9908833|NCT01181323|11025291|FG003|COMPLETED|Overall Study||122
9908834|NCT01181323|11025288|FG000|NOT COMPLETED|Overall Study||1
9908835|NCT01181323|11025289|FG001|NOT COMPLETED|Overall Study||3
9908836|NCT01181323|11025290|FG002|NOT COMPLETED|Overall Study||1
9908837|NCT01181323|11025291|FG003|NOT COMPLETED|Overall Study||3
10009745|NCT01768637|11132442|FG001|Completed Visit 2|Overall Study||13
10009746|NCT01768637|11132441|FG000|COMPLETED|Overall Study||26
10009747|NCT01768637|11132442|FG001|COMPLETED|Overall Study||12
10009748|NCT01768637|11132441|FG000|NOT COMPLETED|Overall Study||3
10009749|NCT01768637|11132442|FG001|NOT COMPLETED|Overall Study||7
10009750|NCT01768676|11132450|FG000|STARTED|Overall Study||90
10009751|NCT01768676|11132451|FG001|STARTED|Overall Study||91
10009752|NCT01768676|11132450|FG000|COMPLETED|Overall Study||66
10009753|NCT01768676|11132451|FG001|COMPLETED|Overall Study||60
10009754|NCT01768676|11132450|FG000|NOT COMPLETED|Overall Study||24
10009755|NCT01768676|11132451|FG001|NOT COMPLETED|Overall Study||31
10009756|NCT01768832|11132460|FG000|STARTED|Overall Study||41
10009757|NCT01768832|11132461|FG001|STARTED|Overall Study||43
10009758|NCT01768832|11132462|FG002|STARTED|Overall Study||35
10009759|NCT01768832|11132460|FG000|COMPLETED|Overall Study||31
10009760|NCT01768832|11132461|FG001|COMPLETED|Overall Study||39
10009761|NCT01768832|11132462|FG002|COMPLETED|Overall Study||26
10009762|NCT01768832|11132460|FG000|NOT COMPLETED|Overall Study||10
10009763|NCT01768832|11132461|FG001|NOT COMPLETED|Overall Study||4
10009764|NCT01768832|11132462|FG002|NOT COMPLETED|Overall Study||9
10009765|NCT01768845|11132470|FG000|STARTED|Overall Study||34
10009766|NCT01768845|11132470|FG000|COMPLETED|Overall Study||11
10009767|NCT01768845|11132470|FG000|NOT COMPLETED|Overall Study||23
10009768|NCT01768858|11132474|FG000|STARTED|Overall Study||96
10009769|NCT01768858|11132474|FG000|COMPLETED|Overall Study||74
10009770|NCT01768858|11132474|FG000|NOT COMPLETED|Overall Study||22
10009771|NCT01769105|11132480|FG000|STARTED|First Intervention||16
10009772|NCT01769105|11132481|FG001|STARTED|First Intervention||19
10009773|NCT01769105|11132480|FG000|COMPLETED|First Intervention||14
10009774|NCT01769105|11132481|FG001|COMPLETED|First Intervention||17
10009775|NCT01769105|11132480|FG000|NOT COMPLETED|First Intervention||2
10009776|NCT01769105|11132481|FG001|NOT COMPLETED|First Intervention||2
10009777|NCT01769105|11132480|FG000|STARTED|Cross-over||14
10009778|NCT01769105|11132481|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
10009779|NCT01769105|11132480|FG000|COMPLETED|Cross-over||9
10009780|NCT01769105|11132481|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0
10009781|NCT01769105|11132480|FG000|NOT COMPLETED|Cross-over||5
10009782|NCT01769105|11132481|FG001|NOT COMPLETED|Cross-over||0
10009783|NCT01769170|11132491|FG000|STARTED|Overall Study||303
10009784|NCT01769170|11132492|FG001|STARTED|Overall Study||149
10009785|NCT01769170|11132491|FG000|COMPLETED|Overall Study||232
10009786|NCT01769170|11132492|FG001|COMPLETED|Overall Study||122
10009787|NCT01769170|11132491|FG000|NOT COMPLETED|Overall Study||71
10009788|NCT01769170|11132492|FG001|NOT COMPLETED|Overall Study||27
10009789|NCT01769196|11132500|FG000|STARTED|Overall Study||272
10009790|NCT01769196|11132501|FG001|STARTED|Overall Study||272
10009791|NCT01769196|11132500|FG000|COMPLETED|Overall Study||0
10009792|NCT01769196|11132501|FG001|COMPLETED|Overall Study||0
10009793|NCT01769196|11132500|FG000|NOT COMPLETED|Overall Study||272
10009794|NCT01769196|11132501|FG001|NOT COMPLETED|Overall Study||272
10009795|NCT01769209|11132507|FG000|STARTED|Overall Study||18
10203631|NCT03465878|11330529|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
10203632|NCT03465878|11330526|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
10203633|NCT03465878|11330527|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
10009796|NCT01769209|11132507|FG000|COMPLETED|Overall Study||18
10009797|NCT01769209|11132507|FG000|NOT COMPLETED|Overall Study||0
10009798|NCT01769222|11132513|FG000|STARTED|Overall Study||3
10009799|NCT01769222|11132514|FG001|STARTED|Overall Study||0
10009800|NCT01769222|11132513|FG000|COMPLETED|Overall Study||3
10009801|NCT01769222|11132514|FG001|COMPLETED|Overall Study||0
10009802|NCT01769222|11132513|FG000|NOT COMPLETED|Overall Study||0
10009803|NCT01769222|11132514|FG001|NOT COMPLETED|Overall Study||0
10203634|NCT03465878|11330528|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
10238737|NCT00484718|11370189|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
10009804|NCT01769248|11132522|FG000|STARTED|Overall Study||70
10009805|NCT01769248|11132523|FG001|STARTED|Overall Study||70
10009806|NCT01769248|11132522|FG000|Participants Who Crossed-over|Overall Study||28
9908838|NCT01181349|11025313|FG000|STARTED|Overall Study||350
9908839|NCT01181349|11025313|FG000|COMPLETED|Overall Study||350
9908840|NCT01181349|11025313|FG000|NOT COMPLETED|Overall Study||0
9955354|NCT01437605|11074283|FG001|NOT COMPLETED|Overall Study||0
10009807|NCT01769248|11132523|FG001|Participants Who Crossed-over|Overall Study||12
10009808|NCT01769248|11132522|FG000|COMPLETED|Overall Study||42
9908841|NCT01181479|11025321|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129
9908842|NCT01181479|11025322|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375
9908843|NCT01181479|11025323|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
9908844|NCT01181479|11025321|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485
9908845|NCT01181479|11025322|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249
9908846|NCT01181479|11025323|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0
10009809|NCT01769248|11132523|FG001|COMPLETED|Overall Study||58
10009810|NCT01769248|11132522|FG000|NOT COMPLETED|Overall Study||28
10009811|NCT01769248|11132523|FG001|NOT COMPLETED|Overall Study||12
10009812|NCT01769274|11132531|FG000|STARTED|Part A||5
10009813|NCT01769274|11132532|FG001|STARTED|Part A||0
10009814|NCT01769274|11132533|FG002|STARTED|Part A||0
10009815|NCT01769274|11132531|FG000|COMPLETED|Part A||5
10009816|NCT01769274|11132532|FG001|COMPLETED|Part A||0
10009817|NCT01769274|11132533|FG002|COMPLETED|Part A||0
10009818|NCT01769274|11132531|FG000|NOT COMPLETED|Part A||0
10009819|NCT01769274|11132532|FG001|NOT COMPLETED|Part A||0
10009820|NCT01769274|11132533|FG002|NOT COMPLETED|Part A||0
10009821|NCT01769274|11132531|FG000|STARTED|Part B:Treatment Session1-Period1||0
10009822|NCT01769274|11132532|FG001|STARTED|Part B:Treatment Session1-Period1||2
10009823|NCT01769274|11132533|FG002|STARTED|Part B:Treatment Session1-Period1||3
10009824|NCT01769274|11132531|FG000|COMPLETED|Part B:Treatment Session1-Period1||0
10009825|NCT01769274|11132532|FG001|COMPLETED|Part B:Treatment Session1-Period1||2
10009826|NCT01769274|11132533|FG002|COMPLETED|Part B:Treatment Session1-Period1||3
10009827|NCT01769274|11132531|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0
10009828|NCT01769274|11132532|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0
10009829|NCT01769274|11132533|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0
10009830|NCT01769274|11132531|FG000|STARTED|Washout Period||0
10009831|NCT01769274|11132532|FG001|STARTED|Washout Period||2
10009832|NCT01769274|11132533|FG002|STARTED|Washout Period||3
10009833|NCT01769274|11132531|FG000|COMPLETED|Washout Period||0
10009834|NCT01769274|11132532|FG001|COMPLETED|Washout Period||2
10009835|NCT01769274|11132533|FG002|COMPLETED|Washout Period||3
9908847|NCT01181479|11025321|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
9908848|NCT01181479|11025322|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
9908849|NCT01181479|11025323|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
9908850|NCT01181479|11025321|FG000|STARTED|Crossover Subjects Recieve AG200-15||0
9908851|NCT01181479|11025322|FG001|STARTED|Crossover Subjects Recieve AG200-15||0
9908852|NCT01181479|11025323|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
9908853|NCT01181479|11025321|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0
9908854|NCT01181479|11025322|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0
9908855|NCT01181479|11025323|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150
9908856|NCT01181479|11025321|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
9908857|NCT01181479|11025322|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
9908858|NCT01181479|11025323|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
9908859|NCT01181492|11025338|FG000|STARTED|Overall Study||103
9908860|NCT01181492|11025339|FG001|STARTED|Overall Study||66
9908861|NCT01181492|11025340|FG002|STARTED|Overall Study||7
9908862|NCT01181492|11025338|FG000|COMPLETED|Overall Study||103
10203635|NCT03465878|11330529|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
10203636|NCT03465878|11330526|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
10203637|NCT03465878|11330527|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
10203638|NCT03465878|11330528|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
10203639|NCT03465878|11330529|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
10203640|NCT03465878|11330526|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
10203641|NCT03465878|11330527|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
10203642|NCT03465878|11330528|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
10203643|NCT03465878|11330529|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
10203644|NCT03465878|11330526|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0
10203645|NCT03465878|11330527|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0
10203646|NCT03465878|11330528|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20
10203647|NCT03465878|11330529|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17
10203648|NCT03465878|11330526|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
10203649|NCT03465878|11330527|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
10238738|NCT00484718|11370190|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
9908863|NCT01181492|11025339|FG001|COMPLETED|Overall Study||66
9908864|NCT01181492|11025340|FG002|COMPLETED|Overall Study||7
9908865|NCT01181492|11025338|FG000|NOT COMPLETED|Overall Study||0
9908866|NCT01181492|11025339|FG001|NOT COMPLETED|Overall Study||0
9908867|NCT01181492|11025340|FG002|NOT COMPLETED|Overall Study||0
10009836|NCT01769274|11132531|FG000|NOT COMPLETED|Washout Period||0
10009837|NCT01769274|11132532|FG001|NOT COMPLETED|Washout Period||0
10009838|NCT01769274|11132533|FG002|NOT COMPLETED|Washout Period||0
10009839|NCT01769274|11132531|FG000|STARTED|Part B:Treatment Session1-Period2||0
10009840|NCT01769274|11132532|FG001|STARTED|Part B:Treatment Session1-Period2||2
10009841|NCT01769274|11132533|FG002|STARTED|Part B:Treatment Session1-Period2||3
10009842|NCT01769274|11132531|FG000|COMPLETED|Part B:Treatment Session1-Period2||0
9908868|NCT01181531|11025350|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157
9908869|NCT01181531|11025351|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155
9908870|NCT01181531|11025350|FG000|Received Investigational Product|Overall Study||155
9908871|NCT01181531|11025351|FG001|Received Investigational Product|Overall Study||153
9908872|NCT01181531|11025350|FG000|COMPLETED|Overall Study||96
9908873|NCT01181531|11025351|FG001|COMPLETED|Overall Study||102
9908874|NCT01181531|11025350|FG000|NOT COMPLETED|Overall Study||61
9908875|NCT01181531|11025351|FG001|NOT COMPLETED|Overall Study||53
9908876|NCT01181596|11025357|FG000|STARTED|Overall Study||31
9908877|NCT01181596|11025357|FG000|COMPLETED|Overall Study||31
9908878|NCT01181596|11025357|FG000|NOT COMPLETED|Overall Study||0
9908879|NCT01181609|11025362|FG000|STARTED|Overall Study||54
10203650|NCT03465878|11330528|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
10203651|NCT03465878|11330529|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
10203652|NCT03465878|11330526|FG000|STARTED|Period2-Part B Second Intervention Day 1||0
10203653|NCT03465878|11330527|FG001|STARTED|Period2-Part B Second Intervention Day 1||0
10203654|NCT03465878|11330528|FG002|STARTED|Period2-Part B Second Intervention Day 1||20
9908880|NCT01181609|11025362|FG000|COMPLETED|Overall Study||1
9908881|NCT01181609|11025362|FG000|NOT COMPLETED|Overall Study||53
9908882|NCT01181674|11025369|FG000|STARTED|Overall Study||28
9908883|NCT01181674|11025370|FG001|STARTED|Overall Study||27
9908884|NCT01181674|11025371|FG002|STARTED|Overall Study||28
9908885|NCT01181674|11025369|FG000|COMPLETED|Overall Study||28
9908886|NCT01181674|11025370|FG001|COMPLETED|Overall Study||27
9908887|NCT01181674|11025371|FG002|COMPLETED|Overall Study|28 included in analyses|26
9908888|NCT01181674|11025369|FG000|NOT COMPLETED|Overall Study||0
9908889|NCT01181674|11025370|FG001|NOT COMPLETED|Overall Study||0
9908890|NCT01181674|11025371|FG002|NOT COMPLETED|Overall Study||2
9908891|NCT01181726|11025381|FG000|STARTED|First Intervention||20
9908892|NCT01181726|11025382|FG001|STARTED|First Intervention||20
9908893|NCT01181726|11025381|FG000|COMPLETED|First Intervention||19
9908894|NCT01181726|11025382|FG001|COMPLETED|First Intervention||20
9908895|NCT01181726|11025381|FG000|NOT COMPLETED|First Intervention||1
9908896|NCT01181726|11025382|FG001|NOT COMPLETED|First Intervention||0
9908897|NCT01181726|11025381|FG000|STARTED|Washout of 28 Days||19
9908898|NCT01181726|11025382|FG001|STARTED|Washout of 28 Days||20
9908899|NCT01181726|11025381|FG000|COMPLETED|Washout of 28 Days||19
9908900|NCT01181726|11025382|FG001|COMPLETED|Washout of 28 Days||20
9908901|NCT01181726|11025381|FG000|NOT COMPLETED|Washout of 28 Days||0
9908902|NCT01181726|11025382|FG001|NOT COMPLETED|Washout of 28 Days||0
9908903|NCT01181726|11025381|FG000|STARTED|Second Intervention||19
9908904|NCT01181726|11025382|FG001|STARTED|Second Intervention||20
9908905|NCT01181726|11025381|FG000|COMPLETED|Second Intervention||19
9908906|NCT01181726|11025382|FG001|COMPLETED|Second Intervention||20
9908907|NCT01181726|11025381|FG000|NOT COMPLETED|Second Intervention||0
9908908|NCT01181726|11025382|FG001|NOT COMPLETED|Second Intervention||0
9908909|NCT01181804|11025392|FG000|STARTED|Period 1, Fed (Part 1)||30
9908910|NCT01181804|11025393|FG001|STARTED|Period 1, Fed (Part 1)||30
9908911|NCT01181804|11025394|FG002|STARTED|Period 1, Fed (Part 1)||0
9908912|NCT01181804|11025395|FG003|STARTED|Period 1, Fed (Part 1)||0
9908913|NCT01181804|11025392|FG000|COMPLETED|Period 1, Fed (Part 1)||30
9908914|NCT01181804|11025393|FG001|COMPLETED|Period 1, Fed (Part 1)||30
9908915|NCT01181804|11025394|FG002|COMPLETED|Period 1, Fed (Part 1)||0
9908916|NCT01181804|11025395|FG003|COMPLETED|Period 1, Fed (Part 1)||0
9908917|NCT01181804|11025392|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0
9908918|NCT01181804|11025393|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0
9908919|NCT01181804|11025394|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0
9908920|NCT01181804|11025395|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0
9908921|NCT01181804|11025392|FG000|STARTED|Period 2, Fed (Part 1)||30
9908922|NCT01181804|11025393|FG001|STARTED|Period 2, Fed (Part 1)||30
9908923|NCT01181804|11025394|FG002|STARTED|Period 2, Fed (Part 1)||0
9908924|NCT01181804|11025395|FG003|STARTED|Period 2, Fed (Part 1)||0
9908925|NCT01181804|11025392|FG000|COMPLETED|Period 2, Fed (Part 1)||30
9908926|NCT01181804|11025393|FG001|COMPLETED|Period 2, Fed (Part 1)||30
9908927|NCT01181804|11025394|FG002|COMPLETED|Period 2, Fed (Part 1)||0
9908928|NCT01181804|11025395|FG003|COMPLETED|Period 2, Fed (Part 1)||0
9908929|NCT01181804|11025392|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0
9908930|NCT01181804|11025393|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0
9908931|NCT01181804|11025394|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0
9908932|NCT01181804|11025395|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0
9908933|NCT01181804|11025392|FG000|STARTED|Period 3, Fasted (Part 2)||0
9908934|NCT01181804|11025393|FG001|STARTED|Period 3, Fasted (Part 2)||0
9908935|NCT01181804|11025394|FG002|STARTED|Period 3, Fasted (Part 2)||59
9908936|NCT01181804|11025395|FG003|STARTED|Period 3, Fasted (Part 2)||58
9908937|NCT01181804|11025392|FG000|COMPLETED|Period 3, Fasted (Part 2)||0
9908938|NCT01181804|11025393|FG001|COMPLETED|Period 3, Fasted (Part 2)||0
9908939|NCT01181804|11025394|FG002|COMPLETED|Period 3, Fasted (Part 2)||59
9908940|NCT01181804|11025395|FG003|COMPLETED|Period 3, Fasted (Part 2)||58
9908941|NCT01181804|11025392|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0
9908942|NCT01181804|11025393|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0
9908943|NCT01181804|11025394|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0
9908944|NCT01181804|11025395|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0
9908945|NCT01181804|11025392|FG000|STARTED|Period 4, Fasted (Part 2)||0
9908946|NCT01181804|11025393|FG001|STARTED|Period 4, Fasted (Part 2)||0
9908947|NCT01181804|11025394|FG002|STARTED|Period 4, Fasted (Part 2)||59
9908948|NCT01181804|11025395|FG003|STARTED|Period 4, Fasted (Part 2)||58
9908949|NCT01181804|11025392|FG000|COMPLETED|Period 4, Fasted (Part 2)||0
9908950|NCT01181804|11025393|FG001|COMPLETED|Period 4, Fasted (Part 2)||0
9908951|NCT01181804|11025394|FG002|COMPLETED|Period 4, Fasted (Part 2)||58
9908952|NCT01181804|11025395|FG003|COMPLETED|Period 4, Fasted (Part 2)||58
9908953|NCT01181804|11025392|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0
9908954|NCT01181804|11025393|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0
9908955|NCT01181804|11025394|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1
9908956|NCT01181804|11025395|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0
9908957|NCT01181895|11025408|FG000|STARTED|Overall Study||116
9908958|NCT01181895|11025409|FG001|STARTED|Overall Study||115
9908959|NCT01181895|11025410|FG002|STARTED|Overall Study||116
9908960|NCT01181895|11025408|FG000|COMPLETED|Overall Study||99
10009843|NCT01769274|11132532|FG001|COMPLETED|Part B:Treatment Session1-Period2||2
10009844|NCT01769274|11132533|FG002|COMPLETED|Part B:Treatment Session1-Period2||3
10009845|NCT01769274|11132531|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0
9908961|NCT01181895|11025409|FG001|COMPLETED|Overall Study||101
9908962|NCT01181895|11025410|FG002|COMPLETED|Overall Study||98
9908963|NCT01181895|11025408|FG000|NOT COMPLETED|Overall Study||17
9908964|NCT01181895|11025409|FG001|NOT COMPLETED|Overall Study||14
9908965|NCT01181895|11025410|FG002|NOT COMPLETED|Overall Study||18
9908966|NCT01181947|11025418|FG000|STARTED|Overall Study||100
9908967|NCT01181947|11025418|FG000|COMPLETED|Overall Study||100
9908968|NCT01181947|11025418|FG000|NOT COMPLETED|Overall Study||0
9955355|NCT01437852|11074289|FG000|STARTED|Overall Study||30
9955356|NCT01437852|11074289|FG000|Received StrataGraft Skin Tissue|Overall Study||30
9955357|NCT01437852|11074289|FG000|Received Autograft|Overall Study||30
9955358|NCT01437852|11074289|FG000|COMPLETED|Overall Study||30
9955359|NCT01437852|11074289|FG000|NOT COMPLETED|Overall Study||0
9955360|NCT01437878|11074296|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
9955361|NCT01437878|11074297|FG001|STARTED|Overall Study||1
9955362|NCT01437878|11074296|FG000|COMPLETED|Overall Study||0
9955363|NCT01437878|11074297|FG001|COMPLETED|Overall Study||1
9955364|NCT01437878|11074296|FG000|NOT COMPLETED|Overall Study||1
9955365|NCT01437878|11074297|FG001|NOT COMPLETED|Overall Study||0
9955366|NCT01437943|11074305|FG000|STARTED|Overall Study||7
9955367|NCT01437943|11074306|FG001|STARTED|Overall Study||3
9955368|NCT01437943|11074305|FG000|COMPLETED|Overall Study||0
9955369|NCT01437943|11074306|FG001|COMPLETED|Overall Study||1
9955370|NCT01437943|11074305|FG000|NOT COMPLETED|Overall Study||7
9955371|NCT01437943|11074306|FG001|NOT COMPLETED|Overall Study||2
9955372|NCT01437995|11074315|FG000|STARTED|Overall Study||151
9955373|NCT01437995|11074316|FG001|STARTED|Overall Study||149
9955374|NCT01437995|11074317|FG002|STARTED|Overall Study||155
9955375|NCT01437995|11074315|FG000|Included in Treatment Failure Analysis|Overall Study||150
9955376|NCT01437995|11074316|FG001|Included in Treatment Failure Analysis|Overall Study||146
9955377|NCT01437995|11074317|FG002|Included in Treatment Failure Analysis|Overall Study||151
9955378|NCT01437995|11074315|FG000|COMPLETED|Overall Study||140
9955379|NCT01437995|11074316|FG001|COMPLETED|Overall Study||131
9955380|NCT01437995|11074317|FG002|COMPLETED|Overall Study||135
9955381|NCT01437995|11074315|FG000|NOT COMPLETED|Overall Study||11
9955382|NCT01437995|11074316|FG001|NOT COMPLETED|Overall Study||18
9955383|NCT01437995|11074317|FG002|NOT COMPLETED|Overall Study||20
9955384|NCT01438008|11074327|FG000|STARTED|Overall Study||4
9955385|NCT01438008|11074328|FG001|STARTED|Overall Study||5
9955386|NCT01438008|11074327|FG000|COMPLETED|Overall Study||4
9955387|NCT01438008|11074328|FG001|COMPLETED|Overall Study||5
9955388|NCT01438008|11074327|FG000|NOT COMPLETED|Overall Study||0
9955389|NCT01438008|11074328|FG001|NOT COMPLETED|Overall Study||0
9955390|NCT01438060|11074336|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102
9955391|NCT01438060|11074337|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106
9955392|NCT01438060|11074336|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
9955393|NCT01438060|11074337|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
9955394|NCT01438060|11074336|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
9955395|NCT01438060|11074337|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
9955396|NCT01438060|11074336|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
9955397|NCT01438060|11074337|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
9955398|NCT01438060|11074336|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22
10009846|NCT01769274|11132532|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0
9955399|NCT01438060|11074337|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25
9955400|NCT01438060|11074336|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
9955401|NCT01438060|11074337|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
9955402|NCT01438060|11074336|FG000|STARTED|On Study Beyond Week 140||0
10019013|NCT01826981|11142055|FG004|NOT COMPLETED|Overall Study||7
9955403|NCT01438060|11074337|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
9955404|NCT01438060|11074336|FG000|COMPLETED|On Study Beyond Week 140||0
9955405|NCT01438060|11074337|FG001|COMPLETED|On Study Beyond Week 140||1
9955406|NCT01438060|11074336|FG000|NOT COMPLETED|On Study Beyond Week 140||0
9955407|NCT01438060|11074337|FG001|NOT COMPLETED|On Study Beyond Week 140||8
9955408|NCT01438151|11074348|FG000|STARTED|Overall Study||11
9955409|NCT01438151|11074348|FG000|COMPLETED|Overall Study||3
9955410|NCT01438151|11074348|FG000|NOT COMPLETED|Overall Study||8
9955411|NCT01438177|11074352|FG000|STARTED|Overall Study||11
9908969|NCT01181986|11025425|FG000|STARTED|Phase 1||19
9908970|NCT01181986|11025426|FG001|STARTED|Phase 1||23
9908971|NCT01181986|11025427|FG002|STARTED|Phase 1||34
9908972|NCT01181986|11025425|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0
9908973|NCT01181986|11025426|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0
9908974|NCT01181986|11025427|FG002|Saline+Exenatide|Phase 1||32
9908975|NCT01181986|11025425|FG000|Saline+Placebo|Phase 1|N/A for this arm|0
9908976|NCT01181986|11025426|FG001|Saline+Placebo|Phase 1|N/A for this arm|0
9908977|NCT01181986|11025427|FG002|Saline+Placebo|Phase 1||33
9908978|NCT01181986|11025425|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
9908979|NCT01181986|11025426|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
9908980|NCT01181986|11025427|FG002|Exendin-9+Exenatide|Phase 1||33
9908981|NCT01181986|11025425|FG000|COMPLETED|Phase 1||18
9908982|NCT01181986|11025426|FG001|COMPLETED|Phase 1||22
9908983|NCT01181986|11025427|FG002|COMPLETED|Phase 1||32
9908984|NCT01181986|11025425|FG000|NOT COMPLETED|Phase 1||1
9908985|NCT01181986|11025426|FG001|NOT COMPLETED|Phase 1||1
9908986|NCT01181986|11025427|FG002|NOT COMPLETED|Phase 1||2
9908987|NCT01181986|11025425|FG000|STARTED|Phase 2||18
9908988|NCT01181986|11025426|FG001|STARTED|Phase 2||22
9908989|NCT01181986|11025427|FG002|STARTED|Phase 2|N/A for Sub-study 2|0
9908990|NCT01181986|11025425|FG000|COMPLETED|Phase 2||18
9908991|NCT01181986|11025426|FG001|COMPLETED|Phase 2||18
9908992|NCT01181986|11025427|FG002|COMPLETED|Phase 2||0
9908993|NCT01181986|11025425|FG000|NOT COMPLETED|Phase 2||0
9908994|NCT01181986|11025426|FG001|NOT COMPLETED|Phase 2||4
9908995|NCT01181986|11025427|FG002|NOT COMPLETED|Phase 2||0
9908996|NCT01182103|11025443|FG000|STARTED|Overall Study||48
9908997|NCT01182103|11025444|FG001|STARTED|Overall Study||62
9908998|NCT01182103|11025443|FG000|COMPLETED|Overall Study||48
9908999|NCT01182103|11025444|FG001|COMPLETED|Overall Study||62
9909000|NCT01182103|11025443|FG000|NOT COMPLETED|Overall Study||0
9909001|NCT01182103|11025444|FG001|NOT COMPLETED|Overall Study||0
9909002|NCT01182181|11025455|FG000|STARTED|First Intervention||11
9909003|NCT01182181|11025456|FG001|STARTED|First Intervention||11
9909004|NCT01182181|11025455|FG000|COMPLETED|First Intervention||10
9909005|NCT01182181|11025456|FG001|COMPLETED|First Intervention||11
9909006|NCT01182181|11025455|FG000|NOT COMPLETED|First Intervention||1
9909007|NCT01182181|11025456|FG001|NOT COMPLETED|First Intervention||0
9909008|NCT01182181|11025455|FG000|STARTED|Washout of 21 Days||10
9909009|NCT01182181|11025456|FG001|STARTED|Washout of 21 Days||11
9909010|NCT01182181|11025455|FG000|COMPLETED|Washout of 21 Days||10
9909011|NCT01182181|11025456|FG001|COMPLETED|Washout of 21 Days||10
9909012|NCT01182181|11025455|FG000|NOT COMPLETED|Washout of 21 Days||0
9909013|NCT01182181|11025456|FG001|NOT COMPLETED|Washout of 21 Days||1
9909014|NCT01182181|11025455|FG000|STARTED|Second Intervention||10
9909015|NCT01182181|11025456|FG001|STARTED|Second Intervention||10
9909016|NCT01182181|11025455|FG000|COMPLETED|Second Intervention||10
9909017|NCT01182181|11025456|FG001|COMPLETED|Second Intervention||10
9909018|NCT01182181|11025455|FG000|NOT COMPLETED|Second Intervention||0
9909019|NCT01182181|11025456|FG001|NOT COMPLETED|Second Intervention||0
9909020|NCT01182194|11025464|FG000|STARTED|First Intervention||16
9909021|NCT01182194|11025465|FG001|STARTED|First Intervention||16
9909022|NCT01182194|11025464|FG000|COMPLETED|First Intervention||16
9909023|NCT01182194|11025465|FG001|COMPLETED|First Intervention||16
9909024|NCT01182194|11025464|FG000|NOT COMPLETED|First Intervention||0
9909025|NCT01182194|11025465|FG001|NOT COMPLETED|First Intervention||0
9909026|NCT01182194|11025464|FG000|STARTED|Washout of 28 Days||16
9909027|NCT01182194|11025465|FG001|STARTED|Washout of 28 Days||16
9909028|NCT01182194|11025464|FG000|COMPLETED|Washout of 28 Days||15
9909029|NCT01182194|11025465|FG001|COMPLETED|Washout of 28 Days||16
9909030|NCT01182194|11025464|FG000|NOT COMPLETED|Washout of 28 Days||1
9909031|NCT01182194|11025465|FG001|NOT COMPLETED|Washout of 28 Days||0
9909032|NCT01182194|11025464|FG000|STARTED|Second Intervention||15
9909033|NCT01182194|11025465|FG001|STARTED|Second Intervention||16
9909034|NCT01182194|11025464|FG000|COMPLETED|Second Intervention||15
9909035|NCT01182194|11025465|FG001|COMPLETED|Second Intervention||16
9909036|NCT01182194|11025464|FG000|NOT COMPLETED|Second Intervention||0
9909037|NCT01182194|11025465|FG001|NOT COMPLETED|Second Intervention||0
9909038|NCT01182207|11025473|FG000|STARTED|First Intervention||18
9909039|NCT01182207|11025474|FG001|STARTED|First Intervention||15
9909040|NCT01182207|11025473|FG000|COMPLETED|First Intervention||18
9909041|NCT01182207|11025474|FG001|COMPLETED|First Intervention||14
9909042|NCT01182207|11025473|FG000|NOT COMPLETED|First Intervention||0
9909043|NCT01182207|11025474|FG001|NOT COMPLETED|First Intervention||1
9909044|NCT01182207|11025473|FG000|STARTED|Washout of 28 Days||18
9909045|NCT01182207|11025474|FG001|STARTED|Washout of 28 Days||14
9909046|NCT01182207|11025473|FG000|COMPLETED|Washout of 28 Days||18
9909047|NCT01182207|11025474|FG001|COMPLETED|Washout of 28 Days||14
9909048|NCT01182207|11025473|FG000|NOT COMPLETED|Washout of 28 Days||0
9909049|NCT01182207|11025474|FG001|NOT COMPLETED|Washout of 28 Days||0
9909050|NCT01182207|11025473|FG000|STARTED|Second Intervention||18
9909051|NCT01182207|11025474|FG001|STARTED|Second Intervention||14
9909052|NCT01182207|11025473|FG000|COMPLETED|Second Intervention||17
9909053|NCT01182207|11025474|FG001|COMPLETED|Second Intervention||14
9909054|NCT01182207|11025473|FG000|NOT COMPLETED|Second Intervention||1
9909055|NCT01182207|11025474|FG001|NOT COMPLETED|Second Intervention||0
9909056|NCT01182285|11025480|FG000|STARTED|First Intervention Week 1-10||13
9909057|NCT01182285|11025481|FG001|STARTED|First Intervention Week 1-10||0
9909058|NCT01182285|11025482|FG002|STARTED|First Intervention Week 1-10||0
10203655|NCT03465878|11330529|FG003|STARTED|Period2-Part B Second Intervention Day 1||17
10203656|NCT03465878|11330526|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
10203657|NCT03465878|11330527|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
10203658|NCT03465878|11330528|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
10203659|NCT03465878|11330529|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
10203660|NCT03465878|11330526|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
10203661|NCT03465878|11330527|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
9909059|NCT01182285|11025480|FG000|COMPLETED|First Intervention Week 1-10||10
9909060|NCT01182285|11025481|FG001|COMPLETED|First Intervention Week 1-10||0
9909061|NCT01182285|11025482|FG002|COMPLETED|First Intervention Week 1-10||0
9909062|NCT01182285|11025480|FG000|NOT COMPLETED|First Intervention Week 1-10||3
9909063|NCT01182285|11025481|FG001|NOT COMPLETED|First Intervention Week 1-10||0
9909064|NCT01182285|11025482|FG002|NOT COMPLETED|First Intervention Week 1-10||0
9909065|NCT01182285|11025480|FG000|STARTED|Second Intervention Week 11-17||0
9909066|NCT01182285|11025481|FG001|STARTED|Second Intervention Week 11-17||0
9909067|NCT01182285|11025482|FG002|STARTED|Second Intervention Week 11-17||0
9909068|NCT01182285|11025480|FG000|COMPLETED|Second Intervention Week 11-17||0
9909069|NCT01182285|11025481|FG001|COMPLETED|Second Intervention Week 11-17||0
9909070|NCT01182285|11025482|FG002|COMPLETED|Second Intervention Week 11-17||0
9909071|NCT01182285|11025480|FG000|NOT COMPLETED|Second Intervention Week 11-17||0
9909072|NCT01182285|11025481|FG001|NOT COMPLETED|Second Intervention Week 11-17||0
9909073|NCT01182285|11025482|FG002|NOT COMPLETED|Second Intervention Week 11-17||0
9909074|NCT01182285|11025480|FG000|STARTED|Third Intervention Week 11-52||0
9909075|NCT01182285|11025481|FG001|STARTED|Third Intervention Week 11-52||0
9909076|NCT01182285|11025482|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
9909077|NCT01182285|11025480|FG000|COMPLETED|Third Intervention Week 11-52||0
9909078|NCT01182285|11025481|FG001|COMPLETED|Third Intervention Week 11-52||0
9909079|NCT01182285|11025482|FG002|COMPLETED|Third Intervention Week 11-52||0
9909080|NCT01182285|11025480|FG000|NOT COMPLETED|Third Intervention Week 11-52||0
9909081|NCT01182285|11025481|FG001|NOT COMPLETED|Third Intervention Week 11-52||0
9909082|NCT01182285|11025482|FG002|NOT COMPLETED|Third Intervention Week 11-52||8
9909083|NCT01182298|11025489|FG000|STARTED|Overall Study||10
9909084|NCT01182298|11025489|FG000|COMPLETED|Overall Study||4
9909085|NCT01182298|11025489|FG000|NOT COMPLETED|Overall Study||6
9909086|NCT01182337|11025495|FG000|STARTED|Overall Study||22
9909087|NCT01182337|11025496|FG001|STARTED|Overall Study||9
9909088|NCT01182337|11025495|FG000|COMPLETED|Overall Study||19
9909089|NCT01182337|11025496|FG001|COMPLETED|Overall Study||7
9909090|NCT01182337|11025495|FG000|NOT COMPLETED|Overall Study||3
9909091|NCT01182337|11025496|FG001|NOT COMPLETED|Overall Study||2
9909092|NCT01182350|11025503|FG000|STARTED|Overall Study||30
9909093|NCT01182350|11025504|FG001|STARTED|Overall Study||14
9909094|NCT01182350|11025505|FG002|STARTED|Overall Study||3
9909095|NCT01182350|11025506|FG003|STARTED|Overall Study||3
9909096|NCT01182350|11025507|FG004|STARTED|Overall Study||3
9909097|NCT01182350|11025503|FG000|Underwent Stereotactic Biopsy|Overall Study||30
9909098|NCT01182350|11025504|FG001|Underwent Stereotactic Biopsy|Overall Study||14
9909099|NCT01182350|11025505|FG002|Underwent Stereotactic Biopsy|Overall Study||3
9909100|NCT01182350|11025506|FG003|Underwent Stereotactic Biopsy|Overall Study||3
9909101|NCT01182350|11025507|FG004|Underwent Stereotactic Biopsy|Overall Study||0
9909102|NCT01182350|11025503|FG000|Started Assigned Chemoradiation|Overall Study||27
9909103|NCT01182350|11025504|FG001|Started Assigned Chemoradiation|Overall Study||14
9909104|NCT01182350|11025505|FG002|Started Assigned Chemoradiation|Overall Study||2
10203662|NCT03465878|11330528|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
10203663|NCT03465878|11330529|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
9909105|NCT01182350|11025506|FG003|Started Assigned Chemoradiation|Overall Study||2
9909106|NCT01182350|11025507|FG004|Started Assigned Chemoradiation|Overall Study||0
9909107|NCT01182350|11025503|FG000|COMPLETED|Overall Study||3
9909108|NCT01182350|11025504|FG001|COMPLETED|Overall Study||0
9909109|NCT01182350|11025505|FG002|COMPLETED|Overall Study||0
9909110|NCT01182350|11025506|FG003|COMPLETED|Overall Study||0
9909111|NCT01182350|11025507|FG004|COMPLETED|Overall Study||0
9909112|NCT01182350|11025503|FG000|NOT COMPLETED|Overall Study||27
9909113|NCT01182350|11025504|FG001|NOT COMPLETED|Overall Study||14
9909114|NCT01182350|11025505|FG002|NOT COMPLETED|Overall Study||3
9909115|NCT01182350|11025506|FG003|NOT COMPLETED|Overall Study||3
9909116|NCT01182350|11025507|FG004|NOT COMPLETED|Overall Study||3
9909117|NCT01182376|11025525|FG000|STARTED|Overall Study||15
9909118|NCT01182376|11025526|FG001|STARTED|Overall Study||18
9909119|NCT01182376|11025525|FG000|COMPLETED|Overall Study||4
9909120|NCT01182376|11025526|FG001|COMPLETED|Overall Study||13
9909121|NCT01182376|11025525|FG000|NOT COMPLETED|Overall Study||11
9909122|NCT01182376|11025526|FG001|NOT COMPLETED|Overall Study||5
9909123|NCT01182415|11025532|FG000|STARTED|Overall Study||30
9909124|NCT01182415|11025532|FG000|COMPLETED|Overall Study||29
9909125|NCT01182415|11025532|FG000|NOT COMPLETED|Overall Study||1
9909126|NCT01182428|11025538|FG000|STARTED|Overall Study||304
9909127|NCT01182428|11025539|FG001|STARTED|Overall Study||151
9909128|NCT01182428|11025538|FG000|COMPLETED|Overall Study||293
9909129|NCT01182428|11025539|FG001|COMPLETED|Overall Study||150
9909130|NCT01182428|11025538|FG000|NOT COMPLETED|Overall Study||11
9909131|NCT01182428|11025539|FG001|NOT COMPLETED|Overall Study||1
9909132|NCT01182441|11025547|FG000|STARTED|Overall Study||269
9909133|NCT01182441|11025548|FG001|STARTED|Overall Study||138
9909134|NCT01182441|11025547|FG000|COMPLETED|Overall Study||49
9909135|NCT01182441|11025548|FG001|COMPLETED|Overall Study||19
9909136|NCT01182441|11025547|FG000|NOT COMPLETED|Overall Study||220
9909137|NCT01182441|11025548|FG001|NOT COMPLETED|Overall Study||119
9909138|NCT01182480|11025554|FG000|STARTED|Overall Study||47
9909139|NCT01182480|11025554|FG000|COMPLETED|Overall Study||47
9909140|NCT01182480|11025554|FG000|NOT COMPLETED|Overall Study||0
9909141|NCT01182493|11025560|FG000|STARTED|Overall Study||168
9909142|NCT01182493|11025561|FG001|STARTED|Overall Study||163
9909143|NCT01182493|11025560|FG000|COMPLETED|Overall Study||152
9909144|NCT01182493|11025561|FG001|COMPLETED|Overall Study||156
9909145|NCT01182493|11025560|FG000|NOT COMPLETED|Overall Study||16
9909146|NCT01182493|11025561|FG001|NOT COMPLETED|Overall Study||7
9909147|NCT01182675|11025569|FG000|STARTED|Overall Study||7
9909148|NCT01182675|11025570|FG001|STARTED|Overall Study||0
9909149|NCT01182675|11025569|FG000|COMPLETED|Overall Study||7
9909150|NCT01182675|11025570|FG001|COMPLETED|Overall Study||0
9909151|NCT01182675|11025569|FG000|NOT COMPLETED|Overall Study||0
9909152|NCT01182675|11025570|FG001|NOT COMPLETED|Overall Study||0
9909153|NCT01182805|11025578|FG000|STARTED|Overall Study||50
9909154|NCT01182805|11025578|FG000|COMPLETED|Overall Study||50
9909155|NCT01182805|11025578|FG000|NOT COMPLETED|Overall Study||0
9909156|NCT01182844|11025586|FG000|STARTED|Overall Study||15
9909157|NCT01182844|11025587|FG001|STARTED|Overall Study||15
9909158|NCT01182844|11025586|FG000|COMPLETED|Overall Study||15
9909159|NCT01182844|11025587|FG001|COMPLETED|Overall Study||13
9909160|NCT01182844|11025586|FG000|NOT COMPLETED|Overall Study||0
9909161|NCT01182844|11025587|FG001|NOT COMPLETED|Overall Study||2
9909162|NCT01183013|11025600|FG000|STARTED|Overall Study||131
9909163|NCT01183013|11025601|FG001|STARTED|Overall Study||140
9909164|NCT01183013|11025602|FG002|STARTED|Overall Study||138
9909165|NCT01183013|11025603|FG003|STARTED|Overall Study||135
9909166|NCT01183013|11025604|FG004|STARTED|Overall Study||126
9909167|NCT01183013|11025605|FG005|STARTED|Overall Study||133
9909168|NCT01183013|11025606|FG006|STARTED|Overall Study||133
9909169|NCT01183013|11025600|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
9909170|NCT01183013|11025601|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
9909171|NCT01183013|11025602|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
9909172|NCT01183013|11025603|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
9909173|NCT01183013|11025604|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
9909174|NCT01183013|11025605|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
9909175|NCT01183013|11025606|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
9909176|NCT01183013|11025600|FG000|NOT COMPLETED|Overall Study||45
9909177|NCT01183013|11025601|FG001|NOT COMPLETED|Overall Study||39
10203664|NCT03465878|11330526|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
10203665|NCT03465878|11330527|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
10203666|NCT03465878|11330528|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
10203667|NCT03465878|11330529|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
10203668|NCT03465878|11330526|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0
10203669|NCT03465878|11330527|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0
10203670|NCT03465878|11330528|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20
10203671|NCT03465878|11330529|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17
10203672|NCT03465878|11330526|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10203673|NCT03465878|11330527|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10203674|NCT03465878|11330528|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10203675|NCT03465878|11330529|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10203676|NCT03465904|11330557|FG000|STARTED|Overall Study||298
10203677|NCT03465904|11330558|FG001|STARTED|Overall Study||303
10203678|NCT03465904|11330557|FG000|COMPLETED|Overall Study||209
10203679|NCT03465904|11330558|FG001|COMPLETED|Overall Study||237
10203680|NCT03465904|11330557|FG000|NOT COMPLETED|Overall Study||89
9909178|NCT01183013|11025602|FG002|NOT COMPLETED|Overall Study||41
9909179|NCT01183013|11025603|FG003|NOT COMPLETED|Overall Study||30
9909180|NCT01183013|11025604|FG004|NOT COMPLETED|Overall Study||36
9909181|NCT01183013|11025605|FG005|NOT COMPLETED|Overall Study||45
9909182|NCT01183013|11025606|FG006|NOT COMPLETED|Overall Study||37
10203681|NCT03465904|11330558|FG001|NOT COMPLETED|Overall Study||66
10203682|NCT03466047|11330564|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
10203683|NCT03466047|11330564|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
9909183|NCT01183065|11025623|FG000|STARTED|Overall Study||13
9909184|NCT01183065|11025623|FG000|COMPLETED|Overall Study||12
9909185|NCT01183065|11025623|FG000|NOT COMPLETED|Overall Study||1
9909186|NCT01183104|11025629|FG000|STARTED|Overall Study||153
9909187|NCT01183104|11025630|FG001|STARTED|Overall Study||152
9909188|NCT01183104|11025629|FG000|Received Study Drug|Overall Study||148
9909189|NCT01183104|11025630|FG001|Received Study Drug|Overall Study||143
9909190|NCT01183104|11025629|FG000|Continued Treatment for 12 Weeks|Overall Study||143
9909191|NCT01183104|11025630|FG001|Continued Treatment for 12 Weeks|Overall Study||129
9909192|NCT01183104|11025629|FG000|Completed 52-week Treatment|Overall Study||119
9909193|NCT01183104|11025630|FG001|Completed 52-week Treatment|Overall Study||111
9909194|NCT01183104|11025629|FG000|Enrolled in Extension Study|Overall Study||80
9909195|NCT01183104|11025630|FG001|Enrolled in Extension Study|Overall Study||61
9909196|NCT01183104|11025629|FG000|COMPLETED|Overall Study||76
9909197|NCT01183104|11025630|FG001|COMPLETED|Overall Study||60
9909198|NCT01183104|11025629|FG000|NOT COMPLETED|Overall Study||77
9909199|NCT01183104|11025630|FG001|NOT COMPLETED|Overall Study||92
9909200|NCT01183143|11025636|FG000|STARTED|Overall Study||215
9909201|NCT01183143|11025636|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
9909202|NCT01183143|11025636|FG000|COMPLETED|Overall Study||65
9909203|NCT01183143|11025636|FG000|NOT COMPLETED|Overall Study||150
9909204|NCT01183169|11025644|FG000|STARTED|Main Phase||121
9909205|NCT01183169|11025645|FG001|STARTED|Main Phase||115
9909206|NCT01183169|11025646|FG002|STARTED|Main Phase||59
9909207|NCT01183169|11025647|FG003|STARTED|Main Phase||55
9909208|NCT01183169|11025648|FG004|STARTED|Main Phase||109
9909209|NCT01183169|11025649|FG005|STARTED|Main Phase||0
9909210|NCT01183169|11025650|FG006|STARTED|Main Phase||0
9909211|NCT01183169|11025644|FG000|Completed Treatment|Main Phase||72
9909212|NCT01183169|11025645|FG001|Completed Treatment|Main Phase||78
9909213|NCT01183169|11025646|FG002|Completed Treatment|Main Phase||17
9909214|NCT01183169|11025647|FG003|Completed Treatment|Main Phase||17
9909215|NCT01183169|11025648|FG004|Completed Treatment|Main Phase||77
9909216|NCT01183169|11025649|FG005|Completed Treatment|Main Phase||0
9909217|NCT01183169|11025650|FG006|Completed Treatment|Main Phase||0
9909218|NCT01183169|11025644|FG000|Switched to ALV|Main Phase||0
9909219|NCT01183169|11025645|FG001|Switched to ALV|Main Phase||0
9909220|NCT01183169|11025646|FG002|Switched to ALV|Main Phase||35
9909221|NCT01183169|11025647|FG003|Switched to ALV|Main Phase||30
9909222|NCT01183169|11025648|FG004|Switched to ALV|Main Phase||0
9909223|NCT01183169|11025649|FG005|Switched to ALV|Main Phase||0
9909224|NCT01183169|11025650|FG006|Switched to ALV|Main Phase||0
9909225|NCT01183169|11025644|FG000|COMPLETED|Main Phase||94
9909226|NCT01183169|11025645|FG001|COMPLETED|Main Phase||93
9909227|NCT01183169|11025646|FG002|COMPLETED|Main Phase||18
9909228|NCT01183169|11025647|FG003|COMPLETED|Main Phase||18
9909229|NCT01183169|11025648|FG004|COMPLETED|Main Phase||83
9909230|NCT01183169|11025649|FG005|COMPLETED|Main Phase||0
9909231|NCT01183169|11025650|FG006|COMPLETED|Main Phase||0
9909232|NCT01183169|11025644|FG000|NOT COMPLETED|Main Phase||27
9909233|NCT01183169|11025645|FG001|NOT COMPLETED|Main Phase||22
10009847|NCT01769274|11132533|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0
10009848|NCT01769274|11132531|FG000|STARTED|Washout Period||0
10009849|NCT01769274|11132532|FG001|STARTED|Washout Period||2
10009850|NCT01769274|11132533|FG002|STARTED|Washout Period||3
9909234|NCT01183169|11025646|FG002|NOT COMPLETED|Main Phase||41
9909235|NCT01183169|11025647|FG003|NOT COMPLETED|Main Phase||37
9909236|NCT01183169|11025648|FG004|NOT COMPLETED|Main Phase||26
9909237|NCT01183169|11025649|FG005|NOT COMPLETED|Main Phase||0
9909238|NCT01183169|11025650|FG006|NOT COMPLETED|Main Phase||0
9909239|NCT01183169|11025644|FG000|STARTED|Post-switch Phase|Not a post-switch group|0
9909240|NCT01183169|11025645|FG001|STARTED|Post-switch Phase|Not a post-switch group|0
9909241|NCT01183169|11025646|FG002|STARTED|Post-switch Phase|Not a post-switch group|0
9909242|NCT01183169|11025647|FG003|STARTED|Post-switch Phase|Not a post-switch group|0
9909243|NCT01183169|11025648|FG004|STARTED|Post-switch Phase|Not a post-switch group|0
9909244|NCT01183169|11025649|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
9909245|NCT01183169|11025650|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
9909246|NCT01183169|11025644|FG000|Completed Treatment|Post-switch Phase||0
9909247|NCT01183169|11025645|FG001|Completed Treatment|Post-switch Phase||0
9909248|NCT01183169|11025646|FG002|Completed Treatment|Post-switch Phase||0
9909249|NCT01183169|11025647|FG003|Completed Treatment|Post-switch Phase||0
9909250|NCT01183169|11025648|FG004|Completed Treatment|Post-switch Phase||0
9909251|NCT01183169|11025649|FG005|Completed Treatment|Post-switch Phase||12
9909252|NCT01183169|11025650|FG006|Completed Treatment|Post-switch Phase||13
9909253|NCT01183169|11025644|FG000|COMPLETED|Post-switch Phase||0
9909254|NCT01183169|11025645|FG001|COMPLETED|Post-switch Phase||0
9909255|NCT01183169|11025646|FG002|COMPLETED|Post-switch Phase||0
9909256|NCT01183169|11025647|FG003|COMPLETED|Post-switch Phase||0
10009851|NCT01769274|11132531|FG000|COMPLETED|Washout Period||0
9909257|NCT01183169|11025648|FG004|COMPLETED|Post-switch Phase||0
9909258|NCT01183169|11025649|FG005|COMPLETED|Post-switch Phase||21
9909259|NCT01183169|11025650|FG006|COMPLETED|Post-switch Phase||21
9909260|NCT01183169|11025644|FG000|NOT COMPLETED|Post-switch Phase||0
9909261|NCT01183169|11025645|FG001|NOT COMPLETED|Post-switch Phase||0
9909262|NCT01183169|11025646|FG002|NOT COMPLETED|Post-switch Phase||0
9909263|NCT01183169|11025647|FG003|NOT COMPLETED|Post-switch Phase||0
9909264|NCT01183169|11025648|FG004|NOT COMPLETED|Post-switch Phase||0
9909265|NCT01183169|11025649|FG005|NOT COMPLETED|Post-switch Phase||14
9909266|NCT01183169|11025650|FG006|NOT COMPLETED|Post-switch Phase||9
9909267|NCT01183234|11025670|FG000|STARTED|First Intervention||14
9909268|NCT01183234|11025671|FG001|STARTED|First Intervention||14
9909269|NCT01183234|11025670|FG000|COMPLETED|First Intervention||13
9909270|NCT01183234|11025671|FG001|COMPLETED|First Intervention||14
9909271|NCT01183234|11025670|FG000|NOT COMPLETED|First Intervention||1
9909272|NCT01183234|11025671|FG001|NOT COMPLETED|First Intervention||0
9909273|NCT01183234|11025670|FG000|STARTED|Washout||13
9909274|NCT01183234|11025671|FG001|STARTED|Washout||14
9909275|NCT01183234|11025670|FG000|COMPLETED|Washout||13
9909276|NCT01183234|11025671|FG001|COMPLETED|Washout||14
9909277|NCT01183234|11025670|FG000|NOT COMPLETED|Washout||0
9909278|NCT01183234|11025671|FG001|NOT COMPLETED|Washout||0
9909279|NCT01183234|11025670|FG000|STARTED|Second Intervention||13
9909280|NCT01183234|11025671|FG001|STARTED|Second Intervention||14
9909281|NCT01183234|11025670|FG000|COMPLETED|Second Intervention||13
9909282|NCT01183234|11025671|FG001|COMPLETED|Second Intervention||14
9909283|NCT01183234|11025670|FG000|NOT COMPLETED|Second Intervention||0
9909284|NCT01183234|11025671|FG001|NOT COMPLETED|Second Intervention||0
9909285|NCT01183260|11025679|FG000|STARTED|Overall Study||14
9909286|NCT01183260|11025680|FG001|STARTED|Overall Study||11
9909287|NCT01183260|11025679|FG000|COMPLETED|Overall Study||10
9909288|NCT01183260|11025680|FG001|COMPLETED|Overall Study||9
9909289|NCT01183260|11025679|FG000|NOT COMPLETED|Overall Study||4
9909290|NCT01183260|11025680|FG001|NOT COMPLETED|Overall Study||2
9909291|NCT01183312|11025688|FG000|STARTED|First Intervention Day||5
9909292|NCT01183312|11025689|FG001|STARTED|First Intervention Day||5
9909293|NCT01183312|11025688|FG000|COMPLETED|First Intervention Day||5
9909294|NCT01183312|11025689|FG001|COMPLETED|First Intervention Day||5
9909295|NCT01183312|11025688|FG000|NOT COMPLETED|First Intervention Day||0
9909296|NCT01183312|11025689|FG001|NOT COMPLETED|First Intervention Day||0
9909297|NCT01183312|11025688|FG000|STARTED|Washout Period of at Least 1 Week||5
9909298|NCT01183312|11025689|FG001|STARTED|Washout Period of at Least 1 Week||5
9909299|NCT01183312|11025688|FG000|COMPLETED|Washout Period of at Least 1 Week||5
9909300|NCT01183312|11025689|FG001|COMPLETED|Washout Period of at Least 1 Week||5
9909301|NCT01183312|11025688|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
9909302|NCT01183312|11025689|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
9909303|NCT01183312|11025688|FG000|STARTED|Second Intervention Day||5
9909304|NCT01183312|11025689|FG001|STARTED|Second Intervention Day||5
9909305|NCT01183312|11025688|FG000|COMPLETED|Second Intervention Day||5
9909306|NCT01183312|11025689|FG001|COMPLETED|Second Intervention Day||5
9909307|NCT01183312|11025688|FG000|NOT COMPLETED|Second Intervention Day||0
9909308|NCT01183312|11025689|FG001|NOT COMPLETED|Second Intervention Day||0
9909309|NCT01183390|11025697|FG000|STARTED|First Intervention||11
9909310|NCT01183390|11025698|FG001|STARTED|First Intervention||11
9909311|NCT01183390|11025697|FG000|COMPLETED|First Intervention||11
9909312|NCT01183390|11025698|FG001|COMPLETED|First Intervention||10
9909313|NCT01183390|11025697|FG000|NOT COMPLETED|First Intervention||0
9909314|NCT01183390|11025698|FG001|NOT COMPLETED|First Intervention||1
9909315|NCT01183390|11025697|FG000|STARTED|Washout of 21 Days||11
9909316|NCT01183390|11025698|FG001|STARTED|Washout of 21 Days||10
9909317|NCT01183390|11025697|FG000|COMPLETED|Washout of 21 Days||11
9909318|NCT01183390|11025698|FG001|COMPLETED|Washout of 21 Days||10
9909319|NCT01183390|11025697|FG000|NOT COMPLETED|Washout of 21 Days||0
9909320|NCT01183390|11025698|FG001|NOT COMPLETED|Washout of 21 Days||0
9909321|NCT01183390|11025697|FG000|STARTED|Second Intervention||11
9909322|NCT01183390|11025698|FG001|STARTED|Second Intervention||10
9909323|NCT01183390|11025697|FG000|COMPLETED|Second Intervention||11
9909324|NCT01183390|11025698|FG001|COMPLETED|Second Intervention||10
9909325|NCT01183390|11025697|FG000|NOT COMPLETED|Second Intervention||0
9909326|NCT01183390|11025698|FG001|NOT COMPLETED|Second Intervention||0
9909327|NCT01183481|11025704|FG000|STARTED|Overall Study||19
9909328|NCT01183481|11025704|FG000|COMPLETED|Overall Study||19
9909329|NCT01183481|11025704|FG000|NOT COMPLETED|Overall Study||0
9909330|NCT01183533|11025709|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
9909331|NCT01183533|11025709|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
9909332|NCT01183533|11025709|FG000|NOT COMPLETED|Overall Study||0
9909333|NCT01183546|11025713|FG000|STARTED|Overall Study||53
9909334|NCT01183546|11025713|FG000|COMPLETED|Overall Study||53
9909335|NCT01183546|11025713|FG000|NOT COMPLETED|Overall Study||0
10111178|NCT02493946|11242231|FG002|STARTED|DB Period||0
10111179|NCT02493946|11242229|FG000|COMPLETED|DB Period||118
9909336|NCT01183559|11025718|FG000|STARTED|Overall Study||9
9909337|NCT01183559|11025718|FG000|COMPLETED|Overall Study||9
9909338|NCT01183559|11025718|FG000|NOT COMPLETED|Overall Study||0
10111180|NCT02493946|11242230|FG001|COMPLETED|DB Period||59
10111181|NCT02493946|11242231|FG002|COMPLETED|DB Period||0
10111182|NCT02493946|11242229|FG000|NOT COMPLETED|DB Period||8
10111183|NCT02493946|11242230|FG001|NOT COMPLETED|DB Period||5
9909339|NCT01183650|11025725|FG000|STARTED|Overall Study||12
9909340|NCT01183650|11025726|FG001|STARTED|Overall Study||12
9909341|NCT01183650|11025725|FG000|COMPLETED|Overall Study||12
9909342|NCT01183650|11025726|FG001|COMPLETED|Overall Study||12
9909343|NCT01183650|11025725|FG000|NOT COMPLETED|Overall Study||0
9909344|NCT01183650|11025726|FG001|NOT COMPLETED|Overall Study||0
9909345|NCT01183689|11025735|FG000|STARTED|Overall Study||202
9909346|NCT01183689|11025736|FG001|STARTED|Overall Study||200
9909347|NCT01183689|11025737|FG002|STARTED|Overall Study||197
9909348|NCT01183689|11025735|FG000|Month 4 Visit|Overall Study||197
9909349|NCT01183689|11025736|FG001|Month 4 Visit|Overall Study||192
9909350|NCT01183689|11025737|FG002|Month 4 Visit|Overall Study||187
9909351|NCT01183689|11025735|FG000|Year 1 Visit|Overall Study||187
9909352|NCT01183689|11025736|FG001|Year 1 Visit|Overall Study||172
10111184|NCT02493946|11242231|FG002|NOT COMPLETED|DB Period||0
10111185|NCT02493946|11242229|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
10203684|NCT03466047|11330564|FG000|NOT COMPLETED|Protein Stomach (1day)||0
10203685|NCT03466047|11330564|FG000|STARTED|Protein Small Intestine (1 Day)||8
10203686|NCT03466047|11330564|FG000|COMPLETED|Protein Small Intestine (1 Day)||8
10203687|NCT03466047|11330564|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0
10203688|NCT03466047|11330564|FG000|STARTED|CHO Stomach (1 Day)||8
10203689|NCT03466047|11330564|FG000|COMPLETED|CHO Stomach (1 Day)||8
10203690|NCT03466047|11330564|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0
10203691|NCT03466047|11330564|FG000|STARTED|CHO Small Intestine (1 Day)||8
10203692|NCT03466047|11330564|FG000|COMPLETED|CHO Small Intestine (1 Day)||8
10203693|NCT03466047|11330564|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0
10203694|NCT03466047|11330564|FG000|STARTED|Fat Stomach (1 Day)||8
10111186|NCT02493946|11242230|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
10111187|NCT02493946|11242231|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
10111188|NCT02493946|11242229|FG000|COMPLETED|Open Label Period||0
10111189|NCT02493946|11242230|FG001|COMPLETED|Open Label Period||0
10111190|NCT02493946|11242231|FG002|COMPLETED|Open Label Period||509
10111191|NCT02493946|11242229|FG000|NOT COMPLETED|Open Label Period||0
10111192|NCT02493946|11242230|FG001|NOT COMPLETED|Open Label Period||0
10111193|NCT02493946|11242231|FG002|NOT COMPLETED|Open Label Period||86
10111194|NCT02494076|11242241|FG000|STARTED|Overall Study||26
10111195|NCT02494076|11242242|FG001|STARTED|Overall Study||26
10111196|NCT02494076|11242241|FG000|COMPLETED|Overall Study||26
10203695|NCT03466047|11330564|FG000|COMPLETED|Fat Stomach (1 Day)||8
10203696|NCT03466047|11330564|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0
9909353|NCT01183689|11025737|FG002|Year 1 Visit|Overall Study||183
9909354|NCT01183689|11025735|FG000|Year 2 Visit|Overall Study||178
9909355|NCT01183689|11025736|FG001|Year 2 Visit|Overall Study||172
9909356|NCT01183689|11025737|FG002|Year 2 Visit|Overall Study||174
9909357|NCT01183689|11025735|FG000|Year 3 Visit|Overall Study||139
9909358|NCT01183689|11025736|FG001|Year 3 Visit|Overall Study||125
9909359|NCT01183689|11025737|FG002|Year 3 Visit|Overall Study||126
9909360|NCT01183689|11025735|FG000|Year 4 Visit|Overall Study||38
9909361|NCT01183689|11025736|FG001|Year 4 Visit|Overall Study||33
9909362|NCT01183689|11025737|FG002|Year 4 Visit|Overall Study||30
9909363|NCT01183689|11025735|FG000|COMPLETED|Overall Study||202
9909364|NCT01183689|11025736|FG001|COMPLETED|Overall Study||200
9909365|NCT01183689|11025737|FG002|COMPLETED|Overall Study||197
9909366|NCT01183689|11025735|FG000|NOT COMPLETED|Overall Study||0
9909367|NCT01183689|11025736|FG001|NOT COMPLETED|Overall Study||0
9909368|NCT01183689|11025737|FG002|NOT COMPLETED|Overall Study||0
9909369|NCT01183728|11025747|FG000|STARTED|Overall Study||12
9909370|NCT01183728|11025747|FG000|COMPLETED|Overall Study||12
9909371|NCT01183728|11025747|FG000|NOT COMPLETED|Overall Study||0
9909372|NCT01183780|11025753|FG000|STARTED|Overall Study||536
9909373|NCT01183780|11025754|FG001|STARTED|Overall Study||536
9909374|NCT01183780|11025753|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528
9909375|NCT01183780|11025754|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529
9909376|NCT01183780|11025753|FG000|COMPLETED|Overall Study||505
9909377|NCT01183780|11025754|FG001|COMPLETED|Overall Study||511
9909378|NCT01183780|11025753|FG000|NOT COMPLETED|Overall Study||31
9909379|NCT01183780|11025754|FG001|NOT COMPLETED|Overall Study||25
9909380|NCT01183858|11025762|FG000|STARTED|Overall Study||154
9909381|NCT01183858|11025763|FG001|STARTED|Overall Study||159
9909382|NCT01183858|11025762|FG000|Safety Population|Overall Study||154
9909383|NCT01183858|11025763|FG001|Safety Population|Overall Study||158
9909384|NCT01183858|11025762|FG000|COMPLETED|Overall Study||1
9909385|NCT01183858|11025763|FG001|COMPLETED|Overall Study||3
9909386|NCT01183858|11025762|FG000|NOT COMPLETED|Overall Study||153
9909387|NCT01183858|11025763|FG001|NOT COMPLETED|Overall Study||156
9909388|NCT01183923|11025769|FG000|STARTED|Intervention 1 (7 Days)||1
9909389|NCT01183923|11025770|FG001|STARTED|Intervention 1 (7 Days)||0
9909390|NCT01183923|11025769|FG000|COMPLETED|Intervention 1 (7 Days)||1
9909391|NCT01183923|11025770|FG001|COMPLETED|Intervention 1 (7 Days)||0
9909392|NCT01183923|11025769|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
9909393|NCT01183923|11025770|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
9909394|NCT01183923|11025769|FG000|STARTED|Washout (14 Days)||1
9909395|NCT01183923|11025770|FG001|STARTED|Washout (14 Days)||0
9909396|NCT01183923|11025769|FG000|COMPLETED|Washout (14 Days)||1
9909397|NCT01183923|11025770|FG001|COMPLETED|Washout (14 Days)||0
9909398|NCT01183923|11025769|FG000|NOT COMPLETED|Washout (14 Days)||0
9909399|NCT01183923|11025770|FG001|NOT COMPLETED|Washout (14 Days)||0
9909400|NCT01183923|11025769|FG000|STARTED|Intervention 2 (7 Days)||1
9909401|NCT01183923|11025770|FG001|STARTED|Intervention 2 (7 Days)||0
9909402|NCT01183923|11025769|FG000|COMPLETED|Intervention 2 (7 Days)||1
9909403|NCT01183923|11025770|FG001|COMPLETED|Intervention 2 (7 Days)||0
9909404|NCT01183923|11025769|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
9909405|NCT01183923|11025770|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
9909406|NCT01183975|11025775|FG000|STARTED|Overall Study||517
9909407|NCT01183975|11025775|FG000|COMPLETED|Overall Study||444
9909408|NCT01183975|11025775|FG000|NOT COMPLETED|Overall Study||73
9909409|NCT01184014|11025781|FG000|STARTED|Overall Study||35
10111197|NCT02494076|11242242|FG001|COMPLETED|Overall Study||26
9909410|NCT01184014|11025782|FG001|STARTED|Overall Study||37
9909411|NCT01184014|11025781|FG000|COMPLETED|Overall Study||30
9909412|NCT01184014|11025782|FG001|COMPLETED|Overall Study||31
9909413|NCT01184014|11025781|FG000|NOT COMPLETED|Overall Study||5
9909414|NCT01184014|11025782|FG001|NOT COMPLETED|Overall Study||6
9909415|NCT01184053|11025788|FG000|STARTED|Overall Study||3
9909416|NCT01184053|11025788|FG000|COMPLETED|Overall Study||0
9909417|NCT01184053|11025788|FG000|NOT COMPLETED|Overall Study||3
9909418|NCT01184079|11025795|FG000|STARTED|Overall Study||111
9909419|NCT01184079|11025796|FG001|STARTED|Overall Study||109
9909420|NCT01184079|11025795|FG000|Dose 2|Overall Study||110
9909421|NCT01184079|11025796|FG001|Dose 2|Overall Study||108
9909422|NCT01184079|11025795|FG000|Dose 3|Overall Study||101
9909423|NCT01184079|11025796|FG001|Dose 3|Overall Study||107
9909424|NCT01184079|11025795|FG000|Final Blood Draw|Overall Study||97
9909425|NCT01184079|11025796|FG001|Final Blood Draw|Overall Study||107
9909426|NCT01184079|11025795|FG000|COMPLETED|Overall Study||97
9909427|NCT01184079|11025796|FG001|COMPLETED|Overall Study||107
9909428|NCT01184079|11025795|FG000|NOT COMPLETED|Overall Study||14
9909429|NCT01184079|11025796|FG001|NOT COMPLETED|Overall Study||2
9909430|NCT01184118|11025804|FG000|STARTED|Overall Study||36
9909431|NCT01184118|11025804|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
9909432|NCT01184118|11025804|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
9909433|NCT01184118|11025804|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18
9909434|NCT01184118|11025804|FG000|COMPLETED|Overall Study||18
9909435|NCT01184118|11025804|FG000|NOT COMPLETED|Overall Study||18
9909436|NCT01184326|11025811|FG000|STARTED|Overall Study||3
9909437|NCT01184326|11025812|FG001|STARTED|Overall Study||6
9909438|NCT01184326|11025813|FG002|STARTED|Overall Study||14
9909439|NCT01184326|11025811|FG000|COMPLETED|Overall Study||0
9909440|NCT01184326|11025812|FG001|COMPLETED|Overall Study||0
9909441|NCT01184326|11025813|FG002|COMPLETED|Overall Study||0
9909442|NCT01184326|11025811|FG000|NOT COMPLETED|Overall Study||3
9909443|NCT01184326|11025812|FG001|NOT COMPLETED|Overall Study||6
9909444|NCT01184326|11025813|FG002|NOT COMPLETED|Overall Study||14
9909445|NCT01184417|11025826|FG000|STARTED|Overall Study||51
9909446|NCT01184417|11025827|FG001|STARTED|Overall Study||51
9909447|NCT01184417|11025826|FG000|COMPLETED|Overall Study||51
9909448|NCT01184417|11025827|FG001|COMPLETED|Overall Study||51
9909449|NCT01184417|11025826|FG000|NOT COMPLETED|Overall Study||0
9909450|NCT01184417|11025827|FG001|NOT COMPLETED|Overall Study||0
9909451|NCT01184508|11025835|FG000|STARTED|Overall Study||45
9909452|NCT01184508|11025836|FG001|STARTED|Overall Study||42
9909453|NCT01184508|11025835|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
9909454|NCT01184508|11025836|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
9909455|NCT01184508|11025835|FG000|COMPLETED|Overall Study||29
9909456|NCT01184508|11025836|FG001|COMPLETED|Overall Study||27
9909457|NCT01184508|11025835|FG000|NOT COMPLETED|Overall Study||16
9909458|NCT01184508|11025836|FG001|NOT COMPLETED|Overall Study||15
9909459|NCT01184755|11025846|FG000|STARTED|Overall Study||126
9909460|NCT01184755|11025847|FG001|STARTED|Overall Study||65
9909461|NCT01184755|11025848|FG002|STARTED|Overall Study||62
9909462|NCT01184755|11025846|FG000|COMPLETED|Overall Study||101
9909463|NCT01184755|11025847|FG001|COMPLETED|Overall Study||54
9909464|NCT01184755|11025848|FG002|COMPLETED|Overall Study||56
9909465|NCT01184755|11025846|FG000|NOT COMPLETED|Overall Study||25
9909466|NCT01184755|11025847|FG001|NOT COMPLETED|Overall Study||11
9909467|NCT01184755|11025848|FG002|NOT COMPLETED|Overall Study||6
9909468|NCT01184846|11025856|FG000|STARTED|Overall Study||28
9909469|NCT01184846|11025856|FG000|COMPLETED|Overall Study||25
9909470|NCT01184846|11025856|FG000|NOT COMPLETED|Overall Study||3
9909471|NCT01184859|11025867|FG000|STARTED|Period 1: Single Dose||23
9909472|NCT01184859|11025868|FG001|STARTED|Period 1: Single Dose||25
9909473|NCT01184859|11025869|FG002|STARTED|Period 1: Single Dose||22
9909474|NCT01184859|11025870|FG003|STARTED|Period 1: Single Dose||22
9909475|NCT01184859|11025871|FG004|STARTED|Period 1: Single Dose||24
9909476|NCT01184859|11025867|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23
9909477|NCT01184859|11025868|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
9909478|NCT01184859|11025869|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22
9909479|NCT01184859|11025870|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
9909480|NCT01184859|11025871|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24
9909481|NCT01184859|11025867|FG000|Per Protocol (PP)|Period 1: Single Dose||23
9909482|NCT01184859|11025868|FG001|Per Protocol (PP)|Period 1: Single Dose||23
9909483|NCT01184859|11025869|FG002|Per Protocol (PP)|Period 1: Single Dose||22
9909484|NCT01184859|11025870|FG003|Per Protocol (PP)|Period 1: Single Dose||21
9909485|NCT01184859|11025871|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
9909486|NCT01184859|11025867|FG000|COMPLETED|Period 1: Single Dose||23
9909487|NCT01184859|11025868|FG001|COMPLETED|Period 1: Single Dose||23
9909488|NCT01184859|11025869|FG002|COMPLETED|Period 1: Single Dose||22
9909489|NCT01184859|11025870|FG003|COMPLETED|Period 1: Single Dose||22
9909490|NCT01184859|11025871|FG004|COMPLETED|Period 1: Single Dose||23
9909491|NCT01184859|11025867|FG000|NOT COMPLETED|Period 1: Single Dose||0
9909492|NCT01184859|11025868|FG001|NOT COMPLETED|Period 1: Single Dose||2
9909493|NCT01184859|11025869|FG002|NOT COMPLETED|Period 1: Single Dose||0
9909494|NCT01184859|11025870|FG003|NOT COMPLETED|Period 1: Single Dose||0
9909495|NCT01184859|11025871|FG004|NOT COMPLETED|Period 1: Single Dose||1
9909496|NCT01184859|11025867|FG000|STARTED|Washout Period||23
9909497|NCT01184859|11025868|FG001|STARTED|Washout Period||23
9909498|NCT01184859|11025869|FG002|STARTED|Washout Period||22
9909499|NCT01184859|11025870|FG003|STARTED|Washout Period||22
9909500|NCT01184859|11025871|FG004|STARTED|Washout Period||23
9909501|NCT01184859|11025867|FG000|COMPLETED|Washout Period||23
9909502|NCT01184859|11025868|FG001|COMPLETED|Washout Period||23
9909503|NCT01184859|11025869|FG002|COMPLETED|Washout Period||22
9909504|NCT01184859|11025870|FG003|COMPLETED|Washout Period||22
9909505|NCT01184859|11025871|FG004|COMPLETED|Washout Period||23
9909506|NCT01184859|11025867|FG000|NOT COMPLETED|Washout Period||0
9909507|NCT01184859|11025868|FG001|NOT COMPLETED|Washout Period||0
9909508|NCT01184859|11025869|FG002|NOT COMPLETED|Washout Period||0
9909509|NCT01184859|11025870|FG003|NOT COMPLETED|Washout Period||0
9909510|NCT01184859|11025871|FG004|NOT COMPLETED|Washout Period||0
9909511|NCT01184859|11025867|FG000|STARTED|Period 2: Daily Dose for 28 Days||23
9909512|NCT01184859|11025868|FG001|STARTED|Period 2: Daily Dose for 28 Days||23
9909513|NCT01184859|11025869|FG002|STARTED|Period 2: Daily Dose for 28 Days||22
9909514|NCT01184859|11025870|FG003|STARTED|Period 2: Daily Dose for 28 Days||22
9909515|NCT01184859|11025871|FG004|STARTED|Period 2: Daily Dose for 28 Days||23
9909516|NCT01184859|11025867|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22
9909517|NCT01184859|11025868|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23
9909518|NCT01184859|11025869|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22
9909519|NCT01184859|11025870|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22
9909520|NCT01184859|11025871|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22
10009852|NCT01769274|11132532|FG001|COMPLETED|Washout Period||2
10009853|NCT01769274|11132533|FG002|COMPLETED|Washout Period||3
10009854|NCT01769274|11132531|FG000|NOT COMPLETED|Washout Period||0
9909521|NCT01184859|11025867|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
9909522|NCT01184859|11025868|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
9909523|NCT01184859|11025869|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
9909524|NCT01184859|11025870|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
9909525|NCT01184859|11025871|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
9909526|NCT01184872|11025890|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
9909527|NCT01184872|11025891|FG001|STARTED|Overall Study||39
9909528|NCT01184872|11025890|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
9909529|NCT01184872|11025891|FG001|Safety Set|Overall Study||40
9909530|NCT01184872|11025890|FG000|Clinical Evaluable Set (CES)|Overall Study||73
9909531|NCT01184872|11025891|FG001|Clinical Evaluable Set (CES)|Overall Study||30
9909532|NCT01184872|11025890|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65
9909533|NCT01184872|11025891|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27
9909534|NCT01184872|11025890|FG000|COMPLETED|Overall Study||71
9909535|NCT01184872|11025891|FG001|COMPLETED|Overall Study||31
9909536|NCT01184872|11025890|FG000|NOT COMPLETED|Overall Study||10
9909537|NCT01184872|11025891|FG001|NOT COMPLETED|Overall Study||8
9909538|NCT01184885|11025897|FG000|STARTED|Overall Study||7
9909539|NCT01184885|11025897|FG000|COMPLETED|Overall Study||7
9909540|NCT01184885|11025897|FG000|NOT COMPLETED|Overall Study||0
9909541|NCT01184898|11025902|FG000|STARTED|Overall Study||36
9909542|NCT01184898|11025902|FG000|COMPLETED|Overall Study||36
9909543|NCT01184898|11025902|FG000|NOT COMPLETED|Overall Study||0
9909544|NCT01184989|11025906|FG000|STARTED|Overall Study|Treated Patients|112
9909545|NCT01184989|11025906|FG000|COMPLETED|Overall Study||100
9909546|NCT01184989|11025906|FG000|NOT COMPLETED|Overall Study||12
9909547|NCT01185028|11025910|FG000|STARTED|Overall Study||8
9909548|NCT01185028|11025910|FG000|COMPLETED|Overall Study||4
9909549|NCT01185028|11025910|FG000|NOT COMPLETED|Overall Study||4
9909550|NCT01185080|11025917|FG000|STARTED|Overall Study||50
9909551|NCT01185080|11025918|FG001|STARTED|Overall Study||16
9909552|NCT01185080|11025919|FG002|STARTED|Overall Study||17
9909553|NCT01185080|11025917|FG000|COMPLETED|Overall Study||49
9909554|NCT01185080|11025918|FG001|COMPLETED|Overall Study||15
9909555|NCT01185080|11025919|FG002|COMPLETED|Overall Study||16
9909556|NCT01185080|11025917|FG000|NOT COMPLETED|Overall Study||1
9909557|NCT01185080|11025918|FG001|NOT COMPLETED|Overall Study||1
9909558|NCT01185080|11025919|FG002|NOT COMPLETED|Overall Study||1
9909559|NCT01185171|11025927|FG000|STARTED|Induction Chemotherapy||59
9909560|NCT01185171|11025927|FG000|COMPLETED|Induction Chemotherapy||57
9909561|NCT01185171|11025927|FG000|NOT COMPLETED|Induction Chemotherapy||2
9909562|NCT01185171|11025927|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69
9909563|NCT01185171|11025927|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66
9909564|NCT01185171|11025927|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
9909565|NCT01185171|11025927|FG000|STARTED|Maintenance||60
9909566|NCT01185171|11025927|FG000|COMPLETED|Maintenance||48
9909567|NCT01185171|11025927|FG000|NOT COMPLETED|Maintenance||12
10009855|NCT01769274|11132532|FG001|NOT COMPLETED|Washout Period||0
9909568|NCT01185249|11025931|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66
9909569|NCT01185249|11025931|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
9909570|NCT01185249|11025931|FG000|NOT COMPLETED|Overall Study||42
9909571|NCT01185288|11025938|FG000|STARTED|Overall Study||154
9909572|NCT01185288|11025939|FG001|STARTED|Overall Study||155
9909573|NCT01185288|11025938|FG000|COMPLETED|Overall Study||135
9909574|NCT01185288|11025939|FG001|COMPLETED|Overall Study||139
9909575|NCT01185288|11025938|FG000|NOT COMPLETED|Overall Study||19
9909576|NCT01185288|11025939|FG001|NOT COMPLETED|Overall Study||16
9909577|NCT01185301|11025949|FG000|STARTED|Overall Study||98
9909578|NCT01185301|11025950|FG001|STARTED|Overall Study||100
9909579|NCT01185301|11025951|FG002|STARTED|Overall Study||99
9909580|NCT01185301|11025952|FG003|STARTED|Overall Study||98
9909581|NCT01185301|11025949|FG000|COMPLETED|Overall Study||83
9909582|NCT01185301|11025950|FG001|COMPLETED|Overall Study||93
9909583|NCT01185301|11025951|FG002|COMPLETED|Overall Study||93
9909584|NCT01185301|11025952|FG003|COMPLETED|Overall Study||89
9909585|NCT01185301|11025949|FG000|NOT COMPLETED|Overall Study||15
9909586|NCT01185301|11025950|FG001|NOT COMPLETED|Overall Study||7
9909587|NCT01185301|11025951|FG002|NOT COMPLETED|Overall Study||6
9909588|NCT01185301|11025952|FG003|NOT COMPLETED|Overall Study||9
9909589|NCT01185340|11025965|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
9909590|NCT01185340|11025966|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9909591|NCT01185340|11025967|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9909592|NCT01185340|11025968|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9909593|NCT01185340|11025965|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
9909594|NCT01185340|11025966|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
9909595|NCT01185340|11025967|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
9909596|NCT01185340|11025968|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
9909597|NCT01185340|11025965|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
9909598|NCT01185340|11025966|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9909599|NCT01185340|11025967|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9909600|NCT01185340|11025968|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9909601|NCT01185340|11025965|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
9909602|NCT01185340|11025966|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9909603|NCT01185340|11025967|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9909604|NCT01185340|11025968|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9909605|NCT01185340|11025965|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9909606|NCT01185340|11025966|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
9909607|NCT01185340|11025967|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
9909608|NCT01185340|11025968|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
9909609|NCT01185340|11025965|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9909610|NCT01185340|11025966|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
9909611|NCT01185340|11025967|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
9909612|NCT01185340|11025968|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
9909613|NCT01185340|11025965|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9909614|NCT01185340|11025966|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
9909615|NCT01185340|11025967|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
9909616|NCT01185340|11025968|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
9909617|NCT01185340|11025965|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9909618|NCT01185340|11025966|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
9909619|NCT01185340|11025967|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
9909620|NCT01185340|11025968|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
9909621|NCT01185353|11025985|FG000|STARTED|Part A (Weeks 0 Through 12)||49
10009856|NCT01769274|11132533|FG002|NOT COMPLETED|Washout Period||0
10009857|NCT01769274|11132531|FG000|STARTED|Part B:Treatment Session2-Period3||0
10009858|NCT01769274|11132532|FG001|STARTED|Part B:Treatment Session2-Period3||2
10009859|NCT01769274|11132533|FG002|STARTED|Part B:Treatment Session2-Period3||3
10009860|NCT01769274|11132531|FG000|COMPLETED|Part B:Treatment Session2-Period3||0
9909622|NCT01185353|11025986|FG001|STARTED|Part A (Weeks 0 Through 12)||52
9909623|NCT01185353|11025987|FG002|STARTED|Part A (Weeks 0 Through 12)||52
9909624|NCT01185353|11025988|FG003|STARTED|Part A (Weeks 0 Through 12)||50
9909625|NCT01185353|11025989|FG004|STARTED|Part A (Weeks 0 Through 12)||98
9909626|NCT01185353|11025990|FG005|STARTED|Part A (Weeks 0 Through 12)||0
9909627|NCT01185353|11025991|FG006|STARTED|Part A (Weeks 0 Through 12)||0
9909628|NCT01185353|11025992|FG007|STARTED|Part A (Weeks 0 Through 12)||0
9909629|NCT01185353|11025993|FG008|STARTED|Part A (Weeks 0 Through 12)||0
9909630|NCT01185353|11025994|FG009|STARTED|Part A (Weeks 0 Through 12)||0
9909631|NCT01185353|11025985|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
9909632|NCT01185353|11025986|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
9909633|NCT01185353|11025987|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
9909634|NCT01185353|11025988|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
9909635|NCT01185353|11025989|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
9909636|NCT01185353|11025990|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
9909637|NCT01185353|11025991|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
9909638|NCT01185353|11025992|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
9909639|NCT01185353|11025993|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
9957060|NCT01449370|11076235|FG000|COMPLETED|Overall Study||0
10009861|NCT01769274|11132532|FG001|COMPLETED|Part B:Treatment Session2-Period3||2
10009862|NCT01769274|11132533|FG002|COMPLETED|Part B:Treatment Session2-Period3||3
10009863|NCT01769274|11132531|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0
9909640|NCT01185353|11025994|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
9909641|NCT01185353|11025985|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44
9909642|NCT01185353|11025986|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51
9909643|NCT01185353|11025987|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50
9909644|NCT01185353|11025988|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49
9909645|NCT01185353|11025989|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82
9909646|NCT01185353|11025990|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0
9909647|NCT01185353|11025991|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0
9909648|NCT01185353|11025992|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0
9909649|NCT01185353|11025993|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0
9909650|NCT01185353|11025994|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0
9909651|NCT01185353|11025985|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
9909652|NCT01185353|11025986|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
9909653|NCT01185353|11025987|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
9909654|NCT01185353|11025988|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
9909655|NCT01185353|11025989|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
9909656|NCT01185353|11025990|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
9909657|NCT01185353|11025991|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
9909658|NCT01185353|11025992|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
9909659|NCT01185353|11025993|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
9909660|NCT01185353|11025994|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
9909661|NCT01185353|11025985|FG000|STARTED|Part B (Weeks 12 Through 24)||0
9909662|NCT01185353|11025986|FG001|STARTED|Part B (Weeks 12 Through 24)||51
9909663|NCT01185353|11025987|FG002|STARTED|Part B (Weeks 12 Through 24)||50
9909664|NCT01185353|11025988|FG003|STARTED|Part B (Weeks 12 Through 24)||49
9909665|NCT01185353|11025989|FG004|STARTED|Part B (Weeks 12 Through 24)||0
9909666|NCT01185353|11025990|FG005|STARTED|Part B (Weeks 12 Through 24)||63
9909667|NCT01185353|11025991|FG006|STARTED|Part B (Weeks 12 Through 24)||63
9909668|NCT01185353|11025992|FG007|STARTED|Part B (Weeks 12 Through 24)||0
9909669|NCT01185353|11025993|FG008|STARTED|Part B (Weeks 12 Through 24)||0
9909670|NCT01185353|11025994|FG009|STARTED|Part B (Weeks 12 Through 24)||0
9909671|NCT01185353|11025985|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0
9909672|NCT01185353|11025986|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50
9909673|NCT01185353|11025987|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48
9909674|NCT01185353|11025988|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45
9909675|NCT01185353|11025989|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0
10009864|NCT01769274|11132532|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0
10009865|NCT01769274|11132533|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0
10009866|NCT01769274|11132531|FG000|STARTED|Washout Period||0
10009867|NCT01769274|11132532|FG001|STARTED|Washout Period||2
10009868|NCT01769274|11132533|FG002|STARTED|Washout Period||3
10009869|NCT01769274|11132531|FG000|COMPLETED|Washout Period||0
10009870|NCT01769274|11132532|FG001|COMPLETED|Washout Period||2
10009871|NCT01769274|11132533|FG002|COMPLETED|Washout Period||3
10009872|NCT01769274|11132531|FG000|NOT COMPLETED|Washout Period||0
10009873|NCT01769274|11132532|FG001|NOT COMPLETED|Washout Period||0
10009874|NCT01769274|11132533|FG002|NOT COMPLETED|Washout Period||0
10009875|NCT01769274|11132531|FG000|STARTED|Part B:Treatment Session2-Period4||0
10009876|NCT01769274|11132532|FG001|STARTED|Part B:Treatment Session2-Period4||2
10009877|NCT01769274|11132533|FG002|STARTED|Part B:Treatment Session2-Period4||3
10009878|NCT01769274|11132531|FG000|COMPLETED|Part B:Treatment Session2-Period4||0
10009879|NCT01769274|11132532|FG001|COMPLETED|Part B:Treatment Session2-Period4||2
10009880|NCT01769274|11132533|FG002|COMPLETED|Part B:Treatment Session2-Period4||3
10009881|NCT01769274|11132531|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0
10009882|NCT01769274|11132532|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0
10009883|NCT01769274|11132533|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0
10009884|NCT01769326|11132548|FG000|STARTED|Overall Study||11
10009885|NCT01769326|11132549|FG001|STARTED|Overall Study||12
10009886|NCT01769326|11132550|FG002|STARTED|Overall Study||9
10009887|NCT01769326|11132551|FG003|STARTED|Overall Study||8
10009888|NCT01769326|11132548|FG000|COMPLETED|Overall Study||9
10009889|NCT01769326|11132549|FG001|COMPLETED|Overall Study||8
10009890|NCT01769326|11132550|FG002|COMPLETED|Overall Study||8
10009891|NCT01769326|11132551|FG003|COMPLETED|Overall Study||8
10009892|NCT01769326|11132548|FG000|NOT COMPLETED|Overall Study||2
10009893|NCT01769326|11132549|FG001|NOT COMPLETED|Overall Study||4
10009894|NCT01769326|11132550|FG002|NOT COMPLETED|Overall Study||1
10009895|NCT01769326|11132551|FG003|NOT COMPLETED|Overall Study||0
10009896|NCT01769339|11132561|FG000|STARTED|Overall Study||115
10009897|NCT01769339|11132561|FG000|COMPLETED|Overall Study||72
10009898|NCT01769339|11132561|FG000|NOT COMPLETED|Overall Study||43
10009899|NCT01769352|11132569|FG000|STARTED|Overall Study||13
10009900|NCT01769352|11132570|FG001|STARTED|Overall Study||12
10009901|NCT01769352|11132571|FG002|STARTED|Overall Study||9
10009902|NCT01769352|11132572|FG003|STARTED|Overall Study||8
10009903|NCT01769352|11132569|FG000|COMPLETED|Overall Study||13
9909676|NCT01185353|11025990|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59
9909677|NCT01185353|11025991|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57
9909678|NCT01185353|11025992|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0
9909679|NCT01185353|11025993|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0
9909680|NCT01185353|11025994|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0
9909681|NCT01185353|11025985|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
9909682|NCT01185353|11025986|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
9957061|NCT01449370|11076236|FG001|COMPLETED|Overall Study||0
9909683|NCT01185353|11025987|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
9909684|NCT01185353|11025988|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
10009904|NCT01769352|11132570|FG001|COMPLETED|Overall Study||12
10009905|NCT01769352|11132571|FG002|COMPLETED|Overall Study||9
10009906|NCT01769352|11132572|FG003|COMPLETED|Overall Study||8
10009907|NCT01769352|11132569|FG000|NOT COMPLETED|Overall Study||0
10009908|NCT01769352|11132570|FG001|NOT COMPLETED|Overall Study||0
9909685|NCT01185353|11025989|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
9909686|NCT01185353|11025990|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
9909687|NCT01185353|11025991|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
9909688|NCT01185353|11025992|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
9909689|NCT01185353|11025993|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
9909690|NCT01185353|11025994|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
9909691|NCT01185353|11025985|FG000|STARTED|Part C (Weeks 24 Through 76)||0
9909692|NCT01185353|11025986|FG001|STARTED|Part C (Weeks 24 Through 76)||0
9909693|NCT01185353|11025987|FG002|STARTED|Part C (Weeks 24 Through 76)||0
9909694|NCT01185353|11025988|FG003|STARTED|Part C (Weeks 24 Through 76)||0
9909695|NCT01185353|11025989|FG004|STARTED|Part C (Weeks 24 Through 76)||0
9909696|NCT01185353|11025990|FG005|STARTED|Part C (Weeks 24 Through 76)||0
9909697|NCT01185353|11025991|FG006|STARTED|Part C (Weeks 24 Through 76)||0
9909698|NCT01185353|11025992|FG007|STARTED|Part C (Weeks 24 Through 76)||108
9909699|NCT01185353|11025993|FG008|STARTED|Part C (Weeks 24 Through 76)||61
9909700|NCT01185353|11025994|FG009|STARTED|Part C (Weeks 24 Through 76)||32
9909701|NCT01185353|11025985|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0
9909702|NCT01185353|11025986|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0
9909703|NCT01185353|11025987|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0
9909704|NCT01185353|11025988|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0
9909705|NCT01185353|11025989|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0
9909706|NCT01185353|11025990|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0
9909707|NCT01185353|11025991|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0
9909708|NCT01185353|11025992|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92
9909709|NCT01185353|11025993|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53
9909710|NCT01185353|11025994|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24
9909711|NCT01185353|11025985|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
9909712|NCT01185353|11025986|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
9909713|NCT01185353|11025987|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
9909714|NCT01185353|11025988|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
9909715|NCT01185353|11025989|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
9909716|NCT01185353|11025990|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
9909717|NCT01185353|11025991|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
9909718|NCT01185353|11025992|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
9909719|NCT01185353|11025993|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
9909720|NCT01185353|11025994|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
9909721|NCT01185353|11025985|FG000|STARTED|Part D (Weeks 76 Through 128)||0
9909722|NCT01185353|11025986|FG001|STARTED|Part D (Weeks 76 Through 128)||0
9909723|NCT01185353|11025987|FG002|STARTED|Part D (Weeks 76 Through 128)||0
9909724|NCT01185353|11025988|FG003|STARTED|Part D (Weeks 76 Through 128)||0
9909725|NCT01185353|11025989|FG004|STARTED|Part D (Weeks 76 Through 128)||0
9909726|NCT01185353|11025990|FG005|STARTED|Part D (Weeks 76 Through 128)||0
9909727|NCT01185353|11025991|FG006|STARTED|Part D (Weeks 76 Through 128)||0
9909728|NCT01185353|11025992|FG007|STARTED|Part D (Weeks 76 Through 128)||79
9909729|NCT01185353|11025993|FG008|STARTED|Part D (Weeks 76 Through 128)||47
9909730|NCT01185353|11025994|FG009|STARTED|Part D (Weeks 76 Through 128)||18
9909731|NCT01185353|11025985|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0
9909732|NCT01185353|11025986|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0
9909733|NCT01185353|11025987|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0
9909734|NCT01185353|11025988|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0
9909735|NCT01185353|11025989|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0
9909736|NCT01185353|11025990|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0
9909737|NCT01185353|11025991|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0
9909738|NCT01185353|11025992|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76
9909739|NCT01185353|11025993|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40
9909740|NCT01185353|11025994|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17
9909741|NCT01185353|11025985|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
9909742|NCT01185353|11025986|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
9909743|NCT01185353|11025987|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
9909744|NCT01185353|11025988|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
9909745|NCT01185353|11025989|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
9909746|NCT01185353|11025990|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
9909747|NCT01185353|11025991|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
9909748|NCT01185353|11025992|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
9909749|NCT01185353|11025993|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
9909750|NCT01185353|11025994|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
9909751|NCT01185366|11026035|FG000|STARTED|First Line Therapy||38
9909752|NCT01185366|11026036|FG001|STARTED|First Line Therapy||34
9909753|NCT01185366|11026035|FG000|Received 1st Drug|First Line Therapy||36
9909754|NCT01185366|11026036|FG001|Received 1st Drug|First Line Therapy||33
10009909|NCT01769352|11132571|FG002|NOT COMPLETED|Overall Study||0
10009910|NCT01769352|11132572|FG003|NOT COMPLETED|Overall Study||0
9909755|NCT01185366|11026035|FG000|COMPLETED|First Line Therapy||35
9909756|NCT01185366|11026036|FG001|COMPLETED|First Line Therapy||33
9909757|NCT01185366|11026035|FG000|NOT COMPLETED|First Line Therapy||3
9909758|NCT01185366|11026036|FG001|NOT COMPLETED|First Line Therapy||1
9909759|NCT01185366|11026035|FG000|STARTED|Crossover to Second Line Therapy||35
9909760|NCT01185366|11026036|FG001|STARTED|Crossover to Second Line Therapy||33
9909761|NCT01185366|11026035|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21
9909762|NCT01185366|11026036|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23
9909763|NCT01185366|11026035|FG000|COMPLETED|Crossover to Second Line Therapy||21
9909764|NCT01185366|11026036|FG001|COMPLETED|Crossover to Second Line Therapy||23
9909765|NCT01185366|11026035|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14
9909766|NCT01185366|11026036|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10
9909767|NCT01185509|11026046|FG000|STARTED|Overall Study||11
9909768|NCT01185509|11026047|FG001|STARTED|Overall Study||20
9909769|NCT01185509|11026046|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
9909770|NCT01185509|11026047|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
9909771|NCT01185509|11026046|FG000|NOT COMPLETED|Overall Study||11
9909772|NCT01185509|11026047|FG001|NOT COMPLETED|Overall Study||20
9909773|NCT01185522|11026054|FG000|STARTED|Overall Study||693
9909774|NCT01185522|11026054|FG000|COMPLETED|Overall Study||585
9909775|NCT01185522|11026054|FG000|NOT COMPLETED|Overall Study||108
9909776|NCT01185548|11026059|FG000|STARTED|Period 1 : Tolbutamide||4
9909777|NCT01185548|11026059|FG000|COMPLETED|Period 1 : Tolbutamide||4
9909778|NCT01185548|11026059|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0
9909779|NCT01185548|11026059|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4
9909780|NCT01185548|11026059|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
9909781|NCT01185548|11026059|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
9909782|NCT01185548|11026059|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2
9909783|NCT01185548|11026059|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
9909784|NCT01185548|11026059|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
9909785|NCT01185561|11026074|FG000|STARTED|Overall Study||36
9909786|NCT01185561|11026075|FG001|STARTED|Overall Study||38
9909787|NCT01185561|11026074|FG000|COMPLETED|Overall Study||34
9909788|NCT01185561|11026075|FG001|COMPLETED|Overall Study||26
9909789|NCT01185561|11026074|FG000|NOT COMPLETED|Overall Study||2
9909790|NCT01185561|11026075|FG001|NOT COMPLETED|Overall Study||12
9909791|NCT01185600|11026083|FG000|STARTED|Overall Study||73
9909792|NCT01185600|11026084|FG001|STARTED|Overall Study||104
9909793|NCT01185600|11026083|FG000|COMPLETED|Overall Study||41
9909794|NCT01185600|11026084|FG001|COMPLETED|Overall Study||59
9909795|NCT01185600|11026083|FG000|NOT COMPLETED|Overall Study||32
9909796|NCT01185600|11026084|FG001|NOT COMPLETED|Overall Study||45
9909797|NCT01185639|11026093|FG000|STARTED|Overall Study||29
9909798|NCT01185639|11026093|FG000|COMPLETED|Overall Study||27
9909799|NCT01185639|11026093|FG000|NOT COMPLETED|Overall Study||2
9909800|NCT01185704|11026099|FG000|STARTED|Overall Study||68
9909801|NCT01185704|11026100|FG001|STARTED|Overall Study||68
9909802|NCT01185704|11026099|FG000|Treated|Overall Study||65
9909803|NCT01185704|11026100|FG001|Treated|Overall Study||65
9909804|NCT01185704|11026099|FG000|COMPLETED|Overall Study||55
9909805|NCT01185704|11026100|FG001|COMPLETED|Overall Study||60
9909806|NCT01185704|11026099|FG000|NOT COMPLETED|Overall Study||13
9909807|NCT01185704|11026100|FG001|NOT COMPLETED|Overall Study||8
9909808|NCT01185782|11026108|FG000|STARTED|Overall Study||129
9909809|NCT01185782|11026109|FG001|STARTED|Overall Study||136
9909810|NCT01185782|11026108|FG000|Treated|Overall Study||129
9909811|NCT01185782|11026109|FG001|Treated|Overall Study||132
9909812|NCT01185782|11026108|FG000|COMPLETED|Overall Study||123
9909813|NCT01185782|11026109|FG001|COMPLETED|Overall Study||125
9909814|NCT01185782|11026108|FG000|NOT COMPLETED|Overall Study||6
9909815|NCT01185782|11026109|FG001|NOT COMPLETED|Overall Study||11
9909816|NCT01185821|11026120|FG000|STARTED|Overall Study||33
9909817|NCT01185821|11026121|FG001|STARTED|Overall Study||29
9909818|NCT01185821|11026122|FG002|STARTED|Overall Study||43
9909819|NCT01185821|11026123|FG003|STARTED|Overall Study||29
9909820|NCT01185821|11026124|FG004|STARTED|Overall Study||50
9909821|NCT01185821|11026120|FG000|Patients With Washout|Overall Study||33
9909822|NCT01185821|11026121|FG001|Patients With Washout|Overall Study||29
9909823|NCT01185821|11026122|FG002|Patients With Washout|Overall Study||39
9909824|NCT01185821|11026123|FG003|Patients With Washout|Overall Study||29
9909825|NCT01185821|11026124|FG004|Patients With Washout|Overall Study||33
9909826|NCT01185821|11026120|FG000|Patients Without Washout|Overall Study||0
9909827|NCT01185821|11026121|FG001|Patients Without Washout|Overall Study||0
9909828|NCT01185821|11026122|FG002|Patients Without Washout|Overall Study||4
9909829|NCT01185821|11026123|FG003|Patients Without Washout|Overall Study||0
9909830|NCT01185821|11026124|FG004|Patients Without Washout|Overall Study||17
9909831|NCT01185821|11026120|FG000|Patients on Placebo in Core|Overall Study||8
9909832|NCT01185821|11026121|FG001|Patients on Placebo in Core|Overall Study||7
9909833|NCT01185821|11026122|FG002|Patients on Placebo in Core|Overall Study||9
9909834|NCT01185821|11026123|FG003|Patients on Placebo in Core|Overall Study||8
9909835|NCT01185821|11026124|FG004|Patients on Placebo in Core|Overall Study||2
9909836|NCT01185821|11026120|FG000|COMPLETED|Overall Study||26
9909837|NCT01185821|11026121|FG001|COMPLETED|Overall Study||20
9909838|NCT01185821|11026122|FG002|COMPLETED|Overall Study||33
9909839|NCT01185821|11026123|FG003|COMPLETED|Overall Study||23
9909840|NCT01185821|11026124|FG004|COMPLETED|Overall Study||26
9909841|NCT01185821|11026120|FG000|NOT COMPLETED|Overall Study||7
9909842|NCT01185821|11026121|FG001|NOT COMPLETED|Overall Study||9
9909843|NCT01185821|11026122|FG002|NOT COMPLETED|Overall Study||10
9909844|NCT01185821|11026123|FG003|NOT COMPLETED|Overall Study||6
9909845|NCT01185821|11026124|FG004|NOT COMPLETED|Overall Study||24
9909846|NCT01185834|11026138|FG000|STARTED|Overall Study||118
9909847|NCT01185834|11026138|FG000|COMPLETED|Overall Study||104
9909848|NCT01185834|11026138|FG000|NOT COMPLETED|Overall Study||14
9909849|NCT01185964|11026145|FG000|STARTED|Phase 1b and Phase 2||15
9909850|NCT01185964|11026146|FG001|STARTED|Phase 1b and Phase 2||66
9909851|NCT01185964|11026147|FG002|STARTED|Phase 1b and Phase 2||67
9909852|NCT01185964|11026148|FG003|STARTED|Phase 1b and Phase 2||0
9909853|NCT01185964|11026145|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
9909854|NCT01185964|11026146|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
9909855|NCT01185964|11026147|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
9909856|NCT01185964|11026148|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
9909857|NCT01185964|11026145|FG000|COMPLETED|Phase 1b and Phase 2||13
9909858|NCT01185964|11026146|FG001|COMPLETED|Phase 1b and Phase 2||56
9909859|NCT01185964|11026147|FG002|COMPLETED|Phase 1b and Phase 2||58
9909860|NCT01185964|11026148|FG003|COMPLETED|Phase 1b and Phase 2||0
9909861|NCT01185964|11026145|FG000|NOT COMPLETED|Phase 1b and Phase 2||2
9909862|NCT01185964|11026146|FG001|NOT COMPLETED|Phase 1b and Phase 2||10
9909863|NCT01185964|11026147|FG002|NOT COMPLETED|Phase 1b and Phase 2||9
9909864|NCT01185964|11026148|FG003|NOT COMPLETED|Phase 1b and Phase 2||0
9909865|NCT01185964|11026145|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0
9909866|NCT01185964|11026146|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0
9909867|NCT01185964|11026147|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0
9909868|NCT01185964|11026148|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
9909869|NCT01185964|11026145|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
9909870|NCT01185964|11026146|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
9909871|NCT01185964|11026147|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
9909872|NCT01185964|11026148|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
9909873|NCT01185964|11026145|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
9909874|NCT01185964|11026146|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
9909875|NCT01185964|11026147|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
9909876|NCT01185964|11026148|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
9909877|NCT01186250|11026166|FG000|STARTED|Overall Study||9
9909878|NCT01186250|11026167|FG001|STARTED|Overall Study||9
9909879|NCT01186250|11026166|FG000|COMPLETED|Overall Study||8
9909880|NCT01186250|11026167|FG001|COMPLETED|Overall Study||9
9909881|NCT01186250|11026166|FG000|NOT COMPLETED|Overall Study||1
9909882|NCT01186250|11026167|FG001|NOT COMPLETED|Overall Study||0
9909883|NCT01186328|11026173|FG000|STARTED|Overall Study||6
9909884|NCT01186328|11026174|FG001|STARTED|Overall Study||0
9909885|NCT01186328|11026175|FG002|STARTED|Overall Study||0
9909886|NCT01186328|11026173|FG000|COMPLETED|Overall Study||5
9909887|NCT01186328|11026174|FG001|COMPLETED|Overall Study||0
9909888|NCT01186328|11026175|FG002|COMPLETED|Overall Study||0
9909889|NCT01186328|11026173|FG000|NOT COMPLETED|Overall Study||1
9909890|NCT01186328|11026174|FG001|NOT COMPLETED|Overall Study||0
9909891|NCT01186328|11026175|FG002|NOT COMPLETED|Overall Study||0
9909892|NCT01186406|11026180|FG000|STARTED|Overall Study||41
9909893|NCT01186406|11026180|FG000|COMPLETED|Overall Study||41
9909894|NCT01186406|11026180|FG000|NOT COMPLETED|Overall Study||0
9909895|NCT01186419|11026186|FG000|STARTED|Overall Study||24
9909896|NCT01186419|11026187|FG001|STARTED|Overall Study||27
9909897|NCT01186419|11026186|FG000|COMPLETED|Overall Study||17
9909898|NCT01186419|11026187|FG001|COMPLETED|Overall Study||18
9909899|NCT01186419|11026186|FG000|NOT COMPLETED|Overall Study||7
9909900|NCT01186419|11026187|FG001|NOT COMPLETED|Overall Study||9
9909901|NCT01186458|11026192|FG000|STARTED|Overall Study||4
9909902|NCT01186458|11026192|FG000|COMPLETED|Overall Study||3
9909903|NCT01186458|11026192|FG000|NOT COMPLETED|Overall Study||1
9909904|NCT01186562|11026198|FG000|STARTED|Overall Study||54
9909905|NCT01186562|11026199|FG001|STARTED|Overall Study||29
9909906|NCT01186562|11026198|FG000|COMPLETED|Overall Study||50
9909907|NCT01186562|11026199|FG001|COMPLETED|Overall Study||27
9909908|NCT01186562|11026198|FG000|NOT COMPLETED|Overall Study||4
9909909|NCT01186562|11026199|FG001|NOT COMPLETED|Overall Study||2
9909910|NCT01186692|11026205|FG000|STARTED|Overall Study||131
9909911|NCT01186692|11026205|FG000|COMPLETED|Overall Study||99
9909912|NCT01186692|11026205|FG000|NOT COMPLETED|Overall Study||32
9909913|NCT01186705|11026213|FG000|STARTED|Overall Study||1
9909914|NCT01186705|11026213|FG000|COMPLETED|Overall Study||1
9909915|NCT01186705|11026213|FG000|NOT COMPLETED|Overall Study||0
9909916|NCT01186744|11026223|FG000|STARTED|Overall Study||218
9909917|NCT01186744|11026224|FG001|STARTED|Overall Study||157
9909918|NCT01186744|11026225|FG002|STARTED|Overall Study||31
9909919|NCT01186744|11026226|FG003|STARTED|Overall Study||82
9909920|NCT01186744|11026227|FG004|STARTED|Overall Study||45
9909921|NCT01186744|11026228|FG005|STARTED|Overall Study||133
9909922|NCT01186744|11026223|FG000|COMPLETED|Overall Study||10
9909923|NCT01186744|11026224|FG001|COMPLETED|Overall Study||5
9909924|NCT01186744|11026225|FG002|COMPLETED|Overall Study||25
9909925|NCT01186744|11026226|FG003|COMPLETED|Overall Study||70
9909926|NCT01186744|11026227|FG004|COMPLETED|Overall Study||39
9909927|NCT01186744|11026228|FG005|COMPLETED|Overall Study||107
9909928|NCT01186744|11026223|FG000|NOT COMPLETED|Overall Study||208
9909929|NCT01186744|11026224|FG001|NOT COMPLETED|Overall Study||152
9909930|NCT01186744|11026225|FG002|NOT COMPLETED|Overall Study||6
9909931|NCT01186744|11026226|FG003|NOT COMPLETED|Overall Study||12
9909932|NCT01186744|11026227|FG004|NOT COMPLETED|Overall Study||6
9909933|NCT01186744|11026228|FG005|NOT COMPLETED|Overall Study||26
9909934|NCT01186770|11026267|FG000|STARTED|Overall Study||201
9909935|NCT01186770|11026268|FG001|STARTED|Overall Study||202
9909936|NCT01186770|11026269|FG002|STARTED|Overall Study||200
9909937|NCT01186770|11026270|FG003|STARTED|Overall Study||201
9909938|NCT01186770|11026267|FG000|Intent-to-treat (ITT Population)|Overall Study||201
9909939|NCT01186770|11026268|FG001|Intent-to-treat (ITT Population)|Overall Study||201
9909940|NCT01186770|11026269|FG002|Intent-to-treat (ITT Population)|Overall Study||200
9909941|NCT01186770|11026270|FG003|Intent-to-treat (ITT Population)|Overall Study||201
9909942|NCT01186770|11026267|FG000|COMPLETED|Overall Study||160
9909943|NCT01186770|11026268|FG001|COMPLETED|Overall Study||156
9909944|NCT01186770|11026269|FG002|COMPLETED|Overall Study||148
9909945|NCT01186770|11026270|FG003|COMPLETED|Overall Study||143
9909946|NCT01186770|11026267|FG000|NOT COMPLETED|Overall Study||41
9909947|NCT01186770|11026268|FG001|NOT COMPLETED|Overall Study||46
9909948|NCT01186770|11026269|FG002|NOT COMPLETED|Overall Study||52
9909949|NCT01186770|11026270|FG003|NOT COMPLETED|Overall Study||58
9909950|NCT01186796|11026282|FG000|STARTED|Overall Study||14
9909951|NCT01186796|11026283|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
9909952|NCT01186796|11026282|FG000|COMPLETED|Overall Study||10
9909953|NCT01186796|11026283|FG001|COMPLETED|Overall Study||14
9909954|NCT01186796|11026282|FG000|NOT COMPLETED|Overall Study||4
9909955|NCT01186796|11026283|FG001|NOT COMPLETED|Overall Study||2
9909956|NCT01186809|11026289|FG000|STARTED|Overall Study||73
9909957|NCT01186809|11026289|FG000|COMPLETED|Overall Study||43
9909958|NCT01186809|11026289|FG000|NOT COMPLETED|Overall Study||30
9909959|NCT01186939|11026293|FG000|STARTED|Overall Study||40
9909960|NCT01186939|11026293|FG000|COMPLETED|Overall Study||0
9909961|NCT01186939|11026293|FG000|NOT COMPLETED|Overall Study||40
9909962|NCT01186978|11026297|FG000|STARTED|Overall Study||63
9909963|NCT01186978|11026297|FG000|COMPLETED|Overall Study||62
9909964|NCT01186978|11026297|FG000|NOT COMPLETED|Overall Study||1
9909965|NCT01187004|11026303|FG000|STARTED|Overall Study||20
9909966|NCT01187004|11026304|FG001|STARTED|Overall Study||144
9909967|NCT01187004|11026303|FG000|COMPLETED|Overall Study||20
9909968|NCT01187004|11026304|FG001|COMPLETED|Overall Study||144
9909969|NCT01187004|11026303|FG000|NOT COMPLETED|Overall Study||0
9909970|NCT01187004|11026304|FG001|NOT COMPLETED|Overall Study||0
9909971|NCT01187017|11026311|FG000|STARTED|Overall Study||1
9909972|NCT01187017|11026311|FG000|COMPLETED|Overall Study||1
9909973|NCT01187017|11026311|FG000|NOT COMPLETED|Overall Study||0
9909974|NCT01187043|11026322|FG000|STARTED|Overall Study||12
9909975|NCT01187043|11026323|FG001|STARTED|Overall Study||10
9909976|NCT01187043|11026324|FG002|STARTED|Overall Study||12
9909977|NCT01187043|11026325|FG003|STARTED|Overall Study||12
9909978|NCT01187043|11026326|FG004|STARTED|Overall Study||12
9909979|NCT01187043|11026322|FG000|COMPLETED|Overall Study||11
9909980|NCT01187043|11026323|FG001|COMPLETED|Overall Study||10
9909981|NCT01187043|11026324|FG002|COMPLETED|Overall Study||8
9909982|NCT01187043|11026325|FG003|COMPLETED|Overall Study||12
9909983|NCT01187043|11026326|FG004|COMPLETED|Overall Study||10
9909984|NCT01187043|11026322|FG000|NOT COMPLETED|Overall Study||1
9909985|NCT01187043|11026323|FG001|NOT COMPLETED|Overall Study||0
9909986|NCT01187043|11026324|FG002|NOT COMPLETED|Overall Study||4
9909987|NCT01187043|11026325|FG003|NOT COMPLETED|Overall Study||0
9909988|NCT01187043|11026326|FG004|NOT COMPLETED|Overall Study||2
9909989|NCT01187095|11026340|FG000|STARTED|Overall Study||153
9909990|NCT01187095|11026341|FG001|STARTED|Overall Study||142
9909991|NCT01187095|11026340|FG000|COMPLETED|Overall Study||108
9909992|NCT01187095|11026341|FG001|COMPLETED|Overall Study||108
9909993|NCT01187095|11026340|FG000|NOT COMPLETED|Overall Study||45
9909994|NCT01187095|11026341|FG001|NOT COMPLETED|Overall Study||34
9909995|NCT01187329|11026349|FG000|STARTED|Overall Study||50
9909996|NCT01187329|11026350|FG001|STARTED|Overall Study||50
9909997|NCT01187329|11026349|FG000|COMPLETED|Overall Study||49
9909998|NCT01187329|11026350|FG001|COMPLETED|Overall Study||48
9909999|NCT01187329|11026349|FG000|NOT COMPLETED|Overall Study||1
9910000|NCT01187329|11026350|FG001|NOT COMPLETED|Overall Study||2
9910001|NCT01187355|11026358|FG000|STARTED|Overall Study||294
9910002|NCT01187355|11026359|FG001|STARTED|Overall Study||297
9910003|NCT01187355|11026358|FG000|COMPLETED|Overall Study||276
9910004|NCT01187355|11026359|FG001|COMPLETED|Overall Study||277
9910005|NCT01187355|11026358|FG000|NOT COMPLETED|Overall Study||18
9910006|NCT01187355|11026359|FG001|NOT COMPLETED|Overall Study||20
9910007|NCT01187381|11026365|FG000|STARTED|Overall Study||250
9910008|NCT01187381|11026365|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
9910009|NCT01187381|11026365|FG000|NOT COMPLETED|Overall Study||0
9910010|NCT01187407|11026373|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
9910011|NCT01187407|11026374|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9910012|NCT01187407|11026375|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9910013|NCT01187407|11026376|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9910014|NCT01187407|11026377|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
9957062|NCT01449370|11076237|FG002|COMPLETED|Overall Study||0
9910015|NCT01187407|11026373|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
9910016|NCT01187407|11026374|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
9910017|NCT01187407|11026375|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
9910018|NCT01187407|11026376|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
9910019|NCT01187407|11026377|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
9910020|NCT01187407|11026373|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
9910021|NCT01187407|11026374|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910022|NCT01187407|11026375|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910023|NCT01187407|11026376|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910024|NCT01187407|11026377|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910025|NCT01187407|11026373|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
9910026|NCT01187407|11026374|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910027|NCT01187407|11026375|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910028|NCT01187407|11026376|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910029|NCT01187407|11026377|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
9910030|NCT01187407|11026373|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9910031|NCT01187407|11026374|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
9910032|NCT01187407|11026375|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
9910033|NCT01187407|11026376|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
9910034|NCT01187407|11026377|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
9910035|NCT01187407|11026373|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9910036|NCT01187407|11026374|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
9910037|NCT01187407|11026375|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
9910038|NCT01187407|11026376|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
9910039|NCT01187407|11026377|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
9910040|NCT01187407|11026373|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9910041|NCT01187407|11026374|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
9910042|NCT01187407|11026375|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
9910043|NCT01187407|11026376|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
9910044|NCT01187407|11026377|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
9910045|NCT01187407|11026373|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
9910046|NCT01187407|11026374|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
9910047|NCT01187407|11026375|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
9910048|NCT01187407|11026376|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
9910049|NCT01187407|11026377|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
9910050|NCT01187446|11026396|FG000|STARTED|Overall Study||14
9910051|NCT01187446|11026397|FG001|STARTED|Overall Study||14
9910052|NCT01187446|11026396|FG000|COMPLETED|Overall Study||14
9910053|NCT01187446|11026397|FG001|COMPLETED|Overall Study||13
9910054|NCT01187446|11026396|FG000|NOT COMPLETED|Overall Study||0
9910055|NCT01187446|11026397|FG001|NOT COMPLETED|Overall Study||1
9910056|NCT01187498|11026405|FG000|STARTED|Overall Study||73
9910057|NCT01187498|11026406|FG001|STARTED|Overall Study||70
9910058|NCT01187498|11026405|FG000|COMPLETED|Overall Study||64
9910059|NCT01187498|11026406|FG001|COMPLETED|Overall Study||60
9910060|NCT01187498|11026405|FG000|NOT COMPLETED|Overall Study||9
9910061|NCT01187498|11026406|FG001|NOT COMPLETED|Overall Study||10
9910062|NCT01187511|11026414|FG000|STARTED|Overall Study||22
9910063|NCT01187511|11026415|FG001|STARTED|Overall Study||22
9910064|NCT01187511|11026414|FG000|COMPLETED|Overall Study||14
9910065|NCT01187511|11026415|FG001|COMPLETED|Overall Study||21
9910066|NCT01187511|11026414|FG000|NOT COMPLETED|Overall Study||8
9910067|NCT01187511|11026415|FG001|NOT COMPLETED|Overall Study||1
9910068|NCT01187550|11026423|FG000|STARTED|Overall Study||183
9910069|NCT01187550|11026424|FG001|STARTED|Overall Study||30
9910070|NCT01187550|11026423|FG000|Treated|Overall Study||175
9910071|NCT01187550|11026424|FG001|Treated|Overall Study||30
9910072|NCT01187550|11026423|FG000|COMPLETED|Overall Study||169
9910073|NCT01187550|11026424|FG001|COMPLETED|Overall Study||29
9910074|NCT01187550|11026423|FG000|NOT COMPLETED|Overall Study||14
9910075|NCT01187550|11026424|FG001|NOT COMPLETED|Overall Study||1
9910076|NCT01187771|11026432|FG000|STARTED|Overall Study||28
9910077|NCT01187771|11026433|FG001|STARTED|Overall Study||21
9910078|NCT01187771|11026432|FG000|COMPLETED|Overall Study||25
9910079|NCT01187771|11026433|FG001|COMPLETED|Overall Study||18
9910080|NCT01187771|11026432|FG000|NOT COMPLETED|Overall Study||3
9910081|NCT01187771|11026433|FG001|NOT COMPLETED|Overall Study||3
9910082|NCT01187901|11026443|FG000|STARTED|Overall Study||46
9910083|NCT01187901|11026444|FG001|STARTED|Overall Study||46
9910084|NCT01187901|11026443|FG000|COMPLETED|Overall Study||37
9910085|NCT01187901|11026444|FG001|COMPLETED|Overall Study||36
9910086|NCT01187901|11026443|FG000|NOT COMPLETED|Overall Study||9
9910087|NCT01187901|11026444|FG001|NOT COMPLETED|Overall Study||10
9957063|NCT01449370|11076238|FG003|COMPLETED|Overall Study||0
9910088|NCT01187914|11026450|FG000|STARTED|Overall Study||40
9910089|NCT01187914|11026450|FG000|COMPLETED|Overall Study||40
9910090|NCT01187914|11026450|FG000|NOT COMPLETED|Overall Study||0
9910091|NCT01187953|11026456|FG000|STARTED|Overall Study||268
9910092|NCT01187953|11026457|FG001|STARTED|Overall Study||275
9910093|NCT01187953|11026456|FG000|Dosed|Overall Study||266
9910094|NCT01187953|11026457|FG001|Dosed|Overall Study||271
9910095|NCT01187953|11026456|FG000|COMPLETED|Overall Study||253
9910096|NCT01187953|11026457|FG001|COMPLETED|Overall Study||254
9910097|NCT01187953|11026456|FG000|NOT COMPLETED|Overall Study||15
9910098|NCT01187953|11026457|FG001|NOT COMPLETED|Overall Study||21
10203697|NCT03466047|11330564|FG000|STARTED|Fat Small Intestine (1 Day)||8
10203698|NCT03466047|11330564|FG000|COMPLETED|Fat Small Intestine (1 Day)||8
10203699|NCT03466047|11330564|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0
10203700|NCT03466060|11330593|FG000|STARTED|Period 1||19
10203701|NCT03466060|11330594|FG001|STARTED|Period 1||18
10203702|NCT03466060|11330595|FG002|STARTED|Period 1||20
10203703|NCT03466060|11330596|FG003|STARTED|Period 1||18
10203704|NCT03466060|11330597|FG004|STARTED|Period 1||20
9910099|NCT01188109|11026463|FG000|STARTED|Overall Study||22
9910100|NCT01188109|11026463|FG000|COMPLETED|Overall Study||22
9910101|NCT01188109|11026463|FG000|NOT COMPLETED|Overall Study||0
9910102|NCT01188226|11026467|FG000|STARTED|Overall Study||10
9910103|NCT01188226|11026467|FG000|COMPLETED|Overall Study||6
9910104|NCT01188226|11026467|FG000|NOT COMPLETED|Overall Study||4
9910105|NCT01188343|11026484|FG000|STARTED|Overall Study||102
9910106|NCT01188343|11026485|FG001|STARTED|Overall Study||219
9910107|NCT01188343|11026486|FG002|STARTED|Overall Study||221
9910108|NCT01188343|11026484|FG000|COMPLETED|Overall Study||101
9910109|NCT01188343|11026485|FG001|COMPLETED|Overall Study||193
9910110|NCT01188343|11026486|FG002|COMPLETED|Overall Study||220
9910111|NCT01188343|11026484|FG000|NOT COMPLETED|Overall Study||1
9910112|NCT01188343|11026485|FG001|NOT COMPLETED|Overall Study||26
9910113|NCT01188343|11026486|FG002|NOT COMPLETED|Overall Study||1
9910114|NCT01188369|11026499|FG000|STARTED|Overall Study||10
9910115|NCT01188369|11026500|FG001|STARTED|Overall Study||10
9910116|NCT01188369|11026499|FG000|COMPLETED|Overall Study||10
9910117|NCT01188369|11026500|FG001|COMPLETED|Overall Study||10
9910118|NCT01188369|11026499|FG000|NOT COMPLETED|Overall Study||0
9910119|NCT01188369|11026500|FG001|NOT COMPLETED|Overall Study||0
9910120|NCT01188421|11026509|FG000|STARTED|Overall Study||31
9910121|NCT01188421|11026510|FG001|STARTED|Overall Study||36
9910122|NCT01188421|11026511|FG002|STARTED|Overall Study||36
9910123|NCT01188421|11026509|FG000|COMPLETED|Overall Study||28
9910124|NCT01188421|11026510|FG001|COMPLETED|Overall Study||26
9910125|NCT01188421|11026511|FG002|COMPLETED|Overall Study||22
9910126|NCT01188421|11026509|FG000|NOT COMPLETED|Overall Study||3
9910127|NCT01188421|11026510|FG001|NOT COMPLETED|Overall Study||10
9910128|NCT01188421|11026511|FG002|NOT COMPLETED|Overall Study||14
9910129|NCT01188447|11026519|FG000|STARTED|Overall Study||4034
9910130|NCT01188447|11026519|FG000|COMPLETED|Overall Study||4034
9910131|NCT01188447|11026519|FG000|NOT COMPLETED|Overall Study||0
9910132|NCT01188460|11026526|FG000|STARTED|Overall Study||25
9910133|NCT01188460|11026527|FG001|STARTED|Overall Study||23
9910134|NCT01188460|11026526|FG000|COMPLETED|Overall Study||25
9910135|NCT01188460|11026527|FG001|COMPLETED|Overall Study||23
9910136|NCT01188460|11026526|FG000|NOT COMPLETED|Overall Study||0
9910137|NCT01188460|11026527|FG001|NOT COMPLETED|Overall Study||0
9910138|NCT01188499|11026538|FG000|STARTED|Overall Study||24
9910139|NCT01188499|11026539|FG001|STARTED|Overall Study||83
10009911|NCT01769365|11132586|FG000|STARTED|Overall Study||102
10009912|NCT01769365|11132587|FG001|STARTED|Overall Study||102
10009913|NCT01769365|11132588|FG002|STARTED|Overall Study||103
10009914|NCT01769365|11132586|FG000|COMPLETED|Overall Study||102
10009915|NCT01769365|11132587|FG001|COMPLETED|Overall Study||100
10009916|NCT01769365|11132588|FG002|COMPLETED|Overall Study||101
10009917|NCT01769365|11132586|FG000|NOT COMPLETED|Overall Study||0
10009918|NCT01769365|11132587|FG001|NOT COMPLETED|Overall Study||2
10009919|NCT01769365|11132588|FG002|NOT COMPLETED|Overall Study||2
10009920|NCT01769378|11132598|FG000|STARTED|Overall Study||240
10009921|NCT01769378|11132599|FG001|STARTED|Overall Study||60
10009922|NCT01769378|11132598|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
10009923|NCT01769378|11132599|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
10009924|NCT01769378|11132598|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215
10009925|NCT01769378|11132599|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56
9910140|NCT01188499|11026540|FG002|STARTED|Overall Study||33
9910141|NCT01188499|11026541|FG003|STARTED|Overall Study||18
9910142|NCT01188499|11026542|FG004|STARTED|Overall Study||18
10009926|NCT01769378|11132598|FG000|NOT COMPLETED|Overall Study||25
9910143|NCT01188499|11026538|FG000|COMPLETED|Overall Study||24
9910144|NCT01188499|11026539|FG001|COMPLETED|Overall Study||83
9910145|NCT01188499|11026540|FG002|COMPLETED|Overall Study||33
9910146|NCT01188499|11026541|FG003|COMPLETED|Overall Study||18
9910147|NCT01188499|11026542|FG004|COMPLETED|Overall Study||18
9910148|NCT01188499|11026538|FG000|NOT COMPLETED|Overall Study||0
10009927|NCT01769378|11132599|FG001|NOT COMPLETED|Overall Study||4
10009928|NCT01769391|11132607|FG000|STARTED|Overall Study||110
10203705|NCT03466060|11330598|FG005|STARTED|Period 1||18
9910149|NCT01188499|11026539|FG001|NOT COMPLETED|Overall Study||0
9910150|NCT01188499|11026540|FG002|NOT COMPLETED|Overall Study||0
9910151|NCT01188499|11026541|FG003|NOT COMPLETED|Overall Study||0
9910152|NCT01188499|11026542|FG004|NOT COMPLETED|Overall Study||0
9910153|NCT01188538|11026556|FG000|STARTED|Overall Study||20
9910154|NCT01188538|11026557|FG001|STARTED|Overall Study||20
9910155|NCT01188538|11026556|FG000|COMPLETED|Overall Study||20
9910156|NCT01188538|11026557|FG001|COMPLETED|Overall Study||19
9910157|NCT01188538|11026556|FG000|NOT COMPLETED|Overall Study||0
9910158|NCT01188538|11026557|FG001|NOT COMPLETED|Overall Study||1
9910159|NCT01188551|11026569|FG000|STARTED|Overall Study||25
9910160|NCT01188551|11026570|FG001|STARTED|Overall Study||25
9910161|NCT01188551|11026571|FG002|STARTED|Overall Study||25
9910162|NCT01188551|11026572|FG003|STARTED|Overall Study||25
9910163|NCT01188551|11026569|FG000|COMPLETED|Overall Study||24
9910164|NCT01188551|11026570|FG001|COMPLETED|Overall Study||25
9910165|NCT01188551|11026571|FG002|COMPLETED|Overall Study||25
9910166|NCT01188551|11026572|FG003|COMPLETED|Overall Study||25
9910167|NCT01188551|11026569|FG000|NOT COMPLETED|Overall Study||1
9910168|NCT01188551|11026570|FG001|NOT COMPLETED|Overall Study||0
9910169|NCT01188551|11026571|FG002|NOT COMPLETED|Overall Study||0
9910170|NCT01188551|11026572|FG003|NOT COMPLETED|Overall Study||0
9910171|NCT01188564|11026584|FG000|STARTED|Double-blind Phase||44
9910172|NCT01188564|11026585|FG001|STARTED|Double-blind Phase||31
9910173|NCT01188564|11026584|FG000|COMPLETED|Double-blind Phase||43
9910174|NCT01188564|11026585|FG001|COMPLETED|Double-blind Phase||31
9910175|NCT01188564|11026584|FG000|NOT COMPLETED|Double-blind Phase||1
9910176|NCT01188564|11026585|FG001|NOT COMPLETED|Double-blind Phase||0
9910177|NCT01188564|11026584|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
9910178|NCT01188564|11026585|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
9910179|NCT01188564|11026584|FG000|COMPLETED|Open Label Phase||24
9910180|NCT01188564|11026585|FG001|COMPLETED|Open Label Phase||20
9910181|NCT01188564|11026584|FG000|NOT COMPLETED|Open Label Phase||0
9910182|NCT01188564|11026585|FG001|NOT COMPLETED|Open Label Phase||0
9910183|NCT01188577|11026593|FG000|STARTED|Visit 1||11
9910184|NCT01188577|11026594|FG001|STARTED|Visit 1||12
9910185|NCT01188577|11026593|FG000|COMPLETED|Visit 1||11
9910186|NCT01188577|11026594|FG001|COMPLETED|Visit 1||12
9910187|NCT01188577|11026593|FG000|NOT COMPLETED|Visit 1||0
9910188|NCT01188577|11026594|FG001|NOT COMPLETED|Visit 1||0
9910189|NCT01188577|11026593|FG000|STARTED|3-14 Day Washout||11
9910190|NCT01188577|11026594|FG001|STARTED|3-14 Day Washout||12
9910191|NCT01188577|11026593|FG000|COMPLETED|3-14 Day Washout||11
9910192|NCT01188577|11026594|FG001|COMPLETED|3-14 Day Washout||12
9910193|NCT01188577|11026593|FG000|NOT COMPLETED|3-14 Day Washout||0
9910194|NCT01188577|11026594|FG001|NOT COMPLETED|3-14 Day Washout||0
9910195|NCT01188577|11026593|FG000|STARTED|Visit 2||11
9910196|NCT01188577|11026594|FG001|STARTED|Visit 2||12
9910197|NCT01188577|11026593|FG000|COMPLETED|Visit 2||11
9910198|NCT01188577|11026594|FG001|COMPLETED|Visit 2||12
9910199|NCT01188577|11026593|FG000|NOT COMPLETED|Visit 2||0
9910200|NCT01188577|11026594|FG001|NOT COMPLETED|Visit 2||0
9910201|NCT01188603|11026600|FG000|STARTED|Overall Study||24
9910202|NCT01188603|11026600|FG000|COMPLETED|Overall Study||24
9910203|NCT01188603|11026600|FG000|NOT COMPLETED|Overall Study||0
9910204|NCT01188655|11026604|FG000|STARTED|Overall Study||89
9910205|NCT01188655|11026604|FG000|COMPLETED|Overall Study||76
9910206|NCT01188655|11026604|FG000|NOT COMPLETED|Overall Study||13
9910207|NCT01188668|11026608|FG000|STARTED|Period 1: ARIP Alone||38
9910208|NCT01188668|11026608|FG000|COMPLETED|Period 1: ARIP Alone||36
9910209|NCT01188668|11026608|FG000|NOT COMPLETED|Period 1: ARIP Alone||2
9910210|NCT01188668|11026608|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36
9910211|NCT01188668|11026608|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
9910212|NCT01188668|11026608|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
9910213|NCT01188681|11026619|FG000|STARTED|Overall Study||6
9910214|NCT01188681|11026620|FG001|STARTED|Overall Study||6
9910215|NCT01188681|11026621|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
9910216|NCT01188681|11026622|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
9910217|NCT01188681|11026619|FG000|COMPLETED|Overall Study||6
9910218|NCT01188681|11026620|FG001|COMPLETED|Overall Study||6
9910219|NCT01188681|11026621|FG002|COMPLETED|Overall Study||32
9910220|NCT01188681|11026622|FG003|COMPLETED|Overall Study||33
9910221|NCT01188681|11026619|FG000|NOT COMPLETED|Overall Study||0
9910222|NCT01188681|11026620|FG001|NOT COMPLETED|Overall Study||0
9910223|NCT01188681|11026621|FG002|NOT COMPLETED|Overall Study||1
9910224|NCT01188681|11026622|FG003|NOT COMPLETED|Overall Study||1
9910225|NCT01188694|11026639|FG000|STARTED|Overall Study||15
9910226|NCT01188694|11026640|FG001|STARTED|Overall Study||16
9910227|NCT01188694|11026641|FG002|STARTED|Overall Study||11
9910228|NCT01188694|11026639|FG000|COMPLETED|Overall Study||10
9910229|NCT01188694|11026640|FG001|COMPLETED|Overall Study||15
9910230|NCT01188694|11026641|FG002|COMPLETED|Overall Study||10
9910231|NCT01188694|11026639|FG000|NOT COMPLETED|Overall Study||5
9910232|NCT01188694|11026640|FG001|NOT COMPLETED|Overall Study||1
9910233|NCT01188694|11026641|FG002|NOT COMPLETED|Overall Study||1
9910234|NCT01188772|11026653|FG000|STARTED|Overall Study||48
9910235|NCT01188772|11026654|FG001|STARTED|Overall Study||48
9910236|NCT01188772|11026655|FG002|STARTED|Overall Study||26
9910237|NCT01188772|11026656|FG003|STARTED|Overall Study||25
9910238|NCT01188772|11026653|FG000|Randomized and Treated|Overall Study||48
9910239|NCT01188772|11026654|FG001|Randomized and Treated|Overall Study||47
9910240|NCT01188772|11026655|FG002|Randomized and Treated|Overall Study||26
9910241|NCT01188772|11026656|FG003|Randomized and Treated|Overall Study||25
9910242|NCT01188772|11026653|FG000|COMPLETED|Overall Study||43
9910243|NCT01188772|11026654|FG001|COMPLETED|Overall Study||45
9910244|NCT01188772|11026655|FG002|COMPLETED|Overall Study||15
9910245|NCT01188772|11026656|FG003|COMPLETED|Overall Study||24
9910246|NCT01188772|11026653|FG000|NOT COMPLETED|Overall Study||5
9910247|NCT01188772|11026654|FG001|NOT COMPLETED|Overall Study||3
9910248|NCT01188772|11026655|FG002|NOT COMPLETED|Overall Study||11
9910249|NCT01188772|11026656|FG003|NOT COMPLETED|Overall Study||1
9910250|NCT01188811|11026671|FG000|STARTED|Overall Study||28
9910251|NCT01188811|11026672|FG001|STARTED|Overall Study||26
9910252|NCT01188811|11026671|FG000|COMPLETED|Overall Study||22
9910253|NCT01188811|11026672|FG001|COMPLETED|Overall Study||24
9910254|NCT01188811|11026671|FG000|NOT COMPLETED|Overall Study||6
9910255|NCT01188811|11026672|FG001|NOT COMPLETED|Overall Study||2
9910256|NCT01188876|11026678|FG000|STARTED|Overall Study||50
9910257|NCT01188876|11026678|FG000|COMPLETED|Overall Study||50
9910258|NCT01188876|11026678|FG000|NOT COMPLETED|Overall Study||0
9910259|NCT01188928|11026686|FG000|STARTED|Overall Study||482
10111198|NCT02494076|11242241|FG000|NOT COMPLETED|Overall Study||0
10111199|NCT02494076|11242242|FG001|NOT COMPLETED|Overall Study||0
10111200|NCT02494102|11242250|FG000|STARTED|Overall Study||42
10111201|NCT02494102|11242251|FG001|STARTED|Overall Study||47
10111202|NCT02494102|11242250|FG000|COMPLETED|Overall Study||42
10111203|NCT02494102|11242251|FG001|COMPLETED|Overall Study||47
10111204|NCT02494102|11242250|FG000|NOT COMPLETED|Overall Study||0
10111205|NCT02494102|11242251|FG001|NOT COMPLETED|Overall Study||0
10111206|NCT02494180|11242259|FG000|STARTED|Overall Study||85
10111207|NCT02494180|11242260|FG001|STARTED|Overall Study||85
10111208|NCT02494180|11242259|FG000|COMPLETED|Overall Study||85
9910260|NCT01188928|11026687|FG001|STARTED|Overall Study||479
9910261|NCT01188928|11026688|FG002|STARTED|Overall Study||96
9910262|NCT01188928|11026689|FG003|STARTED|Overall Study||95
9910263|NCT01188928|11026686|FG000|COMPLETED|Overall Study||444
9910264|NCT01188928|11026687|FG001|COMPLETED|Overall Study||417
9910265|NCT01188928|11026688|FG002|COMPLETED|Overall Study||82
9910266|NCT01188928|11026689|FG003|COMPLETED|Overall Study||77
9910267|NCT01188928|11026686|FG000|NOT COMPLETED|Overall Study||38
9910268|NCT01188928|11026687|FG001|NOT COMPLETED|Overall Study||62
9910269|NCT01188928|11026688|FG002|NOT COMPLETED|Overall Study||14
9910270|NCT01188928|11026689|FG003|NOT COMPLETED|Overall Study||18
9910271|NCT01188967|11026701|FG000|STARTED|Overall Study||10
9910272|NCT01188967|11026702|FG001|STARTED|Overall Study||8
9910273|NCT01188967|11026701|FG000|COMPLETED|Overall Study||5
9910274|NCT01188967|11026702|FG001|COMPLETED|Overall Study||4
9910275|NCT01188967|11026701|FG000|NOT COMPLETED|Overall Study||5
9910276|NCT01188967|11026702|FG001|NOT COMPLETED|Overall Study||4
9910277|NCT01189032|11026713|FG000|STARTED|Overall Study||94
9910278|NCT01189032|11026714|FG001|STARTED|Overall Study||96
9910279|NCT01189032|11026715|FG002|STARTED|Overall Study||96
9910280|NCT01189032|11026713|FG000|COMPLETED|Overall Study||89
9910281|NCT01189032|11026714|FG001|COMPLETED|Overall Study||89
9910282|NCT01189032|11026715|FG002|COMPLETED|Overall Study||90
9910283|NCT01189032|11026713|FG000|NOT COMPLETED|Overall Study||5
9910284|NCT01189032|11026714|FG001|NOT COMPLETED|Overall Study||7
9910285|NCT01189032|11026715|FG002|NOT COMPLETED|Overall Study||6
9910286|NCT01189110|11026725|FG000|STARTED|Overall Study|September, 2010|64
9910287|NCT01189110|11026726|FG001|STARTED|Overall Study||61
9910288|NCT01189110|11026725|FG000|COMPLETED|Overall Study|February, 2011|64
9910289|NCT01189110|11026726|FG001|COMPLETED|Overall Study||61
9910290|NCT01189110|11026725|FG000|NOT COMPLETED|Overall Study||0
9910291|NCT01189110|11026726|FG001|NOT COMPLETED|Overall Study||0
9910292|NCT01189123|11026734|FG000|STARTED|Overall Study||52
9910293|NCT01189123|11026735|FG001|STARTED|Overall Study||53
9910294|NCT01189123|11026734|FG000|COMPLETED|Overall Study||50
9910295|NCT01189123|11026735|FG001|COMPLETED|Overall Study||47
9910296|NCT01189123|11026734|FG000|NOT COMPLETED|Overall Study||2
9910297|NCT01189123|11026735|FG001|NOT COMPLETED|Overall Study||6
9910298|NCT01189136|11026743|FG000|STARTED|Overall Study||42
9910299|NCT01189136|11026744|FG001|STARTED|Overall Study||42
9910300|NCT01189136|11026743|FG000|COMPLETED|Overall Study||42
9910301|NCT01189136|11026744|FG001|COMPLETED|Overall Study||42
9910302|NCT01189136|11026743|FG000|NOT COMPLETED|Overall Study||0
9910303|NCT01189136|11026744|FG001|NOT COMPLETED|Overall Study||0
9910304|NCT01189201|11026750|FG000|STARTED|Overall Study||42
9910305|NCT01189201|11026750|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
9910306|NCT01189201|11026750|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
9910307|NCT01189201|11026750|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
9910308|NCT01189201|11026750|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
9910309|NCT01189201|11026750|FG000|COMPLETED|Overall Study||41
9910310|NCT01189201|11026750|FG000|NOT COMPLETED|Overall Study||1
9910311|NCT01189240|11026765|FG000|STARTED|Overall Study||4
9910312|NCT01189240|11026766|FG001|STARTED|Overall Study||6
10111209|NCT02494180|11242260|FG001|COMPLETED|Overall Study||85
10111210|NCT02494180|11242259|FG000|NOT COMPLETED|Overall Study||0
10111211|NCT02494180|11242260|FG001|NOT COMPLETED|Overall Study||0
10111212|NCT02494297|11242266|FG000|STARTED|Overall Study||1597
9910313|NCT01189240|11026767|FG002|STARTED|Overall Study||3
9910314|NCT01189240|11026765|FG000|COMPLETED|Overall Study||4
9910315|NCT01189240|11026766|FG001|COMPLETED|Overall Study||6
9910316|NCT01189240|11026767|FG002|COMPLETED|Overall Study||3
9910317|NCT01189240|11026765|FG000|NOT COMPLETED|Overall Study||0
9910318|NCT01189240|11026766|FG001|NOT COMPLETED|Overall Study||0
9910319|NCT01189240|11026767|FG002|NOT COMPLETED|Overall Study||0
9910320|NCT01189266|11026780|FG000|STARTED|Overall Study||6
9910321|NCT01189266|11026781|FG001|STARTED|Overall Study||6
9910322|NCT01189266|11026782|FG002|STARTED|Overall Study||67
9910323|NCT01189266|11026780|FG000|COMPLETED|Overall Study||0
9910324|NCT01189266|11026781|FG001|COMPLETED|Overall Study||0
9910325|NCT01189266|11026782|FG002|COMPLETED|Overall Study||2
9910326|NCT01189266|11026780|FG000|NOT COMPLETED|Overall Study||6
9910327|NCT01189266|11026781|FG001|NOT COMPLETED|Overall Study||6
9910328|NCT01189266|11026782|FG002|NOT COMPLETED|Overall Study||65
9910329|NCT01189279|11026794|FG000|STARTED|Overall Study||14
9910330|NCT01189279|11026795|FG001|STARTED|Overall Study||14
9910331|NCT01189279|11026796|FG002|STARTED|Overall Study||14
9910332|NCT01189279|11026794|FG000|COMPLETED|Overall Study||13
9910333|NCT01189279|11026795|FG001|COMPLETED|Overall Study||14
9910334|NCT01189279|11026796|FG002|COMPLETED|Overall Study||13
9910335|NCT01189279|11026794|FG000|NOT COMPLETED|Overall Study||1
9910336|NCT01189279|11026795|FG001|NOT COMPLETED|Overall Study||0
9910337|NCT01189279|11026796|FG002|NOT COMPLETED|Overall Study||1
9910338|NCT01189292|11026806|FG000|STARTED|Intention to Treat Analysis||76
9910339|NCT01189292|11026807|FG001|STARTED|Intention to Treat Analysis||76
9910340|NCT01189292|11026806|FG000|COMPLETED|Intention to Treat Analysis||76
9910341|NCT01189292|11026807|FG001|COMPLETED|Intention to Treat Analysis||76
9910342|NCT01189292|11026806|FG000|NOT COMPLETED|Intention to Treat Analysis||0
9910343|NCT01189292|11026807|FG001|NOT COMPLETED|Intention to Treat Analysis||0
9910344|NCT01189292|11026806|FG000|STARTED|Per Protocol Analysis||76
9910345|NCT01189292|11026807|FG001|STARTED|Per Protocol Analysis||76
9910346|NCT01189292|11026806|FG000|COMPLETED|Per Protocol Analysis||65
9910347|NCT01189292|11026807|FG001|COMPLETED|Per Protocol Analysis||60
9910348|NCT01189292|11026806|FG000|NOT COMPLETED|Per Protocol Analysis||11
9910349|NCT01189292|11026807|FG001|NOT COMPLETED|Per Protocol Analysis||16
9910350|NCT01189370|11026813|FG000|STARTED|Dose Level 1||25
9910351|NCT01189370|11026814|FG001|STARTED|Dose Level 1||0
9910352|NCT01189370|11026815|FG002|STARTED|Dose Level 1||0
9910353|NCT01189370|11026813|FG000|COMPLETED|Dose Level 1||16
9910354|NCT01189370|11026814|FG001|COMPLETED|Dose Level 1||0
9910355|NCT01189370|11026815|FG002|COMPLETED|Dose Level 1||0
9910356|NCT01189370|11026813|FG000|NOT COMPLETED|Dose Level 1||9
9910357|NCT01189370|11026814|FG001|NOT COMPLETED|Dose Level 1||0
9910358|NCT01189370|11026815|FG002|NOT COMPLETED|Dose Level 1||0
9910359|NCT01189370|11026813|FG000|STARTED|Dose Level 2||0
9910360|NCT01189370|11026814|FG001|STARTED|Dose Level 2||16
9910361|NCT01189370|11026815|FG002|STARTED|Dose Level 2||0
9910362|NCT01189370|11026813|FG000|COMPLETED|Dose Level 2||0
9910363|NCT01189370|11026814|FG001|COMPLETED|Dose Level 2||12
9910364|NCT01189370|11026815|FG002|COMPLETED|Dose Level 2||0
9910365|NCT01189370|11026813|FG000|NOT COMPLETED|Dose Level 2||0
9910366|NCT01189370|11026814|FG001|NOT COMPLETED|Dose Level 2||4
9910367|NCT01189370|11026815|FG002|NOT COMPLETED|Dose Level 2||0
9910368|NCT01189370|11026813|FG000|STARTED|Dose Level 3||0
9910369|NCT01189370|11026814|FG001|STARTED|Dose Level 3||0
9910370|NCT01189370|11026815|FG002|STARTED|Dose Level 3||12
9910371|NCT01189370|11026813|FG000|COMPLETED|Dose Level 3||0
9910372|NCT01189370|11026814|FG001|COMPLETED|Dose Level 3||0
9910373|NCT01189370|11026815|FG002|COMPLETED|Dose Level 3||6
9910374|NCT01189370|11026813|FG000|NOT COMPLETED|Dose Level 3||0
9910375|NCT01189370|11026814|FG001|NOT COMPLETED|Dose Level 3||0
9910376|NCT01189370|11026815|FG002|NOT COMPLETED|Dose Level 3||6
9910377|NCT01189409|11026824|FG000|STARTED|First 3 Weeks||37
9910378|NCT01189409|11026825|FG001|STARTED|First 3 Weeks||33
9910379|NCT01189409|11026824|FG000|COMPLETED|First 3 Weeks||19
9910380|NCT01189409|11026825|FG001|COMPLETED|First 3 Weeks||23
9910381|NCT01189409|11026824|FG000|NOT COMPLETED|First 3 Weeks||18
9910382|NCT01189409|11026825|FG001|NOT COMPLETED|First 3 Weeks||10
9910383|NCT01189409|11026824|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
9910384|NCT01189409|11026825|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
9910385|NCT01189409|11026824|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
9910386|NCT01189409|11026825|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
9910387|NCT01189409|11026824|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
9910388|NCT01189409|11026825|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
9910389|NCT01189461|11026838|FG000|STARTED|Overall Study||46
9910390|NCT01189461|11026838|FG000|COMPLETED|Overall Study||12
9910391|NCT01189461|11026838|FG000|NOT COMPLETED|Overall Study||34
9910392|NCT01189487|11026842|FG000|STARTED|Overall Study|Treated participants|47
9910393|NCT01189487|11026842|FG000|COMPLETED|Overall Study||44
9910394|NCT01189487|11026842|FG000|NOT COMPLETED|Overall Study||3
9910395|NCT01189500|11026846|FG000|STARTED|Period 1: TAMOX Alone||30
9910396|NCT01189500|11026846|FG000|COMPLETED|Period 1: TAMOX Alone||29
9910397|NCT01189500|11026846|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1
9910398|NCT01189500|11026846|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
9910399|NCT01189500|11026846|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
9910400|NCT01189500|11026846|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
9910401|NCT01189604|11026860|FG000|STARTED|Overall Study||21
9910402|NCT01189604|11026861|FG001|STARTED|Overall Study||21
9910403|NCT01189604|11026862|FG002|STARTED|Overall Study||20
9910404|NCT01189604|11026863|FG003|STARTED|Overall Study||20
9910405|NCT01189604|11026864|FG004|STARTED|Overall Study||20
9910406|NCT01189604|11026865|FG005|STARTED|Overall Study||11
9910407|NCT01189604|11026866|FG006|STARTED|Overall Study||10
9910408|NCT01189604|11026860|FG000|Administered Study Drug|Overall Study||20
9910409|NCT01189604|11026861|FG001|Administered Study Drug|Overall Study||20
9910410|NCT01189604|11026862|FG002|Administered Study Drug|Overall Study||20
9910411|NCT01189604|11026863|FG003|Administered Study Drug|Overall Study||20
9910412|NCT01189604|11026864|FG004|Administered Study Drug|Overall Study||20
9910413|NCT01189604|11026865|FG005|Administered Study Drug|Overall Study||10
9910414|NCT01189604|11026866|FG006|Administered Study Drug|Overall Study||10
9910415|NCT01189604|11026860|FG000|COMPLETED|Overall Study||20
9910416|NCT01189604|11026861|FG001|COMPLETED|Overall Study||20
9910417|NCT01189604|11026862|FG002|COMPLETED|Overall Study||20
9910418|NCT01189604|11026863|FG003|COMPLETED|Overall Study||20
9910419|NCT01189604|11026864|FG004|COMPLETED|Overall Study||18
9910420|NCT01189604|11026865|FG005|COMPLETED|Overall Study||10
9910421|NCT01189604|11026866|FG006|COMPLETED|Overall Study||9
9910422|NCT01189604|11026860|FG000|NOT COMPLETED|Overall Study||1
9910423|NCT01189604|11026861|FG001|NOT COMPLETED|Overall Study||1
9910424|NCT01189604|11026862|FG002|NOT COMPLETED|Overall Study||0
9910425|NCT01189604|11026863|FG003|NOT COMPLETED|Overall Study||0
9910426|NCT01189604|11026864|FG004|NOT COMPLETED|Overall Study||2
9910427|NCT01189604|11026865|FG005|NOT COMPLETED|Overall Study||1
9910428|NCT01189604|11026866|FG006|NOT COMPLETED|Overall Study||1
9910429|NCT01189617|11026884|FG000|STARTED|Overall Study||35
9910430|NCT01189617|11026885|FG001|STARTED|Overall Study||35
9910431|NCT01189617|11026884|FG000|COMPLETED|Overall Study||35
9910432|NCT01189617|11026885|FG001|COMPLETED|Overall Study||35
9910433|NCT01189617|11026884|FG000|NOT COMPLETED|Overall Study||0
9910434|NCT01189617|11026885|FG001|NOT COMPLETED|Overall Study||0
9910435|NCT01189747|11026893|FG000|STARTED|Overall Study||222
9910436|NCT01189747|11026894|FG001|STARTED|Overall Study||224
9910437|NCT01189747|11026893|FG000|COMPLETED|Overall Study||210
9910438|NCT01189747|11026894|FG001|COMPLETED|Overall Study||206
9910439|NCT01189747|11026893|FG000|NOT COMPLETED|Overall Study||12
9910440|NCT01189747|11026894|FG001|NOT COMPLETED|Overall Study||18
9910441|NCT01189760|11026903|FG000|STARTED|Overall Study||305
9910442|NCT01189760|11026904|FG001|STARTED|Overall Study||306
9910443|NCT01189760|11026905|FG002|STARTED|Overall Study||306
9910444|NCT01189760|11026903|FG000|COMPLETED|Overall Study||291
9910445|NCT01189760|11026904|FG001|COMPLETED|Overall Study||283
9910446|NCT01189760|11026905|FG002|COMPLETED|Overall Study||255
9910447|NCT01189760|11026903|FG000|NOT COMPLETED|Overall Study||14
9910448|NCT01189760|11026904|FG001|NOT COMPLETED|Overall Study||23
9910449|NCT01189760|11026905|FG002|NOT COMPLETED|Overall Study||51
9910450|NCT01189812|11026915|FG000|STARTED|Overall Study||40
9910451|NCT01189812|11026916|FG001|STARTED|Overall Study||40
9910452|NCT01189812|11026915|FG000|COMPLETED|Overall Study||32
9910453|NCT01189812|11026916|FG001|COMPLETED|Overall Study||32
9910454|NCT01189812|11026915|FG000|NOT COMPLETED|Overall Study||8
9910455|NCT01189812|11026916|FG001|NOT COMPLETED|Overall Study||8
9910456|NCT01189890|11026924|FG000|STARTED|Overall Study||241
9910457|NCT01189890|11026925|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
9910458|NCT01189890|11026924|FG000|COMPLETED|Overall Study||204
9910459|NCT01189890|11026925|FG001|COMPLETED|Overall Study||200
9910460|NCT01189890|11026924|FG000|NOT COMPLETED|Overall Study||37
9910461|NCT01189890|11026925|FG001|NOT COMPLETED|Overall Study||39
9910462|NCT01190007|11026931|FG000|STARTED|Overall Study|Treated|159
9910463|NCT01190007|11026931|FG000|COMPLETED|Overall Study||145
9910464|NCT01190007|11026931|FG000|NOT COMPLETED|Overall Study||14
9910465|NCT01190020|11026937|FG000|STARTED|Overall Study||29
9910466|NCT01190020|11026938|FG001|STARTED|Overall Study||12
9910467|NCT01190020|11026937|FG000|COMPLETED|Overall Study||22
9910468|NCT01190020|11026938|FG001|COMPLETED|Overall Study||12
9910469|NCT01190020|11026937|FG000|NOT COMPLETED|Overall Study||7
9910470|NCT01190020|11026938|FG001|NOT COMPLETED|Overall Study||0
9910471|NCT01190085|11026947|FG000|STARTED|Overall Study||13
9910472|NCT01190085|11026948|FG001|STARTED|Overall Study||14
9910473|NCT01190085|11026949|FG002|STARTED|Overall Study||18
9910474|NCT01190085|11026947|FG000|COMPLETED|Overall Study||13
9910475|NCT01190085|11026948|FG001|COMPLETED|Overall Study||14
9910476|NCT01190085|11026949|FG002|COMPLETED|Overall Study||18
9910477|NCT01190085|11026947|FG000|NOT COMPLETED|Overall Study||0
9910478|NCT01190085|11026948|FG001|NOT COMPLETED|Overall Study||0
9910479|NCT01190085|11026949|FG002|NOT COMPLETED|Overall Study||0
9910480|NCT01190098|11026959|FG000|STARTED|Overall Study||42
9910481|NCT01190098|11026960|FG001|STARTED|Overall Study||10
9910482|NCT01190098|11026959|FG000|COMPLETED|Overall Study||39
9910483|NCT01190098|11026960|FG001|COMPLETED|Overall Study||8
9910484|NCT01190098|11026959|FG000|NOT COMPLETED|Overall Study||3
9910485|NCT01190098|11026960|FG001|NOT COMPLETED|Overall Study||2
9910486|NCT01190124|11026969|FG000|STARTED|Overall Study||107
9910487|NCT01190124|11026970|FG001|STARTED|Overall Study||24
9910488|NCT01190124|11026971|FG002|STARTED|Overall Study||20
9910489|NCT01190124|11026969|FG000|COMPLETED|Overall Study||90
9910490|NCT01190124|11026970|FG001|COMPLETED|Overall Study||24
9910491|NCT01190124|11026971|FG002|COMPLETED|Overall Study||19
9910492|NCT01190124|11026969|FG000|NOT COMPLETED|Overall Study||17
9910493|NCT01190124|11026970|FG001|NOT COMPLETED|Overall Study||0
9910494|NCT01190124|11026971|FG002|NOT COMPLETED|Overall Study||1
9910495|NCT01190150|11026984|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
9910496|NCT01190150|11026985|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
9910497|NCT01190150|11026984|FG000|COMPLETED|First Treatment||10
9910498|NCT01190150|11026985|FG001|COMPLETED|First Treatment||9
9910499|NCT01190150|11026984|FG000|NOT COMPLETED|First Treatment||1
9910500|NCT01190150|11026985|FG001|NOT COMPLETED|First Treatment||0
9910501|NCT01190150|11026984|FG000|STARTED|Washout||10
9910502|NCT01190150|11026985|FG001|STARTED|Washout||9
9910503|NCT01190150|11026984|FG000|COMPLETED|Washout||10
9910504|NCT01190150|11026985|FG001|COMPLETED|Washout||7
9910505|NCT01190150|11026984|FG000|NOT COMPLETED|Washout||0
9910506|NCT01190150|11026985|FG001|NOT COMPLETED|Washout||2
9910507|NCT01190150|11026984|FG000|STARTED|Second Treatment||10
9910508|NCT01190150|11026985|FG001|STARTED|Second Treatment||7
9910509|NCT01190150|11026984|FG000|COMPLETED|Second Treatment||10
9910510|NCT01190150|11026985|FG001|COMPLETED|Second Treatment||7
9910511|NCT01190150|11026984|FG000|NOT COMPLETED|Second Treatment||0
9910512|NCT01190150|11026985|FG001|NOT COMPLETED|Second Treatment||0
9910513|NCT01190176|11026991|FG000|STARTED|Overall Study||32
10009929|NCT01769391|11132608|FG001|STARTED|Overall Study||57
10009930|NCT01769391|11132607|FG000|Received at Least One Dose of Study Drug|Overall Study||106
10009931|NCT01769391|11132608|FG001|Received at Least One Dose of Study Drug|Overall Study||55
10009932|NCT01769391|11132607|FG000|COMPLETED|Overall Study||93
9910514|NCT01190176|11026991|FG000|COMPLETED|Overall Study||30
9910515|NCT01190176|11026991|FG000|NOT COMPLETED|Overall Study||2
9910516|NCT01190189|11026995|FG000|STARTED|Overall Study||137
9910517|NCT01190189|11026995|FG000|COMPLETED|Overall Study||131
9910518|NCT01190189|11026995|FG000|NOT COMPLETED|Overall Study||6
9910519|NCT01190215|11027001|FG000|STARTED|Up to Day 28||38
9910520|NCT01190215|11027002|FG001|STARTED|Up to Day 28||39
9910521|NCT01190215|11027001|FG000|COMPLETED|Up to Day 28||38
9910522|NCT01190215|11027002|FG001|COMPLETED|Up to Day 28||39
9910523|NCT01190215|11027001|FG000|NOT COMPLETED|Up to Day 28||0
9910524|NCT01190215|11027002|FG001|NOT COMPLETED|Up to Day 28||0
9910525|NCT01190215|11027001|FG000|STARTED|Up to Month 6||38
9910526|NCT01190215|11027002|FG001|STARTED|Up to Month 6||39
9910527|NCT01190215|11027001|FG000|COMPLETED|Up to Month 6||36
9910528|NCT01190215|11027002|FG001|COMPLETED|Up to Month 6||39
9910529|NCT01190215|11027001|FG000|NOT COMPLETED|Up to Month 6||2
9910530|NCT01190215|11027002|FG001|NOT COMPLETED|Up to Month 6||0
9910531|NCT01190410|11027010|FG000|STARTED|Overall Study||4
9910532|NCT01190410|11027011|FG001|STARTED|Overall Study||12
9910533|NCT01190410|11027010|FG000|Re-Induction|Overall Study||0
9910534|NCT01190410|11027011|FG001|Re-Induction|Overall Study||2
9910535|NCT01190410|11027010|FG000|COMPLETED|Overall Study||3
9910536|NCT01190410|11027011|FG001|COMPLETED|Overall Study||3
9910537|NCT01190410|11027010|FG000|NOT COMPLETED|Overall Study||1
9910538|NCT01190410|11027011|FG001|NOT COMPLETED|Overall Study||9
9910539|NCT01190436|11027023|FG000|STARTED|Overall Study||125
9910540|NCT01190436|11027023|FG000|COMPLETED|Overall Study||86
9910541|NCT01190436|11027023|FG000|NOT COMPLETED|Overall Study||39
9910542|NCT01190449|11027030|FG000|STARTED|Overall Study||15
9910543|NCT01190449|11027031|FG001|STARTED|Overall Study||36
9910544|NCT01190449|11027030|FG000|COMPLETED|Overall Study||15
9910545|NCT01190449|11027031|FG001|COMPLETED|Overall Study||32
9910546|NCT01190449|11027030|FG000|NOT COMPLETED|Overall Study||0
9910547|NCT01190449|11027031|FG001|NOT COMPLETED|Overall Study||4
9910548|NCT01190475|11027040|FG000|STARTED|Overall Study||2
9910549|NCT01190475|11027041|FG001|STARTED|Overall Study||2
9910550|NCT01190475|11027042|FG002|STARTED|Overall Study||2
9910551|NCT01190475|11027040|FG000|COMPLETED|Overall Study||2
9910552|NCT01190475|11027041|FG001|COMPLETED|Overall Study||2
9910553|NCT01190475|11027042|FG002|COMPLETED|Overall Study||1
9910554|NCT01190475|11027040|FG000|NOT COMPLETED|Overall Study||0
9910555|NCT01190475|11027041|FG001|NOT COMPLETED|Overall Study||0
9910556|NCT01190475|11027042|FG002|NOT COMPLETED|Overall Study||1
9910557|NCT01190514|11027052|FG000|STARTED|First Intervention (Period 1)||11
9910558|NCT01190514|11027053|FG001|STARTED|First Intervention (Period 1)||10
9910559|NCT01190514|11027054|FG002|STARTED|First Intervention (Period 1)||10
9910560|NCT01190514|11027055|FG003|STARTED|First Intervention (Period 1)||10
9910561|NCT01190514|11027052|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
9910562|NCT01190514|11027053|FG001|COMPLETED|First Intervention (Period 1)||10
9910563|NCT01190514|11027054|FG002|COMPLETED|First Intervention (Period 1)||10
9910564|NCT01190514|11027055|FG003|COMPLETED|First Intervention (Period 1)||10
9910565|NCT01190514|11027052|FG000|NOT COMPLETED|First Intervention (Period 1)||1
9910566|NCT01190514|11027053|FG001|NOT COMPLETED|First Intervention (Period 1)||0
9910567|NCT01190514|11027054|FG002|NOT COMPLETED|First Intervention (Period 1)||0
9910568|NCT01190514|11027055|FG003|NOT COMPLETED|First Intervention (Period 1)||0
9910569|NCT01190514|11027052|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
9910570|NCT01190514|11027053|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
10009933|NCT01769391|11132608|FG001|COMPLETED|Overall Study||48
9910571|NCT01190514|11027054|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
9910572|NCT01190514|11027055|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
9910573|NCT01190514|11027052|FG000|COMPLETED|Second Intervention (Period 2)||10
9910574|NCT01190514|11027053|FG001|COMPLETED|Second Intervention (Period 2)||10
9910575|NCT01190514|11027054|FG002|COMPLETED|Second Intervention (Period 2)||10
9910576|NCT01190514|11027055|FG003|COMPLETED|Second Intervention (Period 2)||10
9910577|NCT01190514|11027052|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
9910578|NCT01190514|11027053|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
9910579|NCT01190514|11027054|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
9910580|NCT01190514|11027055|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
10203706|NCT03466060|11330593|FG000|COMPLETED|Period 1||19
10203707|NCT03466060|11330594|FG001|COMPLETED|Period 1||16
10203708|NCT03466060|11330595|FG002|COMPLETED|Period 1||17
10203709|NCT03466060|11330596|FG003|COMPLETED|Period 1||17
10203710|NCT03466060|11330597|FG004|COMPLETED|Period 1||20
10203711|NCT03466060|11330598|FG005|COMPLETED|Period 1||18
10203712|NCT03466060|11330593|FG000|NOT COMPLETED|Period 1||0
10203713|NCT03466060|11330594|FG001|NOT COMPLETED|Period 1||2
10203714|NCT03466060|11330595|FG002|NOT COMPLETED|Period 1||3
10203715|NCT03466060|11330596|FG003|NOT COMPLETED|Period 1||1
9910581|NCT01190514|11027052|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
9910582|NCT01190514|11027053|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
9910583|NCT01190514|11027054|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
9910584|NCT01190514|11027055|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
9910585|NCT01190514|11027052|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
9910586|NCT01190514|11027053|FG001|COMPLETED|Third Intervention (Period 3)||10
9910587|NCT01190514|11027054|FG002|COMPLETED|Third Intervention (Period 3)||10
9910588|NCT01190514|11027055|FG003|COMPLETED|Third Intervention (Period 3)||10
9910589|NCT01190514|11027052|FG000|NOT COMPLETED|Third Intervention (Period 3)||1
9910590|NCT01190514|11027053|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
9910591|NCT01190514|11027054|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
9910592|NCT01190514|11027055|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
9910593|NCT01190514|11027052|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
9910594|NCT01190514|11027053|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
9910595|NCT01190514|11027054|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
9910596|NCT01190514|11027055|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
9910597|NCT01190514|11027052|FG000|COMPLETED|Fourth Intervention (Period 4)||9
9910598|NCT01190514|11027053|FG001|COMPLETED|Fourth Intervention (Period 4)||10
9910599|NCT01190514|11027054|FG002|COMPLETED|Fourth Intervention (Period 4)||10
9910600|NCT01190514|11027055|FG003|COMPLETED|Fourth Intervention (Period 4)||10
9910601|NCT01190514|11027052|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0
9910602|NCT01190514|11027053|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0
9910603|NCT01190514|11027054|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0
9910604|NCT01190514|11027055|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0
9910605|NCT01190527|11027065|FG000|STARTED|Overall Study||42
9910606|NCT01190527|11027065|FG000|COMPLETED|Overall Study||42
9910607|NCT01190527|11027065|FG000|NOT COMPLETED|Overall Study||0
9910608|NCT01190566|11027071|FG000|STARTED|Overall Study||6
9910609|NCT01190566|11027072|FG001|STARTED|Overall Study||42
9910610|NCT01190566|11027071|FG000|COMPLETED|Overall Study||6
9910611|NCT01190566|11027072|FG001|COMPLETED|Overall Study||42
9910612|NCT01190566|11027071|FG000|NOT COMPLETED|Overall Study||0
9910613|NCT01190566|11027072|FG001|NOT COMPLETED|Overall Study||0
9910614|NCT01190813|11027081|FG000|STARTED|Overall Study||90
9910615|NCT01190813|11027082|FG001|STARTED|Overall Study||49
9910616|NCT01190813|11027081|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
9910617|NCT01190813|11027082|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
9910618|NCT01190813|11027081|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88
9910619|NCT01190813|11027082|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47
9910620|NCT01190813|11027081|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
9910621|NCT01190813|11027082|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
9910622|NCT01190813|11027081|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88
9910623|NCT01190813|11027082|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48
9910624|NCT01190813|11027081|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
9910625|NCT01190813|11027082|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
9910626|NCT01190813|11027081|FG000|16-week Visit|Overall Study|1 dropped|87
9910627|NCT01190813|11027082|FG001|16-week Visit|Overall Study|2 dropped|46
9910628|NCT01190813|11027081|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
9910629|NCT01190813|11027082|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
9910630|NCT01190813|11027081|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
9910631|NCT01190813|11027082|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
9910632|NCT01190813|11027081|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86
9910633|NCT01190813|11027082|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45
9910634|NCT01190813|11027081|FG000|COMPLETED|Overall Study||86
10203716|NCT03466060|11330597|FG004|NOT COMPLETED|Period 1||0
9910635|NCT01190813|11027082|FG001|COMPLETED|Overall Study||45
9910636|NCT01190813|11027081|FG000|NOT COMPLETED|Overall Study||4
9910637|NCT01190813|11027082|FG001|NOT COMPLETED|Overall Study||4
9910638|NCT01190839|11027090|FG000|STARTED|Overall Study||150
9910639|NCT01190839|11027091|FG001|STARTED|Overall Study||147
9910640|NCT01190839|11027090|FG000|Treated|Overall Study||148
9910641|NCT01190839|11027091|FG001|Treated|Overall Study||143
9910642|NCT01190839|11027090|FG000|COMPLETED|Overall Study||0
10203717|NCT03466060|11330598|FG005|NOT COMPLETED|Period 1||0
10203718|NCT03466060|11330593|FG000|STARTED|Period 2||19
10009934|NCT01769391|11132607|FG000|NOT COMPLETED|Overall Study||17
10009935|NCT01769391|11132608|FG001|NOT COMPLETED|Overall Study||9
10009936|NCT01769404|11132620|FG000|STARTED|Treatment Period 1||12
9910643|NCT01190839|11027091|FG001|COMPLETED|Overall Study||0
9910644|NCT01190839|11027090|FG000|NOT COMPLETED|Overall Study||150
9910645|NCT01190839|11027091|FG001|NOT COMPLETED|Overall Study||147
9910646|NCT01190865|11027099|FG000|STARTED|Overall Study||28
9910647|NCT01190865|11027099|FG000|COMPLETED|Overall Study||25
9910648|NCT01190865|11027099|FG000|NOT COMPLETED|Overall Study||3
9910649|NCT01190878|11027107|FG000|STARTED|Overall Study||40
9910650|NCT01190878|11027108|FG001|STARTED|Overall Study||45
9910651|NCT01190878|11027109|FG002|STARTED|Overall Study||42
9910652|NCT01190878|11027110|FG003|STARTED|Overall Study||42
9910653|NCT01190878|11027107|FG000|COMPLETED|Overall Study||37
9910654|NCT01190878|11027108|FG001|COMPLETED|Overall Study||42
9910655|NCT01190878|11027109|FG002|COMPLETED|Overall Study||37
9910656|NCT01190878|11027110|FG003|COMPLETED|Overall Study||22
9910657|NCT01190878|11027107|FG000|NOT COMPLETED|Overall Study||3
9910658|NCT01190878|11027108|FG001|NOT COMPLETED|Overall Study||3
9910659|NCT01190878|11027109|FG002|NOT COMPLETED|Overall Study||5
9910660|NCT01190878|11027110|FG003|NOT COMPLETED|Overall Study||20
9910661|NCT01190891|11027122|FG000|STARTED|Overall Study||52
9910662|NCT01190891|11027123|FG001|STARTED|Overall Study||52
9910663|NCT01190891|11027122|FG000|COMPLETED|Overall Study||46
9910664|NCT01190891|11027123|FG001|COMPLETED|Overall Study||52
9910665|NCT01190891|11027122|FG000|NOT COMPLETED|Overall Study||6
9910666|NCT01190891|11027123|FG001|NOT COMPLETED|Overall Study||0
9910667|NCT01190930|11027131|FG000|STARTED|Induction||9298
9910668|NCT01190930|11027132|FG001|STARTED|Induction||52
9910669|NCT01190930|11027133|FG002|STARTED|Induction||0
9910670|NCT01190930|11027134|FG003|STARTED|Induction||0
9910671|NCT01190930|11027135|FG004|STARTED|Induction||0
9910672|NCT01190930|11027136|FG005|STARTED|Induction||0
9910673|NCT01190930|11027137|FG006|STARTED|Induction||0
9910674|NCT01190930|11027138|FG007|STARTED|Induction||0
9910675|NCT01190930|11027139|FG008|STARTED|Induction||0
9910676|NCT01190930|11027140|FG009|STARTED|Induction||0
9910677|NCT01190930|11027131|FG000|COMPLETED|Induction||3949
9910678|NCT01190930|11027132|FG001|COMPLETED|Induction||43
9910679|NCT01190930|11027133|FG002|COMPLETED|Induction||0
9910680|NCT01190930|11027134|FG003|COMPLETED|Induction||0
9910681|NCT01190930|11027135|FG004|COMPLETED|Induction||0
9910682|NCT01190930|11027136|FG005|COMPLETED|Induction||0
9910683|NCT01190930|11027137|FG006|COMPLETED|Induction||0
9910684|NCT01190930|11027138|FG007|COMPLETED|Induction||0
9910685|NCT01190930|11027139|FG008|COMPLETED|Induction||0
9910686|NCT01190930|11027140|FG009|COMPLETED|Induction||0
9910687|NCT01190930|11027131|FG000|NOT COMPLETED|Induction||5349
9910688|NCT01190930|11027132|FG001|NOT COMPLETED|Induction||9
9910689|NCT01190930|11027133|FG002|NOT COMPLETED|Induction||0
9910690|NCT01190930|11027134|FG003|NOT COMPLETED|Induction||0
9910691|NCT01190930|11027135|FG004|NOT COMPLETED|Induction||0
9910692|NCT01190930|11027136|FG005|NOT COMPLETED|Induction||0
9910693|NCT01190930|11027137|FG006|NOT COMPLETED|Induction||0
9910694|NCT01190930|11027138|FG007|NOT COMPLETED|Induction||0
9910695|NCT01190930|11027139|FG008|NOT COMPLETED|Induction||0
9910696|NCT01190930|11027140|FG009|NOT COMPLETED|Induction||0
9910697|NCT01190930|11027131|FG000|STARTED|Post Induction Pre-Maintenance||0
9910698|NCT01190930|11027132|FG001|STARTED|Post Induction Pre-Maintenance||43
9910699|NCT01190930|11027133|FG002|STARTED|Post Induction Pre-Maintenance||3122
9910700|NCT01190930|11027134|FG003|STARTED|Post Induction Pre-Maintenance||224
9910701|NCT01190930|11027135|FG004|STARTED|Post Induction Pre-Maintenance||301
9910702|NCT01190930|11027136|FG005|STARTED|Post Induction Pre-Maintenance||302
9910703|NCT01190930|11027137|FG006|STARTED|Post Induction Pre-Maintenance||0
9910704|NCT01190930|11027138|FG007|STARTED|Post Induction Pre-Maintenance||0
9910705|NCT01190930|11027139|FG008|STARTED|Post Induction Pre-Maintenance||0
9910706|NCT01190930|11027140|FG009|STARTED|Post Induction Pre-Maintenance||0
9910707|NCT01190930|11027131|FG000|COMPLETED|Post Induction Pre-Maintenance||0
9910708|NCT01190930|11027132|FG001|COMPLETED|Post Induction Pre-Maintenance||37
9910709|NCT01190930|11027133|FG002|COMPLETED|Post Induction Pre-Maintenance||2364
9910710|NCT01190930|11027134|FG003|COMPLETED|Post Induction Pre-Maintenance||207
9910711|NCT01190930|11027135|FG004|COMPLETED|Post Induction Pre-Maintenance||296
9910712|NCT01190930|11027136|FG005|COMPLETED|Post Induction Pre-Maintenance||296
9910713|NCT01190930|11027137|FG006|COMPLETED|Post Induction Pre-Maintenance||0
9910714|NCT01190930|11027138|FG007|COMPLETED|Post Induction Pre-Maintenance||0
9910715|NCT01190930|11027139|FG008|COMPLETED|Post Induction Pre-Maintenance||0
9910716|NCT01190930|11027140|FG009|COMPLETED|Post Induction Pre-Maintenance||0
9910717|NCT01190930|11027131|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0
9910718|NCT01190930|11027132|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6
10009937|NCT01769404|11132621|FG001|STARTED|Treatment Period 1||13
9910719|NCT01190930|11027133|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758
9910720|NCT01190930|11027134|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17
9910721|NCT01190930|11027135|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5
9910722|NCT01190930|11027136|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6
9910723|NCT01190930|11027137|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0
9910724|NCT01190930|11027138|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0
9910725|NCT01190930|11027139|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0
9910726|NCT01190930|11027140|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0
9910727|NCT01190930|11027131|FG000|STARTED|Maintenance||0
9910728|NCT01190930|11027132|FG001|STARTED|Maintenance||37
9910729|NCT01190930|11027133|FG002|STARTED|Maintenance||0
9910730|NCT01190930|11027134|FG003|STARTED|Maintenance||207
9910731|NCT01190930|11027135|FG004|STARTED|Maintenance||296
9910732|NCT01190930|11027136|FG005|STARTED|Maintenance||296
9910733|NCT01190930|11027137|FG006|STARTED|Maintenance||600
9910734|NCT01190930|11027138|FG007|STARTED|Maintenance||586
9910735|NCT01190930|11027139|FG008|STARTED|Maintenance||586
9910736|NCT01190930|11027140|FG009|STARTED|Maintenance||592
9910737|NCT01190930|11027131|FG000|COMPLETED|Maintenance||0
9910738|NCT01190930|11027132|FG001|COMPLETED|Maintenance||27
9910739|NCT01190930|11027133|FG002|COMPLETED|Maintenance||0
9910740|NCT01190930|11027134|FG003|COMPLETED|Maintenance||167
9910741|NCT01190930|11027135|FG004|COMPLETED|Maintenance||287
9910742|NCT01190930|11027136|FG005|COMPLETED|Maintenance||284
9910743|NCT01190930|11027137|FG006|COMPLETED|Maintenance||574
9910744|NCT01190930|11027138|FG007|COMPLETED|Maintenance||540
9910745|NCT01190930|11027139|FG008|COMPLETED|Maintenance||540
9910746|NCT01190930|11027140|FG009|COMPLETED|Maintenance||555
9910747|NCT01190930|11027131|FG000|NOT COMPLETED|Maintenance||0
9910748|NCT01190930|11027132|FG001|NOT COMPLETED|Maintenance||10
9910749|NCT01190930|11027133|FG002|NOT COMPLETED|Maintenance||0
9910750|NCT01190930|11027134|FG003|NOT COMPLETED|Maintenance||40
9910751|NCT01190930|11027135|FG004|NOT COMPLETED|Maintenance||9
9910752|NCT01190930|11027136|FG005|NOT COMPLETED|Maintenance||12
9910753|NCT01190930|11027137|FG006|NOT COMPLETED|Maintenance||26
9910754|NCT01190930|11027138|FG007|NOT COMPLETED|Maintenance||46
9910755|NCT01190930|11027139|FG008|NOT COMPLETED|Maintenance||46
9910756|NCT01190930|11027140|FG009|NOT COMPLETED|Maintenance||37
9910757|NCT01191008|11027164|FG000|STARTED|Overall Study||633
9910758|NCT01191008|11027164|FG000|COMPLETED|Overall Study||618
9910759|NCT01191008|11027164|FG000|NOT COMPLETED|Overall Study||15
9910760|NCT01191086|11027168|FG000|STARTED|Overall Study||210
9910761|NCT01191086|11027168|FG000|COMPLETED|Overall Study||148
9910762|NCT01191086|11027168|FG000|NOT COMPLETED|Overall Study||62
9910763|NCT01191190|11027172|FG000|STARTED|Overall Study||21
9910764|NCT01191190|11027172|FG000|COMPLETED|Overall Study||20
9910765|NCT01191190|11027172|FG000|NOT COMPLETED|Overall Study||1
9910766|NCT01191242|11027176|FG000|STARTED|Overall Study||31
9910767|NCT01191242|11027176|FG000|COMPLETED|Overall Study||31
9910768|NCT01191242|11027176|FG000|NOT COMPLETED|Overall Study||0
9910769|NCT01191255|11027184|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
9910770|NCT01191255|11027185|FG001|STARTED|Safety Assessment Period||292
9910771|NCT01191255|11027186|FG002|STARTED|Safety Assessment Period||0
9910772|NCT01191255|11027187|FG003|STARTED|Safety Assessment Period||0
9910773|NCT01191255|11027184|FG000|Safety Population|Safety Assessment Period||149
9910774|NCT01191255|11027185|FG001|Safety Population|Safety Assessment Period||289
9910775|NCT01191255|11027186|FG002|Safety Population|Safety Assessment Period||0
9910776|NCT01191255|11027187|FG003|Safety Population|Safety Assessment Period||0
9910777|NCT01191255|11027184|FG000|COMPLETED|Safety Assessment Period||111
9910778|NCT01191255|11027185|FG001|COMPLETED|Safety Assessment Period||193
9910779|NCT01191255|11027186|FG002|COMPLETED|Safety Assessment Period||0
9910780|NCT01191255|11027187|FG003|COMPLETED|Safety Assessment Period||0
9910781|NCT01191255|11027184|FG000|NOT COMPLETED|Safety Assessment Period||38
9910782|NCT01191255|11027185|FG001|NOT COMPLETED|Safety Assessment Period||99
9910783|NCT01191255|11027186|FG002|NOT COMPLETED|Safety Assessment Period||0
9910784|NCT01191255|11027187|FG003|NOT COMPLETED|Safety Assessment Period||0
9910785|NCT01191255|11027184|FG000|STARTED|Efficacy Assessment Period||0
9910786|NCT01191255|11027185|FG001|STARTED|Efficacy Assessment Period||0
9910787|NCT01191255|11027186|FG002|STARTED|Efficacy Assessment Period||96
9910788|NCT01191255|11027187|FG003|STARTED|Efficacy Assessment Period||96
9910789|NCT01191255|11027184|FG000|COMPLETED|Efficacy Assessment Period||0
9910790|NCT01191255|11027185|FG001|COMPLETED|Efficacy Assessment Period||0
9910791|NCT01191255|11027186|FG002|COMPLETED|Efficacy Assessment Period||70
10009938|NCT01769404|11132620|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
10009939|NCT01769404|11132621|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
10009940|NCT01769404|11132620|FG000|COMPLETED|Treatment Period 1||7
10009941|NCT01769404|11132621|FG001|COMPLETED|Treatment Period 1||13
10009942|NCT01769404|11132620|FG000|NOT COMPLETED|Treatment Period 1||5
10009943|NCT01769404|11132621|FG001|NOT COMPLETED|Treatment Period 1||0
10009944|NCT01769404|11132620|FG000|STARTED|Treatment Period 2||7
9910792|NCT01191255|11027187|FG003|COMPLETED|Efficacy Assessment Period||90
9910793|NCT01191255|11027184|FG000|NOT COMPLETED|Efficacy Assessment Period||0
9910794|NCT01191255|11027185|FG001|NOT COMPLETED|Efficacy Assessment Period||0
9910795|NCT01191255|11027186|FG002|NOT COMPLETED|Efficacy Assessment Period||26
9910796|NCT01191255|11027187|FG003|NOT COMPLETED|Efficacy Assessment Period||6
10009945|NCT01769404|11132621|FG001|STARTED|Treatment Period 2||13
10009946|NCT01769404|11132620|FG000|COMPLETED|Treatment Period 2||0
10009947|NCT01769404|11132621|FG001|COMPLETED|Treatment Period 2||13
9910797|NCT01191268|11027200|FG000|STARTED|Overall Study||295
9910798|NCT01191268|11027201|FG001|STARTED|Overall Study||293
9910799|NCT01191268|11027202|FG002|STARTED|Overall Study||296
9910800|NCT01191268|11027200|FG000|Received at Least One Dose of Study Drug|Overall Study||295
9910801|NCT01191268|11027201|FG001|Received at Least One Dose of Study Drug|Overall Study||293
9910802|NCT01191268|11027202|FG002|Received at Least One Dose of Study Drug|Overall Study||296
9910803|NCT01191268|11027200|FG000|COMPLETED|Overall Study||237
10009948|NCT01769404|11132620|FG000|NOT COMPLETED|Treatment Period 2||7
9910804|NCT01191268|11027201|FG001|COMPLETED|Overall Study||238
9910805|NCT01191268|11027202|FG002|COMPLETED|Overall Study||244
9910806|NCT01191268|11027200|FG000|NOT COMPLETED|Overall Study||58
9910807|NCT01191268|11027201|FG001|NOT COMPLETED|Overall Study||55
9910808|NCT01191268|11027202|FG002|NOT COMPLETED|Overall Study||52
9910809|NCT01191320|11027214|FG000|STARTED|Overall Study||43
9910810|NCT01191320|11027215|FG001|STARTED|Overall Study||38
9910811|NCT01191320|11027216|FG002|STARTED|Overall Study||38
9910812|NCT01191320|11027214|FG000|COMPLETED|Overall Study||36
9910813|NCT01191320|11027215|FG001|COMPLETED|Overall Study||32
9910814|NCT01191320|11027216|FG002|COMPLETED|Overall Study||31
9910815|NCT01191320|11027214|FG000|NOT COMPLETED|Overall Study||7
9910816|NCT01191320|11027215|FG001|NOT COMPLETED|Overall Study||6
9910817|NCT01191320|11027216|FG002|NOT COMPLETED|Overall Study||7
9910818|NCT01191333|11027226|FG000|STARTED|Overall Study||81
9910819|NCT01191333|11027227|FG001|STARTED|Overall Study||83
9910820|NCT01191333|11027226|FG000|COMPLETED|Overall Study||60
9910821|NCT01191333|11027227|FG001|COMPLETED|Overall Study||65
9910822|NCT01191333|11027226|FG000|NOT COMPLETED|Overall Study||21
9910823|NCT01191333|11027227|FG001|NOT COMPLETED|Overall Study||18
9910824|NCT01191398|11027236|FG000|STARTED|Overall Study||17
9910825|NCT01191398|11027237|FG001|STARTED|Overall Study||17
9910826|NCT01191398|11027238|FG002|STARTED|Overall Study||18
9910827|NCT01191398|11027236|FG000|COMPLETED|Overall Study||17
9910828|NCT01191398|11027237|FG001|COMPLETED|Overall Study||17
9910829|NCT01191398|11027238|FG002|COMPLETED|Overall Study||18
9910830|NCT01191398|11027236|FG000|NOT COMPLETED|Overall Study||0
9910831|NCT01191398|11027237|FG001|NOT COMPLETED|Overall Study||0
9910832|NCT01191398|11027238|FG002|NOT COMPLETED|Overall Study||0
9910833|NCT01191411|11027249|FG000|STARTED|Overall Study||1593
9910834|NCT01191411|11027250|FG001|STARTED|Overall Study||479
9910835|NCT01191411|11027251|FG002|STARTED|Overall Study||3898
9910836|NCT01191411|11027249|FG000|COMPLETED|Overall Study||648
9910837|NCT01191411|11027250|FG001|COMPLETED|Overall Study||118
9910838|NCT01191411|11027251|FG002|COMPLETED|Overall Study||471
9910839|NCT01191411|11027249|FG000|NOT COMPLETED|Overall Study||945
9910840|NCT01191411|11027250|FG001|NOT COMPLETED|Overall Study||361
9910841|NCT01191411|11027251|FG002|NOT COMPLETED|Overall Study||3427
9910842|NCT01191476|11027262|FG000|STARTED|Overall Study||112
9910843|NCT01191476|11027263|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
9910844|NCT01191476|11027264|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
9910845|NCT01191476|11027262|FG000|COMPLETED|Overall Study||109
9910846|NCT01191476|11027263|FG001|COMPLETED|Overall Study||107
9910847|NCT01191476|11027264|FG002|COMPLETED|Overall Study||111
9910848|NCT01191476|11027262|FG000|NOT COMPLETED|Overall Study||3
9910849|NCT01191476|11027263|FG001|NOT COMPLETED|Overall Study||4
9910850|NCT01191476|11027264|FG002|NOT COMPLETED|Overall Study||0
9910851|NCT01191541|11027276|FG000|STARTED|All the Patients||30
9910852|NCT01191541|11027277|FG001|STARTED|All the Patients||35
9910853|NCT01191541|11027276|FG000|COMPLETED|All the Patients||30
9910854|NCT01191541|11027277|FG001|COMPLETED|All the Patients||35
9910855|NCT01191541|11027276|FG000|NOT COMPLETED|All the Patients||0
9910856|NCT01191541|11027277|FG001|NOT COMPLETED|All the Patients||0
9910857|NCT01191541|11027276|FG000|STARTED|the Randomized Patients||30
9910858|NCT01191541|11027277|FG001|STARTED|the Randomized Patients||35
9910859|NCT01191541|11027276|FG000|COMPLETED|the Randomized Patients||30
9910860|NCT01191541|11027277|FG001|COMPLETED|the Randomized Patients||35
9910861|NCT01191541|11027276|FG000|NOT COMPLETED|the Randomized Patients||0
9910862|NCT01191541|11027277|FG001|NOT COMPLETED|the Randomized Patients||0
9910863|NCT01191723|11027293|FG000|STARTED|Overall Study||9
9910864|NCT01191723|11027294|FG001|STARTED|Overall Study||9
9910865|NCT01191723|11027295|FG002|STARTED|Overall Study||9
9910866|NCT01191723|11027296|FG003|STARTED|Overall Study||9
9910867|NCT01191723|11027297|FG004|STARTED|Overall Study||9
9910868|NCT01191723|11027298|FG005|STARTED|Overall Study||9
9910869|NCT01191723|11027293|FG000|COMPLETED|Overall Study||9
9910870|NCT01191723|11027294|FG001|COMPLETED|Overall Study||9
9910871|NCT01191723|11027295|FG002|COMPLETED|Overall Study||9
9910872|NCT01191723|11027296|FG003|COMPLETED|Overall Study||9
9910873|NCT01191723|11027297|FG004|COMPLETED|Overall Study||9
9910874|NCT01191723|11027298|FG005|COMPLETED|Overall Study||9
9910875|NCT01191723|11027293|FG000|NOT COMPLETED|Overall Study||0
9910876|NCT01191723|11027294|FG001|NOT COMPLETED|Overall Study||0
9910877|NCT01191723|11027295|FG002|NOT COMPLETED|Overall Study||0
9910878|NCT01191723|11027296|FG003|NOT COMPLETED|Overall Study||0
9910879|NCT01191723|11027297|FG004|NOT COMPLETED|Overall Study||0
9910880|NCT01191723|11027298|FG005|NOT COMPLETED|Overall Study||0
9910881|NCT01191736|11027314|FG000|STARTED|Overall Study||51
9910882|NCT01191736|11027315|FG001|STARTED|Overall Study||47
9910883|NCT01191736|11027316|FG002|STARTED|Overall Study||49
9910884|NCT01191736|11027317|FG003|STARTED|Overall Study||46
9910885|NCT01191736|11027318|FG004|STARTED|Overall Study||48
9910886|NCT01191736|11027319|FG005|STARTED|Overall Study||50
9910887|NCT01191736|11027320|FG006|STARTED|Overall Study||45
9910888|NCT01191736|11027314|FG000|COMPLETED|Overall Study||51
9910889|NCT01191736|11027315|FG001|COMPLETED|Overall Study||47
9910890|NCT01191736|11027316|FG002|COMPLETED|Overall Study||49
9910891|NCT01191736|11027317|FG003|COMPLETED|Overall Study||46
9910892|NCT01191736|11027318|FG004|COMPLETED|Overall Study||48
9910893|NCT01191736|11027319|FG005|COMPLETED|Overall Study||50
9910894|NCT01191736|11027320|FG006|COMPLETED|Overall Study||45
9910895|NCT01191736|11027314|FG000|NOT COMPLETED|Overall Study||0
9910896|NCT01191736|11027315|FG001|NOT COMPLETED|Overall Study||0
9910897|NCT01191736|11027316|FG002|NOT COMPLETED|Overall Study||0
9910898|NCT01191736|11027317|FG003|NOT COMPLETED|Overall Study||0
10203719|NCT03466060|11330594|FG001|STARTED|Period 2||16
10203720|NCT03466060|11330595|FG002|STARTED|Period 2||17
10203721|NCT03466060|11330596|FG003|STARTED|Period 2||17
10203722|NCT03466060|11330597|FG004|STARTED|Period 2||20
10203723|NCT03466060|11330598|FG005|STARTED|Period 2||18
10203724|NCT03466060|11330593|FG000|COMPLETED|Period 2||19
10203725|NCT03466060|11330594|FG001|COMPLETED|Period 2||16
10203726|NCT03466060|11330595|FG002|COMPLETED|Period 2||16
10203727|NCT03466060|11330596|FG003|COMPLETED|Period 2||17
10203728|NCT03466060|11330597|FG004|COMPLETED|Period 2||20
10203729|NCT03466060|11330598|FG005|COMPLETED|Period 2||18
10203730|NCT03466060|11330593|FG000|NOT COMPLETED|Period 2||0
10203731|NCT03466060|11330594|FG001|NOT COMPLETED|Period 2||0
10203732|NCT03466060|11330595|FG002|NOT COMPLETED|Period 2||1
10203733|NCT03466060|11330596|FG003|NOT COMPLETED|Period 2||0
10203734|NCT03466060|11330597|FG004|NOT COMPLETED|Period 2||0
10203735|NCT03466060|11330598|FG005|NOT COMPLETED|Period 2||0
10203736|NCT03466073|11330618|FG000|STARTED|Overall Study||6
10203737|NCT03466073|11330619|FG001|STARTED|Overall Study||2
10203738|NCT03466073|11330620|FG002|STARTED|Overall Study||6
10203739|NCT03466073|11330621|FG003|STARTED|Overall Study||6
10203740|NCT03466073|11330622|FG004|STARTED|Overall Study||6
10203741|NCT03466073|11330623|FG005|STARTED|Overall Study||7
10203742|NCT03466073|11330618|FG000|COMPLETED|Overall Study||5
10203743|NCT03466073|11330619|FG001|COMPLETED|Overall Study||2
10203744|NCT03466073|11330620|FG002|COMPLETED|Overall Study||6
10203745|NCT03466073|11330621|FG003|COMPLETED|Overall Study||6
10203746|NCT03466073|11330622|FG004|COMPLETED|Overall Study||6
10203747|NCT03466073|11330623|FG005|COMPLETED|Overall Study||6
10203748|NCT03466073|11330618|FG000|NOT COMPLETED|Overall Study||1
10203749|NCT03466073|11330619|FG001|NOT COMPLETED|Overall Study||0
10203750|NCT03466073|11330620|FG002|NOT COMPLETED|Overall Study||0
10203751|NCT03466073|11330621|FG003|NOT COMPLETED|Overall Study||0
10203752|NCT03466073|11330622|FG004|NOT COMPLETED|Overall Study||0
10203753|NCT03466073|11330623|FG005|NOT COMPLETED|Overall Study||1
10203754|NCT03466086|11330644|FG000|STARTED|Period 1||28
10203755|NCT03466086|11330645|FG001|STARTED|Period 1||27
10203756|NCT03466086|11330644|FG000|COMPLETED|Period 1||26
10203757|NCT03466086|11330645|FG001|COMPLETED|Period 1||27
10203758|NCT03466086|11330644|FG000|NOT COMPLETED|Period 1||2
10203759|NCT03466086|11330645|FG001|NOT COMPLETED|Period 1||0
10203760|NCT03466086|11330644|FG000|STARTED|Period 2||26
10203761|NCT03466086|11330645|FG001|STARTED|Period 2||27
10203762|NCT03466086|11330644|FG000|COMPLETED|Period 2||26
10203763|NCT03466086|11330645|FG001|COMPLETED|Period 2||27
9910899|NCT01191736|11027318|FG004|NOT COMPLETED|Overall Study||0
9910900|NCT01191736|11027319|FG005|NOT COMPLETED|Overall Study||0
9910901|NCT01191736|11027320|FG006|NOT COMPLETED|Overall Study||0
9910902|NCT01191749|11027336|FG000|STARTED|Overall Study||7
9910903|NCT01191749|11027336|FG000|COMPLETED|Overall Study||7
9910904|NCT01191749|11027336|FG000|NOT COMPLETED|Overall Study||0
9910905|NCT01191762|11027342|FG000|STARTED|Overall Study||15
9910906|NCT01191762|11027343|FG001|STARTED|Overall Study||15
9910907|NCT01191762|11027342|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
9910908|NCT01191762|11027343|FG001|COMPLETED|Overall Study||15
9910909|NCT01191762|11027342|FG000|NOT COMPLETED|Overall Study||1
9910910|NCT01191762|11027343|FG001|NOT COMPLETED|Overall Study||0
9910911|NCT01191788|11027351|FG000|STARTED|Overall Study||140
9910912|NCT01191788|11027352|FG001|STARTED|Overall Study||159
9910913|NCT01191788|11027351|FG000|COMPLETED|Overall Study|Completed 3-month followup|119
9910914|NCT01191788|11027352|FG001|COMPLETED|Overall Study|Completed 3-month followup|137
9910915|NCT01191788|11027351|FG000|NOT COMPLETED|Overall Study||21
9910916|NCT01191788|11027352|FG001|NOT COMPLETED|Overall Study||22
9910917|NCT01191801|11027361|FG000|STARTED|Overall Study||356
9910918|NCT01191801|11027362|FG001|STARTED|Overall Study||355
9910919|NCT01191801|11027361|FG000|COMPLETED|Overall Study||40
9910920|NCT01191801|11027362|FG001|COMPLETED|Overall Study||18
9910921|NCT01191801|11027361|FG000|NOT COMPLETED|Overall Study||316
10203764|NCT03466086|11330644|FG000|NOT COMPLETED|Period 2||0
10203765|NCT03466086|11330645|FG001|NOT COMPLETED|Period 2||0
10203766|NCT03466099|11330654|FG000|STARTED|Overall Study||41
10203767|NCT03466099|11330655|FG001|STARTED|Overall Study||44
9910922|NCT01191801|11027362|FG001|NOT COMPLETED|Overall Study||337
9910923|NCT01191827|11027370|FG000|STARTED|Overall Study||20
9910924|NCT01191827|11027371|FG001|STARTED|Overall Study||20
9910925|NCT01191827|11027370|FG000|COMPLETED|Overall Study||20
10203768|NCT03466099|11330656|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
10203769|NCT03466099|11330654|FG000|Treated|Overall Study||41
10203770|NCT03466099|11330655|FG001|Treated|Overall Study||44
10203771|NCT03466099|11330656|FG002|Treated|Overall Study||44
10203772|NCT03466099|11330654|FG000|COMPLETED|Overall Study||24
10203773|NCT03466099|11330655|FG001|COMPLETED|Overall Study||30
10203774|NCT03466099|11330656|FG002|COMPLETED|Overall Study||28
10203775|NCT03466099|11330654|FG000|NOT COMPLETED|Overall Study||17
10203776|NCT03466099|11330655|FG001|NOT COMPLETED|Overall Study||14
10203777|NCT03466099|11330656|FG002|NOT COMPLETED|Overall Study||17
10203778|NCT03466918|11330664|FG000|STARTED|Overall Study||58
10203779|NCT03466918|11330664|FG000|Analysis Population|Overall Study||50
9910926|NCT01191827|11027371|FG001|COMPLETED|Overall Study||20
9910927|NCT01191827|11027370|FG000|NOT COMPLETED|Overall Study||0
9910928|NCT01191827|11027371|FG001|NOT COMPLETED|Overall Study||0
9910929|NCT01191840|11027379|FG000|STARTED|Overall Study||254
9910930|NCT01191840|11027380|FG001|STARTED|Overall Study||255
9910931|NCT01191840|11027379|FG000|COMPLETED|Overall Study||240
9910932|NCT01191840|11027380|FG001|COMPLETED|Overall Study||240
9910933|NCT01191840|11027379|FG000|NOT COMPLETED|Overall Study||14
9910934|NCT01191840|11027380|FG001|NOT COMPLETED|Overall Study||15
9910935|NCT01191944|11027388|FG000|STARTED|Overall Study|Treated titration/maintenance|234
9910936|NCT01191944|11027389|FG001|STARTED|Overall Study|Treated titration/maintenance|239
9910937|NCT01191944|11027388|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217
9910938|NCT01191944|11027389|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220
9910939|NCT01191944|11027388|FG000|NOT COMPLETED|Overall Study||17
9910940|NCT01191944|11027389|FG001|NOT COMPLETED|Overall Study||19
9910941|NCT01192022|11027399|FG000|STARTED|Overall Study||114
9910942|NCT01192022|11027400|FG001|STARTED|Overall Study||110
9910943|NCT01192022|11027401|FG002|STARTED|Overall Study||8
9910944|NCT01192022|11027402|FG003|STARTED|Overall Study||9
9910945|NCT01192022|11027403|FG004|STARTED|Overall Study||12
9910946|NCT01192022|11027399|FG000|Safety Population-Received Treatment|Overall Study||114
9910947|NCT01192022|11027400|FG001|Safety Population-Received Treatment|Overall Study||109
9910948|NCT01192022|11027401|FG002|Safety Population-Received Treatment|Overall Study||8
9910949|NCT01192022|11027402|FG003|Safety Population-Received Treatment|Overall Study||9
9910950|NCT01192022|11027403|FG004|Safety Population-Received Treatment|Overall Study||12
9910951|NCT01192022|11027399|FG000|COMPLETED|Overall Study||101
9910952|NCT01192022|11027400|FG001|COMPLETED|Overall Study||99
9910953|NCT01192022|11027401|FG002|COMPLETED|Overall Study||7
9910954|NCT01192022|11027402|FG003|COMPLETED|Overall Study||7
9910955|NCT01192022|11027403|FG004|COMPLETED|Overall Study||11
9910956|NCT01192022|11027399|FG000|NOT COMPLETED|Overall Study||13
9910957|NCT01192022|11027400|FG001|NOT COMPLETED|Overall Study||11
9910958|NCT01192022|11027401|FG002|NOT COMPLETED|Overall Study||1
9910959|NCT01192022|11027402|FG003|NOT COMPLETED|Overall Study||2
9910960|NCT01192022|11027403|FG004|NOT COMPLETED|Overall Study||1
9910961|NCT01192100|11027414|FG000|STARTED|Overall Study||6
9910962|NCT01192100|11027415|FG001|STARTED|Overall Study||4
9910963|NCT01192100|11027416|FG002|STARTED|Overall Study||3
9910964|NCT01192100|11027417|FG003|STARTED|Overall Study||4
9910965|NCT01192100|11027418|FG004|STARTED|Overall Study||3
9910966|NCT01192100|11027419|FG005|STARTED|Overall Study||2
9910967|NCT01192100|11027414|FG000|Began 1st Intervention Week|Overall Study||6
9910968|NCT01192100|11027415|FG001|Began 1st Intervention Week|Overall Study||4
9910969|NCT01192100|11027416|FG002|Began 1st Intervention Week|Overall Study||3
9910970|NCT01192100|11027417|FG003|Began 1st Intervention Week|Overall Study||4
9910971|NCT01192100|11027418|FG004|Began 1st Intervention Week|Overall Study||3
9910972|NCT01192100|11027419|FG005|Began 1st Intervention Week|Overall Study||2
9910973|NCT01192100|11027414|FG000|Began 2nd Intervention Week|Overall Study||6
10009949|NCT01769404|11132621|FG001|NOT COMPLETED|Treatment Period 2||0
10009950|NCT01769456|11132629|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
10009951|NCT01769456|11132629|FG000|COMPLETED|Overall Study||41
10009952|NCT01769456|11132629|FG000|NOT COMPLETED|Overall Study||37
10009953|NCT01769469|11132634|FG000|STARTED|Overall Study||101
10009954|NCT01769469|11132634|FG000|COMPLETED|Overall Study||66
10009955|NCT01769469|11132634|FG000|NOT COMPLETED|Overall Study||35
10009956|NCT01769508|11132640|FG000|STARTED|Overall Study||12
10009957|NCT01769508|11132640|FG000|COMPLETED|Overall Study||6
10009958|NCT01769508|11132640|FG000|NOT COMPLETED|Overall Study||6
10009959|NCT01769573|11132649|FG000|STARTED|Overall Study||10
10009960|NCT01769573|11132650|FG001|STARTED|Overall Study||6
10009961|NCT01769573|11132651|FG002|STARTED|Overall Study||10
10009962|NCT01769573|11132652|FG003|STARTED|Overall Study||0
10009963|NCT01769573|11132653|FG004|STARTED|Overall Study||10
10009964|NCT01769573|11132649|FG000|COMPLETED|Overall Study||10
10009965|NCT01769573|11132650|FG001|COMPLETED|Overall Study||6
10009966|NCT01769573|11132651|FG002|COMPLETED|Overall Study||10
10009967|NCT01769573|11132652|FG003|COMPLETED|Overall Study||0
10009968|NCT01769573|11132653|FG004|COMPLETED|Overall Study||10
9910974|NCT01192100|11027415|FG001|Began 2nd Intervention Week|Overall Study||4
10009969|NCT01769573|11132649|FG000|NOT COMPLETED|Overall Study||0
10009970|NCT01769573|11132650|FG001|NOT COMPLETED|Overall Study||0
10009971|NCT01769573|11132651|FG002|NOT COMPLETED|Overall Study||0
9910975|NCT01192100|11027416|FG002|Began 2nd Intervention Week|Overall Study||3
9910976|NCT01192100|11027417|FG003|Began 2nd Intervention Week|Overall Study||3
9910977|NCT01192100|11027418|FG004|Began 2nd Intervention Week|Overall Study||2
9910978|NCT01192100|11027419|FG005|Began 2nd Intervention Week|Overall Study||2
9910979|NCT01192100|11027414|FG000|Began 3rd Intervention Week|Overall Study||6
10009972|NCT01769573|11132652|FG003|NOT COMPLETED|Overall Study||0
10009973|NCT01769573|11132653|FG004|NOT COMPLETED|Overall Study||0
10009974|NCT01769586|11132667|FG000|STARTED|Overall Study||100
10009975|NCT01769586|11132668|FG001|STARTED|Overall Study||100
10009976|NCT01769586|11132667|FG000|COMPLETED|Overall Study||100
10009977|NCT01769586|11132668|FG001|COMPLETED|Overall Study||100
9910980|NCT01192100|11027415|FG001|Began 3rd Intervention Week|Overall Study||4
9910981|NCT01192100|11027416|FG002|Began 3rd Intervention Week|Overall Study||3
9910982|NCT01192100|11027417|FG003|Began 3rd Intervention Week|Overall Study||3
9910983|NCT01192100|11027418|FG004|Began 3rd Intervention Week|Overall Study||2
9910984|NCT01192100|11027419|FG005|Began 3rd Intervention Week|Overall Study||2
9910985|NCT01192100|11027414|FG000|COMPLETED|Overall Study||6
9910986|NCT01192100|11027415|FG001|COMPLETED|Overall Study||4
9910987|NCT01192100|11027416|FG002|COMPLETED|Overall Study||3
9910988|NCT01192100|11027417|FG003|COMPLETED|Overall Study||3
9910989|NCT01192100|11027418|FG004|COMPLETED|Overall Study||2
9910990|NCT01192100|11027419|FG005|COMPLETED|Overall Study||2
9910991|NCT01192100|11027414|FG000|NOT COMPLETED|Overall Study||0
9910992|NCT01192100|11027415|FG001|NOT COMPLETED|Overall Study||0
9910993|NCT01192100|11027416|FG002|NOT COMPLETED|Overall Study||0
9910994|NCT01192100|11027417|FG003|NOT COMPLETED|Overall Study||1
9910995|NCT01192100|11027418|FG004|NOT COMPLETED|Overall Study||1
9910996|NCT01192100|11027419|FG005|NOT COMPLETED|Overall Study||0
9910997|NCT01192126|11027429|FG000|STARTED|First Intervention (1 Week)||51
9910998|NCT01192126|11027430|FG001|STARTED|First Intervention (1 Week)||51
9910999|NCT01192126|11027429|FG000|COMPLETED|First Intervention (1 Week)||49
9911000|NCT01192126|11027430|FG001|COMPLETED|First Intervention (1 Week)||50
9911001|NCT01192126|11027429|FG000|NOT COMPLETED|First Intervention (1 Week)||2
9911002|NCT01192126|11027430|FG001|NOT COMPLETED|First Intervention (1 Week)||1
9911003|NCT01192126|11027429|FG000|STARTED|Second Intervention (1 Week)||49
9911004|NCT01192126|11027430|FG001|STARTED|Second Intervention (1 Week)||50
9911005|NCT01192126|11027429|FG000|COMPLETED|Second Intervention (1 Week)||49
9911006|NCT01192126|11027430|FG001|COMPLETED|Second Intervention (1 Week)||50
9911007|NCT01192126|11027429|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
9911008|NCT01192126|11027430|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
9911009|NCT01192139|11027436|FG000|STARTED|Period 1||5
9911010|NCT01192139|11027437|FG001|STARTED|Period 1||5
9911011|NCT01192139|11027438|FG002|STARTED|Period 1||5
9911012|NCT01192139|11027439|FG003|STARTED|Period 1||5
9911013|NCT01192139|11027440|FG004|STARTED|Period 1||5
9911014|NCT01192139|11027441|FG005|STARTED|Period 1||5
9911015|NCT01192139|11027436|FG000|COMPLETED|Period 1||5
9911016|NCT01192139|11027437|FG001|COMPLETED|Period 1||5
9911017|NCT01192139|11027438|FG002|COMPLETED|Period 1||5
9911018|NCT01192139|11027439|FG003|COMPLETED|Period 1||5
9911019|NCT01192139|11027440|FG004|COMPLETED|Period 1||5
9911020|NCT01192139|11027441|FG005|COMPLETED|Period 1||5
9911021|NCT01192139|11027436|FG000|NOT COMPLETED|Period 1||0
9911022|NCT01192139|11027437|FG001|NOT COMPLETED|Period 1||0
9911023|NCT01192139|11027438|FG002|NOT COMPLETED|Period 1||0
9911024|NCT01192139|11027439|FG003|NOT COMPLETED|Period 1||0
9911025|NCT01192139|11027440|FG004|NOT COMPLETED|Period 1||0
9911026|NCT01192139|11027441|FG005|NOT COMPLETED|Period 1||0
9911027|NCT01192139|11027436|FG000|STARTED|Period 2||5
9911028|NCT01192139|11027437|FG001|STARTED|Period 2||5
9911029|NCT01192139|11027438|FG002|STARTED|Period 2||5
9911030|NCT01192139|11027439|FG003|STARTED|Period 2||5
9911031|NCT01192139|11027440|FG004|STARTED|Period 2||5
9911032|NCT01192139|11027441|FG005|STARTED|Period 2||5
9911033|NCT01192139|11027436|FG000|COMPLETED|Period 2||5
9911034|NCT01192139|11027437|FG001|COMPLETED|Period 2||5
9911035|NCT01192139|11027438|FG002|COMPLETED|Period 2||5
9911036|NCT01192139|11027439|FG003|COMPLETED|Period 2||5
9911037|NCT01192139|11027440|FG004|COMPLETED|Period 2||5
9911038|NCT01192139|11027441|FG005|COMPLETED|Period 2||5
9911039|NCT01192139|11027436|FG000|NOT COMPLETED|Period 2||0
9911040|NCT01192139|11027437|FG001|NOT COMPLETED|Period 2||0
9911041|NCT01192139|11027438|FG002|NOT COMPLETED|Period 2||0
9911042|NCT01192139|11027439|FG003|NOT COMPLETED|Period 2||0
9911043|NCT01192139|11027440|FG004|NOT COMPLETED|Period 2||0
9911044|NCT01192139|11027441|FG005|NOT COMPLETED|Period 2||0
9911045|NCT01192139|11027436|FG000|STARTED|Period 3||5
9911046|NCT01192139|11027437|FG001|STARTED|Period 3||5
9911047|NCT01192139|11027438|FG002|STARTED|Period 3||5
9911048|NCT01192139|11027439|FG003|STARTED|Period 3||5
9911049|NCT01192139|11027440|FG004|STARTED|Period 3||5
9911050|NCT01192139|11027441|FG005|STARTED|Period 3||5
9911051|NCT01192139|11027436|FG000|COMPLETED|Period 3||5
9911052|NCT01192139|11027437|FG001|COMPLETED|Period 3||5
9911053|NCT01192139|11027438|FG002|COMPLETED|Period 3||5
9911054|NCT01192139|11027439|FG003|COMPLETED|Period 3||5
9911055|NCT01192139|11027440|FG004|COMPLETED|Period 3||5
9911056|NCT01192139|11027441|FG005|COMPLETED|Period 3||5
9911057|NCT01192139|11027436|FG000|NOT COMPLETED|Period 3||0
9911058|NCT01192139|11027437|FG001|NOT COMPLETED|Period 3||0
9911059|NCT01192139|11027438|FG002|NOT COMPLETED|Period 3||0
9911060|NCT01192139|11027439|FG003|NOT COMPLETED|Period 3||0
9911061|NCT01192139|11027440|FG004|NOT COMPLETED|Period 3||0
9911062|NCT01192139|11027441|FG005|NOT COMPLETED|Period 3||0
9911063|NCT01192152|11027449|FG000|STARTED|Period 1||15
9911064|NCT01192152|11027450|FG001|STARTED|Period 1||15
9911065|NCT01192152|11027449|FG000|COMPLETED|Period 1||15
9911066|NCT01192152|11027450|FG001|COMPLETED|Period 1||14
9911067|NCT01192152|11027449|FG000|NOT COMPLETED|Period 1||0
9911068|NCT01192152|11027450|FG001|NOT COMPLETED|Period 1||1
9911069|NCT01192152|11027449|FG000|STARTED|Period 2||15
9911070|NCT01192152|11027450|FG001|STARTED|Period 2||14
9911071|NCT01192152|11027449|FG000|COMPLETED|Period 2||15
9911072|NCT01192152|11027450|FG001|COMPLETED|Period 2||14
9911073|NCT01192152|11027449|FG000|NOT COMPLETED|Period 2||0
9911074|NCT01192152|11027450|FG001|NOT COMPLETED|Period 2||0
9911075|NCT01192152|11027449|FG000|STARTED|Period 3||15
9911076|NCT01192152|11027450|FG001|STARTED|Period 3||0
9911077|NCT01192152|11027449|FG000|COMPLETED|Period 3||14
9911078|NCT01192152|11027450|FG001|COMPLETED|Period 3||0
9911079|NCT01192152|11027449|FG000|NOT COMPLETED|Period 3||1
9911080|NCT01192152|11027450|FG001|NOT COMPLETED|Period 3||0
9911081|NCT01192178|11027460|FG000|STARTED|Overall Study||171
9911082|NCT01192178|11027461|FG001|STARTED|Overall Study||168
9911083|NCT01192178|11027460|FG000|COMPLETED|Overall Study||147
9911084|NCT01192178|11027461|FG001|COMPLETED|Overall Study||145
9911085|NCT01192178|11027460|FG000|NOT COMPLETED|Overall Study||24
9911086|NCT01192178|11027461|FG001|NOT COMPLETED|Overall Study||23
9911087|NCT01192191|11027471|FG000|STARTED|Overall Study||60
9911088|NCT01192191|11027472|FG001|STARTED|Overall Study||127
9911089|NCT01192191|11027471|FG000|COMPLETED|Overall Study||49
9911090|NCT01192191|11027472|FG001|COMPLETED|Overall Study||106
9911091|NCT01192191|11027471|FG000|NOT COMPLETED|Overall Study||11
9911092|NCT01192191|11027472|FG001|NOT COMPLETED|Overall Study||21
9911093|NCT01192204|11027480|FG000|STARTED|Overall Study||23
9911094|NCT01192204|11027481|FG001|STARTED|Overall Study||18
9911095|NCT01192204|11027480|FG000|COMPLETED|Overall Study||22
9911096|NCT01192204|11027481|FG001|COMPLETED|Overall Study||18
9911097|NCT01192204|11027480|FG000|NOT COMPLETED|Overall Study||1
9911098|NCT01192204|11027481|FG001|NOT COMPLETED|Overall Study||0
9911099|NCT01192282|11027491|FG000|STARTED|Overall Study||156
9911100|NCT01192282|11027491|FG000|COMPLETED|Overall Study||156
9911101|NCT01192282|11027491|FG000|NOT COMPLETED|Overall Study||0
9911102|NCT01192295|11027506|FG000|STARTED|Overall Study||27
9911103|NCT01192295|11027507|FG001|STARTED|Overall Study||128
9911104|NCT01192295|11027506|FG000|COMPLETED|Overall Study||17
9911105|NCT01192295|11027507|FG001|COMPLETED|Overall Study||105
9911106|NCT01192295|11027506|FG000|NOT COMPLETED|Overall Study||10
9911107|NCT01192295|11027507|FG001|NOT COMPLETED|Overall Study||23
9911108|NCT01192347|11027515|FG000|STARTED|Overall Study||175
9911109|NCT01192347|11027515|FG000|COMPLETED|Overall Study||163
9911110|NCT01192347|11027515|FG000|NOT COMPLETED|Overall Study||12
9911111|NCT01192399|11027519|FG000|STARTED|Overall Study||29
9911112|NCT01192399|11027519|FG000|COMPLETED|Overall Study||27
9911113|NCT01192399|11027519|FG000|NOT COMPLETED|Overall Study||2
9911114|NCT01192412|11027525|FG000|STARTED|Overall Study||497
9911115|NCT01192412|11027526|FG001|STARTED|Overall Study||490
9911116|NCT01192412|11027525|FG000|COMPLETED|Overall Study||493
9911117|NCT01192412|11027526|FG001|COMPLETED|Overall Study||488
9911118|NCT01192412|11027525|FG000|NOT COMPLETED|Overall Study||4
9911119|NCT01192412|11027526|FG001|NOT COMPLETED|Overall Study||2
9955412|NCT01438177|11074352|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9
9955413|NCT01438177|11074352|FG000|NOT COMPLETED|Overall Study||2
9955414|NCT01438229|11074356|FG000|STARTED|Overall Study||47
9955415|NCT01438229|11074356|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1
9955416|NCT01438229|11074356|FG000|Underwent Procedure|Overall Study||46
9955417|NCT01438229|11074356|FG000|COMPLETED|Overall Study||44
9955418|NCT01438229|11074356|FG000|NOT COMPLETED|Overall Study||3
9955419|NCT01438294|11074362|FG000|STARTED|Overall Study||16
9955420|NCT01438294|11074363|FG001|STARTED|Overall Study||20
9955421|NCT01438294|11074362|FG000|COMPLETED|Overall Study||13
9955422|NCT01438294|11074363|FG001|COMPLETED|Overall Study||13
9955423|NCT01438294|11074362|FG000|NOT COMPLETED|Overall Study||3
9955424|NCT01438294|11074363|FG001|NOT COMPLETED|Overall Study||7
9955425|NCT01438307|11074371|FG000|STARTED|Overall Study||14
9955426|NCT01438307|11074372|FG001|STARTED|Overall Study||14
9955427|NCT01438307|11074371|FG000|COMPLETED|Overall Study||13
9955428|NCT01438307|11074372|FG001|COMPLETED|Overall Study||13
9955429|NCT01438307|11074371|FG000|NOT COMPLETED|Overall Study||1
9955430|NCT01438307|11074372|FG001|NOT COMPLETED|Overall Study||1
9955431|NCT01438411|11074378|FG000|STARTED|Overall Study||53
9955432|NCT01438411|11074378|FG000|COMPLETED|Overall Study||40
9955433|NCT01438411|11074378|FG000|NOT COMPLETED|Overall Study||13
9955434|NCT01438424|11074382|FG000|STARTED|Overall Study|Received treatment|1051
9955435|NCT01438424|11074382|FG000|COMPLETED|Overall Study|Completed treatment|634
9955436|NCT01438424|11074382|FG000|NOT COMPLETED|Overall Study||417
10009978|NCT01769586|11132667|FG000|NOT COMPLETED|Overall Study||0
10009979|NCT01769586|11132668|FG001|NOT COMPLETED|Overall Study||0
10009980|NCT01769612|11132674|FG000|STARTED|Overall Study||168
10009981|NCT01769612|11132674|FG000|COMPLETED|Overall Study||168
10009982|NCT01769612|11132674|FG000|NOT COMPLETED|Overall Study||0
10009983|NCT01770145|11132680|FG000|STARTED|Baseline||127
10009984|NCT01770145|11132680|FG000|COMPLETED|Baseline||101
10009985|NCT01770145|11132680|FG000|NOT COMPLETED|Baseline||26
10009986|NCT01770145|11132680|FG000|STARTED|Treatment||101
10009987|NCT01770145|11132680|FG000|COMPLETED|Treatment||97
10009988|NCT01770145|11132680|FG000|NOT COMPLETED|Treatment||4
10009989|NCT01770314|11132686|FG000|STARTED|Overall Study||86
10009990|NCT01770314|11132687|FG001|STARTED|Overall Study||90
10009991|NCT01770314|11132686|FG000|Contributed Data to Baseline|Overall Study||68
9957064|NCT01449370|11076239|FG004|COMPLETED|Overall Study||0
9957065|NCT01449370|11076240|FG005|COMPLETED|Overall Study||0
9957066|NCT01449370|11076241|FG006|COMPLETED|Overall Study||0
9957067|NCT01449370|11076242|FG007|COMPLETED|Overall Study||0
9957068|NCT01449370|11076243|FG008|COMPLETED|Overall Study||0
9957069|NCT01449370|11076244|FG009|COMPLETED|Overall Study||0
9957070|NCT01449370|11076245|FG010|COMPLETED|Overall Study||0
9957071|NCT01449370|11076246|FG011|COMPLETED|Overall Study||0
10009992|NCT01770314|11132687|FG001|Contributed Data to Baseline|Overall Study||72
9957072|NCT01449370|11076247|FG012|COMPLETED|Overall Study||0
9957073|NCT01449370|11076248|FG013|COMPLETED|Overall Study||0
9957074|NCT01449370|11076249|FG014|COMPLETED|Overall Study||0
9957075|NCT01449370|11076250|FG015|COMPLETED|Overall Study||0
9911120|NCT01192516|11027535|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66
9911121|NCT01192516|11027536|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66
9911122|NCT01192516|11027537|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63
9911123|NCT01192516|11027535|FG000|COMPLETED|Overall Study||46
9911124|NCT01192516|11027536|FG001|COMPLETED|Overall Study||49
9911125|NCT01192516|11027537|FG002|COMPLETED|Overall Study||55
9911126|NCT01192516|11027535|FG000|NOT COMPLETED|Overall Study||20
9911127|NCT01192516|11027536|FG001|NOT COMPLETED|Overall Study||17
9911128|NCT01192516|11027537|FG002|NOT COMPLETED|Overall Study||8
9911129|NCT01192542|11027549|FG000|STARTED|Period 1||18
9911130|NCT01192542|11027550|FG001|STARTED|Period 1||20
9911131|NCT01192542|11027549|FG000|COMPLETED|Period 1||18
9911132|NCT01192542|11027550|FG001|COMPLETED|Period 1||20
9911133|NCT01192542|11027549|FG000|NOT COMPLETED|Period 1||0
9911134|NCT01192542|11027550|FG001|NOT COMPLETED|Period 1||0
9911135|NCT01192542|11027549|FG000|STARTED|Period 2||18
9911136|NCT01192542|11027550|FG001|STARTED|Period 2||20
9911137|NCT01192542|11027549|FG000|COMPLETED|Period 2||18
9911138|NCT01192542|11027550|FG001|COMPLETED|Period 2||20
9911139|NCT01192542|11027549|FG000|NOT COMPLETED|Period 2||0
9911140|NCT01192542|11027550|FG001|NOT COMPLETED|Period 2||0
9911141|NCT01192815|11027558|FG000|STARTED|Overall Study||2
9911142|NCT01192815|11027558|FG000|COMPLETED|Overall Study||0
9911143|NCT01192815|11027558|FG000|NOT COMPLETED|Overall Study||2
9911144|NCT01192828|11027562|FG000|STARTED|Overall Study||14
9911145|NCT01192828|11027562|FG000|COMPLETED|Overall Study||14
9911146|NCT01192828|11027562|FG000|NOT COMPLETED|Overall Study||0
10111213|NCT02494297|11242266|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
10111214|NCT02494297|11242266|FG000|NOT COMPLETED|Overall Study||0
10111215|NCT02494323|11242270|FG000|STARTED|Overall Study||70
9911147|NCT01193010|11027570|FG000|STARTED|Overall Study||20
9911148|NCT01193010|11027571|FG001|STARTED|Overall Study||20
9911149|NCT01193010|11027570|FG000|COMPLETED|Overall Study||17
9911150|NCT01193010|11027571|FG001|COMPLETED|Overall Study||20
9911151|NCT01193010|11027570|FG000|NOT COMPLETED|Overall Study||3
9911152|NCT01193010|11027571|FG001|NOT COMPLETED|Overall Study||0
9911153|NCT01193049|11027577|FG000|STARTED|Period 1: Placebo Run-In||5
9911154|NCT01193049|11027578|FG001|STARTED|Period 1: Placebo Run-In||6
9911155|NCT01193049|11027577|FG000|COMPLETED|Period 1: Placebo Run-In||5
9911156|NCT01193049|11027578|FG001|COMPLETED|Period 1: Placebo Run-In||6
9911157|NCT01193049|11027577|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0
9911158|NCT01193049|11027578|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0
9911159|NCT01193049|11027577|FG000|STARTED|Washout 1 : 21 Day Washout||5
9911160|NCT01193049|11027578|FG001|STARTED|Washout 1 : 21 Day Washout||6
9911161|NCT01193049|11027577|FG000|COMPLETED|Washout 1 : 21 Day Washout||5
9911162|NCT01193049|11027578|FG001|COMPLETED|Washout 1 : 21 Day Washout||6
9911163|NCT01193049|11027577|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0
9911164|NCT01193049|11027578|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0
9911165|NCT01193049|11027577|FG000|STARTED|Period 2 : Double Blind Crossover||5
9911166|NCT01193049|11027578|FG001|STARTED|Period 2 : Double Blind Crossover||6
9911167|NCT01193049|11027577|FG000|COMPLETED|Period 2 : Double Blind Crossover||5
9911168|NCT01193049|11027578|FG001|COMPLETED|Period 2 : Double Blind Crossover||6
9911169|NCT01193049|11027577|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0
9911170|NCT01193049|11027578|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0
9911171|NCT01193049|11027577|FG000|STARTED|Washout 2 : 21 Day Washout||5
9911172|NCT01193049|11027578|FG001|STARTED|Washout 2 : 21 Day Washout||6
9911173|NCT01193049|11027577|FG000|COMPLETED|Washout 2 : 21 Day Washout||5
9911174|NCT01193049|11027578|FG001|COMPLETED|Washout 2 : 21 Day Washout||6
9911175|NCT01193049|11027577|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0
9911176|NCT01193049|11027578|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0
9911177|NCT01193049|11027577|FG000|STARTED|Period 3 : Double Blind Crossover||5
9911178|NCT01193049|11027578|FG001|STARTED|Period 3 : Double Blind Crossover||6
9911179|NCT01193049|11027577|FG000|COMPLETED|Period 3 : Double Blind Crossover||5
9911180|NCT01193049|11027578|FG001|COMPLETED|Period 3 : Double Blind Crossover||6
9911181|NCT01193049|11027577|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0
9911182|NCT01193049|11027578|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0
9911183|NCT01193101|11027588|FG000|STARTED|Overall Study||100
9911184|NCT01193101|11027589|FG001|STARTED|Overall Study||101
9911185|NCT01193101|11027590|FG002|STARTED|Overall Study||96
9911186|NCT01193101|11027591|FG003|STARTED|Overall Study||92
9911187|NCT01193101|11027588|FG000|Full Analysis Set|Overall Study||100
9911188|NCT01193101|11027589|FG001|Full Analysis Set|Overall Study||101
9911189|NCT01193101|11027590|FG002|Full Analysis Set|Overall Study||96
9911190|NCT01193101|11027591|FG003|Full Analysis Set|Overall Study||92
9911191|NCT01193101|11027588|FG000|Placebo Withdrawal Set|Overall Study||95
9911192|NCT01193101|11027589|FG001|Placebo Withdrawal Set|Overall Study||94
9911193|NCT01193101|11027590|FG002|Placebo Withdrawal Set|Overall Study||93
9911194|NCT01193101|11027591|FG003|Placebo Withdrawal Set|Overall Study||80
9911195|NCT01193101|11027588|FG000|COMPLETED|Overall Study||95
9911196|NCT01193101|11027589|FG001|COMPLETED|Overall Study||94
9911197|NCT01193101|11027590|FG002|COMPLETED|Overall Study||93
9911198|NCT01193101|11027591|FG003|COMPLETED|Overall Study||80
9911199|NCT01193101|11027588|FG000|NOT COMPLETED|Overall Study||5
9911200|NCT01193101|11027589|FG001|NOT COMPLETED|Overall Study||7
9911201|NCT01193101|11027590|FG002|NOT COMPLETED|Overall Study||3
9911202|NCT01193101|11027591|FG003|NOT COMPLETED|Overall Study||12
9911203|NCT01193114|11027603|FG000|STARTED|Overall Study||30
9911204|NCT01193114|11027604|FG001|STARTED|Overall Study||30
9911205|NCT01193114|11027603|FG000|COMPLETED|Overall Study||30
9911206|NCT01193114|11027604|FG001|COMPLETED|Overall Study||30
9911207|NCT01193114|11027603|FG000|NOT COMPLETED|Overall Study||0
9911208|NCT01193114|11027604|FG001|NOT COMPLETED|Overall Study||0
9911209|NCT01193127|11027614|FG000|STARTED|Randomized||57
9911210|NCT01193127|11027615|FG001|STARTED|Randomized||54
9911211|NCT01193127|11027616|FG002|STARTED|Randomized||55
9911212|NCT01193127|11027617|FG003|STARTED|Randomized||57
9911213|NCT01193127|11027614|FG000|COMPLETED|Randomized||57
9911214|NCT01193127|11027615|FG001|COMPLETED|Randomized||54
9911215|NCT01193127|11027616|FG002|COMPLETED|Randomized||55
9911216|NCT01193127|11027617|FG003|COMPLETED|Randomized||56
9911217|NCT01193127|11027614|FG000|NOT COMPLETED|Randomized||0
9911218|NCT01193127|11027615|FG001|NOT COMPLETED|Randomized||0
9911219|NCT01193127|11027616|FG002|NOT COMPLETED|Randomized||0
9911220|NCT01193127|11027617|FG003|NOT COMPLETED|Randomized||1
9911221|NCT01193127|11027614|FG000|STARTED|Treated||57
9911222|NCT01193127|11027615|FG001|STARTED|Treated||54
9911223|NCT01193127|11027616|FG002|STARTED|Treated||55
9911224|NCT01193127|11027617|FG003|STARTED|Treated||56
9911225|NCT01193127|11027614|FG000|COMPLETED|Treated||57
9911226|NCT01193127|11027615|FG001|COMPLETED|Treated||54
9911227|NCT01193127|11027616|FG002|COMPLETED|Treated||55
9911228|NCT01193127|11027617|FG003|COMPLETED|Treated||55
9911229|NCT01193127|11027614|FG000|NOT COMPLETED|Treated||0
9911230|NCT01193127|11027615|FG001|NOT COMPLETED|Treated||0
9911231|NCT01193127|11027616|FG002|NOT COMPLETED|Treated||0
9911232|NCT01193127|11027617|FG003|NOT COMPLETED|Treated||1
9911233|NCT01193153|11027629|FG000|STARTED|Open-label Lead in Period||667
9911234|NCT01193153|11027630|FG001|STARTED|Open-label Lead in Period||0
9911235|NCT01193153|11027629|FG000|COMPLETED|Open-label Lead in Period||432
9911236|NCT01193153|11027630|FG001|COMPLETED|Open-label Lead in Period||0
9911237|NCT01193153|11027629|FG000|NOT COMPLETED|Open-label Lead in Period||235
9911238|NCT01193153|11027630|FG001|NOT COMPLETED|Open-label Lead in Period||0
9911239|NCT01193153|11027629|FG000|STARTED|Open-label Stabilization Period||432
9911240|NCT01193153|11027630|FG001|STARTED|Open-label Stabilization Period||0
9911241|NCT01193153|11027629|FG000|COMPLETED|Open-label Stabilization Period||334
9911242|NCT01193153|11027630|FG001|COMPLETED|Open-label Stabilization Period||0
9911243|NCT01193153|11027629|FG000|NOT COMPLETED|Open-label Stabilization Period||98
9911244|NCT01193153|11027630|FG001|NOT COMPLETED|Open-label Stabilization Period||0
9911245|NCT01193153|11027629|FG000|STARTED|Double Blind Relapse Prevention Period||164
9911246|NCT01193153|11027630|FG001|STARTED|Double Blind Relapse Prevention Period||170
9911247|NCT01193153|11027629|FG000|COMPLETED|Double Blind Relapse Prevention Period||100
9911248|NCT01193153|11027630|FG001|COMPLETED|Double Blind Relapse Prevention Period||65
9911249|NCT01193153|11027629|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64
9911250|NCT01193153|11027630|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105
9911251|NCT01193218|11027644|FG000|STARTED|0-12 Weeks|It is actually placebo group|109
9911252|NCT01193218|11027645|FG001|STARTED|0-12 Weeks|It is actually N/A|0
9911253|NCT01193218|11027646|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110
9911254|NCT01193218|11027647|FG003|STARTED|0-12 Weeks|It is actually N/A|0
9911255|NCT01193218|11027648|FG004|STARTED|0-12 Weeks||109
9911256|NCT01193218|11027649|FG005|STARTED|0-12 Weeks||109
9911257|NCT01193218|11027650|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110
9911258|NCT01193218|11027651|FG007|STARTED|0-12 Weeks|It is actually N/A|0
9911259|NCT01193218|11027644|FG000|COMPLETED|0-12 Weeks||100
9911260|NCT01193218|11027645|FG001|COMPLETED|0-12 Weeks||0
9911261|NCT01193218|11027646|FG002|COMPLETED|0-12 Weeks||107
9911262|NCT01193218|11027647|FG003|COMPLETED|0-12 Weeks||0
9911263|NCT01193218|11027648|FG004|COMPLETED|0-12 Weeks||108
9911264|NCT01193218|11027649|FG005|COMPLETED|0-12 Weeks||106
9911265|NCT01193218|11027650|FG006|COMPLETED|0-12 Weeks||107
9911266|NCT01193218|11027651|FG007|COMPLETED|0-12 Weeks||0
9911267|NCT01193218|11027644|FG000|NOT COMPLETED|0-12 Weeks||9
9911268|NCT01193218|11027645|FG001|NOT COMPLETED|0-12 Weeks||0
9911269|NCT01193218|11027646|FG002|NOT COMPLETED|0-12 Weeks||3
9911270|NCT01193218|11027647|FG003|NOT COMPLETED|0-12 Weeks||0
9911271|NCT01193218|11027648|FG004|NOT COMPLETED|0-12 Weeks||1
9911272|NCT01193218|11027649|FG005|NOT COMPLETED|0-12 Weeks||3
9911273|NCT01193218|11027650|FG006|NOT COMPLETED|0-12 Weeks||3
9911274|NCT01193218|11027651|FG007|NOT COMPLETED|0-12 Weeks||0
9911275|NCT01193218|11027644|FG000|STARTED|12-52 Weeks||50
9911276|NCT01193218|11027645|FG001|STARTED|12-52 Weeks||50
9911277|NCT01193218|11027646|FG002|STARTED|12-52 Weeks||54
9911278|NCT01193218|11027647|FG003|STARTED|12-52 Weeks||53
9911279|NCT01193218|11027648|FG004|STARTED|12-52 Weeks||108
9911280|NCT01193218|11027649|FG005|STARTED|12-52 Weeks||106
9911281|NCT01193218|11027650|FG006|STARTED|12-52 Weeks||54
9911282|NCT01193218|11027651|FG007|STARTED|12-52 Weeks||53
9911283|NCT01193218|11027644|FG000|COMPLETED|12-52 Weeks||45
9911284|NCT01193218|11027645|FG001|COMPLETED|12-52 Weeks||50
9911285|NCT01193218|11027646|FG002|COMPLETED|12-52 Weeks||50
9911286|NCT01193218|11027647|FG003|COMPLETED|12-52 Weeks||50
9911287|NCT01193218|11027648|FG004|COMPLETED|12-52 Weeks||104
9911288|NCT01193218|11027649|FG005|COMPLETED|12-52 Weeks||101
9911289|NCT01193218|11027650|FG006|COMPLETED|12-52 Weeks||51
9911290|NCT01193218|11027651|FG007|COMPLETED|12-52 Weeks||49
9911291|NCT01193218|11027644|FG000|NOT COMPLETED|12-52 Weeks||5
9911292|NCT01193218|11027645|FG001|NOT COMPLETED|12-52 Weeks||0
9911293|NCT01193218|11027646|FG002|NOT COMPLETED|12-52 Weeks||4
9911294|NCT01193218|11027647|FG003|NOT COMPLETED|12-52 Weeks||3
9911295|NCT01193218|11027648|FG004|NOT COMPLETED|12-52 Weeks||4
9911296|NCT01193218|11027649|FG005|NOT COMPLETED|12-52 Weeks||5
9911297|NCT01193218|11027650|FG006|NOT COMPLETED|12-52 Weeks||3
9911298|NCT01193218|11027651|FG007|NOT COMPLETED|12-52 Weeks||4
9911299|NCT01193244|11027669|FG000|STARTED|Overall Study||779
9911300|NCT01193244|11027670|FG001|STARTED|Overall Study||781
9911301|NCT01193244|11027669|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
9911302|NCT01193244|11027670|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
9911303|NCT01193244|11027669|FG000|COMPLETED|Overall Study||391
9911304|NCT01193244|11027670|FG001|COMPLETED|Overall Study||391
9911305|NCT01193244|11027669|FG000|NOT COMPLETED|Overall Study||388
9911306|NCT01193244|11027670|FG001|NOT COMPLETED|Overall Study||390
9911307|NCT01193257|11027678|FG000|STARTED|Overall Study||365
9911308|NCT01193257|11027679|FG001|STARTED|Overall Study||734
9911309|NCT01193257|11027678|FG000|Treated|Overall Study||363
9911310|NCT01193257|11027679|FG001|Treated|Overall Study||732
9911311|NCT01193257|11027678|FG000|COMPLETED|Overall Study||0
9911312|NCT01193257|11027679|FG001|COMPLETED|Overall Study||0
9911313|NCT01193257|11027678|FG000|NOT COMPLETED|Overall Study||365
9911314|NCT01193257|11027679|FG001|NOT COMPLETED|Overall Study||734
9911315|NCT01193283|11027685|FG000|STARTED|Overall Study||22
9911316|NCT01193283|11027685|FG000|COMPLETED|Overall Study||21
9911317|NCT01193283|11027685|FG000|NOT COMPLETED|Overall Study||1
9911318|NCT01193335|11027691|FG000|STARTED|Infant Series||100
9911319|NCT01193335|11027692|FG001|STARTED|Infant Series||100
9911320|NCT01193335|11027691|FG000|COMPLETED|Infant Series||100
9911321|NCT01193335|11027692|FG001|COMPLETED|Infant Series||100
9911322|NCT01193335|11027691|FG000|NOT COMPLETED|Infant Series||0
9911323|NCT01193335|11027692|FG001|NOT COMPLETED|Infant Series||0
9911324|NCT01193335|11027691|FG000|STARTED|After Infant Series||100
9911325|NCT01193335|11027692|FG001|STARTED|After Infant Series||100
9911326|NCT01193335|11027691|FG000|COMPLETED|After Infant Series||99
9911327|NCT01193335|11027692|FG001|COMPLETED|After Infant Series||97
9911328|NCT01193335|11027691|FG000|NOT COMPLETED|After Infant Series||1
9911329|NCT01193335|11027692|FG001|NOT COMPLETED|After Infant Series||3
9911330|NCT01193335|11027691|FG000|STARTED|Toddler Dose||99
9911331|NCT01193335|11027692|FG001|STARTED|Toddler Dose||97
9911332|NCT01193335|11027691|FG000|COMPLETED|Toddler Dose||99
9911333|NCT01193335|11027692|FG001|COMPLETED|Toddler Dose||97
9911334|NCT01193335|11027691|FG000|NOT COMPLETED|Toddler Dose||0
9911335|NCT01193335|11027692|FG001|NOT COMPLETED|Toddler Dose||0
9911336|NCT01193335|11027691|FG000|STARTED|1-Year Follow-up||99
9911337|NCT01193335|11027692|FG001|STARTED|1-Year Follow-up||97
9911338|NCT01193335|11027691|FG000|COMPLETED|1-Year Follow-up||88
9911339|NCT01193335|11027692|FG001|COMPLETED|1-Year Follow-up||88
9911340|NCT01193335|11027691|FG000|NOT COMPLETED|1-Year Follow-up||11
9911341|NCT01193335|11027692|FG001|NOT COMPLETED|1-Year Follow-up||9
9911342|NCT01193335|11027691|FG000|STARTED|2-Year Follow-up||88
9911343|NCT01193335|11027692|FG001|STARTED|2-Year Follow-up||88
9911344|NCT01193335|11027691|FG000|COMPLETED|2-Year Follow-up||81
9911345|NCT01193335|11027692|FG001|COMPLETED|2-Year Follow-up||80
9911346|NCT01193335|11027691|FG000|NOT COMPLETED|2-Year Follow-up||7
9911347|NCT01193335|11027692|FG001|NOT COMPLETED|2-Year Follow-up||8
9911348|NCT01193348|11027714|FG000|STARTED|Screening Period||27
10203780|NCT03466918|11330664|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
10203781|NCT03466918|11330664|FG000|NOT COMPLETED|Overall Study||0
10203782|NCT03467048|11330671|FG000|STARTED|Overall Study||66
10203783|NCT03467048|11330672|FG001|STARTED|Overall Study||64
10203784|NCT03467048|11330671|FG000|COMPLETED|Overall Study||66
10203785|NCT03467048|11330672|FG001|COMPLETED|Overall Study||63
10203786|NCT03467048|11330671|FG000|NOT COMPLETED|Overall Study||0
10203787|NCT03467048|11330672|FG001|NOT COMPLETED|Overall Study||1
10203788|NCT03467217|11330680|FG000|STARTED|Overall Study||43
10203789|NCT03467217|11330681|FG001|STARTED|Overall Study||40
10203790|NCT03467217|11330680|FG000|COMPLETED|Overall Study||33
10203791|NCT03467217|11330681|FG001|COMPLETED|Overall Study||34
10203792|NCT03467217|11330680|FG000|NOT COMPLETED|Overall Study||10
10203793|NCT03467217|11330681|FG001|NOT COMPLETED|Overall Study||6
9911349|NCT01193348|11027714|FG000|COMPLETED|Screening Period||22
9911350|NCT01193348|11027714|FG000|NOT COMPLETED|Screening Period||5
9911351|NCT01193348|11027714|FG000|STARTED|Treatment Period (26 Weeks)||22
9911352|NCT01193348|11027714|FG000|COMPLETED|Treatment Period (26 Weeks)||19
9911353|NCT01193348|11027714|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3
9911354|NCT01193348|11027714|FG000|STARTED|Extension Treatment Period||17
9911355|NCT01193348|11027714|FG000|COMPLETED|Extension Treatment Period||16
9911356|NCT01193348|11027714|FG000|NOT COMPLETED|Extension Treatment Period||1
9911357|NCT01193348|11027714|FG000|STARTED|Post Treatment Period (Patients Who Disc||10
9911358|NCT01193348|11027714|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8
9911359|NCT01193348|11027714|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
9911360|NCT01193517|11027726|FG000|STARTED|Overall Study||3
9911361|NCT01193517|11027727|FG001|STARTED|Overall Study||12
9911362|NCT01193517|11027728|FG002|STARTED|Overall Study||11
9911363|NCT01193517|11027726|FG000|COMPLETED|Overall Study||2
9911364|NCT01193517|11027727|FG001|COMPLETED|Overall Study||12
9911365|NCT01193517|11027728|FG002|COMPLETED|Overall Study||11
9911366|NCT01193517|11027726|FG000|NOT COMPLETED|Overall Study||1
9911367|NCT01193517|11027727|FG001|NOT COMPLETED|Overall Study||0
9911368|NCT01193517|11027728|FG002|NOT COMPLETED|Overall Study||0
9911369|NCT01193582|11027741|FG000|STARTED|Vaccination Series||100
9911370|NCT01193582|11027742|FG001|STARTED|Vaccination Series||101
9911371|NCT01193582|11027743|FG002|STARTED|Vaccination Series||125
9911372|NCT01193582|11027744|FG003|STARTED|Vaccination Series||180
9911373|NCT01193582|11027741|FG000|Vaccinated Dose 1|Vaccination Series||100
9911374|NCT01193582|11027742|FG001|Vaccinated Dose 1|Vaccination Series||100
9911375|NCT01193582|11027743|FG002|Vaccinated Dose 1|Vaccination Series||125
9911376|NCT01193582|11027744|FG003|Vaccinated Dose 1|Vaccination Series||180
9911377|NCT01193582|11027741|FG000|Vaccinated Dose 2|Vaccination Series||92
9911378|NCT01193582|11027742|FG001|Vaccinated Dose 2|Vaccination Series||91
9911379|NCT01193582|11027743|FG002|Vaccinated Dose 2|Vaccination Series||118
9911380|NCT01193582|11027744|FG003|Vaccinated Dose 2|Vaccination Series||0
9911381|NCT01193582|11027741|FG000|Vaccinated Dose 3|Vaccination Series||90
9911382|NCT01193582|11027742|FG001|Vaccinated Dose 3|Vaccination Series||89
9911383|NCT01193582|11027743|FG002|Vaccinated Dose 3|Vaccination Series||0
9911384|NCT01193582|11027744|FG003|Vaccinated Dose 3|Vaccination Series||0
9911385|NCT01193582|11027741|FG000|Vaccinated Dose 4|Vaccination Series||90
9911386|NCT01193582|11027742|FG001|Vaccinated Dose 4|Vaccination Series||0
9911387|NCT01193582|11027743|FG002|Vaccinated Dose 4|Vaccination Series||0
9911388|NCT01193582|11027744|FG003|Vaccinated Dose 4|Vaccination Series||0
9911389|NCT01193582|11027741|FG000|COMPLETED|Vaccination Series||89
9911390|NCT01193582|11027742|FG001|COMPLETED|Vaccination Series||88
9911391|NCT01193582|11027743|FG002|COMPLETED|Vaccination Series||117
9911392|NCT01193582|11027744|FG003|COMPLETED|Vaccination Series||177
9911393|NCT01193582|11027741|FG000|NOT COMPLETED|Vaccination Series||11
9911394|NCT01193582|11027742|FG001|NOT COMPLETED|Vaccination Series||13
9911395|NCT01193582|11027743|FG002|NOT COMPLETED|Vaccination Series||8
9911396|NCT01193582|11027744|FG003|NOT COMPLETED|Vaccination Series||3
9911397|NCT01193582|11027741|FG000|STARTED|12 Month Follow-up||89
9911398|NCT01193582|11027742|FG001|STARTED|12 Month Follow-up||88
9911399|NCT01193582|11027743|FG002|STARTED|12 Month Follow-up||117
9911400|NCT01193582|11027744|FG003|STARTED|12 Month Follow-up||177
9911401|NCT01193582|11027741|FG000|COMPLETED|12 Month Follow-up||83
9911402|NCT01193582|11027742|FG001|COMPLETED|12 Month Follow-up||88
9911403|NCT01193582|11027743|FG002|COMPLETED|12 Month Follow-up||113
9911404|NCT01193582|11027744|FG003|COMPLETED|12 Month Follow-up||166
9911405|NCT01193582|11027741|FG000|NOT COMPLETED|12 Month Follow-up||6
9911406|NCT01193582|11027742|FG001|NOT COMPLETED|12 Month Follow-up||0
9911407|NCT01193582|11027743|FG002|NOT COMPLETED|12 Month Follow-up||4
9911408|NCT01193582|11027744|FG003|NOT COMPLETED|12 Month Follow-up||11
9911409|NCT01193608|11027762|FG000|STARTED|Overall Study||6
9911410|NCT01193608|11027763|FG001|STARTED|Overall Study||6
9911411|NCT01193608|11027764|FG002|STARTED|Overall Study||16
9911412|NCT01193608|11027765|FG003|STARTED|Overall Study||17
9911413|NCT01193608|11027766|FG004|STARTED|Overall Study||24
9911414|NCT01193608|11027767|FG005|STARTED|Overall Study||19
9911415|NCT01193608|11027762|FG000|COMPLETED|Overall Study||6
9911416|NCT01193608|11027763|FG001|COMPLETED|Overall Study||4
9911417|NCT01193608|11027764|FG002|COMPLETED|Overall Study||14
9911418|NCT01193608|11027765|FG003|COMPLETED|Overall Study||14
9911419|NCT01193608|11027766|FG004|COMPLETED|Overall Study||19
9911420|NCT01193608|11027767|FG005|COMPLETED|Overall Study||17
9911421|NCT01193608|11027762|FG000|NOT COMPLETED|Overall Study||0
9911422|NCT01193608|11027763|FG001|NOT COMPLETED|Overall Study||2
9911423|NCT01193608|11027764|FG002|NOT COMPLETED|Overall Study||2
9911424|NCT01193608|11027765|FG003|NOT COMPLETED|Overall Study||3
9911425|NCT01193608|11027766|FG004|NOT COMPLETED|Overall Study||5
9911426|NCT01193608|11027767|FG005|NOT COMPLETED|Overall Study||2
9911427|NCT01193660|11027789|FG000|STARTED|Overall Study||35
9911428|NCT01193660|11027790|FG001|STARTED|Overall Study||36
9911429|NCT01193660|11027791|FG002|STARTED|Overall Study||34
9911430|NCT01193660|11027789|FG000|COMPLETED|Overall Study||31
9911431|NCT01193660|11027790|FG001|COMPLETED|Overall Study||33
9911432|NCT01193660|11027791|FG002|COMPLETED|Overall Study||32
9911433|NCT01193660|11027789|FG000|NOT COMPLETED|Overall Study||4
9911434|NCT01193660|11027790|FG001|NOT COMPLETED|Overall Study||3
9911435|NCT01193660|11027791|FG002|NOT COMPLETED|Overall Study||2
9911436|NCT01193686|11027801|FG000|STARTED|Overall Study||15
9911437|NCT01193686|11027802|FG001|STARTED|Overall Study||9
9911438|NCT01193686|11027801|FG000|Completed Baseline Assessment|Overall Study||15
9911439|NCT01193686|11027802|FG001|Completed Baseline Assessment|Overall Study||9
9911440|NCT01193686|11027801|FG000|Completed Mentor Training|Overall Study||9
9911441|NCT01193686|11027802|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
9911442|NCT01193686|11027801|FG000|Completed Visits and Final Assessment|Overall Study||8
9911443|NCT01193686|11027802|FG001|Completed Visits and Final Assessment|Overall Study||8
9911444|NCT01193686|11027801|FG000|COMPLETED|Overall Study||8
9911445|NCT01193686|11027802|FG001|COMPLETED|Overall Study||8
9911446|NCT01193686|11027801|FG000|NOT COMPLETED|Overall Study||7
9911447|NCT01193686|11027802|FG001|NOT COMPLETED|Overall Study||1
9911448|NCT01193868|11027809|FG000|STARTED|Overall Study||6
9911449|NCT01193868|11027809|FG000|COMPLETED|Overall Study||6
9911450|NCT01193868|11027809|FG000|NOT COMPLETED|Overall Study||0
9911451|NCT01193907|11027817|FG000|STARTED|Overall Study||22
9911452|NCT01193907|11027818|FG001|STARTED|Overall Study||22
9911453|NCT01193907|11027819|FG002|STARTED|Overall Study||22
9911454|NCT01193907|11027820|FG003|STARTED|Overall Study||22
9911455|NCT01193907|11027817|FG000|COMPLETED|Overall Study||21
9911456|NCT01193907|11027818|FG001|COMPLETED|Overall Study||22
9911457|NCT01193907|11027819|FG002|COMPLETED|Overall Study||22
9911458|NCT01193907|11027820|FG003|COMPLETED|Overall Study||21
9911459|NCT01193907|11027817|FG000|NOT COMPLETED|Overall Study||1
9911460|NCT01193907|11027818|FG001|NOT COMPLETED|Overall Study||0
9911461|NCT01193907|11027819|FG002|NOT COMPLETED|Overall Study||0
9911462|NCT01193907|11027820|FG003|NOT COMPLETED|Overall Study||1
9911463|NCT01193920|11027840|FG000|STARTED|Overall Study||40
9911464|NCT01193920|11027841|FG001|STARTED|Overall Study||20
9911465|NCT01193920|11027842|FG002|STARTED|Overall Study||80
9911466|NCT01193920|11027843|FG003|STARTED|Overall Study||80
9911467|NCT01193920|11027844|FG004|STARTED|Overall Study||80
9911468|NCT01193920|11027845|FG005|STARTED|Overall Study||80
9911469|NCT01193920|11027846|FG006|STARTED|Overall Study||80
9911470|NCT01193920|11027847|FG007|STARTED|Overall Study||80
9911471|NCT01193920|11027848|FG008|STARTED|Overall Study||76
9911472|NCT01193920|11027849|FG009|STARTED|Overall Study||81
9911473|NCT01193920|11027840|FG000|COMPLETED|Overall Study||37
9911474|NCT01193920|11027841|FG001|COMPLETED|Overall Study||20
9911475|NCT01193920|11027842|FG002|COMPLETED|Overall Study||74
9911476|NCT01193920|11027843|FG003|COMPLETED|Overall Study||76
9911477|NCT01193920|11027844|FG004|COMPLETED|Overall Study||74
9911478|NCT01193920|11027845|FG005|COMPLETED|Overall Study||76
9911479|NCT01193920|11027846|FG006|COMPLETED|Overall Study||74
9911480|NCT01193920|11027847|FG007|COMPLETED|Overall Study||76
9911481|NCT01193920|11027848|FG008|COMPLETED|Overall Study||71
9911482|NCT01193920|11027849|FG009|COMPLETED|Overall Study||74
9911483|NCT01193920|11027840|FG000|NOT COMPLETED|Overall Study||3
9911484|NCT01193920|11027841|FG001|NOT COMPLETED|Overall Study||0
9911485|NCT01193920|11027842|FG002|NOT COMPLETED|Overall Study||6
9911486|NCT01193920|11027843|FG003|NOT COMPLETED|Overall Study||4
9911487|NCT01193920|11027844|FG004|NOT COMPLETED|Overall Study||6
9911488|NCT01193920|11027845|FG005|NOT COMPLETED|Overall Study||4
9911489|NCT01193920|11027846|FG006|NOT COMPLETED|Overall Study||6
9911490|NCT01193920|11027847|FG007|NOT COMPLETED|Overall Study||4
9911491|NCT01193920|11027848|FG008|NOT COMPLETED|Overall Study||5
9911492|NCT01193920|11027849|FG009|NOT COMPLETED|Overall Study||7
9911493|NCT01194089|11027874|FG000|STARTED|Overall Study||42
9911494|NCT01194089|11027875|FG001|STARTED|Overall Study||47
9911495|NCT01194089|11027874|FG000|COMPLETED|Overall Study||42
9911496|NCT01194089|11027875|FG001|COMPLETED|Overall Study||47
9911497|NCT01194089|11027874|FG000|NOT COMPLETED|Overall Study||0
9911498|NCT01194089|11027875|FG001|NOT COMPLETED|Overall Study||0
9911499|NCT01194154|11027883|FG000|STARTED|Overall Study||117
9911500|NCT01194154|11027884|FG001|STARTED|Overall Study||124
9911501|NCT01194154|11027883|FG000|Full Analysis Set|Overall Study||115
9911502|NCT01194154|11027884|FG001|Full Analysis Set|Overall Study||120
9911503|NCT01194154|11027883|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
9911504|NCT01194154|11027884|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
9911505|NCT01194154|11027883|FG000|COMPLETED|Overall Study||68
9911506|NCT01194154|11027884|FG001|COMPLETED|Overall Study||91
9911507|NCT01194154|11027883|FG000|NOT COMPLETED|Overall Study||49
9911508|NCT01194154|11027884|FG001|NOT COMPLETED|Overall Study||33
9911509|NCT01194245|11027897|FG000|STARTED|Titration Period (4 to 6 Weeks)||135
9911510|NCT01194245|11027898|FG001|STARTED|Titration Period (4 to 6 Weeks)||0
9911511|NCT01194245|11027899|FG002|STARTED|Titration Period (4 to 6 Weeks)||0
9911512|NCT01194245|11027900|FG003|STARTED|Titration Period (4 to 6 Weeks)||0
9911513|NCT01194245|11027901|FG004|STARTED|Titration Period (4 to 6 Weeks)||0
9911514|NCT01194245|11027897|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
9911515|NCT01194245|11027898|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0
9911516|NCT01194245|11027899|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0
9911517|NCT01194245|11027900|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0
9911518|NCT01194245|11027901|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0
9911519|NCT01194245|11027897|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
9911520|NCT01194245|11027898|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
9911521|NCT01194245|11027899|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
9911522|NCT01194245|11027900|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
9911523|NCT01194245|11027901|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
9911524|NCT01194245|11027897|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
9911525|NCT01194245|11027898|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
9911526|NCT01194245|11027899|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
9911527|NCT01194245|11027900|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
9911528|NCT01194245|11027901|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
9911529|NCT01194245|11027897|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
9911530|NCT01194245|11027898|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
9911531|NCT01194245|11027899|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
9911532|NCT01194245|11027900|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
9911533|NCT01194245|11027901|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
9911534|NCT01194245|11027897|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
9911535|NCT01194245|11027898|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
9911536|NCT01194245|11027899|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
9911537|NCT01194245|11027900|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
9911538|NCT01194245|11027901|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
9911539|NCT01194245|11027897|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
9911540|NCT01194245|11027898|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
9911541|NCT01194245|11027899|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
9911542|NCT01194245|11027900|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
9911543|NCT01194245|11027901|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
9911544|NCT01194245|11027897|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
9911545|NCT01194245|11027898|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
9911546|NCT01194245|11027899|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
9911547|NCT01194245|11027900|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
9911548|NCT01194245|11027901|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
9911549|NCT01194245|11027897|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
9911550|NCT01194245|11027898|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
9911551|NCT01194245|11027899|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
9911552|NCT01194245|11027900|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
9911553|NCT01194245|11027901|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
9911554|NCT01194245|11027897|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
9911555|NCT01194245|11027898|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
9911556|NCT01194245|11027899|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
9911557|NCT01194245|11027900|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
9911558|NCT01194245|11027901|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
9911559|NCT01194258|11027910|FG000|STARTED|Titration Period||132
9911560|NCT01194258|11027911|FG001|STARTED|Titration Period||0
9911561|NCT01194258|11027912|FG002|STARTED|Titration Period||0
9911562|NCT01194258|11027913|FG003|STARTED|Titration Period||0
9911563|NCT01194258|11027914|FG004|STARTED|Titration Period||0
9911564|NCT01194258|11027910|FG000|COMPLETED|Titration Period||121
9911565|NCT01194258|11027911|FG001|COMPLETED|Titration Period||0
9911566|NCT01194258|11027912|FG002|COMPLETED|Titration Period||0
9911567|NCT01194258|11027913|FG003|COMPLETED|Titration Period||0
9911568|NCT01194258|11027914|FG004|COMPLETED|Titration Period||0
9911569|NCT01194258|11027910|FG000|NOT COMPLETED|Titration Period||11
9911570|NCT01194258|11027911|FG001|NOT COMPLETED|Titration Period||0
9911571|NCT01194258|11027912|FG002|NOT COMPLETED|Titration Period||0
9911572|NCT01194258|11027913|FG003|NOT COMPLETED|Titration Period||0
9911573|NCT01194258|11027914|FG004|NOT COMPLETED|Titration Period||0
9911574|NCT01194258|11027910|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
9911575|NCT01194258|11027911|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
9911576|NCT01194258|11027912|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
9911577|NCT01194258|11027913|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
9911578|NCT01194258|11027914|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
9911579|NCT01194258|11027910|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
9911580|NCT01194258|11027911|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
9911581|NCT01194258|11027912|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
9911582|NCT01194258|11027913|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
9911583|NCT01194258|11027914|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
9911584|NCT01194258|11027910|FG000|COMPLETED|Period 1 (12 Weeks)||0
9911585|NCT01194258|11027911|FG001|COMPLETED|Period 1 (12 Weeks)||29
9911586|NCT01194258|11027912|FG002|COMPLETED|Period 1 (12 Weeks)||30
9911587|NCT01194258|11027913|FG003|COMPLETED|Period 1 (12 Weeks)||29
9911588|NCT01194258|11027914|FG004|COMPLETED|Period 1 (12 Weeks)||32
9911589|NCT01194258|11027910|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
9911590|NCT01194258|11027911|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0
9911591|NCT01194258|11027912|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0
9911592|NCT01194258|11027913|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0
9911593|NCT01194258|11027914|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1
9911594|NCT01194258|11027910|FG000|STARTED|Period 2 (12 Weeks)||0
9911595|NCT01194258|11027911|FG001|STARTED|Period 2 (12 Weeks)||29
9911596|NCT01194258|11027912|FG002|STARTED|Period 2 (12 Weeks)||30
9911597|NCT01194258|11027913|FG003|STARTED|Period 2 (12 Weeks)||29
9911598|NCT01194258|11027914|FG004|STARTED|Period 2 (12 Weeks)||32
9911599|NCT01194258|11027910|FG000|COMPLETED|Period 2 (12 Weeks)||0
9911600|NCT01194258|11027911|FG001|COMPLETED|Period 2 (12 Weeks)||27
9911601|NCT01194258|11027912|FG002|COMPLETED|Period 2 (12 Weeks)||29
9911602|NCT01194258|11027913|FG003|COMPLETED|Period 2 (12 Weeks)||29
9911603|NCT01194258|11027914|FG004|COMPLETED|Period 2 (12 Weeks)||30
9911604|NCT01194258|11027910|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
9911605|NCT01194258|11027911|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2
9911606|NCT01194258|11027912|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1
9911607|NCT01194258|11027913|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0
9911608|NCT01194258|11027914|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2
9911609|NCT01194271|11027925|FG000|STARTED|Overall Study||19
9911610|NCT01194271|11027925|FG000|COMPLETED|Overall Study||16
9911611|NCT01194271|11027925|FG000|NOT COMPLETED|Overall Study||3
9911612|NCT01194297|11027931|FG000|STARTED|Overall Study||2
9911613|NCT01194297|11027932|FG001|STARTED|Overall Study||1
9911614|NCT01194297|11027931|FG000|COMPLETED|Overall Study||2
9911615|NCT01194297|11027932|FG001|COMPLETED|Overall Study||1
9911616|NCT01194297|11027931|FG000|NOT COMPLETED|Overall Study||0
9911617|NCT01194297|11027932|FG001|NOT COMPLETED|Overall Study||0
9911618|NCT01194414|11027940|FG000|STARTED|24 Weeks Double Blind Period||631
9911619|NCT01194414|11027941|FG001|STARTED|24 Weeks Double Blind Period||631
9911620|NCT01194414|11027942|FG002|STARTED|24 Weeks Double Blind Period||0
9911621|NCT01194414|11027943|FG003|STARTED|24 Weeks Double Blind Period||0
9911622|NCT01194414|11027940|FG000|Per Protocol Population|24 Weeks Double Blind Period||558
9911623|NCT01194414|11027941|FG001|Per Protocol Population|24 Weeks Double Blind Period||537
9911624|NCT01194414|11027942|FG002|Per Protocol Population|24 Weeks Double Blind Period||0
9911625|NCT01194414|11027943|FG003|Per Protocol Population|24 Weeks Double Blind Period||0
9911626|NCT01194414|11027940|FG000|COMPLETED|24 Weeks Double Blind Period||572
9911627|NCT01194414|11027941|FG001|COMPLETED|24 Weeks Double Blind Period||564
9911628|NCT01194414|11027942|FG002|COMPLETED|24 Weeks Double Blind Period||0
9911629|NCT01194414|11027943|FG003|COMPLETED|24 Weeks Double Blind Period||0
9911630|NCT01194414|11027940|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59
9911631|NCT01194414|11027941|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67
9911632|NCT01194414|11027942|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0
9911633|NCT01194414|11027943|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0
9911634|NCT01194414|11027940|FG000|STARTED|72 Weeks Open Label Extension||524
9911635|NCT01194414|11027941|FG001|STARTED|72 Weeks Open Label Extension||377
9911636|NCT01194414|11027942|FG002|STARTED|72 Weeks Open Label Extension||48
9911637|NCT01194414|11027943|FG003|STARTED|72 Weeks Open Label Extension||186
9911638|NCT01194414|11027940|FG000|COMPLETED|72 Weeks Open Label Extension||445
9911639|NCT01194414|11027941|FG001|COMPLETED|72 Weeks Open Label Extension||311
9911640|NCT01194414|11027942|FG002|COMPLETED|72 Weeks Open Label Extension||40
9911641|NCT01194414|11027943|FG003|COMPLETED|72 Weeks Open Label Extension||160
9911642|NCT01194414|11027940|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79
9911643|NCT01194414|11027941|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66
9911644|NCT01194414|11027942|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8
9911645|NCT01194414|11027943|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26
9911646|NCT01194440|11027955|FG000|STARTED|Baseline (First Dose)||59
9911647|NCT01194440|11027955|FG000|COMPLETED|Baseline (First Dose)||52
9911648|NCT01194440|11027955|FG000|NOT COMPLETED|Baseline (First Dose)||7
9911649|NCT01194440|11027955|FG000|STARTED|6-months (2nd Dose)||52
9911650|NCT01194440|11027955|FG000|COMPLETED|6-months (2nd Dose)||48
9911651|NCT01194440|11027955|FG000|NOT COMPLETED|6-months (2nd Dose)||4
9911652|NCT01194453|11027962|FG000|STARTED|Overall Study||144
9911653|NCT01194453|11027963|FG001|STARTED|Overall Study||144
9911654|NCT01194453|11027962|FG000|COMPLETED|Overall Study||127
9911655|NCT01194453|11027963|FG001|COMPLETED|Overall Study||127
9911656|NCT01194453|11027962|FG000|NOT COMPLETED|Overall Study||17
9911657|NCT01194453|11027963|FG001|NOT COMPLETED|Overall Study||17
9911658|NCT01194466|11027969|FG000|STARTED|Overall Study||14
9911659|NCT01194466|11027970|FG001|STARTED|Overall Study||14
9911660|NCT01194466|11027971|FG002|STARTED|Overall Study||13
9911661|NCT01194466|11027969|FG000|COMPLETED|Overall Study||14
9911662|NCT01194466|11027970|FG001|COMPLETED|Overall Study||14
9911663|NCT01194466|11027971|FG002|COMPLETED|Overall Study||13
9911664|NCT01194466|11027969|FG000|NOT COMPLETED|Overall Study||0
9911665|NCT01194466|11027970|FG001|NOT COMPLETED|Overall Study||0
9911666|NCT01194466|11027971|FG002|NOT COMPLETED|Overall Study||0
9911667|NCT01194479|11027981|FG000|STARTED|Overall Study||3
9911668|NCT01194479|11027982|FG001|STARTED|Overall Study||4
9911669|NCT01194479|11027983|FG002|STARTED|Overall Study||2
9911670|NCT01194479|11027984|FG003|STARTED|Overall Study||5
9911671|NCT01194479|11027981|FG000|Cross-over at Second Visit|Overall Study||3
9911672|NCT01194479|11027982|FG001|Cross-over at Second Visit|Overall Study||4
9911673|NCT01194479|11027983|FG002|Cross-over at Second Visit|Overall Study||2
9911674|NCT01194479|11027984|FG003|Cross-over at Second Visit|Overall Study||5
9911675|NCT01194479|11027981|FG000|COMPLETED|Overall Study||3
9911676|NCT01194479|11027982|FG001|COMPLETED|Overall Study||4
9911677|NCT01194479|11027983|FG002|COMPLETED|Overall Study||2
9911678|NCT01194479|11027984|FG003|COMPLETED|Overall Study||5
9911679|NCT01194479|11027981|FG000|NOT COMPLETED|Overall Study||0
9911680|NCT01194479|11027982|FG001|NOT COMPLETED|Overall Study||0
9911681|NCT01194479|11027983|FG002|NOT COMPLETED|Overall Study||0
9911682|NCT01194479|11027984|FG003|NOT COMPLETED|Overall Study||0
9911683|NCT01194531|11027996|FG000|STARTED|Overall Study||29
9911684|NCT01194531|11027997|FG001|STARTED|Overall Study||30
9911685|NCT01194531|11027996|FG000|COMPLETED|Overall Study||24
9911686|NCT01194531|11027997|FG001|COMPLETED|Overall Study||27
9911687|NCT01194531|11027996|FG000|NOT COMPLETED|Overall Study||5
9911688|NCT01194531|11027997|FG001|NOT COMPLETED|Overall Study||3
9911689|NCT01194674|11028003|FG000|STARTED|Overall Study||2
9911690|NCT01194674|11028003|FG000|COMPLETED|Overall Study||2
9911691|NCT01194674|11028003|FG000|NOT COMPLETED|Overall Study||0
9911692|NCT01194804|11028008|FG000|STARTED|Overall Study||27
9911693|NCT01194804|11028008|FG000|COMPLETED|Overall Study||26
9911694|NCT01194804|11028008|FG000|NOT COMPLETED|Overall Study||1
9911695|NCT01194830|11028014|FG000|STARTED|Overall Study||124
9911696|NCT01194830|11028015|FG001|STARTED|Overall Study||110
9911697|NCT01194830|11028014|FG000|COMPLETED|Overall Study||88
9911698|NCT01194830|11028015|FG001|COMPLETED|Overall Study||83
9911699|NCT01194830|11028014|FG000|NOT COMPLETED|Overall Study||36
9911700|NCT01194830|11028015|FG001|NOT COMPLETED|Overall Study||27
9911701|NCT01194869|11028021|FG000|STARTED|Overall Study||25
9911702|NCT01194869|11028021|FG000|COMPLETED|Overall Study||21
9911703|NCT01194869|11028021|FG000|NOT COMPLETED|Overall Study||4
9911704|NCT01194973|11028025|FG000|STARTED|Screening Period||44
9911705|NCT01194973|11028025|FG000|COMPLETED|Screening Period||41
9911706|NCT01194973|11028025|FG000|NOT COMPLETED|Screening Period||3
9911707|NCT01194973|11028025|FG000|STARTED|26 Week Treatment Period||41
9911708|NCT01194973|11028025|FG000|COMPLETED|26 Week Treatment Period||38
9911709|NCT01194973|11028025|FG000|NOT COMPLETED|26 Week Treatment Period||3
9911710|NCT01194999|11028029|FG000|STARTED|Overall Study||132
9911711|NCT01194999|11028029|FG000|COMPLETED|Overall Study||115
9911712|NCT01194999|11028029|FG000|NOT COMPLETED|Overall Study||17
9911713|NCT01195025|11028033|FG000|STARTED|First Intervention A||2
9911714|NCT01195025|11028034|FG001|STARTED|First Intervention A||3
9911715|NCT01195025|11028035|FG002|STARTED|First Intervention A||2
9911716|NCT01195025|11028036|FG003|STARTED|First Intervention A||2
9911717|NCT01195025|11028037|FG004|STARTED|First Intervention A||1
9911718|NCT01195025|11028033|FG000|COMPLETED|First Intervention A||2
9911719|NCT01195025|11028034|FG001|COMPLETED|First Intervention A||3
9911720|NCT01195025|11028035|FG002|COMPLETED|First Intervention A||2
9911721|NCT01195025|11028036|FG003|COMPLETED|First Intervention A||2
9911722|NCT01195025|11028037|FG004|COMPLETED|First Intervention A||1
9911723|NCT01195025|11028033|FG000|NOT COMPLETED|First Intervention A||0
9911724|NCT01195025|11028034|FG001|NOT COMPLETED|First Intervention A||0
9911725|NCT01195025|11028035|FG002|NOT COMPLETED|First Intervention A||0
9911726|NCT01195025|11028036|FG003|NOT COMPLETED|First Intervention A||0
9911727|NCT01195025|11028037|FG004|NOT COMPLETED|First Intervention A||0
9911728|NCT01195025|11028033|FG000|STARTED|Second Intervention B||2
9911729|NCT01195025|11028034|FG001|STARTED|Second Intervention B||3
9911730|NCT01195025|11028035|FG002|STARTED|Second Intervention B||2
9911731|NCT01195025|11028036|FG003|STARTED|Second Intervention B||2
9911732|NCT01195025|11028037|FG004|STARTED|Second Intervention B||1
9911733|NCT01195025|11028033|FG000|COMPLETED|Second Intervention B||2
9911734|NCT01195025|11028034|FG001|COMPLETED|Second Intervention B||3
9911735|NCT01195025|11028035|FG002|COMPLETED|Second Intervention B||2
9911736|NCT01195025|11028036|FG003|COMPLETED|Second Intervention B||2
9911737|NCT01195025|11028037|FG004|COMPLETED|Second Intervention B||1
9911738|NCT01195025|11028033|FG000|NOT COMPLETED|Second Intervention B||0
9911739|NCT01195025|11028034|FG001|NOT COMPLETED|Second Intervention B||0
9911740|NCT01195025|11028035|FG002|NOT COMPLETED|Second Intervention B||0
9911741|NCT01195025|11028036|FG003|NOT COMPLETED|Second Intervention B||0
9911742|NCT01195025|11028037|FG004|NOT COMPLETED|Second Intervention B||0
9911743|NCT01195025|11028033|FG000|STARTED|Third Intervention C||2
9911744|NCT01195025|11028034|FG001|STARTED|Third Intervention C||3
9911745|NCT01195025|11028035|FG002|STARTED|Third Intervention C||2
9911746|NCT01195025|11028036|FG003|STARTED|Third Intervention C||2
9911747|NCT01195025|11028037|FG004|STARTED|Third Intervention C||1
9911748|NCT01195025|11028033|FG000|COMPLETED|Third Intervention C||2
9911749|NCT01195025|11028034|FG001|COMPLETED|Third Intervention C||3
9911750|NCT01195025|11028035|FG002|COMPLETED|Third Intervention C||2
9911751|NCT01195025|11028036|FG003|COMPLETED|Third Intervention C||2
9911752|NCT01195025|11028037|FG004|COMPLETED|Third Intervention C||1
9911753|NCT01195025|11028033|FG000|NOT COMPLETED|Third Intervention C||0
9911754|NCT01195025|11028034|FG001|NOT COMPLETED|Third Intervention C||0
9911755|NCT01195025|11028035|FG002|NOT COMPLETED|Third Intervention C||0
9911756|NCT01195025|11028036|FG003|NOT COMPLETED|Third Intervention C||0
9911757|NCT01195025|11028037|FG004|NOT COMPLETED|Third Intervention C||0
9911758|NCT01195090|11028045|FG000|STARTED|Overall Study||60
9911759|NCT01195090|11028046|FG001|STARTED|Overall Study||60
9911760|NCT01195090|11028045|FG000|COMPLETED|Overall Study||54
9911761|NCT01195090|11028046|FG001|COMPLETED|Overall Study||52
9911762|NCT01195090|11028045|FG000|NOT COMPLETED|Overall Study||6
9911763|NCT01195090|11028046|FG001|NOT COMPLETED|Overall Study||8
9911764|NCT01195103|11028055|FG000|STARTED|Overall Study||6
9911765|NCT01195103|11028056|FG001|STARTED|Overall Study||2
9911766|NCT01195103|11028057|FG002|STARTED|Overall Study||5
9911767|NCT01195103|11028055|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
9911768|NCT01195103|11028056|FG001|COMPLETED|Overall Study||2
9911769|NCT01195103|11028057|FG002|COMPLETED|Overall Study||5
9911770|NCT01195103|11028055|FG000|NOT COMPLETED|Overall Study||1
9911771|NCT01195103|11028056|FG001|NOT COMPLETED|Overall Study||0
9911772|NCT01195103|11028057|FG002|NOT COMPLETED|Overall Study||0
9911773|NCT01195116|11028067|FG000|STARTED|Overall Study||21
9911774|NCT01195116|11028068|FG001|STARTED|Overall Study||20
9911775|NCT01195116|11028067|FG000|COMPLETED|Overall Study||21
9911776|NCT01195116|11028068|FG001|COMPLETED|Overall Study||20
9911777|NCT01195116|11028067|FG000|NOT COMPLETED|Overall Study||0
9911778|NCT01195116|11028068|FG001|NOT COMPLETED|Overall Study||0
9911779|NCT01195272|11028074|FG000|STARTED|Overall Study||21
9911780|NCT01195272|11028074|FG000|COMPLETED|Overall Study||17
9911781|NCT01195272|11028074|FG000|NOT COMPLETED|Overall Study||4
9911782|NCT01195363|11028080|FG000|STARTED|Overall Study||15
9911783|NCT01195363|11028081|FG001|STARTED|Overall Study||13
9911784|NCT01195363|11028080|FG000|COMPLETED|Overall Study||4
9911785|NCT01195363|11028081|FG001|COMPLETED|Overall Study||4
9911786|NCT01195363|11028080|FG000|NOT COMPLETED|Overall Study||11
9911787|NCT01195363|11028081|FG001|NOT COMPLETED|Overall Study||9
9911788|NCT01195415|11028087|FG000|STARTED|Overall Study||25
9911789|NCT01195415|11028087|FG000|COMPLETED|Overall Study||23
9911790|NCT01195415|11028087|FG000|NOT COMPLETED|Overall Study||2
9911791|NCT01195467|11028091|FG000|STARTED|Overall Study||40
9911792|NCT01195467|11028091|FG000|COMPLETED|Overall Study||30
9911793|NCT01195467|11028091|FG000|NOT COMPLETED|Overall Study||10
9911794|NCT01195545|11028095|FG000|STARTED|Overall Study||20
9911795|NCT01195545|11028095|FG000|COMPLETED|Overall Study||16
9911796|NCT01195545|11028095|FG000|NOT COMPLETED|Overall Study||4
9911797|NCT01195584|11028102|FG000|STARTED|Overall Study||20
9911798|NCT01195584|11028103|FG001|STARTED|Overall Study||25
9911799|NCT01195584|11028104|FG002|STARTED|Overall Study||27
9911800|NCT01195584|11028102|FG000|COMPLETED|Overall Study||20
9911801|NCT01195584|11028103|FG001|COMPLETED|Overall Study||25
9911802|NCT01195584|11028104|FG002|COMPLETED|Overall Study||27
9911803|NCT01195584|11028102|FG000|NOT COMPLETED|Overall Study||0
9911804|NCT01195584|11028103|FG001|NOT COMPLETED|Overall Study||0
9911805|NCT01195584|11028104|FG002|NOT COMPLETED|Overall Study||0
9911806|NCT01195597|11028114|FG000|STARTED|Overall Study||40
9911807|NCT01195597|11028114|FG000|COMPLETED|Overall Study||27
9911808|NCT01195597|11028114|FG000|NOT COMPLETED|Overall Study||13
9911809|NCT01195623|11028120|FG000|STARTED|Overall Study|166 legs total operated|148
9911810|NCT01195623|11028121|FG001|STARTED|Overall Study|177 legs total operated|145
9911811|NCT01195623|11028120|FG000|COMPLETED|Overall Study|127 legs|113
9911812|NCT01195623|11028121|FG001|COMPLETED|Overall Study|129 legs|108
9911813|NCT01195623|11028120|FG000|NOT COMPLETED|Overall Study||35
9911814|NCT01195623|11028121|FG001|NOT COMPLETED|Overall Study||37
9911815|NCT01195636|11028129|FG000|STARTED|First Intervention (3 Weeks)||35
9911816|NCT01195636|11028130|FG001|STARTED|First Intervention (3 Weeks)||35
9911817|NCT01195636|11028129|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
9911818|NCT01195636|11028130|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
9911819|NCT01195636|11028129|FG000|COMPLETED|First Intervention (3 Weeks)||30
9911820|NCT01195636|11028130|FG001|COMPLETED|First Intervention (3 Weeks)||32
9911821|NCT01195636|11028129|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5
9911822|NCT01195636|11028130|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3
9911823|NCT01195636|11028129|FG000|STARTED|Washout Period (2 Weeks)||30
9911824|NCT01195636|11028130|FG001|STARTED|Washout Period (2 Weeks)||32
9911825|NCT01195636|11028129|FG000|COMPLETED|Washout Period (2 Weeks)||28
9911826|NCT01195636|11028130|FG001|COMPLETED|Washout Period (2 Weeks)||29
9911827|NCT01195636|11028129|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2
9911828|NCT01195636|11028130|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3
9911829|NCT01195636|11028129|FG000|STARTED|Second Intervention (3 Weeks)||28
9911830|NCT01195636|11028130|FG001|STARTED|Second Intervention (3 Weeks)||29
9911831|NCT01195636|11028129|FG000|COMPLETED|Second Intervention (3 Weeks)||27
9911832|NCT01195636|11028130|FG001|COMPLETED|Second Intervention (3 Weeks)||27
9911833|NCT01195636|11028129|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
9911834|NCT01195636|11028130|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2
9911835|NCT01195662|11028139|FG000|STARTED|Double Blind Treatment Period||224
9911836|NCT01195662|11028140|FG001|STARTED|Double Blind Treatment Period||225
9911837|NCT01195662|11028141|FG002|STARTED|Double Blind Treatment Period||133
9911838|NCT01195662|11028139|FG000|COMPLETED|Double Blind Treatment Period||202
9911839|NCT01195662|11028140|FG001|COMPLETED|Double Blind Treatment Period||211
9911840|NCT01195662|11028141|FG002|COMPLETED|Double Blind Treatment Period||119
9911841|NCT01195662|11028139|FG000|NOT COMPLETED|Double Blind Treatment Period||22
9911842|NCT01195662|11028140|FG001|NOT COMPLETED|Double Blind Treatment Period||14
9911843|NCT01195662|11028141|FG002|NOT COMPLETED|Double Blind Treatment Period||14
9911844|NCT01195662|11028139|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
9911845|NCT01195662|11028140|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
9911846|NCT01195662|11028141|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
9911847|NCT01195662|11028139|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
9911848|NCT01195662|11028140|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
9911849|NCT01195662|11028141|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
9911850|NCT01195662|11028139|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
10009993|NCT01770314|11132686|FG000|Contributed Data to Post-test|Overall Study||65
10009994|NCT01770314|11132687|FG001|Contributed Data to Post-test|Overall Study||67
10009995|NCT01770314|11132686|FG000|Contributed Data to One-month Follow-up|Overall Study||61
10009996|NCT01770314|11132687|FG001|Contributed Data to One-month Follow-up|Overall Study||66
10009997|NCT01770314|11132686|FG000|COMPLETED|Overall Study||86
10009998|NCT01770314|11132687|FG001|COMPLETED|Overall Study||90
10238739|NCT00484718|11370191|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
9911851|NCT01195662|11028140|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
9911852|NCT01195662|11028141|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
9911853|NCT01195675|11028150|FG000|STARTED|Overall Study||30
9911854|NCT01195675|11028150|FG000|Received Empa 25mg|Overall Study||28
9911855|NCT01195675|11028150|FG000|Received Empa 200mg|Overall Study||30
9911856|NCT01195675|11028150|FG000|Received Moxifloxacin|Overall Study||29
9911857|NCT01195675|11028150|FG000|Received Placebo 1|Overall Study||29
9911858|NCT01195675|11028150|FG000|Received Placebo 2|Overall Study||28
9911859|NCT01195675|11028150|FG000|COMPLETED|Overall Study||27
9911860|NCT01195675|11028150|FG000|NOT COMPLETED|Overall Study||3
9911861|NCT01195701|11028167|FG000|STARTED|Overall Study||10
9911862|NCT01195701|11028168|FG001|STARTED|Overall Study||25
9911863|NCT01195701|11028167|FG000|COMPLETED|Overall Study||10
9911864|NCT01195701|11028168|FG001|COMPLETED|Overall Study||20
9911865|NCT01195701|11028167|FG000|NOT COMPLETED|Overall Study||0
9911866|NCT01195701|11028168|FG001|NOT COMPLETED|Overall Study||5
9911867|NCT01195779|11028188|FG000|STARTED|Overall Study||0
9911868|NCT01195779|11028189|FG001|STARTED|Overall Study||0
9911869|NCT01195779|11028190|FG002|STARTED|Overall Study||0
9911870|NCT01195779|11028191|FG003|STARTED|Overall Study||0
9911871|NCT01195779|11028192|FG004|STARTED|Overall Study||1
9911872|NCT01195779|11028193|FG005|STARTED|Overall Study||0
9911873|NCT01195779|11028194|FG006|STARTED|Overall Study||0
9911874|NCT01195779|11028195|FG007|STARTED|Overall Study||1
9911875|NCT01195779|11028196|FG008|STARTED|Overall Study||0
9911876|NCT01195779|11028197|FG009|STARTED|Overall Study||0
9911877|NCT01195779|11028198|FG010|STARTED|Overall Study||0
9911878|NCT01195779|11028199|FG011|STARTED|Overall Study||1
9911879|NCT01195779|11028200|FG012|STARTED|Overall Study||0
9911880|NCT01195779|11028201|FG013|STARTED|Overall Study||1
9911881|NCT01195779|11028188|FG000|COMPLETED|Overall Study||0
9911882|NCT01195779|11028189|FG001|COMPLETED|Overall Study||0
9911883|NCT01195779|11028190|FG002|COMPLETED|Overall Study||0
9911884|NCT01195779|11028191|FG003|COMPLETED|Overall Study||0
9911885|NCT01195779|11028192|FG004|COMPLETED|Overall Study||1
9911886|NCT01195779|11028193|FG005|COMPLETED|Overall Study||0
9911887|NCT01195779|11028194|FG006|COMPLETED|Overall Study||0
9911888|NCT01195779|11028195|FG007|COMPLETED|Overall Study||1
9911889|NCT01195779|11028196|FG008|COMPLETED|Overall Study||0
9911890|NCT01195779|11028197|FG009|COMPLETED|Overall Study||0
9911891|NCT01195779|11028198|FG010|COMPLETED|Overall Study||0
9911892|NCT01195779|11028199|FG011|COMPLETED|Overall Study||1
9911893|NCT01195779|11028200|FG012|COMPLETED|Overall Study||0
9911894|NCT01195779|11028201|FG013|COMPLETED|Overall Study||1
9911895|NCT01195779|11028188|FG000|NOT COMPLETED|Overall Study||0
9911896|NCT01195779|11028189|FG001|NOT COMPLETED|Overall Study||0
9911897|NCT01195779|11028190|FG002|NOT COMPLETED|Overall Study||0
9911898|NCT01195779|11028191|FG003|NOT COMPLETED|Overall Study||0
9911899|NCT01195779|11028192|FG004|NOT COMPLETED|Overall Study||0
9911900|NCT01195779|11028193|FG005|NOT COMPLETED|Overall Study||0
9911901|NCT01195779|11028194|FG006|NOT COMPLETED|Overall Study||0
9911902|NCT01195779|11028195|FG007|NOT COMPLETED|Overall Study||0
9911903|NCT01195779|11028196|FG008|NOT COMPLETED|Overall Study||0
9911904|NCT01195779|11028197|FG009|NOT COMPLETED|Overall Study||0
9911905|NCT01195779|11028198|FG010|NOT COMPLETED|Overall Study||0
9911906|NCT01195779|11028199|FG011|NOT COMPLETED|Overall Study||0
9911907|NCT01195779|11028200|FG012|NOT COMPLETED|Overall Study||0
9911908|NCT01195779|11028201|FG013|NOT COMPLETED|Overall Study||0
9911909|NCT01195831|11028233|FG000|STARTED|Overall Study||120
9911910|NCT01195831|11028234|FG001|STARTED|Overall Study||124
9911911|NCT01195831|11028233|FG000|COMPLETED|Overall Study||112
9911912|NCT01195831|11028234|FG001|COMPLETED|Overall Study||114
9911913|NCT01195831|11028233|FG000|NOT COMPLETED|Overall Study||8
9911914|NCT01195831|11028234|FG001|NOT COMPLETED|Overall Study||10
9911915|NCT01195844|11028240|FG000|STARTED|Overall Study||230
9911916|NCT01195844|11028240|FG000|COMPLETED|Overall Study||190
9911917|NCT01195844|11028240|FG000|NOT COMPLETED|Overall Study||40
9911918|NCT01195883|11028256|FG000|STARTED|Overall Study||553
9911919|NCT01195883|11028257|FG001|STARTED|Overall Study||549
9911920|NCT01195883|11028256|FG000|COMPLETED|Overall Study||534
9911921|NCT01195883|11028257|FG001|COMPLETED|Overall Study||523
9911922|NCT01195883|11028256|FG000|NOT COMPLETED|Overall Study||19
9911923|NCT01195883|11028257|FG001|NOT COMPLETED|Overall Study||26
9911924|NCT01195922|11028263|FG000|STARTED|Overall Study||16
9911925|NCT01195922|11028263|FG000|COMPLETED|Overall Study||16
9911926|NCT01195922|11028263|FG000|NOT COMPLETED|Overall Study||0
9911927|NCT01195948|11028270|FG000|STARTED|Overall Study||10
9911928|NCT01195948|11028271|FG001|STARTED|Overall Study||10
9911929|NCT01195948|11028272|FG002|STARTED|Overall Study||11
9911930|NCT01195948|11028270|FG000|Week 24|Overall Study||10
9911931|NCT01195948|11028271|FG001|Week 24|Overall Study||10
9911932|NCT01195948|11028272|FG002|Week 24|Overall Study||10
9911933|NCT01195948|11028270|FG000|COMPLETED|Overall Study||10
9911934|NCT01195948|11028271|FG001|COMPLETED|Overall Study||9
9911935|NCT01195948|11028272|FG002|COMPLETED|Overall Study||9
9911936|NCT01195948|11028270|FG000|NOT COMPLETED|Overall Study||0
9911937|NCT01195948|11028271|FG001|NOT COMPLETED|Overall Study||1
9911938|NCT01195948|11028272|FG002|NOT COMPLETED|Overall Study||2
9911939|NCT01196026|11028289|FG000|STARTED|Overall Study||10
9911940|NCT01196026|11028290|FG001|STARTED|Overall Study||44
9911941|NCT01196026|11028291|FG002|STARTED|Overall Study||23
9911942|NCT01196026|11028292|FG003|STARTED|Overall Study||10
9911943|NCT01196026|11028293|FG004|STARTED|Overall Study||43
9911944|NCT01196026|11028294|FG005|STARTED|Overall Study||24
9911945|NCT01196026|11028289|FG000|Completed at Day 28|Overall Study||9
9911946|NCT01196026|11028290|FG001|Completed at Day 28|Overall Study||41
9911947|NCT01196026|11028291|FG002|Completed at Day 28|Overall Study||23
9911948|NCT01196026|11028292|FG003|Completed at Day 28|Overall Study||10
9911949|NCT01196026|11028293|FG004|Completed at Day 28|Overall Study||42
9911950|NCT01196026|11028294|FG005|Completed at Day 28|Overall Study||24
9911951|NCT01196026|11028289|FG000|COMPLETED|Overall Study||9
9911952|NCT01196026|11028290|FG001|COMPLETED|Overall Study||36
9911953|NCT01196026|11028291|FG002|COMPLETED|Overall Study||23
9911954|NCT01196026|11028292|FG003|COMPLETED|Overall Study||10
9911955|NCT01196026|11028293|FG004|COMPLETED|Overall Study||42
9911956|NCT01196026|11028294|FG005|COMPLETED|Overall Study||24
9911957|NCT01196026|11028289|FG000|NOT COMPLETED|Overall Study||1
9911958|NCT01196026|11028290|FG001|NOT COMPLETED|Overall Study||8
9911959|NCT01196026|11028291|FG002|NOT COMPLETED|Overall Study||0
9911960|NCT01196026|11028292|FG003|NOT COMPLETED|Overall Study||0
9911961|NCT01196026|11028293|FG004|NOT COMPLETED|Overall Study||1
9911962|NCT01196026|11028294|FG005|NOT COMPLETED|Overall Study||0
9911963|NCT01196052|11028310|FG000|STARTED|Overall Study||153
9911964|NCT01196052|11028310|FG000|Received Trastuzumab Emtansine|Overall Study||148
9911965|NCT01196052|11028310|FG000|COMPLETED|Overall Study||130
9911966|NCT01196052|11028310|FG000|NOT COMPLETED|Overall Study||23
9911967|NCT01196078|11028316|FG000|STARTED|Overall Study||57
9911968|NCT01196078|11028317|FG001|STARTED|Overall Study||57
9911969|NCT01196078|11028316|FG000|COMPLETED|Overall Study||24
9911970|NCT01196078|11028317|FG001|COMPLETED|Overall Study||20
9911971|NCT01196078|11028316|FG000|NOT COMPLETED|Overall Study||33
9911972|NCT01196078|11028317|FG001|NOT COMPLETED|Overall Study||37
9911973|NCT01196091|11028326|FG000|STARTED|Overall Study||387
9911974|NCT01196091|11028327|FG001|STARTED|Overall Study||389
9911975|NCT01196091|11028328|FG002|STARTED|Overall Study||388
9911976|NCT01196091|11028326|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386
9911977|NCT01196091|11028327|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389
9911978|NCT01196091|11028328|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387
9911979|NCT01196091|11028326|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381
9911980|NCT01196091|11028327|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378
9911981|NCT01196091|11028328|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379
9911982|NCT01196091|11028326|FG000|Follow-Up|Overall Study||103
9911983|NCT01196091|11028327|FG001|Follow-Up|Overall Study||105
9911984|NCT01196091|11028328|FG002|Follow-Up|Overall Study||128
9911985|NCT01196091|11028326|FG000|COMPLETED|Overall Study||299
9911986|NCT01196091|11028327|FG001|COMPLETED|Overall Study||291
9911987|NCT01196091|11028328|FG002|COMPLETED|Overall Study||284
9911988|NCT01196091|11028326|FG000|NOT COMPLETED|Overall Study||88
9911989|NCT01196091|11028327|FG001|NOT COMPLETED|Overall Study||98
9911990|NCT01196091|11028328|FG002|NOT COMPLETED|Overall Study||104
9911991|NCT01196104|11028343|FG000|STARTED|Overall Study||19
9911992|NCT01196104|11028344|FG001|STARTED|Overall Study||20
9911993|NCT01196104|11028343|FG000|COMPLETED|Overall Study||15
9911994|NCT01196104|11028344|FG001|COMPLETED|Overall Study||15
9911995|NCT01196104|11028343|FG000|NOT COMPLETED|Overall Study||4
9911996|NCT01196104|11028344|FG001|NOT COMPLETED|Overall Study||5
9911997|NCT01196117|11028352|FG000|STARTED|Placebo, Then CPAP||18
9911998|NCT01196117|11028353|FG001|STARTED|Placebo, Then CPAP||0
9911999|NCT01196117|11028352|FG000|COMPLETED|Placebo, Then CPAP||18
9912000|NCT01196117|11028353|FG001|COMPLETED|Placebo, Then CPAP||0
9912001|NCT01196117|11028352|FG000|NOT COMPLETED|Placebo, Then CPAP||0
9912002|NCT01196117|11028353|FG001|NOT COMPLETED|Placebo, Then CPAP||0
9912003|NCT01196117|11028352|FG000|STARTED|CPAP||0
9912004|NCT01196117|11028353|FG001|STARTED|CPAP||18
9912005|NCT01196117|11028352|FG000|COMPLETED|CPAP||0
9912006|NCT01196117|11028353|FG001|COMPLETED|CPAP||18
9912007|NCT01196117|11028352|FG000|NOT COMPLETED|CPAP||0
9912008|NCT01196117|11028353|FG001|NOT COMPLETED|CPAP||0
9912009|NCT01196377|11028367|FG000|STARTED|Overall Study||4
9912010|NCT01196377|11028368|FG001|STARTED|Overall Study||4
9912011|NCT01196377|11028369|FG002|STARTED|Overall Study||4
9912012|NCT01196377|11028370|FG003|STARTED|Overall Study||4
9912013|NCT01196377|11028367|FG000|COMPLETED|Overall Study||4
9912014|NCT01196377|11028368|FG001|COMPLETED|Overall Study||4
9912015|NCT01196377|11028369|FG002|COMPLETED|Overall Study||4
9912016|NCT01196377|11028370|FG003|COMPLETED|Overall Study||4
9912017|NCT01196377|11028367|FG000|NOT COMPLETED|Overall Study||0
9912018|NCT01196377|11028368|FG001|NOT COMPLETED|Overall Study||0
9912019|NCT01196377|11028369|FG002|NOT COMPLETED|Overall Study||0
9912020|NCT01196377|11028370|FG003|NOT COMPLETED|Overall Study||0
9912021|NCT01196416|11028380|FG000|STARTED|Overall Study||14
9912022|NCT01196416|11028380|FG000|COMPLETED|Overall Study||12
9912023|NCT01196416|11028380|FG000|NOT COMPLETED|Overall Study||2
9912024|NCT01196429|11028386|FG000|STARTED|Overall Study||45
9912025|NCT01196429|11028387|FG001|STARTED|Overall Study||45
9912026|NCT01196429|11028386|FG000|COMPLETED|Overall Study||42
9912027|NCT01196429|11028387|FG001|COMPLETED|Overall Study||45
9912028|NCT01196429|11028386|FG000|NOT COMPLETED|Overall Study||3
9912029|NCT01196429|11028387|FG001|NOT COMPLETED|Overall Study||0
9912030|NCT01196442|11028395|FG000|STARTED|Overall Study||39
9912031|NCT01196442|11028395|FG000|COMPLETED|Overall Study||39
9912032|NCT01196442|11028395|FG000|NOT COMPLETED|Overall Study||0
9912033|NCT01196533|11028400|FG000|STARTED|Overall Study||94
9912034|NCT01196533|11028400|FG000|COMPLETED|Overall Study||94
9912035|NCT01196533|11028400|FG000|NOT COMPLETED|Overall Study||0
9912036|NCT01196741|11028406|FG000|STARTED|Overall Study||71
9912037|NCT01196741|11028407|FG001|STARTED|Overall Study||36
9912038|NCT01196741|11028406|FG000|COMPLETED|Overall Study||11
9912039|NCT01196741|11028407|FG001|COMPLETED|Overall Study||8
9912040|NCT01196741|11028406|FG000|NOT COMPLETED|Overall Study||60
9912041|NCT01196741|11028407|FG001|NOT COMPLETED|Overall Study||28
9912042|NCT01196793|11028413|FG000|STARTED|Overall Study||108
9912043|NCT01196793|11028413|FG000|COMPLETED|Overall Study||108
9912044|NCT01196793|11028413|FG000|NOT COMPLETED|Overall Study||0
9912045|NCT01196819|11028419|FG000|STARTED|Overall Study||231
9912046|NCT01196819|11028420|FG001|STARTED|Overall Study||227
9912047|NCT01196819|11028419|FG000|COMPLETED|Overall Study||225
9912048|NCT01196819|11028420|FG001|COMPLETED|Overall Study||227
9912049|NCT01196819|11028419|FG000|NOT COMPLETED|Overall Study||6
9912050|NCT01196819|11028420|FG001|NOT COMPLETED|Overall Study||0
9912051|NCT01196871|11028432|FG000|STARTED|Stage 1: Period 1||5
9912052|NCT01196871|11028433|FG001|STARTED|Stage 1: Period 1||3
9912053|NCT01196871|11028434|FG002|STARTED|Stage 1: Period 1||4
9912054|NCT01196871|11028435|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
9912055|NCT01196871|11028436|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
9912056|NCT01196871|11028437|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
9912057|NCT01196871|11028432|FG000|PK Population|Stage 1: Period 1||5
9912058|NCT01196871|11028433|FG001|PK Population|Stage 1: Period 1||3
9912059|NCT01196871|11028434|FG002|PK Population|Stage 1: Period 1||4
9912060|NCT01196871|11028435|FG003|PK Population|Stage 1: Period 1||0
9912061|NCT01196871|11028436|FG004|PK Population|Stage 1: Period 1||0
9912062|NCT01196871|11028437|FG005|PK Population|Stage 1: Period 1||0
9912063|NCT01196871|11028432|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
9912064|NCT01196871|11028433|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
9912065|NCT01196871|11028434|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
9912066|NCT01196871|11028435|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
9912067|NCT01196871|11028436|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
9912068|NCT01196871|11028437|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
9912069|NCT01196871|11028432|FG000|COMPLETED|Stage 1: Period 1||5
9912070|NCT01196871|11028433|FG001|COMPLETED|Stage 1: Period 1||3
9912071|NCT01196871|11028434|FG002|COMPLETED|Stage 1: Period 1||4
9912072|NCT01196871|11028435|FG003|COMPLETED|Stage 1: Period 1||0
9912073|NCT01196871|11028436|FG004|COMPLETED|Stage 1: Period 1||0
9912074|NCT01196871|11028437|FG005|COMPLETED|Stage 1: Period 1||0
9912075|NCT01196871|11028432|FG000|NOT COMPLETED|Stage 1: Period 1||0
9912076|NCT01196871|11028433|FG001|NOT COMPLETED|Stage 1: Period 1||0
9912077|NCT01196871|11028434|FG002|NOT COMPLETED|Stage 1: Period 1||0
9912078|NCT01196871|11028435|FG003|NOT COMPLETED|Stage 1: Period 1||0
9912079|NCT01196871|11028436|FG004|NOT COMPLETED|Stage 1: Period 1||0
9912080|NCT01196871|11028437|FG005|NOT COMPLETED|Stage 1: Period 1||0
9912081|NCT01196871|11028432|FG000|STARTED|Stage 1: Period 2||5
9912082|NCT01196871|11028433|FG001|STARTED|Stage 1: Period 2||3
9912083|NCT01196871|11028434|FG002|STARTED|Stage 1: Period 2||4
9912084|NCT01196871|11028435|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
9912085|NCT01196871|11028436|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
9912086|NCT01196871|11028437|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
9912087|NCT01196871|11028432|FG000|PK Population|Stage 1: Period 2||5
9912088|NCT01196871|11028433|FG001|PK Population|Stage 1: Period 2||3
9912089|NCT01196871|11028434|FG002|PK Population|Stage 1: Period 2||4
9912090|NCT01196871|11028435|FG003|PK Population|Stage 1: Period 2||0
9912091|NCT01196871|11028436|FG004|PK Population|Stage 1: Period 2||0
9912092|NCT01196871|11028437|FG005|PK Population|Stage 1: Period 2||0
9912093|NCT01196871|11028432|FG000|COMPLETED|Stage 1: Period 2||5
9912094|NCT01196871|11028433|FG001|COMPLETED|Stage 1: Period 2||3
9912095|NCT01196871|11028434|FG002|COMPLETED|Stage 1: Period 2||4
9912096|NCT01196871|11028435|FG003|COMPLETED|Stage 1: Period 2||0
9912097|NCT01196871|11028436|FG004|COMPLETED|Stage 1: Period 2||0
9912098|NCT01196871|11028437|FG005|COMPLETED|Stage 1: Period 2||0
9912099|NCT01196871|11028432|FG000|NOT COMPLETED|Stage 1: Period 2||0
9912100|NCT01196871|11028433|FG001|NOT COMPLETED|Stage 1: Period 2||0
9912101|NCT01196871|11028434|FG002|NOT COMPLETED|Stage 1: Period 2||0
9912102|NCT01196871|11028435|FG003|NOT COMPLETED|Stage 1: Period 2||0
9912103|NCT01196871|11028436|FG004|NOT COMPLETED|Stage 1: Period 2||0
9912104|NCT01196871|11028437|FG005|NOT COMPLETED|Stage 1: Period 2||0
9912105|NCT01196871|11028432|FG000|STARTED|Stage 1: Period 3||5
9912106|NCT01196871|11028433|FG001|STARTED|Stage 1: Period 3||3
9912107|NCT01196871|11028434|FG002|STARTED|Stage 1: Period 3||4
9912108|NCT01196871|11028435|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
9912109|NCT01196871|11028436|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
9912110|NCT01196871|11028437|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
9912111|NCT01196871|11028432|FG000|COMPLETED|Stage 1: Period 3||5
9912112|NCT01196871|11028433|FG001|COMPLETED|Stage 1: Period 3||3
9912113|NCT01196871|11028434|FG002|COMPLETED|Stage 1: Period 3||4
9912114|NCT01196871|11028435|FG003|COMPLETED|Stage 1: Period 3||0
9912115|NCT01196871|11028436|FG004|COMPLETED|Stage 1: Period 3||0
9912116|NCT01196871|11028437|FG005|COMPLETED|Stage 1: Period 3||0
9912117|NCT01196871|11028432|FG000|NOT COMPLETED|Stage 1: Period 3||0
9912118|NCT01196871|11028433|FG001|NOT COMPLETED|Stage 1: Period 3||0
9912119|NCT01196871|11028434|FG002|NOT COMPLETED|Stage 1: Period 3||0
9912120|NCT01196871|11028435|FG003|NOT COMPLETED|Stage 1: Period 3||0
9912121|NCT01196871|11028436|FG004|NOT COMPLETED|Stage 1: Period 3||0
9912122|NCT01196871|11028437|FG005|NOT COMPLETED|Stage 1: Period 3||0
9912123|NCT01196871|11028432|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
9912124|NCT01196871|11028433|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
9912125|NCT01196871|11028434|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
9912126|NCT01196871|11028435|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
9912127|NCT01196871|11028436|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
9912128|NCT01196871|11028437|FG005|STARTED|Stage 2: Period 1||4
9912129|NCT01196871|11028432|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
9912130|NCT01196871|11028433|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
9912131|NCT01196871|11028434|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
9912132|NCT01196871|11028435|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
9912133|NCT01196871|11028436|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
9912134|NCT01196871|11028437|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
9912135|NCT01196871|11028432|FG000|PK Population|Stage 2: Period 1||0
9912136|NCT01196871|11028433|FG001|PK Population|Stage 2: Period 1||0
9912137|NCT01196871|11028434|FG002|PK Population|Stage 2: Period 1||0
9912138|NCT01196871|11028435|FG003|PK Population|Stage 2: Period 1||1
9912139|NCT01196871|11028436|FG004|PK Population|Stage 2: Period 1||5
9912140|NCT01196871|11028437|FG005|PK Population|Stage 2: Period 1||4
9912141|NCT01196871|11028432|FG000|COMPLETED|Stage 2: Period 1||0
9912142|NCT01196871|11028433|FG001|COMPLETED|Stage 2: Period 1||0
9912143|NCT01196871|11028434|FG002|COMPLETED|Stage 2: Period 1||0
9912144|NCT01196871|11028435|FG003|COMPLETED|Stage 2: Period 1||2
9912145|NCT01196871|11028436|FG004|COMPLETED|Stage 2: Period 1||5
9912146|NCT01196871|11028437|FG005|COMPLETED|Stage 2: Period 1||4
9912147|NCT01196871|11028432|FG000|NOT COMPLETED|Stage 2: Period 1||0
9912148|NCT01196871|11028433|FG001|NOT COMPLETED|Stage 2: Period 1||0
9912149|NCT01196871|11028434|FG002|NOT COMPLETED|Stage 2: Period 1||0
9912150|NCT01196871|11028435|FG003|NOT COMPLETED|Stage 2: Period 1||0
9912151|NCT01196871|11028436|FG004|NOT COMPLETED|Stage 2: Period 1||0
9912152|NCT01196871|11028437|FG005|NOT COMPLETED|Stage 2: Period 1||0
9912153|NCT01196871|11028432|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
9912154|NCT01196871|11028433|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
9912155|NCT01196871|11028434|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
9912156|NCT01196871|11028435|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
9912157|NCT01196871|11028436|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
9912158|NCT01196871|11028437|FG005|STARTED|Stage 2: Period 2||4
9912159|NCT01196871|11028432|FG000|PK Population|Stage 2: Period 2||0
9912160|NCT01196871|11028433|FG001|PK Population|Stage 2: Period 2||0
9912161|NCT01196871|11028434|FG002|PK Population|Stage 2: Period 2||0
9912162|NCT01196871|11028435|FG003|PK Population|Stage 2: Period 2||1
9912163|NCT01196871|11028436|FG004|PK Population|Stage 2: Period 2||6
9912164|NCT01196871|11028437|FG005|PK Population|Stage 2: Period 2||4
9912165|NCT01196871|11028432|FG000|COMPLETED|Stage 2: Period 2||0
9912166|NCT01196871|11028433|FG001|COMPLETED|Stage 2: Period 2||0
9912167|NCT01196871|11028434|FG002|COMPLETED|Stage 2: Period 2||0
9912168|NCT01196871|11028435|FG003|COMPLETED|Stage 2: Period 2||1
10009999|NCT01770314|11132686|FG000|NOT COMPLETED|Overall Study||0
10010000|NCT01770314|11132687|FG001|NOT COMPLETED|Overall Study||0
10010001|NCT01770353|11132695|FG000|STARTED|Overall Study||15
10010002|NCT01770353|11132696|FG001|STARTED|Overall Study||30
10010003|NCT01770353|11132695|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
10010004|NCT01770353|11132696|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
10010005|NCT01770353|11132695|FG000|Received FMX and MM-398|Overall Study||13
10010006|NCT01770353|11132696|FG001|Received FMX and MM-398|Overall Study||29
10010007|NCT01770353|11132695|FG000|COMPLETED|Overall Study||9
10010008|NCT01770353|11132696|FG001|COMPLETED|Overall Study||18
10010009|NCT01770353|11132695|FG000|NOT COMPLETED|Overall Study||6
10010010|NCT01770353|11132696|FG001|NOT COMPLETED|Overall Study||12
10010011|NCT01770366|11132712|FG000|STARTED|Overall Study||4
10010012|NCT01770366|11132713|FG001|STARTED|Overall Study||6
9912169|NCT01196871|11028436|FG004|COMPLETED|Stage 2: Period 2||6
9912170|NCT01196871|11028437|FG005|COMPLETED|Stage 2: Period 2||4
9912171|NCT01196871|11028432|FG000|NOT COMPLETED|Stage 2: Period 2||0
9912172|NCT01196871|11028433|FG001|NOT COMPLETED|Stage 2: Period 2||0
9912173|NCT01196871|11028434|FG002|NOT COMPLETED|Stage 2: Period 2||0
9912174|NCT01196871|11028435|FG003|NOT COMPLETED|Stage 2: Period 2||0
9912175|NCT01196871|11028436|FG004|NOT COMPLETED|Stage 2: Period 2||0
9912176|NCT01196871|11028437|FG005|NOT COMPLETED|Stage 2: Period 2||0
9912177|NCT01196923|11028460|FG000|STARTED|Overall Study||20
9912178|NCT01196923|11028460|FG000|COMPLETED|Overall Study||20
9912179|NCT01196923|11028460|FG000|NOT COMPLETED|Overall Study||0
9912180|NCT01196975|11028469|FG000|STARTED|Overall Study||423
9912181|NCT01196975|11028470|FG001|STARTED|Overall Study||424
9912182|NCT01196975|11028471|FG002|STARTED|Overall Study||425
9912183|NCT01196975|11028472|FG003|STARTED|Overall Study||213
9912184|NCT01196975|11028473|FG004|STARTED|Overall Study||218
9912185|NCT01196975|11028469|FG000|COMPLETED|Overall Study||408
9912186|NCT01196975|11028470|FG001|COMPLETED|Overall Study||415
9912187|NCT01196975|11028471|FG002|COMPLETED|Overall Study||420
10010013|NCT01770366|11132712|FG000|COMPLETED|Overall Study||2
10010014|NCT01770366|11132713|FG001|COMPLETED|Overall Study||4
9912188|NCT01196975|11028472|FG003|COMPLETED|Overall Study||207
9912189|NCT01196975|11028473|FG004|COMPLETED|Overall Study||205
9912190|NCT01196975|11028469|FG000|NOT COMPLETED|Overall Study||15
9912191|NCT01196975|11028470|FG001|NOT COMPLETED|Overall Study||9
9912192|NCT01196975|11028471|FG002|NOT COMPLETED|Overall Study||5
9912193|NCT01196975|11028472|FG003|NOT COMPLETED|Overall Study||6
9912194|NCT01196975|11028473|FG004|NOT COMPLETED|Overall Study||13
9912195|NCT01196988|11028512|FG000|STARTED|Overall Study||915
10010015|NCT01770366|11132712|FG000|NOT COMPLETED|Overall Study||2
10010016|NCT01770366|11132713|FG001|NOT COMPLETED|Overall Study||2
10010017|NCT01770379|11132722|FG000|STARTED|Overall Study||80
10010018|NCT01770379|11132723|FG001|STARTED|Overall Study||81
9912196|NCT01196988|11028513|FG001|STARTED|Overall Study||912
9912197|NCT01196988|11028514|FG002|STARTED|Overall Study||911
9912198|NCT01196988|11028515|FG003|STARTED|Overall Study||277
9912199|NCT01196988|11028512|FG000|COMPLETED|Overall Study||891
9912200|NCT01196988|11028513|FG001|COMPLETED|Overall Study||880
9912201|NCT01196988|11028514|FG002|COMPLETED|Overall Study||886
9912202|NCT01196988|11028515|FG003|COMPLETED|Overall Study||276
9912203|NCT01196988|11028512|FG000|NOT COMPLETED|Overall Study||24
9912204|NCT01196988|11028513|FG001|NOT COMPLETED|Overall Study||32
9912205|NCT01196988|11028514|FG002|NOT COMPLETED|Overall Study||25
9912206|NCT01196988|11028515|FG003|NOT COMPLETED|Overall Study||1
9912207|NCT01197300|11028528|FG000|STARTED|Overall Study||10
9912208|NCT01197300|11028529|FG001|STARTED|Overall Study||15
9912209|NCT01197300|11028528|FG000|COMPLETED|Overall Study||10
9912210|NCT01197300|11028529|FG001|COMPLETED|Overall Study||13
9912211|NCT01197300|11028528|FG000|NOT COMPLETED|Overall Study||0
9912212|NCT01197300|11028529|FG001|NOT COMPLETED|Overall Study||2
9912213|NCT01197326|11028537|FG000|STARTED|Overall Study||205
9912214|NCT01197326|11028538|FG001|STARTED|Overall Study||209
9912215|NCT01197326|11028537|FG000|COMPLETED|Overall Study||205
9912216|NCT01197326|11028538|FG001|COMPLETED|Overall Study||209
9912217|NCT01197326|11028537|FG000|NOT COMPLETED|Overall Study||0
9912218|NCT01197326|11028538|FG001|NOT COMPLETED|Overall Study||0
9912219|NCT01197378|11028546|FG000|STARTED|Overall Study||60
9912220|NCT01197378|11028546|FG000|Received Treatment|Overall Study||59
9912221|NCT01197378|11028546|FG000|COMPLETED|Overall Study||53
9912222|NCT01197378|11028546|FG000|NOT COMPLETED|Overall Study||7
9912223|NCT01197417|11028552|FG000|STARTED|Overall Study||104
9912224|NCT01197417|11028553|FG001|STARTED|Overall Study||104
9912225|NCT01197417|11028552|FG000|Received Study Drug|Overall Study||101
9912226|NCT01197417|11028553|FG001|Received Study Drug|Overall Study||103
9912227|NCT01197417|11028552|FG000|COMPLETED|Overall Study||96
9912228|NCT01197417|11028553|FG001|COMPLETED|Overall Study||86
9912229|NCT01197417|11028552|FG000|NOT COMPLETED|Overall Study||8
9912230|NCT01197417|11028553|FG001|NOT COMPLETED|Overall Study||18
9912231|NCT01197456|11028561|FG000|STARTED|Overall Study||171
9912232|NCT01197456|11028562|FG001|STARTED|Overall Study||61
9912233|NCT01197456|11028561|FG000|COMPLETED|Overall Study||171
9912234|NCT01197456|11028562|FG001|COMPLETED|Overall Study||61
9912235|NCT01197456|11028561|FG000|NOT COMPLETED|Overall Study||0
9912236|NCT01197456|11028562|FG001|NOT COMPLETED|Overall Study||0
9912237|NCT01197495|11028570|FG000|STARTED|Overall Study||157
9912238|NCT01197495|11028571|FG001|STARTED|Overall Study||56
9912239|NCT01197495|11028570|FG000|COMPLETED|Overall Study||144
9912240|NCT01197495|11028571|FG001|COMPLETED|Overall Study||49
9912241|NCT01197495|11028570|FG000|NOT COMPLETED|Overall Study||13
9912242|NCT01197495|11028571|FG001|NOT COMPLETED|Overall Study||7
9912243|NCT01197508|11028581|FG000|STARTED|Overall Study||174
9912244|NCT01197508|11028582|FG001|STARTED|Overall Study||174
9912245|NCT01197508|11028583|FG002|STARTED|Overall Study||174
9912246|NCT01197508|11028584|FG003|STARTED|Overall Study||174
9912247|NCT01197508|11028581|FG000|Received Treatment|Overall Study||174
9912248|NCT01197508|11028582|FG001|Received Treatment|Overall Study||174
9912249|NCT01197508|11028583|FG002|Received Treatment|Overall Study||171
9912250|NCT01197508|11028584|FG003|Received Treatment|Overall Study||174
9912251|NCT01197508|11028581|FG000|COMPLETED|Overall Study||151
9912252|NCT01197508|11028582|FG001|COMPLETED|Overall Study||144
9912253|NCT01197508|11028583|FG002|COMPLETED|Overall Study||125
9912254|NCT01197508|11028584|FG003|COMPLETED|Overall Study||158
9912255|NCT01197508|11028581|FG000|NOT COMPLETED|Overall Study||23
9912256|NCT01197508|11028582|FG001|NOT COMPLETED|Overall Study||30
9912257|NCT01197508|11028583|FG002|NOT COMPLETED|Overall Study||49
9912258|NCT01197508|11028584|FG003|NOT COMPLETED|Overall Study||16
9912259|NCT01197521|11028597|FG000|STARTED|Overall Study|Patients who received treatment|310
9912260|NCT01197521|11028598|FG001|STARTED|Overall Study|Patients who received treatment|304
9912261|NCT01197521|11028599|FG002|STARTED|Overall Study|Patients who received treatment|304
9912262|NCT01197521|11028597|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
9912263|NCT01197521|11028598|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
9912264|NCT01197521|11028599|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
10010019|NCT01770379|11132724|FG002|STARTED|Overall Study||81
9912265|NCT01197521|11028597|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
9912266|NCT01197521|11028598|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
9912267|NCT01197521|11028599|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
9912268|NCT01197521|11028597|FG000|NOT COMPLETED|Overall Study||103
9912269|NCT01197521|11028598|FG001|NOT COMPLETED|Overall Study||113
9912270|NCT01197521|11028599|FG002|NOT COMPLETED|Overall Study||143
9912271|NCT01197534|11028613|FG000|STARTED|Overall Study|Patients who received treatment|308
9912272|NCT01197534|11028614|FG001|STARTED|Overall Study|Patients who received treatment|298
9912273|NCT01197534|11028615|FG002|STARTED|Overall Study|Patients who received treatment|302
9912274|NCT01197534|11028613|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
9912275|NCT01197534|11028614|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
9912276|NCT01197534|11028615|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
9912277|NCT01197534|11028613|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
9912278|NCT01197534|11028614|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
9912279|NCT01197534|11028615|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
9912280|NCT01197534|11028613|FG000|NOT COMPLETED|Overall Study||134
9912281|NCT01197534|11028614|FG001|NOT COMPLETED|Overall Study||130
9912282|NCT01197534|11028615|FG002|NOT COMPLETED|Overall Study||173
9912283|NCT01197547|11028626|FG000|STARTED|Overall Study||1014
9912284|NCT01197547|11028626|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
9912285|NCT01197547|11028626|FG000|NOT COMPLETED|Overall Study||22
9912286|NCT01197560|11028632|FG000|STARTED|Overall Study|This is the intent to treat population|54
9912287|NCT01197560|11028633|FG001|STARTED|Overall Study|This is the intent to treat population|57
9912288|NCT01197560|11028632|FG000|Received ≥ One Dose Study Drug|Overall Study||54
9912289|NCT01197560|11028633|FG001|Received ≥ One Dose Study Drug|Overall Study||55
9912290|NCT01197560|11028632|FG000|Lenalidomide Crossover|Overall Study||0
9912291|NCT01197560|11028633|FG001|Lenalidomide Crossover|Overall Study||29
9912292|NCT01197560|11028632|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
9912293|NCT01197560|11028633|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
9912294|NCT01197560|11028632|FG000|COMPLETED|Overall Study||0
9912295|NCT01197560|11028633|FG001|COMPLETED|Overall Study||4
9912296|NCT01197560|11028632|FG000|NOT COMPLETED|Overall Study||54
9912297|NCT01197560|11028633|FG001|NOT COMPLETED|Overall Study||53
9912298|NCT01197573|11028644|FG000|STARTED|Overall Study||33
9912299|NCT01197573|11028645|FG001|STARTED|Overall Study||46
9912300|NCT01197573|11028646|FG002|STARTED|Overall Study||12
9912301|NCT01197573|11028647|FG003|STARTED|Overall Study||12
9912302|NCT01197573|11028644|FG000|COMPLETED|Overall Study||33
9912303|NCT01197573|11028645|FG001|COMPLETED|Overall Study||46
9912304|NCT01197573|11028646|FG002|COMPLETED|Overall Study||12
9912305|NCT01197573|11028647|FG003|COMPLETED|Overall Study||12
9912306|NCT01197573|11028644|FG000|NOT COMPLETED|Overall Study||0
9912307|NCT01197573|11028645|FG001|NOT COMPLETED|Overall Study||0
9912308|NCT01197573|11028646|FG002|NOT COMPLETED|Overall Study||0
9912309|NCT01197573|11028647|FG003|NOT COMPLETED|Overall Study||0
9912310|NCT01197612|11028657|FG000|STARTED|Overall Study||18
9912311|NCT01197612|11028657|FG000|Week 3|Overall Study||16
9912312|NCT01197612|11028657|FG000|Returned for Week 24|Overall Study||6
9912313|NCT01197612|11028657|FG000|COMPLETED|Overall Study||6
9912314|NCT01197612|11028657|FG000|NOT COMPLETED|Overall Study||12
9912315|NCT01197755|11028667|FG000|STARTED|Overall Study|Patients who received treatment|105
9912316|NCT01197755|11028668|FG001|STARTED|Overall Study|Patients who received treatment|108
9912317|NCT01197755|11028669|FG002|STARTED|Overall Study|Patients who received treatment|109
9912318|NCT01197755|11028667|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
9912319|NCT01197755|11028668|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
9912320|NCT01197755|11028669|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
9912321|NCT01197755|11028667|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
9912322|NCT01197755|11028668|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
9912323|NCT01197755|11028669|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
9912324|NCT01197755|11028667|FG000|NOT COMPLETED|Overall Study||38
9912325|NCT01197755|11028668|FG001|NOT COMPLETED|Overall Study||43
9912326|NCT01197755|11028669|FG002|NOT COMPLETED|Overall Study||54
9912327|NCT01197794|11028686|FG000|STARTED|Overall Study||164
9912328|NCT01197794|11028687|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161
9912329|NCT01197794|11028688|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166
9912330|NCT01197794|11028689|FG003|STARTED|Overall Study||164
9912331|NCT01197794|11028690|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
9912332|NCT01197794|11028691|FG005|STARTED|Overall Study||163
9912333|NCT01197794|11028692|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
9912334|NCT01197794|11028686|FG000|COMPLETED|Overall Study||148
9912335|NCT01197794|11028687|FG001|COMPLETED|Overall Study||146
9912336|NCT01197794|11028688|FG002|COMPLETED|Overall Study||153
9912337|NCT01197794|11028689|FG003|COMPLETED|Overall Study||152
9912338|NCT01197794|11028690|FG004|COMPLETED|Overall Study||149
9912339|NCT01197794|11028691|FG005|COMPLETED|Overall Study||144
9912340|NCT01197794|11028692|FG006|COMPLETED|Overall Study||142
9912341|NCT01197794|11028686|FG000|NOT COMPLETED|Overall Study||16
9912342|NCT01197794|11028687|FG001|NOT COMPLETED|Overall Study||15
9912343|NCT01197794|11028688|FG002|NOT COMPLETED|Overall Study||13
9912344|NCT01197794|11028689|FG003|NOT COMPLETED|Overall Study||12
9912345|NCT01197794|11028690|FG004|NOT COMPLETED|Overall Study||14
9912346|NCT01197794|11028691|FG005|NOT COMPLETED|Overall Study||19
9912347|NCT01197794|11028692|FG006|NOT COMPLETED|Overall Study||21
9912348|NCT01197833|11028712|FG000|STARTED|Overall Study||38
9912349|NCT01197833|11028713|FG001|STARTED|Overall Study||39
9912350|NCT01197833|11028714|FG002|STARTED|Overall Study||40
9912351|NCT01197833|11028712|FG000|COMPLETED|Overall Study||38
9912352|NCT01197833|11028713|FG001|COMPLETED|Overall Study||39
9912353|NCT01197833|11028714|FG002|COMPLETED|Overall Study||40
9912354|NCT01197833|11028712|FG000|NOT COMPLETED|Overall Study||0
9912355|NCT01197833|11028713|FG001|NOT COMPLETED|Overall Study||0
9912356|NCT01197833|11028714|FG002|NOT COMPLETED|Overall Study||0
9912357|NCT01197898|11028724|FG000|STARTED|Overall Study||5
10010020|NCT01770379|11132722|FG000|COMPLETED|Overall Study||41
10010021|NCT01770379|11132723|FG001|COMPLETED|Overall Study||37
10010022|NCT01770379|11132724|FG002|COMPLETED|Overall Study||39
10010023|NCT01770379|11132722|FG000|NOT COMPLETED|Overall Study||39
9912358|NCT01197898|11028725|FG001|STARTED|Overall Study||5
9912359|NCT01197898|11028724|FG000|COMPLETED|Overall Study||5
9912360|NCT01197898|11028725|FG001|COMPLETED|Overall Study||5
9912361|NCT01197898|11028724|FG000|NOT COMPLETED|Overall Study||0
9912362|NCT01197898|11028725|FG001|NOT COMPLETED|Overall Study||0
9912363|NCT01197911|11028734|FG000|STARTED|Overall Study||18
9912364|NCT01197911|11028735|FG001|STARTED|Overall Study||10
9912365|NCT01197911|11028736|FG002|STARTED|Overall Study||10
9912366|NCT01197911|11028734|FG000|COMPLETED|Overall Study||18
9912367|NCT01197911|11028735|FG001|COMPLETED|Overall Study||10
9912368|NCT01197911|11028736|FG002|COMPLETED|Overall Study||9
9912369|NCT01197911|11028734|FG000|NOT COMPLETED|Overall Study||0
9912370|NCT01197911|11028735|FG001|NOT COMPLETED|Overall Study||0
9912371|NCT01197911|11028736|FG002|NOT COMPLETED|Overall Study||1
9955437|NCT01438476|11074398|FG000|STARTED|Overall Study||116
9955438|NCT01438476|11074399|FG001|STARTED|Overall Study||45
9955439|NCT01438476|11074398|FG000|COMPLETED|Overall Study||106
9955440|NCT01438476|11074399|FG001|COMPLETED|Overall Study||34
9955441|NCT01438476|11074398|FG000|NOT COMPLETED|Overall Study||10
9955442|NCT01438476|11074399|FG001|NOT COMPLETED|Overall Study||11
9955443|NCT01438489|11074408|FG000|STARTED|Overall Study||103
9955444|NCT01438489|11074409|FG001|STARTED|Overall Study||100
9955445|NCT01438489|11074410|FG002|STARTED|Overall Study||104
9955446|NCT01438489|11074408|FG000|COMPLETED|Overall Study||77
9955447|NCT01438489|11074409|FG001|COMPLETED|Overall Study||84
9955448|NCT01438489|11074410|FG002|COMPLETED|Overall Study||85
9955449|NCT01438489|11074408|FG000|NOT COMPLETED|Overall Study||26
9955450|NCT01438489|11074409|FG001|NOT COMPLETED|Overall Study||16
9955451|NCT01438489|11074410|FG002|NOT COMPLETED|Overall Study||19
9955452|NCT01438541|11074420|FG000|STARTED|Overall Study||29
9955453|NCT01438541|11074420|FG000|COMPLETED|Overall Study||22
9955454|NCT01438541|11074420|FG000|NOT COMPLETED|Overall Study||7
9955455|NCT01438710|11074424|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
9955456|NCT01438710|11074425|FG001|STARTED|First Week of Treatment||44
9955457|NCT01438710|11074424|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
9955458|NCT01438710|11074425|FG001|COMPLETED|First Week of Treatment||41
9955459|NCT01438710|11074424|FG000|NOT COMPLETED|First Week of Treatment||0
9955460|NCT01438710|11074425|FG001|NOT COMPLETED|First Week of Treatment||3
9955461|NCT01438710|11074424|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
9955462|NCT01438710|11074425|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
9955463|NCT01438710|11074424|FG000|COMPLETED|Second Week of Treatment||40
9955464|NCT01438710|11074425|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
9955465|NCT01438710|11074424|FG000|NOT COMPLETED|Second Week of Treatment||1
9955466|NCT01438710|11074425|FG001|NOT COMPLETED|Second Week of Treatment||0
9955467|NCT01438814|11074432|FG000|STARTED|Overall Study||344
9955468|NCT01438814|11074433|FG001|STARTED|Overall Study||345
9955469|NCT01438814|11074432|FG000|COMPLETED|Overall Study||330
9955470|NCT01438814|11074433|FG001|COMPLETED|Overall Study||331
9955471|NCT01438814|11074432|FG000|NOT COMPLETED|Overall Study||14
9955472|NCT01438814|11074433|FG001|NOT COMPLETED|Overall Study||14
9955473|NCT01438840|11074441|FG000|STARTED|Core Study||17
9955474|NCT01438840|11074442|FG001|STARTED|Core Study||32
9955475|NCT01438840|11074443|FG002|STARTED|Core Study||0
9955476|NCT01438840|11074441|FG000|COMPLETED|Core Study||1
9955477|NCT01438840|11074442|FG001|COMPLETED|Core Study||22
9955478|NCT01438840|11074443|FG002|COMPLETED|Core Study||0
9955479|NCT01438840|11074441|FG000|NOT COMPLETED|Core Study||16
9955480|NCT01438840|11074442|FG001|NOT COMPLETED|Core Study||10
9955481|NCT01438840|11074443|FG002|NOT COMPLETED|Core Study||0
9955482|NCT01438840|11074441|FG000|STARTED|Extension Phase||0
9955483|NCT01438840|11074442|FG001|STARTED|Extension Phase||0
9955484|NCT01438840|11074443|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
9955485|NCT01438840|11074441|FG000|COMPLETED|Extension Phase||0
9955486|NCT01438840|11074442|FG001|COMPLETED|Extension Phase||0
9955487|NCT01438840|11074443|FG002|COMPLETED|Extension Phase||29
9955488|NCT01438840|11074441|FG000|NOT COMPLETED|Extension Phase||0
9955489|NCT01438840|11074442|FG001|NOT COMPLETED|Extension Phase||0
9955490|NCT01438840|11074443|FG002|NOT COMPLETED|Extension Phase||10
10010024|NCT01770379|11132723|FG001|NOT COMPLETED|Overall Study||44
9912372|NCT01198002|11028748|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345
9912373|NCT01198002|11028749|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347
9912374|NCT01198002|11028750|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349
9912375|NCT01198002|11028748|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
9912376|NCT01198002|11028749|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
9912377|NCT01198002|11028750|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
9912378|NCT01198002|11028748|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
9912379|NCT01198002|11028749|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
9912380|NCT01198002|11028750|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
9912381|NCT01198002|11028748|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
9912382|NCT01198002|11028749|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
9912383|NCT01198002|11028750|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
9912384|NCT01198002|11028748|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
9912385|NCT01198002|11028749|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
9912386|NCT01198002|11028750|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
9912387|NCT01198002|11028748|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
9912388|NCT01198002|11028749|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
9912389|NCT01198002|11028750|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
9912390|NCT01198002|11028748|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70
9912391|NCT01198002|11028749|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73
9912392|NCT01198002|11028750|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80
9912393|NCT01198002|11028748|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
9912394|NCT01198002|11028749|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
9912395|NCT01198002|11028750|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
9912396|NCT01198002|11028748|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
9912397|NCT01198002|11028749|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
9912398|NCT01198002|11028750|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
9912399|NCT01198028|11028780|FG000|STARTED|Overall Study||39
9912400|NCT01198028|11028780|FG000|COMPLETED|Overall Study||29
9912401|NCT01198028|11028780|FG000|NOT COMPLETED|Overall Study||10
9912402|NCT01198132|11028786|FG000|STARTED|Overall Study||63
9912403|NCT01198132|11028787|FG001|STARTED|Overall Study||66
9912404|NCT01198132|11028786|FG000|COMPLETED|Overall Study||45
9912405|NCT01198132|11028787|FG001|COMPLETED|Overall Study||45
9912406|NCT01198132|11028786|FG000|NOT COMPLETED|Overall Study||18
9912407|NCT01198132|11028787|FG001|NOT COMPLETED|Overall Study||21
9912408|NCT01198145|11028797|FG000|STARTED|Overall Study||44
9912409|NCT01198145|11028798|FG001|STARTED|Overall Study||43
9912410|NCT01198145|11028797|FG000|COMPLETED|Overall Study||43
9912411|NCT01198145|11028798|FG001|COMPLETED|Overall Study||42
9912412|NCT01198145|11028797|FG000|NOT COMPLETED|Overall Study||1
9912413|NCT01198145|11028798|FG001|NOT COMPLETED|Overall Study||1
9912414|NCT01198158|11028807|FG000|STARTED|Overall Study||41
9912415|NCT01198158|11028808|FG001|STARTED|Overall Study||36
9912416|NCT01198158|11028807|FG000|COMPLETED|Overall Study||41
9912417|NCT01198158|11028808|FG001|COMPLETED|Overall Study||36
9912418|NCT01198158|11028807|FG000|NOT COMPLETED|Overall Study||0
9912419|NCT01198158|11028808|FG001|NOT COMPLETED|Overall Study||0
9912420|NCT01198275|11028816|FG000|STARTED|Overall Study||100
9912421|NCT01198275|11028817|FG001|STARTED|Overall Study||99
9912422|NCT01198275|11028816|FG000|COMPLETED|Overall Study||94
9912423|NCT01198275|11028817|FG001|COMPLETED|Overall Study||94
9912424|NCT01198275|11028816|FG000|NOT COMPLETED|Overall Study||6
9912425|NCT01198275|11028817|FG001|NOT COMPLETED|Overall Study||5
9912426|NCT01198327|11028823|FG000|STARTED|Overall Study||66
9912427|NCT01198327|11028823|FG000|COMPLETED|Overall Study||56
9912428|NCT01198327|11028823|FG000|NOT COMPLETED|Overall Study||10
9912429|NCT01198366|11028836|FG000|STARTED|Overall Study||52
9912430|NCT01198366|11028837|FG001|STARTED|Overall Study||51
9912431|NCT01198366|11028838|FG002|STARTED|Overall Study||51
9912432|NCT01198366|11028839|FG003|STARTED|Overall Study||52
9912433|NCT01198366|11028840|FG004|STARTED|Overall Study||140
9912434|NCT01198366|11028841|FG005|STARTED|Overall Study||141
9912435|NCT01198366|11028836|FG000|COMPLETED|Overall Study||40
9912436|NCT01198366|11028837|FG001|COMPLETED|Overall Study||44
9912437|NCT01198366|11028838|FG002|COMPLETED|Overall Study||43
9912438|NCT01198366|11028839|FG003|COMPLETED|Overall Study||47
9912439|NCT01198366|11028840|FG004|COMPLETED|Overall Study||125
9912440|NCT01198366|11028841|FG005|COMPLETED|Overall Study||128
9912441|NCT01198366|11028836|FG000|NOT COMPLETED|Overall Study||12
9912442|NCT01198366|11028837|FG001|NOT COMPLETED|Overall Study||7
9912443|NCT01198366|11028838|FG002|NOT COMPLETED|Overall Study||8
9912444|NCT01198366|11028839|FG003|NOT COMPLETED|Overall Study||5
9912445|NCT01198366|11028840|FG004|NOT COMPLETED|Overall Study||15
9912446|NCT01198366|11028841|FG005|NOT COMPLETED|Overall Study||13
9912447|NCT01198470|11028855|FG000|STARTED|Overall Study||20
9912448|NCT01198470|11028855|FG000|COMPLETED|Overall Study||18
9912449|NCT01198470|11028855|FG000|NOT COMPLETED|Overall Study||2
9912450|NCT01198509|11028865|FG000|STARTED|Overall Study||5
9912451|NCT01198509|11028866|FG001|STARTED|Overall Study||10
9912452|NCT01198509|11028867|FG002|STARTED|Overall Study||19
9912453|NCT01198509|11028868|FG003|STARTED|Overall Study||66
9912454|NCT01198509|11028869|FG004|STARTED|Overall Study||20
9912455|NCT01198509|11028870|FG005|STARTED|Overall Study||58
9912456|NCT01198509|11028865|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
9912457|NCT01198509|11028866|FG001|COMPLETED|Overall Study||10
9912458|NCT01198509|11028867|FG002|COMPLETED|Overall Study||19
9912459|NCT01198509|11028868|FG003|COMPLETED|Overall Study||66
9912460|NCT01198509|11028869|FG004|COMPLETED|Overall Study||20
9912461|NCT01198509|11028870|FG005|COMPLETED|Overall Study||58
9912462|NCT01198509|11028865|FG000|NOT COMPLETED|Overall Study||1
9912463|NCT01198509|11028866|FG001|NOT COMPLETED|Overall Study||0
9912464|NCT01198509|11028867|FG002|NOT COMPLETED|Overall Study||0
9912465|NCT01198509|11028868|FG003|NOT COMPLETED|Overall Study||0
9912466|NCT01198509|11028869|FG004|NOT COMPLETED|Overall Study||0
9912467|NCT01198509|11028870|FG005|NOT COMPLETED|Overall Study||0
9912468|NCT01198574|11028886|FG000|STARTED|Overall Study||98
9912469|NCT01198574|11028887|FG001|STARTED|Overall Study||102
9912470|NCT01198574|11028888|FG002|STARTED|Overall Study||100
9912471|NCT01198574|11028889|FG003|STARTED|Overall Study||102
9912472|NCT01198574|11028886|FG000|COMPLETED|Overall Study||94
9912473|NCT01198574|11028887|FG001|COMPLETED|Overall Study||101
9912474|NCT01198574|11028888|FG002|COMPLETED|Overall Study||99
9912475|NCT01198574|11028889|FG003|COMPLETED|Overall Study||98
9912476|NCT01198574|11028886|FG000|NOT COMPLETED|Overall Study||4
9912477|NCT01198574|11028887|FG001|NOT COMPLETED|Overall Study||1
9912478|NCT01198574|11028888|FG002|NOT COMPLETED|Overall Study||1
9912479|NCT01198574|11028889|FG003|NOT COMPLETED|Overall Study||4
9912480|NCT01198587|11028903|FG000|STARTED|Overall Study||31
9912481|NCT01198587|11028904|FG001|STARTED|Overall Study||5
9912482|NCT01198587|11028905|FG002|STARTED|Overall Study||30
9912483|NCT01198587|11028906|FG003|STARTED|Overall Study||5
9912484|NCT01198587|11028903|FG000|COMPLETED|Overall Study||23
9912485|NCT01198587|11028904|FG001|COMPLETED|Overall Study||5
9912486|NCT01198587|11028905|FG002|COMPLETED|Overall Study||21
9912487|NCT01198587|11028906|FG003|COMPLETED|Overall Study||5
9912488|NCT01198587|11028903|FG000|NOT COMPLETED|Overall Study||8
9912489|NCT01198587|11028904|FG001|NOT COMPLETED|Overall Study||0
9912490|NCT01198587|11028905|FG002|NOT COMPLETED|Overall Study||9
9912491|NCT01198587|11028906|FG003|NOT COMPLETED|Overall Study||0
9912492|NCT01198600|11028921|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35
9912493|NCT01198600|11028922|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37
9912494|NCT01198600|11028923|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0
9912495|NCT01198600|11028924|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0
9912496|NCT01198600|11028921|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
9912497|NCT01198600|11028922|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
9912498|NCT01198600|11028923|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
9912499|NCT01198600|11028924|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
9912500|NCT01198600|11028921|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
9912501|NCT01198600|11028922|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
9912502|NCT01198600|11028923|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
9912503|NCT01198600|11028924|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
9912504|NCT01198600|11028921|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
9912505|NCT01198600|11028922|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36
9912506|NCT01198600|11028923|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0
9912507|NCT01198600|11028924|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0
10010025|NCT01770379|11132724|FG002|NOT COMPLETED|Overall Study||42
10010026|NCT01770392|11132734|FG000|STARTED|Nintedanib||26
10010027|NCT01770392|11132734|FG000|COMPLETED|Nintedanib||26
10010028|NCT01770392|11132734|FG000|NOT COMPLETED|Nintedanib||0
10010029|NCT01770392|11132734|FG000|STARTED|Washout Period of at Least 14 Days||26
10010030|NCT01770392|11132734|FG000|COMPLETED|Washout Period of at Least 14 Days||25
10010031|NCT01770392|11132734|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1
10010032|NCT01770392|11132734|FG000|STARTED|Nintedanib+ Rifampicin||25
10010033|NCT01770392|11132734|FG000|COMPLETED|Nintedanib+ Rifampicin||25
10010034|NCT01770392|11132734|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0
10010035|NCT01770431|11132746|FG000|STARTED|Overall Study||696
10010036|NCT01770431|11132747|FG001|STARTED|Overall Study||348
10010037|NCT01770431|11132746|FG000|COMPLETED|Overall Study||686
10010038|NCT01770431|11132747|FG001|COMPLETED|Overall Study||316
9912508|NCT01198600|11028921|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
9912509|NCT01198600|11028922|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
9912510|NCT01198600|11028923|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
9912511|NCT01198600|11028924|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
9912512|NCT01198600|11028921|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
9912513|NCT01198600|11028922|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
9912514|NCT01198600|11028923|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
9912515|NCT01198600|11028924|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
10010039|NCT01770431|11132746|FG000|NOT COMPLETED|Overall Study||10
9912516|NCT01198600|11028921|FG000|STARTED|Phase 2: 56 Days of Wear||0
9912517|NCT01198600|11028922|FG001|STARTED|Phase 2: 56 Days of Wear||0
9912518|NCT01198600|11028923|FG002|STARTED|Phase 2: 56 Days of Wear||67
9912519|NCT01198600|11028924|FG003|STARTED|Phase 2: 56 Days of Wear||0
9912520|NCT01198600|11028921|FG000|COMPLETED|Phase 2: 56 Days of Wear||0
10010040|NCT01770431|11132747|FG001|NOT COMPLETED|Overall Study||32
9912521|NCT01198600|11028922|FG001|COMPLETED|Phase 2: 56 Days of Wear||0
9912522|NCT01198600|11028923|FG002|COMPLETED|Phase 2: 56 Days of Wear||62
10203794|NCT03467412|11330687|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
10203795|NCT03467412|11330688|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
10203796|NCT03467412|11330689|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
9912523|NCT01198600|11028924|FG003|COMPLETED|Phase 2: 56 Days of Wear||0
9912524|NCT01198600|11028921|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0
9912525|NCT01198600|11028922|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0
9912526|NCT01198600|11028923|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5
9912527|NCT01198600|11028924|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0
9912528|NCT01198600|11028921|FG000|STARTED|Phase 3: 43 Days of Wear||0
9912529|NCT01198600|11028922|FG001|STARTED|Phase 3: 43 Days of Wear||0
9912530|NCT01198600|11028923|FG002|STARTED|Phase 3: 43 Days of Wear||0
9912531|NCT01198600|11028924|FG003|STARTED|Phase 3: 43 Days of Wear||38
9912532|NCT01198600|11028921|FG000|COMPLETED|Phase 3: 43 Days of Wear||0
9912533|NCT01198600|11028922|FG001|COMPLETED|Phase 3: 43 Days of Wear||0
9912534|NCT01198600|11028923|FG002|COMPLETED|Phase 3: 43 Days of Wear||0
9912535|NCT01198600|11028924|FG003|COMPLETED|Phase 3: 43 Days of Wear||38
10010041|NCT01770483|11132756|FG000|STARTED|Overall Study||33
10010042|NCT01770483|11132757|FG001|STARTED|Overall Study||33
10010043|NCT01770483|11132756|FG000|COMPLETED|Overall Study||33
10010044|NCT01770483|11132757|FG001|COMPLETED|Overall Study||33
10010045|NCT01770483|11132756|FG000|NOT COMPLETED|Overall Study||0
10010046|NCT01770483|11132757|FG001|NOT COMPLETED|Overall Study||0
10111216|NCT02494323|11242270|FG000|COMPLETED|Overall Study||70
10111217|NCT02494323|11242270|FG000|NOT COMPLETED|Overall Study||0
10111218|NCT02494336|11242276|FG000|STARTED|Overall Study||24
10111219|NCT02494336|11242277|FG001|STARTED|Overall Study||24
10111220|NCT02494336|11242276|FG000|COMPLETED|Overall Study||24
9912536|NCT01198600|11028921|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0
9912537|NCT01198600|11028922|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0
9912538|NCT01198600|11028923|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0
9912539|NCT01198600|11028924|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0
9912540|NCT01198691|11028934|FG000|STARTED|Completed Surgery -Received Intervention||50
9912541|NCT01198691|11028935|FG001|STARTED|Completed Surgery -Received Intervention||50
9912542|NCT01198691|11028934|FG000|COMPLETED|Completed Surgery -Received Intervention||50
9912543|NCT01198691|11028935|FG001|COMPLETED|Completed Surgery -Received Intervention||50
9912544|NCT01198691|11028934|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0
9912545|NCT01198691|11028935|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0
9912546|NCT01198691|11028934|FG000|STARTED|Completed VAS Score Postop Day 1||50
9912547|NCT01198691|11028935|FG001|STARTED|Completed VAS Score Postop Day 1||50
9912548|NCT01198691|11028934|FG000|COMPLETED|Completed VAS Score Postop Day 1||47
9912549|NCT01198691|11028935|FG001|COMPLETED|Completed VAS Score Postop Day 1||46
9912550|NCT01198691|11028934|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3
9912551|NCT01198691|11028935|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4
9912552|NCT01198691|11028934|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
9912553|NCT01198691|11028935|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
9912554|NCT01198691|11028934|FG000|COMPLETED|Completed VAS Score at Discharge||45
9912555|NCT01198691|11028935|FG001|COMPLETED|Completed VAS Score at Discharge||44
9912556|NCT01198691|11028934|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5
9912557|NCT01198691|11028935|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6
9912558|NCT01198691|11028934|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
9912559|NCT01198691|11028935|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
9912560|NCT01198691|11028934|FG000|COMPLETED|Survey Prior to Discharge||18
9760488|NCT00381615|10864159|FG002|COMPLETED|Overall Study||24
9760489|NCT00381615|10864160|FG003|COMPLETED|Overall Study||22
9760490|NCT00381615|10864157|FG000|NOT COMPLETED|Overall Study||4
9760491|NCT00381615|10864158|FG001|NOT COMPLETED|Overall Study||5
9760492|NCT00381615|10864159|FG002|NOT COMPLETED|Overall Study||1
9760493|NCT00381615|10864160|FG003|NOT COMPLETED|Overall Study||2
9912561|NCT01198691|11028935|FG001|COMPLETED|Survey Prior to Discharge||17
9912562|NCT01198691|11028934|FG000|NOT COMPLETED|Survey Prior to Discharge||32
9912563|NCT01198691|11028935|FG001|NOT COMPLETED|Survey Prior to Discharge||33
9912564|NCT01198691|11028934|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
9955491|NCT01438957|11074455|FG000|STARTED|Overall Study||22
10010047|NCT01770509|11132765|FG000|STARTED|Overall Study||12
10010048|NCT01770509|11132766|FG001|STARTED|Overall Study||17
10010049|NCT01770509|11132765|FG000|COMPLETED|Overall Study||11
10010050|NCT01770509|11132766|FG001|COMPLETED|Overall Study||14
10111221|NCT02494336|11242277|FG001|COMPLETED|Overall Study||24
10111222|NCT02494336|11242276|FG000|NOT COMPLETED|Overall Study||0
10111223|NCT02494336|11242277|FG001|NOT COMPLETED|Overall Study||0
10111224|NCT02494401|11242285|FG000|STARTED|Overall Study||134
10111225|NCT02494401|11242286|FG001|STARTED|Overall Study||133
10111226|NCT02494401|11242285|FG000|Week 16|Overall Study||123
9760494|NCT00381628|10864176|FG000|STARTED|Overall Study||18
9760495|NCT00381628|10864177|FG001|STARTED|Overall Study||27
9912565|NCT01198691|11028935|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
9912566|NCT01198691|11028934|FG000|COMPLETED|6 Week Post-partum Survey||21
9912567|NCT01198691|11028935|FG001|COMPLETED|6 Week Post-partum Survey||26
9912568|NCT01198691|11028934|FG000|NOT COMPLETED|6 Week Post-partum Survey||29
9912569|NCT01198691|11028935|FG001|NOT COMPLETED|6 Week Post-partum Survey||24
9912570|NCT01198756|11028945|FG000|STARTED|Overall Study||932
9912571|NCT01198756|11028946|FG001|STARTED|Overall Study||929
9912572|NCT01198756|11028947|FG002|STARTED|Overall Study||932
9912573|NCT01198756|11028948|FG003|STARTED|Overall Study||301
9912574|NCT01198756|11028945|FG000|COMPLETED|Overall Study||894
9912575|NCT01198756|11028946|FG001|COMPLETED|Overall Study||889
9912576|NCT01198756|11028947|FG002|COMPLETED|Overall Study||902
9912577|NCT01198756|11028948|FG003|COMPLETED|Overall Study||275
9912578|NCT01198756|11028945|FG000|NOT COMPLETED|Overall Study||38
9912579|NCT01198756|11028946|FG001|NOT COMPLETED|Overall Study||40
9912580|NCT01198756|11028947|FG002|NOT COMPLETED|Overall Study||30
9912581|NCT01198756|11028948|FG003|NOT COMPLETED|Overall Study||26
9912582|NCT01198769|11028965|FG000|STARTED|Overall Study||15
9912583|NCT01198769|11028965|FG000|COMPLETED|Overall Study||15
9912584|NCT01198769|11028965|FG000|NOT COMPLETED|Overall Study||0
9912585|NCT01198795|11028969|FG000|STARTED|Overall Study||162
9912586|NCT01198795|11028969|FG000|COMPLETED|Overall Study||80
9912587|NCT01198795|11028969|FG000|NOT COMPLETED|Overall Study||82
9912588|NCT01198873|11028975|FG000|STARTED|Overall Study||41
9912589|NCT01198873|11028976|FG001|STARTED|Overall Study||35
9912590|NCT01198873|11028975|FG000|Treated|Overall Study||41
9912591|NCT01198873|11028976|FG001|Treated|Overall Study||35
9912592|NCT01198873|11028975|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
9912593|NCT01198873|11028976|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
9912594|NCT01198873|11028975|FG000|COMPLETED|Overall Study||4
9912595|NCT01198873|11028976|FG001|COMPLETED|Overall Study||3
9912596|NCT01198873|11028975|FG000|NOT COMPLETED|Overall Study||37
9912597|NCT01198873|11028976|FG001|NOT COMPLETED|Overall Study||32
9912598|NCT01198977|11028984|FG000|STARTED|Overall Study||31
9912599|NCT01198977|11028985|FG001|STARTED|Overall Study||33
9912600|NCT01198977|11028984|FG000|COMPLETED|Overall Study||30
9912601|NCT01198977|11028985|FG001|COMPLETED|Overall Study||33
9912602|NCT01198977|11028984|FG000|NOT COMPLETED|Overall Study||1
9912603|NCT01198977|11028985|FG001|NOT COMPLETED|Overall Study||0
9912604|NCT01199016|11028993|FG000|STARTED|Overall Study||239
9912605|NCT01199016|11028993|FG000|Treated|Overall Study||236
9912606|NCT01199016|11028993|FG000|COMPLETED|Overall Study||162
9912607|NCT01199016|11028993|FG000|NOT COMPLETED|Overall Study||77
9912608|NCT01199042|11028997|FG000|STARTED|Sleep Laboratory (3 Nights)||29
9912609|NCT01199042|11028997|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27
9912610|NCT01199042|11028997|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
9912611|NCT01199042|11028997|FG000|STARTED|At Home (3 Months)||27
9912612|NCT01199042|11028997|FG000|COMPLETED|At Home (3 Months)||26
9912613|NCT01199042|11028997|FG000|NOT COMPLETED|At Home (3 Months)||1
9912614|NCT01199055|11029009|FG000|STARTED|Overall Study||3
9912615|NCT01199055|11029010|FG001|STARTED|Overall Study||4
9912616|NCT01199055|11029011|FG002|STARTED|Overall Study||9
9912617|NCT01199055|11029009|FG000|COMPLETED|Overall Study||1
9912618|NCT01199055|11029010|FG001|COMPLETED|Overall Study||1
9912619|NCT01199055|11029011|FG002|COMPLETED|Overall Study||5
9912620|NCT01199055|11029009|FG000|NOT COMPLETED|Overall Study||2
9912621|NCT01199055|11029010|FG001|NOT COMPLETED|Overall Study||3
9912622|NCT01199055|11029011|FG002|NOT COMPLETED|Overall Study||4
9912623|NCT01199068|11029024|FG000|STARTED|Overall Study||3
9912624|NCT01199068|11029025|FG001|STARTED|Overall Study||3
10203797|NCT03467412|11330690|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
10203798|NCT03467412|11330691|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
10203799|NCT03467412|11330687|FG000|COMPLETED|Overall Study||22
10203800|NCT03467412|11330688|FG001|COMPLETED|Overall Study||24
9912625|NCT01199068|11029026|FG002|STARTED|Overall Study||9
9912626|NCT01199068|11029024|FG000|Received Treatment|Overall Study||3
9912627|NCT01199068|11029025|FG001|Received Treatment|Overall Study||3
9912628|NCT01199068|11029026|FG002|Received Treatment|Overall Study||8
9912629|NCT01199068|11029024|FG000|COMPLETED|Overall Study||0
9912630|NCT01199068|11029025|FG001|COMPLETED|Overall Study||0
9912631|NCT01199068|11029026|FG002|COMPLETED|Overall Study||0
9912632|NCT01199068|11029024|FG000|NOT COMPLETED|Overall Study||3
9912633|NCT01199068|11029025|FG001|NOT COMPLETED|Overall Study||3
9912634|NCT01199068|11029026|FG002|NOT COMPLETED|Overall Study||9
10203801|NCT03467412|11330689|FG002|COMPLETED|Overall Study||20
9912635|NCT01199146|11029041|FG000|STARTED|Overall Study||42
9912636|NCT01199146|11029041|FG000|COMPLETED|Overall Study||39
9912637|NCT01199146|11029041|FG000|NOT COMPLETED|Overall Study||3
9912638|NCT01199198|11029047|FG000|STARTED|Overall Study||24
9912639|NCT01199198|11029048|FG001|STARTED|Overall Study||24
9912640|NCT01199198|11029047|FG000|COMPLETED|Overall Study||17
9912641|NCT01199198|11029048|FG001|COMPLETED|Overall Study||13
9912642|NCT01199198|11029047|FG000|NOT COMPLETED|Overall Study||7
9912643|NCT01199198|11029048|FG001|NOT COMPLETED|Overall Study||11
9912644|NCT01199237|11029056|FG000|STARTED|Overall Study||41
9912645|NCT01199237|11029057|FG001|STARTED|Overall Study||40
9912646|NCT01199237|11029056|FG000|COMPLETED|Overall Study||41
9912647|NCT01199237|11029057|FG001|COMPLETED|Overall Study||40
9912648|NCT01199237|11029056|FG000|NOT COMPLETED|Overall Study||0
9912649|NCT01199237|11029057|FG001|NOT COMPLETED|Overall Study||0
9912650|NCT01199263|11029067|FG000|STARTED|Overall Study||54
9912651|NCT01199263|11029068|FG001|STARTED|Overall Study||54
9912652|NCT01199263|11029067|FG000|COMPLETED|Overall Study||48
9912653|NCT01199263|11029068|FG001|COMPLETED|Overall Study||52
9912654|NCT01199263|11029067|FG000|NOT COMPLETED|Overall Study||6
9912655|NCT01199263|11029068|FG001|NOT COMPLETED|Overall Study||2
9912656|NCT01199289|11029080|FG000|STARTED|Overall Study||77
9912657|NCT01199289|11029081|FG001|STARTED|Overall Study||75
9912658|NCT01199289|11029082|FG002|STARTED|Overall Study||76
9912659|NCT01199289|11029083|FG003|STARTED|Overall Study||77
9912660|NCT01199289|11029080|FG000|Participants Who Received Study Treatment|Overall Study||76
9912661|NCT01199289|11029081|FG001|Participants Who Received Study Treatment|Overall Study||74
9912662|NCT01199289|11029082|FG002|Participants Who Received Study Treatment|Overall Study||76
9912663|NCT01199289|11029083|FG003|Participants Who Received Study Treatment|Overall Study||76
9912664|NCT01199289|11029080|FG000|COMPLETED|Overall Study||68
9912665|NCT01199289|11029081|FG001|COMPLETED|Overall Study||68
9912666|NCT01199289|11029082|FG002|COMPLETED|Overall Study||71
9912667|NCT01199289|11029083|FG003|COMPLETED|Overall Study||65
9912668|NCT01199289|11029080|FG000|NOT COMPLETED|Overall Study||9
9912669|NCT01199289|11029081|FG001|NOT COMPLETED|Overall Study||7
9912670|NCT01199289|11029082|FG002|NOT COMPLETED|Overall Study||5
9912671|NCT01199289|11029083|FG003|NOT COMPLETED|Overall Study||12
9912672|NCT01199471|11029096|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
9912673|NCT01199471|11029096|FG000|COMPLETED|Overall Study||3994
9912674|NCT01199471|11029096|FG000|NOT COMPLETED|Overall Study||6
9912675|NCT01199575|11029101|FG000|STARTED|Overall Study||30
9912676|NCT01199575|11029101|FG000|COMPLETED|Overall Study||25
9912677|NCT01199575|11029101|FG000|NOT COMPLETED|Overall Study||5
9912678|NCT01199601|11029108|FG000|STARTED|Overall Study|Control Group|422
9912679|NCT01199601|11029109|FG001|STARTED|Overall Study|Intervention Group|422
9912680|NCT01199601|11029108|FG000|COMPLETED|Overall Study||353
9912681|NCT01199601|11029109|FG001|COMPLETED|Overall Study||344
9912682|NCT01199601|11029108|FG000|NOT COMPLETED|Overall Study||69
9912683|NCT01199601|11029109|FG001|NOT COMPLETED|Overall Study||78
9912684|NCT01199705|11029115|FG000|STARTED|IVIG Treatment||25
9912685|NCT01199705|11029115|FG000|COMPLETED|IVIG Treatment||25
9912686|NCT01199705|11029115|FG000|NOT COMPLETED|IVIG Treatment||0
9912687|NCT01199705|11029115|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
9912688|NCT01199705|11029115|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
9912689|NCT01199705|11029115|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
9912690|NCT01199705|11029115|FG000|STARTED|SCIG Treatment (Efficacy)||24
9912691|NCT01199705|11029115|FG000|COMPLETED|SCIG Treatment (Efficacy)||24
9912692|NCT01199705|11029115|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0
9912693|NCT01199731|11029133|FG000|STARTED|Overall Study||9
9912694|NCT01199731|11029134|FG001|STARTED|Overall Study||11
9912695|NCT01199731|11029135|FG002|STARTED|Overall Study||10
9912696|NCT01199731|11029133|FG000|COMPLETED|Overall Study||0
9912697|NCT01199731|11029134|FG001|COMPLETED|Overall Study||0
9912698|NCT01199731|11029135|FG002|COMPLETED|Overall Study||0
9912699|NCT01199731|11029133|FG000|NOT COMPLETED|Overall Study||9
9912700|NCT01199731|11029134|FG001|NOT COMPLETED|Overall Study||11
9912701|NCT01199731|11029135|FG002|NOT COMPLETED|Overall Study||10
9912702|NCT01199744|11029143|FG000|STARTED|Overall Study||1575
9912703|NCT01199744|11029143|FG000|COMPLETED|Overall Study||1575
9912704|NCT01199744|11029143|FG000|NOT COMPLETED|Overall Study||0
9912705|NCT01199822|11029150|FG000|STARTED|Overall Study||3
9912706|NCT01199822|11029151|FG001|STARTED|Overall Study||7
9912707|NCT01199822|11029152|FG002|STARTED|Overall Study||6
9912708|NCT01199822|11029150|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9912709|NCT01199822|11029151|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
9912710|NCT01199822|11029152|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9912711|NCT01199822|11029150|FG000|COMPLETED|Overall Study||3
9912712|NCT01199822|11029151|FG001|COMPLETED|Overall Study||6
10010051|NCT01770509|11132765|FG000|NOT COMPLETED|Overall Study||1
10010052|NCT01770509|11132766|FG001|NOT COMPLETED|Overall Study||3
10010053|NCT01770652|11132776|FG000|STARTED|Overall Study||8
10010054|NCT01770652|11132777|FG001|STARTED|Overall Study||8
10010055|NCT01770652|11132778|FG002|STARTED|Overall Study||8
9912713|NCT01199822|11029152|FG002|COMPLETED|Overall Study||6
9912714|NCT01199822|11029150|FG000|NOT COMPLETED|Overall Study||0
9912715|NCT01199822|11029151|FG001|NOT COMPLETED|Overall Study||1
9912716|NCT01199822|11029152|FG002|NOT COMPLETED|Overall Study||0
9912717|NCT01199848|11029167|FG000|STARTED|Placebo Arm||29
9912718|NCT01199848|11029167|FG000|COMPLETED|Placebo Arm||21
9912719|NCT01199848|11029167|FG000|NOT COMPLETED|Placebo Arm||8
9912720|NCT01199848|11029167|FG000|STARTED|10g STR Arm||21
9912721|NCT01199848|11029167|FG000|COMPLETED|10g STR Arm||21
9912722|NCT01199848|11029167|FG000|NOT COMPLETED|10g STR Arm||0
9912723|NCT01199848|11029167|FG000|STARTED|20G STRB Arm||21
9912724|NCT01199848|11029167|FG000|COMPLETED|20G STRB Arm||21
9912725|NCT01199848|11029167|FG000|NOT COMPLETED|20G STRB Arm||0
9912726|NCT01199848|11029167|FG000|STARTED|40G STRB Arm||21
9912727|NCT01199848|11029167|FG000|COMPLETED|40G STRB Arm||21
10010056|NCT01770652|11132779|FG003|STARTED|Overall Study||8
10010057|NCT01770652|11132776|FG000|COMPLETED|Overall Study||8
10203802|NCT03467412|11330690|FG003|COMPLETED|Overall Study||23
10203803|NCT03467412|11330691|FG004|COMPLETED|Overall Study||17
10203804|NCT03467412|11330687|FG000|NOT COMPLETED|Overall Study||3
10203805|NCT03467412|11330688|FG001|NOT COMPLETED|Overall Study||1
10203806|NCT03467412|11330689|FG002|NOT COMPLETED|Overall Study||5
10203807|NCT03467412|11330690|FG003|NOT COMPLETED|Overall Study||2
9912728|NCT01199848|11029167|FG000|NOT COMPLETED|40G STRB Arm||0
9912729|NCT01199861|11029179|FG000|STARTED|Overall Study||95
9912730|NCT01199861|11029180|FG001|STARTED|Overall Study||43
9912731|NCT01199861|11029179|FG000|COMPLETED|Overall Study||93
9912732|NCT01199861|11029180|FG001|COMPLETED|Overall Study||43
9912733|NCT01199861|11029179|FG000|NOT COMPLETED|Overall Study||2
9912734|NCT01199861|11029180|FG001|NOT COMPLETED|Overall Study||0
9912735|NCT01199926|11029188|FG000|STARTED|Overall Study||17
9912736|NCT01199926|11029189|FG001|STARTED|Overall Study||17
9912737|NCT01199926|11029188|FG000|COMPLETED|Overall Study||10
9912738|NCT01199926|11029189|FG001|COMPLETED|Overall Study||13
9912739|NCT01199926|11029188|FG000|NOT COMPLETED|Overall Study||7
9912740|NCT01199926|11029189|FG001|NOT COMPLETED|Overall Study||4
9912741|NCT01199939|11029195|FG000|STARTED|Overall Study|Number of enrolled participants|54
9912742|NCT01199939|11029195|FG000|COMPLETED|Overall Study||41
9912743|NCT01199939|11029195|FG000|NOT COMPLETED|Overall Study||13
9912744|NCT01199952|11029201|FG000|STARTED|Overall Study||103
9912745|NCT01199952|11029202|FG001|STARTED|Overall Study||104
9912746|NCT01199952|11029201|FG000|COMPLETED|Overall Study||51
10203808|NCT03467412|11330691|FG004|NOT COMPLETED|Overall Study||3
10203809|NCT03467425|11330712|FG000|STARTED|Overall Study||1545
10203810|NCT03467425|11330713|FG001|STARTED|Overall Study||1547
10203811|NCT03467425|11330712|FG000|Randomized But Did Not Start IP|Overall Study||1
10203812|NCT03467425|11330713|FG001|Randomized But Did Not Start IP|Overall Study||0
10203813|NCT03467425|11330712|FG000|Completed IP|Overall Study||1256
10203814|NCT03467425|11330713|FG001|Completed IP|Overall Study||1359
10203815|NCT03467425|11330712|FG000|Not Completed IP|Overall Study||288
10203816|NCT03467425|11330713|FG001|Not Completed IP|Overall Study||188
10203817|NCT03467425|11330712|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
10203818|NCT03467425|11330713|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
10203819|NCT03467425|11330712|FG000|WIP: Protocol Deviation|Overall Study||0
10203820|NCT03467425|11330713|FG001|WIP: Protocol Deviation|Overall Study||2
10203821|NCT03467425|11330712|FG000|WIP: Adverse Event|Overall Study||112
10203822|NCT03467425|11330713|FG001|WIP: Adverse Event|Overall Study||29
10203823|NCT03467425|11330712|FG000|WIP: Lack of Efficacy|Overall Study||56
10203824|NCT03467425|11330713|FG001|WIP: Lack of Efficacy|Overall Study||28
10203825|NCT03467425|11330712|FG000|WIP: Physician Decision|Overall Study||14
10203826|NCT03467425|11330713|FG001|WIP: Physician Decision|Overall Study||27
10203827|NCT03467425|11330712|FG000|WIP: Withdrawal by Participant|Overall Study||91
10203828|NCT03467425|11330713|FG001|WIP: Withdrawal by Participant|Overall Study||78
10203829|NCT03467425|11330712|FG000|COMPLETED|Overall Study||1498
10203830|NCT03467425|11330713|FG001|COMPLETED|Overall Study||1493
10203831|NCT03467425|11330712|FG000|NOT COMPLETED|Overall Study||47
10203832|NCT03467425|11330713|FG001|NOT COMPLETED|Overall Study||54
9912747|NCT01199952|11029202|FG001|COMPLETED|Overall Study||59
9912748|NCT01199952|11029201|FG000|NOT COMPLETED|Overall Study||52
9912749|NCT01199952|11029202|FG001|NOT COMPLETED|Overall Study||45
9912750|NCT01199965|11029211|FG000|STARTED|Overall Study||23
9912751|NCT01199965|11029212|FG001|STARTED|Overall Study||24
9912752|NCT01199965|11029211|FG000|COMPLETED|Overall Study||22
9912753|NCT01199965|11029212|FG001|COMPLETED|Overall Study||24
9912754|NCT01199965|11029211|FG000|NOT COMPLETED|Overall Study||1
9912755|NCT01199965|11029212|FG001|NOT COMPLETED|Overall Study||0
9912756|NCT01200030|11029229|FG000|STARTED|Overall Study||12
9912757|NCT01200030|11029230|FG001|STARTED|Overall Study||13
9912758|NCT01200030|11029231|FG002|STARTED|Overall Study||12
9912759|NCT01200030|11029229|FG000|COMPLETED|Overall Study||12
9912760|NCT01200030|11029230|FG001|COMPLETED|Overall Study||13
9912761|NCT01200030|11029231|FG002|COMPLETED|Overall Study||12
9912762|NCT01200030|11029229|FG000|NOT COMPLETED|Overall Study||0
9912763|NCT01200030|11029230|FG001|NOT COMPLETED|Overall Study||0
9912764|NCT01200030|11029231|FG002|NOT COMPLETED|Overall Study||0
9912765|NCT01200069|11029241|FG000|STARTED|Overall Study||8
9912766|NCT01200069|11029242|FG001|STARTED|Overall Study||6
9912767|NCT01200069|11029241|FG000|COMPLETED|Overall Study||8
9912768|NCT01200069|11029242|FG001|COMPLETED|Overall Study||5
9912769|NCT01200069|11029241|FG000|NOT COMPLETED|Overall Study||0
9912770|NCT01200069|11029242|FG001|NOT COMPLETED|Overall Study||1
9912771|NCT01200160|11029291|FG000|STARTED|Overall Study||128
9912772|NCT01200160|11029291|FG000|COMPLETED|Overall Study||66
9912773|NCT01200160|11029291|FG000|NOT COMPLETED|Overall Study||62
9912774|NCT01200238|11029297|FG000|STARTED|Overall Study||7
9912775|NCT01200238|11029298|FG001|STARTED|Overall Study||10
9912776|NCT01200238|11029297|FG000|COMPLETED|Overall Study||0
10203833|NCT03467477|11330719|FG000|STARTED|Overall Study||161
9912777|NCT01200238|11029298|FG001|COMPLETED|Overall Study||0
9912778|NCT01200238|11029297|FG000|NOT COMPLETED|Overall Study||7
9912779|NCT01200238|11029298|FG001|NOT COMPLETED|Overall Study||10
9912780|NCT01200290|11029304|FG000|STARTED|Treatment Period||18
9912781|NCT01200290|11029304|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18
9912782|NCT01200290|11029304|FG000|COMPLETED|Treatment Period||17
9912783|NCT01200290|11029304|FG000|NOT COMPLETED|Treatment Period||1
9955492|NCT01438957|11074456|FG001|STARTED|Overall Study||23
9912784|NCT01200290|11029304|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
9912785|NCT01200290|11029304|FG000|COMPLETED|Post-Treatment Follow-Up Period||16
9912786|NCT01200290|11029304|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
9912787|NCT01200329|11029308|FG000|STARTED|Overall Study||81
9912788|NCT01200329|11029308|FG000|COMPLETED|Overall Study||78
9912789|NCT01200329|11029308|FG000|NOT COMPLETED|Overall Study||3
9912790|NCT01200342|11029312|FG000|STARTED|Overall Study||7
9912791|NCT01200342|11029312|FG000|COMPLETED|Overall Study||6
9912792|NCT01200342|11029312|FG000|NOT COMPLETED|Overall Study||1
9912793|NCT01200355|11029318|FG000|STARTED|Overall Study||58
9912794|NCT01200355|11029319|FG001|STARTED|Overall Study||55
9912795|NCT01200355|11029318|FG000|COMPLETED|Overall Study||51
9912796|NCT01200355|11029319|FG001|COMPLETED|Overall Study||53
9912797|NCT01200355|11029318|FG000|NOT COMPLETED|Overall Study||7
9912798|NCT01200355|11029319|FG001|NOT COMPLETED|Overall Study||2
9912799|NCT01200368|11029328|FG000|STARTED|Infant Series||183
9912800|NCT01200368|11029329|FG001|STARTED|Infant Series||184
9912801|NCT01200368|11029330|FG002|STARTED|Infant Series||184
9912802|NCT01200368|11029328|FG000|Vaccinated Dose 1|Infant Series||183
9912803|NCT01200368|11029329|FG001|Vaccinated Dose 1|Infant Series||183
9912804|NCT01200368|11029330|FG002|Vaccinated Dose 1|Infant Series||183
9912805|NCT01200368|11029328|FG000|Vaccinated Dose 2|Infant Series||183
9912806|NCT01200368|11029329|FG001|Vaccinated Dose 2|Infant Series||182
9912807|NCT01200368|11029330|FG002|Vaccinated Dose 2|Infant Series||183
9912808|NCT01200368|11029328|FG000|Vaccinated Dose 3|Infant Series||181
9912809|NCT01200368|11029329|FG001|Vaccinated Dose 3|Infant Series||178
9912810|NCT01200368|11029330|FG002|Vaccinated Dose 3|Infant Series||182
9912811|NCT01200368|11029328|FG000|COMPLETED|Infant Series||180
9912812|NCT01200368|11029329|FG001|COMPLETED|Infant Series||178
9912813|NCT01200368|11029330|FG002|COMPLETED|Infant Series||178
9912814|NCT01200368|11029328|FG000|NOT COMPLETED|Infant Series||3
9912815|NCT01200368|11029329|FG001|NOT COMPLETED|Infant Series||6
9912816|NCT01200368|11029330|FG002|NOT COMPLETED|Infant Series||6
9912817|NCT01200368|11029328|FG000|STARTED|After Infant Series||180
9912818|NCT01200368|11029329|FG001|STARTED|After Infant Series||178
9912819|NCT01200368|11029330|FG002|STARTED|After Infant Series||178
9912820|NCT01200368|11029328|FG000|COMPLETED|After Infant Series||162
9912821|NCT01200368|11029329|FG001|COMPLETED|After Infant Series||162
9912822|NCT01200368|11029330|FG002|COMPLETED|After Infant Series||169
9912823|NCT01200368|11029328|FG000|NOT COMPLETED|After Infant Series||18
9912824|NCT01200368|11029329|FG001|NOT COMPLETED|After Infant Series||16
9912825|NCT01200368|11029330|FG002|NOT COMPLETED|After Infant Series||9
9912826|NCT01200368|11029328|FG000|STARTED|Toddler Dose||162
9912827|NCT01200368|11029329|FG001|STARTED|Toddler Dose||162
9912828|NCT01200368|11029330|FG002|STARTED|Toddler Dose||169
9912829|NCT01200368|11029328|FG000|COMPLETED|Toddler Dose||162
9912830|NCT01200368|11029329|FG001|COMPLETED|Toddler Dose||159
9912831|NCT01200368|11029330|FG002|COMPLETED|Toddler Dose||168
9912832|NCT01200368|11029328|FG000|NOT COMPLETED|Toddler Dose||0
9912833|NCT01200368|11029329|FG001|NOT COMPLETED|Toddler Dose||3
9912834|NCT01200368|11029330|FG002|NOT COMPLETED|Toddler Dose||1
9912835|NCT01200394|11029347|FG000|STARTED|Overall Study||64
9912836|NCT01200394|11029348|FG001|STARTED|Overall Study||192
9912837|NCT01200394|11029347|FG000|COMPLETED|Overall Study||62
9912838|NCT01200394|11029348|FG001|COMPLETED|Overall Study||164
9912839|NCT01200394|11029347|FG000|NOT COMPLETED|Overall Study||2
9912840|NCT01200394|11029348|FG001|NOT COMPLETED|Overall Study||28
9912841|NCT01200407|11029355|FG000|STARTED|Overall Study||615
9912842|NCT01200407|11029355|FG000|COMPLETED|Overall Study||533
9912843|NCT01200407|11029355|FG000|NOT COMPLETED|Overall Study||82
9912844|NCT01200433|11029361|FG000|STARTED|Overall Study||21
9912845|NCT01200433|11029362|FG001|STARTED|Overall Study||23
9912846|NCT01200433|11029361|FG000|COMPLETED|Overall Study||21
9912847|NCT01200433|11029362|FG001|COMPLETED|Overall Study||23
9912848|NCT01200433|11029361|FG000|NOT COMPLETED|Overall Study||0
9912849|NCT01200433|11029362|FG001|NOT COMPLETED|Overall Study||0
9912850|NCT01200485|11029368|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
9912851|NCT01200485|11029369|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0
9912852|NCT01200485|11029370|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0
9912853|NCT01200485|11029368|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
10010058|NCT01770652|11132777|FG001|COMPLETED|Overall Study||8
10010059|NCT01770652|11132778|FG002|COMPLETED|Overall Study||8
10010060|NCT01770652|11132779|FG003|COMPLETED|Overall Study||8
10010061|NCT01770652|11132776|FG000|NOT COMPLETED|Overall Study||0
9912854|NCT01200485|11029369|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
9912855|NCT01200485|11029370|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
9912856|NCT01200485|11029368|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
9912857|NCT01200485|11029369|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
9912858|NCT01200485|11029370|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
9912859|NCT01200485|11029368|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
9912860|NCT01200485|11029369|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
10010062|NCT01770652|11132777|FG001|NOT COMPLETED|Overall Study||0
10010063|NCT01770652|11132778|FG002|NOT COMPLETED|Overall Study||0
10010064|NCT01770652|11132779|FG003|NOT COMPLETED|Overall Study||0
10010065|NCT01770691|11132793|FG000|STARTED|Overall Study||7
9912861|NCT01200485|11029370|FG002|STARTED|Cycle 2: Randomization||25
9912862|NCT01200485|11029368|FG000|COMPLETED|Cycle 2: Randomization||0
9912863|NCT01200485|11029369|FG001|COMPLETED|Cycle 2: Randomization||21
9912864|NCT01200485|11029370|FG002|COMPLETED|Cycle 2: Randomization||25
9912865|NCT01200485|11029368|FG000|NOT COMPLETED|Cycle 2: Randomization||0
9912866|NCT01200485|11029369|FG001|NOT COMPLETED|Cycle 2: Randomization||0
9912867|NCT01200485|11029370|FG002|NOT COMPLETED|Cycle 2: Randomization||0
9912868|NCT01200498|11029377|FG000|STARTED|Overall Study||22
9912869|NCT01200498|11029377|FG000|COMPLETED|Overall Study||22
9912870|NCT01200498|11029377|FG000|NOT COMPLETED|Overall Study||0
9912871|NCT01200511|11029381|FG000|STARTED|Overall Study||49
9912872|NCT01200511|11029381|FG000|COMPLETED|Overall Study||44
9912873|NCT01200511|11029381|FG000|NOT COMPLETED|Overall Study||5
9912874|NCT01200524|11029390|FG000|STARTED|Overall Study||41
9912875|NCT01200524|11029391|FG001|STARTED|Overall Study||48
9912876|NCT01200524|11029392|FG002|STARTED|Overall Study||44
9912877|NCT01200524|11029390|FG000|COMPLETED|Overall Study||39
9912878|NCT01200524|11029391|FG001|COMPLETED|Overall Study||47
9912879|NCT01200524|11029392|FG002|COMPLETED|Overall Study||40
9912880|NCT01200524|11029390|FG000|NOT COMPLETED|Overall Study||2
9912881|NCT01200524|11029391|FG001|NOT COMPLETED|Overall Study||1
9912882|NCT01200524|11029392|FG002|NOT COMPLETED|Overall Study||4
9912883|NCT01200589|11029402|FG000|STARTED|Overall Study||219
9912884|NCT01200589|11029403|FG001|STARTED|Overall Study||219
9912885|NCT01200589|11029402|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219
9912886|NCT01200589|11029403|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219
9912887|NCT01200589|11029402|FG000|Safety Set|Overall Study||217
9912888|NCT01200589|11029403|FG001|Safety Set|Overall Study||218
9912889|NCT01200589|11029402|FG000|COMPLETED|Overall Study||29
9912890|NCT01200589|11029403|FG001|COMPLETED|Overall Study||30
9912891|NCT01200589|11029402|FG000|NOT COMPLETED|Overall Study||190
9912892|NCT01200589|11029403|FG001|NOT COMPLETED|Overall Study||189
9912893|NCT01200758|11029411|FG000|STARTED|Stage I||64
9912894|NCT01200758|11029412|FG001|STARTED|Stage I||63
9912895|NCT01200758|11029413|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
9912896|NCT01200758|11029414|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
9912897|NCT01200758|11029411|FG000|COMPLETED|Stage I|Participants completed treatment period.|46
9912898|NCT01200758|11029412|FG001|COMPLETED|Stage I|Participants completed treatment period.|46
9912899|NCT01200758|11029413|FG002|COMPLETED|Stage I||0
9912900|NCT01200758|11029414|FG003|COMPLETED|Stage I||0
9912901|NCT01200758|11029411|FG000|NOT COMPLETED|Stage I||18
9912902|NCT01200758|11029412|FG001|NOT COMPLETED|Stage I||17
9912903|NCT01200758|11029413|FG002|NOT COMPLETED|Stage I||0
9912904|NCT01200758|11029414|FG003|NOT COMPLETED|Stage I||0
9912905|NCT01200758|11029411|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
9912906|NCT01200758|11029412|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
9912907|NCT01200758|11029413|FG002|STARTED|Stage 2||141
9912908|NCT01200758|11029414|FG003|STARTED|Stage 2||142
9912909|NCT01200758|11029411|FG000|COMPLETED|Stage 2||0
9912910|NCT01200758|11029412|FG001|COMPLETED|Stage 2||0
9912911|NCT01200758|11029413|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100
9912912|NCT01200758|11029414|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92
9912913|NCT01200758|11029411|FG000|NOT COMPLETED|Stage 2||0
9912914|NCT01200758|11029412|FG001|NOT COMPLETED|Stage 2||0
9912915|NCT01200758|11029413|FG002|NOT COMPLETED|Stage 2||41
9912916|NCT01200758|11029414|FG003|NOT COMPLETED|Stage 2||50
9912917|NCT01200797|11029426|FG000|STARTED|Overall Study||19
9912918|NCT01200797|11029426|FG000|COMPLETED|Overall Study||0
9912919|NCT01200797|11029426|FG000|NOT COMPLETED|Overall Study||19
9912920|NCT01200810|11029433|FG000|STARTED|Overall Study||5
9912921|NCT01200810|11029434|FG001|STARTED|Overall Study||5
9912922|NCT01200810|11029433|FG000|COMPLETED|Overall Study||0
9912923|NCT01200810|11029434|FG001|COMPLETED|Overall Study||0
9912924|NCT01200810|11029433|FG000|NOT COMPLETED|Overall Study||5
9912925|NCT01200810|11029434|FG001|NOT COMPLETED|Overall Study||5
9912926|NCT01200875|11029440|FG000|STARTED|Overall Study||25
9912927|NCT01200875|11029440|FG000|COMPLETED|Overall Study||25
9912928|NCT01200875|11029440|FG000|NOT COMPLETED|Overall Study||0
9912929|NCT01200992|11029446|FG000|STARTED|Overall Study||39
9912930|NCT01200992|11029447|FG001|STARTED|Overall Study||45
9912931|NCT01200992|11029446|FG000|COMPLETED|Overall Study||2
9912932|NCT01200992|11029447|FG001|COMPLETED|Overall Study||4
9912933|NCT01200992|11029446|FG000|NOT COMPLETED|Overall Study||37
9912934|NCT01200992|11029447|FG001|NOT COMPLETED|Overall Study||41
9912935|NCT01201057|11029459|FG000|STARTED|Overall Study||34
9912936|NCT01201057|11029460|FG001|STARTED|Overall Study||33
9912937|NCT01201057|11029461|FG002|STARTED|Overall Study||32
9912938|NCT01201057|11029462|FG003|STARTED|Overall Study||33
9912939|NCT01201057|11029459|FG000|COMPLETED|Overall Study||32
9912940|NCT01201057|11029460|FG001|COMPLETED|Overall Study||29
9912941|NCT01201057|11029461|FG002|COMPLETED|Overall Study||27
9912942|NCT01201057|11029462|FG003|COMPLETED|Overall Study||29
9912943|NCT01201057|11029459|FG000|NOT COMPLETED|Overall Study||2
9912944|NCT01201057|11029460|FG001|NOT COMPLETED|Overall Study||4
9912945|NCT01201057|11029461|FG002|NOT COMPLETED|Overall Study||5
9912946|NCT01201057|11029462|FG003|NOT COMPLETED|Overall Study||4
9912947|NCT01201265|11029472|FG000|STARTED|Overall Study||40
9912948|NCT01201265|11029472|FG000|COMPLETED|Overall Study||2
9912949|NCT01201265|11029472|FG000|NOT COMPLETED|Overall Study||38
9912950|NCT01201317|11029479|FG000|STARTED|Overall Study||48
9912951|NCT01201317|11029480|FG001|STARTED|Overall Study||45
9912952|NCT01201317|11029481|FG002|STARTED|Overall Study||41
9912953|NCT01201317|11029479|FG000|COMPLETED|Overall Study||39
10010066|NCT01770691|11132793|FG000|COMPLETED|Overall Study||7
9912954|NCT01201317|11029480|FG001|COMPLETED|Overall Study||38
9912955|NCT01201317|11029481|FG002|COMPLETED|Overall Study||33
9912956|NCT01201317|11029479|FG000|NOT COMPLETED|Overall Study||9
9912957|NCT01201317|11029480|FG001|NOT COMPLETED|Overall Study||7
9912958|NCT01201317|11029481|FG002|NOT COMPLETED|Overall Study||8
9912959|NCT01201343|11029489|FG000|STARTED|Overall Study||79
9912960|NCT01201343|11029489|FG000|Treated|Overall Study||76
9912961|NCT01201343|11029489|FG000|COMPLETED|Overall Study||60
9912962|NCT01201343|11029489|FG000|NOT COMPLETED|Overall Study||19
9912963|NCT01201356|11029493|FG000|STARTED|Overall Study||4125
9912964|NCT01201356|11029493|FG000|Safety Set|Overall Study||4083
9912965|NCT01201356|11029493|FG000|Fingolimod Full Analysis Set|Overall Study||4046
9912966|NCT01201356|11029493|FG000|COMPLETED|Overall Study||3481
9912967|NCT01201356|11029493|FG000|NOT COMPLETED|Overall Study||644
9912968|NCT01201486|11029497|FG000|STARTED|Overall Study||6781
9912969|NCT01201486|11029497|FG000|COMPLETED|Overall Study||6781
9912970|NCT01201486|11029497|FG000|NOT COMPLETED|Overall Study||0
9912971|NCT01201629|11029503|FG000|STARTED|Overall Study||8
9912972|NCT01201629|11029504|FG001|STARTED|Overall Study||8
9912973|NCT01201629|11029503|FG000|COMPLETED|Overall Study||8
9912974|NCT01201629|11029504|FG001|COMPLETED|Overall Study||8
9912975|NCT01201629|11029503|FG000|NOT COMPLETED|Overall Study||0
9912976|NCT01201629|11029504|FG001|NOT COMPLETED|Overall Study||0
9912977|NCT01201759|11029512|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10
9912978|NCT01201759|11029513|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8
9912979|NCT01201759|11029512|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8
9912980|NCT01201759|11029513|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7
9912981|NCT01201759|11029512|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
9912982|NCT01201759|11029513|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
9912983|NCT01201759|11029512|FG000|STARTED|Visit 2||8
9912984|NCT01201759|11029513|FG001|STARTED|Visit 2||7
9912985|NCT01201759|11029512|FG000|COMPLETED|Visit 2||8
9912986|NCT01201759|11029513|FG001|COMPLETED|Visit 2||7
9912987|NCT01201759|11029512|FG000|NOT COMPLETED|Visit 2||0
9912988|NCT01201759|11029513|FG001|NOT COMPLETED|Visit 2||0
9912989|NCT01201759|11029512|FG000|STARTED|Visit 3 - Washout||8
9912990|NCT01201759|11029513|FG001|STARTED|Visit 3 - Washout||7
9912991|NCT01201759|11029512|FG000|COMPLETED|Visit 3 - Washout||7
9912992|NCT01201759|11029513|FG001|COMPLETED|Visit 3 - Washout||4
9912993|NCT01201759|11029512|FG000|NOT COMPLETED|Visit 3 - Washout||1
9912994|NCT01201759|11029513|FG001|NOT COMPLETED|Visit 3 - Washout||3
9912995|NCT01201759|11029512|FG000|STARTED|Visit 4 Crossover||7
9912996|NCT01201759|11029513|FG001|STARTED|Visit 4 Crossover||4
9912997|NCT01201759|11029512|FG000|COMPLETED|Visit 4 Crossover||7
9912998|NCT01201759|11029513|FG001|COMPLETED|Visit 4 Crossover||3
9912999|NCT01201759|11029512|FG000|NOT COMPLETED|Visit 4 Crossover||0
9913000|NCT01201759|11029513|FG001|NOT COMPLETED|Visit 4 Crossover||1
9913001|NCT01201759|11029512|FG000|STARTED|Visit 5||7
9913002|NCT01201759|11029513|FG001|STARTED|Visit 5||3
9913003|NCT01201759|11029512|FG000|COMPLETED|Visit 5||7
9913004|NCT01201759|11029513|FG001|COMPLETED|Visit 5||3
9913005|NCT01201759|11029512|FG000|NOT COMPLETED|Visit 5||0
9913006|NCT01201759|11029513|FG001|NOT COMPLETED|Visit 5||0
9913007|NCT01201772|11029524|FG000|STARTED|Overall Study||23
9913008|NCT01201772|11029525|FG001|STARTED|Overall Study||21
9913009|NCT01201772|11029526|FG002|STARTED|Overall Study||21
9913010|NCT01201772|11029524|FG000|COMPLETED|Overall Study||22
9913011|NCT01201772|11029525|FG001|COMPLETED|Overall Study||21
9913012|NCT01201772|11029526|FG002|COMPLETED|Overall Study||21
9913013|NCT01201772|11029524|FG000|NOT COMPLETED|Overall Study||1
9913014|NCT01201772|11029525|FG001|NOT COMPLETED|Overall Study||0
9913015|NCT01201772|11029526|FG002|NOT COMPLETED|Overall Study||0
9913016|NCT01201785|11029532|FG000|STARTED|Overall Study||36
9913017|NCT01201785|11029532|FG000|COMPLETED|Overall Study||20
9913018|NCT01201785|11029532|FG000|NOT COMPLETED|Overall Study||16
9913019|NCT01201798|11029538|FG000|STARTED|Overall Study||56
9913020|NCT01201798|11029539|FG001|STARTED|Overall Study||54
9913021|NCT01201798|11029538|FG000|COMPLETED|Overall Study||47
10010067|NCT01770691|11132793|FG000|NOT COMPLETED|Overall Study||0
10010068|NCT01770743|11132805|FG000|STARTED|Overall Study||44
9913022|NCT01201798|11029539|FG001|COMPLETED|Overall Study||39
9913023|NCT01201798|11029538|FG000|NOT COMPLETED|Overall Study||9
9913024|NCT01201798|11029539|FG001|NOT COMPLETED|Overall Study||15
9913025|NCT01201811|11029545|FG000|STARTED|Overall Study||44
9913026|NCT01201811|11029545|FG000|COMPLETED|Overall Study||25
9913027|NCT01201811|11029545|FG000|NOT COMPLETED|Overall Study||19
9913028|NCT01201850|11029549|FG000|STARTED|Overall Study||7
9913029|NCT01201850|11029549|FG000|COMPLETED|Overall Study||3
9913030|NCT01201850|11029549|FG000|NOT COMPLETED|Overall Study||4
9913031|NCT01201863|11029556|FG000|STARTED|Overall Study||12
9913032|NCT01201863|11029557|FG001|STARTED|Overall Study||10
9913033|NCT01201863|11029558|FG002|STARTED|Overall Study||24
9913034|NCT01201863|11029556|FG000|COMPLETED|Overall Study||11
9913035|NCT01201863|11029557|FG001|COMPLETED|Overall Study||6
9913036|NCT01201863|11029558|FG002|COMPLETED|Overall Study||18
9913037|NCT01201863|11029556|FG000|NOT COMPLETED|Overall Study||1
9913038|NCT01201863|11029557|FG001|NOT COMPLETED|Overall Study||4
9913039|NCT01201863|11029558|FG002|NOT COMPLETED|Overall Study||6
9913040|NCT01201915|11029569|FG000|STARTED|Overall Study||24
9913041|NCT01201915|11029570|FG001|STARTED|Overall Study||25
9913042|NCT01201915|11029571|FG002|STARTED|Overall Study||25
9913043|NCT01201915|11029569|FG000|COMPLETED|Overall Study||16
9913044|NCT01201915|11029570|FG001|COMPLETED|Overall Study||14
9913045|NCT01201915|11029571|FG002|COMPLETED|Overall Study||19
9913046|NCT01201915|11029569|FG000|NOT COMPLETED|Overall Study||8
9913047|NCT01201915|11029570|FG001|NOT COMPLETED|Overall Study||11
9913048|NCT01201915|11029571|FG002|NOT COMPLETED|Overall Study||6
9913049|NCT01201967|11029581|FG000|STARTED|Overall Study||92
9913050|NCT01201967|11029582|FG001|STARTED|Overall Study||91
9913051|NCT01201967|11029581|FG000|COMPLETED|Overall Study||86
9913052|NCT01201967|11029582|FG001|COMPLETED|Overall Study||86
9913053|NCT01201967|11029581|FG000|NOT COMPLETED|Overall Study||6
9913054|NCT01201967|11029582|FG001|NOT COMPLETED|Overall Study||5
9913055|NCT01202071|11029589|FG000|STARTED|Overall Study||6
9913056|NCT01202071|11029590|FG001|STARTED|Overall Study||6
9913057|NCT01202071|11029591|FG002|STARTED|Overall Study||6
9913058|NCT01202071|11029592|FG003|STARTED|Overall Study||6
9913059|NCT01202071|11029589|FG000|COMPLETED|Overall Study||6
9913060|NCT01202071|11029590|FG001|COMPLETED|Overall Study||6
9913061|NCT01202071|11029591|FG002|COMPLETED|Overall Study||6
9913062|NCT01202071|11029592|FG003|COMPLETED|Overall Study||6
9913063|NCT01202071|11029589|FG000|NOT COMPLETED|Overall Study||0
9913064|NCT01202071|11029590|FG001|NOT COMPLETED|Overall Study||0
9913065|NCT01202071|11029591|FG002|NOT COMPLETED|Overall Study||0
9913066|NCT01202071|11029592|FG003|NOT COMPLETED|Overall Study||0
9913067|NCT01202162|11029604|FG000|STARTED|Overall Study||43
9913068|NCT01202162|11029605|FG001|STARTED|Overall Study||42
9913069|NCT01202162|11029604|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
9913070|NCT01202162|11029605|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
9913071|NCT01202162|11029604|FG000|NOT COMPLETED|Overall Study||3
9913072|NCT01202162|11029605|FG001|NOT COMPLETED|Overall Study||2
9913073|NCT01202175|11029613|FG000|STARTED|Overall Study||50
9913074|NCT01202175|11029613|FG000|Nebivolol|Overall Study||25
9913075|NCT01202175|11029613|FG000|Pacebo|Overall Study||25
9913076|NCT01202175|11029613|FG000|COMPLETED|Overall Study||45
9913077|NCT01202175|11029613|FG000|NOT COMPLETED|Overall Study||5
9913078|NCT01202188|11029623|FG000|STARTED|Overall Study||475
9913079|NCT01202188|11029624|FG001|STARTED|Overall Study||477
9913080|NCT01202188|11029625|FG002|STARTED|Overall Study||475
9913081|NCT01202188|11029626|FG003|STARTED|Overall Study||483
9913082|NCT01202188|11029627|FG004|STARTED|Overall Study||234
9913083|NCT01202188|11029623|FG000|Safety Set; Received Study Drug|Overall Study||474
9913084|NCT01202188|11029624|FG001|Safety Set; Received Study Drug|Overall Study||476
9913085|NCT01202188|11029625|FG002|Safety Set; Received Study Drug|Overall Study||473
9913086|NCT01202188|11029626|FG003|Safety Set; Received Study Drug|Overall Study||480
9913087|NCT01202188|11029627|FG004|Safety Set; Received Study Drug|Overall Study||232
9913088|NCT01202188|11029623|FG000|COMPLETED|Overall Study||437
9913089|NCT01202188|11029624|FG001|COMPLETED|Overall Study||421
9913090|NCT01202188|11029625|FG002|COMPLETED|Overall Study||422
9913091|NCT01202188|11029626|FG003|COMPLETED|Overall Study||441
9913092|NCT01202188|11029627|FG004|COMPLETED|Overall Study||189
9913093|NCT01202188|11029623|FG000|NOT COMPLETED|Overall Study||38
9913094|NCT01202188|11029624|FG001|NOT COMPLETED|Overall Study||56
9913095|NCT01202188|11029625|FG002|NOT COMPLETED|Overall Study||53
9913096|NCT01202188|11029626|FG003|NOT COMPLETED|Overall Study||42
9913097|NCT01202188|11029627|FG004|NOT COMPLETED|Overall Study||45
9913098|NCT01202227|11029645|FG000|STARTED|Overall Study|Treated|103
9913099|NCT01202227|11029645|FG000|COMPLETED|Overall Study||84
9913100|NCT01202227|11029645|FG000|NOT COMPLETED|Overall Study||19
9913101|NCT01202253|11029649|FG000|STARTED|Overall Study||50
9913102|NCT01202253|11029649|FG000|COMPLETED|Overall Study||50
9913103|NCT01202253|11029649|FG000|NOT COMPLETED|Overall Study||0
9913104|NCT01202279|11029655|FG000|STARTED|Overall Study||591
9913105|NCT01202279|11029656|FG001|STARTED|Overall Study||588
9913106|NCT01202279|11029655|FG000|COMPLETED|Overall Study||554
9913107|NCT01202279|11029656|FG001|COMPLETED|Overall Study||561
9913108|NCT01202279|11029655|FG000|NOT COMPLETED|Overall Study||37
9913109|NCT01202279|11029656|FG001|NOT COMPLETED|Overall Study||27
9913110|NCT01202409|11029662|FG000|STARTED|Overall Study||19
9913111|NCT01202409|11029662|FG000|COMPLETED|Overall Study||11
9913112|NCT01202409|11029662|FG000|NOT COMPLETED|Overall Study||8
9913113|NCT01202565|11029666|FG000|STARTED|Overall Study||506
9913114|NCT01202565|11029666|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
9913115|NCT01202565|11029666|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
9913116|NCT01202565|11029666|FG000|NOT COMPLETED|Overall Study||67
9913117|NCT01202578|11029670|FG000|STARTED|Overall Study||53
9913118|NCT01202578|11029670|FG000|COMPLETED|Overall Study||53
9913119|NCT01202578|11029670|FG000|NOT COMPLETED|Overall Study||0
9913120|NCT01202591|11029680|FG000|STARTED|Overall Study||5
9913121|NCT01202591|11029681|FG001|STARTED|Overall Study||5
9913122|NCT01202591|11029682|FG002|STARTED|Overall Study||12
9913123|NCT01202591|11029683|FG003|STARTED|Overall Study||9
9913124|NCT01202591|11029684|FG004|STARTED|Overall Study||5
9913125|NCT01202591|11029685|FG005|STARTED|Overall Study||4
9913126|NCT01202591|11029680|FG000|COMPLETED|Overall Study||0
9913127|NCT01202591|11029681|FG001|COMPLETED|Overall Study||0
9913128|NCT01202591|11029682|FG002|COMPLETED|Overall Study||1
9913129|NCT01202591|11029683|FG003|COMPLETED|Overall Study||2
9913130|NCT01202591|11029684|FG004|COMPLETED|Overall Study||0
9913131|NCT01202591|11029685|FG005|COMPLETED|Overall Study||0
9913132|NCT01202591|11029680|FG000|NOT COMPLETED|Overall Study||5
9913133|NCT01202591|11029681|FG001|NOT COMPLETED|Overall Study||5
9913134|NCT01202591|11029682|FG002|NOT COMPLETED|Overall Study||11
9913135|NCT01202591|11029683|FG003|NOT COMPLETED|Overall Study||7
9913136|NCT01202591|11029684|FG004|NOT COMPLETED|Overall Study||5
9913137|NCT01202591|11029685|FG005|NOT COMPLETED|Overall Study||4
9913138|NCT01202643|11029701|FG000|STARTED|Period 1||6
9913139|NCT01202643|11029702|FG001|STARTED|Period 1||6
9913140|NCT01202643|11029701|FG000|COMPLETED|Period 1||6
9913141|NCT01202643|11029702|FG001|COMPLETED|Period 1||6
9913142|NCT01202643|11029701|FG000|NOT COMPLETED|Period 1||0
9913143|NCT01202643|11029702|FG001|NOT COMPLETED|Period 1||0
9913144|NCT01202643|11029701|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
9913145|NCT01202643|11029702|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
9913146|NCT01202643|11029701|FG000|COMPLETED|Crossover Cycle||1
9913147|NCT01202643|11029702|FG001|COMPLETED|Crossover Cycle||2
9913148|NCT01202643|11029701|FG000|NOT COMPLETED|Crossover Cycle||0
9913149|NCT01202643|11029702|FG001|NOT COMPLETED|Crossover Cycle||0
9913150|NCT01202656|11029710|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
9913151|NCT01202656|11029711|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
9913152|NCT01202656|11029710|FG000|COMPLETED|Cycle 1||67
9913153|NCT01202656|11029711|FG001|COMPLETED|Cycle 1||62
9913154|NCT01202656|11029710|FG000|NOT COMPLETED|Cycle 1||0
9913155|NCT01202656|11029711|FG001|NOT COMPLETED|Cycle 1||0
9913156|NCT01202656|11029710|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
9913157|NCT01202656|11029711|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
9913158|NCT01202656|11029710|FG000|COMPLETED|CrossoverCycle||18
9913159|NCT01202656|11029711|FG001|COMPLETED|CrossoverCycle||14
9913160|NCT01202656|11029710|FG000|NOT COMPLETED|CrossoverCycle||0
9913161|NCT01202656|11029711|FG001|NOT COMPLETED|CrossoverCycle||0
9913162|NCT01202721|11029721|FG000|STARTED|Overall Study||18
9913163|NCT01202721|11029722|FG001|STARTED|Overall Study||26
9913164|NCT01202721|11029723|FG002|STARTED|Overall Study||14
9913165|NCT01202721|11029724|FG003|STARTED|Overall Study||27
9913166|NCT01202721|11029721|FG000|COMPLETED|Overall Study||18
9913167|NCT01202721|11029722|FG001|COMPLETED|Overall Study||26
9913168|NCT01202721|11029723|FG002|COMPLETED|Overall Study||14
9913169|NCT01202721|11029724|FG003|COMPLETED|Overall Study||27
9913170|NCT01202721|11029721|FG000|NOT COMPLETED|Overall Study||0
9913171|NCT01202721|11029722|FG001|NOT COMPLETED|Overall Study||0
9913172|NCT01202721|11029723|FG002|NOT COMPLETED|Overall Study||0
9913173|NCT01202721|11029724|FG003|NOT COMPLETED|Overall Study||0
9913174|NCT01202747|11029736|FG000|STARTED|Overall Study||50
9913175|NCT01202747|11029736|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
9913176|NCT01202747|11029736|FG000|NOT COMPLETED|Overall Study||1
9913177|NCT01202760|11029743|FG000|STARTED|Overall Study||379
9913178|NCT01202760|11029744|FG001|STARTED|Overall Study||374
9913179|NCT01202760|11029745|FG002|STARTED|Overall Study||251
9913180|NCT01202760|11029743|FG000|Received at Least One Dose of Study Drug|Overall Study||379
9913181|NCT01202760|11029744|FG001|Received at Least One Dose of Study Drug|Overall Study||371
9913182|NCT01202760|11029745|FG002|Received at Least One Dose of Study Drug|Overall Study||250
9913183|NCT01202760|11029743|FG000|COMPLETED|Overall Study||332
9913184|NCT01202760|11029744|FG001|COMPLETED|Overall Study||322
9913185|NCT01202760|11029745|FG002|COMPLETED|Overall Study||216
9913186|NCT01202760|11029743|FG000|NOT COMPLETED|Overall Study||47
9913187|NCT01202760|11029744|FG001|NOT COMPLETED|Overall Study||52
9913188|NCT01202760|11029745|FG002|NOT COMPLETED|Overall Study||35
9913189|NCT01202773|11029768|FG000|STARTED|Overall Study||153
9913190|NCT01202773|11029769|FG001|STARTED|Overall Study||148
9913191|NCT01202773|11029770|FG002|STARTED|Overall Study||155
9913192|NCT01202773|11029768|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153
9913193|NCT01202773|11029769|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
9913194|NCT01202773|11029770|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154
9913195|NCT01202773|11029768|FG000|Week 16 NR|Overall Study||23
9913196|NCT01202773|11029769|FG001|Week 16 NR|Overall Study||33
9913197|NCT01202773|11029770|FG002|Week 16 NR|Overall Study||37
9913198|NCT01202773|11029768|FG000|Post-Treatment Follow-Up Population|Overall Study||46
9913199|NCT01202773|11029769|FG001|Post-Treatment Follow-Up Population|Overall Study||36
9913200|NCT01202773|11029770|FG002|Post-Treatment Follow-Up Population|Overall Study||51
9913201|NCT01202773|11029768|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
9913202|NCT01202773|11029769|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
9913203|NCT01202773|11029770|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
9913204|NCT01202773|11029768|FG000|NOT COMPLETED|Overall Study||57
9913205|NCT01202773|11029769|FG001|NOT COMPLETED|Overall Study||43
9913206|NCT01202773|11029770|FG002|NOT COMPLETED|Overall Study||55
9913207|NCT01202877|11029791|FG000|STARTED|Overall Study||6
9913208|NCT01202877|11029792|FG001|STARTED|Overall Study||8
9913209|NCT01202877|11029793|FG002|STARTED|Overall Study||40
9913210|NCT01202877|11029791|FG000|COMPLETED|Overall Study||6
9913211|NCT01202877|11029792|FG001|COMPLETED|Overall Study||7
9913212|NCT01202877|11029793|FG002|COMPLETED|Overall Study||34
9913213|NCT01202877|11029791|FG000|NOT COMPLETED|Overall Study||0
9913214|NCT01202877|11029792|FG001|NOT COMPLETED|Overall Study||1
9913215|NCT01202877|11029793|FG002|NOT COMPLETED|Overall Study||6
9913216|NCT01202903|11029803|FG000|STARTED|Overall Study||308
9913217|NCT01202903|11029804|FG001|STARTED|Overall Study||308
9913218|NCT01202903|11029803|FG000|Full Analysis Set|Overall Study||306
9913219|NCT01202903|11029804|FG001|Full Analysis Set|Overall Study||302
9913220|NCT01202903|11029803|FG000|Safety Set*|Overall Study||310
9913221|NCT01202903|11029804|FG001|Safety Set*|Overall Study||299
9913222|NCT01202903|11029803|FG000|COMPLETED|Overall Study||297
10203834|NCT03467477|11330719|FG000|COMPLETED|Overall Study||161
10203835|NCT03467477|11330719|FG000|NOT COMPLETED|Overall Study||0
10203836|NCT03467685|11330728|FG000|STARTED|Overall Study||52
9913223|NCT01202903|11029804|FG001|COMPLETED|Overall Study||292
9913224|NCT01202903|11029803|FG000|NOT COMPLETED|Overall Study||11
9913225|NCT01202903|11029804|FG001|NOT COMPLETED|Overall Study||16
9913226|NCT01202955|11029812|FG000|STARTED|Period 1: 10 Days||9
9913227|NCT01202955|11029813|FG001|STARTED|Period 1: 10 Days||10
9913228|NCT01202955|11029812|FG000|COMPLETED|Period 1: 10 Days||9
9913229|NCT01202955|11029813|FG001|COMPLETED|Period 1: 10 Days||8
9913230|NCT01202955|11029812|FG000|NOT COMPLETED|Period 1: 10 Days||0
9913231|NCT01202955|11029813|FG001|NOT COMPLETED|Period 1: 10 Days||2
9913232|NCT01202955|11029812|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9
9913233|NCT01202955|11029813|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8
9913234|NCT01202955|11029812|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9
9913235|NCT01202955|11029813|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8
9913236|NCT01202955|11029812|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
9913237|NCT01202955|11029813|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
9913238|NCT01202955|11029812|FG000|STARTED|Period 3: 10 Days||9
9913239|NCT01202955|11029813|FG001|STARTED|Period 3: 10 Days||8
9913240|NCT01202955|11029812|FG000|COMPLETED|Period 3: 10 Days||9
9913241|NCT01202955|11029813|FG001|COMPLETED|Period 3: 10 Days||8
9913242|NCT01202955|11029812|FG000|NOT COMPLETED|Period 3: 10 Days||0
9913243|NCT01202955|11029813|FG001|NOT COMPLETED|Period 3: 10 Days||0
9913244|NCT01202994|11029819|FG000|STARTED|Overall Study||27
9913245|NCT01202994|11029819|FG000|COMPLETED|Overall Study||27
9913246|NCT01202994|11029819|FG000|NOT COMPLETED|Overall Study||0
9955493|NCT01438957|11074457|FG002|STARTED|Overall Study||24
9955494|NCT01438957|11074458|FG003|STARTED|Overall Study||25
9955495|NCT01438957|11074459|FG004|STARTED|Overall Study||25
9955496|NCT01438957|11074455|FG000|COMPLETED|Overall Study||21
9955497|NCT01438957|11074456|FG001|COMPLETED|Overall Study||22
9955498|NCT01438957|11074457|FG002|COMPLETED|Overall Study||24
9955499|NCT01438957|11074458|FG003|COMPLETED|Overall Study||24
9955500|NCT01438957|11074459|FG004|COMPLETED|Overall Study||25
9955501|NCT01438957|11074455|FG000|NOT COMPLETED|Overall Study||1
9955502|NCT01438957|11074456|FG001|NOT COMPLETED|Overall Study||1
9955503|NCT01438957|11074457|FG002|NOT COMPLETED|Overall Study||0
9955504|NCT01438957|11074458|FG003|NOT COMPLETED|Overall Study||1
9955505|NCT01438957|11074459|FG004|NOT COMPLETED|Overall Study||0
9955506|NCT01438996|11074474|FG000|STARTED|Overall Study||18
9955507|NCT01438996|11074475|FG001|STARTED|Overall Study||13
9955508|NCT01438996|11074476|FG002|STARTED|Overall Study||20
9955509|NCT01438996|11074474|FG000|COMPLETED|Overall Study||14
9955510|NCT01438996|11074475|FG001|COMPLETED|Overall Study||12
9955511|NCT01438996|11074476|FG002|COMPLETED|Overall Study||20
9955512|NCT01438996|11074474|FG000|NOT COMPLETED|Overall Study||4
9955513|NCT01438996|11074475|FG001|NOT COMPLETED|Overall Study||1
9955514|NCT01438996|11074476|FG002|NOT COMPLETED|Overall Study||0
9955515|NCT01439009|11074486|FG000|STARTED|Overall Study||50
9955516|NCT01439009|11074487|FG001|STARTED|Overall Study||50
9955517|NCT01439009|11074486|FG000|COMPLETED|Overall Study||42
9955518|NCT01439009|11074487|FG001|COMPLETED|Overall Study||47
9955519|NCT01439009|11074486|FG000|NOT COMPLETED|Overall Study||8
9955520|NCT01439009|11074487|FG001|NOT COMPLETED|Overall Study||3
9955521|NCT01439035|11074493|FG000|STARTED|Overall Study||6
9955522|NCT01439035|11074493|FG000|COMPLETED|Overall Study||6
9955523|NCT01439035|11074493|FG000|NOT COMPLETED|Overall Study||0
9955524|NCT01439074|11074499|FG000|STARTED|Overall Study||75
9955525|NCT01439074|11074500|FG001|STARTED|Overall Study||87
9955526|NCT01439074|11074499|FG000|COMPLETED|Overall Study||66
9955527|NCT01439074|11074500|FG001|COMPLETED|Overall Study||74
9955528|NCT01439074|11074499|FG000|NOT COMPLETED|Overall Study||9
9955529|NCT01439074|11074500|FG001|NOT COMPLETED|Overall Study||13
9955530|NCT01439087|11074506|FG000|STARTED|Overall Study||2
9955531|NCT01439087|11074506|FG000|COMPLETED|Overall Study||2
10203837|NCT03467685|11330729|FG001|STARTED|Overall Study||49
10203838|NCT03467685|11330728|FG000|COMPLETED|Overall Study||52
9955532|NCT01439087|11074506|FG000|NOT COMPLETED|Overall Study||0
9955533|NCT01439126|11074512|FG000|STARTED|Overall Study||68
10203839|NCT03467685|11330729|FG001|COMPLETED|Overall Study||49
9955534|NCT01439126|11074513|FG001|STARTED|Overall Study||67
9955535|NCT01439126|11074512|FG000|COMPLETED|Overall Study||37
9955536|NCT01439126|11074513|FG001|COMPLETED|Overall Study||25
9955537|NCT01439126|11074512|FG000|NOT COMPLETED|Overall Study||31
9955538|NCT01439126|11074513|FG001|NOT COMPLETED|Overall Study||42
9955539|NCT01439204|11074521|FG000|STARTED|Overall Study||36
9955540|NCT01439204|11074522|FG001|STARTED|Overall Study||36
10010069|NCT01770743|11132806|FG001|STARTED|Overall Study||34
10010070|NCT01770743|11132807|FG002|STARTED|Overall Study||23
10010071|NCT01770743|11132808|FG003|STARTED|Overall Study||44
9913247|NCT01203046|11029826|FG000|STARTED|Overall Study||28
9913248|NCT01203046|11029827|FG001|STARTED|Overall Study||28
9913249|NCT01203046|11029826|FG000|COMPLETED|Overall Study||28
9913250|NCT01203046|11029827|FG001|COMPLETED|Overall Study||28
9913251|NCT01203046|11029826|FG000|NOT COMPLETED|Overall Study||0
9913252|NCT01203046|11029827|FG001|NOT COMPLETED|Overall Study||0
9913253|NCT01203072|11029840|FG000|STARTED|Overall Study||105
9913254|NCT01203072|11029841|FG001|STARTED|Overall Study||106
9913255|NCT01203072|11029842|FG002|STARTED|Overall Study||104
9913256|NCT01203072|11029843|FG003|STARTED|Overall Study||106
9913257|NCT01203072|11029844|FG004|STARTED|Overall Study||102
9913258|NCT01203072|11029840|FG000|COMPLETED|Overall Study||95
9913259|NCT01203072|11029841|FG001|COMPLETED|Overall Study||100
9913260|NCT01203072|11029842|FG002|COMPLETED|Overall Study||101
9913261|NCT01203072|11029843|FG003|COMPLETED|Overall Study||100
9760496|NCT00381628|10864178|FG002|STARTED|Overall Study||0
9760497|NCT00381628|10864179|FG003|STARTED|Overall Study||14
9760498|NCT00381628|10864176|FG000|COMPLETED|Overall Study||18
9760499|NCT00381628|10864177|FG001|COMPLETED|Overall Study||27
10111227|NCT02494401|11242286|FG001|Week 16|Overall Study||124
10111228|NCT02494401|11242285|FG000|6 Month Follow up|Overall Study||109
10111229|NCT02494401|11242286|FG001|6 Month Follow up|Overall Study||106
10111230|NCT02494401|11242285|FG000|COMPLETED|Overall Study||109
10111231|NCT02494401|11242286|FG001|COMPLETED|Overall Study||106
10111232|NCT02494401|11242285|FG000|NOT COMPLETED|Overall Study||25
10111233|NCT02494401|11242286|FG001|NOT COMPLETED|Overall Study||27
10111234|NCT02494440|11242292|FG000|STARTED|Overall Study||90
10111235|NCT02494440|11242292|FG000|COMPLETED|Overall Study||90
10111236|NCT02494440|11242292|FG000|NOT COMPLETED|Overall Study||0
10111237|NCT02494518|11242299|FG000|STARTED|Overall Study||11
10111238|NCT02494518|11242300|FG001|STARTED|Overall Study||12
10111239|NCT02494518|11242301|FG002|STARTED|Overall Study||11
10111240|NCT02494518|11242299|FG000|COMPLETED|Overall Study||10
10111241|NCT02494518|11242300|FG001|COMPLETED|Overall Study||10
10111242|NCT02494518|11242301|FG002|COMPLETED|Overall Study||8
10111243|NCT02494518|11242299|FG000|NOT COMPLETED|Overall Study||1
10111244|NCT02494518|11242300|FG001|NOT COMPLETED|Overall Study||2
10111245|NCT02494518|11242301|FG002|NOT COMPLETED|Overall Study||3
10111246|NCT02494583|11242312|FG000|STARTED|Overall Study||256
10111247|NCT02494583|11242313|FG001|STARTED|Overall Study||257
9913262|NCT01203072|11029844|FG004|COMPLETED|Overall Study||96
9913263|NCT01203072|11029840|FG000|NOT COMPLETED|Overall Study||10
9913264|NCT01203072|11029841|FG001|NOT COMPLETED|Overall Study||6
9913265|NCT01203072|11029842|FG002|NOT COMPLETED|Overall Study||3
9913266|NCT01203072|11029843|FG003|NOT COMPLETED|Overall Study||6
9913267|NCT01203072|11029844|FG004|NOT COMPLETED|Overall Study||6
9913268|NCT01203098|11029859|FG000|STARTED|Overall Study||89
9913269|NCT01203098|11029860|FG001|STARTED|Overall Study||86
9913270|NCT01203098|11029861|FG002|STARTED|Overall Study||89
9913271|NCT01203098|11029859|FG000|Safety Analysis Dataset|Overall Study||89
9913272|NCT01203098|11029860|FG001|Safety Analysis Dataset|Overall Study||85
9913273|NCT01203098|11029861|FG002|Safety Analysis Dataset|Overall Study||87
9913274|NCT01203098|11029859|FG000|COMPLETED|Overall Study||83
9913275|NCT01203098|11029860|FG001|COMPLETED|Overall Study||82
9913276|NCT01203098|11029861|FG002|COMPLETED|Overall Study||78
9913277|NCT01203098|11029859|FG000|NOT COMPLETED|Overall Study||6
9913278|NCT01203098|11029860|FG001|NOT COMPLETED|Overall Study||4
9913279|NCT01203098|11029861|FG002|NOT COMPLETED|Overall Study||11
9913280|NCT01203189|11029872|FG000|STARTED|First 4 Weeks Treatment||10
9913281|NCT01203189|11029873|FG001|STARTED|First 4 Weeks Treatment||10
9913282|NCT01203189|11029874|FG002|STARTED|First 4 Weeks Treatment||3
9913283|NCT01203189|11029872|FG000|COMPLETED|First 4 Weeks Treatment||8
9913284|NCT01203189|11029873|FG001|COMPLETED|First 4 Weeks Treatment||8
9913285|NCT01203189|11029874|FG002|COMPLETED|First 4 Weeks Treatment||3
9913286|NCT01203189|11029872|FG000|NOT COMPLETED|First 4 Weeks Treatment||2
9913287|NCT01203189|11029873|FG001|NOT COMPLETED|First 4 Weeks Treatment||2
9913288|NCT01203189|11029874|FG002|NOT COMPLETED|First 4 Weeks Treatment||0
9913289|NCT01203189|11029872|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0
9913290|NCT01203189|11029873|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0
9913291|NCT01203189|11029874|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3
9913292|NCT01203189|11029872|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0
9913293|NCT01203189|11029873|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0
10010072|NCT01770743|11132809|FG004|STARTED|Overall Study||23
10010073|NCT01770743|11132805|FG000|Treated|Overall Study||44
10010074|NCT01770743|11132806|FG001|Treated|Overall Study||34
10010075|NCT01770743|11132807|FG002|Treated|Overall Study||23
10010076|NCT01770743|11132808|FG003|Treated|Overall Study||44
10010077|NCT01770743|11132809|FG004|Treated|Overall Study||23
10010078|NCT01770743|11132805|FG000|COMPLETED|Overall Study||42
10010079|NCT01770743|11132806|FG001|COMPLETED|Overall Study||31
10111248|NCT02494583|11242314|FG002|STARTED|Overall Study||250
9760500|NCT00381628|10864178|FG002|COMPLETED|Overall Study||0
9913294|NCT01203189|11029874|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3
10010080|NCT01770743|11132807|FG002|COMPLETED|Overall Study||22
10010081|NCT01770743|11132808|FG003|COMPLETED|Overall Study||42
10111249|NCT02494583|11242312|FG000|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
10111250|NCT02494583|11242313|FG001|Treated|Overall Study||250
9913295|NCT01203189|11029872|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
9913296|NCT01203189|11029873|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
9913297|NCT01203189|11029874|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
9913298|NCT01203319|11029885|FG000|STARTED|Overall Study||434
9913299|NCT01203319|11029886|FG001|STARTED|Overall Study||435
9913300|NCT01203319|11029887|FG002|STARTED|Overall Study||222
9913301|NCT01203319|11029885|FG000|COMPLETED|Overall Study||428
9913302|NCT01203319|11029886|FG001|COMPLETED|Overall Study||426
9913303|NCT01203319|11029887|FG002|COMPLETED|Overall Study||217
9913304|NCT01203319|11029885|FG000|NOT COMPLETED|Overall Study||6
9913305|NCT01203319|11029886|FG001|NOT COMPLETED|Overall Study||9
9913306|NCT01203319|11029887|FG002|NOT COMPLETED|Overall Study||5
9913307|NCT01203644|11029897|FG000|STARTED|Overall Study||26
9913308|NCT01203644|11029898|FG001|STARTED|Overall Study||50
9913309|NCT01203644|11029897|FG000|COMPLETED|Overall Study||26
9913310|NCT01203644|11029898|FG001|COMPLETED|Overall Study||50
9913311|NCT01203644|11029897|FG000|NOT COMPLETED|Overall Study||0
9913312|NCT01203644|11029898|FG001|NOT COMPLETED|Overall Study||0
9913313|NCT01203774|11029907|FG000|STARTED|Overall Study||21
9913314|NCT01203774|11029908|FG001|STARTED|Overall Study||10
9913315|NCT01203774|11029907|FG000|COMPLETED|Overall Study||21
9913316|NCT01203774|11029908|FG001|COMPLETED|Overall Study||10
9913317|NCT01203774|11029907|FG000|NOT COMPLETED|Overall Study||0
9913318|NCT01203774|11029908|FG001|NOT COMPLETED|Overall Study||0
9913319|NCT01203787|11029916|FG000|STARTED|Overall Study||63
9913320|NCT01203787|11029917|FG001|STARTED|Overall Study||57
9913321|NCT01203787|11029916|FG000|COMPLETED|Overall Study||32
9913322|NCT01203787|11029917|FG001|COMPLETED|Overall Study||30
9913323|NCT01203787|11029916|FG000|NOT COMPLETED|Overall Study||31
9913324|NCT01203787|11029917|FG001|NOT COMPLETED|Overall Study||27
9913325|NCT01203826|11029927|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
9913326|NCT01203826|11029928|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
9913327|NCT01203826|11029927|FG000|COMPLETED|Overall Study||6
9913328|NCT01203826|11029928|FG001|COMPLETED|Overall Study||6
9913329|NCT01203826|11029927|FG000|NOT COMPLETED|Overall Study||0
9913330|NCT01203826|11029928|FG001|NOT COMPLETED|Overall Study||0
9913331|NCT01203852|11029934|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
9913332|NCT01203852|11029934|FG000|COMPLETED|Metoprolol 8 Weeks||369
9913333|NCT01203852|11029934|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470
9913334|NCT01203852|11029934|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
9913335|NCT01203852|11029934|FG000|COMPLETED|Washout 2 Weeks||282
9913336|NCT01203852|11029934|FG000|NOT COMPLETED|Washout 2 Weeks||46
9913337|NCT01203852|11029934|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
9913338|NCT01203852|11029934|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
9913339|NCT01203852|11029934|FG000|COMPLETED|Chlorthalidone 8 Weeks||328
9913340|NCT01203852|11029934|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0
9913341|NCT01203878|11029944|FG000|STARTED|Overall Study||9
9913342|NCT01203878|11029945|FG001|STARTED|Overall Study||9
9913343|NCT01203878|11029946|FG002|STARTED|Overall Study||3
9913344|NCT01203878|11029944|FG000|COMPLETED|Overall Study||9
9913345|NCT01203878|11029945|FG001|COMPLETED|Overall Study||9
9913346|NCT01203878|11029946|FG002|COMPLETED|Overall Study||0
9913347|NCT01203878|11029944|FG000|NOT COMPLETED|Overall Study||0
9913348|NCT01203878|11029945|FG001|NOT COMPLETED|Overall Study||0
9913349|NCT01203878|11029946|FG002|NOT COMPLETED|Overall Study||3
9913350|NCT01203917|11029953|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
9913351|NCT01203917|11029953|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
9913352|NCT01203917|11029953|FG000|NOT COMPLETED|Overall Study||36
9913353|NCT01203930|11029959|FG000|STARTED|Overall Study||64
9913354|NCT01203930|11029960|FG001|STARTED|Overall Study||41
9913355|NCT01203930|11029959|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
9913356|NCT01203930|11029960|FG001|COMPLETED|Overall Study||0
9913357|NCT01203930|11029959|FG000|NOT COMPLETED|Overall Study||21
9913358|NCT01203930|11029960|FG001|NOT COMPLETED|Overall Study||41
9913359|NCT01203956|11029968|FG000|STARTED|First Two-week Period||15
9913360|NCT01203956|11029969|FG001|STARTED|First Two-week Period||13
9913361|NCT01203956|11029968|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
9913362|NCT01203956|11029969|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
9913363|NCT01203956|11029968|FG000|NOT COMPLETED|First Two-week Period||0
9913364|NCT01203956|11029969|FG001|NOT COMPLETED|First Two-week Period||0
9913365|NCT01203956|11029968|FG000|STARTED|Second Two-week Period||15
9913366|NCT01203956|11029969|FG001|STARTED|Second Two-week Period||13
9913367|NCT01203956|11029968|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
9913368|NCT01203956|11029969|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
9913369|NCT01203956|11029968|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
9913370|NCT01203956|11029969|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
9913371|NCT01203956|11029968|FG000|NOT COMPLETED|Second Two-week Period||5
9913372|NCT01203956|11029969|FG001|NOT COMPLETED|Second Two-week Period||6
9913373|NCT01204203|11029976|FG000|STARTED|Overall Study||8
9913374|NCT01204203|11029976|FG000|COMPLETED|Overall Study||8
9913375|NCT01204203|11029976|FG000|NOT COMPLETED|Overall Study||0
9913376|NCT01204255|11029980|FG000|STARTED|Overall Study||11
9913377|NCT01204255|11029980|FG000|COMPLETED|Overall Study||10
9913378|NCT01204255|11029980|FG000|NOT COMPLETED|Overall Study||1
9913379|NCT01204294|11029991|FG000|STARTED|Overall Study||82
9913380|NCT01204294|11029992|FG001|STARTED|Overall Study||66
9913381|NCT01204294|11029993|FG002|STARTED|Overall Study||74
9913382|NCT01204294|11029994|FG003|STARTED|Overall Study||143
9913383|NCT01204294|11029995|FG004|STARTED|Overall Study||85
9913384|NCT01204294|11029996|FG005|STARTED|Overall Study||63
9913385|NCT01204294|11029997|FG006|STARTED|Overall Study||61
9913386|NCT01204294|11029991|FG000|COMPLETED|Overall Study||79
9913387|NCT01204294|11029992|FG001|COMPLETED|Overall Study||58
10010082|NCT01770743|11132809|FG004|COMPLETED|Overall Study||21
10010083|NCT01770743|11132805|FG000|NOT COMPLETED|Overall Study||2
10010084|NCT01770743|11132806|FG001|NOT COMPLETED|Overall Study||3
9913388|NCT01204294|11029993|FG002|COMPLETED|Overall Study||69
9913389|NCT01204294|11029994|FG003|COMPLETED|Overall Study||132
9913390|NCT01204294|11029995|FG004|COMPLETED|Overall Study||83
9913391|NCT01204294|11029996|FG005|COMPLETED|Overall Study||58
9913392|NCT01204294|11029997|FG006|COMPLETED|Overall Study||59
9913393|NCT01204294|11029991|FG000|NOT COMPLETED|Overall Study||3
9913394|NCT01204294|11029992|FG001|NOT COMPLETED|Overall Study||8
9913395|NCT01204294|11029993|FG002|NOT COMPLETED|Overall Study||5
9913396|NCT01204294|11029994|FG003|NOT COMPLETED|Overall Study||11
9913397|NCT01204294|11029995|FG004|NOT COMPLETED|Overall Study||2
9913398|NCT01204294|11029996|FG005|NOT COMPLETED|Overall Study||5
9913399|NCT01204294|11029997|FG006|NOT COMPLETED|Overall Study||2
9913400|NCT01204398|11030013|FG000|STARTED|Overall Study|Entered and treated.|27
9913401|NCT01204398|11030013|FG000|COMPLETED|Overall Study|Completed trial medication.|26
9913402|NCT01204398|11030013|FG000|NOT COMPLETED|Overall Study||1
9913403|NCT01204658|11030021|FG000|STARTED|Primary Phase||146
9913404|NCT01204658|11030022|FG001|STARTED|Primary Phase||142
9913405|NCT01204658|11030023|FG002|STARTED|Primary Phase||145
9913406|NCT01204658|11030024|FG003|STARTED|Primary Phase||142
9913407|NCT01204658|11030021|FG000|COMPLETED|Primary Phase||146
10010085|NCT01770743|11132807|FG002|NOT COMPLETED|Overall Study||1
9913408|NCT01204658|11030022|FG001|COMPLETED|Primary Phase||142
9913409|NCT01204658|11030023|FG002|COMPLETED|Primary Phase||144
9913410|NCT01204658|11030024|FG003|COMPLETED|Primary Phase||142
9913411|NCT01204658|11030021|FG000|NOT COMPLETED|Primary Phase||0
9913412|NCT01204658|11030022|FG001|NOT COMPLETED|Primary Phase||0
9913413|NCT01204658|11030023|FG002|NOT COMPLETED|Primary Phase||1
9913414|NCT01204658|11030024|FG003|NOT COMPLETED|Primary Phase||0
9913415|NCT01204658|11030021|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
9913416|NCT01204658|11030022|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
9913417|NCT01204658|11030023|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
9913418|NCT01204658|11030024|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
9913419|NCT01204658|11030021|FG000|COMPLETED|Booster Phase||144
9913420|NCT01204658|11030022|FG001|COMPLETED|Booster Phase||140
9913421|NCT01204658|11030023|FG002|COMPLETED|Booster Phase||140
9913422|NCT01204658|11030024|FG003|COMPLETED|Booster Phase||140
9913423|NCT01204658|11030021|FG000|NOT COMPLETED|Booster Phase||0
9913424|NCT01204658|11030022|FG001|NOT COMPLETED|Booster Phase||0
9913425|NCT01204658|11030023|FG002|NOT COMPLETED|Booster Phase||0
9913426|NCT01204658|11030024|FG003|NOT COMPLETED|Booster Phase||0
9913427|NCT01204671|11030042|FG000|STARTED|Overall Study||1012
9913428|NCT01204671|11030043|FG001|STARTED|Overall Study||1013
9913429|NCT01204671|11030044|FG002|STARTED|Overall Study||1011
9913430|NCT01204671|11030045|FG003|STARTED|Overall Study||1010
9913431|NCT01204671|11030046|FG004|STARTED|Overall Study||610
9913432|NCT01204671|11030042|FG000|COMPLETED|Overall Study||998
9913433|NCT01204671|11030043|FG001|COMPLETED|Overall Study||998
9913434|NCT01204671|11030044|FG002|COMPLETED|Overall Study||998
9913435|NCT01204671|11030045|FG003|COMPLETED|Overall Study||997
9913436|NCT01204671|11030046|FG004|COMPLETED|Overall Study||606
10010086|NCT01770743|11132808|FG003|NOT COMPLETED|Overall Study||2
10010087|NCT01770743|11132809|FG004|NOT COMPLETED|Overall Study||2
10010088|NCT01770860|11132821|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
10010089|NCT01770860|11132821|FG000|Randomization|Overall Study|One participant withdrew before randomization|45
10010090|NCT01770860|11132821|FG000|COMPLETED|Overall Study||40
10010091|NCT01770860|11132821|FG000|NOT COMPLETED|Overall Study||6
9913437|NCT01204671|11030042|FG000|NOT COMPLETED|Overall Study||14
9913438|NCT01204671|11030043|FG001|NOT COMPLETED|Overall Study||15
9913439|NCT01204671|11030044|FG002|NOT COMPLETED|Overall Study||13
9913440|NCT01204671|11030045|FG003|NOT COMPLETED|Overall Study||13
9913441|NCT01204671|11030046|FG004|NOT COMPLETED|Overall Study||4
9913442|NCT01204697|11030064|FG000|STARTED|Overall Study||36
9913443|NCT01204697|11030065|FG001|STARTED|Overall Study||38
10010092|NCT01770912|11132831|FG000|STARTED|Overall Study||12
10010093|NCT01770912|11132832|FG001|STARTED|Overall Study||12
10010094|NCT01770912|11132831|FG000|COMPLETED|Overall Study||10
10010095|NCT01770912|11132832|FG001|COMPLETED|Overall Study||12
10010096|NCT01770912|11132831|FG000|NOT COMPLETED|Overall Study||2
10010097|NCT01770912|11132832|FG001|NOT COMPLETED|Overall Study||0
9913444|NCT01204697|11030064|FG000|Treated|Overall Study||36
9913445|NCT01204697|11030065|FG001|Treated|Overall Study||37
9913446|NCT01204697|11030064|FG000|COMPLETED|Overall Study||5
9913447|NCT01204697|11030065|FG001|COMPLETED|Overall Study||2
9913448|NCT01204697|11030064|FG000|NOT COMPLETED|Overall Study||31
9913449|NCT01204697|11030065|FG001|NOT COMPLETED|Overall Study||36
9913450|NCT01204710|11030073|FG000|STARTED|Randomization Treatment||63
9913451|NCT01204710|11030074|FG001|STARTED|Randomization Treatment||60
9913452|NCT01204710|11030073|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62
9913453|NCT01204710|11030074|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59
9913454|NCT01204710|11030073|FG000|COMPLETED|Randomization Treatment||49
9913455|NCT01204710|11030074|FG001|COMPLETED|Randomization Treatment||47
9913456|NCT01204710|11030073|FG000|NOT COMPLETED|Randomization Treatment||14
9913457|NCT01204710|11030074|FG001|NOT COMPLETED|Randomization Treatment||13
9913458|NCT01204710|11030073|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
9913459|NCT01204710|11030074|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
9913460|NCT01204710|11030073|FG000|COMPLETED|Optional Olaratumab Monotherapy||0
9913461|NCT01204710|11030074|FG001|COMPLETED|Optional Olaratumab Monotherapy||16
9913462|NCT01204710|11030073|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0
9913463|NCT01204710|11030074|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3
9913464|NCT01204736|11030091|FG000|STARTED|Overall Study||4
9913465|NCT01204736|11030092|FG001|STARTED|Overall Study||5
9913466|NCT01204736|11030093|FG002|STARTED|Overall Study||3
9913467|NCT01204736|11030094|FG003|STARTED|Overall Study||2
9913468|NCT01204736|11030091|FG000|COMPLETED|Overall Study||4
9913469|NCT01204736|11030092|FG001|COMPLETED|Overall Study||5
9913470|NCT01204736|11030093|FG002|COMPLETED|Overall Study||3
9913471|NCT01204736|11030094|FG003|COMPLETED|Overall Study||2
9913472|NCT01204736|11030091|FG000|NOT COMPLETED|Overall Study||0
9913473|NCT01204736|11030092|FG001|NOT COMPLETED|Overall Study||0
9913474|NCT01204736|11030093|FG002|NOT COMPLETED|Overall Study||0
9913475|NCT01204736|11030094|FG003|NOT COMPLETED|Overall Study||0
9913476|NCT01204775|11030106|FG000|STARTED|Overall Study||4
9913477|NCT01204775|11030107|FG001|STARTED|Overall Study||4
9913478|NCT01204775|11030106|FG000|Double-blind Treatment Period|Overall Study||4
9913479|NCT01204775|11030107|FG001|Double-blind Treatment Period|Overall Study||4
9913480|NCT01204775|11030106|FG000|COMPLETED|Overall Study||3
9913481|NCT01204775|11030107|FG001|COMPLETED|Overall Study||3
9913482|NCT01204775|11030106|FG000|NOT COMPLETED|Overall Study||1
9913483|NCT01204775|11030107|FG001|NOT COMPLETED|Overall Study||1
9913484|NCT01204853|11030113|FG000|STARTED|Overall Study||2
9913485|NCT01204853|11030113|FG000|COMPLETED|Overall Study||2
9913486|NCT01204853|11030113|FG000|NOT COMPLETED|Overall Study||0
9913487|NCT01204905|11030117|FG000|STARTED|Overall Study||7
9913488|NCT01204905|11030117|FG000|COMPLETED|Overall Study||5
9913489|NCT01204905|11030117|FG000|NOT COMPLETED|Overall Study||2
9913490|NCT01204918|11030124|FG000|STARTED|Overall Study||25
9913491|NCT01204918|11030125|FG001|STARTED|Overall Study||39
9913492|NCT01204918|11030126|FG002|STARTED|Overall Study||40
9913493|NCT01204918|11030124|FG000|Stage 1 Begin|Overall Study||25
10010098|NCT01771055|11132840|FG000|STARTED|Overall Study||4
10010099|NCT01771055|11132841|FG001|STARTED|Overall Study||3
10010100|NCT01771055|11132840|FG000|COMPLETED|Overall Study||4
9913494|NCT01204918|11030125|FG001|Stage 1 Begin|Overall Study||39
9913495|NCT01204918|11030126|FG002|Stage 1 Begin|Overall Study||40
9913496|NCT01204918|11030124|FG000|Stage 1 End|Overall Study||22
9913497|NCT01204918|11030125|FG001|Stage 1 End|Overall Study||35
9913498|NCT01204918|11030126|FG002|Stage 1 End|Overall Study||36
9913499|NCT01204918|11030124|FG000|Stage 2 Begin|Overall Study||22
9913500|NCT01204918|11030125|FG001|Stage 2 Begin|Overall Study||35
9913501|NCT01204918|11030126|FG002|Stage 2 Begin|Overall Study||36
9913502|NCT01204918|11030124|FG000|Stage 2 End|Overall Study||21
9913503|NCT01204918|11030125|FG001|Stage 2 End|Overall Study||29
9913504|NCT01204918|11030126|FG002|Stage 2 End|Overall Study||35
9913505|NCT01204918|11030124|FG000|COMPLETED|Overall Study||21
9913506|NCT01204918|11030125|FG001|COMPLETED|Overall Study||29
9913507|NCT01204918|11030126|FG002|COMPLETED|Overall Study||35
9913508|NCT01204918|11030124|FG000|NOT COMPLETED|Overall Study||4
9913509|NCT01204918|11030125|FG001|NOT COMPLETED|Overall Study||10
9913510|NCT01204918|11030126|FG002|NOT COMPLETED|Overall Study||5
9913511|NCT01205035|11030136|FG000|STARTED|Overall Study||3
9913512|NCT01205035|11030137|FG001|STARTED|Overall Study||3
9913513|NCT01205035|11030136|FG000|COMPLETED|Overall Study||1
9913514|NCT01205035|11030137|FG001|COMPLETED|Overall Study||3
9913515|NCT01205035|11030136|FG000|NOT COMPLETED|Overall Study||2
9913516|NCT01205035|11030137|FG001|NOT COMPLETED|Overall Study||0
9913517|NCT01205126|11030145|FG000|STARTED|Titration Phase||130
9913518|NCT01205126|11030146|FG001|STARTED|Titration Phase||130
9913519|NCT01205126|11030145|FG000|COMPLETED|Titration Phase||107
9913520|NCT01205126|11030146|FG001|COMPLETED|Titration Phase||111
9913521|NCT01205126|11030145|FG000|NOT COMPLETED|Titration Phase||23
9913522|NCT01205126|11030146|FG001|NOT COMPLETED|Titration Phase||19
9913523|NCT01205126|11030145|FG000|STARTED|Between Titration & Maintenance Phase||107
9913524|NCT01205126|11030146|FG001|STARTED|Between Titration & Maintenance Phase||111
9913525|NCT01205126|11030145|FG000|COMPLETED|Between Titration & Maintenance Phase||107
10010101|NCT01771055|11132841|FG001|COMPLETED|Overall Study||3
10010102|NCT01771055|11132840|FG000|NOT COMPLETED|Overall Study||0
9913526|NCT01205126|11030146|FG001|COMPLETED|Between Titration & Maintenance Phase||107
9913527|NCT01205126|11030145|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0
9913528|NCT01205126|11030146|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4
9913529|NCT01205126|11030145|FG000|STARTED|Maintenance Phase||107
9913530|NCT01205126|11030146|FG001|STARTED|Maintenance Phase||107
9913531|NCT01205126|11030145|FG000|COMPLETED|Maintenance Phase||70
9913532|NCT01205126|11030146|FG001|COMPLETED|Maintenance Phase||67
9913533|NCT01205126|11030145|FG000|NOT COMPLETED|Maintenance Phase||37
9913534|NCT01205126|11030146|FG001|NOT COMPLETED|Maintenance Phase||40
9913535|NCT01205152|11030152|FG000|STARTED|Overall Study||10
9913536|NCT01205152|11030152|FG000|COMPLETED|Overall Study||9
9913537|NCT01205152|11030152|FG000|NOT COMPLETED|Overall Study||1
9913538|NCT01205165|11030158|FG000|STARTED|Overall Study||104
9913539|NCT01205165|11030158|FG000|COMPLETED|Overall Study||102
9913540|NCT01205165|11030158|FG000|NOT COMPLETED|Overall Study||2
9913541|NCT01205230|11030165|FG000|STARTED|Overall Study||21
9913542|NCT01205230|11030166|FG001|STARTED|Overall Study||13
9913543|NCT01205230|11030165|FG000|Combination Therapy|Overall Study||21
9913544|NCT01205230|11030166|FG001|Combination Therapy|Overall Study||13
9913545|NCT01205230|11030165|FG000|COMPLETED|Overall Study||16
9913546|NCT01205230|11030166|FG001|COMPLETED|Overall Study||13
9913547|NCT01205230|11030165|FG000|NOT COMPLETED|Overall Study||5
9913548|NCT01205230|11030166|FG001|NOT COMPLETED|Overall Study||0
9913549|NCT01205269|11030177|FG000|STARTED|Period 1 - First Intervention||4
9913550|NCT01205269|11030178|FG001|STARTED|Period 1 - First Intervention||4
9913551|NCT01205269|11030179|FG002|STARTED|Period 1 - First Intervention||4
9913552|NCT01205269|11030180|FG003|STARTED|Period 1 - First Intervention||6
9913553|NCT01205269|11030181|FG004|STARTED|Period 1 - First Intervention||5
9913554|NCT01205269|11030182|FG005|STARTED|Period 1 - First Intervention||5
9913555|NCT01205269|11030177|FG000|COMPLETED|Period 1 - First Intervention||4
9913556|NCT01205269|11030178|FG001|COMPLETED|Period 1 - First Intervention||4
9913557|NCT01205269|11030179|FG002|COMPLETED|Period 1 - First Intervention||4
9913558|NCT01205269|11030180|FG003|COMPLETED|Period 1 - First Intervention||6
9913559|NCT01205269|11030181|FG004|COMPLETED|Period 1 - First Intervention||5
9913560|NCT01205269|11030182|FG005|COMPLETED|Period 1 - First Intervention||5
9913561|NCT01205269|11030177|FG000|NOT COMPLETED|Period 1 - First Intervention||0
9913562|NCT01205269|11030178|FG001|NOT COMPLETED|Period 1 - First Intervention||0
9913563|NCT01205269|11030179|FG002|NOT COMPLETED|Period 1 - First Intervention||0
9913564|NCT01205269|11030180|FG003|NOT COMPLETED|Period 1 - First Intervention||0
9913565|NCT01205269|11030181|FG004|NOT COMPLETED|Period 1 - First Intervention||0
9913566|NCT01205269|11030182|FG005|NOT COMPLETED|Period 1 - First Intervention||0
9913567|NCT01205269|11030177|FG000|STARTED|Period 2 - Washout||4
9913568|NCT01205269|11030178|FG001|STARTED|Period 2 - Washout||4
9913569|NCT01205269|11030179|FG002|STARTED|Period 2 - Washout||4
9913570|NCT01205269|11030180|FG003|STARTED|Period 2 - Washout||6
9913571|NCT01205269|11030181|FG004|STARTED|Period 2 - Washout||5
9913572|NCT01205269|11030182|FG005|STARTED|Period 2 - Washout||5
9913573|NCT01205269|11030177|FG000|COMPLETED|Period 2 - Washout||4
9913574|NCT01205269|11030178|FG001|COMPLETED|Period 2 - Washout||4
9913575|NCT01205269|11030179|FG002|COMPLETED|Period 2 - Washout||4
9913576|NCT01205269|11030180|FG003|COMPLETED|Period 2 - Washout||6
9913577|NCT01205269|11030181|FG004|COMPLETED|Period 2 - Washout||5
10203840|NCT03467685|11330728|FG000|NOT COMPLETED|Overall Study||0
10203841|NCT03467685|11330729|FG001|NOT COMPLETED|Overall Study||0
10203842|NCT03467763|11330735|FG000|STARTED|Overall Study||13
10203843|NCT03467763|11330735|FG000|Weeks 1-2|Overall Study||13
10203844|NCT03467763|11330735|FG000|Weeks 3-4|Overall Study||10
10203845|NCT03467763|11330735|FG000|Weeks 5-6|Overall Study||8
10203846|NCT03467763|11330735|FG000|Weeks 7-8|Overall Study||7
10203847|NCT03467763|11330735|FG000|Weeks 9 - 10|Overall Study||6
10203848|NCT03467763|11330735|FG000|Week 11-12|Overall Study||6
10203849|NCT03467763|11330735|FG000|Weeks 13-14|Overall Study||2
10203850|NCT03467763|11330735|FG000|Weeks 15-16|Overall Study||2
10203851|NCT03467763|11330735|FG000|COMPLETED|Overall Study||10
10203852|NCT03467763|11330735|FG000|NOT COMPLETED|Overall Study||3
10203853|NCT03467945|11330745|FG000|STARTED|Treatment Period 1||10
10203854|NCT03467945|11330746|FG001|STARTED|Treatment Period 1||10
9913578|NCT01205269|11030182|FG005|COMPLETED|Period 2 - Washout||5
9913579|NCT01205269|11030177|FG000|NOT COMPLETED|Period 2 - Washout||0
9913580|NCT01205269|11030178|FG001|NOT COMPLETED|Period 2 - Washout||0
9913581|NCT01205269|11030179|FG002|NOT COMPLETED|Period 2 - Washout||0
9913582|NCT01205269|11030180|FG003|NOT COMPLETED|Period 2 - Washout||0
9913583|NCT01205269|11030181|FG004|NOT COMPLETED|Period 2 - Washout||0
9913584|NCT01205269|11030182|FG005|NOT COMPLETED|Period 2 - Washout||0
10203855|NCT03467945|11330747|FG002|STARTED|Treatment Period 1||10
10203856|NCT03467945|11330748|FG003|STARTED|Treatment Period 1||10
10203857|NCT03467945|11330745|FG000|COMPLETED|Treatment Period 1||10
10203858|NCT03467945|11330746|FG001|COMPLETED|Treatment Period 1||10
9913585|NCT01205269|11030177|FG000|STARTED|Period 3 - Second Intervention||4
9913586|NCT01205269|11030178|FG001|STARTED|Period 3 - Second Intervention||4
9913587|NCT01205269|11030179|FG002|STARTED|Period 3 - Second Intervention||4
9913588|NCT01205269|11030180|FG003|STARTED|Period 3 - Second Intervention||6
9913589|NCT01205269|11030181|FG004|STARTED|Period 3 - Second Intervention||5
9913590|NCT01205269|11030182|FG005|STARTED|Period 3 - Second Intervention||5
9913591|NCT01205269|11030177|FG000|COMPLETED|Period 3 - Second Intervention||4
9913592|NCT01205269|11030178|FG001|COMPLETED|Period 3 - Second Intervention||4
9913593|NCT01205269|11030179|FG002|COMPLETED|Period 3 - Second Intervention||4
9913594|NCT01205269|11030180|FG003|COMPLETED|Period 3 - Second Intervention||6
9913595|NCT01205269|11030181|FG004|COMPLETED|Period 3 - Second Intervention||5
9913596|NCT01205269|11030182|FG005|COMPLETED|Period 3 - Second Intervention||5
9913597|NCT01205269|11030177|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
9913598|NCT01205269|11030178|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
9913599|NCT01205269|11030179|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
9913600|NCT01205269|11030180|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
9913601|NCT01205269|11030181|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
9913602|NCT01205269|11030182|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
9913603|NCT01205269|11030177|FG000|STARTED|Period 4 - Washout||4
9913604|NCT01205269|11030178|FG001|STARTED|Period 4 - Washout||4
9913605|NCT01205269|11030179|FG002|STARTED|Period 4 - Washout||4
9913606|NCT01205269|11030180|FG003|STARTED|Period 4 - Washout||6
9913607|NCT01205269|11030181|FG004|STARTED|Period 4 - Washout||5
9913608|NCT01205269|11030182|FG005|STARTED|Period 4 - Washout||5
9913609|NCT01205269|11030177|FG000|COMPLETED|Period 4 - Washout||4
9913610|NCT01205269|11030178|FG001|COMPLETED|Period 4 - Washout||4
9913611|NCT01205269|11030179|FG002|COMPLETED|Period 4 - Washout||4
9913612|NCT01205269|11030180|FG003|COMPLETED|Period 4 - Washout||5
9913613|NCT01205269|11030181|FG004|COMPLETED|Period 4 - Washout||5
9913614|NCT01205269|11030182|FG005|COMPLETED|Period 4 - Washout||5
9913615|NCT01205269|11030177|FG000|NOT COMPLETED|Period 4 - Washout||0
9913616|NCT01205269|11030178|FG001|NOT COMPLETED|Period 4 - Washout||0
9913617|NCT01205269|11030179|FG002|NOT COMPLETED|Period 4 - Washout||0
9913618|NCT01205269|11030180|FG003|NOT COMPLETED|Period 4 - Washout||1
9913619|NCT01205269|11030181|FG004|NOT COMPLETED|Period 4 - Washout||0
9913620|NCT01205269|11030182|FG005|NOT COMPLETED|Period 4 - Washout||0
9913621|NCT01205269|11030177|FG000|STARTED|Period 5 - Third Intervention||4
9913622|NCT01205269|11030178|FG001|STARTED|Period 5 - Third Intervention||4
9913623|NCT01205269|11030179|FG002|STARTED|Period 5 - Third Intervention||4
9913624|NCT01205269|11030180|FG003|STARTED|Period 5 - Third Intervention||5
9913625|NCT01205269|11030181|FG004|STARTED|Period 5 - Third Intervention||5
9913626|NCT01205269|11030182|FG005|STARTED|Period 5 - Third Intervention||5
9913627|NCT01205269|11030177|FG000|COMPLETED|Period 5 - Third Intervention||4
9913628|NCT01205269|11030178|FG001|COMPLETED|Period 5 - Third Intervention||4
9913629|NCT01205269|11030179|FG002|COMPLETED|Period 5 - Third Intervention||4
9913630|NCT01205269|11030180|FG003|COMPLETED|Period 5 - Third Intervention||5
9913631|NCT01205269|11030181|FG004|COMPLETED|Period 5 - Third Intervention||5
9913632|NCT01205269|11030182|FG005|COMPLETED|Period 5 - Third Intervention||5
9913633|NCT01205269|11030177|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
9913634|NCT01205269|11030178|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
9913635|NCT01205269|11030179|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
9913636|NCT01205269|11030180|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
9913637|NCT01205269|11030181|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
9913638|NCT01205269|11030182|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
9913639|NCT01205399|11030190|FG000|STARTED|Overall Study||78
9913640|NCT01205399|11030190|FG000|COMPLETED|Overall Study||78
9913641|NCT01205399|11030190|FG000|NOT COMPLETED|Overall Study||0
9913642|NCT01205438|11030197|FG000|STARTED|Overall Study||372
9913643|NCT01205438|11030198|FG001|STARTED|Overall Study||376
9913644|NCT01205438|11030199|FG002|STARTED|Overall Study||376
9913645|NCT01205438|11030197|FG000|Received At Least One Dose of Study Drug|Overall Study||371
9913646|NCT01205438|11030198|FG001|Received At Least One Dose of Study Drug|Overall Study||374
9913647|NCT01205438|11030199|FG002|Received At Least One Dose of Study Drug|Overall Study||376
9913648|NCT01205438|11030197|FG000|Participated in Follow Up|Overall Study||72
9913649|NCT01205438|11030198|FG001|Participated in Follow Up|Overall Study||78
9913650|NCT01205438|11030199|FG002|Participated in Follow Up|Overall Study||66
9913651|NCT01205438|11030197|FG000|COMPLETED|Overall Study||295
9913652|NCT01205438|11030198|FG001|COMPLETED|Overall Study||289
9913653|NCT01205438|11030199|FG002|COMPLETED|Overall Study||288
9913654|NCT01205438|11030197|FG000|NOT COMPLETED|Overall Study||77
9913655|NCT01205438|11030198|FG001|NOT COMPLETED|Overall Study||87
9913656|NCT01205438|11030199|FG002|NOT COMPLETED|Overall Study||88
9913657|NCT01205451|11030212|FG000|STARTED|Overall Study||53
9913658|NCT01205451|11030213|FG001|STARTED|Overall Study||56
9913659|NCT01205451|11030212|FG000|COMPLETED|Overall Study||47
9913660|NCT01205451|11030213|FG001|COMPLETED|Overall Study||46
9913661|NCT01205451|11030212|FG000|NOT COMPLETED|Overall Study||6
9913662|NCT01205451|11030213|FG001|NOT COMPLETED|Overall Study||10
9913663|NCT01205503|11030221|FG000|STARTED|First Intervention (1st Cycle)||16
9913664|NCT01205503|11030222|FG001|STARTED|First Intervention (1st Cycle)||16
9913665|NCT01205503|11030221|FG000|COMPLETED|First Intervention (1st Cycle)||16
9913666|NCT01205503|11030222|FG001|COMPLETED|First Intervention (1st Cycle)||16
9913667|NCT01205503|11030221|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0
9913668|NCT01205503|11030222|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0
9913669|NCT01205503|11030221|FG000|STARTED|Second Intervention (2nd Cycle)||16
9913670|NCT01205503|11030222|FG001|STARTED|Second Intervention (2nd Cycle)||16
9913671|NCT01205503|11030221|FG000|COMPLETED|Second Intervention (2nd Cycle)||16
9913672|NCT01205503|11030222|FG001|COMPLETED|Second Intervention (2nd Cycle)||16
9913673|NCT01205503|11030221|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0
9913674|NCT01205503|11030222|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0
9913675|NCT01205529|11030228|FG000|STARTED|Overall Study||161
9913676|NCT01205529|11030228|FG000|COMPLETED|Overall Study||106
9913677|NCT01205529|11030228|FG000|NOT COMPLETED|Overall Study||55
9913678|NCT01205568|11030232|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
9913679|NCT01205568|11030233|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
9913680|NCT01205568|11030232|FG000|COMPLETED|Overall Study||65
9913681|NCT01205568|11030233|FG001|COMPLETED|Overall Study||47
9913682|NCT01205568|11030232|FG000|NOT COMPLETED|Overall Study||0
9913683|NCT01205568|11030233|FG001|NOT COMPLETED|Overall Study||0
9913684|NCT01205581|11030243|FG000|STARTED|Overall Study||14
9913685|NCT01205581|11030244|FG001|STARTED|Overall Study||13
9913686|NCT01205581|11030245|FG002|STARTED|Overall Study||8
9913687|NCT01205581|11030246|FG003|STARTED|Overall Study||9
9913688|NCT01205581|11030247|FG004|STARTED|Overall Study||20
9913689|NCT01205581|11030248|FG005|STARTED|Overall Study||20
9913690|NCT01205581|11030243|FG000|COMPLETED|Overall Study||13
9913691|NCT01205581|11030244|FG001|COMPLETED|Overall Study||13
9913692|NCT01205581|11030245|FG002|COMPLETED|Overall Study||8
9913693|NCT01205581|11030246|FG003|COMPLETED|Overall Study||9
10010103|NCT01771055|11132841|FG001|NOT COMPLETED|Overall Study||0
10010104|NCT01771172|11132847|FG000|STARTED|Overall Study||48
10010105|NCT01771172|11132847|FG000|COMPLETED|Overall Study||46
10010106|NCT01771172|11132847|FG000|NOT COMPLETED|Overall Study||2
10010107|NCT01771250|11132851|FG000|STARTED|Period 1||8
10010108|NCT01771250|11132852|FG001|STARTED|Period 1||7
10010109|NCT01771250|11132851|FG000|Received at Least One Dose of Study Drug|Period 1||7
10010110|NCT01771250|11132852|FG001|Received at Least One Dose of Study Drug|Period 1||7
10010111|NCT01771250|11132851|FG000|COMPLETED|Period 1||7
9913694|NCT01205581|11030247|FG004|COMPLETED|Overall Study||20
9913695|NCT01205581|11030248|FG005|COMPLETED|Overall Study||20
9913696|NCT01205581|11030243|FG000|NOT COMPLETED|Overall Study||1
9913697|NCT01205581|11030244|FG001|NOT COMPLETED|Overall Study||0
9913698|NCT01205581|11030245|FG002|NOT COMPLETED|Overall Study||0
9913699|NCT01205581|11030246|FG003|NOT COMPLETED|Overall Study||0
9913700|NCT01205581|11030247|FG004|NOT COMPLETED|Overall Study||0
9913701|NCT01205581|11030248|FG005|NOT COMPLETED|Overall Study||0
9913702|NCT01205646|11030279|FG000|STARTED|Overall Study||11
9913703|NCT01205646|11030279|FG000|COMPLETED|Overall Study||11
9913704|NCT01205646|11030279|FG000|NOT COMPLETED|Overall Study||0
9913705|NCT01205685|11030283|FG000|STARTED|Overall Study||11
9913706|NCT01205685|11030283|FG000|COMPLETED|Overall Study||0
9913707|NCT01205685|11030283|FG000|NOT COMPLETED|Overall Study||11
9913708|NCT01205776|11030289|FG000|STARTED|Overall Study||948
9913709|NCT01205776|11030290|FG001|STARTED|Overall Study||957
9913710|NCT01205776|11030289|FG000|COMPLETED|Overall Study||884
9913711|NCT01205776|11030290|FG001|COMPLETED|Overall Study||862
9913712|NCT01205776|11030289|FG000|NOT COMPLETED|Overall Study||64
9913713|NCT01205776|11030290|FG001|NOT COMPLETED|Overall Study||95
9913714|NCT01205828|11030296|FG000|STARTED|Overall Study||16
9913715|NCT01205828|11030296|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
9913716|NCT01205828|11030296|FG000|NOT COMPLETED|Overall Study||0
9913717|NCT01206062|11030303|FG000|STARTED|Overall Study||4678
9913718|NCT01206062|11030304|FG001|STARTED|Overall Study||4683
9913719|NCT01206062|11030303|FG000|COMPLETED|Overall Study||4678
9913720|NCT01206062|11030304|FG001|COMPLETED|Overall Study||4683
9913721|NCT01206062|11030303|FG000|NOT COMPLETED|Overall Study||0
9913722|NCT01206062|11030304|FG001|NOT COMPLETED|Overall Study||0
9913723|NCT01206140|11030314|FG000|STARTED|Overall Study||35
9913724|NCT01206140|11030315|FG001|STARTED|Overall Study||35
9913725|NCT01206140|11030314|FG000|COMPLETED|Overall Study||34
9913726|NCT01206140|11030315|FG001|COMPLETED|Overall Study||35
9913727|NCT01206140|11030314|FG000|NOT COMPLETED|Overall Study||1
9913728|NCT01206140|11030315|FG001|NOT COMPLETED|Overall Study||0
9913729|NCT01206166|11030323|FG000|STARTED|Overall Study||73
9913730|NCT01206166|11030324|FG001|STARTED|Overall Study||52
9913731|NCT01206166|11030323|FG000|COMPLETED|Overall Study||71
9913732|NCT01206166|11030324|FG001|COMPLETED|Overall Study||49
10010112|NCT01771250|11132852|FG001|COMPLETED|Period 1||7
9913733|NCT01206166|11030323|FG000|NOT COMPLETED|Overall Study||2
9913734|NCT01206166|11030324|FG001|NOT COMPLETED|Overall Study||3
9913735|NCT01206322|11030335|FG000|STARTED|Overall Study||4
9913736|NCT01206322|11030336|FG001|STARTED|Overall Study||11
9913737|NCT01206322|11030337|FG002|STARTED|Overall Study||9
9913738|NCT01206322|11030338|FG003|STARTED|Overall Study||6
10010113|NCT01771250|11132851|FG000|NOT COMPLETED|Period 1||1
10010114|NCT01771250|11132852|FG001|NOT COMPLETED|Period 1||0
9913739|NCT01206322|11030335|FG000|COMPLETED|Overall Study||4
9913740|NCT01206322|11030336|FG001|COMPLETED|Overall Study||11
9913741|NCT01206322|11030337|FG002|COMPLETED|Overall Study||9
9913742|NCT01206322|11030338|FG003|COMPLETED|Overall Study||5
9913743|NCT01206322|11030335|FG000|NOT COMPLETED|Overall Study||0
9913744|NCT01206322|11030336|FG001|NOT COMPLETED|Overall Study||0
10010115|NCT01771250|11132851|FG000|STARTED|Period 2||7
10010116|NCT01771250|11132852|FG001|STARTED|Period 2||7
10010117|NCT01771250|11132851|FG000|COMPLETED|Period 2||7
9913745|NCT01206322|11030337|FG002|NOT COMPLETED|Overall Study||0
9913746|NCT01206322|11030338|FG003|NOT COMPLETED|Overall Study||1
9913747|NCT01206387|11030350|FG000|STARTED|Overall Study||60
9913748|NCT01206387|11030351|FG001|STARTED|Overall Study||60
9913749|NCT01206387|11030350|FG000|COMPLETED|Overall Study||59
9913750|NCT01206387|11030351|FG001|COMPLETED|Overall Study||60
9913751|NCT01206387|11030350|FG000|NOT COMPLETED|Overall Study||1
9913752|NCT01206387|11030351|FG001|NOT COMPLETED|Overall Study||0
9913753|NCT01206452|11030359|FG000|STARTED|Overall Study||30
9913754|NCT01206452|11030360|FG001|STARTED|Overall Study||30
9913755|NCT01206452|11030359|FG000|COMPLETED|Overall Study||30
9913756|NCT01206452|11030360|FG001|COMPLETED|Overall Study||30
9913757|NCT01206452|11030359|FG000|NOT COMPLETED|Overall Study||0
9913758|NCT01206452|11030360|FG001|NOT COMPLETED|Overall Study||0
9913759|NCT01206465|11030366|FG000|STARTED|Overall Study||3
9913760|NCT01206465|11030367|FG001|STARTED|Overall Study||6
9913761|NCT01206465|11030368|FG002|STARTED|Overall Study||6
9913762|NCT01206465|11030369|FG003|STARTED|Overall Study||6
9913763|NCT01206465|11030370|FG004|STARTED|Overall Study||6
9913764|NCT01206465|11030366|FG000|COMPLETED|Overall Study||3
9913765|NCT01206465|11030367|FG001|COMPLETED|Overall Study||6
9913766|NCT01206465|11030368|FG002|COMPLETED|Overall Study||6
9913767|NCT01206465|11030369|FG003|COMPLETED|Overall Study||6
9913768|NCT01206465|11030370|FG004|COMPLETED|Overall Study||6
9913769|NCT01206465|11030366|FG000|NOT COMPLETED|Overall Study||0
9913770|NCT01206465|11030367|FG001|NOT COMPLETED|Overall Study||0
9913771|NCT01206465|11030368|FG002|NOT COMPLETED|Overall Study||0
9913772|NCT01206465|11030369|FG003|NOT COMPLETED|Overall Study||0
9913773|NCT01206465|11030370|FG004|NOT COMPLETED|Overall Study||0
9913774|NCT01206478|11030388|FG000|STARTED|Overall Study||9
9913775|NCT01206478|11030389|FG001|STARTED|Overall Study||12
9913776|NCT01206478|11030388|FG000|COMPLETED|Overall Study||7
9913777|NCT01206478|11030389|FG001|COMPLETED|Overall Study||7
9913778|NCT01206478|11030388|FG000|NOT COMPLETED|Overall Study||2
9913779|NCT01206478|11030389|FG001|NOT COMPLETED|Overall Study||5
9913780|NCT01206582|11030397|FG000|STARTED|Overall Study||11
9913781|NCT01206582|11030398|FG001|STARTED|Overall Study||9
9913782|NCT01206582|11030397|FG000|COMPLETED|Overall Study||9
9913783|NCT01206582|11030398|FG001|COMPLETED|Overall Study||7
9913784|NCT01206582|11030397|FG000|NOT COMPLETED|Overall Study||2
9913785|NCT01206582|11030398|FG001|NOT COMPLETED|Overall Study||2
9913786|NCT01206595|11030406|FG000|STARTED|Overall Study||38
9913787|NCT01206595|11030407|FG001|STARTED|Overall Study||20
9913788|NCT01206595|11030406|FG000|COMPLETED|Overall Study||38
9913789|NCT01206595|11030407|FG001|COMPLETED|Overall Study||20
9913790|NCT01206595|11030406|FG000|NOT COMPLETED|Overall Study||0
9913791|NCT01206595|11030407|FG001|NOT COMPLETED|Overall Study||0
9913792|NCT01206608|11030417|FG000|STARTED|Overall Study||20
9913793|NCT01206608|11030418|FG001|STARTED|Overall Study||20
9913794|NCT01206608|11030417|FG000|COMPLETED|Overall Study||20
9913795|NCT01206608|11030418|FG001|COMPLETED|Overall Study||20
9913796|NCT01206608|11030417|FG000|NOT COMPLETED|Overall Study||0
9913797|NCT01206608|11030418|FG001|NOT COMPLETED|Overall Study||0
9913798|NCT01206660|11030426|FG000|STARTED|Overall Study||60
9913799|NCT01206660|11030427|FG001|STARTED|Overall Study||60
9913800|NCT01206660|11030426|FG000|COMPLETED|Overall Study||60
9913801|NCT01206660|11030427|FG001|COMPLETED|Overall Study||60
9913802|NCT01206660|11030426|FG000|NOT COMPLETED|Overall Study||0
9913803|NCT01206660|11030427|FG001|NOT COMPLETED|Overall Study||0
9913804|NCT01206738|11030436|FG000|STARTED|Overall Study||63
9913805|NCT01206738|11030437|FG001|STARTED|Overall Study||74
9913806|NCT01206738|11030438|FG002|STARTED|Overall Study||61
9913807|NCT01206738|11030436|FG000|COMPLETED|Overall Study||40
9913808|NCT01206738|11030437|FG001|COMPLETED|Overall Study||49
9913809|NCT01206738|11030438|FG002|COMPLETED|Overall Study||42
9913810|NCT01206738|11030436|FG000|NOT COMPLETED|Overall Study||23
9913811|NCT01206738|11030437|FG001|NOT COMPLETED|Overall Study||25
9913812|NCT01206738|11030438|FG002|NOT COMPLETED|Overall Study||19
9913813|NCT01206764|11030448|FG000|STARTED|Overall Study||142
9913814|NCT01206764|11030448|FG000|COMPLETED|Overall Study||4
9913815|NCT01206764|11030448|FG000|NOT COMPLETED|Overall Study||138
9913816|NCT01206777|11030452|FG000|STARTED|Overall Study||52
9913817|NCT01206777|11030452|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2
9913818|NCT01206777|11030452|FG000|COMPLETED|Overall Study||50
9913819|NCT01206777|11030452|FG000|NOT COMPLETED|Overall Study||2
10010118|NCT01771250|11132852|FG001|COMPLETED|Period 2||7
10010119|NCT01771250|11132851|FG000|NOT COMPLETED|Period 2||0
10203859|NCT03467945|11330747|FG002|COMPLETED|Treatment Period 1||10
10203860|NCT03467945|11330748|FG003|COMPLETED|Treatment Period 1||10
9913820|NCT01206816|11030463|FG000|STARTED|Overall Study|Started=Treated|3
9913821|NCT01206816|11030464|FG001|STARTED|Overall Study|Started=Treated|3
9913822|NCT01206816|11030465|FG002|STARTED|Overall Study|Started=Treated|20
9913823|NCT01206816|11030466|FG003|STARTED|Overall Study|Started=Treated|3
9913824|NCT01206816|11030467|FG004|STARTED|Overall Study|Started=Treated|3
9913825|NCT01206816|11030468|FG005|STARTED|Overall Study|Started=Treated|19
9913826|NCT01206816|11030469|FG006|STARTED|Overall Study|Started=Treated|6
9913827|NCT01206816|11030463|FG000|COMPLETED|Overall Study||0
9913828|NCT01206816|11030464|FG001|COMPLETED|Overall Study||0
9913829|NCT01206816|11030465|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
9913830|NCT01206816|11030466|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
9913831|NCT01206816|11030467|FG004|COMPLETED|Overall Study||0
9913832|NCT01206816|11030468|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
9913833|NCT01206816|11030469|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
9913834|NCT01206816|11030463|FG000|NOT COMPLETED|Overall Study||3
9913835|NCT01206816|11030464|FG001|NOT COMPLETED|Overall Study||3
9913836|NCT01206816|11030465|FG002|NOT COMPLETED|Overall Study||20
9913837|NCT01206816|11030466|FG003|NOT COMPLETED|Overall Study||3
9913838|NCT01206816|11030467|FG004|NOT COMPLETED|Overall Study||3
9913839|NCT01206816|11030468|FG005|NOT COMPLETED|Overall Study||19
9913840|NCT01206816|11030469|FG006|NOT COMPLETED|Overall Study||6
9913841|NCT01207219|11030492|FG000|STARTED|Overall Study||45
9913842|NCT01207219|11030493|FG001|STARTED|Overall Study||40
9913843|NCT01207219|11030494|FG002|STARTED|Overall Study||39
9913844|NCT01207219|11030492|FG000|Included in ITT Analysis|Overall Study||40
9913845|NCT01207219|11030493|FG001|Included in ITT Analysis|Overall Study||37
9913846|NCT01207219|11030494|FG002|Included in ITT Analysis|Overall Study||38
9913847|NCT01207219|11030492|FG000|COMPLETED|Overall Study||34
9913848|NCT01207219|11030493|FG001|COMPLETED|Overall Study||29
9913849|NCT01207219|11030494|FG002|COMPLETED|Overall Study||32
9913850|NCT01207219|11030492|FG000|NOT COMPLETED|Overall Study||11
9913851|NCT01207219|11030493|FG001|NOT COMPLETED|Overall Study||11
9913852|NCT01207219|11030494|FG002|NOT COMPLETED|Overall Study||7
9913853|NCT01207388|11030502|FG000|STARTED|Overall Study||116
10203861|NCT03467945|11330745|FG000|NOT COMPLETED|Treatment Period 1||0
9913854|NCT01207388|11030502|FG000|COMPLETED|Overall Study||48
9913855|NCT01207388|11030502|FG000|NOT COMPLETED|Overall Study||68
9913856|NCT01207401|11030516|FG000|STARTED|Overall Study||26
9913857|NCT01207401|11030517|FG001|STARTED|Overall Study||24
9913858|NCT01207401|11030516|FG000|COMPLETED|Overall Study||26
9913859|NCT01207401|11030517|FG001|COMPLETED|Overall Study||24
9913860|NCT01207401|11030516|FG000|NOT COMPLETED|Overall Study||0
9913861|NCT01207401|11030517|FG001|NOT COMPLETED|Overall Study||0
9913862|NCT01207414|11030525|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241
9913863|NCT01207414|11030526|FG001|STARTED|Overall Study||260
9913864|NCT01207414|11030525|FG000|Safety Population: Received Study Drug|Overall Study||240
9913865|NCT01207414|11030526|FG001|Safety Population: Received Study Drug|Overall Study||260
9913866|NCT01207414|11030525|FG000|COMPLETED|Overall Study||168
9913867|NCT01207414|11030526|FG001|COMPLETED|Overall Study||178
9913868|NCT01207414|11030525|FG000|NOT COMPLETED|Overall Study||73
9913869|NCT01207414|11030526|FG001|NOT COMPLETED|Overall Study||82
9913870|NCT01207427|11030535|FG000|STARTED|Run-in Placebo Period||43
9913871|NCT01207427|11030536|FG001|STARTED|Run-in Placebo Period||45
9913872|NCT01207427|11030537|FG002|STARTED|Run-in Placebo Period||43
9913873|NCT01207427|11030535|FG000|COMPLETED|Run-in Placebo Period||43
9913874|NCT01207427|11030536|FG001|COMPLETED|Run-in Placebo Period||45
9913875|NCT01207427|11030537|FG002|COMPLETED|Run-in Placebo Period||43
9913876|NCT01207427|11030535|FG000|NOT COMPLETED|Run-in Placebo Period||0
9913877|NCT01207427|11030536|FG001|NOT COMPLETED|Run-in Placebo Period||0
9913878|NCT01207427|11030537|FG002|NOT COMPLETED|Run-in Placebo Period||0
9913879|NCT01207427|11030535|FG000|STARTED|Double-blind Treatment Period||43
9913880|NCT01207427|11030536|FG001|STARTED|Double-blind Treatment Period||45
9913881|NCT01207427|11030537|FG002|STARTED|Double-blind Treatment Period||43
9913882|NCT01207427|11030535|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
9913883|NCT01207427|11030536|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
9913884|NCT01207427|11030537|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
9913885|NCT01207427|11030535|FG000|COMPLETED|Double-blind Treatment Period||40
9913886|NCT01207427|11030536|FG001|COMPLETED|Double-blind Treatment Period||43
9913887|NCT01207427|11030537|FG002|COMPLETED|Double-blind Treatment Period||41
9913888|NCT01207427|11030535|FG000|NOT COMPLETED|Double-blind Treatment Period||3
9913889|NCT01207427|11030536|FG001|NOT COMPLETED|Double-blind Treatment Period||2
9913890|NCT01207427|11030537|FG002|NOT COMPLETED|Double-blind Treatment Period||2
9913891|NCT01207427|11030535|FG000|STARTED|Run-out Placebo Period||40
9913892|NCT01207427|11030536|FG001|STARTED|Run-out Placebo Period||43
9913893|NCT01207427|11030537|FG002|STARTED|Run-out Placebo Period||41
9913894|NCT01207427|11030535|FG000|COMPLETED|Run-out Placebo Period||40
9913895|NCT01207427|11030536|FG001|COMPLETED|Run-out Placebo Period||43
9913896|NCT01207427|11030537|FG002|COMPLETED|Run-out Placebo Period||41
9913897|NCT01207427|11030535|FG000|NOT COMPLETED|Run-out Placebo Period||0
9913898|NCT01207427|11030536|FG001|NOT COMPLETED|Run-out Placebo Period||0
9913899|NCT01207427|11030537|FG002|NOT COMPLETED|Run-out Placebo Period||0
9913900|NCT01207440|11030552|FG000|STARTED|Overall Study||203
9913901|NCT01207440|11030553|FG001|STARTED|Overall Study||64
9913902|NCT01207440|11030554|FG002|STARTED|Overall Study||65
9913903|NCT01207440|11030555|FG003|STARTED|Overall Study||18
9913904|NCT01207440|11030556|FG004|STARTED|Overall Study||48
9913905|NCT01207440|11030557|FG005|STARTED|Overall Study||46
9913906|NCT01207440|11030558|FG006|STARTED|Overall Study||5
9913907|NCT01207440|11030552|FG000|COMPLETED|Overall Study||0
9913908|NCT01207440|11030553|FG001|COMPLETED|Overall Study||0
9913909|NCT01207440|11030554|FG002|COMPLETED|Overall Study||0
9913910|NCT01207440|11030555|FG003|COMPLETED|Overall Study||0
9913911|NCT01207440|11030556|FG004|COMPLETED|Overall Study||0
9913912|NCT01207440|11030557|FG005|COMPLETED|Overall Study||0
9913913|NCT01207440|11030558|FG006|COMPLETED|Overall Study||0
9913914|NCT01207440|11030552|FG000|NOT COMPLETED|Overall Study||203
9913915|NCT01207440|11030553|FG001|NOT COMPLETED|Overall Study||64
9913916|NCT01207440|11030554|FG002|NOT COMPLETED|Overall Study||65
9913917|NCT01207440|11030555|FG003|NOT COMPLETED|Overall Study||18
9913918|NCT01207440|11030556|FG004|NOT COMPLETED|Overall Study||48
9913919|NCT01207440|11030557|FG005|NOT COMPLETED|Overall Study||46
9913920|NCT01207440|11030558|FG006|NOT COMPLETED|Overall Study||5
9913921|NCT01207453|11030582|FG000|STARTED|First Intervention||23
9913922|NCT01207453|11030583|FG001|STARTED|First Intervention||18
9913923|NCT01207453|11030582|FG000|COMPLETED|First Intervention||21
9913924|NCT01207453|11030583|FG001|COMPLETED|First Intervention||17
9913925|NCT01207453|11030582|FG000|NOT COMPLETED|First Intervention||2
9913926|NCT01207453|11030583|FG001|NOT COMPLETED|First Intervention||1
9913927|NCT01207453|11030582|FG000|STARTED|Washout||21
9913928|NCT01207453|11030583|FG001|STARTED|Washout||17
9913929|NCT01207453|11030582|FG000|COMPLETED|Washout||19
9913930|NCT01207453|11030583|FG001|COMPLETED|Washout||17
9913931|NCT01207453|11030582|FG000|NOT COMPLETED|Washout||2
9913932|NCT01207453|11030583|FG001|NOT COMPLETED|Washout||0
9913933|NCT01207453|11030582|FG000|STARTED|2nd Intervention||19
9913934|NCT01207453|11030583|FG001|STARTED|2nd Intervention||17
9913935|NCT01207453|11030582|FG000|COMPLETED|2nd Intervention||17
9913936|NCT01207453|11030583|FG001|COMPLETED|2nd Intervention||15
9913937|NCT01207453|11030582|FG000|NOT COMPLETED|2nd Intervention||2
9913938|NCT01207453|11030583|FG001|NOT COMPLETED|2nd Intervention||2
9913939|NCT01207466|11030592|FG000|STARTED|Period 1, One Week of Wear||46
9913940|NCT01207466|11030593|FG001|STARTED|Period 1, One Week of Wear||48
9913941|NCT01207466|11030592|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
9913942|NCT01207466|11030593|FG001|COMPLETED|Period 1, One Week of Wear||48
9913943|NCT01207466|11030592|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
9913944|NCT01207466|11030593|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
9913945|NCT01207466|11030592|FG000|STARTED|Period 2, One Week of Wear||45
9913946|NCT01207466|11030593|FG001|STARTED|Period 2, One Week of Wear||48
9913947|NCT01207466|11030592|FG000|COMPLETED|Period 2, One Week of Wear||45
9913948|NCT01207466|11030593|FG001|COMPLETED|Period 2, One Week of Wear||48
9913949|NCT01207466|11030592|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
9913950|NCT01207466|11030593|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
9913951|NCT01207570|11030601|FG000|STARTED|The First Stage (Before Crossover)||23
9913952|NCT01207570|11030602|FG001|STARTED|The First Stage (Before Crossover)||31
9913953|NCT01207570|11030601|FG000|COMPLETED|The First Stage (Before Crossover)||23
9913954|NCT01207570|11030602|FG001|COMPLETED|The First Stage (Before Crossover)||31
9913955|NCT01207570|11030601|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0
9913956|NCT01207570|11030602|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0
9913957|NCT01207570|11030601|FG000|STARTED|The Second Stage (After Crossover)||31
9913958|NCT01207570|11030602|FG001|STARTED|The Second Stage (After Crossover)||23
9913959|NCT01207570|11030601|FG000|COMPLETED|The Second Stage (After Crossover)||31
9913960|NCT01207570|11030602|FG001|COMPLETED|The Second Stage (After Crossover)||23
9913961|NCT01207570|11030601|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0
9913962|NCT01207570|11030602|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0
9913963|NCT01207583|11030613|FG000|STARTED|Overall Study||14
9913964|NCT01207583|11030614|FG001|STARTED|Overall Study||31
9913965|NCT01207583|11030615|FG002|STARTED|Overall Study||55
9913966|NCT01207583|11030613|FG000|Dose 1|Overall Study||14
9913967|NCT01207583|11030614|FG001|Dose 1|Overall Study||31
9913968|NCT01207583|11030615|FG002|Dose 1|Overall Study||55
9913969|NCT01207583|11030613|FG000|Dose 2|Overall Study||13
9913970|NCT01207583|11030614|FG001|Dose 2|Overall Study||29
9913971|NCT01207583|11030615|FG002|Dose 2|Overall Study||54
9913972|NCT01207583|11030613|FG000|Dose 3|Overall Study||13
9913973|NCT01207583|11030614|FG001|Dose 3|Overall Study||27
9913974|NCT01207583|11030615|FG002|Dose 3|Overall Study||0
9913975|NCT01207583|11030613|FG000|Dose 4|Overall Study||7
9913976|NCT01207583|11030614|FG001|Dose 4|Overall Study||0
9913977|NCT01207583|11030615|FG002|Dose 4|Overall Study||0
9913978|NCT01207583|11030613|FG000|COMPLETED|Overall Study||13
9913979|NCT01207583|11030614|FG001|COMPLETED|Overall Study||26
9913980|NCT01207583|11030615|FG002|COMPLETED|Overall Study||54
9913981|NCT01207583|11030613|FG000|NOT COMPLETED|Overall Study||1
9913982|NCT01207583|11030614|FG001|NOT COMPLETED|Overall Study||5
9913983|NCT01207583|11030615|FG002|NOT COMPLETED|Overall Study||1
9913984|NCT01207596|11030636|FG000|STARTED|Overall Study||30
9913985|NCT01207596|11030636|FG000|COMPLETED|Overall Study||21
9913986|NCT01207596|11030636|FG000|NOT COMPLETED|Overall Study||9
9913987|NCT01207648|11030640|FG000|STARTED|Overall Study||307
9913988|NCT01207648|11030640|FG000|COMPLETED|Overall Study||307
9913989|NCT01207648|11030640|FG000|NOT COMPLETED|Overall Study||0
9913990|NCT01207687|11030644|FG000|STARTED|Overall Study||14
9913991|NCT01207687|11030644|FG000|COMPLETED|Overall Study||12
9913992|NCT01207687|11030644|FG000|NOT COMPLETED|Overall Study||2
9913993|NCT01207752|11030656|FG000|STARTED|Overall Study||35
9913994|NCT01207752|11030657|FG001|STARTED|Overall Study||34
9913995|NCT01207752|11030656|FG000|COMPLETED|Overall Study||33
9913996|NCT01207752|11030657|FG001|COMPLETED|Overall Study||27
9913997|NCT01207752|11030656|FG000|NOT COMPLETED|Overall Study||2
9913998|NCT01207752|11030657|FG001|NOT COMPLETED|Overall Study||7
9913999|NCT01207765|11030663|FG000|STARTED|Overall Study||8
9914000|NCT01207765|11030663|FG000|COMPLETED|Overall Study||8
9914001|NCT01207765|11030663|FG000|NOT COMPLETED|Overall Study||0
9914002|NCT01207908|11030669|FG000|STARTED|Overall Study||22
9914003|NCT01207908|11030670|FG001|STARTED|Overall Study||22
9914004|NCT01207908|11030669|FG000|COMPLETED|Overall Study||17
9914005|NCT01207908|11030670|FG001|COMPLETED|Overall Study||21
9914006|NCT01207908|11030669|FG000|NOT COMPLETED|Overall Study||5
9914007|NCT01207908|11030670|FG001|NOT COMPLETED|Overall Study||1
9914008|NCT01207934|11030679|FG000|STARTED|Overall Study||6
9914009|NCT01207934|11030680|FG001|STARTED|Overall Study||6
9914010|NCT01207934|11030681|FG002|STARTED|Overall Study||6
9914011|NCT01207934|11030679|FG000|COMPLETED|Overall Study||6
9914012|NCT01207934|11030680|FG001|COMPLETED|Overall Study||6
9914013|NCT01207934|11030681|FG002|COMPLETED|Overall Study||6
9914014|NCT01207934|11030679|FG000|NOT COMPLETED|Overall Study||0
9914015|NCT01207934|11030680|FG001|NOT COMPLETED|Overall Study||0
9914016|NCT01207934|11030681|FG002|NOT COMPLETED|Overall Study||0
9914017|NCT01208038|11030689|FG000|STARTED|Overall Study||22
9914018|NCT01208038|11030689|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
9914019|NCT01208038|11030689|FG000|NOT COMPLETED|Overall Study||1
9914020|NCT01208051|11030698|FG000|STARTED|Total Enrollment||4
9914021|NCT01208051|11030699|FG001|STARTED|Total Enrollment||7
9914022|NCT01208051|11030700|FG002|STARTED|Total Enrollment||6
9914023|NCT01208051|11030701|FG003|STARTED|Total Enrollment||39
9914024|NCT01208051|11030702|FG004|STARTED|Total Enrollment||71
9914025|NCT01208051|11030698|FG000|COMPLETED|Total Enrollment||4
9914026|NCT01208051|11030699|FG001|COMPLETED|Total Enrollment||6
9914027|NCT01208051|11030700|FG002|COMPLETED|Total Enrollment||5
9914028|NCT01208051|11030701|FG003|COMPLETED|Total Enrollment||39
9914029|NCT01208051|11030702|FG004|COMPLETED|Total Enrollment||69
9914030|NCT01208051|11030698|FG000|NOT COMPLETED|Total Enrollment||0
9914031|NCT01208051|11030699|FG001|NOT COMPLETED|Total Enrollment||1
9914032|NCT01208051|11030700|FG002|NOT COMPLETED|Total Enrollment||1
9914033|NCT01208051|11030701|FG003|NOT COMPLETED|Total Enrollment||0
9914034|NCT01208051|11030702|FG004|NOT COMPLETED|Total Enrollment||2
9914035|NCT01208051|11030698|FG000|STARTED|Interim Futility Analysis||0
9914036|NCT01208051|11030699|FG001|STARTED|Interim Futility Analysis||0
9914037|NCT01208051|11030700|FG002|STARTED|Interim Futility Analysis||0
9914038|NCT01208051|11030701|FG003|STARTED|Interim Futility Analysis||39
9914039|NCT01208051|11030702|FG004|STARTED|Interim Futility Analysis||68
9914040|NCT01208051|11030698|FG000|COMPLETED|Interim Futility Analysis||0
9914041|NCT01208051|11030699|FG001|COMPLETED|Interim Futility Analysis||0
9914042|NCT01208051|11030700|FG002|COMPLETED|Interim Futility Analysis||0
9914043|NCT01208051|11030701|FG003|COMPLETED|Interim Futility Analysis||39
9914044|NCT01208051|11030702|FG004|COMPLETED|Interim Futility Analysis||68
9914045|NCT01208051|11030698|FG000|NOT COMPLETED|Interim Futility Analysis||0
10010120|NCT01771250|11132852|FG001|NOT COMPLETED|Period 2||0
10010121|NCT01771627|11132860|FG000|STARTED|Overall Study||200
10010122|NCT01771627|11132861|FG001|STARTED|Overall Study||100
10010123|NCT01771627|11132860|FG000|COMPLETED|Overall Study||92
10010124|NCT01771627|11132861|FG001|COMPLETED|Overall Study||50
9914046|NCT01208051|11030699|FG001|NOT COMPLETED|Interim Futility Analysis||0
9914047|NCT01208051|11030700|FG002|NOT COMPLETED|Interim Futility Analysis||0
9914048|NCT01208051|11030701|FG003|NOT COMPLETED|Interim Futility Analysis||0
9914049|NCT01208051|11030702|FG004|NOT COMPLETED|Interim Futility Analysis||0
9914050|NCT01208051|11030698|FG000|STARTED|After Crossover to Cediranib Only||0
9914051|NCT01208051|11030699|FG001|STARTED|After Crossover to Cediranib Only||0
9914052|NCT01208051|11030700|FG002|STARTED|After Crossover to Cediranib Only||0
9914053|NCT01208051|11030701|FG003|STARTED|After Crossover to Cediranib Only||39
9914054|NCT01208051|11030702|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
9914055|NCT01208051|11030698|FG000|COMPLETED|After Crossover to Cediranib Only||0
9914056|NCT01208051|11030699|FG001|COMPLETED|After Crossover to Cediranib Only||0
9914057|NCT01208051|11030700|FG002|COMPLETED|After Crossover to Cediranib Only||0
9914058|NCT01208051|11030701|FG003|COMPLETED|After Crossover to Cediranib Only||39
9914059|NCT01208051|11030702|FG004|COMPLETED|After Crossover to Cediranib Only||69
9914060|NCT01208051|11030698|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0
9914061|NCT01208051|11030699|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0
9914062|NCT01208051|11030700|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0
9914063|NCT01208051|11030701|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0
9914064|NCT01208051|11030702|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0
9914065|NCT01208103|11030718|FG000|STARTED|Overall Study||30
9914066|NCT01208103|11030718|FG000|COMPLETED|Overall Study||28
9914067|NCT01208103|11030718|FG000|NOT COMPLETED|Overall Study||2
9914068|NCT01208220|11030725|FG000|STARTED|Overall Study||1
9914069|NCT01208220|11030726|FG001|STARTED|Overall Study||1
9914070|NCT01208220|11030725|FG000|COMPLETED|Overall Study||1
10010125|NCT01771627|11132860|FG000|NOT COMPLETED|Overall Study||108
10010126|NCT01771627|11132861|FG001|NOT COMPLETED|Overall Study||50
10010127|NCT01771666|11132867|FG000|STARTED|Overall Study||23
10010128|NCT01771666|11132867|FG000|COMPLETED|Overall Study||23
10010129|NCT01771666|11132867|FG000|NOT COMPLETED|Overall Study||0
10010130|NCT01771731|11132873|FG000|STARTED|Overall Study||13
10010131|NCT01771731|11132874|FG001|STARTED|Overall Study||14
10010132|NCT01771731|11132873|FG000|COMPLETED|Overall Study||11
10010133|NCT01771731|11132874|FG001|COMPLETED|Overall Study||12
9914071|NCT01208220|11030726|FG001|COMPLETED|Overall Study||1
9914072|NCT01208220|11030725|FG000|NOT COMPLETED|Overall Study||0
9914073|NCT01208220|11030726|FG001|NOT COMPLETED|Overall Study||0
9914074|NCT01208233|11030738|FG000|STARTED|Overall Study||11
9914075|NCT01208233|11030739|FG001|STARTED|Overall Study||9
9914076|NCT01208233|11030740|FG002|STARTED|Overall Study||11
9914077|NCT01208233|11030741|FG003|STARTED|Overall Study||10
9914078|NCT01208233|11030742|FG004|STARTED|Overall Study||70
9914079|NCT01208233|11030743|FG005|STARTED|Overall Study||67
10010134|NCT01771731|11132873|FG000|NOT COMPLETED|Overall Study||2
10010135|NCT01771731|11132874|FG001|NOT COMPLETED|Overall Study||2
10010136|NCT01771809|11132882|FG000|STARTED|Overall Study||164
10010137|NCT01771809|11132883|FG001|STARTED|Overall Study||166
9914080|NCT01208233|11030738|FG000|COMPLETED|Overall Study||6
9914081|NCT01208233|11030739|FG001|COMPLETED|Overall Study||6
9914082|NCT01208233|11030740|FG002|COMPLETED|Overall Study||7
9914083|NCT01208233|11030741|FG003|COMPLETED|Overall Study||9
9914084|NCT01208233|11030742|FG004|COMPLETED|Overall Study||46
9914085|NCT01208233|11030743|FG005|COMPLETED|Overall Study||46
9914086|NCT01208233|11030738|FG000|NOT COMPLETED|Overall Study||5
9914087|NCT01208233|11030739|FG001|NOT COMPLETED|Overall Study||3
9914088|NCT01208233|11030740|FG002|NOT COMPLETED|Overall Study||4
9914089|NCT01208233|11030741|FG003|NOT COMPLETED|Overall Study||1
9914090|NCT01208233|11030742|FG004|NOT COMPLETED|Overall Study||24
9914091|NCT01208233|11030743|FG005|NOT COMPLETED|Overall Study||21
9914092|NCT01208324|11030767|FG000|STARTED|Pre-randomization of Patch||14
9914093|NCT01208324|11030768|FG001|STARTED|Pre-randomization of Patch||15
9914094|NCT01208324|11030769|FG002|STARTED|Pre-randomization of Patch||10
9914095|NCT01208324|11030770|FG003|STARTED|Pre-randomization of Patch||8
9914096|NCT01208324|11030767|FG000|Test Day 1|Pre-randomization of Patch||14
9914097|NCT01208324|11030768|FG001|Test Day 1|Pre-randomization of Patch||15
9914098|NCT01208324|11030769|FG002|Test Day 1|Pre-randomization of Patch||10
9914099|NCT01208324|11030770|FG003|Test Day 1|Pre-randomization of Patch||8
9914100|NCT01208324|11030767|FG000|Test Day 2|Pre-randomization of Patch||14
9914101|NCT01208324|11030768|FG001|Test Day 2|Pre-randomization of Patch||15
9914102|NCT01208324|11030769|FG002|Test Day 2|Pre-randomization of Patch||8
9914103|NCT01208324|11030770|FG003|Test Day 2|Pre-randomization of Patch||5
9914104|NCT01208324|11030767|FG000|COMPLETED|Pre-randomization of Patch||14
9914105|NCT01208324|11030768|FG001|COMPLETED|Pre-randomization of Patch||15
9914106|NCT01208324|11030769|FG002|COMPLETED|Pre-randomization of Patch||8
9914107|NCT01208324|11030770|FG003|COMPLETED|Pre-randomization of Patch||5
9914108|NCT01208324|11030767|FG000|NOT COMPLETED|Pre-randomization of Patch||0
9914109|NCT01208324|11030768|FG001|NOT COMPLETED|Pre-randomization of Patch||0
10010138|NCT01771809|11132882|FG000|COMPLETED|Overall Study||93
10010139|NCT01771809|11132883|FG001|COMPLETED|Overall Study||83
9914110|NCT01208324|11030769|FG002|NOT COMPLETED|Pre-randomization of Patch||2
9914111|NCT01208324|11030770|FG003|NOT COMPLETED|Pre-randomization of Patch||3
9914112|NCT01208324|11030767|FG000|STARTED|Post-randomization of Patch||14
9914113|NCT01208324|11030768|FG001|STARTED|Post-randomization of Patch||15
9914114|NCT01208324|11030769|FG002|STARTED|Post-randomization of Patch||8
9914115|NCT01208324|11030770|FG003|STARTED|Post-randomization of Patch||5
9914116|NCT01208324|11030767|FG000|Test Day 3|Post-randomization of Patch||13
9914117|NCT01208324|11030768|FG001|Test Day 3|Post-randomization of Patch||15
9914118|NCT01208324|11030769|FG002|Test Day 3|Post-randomization of Patch||8
9914119|NCT01208324|11030770|FG003|Test Day 3|Post-randomization of Patch||5
9914120|NCT01208324|11030767|FG000|Test Day 4|Post-randomization of Patch||13
9914121|NCT01208324|11030768|FG001|Test Day 4|Post-randomization of Patch||15
9914122|NCT01208324|11030769|FG002|Test Day 4|Post-randomization of Patch||8
9914123|NCT01208324|11030770|FG003|Test Day 4|Post-randomization of Patch||5
9914124|NCT01208324|11030767|FG000|COMPLETED|Post-randomization of Patch||13
9914125|NCT01208324|11030768|FG001|COMPLETED|Post-randomization of Patch||15
9914126|NCT01208324|11030769|FG002|COMPLETED|Post-randomization of Patch||8
9914127|NCT01208324|11030770|FG003|COMPLETED|Post-randomization of Patch||5
9914128|NCT01208324|11030767|FG000|NOT COMPLETED|Post-randomization of Patch||1
9914129|NCT01208324|11030768|FG001|NOT COMPLETED|Post-randomization of Patch||0
9914130|NCT01208324|11030769|FG002|NOT COMPLETED|Post-randomization of Patch||0
9914131|NCT01208324|11030770|FG003|NOT COMPLETED|Post-randomization of Patch||0
9914132|NCT01208337|11030780|FG000|STARTED|Overall Study||23
9914133|NCT01208337|11030780|FG000|One-year Follow-up|Overall Study||23
9914134|NCT01208337|11030780|FG000|Five-year Follow-up|Overall Study||20
9914135|NCT01208337|11030780|FG000|COMPLETED|Overall Study||20
9914136|NCT01208337|11030780|FG000|NOT COMPLETED|Overall Study||3
9914137|NCT01208402|11030786|FG000|STARTED|Overall Study||31
9914138|NCT01208402|11030787|FG001|STARTED|Overall Study||28
9914139|NCT01208402|11030786|FG000|COMPLETED|Overall Study||30
9914140|NCT01208402|11030787|FG001|COMPLETED|Overall Study||28
9914141|NCT01208402|11030786|FG000|NOT COMPLETED|Overall Study||1
9914142|NCT01208402|11030787|FG001|NOT COMPLETED|Overall Study||0
9914143|NCT01208415|11030793|FG000|STARTED|Overall Study||40
9914144|NCT01208415|11030793|FG000|6 Months|Overall Study||37
9914145|NCT01208415|11030793|FG000|COMPLETED|Overall Study||0
9914146|NCT01208415|11030793|FG000|NOT COMPLETED|Overall Study||40
9914147|NCT01208870|11030799|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
9914148|NCT01208870|11030800|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
9914149|NCT01208870|11030799|FG000|Pilot 1|Overall Study||20
9914150|NCT01208870|11030800|FG001|Pilot 1|Overall Study||22
9914151|NCT01208870|11030799|FG000|Pilot 2|Overall Study||26
10010140|NCT01771809|11132882|FG000|NOT COMPLETED|Overall Study||71
9914152|NCT01208870|11030800|FG001|Pilot 2|Overall Study||22
9914153|NCT01208870|11030799|FG000|COMPLETED|Overall Study||44
10010141|NCT01771809|11132883|FG001|NOT COMPLETED|Overall Study||83
9914154|NCT01208870|11030800|FG001|COMPLETED|Overall Study||36
9914155|NCT01208870|11030799|FG000|NOT COMPLETED|Overall Study||2
9914156|NCT01208870|11030800|FG001|NOT COMPLETED|Overall Study||8
9914157|NCT01208922|11030810|FG000|STARTED|Overall Study||420
10010142|NCT01771913|11132891|FG000|STARTED|Overall Study||9
9914158|NCT01208922|11030811|FG001|STARTED|Overall Study||415
9914159|NCT01208922|11030810|FG000|COMPLETED|Overall Study||409
9914160|NCT01208922|11030811|FG001|COMPLETED|Overall Study||405
10010143|NCT01771913|11132892|FG001|STARTED|Overall Study||11
10010144|NCT01771913|11132891|FG000|COMPLETED|Overall Study||8
10010145|NCT01771913|11132892|FG001|COMPLETED|Overall Study||11
10010146|NCT01771913|11132891|FG000|NOT COMPLETED|Overall Study||1
10010147|NCT01771913|11132892|FG001|NOT COMPLETED|Overall Study||0
10010148|NCT01771952|11132900|FG000|STARTED|Overall Study||45
9914161|NCT01208922|11030810|FG000|NOT COMPLETED|Overall Study||11
9914162|NCT01208922|11030811|FG001|NOT COMPLETED|Overall Study||10
9914163|NCT01208961|11030817|FG000|STARTED|Low-Fat Period I||27
9914164|NCT01208961|11030818|FG001|STARTED|Low-Fat Period I||27
10010149|NCT01771952|11132901|FG001|STARTED|Overall Study||41
10010150|NCT01771952|11132900|FG000|COMPLETED|Overall Study||42
10010151|NCT01771952|11132901|FG001|COMPLETED|Overall Study||38
10010152|NCT01771952|11132900|FG000|NOT COMPLETED|Overall Study||3
10010153|NCT01771952|11132901|FG001|NOT COMPLETED|Overall Study||3
9914165|NCT01208961|11030817|FG000|COMPLETED|Low-Fat Period I||27
9914166|NCT01208961|11030818|FG001|COMPLETED|Low-Fat Period I||27
9914167|NCT01208961|11030817|FG000|NOT COMPLETED|Low-Fat Period I||0
9914168|NCT01208961|11030818|FG001|NOT COMPLETED|Low-Fat Period I||0
9914169|NCT01208961|11030817|FG000|STARTED|Low-Fat Period II||26
9914170|NCT01208961|11030818|FG001|STARTED|Low-Fat Period II||27
9914171|NCT01208961|11030817|FG000|COMPLETED|Low-Fat Period II||26
9914172|NCT01208961|11030818|FG001|COMPLETED|Low-Fat Period II||27
9914173|NCT01208961|11030817|FG000|NOT COMPLETED|Low-Fat Period II||0
9914174|NCT01208961|11030818|FG001|NOT COMPLETED|Low-Fat Period II||0
9914175|NCT01208961|11030817|FG000|STARTED|High-Fat Period III||26
9914176|NCT01208961|11030818|FG001|STARTED|High-Fat Period III||26
9914177|NCT01208961|11030817|FG000|COMPLETED|High-Fat Period III||25
9914178|NCT01208961|11030818|FG001|COMPLETED|High-Fat Period III||26
9914179|NCT01208961|11030817|FG000|NOT COMPLETED|High-Fat Period III||1
9914180|NCT01208961|11030818|FG001|NOT COMPLETED|High-Fat Period III||0
9914181|NCT01208961|11030817|FG000|STARTED|High-Fat Period IV||25
9914182|NCT01208961|11030818|FG001|STARTED|High-Fat Period IV||26
9914183|NCT01208961|11030817|FG000|COMPLETED|High-Fat Period IV||25
9914184|NCT01208961|11030818|FG001|COMPLETED|High-Fat Period IV||26
9914185|NCT01208961|11030817|FG000|NOT COMPLETED|High-Fat Period IV||0
9914186|NCT01208961|11030818|FG001|NOT COMPLETED|High-Fat Period IV||0
9914187|NCT01209078|11030825|FG000|STARTED|Overall Study||57
9914188|NCT01209078|11030826|FG001|STARTED|Overall Study||27
9914189|NCT01209078|11030825|FG000|COMPLETED|Overall Study||41
9914190|NCT01209078|11030826|FG001|COMPLETED|Overall Study||24
9914191|NCT01209078|11030825|FG000|NOT COMPLETED|Overall Study||16
9914192|NCT01209078|11030826|FG001|NOT COMPLETED|Overall Study||3
9914193|NCT01209143|11030836|FG000|STARTED|Overall Study||24
9914194|NCT01209143|11030837|FG001|STARTED|Overall Study||28
9914195|NCT01209143|11030836|FG000|COMPLETED|Overall Study||5
9914196|NCT01209143|11030837|FG001|COMPLETED|Overall Study||8
9914197|NCT01209143|11030836|FG000|NOT COMPLETED|Overall Study||19
9914198|NCT01209143|11030837|FG001|NOT COMPLETED|Overall Study||20
9914199|NCT01209195|11030845|FG000|STARTED|Overall Study||7
9914200|NCT01209195|11030846|FG001|STARTED|Overall Study||3
9914201|NCT01209195|11030847|FG002|STARTED|Overall Study||6
9914202|NCT01209195|11030848|FG003|STARTED|Overall Study||6
9914203|NCT01209195|11030849|FG004|STARTED|Overall Study||6
9914204|NCT01209195|11030850|FG005|STARTED|Overall Study||13
9914205|NCT01209195|11030845|FG000|COMPLETED|Overall Study||7
9914206|NCT01209195|11030846|FG001|COMPLETED|Overall Study||3
9914207|NCT01209195|11030847|FG002|COMPLETED|Overall Study||6
9914208|NCT01209195|11030848|FG003|COMPLETED|Overall Study||6
9914209|NCT01209195|11030849|FG004|COMPLETED|Overall Study||6
9914210|NCT01209195|11030850|FG005|COMPLETED|Overall Study||13
9914211|NCT01209195|11030845|FG000|NOT COMPLETED|Overall Study||0
9914212|NCT01209195|11030846|FG001|NOT COMPLETED|Overall Study||0
9914213|NCT01209195|11030847|FG002|NOT COMPLETED|Overall Study||0
9914214|NCT01209195|11030848|FG003|NOT COMPLETED|Overall Study||0
9914215|NCT01209195|11030849|FG004|NOT COMPLETED|Overall Study||0
9914216|NCT01209195|11030850|FG005|NOT COMPLETED|Overall Study||0
9914217|NCT01209234|11030868|FG000|STARTED|Overall Study||1070
9914218|NCT01209234|11030869|FG001|STARTED|Overall Study||1070
9914219|NCT01209234|11030868|FG000|COMPLETED|Overall Study||1058
9914220|NCT01209234|11030869|FG001|COMPLETED|Overall Study||1063
9914221|NCT01209234|11030868|FG000|NOT COMPLETED|Overall Study||12
9914222|NCT01209234|11030869|FG001|NOT COMPLETED|Overall Study||7
9914223|NCT01209260|11030877|FG000|STARTED|Overall Study||36
9914224|NCT01209260|11030878|FG001|STARTED|Overall Study||36
9914225|NCT01209260|11030877|FG000|COMPLETED|Overall Study||36
9914226|NCT01209260|11030878|FG001|COMPLETED|Overall Study||36
9914227|NCT01209260|11030877|FG000|NOT COMPLETED|Overall Study||0
9914228|NCT01209260|11030878|FG001|NOT COMPLETED|Overall Study||0
9914229|NCT01209286|11030889|FG000|STARTED|Overall Study||7
9914230|NCT01209286|11030890|FG001|STARTED|Overall Study||23
10010154|NCT01771965|11132909|FG000|STARTED|Overall Study||10
10010155|NCT01771965|11132910|FG001|STARTED|Overall Study||9
10010156|NCT01771965|11132909|FG000|COMPLETED|Overall Study||7
9914231|NCT01209286|11030891|FG002|STARTED|Overall Study||6
9914232|NCT01209286|11030889|FG000|COMPLETED|Overall Study||2
9914233|NCT01209286|11030890|FG001|COMPLETED|Overall Study||13
9914234|NCT01209286|11030891|FG002|COMPLETED|Overall Study||3
9914235|NCT01209286|11030889|FG000|NOT COMPLETED|Overall Study||5
9914236|NCT01209286|11030890|FG001|NOT COMPLETED|Overall Study||10
9914237|NCT01209286|11030891|FG002|NOT COMPLETED|Overall Study||3
9914238|NCT01209325|11030908|FG000|STARTED|Overall Study||149
9914239|NCT01209325|11030908|FG000|Eligible|Overall Study||145
9914240|NCT01209325|11030908|FG000|Received First Vaccine Injection|Overall Study||144
9914241|NCT01209325|11030908|FG000|Received Second Vaccine Injection|Overall Study||141
9914242|NCT01209325|11030908|FG000|Received Third Vaccine Infjection|Overall Study||138
9914243|NCT01209325|11030908|FG000|Returned After Week 28|Overall Study||124
9914244|NCT01209325|11030908|FG000|COMPLETED|Overall Study||106
9914245|NCT01209325|11030908|FG000|NOT COMPLETED|Overall Study||43
9914246|NCT01209442|11030934|FG000|STARTED|Overall Study||30
9914247|NCT01209442|11030934|FG000|COMPLETED|Overall Study||30
9914248|NCT01209442|11030934|FG000|NOT COMPLETED|Overall Study||0
9914249|NCT01209598|11030940|FG000|STARTED|Overall Study||30
9914250|NCT01209598|11030941|FG001|STARTED|Overall Study||60
9914251|NCT01209598|11030940|FG000|COMPLETED|Overall Study||29
9914252|NCT01209598|11030941|FG001|COMPLETED|Overall Study||60
9914253|NCT01209598|11030940|FG000|NOT COMPLETED|Overall Study||1
9914254|NCT01209598|11030941|FG001|NOT COMPLETED|Overall Study||0
9914255|NCT01209624|11030948|FG000|STARTED|Overall Study||902
9914256|NCT01209624|11030948|FG000|Per Protocol Population|Overall Study||469
9914257|NCT01209624|11030948|FG000|COMPLETED|Overall Study||576
9914258|NCT01209624|11030948|FG000|NOT COMPLETED|Overall Study||326
9914259|NCT01209689|11030954|FG000|STARTED|Overall Study||91
9914260|NCT01209689|11030955|FG001|STARTED|Overall Study||22
9914261|NCT01209689|11030954|FG000|COMPLETED|Overall Study||0
9914262|NCT01209689|11030955|FG001|COMPLETED|Overall Study||0
9914263|NCT01209689|11030954|FG000|NOT COMPLETED|Overall Study||91
9914264|NCT01209689|11030955|FG001|NOT COMPLETED|Overall Study||22
9955541|NCT01439204|11074521|FG000|COMPLETED|Overall Study||32
9955542|NCT01439204|11074522|FG001|COMPLETED|Overall Study||33
9955543|NCT01439204|11074521|FG000|NOT COMPLETED|Overall Study||4
9955544|NCT01439204|11074522|FG001|NOT COMPLETED|Overall Study||3
9955545|NCT01439282|11074530|FG000|STARTED|Overall Study||67
9955546|NCT01439282|11074531|FG001|STARTED|Overall Study||10
9955547|NCT01439282|11074530|FG000|COMPLETED|Overall Study||59
9955548|NCT01439282|11074531|FG001|COMPLETED|Overall Study||9
9955549|NCT01439282|11074530|FG000|NOT COMPLETED|Overall Study||8
9955550|NCT01439282|11074531|FG001|NOT COMPLETED|Overall Study||1
9955551|NCT01439360|11074540|FG000|STARTED|Overall Study||6006
9955552|NCT01439360|11074541|FG001|STARTED|Overall Study||6012
9955553|NCT01439360|11074540|FG000|COMPLETED|Overall Study||5808
9955554|NCT01439360|11074541|FG001|COMPLETED|Overall Study||5804
9955555|NCT01439360|11074540|FG000|NOT COMPLETED|Overall Study||198
9955556|NCT01439360|11074541|FG001|NOT COMPLETED|Overall Study||208
9955557|NCT01439373|11074549|FG000|STARTED|Monotherapy (Day 1)||11
9955558|NCT01439373|11074550|FG001|STARTED|Monotherapy (Day 1)||5
9955559|NCT01439373|11074549|FG000|COMPLETED|Monotherapy (Day 1)||11
9955560|NCT01439373|11074550|FG001|COMPLETED|Monotherapy (Day 1)||4
9955561|NCT01439373|11074549|FG000|NOT COMPLETED|Monotherapy (Day 1)||0
9955562|NCT01439373|11074550|FG001|NOT COMPLETED|Monotherapy (Day 1)||1
9955563|NCT01439373|11074549|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
9955564|NCT01439373|11074550|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
9955565|NCT01439373|11074549|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
9955566|NCT01439373|11074550|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
9955567|NCT01439373|11074549|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
9955568|NCT01439373|11074550|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
9955569|NCT01439555|11074560|FG000|STARTED|Overall Study||11
9955570|NCT01439555|11074560|FG000|COMPLETED|Overall Study||10
9955571|NCT01439555|11074560|FG000|NOT COMPLETED|Overall Study||1
9955572|NCT01439568|11074566|FG000|STARTED|Overall Study||47
9955573|NCT01439568|11074567|FG001|STARTED|Overall Study||43
9955574|NCT01439568|11074566|FG000|Received at Least One Dose of Study Drug|Overall Study||47
9955575|NCT01439568|11074567|FG001|Received at Least One Dose of Study Drug|Overall Study||43
9955576|NCT01439568|11074566|FG000|COMPLETED|Overall Study||44
9955577|NCT01439568|11074567|FG001|COMPLETED|Overall Study||41
9955578|NCT01439568|11074566|FG000|NOT COMPLETED|Overall Study||3
9955579|NCT01439568|11074567|FG001|NOT COMPLETED|Overall Study||2
9955580|NCT01439581|11074575|FG000|STARTED|Overall Study||216
9955581|NCT01439581|11074576|FG001|STARTED|Overall Study||212
9955582|NCT01439581|11074575|FG000|COMPLETED|Overall Study||216
9955583|NCT01439581|11074576|FG001|COMPLETED|Overall Study||212
9955584|NCT01439581|11074575|FG000|NOT COMPLETED|Overall Study||0
9955585|NCT01439581|11074576|FG001|NOT COMPLETED|Overall Study||0
9955586|NCT01439594|11074582|FG000|STARTED|Overall Study||17
9955587|NCT01439594|11074582|FG000|COMPLETED|Overall Study||17
9955588|NCT01439594|11074582|FG000|NOT COMPLETED|Overall Study||0
9955589|NCT01439620|11074586|FG000|STARTED|Overall Study||7
9955590|NCT01439620|11074586|FG000|COMPLETED|Overall Study||7
9955591|NCT01439620|11074586|FG000|NOT COMPLETED|Overall Study||0
9955592|NCT01439633|11074590|FG000|STARTED|Overall Study||22
9955593|NCT01439633|11074590|FG000|COMPLETED|Overall Study||22
9955594|NCT01439633|11074590|FG000|NOT COMPLETED|Overall Study||0
9955595|NCT01439672|11074594|FG000|STARTED|Overall Study||35
9955596|NCT01439672|11074594|FG000|COMPLETED|Overall Study||11
9955597|NCT01439672|11074594|FG000|NOT COMPLETED|Overall Study||24
9955598|NCT01439711|11074598|FG000|STARTED|Overall Study||108
9955599|NCT01439711|11074598|FG000|COMPLETED|Overall Study||68
9955600|NCT01439711|11074598|FG000|NOT COMPLETED|Overall Study||40
9955601|NCT01439724|11074604|FG000|STARTED|Overall Study||47
9914265|NCT01209702|11030963|FG000|STARTED|Overall Study||51
9914266|NCT01209702|11030964|FG001|STARTED|Overall Study||51
9914267|NCT01209702|11030965|FG002|STARTED|Overall Study||51
9914268|NCT01209702|11030966|FG003|STARTED|Overall Study||153
9914269|NCT01209702|11030963|FG000|Treated|Overall Study||51
9914270|NCT01209702|11030964|FG001|Treated|Overall Study||51
9914271|NCT01209702|11030965|FG002|Treated|Overall Study||51
9914272|NCT01209702|11030966|FG003|Treated|Overall Study||152
9914273|NCT01209702|11030963|FG000|Escape or Switched to Tocilizumab|Overall Study||51
9914274|NCT01209702|11030964|FG001|Escape or Switched to Tocilizumab|Overall Study||0
9914275|NCT01209702|11030965|FG002|Escape or Switched to Tocilizumab|Overall Study||6
9914276|NCT01209702|11030966|FG003|Escape or Switched to Tocilizumab|Overall Study||0
9914277|NCT01209702|11030963|FG000|Completed 12 Weeks Treatment|Overall Study||50
9914278|NCT01209702|11030964|FG001|Completed 12 Weeks Treatment|Overall Study||48
9914279|NCT01209702|11030965|FG002|Completed 12 Weeks Treatment|Overall Study||12
9914280|NCT01209702|11030966|FG003|Completed 12 Weeks Treatment|Overall Study||59
9914281|NCT01209702|11030963|FG000|Completed 24 Weeks Treatment|Overall Study||19
9914282|NCT01209702|11030964|FG001|Completed 24 Weeks Treatment|Overall Study||28
9914283|NCT01209702|11030965|FG002|Completed 24 Weeks Treatment|Overall Study||3
9914284|NCT01209702|11030966|FG003|Completed 24 Weeks Treatment|Overall Study||10
9914285|NCT01209702|11030963|FG000|COMPLETED|Overall Study||0
9914286|NCT01209702|11030964|FG001|COMPLETED|Overall Study||0
9914287|NCT01209702|11030965|FG002|COMPLETED|Overall Study||0
9914288|NCT01209702|11030966|FG003|COMPLETED|Overall Study||0
9914289|NCT01209702|11030963|FG000|NOT COMPLETED|Overall Study||51
9914290|NCT01209702|11030964|FG001|NOT COMPLETED|Overall Study||51
9914291|NCT01209702|11030965|FG002|NOT COMPLETED|Overall Study||51
9914292|NCT01209702|11030966|FG003|NOT COMPLETED|Overall Study||153
9914293|NCT01209780|11030989|FG000|STARTED|Overall Study||1042
9914294|NCT01209780|11030990|FG001|STARTED|Overall Study||485
9914295|NCT01209780|11030991|FG002|STARTED|Overall Study||48
9914296|NCT01209780|11030992|FG003|STARTED|Overall Study||817
9914297|NCT01209780|11030993|FG004|STARTED|Overall Study||412
9914298|NCT01209780|11030989|FG000|COMPLETED|Overall Study||1016
9914299|NCT01209780|11030990|FG001|COMPLETED|Overall Study||467
9914300|NCT01209780|11030991|FG002|COMPLETED|Overall Study||44
9914301|NCT01209780|11030992|FG003|COMPLETED|Overall Study||807
9914302|NCT01209780|11030993|FG004|COMPLETED|Overall Study||407
9914303|NCT01209780|11030989|FG000|NOT COMPLETED|Overall Study||26
9914304|NCT01209780|11030990|FG001|NOT COMPLETED|Overall Study||18
9914305|NCT01209780|11030991|FG002|NOT COMPLETED|Overall Study||4
9914306|NCT01209780|11030992|FG003|NOT COMPLETED|Overall Study||10
9914307|NCT01209780|11030993|FG004|NOT COMPLETED|Overall Study||5
9914308|NCT01209832|11031006|FG000|STARTED|Period 1||11
9914309|NCT01209832|11031006|FG000|Received At Least 1 Dose of Study Drug|Period 1||10
9914310|NCT01209832|11031006|FG000|COMPLETED|Period 1||10
9914311|NCT01209832|11031006|FG000|NOT COMPLETED|Period 1||1
9914312|NCT01209832|11031006|FG000|STARTED|Period 2||10
9914313|NCT01209832|11031006|FG000|COMPLETED|Period 2||9
9914314|NCT01209832|11031006|FG000|NOT COMPLETED|Period 2||1
9914315|NCT01209832|11031006|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
9914316|NCT01209832|11031006|FG000|COMPLETED|Maintenance Period 1 (M1)||4
9914317|NCT01209832|11031006|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0
9914318|NCT01209832|11031006|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
9914319|NCT01209832|11031006|FG000|COMPLETED|Maintenance Period 2 (M1)||3
9914320|NCT01209832|11031006|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0
9914321|NCT01209949|11031017|FG000|STARTED|Overall Study||30
9914322|NCT01209949|11031017|FG000|COMPLETED|Overall Study||27
9914323|NCT01209949|11031017|FG000|NOT COMPLETED|Overall Study||3
9914324|NCT01210001|11031024|FG000|STARTED|Overall Study||166
9914325|NCT01210001|11031025|FG001|STARTED|Overall Study||165
9914326|NCT01210001|11031026|FG002|STARTED|Overall Study||168
9914327|NCT01210001|11031024|FG000|COMPLETED|Overall Study||147
9914328|NCT01210001|11031025|FG001|COMPLETED|Overall Study||154
9914329|NCT01210001|11031026|FG002|COMPLETED|Overall Study||156
9914330|NCT01210001|11031024|FG000|NOT COMPLETED|Overall Study||19
9914331|NCT01210001|11031025|FG001|NOT COMPLETED|Overall Study||11
9914332|NCT01210001|11031026|FG002|NOT COMPLETED|Overall Study||12
9914333|NCT01210079|11031036|FG000|STARTED|Overall Study||10
9914334|NCT01210079|11031037|FG001|STARTED|Overall Study||16
9914335|NCT01210079|11031036|FG000|COMPLETED|Overall Study||10
9914336|NCT01210079|11031037|FG001|COMPLETED|Overall Study||16
9914337|NCT01210079|11031036|FG000|NOT COMPLETED|Overall Study||0
9914338|NCT01210079|11031037|FG001|NOT COMPLETED|Overall Study||0
9914339|NCT01210118|11031045|FG000|STARTED|Overall Study||45
9914340|NCT01210118|11031046|FG001|STARTED|Overall Study||47
9914341|NCT01210118|11031045|FG000|COMPLETED|Overall Study||42
9914342|NCT01210118|11031046|FG001|COMPLETED|Overall Study||42
9914343|NCT01210118|11031045|FG000|NOT COMPLETED|Overall Study||3
9914344|NCT01210118|11031046|FG001|NOT COMPLETED|Overall Study||5
9914345|NCT01210144|11031057|FG000|STARTED|Overall Study||13
9914346|NCT01210144|11031058|FG001|STARTED|Overall Study||11
9914347|NCT01210144|11031057|FG000|COMPLETED|Overall Study||10
9914348|NCT01210144|11031058|FG001|COMPLETED|Overall Study||11
9914349|NCT01210144|11031057|FG000|NOT COMPLETED|Overall Study||3
9914350|NCT01210144|11031058|FG001|NOT COMPLETED|Overall Study||0
9914351|NCT01210170|11031065|FG000|STARTED|Overall Study||22
9914352|NCT01210170|11031065|FG000|COMPLETED|Overall Study||15
9914353|NCT01210170|11031065|FG000|NOT COMPLETED|Overall Study||7
9914354|NCT01210222|11031086|FG000|STARTED|Overall Study||35
9914355|NCT01210222|11031086|FG000|COMPLETED|Overall Study||32
9914356|NCT01210222|11031086|FG000|NOT COMPLETED|Overall Study||3
9914357|NCT01210352|11031105|FG000|STARTED|Overall Study||6
9914358|NCT01210352|11031106|FG001|STARTED|Overall Study||6
9914359|NCT01210352|11031107|FG002|STARTED|Overall Study||7
9914360|NCT01210352|11031108|FG003|STARTED|Overall Study||7
9914361|NCT01210352|11031109|FG004|STARTED|Overall Study||6
9914362|NCT01210352|11031110|FG005|STARTED|Overall Study||6
9914363|NCT01210352|11031111|FG006|STARTED|Overall Study||7
9914364|NCT01210352|11031112|FG007|STARTED|Overall Study||10
9914365|NCT01210352|11031113|FG008|STARTED|Overall Study||6
9914366|NCT01210352|11031105|FG000|COMPLETED|Overall Study||6
9914367|NCT01210352|11031106|FG001|COMPLETED|Overall Study||6
9914368|NCT01210352|11031107|FG002|COMPLETED|Overall Study||5
9914369|NCT01210352|11031108|FG003|COMPLETED|Overall Study||7
9914370|NCT01210352|11031109|FG004|COMPLETED|Overall Study||6
9914371|NCT01210352|11031110|FG005|COMPLETED|Overall Study||6
9914372|NCT01210352|11031111|FG006|COMPLETED|Overall Study||5
9914373|NCT01210352|11031112|FG007|COMPLETED|Overall Study||7
9914374|NCT01210352|11031113|FG008|COMPLETED|Overall Study||2
9914375|NCT01210352|11031105|FG000|NOT COMPLETED|Overall Study||0
9914376|NCT01210352|11031106|FG001|NOT COMPLETED|Overall Study||0
9914377|NCT01210352|11031107|FG002|NOT COMPLETED|Overall Study||2
9914378|NCT01210352|11031108|FG003|NOT COMPLETED|Overall Study||0
9914379|NCT01210352|11031109|FG004|NOT COMPLETED|Overall Study||0
9914380|NCT01210352|11031110|FG005|NOT COMPLETED|Overall Study||0
9914381|NCT01210352|11031111|FG006|NOT COMPLETED|Overall Study||2
9914382|NCT01210352|11031112|FG007|NOT COMPLETED|Overall Study||3
9914383|NCT01210352|11031113|FG008|NOT COMPLETED|Overall Study||4
9914384|NCT01210443|11031218|FG000|STARTED|Overall Study||2
9914385|NCT01210443|11031218|FG000|COMPLETED|Overall Study||0
9914386|NCT01210443|11031218|FG000|NOT COMPLETED|Overall Study||2
9914387|NCT01210495|11031226|FG000|STARTED|Overall Study||15
9914388|NCT01210495|11031227|FG001|STARTED|Overall Study||7
9914389|NCT01210495|11031228|FG002|STARTED|Overall Study||134
9914390|NCT01210495|11031229|FG003|STARTED|Overall Study||68
9914391|NCT01210495|11031226|FG000|COMPLETED|Overall Study||0
9914392|NCT01210495|11031227|FG001|COMPLETED|Overall Study||0
9914393|NCT01210495|11031228|FG002|COMPLETED|Overall Study||0
9914394|NCT01210495|11031229|FG003|COMPLETED|Overall Study||0
9914395|NCT01210495|11031226|FG000|NOT COMPLETED|Overall Study||15
9914396|NCT01210495|11031227|FG001|NOT COMPLETED|Overall Study||7
9914397|NCT01210495|11031228|FG002|NOT COMPLETED|Overall Study||134
9914398|NCT01210495|11031229|FG003|NOT COMPLETED|Overall Study||68
9914399|NCT01210560|11031241|FG000|STARTED|Intervention 1 (7 Days)||2
9914400|NCT01210560|11031242|FG001|STARTED|Intervention 1 (7 Days)||2
9914401|NCT01210560|11031243|FG002|STARTED|Intervention 1 (7 Days)||2
9914402|NCT01210560|11031244|FG003|STARTED|Intervention 1 (7 Days)||2
9914403|NCT01210560|11031245|FG004|STARTED|Intervention 1 (7 Days)||2
9914404|NCT01210560|11031246|FG005|STARTED|Intervention 1 (7 Days)||2
9914405|NCT01210560|11031247|FG006|STARTED|Intervention 1 (7 Days)||4
9914406|NCT01210560|11031248|FG007|STARTED|Intervention 1 (7 Days)||4
9914407|NCT01210560|11031249|FG008|STARTED|Intervention 1 (7 Days)||5
9914408|NCT01210560|11031241|FG000|COMPLETED|Intervention 1 (7 Days)||2
9914409|NCT01210560|11031242|FG001|COMPLETED|Intervention 1 (7 Days)||2
9914410|NCT01210560|11031243|FG002|COMPLETED|Intervention 1 (7 Days)||2
9914411|NCT01210560|11031244|FG003|COMPLETED|Intervention 1 (7 Days)||2
9914412|NCT01210560|11031245|FG004|COMPLETED|Intervention 1 (7 Days)||2
9914413|NCT01210560|11031246|FG005|COMPLETED|Intervention 1 (7 Days)||2
9914414|NCT01210560|11031247|FG006|COMPLETED|Intervention 1 (7 Days)||4
9914415|NCT01210560|11031248|FG007|COMPLETED|Intervention 1 (7 Days)||4
9914416|NCT01210560|11031249|FG008|COMPLETED|Intervention 1 (7 Days)||5
9914417|NCT01210560|11031241|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
9914418|NCT01210560|11031242|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
9914419|NCT01210560|11031243|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0
9914420|NCT01210560|11031244|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0
9914421|NCT01210560|11031245|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0
9914422|NCT01210560|11031246|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0
9914423|NCT01210560|11031247|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0
9914424|NCT01210560|11031248|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0
9914425|NCT01210560|11031249|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0
9914426|NCT01210560|11031241|FG000|STARTED|Intervention 2 (7 Days)||2
9914427|NCT01210560|11031242|FG001|STARTED|Intervention 2 (7 Days)||2
9914428|NCT01210560|11031243|FG002|STARTED|Intervention 2 (7 Days)||2
9914429|NCT01210560|11031244|FG003|STARTED|Intervention 2 (7 Days)||2
9914430|NCT01210560|11031245|FG004|STARTED|Intervention 2 (7 Days)||2
9914431|NCT01210560|11031246|FG005|STARTED|Intervention 2 (7 Days)||2
9914432|NCT01210560|11031247|FG006|STARTED|Intervention 2 (7 Days)||4
9914433|NCT01210560|11031248|FG007|STARTED|Intervention 2 (7 Days)||4
9914434|NCT01210560|11031249|FG008|STARTED|Intervention 2 (7 Days)||5
9914435|NCT01210560|11031241|FG000|COMPLETED|Intervention 2 (7 Days)||2
9914436|NCT01210560|11031242|FG001|COMPLETED|Intervention 2 (7 Days)||2
9914437|NCT01210560|11031243|FG002|COMPLETED|Intervention 2 (7 Days)||2
9914438|NCT01210560|11031244|FG003|COMPLETED|Intervention 2 (7 Days)||2
9914439|NCT01210560|11031245|FG004|COMPLETED|Intervention 2 (7 Days)||2
9914440|NCT01210560|11031246|FG005|COMPLETED|Intervention 2 (7 Days)||2
9914441|NCT01210560|11031247|FG006|COMPLETED|Intervention 2 (7 Days)||4
9914442|NCT01210560|11031248|FG007|COMPLETED|Intervention 2 (7 Days)||4
9914443|NCT01210560|11031249|FG008|COMPLETED|Intervention 2 (7 Days)||5
9914444|NCT01210560|11031241|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
9914445|NCT01210560|11031242|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
9914446|NCT01210560|11031243|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0
9914447|NCT01210560|11031244|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0
9914448|NCT01210560|11031245|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0
9914449|NCT01210560|11031246|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0
9914450|NCT01210560|11031247|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0
9914451|NCT01210560|11031248|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0
9914452|NCT01210560|11031249|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0
9914453|NCT01210560|11031241|FG000|STARTED|Intervention 3 (7 Days)||2
9914454|NCT01210560|11031242|FG001|STARTED|Intervention 3 (7 Days)||2
9914455|NCT01210560|11031243|FG002|STARTED|Intervention 3 (7 Days)||2
9914456|NCT01210560|11031244|FG003|STARTED|Intervention 3 (7 Days)||2
9914457|NCT01210560|11031245|FG004|STARTED|Intervention 3 (7 Days)||2
9914458|NCT01210560|11031246|FG005|STARTED|Intervention 3 (7 Days)||2
9914459|NCT01210560|11031247|FG006|STARTED|Intervention 3 (7 Days)||4
9914460|NCT01210560|11031248|FG007|STARTED|Intervention 3 (7 Days)||4
9914461|NCT01210560|11031249|FG008|STARTED|Intervention 3 (7 Days)||5
9914462|NCT01210560|11031241|FG000|COMPLETED|Intervention 3 (7 Days)||2
9914463|NCT01210560|11031242|FG001|COMPLETED|Intervention 3 (7 Days)||2
9914464|NCT01210560|11031243|FG002|COMPLETED|Intervention 3 (7 Days)||2
9914465|NCT01210560|11031244|FG003|COMPLETED|Intervention 3 (7 Days)||2
9914466|NCT01210560|11031245|FG004|COMPLETED|Intervention 3 (7 Days)||2
9914467|NCT01210560|11031246|FG005|COMPLETED|Intervention 3 (7 Days)||2
9914468|NCT01210560|11031247|FG006|COMPLETED|Intervention 3 (7 Days)||4
9914469|NCT01210560|11031248|FG007|COMPLETED|Intervention 3 (7 Days)||4
9914470|NCT01210560|11031249|FG008|COMPLETED|Intervention 3 (7 Days)||5
9914471|NCT01210560|11031241|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0
9914472|NCT01210560|11031242|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0
9914473|NCT01210560|11031243|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0
9914474|NCT01210560|11031244|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0
9914475|NCT01210560|11031245|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0
9914476|NCT01210560|11031246|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0
9914477|NCT01210560|11031247|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0
9914478|NCT01210560|11031248|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0
9914479|NCT01210560|11031249|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0
9914480|NCT01210651|11031264|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
9914481|NCT01210651|11031265|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
9914482|NCT01210651|11031264|FG000|Number Attending 1st Assigned Session|Overall Study||18
9914483|NCT01210651|11031265|FG001|Number Attending 1st Assigned Session|Overall Study||12
9914484|NCT01210651|11031264|FG000|COMPLETED|Overall Study||15
9914485|NCT01210651|11031265|FG001|COMPLETED|Overall Study||10
9914486|NCT01210651|11031264|FG000|NOT COMPLETED|Overall Study||5
9914487|NCT01210651|11031265|FG001|NOT COMPLETED|Overall Study||8
9914488|NCT01210664|11031275|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
9914489|NCT01210664|11031276|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914490|NCT01210664|11031277|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914491|NCT01210664|11031278|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914492|NCT01210664|11031275|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
9914493|NCT01210664|11031276|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914494|NCT01210664|11031277|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914495|NCT01210664|11031278|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914496|NCT01210664|11031275|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
9914497|NCT01210664|11031276|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914498|NCT01210664|11031277|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914499|NCT01210664|11031278|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914500|NCT01210664|11031275|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914501|NCT01210664|11031276|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914502|NCT01210664|11031277|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914503|NCT01210664|11031278|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
9914504|NCT01210664|11031275|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914505|NCT01210664|11031276|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
9914506|NCT01210664|11031277|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914507|NCT01210664|11031278|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914508|NCT01210664|11031275|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914509|NCT01210664|11031276|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
9914510|NCT01210664|11031277|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914511|NCT01210664|11031278|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914512|NCT01210664|11031275|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914513|NCT01210664|11031276|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
9914514|NCT01210664|11031277|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914515|NCT01210664|11031278|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914516|NCT01210664|11031275|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914517|NCT01210664|11031276|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914518|NCT01210664|11031277|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10203862|NCT03467945|11330746|FG001|NOT COMPLETED|Treatment Period 1||0
9914519|NCT01210664|11031278|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
9914520|NCT01210664|11031275|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914521|NCT01210664|11031276|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914522|NCT01210664|11031277|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
9914523|NCT01210664|11031278|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914524|NCT01210664|11031275|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914525|NCT01210664|11031276|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914526|NCT01210664|11031277|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
9914527|NCT01210664|11031278|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914528|NCT01210664|11031275|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914529|NCT01210664|11031276|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914530|NCT01210664|11031277|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
9914531|NCT01210664|11031278|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914532|NCT01210664|11031275|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914533|NCT01210664|11031276|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914534|NCT01210664|11031277|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
9914535|NCT01210664|11031278|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
9914536|NCT01210664|11031275|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914537|NCT01210664|11031276|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914538|NCT01210664|11031277|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914539|NCT01210664|11031278|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
9914540|NCT01210664|11031275|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914541|NCT01210664|11031276|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914542|NCT01210664|11031277|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914543|NCT01210664|11031278|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
9914544|NCT01210664|11031275|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914545|NCT01210664|11031276|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914546|NCT01210664|11031277|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914547|NCT01210664|11031278|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
9914548|NCT01210664|11031275|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914549|NCT01210664|11031276|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914550|NCT01210664|11031277|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9914551|NCT01210664|11031278|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
9914552|NCT01210690|11031288|FG000|STARTED|Overall Study||101
9914553|NCT01210690|11031288|FG000|COMPLETED|Overall Study||75
9914554|NCT01210690|11031288|FG000|NOT COMPLETED|Overall Study||26
9914555|NCT01210716|11031293|FG000|STARTED|First TPE Procedure||20
9914556|NCT01210716|11031294|FG001|STARTED|First TPE Procedure||17
9914557|NCT01210716|11031293|FG000|COMPLETED|First TPE Procedure||18
10203863|NCT03467945|11330747|FG002|NOT COMPLETED|Treatment Period 1||0
10203864|NCT03467945|11330748|FG003|NOT COMPLETED|Treatment Period 1||0
10203865|NCT03467945|11330745|FG000|STARTED|Treatment Period 2||10
9914558|NCT01210716|11031294|FG001|COMPLETED|First TPE Procedure||15
10203866|NCT03467945|11330746|FG001|STARTED|Treatment Period 2||10
10203867|NCT03467945|11330747|FG002|STARTED|Treatment Period 2||10
10203868|NCT03467945|11330748|FG003|STARTED|Treatment Period 2||10
10203869|NCT03467945|11330745|FG000|COMPLETED|Treatment Period 2||10
10203870|NCT03467945|11330746|FG001|COMPLETED|Treatment Period 2||9
10203871|NCT03467945|11330747|FG002|COMPLETED|Treatment Period 2||10
10203872|NCT03467945|11330748|FG003|COMPLETED|Treatment Period 2||10
10203873|NCT03467945|11330745|FG000|NOT COMPLETED|Treatment Period 2||0
10203874|NCT03467945|11330746|FG001|NOT COMPLETED|Treatment Period 2||1
10203875|NCT03467945|11330747|FG002|NOT COMPLETED|Treatment Period 2||0
10203876|NCT03467945|11330748|FG003|NOT COMPLETED|Treatment Period 2||0
10203877|NCT03467945|11330745|FG000|STARTED|Treatment Period 3||10
10203878|NCT03467945|11330746|FG001|STARTED|Treatment Period 3||9
10203879|NCT03467945|11330747|FG002|STARTED|Treatment Period 3||10
10203880|NCT03467945|11330748|FG003|STARTED|Treatment Period 3||10
10203881|NCT03467945|11330745|FG000|COMPLETED|Treatment Period 3||9
10203882|NCT03467945|11330746|FG001|COMPLETED|Treatment Period 3||9
10203883|NCT03467945|11330747|FG002|COMPLETED|Treatment Period 3||8
10203884|NCT03467945|11330748|FG003|COMPLETED|Treatment Period 3||9
10203885|NCT03467945|11330745|FG000|NOT COMPLETED|Treatment Period 3||1
10203886|NCT03467945|11330746|FG001|NOT COMPLETED|Treatment Period 3||0
10203887|NCT03467945|11330747|FG002|NOT COMPLETED|Treatment Period 3||2
10203888|NCT03467945|11330748|FG003|NOT COMPLETED|Treatment Period 3||1
9914559|NCT01210716|11031293|FG000|NOT COMPLETED|First TPE Procedure||2
9914560|NCT01210716|11031294|FG001|NOT COMPLETED|First TPE Procedure||2
9914561|NCT01210716|11031293|FG000|STARTED|Second TPE Procedure||18
10203889|NCT03467945|11330745|FG000|STARTED|Treatment Period 4||9
10203890|NCT03467945|11330746|FG001|STARTED|Treatment Period 4||9
10203891|NCT03467945|11330747|FG002|STARTED|Treatment Period 4||8
10203892|NCT03467945|11330748|FG003|STARTED|Treatment Period 4||9
10203893|NCT03467945|11330745|FG000|COMPLETED|Treatment Period 4||9
10203894|NCT03467945|11330746|FG001|COMPLETED|Treatment Period 4||9
10203895|NCT03467945|11330747|FG002|COMPLETED|Treatment Period 4||8
10203896|NCT03467945|11330748|FG003|COMPLETED|Treatment Period 4||9
10203897|NCT03467945|11330745|FG000|NOT COMPLETED|Treatment Period 4||0
10203898|NCT03467945|11330746|FG001|NOT COMPLETED|Treatment Period 4||0
10010157|NCT01771965|11132910|FG001|COMPLETED|Overall Study||4
10010158|NCT01771965|11132909|FG000|NOT COMPLETED|Overall Study||3
10010159|NCT01771965|11132910|FG001|NOT COMPLETED|Overall Study||5
10010160|NCT01771991|11132918|FG000|STARTED|Overall Study||38
10010161|NCT01771991|11132919|FG001|STARTED|Overall Study||36
10010162|NCT01771991|11132918|FG000|Started Treatment|Overall Study||37
10010163|NCT01771991|11132919|FG001|Started Treatment|Overall Study||34
10010164|NCT01771991|11132918|FG000|COMPLETED|Overall Study||30
10010165|NCT01771991|11132919|FG001|COMPLETED|Overall Study||30
10010166|NCT01771991|11132918|FG000|NOT COMPLETED|Overall Study||8
10010167|NCT01771991|11132919|FG001|NOT COMPLETED|Overall Study||6
10010168|NCT01772134|11132929|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
10010169|NCT01772134|11132930|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
10010170|NCT01772134|11132931|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
10010171|NCT01772134|11132929|FG000|Received Randomized Study Medication|Overall Study||205
10010172|NCT01772134|11132930|FG001|Received Randomized Study Medication|Overall Study||204
10010173|NCT01772134|11132931|FG002|Received Randomized Study Medication|Overall Study||205
10010174|NCT01772134|11132929|FG000|COMPLETED|Overall Study||178
10010175|NCT01772134|11132930|FG001|COMPLETED|Overall Study||190
10010176|NCT01772134|11132931|FG002|COMPLETED|Overall Study||184
10010177|NCT01772134|11132929|FG000|NOT COMPLETED|Overall Study||29
10010178|NCT01772134|11132930|FG001|NOT COMPLETED|Overall Study||14
10010179|NCT01772134|11132931|FG002|NOT COMPLETED|Overall Study||22
10010180|NCT01772147|11132942|FG000|STARTED|Overall Study||201
10010181|NCT01772147|11132943|FG001|STARTED|Overall Study||203
10010182|NCT01772147|11132944|FG002|STARTED|Overall Study||202
10010183|NCT01772147|11132942|FG000|COMPLETED|Overall Study||170
10010184|NCT01772147|11132943|FG001|COMPLETED|Overall Study||178
10010185|NCT01772147|11132944|FG002|COMPLETED|Overall Study||184
10010186|NCT01772147|11132942|FG000|NOT COMPLETED|Overall Study||31
10010187|NCT01772147|11132943|FG001|NOT COMPLETED|Overall Study||25
10010188|NCT01772147|11132944|FG002|NOT COMPLETED|Overall Study||18
10010189|NCT01772160|11132952|FG000|STARTED|Overall Study||394
10010190|NCT01772160|11132952|FG000|COMPLETED|Overall Study||346
10010191|NCT01772160|11132952|FG000|NOT COMPLETED|Overall Study||48
10010192|NCT01772316|11132956|FG000|STARTED|Overall Study||47
10010193|NCT01772316|11132956|FG000|COMPLETED|Overall Study||40
10010194|NCT01772316|11132956|FG000|NOT COMPLETED|Overall Study||7
10010195|NCT01772368|11132960|FG000|STARTED|Overall Study||72
10010196|NCT01772368|11132960|FG000|Received Fp MDPI 100 mcg|Overall Study||67
10010197|NCT01772368|11132960|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68
10010198|NCT01772368|11132960|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69
10010199|NCT01772368|11132960|FG000|Received FS MDPI 100/25 mcg|Overall Study||67
10010200|NCT01772368|11132960|FG000|Received FS MDPI 100/50 mcg|Overall Study||68
10010201|NCT01772368|11132960|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66
10010202|NCT01772368|11132960|FG000|COMPLETED|Overall Study||65
10010203|NCT01772368|11132960|FG000|NOT COMPLETED|Overall Study||7
10010204|NCT01772537|11132979|FG000|STARTED|Overall Study||5
10010205|NCT01772537|11132980|FG001|STARTED|Overall Study||3
10010206|NCT01772537|11132981|FG002|STARTED|Overall Study||6
10010207|NCT01772537|11132979|FG000|COMPLETED|Overall Study||4
10010208|NCT01772537|11132980|FG001|COMPLETED|Overall Study||3
9914562|NCT01210716|11031294|FG001|STARTED|Second TPE Procedure||15
9914563|NCT01210716|11031293|FG000|COMPLETED|Second TPE Procedure||15
9914564|NCT01210716|11031294|FG001|COMPLETED|Second TPE Procedure||15
9914565|NCT01210716|11031293|FG000|NOT COMPLETED|Second TPE Procedure||3
9914566|NCT01210716|11031294|FG001|NOT COMPLETED|Second TPE Procedure||0
9914567|NCT01210807|11031302|FG000|STARTED|Overall Study||36
9914568|NCT01210807|11031303|FG001|STARTED|Overall Study||34
9914569|NCT01210807|11031302|FG000|COMPLETED|Overall Study||33
9914570|NCT01210807|11031303|FG001|COMPLETED|Overall Study||31
9914571|NCT01210807|11031302|FG000|NOT COMPLETED|Overall Study||3
9914572|NCT01210807|11031303|FG001|NOT COMPLETED|Overall Study||3
9914573|NCT01210820|11031311|FG000|STARTED|Overall Study||17
9914574|NCT01210820|11031312|FG001|STARTED|Overall Study||4
9914575|NCT01210820|11031311|FG000|COMPLETED|Overall Study||17
9914576|NCT01210820|11031312|FG001|COMPLETED|Overall Study||4
9914577|NCT01210820|11031311|FG000|NOT COMPLETED|Overall Study||0
9914578|NCT01210820|11031312|FG001|NOT COMPLETED|Overall Study||0
9914579|NCT01211106|11031320|FG000|STARTED|Overall Study||95
9914580|NCT01211106|11031321|FG001|STARTED|Overall Study||88
9914581|NCT01211106|11031320|FG000|COMPLETED|Overall Study||82
9914582|NCT01211106|11031321|FG001|COMPLETED|Overall Study||77
9914583|NCT01211106|11031320|FG000|NOT COMPLETED|Overall Study||13
9914584|NCT01211106|11031321|FG001|NOT COMPLETED|Overall Study||11
9914585|NCT01211145|11031333|FG000|STARTED|Overall Study||296
9914586|NCT01211145|11031334|FG001|STARTED|Overall Study||115
9914587|NCT01211145|11031335|FG002|STARTED|Overall Study||99
10010209|NCT01772537|11132981|FG002|COMPLETED|Overall Study||6
10010210|NCT01772537|11132979|FG000|NOT COMPLETED|Overall Study||1
10010211|NCT01772537|11132980|FG001|NOT COMPLETED|Overall Study||0
10010212|NCT01772537|11132981|FG002|NOT COMPLETED|Overall Study||0
10010213|NCT01772550|11132994|FG000|STARTED|Overall Study||102
10010214|NCT01772550|11132995|FG001|STARTED|Overall Study||103
10010215|NCT01772550|11132996|FG002|STARTED|Overall Study||33
10010216|NCT01772550|11132994|FG000|CT Pancreas|Overall Study||40
10010217|NCT01772550|11132995|FG001|CT Pancreas|Overall Study||36
10010218|NCT01772550|11132996|FG002|CT Pancreas|Overall Study||8
9914588|NCT01211145|11031336|FG003|STARTED|Overall Study||288
9914589|NCT01211145|11031333|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
9914590|NCT01211145|11031334|FG001|COMPLETED|Overall Study||98
9914591|NCT01211145|11031335|FG002|COMPLETED|Overall Study||86
9914592|NCT01211145|11031336|FG003|COMPLETED|Overall Study||268
9914593|NCT01211145|11031333|FG000|NOT COMPLETED|Overall Study||26
9914594|NCT01211145|11031334|FG001|NOT COMPLETED|Overall Study||17
9914595|NCT01211145|11031335|FG002|NOT COMPLETED|Overall Study||13
9914596|NCT01211145|11031336|FG003|NOT COMPLETED|Overall Study||20
9914597|NCT01211184|11031349|FG000|STARTED|Overall Study||20
9914598|NCT01211184|11031350|FG001|STARTED|Overall Study||20
9914599|NCT01211184|11031351|FG002|STARTED|Overall Study||20
9914600|NCT01211184|11031349|FG000|COMPLETED|Overall Study||20
9914601|NCT01211184|11031350|FG001|COMPLETED|Overall Study||18
9914602|NCT01211184|11031351|FG002|COMPLETED|Overall Study||19
9914603|NCT01211184|11031349|FG000|NOT COMPLETED|Overall Study||0
9914604|NCT01211184|11031350|FG001|NOT COMPLETED|Overall Study||2
9914605|NCT01211184|11031351|FG002|NOT COMPLETED|Overall Study||1
9914606|NCT01211197|11031362|FG000|STARTED|Treatment Period 1 (1 Day)||3
9914607|NCT01211197|11031363|FG001|STARTED|Treatment Period 1 (1 Day)||3
9914608|NCT01211197|11031364|FG002|STARTED|Treatment Period 1 (1 Day)||3
9914609|NCT01211197|11031365|FG003|STARTED|Treatment Period 1 (1 Day)||3
9914610|NCT01211197|11031366|FG004|STARTED|Treatment Period 1 (1 Day)||2
9914611|NCT01211197|11031367|FG005|STARTED|Treatment Period 1 (1 Day)||2
9914612|NCT01211197|11031362|FG000|COMPLETED|Treatment Period 1 (1 Day)||3
9914613|NCT01211197|11031363|FG001|COMPLETED|Treatment Period 1 (1 Day)||3
9914614|NCT01211197|11031364|FG002|COMPLETED|Treatment Period 1 (1 Day)||3
9914615|NCT01211197|11031365|FG003|COMPLETED|Treatment Period 1 (1 Day)||3
9914616|NCT01211197|11031366|FG004|COMPLETED|Treatment Period 1 (1 Day)||2
9914617|NCT01211197|11031367|FG005|COMPLETED|Treatment Period 1 (1 Day)||2
9914618|NCT01211197|11031362|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9914619|NCT01211197|11031363|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9914620|NCT01211197|11031364|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9914621|NCT01211197|11031365|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9914622|NCT01211197|11031366|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9914623|NCT01211197|11031367|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9914624|NCT01211197|11031362|FG000|STARTED|Washout Period 1 (7 Days)||3
9914625|NCT01211197|11031363|FG001|STARTED|Washout Period 1 (7 Days)||3
9914626|NCT01211197|11031364|FG002|STARTED|Washout Period 1 (7 Days)||3
9914627|NCT01211197|11031365|FG003|STARTED|Washout Period 1 (7 Days)||3
9914628|NCT01211197|11031366|FG004|STARTED|Washout Period 1 (7 Days)||2
9914629|NCT01211197|11031367|FG005|STARTED|Washout Period 1 (7 Days)||2
9914630|NCT01211197|11031362|FG000|COMPLETED|Washout Period 1 (7 Days)||3
9914631|NCT01211197|11031363|FG001|COMPLETED|Washout Period 1 (7 Days)||3
9914632|NCT01211197|11031364|FG002|COMPLETED|Washout Period 1 (7 Days)||2
9914633|NCT01211197|11031365|FG003|COMPLETED|Washout Period 1 (7 Days)||3
9914634|NCT01211197|11031366|FG004|COMPLETED|Washout Period 1 (7 Days)||2
9914635|NCT01211197|11031367|FG005|COMPLETED|Washout Period 1 (7 Days)||2
9914636|NCT01211197|11031362|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9914637|NCT01211197|11031363|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9914638|NCT01211197|11031364|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
9914639|NCT01211197|11031365|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
9914640|NCT01211197|11031366|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
9914641|NCT01211197|11031367|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
9914642|NCT01211197|11031362|FG000|STARTED|Treatment Period 2 (1 Day)||3
9914643|NCT01211197|11031363|FG001|STARTED|Treatment Period 2 (1 Day)||3
9914644|NCT01211197|11031364|FG002|STARTED|Treatment Period 2 (1 Day)||2
9914645|NCT01211197|11031365|FG003|STARTED|Treatment Period 2 (1 Day)||3
9914646|NCT01211197|11031366|FG004|STARTED|Treatment Period 2 (1 Day)||2
9914647|NCT01211197|11031367|FG005|STARTED|Treatment Period 2 (1 Day)||2
9914648|NCT01211197|11031362|FG000|COMPLETED|Treatment Period 2 (1 Day)||3
9914649|NCT01211197|11031363|FG001|COMPLETED|Treatment Period 2 (1 Day)||3
9914650|NCT01211197|11031364|FG002|COMPLETED|Treatment Period 2 (1 Day)||2
9914651|NCT01211197|11031365|FG003|COMPLETED|Treatment Period 2 (1 Day)||3
9914652|NCT01211197|11031366|FG004|COMPLETED|Treatment Period 2 (1 Day)||2
9914653|NCT01211197|11031367|FG005|COMPLETED|Treatment Period 2 (1 Day)||2
9914654|NCT01211197|11031362|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9914655|NCT01211197|11031363|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9914656|NCT01211197|11031364|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9914657|NCT01211197|11031365|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9914658|NCT01211197|11031366|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9914659|NCT01211197|11031367|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9914660|NCT01211197|11031362|FG000|STARTED|Washout Period 2 (7 Days)||3
9914661|NCT01211197|11031363|FG001|STARTED|Washout Period 2 (7 Days)||3
9914662|NCT01211197|11031364|FG002|STARTED|Washout Period 2 (7 Days)||2
9914663|NCT01211197|11031365|FG003|STARTED|Washout Period 2 (7 Days)||3
9914664|NCT01211197|11031366|FG004|STARTED|Washout Period 2 (7 Days)||2
9914665|NCT01211197|11031367|FG005|STARTED|Washout Period 2 (7 Days)||2
9914666|NCT01211197|11031362|FG000|COMPLETED|Washout Period 2 (7 Days)||2
9914667|NCT01211197|11031363|FG001|COMPLETED|Washout Period 2 (7 Days)||3
9914668|NCT01211197|11031364|FG002|COMPLETED|Washout Period 2 (7 Days)||2
9914669|NCT01211197|11031365|FG003|COMPLETED|Washout Period 2 (7 Days)||3
9914670|NCT01211197|11031366|FG004|COMPLETED|Washout Period 2 (7 Days)||2
9914671|NCT01211197|11031367|FG005|COMPLETED|Washout Period 2 (7 Days)||2
9914672|NCT01211197|11031362|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
9914673|NCT01211197|11031363|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9914674|NCT01211197|11031364|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9914675|NCT01211197|11031365|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9914676|NCT01211197|11031366|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
9914677|NCT01211197|11031367|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
9914678|NCT01211197|11031362|FG000|STARTED|Treatment Period 3 (1 Day)||2
9914679|NCT01211197|11031363|FG001|STARTED|Treatment Period 3 (1 Day)||3
9914680|NCT01211197|11031364|FG002|STARTED|Treatment Period 3 (1 Day)||2
9914681|NCT01211197|11031365|FG003|STARTED|Treatment Period 3 (1 Day)||3
9914682|NCT01211197|11031366|FG004|STARTED|Treatment Period 3 (1 Day)||2
9914683|NCT01211197|11031367|FG005|STARTED|Treatment Period 3 (1 Day)||2
9914684|NCT01211197|11031362|FG000|COMPLETED|Treatment Period 3 (1 Day)||2
9914685|NCT01211197|11031363|FG001|COMPLETED|Treatment Period 3 (1 Day)||3
9914686|NCT01211197|11031364|FG002|COMPLETED|Treatment Period 3 (1 Day)||2
9914687|NCT01211197|11031365|FG003|COMPLETED|Treatment Period 3 (1 Day)||3
9914688|NCT01211197|11031366|FG004|COMPLETED|Treatment Period 3 (1 Day)||2
9914689|NCT01211197|11031367|FG005|COMPLETED|Treatment Period 3 (1 Day)||2
9914690|NCT01211197|11031362|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9914691|NCT01211197|11031363|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9914692|NCT01211197|11031364|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9914693|NCT01211197|11031365|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9914694|NCT01211197|11031366|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9914695|NCT01211197|11031367|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9914696|NCT01211262|11031377|FG000|STARTED|Overall Study||66
9914697|NCT01211262|11031378|FG001|STARTED|Overall Study||18
9914698|NCT01211262|11031377|FG000|COMPLETED|Overall Study||43
9914699|NCT01211262|11031378|FG001|COMPLETED|Overall Study||8
9914700|NCT01211262|11031377|FG000|NOT COMPLETED|Overall Study||23
9914701|NCT01211262|11031378|FG001|NOT COMPLETED|Overall Study||10
9914702|NCT01211288|11031389|FG000|STARTED|Overall Study||21
9914703|NCT01211288|11031390|FG001|STARTED|Overall Study||20
9914704|NCT01211288|11031389|FG000|COMPLETED|Overall Study||20
9914705|NCT01211288|11031390|FG001|COMPLETED|Overall Study||19
9914706|NCT01211288|11031389|FG000|NOT COMPLETED|Overall Study||1
9914707|NCT01211288|11031390|FG001|NOT COMPLETED|Overall Study||1
9914708|NCT01211340|11031400|FG000|STARTED|Overall Study||223
9914709|NCT01211340|11031401|FG001|STARTED|Overall Study||223
9914710|NCT01211340|11031400|FG000|COMPLETED|Overall Study||223
9914711|NCT01211340|11031401|FG001|COMPLETED|Overall Study||223
9914712|NCT01211340|11031400|FG000|NOT COMPLETED|Overall Study||0
9914713|NCT01211340|11031401|FG001|NOT COMPLETED|Overall Study||0
9914714|NCT01211483|11031411|FG000|STARTED|Phase 1b||7
9914715|NCT01211483|11031412|FG001|STARTED|Phase 1b||0
9914716|NCT01211483|11031413|FG002|STARTED|Phase 1b||0
9914717|NCT01211483|11031414|FG003|STARTED|Phase 1b||0
9914718|NCT01211483|11031411|FG000|COMPLETED|Phase 1b||0
9914719|NCT01211483|11031412|FG001|COMPLETED|Phase 1b||0
9914720|NCT01211483|11031413|FG002|COMPLETED|Phase 1b||0
9914721|NCT01211483|11031414|FG003|COMPLETED|Phase 1b||0
9914722|NCT01211483|11031411|FG000|NOT COMPLETED|Phase 1b||7
9914723|NCT01211483|11031412|FG001|NOT COMPLETED|Phase 1b||0
9914724|NCT01211483|11031413|FG002|NOT COMPLETED|Phase 1b||0
9914725|NCT01211483|11031414|FG003|NOT COMPLETED|Phase 1b||0
9914726|NCT01211483|11031411|FG000|STARTED|Phase 2||0
9914727|NCT01211483|11031412|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72
9914728|NCT01211483|11031413|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72
9914729|NCT01211483|11031414|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71
9914730|NCT01211483|11031411|FG000|COMPLETED|Phase 2||0
9914731|NCT01211483|11031412|FG001|COMPLETED|Phase 2||0
9914732|NCT01211483|11031413|FG002|COMPLETED|Phase 2||0
9914733|NCT01211483|11031414|FG003|COMPLETED|Phase 2||0
9914734|NCT01211483|11031411|FG000|NOT COMPLETED|Phase 2||0
9914735|NCT01211483|11031412|FG001|NOT COMPLETED|Phase 2||72
9914736|NCT01211483|11031413|FG002|NOT COMPLETED|Phase 2||72
9914737|NCT01211483|11031414|FG003|NOT COMPLETED|Phase 2||71
9914738|NCT01211522|11031431|FG000|STARTED|Overall Study||192
9914739|NCT01211522|11031432|FG001|STARTED|Overall Study||190
9914740|NCT01211522|11031433|FG002|STARTED|Overall Study||184
9914741|NCT01211522|11031431|FG000|COMPLETED|Overall Study||189
9914742|NCT01211522|11031432|FG001|COMPLETED|Overall Study||183
9914743|NCT01211522|11031433|FG002|COMPLETED|Overall Study||179
9914744|NCT01211522|11031431|FG000|NOT COMPLETED|Overall Study||3
9914745|NCT01211522|11031432|FG001|NOT COMPLETED|Overall Study||7
9914746|NCT01211522|11031433|FG002|NOT COMPLETED|Overall Study||5
9914747|NCT01211535|11031443|FG000|STARTED|Overall Study||52
9914748|NCT01211535|11031444|FG001|STARTED|Overall Study||52
9914749|NCT01211535|11031443|FG000|COMPLETED|Overall Study||52
9914750|NCT01211535|11031444|FG001|COMPLETED|Overall Study||51
9914751|NCT01211535|11031443|FG000|NOT COMPLETED|Overall Study||0
9914752|NCT01211535|11031444|FG001|NOT COMPLETED|Overall Study||1
9914753|NCT01211600|11031452|FG000|STARTED|Overall Study||370
9914754|NCT01211600|11031453|FG001|STARTED|Overall Study||376
9914755|NCT01211600|11031452|FG000|COMPLETED|Overall Study||370
9914756|NCT01211600|11031453|FG001|COMPLETED|Overall Study||376
9914757|NCT01211600|11031452|FG000|NOT COMPLETED|Overall Study||0
9914758|NCT01211600|11031453|FG001|NOT COMPLETED|Overall Study||0
9914759|NCT01211613|11031464|FG000|STARTED|Overall Study||37
9914760|NCT01211613|11031465|FG001|STARTED|Overall Study||35
9914761|NCT01211613|11031466|FG002|STARTED|Overall Study||35
9914762|NCT01211613|11031464|FG000|COMPLETED|Overall Study||34
9914763|NCT01211613|11031465|FG001|COMPLETED|Overall Study||33
9914764|NCT01211613|11031466|FG002|COMPLETED|Overall Study||33
9914765|NCT01211613|11031464|FG000|NOT COMPLETED|Overall Study||3
9914766|NCT01211613|11031465|FG001|NOT COMPLETED|Overall Study||2
9914767|NCT01211613|11031466|FG002|NOT COMPLETED|Overall Study||2
9914768|NCT01211665|11031476|FG000|STARTED|Overall Study||2
9914769|NCT01211665|11031477|FG001|STARTED|Overall Study||1
9914770|NCT01211665|11031476|FG000|COMPLETED|Overall Study||0
9914771|NCT01211665|11031477|FG001|COMPLETED|Overall Study|completed treatment with study drug|1
9914772|NCT01211665|11031476|FG000|NOT COMPLETED|Overall Study||2
9914773|NCT01211665|11031477|FG001|NOT COMPLETED|Overall Study||0
9914774|NCT01211730|11031485|FG000|STARTED|Overall Study||82
9914775|NCT01211730|11031486|FG001|STARTED|Overall Study||82
9914776|NCT01211730|11031485|FG000|COMPLETED|Overall Study||82
9914777|NCT01211730|11031486|FG001|COMPLETED|Overall Study||82
9914778|NCT01211730|11031485|FG000|NOT COMPLETED|Overall Study||0
9914779|NCT01211730|11031486|FG001|NOT COMPLETED|Overall Study||0
9914780|NCT01211769|11031496|FG000|STARTED|Overall Study||20
9914781|NCT01211769|11031497|FG001|STARTED|Overall Study||20
9914782|NCT01211769|11031498|FG002|STARTED|Overall Study||20
9914783|NCT01211769|11031499|FG003|STARTED|Overall Study||20
9914784|NCT01211769|11031496|FG000|Participants/Group|Overall Study||20
9914785|NCT01211769|11031497|FG001|Participants/Group|Overall Study||20
9914786|NCT01211769|11031498|FG002|Participants/Group|Overall Study||20
9914787|NCT01211769|11031499|FG003|Participants/Group|Overall Study||20
9914788|NCT01211769|11031496|FG000|COMPLETED|Overall Study||11
9914789|NCT01211769|11031497|FG001|COMPLETED|Overall Study||10
9914790|NCT01211769|11031498|FG002|COMPLETED|Overall Study||12
9914791|NCT01211769|11031499|FG003|COMPLETED|Overall Study||9
9914792|NCT01211769|11031496|FG000|NOT COMPLETED|Overall Study||9
9914793|NCT01211769|11031497|FG001|NOT COMPLETED|Overall Study||10
9914794|NCT01211769|11031498|FG002|NOT COMPLETED|Overall Study||8
9914795|NCT01211769|11031499|FG003|NOT COMPLETED|Overall Study||11
9914796|NCT01211873|11031512|FG000|STARTED|Overall Study||245
9914797|NCT01211873|11031513|FG001|STARTED|Overall Study||119
9914798|NCT01211873|11031514|FG002|STARTED|Overall Study||38
9914799|NCT01211873|11031512|FG000|COMPLETED|Overall Study||240
9914800|NCT01211873|11031513|FG001|COMPLETED|Overall Study||117
9914801|NCT01211873|11031514|FG002|COMPLETED|Overall Study||36
9914802|NCT01211873|11031512|FG000|NOT COMPLETED|Overall Study||5
9914803|NCT01211873|11031513|FG001|NOT COMPLETED|Overall Study||2
9914804|NCT01211873|11031514|FG002|NOT COMPLETED|Overall Study||2
9914805|NCT01212094|11031526|FG000|STARTED|Year 1: Baseline Monitoring||43
9914806|NCT01212094|11031527|FG001|STARTED|Year 1: Baseline Monitoring||0
9914807|NCT01212094|11031528|FG002|STARTED|Year 1: Baseline Monitoring||0
9914808|NCT01212094|11031526|FG000|COMPLETED|Year 1: Baseline Monitoring||27
9914809|NCT01212094|11031527|FG001|COMPLETED|Year 1: Baseline Monitoring||0
9914810|NCT01212094|11031528|FG002|COMPLETED|Year 1: Baseline Monitoring||0
9914811|NCT01212094|11031526|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16
9914812|NCT01212094|11031527|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0
9914813|NCT01212094|11031528|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0
9914814|NCT01212094|11031526|FG000|STARTED|Years 2 & 3: Treatment Randomization||0
9914815|NCT01212094|11031527|FG001|STARTED|Years 2 & 3: Treatment Randomization||9
9914816|NCT01212094|11031528|FG002|STARTED|Years 2 & 3: Treatment Randomization||18
9914817|NCT01212094|11031526|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0
9914818|NCT01212094|11031527|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5
9914819|NCT01212094|11031528|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7
9914820|NCT01212094|11031526|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
9914821|NCT01212094|11031527|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
9914822|NCT01212094|11031528|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
9914823|NCT01212107|11031547|FG000|STARTED|Overall Study||3
9914824|NCT01212107|11031548|FG001|STARTED|Overall Study||3
9914825|NCT01212107|11031549|FG002|STARTED|Overall Study||6
9914826|NCT01212107|11031550|FG003|STARTED|Overall Study||3
9914827|NCT01212107|11031551|FG004|STARTED|Overall Study||3
9914828|NCT01212107|11031552|FG005|STARTED|Overall Study||3
9914829|NCT01212107|11031553|FG006|STARTED|Overall Study||3
9914830|NCT01212107|11031554|FG007|STARTED|Overall Study||3
9914831|NCT01212107|11031555|FG008|STARTED|Overall Study||3
9914832|NCT01212107|11031556|FG009|STARTED|Overall Study||3
9914833|NCT01212107|11031557|FG010|STARTED|Overall Study||3
9914834|NCT01212107|11031558|FG011|STARTED|Overall Study||58
9914835|NCT01212107|11031547|FG000|COMPLETED|Overall Study||2
9914836|NCT01212107|11031548|FG001|COMPLETED|Overall Study||2
9914837|NCT01212107|11031549|FG002|COMPLETED|Overall Study||3
9914838|NCT01212107|11031550|FG003|COMPLETED|Overall Study||3
9914839|NCT01212107|11031551|FG004|COMPLETED|Overall Study||2
9914840|NCT01212107|11031552|FG005|COMPLETED|Overall Study||2
9914841|NCT01212107|11031553|FG006|COMPLETED|Overall Study||3
9914842|NCT01212107|11031554|FG007|COMPLETED|Overall Study||2
9914843|NCT01212107|11031555|FG008|COMPLETED|Overall Study||1
9914844|NCT01212107|11031556|FG009|COMPLETED|Overall Study||1
9914845|NCT01212107|11031557|FG010|COMPLETED|Overall Study||2
9914846|NCT01212107|11031558|FG011|COMPLETED|Overall Study||26
9914847|NCT01212107|11031547|FG000|NOT COMPLETED|Overall Study||1
9914848|NCT01212107|11031548|FG001|NOT COMPLETED|Overall Study||1
9914849|NCT01212107|11031549|FG002|NOT COMPLETED|Overall Study||3
9914850|NCT01212107|11031550|FG003|NOT COMPLETED|Overall Study||0
9914851|NCT01212107|11031551|FG004|NOT COMPLETED|Overall Study||1
9914852|NCT01212107|11031552|FG005|NOT COMPLETED|Overall Study||1
9914853|NCT01212107|11031553|FG006|NOT COMPLETED|Overall Study||0
9914854|NCT01212107|11031554|FG007|NOT COMPLETED|Overall Study||1
9914855|NCT01212107|11031555|FG008|NOT COMPLETED|Overall Study||2
9914856|NCT01212107|11031556|FG009|NOT COMPLETED|Overall Study||2
10010219|NCT01772550|11132994|FG000|CT Angiogram|Overall Study||24
10010220|NCT01772550|11132995|FG001|CT Angiogram|Overall Study||25
10203899|NCT03467945|11330747|FG002|NOT COMPLETED|Treatment Period 4||0
9914857|NCT01212107|11031557|FG010|NOT COMPLETED|Overall Study||1
9914858|NCT01212107|11031558|FG011|NOT COMPLETED|Overall Study||32
9914859|NCT01212159|11031602|FG000|STARTED|Overall Study||26
9914860|NCT01212159|11031603|FG001|STARTED|Overall Study||44
9914861|NCT01212159|11031602|FG000|COMPLETED|Overall Study||14
9914862|NCT01212159|11031603|FG001|COMPLETED|Overall Study||32
9914863|NCT01212159|11031602|FG000|NOT COMPLETED|Overall Study||12
9914864|NCT01212159|11031603|FG001|NOT COMPLETED|Overall Study||12
9914865|NCT01212172|11031609|FG000|STARTED|Overall Study||10
9914866|NCT01212172|11031610|FG001|STARTED|Overall Study||10
9914867|NCT01212172|11031609|FG000|COMPLETED|Overall Study||9
9914868|NCT01212172|11031610|FG001|COMPLETED|Overall Study||9
9914869|NCT01212172|11031609|FG000|NOT COMPLETED|Overall Study||1
9914870|NCT01212172|11031610|FG001|NOT COMPLETED|Overall Study||1
9914871|NCT01212185|11031620|FG000|STARTED|Overall Study||6
9914872|NCT01212185|11031621|FG001|STARTED|Overall Study||8
9914873|NCT01212185|11031620|FG000|COMPLETED|Overall Study||4
9914874|NCT01212185|11031621|FG001|COMPLETED|Overall Study||7
9914875|NCT01212185|11031620|FG000|NOT COMPLETED|Overall Study||2
9914876|NCT01212185|11031621|FG001|NOT COMPLETED|Overall Study||1
9914877|NCT01212302|11031627|FG000|STARTED|Overall Study||504
10010221|NCT01772550|11132996|FG002|CT Angiogram|Overall Study||4
10203900|NCT03467945|11330748|FG003|NOT COMPLETED|Treatment Period 4||0
10203901|NCT03467971|11330761|FG000|STARTED|Treatment Period 1||10
9914878|NCT01212302|11031627|FG000|COMPLETED|Overall Study||504
9914879|NCT01212302|11031627|FG000|NOT COMPLETED|Overall Study||0
9914880|NCT01212445|11031634|FG000|STARTED|Overall Study||52
9914881|NCT01212445|11031635|FG001|STARTED|Overall Study||51
9914882|NCT01212445|11031636|FG002|STARTED|Overall Study||51
9914883|NCT01212445|11031634|FG000|COMPLETED|Overall Study||52
9914884|NCT01212445|11031635|FG001|COMPLETED|Overall Study||51
9914885|NCT01212445|11031636|FG002|COMPLETED|Overall Study||51
9914886|NCT01212445|11031634|FG000|NOT COMPLETED|Overall Study||0
9914887|NCT01212445|11031635|FG001|NOT COMPLETED|Overall Study||0
9914888|NCT01212445|11031636|FG002|NOT COMPLETED|Overall Study||0
9914889|NCT01212471|11031648|FG000|STARTED|Overall Study||141
9914890|NCT01212471|11031649|FG001|STARTED|Overall Study||140
9914891|NCT01212471|11031650|FG002|STARTED|Overall Study||139
9914892|NCT01212471|11031648|FG000|COMPLETED|Overall Study||139
9914893|NCT01212471|11031649|FG001|COMPLETED|Overall Study||137
9914894|NCT01212471|11031650|FG002|COMPLETED|Overall Study||132
9914895|NCT01212471|11031648|FG000|NOT COMPLETED|Overall Study||2
10203902|NCT03467971|11330762|FG001|STARTED|Treatment Period 1||11
10203903|NCT03467971|11330761|FG000|COMPLETED|Treatment Period 1||10
10203904|NCT03467971|11330762|FG001|COMPLETED|Treatment Period 1||11
10203905|NCT03467971|11330761|FG000|NOT COMPLETED|Treatment Period 1||0
10203906|NCT03467971|11330762|FG001|NOT COMPLETED|Treatment Period 1||0
9914896|NCT01212471|11031649|FG001|NOT COMPLETED|Overall Study||3
9914897|NCT01212471|11031650|FG002|NOT COMPLETED|Overall Study||7
9914898|NCT01212484|11031658|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6
9914899|NCT01212484|11031659|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6
9914900|NCT01212484|11031658|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
9914901|NCT01212484|11031659|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
9914902|NCT01212484|11031658|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
9914903|NCT01212484|11031659|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
9914904|NCT01212484|11031658|FG000|STARTED|First Intervention (4 Weeks)||5
9914905|NCT01212484|11031659|FG001|STARTED|First Intervention (4 Weeks)||6
9914906|NCT01212484|11031658|FG000|COMPLETED|First Intervention (4 Weeks)||5
9914907|NCT01212484|11031659|FG001|COMPLETED|First Intervention (4 Weeks)||4
9914908|NCT01212484|11031658|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
9914909|NCT01212484|11031659|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
9914910|NCT01212484|11031658|FG000|STARTED|Second Intervention (4 Weeks)||5
9914911|NCT01212484|11031659|FG001|STARTED|Second Intervention (4 Weeks)||4
9914912|NCT01212484|11031658|FG000|COMPLETED|Second Intervention (4 Weeks)||5
9914913|NCT01212484|11031659|FG001|COMPLETED|Second Intervention (4 Weeks)||3
9914914|NCT01212484|11031658|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
9914915|NCT01212484|11031659|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
9914916|NCT01212588|11031667|FG000|STARTED|Overall Study||10
9914917|NCT01212588|11031668|FG001|STARTED|Overall Study||12
9914918|NCT01212588|11031667|FG000|COMPLETED|Overall Study||9
10010222|NCT01772550|11132994|FG000|CT Liver|Overall Study||18
10203907|NCT03467971|11330761|FG000|STARTED|Treatment Period 2||10
10203908|NCT03467971|11330762|FG001|STARTED|Treatment Period 2||11
10203909|NCT03467971|11330761|FG000|COMPLETED|Treatment Period 2||10
9914919|NCT01212588|11031668|FG001|COMPLETED|Overall Study||10
9914920|NCT01212588|11031667|FG000|NOT COMPLETED|Overall Study||1
9914921|NCT01212588|11031668|FG001|NOT COMPLETED|Overall Study||2
9914922|NCT01212627|11031674|FG000|STARTED|Overall Study||12
9914923|NCT01212627|11031674|FG000|COMPLETED|Overall Study||12
9914924|NCT01212627|11031674|FG000|NOT COMPLETED|Overall Study||0
9914925|NCT01212744|11031678|FG000|STARTED|Overall Study||16
9914926|NCT01212744|11031678|FG000|COMPLETED|Overall Study||15
9914927|NCT01212744|11031678|FG000|NOT COMPLETED|Overall Study||1
9914928|NCT01212757|11031687|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
9914929|NCT01212757|11031688|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
9914930|NCT01212757|11031689|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
9914931|NCT01212757|11031690|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9914932|NCT01212757|11031691|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9914933|NCT01212757|11031692|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9914934|NCT01212757|11031693|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9914935|NCT01212757|11031694|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9914936|NCT01212757|11031695|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9914937|NCT01212757|11031687|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
9914938|NCT01212757|11031688|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
9914939|NCT01212757|11031689|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
9914940|NCT01212757|11031690|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9914941|NCT01212757|11031691|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9914942|NCT01212757|11031692|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9914943|NCT01212757|11031693|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9914944|NCT01212757|11031694|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9914945|NCT01212757|11031695|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9914946|NCT01212757|11031687|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
9914947|NCT01212757|11031688|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
9914948|NCT01212757|11031689|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
9914949|NCT01212757|11031690|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914950|NCT01212757|11031691|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914951|NCT01212757|11031692|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914952|NCT01212757|11031693|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914953|NCT01212757|11031694|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914954|NCT01212757|11031695|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914955|NCT01212757|11031687|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
9914956|NCT01212757|11031688|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
9914957|NCT01212757|11031689|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
9914958|NCT01212757|11031690|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914959|NCT01212757|11031691|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914960|NCT01212757|11031692|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914961|NCT01212757|11031693|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914962|NCT01212757|11031694|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914963|NCT01212757|11031695|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9914964|NCT01212757|11031687|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
9914965|NCT01212757|11031688|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
9914966|NCT01212757|11031689|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
9914967|NCT01212757|11031690|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914968|NCT01212757|11031691|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914969|NCT01212757|11031692|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914970|NCT01212757|11031693|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914971|NCT01212757|11031694|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914972|NCT01212757|11031695|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914973|NCT01212757|11031687|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
9914974|NCT01212757|11031688|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
9914975|NCT01212757|11031689|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
9914976|NCT01212757|11031690|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914977|NCT01212757|11031691|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914978|NCT01212757|11031692|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914979|NCT01212757|11031693|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914980|NCT01212757|11031694|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914981|NCT01212757|11031695|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9914982|NCT01212757|11031687|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
9914983|NCT01212757|11031688|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
9914984|NCT01212757|11031689|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
9914985|NCT01212757|11031690|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
9914986|NCT01212757|11031691|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
10203910|NCT03467971|11330762|FG001|COMPLETED|Treatment Period 2||10
10203911|NCT03467971|11330761|FG000|NOT COMPLETED|Treatment Period 2||0
10203912|NCT03467971|11330762|FG001|NOT COMPLETED|Treatment Period 2||1
10203913|NCT03468075|11330769|FG000|STARTED|Overall Study||10
10203914|NCT03468075|11330769|FG000|COMPLETED|Overall Study||10
9914987|NCT01212757|11031692|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
9914988|NCT01212757|11031693|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
9914989|NCT01212757|11031694|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
9914990|NCT01212757|11031695|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
9914991|NCT01212757|11031687|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9914992|NCT01212757|11031688|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
9914993|NCT01212757|11031689|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
9914994|NCT01212757|11031690|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
9914995|NCT01212757|11031691|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
9914996|NCT01212757|11031692|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
9914997|NCT01212757|11031693|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
9914998|NCT01212757|11031694|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9914999|NCT01212757|11031695|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9915000|NCT01212757|11031687|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9915001|NCT01212757|11031688|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
9915002|NCT01212757|11031689|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
9915003|NCT01212757|11031690|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
9915004|NCT01212757|11031691|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
9915005|NCT01212757|11031692|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
9915006|NCT01212757|11031693|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9915007|NCT01212757|11031694|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9915008|NCT01212757|11031695|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9915009|NCT01212757|11031687|FG000|STARTED|Long-Term Safety Phase (Year 2)||0
9915010|NCT01212757|11031688|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
9915011|NCT01212757|11031689|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
9915012|NCT01212757|11031690|FG003|STARTED|Long-Term Safety Phase (Year 2)||0
9915013|NCT01212757|11031691|FG004|STARTED|Long-Term Safety Phase (Year 2)||0
9915014|NCT01212757|11031692|FG005|STARTED|Long-Term Safety Phase (Year 2)||0
9915015|NCT01212757|11031693|FG006|STARTED|Long-Term Safety Phase (Year 2)||0
9915016|NCT01212757|11031694|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
9915017|NCT01212757|11031695|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
9915018|NCT01212757|11031687|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0
9915019|NCT01212757|11031688|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107
9915020|NCT01212757|11031689|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95
9915021|NCT01212757|11031690|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0
9915022|NCT01212757|11031691|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0
9915023|NCT01212757|11031692|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0
9915024|NCT01212757|11031693|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0
9915025|NCT01212757|11031694|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48
9915026|NCT01212757|11031695|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51
9915027|NCT01212757|11031687|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
9915028|NCT01212757|11031688|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
9915029|NCT01212757|11031689|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
9915030|NCT01212757|11031690|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
9915031|NCT01212757|11031691|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
9915032|NCT01212757|11031692|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
9915033|NCT01212757|11031693|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
9915034|NCT01212757|11031694|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
9915035|NCT01212757|11031695|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
9915036|NCT01212757|11031687|FG000|STARTED|Long-Term Safety Phase (Year 3)||0
9915037|NCT01212757|11031688|FG001|STARTED|Long-Term Safety Phase (Year 3)||107
9915038|NCT01212757|11031689|FG002|STARTED|Long-Term Safety Phase (Year 3)||95
9915039|NCT01212757|11031690|FG003|STARTED|Long-Term Safety Phase (Year 3)||0
10010223|NCT01772550|11132995|FG001|CT Liver|Overall Study||14
10010224|NCT01772550|11132996|FG002|CT Liver|Overall Study||8
10010225|NCT01772550|11132994|FG000|CT Kidney|Overall Study||12
10010226|NCT01772550|11132995|FG001|CT Kidney|Overall Study||19
9760501|NCT00381628|10864179|FG003|COMPLETED|Overall Study||14
9760502|NCT00381628|10864176|FG000|NOT COMPLETED|Overall Study||0
9915040|NCT01212757|11031691|FG004|STARTED|Long-Term Safety Phase (Year 3)||0
9915041|NCT01212757|11031692|FG005|STARTED|Long-Term Safety Phase (Year 3)||0
9915042|NCT01212757|11031693|FG006|STARTED|Long-Term Safety Phase (Year 3)||0
9915043|NCT01212757|11031694|FG007|STARTED|Long-Term Safety Phase (Year 3)||48
9915044|NCT01212757|11031695|FG008|STARTED|Long-Term Safety Phase (Year 3)||51
9915045|NCT01212757|11031687|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0
9915046|NCT01212757|11031688|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89
9915047|NCT01212757|11031689|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84
9915048|NCT01212757|11031690|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0
9915049|NCT01212757|11031691|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0
9915050|NCT01212757|11031692|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0
9915051|NCT01212757|11031693|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0
9915052|NCT01212757|11031694|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42
9915053|NCT01212757|11031695|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46
10010227|NCT01772550|11132996|FG002|CT Kidney|Overall Study||6
9915054|NCT01212757|11031687|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
9915055|NCT01212757|11031688|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
9915056|NCT01212757|11031689|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
9915057|NCT01212757|11031690|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
9915058|NCT01212757|11031691|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
9915059|NCT01212757|11031692|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
9915060|NCT01212757|11031693|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
9915061|NCT01212757|11031694|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
9915062|NCT01212757|11031695|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
9915063|NCT01212757|11031687|FG000|STARTED|Long-Term Safety Phase (Year 4)||0
9915064|NCT01212757|11031688|FG001|STARTED|Long-Term Safety Phase (Year 4)||89
9915065|NCT01212757|11031689|FG002|STARTED|Long-Term Safety Phase (Year 4)||84
9915066|NCT01212757|11031690|FG003|STARTED|Long-Term Safety Phase (Year 4)||0
9915067|NCT01212757|11031691|FG004|STARTED|Long-Term Safety Phase (Year 4)||0
9915068|NCT01212757|11031692|FG005|STARTED|Long-Term Safety Phase (Year 4)||0
9915069|NCT01212757|11031693|FG006|STARTED|Long-Term Safety Phase (Year 4)||0
9915070|NCT01212757|11031694|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
9915071|NCT01212757|11031695|FG008|STARTED|Long-Term Safety Phase (Year 4)||46
9915072|NCT01212757|11031687|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0
9915073|NCT01212757|11031688|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80
9915074|NCT01212757|11031689|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77
9915075|NCT01212757|11031690|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0
9915076|NCT01212757|11031691|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0
9915077|NCT01212757|11031692|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0
9915078|NCT01212757|11031693|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0
9915079|NCT01212757|11031694|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37
9915080|NCT01212757|11031695|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39
9915081|NCT01212757|11031687|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
9915082|NCT01212757|11031688|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
9915083|NCT01212757|11031689|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
9915084|NCT01212757|11031690|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
9915085|NCT01212757|11031691|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
9915086|NCT01212757|11031692|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
9915087|NCT01212757|11031693|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
9915088|NCT01212757|11031694|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
9915089|NCT01212757|11031695|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
9915090|NCT01212757|11031687|FG000|STARTED|Long-Term Safety Phase (Year 5)||0
9915091|NCT01212757|11031688|FG001|STARTED|Long-Term Safety Phase (Year 5)||80
9915092|NCT01212757|11031689|FG002|STARTED|Long-Term Safety Phase (Year 5)||77
9915093|NCT01212757|11031690|FG003|STARTED|Long-Term Safety Phase (Year 5)||0
9915094|NCT01212757|11031691|FG004|STARTED|Long-Term Safety Phase (Year 5)||0
9915095|NCT01212757|11031692|FG005|STARTED|Long-Term Safety Phase (Year 5)||0
9915096|NCT01212757|11031693|FG006|STARTED|Long-Term Safety Phase (Year 5)||0
9915097|NCT01212757|11031694|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
9915098|NCT01212757|11031695|FG008|STARTED|Long-Term Safety Phase (Year 5)||39
9915099|NCT01212757|11031687|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0
9915100|NCT01212757|11031688|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72
9915101|NCT01212757|11031689|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69
9915102|NCT01212757|11031690|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0
9915103|NCT01212757|11031691|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0
9915104|NCT01212757|11031692|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0
9915105|NCT01212757|11031693|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0
9915106|NCT01212757|11031694|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33
9915107|NCT01212757|11031695|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37
9915108|NCT01212757|11031687|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
9915109|NCT01212757|11031688|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
9915110|NCT01212757|11031689|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
9915111|NCT01212757|11031690|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
9915112|NCT01212757|11031691|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
9915113|NCT01212757|11031692|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
9915114|NCT01212757|11031693|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
9915115|NCT01212757|11031694|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
9915116|NCT01212757|11031695|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
9915117|NCT01212770|11031716|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
10203915|NCT03468075|11330769|FG000|NOT COMPLETED|Overall Study||0
10203916|NCT03468179|11330773|FG000|STARTED|Overall Study||10
10203917|NCT03468179|11330773|FG000|COMPLETED|Overall Study||10
10203918|NCT03468179|11330773|FG000|NOT COMPLETED|Overall Study||0
10203919|NCT03468543|11330780|FG000|STARTED|Overall Study||3
10203920|NCT03468543|11330780|FG000|COMPLETED|Overall Study||0
10203921|NCT03468543|11330780|FG000|NOT COMPLETED|Overall Study||3
9915118|NCT01212770|11031717|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
9915119|NCT01212770|11031718|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
9915120|NCT01212770|11031719|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10203922|NCT03468816|11330786|FG000|STARTED|Overall Study||2
10203923|NCT03468816|11330787|FG001|STARTED|Overall Study||3
10203924|NCT03468816|11330786|FG000|COMPLETED|Overall Study||2
10203925|NCT03468816|11330787|FG001|COMPLETED|Overall Study||3
9915121|NCT01212770|11031720|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9915122|NCT01212770|11031721|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9915123|NCT01212770|11031722|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9915124|NCT01212770|11031723|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9915125|NCT01212770|11031724|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9915126|NCT01212770|11031716|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
9915127|NCT01212770|11031717|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
9915128|NCT01212770|11031718|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
9915129|NCT01212770|11031719|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9915130|NCT01212770|11031720|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9915131|NCT01212770|11031721|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9915132|NCT01212770|11031722|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9915133|NCT01212770|11031723|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9915134|NCT01212770|11031724|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9915135|NCT01212770|11031716|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
9915136|NCT01212770|11031717|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
9915137|NCT01212770|11031718|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
9915138|NCT01212770|11031719|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915139|NCT01212770|11031720|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915140|NCT01212770|11031721|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915141|NCT01212770|11031722|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915142|NCT01212770|11031723|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915143|NCT01212770|11031724|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915144|NCT01212770|11031716|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
9915145|NCT01212770|11031717|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
9915146|NCT01212770|11031718|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
9915147|NCT01212770|11031719|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915148|NCT01212770|11031720|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915149|NCT01212770|11031721|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915150|NCT01212770|11031722|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915151|NCT01212770|11031723|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915152|NCT01212770|11031724|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9915153|NCT01212770|11031716|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
9915154|NCT01212770|11031717|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
9915155|NCT01212770|11031718|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
9915156|NCT01212770|11031719|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915157|NCT01212770|11031720|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915158|NCT01212770|11031721|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915159|NCT01212770|11031722|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915160|NCT01212770|11031723|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915161|NCT01212770|11031724|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915162|NCT01212770|11031716|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
9915163|NCT01212770|11031717|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
9915164|NCT01212770|11031718|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
9915165|NCT01212770|11031719|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915166|NCT01212770|11031720|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915167|NCT01212770|11031721|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915168|NCT01212770|11031722|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915169|NCT01212770|11031723|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915170|NCT01212770|11031724|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9915171|NCT01212770|11031716|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
9915172|NCT01212770|11031717|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
9915173|NCT01212770|11031718|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
9915174|NCT01212770|11031719|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
9915175|NCT01212770|11031720|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
9915176|NCT01212770|11031721|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
9915177|NCT01212770|11031722|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
9915178|NCT01212770|11031723|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
9915179|NCT01212770|11031724|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
9915180|NCT01212770|11031716|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
9915181|NCT01212770|11031717|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
9915182|NCT01212770|11031718|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
9915183|NCT01212770|11031719|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
9915184|NCT01212770|11031720|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
9915185|NCT01212770|11031721|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
9915186|NCT01212770|11031722|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
9915187|NCT01212770|11031723|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
9915188|NCT01212770|11031724|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
9915189|NCT01212770|11031716|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
9915190|NCT01212770|11031717|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
9915191|NCT01212770|11031718|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
9915192|NCT01212770|11031719|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
9915193|NCT01212770|11031720|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
9915194|NCT01212770|11031721|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
9915195|NCT01212770|11031722|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
9915196|NCT01212770|11031723|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
9915197|NCT01212770|11031724|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
9915198|NCT01212770|11031716|FG000|STARTED|Long-term Safety Phase (Year 2)||0
9915199|NCT01212770|11031717|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
9915200|NCT01212770|11031718|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
9915201|NCT01212770|11031719|FG003|STARTED|Long-term Safety Phase (Year 2)||0
9915202|NCT01212770|11031720|FG004|STARTED|Long-term Safety Phase (Year 2)||0
9915203|NCT01212770|11031721|FG005|STARTED|Long-term Safety Phase (Year 2)||0
9915204|NCT01212770|11031722|FG006|STARTED|Long-term Safety Phase (Year 2)||0
9915205|NCT01212770|11031723|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
9915206|NCT01212770|11031724|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
9915207|NCT01212770|11031716|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
9915208|NCT01212770|11031717|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88
9915209|NCT01212770|11031718|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106
9915210|NCT01212770|11031719|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
9915211|NCT01212770|11031720|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
9915212|NCT01212770|11031721|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
9915213|NCT01212770|11031722|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
9915214|NCT01212770|11031723|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42
9915215|NCT01212770|11031724|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50
9915216|NCT01212770|11031716|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9915217|NCT01212770|11031717|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
9915218|NCT01212770|11031718|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
9915219|NCT01212770|11031719|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9915220|NCT01212770|11031720|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9915221|NCT01212770|11031721|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9915222|NCT01212770|11031722|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9915223|NCT01212770|11031723|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
10010228|NCT01772550|11132994|FG000|CT Cardiac|Overall Study||7
10010229|NCT01772550|11132995|FG001|CT Cardiac|Overall Study||7
10010230|NCT01772550|11132996|FG002|CT Cardiac|Overall Study||1
10010231|NCT01772550|11132994|FG000|COMPLETED|Overall Study||101
10203926|NCT03468816|11330786|FG000|NOT COMPLETED|Overall Study||0
10203927|NCT03468816|11330787|FG001|NOT COMPLETED|Overall Study||0
10203928|NCT03468855|11330795|FG000|STARTED|Overall Study||34
10203929|NCT03468855|11330795|FG000|COMPLETED|Overall Study||23
10203930|NCT03468855|11330795|FG000|NOT COMPLETED|Overall Study||11
10203931|NCT03468920|11330801|FG000|STARTED|Overall Study||60
10203932|NCT03468920|11330802|FG001|STARTED|Overall Study||60
10203933|NCT03468920|11330801|FG000|COMPLETED|Overall Study||60
10203934|NCT03468920|11330802|FG001|COMPLETED|Overall Study||60
10203935|NCT03468920|11330801|FG000|NOT COMPLETED|Overall Study||0
10203936|NCT03468920|11330802|FG001|NOT COMPLETED|Overall Study||0
10203937|NCT03468933|11330810|FG000|STARTED|Overall Study||16
10203938|NCT03468933|11330811|FG001|STARTED|Overall Study||16
10203939|NCT03468933|11330810|FG000|COMPLETED|Overall Study||16
10203940|NCT03468933|11330811|FG001|COMPLETED|Overall Study||16
10203941|NCT03468933|11330810|FG000|NOT COMPLETED|Overall Study||0
10203942|NCT03468933|11330811|FG001|NOT COMPLETED|Overall Study||0
10203943|NCT03469336|11330817|FG000|STARTED|Overall Study||18
10203944|NCT03469336|11330817|FG000|COMPLETED|Overall Study||17
10203945|NCT03469336|11330817|FG000|NOT COMPLETED|Overall Study||1
10203946|NCT03469349|11330829|FG000|STARTED|Overall Study||182
10203947|NCT03469349|11330830|FG001|STARTED|Overall Study||184
10203948|NCT03469349|11330829|FG000|COMPLETED|Overall Study||177
10203949|NCT03469349|11330830|FG001|COMPLETED|Overall Study||174
10203950|NCT03469349|11330829|FG000|NOT COMPLETED|Overall Study||5
10203951|NCT03469349|11330830|FG001|NOT COMPLETED|Overall Study||10
10203952|NCT03470012|11330836|FG000|STARTED|Overall Study||24
10203953|NCT03470012|11330836|FG000|COMPLETED|Overall Study||24
10203954|NCT03470012|11330836|FG000|NOT COMPLETED|Overall Study||0
10203955|NCT03470194|11330842|FG000|STARTED|Overall Study||49
10203956|NCT03470194|11330843|FG001|STARTED|Overall Study||57
10203957|NCT03470194|11330842|FG000|COMPLETED|Overall Study||38
10203958|NCT03470194|11330843|FG001|COMPLETED|Overall Study||40
10203959|NCT03470194|11330842|FG000|NOT COMPLETED|Overall Study||11
10203960|NCT03470194|11330843|FG001|NOT COMPLETED|Overall Study||17
10203961|NCT03470493|11330849|FG000|STARTED|Overall Study||130
10203962|NCT03470493|11330849|FG000|Met Primary Endpoint|Overall Study||80
10203963|NCT03470493|11330849|FG000|COMPLETED|Overall Study||130
10203964|NCT03470493|11330849|FG000|NOT COMPLETED|Overall Study||0
9915224|NCT01212770|11031724|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
9915225|NCT01212770|11031716|FG000|STARTED|Long-term Safety Phase (Year 3)||0
9915226|NCT01212770|11031717|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
9915227|NCT01212770|11031718|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
9915228|NCT01212770|11031719|FG003|STARTED|Long-term Safety Phase (Year 3)||0
9915229|NCT01212770|11031720|FG004|STARTED|Long-term Safety Phase (Year 3)||0
9915230|NCT01212770|11031721|FG005|STARTED|Long-term Safety Phase (Year 3)||0
9915231|NCT01212770|11031722|FG006|STARTED|Long-term Safety Phase (Year 3)||0
9915232|NCT01212770|11031723|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
9915233|NCT01212770|11031724|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
9915234|NCT01212770|11031716|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
9915235|NCT01212770|11031717|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
9915236|NCT01212770|11031718|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94
9915237|NCT01212770|11031719|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
9915238|NCT01212770|11031720|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
9915239|NCT01212770|11031721|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
9915240|NCT01212770|11031722|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
9915241|NCT01212770|11031723|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35
9915242|NCT01212770|11031724|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44
9915243|NCT01212770|11031716|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9915244|NCT01212770|11031717|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
9915245|NCT01212770|11031718|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
9915246|NCT01212770|11031719|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9915247|NCT01212770|11031720|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9915248|NCT01212770|11031721|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9915249|NCT01212770|11031722|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9915250|NCT01212770|11031723|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
9915251|NCT01212770|11031724|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
9915252|NCT01212770|11031716|FG000|STARTED|Long-term Safety Phase (Year 4)||0
9915253|NCT01212770|11031717|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
9915254|NCT01212770|11031718|FG002|STARTED|Long-term Safety Phase (Year 4)||94
9915255|NCT01212770|11031719|FG003|STARTED|Long-term Safety Phase (Year 4)||0
9915256|NCT01212770|11031720|FG004|STARTED|Long-term Safety Phase (Year 4)||0
9915257|NCT01212770|11031721|FG005|STARTED|Long-term Safety Phase (Year 4)||0
9915258|NCT01212770|11031722|FG006|STARTED|Long-term Safety Phase (Year 4)||0
9915259|NCT01212770|11031723|FG007|STARTED|Long-term Safety Phase (Year 4)||35
9915260|NCT01212770|11031724|FG008|STARTED|Long-term Safety Phase (Year 4)||44
9915261|NCT01212770|11031716|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
9915262|NCT01212770|11031717|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71
9915263|NCT01212770|11031718|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83
10203965|NCT03470545|11330855|FG000|STARTED|Overall Study||123
10203966|NCT03470545|11330856|FG001|STARTED|Overall Study||128
10203967|NCT03470545|11330855|FG000|COMPLETED|Overall Study||119
10203968|NCT03470545|11330856|FG001|COMPLETED|Overall Study||125
10203969|NCT03470545|11330855|FG000|NOT COMPLETED|Overall Study||4
10203970|NCT03470545|11330856|FG001|NOT COMPLETED|Overall Study||3
10203971|NCT03470740|11330865|FG000|STARTED|Overall Study||112
10203972|NCT03470740|11330866|FG001|STARTED|Overall Study||112
10203973|NCT03470740|11330865|FG000|COMPLETED|Overall Study||108
10203974|NCT03470740|11330866|FG001|COMPLETED|Overall Study||106
10203975|NCT03470740|11330865|FG000|NOT COMPLETED|Overall Study||4
10203976|NCT03470740|11330866|FG001|NOT COMPLETED|Overall Study||6
10203977|NCT03471065|11330873|FG000|STARTED|Overall Study||100
10203978|NCT03471065|11330873|FG000|COMPLETED|Overall Study||100
10203979|NCT03471065|11330873|FG000|NOT COMPLETED|Overall Study||0
10203980|NCT03471078|11330879|FG000|STARTED|Overall Study||82
10203981|NCT03471078|11330880|FG001|STARTED|Overall Study||40
10203982|NCT03471078|11330879|FG000|COMPLETED|Overall Study||61
10203983|NCT03471078|11330880|FG001|COMPLETED|Overall Study||34
10203984|NCT03471078|11330879|FG000|NOT COMPLETED|Overall Study||21
10203985|NCT03471078|11330880|FG001|NOT COMPLETED|Overall Study||6
10203986|NCT03471832|11330886|FG000|STARTED|Overall Study||40
10203987|NCT03471832|11330887|FG001|STARTED|Overall Study||40
10203988|NCT03471832|11330886|FG000|COMPLETED|Overall Study||40
10203989|NCT03471832|11330887|FG001|COMPLETED|Overall Study||40
10203990|NCT03471832|11330886|FG000|NOT COMPLETED|Overall Study||0
10203991|NCT03471832|11330887|FG001|NOT COMPLETED|Overall Study||0
10203992|NCT03471871|11330897|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10203993|NCT03471871|11330898|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10203994|NCT03471871|11330899|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10203995|NCT03471871|11330900|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
10203996|NCT03471871|11330901|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
10203997|NCT03471871|11330897|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10203998|NCT03471871|11330898|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10203999|NCT03471871|11330899|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10204000|NCT03471871|11330900|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
10204001|NCT03471871|11330901|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
10204002|NCT03471871|11330897|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
9915264|NCT01212770|11031719|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
9915265|NCT01212770|11031720|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
9915266|NCT01212770|11031721|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
9915267|NCT01212770|11031722|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
9915268|NCT01212770|11031723|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32
9915269|NCT01212770|11031724|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42
9915270|NCT01212770|11031716|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9915271|NCT01212770|11031717|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
9915272|NCT01212770|11031718|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
9915273|NCT01212770|11031719|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9915274|NCT01212770|11031720|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9915275|NCT01212770|11031721|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9915276|NCT01212770|11031722|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9915277|NCT01212770|11031723|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
9915278|NCT01212770|11031724|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
9915279|NCT01212770|11031716|FG000|STARTED|Long-term Safety Phase (Year 5)||0
9915280|NCT01212770|11031717|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
9915281|NCT01212770|11031718|FG002|STARTED|Long-term Safety Phase (Year 5)||83
9915282|NCT01212770|11031719|FG003|STARTED|Long-term Safety Phase (Year 5)||0
9915283|NCT01212770|11031720|FG004|STARTED|Long-term Safety Phase (Year 5)||0
9915284|NCT01212770|11031721|FG005|STARTED|Long-term Safety Phase (Year 5)||0
9915285|NCT01212770|11031722|FG006|STARTED|Long-term Safety Phase (Year 5)||0
9915286|NCT01212770|11031723|FG007|STARTED|Long-term Safety Phase (Year 5)||32
9915287|NCT01212770|11031724|FG008|STARTED|Long-term Safety Phase (Year 5)||42
9915288|NCT01212770|11031716|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
9915289|NCT01212770|11031717|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68
9915290|NCT01212770|11031718|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72
9915291|NCT01212770|11031719|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
9915292|NCT01212770|11031720|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
9915293|NCT01212770|11031721|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
9915294|NCT01212770|11031722|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
9915295|NCT01212770|11031723|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30
9915296|NCT01212770|11031724|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
9915297|NCT01212770|11031716|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9915298|NCT01212770|11031717|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
9915299|NCT01212770|11031718|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
9915300|NCT01212770|11031719|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9915301|NCT01212770|11031720|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9915302|NCT01212770|11031721|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9915303|NCT01212770|11031722|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9915304|NCT01212770|11031723|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
9915305|NCT01212770|11031724|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
9915306|NCT01212874|11031748|FG000|STARTED|Overall Study||35
9915307|NCT01212874|11031749|FG001|STARTED|Overall Study||35
9915308|NCT01212874|11031748|FG000|Received Allocated Intervention|Overall Study||13
9915309|NCT01212874|11031749|FG001|Received Allocated Intervention|Overall Study||12
9915310|NCT01212874|11031748|FG000|COMPLETED|Overall Study||13
9915311|NCT01212874|11031749|FG001|COMPLETED|Overall Study||12
9915312|NCT01212874|11031748|FG000|NOT COMPLETED|Overall Study||22
9915313|NCT01212874|11031749|FG001|NOT COMPLETED|Overall Study||23
9915314|NCT01212900|11031757|FG000|STARTED|Overall Study||116
9915315|NCT01212900|11031758|FG001|STARTED|Overall Study||114
9915316|NCT01212900|11031757|FG000|COMPLETED|Overall Study||104
9915317|NCT01212900|11031758|FG001|COMPLETED|Overall Study||107
9915318|NCT01212900|11031757|FG000|NOT COMPLETED|Overall Study||12
9915319|NCT01212900|11031758|FG001|NOT COMPLETED|Overall Study||7
9915320|NCT01212952|11031767|FG000|STARTED|Overall Study||3
10204003|NCT03471871|11330898|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10204004|NCT03471871|11330899|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10204005|NCT03471871|11330900|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
10204006|NCT03471871|11330901|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
10204007|NCT03471871|11330897|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
10204008|NCT03471871|11330898|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
10204009|NCT03471871|11330899|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
10204010|NCT03471871|11330900|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
10204011|NCT03471871|11330901|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
10204012|NCT03471871|11330897|FG000|STARTED|Washout Period 1 (14 Days)||6
10204013|NCT03471871|11330898|FG001|STARTED|Washout Period 1 (14 Days)||5
10204014|NCT03471871|11330899|FG002|STARTED|Washout Period 1 (14 Days)||5
10204015|NCT03471871|11330900|FG003|STARTED|Washout Period 1 (14 Days)||18
10204016|NCT03471871|11330901|FG004|STARTED|Washout Period 1 (14 Days)||19
10204017|NCT03471871|11330897|FG000|COMPLETED|Washout Period 1 (14 Days)||6
10204018|NCT03471871|11330898|FG001|COMPLETED|Washout Period 1 (14 Days)||5
10204019|NCT03471871|11330899|FG002|COMPLETED|Washout Period 1 (14 Days)||5
10204020|NCT03471871|11330900|FG003|COMPLETED|Washout Period 1 (14 Days)||18
9915321|NCT01212952|11031768|FG001|STARTED|Overall Study||6
9915322|NCT01212952|11031769|FG002|STARTED|Overall Study||41
9915323|NCT01212952|11031767|FG000|COMPLETED|Overall Study||3
9915324|NCT01212952|11031768|FG001|COMPLETED|Overall Study||6
10204021|NCT03471871|11330901|FG004|COMPLETED|Washout Period 1 (14 Days)||19
10204022|NCT03471871|11330897|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
10204023|NCT03471871|11330898|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
10204024|NCT03471871|11330899|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
10204025|NCT03471871|11330900|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
10204026|NCT03471871|11330901|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
10204027|NCT03471871|11330897|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
10204028|NCT03471871|11330898|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10204029|NCT03471871|11330899|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10204030|NCT03471871|11330900|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
10204031|NCT03471871|11330901|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
10204032|NCT03471871|11330897|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
10204033|NCT03471871|11330898|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10204034|NCT03471871|11330899|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10204035|NCT03471871|11330900|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
10204036|NCT03471871|11330901|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
10204037|NCT03471871|11330897|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10204038|NCT03471871|11330898|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10204039|NCT03471871|11330899|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10204040|NCT03471871|11330900|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10204041|NCT03471871|11330901|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
10204042|NCT03471871|11330897|FG000|STARTED|Washout Period 2 (14 Days)||6
10204043|NCT03471871|11330898|FG001|STARTED|Washout Period 2 (14 Days)||5
10204044|NCT03471871|11330899|FG002|STARTED|Washout Period 2 (14 Days)||5
10204045|NCT03471871|11330900|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
10204046|NCT03471871|11330901|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
10204047|NCT03471871|11330897|FG000|COMPLETED|Washout Period 2 (14 Days)||6
10204048|NCT03471871|11330898|FG001|COMPLETED|Washout Period 2 (14 Days)||5
10204049|NCT03471871|11330899|FG002|COMPLETED|Washout Period 2 (14 Days)||5
10204050|NCT03471871|11330900|FG003|COMPLETED|Washout Period 2 (14 Days)||0
10204051|NCT03471871|11330901|FG004|COMPLETED|Washout Period 2 (14 Days)||0
10204052|NCT03471871|11330897|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
10204053|NCT03471871|11330898|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
10204054|NCT03471871|11330899|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
10204055|NCT03471871|11330900|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
10204056|NCT03471871|11330901|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
10204057|NCT03471871|11330897|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6
10204058|NCT03471871|11330898|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5
10204059|NCT03471871|11330899|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5
10204060|NCT03471871|11330900|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0
10204061|NCT03471871|11330901|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0
9915325|NCT01212952|11031769|FG002|COMPLETED|Overall Study||41
9915326|NCT01212952|11031767|FG000|NOT COMPLETED|Overall Study||0
9915327|NCT01212952|11031768|FG001|NOT COMPLETED|Overall Study||0
9915328|NCT01212952|11031769|FG002|NOT COMPLETED|Overall Study||0
9915329|NCT01212991|11031781|FG000|STARTED|Double-blind||872
9915330|NCT01212991|11031782|FG001|STARTED|Double-blind||845
9915331|NCT01212991|11031783|FG002|STARTED|Double-blind||0
9915332|NCT01212991|11031781|FG000|Safety Population|Double-blind||871
9915333|NCT01212991|11031782|FG001|Safety Population|Double-blind||844
9915334|NCT01212991|11031783|FG002|Safety Population|Double-blind||0
9915335|NCT01212991|11031781|FG000|COMPLETED|Double-blind||0
9915336|NCT01212991|11031782|FG001|COMPLETED|Double-blind||234
9915337|NCT01212991|11031783|FG002|COMPLETED|Double-blind||0
9915338|NCT01212991|11031781|FG000|NOT COMPLETED|Double-blind||872
9915339|NCT01212991|11031782|FG001|NOT COMPLETED|Double-blind||611
9915340|NCT01212991|11031783|FG002|NOT COMPLETED|Double-blind||0
9915341|NCT01212991|11031781|FG000|STARTED|Open-label||0
9915342|NCT01212991|11031782|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
9915343|NCT01212991|11031783|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
9915344|NCT01212991|11031781|FG000|COMPLETED|Open-label||0
9915345|NCT01212991|11031782|FG001|COMPLETED|Open-label||0
9915346|NCT01212991|11031783|FG002|COMPLETED|Open-label||0
9915347|NCT01212991|11031781|FG000|NOT COMPLETED|Open-label||0
9915348|NCT01212991|11031782|FG001|NOT COMPLETED|Open-label||0
9915349|NCT01212991|11031783|FG002|NOT COMPLETED|Open-label||234
9915350|NCT01213043|11031793|FG000|STARTED|Treatment Period 1||15
9915351|NCT01213043|11031794|FG001|STARTED|Treatment Period 1||15
10204062|NCT03471871|11330897|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
10204063|NCT03471871|11330898|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
9915352|NCT01213043|11031793|FG000|COMPLETED|Treatment Period 1||15
9915353|NCT01213043|11031794|FG001|COMPLETED|Treatment Period 1||15
9915354|NCT01213043|11031793|FG000|NOT COMPLETED|Treatment Period 1||0
9915355|NCT01213043|11031794|FG001|NOT COMPLETED|Treatment Period 1||0
9915356|NCT01213043|11031793|FG000|STARTED|Washout Period||15
9915357|NCT01213043|11031794|FG001|STARTED|Washout Period||15
9915358|NCT01213043|11031793|FG000|COMPLETED|Washout Period||15
9915359|NCT01213043|11031794|FG001|COMPLETED|Washout Period||15
9915360|NCT01213043|11031793|FG000|NOT COMPLETED|Washout Period||0
9915361|NCT01213043|11031794|FG001|NOT COMPLETED|Washout Period||0
9915362|NCT01213043|11031793|FG000|STARTED|Treatment Period 2||15
9915363|NCT01213043|11031794|FG001|STARTED|Treatment Period 2||15
9915364|NCT01213043|11031793|FG000|COMPLETED|Treatment Period 2||15
9915365|NCT01213043|11031794|FG001|COMPLETED|Treatment Period 2||15
9915366|NCT01213043|11031793|FG000|NOT COMPLETED|Treatment Period 2||0
9915367|NCT01213043|11031794|FG001|NOT COMPLETED|Treatment Period 2||0
9915368|NCT01213043|11031793|FG000|STARTED|Follow-up||15
9915369|NCT01213043|11031794|FG001|STARTED|Follow-up||15
9915370|NCT01213043|11031793|FG000|COMPLETED|Follow-up||15
9915371|NCT01213043|11031794|FG001|COMPLETED|Follow-up||15
9915372|NCT01213043|11031793|FG000|NOT COMPLETED|Follow-up||0
9915373|NCT01213043|11031794|FG001|NOT COMPLETED|Follow-up||0
9915374|NCT01213082|11031803|FG000|STARTED|Overall Study||12
9915375|NCT01213082|11031804|FG001|STARTED|Overall Study||11
9915376|NCT01213082|11031805|FG002|STARTED|Overall Study||11
9915377|NCT01213082|11031803|FG000|COMPLETED|Overall Study||6
9915378|NCT01213082|11031804|FG001|COMPLETED|Overall Study||4
9915379|NCT01213082|11031805|FG002|COMPLETED|Overall Study||6
9915380|NCT01213082|11031803|FG000|NOT COMPLETED|Overall Study||6
9915381|NCT01213082|11031804|FG001|NOT COMPLETED|Overall Study||7
9915382|NCT01213082|11031805|FG002|NOT COMPLETED|Overall Study||5
9915383|NCT01213173|11031815|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125
9915384|NCT01213173|11031816|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126
9915385|NCT01213173|11031815|FG000|Patients Included in Safety Population|Overall Study||139
9915386|NCT01213173|11031816|FG001|Patients Included in Safety Population|Overall Study||112
9915387|NCT01213173|11031815|FG000|Patients Included in ITT Population|Overall Study||116
9915388|NCT01213173|11031816|FG001|Patients Included in ITT Population|Overall Study||115
9915389|NCT01213173|11031815|FG000|Patients Included in PP Population|Overall Study||102
9915390|NCT01213173|11031816|FG001|Patients Included in PP Population|Overall Study||89
9915391|NCT01213173|11031815|FG000|COMPLETED|Overall Study|Patients who completed the study|113
9915392|NCT01213173|11031816|FG001|COMPLETED|Overall Study|Patients who completed the study|110
9915393|NCT01213173|11031815|FG000|NOT COMPLETED|Overall Study||12
9915394|NCT01213173|11031816|FG001|NOT COMPLETED|Overall Study||16
9915395|NCT01213199|11031822|FG000|STARTED|Overall Study||20
9915396|NCT01213199|11031822|FG000|COMPLETED|Overall Study||16
9915397|NCT01213199|11031822|FG000|NOT COMPLETED|Overall Study||4
9915398|NCT01213251|11031829|FG000|STARTED|Overall Study||40
9915399|NCT01213251|11031830|FG001|STARTED|Overall Study||41
9915400|NCT01213251|11031831|FG002|STARTED|Overall Study||45
9915401|NCT01213251|11031829|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
9915402|NCT01213251|11031830|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
9915403|NCT01213251|11031831|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
9915404|NCT01213251|11031829|FG000|NOT COMPLETED|Overall Study||6
9915405|NCT01213251|11031830|FG001|NOT COMPLETED|Overall Study||4
9915406|NCT01213251|11031831|FG002|NOT COMPLETED|Overall Study||11
9915407|NCT01213264|11031847|FG000|STARTED|Overall Study||155
9915408|NCT01213264|11031848|FG001|STARTED|Overall Study||177
9915409|NCT01213264|11031849|FG002|STARTED|Overall Study||327
10204064|NCT03471871|11330899|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
10204065|NCT03471871|11330900|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10204066|NCT03471871|11330901|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10204067|NCT03471871|11330897|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10204068|NCT03471871|11330898|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10204069|NCT03471871|11330899|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10204070|NCT03471871|11330900|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10204071|NCT03471871|11330901|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10204072|NCT03471871|11330897|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6
10204073|NCT03471871|11330898|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5
10204074|NCT03471871|11330899|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5
10204075|NCT03471871|11330900|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
10204076|NCT03471871|11330901|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
10204077|NCT03471871|11330897|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
10204078|NCT03471871|11330898|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
10204079|NCT03471871|11330899|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
10204080|NCT03471871|11330900|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
10204081|NCT03471871|11330901|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
10204082|NCT03471871|11330897|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
10204083|NCT03471871|11330898|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
10204084|NCT03471871|11330899|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
10204085|NCT03471871|11330900|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
10204086|NCT03471871|11330901|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
10204087|NCT03471975|11330915|FG000|STARTED|Overall Study||17
10204088|NCT03471975|11330916|FG001|STARTED|Overall Study||20
9915410|NCT01213264|11031847|FG000|COMPLETED|Overall Study||153
9915411|NCT01213264|11031848|FG001|COMPLETED|Overall Study||175
9915412|NCT01213264|11031849|FG002|COMPLETED|Overall Study||321
9915413|NCT01213264|11031847|FG000|NOT COMPLETED|Overall Study||2
9915414|NCT01213264|11031848|FG001|NOT COMPLETED|Overall Study||2
9915415|NCT01213264|11031849|FG002|NOT COMPLETED|Overall Study||6
9915416|NCT01213316|11031860|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
9915417|NCT01213316|11031860|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
9915418|NCT01213316|11031860|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
9915419|NCT01213316|11031860|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67
9915420|NCT01213316|11031860|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
9915421|NCT01213316|11031860|FG000|COMPLETED|Overall Study||451
9915422|NCT01213316|11031860|FG000|NOT COMPLETED|Overall Study||0
9915423|NCT01213472|11031868|FG000|STARTED|Overall Study||33
9915424|NCT01213472|11031868|FG000|COMPLETED|Overall Study||6
9915425|NCT01213472|11031868|FG000|NOT COMPLETED|Overall Study||27
9915426|NCT01213524|11031874|FG000|STARTED|Baseline|Total number who signed informed consent.|75
9915427|NCT01213524|11031874|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
9915428|NCT01213524|11031874|FG000|NOT COMPLETED|Baseline||7
9915429|NCT01213524|11031874|FG000|STARTED|Session 2||68
10010232|NCT01772550|11132995|FG001|COMPLETED|Overall Study||102
10010233|NCT01772550|11132996|FG002|COMPLETED|Overall Study||27
10204089|NCT03471975|11330915|FG000|COMPLETED|Overall Study||17
9915430|NCT01213524|11031874|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63
9915431|NCT01213524|11031874|FG000|NOT COMPLETED|Session 2||5
9915432|NCT01213524|11031874|FG000|STARTED|Session 3||63
9915433|NCT01213524|11031874|FG000|COMPLETED|Session 3|Number who continued in study to next session|59
9915434|NCT01213524|11031874|FG000|NOT COMPLETED|Session 3||4
9915435|NCT01213524|11031874|FG000|STARTED|Session 4||59
9915436|NCT01213524|11031874|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56
9915437|NCT01213524|11031874|FG000|NOT COMPLETED|Session 4||3
9915438|NCT01213524|11031874|FG000|STARTED|Session 5||56
9915439|NCT01213524|11031874|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56
9915440|NCT01213524|11031874|FG000|NOT COMPLETED|Session 5||0
9915441|NCT01213524|11031874|FG000|STARTED|Session 6||56
9915442|NCT01213524|11031874|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56
9915443|NCT01213524|11031874|FG000|NOT COMPLETED|Session 6||0
9915444|NCT01213524|11031874|FG000|STARTED|Session 7||56
9915445|NCT01213524|11031874|FG000|COMPLETED|Session 7||56
9915446|NCT01213524|11031874|FG000|NOT COMPLETED|Session 7||0
9915447|NCT01213576|11031889|FG000|STARTED|Overall Study||18
9915448|NCT01213576|11031890|FG001|STARTED|Overall Study||17
9915449|NCT01213576|11031891|FG002|STARTED|Overall Study||18
9915450|NCT01213576|11031892|FG003|STARTED|Overall Study||17
9915451|NCT01213576|11031889|FG000|COMPLETED|Overall Study||15
9915452|NCT01213576|11031890|FG001|COMPLETED|Overall Study||13
9915453|NCT01213576|11031891|FG002|COMPLETED|Overall Study||13
9915454|NCT01213576|11031892|FG003|COMPLETED|Overall Study||13
9915455|NCT01213576|11031889|FG000|NOT COMPLETED|Overall Study||3
9915456|NCT01213576|11031890|FG001|NOT COMPLETED|Overall Study||4
9915457|NCT01213576|11031891|FG002|NOT COMPLETED|Overall Study||5
9915458|NCT01213576|11031892|FG003|NOT COMPLETED|Overall Study||4
9915459|NCT01213589|11031905|FG000|STARTED|Overall Study||50
9915460|NCT01213589|11031906|FG001|STARTED|Overall Study||24
9915461|NCT01213589|11031907|FG002|STARTED|Overall Study||26
9915462|NCT01213589|11031905|FG000|COMPLETED|Overall Study||37
9915463|NCT01213589|11031906|FG001|COMPLETED|Overall Study||19
9915464|NCT01213589|11031907|FG002|COMPLETED|Overall Study||18
9915465|NCT01213589|11031905|FG000|NOT COMPLETED|Overall Study||13
9915466|NCT01213589|11031906|FG001|NOT COMPLETED|Overall Study||5
9915467|NCT01213589|11031907|FG002|NOT COMPLETED|Overall Study||8
9915468|NCT01213706|11031915|FG000|STARTED|Sham WBPA||45
9915469|NCT01213706|11031915|FG000|COMPLETED|Sham WBPA||45
9915470|NCT01213706|11031915|FG000|NOT COMPLETED|Sham WBPA||0
9915471|NCT01213706|11031915|FG000|STARTED|Washout (1 Hour)||45
9915472|NCT01213706|11031915|FG000|COMPLETED|Washout (1 Hour)||45
9915473|NCT01213706|11031915|FG000|NOT COMPLETED|Washout (1 Hour)||0
9915474|NCT01213706|11031915|FG000|STARTED|WBPA||45
9915475|NCT01213706|11031915|FG000|COMPLETED|WBPA||45
9915476|NCT01213706|11031915|FG000|NOT COMPLETED|WBPA||0
10010234|NCT01772550|11132994|FG000|NOT COMPLETED|Overall Study||1
10204090|NCT03471975|11330916|FG001|COMPLETED|Overall Study||20
10204091|NCT03471975|11330915|FG000|NOT COMPLETED|Overall Study||0
10204092|NCT03471975|11330916|FG001|NOT COMPLETED|Overall Study||0
10204093|NCT03472014|11330922|FG000|STARTED|Overall Study||22
10204094|NCT03472014|11330922|FG000|COMPLETED|Overall Study||18
9915477|NCT01213823|11031923|FG000|STARTED|Overall Study||69
10010235|NCT01772550|11132995|FG001|NOT COMPLETED|Overall Study||1
10204095|NCT03472014|11330922|FG000|NOT COMPLETED|Overall Study||4
10204096|NCT03472287|11330928|FG000|STARTED|Overall Study||8
9915478|NCT01213823|11031924|FG001|STARTED|Overall Study||467
9915479|NCT01213823|11031923|FG000|COMPLETED|Overall Study||69
9915480|NCT01213823|11031924|FG001|COMPLETED|Overall Study||467
9915481|NCT01213823|11031923|FG000|NOT COMPLETED|Overall Study||0
10010236|NCT01772550|11132996|FG002|NOT COMPLETED|Overall Study||6
10204097|NCT03472287|11330929|FG001|STARTED|Overall Study||3
10204098|NCT03472287|11330928|FG000|COMPLETED|Overall Study||8
10204099|NCT03472287|11330929|FG001|COMPLETED|Overall Study||3
10204100|NCT03472287|11330928|FG000|NOT COMPLETED|Overall Study||0
10204101|NCT03472287|11330929|FG001|NOT COMPLETED|Overall Study||0
10204102|NCT03472326|11330937|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11
10204103|NCT03472326|11330938|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10
10204104|NCT03472326|11330939|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0
10204105|NCT03472326|11330940|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0
10204106|NCT03472326|11330937|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
10204107|NCT03472326|11330938|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
10204108|NCT03472326|11330939|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10204109|NCT03472326|11330940|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10204110|NCT03472326|11330937|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10204111|NCT03472326|11330938|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10204112|NCT03472326|11330939|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10204113|NCT03472326|11330940|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10204114|NCT03472326|11330937|FG000|STARTED|Part 2: Combination Therapy||0
10204115|NCT03472326|11330938|FG001|STARTED|Part 2: Combination Therapy||0
9915482|NCT01213823|11031924|FG001|NOT COMPLETED|Overall Study||0
9915483|NCT01213836|11031932|FG000|STARTED|Period 1, First Intervention||34
9915484|NCT01213836|11031933|FG001|STARTED|Period 1, First Intervention||32
9915485|NCT01213836|11031932|FG000|COMPLETED|Period 1, First Intervention||31
9915486|NCT01213836|11031933|FG001|COMPLETED|Period 1, First Intervention||29
9915487|NCT01213836|11031932|FG000|NOT COMPLETED|Period 1, First Intervention||3
10010237|NCT01772576|11133004|FG000|STARTED|Overall Study||167
10010238|NCT01772576|11133004|FG000|COMPLETED|Overall Study||133
10010239|NCT01772576|11133004|FG000|NOT COMPLETED|Overall Study||34
10010240|NCT01772654|11133010|FG000|STARTED|Overall Study||2
10010241|NCT01772654|11133011|FG001|STARTED|Overall Study||15
10204116|NCT03472326|11330939|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
9915488|NCT01213836|11031933|FG001|NOT COMPLETED|Period 1, First Intervention||3
9915489|NCT01213836|11031932|FG000|STARTED|Period 2, Second Intervention||31
9915490|NCT01213836|11031933|FG001|STARTED|Period 2, Second Intervention||29
9915491|NCT01213836|11031932|FG000|COMPLETED|Period 2, Second Intervention||31
9915492|NCT01213836|11031933|FG001|COMPLETED|Period 2, Second Intervention||29
9915493|NCT01213836|11031932|FG000|NOT COMPLETED|Period 2, Second Intervention||0
9915494|NCT01213836|11031933|FG001|NOT COMPLETED|Period 2, Second Intervention||0
9915495|NCT01213940|11031944|FG000|STARTED|Overall Study||14
9915496|NCT01213940|11031945|FG001|STARTED|Overall Study||6
9915497|NCT01213940|11031944|FG000|COMPLETED|Overall Study||14
9915498|NCT01213940|11031945|FG001|COMPLETED|Overall Study||6
9915499|NCT01213940|11031944|FG000|NOT COMPLETED|Overall Study||0
9915500|NCT01213940|11031945|FG001|NOT COMPLETED|Overall Study||0
9915501|NCT01213966|11031955|FG000|STARTED|Overall Study||20
9915502|NCT01213966|11031956|FG001|STARTED|Overall Study||20
9915503|NCT01213966|11031957|FG002|STARTED|Overall Study||20
10204117|NCT03472326|11330940|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
10204118|NCT03472326|11330937|FG000|COMPLETED|Part 2: Combination Therapy||0
10204119|NCT03472326|11330938|FG001|COMPLETED|Part 2: Combination Therapy||0
10204120|NCT03472326|11330939|FG002|COMPLETED|Part 2: Combination Therapy||0
10204121|NCT03472326|11330940|FG003|COMPLETED|Part 2: Combination Therapy||0
10204122|NCT03472326|11330937|FG000|NOT COMPLETED|Part 2: Combination Therapy||0
10204123|NCT03472326|11330938|FG001|NOT COMPLETED|Part 2: Combination Therapy||0
10204124|NCT03472326|11330939|FG002|NOT COMPLETED|Part 2: Combination Therapy||1
10204125|NCT03472326|11330940|FG003|NOT COMPLETED|Part 2: Combination Therapy||3
10204126|NCT03472469|11330951|FG000|STARTED|Overall Study||787
9915504|NCT01213966|11031958|FG003|STARTED|Overall Study||21
9915505|NCT01213966|11031955|FG000|COMPLETED|Overall Study||19
9915506|NCT01213966|11031956|FG001|COMPLETED|Overall Study||20
9915507|NCT01213966|11031957|FG002|COMPLETED|Overall Study||17
9915508|NCT01213966|11031958|FG003|COMPLETED|Overall Study||20
9915509|NCT01213966|11031955|FG000|NOT COMPLETED|Overall Study||1
9915510|NCT01213966|11031956|FG001|NOT COMPLETED|Overall Study||0
9915511|NCT01213966|11031957|FG002|NOT COMPLETED|Overall Study||3
9915512|NCT01213966|11031958|FG003|NOT COMPLETED|Overall Study||1
9915513|NCT01214044|11031968|FG000|STARTED|Visit 1: Screening and Consent, Washout||31
9915514|NCT01214044|11031968|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19
9915515|NCT01214044|11031968|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
10010242|NCT01772654|11133010|FG000|COMPLETED|Overall Study||2
10010243|NCT01772654|11133011|FG001|COMPLETED|Overall Study||15
10010244|NCT01772654|11133010|FG000|NOT COMPLETED|Overall Study||0
10204127|NCT03472469|11330952|FG001|STARTED|Overall Study||774
10204128|NCT03472469|11330951|FG000|COMPLETED|Overall Study||787
9915516|NCT01214044|11031968|FG000|STARTED|Visit 2: End Washout & Start Placebo||19
10010245|NCT01772654|11133011|FG001|NOT COMPLETED|Overall Study||0
10204129|NCT03472469|11330952|FG001|COMPLETED|Overall Study||774
10204130|NCT03472469|11330951|FG000|NOT COMPLETED|Overall Study||0
10204131|NCT03472469|11330952|FG001|NOT COMPLETED|Overall Study||0
10204132|NCT03472534|11330958|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
10204133|NCT03472534|11330958|FG000|Diacerein 1% Ointment|Overall Study||46
10010246|NCT01772693|11133019|FG000|STARTED|Overall Study||20
9915517|NCT01214044|11031968|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
9915518|NCT01214044|11031968|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
9915519|NCT01214044|11031968|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
9915520|NCT01214044|11031968|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
9915521|NCT01214044|11031968|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
9915522|NCT01214044|11031968|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
9915523|NCT01214044|11031968|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
9915524|NCT01214044|11031968|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
9915525|NCT01214057|11031978|FG000|STARTED|Overall Study||12
9915526|NCT01214057|11031979|FG001|STARTED|Overall Study||11
9915527|NCT01214057|11031978|FG000|COMPLETED|Overall Study||12
9915528|NCT01214057|11031979|FG001|COMPLETED|Overall Study||11
9915529|NCT01214057|11031978|FG000|NOT COMPLETED|Overall Study||0
9915530|NCT01214057|11031979|FG001|NOT COMPLETED|Overall Study||0
9915531|NCT01214083|11031988|FG000|STARTED|Overall Study||31
9915532|NCT01214083|11031989|FG001|STARTED|Overall Study||33
9915533|NCT01214083|11031990|FG002|STARTED|Overall Study||31
9915534|NCT01214083|11031988|FG000|COMPLETED|Overall Study||19
9915535|NCT01214083|11031989|FG001|COMPLETED|Overall Study||23
9915536|NCT01214083|11031990|FG002|COMPLETED|Overall Study||21
9915537|NCT01214083|11031988|FG000|NOT COMPLETED|Overall Study||12
9915538|NCT01214083|11031989|FG001|NOT COMPLETED|Overall Study||10
9915539|NCT01214083|11031990|FG002|NOT COMPLETED|Overall Study||10
9915540|NCT01214109|11031998|FG000|STARTED|Overall Study||24
9915541|NCT01214109|11031999|FG001|STARTED|Overall Study||24
9915542|NCT01214109|11032000|FG002|STARTED|Overall Study||24
9915543|NCT01214109|11032001|FG003|STARTED|Overall Study||24
9915544|NCT01214109|11031998|FG000|COMPLETED|Overall Study||24
9915545|NCT01214109|11031999|FG001|COMPLETED|Overall Study||24
9915546|NCT01214109|11032000|FG002|COMPLETED|Overall Study||24
9915547|NCT01214109|11032001|FG003|COMPLETED|Overall Study||24
9915548|NCT01214109|11031998|FG000|NOT COMPLETED|Overall Study||0
9915549|NCT01214109|11031999|FG001|NOT COMPLETED|Overall Study||0
9915550|NCT01214109|11032000|FG002|NOT COMPLETED|Overall Study||0
9915551|NCT01214109|11032001|FG003|NOT COMPLETED|Overall Study||0
9915552|NCT01214161|11032016|FG000|STARTED|Overall Study||100
9915553|NCT01214161|11032017|FG001|STARTED|Overall Study||100
9915554|NCT01214161|11032016|FG000|COMPLETED|Overall Study||100
9915555|NCT01214161|11032017|FG001|COMPLETED|Overall Study||100
9915556|NCT01214161|11032016|FG000|NOT COMPLETED|Overall Study||0
9915557|NCT01214161|11032017|FG001|NOT COMPLETED|Overall Study||0
9915558|NCT01214174|11032028|FG000|STARTED|Overall Study||13
9915559|NCT01214174|11032029|FG001|STARTED|Overall Study||16
9915560|NCT01214174|11032030|FG002|STARTED|Overall Study||14
9915561|NCT01214174|11032028|FG000|COMPLETED|Overall Study||13
9915562|NCT01214174|11032029|FG001|COMPLETED|Overall Study||16
9915563|NCT01214174|11032030|FG002|COMPLETED|Overall Study||13
9915564|NCT01214174|11032028|FG000|NOT COMPLETED|Overall Study||0
9915565|NCT01214174|11032029|FG001|NOT COMPLETED|Overall Study||0
9915566|NCT01214174|11032030|FG002|NOT COMPLETED|Overall Study||1
9915567|NCT01214187|11032040|FG000|STARTED|Overall Study||29
9915568|NCT01214187|11032041|FG001|STARTED|Overall Study||29
9915569|NCT01214187|11032040|FG000|COMPLETED|Overall Study||22
9915570|NCT01214187|11032041|FG001|COMPLETED|Overall Study||23
9915571|NCT01214187|11032040|FG000|NOT COMPLETED|Overall Study||7
9915572|NCT01214187|11032041|FG001|NOT COMPLETED|Overall Study||6
9915573|NCT01214200|11032047|FG000|STARTED|Overall Study||20
9915574|NCT01214200|11032047|FG000|COMPLETED|Overall Study||9
9915575|NCT01214200|11032047|FG000|NOT COMPLETED|Overall Study||11
9915576|NCT01214239|11032055|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99
9915577|NCT01214239|11032056|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
9915578|NCT01214239|11032055|FG000|COMPLETED|Overall Study||87
9915579|NCT01214239|11032056|FG001|COMPLETED|Overall Study||182
9915580|NCT01214239|11032055|FG000|NOT COMPLETED|Overall Study||12
9915581|NCT01214239|11032056|FG001|NOT COMPLETED|Overall Study||18
9915582|NCT01214252|11032062|FG000|STARTED|Overall Study||425
9915583|NCT01214252|11032062|FG000|COMPLETED|Overall Study||343
9915584|NCT01214252|11032062|FG000|NOT COMPLETED|Overall Study||82
9915585|NCT01214317|11032069|FG000|STARTED|Overall Study||18
9915586|NCT01214317|11032070|FG001|STARTED|Overall Study||22
9915587|NCT01214317|11032069|FG000|COMPLETED|Overall Study||18
9915588|NCT01214317|11032070|FG001|COMPLETED|Overall Study||22
9915589|NCT01214317|11032069|FG000|NOT COMPLETED|Overall Study||0
9915590|NCT01214317|11032070|FG001|NOT COMPLETED|Overall Study||0
9915591|NCT01214330|11032078|FG000|STARTED|Overall Study||150
9915592|NCT01214330|11032078|FG000|COMPLETED|Overall Study||102
9915593|NCT01214330|11032078|FG000|NOT COMPLETED|Overall Study||48
9915594|NCT01214356|11032084|FG000|STARTED|Overall Study||27
9915595|NCT01214356|11032085|FG001|STARTED|Overall Study||27
9915596|NCT01214356|11032084|FG000|COMPLETED|Overall Study||10
9915597|NCT01214356|11032085|FG001|COMPLETED|Overall Study||13
9915598|NCT01214356|11032084|FG000|NOT COMPLETED|Overall Study||17
9915599|NCT01214356|11032085|FG001|NOT COMPLETED|Overall Study||14
9915600|NCT01214395|11032091|FG000|STARTED|Overall Study||5
9915601|NCT01214395|11032091|FG000|COMPLETED|Overall Study||0
9915602|NCT01214395|11032091|FG000|NOT COMPLETED|Overall Study||5
9915603|NCT01214421|11032100|FG000|STARTED|Overall Study||557
9915604|NCT01214421|11032101|FG001|STARTED|Overall Study||314
9915605|NCT01214421|11032102|FG002|STARTED|Overall Study||181
9915606|NCT01214421|11032103|FG003|STARTED|Overall Study||31
9915607|NCT01214421|11032100|FG000|COMPLETED|Overall Study||507
9915608|NCT01214421|11032101|FG001|COMPLETED|Overall Study||256
9915609|NCT01214421|11032102|FG002|COMPLETED|Overall Study||143
10010247|NCT01772693|11133020|FG001|STARTED|Overall Study||7
10010248|NCT01772693|11133019|FG000|COMPLETED|Overall Study||14
10010249|NCT01772693|11133020|FG001|COMPLETED|Overall Study||6
10204134|NCT03472534|11330958|FG000|Vehicle Ointment|Overall Study||46
10204135|NCT03472534|11330958|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
10204136|NCT03472534|11330958|FG000|0.9% Saline|Overall Study||46
9915610|NCT01214421|11032103|FG003|COMPLETED|Overall Study||22
9915611|NCT01214421|11032100|FG000|NOT COMPLETED|Overall Study||50
9915612|NCT01214421|11032101|FG001|NOT COMPLETED|Overall Study||58
9915613|NCT01214421|11032102|FG002|NOT COMPLETED|Overall Study||38
9915614|NCT01214421|11032103|FG003|NOT COMPLETED|Overall Study||9
9915615|NCT01214434|11032115|FG000|STARTED|Overall Study||15
9915616|NCT01214434|11032116|FG001|STARTED|Overall Study||27
9915617|NCT01214434|11032115|FG000|COMPLETED|Overall Study||11
9915618|NCT01214434|11032116|FG001|COMPLETED|Overall Study||25
9915619|NCT01214434|11032115|FG000|NOT COMPLETED|Overall Study||4
9915620|NCT01214434|11032116|FG001|NOT COMPLETED|Overall Study||2
9915621|NCT01214603|11032125|FG000|STARTED|Overall Study||7
9915622|NCT01214603|11032126|FG001|STARTED|Overall Study||6
9915623|NCT01214603|11032127|FG002|STARTED|Overall Study||7
9915624|NCT01214603|11032125|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7
9915625|NCT01214603|11032126|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6
9915626|NCT01214603|11032127|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7
9915627|NCT01214603|11032125|FG000|COMPLETED|Overall Study||2
9915628|NCT01214603|11032126|FG001|COMPLETED|Overall Study||5
9915629|NCT01214603|11032127|FG002|COMPLETED|Overall Study||3
9915630|NCT01214603|11032125|FG000|NOT COMPLETED|Overall Study||5
9915631|NCT01214603|11032126|FG001|NOT COMPLETED|Overall Study||1
9915632|NCT01214603|11032127|FG002|NOT COMPLETED|Overall Study||4
9915633|NCT01214616|11032140|FG000|STARTED|Overall Study||3
9915634|NCT01214616|11032141|FG001|STARTED|Overall Study||5
9915635|NCT01214616|11032142|FG002|STARTED|Overall Study||3
9915636|NCT01214616|11032143|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
9915637|NCT01214616|11032140|FG000|COMPLETED|Overall Study||0
9915638|NCT01214616|11032141|FG001|COMPLETED|Overall Study||0
9915639|NCT01214616|11032142|FG002|COMPLETED|Overall Study||0
9915640|NCT01214616|11032143|FG003|COMPLETED|Overall Study||0
9915641|NCT01214616|11032140|FG000|NOT COMPLETED|Overall Study||3
9915642|NCT01214616|11032141|FG001|NOT COMPLETED|Overall Study||5
9915643|NCT01214616|11032142|FG002|NOT COMPLETED|Overall Study||3
9915644|NCT01214616|11032143|FG003|NOT COMPLETED|Overall Study||6
9915645|NCT01214629|11032172|FG000|STARTED|Overall Study||1
9915646|NCT01214629|11032173|FG001|STARTED|Overall Study||1
9915647|NCT01214629|11032174|FG002|STARTED|Overall Study||1
9915648|NCT01214629|11032175|FG003|STARTED|Overall Study||3
9915649|NCT01214629|11032176|FG004|STARTED|Overall Study||3
9915650|NCT01214629|11032177|FG005|STARTED|Overall Study||13
9915651|NCT01214629|11032178|FG006|STARTED|Overall Study||5
9915652|NCT01214629|11032179|FG007|STARTED|Overall Study||3
9915653|NCT01214629|11032180|FG008|STARTED|Overall Study||3
10204137|NCT03472534|11330958|FG000|COMPLETED|Overall Study||35
10204138|NCT03472534|11330958|FG000|NOT COMPLETED|Overall Study||11
10204139|NCT03472547|11330962|FG000|STARTED|Overall Study||234
10204140|NCT03472547|11330962|FG000|COMPLETED|Overall Study||204
10204141|NCT03472547|11330962|FG000|NOT COMPLETED|Overall Study||30
10204142|NCT03473171|11330966|FG000|STARTED|Overall Study||5
10204143|NCT03473171|11330966|FG000|COMPLETED|Overall Study||5
10204144|NCT03473171|11330966|FG000|NOT COMPLETED|Overall Study||0
10204145|NCT03473184|11330970|FG000|STARTED|Overall Study||34
10204146|NCT03473184|11330970|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34
10204147|NCT03473184|11330970|FG000|Vehicle Ointment Irradiated|Overall Study||34
10204148|NCT03473184|11330970|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34
10204149|NCT03473184|11330970|FG000|Vehicle Ointment Non-irradiated|Overall Study||34
10204150|NCT03473184|11330970|FG000|Untreated Irradiated|Overall Study||34
10204151|NCT03473184|11330970|FG000|COMPLETED|Overall Study||34
10204152|NCT03473184|11330970|FG000|NOT COMPLETED|Overall Study||0
10204153|NCT03473197|11330974|FG000|STARTED|Overall Study||61
10204154|NCT03473197|11330974|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51
10204155|NCT03473197|11330974|FG000|Vehicle Ointment Irradiated|Overall Study||51
10204156|NCT03473197|11330974|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51
10204157|NCT03473197|11330974|FG000|Vehicle Ointment Non-irradiated|Overall Study||51
10204158|NCT03473197|11330974|FG000|Untreated Irradiated|Overall Study||51
10204159|NCT03473197|11330974|FG000|COMPLETED|Overall Study||51
10204160|NCT03473197|11330974|FG000|NOT COMPLETED|Overall Study||10
9915654|NCT01214629|11032181|FG009|STARTED|Overall Study||18
10204161|NCT03473236|11330988|FG000|STARTED|Overall Study||10
9915655|NCT01214629|11032182|FG010|STARTED|Overall Study||3
9915656|NCT01214629|11032172|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
9915657|NCT01214629|11032173|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
9915658|NCT01214629|11032174|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1
9915659|NCT01214629|11032175|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10010250|NCT01772693|11133019|FG000|NOT COMPLETED|Overall Study||6
10010251|NCT01772693|11133020|FG001|NOT COMPLETED|Overall Study||1
10204162|NCT03473236|11330989|FG001|STARTED|Overall Study||6
9915660|NCT01214629|11032176|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
9915661|NCT01214629|11032177|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13
9915662|NCT01214629|11032178|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
9915663|NCT01214629|11032179|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
9915664|NCT01214629|11032180|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
9915665|NCT01214629|11032181|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18
9915666|NCT01214629|11032182|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
9915667|NCT01214629|11032172|FG000|COMPLETED|Overall Study||0
9915668|NCT01214629|11032173|FG001|COMPLETED|Overall Study||0
9915669|NCT01214629|11032174|FG002|COMPLETED|Overall Study||1
9915670|NCT01214629|11032175|FG003|COMPLETED|Overall Study||1
9915671|NCT01214629|11032176|FG004|COMPLETED|Overall Study||1
9915672|NCT01214629|11032177|FG005|COMPLETED|Overall Study||9
9915673|NCT01214629|11032178|FG006|COMPLETED|Overall Study||4
9915674|NCT01214629|11032179|FG007|COMPLETED|Overall Study||2
9915675|NCT01214629|11032180|FG008|COMPLETED|Overall Study||2
9915676|NCT01214629|11032181|FG009|COMPLETED|Overall Study||11
9915677|NCT01214629|11032182|FG010|COMPLETED|Overall Study||1
9915678|NCT01214629|11032172|FG000|NOT COMPLETED|Overall Study||1
9915679|NCT01214629|11032173|FG001|NOT COMPLETED|Overall Study||1
9915680|NCT01214629|11032174|FG002|NOT COMPLETED|Overall Study||0
9915681|NCT01214629|11032175|FG003|NOT COMPLETED|Overall Study||2
9915682|NCT01214629|11032176|FG004|NOT COMPLETED|Overall Study||2
9915683|NCT01214629|11032177|FG005|NOT COMPLETED|Overall Study||4
9915684|NCT01214629|11032178|FG006|NOT COMPLETED|Overall Study||1
9915685|NCT01214629|11032179|FG007|NOT COMPLETED|Overall Study||1
9915686|NCT01214629|11032180|FG008|NOT COMPLETED|Overall Study||1
9915687|NCT01214629|11032181|FG009|NOT COMPLETED|Overall Study||7
9915688|NCT01214629|11032182|FG010|NOT COMPLETED|Overall Study||2
9915689|NCT01214642|11032232|FG000|STARTED|Overall Study||3
9915690|NCT01214642|11032233|FG001|STARTED|Overall Study||3
9915691|NCT01214642|11032234|FG002|STARTED|Overall Study||6
9915692|NCT01214642|11032235|FG003|STARTED|Overall Study||6
9915693|NCT01214642|11032236|FG004|STARTED|Overall Study||6
9915694|NCT01214642|11032237|FG005|STARTED|Overall Study||3
9915695|NCT01214642|11032238|FG006|STARTED|Overall Study||6
9915696|NCT01214642|11032239|FG007|STARTED|Overall Study||3
9915697|NCT01214642|11032240|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
9915698|NCT01214642|11032241|FG009|STARTED|Overall Study||4
9915699|NCT01214642|11032242|FG010|STARTED|Overall Study||4
9915700|NCT01214642|11032243|FG011|STARTED|Overall Study||6
9915701|NCT01214642|11032232|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9915702|NCT01214642|11032233|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9915703|NCT01214642|11032234|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9915704|NCT01214642|11032235|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9915705|NCT01214642|11032236|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
9915706|NCT01214642|11032237|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
9915707|NCT01214642|11032238|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
9915708|NCT01214642|11032239|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
9915709|NCT01214642|11032240|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13
9915710|NCT01214642|11032241|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4
9915711|NCT01214642|11032242|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4
9915712|NCT01214642|11032243|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6
9915713|NCT01214642|11032232|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3
9915714|NCT01214642|11032233|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1
9915715|NCT01214642|11032234|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5
9915716|NCT01214642|11032235|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4
9915717|NCT01214642|11032236|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6
9915718|NCT01214642|11032237|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1
9915719|NCT01214642|11032238|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6
9915720|NCT01214642|11032239|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3
9915721|NCT01214642|11032240|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12
9915722|NCT01214642|11032241|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2
9915723|NCT01214642|11032242|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2
9915724|NCT01214642|11032243|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5
9915725|NCT01214642|11032232|FG000|COMPLETED|Overall Study||0
9915726|NCT01214642|11032233|FG001|COMPLETED|Overall Study||0
9915727|NCT01214642|11032234|FG002|COMPLETED|Overall Study||0
9915728|NCT01214642|11032235|FG003|COMPLETED|Overall Study||0
9915729|NCT01214642|11032236|FG004|COMPLETED|Overall Study||0
9915730|NCT01214642|11032237|FG005|COMPLETED|Overall Study||0
9915731|NCT01214642|11032238|FG006|COMPLETED|Overall Study||0
9915732|NCT01214642|11032239|FG007|COMPLETED|Overall Study||0
9915733|NCT01214642|11032240|FG008|COMPLETED|Overall Study||0
9915734|NCT01214642|11032241|FG009|COMPLETED|Overall Study||0
9915735|NCT01214642|11032242|FG010|COMPLETED|Overall Study||0
9915736|NCT01214642|11032243|FG011|COMPLETED|Overall Study||0
9915737|NCT01214642|11032232|FG000|NOT COMPLETED|Overall Study||3
9915738|NCT01214642|11032233|FG001|NOT COMPLETED|Overall Study||3
9915739|NCT01214642|11032234|FG002|NOT COMPLETED|Overall Study||6
9915740|NCT01214642|11032235|FG003|NOT COMPLETED|Overall Study||6
9915741|NCT01214642|11032236|FG004|NOT COMPLETED|Overall Study||6
9915742|NCT01214642|11032237|FG005|NOT COMPLETED|Overall Study||3
9915743|NCT01214642|11032238|FG006|NOT COMPLETED|Overall Study||6
9915744|NCT01214642|11032239|FG007|NOT COMPLETED|Overall Study||3
9915745|NCT01214642|11032240|FG008|NOT COMPLETED|Overall Study||13
9915746|NCT01214642|11032241|FG009|NOT COMPLETED|Overall Study||4
9915747|NCT01214642|11032242|FG010|NOT COMPLETED|Overall Study||4
9915748|NCT01214642|11032243|FG011|NOT COMPLETED|Overall Study||6
9915749|NCT01214655|11032289|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
9915750|NCT01214655|11032290|FG001|STARTED|Part A||0
9915751|NCT01214655|11032291|FG002|STARTED|Part A||0
9915752|NCT01214655|11032289|FG000|Received 2 mg Study Drug|Part A||3
9915753|NCT01214655|11032290|FG001|Received 2 mg Study Drug|Part A||0
9915754|NCT01214655|11032291|FG002|Received 2 mg Study Drug|Part A||0
9915755|NCT01214655|11032289|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3
9915756|NCT01214655|11032290|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0
9915757|NCT01214655|11032291|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0
9915758|NCT01214655|11032289|FG000|Joined 4 mg Group|Part A||1
9915759|NCT01214655|11032290|FG001|Joined 4 mg Group|Part A||0
9915760|NCT01214655|11032291|FG002|Joined 4 mg Group|Part A||0
9915761|NCT01214655|11032289|FG000|Escalated From 4 mg Study Drug|Part A||0
9915762|NCT01214655|11032290|FG001|Escalated From 4 mg Study Drug|Part A||0
9915763|NCT01214655|11032291|FG002|Escalated From 4 mg Study Drug|Part A||0
9915764|NCT01214655|11032289|FG000|Joined 5 mg Study Drug|Part A||2
9915765|NCT01214655|11032290|FG001|Joined 5 mg Study Drug|Part A||0
9915766|NCT01214655|11032291|FG002|Joined 5 mg Study Drug|Part A||0
9915767|NCT01214655|11032289|FG000|Escalated From 5 mg Study Drug|Part A||1
9915768|NCT01214655|11032290|FG001|Escalated From 5 mg Study Drug|Part A||0
9915769|NCT01214655|11032291|FG002|Escalated From 5 mg Study Drug|Part A||0
9915770|NCT01214655|11032289|FG000|Joined 6 mg Group|Part A||4
9915771|NCT01214655|11032290|FG001|Joined 6 mg Group|Part A||0
9915772|NCT01214655|11032291|FG002|Joined 6 mg Group|Part A||0
9915773|NCT01214655|11032289|FG000|Received 6 mg Study Drug|Part A||5
9915774|NCT01214655|11032290|FG001|Received 6 mg Study Drug|Part A||0
9915775|NCT01214655|11032291|FG002|Received 6 mg Study Drug|Part A||0
9915776|NCT01214655|11032289|FG000|COMPLETED|Part A||2
9915777|NCT01214655|11032290|FG001|COMPLETED|Part A||0
9915778|NCT01214655|11032291|FG002|COMPLETED|Part A||0
9915779|NCT01214655|11032289|FG000|NOT COMPLETED|Part A||8
9915780|NCT01214655|11032290|FG001|NOT COMPLETED|Part A||0
9915781|NCT01214655|11032291|FG002|NOT COMPLETED|Part A||0
9915782|NCT01214655|11032289|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
9915783|NCT01214655|11032290|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
9915784|NCT01214655|11032291|FG002|STARTED|Part B||0
9915785|NCT01214655|11032289|FG000|Received at Least 1 Dose of Study Drug|Part B||0
9915786|NCT01214655|11032290|FG001|Received at Least 1 Dose of Study Drug|Part B||15
9915787|NCT01214655|11032291|FG002|Received at Least 1 Dose of Study Drug|Part B||0
9915788|NCT01214655|11032289|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0
9915789|NCT01214655|11032290|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4
9915790|NCT01214655|11032291|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0
9915791|NCT01214655|11032289|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0
9915792|NCT01214655|11032290|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2
9915793|NCT01214655|11032291|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0
9915794|NCT01214655|11032289|FG000|Joined 10 mg/m²/Day Study D|Part B||0
9915795|NCT01214655|11032290|FG001|Joined 10 mg/m²/Day Study D|Part B||3
9915796|NCT01214655|11032291|FG002|Joined 10 mg/m²/Day Study D|Part B||0
9915797|NCT01214655|11032289|FG000|Escalated to 12 mg/m²/Day|Part B||0
9915798|NCT01214655|11032290|FG001|Escalated to 12 mg/m²/Day|Part B||2
9915799|NCT01214655|11032291|FG002|Escalated to 12 mg/m²/Day|Part B||0
9915800|NCT01214655|11032289|FG000|Joined 12 mg/m²/Day|Part B||0
9915801|NCT01214655|11032290|FG001|Joined 12 mg/m²/Day|Part B||5
9915802|NCT01214655|11032291|FG002|Joined 12 mg/m²/Day|Part B||0
9915803|NCT01214655|11032289|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0
9915804|NCT01214655|11032290|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1
9915805|NCT01214655|11032291|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0
9915806|NCT01214655|11032289|FG000|Joined 14 mg/m²/Day|Part B||0
9915807|NCT01214655|11032290|FG001|Joined 14 mg/m²/Day|Part B||3
9915808|NCT01214655|11032291|FG002|Joined 14 mg/m²/Day|Part B||0
9915809|NCT01214655|11032289|FG000|COMPLETED|Part B||0
9915810|NCT01214655|11032290|FG001|COMPLETED|Part B||2
9915811|NCT01214655|11032291|FG002|COMPLETED|Part B||0
9915812|NCT01214655|11032289|FG000|NOT COMPLETED|Part B||0
9915813|NCT01214655|11032290|FG001|NOT COMPLETED|Part B||13
9915814|NCT01214655|11032291|FG002|NOT COMPLETED|Part B||0
9915815|NCT01214655|11032289|FG000|STARTED|Part C||0
9915816|NCT01214655|11032290|FG001|STARTED|Part C||0
9915817|NCT01214655|11032291|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
9915818|NCT01214655|11032289|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
9915819|NCT01214655|11032290|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
9915820|NCT01214655|11032291|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
9915821|NCT01214655|11032289|FG000|COMPLETED|Part C||0
9915822|NCT01214655|11032290|FG001|COMPLETED|Part C||0
9915823|NCT01214655|11032291|FG002|COMPLETED|Part C||1
9915824|NCT01214655|11032289|FG000|NOT COMPLETED|Part C||0
9915825|NCT01214655|11032290|FG001|NOT COMPLETED|Part C||0
9915826|NCT01214655|11032291|FG002|NOT COMPLETED|Part C||7
9915827|NCT01214668|11032343|FG000|STARTED|Overall Study||4
9915828|NCT01214668|11032344|FG001|STARTED|Overall Study||3
9915829|NCT01214668|11032345|FG002|STARTED|Overall Study||6
9915830|NCT01214668|11032346|FG003|STARTED|Overall Study||6
9915831|NCT01214668|11032347|FG004|STARTED|Overall Study||6
9915832|NCT01214668|11032348|FG005|STARTED|Overall Study||6
9915833|NCT01214668|11032343|FG000|Received at Least One Dose of Study Drug|Overall Study||4
9915834|NCT01214668|11032344|FG001|Received at Least One Dose of Study Drug|Overall Study||3
9915835|NCT01214668|11032345|FG002|Received at Least One Dose of Study Drug|Overall Study||6
9915836|NCT01214668|11032346|FG003|Received at Least One Dose of Study Drug|Overall Study||6
9915837|NCT01214668|11032347|FG004|Received at Least One Dose of Study Drug|Overall Study||6
9915838|NCT01214668|11032348|FG005|Received at Least One Dose of Study Drug|Overall Study||6
9915839|NCT01214668|11032343|FG000|COMPLETED|Overall Study||0
9915840|NCT01214668|11032344|FG001|COMPLETED|Overall Study||0
9915841|NCT01214668|11032345|FG002|COMPLETED|Overall Study||0
9915842|NCT01214668|11032346|FG003|COMPLETED|Overall Study||0
9915843|NCT01214668|11032347|FG004|COMPLETED|Overall Study||0
9915844|NCT01214668|11032348|FG005|COMPLETED|Overall Study||0
9915845|NCT01214668|11032343|FG000|NOT COMPLETED|Overall Study||4
9915846|NCT01214668|11032344|FG001|NOT COMPLETED|Overall Study||3
9915847|NCT01214668|11032345|FG002|NOT COMPLETED|Overall Study||6
9915848|NCT01214668|11032346|FG003|NOT COMPLETED|Overall Study||6
9915849|NCT01214668|11032347|FG004|NOT COMPLETED|Overall Study||6
9915850|NCT01214668|11032348|FG005|NOT COMPLETED|Overall Study||6
9915851|NCT01214720|11032365|FG000|STARTED|Overall Study||306
9915852|NCT01214720|11032366|FG001|STARTED|Overall Study||301
9915853|NCT01214720|11032365|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
9915854|NCT01214720|11032366|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
9915855|NCT01214720|11032365|FG000|NOT COMPLETED|Overall Study||85
9915856|NCT01214720|11032366|FG001|NOT COMPLETED|Overall Study||68
9915857|NCT01214759|11032372|FG000|STARTED|Overall Study||103
9915858|NCT01214759|11032372|FG000|28 Days nPEP Completion|Overall Study||85
9915859|NCT01214759|11032372|FG000|COMPLETED|Overall Study||55
9915860|NCT01214759|11032372|FG000|NOT COMPLETED|Overall Study||48
9915861|NCT01214811|11032376|FG000|STARTED|Overall Study||27
9915862|NCT01214811|11032376|FG000|COMPLETED|Overall Study||24
9915863|NCT01214811|11032376|FG000|NOT COMPLETED|Overall Study||3
9915864|NCT01214824|11032380|FG000|STARTED|Overall Study||32
9915865|NCT01214824|11032380|FG000|COMPLETED|Overall Study||29
9915866|NCT01214824|11032380|FG000|NOT COMPLETED|Overall Study||3
9915867|NCT01214837|11032388|FG000|STARTED|Overall Study||249
9915868|NCT01214837|11032389|FG001|STARTED|Overall Study||256
9915869|NCT01214837|11032390|FG002|STARTED|Overall Study||246
9915870|NCT01214837|11032388|FG000|COMPLETED|Overall Study||195
9915871|NCT01214837|11032389|FG001|COMPLETED|Overall Study||192
9915872|NCT01214837|11032390|FG002|COMPLETED|Overall Study||184
9915873|NCT01214837|11032388|FG000|NOT COMPLETED|Overall Study||54
9915874|NCT01214837|11032389|FG001|NOT COMPLETED|Overall Study||64
9915875|NCT01214837|11032390|FG002|NOT COMPLETED|Overall Study||62
9915876|NCT01214850|11032402|FG000|STARTED|Overall Study||979
9915877|NCT01214850|11032403|FG001|STARTED|Overall Study||988
9915878|NCT01214850|11032404|FG002|STARTED|Overall Study||987
9915879|NCT01214850|11032402|FG000|COMPLETED|Overall Study||796
10204163|NCT03473236|11330990|FG002|STARTED|Overall Study||6
10204164|NCT03473236|11330991|FG003|STARTED|Overall Study||6
10204165|NCT03473236|11330992|FG004|STARTED|Overall Study||6
10204166|NCT03473236|11330993|FG005|STARTED|Overall Study||7
10204167|NCT03473236|11330994|FG006|STARTED|Overall Study||6
10204168|NCT03473236|11330995|FG007|STARTED|Overall Study||6
10204169|NCT03473236|11330996|FG008|STARTED|Overall Study||7
10204170|NCT03473236|11330997|FG009|STARTED|Overall Study||6
10204171|NCT03473236|11330988|FG000|COMPLETED|Overall Study||10
10204172|NCT03473236|11330989|FG001|COMPLETED|Overall Study||6
10204173|NCT03473236|11330990|FG002|COMPLETED|Overall Study||6
10204174|NCT03473236|11330991|FG003|COMPLETED|Overall Study||6
10204175|NCT03473236|11330992|FG004|COMPLETED|Overall Study||6
10204176|NCT03473236|11330993|FG005|COMPLETED|Overall Study||6
10204177|NCT03473236|11330994|FG006|COMPLETED|Overall Study||6
10204178|NCT03473236|11330995|FG007|COMPLETED|Overall Study||6
10204179|NCT03473236|11330996|FG008|COMPLETED|Overall Study||6
10204180|NCT03473236|11330997|FG009|COMPLETED|Overall Study||6
10204181|NCT03473236|11330988|FG000|NOT COMPLETED|Overall Study||0
10204182|NCT03473236|11330989|FG001|NOT COMPLETED|Overall Study||0
10204183|NCT03473236|11330990|FG002|NOT COMPLETED|Overall Study||0
9915880|NCT01214850|11032403|FG001|COMPLETED|Overall Study||844
9915881|NCT01214850|11032404|FG002|COMPLETED|Overall Study||826
9915882|NCT01214850|11032402|FG000|NOT COMPLETED|Overall Study||183
9915883|NCT01214850|11032403|FG001|NOT COMPLETED|Overall Study||144
9915884|NCT01214850|11032404|FG002|NOT COMPLETED|Overall Study||161
9915885|NCT01214915|11032415|FG000|STARTED|Overall Study||53
9915886|NCT01214915|11032415|FG000|COMPLETED|Overall Study||42
9915887|NCT01214915|11032415|FG000|NOT COMPLETED|Overall Study||11
9915888|NCT01214980|11032421|FG000|STARTED|Overall Study||16
9915889|NCT01214980|11032422|FG001|STARTED|Overall Study||16
9915890|NCT01214980|11032421|FG000|COMPLETED|Overall Study||13
9915891|NCT01214980|11032422|FG001|COMPLETED|Overall Study||14
9915892|NCT01214980|11032421|FG000|NOT COMPLETED|Overall Study||3
10204184|NCT03473236|11330991|FG003|NOT COMPLETED|Overall Study||0
10204185|NCT03473236|11330992|FG004|NOT COMPLETED|Overall Study||0
10204186|NCT03473236|11330993|FG005|NOT COMPLETED|Overall Study||1
10204187|NCT03473236|11330994|FG006|NOT COMPLETED|Overall Study||0
10204188|NCT03473236|11330995|FG007|NOT COMPLETED|Overall Study||0
10204189|NCT03473236|11330996|FG008|NOT COMPLETED|Overall Study||1
9915893|NCT01214980|11032422|FG001|NOT COMPLETED|Overall Study||2
9955602|NCT01439724|11074605|FG001|STARTED|Overall Study||47
9955603|NCT01439724|11074604|FG000|COMPLETED|Overall Study||38
9955604|NCT01439724|11074605|FG001|COMPLETED|Overall Study||39
9955605|NCT01439724|11074604|FG000|NOT COMPLETED|Overall Study||9
9955606|NCT01439724|11074605|FG001|NOT COMPLETED|Overall Study||8
10204190|NCT03473236|11330997|FG009|NOT COMPLETED|Overall Study||0
10204191|NCT03473301|11331030|FG000|STARTED|Overall Study||31
10204192|NCT03473301|11331031|FG001|STARTED|Overall Study||29
10204193|NCT03473301|11331032|FG002|STARTED|Overall Study||31
10204194|NCT03473301|11331030|FG000|COMPLETED|Overall Study||20
10204195|NCT03473301|11331031|FG001|COMPLETED|Overall Study||23
10204196|NCT03473301|11331032|FG002|COMPLETED|Overall Study||25
10204197|NCT03473301|11331030|FG000|NOT COMPLETED|Overall Study||11
10204198|NCT03473301|11331031|FG001|NOT COMPLETED|Overall Study||6
9955607|NCT01439815|11074613|FG000|STARTED|Overall Study||11
9955608|NCT01439815|11074614|FG001|STARTED|Overall Study||11
9955609|NCT01439815|11074613|FG000|All Randomized Participant Population|Overall Study||11
9955610|NCT01439815|11074614|FG001|All Randomized Participant Population|Overall Study||11
9955611|NCT01439815|11074613|FG000|COMPLETED|Overall Study||11
9955612|NCT01439815|11074614|FG001|COMPLETED|Overall Study||9
9955613|NCT01439815|11074613|FG000|NOT COMPLETED|Overall Study||0
9955614|NCT01439815|11074614|FG001|NOT COMPLETED|Overall Study||2
9955615|NCT01439854|11074622|FG000|STARTED|Overall Study||8
9955616|NCT01439854|11074623|FG001|STARTED|Overall Study||10
9955617|NCT01439854|11074622|FG000|COMPLETED|Overall Study||8
9955618|NCT01439854|11074623|FG001|COMPLETED|Overall Study||10
9955619|NCT01439854|11074622|FG000|NOT COMPLETED|Overall Study||0
9955620|NCT01439854|11074623|FG001|NOT COMPLETED|Overall Study||0
9955621|NCT01439867|11074631|FG000|STARTED|Overall Study||8
9955622|NCT01439867|11074632|FG001|STARTED|Overall Study||10
9955623|NCT01439867|11074631|FG000|Received Treatment|Overall Study||7
9955624|NCT01439867|11074632|FG001|Received Treatment|Overall Study||10
9955625|NCT01439867|11074631|FG000|COMPLETED|Overall Study||2
9955626|NCT01439867|11074632|FG001|COMPLETED|Overall Study||2
9955627|NCT01439867|11074631|FG000|NOT COMPLETED|Overall Study||6
9955628|NCT01439867|11074632|FG001|NOT COMPLETED|Overall Study||8
9955629|NCT01439880|11074642|FG000|STARTED|SOC-controlled Period (Year 1)||442
9955630|NCT01439880|11074643|FG001|STARTED|SOC-controlled Period (Year 1)||882
9955631|NCT01439880|11074642|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0
9955632|NCT01439880|11074643|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881
9955633|NCT01439880|11074642|FG000|COMPLETED|SOC-controlled Period (Year 1)||398
9955634|NCT01439880|11074643|FG001|COMPLETED|SOC-controlled Period (Year 1)||822
9955635|NCT01439880|11074642|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44
9955636|NCT01439880|11074643|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60
9955637|NCT01439880|11074642|FG000|STARTED|All-IP Period (Years 2 to 5)||398
9955638|NCT01439880|11074643|FG001|STARTED|All-IP Period (Years 2 to 5)||822
9955639|NCT01439880|11074642|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374
9955640|NCT01439880|11074643|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777
9955641|NCT01439880|11074642|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328
9955642|NCT01439880|11074643|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682
10204199|NCT03473301|11331032|FG002|NOT COMPLETED|Overall Study||6
10204200|NCT03473665|11331042|FG000|STARTED|Overall Study||9
10204201|NCT03473665|11331042|FG000|COMPLETED|Overall Study||9
10204202|NCT03473665|11331042|FG000|NOT COMPLETED|Overall Study||0
10204203|NCT03473808|11331051|FG000|STARTED|Overall Study||5
10204204|NCT03473808|11331051|FG000|COMPLETED|Overall Study||4
10204205|NCT03473808|11331051|FG000|NOT COMPLETED|Overall Study||1
10204206|NCT03473886|11331055|FG000|STARTED|Overall Study||8
10204207|NCT03473886|11331055|FG000|COMPLETED|Overall Study||7
10204208|NCT03473886|11331055|FG000|NOT COMPLETED|Overall Study||1
10204209|NCT03474081|11331061|FG000|STARTED|Overall Study||400
10204210|NCT03474081|11331062|FG001|STARTED|Overall Study||400
10204211|NCT03474081|11331061|FG000|Received Study Treatment|Overall Study||400
9955643|NCT01439880|11074642|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
9955644|NCT01439880|11074643|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
9955645|NCT01439945|11074663|FG000|STARTED|Double-Blind Treatment Phase||97
9955646|NCT01439945|11074664|FG001|STARTED|Double-Blind Treatment Phase||96
9955647|NCT01439945|11074665|FG002|STARTED|Double-Blind Treatment Phase||48
10204212|NCT03474081|11331062|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
10204213|NCT03474081|11331061|FG000|COMPLETED|Overall Study||383
10204214|NCT03474081|11331062|FG001|COMPLETED|Overall Study||387
10204215|NCT03474081|11331061|FG000|NOT COMPLETED|Overall Study||17
10204216|NCT03474081|11331062|FG001|NOT COMPLETED|Overall Study||13
10204217|NCT03474172|11331070|FG000|STARTED|Overall Study||30
10204218|NCT03474172|11331071|FG001|STARTED|Overall Study||30
10204219|NCT03474172|11331070|FG000|COMPLETED|Overall Study||30
9955648|NCT01439945|11074666|FG003|STARTED|Double-Blind Treatment Phase||48
9955649|NCT01439945|11074663|FG000|COMPLETED|Double-Blind Treatment Phase||93
9955650|NCT01439945|11074664|FG001|COMPLETED|Double-Blind Treatment Phase||91
9955651|NCT01439945|11074665|FG002|COMPLETED|Double-Blind Treatment Phase||45
9955652|NCT01439945|11074666|FG003|COMPLETED|Double-Blind Treatment Phase||46
10204220|NCT03474172|11331071|FG001|COMPLETED|Overall Study||30
10204221|NCT03474172|11331070|FG000|NOT COMPLETED|Overall Study||0
10204222|NCT03474172|11331071|FG001|NOT COMPLETED|Overall Study||0
10204223|NCT03474406|11331080|FG000|STARTED|Overall Study||150
10204224|NCT03474406|11331080|FG000|COMPLETED|Overall Study||72
9915894|NCT01215032|11032428|FG000|STARTED|Overall Study||21
9915895|NCT01215032|11032428|FG000|COMPLETED|Overall Study||1
9915896|NCT01215032|11032428|FG000|NOT COMPLETED|Overall Study||20
9915897|NCT01215097|11032436|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
9915898|NCT01215097|11032437|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
9915899|NCT01215097|11032436|FG000|COMPLETED|Overall Study||88
9915900|NCT01215097|11032437|FG001|COMPLETED|Overall Study||191
9915901|NCT01215097|11032436|FG000|NOT COMPLETED|Overall Study||12
9915902|NCT01215097|11032437|FG001|NOT COMPLETED|Overall Study||14
9915903|NCT01215110|11032448|FG000|STARTED|Overall Study||15
9915904|NCT01215110|11032449|FG001|STARTED|Overall Study||15
9915905|NCT01215110|11032450|FG002|STARTED|Overall Study||15
9915906|NCT01215110|11032451|FG003|STARTED|Overall Study||15
9915907|NCT01215110|11032452|FG004|STARTED|Overall Study||8
9915908|NCT01215110|11032448|FG000|COMPLETED|Overall Study||15
9915909|NCT01215110|11032449|FG001|COMPLETED|Overall Study||15
9915910|NCT01215110|11032450|FG002|COMPLETED|Overall Study||13
9915911|NCT01215110|11032451|FG003|COMPLETED|Overall Study||14
9915912|NCT01215110|11032452|FG004|COMPLETED|Overall Study||8
9915913|NCT01215110|11032448|FG000|NOT COMPLETED|Overall Study||0
9915914|NCT01215110|11032449|FG001|NOT COMPLETED|Overall Study||0
9915915|NCT01215110|11032450|FG002|NOT COMPLETED|Overall Study||2
9915916|NCT01215110|11032451|FG003|NOT COMPLETED|Overall Study||1
9915917|NCT01215110|11032452|FG004|NOT COMPLETED|Overall Study||0
9915918|NCT01215123|11032468|FG000|STARTED|Overall Study||28
9915919|NCT01215123|11032468|FG000|COMPLETED|Overall Study||28
9915920|NCT01215123|11032468|FG000|NOT COMPLETED|Overall Study||0
9915921|NCT01215175|11032477|FG000|STARTED|Overall Study||30
9915922|NCT01215175|11032478|FG001|STARTED|Overall Study||30
9915923|NCT01215175|11032479|FG002|STARTED|Overall Study||33
9915924|NCT01215175|11032480|FG003|STARTED|Overall Study||29
9915925|NCT01215175|11032481|FG004|STARTED|Overall Study||28
9915926|NCT01215175|11032477|FG000|Treated|Overall Study||30
9915927|NCT01215175|11032478|FG001|Treated|Overall Study||30
9915928|NCT01215175|11032479|FG002|Treated|Overall Study||33
9915929|NCT01215175|11032480|FG003|Treated|Overall Study||29
9915930|NCT01215175|11032481|FG004|Treated|Overall Study||28
9915931|NCT01215175|11032477|FG000|COMPLETED|Overall Study||30
9915932|NCT01215175|11032478|FG001|COMPLETED|Overall Study||29
9915933|NCT01215175|11032479|FG002|COMPLETED|Overall Study||33
9915934|NCT01215175|11032480|FG003|COMPLETED|Overall Study||28
9915935|NCT01215175|11032481|FG004|COMPLETED|Overall Study||28
9915936|NCT01215175|11032477|FG000|NOT COMPLETED|Overall Study||0
9915937|NCT01215175|11032478|FG001|NOT COMPLETED|Overall Study||1
9915938|NCT01215175|11032479|FG002|NOT COMPLETED|Overall Study||0
9915939|NCT01215175|11032480|FG003|NOT COMPLETED|Overall Study||1
9915940|NCT01215175|11032481|FG004|NOT COMPLETED|Overall Study||0
9915941|NCT01215188|11032496|FG000|STARTED|Overall Study||378
9915942|NCT01215188|11032497|FG001|STARTED|Overall Study||386
9915943|NCT01215188|11032498|FG002|STARTED|Overall Study||378
9915944|NCT01215188|11032496|FG000|COMPLETED|Overall Study||320
9915945|NCT01215188|11032497|FG001|COMPLETED|Overall Study||327
9915946|NCT01215188|11032498|FG002|COMPLETED|Overall Study||326
9915947|NCT01215188|11032496|FG000|NOT COMPLETED|Overall Study||58
9915948|NCT01215188|11032497|FG001|NOT COMPLETED|Overall Study||59
9915949|NCT01215188|11032498|FG002|NOT COMPLETED|Overall Study||52
9915950|NCT01215227|11032512|FG000|STARTED|Overall Study||218
9915951|NCT01215227|11032513|FG001|STARTED|Overall Study||215
9915952|NCT01215227|11032514|FG002|STARTED|Overall Study||107
9915953|NCT01215227|11032515|FG003|STARTED|Overall Study||97
10010252|NCT01772758|11133030|FG000|STARTED|Overall Study||18
10010253|NCT01772758|11133031|FG001|STARTED|Overall Study||17
10010254|NCT01772758|11133032|FG002|STARTED|Overall Study||12
10010255|NCT01772758|11133033|FG003|STARTED|Overall Study||17
10010256|NCT01772758|11133030|FG000|COMPLETED|Overall Study||18
10010257|NCT01772758|11133031|FG001|COMPLETED|Overall Study||17
10010258|NCT01772758|11133032|FG002|COMPLETED|Overall Study||12
10010259|NCT01772758|11133033|FG003|COMPLETED|Overall Study||17
10010260|NCT01772758|11133030|FG000|NOT COMPLETED|Overall Study||0
10010261|NCT01772758|11133031|FG001|NOT COMPLETED|Overall Study||0
10010262|NCT01772758|11133032|FG002|NOT COMPLETED|Overall Study||0
10010263|NCT01772758|11133033|FG003|NOT COMPLETED|Overall Study||0
10010264|NCT01772823|11133045|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
10010265|NCT01772823|11133046|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
10010266|NCT01772823|11133045|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
10010267|NCT01772823|11133046|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
10010268|NCT01772823|11133045|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
9915954|NCT01215227|11032516|FG004|STARTED|Overall Study||93
9915955|NCT01215227|11032517|FG005|STARTED|Overall Study||109
9915956|NCT01215227|11032512|FG000|Treated|Overall Study||218
9915957|NCT01215227|11032513|FG001|Treated|Overall Study||215
9915958|NCT01215227|11032514|FG002|Treated|Overall Study||106
9915959|NCT01215227|11032515|FG003|Treated|Overall Study||96
9915960|NCT01215227|11032516|FG004|Treated|Overall Study||93
9915961|NCT01215227|11032517|FG005|Treated|Overall Study||108
10010269|NCT01772823|11133046|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
10010270|NCT01772823|11133045|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116
10010271|NCT01772823|11133046|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70
10010272|NCT01772823|11133045|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88
10010273|NCT01772823|11133046|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52
10010274|NCT01772823|11133045|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
10010275|NCT01772823|11133046|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
10010276|NCT01772823|11133045|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
10010277|NCT01772823|11133046|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
10010278|NCT01772823|11133045|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
10010279|NCT01772823|11133046|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
10010280|NCT01772823|11133045|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
10010281|NCT01772823|11133046|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
10010282|NCT01773070|11133057|FG000|STARTED|Overall Study||478
10010283|NCT01773070|11133057|FG000|COMPLETED|Overall Study||397
10010284|NCT01773070|11133057|FG000|NOT COMPLETED|Overall Study||81
10010285|NCT01773109|11133061|FG000|STARTED|Overall Study||40
10010286|NCT01773109|11133061|FG000|COMPLETED|Overall Study||37
10010287|NCT01773109|11133061|FG000|NOT COMPLETED|Overall Study||3
10010288|NCT01773122|11133069|FG000|STARTED|Overall Study||20
10010289|NCT01773122|11133070|FG001|STARTED|Overall Study||19
10010290|NCT01773122|11133071|FG002|STARTED|Overall Study||19
10010291|NCT01773122|11133072|FG003|STARTED|Overall Study||19
10010292|NCT01773122|11133069|FG000|COMPLETED|Overall Study||17
10204225|NCT03474406|11331080|FG000|NOT COMPLETED|Overall Study||78
10204226|NCT03474874|11331084|FG000|STARTED|Overall Study||68
10204227|NCT03474874|11331084|FG000|COMPLETED|Overall Study||54
10204228|NCT03474874|11331084|FG000|NOT COMPLETED|Overall Study||14
10204229|NCT03475056|11331092|FG000|STARTED|Overall Study||20
10204230|NCT03475056|11331093|FG001|STARTED|Overall Study||20
10204231|NCT03475056|11331092|FG000|Received Product Administration|Overall Study||20
10204232|NCT03475056|11331093|FG001|Received Product Administration|Overall Study||20
10204233|NCT03475056|11331092|FG000|COMPLETED|Overall Study||20
10204234|NCT03475056|11331093|FG001|COMPLETED|Overall Study||17
10204235|NCT03475056|11331092|FG000|NOT COMPLETED|Overall Study||0
10204236|NCT03475056|11331093|FG001|NOT COMPLETED|Overall Study||3
10204237|NCT03475316|11331102|FG000|STARTED|6 Month Intervention||13
10204238|NCT03475316|11331103|FG001|STARTED|6 Month Intervention||12
10204239|NCT03475316|11331102|FG000|COMPLETED|6 Month Intervention||8
10204240|NCT03475316|11331103|FG001|COMPLETED|6 Month Intervention||8
10204241|NCT03475316|11331102|FG000|NOT COMPLETED|6 Month Intervention||5
10204242|NCT03475316|11331103|FG001|NOT COMPLETED|6 Month Intervention||4
10204243|NCT03475316|11331102|FG000|STARTED|9 Months||8
10204244|NCT03475316|11331103|FG001|STARTED|9 Months||8
10204245|NCT03475316|11331102|FG000|COMPLETED|9 Months||5
10204246|NCT03475316|11331103|FG001|COMPLETED|9 Months||4
10204247|NCT03475316|11331102|FG000|NOT COMPLETED|9 Months||3
10204248|NCT03475316|11331103|FG001|NOT COMPLETED|9 Months||4
10204249|NCT03475875|11331109|FG000|STARTED|Period 1||46
10204250|NCT03475875|11331110|FG001|STARTED|Period 1||45
10204251|NCT03475875|11331109|FG000|COMPLETED|Period 1||43
10204252|NCT03475875|11331110|FG001|COMPLETED|Period 1||44
10204253|NCT03475875|11331109|FG000|NOT COMPLETED|Period 1||3
10204254|NCT03475875|11331110|FG001|NOT COMPLETED|Period 1||1
10204255|NCT03475875|11331109|FG000|STARTED|Period 2||43
10204256|NCT03475875|11331110|FG001|STARTED|Period 2||44
10204257|NCT03475875|11331109|FG000|COMPLETED|Period 2||40
10204258|NCT03475875|11331110|FG001|COMPLETED|Period 2||43
10204259|NCT03475875|11331109|FG000|NOT COMPLETED|Period 2||3
10204260|NCT03475875|11331110|FG001|NOT COMPLETED|Period 2||1
10204261|NCT03475875|11331109|FG000|STARTED|Period 3||40
10204262|NCT03475875|11331110|FG001|STARTED|Period 3||43
10204263|NCT03475875|11331109|FG000|COMPLETED|Period 3||40
10204264|NCT03475875|11331110|FG001|COMPLETED|Period 3||43
10204265|NCT03475875|11331109|FG000|NOT COMPLETED|Period 3||0
10204266|NCT03475875|11331110|FG001|NOT COMPLETED|Period 3||0
10204267|NCT03475992|11331119|FG000|STARTED|Overall Study||11
10204268|NCT03475992|11331120|FG001|STARTED|Overall Study||9
10204269|NCT03475992|11331121|FG002|STARTED|Overall Study||5
10204270|NCT03475992|11331119|FG000|COMPLETED|Overall Study||11
10204271|NCT03475992|11331120|FG001|COMPLETED|Overall Study||9
10204272|NCT03475992|11331121|FG002|COMPLETED|Overall Study||5
10204273|NCT03475992|11331119|FG000|NOT COMPLETED|Overall Study||0
10204274|NCT03475992|11331120|FG001|NOT COMPLETED|Overall Study||0
10204275|NCT03475992|11331121|FG002|NOT COMPLETED|Overall Study||0
10204276|NCT03476278|11331129|FG000|STARTED|Overall Study||300
10204277|NCT03476278|11331129|FG000|COMPLETED|Overall Study||300
10204278|NCT03476278|11331129|FG000|NOT COMPLETED|Overall Study||0
10204279|NCT03476798|11331143|FG000|STARTED|Overall Study||33
10204280|NCT03476798|11331143|FG000|COMPLETED|Overall Study||28
10204281|NCT03476798|11331143|FG000|NOT COMPLETED|Overall Study||5
10204282|NCT03476850|11331149|FG000|STARTED|Overall Study||24
10204283|NCT03476850|11331150|FG001|STARTED|Overall Study||24
10204284|NCT03476850|11331149|FG000|COMPLETED|Overall Study||24
10204285|NCT03476850|11331150|FG001|COMPLETED|Overall Study||24
10204286|NCT03476850|11331149|FG000|NOT COMPLETED|Overall Study||0
10204287|NCT03476850|11331150|FG001|NOT COMPLETED|Overall Study||0
10204288|NCT03477006|11331158|FG000|STARTED|Overall Study||40
10204289|NCT03477006|11331159|FG001|STARTED|Overall Study||46
10204290|NCT03477006|11331158|FG000|COMPLETED|Overall Study||40
10204291|NCT03477006|11331159|FG001|COMPLETED|Overall Study||46
10204292|NCT03477006|11331158|FG000|NOT COMPLETED|Overall Study||0
10204293|NCT03477006|11331159|FG001|NOT COMPLETED|Overall Study||0
10204294|NCT03477279|11331170|FG000|STARTED|Overall Study||250
10010293|NCT01773122|11133070|FG001|COMPLETED|Overall Study||18
10010294|NCT01773122|11133071|FG002|COMPLETED|Overall Study||19
10010295|NCT01773122|11133072|FG003|COMPLETED|Overall Study||18
10010296|NCT01773122|11133069|FG000|NOT COMPLETED|Overall Study||3
10010297|NCT01773122|11133070|FG001|NOT COMPLETED|Overall Study||1
10010298|NCT01773122|11133071|FG002|NOT COMPLETED|Overall Study||0
10204295|NCT03477279|11331171|FG001|STARTED|Overall Study||250
10204296|NCT03477279|11331172|FG002|STARTED|Overall Study||98
9915962|NCT01215227|11032512|FG000|COMPLETED|Overall Study||97
9915963|NCT01215227|11032513|FG001|COMPLETED|Overall Study||96
9915964|NCT01215227|11032514|FG002|COMPLETED|Overall Study||50
9915965|NCT01215227|11032515|FG003|COMPLETED|Overall Study||48
9915966|NCT01215227|11032516|FG004|COMPLETED|Overall Study||45
9915967|NCT01215227|11032517|FG005|COMPLETED|Overall Study||51
9915968|NCT01215227|11032512|FG000|NOT COMPLETED|Overall Study||121
9915969|NCT01215227|11032513|FG001|NOT COMPLETED|Overall Study||119
9915970|NCT01215227|11032514|FG002|NOT COMPLETED|Overall Study||57
9915971|NCT01215227|11032515|FG003|NOT COMPLETED|Overall Study||49
9915972|NCT01215227|11032516|FG004|NOT COMPLETED|Overall Study||48
9915973|NCT01215227|11032517|FG005|NOT COMPLETED|Overall Study||58
9915974|NCT01215240|11032533|FG000|STARTED|Overall Study||10
9915975|NCT01215240|11032534|FG001|STARTED|Overall Study||12
9915976|NCT01215240|11032533|FG000|COMPLETED|Overall Study||10
9915977|NCT01215240|11032534|FG001|COMPLETED|Overall Study||12
9915978|NCT01215240|11032533|FG000|NOT COMPLETED|Overall Study||0
9915979|NCT01215240|11032534|FG001|NOT COMPLETED|Overall Study||0
9915980|NCT01215253|11032542|FG000|STARTED|Overall Study||510
9915981|NCT01215253|11032543|FG001|STARTED|Overall Study||502
9915982|NCT01215253|11032542|FG000|COMPLETED|Overall Study||424
9915983|NCT01215253|11032543|FG001|COMPLETED|Overall Study||439
9915984|NCT01215253|11032542|FG000|NOT COMPLETED|Overall Study||86
9915985|NCT01215253|11032543|FG001|NOT COMPLETED|Overall Study||63
9915986|NCT01215279|11032552|FG000|STARTED|Overall Study||31
9915987|NCT01215279|11032553|FG001|STARTED|Overall Study||32
9915988|NCT01215279|11032552|FG000|COMPLETED|Overall Study||31
9915989|NCT01215279|11032553|FG001|COMPLETED|Overall Study||32
9915990|NCT01215279|11032552|FG000|NOT COMPLETED|Overall Study||0
9915991|NCT01215279|11032553|FG001|NOT COMPLETED|Overall Study||0
9915992|NCT01215292|11032564|FG000|STARTED|Overall Study||8
9915993|NCT01215292|11032565|FG001|STARTED|Overall Study||8
9915994|NCT01215292|11032566|FG002|STARTED|Overall Study||8
9915995|NCT01215292|11032567|FG003|STARTED|Overall Study||8
9915996|NCT01215292|11032568|FG004|STARTED|Overall Study||8
9915997|NCT01215292|11032564|FG000|COMPLETED|Overall Study||8
9915998|NCT01215292|11032565|FG001|COMPLETED|Overall Study||8
9915999|NCT01215292|11032566|FG002|COMPLETED|Overall Study||8
9916000|NCT01215292|11032567|FG003|COMPLETED|Overall Study||8
9916001|NCT01215292|11032568|FG004|COMPLETED|Overall Study||8
9916002|NCT01215292|11032564|FG000|NOT COMPLETED|Overall Study||0
10010299|NCT01773122|11133072|FG003|NOT COMPLETED|Overall Study||1
10010300|NCT01773135|11133084|FG000|STARTED|Overall Study||262
10204297|NCT03477279|11331173|FG003|STARTED|Overall Study||168
10204298|NCT03477279|11331174|FG004|STARTED|Overall Study||350
10204299|NCT03477279|11331170|FG000|COMPLETED|Overall Study||203
10204300|NCT03477279|11331171|FG001|COMPLETED|Overall Study||202
10204301|NCT03477279|11331172|FG002|COMPLETED|Overall Study||98
10204302|NCT03477279|11331173|FG003|COMPLETED|Overall Study||136
10204303|NCT03477279|11331174|FG004|COMPLETED|Overall Study||349
10204304|NCT03477279|11331170|FG000|NOT COMPLETED|Overall Study||47
10204305|NCT03477279|11331171|FG001|NOT COMPLETED|Overall Study||48
10204306|NCT03477279|11331172|FG002|NOT COMPLETED|Overall Study||0
10204307|NCT03477279|11331173|FG003|NOT COMPLETED|Overall Study||32
10204308|NCT03477279|11331174|FG004|NOT COMPLETED|Overall Study||1
10204309|NCT03477838|11331187|FG000|STARTED|Overall Study||28
10204310|NCT03477838|11331187|FG000|COMPLETED|Overall Study||14
10204311|NCT03477838|11331187|FG000|NOT COMPLETED|Overall Study||14
10204312|NCT03478163|11331193|FG000|STARTED|Overall Study||5
10204313|NCT03478163|11331194|FG001|STARTED|Overall Study||6
10204314|NCT03478163|11331193|FG000|COMPLETED|Overall Study||5
10204315|NCT03478163|11331194|FG001|COMPLETED|Overall Study||6
10204316|NCT03478163|11331193|FG000|NOT COMPLETED|Overall Study||0
10010301|NCT01773135|11133084|FG000|COMPLETED|Overall Study||262
10010302|NCT01773135|11133084|FG000|NOT COMPLETED|Overall Study||0
10010303|NCT01773187|11133091|FG000|STARTED|Overall Study||220
10204317|NCT03478163|11331194|FG001|NOT COMPLETED|Overall Study||0
10204318|NCT03478254|11331200|FG000|STARTED|Overall Study||300
9916003|NCT01215292|11032565|FG001|NOT COMPLETED|Overall Study||0
9916004|NCT01215292|11032566|FG002|NOT COMPLETED|Overall Study||0
9916005|NCT01215292|11032567|FG003|NOT COMPLETED|Overall Study||0
9916006|NCT01215292|11032568|FG004|NOT COMPLETED|Overall Study||0
9916007|NCT01215318|11032590|FG000|STARTED|Overall Study||20
9916008|NCT01215318|11032591|FG001|STARTED|Overall Study||24
9916009|NCT01215318|11032590|FG000|COMPLETED|Overall Study||20
9916010|NCT01215318|11032591|FG001|COMPLETED|Overall Study||24
9916011|NCT01215318|11032590|FG000|NOT COMPLETED|Overall Study||0
9916012|NCT01215318|11032591|FG001|NOT COMPLETED|Overall Study||0
9916013|NCT01215344|11032601|FG000|STARTED|Overall Study||33
9916014|NCT01215344|11032602|FG001|STARTED|Overall Study||3
10010304|NCT01773187|11133092|FG001|STARTED|Overall Study||107
10204319|NCT03478254|11331200|FG000|COMPLETED|Overall Study||300
10204320|NCT03478254|11331200|FG000|NOT COMPLETED|Overall Study||0
10204321|NCT03478371|11331205|FG000|STARTED|Overall Study||94
10204322|NCT03478371|11331205|FG000|Received Tampon D|Overall Study||91
10010305|NCT01773187|11133091|FG000|COMPLETED|Overall Study||167
10010306|NCT01773187|11133092|FG001|COMPLETED|Overall Study||75
9916015|NCT01215344|11032601|FG000|COMPLETED|Overall Study||23
9916016|NCT01215344|11032602|FG001|COMPLETED|Overall Study||3
9916017|NCT01215344|11032601|FG000|NOT COMPLETED|Overall Study||10
9916018|NCT01215344|11032602|FG001|NOT COMPLETED|Overall Study||0
9916019|NCT01215357|11032610|FG000|STARTED|Overall Study||34
9916020|NCT01215357|11032610|FG000|COMPLETED|Overall Study||22
9916021|NCT01215357|11032610|FG000|NOT COMPLETED|Overall Study||12
9916022|NCT01215422|11032618|FG000|STARTED|Overall Study||14
9916023|NCT01215422|11032619|FG001|STARTED|Overall Study||249
9916024|NCT01215422|11032620|FG002|STARTED|Overall Study||196
9916025|NCT01215422|11032621|FG003|STARTED|Overall Study||201
9916026|NCT01215422|11032618|FG000|COMPLETED|Overall Study||6
9916027|NCT01215422|11032619|FG001|COMPLETED|Overall Study||249
9916028|NCT01215422|11032620|FG002|COMPLETED|Overall Study||193
9916029|NCT01215422|11032621|FG003|COMPLETED|Overall Study||193
9916030|NCT01215422|11032618|FG000|NOT COMPLETED|Overall Study||8
9916031|NCT01215422|11032619|FG001|NOT COMPLETED|Overall Study||0
9916032|NCT01215422|11032620|FG002|NOT COMPLETED|Overall Study||3
9916033|NCT01215422|11032621|FG003|NOT COMPLETED|Overall Study||8
9916034|NCT01215435|11032645|FG000|STARTED|Overall Study||122
9916035|NCT01215435|11032646|FG001|STARTED|Overall Study||123
9916036|NCT01215435|11032645|FG000|COMPLETED|Overall Study||103
9916037|NCT01215435|11032646|FG001|COMPLETED|Overall Study||107
9916038|NCT01215435|11032645|FG000|NOT COMPLETED|Overall Study||19
9916039|NCT01215435|11032646|FG001|NOT COMPLETED|Overall Study||16
10204323|NCT03478371|11331205|FG000|Received Tampon M|Overall Study||92
10204324|NCT03478371|11331205|FG000|Recived Tampon T|Overall Study||90
10204325|NCT03478371|11331205|FG000|Received Tampon V|Overall Study||91
10204326|NCT03478371|11331205|FG000|COMPLETED|Overall Study||89
10204327|NCT03478371|11331205|FG000|NOT COMPLETED|Overall Study||5
10204328|NCT03478644|11331217|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
10204329|NCT03478644|11331218|FG001|STARTED|Phase 1||0
10204330|NCT03478644|11331217|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
10204331|NCT03478644|11331218|FG001|COMPLETED|Phase 1||0
10204332|NCT03478644|11331217|FG000|NOT COMPLETED|Phase 1||0
10204333|NCT03478644|11331218|FG001|NOT COMPLETED|Phase 1||0
10204334|NCT03478644|11331217|FG000|STARTED|Phase 2||76
10204335|NCT03478644|11331218|FG001|STARTED|Phase 2||76
10204336|NCT03478644|11331217|FG000|COMPLETED|Phase 2||73
10204337|NCT03478644|11331218|FG001|COMPLETED|Phase 2||75
10204338|NCT03478644|11331217|FG000|NOT COMPLETED|Phase 2||3
10204339|NCT03478644|11331218|FG001|NOT COMPLETED|Phase 2||1
10204340|NCT03478657|11331226|FG000|STARTED|Overall Study||88
10204341|NCT03478657|11331227|FG001|STARTED|Overall Study||134
10204342|NCT03478657|11331226|FG000|COMPLETED|Overall Study||88
10204343|NCT03478657|11331227|FG001|COMPLETED|Overall Study||133
10204344|NCT03478657|11331226|FG000|NOT COMPLETED|Overall Study||0
10204345|NCT03478657|11331227|FG001|NOT COMPLETED|Overall Study||1
10204346|NCT03478683|11331235|FG000|STARTED|Overall Study||363
10204347|NCT03478683|11331236|FG001|STARTED|Overall Study||365
10204348|NCT03478683|11331235|FG000|COMPLETED|Overall Study||350
10204349|NCT03478683|11331236|FG001|COMPLETED|Overall Study||347
10204350|NCT03478683|11331235|FG000|NOT COMPLETED|Overall Study||13
10204351|NCT03478683|11331236|FG001|NOT COMPLETED|Overall Study||18
10204352|NCT03478696|11331244|FG000|STARTED|Overall Study||366
10204353|NCT03478696|11331245|FG001|STARTED|Overall Study||366
10204354|NCT03478696|11331244|FG000|COMPLETED|Overall Study||349
10204355|NCT03478696|11331245|FG001|COMPLETED|Overall Study||354
10204356|NCT03478696|11331244|FG000|NOT COMPLETED|Overall Study||17
10204357|NCT03478696|11331245|FG001|NOT COMPLETED|Overall Study||12
10204358|NCT03478787|11331253|FG000|STARTED|Overall Study||163
10204359|NCT03478787|11331254|FG001|STARTED|Overall Study||164
10204360|NCT03478787|11331253|FG000|COMPLETED|Overall Study||134
10204361|NCT03478787|11331254|FG001|COMPLETED|Overall Study||151
10204362|NCT03478787|11331253|FG000|NOT COMPLETED|Overall Study||29
10204363|NCT03478787|11331254|FG001|NOT COMPLETED|Overall Study||13
10204364|NCT03478891|11331263|FG000|STARTED|Overall Study||3
10204365|NCT03478891|11331264|FG001|STARTED|Overall Study||5
10204366|NCT03478891|11331265|FG002|STARTED|Overall Study||11
10204367|NCT03478891|11331263|FG000|Received MAb114|Overall Study||3
10204368|NCT03478891|11331264|FG001|Received MAb114|Overall Study||5
10204369|NCT03478891|11331265|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
10204370|NCT03478891|11331263|FG000|COMPLETED|Overall Study||2
9916040|NCT01215513|11032652|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
9916041|NCT01215513|11032652|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
9916042|NCT01215513|11032652|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
9916043|NCT01215513|11032652|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
10010307|NCT01773187|11133091|FG000|NOT COMPLETED|Overall Study||53
10204371|NCT03478891|11331264|FG001|COMPLETED|Overall Study||5
10204372|NCT03478891|11331265|FG002|COMPLETED|Overall Study||8
10204373|NCT03478891|11331263|FG000|NOT COMPLETED|Overall Study||1
10204374|NCT03478891|11331264|FG001|NOT COMPLETED|Overall Study||0
10204375|NCT03478891|11331265|FG002|NOT COMPLETED|Overall Study||3
10204376|NCT03478904|11331277|FG000|STARTED|Overall Study||1
10204377|NCT03478904|11331277|FG000|COMPLETED|Overall Study||1
9916044|NCT01215513|11032652|FG000|COMPLETED|Overall Study||112
9916045|NCT01215513|11032652|FG000|NOT COMPLETED|Overall Study||45
9916046|NCT01215643|11032662|FG000|STARTED|Overall Study||83
9916047|NCT01215643|11032663|FG001|STARTED|Overall Study||84
9916048|NCT01215643|11032664|FG002|STARTED|Overall Study||94
9916049|NCT01215643|11032665|FG003|STARTED|Overall Study||39
9916050|NCT01215643|11032666|FG004|STARTED|Overall Study||40
9916051|NCT01215643|11032662|FG000|COMPLETED|Overall Study||74
9916052|NCT01215643|11032663|FG001|COMPLETED|Overall Study||80
9916053|NCT01215643|11032664|FG002|COMPLETED|Overall Study||82
9916054|NCT01215643|11032665|FG003|COMPLETED|Overall Study||35
9916055|NCT01215643|11032666|FG004|COMPLETED|Overall Study||29
9916056|NCT01215643|11032662|FG000|NOT COMPLETED|Overall Study||9
9916057|NCT01215643|11032663|FG001|NOT COMPLETED|Overall Study||4
9916058|NCT01215643|11032664|FG002|NOT COMPLETED|Overall Study||12
9916059|NCT01215643|11032665|FG003|NOT COMPLETED|Overall Study||4
9916060|NCT01215643|11032666|FG004|NOT COMPLETED|Overall Study||11
9916061|NCT01215695|11032685|FG000|STARTED|Overall Study||70
9916062|NCT01215695|11032686|FG001|STARTED|Overall Study||70
9916063|NCT01215695|11032685|FG000|COMPLETED|Overall Study||70
9916064|NCT01215695|11032686|FG001|COMPLETED|Overall Study||70
9916065|NCT01215695|11032685|FG000|NOT COMPLETED|Overall Study||0
9916066|NCT01215695|11032686|FG001|NOT COMPLETED|Overall Study||0
9916067|NCT01215721|11032692|FG000|STARTED|Overall Study||40
9916068|NCT01215721|11032692|FG000|COMPLETED|Overall Study||38
9916069|NCT01215721|11032692|FG000|NOT COMPLETED|Overall Study||2
9916070|NCT01215734|11032698|FG000|STARTED|Overall Study||29
9916071|NCT01215734|11032699|FG001|STARTED|Overall Study||15
9916072|NCT01215734|11032698|FG000|COMPLETED|Overall Study||29
9916073|NCT01215734|11032699|FG001|COMPLETED|Overall Study||14
9916074|NCT01215734|11032698|FG000|NOT COMPLETED|Overall Study||0
9916075|NCT01215734|11032699|FG001|NOT COMPLETED|Overall Study||1
9916076|NCT01215786|11032708|FG000|STARTED|Overall Study||21
9916077|NCT01215786|11032709|FG001|STARTED|Overall Study||19
9916078|NCT01215786|11032710|FG002|STARTED|Overall Study||10
9916079|NCT01215786|11032708|FG000|COMPLETED|Overall Study||21
9916080|NCT01215786|11032709|FG001|COMPLETED|Overall Study||19
9916081|NCT01215786|11032710|FG002|COMPLETED|Overall Study||10
9916082|NCT01215786|11032708|FG000|NOT COMPLETED|Overall Study||0
9916083|NCT01215786|11032709|FG001|NOT COMPLETED|Overall Study||0
9916084|NCT01215786|11032710|FG002|NOT COMPLETED|Overall Study||0
9916085|NCT01215851|11032724|FG000|STARTED|Treatment Period||15
9916086|NCT01215851|11032725|FG001|STARTED|Treatment Period||15
9916087|NCT01215851|11032726|FG002|STARTED|Treatment Period||15
9916088|NCT01215851|11032727|FG003|STARTED|Treatment Period||15
9916089|NCT01215851|11032728|FG004|STARTED|Treatment Period||10
9916090|NCT01215851|11032729|FG005|STARTED|Treatment Period||15
9916091|NCT01215851|11032724|FG000|COMPLETED|Treatment Period||14
9916092|NCT01215851|11032725|FG001|COMPLETED|Treatment Period||14
9916093|NCT01215851|11032726|FG002|COMPLETED|Treatment Period||14
9916094|NCT01215851|11032727|FG003|COMPLETED|Treatment Period||12
9916095|NCT01215851|11032728|FG004|COMPLETED|Treatment Period||10
9916096|NCT01215851|11032729|FG005|COMPLETED|Treatment Period||14
9916097|NCT01215851|11032724|FG000|NOT COMPLETED|Treatment Period||1
9916098|NCT01215851|11032725|FG001|NOT COMPLETED|Treatment Period||1
9916099|NCT01215851|11032726|FG002|NOT COMPLETED|Treatment Period||1
9916100|NCT01215851|11032727|FG003|NOT COMPLETED|Treatment Period||3
9916101|NCT01215851|11032728|FG004|NOT COMPLETED|Treatment Period||0
9916102|NCT01215851|11032729|FG005|NOT COMPLETED|Treatment Period||1
9916103|NCT01215851|11032724|FG000|STARTED|Follow up Period||14
9916104|NCT01215851|11032725|FG001|STARTED|Follow up Period||14
9916105|NCT01215851|11032726|FG002|STARTED|Follow up Period||14
9916106|NCT01215851|11032727|FG003|STARTED|Follow up Period||12
9916107|NCT01215851|11032728|FG004|STARTED|Follow up Period||10
9916108|NCT01215851|11032729|FG005|STARTED|Follow up Period||14
10010308|NCT01773187|11133092|FG001|NOT COMPLETED|Overall Study||32
10010309|NCT01773226|11133098|FG000|STARTED|Overall Study||11
10010310|NCT01773226|11133098|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
10010311|NCT01773226|11133098|FG000|NOT COMPLETED|Overall Study||1
10010312|NCT01773291|11133105|FG000|STARTED|Overall Study||8
10010313|NCT01773291|11133106|FG001|STARTED|Overall Study||9
10010314|NCT01773291|11133107|FG002|STARTED|Overall Study||7
9916109|NCT01215851|11032724|FG000|COMPLETED|Follow up Period||14
9916110|NCT01215851|11032725|FG001|COMPLETED|Follow up Period||14
9916111|NCT01215851|11032726|FG002|COMPLETED|Follow up Period||14
9916112|NCT01215851|11032727|FG003|COMPLETED|Follow up Period||12
9916113|NCT01215851|11032728|FG004|COMPLETED|Follow up Period||10
9916114|NCT01215851|11032729|FG005|COMPLETED|Follow up Period||13
9916115|NCT01215851|11032724|FG000|NOT COMPLETED|Follow up Period||0
9916116|NCT01215851|11032725|FG001|NOT COMPLETED|Follow up Period||0
9916117|NCT01215851|11032726|FG002|NOT COMPLETED|Follow up Period||0
10010315|NCT01773291|11133105|FG000|COMPLETED|Overall Study||7
10010316|NCT01773291|11133106|FG001|COMPLETED|Overall Study||9
9916118|NCT01215851|11032727|FG003|NOT COMPLETED|Follow up Period||0
9916119|NCT01215851|11032728|FG004|NOT COMPLETED|Follow up Period||0
9916120|NCT01215851|11032729|FG005|NOT COMPLETED|Follow up Period||1
9916121|NCT01215916|11032753|FG000|STARTED|Overall Study||1
9916122|NCT01215916|11032754|FG001|STARTED|Overall Study||5
9916123|NCT01215916|11032755|FG002|STARTED|Overall Study||3
9916124|NCT01215916|11032756|FG003|STARTED|Overall Study||6
9916125|NCT01215916|11032757|FG004|STARTED|Overall Study||6
9916126|NCT01215916|11032758|FG005|STARTED|Overall Study||4
10010317|NCT01773291|11133107|FG002|COMPLETED|Overall Study||6
10010318|NCT01773291|11133105|FG000|NOT COMPLETED|Overall Study||1
10010319|NCT01773291|11133106|FG001|NOT COMPLETED|Overall Study||0
9916127|NCT01215916|11032759|FG006|STARTED|Overall Study||9
9916128|NCT01215916|11032760|FG007|STARTED|Overall Study||3
9916129|NCT01215916|11032761|FG008|STARTED|Overall Study||2
9916130|NCT01215916|11032753|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1
9916131|NCT01215916|11032754|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5
9916132|NCT01215916|11032755|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3
9916133|NCT01215916|11032756|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6
9916134|NCT01215916|11032757|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6
9916135|NCT01215916|11032758|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4
9916136|NCT01215916|11032759|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9
9916137|NCT01215916|11032760|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3
9916138|NCT01215916|11032761|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2
10111251|NCT02494583|11242314|FG002|Treated|Overall Study||244
10111252|NCT02494583|11242312|FG000|COMPLETED|Overall Study||0
9916139|NCT01215916|11032753|FG000|COMPLETED|Overall Study||0
9916140|NCT01215916|11032754|FG001|COMPLETED|Overall Study||0
9916141|NCT01215916|11032755|FG002|COMPLETED|Overall Study||0
9916142|NCT01215916|11032756|FG003|COMPLETED|Overall Study||0
9916143|NCT01215916|11032757|FG004|COMPLETED|Overall Study||0
9916144|NCT01215916|11032758|FG005|COMPLETED|Overall Study||0
9916145|NCT01215916|11032759|FG006|COMPLETED|Overall Study||0
9916146|NCT01215916|11032760|FG007|COMPLETED|Overall Study||0
9916147|NCT01215916|11032761|FG008|COMPLETED|Overall Study||0
9916148|NCT01215916|11032753|FG000|NOT COMPLETED|Overall Study||1
9916149|NCT01215916|11032754|FG001|NOT COMPLETED|Overall Study||5
9916150|NCT01215916|11032755|FG002|NOT COMPLETED|Overall Study||3
9916151|NCT01215916|11032756|FG003|NOT COMPLETED|Overall Study||6
9916152|NCT01215916|11032757|FG004|NOT COMPLETED|Overall Study||6
9916153|NCT01215916|11032758|FG005|NOT COMPLETED|Overall Study||4
9916154|NCT01215916|11032759|FG006|NOT COMPLETED|Overall Study||9
9916155|NCT01215916|11032760|FG007|NOT COMPLETED|Overall Study||3
9916156|NCT01215916|11032761|FG008|NOT COMPLETED|Overall Study||2
9916157|NCT01215929|11032787|FG000|STARTED|Overall Study||18
9916158|NCT01215929|11032788|FG001|STARTED|Overall Study||17
9916159|NCT01215929|11032787|FG000|COMPLETED|Overall Study||12
9916160|NCT01215929|11032788|FG001|COMPLETED|Overall Study||12
9916161|NCT01215929|11032787|FG000|NOT COMPLETED|Overall Study||6
9916162|NCT01215929|11032788|FG001|NOT COMPLETED|Overall Study||5
9916163|NCT01215942|11032796|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
9916164|NCT01215942|11032797|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
9916165|NCT01215942|11032796|FG000|COMPLETED|Treatment Period||0
9916166|NCT01215942|11032797|FG001|COMPLETED|Treatment Period||0
9916167|NCT01215942|11032796|FG000|NOT COMPLETED|Treatment Period||414
9916168|NCT01215942|11032797|FG001|NOT COMPLETED|Treatment Period||672
9916169|NCT01215942|11032796|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
9916170|NCT01215942|11032797|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
9916171|NCT01215942|11032796|FG000|COMPLETED|Post-Treatment Follow-Up Period||283
9916172|NCT01215942|11032797|FG001|COMPLETED|Post-Treatment Follow-Up Period||445
9916173|NCT01215942|11032796|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85
9916174|NCT01215942|11032797|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146
9916175|NCT01215955|11032818|FG000|STARTED|Overall Study||268
9916176|NCT01215955|11032819|FG001|STARTED|Overall Study||263
9916177|NCT01215955|11032820|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
9916178|NCT01215955|11032821|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
9916179|NCT01215955|11032818|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267
9916180|NCT01215955|11032819|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261
9916181|NCT01215955|11032820|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288
9916182|NCT01215955|11032821|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290
9916183|NCT01215955|11032818|FG000|COMPLETED|Overall Study||223
9916184|NCT01215955|11032819|FG001|COMPLETED|Overall Study||210
9916185|NCT01215955|11032820|FG002|COMPLETED|Overall Study||244
9916186|NCT01215955|11032821|FG003|COMPLETED|Overall Study||241
9916187|NCT01215955|11032818|FG000|NOT COMPLETED|Overall Study||45
9916188|NCT01215955|11032819|FG001|NOT COMPLETED|Overall Study||53
9916189|NCT01215955|11032820|FG002|NOT COMPLETED|Overall Study||48
9916190|NCT01215955|11032821|FG003|NOT COMPLETED|Overall Study||53
9916191|NCT01215968|11032836|FG000|STARTED|Overall Study||13
9916192|NCT01215968|11032837|FG001|STARTED|Overall Study||25
9916193|NCT01215968|11032836|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
9916194|NCT01215968|11032837|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
9916195|NCT01215968|11032836|FG000|COMPLETED|Overall Study||11
9916196|NCT01215968|11032837|FG001|COMPLETED|Overall Study||18
10010320|NCT01773291|11133107|FG002|NOT COMPLETED|Overall Study||1
10010321|NCT01773421|11133120|FG000|STARTED|Treatment Phase||7
10010322|NCT01773421|11133121|FG001|STARTED|Treatment Phase||8
10111253|NCT02494583|11242313|FG001|COMPLETED|Overall Study||0
10111254|NCT02494583|11242314|FG002|COMPLETED|Overall Study||0
9916197|NCT01215968|11032836|FG000|NOT COMPLETED|Overall Study||2
9916198|NCT01215968|11032837|FG001|NOT COMPLETED|Overall Study||7
9916199|NCT01215981|11032848|FG000|STARTED|Overall Study||35
9916200|NCT01215981|11032849|FG001|STARTED|Overall Study||33
9916201|NCT01215981|11032848|FG000|COMPLETED|Overall Study||33
9916202|NCT01215981|11032849|FG001|COMPLETED|Overall Study||32
9916203|NCT01215981|11032848|FG000|NOT COMPLETED|Overall Study||2
9916204|NCT01215981|11032849|FG001|NOT COMPLETED|Overall Study||1
9916205|NCT01216072|11032857|FG000|STARTED|Open-Label Core Period ( 6 Months)||790
9916206|NCT01216072|11032858|FG001|STARTED|Open-Label Core Period ( 6 Months)||263
9916207|NCT01216072|11032857|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
9916208|NCT01216072|11032858|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
9916209|NCT01216072|11032857|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783
9916210|NCT01216072|11032858|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245
9916211|NCT01216072|11032857|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714
9916212|NCT01216072|11032858|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229
9916213|NCT01216072|11032857|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
9916214|NCT01216072|11032858|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
9916215|NCT01216072|11032857|FG000|STARTED|Open-Label Extension Period (3 Months)||0
9916216|NCT01216072|11032858|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
9916217|NCT01216072|11032857|FG000|Safety Set|Open-Label Extension Period (3 Months)||0
9916218|NCT01216072|11032858|FG001|Safety Set|Open-Label Extension Period (3 Months)||193
9916219|NCT01216072|11032857|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0
9916220|NCT01216072|11032858|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181
9916221|NCT01216072|11032857|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
9916222|NCT01216072|11032858|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
9916223|NCT01216163|11032870|FG000|STARTED|Overall Study||45
9916224|NCT01216163|11032871|FG001|STARTED|Overall Study||88
9916225|NCT01216163|11032872|FG002|STARTED|Overall Study||85
9916226|NCT01216163|11032870|FG000|COMPLETED|Overall Study||44
9916227|NCT01216163|11032871|FG001|COMPLETED|Overall Study||87
9916228|NCT01216163|11032872|FG002|COMPLETED|Overall Study||85
9916229|NCT01216163|11032870|FG000|NOT COMPLETED|Overall Study||1
9916230|NCT01216163|11032871|FG001|NOT COMPLETED|Overall Study||1
9916231|NCT01216163|11032872|FG002|NOT COMPLETED|Overall Study||0
9916232|NCT01216176|11032883|FG000|STARTED|Overall Study||12
9916233|NCT01216176|11032884|FG001|STARTED|Overall Study||39
9916234|NCT01216176|11032885|FG002|STARTED|Overall Study||20
9916235|NCT01216176|11032883|FG000|COMPLETED|Overall Study||12
9916236|NCT01216176|11032884|FG001|COMPLETED|Overall Study||31
9916237|NCT01216176|11032885|FG002|COMPLETED|Overall Study||19
9916238|NCT01216176|11032883|FG000|NOT COMPLETED|Overall Study||0
9916239|NCT01216176|11032884|FG001|NOT COMPLETED|Overall Study||8
10204378|NCT03478904|11331277|FG000|NOT COMPLETED|Overall Study||0
10204379|NCT03478969|11331291|FG000|STARTED|Overall Study||62
10204380|NCT03478969|11331292|FG001|STARTED|Overall Study||61
10204381|NCT03478969|11331293|FG002|STARTED|Overall Study||58
10204382|NCT03478969|11331291|FG000|Participants at End of Parallel Phase|Overall Study||55
10204383|NCT03478969|11331292|FG001|Participants at End of Parallel Phase|Overall Study||58
10204384|NCT03478969|11331293|FG002|Participants at End of Parallel Phase|Overall Study||52
10204385|NCT03478969|11331291|FG000|COMPLETED|Overall Study||53
10204386|NCT03478969|11331292|FG001|COMPLETED|Overall Study||49
10204387|NCT03478969|11331293|FG002|COMPLETED|Overall Study||40
10204388|NCT03478969|11331291|FG000|NOT COMPLETED|Overall Study||9
10204389|NCT03478969|11331292|FG001|NOT COMPLETED|Overall Study||12
10204390|NCT03478969|11331293|FG002|NOT COMPLETED|Overall Study||18
10204391|NCT03478982|11331307|FG000|STARTED|Overall Study||11
10204392|NCT03478982|11331308|FG001|STARTED|Overall Study||50
10204393|NCT03478982|11331309|FG002|STARTED|Overall Study||47
10204394|NCT03478982|11331310|FG003|STARTED|Overall Study||48
10204395|NCT03478982|11331307|FG000|Enrolled Participants But Not Treated|Overall Study||3
10204396|NCT03478982|11331308|FG001|Enrolled Participants But Not Treated|Overall Study||10
10204397|NCT03478982|11331309|FG002|Enrolled Participants But Not Treated|Overall Study||9
10204398|NCT03478982|11331310|FG003|Enrolled Participants But Not Treated|Overall Study||10
10204399|NCT03478982|11331307|FG000|Intent-to-treat (ITT) Population|Overall Study||8
10204400|NCT03478982|11331308|FG001|Intent-to-treat (ITT) Population|Overall Study||40
10204401|NCT03478982|11331309|FG002|Intent-to-treat (ITT) Population|Overall Study||38
10204402|NCT03478982|11331310|FG003|Intent-to-treat (ITT) Population|Overall Study||38
10204403|NCT03478982|11331307|FG000|COMPLETED|Overall Study||11
10204404|NCT03478982|11331308|FG001|COMPLETED|Overall Study||50
10204405|NCT03478982|11331309|FG002|COMPLETED|Overall Study||47
9916240|NCT01216176|11032885|FG002|NOT COMPLETED|Overall Study||1
9916241|NCT01216189|11032896|FG000|STARTED|Overall Study||110
9916242|NCT01216189|11032897|FG001|STARTED|Overall Study||32
9916243|NCT01216189|11032896|FG000|COMPLETED|Overall Study||85
9916244|NCT01216189|11032897|FG001|COMPLETED|Overall Study||27
9916245|NCT01216189|11032896|FG000|NOT COMPLETED|Overall Study||25
10204406|NCT03478982|11331310|FG003|COMPLETED|Overall Study||48
10204407|NCT03478982|11331307|FG000|NOT COMPLETED|Overall Study||0
10204408|NCT03478982|11331308|FG001|NOT COMPLETED|Overall Study||0
10204409|NCT03478982|11331309|FG002|NOT COMPLETED|Overall Study||0
10204410|NCT03478982|11331310|FG003|NOT COMPLETED|Overall Study||0
10238740|NCT00484718|11370192|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
9916246|NCT01216189|11032897|FG001|NOT COMPLETED|Overall Study||5
9916247|NCT01216202|11032905|FG000|STARTED|Overall Study||101
9916248|NCT01216202|11032906|FG001|STARTED|Overall Study||77
9916249|NCT01216202|11032905|FG000|Analysed at Baseline|Overall Study||93
9916250|NCT01216202|11032906|FG001|Analysed at Baseline|Overall Study||75
9916251|NCT01216202|11032905|FG000|Analysed After RT|Overall Study||79
9916252|NCT01216202|11032906|FG001|Analysed After RT|Overall Study||0
9916253|NCT01216202|11032905|FG000|COMPLETED|Overall Study||79
9916254|NCT01216202|11032906|FG001|COMPLETED|Overall Study||75
9916255|NCT01216202|11032905|FG000|NOT COMPLETED|Overall Study||22
9916256|NCT01216202|11032906|FG001|NOT COMPLETED|Overall Study||2
9916257|NCT01216241|11032916|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
9916258|NCT01216241|11032917|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
9916259|NCT01216241|11032916|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
9916260|NCT01216241|11032917|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
9916261|NCT01216241|11032916|FG000|NOT COMPLETED|Overall Study||0
9916262|NCT01216241|11032917|FG001|NOT COMPLETED|Overall Study||0
9916263|NCT01216319|11032923|FG000|STARTED|Overall Study||50
9916264|NCT01216319|11032923|FG000|COMPLETED|Overall Study||46
9916265|NCT01216319|11032923|FG000|NOT COMPLETED|Overall Study||4
9916266|NCT01216332|11032929|FG000|STARTED|Overall Study||34
9916267|NCT01216332|11032930|FG001|STARTED|Overall Study||16
9916268|NCT01216332|11032929|FG000|COMPLETED|Overall Study||30
9916269|NCT01216332|11032930|FG001|COMPLETED|Overall Study||16
9916270|NCT01216332|11032929|FG000|NOT COMPLETED|Overall Study||4
9916271|NCT01216332|11032930|FG001|NOT COMPLETED|Overall Study||0
9916272|NCT01216397|11032936|FG000|STARTED|Period 1||20
9916273|NCT01216397|11032937|FG001|STARTED|Period 1||20
9916274|NCT01216397|11032936|FG000|COMPLETED|Period 1||20
9916275|NCT01216397|11032937|FG001|COMPLETED|Period 1||20
9916276|NCT01216397|11032936|FG000|NOT COMPLETED|Period 1||0
9916277|NCT01216397|11032937|FG001|NOT COMPLETED|Period 1||0
9916278|NCT01216397|11032936|FG000|STARTED|Washout (35 Days)||20
9916279|NCT01216397|11032937|FG001|STARTED|Washout (35 Days)||20
9916280|NCT01216397|11032936|FG000|COMPLETED|Washout (35 Days)||20
9916281|NCT01216397|11032937|FG001|COMPLETED|Washout (35 Days)||20
9916282|NCT01216397|11032936|FG000|NOT COMPLETED|Washout (35 Days)||0
9916283|NCT01216397|11032937|FG001|NOT COMPLETED|Washout (35 Days)||0
9916284|NCT01216397|11032936|FG000|STARTED|Period 2||20
9916285|NCT01216397|11032937|FG001|STARTED|Period 2||20
9916286|NCT01216397|11032936|FG000|COMPLETED|Period 2||20
9916287|NCT01216397|11032937|FG001|COMPLETED|Period 2||20
9916288|NCT01216397|11032936|FG000|NOT COMPLETED|Period 2||0
9916289|NCT01216397|11032937|FG001|NOT COMPLETED|Period 2||0
9916290|NCT01216410|11032946|FG000|STARTED|Overall Study||103
9916291|NCT01216410|11032947|FG001|STARTED|Overall Study||100
9916292|NCT01216410|11032948|FG002|STARTED|Overall Study||103
9916293|NCT01216410|11032946|FG000|COMPLETED|Overall Study||101
9916294|NCT01216410|11032947|FG001|COMPLETED|Overall Study||99
9916295|NCT01216410|11032948|FG002|COMPLETED|Overall Study||100
9916296|NCT01216410|11032946|FG000|NOT COMPLETED|Overall Study||2
9916297|NCT01216410|11032947|FG001|NOT COMPLETED|Overall Study||1
9916298|NCT01216410|11032948|FG002|NOT COMPLETED|Overall Study||3
9916299|NCT01216735|11032958|FG000|STARTED|First Intervention (3 Weeks)||8
9916300|NCT01216735|11032959|FG001|STARTED|First Intervention (3 Weeks)||7
9916301|NCT01216735|11032958|FG000|COMPLETED|First Intervention (3 Weeks)||8
9916302|NCT01216735|11032959|FG001|COMPLETED|First Intervention (3 Weeks)||7
9916303|NCT01216735|11032958|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
9916304|NCT01216735|11032959|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
9916305|NCT01216735|11032958|FG000|STARTED|Washout (3 Weeks)||8
9916306|NCT01216735|11032959|FG001|STARTED|Washout (3 Weeks)||7
9916307|NCT01216735|11032958|FG000|COMPLETED|Washout (3 Weeks)||8
9916308|NCT01216735|11032959|FG001|COMPLETED|Washout (3 Weeks)||7
9916309|NCT01216735|11032958|FG000|NOT COMPLETED|Washout (3 Weeks)||0
9916310|NCT01216735|11032959|FG001|NOT COMPLETED|Washout (3 Weeks)||0
9916311|NCT01216735|11032958|FG000|STARTED|Second Intervention (3 Weeks)||8
9916312|NCT01216735|11032959|FG001|STARTED|Second Intervention (3 Weeks)||7
9916313|NCT01216735|11032958|FG000|COMPLETED|Second Intervention (3 Weeks)||8
9916314|NCT01216735|11032959|FG001|COMPLETED|Second Intervention (3 Weeks)||7
9916315|NCT01216735|11032958|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
9916316|NCT01216735|11032959|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9916317|NCT01216748|11032965|FG000|STARTED|Overall Study||10
9916318|NCT01216748|11032965|FG000|Quiet Breathing|Overall Study||10
9916319|NCT01216748|11032965|FG000|Hypocapnic Hyperventilation|Overall Study||10
9916320|NCT01216748|11032965|FG000|Hypercapnic Hyperventilation|Overall Study||10
9916321|NCT01216748|11032965|FG000|Eucapnic Hyperventilation|Overall Study||10
9916322|NCT01216748|11032965|FG000|COMPLETED|Overall Study||10
9916323|NCT01216748|11032965|FG000|NOT COMPLETED|Overall Study||0
9916324|NCT01216761|11032969|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
9916325|NCT01216761|11032970|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
9916326|NCT01216761|11032971|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
9916327|NCT01216761|11032969|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
9916328|NCT01216761|11032970|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
9916329|NCT01216761|11032971|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
9916330|NCT01216761|11032969|FG000|NOT COMPLETED|Overall Study||0
9916331|NCT01216761|11032970|FG001|NOT COMPLETED|Overall Study||0
9916332|NCT01216761|11032971|FG002|NOT COMPLETED|Overall Study||0
9916333|NCT01216943|11032979|FG000|STARTED|Overall Study||126
9916334|NCT01216943|11032979|FG000|COMPLETED|Overall Study||113
9916335|NCT01216943|11032979|FG000|NOT COMPLETED|Overall Study||13
9916336|NCT01217073|11032989|FG000|STARTED|Base Period||113
9916337|NCT01217073|11032990|FG001|STARTED|Base Period||115
9916338|NCT01217073|11032991|FG002|STARTED|Base Period||114
9916339|NCT01217073|11032992|FG003|STARTED|Base Period||115
9916340|NCT01217073|11032993|FG004|STARTED|Base Period||114
9916341|NCT01217073|11032994|FG005|STARTED|Base Period||114
9916342|NCT01217073|11032995|FG006|STARTED|Base Period||0
9916343|NCT01217073|11032996|FG007|STARTED|Base Period||0
9916344|NCT01217073|11032989|FG000|COMPLETED|Base Period||106
9916345|NCT01217073|11032990|FG001|COMPLETED|Base Period||110
9916346|NCT01217073|11032991|FG002|COMPLETED|Base Period||107
9916347|NCT01217073|11032992|FG003|COMPLETED|Base Period||113
9916348|NCT01217073|11032993|FG004|COMPLETED|Base Period||99
9916349|NCT01217073|11032994|FG005|COMPLETED|Base Period||105
9916350|NCT01217073|11032995|FG006|COMPLETED|Base Period||0
9916351|NCT01217073|11032996|FG007|COMPLETED|Base Period||0
9916352|NCT01217073|11032989|FG000|NOT COMPLETED|Base Period||7
10204411|NCT03479216|11331322|FG000|STARTED|Overall Study||31
10204412|NCT03479216|11331323|FG001|STARTED|Overall Study||31
10204413|NCT03479216|11331322|FG000|COMPLETED|Overall Study||26
10204414|NCT03479216|11331323|FG001|COMPLETED|Overall Study||26
10204415|NCT03479216|11331322|FG000|NOT COMPLETED|Overall Study||5
10204416|NCT03479216|11331323|FG001|NOT COMPLETED|Overall Study||5
10204417|NCT03479944|11331329|FG000|STARTED|Overall Study||55
10204418|NCT03479944|11331329|FG000|FLACS|Overall Study||55
10204419|NCT03479944|11331329|FG000|Conventional|Overall Study||55
10204420|NCT03479944|11331329|FG000|Full Analysis Set|Overall Study||53
10204421|NCT03479944|11331329|FG000|COMPLETED|Overall Study||55
10204422|NCT03479944|11331329|FG000|NOT COMPLETED|Overall Study||0
10204423|NCT03480009|11331341|FG000|STARTED|Overall Study||62
10204424|NCT03480009|11331342|FG001|STARTED|Overall Study||62
10204425|NCT03480009|11331343|FG002|STARTED|Overall Study||16
10204426|NCT03480009|11331344|FG003|STARTED|Overall Study||16
10204427|NCT03480009|11331341|FG000|COMPLETED|Overall Study||58
10204428|NCT03480009|11331342|FG001|COMPLETED|Overall Study||57
10204429|NCT03480009|11331343|FG002|COMPLETED|Overall Study||12
10204430|NCT03480009|11331344|FG003|COMPLETED|Overall Study||16
10204431|NCT03480009|11331341|FG000|NOT COMPLETED|Overall Study||4
10204432|NCT03480009|11331342|FG001|NOT COMPLETED|Overall Study||5
10204433|NCT03480009|11331343|FG002|NOT COMPLETED|Overall Study||4
10204434|NCT03480009|11331344|FG003|NOT COMPLETED|Overall Study||0
10204435|NCT03480022|11331359|FG000|STARTED|Overall Study||55
10204436|NCT03480022|11331360|FG001|STARTED|Overall Study||27
10204437|NCT03480022|11331359|FG000|COMPLETED|Overall Study||44
10204438|NCT03480022|11331360|FG001|COMPLETED|Overall Study||23
10204439|NCT03480022|11331359|FG000|NOT COMPLETED|Overall Study||11
10204440|NCT03480022|11331360|FG001|NOT COMPLETED|Overall Study||4
10204441|NCT03480048|11331368|FG000|STARTED|Overall Study||28
10204442|NCT03480048|11331369|FG001|STARTED|Overall Study||25
9916353|NCT01217073|11032990|FG001|NOT COMPLETED|Base Period||5
9916354|NCT01217073|11032991|FG002|NOT COMPLETED|Base Period||7
9916355|NCT01217073|11032992|FG003|NOT COMPLETED|Base Period||2
9916356|NCT01217073|11032993|FG004|NOT COMPLETED|Base Period||15
9916357|NCT01217073|11032994|FG005|NOT COMPLETED|Base Period||9
9916358|NCT01217073|11032995|FG006|NOT COMPLETED|Base Period||0
9916359|NCT01217073|11032996|FG007|NOT COMPLETED|Base Period||0
9916360|NCT01217073|11032989|FG000|STARTED|Extension Period||0
9916361|NCT01217073|11032990|FG001|STARTED|Extension Period||0
9916362|NCT01217073|11032991|FG002|STARTED|Extension Period||0
9916363|NCT01217073|11032992|FG003|STARTED|Extension Period||0
9916364|NCT01217073|11032993|FG004|STARTED|Extension Period||0
9916365|NCT01217073|11032994|FG005|STARTED|Extension Period||0
9916366|NCT01217073|11032995|FG006|STARTED|Extension Period||405
9916367|NCT01217073|11032996|FG007|STARTED|Extension Period||80
9916368|NCT01217073|11032989|FG000|COMPLETED|Extension Period||0
9916369|NCT01217073|11032990|FG001|COMPLETED|Extension Period||0
9916370|NCT01217073|11032991|FG002|COMPLETED|Extension Period||0
9916371|NCT01217073|11032992|FG003|COMPLETED|Extension Period||0
9916372|NCT01217073|11032993|FG004|COMPLETED|Extension Period||0
9916373|NCT01217073|11032994|FG005|COMPLETED|Extension Period||0
9916374|NCT01217073|11032995|FG006|COMPLETED|Extension Period||314
10204443|NCT03480048|11331368|FG000|COMPLETED|Overall Study||18
10204444|NCT03480048|11331369|FG001|COMPLETED|Overall Study||17
9916375|NCT01217073|11032996|FG007|COMPLETED|Extension Period||60
9916376|NCT01217073|11032989|FG000|NOT COMPLETED|Extension Period||0
9916377|NCT01217073|11032990|FG001|NOT COMPLETED|Extension Period||0
9916378|NCT01217073|11032991|FG002|NOT COMPLETED|Extension Period||0
9916379|NCT01217073|11032992|FG003|NOT COMPLETED|Extension Period||0
10204445|NCT03480048|11331368|FG000|NOT COMPLETED|Overall Study||10
10204446|NCT03480048|11331369|FG001|NOT COMPLETED|Overall Study||8
10204447|NCT03480152|11331377|FG000|STARTED|Phase I||3
10204448|NCT03480152|11331378|FG001|STARTED|Phase I||2
10204449|NCT03480152|11331379|FG002|STARTED|Phase I||0
10204450|NCT03480152|11331377|FG000|Received Intervention|Phase I||2
9916380|NCT01217073|11032993|FG004|NOT COMPLETED|Extension Period||0
9916381|NCT01217073|11032994|FG005|NOT COMPLETED|Extension Period||0
9916382|NCT01217073|11032995|FG006|NOT COMPLETED|Extension Period||91
9916383|NCT01217073|11032996|FG007|NOT COMPLETED|Extension Period||20
9916384|NCT01217112|11033025|FG000|STARTED|Overall Study||11
9916385|NCT01217112|11033026|FG001|STARTED|Overall Study||12
9916386|NCT01217112|11033027|FG002|STARTED|Overall Study||13
9916387|NCT01217112|11033028|FG003|STARTED|Overall Study||12
9916388|NCT01217112|11033029|FG004|STARTED|Overall Study||14
9916389|NCT01217112|11033025|FG000|COMPLETED|Overall Study||11
9916390|NCT01217112|11033026|FG001|COMPLETED|Overall Study||10
9916391|NCT01217112|11033027|FG002|COMPLETED|Overall Study||12
9916392|NCT01217112|11033028|FG003|COMPLETED|Overall Study||10
9916393|NCT01217112|11033029|FG004|COMPLETED|Overall Study||13
9916394|NCT01217112|11033025|FG000|NOT COMPLETED|Overall Study||0
9916395|NCT01217112|11033026|FG001|NOT COMPLETED|Overall Study||2
9916396|NCT01217112|11033027|FG002|NOT COMPLETED|Overall Study||1
9916397|NCT01217112|11033028|FG003|NOT COMPLETED|Overall Study||2
9916398|NCT01217112|11033029|FG004|NOT COMPLETED|Overall Study||1
9916399|NCT01217190|11033043|FG000|STARTED|First Dosing||24
9916400|NCT01217190|11033044|FG001|STARTED|First Dosing||24
9916401|NCT01217190|11033043|FG000|COMPLETED|First Dosing||24
9916402|NCT01217190|11033044|FG001|COMPLETED|First Dosing||24
9916403|NCT01217190|11033043|FG000|NOT COMPLETED|First Dosing||0
9916404|NCT01217190|11033044|FG001|NOT COMPLETED|First Dosing||0
9916405|NCT01217190|11033043|FG000|STARTED|Second Dosing||24
9916406|NCT01217190|11033044|FG001|STARTED|Second Dosing||24
9916407|NCT01217190|11033043|FG000|COMPLETED|Second Dosing||24
9916408|NCT01217190|11033044|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
9916409|NCT01217190|11033043|FG000|NOT COMPLETED|Second Dosing||0
9916410|NCT01217190|11033044|FG001|NOT COMPLETED|Second Dosing||2
9916411|NCT01217229|11033053|FG000|STARTED|Overall Study||20
9916412|NCT01217229|11033053|FG000|COMPLETED|Overall Study||0
9916413|NCT01217229|11033053|FG000|NOT COMPLETED|Overall Study||20
9916414|NCT01217307|11033059|FG000|STARTED|Overall Study||191
9916415|NCT01217307|11033060|FG001|STARTED|Overall Study||189
9916416|NCT01217307|11033059|FG000|COMPLETED|Overall Study||191
9916417|NCT01217307|11033060|FG001|COMPLETED|Overall Study||188
9916418|NCT01217307|11033059|FG000|NOT COMPLETED|Overall Study||0
9916419|NCT01217307|11033060|FG001|NOT COMPLETED|Overall Study||1
9916420|NCT01217385|11033066|FG000|STARTED|Overall Study||60
9916421|NCT01217385|11033066|FG000|COMPLETED|Overall Study||34
9916422|NCT01217385|11033066|FG000|NOT COMPLETED|Overall Study||26
9916423|NCT01217411|11033078|FG000|STARTED|Overall Study||3
9916424|NCT01217411|11033079|FG001|STARTED|Overall Study||2
9916425|NCT01217411|11033078|FG000|5mg|Overall Study||3
9916426|NCT01217411|11033079|FG001|5mg|Overall Study||2
9916427|NCT01217411|11033078|FG000|10mg|Overall Study||0
9916428|NCT01217411|11033079|FG001|10mg|Overall Study||0
9916429|NCT01217411|11033078|FG000|20mg|Overall Study||0
9916430|NCT01217411|11033079|FG001|20mg|Overall Study||0
9916431|NCT01217411|11033078|FG000|COMPLETED|Overall Study||0
9916432|NCT01217411|11033079|FG001|COMPLETED|Overall Study||0
9916433|NCT01217411|11033078|FG000|NOT COMPLETED|Overall Study||3
9916434|NCT01217411|11033079|FG001|NOT COMPLETED|Overall Study||2
9916435|NCT01217437|11033089|FG000|STARTED|Overall Study||55
9916436|NCT01217437|11033090|FG001|STARTED|Overall Study||53
9916437|NCT01217437|11033089|FG000|COMPLETED|Overall Study||12
9916438|NCT01217437|11033090|FG001|COMPLETED|Overall Study||12
9916439|NCT01217437|11033089|FG000|NOT COMPLETED|Overall Study||43
9916440|NCT01217437|11033090|FG001|NOT COMPLETED|Overall Study||41
9916441|NCT01217463|11033098|FG000|STARTED|Overall Study||99
9916442|NCT01217463|11033099|FG001|STARTED|Overall Study||102
9916443|NCT01217463|11033098|FG000|COMPLETED|Overall Study||86
9916444|NCT01217463|11033099|FG001|COMPLETED|Overall Study||94
9916445|NCT01217463|11033098|FG000|NOT COMPLETED|Overall Study||13
9916446|NCT01217463|11033099|FG001|NOT COMPLETED|Overall Study||8
9916447|NCT01217476|11033109|FG000|STARTED|Overall Study||105
9916448|NCT01217476|11033110|FG001|STARTED|Overall Study||102
9916449|NCT01217476|11033109|FG000|COMPLETED|Overall Study||93
9916450|NCT01217476|11033110|FG001|COMPLETED|Overall Study||95
9916451|NCT01217476|11033109|FG000|NOT COMPLETED|Overall Study||12
9916452|NCT01217476|11033110|FG001|NOT COMPLETED|Overall Study||7
9916453|NCT01217515|11033119|FG000|STARTED|Overall Study||154
9916454|NCT01217515|11033120|FG001|STARTED|Overall Study||156
9916455|NCT01217515|11033121|FG002|STARTED|Overall Study||155
9916456|NCT01217515|11033119|FG000|COMPLETED|Overall Study||147
9916457|NCT01217515|11033120|FG001|COMPLETED|Overall Study||148
9916458|NCT01217515|11033121|FG002|COMPLETED|Overall Study||145
9916459|NCT01217515|11033119|FG000|NOT COMPLETED|Overall Study||7
9916460|NCT01217515|11033120|FG001|NOT COMPLETED|Overall Study||8
9916461|NCT01217515|11033121|FG002|NOT COMPLETED|Overall Study||10
9916462|NCT01217606|11033131|FG000|STARTED|Initial Treatment Phase||90
9916463|NCT01217606|11033132|FG001|STARTED|Initial Treatment Phase||95
9916464|NCT01217606|11033131|FG000|COMPLETED|Initial Treatment Phase||76
9916465|NCT01217606|11033132|FG001|COMPLETED|Initial Treatment Phase||83
9916466|NCT01217606|11033131|FG000|NOT COMPLETED|Initial Treatment Phase||14
9916467|NCT01217606|11033132|FG001|NOT COMPLETED|Initial Treatment Phase||12
9916468|NCT01217606|11033131|FG000|STARTED|9-Month Masked Extension||67
9916469|NCT01217606|11033132|FG001|STARTED|9-Month Masked Extension||73
9916470|NCT01217606|11033131|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9
9916471|NCT01217606|11033132|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10
9916472|NCT01217606|11033131|FG000|COMPLETED|9-Month Masked Extension||54
9916473|NCT01217606|11033132|FG001|COMPLETED|9-Month Masked Extension||62
9916474|NCT01217606|11033131|FG000|NOT COMPLETED|9-Month Masked Extension||13
9916475|NCT01217606|11033132|FG001|NOT COMPLETED|9-Month Masked Extension||11
9916476|NCT01217749|11033141|FG000|STARTED|Overall Study||27
9916477|NCT01217749|11033142|FG001|STARTED|Overall Study||20
9916478|NCT01217749|11033143|FG002|STARTED|Overall Study||24
9916479|NCT01217749|11033141|FG000|COMPLETED|Overall Study||24
9916480|NCT01217749|11033142|FG001|COMPLETED|Overall Study||17
9916481|NCT01217749|11033143|FG002|COMPLETED|Overall Study||22
9916482|NCT01217749|11033141|FG000|NOT COMPLETED|Overall Study||3
9916483|NCT01217749|11033142|FG001|NOT COMPLETED|Overall Study||3
9916484|NCT01217749|11033143|FG002|NOT COMPLETED|Overall Study||2
9916485|NCT01217801|11033155|FG000|STARTED|Period 1||24
9916486|NCT01217801|11033156|FG001|STARTED|Period 1||24
9916487|NCT01217801|11033155|FG000|COMPLETED|Period 1||23
9916488|NCT01217801|11033156|FG001|COMPLETED|Period 1||22
9916489|NCT01217801|11033155|FG000|NOT COMPLETED|Period 1||1
9916490|NCT01217801|11033156|FG001|NOT COMPLETED|Period 1||2
9916491|NCT01217801|11033155|FG000|STARTED|Period 2||23
9916492|NCT01217801|11033156|FG001|STARTED|Period 2||22
9916493|NCT01217801|11033155|FG000|COMPLETED|Period 2||23
9916494|NCT01217801|11033156|FG001|COMPLETED|Period 2||22
9916495|NCT01217801|11033155|FG000|NOT COMPLETED|Period 2||0
9916496|NCT01217801|11033156|FG001|NOT COMPLETED|Period 2||0
9916497|NCT01217814|11033165|FG000|STARTED|Overall Study||4
9916498|NCT01217814|11033166|FG001|STARTED|Overall Study||5
9916499|NCT01217814|11033167|FG002|STARTED|Overall Study||7
9916500|NCT01217814|11033165|FG000|COMPLETED|Overall Study||3
9916501|NCT01217814|11033166|FG001|COMPLETED|Overall Study||4
9916502|NCT01217814|11033167|FG002|COMPLETED|Overall Study||6
9916503|NCT01217814|11033165|FG000|NOT COMPLETED|Overall Study||1
9916504|NCT01217814|11033166|FG001|NOT COMPLETED|Overall Study||1
9916505|NCT01217814|11033167|FG002|NOT COMPLETED|Overall Study||1
9916506|NCT01217827|11033178|FG000|STARTED|Overall Study||46
9916507|NCT01217827|11033179|FG001|STARTED|Overall Study||43
9916508|NCT01217827|11033178|FG000|COMPLETED|Overall Study||46
9916509|NCT01217827|11033179|FG001|COMPLETED|Overall Study||43
9916510|NCT01217827|11033178|FG000|NOT COMPLETED|Overall Study||0
9916511|NCT01217827|11033179|FG001|NOT COMPLETED|Overall Study||0
9916512|NCT01217840|11033187|FG000|STARTED|Overall Study||20
9916513|NCT01217840|11033188|FG001|STARTED|Overall Study||20
9916514|NCT01217840|11033187|FG000|COMPLETED|Overall Study||14
9916515|NCT01217840|11033188|FG001|COMPLETED|Overall Study||17
9916516|NCT01217840|11033187|FG000|NOT COMPLETED|Overall Study||6
9916517|NCT01217840|11033188|FG001|NOT COMPLETED|Overall Study||3
9916518|NCT01217892|11033199|FG000|STARTED|Overall Study||100
9916519|NCT01217892|11033200|FG001|STARTED|Overall Study||100
9916520|NCT01217892|11033201|FG002|STARTED|Overall Study||99
9916521|NCT01217892|11033202|FG003|STARTED|Overall Study||101
9916522|NCT01217892|11033199|FG000|COMPLETED|Overall Study||93
9916523|NCT01217892|11033200|FG001|COMPLETED|Overall Study||94
9916524|NCT01217892|11033201|FG002|COMPLETED|Overall Study||90
9916525|NCT01217892|11033202|FG003|COMPLETED|Overall Study||93
9916526|NCT01217892|11033199|FG000|NOT COMPLETED|Overall Study||7
9916527|NCT01217892|11033200|FG001|NOT COMPLETED|Overall Study||6
9916528|NCT01217892|11033201|FG002|NOT COMPLETED|Overall Study||9
9916529|NCT01217892|11033202|FG003|NOT COMPLETED|Overall Study||8
9916530|NCT01217944|11033215|FG000|STARTED|Overall Study||106
9916531|NCT01217944|11033216|FG001|STARTED|Overall Study||116
9916532|NCT01217944|11033217|FG002|STARTED|Overall Study||55
9916533|NCT01217944|11033215|FG000|Completed 3 Months|Overall Study||105
9916534|NCT01217944|11033216|FG001|Completed 3 Months|Overall Study||116
9916535|NCT01217944|11033217|FG002|Completed 3 Months|Overall Study||55
9916536|NCT01217944|11033215|FG000|Completed 6 Months|Overall Study||103
9916537|NCT01217944|11033216|FG001|Completed 6 Months|Overall Study||116
9916538|NCT01217944|11033217|FG002|Completed 6 Months|Overall Study||55
9916539|NCT01217944|11033215|FG000|COMPLETED|Overall Study||100
9916540|NCT01217944|11033216|FG001|COMPLETED|Overall Study||112
9916541|NCT01217944|11033217|FG002|COMPLETED|Overall Study||55
9916542|NCT01217944|11033215|FG000|NOT COMPLETED|Overall Study||6
9916543|NCT01217944|11033216|FG001|NOT COMPLETED|Overall Study||4
9916544|NCT01217944|11033217|FG002|NOT COMPLETED|Overall Study||0
9916545|NCT01217957|11033232|FG000|STARTED|Phase 1||3
9916546|NCT01217957|11033233|FG001|STARTED|Phase 1||3
9916547|NCT01217957|11033234|FG002|STARTED|Phase 1||6
9916548|NCT01217957|11033235|FG003|STARTED|Phase 1||3
9916549|NCT01217957|11033236|FG004|STARTED|Phase 1||0
9916550|NCT01217957|11033232|FG000|COMPLETED|Phase 1||2
9916551|NCT01217957|11033233|FG001|COMPLETED|Phase 1||3
9916552|NCT01217957|11033234|FG002|COMPLETED|Phase 1||5
9916553|NCT01217957|11033235|FG003|COMPLETED|Phase 1||2
9916554|NCT01217957|11033236|FG004|COMPLETED|Phase 1||0
9916555|NCT01217957|11033232|FG000|NOT COMPLETED|Phase 1||1
9916556|NCT01217957|11033233|FG001|NOT COMPLETED|Phase 1||0
9916557|NCT01217957|11033234|FG002|NOT COMPLETED|Phase 1||1
9916558|NCT01217957|11033235|FG003|NOT COMPLETED|Phase 1||1
9916559|NCT01217957|11033236|FG004|NOT COMPLETED|Phase 1||0
9916560|NCT01217957|11033232|FG000|STARTED|Phase 2||0
9916561|NCT01217957|11033233|FG001|STARTED|Phase 2||0
9916562|NCT01217957|11033234|FG002|STARTED|Phase 2||0
9916563|NCT01217957|11033235|FG003|STARTED|Phase 2||0
9916564|NCT01217957|11033236|FG004|STARTED|Phase 2||50
9916565|NCT01217957|11033232|FG000|COMPLETED|Phase 2||0
9916566|NCT01217957|11033233|FG001|COMPLETED|Phase 2||0
9916567|NCT01217957|11033234|FG002|COMPLETED|Phase 2||0
9916568|NCT01217957|11033235|FG003|COMPLETED|Phase 2||0
9916569|NCT01217957|11033236|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
9916570|NCT01217957|11033232|FG000|NOT COMPLETED|Phase 2||0
9916571|NCT01217957|11033233|FG001|NOT COMPLETED|Phase 2||0
9916572|NCT01217957|11033234|FG002|NOT COMPLETED|Phase 2||0
9916573|NCT01217957|11033235|FG003|NOT COMPLETED|Phase 2||0
9916574|NCT01217957|11033236|FG004|NOT COMPLETED|Phase 2||1
9916575|NCT01218009|11033259|FG000|STARTED|Overall Study||166
9916576|NCT01218009|11033260|FG001|STARTED|Overall Study||165
9916577|NCT01218009|11033259|FG000|COMPLETED|Overall Study||0
9916578|NCT01218009|11033260|FG001|COMPLETED|Overall Study||0
9916579|NCT01218009|11033259|FG000|NOT COMPLETED|Overall Study||166
9916580|NCT01218009|11033260|FG001|NOT COMPLETED|Overall Study||165
9916581|NCT01218048|11033266|FG000|STARTED|Overall Study||40
9916582|NCT01218048|11033266|FG000|COMPLETED|Overall Study||40
9916583|NCT01218048|11033266|FG000|NOT COMPLETED|Overall Study||0
9916584|NCT01218087|11033273|FG000|STARTED|Overall Study||42
9916585|NCT01218087|11033274|FG001|STARTED|Overall Study||41
9916586|NCT01218087|11033273|FG000|COMPLETED|Overall Study||27
9916587|NCT01218087|11033274|FG001|COMPLETED|Overall Study||35
9916588|NCT01218087|11033273|FG000|NOT COMPLETED|Overall Study||15
10204451|NCT03480152|11331378|FG001|Received Intervention|Phase I||2
10204452|NCT03480152|11331379|FG002|Received Intervention|Phase I||0
10204453|NCT03480152|11331377|FG000|COMPLETED|Phase I||2
10204454|NCT03480152|11331378|FG001|COMPLETED|Phase I||2
10204455|NCT03480152|11331379|FG002|COMPLETED|Phase I||0
10204456|NCT03480152|11331377|FG000|NOT COMPLETED|Phase I||1
10204457|NCT03480152|11331378|FG001|NOT COMPLETED|Phase I||0
10204458|NCT03480152|11331379|FG002|NOT COMPLETED|Phase I||0
10204459|NCT03480152|11331377|FG000|STARTED|Phase II||0
10204460|NCT03480152|11331378|FG001|STARTED|Phase II||0
10204461|NCT03480152|11331379|FG002|STARTED|Phase II||0
10204462|NCT03480152|11331377|FG000|COMPLETED|Phase II||0
10204463|NCT03480152|11331378|FG001|COMPLETED|Phase II||0
10204464|NCT03480152|11331379|FG002|COMPLETED|Phase II||0
10204465|NCT03480152|11331377|FG000|NOT COMPLETED|Phase II||0
10204466|NCT03480152|11331378|FG001|NOT COMPLETED|Phase II||0
10204467|NCT03480152|11331379|FG002|NOT COMPLETED|Phase II||0
10204468|NCT03480243|11331387|FG000|STARTED|Padsevonil (Period 1)||28
10204469|NCT03480243|11331387|FG000|COMPLETED|Padsevonil (Period 1)||28
10204470|NCT03480243|11331387|FG000|NOT COMPLETED|Padsevonil (Period 1)||0
10204471|NCT03480243|11331387|FG000|STARTED|Padsevonil (Period 2)||28
10204472|NCT03480243|11331387|FG000|COMPLETED|Padsevonil (Period 2)||27
10204473|NCT03480243|11331387|FG000|NOT COMPLETED|Padsevonil (Period 2)||1
10204474|NCT03480243|11331387|FG000|STARTED|Erythromycin (Period 3a)||27
10204475|NCT03480243|11331387|FG000|COMPLETED|Erythromycin (Period 3a)||27
10204476|NCT03480243|11331387|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0
10204477|NCT03480243|11331387|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27
10204478|NCT03480243|11331387|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
10204479|NCT03480243|11331387|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
10204480|NCT03480243|11331387|FG000|STARTED|Erythromycin (Period 3c)||26
10204481|NCT03480243|11331387|FG000|COMPLETED|Erythromycin (Period 3c)||26
10204482|NCT03480243|11331387|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0
10204483|NCT03480425|11331400|FG000|STARTED|Overall Study||11
10204484|NCT03480425|11331400|FG000|COMPLETED|Overall Study||10
10204485|NCT03480425|11331400|FG000|NOT COMPLETED|Overall Study||1
10204486|NCT03480685|11331404|FG000|STARTED|Overall Study||12
10204487|NCT03480685|11331404|FG000|COMPLETED|Overall Study||12
10204488|NCT03480685|11331404|FG000|NOT COMPLETED|Overall Study||0
10204489|NCT03480750|11331416|FG000|STARTED|Overall Study||3
10204490|NCT03480750|11331417|FG001|STARTED|Overall Study||4
10204491|NCT03480750|11331418|FG002|STARTED|Overall Study||3
10204492|NCT03480750|11331419|FG003|STARTED|Overall Study||3
10204493|NCT03480750|11331420|FG004|STARTED|Overall Study||3
10204494|NCT03480750|11331421|FG005|STARTED|Overall Study||2
10204495|NCT03480750|11331416|FG000|COMPLETED|Overall Study||3
10204496|NCT03480750|11331417|FG001|COMPLETED|Overall Study||3
10204497|NCT03480750|11331418|FG002|COMPLETED|Overall Study||3
10204498|NCT03480750|11331419|FG003|COMPLETED|Overall Study||3
10204499|NCT03480750|11331420|FG004|COMPLETED|Overall Study||3
10204500|NCT03480750|11331421|FG005|COMPLETED|Overall Study||1
9916589|NCT01218087|11033274|FG001|NOT COMPLETED|Overall Study||6
9916590|NCT01218100|11033284|FG000|STARTED|Overall Study||95
9916591|NCT01218100|11033285|FG001|STARTED|Overall Study||190
9916592|NCT01218100|11033286|FG002|STARTED|Overall Study||189
9916593|NCT01218100|11033287|FG003|STARTED|Overall Study||190
9916594|NCT01218100|11033284|FG000|COMPLETED|Overall Study||71
9916595|NCT01218100|11033285|FG001|COMPLETED|Overall Study||165
9916596|NCT01218100|11033286|FG002|COMPLETED|Overall Study||162
9916597|NCT01218100|11033287|FG003|COMPLETED|Overall Study||156
9916598|NCT01218100|11033284|FG000|NOT COMPLETED|Overall Study||24
10204501|NCT03480750|11331416|FG000|NOT COMPLETED|Overall Study||0
10204502|NCT03480750|11331417|FG001|NOT COMPLETED|Overall Study||1
10204503|NCT03480750|11331418|FG002|NOT COMPLETED|Overall Study||0
10204504|NCT03480750|11331419|FG003|NOT COMPLETED|Overall Study||0
10204505|NCT03480750|11331420|FG004|NOT COMPLETED|Overall Study||0
10204506|NCT03480750|11331421|FG005|NOT COMPLETED|Overall Study||1
10204507|NCT03480763|11331446|FG000|STARTED|Overall Study||327
10204508|NCT03480763|11331447|FG001|STARTED|Overall Study||325
10204509|NCT03480763|11331446|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
10204510|NCT03480763|11331447|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
9916599|NCT01218100|11033285|FG001|NOT COMPLETED|Overall Study||25
9916600|NCT01218100|11033286|FG002|NOT COMPLETED|Overall Study||27
9916601|NCT01218100|11033287|FG003|NOT COMPLETED|Overall Study||34
9916602|NCT01218113|11033300|FG000|STARTED|Overall Study||62
9916603|NCT01218113|11033301|FG001|STARTED|Overall Study||64
9916604|NCT01218113|11033302|FG002|STARTED|Overall Study||64
9916605|NCT01218113|11033300|FG000|COMPLETED|Overall Study||57
9916606|NCT01218113|11033301|FG001|COMPLETED|Overall Study||63
9916607|NCT01218113|11033302|FG002|COMPLETED|Overall Study||58
9916608|NCT01218113|11033300|FG000|NOT COMPLETED|Overall Study||5
10204511|NCT03480763|11331446|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
10204512|NCT03480763|11331447|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
10204513|NCT03480763|11331446|FG000|COMPLETED|Overall Study||303
10204514|NCT03480763|11331447|FG001|COMPLETED|Overall Study||306
10204515|NCT03480763|11331446|FG000|NOT COMPLETED|Overall Study||24
10204516|NCT03480763|11331447|FG001|NOT COMPLETED|Overall Study||19
10204517|NCT03480841|11331459|FG000|STARTED|Overall Study||10
10204518|NCT03480841|11331459|FG000|Time 1 Data Collection (T1)|Overall Study||10
10204519|NCT03480841|11331459|FG000|LENA Baseline|Overall Study||10
10204520|NCT03480841|11331459|FG000|LENA Time 1|Overall Study||10
10204521|NCT03480841|11331459|FG000|LENA Time 2|Overall Study||10
10204522|NCT03480841|11331459|FG000|LENA Time 3|Overall Study||10
10204523|NCT03480841|11331459|FG000|LENA Time 4|Overall Study||9
10204524|NCT03480841|11331459|FG000|LENA Time 5|Overall Study||8
10204525|NCT03480841|11331459|FG000|Time 2 Data Collection (T2)|Overall Study||8
10204526|NCT03480841|11331459|FG000|COMPLETED|Overall Study||8
10204527|NCT03480841|11331459|FG000|NOT COMPLETED|Overall Study||2
10204528|NCT03480919|11331466|FG000|STARTED|Overall Study||1
10204529|NCT03480919|11331467|FG001|STARTED|Overall Study||2
10204530|NCT03480919|11331468|FG002|STARTED|Overall Study||1
10204531|NCT03480919|11331466|FG000|COMPLETED|Overall Study||1
10204532|NCT03480919|11331467|FG001|COMPLETED|Overall Study||2
10204533|NCT03480919|11331468|FG002|COMPLETED|Overall Study||1
10204534|NCT03480919|11331466|FG000|NOT COMPLETED|Overall Study||0
10204535|NCT03480919|11331467|FG001|NOT COMPLETED|Overall Study||0
10204536|NCT03480919|11331468|FG002|NOT COMPLETED|Overall Study||0
10204537|NCT03480932|11331479|FG000|STARTED|Overall Study||50
10204538|NCT03480932|11331480|FG001|STARTED|Overall Study||50
10204539|NCT03480932|11331481|FG002|STARTED|Overall Study||50
10204540|NCT03480932|11331479|FG000|COMPLETED|Overall Study||47
10204541|NCT03480932|11331480|FG001|COMPLETED|Overall Study||45
10204542|NCT03480932|11331481|FG002|COMPLETED|Overall Study||45
10204543|NCT03480932|11331479|FG000|NOT COMPLETED|Overall Study||3
10204544|NCT03480932|11331480|FG001|NOT COMPLETED|Overall Study||5
10204545|NCT03480932|11331481|FG002|NOT COMPLETED|Overall Study||5
10204546|NCT03481270|11331491|FG000|STARTED|Overall Study||324
10204547|NCT03481270|11331492|FG001|STARTED|Overall Study||313
10204548|NCT03481270|11331491|FG000|COMPLETED|Overall Study||324
10204549|NCT03481270|11331492|FG001|COMPLETED|Overall Study||313
10204550|NCT03481270|11331491|FG000|NOT COMPLETED|Overall Study||0
10204551|NCT03481270|11331492|FG001|NOT COMPLETED|Overall Study||0
10204552|NCT03481309|11331504|FG000|STARTED|First Intervention (1 Day)||4
10204553|NCT03481309|11331505|FG001|STARTED|First Intervention (1 Day)||3
10204554|NCT03481309|11331506|FG002|STARTED|First Intervention (1 Day)||3
10204555|NCT03481309|11331507|FG003|STARTED|First Intervention (1 Day)||3
10204556|NCT03481309|11331508|FG004|STARTED|First Intervention (1 Day)||3
10204557|NCT03481309|11331509|FG005|STARTED|First Intervention (1 Day)||3
10204558|NCT03481309|11331504|FG000|COMPLETED|First Intervention (1 Day)||4
10204559|NCT03481309|11331505|FG001|COMPLETED|First Intervention (1 Day)||3
10204560|NCT03481309|11331506|FG002|COMPLETED|First Intervention (1 Day)||3
10204561|NCT03481309|11331507|FG003|COMPLETED|First Intervention (1 Day)||3
10204562|NCT03481309|11331508|FG004|COMPLETED|First Intervention (1 Day)||3
10204563|NCT03481309|11331509|FG005|COMPLETED|First Intervention (1 Day)||3
10204564|NCT03481309|11331504|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10204565|NCT03481309|11331505|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10204566|NCT03481309|11331506|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10204567|NCT03481309|11331507|FG003|NOT COMPLETED|First Intervention (1 Day)||0
9916609|NCT01218113|11033301|FG001|NOT COMPLETED|Overall Study||1
9916610|NCT01218113|11033302|FG002|NOT COMPLETED|Overall Study||6
9916611|NCT01218126|11033321|FG000|STARTED|Overall Study||153
9916612|NCT01218126|11033322|FG001|STARTED|Overall Study||149
9916613|NCT01218126|11033323|FG002|STARTED|Overall Study||151
9916614|NCT01218126|11033324|FG003|STARTED|Overall Study||149
9916615|NCT01218126|11033321|FG000|COMPLETED|Overall Study||129
10204568|NCT03481309|11331508|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10204569|NCT03481309|11331509|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10204570|NCT03481309|11331504|FG000|STARTED|Washout (at Least 3 Days)||4
10204571|NCT03481309|11331505|FG001|STARTED|Washout (at Least 3 Days)||3
10204572|NCT03481309|11331506|FG002|STARTED|Washout (at Least 3 Days)||3
10204573|NCT03481309|11331507|FG003|STARTED|Washout (at Least 3 Days)||3
10204574|NCT03481309|11331508|FG004|STARTED|Washout (at Least 3 Days)||3
10204575|NCT03481309|11331509|FG005|STARTED|Washout (at Least 3 Days)||3
10204576|NCT03481309|11331504|FG000|COMPLETED|Washout (at Least 3 Days)||3
10204577|NCT03481309|11331505|FG001|COMPLETED|Washout (at Least 3 Days)||3
10204578|NCT03481309|11331506|FG002|COMPLETED|Washout (at Least 3 Days)||3
10204579|NCT03481309|11331507|FG003|COMPLETED|Washout (at Least 3 Days)||3
9916616|NCT01218126|11033322|FG001|COMPLETED|Overall Study||127
10204580|NCT03481309|11331508|FG004|COMPLETED|Washout (at Least 3 Days)||3
9916617|NCT01218126|11033323|FG002|COMPLETED|Overall Study||127
9916618|NCT01218126|11033324|FG003|COMPLETED|Overall Study||114
9916619|NCT01218126|11033321|FG000|NOT COMPLETED|Overall Study||24
9916620|NCT01218126|11033322|FG001|NOT COMPLETED|Overall Study||22
9916621|NCT01218126|11033323|FG002|NOT COMPLETED|Overall Study||24
9916622|NCT01218126|11033324|FG003|NOT COMPLETED|Overall Study||35
9916623|NCT01218204|11033336|FG000|STARTED|Part A||6
9916624|NCT01218204|11033337|FG001|STARTED|Part A||0
9916625|NCT01218204|11033338|FG002|STARTED|Part A||0
9916626|NCT01218204|11033339|FG003|STARTED|Part A||0
9916627|NCT01218204|11033336|FG000|COMPLETED|Part A||6
9916628|NCT01218204|11033337|FG001|COMPLETED|Part A||0
9916629|NCT01218204|11033338|FG002|COMPLETED|Part A||0
9916630|NCT01218204|11033339|FG003|COMPLETED|Part A||0
9916631|NCT01218204|11033336|FG000|NOT COMPLETED|Part A||0
9916632|NCT01218204|11033337|FG001|NOT COMPLETED|Part A||0
9916633|NCT01218204|11033338|FG002|NOT COMPLETED|Part A||0
9916634|NCT01218204|11033339|FG003|NOT COMPLETED|Part A||0
9916635|NCT01218204|11033336|FG000|STARTED|Part B Washout||0
9916636|NCT01218204|11033337|FG001|STARTED|Part B Washout||281
9916637|NCT01218204|11033338|FG002|STARTED|Part B Washout||0
9916638|NCT01218204|11033339|FG003|STARTED|Part B Washout||0
9916639|NCT01218204|11033336|FG000|COMPLETED|Part B Washout||0
9916640|NCT01218204|11033337|FG001|COMPLETED|Part B Washout||136
9916641|NCT01218204|11033338|FG002|COMPLETED|Part B Washout||0
9916642|NCT01218204|11033339|FG003|COMPLETED|Part B Washout||0
9916643|NCT01218204|11033336|FG000|NOT COMPLETED|Part B Washout||0
9916644|NCT01218204|11033337|FG001|NOT COMPLETED|Part B Washout||145
9916645|NCT01218204|11033338|FG002|NOT COMPLETED|Part B Washout||0
9916646|NCT01218204|11033339|FG003|NOT COMPLETED|Part B Washout||0
9916647|NCT01218204|11033336|FG000|STARTED|Part B Run-in||0
9916648|NCT01218204|11033337|FG001|STARTED|Part B Run-in||0
9916649|NCT01218204|11033338|FG002|STARTED|Part B Run-in||89
9916650|NCT01218204|11033339|FG003|STARTED|Part B Run-in||0
9916651|NCT01218204|11033336|FG000|COMPLETED|Part B Run-in||0
9916652|NCT01218204|11033337|FG001|COMPLETED|Part B Run-in||0
9916653|NCT01218204|11033338|FG002|COMPLETED|Part B Run-in||83
9916654|NCT01218204|11033339|FG003|COMPLETED|Part B Run-in||0
9916655|NCT01218204|11033336|FG000|NOT COMPLETED|Part B Run-in||0
9916656|NCT01218204|11033337|FG001|NOT COMPLETED|Part B Run-in||0
9916657|NCT01218204|11033338|FG002|NOT COMPLETED|Part B Run-in||6
9916658|NCT01218204|11033339|FG003|NOT COMPLETED|Part B Run-in||0
9916659|NCT01218204|11033336|FG000|STARTED|Part B Pooled Treatment Arm||0
9916660|NCT01218204|11033337|FG001|STARTED|Part B Pooled Treatment Arm||0
9916661|NCT01218204|11033338|FG002|STARTED|Part B Pooled Treatment Arm||0
9916662|NCT01218204|11033339|FG003|STARTED|Part B Pooled Treatment Arm||130
9916663|NCT01218204|11033336|FG000|COMPLETED|Part B Pooled Treatment Arm||0
9916664|NCT01218204|11033337|FG001|COMPLETED|Part B Pooled Treatment Arm||0
9916665|NCT01218204|11033338|FG002|COMPLETED|Part B Pooled Treatment Arm||0
9916666|NCT01218204|11033339|FG003|COMPLETED|Part B Pooled Treatment Arm||127
9916667|NCT01218204|11033336|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0
9916668|NCT01218204|11033337|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0
9916669|NCT01218204|11033338|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0
9916670|NCT01218204|11033339|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3
9916671|NCT01218243|11033388|FG000|STARTED|Overall Study||50
9916672|NCT01218243|11033389|FG001|STARTED|Overall Study||50
9916673|NCT01218243|11033388|FG000|Treatment Completed|Overall Study||45
9916674|NCT01218243|11033389|FG001|Treatment Completed|Overall Study||42
9916675|NCT01218243|11033388|FG000|COMPLETED|Overall Study||41
9916676|NCT01218243|11033389|FG001|COMPLETED|Overall Study||36
9916677|NCT01218243|11033388|FG000|NOT COMPLETED|Overall Study||9
9916678|NCT01218243|11033389|FG001|NOT COMPLETED|Overall Study||14
9916679|NCT01218308|11033397|FG000|STARTED|Overall Study||2584
9916680|NCT01218308|11033398|FG001|STARTED|Overall Study||2584
9916681|NCT01218308|11033397|FG000|COMPLETED|Overall Study||2481
9916682|NCT01218308|11033398|FG001|COMPLETED|Overall Study||2464
9916683|NCT01218308|11033397|FG000|NOT COMPLETED|Overall Study||103
9916684|NCT01218308|11033398|FG001|NOT COMPLETED|Overall Study||120
9916685|NCT01218399|11033406|FG000|STARTED|Overall Study||5
9916686|NCT01218399|11033407|FG001|STARTED|Overall Study||5
9916687|NCT01218399|11033406|FG000|COMPLETED|Overall Study||5
9916688|NCT01218399|11033407|FG001|COMPLETED|Overall Study||5
9916689|NCT01218399|11033406|FG000|NOT COMPLETED|Overall Study||0
9916690|NCT01218399|11033407|FG001|NOT COMPLETED|Overall Study||0
9916691|NCT01218438|11033413|FG000|STARTED|Epoch 1||77
9916692|NCT01218438|11033413|FG000|COMPLETED|Epoch 1||74
9916693|NCT01218438|11033413|FG000|NOT COMPLETED|Epoch 1||3
9916694|NCT01218438|11033413|FG000|STARTED|Epoch 2||45
9916695|NCT01218438|11033413|FG000|COMPLETED|Epoch 2||45
9916696|NCT01218438|11033413|FG000|NOT COMPLETED|Epoch 2||0
9916697|NCT01218438|11033413|FG000|STARTED|Epoch 3||74
9916698|NCT01218438|11033413|FG000|COMPLETED|Epoch 3||70
9916699|NCT01218438|11033413|FG000|NOT COMPLETED|Epoch 3||4
9916700|NCT01218438|11033413|FG000|STARTED|Epoch 4||70
9916701|NCT01218438|11033413|FG000|COMPLETED|Epoch 4||67
9916702|NCT01218438|11033413|FG000|NOT COMPLETED|Epoch 4||3
9916703|NCT01218477|11033491|FG000|STARTED|Overall Study|Participants who received treatment|3
9916704|NCT01218477|11033492|FG001|STARTED|Overall Study|Participants who received treatment|8
9916705|NCT01218477|11033493|FG002|STARTED|Overall Study|Participants who received treatment|14
9916706|NCT01218477|11033494|FG003|STARTED|Overall Study|Participants who received treatment|2
9916707|NCT01218477|11033491|FG000|COMPLETED|Overall Study|Still receiving study drug|0
9957076|NCT01449370|11076251|FG016|COMPLETED|Overall Study||0
9916708|NCT01218477|11033492|FG001|COMPLETED|Overall Study|Still receiving study drug|0
9916709|NCT01218477|11033493|FG002|COMPLETED|Overall Study|Still receiving study drug|0
9916710|NCT01218477|11033494|FG003|COMPLETED|Overall Study|Still receiving study drug|0
9916711|NCT01218477|11033491|FG000|NOT COMPLETED|Overall Study||3
9916712|NCT01218477|11033492|FG001|NOT COMPLETED|Overall Study||8
9916713|NCT01218477|11033493|FG002|NOT COMPLETED|Overall Study||14
9916714|NCT01218477|11033494|FG003|NOT COMPLETED|Overall Study||2
9916715|NCT01218516|11033510|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67
9916716|NCT01218516|11033511|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63
10204581|NCT03481309|11331509|FG005|COMPLETED|Washout (at Least 3 Days)||3
10204582|NCT03481309|11331504|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1
10204583|NCT03481309|11331505|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
10204584|NCT03481309|11331506|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
10204585|NCT03481309|11331507|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
10204586|NCT03481309|11331508|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
10204587|NCT03481309|11331509|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
10204588|NCT03481309|11331504|FG000|STARTED|Second Intervention (1 Day)||3
10204589|NCT03481309|11331505|FG001|STARTED|Second Intervention (1 Day)||3
10204590|NCT03481309|11331506|FG002|STARTED|Second Intervention (1 Day)||3
10204591|NCT03481309|11331507|FG003|STARTED|Second Intervention (1 Day)||3
10204592|NCT03481309|11331508|FG004|STARTED|Second Intervention (1 Day)||3
10204593|NCT03481309|11331509|FG005|STARTED|Second Intervention (1 Day)||3
10204594|NCT03481309|11331504|FG000|COMPLETED|Second Intervention (1 Day)||3
10204595|NCT03481309|11331505|FG001|COMPLETED|Second Intervention (1 Day)||3
10204596|NCT03481309|11331506|FG002|COMPLETED|Second Intervention (1 Day)||3
10204597|NCT03481309|11331507|FG003|COMPLETED|Second Intervention (1 Day)||3
10204598|NCT03481309|11331508|FG004|COMPLETED|Second Intervention (1 Day)||3
10204599|NCT03481309|11331509|FG005|COMPLETED|Second Intervention (1 Day)||3
10204600|NCT03481309|11331504|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10204601|NCT03481309|11331505|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10204602|NCT03481309|11331506|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10204603|NCT03481309|11331507|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10204604|NCT03481309|11331508|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10204605|NCT03481309|11331509|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10204606|NCT03481309|11331504|FG000|STARTED|Washout (at Least 3 Days)||3
10204607|NCT03481309|11331505|FG001|STARTED|Washout (at Least 3 Days)||3
10204608|NCT03481309|11331506|FG002|STARTED|Washout (at Least 3 Days)||3
10204609|NCT03481309|11331507|FG003|STARTED|Washout (at Least 3 Days)||3
10204610|NCT03481309|11331508|FG004|STARTED|Washout (at Least 3 Days)||3
10204611|NCT03481309|11331509|FG005|STARTED|Washout (at Least 3 Days)||3
10204612|NCT03481309|11331504|FG000|COMPLETED|Washout (at Least 3 Days)||3
10204613|NCT03481309|11331505|FG001|COMPLETED|Washout (at Least 3 Days)||3
10204614|NCT03481309|11331506|FG002|COMPLETED|Washout (at Least 3 Days)||3
10204615|NCT03481309|11331507|FG003|COMPLETED|Washout (at Least 3 Days)||3
10204616|NCT03481309|11331508|FG004|COMPLETED|Washout (at Least 3 Days)||3
10204617|NCT03481309|11331509|FG005|COMPLETED|Washout (at Least 3 Days)||3
10204618|NCT03481309|11331504|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
10204619|NCT03481309|11331505|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
10204620|NCT03481309|11331506|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
10204621|NCT03481309|11331507|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
10204622|NCT03481309|11331508|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
10204623|NCT03481309|11331509|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
10204624|NCT03481309|11331504|FG000|STARTED|Third Intervention (1 Day)||3
10204625|NCT03481309|11331505|FG001|STARTED|Third Intervention (1 Day)||3
10204626|NCT03481309|11331506|FG002|STARTED|Third Intervention (1 Day)||3
10204627|NCT03481309|11331507|FG003|STARTED|Third Intervention (1 Day)||3
10204628|NCT03481309|11331508|FG004|STARTED|Third Intervention (1 Day)||3
10204629|NCT03481309|11331509|FG005|STARTED|Third Intervention (1 Day)||3
10204630|NCT03481309|11331504|FG000|COMPLETED|Third Intervention (1 Day)||3
10204631|NCT03481309|11331505|FG001|COMPLETED|Third Intervention (1 Day)||3
10204632|NCT03481309|11331506|FG002|COMPLETED|Third Intervention (1 Day)||3
10204633|NCT03481309|11331507|FG003|COMPLETED|Third Intervention (1 Day)||3
9916717|NCT01218516|11033512|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0
9916718|NCT01218516|11033513|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0
9916719|NCT01218516|11033510|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38
9916720|NCT01218516|11033511|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28
9916721|NCT01218516|11033512|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0
9916722|NCT01218516|11033513|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0
9916723|NCT01218516|11033510|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
9916724|NCT01218516|11033511|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
9916725|NCT01218516|11033512|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
9916726|NCT01218516|11033513|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
9955653|NCT01439945|11074663|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4
10204634|NCT03481309|11331508|FG004|COMPLETED|Third Intervention (1 Day)||3
10204635|NCT03481309|11331509|FG005|COMPLETED|Third Intervention (1 Day)||3
10204636|NCT03481309|11331504|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10204637|NCT03481309|11331505|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10204638|NCT03481309|11331506|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10204639|NCT03481309|11331507|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
9916727|NCT01218516|11033510|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
9916728|NCT01218516|11033511|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
10204640|NCT03481309|11331508|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10204641|NCT03481309|11331509|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10204642|NCT03481595|11331519|FG000|STARTED|Overall Study||146
10204643|NCT03481595|11331520|FG001|STARTED|Overall Study||148
10204644|NCT03481595|11331519|FG000|COMPLETED|Overall Study||143
10204645|NCT03481595|11331520|FG001|COMPLETED|Overall Study||127
10204646|NCT03481595|11331519|FG000|NOT COMPLETED|Overall Study||3
10204647|NCT03481595|11331520|FG001|NOT COMPLETED|Overall Study||21
10204648|NCT03481725|11331528|FG000|STARTED|Overall Study||31
10204649|NCT03481725|11331529|FG001|STARTED|Overall Study||34
10204650|NCT03481725|11331528|FG000|COMPLETED|Overall Study||30
10204651|NCT03481725|11331529|FG001|COMPLETED|Overall Study||34
10204652|NCT03481725|11331528|FG000|NOT COMPLETED|Overall Study||1
10204653|NCT03481725|11331529|FG001|NOT COMPLETED|Overall Study||0
10204654|NCT03481816|11331539|FG000|STARTED|Starting Dose||6
10204655|NCT03481816|11331540|FG001|STARTED|Starting Dose||0
10204656|NCT03481816|11331539|FG000|COMPLETED|Starting Dose||5
10204657|NCT03481816|11331540|FG001|COMPLETED|Starting Dose||0
10204658|NCT03481816|11331539|FG000|NOT COMPLETED|Starting Dose||1
10204659|NCT03481816|11331540|FG001|NOT COMPLETED|Starting Dose||0
10204660|NCT03481816|11331539|FG000|STARTED|Dose Expansion||0
10204661|NCT03481816|11331540|FG001|STARTED|Dose Expansion||12
10204662|NCT03481816|11331539|FG000|COMPLETED|Dose Expansion||0
10204663|NCT03481816|11331540|FG001|COMPLETED|Dose Expansion||0
10204664|NCT03481816|11331539|FG000|NOT COMPLETED|Dose Expansion||0
10204665|NCT03481816|11331540|FG001|NOT COMPLETED|Dose Expansion||12
10204666|NCT03482011|11331550|FG000|STARTED|Induction Period (16 Weeks)||107
10204667|NCT03482011|11331551|FG001|STARTED|Induction Period (16 Weeks)||423
10204668|NCT03482011|11331552|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10204669|NCT03482011|11331553|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10204670|NCT03482011|11331554|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10204671|NCT03482011|11331555|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10204672|NCT03482011|11331556|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10204673|NCT03482011|11331557|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10204674|NCT03482011|11331550|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
10204675|NCT03482011|11331551|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
10204676|NCT03482011|11331552|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10204677|NCT03482011|11331553|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10204678|NCT03482011|11331554|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10204679|NCT03482011|11331555|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10204680|NCT03482011|11331556|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10204681|NCT03482011|11331557|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10204682|NCT03482011|11331550|FG000|COMPLETED|Induction Period (16 Weeks)||101
10204683|NCT03482011|11331551|FG001|COMPLETED|Induction Period (16 Weeks)||412
10204684|NCT03482011|11331552|FG002|COMPLETED|Induction Period (16 Weeks)||0
10204685|NCT03482011|11331553|FG003|COMPLETED|Induction Period (16 Weeks)||0
10204686|NCT03482011|11331554|FG004|COMPLETED|Induction Period (16 Weeks)||0
10204687|NCT03482011|11331555|FG005|COMPLETED|Induction Period (16 Weeks)||0
10204688|NCT03482011|11331556|FG006|COMPLETED|Induction Period (16 Weeks)||0
10204689|NCT03482011|11331557|FG007|COMPLETED|Induction Period (16 Weeks)||0
10204690|NCT03482011|11331550|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6
10204691|NCT03482011|11331551|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11
10204692|NCT03482011|11331552|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
10204693|NCT03482011|11331553|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0
10204694|NCT03482011|11331554|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
10204695|NCT03482011|11331555|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
10204696|NCT03482011|11331556|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
10204697|NCT03482011|11331557|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
10204698|NCT03482011|11331550|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10204699|NCT03482011|11331551|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10204700|NCT03482011|11331552|FG002|STARTED|Maintenance Period (36 Weeks)||7
10204701|NCT03482011|11331553|FG003|STARTED|Maintenance Period (36 Weeks)||94
10204702|NCT03482011|11331554|FG004|STARTED|Maintenance Period (36 Weeks)||91
10204703|NCT03482011|11331555|FG005|STARTED|Maintenance Period (36 Weeks)||90
10204704|NCT03482011|11331556|FG006|STARTED|Maintenance Period (36 Weeks)||91
9916729|NCT01218516|11033512|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
9916730|NCT01218516|11033513|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
9916731|NCT01218516|11033510|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
9916732|NCT01218516|11033511|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
9916733|NCT01218516|11033512|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
9955654|NCT01439945|11074664|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5
9916734|NCT01218516|11033513|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
9916735|NCT01218516|11033510|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0
9916736|NCT01218516|11033511|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0
9916737|NCT01218516|11033512|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38
9916738|NCT01218516|11033513|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28
9916739|NCT01218516|11033510|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
9916740|NCT01218516|11033511|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
9916741|NCT01218516|11033512|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
9916742|NCT01218516|11033513|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
9916743|NCT01218542|11033523|FG000|STARTED|Overall Study||22
9916744|NCT01218542|11033523|FG000|COMPLETED|Overall Study||13
9916745|NCT01218542|11033523|FG000|NOT COMPLETED|Overall Study||9
9916746|NCT01218594|11033528|FG000|STARTED|Overall Study||48
9916747|NCT01218594|11033528|FG000|COMPLETED|Overall Study||36
9916748|NCT01218594|11033528|FG000|NOT COMPLETED|Overall Study||12
9916749|NCT01218646|11033536|FG000|STARTED|Overall Study||225
9916750|NCT01218646|11033537|FG001|STARTED|Overall Study||225
9916751|NCT01218646|11033538|FG002|STARTED|Overall Study||225
9916752|NCT01218646|11033539|FG003|STARTED|Overall Study||64
9916753|NCT01218646|11033536|FG000|COMPLETED|Overall Study||224
9916754|NCT01218646|11033537|FG001|COMPLETED|Overall Study||225
9916755|NCT01218646|11033538|FG002|COMPLETED|Overall Study||223
9916756|NCT01218646|11033539|FG003|COMPLETED|Overall Study||63
10204705|NCT03482011|11331557|FG007|STARTED|Maintenance Period (36 Weeks)||140
10204706|NCT03482011|11331550|FG000|Relapse|Maintenance Period (36 Weeks)||0
10204707|NCT03482011|11331551|FG001|Relapse|Maintenance Period (36 Weeks)||0
10204708|NCT03482011|11331552|FG002|Relapse|Maintenance Period (36 Weeks)||1
10204709|NCT03482011|11331553|FG003|Relapse|Maintenance Period (36 Weeks)||0
10204710|NCT03482011|11331554|FG004|Relapse|Maintenance Period (36 Weeks)||41
10204711|NCT03482011|11331555|FG005|Relapse|Maintenance Period (36 Weeks)||3
10204712|NCT03482011|11331556|FG006|Relapse|Maintenance Period (36 Weeks)||2
10204713|NCT03482011|11331557|FG007|Relapse|Maintenance Period (36 Weeks)||0
10204714|NCT03482011|11331550|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
10204715|NCT03482011|11331551|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
10204716|NCT03482011|11331552|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
10204717|NCT03482011|11331553|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
10204718|NCT03482011|11331554|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
10204719|NCT03482011|11331555|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
10204720|NCT03482011|11331556|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
10204721|NCT03482011|11331557|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
10204722|NCT03482011|11331550|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
10204723|NCT03482011|11331551|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
10204724|NCT03482011|11331552|FG002|COMPLETED|Maintenance Period (36 Weeks)||6
10204725|NCT03482011|11331553|FG003|COMPLETED|Maintenance Period (36 Weeks)||90
10204726|NCT03482011|11331554|FG004|COMPLETED|Maintenance Period (36 Weeks)||86
10204727|NCT03482011|11331555|FG005|COMPLETED|Maintenance Period (36 Weeks)||86
10204728|NCT03482011|11331556|FG006|COMPLETED|Maintenance Period (36 Weeks)||87
10204729|NCT03482011|11331557|FG007|COMPLETED|Maintenance Period (36 Weeks)||123
10204730|NCT03482011|11331550|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10204731|NCT03482011|11331551|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10204732|NCT03482011|11331552|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10204733|NCT03482011|11331553|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10204734|NCT03482011|11331554|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5
10204735|NCT03482011|11331555|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10204736|NCT03482011|11331556|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10204737|NCT03482011|11331557|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17
10204738|NCT03482011|11331550|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
10204739|NCT03482011|11331551|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
10204740|NCT03482011|11331552|FG002|STARTED|Follow-up Period (12 Weeks)||1
10204741|NCT03482011|11331553|FG003|STARTED|Follow-up Period (12 Weeks)||10
10204742|NCT03482011|11331554|FG004|STARTED|Follow-up Period (12 Weeks)||2
10204743|NCT03482011|11331555|FG005|STARTED|Follow-up Period (12 Weeks)||4
10204744|NCT03482011|11331556|FG006|STARTED|Follow-up Period (12 Weeks)||4
10204745|NCT03482011|11331557|FG007|STARTED|Follow-up Period (12 Weeks)||21
10204746|NCT03482011|11331550|FG000|COMPLETED|Follow-up Period (12 Weeks)||0
10204747|NCT03482011|11331551|FG001|COMPLETED|Follow-up Period (12 Weeks)||0
10204748|NCT03482011|11331552|FG002|COMPLETED|Follow-up Period (12 Weeks)||0
10204749|NCT03482011|11331553|FG003|COMPLETED|Follow-up Period (12 Weeks)||5
9916757|NCT01218646|11033536|FG000|NOT COMPLETED|Overall Study||1
9916758|NCT01218646|11033537|FG001|NOT COMPLETED|Overall Study||0
9916759|NCT01218646|11033538|FG002|NOT COMPLETED|Overall Study||2
9916760|NCT01218646|11033539|FG003|NOT COMPLETED|Overall Study||1
9916761|NCT01218659|11033551|FG000|STARTED|18-Month Randomized Period||36
10204750|NCT03482011|11331554|FG004|COMPLETED|Follow-up Period (12 Weeks)||2
10204751|NCT03482011|11331555|FG005|COMPLETED|Follow-up Period (12 Weeks)||3
10204752|NCT03482011|11331556|FG006|COMPLETED|Follow-up Period (12 Weeks)||2
10204753|NCT03482011|11331557|FG007|COMPLETED|Follow-up Period (12 Weeks)||4
9916762|NCT01218659|11033552|FG001|STARTED|18-Month Randomized Period||24
9916763|NCT01218659|11033553|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
9916764|NCT01218659|11033551|FG000|Safety Population|18-Month Randomized Period||36
9916765|NCT01218659|11033552|FG001|Safety Population|18-Month Randomized Period||21
9916766|NCT01218659|11033553|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
9916767|NCT01218659|11033551|FG000|COMPLETED|18-Month Randomized Period||34
9916768|NCT01218659|11033552|FG001|COMPLETED|18-Month Randomized Period||18
9916769|NCT01218659|11033553|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
9916770|NCT01218659|11033551|FG000|NOT COMPLETED|18-Month Randomized Period||2
9916771|NCT01218659|11033552|FG001|NOT COMPLETED|18-Month Randomized Period||6
9916772|NCT01218659|11033553|FG002|NOT COMPLETED|18-Month Randomized Period||0
9916773|NCT01218659|11033551|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
9916774|NCT01218659|11033552|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
9916775|NCT01218659|11033553|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
9916776|NCT01218659|11033551|FG000|Safety Population|12-Month OLE||0
9916777|NCT01218659|11033552|FG001|Safety Population|12-Month OLE||0
9916778|NCT01218659|11033553|FG002|Safety Population|12-Month OLE||51
9916779|NCT01218659|11033551|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
9916780|NCT01218659|11033552|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
9916781|NCT01218659|11033553|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46
9916782|NCT01218659|11033551|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
9916783|NCT01218659|11033552|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
9916784|NCT01218659|11033553|FG002|COMPLETED|12-Month OLE||42
9916785|NCT01218659|11033551|FG000|NOT COMPLETED|12-Month OLE||0
9916786|NCT01218659|11033552|FG001|NOT COMPLETED|12-Month OLE||0
10204754|NCT03482011|11331550|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0
10204755|NCT03482011|11331551|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0
10204756|NCT03482011|11331552|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1
10204757|NCT03482011|11331553|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5
10204758|NCT03482011|11331554|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0
10204759|NCT03482011|11331555|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1
10204760|NCT03482011|11331556|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2
10204761|NCT03482011|11331557|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17
10204762|NCT03482453|11331594|FG000|STARTED|Part 1 (1 Day)||10
10204763|NCT03482453|11331595|FG001|STARTED|Part 1 (1 Day)||6
10204764|NCT03482453|11331596|FG002|STARTED|Part 1 (1 Day)||6
10204765|NCT03482453|11331597|FG003|STARTED|Part 1 (1 Day)||6
10204766|NCT03482453|11331598|FG004|STARTED|Part 1 (1 Day)||6
10204767|NCT03482453|11331599|FG005|STARTED|Part 1 (1 Day)||6
10204768|NCT03482453|11331600|FG006|STARTED|Part 1 (1 Day)||0
10204769|NCT03482453|11331601|FG007|STARTED|Part 1 (1 Day)||0
10204770|NCT03482453|11331602|FG008|STARTED|Part 1 (1 Day)||0
10204771|NCT03482453|11331603|FG009|STARTED|Part 1 (1 Day)||0
10204772|NCT03482453|11331604|FG010|STARTED|Part 1 (1 Day)||0
10204773|NCT03482453|11331605|FG011|STARTED|Part 1 (1 Day)||0
10204774|NCT03482453|11331594|FG000|COMPLETED|Part 1 (1 Day)||10
10204775|NCT03482453|11331595|FG001|COMPLETED|Part 1 (1 Day)||6
10204776|NCT03482453|11331596|FG002|COMPLETED|Part 1 (1 Day)||6
10204777|NCT03482453|11331597|FG003|COMPLETED|Part 1 (1 Day)||6
10204778|NCT03482453|11331598|FG004|COMPLETED|Part 1 (1 Day)||6
10204779|NCT03482453|11331599|FG005|COMPLETED|Part 1 (1 Day)||6
10204780|NCT03482453|11331600|FG006|COMPLETED|Part 1 (1 Day)||0
10204781|NCT03482453|11331601|FG007|COMPLETED|Part 1 (1 Day)||0
10204782|NCT03482453|11331602|FG008|COMPLETED|Part 1 (1 Day)||0
10204783|NCT03482453|11331603|FG009|COMPLETED|Part 1 (1 Day)||0
10204784|NCT03482453|11331604|FG010|COMPLETED|Part 1 (1 Day)||0
10204785|NCT03482453|11331605|FG011|COMPLETED|Part 1 (1 Day)||0
10204786|NCT03482453|11331594|FG000|NOT COMPLETED|Part 1 (1 Day)||0
10204787|NCT03482453|11331595|FG001|NOT COMPLETED|Part 1 (1 Day)||0
10204788|NCT03482453|11331596|FG002|NOT COMPLETED|Part 1 (1 Day)||0
10204789|NCT03482453|11331597|FG003|NOT COMPLETED|Part 1 (1 Day)||0
10204790|NCT03482453|11331598|FG004|NOT COMPLETED|Part 1 (1 Day)||0
10204791|NCT03482453|11331599|FG005|NOT COMPLETED|Part 1 (1 Day)||0
10204792|NCT03482453|11331600|FG006|NOT COMPLETED|Part 1 (1 Day)||0
10204793|NCT03482453|11331601|FG007|NOT COMPLETED|Part 1 (1 Day)||0
10204794|NCT03482453|11331602|FG008|NOT COMPLETED|Part 1 (1 Day)||0
10204795|NCT03482453|11331603|FG009|NOT COMPLETED|Part 1 (1 Day)||0
10204796|NCT03482453|11331604|FG010|NOT COMPLETED|Part 1 (1 Day)||0
10204797|NCT03482453|11331605|FG011|NOT COMPLETED|Part 1 (1 Day)||0
10204798|NCT03482453|11331594|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204799|NCT03482453|11331595|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204800|NCT03482453|11331596|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204801|NCT03482453|11331597|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204802|NCT03482453|11331598|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204803|NCT03482453|11331599|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204804|NCT03482453|11331600|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
9916787|NCT01218659|11033553|FG002|NOT COMPLETED|12-Month OLE||10
9916788|NCT01218672|11033562|FG000|STARTED|Overall Study||139
9916789|NCT01218672|11033563|FG001|STARTED|Overall Study||142
9916790|NCT01218672|11033562|FG000|Treated|Overall Study||136
9916791|NCT01218672|11033563|FG001|Treated|Overall Study||133
9916792|NCT01218672|11033562|FG000|COMPLETED|Overall Study||128
9916793|NCT01218672|11033563|FG001|COMPLETED|Overall Study||121
9916794|NCT01218672|11033562|FG000|NOT COMPLETED|Overall Study||11
9916795|NCT01218672|11033563|FG001|NOT COMPLETED|Overall Study||21
9916796|NCT01218802|11033573|FG000|STARTED|Overall Study||72
9916797|NCT01218802|11033574|FG001|STARTED|Overall Study||75
9916798|NCT01218802|11033573|FG000|COMPLETED|Overall Study||62
9916799|NCT01218802|11033574|FG001|COMPLETED|Overall Study||57
9916800|NCT01218802|11033573|FG000|NOT COMPLETED|Overall Study||10
9916801|NCT01218802|11033574|FG001|NOT COMPLETED|Overall Study||18
9916802|NCT01218867|11033591|FG000|STARTED|Overall Study||1
9916803|NCT01218867|11033592|FG001|STARTED|Overall Study||1
9916804|NCT01218867|11033593|FG002|STARTED|Overall Study||3
9916805|NCT01218867|11033594|FG003|STARTED|Overall Study||1
9916806|NCT01218867|11033595|FG004|STARTED|Overall Study||1
10204805|NCT03482453|11331601|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
10204806|NCT03482453|11331602|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10204807|NCT03482453|11331603|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10204808|NCT03482453|11331604|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
10204809|NCT03482453|11331605|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
10204810|NCT03482453|11331594|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204811|NCT03482453|11331595|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204812|NCT03482453|11331596|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204813|NCT03482453|11331597|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204814|NCT03482453|11331598|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204815|NCT03482453|11331599|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204816|NCT03482453|11331600|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
10204817|NCT03482453|11331601|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
10204818|NCT03482453|11331602|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10204819|NCT03482453|11331603|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10204820|NCT03482453|11331604|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
10204821|NCT03482453|11331605|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
10204822|NCT03482453|11331594|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204823|NCT03482453|11331595|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204824|NCT03482453|11331596|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204825|NCT03482453|11331597|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204826|NCT03482453|11331598|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204827|NCT03482453|11331599|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204828|NCT03482453|11331600|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204829|NCT03482453|11331601|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204830|NCT03482453|11331602|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204831|NCT03482453|11331603|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204832|NCT03482453|11331604|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
10204833|NCT03482453|11331605|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10204834|NCT03482453|11331594|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10204835|NCT03482453|11331595|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10204836|NCT03482453|11331596|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10204837|NCT03482453|11331597|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10204838|NCT03482453|11331598|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10204839|NCT03482453|11331599|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10204840|NCT03482453|11331600|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3
10204841|NCT03482453|11331601|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3
10204842|NCT03482453|11331602|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5
10204843|NCT03482453|11331603|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5
10204844|NCT03482453|11331604|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6
10204845|NCT03482453|11331605|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6
10204846|NCT03482453|11331594|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204847|NCT03482453|11331595|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204848|NCT03482453|11331596|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204849|NCT03482453|11331597|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204850|NCT03482453|11331598|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204851|NCT03482453|11331599|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204852|NCT03482453|11331600|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
10204853|NCT03482453|11331601|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
10204854|NCT03482453|11331602|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
9916807|NCT01218867|11033596|FG005|STARTED|Overall Study||1
9916808|NCT01218867|11033597|FG006|STARTED|Overall Study||4
9916809|NCT01218867|11033598|FG007|STARTED|Overall Study||3
9916810|NCT01218867|11033599|FG008|STARTED|Overall Study||3
9916811|NCT01218867|11033600|FG009|STARTED|Overall Study||4
9916812|NCT01218867|11033601|FG010|STARTED|Overall Study||2
9916813|NCT01218867|11033591|FG000|COMPLETED|Overall Study||1
9916814|NCT01218867|11033592|FG001|COMPLETED|Overall Study||1
9916815|NCT01218867|11033593|FG002|COMPLETED|Overall Study||3
9916816|NCT01218867|11033594|FG003|COMPLETED|Overall Study||1
9916817|NCT01218867|11033595|FG004|COMPLETED|Overall Study||1
9916818|NCT01218867|11033596|FG005|COMPLETED|Overall Study||1
9916819|NCT01218867|11033597|FG006|COMPLETED|Overall Study||3
9916820|NCT01218867|11033598|FG007|COMPLETED|Overall Study||3
9916821|NCT01218867|11033599|FG008|COMPLETED|Overall Study||3
9916822|NCT01218867|11033600|FG009|COMPLETED|Overall Study||4
9916823|NCT01218867|11033601|FG010|COMPLETED|Overall Study||2
9916824|NCT01218867|11033591|FG000|NOT COMPLETED|Overall Study||0
9916825|NCT01218867|11033592|FG001|NOT COMPLETED|Overall Study||0
9916826|NCT01218867|11033593|FG002|NOT COMPLETED|Overall Study||0
9916827|NCT01218867|11033594|FG003|NOT COMPLETED|Overall Study||0
9916828|NCT01218867|11033595|FG004|NOT COMPLETED|Overall Study||0
9916829|NCT01218867|11033596|FG005|NOT COMPLETED|Overall Study||0
9916830|NCT01218867|11033597|FG006|NOT COMPLETED|Overall Study||1
9916831|NCT01218867|11033598|FG007|NOT COMPLETED|Overall Study||0
9916832|NCT01218867|11033599|FG008|NOT COMPLETED|Overall Study||0
9916833|NCT01218867|11033600|FG009|NOT COMPLETED|Overall Study||0
9916834|NCT01218867|11033601|FG010|NOT COMPLETED|Overall Study||0
9916835|NCT01218958|11033639|FG000|STARTED|Overall Study||210
9916836|NCT01218958|11033640|FG001|STARTED|Overall Study||205
9916837|NCT01218958|11033641|FG002|STARTED|Overall Study||209
9916838|NCT01218958|11033639|FG000|COMPLETED|Overall Study||126
9916839|NCT01218958|11033640|FG001|COMPLETED|Overall Study||124
9916840|NCT01218958|11033641|FG002|COMPLETED|Overall Study||128
10204855|NCT03482453|11331603|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
10204856|NCT03482453|11331604|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
10204857|NCT03482453|11331605|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
10204858|NCT03482453|11331594|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204859|NCT03482453|11331595|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204860|NCT03482453|11331596|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204861|NCT03482453|11331597|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204862|NCT03482453|11331598|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204863|NCT03482453|11331599|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204864|NCT03482453|11331600|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204865|NCT03482453|11331601|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204866|NCT03482453|11331602|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204867|NCT03482453|11331603|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204868|NCT03482453|11331604|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204869|NCT03482453|11331605|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10204870|NCT03482453|11331594|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204871|NCT03482453|11331595|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204872|NCT03482453|11331596|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204873|NCT03482453|11331597|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204874|NCT03482453|11331598|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204875|NCT03482453|11331599|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204876|NCT03482453|11331600|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10204877|NCT03482453|11331601|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10204878|NCT03482453|11331602|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10204879|NCT03482453|11331603|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10204880|NCT03482453|11331604|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10204881|NCT03482453|11331605|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10204882|NCT03482453|11331594|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204883|NCT03482453|11331595|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204884|NCT03482453|11331596|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204885|NCT03482453|11331597|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204886|NCT03482453|11331598|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204887|NCT03482453|11331599|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204888|NCT03482453|11331600|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10204889|NCT03482453|11331601|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10204890|NCT03482453|11331602|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10204891|NCT03482453|11331603|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10204892|NCT03482453|11331604|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10204893|NCT03482453|11331605|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10204894|NCT03482453|11331594|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204895|NCT03482453|11331595|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204896|NCT03482453|11331596|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204897|NCT03482453|11331597|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204898|NCT03482453|11331598|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204899|NCT03482453|11331599|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9916841|NCT01218958|11033639|FG000|NOT COMPLETED|Overall Study||84
9916842|NCT01218958|11033640|FG001|NOT COMPLETED|Overall Study||81
9916843|NCT01218958|11033641|FG002|NOT COMPLETED|Overall Study||81
9916844|NCT01218971|11033651|FG000|STARTED|Overall Study||175
9916845|NCT01218971|11033652|FG001|STARTED|Overall Study||157
9916846|NCT01218971|11033651|FG000|COMPLETED|Overall Study||71
9916847|NCT01218971|11033652|FG001|COMPLETED|Overall Study||77
9916848|NCT01218971|11033651|FG000|NOT COMPLETED|Overall Study||104
9916849|NCT01218971|11033652|FG001|NOT COMPLETED|Overall Study||80
9916850|NCT01218984|11033665|FG000|STARTED|Overall Study||9
10204900|NCT03482453|11331600|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204901|NCT03482453|11331601|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204902|NCT03482453|11331602|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204903|NCT03482453|11331603|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204904|NCT03482453|11331604|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204905|NCT03482453|11331605|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10204906|NCT03482583|11331644|FG000|STARTED|Overall Study||37
10204907|NCT03482583|11331645|FG001|STARTED|Overall Study||14
10204908|NCT03482583|11331646|FG002|STARTED|Overall Study||39
10204909|NCT03482583|11331644|FG000|COMPLETED|Overall Study||12
10204910|NCT03482583|11331645|FG001|COMPLETED|Overall Study||5
10204911|NCT03482583|11331646|FG002|COMPLETED|Overall Study||18
10204912|NCT03482583|11331644|FG000|NOT COMPLETED|Overall Study||25
10204913|NCT03482583|11331645|FG001|NOT COMPLETED|Overall Study||9
10204914|NCT03482583|11331646|FG002|NOT COMPLETED|Overall Study||21
10204915|NCT03482635|11331659|FG000|STARTED|Overall Study||23
10204916|NCT03482635|11331660|FG001|STARTED|Overall Study||24
10204917|NCT03482635|11331661|FG002|STARTED|Overall Study||23
10204918|NCT03482635|11331662|FG003|STARTED|Overall Study||28
10204919|NCT03482635|11331659|FG000|Treated|Overall Study||23
10204920|NCT03482635|11331660|FG001|Treated|Overall Study||24
10204921|NCT03482635|11331661|FG002|Treated|Overall Study||23
10204922|NCT03482635|11331662|FG003|Treated|Overall Study||27
10204923|NCT03482635|11331659|FG000|COMPLETED|Overall Study||18
10204924|NCT03482635|11331660|FG001|COMPLETED|Overall Study||21
10204925|NCT03482635|11331661|FG002|COMPLETED|Overall Study||22
10204926|NCT03482635|11331662|FG003|COMPLETED|Overall Study||20
10204927|NCT03482635|11331659|FG000|NOT COMPLETED|Overall Study||5
10204928|NCT03482635|11331660|FG001|NOT COMPLETED|Overall Study||3
10204929|NCT03482635|11331661|FG002|NOT COMPLETED|Overall Study||1
10204930|NCT03482635|11331662|FG003|NOT COMPLETED|Overall Study||8
10204931|NCT03482713|11331674|FG000|STARTED|Overall Study||11
10204932|NCT03482713|11331675|FG001|STARTED|Overall Study||12
10204933|NCT03482713|11331674|FG000|COMPLETED|Overall Study||11
10204934|NCT03482713|11331675|FG001|COMPLETED|Overall Study||12
10204935|NCT03482713|11331674|FG000|NOT COMPLETED|Overall Study||0
10204936|NCT03482713|11331675|FG001|NOT COMPLETED|Overall Study||0
10204937|NCT03482882|11331681|FG000|STARTED|Overall Study||47
10204938|NCT03482882|11331681|FG000|COMPLETED|Overall Study||40
10204939|NCT03482882|11331681|FG000|NOT COMPLETED|Overall Study||7
10204940|NCT03482973|11331687|FG000|STARTED|Overall Study||40
10204941|NCT03482973|11331688|FG001|STARTED|Overall Study||40
10204942|NCT03482973|11331687|FG000|COMPLETED|Overall Study||40
10204943|NCT03482973|11331688|FG001|COMPLETED|Overall Study||40
10204944|NCT03482973|11331687|FG000|NOT COMPLETED|Overall Study||0
10204945|NCT03482973|11331688|FG001|NOT COMPLETED|Overall Study||0
10204946|NCT03483506|11331694|FG000|STARTED|Overall Study||12
10204947|NCT03483506|11331694|FG000|COMPLETED|Overall Study||12
10204948|NCT03483506|11331694|FG000|NOT COMPLETED|Overall Study||0
10204949|NCT03483623|11331700|FG000|STARTED|Overall Study||44
10204950|NCT03483623|11331700|FG000|Started NATO WELP|Overall Study||44
10204951|NCT03483623|11331700|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10204952|NCT03483623|11331700|FG000|Started NATO FIS|Overall Study||44
10204953|NCT03483623|11331700|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10204954|NCT03483623|11331700|FG000|Started RAVEN WELP|Overall Study||44
10204955|NCT03483623|11331700|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10204956|NCT03483623|11331700|FG000|Started RAVEN FIS|Overall Study||44
10204957|NCT03483623|11331700|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10204958|NCT03483623|11331700|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10204959|NCT03483623|11331700|FG000|NOT COMPLETED|Overall Study||1
10204960|NCT03483675|11331706|FG000|STARTED|Overall Study||9
10204961|NCT03483675|11331707|FG001|STARTED|Overall Study||8
10204962|NCT03483675|11331706|FG000|COMPLETED|Overall Study||9
10204963|NCT03483675|11331707|FG001|COMPLETED|Overall Study||8
10204964|NCT03483675|11331706|FG000|NOT COMPLETED|Overall Study||0
10204965|NCT03483675|11331707|FG001|NOT COMPLETED|Overall Study||0
10204966|NCT03483896|11331716|FG000|STARTED|Overall Study||33
10204967|NCT03483896|11331717|FG001|STARTED|Overall Study||50
10204968|NCT03483896|11331716|FG000|COMPLETED|Overall Study||31
10204969|NCT03483896|11331717|FG001|COMPLETED|Overall Study||46
10204970|NCT03483896|11331716|FG000|NOT COMPLETED|Overall Study||2
10204971|NCT03483896|11331717|FG001|NOT COMPLETED|Overall Study||4
10204972|NCT03483935|11331725|FG000|STARTED|Stage 1: Dose Setting Study||7
10204973|NCT03483935|11331725|FG000|COMPLETED|Stage 1: Dose Setting Study||7
10204974|NCT03483935|11331725|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0
10204975|NCT03483935|11331725|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
10204976|NCT03483935|11331725|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11
10204977|NCT03483935|11331725|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
10204978|NCT03483935|11331725|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11
10204979|NCT03483935|11331725|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
10204980|NCT03483961|11331743|FG000|STARTED|Overall Study||53
10204981|NCT03483961|11331744|FG001|STARTED|Overall Study||52
10204982|NCT03483961|11331745|FG002|STARTED|Overall Study||51
10204983|NCT03483961|11331746|FG003|STARTED|Overall Study||50
9916851|NCT01218984|11033666|FG001|STARTED|Overall Study||8
9916852|NCT01218984|11033667|FG002|STARTED|Overall Study||10
9916853|NCT01218984|11033665|FG000|COMPLETED|Overall Study||8
9916854|NCT01218984|11033666|FG001|COMPLETED|Overall Study||6
9916855|NCT01218984|11033667|FG002|COMPLETED|Overall Study||7
9916856|NCT01218984|11033665|FG000|NOT COMPLETED|Overall Study||1
9916857|NCT01218984|11033666|FG001|NOT COMPLETED|Overall Study||2
9916858|NCT01218984|11033667|FG002|NOT COMPLETED|Overall Study||3
9916859|NCT01218997|11033677|FG000|STARTED|Overall Study||371
9916860|NCT01218997|11033678|FG001|STARTED|Overall Study||65
10204984|NCT03483961|11331747|FG004|STARTED|Overall Study||53
10204985|NCT03483961|11331748|FG005|STARTED|Overall Study||53
10204986|NCT03483961|11331749|FG006|STARTED|Overall Study||51
10204987|NCT03483961|11331750|FG007|STARTED|Overall Study||52
10204988|NCT03483961|11331751|FG008|STARTED|Overall Study||20
10204989|NCT03483961|11331752|FG009|STARTED|Overall Study||10
10204990|NCT03483961|11331743|FG000|Exposed / Safety|Overall Study||53
10204991|NCT03483961|11331744|FG001|Exposed / Safety|Overall Study||52
10204992|NCT03483961|11331745|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50
10204993|NCT03483961|11331746|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51
10204994|NCT03483961|11331747|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53
10204995|NCT03483961|11331748|FG005|Exposed / Safety|Overall Study||53
10204996|NCT03483961|11331749|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51
10204997|NCT03483961|11331750|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52
10204998|NCT03483961|11331751|FG008|Exposed / Safety|Overall Study||20
10204999|NCT03483961|11331752|FG009|Exposed / Safety|Overall Study||10
10205000|NCT03483961|11331743|FG000|Immunogenicity-evaluable|Overall Study||47
10205001|NCT03483961|11331744|FG001|Immunogenicity-evaluable|Overall Study||44
10205002|NCT03483961|11331745|FG002|Immunogenicity-evaluable|Overall Study||44
10205003|NCT03483961|11331746|FG003|Immunogenicity-evaluable|Overall Study||45
10205004|NCT03483961|11331747|FG004|Immunogenicity-evaluable|Overall Study||48
10205005|NCT03483961|11331748|FG005|Immunogenicity-evaluable|Overall Study||48
10205006|NCT03483961|11331749|FG006|Immunogenicity-evaluable|Overall Study||47
10205007|NCT03483961|11331750|FG007|Immunogenicity-evaluable|Overall Study||50
10205008|NCT03483961|11331751|FG008|Immunogenicity-evaluable|Overall Study||20
10205009|NCT03483961|11331752|FG009|Immunogenicity-evaluable|Overall Study||10
10205010|NCT03483961|11331743|FG000|COMPLETED|Overall Study||42
10205011|NCT03483961|11331744|FG001|COMPLETED|Overall Study||42
10205012|NCT03483961|11331745|FG002|COMPLETED|Overall Study||39
10205013|NCT03483961|11331746|FG003|COMPLETED|Overall Study||41
10205014|NCT03483961|11331747|FG004|COMPLETED|Overall Study||43
10205015|NCT03483961|11331748|FG005|COMPLETED|Overall Study||47
10205016|NCT03483961|11331749|FG006|COMPLETED|Overall Study||46
10205017|NCT03483961|11331750|FG007|COMPLETED|Overall Study||39
10205018|NCT03483961|11331751|FG008|COMPLETED|Overall Study||18
10205019|NCT03483961|11331752|FG009|COMPLETED|Overall Study||10
10205020|NCT03483961|11331743|FG000|NOT COMPLETED|Overall Study||11
10205021|NCT03483961|11331744|FG001|NOT COMPLETED|Overall Study||10
10205022|NCT03483961|11331745|FG002|NOT COMPLETED|Overall Study||12
10205023|NCT03483961|11331746|FG003|NOT COMPLETED|Overall Study||9
10205024|NCT03483961|11331747|FG004|NOT COMPLETED|Overall Study||10
10205025|NCT03483961|11331748|FG005|NOT COMPLETED|Overall Study||6
10205026|NCT03483961|11331749|FG006|NOT COMPLETED|Overall Study||5
10205027|NCT03483961|11331750|FG007|NOT COMPLETED|Overall Study||13
10205028|NCT03483961|11331751|FG008|NOT COMPLETED|Overall Study||2
10205029|NCT03483961|11331752|FG009|NOT COMPLETED|Overall Study||0
10205030|NCT03484273|11331773|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
10205031|NCT03484273|11331773|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
10205032|NCT03484273|11331773|FG000|NOT COMPLETED|Overall Study||2
10205033|NCT03484429|11331787|FG000|STARTED|Overall Study||8
10205034|NCT03484429|11331788|FG001|STARTED|Overall Study||8
10205035|NCT03484429|11331787|FG000|Postamputation Week 1-4|Overall Study||8
10205036|NCT03484429|11331788|FG001|Postamputation Week 1-4|Overall Study||8
10205037|NCT03484429|11331787|FG000|Postamputation Week 5-8|Overall Study||5
10205038|NCT03484429|11331788|FG001|Postamputation Week 5-8|Overall Study||8
10205039|NCT03484429|11331787|FG000|Postamputation Month 3|Overall Study||5
10205040|NCT03484429|11331788|FG001|Postamputation Month 3|Overall Study||7
10205041|NCT03484429|11331787|FG000|COMPLETED|Overall Study||5
10205042|NCT03484429|11331788|FG001|COMPLETED|Overall Study||8
10205043|NCT03484429|11331787|FG000|NOT COMPLETED|Overall Study||3
10205044|NCT03484429|11331788|FG001|NOT COMPLETED|Overall Study||0
9916861|NCT01218997|11033677|FG000|COMPLETED|Overall Study||126
9916862|NCT01218997|11033678|FG001|COMPLETED|Overall Study||24
9916863|NCT01218997|11033677|FG000|NOT COMPLETED|Overall Study||245
9916864|NCT01218997|11033678|FG001|NOT COMPLETED|Overall Study||41
10205045|NCT03485222|11331796|FG000|STARTED|Overall Study||42
10205046|NCT03485222|11331797|FG001|STARTED|Overall Study||42
10205047|NCT03485222|11331796|FG000|COMPLETED|Overall Study||40
10205048|NCT03485222|11331797|FG001|COMPLETED|Overall Study||40
10205049|NCT03485222|11331796|FG000|NOT COMPLETED|Overall Study||2
10205050|NCT03485222|11331797|FG001|NOT COMPLETED|Overall Study||2
10205051|NCT03485495|11331805|FG000|STARTED|Overall Study||65
9916865|NCT01219738|11033684|FG000|STARTED|Overall Study||20
9916866|NCT01219738|11033684|FG000|Budesonide 360|Overall Study||20
9916867|NCT01219738|11033684|FG000|Budesonide 720|Overall Study||20
9916868|NCT01219738|11033684|FG000|Budesonide 1440|Overall Study||20
9916869|NCT01219738|11033684|FG000|Budesonide 720- 4 Times|Overall Study||20
9916870|NCT01219738|11033684|FG000|COMPLETED|Overall Study||20
9916871|NCT01219738|11033684|FG000|NOT COMPLETED|Overall Study||0
9916872|NCT01219777|11033697|FG000|STARTED|Overall Study||9
9916873|NCT01219777|11033697|FG000|COMPLETED|Overall Study||9
10205052|NCT03485495|11331806|FG001|STARTED|Overall Study||59
10205053|NCT03485495|11331805|FG000|COMPLETED|Overall Study||64
10205054|NCT03485495|11331806|FG001|COMPLETED|Overall Study||59
10205055|NCT03485495|11331805|FG000|NOT COMPLETED|Overall Study||1
10205056|NCT03485495|11331806|FG001|NOT COMPLETED|Overall Study||0
10205057|NCT03485976|11331812|FG000|STARTED|Overall Study||12
10205058|NCT03485976|11331812|FG000|COMPLETED|Overall Study||11
10205059|NCT03485976|11331812|FG000|NOT COMPLETED|Overall Study||1
10205060|NCT03486392|11331821|FG000|STARTED|Overall Study||60
10205061|NCT03486392|11331822|FG001|STARTED|Overall Study||59
10205062|NCT03486392|11331823|FG002|STARTED|Overall Study||118
10205063|NCT03486392|11331824|FG003|STARTED|Overall Study||118
10205064|NCT03486392|11331825|FG004|STARTED|Overall Study||119
10205065|NCT03486392|11331821|FG000|COMPLETED|Overall Study||57
10205066|NCT03486392|11331822|FG001|COMPLETED|Overall Study||59
10205067|NCT03486392|11331823|FG002|COMPLETED|Overall Study||104
10205068|NCT03486392|11331824|FG003|COMPLETED|Overall Study||109
10205069|NCT03486392|11331825|FG004|COMPLETED|Overall Study||115
10205070|NCT03486392|11331821|FG000|NOT COMPLETED|Overall Study||3
10205071|NCT03486392|11331822|FG001|NOT COMPLETED|Overall Study||0
10205072|NCT03486392|11331823|FG002|NOT COMPLETED|Overall Study||14
10205073|NCT03486392|11331824|FG003|NOT COMPLETED|Overall Study||9
10205074|NCT03486392|11331825|FG004|NOT COMPLETED|Overall Study||4
10205075|NCT03486834|11331840|FG000|STARTED|Overall Study||733
10205076|NCT03486834|11331841|FG001|STARTED|Overall Study||733
10205077|NCT03486834|11331842|FG002|STARTED|Overall Study||734
10205078|NCT03486834|11331840|FG000|Treatment 1|Overall Study||729
10205079|NCT03486834|11331841|FG001|Treatment 1|Overall Study||729
10205080|NCT03486834|11331842|FG002|Treatment 1|Overall Study||733
10205081|NCT03486834|11331840|FG000|Treatment 2|Overall Study||680
10205082|NCT03486834|11331841|FG001|Treatment 2|Overall Study||680
10205083|NCT03486834|11331842|FG002|Treatment 2|Overall Study||679
10205084|NCT03486834|11331840|FG000|Treatment 3|Overall Study||614
10205085|NCT03486834|11331841|FG001|Treatment 3|Overall Study||631
10205086|NCT03486834|11331842|FG002|Treatment 3|Overall Study||622
10205087|NCT03486834|11331840|FG000|COMPLETED|Overall Study||614
10205088|NCT03486834|11331841|FG001|COMPLETED|Overall Study||631
10205089|NCT03486834|11331842|FG002|COMPLETED|Overall Study||622
10205090|NCT03486834|11331840|FG000|NOT COMPLETED|Overall Study||119
10205091|NCT03486834|11331841|FG001|NOT COMPLETED|Overall Study||102
10205092|NCT03486834|11331842|FG002|NOT COMPLETED|Overall Study||112
10205093|NCT03486990|11331861|FG000|STARTED|Overall Study||2
10205094|NCT03486990|11331862|FG001|STARTED|Overall Study||2
10205095|NCT03486990|11331863|FG002|STARTED|Overall Study||3
10205096|NCT03486990|11331864|FG003|STARTED|Overall Study||3
10205097|NCT03486990|11331865|FG004|STARTED|Overall Study||3
10205098|NCT03486990|11331866|FG005|STARTED|Overall Study||4
10205099|NCT03486990|11331867|FG006|STARTED|Overall Study||2
10205100|NCT03486990|11331868|FG007|STARTED|Overall Study||2
10205101|NCT03486990|11331869|FG008|STARTED|Overall Study||2
10205102|NCT03486990|11331861|FG000|COMPLETED|Overall Study||2
10205103|NCT03486990|11331862|FG001|COMPLETED|Overall Study||2
10205104|NCT03486990|11331863|FG002|COMPLETED|Overall Study||3
10205105|NCT03486990|11331864|FG003|COMPLETED|Overall Study||3
10205106|NCT03486990|11331865|FG004|COMPLETED|Overall Study||3
10205107|NCT03486990|11331866|FG005|COMPLETED|Overall Study||4
10205108|NCT03486990|11331867|FG006|COMPLETED|Overall Study||2
10205109|NCT03486990|11331868|FG007|COMPLETED|Overall Study||2
10205110|NCT03486990|11331869|FG008|COMPLETED|Overall Study||2
10205111|NCT03486990|11331861|FG000|NOT COMPLETED|Overall Study||0
10205112|NCT03486990|11331862|FG001|NOT COMPLETED|Overall Study||0
10205113|NCT03486990|11331863|FG002|NOT COMPLETED|Overall Study||0
10205114|NCT03486990|11331864|FG003|NOT COMPLETED|Overall Study||0
10205115|NCT03486990|11331865|FG004|NOT COMPLETED|Overall Study||0
10205116|NCT03486990|11331866|FG005|NOT COMPLETED|Overall Study||0
10205117|NCT03486990|11331867|FG006|NOT COMPLETED|Overall Study||0
9916874|NCT01219777|11033697|FG000|NOT COMPLETED|Overall Study||0
9916875|NCT01219855|11033707|FG000|STARTED|Overall Study||17
10205118|NCT03486990|11331868|FG007|NOT COMPLETED|Overall Study||0
10205119|NCT03486990|11331869|FG008|NOT COMPLETED|Overall Study||0
10205120|NCT03487276|11331910|FG000|STARTED|Main Period (16 Weeks)||37
10205121|NCT03487276|11331911|FG001|STARTED|Main Period (16 Weeks)||34
10205122|NCT03487276|11331912|FG002|STARTED|Main Period (16 Weeks)||36
10205123|NCT03487276|11331913|FG003|STARTED|Main Period (16 Weeks)||36
9916876|NCT01219855|11033708|FG001|STARTED|Overall Study||17
9916877|NCT01219855|11033709|FG002|STARTED|Overall Study||17
10205124|NCT03487276|11331914|FG004|STARTED|Main Period (16 Weeks)||36
10205125|NCT03487276|11331910|FG000|COMPLETED|Main Period (16 Weeks)||34
10205126|NCT03487276|11331911|FG001|COMPLETED|Main Period (16 Weeks)||30
10205127|NCT03487276|11331912|FG002|COMPLETED|Main Period (16 Weeks)||32
10205128|NCT03487276|11331913|FG003|COMPLETED|Main Period (16 Weeks)||30
10205129|NCT03487276|11331914|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
9916878|NCT01219855|11033710|FG003|STARTED|Overall Study||13
9916879|NCT01219855|11033711|FG004|STARTED|Overall Study||14
9916880|NCT01219855|11033707|FG000|COMPLETED|Overall Study||16
9916881|NCT01219855|11033708|FG001|COMPLETED|Overall Study||12
9916882|NCT01219855|11033709|FG002|COMPLETED|Overall Study||16
9916883|NCT01219855|11033710|FG003|COMPLETED|Overall Study||12
9916884|NCT01219855|11033711|FG004|COMPLETED|Overall Study||13
9916885|NCT01219855|11033707|FG000|NOT COMPLETED|Overall Study||1
10205130|NCT03487276|11331910|FG000|NOT COMPLETED|Main Period (16 Weeks)||3
10205131|NCT03487276|11331911|FG001|NOT COMPLETED|Main Period (16 Weeks)||4
10205132|NCT03487276|11331912|FG002|NOT COMPLETED|Main Period (16 Weeks)||4
10205133|NCT03487276|11331913|FG003|NOT COMPLETED|Main Period (16 Weeks)||6
10205134|NCT03487276|11331914|FG004|NOT COMPLETED|Main Period (16 Weeks)||5
10205135|NCT03487276|11331910|FG000|STARTED|Extension Period (28 Weeks)||0
10205136|NCT03487276|11331911|FG001|STARTED|Extension Period (28 Weeks)||0
10205137|NCT03487276|11331912|FG002|STARTED|Extension Period (28 Weeks)||72
10205138|NCT03487276|11331913|FG003|STARTED|Extension Period (28 Weeks)||84
10205139|NCT03487276|11331914|FG004|STARTED|Extension Period (28 Weeks)||0
10205140|NCT03487276|11331910|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205141|NCT03487276|11331911|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205142|NCT03487276|11331912|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
10205143|NCT03487276|11331913|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
10205144|NCT03487276|11331914|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205145|NCT03487276|11331910|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205146|NCT03487276|11331911|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205147|NCT03487276|11331912|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
10205148|NCT03487276|11331913|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
10205149|NCT03487276|11331914|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205150|NCT03487276|11331910|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205151|NCT03487276|11331911|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205152|NCT03487276|11331912|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
10205153|NCT03487276|11331913|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
10205154|NCT03487276|11331914|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205155|NCT03487276|11331910|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205156|NCT03487276|11331911|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205157|NCT03487276|11331912|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
10205158|NCT03487276|11331913|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
10205159|NCT03487276|11331914|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205160|NCT03487276|11331910|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205161|NCT03487276|11331911|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205162|NCT03487276|11331912|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
10205163|NCT03487276|11331913|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
10205164|NCT03487276|11331914|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10205165|NCT03487276|11331910|FG000|COMPLETED|Extension Period (28 Weeks)||0
10205166|NCT03487276|11331911|FG001|COMPLETED|Extension Period (28 Weeks)||0
10205167|NCT03487276|11331912|FG002|COMPLETED|Extension Period (28 Weeks)||67
10205168|NCT03487276|11331913|FG003|COMPLETED|Extension Period (28 Weeks)||54
10205169|NCT03487276|11331914|FG004|COMPLETED|Extension Period (28 Weeks)||0
10205170|NCT03487276|11331910|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0
10205171|NCT03487276|11331911|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0
10205172|NCT03487276|11331912|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5
10205173|NCT03487276|11331913|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30
10205174|NCT03487276|11331914|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0
10205175|NCT03487445|11331937|FG000|STARTED|Randomization||25
10205176|NCT03487445|11331938|FG001|STARTED|Randomization||23
10205177|NCT03487445|11331937|FG000|COMPLETED|Randomization||24
10205178|NCT03487445|11331938|FG001|COMPLETED|Randomization||23
10205179|NCT03487445|11331937|FG000|NOT COMPLETED|Randomization||1
10205180|NCT03487445|11331938|FG001|NOT COMPLETED|Randomization||0
10205181|NCT03487445|11331937|FG000|STARTED|Treatment Period||24
10205182|NCT03487445|11331938|FG001|STARTED|Treatment Period||23
10205183|NCT03487445|11331937|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23
10205184|NCT03487445|11331938|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22
9916886|NCT01219855|11033708|FG001|NOT COMPLETED|Overall Study||5
9916887|NCT01219855|11033709|FG002|NOT COMPLETED|Overall Study||1
9916888|NCT01219855|11033710|FG003|NOT COMPLETED|Overall Study||1
9916889|NCT01219855|11033711|FG004|NOT COMPLETED|Overall Study||1
9916890|NCT01219881|11033724|FG000|STARTED|Overall Study||38
9916891|NCT01219881|11033725|FG001|STARTED|Overall Study||37
9916892|NCT01219881|11033724|FG000|COMPLETED|Overall Study||34
9916893|NCT01219881|11033725|FG001|COMPLETED|Overall Study||32
9916894|NCT01219881|11033724|FG000|NOT COMPLETED|Overall Study||4
10205185|NCT03487445|11331937|FG000|Per Protocol Set|Treatment Period||20
10205186|NCT03487445|11331938|FG001|Per Protocol Set|Treatment Period||20
10205187|NCT03487445|11331937|FG000|COMPLETED|Treatment Period||24
10205188|NCT03487445|11331938|FG001|COMPLETED|Treatment Period||23
10205189|NCT03487445|11331937|FG000|NOT COMPLETED|Treatment Period||0
10205190|NCT03487445|11331938|FG001|NOT COMPLETED|Treatment Period||0
10205191|NCT03487549|11331946|FG000|STARTED|Overall Study||21
10205192|NCT03487549|11331947|FG001|STARTED|Overall Study||35
10205193|NCT03487549|11331946|FG000|COMPLETED|Overall Study||17
10205194|NCT03487549|11331947|FG001|COMPLETED|Overall Study||33
10205195|NCT03487549|11331946|FG000|NOT COMPLETED|Overall Study||4
10205196|NCT03487549|11331947|FG001|NOT COMPLETED|Overall Study||2
10205197|NCT03487588|11331953|FG000|STARTED|Overall Study||41
10205198|NCT03487588|11331953|FG000|COMPLETED|Overall Study||41
10205199|NCT03487588|11331953|FG000|NOT COMPLETED|Overall Study||0
10205200|NCT03487718|11331959|FG000|STARTED|Overall Study||12
10205201|NCT03487718|11331960|FG001|STARTED|Overall Study||15
10205202|NCT03487718|11331959|FG000|COMPLETED|Overall Study||11
10205203|NCT03487718|11331960|FG001|COMPLETED|Overall Study||11
10205204|NCT03487718|11331959|FG000|NOT COMPLETED|Overall Study||1
10205205|NCT03487718|11331960|FG001|NOT COMPLETED|Overall Study||4
10205206|NCT03487848|11331966|FG000|STARTED|Overall Study||5
10205207|NCT03487848|11331966|FG000|COMPLETED|Overall Study||4
10205208|NCT03487848|11331966|FG000|NOT COMPLETED|Overall Study||1
10205209|NCT03488108|11331972|FG000|STARTED|First Intervention (12 Weeks)||10
10205210|NCT03488108|11331973|FG001|STARTED|First Intervention (12 Weeks)||10
10205211|NCT03488108|11331972|FG000|COMPLETED|First Intervention (12 Weeks)||10
10205212|NCT03488108|11331973|FG001|COMPLETED|First Intervention (12 Weeks)||9
10205213|NCT03488108|11331972|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10205214|NCT03488108|11331973|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10205215|NCT03488108|11331972|FG000|STARTED|Washout (2 Months)||10
10205216|NCT03488108|11331973|FG001|STARTED|Washout (2 Months)||9
10205217|NCT03488108|11331972|FG000|COMPLETED|Washout (2 Months)||10
10205218|NCT03488108|11331973|FG001|COMPLETED|Washout (2 Months)||9
10205219|NCT03488108|11331972|FG000|NOT COMPLETED|Washout (2 Months)||0
10205220|NCT03488108|11331973|FG001|NOT COMPLETED|Washout (2 Months)||0
10205221|NCT03488108|11331972|FG000|STARTED|Second Intervention (12 Weeks)||10
10205222|NCT03488108|11331973|FG001|STARTED|Second Intervention (12 Weeks)||9
10205223|NCT03488108|11331972|FG000|COMPLETED|Second Intervention (12 Weeks)||9
10205224|NCT03488108|11331973|FG001|COMPLETED|Second Intervention (12 Weeks)||9
10205225|NCT03488108|11331972|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
10205226|NCT03488108|11331973|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10205227|NCT03488225|11331981|FG000|STARTED|Overall Study||4
10205228|NCT03488225|11331981|FG000|COMPLETED|Overall Study||0
10205229|NCT03488225|11331981|FG000|NOT COMPLETED|Overall Study||4
10205230|NCT03488238|11331985|FG000|STARTED|Overall Study||31
10205231|NCT03488238|11331985|FG000|COMPLETED|Overall Study||29
10205232|NCT03488238|11331985|FG000|NOT COMPLETED|Overall Study||2
10205233|NCT03488849|11331992|FG000|STARTED|Overall Study||10
10205234|NCT03488849|11331993|FG001|STARTED|Overall Study||8
10205235|NCT03488849|11331994|FG002|STARTED|Overall Study||6
10205236|NCT03488849|11331992|FG000|COMPLETED|Overall Study||10
10205237|NCT03488849|11331993|FG001|COMPLETED|Overall Study||8
10205238|NCT03488849|11331994|FG002|COMPLETED|Overall Study||6
10205239|NCT03488849|11331992|FG000|NOT COMPLETED|Overall Study||0
10205240|NCT03488849|11331993|FG001|NOT COMPLETED|Overall Study||0
10205241|NCT03488849|11331994|FG002|NOT COMPLETED|Overall Study||0
10205242|NCT03488927|11332005|FG000|STARTED|Overall Study||305
10205243|NCT03488927|11332006|FG001|STARTED|Overall Study||432
10205244|NCT03488927|11332007|FG002|STARTED|Overall Study||531
10205245|NCT03488927|11332005|FG000|COMPLETED|Overall Study||261
10205246|NCT03488927|11332006|FG001|COMPLETED|Overall Study||314
10205247|NCT03488927|11332007|FG002|COMPLETED|Overall Study||314
10205248|NCT03488927|11332005|FG000|NOT COMPLETED|Overall Study||44
10205249|NCT03488927|11332006|FG001|NOT COMPLETED|Overall Study||118
10205250|NCT03488927|11332007|FG002|NOT COMPLETED|Overall Study||217
9916895|NCT01219881|11033725|FG001|NOT COMPLETED|Overall Study||5
9916896|NCT01219933|11033731|FG000|STARTED|Overall Study||68
10205251|NCT03489304|11332015|FG000|STARTED|Overall Study||20
10205252|NCT03489304|11332015|FG000|COMPLETED|Overall Study||16
9916897|NCT01219933|11033731|FG000|COMPLETED|Overall Study||30
10205253|NCT03489304|11332015|FG000|NOT COMPLETED|Overall Study||4
10205254|NCT03489343|11332026|FG000|STARTED|Overall Study||1
10205255|NCT03489343|11332027|FG001|STARTED|Overall Study||1
10205256|NCT03489343|11332028|FG002|STARTED|Overall Study||3
10205257|NCT03489343|11332029|FG003|STARTED|Overall Study||3
10205258|NCT03489343|11332030|FG004|STARTED|Overall Study||3
10205259|NCT03489343|11332031|FG005|STARTED|Overall Study||7
10205260|NCT03489343|11332032|FG006|STARTED|Overall Study||6
10205261|NCT03489343|11332026|FG000|COMPLETED|Overall Study||0
10205262|NCT03489343|11332027|FG001|COMPLETED|Overall Study||0
10205263|NCT03489343|11332028|FG002|COMPLETED|Overall Study||0
10205264|NCT03489343|11332029|FG003|COMPLETED|Overall Study||0
10205265|NCT03489343|11332030|FG004|COMPLETED|Overall Study||0
10205266|NCT03489343|11332031|FG005|COMPLETED|Overall Study||0
9916898|NCT01219933|11033731|FG000|NOT COMPLETED|Overall Study||38
9916899|NCT01219959|11033738|FG000|STARTED|Overall Study||127
9916900|NCT01219959|11033739|FG001|STARTED|Overall Study||124
9916901|NCT01219959|11033738|FG000|COMPLETED|Overall Study||120
9916902|NCT01219959|11033739|FG001|COMPLETED|Overall Study||101
9916903|NCT01219959|11033738|FG000|NOT COMPLETED|Overall Study||7
9916904|NCT01219959|11033739|FG001|NOT COMPLETED|Overall Study||23
9916905|NCT01219985|11033745|FG000|STARTED|Overall Study||50
9916906|NCT01219985|11033745|FG000|COMPLETED|Overall Study||30
9916907|NCT01219985|11033745|FG000|NOT COMPLETED|Overall Study||20
9916908|NCT01220024|11033753|FG000|STARTED|Overall Study||25
9916909|NCT01220024|11033754|FG001|STARTED|Overall Study||25
9916910|NCT01220024|11033753|FG000|COMPLETED|Overall Study||24
9916911|NCT01220024|11033754|FG001|COMPLETED|Overall Study||24
9916912|NCT01220024|11033753|FG000|NOT COMPLETED|Overall Study||1
9916913|NCT01220024|11033754|FG001|NOT COMPLETED|Overall Study||1
9916914|NCT01220128|11033767|FG000|STARTED|Overall Study||15
9916915|NCT01220128|11033768|FG001|STARTED|Overall Study||7
9916916|NCT01220128|11033769|FG002|STARTED|Overall Study||9
9916917|NCT01220128|11033770|FG003|STARTED|Overall Study||6
9916918|NCT01220128|11033771|FG004|STARTED|Overall Study||11
9916919|NCT01220128|11033772|FG005|STARTED|Overall Study||4
9916920|NCT01220128|11033773|FG006|STARTED|Overall Study||8
9916921|NCT01220128|11033767|FG000|COMPLETED|Overall Study||11
9916922|NCT01220128|11033768|FG001|COMPLETED|Overall Study||6
9916923|NCT01220128|11033769|FG002|COMPLETED|Overall Study||6
9916924|NCT01220128|11033770|FG003|COMPLETED|Overall Study||6
9916925|NCT01220128|11033771|FG004|COMPLETED|Overall Study||11
9916926|NCT01220128|11033772|FG005|COMPLETED|Overall Study||4
9916927|NCT01220128|11033773|FG006|COMPLETED|Overall Study||3
9916928|NCT01220128|11033767|FG000|NOT COMPLETED|Overall Study||4
9916929|NCT01220128|11033768|FG001|NOT COMPLETED|Overall Study||1
9916930|NCT01220128|11033769|FG002|NOT COMPLETED|Overall Study||3
9916931|NCT01220128|11033770|FG003|NOT COMPLETED|Overall Study||0
9916932|NCT01220128|11033771|FG004|NOT COMPLETED|Overall Study||0
9916933|NCT01220128|11033772|FG005|NOT COMPLETED|Overall Study||0
9916934|NCT01220128|11033773|FG006|NOT COMPLETED|Overall Study||5
9916935|NCT01220167|11033793|FG000|STARTED|Period 1||6
9916936|NCT01220167|11033794|FG001|STARTED|Period 1||6
9916937|NCT01220167|11033795|FG002|STARTED|Period 1||6
9916938|NCT01220167|11033793|FG000|COMPLETED|Period 1||6
9916939|NCT01220167|11033794|FG001|COMPLETED|Period 1||6
9916940|NCT01220167|11033795|FG002|COMPLETED|Period 1||6
9916941|NCT01220167|11033793|FG000|NOT COMPLETED|Period 1||0
9916942|NCT01220167|11033794|FG001|NOT COMPLETED|Period 1||0
9916943|NCT01220167|11033795|FG002|NOT COMPLETED|Period 1||0
9916944|NCT01220167|11033793|FG000|STARTED|Period 2||6
9916945|NCT01220167|11033794|FG001|STARTED|Period 2||6
9916946|NCT01220167|11033795|FG002|STARTED|Period 2||6
9916947|NCT01220167|11033793|FG000|COMPLETED|Period 2||6
9916948|NCT01220167|11033794|FG001|COMPLETED|Period 2||6
9916949|NCT01220167|11033795|FG002|COMPLETED|Period 2||6
9916950|NCT01220167|11033793|FG000|NOT COMPLETED|Period 2||0
9916951|NCT01220167|11033794|FG001|NOT COMPLETED|Period 2||0
9916952|NCT01220167|11033795|FG002|NOT COMPLETED|Period 2||0
9916953|NCT01220167|11033793|FG000|STARTED|Period 3||6
9916954|NCT01220167|11033794|FG001|STARTED|Period 3||6
9916955|NCT01220167|11033795|FG002|STARTED|Period 3||6
9916956|NCT01220167|11033793|FG000|COMPLETED|Period 3||6
9916957|NCT01220167|11033794|FG001|COMPLETED|Period 3||5
9916958|NCT01220167|11033795|FG002|COMPLETED|Period 3||6
9916959|NCT01220167|11033793|FG000|NOT COMPLETED|Period 3||0
9916960|NCT01220167|11033794|FG001|NOT COMPLETED|Period 3||1
9916961|NCT01220167|11033795|FG002|NOT COMPLETED|Period 3||0
9916962|NCT01220180|11033804|FG000|STARTED|Overall Study||4175
9916963|NCT01220180|11033804|FG000|Treated|Overall Study||4174
9916964|NCT01220180|11033804|FG000|COMPLETED|Overall Study||3968
9916965|NCT01220180|11033804|FG000|NOT COMPLETED|Overall Study||207
9916966|NCT01220297|11033810|FG000|STARTED|Overall Study||3
9916967|NCT01220297|11033810|FG000|COMPLETED|Overall Study||0
9916968|NCT01220297|11033810|FG000|NOT COMPLETED|Overall Study||3
9916969|NCT01220401|11033816|FG000|STARTED|Overall Study||21
9916970|NCT01220401|11033816|FG000|COMPLETED|Overall Study||18
9916971|NCT01220401|11033816|FG000|NOT COMPLETED|Overall Study||3
9955655|NCT01439945|11074665|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
9955656|NCT01439945|11074666|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2
9955657|NCT01439945|11074663|FG000|STARTED|Optional Continuation Phase||72
9955658|NCT01439945|11074664|FG001|STARTED|Optional Continuation Phase||44
9955659|NCT01439945|11074665|FG002|STARTED|Optional Continuation Phase||0
9955660|NCT01439945|11074666|FG003|STARTED|Optional Continuation Phase||0
9955661|NCT01439945|11074663|FG000|COMPLETED|Optional Continuation Phase||72
9955662|NCT01439945|11074664|FG001|COMPLETED|Optional Continuation Phase||44
9955663|NCT01439945|11074665|FG002|COMPLETED|Optional Continuation Phase||0
9955664|NCT01439945|11074666|FG003|COMPLETED|Optional Continuation Phase||0
9955665|NCT01439945|11074663|FG000|NOT COMPLETED|Optional Continuation Phase||0
9955666|NCT01439945|11074664|FG001|NOT COMPLETED|Optional Continuation Phase||0
9955667|NCT01439945|11074665|FG002|NOT COMPLETED|Optional Continuation Phase||0
9955668|NCT01439945|11074666|FG003|NOT COMPLETED|Optional Continuation Phase||0
9955669|NCT01439971|11074682|FG000|STARTED|Overall Study||1
9955670|NCT01439971|11074683|FG001|STARTED|Overall Study||7
9955671|NCT01439971|11074684|FG002|STARTED|Overall Study||8
9955672|NCT01439971|11074685|FG003|STARTED|Overall Study||6
9955673|NCT01439971|11074686|FG004|STARTED|Overall Study||7
9916972|NCT01220414|11033822|FG000|STARTED|Overall Study||15
9916973|NCT01220414|11033823|FG001|STARTED|Overall Study||14
9916974|NCT01220414|11033824|FG002|STARTED|Overall Study||14
9916975|NCT01220414|11033825|FG003|STARTED|Overall Study||15
9916976|NCT01220414|11033822|FG000|COMPLETED|Overall Study||14
9916977|NCT01220414|11033823|FG001|COMPLETED|Overall Study||14
9916978|NCT01220414|11033824|FG002|COMPLETED|Overall Study||14
9916979|NCT01220414|11033825|FG003|COMPLETED|Overall Study||14
9916980|NCT01220414|11033822|FG000|NOT COMPLETED|Overall Study||1
9916981|NCT01220414|11033823|FG001|NOT COMPLETED|Overall Study||0
9916982|NCT01220414|11033824|FG002|NOT COMPLETED|Overall Study||0
9916983|NCT01220414|11033825|FG003|NOT COMPLETED|Overall Study||1
9916984|NCT01220466|11033835|FG000|STARTED|Overall Study|19 eyes|11
9916985|NCT01220466|11033836|FG001|STARTED|Overall Study|108 eyes|56
9916986|NCT01220466|11033837|FG002|STARTED|Overall Study|16 eyes|10
9916987|NCT01220466|11033835|FG000|COMPLETED|Overall Study|19 eyes|11
9916988|NCT01220466|11033836|FG001|COMPLETED|Overall Study|108 eyes|56
9916989|NCT01220466|11033837|FG002|COMPLETED|Overall Study|16 eyes|10
9916990|NCT01220466|11033835|FG000|NOT COMPLETED|Overall Study||0
9916991|NCT01220466|11033836|FG001|NOT COMPLETED|Overall Study||0
9916992|NCT01220466|11033837|FG002|NOT COMPLETED|Overall Study||0
10010323|NCT01773421|11133122|FG002|STARTED|Treatment Phase||19
10010324|NCT01773421|11133123|FG003|STARTED|Treatment Phase||7
10010325|NCT01773421|11133124|FG004|STARTED|Treatment Phase||0
10010326|NCT01773421|11133125|FG005|STARTED|Treatment Phase||0
10010327|NCT01773421|11133126|FG006|STARTED|Treatment Phase||0
10010328|NCT01773421|11133120|FG000|COMPLETED|Treatment Phase||7
10010329|NCT01773421|11133121|FG001|COMPLETED|Treatment Phase||8
10010330|NCT01773421|11133122|FG002|COMPLETED|Treatment Phase||13
10010331|NCT01773421|11133123|FG003|COMPLETED|Treatment Phase||5
9916993|NCT01220557|11033847|FG000|STARTED|Overall Study||81
9916994|NCT01220557|11033848|FG001|STARTED|Overall Study||79
9916995|NCT01220557|11033847|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
9916996|NCT01220557|11033848|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
9916997|NCT01220557|11033847|FG000|NOT COMPLETED|Overall Study||6
9916998|NCT01220557|11033848|FG001|NOT COMPLETED|Overall Study||5
9916999|NCT01220609|11033854|FG000|STARTED|Overall Study||26
9917000|NCT01220609|11033854|FG000|COMPLETED|Overall Study|Eligible and treated patients|23
9917001|NCT01220609|11033854|FG000|NOT COMPLETED|Overall Study||3
9917002|NCT01220687|11033866|FG000|STARTED|Overall Study||16
9917003|NCT01220687|11033867|FG001|STARTED|Overall Study||15
9917004|NCT01220687|11033866|FG000|COMPLETED|Overall Study||14
9917005|NCT01220687|11033867|FG001|COMPLETED|Overall Study||14
9917006|NCT01220687|11033866|FG000|NOT COMPLETED|Overall Study||2
9917007|NCT01220687|11033867|FG001|NOT COMPLETED|Overall Study||1
9917008|NCT01220726|11033875|FG000|STARTED|Overall Study||15
9917009|NCT01220726|11033876|FG001|STARTED|Overall Study||15
9917010|NCT01220726|11033875|FG000|COMPLETED|Overall Study||15
9917011|NCT01220726|11033876|FG001|COMPLETED|Overall Study||13
9917012|NCT01220726|11033875|FG000|NOT COMPLETED|Overall Study||0
9917013|NCT01220726|11033876|FG001|NOT COMPLETED|Overall Study||2
9917014|NCT01220739|11033884|FG000|STARTED|Overall Study||7
9917015|NCT01220739|11033885|FG001|STARTED|Overall Study||5
9917016|NCT01220739|11033884|FG000|COMPLETED|Overall Study||7
9917017|NCT01220739|11033885|FG001|COMPLETED|Overall Study||5
9917018|NCT01220739|11033884|FG000|NOT COMPLETED|Overall Study||0
9917019|NCT01220739|11033885|FG001|NOT COMPLETED|Overall Study||0
9917020|NCT01220856|11033893|FG000|STARTED|Overall Study||6
9917021|NCT01220856|11033894|FG001|STARTED|Overall Study||3
9917022|NCT01220856|11033893|FG000|COMPLETED|Overall Study||2
9917023|NCT01220856|11033894|FG001|COMPLETED|Overall Study||0
9917024|NCT01220856|11033893|FG000|NOT COMPLETED|Overall Study||4
9917025|NCT01220856|11033894|FG001|NOT COMPLETED|Overall Study||3
9917026|NCT01220869|11033903|FG000|STARTED|Overall Study||110
9917027|NCT01220869|11033903|FG000|COMPLETED|Overall Study||104
9917028|NCT01220869|11033903|FG000|NOT COMPLETED|Overall Study||6
9917029|NCT01220973|11033907|FG000|STARTED|Overall Study||27
9917030|NCT01220973|11033907|FG000|COMPLETED|Overall Study||23
9917031|NCT01220973|11033907|FG000|NOT COMPLETED|Overall Study||4
9917032|NCT01220999|11033916|FG000|STARTED|Overall Study||2
9917033|NCT01220999|11033917|FG001|STARTED|Overall Study||4
9917034|NCT01220999|11033918|FG002|STARTED|Overall Study||5
9917035|NCT01220999|11033919|FG003|STARTED|Overall Study||3
9917036|NCT01220999|11033920|FG004|STARTED|Overall Study||5
9917037|NCT01220999|11033916|FG000|COMPLETED|Overall Study||2
9917038|NCT01220999|11033917|FG001|COMPLETED|Overall Study||4
9917039|NCT01220999|11033918|FG002|COMPLETED|Overall Study||4
9917040|NCT01220999|11033919|FG003|COMPLETED|Overall Study||3
9917041|NCT01220999|11033920|FG004|COMPLETED|Overall Study||5
9917042|NCT01220999|11033916|FG000|NOT COMPLETED|Overall Study||0
9917043|NCT01220999|11033917|FG001|NOT COMPLETED|Overall Study||0
9917044|NCT01220999|11033918|FG002|NOT COMPLETED|Overall Study||1
9917045|NCT01220999|11033919|FG003|NOT COMPLETED|Overall Study||0
9917046|NCT01220999|11033920|FG004|NOT COMPLETED|Overall Study||0
9917047|NCT01221090|11033936|FG000|STARTED|Overall Study||101
9917048|NCT01221090|11033937|FG001|STARTED|Overall Study||81
10010332|NCT01773421|11133124|FG004|COMPLETED|Treatment Phase||0
9917049|NCT01221090|11033938|FG002|STARTED|Overall Study||99
10010333|NCT01773421|11133125|FG005|COMPLETED|Treatment Phase||0
10010334|NCT01773421|11133126|FG006|COMPLETED|Treatment Phase||0
10010335|NCT01773421|11133120|FG000|NOT COMPLETED|Treatment Phase||0
9917050|NCT01221090|11033939|FG003|STARTED|Overall Study||95
9917051|NCT01221090|11033936|FG000|COMPLETED|Overall Study||86
9917052|NCT01221090|11033937|FG001|COMPLETED|Overall Study||47
9917053|NCT01221090|11033938|FG002|COMPLETED|Overall Study||57
9917054|NCT01221090|11033939|FG003|COMPLETED|Overall Study||73
9917055|NCT01221090|11033936|FG000|NOT COMPLETED|Overall Study||15
9917056|NCT01221090|11033937|FG001|NOT COMPLETED|Overall Study||34
9917057|NCT01221090|11033938|FG002|NOT COMPLETED|Overall Study||42
9917058|NCT01221090|11033939|FG003|NOT COMPLETED|Overall Study||22
9917059|NCT01221181|11033949|FG000|STARTED|Overall Study||6
9917060|NCT01221181|11033949|FG000|COMPLETED|Overall Study||5
9917061|NCT01221181|11033949|FG000|NOT COMPLETED|Overall Study||1
9917062|NCT01221194|11033955|FG000|STARTED|Overall Study||195
9917063|NCT01221194|11033956|FG001|STARTED|Overall Study||186
9917064|NCT01221194|11033955|FG000|COMPLETED|Overall Study||195
9917065|NCT01221194|11033956|FG001|COMPLETED|Overall Study||186
9917066|NCT01221194|11033955|FG000|NOT COMPLETED|Overall Study||0
9917067|NCT01221194|11033956|FG001|NOT COMPLETED|Overall Study||0
9917068|NCT01221207|11033965|FG000|STARTED|Overall Study||75
9917069|NCT01221207|11033966|FG001|STARTED|Overall Study||75
9917070|NCT01221207|11033967|FG002|STARTED|Overall Study||75
9917071|NCT01221207|11033965|FG000|COMPLETED|Overall Study||43
9917072|NCT01221207|11033966|FG001|COMPLETED|Overall Study||66
9917073|NCT01221207|11033967|FG002|COMPLETED|Overall Study||54
9917074|NCT01221207|11033965|FG000|NOT COMPLETED|Overall Study||32
9917075|NCT01221207|11033966|FG001|NOT COMPLETED|Overall Study||9
9917076|NCT01221207|11033967|FG002|NOT COMPLETED|Overall Study||21
9917077|NCT01221233|11033977|FG000|STARTED|Overall Study||18
9917078|NCT01221233|11033978|FG001|STARTED|Overall Study||20
9917079|NCT01221233|11033977|FG000|COMPLETED|Overall Study||15
9917080|NCT01221233|11033978|FG001|COMPLETED|Overall Study||19
9917081|NCT01221233|11033977|FG000|NOT COMPLETED|Overall Study||3
9917082|NCT01221233|11033978|FG001|NOT COMPLETED|Overall Study||1
9917083|NCT01221272|11033984|FG000|STARTED|Period 1||41
9917084|NCT01221272|11033985|FG001|STARTED|Period 1||40
9917085|NCT01221272|11033984|FG000|COMPLETED|Period 1||39
9917086|NCT01221272|11033985|FG001|COMPLETED|Period 1||38
9917087|NCT01221272|11033984|FG000|NOT COMPLETED|Period 1||2
9917088|NCT01221272|11033985|FG001|NOT COMPLETED|Period 1||2
9917089|NCT01221272|11033984|FG000|STARTED|Period 2||39
9917090|NCT01221272|11033985|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
9917091|NCT01221272|11033984|FG000|COMPLETED|Period 2||39
9917092|NCT01221272|11033985|FG001|COMPLETED|Period 2||37
9917093|NCT01221272|11033984|FG000|NOT COMPLETED|Period 2||0
9917094|NCT01221272|11033985|FG001|NOT COMPLETED|Period 2||2
9917095|NCT01221285|11033994|FG000|STARTED|Overall Study||11
9917096|NCT01221285|11033994|FG000|COMPLETED|Overall Study||10
9917097|NCT01221285|11033994|FG000|NOT COMPLETED|Overall Study||1
9917098|NCT01221298|11033998|FG000|STARTED|Overall Study||11
9917099|NCT01221298|11033998|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11
9917100|NCT01221298|11033998|FG000|NOT COMPLETED|Overall Study||0
9917101|NCT01221311|11034004|FG000|STARTED|Overall Study||57
9917102|NCT01221311|11034005|FG001|STARTED|Overall Study||55
9917103|NCT01221311|11034004|FG000|COMPLETED|Overall Study||57
9917104|NCT01221311|11034005|FG001|COMPLETED|Overall Study||55
9917105|NCT01221311|11034004|FG000|NOT COMPLETED|Overall Study||0
9917106|NCT01221311|11034005|FG001|NOT COMPLETED|Overall Study||0
9917107|NCT01221350|11034013|FG000|STARTED|Overall Study||28
9917108|NCT01221350|11034014|FG001|STARTED|Overall Study||27
9917109|NCT01221350|11034013|FG000|Received Intervention|Overall Study||28
9917110|NCT01221350|11034014|FG001|Received Intervention|Overall Study||27
9917111|NCT01221350|11034013|FG000|Analysis Population|Overall Study||23
9917112|NCT01221350|11034014|FG001|Analysis Population|Overall Study||24
9917113|NCT01221350|11034013|FG000|COMPLETED|Overall Study||23
9917114|NCT01221350|11034014|FG001|COMPLETED|Overall Study||24
9917115|NCT01221350|11034013|FG000|NOT COMPLETED|Overall Study||5
9917116|NCT01221350|11034014|FG001|NOT COMPLETED|Overall Study||3
9917117|NCT01221363|11034024|FG000|STARTED|Overall Study||93
9917118|NCT01221363|11034025|FG001|STARTED|Overall Study||73
9917119|NCT01221363|11034024|FG000|COMPLETED|Overall Study||81
9917120|NCT01221363|11034025|FG001|COMPLETED|Overall Study||68
10205267|NCT03489343|11332032|FG006|COMPLETED|Overall Study||0
10205268|NCT03489343|11332026|FG000|NOT COMPLETED|Overall Study||1
10205269|NCT03489343|11332027|FG001|NOT COMPLETED|Overall Study||1
10205270|NCT03489343|11332028|FG002|NOT COMPLETED|Overall Study||3
9917121|NCT01221363|11034024|FG000|NOT COMPLETED|Overall Study||12
9917122|NCT01221363|11034025|FG001|NOT COMPLETED|Overall Study||5
9917123|NCT01221441|11034033|FG000|STARTED|Overall Study||67
9917124|NCT01221441|11034034|FG001|STARTED|Overall Study||35
9917125|NCT01221441|11034033|FG000|COMPLETED|Overall Study||45
9917126|NCT01221441|11034034|FG001|COMPLETED|Overall Study||23
9917127|NCT01221441|11034033|FG000|NOT COMPLETED|Overall Study||22
9917128|NCT01221441|11034034|FG001|NOT COMPLETED|Overall Study||12
9917129|NCT01221597|11034042|FG000|STARTED|Overall Study||277
9917130|NCT01221597|11034043|FG001|STARTED|Overall Study||140
9917131|NCT01221597|11034042|FG000|COMPLETED|Overall Study||241
9917132|NCT01221597|11034043|FG001|COMPLETED|Overall Study||124
9917133|NCT01221597|11034042|FG000|NOT COMPLETED|Overall Study||36
9917134|NCT01221597|11034043|FG001|NOT COMPLETED|Overall Study||16
9917135|NCT01221623|11034052|FG000|STARTED|Overall Study||274
10205271|NCT03489343|11332029|FG003|NOT COMPLETED|Overall Study||3
10205272|NCT03489343|11332030|FG004|NOT COMPLETED|Overall Study||3
10010336|NCT01773421|11133121|FG001|NOT COMPLETED|Treatment Phase||0
10010337|NCT01773421|11133122|FG002|NOT COMPLETED|Treatment Phase||6
10010338|NCT01773421|11133123|FG003|NOT COMPLETED|Treatment Phase||2
9917136|NCT01221623|11034053|FG001|STARTED|Overall Study||141
9917137|NCT01221623|11034052|FG000|COMPLETED|Overall Study||236
9917138|NCT01221623|11034053|FG001|COMPLETED|Overall Study||127
9917139|NCT01221623|11034052|FG000|NOT COMPLETED|Overall Study||38
9917140|NCT01221623|11034053|FG001|NOT COMPLETED|Overall Study||14
9917141|NCT01221727|11034061|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21
9917142|NCT01221727|11034062|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9
9917143|NCT01221727|11034061|FG000|Treated|Overall Study|Number of subjects received investigational product|19
9917144|NCT01221727|11034062|FG001|Treated|Overall Study|Number of subjects received investigational product|8
9917145|NCT01221727|11034061|FG000|COMPLETED|Overall Study||18
9917146|NCT01221727|11034062|FG001|COMPLETED|Overall Study||8
9917147|NCT01221727|11034061|FG000|NOT COMPLETED|Overall Study||3
9917148|NCT01221727|11034062|FG001|NOT COMPLETED|Overall Study||1
9917149|NCT01221753|11034074|FG000|STARTED|Overall Study||7
9917150|NCT01221753|11034074|FG000|COMPLETED|Overall Study||6
9917151|NCT01221753|11034074|FG000|NOT COMPLETED|Overall Study||1
9917152|NCT01221857|11034078|FG000|STARTED|Overall Study||12
9917153|NCT01221857|11034078|FG000|COMPLETED|Overall Study||12
9917154|NCT01221857|11034078|FG000|NOT COMPLETED|Overall Study||0
9917155|NCT01221948|11034086|FG000|STARTED|Overall Study||53
9917156|NCT01221948|11034086|FG000|COMPLETED|Overall Study||39
10010339|NCT01773421|11133124|FG004|NOT COMPLETED|Treatment Phase||0
10010340|NCT01773421|11133125|FG005|NOT COMPLETED|Treatment Phase||0
10010341|NCT01773421|11133126|FG006|NOT COMPLETED|Treatment Phase||0
10010342|NCT01773421|11133120|FG000|STARTED|Extension Phase||0
10010343|NCT01773421|11133121|FG001|STARTED|Extension Phase||0
10010344|NCT01773421|11133122|FG002|STARTED|Extension Phase||0
10010345|NCT01773421|11133123|FG003|STARTED|Extension Phase||0
10010346|NCT01773421|11133124|FG004|STARTED|Extension Phase||15
10010347|NCT01773421|11133125|FG005|STARTED|Extension Phase||3
10010348|NCT01773421|11133126|FG006|STARTED|Extension Phase||0
10010349|NCT01773421|11133120|FG000|COMPLETED|Extension Phase||0
10010350|NCT01773421|11133121|FG001|COMPLETED|Extension Phase||0
10010351|NCT01773421|11133122|FG002|COMPLETED|Extension Phase||0
10010352|NCT01773421|11133123|FG003|COMPLETED|Extension Phase||0
10010353|NCT01773421|11133124|FG004|COMPLETED|Extension Phase||12
10010354|NCT01773421|11133125|FG005|COMPLETED|Extension Phase||1
10010355|NCT01773421|11133126|FG006|COMPLETED|Extension Phase||0
10010356|NCT01773421|11133120|FG000|NOT COMPLETED|Extension Phase||0
10010357|NCT01773421|11133121|FG001|NOT COMPLETED|Extension Phase||0
10010358|NCT01773421|11133122|FG002|NOT COMPLETED|Extension Phase||0
10010359|NCT01773421|11133123|FG003|NOT COMPLETED|Extension Phase||0
10010360|NCT01773421|11133124|FG004|NOT COMPLETED|Extension Phase||3
10010361|NCT01773421|11133125|FG005|NOT COMPLETED|Extension Phase||2
10010362|NCT01773421|11133126|FG006|NOT COMPLETED|Extension Phase||0
10010363|NCT01773473|11133144|FG000|STARTED|Overall Study||207
10010364|NCT01773473|11133145|FG001|STARTED|Overall Study||196
10010365|NCT01773473|11133144|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207
10010366|NCT01773473|11133145|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
10010367|NCT01773473|11133144|FG000|COMPLETED|Overall Study||191
10205273|NCT03489343|11332031|FG005|NOT COMPLETED|Overall Study||7
9917157|NCT01221948|11034086|FG000|NOT COMPLETED|Overall Study||14
9917158|NCT01222078|11034090|FG000|STARTED|Overall Study||1
9917159|NCT01222078|11034090|FG000|COMPLETED|Overall Study||0
9917160|NCT01222078|11034090|FG000|NOT COMPLETED|Overall Study||1
9917161|NCT01222091|11034095|FG000|STARTED|Overall Study||5
9917162|NCT01222091|11034096|FG001|STARTED|Overall Study||5
9917163|NCT01222091|11034095|FG000|COMPLETED|Overall Study||5
9917164|NCT01222091|11034096|FG001|COMPLETED|Overall Study||5
10205274|NCT03489343|11332032|FG006|NOT COMPLETED|Overall Study||6
9917165|NCT01222091|11034095|FG000|NOT COMPLETED|Overall Study||0
9917166|NCT01222091|11034096|FG001|NOT COMPLETED|Overall Study||0
9917167|NCT01222104|11034102|FG000|STARTED|Overall Study||634
9917168|NCT01222104|11034102|FG000|Angio-Seal Deployment Attempted|Overall Study||534
9917169|NCT01222104|11034102|FG000|Successful Deployment|Overall Study||529
9917170|NCT01222104|11034102|FG000|Successful Deployment and Hemostasis|Overall Study||524
9917171|NCT01222104|11034102|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497
9917172|NCT01222104|11034102|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90
9917173|NCT01222104|11034102|FG000|COMPLETED|Overall Study||587
9917174|NCT01222104|11034102|FG000|NOT COMPLETED|Overall Study||47
9917175|NCT01222117|11034123|FG000|STARTED|Overall Study||20
9917176|NCT01222117|11034124|FG001|STARTED|Overall Study||20
9917177|NCT01222117|11034125|FG002|STARTED|Overall Study||22
9917178|NCT01222117|11034126|FG003|STARTED|Overall Study||20
9917179|NCT01222117|11034127|FG004|STARTED|Overall Study||9
9917180|NCT01222117|11034128|FG005|STARTED|Overall Study||10
9917181|NCT01222117|11034129|FG006|STARTED|Overall Study||13
9917182|NCT01222117|11034130|FG007|STARTED|Overall Study||12
10205275|NCT03489369|11332052|FG000|STARTED|Overall Study||3
9917183|NCT01222117|11034131|FG008|STARTED|Overall Study||23
9917184|NCT01222117|11034132|FG009|STARTED|Overall Study||19
10010368|NCT01773473|11133145|FG001|COMPLETED|Overall Study||177
10010369|NCT01773473|11133144|FG000|NOT COMPLETED|Overall Study||16
10010370|NCT01773473|11133145|FG001|NOT COMPLETED|Overall Study||19
10010371|NCT01773889|11133151|FG000|STARTED|Overall Study||2
10010372|NCT01773889|11133151|FG000|COMPLETED|Overall Study||0
10205276|NCT03489369|11332053|FG001|STARTED|Overall Study||3
10205277|NCT03489369|11332054|FG002|STARTED|Overall Study||3
10205278|NCT03489369|11332055|FG003|STARTED|Overall Study||6
10205279|NCT03489369|11332052|FG000|COMPLETED|Overall Study||0
10205280|NCT03489369|11332053|FG001|COMPLETED|Overall Study||0
9917185|NCT01222117|11034133|FG010|STARTED|Overall Study||6
9917186|NCT01222117|11034123|FG000|COMPLETED|Overall Study||17
9917187|NCT01222117|11034124|FG001|COMPLETED|Overall Study||19
9917188|NCT01222117|11034125|FG002|COMPLETED|Overall Study||22
9917189|NCT01222117|11034126|FG003|COMPLETED|Overall Study||19
9917190|NCT01222117|11034127|FG004|COMPLETED|Overall Study||8
9917191|NCT01222117|11034128|FG005|COMPLETED|Overall Study||9
9917192|NCT01222117|11034129|FG006|COMPLETED|Overall Study||13
9917193|NCT01222117|11034130|FG007|COMPLETED|Overall Study||12
9917194|NCT01222117|11034131|FG008|COMPLETED|Overall Study||20
9917195|NCT01222117|11034132|FG009|COMPLETED|Overall Study||17
9917196|NCT01222117|11034133|FG010|COMPLETED|Overall Study||6
9917197|NCT01222117|11034123|FG000|NOT COMPLETED|Overall Study||3
9917198|NCT01222117|11034124|FG001|NOT COMPLETED|Overall Study||1
9917199|NCT01222117|11034125|FG002|NOT COMPLETED|Overall Study||0
9917200|NCT01222117|11034126|FG003|NOT COMPLETED|Overall Study||1
9917201|NCT01222117|11034127|FG004|NOT COMPLETED|Overall Study||1
9917202|NCT01222117|11034128|FG005|NOT COMPLETED|Overall Study||1
9917203|NCT01222117|11034129|FG006|NOT COMPLETED|Overall Study||0
9917204|NCT01222117|11034130|FG007|NOT COMPLETED|Overall Study||0
9917205|NCT01222117|11034131|FG008|NOT COMPLETED|Overall Study||3
9917206|NCT01222117|11034132|FG009|NOT COMPLETED|Overall Study||2
9917207|NCT01222117|11034133|FG010|NOT COMPLETED|Overall Study||0
9917208|NCT01222195|11034157|FG000|STARTED|Overall Study||1
9917209|NCT01222195|11034157|FG000|COMPLETED|Overall Study||1
9917210|NCT01222195|11034157|FG000|NOT COMPLETED|Overall Study||0
9917211|NCT01222234|11034164|FG000|STARTED|Overall Study||15
9917212|NCT01222234|11034165|FG001|STARTED|Overall Study||17
9917213|NCT01222234|11034166|FG002|STARTED|Overall Study||24
9917214|NCT01222234|11034164|FG000|COMPLETED|Overall Study||15
9917215|NCT01222234|11034165|FG001|COMPLETED|Overall Study||15
9917216|NCT01222234|11034166|FG002|COMPLETED|Overall Study||22
9917217|NCT01222234|11034164|FG000|NOT COMPLETED|Overall Study||0
9917218|NCT01222234|11034165|FG001|NOT COMPLETED|Overall Study||2
9917219|NCT01222234|11034166|FG002|NOT COMPLETED|Overall Study||2
9917220|NCT01222260|11034175|FG000|STARTED|Overall Study||31
9917221|NCT01222260|11034175|FG000|COMPLETED|Overall Study||29
9917222|NCT01222260|11034175|FG000|NOT COMPLETED|Overall Study||2
9917223|NCT01222273|11034179|FG000|STARTED|Overall Study||7
9917224|NCT01222273|11034179|FG000|COMPLETED|Overall Study||7
9917225|NCT01222273|11034179|FG000|NOT COMPLETED|Overall Study||0
9917226|NCT01222286|11034185|FG000|STARTED|Overall Study||16
9917227|NCT01222286|11034186|FG001|STARTED|Overall Study||14
9917228|NCT01222286|11034185|FG000|COMPLETED|Overall Study||16
9917229|NCT01222286|11034186|FG001|COMPLETED|Overall Study||14
9917230|NCT01222286|11034185|FG000|NOT COMPLETED|Overall Study||0
9917231|NCT01222286|11034186|FG001|NOT COMPLETED|Overall Study||0
9917232|NCT01222299|11034196|FG000|STARTED|Overall Study||21
9917233|NCT01222299|11034197|FG001|STARTED|Overall Study||23
9917234|NCT01222299|11034198|FG002|STARTED|Overall Study||22
9917235|NCT01222299|11034199|FG003|STARTED|Overall Study||23
9917236|NCT01222299|11034196|FG000|COMPLETED|Overall Study||21
9917237|NCT01222299|11034197|FG001|COMPLETED|Overall Study||21
9917238|NCT01222299|11034198|FG002|COMPLETED|Overall Study||20
9917239|NCT01222299|11034199|FG003|COMPLETED|Overall Study||18
9917240|NCT01222299|11034196|FG000|NOT COMPLETED|Overall Study||0
9917241|NCT01222299|11034197|FG001|NOT COMPLETED|Overall Study||2
9917242|NCT01222299|11034198|FG002|NOT COMPLETED|Overall Study||2
9917243|NCT01222299|11034199|FG003|NOT COMPLETED|Overall Study||5
9917244|NCT01222390|11034209|FG000|STARTED|Overall Study||12
9917245|NCT01222390|11034209|FG000|COMPLETED|Overall Study||12
9917246|NCT01222390|11034209|FG000|NOT COMPLETED|Overall Study||0
9917247|NCT01222403|11034215|FG000|STARTED|Overall Study||386
9917248|NCT01222403|11034216|FG001|STARTED|Overall Study||381
9917249|NCT01222403|11034215|FG000|COMPLETED|Overall Study||386
9917250|NCT01222403|11034216|FG001|COMPLETED|Overall Study||379
9917251|NCT01222403|11034215|FG000|NOT COMPLETED|Overall Study||0
9917252|NCT01222403|11034216|FG001|NOT COMPLETED|Overall Study||2
9917253|NCT01222416|11034224|FG000|STARTED|Overall Study||50
9917254|NCT01222416|11034225|FG001|STARTED|Overall Study||0
9917255|NCT01222416|11034224|FG000|COMPLETED|Overall Study||30
9917256|NCT01222416|11034225|FG001|COMPLETED|Overall Study||0
9917257|NCT01222416|11034224|FG000|NOT COMPLETED|Overall Study||20
9917258|NCT01222416|11034225|FG001|NOT COMPLETED|Overall Study||0
9917259|NCT01222494|11034234|FG000|STARTED|Overall Study||7
9917260|NCT01222494|11034235|FG001|STARTED|Overall Study||19
10205281|NCT03489369|11332054|FG002|COMPLETED|Overall Study||0
10205282|NCT03489369|11332055|FG003|COMPLETED|Overall Study||0
9917261|NCT01222494|11034236|FG002|STARTED|Overall Study||21
9917262|NCT01222494|11034234|FG000|COMPLETED|Overall Study||6
9917263|NCT01222494|11034235|FG001|COMPLETED|Overall Study||15
9917264|NCT01222494|11034236|FG002|COMPLETED|Overall Study||17
9917265|NCT01222494|11034234|FG000|NOT COMPLETED|Overall Study||1
9917266|NCT01222494|11034235|FG001|NOT COMPLETED|Overall Study||4
9917267|NCT01222494|11034236|FG002|NOT COMPLETED|Overall Study||4
9917268|NCT01222507|11034244|FG000|STARTED|Overall Study||62
9917269|NCT01222507|11034244|FG000|COMPLETED|Overall Study||60
10205283|NCT03489369|11332052|FG000|NOT COMPLETED|Overall Study||3
10205284|NCT03489369|11332053|FG001|NOT COMPLETED|Overall Study||3
9917270|NCT01222507|11034244|FG000|NOT COMPLETED|Overall Study||2
9917271|NCT01222520|11034250|FG000|STARTED|Open-label run-in Period||0
9917272|NCT01222520|11034251|FG001|STARTED|Open-label run-in Period||197
9917273|NCT01222520|11034250|FG000|COMPLETED|Open-label run-in Period||0
9917274|NCT01222520|11034251|FG001|COMPLETED|Open-label run-in Period||174
9917275|NCT01222520|11034250|FG000|NOT COMPLETED|Open-label run-in Period||0
9917276|NCT01222520|11034251|FG001|NOT COMPLETED|Open-label run-in Period||23
9917277|NCT01222520|11034250|FG000|STARTED|Double-blind Period||87
9917278|NCT01222520|11034251|FG001|STARTED|Double-blind Period||87
9917279|NCT01222520|11034250|FG000|COMPLETED|Double-blind Period||86
9917280|NCT01222520|11034251|FG001|COMPLETED|Double-blind Period||85
9917281|NCT01222520|11034250|FG000|NOT COMPLETED|Double-blind Period||1
9917282|NCT01222520|11034251|FG001|NOT COMPLETED|Double-blind Period||2
9917283|NCT01222533|11034257|FG000|STARTED|Overall Study|Entered and treated.|154
9917284|NCT01222533|11034257|FG000|Received Placebo|Overall Study||147
9917285|NCT01222533|11034257|FG000|Received Tio R1.25|Overall Study||147
9917286|NCT01222533|11034257|FG000|Received Tio R2.5|Overall Study||145
9917287|NCT01222533|11034257|FG000|Received Tio R5|Overall Study||150
9917288|NCT01222533|11034257|FG000|Received Tio HH18|Overall Study||146
9917289|NCT01222533|11034257|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
9917290|NCT01222533|11034257|FG000|NOT COMPLETED|Overall Study||14
9917291|NCT01222572|11034269|FG000|STARTED|Overall Study||1
9917292|NCT01222572|11034270|FG001|STARTED|Overall Study||0
9917293|NCT01222572|11034271|FG002|STARTED|Overall Study||0
9917294|NCT01222572|11034269|FG000|COMPLETED|Overall Study||1
9917295|NCT01222572|11034270|FG001|COMPLETED|Overall Study||0
9917296|NCT01222572|11034271|FG002|COMPLETED|Overall Study||0
9917297|NCT01222572|11034269|FG000|NOT COMPLETED|Overall Study||0
9917298|NCT01222572|11034270|FG001|NOT COMPLETED|Overall Study||0
9917299|NCT01222572|11034271|FG002|NOT COMPLETED|Overall Study||0
9917300|NCT01222585|11034275|FG000|STARTED|Overall Study||24
9917301|NCT01222585|11034275|FG000|COMPLETED|Overall Study||24
9917302|NCT01222585|11034275|FG000|NOT COMPLETED|Overall Study||0
9917303|NCT01222689|11034279|FG000|STARTED|Overall Study||46
9917304|NCT01222689|11034279|FG000|COMPLETED|Overall Study||46
9917305|NCT01222689|11034279|FG000|NOT COMPLETED|Overall Study||0
9917306|NCT01222715|11034285|FG000|STARTED|Overall Study||44
9917307|NCT01222715|11034286|FG001|STARTED|Overall Study||43
9917308|NCT01222715|11034285|FG000|COMPLETED|Overall Study||8
9917309|NCT01222715|11034286|FG001|COMPLETED|Overall Study||16
9917310|NCT01222715|11034285|FG000|NOT COMPLETED|Overall Study||36
9917311|NCT01222715|11034286|FG001|NOT COMPLETED|Overall Study||27
9917312|NCT01222767|11034292|FG000|STARTED|Overall Study||17
9917313|NCT01222767|11034292|FG000|Received Treatment|Overall Study||16
9917314|NCT01222767|11034292|FG000|COMPLETED|Overall Study||0
9917315|NCT01222767|11034292|FG000|NOT COMPLETED|Overall Study||17
9917316|NCT01222832|11034298|FG000|STARTED|Overall Study||113
9917317|NCT01222832|11034299|FG001|STARTED|Overall Study||113
9917318|NCT01222832|11034298|FG000|COMPLETED|Overall Study||113
9917319|NCT01222832|11034299|FG001|COMPLETED|Overall Study||112
9917320|NCT01222832|11034298|FG000|NOT COMPLETED|Overall Study||0
9917321|NCT01222832|11034299|FG001|NOT COMPLETED|Overall Study||1
9917322|NCT01222884|11034307|FG000|STARTED|Overall Study||234
9917323|NCT01222884|11034308|FG001|STARTED|Overall Study||117
9917324|NCT01222884|11034307|FG000|COMPLETED|Overall Study||210
9917325|NCT01222884|11034308|FG001|COMPLETED|Overall Study||113
9917326|NCT01222884|11034307|FG000|NOT COMPLETED|Overall Study||24
9917327|NCT01222884|11034308|FG001|NOT COMPLETED|Overall Study||4
9917328|NCT01223027|11034316|FG000|STARTED|Overall Study||284
9917329|NCT01223027|11034317|FG001|STARTED|Overall Study||286
9917330|NCT01223027|11034316|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
9917331|NCT01223027|11034317|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
9917332|NCT01223027|11034316|FG000|NOT COMPLETED|Overall Study||274
9917333|NCT01223027|11034317|FG001|NOT COMPLETED|Overall Study||277
9917334|NCT01223183|11034325|FG000|STARTED|Imaging Day 1||10
9917335|NCT01223183|11034326|FG001|STARTED|Imaging Day 1||10
9917336|NCT01223183|11034325|FG000|COMPLETED|Imaging Day 1||10
9917337|NCT01223183|11034326|FG001|COMPLETED|Imaging Day 1||9
9917338|NCT01223183|11034325|FG000|NOT COMPLETED|Imaging Day 1||0
9917339|NCT01223183|11034326|FG001|NOT COMPLETED|Imaging Day 1||1
9917340|NCT01223183|11034325|FG000|STARTED|Washout Period (5-24 Days)||10
9917341|NCT01223183|11034326|FG001|STARTED|Washout Period (5-24 Days)||9
9917342|NCT01223183|11034325|FG000|COMPLETED|Washout Period (5-24 Days)||8
9917343|NCT01223183|11034326|FG001|COMPLETED|Washout Period (5-24 Days)||9
9917344|NCT01223183|11034325|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2
9917345|NCT01223183|11034326|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0
9917346|NCT01223183|11034325|FG000|STARTED|Imaging Day 2||8
9917347|NCT01223183|11034326|FG001|STARTED|Imaging Day 2||9
9917348|NCT01223183|11034325|FG000|COMPLETED|Imaging Day 2||8
9917349|NCT01223183|11034326|FG001|COMPLETED|Imaging Day 2||9
9917350|NCT01223183|11034325|FG000|NOT COMPLETED|Imaging Day 2||0
9917351|NCT01223183|11034326|FG001|NOT COMPLETED|Imaging Day 2||0
9917352|NCT01223196|11034335|FG000|STARTED|Overall Study||13
9917353|NCT01223196|11034336|FG001|STARTED|Overall Study||11
9917354|NCT01223196|11034335|FG000|COMPLETED|Overall Study||9
9917355|NCT01223196|11034336|FG001|COMPLETED|Overall Study||11
9917356|NCT01223196|11034335|FG000|NOT COMPLETED|Overall Study||4
9917357|NCT01223196|11034336|FG001|NOT COMPLETED|Overall Study||0
9917358|NCT01223235|11034344|FG000|STARTED|Overall Study||22
9917359|NCT01223235|11034344|FG000|COMPLETED|Overall Study||21
9917360|NCT01223235|11034344|FG000|NOT COMPLETED|Overall Study||1
9917361|NCT01223352|11034350|FG000|STARTED|Overall Study||31
9917362|NCT01223352|11034351|FG001|STARTED|Overall Study||33
9917363|NCT01223352|11034350|FG000|COMPLETED|Overall Study||31
9917364|NCT01223352|11034351|FG001|COMPLETED|Overall Study||33
9917365|NCT01223352|11034350|FG000|NOT COMPLETED|Overall Study||0
9917366|NCT01223352|11034351|FG001|NOT COMPLETED|Overall Study||0
9917367|NCT01223365|11034363|FG000|STARTED|Open-label Titration Period||330
9917368|NCT01223365|11034363|FG000|Safety Analysis Set|Open-label Titration Period||329
9917369|NCT01223365|11034363|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294
9917370|NCT01223365|11034363|FG000|COMPLETED|Open-label Titration Period||291
9917371|NCT01223365|11034363|FG000|NOT COMPLETED|Open-label Titration Period||39
9917372|NCT01223365|11034363|FG000|STARTED|Open-label Treatment Period||291
9917373|NCT01223365|11034363|FG000|COMPLETED|Open-label Treatment Period||189
9917374|NCT01223365|11034363|FG000|NOT COMPLETED|Open-label Treatment Period||102
9917375|NCT01223378|11034377|FG000|STARTED|Overall Study||82
9917376|NCT01223378|11034378|FG001|STARTED|Overall Study||85
9917377|NCT01223378|11034379|FG002|STARTED|Overall Study||83
9917378|NCT01223378|11034380|FG003|STARTED|Overall Study||81
9917379|NCT01223378|11034381|FG004|STARTED|Overall Study||82
9917380|NCT01223378|11034377|FG000|COMPLETED|Overall Study||76
9917381|NCT01223378|11034378|FG001|COMPLETED|Overall Study||81
9917382|NCT01223378|11034379|FG002|COMPLETED|Overall Study||80
9917383|NCT01223378|11034380|FG003|COMPLETED|Overall Study||80
9917384|NCT01223378|11034381|FG004|COMPLETED|Overall Study||79
9917385|NCT01223378|11034377|FG000|NOT COMPLETED|Overall Study||6
9917386|NCT01223378|11034378|FG001|NOT COMPLETED|Overall Study||4
9917387|NCT01223378|11034379|FG002|NOT COMPLETED|Overall Study||3
9917388|NCT01223378|11034380|FG003|NOT COMPLETED|Overall Study||1
9917389|NCT01223378|11034381|FG004|NOT COMPLETED|Overall Study||3
9917390|NCT01223404|11034393|FG000|STARTED|First Intervention (1 Day)||4
9917391|NCT01223404|11034394|FG001|STARTED|First Intervention (1 Day)||3
9917392|NCT01223404|11034395|FG002|STARTED|First Intervention (1 Day)||4
9917393|NCT01223404|11034396|FG003|STARTED|First Intervention (1 Day)||5
9917394|NCT01223404|11034397|FG004|STARTED|First Intervention (1 Day)||2
9917395|NCT01223404|11034398|FG005|STARTED|First Intervention (1 Day)||3
9917396|NCT01223404|11034393|FG000|COMPLETED|First Intervention (1 Day)||4
9917397|NCT01223404|11034394|FG001|COMPLETED|First Intervention (1 Day)||3
9917398|NCT01223404|11034395|FG002|COMPLETED|First Intervention (1 Day)||4
9917399|NCT01223404|11034396|FG003|COMPLETED|First Intervention (1 Day)||4
9917400|NCT01223404|11034397|FG004|COMPLETED|First Intervention (1 Day)||2
9917401|NCT01223404|11034398|FG005|COMPLETED|First Intervention (1 Day)||3
9917402|NCT01223404|11034393|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9917403|NCT01223404|11034394|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9917404|NCT01223404|11034395|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9917405|NCT01223404|11034396|FG003|NOT COMPLETED|First Intervention (1 Day)||1
9917406|NCT01223404|11034397|FG004|NOT COMPLETED|First Intervention (1 Day)||0
9917407|NCT01223404|11034398|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10205285|NCT03489369|11332054|FG002|NOT COMPLETED|Overall Study||3
10205286|NCT03489369|11332055|FG003|NOT COMPLETED|Overall Study||6
10205287|NCT03489551|11332065|FG000|STARTED|Overall Study||17
9917408|NCT01223404|11034393|FG000|STARTED|Second Intervention (1 Day)||4
9917409|NCT01223404|11034394|FG001|STARTED|Second Intervention (1 Day)||3
9917410|NCT01223404|11034395|FG002|STARTED|Second Intervention (1 Day)||4
9917411|NCT01223404|11034396|FG003|STARTED|Second Intervention (1 Day)||4
9917412|NCT01223404|11034397|FG004|STARTED|Second Intervention (1 Day)||2
9917413|NCT01223404|11034398|FG005|STARTED|Second Intervention (1 Day)||3
9917414|NCT01223404|11034393|FG000|COMPLETED|Second Intervention (1 Day)||3
9917415|NCT01223404|11034394|FG001|COMPLETED|Second Intervention (1 Day)||3
9917416|NCT01223404|11034395|FG002|COMPLETED|Second Intervention (1 Day)||4
9917417|NCT01223404|11034396|FG003|COMPLETED|Second Intervention (1 Day)||4
9917418|NCT01223404|11034397|FG004|COMPLETED|Second Intervention (1 Day)||2
9917419|NCT01223404|11034398|FG005|COMPLETED|Second Intervention (1 Day)||3
9917420|NCT01223404|11034393|FG000|NOT COMPLETED|Second Intervention (1 Day)||1
9917421|NCT01223404|11034394|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9917422|NCT01223404|11034395|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
9917423|NCT01223404|11034396|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9917424|NCT01223404|11034397|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
9917425|NCT01223404|11034398|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
9917426|NCT01223404|11034393|FG000|STARTED|Third Intervention (1 Day)||3
9917427|NCT01223404|11034394|FG001|STARTED|Third Intervention (1 Day)||3
9917428|NCT01223404|11034395|FG002|STARTED|Third Intervention (1 Day)||4
9917429|NCT01223404|11034396|FG003|STARTED|Third Intervention (1 Day)||4
9917430|NCT01223404|11034397|FG004|STARTED|Third Intervention (1 Day)||2
9917431|NCT01223404|11034398|FG005|STARTED|Third Intervention (1 Day)||3
9917432|NCT01223404|11034393|FG000|COMPLETED|Third Intervention (1 Day)||3
9917433|NCT01223404|11034394|FG001|COMPLETED|Third Intervention (1 Day)||3
9917434|NCT01223404|11034395|FG002|COMPLETED|Third Intervention (1 Day)||4
9917435|NCT01223404|11034396|FG003|COMPLETED|Third Intervention (1 Day)||3
9917436|NCT01223404|11034397|FG004|COMPLETED|Third Intervention (1 Day)||2
9917437|NCT01223404|11034398|FG005|COMPLETED|Third Intervention (1 Day)||3
10205288|NCT03489551|11332065|FG000|COMPLETED|Overall Study||15
10205289|NCT03489551|11332065|FG000|NOT COMPLETED|Overall Study||2
9917438|NCT01223404|11034393|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9917439|NCT01223404|11034394|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9917440|NCT01223404|11034395|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
9917441|NCT01223404|11034396|FG003|NOT COMPLETED|Third Intervention (1 Day)||1
9917442|NCT01223404|11034397|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
9917443|NCT01223404|11034398|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
9917444|NCT01223469|11034416|FG000|STARTED|Overall Study||34
9917445|NCT01223469|11034417|FG001|STARTED|Overall Study||43
9917446|NCT01223469|11034416|FG000|COMPLETED|Overall Study||34
9917447|NCT01223469|11034417|FG001|COMPLETED|Overall Study||43
9917448|NCT01223469|11034416|FG000|NOT COMPLETED|Overall Study||0
9917449|NCT01223469|11034417|FG001|NOT COMPLETED|Overall Study||0
9917450|NCT01223703|11034425|FG000|STARTED|Overall Study||67
9917451|NCT01223703|11034426|FG001|STARTED|Overall Study||66
9917452|NCT01223703|11034425|FG000|COMPLETED|Overall Study||67
9917453|NCT01223703|11034426|FG001|COMPLETED|Overall Study||66
9917454|NCT01223703|11034425|FG000|NOT COMPLETED|Overall Study||0
9917455|NCT01223703|11034426|FG001|NOT COMPLETED|Overall Study||0
9917456|NCT01223937|11034434|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
9917457|NCT01223937|11034435|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
9917458|NCT01223937|11034434|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
9917459|NCT01223937|11034435|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
9917460|NCT01223937|11034434|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
9917461|NCT01223937|11034435|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
9917462|NCT01223937|11034434|FG000|COMPLETED|Overall Study||114
9917463|NCT01223937|11034435|FG001|COMPLETED|Overall Study||119
9917464|NCT01223937|11034434|FG000|NOT COMPLETED|Overall Study||17
9917465|NCT01223937|11034435|FG001|NOT COMPLETED|Overall Study||18
9917466|NCT01223963|11034441|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
10010373|NCT01773889|11133151|FG000|NOT COMPLETED|Overall Study||2
10010374|NCT01773954|11133155|FG000|STARTED|Overall Study||40
10010375|NCT01773954|11133155|FG000|COMPLETED|Overall Study||31
10010376|NCT01773954|11133155|FG000|NOT COMPLETED|Overall Study||9
10010377|NCT01773967|11133161|FG000|STARTED|Overall Study||483
10010378|NCT01773967|11133162|FG001|STARTED|Overall Study||488
9917467|NCT01223963|11034441|FG000|COMPLETED|Overall Study||93
9917468|NCT01223963|11034441|FG000|NOT COMPLETED|Overall Study||0
9917469|NCT01224015|11034449|FG000|STARTED|Overall Study||361
9917470|NCT01224015|11034450|FG001|STARTED|Overall Study||227
9917471|NCT01224015|11034451|FG002|STARTED|Overall Study||96
9917472|NCT01224015|11034449|FG000|COMPLETED|Overall Study||347
9917473|NCT01224015|11034450|FG001|COMPLETED|Overall Study||211
9917474|NCT01224015|11034451|FG002|COMPLETED|Overall Study||83
10010379|NCT01773967|11133161|FG000|COMPLETED|Overall Study||468
10010380|NCT01773967|11133162|FG001|COMPLETED|Overall Study||475
10010381|NCT01773967|11133161|FG000|NOT COMPLETED|Overall Study||15
10010382|NCT01773967|11133162|FG001|NOT COMPLETED|Overall Study||13
10010383|NCT01773993|11133168|FG000|STARTED|Overall Study||534
10010384|NCT01773993|11133168|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
9917475|NCT01224015|11034449|FG000|NOT COMPLETED|Overall Study||14
9917476|NCT01224015|11034450|FG001|NOT COMPLETED|Overall Study||16
9917477|NCT01224015|11034451|FG002|NOT COMPLETED|Overall Study||13
9917478|NCT01224145|11034459|FG000|STARTED|Overall Study||10
9917479|NCT01224145|11034459|FG000|COMPLETED|Overall Study||10
9917480|NCT01224145|11034459|FG000|NOT COMPLETED|Overall Study||0
9917481|NCT01224158|11034466|FG000|STARTED|Overall Study||76
9917482|NCT01224158|11034467|FG001|STARTED|Overall Study||77
9917483|NCT01224158|11034466|FG000|COMPLETED|Overall Study||75
9917484|NCT01224158|11034467|FG001|COMPLETED|Overall Study||77
9917485|NCT01224158|11034466|FG000|NOT COMPLETED|Overall Study||1
9917486|NCT01224158|11034467|FG001|NOT COMPLETED|Overall Study||0
9917487|NCT01224171|11034475|FG000|STARTED|Overall Study||207
9917488|NCT01224171|11034476|FG001|STARTED|Overall Study||209
9917489|NCT01224171|11034475|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
9917490|NCT01224171|11034476|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
9917491|NCT01224171|11034475|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
9917492|NCT01224171|11034476|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
9917493|NCT01224171|11034475|FG000|NOT COMPLETED|Overall Study||15
9917494|NCT01224171|11034476|FG001|NOT COMPLETED|Overall Study||13
9917495|NCT01224210|11034482|FG000|STARTED|Overall Study||30
9917496|NCT01224210|11034482|FG000|COMPLETED|Overall Study||23
9917497|NCT01224210|11034482|FG000|NOT COMPLETED|Overall Study||7
9917498|NCT01224236|11034489|FG000|STARTED|Overall Study||76
9917499|NCT01224236|11034490|FG001|STARTED|Overall Study||74
9917500|NCT01224236|11034489|FG000|COMPLETED|Overall Study||75
9917501|NCT01224236|11034490|FG001|COMPLETED|Overall Study||73
10010385|NCT01773993|11133168|FG000|NOT COMPLETED|Overall Study||35
10010386|NCT01774045|11133174|FG000|STARTED|Overall Study||23
10010387|NCT01774045|11133175|FG001|STARTED|Overall Study||7
9917502|NCT01224236|11034489|FG000|NOT COMPLETED|Overall Study||1
9917503|NCT01224236|11034490|FG001|NOT COMPLETED|Overall Study||1
9917504|NCT01224431|11034498|FG000|STARTED|Overall Study||30
9917505|NCT01224431|11034499|FG001|STARTED|Overall Study||30
9917506|NCT01224431|11034498|FG000|COMPLETED|Overall Study||30
9917507|NCT01224431|11034499|FG001|COMPLETED|Overall Study||25
9917508|NCT01224431|11034498|FG000|NOT COMPLETED|Overall Study||0
9917509|NCT01224431|11034499|FG001|NOT COMPLETED|Overall Study||5
9917510|NCT01224444|11034507|FG000|STARTED|Overall Study||269
9917511|NCT01224444|11034507|FG000|COMPLETED|Overall Study||269
9917512|NCT01224444|11034507|FG000|NOT COMPLETED|Overall Study||0
9917513|NCT01224626|11034511|FG000|STARTED|Overall Study||42
9917514|NCT01224626|11034511|FG000|COMPLETED|Overall Study||41
9917515|NCT01224626|11034511|FG000|NOT COMPLETED|Overall Study||1
9917516|NCT01224639|11034523|FG000|STARTED|Overall Study||19
9917517|NCT01224639|11034524|FG001|STARTED|Overall Study||5
9917518|NCT01224639|11034525|FG002|STARTED|Overall Study||21
9917519|NCT01224639|11034526|FG003|STARTED|Overall Study||3
9917520|NCT01224639|11034527|FG004|STARTED|Overall Study||21
9917521|NCT01224639|11034528|FG005|STARTED|Overall Study||4
9917522|NCT01224639|11034529|FG006|STARTED|Overall Study||18
9917523|NCT01224639|11034530|FG007|STARTED|Overall Study||5
9917524|NCT01224639|11034523|FG000|COMPLETED|Overall Study||19
9917525|NCT01224639|11034524|FG001|COMPLETED|Overall Study||5
9917526|NCT01224639|11034525|FG002|COMPLETED|Overall Study||21
9917527|NCT01224639|11034526|FG003|COMPLETED|Overall Study||3
9917528|NCT01224639|11034527|FG004|COMPLETED|Overall Study||19
9917529|NCT01224639|11034528|FG005|COMPLETED|Overall Study||4
9917530|NCT01224639|11034529|FG006|COMPLETED|Overall Study||17
9917531|NCT01224639|11034530|FG007|COMPLETED|Overall Study||3
9917532|NCT01224639|11034523|FG000|NOT COMPLETED|Overall Study||0
9917533|NCT01224639|11034524|FG001|NOT COMPLETED|Overall Study||0
9917534|NCT01224639|11034525|FG002|NOT COMPLETED|Overall Study||0
9917535|NCT01224639|11034526|FG003|NOT COMPLETED|Overall Study||0
9917536|NCT01224639|11034527|FG004|NOT COMPLETED|Overall Study||2
9917537|NCT01224639|11034528|FG005|NOT COMPLETED|Overall Study||0
9917538|NCT01224639|11034529|FG006|NOT COMPLETED|Overall Study||1
9917539|NCT01224639|11034530|FG007|NOT COMPLETED|Overall Study||2
9917540|NCT01224678|11034550|FG000|STARTED|Overall Study||150
9917541|NCT01224678|11034551|FG001|STARTED|Overall Study||150
9917542|NCT01224678|11034550|FG000|COMPLETED|Overall Study||150
9917543|NCT01224678|11034551|FG001|COMPLETED|Overall Study||150
9917544|NCT01224678|11034550|FG000|NOT COMPLETED|Overall Study||0
9917545|NCT01224678|11034551|FG001|NOT COMPLETED|Overall Study||0
9917546|NCT01224782|11034557|FG000|STARTED|Overall Study||994
9917547|NCT01224782|11034557|FG000|COMPLETED|Overall Study||730
9917548|NCT01224782|11034557|FG000|NOT COMPLETED|Overall Study||264
9917549|NCT01224821|11034561|FG000|STARTED|Dosimetric and Therapeutic Treatment||47
9917550|NCT01224821|11034561|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
9917551|NCT01224821|11034561|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
9917552|NCT01224821|11034561|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
9917553|NCT01224821|11034561|FG000|COMPLETED|Long-Term Follow-Up||0
9917554|NCT01224821|11034561|FG000|NOT COMPLETED|Long-Term Follow-Up||11
9917555|NCT01224925|11034567|FG000|STARTED|Overall Study||37
9917556|NCT01224925|11034568|FG001|STARTED|Overall Study||33
9917557|NCT01224925|11034567|FG000|COMPLETED|Overall Study||34
9917558|NCT01224925|11034568|FG001|COMPLETED|Overall Study||31
9917559|NCT01224925|11034567|FG000|NOT COMPLETED|Overall Study||3
9917560|NCT01224925|11034568|FG001|NOT COMPLETED|Overall Study||2
9917561|NCT01225029|11034578|FG000|STARTED|Overall Study||32
9917562|NCT01225029|11034579|FG001|STARTED|Overall Study||32
9917563|NCT01225029|11034578|FG000|COMPLETED|Overall Study||32
9917564|NCT01225029|11034579|FG001|COMPLETED|Overall Study||32
9917565|NCT01225029|11034578|FG000|NOT COMPLETED|Overall Study||0
9917566|NCT01225029|11034579|FG001|NOT COMPLETED|Overall Study||0
9917567|NCT01225055|11034588|FG000|STARTED|Overall Study||20
9917568|NCT01225055|11034589|FG001|STARTED|Overall Study||20
9917569|NCT01225055|11034590|FG002|STARTED|Overall Study||21
9917570|NCT01225055|11034588|FG000|COMPLETED|Overall Study||20
9917571|NCT01225055|11034589|FG001|COMPLETED|Overall Study||18
9917572|NCT01225055|11034590|FG002|COMPLETED|Overall Study||18
9917573|NCT01225055|11034588|FG000|NOT COMPLETED|Overall Study||0
9917574|NCT01225055|11034589|FG001|NOT COMPLETED|Overall Study||2
9917575|NCT01225055|11034590|FG002|NOT COMPLETED|Overall Study||3
9917576|NCT01225068|11034600|FG000|STARTED|Overall Study||20
9917577|NCT01225068|11034601|FG001|STARTED|Overall Study||20
9917578|NCT01225068|11034600|FG000|COMPLETED|Overall Study||16
9917579|NCT01225068|11034601|FG001|COMPLETED|Overall Study||19
9917580|NCT01225068|11034600|FG000|NOT COMPLETED|Overall Study||4
9917581|NCT01225068|11034601|FG001|NOT COMPLETED|Overall Study||1
9917582|NCT01225146|11034609|FG000|STARTED|Overall Study||6
9917583|NCT01225146|11034610|FG001|STARTED|Overall Study||2
9917584|NCT01225146|11034609|FG000|COMPLETED|Overall Study||6
9917585|NCT01225146|11034610|FG001|COMPLETED|Overall Study||0
9917586|NCT01225146|11034609|FG000|NOT COMPLETED|Overall Study||0
9917587|NCT01225146|11034610|FG001|NOT COMPLETED|Overall Study||2
9917588|NCT01225159|11034620|FG000|STARTED|Overall Study||100
9917589|NCT01225159|11034621|FG001|STARTED|Overall Study||100
9917590|NCT01225159|11034620|FG000|COMPLETED|Overall Study||99
9917591|NCT01225159|11034621|FG001|COMPLETED|Overall Study||100
9917592|NCT01225159|11034620|FG000|NOT COMPLETED|Overall Study||1
9917593|NCT01225159|11034621|FG001|NOT COMPLETED|Overall Study||0
9917594|NCT01225172|11034629|FG000|STARTED|Overall Study||52
9917595|NCT01225172|11034630|FG001|STARTED|Overall Study||7
9917596|NCT01225172|11034629|FG000|COMPLETED|Overall Study||46
9917597|NCT01225172|11034630|FG001|COMPLETED|Overall Study||6
9917598|NCT01225172|11034629|FG000|NOT COMPLETED|Overall Study||6
9917599|NCT01225172|11034630|FG001|NOT COMPLETED|Overall Study||1
9917600|NCT01225211|11034646|FG000|STARTED|Overall Study||21
9917601|NCT01225211|11034647|FG001|STARTED|Overall Study||20
9917602|NCT01225211|11034648|FG002|STARTED|Overall Study||21
9917603|NCT01225211|11034649|FG003|STARTED|Overall Study||27
9917604|NCT01225211|11034650|FG004|STARTED|Overall Study||23
9917605|NCT01225211|11034651|FG005|STARTED|Overall Study||21
9917606|NCT01225211|11034652|FG006|STARTED|Overall Study||42
9917607|NCT01225211|11034653|FG007|STARTED|Overall Study||11
9917608|NCT01225211|11034654|FG008|STARTED|Overall Study||63
9917609|NCT01225211|11034655|FG009|STARTED|Overall Study||62
9917610|NCT01225211|11034646|FG000|COMPLETED|Overall Study||21
9917611|NCT01225211|11034647|FG001|COMPLETED|Overall Study||20
9917612|NCT01225211|11034648|FG002|COMPLETED|Overall Study||20
9917613|NCT01225211|11034649|FG003|COMPLETED|Overall Study||27
9917614|NCT01225211|11034650|FG004|COMPLETED|Overall Study||23
9917615|NCT01225211|11034651|FG005|COMPLETED|Overall Study||21
9917616|NCT01225211|11034652|FG006|COMPLETED|Overall Study||41
9917617|NCT01225211|11034653|FG007|COMPLETED|Overall Study||11
9917618|NCT01225211|11034654|FG008|COMPLETED|Overall Study||62
9917619|NCT01225211|11034655|FG009|COMPLETED|Overall Study||57
9917620|NCT01225211|11034646|FG000|NOT COMPLETED|Overall Study||0
9917621|NCT01225211|11034647|FG001|NOT COMPLETED|Overall Study||0
9917622|NCT01225211|11034648|FG002|NOT COMPLETED|Overall Study||1
9917623|NCT01225211|11034649|FG003|NOT COMPLETED|Overall Study||0
9917624|NCT01225211|11034650|FG004|NOT COMPLETED|Overall Study||0
9917625|NCT01225211|11034651|FG005|NOT COMPLETED|Overall Study||0
9917626|NCT01225211|11034652|FG006|NOT COMPLETED|Overall Study||1
9917627|NCT01225211|11034653|FG007|NOT COMPLETED|Overall Study||0
9917628|NCT01225211|11034654|FG008|NOT COMPLETED|Overall Study||1
9917629|NCT01225211|11034655|FG009|NOT COMPLETED|Overall Study||5
10010388|NCT01774045|11133174|FG000|COMPLETED|Overall Study||23
10010389|NCT01774045|11133175|FG001|COMPLETED|Overall Study||7
9917630|NCT01225250|11034714|FG000|STARTED|Overall Study||15
9917631|NCT01225250|11034715|FG001|STARTED|Overall Study||15
9917632|NCT01225250|11034714|FG000|COMPLETED|Overall Study||10
9917633|NCT01225250|11034715|FG001|COMPLETED|Overall Study||10
9917634|NCT01225250|11034714|FG000|NOT COMPLETED|Overall Study||5
9917635|NCT01225250|11034715|FG001|NOT COMPLETED|Overall Study||5
9917636|NCT01225263|11034723|FG000|STARTED|Weeks 1 to 12||28
9917637|NCT01225263|11034724|FG001|STARTED|Weeks 1 to 12||29
9917638|NCT01225263|11034723|FG000|COMPLETED|Weeks 1 to 12||28
9917639|NCT01225263|11034724|FG001|COMPLETED|Weeks 1 to 12||29
9917640|NCT01225263|11034723|FG000|NOT COMPLETED|Weeks 1 to 12||0
9917641|NCT01225263|11034724|FG001|NOT COMPLETED|Weeks 1 to 12||0
9917642|NCT01225263|11034723|FG000|STARTED|Weeks 13 to 24||28
9917643|NCT01225263|11034724|FG001|STARTED|Weeks 13 to 24||29
9917644|NCT01225263|11034723|FG000|COMPLETED|Weeks 13 to 24||24
9917645|NCT01225263|11034724|FG001|COMPLETED|Weeks 13 to 24||28
9917646|NCT01225263|11034723|FG000|NOT COMPLETED|Weeks 13 to 24||4
9917647|NCT01225263|11034724|FG001|NOT COMPLETED|Weeks 13 to 24||1
9917648|NCT01225289|11034733|FG000|STARTED|Overall Study||18
9917649|NCT01225289|11034734|FG001|STARTED|Overall Study||18
9917650|NCT01225289|11034733|FG000|COMPLETED|Overall Study||18
9917651|NCT01225289|11034734|FG001|COMPLETED|Overall Study||17
9917652|NCT01225289|11034733|FG000|NOT COMPLETED|Overall Study||0
9917653|NCT01225289|11034734|FG001|NOT COMPLETED|Overall Study||1
9917654|NCT01225354|11034740|FG000|STARTED|Overall Study||20
9917655|NCT01225354|11034740|FG000|COMPLETED|Overall Study||19
9917656|NCT01225354|11034740|FG000|NOT COMPLETED|Overall Study||1
9917657|NCT01225549|11034745|FG000|STARTED|Period 1 - First Treatment Period||1
9917658|NCT01225549|11034746|FG001|STARTED|Period 1 - First Treatment Period||4
9917659|NCT01225549|11034747|FG002|STARTED|Period 1 - First Treatment Period||3
9917660|NCT01225549|11034748|FG003|STARTED|Period 1 - First Treatment Period||1
9917661|NCT01225549|11034749|FG004|STARTED|Period 1 - First Treatment Period||1
10010390|NCT01774045|11133174|FG000|NOT COMPLETED|Overall Study||0
10010391|NCT01774045|11133175|FG001|NOT COMPLETED|Overall Study||0
10010392|NCT01774084|11133184|FG000|STARTED|Overall Study||11
10010393|NCT01774084|11133185|FG001|STARTED|Overall Study||12
10010394|NCT01774084|11133184|FG000|COMPLETED|Overall Study||10
10010395|NCT01774084|11133185|FG001|COMPLETED|Overall Study||12
10010396|NCT01774084|11133184|FG000|NOT COMPLETED|Overall Study||1
9917662|NCT01225549|11034750|FG005|STARTED|Period 1 - First Treatment Period||1
9917663|NCT01225549|11034751|FG006|STARTED|Period 1 - First Treatment Period||3
9917664|NCT01225549|11034752|FG007|STARTED|Period 1 - First Treatment Period||1
9917665|NCT01225549|11034753|FG008|STARTED|Period 1 - First Treatment Period||4
9917666|NCT01225549|11034754|FG009|STARTED|Period 1 - First Treatment Period||1
9917667|NCT01225549|11034745|FG000|COMPLETED|Period 1 - First Treatment Period||1
9917668|NCT01225549|11034746|FG001|COMPLETED|Period 1 - First Treatment Period||4
9917669|NCT01225549|11034747|FG002|COMPLETED|Period 1 - First Treatment Period||3
9917670|NCT01225549|11034748|FG003|COMPLETED|Period 1 - First Treatment Period||1
9917671|NCT01225549|11034749|FG004|COMPLETED|Period 1 - First Treatment Period||1
9917672|NCT01225549|11034750|FG005|COMPLETED|Period 1 - First Treatment Period||1
10010397|NCT01774084|11133185|FG001|NOT COMPLETED|Overall Study||0
10010398|NCT01774097|11133193|FG000|STARTED|Overall Study||40
10010399|NCT01774097|11133194|FG001|STARTED|Overall Study||42
10010400|NCT01774097|11133193|FG000|COMPLETED|Overall Study||38
10010401|NCT01774097|11133194|FG001|COMPLETED|Overall Study||40
10010402|NCT01774097|11133193|FG000|NOT COMPLETED|Overall Study||2
10010403|NCT01774097|11133194|FG001|NOT COMPLETED|Overall Study||2
10010404|NCT01774110|11133202|FG000|STARTED|Overall Study||12
10010405|NCT01774110|11133202|FG000|COMPLETED|Overall Study||5
10010406|NCT01774110|11133202|FG000|NOT COMPLETED|Overall Study||7
10010407|NCT01774149|11133209|FG000|STARTED|Overall Study||15
9917673|NCT01225549|11034751|FG006|COMPLETED|Period 1 - First Treatment Period||3
9917674|NCT01225549|11034752|FG007|COMPLETED|Period 1 - First Treatment Period||1
9917675|NCT01225549|11034753|FG008|COMPLETED|Period 1 - First Treatment Period||4
9917676|NCT01225549|11034754|FG009|COMPLETED|Period 1 - First Treatment Period||1
9917677|NCT01225549|11034745|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0
9917678|NCT01225549|11034746|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0
9917679|NCT01225549|11034747|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0
9917680|NCT01225549|11034748|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0
9917681|NCT01225549|11034749|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0
9917682|NCT01225549|11034750|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0
9917683|NCT01225549|11034751|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0
9917684|NCT01225549|11034752|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0
9917685|NCT01225549|11034753|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0
9917686|NCT01225549|11034754|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0
9917687|NCT01225549|11034745|FG000|STARTED|Period 2 - Washout||1
9917688|NCT01225549|11034746|FG001|STARTED|Period 2 - Washout||4
9917689|NCT01225549|11034747|FG002|STARTED|Period 2 - Washout||3
9917690|NCT01225549|11034748|FG003|STARTED|Period 2 - Washout||1
9917691|NCT01225549|11034749|FG004|STARTED|Period 2 - Washout||1
9917692|NCT01225549|11034750|FG005|STARTED|Period 2 - Washout||1
9917693|NCT01225549|11034751|FG006|STARTED|Period 2 - Washout||3
9917694|NCT01225549|11034752|FG007|STARTED|Period 2 - Washout||1
9917695|NCT01225549|11034753|FG008|STARTED|Period 2 - Washout||4
9917696|NCT01225549|11034754|FG009|STARTED|Period 2 - Washout||1
9917697|NCT01225549|11034745|FG000|COMPLETED|Period 2 - Washout||1
9917698|NCT01225549|11034746|FG001|COMPLETED|Period 2 - Washout||4
9917699|NCT01225549|11034747|FG002|COMPLETED|Period 2 - Washout||3
9917700|NCT01225549|11034748|FG003|COMPLETED|Period 2 - Washout||1
9917701|NCT01225549|11034749|FG004|COMPLETED|Period 2 - Washout||1
9917702|NCT01225549|11034750|FG005|COMPLETED|Period 2 - Washout||1
9917703|NCT01225549|11034751|FG006|COMPLETED|Period 2 - Washout||3
9917704|NCT01225549|11034752|FG007|COMPLETED|Period 2 - Washout||1
9917705|NCT01225549|11034753|FG008|COMPLETED|Period 2 - Washout||4
9917706|NCT01225549|11034754|FG009|COMPLETED|Period 2 - Washout||1
9917707|NCT01225549|11034745|FG000|NOT COMPLETED|Period 2 - Washout||0
9917708|NCT01225549|11034746|FG001|NOT COMPLETED|Period 2 - Washout||0
9917709|NCT01225549|11034747|FG002|NOT COMPLETED|Period 2 - Washout||0
9917710|NCT01225549|11034748|FG003|NOT COMPLETED|Period 2 - Washout||0
9917711|NCT01225549|11034749|FG004|NOT COMPLETED|Period 2 - Washout||0
9917712|NCT01225549|11034750|FG005|NOT COMPLETED|Period 2 - Washout||0
9917713|NCT01225549|11034751|FG006|NOT COMPLETED|Period 2 - Washout||0
9917714|NCT01225549|11034752|FG007|NOT COMPLETED|Period 2 - Washout||0
9917715|NCT01225549|11034753|FG008|NOT COMPLETED|Period 2 - Washout||0
9917716|NCT01225549|11034754|FG009|NOT COMPLETED|Period 2 - Washout||0
9917717|NCT01225549|11034745|FG000|STARTED|Period 3 - Second Treatment Period||1
9917718|NCT01225549|11034746|FG001|STARTED|Period 3 - Second Treatment Period||4
9917719|NCT01225549|11034747|FG002|STARTED|Period 3 - Second Treatment Period||3
9917720|NCT01225549|11034748|FG003|STARTED|Period 3 - Second Treatment Period||1
9917721|NCT01225549|11034749|FG004|STARTED|Period 3 - Second Treatment Period||1
9917722|NCT01225549|11034750|FG005|STARTED|Period 3 - Second Treatment Period||1
9917723|NCT01225549|11034751|FG006|STARTED|Period 3 - Second Treatment Period||3
9917724|NCT01225549|11034752|FG007|STARTED|Period 3 - Second Treatment Period||1
9917725|NCT01225549|11034753|FG008|STARTED|Period 3 - Second Treatment Period||4
9917726|NCT01225549|11034754|FG009|STARTED|Period 3 - Second Treatment Period||1
9917727|NCT01225549|11034745|FG000|COMPLETED|Period 3 - Second Treatment Period||1
9917728|NCT01225549|11034746|FG001|COMPLETED|Period 3 - Second Treatment Period||4
9917729|NCT01225549|11034747|FG002|COMPLETED|Period 3 - Second Treatment Period||3
9917730|NCT01225549|11034748|FG003|COMPLETED|Period 3 - Second Treatment Period||1
9917731|NCT01225549|11034749|FG004|COMPLETED|Period 3 - Second Treatment Period||1
9917732|NCT01225549|11034750|FG005|COMPLETED|Period 3 - Second Treatment Period||1
9917733|NCT01225549|11034751|FG006|COMPLETED|Period 3 - Second Treatment Period||3
9917734|NCT01225549|11034752|FG007|COMPLETED|Period 3 - Second Treatment Period||1
9917735|NCT01225549|11034753|FG008|COMPLETED|Period 3 - Second Treatment Period||4
9917736|NCT01225549|11034754|FG009|COMPLETED|Period 3 - Second Treatment Period||1
9917737|NCT01225549|11034745|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917738|NCT01225549|11034746|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917739|NCT01225549|11034747|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917740|NCT01225549|11034748|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917741|NCT01225549|11034749|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0
10010408|NCT01774149|11133210|FG001|STARTED|Overall Study||15
10010409|NCT01774149|11133209|FG000|COMPLETED|Overall Study||14
10010410|NCT01774149|11133210|FG001|COMPLETED|Overall Study||12
9917742|NCT01225549|11034750|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917743|NCT01225549|11034751|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917744|NCT01225549|11034752|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917745|NCT01225549|11034753|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917746|NCT01225549|11034754|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0
9917747|NCT01225549|11034745|FG000|STARTED|Period 4 - Washout||1
9917748|NCT01225549|11034746|FG001|STARTED|Period 4 - Washout||4
9917749|NCT01225549|11034747|FG002|STARTED|Period 4 - Washout||3
9917750|NCT01225549|11034748|FG003|STARTED|Period 4 - Washout||1
9917751|NCT01225549|11034749|FG004|STARTED|Period 4 - Washout||1
9917752|NCT01225549|11034750|FG005|STARTED|Period 4 - Washout||1
9917753|NCT01225549|11034751|FG006|STARTED|Period 4 - Washout||3
9917754|NCT01225549|11034752|FG007|STARTED|Period 4 - Washout||1
9917755|NCT01225549|11034753|FG008|STARTED|Period 4 - Washout||4
9917756|NCT01225549|11034754|FG009|STARTED|Period 4 - Washout||1
9917757|NCT01225549|11034745|FG000|COMPLETED|Period 4 - Washout||1
9917758|NCT01225549|11034746|FG001|COMPLETED|Period 4 - Washout||3
9917759|NCT01225549|11034747|FG002|COMPLETED|Period 4 - Washout||3
9917760|NCT01225549|11034748|FG003|COMPLETED|Period 4 - Washout||1
9917761|NCT01225549|11034749|FG004|COMPLETED|Period 4 - Washout||1
9917762|NCT01225549|11034750|FG005|COMPLETED|Period 4 - Washout||1
9917763|NCT01225549|11034751|FG006|COMPLETED|Period 4 - Washout||3
9917764|NCT01225549|11034752|FG007|COMPLETED|Period 4 - Washout||1
9917765|NCT01225549|11034753|FG008|COMPLETED|Period 4 - Washout||4
10010411|NCT01774149|11133209|FG000|NOT COMPLETED|Overall Study||1
10010412|NCT01774149|11133210|FG001|NOT COMPLETED|Overall Study||3
10010413|NCT01774305|11133218|FG000|STARTED|Overall Study||71
10010414|NCT01774305|11133219|FG001|STARTED|Overall Study||71
10010415|NCT01774305|11133218|FG000|COMPLETED|Overall Study||70
10010416|NCT01774305|11133219|FG001|COMPLETED|Overall Study||71
9917766|NCT01225549|11034754|FG009|COMPLETED|Period 4 - Washout||1
9917767|NCT01225549|11034745|FG000|NOT COMPLETED|Period 4 - Washout||0
9917768|NCT01225549|11034746|FG001|NOT COMPLETED|Period 4 - Washout||1
9917769|NCT01225549|11034747|FG002|NOT COMPLETED|Period 4 - Washout||0
9917770|NCT01225549|11034748|FG003|NOT COMPLETED|Period 4 - Washout||0
9917771|NCT01225549|11034749|FG004|NOT COMPLETED|Period 4 - Washout||0
9917772|NCT01225549|11034750|FG005|NOT COMPLETED|Period 4 - Washout||0
9917773|NCT01225549|11034751|FG006|NOT COMPLETED|Period 4 - Washout||0
9917774|NCT01225549|11034752|FG007|NOT COMPLETED|Period 4 - Washout||0
9917775|NCT01225549|11034753|FG008|NOT COMPLETED|Period 4 - Washout||0
9917776|NCT01225549|11034754|FG009|NOT COMPLETED|Period 4 - Washout||0
9917777|NCT01225549|11034745|FG000|STARTED|Period 5 - Third Treatment Period||1
9917778|NCT01225549|11034746|FG001|STARTED|Period 5 - Third Treatment Period||3
9917779|NCT01225549|11034747|FG002|STARTED|Period 5 - Third Treatment Period||3
9917780|NCT01225549|11034748|FG003|STARTED|Period 5 - Third Treatment Period||1
9917781|NCT01225549|11034749|FG004|STARTED|Period 5 - Third Treatment Period||1
9917782|NCT01225549|11034750|FG005|STARTED|Period 5 - Third Treatment Period||1
9917783|NCT01225549|11034751|FG006|STARTED|Period 5 - Third Treatment Period||3
9917784|NCT01225549|11034752|FG007|STARTED|Period 5 - Third Treatment Period||1
9917785|NCT01225549|11034753|FG008|STARTED|Period 5 - Third Treatment Period||4
9917786|NCT01225549|11034754|FG009|STARTED|Period 5 - Third Treatment Period||1
9917787|NCT01225549|11034745|FG000|COMPLETED|Period 5 - Third Treatment Period||1
9917788|NCT01225549|11034746|FG001|COMPLETED|Period 5 - Third Treatment Period||3
9917789|NCT01225549|11034747|FG002|COMPLETED|Period 5 - Third Treatment Period||3
9917790|NCT01225549|11034748|FG003|COMPLETED|Period 5 - Third Treatment Period||1
9917791|NCT01225549|11034749|FG004|COMPLETED|Period 5 - Third Treatment Period||1
9917792|NCT01225549|11034750|FG005|COMPLETED|Period 5 - Third Treatment Period||1
9917793|NCT01225549|11034751|FG006|COMPLETED|Period 5 - Third Treatment Period||3
9917794|NCT01225549|11034752|FG007|COMPLETED|Period 5 - Third Treatment Period||1
9917795|NCT01225549|11034753|FG008|COMPLETED|Period 5 - Third Treatment Period||4
9917796|NCT01225549|11034754|FG009|COMPLETED|Period 5 - Third Treatment Period||1
9917797|NCT01225549|11034745|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917798|NCT01225549|11034746|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917799|NCT01225549|11034747|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917800|NCT01225549|11034748|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917801|NCT01225549|11034749|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917802|NCT01225549|11034750|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917803|NCT01225549|11034751|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917804|NCT01225549|11034752|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917805|NCT01225549|11034753|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917806|NCT01225549|11034754|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0
9917807|NCT01225549|11034745|FG000|STARTED|Period 6 - Washout||1
9917808|NCT01225549|11034746|FG001|STARTED|Period 6 - Washout||3
9917809|NCT01225549|11034747|FG002|STARTED|Period 6 - Washout||3
9917810|NCT01225549|11034748|FG003|STARTED|Period 6 - Washout||1
9917811|NCT01225549|11034749|FG004|STARTED|Period 6 - Washout||1
9917812|NCT01225549|11034750|FG005|STARTED|Period 6 - Washout||1
9917813|NCT01225549|11034751|FG006|STARTED|Period 6 - Washout||3
9917814|NCT01225549|11034752|FG007|STARTED|Period 6 - Washout||1
9917815|NCT01225549|11034753|FG008|STARTED|Period 6 - Washout||4
9917816|NCT01225549|11034754|FG009|STARTED|Period 6 - Washout||1
9917817|NCT01225549|11034745|FG000|COMPLETED|Period 6 - Washout||1
10010417|NCT01774305|11133218|FG000|NOT COMPLETED|Overall Study||1
9917818|NCT01225549|11034746|FG001|COMPLETED|Period 6 - Washout||3
9917819|NCT01225549|11034747|FG002|COMPLETED|Period 6 - Washout||3
9917820|NCT01225549|11034748|FG003|COMPLETED|Period 6 - Washout||0
9917821|NCT01225549|11034749|FG004|COMPLETED|Period 6 - Washout||1
9917822|NCT01225549|11034750|FG005|COMPLETED|Period 6 - Washout||1
9917823|NCT01225549|11034751|FG006|COMPLETED|Period 6 - Washout||3
9917824|NCT01225549|11034752|FG007|COMPLETED|Period 6 - Washout||1
9917825|NCT01225549|11034753|FG008|COMPLETED|Period 6 - Washout||4
9917826|NCT01225549|11034754|FG009|COMPLETED|Period 6 - Washout||1
9917827|NCT01225549|11034745|FG000|NOT COMPLETED|Period 6 - Washout||0
9917828|NCT01225549|11034746|FG001|NOT COMPLETED|Period 6 - Washout||0
9917829|NCT01225549|11034747|FG002|NOT COMPLETED|Period 6 - Washout||0
9917830|NCT01225549|11034748|FG003|NOT COMPLETED|Period 6 - Washout||1
9917831|NCT01225549|11034749|FG004|NOT COMPLETED|Period 6 - Washout||0
9917832|NCT01225549|11034750|FG005|NOT COMPLETED|Period 6 - Washout||0
9917833|NCT01225549|11034751|FG006|NOT COMPLETED|Period 6 - Washout||0
9917834|NCT01225549|11034752|FG007|NOT COMPLETED|Period 6 - Washout||0
9917835|NCT01225549|11034753|FG008|NOT COMPLETED|Period 6 - Washout||0
9917836|NCT01225549|11034754|FG009|NOT COMPLETED|Period 6 - Washout||0
9917837|NCT01225549|11034745|FG000|STARTED|Period 7 - Fourth Treatment Period||1
9917838|NCT01225549|11034746|FG001|STARTED|Period 7 - Fourth Treatment Period||3
9917839|NCT01225549|11034747|FG002|STARTED|Period 7 - Fourth Treatment Period||3
9917840|NCT01225549|11034748|FG003|STARTED|Period 7 - Fourth Treatment Period||0
9917841|NCT01225549|11034749|FG004|STARTED|Period 7 - Fourth Treatment Period||1
9917842|NCT01225549|11034750|FG005|STARTED|Period 7 - Fourth Treatment Period||1
9917843|NCT01225549|11034751|FG006|STARTED|Period 7 - Fourth Treatment Period||3
9917844|NCT01225549|11034752|FG007|STARTED|Period 7 - Fourth Treatment Period||1
9917845|NCT01225549|11034753|FG008|STARTED|Period 7 - Fourth Treatment Period||4
9917846|NCT01225549|11034754|FG009|STARTED|Period 7 - Fourth Treatment Period||1
9917847|NCT01225549|11034745|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1
9917848|NCT01225549|11034746|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3
9917849|NCT01225549|11034747|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3
9917850|NCT01225549|11034748|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0
9917851|NCT01225549|11034749|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1
9917852|NCT01225549|11034750|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1
9917853|NCT01225549|11034751|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3
9917854|NCT01225549|11034752|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1
9917855|NCT01225549|11034753|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4
9917856|NCT01225549|11034754|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1
9917857|NCT01225549|11034745|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917858|NCT01225549|11034746|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917859|NCT01225549|11034747|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917860|NCT01225549|11034748|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917861|NCT01225549|11034749|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917862|NCT01225549|11034750|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917863|NCT01225549|11034751|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917864|NCT01225549|11034752|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917865|NCT01225549|11034753|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917866|NCT01225549|11034754|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
9917867|NCT01225562|11034767|FG000|STARTED|Overall Study||7050
9917868|NCT01225562|11034768|FG001|STARTED|Overall Study||7045
9917869|NCT01225562|11034769|FG002|STARTED|Overall Study||7067
9917870|NCT01225562|11034767|FG000|COMPLETED|Overall Study||6995
9917871|NCT01225562|11034768|FG001|COMPLETED|Overall Study||6989
9917872|NCT01225562|11034769|FG002|COMPLETED|Overall Study||7014
9917873|NCT01225562|11034767|FG000|NOT COMPLETED|Overall Study||55
9917874|NCT01225562|11034768|FG001|NOT COMPLETED|Overall Study||56
9917875|NCT01225562|11034769|FG002|NOT COMPLETED|Overall Study||53
9917876|NCT01225731|11034782|FG000|STARTED|Part 1||42
9917877|NCT01225731|11034783|FG001|STARTED|Part 1||92
9917878|NCT01225731|11034784|FG002|STARTED|Part 1||89
9917879|NCT01225731|11034785|FG003|STARTED|Part 1||86
9917880|NCT01225731|11034786|FG004|STARTED|Part 1||46
9917881|NCT01225731|11034787|FG005|STARTED|Part 1||0
9917882|NCT01225731|11034788|FG006|STARTED|Part 1||0
9917883|NCT01225731|11034789|FG007|STARTED|Part 1||0
9917884|NCT01225731|11034790|FG008|STARTED|Part 1||0
9917885|NCT01225731|11034791|FG009|STARTED|Part 1||0
9917886|NCT01225731|11034792|FG010|STARTED|Part 1||0
9917887|NCT01225731|11034793|FG011|STARTED|Part 1||0
9917888|NCT01225731|11034794|FG012|STARTED|Part 1||0
9917889|NCT01225731|11034782|FG000|COMPLETED|Part 1||40
9917890|NCT01225731|11034783|FG001|COMPLETED|Part 1||87
9917891|NCT01225731|11034784|FG002|COMPLETED|Part 1||88
9917892|NCT01225731|11034785|FG003|COMPLETED|Part 1||84
9917893|NCT01225731|11034786|FG004|COMPLETED|Part 1||40
9917894|NCT01225731|11034787|FG005|COMPLETED|Part 1||0
9917895|NCT01225731|11034788|FG006|COMPLETED|Part 1||0
9917896|NCT01225731|11034789|FG007|COMPLETED|Part 1||0
9917897|NCT01225731|11034790|FG008|COMPLETED|Part 1||0
9917898|NCT01225731|11034791|FG009|COMPLETED|Part 1||0
9917899|NCT01225731|11034792|FG010|COMPLETED|Part 1||0
9917900|NCT01225731|11034793|FG011|COMPLETED|Part 1||0
9917901|NCT01225731|11034794|FG012|COMPLETED|Part 1||0
9917902|NCT01225731|11034782|FG000|NOT COMPLETED|Part 1||2
9917903|NCT01225731|11034783|FG001|NOT COMPLETED|Part 1||5
9917904|NCT01225731|11034784|FG002|NOT COMPLETED|Part 1||1
9917905|NCT01225731|11034785|FG003|NOT COMPLETED|Part 1||2
9917906|NCT01225731|11034786|FG004|NOT COMPLETED|Part 1||6
9917907|NCT01225731|11034787|FG005|NOT COMPLETED|Part 1||0
9917908|NCT01225731|11034788|FG006|NOT COMPLETED|Part 1||0
9917909|NCT01225731|11034789|FG007|NOT COMPLETED|Part 1||0
9917910|NCT01225731|11034790|FG008|NOT COMPLETED|Part 1||0
9917911|NCT01225731|11034791|FG009|NOT COMPLETED|Part 1||0
9917912|NCT01225731|11034792|FG010|NOT COMPLETED|Part 1||0
9917913|NCT01225731|11034793|FG011|NOT COMPLETED|Part 1||0
9917914|NCT01225731|11034794|FG012|NOT COMPLETED|Part 1||0
9917915|NCT01225731|11034782|FG000|STARTED|Part 2|Participants could progress into Part 2|0
9917916|NCT01225731|11034783|FG001|STARTED|Part 2|Participants could progress into Part 2|0
9917917|NCT01225731|11034784|FG002|STARTED|Part 2|Participants could progress into Part 2|0
9917918|NCT01225731|11034785|FG003|STARTED|Part 2|Participants could progress into Part 2|0
9917919|NCT01225731|11034786|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
9917920|NCT01225731|11034787|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
9917921|NCT01225731|11034788|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
9917922|NCT01225731|11034789|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
9917923|NCT01225731|11034790|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
9917924|NCT01225731|11034791|FG009|STARTED|Part 2||0
9917925|NCT01225731|11034792|FG010|STARTED|Part 2||0
9917926|NCT01225731|11034793|FG011|STARTED|Part 2||0
9917927|NCT01225731|11034794|FG012|STARTED|Part 2||0
9917928|NCT01225731|11034782|FG000|COMPLETED|Part 2||0
9917929|NCT01225731|11034783|FG001|COMPLETED|Part 2||0
9917930|NCT01225731|11034784|FG002|COMPLETED|Part 2||0
9917931|NCT01225731|11034785|FG003|COMPLETED|Part 2||0
9917932|NCT01225731|11034786|FG004|COMPLETED|Part 2||0
9917933|NCT01225731|11034787|FG005|COMPLETED|Part 2||10
9917934|NCT01225731|11034788|FG006|COMPLETED|Part 2||86
9917935|NCT01225731|11034789|FG007|COMPLETED|Part 2||128
9917936|NCT01225731|11034790|FG008|COMPLETED|Part 2||68
9917937|NCT01225731|11034791|FG009|COMPLETED|Part 2||0
9917938|NCT01225731|11034792|FG010|COMPLETED|Part 2||0
9917939|NCT01225731|11034793|FG011|COMPLETED|Part 2||0
9917940|NCT01225731|11034794|FG012|COMPLETED|Part 2||0
9917941|NCT01225731|11034782|FG000|NOT COMPLETED|Part 2||0
9917942|NCT01225731|11034783|FG001|NOT COMPLETED|Part 2||0
9917943|NCT01225731|11034784|FG002|NOT COMPLETED|Part 2||0
9917944|NCT01225731|11034785|FG003|NOT COMPLETED|Part 2||0
9917945|NCT01225731|11034786|FG004|NOT COMPLETED|Part 2||0
9917946|NCT01225731|11034787|FG005|NOT COMPLETED|Part 2||3
9917947|NCT01225731|11034788|FG006|NOT COMPLETED|Part 2||8
9917948|NCT01225731|11034789|FG007|NOT COMPLETED|Part 2||25
9917949|NCT01225731|11034790|FG008|NOT COMPLETED|Part 2||11
9917950|NCT01225731|11034791|FG009|NOT COMPLETED|Part 2||0
9917951|NCT01225731|11034792|FG010|NOT COMPLETED|Part 2||0
9917952|NCT01225731|11034793|FG011|NOT COMPLETED|Part 2||0
9917953|NCT01225731|11034794|FG012|NOT COMPLETED|Part 2||0
9917954|NCT01225731|11034782|FG000|STARTED|Part 3||0
9917955|NCT01225731|11034783|FG001|STARTED|Part 3||0
9917956|NCT01225731|11034784|FG002|STARTED|Part 3||0
9917957|NCT01225731|11034785|FG003|STARTED|Part 3||0
9917958|NCT01225731|11034786|FG004|STARTED|Part 3||0
9917959|NCT01225731|11034787|FG005|STARTED|Part 3|Participants could enter the follow-up period|0
9917960|NCT01225731|11034788|FG006|STARTED|Part 3|Participants could enter the follow-up period|0
9917961|NCT01225731|11034789|FG007|STARTED|Part 3|Participants could enter the follow-up period|0
9917962|NCT01225731|11034790|FG008|STARTED|Part 3|Participants could enter the follow-up period|0
9917963|NCT01225731|11034791|FG009|STARTED|Part 3|Not all participants entered follow-up|10
9917964|NCT01225731|11034792|FG010|STARTED|Part 3|Not all participants entered follow-up|86
9917965|NCT01225731|11034793|FG011|STARTED|Part 3|Not all participants entered follow-up|126
9917966|NCT01225731|11034794|FG012|STARTED|Part 3|Not all participants entered follow-up|67
9917967|NCT01225731|11034782|FG000|COMPLETED|Part 3||0
9917968|NCT01225731|11034783|FG001|COMPLETED|Part 3||0
9917969|NCT01225731|11034784|FG002|COMPLETED|Part 3||0
9917970|NCT01225731|11034785|FG003|COMPLETED|Part 3||0
9917971|NCT01225731|11034786|FG004|COMPLETED|Part 3||0
9917972|NCT01225731|11034787|FG005|COMPLETED|Part 3||0
9917973|NCT01225731|11034788|FG006|COMPLETED|Part 3||0
9917974|NCT01225731|11034789|FG007|COMPLETED|Part 3||0
9917975|NCT01225731|11034790|FG008|COMPLETED|Part 3||0
9917976|NCT01225731|11034791|FG009|COMPLETED|Part 3||10
9917977|NCT01225731|11034792|FG010|COMPLETED|Part 3||80
9917978|NCT01225731|11034793|FG011|COMPLETED|Part 3||116
9917979|NCT01225731|11034794|FG012|COMPLETED|Part 3||60
9917980|NCT01225731|11034782|FG000|NOT COMPLETED|Part 3||0
9917981|NCT01225731|11034783|FG001|NOT COMPLETED|Part 3||0
9917982|NCT01225731|11034784|FG002|NOT COMPLETED|Part 3||0
9917983|NCT01225731|11034785|FG003|NOT COMPLETED|Part 3||0
9917984|NCT01225731|11034786|FG004|NOT COMPLETED|Part 3||0
9917985|NCT01225731|11034787|FG005|NOT COMPLETED|Part 3||0
9917986|NCT01225731|11034788|FG006|NOT COMPLETED|Part 3||0
9917987|NCT01225731|11034789|FG007|NOT COMPLETED|Part 3||0
9917988|NCT01225731|11034790|FG008|NOT COMPLETED|Part 3||0
9917989|NCT01225731|11034791|FG009|NOT COMPLETED|Part 3||0
9917990|NCT01225731|11034792|FG010|NOT COMPLETED|Part 3||6
9917991|NCT01225731|11034793|FG011|NOT COMPLETED|Part 3||10
9917992|NCT01225731|11034794|FG012|NOT COMPLETED|Part 3||7
9917993|NCT01225822|11034828|FG000|STARTED|Overall Study||389
9917994|NCT01225822|11034829|FG001|STARTED|Overall Study||390
9917995|NCT01225822|11034830|FG002|STARTED|Overall Study||393
9917996|NCT01225822|11034831|FG003|STARTED|Overall Study||385
9917997|NCT01225822|11034832|FG004|STARTED|Overall Study||392
9917998|NCT01225822|11034828|FG000|COMPLETED|Overall Study||351
9917999|NCT01225822|11034829|FG001|COMPLETED|Overall Study||334
9918000|NCT01225822|11034830|FG002|COMPLETED|Overall Study||355
9918001|NCT01225822|11034831|FG003|COMPLETED|Overall Study||333
9918002|NCT01225822|11034832|FG004|COMPLETED|Overall Study||361
9918003|NCT01225822|11034828|FG000|NOT COMPLETED|Overall Study||38
9918004|NCT01225822|11034829|FG001|NOT COMPLETED|Overall Study||56
9918005|NCT01225822|11034830|FG002|NOT COMPLETED|Overall Study||38
9918006|NCT01225822|11034831|FG003|NOT COMPLETED|Overall Study||52
9918007|NCT01225822|11034832|FG004|NOT COMPLETED|Overall Study||31
9918008|NCT01225835|11034849|FG000|STARTED|Overall Study||62
9918009|NCT01225835|11034850|FG001|STARTED|Overall Study||62
9918010|NCT01225835|11034849|FG000|Per Protocol Population|Overall Study||48
9918011|NCT01225835|11034850|FG001|Per Protocol Population|Overall Study||58
9918012|NCT01225835|11034849|FG000|COMPLETED|Overall Study|hCG criterion met|55
9918013|NCT01225835|11034850|FG001|COMPLETED|Overall Study|hCG criterion met|59
9918014|NCT01225835|11034849|FG000|NOT COMPLETED|Overall Study||7
9918015|NCT01225835|11034850|FG001|NOT COMPLETED|Overall Study||3
9918016|NCT01225887|11034862|FG000|STARTED|Overall Study||37
9918017|NCT01225887|11034862|FG000|COMPLETED|Overall Study||32
9918018|NCT01225887|11034862|FG000|NOT COMPLETED|Overall Study||5
9918019|NCT01225926|11034868|FG000|STARTED|Overall Study||12
9918020|NCT01225926|11034869|FG001|STARTED|Overall Study||12
9918021|NCT01225926|11034868|FG000|COMPLETED|Overall Study||12
9918022|NCT01225926|11034869|FG001|COMPLETED|Overall Study||12
9918023|NCT01225926|11034868|FG000|NOT COMPLETED|Overall Study||0
9918024|NCT01225926|11034869|FG001|NOT COMPLETED|Overall Study||0
9918025|NCT01225952|11034878|FG000|STARTED|Overall Study||31
9918026|NCT01225952|11034879|FG001|STARTED|Overall Study||31
9918027|NCT01225952|11034880|FG002|STARTED|Overall Study||31
9918028|NCT01225952|11034878|FG000|COMPLETED|Overall Study||25
9918029|NCT01225952|11034879|FG001|COMPLETED|Overall Study||27
9918030|NCT01225952|11034880|FG002|COMPLETED|Overall Study||25
9918031|NCT01225952|11034878|FG000|NOT COMPLETED|Overall Study||6
9918032|NCT01225952|11034879|FG001|NOT COMPLETED|Overall Study||4
9918033|NCT01225952|11034880|FG002|NOT COMPLETED|Overall Study||6
9918034|NCT01225991|11034888|FG000|STARTED|Overall Study||18
9918035|NCT01225991|11034888|FG000|COMPLETED|Overall Study||12
9918036|NCT01225991|11034888|FG000|NOT COMPLETED|Overall Study||6
9918037|NCT01226043|11034894|FG000|STARTED|4-week Crossover Phase - Period 1||202
9918038|NCT01226043|11034895|FG001|STARTED|4-week Crossover Phase - Period 1||203
9918039|NCT01226043|11034896|FG002|STARTED|4-week Crossover Phase - Period 1||0
9918040|NCT01226043|11034897|FG003|STARTED|4-week Crossover Phase - Period 1||0
9918041|NCT01226043|11034894|FG000|TREATED|4-week Crossover Phase - Period 1||202
9918042|NCT01226043|11034895|FG001|TREATED|4-week Crossover Phase - Period 1||200
9918043|NCT01226043|11034896|FG002|TREATED|4-week Crossover Phase - Period 1||0
9918044|NCT01226043|11034897|FG003|TREATED|4-week Crossover Phase - Period 1||0
9918045|NCT01226043|11034894|FG000|COMPLETED|4-week Crossover Phase - Period 1||199
9918046|NCT01226043|11034895|FG001|COMPLETED|4-week Crossover Phase - Period 1||194
9918047|NCT01226043|11034896|FG002|COMPLETED|4-week Crossover Phase - Period 1||0
9918048|NCT01226043|11034897|FG003|COMPLETED|4-week Crossover Phase - Period 1||0
9918049|NCT01226043|11034894|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3
9918050|NCT01226043|11034895|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9
9918051|NCT01226043|11034896|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0
9918052|NCT01226043|11034897|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0
9918053|NCT01226043|11034894|FG000|STARTED|4-week Crossover Phase - Period 2||199
9918054|NCT01226043|11034895|FG001|STARTED|4-week Crossover Phase - Period 2||194
9918055|NCT01226043|11034896|FG002|STARTED|4-week Crossover Phase - Period 2||0
9918056|NCT01226043|11034897|FG003|STARTED|4-week Crossover Phase - Period 2||0
9918057|NCT01226043|11034894|FG000|TREATED|4-week Crossover Phase - Period 2||199
9918058|NCT01226043|11034895|FG001|TREATED|4-week Crossover Phase - Period 2||194
9918059|NCT01226043|11034896|FG002|TREATED|4-week Crossover Phase - Period 2||0
9918060|NCT01226043|11034897|FG003|TREATED|4-week Crossover Phase - Period 2||0
9918061|NCT01226043|11034894|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
9918062|NCT01226043|11034895|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
9918063|NCT01226043|11034896|FG002|COMPLETED|4-week Crossover Phase - Period 2||0
9918064|NCT01226043|11034897|FG003|COMPLETED|4-week Crossover Phase - Period 2||0
9918065|NCT01226043|11034894|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4
9918066|NCT01226043|11034895|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6
9918067|NCT01226043|11034896|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0
9918068|NCT01226043|11034897|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0
9918069|NCT01226043|11034894|FG000|STARTED|6-week Re-randomization Phase||0
9918070|NCT01226043|11034895|FG001|STARTED|6-week Re-randomization Phase||0
9918071|NCT01226043|11034896|FG002|STARTED|6-week Re-randomization Phase||166
9918072|NCT01226043|11034897|FG003|STARTED|6-week Re-randomization Phase||167
9918073|NCT01226043|11034894|FG000|TREATED|6-week Re-randomization Phase||0
9918074|NCT01226043|11034895|FG001|TREATED|6-week Re-randomization Phase||0
9918075|NCT01226043|11034896|FG002|TREATED|6-week Re-randomization Phase||165
9918076|NCT01226043|11034897|FG003|TREATED|6-week Re-randomization Phase||165
9918077|NCT01226043|11034894|FG000|COMPLETED|6-week Re-randomization Phase||0
9918078|NCT01226043|11034895|FG001|COMPLETED|6-week Re-randomization Phase||0
9918079|NCT01226043|11034896|FG002|COMPLETED|6-week Re-randomization Phase||159
9955674|NCT01439971|11074682|FG000|Received Treatment|Overall Study||1
9918080|NCT01226043|11034897|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
9918081|NCT01226043|11034894|FG000|NOT COMPLETED|6-week Re-randomization Phase||0
9918082|NCT01226043|11034895|FG001|NOT COMPLETED|6-week Re-randomization Phase||0
9918083|NCT01226043|11034896|FG002|NOT COMPLETED|6-week Re-randomization Phase||7
9918084|NCT01226043|11034897|FG003|NOT COMPLETED|6-week Re-randomization Phase||11
9918085|NCT01226043|11034894|FG000|STARTED|30-week Observational Phase||0
10010418|NCT01774305|11133219|FG001|NOT COMPLETED|Overall Study||0
10010419|NCT01774344|11133227|FG000|STARTED|Overall Study||194
10010420|NCT01774344|11133228|FG001|STARTED|Overall Study||379
10010421|NCT01774344|11133227|FG000|Treated|Overall Study||193
10010422|NCT01774344|11133228|FG001|Treated|Overall Study||374
9918086|NCT01226043|11034895|FG001|STARTED|30-week Observational Phase||0
9918087|NCT01226043|11034896|FG002|STARTED|30-week Observational Phase||159
9918088|NCT01226043|11034897|FG003|STARTED|30-week Observational Phase||153
9918089|NCT01226043|11034894|FG000|TREATED|30-week Observational Phase||0
9918090|NCT01226043|11034895|FG001|TREATED|30-week Observational Phase||0
9918091|NCT01226043|11034896|FG002|TREATED|30-week Observational Phase||159
9918092|NCT01226043|11034897|FG003|TREATED|30-week Observational Phase||153
9918093|NCT01226043|11034894|FG000|COMPLETED|30-week Observational Phase||0
9918094|NCT01226043|11034895|FG001|COMPLETED|30-week Observational Phase||0
9918095|NCT01226043|11034896|FG002|COMPLETED|30-week Observational Phase||153
9918096|NCT01226043|11034897|FG003|COMPLETED|30-week Observational Phase||140
9918097|NCT01226043|11034894|FG000|NOT COMPLETED|30-week Observational Phase||0
9918098|NCT01226043|11034895|FG001|NOT COMPLETED|30-week Observational Phase||0
9918099|NCT01226043|11034896|FG002|NOT COMPLETED|30-week Observational Phase||6
9918100|NCT01226043|11034897|FG003|NOT COMPLETED|30-week Observational Phase||13
9955675|NCT01439971|11074683|FG001|Received Treatment|Overall Study||6
9955676|NCT01439971|11074684|FG002|Received Treatment|Overall Study||6
9955677|NCT01439971|11074685|FG003|Received Treatment|Overall Study||6
9955678|NCT01439971|11074686|FG004|Received Treatment|Overall Study||6
9955679|NCT01439971|11074682|FG000|COMPLETED|Overall Study||1
9955680|NCT01439971|11074683|FG001|COMPLETED|Overall Study||6
9955681|NCT01439971|11074684|FG002|COMPLETED|Overall Study||6
9955682|NCT01439971|11074685|FG003|COMPLETED|Overall Study||6
9955683|NCT01439971|11074686|FG004|COMPLETED|Overall Study||6
9955684|NCT01439971|11074682|FG000|NOT COMPLETED|Overall Study||0
9955685|NCT01439971|11074683|FG001|NOT COMPLETED|Overall Study||1
9955686|NCT01439971|11074684|FG002|NOT COMPLETED|Overall Study||2
9955687|NCT01439971|11074685|FG003|NOT COMPLETED|Overall Study||0
9955688|NCT01439971|11074686|FG004|NOT COMPLETED|Overall Study||1
9955689|NCT01440049|11074698|FG000|STARTED|Overall Study||160
9955690|NCT01440049|11074698|FG000|COMPLETED|Overall Study||155
9955691|NCT01440049|11074698|FG000|NOT COMPLETED|Overall Study||5
9955692|NCT01440101|11074705|FG000|STARTED|Overall Study||12
9955693|NCT01440101|11074706|FG001|STARTED|Overall Study||47
9955694|NCT01440101|11074707|FG002|STARTED|Overall Study||47
9955695|NCT01440101|11074705|FG000|COMPLETED|Overall Study||10
9955696|NCT01440101|11074706|FG001|COMPLETED|Overall Study||43
9955697|NCT01440101|11074707|FG002|COMPLETED|Overall Study||46
9955698|NCT01440101|11074705|FG000|NOT COMPLETED|Overall Study||2
9955699|NCT01440101|11074706|FG001|NOT COMPLETED|Overall Study||4
9955700|NCT01440101|11074707|FG002|NOT COMPLETED|Overall Study||1
9955701|NCT01440283|11074716|FG000|STARTED|Overall Study||14
9955702|NCT01440283|11074716|FG000|COMPLETED|Overall Study||4
9955703|NCT01440283|11074716|FG000|NOT COMPLETED|Overall Study||10
9955704|NCT01440322|11074728|FG000|STARTED|Overall Study||97
9955705|NCT01440322|11074729|FG001|STARTED|Overall Study||50
9955706|NCT01440322|11074728|FG000|COMPLETED|Overall Study||90
9955707|NCT01440322|11074729|FG001|COMPLETED|Overall Study||49
9955708|NCT01440322|11074728|FG000|NOT COMPLETED|Overall Study||7
9955709|NCT01440322|11074729|FG001|NOT COMPLETED|Overall Study||1
9955710|NCT01440374|11074738|FG000|STARTED|Part 1: Open-label Phase||17
9955711|NCT01440374|11074739|FG001|STARTED|Part 1: Open-label Phase||0
9955712|NCT01440374|11074740|FG002|STARTED|Part 1: Open-label Phase||0
9955713|NCT01440374|11074741|FG003|STARTED|Part 1: Open-label Phase||0
9955714|NCT01440374|11074738|FG000|COMPLETED|Part 1: Open-label Phase||11
9955715|NCT01440374|11074739|FG001|COMPLETED|Part 1: Open-label Phase||0
9955716|NCT01440374|11074740|FG002|COMPLETED|Part 1: Open-label Phase||0
9955717|NCT01440374|11074741|FG003|COMPLETED|Part 1: Open-label Phase||0
9955718|NCT01440374|11074738|FG000|NOT COMPLETED|Part 1: Open-label Phase||6
9955719|NCT01440374|11074739|FG001|NOT COMPLETED|Part 1: Open-label Phase||0
9955720|NCT01440374|11074740|FG002|NOT COMPLETED|Part 1: Open-label Phase||0
9955721|NCT01440374|11074741|FG003|NOT COMPLETED|Part 1: Open-label Phase||0
9955722|NCT01440374|11074738|FG000|STARTED|Part 2; Double-blind Phase||0
9955723|NCT01440374|11074739|FG001|STARTED|Part 2; Double-blind Phase||47
9955724|NCT01440374|11074740|FG002|STARTED|Part 2; Double-blind Phase||98
9955725|NCT01440374|11074741|FG003|STARTED|Part 2; Double-blind Phase||0
9955726|NCT01440374|11074738|FG000|COMPLETED|Part 2; Double-blind Phase||0
9955727|NCT01440374|11074739|FG001|COMPLETED|Part 2; Double-blind Phase||27
9955728|NCT01440374|11074740|FG002|COMPLETED|Part 2; Double-blind Phase||43
9955729|NCT01440374|11074741|FG003|COMPLETED|Part 2; Double-blind Phase||0
9955730|NCT01440374|11074738|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0
9955731|NCT01440374|11074739|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20
9955732|NCT01440374|11074740|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55
9955733|NCT01440374|11074741|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0
9918101|NCT01226095|11034927|FG000|STARTED|Overall Study||519
9918102|NCT01226095|11034927|FG000|COMPLETED|Overall Study||518
9918103|NCT01226095|11034927|FG000|NOT COMPLETED|Overall Study||1
9918104|NCT01226121|11034941|FG000|STARTED|Overall Study||13
9918105|NCT01226121|11034942|FG001|STARTED|Overall Study||11
9918106|NCT01226121|11034943|FG002|STARTED|Overall Study||13
9918107|NCT01226121|11034941|FG000|30 Day Evaluation|Overall Study||12
9918108|NCT01226121|11034942|FG001|30 Day Evaluation|Overall Study||11
9918109|NCT01226121|11034943|FG002|30 Day Evaluation|Overall Study||13
9918110|NCT01226121|11034941|FG000|COMPLETED|Overall Study||11
9918111|NCT01226121|11034942|FG001|COMPLETED|Overall Study||11
9918112|NCT01226121|11034943|FG002|COMPLETED|Overall Study||12
9918113|NCT01226121|11034941|FG000|NOT COMPLETED|Overall Study||2
9918114|NCT01226121|11034942|FG001|NOT COMPLETED|Overall Study||0
9918115|NCT01226121|11034943|FG002|NOT COMPLETED|Overall Study||1
9918116|NCT01226420|11034951|FG000|STARTED|Overall Study||6
9918117|NCT01226420|11034951|FG000|COMPLETED|Overall Study||6
9918118|NCT01226420|11034951|FG000|NOT COMPLETED|Overall Study||0
9918119|NCT01226459|11034957|FG000|STARTED|Overall Study||201
9918120|NCT01226459|11034958|FG001|STARTED|Overall Study||203
9918121|NCT01226459|11034957|FG000|COMPLETED|Overall Study||180
9918122|NCT01226459|11034958|FG001|COMPLETED|Overall Study||171
9918123|NCT01226459|11034957|FG000|NOT COMPLETED|Overall Study||21
9918124|NCT01226459|11034958|FG001|NOT COMPLETED|Overall Study||32
9918125|NCT01226472|11034964|FG000|STARTED|Overall Study||1
9918126|NCT01226472|11034964|FG000|COMPLETED|Overall Study||0
9918127|NCT01226472|11034964|FG000|NOT COMPLETED|Overall Study||1
9918128|NCT01226485|11034975|FG000|STARTED|Overall Study||3
9918129|NCT01226485|11034976|FG001|STARTED|Overall Study||6
9918130|NCT01226485|11034977|FG002|STARTED|Overall Study||3
9918131|NCT01226485|11034978|FG003|STARTED|Overall Study||6
9918132|NCT01226485|11034979|FG004|STARTED|Overall Study||7
9918133|NCT01226485|11034980|FG005|STARTED|Overall Study||19
9918134|NCT01226485|11034981|FG006|STARTED|Overall Study||40
9918135|NCT01226485|11034975|FG000|Received at Least One Dose of Drug|Overall Study||3
9918136|NCT01226485|11034976|FG001|Received at Least One Dose of Drug|Overall Study||6
9918137|NCT01226485|11034977|FG002|Received at Least One Dose of Drug|Overall Study||3
9918138|NCT01226485|11034978|FG003|Received at Least One Dose of Drug|Overall Study||6
9918139|NCT01226485|11034979|FG004|Received at Least One Dose of Drug|Overall Study||7
9918140|NCT01226485|11034980|FG005|Received at Least One Dose of Drug|Overall Study||19
9918141|NCT01226485|11034981|FG006|Received at Least One Dose of Drug|Overall Study||40
9918142|NCT01226485|11034975|FG000|COMPLETED|Overall Study||3
9918143|NCT01226485|11034976|FG001|COMPLETED|Overall Study||6
9918144|NCT01226485|11034977|FG002|COMPLETED|Overall Study||3
9918145|NCT01226485|11034978|FG003|COMPLETED|Overall Study||6
9918146|NCT01226485|11034979|FG004|COMPLETED|Overall Study||7
9918147|NCT01226485|11034980|FG005|COMPLETED|Overall Study||19
9918148|NCT01226485|11034981|FG006|COMPLETED|Overall Study||40
9918149|NCT01226485|11034975|FG000|NOT COMPLETED|Overall Study||0
9918150|NCT01226485|11034976|FG001|NOT COMPLETED|Overall Study||0
9918151|NCT01226485|11034977|FG002|NOT COMPLETED|Overall Study||0
9918152|NCT01226485|11034978|FG003|NOT COMPLETED|Overall Study||0
9918153|NCT01226485|11034979|FG004|NOT COMPLETED|Overall Study||0
9918154|NCT01226485|11034980|FG005|NOT COMPLETED|Overall Study||0
9918155|NCT01226485|11034981|FG006|NOT COMPLETED|Overall Study||0
9918156|NCT01226511|11035007|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
9918157|NCT01226511|11035008|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
9918158|NCT01226511|11035007|FG000|COMPLETED|Acute Treatment Period||108
9918159|NCT01226511|11035008|FG001|COMPLETED|Acute Treatment Period||110
9918160|NCT01226511|11035007|FG000|NOT COMPLETED|Acute Treatment Period||32
9918161|NCT01226511|11035008|FG001|NOT COMPLETED|Acute Treatment Period||31
9918162|NCT01226511|11035007|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
9918163|NCT01226511|11035008|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
9918164|NCT01226511|11035007|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
9918165|NCT01226511|11035008|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
9918166|NCT01226511|11035007|FG000|NOT COMPLETED|Extension Treatment Period||27
9918167|NCT01226511|11035008|FG001|NOT COMPLETED|Extension Treatment Period||27
9918168|NCT01226511|11035007|FG000|STARTED|Taper Period||51
9918169|NCT01226511|11035008|FG001|STARTED|Taper Period||57
9918170|NCT01226511|11035007|FG000|COMPLETED|Taper Period||46
9918171|NCT01226511|11035008|FG001|COMPLETED|Taper Period||54
9918172|NCT01226511|11035007|FG000|NOT COMPLETED|Taper Period||5
9918173|NCT01226511|11035008|FG001|NOT COMPLETED|Taper Period||3
9918174|NCT01226706|11035022|FG000|STARTED|Overall Study||10
9918175|NCT01226706|11035023|FG001|STARTED|Overall Study||11
9918176|NCT01226706|11035022|FG000|COMPLETED|Overall Study||10
9918177|NCT01226706|11035023|FG001|COMPLETED|Overall Study||11
9918178|NCT01226706|11035022|FG000|NOT COMPLETED|Overall Study||0
9918179|NCT01226706|11035023|FG001|NOT COMPLETED|Overall Study||0
9918180|NCT01226719|11035031|FG000|STARTED|Overall Study||15
9918181|NCT01226719|11035031|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
9918182|NCT01226719|11035031|FG000|NOT COMPLETED|Overall Study||13
9918183|NCT01226745|11035041|FG000|STARTED|Overall Study||80
9918184|NCT01226745|11035042|FG001|STARTED|Overall Study||87
9918185|NCT01226745|11035043|FG002|STARTED|Overall Study||89
9918186|NCT01226745|11035044|FG003|STARTED|Overall Study||29
9918187|NCT01226745|11035045|FG004|STARTED|Overall Study||26
9918188|NCT01226745|11035046|FG005|STARTED|Overall Study||29
9918189|NCT01226745|11035041|FG000|COMPLETED|Overall Study||63
9918190|NCT01226745|11035042|FG001|COMPLETED|Overall Study||71
9918191|NCT01226745|11035043|FG002|COMPLETED|Overall Study||69
9918192|NCT01226745|11035044|FG003|COMPLETED|Overall Study||24
9918193|NCT01226745|11035045|FG004|COMPLETED|Overall Study||22
9918194|NCT01226745|11035046|FG005|COMPLETED|Overall Study||24
9918195|NCT01226745|11035041|FG000|NOT COMPLETED|Overall Study||17
9918196|NCT01226745|11035042|FG001|NOT COMPLETED|Overall Study||16
9918197|NCT01226745|11035043|FG002|NOT COMPLETED|Overall Study||20
9918198|NCT01226745|11035044|FG003|NOT COMPLETED|Overall Study||5
9918199|NCT01226745|11035045|FG004|NOT COMPLETED|Overall Study||4
9918200|NCT01226745|11035046|FG005|NOT COMPLETED|Overall Study||5
9918201|NCT01226914|11035063|FG000|STARTED|Overall Study||28
9918202|NCT01226914|11035064|FG001|STARTED|Overall Study||27
9918203|NCT01226914|11035063|FG000|COMPLETED|Overall Study||28
9918204|NCT01226914|11035064|FG001|COMPLETED|Overall Study||27
9918205|NCT01226914|11035063|FG000|NOT COMPLETED|Overall Study||0
9918206|NCT01226914|11035064|FG001|NOT COMPLETED|Overall Study||0
9918207|NCT01226979|11035070|FG000|STARTED|Overall Study||16
9918208|NCT01226979|11035070|FG000|COMPLETED|Overall Study||16
9918209|NCT01226979|11035070|FG000|NOT COMPLETED|Overall Study||0
9918210|NCT01227005|11035077|FG000|STARTED|Overall Study||55
9918211|NCT01227005|11035078|FG001|STARTED|Overall Study||52
9918212|NCT01227005|11035077|FG000|COMPLETED|Overall Study||50
9918213|NCT01227005|11035078|FG001|COMPLETED|Overall Study||51
9918214|NCT01227005|11035077|FG000|NOT COMPLETED|Overall Study||5
9918215|NCT01227005|11035078|FG001|NOT COMPLETED|Overall Study||1
9918216|NCT01227018|11035084|FG000|STARTED|Overall Study||15
9918217|NCT01227018|11035084|FG000|COMPLETED|Overall Study||0
9918218|NCT01227018|11035084|FG000|NOT COMPLETED|Overall Study||15
9918219|NCT01227044|11035090|FG000|STARTED|Overall Study||25
9918220|NCT01227044|11035091|FG001|STARTED|Overall Study||26
9918221|NCT01227044|11035090|FG000|COMPLETED|Overall Study||19
9918222|NCT01227044|11035091|FG001|COMPLETED|Overall Study||17
9918223|NCT01227044|11035090|FG000|NOT COMPLETED|Overall Study||6
9918224|NCT01227044|11035091|FG001|NOT COMPLETED|Overall Study||9
9918225|NCT01227057|11035099|FG000|STARTED|Overall Study||31
9918226|NCT01227057|11035100|FG001|STARTED|Overall Study||27
9918227|NCT01227057|11035099|FG000|COMPLETED|Overall Study||25
9918228|NCT01227057|11035100|FG001|COMPLETED|Overall Study||19
9918229|NCT01227057|11035099|FG000|NOT COMPLETED|Overall Study||6
9918230|NCT01227057|11035100|FG001|NOT COMPLETED|Overall Study||8
9918231|NCT01227252|11035111|FG000|STARTED|Overall Study||12
9918232|NCT01227252|11035112|FG001|STARTED|Overall Study||10
9918233|NCT01227252|11035113|FG002|STARTED|Overall Study||10
9918234|NCT01227252|11035114|FG003|STARTED|Overall Study||10
9918235|NCT01227252|11035111|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
9918236|NCT01227252|11035112|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
9918237|NCT01227252|11035113|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
9918238|NCT01227252|11035114|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
9918239|NCT01227252|11035111|FG000|COMPLETED|Overall Study||12
9918240|NCT01227252|11035112|FG001|COMPLETED|Overall Study||7
9918241|NCT01227252|11035113|FG002|COMPLETED|Overall Study||10
9918242|NCT01227252|11035114|FG003|COMPLETED|Overall Study||10
9918243|NCT01227252|11035111|FG000|NOT COMPLETED|Overall Study||0
9918244|NCT01227252|11035112|FG001|NOT COMPLETED|Overall Study||3
9918245|NCT01227252|11035113|FG002|NOT COMPLETED|Overall Study||0
9918246|NCT01227252|11035114|FG003|NOT COMPLETED|Overall Study||0
9918247|NCT01227265|11035130|FG000|STARTED|Overall Study||158
9918248|NCT01227265|11035131|FG001|STARTED|Overall Study||159
9918249|NCT01227265|11035132|FG002|STARTED|Overall Study||159
9918250|NCT01227265|11035130|FG000|Treated|Overall Study||157
9918251|NCT01227265|11035131|FG001|Treated|Overall Study||157
9918252|NCT01227265|11035132|FG002|Treated|Overall Study||159
9918253|NCT01227265|11035130|FG000|COMPLETED|Overall Study||139
9918254|NCT01227265|11035131|FG001|COMPLETED|Overall Study||139
9918255|NCT01227265|11035132|FG002|COMPLETED|Overall Study||145
9918256|NCT01227265|11035130|FG000|NOT COMPLETED|Overall Study||19
9918257|NCT01227265|11035131|FG001|NOT COMPLETED|Overall Study||20
9918258|NCT01227265|11035132|FG002|NOT COMPLETED|Overall Study||14
9918259|NCT01227278|11035142|FG000|STARTED|Overall Study||50
9918260|NCT01227278|11035143|FG001|STARTED|Overall Study||51
9918261|NCT01227278|11035142|FG000|COMPLETED|Overall Study||45
9918262|NCT01227278|11035143|FG001|COMPLETED|Overall Study||43
9918263|NCT01227278|11035142|FG000|NOT COMPLETED|Overall Study||5
9918264|NCT01227278|11035143|FG001|NOT COMPLETED|Overall Study||8
9918265|NCT01227382|11035149|FG000|STARTED|Overall Study||26
9918266|NCT01227382|11035149|FG000|COMPLETED|Overall Study||26
9918267|NCT01227382|11035149|FG000|NOT COMPLETED|Overall Study||0
9918268|NCT01227395|11035157|FG000|STARTED|Overall Study||391
9918269|NCT01227395|11035158|FG001|STARTED|Overall Study||85
9918270|NCT01227395|11035157|FG000|COMPLETED|Overall Study||391
9918271|NCT01227395|11035158|FG001|COMPLETED|Overall Study||84
9918272|NCT01227395|11035157|FG000|NOT COMPLETED|Overall Study||0
9918273|NCT01227395|11035158|FG001|NOT COMPLETED|Overall Study||1
9918274|NCT01227421|11035186|FG000|STARTED|Overall Study||201
9918275|NCT01227421|11035187|FG001|STARTED|Overall Study||212
9918276|NCT01227421|11035188|FG002|STARTED|Overall Study||211
9918277|NCT01227421|11035186|FG000|COMPLETED|Overall Study||190
9918278|NCT01227421|11035187|FG001|COMPLETED|Overall Study||194
9918279|NCT01227421|11035188|FG002|COMPLETED|Overall Study||201
9918280|NCT01227421|11035186|FG000|NOT COMPLETED|Overall Study||11
9918281|NCT01227421|11035187|FG001|NOT COMPLETED|Overall Study||18
9918282|NCT01227421|11035188|FG002|NOT COMPLETED|Overall Study||10
9918283|NCT01227434|11035198|FG000|STARTED|Overall Study||6
9918284|NCT01227434|11035199|FG001|STARTED|Overall Study||16
9918285|NCT01227434|11035198|FG000|COMPLETED|Overall Study||6
9918286|NCT01227434|11035199|FG001|COMPLETED|Overall Study||16
9918287|NCT01227434|11035198|FG000|NOT COMPLETED|Overall Study||0
9918288|NCT01227434|11035199|FG001|NOT COMPLETED|Overall Study||0
9918289|NCT01227512|11035208|FG000|STARTED|Overall Study||66
9918290|NCT01227512|11035209|FG001|STARTED|Overall Study||58
9918291|NCT01227512|11035208|FG000|COMPLETED|Overall Study||53
9918292|NCT01227512|11035209|FG001|COMPLETED|Overall Study||48
9918293|NCT01227512|11035208|FG000|NOT COMPLETED|Overall Study||13
9918294|NCT01227512|11035209|FG001|NOT COMPLETED|Overall Study||10
9918295|NCT01227551|11035217|FG000|STARTED|Overall Study||57
9918296|NCT01227551|11035217|FG000|COMPLETED|Overall Study||23
9918297|NCT01227551|11035217|FG000|NOT COMPLETED|Overall Study||34
10205290|NCT03489720|11332071|FG000|STARTED|Overall Study||24
10205291|NCT03489720|11332072|FG001|STARTED|Overall Study||22
10205292|NCT03489720|11332071|FG000|COMPLETED|Overall Study||22
10205293|NCT03489720|11332072|FG001|COMPLETED|Overall Study||22
10205294|NCT03489720|11332071|FG000|NOT COMPLETED|Overall Study||2
9918298|NCT01227564|11035224|FG000|STARTED|Overall Study||22
9918299|NCT01227564|11035225|FG001|STARTED|Overall Study||20
9918300|NCT01227564|11035226|FG002|STARTED|Overall Study||21
9918301|NCT01227564|11035224|FG000|Treated|Overall Study||22
9918302|NCT01227564|11035225|FG001|Treated|Overall Study||20
9918303|NCT01227564|11035226|FG002|Treated|Overall Study||21
9918304|NCT01227564|11035224|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
9918305|NCT01227564|11035225|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
9918306|NCT01227564|11035226|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
9918307|NCT01227564|11035224|FG000|COMPLETED|Overall Study|Completed study|18
9918308|NCT01227564|11035225|FG001|COMPLETED|Overall Study|Completed study|18
9918309|NCT01227564|11035226|FG002|COMPLETED|Overall Study|Completed study|15
9918310|NCT01227564|11035224|FG000|NOT COMPLETED|Overall Study||4
9918311|NCT01227564|11035225|FG001|NOT COMPLETED|Overall Study||2
9918312|NCT01227564|11035226|FG002|NOT COMPLETED|Overall Study||6
9918313|NCT01227577|11035236|FG000|STARTED|Overall Study||128
9918314|NCT01227577|11035236|FG000|COMPLETED|Overall Study||93
9918315|NCT01227577|11035236|FG000|NOT COMPLETED|Overall Study||35
9918316|NCT01227629|11035250|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
9918317|NCT01227629|11035251|FG001|STARTED|Overall Study||20
9918318|NCT01227629|11035252|FG002|STARTED|Overall Study||27
9918319|NCT01227629|11035253|FG003|STARTED|Overall Study||99
9918320|NCT01227629|11035254|FG004|STARTED|Overall Study||34
9918321|NCT01227629|11035255|FG005|STARTED|Overall Study||33
9918322|NCT01227629|11035256|FG006|STARTED|Overall Study||98
9918323|NCT01227629|11035257|FG007|STARTED|Overall Study||33
9918324|NCT01227629|11035258|FG008|STARTED|Overall Study||30
9918325|NCT01227629|11035259|FG009|STARTED|Overall Study||70
9918326|NCT01227629|11035250|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
9918327|NCT01227629|11035251|FG001|COMPLETED|Overall Study||18
9918328|NCT01227629|11035252|FG002|COMPLETED|Overall Study||26
9918329|NCT01227629|11035253|FG003|COMPLETED|Overall Study||91
9918330|NCT01227629|11035254|FG004|COMPLETED|Overall Study||32
9918331|NCT01227629|11035255|FG005|COMPLETED|Overall Study||32
9918332|NCT01227629|11035256|FG006|COMPLETED|Overall Study||90
9918333|NCT01227629|11035257|FG007|COMPLETED|Overall Study||27
9918334|NCT01227629|11035258|FG008|COMPLETED|Overall Study||24
9918335|NCT01227629|11035259|FG009|COMPLETED|Overall Study||68
9918336|NCT01227629|11035250|FG000|NOT COMPLETED|Overall Study||2
9918337|NCT01227629|11035251|FG001|NOT COMPLETED|Overall Study||2
9918338|NCT01227629|11035252|FG002|NOT COMPLETED|Overall Study||1
9918339|NCT01227629|11035253|FG003|NOT COMPLETED|Overall Study||8
9918340|NCT01227629|11035254|FG004|NOT COMPLETED|Overall Study||2
9918341|NCT01227629|11035255|FG005|NOT COMPLETED|Overall Study||1
9918342|NCT01227629|11035256|FG006|NOT COMPLETED|Overall Study||8
9918343|NCT01227629|11035257|FG007|NOT COMPLETED|Overall Study||6
9918344|NCT01227629|11035258|FG008|NOT COMPLETED|Overall Study||6
9918345|NCT01227629|11035259|FG009|NOT COMPLETED|Overall Study||2
9918346|NCT01227655|11035308|FG000|STARTED|Overall Study||129
9918347|NCT01227655|11035309|FG001|STARTED|Overall Study||154
9918348|NCT01227655|11035310|FG002|STARTED|Overall Study||144
9918349|NCT01227655|11035308|FG000|Safety Set|Overall Study||125
9918350|NCT01227655|11035309|FG001|Safety Set|Overall Study||150
9918351|NCT01227655|11035310|FG002|Safety Set|Overall Study||136
9918352|NCT01227655|11035308|FG000|Full Analysis Set|Overall Study||125
9918353|NCT01227655|11035309|FG001|Full Analysis Set|Overall Study||147
9918354|NCT01227655|11035310|FG002|Full Analysis Set|Overall Study||135
9918355|NCT01227655|11035308|FG000|COMPLETED|Overall Study||118
10205295|NCT03489720|11332072|FG001|NOT COMPLETED|Overall Study||0
9918356|NCT01227655|11035309|FG001|COMPLETED|Overall Study||128
9918357|NCT01227655|11035310|FG002|COMPLETED|Overall Study||130
9918358|NCT01227655|11035308|FG000|NOT COMPLETED|Overall Study||11
9918359|NCT01227655|11035309|FG001|NOT COMPLETED|Overall Study||26
9918360|NCT01227655|11035310|FG002|NOT COMPLETED|Overall Study||14
9918361|NCT01227668|11035320|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
9918362|NCT01227668|11035321|FG001|STARTED|Phase 1 (Stabilization Phase)||0
9918363|NCT01227668|11035320|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155
9918364|NCT01227668|11035321|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0
9918365|NCT01227668|11035320|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85
9918366|NCT01227668|11035321|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0
9918367|NCT01227668|11035320|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
9918368|NCT01227668|11035321|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
9918369|NCT01227668|11035320|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41
9918370|NCT01227668|11035321|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44
9918371|NCT01227668|11035320|FG000|Received Treatment|Phase 2 (Randomization Phase)||39
9918372|NCT01227668|11035321|FG001|Received Treatment|Phase 2 (Randomization Phase)||43
9918373|NCT01227668|11035320|FG000|COMPLETED|Phase 2 (Randomization Phase)||22
9918374|NCT01227668|11035321|FG001|COMPLETED|Phase 2 (Randomization Phase)||19
9918375|NCT01227668|11035320|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19
9918376|NCT01227668|11035321|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25
9918377|NCT01227681|11035334|FG000|STARTED|Overall Study||4
9918378|NCT01227681|11035335|FG001|STARTED|Overall Study||0
9918379|NCT01227681|11035336|FG002|STARTED|Overall Study||0
9918380|NCT01227681|11035334|FG000|COMPLETED|Overall Study||4
9918381|NCT01227681|11035335|FG001|COMPLETED|Overall Study||0
9918382|NCT01227681|11035336|FG002|COMPLETED|Overall Study||0
9918383|NCT01227681|11035334|FG000|NOT COMPLETED|Overall Study||0
9918384|NCT01227681|11035335|FG001|NOT COMPLETED|Overall Study||0
9918385|NCT01227681|11035336|FG002|NOT COMPLETED|Overall Study||0
9918386|NCT01227707|11035340|FG000|STARTED|Overall Study||43
9918387|NCT01227707|11035340|FG000|COMPLETED|Overall Study||19
9918388|NCT01227707|11035340|FG000|NOT COMPLETED|Overall Study||24
9918389|NCT01227785|11035344|FG000|STARTED|Overall Study||120
9918390|NCT01227785|11035344|FG000|COMPLETED|Overall Study||108
9918391|NCT01227785|11035344|FG000|NOT COMPLETED|Overall Study||12
9918392|NCT01227824|11035357|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411
9918393|NCT01227824|11035358|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411
9918394|NCT01227824|11035359|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0
9918395|NCT01227824|11035357|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
9918396|NCT01227824|11035358|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
9918397|NCT01227824|11035359|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
9918398|NCT01227824|11035357|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
9918399|NCT01227824|11035358|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
9918400|NCT01227824|11035359|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
9918401|NCT01227824|11035357|FG000|STARTED|Open-label Phase: Median of 1267 Days||0
9918402|NCT01227824|11035358|FG001|STARTED|Open-label Phase: Median of 1267 Days||0
9918403|NCT01227824|11035359|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
9918404|NCT01227824|11035357|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0
9918405|NCT01227824|11035358|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0
9918406|NCT01227824|11035359|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294
9918407|NCT01227824|11035357|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
9918408|NCT01227824|11035358|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
9918409|NCT01227824|11035359|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
9918410|NCT01227889|11035368|FG000|STARTED|Randomized Phase (RP)||187
9918411|NCT01227889|11035369|FG001|STARTED|Randomized Phase (RP)||63
9918412|NCT01227889|11035368|FG000|COMPLETED|Randomized Phase (RP)||0
9918413|NCT01227889|11035369|FG001|COMPLETED|Randomized Phase (RP)||0
9918414|NCT01227889|11035368|FG000|NOT COMPLETED|Randomized Phase (RP)||187
9918415|NCT01227889|11035369|FG001|NOT COMPLETED|Randomized Phase (RP)||63
9918416|NCT01227889|11035368|FG000|STARTED|Crossover Phase||0
9918417|NCT01227889|11035369|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
9918418|NCT01227889|11035368|FG000|COMPLETED|Crossover Phase||0
9918419|NCT01227889|11035369|FG001|COMPLETED|Crossover Phase||0
9918420|NCT01227889|11035368|FG000|NOT COMPLETED|Crossover Phase||0
9918421|NCT01227889|11035369|FG001|NOT COMPLETED|Crossover Phase||37
9918422|NCT01227902|11035387|FG000|STARTED|Overall Study||56
9918423|NCT01227902|11035388|FG001|STARTED|Overall Study||51
9918424|NCT01227902|11035389|FG002|STARTED|Overall Study||44
9918425|NCT01227902|11035390|FG003|STARTED|Overall Study||52
9918426|NCT01227902|11035387|FG000|COMPLETED|Overall Study||38
9918427|NCT01227902|11035388|FG001|COMPLETED|Overall Study||38
9918428|NCT01227902|11035389|FG002|COMPLETED|Overall Study||25
9918429|NCT01227902|11035390|FG003|COMPLETED|Overall Study||42
9918430|NCT01227902|11035387|FG000|NOT COMPLETED|Overall Study||18
9918431|NCT01227902|11035388|FG001|NOT COMPLETED|Overall Study||13
9918432|NCT01227902|11035389|FG002|NOT COMPLETED|Overall Study||19
9918433|NCT01227902|11035390|FG003|NOT COMPLETED|Overall Study||10
9918434|NCT01227928|11035403|FG000|STARTED|Overall Study||72
9918435|NCT01227928|11035404|FG001|STARTED|Overall Study||73
9918436|NCT01227928|11035403|FG000|COMPLETED|Overall Study||50
9918437|NCT01227928|11035404|FG001|COMPLETED|Overall Study||56
9918438|NCT01227928|11035403|FG000|NOT COMPLETED|Overall Study||22
9918439|NCT01227928|11035404|FG001|NOT COMPLETED|Overall Study||17
9918440|NCT01227954|11035410|FG000|STARTED|Overall Study||113
9918441|NCT01227954|11035410|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100
9918442|NCT01227954|11035410|FG000|NOT COMPLETED|Overall Study||13
9918443|NCT01227967|11035416|FG000|STARTED|Overall Study||314
9918444|NCT01227967|11035417|FG001|STARTED|Overall Study||316
9918445|NCT01227967|11035416|FG000|COMPLETED|Overall Study||298
9918446|NCT01227967|11035417|FG001|COMPLETED|Overall Study||303
9918447|NCT01227967|11035416|FG000|NOT COMPLETED|Overall Study||16
9918448|NCT01227967|11035417|FG001|NOT COMPLETED|Overall Study||13
9918449|NCT01227980|11035425|FG000|STARTED|Overall Study||40
9918450|NCT01227980|11035426|FG001|STARTED|Overall Study||30
9918451|NCT01227980|11035425|FG000|Scripts Challenge Sessions|Overall Study||26
9918452|NCT01227980|11035426|FG001|Scripts Challenge Sessions|Overall Study||25
9918453|NCT01227980|11035425|FG000|Measure Drug Level Concentration|Overall Study||10
9918454|NCT01227980|11035426|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
9918455|NCT01227980|11035425|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
9918456|NCT01227980|11035426|FG001|COMPLETED|Overall Study||25
9918457|NCT01227980|11035425|FG000|NOT COMPLETED|Overall Study||2
9918458|NCT01227980|11035426|FG001|NOT COMPLETED|Overall Study||5
9918459|NCT01227993|11035432|FG000|STARTED|Overall Study||3
9918460|NCT01227993|11035432|FG000|COMPLETED|Overall Study||3
9918461|NCT01227993|11035432|FG000|NOT COMPLETED|Overall Study||0
9918462|NCT01228019|11035436|FG000|STARTED|Overall Study||1166
9918463|NCT01228019|11035436|FG000|COMPLETED|Overall Study||862
9918464|NCT01228019|11035436|FG000|NOT COMPLETED|Overall Study||304
9918465|NCT01228071|11035440|FG000|STARTED|Overall Study||34
9918466|NCT01228071|11035440|FG000|COMPLETED|Overall Study||32
9918467|NCT01228071|11035440|FG000|NOT COMPLETED|Overall Study||2
9918468|NCT01228084|11035444|FG000|STARTED|Overall Study||20
9918469|NCT01228084|11035444|FG000|COMPLETED|Overall Study||16
9918470|NCT01228084|11035444|FG000|NOT COMPLETED|Overall Study||4
9918471|NCT01228149|11035450|FG000|STARTED|Overall Study||32
9918472|NCT01228149|11035451|FG001|STARTED|Overall Study||30
9918473|NCT01228149|11035450|FG000|COMPLETED|Overall Study||27
9918474|NCT01228149|11035451|FG001|COMPLETED|Overall Study||26
9918475|NCT01228149|11035450|FG000|NOT COMPLETED|Overall Study||5
9918476|NCT01228149|11035451|FG001|NOT COMPLETED|Overall Study||4
9918477|NCT01228175|11035462|FG000|STARTED|Overall Study||119
9918478|NCT01228175|11035463|FG001|STARTED|Overall Study||99
9918479|NCT01228175|11035462|FG000|COMPLETED|Overall Study||53
9918480|NCT01228175|11035463|FG001|COMPLETED|Overall Study||46
9918481|NCT01228175|11035462|FG000|NOT COMPLETED|Overall Study||66
9918482|NCT01228175|11035463|FG001|NOT COMPLETED|Overall Study||53
9918483|NCT01228318|11035471|FG000|STARTED|Overall Study||34
9918484|NCT01228318|11035472|FG001|STARTED|Overall Study||29
9918485|NCT01228318|11035471|FG000|COMPLETED|Overall Study||30
9918486|NCT01228318|11035472|FG001|COMPLETED|Overall Study||22
9918487|NCT01228318|11035471|FG000|NOT COMPLETED|Overall Study||4
9918488|NCT01228318|11035472|FG001|NOT COMPLETED|Overall Study||7
9918489|NCT01228435|11035480|FG000|STARTED|Overall Study||1
9918490|NCT01228435|11035481|FG001|STARTED|Overall Study||2
9918491|NCT01228435|11035480|FG000|COMPLETED|Overall Study||1
9918492|NCT01228435|11035481|FG001|COMPLETED|Overall Study||2
9918493|NCT01228435|11035480|FG000|NOT COMPLETED|Overall Study||0
9918494|NCT01228435|11035481|FG001|NOT COMPLETED|Overall Study||0
9918495|NCT01228591|11035487|FG000|STARTED|Baseline||18
9918496|NCT01228591|11035488|FG001|STARTED|Baseline||18
9918497|NCT01228591|11035487|FG000|COMPLETED|Baseline||17
9918498|NCT01228591|11035488|FG001|COMPLETED|Baseline||16
9918499|NCT01228591|11035487|FG000|NOT COMPLETED|Baseline||1
9918500|NCT01228591|11035488|FG001|NOT COMPLETED|Baseline||2
9918501|NCT01228591|11035487|FG000|STARTED|1-Week Follow-Up||17
9918502|NCT01228591|11035488|FG001|STARTED|1-Week Follow-Up||16
9918503|NCT01228591|11035487|FG000|COMPLETED|1-Week Follow-Up||17
9918504|NCT01228591|11035488|FG001|COMPLETED|1-Week Follow-Up||16
9918505|NCT01228591|11035487|FG000|NOT COMPLETED|1-Week Follow-Up||0
9918506|NCT01228591|11035488|FG001|NOT COMPLETED|1-Week Follow-Up||0
9918507|NCT01228591|11035487|FG000|STARTED|Final Visit||17
9918508|NCT01228591|11035488|FG001|STARTED|Final Visit||16
9918509|NCT01228591|11035487|FG000|COMPLETED|Final Visit||17
9918510|NCT01228591|11035488|FG001|COMPLETED|Final Visit||16
9918511|NCT01228591|11035487|FG000|NOT COMPLETED|Final Visit||0
9918512|NCT01228591|11035488|FG001|NOT COMPLETED|Final Visit||0
9918513|NCT01228734|11035500|FG000|STARTED|Overall Study||193
9918514|NCT01228734|11035501|FG001|STARTED|Overall Study||204
9918515|NCT01228734|11035500|FG000|Modified Intent-to-treat Population|Overall Study||193
9918516|NCT01228734|11035501|FG001|Modified Intent-to-treat Population|Overall Study||200
9918517|NCT01228734|11035500|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
9918518|NCT01228734|11035501|FG001|Modified Safety Population|Overall Study||199
9918519|NCT01228734|11035500|FG000|COMPLETED|Overall Study||193
9918520|NCT01228734|11035501|FG001|COMPLETED|Overall Study||200
9918521|NCT01228734|11035500|FG000|NOT COMPLETED|Overall Study||0
9918522|NCT01228734|11035501|FG001|NOT COMPLETED|Overall Study||4
9918523|NCT01228747|11035509|FG000|STARTED|Overall Study||125
9918524|NCT01228747|11035510|FG001|STARTED|Overall Study||126
9918525|NCT01228747|11035509|FG000|COMPLETED|Overall Study||60
9918526|NCT01228747|11035510|FG001|COMPLETED|Overall Study||81
9918527|NCT01228747|11035509|FG000|NOT COMPLETED|Overall Study||65
9918528|NCT01228747|11035510|FG001|NOT COMPLETED|Overall Study||45
9918529|NCT01228903|11035518|FG000|STARTED|Overall Study||41
9918530|NCT01228903|11035519|FG001|STARTED|Overall Study||39
9918531|NCT01228903|11035518|FG000|COMPLETED|Overall Study||36
9918532|NCT01228903|11035519|FG001|COMPLETED|Overall Study||34
9918533|NCT01228903|11035518|FG000|NOT COMPLETED|Overall Study||5
9918534|NCT01228903|11035519|FG001|NOT COMPLETED|Overall Study||5
9918535|NCT01228929|11035528|FG000|STARTED|Nominal Condition||6
9918536|NCT01228929|11035529|FG001|STARTED|Nominal Condition||6
9918537|NCT01228929|11035530|FG002|STARTED|Nominal Condition||6
9918538|NCT01228929|11035528|FG000|COMPLETED|Nominal Condition||6
9918539|NCT01228929|11035529|FG001|COMPLETED|Nominal Condition||6
9918540|NCT01228929|11035530|FG002|COMPLETED|Nominal Condition||6
9918541|NCT01228929|11035528|FG000|NOT COMPLETED|Nominal Condition||0
9918542|NCT01228929|11035529|FG001|NOT COMPLETED|Nominal Condition||0
9918543|NCT01228929|11035530|FG002|NOT COMPLETED|Nominal Condition||0
9918544|NCT01228929|11035528|FG000|STARTED|Low Humidity Condition||6
9918545|NCT01228929|11035529|FG001|STARTED|Low Humidity Condition||6
9918546|NCT01228929|11035530|FG002|STARTED|Low Humidity Condition||6
9918547|NCT01228929|11035528|FG000|COMPLETED|Low Humidity Condition||6
9918548|NCT01228929|11035529|FG001|COMPLETED|Low Humidity Condition||6
9918549|NCT01228929|11035530|FG002|COMPLETED|Low Humidity Condition||6
9918550|NCT01228929|11035528|FG000|NOT COMPLETED|Low Humidity Condition||0
9918551|NCT01228929|11035529|FG001|NOT COMPLETED|Low Humidity Condition||0
9918552|NCT01228929|11035530|FG002|NOT COMPLETED|Low Humidity Condition||0
9918553|NCT01228929|11035528|FG000|STARTED|High Temperature Condition||6
9918554|NCT01228929|11035529|FG001|STARTED|High Temperature Condition||6
9918555|NCT01228929|11035530|FG002|STARTED|High Temperature Condition||6
9918556|NCT01228929|11035528|FG000|COMPLETED|High Temperature Condition||6
9918557|NCT01228929|11035529|FG001|COMPLETED|High Temperature Condition||6
9918558|NCT01228929|11035530|FG002|COMPLETED|High Temperature Condition||6
9918559|NCT01228929|11035528|FG000|NOT COMPLETED|High Temperature Condition||0
9918560|NCT01228929|11035529|FG001|NOT COMPLETED|High Temperature Condition||0
9918561|NCT01228929|11035530|FG002|NOT COMPLETED|High Temperature Condition||0
9918562|NCT01228968|11035538|FG000|STARTED|Overall Study||9
9918563|NCT01228968|11035538|FG000|COMPLETED|Overall Study||9
9918564|NCT01228968|11035538|FG000|NOT COMPLETED|Overall Study||0
9918565|NCT01229111|11035542|FG000|STARTED|Overall Study||14
9918566|NCT01229111|11035542|FG000|COMPLETED|Overall Study||13
9918567|NCT01229111|11035542|FG000|NOT COMPLETED|Overall Study||1
9918568|NCT01229150|11035550|FG000|STARTED|Overall Study||30
9918569|NCT01229150|11035551|FG001|STARTED|Overall Study||11
9918570|NCT01229150|11035552|FG002|STARTED|Overall Study||19
9918571|NCT01229150|11035553|FG003|STARTED|Overall Study||19
9918572|NCT01229150|11035550|FG000|COMPLETED|Overall Study||28
9918573|NCT01229150|11035551|FG001|COMPLETED|Overall Study||9
9918574|NCT01229150|11035552|FG002|COMPLETED|Overall Study||19
9918575|NCT01229150|11035553|FG003|COMPLETED|Overall Study||19
9918576|NCT01229150|11035550|FG000|NOT COMPLETED|Overall Study||2
9918577|NCT01229150|11035551|FG001|NOT COMPLETED|Overall Study||2
9918578|NCT01229150|11035552|FG002|NOT COMPLETED|Overall Study||0
9918579|NCT01229150|11035553|FG003|NOT COMPLETED|Overall Study||0
9918580|NCT01229176|11035575|FG000|STARTED|Overall Study||40
9918581|NCT01229176|11035576|FG001|STARTED|Overall Study||40
9918582|NCT01229176|11035577|FG002|STARTED|Overall Study||20
9918583|NCT01229176|11035578|FG003|STARTED|Overall Study||20
9918584|NCT01229176|11035579|FG004|STARTED|Overall Study||20
9918585|NCT01229176|11035580|FG005|STARTED|Overall Study||20
9918586|NCT01229176|11035581|FG006|STARTED|Overall Study||20
9918587|NCT01229176|11035582|FG007|STARTED|Overall Study||20
9918588|NCT01229176|11035575|FG000|COMPLETED|Overall Study||40
9918589|NCT01229176|11035576|FG001|COMPLETED|Overall Study||37
9918590|NCT01229176|11035577|FG002|COMPLETED|Overall Study||20
9918591|NCT01229176|11035578|FG003|COMPLETED|Overall Study||19
9918592|NCT01229176|11035579|FG004|COMPLETED|Overall Study||18
9918593|NCT01229176|11035580|FG005|COMPLETED|Overall Study||18
9918594|NCT01229176|11035581|FG006|COMPLETED|Overall Study||20
9918595|NCT01229176|11035582|FG007|COMPLETED|Overall Study||17
9918596|NCT01229176|11035575|FG000|NOT COMPLETED|Overall Study||0
9918597|NCT01229176|11035576|FG001|NOT COMPLETED|Overall Study||3
9918598|NCT01229176|11035577|FG002|NOT COMPLETED|Overall Study||0
9918599|NCT01229176|11035578|FG003|NOT COMPLETED|Overall Study||1
9918600|NCT01229176|11035579|FG004|NOT COMPLETED|Overall Study||2
9918601|NCT01229176|11035580|FG005|NOT COMPLETED|Overall Study||2
9918602|NCT01229176|11035581|FG006|NOT COMPLETED|Overall Study||0
9918603|NCT01229176|11035582|FG007|NOT COMPLETED|Overall Study||3
9918604|NCT01229228|11035605|FG000|STARTED|Overall Study||51
9918605|NCT01229228|11035606|FG001|STARTED|Overall Study||51
9918606|NCT01229228|11035607|FG002|STARTED|Overall Study||50
9918607|NCT01229228|11035608|FG003|STARTED|Overall Study||51
9918608|NCT01229228|11035609|FG004|STARTED|Overall Study||51
9918609|NCT01229228|11035605|FG000|COMPLETED|Overall Study||50
9918610|NCT01229228|11035606|FG001|COMPLETED|Overall Study||51
9918611|NCT01229228|11035607|FG002|COMPLETED|Overall Study||49
9918612|NCT01229228|11035608|FG003|COMPLETED|Overall Study||51
9918613|NCT01229228|11035609|FG004|COMPLETED|Overall Study||50
9918614|NCT01229228|11035605|FG000|NOT COMPLETED|Overall Study||1
9918615|NCT01229228|11035606|FG001|NOT COMPLETED|Overall Study||0
9918616|NCT01229228|11035607|FG002|NOT COMPLETED|Overall Study||1
9918617|NCT01229228|11035608|FG003|NOT COMPLETED|Overall Study||0
9918618|NCT01229228|11035609|FG004|NOT COMPLETED|Overall Study||1
9918619|NCT01229254|11035624|FG000|STARTED|Overall Study||42
9918620|NCT01229254|11035625|FG001|STARTED|Overall Study||74
9918621|NCT01229254|11035626|FG002|STARTED|Overall Study||73
9918622|NCT01229254|11035624|FG000|COMPLETED|Overall Study||27
9918623|NCT01229254|11035625|FG001|COMPLETED|Overall Study||58
9918624|NCT01229254|11035626|FG002|COMPLETED|Overall Study||61
9918625|NCT01229254|11035624|FG000|NOT COMPLETED|Overall Study||15
9918626|NCT01229254|11035625|FG001|NOT COMPLETED|Overall Study||16
9918627|NCT01229254|11035626|FG002|NOT COMPLETED|Overall Study||12
10010423|NCT01774344|11133227|FG000|Entered Survival FU|Overall Study||145
10010424|NCT01774344|11133228|FG001|Entered Survival FU|Overall Study||291
10010425|NCT01774344|11133227|FG000|COMPLETED|Overall Study||132
10010426|NCT01774344|11133228|FG001|COMPLETED|Overall Study||258
10010427|NCT01774344|11133227|FG000|NOT COMPLETED|Overall Study||62
10010428|NCT01774344|11133228|FG001|NOT COMPLETED|Overall Study||121
10010429|NCT01774591|11133236|FG000|STARTED|Overall Study||10
10010430|NCT01774591|11133237|FG001|STARTED|Overall Study||11
10010431|NCT01774591|11133236|FG000|COMPLETED|Overall Study||9
10010432|NCT01774591|11133237|FG001|COMPLETED|Overall Study||7
10010433|NCT01774591|11133236|FG000|NOT COMPLETED|Overall Study||1
10010434|NCT01774591|11133237|FG001|NOT COMPLETED|Overall Study||4
9918628|NCT01229267|11035640|FG000|STARTED|Overall Study||189
9918629|NCT01229267|11035641|FG001|STARTED|Overall Study||184
9918630|NCT01229267|11035642|FG002|STARTED|Overall Study||187
9918631|NCT01229267|11035643|FG003|STARTED|Overall Study||106
9918632|NCT01229267|11035644|FG004|STARTED|Overall Study||564
9918633|NCT01229267|11035640|FG000|Received Vaccination 1|Overall Study||188
9918634|NCT01229267|11035641|FG001|Received Vaccination 1|Overall Study||180
9918635|NCT01229267|11035642|FG002|Received Vaccination 1|Overall Study||186
9918636|NCT01229267|11035643|FG003|Received Vaccination 1|Overall Study||104
9918637|NCT01229267|11035644|FG004|Received Vaccination 1|Overall Study||556
9918638|NCT01229267|11035640|FG000|Received Vaccination 2|Overall Study||171
9918639|NCT01229267|11035641|FG001|Received Vaccination 2|Overall Study||163
9918640|NCT01229267|11035642|FG002|Received Vaccination 2|Overall Study||168
9918641|NCT01229267|11035643|FG003|Received Vaccination 2|Overall Study||94
9918642|NCT01229267|11035644|FG004|Received Vaccination 2|Overall Study||511
9918643|NCT01229267|11035640|FG000|Received Vaccination 3|Overall Study||163
9918644|NCT01229267|11035641|FG001|Received Vaccination 3|Overall Study||155
9918645|NCT01229267|11035642|FG002|Received Vaccination 3|Overall Study||160
9918646|NCT01229267|11035643|FG003|Received Vaccination 3|Overall Study||89
9918647|NCT01229267|11035644|FG004|Received Vaccination 3|Overall Study||491
10010435|NCT01774604|11133245|FG000|STARTED|Overall Study||223
10010436|NCT01774604|11133246|FG001|STARTED|Overall Study||226
9918648|NCT01229267|11035640|FG000|Received Vaccination 4|Overall Study||155
9918649|NCT01229267|11035641|FG001|Received Vaccination 4|Overall Study||149
9918650|NCT01229267|11035642|FG002|Received Vaccination 4|Overall Study||149
9918651|NCT01229267|11035643|FG003|Received Vaccination 4|Overall Study||87
9918652|NCT01229267|11035644|FG004|Received Vaccination 4|Overall Study||477
9918653|NCT01229267|11035640|FG000|COMPLETED|Overall Study||108
9918654|NCT01229267|11035641|FG001|COMPLETED|Overall Study||102
9918655|NCT01229267|11035642|FG002|COMPLETED|Overall Study||101
9918656|NCT01229267|11035643|FG003|COMPLETED|Overall Study||71
9918657|NCT01229267|11035644|FG004|COMPLETED|Overall Study||344
9918658|NCT01229267|11035640|FG000|NOT COMPLETED|Overall Study||81
9918659|NCT01229267|11035641|FG001|NOT COMPLETED|Overall Study||82
9918660|NCT01229267|11035642|FG002|NOT COMPLETED|Overall Study||86
9918661|NCT01229267|11035643|FG003|NOT COMPLETED|Overall Study||35
9918662|NCT01229267|11035644|FG004|NOT COMPLETED|Overall Study||220
9918663|NCT01229371|11035655|FG000|STARTED|Overall Study||109
9918664|NCT01229371|11035656|FG001|STARTED|Overall Study||111
9918665|NCT01229371|11035657|FG002|STARTED|Overall Study||110
9918666|NCT01229371|11035658|FG003|STARTED|Overall Study||110
10010437|NCT01774604|11133245|FG000|COMPLETED|Overall Study||223
10010438|NCT01774604|11133246|FG001|COMPLETED|Overall Study||226
9760503|NCT00381628|10864177|FG001|NOT COMPLETED|Overall Study||0
9760504|NCT00381628|10864178|FG002|NOT COMPLETED|Overall Study||0
9760505|NCT00381628|10864179|FG003|NOT COMPLETED|Overall Study||0
9760506|NCT00381680|10864191|FG000|STARTED|Overall Study||206
9760507|NCT00381680|10864192|FG001|STARTED|Overall Study||69
9760508|NCT00381680|10864191|FG000|COMPLETED|Overall Study||81
9760509|NCT00381680|10864192|FG001|COMPLETED|Overall Study||19
9760510|NCT00381680|10864191|FG000|NOT COMPLETED|Overall Study||125
9760511|NCT00381680|10864192|FG001|NOT COMPLETED|Overall Study||50
9760512|NCT00381693|10864202|FG000|STARTED|Overall Study||10
9760513|NCT00381693|10864202|FG000|COMPLETED|Overall Study||2
9760514|NCT00381693|10864202|FG000|NOT COMPLETED|Overall Study||8
9760515|NCT00381706|10864212|FG000|STARTED|Overall Study||82
9760516|NCT00381706|10864213|FG001|STARTED|Overall Study||83
9760517|NCT00381706|10864214|FG002|STARTED|Overall Study||80
9760518|NCT00381706|10864212|FG000|COMPLETED|Overall Study||75
9760519|NCT00381706|10864213|FG001|COMPLETED|Overall Study||81
9760520|NCT00381706|10864214|FG002|COMPLETED|Overall Study||79
9760521|NCT00381706|10864212|FG000|NOT COMPLETED|Overall Study||7
9760522|NCT00381706|10864213|FG001|NOT COMPLETED|Overall Study||2
9760523|NCT00381706|10864214|FG002|NOT COMPLETED|Overall Study||1
9760524|NCT00381797|10864233|FG000|STARTED|Overall Study||18
9760525|NCT00381797|10864234|FG001|STARTED|Overall Study||17
9760526|NCT00381797|10864235|FG002|STARTED|Overall Study||10
9918667|NCT01229371|11035655|FG000|COMPLETED|Overall Study||109
9918668|NCT01229371|11035656|FG001|COMPLETED|Overall Study||110
9918669|NCT01229371|11035657|FG002|COMPLETED|Overall Study||110
9918670|NCT01229371|11035658|FG003|COMPLETED|Overall Study||110
9918671|NCT01229371|11035655|FG000|NOT COMPLETED|Overall Study||0
9918672|NCT01229371|11035656|FG001|NOT COMPLETED|Overall Study||1
9918673|NCT01229371|11035657|FG002|NOT COMPLETED|Overall Study||0
9918674|NCT01229371|11035658|FG003|NOT COMPLETED|Overall Study||0
9918675|NCT01229397|11035670|FG000|STARTED|Overall Study||103
9918676|NCT01229397|11035671|FG001|STARTED|Overall Study||102
9918677|NCT01229397|11035670|FG000|COMPLETED|Overall Study||92
9918678|NCT01229397|11035671|FG001|COMPLETED|Overall Study||93
9918679|NCT01229397|11035670|FG000|NOT COMPLETED|Overall Study||11
10010439|NCT01774604|11133245|FG000|NOT COMPLETED|Overall Study||0
10010440|NCT01774604|11133246|FG001|NOT COMPLETED|Overall Study||0
10010441|NCT01774760|11133252|FG000|STARTED|Overall Study||10
9918680|NCT01229397|11035671|FG001|NOT COMPLETED|Overall Study||9
9918681|NCT01229410|11035683|FG000|STARTED|Overall Study||12
9918682|NCT01229410|11035684|FG001|STARTED|Overall Study||12
9918683|NCT01229410|11035683|FG000|COMPLETED|Overall Study||7
9918684|NCT01229410|11035684|FG001|COMPLETED|Overall Study||9
9918685|NCT01229410|11035683|FG000|NOT COMPLETED|Overall Study||5
9918686|NCT01229410|11035684|FG001|NOT COMPLETED|Overall Study||3
9918687|NCT01229423|11035690|FG000|STARTED|Overall Study||62
9918688|NCT01229423|11035690|FG000|COMPLETED|Overall Study||47
9918689|NCT01229423|11035690|FG000|NOT COMPLETED|Overall Study||15
9918690|NCT01229436|11035694|FG000|STARTED|Overall Study||254
9918691|NCT01229436|11035694|FG000|COMPLETED|Overall Study||249
9918692|NCT01229436|11035694|FG000|NOT COMPLETED|Overall Study||5
9918693|NCT01229449|11035703|FG000|STARTED|Overall Study||173
9918694|NCT01229449|11035704|FG001|STARTED|Overall Study||168
9918695|NCT01229449|11035705|FG002|STARTED|Overall Study||169
9918696|NCT01229449|11035706|FG003|STARTED|Overall Study||113
9918697|NCT01229449|11035707|FG004|STARTED|Overall Study||55
9918698|NCT01229449|11035703|FG000|COMPLETED|Overall Study||172
9918699|NCT01229449|11035704|FG001|COMPLETED|Overall Study||164
9918700|NCT01229449|11035705|FG002|COMPLETED|Overall Study||167
9918701|NCT01229449|11035706|FG003|COMPLETED|Overall Study||112
9918702|NCT01229449|11035707|FG004|COMPLETED|Overall Study||54
9918703|NCT01229449|11035703|FG000|NOT COMPLETED|Overall Study||1
9918704|NCT01229449|11035704|FG001|NOT COMPLETED|Overall Study||4
9918705|NCT01229449|11035705|FG002|NOT COMPLETED|Overall Study||2
9918706|NCT01229449|11035706|FG003|NOT COMPLETED|Overall Study||1
9918707|NCT01229449|11035707|FG004|NOT COMPLETED|Overall Study||1
9918708|NCT01229462|11035721|FG000|STARTED|Overall Study||120
9918709|NCT01229462|11035722|FG001|STARTED|Overall Study||118
9918710|NCT01229462|11035721|FG000|COMPLETED|Overall Study||115
9918711|NCT01229462|11035722|FG001|COMPLETED|Overall Study||109
9918712|NCT01229462|11035721|FG000|NOT COMPLETED|Overall Study||5
9918713|NCT01229462|11035722|FG001|NOT COMPLETED|Overall Study||9
9918714|NCT01229527|11035731|FG000|STARTED|Overall Study||30
9918715|NCT01229527|11035732|FG001|STARTED|Overall Study||30
9918716|NCT01229527|11035733|FG002|STARTED|Overall Study||30
9918717|NCT01229527|11035731|FG000|COMPLETED|Overall Study||30
9918718|NCT01229527|11035732|FG001|COMPLETED|Overall Study||30
9918719|NCT01229527|11035733|FG002|COMPLETED|Overall Study||30
9918720|NCT01229527|11035731|FG000|NOT COMPLETED|Overall Study||0
9918721|NCT01229527|11035732|FG001|NOT COMPLETED|Overall Study||0
9918722|NCT01229527|11035733|FG002|NOT COMPLETED|Overall Study||0
9918723|NCT01229722|11035743|FG000|STARTED|Overall Study||36
9918724|NCT01229722|11035744|FG001|STARTED|Overall Study||34
9918725|NCT01229722|11035743|FG000|COMPLETED|Overall Study||36
9918726|NCT01229722|11035744|FG001|COMPLETED|Overall Study||30
9918727|NCT01229722|11035743|FG000|NOT COMPLETED|Overall Study||0
9918728|NCT01229722|11035744|FG001|NOT COMPLETED|Overall Study||4
9918729|NCT01229735|11035756|FG000|STARTED|Overall Study||177
9918730|NCT01229735|11035757|FG001|STARTED|Overall Study||166
9918731|NCT01229735|11035756|FG000|COMPLETED|Overall Study||111
9918732|NCT01229735|11035757|FG001|COMPLETED|Overall Study||100
9918733|NCT01229735|11035756|FG000|NOT COMPLETED|Overall Study||66
9918734|NCT01229735|11035757|FG001|NOT COMPLETED|Overall Study||66
9918735|NCT01229891|11035768|FG000|STARTED|Overall Study||30
9918736|NCT01229891|11035769|FG001|STARTED|Overall Study||30
9918737|NCT01229891|11035770|FG002|STARTED|Overall Study||30
9918738|NCT01229891|11035768|FG000|COMPLETED|Overall Study||30
9918739|NCT01229891|11035769|FG001|COMPLETED|Overall Study||30
9918740|NCT01229891|11035770|FG002|COMPLETED|Overall Study||30
9918741|NCT01229891|11035768|FG000|NOT COMPLETED|Overall Study||0
9918742|NCT01229891|11035769|FG001|NOT COMPLETED|Overall Study||0
9918743|NCT01229891|11035770|FG002|NOT COMPLETED|Overall Study||0
9918744|NCT01230021|11035778|FG000|STARTED|Overall Study||6
9918745|NCT01230021|11035778|FG000|COMPLETED|Overall Study||6
9918746|NCT01230021|11035778|FG000|NOT COMPLETED|Overall Study||0
9918747|NCT01230060|11035782|FG000|STARTED|Overall Study||122
9918748|NCT01230060|11035782|FG000|COMPLETED|Overall Study||121
9918749|NCT01230060|11035782|FG000|NOT COMPLETED|Overall Study||1
9918750|NCT01230125|11035788|FG000|STARTED|Overall Study||207
9918751|NCT01230125|11035789|FG001|STARTED|Overall Study||104
9918752|NCT01230125|11035788|FG000|COMPLETED|Overall Study||134
9918753|NCT01230125|11035789|FG001|COMPLETED|Overall Study||54
9918754|NCT01230125|11035788|FG000|NOT COMPLETED|Overall Study||73
9918755|NCT01230125|11035789|FG001|NOT COMPLETED|Overall Study||50
9918756|NCT01230177|11035795|FG000|STARTED|Overall Study||3
9918757|NCT01230177|11035795|FG000|COMPLETED|Overall Study||3
9918758|NCT01230177|11035795|FG000|NOT COMPLETED|Overall Study||0
9918759|NCT01230424|11035801|FG000|STARTED|Overall Study||70
9918760|NCT01230424|11035802|FG001|STARTED|Overall Study||70
9918761|NCT01230424|11035801|FG000|COMPLETED|Overall Study||70
9918762|NCT01230424|11035802|FG001|COMPLETED|Overall Study||70
9918763|NCT01230424|11035801|FG000|NOT COMPLETED|Overall Study||0
9918764|NCT01230424|11035802|FG001|NOT COMPLETED|Overall Study||0
9918765|NCT01230502|11035814|FG000|STARTED|Overall Study||9
9918766|NCT01230502|11035815|FG001|STARTED|Overall Study||0
9918767|NCT01230502|11035816|FG002|STARTED|Overall Study||0
9918768|NCT01230502|11035814|FG000|COMPLETED|Overall Study||9
9918769|NCT01230502|11035815|FG001|COMPLETED|Overall Study||0
9918770|NCT01230502|11035816|FG002|COMPLETED|Overall Study||0
9918771|NCT01230502|11035814|FG000|NOT COMPLETED|Overall Study||0
9918772|NCT01230502|11035815|FG001|NOT COMPLETED|Overall Study||0
9918773|NCT01230502|11035816|FG002|NOT COMPLETED|Overall Study||0
9918774|NCT01230554|11035827|FG000|STARTED|Overall Study||212
9918775|NCT01230554|11035827|FG000|COMPLETED|Overall Study||209
9918776|NCT01230554|11035827|FG000|NOT COMPLETED|Overall Study||3
9918777|NCT01230593|11035834|FG000|STARTED|Overall Study||50
9918778|NCT01230593|11035835|FG001|STARTED|Overall Study||50
9918779|NCT01230593|11035836|FG002|STARTED|Overall Study||50
9918780|NCT01230593|11035834|FG000|COMPLETED|Overall Study||35
9918781|NCT01230593|11035835|FG001|COMPLETED|Overall Study||32
9918782|NCT01230593|11035836|FG002|COMPLETED|Overall Study||38
9918783|NCT01230593|11035834|FG000|NOT COMPLETED|Overall Study||15
9918784|NCT01230593|11035835|FG001|NOT COMPLETED|Overall Study||18
9918785|NCT01230593|11035836|FG002|NOT COMPLETED|Overall Study||12
9918786|NCT01230710|11035844|FG000|STARTED|Overall Study||51
9918787|NCT01230710|11035844|FG000|COMPLETED|Overall Study||2
9918788|NCT01230710|11035844|FG000|NOT COMPLETED|Overall Study||49
9918789|NCT01230749|11035852|FG000|STARTED|Overall Study||22
9918790|NCT01230749|11035853|FG001|STARTED|Overall Study||22
9918791|NCT01230749|11035854|FG002|STARTED|Overall Study||23
9918792|NCT01230749|11035855|FG003|STARTED|Overall Study||22
9918793|NCT01230749|11035852|FG000|COMPLETED|Overall Study||22
9918794|NCT01230749|11035853|FG001|COMPLETED|Overall Study||20
9918795|NCT01230749|11035854|FG002|COMPLETED|Overall Study||21
9918796|NCT01230749|11035855|FG003|COMPLETED|Overall Study||20
9918797|NCT01230749|11035852|FG000|NOT COMPLETED|Overall Study||0
9918798|NCT01230749|11035853|FG001|NOT COMPLETED|Overall Study||2
9918799|NCT01230749|11035854|FG002|NOT COMPLETED|Overall Study||2
9918800|NCT01230749|11035855|FG003|NOT COMPLETED|Overall Study||2
9918801|NCT01230801|11035871|FG000|STARTED|Overall Study||3
9918802|NCT01230801|11035872|FG001|STARTED|Overall Study||3
9918803|NCT01230801|11035873|FG002|STARTED|Overall Study||16
9918804|NCT01230801|11035871|FG000|COMPLETED|Overall Study||3
9918805|NCT01230801|11035872|FG001|COMPLETED|Overall Study||3
9918806|NCT01230801|11035873|FG002|COMPLETED|Overall Study||15
9918807|NCT01230801|11035871|FG000|NOT COMPLETED|Overall Study||0
9918808|NCT01230801|11035872|FG001|NOT COMPLETED|Overall Study||0
9918809|NCT01230801|11035873|FG002|NOT COMPLETED|Overall Study||1
9918810|NCT01230814|11035886|FG000|STARTED|Overall Study||118
9918811|NCT01230814|11035887|FG001|STARTED|Overall Study||116
9918812|NCT01230814|11035886|FG000|COMPLETED|Overall Study||105
9918813|NCT01230814|11035887|FG001|COMPLETED|Overall Study||112
9918814|NCT01230814|11035886|FG000|NOT COMPLETED|Overall Study||13
9918815|NCT01230814|11035887|FG001|NOT COMPLETED|Overall Study||4
9918816|NCT01230827|11035897|FG000|STARTED|Overall Study||19
9918817|NCT01230827|11035898|FG001|STARTED|Overall Study||11
9918818|NCT01230827|11035899|FG002|STARTED|Overall Study||65
9918819|NCT01230827|11035900|FG003|STARTED|Overall Study||78
9918820|NCT01230827|11035897|FG000|COMPLETED|Overall Study||0
9918821|NCT01230827|11035898|FG001|COMPLETED|Overall Study||0
9918822|NCT01230827|11035899|FG002|COMPLETED|Overall Study||0
9918823|NCT01230827|11035900|FG003|COMPLETED|Overall Study||0
9918824|NCT01230827|11035897|FG000|NOT COMPLETED|Overall Study||19
9918825|NCT01230827|11035898|FG001|NOT COMPLETED|Overall Study||11
9918826|NCT01230827|11035899|FG002|NOT COMPLETED|Overall Study||65
9918827|NCT01230827|11035900|FG003|NOT COMPLETED|Overall Study||78
9918828|NCT01230892|11035910|FG000|STARTED|Overall Study||15
9918829|NCT01230892|11035911|FG001|STARTED|Overall Study||14
9918830|NCT01230892|11035910|FG000|COMPLETED|Overall Study||12
9918831|NCT01230892|11035911|FG001|COMPLETED|Overall Study||13
9918832|NCT01230892|11035910|FG000|NOT COMPLETED|Overall Study||3
9918833|NCT01230892|11035911|FG001|NOT COMPLETED|Overall Study||1
9918834|NCT01230931|11035919|FG000|STARTED|Overall Study||10
9918835|NCT01230931|11035920|FG001|STARTED|Overall Study||10
9918836|NCT01230931|11035919|FG000|COMPLETED|Overall Study||10
9918837|NCT01230931|11035920|FG001|COMPLETED|Overall Study||10
9918838|NCT01230931|11035919|FG000|NOT COMPLETED|Overall Study||0
9918839|NCT01230931|11035920|FG001|NOT COMPLETED|Overall Study||0
9918840|NCT01231230|11035927|FG000|STARTED|Overall Study||14
9918841|NCT01231230|11035927|FG000|Fluticasone|Overall Study||14
9918842|NCT01231230|11035927|FG000|Salmeterol|Overall Study||14
9918843|NCT01231230|11035927|FG000|Fluticasone/Salmeterol|Overall Study||14
9918844|NCT01231230|11035927|FG000|Placebo|Overall Study||14
9918845|NCT01231230|11035927|FG000|COMPLETED|Overall Study||14
9918846|NCT01231230|11035927|FG000|NOT COMPLETED|Overall Study||0
9918847|NCT01231321|11035937|FG000|STARTED|Overall Study||100
9918848|NCT01231321|11035937|FG000|COMPLETED|Overall Study||95
9918849|NCT01231321|11035937|FG000|NOT COMPLETED|Overall Study||5
9918850|NCT01231334|11035949|FG000|STARTED|Overall Study||145
9918851|NCT01231334|11035950|FG001|STARTED|Overall Study||141
9918852|NCT01231334|11035949|FG000|COMPLETED|Overall Study||126
9918853|NCT01231334|11035950|FG001|COMPLETED|Overall Study||120
9918854|NCT01231334|11035949|FG000|NOT COMPLETED|Overall Study||19
9918855|NCT01231334|11035950|FG001|NOT COMPLETED|Overall Study||21
9918856|NCT01231373|11035960|FG000|STARTED|Overall Study||59
9918857|NCT01231373|11035961|FG001|STARTED|Overall Study||58
9918858|NCT01231373|11035962|FG002|STARTED|Overall Study||60
9918859|NCT01231373|11035963|FG003|STARTED|Overall Study||58
9918860|NCT01231373|11035960|FG000|Patients Receiving Blinded Treatment|Overall Study||57
9918861|NCT01231373|11035961|FG001|Patients Receiving Blinded Treatment|Overall Study||57
9918862|NCT01231373|11035962|FG002|Patients Receiving Blinded Treatment|Overall Study||60
9918863|NCT01231373|11035963|FG003|Patients Receiving Blinded Treatment|Overall Study||58
9918864|NCT01231373|11035960|FG000|COMPLETED|Overall Study||56
9918865|NCT01231373|11035961|FG001|COMPLETED|Overall Study||57
9918866|NCT01231373|11035962|FG002|COMPLETED|Overall Study||60
9918867|NCT01231373|11035963|FG003|COMPLETED|Overall Study||57
9918868|NCT01231373|11035960|FG000|NOT COMPLETED|Overall Study||3
9918869|NCT01231373|11035961|FG001|NOT COMPLETED|Overall Study||1
9918870|NCT01231373|11035962|FG002|NOT COMPLETED|Overall Study||0
9918871|NCT01231373|11035963|FG003|NOT COMPLETED|Overall Study||1
9918872|NCT01231399|11035975|FG000|STARTED|Overall Study||6
9918873|NCT01231399|11035975|FG000|COMPLETED|Overall Study||6
9918874|NCT01231399|11035975|FG000|NOT COMPLETED|Overall Study||0
9918875|NCT01231412|11035983|FG000|STARTED|Overall Study||77
9918876|NCT01231412|11035984|FG001|STARTED|Overall Study||91
9918877|NCT01231412|11035985|FG002|STARTED|Overall Study||6
9918878|NCT01231412|11035983|FG000|COMPLETED|Overall Study||77
9918879|NCT01231412|11035984|FG001|COMPLETED|Overall Study||90
9918880|NCT01231412|11035985|FG002|COMPLETED|Overall Study||6
9918881|NCT01231412|11035983|FG000|NOT COMPLETED|Overall Study||0
9918882|NCT01231412|11035984|FG001|NOT COMPLETED|Overall Study||1
9918883|NCT01231412|11035985|FG002|NOT COMPLETED|Overall Study||0
9918884|NCT01231464|11035995|FG000|STARTED|Overall Study||182
9918885|NCT01231464|11035996|FG001|STARTED|Overall Study||183
9918886|NCT01231464|11035995|FG000|COMPLETED|Overall Study||177
9918887|NCT01231464|11035996|FG001|COMPLETED|Overall Study||176
9918888|NCT01231464|11035995|FG000|NOT COMPLETED|Overall Study||5
9918889|NCT01231464|11035996|FG001|NOT COMPLETED|Overall Study||7
9918890|NCT01231503|11036012|FG000|STARTED|Overall Study||60
9918891|NCT01231503|11036013|FG001|STARTED|Overall Study||59
9918892|NCT01231503|11036014|FG002|STARTED|Overall Study||60
9918893|NCT01231503|11036015|FG003|STARTED|Overall Study||60
9918894|NCT01231503|11036016|FG004|STARTED|Overall Study||60
9918895|NCT01231503|11036017|FG005|STARTED|Overall Study||60
9918896|NCT01231503|11036018|FG006|STARTED|Overall Study||60
9918897|NCT01231503|11036019|FG007|STARTED|Overall Study||60
9918898|NCT01231503|11036012|FG000|COMPLETED|Overall Study||46
9918899|NCT01231503|11036013|FG001|COMPLETED|Overall Study||46
9918900|NCT01231503|11036014|FG002|COMPLETED|Overall Study||48
9918901|NCT01231503|11036015|FG003|COMPLETED|Overall Study||52
9918902|NCT01231503|11036016|FG004|COMPLETED|Overall Study||50
9918903|NCT01231503|11036017|FG005|COMPLETED|Overall Study||44
9918904|NCT01231503|11036018|FG006|COMPLETED|Overall Study||53
9918905|NCT01231503|11036019|FG007|COMPLETED|Overall Study||52
9918906|NCT01231503|11036012|FG000|NOT COMPLETED|Overall Study||14
9918907|NCT01231503|11036013|FG001|NOT COMPLETED|Overall Study||13
9918908|NCT01231503|11036014|FG002|NOT COMPLETED|Overall Study||12
9918909|NCT01231503|11036015|FG003|NOT COMPLETED|Overall Study||8
9918910|NCT01231503|11036016|FG004|NOT COMPLETED|Overall Study||10
10010442|NCT01774760|11133252|FG000|COMPLETED|Overall Study||10
10010443|NCT01774760|11133252|FG000|NOT COMPLETED|Overall Study||0
9918911|NCT01231503|11036017|FG005|NOT COMPLETED|Overall Study||16
9918912|NCT01231503|11036018|FG006|NOT COMPLETED|Overall Study||7
9918913|NCT01231503|11036019|FG007|NOT COMPLETED|Overall Study||8
9918914|NCT01231555|11036050|FG000|STARTED|Overall Study||8
9918915|NCT01231555|11036051|FG001|STARTED|Overall Study||7
9918916|NCT01231555|11036052|FG002|STARTED|Overall Study||8
9918917|NCT01231555|11036050|FG000|COMPLETED|Overall Study||0
9918918|NCT01231555|11036051|FG001|COMPLETED|Overall Study||0
9918919|NCT01231555|11036052|FG002|COMPLETED|Overall Study||0
9918920|NCT01231555|11036050|FG000|NOT COMPLETED|Overall Study||8
9918921|NCT01231555|11036051|FG001|NOT COMPLETED|Overall Study||7
9918922|NCT01231555|11036052|FG002|NOT COMPLETED|Overall Study||8
9918923|NCT01231581|11036062|FG000|STARTED|Overall Study||80
9918924|NCT01231581|11036063|FG001|STARTED|Overall Study||80
9918925|NCT01231581|11036062|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
9918926|NCT01231581|11036063|FG001|Ongoing|Overall Study||0
9918927|NCT01231581|11036062|FG000|COMPLETED|Overall Study||0
9918928|NCT01231581|11036063|FG001|COMPLETED|Overall Study||0
9918929|NCT01231581|11036062|FG000|NOT COMPLETED|Overall Study||80
10010444|NCT01774786|11133258|FG000|STARTED|Overall Study||388
9918930|NCT01231581|11036063|FG001|NOT COMPLETED|Overall Study||80
9918931|NCT01231607|11036074|FG000|STARTED|Overall Study||185
9918932|NCT01231607|11036075|FG001|STARTED|Overall Study||188
9918933|NCT01231607|11036076|FG002|STARTED|Overall Study||184
9918934|NCT01231607|11036077|FG003|STARTED|Overall Study||179
9918935|NCT01231607|11036078|FG004|STARTED|Overall Study||181
9918936|NCT01231607|11036074|FG000|COMPLETED|Overall Study||156
9918937|NCT01231607|11036075|FG001|COMPLETED|Overall Study||154
9918938|NCT01231607|11036076|FG002|COMPLETED|Overall Study||153
9918939|NCT01231607|11036077|FG003|COMPLETED|Overall Study||141
9918940|NCT01231607|11036078|FG004|COMPLETED|Overall Study||157
9918941|NCT01231607|11036074|FG000|NOT COMPLETED|Overall Study||29
9918942|NCT01231607|11036075|FG001|NOT COMPLETED|Overall Study||34
9918943|NCT01231607|11036076|FG002|NOT COMPLETED|Overall Study||31
9918944|NCT01231607|11036077|FG003|NOT COMPLETED|Overall Study||38
9918945|NCT01231607|11036078|FG004|NOT COMPLETED|Overall Study||24
9918946|NCT01231620|11036096|FG000|STARTED|Overall Study||201
9918947|NCT01231620|11036097|FG001|STARTED|Overall Study||209
9918948|NCT01231620|11036098|FG002|STARTED|Overall Study||205
9918949|NCT01231620|11036096|FG000|COMPLETED|Overall Study||175
9918950|NCT01231620|11036097|FG001|COMPLETED|Overall Study||178
9918951|NCT01231620|11036098|FG002|COMPLETED|Overall Study||166
9918952|NCT01231620|11036096|FG000|NOT COMPLETED|Overall Study||26
9918953|NCT01231620|11036097|FG001|NOT COMPLETED|Overall Study||31
9918954|NCT01231620|11036098|FG002|NOT COMPLETED|Overall Study||39
9918955|NCT01231633|11036108|FG000|STARTED|Overall Study||14
9918956|NCT01231633|11036109|FG001|STARTED|Overall Study||13
9918957|NCT01231633|11036108|FG000|COMPLETED|Overall Study||14
9918958|NCT01231633|11036109|FG001|COMPLETED|Overall Study||13
9918959|NCT01231633|11036108|FG000|NOT COMPLETED|Overall Study||0
9918960|NCT01231633|11036109|FG001|NOT COMPLETED|Overall Study||0
9918961|NCT01231646|11036119|FG000|STARTED|Overall Study||28
9918962|NCT01231646|11036120|FG001|STARTED|Overall Study||10
9918963|NCT01231646|11036119|FG000|COMPLETED|Overall Study||28
9918964|NCT01231646|11036120|FG001|COMPLETED|Overall Study||10
9918965|NCT01231646|11036119|FG000|NOT COMPLETED|Overall Study||0
9918966|NCT01231646|11036120|FG001|NOT COMPLETED|Overall Study||0
9955734|NCT01440374|11074738|FG000|STARTED|Part 3: Extension||0
9955735|NCT01440374|11074739|FG001|STARTED|Part 3: Extension||0
9955736|NCT01440374|11074740|FG002|STARTED|Part 3: Extension||0
9955737|NCT01440374|11074741|FG003|STARTED|Part 3: Extension||59
9955738|NCT01440374|11074738|FG000|COMPLETED|Part 3: Extension||0
9955739|NCT01440374|11074739|FG001|COMPLETED|Part 3: Extension||0
9955740|NCT01440374|11074740|FG002|COMPLETED|Part 3: Extension||0
9955741|NCT01440374|11074741|FG003|COMPLETED|Part 3: Extension||27
9955742|NCT01440374|11074738|FG000|NOT COMPLETED|Part 3: Extension||0
9955743|NCT01440374|11074739|FG001|NOT COMPLETED|Part 3: Extension||0
9955744|NCT01440374|11074740|FG002|NOT COMPLETED|Part 3: Extension||0
9955745|NCT01440374|11074741|FG003|NOT COMPLETED|Part 3: Extension||32
9955746|NCT01440387|11074755|FG000|STARTED|Overall Study||56
9955747|NCT01440387|11074756|FG001|STARTED|Overall Study||56
9955748|NCT01440387|11074755|FG000|COMPLETED|Overall Study||56
9955749|NCT01440387|11074756|FG001|COMPLETED|Overall Study||56
9955750|NCT01440387|11074755|FG000|NOT COMPLETED|Overall Study||0
9955751|NCT01440387|11074756|FG001|NOT COMPLETED|Overall Study||0
9955752|NCT01440543|11074766|FG000|STARTED|Overall Study||106
9955753|NCT01440543|11074767|FG001|STARTED|Overall Study||105
9955754|NCT01440543|11074768|FG002|STARTED|Overall Study||102
9955755|NCT01440543|11074769|FG003|STARTED|Overall Study||107
9955756|NCT01440543|11074766|FG000|COMPLETED|Overall Study||102
9955757|NCT01440543|11074767|FG001|COMPLETED|Overall Study||101
9955758|NCT01440543|11074768|FG002|COMPLETED|Overall Study||100
9955759|NCT01440543|11074769|FG003|COMPLETED|Overall Study||101
9955760|NCT01440543|11074766|FG000|NOT COMPLETED|Overall Study||4
9955761|NCT01440543|11074767|FG001|NOT COMPLETED|Overall Study||4
9955762|NCT01440543|11074768|FG002|NOT COMPLETED|Overall Study||2
9955763|NCT01440543|11074769|FG003|NOT COMPLETED|Overall Study||6
9955764|NCT01440569|11074781|FG000|STARTED|Main Study||296
9955765|NCT01440569|11074782|FG001|STARTED|Main Study||18
9955766|NCT01440569|11074781|FG000|Enrolled and Treated|Main Study||295
9955767|NCT01440569|11074782|FG001|Enrolled and Treated|Main Study||18
9955768|NCT01440569|11074781|FG000|COMPLETED|Main Study||260
9955769|NCT01440569|11074782|FG001|COMPLETED|Main Study||14
9955770|NCT01440569|11074781|FG000|NOT COMPLETED|Main Study||36
9955771|NCT01440569|11074782|FG001|NOT COMPLETED|Main Study||4
9955772|NCT01440569|11074781|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
9955773|NCT01440569|11074782|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
9955774|NCT01440569|11074781|FG000|COMPLETED|Open-Label Rollover Phase||204
9955775|NCT01440569|11074782|FG001|COMPLETED|Open-Label Rollover Phase||7
9955776|NCT01440569|11074781|FG000|NOT COMPLETED|Open-Label Rollover Phase||47
9955777|NCT01440569|11074782|FG001|NOT COMPLETED|Open-Label Rollover Phase||6
9955778|NCT01440634|11074790|FG000|STARTED|Cross Sectional Phase||0
9955779|NCT01440634|11074791|FG001|STARTED|Cross Sectional Phase||347
9955780|NCT01440634|11074790|FG000|COMPLETED|Cross Sectional Phase||0
9955781|NCT01440634|11074791|FG001|COMPLETED|Cross Sectional Phase||347
9955782|NCT01440634|11074790|FG000|NOT COMPLETED|Cross Sectional Phase||0
9955783|NCT01440634|11074791|FG001|NOT COMPLETED|Cross Sectional Phase||0
9955784|NCT01440634|11074790|FG000|STARTED|Randomization Phase||30
9955785|NCT01440634|11074791|FG001|STARTED|Randomization Phase||24
9955786|NCT01440634|11074790|FG000|COMPLETED|Randomization Phase||24
9955787|NCT01440634|11074791|FG001|COMPLETED|Randomization Phase||14
9955788|NCT01440634|11074790|FG000|NOT COMPLETED|Randomization Phase||6
9955789|NCT01440634|11074791|FG001|NOT COMPLETED|Randomization Phase||10
9955790|NCT01440647|11074799|FG000|STARTED|Overall Study||16
9955791|NCT01440647|11074800|FG001|STARTED|Overall Study||18
9955792|NCT01440647|11074799|FG000|COMPLETED|Overall Study||14
9955793|NCT01440647|11074800|FG001|COMPLETED|Overall Study||15
9955794|NCT01440647|11074799|FG000|NOT COMPLETED|Overall Study||2
9918967|NCT01231659|11036126|FG000|STARTED|Overall Study||72
9918968|NCT01231659|11036126|FG000|Per Protocol (PP) Set|Overall Study||72
9918969|NCT01231659|11036126|FG000|Safety Set|Overall Study||72
9918970|NCT01231659|11036126|FG000|COMPLETED|Overall Study||0
9918971|NCT01231659|11036126|FG000|NOT COMPLETED|Overall Study||72
9918972|NCT01231841|11036130|FG000|STARTED|Overall Study||20
10010445|NCT01774786|11133259|FG001|STARTED|Overall Study||392
10010446|NCT01774786|11133258|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
10010447|NCT01774786|11133259|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
10010448|NCT01774786|11133258|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384
10010449|NCT01774786|11133259|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
10010450|NCT01774786|11133258|FG000|Received Placebo (No Pertuzumab)|Overall Study||0
10010451|NCT01774786|11133259|FG001|Received Placebo (No Pertuzumab)|Overall Study||388
9918973|NCT01231841|11036130|FG000|COMPLETED|Overall Study||20
9918974|NCT01231841|11036130|FG000|NOT COMPLETED|Overall Study||0
9918975|NCT01231984|11036136|FG000|STARTED|Study Period 1||69
9918976|NCT01231984|11036137|FG001|STARTED|Study Period 1||70
9918977|NCT01231984|11036138|FG002|STARTED|Study Period 1||66
9918978|NCT01231984|11036139|FG003|STARTED|Study Period 1||69
9918979|NCT01231984|11036136|FG000|COMPLETED|Study Period 1||57
9918980|NCT01231984|11036137|FG001|COMPLETED|Study Period 1||63
9918981|NCT01231984|11036138|FG002|COMPLETED|Study Period 1||59
9918982|NCT01231984|11036139|FG003|COMPLETED|Study Period 1||60
9918983|NCT01231984|11036136|FG000|NOT COMPLETED|Study Period 1||12
9918984|NCT01231984|11036137|FG001|NOT COMPLETED|Study Period 1||7
9918985|NCT01231984|11036138|FG002|NOT COMPLETED|Study Period 1||7
9918986|NCT01231984|11036139|FG003|NOT COMPLETED|Study Period 1||9
9918987|NCT01231984|11036136|FG000|STARTED|Study Period 2||57
9918988|NCT01231984|11036137|FG001|STARTED|Study Period 2||63
9918989|NCT01231984|11036138|FG002|STARTED|Study Period 2||59
9918990|NCT01231984|11036139|FG003|STARTED|Study Period 2||60
9918991|NCT01231984|11036136|FG000|COMPLETED|Study Period 2||54
9918992|NCT01231984|11036137|FG001|COMPLETED|Study Period 2||61
9918993|NCT01231984|11036138|FG002|COMPLETED|Study Period 2||59
9918994|NCT01231984|11036139|FG003|COMPLETED|Study Period 2||56
9918995|NCT01231984|11036136|FG000|NOT COMPLETED|Study Period 2||3
9918996|NCT01231984|11036137|FG001|NOT COMPLETED|Study Period 2||2
9918997|NCT01231984|11036138|FG002|NOT COMPLETED|Study Period 2||0
9918998|NCT01231984|11036139|FG003|NOT COMPLETED|Study Period 2||4
9918999|NCT01232127|11036157|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
9919000|NCT01232127|11036158|FG001|STARTED|Period 1: Days 1-10||0
9919001|NCT01232127|11036159|FG002|STARTED|Period 1: Days 1-10||0
9919002|NCT01232127|11036157|FG000|COMPLETED|Period 1: Days 1-10||24
9919003|NCT01232127|11036158|FG001|COMPLETED|Period 1: Days 1-10||0
9919004|NCT01232127|11036159|FG002|COMPLETED|Period 1: Days 1-10||0
9919005|NCT01232127|11036157|FG000|NOT COMPLETED|Period 1: Days 1-10||1
9919006|NCT01232127|11036158|FG001|NOT COMPLETED|Period 1: Days 1-10||0
9919007|NCT01232127|11036159|FG002|NOT COMPLETED|Period 1: Days 1-10||0
9919008|NCT01232127|11036157|FG000|STARTED|Period 2: Days 11-17||0
9919009|NCT01232127|11036158|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
9919010|NCT01232127|11036159|FG002|STARTED|Period 2: Days 11-17||0
9919011|NCT01232127|11036157|FG000|COMPLETED|Period 2: Days 11-17||0
9919012|NCT01232127|11036158|FG001|COMPLETED|Period 2: Days 11-17||24
9919013|NCT01232127|11036159|FG002|COMPLETED|Period 2: Days 11-17||0
9919014|NCT01232127|11036157|FG000|NOT COMPLETED|Period 2: Days 11-17||0
9919015|NCT01232127|11036158|FG001|NOT COMPLETED|Period 2: Days 11-17||0
9919016|NCT01232127|11036159|FG002|NOT COMPLETED|Period 2: Days 11-17||0
9919017|NCT01232127|11036157|FG000|STARTED|Period 3: Days 18-24||0
9919018|NCT01232127|11036158|FG001|STARTED|Period 3: Days 18-24||0
9919019|NCT01232127|11036159|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
10010452|NCT01774786|11133258|FG000|COMPLETED|Overall Study||60
10010453|NCT01774786|11133259|FG001|COMPLETED|Overall Study||46
10010454|NCT01774786|11133258|FG000|NOT COMPLETED|Overall Study||328
10010455|NCT01774786|11133259|FG001|NOT COMPLETED|Overall Study||346
10010456|NCT01774799|11133269|FG000|STARTED|Overall Study||212
10010457|NCT01774799|11133270|FG001|STARTED|Overall Study||190
10010458|NCT01774799|11133271|FG002|STARTED|Overall Study||212
10010459|NCT01774799|11133272|FG003|STARTED|Overall Study||190
10010460|NCT01774799|11133269|FG000|COMPLETED|Overall Study||211
10010461|NCT01774799|11133270|FG001|COMPLETED|Overall Study||189
10010462|NCT01774799|11133271|FG002|COMPLETED|Overall Study||212
10010463|NCT01774799|11133272|FG003|COMPLETED|Overall Study||190
10010464|NCT01774799|11133269|FG000|NOT COMPLETED|Overall Study||1
10010465|NCT01774799|11133270|FG001|NOT COMPLETED|Overall Study||1
10010466|NCT01774799|11133271|FG002|NOT COMPLETED|Overall Study||0
10010467|NCT01774799|11133272|FG003|NOT COMPLETED|Overall Study||0
10010468|NCT01774851|11133280|FG000|STARTED|Overall Study||42
10010469|NCT01774851|11133281|FG001|STARTED|Overall Study||42
9919020|NCT01232127|11036157|FG000|COMPLETED|Period 3: Days 18-24||0
9919021|NCT01232127|11036158|FG001|COMPLETED|Period 3: Days 18-24||0
9919022|NCT01232127|11036159|FG002|COMPLETED|Period 3: Days 18-24||24
9919023|NCT01232127|11036157|FG000|NOT COMPLETED|Period 3: Days 18-24||0
9919024|NCT01232127|11036158|FG001|NOT COMPLETED|Period 3: Days 18-24||0
9919025|NCT01232127|11036159|FG002|NOT COMPLETED|Period 3: Days 18-24||0
9919026|NCT01232205|11036173|FG000|STARTED|Overall Study||52
9919027|NCT01232205|11036174|FG001|STARTED|Overall Study||58
9919028|NCT01232205|11036173|FG000|COMPLETED|Overall Study||49
9919029|NCT01232205|11036174|FG001|COMPLETED|Overall Study||55
9919030|NCT01232205|11036173|FG000|NOT COMPLETED|Overall Study||3
9919031|NCT01232205|11036174|FG001|NOT COMPLETED|Overall Study||3
9919032|NCT01232296|11036182|FG000|STARTED|Overall Study||82
9919033|NCT01232296|11036183|FG001|STARTED|Overall Study||83
9919034|NCT01232296|11036182|FG000|Full Analysis Set|Overall Study||82
9919035|NCT01232296|11036183|FG001|Full Analysis Set|Overall Study||83
9919036|NCT01232296|11036182|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
9919037|NCT01232296|11036183|FG001|Safety Set|Overall Study||83
9919038|NCT01232296|11036182|FG000|COMPLETED|Overall Study||0
9919039|NCT01232296|11036183|FG001|COMPLETED|Overall Study||0
9919040|NCT01232296|11036182|FG000|NOT COMPLETED|Overall Study||82
9919041|NCT01232296|11036183|FG001|NOT COMPLETED|Overall Study||83
9919042|NCT01232452|11036191|FG000|STARTED|Overall Study||87
9919043|NCT01232452|11036192|FG001|STARTED|Overall Study||85
9919044|NCT01232452|11036191|FG000|Received at Least One Dose of Study Drug|Overall Study||85
9919045|NCT01232452|11036192|FG001|Received at Least One Dose of Study Drug|Overall Study||81
9919046|NCT01232452|11036191|FG000|COMPLETED|Overall Study||48
9919047|NCT01232452|11036192|FG001|COMPLETED|Overall Study||46
9919048|NCT01232452|11036191|FG000|NOT COMPLETED|Overall Study||39
9919049|NCT01232452|11036192|FG001|NOT COMPLETED|Overall Study||39
9919050|NCT01232465|11036200|FG000|STARTED|Overall Study||337
9919051|NCT01232465|11036201|FG001|STARTED|Overall Study||402
9919052|NCT01232465|11036200|FG000|COMPLETED|Overall Study||337
9919053|NCT01232465|11036201|FG001|COMPLETED|Overall Study||402
9919054|NCT01232465|11036200|FG000|NOT COMPLETED|Overall Study||0
9919055|NCT01232465|11036201|FG001|NOT COMPLETED|Overall Study||0
9919056|NCT01232491|11036209|FG000|STARTED|Overall Study||306
9919057|NCT01232491|11036210|FG001|STARTED|Overall Study||305
9919058|NCT01232491|11036209|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
9919059|NCT01232491|11036210|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
9919060|NCT01232491|11036209|FG000|COMPLETED|Overall Study||246
9919061|NCT01232491|11036210|FG001|COMPLETED|Overall Study||242
9919062|NCT01232491|11036209|FG000|NOT COMPLETED|Overall Study||60
9919063|NCT01232491|11036210|FG001|NOT COMPLETED|Overall Study||63
9919064|NCT01232504|11036219|FG000|STARTED|Overall Study||68
9919065|NCT01232504|11036220|FG001|STARTED|Overall Study||69
9919066|NCT01232504|11036221|FG002|STARTED|Overall Study||69
9919067|NCT01232504|11036219|FG000|COMPLETED|Overall Study||59
9919068|NCT01232504|11036220|FG001|COMPLETED|Overall Study||67
9919069|NCT01232504|11036221|FG002|COMPLETED|Overall Study||61
9919070|NCT01232504|11036219|FG000|NOT COMPLETED|Overall Study||9
9919071|NCT01232504|11036220|FG001|NOT COMPLETED|Overall Study||2
9919072|NCT01232504|11036221|FG002|NOT COMPLETED|Overall Study||8
9919073|NCT01232556|11036239|FG000|STARTED|Overall Study||166
9919074|NCT01232556|11036240|FG001|STARTED|Overall Study||172
9919075|NCT01232556|11036239|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
9919076|NCT01232556|11036240|FG001|Treated|Overall Study||167
9919077|NCT01232556|11036239|FG000|COMPLETED|Overall Study||7
9919078|NCT01232556|11036240|FG001|COMPLETED|Overall Study||1
9919079|NCT01232556|11036239|FG000|NOT COMPLETED|Overall Study||159
9919080|NCT01232556|11036240|FG001|NOT COMPLETED|Overall Study||171
9919081|NCT01232569|11036248|FG000|STARTED|Double-blind Treatment Period||438
9919082|NCT01232569|11036249|FG001|STARTED|Double-blind Treatment Period||218
9919083|NCT01232569|11036250|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
9919084|NCT01232569|11036251|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
9919085|NCT01232569|11036248|FG000|COMPLETED|Double-blind Treatment Period||410
9919086|NCT01232569|11036249|FG001|COMPLETED|Double-blind Treatment Period||209
9919087|NCT01232569|11036250|FG002|COMPLETED|Double-blind Treatment Period||0
9919088|NCT01232569|11036251|FG003|COMPLETED|Double-blind Treatment Period||0
9919089|NCT01232569|11036248|FG000|NOT COMPLETED|Double-blind Treatment Period||28
9919090|NCT01232569|11036249|FG001|NOT COMPLETED|Double-blind Treatment Period||9
9919091|NCT01232569|11036250|FG002|NOT COMPLETED|Double-blind Treatment Period||0
9919092|NCT01232569|11036251|FG003|NOT COMPLETED|Double-blind Treatment Period||0
9919093|NCT01232569|11036248|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
9919094|NCT01232569|11036249|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
9919095|NCT01232569|11036250|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
9919096|NCT01232569|11036251|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
9919097|NCT01232569|11036248|FG000|COMPLETED|Open-label Extension Period||0
9919098|NCT01232569|11036249|FG001|COMPLETED|Open-label Extension Period||0
9919099|NCT01232569|11036250|FG002|COMPLETED|Open-label Extension Period||203
9919100|NCT01232569|11036251|FG003|COMPLETED|Open-label Extension Period||200
9919101|NCT01232569|11036248|FG000|NOT COMPLETED|Open-label Extension Period||0
9919102|NCT01232569|11036249|FG001|NOT COMPLETED|Open-label Extension Period||0
9919103|NCT01232569|11036250|FG002|NOT COMPLETED|Open-label Extension Period||27
9919104|NCT01232569|11036251|FG003|NOT COMPLETED|Open-label Extension Period||27
9919105|NCT01232738|11036260|FG000|STARTED|Overall Study||36
9919106|NCT01232738|11036260|FG000|COMPLETED|Overall Study||23
9919107|NCT01232738|11036260|FG000|NOT COMPLETED|Overall Study||13
9919108|NCT01232790|11036268|FG000|STARTED|Randomization||14
9919109|NCT01232790|11036269|FG001|STARTED|Randomization||14
9919110|NCT01232790|11036268|FG000|COMPLETED|Randomization||12
9919111|NCT01232790|11036269|FG001|COMPLETED|Randomization||12
9919112|NCT01232790|11036268|FG000|NOT COMPLETED|Randomization||2
9919113|NCT01232790|11036269|FG001|NOT COMPLETED|Randomization||2
9919114|NCT01232790|11036268|FG000|STARTED|Initial Assessment||12
9919115|NCT01232790|11036269|FG001|STARTED|Initial Assessment||12
9919116|NCT01232790|11036268|FG000|COMPLETED|Initial Assessment||12
9919117|NCT01232790|11036269|FG001|COMPLETED|Initial Assessment||11
9919118|NCT01232790|11036268|FG000|NOT COMPLETED|Initial Assessment||0
9919119|NCT01232790|11036269|FG001|NOT COMPLETED|Initial Assessment||1
9919120|NCT01232790|11036268|FG000|STARTED|First Crossover||12
9919121|NCT01232790|11036269|FG001|STARTED|First Crossover||11
9919122|NCT01232790|11036268|FG000|COMPLETED|First Crossover||11
9919123|NCT01232790|11036269|FG001|COMPLETED|First Crossover||11
9919124|NCT01232790|11036268|FG000|NOT COMPLETED|First Crossover||1
9919125|NCT01232790|11036269|FG001|NOT COMPLETED|First Crossover||0
9919126|NCT01232790|11036268|FG000|STARTED|Second Crossover||11
9919127|NCT01232790|11036269|FG001|STARTED|Second Crossover||11
9919128|NCT01232790|11036268|FG000|COMPLETED|Second Crossover||10
9919129|NCT01232790|11036269|FG001|COMPLETED|Second Crossover||9
9919130|NCT01232790|11036268|FG000|NOT COMPLETED|Second Crossover||1
9919131|NCT01232790|11036269|FG001|NOT COMPLETED|Second Crossover||2
9919132|NCT01232829|11036285|FG000|STARTED|Overall Study||18
9919133|NCT01232829|11036285|FG000|COMPLETED|Overall Study||18
9919134|NCT01232829|11036285|FG000|NOT COMPLETED|Overall Study||0
9919135|NCT01232868|11036291|FG000|STARTED|Overall Study||22
9919136|NCT01232868|11036292|FG001|STARTED|Overall Study||44
9919137|NCT01232868|11036291|FG000|COMPLETED|Overall Study||20
9919138|NCT01232868|11036292|FG001|COMPLETED|Overall Study||40
9919139|NCT01232868|11036291|FG000|NOT COMPLETED|Overall Study||2
9919140|NCT01232868|11036292|FG001|NOT COMPLETED|Overall Study||4
9919141|NCT01232894|11036300|FG000|STARTED|Overall Study||60
9919142|NCT01232894|11036301|FG001|STARTED|Overall Study||30
9919143|NCT01232894|11036300|FG000|Received Study Drug|Overall Study||59
9919144|NCT01232894|11036301|FG001|Received Study Drug|Overall Study||28
9919145|NCT01232894|11036300|FG000|COMPLETED|Overall Study||48
9919146|NCT01232894|11036301|FG001|COMPLETED|Overall Study||22
9919147|NCT01232894|11036300|FG000|NOT COMPLETED|Overall Study||12
9919148|NCT01232894|11036301|FG001|NOT COMPLETED|Overall Study||8
9919149|NCT01232920|11036309|FG000|STARTED|Overall Study||41
9919150|NCT01232920|11036310|FG001|STARTED|Overall Study||39
9919151|NCT01232920|11036309|FG000|COMPLETED|Overall Study||35
9919152|NCT01232920|11036310|FG001|COMPLETED|Overall Study||32
9919153|NCT01232920|11036309|FG000|NOT COMPLETED|Overall Study||6
9919154|NCT01232920|11036310|FG001|NOT COMPLETED|Overall Study||7
9919155|NCT01232946|11036319|FG000|STARTED|Overall Study||9
9919156|NCT01232946|11036320|FG001|STARTED|Overall Study||10
9919157|NCT01232946|11036321|FG002|STARTED|Overall Study||11
9919158|NCT01232946|11036319|FG000|COMPLETED|Overall Study||9
9919159|NCT01232946|11036320|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9
9919160|NCT01232946|11036321|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
9919161|NCT01232946|11036319|FG000|NOT COMPLETED|Overall Study||0
9919162|NCT01232946|11036320|FG001|NOT COMPLETED|Overall Study||1
9919163|NCT01232946|11036321|FG002|NOT COMPLETED|Overall Study||2
9919164|NCT01233050|11036331|FG000|STARTED|Overall Study||400
9919165|NCT01233050|11036332|FG001|STARTED|Overall Study||402
9919166|NCT01233050|11036331|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
9919167|NCT01233050|11036332|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
9919168|NCT01233050|11036331|FG000|NOT COMPLETED|Overall Study||8
9919169|NCT01233050|11036332|FG001|NOT COMPLETED|Overall Study||6
9919170|NCT01233076|11036338|FG000|STARTED|Period 1, One Week||30
9919171|NCT01233076|11036339|FG001|STARTED|Period 1, One Week||30
9919172|NCT01233076|11036338|FG000|COMPLETED|Period 1, One Week||30
9919173|NCT01233076|11036339|FG001|COMPLETED|Period 1, One Week||30
9919174|NCT01233076|11036338|FG000|NOT COMPLETED|Period 1, One Week||0
9919175|NCT01233076|11036339|FG001|NOT COMPLETED|Period 1, One Week||0
9919176|NCT01233076|11036338|FG000|STARTED|Period 2, One Week||30
9919177|NCT01233076|11036339|FG001|STARTED|Period 2, One Week||30
9919178|NCT01233076|11036338|FG000|COMPLETED|Period 2, One Week||29
9919179|NCT01233076|11036339|FG001|COMPLETED|Period 2, One Week||30
9919180|NCT01233076|11036338|FG000|NOT COMPLETED|Period 2, One Week||1
9919181|NCT01233076|11036339|FG001|NOT COMPLETED|Period 2, One Week||0
9919182|NCT01233232|11036348|FG000|STARTED|Overall Study||29
9919183|NCT01233232|11036349|FG001|STARTED|Overall Study||30
10111255|NCT02494583|11242312|FG000|NOT COMPLETED|Overall Study||256
10111256|NCT02494583|11242313|FG001|NOT COMPLETED|Overall Study||257
10111257|NCT02494583|11242314|FG002|NOT COMPLETED|Overall Study||250
10111258|NCT02494596|11242322|FG000|STARTED|Overall Study||5
9919184|NCT01233232|11036350|FG002|STARTED|Overall Study||28
9919185|NCT01233232|11036348|FG000|COMPLETED|Overall Study||28
9919186|NCT01233232|11036349|FG001|COMPLETED|Overall Study||30
9919187|NCT01233232|11036350|FG002|COMPLETED|Overall Study||28
9919188|NCT01233232|11036348|FG000|NOT COMPLETED|Overall Study||1
9919189|NCT01233232|11036349|FG001|NOT COMPLETED|Overall Study||0
9919190|NCT01233232|11036350|FG002|NOT COMPLETED|Overall Study||0
9919191|NCT01233258|11036363|FG000|STARTED|First Intervention (6 Months)||11
9919192|NCT01233258|11036364|FG001|STARTED|First Intervention (6 Months)||10
9919193|NCT01233258|11036365|FG002|STARTED|First Intervention (6 Months)||14
9919194|NCT01233258|11036366|FG003|STARTED|First Intervention (6 Months)||16
9919195|NCT01233258|11036367|FG004|STARTED|First Intervention (6 Months)||16
9919196|NCT01233258|11036368|FG005|STARTED|First Intervention (6 Months)||16
9919197|NCT01233258|11036363|FG000|Participants Received Treatment|First Intervention (6 Months)||11
9919198|NCT01233258|11036364|FG001|Participants Received Treatment|First Intervention (6 Months)||10
9919199|NCT01233258|11036365|FG002|Participants Received Treatment|First Intervention (6 Months)||13
9919200|NCT01233258|11036366|FG003|Participants Received Treatment|First Intervention (6 Months)||15
9919201|NCT01233258|11036367|FG004|Participants Received Treatment|First Intervention (6 Months)||16
9919202|NCT01233258|11036368|FG005|Participants Received Treatment|First Intervention (6 Months)||15
9919203|NCT01233258|11036363|FG000|COMPLETED|First Intervention (6 Months)||10
9919204|NCT01233258|11036364|FG001|COMPLETED|First Intervention (6 Months)||10
9919205|NCT01233258|11036365|FG002|COMPLETED|First Intervention (6 Months)||13
9919206|NCT01233258|11036366|FG003|COMPLETED|First Intervention (6 Months)||15
9919207|NCT01233258|11036367|FG004|COMPLETED|First Intervention (6 Months)||16
9919208|NCT01233258|11036368|FG005|COMPLETED|First Intervention (6 Months)||15
9919209|NCT01233258|11036363|FG000|NOT COMPLETED|First Intervention (6 Months)||1
9919210|NCT01233258|11036364|FG001|NOT COMPLETED|First Intervention (6 Months)||0
9919211|NCT01233258|11036365|FG002|NOT COMPLETED|First Intervention (6 Months)||1
9919212|NCT01233258|11036366|FG003|NOT COMPLETED|First Intervention (6 Months)||1
9919213|NCT01233258|11036367|FG004|NOT COMPLETED|First Intervention (6 Months)||0
9919214|NCT01233258|11036368|FG005|NOT COMPLETED|First Intervention (6 Months)||1
9919215|NCT01233258|11036363|FG000|STARTED|Washout (2-3 Days)||10
9919216|NCT01233258|11036364|FG001|STARTED|Washout (2-3 Days)||10
9919217|NCT01233258|11036365|FG002|STARTED|Washout (2-3 Days)||13
9919218|NCT01233258|11036366|FG003|STARTED|Washout (2-3 Days)||15
9919219|NCT01233258|11036367|FG004|STARTED|Washout (2-3 Days)||16
9919220|NCT01233258|11036368|FG005|STARTED|Washout (2-3 Days)||15
9919221|NCT01233258|11036363|FG000|COMPLETED|Washout (2-3 Days)||10
9919222|NCT01233258|11036364|FG001|COMPLETED|Washout (2-3 Days)||10
9919223|NCT01233258|11036365|FG002|COMPLETED|Washout (2-3 Days)||13
9919224|NCT01233258|11036366|FG003|COMPLETED|Washout (2-3 Days)||15
9919225|NCT01233258|11036367|FG004|COMPLETED|Washout (2-3 Days)||16
9919226|NCT01233258|11036368|FG005|COMPLETED|Washout (2-3 Days)||15
9919227|NCT01233258|11036363|FG000|NOT COMPLETED|Washout (2-3 Days)||0
9919228|NCT01233258|11036364|FG001|NOT COMPLETED|Washout (2-3 Days)||0
9919229|NCT01233258|11036365|FG002|NOT COMPLETED|Washout (2-3 Days)||0
9919230|NCT01233258|11036366|FG003|NOT COMPLETED|Washout (2-3 Days)||0
9919231|NCT01233258|11036367|FG004|NOT COMPLETED|Washout (2-3 Days)||0
9919232|NCT01233258|11036368|FG005|NOT COMPLETED|Washout (2-3 Days)||0
9919233|NCT01233258|11036363|FG000|STARTED|Second Intervention (6 Months)||10
9919234|NCT01233258|11036364|FG001|STARTED|Second Intervention (6 Months)||10
9919235|NCT01233258|11036365|FG002|STARTED|Second Intervention (6 Months)||13
9919236|NCT01233258|11036366|FG003|STARTED|Second Intervention (6 Months)||15
9919237|NCT01233258|11036367|FG004|STARTED|Second Intervention (6 Months)||16
9919238|NCT01233258|11036368|FG005|STARTED|Second Intervention (6 Months)||15
9919239|NCT01233258|11036363|FG000|COMPLETED|Second Intervention (6 Months)||10
9919240|NCT01233258|11036364|FG001|COMPLETED|Second Intervention (6 Months)||10
9919241|NCT01233258|11036365|FG002|COMPLETED|Second Intervention (6 Months)||13
9919242|NCT01233258|11036366|FG003|COMPLETED|Second Intervention (6 Months)||15
9919243|NCT01233258|11036367|FG004|COMPLETED|Second Intervention (6 Months)||16
9919244|NCT01233258|11036368|FG005|COMPLETED|Second Intervention (6 Months)||15
9919245|NCT01233258|11036363|FG000|NOT COMPLETED|Second Intervention (6 Months)||0
9919246|NCT01233258|11036364|FG001|NOT COMPLETED|Second Intervention (6 Months)||0
9919247|NCT01233258|11036365|FG002|NOT COMPLETED|Second Intervention (6 Months)||0
9919248|NCT01233258|11036366|FG003|NOT COMPLETED|Second Intervention (6 Months)||0
9919249|NCT01233258|11036367|FG004|NOT COMPLETED|Second Intervention (6 Months)||0
9919250|NCT01233258|11036368|FG005|NOT COMPLETED|Second Intervention (6 Months)||0
9919251|NCT01233284|11036383|FG000|STARTED|Period 1 (4 Weeks)||37
9919252|NCT01233284|11036384|FG001|STARTED|Period 1 (4 Weeks)||38
9919253|NCT01233284|11036385|FG002|STARTED|Period 1 (4 Weeks)||38
9919254|NCT01233284|11036386|FG003|STARTED|Period 1 (4 Weeks)||35
9919255|NCT01233284|11036387|FG004|STARTED|Period 1 (4 Weeks)||1
9919256|NCT01233284|11036383|FG000|COMPLETED|Period 1 (4 Weeks)||36
9919257|NCT01233284|11036384|FG001|COMPLETED|Period 1 (4 Weeks)||37
9919258|NCT01233284|11036385|FG002|COMPLETED|Period 1 (4 Weeks)||37
9919259|NCT01233284|11036386|FG003|COMPLETED|Period 1 (4 Weeks)||35
9919260|NCT01233284|11036387|FG004|COMPLETED|Period 1 (4 Weeks)||1
9919261|NCT01233284|11036383|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
9919262|NCT01233284|11036384|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
9919263|NCT01233284|11036385|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
9919264|NCT01233284|11036386|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
9919265|NCT01233284|11036387|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0
9919266|NCT01233284|11036383|FG000|STARTED|Period 2 (4 Weeks)||36
9919267|NCT01233284|11036384|FG001|STARTED|Period 2 (4 Weeks)||37
9919268|NCT01233284|11036385|FG002|STARTED|Period 2 (4 Weeks)||37
9919269|NCT01233284|11036386|FG003|STARTED|Period 2 (4 Weeks)||35
9919270|NCT01233284|11036387|FG004|STARTED|Period 2 (4 Weeks)||1
9919271|NCT01233284|11036383|FG000|COMPLETED|Period 2 (4 Weeks)||36
9919272|NCT01233284|11036384|FG001|COMPLETED|Period 2 (4 Weeks)||37
9919273|NCT01233284|11036385|FG002|COMPLETED|Period 2 (4 Weeks)||36
9919274|NCT01233284|11036386|FG003|COMPLETED|Period 2 (4 Weeks)||35
9919275|NCT01233284|11036387|FG004|COMPLETED|Period 2 (4 Weeks)||1
9919276|NCT01233284|11036383|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
9919277|NCT01233284|11036384|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
9919278|NCT01233284|11036385|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1
9919279|NCT01233284|11036386|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
9919280|NCT01233284|11036387|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
9919281|NCT01233284|11036383|FG000|STARTED|Period 3 (4 Weeks)||36
9919282|NCT01233284|11036384|FG001|STARTED|Period 3 (4 Weeks)||37
9919283|NCT01233284|11036385|FG002|STARTED|Period 3 (4 Weeks)||36
9919284|NCT01233284|11036386|FG003|STARTED|Period 3 (4 Weeks)||35
9919285|NCT01233284|11036387|FG004|STARTED|Period 3 (4 Weeks)||1
9919286|NCT01233284|11036383|FG000|COMPLETED|Period 3 (4 Weeks)||36
10010470|NCT01774851|11133280|FG000|COMPLETED|Overall Study||42
10010471|NCT01774851|11133281|FG001|COMPLETED|Overall Study||42
10010472|NCT01774851|11133280|FG000|NOT COMPLETED|Overall Study||0
10010473|NCT01774851|11133281|FG001|NOT COMPLETED|Overall Study||0
10010474|NCT01774903|11133287|FG000|STARTED|Overall Study||45
9919287|NCT01233284|11036384|FG001|COMPLETED|Period 3 (4 Weeks)||37
9919288|NCT01233284|11036385|FG002|COMPLETED|Period 3 (4 Weeks)||35
9919289|NCT01233284|11036386|FG003|COMPLETED|Period 3 (4 Weeks)||34
9919290|NCT01233284|11036387|FG004|COMPLETED|Period 3 (4 Weeks)||1
9919291|NCT01233284|11036383|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
9919292|NCT01233284|11036384|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
9919293|NCT01233284|11036385|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1
9919294|NCT01233284|11036386|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1
9919295|NCT01233284|11036387|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
9919296|NCT01233284|11036383|FG000|STARTED|Period 4 (4 Weeks)||36
9919297|NCT01233284|11036384|FG001|STARTED|Period 4 (4 Weeks)||37
9919298|NCT01233284|11036385|FG002|STARTED|Period 4 (4 Weeks)||35
9919299|NCT01233284|11036386|FG003|STARTED|Period 4 (4 Weeks)||34
9919300|NCT01233284|11036387|FG004|STARTED|Period 4 (4 Weeks)||1
9919301|NCT01233284|11036383|FG000|COMPLETED|Period 4 (4 Weeks)||36
9919302|NCT01233284|11036384|FG001|COMPLETED|Period 4 (4 Weeks)||36
9919303|NCT01233284|11036385|FG002|COMPLETED|Period 4 (4 Weeks)||35
9919304|NCT01233284|11036386|FG003|COMPLETED|Period 4 (4 Weeks)||33
9919305|NCT01233284|11036387|FG004|COMPLETED|Period 4 (4 Weeks)||1
9919306|NCT01233284|11036383|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0
9919307|NCT01233284|11036384|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1
9919308|NCT01233284|11036385|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0
9919309|NCT01233284|11036386|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1
9919310|NCT01233284|11036387|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0
9919311|NCT01233518|11036397|FG000|STARTED|Overall Study||285
9919312|NCT01233518|11036397|FG000|COMPLETED|Overall Study||252
9919313|NCT01233518|11036397|FG000|NOT COMPLETED|Overall Study||33
9919314|NCT01233609|11036404|FG000|STARTED|Overall Study||46
9919315|NCT01233609|11036405|FG001|STARTED|Overall Study||44
9919316|NCT01233609|11036404|FG000|COMPLETED|Overall Study||37
9919317|NCT01233609|11036405|FG001|COMPLETED|Overall Study||42
9919318|NCT01233609|11036404|FG000|NOT COMPLETED|Overall Study||9
9919319|NCT01233609|11036405|FG001|NOT COMPLETED|Overall Study||2
9919320|NCT01233687|11036419|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
9919321|NCT01233687|11036419|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
9919322|NCT01233687|11036419|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
9919323|NCT01233687|11036419|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
9919324|NCT01233687|11036419|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
9919325|NCT01233687|11036419|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45
9919326|NCT01233687|11036419|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
9919327|NCT01233726|11036426|FG000|STARTED|Overall Study||53
9919328|NCT01233726|11036427|FG001|STARTED|Overall Study||53
9919329|NCT01233726|11036428|FG002|STARTED|Overall Study||53
9919330|NCT01233726|11036426|FG000|COMPLETED|Overall Study||52
9919331|NCT01233726|11036427|FG001|COMPLETED|Overall Study||53
9919332|NCT01233726|11036428|FG002|COMPLETED|Overall Study||52
9919333|NCT01233726|11036426|FG000|NOT COMPLETED|Overall Study||1
9919334|NCT01233726|11036427|FG001|NOT COMPLETED|Overall Study||0
9919335|NCT01233726|11036428|FG002|NOT COMPLETED|Overall Study||1
9919336|NCT01233817|11036439|FG000|STARTED|Overall Study||12
9919337|NCT01233817|11036439|FG000|COMPLETED|Overall Study||9
9919338|NCT01233817|11036439|FG000|NOT COMPLETED|Overall Study||3
9919339|NCT01233869|11036447|FG000|STARTED|Initial Treatment Period (24 Months)||58
10010475|NCT01774903|11133287|FG000|COMPLETED|Overall Study||34
9919340|NCT01233869|11036448|FG001|STARTED|Initial Treatment Period (24 Months)||31
9919341|NCT01233869|11036449|FG002|STARTED|Initial Treatment Period (24 Months)||24
9919342|NCT01233869|11036450|FG003|STARTED|Initial Treatment Period (24 Months)||56
9919343|NCT01233869|11036447|FG000|COMPLETED|Initial Treatment Period (24 Months)||34
9919344|NCT01233869|11036448|FG001|COMPLETED|Initial Treatment Period (24 Months)||3
9919345|NCT01233869|11036449|FG002|COMPLETED|Initial Treatment Period (24 Months)||22
9919346|NCT01233869|11036450|FG003|COMPLETED|Initial Treatment Period (24 Months)||34
9919347|NCT01233869|11036447|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24
9919348|NCT01233869|11036448|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28
9919349|NCT01233869|11036449|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2
9919350|NCT01233869|11036450|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22
9919351|NCT01233869|11036447|FG000|STARTED|Washout Period 30 Days||34
9919352|NCT01233869|11036448|FG001|STARTED|Washout Period 30 Days||3
9919353|NCT01233869|11036449|FG002|STARTED|Washout Period 30 Days||22
9919354|NCT01233869|11036450|FG003|STARTED|Washout Period 30 Days||34
9919355|NCT01233869|11036447|FG000|COMPLETED|Washout Period 30 Days||34
9919356|NCT01233869|11036448|FG001|COMPLETED|Washout Period 30 Days||3
9919357|NCT01233869|11036449|FG002|COMPLETED|Washout Period 30 Days||22
10010476|NCT01774903|11133287|FG000|NOT COMPLETED|Overall Study||11
10010477|NCT01774929|11133292|FG000|STARTED|Overall Study||35
10010478|NCT01774929|11133292|FG000|COMPLETED|Overall Study||32
10010479|NCT01774929|11133292|FG000|NOT COMPLETED|Overall Study||3
10010480|NCT01774968|11133298|FG000|STARTED|Overall Study||162
9919358|NCT01233869|11036450|FG003|COMPLETED|Washout Period 30 Days||34
9919359|NCT01233869|11036447|FG000|NOT COMPLETED|Washout Period 30 Days||0
9919360|NCT01233869|11036448|FG001|NOT COMPLETED|Washout Period 30 Days||0
9919361|NCT01233869|11036449|FG002|NOT COMPLETED|Washout Period 30 Days||0
9919362|NCT01233869|11036450|FG003|NOT COMPLETED|Washout Period 30 Days||0
9919363|NCT01233869|11036447|FG000|STARTED|Extended Treatment Period (46 Months)||34
9919364|NCT01233869|11036448|FG001|STARTED|Extended Treatment Period (46 Months)||3
9919365|NCT01233869|11036449|FG002|STARTED|Extended Treatment Period (46 Months)||22
9919366|NCT01233869|11036450|FG003|STARTED|Extended Treatment Period (46 Months)||34
9919367|NCT01233869|11036447|FG000|COMPLETED|Extended Treatment Period (46 Months)||20
9919368|NCT01233869|11036448|FG001|COMPLETED|Extended Treatment Period (46 Months)||0
9919369|NCT01233869|11036449|FG002|COMPLETED|Extended Treatment Period (46 Months)||17
9919370|NCT01233869|11036450|FG003|COMPLETED|Extended Treatment Period (46 Months)||18
9919371|NCT01233869|11036447|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14
9919372|NCT01233869|11036448|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3
9919373|NCT01233869|11036449|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5
9919374|NCT01233869|11036450|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16
9919375|NCT01233921|11036462|FG000|STARTED|Overall Study||3
9919376|NCT01233921|11036463|FG001|STARTED|Overall Study||3
9919377|NCT01233921|11036462|FG000|COMPLETED|Overall Study||3
9919378|NCT01233921|11036463|FG001|COMPLETED|Overall Study||3
9919379|NCT01233921|11036462|FG000|NOT COMPLETED|Overall Study||0
9919380|NCT01233921|11036463|FG001|NOT COMPLETED|Overall Study||0
9919381|NCT01233999|11036469|FG000|STARTED|Overall Study||10
9919382|NCT01233999|11036469|FG000|COMPLETED|Overall Study||8
9919383|NCT01233999|11036469|FG000|NOT COMPLETED|Overall Study||2
9919384|NCT01234207|11036473|FG000|STARTED|First Intervention||47
9919385|NCT01234207|11036474|FG001|STARTED|First Intervention||48
9919386|NCT01234207|11036473|FG000|COMPLETED|First Intervention||47
9919387|NCT01234207|11036474|FG001|COMPLETED|First Intervention||48
9919388|NCT01234207|11036473|FG000|NOT COMPLETED|First Intervention||0
9919389|NCT01234207|11036474|FG001|NOT COMPLETED|First Intervention||0
9919390|NCT01234207|11036473|FG000|STARTED|1-Week Washout Period||47
9919391|NCT01234207|11036474|FG001|STARTED|1-Week Washout Period||48
9919392|NCT01234207|11036473|FG000|COMPLETED|1-Week Washout Period||47
9919393|NCT01234207|11036474|FG001|COMPLETED|1-Week Washout Period||48
9919394|NCT01234207|11036473|FG000|NOT COMPLETED|1-Week Washout Period||0
9919395|NCT01234207|11036474|FG001|NOT COMPLETED|1-Week Washout Period||0
9919396|NCT01234207|11036473|FG000|STARTED|Second Intervention||47
9919397|NCT01234207|11036474|FG001|STARTED|Second Intervention||48
9919398|NCT01234207|11036473|FG000|COMPLETED|Second Intervention||47
9919399|NCT01234207|11036474|FG001|COMPLETED|Second Intervention||48
9919400|NCT01234207|11036473|FG000|NOT COMPLETED|Second Intervention||0
9919401|NCT01234207|11036474|FG001|NOT COMPLETED|Second Intervention||0
9919402|NCT01234337|11036484|FG000|STARTED|Overall Study||266
9919403|NCT01234337|11036485|FG001|STARTED|Overall Study||271
9919404|NCT01234337|11036484|FG000|Participants Received Treatment|Overall Study||260
9919405|NCT01234337|11036485|FG001|Participants Received Treatment|Overall Study||267
9919406|NCT01234337|11036484|FG000|COMPLETED|Overall Study||0
9919407|NCT01234337|11036485|FG001|COMPLETED|Overall Study||0
9919408|NCT01234337|11036484|FG000|NOT COMPLETED|Overall Study||266
9919409|NCT01234337|11036485|FG001|NOT COMPLETED|Overall Study||271
9919410|NCT01234350|11036493|FG000|STARTED|Overall Study||1000
9919411|NCT01234350|11036494|FG001|STARTED|Overall Study||493
9919412|NCT01234350|11036493|FG000|COMPLETED|Overall Study||313
9919413|NCT01234350|11036494|FG001|COMPLETED|Overall Study||226
9919414|NCT01234350|11036493|FG000|NOT COMPLETED|Overall Study||687
9919415|NCT01234350|11036494|FG001|NOT COMPLETED|Overall Study||267
9919416|NCT01234402|11036505|FG000|STARTED|Overall Study||52
9919417|NCT01234402|11036506|FG001|STARTED|Overall Study||51
9919418|NCT01234402|11036507|FG002|STARTED|Overall Study||50
9919419|NCT01234402|11036505|FG000|Received at Least One Dose of Study Drug|Overall Study||52
9919420|NCT01234402|11036506|FG001|Received at Least One Dose of Study Drug|Overall Study||49
9919421|NCT01234402|11036507|FG002|Received at Least One Dose of Study Drug|Overall Study||49
9919422|NCT01234402|11036505|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0
9919423|NCT01234402|11036506|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0
9919424|NCT01234402|11036507|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29
9919425|NCT01234402|11036505|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0
9919426|NCT01234402|11036506|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0
9919427|NCT01234402|11036507|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1
9919428|NCT01234402|11036505|FG000|COMPLETED|Overall Study||51
9919429|NCT01234402|11036506|FG001|COMPLETED|Overall Study||45
9919430|NCT01234402|11036507|FG002|COMPLETED|Overall Study||42
10010481|NCT01774968|11133299|FG001|STARTED|Overall Study||163
9919431|NCT01234402|11036505|FG000|NOT COMPLETED|Overall Study||1
9919432|NCT01234402|11036506|FG001|NOT COMPLETED|Overall Study||6
9919433|NCT01234402|11036507|FG002|NOT COMPLETED|Overall Study||8
9919434|NCT01234467|11036517|FG000|STARTED|Overall Study||23
9919435|NCT01234467|11036517|FG000|COMPLETED|Overall Study||11
9919436|NCT01234467|11036517|FG000|NOT COMPLETED|Overall Study||12
9919437|NCT01234480|11036521|FG000|STARTED|Overall Study||5859
9919438|NCT01234480|11036521|FG000|COMPLETED|Overall Study||5416
9919439|NCT01234480|11036521|FG000|NOT COMPLETED|Overall Study||443
9919440|NCT01234649|11036530|FG000|STARTED|Overall Study||78
9919441|NCT01234649|11036531|FG001|STARTED|Overall Study||75
9919442|NCT01234649|11036530|FG000|COMPLETED|Overall Study||35
9919443|NCT01234649|11036531|FG001|COMPLETED|Overall Study||37
9919444|NCT01234649|11036530|FG000|NOT COMPLETED|Overall Study||43
9919445|NCT01234649|11036531|FG001|NOT COMPLETED|Overall Study||38
9919446|NCT01234675|11036537|FG000|STARTED|First Intervention (6 Weeks)||10
9919447|NCT01234675|11036538|FG001|STARTED|First Intervention (6 Weeks)||9
9919448|NCT01234675|11036537|FG000|COMPLETED|First Intervention (6 Weeks)||9
9919449|NCT01234675|11036538|FG001|COMPLETED|First Intervention (6 Weeks)||8
9919450|NCT01234675|11036537|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
9919451|NCT01234675|11036538|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
9919452|NCT01234675|11036537|FG000|STARTED|Second Intervention (6 Weeks)||9
9919453|NCT01234675|11036538|FG001|STARTED|Second Intervention (6 Weeks)||8
9919454|NCT01234675|11036537|FG000|COMPLETED|Second Intervention (6 Weeks)||7
9919455|NCT01234675|11036538|FG001|COMPLETED|Second Intervention (6 Weeks)||8
9919456|NCT01234675|11036537|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2
9919457|NCT01234675|11036538|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9919458|NCT01234714|11036544|FG000|STARTED|Overall Study||84
9919459|NCT01234714|11036544|FG000|COMPLETED|Overall Study||84
9919460|NCT01234714|11036544|FG000|NOT COMPLETED|Overall Study||0
9919461|NCT01234766|11036551|FG000|STARTED|Overall Study||39
9919462|NCT01234766|11036551|FG000|COMPLETED|Overall Study||35
9919463|NCT01234766|11036551|FG000|NOT COMPLETED|Overall Study||4
9919464|NCT01234831|11036557|FG000|STARTED|Overall Study||261
9919465|NCT01234831|11036558|FG001|STARTED|Overall Study||202
9919466|NCT01234831|11036557|FG000|COMPLETED|Overall Study||259
9919467|NCT01234831|11036558|FG001|COMPLETED|Overall Study||198
9919468|NCT01234831|11036557|FG000|NOT COMPLETED|Overall Study||2
9919469|NCT01234831|11036558|FG001|NOT COMPLETED|Overall Study||4
9919470|NCT01234870|11036565|FG000|STARTED|Overall Study||40
9919471|NCT01234870|11036565|FG000|COMPLETED|Overall Study||40
9919472|NCT01234870|11036565|FG000|NOT COMPLETED|Overall Study||0
9919473|NCT01234883|11036572|FG000|STARTED|Overall Study||51
9919474|NCT01234883|11036573|FG001|STARTED|Overall Study||49
9919475|NCT01234883|11036572|FG000|COMPLETED|Overall Study||41
9919476|NCT01234883|11036573|FG001|COMPLETED|Overall Study||36
9919477|NCT01234883|11036572|FG000|NOT COMPLETED|Overall Study||10
9919478|NCT01234883|11036573|FG001|NOT COMPLETED|Overall Study||13
9919479|NCT01234922|11036583|FG000|STARTED|Overall Study||1
9919480|NCT01234922|11036584|FG001|STARTED|Overall Study||1
9919481|NCT01234922|11036585|FG002|STARTED|Overall Study||2
9919482|NCT01234922|11036586|FG003|STARTED|Overall Study||2
9919483|NCT01234922|11036583|FG000|COMPLETED|Overall Study||1
10010482|NCT01774968|11133298|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
10010483|NCT01774968|11133299|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161
10010484|NCT01774968|11133298|FG000|COMPLETED|Overall Study||132
10010485|NCT01774968|11133299|FG001|COMPLETED|Overall Study||128
10010486|NCT01774968|11133298|FG000|NOT COMPLETED|Overall Study||30
10010487|NCT01774968|11133299|FG001|NOT COMPLETED|Overall Study||35
10010488|NCT01774981|11133313|FG000|STARTED|Overall Study||3
9919484|NCT01234922|11036584|FG001|COMPLETED|Overall Study||1
9919485|NCT01234922|11036585|FG002|COMPLETED|Overall Study||2
9919486|NCT01234922|11036586|FG003|COMPLETED|Overall Study||2
9919487|NCT01234922|11036583|FG000|NOT COMPLETED|Overall Study||0
9919488|NCT01234922|11036584|FG001|NOT COMPLETED|Overall Study||0
9919489|NCT01234922|11036585|FG002|NOT COMPLETED|Overall Study||0
9919490|NCT01234922|11036586|FG003|NOT COMPLETED|Overall Study||0
9919491|NCT01235195|11036596|FG000|STARTED|First Intervention||15
9919492|NCT01235195|11036597|FG001|STARTED|First Intervention||15
9919493|NCT01235195|11036596|FG000|COMPLETED|First Intervention||15
9919494|NCT01235195|11036597|FG001|COMPLETED|First Intervention||15
9919495|NCT01235195|11036596|FG000|NOT COMPLETED|First Intervention||0
9919496|NCT01235195|11036597|FG001|NOT COMPLETED|First Intervention||0
9919497|NCT01235195|11036596|FG000|STARTED|Washout Period of At Least 8 Days||15
9919498|NCT01235195|11036597|FG001|STARTED|Washout Period of At Least 8 Days||15
9919499|NCT01235195|11036596|FG000|COMPLETED|Washout Period of At Least 8 Days||15
9919500|NCT01235195|11036597|FG001|COMPLETED|Washout Period of At Least 8 Days||15
9919501|NCT01235195|11036596|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0
9919502|NCT01235195|11036597|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0
9919503|NCT01235195|11036596|FG000|STARTED|Second Intervention||15
9919504|NCT01235195|11036597|FG001|STARTED|Second Intervention||15
9919505|NCT01235195|11036596|FG000|COMPLETED|Second Intervention||15
9919506|NCT01235195|11036597|FG001|COMPLETED|Second Intervention||15
9919507|NCT01235195|11036596|FG000|NOT COMPLETED|Second Intervention||0
9919508|NCT01235195|11036597|FG001|NOT COMPLETED|Second Intervention||0
9919518|NCT01235338|11036618|FG000|STARTED|Overall Study||42
9919519|NCT01235338|11036619|FG001|STARTED|Overall Study||38
9919520|NCT01235338|11036618|FG000|COMPLETED|Overall Study||31
9919521|NCT01235338|11036619|FG001|COMPLETED|Overall Study||33
9919522|NCT01235338|11036618|FG000|NOT COMPLETED|Overall Study||11
9919523|NCT01235338|11036619|FG001|NOT COMPLETED|Overall Study||5
9919524|NCT01235351|11036629|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247
9919525|NCT01235351|11036630|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86
9919526|NCT01235351|11036629|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
9919527|NCT01235351|11036630|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
9919528|NCT01235351|11036629|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
9919529|NCT01235351|11036630|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
9919530|NCT01235351|11036629|FG000|STARTED|Treatment With Different Dose Sequences||233
9919531|NCT01235351|11036630|FG001|STARTED|Treatment With Different Dose Sequences||82
9919532|NCT01235351|11036629|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
9919533|NCT01235351|11036630|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
9919534|NCT01235351|11036629|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
9919535|NCT01235351|11036630|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
9919536|NCT01235351|11036629|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
9919537|NCT01235351|11036630|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
9919538|NCT01235351|11036629|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
9919539|NCT01235351|11036630|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
9919540|NCT01235351|11036629|FG000|COMPLETED|Treatment With Different Dose Sequences||233
9919541|NCT01235351|11036630|FG001|COMPLETED|Treatment With Different Dose Sequences||82
9919542|NCT01235351|11036629|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0
9919543|NCT01235351|11036630|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0
9919544|NCT01235377|11036642|FG000|STARTED|Overall Study||11
9919545|NCT01235377|11036643|FG001|STARTED|Overall Study||9
9919546|NCT01235377|11036642|FG000|COMPLETED|Overall Study||10
9919547|NCT01235377|11036643|FG001|COMPLETED|Overall Study||8
9919548|NCT01235377|11036642|FG000|NOT COMPLETED|Overall Study||1
9919549|NCT01235377|11036643|FG001|NOT COMPLETED|Overall Study||1
9919550|NCT01235403|11036649|FG000|STARTED|Overall Study||100
9919551|NCT01235403|11036649|FG000|COMPLETED|Overall Study||74
9919552|NCT01235403|11036649|FG000|NOT COMPLETED|Overall Study||26
9919553|NCT01235442|11036655|FG000|STARTED|Overall Study||297
9919554|NCT01235442|11036656|FG001|STARTED|Overall Study||295
9919555|NCT01235442|11036655|FG000|COMPLETED|Overall Study||253
9919556|NCT01235442|11036656|FG001|COMPLETED|Overall Study||251
9919557|NCT01235442|11036655|FG000|NOT COMPLETED|Overall Study||44
9919558|NCT01235442|11036656|FG001|NOT COMPLETED|Overall Study||44
9919559|NCT01235507|11036662|FG000|STARTED|Overall Study||71
9919560|NCT01235507|11036662|FG000|COMPLETED|Overall Study||69
9919561|NCT01235507|11036662|FG000|NOT COMPLETED|Overall Study||2
9919562|NCT01235546|11036668|FG000|STARTED|Overall Study||994
9919563|NCT01235546|11036669|FG001|STARTED|Overall Study||1019
9919564|NCT01235546|11036668|FG000|COMPLETED|Overall Study||992
9919565|NCT01235546|11036669|FG001|COMPLETED|Overall Study||1018
9919566|NCT01235546|11036668|FG000|NOT COMPLETED|Overall Study||2
9919567|NCT01235546|11036669|FG001|NOT COMPLETED|Overall Study||1
9919568|NCT01235598|11036686|FG000|STARTED|Overall Study||13
9919569|NCT01235598|11036687|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
9919570|NCT01235598|11036686|FG000|COMPLETED|Overall Study||12
9919571|NCT01235598|11036687|FG001|COMPLETED|Overall Study||24
9919572|NCT01235598|11036686|FG000|NOT COMPLETED|Overall Study||1
9919573|NCT01235598|11036687|FG001|NOT COMPLETED|Overall Study||4
9919574|NCT01235689|11036696|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
9919575|NCT01235689|11036697|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
9919576|NCT01235689|11036696|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63
9919577|NCT01235689|11036697|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69
9919578|NCT01235689|11036696|FG000|Randomized at Week 9|Overall Study||59
9919579|NCT01235689|11036697|FG001|Randomized at Week 9|Overall Study||53
9919580|NCT01235689|11036696|FG000|COMPLETED|Overall Study||93
9919581|NCT01235689|11036697|FG001|COMPLETED|Overall Study||90
9919582|NCT01235689|11036696|FG000|NOT COMPLETED|Overall Study||29
9919583|NCT01235689|11036697|FG001|NOT COMPLETED|Overall Study||32
9919584|NCT01235715|11036705|FG000|STARTED|Overall Study||98
9919585|NCT01235715|11036706|FG001|STARTED|Overall Study||102
9919586|NCT01235715|11036705|FG000|COMPLETED|Overall Study||98
9919587|NCT01235715|11036706|FG001|COMPLETED|Overall Study||100
9919588|NCT01235715|11036705|FG000|NOT COMPLETED|Overall Study||0
9919589|NCT01235715|11036706|FG001|NOT COMPLETED|Overall Study||2
9919590|NCT01235728|11036713|FG000|STARTED|Overall Study||3
9919591|NCT01235728|11036714|FG001|STARTED|Overall Study||3
9919592|NCT01235728|11036715|FG002|STARTED|Overall Study||3
9919593|NCT01235728|11036716|FG003|STARTED|Overall Study||3
9919594|NCT01235728|11036717|FG004|STARTED|Overall Study||3
9919595|NCT01235728|11036718|FG005|STARTED|Overall Study||3
9919596|NCT01235728|11036719|FG006|STARTED|Overall Study||3
9919597|NCT01235728|11036720|FG007|STARTED|Overall Study||3
9919598|NCT01235728|11036713|FG000|COMPLETED|Overall Study||3
9919599|NCT01235728|11036714|FG001|COMPLETED|Overall Study||3
9919600|NCT01235728|11036715|FG002|COMPLETED|Overall Study||3
9919601|NCT01235728|11036716|FG003|COMPLETED|Overall Study||2
9919602|NCT01235728|11036717|FG004|COMPLETED|Overall Study||3
9919603|NCT01235728|11036718|FG005|COMPLETED|Overall Study||3
9919604|NCT01235728|11036719|FG006|COMPLETED|Overall Study||3
9919605|NCT01235728|11036720|FG007|COMPLETED|Overall Study||3
9919606|NCT01235728|11036713|FG000|NOT COMPLETED|Overall Study||0
9919607|NCT01235728|11036714|FG001|NOT COMPLETED|Overall Study||0
9919608|NCT01235728|11036715|FG002|NOT COMPLETED|Overall Study||0
9919609|NCT01235728|11036716|FG003|NOT COMPLETED|Overall Study||1
9919610|NCT01235728|11036717|FG004|NOT COMPLETED|Overall Study||0
9919611|NCT01235728|11036718|FG005|NOT COMPLETED|Overall Study||0
9919612|NCT01235728|11036719|FG006|NOT COMPLETED|Overall Study||0
9919613|NCT01235728|11036720|FG007|NOT COMPLETED|Overall Study||0
9919614|NCT01235741|11036731|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
9919615|NCT01235741|11036732|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
9919616|NCT01235741|11036733|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
9919617|NCT01235741|11036731|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
9919618|NCT01235741|11036732|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
9919619|NCT01235741|11036733|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
9919620|NCT01235741|11036731|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
9919621|NCT01235741|11036732|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
9919622|NCT01235741|11036733|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
9919623|NCT01235741|11036731|FG000|STARTED|Randomized to Treatment||0
9919624|NCT01235741|11036732|FG001|STARTED|Randomized to Treatment||36
9919625|NCT01235741|11036733|FG002|STARTED|Randomized to Treatment||36
9919626|NCT01235741|11036731|FG000|COMPLETED|Randomized to Treatment||0
9919627|NCT01235741|11036732|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
9919628|NCT01235741|11036733|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
9919629|NCT01235741|11036731|FG000|NOT COMPLETED|Randomized to Treatment||0
9919630|NCT01235741|11036732|FG001|NOT COMPLETED|Randomized to Treatment||36
9919631|NCT01235741|11036733|FG002|NOT COMPLETED|Randomized to Treatment||36
9919632|NCT01235741|11036731|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0
9919633|NCT01235741|11036732|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
9919634|NCT01235741|11036733|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
9919635|NCT01235741|11036731|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0
9919636|NCT01235741|11036732|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
9919637|NCT01235741|11036733|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
9919638|NCT01235741|11036731|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
9919639|NCT01235741|11036732|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
9919640|NCT01235741|11036733|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
9919641|NCT01235793|11036745|FG000|STARTED|Overall Study||11
9919642|NCT01235793|11036745|FG000|COMPLETED|Overall Study||5
9919643|NCT01235793|11036745|FG000|NOT COMPLETED|Overall Study||6
9919644|NCT01235897|11036750|FG000|STARTED|Overall Study||16
9919645|NCT01235897|11036750|FG000|COMPLETED|Overall Study||16
9919646|NCT01235897|11036750|FG000|NOT COMPLETED|Overall Study||0
9919647|NCT01235910|11036755|FG000|STARTED|Overall Study||1
9919648|NCT01235910|11036755|FG000|COMPLETED|Overall Study||1
9919649|NCT01235910|11036755|FG000|NOT COMPLETED|Overall Study||0
9919650|NCT01235949|11036777|FG000|STARTED|Primary Phase||198
9919651|NCT01235949|11036778|FG001|STARTED|Primary Phase||198
9919652|NCT01235949|11036779|FG002|STARTED|Primary Phase||199
9919653|NCT01235949|11036780|FG003|STARTED|Primary Phase||71
9919654|NCT01235949|11036781|FG004|STARTED|Primary Phase||72
9919655|NCT01235949|11036782|FG005|STARTED|Primary Phase||74
9919656|NCT01235949|11036783|FG006|STARTED|Primary Phase||0
9919657|NCT01235949|11036784|FG007|STARTED|Primary Phase||0
9919658|NCT01235949|11036785|FG008|STARTED|Primary Phase||0
9919659|NCT01235949|11036786|FG009|STARTED|Primary Phase||0
9919660|NCT01235949|11036787|FG010|STARTED|Primary Phase||0
9919661|NCT01235949|11036788|FG011|STARTED|Primary Phase||0
9919662|NCT01235949|11036789|FG012|STARTED|Primary Phase||0
9919663|NCT01235949|11036790|FG013|STARTED|Primary Phase||0
9919664|NCT01235949|11036791|FG014|STARTED|Primary Phase||0
9919665|NCT01235949|11036792|FG015|STARTED|Primary Phase||0
9919666|NCT01235949|11036793|FG016|STARTED|Primary Phase||0
9919667|NCT01235949|11036794|FG017|STARTED|Primary Phase||0
9919668|NCT01235949|11036777|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
9919669|NCT01235949|11036778|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
9919670|NCT01235949|11036779|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
10205296|NCT03489850|11332084|FG000|STARTED|Overall Study||24
10205297|NCT03489850|11332085|FG001|STARTED|Overall Study||28
10205298|NCT03489850|11332084|FG000|COMPLETED|Overall Study||23
9919671|NCT01235949|11036780|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
9919672|NCT01235949|11036781|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
9919673|NCT01235949|11036782|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
9919674|NCT01235949|11036783|FG006|COMPLETED|Primary Phase||0
9919675|NCT01235949|11036784|FG007|COMPLETED|Primary Phase||0
9919676|NCT01235949|11036785|FG008|COMPLETED|Primary Phase||0
9919677|NCT01235949|11036786|FG009|COMPLETED|Primary Phase||0
9919678|NCT01235949|11036787|FG010|COMPLETED|Primary Phase||0
9919679|NCT01235949|11036788|FG011|COMPLETED|Primary Phase||0
9919680|NCT01235949|11036789|FG012|COMPLETED|Primary Phase||0
9919681|NCT01235949|11036790|FG013|COMPLETED|Primary Phase||0
9919682|NCT01235949|11036791|FG014|COMPLETED|Primary Phase||0
9919683|NCT01235949|11036792|FG015|COMPLETED|Primary Phase||0
9919684|NCT01235949|11036793|FG016|COMPLETED|Primary Phase||0
9919685|NCT01235949|11036794|FG017|COMPLETED|Primary Phase||0
9919686|NCT01235949|11036777|FG000|NOT COMPLETED|Primary Phase||4
9919687|NCT01235949|11036778|FG001|NOT COMPLETED|Primary Phase||3
9919688|NCT01235949|11036779|FG002|NOT COMPLETED|Primary Phase||3
9919689|NCT01235949|11036780|FG003|NOT COMPLETED|Primary Phase||2
9919690|NCT01235949|11036781|FG004|NOT COMPLETED|Primary Phase||1
9919691|NCT01235949|11036782|FG005|NOT COMPLETED|Primary Phase||7
9919692|NCT01235949|11036783|FG006|NOT COMPLETED|Primary Phase||0
9919693|NCT01235949|11036784|FG007|NOT COMPLETED|Primary Phase||0
9919694|NCT01235949|11036785|FG008|NOT COMPLETED|Primary Phase||0
9919695|NCT01235949|11036786|FG009|NOT COMPLETED|Primary Phase||0
9919696|NCT01235949|11036787|FG010|NOT COMPLETED|Primary Phase||0
9919697|NCT01235949|11036788|FG011|NOT COMPLETED|Primary Phase||0
9919698|NCT01235949|11036789|FG012|NOT COMPLETED|Primary Phase||0
9919699|NCT01235949|11036790|FG013|NOT COMPLETED|Primary Phase||0
9919700|NCT01235949|11036791|FG014|NOT COMPLETED|Primary Phase||0
9919701|NCT01235949|11036792|FG015|NOT COMPLETED|Primary Phase||0
9919702|NCT01235949|11036793|FG016|NOT COMPLETED|Primary Phase||0
9919703|NCT01235949|11036794|FG017|NOT COMPLETED|Primary Phase||0
9919704|NCT01235949|11036777|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
9919705|NCT01235949|11036778|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
9919706|NCT01235949|11036779|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
9919707|NCT01235949|11036780|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
9919708|NCT01235949|11036781|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
9919709|NCT01235949|11036782|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
9919710|NCT01235949|11036783|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
9919711|NCT01235949|11036784|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
9919712|NCT01235949|11036785|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
9919713|NCT01235949|11036786|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
9919714|NCT01235949|11036787|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
9919715|NCT01235949|11036788|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
9919716|NCT01235949|11036789|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
9919717|NCT01235949|11036790|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
9919718|NCT01235949|11036791|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
9919719|NCT01235949|11036792|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
9919720|NCT01235949|11036793|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
9919721|NCT01235949|11036794|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
9919722|NCT01235949|11036777|FG000|COMPLETED|Booster Phase||0
9919723|NCT01235949|11036778|FG001|COMPLETED|Booster Phase||0
9919724|NCT01235949|11036779|FG002|COMPLETED|Booster Phase||0
9919725|NCT01235949|11036780|FG003|COMPLETED|Booster Phase||0
9919726|NCT01235949|11036781|FG004|COMPLETED|Booster Phase||0
9919727|NCT01235949|11036782|FG005|COMPLETED|Booster Phase||0
9919728|NCT01235949|11036783|FG006|COMPLETED|Booster Phase||64
9919729|NCT01235949|11036784|FG007|COMPLETED|Booster Phase||59
10010489|NCT01774981|11133314|FG001|STARTED|Overall Study||4
10010490|NCT01774981|11133315|FG002|STARTED|Overall Study||4
10010491|NCT01774981|11133316|FG003|STARTED|Overall Study||4
10010492|NCT01774981|11133317|FG004|STARTED|Overall Study||6
10010493|NCT01774981|11133318|FG005|STARTED|Overall Study||14
10205299|NCT03489850|11332085|FG001|COMPLETED|Overall Study||27
10205300|NCT03489850|11332084|FG000|NOT COMPLETED|Overall Study||1
10205301|NCT03489850|11332085|FG001|NOT COMPLETED|Overall Study||1
10205302|NCT03489863|11332093|FG000|STARTED|Overall Study||7
9919730|NCT01235949|11036785|FG008|COMPLETED|Booster Phase||61
9919731|NCT01235949|11036786|FG009|COMPLETED|Booster Phase||62
9919732|NCT01235949|11036787|FG010|COMPLETED|Booster Phase||61
9919733|NCT01235949|11036788|FG011|COMPLETED|Booster Phase||60
9919734|NCT01235949|11036789|FG012|COMPLETED|Booster Phase||60
9919735|NCT01235949|11036790|FG013|COMPLETED|Booster Phase||65
9919736|NCT01235949|11036791|FG014|COMPLETED|Booster Phase||60
9919737|NCT01235949|11036792|FG015|COMPLETED|Booster Phase||66
9919738|NCT01235949|11036793|FG016|COMPLETED|Booster Phase||68
9919739|NCT01235949|11036794|FG017|COMPLETED|Booster Phase||65
9919740|NCT01235949|11036777|FG000|NOT COMPLETED|Booster Phase||0
9919741|NCT01235949|11036778|FG001|NOT COMPLETED|Booster Phase||0
9919742|NCT01235949|11036779|FG002|NOT COMPLETED|Booster Phase||0
9919743|NCT01235949|11036780|FG003|NOT COMPLETED|Booster Phase||0
9919744|NCT01235949|11036781|FG004|NOT COMPLETED|Booster Phase||0
9919745|NCT01235949|11036782|FG005|NOT COMPLETED|Booster Phase||0
9919746|NCT01235949|11036783|FG006|NOT COMPLETED|Booster Phase||0
9919747|NCT01235949|11036784|FG007|NOT COMPLETED|Booster Phase||1
9919748|NCT01235949|11036785|FG008|NOT COMPLETED|Booster Phase||2
9919749|NCT01235949|11036786|FG009|NOT COMPLETED|Booster Phase||1
9919750|NCT01235949|11036787|FG010|NOT COMPLETED|Booster Phase||2
9919751|NCT01235949|11036788|FG011|NOT COMPLETED|Booster Phase||3
9919752|NCT01235949|11036789|FG012|NOT COMPLETED|Booster Phase||3
9919753|NCT01235949|11036790|FG013|NOT COMPLETED|Booster Phase||0
9919754|NCT01235949|11036791|FG014|NOT COMPLETED|Booster Phase||2
9919755|NCT01235949|11036792|FG015|NOT COMPLETED|Booster Phase||1
9919756|NCT01235949|11036793|FG016|NOT COMPLETED|Booster Phase||0
9919757|NCT01235949|11036794|FG017|NOT COMPLETED|Booster Phase||2
9919758|NCT01235975|11036834|FG000|STARTED|Overall Study||274
9919759|NCT01235975|11036835|FG001|STARTED|Overall Study||95
9919760|NCT01235975|11036834|FG000|COMPLETED|Overall Study||257
9919761|NCT01235975|11036835|FG001|COMPLETED|Overall Study||88
9919762|NCT01235975|11036834|FG000|NOT COMPLETED|Overall Study||17
9919763|NCT01235975|11036835|FG001|NOT COMPLETED|Overall Study||7
9919764|NCT01236001|11036843|FG000|STARTED|Overall Study||105
9919765|NCT01236001|11036844|FG001|STARTED|Overall Study||87
9919766|NCT01236001|11036843|FG000|COMPLETED|Overall Study||87
9919767|NCT01236001|11036844|FG001|COMPLETED|Overall Study||65
9919768|NCT01236001|11036843|FG000|NOT COMPLETED|Overall Study||18
9919769|NCT01236001|11036844|FG001|NOT COMPLETED|Overall Study||22
9919770|NCT01236053|11036873|FG000|STARTED|Overall Study||179138
9919771|NCT01236053|11036874|FG001|STARTED|Overall Study||1710950
9919772|NCT01236053|11036875|FG002|STARTED|Overall Study||1877
9919773|NCT01236053|11036876|FG003|STARTED|Overall Study||17853
9919774|NCT01236053|11036877|FG004|STARTED|Overall Study||212
9919775|NCT01236053|11036878|FG005|STARTED|Overall Study||2067
9919776|NCT01236053|11036879|FG006|STARTED|Overall Study||10855
9919777|NCT01236053|11036880|FG007|STARTED|Overall Study||102836
9919778|NCT01236053|11036881|FG008|STARTED|Overall Study||300
9919779|NCT01236053|11036882|FG009|STARTED|Overall Study||2935
9919780|NCT01236053|11036883|FG010|STARTED|Overall Study||19564
9919781|NCT01236053|11036884|FG011|STARTED|Overall Study||188924
9919782|NCT01236053|11036885|FG012|STARTED|Overall Study||148
9919783|NCT01236053|11036886|FG013|STARTED|Overall Study||1396
9919784|NCT01236053|11036887|FG014|STARTED|Overall Study||4600
9919785|NCT01236053|11036888|FG015|STARTED|Overall Study||43559
9919786|NCT01236053|11036889|FG016|STARTED|Overall Study||38
9919787|NCT01236053|11036890|FG017|STARTED|Overall Study||380
9919788|NCT01236053|11036891|FG018|STARTED|Overall Study||2155
9919789|NCT01236053|11036892|FG019|STARTED|Overall Study||20382
9919790|NCT01236053|11036893|FG020|STARTED|Overall Study||1272
9919791|NCT01236053|11036894|FG021|STARTED|Overall Study||12167
9919792|NCT01236053|11036873|FG000|COMPLETED|Overall Study||179138
9919793|NCT01236053|11036874|FG001|COMPLETED|Overall Study||1710950
9919794|NCT01236053|11036875|FG002|COMPLETED|Overall Study||1877
9919795|NCT01236053|11036876|FG003|COMPLETED|Overall Study||17853
9919796|NCT01236053|11036877|FG004|COMPLETED|Overall Study||212
9919797|NCT01236053|11036878|FG005|COMPLETED|Overall Study||2067
9919798|NCT01236053|11036879|FG006|COMPLETED|Overall Study||10855
9919799|NCT01236053|11036880|FG007|COMPLETED|Overall Study||102836
9919800|NCT01236053|11036881|FG008|COMPLETED|Overall Study||300
9919801|NCT01236053|11036882|FG009|COMPLETED|Overall Study||2935
9919802|NCT01236053|11036883|FG010|COMPLETED|Overall Study||19564
9919803|NCT01236053|11036884|FG011|COMPLETED|Overall Study||188924
9919804|NCT01236053|11036885|FG012|COMPLETED|Overall Study||148
9919805|NCT01236053|11036886|FG013|COMPLETED|Overall Study||1396
9919806|NCT01236053|11036887|FG014|COMPLETED|Overall Study||4600
9919807|NCT01236053|11036888|FG015|COMPLETED|Overall Study||43559
9919808|NCT01236053|11036889|FG016|COMPLETED|Overall Study||38
9919809|NCT01236053|11036890|FG017|COMPLETED|Overall Study||380
9919810|NCT01236053|11036891|FG018|COMPLETED|Overall Study||2155
9919811|NCT01236053|11036892|FG019|COMPLETED|Overall Study||20382
9919812|NCT01236053|11036893|FG020|COMPLETED|Overall Study||1272
9919813|NCT01236053|11036894|FG021|COMPLETED|Overall Study||12167
9919814|NCT01236053|11036873|FG000|NOT COMPLETED|Overall Study||0
9919815|NCT01236053|11036874|FG001|NOT COMPLETED|Overall Study||0
9919816|NCT01236053|11036875|FG002|NOT COMPLETED|Overall Study||0
9919817|NCT01236053|11036876|FG003|NOT COMPLETED|Overall Study||0
9919818|NCT01236053|11036877|FG004|NOT COMPLETED|Overall Study||0
9919819|NCT01236053|11036878|FG005|NOT COMPLETED|Overall Study||0
9919820|NCT01236053|11036879|FG006|NOT COMPLETED|Overall Study||0
9919821|NCT01236053|11036880|FG007|NOT COMPLETED|Overall Study||0
9919822|NCT01236053|11036881|FG008|NOT COMPLETED|Overall Study||0
9919823|NCT01236053|11036882|FG009|NOT COMPLETED|Overall Study||0
9919824|NCT01236053|11036883|FG010|NOT COMPLETED|Overall Study||0
9919825|NCT01236053|11036884|FG011|NOT COMPLETED|Overall Study||0
9919826|NCT01236053|11036885|FG012|NOT COMPLETED|Overall Study||0
9919827|NCT01236053|11036886|FG013|NOT COMPLETED|Overall Study||0
9919828|NCT01236053|11036887|FG014|NOT COMPLETED|Overall Study||0
9919829|NCT01236053|11036888|FG015|NOT COMPLETED|Overall Study||0
9919830|NCT01236053|11036889|FG016|NOT COMPLETED|Overall Study||0
9919831|NCT01236053|11036890|FG017|NOT COMPLETED|Overall Study||0
9919832|NCT01236053|11036891|FG018|NOT COMPLETED|Overall Study||0
9919833|NCT01236053|11036892|FG019|NOT COMPLETED|Overall Study||0
9919834|NCT01236053|11036893|FG020|NOT COMPLETED|Overall Study||0
9919835|NCT01236053|11036894|FG021|NOT COMPLETED|Overall Study||0
9919836|NCT01236105|11036943|FG000|STARTED|Overall Study||21
9919837|NCT01236105|11036943|FG000|COMPLETED|Overall Study||21
9919838|NCT01236105|11036943|FG000|NOT COMPLETED|Overall Study||0
9919839|NCT01236118|11036954|FG000|STARTED|Overall Study||6
9919840|NCT01236118|11036955|FG001|STARTED|Overall Study||5
9919841|NCT01236118|11036956|FG002|STARTED|Overall Study||17
9919842|NCT01236118|11036954|FG000|COMPLETED|Overall Study||4
9919843|NCT01236118|11036955|FG001|COMPLETED|Overall Study||4
9919844|NCT01236118|11036956|FG002|COMPLETED|Overall Study||14
9919845|NCT01236118|11036954|FG000|NOT COMPLETED|Overall Study||2
9919846|NCT01236118|11036955|FG001|NOT COMPLETED|Overall Study||1
9919847|NCT01236118|11036956|FG002|NOT COMPLETED|Overall Study||3
9919848|NCT01236170|11036964|FG000|STARTED|Overall Study||497
9919849|NCT01236170|11036964|FG000|COMPLETED|Overall Study||482
9919850|NCT01236170|11036964|FG000|NOT COMPLETED|Overall Study||15
9919851|NCT01236196|11036970|FG000|STARTED|Overall Study||18
9919852|NCT01236196|11036971|FG001|STARTED|Overall Study||21
9919853|NCT01236196|11036970|FG000|COMPLETED|Overall Study||17
9919854|NCT01236196|11036971|FG001|COMPLETED|Overall Study||13
9919855|NCT01236196|11036970|FG000|NOT COMPLETED|Overall Study||1
9919856|NCT01236196|11036971|FG001|NOT COMPLETED|Overall Study||8
9919857|NCT01236300|11036977|FG000|STARTED|Overall Study||66
9919858|NCT01236300|11036977|FG000|COMPLETED|Overall Study||66
9919859|NCT01236300|11036977|FG000|NOT COMPLETED|Overall Study||0
9919860|NCT01236326|11036984|FG000|STARTED|Overall Study||50
9919861|NCT01236326|11036985|FG001|STARTED|Overall Study||55
9919862|NCT01236326|11036984|FG000|COMPLETED|Overall Study||49
9919863|NCT01236326|11036985|FG001|COMPLETED|Overall Study||51
9919864|NCT01236326|11036984|FG000|NOT COMPLETED|Overall Study||1
9919865|NCT01236326|11036985|FG001|NOT COMPLETED|Overall Study||4
9919866|NCT01236339|11036993|FG000|STARTED|Overall Study||13
9919867|NCT01236339|11036994|FG001|STARTED|Overall Study||13
9919868|NCT01236339|11036993|FG000|LVP Crossover to TIPS|Overall Study||0
9919869|NCT01236339|11036994|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
9919870|NCT01236339|11036993|FG000|COMPLETED|Overall Study||2
9919871|NCT01236339|11036994|FG001|COMPLETED|Overall Study||0
9919872|NCT01236339|11036993|FG000|NOT COMPLETED|Overall Study||11
9919873|NCT01236339|11036994|FG001|NOT COMPLETED|Overall Study||13
9919874|NCT01236352|11037012|FG000|STARTED|Overall Study||4
9919875|NCT01236352|11037013|FG001|STARTED|Overall Study||4
9919876|NCT01236352|11037014|FG002|STARTED|Overall Study||4
9919877|NCT01236352|11037015|FG003|STARTED|Overall Study||4
9919878|NCT01236352|11037016|FG004|STARTED|Overall Study||4
9919879|NCT01236352|11037017|FG005|STARTED|Overall Study||4
9919880|NCT01236352|11037018|FG006|STARTED|Overall Study||8
9919881|NCT01236352|11037019|FG007|STARTED|Overall Study||7
9919882|NCT01236352|11037020|FG008|STARTED|Overall Study||3
9919883|NCT01236352|11037021|FG009|STARTED|Overall Study||22
9919884|NCT01236352|11037022|FG010|STARTED|Overall Study||20
9919885|NCT01236352|11037012|FG000|COMPLETED|Overall Study||0
9919886|NCT01236352|11037013|FG001|COMPLETED|Overall Study||0
9919887|NCT01236352|11037014|FG002|COMPLETED|Overall Study||0
9919888|NCT01236352|11037015|FG003|COMPLETED|Overall Study||1
9919889|NCT01236352|11037016|FG004|COMPLETED|Overall Study||0
9919890|NCT01236352|11037017|FG005|COMPLETED|Overall Study||0
9919891|NCT01236352|11037018|FG006|COMPLETED|Overall Study||0
9919892|NCT01236352|11037019|FG007|COMPLETED|Overall Study||0
9919893|NCT01236352|11037020|FG008|COMPLETED|Overall Study||0
10010494|NCT01774981|11133319|FG006|STARTED|Overall Study||13
9919894|NCT01236352|11037021|FG009|COMPLETED|Overall Study||0
9919895|NCT01236352|11037022|FG010|COMPLETED|Overall Study||0
9919896|NCT01236352|11037012|FG000|NOT COMPLETED|Overall Study||4
9919897|NCT01236352|11037013|FG001|NOT COMPLETED|Overall Study||4
9919898|NCT01236352|11037014|FG002|NOT COMPLETED|Overall Study||4
9919899|NCT01236352|11037015|FG003|NOT COMPLETED|Overall Study||3
10010495|NCT01774981|11133320|FG007|STARTED|Overall Study||12
9919900|NCT01236352|11037016|FG004|NOT COMPLETED|Overall Study||4
9919901|NCT01236352|11037017|FG005|NOT COMPLETED|Overall Study||4
9919902|NCT01236352|11037018|FG006|NOT COMPLETED|Overall Study||8
9919903|NCT01236352|11037019|FG007|NOT COMPLETED|Overall Study||7
9919904|NCT01236352|11037020|FG008|NOT COMPLETED|Overall Study||3
9919905|NCT01236352|11037021|FG009|NOT COMPLETED|Overall Study||22
9919906|NCT01236352|11037022|FG010|NOT COMPLETED|Overall Study||20
9919907|NCT01236365|11037048|FG000|STARTED|Overall Study||21
9919908|NCT01236365|11037049|FG001|STARTED|Overall Study||21
9919909|NCT01236365|11037048|FG000|COMPLETED|Overall Study||19
9919910|NCT01236365|11037049|FG001|COMPLETED|Overall Study||19
9919911|NCT01236365|11037048|FG000|NOT COMPLETED|Overall Study||2
9919912|NCT01236365|11037049|FG001|NOT COMPLETED|Overall Study||2
9919913|NCT01236378|11037067|FG000|STARTED|Overall Study||24
9919914|NCT01236378|11037067|FG000|COMPLETED|Overall Study||24
9919915|NCT01236378|11037067|FG000|NOT COMPLETED|Overall Study||0
9919916|NCT01236391|11037071|FG000|STARTED|Overall Study|Participants who received study treatment|111
9919917|NCT01236391|11037071|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
9919918|NCT01236391|11037071|FG000|NOT COMPLETED|Overall Study||16
9919919|NCT01236534|11037080|FG000|STARTED|Overall Study||11
9919920|NCT01236534|11037081|FG001|STARTED|Overall Study||10
9919921|NCT01236534|11037080|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
9919922|NCT01236534|11037081|FG001|COMPLETED|Overall Study||10
9919923|NCT01236534|11037080|FG000|NOT COMPLETED|Overall Study||3
9919924|NCT01236534|11037081|FG001|NOT COMPLETED|Overall Study||0
9919925|NCT01236573|11037098|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
9919926|NCT01236573|11037099|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
9919927|NCT01236573|11037100|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
9919928|NCT01236573|11037101|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
9919929|NCT01236573|11037102|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919930|NCT01236573|11037103|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919931|NCT01236573|11037104|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919932|NCT01236573|11037105|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919933|NCT01236573|11037106|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919934|NCT01236573|11037107|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919935|NCT01236573|11037108|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919936|NCT01236573|11037098|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
9919937|NCT01236573|11037099|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
9919938|NCT01236573|11037100|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
9919939|NCT01236573|11037101|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
9919940|NCT01236573|11037102|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919941|NCT01236573|11037103|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919942|NCT01236573|11037104|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919943|NCT01236573|11037105|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919944|NCT01236573|11037106|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919945|NCT01236573|11037107|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919946|NCT01236573|11037108|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919947|NCT01236573|11037098|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919948|NCT01236573|11037099|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919949|NCT01236573|11037100|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919950|NCT01236573|11037101|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919951|NCT01236573|11037102|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919952|NCT01236573|11037103|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919953|NCT01236573|11037104|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919954|NCT01236573|11037105|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919955|NCT01236573|11037106|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919956|NCT01236573|11037107|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919957|NCT01236573|11037108|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
9919958|NCT01236573|11037098|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919959|NCT01236573|11037099|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919960|NCT01236573|11037100|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919961|NCT01236573|11037101|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919962|NCT01236573|11037102|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
9919963|NCT01236573|11037103|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
9919964|NCT01236573|11037104|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
9919965|NCT01236573|11037105|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
9919966|NCT01236573|11037106|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
9919967|NCT01236573|11037107|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
9919968|NCT01236573|11037108|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919969|NCT01236573|11037098|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919970|NCT01236573|11037099|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919971|NCT01236573|11037100|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919972|NCT01236573|11037101|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919973|NCT01236573|11037102|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
9919974|NCT01236573|11037103|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
9919975|NCT01236573|11037104|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
9919976|NCT01236573|11037105|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
9919977|NCT01236573|11037106|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
9919978|NCT01236573|11037107|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
9919979|NCT01236573|11037108|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919980|NCT01236573|11037098|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919981|NCT01236573|11037099|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919982|NCT01236573|11037100|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919983|NCT01236573|11037101|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919984|NCT01236573|11037102|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919985|NCT01236573|11037103|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919986|NCT01236573|11037104|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
9919987|NCT01236573|11037105|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919988|NCT01236573|11037106|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
9919989|NCT01236573|11037107|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
9919990|NCT01236573|11037108|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
9919991|NCT01236573|11037098|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919992|NCT01236573|11037099|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919993|NCT01236573|11037100|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919994|NCT01236573|11037101|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919995|NCT01236573|11037102|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919996|NCT01236573|11037103|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919997|NCT01236573|11037104|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919998|NCT01236573|11037105|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9919999|NCT01236573|11037106|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920000|NCT01236573|11037107|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920001|NCT01236573|11037108|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
9920002|NCT01236573|11037098|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920003|NCT01236573|11037099|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920004|NCT01236573|11037100|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920005|NCT01236573|11037101|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920006|NCT01236573|11037102|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920007|NCT01236573|11037103|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920008|NCT01236573|11037104|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920009|NCT01236573|11037105|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920010|NCT01236573|11037106|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920011|NCT01236573|11037107|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920012|NCT01236573|11037108|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
9920013|NCT01236573|11037098|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920014|NCT01236573|11037099|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920015|NCT01236573|11037100|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920016|NCT01236573|11037101|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920017|NCT01236573|11037102|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920018|NCT01236573|11037103|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920019|NCT01236573|11037104|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920020|NCT01236573|11037105|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920021|NCT01236573|11037106|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920022|NCT01236573|11037107|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
9920023|NCT01236573|11037108|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
9920024|NCT01236742|11037136|FG000|STARTED|Overall Study||18
9920025|NCT01236742|11037137|FG001|STARTED|Overall Study||19
9920026|NCT01236742|11037138|FG002|STARTED|Overall Study||16
9920027|NCT01236742|11037136|FG000|COMPLETED|Overall Study||15
9920028|NCT01236742|11037137|FG001|COMPLETED|Overall Study||16
9920029|NCT01236742|11037138|FG002|COMPLETED|Overall Study||13
9920030|NCT01236742|11037136|FG000|NOT COMPLETED|Overall Study||3
9920031|NCT01236742|11037137|FG001|NOT COMPLETED|Overall Study||3
9920032|NCT01236742|11037138|FG002|NOT COMPLETED|Overall Study||3
9920033|NCT01236755|11037146|FG000|STARTED|Spectacles Wearing Phase||91
9920034|NCT01236755|11037146|FG000|COMPLETED|Spectacles Wearing Phase||74
9920035|NCT01236755|11037146|FG000|NOT COMPLETED|Spectacles Wearing Phase||17
9920036|NCT01236755|11037146|FG000|STARTED|Orthokeratology Wearing Phase||74
9920037|NCT01236755|11037146|FG000|COMPLETED|Orthokeratology Wearing Phase||66
9920038|NCT01236755|11037146|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8
9920039|NCT01236768|11037153|FG000|STARTED|Overall Study||201
9920040|NCT01236768|11037154|FG001|STARTED|Overall Study||206
9920041|NCT01236768|11037153|FG000|COMPLETED|Overall Study||112
9920042|NCT01236768|11037154|FG001|COMPLETED|Overall Study||145
9920043|NCT01236768|11037153|FG000|NOT COMPLETED|Overall Study||89
9920044|NCT01236768|11037154|FG001|NOT COMPLETED|Overall Study||61
9920045|NCT01237041|11037166|FG000|STARTED|Overall Study||2
9920046|NCT01237041|11037167|FG001|STARTED|Overall Study||3
9920047|NCT01237041|11037168|FG002|STARTED|Overall Study||2
9920048|NCT01237041|11037169|FG003|STARTED|Overall Study||5
9920049|NCT01237041|11037170|FG004|STARTED|Overall Study||5
9920050|NCT01237041|11037166|FG000|COMPLETED|Overall Study||2
9920051|NCT01237041|11037167|FG001|COMPLETED|Overall Study||3
9920052|NCT01237041|11037168|FG002|COMPLETED|Overall Study||2
9920053|NCT01237041|11037169|FG003|COMPLETED|Overall Study||5
9920054|NCT01237041|11037170|FG004|COMPLETED|Overall Study||5
9920055|NCT01237041|11037166|FG000|NOT COMPLETED|Overall Study||0
9920056|NCT01237041|11037167|FG001|NOT COMPLETED|Overall Study||0
9920057|NCT01237041|11037168|FG002|NOT COMPLETED|Overall Study||0
9920058|NCT01237041|11037169|FG003|NOT COMPLETED|Overall Study||0
9760527|NCT00381797|10864236|FG003|STARTED|Overall Study||15
9760528|NCT00381797|10864237|FG004|STARTED|Overall Study||37
9920059|NCT01237041|11037170|FG004|NOT COMPLETED|Overall Study||0
9920060|NCT01237054|11037180|FG000|STARTED|Overall Study||31
9920061|NCT01237054|11037180|FG000|COMPLETED|Overall Study||30
9920062|NCT01237054|11037180|FG000|NOT COMPLETED|Overall Study||1
9920063|NCT01237080|11037189|FG000|STARTED|Overall Study||50
9760529|NCT00381797|10864233|FG000|COMPLETED|Overall Study||17
9760530|NCT00381797|10864234|FG001|COMPLETED|Overall Study||16
9920064|NCT01237080|11037190|FG001|STARTED|Overall Study||50
9920065|NCT01237080|11037189|FG000|COMPLETED|Overall Study||50
9920066|NCT01237080|11037190|FG001|COMPLETED|Overall Study||50
9920067|NCT01237080|11037189|FG000|NOT COMPLETED|Overall Study||0
9920068|NCT01237080|11037190|FG001|NOT COMPLETED|Overall Study||0
9920069|NCT01237197|11037198|FG000|STARTED|Randomization Period||13
9920070|NCT01237197|11037199|FG001|STARTED|Randomization Period||13
9920071|NCT01237197|11037198|FG000|COMPLETED|Randomization Period||12
9920072|NCT01237197|11037199|FG001|COMPLETED|Randomization Period||10
9920073|NCT01237197|11037198|FG000|NOT COMPLETED|Randomization Period||1
9920074|NCT01237197|11037199|FG001|NOT COMPLETED|Randomization Period||3
9920075|NCT01237197|11037198|FG000|STARTED|Open Label Period||12
9920076|NCT01237197|11037199|FG001|STARTED|Open Label Period||10
9920077|NCT01237197|11037198|FG000|COMPLETED|Open Label Period||12
9920078|NCT01237197|11037199|FG001|COMPLETED|Open Label Period||10
9920079|NCT01237197|11037198|FG000|NOT COMPLETED|Open Label Period||0
9920080|NCT01237197|11037199|FG001|NOT COMPLETED|Open Label Period||0
9920081|NCT01237223|11037211|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
9920082|NCT01237223|11037212|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
9920083|NCT01237223|11037213|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
9920084|NCT01237223|11037214|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
9920085|NCT01237223|11037215|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
9920086|NCT01237223|11037216|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
9920087|NCT01237223|11037211|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
9920088|NCT01237223|11037212|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920089|NCT01237223|11037213|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920090|NCT01237223|11037214|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920091|NCT01237223|11037215|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920092|NCT01237223|11037216|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920093|NCT01237223|11037211|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
9920094|NCT01237223|11037212|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920095|NCT01237223|11037213|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920096|NCT01237223|11037214|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920097|NCT01237223|11037215|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920098|NCT01237223|11037216|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9920099|NCT01237223|11037211|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
9920100|NCT01237223|11037212|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
9920101|NCT01237223|11037213|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
9920102|NCT01237223|11037214|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
9920103|NCT01237223|11037215|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
9920104|NCT01237223|11037216|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
9920105|NCT01237223|11037211|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
9920106|NCT01237223|11037212|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
9920107|NCT01237223|11037213|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
9920108|NCT01237223|11037214|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
9920109|NCT01237223|11037215|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
9920110|NCT01237223|11037216|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
9920111|NCT01237223|11037211|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
9920112|NCT01237223|11037212|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
9920113|NCT01237223|11037213|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
9920114|NCT01237223|11037214|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
9920115|NCT01237223|11037215|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
9920116|NCT01237223|11037216|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
9920117|NCT01237301|11037234|FG000|STARTED|Overall Study||65
9920118|NCT01237301|11037235|FG001|STARTED|Overall Study||59
9920119|NCT01237301|11037234|FG000|COMPLETED|Overall Study||60
9920120|NCT01237301|11037235|FG001|COMPLETED|Overall Study||55
9920121|NCT01237301|11037234|FG000|NOT COMPLETED|Overall Study||5
9920122|NCT01237301|11037235|FG001|NOT COMPLETED|Overall Study||4
9920123|NCT01237327|11037245|FG000|STARTED|Overall Study||43
9920124|NCT01237327|11037246|FG001|STARTED|Overall Study||41
9920125|NCT01237327|11037245|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
9920126|NCT01237327|11037246|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
9920127|NCT01237327|11037245|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
9920128|NCT01237327|11037246|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
9920129|NCT01237327|11037245|FG000|Continued Treatment in Extension Study|Overall Study||21
9920130|NCT01237327|11037246|FG001|Continued Treatment in Extension Study|Overall Study||17
9920131|NCT01237327|11037245|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
9920132|NCT01237327|11037246|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
9920133|NCT01237327|11037245|FG000|NOT COMPLETED|Overall Study||42
9920134|NCT01237327|11037246|FG001|NOT COMPLETED|Overall Study||40
9920135|NCT01237340|11037252|FG000|STARTED|Overall Study||59
9920136|NCT01237340|11037252|FG000|COMPLETED|Overall Study||19
9920137|NCT01237340|11037252|FG000|NOT COMPLETED|Overall Study||40
9920138|NCT01237353|11037259|FG000|STARTED|Overall Study||6
9920139|NCT01237353|11037259|FG000|COMPLETED|Overall Study||6
9920140|NCT01237353|11037259|FG000|NOT COMPLETED|Overall Study||0
9920141|NCT01237587|11037265|FG000|STARTED|Double Blind Treatment (Acute Phase)||91
9920142|NCT01237587|11037266|FG001|STARTED|Double Blind Treatment (Acute Phase)||93
9920143|NCT01237587|11037265|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
9920144|NCT01237587|11037266|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
9920145|NCT01237587|11037265|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74
9920146|NCT01237587|11037266|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75
9920147|NCT01237587|11037265|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
9920148|NCT01237587|11037266|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
9920149|NCT01237587|11037265|FG000|STARTED|Open Label Treatment (Extension Phase)||74
9920150|NCT01237587|11037266|FG001|STARTED|Open Label Treatment (Extension Phase)||75
9920151|NCT01237587|11037265|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
9920152|NCT01237587|11037266|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
9920153|NCT01237587|11037265|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56
9920154|NCT01237587|11037266|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50
9920155|NCT01237587|11037265|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
9920156|NCT01237587|11037266|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
9920157|NCT01237587|11037265|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
9920158|NCT01237587|11037266|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
9920159|NCT01237587|11037265|FG000|COMPLETED|Taper Phase||31
9920160|NCT01237587|11037266|FG001|COMPLETED|Taper Phase||34
9920161|NCT01237587|11037265|FG000|NOT COMPLETED|Taper Phase||5
9920162|NCT01237587|11037266|FG001|NOT COMPLETED|Taper Phase||10
9920163|NCT01237678|11037282|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
9920164|NCT01237678|11037283|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
9920165|NCT01237678|11037284|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
9920166|NCT01237678|11037282|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
9920167|NCT01237678|11037283|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
9920168|NCT01237678|11037284|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
9920169|NCT01237678|11037282|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
9920170|NCT01237678|11037283|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
9920171|NCT01237678|11037284|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
9920172|NCT01237678|11037282|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
9920173|NCT01237678|11037283|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
9920174|NCT01237678|11037284|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
9920175|NCT01237678|11037282|FG000|STARTED|Phase II||0
9920176|NCT01237678|11037283|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
9920177|NCT01237678|11037284|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
9920178|NCT01237678|11037282|FG000|Received Intervention|Phase II||0
9920179|NCT01237678|11037283|FG001|Received Intervention|Phase II||94
9920180|NCT01237678|11037284|FG002|Received Intervention|Phase II||47
9920181|NCT01237678|11037282|FG000|COMPLETED|Phase II||0
9920182|NCT01237678|11037283|FG001|COMPLETED|Phase II||0
9920183|NCT01237678|11037284|FG002|COMPLETED|Phase II||0
9920184|NCT01237678|11037282|FG000|NOT COMPLETED|Phase II||0
9920185|NCT01237678|11037283|FG001|NOT COMPLETED|Phase II||98
9920186|NCT01237678|11037284|FG002|NOT COMPLETED|Phase II||50
9920187|NCT01237821|11037301|FG000|STARTED|Overall Study||32
9920188|NCT01237821|11037302|FG001|STARTED|Overall Study||34
9920189|NCT01237821|11037301|FG000|COMPLETED|Overall Study||26
9920190|NCT01237821|11037302|FG001|COMPLETED|Overall Study||34
9920191|NCT01237821|11037301|FG000|NOT COMPLETED|Overall Study||6
9920192|NCT01237821|11037302|FG001|NOT COMPLETED|Overall Study||0
9920193|NCT01237899|11037319|FG000|STARTED|First Dosing Period||1
9920194|NCT01237899|11037320|FG001|STARTED|First Dosing Period||3
9920195|NCT01237899|11037321|FG002|STARTED|First Dosing Period||4
9920196|NCT01237899|11037322|FG003|STARTED|First Dosing Period||3
9920197|NCT01237899|11037323|FG004|STARTED|First Dosing Period||2
9920198|NCT01237899|11037324|FG005|STARTED|First Dosing Period||4
9920199|NCT01237899|11037325|FG006|STARTED|First Dosing Period||1
9920200|NCT01237899|11037326|FG007|STARTED|First Dosing Period||3
9920201|NCT01237899|11037327|FG008|STARTED|First Dosing Period||4
9920202|NCT01237899|11037328|FG009|STARTED|First Dosing Period||3
9920203|NCT01237899|11037329|FG010|STARTED|First Dosing Period||4
9920204|NCT01237899|11037319|FG000|COMPLETED|First Dosing Period||1
9920205|NCT01237899|11037320|FG001|COMPLETED|First Dosing Period||3
9920206|NCT01237899|11037321|FG002|COMPLETED|First Dosing Period||4
9920207|NCT01237899|11037322|FG003|COMPLETED|First Dosing Period||3
9920208|NCT01237899|11037323|FG004|COMPLETED|First Dosing Period||2
9920209|NCT01237899|11037324|FG005|COMPLETED|First Dosing Period||4
9920210|NCT01237899|11037325|FG006|COMPLETED|First Dosing Period||1
9920211|NCT01237899|11037326|FG007|COMPLETED|First Dosing Period||3
9920212|NCT01237899|11037327|FG008|COMPLETED|First Dosing Period||4
9920213|NCT01237899|11037328|FG009|COMPLETED|First Dosing Period||3
9920214|NCT01237899|11037329|FG010|COMPLETED|First Dosing Period||4
9920215|NCT01237899|11037319|FG000|NOT COMPLETED|First Dosing Period||0
9920216|NCT01237899|11037320|FG001|NOT COMPLETED|First Dosing Period||0
9920217|NCT01237899|11037321|FG002|NOT COMPLETED|First Dosing Period||0
9920218|NCT01237899|11037322|FG003|NOT COMPLETED|First Dosing Period||0
9920219|NCT01237899|11037323|FG004|NOT COMPLETED|First Dosing Period||0
9920220|NCT01237899|11037324|FG005|NOT COMPLETED|First Dosing Period||0
9920221|NCT01237899|11037325|FG006|NOT COMPLETED|First Dosing Period||0
9920222|NCT01237899|11037326|FG007|NOT COMPLETED|First Dosing Period||0
9920223|NCT01237899|11037327|FG008|NOT COMPLETED|First Dosing Period||0
9920224|NCT01237899|11037328|FG009|NOT COMPLETED|First Dosing Period||0
9920225|NCT01237899|11037329|FG010|NOT COMPLETED|First Dosing Period||0
9920226|NCT01237899|11037319|FG000|STARTED|Washout Period of at Least 7 Days||1
9920227|NCT01237899|11037320|FG001|STARTED|Washout Period of at Least 7 Days||3
9920228|NCT01237899|11037321|FG002|STARTED|Washout Period of at Least 7 Days||4
9920229|NCT01237899|11037322|FG003|STARTED|Washout Period of at Least 7 Days||3
9920230|NCT01237899|11037323|FG004|STARTED|Washout Period of at Least 7 Days||2
9920231|NCT01237899|11037324|FG005|STARTED|Washout Period of at Least 7 Days||4
9920232|NCT01237899|11037325|FG006|STARTED|Washout Period of at Least 7 Days||1
9920233|NCT01237899|11037326|FG007|STARTED|Washout Period of at Least 7 Days||3
9920234|NCT01237899|11037327|FG008|STARTED|Washout Period of at Least 7 Days||4
9920235|NCT01237899|11037328|FG009|STARTED|Washout Period of at Least 7 Days||3
9920236|NCT01237899|11037329|FG010|STARTED|Washout Period of at Least 7 Days||4
9920237|NCT01237899|11037319|FG000|COMPLETED|Washout Period of at Least 7 Days||1
9920238|NCT01237899|11037320|FG001|COMPLETED|Washout Period of at Least 7 Days||3
9920239|NCT01237899|11037321|FG002|COMPLETED|Washout Period of at Least 7 Days||3
9920240|NCT01237899|11037322|FG003|COMPLETED|Washout Period of at Least 7 Days||3
9920241|NCT01237899|11037323|FG004|COMPLETED|Washout Period of at Least 7 Days||2
9920242|NCT01237899|11037324|FG005|COMPLETED|Washout Period of at Least 7 Days||4
9920243|NCT01237899|11037325|FG006|COMPLETED|Washout Period of at Least 7 Days||1
9920244|NCT01237899|11037326|FG007|COMPLETED|Washout Period of at Least 7 Days||3
9920245|NCT01237899|11037327|FG008|COMPLETED|Washout Period of at Least 7 Days||4
9920246|NCT01237899|11037328|FG009|COMPLETED|Washout Period of at Least 7 Days||3
9920247|NCT01237899|11037329|FG010|COMPLETED|Washout Period of at Least 7 Days||4
9920248|NCT01237899|11037319|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920249|NCT01237899|11037320|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920250|NCT01237899|11037321|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1
9920251|NCT01237899|11037322|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920252|NCT01237899|11037323|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920253|NCT01237899|11037324|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920254|NCT01237899|11037325|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920255|NCT01237899|11037326|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920256|NCT01237899|11037327|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920257|NCT01237899|11037328|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920258|NCT01237899|11037329|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0
9920259|NCT01237899|11037319|FG000|STARTED|Second Dosing Period||1
9920260|NCT01237899|11037320|FG001|STARTED|Second Dosing Period||3
9920261|NCT01237899|11037321|FG002|STARTED|Second Dosing Period||3
9920262|NCT01237899|11037322|FG003|STARTED|Second Dosing Period||3
9920263|NCT01237899|11037323|FG004|STARTED|Second Dosing Period||2
9920264|NCT01237899|11037324|FG005|STARTED|Second Dosing Period||4
9920265|NCT01237899|11037325|FG006|STARTED|Second Dosing Period||1
9920266|NCT01237899|11037326|FG007|STARTED|Second Dosing Period||3
9920267|NCT01237899|11037327|FG008|STARTED|Second Dosing Period||4
9920268|NCT01237899|11037328|FG009|STARTED|Second Dosing Period||3
9920269|NCT01237899|11037329|FG010|STARTED|Second Dosing Period||4
9920270|NCT01237899|11037319|FG000|COMPLETED|Second Dosing Period||1
9920271|NCT01237899|11037320|FG001|COMPLETED|Second Dosing Period||3
9920272|NCT01237899|11037321|FG002|COMPLETED|Second Dosing Period||3
9920273|NCT01237899|11037322|FG003|COMPLETED|Second Dosing Period||3
9920274|NCT01237899|11037323|FG004|COMPLETED|Second Dosing Period||2
9920275|NCT01237899|11037324|FG005|COMPLETED|Second Dosing Period||4
9920276|NCT01237899|11037325|FG006|COMPLETED|Second Dosing Period||1
9920277|NCT01237899|11037326|FG007|COMPLETED|Second Dosing Period||3
9920278|NCT01237899|11037327|FG008|COMPLETED|Second Dosing Period||4
9920279|NCT01237899|11037328|FG009|COMPLETED|Second Dosing Period||3
9920280|NCT01237899|11037329|FG010|COMPLETED|Second Dosing Period||4
9920281|NCT01237899|11037319|FG000|NOT COMPLETED|Second Dosing Period||0
9920282|NCT01237899|11037320|FG001|NOT COMPLETED|Second Dosing Period||0
9920283|NCT01237899|11037321|FG002|NOT COMPLETED|Second Dosing Period||0
9920284|NCT01237899|11037322|FG003|NOT COMPLETED|Second Dosing Period||0
9920285|NCT01237899|11037323|FG004|NOT COMPLETED|Second Dosing Period||0
9920286|NCT01237899|11037324|FG005|NOT COMPLETED|Second Dosing Period||0
9920287|NCT01237899|11037325|FG006|NOT COMPLETED|Second Dosing Period||0
9920288|NCT01237899|11037326|FG007|NOT COMPLETED|Second Dosing Period||0
9920289|NCT01237899|11037327|FG008|NOT COMPLETED|Second Dosing Period||0
9920290|NCT01237899|11037328|FG009|NOT COMPLETED|Second Dosing Period||0
9920291|NCT01237899|11037329|FG010|NOT COMPLETED|Second Dosing Period||0
9920292|NCT01237951|11037347|FG000|STARTED|Overall Study||75
9920293|NCT01237951|11037347|FG000|COMPLETED|Overall Study||74
9920294|NCT01237951|11037347|FG000|NOT COMPLETED|Overall Study||1
9920295|NCT01238120|11037355|FG000|STARTED|Overall Study||25
9920296|NCT01238120|11037356|FG001|STARTED|Overall Study||23
9920297|NCT01238120|11037357|FG002|STARTED|Overall Study||25
9920298|NCT01238120|11037358|FG003|STARTED|Overall Study||24
9920299|NCT01238120|11037355|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21
9920300|NCT01238120|11037356|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22
9920301|NCT01238120|11037357|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22
9920302|NCT01238120|11037358|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21
9920303|NCT01238120|11037355|FG000|COMPLETED|Overall Study||17
9920304|NCT01238120|11037356|FG001|COMPLETED|Overall Study||22
9920305|NCT01238120|11037357|FG002|COMPLETED|Overall Study||21
9920306|NCT01238120|11037358|FG003|COMPLETED|Overall Study||18
9920307|NCT01238120|11037355|FG000|NOT COMPLETED|Overall Study||8
9920308|NCT01238120|11037356|FG001|NOT COMPLETED|Overall Study||1
9920309|NCT01238120|11037357|FG002|NOT COMPLETED|Overall Study||4
9920310|NCT01238120|11037358|FG003|NOT COMPLETED|Overall Study||6
9920311|NCT01238172|11037370|FG000|STARTED|Overall Study||237
9920312|NCT01238172|11037371|FG001|STARTED|Overall Study||241
9920313|NCT01238172|11037370|FG000|COMPLETED|Overall Study||226
9920314|NCT01238172|11037371|FG001|COMPLETED|Overall Study||217
9920315|NCT01238172|11037370|FG000|NOT COMPLETED|Overall Study||11
9920316|NCT01238172|11037371|FG001|NOT COMPLETED|Overall Study||24
9920317|NCT01238341|11037377|FG000|STARTED|Overall Study||7
9920318|NCT01238341|11037377|FG000|COMPLETED|Overall Study||7
9920319|NCT01238341|11037377|FG000|NOT COMPLETED|Overall Study||0
9955795|NCT01440647|11074800|FG001|NOT COMPLETED|Overall Study||3
9955796|NCT01440764|11074808|FG000|STARTED|Test Day 1||4
9955797|NCT01440764|11074809|FG001|STARTED|Test Day 1||2
9955798|NCT01440764|11074810|FG002|STARTED|Test Day 1||6
9955799|NCT01440764|11074811|FG003|STARTED|Test Day 1||1
9955800|NCT01440764|11074812|FG004|STARTED|Test Day 1||3
9955801|NCT01440764|11074813|FG005|STARTED|Test Day 1||5
9955802|NCT01440764|11074814|FG006|STARTED|Test Day 1||3
9955803|NCT01440764|11074808|FG000|COMPLETED|Test Day 1||4
9955804|NCT01440764|11074809|FG001|COMPLETED|Test Day 1||2
9955805|NCT01440764|11074810|FG002|COMPLETED|Test Day 1||6
9955806|NCT01440764|11074811|FG003|COMPLETED|Test Day 1||1
9955807|NCT01440764|11074812|FG004|COMPLETED|Test Day 1||3
9955808|NCT01440764|11074813|FG005|COMPLETED|Test Day 1||5
9955809|NCT01440764|11074814|FG006|COMPLETED|Test Day 1||3
9955810|NCT01440764|11074808|FG000|NOT COMPLETED|Test Day 1||0
9955811|NCT01440764|11074809|FG001|NOT COMPLETED|Test Day 1||0
9955812|NCT01440764|11074810|FG002|NOT COMPLETED|Test Day 1||0
9955813|NCT01440764|11074811|FG003|NOT COMPLETED|Test Day 1||0
9955814|NCT01440764|11074812|FG004|NOT COMPLETED|Test Day 1||0
9955815|NCT01440764|11074813|FG005|NOT COMPLETED|Test Day 1||0
9955816|NCT01440764|11074814|FG006|NOT COMPLETED|Test Day 1||0
9955817|NCT01440764|11074808|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
9955818|NCT01440764|11074809|FG001|STARTED|Test Day 2||2
9955819|NCT01440764|11074810|FG002|STARTED|Test Day 2||6
9955820|NCT01440764|11074811|FG003|STARTED|Test Day 2||1
9955821|NCT01440764|11074812|FG004|STARTED|Test Day 2||3
9955822|NCT01440764|11074813|FG005|STARTED|Test Day 2||5
9955823|NCT01440764|11074814|FG006|STARTED|Test Day 2||3
9955824|NCT01440764|11074808|FG000|COMPLETED|Test Day 2||3
9955825|NCT01440764|11074809|FG001|COMPLETED|Test Day 2||2
9955826|NCT01440764|11074810|FG002|COMPLETED|Test Day 2||6
9955827|NCT01440764|11074811|FG003|COMPLETED|Test Day 2||1
9955828|NCT01440764|11074812|FG004|COMPLETED|Test Day 2||3
9955829|NCT01440764|11074813|FG005|COMPLETED|Test Day 2||5
9955830|NCT01440764|11074814|FG006|COMPLETED|Test Day 2||3
9955831|NCT01440764|11074808|FG000|NOT COMPLETED|Test Day 2||0
9955832|NCT01440764|11074809|FG001|NOT COMPLETED|Test Day 2||0
9955833|NCT01440764|11074810|FG002|NOT COMPLETED|Test Day 2||0
9955834|NCT01440764|11074811|FG003|NOT COMPLETED|Test Day 2||0
9955835|NCT01440764|11074812|FG004|NOT COMPLETED|Test Day 2||0
9955836|NCT01440764|11074813|FG005|NOT COMPLETED|Test Day 2||0
9955837|NCT01440764|11074814|FG006|NOT COMPLETED|Test Day 2||0
9955838|NCT01440764|11074808|FG000|STARTED|Test Day 3||3
9955839|NCT01440764|11074809|FG001|STARTED|Test Day 3||2
9955840|NCT01440764|11074810|FG002|STARTED|Test Day 3||6
9955841|NCT01440764|11074811|FG003|STARTED|Test Day 3||1
9955842|NCT01440764|11074812|FG004|STARTED|Test Day 3||3
9955843|NCT01440764|11074813|FG005|STARTED|Test Day 3||5
9955844|NCT01440764|11074814|FG006|STARTED|Test Day 3||3
9955845|NCT01440764|11074808|FG000|COMPLETED|Test Day 3||3
9955846|NCT01440764|11074809|FG001|COMPLETED|Test Day 3||2
9955847|NCT01440764|11074810|FG002|COMPLETED|Test Day 3||6
9955848|NCT01440764|11074811|FG003|COMPLETED|Test Day 3||1
9955849|NCT01440764|11074812|FG004|COMPLETED|Test Day 3||3
9955850|NCT01440764|11074813|FG005|COMPLETED|Test Day 3||5
9955851|NCT01440764|11074814|FG006|COMPLETED|Test Day 3||3
9955852|NCT01440764|11074808|FG000|NOT COMPLETED|Test Day 3||0
9955853|NCT01440764|11074809|FG001|NOT COMPLETED|Test Day 3||0
9955854|NCT01440764|11074810|FG002|NOT COMPLETED|Test Day 3||0
9955855|NCT01440764|11074811|FG003|NOT COMPLETED|Test Day 3||0
9955856|NCT01440764|11074812|FG004|NOT COMPLETED|Test Day 3||0
9955857|NCT01440764|11074813|FG005|NOT COMPLETED|Test Day 3||0
9955858|NCT01440764|11074814|FG006|NOT COMPLETED|Test Day 3||0
9955859|NCT01440803|11074834|FG000|STARTED|Overall Study||13
9955860|NCT01440803|11074835|FG001|STARTED|Overall Study||28
9955861|NCT01440803|11074834|FG000|Period 1 - Forteo/Placebo|Overall Study||13
9955862|NCT01440803|11074835|FG001|Period 1 - Forteo/Placebo|Overall Study||28
9955863|NCT01440803|11074834|FG000|Period 2 - Forteo/Forteo|Overall Study||13
9955864|NCT01440803|11074835|FG001|Period 2 - Forteo/Forteo|Overall Study||28
9955865|NCT01440803|11074834|FG000|Period 3 - Forteo Open Label|Overall Study||13
9955866|NCT01440803|11074835|FG001|Period 3 - Forteo Open Label|Overall Study||27
9955867|NCT01440803|11074834|FG000|COMPLETED|Overall Study||11
9920320|NCT01238471|11037383|FG000|STARTED|Overall Study||10
9920321|NCT01238471|11037384|FG001|STARTED|Overall Study||10
9920322|NCT01238471|11037383|FG000|COMPLETED|Overall Study||10
9920323|NCT01238471|11037384|FG001|COMPLETED|Overall Study||10
9920324|NCT01238471|11037383|FG000|NOT COMPLETED|Overall Study||0
9920325|NCT01238471|11037384|FG001|NOT COMPLETED|Overall Study||0
9920326|NCT01238536|11037392|FG000|STARTED|Overall Study||200
9920327|NCT01238536|11037393|FG001|STARTED|Overall Study||200
9920328|NCT01238536|11037392|FG000|COMPLETED|Overall Study||153
9920329|NCT01238536|11037393|FG001|COMPLETED|Overall Study||150
9920330|NCT01238536|11037392|FG000|NOT COMPLETED|Overall Study||47
9920331|NCT01238536|11037393|FG001|NOT COMPLETED|Overall Study||50
9920332|NCT01238549|11037401|FG000|STARTED|Overall Study||284
9920333|NCT01238549|11037401|FG000|COMPLETED|Overall Study||248
9920334|NCT01238549|11037401|FG000|NOT COMPLETED|Overall Study||36
9920335|NCT01238575|11037407|FG000|STARTED|Overall Study||30
9920336|NCT01238575|11037408|FG001|STARTED|Overall Study||32
9920337|NCT01238575|11037407|FG000|COMPLETED|Overall Study||26
9920338|NCT01238575|11037408|FG001|COMPLETED|Overall Study||28
10010496|NCT01774981|11133313|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10010497|NCT01774981|11133314|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10010498|NCT01774981|11133315|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
9920339|NCT01238575|11037407|FG000|NOT COMPLETED|Overall Study||4
9920340|NCT01238575|11037408|FG001|NOT COMPLETED|Overall Study||4
9920341|NCT01238588|11037414|FG000|STARTED|Overall Study||12
9920342|NCT01238588|11037414|FG000|COMPLETED|Overall Study||9
9920343|NCT01238588|11037414|FG000|NOT COMPLETED|Overall Study||3
9920344|NCT01238640|11037418|FG000|STARTED|Overall Study||84
9920345|NCT01238640|11037418|FG000|COMPLETED|Overall Study||84
9920346|NCT01238640|11037418|FG000|NOT COMPLETED|Overall Study||0
9920347|NCT01238822|11037426|FG000|STARTED|Overall Study||96
9920348|NCT01238822|11037426|FG000|Received Placebo|Overall Study||93
9920349|NCT01238822|11037426|FG000|Received Low Dosage|Overall Study||93
9920350|NCT01238822|11037426|FG000|Received Medium Dosage|Overall Study||93
9920351|NCT01238822|11037426|FG000|Received High Dosage|Overall Study||93
9920352|NCT01238822|11037426|FG000|COMPLETED|Overall Study||93
9920353|NCT01238822|11037426|FG000|NOT COMPLETED|Overall Study||3
9920354|NCT01238835|11037436|FG000|STARTED|Overall Study||218
9920355|NCT01238835|11037436|FG000|COMPLETED|Overall Study||82
9920356|NCT01238835|11037436|FG000|NOT COMPLETED|Overall Study||136
10111259|NCT02494596|11242323|FG001|STARTED|Overall Study||7
10111260|NCT02494596|11242324|FG002|STARTED|Overall Study||7
9920357|NCT01238848|11037442|FG000|STARTED|Overall Study||50
9920358|NCT01238848|11037443|FG001|STARTED|Overall Study||50
9920359|NCT01238848|11037442|FG000|COMPLETED|Overall Study||37
9920360|NCT01238848|11037443|FG001|COMPLETED|Overall Study||45
9920361|NCT01238848|11037442|FG000|NOT COMPLETED|Overall Study||13
9920362|NCT01238848|11037443|FG001|NOT COMPLETED|Overall Study||5
9920363|NCT01238861|11037455|FG000|STARTED|Overall Study||80
9920364|NCT01238861|11037456|FG001|STARTED|Overall Study||81
9920365|NCT01238861|11037457|FG002|STARTED|Overall Study||81
9920366|NCT01238861|11037458|FG003|STARTED|Overall Study||82
9920367|NCT01238861|11037459|FG004|STARTED|Overall Study||142
9920368|NCT01238861|11037460|FG005|STARTED|Overall Study||140
9920369|NCT01238861|11037455|FG000|COMPLETED|Overall Study||69
9920370|NCT01238861|11037456|FG001|COMPLETED|Overall Study||73
9920371|NCT01238861|11037457|FG002|COMPLETED|Overall Study||70
9920372|NCT01238861|11037458|FG003|COMPLETED|Overall Study||69
9920373|NCT01238861|11037459|FG004|COMPLETED|Overall Study||129
9920374|NCT01238861|11037460|FG005|COMPLETED|Overall Study||125
9920375|NCT01238861|11037455|FG000|NOT COMPLETED|Overall Study||11
9920376|NCT01238861|11037456|FG001|NOT COMPLETED|Overall Study||8
9920377|NCT01238861|11037457|FG002|NOT COMPLETED|Overall Study||11
9920378|NCT01238861|11037458|FG003|NOT COMPLETED|Overall Study||13
9920379|NCT01238861|11037459|FG004|NOT COMPLETED|Overall Study||13
9920380|NCT01238861|11037460|FG005|NOT COMPLETED|Overall Study||15
9920381|NCT01238900|11037481|FG000|STARTED|6 Months Post Stent Placement||23
10010499|NCT01774981|11133316|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
10010500|NCT01774981|11133317|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10010501|NCT01774981|11133318|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14
10010502|NCT01774981|11133319|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13
10111261|NCT02494596|11242322|FG000|COMPLETED|Overall Study||2
9920382|NCT01238900|11037481|FG000|COMPLETED|6 Months Post Stent Placement||23
9920383|NCT01238900|11037481|FG000|NOT COMPLETED|6 Months Post Stent Placement||0
9920384|NCT01238900|11037481|FG000|STARTED|<12 Months Post Stent Removal||23
9920385|NCT01238900|11037481|FG000|COMPLETED|<12 Months Post Stent Removal||18
9920386|NCT01238900|11037481|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5
9920387|NCT01238991|11037496|FG000|STARTED|Overall Study||7
9920388|NCT01238991|11037497|FG001|STARTED|Overall Study||3
9920389|NCT01238991|11037498|FG002|STARTED|Overall Study||11
9920390|NCT01238991|11037499|FG003|STARTED|Overall Study||6
9920391|NCT01238991|11037500|FG004|STARTED|Overall Study||5
9920392|NCT01238991|11037501|FG005|STARTED|Overall Study||2
9920393|NCT01238991|11037502|FG006|STARTED|Overall Study||8
9920394|NCT01238991|11037503|FG007|STARTED|Overall Study||5
9920395|NCT01238991|11037504|FG008|STARTED|Overall Study||4
9920396|NCT01238991|11037505|FG009|STARTED|Overall Study||2
9920397|NCT01238991|11037496|FG000|Received Treatment|Overall Study||7
9920398|NCT01238991|11037497|FG001|Received Treatment|Overall Study||3
9920399|NCT01238991|11037498|FG002|Received Treatment|Overall Study||11
9920400|NCT01238991|11037499|FG003|Received Treatment|Overall Study||6
9920401|NCT01238991|11037500|FG004|Received Treatment|Overall Study||5
9920402|NCT01238991|11037501|FG005|Received Treatment|Overall Study||2
9920403|NCT01238991|11037502|FG006|Received Treatment|Overall Study||8
9920404|NCT01238991|11037503|FG007|Received Treatment|Overall Study||5
9920405|NCT01238991|11037504|FG008|Received Treatment|Overall Study||4
9920406|NCT01238991|11037505|FG009|Received Treatment|Overall Study||2
9920407|NCT01238991|11037496|FG000|COMPLETED|Overall Study||5
9920408|NCT01238991|11037497|FG001|COMPLETED|Overall Study||3
9920409|NCT01238991|11037498|FG002|COMPLETED|Overall Study||5
9920410|NCT01238991|11037499|FG003|COMPLETED|Overall Study||4
9920411|NCT01238991|11037500|FG004|COMPLETED|Overall Study||3
9920412|NCT01238991|11037501|FG005|COMPLETED|Overall Study||2
9920413|NCT01238991|11037502|FG006|COMPLETED|Overall Study||0
9920414|NCT01238991|11037503|FG007|COMPLETED|Overall Study||0
9920415|NCT01238991|11037504|FG008|COMPLETED|Overall Study||0
9920416|NCT01238991|11037505|FG009|COMPLETED|Overall Study||0
9920417|NCT01238991|11037496|FG000|NOT COMPLETED|Overall Study||2
9920418|NCT01238991|11037497|FG001|NOT COMPLETED|Overall Study||0
9920419|NCT01238991|11037498|FG002|NOT COMPLETED|Overall Study||6
10010503|NCT01774981|11133320|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12
10010504|NCT01774981|11133313|FG000|COMPLETED|Overall Study||3
10010505|NCT01774981|11133314|FG001|COMPLETED|Overall Study||4
10205303|NCT03489863|11332094|FG001|STARTED|Overall Study||7
10205304|NCT03489863|11332093|FG000|COMPLETED|Overall Study||7
10205305|NCT03489863|11332094|FG001|COMPLETED|Overall Study||6
9920420|NCT01238991|11037499|FG003|NOT COMPLETED|Overall Study||2
9920421|NCT01238991|11037500|FG004|NOT COMPLETED|Overall Study||2
9920422|NCT01238991|11037501|FG005|NOT COMPLETED|Overall Study||0
9920423|NCT01238991|11037502|FG006|NOT COMPLETED|Overall Study||8
9920424|NCT01238991|11037503|FG007|NOT COMPLETED|Overall Study||5
9920425|NCT01238991|11037504|FG008|NOT COMPLETED|Overall Study||4
10205306|NCT03489863|11332093|FG000|NOT COMPLETED|Overall Study||0
10205307|NCT03489863|11332094|FG001|NOT COMPLETED|Overall Study||1
10205308|NCT03489941|11332100|FG000|STARTED|Overall Study||51
10205309|NCT03489941|11332101|FG001|STARTED|Overall Study||52
10205310|NCT03489941|11332102|FG002|STARTED|Overall Study||27
10205311|NCT03489941|11332100|FG000|COMPLETED|Overall Study||51
10205312|NCT03489941|11332101|FG001|COMPLETED|Overall Study||52
9920426|NCT01238991|11037505|FG009|NOT COMPLETED|Overall Study||2
9920427|NCT01239043|11037532|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
9920428|NCT01239043|11037533|FG001|STARTED|Overall Study||103
9920429|NCT01239043|11037532|FG000|COMPLETED|Overall Study||34
9920430|NCT01239043|11037533|FG001|COMPLETED|Overall Study||102
9920431|NCT01239043|11037532|FG000|NOT COMPLETED|Overall Study||2
9920432|NCT01239043|11037533|FG001|NOT COMPLETED|Overall Study||1
9920433|NCT01239056|11037539|FG000|STARTED|Overall Study||20
9920434|NCT01239056|11037539|FG000|COMPLETED|Overall Study||20
9920435|NCT01239056|11037539|FG000|NOT COMPLETED|Overall Study||0
9920436|NCT01239121|11037547|FG000|STARTED|Overall Study||188
9920437|NCT01239121|11037548|FG001|STARTED|Overall Study||199
9920438|NCT01239121|11037549|FG002|STARTED|Overall Study||15
9920439|NCT01239121|11037547|FG000|COMPLETED|Overall Study||186
9920440|NCT01239121|11037548|FG001|COMPLETED|Overall Study||195
9920441|NCT01239121|11037549|FG002|COMPLETED|Overall Study||15
9920442|NCT01239121|11037547|FG000|NOT COMPLETED|Overall Study||2
9920443|NCT01239121|11037548|FG001|NOT COMPLETED|Overall Study||4
9920444|NCT01239121|11037549|FG002|NOT COMPLETED|Overall Study||0
9920445|NCT01239160|11037559|FG000|STARTED|Overall Study||114
9920446|NCT01239160|11037560|FG001|STARTED|Overall Study||114
9920447|NCT01239160|11037561|FG002|STARTED|Overall Study||10
9920448|NCT01239160|11037559|FG000|COMPLETED|Overall Study||89
9920449|NCT01239160|11037560|FG001|COMPLETED|Overall Study||95
9920450|NCT01239160|11037561|FG002|COMPLETED|Overall Study||0
9920451|NCT01239160|11037559|FG000|NOT COMPLETED|Overall Study||25
9920452|NCT01239160|11037560|FG001|NOT COMPLETED|Overall Study||19
9920453|NCT01239160|11037561|FG002|NOT COMPLETED|Overall Study||10
9920454|NCT01239212|11037567|FG000|STARTED|Overall Study||7
10010506|NCT01774981|11133315|FG002|COMPLETED|Overall Study||4
10205313|NCT03489941|11332102|FG002|COMPLETED|Overall Study||27
10205314|NCT03489941|11332100|FG000|NOT COMPLETED|Overall Study||0
10205315|NCT03489941|11332101|FG001|NOT COMPLETED|Overall Study||0
10205316|NCT03489941|11332102|FG002|NOT COMPLETED|Overall Study||0
9920455|NCT01239212|11037567|FG000|COMPLETED|Overall Study||7
9920456|NCT01239212|11037567|FG000|NOT COMPLETED|Overall Study||0
9920457|NCT01239316|11037571|FG000|STARTED|Overall Study||12
9920458|NCT01239316|11037571|FG000|COMPLETED|Overall Study||0
9920459|NCT01239316|11037571|FG000|NOT COMPLETED|Overall Study||12
9920460|NCT01239342|11037577|FG000|STARTED|Overall Study||29
9920461|NCT01239342|11037578|FG001|STARTED|Overall Study||14
9920462|NCT01239342|11037577|FG000|COMPLETED|Overall Study||26
9920463|NCT01239342|11037578|FG001|COMPLETED|Overall Study||8
9920464|NCT01239342|11037577|FG000|NOT COMPLETED|Overall Study||3
9920465|NCT01239342|11037578|FG001|NOT COMPLETED|Overall Study||6
9920466|NCT01239355|11037584|FG000|STARTED|Overall Study||15
9920467|NCT01239355|11037584|FG000|COMPLETED|Overall Study||15
9920468|NCT01239355|11037584|FG000|NOT COMPLETED|Overall Study||0
9920469|NCT01239381|11037588|FG000|STARTED|Overall Study||92
9920470|NCT01239381|11037588|FG000|COMPLETED|Overall Study||90
9920471|NCT01239381|11037588|FG000|NOT COMPLETED|Overall Study||2
9920472|NCT01239394|11037593|FG000|STARTED|Overall Study||42
9920473|NCT01239394|11037593|FG000|COMPLETED|Overall Study||41
9920474|NCT01239394|11037593|FG000|NOT COMPLETED|Overall Study||1
9920475|NCT01239472|11037599|FG000|STARTED|Overall Study||15
9920476|NCT01239472|11037600|FG001|STARTED|Overall Study||15
9920477|NCT01239472|11037599|FG000|COMPLETED|Overall Study||10
9920478|NCT01239472|11037600|FG001|COMPLETED|Overall Study||12
9920479|NCT01239472|11037599|FG000|NOT COMPLETED|Overall Study||5
9920480|NCT01239472|11037600|FG001|NOT COMPLETED|Overall Study||3
9920481|NCT01239511|11037612|FG000|STARTED|Overall Study||47
9920482|NCT01239511|11037613|FG001|STARTED|Overall Study||45
9920483|NCT01239511|11037614|FG002|STARTED|Overall Study||47
9920484|NCT01239511|11037615|FG003|STARTED|Overall Study||47
9920485|NCT01239511|11037612|FG000|COMPLETED|Overall Study||46
9920486|NCT01239511|11037613|FG001|COMPLETED|Overall Study||40
9920487|NCT01239511|11037614|FG002|COMPLETED|Overall Study||43
9920488|NCT01239511|11037615|FG003|COMPLETED|Overall Study||38
9920489|NCT01239511|11037612|FG000|NOT COMPLETED|Overall Study||1
9920490|NCT01239511|11037613|FG001|NOT COMPLETED|Overall Study||5
9920491|NCT01239511|11037614|FG002|NOT COMPLETED|Overall Study||4
9920492|NCT01239511|11037615|FG003|NOT COMPLETED|Overall Study||9
9920493|NCT01239732|11037625|FG000|STARTED|Overall Study||1021
9920494|NCT01239732|11037625|FG000|COMPLETED|Overall Study||0
9920495|NCT01239732|11037625|FG000|NOT COMPLETED|Overall Study||1021
9920496|NCT01239745|11037629|FG000|STARTED|Overall Study||46
9920497|NCT01239745|11037629|FG000|COMPLETED|Overall Study||0
9920498|NCT01239745|11037629|FG000|NOT COMPLETED|Overall Study||46
9920499|NCT01239992|11037633|FG000|STARTED|Overall Study||12
9920500|NCT01239992|11037633|FG000|COMPLETED|Overall Study||10
9920501|NCT01239992|11037633|FG000|NOT COMPLETED|Overall Study||2
9920502|NCT01240122|11037637|FG000|STARTED|Overall Study||29
9920503|NCT01240122|11037637|FG000|COMPLETED|Overall Study||29
9920504|NCT01240122|11037637|FG000|NOT COMPLETED|Overall Study||0
9920505|NCT01240135|11037648|FG000|STARTED|Period One, 14 Days of Wear||44
9920506|NCT01240135|11037649|FG001|STARTED|Period One, 14 Days of Wear||45
9920507|NCT01240135|11037648|FG000|COMPLETED|Period One, 14 Days of Wear||44
9920508|NCT01240135|11037649|FG001|COMPLETED|Period One, 14 Days of Wear||45
9920509|NCT01240135|11037648|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0
9920510|NCT01240135|11037649|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0
9920511|NCT01240135|11037648|FG000|STARTED|Period Two, 14 Days of Wear||44
9920512|NCT01240135|11037649|FG001|STARTED|Period Two, 14 Days of Wear||45
9920513|NCT01240135|11037648|FG000|COMPLETED|Period Two, 14 Days of Wear||43
9920514|NCT01240135|11037649|FG001|COMPLETED|Period Two, 14 Days of Wear||43
9920515|NCT01240135|11037648|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1
9920516|NCT01240135|11037649|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2
9920517|NCT01240200|11037657|FG000|STARTED|12-week Crossover Phase - Period 1||25
9920518|NCT01240200|11037658|FG001|STARTED|12-week Crossover Phase - Period 1||24
9920519|NCT01240200|11037657|FG000|COMPLETED|12-week Crossover Phase - Period 1||23
9920520|NCT01240200|11037658|FG001|COMPLETED|12-week Crossover Phase - Period 1||23
9920521|NCT01240200|11037657|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2
9920522|NCT01240200|11037658|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1
9920523|NCT01240200|11037657|FG000|STARTED|12-week Crossover Phase - Period 2||23
9920524|NCT01240200|11037658|FG001|STARTED|12-week Crossover Phase - Period 2||23
9920525|NCT01240200|11037657|FG000|COMPLETED|12-week Crossover Phase - Period 2||23
9920526|NCT01240200|11037658|FG001|COMPLETED|12-week Crossover Phase - Period 2||23
9920527|NCT01240200|11037657|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0
9920528|NCT01240200|11037658|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0
9920529|NCT01240330|11037667|FG000|STARTED|Overall Study||33
9920530|NCT01240330|11037667|FG000|COMPLETED|Overall Study||33
9920531|NCT01240330|11037667|FG000|NOT COMPLETED|Overall Study||0
9920532|NCT01240356|11037673|FG000|STARTED|Overall Study||18
9920533|NCT01240356|11037674|FG001|STARTED|Overall Study||20
9920534|NCT01240356|11037673|FG000|COMPLETED|Overall Study||15
9920535|NCT01240356|11037674|FG001|COMPLETED|Overall Study||20
9920536|NCT01240356|11037673|FG000|NOT COMPLETED|Overall Study||3
9920537|NCT01240356|11037674|FG001|NOT COMPLETED|Overall Study||0
9920538|NCT01240382|11037685|FG000|STARTED|Overall Study||144
9920539|NCT01240382|11037686|FG001|STARTED|Overall Study||143
9920540|NCT01240382|11037685|FG000|COMPLETED|Overall Study||142
9920541|NCT01240382|11037686|FG001|COMPLETED|Overall Study||139
9920542|NCT01240382|11037685|FG000|NOT COMPLETED|Overall Study||2
9920543|NCT01240382|11037686|FG001|NOT COMPLETED|Overall Study||4
9920544|NCT01240551|11037694|FG000|STARTED|Overall Study||30
9920545|NCT01240551|11037695|FG001|STARTED|Overall Study||30
9920546|NCT01240551|11037694|FG000|COMPLETED|Overall Study||26
9920547|NCT01240551|11037695|FG001|COMPLETED|Overall Study||27
9920548|NCT01240551|11037694|FG000|NOT COMPLETED|Overall Study||4
9920549|NCT01240551|11037695|FG001|NOT COMPLETED|Overall Study||3
9920550|NCT01240590|11037706|FG000|STARTED|Phase I||0
9920551|NCT01240590|11037707|FG001|STARTED|Phase I||6
9920552|NCT01240590|11037708|FG002|STARTED|Phase I||3
9920553|NCT01240590|11037709|FG003|STARTED|Phase I||0
9920554|NCT01240590|11037710|FG004|STARTED|Phase I||0
9920555|NCT01240590|11037706|FG000|COMPLETED|Phase I||0
9920556|NCT01240590|11037707|FG001|COMPLETED|Phase I||6
9920557|NCT01240590|11037708|FG002|COMPLETED|Phase I||0
9920558|NCT01240590|11037709|FG003|COMPLETED|Phase I||0
9920559|NCT01240590|11037710|FG004|COMPLETED|Phase I||0
9920560|NCT01240590|11037706|FG000|NOT COMPLETED|Phase I||0
9920561|NCT01240590|11037707|FG001|NOT COMPLETED|Phase I||0
9920562|NCT01240590|11037708|FG002|NOT COMPLETED|Phase I||3
9920563|NCT01240590|11037709|FG003|NOT COMPLETED|Phase I||0
9920564|NCT01240590|11037710|FG004|NOT COMPLETED|Phase I||0
9920565|NCT01240590|11037706|FG000|STARTED|Phase II||0
9920566|NCT01240590|11037707|FG001|STARTED|Phase II||0
9920567|NCT01240590|11037708|FG002|STARTED|Phase II||0
9920568|NCT01240590|11037709|FG003|STARTED|Phase II||17
9920569|NCT01240590|11037710|FG004|STARTED|Phase II||1
9920570|NCT01240590|11037706|FG000|COMPLETED|Phase II||0
9920571|NCT01240590|11037707|FG001|COMPLETED|Phase II||0
9920572|NCT01240590|11037708|FG002|COMPLETED|Phase II||0
9920573|NCT01240590|11037709|FG003|COMPLETED|Phase II||15
9920574|NCT01240590|11037710|FG004|COMPLETED|Phase II||0
9920575|NCT01240590|11037706|FG000|NOT COMPLETED|Phase II||0
9920576|NCT01240590|11037707|FG001|NOT COMPLETED|Phase II||0
9920577|NCT01240590|11037708|FG002|NOT COMPLETED|Phase II||0
9920578|NCT01240590|11037709|FG003|NOT COMPLETED|Phase II||2
9920579|NCT01240590|11037710|FG004|NOT COMPLETED|Phase II||1
9920580|NCT01240746|11037739|FG000|STARTED|Overall Study||736
9920581|NCT01240746|11037740|FG001|STARTED|Overall Study||725
9920582|NCT01240746|11037741|FG002|STARTED|Overall Study||2902
9920583|NCT01240746|11037739|FG000|COMPLETED|Overall Study||677
9920584|NCT01240746|11037740|FG001|COMPLETED|Overall Study||677
9920585|NCT01240746|11037741|FG002|COMPLETED|Overall Study||2659
9920586|NCT01240746|11037739|FG000|NOT COMPLETED|Overall Study||59
9920587|NCT01240746|11037740|FG001|NOT COMPLETED|Overall Study||48
9920588|NCT01240746|11037741|FG002|NOT COMPLETED|Overall Study||243
9920589|NCT01240785|11037751|FG000|STARTED|Overall Study||111
9920590|NCT01240785|11037752|FG001|STARTED|Overall Study||110
9920591|NCT01240785|11037751|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
9920592|NCT01240785|11037752|FG001|COMPLETED|Overall Study||107
9920593|NCT01240785|11037751|FG000|NOT COMPLETED|Overall Study||1
9920594|NCT01240785|11037752|FG001|NOT COMPLETED|Overall Study||3
9920595|NCT01240811|11037761|FG000|STARTED|Overall Study||8
9920596|NCT01240811|11037762|FG001|STARTED|Overall Study||17
9920597|NCT01240811|11037763|FG002|STARTED|Overall Study||17
9920598|NCT01240811|11037761|FG000|COMPLETED|Overall Study||8
9920599|NCT01240811|11037762|FG001|COMPLETED|Overall Study||16
9920600|NCT01240811|11037763|FG002|COMPLETED|Overall Study||16
9920601|NCT01240811|11037761|FG000|NOT COMPLETED|Overall Study||0
9920602|NCT01240811|11037762|FG001|NOT COMPLETED|Overall Study||1
9920603|NCT01240811|11037763|FG002|NOT COMPLETED|Overall Study||1
9920604|NCT01240863|11037775|FG000|STARTED|Open-label Titration Period||391
9920605|NCT01240863|11037776|FG001|STARTED|Open-label Titration Period||0
9920606|NCT01240863|11037777|FG002|STARTED|Open-label Titration Period||0
9920607|NCT01240863|11037775|FG000|Safety Analysis Set|Open-label Titration Period||389
9920608|NCT01240863|11037776|FG001|Safety Analysis Set|Open-label Titration Period||0
9920609|NCT01240863|11037777|FG002|Safety Analysis Set|Open-label Titration Period||0
9920610|NCT01240863|11037775|FG000|COMPLETED|Open-label Titration Period||294
9920611|NCT01240863|11037776|FG001|COMPLETED|Open-label Titration Period||0
9920612|NCT01240863|11037777|FG002|COMPLETED|Open-label Titration Period||0
9920613|NCT01240863|11037775|FG000|NOT COMPLETED|Open-label Titration Period||97
9920614|NCT01240863|11037776|FG001|NOT COMPLETED|Open-label Titration Period||0
9920615|NCT01240863|11037777|FG002|NOT COMPLETED|Open-label Titration Period||0
9920616|NCT01240863|11037775|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
9920617|NCT01240863|11037776|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148
9920618|NCT01240863|11037777|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146
9920619|NCT01240863|11037775|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
9920620|NCT01240863|11037776|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
9920621|NCT01240863|11037777|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
9920622|NCT01240863|11037775|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
9920623|NCT01240863|11037776|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
9920624|NCT01240863|11037777|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
9920625|NCT01240863|11037775|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
9920626|NCT01240863|11037776|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
9920627|NCT01240863|11037777|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
9920628|NCT01240915|11037797|FG000|STARTED|Overall Study||2
9920629|NCT01240915|11037798|FG001|STARTED|Overall Study||3
9920630|NCT01240915|11037799|FG002|STARTED|Overall Study||2
9920631|NCT01240915|11037800|FG003|STARTED|Overall Study||4
9920632|NCT01240915|11037801|FG004|STARTED|Overall Study||6
9920633|NCT01240915|11037802|FG005|STARTED|Overall Study||23
9920634|NCT01240915|11037803|FG006|STARTED|Overall Study||25
9920635|NCT01240915|11037804|FG007|STARTED|Overall Study||19
9920636|NCT01240915|11037805|FG008|STARTED|Overall Study||21
9920637|NCT01240915|11037797|FG000|COMPLETED|Overall Study||0
9920638|NCT01240915|11037798|FG001|COMPLETED|Overall Study||2
9920639|NCT01240915|11037799|FG002|COMPLETED|Overall Study||2
9920640|NCT01240915|11037800|FG003|COMPLETED|Overall Study||1
9920641|NCT01240915|11037801|FG004|COMPLETED|Overall Study||2
9920642|NCT01240915|11037802|FG005|COMPLETED|Overall Study||13
9920643|NCT01240915|11037803|FG006|COMPLETED|Overall Study||17
9920644|NCT01240915|11037804|FG007|COMPLETED|Overall Study||15
9920645|NCT01240915|11037805|FG008|COMPLETED|Overall Study||13
9920646|NCT01240915|11037797|FG000|NOT COMPLETED|Overall Study||2
9920647|NCT01240915|11037798|FG001|NOT COMPLETED|Overall Study||1
9920648|NCT01240915|11037799|FG002|NOT COMPLETED|Overall Study||0
9920649|NCT01240915|11037800|FG003|NOT COMPLETED|Overall Study||3
9920650|NCT01240915|11037801|FG004|NOT COMPLETED|Overall Study||4
9920651|NCT01240915|11037802|FG005|NOT COMPLETED|Overall Study||10
9920652|NCT01240915|11037803|FG006|NOT COMPLETED|Overall Study||8
9920653|NCT01240915|11037804|FG007|NOT COMPLETED|Overall Study||4
9920654|NCT01240915|11037805|FG008|NOT COMPLETED|Overall Study||8
9920655|NCT01241240|11037829|FG000|STARTED|Overall Study||94
9920656|NCT01241240|11037830|FG001|STARTED|Overall Study||98
9920657|NCT01241240|11037829|FG000|COMPLETED|Overall Study||86
9920658|NCT01241240|11037830|FG001|COMPLETED|Overall Study||89
9920659|NCT01241240|11037829|FG000|NOT COMPLETED|Overall Study||8
9920660|NCT01241240|11037830|FG001|NOT COMPLETED|Overall Study||9
9920661|NCT01241292|11037838|FG000|STARTED|Overall Study||3
9920662|NCT01241292|11037839|FG001|STARTED|Overall Study||3
9920663|NCT01241292|11037838|FG000|Entered Treatment Period|Overall Study||3
9920664|NCT01241292|11037839|FG001|Entered Treatment Period|Overall Study||3
9920665|NCT01241292|11037838|FG000|COMPLETED|Overall Study|completed=treatment on-going|0
9920666|NCT01241292|11037839|FG001|COMPLETED|Overall Study|completed=treatment on-going|0
9920667|NCT01241292|11037838|FG000|NOT COMPLETED|Overall Study||3
9920668|NCT01241292|11037839|FG001|NOT COMPLETED|Overall Study||3
9920669|NCT01241318|11037851|FG000|STARTED|Overall Study|Women enrolled|19629
9920670|NCT01241318|11037852|FG001|STARTED|Overall Study|Women enrolled|20050
9920671|NCT01241318|11037851|FG000|Liveborn Infant|Overall Study|Infants|18510
9920672|NCT01241318|11037852|FG001|Liveborn Infant|Overall Study|Infants|19346
9920673|NCT01241318|11037851|FG000|COMPLETED|Overall Study|Infants|18450
9920674|NCT01241318|11037852|FG001|COMPLETED|Overall Study|Infants|19308
9920675|NCT01241318|11037851|FG000|NOT COMPLETED|Overall Study||1179
9920676|NCT01241318|11037852|FG001|NOT COMPLETED|Overall Study||742
9920677|NCT01241344|11037865|FG000|STARTED|Overall Study||14
9920678|NCT01241344|11037866|FG001|STARTED|Overall Study||16
9920679|NCT01241344|11037867|FG002|STARTED|Overall Study||18
9920680|NCT01241344|11037868|FG003|STARTED|Overall Study||4
9920681|NCT01241344|11037865|FG000|Randomized to Open-label|Overall Study||3
9920682|NCT01241344|11037866|FG001|Randomized to Open-label|Overall Study||4
9920683|NCT01241344|11037867|FG002|Randomized to Open-label|Overall Study||5
9920684|NCT01241344|11037868|FG003|Randomized to Open-label|Overall Study||0
9920685|NCT01241344|11037865|FG000|COMPLETED|Overall Study||9
9920686|NCT01241344|11037866|FG001|COMPLETED|Overall Study||7
9920687|NCT01241344|11037867|FG002|COMPLETED|Overall Study||9
9920688|NCT01241344|11037868|FG003|COMPLETED|Overall Study||2
9920689|NCT01241344|11037865|FG000|NOT COMPLETED|Overall Study||5
9920690|NCT01241344|11037866|FG001|NOT COMPLETED|Overall Study||9
10205317|NCT03490032|11332111|FG000|STARTED|Overall Study||6
10205318|NCT03490032|11332112|FG001|STARTED|Overall Study||12
9920691|NCT01241344|11037867|FG002|NOT COMPLETED|Overall Study||9
9920692|NCT01241344|11037868|FG003|NOT COMPLETED|Overall Study||2
9920693|NCT01241435|11037881|FG000|STARTED|Overall Study||12
9920694|NCT01241435|11037882|FG001|STARTED|Overall Study||8
9920695|NCT01241435|11037883|FG002|STARTED|Overall Study||8
9920696|NCT01241435|11037884|FG003|STARTED|Overall Study||8
9920697|NCT01241435|11037881|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
9920698|NCT01241435|11037882|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
9920699|NCT01241435|11037883|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
9920700|NCT01241435|11037884|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
9920701|NCT01241435|11037881|FG000|COMPLETED|Overall Study||12
9920702|NCT01241435|11037882|FG001|COMPLETED|Overall Study||8
9920703|NCT01241435|11037883|FG002|COMPLETED|Overall Study||8
9920704|NCT01241435|11037884|FG003|COMPLETED|Overall Study||8
9920705|NCT01241435|11037881|FG000|NOT COMPLETED|Overall Study||0
9920706|NCT01241435|11037882|FG001|NOT COMPLETED|Overall Study||0
9920707|NCT01241435|11037883|FG002|NOT COMPLETED|Overall Study||0
9920708|NCT01241435|11037884|FG003|NOT COMPLETED|Overall Study||0
9920709|NCT01241448|11037898|FG000|STARTED|Overall Study||66
9920710|NCT01241448|11037899|FG001|STARTED|Overall Study||65
9920711|NCT01241448|11037900|FG002|STARTED|Overall Study||66
9920712|NCT01241448|11037901|FG003|STARTED|Overall Study||66
9920713|NCT01241448|11037898|FG000|Intent-to-Treat Population (ITT)|Overall Study||63
9920714|NCT01241448|11037899|FG001|Intent-to-Treat Population (ITT)|Overall Study||63
9920715|NCT01241448|11037900|FG002|Intent-to-Treat Population (ITT)|Overall Study||64
9920716|NCT01241448|11037901|FG003|Intent-to-Treat Population (ITT)|Overall Study||64
9920717|NCT01241448|11037898|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61
9920718|NCT01241448|11037899|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61
9920719|NCT01241448|11037900|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64
10205319|NCT03490032|11332113|FG002|STARTED|Overall Study||12
10205320|NCT03490032|11332111|FG000|COMPLETED|Overall Study||5
10205321|NCT03490032|11332112|FG001|COMPLETED|Overall Study||12
10205322|NCT03490032|11332113|FG002|COMPLETED|Overall Study||12
9920720|NCT01241448|11037901|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62
9920721|NCT01241448|11037898|FG000|COMPLETED|Overall Study||29
9920722|NCT01241448|11037899|FG001|COMPLETED|Overall Study||36
9920723|NCT01241448|11037900|FG002|COMPLETED|Overall Study||43
9920724|NCT01241448|11037901|FG003|COMPLETED|Overall Study||43
9920725|NCT01241448|11037898|FG000|NOT COMPLETED|Overall Study||37
9920726|NCT01241448|11037899|FG001|NOT COMPLETED|Overall Study||29
9920727|NCT01241448|11037900|FG002|NOT COMPLETED|Overall Study||23
9920728|NCT01241448|11037901|FG003|NOT COMPLETED|Overall Study||23
9920729|NCT01241461|11037914|FG000|STARTED|Overall Study||3
9920730|NCT01241461|11037915|FG001|STARTED|Overall Study||6
9920731|NCT01241461|11037914|FG000|COMPLETED|Overall Study||0
9920732|NCT01241461|11037915|FG001|COMPLETED|Overall Study||0
9920733|NCT01241461|11037914|FG000|NOT COMPLETED|Overall Study||3
9920734|NCT01241461|11037915|FG001|NOT COMPLETED|Overall Study||6
9920735|NCT01241513|11037927|FG000|STARTED|Overall Study||10
9920736|NCT01241513|11037928|FG001|STARTED|Overall Study||9
9920737|NCT01241513|11037927|FG000|COMPLETED|Overall Study|Study has been completed|10
9920738|NCT01241513|11037928|FG001|COMPLETED|Overall Study||9
9920739|NCT01241513|11037927|FG000|NOT COMPLETED|Overall Study||0
9920740|NCT01241513|11037928|FG001|NOT COMPLETED|Overall Study||0
9920741|NCT01241539|11037933|FG000|STARTED|Period 1||7
9920742|NCT01241539|11037933|FG000|COMPLETED|Period 1||7
9920743|NCT01241539|11037933|FG000|NOT COMPLETED|Period 1||0
9920744|NCT01241539|11037933|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
9920745|NCT01241539|11037933|FG000|COMPLETED|Period 2||7
9920746|NCT01241539|11037933|FG000|NOT COMPLETED|Period 2||0
9920747|NCT01241552|11037943|FG000|STARTED|Overall Study||242
9920748|NCT01241552|11037944|FG001|STARTED|Overall Study||403
9920749|NCT01241552|11037945|FG002|STARTED|Overall Study||403
9920750|NCT01241552|11037946|FG003|STARTED|Overall Study||404
9920751|NCT01241552|11037943|FG000|Treated|Overall Study||235
9920752|NCT01241552|11037944|FG001|Treated|Overall Study||392
9920753|NCT01241552|11037945|FG002|Treated|Overall Study||388
9920754|NCT01241552|11037946|FG003|Treated|Overall Study||397
9920755|NCT01241552|11037943|FG000|COMPLETED|Overall Study||201
9920756|NCT01241552|11037944|FG001|COMPLETED|Overall Study||340
9920757|NCT01241552|11037945|FG002|COMPLETED|Overall Study||343
9920758|NCT01241552|11037946|FG003|COMPLETED|Overall Study||340
9920759|NCT01241552|11037943|FG000|NOT COMPLETED|Overall Study||41
9920760|NCT01241552|11037944|FG001|NOT COMPLETED|Overall Study||63
9920761|NCT01241552|11037945|FG002|NOT COMPLETED|Overall Study||60
9920762|NCT01241552|11037946|FG003|NOT COMPLETED|Overall Study||64
9920763|NCT01241565|11037956|FG000|STARTED|Overall Study||50
9920764|NCT01241565|11037956|FG000|COMPLETED|Overall Study||50
9920765|NCT01241565|11037956|FG000|NOT COMPLETED|Overall Study||0
9920766|NCT01241591|11037965|FG000|STARTED|Overall Study||329
9920767|NCT01241591|11037966|FG001|STARTED|Overall Study||330
9920768|NCT01241591|11037967|FG002|STARTED|Overall Study||335
9920769|NCT01241591|11037968|FG003|STARTED|Overall Study||107
9920770|NCT01241591|11037965|FG000|COMPLETED|Overall Study||306
9920771|NCT01241591|11037966|FG001|COMPLETED|Overall Study||306
9920772|NCT01241591|11037967|FG002|COMPLETED|Overall Study||313
9920773|NCT01241591|11037968|FG003|COMPLETED|Overall Study||95
9920774|NCT01241591|11037965|FG000|NOT COMPLETED|Overall Study||23
9920775|NCT01241591|11037966|FG001|NOT COMPLETED|Overall Study||24
9920776|NCT01241591|11037967|FG002|NOT COMPLETED|Overall Study||22
9920777|NCT01241591|11037968|FG003|NOT COMPLETED|Overall Study||12
9920778|NCT01241604|11037978|FG000|STARTED|Screening Period||11
9920779|NCT01241604|11037979|FG001|STARTED|Screening Period||0
9920780|NCT01241604|11037980|FG002|STARTED|Screening Period||0
9920781|NCT01241604|11037978|FG000|COMPLETED|Screening Period||8
9920782|NCT01241604|11037979|FG001|COMPLETED|Screening Period||0
9920783|NCT01241604|11037980|FG002|COMPLETED|Screening Period||0
9920784|NCT01241604|11037978|FG000|NOT COMPLETED|Screening Period||3
9920785|NCT01241604|11037979|FG001|NOT COMPLETED|Screening Period||0
9920786|NCT01241604|11037980|FG002|NOT COMPLETED|Screening Period||0
9920787|NCT01241604|11037978|FG000|STARTED|Study Period||0
9920788|NCT01241604|11037979|FG001|STARTED|Study Period||5
9920789|NCT01241604|11037980|FG002|STARTED|Study Period||3
9920790|NCT01241604|11037978|FG000|COMPLETED|Study Period||0
9920791|NCT01241604|11037979|FG001|COMPLETED|Study Period||5
9920792|NCT01241604|11037980|FG002|COMPLETED|Study Period||3
9920793|NCT01241604|11037978|FG000|NOT COMPLETED|Study Period||0
9920794|NCT01241604|11037979|FG001|NOT COMPLETED|Study Period||0
9920795|NCT01241604|11037980|FG002|NOT COMPLETED|Study Period||0
9920796|NCT01241760|11037989|FG000|STARTED|Overall Study||371
9920797|NCT01241760|11037990|FG001|STARTED|Overall Study||369
9920798|NCT01241760|11037989|FG000|COMPLETED|Overall Study||337
9920799|NCT01241760|11037990|FG001|COMPLETED|Overall Study||329
9920800|NCT01241760|11037989|FG000|NOT COMPLETED|Overall Study||34
9920801|NCT01241760|11037990|FG001|NOT COMPLETED|Overall Study||40
9920802|NCT01241903|11037999|FG000|STARTED|Overall Study||27
9920803|NCT01241903|11038000|FG001|STARTED|Overall Study||27
9920804|NCT01241903|11037999|FG000|COMPLETED|Overall Study||26
9920805|NCT01241903|11038000|FG001|COMPLETED|Overall Study||27
9920806|NCT01241903|11037999|FG000|NOT COMPLETED|Overall Study||1
9920807|NCT01241903|11038000|FG001|NOT COMPLETED|Overall Study||0
9920808|NCT01241916|11038008|FG000|STARTED|Overall Study||35
9920809|NCT01241916|11038009|FG001|STARTED|Overall Study||31
9920810|NCT01241916|11038008|FG000|COMPLETED|Overall Study||28
9920811|NCT01241916|11038009|FG001|COMPLETED|Overall Study||21
9920812|NCT01241916|11038008|FG000|NOT COMPLETED|Overall Study||7
9920813|NCT01241916|11038009|FG001|NOT COMPLETED|Overall Study||10
9920814|NCT01242085|11038018|FG000|STARTED|Overall Study||30
9920815|NCT01242085|11038019|FG001|STARTED|Overall Study||33
9920816|NCT01242085|11038020|FG002|STARTED|Overall Study||1
9920817|NCT01242085|11038018|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
9920818|NCT01242085|11038019|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
9920819|NCT01242085|11038020|FG002|COMPLETED|Overall Study||1
9920820|NCT01242085|11038018|FG000|NOT COMPLETED|Overall Study||8
9920821|NCT01242085|11038019|FG001|NOT COMPLETED|Overall Study||7
9920822|NCT01242085|11038020|FG002|NOT COMPLETED|Overall Study||0
9920823|NCT01242111|11038026|FG000|STARTED|Overall Study||20
9920824|NCT01242111|11038026|FG000|COMPLETED|Overall Study||17
9920825|NCT01242111|11038026|FG000|NOT COMPLETED|Overall Study||3
9920826|NCT01242176|11038030|FG000|STARTED|First Intervention||12
9920827|NCT01242176|11038031|FG001|STARTED|First Intervention||12
9920828|NCT01242176|11038030|FG000|COMPLETED|First Intervention||12
9920829|NCT01242176|11038031|FG001|COMPLETED|First Intervention||12
9920830|NCT01242176|11038030|FG000|NOT COMPLETED|First Intervention||0
9920831|NCT01242176|11038031|FG001|NOT COMPLETED|First Intervention||0
9920832|NCT01242176|11038030|FG000|STARTED|Washout Period of 7 Days||12
9920833|NCT01242176|11038031|FG001|STARTED|Washout Period of 7 Days||12
9920834|NCT01242176|11038030|FG000|COMPLETED|Washout Period of 7 Days||11
9920835|NCT01242176|11038031|FG001|COMPLETED|Washout Period of 7 Days||10
9920836|NCT01242176|11038030|FG000|NOT COMPLETED|Washout Period of 7 Days||1
9920837|NCT01242176|11038031|FG001|NOT COMPLETED|Washout Period of 7 Days||2
9920838|NCT01242176|11038030|FG000|STARTED|Second Intervention||11
9920839|NCT01242176|11038031|FG001|STARTED|Second Intervention||10
9920840|NCT01242176|11038030|FG000|COMPLETED|Second Intervention||11
9920841|NCT01242176|11038031|FG001|COMPLETED|Second Intervention||10
9920842|NCT01242176|11038030|FG000|NOT COMPLETED|Second Intervention||0
9920843|NCT01242176|11038031|FG001|NOT COMPLETED|Second Intervention||0
9920844|NCT01242241|11038039|FG000|STARTED|Overall Study||40
9920845|NCT01242241|11038040|FG001|STARTED|Overall Study||40
9920846|NCT01242241|11038039|FG000|COMPLETED|Overall Study||40
9920847|NCT01242241|11038040|FG001|COMPLETED|Overall Study||40
9920848|NCT01242241|11038039|FG000|NOT COMPLETED|Overall Study||0
9920849|NCT01242241|11038040|FG001|NOT COMPLETED|Overall Study||0
9920850|NCT01242371|11038048|FG000|STARTED|Overall Study||33
9920851|NCT01242371|11038049|FG001|STARTED|Overall Study||32
9920852|NCT01242371|11038048|FG000|COMPLETED|Overall Study||31
9920853|NCT01242371|11038049|FG001|COMPLETED|Overall Study||27
9920854|NCT01242371|11038048|FG000|NOT COMPLETED|Overall Study||2
9920855|NCT01242371|11038049|FG001|NOT COMPLETED|Overall Study||5
9920856|NCT01242514|11038058|FG000|STARTED|Overall Study|Patients who received treatment|1343
9920857|NCT01242514|11038059|FG001|STARTED|Overall Study|Patients who received treatment|357
9920858|NCT01242514|11038060|FG002|STARTED|Overall Study|Patients who received treatment|212
9920859|NCT01242514|11038058|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
9920860|NCT01242514|11038059|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
9920861|NCT01242514|11038060|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
9920862|NCT01242514|11038058|FG000|COMPLETED|Overall Study|Due to project closure.|0
9920863|NCT01242514|11038059|FG001|COMPLETED|Overall Study|Due to project closure.|0
9920864|NCT01242514|11038060|FG002|COMPLETED|Overall Study|Due to project closure.|0
9920865|NCT01242514|11038058|FG000|NOT COMPLETED|Overall Study||1343
9920866|NCT01242514|11038059|FG001|NOT COMPLETED|Overall Study||357
9920867|NCT01242514|11038060|FG002|NOT COMPLETED|Overall Study||212
9920868|NCT01242527|11038072|FG000|STARTED|Overall Study||99
9920869|NCT01242527|11038073|FG001|STARTED|Overall Study||100
9920870|NCT01242527|11038074|FG002|STARTED|Overall Study||101
9920871|NCT01242527|11038075|FG003|STARTED|Overall Study||99
9920872|NCT01242527|11038072|FG000|COMPLETED|Overall Study||94
9920873|NCT01242527|11038073|FG001|COMPLETED|Overall Study||93
9920874|NCT01242527|11038074|FG002|COMPLETED|Overall Study||87
9920875|NCT01242527|11038075|FG003|COMPLETED|Overall Study||90
9920876|NCT01242527|11038072|FG000|NOT COMPLETED|Overall Study||5
9920877|NCT01242527|11038073|FG001|NOT COMPLETED|Overall Study||7
9920878|NCT01242527|11038074|FG002|NOT COMPLETED|Overall Study||14
9920879|NCT01242527|11038075|FG003|NOT COMPLETED|Overall Study||9
9920880|NCT01242644|11038088|FG000|STARTED|Overall Study||16
9920881|NCT01242644|11038089|FG001|STARTED|Overall Study||17
9920882|NCT01242644|11038090|FG002|STARTED|Overall Study||15
9920883|NCT01242644|11038088|FG000|COMPLETED|Overall Study||16
9920884|NCT01242644|11038089|FG001|COMPLETED|Overall Study||17
9920885|NCT01242644|11038090|FG002|COMPLETED|Overall Study||15
9920886|NCT01242644|11038088|FG000|NOT COMPLETED|Overall Study||0
9920887|NCT01242644|11038089|FG001|NOT COMPLETED|Overall Study||0
9920888|NCT01242644|11038090|FG002|NOT COMPLETED|Overall Study||0
9920889|NCT01242748|11038100|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
9920890|NCT01242748|11038101|FG001|STARTED|Overall Study||94
9920891|NCT01242748|11038100|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
9920892|NCT01242748|11038101|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283
9920893|NCT01242748|11038100|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
9920894|NCT01242748|11038101|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
9920895|NCT01242748|11038100|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
9920896|NCT01242748|11038101|FG001|COMPLETED|Overall Study||80
9920897|NCT01242748|11038100|FG000|NOT COMPLETED|Overall Study||38
9920898|NCT01242748|11038101|FG001|NOT COMPLETED|Overall Study||14
9920899|NCT01242813|11038107|FG000|STARTED|Overall Study||20
9920900|NCT01242813|11038107|FG000|COMPLETED|Overall Study||18
9920901|NCT01242813|11038107|FG000|NOT COMPLETED|Overall Study||2
9920902|NCT01243112|11038111|FG000|STARTED|Overall Study||25
9920903|NCT01243112|11038111|FG000|COMPLETED|Overall Study||25
9920904|NCT01243112|11038111|FG000|NOT COMPLETED|Overall Study||0
9920905|NCT01243151|11038120|FG000|STARTED|Overall Study||12
9920906|NCT01243151|11038121|FG001|STARTED|Overall Study||14
9920907|NCT01243151|11038122|FG002|STARTED|Overall Study||14
9920908|NCT01243151|11038123|FG003|STARTED|Overall Study||14
9920909|NCT01243151|11038124|FG004|STARTED|Overall Study||14
9920910|NCT01243151|11038120|FG000|Treated|Overall Study||12
9920911|NCT01243151|11038121|FG001|Treated|Overall Study||14
9920912|NCT01243151|11038122|FG002|Treated|Overall Study||14
9920913|NCT01243151|11038123|FG003|Treated|Overall Study||13
9920914|NCT01243151|11038124|FG004|Treated|Overall Study||14
9920915|NCT01243151|11038120|FG000|COMPLETED|Overall Study||12
9920916|NCT01243151|11038121|FG001|COMPLETED|Overall Study||13
9920917|NCT01243151|11038122|FG002|COMPLETED|Overall Study||13
9920918|NCT01243151|11038123|FG003|COMPLETED|Overall Study||12
9920919|NCT01243151|11038124|FG004|COMPLETED|Overall Study||14
9920920|NCT01243151|11038120|FG000|NOT COMPLETED|Overall Study||0
9920921|NCT01243151|11038121|FG001|NOT COMPLETED|Overall Study||1
9920922|NCT01243151|11038122|FG002|NOT COMPLETED|Overall Study||1
10010507|NCT01774981|11133316|FG003|COMPLETED|Overall Study||4
10010508|NCT01774981|11133317|FG004|COMPLETED|Overall Study||5
10010509|NCT01774981|11133318|FG005|COMPLETED|Overall Study||13
10010510|NCT01774981|11133319|FG006|COMPLETED|Overall Study||13
10010511|NCT01774981|11133320|FG007|COMPLETED|Overall Study||11
10010512|NCT01774981|11133313|FG000|NOT COMPLETED|Overall Study||0
9920923|NCT01243151|11038123|FG003|NOT COMPLETED|Overall Study||2
9920924|NCT01243151|11038124|FG004|NOT COMPLETED|Overall Study||0
9920925|NCT01243177|11038142|FG000|STARTED|Overall Study||444
9920926|NCT01243177|11038143|FG001|STARTED|Overall Study||442
9920927|NCT01243177|11038142|FG000|COMPLETED|Overall Study||266
9920928|NCT01243177|11038143|FG001|COMPLETED|Overall Study||264
9920929|NCT01243177|11038142|FG000|NOT COMPLETED|Overall Study||178
9920930|NCT01243177|11038143|FG001|NOT COMPLETED|Overall Study||178
9920931|NCT01243242|11038151|FG000|STARTED|Overall Study||60
9920932|NCT01243242|11038152|FG001|STARTED|Overall Study||60
9920933|NCT01243242|11038151|FG000|COMPLETED|Overall Study||57
9920934|NCT01243242|11038152|FG001|COMPLETED|Overall Study||56
9920935|NCT01243242|11038151|FG000|NOT COMPLETED|Overall Study||3
9920936|NCT01243242|11038152|FG001|NOT COMPLETED|Overall Study||4
9920937|NCT01243268|11038158|FG000|STARTED|Overall Study||674
9920938|NCT01243268|11038158|FG000|COMPLETED|Overall Study||610
9920939|NCT01243268|11038158|FG000|NOT COMPLETED|Overall Study||64
9920940|NCT01243294|11038162|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28
9920941|NCT01243294|11038163|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26
9920942|NCT01243294|11038162|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
9920943|NCT01243294|11038163|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
9920944|NCT01243294|11038162|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
9920945|NCT01243294|11038163|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
9920946|NCT01243294|11038162|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28
9920947|NCT01243294|11038163|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26
9920948|NCT01243294|11038162|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
9920949|NCT01243294|11038163|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
9920950|NCT01243294|11038162|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
9920951|NCT01243294|11038163|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
9920952|NCT01243320|11038169|FG000|STARTED|10ppm Oral Silver (3 Days)||36
9920953|NCT01243320|11038169|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36
9920954|NCT01243320|11038169|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
9920955|NCT01243320|11038169|FG000|STARTED|10ppm Oral Silver (7 Days)||36
9920956|NCT01243320|11038169|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36
9920957|NCT01243320|11038169|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
10010513|NCT01774981|11133314|FG001|NOT COMPLETED|Overall Study||0
10010514|NCT01774981|11133315|FG002|NOT COMPLETED|Overall Study||0
10010515|NCT01774981|11133316|FG003|NOT COMPLETED|Overall Study||0
9920958|NCT01243320|11038169|FG000|STARTED|10ppm Oral Silver (14 Days)||36
9920959|NCT01243320|11038169|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36
9920960|NCT01243320|11038169|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
9920961|NCT01243320|11038169|FG000|STARTED|Washout (3 Days)||36
9920962|NCT01243320|11038169|FG000|COMPLETED|Washout (3 Days)||36
9920963|NCT01243320|11038169|FG000|NOT COMPLETED|Washout (3 Days)||0
9920964|NCT01243320|11038169|FG000|STARTED|32ppm Oral Silver (14 Days)||24
9920965|NCT01243320|11038169|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24
9920966|NCT01243320|11038169|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
9920967|NCT01243333|11038175|FG000|STARTED|Overall Study||26
9920968|NCT01243333|11038175|FG000|COMPLETED|Overall Study||18
9920969|NCT01243333|11038175|FG000|NOT COMPLETED|Overall Study||8
9920970|NCT01243411|11038179|FG000|STARTED|Overall Study||347
9920971|NCT01243411|11038179|FG000|COMPLETED|Overall Study||306
9920972|NCT01243411|11038179|FG000|NOT COMPLETED|Overall Study||41
9920973|NCT01243424|11038185|FG000|STARTED|Discontinuation From Study (Treated Set)||3028
9920974|NCT01243424|11038186|FG001|STARTED|Discontinuation From Study (Treated Set)||3014
9920975|NCT01243424|11038185|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
10010516|NCT01774981|11133317|FG004|NOT COMPLETED|Overall Study||1
9920976|NCT01243424|11038186|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
9920977|NCT01243424|11038185|FG000|Treated|Discontinuation From Study (Treated Set)||3023
9920978|NCT01243424|11038186|FG001|Treated|Discontinuation From Study (Treated Set)||3010
9920979|NCT01243424|11038185|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899
9920980|NCT01243424|11038186|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895
9920981|NCT01243424|11038185|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
9920982|NCT01243424|11038186|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
9920983|NCT01243424|11038185|FG000|STARTED|Discontinuation From Treatment||3028
9920984|NCT01243424|11038186|FG001|STARTED|Discontinuation From Treatment||3014
9920985|NCT01243424|11038185|FG000|Treated|Discontinuation From Treatment||3023
9920986|NCT01243424|11038186|FG001|Treated|Discontinuation From Treatment||3010
9920987|NCT01243424|11038185|FG000|COMPLETED|Discontinuation From Treatment||1896
9920988|NCT01243424|11038186|FG001|COMPLETED|Discontinuation From Treatment||1832
9920989|NCT01243424|11038185|FG000|NOT COMPLETED|Discontinuation From Treatment||1132
9920990|NCT01243424|11038186|FG001|NOT COMPLETED|Discontinuation From Treatment||1182
9920991|NCT01243450|11038196|FG000|STARTED|Overall Study||401
9920992|NCT01243450|11038197|FG001|STARTED|Overall Study||135
9920993|NCT01243450|11038198|FG002|STARTED|Overall Study||404
9920994|NCT01243450|11038196|FG000|COMPLETED|Overall Study||318
9920995|NCT01243450|11038197|FG001|COMPLETED|Overall Study||110
9920996|NCT01243450|11038198|FG002|COMPLETED|Overall Study||337
9920997|NCT01243450|11038196|FG000|NOT COMPLETED|Overall Study||83
9920998|NCT01243450|11038197|FG001|NOT COMPLETED|Overall Study||25
9920999|NCT01243450|11038198|FG002|NOT COMPLETED|Overall Study||67
9921000|NCT01243567|11038208|FG000|STARTED|Overall Study||43
9921001|NCT01243567|11038209|FG001|STARTED|Overall Study||38
9921002|NCT01243567|11038208|FG000|COMPLETED|Overall Study||42
9921003|NCT01243567|11038209|FG001|COMPLETED|Overall Study||38
9921004|NCT01243567|11038208|FG000|NOT COMPLETED|Overall Study||1
9921005|NCT01243567|11038209|FG001|NOT COMPLETED|Overall Study||0
9921006|NCT01243580|11038217|FG000|STARTED|Overall Study||18
9921007|NCT01243580|11038218|FG001|STARTED|Overall Study||18
9921008|NCT01243580|11038217|FG000|COMPLETED|Overall Study||18
9921009|NCT01243580|11038218|FG001|COMPLETED|Overall Study||16
9921010|NCT01243580|11038217|FG000|NOT COMPLETED|Overall Study||0
9921011|NCT01243580|11038218|FG001|NOT COMPLETED|Overall Study||2
9921012|NCT01243593|11038228|FG000|STARTED|Overall Study||16
9921013|NCT01243593|11038229|FG001|STARTED|Overall Study||16
9921014|NCT01243593|11038228|FG000|COMPLETED|Overall Study||16
9921015|NCT01243593|11038229|FG001|COMPLETED|Overall Study||16
9921016|NCT01243593|11038228|FG000|NOT COMPLETED|Overall Study||0
9921017|NCT01243593|11038229|FG001|NOT COMPLETED|Overall Study||0
9921018|NCT01243619|11038235|FG000|STARTED|Overall Study||5
9921019|NCT01243619|11038235|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
9921020|NCT01243619|11038235|FG000|NOT COMPLETED|Overall Study||0
9921021|NCT01243671|11038239|FG000|STARTED|Overall Study||20
9921022|NCT01243671|11038239|FG000|Completed 24 Weeks of Treatment|Overall Study||18
9921023|NCT01243671|11038239|FG000|Completed 52 Weeks of Treatment|Overall Study||17
9921024|NCT01243671|11038239|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
9921025|NCT01243671|11038239|FG000|NOT COMPLETED|Overall Study||5
9921026|NCT01243762|11038250|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4
9921027|NCT01243762|11038251|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13
9921028|NCT01243762|11038252|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3
9921029|NCT01243762|11038253|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8
9921030|NCT01243762|11038254|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10
9921031|NCT01243762|11038255|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3
9921032|NCT01243762|11038256|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0
9921033|NCT01243762|11038250|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
9921034|NCT01243762|11038251|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
9921035|NCT01243762|11038252|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0
9921036|NCT01243762|11038253|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
9921037|NCT01243762|11038254|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
9921038|NCT01243762|11038255|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0
9921039|NCT01243762|11038256|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0
9921040|NCT01243762|11038250|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
9921041|NCT01243762|11038251|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
9921042|NCT01243762|11038252|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
9921043|NCT01243762|11038253|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
9921044|NCT01243762|11038254|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
9921045|NCT01243762|11038255|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
9921046|NCT01243762|11038256|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
9921047|NCT01243762|11038250|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
9921048|NCT01243762|11038251|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
10205323|NCT03490032|11332111|FG000|NOT COMPLETED|Overall Study||1
9921049|NCT01243762|11038252|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
9921050|NCT01243762|11038253|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
9921051|NCT01243762|11038254|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
9921052|NCT01243762|11038255|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
9921053|NCT01243762|11038256|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
9921054|NCT01243762|11038250|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921055|NCT01243762|11038251|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921056|NCT01243762|11038252|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921057|NCT01243762|11038253|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921058|NCT01243762|11038254|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10205324|NCT03490032|11332112|FG001|NOT COMPLETED|Overall Study||0
9921059|NCT01243762|11038255|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921060|NCT01243762|11038256|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921061|NCT01243762|11038250|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
9921062|NCT01243762|11038251|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
9921063|NCT01243762|11038252|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921064|NCT01243762|11038253|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
9921065|NCT01243762|11038254|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
9921066|NCT01243762|11038255|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
9921067|NCT01243762|11038256|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
9921068|NCT01243775|11038275|FG000|STARTED|Overall Study||33
9921069|NCT01243775|11038275|FG000|COMPLETED|Overall Study||31
9921070|NCT01243775|11038275|FG000|NOT COMPLETED|Overall Study||2
9921071|NCT01243944|11038281|FG000|STARTED|Overall Study||110
9921072|NCT01243944|11038282|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
9921073|NCT01243944|11038281|FG000|Treated|Overall Study||110
9921074|NCT01243944|11038282|FG001|Treated|Overall Study||111
9921075|NCT01243944|11038281|FG000|Followed for Survival|Overall Study||22
9921076|NCT01243944|11038282|FG001|Followed for Survival|Overall Study||21
9921077|NCT01243944|11038281|FG000|COMPLETED|Overall Study||65
9921078|NCT01243944|11038282|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
9921079|NCT01243944|11038281|FG000|NOT COMPLETED|Overall Study||45
9921080|NCT01243944|11038282|FG001|NOT COMPLETED|Overall Study||51
9921081|NCT01243957|11038289|FG000|STARTED|Overall Study||20
9921082|NCT01243957|11038289|FG000|COMPLETED|Overall Study||20
9921083|NCT01243957|11038289|FG000|NOT COMPLETED|Overall Study||0
9921084|NCT01244035|11038295|FG000|STARTED|Part 1: Period 1||5
9921085|NCT01244035|11038296|FG001|STARTED|Part 1: Period 1||5
9921086|NCT01244035|11038297|FG002|STARTED|Part 1: Period 1||6
9921087|NCT01244035|11038298|FG003|STARTED|Part 1: Period 1||5
9921088|NCT01244035|11038299|FG004|STARTED|Part 1: Period 1||5
9921089|NCT01244035|11038300|FG005|STARTED|Part 1: Period 1||5
9921090|NCT01244035|11038295|FG000|COMPLETED|Part 1: Period 1||4
9921091|NCT01244035|11038296|FG001|COMPLETED|Part 1: Period 1||3
9921092|NCT01244035|11038297|FG002|COMPLETED|Part 1: Period 1||4
9921093|NCT01244035|11038298|FG003|COMPLETED|Part 1: Period 1||5
9921094|NCT01244035|11038299|FG004|COMPLETED|Part 1: Period 1||4
9921095|NCT01244035|11038300|FG005|COMPLETED|Part 1: Period 1||3
9921096|NCT01244035|11038295|FG000|NOT COMPLETED|Part 1: Period 1||1
9921097|NCT01244035|11038296|FG001|NOT COMPLETED|Part 1: Period 1||2
9921098|NCT01244035|11038297|FG002|NOT COMPLETED|Part 1: Period 1||2
9921099|NCT01244035|11038298|FG003|NOT COMPLETED|Part 1: Period 1||0
9921100|NCT01244035|11038299|FG004|NOT COMPLETED|Part 1: Period 1||1
9921101|NCT01244035|11038300|FG005|NOT COMPLETED|Part 1: Period 1||2
9921102|NCT01244035|11038295|FG000|STARTED|Part 1: Period 2||4
9921103|NCT01244035|11038296|FG001|STARTED|Part 1: Period 2||3
9921104|NCT01244035|11038297|FG002|STARTED|Part 1: Period 2||4
9921105|NCT01244035|11038298|FG003|STARTED|Part 1: Period 2||5
9921106|NCT01244035|11038299|FG004|STARTED|Part 1: Period 2||4
9921107|NCT01244035|11038300|FG005|STARTED|Part 1: Period 2||3
9921108|NCT01244035|11038295|FG000|COMPLETED|Part 1: Period 2||4
9921109|NCT01244035|11038296|FG001|COMPLETED|Part 1: Period 2||3
9921110|NCT01244035|11038297|FG002|COMPLETED|Part 1: Period 2||3
9921111|NCT01244035|11038298|FG003|COMPLETED|Part 1: Period 2||5
9921112|NCT01244035|11038299|FG004|COMPLETED|Part 1: Period 2||4
9921113|NCT01244035|11038300|FG005|COMPLETED|Part 1: Period 2||3
9921114|NCT01244035|11038295|FG000|NOT COMPLETED|Part 1: Period 2||0
9921115|NCT01244035|11038296|FG001|NOT COMPLETED|Part 1: Period 2||0
9921116|NCT01244035|11038297|FG002|NOT COMPLETED|Part 1: Period 2||1
9921117|NCT01244035|11038298|FG003|NOT COMPLETED|Part 1: Period 2||0
9921118|NCT01244035|11038299|FG004|NOT COMPLETED|Part 1: Period 2||0
9921119|NCT01244035|11038300|FG005|NOT COMPLETED|Part 1: Period 2||0
9921120|NCT01244035|11038295|FG000|STARTED|Part 1: Period 3||4
9921121|NCT01244035|11038296|FG001|STARTED|Part 1: Period 3||3
9921122|NCT01244035|11038297|FG002|STARTED|Part 1: Period 3||3
9921123|NCT01244035|11038298|FG003|STARTED|Part 1: Period 3||5
9921124|NCT01244035|11038299|FG004|STARTED|Part 1: Period 3||4
9921125|NCT01244035|11038300|FG005|STARTED|Part 1: Period 3||3
9921126|NCT01244035|11038295|FG000|COMPLETED|Part 1: Period 3||4
9921127|NCT01244035|11038296|FG001|COMPLETED|Part 1: Period 3||2
9921128|NCT01244035|11038297|FG002|COMPLETED|Part 1: Period 3||3
9921129|NCT01244035|11038298|FG003|COMPLETED|Part 1: Period 3||5
9921130|NCT01244035|11038299|FG004|COMPLETED|Part 1: Period 3||3
9921131|NCT01244035|11038300|FG005|COMPLETED|Part 1: Period 3||2
9921132|NCT01244035|11038295|FG000|NOT COMPLETED|Part 1: Period 3||0
9921133|NCT01244035|11038296|FG001|NOT COMPLETED|Part 1: Period 3||1
9921134|NCT01244035|11038297|FG002|NOT COMPLETED|Part 1: Period 3||0
9921135|NCT01244035|11038298|FG003|NOT COMPLETED|Part 1: Period 3||0
9921136|NCT01244035|11038299|FG004|NOT COMPLETED|Part 1: Period 3||1
9921137|NCT01244035|11038300|FG005|NOT COMPLETED|Part 1: Period 3||1
9921138|NCT01244061|11038322|FG000|STARTED|Overall Study||251
9921139|NCT01244061|11038323|FG001|STARTED|Overall Study||247
9921140|NCT01244061|11038322|FG000|COMPLETED|Overall Study||169
9921141|NCT01244061|11038323|FG001|COMPLETED|Overall Study||144
9921142|NCT01244061|11038322|FG000|NOT COMPLETED|Overall Study||82
9921143|NCT01244061|11038323|FG001|NOT COMPLETED|Overall Study||103
9921144|NCT01244126|11038332|FG000|STARTED|Overall Study||59
9921145|NCT01244126|11038333|FG001|STARTED|Overall Study||55
9921146|NCT01244126|11038334|FG002|STARTED|Overall Study||57
9921147|NCT01244126|11038332|FG000|COMPLETED|Overall Study||56
9921148|NCT01244126|11038333|FG001|COMPLETED|Overall Study||52
9921149|NCT01244126|11038334|FG002|COMPLETED|Overall Study||48
9921150|NCT01244126|11038332|FG000|NOT COMPLETED|Overall Study||3
9921151|NCT01244126|11038333|FG001|NOT COMPLETED|Overall Study||3
9921152|NCT01244126|11038334|FG002|NOT COMPLETED|Overall Study||9
9921153|NCT01244191|11038344|FG000|STARTED|Overall Study||526
9921154|NCT01244191|11038345|FG001|STARTED|Overall Study||522
9921155|NCT01244191|11038344|FG000|Did Not Receive Treatment|Overall Study||6
9921156|NCT01244191|11038345|FG001|Did Not Receive Treatment|Overall Study||5
9921157|NCT01244191|11038344|FG000|COMPLETED|Overall Study||46
9921158|NCT01244191|11038345|FG001|COMPLETED|Overall Study||24
9921159|NCT01244191|11038344|FG000|NOT COMPLETED|Overall Study||480
9921160|NCT01244191|11038345|FG001|NOT COMPLETED|Overall Study||498
9921161|NCT01244243|11038351|FG000|STARTED|Overall Study||41
9921162|NCT01244243|11038351|FG000|COMPLETED|Overall Study||41
9921163|NCT01244243|11038351|FG000|NOT COMPLETED|Overall Study||0
9921164|NCT01244412|11038355|FG000|STARTED|Overall Study||1
9921165|NCT01244412|11038355|FG000|COMPLETED|Overall Study||1
9921166|NCT01244412|11038355|FG000|NOT COMPLETED|Overall Study||0
9921167|NCT01244425|11038361|FG000|STARTED|Overall Study||35
9921168|NCT01244425|11038362|FG001|STARTED|Overall Study||35
9921169|NCT01244425|11038361|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
9921170|NCT01244425|11038362|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
9921171|NCT01244425|11038361|FG000|NOT COMPLETED|Overall Study||3
9921172|NCT01244425|11038362|FG001|NOT COMPLETED|Overall Study||3
9921173|NCT01244451|11038376|FG000|STARTED|Overall Study||49
9921174|NCT01244451|11038376|FG000|COMPLETED|Overall Study||36
9921175|NCT01244451|11038376|FG000|NOT COMPLETED|Overall Study||13
9921176|NCT01244477|11038383|FG000|STARTED|Overall Study||38
9921177|NCT01244477|11038384|FG001|STARTED|Overall Study||23
9921178|NCT01244477|11038383|FG000|COMPLETED|Overall Study||18
9921179|NCT01244477|11038384|FG001|COMPLETED|Overall Study||20
9921180|NCT01244477|11038383|FG000|NOT COMPLETED|Overall Study||20
9921181|NCT01244477|11038384|FG001|NOT COMPLETED|Overall Study||3
9921182|NCT01244490|11038395|FG000|STARTED|Overall Study||111
9921183|NCT01244490|11038396|FG001|STARTED|Overall Study||115
9921184|NCT01244490|11038397|FG002|STARTED|Overall Study||112
9921185|NCT01244490|11038395|FG000|COMPLETED|Overall Study||92
9921186|NCT01244490|11038396|FG001|COMPLETED|Overall Study||91
9921187|NCT01244490|11038397|FG002|COMPLETED|Overall Study||89
9921188|NCT01244490|11038395|FG000|NOT COMPLETED|Overall Study||19
9921189|NCT01244490|11038396|FG001|NOT COMPLETED|Overall Study||24
9921190|NCT01244490|11038397|FG002|NOT COMPLETED|Overall Study||23
9921191|NCT01244503|11038405|FG000|STARTED|Overall Study||61
9921192|NCT01244503|11038405|FG000|COMPLETED|Overall Study||61
9921193|NCT01244503|11038405|FG000|NOT COMPLETED|Overall Study||0
9921194|NCT01244516|11038412|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170
9921195|NCT01244516|11038413|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177
9921196|NCT01244516|11038414|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173
9921197|NCT01244516|11038412|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
9921198|NCT01244516|11038413|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
9921199|NCT01244516|11038414|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
9921200|NCT01244516|11038412|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
9921201|NCT01244516|11038413|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
9921202|NCT01244516|11038414|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
9921203|NCT01244516|11038412|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166
9921204|NCT01244516|11038413|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171
9921205|NCT01244516|11038414|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170
9921206|NCT01244516|11038412|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163
9921207|NCT01244516|11038413|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170
9921208|NCT01244516|11038414|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168
9921209|NCT01244516|11038412|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
9921210|NCT01244516|11038413|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
9921211|NCT01244516|11038414|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
9921212|NCT01244529|11038423|FG000|STARTED|Overall Study||41
9921213|NCT01244529|11038423|FG000|COMPLETED|Overall Study||41
9921214|NCT01244529|11038423|FG000|NOT COMPLETED|Overall Study||0
9921215|NCT01244633|11038439|FG000|STARTED|Overall Study||18
9921216|NCT01244633|11038439|FG000|COMPLETED|Overall Study||15
9921217|NCT01244633|11038439|FG000|NOT COMPLETED|Overall Study||3
9955868|NCT01440803|11074835|FG001|COMPLETED|Overall Study||24
9955869|NCT01440803|11074834|FG000|NOT COMPLETED|Overall Study||2
9955870|NCT01440803|11074835|FG001|NOT COMPLETED|Overall Study||4
9955871|NCT01440816|11074844|FG000|STARTED|Overall Study||3
9955872|NCT01440816|11074845|FG001|STARTED|Overall Study||12
9955873|NCT01440816|11074844|FG000|COMPLETED|Overall Study||2
9955874|NCT01440816|11074845|FG001|COMPLETED|Overall Study||1
9955875|NCT01440816|11074844|FG000|NOT COMPLETED|Overall Study||1
9955876|NCT01440816|11074845|FG001|NOT COMPLETED|Overall Study||11
9955877|NCT01440881|11074855|FG000|STARTED|Overall Study||14
9955878|NCT01440881|11074856|FG001|STARTED|Overall Study||15
9955879|NCT01440881|11074855|FG000|COMPLETED|Overall Study||14
9955880|NCT01440881|11074856|FG001|COMPLETED|Overall Study||14
9955881|NCT01440881|11074855|FG000|NOT COMPLETED|Overall Study||0
9921218|NCT01244711|11038443|FG000|STARTED|Overall Study||1
9921219|NCT01244711|11038443|FG000|COMPLETED|Overall Study||1
9921220|NCT01244711|11038443|FG000|NOT COMPLETED|Overall Study||0
9921221|NCT01244724|11038447|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
9921222|NCT01244724|11038447|FG000|Week 2 Visit|Overall Study||15
9921223|NCT01244724|11038447|FG000|COMPLETED|Overall Study||9
9921224|NCT01244724|11038447|FG000|NOT COMPLETED|Overall Study||8
9921225|NCT01244893|11038451|FG000|STARTED|Baseline||22
9921226|NCT01244893|11038452|FG001|STARTED|Baseline||22
9921227|NCT01244893|11038451|FG000|COMPLETED|Baseline||22
9921228|NCT01244893|11038452|FG001|COMPLETED|Baseline||21
9921229|NCT01244893|11038451|FG000|NOT COMPLETED|Baseline||0
9921230|NCT01244893|11038452|FG001|NOT COMPLETED|Baseline||1
9921231|NCT01244893|11038451|FG000|STARTED|1-Week Follow Up||22
9921232|NCT01244893|11038452|FG001|STARTED|1-Week Follow Up||21
9921233|NCT01244893|11038451|FG000|COMPLETED|1-Week Follow Up||21
9921234|NCT01244893|11038452|FG001|COMPLETED|1-Week Follow Up||21
9921235|NCT01244893|11038451|FG000|NOT COMPLETED|1-Week Follow Up||1
9921236|NCT01244893|11038452|FG001|NOT COMPLETED|1-Week Follow Up||0
9921237|NCT01244893|11038451|FG000|STARTED|Final Visit||21
9921238|NCT01244893|11038452|FG001|STARTED|Final Visit||21
9921239|NCT01244893|11038451|FG000|COMPLETED|Final Visit||21
9921240|NCT01244893|11038452|FG001|COMPLETED|Final Visit||21
9921241|NCT01244893|11038451|FG000|NOT COMPLETED|Final Visit||0
9921242|NCT01244893|11038452|FG001|NOT COMPLETED|Final Visit||0
9921243|NCT01244906|11038463|FG000|STARTED|Overall Study||26
9921244|NCT01244906|11038463|FG000|COMPLETED|Overall Study||18
9921245|NCT01244906|11038463|FG000|NOT COMPLETED|Overall Study||8
9921246|NCT01244984|11038470|FG000|STARTED|Overall Study||60
9921247|NCT01244984|11038471|FG001|STARTED|Overall Study||93
9921248|NCT01244984|11038472|FG002|STARTED|Overall Study||90
9921249|NCT01244984|11038470|FG000|COMPLETED|Overall Study||55
9921250|NCT01244984|11038471|FG001|COMPLETED|Overall Study||79
9921251|NCT01244984|11038472|FG002|COMPLETED|Overall Study||86
9921252|NCT01244984|11038470|FG000|NOT COMPLETED|Overall Study||5
9921253|NCT01244984|11038471|FG001|NOT COMPLETED|Overall Study||14
9921254|NCT01244984|11038472|FG002|NOT COMPLETED|Overall Study||4
9921255|NCT01245049|11038483|FG000|STARTED|Overall Study||255
9921256|NCT01245049|11038484|FG001|STARTED|Overall Study||130
9921257|NCT01245049|11038483|FG000|COMPLETED|Overall Study||254
9921258|NCT01245049|11038484|FG001|COMPLETED|Overall Study||126
9921259|NCT01245049|11038483|FG000|NOT COMPLETED|Overall Study||1
9921260|NCT01245049|11038484|FG001|NOT COMPLETED|Overall Study||4
9921261|NCT01245062|11038492|FG000|STARTED|Randomization and Crossover Phase||214
9921262|NCT01245062|11038493|FG001|STARTED|Randomization and Crossover Phase||108
9921263|NCT01245062|11038494|FG002|STARTED|Randomization and Crossover Phase||0
9921264|NCT01245062|11038492|FG000|COMPLETED|Randomization and Crossover Phase||173
9921265|NCT01245062|11038493|FG001|COMPLETED|Randomization and Crossover Phase||77
9921266|NCT01245062|11038494|FG002|COMPLETED|Randomization and Crossover Phase||0
9921267|NCT01245062|11038492|FG000|NOT COMPLETED|Randomization and Crossover Phase||41
9921268|NCT01245062|11038493|FG001|NOT COMPLETED|Randomization and Crossover Phase||31
9921269|NCT01245062|11038494|FG002|NOT COMPLETED|Randomization and Crossover Phase||0
9921270|NCT01245062|11038492|FG000|STARTED|Cross-over Phase||0
9921271|NCT01245062|11038493|FG001|STARTED|Cross-over Phase||0
9921272|NCT01245062|11038494|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
9921273|NCT01245062|11038492|FG000|COMPLETED|Cross-over Phase||0
9921274|NCT01245062|11038493|FG001|COMPLETED|Cross-over Phase||0
9921275|NCT01245062|11038494|FG002|COMPLETED|Cross-over Phase||53
9921276|NCT01245062|11038492|FG000|NOT COMPLETED|Cross-over Phase||0
9921277|NCT01245062|11038493|FG001|NOT COMPLETED|Cross-over Phase||0
9921278|NCT01245062|11038494|FG002|NOT COMPLETED|Cross-over Phase||17
9921279|NCT01245101|11038504|FG000|STARTED|Period 1 (Treatment)||15
9921280|NCT01245101|11038505|FG001|STARTED|Period 1 (Treatment)||0
9921281|NCT01245101|11038504|FG000|COMPLETED|Period 1 (Treatment)||13
9921282|NCT01245101|11038505|FG001|COMPLETED|Period 1 (Treatment)||0
9921283|NCT01245101|11038504|FG000|NOT COMPLETED|Period 1 (Treatment)||2
9921284|NCT01245101|11038505|FG001|NOT COMPLETED|Period 1 (Treatment)||0
9921285|NCT01245101|11038504|FG000|STARTED|Period 2 (Washout)||13
9921286|NCT01245101|11038505|FG001|STARTED|Period 2 (Washout)||0
9921287|NCT01245101|11038504|FG000|COMPLETED|Period 2 (Washout)||12
9921288|NCT01245101|11038505|FG001|COMPLETED|Period 2 (Washout)||0
9921289|NCT01245101|11038504|FG000|NOT COMPLETED|Period 2 (Washout)||1
9921290|NCT01245101|11038505|FG001|NOT COMPLETED|Period 2 (Washout)||0
9921291|NCT01245101|11038504|FG000|STARTED|Period 3 (Treatment)||12
9921292|NCT01245101|11038505|FG001|STARTED|Period 3 (Treatment)||0
9921293|NCT01245101|11038504|FG000|COMPLETED|Period 3 (Treatment)||11
9921294|NCT01245101|11038505|FG001|COMPLETED|Period 3 (Treatment)||0
9921295|NCT01245101|11038504|FG000|NOT COMPLETED|Period 3 (Treatment)||1
9921296|NCT01245101|11038505|FG001|NOT COMPLETED|Period 3 (Treatment)||0
9921297|NCT01245140|11038513|FG000|STARTED|Overall Study||9
9921298|NCT01245140|11038514|FG001|STARTED|Overall Study||24
9921299|NCT01245140|11038513|FG000|COMPLETED|Overall Study||6
9921300|NCT01245140|11038514|FG001|COMPLETED|Overall Study||14
9921301|NCT01245140|11038513|FG000|NOT COMPLETED|Overall Study||3
9921302|NCT01245140|11038514|FG001|NOT COMPLETED|Overall Study||10
9921303|NCT01245270|11038522|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
9921304|NCT01245270|11038523|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
9921305|NCT01245270|11038522|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
9921306|NCT01245270|11038523|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
9921307|NCT01245270|11038522|FG000|NOT COMPLETED|Overall Study||0
9921308|NCT01245270|11038523|FG001|NOT COMPLETED|Overall Study||0
9921309|NCT01245283|11038534|FG000|STARTED|Overall Study||32
9921310|NCT01245283|11038535|FG001|STARTED|Overall Study||28
9921311|NCT01245283|11038536|FG002|STARTED|Overall Study||30
9921312|NCT01245283|11038534|FG000|COMPLETED|Overall Study||18
9921313|NCT01245283|11038535|FG001|COMPLETED|Overall Study||17
9921314|NCT01245283|11038536|FG002|COMPLETED|Overall Study||19
9921315|NCT01245283|11038534|FG000|NOT COMPLETED|Overall Study||14
9921316|NCT01245283|11038535|FG001|NOT COMPLETED|Overall Study||11
9921317|NCT01245283|11038536|FG002|NOT COMPLETED|Overall Study||11
9921318|NCT01245374|11038547|FG000|STARTED|Overall Study||103
9921319|NCT01245374|11038547|FG000|COMPLETED|Overall Study||99
9921320|NCT01245374|11038547|FG000|NOT COMPLETED|Overall Study||4
9921321|NCT01245387|11038552|FG000|STARTED|Overall Study||1001
9921322|NCT01245387|11038552|FG000|COMPLETED|Overall Study||188
9921323|NCT01245387|11038552|FG000|NOT COMPLETED|Overall Study||813
9921324|NCT01245413|11038556|FG000|STARTED|Sensura First,||16
9921325|NCT01245413|11038557|FG001|STARTED|Sensura First,||16
9921326|NCT01245413|11038556|FG000|COMPLETED|Sensura First,||16
9921327|NCT01245413|11038557|FG001|COMPLETED|Sensura First,||16
9921328|NCT01245413|11038556|FG000|NOT COMPLETED|Sensura First,||0
9921329|NCT01245413|11038557|FG001|NOT COMPLETED|Sensura First,||0
9921330|NCT01245413|11038556|FG000|STARTED|Athena First,||16
9921331|NCT01245413|11038557|FG001|STARTED|Athena First,||16
9921332|NCT01245413|11038556|FG000|COMPLETED|Athena First,||16
9921333|NCT01245413|11038557|FG001|COMPLETED|Athena First,||16
9921334|NCT01245413|11038556|FG000|NOT COMPLETED|Athena First,||0
9921335|NCT01245413|11038557|FG001|NOT COMPLETED|Athena First,||0
9921336|NCT01245439|11038563|FG000|STARTED|Overall Study||65
9921337|NCT01245439|11038563|FG000|COMPLETED|Overall Study||65
9921338|NCT01245439|11038563|FG000|NOT COMPLETED|Overall Study||0
9921339|NCT01245595|11038571|FG000|STARTED|Overall Study||72
9921340|NCT01245595|11038572|FG001|STARTED|Overall Study||72
9921341|NCT01245595|11038571|FG000|Completed Full Course of Study Drug|Overall Study||57
9921342|NCT01245595|11038572|FG001|Completed Full Course of Study Drug|Overall Study||61
9921343|NCT01245595|11038571|FG000|COMPLETED|Overall Study||72
9921344|NCT01245595|11038572|FG001|COMPLETED|Overall Study||72
9921345|NCT01245595|11038571|FG000|NOT COMPLETED|Overall Study||0
9921346|NCT01245595|11038572|FG001|NOT COMPLETED|Overall Study||0
9921347|NCT01245647|11038580|FG000|STARTED|Overall Study||7
9921348|NCT01245647|11038581|FG001|STARTED|Overall Study||12
9921349|NCT01245647|11038580|FG000|COMPLETED|Overall Study||7
9921350|NCT01245647|11038581|FG001|COMPLETED|Overall Study||8
9921351|NCT01245647|11038580|FG000|NOT COMPLETED|Overall Study||0
9921352|NCT01245647|11038581|FG001|NOT COMPLETED|Overall Study||4
9921353|NCT01245673|11038587|FG000|STARTED|Enrollment||28
9921354|NCT01245673|11038587|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
9921355|NCT01245673|11038587|FG000|NOT COMPLETED|Enrollment||1
9921356|NCT01245673|11038587|FG000|STARTED|Pre Transplant Vaccinations||27
9921357|NCT01245673|11038587|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
9921358|NCT01245673|11038587|FG000|COMPLETED|Pre Transplant Vaccinations||27
9921359|NCT01245673|11038587|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0
9921360|NCT01245673|11038587|FG000|STARTED|Activated/Costimulated Autologous T Cell||27
9921361|NCT01245673|11038587|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27
9921362|NCT01245673|11038587|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
9921363|NCT01245673|11038587|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
9921364|NCT01245673|11038587|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
9921365|NCT01245673|11038587|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
9921366|NCT01245673|11038587|FG000|STARTED|Start Lenalidomide||26
9921367|NCT01245673|11038587|FG000|COMPLETED|Start Lenalidomide||26
9921368|NCT01245673|11038587|FG000|NOT COMPLETED|Start Lenalidomide||0
9921369|NCT01245673|11038587|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
9921370|NCT01245673|11038587|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
9921371|NCT01245673|11038587|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
9921372|NCT01245699|11038593|FG000|STARTED|Overall Study||61
9921373|NCT01245699|11038594|FG001|STARTED|Overall Study||54
9921374|NCT01245699|11038593|FG000|COMPLETED|Overall Study||52
9921375|NCT01245699|11038594|FG001|COMPLETED|Overall Study||49
9921376|NCT01245699|11038593|FG000|NOT COMPLETED|Overall Study||9
9921377|NCT01245699|11038594|FG001|NOT COMPLETED|Overall Study||5
9921378|NCT01245738|11038601|FG000|STARTED|Overall Study||514
9921379|NCT01245738|11038601|FG000|COMPLETED|Overall Study||474
9921380|NCT01245738|11038601|FG000|NOT COMPLETED|Overall Study||40
9921381|NCT01245751|11038609|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
9921382|NCT01245751|11038610|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
9921383|NCT01245751|11038611|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
9921384|NCT01245751|11038612|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
9921385|NCT01245751|11038609|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
9921386|NCT01245751|11038610|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
9921387|NCT01245751|11038611|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
9921388|NCT01245751|11038612|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
9921389|NCT01245751|11038609|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
9921390|NCT01245751|11038610|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
9921391|NCT01245751|11038611|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
9921392|NCT01245751|11038612|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
9921393|NCT01245751|11038609|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
9921394|NCT01245751|11038610|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
9921395|NCT01245751|11038611|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
9921396|NCT01245751|11038612|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
9921397|NCT01245751|11038609|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
9921398|NCT01245751|11038610|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
9921399|NCT01245751|11038611|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
9921400|NCT01245751|11038612|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
9921401|NCT01245751|11038609|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
9921402|NCT01245751|11038610|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
9921403|NCT01245751|11038611|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
9921404|NCT01245751|11038612|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
9921405|NCT01245751|11038609|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
9921406|NCT01245751|11038610|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
9921407|NCT01245751|11038611|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
9921408|NCT01245751|11038612|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
9921409|NCT01245764|11038627|FG000|STARTED|Study Phase A||80
9921410|NCT01245764|11038628|FG001|STARTED|Study Phase A||30
9921411|NCT01245764|11038629|FG002|STARTED|Study Phase A||120
9921412|NCT01245764|11038630|FG003|STARTED|Study Phase A||20
9921413|NCT01245764|11038627|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77
9921414|NCT01245764|11038628|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28
9921415|NCT01245764|11038629|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117
9921416|NCT01245764|11038630|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19
9921417|NCT01245764|11038627|FG000|COMPLETED|Study Phase A||71
9921418|NCT01245764|11038628|FG001|COMPLETED|Study Phase A||25
9921419|NCT01245764|11038629|FG002|COMPLETED|Study Phase A||110
9921420|NCT01245764|11038630|FG003|COMPLETED|Study Phase A||17
9921421|NCT01245764|11038627|FG000|NOT COMPLETED|Study Phase A||9
9921422|NCT01245764|11038628|FG001|NOT COMPLETED|Study Phase A||5
9921423|NCT01245764|11038629|FG002|NOT COMPLETED|Study Phase A||10
9921424|NCT01245764|11038630|FG003|NOT COMPLETED|Study Phase A||3
9921425|NCT01245764|11038627|FG000|STARTED|Study Phase B||0
9921426|NCT01245764|11038628|FG001|STARTED|Study Phase B||0
9921427|NCT01245764|11038629|FG002|STARTED|Study Phase B||0
9921428|NCT01245764|11038630|FG003|STARTED|Study Phase B||17
9921429|NCT01245764|11038627|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0
9921430|NCT01245764|11038628|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0
9921431|NCT01245764|11038629|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0
9921432|NCT01245764|11038630|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17
9921433|NCT01245764|11038627|FG000|COMPLETED|Study Phase B||0
9921434|NCT01245764|11038628|FG001|COMPLETED|Study Phase B||0
9921435|NCT01245764|11038629|FG002|COMPLETED|Study Phase B||0
9921436|NCT01245764|11038630|FG003|COMPLETED|Study Phase B||17
9921437|NCT01245764|11038627|FG000|NOT COMPLETED|Study Phase B||0
9921438|NCT01245764|11038628|FG001|NOT COMPLETED|Study Phase B||0
9921439|NCT01245764|11038629|FG002|NOT COMPLETED|Study Phase B||0
9921440|NCT01245764|11038630|FG003|NOT COMPLETED|Study Phase B||0
9921441|NCT01245972|11038651|FG000|STARTED|Overall Study||7
9921442|NCT01245972|11038652|FG001|STARTED|Overall Study||8
9921443|NCT01245972|11038653|FG002|STARTED|Overall Study||8
9921444|NCT01245972|11038651|FG000|COMPLETED|Overall Study||7
9921445|NCT01245972|11038652|FG001|COMPLETED|Overall Study||8
9921446|NCT01245972|11038653|FG002|COMPLETED|Overall Study||8
9921447|NCT01245972|11038651|FG000|NOT COMPLETED|Overall Study||0
9921448|NCT01245972|11038652|FG001|NOT COMPLETED|Overall Study||0
9921449|NCT01245972|11038653|FG002|NOT COMPLETED|Overall Study||0
9921450|NCT01246050|11038663|FG000|STARTED|Overall Study||6
9921451|NCT01246050|11038664|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
9921452|NCT01246050|11038663|FG000|COMPLETED|Overall Study||6
9921453|NCT01246050|11038664|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
9921454|NCT01246050|11038663|FG000|NOT COMPLETED|Overall Study||0
9921455|NCT01246050|11038664|FG001|NOT COMPLETED|Overall Study||0
9921456|NCT01246063|11038676|FG000|STARTED|Overall Study||3
9921457|NCT01246063|11038677|FG001|STARTED|Overall Study||4
9921458|NCT01246063|11038678|FG002|STARTED|Overall Study||4
9921459|NCT01246063|11038679|FG003|STARTED|Overall Study||5
9921460|NCT01246063|11038680|FG004|STARTED|Overall Study||7
9921461|NCT01246063|11038681|FG005|STARTED|Overall Study||17
9921462|NCT01246063|11038676|FG000|COMPLETED|Overall Study||3
9921463|NCT01246063|11038677|FG001|COMPLETED|Overall Study||4
9921464|NCT01246063|11038678|FG002|COMPLETED|Overall Study||4
9921465|NCT01246063|11038679|FG003|COMPLETED|Overall Study||5
9921466|NCT01246063|11038680|FG004|COMPLETED|Overall Study||7
9921467|NCT01246063|11038681|FG005|COMPLETED|Overall Study||17
9921468|NCT01246063|11038676|FG000|NOT COMPLETED|Overall Study||0
9921469|NCT01246063|11038677|FG001|NOT COMPLETED|Overall Study||0
9921470|NCT01246063|11038678|FG002|NOT COMPLETED|Overall Study||0
9921471|NCT01246063|11038679|FG003|NOT COMPLETED|Overall Study||0
9921472|NCT01246063|11038680|FG004|NOT COMPLETED|Overall Study||0
9921473|NCT01246063|11038681|FG005|NOT COMPLETED|Overall Study||0
9921474|NCT01246076|11038699|FG000|STARTED|Overall Study||24
9921475|NCT01246076|11038699|FG000|COMPLETED|Overall Study||24
9921476|NCT01246076|11038699|FG000|NOT COMPLETED|Overall Study||0
9921477|NCT01246206|11038703|FG000|STARTED|Overall Study||21
9921478|NCT01246206|11038703|FG000|COMPLETED|Overall Study||20
9921479|NCT01246206|11038703|FG000|NOT COMPLETED|Overall Study||1
9921480|NCT01246258|11038707|FG000|STARTED|Overall Study||5
9921481|NCT01246258|11038707|FG000|COMPLETED|Overall Study||5
9921482|NCT01246258|11038707|FG000|NOT COMPLETED|Overall Study||0
9921483|NCT01246349|11038714|FG000|STARTED|Overall Study||20
9921484|NCT01246349|11038715|FG001|STARTED|Overall Study||20
9921485|NCT01246349|11038714|FG000|COMPLETED|Overall Study||20
9921486|NCT01246349|11038715|FG001|COMPLETED|Overall Study||20
9921487|NCT01246349|11038714|FG000|NOT COMPLETED|Overall Study||0
9921488|NCT01246349|11038715|FG001|NOT COMPLETED|Overall Study||0
9921489|NCT01246401|11038723|FG000|STARTED|Overall Study||66
9921490|NCT01246401|11038724|FG001|STARTED|Overall Study||27
9921491|NCT01246401|11038723|FG000|COMPLETED|Overall Study||66
9921492|NCT01246401|11038724|FG001|COMPLETED|Overall Study||27
9921493|NCT01246401|11038723|FG000|NOT COMPLETED|Overall Study||0
9921494|NCT01246401|11038724|FG001|NOT COMPLETED|Overall Study||0
9921495|NCT01246466|11038732|FG000|STARTED|Overall Study||24
9921496|NCT01246466|11038732|FG000|COMPLETED|Overall Study||22
9921497|NCT01246466|11038732|FG000|NOT COMPLETED|Overall Study||2
9921498|NCT01246479|11038737|FG000|STARTED|Overall Study||23
9921499|NCT01246479|11038737|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18
9921500|NCT01246479|11038737|FG000|NOT COMPLETED|Overall Study||5
9921501|NCT01246583|11038745|FG000|STARTED|Overall Study||23
9921502|NCT01246583|11038746|FG001|STARTED|Overall Study||13
9921503|NCT01246583|11038747|FG002|STARTED|Overall Study||25
9921504|NCT01246583|11038748|FG003|STARTED|Overall Study||10
9921505|NCT01246583|11038745|FG000|COMPLETED|Overall Study||22
9921506|NCT01246583|11038746|FG001|COMPLETED|Overall Study||13
9921507|NCT01246583|11038747|FG002|COMPLETED|Overall Study||24
9921508|NCT01246583|11038748|FG003|COMPLETED|Overall Study||9
9921509|NCT01246583|11038745|FG000|NOT COMPLETED|Overall Study||1
9921510|NCT01246583|11038746|FG001|NOT COMPLETED|Overall Study||0
9921511|NCT01246583|11038747|FG002|NOT COMPLETED|Overall Study||1
9921512|NCT01246583|11038748|FG003|NOT COMPLETED|Overall Study||1
9921513|NCT01246713|11038759|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6
9921514|NCT01246713|11038760|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9
9921515|NCT01246713|11038759|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6
9921516|NCT01246713|11038760|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9
9921517|NCT01246713|11038759|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
9921518|NCT01246713|11038760|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
9921519|NCT01246713|11038759|FG000|STARTED|Washout (at Least 14 Days)||6
9921520|NCT01246713|11038760|FG001|STARTED|Washout (at Least 14 Days)||9
9921521|NCT01246713|11038759|FG000|COMPLETED|Washout (at Least 14 Days)||6
9921522|NCT01246713|11038760|FG001|COMPLETED|Washout (at Least 14 Days)||9
9921523|NCT01246713|11038759|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
9921524|NCT01246713|11038760|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
9921525|NCT01246713|11038759|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6
9921526|NCT01246713|11038760|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9
9921527|NCT01246713|11038759|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
9921528|NCT01246713|11038760|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
9921529|NCT01246713|11038759|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
9921530|NCT01246713|11038760|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
9921531|NCT01246791|11038766|FG000|STARTED|Overall Study||12
9921532|NCT01246791|11038766|FG000|COMPLETED|Overall Study||12
9921533|NCT01246791|11038766|FG000|NOT COMPLETED|Overall Study||0
9921534|NCT01246895|11038772|FG000|STARTED|Overall Study||37
9921535|NCT01246895|11038773|FG001|STARTED|Overall Study||30
9921536|NCT01246895|11038772|FG000|COMPLETED|Overall Study||34
9921537|NCT01246895|11038773|FG001|COMPLETED|Overall Study||26
9921538|NCT01246895|11038772|FG000|NOT COMPLETED|Overall Study||3
9921539|NCT01246895|11038773|FG001|NOT COMPLETED|Overall Study||4
9921540|NCT01246960|11038783|FG000|STARTED|Overall Study||84
9921541|NCT01246960|11038784|FG001|STARTED|Overall Study||84
9921542|NCT01246960|11038783|FG000|Received Any Quantity of Study Drug|Overall Study||82
9921543|NCT01246960|11038784|FG001|Received Any Quantity of Study Drug|Overall Study||80
9921544|NCT01246960|11038783|FG000|COMPLETED|Overall Study||78
9921545|NCT01246960|11038784|FG001|COMPLETED|Overall Study||80
9921546|NCT01246960|11038783|FG000|NOT COMPLETED|Overall Study||6
9921547|NCT01246960|11038784|FG001|NOT COMPLETED|Overall Study||4
9921548|NCT01246973|11038792|FG000|STARTED|Overall Study||344
9921549|NCT01246973|11038793|FG001|STARTED|Overall Study||342
9921550|NCT01246973|11038792|FG000|COMPLETED|Overall Study||283
9921551|NCT01246973|11038793|FG001|COMPLETED|Overall Study||295
9921552|NCT01246973|11038792|FG000|NOT COMPLETED|Overall Study||61
9921553|NCT01246973|11038793|FG001|NOT COMPLETED|Overall Study||47
9921554|NCT01246986|11038806|FG000|STARTED|Overall Study||37
9921555|NCT01246986|11038807|FG001|STARTED|Overall Study||72
9921556|NCT01246986|11038808|FG002|STARTED|Overall Study||40
9921557|NCT01246986|11038809|FG003|STARTED|Overall Study||3
9921558|NCT01246986|11038810|FG004|STARTED|Overall Study||44
9921559|NCT01246986|11038811|FG005|STARTED|Overall Study||3
9921560|NCT01246986|11038812|FG006|STARTED|Overall Study||5
9921561|NCT01246986|11038806|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37
9921562|NCT01246986|11038807|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
9921563|NCT01246986|11038808|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
9921564|NCT01246986|11038809|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
9921565|NCT01246986|11038810|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44
9921566|NCT01246986|11038811|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
9921567|NCT01246986|11038812|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
9921568|NCT01246986|11038806|FG000|COMPLETED|Overall Study||34
9921569|NCT01246986|11038807|FG001|COMPLETED|Overall Study||67
9921570|NCT01246986|11038808|FG002|COMPLETED|Overall Study||34
9921571|NCT01246986|11038809|FG003|COMPLETED|Overall Study||3
9921572|NCT01246986|11038810|FG004|COMPLETED|Overall Study||40
9921573|NCT01246986|11038811|FG005|COMPLETED|Overall Study||2
10010517|NCT01774981|11133318|FG005|NOT COMPLETED|Overall Study||1
10010518|NCT01774981|11133319|FG006|NOT COMPLETED|Overall Study||0
10010519|NCT01774981|11133320|FG007|NOT COMPLETED|Overall Study||1
10010520|NCT01775124|11133345|FG000|STARTED|Core Period||168
10010521|NCT01775124|11133346|FG001|STARTED|Core Period||166
10010522|NCT01775124|11133345|FG000|Full Analysis Set|Core Period||167
10010523|NCT01775124|11133346|FG001|Full Analysis Set|Core Period||166
10010524|NCT01775124|11133345|FG000|Per Protocol Set|Core Period||157
10010525|NCT01775124|11133346|FG001|Per Protocol Set|Core Period||155
9921574|NCT01246986|11038812|FG006|COMPLETED|Overall Study||5
9921575|NCT01246986|11038806|FG000|NOT COMPLETED|Overall Study||3
9921576|NCT01246986|11038807|FG001|NOT COMPLETED|Overall Study||5
9921577|NCT01246986|11038808|FG002|NOT COMPLETED|Overall Study||6
9921578|NCT01246986|11038809|FG003|NOT COMPLETED|Overall Study||0
9921579|NCT01246986|11038810|FG004|NOT COMPLETED|Overall Study||4
9921580|NCT01246986|11038811|FG005|NOT COMPLETED|Overall Study||1
9921581|NCT01246986|11038812|FG006|NOT COMPLETED|Overall Study||0
9921582|NCT01246999|11038847|FG000|STARTED|Overall Study||11
9921583|NCT01246999|11038848|FG001|STARTED|Overall Study||4
9921584|NCT01246999|11038849|FG002|STARTED|Overall Study||2
9921585|NCT01246999|11038850|FG003|STARTED|Overall Study||17
9921586|NCT01246999|11038847|FG000|COMPLETED|Overall Study||11
9921587|NCT01246999|11038848|FG001|COMPLETED|Overall Study||3
9921588|NCT01246999|11038849|FG002|COMPLETED|Overall Study||2
9921589|NCT01246999|11038850|FG003|COMPLETED|Overall Study||15
9921590|NCT01246999|11038847|FG000|NOT COMPLETED|Overall Study||0
9921591|NCT01246999|11038848|FG001|NOT COMPLETED|Overall Study||1
9921592|NCT01246999|11038849|FG002|NOT COMPLETED|Overall Study||0
9921593|NCT01246999|11038850|FG003|NOT COMPLETED|Overall Study||2
9921594|NCT01247064|11038865|FG000|STARTED|Overall Study||31
9921595|NCT01247064|11038866|FG001|STARTED|Overall Study||31
9921596|NCT01247064|11038865|FG000|COMPLETED|Overall Study||31
9921597|NCT01247064|11038866|FG001|COMPLETED|Overall Study||31
9921598|NCT01247064|11038865|FG000|NOT COMPLETED|Overall Study||0
9921599|NCT01247064|11038866|FG001|NOT COMPLETED|Overall Study||0
9921600|NCT01247090|11038875|FG000|STARTED|Overall Study||4
9921601|NCT01247090|11038876|FG001|STARTED|Overall Study||4
9921602|NCT01247090|11038877|FG002|STARTED|Overall Study||4
9921603|NCT01247090|11038875|FG000|COMPLETED|Overall Study||3
9921604|NCT01247090|11038876|FG001|COMPLETED|Overall Study||3
9921605|NCT01247090|11038877|FG002|COMPLETED|Overall Study||4
9921606|NCT01247090|11038875|FG000|NOT COMPLETED|Overall Study||1
9921607|NCT01247090|11038876|FG001|NOT COMPLETED|Overall Study||1
9921608|NCT01247090|11038877|FG002|NOT COMPLETED|Overall Study||0
9921609|NCT01247220|11038887|FG000|STARTED|Overall Study||6
9921610|NCT01247220|11038888|FG001|STARTED|Overall Study||6
9921611|NCT01247220|11038887|FG000|COMPLETED|Overall Study||6
9921612|NCT01247220|11038888|FG001|COMPLETED|Overall Study||6
9921613|NCT01247220|11038887|FG000|NOT COMPLETED|Overall Study||0
9921614|NCT01247220|11038888|FG001|NOT COMPLETED|Overall Study||0
9921615|NCT01247272|11038896|FG000|STARTED|First Intervention||13
9921616|NCT01247272|11038897|FG001|STARTED|First Intervention||13
9921617|NCT01247272|11038896|FG000|COMPLETED|First Intervention||13
9921618|NCT01247272|11038897|FG001|COMPLETED|First Intervention||13
9921619|NCT01247272|11038896|FG000|NOT COMPLETED|First Intervention||0
9921620|NCT01247272|11038897|FG001|NOT COMPLETED|First Intervention||0
10010526|NCT01775124|11133345|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
10010527|NCT01775124|11133346|FG001|Safety Set|Core Period||166
10010528|NCT01775124|11133345|FG000|COMPLETED|Core Period||157
9921621|NCT01247272|11038896|FG000|STARTED|Washout of 28 Days||13
9921622|NCT01247272|11038897|FG001|STARTED|Washout of 28 Days||13
9921623|NCT01247272|11038896|FG000|COMPLETED|Washout of 28 Days||13
9921624|NCT01247272|11038897|FG001|COMPLETED|Washout of 28 Days||13
9921625|NCT01247272|11038896|FG000|NOT COMPLETED|Washout of 28 Days||0
9921626|NCT01247272|11038897|FG001|NOT COMPLETED|Washout of 28 Days||0
9921627|NCT01247272|11038896|FG000|STARTED|Second Intervention||13
9921628|NCT01247272|11038897|FG001|STARTED|Second Intervention||13
9921629|NCT01247272|11038896|FG000|COMPLETED|Second Intervention||13
9921630|NCT01247272|11038897|FG001|COMPLETED|Second Intervention||13
10010529|NCT01775124|11133346|FG001|COMPLETED|Core Period||156
10010530|NCT01775124|11133345|FG000|NOT COMPLETED|Core Period||11
9921631|NCT01247272|11038896|FG000|NOT COMPLETED|Second Intervention||0
9921632|NCT01247272|11038897|FG001|NOT COMPLETED|Second Intervention||0
9921633|NCT01247285|11038905|FG000|STARTED|First Intervention||13
9921634|NCT01247285|11038906|FG001|STARTED|First Intervention||13
9921635|NCT01247285|11038905|FG000|COMPLETED|First Intervention||13
9921636|NCT01247285|11038906|FG001|COMPLETED|First Intervention||13
9921637|NCT01247285|11038905|FG000|NOT COMPLETED|First Intervention||0
9921638|NCT01247285|11038906|FG001|NOT COMPLETED|First Intervention||0
9921639|NCT01247285|11038905|FG000|STARTED|Washout of 28 Days||13
9921640|NCT01247285|11038906|FG001|STARTED|Washout of 28 Days||13
9921641|NCT01247285|11038905|FG000|COMPLETED|Washout of 28 Days||13
9921642|NCT01247285|11038906|FG001|COMPLETED|Washout of 28 Days||13
9921643|NCT01247285|11038905|FG000|NOT COMPLETED|Washout of 28 Days||0
9921644|NCT01247285|11038906|FG001|NOT COMPLETED|Washout of 28 Days||0
9921645|NCT01247285|11038905|FG000|STARTED|Second Intervention||13
9921646|NCT01247285|11038906|FG001|STARTED|Second Intervention||13
9921647|NCT01247285|11038905|FG000|COMPLETED|Second Intervention||13
9921648|NCT01247285|11038906|FG001|COMPLETED|Second Intervention||13
9921649|NCT01247285|11038905|FG000|NOT COMPLETED|Second Intervention||0
9921650|NCT01247285|11038906|FG001|NOT COMPLETED|Second Intervention||0
9921651|NCT01247298|11038912|FG000|STARTED|Overall Study||17
9921652|NCT01247298|11038912|FG000|COMPLETED|Overall Study||17
9921653|NCT01247298|11038912|FG000|NOT COMPLETED|Overall Study||0
9921654|NCT01247350|11038922|FG000|STARTED|Overall Study||6
9921655|NCT01247350|11038923|FG001|STARTED|Overall Study||6
9921656|NCT01247350|11038924|FG002|STARTED|Overall Study||6
9921657|NCT01247350|11038925|FG003|STARTED|Overall Study||7
9921658|NCT01247350|11038926|FG004|STARTED|Overall Study||9
9921659|NCT01247350|11038922|FG000|Received Multiple Doses of Study Drug|Overall Study||0
9921660|NCT01247350|11038923|FG001|Received Multiple Doses of Study Drug|Overall Study||0
9921661|NCT01247350|11038924|FG002|Received Multiple Doses of Study Drug|Overall Study||6
9921662|NCT01247350|11038925|FG003|Received Multiple Doses of Study Drug|Overall Study||6
9921663|NCT01247350|11038926|FG004|Received Multiple Doses of Study Drug|Overall Study||5
9921664|NCT01247350|11038922|FG000|COMPLETED|Overall Study||6
9921665|NCT01247350|11038923|FG001|COMPLETED|Overall Study||6
9921666|NCT01247350|11038924|FG002|COMPLETED|Overall Study||5
9921667|NCT01247350|11038925|FG003|COMPLETED|Overall Study||6
9921668|NCT01247350|11038926|FG004|COMPLETED|Overall Study||8
9921669|NCT01247350|11038922|FG000|NOT COMPLETED|Overall Study||0
9921670|NCT01247350|11038923|FG001|NOT COMPLETED|Overall Study||0
9921671|NCT01247350|11038924|FG002|NOT COMPLETED|Overall Study||1
9921672|NCT01247350|11038925|FG003|NOT COMPLETED|Overall Study||1
9921673|NCT01247350|11038926|FG004|NOT COMPLETED|Overall Study||1
9921674|NCT01247363|11038952|FG000|STARTED|Overall Study||20
9921675|NCT01247363|11038952|FG000|COMPLETED|Overall Study||20
9921676|NCT01247363|11038952|FG000|NOT COMPLETED|Overall Study||0
9921677|NCT01247428|11038967|FG000|STARTED|Overall Study||30
9921678|NCT01247428|11038967|FG000|COMPLETED|Overall Study||30
9921679|NCT01247428|11038967|FG000|NOT COMPLETED|Overall Study||0
9921680|NCT01247571|11038971|FG000|STARTED|Overall Study||22
9921681|NCT01247571|11038971|FG000|COMPLETED|Overall Study||19
9921682|NCT01247571|11038971|FG000|NOT COMPLETED|Overall Study||3
9921683|NCT01247675|11038979|FG000|STARTED|Overall Study||10
9921684|NCT01247675|11038980|FG001|STARTED|Overall Study||10
9921685|NCT01247675|11038981|FG002|STARTED|Overall Study||9
9921686|NCT01247675|11038982|FG003|STARTED|Overall Study||8
9921687|NCT01247675|11038979|FG000|COMPLETED|Overall Study||8
9921688|NCT01247675|11038980|FG001|COMPLETED|Overall Study||8
9921689|NCT01247675|11038981|FG002|COMPLETED|Overall Study||9
9921690|NCT01247675|11038982|FG003|COMPLETED|Overall Study||8
9921691|NCT01247675|11038979|FG000|NOT COMPLETED|Overall Study||2
9921692|NCT01247675|11038980|FG001|NOT COMPLETED|Overall Study||2
9921693|NCT01247675|11038981|FG002|NOT COMPLETED|Overall Study||0
9921694|NCT01247675|11038982|FG003|NOT COMPLETED|Overall Study||0
9921695|NCT01247922|11038994|FG000|STARTED|Overall Study||4
9921696|NCT01247922|11038994|FG000|Treated|Overall Study||4
9921697|NCT01247922|11038994|FG000|COMPLETED|Overall Study||0
9921698|NCT01247922|11038994|FG000|NOT COMPLETED|Overall Study||4
9921699|NCT01247974|11039000|FG000|STARTED|Overall Study||217
9921700|NCT01247974|11039001|FG001|STARTED|Overall Study||222
9921701|NCT01247974|11039000|FG000|COMPLETED|Overall Study||191
9921702|NCT01247974|11039001|FG001|COMPLETED|Overall Study||203
9921703|NCT01247974|11039000|FG000|NOT COMPLETED|Overall Study||26
9921704|NCT01247974|11039001|FG001|NOT COMPLETED|Overall Study||19
9921705|NCT01248013|11039007|FG000|STARTED|Overall Study||89
9921706|NCT01248013|11039007|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
9921707|NCT01248013|11039007|FG000|COMPLETED|Overall Study||75
9921708|NCT01248013|11039007|FG000|NOT COMPLETED|Overall Study||14
9921709|NCT01248065|11039013|FG000|STARTED|Overall Study||207
9921710|NCT01248065|11039014|FG001|STARTED|Overall Study||201
9921711|NCT01248065|11039013|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
9921712|NCT01248065|11039014|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
9921713|NCT01248065|11039013|FG000|NOT COMPLETED|Overall Study||26
9921714|NCT01248065|11039014|FG001|NOT COMPLETED|Overall Study||22
9921715|NCT01248104|11039022|FG000|STARTED|Overall Study||50
9921716|NCT01248104|11039023|FG001|STARTED|Overall Study||50
9921717|NCT01248104|11039022|FG000|COMPLETED|Overall Study||40
9921718|NCT01248104|11039023|FG001|COMPLETED|Overall Study||42
9921719|NCT01248104|11039022|FG000|NOT COMPLETED|Overall Study||10
9921720|NCT01248104|11039023|FG001|NOT COMPLETED|Overall Study||8
9921721|NCT01248221|11039031|FG000|STARTED|Overall Study||15
9921722|NCT01248221|11039032|FG001|STARTED|Overall Study||15
9921723|NCT01248221|11039031|FG000|COMPLETED|Overall Study||15
9921724|NCT01248221|11039032|FG001|COMPLETED|Overall Study||15
9921725|NCT01248221|11039031|FG000|NOT COMPLETED|Overall Study||0
9921726|NCT01248221|11039032|FG001|NOT COMPLETED|Overall Study||0
9921727|NCT01248364|11039044|FG000|STARTED|Overall Study||32
9921728|NCT01248364|11039045|FG001|STARTED|Overall Study||34
9921729|NCT01248364|11039046|FG002|STARTED|Overall Study||13
9921730|NCT01248364|11039047|FG003|STARTED|Overall Study||12
9921731|NCT01248364|11039044|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
9921732|NCT01248364|11039045|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
9921733|NCT01248364|11039046|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
9921734|NCT01248364|11039047|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
9921735|NCT01248364|11039044|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32
9921736|NCT01248364|11039045|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33
9921737|NCT01248364|11039046|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13
9921738|NCT01248364|11039047|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0
9921739|NCT01248364|11039044|FG000|COMPLETED|Overall Study||32
9921740|NCT01248364|11039045|FG001|COMPLETED|Overall Study||33
9921741|NCT01248364|11039046|FG002|COMPLETED|Overall Study||13
9921742|NCT01248364|11039047|FG003|COMPLETED|Overall Study||12
9921743|NCT01248364|11039044|FG000|NOT COMPLETED|Overall Study||0
9921744|NCT01248364|11039045|FG001|NOT COMPLETED|Overall Study||1
9921745|NCT01248364|11039046|FG002|NOT COMPLETED|Overall Study||0
9921746|NCT01248364|11039047|FG003|NOT COMPLETED|Overall Study||0
9921747|NCT01248416|11039060|FG000|STARTED|Overall Study||25
9921748|NCT01248416|11039061|FG001|STARTED|Overall Study||25
9921749|NCT01248416|11039062|FG002|STARTED|Overall Study||26
9921750|NCT01248416|11039060|FG000|COMPLETED|Overall Study||21
9921751|NCT01248416|11039061|FG001|COMPLETED|Overall Study||25
9921752|NCT01248416|11039062|FG002|COMPLETED|Overall Study||25
9921753|NCT01248416|11039060|FG000|NOT COMPLETED|Overall Study||4
9921754|NCT01248416|11039061|FG001|NOT COMPLETED|Overall Study||0
9921755|NCT01248416|11039062|FG002|NOT COMPLETED|Overall Study||1
9921756|NCT01248455|11039072|FG000|STARTED|Overall Study||9
9921757|NCT01248455|11039072|FG000|COMPLETED|Overall Study||8
9921758|NCT01248455|11039072|FG000|NOT COMPLETED|Overall Study||1
9921759|NCT01248468|11039079|FG000|STARTED|Overall Study||299
9921760|NCT01248468|11039080|FG001|STARTED|Overall Study||304
9921761|NCT01248468|11039081|FG002|STARTED|Overall Study||149
9921762|NCT01248468|11039079|FG000|Safety Population|Overall Study||266
9921763|NCT01248468|11039080|FG001|Safety Population|Overall Study||271
9921764|NCT01248468|11039081|FG002|Safety Population|Overall Study||133
9921765|NCT01248468|11039079|FG000|ITT Population|Overall Study||256
9921766|NCT01248468|11039080|FG001|ITT Population|Overall Study||261
9921767|NCT01248468|11039081|FG002|ITT Population|Overall Study||125
9921768|NCT01248468|11039079|FG000|COMPLETED|Overall Study||284
9921769|NCT01248468|11039080|FG001|COMPLETED|Overall Study||290
9921770|NCT01248468|11039081|FG002|COMPLETED|Overall Study||145
9921771|NCT01248468|11039079|FG000|NOT COMPLETED|Overall Study||15
9921772|NCT01248468|11039080|FG001|NOT COMPLETED|Overall Study||14
9921773|NCT01248468|11039081|FG002|NOT COMPLETED|Overall Study||4
9921774|NCT01248585|11039091|FG000|STARTED|Overall Study||148
9921775|NCT01248585|11039092|FG001|STARTED|Overall Study||150
9921776|NCT01248585|11039091|FG000|COMPLETED|Overall Study||148
9921777|NCT01248585|11039092|FG001|COMPLETED|Overall Study||150
9921778|NCT01248585|11039091|FG000|NOT COMPLETED|Overall Study||0
9921779|NCT01248585|11039092|FG001|NOT COMPLETED|Overall Study||0
9921780|NCT01248715|11039100|FG000|STARTED|Overall Study||556
9921781|NCT01248715|11039101|FG001|STARTED|Overall Study||551
9921782|NCT01248715|11039100|FG000|COMPLETED|Overall Study||55
9921783|NCT01248715|11039101|FG001|COMPLETED|Overall Study||41
9921784|NCT01248715|11039100|FG000|NOT COMPLETED|Overall Study||501
10010531|NCT01775124|11133346|FG001|NOT COMPLETED|Core Period||10
9921785|NCT01248715|11039101|FG001|NOT COMPLETED|Overall Study||510
9921786|NCT01248728|11039109|FG000|STARTED|Overall Study||19
9921787|NCT01248728|11039110|FG001|STARTED|Overall Study||19
9921788|NCT01248728|11039109|FG000|COMPLETED|Overall Study||15
9921789|NCT01248728|11039110|FG001|COMPLETED|Overall Study||17
9921790|NCT01248728|11039109|FG000|NOT COMPLETED|Overall Study||4
9921791|NCT01248728|11039110|FG001|NOT COMPLETED|Overall Study||2
9921792|NCT01248741|11039118|FG000|STARTED|Overall Study||20
9921793|NCT01248741|11039118|FG000|COMPLETED|Overall Study||20
9921794|NCT01248741|11039118|FG000|NOT COMPLETED|Overall Study||0
9921795|NCT01248780|11039124|FG000|STARTED|Overall Study||132
9921796|NCT01248780|11039125|FG001|STARTED|Overall Study||132
9921797|NCT01248780|11039124|FG000|COMPLETED|Overall Study||123
9921798|NCT01248780|11039125|FG001|COMPLETED|Overall Study||117
9921799|NCT01248780|11039124|FG000|NOT COMPLETED|Overall Study||9
9921800|NCT01248780|11039125|FG001|NOT COMPLETED|Overall Study||15
9921801|NCT01248793|11039133|FG000|STARTED|Overall Study||105
9921802|NCT01248793|11039134|FG001|STARTED|Overall Study||108
9921803|NCT01248793|11039133|FG000|COMPLETED|Overall Study||101
9921804|NCT01248793|11039134|FG001|COMPLETED|Overall Study||102
9921805|NCT01248793|11039133|FG000|NOT COMPLETED|Overall Study||4
9921806|NCT01248793|11039134|FG001|NOT COMPLETED|Overall Study||6
9921807|NCT01248884|11039143|FG000|STARTED|Overall Study||240
9921808|NCT01248884|11039144|FG001|STARTED|Overall Study||242
9921809|NCT01248884|11039145|FG002|STARTED|Overall Study||239
9921810|NCT01248884|11039143|FG000|COMPLETED|Overall Study||238
10205325|NCT03490032|11332113|FG002|NOT COMPLETED|Overall Study||0
10205326|NCT03490110|11332124|FG000|STARTED|Overall Study||9
9921811|NCT01248884|11039144|FG001|COMPLETED|Overall Study||239
9921812|NCT01248884|11039145|FG002|COMPLETED|Overall Study||238
9921813|NCT01248884|11039143|FG000|NOT COMPLETED|Overall Study||2
9921814|NCT01248884|11039144|FG001|NOT COMPLETED|Overall Study||3
9921815|NCT01248884|11039145|FG002|NOT COMPLETED|Overall Study||1
9921816|NCT01248936|11039155|FG000|STARTED|Overall Study||374
9921817|NCT01248936|11039155|FG000|COMPLETED|Overall Study||0
9921818|NCT01248936|11039155|FG000|NOT COMPLETED|Overall Study||374
9921819|NCT01248949|11039165|FG000|STARTED|Overall Study||42
9921820|NCT01248949|11039166|FG001|STARTED|Overall Study||16
9921821|NCT01248949|11039167|FG002|STARTED|Overall Study||38
9921822|NCT01248949|11039168|FG003|STARTED|Overall Study||13
9921823|NCT01248949|11039169|FG004|STARTED|Overall Study||7
9921824|NCT01248949|11039165|FG000|COMPLETED|Overall Study||9
9921825|NCT01248949|11039166|FG001|COMPLETED|Overall Study||3
9921826|NCT01248949|11039167|FG002|COMPLETED|Overall Study||1
9921827|NCT01248949|11039168|FG003|COMPLETED|Overall Study||3
9921828|NCT01248949|11039169|FG004|COMPLETED|Overall Study||3
9921829|NCT01248949|11039165|FG000|NOT COMPLETED|Overall Study||33
9921830|NCT01248949|11039166|FG001|NOT COMPLETED|Overall Study||13
9921831|NCT01248949|11039167|FG002|NOT COMPLETED|Overall Study||37
9921832|NCT01248949|11039168|FG003|NOT COMPLETED|Overall Study||10
9921833|NCT01248949|11039169|FG004|NOT COMPLETED|Overall Study||4
9921834|NCT01248962|11039183|FG000|STARTED|Overall Study||74
9921835|NCT01248962|11039184|FG001|STARTED|Overall Study||72
9921836|NCT01248962|11039183|FG000|COMPLETED|Overall Study||58
9921837|NCT01248962|11039184|FG001|COMPLETED|Overall Study||56
9921838|NCT01248962|11039183|FG000|NOT COMPLETED|Overall Study||16
9921839|NCT01248962|11039184|FG001|NOT COMPLETED|Overall Study||16
9921840|NCT01249027|11039191|FG000|STARTED|1 Year Clinical Follow up||2482
9921841|NCT01249027|11039191|FG000|COMPLETED|1 Year Clinical Follow up||2391
9921842|NCT01249027|11039191|FG000|NOT COMPLETED|1 Year Clinical Follow up||91
9921843|NCT01249027|11039191|FG000|STARTED|2 Years Clinical Follow up||2391
9921844|NCT01249027|11039191|FG000|COMPLETED|2 Years Clinical Follow up||2254
9921845|NCT01249027|11039191|FG000|NOT COMPLETED|2 Years Clinical Follow up||137
9921846|NCT01249027|11039191|FG000|STARTED|3 Years Clinical Follow up||2254
9921847|NCT01249027|11039191|FG000|COMPLETED|3 Years Clinical Follow up||2223
9921848|NCT01249027|11039191|FG000|NOT COMPLETED|3 Years Clinical Follow up||31
9921849|NCT01249027|11039191|FG000|STARTED|4 Years Clinical Follow up||2223
9921850|NCT01249027|11039191|FG000|COMPLETED|4 Years Clinical Follow up||2210
9921851|NCT01249027|11039191|FG000|NOT COMPLETED|4 Years Clinical Follow up||13
9921852|NCT01249027|11039191|FG000|STARTED|5 Years Clinical Follow up||2210
9921853|NCT01249027|11039191|FG000|COMPLETED|5 Years Clinical Follow up||2142
9921854|NCT01249027|11039191|FG000|NOT COMPLETED|5 Years Clinical Follow up||68
9921855|NCT01249092|11039195|FG000|STARTED|Overall Study||20
9921856|NCT01249092|11039195|FG000|COMPLETED|Overall Study||18
9921857|NCT01249092|11039195|FG000|NOT COMPLETED|Overall Study||2
9921858|NCT01249118|11039201|FG000|STARTED|First Intervention Period||2
9921859|NCT01249118|11039202|FG001|STARTED|First Intervention Period||6
9921860|NCT01249118|11039203|FG002|STARTED|First Intervention Period||5
9921861|NCT01249118|11039201|FG000|COMPLETED|First Intervention Period||2
9921862|NCT01249118|11039202|FG001|COMPLETED|First Intervention Period||6
9921863|NCT01249118|11039203|FG002|COMPLETED|First Intervention Period||5
9921864|NCT01249118|11039201|FG000|NOT COMPLETED|First Intervention Period||0
9921865|NCT01249118|11039202|FG001|NOT COMPLETED|First Intervention Period||0
9921866|NCT01249118|11039203|FG002|NOT COMPLETED|First Intervention Period||0
9921867|NCT01249118|11039201|FG000|STARTED|First Washout Period||2
9921868|NCT01249118|11039202|FG001|STARTED|First Washout Period||6
9921869|NCT01249118|11039203|FG002|STARTED|First Washout Period||5
9921870|NCT01249118|11039201|FG000|COMPLETED|First Washout Period||2
9921871|NCT01249118|11039202|FG001|COMPLETED|First Washout Period||5
9921872|NCT01249118|11039203|FG002|COMPLETED|First Washout Period||5
9921873|NCT01249118|11039201|FG000|NOT COMPLETED|First Washout Period||0
9921874|NCT01249118|11039202|FG001|NOT COMPLETED|First Washout Period||1
9921875|NCT01249118|11039203|FG002|NOT COMPLETED|First Washout Period||0
9921876|NCT01249118|11039201|FG000|STARTED|Second Intervention Period||2
9921877|NCT01249118|11039202|FG001|STARTED|Second Intervention Period||5
9921878|NCT01249118|11039203|FG002|STARTED|Second Intervention Period||5
9921879|NCT01249118|11039201|FG000|COMPLETED|Second Intervention Period||2
9921880|NCT01249118|11039202|FG001|COMPLETED|Second Intervention Period||5
9921881|NCT01249118|11039203|FG002|COMPLETED|Second Intervention Period||5
10205327|NCT03490110|11332125|FG001|STARTED|Overall Study||9
9921882|NCT01249118|11039201|FG000|NOT COMPLETED|Second Intervention Period||0
9921883|NCT01249118|11039202|FG001|NOT COMPLETED|Second Intervention Period||0
9921884|NCT01249118|11039203|FG002|NOT COMPLETED|Second Intervention Period||0
9921885|NCT01249118|11039201|FG000|STARTED|Second Washout Period||2
9921886|NCT01249118|11039202|FG001|STARTED|Second Washout Period||5
9921887|NCT01249118|11039203|FG002|STARTED|Second Washout Period||5
9921888|NCT01249118|11039201|FG000|COMPLETED|Second Washout Period||2
9921889|NCT01249118|11039202|FG001|COMPLETED|Second Washout Period||5
9921890|NCT01249118|11039203|FG002|COMPLETED|Second Washout Period||5
9921891|NCT01249118|11039201|FG000|NOT COMPLETED|Second Washout Period||0
9921892|NCT01249118|11039202|FG001|NOT COMPLETED|Second Washout Period||0
9921893|NCT01249118|11039203|FG002|NOT COMPLETED|Second Washout Period||0
9921894|NCT01249131|11039210|FG000|STARTED|First Intervention||3
9921895|NCT01249131|11039211|FG001|STARTED|First Intervention||3
9921896|NCT01249131|11039212|FG002|STARTED|First Intervention||4
9921897|NCT01249131|11039213|FG003|STARTED|First Intervention||3
9921898|NCT01249131|11039214|FG004|STARTED|First Intervention||3
9921899|NCT01249131|11039215|FG005|STARTED|First Intervention||4
9921900|NCT01249131|11039210|FG000|COMPLETED|First Intervention||3
9921901|NCT01249131|11039211|FG001|COMPLETED|First Intervention||3
9921902|NCT01249131|11039212|FG002|COMPLETED|First Intervention||4
9921903|NCT01249131|11039213|FG003|COMPLETED|First Intervention||3
9921904|NCT01249131|11039214|FG004|COMPLETED|First Intervention||3
9921905|NCT01249131|11039215|FG005|COMPLETED|First Intervention||4
9921906|NCT01249131|11039210|FG000|NOT COMPLETED|First Intervention||0
9921907|NCT01249131|11039211|FG001|NOT COMPLETED|First Intervention||0
9921908|NCT01249131|11039212|FG002|NOT COMPLETED|First Intervention||0
9921909|NCT01249131|11039213|FG003|NOT COMPLETED|First Intervention||0
9921910|NCT01249131|11039214|FG004|NOT COMPLETED|First Intervention||0
9921911|NCT01249131|11039215|FG005|NOT COMPLETED|First Intervention||0
9921912|NCT01249131|11039210|FG000|STARTED|Washout Period of 10 Days||3
9921913|NCT01249131|11039211|FG001|STARTED|Washout Period of 10 Days||3
9921914|NCT01249131|11039212|FG002|STARTED|Washout Period of 10 Days||4
9921915|NCT01249131|11039213|FG003|STARTED|Washout Period of 10 Days||3
9921916|NCT01249131|11039214|FG004|STARTED|Washout Period of 10 Days||3
9921917|NCT01249131|11039215|FG005|STARTED|Washout Period of 10 Days||4
9921918|NCT01249131|11039210|FG000|COMPLETED|Washout Period of 10 Days||3
9921919|NCT01249131|11039211|FG001|COMPLETED|Washout Period of 10 Days||3
9921920|NCT01249131|11039212|FG002|COMPLETED|Washout Period of 10 Days||4
9921921|NCT01249131|11039213|FG003|COMPLETED|Washout Period of 10 Days||3
9921922|NCT01249131|11039214|FG004|COMPLETED|Washout Period of 10 Days||2
9921923|NCT01249131|11039215|FG005|COMPLETED|Washout Period of 10 Days||4
9921924|NCT01249131|11039210|FG000|NOT COMPLETED|Washout Period of 10 Days||0
9921925|NCT01249131|11039211|FG001|NOT COMPLETED|Washout Period of 10 Days||0
9921926|NCT01249131|11039212|FG002|NOT COMPLETED|Washout Period of 10 Days||0
9921927|NCT01249131|11039213|FG003|NOT COMPLETED|Washout Period of 10 Days||0
10010532|NCT01775124|11133345|FG000|STARTED|Extension Period||157
10010533|NCT01775124|11133346|FG001|STARTED|Extension Period||156
10010534|NCT01775124|11133345|FG000|COMPLETED|Extension Period||145
10010535|NCT01775124|11133346|FG001|COMPLETED|Extension Period||138
10010536|NCT01775124|11133345|FG000|NOT COMPLETED|Extension Period||12
10010537|NCT01775124|11133346|FG001|NOT COMPLETED|Extension Period||18
10010538|NCT01775137|11133353|FG000|STARTED|Overall Study||45
10010539|NCT01775137|11133353|FG000|COMPLETED|Overall Study||34
10010540|NCT01775137|11133353|FG000|NOT COMPLETED|Overall Study||11
10010541|NCT01775189|11133360|FG000|STARTED|Naloxone Challenge Phase||45
10010542|NCT01775189|11133361|FG001|STARTED|Naloxone Challenge Phase||0
10010543|NCT01775189|11133362|FG002|STARTED|Naloxone Challenge Phase||0
10010544|NCT01775189|11133363|FG003|STARTED|Naloxone Challenge Phase||0
10010545|NCT01775189|11133364|FG004|STARTED|Naloxone Challenge Phase||0
10010546|NCT01775189|11133365|FG005|STARTED|Naloxone Challenge Phase||0
10010547|NCT01775189|11133366|FG006|STARTED|Naloxone Challenge Phase||0
10010548|NCT01775189|11133360|FG000|COMPLETED|Naloxone Challenge Phase||45
10010549|NCT01775189|11133361|FG001|COMPLETED|Naloxone Challenge Phase||0
9921928|NCT01249131|11039214|FG004|NOT COMPLETED|Washout Period of 10 Days||1
9921929|NCT01249131|11039215|FG005|NOT COMPLETED|Washout Period of 10 Days||0
9921930|NCT01249131|11039210|FG000|STARTED|Second Intervention||3
9921931|NCT01249131|11039211|FG001|STARTED|Second Intervention||3
10010550|NCT01775189|11133362|FG002|COMPLETED|Naloxone Challenge Phase||0
10010551|NCT01775189|11133363|FG003|COMPLETED|Naloxone Challenge Phase||0
10010552|NCT01775189|11133364|FG004|COMPLETED|Naloxone Challenge Phase||0
10010553|NCT01775189|11133365|FG005|COMPLETED|Naloxone Challenge Phase||0
10010554|NCT01775189|11133366|FG006|COMPLETED|Naloxone Challenge Phase||0
9921932|NCT01249131|11039212|FG002|STARTED|Second Intervention||4
9921933|NCT01249131|11039213|FG003|STARTED|Second Intervention||3
9921934|NCT01249131|11039214|FG004|STARTED|Second Intervention||2
9921935|NCT01249131|11039215|FG005|STARTED|Second Intervention||4
9921936|NCT01249131|11039210|FG000|COMPLETED|Second Intervention||3
10010555|NCT01775189|11133360|FG000|NOT COMPLETED|Naloxone Challenge Phase||0
10010556|NCT01775189|11133361|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
10010557|NCT01775189|11133362|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
9921937|NCT01249131|11039211|FG001|COMPLETED|Second Intervention||3
9921938|NCT01249131|11039212|FG002|COMPLETED|Second Intervention||4
9921939|NCT01249131|11039213|FG003|COMPLETED|Second Intervention||3
9921940|NCT01249131|11039214|FG004|COMPLETED|Second Intervention||2
9921941|NCT01249131|11039215|FG005|COMPLETED|Second Intervention||4
9921942|NCT01249131|11039210|FG000|NOT COMPLETED|Second Intervention||0
9921943|NCT01249131|11039211|FG001|NOT COMPLETED|Second Intervention||0
9921944|NCT01249131|11039212|FG002|NOT COMPLETED|Second Intervention||0
10010558|NCT01775189|11133363|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
10010559|NCT01775189|11133364|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
10010560|NCT01775189|11133365|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
9921945|NCT01249131|11039213|FG003|NOT COMPLETED|Second Intervention||0
9921946|NCT01249131|11039214|FG004|NOT COMPLETED|Second Intervention||0
9921947|NCT01249131|11039215|FG005|NOT COMPLETED|Second Intervention||0
9921948|NCT01249131|11039210|FG000|STARTED|Washout Period of 10 Days||3
9921949|NCT01249131|11039211|FG001|STARTED|Washout Period of 10 Days||3
9921950|NCT01249131|11039212|FG002|STARTED|Washout Period of 10 Days||4
9921951|NCT01249131|11039213|FG003|STARTED|Washout Period of 10 Days||3
9921952|NCT01249131|11039214|FG004|STARTED|Washout Period of 10 Days||2
9921953|NCT01249131|11039215|FG005|STARTED|Washout Period of 10 Days||4
9921954|NCT01249131|11039210|FG000|COMPLETED|Washout Period of 10 Days||3
9921955|NCT01249131|11039211|FG001|COMPLETED|Washout Period of 10 Days||3
9921956|NCT01249131|11039212|FG002|COMPLETED|Washout Period of 10 Days||4
9921957|NCT01249131|11039213|FG003|COMPLETED|Washout Period of 10 Days||3
9921958|NCT01249131|11039214|FG004|COMPLETED|Washout Period of 10 Days||2
9921959|NCT01249131|11039215|FG005|COMPLETED|Washout Period of 10 Days||4
9921960|NCT01249131|11039210|FG000|NOT COMPLETED|Washout Period of 10 Days||0
9921961|NCT01249131|11039211|FG001|NOT COMPLETED|Washout Period of 10 Days||0
9921962|NCT01249131|11039212|FG002|NOT COMPLETED|Washout Period of 10 Days||0
9921963|NCT01249131|11039213|FG003|NOT COMPLETED|Washout Period of 10 Days||0
9921964|NCT01249131|11039214|FG004|NOT COMPLETED|Washout Period of 10 Days||0
9921965|NCT01249131|11039215|FG005|NOT COMPLETED|Washout Period of 10 Days||0
9921966|NCT01249131|11039210|FG000|STARTED|Third Intervention||3
9921967|NCT01249131|11039211|FG001|STARTED|Third Intervention||3
9921968|NCT01249131|11039212|FG002|STARTED|Third Intervention||4
9921969|NCT01249131|11039213|FG003|STARTED|Third Intervention||3
9921970|NCT01249131|11039214|FG004|STARTED|Third Intervention||2
9921971|NCT01249131|11039215|FG005|STARTED|Third Intervention||4
9921972|NCT01249131|11039210|FG000|COMPLETED|Third Intervention||3
10205328|NCT03490110|11332124|FG000|COMPLETED|Overall Study||6
10205329|NCT03490110|11332125|FG001|COMPLETED|Overall Study||6
10205330|NCT03490110|11332124|FG000|NOT COMPLETED|Overall Study||3
10205331|NCT03490110|11332125|FG001|NOT COMPLETED|Overall Study||3
10205332|NCT03490942|11332134|FG000|STARTED|Overall Study||15
9921973|NCT01249131|11039211|FG001|COMPLETED|Third Intervention||3
9921974|NCT01249131|11039212|FG002|COMPLETED|Third Intervention||4
9921975|NCT01249131|11039213|FG003|COMPLETED|Third Intervention||3
9921976|NCT01249131|11039214|FG004|COMPLETED|Third Intervention||2
9921977|NCT01249131|11039215|FG005|COMPLETED|Third Intervention||4
10010561|NCT01775189|11133366|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
10010562|NCT01775189|11133360|FG000|STARTED|Drug Discrimination Phase: Day 1||0
10010563|NCT01775189|11133361|FG001|STARTED|Drug Discrimination Phase: Day 1||22
10010564|NCT01775189|11133362|FG002|STARTED|Drug Discrimination Phase: Day 1||23
10010565|NCT01775189|11133363|FG003|STARTED|Drug Discrimination Phase: Day 1||0
10010566|NCT01775189|11133364|FG004|STARTED|Drug Discrimination Phase: Day 1||0
10010567|NCT01775189|11133365|FG005|STARTED|Drug Discrimination Phase: Day 1||0
10010568|NCT01775189|11133366|FG006|STARTED|Drug Discrimination Phase: Day 1||0
10010569|NCT01775189|11133360|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
10010570|NCT01775189|11133361|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19
10010571|NCT01775189|11133362|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23
9921978|NCT01249131|11039210|FG000|NOT COMPLETED|Third Intervention||0
9921979|NCT01249131|11039211|FG001|NOT COMPLETED|Third Intervention||0
9921980|NCT01249131|11039212|FG002|NOT COMPLETED|Third Intervention||0
9921981|NCT01249131|11039213|FG003|NOT COMPLETED|Third Intervention||0
9921982|NCT01249131|11039214|FG004|NOT COMPLETED|Third Intervention||0
9921983|NCT01249131|11039215|FG005|NOT COMPLETED|Third Intervention||0
9921984|NCT01249261|11039225|FG000|STARTED|Overall Study||30
9921985|NCT01249261|11039226|FG001|STARTED|Overall Study||31
9921986|NCT01249261|11039225|FG000|COMPLETED|Overall Study||29
9921987|NCT01249261|11039226|FG001|COMPLETED|Overall Study||31
9921988|NCT01249261|11039225|FG000|NOT COMPLETED|Overall Study||1
9921989|NCT01249261|11039226|FG001|NOT COMPLETED|Overall Study||0
9921990|NCT01249274|11039234|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
9921991|NCT01249274|11039235|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
9921992|NCT01249274|11039234|FG000|Completed Treatment|Overall Study||21
9921993|NCT01249274|11039235|FG001|Completed Treatment|Overall Study||19
9921994|NCT01249274|11039234|FG000|Completed Treatment & Post Trial Visit|Overall Study||20
9921995|NCT01249274|11039235|FG001|Completed Treatment & Post Trial Visit|Overall Study||17
9921996|NCT01249274|11039234|FG000|Completed Post Trial Visit But Not tx|Overall Study||1
9921997|NCT01249274|11039235|FG001|Completed Post Trial Visit But Not tx|Overall Study||2
9921998|NCT01249274|11039234|FG000|COMPLETED|Overall Study||21
9921999|NCT01249274|11039235|FG001|COMPLETED|Overall Study||19
9922000|NCT01249274|11039234|FG000|NOT COMPLETED|Overall Study||4
9922001|NCT01249274|11039235|FG001|NOT COMPLETED|Overall Study||6
9922002|NCT01249365|11039243|FG000|STARTED|Overall Study||199
9922003|NCT01249365|11039243|FG000|COMPLETED|Overall Study||198
10010572|NCT01775189|11133363|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
10205333|NCT03490942|11332135|FG001|STARTED|Overall Study||18
9922004|NCT01249365|11039243|FG000|NOT COMPLETED|Overall Study||1
9922005|NCT01249404|11039250|FG000|STARTED|Overall Study||127
9922006|NCT01249404|11039251|FG001|STARTED|Overall Study||129
9922007|NCT01249404|11039252|FG002|STARTED|Overall Study||132
9922008|NCT01249404|11039250|FG000|COMPLETED|Overall Study||120
9922009|NCT01249404|11039251|FG001|COMPLETED|Overall Study||121
9922010|NCT01249404|11039252|FG002|COMPLETED|Overall Study||125
9922011|NCT01249404|11039250|FG000|NOT COMPLETED|Overall Study||7
9922012|NCT01249404|11039251|FG001|NOT COMPLETED|Overall Study||8
9922013|NCT01249404|11039252|FG002|NOT COMPLETED|Overall Study||7
9922014|NCT01249417|11039263|FG000|STARTED|Randomised Population||80
9922015|NCT01249417|11039264|FG001|STARTED|Randomised Population||80
9922016|NCT01249417|11039265|FG002|STARTED|Randomised Population||81
9922017|NCT01249417|11039263|FG000|Treated|Randomised Population||80
9922018|NCT01249417|11039264|FG001|Treated|Randomised Population||80
9922019|NCT01249417|11039265|FG002|Treated|Randomised Population||79
9922020|NCT01249417|11039263|FG000|COMPLETED|Randomised Population||79
9922021|NCT01249417|11039264|FG001|COMPLETED|Randomised Population||79
9922022|NCT01249417|11039265|FG002|COMPLETED|Randomised Population||77
9922023|NCT01249417|11039263|FG000|NOT COMPLETED|Randomised Population||1
9922024|NCT01249417|11039264|FG001|NOT COMPLETED|Randomised Population||1
9922025|NCT01249417|11039265|FG002|NOT COMPLETED|Randomised Population||4
9922026|NCT01249417|11039263|FG000|STARTED|Treatment Phase - ITT Population||79
9922027|NCT01249417|11039264|FG001|STARTED|Treatment Phase - ITT Population||79
9922028|NCT01249417|11039265|FG002|STARTED|Treatment Phase - ITT Population||77
9922029|NCT01249417|11039263|FG000|COMPLETED|Treatment Phase - ITT Population||78
9922030|NCT01249417|11039264|FG001|COMPLETED|Treatment Phase - ITT Population||75
9922031|NCT01249417|11039265|FG002|COMPLETED|Treatment Phase - ITT Population||73
9922032|NCT01249417|11039263|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1
9922033|NCT01249417|11039264|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4
9922034|NCT01249417|11039265|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4
9922035|NCT01249625|11039275|FG000|STARTED|Overall Study||1374
9922036|NCT01249625|11039276|FG001|STARTED|Overall Study||1488
9922037|NCT01249625|11039275|FG000|COMPLETED|Overall Study||1374
9922038|NCT01249625|11039276|FG001|COMPLETED|Overall Study||1488
9922039|NCT01249625|11039275|FG000|NOT COMPLETED|Overall Study||0
9922040|NCT01249625|11039276|FG001|NOT COMPLETED|Overall Study||0
9922041|NCT01249651|11039282|FG000|STARTED|Overall Study|Enrolled|101
9922042|NCT01249651|11039282|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94
9922043|NCT01249651|11039282|FG000|NOT COMPLETED|Overall Study||7
9922044|NCT01249664|11039288|FG000|STARTED|Overall Study||91
9922045|NCT01249664|11039289|FG001|STARTED|Overall Study||31
9922046|NCT01249664|11039288|FG000|Participants Received Treatment|Overall Study|Safety population|91
9922047|NCT01249664|11039289|FG001|Participants Received Treatment|Overall Study|Safety population|31
9922048|NCT01249664|11039288|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
9922049|NCT01249664|11039289|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
9922050|NCT01249664|11039288|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
9922051|NCT01249664|11039289|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
9922052|NCT01249664|11039288|FG000|Completed 48 Weeks Treatment|Overall Study||78
9922053|NCT01249664|11039289|FG001|Completed 48 Weeks Treatment|Overall Study||24
9922054|NCT01249664|11039288|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85
9922055|NCT01249664|11039289|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31
9922056|NCT01249664|11039288|FG000|NOT COMPLETED|Overall Study||6
9922057|NCT01249664|11039289|FG001|NOT COMPLETED|Overall Study||0
9922058|NCT01249833|11039299|FG000|STARTED|Overall Study||59
9922059|NCT01249833|11039300|FG001|STARTED|Overall Study||63
9922060|NCT01249833|11039299|FG000|COMPLETED|Overall Study||59
9922061|NCT01249833|11039300|FG001|COMPLETED|Overall Study||62
9922062|NCT01249833|11039299|FG000|NOT COMPLETED|Overall Study||0
9922063|NCT01249833|11039300|FG001|NOT COMPLETED|Overall Study||1
9922064|NCT01249872|11039312|FG000|STARTED|Overall Study||16
9922065|NCT01249872|11039313|FG001|STARTED|Overall Study||16
9922066|NCT01249872|11039314|FG002|STARTED|Overall Study||16
9922067|NCT01249872|11039315|FG003|STARTED|Overall Study||16
9922068|NCT01249872|11039316|FG004|STARTED|Overall Study||16
9922069|NCT01249872|11039317|FG005|STARTED|Overall Study||16
9922070|NCT01249872|11039312|FG000|COMPLETED|Overall Study||16
9922071|NCT01249872|11039313|FG001|COMPLETED|Overall Study||16
9922072|NCT01249872|11039314|FG002|COMPLETED|Overall Study||16
9922073|NCT01249872|11039315|FG003|COMPLETED|Overall Study||16
9922074|NCT01249872|11039316|FG004|COMPLETED|Overall Study||16
9922075|NCT01249872|11039317|FG005|COMPLETED|Overall Study||16
9922076|NCT01249872|11039312|FG000|NOT COMPLETED|Overall Study||0
9922077|NCT01249872|11039313|FG001|NOT COMPLETED|Overall Study||0
9922078|NCT01249872|11039314|FG002|NOT COMPLETED|Overall Study||0
9922079|NCT01249872|11039315|FG003|NOT COMPLETED|Overall Study||0
9922080|NCT01249872|11039316|FG004|NOT COMPLETED|Overall Study||0
9922081|NCT01249872|11039317|FG005|NOT COMPLETED|Overall Study||0
9922082|NCT01250002|11039341|FG000|STARTED|Overall Study||35
9922083|NCT01250002|11039342|FG001|STARTED|Overall Study||35
9922084|NCT01250002|11039341|FG000|COMPLETED|Overall Study||31
9922085|NCT01250002|11039342|FG001|COMPLETED|Overall Study||32
9922086|NCT01250002|11039341|FG000|NOT COMPLETED|Overall Study||4
9922087|NCT01250002|11039342|FG001|NOT COMPLETED|Overall Study||3
9922088|NCT01250054|11039348|FG000|STARTED|Period 1, One Week of Wear||8
9922089|NCT01250054|11039349|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
9922090|NCT01250054|11039348|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
9922091|NCT01250054|11039349|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
9922092|NCT01250054|11039348|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
9922093|NCT01250054|11039349|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
9922094|NCT01250054|11039348|FG000|STARTED|Period 2, One Week of Wear||7
9922095|NCT01250054|11039349|FG001|STARTED|Period 2, One Week of Wear||8
9922096|NCT01250054|11039348|FG000|COMPLETED|Period 2, One Week of Wear||6
9922097|NCT01250054|11039349|FG001|COMPLETED|Period 2, One Week of Wear||8
9922098|NCT01250054|11039348|FG000|NOT COMPLETED|Period 2, One Week of Wear||1
9922099|NCT01250054|11039349|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
9922100|NCT01250119|11039355|FG000|STARTED|Diagnostic Phase||688
9922101|NCT01250119|11039356|FG001|STARTED|Diagnostic Phase||0
9922102|NCT01250119|11039355|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
9922103|NCT01250119|11039356|FG001|COMPLETED|Diagnostic Phase||0
9922104|NCT01250119|11039355|FG000|NOT COMPLETED|Diagnostic Phase||113
9922105|NCT01250119|11039356|FG001|NOT COMPLETED|Diagnostic Phase||0
9922106|NCT01250119|11039355|FG000|STARTED|Treatment Phase||0
9922107|NCT01250119|11039356|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
9922108|NCT01250119|11039355|FG000|COMPLETED|Treatment Phase||0
9922109|NCT01250119|11039356|FG001|COMPLETED|Treatment Phase||0
9922110|NCT01250119|11039355|FG000|NOT COMPLETED|Treatment Phase||0
9922111|NCT01250119|11039356|FG001|NOT COMPLETED|Treatment Phase||41
9922112|NCT01250145|11039365|FG000|STARTED|Overall Study||41
9922113|NCT01250145|11039366|FG001|STARTED|Overall Study||210
9922114|NCT01250145|11039365|FG000|COMPLETED|Overall Study||39
9922115|NCT01250145|11039366|FG001|COMPLETED|Overall Study||205
9922116|NCT01250145|11039365|FG000|NOT COMPLETED|Overall Study||2
9922117|NCT01250145|11039366|FG001|NOT COMPLETED|Overall Study||5
9922118|NCT01250171|11039389|FG000|STARTED|Overall Study||26
9922119|NCT01250171|11039390|FG001|STARTED|Overall Study||22
9922120|NCT01250171|11039391|FG002|STARTED|Overall Study||24
9922121|NCT01250171|11039389|FG000|COMPLETED|Overall Study||25
9922122|NCT01250171|11039390|FG001|COMPLETED|Overall Study||22
9922123|NCT01250171|11039391|FG002|COMPLETED|Overall Study||24
9922124|NCT01250171|11039389|FG000|NOT COMPLETED|Overall Study||1
9922125|NCT01250171|11039390|FG001|NOT COMPLETED|Overall Study||0
9922126|NCT01250171|11039391|FG002|NOT COMPLETED|Overall Study||0
9922127|NCT01250184|11039402|FG000|STARTED|Overall Study||43
9922128|NCT01250184|11039403|FG001|STARTED|Overall Study||41
9922129|NCT01250184|11039404|FG002|STARTED|Overall Study||43
9922130|NCT01250184|11039402|FG000|COMPLETED|Overall Study||43
9922131|NCT01250184|11039403|FG001|COMPLETED|Overall Study||41
9922132|NCT01250184|11039404|FG002|COMPLETED|Overall Study||43
9922133|NCT01250184|11039402|FG000|NOT COMPLETED|Overall Study||0
9922134|NCT01250184|11039403|FG001|NOT COMPLETED|Overall Study||0
9922135|NCT01250184|11039404|FG002|NOT COMPLETED|Overall Study||0
9922136|NCT01250210|11039415|FG000|STARTED|Overall Study||45
9922137|NCT01250210|11039416|FG001|STARTED|Overall Study||45
9922138|NCT01250210|11039417|FG002|STARTED|Overall Study||33
9922139|NCT01250210|11039415|FG000|COMPLETED|Overall Study||41
9922140|NCT01250210|11039416|FG001|COMPLETED|Overall Study||41
9922141|NCT01250210|11039417|FG002|COMPLETED|Overall Study||25
9922142|NCT01250210|11039415|FG000|NOT COMPLETED|Overall Study||4
9922143|NCT01250210|11039416|FG001|NOT COMPLETED|Overall Study||4
9922144|NCT01250210|11039417|FG002|NOT COMPLETED|Overall Study||8
9922145|NCT01250379|11039427|FG000|STARTED|Overall Study||247
9922146|NCT01250379|11039428|FG001|STARTED|Overall Study||247
9922147|NCT01250379|11039427|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
9922148|NCT01250379|11039428|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
9922149|NCT01250379|11039427|FG000|NOT COMPLETED|Overall Study||202
9922150|NCT01250379|11039428|FG001|NOT COMPLETED|Overall Study||193
9922151|NCT01250418|11039436|FG000|STARTED|Overall Study||9
9922152|NCT01250418|11039437|FG001|STARTED|Overall Study||16
9922153|NCT01250418|11039436|FG000|COMPLETED|Overall Study||8
9922154|NCT01250418|11039437|FG001|COMPLETED|Overall Study||15
9922155|NCT01250418|11039436|FG000|NOT COMPLETED|Overall Study||1
9922156|NCT01250418|11039437|FG001|NOT COMPLETED|Overall Study||1
9922157|NCT01250509|11039445|FG000|STARTED|Overall Study||24
9922158|NCT01250509|11039446|FG001|STARTED|Overall Study||23
9922159|NCT01250509|11039445|FG000|COMPLETED|Overall Study||19
9922160|NCT01250509|11039446|FG001|COMPLETED|Overall Study||21
9922161|NCT01250509|11039445|FG000|NOT COMPLETED|Overall Study||5
9922162|NCT01250509|11039446|FG001|NOT COMPLETED|Overall Study||2
9922163|NCT01250717|11039454|FG000|STARTED|Overall Study||28
9922164|NCT01250717|11039454|FG000|COMPLETED|Overall Study||28
9922165|NCT01250717|11039454|FG000|NOT COMPLETED|Overall Study||0
9922166|NCT01250730|11039461|FG000|STARTED|Overall Study||6
10010573|NCT01775189|11133364|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
10010574|NCT01775189|11133365|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
10010575|NCT01775189|11133366|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
10010576|NCT01775189|11133360|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9922167|NCT01250730|11039462|FG001|STARTED|Overall Study||6
9922168|NCT01250730|11039463|FG002|STARTED|Overall Study||6
9922169|NCT01250730|11039461|FG000|COMPLETED|Overall Study||6
9922170|NCT01250730|11039462|FG001|COMPLETED|Overall Study||6
9922171|NCT01250730|11039463|FG002|COMPLETED|Overall Study||6
9922172|NCT01250730|11039461|FG000|NOT COMPLETED|Overall Study||0
9922173|NCT01250730|11039462|FG001|NOT COMPLETED|Overall Study||0
9922174|NCT01250730|11039463|FG002|NOT COMPLETED|Overall Study||0
9922175|NCT01250756|11039473|FG000|STARTED|Infant Series||161
9922176|NCT01250756|11039474|FG001|STARTED|Infant Series||160
9922177|NCT01250756|11039473|FG000|Vaccinated Dose 1|Infant Series||159
9922178|NCT01250756|11039474|FG001|Vaccinated Dose 1|Infant Series||158
9922179|NCT01250756|11039473|FG000|Vaccinated Dose 2|Infant Series||147
9922180|NCT01250756|11039474|FG001|Vaccinated Dose 2|Infant Series||157
9922181|NCT01250756|11039473|FG000|Vaccinated Dose 3|Infant Series||133
9922182|NCT01250756|11039474|FG001|Vaccinated Dose 3|Infant Series||155
9922183|NCT01250756|11039473|FG000|COMPLETED|Infant Series||133
9922184|NCT01250756|11039474|FG001|COMPLETED|Infant Series||153
9922185|NCT01250756|11039473|FG000|NOT COMPLETED|Infant Series||28
9922186|NCT01250756|11039474|FG001|NOT COMPLETED|Infant Series||7
9922187|NCT01250756|11039473|FG000|STARTED|After Infant Series||133
9922188|NCT01250756|11039474|FG001|STARTED|After Infant Series||153
9922189|NCT01250756|11039473|FG000|COMPLETED|After Infant Series||122
9922190|NCT01250756|11039474|FG001|COMPLETED|After Infant Series||149
9922191|NCT01250756|11039473|FG000|NOT COMPLETED|After Infant Series||11
9922192|NCT01250756|11039474|FG001|NOT COMPLETED|After Infant Series||4
9922193|NCT01250756|11039473|FG000|STARTED|Toddler Dose||122
9922194|NCT01250756|11039474|FG001|STARTED|Toddler Dose||149
9922195|NCT01250756|11039473|FG000|COMPLETED|Toddler Dose||122
9922196|NCT01250756|11039474|FG001|COMPLETED|Toddler Dose||148
9922197|NCT01250756|11039473|FG000|NOT COMPLETED|Toddler Dose||0
9922198|NCT01250756|11039474|FG001|NOT COMPLETED|Toddler Dose||1
9922199|NCT01250756|11039473|FG000|STARTED|After Toddler Dose||0
9922200|NCT01250756|11039474|FG001|STARTED|After Toddler Dose||148
9922201|NCT01250756|11039473|FG000|COMPLETED|After Toddler Dose||0
9922202|NCT01250756|11039474|FG001|COMPLETED|After Toddler Dose||147
9922203|NCT01250756|11039473|FG000|NOT COMPLETED|After Toddler Dose||0
9922204|NCT01250756|11039474|FG001|NOT COMPLETED|After Toddler Dose||1
9922205|NCT01250769|11039490|FG000|STARTED|Overall Study||11
9922206|NCT01250769|11039491|FG001|STARTED|Overall Study||73
9922207|NCT01250769|11039492|FG002|STARTED|Overall Study||75
9922208|NCT01250769|11039493|FG003|STARTED|Overall Study||11
9922209|NCT01250769|11039490|FG000|Day 14|Overall Study||11
9922210|NCT01250769|11039491|FG001|Day 14|Overall Study||72
9922211|NCT01250769|11039492|FG002|Day 14|Overall Study||74
9922212|NCT01250769|11039493|FG003|Day 14|Overall Study||11
9922213|NCT01250769|11039490|FG000|COMPLETED|Overall Study||11
9922214|NCT01250769|11039491|FG001|COMPLETED|Overall Study||72
9922215|NCT01250769|11039492|FG002|COMPLETED|Overall Study||73
9922216|NCT01250769|11039493|FG003|COMPLETED|Overall Study||11
9922217|NCT01250769|11039490|FG000|NOT COMPLETED|Overall Study||0
9922218|NCT01250769|11039491|FG001|NOT COMPLETED|Overall Study||1
9922219|NCT01250769|11039492|FG002|NOT COMPLETED|Overall Study||2
9922220|NCT01250769|11039493|FG003|NOT COMPLETED|Overall Study||0
9922221|NCT01250834|11039503|FG000|STARTED|Overall Study||27
9922222|NCT01250834|11039503|FG000|COMPLETED|Overall Study||27
9922223|NCT01250834|11039503|FG000|NOT COMPLETED|Overall Study||0
9955882|NCT01440881|11074856|FG001|NOT COMPLETED|Overall Study||1
9955883|NCT01440920|11074866|FG000|STARTED|Overall Study||3
9955884|NCT01440920|11074867|FG001|STARTED|Overall Study||3
9955885|NCT01440920|11074868|FG002|STARTED|Overall Study||3
9955886|NCT01440920|11074866|FG000|COMPLETED|Overall Study||3
9955887|NCT01440920|11074867|FG001|COMPLETED|Overall Study||3
9955888|NCT01440920|11074868|FG002|COMPLETED|Overall Study||3
10205334|NCT03490942|11332136|FG002|STARTED|Overall Study||16
10205335|NCT03490942|11332134|FG000|COMPLETED|Overall Study||5
10205336|NCT03490942|11332135|FG001|COMPLETED|Overall Study||8
10205337|NCT03490942|11332136|FG002|COMPLETED|Overall Study||9
9955889|NCT01440920|11074866|FG000|NOT COMPLETED|Overall Study||0
9955890|NCT01440920|11074867|FG001|NOT COMPLETED|Overall Study||0
9955891|NCT01440920|11074868|FG002|NOT COMPLETED|Overall Study||0
9955892|NCT01440946|11074878|FG000|STARTED|Overall Study||15
9955893|NCT01440946|11074879|FG001|STARTED|Overall Study||15
9955894|NCT01440946|11074878|FG000|COMPLETED|Overall Study||13
10205338|NCT03490942|11332134|FG000|NOT COMPLETED|Overall Study||10
10205339|NCT03490942|11332135|FG001|NOT COMPLETED|Overall Study||10
9955895|NCT01440946|11074879|FG001|COMPLETED|Overall Study||14
10205340|NCT03490942|11332136|FG002|NOT COMPLETED|Overall Study||7
10205341|NCT03490981|11332146|FG000|STARTED|Overall Study||15
9955896|NCT01440946|11074878|FG000|NOT COMPLETED|Overall Study||2
9955897|NCT01440946|11074879|FG001|NOT COMPLETED|Overall Study||1
9955898|NCT01440959|11074886|FG000|STARTED|Overall Study||30
9955899|NCT01440959|11074886|FG000|COMPLETED|Overall Study||30
9955900|NCT01440959|11074886|FG000|NOT COMPLETED|Overall Study||0
9955901|NCT01440972|11074892|FG000|STARTED|Overall Study||24
9955902|NCT01440972|11074893|FG001|STARTED|Overall Study||21
9955903|NCT01440972|11074892|FG000|COMPLETED|Overall Study||21
9955904|NCT01440972|11074893|FG001|COMPLETED|Overall Study||19
10205342|NCT03490981|11332147|FG001|STARTED|Overall Study||15
9922224|NCT01250873|11039510|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20
9922225|NCT01250873|11039510|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
9922226|NCT01250873|11039510|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
9922227|NCT01250873|11039510|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
9922228|NCT01250873|11039510|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
9922229|NCT01250873|11039510|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
9922230|NCT01250873|11039510|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
9922231|NCT01250873|11039510|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
9922232|NCT01250873|11039510|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
9922233|NCT01250899|11039518|FG000|STARTED|Overall Study||40
9922234|NCT01250899|11039519|FG001|STARTED|Overall Study||82
9922235|NCT01250899|11039518|FG000|COMPLETED|Overall Study||40
9922236|NCT01250899|11039519|FG001|COMPLETED|Overall Study||82
9922237|NCT01250899|11039518|FG000|NOT COMPLETED|Overall Study||0
9922238|NCT01250899|11039519|FG001|NOT COMPLETED|Overall Study||0
9922239|NCT01250925|11039526|FG000|STARTED|Overall Study||31
9922240|NCT01250925|11039527|FG001|STARTED|Overall Study||31
9922241|NCT01250925|11039528|FG002|STARTED|Overall Study||32
9922242|NCT01250925|11039526|FG000|COMPLETED|Overall Study||26
9922243|NCT01250925|11039527|FG001|COMPLETED|Overall Study||28
9922244|NCT01250925|11039528|FG002|COMPLETED|Overall Study||30
9922245|NCT01250925|11039526|FG000|NOT COMPLETED|Overall Study||5
9922246|NCT01250925|11039527|FG001|NOT COMPLETED|Overall Study||3
9922247|NCT01250925|11039528|FG002|NOT COMPLETED|Overall Study||2
9922248|NCT01250977|11039538|FG000|STARTED|Overall Study||6
9922249|NCT01250977|11039539|FG001|STARTED|Overall Study||14
9922250|NCT01250977|11039538|FG000|COMPLETED|Overall Study||6
9922251|NCT01250977|11039539|FG001|COMPLETED|Overall Study||12
9922252|NCT01250977|11039538|FG000|NOT COMPLETED|Overall Study||0
9922253|NCT01250977|11039539|FG001|NOT COMPLETED|Overall Study||2
9922254|NCT01250990|11039547|FG000|STARTED|Overall Study||11
9922255|NCT01250990|11039548|FG001|STARTED|Overall Study||11
9922256|NCT01250990|11039547|FG000|COMPLETED|Overall Study||7
9922257|NCT01250990|11039548|FG001|COMPLETED|Overall Study||9
9922258|NCT01250990|11039547|FG000|NOT COMPLETED|Overall Study||4
9922259|NCT01250990|11039548|FG001|NOT COMPLETED|Overall Study||2
9922260|NCT01251042|11039556|FG000|STARTED|Overall Study||26
9922261|NCT01251042|11039557|FG001|STARTED|Overall Study||23
9922262|NCT01251042|11039556|FG000|COMPLETED|Overall Study||26
9922263|NCT01251042|11039557|FG001|COMPLETED|Overall Study||23
9922264|NCT01251042|11039556|FG000|NOT COMPLETED|Overall Study||0
9922265|NCT01251042|11039557|FG001|NOT COMPLETED|Overall Study||0
9922266|NCT01251146|11039565|FG000|STARTED|Overall Study||86
9922267|NCT01251146|11039566|FG001|STARTED|Overall Study||91
9922268|NCT01251146|11039565|FG000|COMPLETED|Overall Study||83
9922269|NCT01251146|11039566|FG001|COMPLETED|Overall Study||81
10111262|NCT02494596|11242323|FG001|COMPLETED|Overall Study||2
10111263|NCT02494596|11242324|FG002|COMPLETED|Overall Study||6
10111264|NCT02494596|11242322|FG000|NOT COMPLETED|Overall Study||3
10111265|NCT02494596|11242323|FG001|NOT COMPLETED|Overall Study||5
10111266|NCT02494596|11242324|FG002|NOT COMPLETED|Overall Study||1
10111267|NCT02494713|11242335|FG000|STARTED|Overall Study||4
10111268|NCT02494713|11242335|FG000|COMPLETED|Overall Study||4
10111269|NCT02494713|11242335|FG000|NOT COMPLETED|Overall Study||0
10111270|NCT02494778|11242339|FG000|STARTED|Overall Study||248
10111271|NCT02494778|11242339|FG000|COMPLETED|Overall Study||27
10111272|NCT02494778|11242339|FG000|NOT COMPLETED|Overall Study||221
10111273|NCT02494817|11242345|FG000|STARTED|Overall Study|representing 81 couples|162
10111274|NCT02494817|11242346|FG001|STARTED|Overall Study|representing 68 couples|136
10111275|NCT02494817|11242345|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
10111276|NCT02494817|11242346|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
10111277|NCT02494817|11242345|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
10111278|NCT02494817|11242346|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
10111279|NCT02494817|11242345|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
10111280|NCT02494817|11242346|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
10111281|NCT02494817|11242345|FG000|NOT COMPLETED|Overall Study||55
10111282|NCT02494817|11242346|FG001|NOT COMPLETED|Overall Study||49
10111283|NCT02495025|11242354|FG000|STARTED|Overall Study||77
10111284|NCT02495025|11242355|FG001|STARTED|Overall Study||75
10111285|NCT02495025|11242354|FG000|COMPLETED|Overall Study||51
10111286|NCT02495025|11242355|FG001|COMPLETED|Overall Study||61
10111287|NCT02495025|11242354|FG000|NOT COMPLETED|Overall Study||26
10111288|NCT02495025|11242355|FG001|NOT COMPLETED|Overall Study||14
10111289|NCT02495038|11242364|FG000|STARTED|Overall Study||27
10111290|NCT02495038|11242365|FG001|STARTED|Overall Study||27
10111291|NCT02495038|11242366|FG002|STARTED|Overall Study||27
10111292|NCT02495038|11242364|FG000|COMPLETED|Overall Study||27
10111293|NCT02495038|11242365|FG001|COMPLETED|Overall Study||27
10111294|NCT02495038|11242366|FG002|COMPLETED|Overall Study||27
9922270|NCT01251146|11039565|FG000|NOT COMPLETED|Overall Study||3
9922271|NCT01251146|11039566|FG001|NOT COMPLETED|Overall Study||10
9922272|NCT01251276|11039574|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
9922273|NCT01251276|11039575|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
9922274|NCT01251276|11039574|FG000|Vaccinated|Overall Study||96
9922275|NCT01251276|11039575|FG001|Vaccinated|Overall Study||108
10111295|NCT02495038|11242364|FG000|NOT COMPLETED|Overall Study||0
10111296|NCT02495038|11242365|FG001|NOT COMPLETED|Overall Study||0
10111297|NCT02495038|11242366|FG002|NOT COMPLETED|Overall Study||0
10111298|NCT02495103|11242376|FG000|STARTED|Overall Study||3
10111299|NCT02495103|11242377|FG001|STARTED|Overall Study||4
10111300|NCT02495103|11242376|FG000|COMPLETED|Overall Study||3
10111301|NCT02495103|11242377|FG001|COMPLETED|Overall Study||4
10111302|NCT02495103|11242376|FG000|NOT COMPLETED|Overall Study||0
10111303|NCT02495103|11242377|FG001|NOT COMPLETED|Overall Study||0
10111304|NCT02495168|11242388|FG000|STARTED|Overall Study||504
10111305|NCT02495168|11242389|FG001|STARTED|Overall Study||516
10111306|NCT02495168|11242390|FG002|STARTED|Overall Study||127
10111307|NCT02495168|11242388|FG000|Safety Population|Overall Study||501
10111308|NCT02495168|11242389|FG001|Safety Population|Overall Study||514
10111309|NCT02495168|11242390|FG002|Safety Population|Overall Study||126
10111310|NCT02495168|11242388|FG000|Modified Intent-to-Treat Population|Overall Study||468
10111311|NCT02495168|11242389|FG001|Modified Intent-to-Treat Population|Overall Study||478
10111312|NCT02495168|11242390|FG002|Modified Intent-to-Treat Population|Overall Study||111
10111313|NCT02495168|11242388|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
10111314|NCT02495168|11242389|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
10111315|NCT02495168|11242390|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
10111316|NCT02495168|11242388|FG000|Day 42 (D42PPS) Population|Overall Study||382
10111317|NCT02495168|11242389|FG001|Day 42 (D42PPS) Population|Overall Study||383
10111318|NCT02495168|11242390|FG002|Day 42 (D42PPS) Population|Overall Study||88
10111319|NCT02495168|11242388|FG000|COMPLETED|Overall Study||466
10111320|NCT02495168|11242389|FG001|COMPLETED|Overall Study||462
10111321|NCT02495168|11242390|FG002|COMPLETED|Overall Study||110
10111322|NCT02495168|11242388|FG000|NOT COMPLETED|Overall Study||38
10111323|NCT02495168|11242389|FG001|NOT COMPLETED|Overall Study||54
10111324|NCT02495168|11242390|FG002|NOT COMPLETED|Overall Study||17
10111325|NCT02495233|11242400|FG000|STARTED|Overall Study||3
10111326|NCT02495233|11242401|FG001|STARTED|Overall Study||7
10111327|NCT02495233|11242400|FG000|COMPLETED|Overall Study||3
10111328|NCT02495233|11242401|FG001|COMPLETED|Overall Study||6
10111329|NCT02495233|11242400|FG000|NOT COMPLETED|Overall Study||0
10111330|NCT02495233|11242401|FG001|NOT COMPLETED|Overall Study||1
10111331|NCT02495259|11242410|FG000|STARTED|Overall Study||7
10205343|NCT03490981|11332146|FG000|COMPLETED|Overall Study||14
10205344|NCT03490981|11332147|FG001|COMPLETED|Overall Study||13
10205345|NCT03490981|11332146|FG000|NOT COMPLETED|Overall Study||1
10205346|NCT03490981|11332147|FG001|NOT COMPLETED|Overall Study||2
10205347|NCT03491150|11332155|FG000|STARTED|Overall Study||76
10205348|NCT03491150|11332156|FG001|STARTED|Overall Study||73
10205349|NCT03491150|11332155|FG000|COMPLETED|Overall Study||0
10205350|NCT03491150|11332156|FG001|COMPLETED|Overall Study||0
10205351|NCT03491150|11332155|FG000|NOT COMPLETED|Overall Study||76
10205352|NCT03491150|11332156|FG001|NOT COMPLETED|Overall Study||73
10205353|NCT03491228|11332162|FG000|STARTED|Overall Study||107
10205354|NCT03491228|11332162|FG000|COMPLETED|Overall Study||107
10205355|NCT03491228|11332162|FG000|NOT COMPLETED|Overall Study||0
10111332|NCT02495259|11242411|FG001|STARTED|Overall Study||4
10111333|NCT02495259|11242412|FG002|STARTED|Overall Study||8
10111334|NCT02495259|11242410|FG000|COMPLETED|Overall Study||7
10111335|NCT02495259|11242411|FG001|COMPLETED|Overall Study||3
10111336|NCT02495259|11242412|FG002|COMPLETED|Overall Study||8
10111337|NCT02495259|11242410|FG000|NOT COMPLETED|Overall Study||0
10111338|NCT02495259|11242411|FG001|NOT COMPLETED|Overall Study||1
10111339|NCT02495259|11242412|FG002|NOT COMPLETED|Overall Study||0
10111340|NCT02495389|11242420|FG000|STARTED|Overall Study||84
10111341|NCT02495389|11242420|FG000|COMPLETED|Overall Study||44
10111342|NCT02495389|11242420|FG000|NOT COMPLETED|Overall Study||40
10111343|NCT02495454|11242424|FG000|STARTED|Overall Study||34
10111344|NCT02495454|11242424|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
10111345|NCT02495454|11242424|FG000|NOT COMPLETED|Overall Study||1
10111346|NCT02495467|11242431|FG000|STARTED|First Intervention (4 Weeks)||114
10111347|NCT02495467|11242432|FG001|STARTED|First Intervention (4 Weeks)||118
10111348|NCT02495467|11242431|FG000|COMPLETED|First Intervention (4 Weeks)||114
9922276|NCT01251276|11039574|FG000|COMPLETED|Overall Study||95
9922277|NCT01251276|11039575|FG001|COMPLETED|Overall Study||107
9922278|NCT01251276|11039574|FG000|NOT COMPLETED|Overall Study||1
9922279|NCT01251276|11039575|FG001|NOT COMPLETED|Overall Study||1
9922280|NCT01251315|11039587|FG000|STARTED|Overall Study||4
9922281|NCT01251315|11039588|FG001|STARTED|Overall Study||4
9922282|NCT01251315|11039589|FG002|STARTED|Overall Study||4
9922283|NCT01251315|11039590|FG003|STARTED|Overall Study||4
9922284|NCT01251315|11039591|FG004|STARTED|Overall Study||4
9922285|NCT01251315|11039592|FG005|STARTED|Overall Study||4
10111349|NCT02495467|11242432|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
10205356|NCT03491553|11332172|FG000|STARTED|Main Study (Up to Week 48)||9
10205357|NCT03491553|11332173|FG001|STARTED|Main Study (Up to Week 48)||10
10205358|NCT03491553|11332174|FG002|STARTED|Main Study (Up to Week 48)||10
10111350|NCT02495467|11242431|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10205359|NCT03491553|11332175|FG003|STARTED|Main Study (Up to Week 48)||10
10205360|NCT03491553|11332176|FG004|STARTED|Main Study (Up to Week 48)||5
9922286|NCT01251315|11039587|FG000|COMPLETED|Overall Study||4
9922287|NCT01251315|11039588|FG001|COMPLETED|Overall Study||4
9922288|NCT01251315|11039589|FG002|COMPLETED|Overall Study||4
9922289|NCT01251315|11039590|FG003|COMPLETED|Overall Study||4
9922290|NCT01251315|11039591|FG004|COMPLETED|Overall Study||4
9922291|NCT01251315|11039592|FG005|COMPLETED|Overall Study||4
9922292|NCT01251315|11039587|FG000|NOT COMPLETED|Overall Study||0
9922293|NCT01251315|11039588|FG001|NOT COMPLETED|Overall Study||0
9922294|NCT01251315|11039589|FG002|NOT COMPLETED|Overall Study||0
9922295|NCT01251315|11039590|FG003|NOT COMPLETED|Overall Study||0
9922296|NCT01251315|11039591|FG004|NOT COMPLETED|Overall Study||0
9922297|NCT01251315|11039592|FG005|NOT COMPLETED|Overall Study||0
9922298|NCT01251354|11039610|FG000|STARTED|Overall Study||6
9922299|NCT01251354|11039610|FG000|COMPLETED|Overall Study||0
9922300|NCT01251354|11039610|FG000|NOT COMPLETED|Overall Study||6
9922301|NCT01251367|11039614|FG000|STARTED|Overall Study||345
9922302|NCT01251367|11039614|FG000|Cycle 1|Overall Study||345
9922303|NCT01251367|11039614|FG000|Cycle 2|Overall Study||297
9922304|NCT01251367|11039614|FG000|Cycle 3|Overall Study||224
9922305|NCT01251367|11039614|FG000|Cycle 4|Overall Study||139
9922306|NCT01251367|11039614|FG000|COMPLETED|Overall Study||269
9922307|NCT01251367|11039614|FG000|NOT COMPLETED|Overall Study||76
9922308|NCT01251380|11039618|FG000|STARTED|Overall Study|Safety population.|216
9922309|NCT01251380|11039618|FG000|Cycle 1|Overall Study||207
9922310|NCT01251380|11039618|FG000|Cycle 2|Overall Study||175
9922311|NCT01251380|11039618|FG000|Cycle 3|Overall Study||86
9922312|NCT01251380|11039618|FG000|Cycle 4|Overall Study||11
10205361|NCT03491553|11332177|FG005|STARTED|Main Study (Up to Week 48)||4
10205362|NCT03491553|11332172|FG000|COMPLETED|Main Study (Up to Week 48)||8
10205363|NCT03491553|11332173|FG001|COMPLETED|Main Study (Up to Week 48)||9
10205364|NCT03491553|11332174|FG002|COMPLETED|Main Study (Up to Week 48)||10
10205365|NCT03491553|11332175|FG003|COMPLETED|Main Study (Up to Week 48)||9
10205366|NCT03491553|11332176|FG004|COMPLETED|Main Study (Up to Week 48)||5
10205367|NCT03491553|11332177|FG005|COMPLETED|Main Study (Up to Week 48)||4
10205368|NCT03491553|11332172|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1
10205369|NCT03491553|11332173|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1
10205370|NCT03491553|11332174|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0
10205371|NCT03491553|11332175|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1
9922313|NCT01251380|11039618|FG000|COMPLETED|Overall Study||194
9922314|NCT01251380|11039618|FG000|NOT COMPLETED|Overall Study||22
9922315|NCT01251393|11039629|FG000|STARTED|Overall Study||56
9922316|NCT01251393|11039630|FG001|STARTED|Overall Study||55
9922317|NCT01251393|11039629|FG000|COMPLETED|Overall Study||24
9922318|NCT01251393|11039630|FG001|COMPLETED|Overall Study||11
9922319|NCT01251393|11039629|FG000|NOT COMPLETED|Overall Study||32
9922320|NCT01251393|11039630|FG001|NOT COMPLETED|Overall Study||44
9922321|NCT01251536|11039639|FG000|STARTED|Overall Study||8
9922322|NCT01251536|11039640|FG001|STARTED|Overall Study||93
9922323|NCT01251536|11039641|FG002|STARTED|Overall Study||7
9922324|NCT01251536|11039639|FG000|COMPLETED|Overall Study||8
9922325|NCT01251536|11039640|FG001|COMPLETED|Overall Study||93
9922326|NCT01251536|11039641|FG002|COMPLETED|Overall Study||7
9922327|NCT01251536|11039639|FG000|NOT COMPLETED|Overall Study||0
9922328|NCT01251536|11039640|FG001|NOT COMPLETED|Overall Study||0
9922329|NCT01251536|11039641|FG002|NOT COMPLETED|Overall Study||0
9922330|NCT01251575|11039651|FG000|STARTED|Overall Study||77
9922331|NCT01251575|11039651|FG000|COMPLETED|Overall Study||76
9922332|NCT01251575|11039651|FG000|NOT COMPLETED|Overall Study||1
9922333|NCT01251588|11039659|FG000|STARTED|Overall Study||65
9922334|NCT01251588|11039660|FG001|STARTED|Overall Study||63
9922335|NCT01251588|11039659|FG000|COMPLETED|Overall Study||65
9922336|NCT01251588|11039660|FG001|COMPLETED|Overall Study||59
9922337|NCT01251588|11039659|FG000|NOT COMPLETED|Overall Study||0
9922338|NCT01251588|11039660|FG001|NOT COMPLETED|Overall Study||4
9922339|NCT01251614|11039671|FG000|STARTED|Overall Study||37
9922340|NCT01251614|11039672|FG001|STARTED|Overall Study||39
9922341|NCT01251614|11039673|FG002|STARTED|Overall Study||38
9922342|NCT01251614|11039671|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
9922343|NCT01251614|11039672|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
9922344|NCT01251614|11039673|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
9922345|NCT01251614|11039671|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
9922346|NCT01251614|11039672|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
9922347|NCT01251614|11039673|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
9922348|NCT01251614|11039671|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
9922349|NCT01251614|11039672|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
9922350|NCT01251614|11039673|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
9922351|NCT01251614|11039671|FG000|COMPLETED|Overall Study||34
9922352|NCT01251614|11039672|FG001|COMPLETED|Overall Study||26
10205372|NCT03491553|11332176|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0
10205373|NCT03491553|11332177|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0
10205374|NCT03491553|11332172|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10238741|NCT00484718|11370187|FG000|STARTED|Treatment Period 2 (2 Weeks)||1
9922353|NCT01251614|11039673|FG002|COMPLETED|Overall Study||30
9922354|NCT01251614|11039671|FG000|NOT COMPLETED|Overall Study||3
9922355|NCT01251614|11039672|FG001|NOT COMPLETED|Overall Study||13
9922356|NCT01251614|11039673|FG002|NOT COMPLETED|Overall Study||8
9922357|NCT01251653|11039700|FG000|STARTED|Overall Study||3
9922358|NCT01251653|11039701|FG001|STARTED|Overall Study||8
9922359|NCT01251653|11039702|FG002|STARTED|Overall Study||20
9922360|NCT01251653|11039703|FG003|STARTED|Overall Study||6
9922361|NCT01251653|11039704|FG004|STARTED|Overall Study||2
9922362|NCT01251653|11039705|FG005|STARTED|Overall Study||18
9922363|NCT01251653|11039706|FG006|STARTED|Overall Study||18
9922364|NCT01251653|11039707|FG007|STARTED|Overall Study||12
9922365|NCT01251653|11039708|FG008|STARTED|Overall Study||6
9922366|NCT01251653|11039700|FG000|COMPLETED|Overall Study||0
9922367|NCT01251653|11039701|FG001|COMPLETED|Overall Study||0
9922368|NCT01251653|11039702|FG002|COMPLETED|Overall Study||0
9922369|NCT01251653|11039703|FG003|COMPLETED|Overall Study||0
9922370|NCT01251653|11039704|FG004|COMPLETED|Overall Study||0
9922371|NCT01251653|11039705|FG005|COMPLETED|Overall Study||0
9922372|NCT01251653|11039706|FG006|COMPLETED|Overall Study||0
9922373|NCT01251653|11039707|FG007|COMPLETED|Overall Study||0
9922374|NCT01251653|11039708|FG008|COMPLETED|Overall Study||0
9922375|NCT01251653|11039700|FG000|NOT COMPLETED|Overall Study||3
9922376|NCT01251653|11039701|FG001|NOT COMPLETED|Overall Study||8
9922377|NCT01251653|11039702|FG002|NOT COMPLETED|Overall Study||20
9922378|NCT01251653|11039703|FG003|NOT COMPLETED|Overall Study||6
9922379|NCT01251653|11039704|FG004|NOT COMPLETED|Overall Study||2
9922380|NCT01251653|11039705|FG005|NOT COMPLETED|Overall Study||18
9922381|NCT01251653|11039706|FG006|NOT COMPLETED|Overall Study||18
9922382|NCT01251653|11039707|FG007|NOT COMPLETED|Overall Study||12
9922383|NCT01251653|11039708|FG008|NOT COMPLETED|Overall Study||6
9922384|NCT01251744|11039746|FG000|STARTED|Overall Study||77
9922385|NCT01251744|11039747|FG001|STARTED|Overall Study||78
9922386|NCT01251744|11039746|FG000|COMPLETED|Overall Study||76
9922387|NCT01251744|11039747|FG001|COMPLETED|Overall Study||78
9922388|NCT01251744|11039746|FG000|NOT COMPLETED|Overall Study||1
9922389|NCT01251744|11039747|FG001|NOT COMPLETED|Overall Study||0
9922390|NCT01251757|11039763|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
9922391|NCT01251757|11039764|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
9922392|NCT01251757|11039765|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
9922393|NCT01251757|11039763|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
9922394|NCT01251757|11039764|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
9922395|NCT01251757|11039765|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
9922396|NCT01251757|11039763|FG000|NOT COMPLETED|Overall Study||0
9922397|NCT01251757|11039764|FG001|NOT COMPLETED|Overall Study||0
9922398|NCT01251757|11039765|FG002|NOT COMPLETED|Overall Study||0
9922399|NCT01251770|11039779|FG000|STARTED|Overall Study||42
9922400|NCT01251770|11039780|FG001|STARTED|Overall Study||36
9922401|NCT01251770|11039779|FG000|COMPLETED|Overall Study||29
9922402|NCT01251770|11039780|FG001|COMPLETED|Overall Study||29
9922403|NCT01251770|11039779|FG000|NOT COMPLETED|Overall Study||13
9922404|NCT01251770|11039780|FG001|NOT COMPLETED|Overall Study||7
9922405|NCT01251887|11039789|FG000|STARTED|Overall Study||18
9922406|NCT01251887|11039790|FG001|STARTED|Overall Study||29
9922407|NCT01251887|11039791|FG002|STARTED|Overall Study||18
9922408|NCT01251887|11039789|FG000|COMPLETED|Overall Study||17
9922409|NCT01251887|11039790|FG001|COMPLETED|Overall Study||26
9922410|NCT01251887|11039791|FG002|COMPLETED|Overall Study||16
9922411|NCT01251887|11039789|FG000|NOT COMPLETED|Overall Study||1
9922412|NCT01251887|11039790|FG001|NOT COMPLETED|Overall Study||3
9922413|NCT01251887|11039791|FG002|NOT COMPLETED|Overall Study||2
9922414|NCT01251965|11039802|FG000|STARTED|Overall Study||4
9922415|NCT01251965|11039803|FG001|STARTED|Overall Study||5
9922416|NCT01251965|11039804|FG002|STARTED|Overall Study||18
9922417|NCT01251965|11039802|FG000|COMPLETED|Overall Study||3
9922418|NCT01251965|11039803|FG001|COMPLETED|Overall Study||3
9760531|NCT00381797|10864235|FG002|COMPLETED|Overall Study||10
9760532|NCT00381797|10864236|FG003|COMPLETED|Overall Study||14
9760533|NCT00381797|10864237|FG004|COMPLETED|Overall Study||35
9760534|NCT00381797|10864233|FG000|NOT COMPLETED|Overall Study||1
9922419|NCT01251965|11039804|FG002|COMPLETED|Overall Study||7
9922420|NCT01251965|11039802|FG000|NOT COMPLETED|Overall Study||1
9922421|NCT01251965|11039803|FG001|NOT COMPLETED|Overall Study||2
9922422|NCT01251965|11039804|FG002|NOT COMPLETED|Overall Study||11
9922423|NCT01251978|11039815|FG000|STARTED|Overall Study||5
9922424|NCT01251978|11039816|FG001|STARTED|Overall Study||3
9922425|NCT01251978|11039815|FG000|COMPLETED|Overall Study||5
10010577|NCT01775189|11133361|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
10010578|NCT01775189|11133362|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9922426|NCT01251978|11039816|FG001|COMPLETED|Overall Study||3
9922427|NCT01251978|11039815|FG000|NOT COMPLETED|Overall Study||0
9922428|NCT01251978|11039816|FG001|NOT COMPLETED|Overall Study||0
9922429|NCT01252095|11039824|FG000|STARTED|Overall Study||3
9922430|NCT01252095|11039825|FG001|STARTED|Overall Study||1
9922431|NCT01252095|11039824|FG000|COMPLETED|Overall Study||2
10010579|NCT01775189|11133363|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10010580|NCT01775189|11133364|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9760535|NCT00381797|10864234|FG001|NOT COMPLETED|Overall Study||1
9922432|NCT01252095|11039825|FG001|COMPLETED|Overall Study||1
9922433|NCT01252095|11039824|FG000|NOT COMPLETED|Overall Study||1
9922434|NCT01252095|11039825|FG001|NOT COMPLETED|Overall Study||0
9922435|NCT01252134|11039831|FG000|STARTED|Period 1, 8 Hours||3
9922436|NCT01252134|11039832|FG001|STARTED|Period 1, 8 Hours||4
9922437|NCT01252134|11039833|FG002|STARTED|Period 1, 8 Hours||3
9922438|NCT01252134|11039834|FG003|STARTED|Period 1, 8 Hours||5
9922439|NCT01252134|11039835|FG004|STARTED|Period 1, 8 Hours||3
9922440|NCT01252134|11039836|FG005|STARTED|Period 1, 8 Hours||4
9922441|NCT01252134|11039831|FG000|COMPLETED|Period 1, 8 Hours||3
9922442|NCT01252134|11039832|FG001|COMPLETED|Period 1, 8 Hours||3
9922443|NCT01252134|11039833|FG002|COMPLETED|Period 1, 8 Hours||2
9922444|NCT01252134|11039834|FG003|COMPLETED|Period 1, 8 Hours||5
9922445|NCT01252134|11039835|FG004|COMPLETED|Period 1, 8 Hours||3
9922446|NCT01252134|11039836|FG005|COMPLETED|Period 1, 8 Hours||4
9922447|NCT01252134|11039831|FG000|NOT COMPLETED|Period 1, 8 Hours||0
9922448|NCT01252134|11039832|FG001|NOT COMPLETED|Period 1, 8 Hours||1
9922449|NCT01252134|11039833|FG002|NOT COMPLETED|Period 1, 8 Hours||1
9922450|NCT01252134|11039834|FG003|NOT COMPLETED|Period 1, 8 Hours||0
9922451|NCT01252134|11039835|FG004|NOT COMPLETED|Period 1, 8 Hours||0
9922452|NCT01252134|11039836|FG005|NOT COMPLETED|Period 1, 8 Hours||0
9922453|NCT01252134|11039831|FG000|STARTED|Period 2, 8 Hours||3
9922454|NCT01252134|11039832|FG001|STARTED|Period 2, 8 Hours||3
9922455|NCT01252134|11039833|FG002|STARTED|Period 2, 8 Hours||2
9922456|NCT01252134|11039834|FG003|STARTED|Period 2, 8 Hours||5
9922457|NCT01252134|11039835|FG004|STARTED|Period 2, 8 Hours||3
9922458|NCT01252134|11039836|FG005|STARTED|Period 2, 8 Hours||4
9922459|NCT01252134|11039831|FG000|COMPLETED|Period 2, 8 Hours||3
9922460|NCT01252134|11039832|FG001|COMPLETED|Period 2, 8 Hours||3
9922461|NCT01252134|11039833|FG002|COMPLETED|Period 2, 8 Hours||2
9922462|NCT01252134|11039834|FG003|COMPLETED|Period 2, 8 Hours||5
9922463|NCT01252134|11039835|FG004|COMPLETED|Period 2, 8 Hours||3
9922464|NCT01252134|11039836|FG005|COMPLETED|Period 2, 8 Hours||4
9922465|NCT01252134|11039831|FG000|NOT COMPLETED|Period 2, 8 Hours||0
9922466|NCT01252134|11039832|FG001|NOT COMPLETED|Period 2, 8 Hours||0
9922467|NCT01252134|11039833|FG002|NOT COMPLETED|Period 2, 8 Hours||0
9922468|NCT01252134|11039834|FG003|NOT COMPLETED|Period 2, 8 Hours||0
9922469|NCT01252134|11039835|FG004|NOT COMPLETED|Period 2, 8 Hours||0
9922470|NCT01252134|11039836|FG005|NOT COMPLETED|Period 2, 8 Hours||0
9922471|NCT01252134|11039831|FG000|STARTED|Period 3, 8 Hours||3
9922472|NCT01252134|11039832|FG001|STARTED|Period 3, 8 Hours||3
9922473|NCT01252134|11039833|FG002|STARTED|Period 3, 8 Hours||2
9922474|NCT01252134|11039834|FG003|STARTED|Period 3, 8 Hours||5
9922475|NCT01252134|11039835|FG004|STARTED|Period 3, 8 Hours||3
9922476|NCT01252134|11039836|FG005|STARTED|Period 3, 8 Hours||4
9922477|NCT01252134|11039831|FG000|COMPLETED|Period 3, 8 Hours||3
9922478|NCT01252134|11039832|FG001|COMPLETED|Period 3, 8 Hours||3
9922479|NCT01252134|11039833|FG002|COMPLETED|Period 3, 8 Hours||2
9922480|NCT01252134|11039834|FG003|COMPLETED|Period 3, 8 Hours||5
9922481|NCT01252134|11039835|FG004|COMPLETED|Period 3, 8 Hours||3
9922482|NCT01252134|11039836|FG005|COMPLETED|Period 3, 8 Hours||4
9922483|NCT01252134|11039831|FG000|NOT COMPLETED|Period 3, 8 Hours||0
9922484|NCT01252134|11039832|FG001|NOT COMPLETED|Period 3, 8 Hours||0
9922485|NCT01252134|11039833|FG002|NOT COMPLETED|Period 3, 8 Hours||0
9922486|NCT01252134|11039834|FG003|NOT COMPLETED|Period 3, 8 Hours||0
9922487|NCT01252134|11039835|FG004|NOT COMPLETED|Period 3, 8 Hours||0
9922488|NCT01252134|11039836|FG005|NOT COMPLETED|Period 3, 8 Hours||0
9922489|NCT01252147|11039844|FG000|STARTED|Overall Study||68
9922490|NCT01252147|11039844|FG000|COMPLETED|Overall Study||68
9922491|NCT01252147|11039844|FG000|NOT COMPLETED|Overall Study||0
9922492|NCT01252186|11039851|FG000|STARTED|Overall Study||87
9922493|NCT01252186|11039852|FG001|STARTED|Overall Study||91
9922494|NCT01252186|11039853|FG002|STARTED|Overall Study||87
9922495|NCT01252186|11039851|FG000|Received Study Drug|Overall Study||83
9922496|NCT01252186|11039852|FG001|Received Study Drug|Overall Study||89
9922497|NCT01252186|11039853|FG002|Received Study Drug|Overall Study||80
9922498|NCT01252186|11039851|FG000|COMPLETED|Overall Study||57
9922499|NCT01252186|11039852|FG001|COMPLETED|Overall Study||59
9922500|NCT01252186|11039853|FG002|COMPLETED|Overall Study||53
9922501|NCT01252186|11039851|FG000|NOT COMPLETED|Overall Study||30
9922502|NCT01252186|11039852|FG001|NOT COMPLETED|Overall Study||32
9922503|NCT01252186|11039853|FG002|NOT COMPLETED|Overall Study||34
9922504|NCT01252238|11039864|FG000|STARTED|Overall Study||8
9922505|NCT01252238|11039865|FG001|STARTED|Overall Study||8
9922506|NCT01252238|11039866|FG002|STARTED|Overall Study||8
9922507|NCT01252238|11039864|FG000|COMPLETED|Overall Study|sponsor terminated study|4
9922508|NCT01252238|11039865|FG001|COMPLETED|Overall Study|sponsor terminated study|4
9922509|NCT01252238|11039866|FG002|COMPLETED|Overall Study|sponsor terminated study|4
9922510|NCT01252238|11039864|FG000|NOT COMPLETED|Overall Study||4
9922511|NCT01252238|11039865|FG001|NOT COMPLETED|Overall Study||4
9922512|NCT01252238|11039866|FG002|NOT COMPLETED|Overall Study||4
9922513|NCT01252251|11039877|FG000|STARTED|Overall Study||14
9922514|NCT01252251|11039877|FG000|COMPLETED|Overall Study||13
9922515|NCT01252251|11039877|FG000|NOT COMPLETED|Overall Study||1
9922516|NCT01252277|11039881|FG000|STARTED|Overall Study||36
9922517|NCT01252277|11039881|FG000|COMPLETED|Overall Study||34
9922518|NCT01252277|11039881|FG000|NOT COMPLETED|Overall Study||2
9922519|NCT01252290|11039886|FG000|STARTED|Overall Study||35
9922520|NCT01252290|11039886|FG000|COMPLETED|Overall Study||34
9922521|NCT01252290|11039886|FG000|NOT COMPLETED|Overall Study||1
9922522|NCT01252355|11039893|FG000|STARTED|Overall Study|Randomized.|177
9922523|NCT01252355|11039894|FG001|STARTED|Overall Study|Randomized.|178
9922524|NCT01252355|11039895|FG002|STARTED|Overall Study|Randomized.|179
9922525|NCT01252355|11039893|FG000|Treated|Overall Study||175
9922526|NCT01252355|11039894|FG001|Treated|Overall Study||178
9922527|NCT01252355|11039895|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
9922528|NCT01252355|11039893|FG000|COMPLETED|Overall Study||0
9922529|NCT01252355|11039894|FG001|COMPLETED|Overall Study||0
9922530|NCT01252355|11039895|FG002|COMPLETED|Overall Study||0
9922531|NCT01252355|11039893|FG000|NOT COMPLETED|Overall Study||177
9922532|NCT01252355|11039894|FG001|NOT COMPLETED|Overall Study||178
9922533|NCT01252355|11039895|FG002|NOT COMPLETED|Overall Study||179
9922534|NCT01252563|11039903|FG000|STARTED|Overall Study||13775
9922535|NCT01252563|11039903|FG000|COMPLETED|Overall Study||13343
9922536|NCT01252563|11039903|FG000|NOT COMPLETED|Overall Study||432
9922537|NCT01252667|11039944|FG000|STARTED|Overall Study||3
9922538|NCT01252667|11039945|FG001|STARTED|Overall Study||3
9922539|NCT01252667|11039946|FG002|STARTED|Overall Study||3
9922540|NCT01252667|11039947|FG003|STARTED|Overall Study||0
9922541|NCT01252667|11039948|FG004|STARTED|Overall Study||0
9922542|NCT01252667|11039949|FG005|STARTED|Overall Study||35
9922543|NCT01252667|11039944|FG000|COMPLETED|Overall Study||3
9922544|NCT01252667|11039945|FG001|COMPLETED|Overall Study||3
9922545|NCT01252667|11039946|FG002|COMPLETED|Overall Study||3
9922546|NCT01252667|11039947|FG003|COMPLETED|Overall Study||0
9922547|NCT01252667|11039948|FG004|COMPLETED|Overall Study||0
9922548|NCT01252667|11039949|FG005|COMPLETED|Overall Study||34
9922549|NCT01252667|11039944|FG000|NOT COMPLETED|Overall Study||0
9922550|NCT01252667|11039945|FG001|NOT COMPLETED|Overall Study||0
9922551|NCT01252667|11039946|FG002|NOT COMPLETED|Overall Study||0
9922552|NCT01252667|11039947|FG003|NOT COMPLETED|Overall Study||0
9922553|NCT01252667|11039948|FG004|NOT COMPLETED|Overall Study||0
9922554|NCT01252667|11039949|FG005|NOT COMPLETED|Overall Study||1
9922555|NCT01252732|11039965|FG000|STARTED|Overall Study|Randomized|509
9922556|NCT01252732|11039966|FG001|STARTED|Overall Study|Randomized|510
9922557|NCT01252732|11039965|FG000|Modified Intent to Treat Population|Overall Study||503
9922558|NCT01252732|11039966|FG001|Modified Intent to Treat Population|Overall Study||502
9922559|NCT01252732|11039965|FG000|COMPLETED|Overall Study||455
9922560|NCT01252732|11039966|FG001|COMPLETED|Overall Study||446
9922561|NCT01252732|11039965|FG000|NOT COMPLETED|Overall Study||54
9922562|NCT01252732|11039966|FG001|NOT COMPLETED|Overall Study||64
9922563|NCT01252745|11039975|FG000|STARTED|Overall Study||8
9922564|NCT01252745|11039976|FG001|STARTED|Overall Study||7
9922565|NCT01252745|11039977|FG002|STARTED|Overall Study||7
9922566|NCT01252745|11039975|FG000|COMPLETED|Overall Study||8
9922567|NCT01252745|11039976|FG001|COMPLETED|Overall Study||7
9922568|NCT01252745|11039977|FG002|COMPLETED|Overall Study||7
9922569|NCT01252745|11039975|FG000|NOT COMPLETED|Overall Study||0
9922570|NCT01252745|11039976|FG001|NOT COMPLETED|Overall Study||0
9922571|NCT01252745|11039977|FG002|NOT COMPLETED|Overall Study||0
9922572|NCT01252810|11039990|FG000|STARTED|Overall Study||142
9922573|NCT01252810|11039991|FG001|STARTED|Overall Study||142
9922574|NCT01252810|11039990|FG000|COMPLETED|Overall Study||128
9922575|NCT01252810|11039991|FG001|COMPLETED|Overall Study||139
9922576|NCT01252810|11039990|FG000|NOT COMPLETED|Overall Study||14
9922577|NCT01252810|11039991|FG001|NOT COMPLETED|Overall Study||3
9922578|NCT01252940|11039999|FG000|STARTED|Main Study Phase||321
9922579|NCT01252940|11040000|FG001|STARTED|Main Study Phase||161
9922580|NCT01252940|11039999|FG000|Completed 24 Weeks|Main Study Phase||0
9922581|NCT01252940|11040000|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
9922582|NCT01252940|11039999|FG000|COMPLETED|Main Study Phase||295
9922583|NCT01252940|11040000|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
9922584|NCT01252940|11039999|FG000|NOT COMPLETED|Main Study Phase||26
9922585|NCT01252940|11040000|FG001|NOT COMPLETED|Main Study Phase||12
9922586|NCT01252940|11039999|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
9922587|NCT01252940|11040000|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
9922588|NCT01252940|11039999|FG000|COMPLETED|Extension Phase||100
9922589|NCT01252940|11040000|FG001|COMPLETED|Extension Phase||46
9922590|NCT01252940|11039999|FG000|NOT COMPLETED|Extension Phase||10
9922591|NCT01252940|11040000|FG001|NOT COMPLETED|Extension Phase||3
9922592|NCT01252966|11040009|FG000|STARTED|Overall Study||108
9922593|NCT01252966|11040010|FG001|STARTED|Overall Study||105
9922594|NCT01252966|11040009|FG000|COMPLETED|Overall Study||85
9922595|NCT01252966|11040010|FG001|COMPLETED|Overall Study||92
9922596|NCT01252966|11040009|FG000|NOT COMPLETED|Overall Study||23
9922597|NCT01252966|11040010|FG001|NOT COMPLETED|Overall Study||13
9922598|NCT01253018|11040020|FG000|STARTED|Overall Study||22
9922599|NCT01253018|11040021|FG001|STARTED|Overall Study||23
9922600|NCT01253018|11040020|FG000|COMPLETED|Overall Study||18
9922601|NCT01253018|11040021|FG001|COMPLETED|Overall Study||21
9922602|NCT01253018|11040020|FG000|NOT COMPLETED|Overall Study||4
9922603|NCT01253018|11040021|FG001|NOT COMPLETED|Overall Study||2
9922604|NCT01253044|11040030|FG000|STARTED|Overall Study||80
9922605|NCT01253044|11040031|FG001|STARTED|Overall Study||80
9922606|NCT01253044|11040030|FG000|COMPLETED|Overall Study||42
9922607|NCT01253044|11040031|FG001|COMPLETED|Overall Study||51
9922608|NCT01253044|11040030|FG000|NOT COMPLETED|Overall Study||38
9922609|NCT01253044|11040031|FG001|NOT COMPLETED|Overall Study||29
9922610|NCT01253135|11040037|FG000|STARTED|Original Protocol||15
9922611|NCT01253135|11040037|FG000|COMPLETED|Original Protocol||0
9922612|NCT01253135|11040037|FG000|NOT COMPLETED|Original Protocol||15
9922613|NCT01253135|11040037|FG000|STARTED|Amended Protocol||25
9922614|NCT01253135|11040037|FG000|COMPLETED|Amended Protocol||24
9922615|NCT01253135|11040037|FG000|NOT COMPLETED|Amended Protocol||1
9922616|NCT01253148|11040045|FG000|STARTED|Overall Study||25
9922617|NCT01253148|11040045|FG000|COMPLETED|Overall Study||25
9922618|NCT01253148|11040045|FG000|NOT COMPLETED|Overall Study||0
9922619|NCT01253174|11040049|FG000|STARTED|Period 1||6
9922620|NCT01253174|11040050|FG001|STARTED|Period 1||10
9922621|NCT01253174|11040051|FG002|STARTED|Period 1||9
9922622|NCT01253174|11040052|FG003|STARTED|Period 1||7
9922623|NCT01253174|11040053|FG004|STARTED|Period 1||9
9922624|NCT01253174|11040054|FG005|STARTED|Period 1||7
9922625|NCT01253174|11040049|FG000|COMPLETED|Period 1||6
9922626|NCT01253174|11040050|FG001|COMPLETED|Period 1||9
9922627|NCT01253174|11040051|FG002|COMPLETED|Period 1||8
9922628|NCT01253174|11040052|FG003|COMPLETED|Period 1||7
9922629|NCT01253174|11040053|FG004|COMPLETED|Period 1||8
9922630|NCT01253174|11040054|FG005|COMPLETED|Period 1||7
9922631|NCT01253174|11040049|FG000|NOT COMPLETED|Period 1||0
9922632|NCT01253174|11040050|FG001|NOT COMPLETED|Period 1||1
9922633|NCT01253174|11040051|FG002|NOT COMPLETED|Period 1||1
9922634|NCT01253174|11040052|FG003|NOT COMPLETED|Period 1||0
9922635|NCT01253174|11040053|FG004|NOT COMPLETED|Period 1||1
9922636|NCT01253174|11040054|FG005|NOT COMPLETED|Period 1||0
9922637|NCT01253174|11040049|FG000|STARTED|Period 2||6
9922638|NCT01253174|11040050|FG001|STARTED|Period 2||9
9922639|NCT01253174|11040051|FG002|STARTED|Period 2||8
9922640|NCT01253174|11040052|FG003|STARTED|Period 2||7
9922641|NCT01253174|11040053|FG004|STARTED|Period 2||8
9922642|NCT01253174|11040054|FG005|STARTED|Period 2||7
9922643|NCT01253174|11040049|FG000|COMPLETED|Period 2||6
9922644|NCT01253174|11040050|FG001|COMPLETED|Period 2||9
9922645|NCT01253174|11040051|FG002|COMPLETED|Period 2||7
9922646|NCT01253174|11040052|FG003|COMPLETED|Period 2||7
9922647|NCT01253174|11040053|FG004|COMPLETED|Period 2||8
10010581|NCT01775189|11133365|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10010582|NCT01775189|11133366|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10010583|NCT01775189|11133360|FG000|STARTED|Drug Discrimination Phase: Day 2||0
10010584|NCT01775189|11133361|FG001|STARTED|Drug Discrimination Phase: Day 2||19
10010585|NCT01775189|11133362|FG002|STARTED|Drug Discrimination Phase: Day 2||23
10010586|NCT01775189|11133363|FG003|STARTED|Drug Discrimination Phase: Day 2||0
9922648|NCT01253174|11040054|FG005|COMPLETED|Period 2||7
9922649|NCT01253174|11040049|FG000|NOT COMPLETED|Period 2||0
9922650|NCT01253174|11040050|FG001|NOT COMPLETED|Period 2||0
9922651|NCT01253174|11040051|FG002|NOT COMPLETED|Period 2||1
9922652|NCT01253174|11040052|FG003|NOT COMPLETED|Period 2||0
9922653|NCT01253174|11040053|FG004|NOT COMPLETED|Period 2||0
9922654|NCT01253174|11040054|FG005|NOT COMPLETED|Period 2||0
9922655|NCT01253174|11040049|FG000|STARTED|Period 3||6
9922656|NCT01253174|11040050|FG001|STARTED|Period 3||9
9922657|NCT01253174|11040051|FG002|STARTED|Period 3||7
9922658|NCT01253174|11040052|FG003|STARTED|Period 3||7
9922659|NCT01253174|11040053|FG004|STARTED|Period 3||8
9922660|NCT01253174|11040054|FG005|STARTED|Period 3||7
9922661|NCT01253174|11040049|FG000|COMPLETED|Period 3||6
9922662|NCT01253174|11040050|FG001|COMPLETED|Period 3||8
9922663|NCT01253174|11040051|FG002|COMPLETED|Period 3||6
9922664|NCT01253174|11040052|FG003|COMPLETED|Period 3||7
9922665|NCT01253174|11040053|FG004|COMPLETED|Period 3||7
9922666|NCT01253174|11040054|FG005|COMPLETED|Period 3||7
9922667|NCT01253174|11040049|FG000|NOT COMPLETED|Period 3||0
9922668|NCT01253174|11040050|FG001|NOT COMPLETED|Period 3||1
9922669|NCT01253174|11040051|FG002|NOT COMPLETED|Period 3||1
9922670|NCT01253174|11040052|FG003|NOT COMPLETED|Period 3||0
9922671|NCT01253174|11040053|FG004|NOT COMPLETED|Period 3||1
9922672|NCT01253174|11040054|FG005|NOT COMPLETED|Period 3||0
9922673|NCT01253187|11040063|FG000|STARTED|Period 1||7
9922674|NCT01253187|11040064|FG001|STARTED|Period 1||8
9922675|NCT01253187|11040065|FG002|STARTED|Period 1||7
9922676|NCT01253187|11040066|FG003|STARTED|Period 1||7
9922677|NCT01253187|11040067|FG004|STARTED|Period 1||9
9922678|NCT01253187|11040068|FG005|STARTED|Period 1||6
9922679|NCT01253187|11040063|FG000|COMPLETED|Period 1||7
9922680|NCT01253187|11040064|FG001|COMPLETED|Period 1||8
9922681|NCT01253187|11040065|FG002|COMPLETED|Period 1||7
9922682|NCT01253187|11040066|FG003|COMPLETED|Period 1||7
9922683|NCT01253187|11040067|FG004|COMPLETED|Period 1||9
9922684|NCT01253187|11040068|FG005|COMPLETED|Period 1||6
9922685|NCT01253187|11040063|FG000|NOT COMPLETED|Period 1||0
9922686|NCT01253187|11040064|FG001|NOT COMPLETED|Period 1||0
9922687|NCT01253187|11040065|FG002|NOT COMPLETED|Period 1||0
9922688|NCT01253187|11040066|FG003|NOT COMPLETED|Period 1||0
9922689|NCT01253187|11040067|FG004|NOT COMPLETED|Period 1||0
9922690|NCT01253187|11040068|FG005|NOT COMPLETED|Period 1||0
9922691|NCT01253187|11040063|FG000|STARTED|Period 2||7
9922692|NCT01253187|11040064|FG001|STARTED|Period 2||8
9922693|NCT01253187|11040065|FG002|STARTED|Period 2||7
9922694|NCT01253187|11040066|FG003|STARTED|Period 2||7
9922695|NCT01253187|11040067|FG004|STARTED|Period 2||9
9922696|NCT01253187|11040068|FG005|STARTED|Period 2||6
10010587|NCT01775189|11133364|FG004|STARTED|Drug Discrimination Phase: Day 2||0
10010588|NCT01775189|11133365|FG005|STARTED|Drug Discrimination Phase: Day 2||0
10010589|NCT01775189|11133366|FG006|STARTED|Drug Discrimination Phase: Day 2||0
10010590|NCT01775189|11133360|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
10010591|NCT01775189|11133361|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16
10010592|NCT01775189|11133362|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
10010593|NCT01775189|11133363|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
10010594|NCT01775189|11133364|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
10010595|NCT01775189|11133365|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
10010596|NCT01775189|11133366|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
10010597|NCT01775189|11133360|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10010598|NCT01775189|11133361|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
10010599|NCT01775189|11133362|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
10010600|NCT01775189|11133363|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10010601|NCT01775189|11133364|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10010602|NCT01775189|11133365|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10010603|NCT01775189|11133366|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10010604|NCT01775189|11133360|FG000|STARTED|Treatment Phase: First Intervention||0
10010605|NCT01775189|11133361|FG001|STARTED|Treatment Phase: First Intervention||0
10010606|NCT01775189|11133362|FG002|STARTED|Treatment Phase: First Intervention||0
10010607|NCT01775189|11133363|FG003|STARTED|Treatment Phase: First Intervention||8
10010608|NCT01775189|11133364|FG004|STARTED|Treatment Phase: First Intervention||8
10010609|NCT01775189|11133365|FG005|STARTED|Treatment Phase: First Intervention||8
10010610|NCT01775189|11133366|FG006|STARTED|Treatment Phase: First Intervention||8
10010611|NCT01775189|11133360|FG000|COMPLETED|Treatment Phase: First Intervention||0
10010612|NCT01775189|11133361|FG001|COMPLETED|Treatment Phase: First Intervention||0
9922697|NCT01253187|11040063|FG000|COMPLETED|Period 2||7
9922698|NCT01253187|11040064|FG001|COMPLETED|Period 2||8
9922699|NCT01253187|11040065|FG002|COMPLETED|Period 2||7
9922700|NCT01253187|11040066|FG003|COMPLETED|Period 2||7
9922701|NCT01253187|11040067|FG004|COMPLETED|Period 2||8
9922702|NCT01253187|11040068|FG005|COMPLETED|Period 2||6
9922703|NCT01253187|11040063|FG000|NOT COMPLETED|Period 2||0
9922704|NCT01253187|11040064|FG001|NOT COMPLETED|Period 2||0
9922705|NCT01253187|11040065|FG002|NOT COMPLETED|Period 2||0
9922706|NCT01253187|11040066|FG003|NOT COMPLETED|Period 2||0
9922707|NCT01253187|11040067|FG004|NOT COMPLETED|Period 2||1
9922708|NCT01253187|11040068|FG005|NOT COMPLETED|Period 2||0
9922709|NCT01253187|11040063|FG000|STARTED|Period 3||7
9922710|NCT01253187|11040064|FG001|STARTED|Period 3||8
9922711|NCT01253187|11040065|FG002|STARTED|Period 3||7
9922712|NCT01253187|11040066|FG003|STARTED|Period 3||7
9922713|NCT01253187|11040067|FG004|STARTED|Period 3||8
9922714|NCT01253187|11040068|FG005|STARTED|Period 3||6
9922715|NCT01253187|11040063|FG000|COMPLETED|Period 3||6
9922716|NCT01253187|11040064|FG001|COMPLETED|Period 3||7
9922717|NCT01253187|11040065|FG002|COMPLETED|Period 3||7
9922718|NCT01253187|11040066|FG003|COMPLETED|Period 3||7
9922719|NCT01253187|11040067|FG004|COMPLETED|Period 3||7
9922720|NCT01253187|11040068|FG005|COMPLETED|Period 3||6
9922721|NCT01253187|11040063|FG000|NOT COMPLETED|Period 3||1
9922722|NCT01253187|11040064|FG001|NOT COMPLETED|Period 3||1
9922723|NCT01253187|11040065|FG002|NOT COMPLETED|Period 3||0
9922724|NCT01253187|11040066|FG003|NOT COMPLETED|Period 3||0
9922725|NCT01253187|11040067|FG004|NOT COMPLETED|Period 3||1
9922726|NCT01253187|11040068|FG005|NOT COMPLETED|Period 3||0
9922727|NCT01253200|11040084|FG000|STARTED|Overall Study||125
9922728|NCT01253200|11040085|FG001|STARTED|Overall Study||125
9922729|NCT01253200|11040086|FG002|STARTED|Overall Study||30
9922730|NCT01253200|11040087|FG003|STARTED|Overall Study||17
9922731|NCT01253200|11040088|FG004|STARTED|Overall Study||5
9922732|NCT01253200|11040084|FG000|Procedure|Overall Study||109
9922733|NCT01253200|11040085|FG001|Procedure|Overall Study||111
9922734|NCT01253200|11040086|FG002|Procedure|Overall Study||28
9922735|NCT01253200|11040087|FG003|Procedure|Overall Study||12
9922736|NCT01253200|11040088|FG004|Procedure|Overall Study||0
9922737|NCT01253200|11040084|FG000|10 Day Follow-up|Overall Study||106
9922738|NCT01253200|11040085|FG001|10 Day Follow-up|Overall Study||111
9922739|NCT01253200|11040086|FG002|10 Day Follow-up|Overall Study||28
9922740|NCT01253200|11040087|FG003|10 Day Follow-up|Overall Study||12
9922741|NCT01253200|11040088|FG004|10 Day Follow-up|Overall Study||0
9922742|NCT01253200|11040084|FG000|3 Month Follow-up|Overall Study||104
9922743|NCT01253200|11040085|FG001|3 Month Follow-up|Overall Study||106
9922744|NCT01253200|11040086|FG002|3 Month Follow-up|Overall Study||28
9922745|NCT01253200|11040087|FG003|3 Month Follow-up|Overall Study||12
9922746|NCT01253200|11040088|FG004|3 Month Follow-up|Overall Study||0
9922747|NCT01253200|11040084|FG000|COMPLETED|Overall Study||104
9922748|NCT01253200|11040085|FG001|COMPLETED|Overall Study||106
9922749|NCT01253200|11040086|FG002|COMPLETED|Overall Study||28
9922750|NCT01253200|11040087|FG003|COMPLETED|Overall Study||12
9922751|NCT01253200|11040088|FG004|COMPLETED|Overall Study||0
9922752|NCT01253200|11040084|FG000|NOT COMPLETED|Overall Study||21
9922753|NCT01253200|11040085|FG001|NOT COMPLETED|Overall Study||19
9922754|NCT01253200|11040086|FG002|NOT COMPLETED|Overall Study||2
9922755|NCT01253200|11040087|FG003|NOT COMPLETED|Overall Study||5
9922756|NCT01253200|11040088|FG004|NOT COMPLETED|Overall Study||5
9922757|NCT01253226|11040102|FG000|STARTED|Overall Study||6
9922758|NCT01253226|11040103|FG001|STARTED|Overall Study||6
9922759|NCT01253226|11040104|FG002|STARTED|Overall Study||6
9922760|NCT01253226|11040105|FG003|STARTED|Overall Study||6
9922761|NCT01253226|11040106|FG004|STARTED|Overall Study||8
9922762|NCT01253226|11040102|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9922763|NCT01253226|11040103|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9922764|NCT01253226|11040104|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9922765|NCT01253226|11040105|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9922766|NCT01253226|11040106|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
9922767|NCT01253226|11040102|FG000|COMPLETED|Overall Study||6
9922768|NCT01253226|11040103|FG001|COMPLETED|Overall Study||5
9922769|NCT01253226|11040104|FG002|COMPLETED|Overall Study||5
9922770|NCT01253226|11040105|FG003|COMPLETED|Overall Study||5
10205375|NCT03491553|11332173|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
9922771|NCT01253226|11040106|FG004|COMPLETED|Overall Study||6
9922772|NCT01253226|11040102|FG000|NOT COMPLETED|Overall Study||0
9922773|NCT01253226|11040103|FG001|NOT COMPLETED|Overall Study||1
9922774|NCT01253226|11040104|FG002|NOT COMPLETED|Overall Study||1
9922775|NCT01253226|11040105|FG003|NOT COMPLETED|Overall Study||1
9922776|NCT01253226|11040106|FG004|NOT COMPLETED|Overall Study||2
9922777|NCT01253265|11040123|FG000|STARTED|Overall Study||6
9922778|NCT01253265|11040124|FG001|STARTED|Overall Study||6
9922779|NCT01253265|11040125|FG002|STARTED|Overall Study||6
9922780|NCT01253265|11040126|FG003|STARTED|Overall Study||6
9922781|NCT01253265|11040127|FG004|STARTED|Overall Study||8
9922782|NCT01253265|11040123|FG000|COMPLETED|Overall Study||5
9922783|NCT01253265|11040124|FG001|COMPLETED|Overall Study||6
9922784|NCT01253265|11040125|FG002|COMPLETED|Overall Study||6
9922785|NCT01253265|11040126|FG003|COMPLETED|Overall Study||6
9922786|NCT01253265|11040127|FG004|COMPLETED|Overall Study||7
9922787|NCT01253265|11040123|FG000|NOT COMPLETED|Overall Study||1
9922788|NCT01253265|11040124|FG001|NOT COMPLETED|Overall Study||0
9922789|NCT01253265|11040125|FG002|NOT COMPLETED|Overall Study||0
9922790|NCT01253265|11040126|FG003|NOT COMPLETED|Overall Study||0
9922791|NCT01253265|11040127|FG004|NOT COMPLETED|Overall Study||1
9922792|NCT01253291|11040144|FG000|STARTED|Overall Study||6
9922793|NCT01253291|11040145|FG001|STARTED|Overall Study||6
9922794|NCT01253291|11040146|FG002|STARTED|Overall Study||4
9922795|NCT01253291|11040147|FG003|STARTED|Overall Study||5
9922796|NCT01253291|11040148|FG004|STARTED|Overall Study||5
9922797|NCT01253291|11040144|FG000|Received Study Drug During BCDL|Overall Study||6
9922798|NCT01253291|11040145|FG001|Received Study Drug During BCDL|Overall Study||6
9922799|NCT01253291|11040146|FG002|Received Study Drug During BCDL|Overall Study||4
9922800|NCT01253291|11040147|FG003|Received Study Drug During BCDL|Overall Study||5
9922801|NCT01253291|11040148|FG004|Received Study Drug During BCDL|Overall Study||5
9922802|NCT01253291|11040144|FG000|COMPLETED|Overall Study||2
9922803|NCT01253291|11040145|FG001|COMPLETED|Overall Study||4
9922804|NCT01253291|11040146|FG002|COMPLETED|Overall Study||4
9922805|NCT01253291|11040147|FG003|COMPLETED|Overall Study||5
9922806|NCT01253291|11040148|FG004|COMPLETED|Overall Study||3
9922807|NCT01253291|11040144|FG000|NOT COMPLETED|Overall Study||4
9922808|NCT01253291|11040145|FG001|NOT COMPLETED|Overall Study||2
9922809|NCT01253291|11040146|FG002|NOT COMPLETED|Overall Study||0
9922810|NCT01253291|11040147|FG003|NOT COMPLETED|Overall Study||0
9922811|NCT01253291|11040148|FG004|NOT COMPLETED|Overall Study||2
9922812|NCT01253304|11040165|FG000|STARTED|Overall Study||11
9922813|NCT01253304|11040166|FG001|STARTED|Overall Study||6
9922814|NCT01253304|11040167|FG002|STARTED|Overall Study||6
9922815|NCT01253304|11040168|FG003|STARTED|Overall Study||3
9922816|NCT01253304|11040165|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
9922817|NCT01253304|11040166|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9922818|NCT01253304|11040167|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9922819|NCT01253304|11040168|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10205376|NCT03491553|11332174|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
9922820|NCT01253304|11040165|FG000|COMPLETED|Overall Study||11
9922821|NCT01253304|11040166|FG001|COMPLETED|Overall Study||6
9922822|NCT01253304|11040167|FG002|COMPLETED|Overall Study||6
9922823|NCT01253304|11040168|FG003|COMPLETED|Overall Study||2
9922824|NCT01253304|11040165|FG000|NOT COMPLETED|Overall Study||0
9922825|NCT01253304|11040166|FG001|NOT COMPLETED|Overall Study||0
9922826|NCT01253304|11040167|FG002|NOT COMPLETED|Overall Study||0
9922827|NCT01253304|11040168|FG003|NOT COMPLETED|Overall Study||1
9922828|NCT01253317|11040178|FG000|STARTED|Overall Study||12
9922829|NCT01253317|11040178|FG000|COMPLETED|Overall Study||10
9922830|NCT01253317|11040178|FG000|NOT COMPLETED|Overall Study||2
9922831|NCT01253343|11040188|FG000|STARTED|Overall Study||9
9922832|NCT01253343|11040189|FG001|STARTED|Overall Study||8
9922833|NCT01253343|11040188|FG000|COMPLETED|Overall Study||9
9922834|NCT01253343|11040189|FG001|COMPLETED|Overall Study||8
9922835|NCT01253343|11040188|FG000|NOT COMPLETED|Overall Study||0
9922836|NCT01253343|11040189|FG001|NOT COMPLETED|Overall Study||0
9922837|NCT01253369|11040211|FG000|STARTED|Overall Study||33
9922838|NCT01253369|11040211|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
9922839|NCT01253369|11040211|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
9922840|NCT01253369|11040211|FG000|NOT COMPLETED|Overall Study||33
9922841|NCT01253408|11040218|FG000|STARTED|Overall Study||10
9922842|NCT01253408|11040219|FG001|STARTED|Overall Study||13
9922843|NCT01253408|11040220|FG002|STARTED|Overall Study||13
9922844|NCT01253408|11040218|FG000|COMPLETED|Overall Study||10
9922845|NCT01253408|11040219|FG001|COMPLETED|Overall Study||12
9922846|NCT01253408|11040220|FG002|COMPLETED|Overall Study||13
9922847|NCT01253408|11040218|FG000|NOT COMPLETED|Overall Study||0
9922848|NCT01253408|11040219|FG001|NOT COMPLETED|Overall Study||1
9922849|NCT01253408|11040220|FG002|NOT COMPLETED|Overall Study||0
9922850|NCT01253421|11040232|FG000|STARTED|Assessment and Scheduling||159
9922851|NCT01253421|11040233|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
9922852|NCT01253421|11040234|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
9922853|NCT01253421|11040235|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
9922854|NCT01253421|11040236|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
9922855|NCT01253421|11040232|FG000|Eligible After Screening Visit|Assessment and Scheduling||85
9922856|NCT01253421|11040233|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
9922857|NCT01253421|11040234|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
9922858|NCT01253421|11040235|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
9922859|NCT01253421|11040236|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
9922860|NCT01253421|11040232|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
9922861|NCT01253421|11040233|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
9922862|NCT01253421|11040234|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
9922863|NCT01253421|11040235|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
9922864|NCT01253421|11040236|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
9922865|NCT01253421|11040232|FG000|COMPLETED|Assessment and Scheduling||60
9922866|NCT01253421|11040233|FG001|COMPLETED|Assessment and Scheduling||0
9922867|NCT01253421|11040234|FG002|COMPLETED|Assessment and Scheduling||0
9922868|NCT01253421|11040235|FG003|COMPLETED|Assessment and Scheduling||0
9922869|NCT01253421|11040236|FG004|COMPLETED|Assessment and Scheduling||0
9922870|NCT01253421|11040232|FG000|NOT COMPLETED|Assessment and Scheduling||99
9922871|NCT01253421|11040233|FG001|NOT COMPLETED|Assessment and Scheduling||0
9922872|NCT01253421|11040234|FG002|NOT COMPLETED|Assessment and Scheduling||0
9922873|NCT01253421|11040235|FG003|NOT COMPLETED|Assessment and Scheduling||0
9922874|NCT01253421|11040236|FG004|NOT COMPLETED|Assessment and Scheduling||0
9922875|NCT01253421|11040232|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
9922876|NCT01253421|11040233|FG001|STARTED|Drug+Scanning Visit||15
9922877|NCT01253421|11040234|FG002|STARTED|Drug+Scanning Visit||14
9922878|NCT01253421|11040235|FG003|STARTED|Drug+Scanning Visit||16
9922879|NCT01253421|11040236|FG004|STARTED|Drug+Scanning Visit||15
9922880|NCT01253421|11040232|FG000|Received Drug Challenge|Drug+Scanning Visit||0
9922881|NCT01253421|11040233|FG001|Received Drug Challenge|Drug+Scanning Visit||15
9922882|NCT01253421|11040234|FG002|Received Drug Challenge|Drug+Scanning Visit||14
9922883|NCT01253421|11040235|FG003|Received Drug Challenge|Drug+Scanning Visit||16
9922884|NCT01253421|11040236|FG004|Received Drug Challenge|Drug+Scanning Visit||15
9922885|NCT01253421|11040232|FG000|COMPLETED|Drug+Scanning Visit||0
9922886|NCT01253421|11040233|FG001|COMPLETED|Drug+Scanning Visit||15
9922887|NCT01253421|11040234|FG002|COMPLETED|Drug+Scanning Visit||14
9922888|NCT01253421|11040235|FG003|COMPLETED|Drug+Scanning Visit||16
9922889|NCT01253421|11040236|FG004|COMPLETED|Drug+Scanning Visit||14
9922890|NCT01253421|11040232|FG000|NOT COMPLETED|Drug+Scanning Visit||0
9922891|NCT01253421|11040233|FG001|NOT COMPLETED|Drug+Scanning Visit||0
9922892|NCT01253421|11040234|FG002|NOT COMPLETED|Drug+Scanning Visit||0
9922893|NCT01253421|11040235|FG003|NOT COMPLETED|Drug+Scanning Visit||0
9922894|NCT01253421|11040236|FG004|NOT COMPLETED|Drug+Scanning Visit||1
9922895|NCT01253447|11040246|FG000|STARTED|Overall Study||19
9922896|NCT01253447|11040246|FG000|COMPLETED|Overall Study||17
9922897|NCT01253447|11040246|FG000|NOT COMPLETED|Overall Study||2
9922898|NCT01253460|11040251|FG000|STARTED|Overall Study||18
9922899|NCT01253460|11040251|FG000|COMPLETED|Overall Study||18
9922900|NCT01253460|11040251|FG000|NOT COMPLETED|Overall Study||0
10010613|NCT01775189|11133362|FG002|COMPLETED|Treatment Phase: First Intervention||0
10010614|NCT01775189|11133363|FG003|COMPLETED|Treatment Phase: First Intervention||8
9922901|NCT01253525|11040255|FG000|STARTED|Overall Study||6
9922902|NCT01253525|11040255|FG000|Received Any Quantity of Study Drug|Overall Study||6
9922903|NCT01253525|11040255|FG000|COMPLETED|Overall Study||6
10010615|NCT01775189|11133364|FG004|COMPLETED|Treatment Phase: First Intervention||8
9922904|NCT01253525|11040255|FG000|NOT COMPLETED|Overall Study||0
9922905|NCT01253564|11040259|FG000|STARTED|Overall Study||24
9922906|NCT01253564|11040259|FG000|COMPLETED|Overall Study||0
9922907|NCT01253564|11040259|FG000|NOT COMPLETED|Overall Study||24
9922908|NCT01253577|11040263|FG000|STARTED|Overall Study||105
9922909|NCT01253577|11040263|FG000|COMPLETED|Overall Study||102
9922910|NCT01253577|11040263|FG000|NOT COMPLETED|Overall Study||3
9922911|NCT01253642|11040269|FG000|STARTED|Overall Study||11
9922912|NCT01253642|11040269|FG000|COMPLETED|Overall Study||6
9922913|NCT01253642|11040269|FG000|NOT COMPLETED|Overall Study||5
9922914|NCT01253811|11040274|FG000|STARTED|Overall Study||6
9922915|NCT01253811|11040274|FG000|Exposed|Overall Study||6
9922916|NCT01253811|11040274|FG000|COMPLETED|Overall Study||5
9922917|NCT01253811|11040274|FG000|NOT COMPLETED|Overall Study||1
9922918|NCT01253824|11040280|FG000|STARTED|Overall Study||7
9922919|NCT01253824|11040281|FG001|STARTED|Overall Study||7
9922920|NCT01253824|11040280|FG000|COMPLETED|Overall Study||7
9922921|NCT01253824|11040281|FG001|COMPLETED|Overall Study||7
9922922|NCT01253824|11040280|FG000|NOT COMPLETED|Overall Study||0
9922923|NCT01253824|11040281|FG001|NOT COMPLETED|Overall Study||0
9922924|NCT01253902|11040290|FG000|STARTED|Overall Study||56
10010616|NCT01775189|11133365|FG005|COMPLETED|Treatment Phase: First Intervention||8
10010617|NCT01775189|11133366|FG006|COMPLETED|Treatment Phase: First Intervention||8
10010618|NCT01775189|11133360|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
9922925|NCT01253902|11040291|FG001|STARTED|Overall Study||53
9922926|NCT01253902|11040292|FG002|STARTED|Overall Study||55
9922927|NCT01253902|11040290|FG000|COMPLETED|Overall Study||51
9922928|NCT01253902|11040291|FG001|COMPLETED|Overall Study||51
9922929|NCT01253902|11040292|FG002|COMPLETED|Overall Study||51
9922930|NCT01253902|11040290|FG000|NOT COMPLETED|Overall Study||5
9922931|NCT01253902|11040291|FG001|NOT COMPLETED|Overall Study||2
9922932|NCT01253902|11040292|FG002|NOT COMPLETED|Overall Study||4
9922933|NCT01253980|11040302|FG000|STARTED|Overall Study||35
9922934|NCT01253980|11040303|FG001|STARTED|Overall Study||39
9922935|NCT01253980|11040302|FG000|COMPLETED|Overall Study||35
9922936|NCT01253980|11040303|FG001|COMPLETED|Overall Study||39
9922937|NCT01253980|11040302|FG000|NOT COMPLETED|Overall Study||0
9922938|NCT01253980|11040303|FG001|NOT COMPLETED|Overall Study||0
9922939|NCT01254019|11040311|FG000|STARTED|Overall Study||61
9922940|NCT01254019|11040312|FG001|STARTED|Overall Study||125
9922941|NCT01254019|11040311|FG000|COMPLETED|Overall Study||60
9922942|NCT01254019|11040312|FG001|COMPLETED|Overall Study||121
9922943|NCT01254019|11040311|FG000|NOT COMPLETED|Overall Study||1
9922944|NCT01254019|11040312|FG001|NOT COMPLETED|Overall Study||4
9922945|NCT01254045|11040321|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
9922946|NCT01254045|11040322|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2
9922947|NCT01254045|11040323|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2
9922948|NCT01254045|11040324|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1
9922949|NCT01254045|11040325|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1
9922950|NCT01254045|11040326|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1
9922951|NCT01254045|11040321|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1
9922952|NCT01254045|11040322|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2
9922953|NCT01254045|11040323|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2
9922954|NCT01254045|11040324|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1
9922955|NCT01254045|11040325|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1
9922956|NCT01254045|11040326|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1
9922957|NCT01254045|11040321|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
9922958|NCT01254045|11040322|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
9922959|NCT01254045|11040323|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
9922960|NCT01254045|11040324|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
9922961|NCT01254045|11040325|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
9922962|NCT01254045|11040326|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
9922963|NCT01254045|11040321|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1
9922964|NCT01254045|11040322|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2
9922965|NCT01254045|11040323|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2
9922966|NCT01254045|11040324|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1
9922967|NCT01254045|11040325|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1
9922968|NCT01254045|11040326|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1
9922969|NCT01254045|11040321|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
9922970|NCT01254045|11040322|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
9922971|NCT01254045|11040323|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
9922972|NCT01254045|11040324|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
9922973|NCT01254045|11040325|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
9922974|NCT01254045|11040326|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
9922975|NCT01254045|11040321|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
9922976|NCT01254045|11040322|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
9922977|NCT01254045|11040323|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
9922978|NCT01254045|11040324|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
9922979|NCT01254045|11040325|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
9922980|NCT01254045|11040326|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
9922981|NCT01254045|11040321|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1
9922982|NCT01254045|11040322|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2
9922983|NCT01254045|11040323|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2
10010619|NCT01775189|11133361|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
9922984|NCT01254045|11040324|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1
9922985|NCT01254045|11040325|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1
9922986|NCT01254045|11040326|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1
9922987|NCT01254045|11040321|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
9922988|NCT01254045|11040322|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
9922989|NCT01254045|11040323|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
9922990|NCT01254045|11040324|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
9922991|NCT01254045|11040325|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
9922992|NCT01254045|11040326|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
9922993|NCT01254045|11040321|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
9922994|NCT01254045|11040322|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
9922995|NCT01254045|11040323|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
9922996|NCT01254045|11040324|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
9922997|NCT01254045|11040325|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
9922998|NCT01254045|11040326|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
9922999|NCT01254188|11040336|FG000|STARTED|Overall Study||421
9923000|NCT01254188|11040336|FG000|COMPLETED|Overall Study||328
9923001|NCT01254188|11040336|FG000|NOT COMPLETED|Overall Study||93
9923002|NCT01254214|11040342|FG000|STARTED|Overall Study||27
9923003|NCT01254214|11040343|FG001|STARTED|Overall Study||28
9923004|NCT01254214|11040342|FG000|COMPLETED|Overall Study||24
9923005|NCT01254214|11040343|FG001|COMPLETED|Overall Study||27
9923006|NCT01254214|11040342|FG000|NOT COMPLETED|Overall Study||3
9923007|NCT01254214|11040343|FG001|NOT COMPLETED|Overall Study||1
9923008|NCT01254227|11040349|FG000|STARTED|Overall Study||60
9923009|NCT01254227|11040349|FG000|Completion of 12 Months|Overall Study||39
9923010|NCT01254227|11040349|FG000|Completion of 24 Months|Overall Study||34
9923011|NCT01254227|11040349|FG000|COMPLETED|Overall Study||34
9923012|NCT01254227|11040349|FG000|NOT COMPLETED|Overall Study||26
9923013|NCT01254292|11040355|FG000|STARTED|Comparative Phase||282
9923014|NCT01254292|11040356|FG001|STARTED|Comparative Phase||285
9923015|NCT01254292|11040355|FG000|Participants Received Treatment|Comparative Phase|safety population|279
9923016|NCT01254292|11040356|FG001|Participants Received Treatment|Comparative Phase|safety population|281
9923017|NCT01254292|11040355|FG000|COMPLETED|Comparative Phase||227
9923018|NCT01254292|11040356|FG001|COMPLETED|Comparative Phase||204
9923019|NCT01254292|11040355|FG000|NOT COMPLETED|Comparative Phase||55
9923020|NCT01254292|11040356|FG001|NOT COMPLETED|Comparative Phase||81
9923021|NCT01254292|11040355|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
9923022|NCT01254292|11040356|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
9923023|NCT01254292|11040355|FG000|COMPLETED|LCS12 Extension Phase||163
9923024|NCT01254292|11040356|FG001|COMPLETED|LCS12 Extension Phase||0
9923025|NCT01254292|11040355|FG000|NOT COMPLETED|LCS12 Extension Phase||37
9923026|NCT01254292|11040356|FG001|NOT COMPLETED|LCS12 Extension Phase||0
9923027|NCT01254305|11040366|FG000|STARTED|Overall Study||93
9923028|NCT01254305|11040367|FG001|STARTED|Overall Study||90
9923029|NCT01254305|11040368|FG002|STARTED|Overall Study||79
9923030|NCT01254305|11040366|FG000|Safety Population|Overall Study||89
9923031|NCT01254305|11040367|FG001|Safety Population|Overall Study||85
9923032|NCT01254305|11040368|FG002|Safety Population|Overall Study||77
9923033|NCT01254305|11040366|FG000|COMPLETED|Overall Study||71
9923034|NCT01254305|11040367|FG001|COMPLETED|Overall Study||72
9923035|NCT01254305|11040368|FG002|COMPLETED|Overall Study||62
9923036|NCT01254305|11040366|FG000|NOT COMPLETED|Overall Study||22
9923037|NCT01254305|11040367|FG001|NOT COMPLETED|Overall Study||18
9923038|NCT01254305|11040368|FG002|NOT COMPLETED|Overall Study||17
9923039|NCT01254318|11040379|FG000|STARTED|Overall Study|Alive at start of study|130
9923040|NCT01254318|11040379|FG000|COMPLETED|Overall Study|Alive at end of study|78
9923041|NCT01254318|11040379|FG000|NOT COMPLETED|Overall Study||52
9923042|NCT01254331|11040383|FG000|STARTED|Initial Phase||51
9923043|NCT01254331|11040383|FG000|COMPLETED|Initial Phase||46
9923044|NCT01254331|11040383|FG000|NOT COMPLETED|Initial Phase||5
10111351|NCT02495467|11242432|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10111352|NCT02495467|11242431|FG000|STARTED|Washout (1 Week)||114
10111353|NCT02495467|11242432|FG001|STARTED|Washout (1 Week)||118
10111354|NCT02495467|11242431|FG000|COMPLETED|Washout (1 Week)||112
10111355|NCT02495467|11242432|FG001|COMPLETED|Washout (1 Week)||116
9923045|NCT01254331|11040383|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
9923046|NCT01254331|11040383|FG000|COMPLETED|Extension Phase||41
9923047|NCT01254331|11040383|FG000|NOT COMPLETED|Extension Phase||4
9923048|NCT01254344|11040389|FG000|STARTED|Overall Study||299
9923049|NCT01254344|11040390|FG001|STARTED|Overall Study||300
9923050|NCT01254344|11040389|FG000|Treated|Overall Study||290
10111356|NCT02495467|11242431|FG000|NOT COMPLETED|Washout (1 Week)||2
10111357|NCT02495467|11242432|FG001|NOT COMPLETED|Washout (1 Week)||2
9923051|NCT01254344|11040390|FG001|Treated|Overall Study||297
9923052|NCT01254344|11040389|FG000|COMPLETED|Overall Study||286
9923053|NCT01254344|11040390|FG001|COMPLETED|Overall Study||281
9923054|NCT01254344|11040389|FG000|NOT COMPLETED|Overall Study||13
9923055|NCT01254344|11040390|FG001|NOT COMPLETED|Overall Study||19
9923056|NCT01254396|11040396|FG000|STARTED|First Intervention Period||6
9923057|NCT01254396|11040397|FG001|STARTED|First Intervention Period||6
9923058|NCT01254396|11040396|FG000|COMPLETED|First Intervention Period||6
9923059|NCT01254396|11040397|FG001|COMPLETED|First Intervention Period||6
9923060|NCT01254396|11040396|FG000|NOT COMPLETED|First Intervention Period||0
9923061|NCT01254396|11040397|FG001|NOT COMPLETED|First Intervention Period||0
9923062|NCT01254396|11040396|FG000|STARTED|Washout Period (at Least 1 Day)||6
9923063|NCT01254396|11040397|FG001|STARTED|Washout Period (at Least 1 Day)||6
9923064|NCT01254396|11040396|FG000|COMPLETED|Washout Period (at Least 1 Day)||6
9923065|NCT01254396|11040397|FG001|COMPLETED|Washout Period (at Least 1 Day)||6
9923066|NCT01254396|11040396|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0
9923067|NCT01254396|11040397|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0
9923068|NCT01254396|11040396|FG000|STARTED|Second Intervention Period||6
9923069|NCT01254396|11040397|FG001|STARTED|Second Intervention Period||6
9923070|NCT01254396|11040396|FG000|COMPLETED|Second Intervention Period||6
9923071|NCT01254396|11040397|FG001|COMPLETED|Second Intervention Period||6
9923072|NCT01254396|11040396|FG000|NOT COMPLETED|Second Intervention Period||0
9923073|NCT01254396|11040397|FG001|NOT COMPLETED|Second Intervention Period||0
9923074|NCT01254552|11040403|FG000|STARTED|Screening Visit||351
9923075|NCT01254552|11040403|FG000|COMPLETED|Screening Visit||348
9923076|NCT01254552|11040403|FG000|NOT COMPLETED|Screening Visit||3
9923077|NCT01254552|11040403|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348
9923078|NCT01254552|11040403|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328
9923079|NCT01254552|11040403|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
9923080|NCT01254552|11040403|FG000|STARTED|CCTA With Xenetix 350||328
9923081|NCT01254552|11040403|FG000|COMPLETED|CCTA With Xenetix 350||322
9923082|NCT01254552|11040403|FG000|NOT COMPLETED|CCTA With Xenetix 350||6
9923083|NCT01254565|11040417|FG000|STARTED|Overall Study||5
9923084|NCT01254565|11040418|FG001|STARTED|Overall Study||7
9923085|NCT01254565|11040419|FG002|STARTED|Overall Study||21
9923086|NCT01254565|11040420|FG003|STARTED|Overall Study||21
9923087|NCT01254565|11040421|FG004|STARTED|Overall Study||16
9923088|NCT01254565|11040422|FG005|STARTED|Overall Study||17
9923089|NCT01254565|11040417|FG000|Received Treatment|Overall Study||4
9923090|NCT01254565|11040418|FG001|Received Treatment|Overall Study||6
9923091|NCT01254565|11040419|FG002|Received Treatment|Overall Study||21
9923092|NCT01254565|11040420|FG003|Received Treatment|Overall Study||21
9923093|NCT01254565|11040421|FG004|Received Treatment|Overall Study||13
9923094|NCT01254565|11040422|FG005|Received Treatment|Overall Study||13
9923095|NCT01254565|11040417|FG000|COMPLETED|Overall Study||4
9923096|NCT01254565|11040418|FG001|COMPLETED|Overall Study||6
9923097|NCT01254565|11040419|FG002|COMPLETED|Overall Study||21
9923098|NCT01254565|11040420|FG003|COMPLETED|Overall Study||20
9923099|NCT01254565|11040421|FG004|COMPLETED|Overall Study||12
9923100|NCT01254565|11040422|FG005|COMPLETED|Overall Study||13
9923101|NCT01254565|11040417|FG000|NOT COMPLETED|Overall Study||1
9923102|NCT01254565|11040418|FG001|NOT COMPLETED|Overall Study||1
9923103|NCT01254565|11040419|FG002|NOT COMPLETED|Overall Study||0
9923104|NCT01254565|11040420|FG003|NOT COMPLETED|Overall Study||1
9923105|NCT01254565|11040421|FG004|NOT COMPLETED|Overall Study||4
9923106|NCT01254565|11040422|FG005|NOT COMPLETED|Overall Study||4
9923107|NCT01254604|11040438|FG000|STARTED|Overall Study||95
9923108|NCT01254604|11040439|FG001|STARTED|Overall Study||95
9923109|NCT01254604|11040438|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
9923110|NCT01254604|11040439|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
9923111|NCT01254604|11040438|FG000|COMPLETED|Overall Study||87
9923112|NCT01254604|11040439|FG001|COMPLETED|Overall Study||86
9923113|NCT01254604|11040438|FG000|NOT COMPLETED|Overall Study||8
9923114|NCT01254604|11040439|FG001|NOT COMPLETED|Overall Study||9
9923115|NCT01254630|11040449|FG000|STARTED|Overall Study||1348
9923116|NCT01254630|11040450|FG001|STARTED|Overall Study||1288
9923117|NCT01254630|11040451|FG002|STARTED|Overall Study||1364
9923118|NCT01254630|11040452|FG003|STARTED|Overall Study||1285
9923119|NCT01254630|11040449|FG000|Received Vaccination 1|Overall Study||1328
9923120|NCT01254630|11040450|FG001|Received Vaccination 1|Overall Study||1277
10111358|NCT02495467|11242431|FG000|STARTED|Second Intervention (4 Weeks)||112
10111359|NCT02495467|11242432|FG001|STARTED|Second Intervention (4 Weeks)||116
10111360|NCT02495467|11242431|FG000|COMPLETED|Second Intervention (4 Weeks)||112
10111361|NCT02495467|11242432|FG001|COMPLETED|Second Intervention (4 Weeks)||113
10111362|NCT02495467|11242431|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10111363|NCT02495467|11242432|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
10111364|NCT02495623|11242441|FG000|STARTED|Overall Study||25
10111365|NCT02495623|11242442|FG001|STARTED|Overall Study||26
10111366|NCT02495623|11242443|FG002|STARTED|Overall Study||28
10111367|NCT02495623|11242441|FG000|Dosed|Overall Study||22
10111368|NCT02495623|11242442|FG001|Dosed|Overall Study||19
10111369|NCT02495623|11242443|FG002|Dosed|Overall Study||22
10111370|NCT02495623|11242441|FG000|COMPLETED|Overall Study||20
9923121|NCT01254630|11040451|FG002|Received Vaccination 1|Overall Study||1350
9923122|NCT01254630|11040452|FG003|Received Vaccination 1|Overall Study||1275
9923123|NCT01254630|11040449|FG000|Received Vaccination 2|Overall Study||1255
9923124|NCT01254630|11040450|FG001|Received Vaccination 2|Overall Study||1217
9923125|NCT01254630|11040451|FG002|Received Vaccination 2|Overall Study||1286
9923126|NCT01254630|11040452|FG003|Received Vaccination 2|Overall Study||1226
9923127|NCT01254630|11040449|FG000|Received Vaccination 3|Overall Study||1198
9923128|NCT01254630|11040450|FG001|Received Vaccination 3|Overall Study||1178
9923129|NCT01254630|11040451|FG002|Received Vaccination 3|Overall Study||1247
9923130|NCT01254630|11040452|FG003|Received Vaccination 3|Overall Study||1194
9923131|NCT01254630|11040449|FG000|Received Vaccination 4|Overall Study||1155
9923132|NCT01254630|11040450|FG001|Received Vaccination 4|Overall Study||1145
9923133|NCT01254630|11040451|FG002|Received Vaccination 4|Overall Study||1212
9923134|NCT01254630|11040452|FG003|Received Vaccination 4|Overall Study||1160
9923135|NCT01254630|11040449|FG000|COMPLETED|Overall Study||546
9923136|NCT01254630|11040450|FG001|COMPLETED|Overall Study||0
9923137|NCT01254630|11040451|FG002|COMPLETED|Overall Study||552
9923138|NCT01254630|11040452|FG003|COMPLETED|Overall Study||0
9923139|NCT01254630|11040449|FG000|NOT COMPLETED|Overall Study||802
9923140|NCT01254630|11040450|FG001|NOT COMPLETED|Overall Study||1288
9923141|NCT01254630|11040451|FG002|NOT COMPLETED|Overall Study||812
9923142|NCT01254630|11040452|FG003|NOT COMPLETED|Overall Study||1285
9923143|NCT01254643|11040460|FG000|STARTED|Overall Study||100
9923144|NCT01254643|11040460|FG000|Vaccination 1|Overall Study||100
9923145|NCT01254643|11040460|FG000|Vaccination 2|Overall Study||99
9923146|NCT01254643|11040460|FG000|Vaccination 3|Overall Study||99
9923147|NCT01254643|11040460|FG000|COMPLETED|Overall Study||99
9923148|NCT01254643|11040460|FG000|NOT COMPLETED|Overall Study||1
9923149|NCT01254656|11040467|FG000|STARTED|Overall Study||47
9923150|NCT01254656|11040468|FG001|STARTED|Overall Study||43
9923151|NCT01254656|11040469|FG002|STARTED|Overall Study||18
9923152|NCT01254656|11040467|FG000|Treated|Overall Study||47
9923153|NCT01254656|11040468|FG001|Treated|Overall Study||43
9923154|NCT01254656|11040469|FG002|Treated|Overall Study||18
9923155|NCT01254656|11040467|FG000|COMPLETED|Overall Study||0
9923156|NCT01254656|11040468|FG001|COMPLETED|Overall Study||0
9923157|NCT01254656|11040469|FG002|COMPLETED|Overall Study||0
9923158|NCT01254656|11040467|FG000|NOT COMPLETED|Overall Study||47
9923159|NCT01254656|11040468|FG001|NOT COMPLETED|Overall Study||43
9923160|NCT01254656|11040469|FG002|NOT COMPLETED|Overall Study||18
9923161|NCT01254669|11040479|FG000|STARTED|Overall Study||100
9923162|NCT01254669|11040480|FG001|STARTED|Overall Study||100
9923163|NCT01254669|11040479|FG000|COMPLETED|Overall Study||97
9923164|NCT01254669|11040480|FG001|COMPLETED|Overall Study||96
9923165|NCT01254669|11040479|FG000|NOT COMPLETED|Overall Study||3
9923166|NCT01254669|11040480|FG001|NOT COMPLETED|Overall Study||4
9923167|NCT01254721|11040490|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67
9923168|NCT01254721|11040491|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
9923169|NCT01254721|11040490|FG000|COMPLETED|Overall Study||52
9923170|NCT01254721|11040491|FG001|COMPLETED|Overall Study||42
9923171|NCT01254721|11040490|FG000|NOT COMPLETED|Overall Study||15
9923172|NCT01254721|11040491|FG001|NOT COMPLETED|Overall Study||22
9923173|NCT01254747|11040501|FG000|STARTED|Overall Study||40
9923174|NCT01254747|11040502|FG001|STARTED|Overall Study||29
9923175|NCT01254747|11040503|FG002|STARTED|Overall Study||30
9923176|NCT01254747|11040504|FG003|STARTED|Overall Study||30
9923177|NCT01254747|11040501|FG000|COMPLETED|Overall Study||40
9923178|NCT01254747|11040502|FG001|COMPLETED|Overall Study||23
9923179|NCT01254747|11040503|FG002|COMPLETED|Overall Study||26
9923180|NCT01254747|11040504|FG003|COMPLETED|Overall Study||28
9923181|NCT01254747|11040501|FG000|NOT COMPLETED|Overall Study||0
9923182|NCT01254747|11040502|FG001|NOT COMPLETED|Overall Study||6
9923183|NCT01254747|11040503|FG002|NOT COMPLETED|Overall Study||4
9923184|NCT01254747|11040504|FG003|NOT COMPLETED|Overall Study||2
9923185|NCT01254760|11040514|FG000|STARTED|First Period, 5 Days of Wear||34
9923186|NCT01254760|11040515|FG001|STARTED|First Period, 5 Days of Wear||38
9923187|NCT01254760|11040514|FG000|COMPLETED|First Period, 5 Days of Wear||34
9923188|NCT01254760|11040515|FG001|COMPLETED|First Period, 5 Days of Wear||38
9923189|NCT01254760|11040514|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0
9923190|NCT01254760|11040515|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0
9923191|NCT01254760|11040514|FG000|STARTED|Second Period, 5 Days of Wear||34
9923192|NCT01254760|11040515|FG001|STARTED|Second Period, 5 Days of Wear||38
9923193|NCT01254760|11040514|FG000|COMPLETED|Second Period, 5 Days of Wear||34
9923194|NCT01254760|11040515|FG001|COMPLETED|Second Period, 5 Days of Wear||38
9923195|NCT01254760|11040514|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0
9923196|NCT01254760|11040515|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0
9923197|NCT01254851|11040524|FG000|STARTED|Overall Study||69
9923198|NCT01254851|11040525|FG001|STARTED|Overall Study||77
9923199|NCT01254851|11040524|FG000|COMPLETED|Overall Study||61
9923200|NCT01254851|11040525|FG001|COMPLETED|Overall Study||68
9923201|NCT01254851|11040524|FG000|NOT COMPLETED|Overall Study||8
9923202|NCT01254851|11040525|FG001|NOT COMPLETED|Overall Study||9
9923203|NCT01254877|11040534|FG000|STARTED|Overall Study||67
9923204|NCT01254877|11040535|FG001|STARTED|Overall Study||69
9923205|NCT01254877|11040536|FG002|STARTED|Overall Study||69
9923206|NCT01254877|11040534|FG000|COMPLETED|Overall Study||57
9923207|NCT01254877|11040535|FG001|COMPLETED|Overall Study||58
9923208|NCT01254877|11040536|FG002|COMPLETED|Overall Study||64
9923209|NCT01254877|11040534|FG000|NOT COMPLETED|Overall Study||10
9923210|NCT01254877|11040535|FG001|NOT COMPLETED|Overall Study||11
9923211|NCT01254877|11040536|FG002|NOT COMPLETED|Overall Study||5
9923212|NCT01254890|11040546|FG000|STARTED|Overall Study||3
9923213|NCT01254890|11040547|FG001|STARTED|Overall Study||57
9923214|NCT01254890|11040546|FG000|COMPLETED|Overall Study||2
9923215|NCT01254890|11040547|FG001|COMPLETED|Overall Study||47
9923216|NCT01254890|11040546|FG000|NOT COMPLETED|Overall Study||1
9923217|NCT01254890|11040547|FG001|NOT COMPLETED|Overall Study||10
9923218|NCT01255137|11040552|FG000|STARTED|Overall Study||13
9923219|NCT01255137|11040552|FG000|COMPLETED|Overall Study||13
9923220|NCT01255137|11040552|FG000|NOT COMPLETED|Overall Study||0
9923221|NCT01255163|11040558|FG000|STARTED|Overall Study||13
9923222|NCT01255163|11040559|FG001|STARTED|Overall Study||14
9923223|NCT01255163|11040558|FG000|COMPLETED|Overall Study||9
9923224|NCT01255163|11040559|FG001|COMPLETED|Overall Study||9
9923225|NCT01255163|11040558|FG000|NOT COMPLETED|Overall Study||4
9923226|NCT01255163|11040559|FG001|NOT COMPLETED|Overall Study||5
9923227|NCT01255306|11040569|FG000|STARTED|Overall Study||26
9923228|NCT01255306|11040570|FG001|STARTED|Overall Study||33
9923229|NCT01255306|11040569|FG000|COMPLETED|Overall Study||25
9923230|NCT01255306|11040570|FG001|COMPLETED|Overall Study||32
9923231|NCT01255306|11040569|FG000|NOT COMPLETED|Overall Study||1
9923232|NCT01255306|11040570|FG001|NOT COMPLETED|Overall Study||1
9923233|NCT01255423|11040581|FG000|STARTED|Overall Study||104
9923234|NCT01255423|11040582|FG001|STARTED|Overall Study||102
9923235|NCT01255423|11040581|FG000|COMPLETED|Overall Study||101
9923236|NCT01255423|11040582|FG001|COMPLETED|Overall Study||99
9923237|NCT01255423|11040581|FG000|NOT COMPLETED|Overall Study||3
9923238|NCT01255423|11040582|FG001|NOT COMPLETED|Overall Study||3
9923239|NCT01255436|11040590|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
9923240|NCT01255436|11040591|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
9923241|NCT01255436|11040590|FG000|COMPLETED|Overall Study||151
9923242|NCT01255436|11040591|FG001|COMPLETED|Overall Study||135
9923243|NCT01255436|11040590|FG000|NOT COMPLETED|Overall Study||182
9923244|NCT01255436|11040591|FG001|NOT COMPLETED|Overall Study||194
9923245|NCT01255449|11040597|FG000|STARTED|Overall Study||26
9923246|NCT01255449|11040597|FG000|COMPLETED|Overall Study||26
9923247|NCT01255449|11040597|FG000|NOT COMPLETED|Overall Study||0
9923248|NCT01255592|11040604|FG000|STARTED|Overall Study||26
9923249|NCT01255592|11040605|FG001|STARTED|Overall Study||26
9923250|NCT01255592|11040604|FG000|COMPLETED|Overall Study||20
9923251|NCT01255592|11040605|FG001|COMPLETED|Overall Study||25
9923252|NCT01255592|11040604|FG000|NOT COMPLETED|Overall Study||6
9923253|NCT01255592|11040605|FG001|NOT COMPLETED|Overall Study||1
9923254|NCT01255631|11040614|FG000|STARTED|Overall Study||13
9923255|NCT01255631|11040615|FG001|STARTED|Overall Study||9
9923256|NCT01255631|11040614|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4
9923257|NCT01255631|11040615|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3
9923258|NCT01255631|11040614|FG000|NOT COMPLETED|Overall Study||9
9923259|NCT01255631|11040615|FG001|NOT COMPLETED|Overall Study||6
9923260|NCT01255670|11040623|FG000|STARTED|Overall Study||100
9923261|NCT01255670|11040624|FG001|STARTED|Overall Study||100
9923262|NCT01255670|11040623|FG000|COMPLETED|Overall Study||74
9923263|NCT01255670|11040624|FG001|COMPLETED|Overall Study||80
9923264|NCT01255670|11040623|FG000|NOT COMPLETED|Overall Study||26
9923265|NCT01255670|11040624|FG001|NOT COMPLETED|Overall Study||20
9923266|NCT01255722|11040633|FG000|STARTED|Overall Study||155
9923267|NCT01255722|11040634|FG001|STARTED|Overall Study||160
9923268|NCT01255722|11040635|FG002|STARTED|Overall Study||153
9923269|NCT01255722|11040633|FG000|COMPLETED|Overall Study||152
9923270|NCT01255722|11040634|FG001|COMPLETED|Overall Study||159
9923271|NCT01255722|11040635|FG002|COMPLETED|Overall Study||152
9923272|NCT01255722|11040633|FG000|NOT COMPLETED|Overall Study||3
9923273|NCT01255722|11040634|FG001|NOT COMPLETED|Overall Study||1
9923274|NCT01255722|11040635|FG002|NOT COMPLETED|Overall Study||1
9955905|NCT01440972|11074892|FG000|NOT COMPLETED|Overall Study||3
9955906|NCT01440972|11074893|FG001|NOT COMPLETED|Overall Study||2
9955907|NCT01441037|11074899|FG000|STARTED|Overall Study||27
9955908|NCT01441037|11074899|FG000|COMPLETED|Overall Study||27
9955909|NCT01441037|11074899|FG000|NOT COMPLETED|Overall Study||0
9955910|NCT01441063|11074903|FG000|STARTED|Tocilizumab Alone||8
9955911|NCT01441063|11074903|FG000|COMPLETED|Tocilizumab Alone||5
9955912|NCT01441063|11074903|FG000|NOT COMPLETED|Tocilizumab Alone||3
9955913|NCT01441063|11074903|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
9955914|NCT01441063|11074903|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
9955915|NCT01441063|11074903|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
9955916|NCT01441076|11074910|FG000|STARTED|Overall Study||6
9955917|NCT01441076|11074910|FG000|COMPLETED|Overall Study||4
9955918|NCT01441076|11074910|FG000|NOT COMPLETED|Overall Study||2
9955919|NCT01441102|11074914|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
9955920|NCT01441102|11074914|FG000|COMPLETED|Overall Study||4
9955921|NCT01441102|11074914|FG000|NOT COMPLETED|Overall Study||3
9955922|NCT01441180|11074921|FG000|STARTED|Overall Study||10
9955923|NCT01441180|11074922|FG001|STARTED|Overall Study||25
9955924|NCT01441180|11074923|FG002|STARTED|Overall Study||25
9955925|NCT01441180|11074921|FG000|COMPLETED|Overall Study||9
9955926|NCT01441180|11074922|FG001|COMPLETED|Overall Study||24
9955927|NCT01441180|11074923|FG002|COMPLETED|Overall Study||22
9955928|NCT01441180|11074921|FG000|NOT COMPLETED|Overall Study||1
9955929|NCT01441180|11074922|FG001|NOT COMPLETED|Overall Study||1
9955930|NCT01441180|11074923|FG002|NOT COMPLETED|Overall Study||3
9955931|NCT01441245|11074936|FG000|STARTED|Overall Study||30
9955932|NCT01441245|11074937|FG001|STARTED|Overall Study||27
9955933|NCT01441245|11074936|FG000|COMPLETED|Overall Study||30
9955934|NCT01441245|11074937|FG001|COMPLETED|Overall Study||27
9955935|NCT01441245|11074936|FG000|NOT COMPLETED|Overall Study||0
9955936|NCT01441245|11074937|FG001|NOT COMPLETED|Overall Study||0
9955937|NCT01441401|11074959|FG000|STARTED|Overall Study||82
9955938|NCT01441401|11074959|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
9955939|NCT01441401|11074959|FG000|NOT COMPLETED|Overall Study||0
9955940|NCT01441414|11074977|FG000|STARTED|Overall Study||18
9923275|NCT01255761|11040646|FG000|STARTED|Overall Study||369
9923276|NCT01255761|11040647|FG001|STARTED|Overall Study||367
9923277|NCT01255761|11040646|FG000|COMPLETED|Overall Study||187
9923278|NCT01255761|11040647|FG001|COMPLETED|Overall Study||192
9923279|NCT01255761|11040646|FG000|NOT COMPLETED|Overall Study||182
9923280|NCT01255761|11040647|FG001|NOT COMPLETED|Overall Study||175
9923281|NCT01255787|11040657|FG000|STARTED|Overall Study||152
9923282|NCT01255787|11040658|FG001|STARTED|Overall Study||144
9923283|NCT01255787|11040659|FG002|STARTED|Overall Study||150
9923284|NCT01255787|11040660|FG003|STARTED|Overall Study||154
9923285|NCT01255787|11040657|FG000|Treated|Overall Study||152
9923286|NCT01255787|11040658|FG001|Treated|Overall Study||144
9923287|NCT01255787|11040659|FG002|Treated|Overall Study||148
9923288|NCT01255787|11040660|FG003|Treated|Overall Study||150
9923289|NCT01255787|11040657|FG000|COMPLETED|Overall Study||136
9923290|NCT01255787|11040658|FG001|COMPLETED|Overall Study||127
9923291|NCT01255787|11040659|FG002|COMPLETED|Overall Study||132
9923292|NCT01255787|11040660|FG003|COMPLETED|Overall Study||132
9923293|NCT01255787|11040657|FG000|NOT COMPLETED|Overall Study||16
9923294|NCT01255787|11040658|FG001|NOT COMPLETED|Overall Study||17
9923295|NCT01255787|11040659|FG002|NOT COMPLETED|Overall Study||18
9923296|NCT01255787|11040660|FG003|NOT COMPLETED|Overall Study||22
9923297|NCT01255865|11040677|FG000|STARTED|Overall Study||1
9923298|NCT01255865|11040678|FG001|STARTED|Overall Study||10
9923299|NCT01255865|11040679|FG002|STARTED|Overall Study||10
9923300|NCT01255865|11040680|FG003|STARTED|Overall Study||30
9923301|NCT01255865|11040681|FG004|STARTED|Overall Study||20
9923302|NCT01255865|11040682|FG005|STARTED|Overall Study||20
9923303|NCT01255865|11040683|FG006|STARTED|Overall Study||20
9923304|NCT01255865|11040677|FG000|COMPLETED|Overall Study||1
9923305|NCT01255865|11040678|FG001|COMPLETED|Overall Study||10
9923306|NCT01255865|11040679|FG002|COMPLETED|Overall Study||10
9923307|NCT01255865|11040680|FG003|COMPLETED|Overall Study||30
9923308|NCT01255865|11040681|FG004|COMPLETED|Overall Study||20
9923309|NCT01255865|11040682|FG005|COMPLETED|Overall Study||20
9923310|NCT01255865|11040683|FG006|COMPLETED|Overall Study||20
9923311|NCT01255865|11040677|FG000|NOT COMPLETED|Overall Study||0
9923312|NCT01255865|11040678|FG001|NOT COMPLETED|Overall Study||0
9923313|NCT01255865|11040679|FG002|NOT COMPLETED|Overall Study||0
9923314|NCT01255865|11040680|FG003|NOT COMPLETED|Overall Study||0
9923315|NCT01255865|11040681|FG004|NOT COMPLETED|Overall Study||0
9923316|NCT01255865|11040682|FG005|NOT COMPLETED|Overall Study||0
9923317|NCT01255865|11040683|FG006|NOT COMPLETED|Overall Study||0
9923318|NCT01255904|11040701|FG000|STARTED|Overall Study||45
9923319|NCT01255904|11040702|FG001|STARTED|Overall Study||45
9923320|NCT01255904|11040701|FG000|COMPLETED|Overall Study||44
9923321|NCT01255904|11040702|FG001|COMPLETED|Overall Study||41
9923322|NCT01255904|11040701|FG000|NOT COMPLETED|Overall Study||1
9923323|NCT01255904|11040702|FG001|NOT COMPLETED|Overall Study||4
9923324|NCT01256008|11040711|FG000|STARTED|Overall Study||98
9923325|NCT01256008|11040712|FG001|STARTED|Overall Study||98
9923326|NCT01256008|11040713|FG002|STARTED|Overall Study||196
9923327|NCT01256008|11040711|FG000|COMPLETED|Overall Study||90
9923328|NCT01256008|11040712|FG001|COMPLETED|Overall Study||91
9923329|NCT01256008|11040713|FG002|COMPLETED|Overall Study||175
9923330|NCT01256008|11040711|FG000|NOT COMPLETED|Overall Study||8
9923331|NCT01256008|11040712|FG001|NOT COMPLETED|Overall Study||7
9923332|NCT01256008|11040713|FG002|NOT COMPLETED|Overall Study||21
9923333|NCT01256034|11040725|FG000|STARTED|Overall Study||25
9923334|NCT01256034|11040726|FG001|STARTED|Overall Study||25
9923335|NCT01256034|11040725|FG000|COMPLETED|Overall Study||0
9923336|NCT01256034|11040726|FG001|COMPLETED|Overall Study||0
9923337|NCT01256034|11040725|FG000|NOT COMPLETED|Overall Study||25
9923338|NCT01256034|11040726|FG001|NOT COMPLETED|Overall Study||25
9923339|NCT01256060|11040732|FG000|STARTED|Overall Study||3
9923340|NCT01256060|11040733|FG001|STARTED|Overall Study||3
9923341|NCT01256060|11040734|FG002|STARTED|Overall Study||3
9923342|NCT01256060|11040735|FG003|STARTED|Overall Study||6
9923343|NCT01256060|11040732|FG000|COMPLETED|Overall Study||3
9923344|NCT01256060|11040733|FG001|COMPLETED|Overall Study||2
9923345|NCT01256060|11040734|FG002|COMPLETED|Overall Study||3
9923346|NCT01256060|11040735|FG003|COMPLETED|Overall Study||6
9923347|NCT01256060|11040732|FG000|NOT COMPLETED|Overall Study||0
9923348|NCT01256060|11040733|FG001|NOT COMPLETED|Overall Study||1
9923349|NCT01256060|11040734|FG002|NOT COMPLETED|Overall Study||0
9923350|NCT01256060|11040735|FG003|NOT COMPLETED|Overall Study||0
9923351|NCT01256164|11040743|FG000|STARTED|Overall Study||47
9923352|NCT01256164|11040744|FG001|STARTED|Overall Study||23
9923353|NCT01256164|11040743|FG000|COMPLETED|Overall Study||47
9923354|NCT01256164|11040744|FG001|COMPLETED|Overall Study||23
9923355|NCT01256164|11040743|FG000|NOT COMPLETED|Overall Study||0
9923356|NCT01256164|11040744|FG001|NOT COMPLETED|Overall Study||0
9923357|NCT01256177|11040752|FG000|STARTED|Overall Study||148
9923358|NCT01256177|11040753|FG001|STARTED|Overall Study||148
9923359|NCT01256177|11040752|FG000|COMPLETED|Overall Study||98
9923360|NCT01256177|11040753|FG001|COMPLETED|Overall Study||111
9923361|NCT01256177|11040752|FG000|NOT COMPLETED|Overall Study||50
9923362|NCT01256177|11040753|FG001|NOT COMPLETED|Overall Study||37
9923363|NCT01256190|11040761|FG000|STARTED|Overall Study||39
9923364|NCT01256190|11040762|FG001|STARTED|Overall Study||17
9923365|NCT01256190|11040761|FG000|COMPLETED|Overall Study||37
9923366|NCT01256190|11040762|FG001|COMPLETED|Overall Study||17
9923367|NCT01256190|11040761|FG000|NOT COMPLETED|Overall Study||2
9923368|NCT01256190|11040762|FG001|NOT COMPLETED|Overall Study||0
9923369|NCT01256294|11040768|FG000|STARTED|Overall Study||36
9923370|NCT01256294|11040769|FG001|STARTED|Overall Study||35
9923371|NCT01256294|11040768|FG000|COMPLETED|Overall Study||32
9923372|NCT01256294|11040769|FG001|COMPLETED|Overall Study||33
9923373|NCT01256294|11040768|FG000|NOT COMPLETED|Overall Study||4
9923374|NCT01256294|11040769|FG001|NOT COMPLETED|Overall Study||2
9923375|NCT01256385|11040777|FG000|STARTED|Overall Study||43
9923376|NCT01256385|11040778|FG001|STARTED|Overall Study||43
9923377|NCT01256385|11040777|FG000|Crossover From Arm B to Arm A|Overall Study||0
9923378|NCT01256385|11040778|FG001|Crossover From Arm B to Arm A|Overall Study||15
9923379|NCT01256385|11040777|FG000|COMPLETED|Overall Study||40
9923380|NCT01256385|11040778|FG001|COMPLETED|Overall Study||40
9923381|NCT01256385|11040777|FG000|NOT COMPLETED|Overall Study||3
9923382|NCT01256385|11040778|FG001|NOT COMPLETED|Overall Study||3
9923383|NCT01256411|11040788|FG000|STARTED|Extension by Maximum Treatment||139
9923384|NCT01256411|11040789|FG001|STARTED|Extension by Maximum Treatment||89
9923385|NCT01256411|11040790|FG002|STARTED|Extension by Maximum Treatment||109
9923386|NCT01256411|11040791|FG003|STARTED|Extension by Maximum Treatment||4
9923387|NCT01256411|11040792|FG004|STARTED|Extension by Maximum Treatment||0
9923388|NCT01256411|11040793|FG005|STARTED|Extension by Maximum Treatment||0
9923389|NCT01256411|11040788|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12
9923390|NCT01256411|11040789|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0
9923391|NCT01256411|11040790|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0
9923392|NCT01256411|11040791|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0
9923393|NCT01256411|11040792|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0
9923394|NCT01256411|11040793|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0
9923395|NCT01256411|11040788|FG000|COMPLETED|Extension by Maximum Treatment||132
9923396|NCT01256411|11040789|FG001|COMPLETED|Extension by Maximum Treatment||79
9923397|NCT01256411|11040790|FG002|COMPLETED|Extension by Maximum Treatment||105
9923398|NCT01256411|11040791|FG003|COMPLETED|Extension by Maximum Treatment||4
9923399|NCT01256411|11040792|FG004|COMPLETED|Extension by Maximum Treatment||0
9923400|NCT01256411|11040793|FG005|COMPLETED|Extension by Maximum Treatment||0
9923401|NCT01256411|11040788|FG000|NOT COMPLETED|Extension by Maximum Treatment||7
9923402|NCT01256411|11040789|FG001|NOT COMPLETED|Extension by Maximum Treatment||10
9923403|NCT01256411|11040790|FG002|NOT COMPLETED|Extension by Maximum Treatment||4
9923404|NCT01256411|11040791|FG003|NOT COMPLETED|Extension by Maximum Treatment||0
9923405|NCT01256411|11040792|FG004|NOT COMPLETED|Extension by Maximum Treatment||0
9923406|NCT01256411|11040793|FG005|NOT COMPLETED|Extension by Maximum Treatment||0
9923407|NCT01256411|11040788|FG000|STARTED|Extension by Mono or Combination Therapy||0
9923408|NCT01256411|11040789|FG001|STARTED|Extension by Mono or Combination Therapy||0
9923409|NCT01256411|11040790|FG002|STARTED|Extension by Mono or Combination Therapy||0
9923410|NCT01256411|11040791|FG003|STARTED|Extension by Mono or Combination Therapy||0
9923411|NCT01256411|11040792|FG004|STARTED|Extension by Mono or Combination Therapy||228
9923412|NCT01256411|11040793|FG005|STARTED|Extension by Mono or Combination Therapy||113
9923413|NCT01256411|11040788|FG000|COMPLETED|Extension by Mono or Combination Therapy||0
9923414|NCT01256411|11040789|FG001|COMPLETED|Extension by Mono or Combination Therapy||0
9923415|NCT01256411|11040790|FG002|COMPLETED|Extension by Mono or Combination Therapy||0
9923416|NCT01256411|11040791|FG003|COMPLETED|Extension by Mono or Combination Therapy||0
9923417|NCT01256411|11040792|FG004|COMPLETED|Extension by Mono or Combination Therapy||211
9923418|NCT01256411|11040793|FG005|COMPLETED|Extension by Mono or Combination Therapy||109
9923419|NCT01256411|11040788|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0
9923420|NCT01256411|11040789|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0
9923421|NCT01256411|11040790|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0
9923422|NCT01256411|11040791|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0
9923423|NCT01256411|11040792|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17
9923424|NCT01256411|11040793|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4
9923425|NCT01256424|11040811|FG000|STARTED|Overall Study||65
9923426|NCT01256424|11040812|FG001|STARTED|Overall Study||67
9923427|NCT01256424|11040813|FG002|STARTED|Overall Study||62
9923428|NCT01256424|11040814|FG003|STARTED|Overall Study||68
9923429|NCT01256424|11040811|FG000|COMPLETED|Overall Study||56
9923430|NCT01256424|11040812|FG001|COMPLETED|Overall Study||59
9923431|NCT01256424|11040813|FG002|COMPLETED|Overall Study||55
9923432|NCT01256424|11040814|FG003|COMPLETED|Overall Study||61
9923433|NCT01256424|11040811|FG000|NOT COMPLETED|Overall Study||9
9923434|NCT01256424|11040812|FG001|NOT COMPLETED|Overall Study||8
9923435|NCT01256424|11040813|FG002|NOT COMPLETED|Overall Study||7
9923436|NCT01256424|11040814|FG003|NOT COMPLETED|Overall Study||7
9923437|NCT01256450|11040827|FG000|STARTED|Open-label Titration||334
9923438|NCT01256450|11040828|FG001|STARTED|Open-label Titration||0
9923439|NCT01256450|11040829|FG002|STARTED|Open-label Titration||0
9923440|NCT01256450|11040827|FG000|COMPLETED|Open-label Titration||235
9923441|NCT01256450|11040828|FG001|COMPLETED|Open-label Titration||0
9923442|NCT01256450|11040829|FG002|COMPLETED|Open-label Titration||0
9923443|NCT01256450|11040827|FG000|NOT COMPLETED|Open-label Titration||99
9923444|NCT01256450|11040828|FG001|NOT COMPLETED|Open-label Titration||0
9923445|NCT01256450|11040829|FG002|NOT COMPLETED|Open-label Titration||0
9923446|NCT01256450|11040827|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
9955941|NCT01441414|11074977|FG000|COMPLETED|Overall Study||3
9955942|NCT01441414|11074977|FG000|NOT COMPLETED|Overall Study||15
9923447|NCT01256450|11040828|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
9923448|NCT01256450|11040829|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
9923449|NCT01256450|11040827|FG000|COMPLETED|Double-blind Treatment||0
9923450|NCT01256450|11040828|FG001|COMPLETED|Double-blind Treatment||89
9923451|NCT01256450|11040829|FG002|COMPLETED|Double-blind Treatment||81
9923452|NCT01256450|11040827|FG000|NOT COMPLETED|Double-blind Treatment||0
9923453|NCT01256450|11040828|FG001|NOT COMPLETED|Double-blind Treatment||28
9923454|NCT01256450|11040829|FG002|NOT COMPLETED|Double-blind Treatment||37
9923455|NCT01256476|11040838|FG000|STARTED|Overall Study||164
9923456|NCT01256476|11040839|FG001|STARTED|Overall Study||164
9923457|NCT01256476|11040838|FG000|COMPLETED|Overall Study||158
9923458|NCT01256476|11040839|FG001|COMPLETED|Overall Study||157
9923459|NCT01256476|11040838|FG000|NOT COMPLETED|Overall Study||6
9923460|NCT01256476|11040839|FG001|NOT COMPLETED|Overall Study||7
9923461|NCT01256502|11040845|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
9923462|NCT01256502|11040845|FG000|COMPLETED|Overall Study||129
9923463|NCT01256502|11040845|FG000|NOT COMPLETED|Overall Study||10
9923464|NCT01256567|11040854|FG000|STARTED|Overall Study||7
9923465|NCT01256567|11040854|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
9923466|NCT01256567|11040854|FG000|COMPLETED|Overall Study||6
9923467|NCT01256567|11040854|FG000|NOT COMPLETED|Overall Study||1
9923468|NCT01256593|11040859|FG000|STARTED|Overall Study||3827
9923469|NCT01256593|11040859|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
9923470|NCT01256593|11040859|FG000|NOT COMPLETED|Overall Study||214
9923471|NCT01256658|11040865|FG000|STARTED|Period 1||6817
9923472|NCT01256658|11040866|FG001|STARTED|Period 1||7258
9923473|NCT01256658|11040865|FG000|COMPLETED|Period 1||5897
9923474|NCT01256658|11040866|FG001|COMPLETED|Period 1||6510
9923475|NCT01256658|11040865|FG000|NOT COMPLETED|Period 1||920
9923476|NCT01256658|11040866|FG001|NOT COMPLETED|Period 1||748
9923477|NCT01256658|11040865|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
9923478|NCT01256658|11040866|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
9923479|NCT01256658|11040865|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
9923480|NCT01256658|11040866|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
9923481|NCT01256658|11040865|FG000|Death|Period 2 - Follow up Only - No Treatment||6
9923482|NCT01256658|11040866|FG001|Death|Period 2 - Follow up Only - No Treatment||8
9923483|NCT01256658|11040865|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
9923484|NCT01256658|11040866|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
9923485|NCT01256658|11040865|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0
9923486|NCT01256658|11040866|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0
9923487|NCT01256658|11040865|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
9923488|NCT01256658|11040866|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
9923489|NCT01256671|11040875|FG000|STARTED|Overall Study||530
9923490|NCT01256671|11040875|FG000|Safety Population|Overall Study||521
9923491|NCT01256671|11040875|FG000|COMPLETED|Overall Study||435
9923492|NCT01256671|11040875|FG000|NOT COMPLETED|Overall Study||95
9923493|NCT01256684|11040882|FG000|STARTED|Overall Study||81
9923494|NCT01256684|11040883|FG001|STARTED|Overall Study||87
9923495|NCT01256684|11040884|FG002|STARTED|Overall Study||87
9923496|NCT01256684|11040882|FG000|Safety Population|Overall Study||80
9923497|NCT01256684|11040883|FG001|Safety Population|Overall Study||86
9923498|NCT01256684|11040884|FG002|Safety Population|Overall Study||87
9923499|NCT01256684|11040882|FG000|ITT Population|Overall Study||77
9923500|NCT01256684|11040883|FG001|ITT Population|Overall Study||79
9923501|NCT01256684|11040884|FG002|ITT Population|Overall Study||81
9923502|NCT01256684|11040882|FG000|COMPLETED|Overall Study||72
9923503|NCT01256684|11040883|FG001|COMPLETED|Overall Study||74
9923504|NCT01256684|11040884|FG002|COMPLETED|Overall Study||76
9923505|NCT01256684|11040882|FG000|NOT COMPLETED|Overall Study||9
9923506|NCT01256684|11040883|FG001|NOT COMPLETED|Overall Study||13
9923507|NCT01256684|11040884|FG002|NOT COMPLETED|Overall Study||11
9923508|NCT01256788|11040895|FG000|STARTED|Overall Study||12
9923509|NCT01256788|11040896|FG001|STARTED|Overall Study||14
9923510|NCT01256788|11040897|FG002|STARTED|Overall Study||8
9923511|NCT01256788|11040895|FG000|COMPLETED|Overall Study||7
9923512|NCT01256788|11040896|FG001|COMPLETED|Overall Study||6
9923513|NCT01256788|11040897|FG002|COMPLETED|Overall Study||5
9923514|NCT01256788|11040895|FG000|NOT COMPLETED|Overall Study||5
9923515|NCT01256788|11040896|FG001|NOT COMPLETED|Overall Study||8
9923516|NCT01256788|11040897|FG002|NOT COMPLETED|Overall Study||3
9923517|NCT01256840|11040908|FG000|STARTED|Overall Study||30
9923518|NCT01256840|11040909|FG001|STARTED|Overall Study||16
9923519|NCT01256840|11040910|FG002|STARTED|Overall Study||25
9923520|NCT01256840|11040908|FG000|COMPLETED|Overall Study||30
9923521|NCT01256840|11040909|FG001|COMPLETED|Overall Study||16
9923522|NCT01256840|11040910|FG002|COMPLETED|Overall Study||25
9923523|NCT01256840|11040908|FG000|NOT COMPLETED|Overall Study||0
9923524|NCT01256840|11040909|FG001|NOT COMPLETED|Overall Study||0
9923525|NCT01256840|11040910|FG002|NOT COMPLETED|Overall Study||0
9923526|NCT01256879|11040918|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
9923527|NCT01256879|11040918|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
9923528|NCT01256879|11040918|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
9923529|NCT01256879|11040918|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
9923530|NCT01256879|11040918|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
9923531|NCT01256879|11040918|FG000|COMPLETED|Overall Study||24
9923532|NCT01256879|11040918|FG000|NOT COMPLETED|Overall Study||1
9923533|NCT01256918|11040928|FG000|STARTED|Overall Study||200
9923534|NCT01256918|11040928|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200
9923535|NCT01256918|11040928|FG000|COMPLETED|Overall Study||200
9923536|NCT01256918|11040928|FG000|NOT COMPLETED|Overall Study||0
9923537|NCT01256944|11040941|FG000|STARTED|Overall Study||70
9923538|NCT01256944|11040942|FG001|STARTED|Overall Study||220
9923539|NCT01256944|11040941|FG000|COMPLETED|Overall Study||70
9923540|NCT01256944|11040942|FG001|COMPLETED|Overall Study||220
9923541|NCT01256944|11040941|FG000|NOT COMPLETED|Overall Study||0
9923542|NCT01256944|11040942|FG001|NOT COMPLETED|Overall Study||0
9923543|NCT01256983|11040954|FG000|STARTED|Overall Study||15
9923544|NCT01256983|11040955|FG001|STARTED|Overall Study||15
9923545|NCT01256983|11040954|FG000|COMPLETED|Overall Study||14
9923546|NCT01256983|11040955|FG001|COMPLETED|Overall Study||12
9923547|NCT01256983|11040954|FG000|NOT COMPLETED|Overall Study||1
9923548|NCT01256983|11040955|FG001|NOT COMPLETED|Overall Study||3
9923549|NCT01257087|11040963|FG000|STARTED|Overall Study||18
9923550|NCT01257087|11040964|FG001|STARTED|Overall Study||17
9923551|NCT01257087|11040963|FG000|COMPLETED|Overall Study||18
9923552|NCT01257087|11040964|FG001|COMPLETED|Overall Study||17
9923553|NCT01257087|11040963|FG000|NOT COMPLETED|Overall Study||0
9923554|NCT01257087|11040964|FG001|NOT COMPLETED|Overall Study||0
9923555|NCT01257204|11040973|FG000|STARTED|Treatment Period (up to Week 24)||50
9923556|NCT01257204|11040974|FG001|STARTED|Treatment Period (up to Week 24)||50
9923557|NCT01257204|11040975|FG002|STARTED|Treatment Period (up to Week 24)||51
9923558|NCT01257204|11040973|FG000|COMPLETED|Treatment Period (up to Week 24)||45
9923559|NCT01257204|11040974|FG001|COMPLETED|Treatment Period (up to Week 24)||44
9923560|NCT01257204|11040975|FG002|COMPLETED|Treatment Period (up to Week 24)||42
9923561|NCT01257204|11040973|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5
9923562|NCT01257204|11040974|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
9923563|NCT01257204|11040975|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
9923564|NCT01257204|11040973|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
9923565|NCT01257204|11040974|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
9923566|NCT01257204|11040975|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
9923567|NCT01257204|11040973|FG000|COMPLETED|Follow-up Period (up to Week 48)||48
9923568|NCT01257204|11040974|FG001|COMPLETED|Follow-up Period (up to Week 48)||41
9923569|NCT01257204|11040975|FG002|COMPLETED|Follow-up Period (up to Week 48)||39
9923570|NCT01257204|11040973|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1
9923571|NCT01257204|11040974|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6
9923572|NCT01257204|11040975|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10
9923573|NCT01257217|11040997|FG000|STARTED|Overall Study||15
9923574|NCT01257217|11040998|FG001|STARTED|Overall Study||10
9923575|NCT01257217|11040997|FG000|COMPLETED|Overall Study||13
9923576|NCT01257217|11040998|FG001|COMPLETED|Overall Study||10
9923577|NCT01257217|11040997|FG000|NOT COMPLETED|Overall Study||2
9923578|NCT01257217|11040998|FG001|NOT COMPLETED|Overall Study||0
9923579|NCT01257230|11041011|FG000|STARTED|Overall Study||138
9923580|NCT01257230|11041012|FG001|STARTED|Overall Study||125
9923581|NCT01257230|11041013|FG002|STARTED|Overall Study||135
9923582|NCT01257230|11041011|FG000|COMPLETED|Overall Study||132
9923583|NCT01257230|11041012|FG001|COMPLETED|Overall Study||115
9923584|NCT01257230|11041013|FG002|COMPLETED|Overall Study||129
9923585|NCT01257230|11041011|FG000|NOT COMPLETED|Overall Study||6
9923586|NCT01257230|11041012|FG001|NOT COMPLETED|Overall Study||10
9923587|NCT01257230|11041013|FG002|NOT COMPLETED|Overall Study||6
9923588|NCT01257347|11041026|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
9923589|NCT01257347|11041027|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
9923590|NCT01257347|11041028|FG002|STARTED|Overall Study||35
9923591|NCT01257347|11041029|FG003|STARTED|Overall Study||65
9923592|NCT01257347|11041026|FG000|COMPLETED|Overall Study||12
9923593|NCT01257347|11041027|FG001|COMPLETED|Overall Study||12
9923594|NCT01257347|11041028|FG002|COMPLETED|Overall Study||35
9923595|NCT01257347|11041029|FG003|COMPLETED|Overall Study||65
9923596|NCT01257347|11041026|FG000|NOT COMPLETED|Overall Study||0
9923597|NCT01257347|11041027|FG001|NOT COMPLETED|Overall Study||0
9923598|NCT01257347|11041028|FG002|NOT COMPLETED|Overall Study||0
9923599|NCT01257347|11041029|FG003|NOT COMPLETED|Overall Study||0
9923600|NCT01257425|11041044|FG000|STARTED|Overall Study||52
9923601|NCT01257425|11041045|FG001|STARTED|Overall Study||51
9923602|NCT01257425|11041044|FG000|COMPLETED|Overall Study||46
9923603|NCT01257425|11041045|FG001|COMPLETED|Overall Study||45
9923604|NCT01257425|11041044|FG000|NOT COMPLETED|Overall Study||6
9923605|NCT01257425|11041045|FG001|NOT COMPLETED|Overall Study||6
9923606|NCT01257438|11041053|FG000|STARTED|Overall Study||132
9923607|NCT01257438|11041054|FG001|STARTED|Overall Study||143
9923608|NCT01257438|11041053|FG000|COMPLETED|Overall Study||102
9923609|NCT01257438|11041054|FG001|COMPLETED|Overall Study||97
9923610|NCT01257438|11041053|FG000|NOT COMPLETED|Overall Study||30
9923611|NCT01257438|11041054|FG001|NOT COMPLETED|Overall Study||46
9923612|NCT01257503|11041062|FG000|STARTED|Overall Study||133
9923613|NCT01257503|11041063|FG001|STARTED|Overall Study||130
9923614|NCT01257503|11041062|FG000|Returned Symptom Diaries|Overall Study||80
9923615|NCT01257503|11041063|FG001|Returned Symptom Diaries|Overall Study||83
9923616|NCT01257503|11041062|FG000|Returned Dosage Logbooks|Overall Study||75
9923617|NCT01257503|11041063|FG001|Returned Dosage Logbooks|Overall Study||80
9923618|NCT01257503|11041062|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
9923619|NCT01257503|11041063|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
9923620|NCT01257503|11041062|FG000|NOT COMPLETED|Overall Study||8
9923621|NCT01257503|11041063|FG001|NOT COMPLETED|Overall Study||11
9923622|NCT01257542|11041071|FG000|STARTED|Overall Study||55
9923623|NCT01257542|11041072|FG001|STARTED|Overall Study||52
9923624|NCT01257542|11041071|FG000|COMPLETED|Overall Study||52
9923625|NCT01257542|11041072|FG001|COMPLETED|Overall Study||45
9923626|NCT01257542|11041071|FG000|NOT COMPLETED|Overall Study||3
9923627|NCT01257542|11041072|FG001|NOT COMPLETED|Overall Study||7
9923628|NCT01257581|11041081|FG000|STARTED|Overall Study||22
9923629|NCT01257581|11041082|FG001|STARTED|Overall Study||21
9923630|NCT01257581|11041083|FG002|STARTED|Overall Study||17
9923631|NCT01257581|11041081|FG000|COMPLETED|Overall Study||17
9923632|NCT01257581|11041082|FG001|COMPLETED|Overall Study||18
9923633|NCT01257581|11041083|FG002|COMPLETED|Overall Study||11
9923634|NCT01257581|11041081|FG000|NOT COMPLETED|Overall Study||5
9923635|NCT01257581|11041082|FG001|NOT COMPLETED|Overall Study||3
9923636|NCT01257581|11041083|FG002|NOT COMPLETED|Overall Study||6
9923637|NCT01257698|11041093|FG000|STARTED|Overall Study||12
9923638|NCT01257698|11041094|FG001|STARTED|Overall Study||9
9923639|NCT01257698|11041093|FG000|COMPLETED|Overall Study||8
9923640|NCT01257698|11041094|FG001|COMPLETED|Overall Study||9
9923641|NCT01257698|11041093|FG000|NOT COMPLETED|Overall Study||4
9923642|NCT01257698|11041094|FG001|NOT COMPLETED|Overall Study||0
9923643|NCT01257737|11041102|FG000|STARTED|Overall Study||45
9923644|NCT01257737|11041103|FG001|STARTED|Overall Study||43
9923645|NCT01257737|11041102|FG000|COMPLETED|Overall Study||43
9923646|NCT01257737|11041103|FG001|COMPLETED|Overall Study||39
9923647|NCT01257737|11041102|FG000|NOT COMPLETED|Overall Study||2
9923648|NCT01257737|11041103|FG001|NOT COMPLETED|Overall Study||4
9923649|NCT01257750|11041110|FG000|STARTED|Overall Study||20
9923650|NCT01257750|11041110|FG000|COMPLETED|Overall Study||20
9923651|NCT01257750|11041110|FG000|NOT COMPLETED|Overall Study||0
9923652|NCT01257802|11041117|FG000|STARTED|Overall Study||6
9923653|NCT01257802|11041118|FG001|STARTED|Overall Study||8
9923654|NCT01257802|11041117|FG000|6 Month / 24 Week Visit|Overall Study||5
9923655|NCT01257802|11041118|FG001|6 Month / 24 Week Visit|Overall Study||2
9923656|NCT01257802|11041117|FG000|COMPLETED|Overall Study||5
9923657|NCT01257802|11041118|FG001|COMPLETED|Overall Study||2
9923658|NCT01257802|11041117|FG000|NOT COMPLETED|Overall Study||1
9923659|NCT01257802|11041118|FG001|NOT COMPLETED|Overall Study||6
9923660|NCT01257880|11041127|FG000|STARTED|Overall Study||12
9923661|NCT01257880|11041128|FG001|STARTED|Overall Study||19
9923662|NCT01257880|11041127|FG000|COMPLETED|Overall Study||12
9923663|NCT01257880|11041128|FG001|COMPLETED|Overall Study||19
9923664|NCT01257880|11041127|FG000|NOT COMPLETED|Overall Study||0
9923665|NCT01257880|11041128|FG001|NOT COMPLETED|Overall Study||0
9923666|NCT01258049|11041136|FG000|STARTED|Overall Study||77
9923667|NCT01258049|11041137|FG001|STARTED|Overall Study||74
9923668|NCT01258049|11041136|FG000|COMPLETED|Overall Study||75
9923669|NCT01258049|11041137|FG001|COMPLETED|Overall Study||72
9923670|NCT01258049|11041136|FG000|NOT COMPLETED|Overall Study||2
9923671|NCT01258049|11041137|FG001|NOT COMPLETED|Overall Study||2
9923672|NCT01258075|11041145|FG000|STARTED|Overall Study||141
9923673|NCT01258075|11041146|FG001|STARTED|Overall Study||95
9923674|NCT01258075|11041145|FG000|COMPLETED|Overall Study||99
9923675|NCT01258075|11041146|FG001|COMPLETED|Overall Study||72
9923676|NCT01258075|11041145|FG000|NOT COMPLETED|Overall Study||42
9923677|NCT01258075|11041146|FG001|NOT COMPLETED|Overall Study||23
9923678|NCT01258101|11041156|FG000|STARTED|Overall Study||151
9923679|NCT01258101|11041157|FG001|STARTED|Overall Study||144
9923680|NCT01258101|11041158|FG002|STARTED|Overall Study||33
9923681|NCT01258101|11041159|FG003|STARTED|Overall Study||52
9923682|NCT01258101|11041156|FG000|Safety Analysis Population|Overall Study||144
9923683|NCT01258101|11041157|FG001|Safety Analysis Population|Overall Study||141
9923684|NCT01258101|11041158|FG002|Safety Analysis Population|Overall Study||30
9923685|NCT01258101|11041159|FG003|Safety Analysis Population|Overall Study||48
9923686|NCT01258101|11041156|FG000|Standard Analysis Population|Overall Study||115
9923687|NCT01258101|11041157|FG001|Standard Analysis Population|Overall Study||110
9923688|NCT01258101|11041158|FG002|Standard Analysis Population|Overall Study||21
9923689|NCT01258101|11041159|FG003|Standard Analysis Population|Overall Study||26
9923690|NCT01258101|11041156|FG000|COMPLETED|Overall Study||118
9923691|NCT01258101|11041157|FG001|COMPLETED|Overall Study||110
9923692|NCT01258101|11041158|FG002|COMPLETED|Overall Study||22
9923693|NCT01258101|11041159|FG003|COMPLETED|Overall Study||27
9923694|NCT01258101|11041156|FG000|NOT COMPLETED|Overall Study||33
9923695|NCT01258101|11041157|FG001|NOT COMPLETED|Overall Study||34
9923696|NCT01258101|11041158|FG002|NOT COMPLETED|Overall Study||11
9923697|NCT01258101|11041159|FG003|NOT COMPLETED|Overall Study||25
9923698|NCT01258153|11041172|FG000|STARTED|Overall Study||40
9923699|NCT01258153|11041173|FG001|STARTED|Overall Study||38
9923700|NCT01258153|11041174|FG002|STARTED|Overall Study||37
9923701|NCT01258153|11041172|FG000|COMPLETED|Overall Study||39
9923702|NCT01258153|11041173|FG001|COMPLETED|Overall Study||37
10010620|NCT01775189|11133362|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
10010621|NCT01775189|11133363|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
10010622|NCT01775189|11133364|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
10010623|NCT01775189|11133365|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
9923703|NCT01258153|11041174|FG002|COMPLETED|Overall Study||36
9923704|NCT01258153|11041172|FG000|NOT COMPLETED|Overall Study||1
9923705|NCT01258153|11041173|FG001|NOT COMPLETED|Overall Study||1
9923706|NCT01258153|11041174|FG002|NOT COMPLETED|Overall Study||1
9923707|NCT01258348|11041184|FG000|STARTED|Overall Study||1
9923708|NCT01258348|11041185|FG001|STARTED|Overall Study||5
9923709|NCT01258348|11041186|FG002|STARTED|Overall Study||3
9923710|NCT01258348|11041187|FG003|STARTED|Overall Study||6
9923711|NCT01258348|11041188|FG004|STARTED|Overall Study||6
9923712|NCT01258348|11041184|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
9923713|NCT01258348|11041185|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
9923714|NCT01258348|11041186|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9923715|NCT01258348|11041187|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9923716|NCT01258348|11041188|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
9923717|NCT01258348|11041184|FG000|COMPLETED|Overall Study||0
9923718|NCT01258348|11041185|FG001|COMPLETED|Overall Study||0
9923719|NCT01258348|11041186|FG002|COMPLETED|Overall Study||0
9923720|NCT01258348|11041187|FG003|COMPLETED|Overall Study||0
9923721|NCT01258348|11041188|FG004|COMPLETED|Overall Study||0
9923722|NCT01258348|11041184|FG000|NOT COMPLETED|Overall Study||1
9923723|NCT01258348|11041185|FG001|NOT COMPLETED|Overall Study||5
9923724|NCT01258348|11041186|FG002|NOT COMPLETED|Overall Study||3
9923725|NCT01258348|11041187|FG003|NOT COMPLETED|Overall Study||6
9923726|NCT01258348|11041188|FG004|NOT COMPLETED|Overall Study||6
9923727|NCT01258374|11041202|FG000|STARTED|Overall Study||15
9923728|NCT01258374|11041202|FG000|COMPLETED|Overall Study||15
9923729|NCT01258374|11041202|FG000|NOT COMPLETED|Overall Study||0
9923730|NCT01258387|11041215|FG000|STARTED|Overall Study||6
9923731|NCT01258387|11041216|FG001|STARTED|Overall Study||6
9923732|NCT01258387|11041217|FG002|STARTED|Overall Study||6
9923733|NCT01258387|11041218|FG003|STARTED|Overall Study||6
9923734|NCT01258387|11041219|FG004|STARTED|Overall Study||6
9923735|NCT01258387|11041220|FG005|STARTED|Overall Study||6
9923736|NCT01258387|11041221|FG006|STARTED|Overall Study||4
9923737|NCT01258387|11041215|FG000|Patients Randomized to GGF2|Overall Study||4
9923738|NCT01258387|11041216|FG001|Patients Randomized to GGF2|Overall Study||4
9923739|NCT01258387|11041217|FG002|Patients Randomized to GGF2|Overall Study||4
9923740|NCT01258387|11041218|FG003|Patients Randomized to GGF2|Overall Study||4
9923741|NCT01258387|11041219|FG004|Patients Randomized to GGF2|Overall Study||4
9923742|NCT01258387|11041220|FG005|Patients Randomized to GGF2|Overall Study||4
9923743|NCT01258387|11041221|FG006|Patients Randomized to GGF2|Overall Study||3
9923744|NCT01258387|11041215|FG000|Patients Randomized to Placebo|Overall Study||2
9923745|NCT01258387|11041216|FG001|Patients Randomized to Placebo|Overall Study||2
9923746|NCT01258387|11041217|FG002|Patients Randomized to Placebo|Overall Study||2
9923747|NCT01258387|11041218|FG003|Patients Randomized to Placebo|Overall Study||2
9923748|NCT01258387|11041219|FG004|Patients Randomized to Placebo|Overall Study||2
9923749|NCT01258387|11041220|FG005|Patients Randomized to Placebo|Overall Study||2
9923750|NCT01258387|11041221|FG006|Patients Randomized to Placebo|Overall Study||1
9923751|NCT01258387|11041215|FG000|COMPLETED|Overall Study||6
9923752|NCT01258387|11041216|FG001|COMPLETED|Overall Study||6
9923753|NCT01258387|11041217|FG002|COMPLETED|Overall Study||6
9923754|NCT01258387|11041218|FG003|COMPLETED|Overall Study||6
9923755|NCT01258387|11041219|FG004|COMPLETED|Overall Study||6
9923756|NCT01258387|11041220|FG005|COMPLETED|Overall Study||6
9923757|NCT01258387|11041221|FG006|COMPLETED|Overall Study||4
9923758|NCT01258387|11041215|FG000|NOT COMPLETED|Overall Study||0
9923759|NCT01258387|11041216|FG001|NOT COMPLETED|Overall Study||0
9923760|NCT01258387|11041217|FG002|NOT COMPLETED|Overall Study||0
9923761|NCT01258387|11041218|FG003|NOT COMPLETED|Overall Study||0
9923762|NCT01258387|11041219|FG004|NOT COMPLETED|Overall Study||0
9923763|NCT01258387|11041220|FG005|NOT COMPLETED|Overall Study||0
9923764|NCT01258387|11041221|FG006|NOT COMPLETED|Overall Study||0
9923765|NCT01258504|11041239|FG000|STARTED|Bosentan Single Dose||13
9923766|NCT01258504|11041239|FG000|COMPLETED|Bosentan Single Dose||13
9923767|NCT01258504|11041239|FG000|NOT COMPLETED|Bosentan Single Dose||0
9923768|NCT01258504|11041239|FG000|STARTED|Bosentan Steady-state||13
9923769|NCT01258504|11041239|FG000|COMPLETED|Bosentan Steady-state||13
9923770|NCT01258504|11041239|FG000|NOT COMPLETED|Bosentan Steady-state||0
9923771|NCT01258504|11041239|FG000|STARTED|Bosentan and SJW||13
9923772|NCT01258504|11041239|FG000|COMPLETED|Bosentan and SJW||13
9923773|NCT01258504|11041239|FG000|NOT COMPLETED|Bosentan and SJW||0
9923774|NCT01258582|11041250|FG000|STARTED|Overall Study||830
9923775|NCT01258582|11041251|FG001|STARTED|Overall Study||821
9923776|NCT01258582|11041250|FG000|COMPLETED|Overall Study||548
9923777|NCT01258582|11041251|FG001|COMPLETED|Overall Study||563
9923778|NCT01258582|11041250|FG000|NOT COMPLETED|Overall Study||282
10010624|NCT01775189|11133366|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
9923779|NCT01258582|11041251|FG001|NOT COMPLETED|Overall Study||258
9923780|NCT01258595|11041259|FG000|STARTED|Overall Study||148
9923781|NCT01258595|11041260|FG001|STARTED|Overall Study||152
9923782|NCT01258595|11041259|FG000|COMPLETED|Overall Study||147
9923783|NCT01258595|11041260|FG001|COMPLETED|Overall Study||151
9923784|NCT01258595|11041259|FG000|NOT COMPLETED|Overall Study||1
9923785|NCT01258595|11041260|FG001|NOT COMPLETED|Overall Study||1
9923786|NCT01258608|11041268|FG000|STARTED|Overall Study||51
9923787|NCT01258608|11041269|FG001|STARTED|Overall Study||50
9923788|NCT01258608|11041268|FG000|COMPLETED|Overall Study||30
9923789|NCT01258608|11041269|FG001|COMPLETED|Overall Study||31
9923790|NCT01258608|11041268|FG000|NOT COMPLETED|Overall Study||21
10205377|NCT03491553|11332175|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10205378|NCT03491553|11332176|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10205379|NCT03491553|11332177|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10205380|NCT03491553|11332172|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9923791|NCT01258608|11041269|FG001|NOT COMPLETED|Overall Study||19
9923792|NCT01258660|11041278|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86
9923793|NCT01258660|11041279|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86
9923794|NCT01258660|11041278|FG000|Received Treatment|Overall Study||79
9923795|NCT01258660|11041279|FG001|Received Treatment|Overall Study||82
9923796|NCT01258660|11041278|FG000|Completed Treatment|Overall Study||79
9923797|NCT01258660|11041279|FG001|Completed Treatment|Overall Study||81
9923798|NCT01258660|11041278|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
9923799|NCT01258660|11041279|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
9923800|NCT01258660|11041278|FG000|NOT COMPLETED|Overall Study||11
9923801|NCT01258660|11041279|FG001|NOT COMPLETED|Overall Study||11
9923802|NCT01258738|11041288|FG000|STARTED|Double-blind Period||111
9923803|NCT01258738|11041289|FG001|STARTED|Double-blind Period||114
9923804|NCT01258738|11041288|FG000|Treated|Double-blind Period||111
9923805|NCT01258738|11041289|FG001|Treated|Double-blind Period||113
9923806|NCT01258738|11041288|FG000|COMPLETED|Double-blind Period||102
9923807|NCT01258738|11041289|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
9923808|NCT01258738|11041288|FG000|NOT COMPLETED|Double-blind Period||9
9923809|NCT01258738|11041289|FG001|NOT COMPLETED|Double-blind Period||7
9923810|NCT01258738|11041288|FG000|STARTED|Open-label Period||102
9923811|NCT01258738|11041289|FG001|STARTED|Open-label Period||106
9923812|NCT01258738|11041288|FG000|COMPLETED|Open-label Period||85
9923813|NCT01258738|11041289|FG001|COMPLETED|Open-label Period||85
9923814|NCT01258738|11041288|FG000|NOT COMPLETED|Open-label Period||17
9923815|NCT01258738|11041289|FG001|NOT COMPLETED|Open-label Period||21
9923816|NCT01258790|11041297|FG000|STARTED|Overall Study||6
9923817|NCT01258790|11041298|FG001|STARTED|Overall Study||6
9923818|NCT01258790|11041297|FG000|COMPLETED|Overall Study||6
9923819|NCT01258790|11041298|FG001|COMPLETED|Overall Study||6
9923820|NCT01258790|11041297|FG000|NOT COMPLETED|Overall Study||0
9923821|NCT01258790|11041298|FG001|NOT COMPLETED|Overall Study||0
9923822|NCT01258855|11041306|FG000|STARTED|Overall Study||55
9923823|NCT01258855|11041307|FG001|STARTED|Overall Study||29
9923824|NCT01258855|11041306|FG000|COMPLETED|Overall Study||55
9923825|NCT01258855|11041307|FG001|COMPLETED|Overall Study||29
9923826|NCT01258855|11041306|FG000|NOT COMPLETED|Overall Study||0
9923827|NCT01258855|11041307|FG001|NOT COMPLETED|Overall Study||0
9923828|NCT01258985|11041315|FG000|STARTED|Overall Study||106
9923829|NCT01258985|11041316|FG001|STARTED|Overall Study||98
9923830|NCT01258985|11041315|FG000|COMPLETED|Overall Study||106
9923831|NCT01258985|11041316|FG001|COMPLETED|Overall Study||98
9923832|NCT01258985|11041315|FG000|NOT COMPLETED|Overall Study||0
9923833|NCT01258985|11041316|FG001|NOT COMPLETED|Overall Study||0
9923834|NCT01258998|11041322|FG000|STARTED|Overall Study||60
9923835|NCT01258998|11041322|FG000|COMPLETED|Overall Study||59
9923836|NCT01258998|11041322|FG000|NOT COMPLETED|Overall Study||1
9923837|NCT01259011|11041328|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101
9923838|NCT01259011|11041329|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109
9923839|NCT01259011|11041328|FG000|COMPLETED|Main Study Period||101
9923840|NCT01259011|11041329|FG001|COMPLETED|Main Study Period||109
9923841|NCT01259011|11041328|FG000|NOT COMPLETED|Main Study Period||0
9923842|NCT01259011|11041329|FG001|NOT COMPLETED|Main Study Period||0
9923843|NCT01259011|11041328|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
9923844|NCT01259011|11041329|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
9923845|NCT01259011|11041328|FG000|COMPLETED|After Patient Death||17
9923846|NCT01259011|11041329|FG001|COMPLETED|After Patient Death||28
9923847|NCT01259011|11041328|FG000|NOT COMPLETED|After Patient Death||0
9923848|NCT01259011|11041329|FG001|NOT COMPLETED|After Patient Death||0
9923849|NCT01259063|11041337|FG000|STARTED|Overall Study||33
9923850|NCT01259063|11041337|FG000|COMPLETED|Overall Study||33
9923851|NCT01259063|11041337|FG000|NOT COMPLETED|Overall Study||0
9923852|NCT01259089|11041341|FG000|STARTED|Reached First Response at 4 Weeks||3
9923853|NCT01259089|11041342|FG001|STARTED|Reached First Response at 4 Weeks||3
9923854|NCT01259089|11041343|FG002|STARTED|Reached First Response at 4 Weeks||3
9923855|NCT01259089|11041344|FG003|STARTED|Reached First Response at 4 Weeks||3
10010625|NCT01775189|11133360|FG000|STARTED|Treatment Phase: Washout Period 1||0
10010626|NCT01775189|11133361|FG001|STARTED|Treatment Phase: Washout Period 1||0
10010627|NCT01775189|11133362|FG002|STARTED|Treatment Phase: Washout Period 1||0
10010628|NCT01775189|11133363|FG003|STARTED|Treatment Phase: Washout Period 1||8
10010629|NCT01775189|11133364|FG004|STARTED|Treatment Phase: Washout Period 1||8
10010630|NCT01775189|11133365|FG005|STARTED|Treatment Phase: Washout Period 1||8
10010631|NCT01775189|11133366|FG006|STARTED|Treatment Phase: Washout Period 1||8
10010632|NCT01775189|11133360|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
9923856|NCT01259089|11041345|FG004|STARTED|Reached First Response at 4 Weeks||6
9923857|NCT01259089|11041346|FG005|STARTED|Reached First Response at 4 Weeks||20
9923858|NCT01259089|11041341|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3
9923859|NCT01259089|11041342|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3
9923860|NCT01259089|11041343|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3
9923861|NCT01259089|11041344|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3
9923862|NCT01259089|11041345|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6
9923863|NCT01259089|11041346|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19
9923864|NCT01259089|11041341|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
9923865|NCT01259089|11041342|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
9923866|NCT01259089|11041343|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
9923867|NCT01259089|11041344|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
9923868|NCT01259089|11041345|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
9923869|NCT01259089|11041346|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
9923870|NCT01259089|11041341|FG000|COMPLETED|Reached First Response at 4 Weeks||3
9923871|NCT01259089|11041342|FG001|COMPLETED|Reached First Response at 4 Weeks||3
9923872|NCT01259089|11041343|FG002|COMPLETED|Reached First Response at 4 Weeks||3
9923873|NCT01259089|11041344|FG003|COMPLETED|Reached First Response at 4 Weeks||3
9923874|NCT01259089|11041345|FG004|COMPLETED|Reached First Response at 4 Weeks||6
9923875|NCT01259089|11041346|FG005|COMPLETED|Reached First Response at 4 Weeks||18
9923876|NCT01259089|11041341|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0
9923877|NCT01259089|11041342|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0
9923878|NCT01259089|11041343|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0
9923879|NCT01259089|11041344|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0
9923880|NCT01259089|11041345|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0
9923881|NCT01259089|11041346|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2
9923882|NCT01259089|11041341|FG000|STARTED|Confirmed Response at 8 Weeks||3
9923883|NCT01259089|11041342|FG001|STARTED|Confirmed Response at 8 Weeks||3
9923884|NCT01259089|11041343|FG002|STARTED|Confirmed Response at 8 Weeks||3
9923885|NCT01259089|11041344|FG003|STARTED|Confirmed Response at 8 Weeks||3
9923886|NCT01259089|11041345|FG004|STARTED|Confirmed Response at 8 Weeks||6
9923887|NCT01259089|11041346|FG005|STARTED|Confirmed Response at 8 Weeks||18
9923888|NCT01259089|11041341|FG000|COMPLETED|Confirmed Response at 8 Weeks||3
9923889|NCT01259089|11041342|FG001|COMPLETED|Confirmed Response at 8 Weeks||3
9923890|NCT01259089|11041343|FG002|COMPLETED|Confirmed Response at 8 Weeks||2
9923891|NCT01259089|11041344|FG003|COMPLETED|Confirmed Response at 8 Weeks||2
9923892|NCT01259089|11041345|FG004|COMPLETED|Confirmed Response at 8 Weeks||2
9923893|NCT01259089|11041346|FG005|COMPLETED|Confirmed Response at 8 Weeks||8
9923894|NCT01259089|11041341|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0
9923895|NCT01259089|11041342|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0
9923896|NCT01259089|11041343|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1
9923897|NCT01259089|11041344|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1
9923898|NCT01259089|11041345|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4
9923899|NCT01259089|11041346|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10
9923900|NCT01259089|11041341|FG000|STARTED|Continued Treatment After 8 Weeks||3
9923901|NCT01259089|11041342|FG001|STARTED|Continued Treatment After 8 Weeks||3
9923902|NCT01259089|11041343|FG002|STARTED|Continued Treatment After 8 Weeks||2
9923903|NCT01259089|11041344|FG003|STARTED|Continued Treatment After 8 Weeks||2
9923904|NCT01259089|11041345|FG004|STARTED|Continued Treatment After 8 Weeks||2
9923905|NCT01259089|11041346|FG005|STARTED|Continued Treatment After 8 Weeks||8
9923906|NCT01259089|11041341|FG000|COMPLETED|Continued Treatment After 8 Weeks||1
9923907|NCT01259089|11041342|FG001|COMPLETED|Continued Treatment After 8 Weeks||2
9923908|NCT01259089|11041343|FG002|COMPLETED|Continued Treatment After 8 Weeks||1
9923909|NCT01259089|11041344|FG003|COMPLETED|Continued Treatment After 8 Weeks||1
9923910|NCT01259089|11041345|FG004|COMPLETED|Continued Treatment After 8 Weeks||0
9923911|NCT01259089|11041346|FG005|COMPLETED|Continued Treatment After 8 Weeks||7
9923912|NCT01259089|11041341|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2
9923913|NCT01259089|11041342|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1
9923914|NCT01259089|11041343|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1
9923915|NCT01259089|11041344|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1
9923916|NCT01259089|11041345|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2
9923917|NCT01259089|11041346|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1
9923918|NCT01259089|11041341|FG000|STARTED|Survival Follow up for Two Years||3
9923919|NCT01259089|11041342|FG001|STARTED|Survival Follow up for Two Years||3
10010633|NCT01775189|11133361|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
10010634|NCT01775189|11133362|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
10010635|NCT01775189|11133363|FG003|COMPLETED|Treatment Phase: Washout Period 1||8
9923920|NCT01259089|11041343|FG002|STARTED|Survival Follow up for Two Years||3
9923921|NCT01259089|11041344|FG003|STARTED|Survival Follow up for Two Years||3
9923922|NCT01259089|11041345|FG004|STARTED|Survival Follow up for Two Years||6
9923923|NCT01259089|11041346|FG005|STARTED|Survival Follow up for Two Years||19
9923924|NCT01259089|11041341|FG000|COMPLETED|Survival Follow up for Two Years||0
9923925|NCT01259089|11041342|FG001|COMPLETED|Survival Follow up for Two Years||1
9923926|NCT01259089|11041343|FG002|COMPLETED|Survival Follow up for Two Years||1
9923927|NCT01259089|11041344|FG003|COMPLETED|Survival Follow up for Two Years||0
9923928|NCT01259089|11041345|FG004|COMPLETED|Survival Follow up for Two Years||0
9923929|NCT01259089|11041346|FG005|COMPLETED|Survival Follow up for Two Years||0
9923930|NCT01259089|11041341|FG000|NOT COMPLETED|Survival Follow up for Two Years||3
9923931|NCT01259089|11041342|FG001|NOT COMPLETED|Survival Follow up for Two Years||2
9923932|NCT01259089|11041343|FG002|NOT COMPLETED|Survival Follow up for Two Years||2
9923933|NCT01259089|11041344|FG003|NOT COMPLETED|Survival Follow up for Two Years||3
9923934|NCT01259089|11041345|FG004|NOT COMPLETED|Survival Follow up for Two Years||6
9923935|NCT01259089|11041346|FG005|NOT COMPLETED|Survival Follow up for Two Years||19
9923936|NCT01259102|11041365|FG000|STARTED|Overall Study||13
9923937|NCT01259102|11041366|FG001|STARTED|Overall Study||14
9923938|NCT01259102|11041367|FG002|STARTED|Overall Study||15
9923939|NCT01259102|11041368|FG003|STARTED|Overall Study||14
9923940|NCT01259102|11041369|FG004|STARTED|Overall Study||14
9923941|NCT01259102|11041365|FG000|COMPLETED|Overall Study||12
9923942|NCT01259102|11041366|FG001|COMPLETED|Overall Study||14
9923943|NCT01259102|11041367|FG002|COMPLETED|Overall Study||13
9923944|NCT01259102|11041368|FG003|COMPLETED|Overall Study||12
9923945|NCT01259102|11041369|FG004|COMPLETED|Overall Study||13
9923946|NCT01259102|11041365|FG000|NOT COMPLETED|Overall Study||1
9923947|NCT01259102|11041366|FG001|NOT COMPLETED|Overall Study||0
9923948|NCT01259102|11041367|FG002|NOT COMPLETED|Overall Study||2
9923949|NCT01259102|11041368|FG003|NOT COMPLETED|Overall Study||2
9923950|NCT01259102|11041369|FG004|NOT COMPLETED|Overall Study||1
9923951|NCT01259115|11041381|FG000|STARTED|Period 1||10
9923952|NCT01259115|11041382|FG001|STARTED|Period 1||10
9923953|NCT01259115|11041381|FG000|COMPLETED|Period 1||7
9923954|NCT01259115|11041382|FG001|COMPLETED|Period 1||9
9923955|NCT01259115|11041381|FG000|NOT COMPLETED|Period 1||3
9923956|NCT01259115|11041382|FG001|NOT COMPLETED|Period 1||1
9923957|NCT01259115|11041381|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7
9923958|NCT01259115|11041382|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9
9923959|NCT01259115|11041381|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7
9923960|NCT01259115|11041382|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9
9923961|NCT01259115|11041381|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
9923962|NCT01259115|11041382|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
9923963|NCT01259115|11041381|FG000|STARTED|Period 2||7
9923964|NCT01259115|11041382|FG001|STARTED|Period 2||9
9923965|NCT01259115|11041381|FG000|COMPLETED|Period 2||6
9923966|NCT01259115|11041382|FG001|COMPLETED|Period 2||9
9923967|NCT01259115|11041381|FG000|NOT COMPLETED|Period 2||1
9923968|NCT01259115|11041382|FG001|NOT COMPLETED|Period 2||0
9923969|NCT01259128|11041395|FG000|STARTED|Overall Study||15
9923970|NCT01259128|11041396|FG001|STARTED|Overall Study||17
9923971|NCT01259128|11041395|FG000|COMPLETED|Overall Study||15
9923972|NCT01259128|11041396|FG001|COMPLETED|Overall Study||15
9923973|NCT01259128|11041395|FG000|NOT COMPLETED|Overall Study||0
9923974|NCT01259128|11041396|FG001|NOT COMPLETED|Overall Study||2
9923975|NCT01259245|11041404|FG000|STARTED|Overall Study||98
9923976|NCT01259245|11041405|FG001|STARTED|Overall Study||94
9923977|NCT01259245|11041404|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
9923978|NCT01259245|11041405|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
9923979|NCT01259245|11041404|FG000|NOT COMPLETED|Overall Study||28
9923980|NCT01259245|11041405|FG001|NOT COMPLETED|Overall Study||26
9923981|NCT01259297|11041421|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
9923982|NCT01259297|11041422|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0
9923983|NCT01259297|11041423|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
9923984|NCT01259297|11041424|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0
9923985|NCT01259297|11041425|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0
9923986|NCT01259297|11041426|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0
9923987|NCT01259297|11041427|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0
9923988|NCT01259297|11041428|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0
9923989|NCT01259297|11041421|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
9923990|NCT01259297|11041422|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9923991|NCT01259297|11041423|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
9923992|NCT01259297|11041424|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10010636|NCT01775189|11133364|FG004|COMPLETED|Treatment Phase: Washout Period 1||8
10010637|NCT01775189|11133365|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
9923993|NCT01259297|11041425|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9923994|NCT01259297|11041426|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9923995|NCT01259297|11041427|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9923996|NCT01259297|11041428|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9923997|NCT01259297|11041421|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
9923998|NCT01259297|11041422|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10010638|NCT01775189|11133366|FG006|COMPLETED|Treatment Phase: Washout Period 1||8
9923999|NCT01259297|11041423|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
9924000|NCT01259297|11041424|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9924001|NCT01259297|11041425|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9924002|NCT01259297|11041426|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9924003|NCT01259297|11041427|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9924004|NCT01259297|11041428|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10010639|NCT01775189|11133360|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10010640|NCT01775189|11133361|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10010641|NCT01775189|11133362|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10010642|NCT01775189|11133363|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10010643|NCT01775189|11133364|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10010644|NCT01775189|11133365|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1
10010645|NCT01775189|11133366|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10010646|NCT01775189|11133360|FG000|STARTED|Treatment Phase: Second Intervention||0
10010647|NCT01775189|11133361|FG001|STARTED|Treatment Phase: Second Intervention||0
10010648|NCT01775189|11133362|FG002|STARTED|Treatment Phase: Second Intervention||0
10010649|NCT01775189|11133363|FG003|STARTED|Treatment Phase: Second Intervention||8
10010650|NCT01775189|11133364|FG004|STARTED|Treatment Phase: Second Intervention||8
10010651|NCT01775189|11133365|FG005|STARTED|Treatment Phase: Second Intervention||7
10010652|NCT01775189|11133366|FG006|STARTED|Treatment Phase: Second Intervention||8
10010653|NCT01775189|11133360|FG000|COMPLETED|Treatment Phase: Second Intervention||0
10010654|NCT01775189|11133361|FG001|COMPLETED|Treatment Phase: Second Intervention||0
10010655|NCT01775189|11133362|FG002|COMPLETED|Treatment Phase: Second Intervention||0
10010656|NCT01775189|11133363|FG003|COMPLETED|Treatment Phase: Second Intervention||8
9924005|NCT01259297|11041421|FG000|STARTED|Double Blind Randomized Period||244
9924006|NCT01259297|11041422|FG001|STARTED|Double Blind Randomized Period||232
9924007|NCT01259297|11041423|FG002|STARTED|Double Blind Randomized Period||189
9924008|NCT01259297|11041424|FG003|STARTED|Double Blind Randomized Period||195
9924009|NCT01259297|11041425|FG004|STARTED|Double Blind Randomized Period||251
9924010|NCT01259297|11041426|FG005|STARTED|Double Blind Randomized Period||253
9924011|NCT01259297|11041427|FG006|STARTED|Double Blind Randomized Period||196
9924012|NCT01259297|11041428|FG007|STARTED|Double Blind Randomized Period||199
9924013|NCT01259297|11041421|FG000|COMPLETED|Double Blind Randomized Period||242
9924014|NCT01259297|11041422|FG001|COMPLETED|Double Blind Randomized Period||229
9924015|NCT01259297|11041423|FG002|COMPLETED|Double Blind Randomized Period||188
9924016|NCT01259297|11041424|FG003|COMPLETED|Double Blind Randomized Period||191
9924017|NCT01259297|11041425|FG004|COMPLETED|Double Blind Randomized Period||247
9924018|NCT01259297|11041426|FG005|COMPLETED|Double Blind Randomized Period||245
9924019|NCT01259297|11041427|FG006|COMPLETED|Double Blind Randomized Period||190
9924020|NCT01259297|11041428|FG007|COMPLETED|Double Blind Randomized Period||196
9924021|NCT01259297|11041421|FG000|NOT COMPLETED|Double Blind Randomized Period||2
9924022|NCT01259297|11041422|FG001|NOT COMPLETED|Double Blind Randomized Period||3
9924023|NCT01259297|11041423|FG002|NOT COMPLETED|Double Blind Randomized Period||1
9924024|NCT01259297|11041424|FG003|NOT COMPLETED|Double Blind Randomized Period||4
9924025|NCT01259297|11041425|FG004|NOT COMPLETED|Double Blind Randomized Period||4
9924026|NCT01259297|11041426|FG005|NOT COMPLETED|Double Blind Randomized Period||8
9924027|NCT01259297|11041427|FG006|NOT COMPLETED|Double Blind Randomized Period||6
9924028|NCT01259297|11041428|FG007|NOT COMPLETED|Double Blind Randomized Period||3
9924029|NCT01259375|11041445|FG000|STARTED|Overall Study||24
9924030|NCT01259375|11041445|FG000|COMPLETED|Overall Study||23
9924031|NCT01259375|11041445|FG000|NOT COMPLETED|Overall Study||1
9924032|NCT01259388|11041453|FG000|STARTED|Overall Study||11
9924033|NCT01259388|11041454|FG001|STARTED|Overall Study||12
9924034|NCT01259388|11041453|FG000|COMPLETED|Overall Study||6
9924035|NCT01259388|11041454|FG001|COMPLETED|Overall Study||11
9924036|NCT01259388|11041453|FG000|NOT COMPLETED|Overall Study||5
9924037|NCT01259388|11041454|FG001|NOT COMPLETED|Overall Study||1
9924038|NCT01259401|11041462|FG000|STARTED|End of 4-week Intervention||21
9924039|NCT01259401|11041463|FG001|STARTED|End of 4-week Intervention||21
9924040|NCT01259401|11041462|FG000|COMPLETED|End of 4-week Intervention||21
9924041|NCT01259401|11041463|FG001|COMPLETED|End of 4-week Intervention||21
9924042|NCT01259401|11041462|FG000|NOT COMPLETED|End of 4-week Intervention||0
9924043|NCT01259401|11041463|FG001|NOT COMPLETED|End of 4-week Intervention||0
9924044|NCT01259401|11041462|FG000|STARTED|4-month Follow-up||21
9924045|NCT01259401|11041463|FG001|STARTED|4-month Follow-up||21
9924046|NCT01259401|11041462|FG000|COMPLETED|4-month Follow-up||21
9924047|NCT01259401|11041463|FG001|COMPLETED|4-month Follow-up||19
9924048|NCT01259401|11041462|FG000|NOT COMPLETED|4-month Follow-up||0
9924049|NCT01259401|11041463|FG001|NOT COMPLETED|4-month Follow-up||2
9924050|NCT01259427|11041471|FG000|STARTED|Overall Study||124
9924051|NCT01259427|11041472|FG001|STARTED|Overall Study||124
9924052|NCT01259427|11041471|FG000|COMPLETED|Overall Study||106
9924053|NCT01259427|11041472|FG001|COMPLETED|Overall Study||110
9924054|NCT01259427|11041471|FG000|NOT COMPLETED|Overall Study||18
9924055|NCT01259427|11041472|FG001|NOT COMPLETED|Overall Study||14
9924056|NCT01259440|11041481|FG000|STARTED|Overall Study||13
10010657|NCT01775189|11133364|FG004|COMPLETED|Treatment Phase: Second Intervention||8
10010658|NCT01775189|11133365|FG005|COMPLETED|Treatment Phase: Second Intervention||7
10010659|NCT01775189|11133366|FG006|COMPLETED|Treatment Phase: Second Intervention||8
10010660|NCT01775189|11133360|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
9924057|NCT01259440|11041482|FG001|STARTED|Overall Study||10
9924058|NCT01259440|11041481|FG000|COMPLETED|Overall Study||13
9924059|NCT01259440|11041482|FG001|COMPLETED|Overall Study||10
9924060|NCT01259440|11041481|FG000|NOT COMPLETED|Overall Study||0
9924061|NCT01259440|11041482|FG001|NOT COMPLETED|Overall Study||0
9924062|NCT01259466|11041490|FG000|STARTED|Overall Study||27
9924063|NCT01259466|11041491|FG001|STARTED|Overall Study||27
9924064|NCT01259466|11041490|FG000|COMPLETED|Overall Study||26
9924065|NCT01259466|11041491|FG001|COMPLETED|Overall Study||18
9924066|NCT01259466|11041490|FG000|NOT COMPLETED|Overall Study||1
9924067|NCT01259466|11041491|FG001|NOT COMPLETED|Overall Study||9
9924068|NCT01259492|11041501|FG000|STARTED|Period 1 (9 Weeks)||181
9924069|NCT01259492|11041502|FG001|STARTED|Period 1 (9 Weeks)||182
9924070|NCT01259492|11041503|FG002|STARTED|Period 1 (9 Weeks)||181
9924071|NCT01259492|11041504|FG003|STARTED|Period 1 (9 Weeks)||181
9924072|NCT01259492|11041501|FG000|Full Analysis Set|Period 1 (9 Weeks)||174
9924073|NCT01259492|11041502|FG001|Full Analysis Set|Period 1 (9 Weeks)||175
9924074|NCT01259492|11041503|FG002|Full Analysis Set|Period 1 (9 Weeks)||179
9924075|NCT01259492|11041504|FG003|Full Analysis Set|Period 1 (9 Weeks)||172
9924076|NCT01259492|11041501|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
9924077|NCT01259492|11041502|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
9924078|NCT01259492|11041503|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
9924079|NCT01259492|11041504|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
9924080|NCT01259492|11041501|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29
9924081|NCT01259492|11041502|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41
9924082|NCT01259492|11041503|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43
9924083|NCT01259492|11041504|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28
9924084|NCT01259492|11041501|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
9924085|NCT01259492|11041502|FG001|STARTED|Period 2 (Week 10 to Week 14)||141
9924086|NCT01259492|11041503|FG002|STARTED|Period 2 (Week 10 to Week 14)||138
9924087|NCT01259492|11041504|FG003|STARTED|Period 2 (Week 10 to Week 14)||153
9924088|NCT01259492|11041501|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
9924089|NCT01259492|11041502|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
9924090|NCT01259492|11041503|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
9924091|NCT01259492|11041504|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
9924092|NCT01259492|11041501|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
9924093|NCT01259492|11041502|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
9924094|NCT01259492|11041503|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
9924095|NCT01259492|11041504|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
9924096|NCT01259492|11041501|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
9924097|NCT01259492|11041502|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132
9924098|NCT01259492|11041503|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120
9924099|NCT01259492|11041504|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123
9924100|NCT01259492|11041501|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
9924101|NCT01259492|11041502|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
9924102|NCT01259492|11041503|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
9924103|NCT01259492|11041504|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
9924104|NCT01259492|11041501|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
9924105|NCT01259492|11041502|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
9924106|NCT01259492|11041503|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
9924107|NCT01259492|11041504|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
9924108|NCT01259492|11041501|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
9924109|NCT01259492|11041502|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
9924110|NCT01259492|11041503|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
9924111|NCT01259492|11041504|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
9924112|NCT01259596|11041515|FG000|STARTED|Overall Study||70
9924113|NCT01259596|11041516|FG001|STARTED|Overall Study||71
9924114|NCT01259596|11041515|FG000|COMPLETED|Overall Study||66
9924115|NCT01259596|11041516|FG001|COMPLETED|Overall Study||65
9924116|NCT01259596|11041515|FG000|NOT COMPLETED|Overall Study||4
9924117|NCT01259596|11041516|FG001|NOT COMPLETED|Overall Study||6
9924118|NCT01259713|11041526|FG000|STARTED|Overall Study||237
9924119|NCT01259713|11041527|FG001|STARTED|Overall Study||118
9924120|NCT01259713|11041526|FG000|COMPLETED|Overall Study||142
9924121|NCT01259713|11041527|FG001|COMPLETED|Overall Study||77
9924122|NCT01259713|11041526|FG000|NOT COMPLETED|Overall Study||95
9924123|NCT01259713|11041527|FG001|NOT COMPLETED|Overall Study||41
9924124|NCT01259726|11041537|FG000|STARTED|Overall Study||43
9924125|NCT01259726|11041538|FG001|STARTED|Overall Study||41
9924126|NCT01259726|11041539|FG002|STARTED|Overall Study||43
9924127|NCT01259726|11041540|FG003|STARTED|Overall Study||41
9924128|NCT01259726|11041537|FG000|Treated|Overall Study||40
9924129|NCT01259726|11041538|FG001|Treated|Overall Study||37
9924130|NCT01259726|11041539|FG002|Treated|Overall Study||41
9924131|NCT01259726|11041540|FG003|Treated|Overall Study||39
10010661|NCT01775189|11133361|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
10010662|NCT01775189|11133362|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
10010663|NCT01775189|11133363|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
9924132|NCT01259726|11041537|FG000|COMPLETED|Overall Study||38
9924133|NCT01259726|11041538|FG001|COMPLETED|Overall Study||37
9924134|NCT01259726|11041539|FG002|COMPLETED|Overall Study||39
9924135|NCT01259726|11041540|FG003|COMPLETED|Overall Study||36
9924136|NCT01259726|11041537|FG000|NOT COMPLETED|Overall Study||5
9924137|NCT01259726|11041538|FG001|NOT COMPLETED|Overall Study||4
9924138|NCT01259726|11041539|FG002|NOT COMPLETED|Overall Study||4
9924139|NCT01259726|11041540|FG003|NOT COMPLETED|Overall Study||5
9924140|NCT01259856|11041552|FG000|STARTED|Overall Study||82
9924141|NCT01259856|11041553|FG001|STARTED|Overall Study||86
9924142|NCT01259856|11041552|FG000|COMPLETED|Overall Study||13
9924143|NCT01259856|11041553|FG001|COMPLETED|Overall Study||12
9924144|NCT01259856|11041552|FG000|NOT COMPLETED|Overall Study||69
9924145|NCT01259856|11041553|FG001|NOT COMPLETED|Overall Study||74
9924146|NCT01259869|11041559|FG000|STARTED|Overall Study||34
9924147|NCT01259869|11041559|FG000|COMPLETED|Overall Study||33
9924148|NCT01259869|11041559|FG000|NOT COMPLETED|Overall Study||1
9924149|NCT01260142|11041569|FG000|STARTED|Treatment Period 1||6
9924150|NCT01260142|11041570|FG001|STARTED|Treatment Period 1||6
9924151|NCT01260142|11041571|FG002|STARTED|Treatment Period 1||6
10010664|NCT01775189|11133364|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
10010665|NCT01775189|11133365|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
10010666|NCT01775189|11133366|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
10010667|NCT01775189|11133360|FG000|STARTED|Treatment Phase: Washout Period 2||0
9924152|NCT01260142|11041572|FG003|STARTED|Treatment Period 1||6
9924153|NCT01260142|11041573|FG004|STARTED|Treatment Period 1||6
9924154|NCT01260142|11041574|FG005|STARTED|Treatment Period 1||6
9924155|NCT01260142|11041569|FG000|COMPLETED|Treatment Period 1||5
9924156|NCT01260142|11041570|FG001|COMPLETED|Treatment Period 1||5
9924157|NCT01260142|11041571|FG002|COMPLETED|Treatment Period 1||6
9924158|NCT01260142|11041572|FG003|COMPLETED|Treatment Period 1||6
9924159|NCT01260142|11041573|FG004|COMPLETED|Treatment Period 1||4
9924160|NCT01260142|11041574|FG005|COMPLETED|Treatment Period 1||3
9924161|NCT01260142|11041569|FG000|NOT COMPLETED|Treatment Period 1||1
9924162|NCT01260142|11041570|FG001|NOT COMPLETED|Treatment Period 1||1
9924163|NCT01260142|11041571|FG002|NOT COMPLETED|Treatment Period 1||0
9924164|NCT01260142|11041572|FG003|NOT COMPLETED|Treatment Period 1||0
9924165|NCT01260142|11041573|FG004|NOT COMPLETED|Treatment Period 1||2
9924166|NCT01260142|11041574|FG005|NOT COMPLETED|Treatment Period 1||3
9924167|NCT01260142|11041569|FG000|STARTED|Treatment Period 2||5
9924168|NCT01260142|11041570|FG001|STARTED|Treatment Period 2||5
9924169|NCT01260142|11041571|FG002|STARTED|Treatment Period 2||6
9924170|NCT01260142|11041572|FG003|STARTED|Treatment Period 2||6
9924171|NCT01260142|11041573|FG004|STARTED|Treatment Period 2||4
9924172|NCT01260142|11041574|FG005|STARTED|Treatment Period 2||3
9924173|NCT01260142|11041569|FG000|COMPLETED|Treatment Period 2||5
9924174|NCT01260142|11041570|FG001|COMPLETED|Treatment Period 2||5
9924175|NCT01260142|11041571|FG002|COMPLETED|Treatment Period 2||6
9924176|NCT01260142|11041572|FG003|COMPLETED|Treatment Period 2||6
9924177|NCT01260142|11041573|FG004|COMPLETED|Treatment Period 2||4
9924178|NCT01260142|11041574|FG005|COMPLETED|Treatment Period 2||3
9924179|NCT01260142|11041569|FG000|NOT COMPLETED|Treatment Period 2||0
9924180|NCT01260142|11041570|FG001|NOT COMPLETED|Treatment Period 2||0
9924181|NCT01260142|11041571|FG002|NOT COMPLETED|Treatment Period 2||0
9924182|NCT01260142|11041572|FG003|NOT COMPLETED|Treatment Period 2||0
9924183|NCT01260142|11041573|FG004|NOT COMPLETED|Treatment Period 2||0
9924184|NCT01260142|11041574|FG005|NOT COMPLETED|Treatment Period 2||0
9924185|NCT01260181|11041594|FG000|STARTED|Overall Study||30
9924186|NCT01260181|11041594|FG000|COMPLETED|Overall Study||29
9924187|NCT01260181|11041594|FG000|NOT COMPLETED|Overall Study||1
9924188|NCT01260194|11041598|FG000|STARTED|Overall Study||4
9924189|NCT01260194|11041598|FG000|COMPLETED|Overall Study||3
9924190|NCT01260194|11041598|FG000|NOT COMPLETED|Overall Study||1
9924191|NCT01260272|11041604|FG000|STARTED|Overall Study||17
9924192|NCT01260272|11041605|FG001|STARTED|Overall Study||32
9924193|NCT01260272|11041604|FG000|COMPLETED|Overall Study||15
9924194|NCT01260272|11041605|FG001|COMPLETED|Overall Study||30
9924195|NCT01260272|11041604|FG000|NOT COMPLETED|Overall Study||2
9924196|NCT01260272|11041605|FG001|NOT COMPLETED|Overall Study||2
9924197|NCT01260311|11041613|FG000|STARTED|Overall Study||508
9924198|NCT01260311|11041613|FG000|COMPLETED|Overall Study||381
9924199|NCT01260311|11041613|FG000|NOT COMPLETED|Overall Study||127
9924200|NCT01260324|11041619|FG000|STARTED|Overall Study||1283
9924201|NCT01260324|11041620|FG001|STARTED|Overall Study||20000
9924202|NCT01260324|11041619|FG000|COMPLETED|Overall Study||1283
9924203|NCT01260324|11041620|FG001|COMPLETED|Overall Study||20000
9924204|NCT01260324|11041619|FG000|NOT COMPLETED|Overall Study||0
9924205|NCT01260324|11041620|FG001|NOT COMPLETED|Overall Study||0
9924206|NCT01260350|11041646|FG000|STARTED|Overall Study||10
9924207|NCT01260350|11041647|FG001|STARTED|Overall Study||9
9924208|NCT01260350|11041648|FG002|STARTED|Overall Study||10
9924209|NCT01260350|11041649|FG003|STARTED|Overall Study||11
9924210|NCT01260350|11041650|FG004|STARTED|Overall Study||10
9924211|NCT01260350|11041651|FG005|STARTED|Overall Study||10
9924212|NCT01260350|11041652|FG006|STARTED|Overall Study||10
9924213|NCT01260350|11041653|FG007|STARTED|Overall Study||25
9924214|NCT01260350|11041654|FG008|STARTED|Overall Study||25
9924215|NCT01260350|11041655|FG009|STARTED|Overall Study||25
9924216|NCT01260350|11041656|FG010|STARTED|Overall Study||10
9924217|NCT01260350|11041657|FG011|STARTED|Overall Study||9
9924218|NCT01260350|11041658|FG012|STARTED|Overall Study||25
9924219|NCT01260350|11041659|FG013|STARTED|Overall Study||10
9924220|NCT01260350|11041660|FG014|STARTED|Overall Study||25
9924221|NCT01260350|11041661|FG015|STARTED|Overall Study||10
9924222|NCT01260350|11041662|FG016|STARTED|Overall Study||9
9924223|NCT01260350|11041663|FG017|STARTED|Overall Study||10
9924224|NCT01260350|11041664|FG018|STARTED|Overall Study||0
9924225|NCT01260350|11041665|FG019|STARTED|Overall Study||14
9924226|NCT01260350|11041666|FG020|STARTED|Overall Study||25
9924227|NCT01260350|11041667|FG021|STARTED|Overall Study||0
9924228|NCT01260350|11041646|FG000|COMPLETED|Overall Study||10
9924229|NCT01260350|11041647|FG001|COMPLETED|Overall Study||9
9924230|NCT01260350|11041648|FG002|COMPLETED|Overall Study||10
9924231|NCT01260350|11041649|FG003|COMPLETED|Overall Study||11
9924232|NCT01260350|11041650|FG004|COMPLETED|Overall Study||10
9924233|NCT01260350|11041651|FG005|COMPLETED|Overall Study||10
9924234|NCT01260350|11041652|FG006|COMPLETED|Overall Study||10
9924235|NCT01260350|11041653|FG007|COMPLETED|Overall Study||25
9924236|NCT01260350|11041654|FG008|COMPLETED|Overall Study||24
9924237|NCT01260350|11041655|FG009|COMPLETED|Overall Study||25
9924238|NCT01260350|11041656|FG010|COMPLETED|Overall Study||10
9924239|NCT01260350|11041657|FG011|COMPLETED|Overall Study||9
9924240|NCT01260350|11041658|FG012|COMPLETED|Overall Study||25
9924241|NCT01260350|11041659|FG013|COMPLETED|Overall Study||10
9924242|NCT01260350|11041660|FG014|COMPLETED|Overall Study||25
9924243|NCT01260350|11041661|FG015|COMPLETED|Overall Study||10
9924244|NCT01260350|11041662|FG016|COMPLETED|Overall Study||9
9924245|NCT01260350|11041663|FG017|COMPLETED|Overall Study||9
9924246|NCT01260350|11041664|FG018|COMPLETED|Overall Study||0
9924247|NCT01260350|11041665|FG019|COMPLETED|Overall Study||14
9924248|NCT01260350|11041666|FG020|COMPLETED|Overall Study||22
9924249|NCT01260350|11041667|FG021|COMPLETED|Overall Study||0
9924250|NCT01260350|11041646|FG000|NOT COMPLETED|Overall Study||0
9924251|NCT01260350|11041647|FG001|NOT COMPLETED|Overall Study||0
9924252|NCT01260350|11041648|FG002|NOT COMPLETED|Overall Study||0
9924253|NCT01260350|11041649|FG003|NOT COMPLETED|Overall Study||0
9924254|NCT01260350|11041650|FG004|NOT COMPLETED|Overall Study||0
9924255|NCT01260350|11041651|FG005|NOT COMPLETED|Overall Study||0
9924256|NCT01260350|11041652|FG006|NOT COMPLETED|Overall Study||0
9924257|NCT01260350|11041653|FG007|NOT COMPLETED|Overall Study||0
9924258|NCT01260350|11041654|FG008|NOT COMPLETED|Overall Study||1
9924259|NCT01260350|11041655|FG009|NOT COMPLETED|Overall Study||0
9924260|NCT01260350|11041656|FG010|NOT COMPLETED|Overall Study||0
9924261|NCT01260350|11041657|FG011|NOT COMPLETED|Overall Study||0
9924262|NCT01260350|11041658|FG012|NOT COMPLETED|Overall Study||0
9924263|NCT01260350|11041659|FG013|NOT COMPLETED|Overall Study||0
9924264|NCT01260350|11041660|FG014|NOT COMPLETED|Overall Study||0
9924265|NCT01260350|11041661|FG015|NOT COMPLETED|Overall Study||0
9924266|NCT01260350|11041662|FG016|NOT COMPLETED|Overall Study||0
9924267|NCT01260350|11041663|FG017|NOT COMPLETED|Overall Study||1
9924268|NCT01260350|11041664|FG018|NOT COMPLETED|Overall Study||0
9924269|NCT01260350|11041665|FG019|NOT COMPLETED|Overall Study||0
9924270|NCT01260350|11041666|FG020|NOT COMPLETED|Overall Study||3
9924271|NCT01260350|11041667|FG021|NOT COMPLETED|Overall Study||0
9924272|NCT01260454|11041721|FG000|STARTED|Overall Study||6
9924273|NCT01260454|11041721|FG000|COMPLETED|Overall Study||6
9924274|NCT01260454|11041721|FG000|NOT COMPLETED|Overall Study||0
9924275|NCT01260467|11041725|FG000|STARTED|Overall Study||4
9924276|NCT01260467|11041725|FG000|COMPLETED|Overall Study||2
9924277|NCT01260467|11041725|FG000|NOT COMPLETED|Overall Study||2
9924278|NCT01260493|11041733|FG000|STARTED|Overall Study||92
9924279|NCT01260493|11041734|FG001|STARTED|Overall Study||89
9924280|NCT01260493|11041733|FG000|COMPLETED|Overall Study||76
9924281|NCT01260493|11041734|FG001|COMPLETED|Overall Study||85
9924282|NCT01260493|11041733|FG000|NOT COMPLETED|Overall Study||16
9924283|NCT01260493|11041734|FG001|NOT COMPLETED|Overall Study||4
9924284|NCT01260584|11041744|FG000|STARTED|Period 1||27
9924285|NCT01260584|11041745|FG001|STARTED|Period 1||28
9924286|NCT01260584|11041746|FG002|STARTED|Period 1||27
9924287|NCT01260584|11041747|FG003|STARTED|Period 1||28
9924288|NCT01260584|11041744|FG000|COMPLETED|Period 1||27
9924289|NCT01260584|11041745|FG001|COMPLETED|Period 1||28
9924290|NCT01260584|11041746|FG002|COMPLETED|Period 1||25
9924291|NCT01260584|11041747|FG003|COMPLETED|Period 1||27
9924292|NCT01260584|11041744|FG000|NOT COMPLETED|Period 1||0
9924293|NCT01260584|11041745|FG001|NOT COMPLETED|Period 1||0
9924294|NCT01260584|11041746|FG002|NOT COMPLETED|Period 1||2
9924295|NCT01260584|11041747|FG003|NOT COMPLETED|Period 1||1
9924296|NCT01260584|11041744|FG000|STARTED|Period 2||27
9924297|NCT01260584|11041745|FG001|STARTED|Period 2||28
9924298|NCT01260584|11041746|FG002|STARTED|Period 2||25
9924299|NCT01260584|11041747|FG003|STARTED|Period 2||27
9924300|NCT01260584|11041744|FG000|COMPLETED|Period 2||26
9924301|NCT01260584|11041745|FG001|COMPLETED|Period 2||25
9924302|NCT01260584|11041746|FG002|COMPLETED|Period 2||20
9924303|NCT01260584|11041747|FG003|COMPLETED|Period 2||26
9924304|NCT01260584|11041744|FG000|NOT COMPLETED|Period 2||1
9924305|NCT01260584|11041745|FG001|NOT COMPLETED|Period 2||3
9924306|NCT01260584|11041746|FG002|NOT COMPLETED|Period 2||5
9924307|NCT01260584|11041747|FG003|NOT COMPLETED|Period 2||1
9924308|NCT01260649|11041759|FG000|STARTED|Overall Study||8
9924309|NCT01260649|11041760|FG001|STARTED|Overall Study||9
9924310|NCT01260649|11041759|FG000|COMPLETED|Overall Study||6
9924311|NCT01260649|11041760|FG001|COMPLETED|Overall Study||8
9924312|NCT01260649|11041759|FG000|NOT COMPLETED|Overall Study||2
9924313|NCT01260649|11041760|FG001|NOT COMPLETED|Overall Study||1
9924314|NCT01260662|11041769|FG000|STARTED|Overall Study||90
9924315|NCT01260662|11041770|FG001|STARTED|Overall Study||85
9924316|NCT01260662|11041771|FG002|STARTED|Overall Study||96
9924317|NCT01260662|11041769|FG000|COMPLETED|Overall Study||90
9924318|NCT01260662|11041770|FG001|COMPLETED|Overall Study||85
9924319|NCT01260662|11041771|FG002|COMPLETED|Overall Study||96
9924320|NCT01260662|11041769|FG000|NOT COMPLETED|Overall Study||0
9924321|NCT01260662|11041770|FG001|NOT COMPLETED|Overall Study||0
9924322|NCT01260662|11041771|FG002|NOT COMPLETED|Overall Study||0
10010668|NCT01775189|11133361|FG001|STARTED|Treatment Phase: Washout Period 2||0
10010669|NCT01775189|11133362|FG002|STARTED|Treatment Phase: Washout Period 2||0
10010670|NCT01775189|11133363|FG003|STARTED|Treatment Phase: Washout Period 2||8
10010671|NCT01775189|11133364|FG004|STARTED|Treatment Phase: Washout Period 2||8
10010672|NCT01775189|11133365|FG005|STARTED|Treatment Phase: Washout Period 2||7
10010673|NCT01775189|11133366|FG006|STARTED|Treatment Phase: Washout Period 2||8
10010674|NCT01775189|11133360|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
10010675|NCT01775189|11133361|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
10010676|NCT01775189|11133362|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
10010677|NCT01775189|11133363|FG003|COMPLETED|Treatment Phase: Washout Period 2||7
10010678|NCT01775189|11133364|FG004|COMPLETED|Treatment Phase: Washout Period 2||8
10010679|NCT01775189|11133365|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
10010680|NCT01775189|11133366|FG006|COMPLETED|Treatment Phase: Washout Period 2||8
10010681|NCT01775189|11133360|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
9924323|NCT01260688|11041781|FG000|STARTED|Overall Study||11
9924324|NCT01260688|11041782|FG001|STARTED|Overall Study||11
9924325|NCT01260688|11041781|FG000|COMPLETED|Overall Study||11
9924326|NCT01260688|11041782|FG001|COMPLETED|Overall Study||11
9924327|NCT01260688|11041781|FG000|NOT COMPLETED|Overall Study||0
9924328|NCT01260688|11041782|FG001|NOT COMPLETED|Overall Study||0
9924329|NCT01260701|11041791|FG000|STARTED|Overall Study||75
9924330|NCT01260701|11041791|FG000|Eligible|Overall Study||71
9924331|NCT01260701|11041791|FG000|Eligible and Began Protocol Therapy|Overall Study||70
9924332|NCT01260701|11041791|FG000|COMPLETED|Overall Study||0
9924333|NCT01260701|11041791|FG000|NOT COMPLETED|Overall Study||75
9924334|NCT01260883|11041798|FG000|STARTED|Overall Study||22
9924335|NCT01260883|11041799|FG001|STARTED|Overall Study||11
9924336|NCT01260883|11041800|FG002|STARTED|Overall Study||18
9924337|NCT01260883|11041798|FG000|COMPLETED|Overall Study||22
9924338|NCT01260883|11041799|FG001|COMPLETED|Overall Study||11
9924339|NCT01260883|11041800|FG002|COMPLETED|Overall Study||18
9924340|NCT01260883|11041798|FG000|NOT COMPLETED|Overall Study||0
9924341|NCT01260883|11041799|FG001|NOT COMPLETED|Overall Study||0
9924342|NCT01260883|11041800|FG002|NOT COMPLETED|Overall Study||0
9924343|NCT01260896|11041831|FG000|STARTED|First Intervention||12
9924344|NCT01260896|11041832|FG001|STARTED|First Intervention||12
9924345|NCT01260896|11041831|FG000|COMPLETED|First Intervention||10
9924346|NCT01260896|11041832|FG001|COMPLETED|First Intervention||12
9924347|NCT01260896|11041831|FG000|NOT COMPLETED|First Intervention||2
9924348|NCT01260896|11041832|FG001|NOT COMPLETED|First Intervention||0
9924349|NCT01260896|11041831|FG000|STARTED|Washout of 7 Days||10
9924350|NCT01260896|11041832|FG001|STARTED|Washout of 7 Days||12
9924351|NCT01260896|11041831|FG000|COMPLETED|Washout of 7 Days||10
9924352|NCT01260896|11041832|FG001|COMPLETED|Washout of 7 Days||12
9924353|NCT01260896|11041831|FG000|NOT COMPLETED|Washout of 7 Days||0
9924354|NCT01260896|11041832|FG001|NOT COMPLETED|Washout of 7 Days||0
9924355|NCT01260896|11041831|FG000|STARTED|Second Intervention||10
9924356|NCT01260896|11041832|FG001|STARTED|Second Intervention||12
9924357|NCT01260896|11041831|FG000|COMPLETED|Second Intervention||10
9924358|NCT01260896|11041832|FG001|COMPLETED|Second Intervention||12
9924359|NCT01260896|11041831|FG000|NOT COMPLETED|Second Intervention||0
9924360|NCT01260896|11041832|FG001|NOT COMPLETED|Second Intervention||0
9924361|NCT01260922|11041840|FG000|STARTED|First Intervention||13
9924362|NCT01260922|11041841|FG001|STARTED|First Intervention||13
9924363|NCT01260922|11041840|FG000|COMPLETED|First Intervention||13
9924364|NCT01260922|11041841|FG001|COMPLETED|First Intervention||12
9924365|NCT01260922|11041840|FG000|NOT COMPLETED|First Intervention||0
9924366|NCT01260922|11041841|FG001|NOT COMPLETED|First Intervention||1
9924367|NCT01260922|11041840|FG000|STARTED|Washout of 28 Days||13
9924368|NCT01260922|11041841|FG001|STARTED|Washout of 28 Days||12
9924369|NCT01260922|11041840|FG000|COMPLETED|Washout of 28 Days||9
9924370|NCT01260922|11041841|FG001|COMPLETED|Washout of 28 Days||10
9924371|NCT01260922|11041840|FG000|NOT COMPLETED|Washout of 28 Days||4
9924372|NCT01260922|11041841|FG001|NOT COMPLETED|Washout of 28 Days||2
9924373|NCT01260922|11041840|FG000|STARTED|Second Intervention||9
9924374|NCT01260922|11041841|FG001|STARTED|Second Intervention||10
9924375|NCT01260922|11041840|FG000|COMPLETED|Second Intervention||9
9924376|NCT01260922|11041841|FG001|COMPLETED|Second Intervention||8
9924377|NCT01260922|11041840|FG000|NOT COMPLETED|Second Intervention||0
9924378|NCT01260922|11041841|FG001|NOT COMPLETED|Second Intervention||2
9924379|NCT01260948|11041849|FG000|STARTED|First Intervention||13
9924380|NCT01260948|11041850|FG001|STARTED|First Intervention||13
9924381|NCT01260948|11041849|FG000|COMPLETED|First Intervention||13
10010682|NCT01775189|11133361|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10010683|NCT01775189|11133362|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
9924382|NCT01260948|11041850|FG001|COMPLETED|First Intervention||13
9924383|NCT01260948|11041849|FG000|NOT COMPLETED|First Intervention||0
9924384|NCT01260948|11041850|FG001|NOT COMPLETED|First Intervention||0
9924385|NCT01260948|11041849|FG000|STARTED|Washout of 28 Days||13
9924386|NCT01260948|11041850|FG001|STARTED|Washout of 28 Days||13
9924387|NCT01260948|11041849|FG000|COMPLETED|Washout of 28 Days||12
9924388|NCT01260948|11041850|FG001|COMPLETED|Washout of 28 Days||10
9924389|NCT01260948|11041849|FG000|NOT COMPLETED|Washout of 28 Days||1
9924390|NCT01260948|11041850|FG001|NOT COMPLETED|Washout of 28 Days||3
9924391|NCT01260948|11041849|FG000|STARTED|Second Intervention||12
9924392|NCT01260948|11041850|FG001|STARTED|Second Intervention||10
9924393|NCT01260948|11041849|FG000|COMPLETED|Second Intervention||12
9924394|NCT01260948|11041850|FG001|COMPLETED|Second Intervention||9
9924395|NCT01260948|11041849|FG000|NOT COMPLETED|Second Intervention||0
9924396|NCT01260948|11041850|FG001|NOT COMPLETED|Second Intervention||1
9924397|NCT01261000|11041856|FG000|STARTED|Overall Study||8
9924398|NCT01261000|11041856|FG000|COMPLETED|Overall Study||7
9924399|NCT01261000|11041856|FG000|NOT COMPLETED|Overall Study||1
9955943|NCT01441440|11074996|FG000|STARTED|Overall Study|Safety analysis set|183
9955944|NCT01441440|11074997|FG001|STARTED|Overall Study|Safety analysis set|174
9955945|NCT01441440|11074998|FG002|STARTED|Overall Study|Safety analysis set|180
9955946|NCT01441440|11074996|FG000|COMPLETED|Overall Study||166
9955947|NCT01441440|11074997|FG001|COMPLETED|Overall Study||151
9955948|NCT01441440|11074998|FG002|COMPLETED|Overall Study||158
9955949|NCT01441440|11074996|FG000|NOT COMPLETED|Overall Study||17
9955950|NCT01441440|11074997|FG001|NOT COMPLETED|Overall Study||23
9955951|NCT01441440|11074998|FG002|NOT COMPLETED|Overall Study||22
9955952|NCT01441466|11075008|FG000|STARTED|Overall Study||37
9955953|NCT01441466|11075009|FG001|STARTED|Overall Study||11
9955954|NCT01441466|11075008|FG000|COMPLETED|Overall Study||37
9955955|NCT01441466|11075009|FG001|COMPLETED|Overall Study||11
9955956|NCT01441466|11075008|FG000|NOT COMPLETED|Overall Study||0
9955957|NCT01441466|11075009|FG001|NOT COMPLETED|Overall Study||0
9955958|NCT01441492|11075018|FG000|STARTED|Overall Study||197
9955959|NCT01441492|11075019|FG001|STARTED|Overall Study||202
9955960|NCT01441492|11075018|FG000|COMPLETED|Overall Study||170
9955961|NCT01441492|11075019|FG001|COMPLETED|Overall Study||174
9955962|NCT01441492|11075018|FG000|NOT COMPLETED|Overall Study||27
9955963|NCT01441492|11075019|FG001|NOT COMPLETED|Overall Study||28
9955964|NCT01441570|11075029|FG000|STARTED|Overall Study||6
9955965|NCT01441570|11075030|FG001|STARTED|Overall Study||5
9955966|NCT01441570|11075029|FG000|COMPLETED|Overall Study||6
9955967|NCT01441570|11075030|FG001|COMPLETED|Overall Study||5
9955968|NCT01441570|11075029|FG000|NOT COMPLETED|Overall Study||0
9955969|NCT01441570|11075030|FG001|NOT COMPLETED|Overall Study||0
9955970|NCT01441596|11075039|FG000|STARTED|Overall Study||40
9955971|NCT01441596|11075040|FG001|STARTED|Overall Study||38
9955972|NCT01441596|11075041|FG002|STARTED|Overall Study||43
9955973|NCT01441596|11075039|FG000|COMPLETED|Overall Study||36
9955974|NCT01441596|11075040|FG001|COMPLETED|Overall Study||35
9955975|NCT01441596|11075041|FG002|COMPLETED|Overall Study||39
9955976|NCT01441596|11075039|FG000|NOT COMPLETED|Overall Study||4
9955977|NCT01441596|11075040|FG001|NOT COMPLETED|Overall Study||3
9955978|NCT01441596|11075041|FG002|NOT COMPLETED|Overall Study||4
9955979|NCT01441635|11075059|FG000|STARTED|Overall Study||32
9955980|NCT01441635|11075060|FG001|STARTED|Overall Study||33
9955981|NCT01441635|11075061|FG002|STARTED|Overall Study||16
9955982|NCT01441635|11075062|FG003|STARTED|Overall Study||35
9955983|NCT01441635|11075063|FG004|STARTED|Overall Study||18
9955984|NCT01441635|11075064|FG005|STARTED|Overall Study||34
9955985|NCT01441635|11075065|FG006|STARTED|Overall Study||30
9955986|NCT01441635|11075066|FG007|STARTED|Overall Study||30
9955987|NCT01441635|11075067|FG008|STARTED|Overall Study||16
9955988|NCT01441635|11075068|FG009|STARTED|Overall Study||27
9955989|NCT01441635|11075059|FG000|COMPLETED|Overall Study||26
9955990|NCT01441635|11075060|FG001|COMPLETED|Overall Study||27
9955991|NCT01441635|11075061|FG002|COMPLETED|Overall Study||13
9955992|NCT01441635|11075062|FG003|COMPLETED|Overall Study||28
9955993|NCT01441635|11075063|FG004|COMPLETED|Overall Study||16
9955994|NCT01441635|11075064|FG005|COMPLETED|Overall Study||29
9955995|NCT01441635|11075065|FG006|COMPLETED|Overall Study||24
9955996|NCT01441635|11075066|FG007|COMPLETED|Overall Study||26
9955997|NCT01441635|11075067|FG008|COMPLETED|Overall Study||14
9955998|NCT01441635|11075068|FG009|COMPLETED|Overall Study||25
9955999|NCT01441635|11075059|FG000|NOT COMPLETED|Overall Study||6
9956000|NCT01441635|11075060|FG001|NOT COMPLETED|Overall Study||6
9956001|NCT01441635|11075061|FG002|NOT COMPLETED|Overall Study||3
9956002|NCT01441635|11075062|FG003|NOT COMPLETED|Overall Study||7
9956003|NCT01441635|11075063|FG004|NOT COMPLETED|Overall Study||2
9956004|NCT01441635|11075064|FG005|NOT COMPLETED|Overall Study||5
10010684|NCT01775189|11133363|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1
9956005|NCT01441635|11075065|FG006|NOT COMPLETED|Overall Study||6
9956006|NCT01441635|11075066|FG007|NOT COMPLETED|Overall Study||4
9956007|NCT01441635|11075067|FG008|NOT COMPLETED|Overall Study||2
9956008|NCT01441635|11075068|FG009|NOT COMPLETED|Overall Study||2
9956009|NCT01441765|11075092|FG000|STARTED|Overall Study||11
9956010|NCT01441765|11075093|FG001|STARTED|Overall Study|not opened|0
9956011|NCT01441765|11075092|FG000|COMPLETED|Overall Study||10
9956012|NCT01441765|11075093|FG001|COMPLETED|Overall Study|not opened|0
9956013|NCT01441765|11075092|FG000|NOT COMPLETED|Overall Study||1
9956014|NCT01441765|11075093|FG001|NOT COMPLETED|Overall Study||0
9956015|NCT01441843|11075101|FG000|STARTED|Overall Study||200
9956016|NCT01441843|11075102|FG001|STARTED|Overall Study||200
9956017|NCT01441843|11075101|FG000|COMPLETED|Overall Study||188
10010685|NCT01775189|11133364|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10010686|NCT01775189|11133365|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10010687|NCT01775189|11133366|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10010688|NCT01775189|11133360|FG000|STARTED|Treatment Phase: Third Intervention||0
9924400|NCT01261052|11041860|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14
9924401|NCT01261052|11041860|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14
9924402|NCT01261052|11041860|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
9924403|NCT01261052|11041860|FG000|STARTED|APD Only Intervention (33 Hours)||14
9924404|NCT01261052|11041860|FG000|COMPLETED|APD Only Intervention (33 Hours)||14
9924405|NCT01261052|11041860|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0
9924406|NCT01261325|11041868|FG000|STARTED|Overall Study||263
9924407|NCT01261325|11041869|FG001|STARTED|Overall Study||254
9924408|NCT01261325|11041870|FG002|STARTED|Overall Study||251
9924409|NCT01261325|11041868|FG000|COMPLETED|Overall Study||246
9924410|NCT01261325|11041869|FG001|COMPLETED|Overall Study||225
9924411|NCT01261325|11041870|FG002|COMPLETED|Overall Study||225
9924412|NCT01261325|11041868|FG000|NOT COMPLETED|Overall Study||17
9924413|NCT01261325|11041869|FG001|NOT COMPLETED|Overall Study||29
9924414|NCT01261325|11041870|FG002|NOT COMPLETED|Overall Study||26
9924415|NCT01261338|11041883|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
9924416|NCT01261338|11041884|FG001|STARTED|Overall Study||14
9924417|NCT01261338|11041883|FG000|COMPLETED|Overall Study||11
9924418|NCT01261338|11041884|FG001|COMPLETED|Overall Study||12
9924419|NCT01261338|11041883|FG000|NOT COMPLETED|Overall Study||3
9924420|NCT01261338|11041884|FG001|NOT COMPLETED|Overall Study||2
9924421|NCT01261390|11041894|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
9924422|NCT01261390|11041895|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
9924423|NCT01261390|11041896|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
9924424|NCT01261390|11041897|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
9924425|NCT01261390|11041894|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
9924426|NCT01261390|11041895|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
9924427|NCT01261390|11041896|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
9924428|NCT01261390|11041897|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
9924429|NCT01261390|11041894|FG000|12-Month Visit|Overall Study||23
9924430|NCT01261390|11041895|FG001|12-Month Visit|Overall Study||21
10010689|NCT01775189|11133361|FG001|STARTED|Treatment Phase: Third Intervention||0
10010690|NCT01775189|11133362|FG002|STARTED|Treatment Phase: Third Intervention||0
10010691|NCT01775189|11133363|FG003|STARTED|Treatment Phase: Third Intervention||7
9924431|NCT01261390|11041896|FG002|12-Month Visit|Overall Study||19
9924432|NCT01261390|11041897|FG003|12-Month Visit|Overall Study||19
9924433|NCT01261390|11041894|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
9924434|NCT01261390|11041895|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
9924435|NCT01261390|11041896|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
9924436|NCT01261390|11041897|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
9924437|NCT01261390|11041894|FG000|NOT COMPLETED|Overall Study||7
9924438|NCT01261390|11041895|FG001|NOT COMPLETED|Overall Study||9
9924439|NCT01261390|11041896|FG002|NOT COMPLETED|Overall Study||7
9924440|NCT01261390|11041897|FG003|NOT COMPLETED|Overall Study||8
9924441|NCT01261507|11041912|FG000|STARTED|Overall Study||15
9924442|NCT01261507|11041912|FG000|COMPLETED|Overall Study||15
9924443|NCT01261507|11041912|FG000|NOT COMPLETED|Overall Study||0
9924444|NCT01261559|11041921|FG000|STARTED|Overall Study||36
9924445|NCT01261559|11041922|FG001|STARTED|Overall Study||36
9924446|NCT01261559|11041921|FG000|COMPLETED|Overall Study||36
9924447|NCT01261559|11041922|FG001|COMPLETED|Overall Study||36
9924448|NCT01261559|11041921|FG000|NOT COMPLETED|Overall Study||0
9924449|NCT01261559|11041922|FG001|NOT COMPLETED|Overall Study||0
9924450|NCT01261611|11041932|FG000|STARTED|Treatment Cycle 1||156
9924451|NCT01261611|11041933|FG001|STARTED|Treatment Cycle 1||159
9924452|NCT01261611|11041934|FG002|STARTED|Treatment Cycle 1||54
9924453|NCT01261611|11041932|FG000|COMPLETED|Treatment Cycle 1||152
9924454|NCT01261611|11041933|FG001|COMPLETED|Treatment Cycle 1||156
9924455|NCT01261611|11041934|FG002|COMPLETED|Treatment Cycle 1||52
9924456|NCT01261611|11041932|FG000|NOT COMPLETED|Treatment Cycle 1||4
9924457|NCT01261611|11041933|FG001|NOT COMPLETED|Treatment Cycle 1||3
9924458|NCT01261611|11041934|FG002|NOT COMPLETED|Treatment Cycle 1||2
9924459|NCT01261611|11041932|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
9924460|NCT01261611|11041933|FG001|STARTED|Treatment Cycle 2||0
9924461|NCT01261611|11041934|FG002|STARTED|Treatment Cycle 2||0
9924462|NCT01261611|11041932|FG000|COMPLETED|Treatment Cycle 2||346
9924463|NCT01261611|11041933|FG001|COMPLETED|Treatment Cycle 2||0
9924464|NCT01261611|11041934|FG002|COMPLETED|Treatment Cycle 2||0
9924465|NCT01261611|11041932|FG000|NOT COMPLETED|Treatment Cycle 2||13
9924466|NCT01261611|11041933|FG001|NOT COMPLETED|Treatment Cycle 2||0
10010692|NCT01775189|11133364|FG004|STARTED|Treatment Phase: Third Intervention||8
9924467|NCT01261611|11041934|FG002|NOT COMPLETED|Treatment Cycle 2||0
9924468|NCT01261611|11041932|FG000|STARTED|Treatment Cycle 3||346
9924469|NCT01261611|11041933|FG001|STARTED|Treatment Cycle 3||0
9924470|NCT01261611|11041934|FG002|STARTED|Treatment Cycle 3||0
9924471|NCT01261611|11041932|FG000|COMPLETED|Treatment Cycle 3||316
9924472|NCT01261611|11041933|FG001|COMPLETED|Treatment Cycle 3||0
9924473|NCT01261611|11041934|FG002|COMPLETED|Treatment Cycle 3||0
9924474|NCT01261611|11041932|FG000|NOT COMPLETED|Treatment Cycle 3||30
9924475|NCT01261611|11041933|FG001|NOT COMPLETED|Treatment Cycle 3||0
9924476|NCT01261611|11041934|FG002|NOT COMPLETED|Treatment Cycle 3||0
9924477|NCT01261611|11041932|FG000|STARTED|Treatment Cycle 4||316
9924478|NCT01261611|11041933|FG001|STARTED|Treatment Cycle 4||0
9924479|NCT01261611|11041934|FG002|STARTED|Treatment Cycle 4||0
9924480|NCT01261611|11041932|FG000|COMPLETED|Treatment Cycle 4||220
9924481|NCT01261611|11041933|FG001|COMPLETED|Treatment Cycle 4||0
9924482|NCT01261611|11041934|FG002|COMPLETED|Treatment Cycle 4||0
9924483|NCT01261611|11041932|FG000|NOT COMPLETED|Treatment Cycle 4||96
9924484|NCT01261611|11041933|FG001|NOT COMPLETED|Treatment Cycle 4||0
9924485|NCT01261611|11041934|FG002|NOT COMPLETED|Treatment Cycle 4||0
9924486|NCT01261611|11041932|FG000|STARTED|Treatment Cycle 5||220
9924487|NCT01261611|11041933|FG001|STARTED|Treatment Cycle 5||0
9924488|NCT01261611|11041934|FG002|STARTED|Treatment Cycle 5||0
9924489|NCT01261611|11041932|FG000|COMPLETED|Treatment Cycle 5||217
9924490|NCT01261611|11041933|FG001|COMPLETED|Treatment Cycle 5||0
9924491|NCT01261611|11041934|FG002|COMPLETED|Treatment Cycle 5||0
9924492|NCT01261611|11041932|FG000|NOT COMPLETED|Treatment Cycle 5||3
9924493|NCT01261611|11041933|FG001|NOT COMPLETED|Treatment Cycle 5||0
9924494|NCT01261611|11041934|FG002|NOT COMPLETED|Treatment Cycle 5||0
9924495|NCT01261624|11041948|FG000|STARTED|Week 0 to Week 12||10
9924496|NCT01261624|11041949|FG001|STARTED|Week 0 to Week 12||6
9924497|NCT01261624|11041948|FG000|COMPLETED|Week 0 to Week 12||9
9924498|NCT01261624|11041949|FG001|COMPLETED|Week 0 to Week 12||3
9924499|NCT01261624|11041948|FG000|NOT COMPLETED|Week 0 to Week 12||1
9924500|NCT01261624|11041949|FG001|NOT COMPLETED|Week 0 to Week 12||3
9924501|NCT01261624|11041948|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
9924502|NCT01261624|11041949|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
9924503|NCT01261624|11041948|FG000|COMPLETED|Week 13 to Week 24||1
9924504|NCT01261624|11041949|FG001|COMPLETED|Week 13 to Week 24||10
9924505|NCT01261624|11041948|FG000|NOT COMPLETED|Week 13 to Week 24||0
9924506|NCT01261624|11041949|FG001|NOT COMPLETED|Week 13 to Week 24||1
9924507|NCT01261780|11041963|FG000|STARTED|Overall Study||7
9924508|NCT01261780|11041964|FG001|STARTED|Overall Study||7
9924509|NCT01261780|11041963|FG000|COMPLETED|Overall Study||5
9924510|NCT01261780|11041964|FG001|COMPLETED|Overall Study||5
9924511|NCT01261780|11041963|FG000|NOT COMPLETED|Overall Study||2
9924512|NCT01261780|11041964|FG001|NOT COMPLETED|Overall Study||2
9924513|NCT01261793|11041973|FG000|STARTED|Overall Study||263
9924514|NCT01261793|11041974|FG001|STARTED|Overall Study||262
9924515|NCT01261793|11041975|FG002|STARTED|Overall Study||266
9924516|NCT01261793|11041973|FG000|COMPLETED|Overall Study||178
9924517|NCT01261793|11041974|FG001|COMPLETED|Overall Study||171
9924518|NCT01261793|11041975|FG002|COMPLETED|Overall Study||184
9924519|NCT01261793|11041973|FG000|NOT COMPLETED|Overall Study||85
9924520|NCT01261793|11041974|FG001|NOT COMPLETED|Overall Study||91
9924521|NCT01261793|11041975|FG002|NOT COMPLETED|Overall Study||82
9924522|NCT01261819|11041985|FG000|STARTED|Overall Study||33
9924523|NCT01261819|11041986|FG001|STARTED|Overall Study||33
9924524|NCT01261819|11041985|FG000|COMPLETED|Overall Study||33
9924525|NCT01261819|11041986|FG001|COMPLETED|Overall Study||33
9924526|NCT01261819|11041985|FG000|NOT COMPLETED|Overall Study||0
9924527|NCT01261819|11041986|FG001|NOT COMPLETED|Overall Study||0
9924528|NCT01261975|11041992|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36
9924529|NCT01261975|11041992|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
9924530|NCT01261975|11041992|FG000|NOT COMPLETED|Overall Study||1
9924531|NCT01262027|11041999|FG000|STARTED|Overall Study||22
9924532|NCT01262027|11041999|FG000|COMPLETED|Overall Study||17
9924533|NCT01262027|11041999|FG000|NOT COMPLETED|Overall Study||5
9924534|NCT01262092|11042005|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
9924535|NCT01262092|11042006|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
9924536|NCT01262092|11042005|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
9924537|NCT01262092|11042006|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
9924538|NCT01262092|11042005|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
9924539|NCT01262092|11042006|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
9924540|NCT01262092|11042005|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
9924541|NCT01262092|11042006|FG001|STARTED|Buprenorphine Taper||13
9924542|NCT01262092|11042005|FG000|COMPLETED|Buprenorphine Taper||11
9924543|NCT01262092|11042006|FG001|COMPLETED|Buprenorphine Taper||12
9924544|NCT01262092|11042005|FG000|NOT COMPLETED|Buprenorphine Taper||1
9924545|NCT01262092|11042006|FG001|NOT COMPLETED|Buprenorphine Taper||1
9924546|NCT01262092|11042005|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
9924547|NCT01262092|11042006|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
9924548|NCT01262092|11042005|FG000|COMPLETED|Gabapentin Taper||9
9924549|NCT01262092|11042006|FG001|COMPLETED|Gabapentin Taper||11
9924550|NCT01262092|11042005|FG000|NOT COMPLETED|Gabapentin Taper||1
9924551|NCT01262092|11042006|FG001|NOT COMPLETED|Gabapentin Taper||0
9924552|NCT01262105|11042014|FG000|STARTED|Overall Study||13
9924553|NCT01262105|11042015|FG001|STARTED|Overall Study||10
9924554|NCT01262105|11042014|FG000|COMPLETED|Overall Study||13
9924555|NCT01262105|11042015|FG001|COMPLETED|Overall Study||10
9924556|NCT01262105|11042014|FG000|NOT COMPLETED|Overall Study||0
9924557|NCT01262105|11042015|FG001|NOT COMPLETED|Overall Study||0
9924558|NCT01262118|11042023|FG000|STARTED|Baseline Assessment Period (3 Days)||36
9924559|NCT01262118|11042024|FG001|STARTED|Baseline Assessment Period (3 Days)||33
9924560|NCT01262118|11042023|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36
9924561|NCT01262118|11042024|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33
9924562|NCT01262118|11042023|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
9924563|NCT01262118|11042024|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
9924564|NCT01262118|11042023|FG000|STARTED|Treatment Period (6 Weeks)||36
9924565|NCT01262118|11042024|FG001|STARTED|Treatment Period (6 Weeks)||0
9924566|NCT01262118|11042023|FG000|COMPLETED|Treatment Period (6 Weeks)||36
9924567|NCT01262118|11042024|FG001|COMPLETED|Treatment Period (6 Weeks)||0
9924568|NCT01262118|11042023|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0
9924569|NCT01262118|11042024|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0
9924570|NCT01262131|11042033|FG000|STARTED|Overall Study||5
9924571|NCT01262131|11042034|FG001|STARTED|Overall Study||4
9924572|NCT01262131|11042035|FG002|STARTED|Overall Study||4
9924573|NCT01262131|11042033|FG000|COMPLETED|Overall Study||5
9924574|NCT01262131|11042034|FG001|COMPLETED|Overall Study||4
9924575|NCT01262131|11042035|FG002|COMPLETED|Overall Study||4
9924576|NCT01262131|11042033|FG000|NOT COMPLETED|Overall Study||0
9924577|NCT01262131|11042034|FG001|NOT COMPLETED|Overall Study||0
9924578|NCT01262131|11042035|FG002|NOT COMPLETED|Overall Study||0
9924579|NCT01262287|11042045|FG000|STARTED|Overall Study||20
9924580|NCT01262287|11042046|FG001|STARTED|Overall Study||19
9924581|NCT01262287|11042045|FG000|COMPLETED|Overall Study||18
9924582|NCT01262287|11042046|FG001|COMPLETED|Overall Study||18
9924583|NCT01262287|11042045|FG000|NOT COMPLETED|Overall Study||2
9924584|NCT01262287|11042046|FG001|NOT COMPLETED|Overall Study||1
9924585|NCT01262352|11042058|FG000|STARTED|Period 1||11
9924586|NCT01262352|11042059|FG001|STARTED|Period 1||10
9924587|NCT01262352|11042058|FG000|Dosed|Period 1||10
9924588|NCT01262352|11042059|FG001|Dosed|Period 1||10
9924589|NCT01262352|11042058|FG000|COMPLETED|Period 1||10
9924590|NCT01262352|11042059|FG001|COMPLETED|Period 1||10
9924591|NCT01262352|11042058|FG000|NOT COMPLETED|Period 1||1
9924592|NCT01262352|11042059|FG001|NOT COMPLETED|Period 1||0
9924593|NCT01262352|11042058|FG000|STARTED|Washout||10
9924594|NCT01262352|11042059|FG001|STARTED|Washout||10
9924595|NCT01262352|11042058|FG000|COMPLETED|Washout||9
9924596|NCT01262352|11042059|FG001|COMPLETED|Washout||8
9924597|NCT01262352|11042058|FG000|NOT COMPLETED|Washout||1
9924598|NCT01262352|11042059|FG001|NOT COMPLETED|Washout||2
9924599|NCT01262352|11042058|FG000|STARTED|Period 2||9
9924600|NCT01262352|11042059|FG001|STARTED|Period 2||8
9924601|NCT01262352|11042058|FG000|Dosed|Period 2||9
9924602|NCT01262352|11042059|FG001|Dosed|Period 2||8
9924603|NCT01262352|11042058|FG000|COMPLETED|Period 2||9
9924604|NCT01262352|11042059|FG001|COMPLETED|Period 2||8
9924605|NCT01262352|11042058|FG000|NOT COMPLETED|Period 2||0
9924606|NCT01262352|11042059|FG001|NOT COMPLETED|Period 2||0
9924607|NCT01262365|11042068|FG000|STARTED|Overall Study||266
9924608|NCT01262365|11042069|FG001|STARTED|Overall Study||262
9924609|NCT01262365|11042070|FG002|STARTED|Overall Study||265
9924610|NCT01262365|11042068|FG000|COMPLETED|Overall Study||176
9924611|NCT01262365|11042069|FG001|COMPLETED|Overall Study||181
9924612|NCT01262365|11042070|FG002|COMPLETED|Overall Study||171
9924613|NCT01262365|11042068|FG000|NOT COMPLETED|Overall Study||90
9924614|NCT01262365|11042069|FG001|NOT COMPLETED|Overall Study||81
9924615|NCT01262365|11042070|FG002|NOT COMPLETED|Overall Study||94
9924616|NCT01262456|11042081|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
9924617|NCT01262456|11042082|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
9924618|NCT01262456|11042083|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
9924619|NCT01262456|11042081|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
9924620|NCT01262456|11042082|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
9924621|NCT01262456|11042083|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
9924622|NCT01262456|11042081|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
9924623|NCT01262456|11042082|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
9924624|NCT01262456|11042083|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
9924625|NCT01262456|11042081|FG000|COMPLETED|3-Month Double-Blind Period||124
9924626|NCT01262456|11042082|FG001|COMPLETED|3-Month Double-Blind Period||100
9924627|NCT01262456|11042083|FG002|COMPLETED|3-Month Double-Blind Period||103
9924628|NCT01262456|11042081|FG000|NOT COMPLETED|3-Month Double-Blind Period||19
9924629|NCT01262456|11042082|FG001|NOT COMPLETED|3-Month Double-Blind Period||23
9924630|NCT01262456|11042083|FG002|NOT COMPLETED|3-Month Double-Blind Period||26
9924631|NCT01262456|11042081|FG000|STARTED|1-Month Open-Label Extension Period||124
9924632|NCT01262456|11042082|FG001|STARTED|1-Month Open-Label Extension Period||100
9924633|NCT01262456|11042083|FG002|STARTED|1-Month Open-Label Extension Period||103
9924634|NCT01262456|11042081|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
9924635|NCT01262456|11042082|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
9924636|NCT01262456|11042083|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
9924637|NCT01262456|11042081|FG000|COMPLETED|1-Month Open-Label Extension Period||120
9924638|NCT01262456|11042082|FG001|COMPLETED|1-Month Open-Label Extension Period||97
9924639|NCT01262456|11042083|FG002|COMPLETED|1-Month Open-Label Extension Period||98
9924640|NCT01262456|11042081|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4
9924641|NCT01262456|11042082|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3
9924642|NCT01262456|11042083|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5
9924643|NCT01262547|11042099|FG000|STARTED|Overall Study||3
9924644|NCT01262547|11042099|FG000|COMPLETED|Overall Study||3
9924645|NCT01262547|11042099|FG000|NOT COMPLETED|Overall Study||0
9924646|NCT01262560|11042111|FG000|STARTED|Overall Study||53
9924647|NCT01262560|11042112|FG001|STARTED|Overall Study||54
9924648|NCT01262560|11042113|FG002|STARTED|Overall Study||56
9924649|NCT01262560|11042111|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
9924650|NCT01262560|11042112|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
9924651|NCT01262560|11042113|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
9924652|NCT01262560|11042111|FG000|NOT COMPLETED|Overall Study||0
9924653|NCT01262560|11042112|FG001|NOT COMPLETED|Overall Study||1
9924654|NCT01262560|11042113|FG002|NOT COMPLETED|Overall Study||2
9924655|NCT01262573|11042123|FG000|STARTED|Overall Study||32
9924656|NCT01262573|11042124|FG001|STARTED|Overall Study||32
9924657|NCT01262573|11042123|FG000|COMPLETED|Overall Study||32
9924658|NCT01262573|11042124|FG001|COMPLETED|Overall Study||31
9924659|NCT01262573|11042123|FG000|NOT COMPLETED|Overall Study||0
9924660|NCT01262573|11042124|FG001|NOT COMPLETED|Overall Study||1
9924661|NCT01262599|11042132|FG000|STARTED|Overall Study||16
9924662|NCT01262599|11042133|FG001|STARTED|Overall Study||16
9924663|NCT01262599|11042132|FG000|COMPLETED|Overall Study||16
9924664|NCT01262599|11042133|FG001|COMPLETED|Overall Study||16
9924665|NCT01262599|11042132|FG000|NOT COMPLETED|Overall Study||0
9924666|NCT01262599|11042133|FG001|NOT COMPLETED|Overall Study||0
9924667|NCT01262638|11042145|FG000|STARTED|Overall Study||45
9924668|NCT01262638|11042146|FG001|STARTED|Overall Study||44
9924669|NCT01262638|11042147|FG002|STARTED|Overall Study||44
9924670|NCT01262638|11042148|FG003|STARTED|Overall Study||44
9924671|NCT01262638|11042145|FG000|COMPLETED|Overall Study||38
9924672|NCT01262638|11042146|FG001|COMPLETED|Overall Study||38
9924673|NCT01262638|11042147|FG002|COMPLETED|Overall Study||38
9924674|NCT01262638|11042148|FG003|COMPLETED|Overall Study||37
9924675|NCT01262638|11042145|FG000|NOT COMPLETED|Overall Study||7
9924676|NCT01262638|11042146|FG001|NOT COMPLETED|Overall Study||6
9924677|NCT01262638|11042147|FG002|NOT COMPLETED|Overall Study||6
9924678|NCT01262638|11042148|FG003|NOT COMPLETED|Overall Study||7
9924679|NCT01262651|11042163|FG000|STARTED|Overall Study||199
9924680|NCT01262651|11042164|FG001|STARTED|Overall Study||198
9924681|NCT01262651|11042163|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199
9924682|NCT01262651|11042164|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198
9924683|NCT01262651|11042163|FG000|Safety Population|Overall Study||199
9924684|NCT01262651|11042164|FG001|Safety Population|Overall Study||198
9924685|NCT01262651|11042163|FG000|ITT Population|Overall Study||199
9924686|NCT01262651|11042164|FG001|ITT Population|Overall Study||198
9924687|NCT01262651|11042163|FG000|COMPLETED|Overall Study||141
9924688|NCT01262651|11042164|FG001|COMPLETED|Overall Study||150
9924689|NCT01262651|11042163|FG000|NOT COMPLETED|Overall Study||58
9924690|NCT01262651|11042164|FG001|NOT COMPLETED|Overall Study||48
9924691|NCT01262677|11042173|FG000|STARTED|Overall Study||100
9924692|NCT01262677|11042174|FG001|STARTED|Overall Study||113
9924693|NCT01262677|11042175|FG002|STARTED|Overall Study||110
9924694|NCT01262677|11042173|FG000|COMPLETED|Overall Study||91
9924695|NCT01262677|11042174|FG001|COMPLETED|Overall Study||98
9924696|NCT01262677|11042175|FG002|COMPLETED|Overall Study||98
9924697|NCT01262677|11042173|FG000|NOT COMPLETED|Overall Study||9
9924698|NCT01262677|11042174|FG001|NOT COMPLETED|Overall Study||15
9924699|NCT01262677|11042175|FG002|NOT COMPLETED|Overall Study||12
9924700|NCT01262755|11042183|FG000|STARTED|Overall Study||450
9924701|NCT01262755|11042183|FG000|COMPLETED|Overall Study||450
9924702|NCT01262755|11042183|FG000|NOT COMPLETED|Overall Study||0
9924703|NCT01262820|11042187|FG000|STARTED|Overall Study||15
9924704|NCT01262820|11042187|FG000|COMPLETED|Overall Study||0
9924705|NCT01262820|11042187|FG000|NOT COMPLETED|Overall Study||15
9924706|NCT01262846|11042193|FG000|STARTED|Overall Study||95
9924707|NCT01262846|11042194|FG001|STARTED|Overall Study||100
9924708|NCT01262846|11042193|FG000|COMPLETED|Overall Study||93
9924709|NCT01262846|11042194|FG001|COMPLETED|Overall Study||97
9924710|NCT01262846|11042193|FG000|NOT COMPLETED|Overall Study||2
9924711|NCT01262846|11042194|FG001|NOT COMPLETED|Overall Study||3
9924712|NCT01262872|11042208|FG000|STARTED|Step 1||60
9924713|NCT01262872|11042209|FG001|STARTED|Step 1||60
9956018|NCT01441843|11075102|FG001|COMPLETED|Overall Study||195
9924714|NCT01262872|11042210|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924715|NCT01262872|11042211|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924716|NCT01262872|11042212|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924717|NCT01262872|11042213|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924718|NCT01262872|11042214|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924719|NCT01262872|11042215|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924720|NCT01262872|11042208|FG000|COMPLETED|Step 1||60
9760536|NCT00381797|10864235|FG002|NOT COMPLETED|Overall Study||0
9760537|NCT00381797|10864236|FG003|NOT COMPLETED|Overall Study||1
9760538|NCT00381797|10864237|FG004|NOT COMPLETED|Overall Study||2
9760539|NCT00381810|10864270|FG000|STARTED|Treatment and Safety Follow-up||31
9760540|NCT00381810|10864270|FG000|COMPLETED|Treatment and Safety Follow-up||16
9760541|NCT00381810|10864270|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15
9829207|NCT00758745|10939783|FG000|STARTED|Overall Study||81
9829208|NCT00758745|10939784|FG001|STARTED|Overall Study||81
9829209|NCT00758745|10939783|FG000|COMPLETED|Overall Study||60
9829210|NCT00758745|10939784|FG001|COMPLETED|Overall Study||60
9829211|NCT00758745|10939783|FG000|NOT COMPLETED|Overall Study||21
9829212|NCT00758745|10939784|FG001|NOT COMPLETED|Overall Study||21
9829213|NCT00758758|10939798|FG000|STARTED|Overall Study||14
9829214|NCT00758758|10939799|FG001|STARTED|Overall Study||74
9829215|NCT00758758|10939800|FG002|STARTED|Overall Study||53
9829216|NCT00758758|10939801|FG003|STARTED|Overall Study||6
9829217|NCT00758758|10939802|FG004|STARTED|Overall Study||3
9829218|NCT00758758|10939803|FG005|STARTED|Overall Study||50
9829219|NCT00758758|10939804|FG006|STARTED|Overall Study||31
9829220|NCT00758758|10939805|FG007|STARTED|Overall Study||0
9829221|NCT00758758|10939798|FG000|COMPLETED|Overall Study||11
9829222|NCT00758758|10939799|FG001|COMPLETED|Overall Study||49
9829223|NCT00758758|10939800|FG002|COMPLETED|Overall Study||35
9829224|NCT00758758|10939801|FG003|COMPLETED|Overall Study||4
9829225|NCT00758758|10939802|FG004|COMPLETED|Overall Study||1
9829226|NCT00758758|10939803|FG005|COMPLETED|Overall Study||36
9829227|NCT00758758|10939804|FG006|COMPLETED|Overall Study||17
9829228|NCT00758758|10939805|FG007|COMPLETED|Overall Study||0
9829229|NCT00758758|10939798|FG000|NOT COMPLETED|Overall Study||3
9829230|NCT00758758|10939799|FG001|NOT COMPLETED|Overall Study||25
9829231|NCT00758758|10939800|FG002|NOT COMPLETED|Overall Study||18
9829232|NCT00758758|10939801|FG003|NOT COMPLETED|Overall Study||2
9829233|NCT00758758|10939802|FG004|NOT COMPLETED|Overall Study||2
9829234|NCT00758758|10939803|FG005|NOT COMPLETED|Overall Study||14
9829235|NCT00758758|10939804|FG006|NOT COMPLETED|Overall Study||14
9829236|NCT00758758|10939805|FG007|NOT COMPLETED|Overall Study||0
9829237|NCT00758771|10939833|FG000|STARTED|Overall Study||18
9829238|NCT00758771|10939834|FG001|STARTED|Overall Study||20
9829239|NCT00758771|10939833|FG000|COMPLETED|Overall Study||15
9829240|NCT00758771|10939834|FG001|COMPLETED|Overall Study||15
9829241|NCT00758771|10939833|FG000|NOT COMPLETED|Overall Study||3
9829242|NCT00758771|10939834|FG001|NOT COMPLETED|Overall Study||5
9829243|NCT00758784|10939840|FG000|STARTED|Overall Study||38
9829244|NCT00758784|10939840|FG000|COMPLETED|Overall Study||36
9829245|NCT00758784|10939840|FG000|NOT COMPLETED|Overall Study||2
9829246|NCT00758836|10939848|FG000|STARTED|Overall Study||171
9829247|NCT00758836|10939849|FG001|STARTED|Overall Study||171
9829248|NCT00758836|10939850|FG002|STARTED|Overall Study||171
9829249|NCT00758836|10939851|FG003|STARTED|Overall Study||170
9829250|NCT00758836|10939848|FG000|Treated|Overall Study||147
9829251|NCT00758836|10939849|FG001|Treated|Overall Study||145
9829252|NCT00758836|10939850|FG002|Treated|Overall Study||133
9829253|NCT00758836|10939851|FG003|Treated|Overall Study||138
9829254|NCT00758836|10939848|FG000|COMPLETED|Overall Study||147
9829255|NCT00758836|10939849|FG001|COMPLETED|Overall Study||145
9829256|NCT00758836|10939850|FG002|COMPLETED|Overall Study||133
9829257|NCT00758836|10939851|FG003|COMPLETED|Overall Study||138
9829258|NCT00758836|10939848|FG000|NOT COMPLETED|Overall Study||24
9829259|NCT00758836|10939849|FG001|NOT COMPLETED|Overall Study||26
9829260|NCT00758836|10939850|FG002|NOT COMPLETED|Overall Study||38
9829261|NCT00758836|10939851|FG003|NOT COMPLETED|Overall Study||32
9829262|NCT00758862|10939861|FG000|STARTED|Overall Study||20
9829263|NCT00758862|10939861|FG000|COMPLETED|Overall Study||19
9829264|NCT00758862|10939861|FG000|NOT COMPLETED|Overall Study||1
9829265|NCT00759031|10939867|FG000|STARTED|First Intervention (1 Day)||10
9829266|NCT00759031|10939868|FG001|STARTED|First Intervention (1 Day)||9
9829267|NCT00759031|10939867|FG000|COMPLETED|First Intervention (1 Day)||8
9829268|NCT00759031|10939868|FG001|COMPLETED|First Intervention (1 Day)||8
9829269|NCT00759031|10939867|FG000|NOT COMPLETED|First Intervention (1 Day)||2
9829270|NCT00759031|10939868|FG001|NOT COMPLETED|First Intervention (1 Day)||1
9829271|NCT00759031|10939867|FG000|STARTED|Washout After 1st Intervention (1 Week)||8
9829272|NCT00759031|10939868|FG001|STARTED|Washout After 1st Intervention (1 Week)||8
9829273|NCT00759031|10939867|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8
9829274|NCT00759031|10939868|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8
9924721|NCT01262872|11042209|FG001|COMPLETED|Step 1||60
9924722|NCT01262872|11042210|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924723|NCT01262872|11042211|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
9924724|NCT01262872|11042212|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924725|NCT01262872|11042213|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924726|NCT01262872|11042214|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924727|NCT01262872|11042215|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924728|NCT01262872|11042208|FG000|NOT COMPLETED|Step 1||0
9924729|NCT01262872|11042209|FG001|NOT COMPLETED|Step 1||0
9924730|NCT01262872|11042210|FG002|NOT COMPLETED|Step 1||0
9924731|NCT01262872|11042211|FG003|NOT COMPLETED|Step 1||0
9924732|NCT01262872|11042212|FG004|NOT COMPLETED|Step 1||0
9924733|NCT01262872|11042213|FG005|NOT COMPLETED|Step 1||0
9924734|NCT01262872|11042214|FG006|NOT COMPLETED|Step 1||0
9924735|NCT01262872|11042215|FG007|NOT COMPLETED|Step 1||0
9924736|NCT01262872|11042208|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924737|NCT01262872|11042209|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924738|NCT01262872|11042210|FG002|STARTED|Step 2||200
9924739|NCT01262872|11042211|FG003|STARTED|Step 2||200
9924740|NCT01262872|11042212|FG004|STARTED|Step 2||200
9924741|NCT01262872|11042213|FG005|STARTED|Step 2||200
9924742|NCT01262872|11042214|FG006|STARTED|Step 2||200
9924743|NCT01262872|11042215|FG007|STARTED|Step 2||200
9924744|NCT01262872|11042208|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
9924745|NCT01262872|11042209|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10010693|NCT01775189|11133365|FG005|STARTED|Treatment Phase: Third Intervention||7
10010694|NCT01775189|11133366|FG006|STARTED|Treatment Phase: Third Intervention||8
10010695|NCT01775189|11133360|FG000|COMPLETED|Treatment Phase: Third Intervention||0
10010696|NCT01775189|11133361|FG001|COMPLETED|Treatment Phase: Third Intervention||0
10010697|NCT01775189|11133362|FG002|COMPLETED|Treatment Phase: Third Intervention||0
10010698|NCT01775189|11133363|FG003|COMPLETED|Treatment Phase: Third Intervention||7
9924746|NCT01262872|11042210|FG002|COMPLETED|Step 2||191
9924747|NCT01262872|11042211|FG003|COMPLETED|Step 2||190
9924748|NCT01262872|11042212|FG004|COMPLETED|Step 2||195
9924749|NCT01262872|11042213|FG005|COMPLETED|Step 2||191
9924750|NCT01262872|11042214|FG006|COMPLETED|Step 2||191
9924751|NCT01262872|11042215|FG007|COMPLETED|Step 2||194
9924752|NCT01262872|11042208|FG000|NOT COMPLETED|Step 2||0
9924753|NCT01262872|11042209|FG001|NOT COMPLETED|Step 2||0
9924754|NCT01262872|11042210|FG002|NOT COMPLETED|Step 2||9
9924755|NCT01262872|11042211|FG003|NOT COMPLETED|Step 2||10
9924756|NCT01262872|11042212|FG004|NOT COMPLETED|Step 2||5
10010699|NCT01775189|11133364|FG004|COMPLETED|Treatment Phase: Third Intervention||8
10010700|NCT01775189|11133365|FG005|COMPLETED|Treatment Phase: Third Intervention||7
10010701|NCT01775189|11133366|FG006|COMPLETED|Treatment Phase: Third Intervention||8
10010702|NCT01775189|11133360|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
10010703|NCT01775189|11133361|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
10010704|NCT01775189|11133362|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
10010705|NCT01775189|11133363|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
10010706|NCT01775189|11133364|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
10010707|NCT01775189|11133365|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
9924757|NCT01262872|11042213|FG005|NOT COMPLETED|Step 2||9
9924758|NCT01262872|11042214|FG006|NOT COMPLETED|Step 2||9
9924759|NCT01262872|11042215|FG007|NOT COMPLETED|Step 2||6
9924760|NCT01262898|11042253|FG000|STARTED|Overall Study||21
9924761|NCT01262898|11042254|FG001|STARTED|Overall Study||18
9924762|NCT01262898|11042255|FG002|STARTED|Overall Study||18
9924763|NCT01262898|11042256|FG003|STARTED|Overall Study||22
9924764|NCT01262898|11042253|FG000|COMPLETED|Overall Study||18
9924765|NCT01262898|11042254|FG001|COMPLETED|Overall Study||16
9924766|NCT01262898|11042255|FG002|COMPLETED|Overall Study||18
9924767|NCT01262898|11042256|FG003|COMPLETED|Overall Study||22
9924768|NCT01262898|11042253|FG000|NOT COMPLETED|Overall Study||3
9924769|NCT01262898|11042254|FG001|NOT COMPLETED|Overall Study||2
9924770|NCT01262898|11042255|FG002|NOT COMPLETED|Overall Study||0
9924771|NCT01262898|11042256|FG003|NOT COMPLETED|Overall Study||0
9924772|NCT01262976|11042275|FG000|STARTED|Up to Month 2||40
9924773|NCT01262976|11042276|FG001|STARTED|Up to Month 2||40
9924774|NCT01262976|11042277|FG002|STARTED|Up to Month 2||40
9924775|NCT01262976|11042278|FG003|STARTED|Up to Month 2||40
10010708|NCT01775189|11133366|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
10010709|NCT01775189|11133360|FG000|STARTED|Treatment Phase: Washout Period 3||0
10010710|NCT01775189|11133361|FG001|STARTED|Treatment Phase: Washout Period 3||0
10010711|NCT01775189|11133362|FG002|STARTED|Treatment Phase: Washout Period 3||0
10010712|NCT01775189|11133363|FG003|STARTED|Treatment Phase: Washout Period 3||7
10010713|NCT01775189|11133364|FG004|STARTED|Treatment Phase: Washout Period 3||8
10010714|NCT01775189|11133365|FG005|STARTED|Treatment Phase: Washout Period 3||7
9924776|NCT01262976|11042279|FG004|STARTED|Up to Month 2||40
9924777|NCT01262976|11042280|FG005|STARTED|Up to Month 2||40
9924778|NCT01262976|11042275|FG000|COMPLETED|Up to Month 2||37
9924779|NCT01262976|11042276|FG001|COMPLETED|Up to Month 2||39
9924780|NCT01262976|11042277|FG002|COMPLETED|Up to Month 2||39
9924781|NCT01262976|11042278|FG003|COMPLETED|Up to Month 2||38
9924782|NCT01262976|11042279|FG004|COMPLETED|Up to Month 2||38
9924783|NCT01262976|11042280|FG005|COMPLETED|Up to Month 2||36
9924784|NCT01262976|11042275|FG000|NOT COMPLETED|Up to Month 2||3
9924785|NCT01262976|11042276|FG001|NOT COMPLETED|Up to Month 2||1
9924786|NCT01262976|11042277|FG002|NOT COMPLETED|Up to Month 2||1
9924787|NCT01262976|11042278|FG003|NOT COMPLETED|Up to Month 2||2
9924788|NCT01262976|11042279|FG004|NOT COMPLETED|Up to Month 2||2
9924789|NCT01262976|11042280|FG005|NOT COMPLETED|Up to Month 2||4
9924790|NCT01262976|11042275|FG000|STARTED|Up to Month 7||40
9924791|NCT01262976|11042276|FG001|STARTED|Up to Month 7||40
9924792|NCT01262976|11042277|FG002|STARTED|Up to Month 7||40
9924793|NCT01262976|11042278|FG003|STARTED|Up to Month 7||40
9924794|NCT01262976|11042279|FG004|STARTED|Up to Month 7||40
9924795|NCT01262976|11042280|FG005|STARTED|Up to Month 7||40
9924796|NCT01262976|11042275|FG000|COMPLETED|Up to Month 7||35
9924797|NCT01262976|11042276|FG001|COMPLETED|Up to Month 7||40
9924798|NCT01262976|11042277|FG002|COMPLETED|Up to Month 7||34
9924799|NCT01262976|11042278|FG003|COMPLETED|Up to Month 7||34
9924800|NCT01262976|11042279|FG004|COMPLETED|Up to Month 7||38
9924801|NCT01262976|11042280|FG005|COMPLETED|Up to Month 7||36
9924802|NCT01262976|11042275|FG000|NOT COMPLETED|Up to Month 7||5
9924803|NCT01262976|11042276|FG001|NOT COMPLETED|Up to Month 7||0
9924804|NCT01262976|11042277|FG002|NOT COMPLETED|Up to Month 7||6
9924805|NCT01262976|11042278|FG003|NOT COMPLETED|Up to Month 7||6
9924806|NCT01262976|11042279|FG004|NOT COMPLETED|Up to Month 7||2
9924807|NCT01262976|11042280|FG005|NOT COMPLETED|Up to Month 7||4
9924808|NCT01262976|11042275|FG000|STARTED|Up to Year 1||40
9924809|NCT01262976|11042276|FG001|STARTED|Up to Year 1||40
9924810|NCT01262976|11042277|FG002|STARTED|Up to Year 1||40
9924811|NCT01262976|11042278|FG003|STARTED|Up to Year 1||40
9924812|NCT01262976|11042279|FG004|STARTED|Up to Year 1||40
9924813|NCT01262976|11042280|FG005|STARTED|Up to Year 1||40
9924814|NCT01262976|11042275|FG000|COMPLETED|Up to Year 1||31
9924815|NCT01262976|11042276|FG001|COMPLETED|Up to Year 1||39
9924816|NCT01262976|11042277|FG002|COMPLETED|Up to Year 1||37
9924817|NCT01262976|11042278|FG003|COMPLETED|Up to Year 1||36
9924818|NCT01262976|11042279|FG004|COMPLETED|Up to Year 1||29
9924819|NCT01262976|11042280|FG005|COMPLETED|Up to Year 1||31
9924820|NCT01262976|11042275|FG000|NOT COMPLETED|Up to Year 1||9
9924821|NCT01262976|11042276|FG001|NOT COMPLETED|Up to Year 1||1
9924822|NCT01262976|11042277|FG002|NOT COMPLETED|Up to Year 1||3
9924823|NCT01262976|11042278|FG003|NOT COMPLETED|Up to Year 1||4
9924824|NCT01262976|11042279|FG004|NOT COMPLETED|Up to Year 1||11
9924825|NCT01262976|11042280|FG005|NOT COMPLETED|Up to Year 1||9
9924826|NCT01262976|11042275|FG000|STARTED|Up to Year 2||40
9924827|NCT01262976|11042276|FG001|STARTED|Up to Year 2||40
9924828|NCT01262976|11042277|FG002|STARTED|Up to Year 2||40
9924829|NCT01262976|11042278|FG003|STARTED|Up to Year 2||40
9924830|NCT01262976|11042279|FG004|STARTED|Up to Year 2||40
9924831|NCT01262976|11042280|FG005|STARTED|Up to Year 2||40
9924832|NCT01262976|11042275|FG000|COMPLETED|Up to Year 2||35
9924833|NCT01262976|11042276|FG001|COMPLETED|Up to Year 2||39
9924834|NCT01262976|11042277|FG002|COMPLETED|Up to Year 2||35
9924835|NCT01262976|11042278|FG003|COMPLETED|Up to Year 2||36
9924836|NCT01262976|11042279|FG004|COMPLETED|Up to Year 2||36
9924837|NCT01262976|11042280|FG005|COMPLETED|Up to Year 2||35
9924838|NCT01262976|11042275|FG000|NOT COMPLETED|Up to Year 2||5
9924839|NCT01262976|11042276|FG001|NOT COMPLETED|Up to Year 2||1
9924840|NCT01262976|11042277|FG002|NOT COMPLETED|Up to Year 2||5
9924841|NCT01262976|11042278|FG003|NOT COMPLETED|Up to Year 2||4
9924842|NCT01262976|11042279|FG004|NOT COMPLETED|Up to Year 2||4
9924843|NCT01262976|11042280|FG005|NOT COMPLETED|Up to Year 2||5
9924844|NCT01262976|11042275|FG000|STARTED|Up to Year 3||40
9924845|NCT01262976|11042276|FG001|STARTED|Up to Year 3||40
9924846|NCT01262976|11042277|FG002|STARTED|Up to Year 3||40
9924847|NCT01262976|11042278|FG003|STARTED|Up to Year 3||40
9924848|NCT01262976|11042279|FG004|STARTED|Up to Year 3||40
9924849|NCT01262976|11042280|FG005|STARTED|Up to Year 3||40
9924850|NCT01262976|11042275|FG000|COMPLETED|Up to Year 3||34
9924851|NCT01262976|11042276|FG001|COMPLETED|Up to Year 3||38
9924852|NCT01262976|11042277|FG002|COMPLETED|Up to Year 3||33
9924853|NCT01262976|11042278|FG003|COMPLETED|Up to Year 3||35
9924854|NCT01262976|11042279|FG004|COMPLETED|Up to Year 3||38
9924855|NCT01262976|11042280|FG005|COMPLETED|Up to Year 3||36
9924856|NCT01262976|11042275|FG000|NOT COMPLETED|Up to Year 3||6
9924857|NCT01262976|11042276|FG001|NOT COMPLETED|Up to Year 3||2
9924858|NCT01262976|11042277|FG002|NOT COMPLETED|Up to Year 3||7
9924859|NCT01262976|11042278|FG003|NOT COMPLETED|Up to Year 3||5
9924860|NCT01262976|11042279|FG004|NOT COMPLETED|Up to Year 3||2
9924861|NCT01262976|11042280|FG005|NOT COMPLETED|Up to Year 3||4
9924862|NCT01262989|11042295|FG000|STARTED|Period 1||20
9924863|NCT01262989|11042296|FG001|STARTED|Period 1||20
9924864|NCT01262989|11042295|FG000|COMPLETED|Period 1||19
9924865|NCT01262989|11042296|FG001|COMPLETED|Period 1||17
9924866|NCT01262989|11042295|FG000|NOT COMPLETED|Period 1||1
9924867|NCT01262989|11042296|FG001|NOT COMPLETED|Period 1||3
9924868|NCT01262989|11042295|FG000|STARTED|7-Day Washout Period||19
9924869|NCT01262989|11042296|FG001|STARTED|7-Day Washout Period||17
9924870|NCT01262989|11042295|FG000|COMPLETED|7-Day Washout Period||19
9924871|NCT01262989|11042296|FG001|COMPLETED|7-Day Washout Period||17
9924872|NCT01262989|11042295|FG000|NOT COMPLETED|7-Day Washout Period||0
9924873|NCT01262989|11042296|FG001|NOT COMPLETED|7-Day Washout Period||0
9924874|NCT01262989|11042295|FG000|STARTED|Period 2||19
9924875|NCT01262989|11042296|FG001|STARTED|Period 2||17
9924876|NCT01262989|11042295|FG000|COMPLETED|Period 2||19
9924877|NCT01262989|11042296|FG001|COMPLETED|Period 2||16
9924878|NCT01262989|11042295|FG000|NOT COMPLETED|Period 2||0
9924879|NCT01262989|11042296|FG001|NOT COMPLETED|Period 2||1
9924880|NCT01263015|11042304|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414
9924881|NCT01263015|11042305|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419
9924882|NCT01263015|11042304|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
9924883|NCT01263015|11042305|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
9924884|NCT01263015|11042304|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
9924885|NCT01263015|11042305|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
9924886|NCT01263015|11042304|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341
9924887|NCT01263015|11042305|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309
9924888|NCT01263015|11042304|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317
9924889|NCT01263015|11042305|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278
9924890|NCT01263015|11042304|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
9924891|NCT01263015|11042305|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
9924892|NCT01263054|11042313|FG000|STARTED|Overall Study||29
9924893|NCT01263054|11042314|FG001|STARTED|Overall Study||34
9924894|NCT01263054|11042313|FG000|COMPLETED|Overall Study||24
9924895|NCT01263054|11042314|FG001|COMPLETED|Overall Study||28
9924896|NCT01263054|11042313|FG000|NOT COMPLETED|Overall Study||5
9924897|NCT01263054|11042314|FG001|NOT COMPLETED|Overall Study||6
9924898|NCT01263093|11042322|FG000|STARTED|Period 1||24
9924899|NCT01263093|11042323|FG001|STARTED|Period 1||23
9924900|NCT01263093|11042322|FG000|COMPLETED|Period 1||24
9924901|NCT01263093|11042323|FG001|COMPLETED|Period 1||23
9924902|NCT01263093|11042322|FG000|NOT COMPLETED|Period 1||0
9924903|NCT01263093|11042323|FG001|NOT COMPLETED|Period 1||0
9924904|NCT01263093|11042322|FG000|STARTED|Washout||24
9924905|NCT01263093|11042323|FG001|STARTED|Washout||23
9924906|NCT01263093|11042322|FG000|COMPLETED|Washout||23
9924907|NCT01263093|11042323|FG001|COMPLETED|Washout||23
9924908|NCT01263093|11042322|FG000|NOT COMPLETED|Washout||1
9924909|NCT01263093|11042323|FG001|NOT COMPLETED|Washout||0
9924910|NCT01263093|11042322|FG000|STARTED|Period 2||23
9924911|NCT01263093|11042323|FG001|STARTED|Period 2||23
9924912|NCT01263093|11042322|FG000|COMPLETED|Period 2||22
9924913|NCT01263093|11042323|FG001|COMPLETED|Period 2||23
9924914|NCT01263093|11042322|FG000|NOT COMPLETED|Period 2||1
9924915|NCT01263093|11042323|FG001|NOT COMPLETED|Period 2||0
9924916|NCT01263106|11042330|FG000|STARTED|Period 1 (7 Days)||11
9924917|NCT01263106|11042331|FG001|STARTED|Period 1 (7 Days)||10
9924918|NCT01263106|11042330|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
9924919|NCT01263106|11042331|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
9924920|NCT01263106|11042330|FG000|NOT COMPLETED|Period 1 (7 Days)||0
9924921|NCT01263106|11042331|FG001|NOT COMPLETED|Period 1 (7 Days)||0
9924922|NCT01263106|11042330|FG000|STARTED|Washout (at Least 7 Days)||11
9924923|NCT01263106|11042331|FG001|STARTED|Washout (at Least 7 Days)||10
9924924|NCT01263106|11042330|FG000|COMPLETED|Washout (at Least 7 Days)||10
9924925|NCT01263106|11042331|FG001|COMPLETED|Washout (at Least 7 Days)||9
9924926|NCT01263106|11042330|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1
9924927|NCT01263106|11042331|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1
9924928|NCT01263106|11042330|FG000|STARTED|Period 2 (7 Days)||10
9924929|NCT01263106|11042331|FG001|STARTED|Period 2 (7 Days)||9
9924930|NCT01263106|11042330|FG000|COMPLETED|Period 2 (7 Days)||10
9924931|NCT01263106|11042331|FG001|COMPLETED|Period 2 (7 Days)||9
9924932|NCT01263106|11042330|FG000|NOT COMPLETED|Period 2 (7 Days)||0
9924933|NCT01263106|11042331|FG001|NOT COMPLETED|Period 2 (7 Days)||0
9924934|NCT01263119|11042340|FG000|STARTED|Period 1||18
10010715|NCT01775189|11133366|FG006|STARTED|Treatment Phase: Washout Period 3||8
10010716|NCT01775189|11133360|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
10010717|NCT01775189|11133361|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
9924935|NCT01263119|11042340|FG000|COMPLETED|Period 1||16
9924936|NCT01263119|11042340|FG000|NOT COMPLETED|Period 1||2
9924937|NCT01263119|11042340|FG000|STARTED|Period 2||16
9924938|NCT01263119|11042340|FG000|COMPLETED|Period 2||14
9924939|NCT01263119|11042340|FG000|NOT COMPLETED|Period 2||2
9924940|NCT01263132|11042350|FG000|STARTED|Overall Study||38
9924941|NCT01263132|11042351|FG001|STARTED|Overall Study||37
9924942|NCT01263132|11042350|FG000|COMPLETED|Overall Study||38
9924943|NCT01263132|11042351|FG001|COMPLETED|Overall Study||37
9924944|NCT01263132|11042350|FG000|NOT COMPLETED|Overall Study||0
9924945|NCT01263132|11042351|FG001|NOT COMPLETED|Overall Study||0
9924946|NCT01263197|11042359|FG000|STARTED|First Intervention (Period 1)||8
9924947|NCT01263197|11042360|FG001|STARTED|First Intervention (Period 1)||8
9924948|NCT01263197|11042361|FG002|STARTED|First Intervention (Period 1)||8
9924949|NCT01263197|11042362|FG003|STARTED|First Intervention (Period 1)||8
9924950|NCT01263197|11042363|FG004|STARTED|First Intervention (Period 1)||8
10010718|NCT01775189|11133362|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
9924951|NCT01263197|11042364|FG005|STARTED|First Intervention (Period 1)||8
9924952|NCT01263197|11042359|FG000|COMPLETED|First Intervention (Period 1)||8
9924953|NCT01263197|11042360|FG001|COMPLETED|First Intervention (Period 1)||8
9924954|NCT01263197|11042361|FG002|COMPLETED|First Intervention (Period 1)||8
9924955|NCT01263197|11042362|FG003|COMPLETED|First Intervention (Period 1)||8
9924956|NCT01263197|11042363|FG004|COMPLETED|First Intervention (Period 1)||8
9924957|NCT01263197|11042364|FG005|COMPLETED|First Intervention (Period 1)||7
9924958|NCT01263197|11042359|FG000|NOT COMPLETED|First Intervention (Period 1)||0
9924959|NCT01263197|11042360|FG001|NOT COMPLETED|First Intervention (Period 1)||0
9924960|NCT01263197|11042361|FG002|NOT COMPLETED|First Intervention (Period 1)||0
9924961|NCT01263197|11042362|FG003|NOT COMPLETED|First Intervention (Period 1)||0
9924962|NCT01263197|11042363|FG004|NOT COMPLETED|First Intervention (Period 1)||0
9924963|NCT01263197|11042364|FG005|NOT COMPLETED|First Intervention (Period 1)||1
9924964|NCT01263197|11042359|FG000|STARTED|Washout Period 1||8
9924965|NCT01263197|11042360|FG001|STARTED|Washout Period 1||8
9924966|NCT01263197|11042361|FG002|STARTED|Washout Period 1||8
9924967|NCT01263197|11042362|FG003|STARTED|Washout Period 1||8
9924968|NCT01263197|11042363|FG004|STARTED|Washout Period 1||8
9924969|NCT01263197|11042364|FG005|STARTED|Washout Period 1||7
9924970|NCT01263197|11042359|FG000|COMPLETED|Washout Period 1||8
9924971|NCT01263197|11042360|FG001|COMPLETED|Washout Period 1||8
9924972|NCT01263197|11042361|FG002|COMPLETED|Washout Period 1||8
9924973|NCT01263197|11042362|FG003|COMPLETED|Washout Period 1||8
9924974|NCT01263197|11042363|FG004|COMPLETED|Washout Period 1||7
9924975|NCT01263197|11042364|FG005|COMPLETED|Washout Period 1||7
9924976|NCT01263197|11042359|FG000|NOT COMPLETED|Washout Period 1||0
9924977|NCT01263197|11042360|FG001|NOT COMPLETED|Washout Period 1||0
9924978|NCT01263197|11042361|FG002|NOT COMPLETED|Washout Period 1||0
9924979|NCT01263197|11042362|FG003|NOT COMPLETED|Washout Period 1||0
9924980|NCT01263197|11042363|FG004|NOT COMPLETED|Washout Period 1||1
9924981|NCT01263197|11042364|FG005|NOT COMPLETED|Washout Period 1||0
9924982|NCT01263197|11042359|FG000|STARTED|Second Intervention (Period 2)||8
9924983|NCT01263197|11042360|FG001|STARTED|Second Intervention (Period 2)||8
9924984|NCT01263197|11042361|FG002|STARTED|Second Intervention (Period 2)||8
9924985|NCT01263197|11042362|FG003|STARTED|Second Intervention (Period 2)||8
9924986|NCT01263197|11042363|FG004|STARTED|Second Intervention (Period 2)||7
9924987|NCT01263197|11042364|FG005|STARTED|Second Intervention (Period 2)||7
10111371|NCT02495623|11242442|FG001|COMPLETED|Overall Study||17
10111372|NCT02495623|11242443|FG002|COMPLETED|Overall Study||20
10111373|NCT02495623|11242441|FG000|NOT COMPLETED|Overall Study||5
10111374|NCT02495623|11242442|FG001|NOT COMPLETED|Overall Study||9
10111375|NCT02495623|11242443|FG002|NOT COMPLETED|Overall Study||8
10111376|NCT02495779|11242451|FG000|STARTED|Overall Study||54
10111377|NCT02495779|11242451|FG000|COMPLETED|Overall Study||48
10111378|NCT02495779|11242451|FG000|NOT COMPLETED|Overall Study||6
10111379|NCT02495831|11242455|FG000|STARTED|First Intervention||13
10111380|NCT02495831|11242456|FG001|STARTED|First Intervention||10
10111381|NCT02495831|11242455|FG000|COMPLETED|First Intervention||13
10111382|NCT02495831|11242456|FG001|COMPLETED|First Intervention||10
10111383|NCT02495831|11242455|FG000|NOT COMPLETED|First Intervention||0
10111384|NCT02495831|11242456|FG001|NOT COMPLETED|First Intervention||0
10111385|NCT02495831|11242455|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
10111386|NCT02495831|11242456|FG001|STARTED|Second Intervention||10
10111387|NCT02495831|11242455|FG000|COMPLETED|Second Intervention||12
10111388|NCT02495831|11242456|FG001|COMPLETED|Second Intervention||10
10111389|NCT02495831|11242455|FG000|NOT COMPLETED|Second Intervention||0
10111390|NCT02495831|11242456|FG001|NOT COMPLETED|Second Intervention||0
10111391|NCT02495844|11242464|FG000|STARTED|Overall Study||27
10111392|NCT02495844|11242465|FG001|STARTED|Overall Study||28
10111393|NCT02495844|11242464|FG000|COMPLETED|Overall Study||26
10111394|NCT02495844|11242465|FG001|COMPLETED|Overall Study||24
10111395|NCT02495844|11242464|FG000|NOT COMPLETED|Overall Study||1
10111396|NCT02495844|11242465|FG001|NOT COMPLETED|Overall Study||4
10111397|NCT02495857|11242476|FG000|STARTED|Overall Study||200
10111398|NCT02495857|11242477|FG001|STARTED|Overall Study||200
10111399|NCT02495857|11242478|FG002|STARTED|Overall Study||199
10111400|NCT02495857|11242476|FG000|COMPLETED|Overall Study||178
10111401|NCT02495857|11242477|FG001|COMPLETED|Overall Study||184
10111402|NCT02495857|11242478|FG002|COMPLETED|Overall Study||181
10111403|NCT02495857|11242476|FG000|NOT COMPLETED|Overall Study||22
10111404|NCT02495857|11242477|FG001|NOT COMPLETED|Overall Study||16
10111405|NCT02495857|11242478|FG002|NOT COMPLETED|Overall Study||18
10111406|NCT02495883|11242488|FG000|STARTED|Overall Study||32
10111407|NCT02495883|11242489|FG001|STARTED|Overall Study||24
10111408|NCT02495883|11242488|FG000|COMPLETED|Overall Study||31
10111409|NCT02495883|11242489|FG001|COMPLETED|Overall Study||24
10111410|NCT02495883|11242488|FG000|NOT COMPLETED|Overall Study||1
10111411|NCT02495883|11242489|FG001|NOT COMPLETED|Overall Study||0
9924988|NCT01263197|11042359|FG000|COMPLETED|Second Intervention (Period 2)||8
9924989|NCT01263197|11042360|FG001|COMPLETED|Second Intervention (Period 2)||8
9924990|NCT01263197|11042361|FG002|COMPLETED|Second Intervention (Period 2)||8
9924991|NCT01263197|11042362|FG003|COMPLETED|Second Intervention (Period 2)||8
9924992|NCT01263197|11042363|FG004|COMPLETED|Second Intervention (Period 2)||7
9924993|NCT01263197|11042364|FG005|COMPLETED|Second Intervention (Period 2)||7
9924994|NCT01263197|11042359|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
10111412|NCT02495948|11242494|FG000|STARTED|Period 1, First 30 Days of Wear||83
10111413|NCT02495948|11242495|FG001|STARTED|Period 1, First 30 Days of Wear||84
10111414|NCT02495948|11242494|FG000|COMPLETED|Period 1, First 30 Days of Wear||83
10111415|NCT02495948|11242495|FG001|COMPLETED|Period 1, First 30 Days of Wear||83
10111416|NCT02495948|11242494|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10111417|NCT02495948|11242495|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
10111418|NCT02495948|11242494|FG000|STARTED|Period 2, Second 30 Days of Wear||83
10111419|NCT02495948|11242495|FG001|STARTED|Period 2, Second 30 Days of Wear||83
10111420|NCT02495948|11242494|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82
10111421|NCT02495948|11242495|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82
10111422|NCT02495948|11242494|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10111423|NCT02495948|11242495|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10111424|NCT02496000|11242505|FG000|STARTED|Overall Study||64
10111425|NCT02496000|11242506|FG001|STARTED|Overall Study||61
10111426|NCT02496000|11242507|FG002|STARTED|Overall Study||63
10111427|NCT02496000|11242505|FG000|COMPLETED|Overall Study||62
10111428|NCT02496000|11242506|FG001|COMPLETED|Overall Study||56
10111429|NCT02496000|11242507|FG002|COMPLETED|Overall Study||61
10111430|NCT02496000|11242505|FG000|NOT COMPLETED|Overall Study||2
10111431|NCT02496000|11242506|FG001|NOT COMPLETED|Overall Study||5
10111432|NCT02496000|11242507|FG002|NOT COMPLETED|Overall Study||2
10111433|NCT02496091|11242516|FG000|STARTED|Overall Study||144
10111434|NCT02496091|11242516|FG000|COMPLETED|Overall Study||142
10111435|NCT02496091|11242516|FG000|NOT COMPLETED|Overall Study||2
9924995|NCT01263197|11042360|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
9924996|NCT01263197|11042361|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
9924997|NCT01263197|11042362|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
9924998|NCT01263197|11042363|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
9924999|NCT01263197|11042364|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
9925000|NCT01263197|11042359|FG000|STARTED|Washout Period 2||8
9925001|NCT01263197|11042360|FG001|STARTED|Washout Period 2||8
9925002|NCT01263197|11042361|FG002|STARTED|Washout Period 2||8
9925003|NCT01263197|11042362|FG003|STARTED|Washout Period 2||8
9925004|NCT01263197|11042363|FG004|STARTED|Washout Period 2||7
9925005|NCT01263197|11042364|FG005|STARTED|Washout Period 2||7
9925006|NCT01263197|11042359|FG000|COMPLETED|Washout Period 2||8
9925007|NCT01263197|11042360|FG001|COMPLETED|Washout Period 2||8
9925008|NCT01263197|11042361|FG002|COMPLETED|Washout Period 2||8
9925009|NCT01263197|11042362|FG003|COMPLETED|Washout Period 2||7
9925010|NCT01263197|11042363|FG004|COMPLETED|Washout Period 2||7
9925011|NCT01263197|11042364|FG005|COMPLETED|Washout Period 2||6
9925012|NCT01263197|11042359|FG000|NOT COMPLETED|Washout Period 2||0
9925013|NCT01263197|11042360|FG001|NOT COMPLETED|Washout Period 2||0
9925014|NCT01263197|11042361|FG002|NOT COMPLETED|Washout Period 2||0
9925015|NCT01263197|11042362|FG003|NOT COMPLETED|Washout Period 2||1
9925016|NCT01263197|11042363|FG004|NOT COMPLETED|Washout Period 2||0
9925017|NCT01263197|11042364|FG005|NOT COMPLETED|Washout Period 2||1
9925018|NCT01263197|11042359|FG000|STARTED|Third Intervention (Period 3)||8
9925019|NCT01263197|11042360|FG001|STARTED|Third Intervention (Period 3)||8
9925020|NCT01263197|11042361|FG002|STARTED|Third Intervention (Period 3)||8
9925021|NCT01263197|11042362|FG003|STARTED|Third Intervention (Period 3)||7
9925022|NCT01263197|11042363|FG004|STARTED|Third Intervention (Period 3)||7
9925023|NCT01263197|11042364|FG005|STARTED|Third Intervention (Period 3)||6
9925024|NCT01263197|11042359|FG000|COMPLETED|Third Intervention (Period 3)||8
9925025|NCT01263197|11042360|FG001|COMPLETED|Third Intervention (Period 3)||7
9925026|NCT01263197|11042361|FG002|COMPLETED|Third Intervention (Period 3)||8
9925027|NCT01263197|11042362|FG003|COMPLETED|Third Intervention (Period 3)||7
9925028|NCT01263197|11042363|FG004|COMPLETED|Third Intervention (Period 3)||7
9925029|NCT01263197|11042364|FG005|COMPLETED|Third Intervention (Period 3)||6
9925030|NCT01263197|11042359|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
9925031|NCT01263197|11042360|FG001|NOT COMPLETED|Third Intervention (Period 3)||1
9925032|NCT01263197|11042361|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
9925033|NCT01263197|11042362|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
9925034|NCT01263197|11042363|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
9925035|NCT01263197|11042364|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
9925036|NCT01263223|11042378|FG000|STARTED|Period 1||12
9925037|NCT01263223|11042379|FG001|STARTED|Period 1||12
9925038|NCT01263223|11042378|FG000|COMPLETED|Period 1||12
9925039|NCT01263223|11042379|FG001|COMPLETED|Period 1||12
9925040|NCT01263223|11042378|FG000|NOT COMPLETED|Period 1||0
9925041|NCT01263223|11042379|FG001|NOT COMPLETED|Period 1||0
9925042|NCT01263223|11042378|FG000|STARTED|3-Day Washout||12
9925043|NCT01263223|11042379|FG001|STARTED|3-Day Washout||12
9925044|NCT01263223|11042378|FG000|COMPLETED|3-Day Washout||12
9925045|NCT01263223|11042379|FG001|COMPLETED|3-Day Washout||12
9925046|NCT01263223|11042378|FG000|NOT COMPLETED|3-Day Washout||0
9925047|NCT01263223|11042379|FG001|NOT COMPLETED|3-Day Washout||0
9925048|NCT01263223|11042378|FG000|STARTED|Period 2||12
9925049|NCT01263223|11042379|FG001|STARTED|Period 2||12
9925050|NCT01263223|11042378|FG000|COMPLETED|Period 2||12
9925051|NCT01263223|11042379|FG001|COMPLETED|Period 2||11
9925052|NCT01263223|11042378|FG000|NOT COMPLETED|Period 2||0
9925053|NCT01263223|11042379|FG001|NOT COMPLETED|Period 2||1
9925054|NCT01263223|11042378|FG000|STARTED|Period 3||12
9925055|NCT01263223|11042379|FG001|STARTED|Period 3||11
9925056|NCT01263223|11042378|FG000|COMPLETED|Period 3||12
9925057|NCT01263223|11042379|FG001|COMPLETED|Period 3||11
9925058|NCT01263223|11042378|FG000|NOT COMPLETED|Period 3||0
10111436|NCT02496221|11242521|FG000|STARTED|Treatment Period 1 - 4 Days||10
10111437|NCT02496221|11242522|FG001|STARTED|Treatment Period 1 - 4 Days||10
10111438|NCT02496221|11242521|FG000|COMPLETED|Treatment Period 1 - 4 Days||10
10111439|NCT02496221|11242522|FG001|COMPLETED|Treatment Period 1 - 4 Days||10
9925059|NCT01263223|11042379|FG001|NOT COMPLETED|Period 3||0
9925060|NCT01263223|11042378|FG000|STARTED|7-day Follow-up||12
9925061|NCT01263223|11042379|FG001|STARTED|7-day Follow-up||11
9925062|NCT01263223|11042378|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
9925063|NCT01263223|11042379|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
9925064|NCT01263223|11042378|FG000|NOT COMPLETED|7-day Follow-up||1
9925065|NCT01263223|11042379|FG001|NOT COMPLETED|7-day Follow-up||1
9925066|NCT01263301|11042390|FG000|STARTED|Overall Study||5
9925067|NCT01263301|11042391|FG001|STARTED|Overall Study||11
9925068|NCT01263301|11042390|FG000|COMPLETED|Overall Study||5
9925069|NCT01263301|11042391|FG001|COMPLETED|Overall Study||11
9925070|NCT01263301|11042390|FG000|NOT COMPLETED|Overall Study||0
9925071|NCT01263301|11042391|FG001|NOT COMPLETED|Overall Study||0
9925072|NCT01263314|11042405|FG000|STARTED|Period 1||2
9925073|NCT01263314|11042406|FG001|STARTED|Period 1||2
9925074|NCT01263314|11042407|FG002|STARTED|Period 1||2
9925075|NCT01263314|11042408|FG003|STARTED|Period 1||2
9925076|NCT01263314|11042409|FG004|STARTED|Period 1||2
9925077|NCT01263314|11042410|FG005|STARTED|Period 1||2
9925078|NCT01263314|11042411|FG006|STARTED|Period 1||2
9925079|NCT01263314|11042412|FG007|STARTED|Period 1||2
9925080|NCT01263314|11042405|FG000|COMPLETED|Period 1||2
9925081|NCT01263314|11042406|FG001|COMPLETED|Period 1||2
9925082|NCT01263314|11042407|FG002|COMPLETED|Period 1||2
9925083|NCT01263314|11042408|FG003|COMPLETED|Period 1||2
9925084|NCT01263314|11042409|FG004|COMPLETED|Period 1||2
9925085|NCT01263314|11042410|FG005|COMPLETED|Period 1||2
9925086|NCT01263314|11042411|FG006|COMPLETED|Period 1||2
9925087|NCT01263314|11042412|FG007|COMPLETED|Period 1||2
9925088|NCT01263314|11042405|FG000|NOT COMPLETED|Period 1||0
9925089|NCT01263314|11042406|FG001|NOT COMPLETED|Period 1||0
9925090|NCT01263314|11042407|FG002|NOT COMPLETED|Period 1||0
9925091|NCT01263314|11042408|FG003|NOT COMPLETED|Period 1||0
9925092|NCT01263314|11042409|FG004|NOT COMPLETED|Period 1||0
9925093|NCT01263314|11042410|FG005|NOT COMPLETED|Period 1||0
9925094|NCT01263314|11042411|FG006|NOT COMPLETED|Period 1||0
9925095|NCT01263314|11042412|FG007|NOT COMPLETED|Period 1||0
9925096|NCT01263314|11042405|FG000|STARTED|Period 2||2
9925097|NCT01263314|11042406|FG001|STARTED|Period 2||2
9925098|NCT01263314|11042407|FG002|STARTED|Period 2||2
9925099|NCT01263314|11042408|FG003|STARTED|Period 2||2
9925100|NCT01263314|11042409|FG004|STARTED|Period 2||2
9925101|NCT01263314|11042410|FG005|STARTED|Period 2||2
9925102|NCT01263314|11042411|FG006|STARTED|Period 2||2
9925103|NCT01263314|11042412|FG007|STARTED|Period 2||2
9925104|NCT01263314|11042405|FG000|COMPLETED|Period 2||2
9925105|NCT01263314|11042406|FG001|COMPLETED|Period 2||2
9925106|NCT01263314|11042407|FG002|COMPLETED|Period 2||2
9925107|NCT01263314|11042408|FG003|COMPLETED|Period 2||2
9925108|NCT01263314|11042409|FG004|COMPLETED|Period 2||2
9925109|NCT01263314|11042410|FG005|COMPLETED|Period 2||2
9925110|NCT01263314|11042411|FG006|COMPLETED|Period 2||2
9925111|NCT01263314|11042412|FG007|COMPLETED|Period 2||2
9925112|NCT01263314|11042405|FG000|NOT COMPLETED|Period 2||0
9925113|NCT01263314|11042406|FG001|NOT COMPLETED|Period 2||0
9925114|NCT01263314|11042407|FG002|NOT COMPLETED|Period 2||0
9925115|NCT01263314|11042408|FG003|NOT COMPLETED|Period 2||0
9925116|NCT01263314|11042409|FG004|NOT COMPLETED|Period 2||0
9925117|NCT01263314|11042410|FG005|NOT COMPLETED|Period 2||0
9925118|NCT01263314|11042411|FG006|NOT COMPLETED|Period 2||0
9925119|NCT01263314|11042412|FG007|NOT COMPLETED|Period 2||0
9925120|NCT01263314|11042405|FG000|STARTED|Period 3||2
9925121|NCT01263314|11042406|FG001|STARTED|Period 3||2
9925122|NCT01263314|11042407|FG002|STARTED|Period 3||2
9925123|NCT01263314|11042408|FG003|STARTED|Period 3||2
9925124|NCT01263314|11042409|FG004|STARTED|Period 3||2
9925125|NCT01263314|11042410|FG005|STARTED|Period 3||2
9925126|NCT01263314|11042411|FG006|STARTED|Period 3||2
9925127|NCT01263314|11042412|FG007|STARTED|Period 3||2
9925128|NCT01263314|11042405|FG000|COMPLETED|Period 3||2
9925129|NCT01263314|11042406|FG001|COMPLETED|Period 3||2
9925130|NCT01263314|11042407|FG002|COMPLETED|Period 3||2
9925131|NCT01263314|11042408|FG003|COMPLETED|Period 3||2
9925132|NCT01263314|11042409|FG004|COMPLETED|Period 3||2
9925133|NCT01263314|11042410|FG005|COMPLETED|Period 3||2
9925134|NCT01263314|11042411|FG006|COMPLETED|Period 3||2
9925135|NCT01263314|11042412|FG007|COMPLETED|Period 3||2
9925136|NCT01263314|11042405|FG000|NOT COMPLETED|Period 3||0
9925137|NCT01263314|11042406|FG001|NOT COMPLETED|Period 3||0
9925138|NCT01263314|11042407|FG002|NOT COMPLETED|Period 3||0
9925139|NCT01263314|11042408|FG003|NOT COMPLETED|Period 3||0
9925140|NCT01263314|11042409|FG004|NOT COMPLETED|Period 3||0
9925141|NCT01263314|11042410|FG005|NOT COMPLETED|Period 3||0
9925142|NCT01263314|11042411|FG006|NOT COMPLETED|Period 3||0
9925143|NCT01263314|11042412|FG007|NOT COMPLETED|Period 3||0
9925144|NCT01263444|11042436|FG000|STARTED|Overall Study||47
9925145|NCT01263444|11042436|FG000|COMPLETED|Overall Study||37
9925146|NCT01263444|11042436|FG000|NOT COMPLETED|Overall Study||10
9925147|NCT01263470|11042446|FG000|STARTED|Overall Study||75
9925148|NCT01263470|11042447|FG001|STARTED|Overall Study||79
9925149|NCT01263470|11042448|FG002|STARTED|Overall Study||84
9925150|NCT01263470|11042449|FG003|STARTED|Overall Study||80
9925151|NCT01263470|11042450|FG004|STARTED|Overall Study||79
9925152|NCT01263470|11042451|FG005|STARTED|Overall Study||83
9925153|NCT01263470|11042446|FG000|COMPLETED|Overall Study||73
9925154|NCT01263470|11042447|FG001|COMPLETED|Overall Study||74
9925155|NCT01263470|11042448|FG002|COMPLETED|Overall Study||80
9925156|NCT01263470|11042449|FG003|COMPLETED|Overall Study||77
9925157|NCT01263470|11042450|FG004|COMPLETED|Overall Study||76
9925158|NCT01263470|11042451|FG005|COMPLETED|Overall Study||78
9925159|NCT01263470|11042446|FG000|NOT COMPLETED|Overall Study||2
9925160|NCT01263470|11042447|FG001|NOT COMPLETED|Overall Study||5
9925161|NCT01263470|11042448|FG002|NOT COMPLETED|Overall Study||4
9925162|NCT01263470|11042449|FG003|NOT COMPLETED|Overall Study||3
9925163|NCT01263470|11042450|FG004|NOT COMPLETED|Overall Study||3
9925164|NCT01263470|11042451|FG005|NOT COMPLETED|Overall Study||5
9925165|NCT01263483|11042468|FG000|STARTED|Overall Study||75
9925166|NCT01263483|11042469|FG001|STARTED|Overall Study||76
9925167|NCT01263483|11042470|FG002|STARTED|Overall Study||79
9925168|NCT01263483|11042468|FG000|COMPLETED|Overall Study||68
9925169|NCT01263483|11042469|FG001|COMPLETED|Overall Study||74
9925170|NCT01263483|11042470|FG002|COMPLETED|Overall Study||74
9925171|NCT01263483|11042468|FG000|NOT COMPLETED|Overall Study||7
9925172|NCT01263483|11042469|FG001|NOT COMPLETED|Overall Study||2
9925173|NCT01263483|11042470|FG002|NOT COMPLETED|Overall Study||5
9925174|NCT01263496|11042483|FG000|STARTED|Enrolled - Long-Term Extension Study||72
9925175|NCT01263496|11042484|FG001|STARTED|Enrolled - Long-Term Extension Study||75
9925176|NCT01263496|11042485|FG002|STARTED|Enrolled - Long-Term Extension Study||72
9925177|NCT01263496|11042486|FG003|STARTED|Enrolled - Long-Term Extension Study||75
9925178|NCT01263496|11042487|FG004|STARTED|Enrolled - Long-Term Extension Study||74
9925179|NCT01263496|11042488|FG005|STARTED|Enrolled - Long-Term Extension Study||17
9925180|NCT01263496|11042489|FG006|STARTED|Enrolled - Long-Term Extension Study||17
9925181|NCT01263496|11042490|FG007|STARTED|Enrolled - Long-Term Extension Study||18
9925182|NCT01263496|11042491|FG008|STARTED|Enrolled - Long-Term Extension Study||18
9925183|NCT01263496|11042483|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71
9925184|NCT01263496|11042484|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75
9925185|NCT01263496|11042485|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72
9925186|NCT01263496|11042486|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74
9925187|NCT01263496|11042487|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72
9925188|NCT01263496|11042488|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17
9925189|NCT01263496|11042489|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17
9925190|NCT01263496|11042490|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18
9925191|NCT01263496|11042491|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18
9925192|NCT01263496|11042483|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
9925193|NCT01263496|11042484|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925194|NCT01263496|11042485|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925195|NCT01263496|11042486|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
9925196|NCT01263496|11042487|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
9925197|NCT01263496|11042488|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925198|NCT01263496|11042489|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925199|NCT01263496|11042490|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925200|NCT01263496|11042491|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925201|NCT01263496|11042483|FG000|STARTED|Entered - Long-Term Extension Study||71
9925202|NCT01263496|11042484|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
9925203|NCT01263496|11042485|FG002|STARTED|Entered - Long-Term Extension Study||72
9925204|NCT01263496|11042486|FG003|STARTED|Entered - Long-Term Extension Study||74
9925205|NCT01263496|11042487|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
9925206|NCT01263496|11042488|FG005|STARTED|Entered - Long-Term Extension Study||17
9925207|NCT01263496|11042489|FG006|STARTED|Entered - Long-Term Extension Study||17
9925208|NCT01263496|11042490|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
9925209|NCT01263496|11042491|FG008|STARTED|Entered - Long-Term Extension Study||18
9925210|NCT01263496|11042483|FG000|COMPLETED|Entered - Long-Term Extension Study||62
9925211|NCT01263496|11042484|FG001|COMPLETED|Entered - Long-Term Extension Study||59
9925212|NCT01263496|11042485|FG002|COMPLETED|Entered - Long-Term Extension Study||62
9925213|NCT01263496|11042486|FG003|COMPLETED|Entered - Long-Term Extension Study||68
9925214|NCT01263496|11042487|FG004|COMPLETED|Entered - Long-Term Extension Study||61
9925215|NCT01263496|11042488|FG005|COMPLETED|Entered - Long-Term Extension Study||16
9925216|NCT01263496|11042489|FG006|COMPLETED|Entered - Long-Term Extension Study||16
9925217|NCT01263496|11042490|FG007|COMPLETED|Entered - Long-Term Extension Study||16
9925218|NCT01263496|11042491|FG008|COMPLETED|Entered - Long-Term Extension Study||15
9925219|NCT01263496|11042483|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
9925220|NCT01263496|11042484|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
9925221|NCT01263496|11042485|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10
9925222|NCT01263496|11042486|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6
9925223|NCT01263496|11042487|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10
9925224|NCT01263496|11042488|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1
9925225|NCT01263496|11042489|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
9925226|NCT01263496|11042490|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1
9925227|NCT01263496|11042491|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3
9925228|NCT01263509|11042505|FG000|STARTED|Enrolled - Long-Term Extension Study||61
9925229|NCT01263509|11042506|FG001|STARTED|Enrolled - Long-Term Extension Study||60
9925230|NCT01263509|11042507|FG002|STARTED|Enrolled - Long-Term Extension Study||32
9925231|NCT01263509|11042508|FG003|STARTED|Enrolled - Long-Term Extension Study||26
9925232|NCT01263509|11042505|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61
9925233|NCT01263509|11042506|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60
9925234|NCT01263509|11042507|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32
9925235|NCT01263509|11042508|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26
9925236|NCT01263509|11042505|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925237|NCT01263509|11042506|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925238|NCT01263509|11042507|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925239|NCT01263509|11042508|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9925240|NCT01263509|11042505|FG000|STARTED|Entered - Long-Term Extension Study||61
9925241|NCT01263509|11042506|FG001|STARTED|Entered - Long-Term Extension Study||60
9925242|NCT01263509|11042507|FG002|STARTED|Entered - Long-Term Extension Study||32
9925243|NCT01263509|11042508|FG003|STARTED|Entered - Long-Term Extension Study||26
9925244|NCT01263509|11042505|FG000|COMPLETED|Entered - Long-Term Extension Study||53
9925245|NCT01263509|11042506|FG001|COMPLETED|Entered - Long-Term Extension Study||48
9925246|NCT01263509|11042507|FG002|COMPLETED|Entered - Long-Term Extension Study||27
9925247|NCT01263509|11042508|FG003|COMPLETED|Entered - Long-Term Extension Study||24
9925248|NCT01263509|11042505|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8
9925249|NCT01263509|11042506|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12
9925250|NCT01263509|11042507|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5
9925251|NCT01263509|11042508|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2
9925252|NCT01263561|11042516|FG000|STARTED|Overall Study||31
9925253|NCT01263561|11042517|FG001|STARTED|Overall Study||33
9925254|NCT01263561|11042516|FG000|COMPLETED|Overall Study||30
9925255|NCT01263561|11042517|FG001|COMPLETED|Overall Study||31
9925256|NCT01263561|11042516|FG000|NOT COMPLETED|Overall Study||1
9925257|NCT01263561|11042517|FG001|NOT COMPLETED|Overall Study||2
9925258|NCT01263639|11042525|FG000|STARTED|Overall Study||107
9925259|NCT01263639|11042526|FG001|STARTED|Overall Study||121
9925260|NCT01263639|11042525|FG000|COMPLETED|Overall Study||34
9925261|NCT01263639|11042526|FG001|COMPLETED|Overall Study||42
9925262|NCT01263639|11042525|FG000|NOT COMPLETED|Overall Study||73
9925263|NCT01263639|11042526|FG001|NOT COMPLETED|Overall Study||79
9925264|NCT01263665|11042532|FG000|STARTED|Overall Study||71
9925265|NCT01263665|11042532|FG000|COMPLETED|Overall Study||62
9925266|NCT01263665|11042532|FG000|NOT COMPLETED|Overall Study||9
9925267|NCT01263691|11042542|FG000|STARTED|Overall Study||18
9925268|NCT01263691|11042543|FG001|STARTED|Overall Study||18
9925269|NCT01263691|11042544|FG002|STARTED|Overall Study||17
9925270|NCT01263691|11042545|FG003|STARTED|Overall Study||19
9925271|NCT01263691|11042546|FG004|STARTED|Overall Study||18
9925272|NCT01263691|11042547|FG005|STARTED|Overall Study||15
9925273|NCT01263691|11042542|FG000|COMPLETED|Overall Study||15
9925274|NCT01263691|11042543|FG001|COMPLETED|Overall Study||18
9925275|NCT01263691|11042544|FG002|COMPLETED|Overall Study||16
9925276|NCT01263691|11042545|FG003|COMPLETED|Overall Study||18
9925277|NCT01263691|11042546|FG004|COMPLETED|Overall Study||18
9925278|NCT01263691|11042547|FG005|COMPLETED|Overall Study||15
9925279|NCT01263691|11042542|FG000|NOT COMPLETED|Overall Study||3
9925280|NCT01263691|11042543|FG001|NOT COMPLETED|Overall Study||0
9925281|NCT01263691|11042544|FG002|NOT COMPLETED|Overall Study||1
9925282|NCT01263691|11042545|FG003|NOT COMPLETED|Overall Study||1
9925283|NCT01263691|11042546|FG004|NOT COMPLETED|Overall Study||0
9925284|NCT01263691|11042547|FG005|NOT COMPLETED|Overall Study||0
9925285|NCT01263704|11042582|FG000|STARTED|Overall Study||42
9925286|NCT01263704|11042582|FG000|COMPLETED|Overall Study||13
9925287|NCT01263704|11042582|FG000|NOT COMPLETED|Overall Study||29
9925288|NCT01263717|11042588|FG000|STARTED|Overall Study||28
9925289|NCT01263717|11042589|FG001|STARTED|Overall Study||26
9925290|NCT01263717|11042588|FG000|Baseline Visit|Overall Study||28
9925291|NCT01263717|11042589|FG001|Baseline Visit|Overall Study||22
9925292|NCT01263717|11042588|FG000|COMPLETED|Overall Study||23
9925293|NCT01263717|11042589|FG001|COMPLETED|Overall Study||20
9925294|NCT01263717|11042588|FG000|NOT COMPLETED|Overall Study||5
10010719|NCT01775189|11133363|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
9925295|NCT01263717|11042589|FG001|NOT COMPLETED|Overall Study||6
9925296|NCT01263782|11042599|FG000|STARTED|Overall Study||6
9925297|NCT01263782|11042600|FG001|STARTED|Overall Study||6
9925298|NCT01263782|11042601|FG002|STARTED|Overall Study||6
9925299|NCT01263782|11042602|FG003|STARTED|Overall Study||6
9925300|NCT01263782|11042599|FG000|COMPLETED|Overall Study||6
9925301|NCT01263782|11042600|FG001|COMPLETED|Overall Study||6
9925302|NCT01263782|11042601|FG002|COMPLETED|Overall Study||3
9925303|NCT01263782|11042602|FG003|COMPLETED|Overall Study||5
9925304|NCT01263782|11042599|FG000|NOT COMPLETED|Overall Study||0
9925305|NCT01263782|11042600|FG001|NOT COMPLETED|Overall Study||0
9925306|NCT01263782|11042601|FG002|NOT COMPLETED|Overall Study||3
9925307|NCT01263782|11042602|FG003|NOT COMPLETED|Overall Study||1
9925308|NCT01263873|11042614|FG000|STARTED|Overall Study||30
9925309|NCT01263873|11042615|FG001|STARTED|Overall Study||30
9925310|NCT01263873|11042614|FG000|COMPLETED|Overall Study||29
9925311|NCT01263873|11042615|FG001|COMPLETED|Overall Study||29
9925312|NCT01263873|11042614|FG000|NOT COMPLETED|Overall Study||1
9925313|NCT01263873|11042615|FG001|NOT COMPLETED|Overall Study||1
9925314|NCT01263925|11042623|FG000|STARTED|Overall Study||276
9925315|NCT01263925|11042624|FG001|STARTED|Overall Study||285
9925316|NCT01263925|11042623|FG000|Full Analysis Set|Overall Study||269
9925317|NCT01263925|11042624|FG001|Full Analysis Set|Overall Study||272
9925318|NCT01263925|11042623|FG000|COMPLETED|Overall Study||225
9925319|NCT01263925|11042624|FG001|COMPLETED|Overall Study||233
9925320|NCT01263925|11042623|FG000|NOT COMPLETED|Overall Study||51
9925321|NCT01263925|11042624|FG001|NOT COMPLETED|Overall Study||52
9925322|NCT01263938|11042630|FG000|STARTED|Overall Study||5
9925323|NCT01263938|11042630|FG000|COMPLETED|Overall Study||5
9925324|NCT01263938|11042630|FG000|NOT COMPLETED|Overall Study||0
9925325|NCT01264016|11042635|FG000|STARTED|Overall Study||96
9925326|NCT01264016|11042635|FG000|COMPLETED|Overall Study||94
9925327|NCT01264016|11042635|FG000|NOT COMPLETED|Overall Study||2
9925328|NCT01264081|11042640|FG000|STARTED|Participants Screened||34
9925329|NCT01264081|11042640|FG000|COMPLETED|Participants Screened||4
9925330|NCT01264081|11042640|FG000|NOT COMPLETED|Participants Screened||30
9925331|NCT01264081|11042640|FG000|STARTED|Started Treatment||4
9925332|NCT01264081|11042640|FG000|COMPLETED|Started Treatment||2
9925333|NCT01264081|11042640|FG000|NOT COMPLETED|Started Treatment||2
9925334|NCT01264081|11042640|FG000|STARTED|Analysis||2
9925335|NCT01264081|11042640|FG000|COMPLETED|Analysis||2
9925336|NCT01264081|11042640|FG000|NOT COMPLETED|Analysis||0
9925337|NCT01264380|11042644|FG000|STARTED|Period A||8
9925338|NCT01264380|11042645|FG001|STARTED|Period A||8
9925339|NCT01264380|11042646|FG002|STARTED|Period A||0
9925340|NCT01264380|11042644|FG000|COMPLETED|Period A||8
9925341|NCT01264380|11042645|FG001|COMPLETED|Period A||8
9925342|NCT01264380|11042646|FG002|COMPLETED|Period A||0
9925343|NCT01264380|11042644|FG000|NOT COMPLETED|Period A||0
9925344|NCT01264380|11042645|FG001|NOT COMPLETED|Period A||0
9925345|NCT01264380|11042646|FG002|NOT COMPLETED|Period A||0
9925346|NCT01264380|11042644|FG000|STARTED|Period B||8
9925347|NCT01264380|11042645|FG001|STARTED|Period B||8
9925348|NCT01264380|11042646|FG002|STARTED|Period B||0
9925349|NCT01264380|11042644|FG000|COMPLETED|Period B||8
9925350|NCT01264380|11042645|FG001|COMPLETED|Period B||8
9925351|NCT01264380|11042646|FG002|COMPLETED|Period B||0
9925352|NCT01264380|11042644|FG000|NOT COMPLETED|Period B||0
9925353|NCT01264380|11042645|FG001|NOT COMPLETED|Period B||0
9925354|NCT01264380|11042646|FG002|NOT COMPLETED|Period B||0
9925355|NCT01264380|11042644|FG000|STARTED|Period C||0
9925356|NCT01264380|11042645|FG001|STARTED|Period C||0
9925357|NCT01264380|11042646|FG002|STARTED|Period C||16
9925358|NCT01264380|11042644|FG000|COMPLETED|Period C||0
9925359|NCT01264380|11042645|FG001|COMPLETED|Period C||0
9925360|NCT01264380|11042646|FG002|COMPLETED|Period C||2
9925361|NCT01264380|11042644|FG000|NOT COMPLETED|Period C||0
9925362|NCT01264380|11042645|FG001|NOT COMPLETED|Period C||0
9925363|NCT01264380|11042646|FG002|NOT COMPLETED|Period C||14
9925364|NCT01264419|11042654|FG000|STARTED|Overall Study||75
9925365|NCT01264419|11042654|FG000|COMPLETED|Overall Study||72
9925366|NCT01264419|11042654|FG000|NOT COMPLETED|Overall Study||3
9925367|NCT01264601|11042660|FG000|STARTED|Overall Study||17
9925368|NCT01264601|11042661|FG001|STARTED|Overall Study||14
9925369|NCT01264601|11042660|FG000|COMPLETED|Overall Study||17
9925370|NCT01264601|11042661|FG001|COMPLETED|Overall Study||14
9925371|NCT01264601|11042660|FG000|NOT COMPLETED|Overall Study||0
9925372|NCT01264601|11042661|FG001|NOT COMPLETED|Overall Study||0
9925373|NCT01264614|11042669|FG000|STARTED|Overall Study||13
9925374|NCT01264614|11042670|FG001|STARTED|Overall Study||9
9925375|NCT01264614|11042669|FG000|COMPLETED|Overall Study||12
9925376|NCT01264614|11042670|FG001|COMPLETED|Overall Study||7
9925377|NCT01264614|11042669|FG000|NOT COMPLETED|Overall Study||1
9925378|NCT01264614|11042670|FG001|NOT COMPLETED|Overall Study||2
9925379|NCT01264705|11042679|FG000|STARTED|Overall Study||3
9925380|NCT01264705|11042680|FG001|STARTED|Overall Study||3
9925381|NCT01264705|11042681|FG002|STARTED|Overall Study||41
9925382|NCT01264705|11042679|FG000|COMPLETED|Overall Study||3
9925383|NCT01264705|11042680|FG001|COMPLETED|Overall Study||3
9925384|NCT01264705|11042681|FG002|COMPLETED|Overall Study||41
9925385|NCT01264705|11042679|FG000|NOT COMPLETED|Overall Study||0
9925386|NCT01264705|11042680|FG001|NOT COMPLETED|Overall Study||0
9925387|NCT01264705|11042681|FG002|NOT COMPLETED|Overall Study||0
9925388|NCT01264718|11042694|FG000|STARTED|Overall Study||172
9925389|NCT01264718|11042695|FG001|STARTED|Overall Study||157
9925390|NCT01264718|11042694|FG000|COMPLETED|Overall Study||123
9925391|NCT01264718|11042695|FG001|COMPLETED|Overall Study||114
9925392|NCT01264718|11042694|FG000|NOT COMPLETED|Overall Study||49
9925393|NCT01264718|11042695|FG001|NOT COMPLETED|Overall Study||43
9925394|NCT01264770|11042707|FG000|STARTED|Overall Study|Patients who received treatment|54
9925395|NCT01264770|11042708|FG001|STARTED|Overall Study|Patients who received treatment|48
9925396|NCT01264770|11042709|FG002|STARTED|Overall Study|Patients who received treatment|57
9925397|NCT01264770|11042710|FG003|STARTED|Overall Study|Patients who received treatment|54
9925398|NCT01264770|11042711|FG004|STARTED|Overall Study|Patients who received treatment|27
9925399|NCT01264770|11042712|FG005|STARTED|Overall Study|Patients who received treatment|25
9925400|NCT01264770|11042707|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
9925401|NCT01264770|11042708|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
9925402|NCT01264770|11042709|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
9925403|NCT01264770|11042710|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
9925404|NCT01264770|11042711|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
9925405|NCT01264770|11042712|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
9925406|NCT01264770|11042707|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
9925407|NCT01264770|11042708|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
9925408|NCT01264770|11042709|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
9925409|NCT01264770|11042710|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
9925410|NCT01264770|11042711|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
9925411|NCT01264770|11042712|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
9925412|NCT01264770|11042707|FG000|NOT COMPLETED|Overall Study||18
9925413|NCT01264770|11042708|FG001|NOT COMPLETED|Overall Study||10
9925414|NCT01264770|11042709|FG002|NOT COMPLETED|Overall Study||16
9925415|NCT01264770|11042710|FG003|NOT COMPLETED|Overall Study||6
9925416|NCT01264770|11042711|FG004|NOT COMPLETED|Overall Study||8
9925417|NCT01264770|11042712|FG005|NOT COMPLETED|Overall Study||6
9925418|NCT01264887|11042732|FG000|STARTED|Overall Study||31
9925419|NCT01264887|11042732|FG000|COMPLETED|Overall Study||0
9925420|NCT01264887|11042732|FG000|NOT COMPLETED|Overall Study||31
9925421|NCT01264939|11042740|FG000|STARTED|Overall Study||84
9925422|NCT01264939|11042741|FG001|STARTED|Overall Study||252
9925423|NCT01264939|11042740|FG000|COMPLETED|Overall Study||66
9925424|NCT01264939|11042741|FG001|COMPLETED|Overall Study||224
9925425|NCT01264939|11042740|FG000|NOT COMPLETED|Overall Study||18
9925426|NCT01264939|11042741|FG001|NOT COMPLETED|Overall Study||28
9925427|NCT01264952|11042750|FG000|STARTED|Overall Study||6
9925428|NCT01264952|11042751|FG001|STARTED|Overall Study||2
9925429|NCT01264952|11042752|FG002|STARTED|Overall Study||8
9925430|NCT01264952|11042750|FG000|COMPLETED|Overall Study||6
9925431|NCT01264952|11042751|FG001|COMPLETED|Overall Study||2
9925432|NCT01264952|11042752|FG002|COMPLETED|Overall Study||8
9925433|NCT01264952|11042750|FG000|NOT COMPLETED|Overall Study||0
9925434|NCT01264952|11042751|FG001|NOT COMPLETED|Overall Study||0
9925435|NCT01264952|11042752|FG002|NOT COMPLETED|Overall Study||0
9925436|NCT01265056|11042762|FG000|STARTED|Initial Study Period||26
9925437|NCT01265056|11042763|FG001|STARTED|Initial Study Period||27
9925438|NCT01265056|11042762|FG000|COMPLETED|Initial Study Period||24
9925439|NCT01265056|11042763|FG001|COMPLETED|Initial Study Period||25
9925440|NCT01265056|11042762|FG000|NOT COMPLETED|Initial Study Period||2
9925441|NCT01265056|11042763|FG001|NOT COMPLETED|Initial Study Period||2
9925442|NCT01265056|11042762|FG000|STARTED|Follow up||26
9925443|NCT01265056|11042763|FG001|STARTED|Follow up||27
9925444|NCT01265056|11042762|FG000|COMPLETED|Follow up||19
9925445|NCT01265056|11042763|FG001|COMPLETED|Follow up||24
9925446|NCT01265056|11042762|FG000|NOT COMPLETED|Follow up||7
9925447|NCT01265056|11042763|FG001|NOT COMPLETED|Follow up||3
9925448|NCT01265394|11042769|FG000|STARTED|Overall Study||218
9925449|NCT01265394|11042769|FG000|COMPLETED|Overall Study||181
9925450|NCT01265394|11042769|FG000|NOT COMPLETED|Overall Study||37
9925451|NCT01265420|11042774|FG000|STARTED|Overall Study||7
9925452|NCT01265420|11042774|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
9925453|NCT01265420|11042774|FG000|NOT COMPLETED|Overall Study||1
9925454|NCT01265446|11042780|FG000|STARTED|Overall Study||125
9925455|NCT01265446|11042781|FG001|STARTED|Overall Study||125
9925456|NCT01265446|11042780|FG000|COMPLETED|Overall Study||124
9925457|NCT01265446|11042781|FG001|COMPLETED|Overall Study||125
9925458|NCT01265446|11042780|FG000|NOT COMPLETED|Overall Study||1
9925459|NCT01265446|11042781|FG001|NOT COMPLETED|Overall Study||0
9925460|NCT01265459|11042790|FG000|STARTED|Overall Study||23
9925461|NCT01265459|11042791|FG001|STARTED|Overall Study||23
9925462|NCT01265459|11042792|FG002|STARTED|Overall Study||22
9925463|NCT01265459|11042790|FG000|COMPLETED|Overall Study||23
9925464|NCT01265459|11042791|FG001|COMPLETED|Overall Study||23
9925465|NCT01265459|11042792|FG002|COMPLETED|Overall Study||20
9925466|NCT01265459|11042790|FG000|NOT COMPLETED|Overall Study||0
9925467|NCT01265459|11042791|FG001|NOT COMPLETED|Overall Study||0
9925468|NCT01265459|11042792|FG002|NOT COMPLETED|Overall Study||2
9925469|NCT01265498|11042814|FG000|STARTED|Overall Study||141
9925470|NCT01265498|11042815|FG001|STARTED|Overall Study||142
9925471|NCT01265498|11042814|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102
9925472|NCT01265498|11042815|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98
9925473|NCT01265498|11042814|FG000|COMPLETED|Overall Study||110
9925474|NCT01265498|11042815|FG001|COMPLETED|Overall Study||109
9925475|NCT01265498|11042814|FG000|NOT COMPLETED|Overall Study||31
9925476|NCT01265498|11042815|FG001|NOT COMPLETED|Overall Study||33
9925477|NCT01265511|11042823|FG000|STARTED|Overall Study||2
9925478|NCT01265511|11042824|FG001|STARTED|Overall Study||8
9925479|NCT01265511|11042823|FG000|COMPLETED|Overall Study||0
9925480|NCT01265511|11042824|FG001|COMPLETED|Overall Study||5
9925481|NCT01265511|11042823|FG000|NOT COMPLETED|Overall Study||2
9925482|NCT01265511|11042824|FG001|NOT COMPLETED|Overall Study||3
9925483|NCT01265524|11042832|FG000|STARTED|Overall Study||59
9925484|NCT01265524|11042833|FG001|STARTED|Overall Study||52
9925485|NCT01265524|11042832|FG000|COMPLETED|Overall Study||41
9925486|NCT01265524|11042833|FG001|COMPLETED|Overall Study||46
9925487|NCT01265524|11042832|FG000|NOT COMPLETED|Overall Study||18
9925488|NCT01265524|11042833|FG001|NOT COMPLETED|Overall Study||6
9925489|NCT01265537|11042841|FG000|STARTED|Overall Study||15
9925490|NCT01265537|11042842|FG001|STARTED|Overall Study||15
9925491|NCT01265537|11042841|FG000|COMPLETED|Overall Study||13
9925492|NCT01265537|11042842|FG001|COMPLETED|Overall Study||13
9925493|NCT01265537|11042841|FG000|NOT COMPLETED|Overall Study||2
9925494|NCT01265537|11042842|FG001|NOT COMPLETED|Overall Study||2
9925495|NCT01265550|11042852|FG000|STARTED|Pre Randomization||0
9925496|NCT01265550|11042853|FG001|STARTED|Pre Randomization||0
9925497|NCT01265550|11042854|FG002|STARTED|Pre Randomization||0
9925498|NCT01265550|11042855|FG003|STARTED|Pre Randomization||366
9925499|NCT01265550|11042852|FG000|COMPLETED|Pre Randomization||0
9925500|NCT01265550|11042853|FG001|COMPLETED|Pre Randomization||0
9925501|NCT01265550|11042854|FG002|COMPLETED|Pre Randomization||0
9925502|NCT01265550|11042855|FG003|COMPLETED|Pre Randomization||78
9925503|NCT01265550|11042852|FG000|NOT COMPLETED|Pre Randomization||0
9925504|NCT01265550|11042853|FG001|NOT COMPLETED|Pre Randomization||0
9925505|NCT01265550|11042854|FG002|NOT COMPLETED|Pre Randomization||0
9925506|NCT01265550|11042855|FG003|NOT COMPLETED|Pre Randomization||288
9925507|NCT01265550|11042852|FG000|STARTED|Post Randomization||25
9925508|NCT01265550|11042853|FG001|STARTED|Post Randomization||27
9925509|NCT01265550|11042854|FG002|STARTED|Post Randomization||26
9925510|NCT01265550|11042855|FG003|STARTED|Post Randomization||0
9925511|NCT01265550|11042852|FG000|COMPLETED|Post Randomization||10
9925512|NCT01265550|11042853|FG001|COMPLETED|Post Randomization||19
9925513|NCT01265550|11042854|FG002|COMPLETED|Post Randomization||6
9925514|NCT01265550|11042855|FG003|COMPLETED|Post Randomization||0
9925515|NCT01265550|11042852|FG000|NOT COMPLETED|Post Randomization||15
9925516|NCT01265550|11042853|FG001|NOT COMPLETED|Post Randomization||8
9925517|NCT01265550|11042854|FG002|NOT COMPLETED|Post Randomization||20
9925518|NCT01265550|11042855|FG003|NOT COMPLETED|Post Randomization||0
9925519|NCT01265563|11042874|FG000|STARTED|Overall Study||16
9925520|NCT01265563|11042875|FG001|STARTED|Overall Study||13
9925521|NCT01265563|11042876|FG002|STARTED|Overall Study||17
9925522|NCT01265563|11042877|FG003|STARTED|Overall Study||16
9925523|NCT01265563|11042878|FG004|STARTED|Overall Study||16
9925524|NCT01265563|11042874|FG000|COMPLETED|Overall Study||16
9925525|NCT01265563|11042875|FG001|COMPLETED|Overall Study||12
9925526|NCT01265563|11042876|FG002|COMPLETED|Overall Study||16
9925527|NCT01265563|11042877|FG003|COMPLETED|Overall Study||16
9925528|NCT01265563|11042878|FG004|COMPLETED|Overall Study||14
9925529|NCT01265563|11042874|FG000|NOT COMPLETED|Overall Study||0
9925530|NCT01265563|11042875|FG001|NOT COMPLETED|Overall Study||1
9925531|NCT01265563|11042876|FG002|NOT COMPLETED|Overall Study||1
9925532|NCT01265563|11042877|FG003|NOT COMPLETED|Overall Study||0
9925533|NCT01265563|11042878|FG004|NOT COMPLETED|Overall Study||2
9925534|NCT01265615|11042899|FG000|STARTED|Overall Study||30
9925535|NCT01265615|11042900|FG001|STARTED|Overall Study||30
9925536|NCT01265615|11042901|FG002|STARTED|Overall Study||30
9925537|NCT01265615|11042902|FG003|STARTED|Overall Study||30
9925538|NCT01265615|11042899|FG000|COMPLETED|Overall Study||28
9925539|NCT01265615|11042900|FG001|COMPLETED|Overall Study||28
9925540|NCT01265615|11042901|FG002|COMPLETED|Overall Study||26
9925541|NCT01265615|11042902|FG003|COMPLETED|Overall Study||27
9925542|NCT01265615|11042899|FG000|NOT COMPLETED|Overall Study||2
9925543|NCT01265615|11042900|FG001|NOT COMPLETED|Overall Study||2
9925544|NCT01265615|11042901|FG002|NOT COMPLETED|Overall Study||4
9925545|NCT01265615|11042902|FG003|NOT COMPLETED|Overall Study||3
9925546|NCT01265667|11042914|FG000|STARTED|Overall Study||145
9925547|NCT01265667|11042915|FG001|STARTED|Overall Study||148
9925548|NCT01265667|11042914|FG000|COMPLETED|Overall Study||125
9925549|NCT01265667|11042915|FG001|COMPLETED|Overall Study||135
9925550|NCT01265667|11042914|FG000|NOT COMPLETED|Overall Study||20
9925551|NCT01265667|11042915|FG001|NOT COMPLETED|Overall Study||13
9925552|NCT01265719|11042923|FG000|STARTED|Overall Study||102
9925553|NCT01265719|11042924|FG001|STARTED|Overall Study||73
9925554|NCT01265719|11042923|FG000|COMPLETED|Overall Study||88
9925555|NCT01265719|11042924|FG001|COMPLETED|Overall Study||60
9925556|NCT01265719|11042923|FG000|NOT COMPLETED|Overall Study||14
9925557|NCT01265719|11042924|FG001|NOT COMPLETED|Overall Study||13
9925558|NCT01265797|11042932|FG000|STARTED|Run-in Month||34
9925559|NCT01265797|11042933|FG001|STARTED|Run-in Month||34
9925560|NCT01265797|11042932|FG000|COMPLETED|Run-in Month||34
9925561|NCT01265797|11042933|FG001|COMPLETED|Run-in Month||29
9925562|NCT01265797|11042932|FG000|NOT COMPLETED|Run-in Month||0
9925563|NCT01265797|11042933|FG001|NOT COMPLETED|Run-in Month||5
9925564|NCT01265797|11042932|FG000|STARTED|Blinded Month||34
9925565|NCT01265797|11042933|FG001|STARTED|Blinded Month||29
9925566|NCT01265797|11042932|FG000|COMPLETED|Blinded Month||24
9925567|NCT01265797|11042933|FG001|COMPLETED|Blinded Month||27
9925568|NCT01265797|11042932|FG000|NOT COMPLETED|Blinded Month||10
9925569|NCT01265797|11042933|FG001|NOT COMPLETED|Blinded Month||2
9925570|NCT01265797|11042932|FG000|STARTED|Open Label Month||24
10205381|NCT03491553|11332173|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
9925571|NCT01265797|11042933|FG001|STARTED|Open Label Month||27
9925572|NCT01265797|11042932|FG000|COMPLETED|Open Label Month||24
9925573|NCT01265797|11042933|FG001|COMPLETED|Open Label Month||26
9925574|NCT01265797|11042932|FG000|NOT COMPLETED|Open Label Month||0
9925575|NCT01265797|11042933|FG001|NOT COMPLETED|Open Label Month||1
9925576|NCT01265823|11042941|FG000|STARTED|Overall Study||150
9925577|NCT01265823|11042941|FG000|COMPLETED|Overall Study||143
9925578|NCT01265823|11042941|FG000|NOT COMPLETED|Overall Study||7
9925579|NCT01265875|11042949|FG000|STARTED|Overall Study||12
9925580|NCT01265875|11042949|FG000|COMPLETED|Overall Study||11
9925581|NCT01265875|11042949|FG000|NOT COMPLETED|Overall Study||1
9925582|NCT01265953|11042956|FG000|STARTED|Overall Study||50
9925583|NCT01265953|11042957|FG001|STARTED|Overall Study||48
9925584|NCT01265953|11042956|FG000|COMPLETED|Overall Study||45
9925585|NCT01265953|11042957|FG001|COMPLETED|Overall Study||45
9925586|NCT01265953|11042956|FG000|NOT COMPLETED|Overall Study||5
9925587|NCT01265953|11042957|FG001|NOT COMPLETED|Overall Study||3
9925588|NCT01265966|11042966|FG000|STARTED|Overall Study||47
9925589|NCT01265966|11042967|FG001|STARTED|Overall Study||41
9925590|NCT01265966|11042968|FG002|STARTED|Overall Study||29
9925591|NCT01265966|11042966|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
10205382|NCT03491553|11332174|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10205383|NCT03491553|11332175|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10205384|NCT03491553|11332176|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10010720|NCT01775189|11133364|FG004|COMPLETED|Treatment Phase: Washout Period 3||8
10205385|NCT03491553|11332177|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9925592|NCT01265966|11042967|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
9925593|NCT01265966|11042968|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
9925594|NCT01265966|11042966|FG000|COMPLETED|Overall Study||44
9925595|NCT01265966|11042967|FG001|COMPLETED|Overall Study||39
9925596|NCT01265966|11042968|FG002|COMPLETED|Overall Study||27
9925597|NCT01265966|11042966|FG000|NOT COMPLETED|Overall Study||3
9925598|NCT01265966|11042967|FG001|NOT COMPLETED|Overall Study||2
9925599|NCT01265966|11042968|FG002|NOT COMPLETED|Overall Study||2
9925600|NCT01265992|11042976|FG000|STARTED|Overall Study||50
9925601|NCT01265992|11042976|FG000|Received Treatment|Overall Study||49
9925602|NCT01265992|11042976|FG000|COMPLETED|Overall Study||41
9925603|NCT01265992|11042976|FG000|NOT COMPLETED|Overall Study||9
9925604|NCT01266018|11042980|FG000|STARTED|Overall Study||9
9925605|NCT01266018|11042981|FG001|STARTED|Overall Study||13
9925606|NCT01266018|11042980|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
9925607|NCT01266018|11042981|FG001|COMPLETED|Overall Study||12
9925608|NCT01266018|11042980|FG000|NOT COMPLETED|Overall Study||1
9925609|NCT01266018|11042981|FG001|NOT COMPLETED|Overall Study||1
9925610|NCT01266070|11042987|FG000|STARTED|Overall Study||6
9925611|NCT01266070|11042987|FG000|COMPLETED|Overall Study||2
9925612|NCT01266070|11042987|FG000|NOT COMPLETED|Overall Study||4
9925613|NCT01266122|11042993|FG000|STARTED|Overall Study||48
9925614|NCT01266122|11042994|FG001|STARTED|Overall Study||48
9925615|NCT01266122|11042993|FG000|COMPLETED|Overall Study||42
9925616|NCT01266122|11042994|FG001|COMPLETED|Overall Study||42
9925617|NCT01266122|11042993|FG000|NOT COMPLETED|Overall Study||6
9925618|NCT01266122|11042994|FG001|NOT COMPLETED|Overall Study||6
9925619|NCT01266148|11043002|FG000|STARTED|Overall Study||56
9925620|NCT01266148|11043003|FG001|STARTED|Overall Study||59
9925621|NCT01266148|11043002|FG000|COMPLETED|Overall Study||49
9925622|NCT01266148|11043003|FG001|COMPLETED|Overall Study||56
9925623|NCT01266148|11043002|FG000|NOT COMPLETED|Overall Study||7
9925624|NCT01266148|11043003|FG001|NOT COMPLETED|Overall Study||3
9925625|NCT01266161|11043011|FG000|STARTED|Overall Study||52
9925626|NCT01266161|11043012|FG001|STARTED|Overall Study||54
9925627|NCT01266161|11043011|FG000|COMPLETED|Overall Study||48
9925628|NCT01266161|11043012|FG001|COMPLETED|Overall Study||53
9925629|NCT01266161|11043011|FG000|NOT COMPLETED|Overall Study||4
9925630|NCT01266161|11043012|FG001|NOT COMPLETED|Overall Study||1
9925631|NCT01266265|11043020|FG000|STARTED|Overall Study||666
9925632|NCT01266265|11043021|FG001|STARTED|Overall Study||667
9925633|NCT01266265|11043020|FG000|COMPLETED|Overall Study||461
9925634|NCT01266265|11043021|FG001|COMPLETED|Overall Study||477
9925635|NCT01266265|11043020|FG000|NOT COMPLETED|Overall Study||205
9925636|NCT01266265|11043021|FG001|NOT COMPLETED|Overall Study||190
9925637|NCT01266291|11043027|FG000|STARTED|Overall Study||1
9925638|NCT01266291|11043027|FG000|COMPLETED|Overall Study||0
9925639|NCT01266291|11043027|FG000|NOT COMPLETED|Overall Study||1
9925640|NCT01266317|11043031|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
9925641|NCT01266317|11043031|FG000|COMPLETED|Overall Study||7
9925642|NCT01266317|11043031|FG000|NOT COMPLETED|Overall Study||2
9956019|NCT01441843|11075101|FG000|NOT COMPLETED|Overall Study||12
9956020|NCT01441843|11075102|FG001|NOT COMPLETED|Overall Study||5
9956021|NCT01441882|11075108|FG000|STARTED|Overall Study||19
9956022|NCT01441882|11075108|FG000|COMPLETED|Overall Study||13
9956023|NCT01441882|11075108|FG000|NOT COMPLETED|Overall Study||6
9956024|NCT01441960|11075112|FG000|STARTED|First Neuromuscular Blocking Agent:||26
9956025|NCT01441960|11075113|FG001|STARTED|First Neuromuscular Blocking Agent:||19
9956026|NCT01441960|11075112|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18
9925643|NCT01266447|11043035|FG000|STARTED|Overall Study||27
9925644|NCT01266447|11043035|FG000|COMPLETED|Overall Study|Eligible and treated patients|27
9925645|NCT01266447|11043035|FG000|NOT COMPLETED|Overall Study||0
9925646|NCT01266460|11043039|FG000|STARTED|Overall Study||50
9925647|NCT01266460|11043039|FG000|COMPLETED|Overall Study||16
10010721|NCT01775189|11133365|FG005|COMPLETED|Treatment Phase: Washout Period 3||7
10010722|NCT01775189|11133366|FG006|COMPLETED|Treatment Phase: Washout Period 3||7
10010723|NCT01775189|11133360|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
9925648|NCT01266460|11043039|FG000|NOT COMPLETED|Overall Study||34
9925649|NCT01266590|11043043|FG000|STARTED|Overall Study||30
9925650|NCT01266590|11043043|FG000|COMPLETED|Overall Study||24
9925651|NCT01266590|11043043|FG000|NOT COMPLETED|Overall Study||6
9925652|NCT01266603|11043050|FG000|STARTED|Overall Study||44
9925653|NCT01266603|11043050|FG000|MAGE-A3 Positive Tumor|Overall Study||18
9925654|NCT01266603|11043050|FG000|Patients Evaluable for Safety|Overall Study||17
9925655|NCT01266603|11043050|FG000|Patients Evaluable for Response|Overall Study||16
9925656|NCT01266603|11043050|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4
9925657|NCT01266603|11043050|FG000|Maintenance Completion|Overall Study||2
9925658|NCT01266603|11043050|FG000|COMPLETED|Overall Study||2
9925659|NCT01266603|11043050|FG000|NOT COMPLETED|Overall Study||42
9925660|NCT01266642|11043056|FG000|STARTED|Overall Study||149
9925661|NCT01266642|11043057|FG001|STARTED|Overall Study||138
9925662|NCT01266642|11043056|FG000|COMPLETED|Overall Study||149
9925663|NCT01266642|11043057|FG001|COMPLETED|Overall Study||137
9925664|NCT01266642|11043056|FG000|NOT COMPLETED|Overall Study||0
10010724|NCT01775189|11133361|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10010725|NCT01775189|11133362|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10010726|NCT01775189|11133363|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1
10010727|NCT01775189|11133364|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10010728|NCT01775189|11133365|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10010729|NCT01775189|11133366|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1
10010730|NCT01775189|11133360|FG000|STARTED|Treatment Phase: Fourth Intervention||0
10205386|NCT03491553|11332172|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10205387|NCT03491553|11332173|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9925665|NCT01266642|11043057|FG001|NOT COMPLETED|Overall Study||1
9925666|NCT01266850|11043068|FG000|STARTED|Overall Study||242
9925667|NCT01266850|11043069|FG001|STARTED|Overall Study||248
9925668|NCT01266850|11043070|FG002|STARTED|Overall Study||238
9925669|NCT01266850|11043071|FG003|STARTED|Overall Study||329
9925670|NCT01266850|11043072|FG004|STARTED|Overall Study||327
9925671|NCT01266850|11043068|FG000|Received Second Vaccine|Overall Study||231
9925672|NCT01266850|11043069|FG001|Received Second Vaccine|Overall Study||233
9925673|NCT01266850|11043070|FG002|Received Second Vaccine|Overall Study||227
9925674|NCT01266850|11043071|FG003|Received Second Vaccine|Overall Study||311
9925675|NCT01266850|11043072|FG004|Received Second Vaccine|Overall Study||307
9925676|NCT01266850|11043068|FG000|Received Third Vaccine|Overall Study||221
9925677|NCT01266850|11043069|FG001|Received Third Vaccine|Overall Study||221
9925678|NCT01266850|11043070|FG002|Received Third Vaccine|Overall Study||217
9925679|NCT01266850|11043071|FG003|Received Third Vaccine|Overall Study||0
9925680|NCT01266850|11043072|FG004|Received Third Vaccine|Overall Study||299
9925681|NCT01266850|11043068|FG000|COMPLETED|Overall Study||212
9925682|NCT01266850|11043069|FG001|COMPLETED|Overall Study||212
9925683|NCT01266850|11043070|FG002|COMPLETED|Overall Study||214
9925684|NCT01266850|11043071|FG003|COMPLETED|Overall Study||301
9925685|NCT01266850|11043072|FG004|COMPLETED|Overall Study||297
9925686|NCT01266850|11043068|FG000|NOT COMPLETED|Overall Study||30
9925687|NCT01266850|11043069|FG001|NOT COMPLETED|Overall Study||36
9925688|NCT01266850|11043070|FG002|NOT COMPLETED|Overall Study||24
9925689|NCT01266850|11043071|FG003|NOT COMPLETED|Overall Study||28
9925690|NCT01266850|11043072|FG004|NOT COMPLETED|Overall Study||30
9925691|NCT01266876|11043089|FG000|STARTED|Overall Study||15
9925692|NCT01266876|11043090|FG001|STARTED|Overall Study||15
9925693|NCT01266876|11043091|FG002|STARTED|Overall Study||16
9925694|NCT01266876|11043092|FG003|STARTED|Overall Study||15
9925695|NCT01266876|11043093|FG004|STARTED|Overall Study||16
9925696|NCT01266876|11043089|FG000|COMPLETED|Overall Study||15
9925697|NCT01266876|11043090|FG001|COMPLETED|Overall Study||15
9925698|NCT01266876|11043091|FG002|COMPLETED|Overall Study||16
9925699|NCT01266876|11043092|FG003|COMPLETED|Overall Study||14
9925700|NCT01266876|11043093|FG004|COMPLETED|Overall Study||16
9925701|NCT01266876|11043089|FG000|NOT COMPLETED|Overall Study||0
9925702|NCT01266876|11043090|FG001|NOT COMPLETED|Overall Study||0
9925703|NCT01266876|11043091|FG002|NOT COMPLETED|Overall Study||0
9925704|NCT01266876|11043092|FG003|NOT COMPLETED|Overall Study||1
9925705|NCT01266876|11043093|FG004|NOT COMPLETED|Overall Study||0
9925706|NCT01266902|11043107|FG000|STARTED|Period 1 (Main Study)||119
9925707|NCT01266902|11043108|FG001|STARTED|Period 1 (Main Study)||363
9925708|NCT01266902|11043109|FG002|STARTED|Period 1 (Main Study)||0
9925709|NCT01266902|11043107|FG000|COMPLETED|Period 1 (Main Study)||89
9925710|NCT01266902|11043108|FG001|COMPLETED|Period 1 (Main Study)||282
9925711|NCT01266902|11043109|FG002|COMPLETED|Period 1 (Main Study)||0
9925712|NCT01266902|11043107|FG000|NOT COMPLETED|Period 1 (Main Study)||30
9925713|NCT01266902|11043108|FG001|NOT COMPLETED|Period 1 (Main Study)||81
9925714|NCT01266902|11043109|FG002|NOT COMPLETED|Period 1 (Main Study)||0
9925715|NCT01266902|11043107|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0
9925716|NCT01266902|11043108|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0
9925717|NCT01266902|11043109|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45
9925718|NCT01266902|11043107|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0
9925719|NCT01266902|11043108|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0
9925720|NCT01266902|11043109|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37
9925721|NCT01266902|11043107|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
9925722|NCT01266902|11043108|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
9925723|NCT01266902|11043109|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
9925724|NCT01266967|11043119|FG000|STARTED|Overall Study||89
9925725|NCT01266967|11043120|FG001|STARTED|Overall Study||83
9925726|NCT01266967|11043119|FG000|COMPLETED|Overall Study||0
9925727|NCT01266967|11043120|FG001|COMPLETED|Overall Study||0
9925728|NCT01266967|11043119|FG000|NOT COMPLETED|Overall Study||89
9925729|NCT01266967|11043120|FG001|NOT COMPLETED|Overall Study||83
9925730|NCT01266993|11043131|FG000|STARTED|Persistence Phase (Month 32-44)||199
9925731|NCT01266993|11043132|FG001|STARTED|Persistence Phase (Month 32-44)||72
9925732|NCT01266993|11043131|FG000|COMPLETED|Persistence Phase (Month 32-44)||199
9925733|NCT01266993|11043132|FG001|COMPLETED|Persistence Phase (Month 32-44)||72
9925734|NCT01266993|11043131|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0
9925735|NCT01266993|11043132|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0
9925736|NCT01266993|11043131|FG000|STARTED|Persistence Phase (Month 44-56)||193
9925737|NCT01266993|11043132|FG001|STARTED|Persistence Phase (Month 44-56)||68
9925738|NCT01266993|11043131|FG000|COMPLETED|Persistence Phase (Month 44-56)||193
9925739|NCT01266993|11043132|FG001|COMPLETED|Persistence Phase (Month 44-56)||68
9925740|NCT01266993|11043131|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0
9925741|NCT01266993|11043132|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0
9925742|NCT01266993|11043131|FG000|STARTED|Persistence Phase (Month 56-68)||193
9925743|NCT01266993|11043132|FG001|STARTED|Persistence Phase (Month 56-68)||67
9925744|NCT01266993|11043131|FG000|COMPLETED|Persistence Phase (Month 56-68)||193
9925745|NCT01266993|11043132|FG001|COMPLETED|Persistence Phase (Month 56-68)||67
9925746|NCT01266993|11043131|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0
9925747|NCT01266993|11043132|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0
9925748|NCT01266993|11043131|FG000|STARTED|Booster Phase (Month 68-69)||179
9925749|NCT01266993|11043132|FG001|STARTED|Booster Phase (Month 68-69)||62
9925750|NCT01266993|11043131|FG000|COMPLETED|Booster Phase (Month 68-69)||174
9925751|NCT01266993|11043132|FG001|COMPLETED|Booster Phase (Month 68-69)||60
9925752|NCT01266993|11043131|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5
9925753|NCT01266993|11043132|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2
9925754|NCT01267019|11043141|FG000|STARTED|Overall Study||47
9925755|NCT01267019|11043142|FG001|STARTED|Overall Study||53
9925756|NCT01267019|11043143|FG002|STARTED|Overall Study||53
9925757|NCT01267019|11043141|FG000|COMPLETED|Overall Study||41
9925758|NCT01267019|11043142|FG001|COMPLETED|Overall Study||47
9925759|NCT01267019|11043143|FG002|COMPLETED|Overall Study||47
9925760|NCT01267019|11043141|FG000|NOT COMPLETED|Overall Study||6
9925761|NCT01267019|11043142|FG001|NOT COMPLETED|Overall Study||6
9925762|NCT01267019|11043143|FG002|NOT COMPLETED|Overall Study||6
9925763|NCT01267045|11043153|FG000|STARTED|2-month Outcomes||26
9925764|NCT01267045|11043154|FG001|STARTED|2-month Outcomes||29
9925765|NCT01267045|11043153|FG000|COMPLETED|2-month Outcomes||22
9925766|NCT01267045|11043154|FG001|COMPLETED|2-month Outcomes||26
9925767|NCT01267045|11043153|FG000|NOT COMPLETED|2-month Outcomes||4
9925768|NCT01267045|11043154|FG001|NOT COMPLETED|2-month Outcomes||3
9925769|NCT01267045|11043153|FG000|STARTED|6-month Outcome||22
9925770|NCT01267045|11043154|FG001|STARTED|6-month Outcome||26
9925771|NCT01267045|11043153|FG000|COMPLETED|6-month Outcome||22
9925772|NCT01267045|11043154|FG001|COMPLETED|6-month Outcome||23
9925773|NCT01267045|11043153|FG000|NOT COMPLETED|6-month Outcome||0
9925774|NCT01267045|11043154|FG001|NOT COMPLETED|6-month Outcome||3
9925775|NCT01267136|11043163|FG000|STARTED|Overall Study||42
9925776|NCT01267136|11043164|FG001|STARTED|Overall Study||42
9925777|NCT01267136|11043163|FG000|COMPLETED|Overall Study||38
9925778|NCT01267136|11043164|FG001|COMPLETED|Overall Study||36
9925779|NCT01267136|11043163|FG000|NOT COMPLETED|Overall Study||4
9925780|NCT01267136|11043164|FG001|NOT COMPLETED|Overall Study||6
9925781|NCT01267175|11043172|FG000|STARTED|Overall Study||31
9925782|NCT01267175|11043172|FG000|COMPLETED|Overall Study||29
9925783|NCT01267175|11043172|FG000|NOT COMPLETED|Overall Study||2
9925784|NCT01267201|11043176|FG000|STARTED|First Intervention Period||4
9925785|NCT01267201|11043177|FG001|STARTED|First Intervention Period||4
9925786|NCT01267201|11043178|FG002|STARTED|First Intervention Period||4
9925787|NCT01267201|11043179|FG003|STARTED|First Intervention Period||4
9925788|NCT01267201|11043180|FG004|STARTED|First Intervention Period||4
9925789|NCT01267201|11043181|FG005|STARTED|First Intervention Period||4
9925790|NCT01267201|11043176|FG000|COMPLETED|First Intervention Period||3
9925791|NCT01267201|11043177|FG001|COMPLETED|First Intervention Period||4
9925792|NCT01267201|11043178|FG002|COMPLETED|First Intervention Period||4
9925793|NCT01267201|11043179|FG003|COMPLETED|First Intervention Period||4
9925794|NCT01267201|11043180|FG004|COMPLETED|First Intervention Period||4
9925795|NCT01267201|11043181|FG005|COMPLETED|First Intervention Period||4
9925796|NCT01267201|11043176|FG000|NOT COMPLETED|First Intervention Period||1
9925797|NCT01267201|11043177|FG001|NOT COMPLETED|First Intervention Period||0
9925798|NCT01267201|11043178|FG002|NOT COMPLETED|First Intervention Period||0
9925799|NCT01267201|11043179|FG003|NOT COMPLETED|First Intervention Period||0
9925800|NCT01267201|11043180|FG004|NOT COMPLETED|First Intervention Period||0
9925801|NCT01267201|11043181|FG005|NOT COMPLETED|First Intervention Period||0
9925802|NCT01267201|11043176|FG000|STARTED|Washout Period (At Least 2 Days)||3
9925803|NCT01267201|11043177|FG001|STARTED|Washout Period (At Least 2 Days)||4
9925804|NCT01267201|11043178|FG002|STARTED|Washout Period (At Least 2 Days)||4
9925805|NCT01267201|11043179|FG003|STARTED|Washout Period (At Least 2 Days)||4
9925806|NCT01267201|11043180|FG004|STARTED|Washout Period (At Least 2 Days)||4
9925807|NCT01267201|11043181|FG005|STARTED|Washout Period (At Least 2 Days)||4
9925808|NCT01267201|11043176|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
9925809|NCT01267201|11043177|FG001|COMPLETED|Washout Period (At Least 2 Days)||4
9925810|NCT01267201|11043178|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
9925811|NCT01267201|11043179|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
9925812|NCT01267201|11043180|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
9925813|NCT01267201|11043181|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
9925814|NCT01267201|11043176|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925815|NCT01267201|11043177|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925816|NCT01267201|11043178|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925817|NCT01267201|11043179|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925818|NCT01267201|11043180|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925819|NCT01267201|11043181|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925820|NCT01267201|11043176|FG000|STARTED|Second Intervention Period||3
9925821|NCT01267201|11043177|FG001|STARTED|Second Intervention Period||4
9925822|NCT01267201|11043178|FG002|STARTED|Second Intervention Period||4
9925823|NCT01267201|11043179|FG003|STARTED|Second Intervention Period||4
9925824|NCT01267201|11043180|FG004|STARTED|Second Intervention Period||4
9925825|NCT01267201|11043181|FG005|STARTED|Second Intervention Period||4
9925826|NCT01267201|11043176|FG000|COMPLETED|Second Intervention Period||3
9925827|NCT01267201|11043177|FG001|COMPLETED|Second Intervention Period||3
9925828|NCT01267201|11043178|FG002|COMPLETED|Second Intervention Period||4
9925829|NCT01267201|11043179|FG003|COMPLETED|Second Intervention Period||4
9925830|NCT01267201|11043180|FG004|COMPLETED|Second Intervention Period||4
9925831|NCT01267201|11043181|FG005|COMPLETED|Second Intervention Period||4
9925832|NCT01267201|11043176|FG000|NOT COMPLETED|Second Intervention Period||0
9925833|NCT01267201|11043177|FG001|NOT COMPLETED|Second Intervention Period||1
9925834|NCT01267201|11043178|FG002|NOT COMPLETED|Second Intervention Period||0
9925835|NCT01267201|11043179|FG003|NOT COMPLETED|Second Intervention Period||0
9925836|NCT01267201|11043180|FG004|NOT COMPLETED|Second Intervention Period||0
9925837|NCT01267201|11043181|FG005|NOT COMPLETED|Second Intervention Period||0
9925838|NCT01267201|11043176|FG000|STARTED|Washout Period (At Least 2 Days)||3
9925839|NCT01267201|11043177|FG001|STARTED|Washout Period (At Least 2 Days)||3
9925840|NCT01267201|11043178|FG002|STARTED|Washout Period (At Least 2 Days)||4
9925841|NCT01267201|11043179|FG003|STARTED|Washout Period (At Least 2 Days)||4
9925842|NCT01267201|11043180|FG004|STARTED|Washout Period (At Least 2 Days)||4
9925843|NCT01267201|11043181|FG005|STARTED|Washout Period (At Least 2 Days)||4
9925844|NCT01267201|11043176|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
9925845|NCT01267201|11043177|FG001|COMPLETED|Washout Period (At Least 2 Days)||3
9925846|NCT01267201|11043178|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
9925847|NCT01267201|11043179|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
9925848|NCT01267201|11043180|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
9925849|NCT01267201|11043181|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
9925850|NCT01267201|11043176|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925851|NCT01267201|11043177|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925852|NCT01267201|11043178|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925853|NCT01267201|11043179|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925854|NCT01267201|11043180|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925855|NCT01267201|11043181|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
9925856|NCT01267201|11043176|FG000|STARTED|Third Intervention Period||3
9925857|NCT01267201|11043177|FG001|STARTED|Third Intervention Period||3
9925858|NCT01267201|11043178|FG002|STARTED|Third Intervention Period||4
9925859|NCT01267201|11043179|FG003|STARTED|Third Intervention Period||4
9925860|NCT01267201|11043180|FG004|STARTED|Third Intervention Period||4
10010731|NCT01775189|11133361|FG001|STARTED|Treatment Phase: Fourth Intervention||0
10010732|NCT01775189|11133362|FG002|STARTED|Treatment Phase: Fourth Intervention||0
10010733|NCT01775189|11133363|FG003|STARTED|Treatment Phase: Fourth Intervention||6
9925861|NCT01267201|11043181|FG005|STARTED|Third Intervention Period||4
9925862|NCT01267201|11043176|FG000|COMPLETED|Third Intervention Period||3
9925863|NCT01267201|11043177|FG001|COMPLETED|Third Intervention Period||3
9925864|NCT01267201|11043178|FG002|COMPLETED|Third Intervention Period||4
9925865|NCT01267201|11043179|FG003|COMPLETED|Third Intervention Period||4
9925866|NCT01267201|11043180|FG004|COMPLETED|Third Intervention Period||4
10010734|NCT01775189|11133364|FG004|STARTED|Treatment Phase: Fourth Intervention||8
10010735|NCT01775189|11133365|FG005|STARTED|Treatment Phase: Fourth Intervention||7
10010736|NCT01775189|11133366|FG006|STARTED|Treatment Phase: Fourth Intervention||7
10010737|NCT01775189|11133360|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
10010738|NCT01775189|11133361|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
9925867|NCT01267201|11043181|FG005|COMPLETED|Third Intervention Period||4
9925868|NCT01267201|11043176|FG000|NOT COMPLETED|Third Intervention Period||0
9925869|NCT01267201|11043177|FG001|NOT COMPLETED|Third Intervention Period||0
9925870|NCT01267201|11043178|FG002|NOT COMPLETED|Third Intervention Period||0
9925871|NCT01267201|11043179|FG003|NOT COMPLETED|Third Intervention Period||0
10010739|NCT01775189|11133362|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
10010740|NCT01775189|11133363|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6
10010741|NCT01775189|11133364|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8
10010742|NCT01775189|11133365|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7
9925872|NCT01267201|11043180|FG004|NOT COMPLETED|Third Intervention Period||0
9925873|NCT01267201|11043181|FG005|NOT COMPLETED|Third Intervention Period||0
9925874|NCT01267227|11043193|FG000|STARTED|Overall Study||20
9925875|NCT01267227|11043194|FG001|STARTED|Overall Study||20
9925876|NCT01267227|11043195|FG002|STARTED|Overall Study||20
9925877|NCT01267227|11043196|FG003|STARTED|Overall Study||20
9925878|NCT01267227|11043193|FG000|COMPLETED|Overall Study||19
9925879|NCT01267227|11043194|FG001|COMPLETED|Overall Study||19
9925880|NCT01267227|11043195|FG002|COMPLETED|Overall Study||18
9925881|NCT01267227|11043196|FG003|COMPLETED|Overall Study||17
9925882|NCT01267227|11043193|FG000|NOT COMPLETED|Overall Study||1
9925883|NCT01267227|11043194|FG001|NOT COMPLETED|Overall Study||1
9925884|NCT01267227|11043195|FG002|NOT COMPLETED|Overall Study||2
9925885|NCT01267227|11043196|FG003|NOT COMPLETED|Overall Study||3
9925886|NCT01267240|11043210|FG000|STARTED|Overall Study||25
9925887|NCT01267240|11043210|FG000|COMPLETED|Overall Study||25
9925888|NCT01267240|11043210|FG000|NOT COMPLETED|Overall Study||0
9925889|NCT01267253|11043214|FG000|STARTED|Overall Study||31
9925890|NCT01267253|11043214|FG000|COMPLETED|Overall Study|Eligible and treated patients|28
9925891|NCT01267253|11043214|FG000|NOT COMPLETED|Overall Study||3
9925892|NCT01267266|11043218|FG000|STARTED|Enrollment Phase||33
9925893|NCT01267266|11043219|FG001|STARTED|Enrollment Phase||0
9925894|NCT01267266|11043218|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
9925895|NCT01267266|11043219|FG001|COMPLETED|Enrollment Phase||0
9925896|NCT01267266|11043218|FG000|NOT COMPLETED|Enrollment Phase||2
9925897|NCT01267266|11043219|FG001|NOT COMPLETED|Enrollment Phase||0
9925898|NCT01267266|11043218|FG000|STARTED|Lead-in Phase||31
9925899|NCT01267266|11043219|FG001|STARTED|Lead-in Phase||0
9925900|NCT01267266|11043218|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
9925901|NCT01267266|11043219|FG001|COMPLETED|Lead-in Phase||0
9925902|NCT01267266|11043218|FG000|NOT COMPLETED|Lead-in Phase||23
9925903|NCT01267266|11043219|FG001|NOT COMPLETED|Lead-in Phase||0
9925904|NCT01267266|11043218|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
9925905|NCT01267266|11043219|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
9925906|NCT01267266|11043218|FG000|COMPLETED|Randomized Phase||3
9925907|NCT01267266|11043219|FG001|COMPLETED|Randomized Phase||5
9925908|NCT01267266|11043218|FG000|NOT COMPLETED|Randomized Phase||0
9925909|NCT01267266|11043219|FG001|NOT COMPLETED|Randomized Phase||0
9925910|NCT01267279|11043230|FG000|STARTED|Overall Study||24
9925911|NCT01267279|11043231|FG001|STARTED|Overall Study||27
9925912|NCT01267279|11043230|FG000|COMPLETED|Overall Study||22
9925913|NCT01267279|11043231|FG001|COMPLETED|Overall Study||21
9925914|NCT01267279|11043230|FG000|NOT COMPLETED|Overall Study||2
9925915|NCT01267279|11043231|FG001|NOT COMPLETED|Overall Study||6
9925916|NCT01267292|11043239|FG000|STARTED|Overall Study||24
9925917|NCT01267292|11043240|FG001|STARTED|Overall Study||26
9925918|NCT01267292|11043239|FG000|COMPLETED|Overall Study||20
9925919|NCT01267292|11043240|FG001|COMPLETED|Overall Study||20
9925920|NCT01267292|11043239|FG000|NOT COMPLETED|Overall Study||4
9925921|NCT01267292|11043240|FG001|NOT COMPLETED|Overall Study||6
9925922|NCT01267422|11043246|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5
9925923|NCT01267422|11043247|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4
9925924|NCT01267422|11043246|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
9925925|NCT01267422|11043247|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
9925926|NCT01267422|11043246|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
9925927|NCT01267422|11043247|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
9925928|NCT01267422|11043246|FG000|STARTED|Safety and Efficacy Study||5
9925929|NCT01267422|11043247|FG001|STARTED|Safety and Efficacy Study||4
9925930|NCT01267422|11043246|FG000|COMPLETED|Safety and Efficacy Study||5
9925931|NCT01267422|11043247|FG001|COMPLETED|Safety and Efficacy Study||4
9925932|NCT01267422|11043246|FG000|NOT COMPLETED|Safety and Efficacy Study||0
9925933|NCT01267422|11043247|FG001|NOT COMPLETED|Safety and Efficacy Study||0
9925934|NCT01267656|11043265|FG000|STARTED|Overall Study||83
9925935|NCT01267656|11043266|FG001|STARTED|Overall Study||83
9925936|NCT01267656|11043265|FG000|COMPLETED|Overall Study||82
9925937|NCT01267656|11043266|FG001|COMPLETED|Overall Study||82
9925938|NCT01267656|11043265|FG000|NOT COMPLETED|Overall Study||1
9925939|NCT01267656|11043266|FG001|NOT COMPLETED|Overall Study||1
9925940|NCT01267864|11043275|FG000|STARTED|Overall Study||110
9925941|NCT01267864|11043276|FG001|STARTED|Overall Study||110
9925942|NCT01267864|11043277|FG002|STARTED|Overall Study||110
9925943|NCT01267864|11043275|FG000|COMPLETED|Overall Study||110
9925944|NCT01267864|11043276|FG001|COMPLETED|Overall Study||110
9925945|NCT01267864|11043277|FG002|COMPLETED|Overall Study||110
9925946|NCT01267864|11043275|FG000|NOT COMPLETED|Overall Study||0
9925947|NCT01267864|11043276|FG001|NOT COMPLETED|Overall Study||0
9925948|NCT01267864|11043277|FG002|NOT COMPLETED|Overall Study||0
9925949|NCT01267929|11043287|FG000|STARTED|Overall Study||15
9925950|NCT01267929|11043288|FG001|STARTED|Overall Study||15
9925951|NCT01267929|11043287|FG000|COMPLETED|Overall Study||15
9925952|NCT01267929|11043288|FG001|COMPLETED|Overall Study||15
9925953|NCT01267929|11043287|FG000|NOT COMPLETED|Overall Study||0
9925954|NCT01267929|11043288|FG001|NOT COMPLETED|Overall Study||0
9925955|NCT01267994|11043294|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
9925956|NCT01267994|11043294|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
9925957|NCT01267994|11043294|FG000|NOT COMPLETED|Overall Study||2
9925958|NCT01268046|11043303|FG000|STARTED|Overall Study||13
9925959|NCT01268046|11043304|FG001|STARTED|Overall Study||9
9925960|NCT01268046|11043305|FG002|STARTED|Overall Study||8
9925961|NCT01268046|11043306|FG003|STARTED|Overall Study||8
9925962|NCT01268046|11043303|FG000|COMPLETED|Overall Study||12
9925963|NCT01268046|11043304|FG001|COMPLETED|Overall Study||9
9925964|NCT01268046|11043305|FG002|COMPLETED|Overall Study||7
9925965|NCT01268046|11043306|FG003|COMPLETED|Overall Study||7
9925966|NCT01268046|11043303|FG000|NOT COMPLETED|Overall Study||1
9925967|NCT01268046|11043304|FG001|NOT COMPLETED|Overall Study||0
9925968|NCT01268046|11043305|FG002|NOT COMPLETED|Overall Study||1
9925969|NCT01268046|11043306|FG003|NOT COMPLETED|Overall Study||1
9956027|NCT01441960|11075113|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13
9956028|NCT01441960|11075112|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
9956029|NCT01441960|11075113|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
9956030|NCT01441960|11075112|FG000|STARTED|Second Neuromuscular Blocking Agent||18
9956031|NCT01441960|11075113|FG001|STARTED|Second Neuromuscular Blocking Agent||13
9956032|NCT01441960|11075112|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18
9956033|NCT01441960|11075113|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13
9956034|NCT01441960|11075112|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
9956035|NCT01441960|11075113|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
9956036|NCT01441973|11075125|FG000|STARTED|Overall Study||15
9956037|NCT01441973|11075126|FG001|STARTED|Overall Study||16
9956038|NCT01441973|11075125|FG000|COMPLETED|Overall Study|Still receiving treatment|0
9956039|NCT01441973|11075126|FG001|COMPLETED|Overall Study|Still receiving treatment|0
9956040|NCT01441973|11075125|FG000|NOT COMPLETED|Overall Study||15
9956041|NCT01441973|11075126|FG001|NOT COMPLETED|Overall Study||16
9956042|NCT01442038|11075135|FG000|STARTED|Overall Study||1332
9956043|NCT01442038|11075136|FG001|STARTED|Overall Study||1319
9956044|NCT01442038|11075135|FG000|COMPLETED|Overall Study||1029
9956045|NCT01442038|11075136|FG001|COMPLETED|Overall Study||1040
9956046|NCT01442038|11075135|FG000|NOT COMPLETED|Overall Study||303
9956047|NCT01442038|11075136|FG001|NOT COMPLETED|Overall Study||279
9956048|NCT01442064|11075148|FG000|STARTED|Overall Study||97
9956049|NCT01442064|11075149|FG001|STARTED|Overall Study||103
9956050|NCT01442064|11075150|FG002|STARTED|Overall Study||104
9956051|NCT01442064|11075151|FG003|STARTED|Overall Study||98
9956052|NCT01442064|11075152|FG004|STARTED|Overall Study||107
9956053|NCT01442064|11075153|FG005|STARTED|Overall Study||99
9956054|NCT01442064|11075148|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
9956055|NCT01442064|11075149|FG001|Ranibizumab-Treated Subjects|Overall Study||103
9956056|NCT01442064|11075150|FG002|Ranibizumab-Treated Subjects|Overall Study||104
9956057|NCT01442064|11075151|FG003|Ranibizumab-Treated Subjects|Overall Study||96
9956058|NCT01442064|11075152|FG004|Ranibizumab-Treated Subjects|Overall Study||107
9956059|NCT01442064|11075153|FG005|Ranibizumab-Treated Subjects|Overall Study||99
9956060|NCT01442064|11075148|FG000|Received Study Drug in Extension Study|Overall Study||61
9956061|NCT01442064|11075149|FG001|Received Study Drug in Extension Study|Overall Study||70
9956062|NCT01442064|11075150|FG002|Received Study Drug in Extension Study|Overall Study||60
9956063|NCT01442064|11075151|FG003|Received Study Drug in Extension Study|Overall Study||70
9956064|NCT01442064|11075152|FG004|Received Study Drug in Extension Study|Overall Study||89
9956065|NCT01442064|11075153|FG005|Received Study Drug in Extension Study|Overall Study||81
9956066|NCT01442064|11075148|FG000|COMPLETED|Overall Study||0
9956067|NCT01442064|11075149|FG001|COMPLETED|Overall Study||2
9956068|NCT01442064|11075150|FG002|COMPLETED|Overall Study||0
9956069|NCT01442064|11075151|FG003|COMPLETED|Overall Study||0
9956070|NCT01442064|11075152|FG004|COMPLETED|Overall Study||1
9956071|NCT01442064|11075153|FG005|COMPLETED|Overall Study||0
9956072|NCT01442064|11075148|FG000|NOT COMPLETED|Overall Study||97
9956073|NCT01442064|11075149|FG001|NOT COMPLETED|Overall Study||101
9956074|NCT01442064|11075150|FG002|NOT COMPLETED|Overall Study||104
9956075|NCT01442064|11075151|FG003|NOT COMPLETED|Overall Study||98
9956076|NCT01442064|11075152|FG004|NOT COMPLETED|Overall Study||106
9956077|NCT01442064|11075153|FG005|NOT COMPLETED|Overall Study||99
9956078|NCT01442103|11075170|FG000|STARTED|Overall Study||10
9956079|NCT01442103|11075170|FG000|COMPLETED|Overall Study||8
9956080|NCT01442103|11075170|FG000|NOT COMPLETED|Overall Study||2
9956081|NCT01442129|11075176|FG000|STARTED|Overall Study||20
9956082|NCT01442129|11075177|FG001|STARTED|Overall Study||10
9956083|NCT01442129|11075176|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
9956084|NCT01442129|11075177|FG001|COMPLETED|Overall Study||10
9956085|NCT01442129|11075176|FG000|NOT COMPLETED|Overall Study||0
9956086|NCT01442129|11075177|FG001|NOT COMPLETED|Overall Study||0
9956087|NCT01442155|11075183|FG000|STARTED|Overall Study||74
9956088|NCT01442155|11075183|FG000|COMPLETED|Overall Study||9
9956089|NCT01442155|11075183|FG000|NOT COMPLETED|Overall Study||65
9956090|NCT01442181|11075189|FG000|STARTED|Overall Study||14
9956091|NCT01442181|11075190|FG001|STARTED|Overall Study||11
9956092|NCT01442181|11075189|FG000|COMPLETED|Overall Study||10
9956093|NCT01442181|11075190|FG001|COMPLETED|Overall Study||8
9925970|NCT01268059|11043320|FG000|STARTED|Overall Study||40
9925971|NCT01268059|11043321|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
9925972|NCT01268059|11043322|FG002|STARTED|Overall Study||6
9925973|NCT01268059|11043323|FG003|STARTED|Overall Study||8
9925974|NCT01268059|11043320|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
9925975|NCT01268059|11043321|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
9925976|NCT01268059|11043322|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
9925977|NCT01268059|11043323|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
9925978|NCT01268059|11043320|FG000|NOT COMPLETED|Overall Study||28
9925979|NCT01268059|11043321|FG001|NOT COMPLETED|Overall Study||35
9925980|NCT01268059|11043322|FG002|NOT COMPLETED|Overall Study||3
9925981|NCT01268059|11043323|FG003|NOT COMPLETED|Overall Study||5
9925982|NCT01268098|11043338|FG000|STARTED|Overall Study||19
9925983|NCT01268098|11043339|FG001|STARTED|Overall Study||23
9925984|NCT01268098|11043338|FG000|COMPLETED|Overall Study||18
9925985|NCT01268098|11043339|FG001|COMPLETED|Overall Study||23
9925986|NCT01268098|11043338|FG000|NOT COMPLETED|Overall Study||1
9925987|NCT01268098|11043339|FG001|NOT COMPLETED|Overall Study||0
9925988|NCT01268111|11043347|FG000|STARTED|Overall Study||6
9925989|NCT01268111|11043348|FG001|STARTED|Overall Study||6
9925990|NCT01268111|11043347|FG000|COMPLETED|Overall Study||6
9925991|NCT01268111|11043348|FG001|COMPLETED|Overall Study||6
9925992|NCT01268111|11043347|FG000|NOT COMPLETED|Overall Study||0
9925993|NCT01268111|11043348|FG001|NOT COMPLETED|Overall Study||0
9925994|NCT01268150|11043354|FG000|STARTED|Treatment Phase||56
9925995|NCT01268150|11043354|FG000|COMPLETED|Treatment Phase||28
9925996|NCT01268150|11043354|FG000|NOT COMPLETED|Treatment Phase||28
9925997|NCT01268150|11043354|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
9925998|NCT01268150|11043354|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
9925999|NCT01268150|11043354|FG000|COMPLETED|Extension Phase||1
9926000|NCT01268150|11043354|FG000|NOT COMPLETED|Extension Phase||27
9926001|NCT01268189|11043358|FG000|STARTED|Overall Study||20
9926002|NCT01268189|11043358|FG000|COMPLETED|Overall Study||17
9926003|NCT01268189|11043358|FG000|NOT COMPLETED|Overall Study||3
9926004|NCT01268267|11043364|FG000|STARTED|Overall Study||94
9926005|NCT01268267|11043364|FG000|COMPLETED|Overall Study||93
9926006|NCT01268267|11043364|FG000|NOT COMPLETED|Overall Study||1
9926007|NCT01268293|11043369|FG000|STARTED|Overall Study||9
9926008|NCT01268293|11043369|FG000|Completed Cycle 1|Overall Study||9
9926009|NCT01268293|11043369|FG000|COMPLETED|Overall Study||0
9926010|NCT01268293|11043369|FG000|NOT COMPLETED|Overall Study||9
9926011|NCT01268306|11043373|FG000|STARTED|Overall Study||8
9926012|NCT01268306|11043373|FG000|COMPLETED|Overall Study||7
9926013|NCT01268306|11043373|FG000|NOT COMPLETED|Overall Study||1
9926014|NCT01268488|11043377|FG000|STARTED|Overall Study||98
9926015|NCT01268488|11043377|FG000|COMPLETED|Overall Study||93
9926016|NCT01268488|11043377|FG000|NOT COMPLETED|Overall Study||5
9926017|NCT01268501|11043382|FG000|STARTED|Overall Study||96
9926018|NCT01268501|11043382|FG000|COMPLETED|Overall Study||87
9926019|NCT01268501|11043382|FG000|NOT COMPLETED|Overall Study||9
9926020|NCT01268514|11043386|FG000|STARTED|Overall Study||115
9926021|NCT01268514|11043386|FG000|Participants Who Received the Device|Overall Study||114
9926022|NCT01268514|11043386|FG000|COMPLETED|Overall Study||74
9926023|NCT01268514|11043386|FG000|NOT COMPLETED|Overall Study||41
9926024|NCT01268527|11043394|FG000|STARTED|Overall Study||15
9926025|NCT01268527|11043395|FG001|STARTED|Overall Study||15
9926026|NCT01268527|11043394|FG000|COMPLETED|Overall Study||15
9926027|NCT01268527|11043395|FG001|COMPLETED|Overall Study||15
9926028|NCT01268527|11043394|FG000|NOT COMPLETED|Overall Study||0
9926029|NCT01268527|11043395|FG001|NOT COMPLETED|Overall Study||0
9926030|NCT01268553|11043414|FG000|STARTED|Overall Study||6
9926031|NCT01268553|11043414|FG000|COMPLETED|Overall Study||6
9926032|NCT01268553|11043414|FG000|NOT COMPLETED|Overall Study||0
9926033|NCT01268566|11043418|FG000|STARTED|Overall Study||56
9926034|NCT01268566|11043418|FG000|COMPLETED|Overall Study||13
9926035|NCT01268566|11043418|FG000|NOT COMPLETED|Overall Study||43
10010743|NCT01775189|11133366|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7
10010744|NCT01775189|11133360|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10010745|NCT01775189|11133361|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10010746|NCT01775189|11133362|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
9926036|NCT01268644|11043422|FG000|STARTED|Baseline Period (Week 0)||8
9926037|NCT01268644|11043422|FG000|COMPLETED|Baseline Period (Week 0)||8
9926038|NCT01268644|11043422|FG000|NOT COMPLETED|Baseline Period (Week 0)||0
9926039|NCT01268644|11043422|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
9926040|NCT01268644|11043422|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
9926041|NCT01268644|11043422|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
9926042|NCT01268644|11043422|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
9926043|NCT01268644|11043422|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
9926044|NCT01268644|11043422|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
9926045|NCT01268644|11043422|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
9956094|NCT01442181|11075189|FG000|NOT COMPLETED|Overall Study||4
9926046|NCT01268644|11043422|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
9926047|NCT01268644|11043422|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
9926048|NCT01268683|11043429|FG000|STARTED|Overall Study||10
9926049|NCT01268683|11043429|FG000|COMPLETED|Overall Study||8
9926050|NCT01268683|11043429|FG000|NOT COMPLETED|Overall Study||2
9926051|NCT01268891|11043435|FG000|STARTED|Overall Study||66
9926052|NCT01268891|11043436|FG001|STARTED|Overall Study||66
9926053|NCT01268891|11043435|FG000|COMPLETED|Overall Study||58
9926054|NCT01268891|11043436|FG001|COMPLETED|Overall Study||58
9926055|NCT01268891|11043435|FG000|NOT COMPLETED|Overall Study||8
9926056|NCT01268891|11043436|FG001|NOT COMPLETED|Overall Study||8
9926057|NCT01268943|11043446|FG000|STARTED|Overall Study||6
9926058|NCT01268943|11043447|FG001|STARTED|Overall Study||3
9926059|NCT01268943|11043448|FG002|STARTED|Overall Study||3
9926060|NCT01268943|11043449|FG003|STARTED|Overall Study||6
9926061|NCT01268943|11043446|FG000|COMPLETED|Overall Study||6
9926062|NCT01268943|11043447|FG001|COMPLETED|Overall Study||3
9926063|NCT01268943|11043448|FG002|COMPLETED|Overall Study||3
9926064|NCT01268943|11043449|FG003|COMPLETED|Overall Study||6
9926065|NCT01268943|11043446|FG000|NOT COMPLETED|Overall Study||0
9926066|NCT01268943|11043447|FG001|NOT COMPLETED|Overall Study||0
9926067|NCT01268943|11043448|FG002|NOT COMPLETED|Overall Study||0
9926068|NCT01268943|11043449|FG003|NOT COMPLETED|Overall Study||0
9926069|NCT01269047|11043462|FG000|STARTED|Overall Study||13
9926070|NCT01269047|11043463|FG001|STARTED|Overall Study||13
9926071|NCT01269047|11043464|FG002|STARTED|Overall Study||11
9926072|NCT01269047|11043462|FG000|COMPLETED|Overall Study||12
9926073|NCT01269047|11043463|FG001|COMPLETED|Overall Study||11
9926074|NCT01269047|11043464|FG002|COMPLETED|Overall Study||10
9926075|NCT01269047|11043462|FG000|NOT COMPLETED|Overall Study||1
9926076|NCT01269047|11043463|FG001|NOT COMPLETED|Overall Study||2
9926077|NCT01269047|11043464|FG002|NOT COMPLETED|Overall Study||1
9926078|NCT01269125|11043477|FG000|STARTED|Overall Study||60
9926079|NCT01269125|11043478|FG001|STARTED|Overall Study||60
9926080|NCT01269125|11043479|FG002|STARTED|Overall Study||60
9926081|NCT01269125|11043477|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
9926082|NCT01269125|11043478|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
9926083|NCT01269125|11043479|FG002|COMPLETED|Overall Study||60
9926084|NCT01269125|11043477|FG000|NOT COMPLETED|Overall Study||7
9926085|NCT01269125|11043478|FG001|NOT COMPLETED|Overall Study||5
9926086|NCT01269125|11043479|FG002|NOT COMPLETED|Overall Study||0
9926087|NCT01269346|11043487|FG000|STARTED|Treatment Phase||52
9926088|NCT01269346|11043487|FG000|Completed 6 Cycles|Treatment Phase||45
9926089|NCT01269346|11043487|FG000|COMPLETED|Treatment Phase||43
9926090|NCT01269346|11043487|FG000|NOT COMPLETED|Treatment Phase||9
9926091|NCT01269346|11043487|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
9926092|NCT01269346|11043487|FG000|COMPLETED|Extension Phase||0
9926093|NCT01269346|11043487|FG000|NOT COMPLETED|Extension Phase||43
9926094|NCT01269372|11043492|FG000|STARTED|Overall Study||30
9926095|NCT01269372|11043492|FG000|COMPLETED|Overall Study||30
9926096|NCT01269372|11043492|FG000|NOT COMPLETED|Overall Study||0
9926097|NCT01269385|11043501|FG000|STARTED|Overall Study||4
9926098|NCT01269385|11043502|FG001|STARTED|Overall Study||4
9926099|NCT01269385|11043503|FG002|STARTED|Overall Study||6
9926100|NCT01269385|11043504|FG003|STARTED|Overall Study||8
9926101|NCT01269385|11043501|FG000|COMPLETED|Overall Study||3
9926102|NCT01269385|11043502|FG001|COMPLETED|Overall Study||3
9926103|NCT01269385|11043503|FG002|COMPLETED|Overall Study||6
9926104|NCT01269385|11043504|FG003|COMPLETED|Overall Study||8
9926105|NCT01269385|11043501|FG000|NOT COMPLETED|Overall Study||1
9926106|NCT01269385|11043502|FG001|NOT COMPLETED|Overall Study||1
9926107|NCT01269385|11043503|FG002|NOT COMPLETED|Overall Study||0
9926108|NCT01269385|11043504|FG003|NOT COMPLETED|Overall Study||0
9926109|NCT01269710|11043514|FG000|STARTED|Overall Study||4
9926110|NCT01269710|11043514|FG000|Week 12|Overall Study||3
9926111|NCT01269710|11043514|FG000|Week 36|Overall Study||2
9926112|NCT01269710|11043514|FG000|COMPLETED|Overall Study|This refers to Week 52.|1
9926113|NCT01269710|11043514|FG000|NOT COMPLETED|Overall Study||3
9926114|NCT01269736|11043520|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
9926115|NCT01269736|11043521|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
9926116|NCT01269736|11043520|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
9926117|NCT01269736|11043521|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
9926118|NCT01269736|11043520|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
9926119|NCT01269736|11043521|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
9926120|NCT01269736|11043520|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
9926121|NCT01269736|11043521|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
9926122|NCT01269736|11043520|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
9926123|NCT01269736|11043521|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
9926124|NCT01269736|11043520|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0
9926125|NCT01269736|11043521|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0
9926126|NCT01269736|11043520|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
9926127|NCT01269736|11043521|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
9926128|NCT01269736|11043520|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
9926129|NCT01269736|11043521|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
9926130|NCT01269736|11043520|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
9926131|NCT01269736|11043521|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
9926132|NCT01269736|11043520|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
9926133|NCT01269736|11043521|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
9926134|NCT01269736|11043520|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
9926135|NCT01269736|11043521|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
9926136|NCT01269736|11043520|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0
9926137|NCT01269736|11043521|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0
9926138|NCT01269736|11043520|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
9926139|NCT01269736|11043521|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
9926140|NCT01269736|11043520|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
9926141|NCT01269736|11043521|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
9926142|NCT01269736|11043520|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
9926143|NCT01269736|11043521|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
9926144|NCT01269736|11043520|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
9926145|NCT01269736|11043521|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
9926146|NCT01269736|11043520|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
9926147|NCT01269736|11043521|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
9926148|NCT01269736|11043520|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
9926149|NCT01269736|11043521|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
9926150|NCT01269801|11043531|FG000|STARTED|Overall Study||74
9926151|NCT01269801|11043532|FG001|STARTED|Overall Study||80
9926152|NCT01269801|11043531|FG000|COMPLETED|Overall Study||74
9926153|NCT01269801|11043532|FG001|COMPLETED|Overall Study||77
9926154|NCT01269801|11043531|FG000|NOT COMPLETED|Overall Study||0
9926155|NCT01269801|11043532|FG001|NOT COMPLETED|Overall Study||3
9926156|NCT01269918|11043540|FG000|STARTED|Overall Study||71
9926157|NCT01269918|11043541|FG001|STARTED|Overall Study||71
9926158|NCT01269918|11043540|FG000|COMPLETED|Overall Study||71
9926159|NCT01269918|11043541|FG001|COMPLETED|Overall Study||68
9926160|NCT01269918|11043540|FG000|NOT COMPLETED|Overall Study||0
9926161|NCT01269918|11043541|FG001|NOT COMPLETED|Overall Study||3
9926162|NCT01270126|11043549|FG000|STARTED|Overall Study||12
9926163|NCT01270126|11043550|FG001|STARTED|Overall Study||10
9926164|NCT01270126|11043549|FG000|COMPLETED|Overall Study||12
9926165|NCT01270126|11043550|FG001|COMPLETED|Overall Study||10
9926166|NCT01270126|11043549|FG000|NOT COMPLETED|Overall Study||0
9926167|NCT01270126|11043550|FG001|NOT COMPLETED|Overall Study||0
9926168|NCT01270139|11043559|FG000|STARTED|Overall Study|Intention-to-treat population|60
9926169|NCT01270139|11043560|FG001|STARTED|Overall Study|Intention-to-treat population|60
9926170|NCT01270139|11043561|FG002|STARTED|Overall Study|Intention-to-treat population|60
9926171|NCT01270139|11043559|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42
9926172|NCT01270139|11043560|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34
9926173|NCT01270139|11043561|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40
9926174|NCT01270139|11043559|FG000|NOT COMPLETED|Overall Study||18
9926175|NCT01270139|11043560|FG001|NOT COMPLETED|Overall Study||26
9926176|NCT01270139|11043561|FG002|NOT COMPLETED|Overall Study||20
9926177|NCT01270256|11043578|FG000|STARTED|Overall Study||21
9926178|NCT01270256|11043579|FG001|STARTED|Overall Study||20
9926179|NCT01270256|11043578|FG000|COMPLETED|Overall Study||20
9926180|NCT01270256|11043579|FG001|COMPLETED|Overall Study||20
9926181|NCT01270256|11043578|FG000|NOT COMPLETED|Overall Study||1
9926182|NCT01270256|11043579|FG001|NOT COMPLETED|Overall Study||0
9926183|NCT01270321|11043588|FG000|STARTED|Overall Study||19
9926184|NCT01270321|11043589|FG001|STARTED|Overall Study||11
9926185|NCT01270321|11043590|FG002|STARTED|Overall Study||12
9926186|NCT01270321|11043588|FG000|COMPLETED|Overall Study||9
9926187|NCT01270321|11043589|FG001|COMPLETED|Overall Study||1
9926188|NCT01270321|11043590|FG002|COMPLETED|Overall Study||3
9926189|NCT01270321|11043588|FG000|NOT COMPLETED|Overall Study||10
9926190|NCT01270321|11043589|FG001|NOT COMPLETED|Overall Study||10
9926191|NCT01270321|11043590|FG002|NOT COMPLETED|Overall Study||9
9926192|NCT01270464|11043601|FG000|STARTED|Overall Study||105
9926193|NCT01270464|11043602|FG001|STARTED|Overall Study||104
9926194|NCT01270464|11043603|FG002|STARTED|Overall Study||106
9926195|NCT01270464|11043601|FG000|Safety Analysis Set|Overall Study||105
9926196|NCT01270464|11043602|FG001|Safety Analysis Set|Overall Study||103
9926197|NCT01270464|11043603|FG002|Safety Analysis Set|Overall Study||103
9926198|NCT01270464|11043601|FG000|Full Analysis Set|Overall Study||105
9926199|NCT01270464|11043602|FG001|Full Analysis Set|Overall Study||103
9926200|NCT01270464|11043603|FG002|Full Analysis Set|Overall Study||103
9926201|NCT01270464|11043601|FG000|Pharmacokinetic Analysis Set|Overall Study||105
9926202|NCT01270464|11043602|FG001|Pharmacokinetic Analysis Set|Overall Study||103
9926203|NCT01270464|11043603|FG002|Pharmacokinetic Analysis Set|Overall Study||103
9926204|NCT01270464|11043601|FG000|COMPLETED|Overall Study||85
9926205|NCT01270464|11043602|FG001|COMPLETED|Overall Study||92
9926206|NCT01270464|11043603|FG002|COMPLETED|Overall Study||88
9926207|NCT01270464|11043601|FG000|NOT COMPLETED|Overall Study||20
9926208|NCT01270464|11043602|FG001|NOT COMPLETED|Overall Study||12
9926209|NCT01270464|11043603|FG002|NOT COMPLETED|Overall Study||18
9926210|NCT01270503|11043611|FG000|STARTED|Overall Study||538
9926211|NCT01270503|11043611|FG000|COMPLETED|Overall Study||537
9926212|NCT01270503|11043611|FG000|NOT COMPLETED|Overall Study||1
9926213|NCT01270516|11043620|FG000|STARTED|Overall Study||20
9926214|NCT01270516|11043621|FG001|STARTED|Overall Study||17
9926215|NCT01270516|11043622|FG002|STARTED|Overall Study||18
9926216|NCT01270516|11043623|FG003|STARTED|Overall Study||18
9926217|NCT01270516|11043620|FG000|COMPLETED|Overall Study||17
9926218|NCT01270516|11043621|FG001|COMPLETED|Overall Study||13
9926219|NCT01270516|11043622|FG002|COMPLETED|Overall Study||13
9926220|NCT01270516|11043623|FG003|COMPLETED|Overall Study||13
9926221|NCT01270516|11043620|FG000|NOT COMPLETED|Overall Study||3
9926222|NCT01270516|11043621|FG001|NOT COMPLETED|Overall Study||4
9926223|NCT01270516|11043622|FG002|NOT COMPLETED|Overall Study||5
9926224|NCT01270516|11043623|FG003|NOT COMPLETED|Overall Study||5
9926225|NCT01270529|11043636|FG000|STARTED|Overall Study||12
9926226|NCT01270529|11043637|FG001|STARTED|Overall Study||7
9926227|NCT01270529|11043638|FG002|STARTED|Overall Study||25
9926228|NCT01270529|11043636|FG000|COMPLETED|Overall Study||12
9926229|NCT01270529|11043637|FG001|COMPLETED|Overall Study||7
9926230|NCT01270529|11043638|FG002|COMPLETED|Overall Study||25
9926231|NCT01270529|11043636|FG000|NOT COMPLETED|Overall Study||0
9926232|NCT01270529|11043637|FG001|NOT COMPLETED|Overall Study||0
9926233|NCT01270529|11043638|FG002|NOT COMPLETED|Overall Study||0
9926234|NCT01270542|11043648|FG000|STARTED|Overall Study||10
9926235|NCT01270542|11043649|FG001|STARTED|Overall Study||9
9926236|NCT01270542|11043648|FG000|COMPLETED|Overall Study||9
9926237|NCT01270542|11043649|FG001|COMPLETED|Overall Study||8
9926238|NCT01270542|11043648|FG000|NOT COMPLETED|Overall Study||1
9926239|NCT01270542|11043649|FG001|NOT COMPLETED|Overall Study||1
9926240|NCT01270555|11043655|FG000|STARTED|Overall Study||32
9926241|NCT01270555|11043655|FG000|COMPLETED|Overall Study||19
9926242|NCT01270555|11043655|FG000|NOT COMPLETED|Overall Study||13
9926243|NCT01270620|11043661|FG000|STARTED|Overall Study||50
9926244|NCT01270620|11043662|FG001|STARTED|Overall Study||50
9926245|NCT01270620|11043661|FG000|COMPLETED|Overall Study||49
9926246|NCT01270620|11043662|FG001|COMPLETED|Overall Study||47
9926247|NCT01270620|11043661|FG000|NOT COMPLETED|Overall Study||1
9926248|NCT01270620|11043662|FG001|NOT COMPLETED|Overall Study||3
9926249|NCT01270659|11043678|FG000|STARTED|Overall Study||6
9926250|NCT01270659|11043679|FG001|STARTED|Overall Study||25
9926251|NCT01270659|11043680|FG002|STARTED|Overall Study||4
9926252|NCT01270659|11043681|FG003|STARTED|Overall Study||25
9926253|NCT01270659|11043678|FG000|COMPLETED|Overall Study||6
9926254|NCT01270659|11043679|FG001|COMPLETED|Overall Study||25
9926255|NCT01270659|11043680|FG002|COMPLETED|Overall Study||4
9926256|NCT01270659|11043681|FG003|COMPLETED|Overall Study||25
9926257|NCT01270659|11043678|FG000|NOT COMPLETED|Overall Study||0
9926258|NCT01270659|11043679|FG001|NOT COMPLETED|Overall Study||0
9926259|NCT01270659|11043680|FG002|NOT COMPLETED|Overall Study||0
9926260|NCT01270659|11043681|FG003|NOT COMPLETED|Overall Study||0
9926261|NCT01270711|11043699|FG000|STARTED|Part 1: Compliance||7537
9926262|NCT01270711|11043700|FG001|STARTED|Part 1: Compliance||6580
9926263|NCT01270711|11043701|FG002|STARTED|Part 1: Compliance||326
9926264|NCT01270711|11043702|FG003|STARTED|Part 1: Compliance||5486
9926265|NCT01270711|11043703|FG004|STARTED|Part 1: Compliance||2024
9926266|NCT01270711|11043704|FG005|STARTED|Part 1: Compliance||0
9926267|NCT01270711|11043705|FG006|STARTED|Part 1: Compliance||0
9926268|NCT01270711|11043706|FG007|STARTED|Part 1: Compliance||0
9926269|NCT01270711|11043699|FG000|COMPLETED|Part 1: Compliance||7537
9926270|NCT01270711|11043700|FG001|COMPLETED|Part 1: Compliance||6580
9926271|NCT01270711|11043701|FG002|COMPLETED|Part 1: Compliance||326
9926272|NCT01270711|11043702|FG003|COMPLETED|Part 1: Compliance||5486
9926273|NCT01270711|11043703|FG004|COMPLETED|Part 1: Compliance||2024
9926274|NCT01270711|11043704|FG005|COMPLETED|Part 1: Compliance||0
9926275|NCT01270711|11043705|FG006|COMPLETED|Part 1: Compliance||0
9926276|NCT01270711|11043706|FG007|COMPLETED|Part 1: Compliance||0
9926277|NCT01270711|11043699|FG000|NOT COMPLETED|Part 1: Compliance||0
9926278|NCT01270711|11043700|FG001|NOT COMPLETED|Part 1: Compliance||0
9926279|NCT01270711|11043701|FG002|NOT COMPLETED|Part 1: Compliance||0
9926280|NCT01270711|11043702|FG003|NOT COMPLETED|Part 1: Compliance||0
9926281|NCT01270711|11043703|FG004|NOT COMPLETED|Part 1: Compliance||0
9926282|NCT01270711|11043704|FG005|NOT COMPLETED|Part 1: Compliance||0
9926283|NCT01270711|11043705|FG006|NOT COMPLETED|Part 1: Compliance||0
9926284|NCT01270711|11043706|FG007|NOT COMPLETED|Part 1: Compliance||0
9926285|NCT01270711|11043699|FG000|STARTED|Part 2: Effectiveness||0
9926286|NCT01270711|11043700|FG001|STARTED|Part 2: Effectiveness||0
9926287|NCT01270711|11043701|FG002|STARTED|Part 2: Effectiveness||0
9926288|NCT01270711|11043702|FG003|STARTED|Part 2: Effectiveness||0
9926289|NCT01270711|11043703|FG004|STARTED|Part 2: Effectiveness||0
9926290|NCT01270711|11043704|FG005|STARTED|Part 2: Effectiveness||11
9926291|NCT01270711|11043705|FG006|STARTED|Part 2: Effectiveness||2
9926292|NCT01270711|11043706|FG007|STARTED|Part 2: Effectiveness||48
9926293|NCT01270711|11043699|FG000|COMPLETED|Part 2: Effectiveness||0
9926294|NCT01270711|11043700|FG001|COMPLETED|Part 2: Effectiveness||0
9926295|NCT01270711|11043701|FG002|COMPLETED|Part 2: Effectiveness||0
9926296|NCT01270711|11043702|FG003|COMPLETED|Part 2: Effectiveness||0
9926297|NCT01270711|11043703|FG004|COMPLETED|Part 2: Effectiveness||0
9926298|NCT01270711|11043704|FG005|COMPLETED|Part 2: Effectiveness||11
9926299|NCT01270711|11043705|FG006|COMPLETED|Part 2: Effectiveness||2
9926300|NCT01270711|11043706|FG007|COMPLETED|Part 2: Effectiveness||48
9926301|NCT01270711|11043699|FG000|NOT COMPLETED|Part 2: Effectiveness||0
9926302|NCT01270711|11043700|FG001|NOT COMPLETED|Part 2: Effectiveness||0
9926303|NCT01270711|11043701|FG002|NOT COMPLETED|Part 2: Effectiveness||0
9926304|NCT01270711|11043702|FG003|NOT COMPLETED|Part 2: Effectiveness||0
9926305|NCT01270711|11043703|FG004|NOT COMPLETED|Part 2: Effectiveness||0
9926306|NCT01270711|11043704|FG005|NOT COMPLETED|Part 2: Effectiveness||0
9926307|NCT01270711|11043705|FG006|NOT COMPLETED|Part 2: Effectiveness||0
9926308|NCT01270711|11043706|FG007|NOT COMPLETED|Part 2: Effectiveness||0
9926309|NCT01270802|11043727|FG000|STARTED|Overall Study||15
9926310|NCT01270802|11043728|FG001|STARTED|Overall Study||15
9926311|NCT01270802|11043727|FG000|COMPLETED|Overall Study||13
9926312|NCT01270802|11043728|FG001|COMPLETED|Overall Study||14
9926313|NCT01270802|11043727|FG000|NOT COMPLETED|Overall Study||2
9926314|NCT01270802|11043728|FG001|NOT COMPLETED|Overall Study||1
9926315|NCT01270828|11043737|FG000|STARTED|Pregabalin CR SB||0
9926316|NCT01270828|11043738|FG001|STARTED|Pregabalin CR SB||0
9926317|NCT01270828|11043739|FG002|STARTED|Pregabalin CR SB||806
9926318|NCT01270828|11043737|FG000|COMPLETED|Pregabalin CR SB||0
9926319|NCT01270828|11043738|FG001|COMPLETED|Pregabalin CR SB||0
9926320|NCT01270828|11043739|FG002|COMPLETED|Pregabalin CR SB||660
9926321|NCT01270828|11043737|FG000|NOT COMPLETED|Pregabalin CR SB||0
9926322|NCT01270828|11043738|FG001|NOT COMPLETED|Pregabalin CR SB||0
9926323|NCT01270828|11043739|FG002|NOT COMPLETED|Pregabalin CR SB||146
9926324|NCT01270828|11043737|FG000|STARTED|Double Blind Phase||208
9926325|NCT01270828|11043738|FG001|STARTED|Double Blind Phase||205
9926326|NCT01270828|11043739|FG002|STARTED|Double Blind Phase||0
9926327|NCT01270828|11043737|FG000|COMPLETED|Double Blind Phase||182
9926328|NCT01270828|11043738|FG001|COMPLETED|Double Blind Phase||160
9926329|NCT01270828|11043739|FG002|COMPLETED|Double Blind Phase||0
9926330|NCT01270828|11043737|FG000|NOT COMPLETED|Double Blind Phase||26
9926331|NCT01270828|11043738|FG001|NOT COMPLETED|Double Blind Phase||45
9926332|NCT01270828|11043739|FG002|NOT COMPLETED|Double Blind Phase||0
9926333|NCT01270841|11043751|FG000|STARTED|Overall Study||29
9926334|NCT01270841|11043752|FG001|STARTED|Overall Study||33
9926335|NCT01270841|11043753|FG002|STARTED|Overall Study||29
9926336|NCT01270841|11043754|FG003|STARTED|Overall Study||33
9926337|NCT01270841|11043751|FG000|COMPLETED|Overall Study||16
9926338|NCT01270841|11043752|FG001|COMPLETED|Overall Study||19
9926339|NCT01270841|11043753|FG002|COMPLETED|Overall Study||18
9926340|NCT01270841|11043754|FG003|COMPLETED|Overall Study||20
9926341|NCT01270841|11043751|FG000|NOT COMPLETED|Overall Study||13
9926342|NCT01270841|11043752|FG001|NOT COMPLETED|Overall Study||14
9926343|NCT01270841|11043753|FG002|NOT COMPLETED|Overall Study||11
9926344|NCT01270841|11043754|FG003|NOT COMPLETED|Overall Study||13
9926345|NCT01270867|11043766|FG000|STARTED|Overall Study||90
9926346|NCT01270867|11043767|FG001|STARTED|Overall Study||88
9926347|NCT01270867|11043766|FG000|COMPLETED|Overall Study||89
9926348|NCT01270867|11043767|FG001|COMPLETED|Overall Study||88
9926349|NCT01270867|11043766|FG000|NOT COMPLETED|Overall Study||1
9926350|NCT01270867|11043767|FG001|NOT COMPLETED|Overall Study||0
9926351|NCT01270880|11043773|FG000|STARTED|Overall Study||18
9926352|NCT01270880|11043773|FG000|COMPLETED|Overall Study||17
9926353|NCT01270880|11043773|FG000|NOT COMPLETED|Overall Study||1
9926354|NCT01270958|11043777|FG000|STARTED|Overall Study||60
9926355|NCT01270958|11043777|FG000|COMPLETED|Overall Study||56
9926356|NCT01270958|11043777|FG000|NOT COMPLETED|Overall Study||4
9926357|NCT01270971|11043783|FG000|STARTED|Overall Study||400
9926358|NCT01270971|11043784|FG001|STARTED|Overall Study||194
9926359|NCT01270971|11043783|FG000|COMPLETED|Overall Study||348
9926360|NCT01270971|11043784|FG001|COMPLETED|Overall Study||171
9926361|NCT01270971|11043783|FG000|NOT COMPLETED|Overall Study||52
9926362|NCT01270971|11043784|FG001|NOT COMPLETED|Overall Study||23
9926363|NCT01271010|11043790|FG000|STARTED|Overall Study||89
9926364|NCT01271010|11043790|FG000|COMPLETED|Overall Study||28
9926365|NCT01271010|11043790|FG000|NOT COMPLETED|Overall Study||61
9926366|NCT01271036|11043796|FG000|STARTED|Overall Study||62
9926367|NCT01271036|11043797|FG001|STARTED|Overall Study||62
9926368|NCT01271036|11043796|FG000|COMPLETED|Overall Study||62
9926369|NCT01271036|11043797|FG001|COMPLETED|Overall Study||62
9926370|NCT01271036|11043796|FG000|NOT COMPLETED|Overall Study||0
9926371|NCT01271036|11043797|FG001|NOT COMPLETED|Overall Study||0
9926372|NCT01271244|11043805|FG000|STARTED|Overall Study||18
9926373|NCT01271244|11043806|FG001|STARTED|Overall Study||8
9926374|NCT01271244|11043805|FG000|COMPLETED|Overall Study||11
9926375|NCT01271244|11043806|FG001|COMPLETED|Overall Study||5
9926376|NCT01271244|11043805|FG000|NOT COMPLETED|Overall Study||7
9926377|NCT01271244|11043806|FG001|NOT COMPLETED|Overall Study||3
9926378|NCT01271413|11043814|FG000|STARTED|Overall Study||37
9926379|NCT01271413|11043815|FG001|STARTED|Overall Study||36
9926380|NCT01271413|11043814|FG000|COMPLETED|Overall Study||28
9926381|NCT01271413|11043815|FG001|COMPLETED|Overall Study||28
9926382|NCT01271413|11043814|FG000|NOT COMPLETED|Overall Study||9
9926383|NCT01271413|11043815|FG001|NOT COMPLETED|Overall Study||8
9926384|NCT01271452|11043823|FG000|STARTED|Overall Study||112
9926385|NCT01271452|11043824|FG001|STARTED|Overall Study||112
9926386|NCT01271452|11043823|FG000|COMPLETED|Overall Study||105
9926387|NCT01271452|11043824|FG001|COMPLETED|Overall Study||104
9926388|NCT01271452|11043823|FG000|NOT COMPLETED|Overall Study||7
9926389|NCT01271452|11043824|FG001|NOT COMPLETED|Overall Study||8
9926390|NCT01271504|11043834|FG000|STARTED|Overall Study||7
9926391|NCT01271504|11043835|FG001|STARTED|Overall Study||8
9926392|NCT01271504|11043836|FG002|STARTED|Overall Study||44
9926393|NCT01271504|11043837|FG003|STARTED|Overall Study||43
9926394|NCT01271504|11043834|FG000|Treated|Overall Study||7
9926395|NCT01271504|11043835|FG001|Treated|Overall Study||7
9926396|NCT01271504|11043836|FG002|Treated|Overall Study||42
9926397|NCT01271504|11043837|FG003|Treated|Overall Study||42
9926398|NCT01271504|11043834|FG000|COMPLETED|Overall Study||0
9926399|NCT01271504|11043835|FG001|COMPLETED|Overall Study||0
9926400|NCT01271504|11043836|FG002|COMPLETED|Overall Study||0
9926401|NCT01271504|11043837|FG003|COMPLETED|Overall Study||0
9926402|NCT01271504|11043834|FG000|NOT COMPLETED|Overall Study||7
9926403|NCT01271504|11043835|FG001|NOT COMPLETED|Overall Study||8
9926404|NCT01271504|11043836|FG002|NOT COMPLETED|Overall Study||44
9926405|NCT01271504|11043837|FG003|NOT COMPLETED|Overall Study||43
9926406|NCT01271543|11043859|FG000|STARTED|Overall Study||30
9926407|NCT01271543|11043860|FG001|STARTED|Overall Study||30
9926408|NCT01271543|11043859|FG000|COMPLETED|Overall Study||29
9926409|NCT01271543|11043860|FG001|COMPLETED|Overall Study||29
9926410|NCT01271543|11043859|FG000|NOT COMPLETED|Overall Study||1
9926411|NCT01271543|11043860|FG001|NOT COMPLETED|Overall Study||1
9926412|NCT01271686|11043867|FG000|STARTED|Overall Study||16
9926413|NCT01271686|11043867|FG000|COMPLETED|Overall Study||16
9926414|NCT01271686|11043867|FG000|NOT COMPLETED|Overall Study||0
9926415|NCT01271712|11043873|FG000|STARTED|Double Blind Treatment||133
9926416|NCT01271712|11043874|FG001|STARTED|Double Blind Treatment||66
9926417|NCT01271712|11043873|FG000|Participants Received Treatment|Double Blind Treatment||132
9926418|NCT01271712|11043874|FG001|Participants Received Treatment|Double Blind Treatment||66
9926419|NCT01271712|11043873|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
9926420|NCT01271712|11043874|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
9926421|NCT01271712|11043873|FG000|NOT COMPLETED|Double Blind Treatment||42
9926422|NCT01271712|11043874|FG001|NOT COMPLETED|Double Blind Treatment||8
9926423|NCT01271712|11043873|FG000|STARTED|Open Label Treatment||91
9926424|NCT01271712|11043874|FG001|STARTED|Open Label Treatment||58
9926425|NCT01271712|11043873|FG000|COMPLETED|Open Label Treatment||0
9926426|NCT01271712|11043874|FG001|COMPLETED|Open Label Treatment||0
9926427|NCT01271712|11043873|FG000|NOT COMPLETED|Open Label Treatment||91
9926428|NCT01271712|11043874|FG001|NOT COMPLETED|Open Label Treatment||58
9926429|NCT01271712|11043873|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
9926430|NCT01271712|11043874|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
9926431|NCT01271712|11043873|FG000|COMPLETED|Safety Follow-up||97
9926432|NCT01271712|11043874|FG001|COMPLETED|Safety Follow-up||37
9926433|NCT01271712|11043873|FG000|NOT COMPLETED|Safety Follow-up||21
9926434|NCT01271712|11043874|FG001|NOT COMPLETED|Safety Follow-up||15
9926435|NCT01271712|11043873|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
9926436|NCT01271712|11043874|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
9926437|NCT01271712|11043873|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
9926438|NCT01271712|11043874|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
9926439|NCT01271712|11043873|FG000|NOT COMPLETED|Survival Follow-up||15
9926440|NCT01271712|11043874|FG001|NOT COMPLETED|Survival Follow-up||6
9926441|NCT01271725|11043883|FG000|STARTED|Part A|Started are the treated patients|74
9926442|NCT01271725|11043884|FG001|STARTED|Part A||0
9926443|NCT01271725|11043883|FG000|COMPLETED|Part A||39
9926444|NCT01271725|11043884|FG001|COMPLETED|Part A||0
9926445|NCT01271725|11043883|FG000|NOT COMPLETED|Part A||35
9926446|NCT01271725|11043884|FG001|NOT COMPLETED|Part A||0
9926447|NCT01271725|11043883|FG000|STARTED|Part B||0
9926448|NCT01271725|11043884|FG001|STARTED|Part B||39
9926449|NCT01271725|11043883|FG000|COMPLETED|Part B||0
9926450|NCT01271725|11043884|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
9926451|NCT01271725|11043883|FG000|NOT COMPLETED|Part B||0
9926452|NCT01271725|11043884|FG001|NOT COMPLETED|Part B||12
9926453|NCT01271803|11043896|FG000|STARTED|Overall Study||66
9926454|NCT01271803|11043897|FG001|STARTED|Overall Study||63
9926455|NCT01271803|11043898|FG002|STARTED|Overall Study||2
9926456|NCT01271803|11043896|FG000|COMPLETED|Overall Study||11
9926457|NCT01271803|11043897|FG001|COMPLETED|Overall Study||24
9926458|NCT01271803|11043898|FG002|COMPLETED|Overall Study||0
9926459|NCT01271803|11043896|FG000|NOT COMPLETED|Overall Study||55
9926460|NCT01271803|11043897|FG001|NOT COMPLETED|Overall Study||39
9926461|NCT01271803|11043898|FG002|NOT COMPLETED|Overall Study||2
9926462|NCT01271855|11043945|FG000|STARTED|Overall Study||48
9926463|NCT01271855|11043946|FG001|STARTED|Overall Study||52
9926464|NCT01271855|11043945|FG000|COMPLETED|Overall Study||48
9926465|NCT01271855|11043946|FG001|COMPLETED|Overall Study||52
9926466|NCT01271855|11043945|FG000|NOT COMPLETED|Overall Study||0
9926467|NCT01271855|11043946|FG001|NOT COMPLETED|Overall Study||0
9926468|NCT01271868|11043952|FG000|STARTED|Pharmacokinetic Study||9
9926469|NCT01271868|11043952|FG000|COMPLETED|Pharmacokinetic Study||9
9926470|NCT01271868|11043952|FG000|NOT COMPLETED|Pharmacokinetic Study||0
9926471|NCT01271868|11043952|FG000|STARTED|Treatment Study||9
9926472|NCT01271868|11043952|FG000|COMPLETED|Treatment Study||9
9926473|NCT01271868|11043952|FG000|NOT COMPLETED|Treatment Study||0
9926474|NCT01271907|11043961|FG000|STARTED|Overall Study||3
9926475|NCT01271907|11043962|FG001|STARTED|Overall Study||0
9926476|NCT01271907|11043963|FG002|STARTED|Overall Study||0
9926477|NCT01271907|11043961|FG000|COMPLETED|Overall Study||3
9926478|NCT01271907|11043962|FG001|COMPLETED|Overall Study||0
9926479|NCT01271907|11043963|FG002|COMPLETED|Overall Study||0
9926480|NCT01271907|11043961|FG000|NOT COMPLETED|Overall Study||0
9926481|NCT01271907|11043962|FG001|NOT COMPLETED|Overall Study||0
9926482|NCT01271907|11043963|FG002|NOT COMPLETED|Overall Study||0
9926483|NCT01271933|11043971|FG000|STARTED|Single-Blind Phase||441
9926484|NCT01271933|11043972|FG001|STARTED|Single-Blind Phase||0
9926485|NCT01271933|11043973|FG002|STARTED|Single-Blind Phase||0
9926486|NCT01271933|11043971|FG000|COMPLETED|Single-Blind Phase||320
9926487|NCT01271933|11043972|FG001|COMPLETED|Single-Blind Phase||0
9926488|NCT01271933|11043973|FG002|COMPLETED|Single-Blind Phase||0
9926489|NCT01271933|11043971|FG000|NOT COMPLETED|Single-Blind Phase||121
9926490|NCT01271933|11043972|FG001|NOT COMPLETED|Single-Blind Phase||0
9926491|NCT01271933|11043973|FG002|NOT COMPLETED|Single-Blind Phase||0
10205388|NCT03491553|11332174|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10205389|NCT03491553|11332175|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10205390|NCT03491553|11332176|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10205391|NCT03491553|11332177|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10205392|NCT03491800|11332196|FG000|STARTED|Overall Study||23
10205393|NCT03491800|11332197|FG001|STARTED|Overall Study||23
10205394|NCT03491800|11332198|FG002|STARTED|Overall Study||7
10205395|NCT03491800|11332196|FG000|COMPLETED|Overall Study||23
10205396|NCT03491800|11332197|FG001|COMPLETED|Overall Study||23
9926492|NCT01271933|11043971|FG000|STARTED|Double-Blind Phase||0
9926493|NCT01271933|11043972|FG001|STARTED|Double-Blind Phase||63
9926494|NCT01271933|11043973|FG002|STARTED|Double-Blind Phase||59
9926495|NCT01271933|11043971|FG000|Treated|Double-Blind Phase||0
9926496|NCT01271933|11043972|FG001|Treated|Double-Blind Phase||63
9926497|NCT01271933|11043973|FG002|Treated|Double-Blind Phase||58
9926498|NCT01271933|11043971|FG000|COMPLETED|Double-Blind Phase||0
9926499|NCT01271933|11043972|FG001|COMPLETED|Double-Blind Phase||46
9926500|NCT01271933|11043973|FG002|COMPLETED|Double-Blind Phase||47
9926501|NCT01271933|11043971|FG000|NOT COMPLETED|Double-Blind Phase||0
9926502|NCT01271933|11043972|FG001|NOT COMPLETED|Double-Blind Phase||17
9926503|NCT01271933|11043973|FG002|NOT COMPLETED|Double-Blind Phase||12
9926504|NCT01271946|11043985|FG000|STARTED|Overall Study||346
9926505|NCT01271946|11043986|FG001|STARTED|Overall Study||5
9926506|NCT01271946|11043985|FG000|COMPLETED|Overall Study||346
9926507|NCT01271946|11043986|FG001|COMPLETED|Overall Study||5
9926508|NCT01271946|11043985|FG000|NOT COMPLETED|Overall Study||0
9926509|NCT01271946|11043986|FG001|NOT COMPLETED|Overall Study||0
9926510|NCT01272011|11044009|FG000|STARTED|Overall Study||3
9926511|NCT01272011|11044010|FG001|STARTED|Overall Study||10
9926512|NCT01272011|11044011|FG002|STARTED|Overall Study||3
9926513|NCT01272011|11044009|FG000|COMPLETED|Overall Study||3
9926514|NCT01272011|11044010|FG001|COMPLETED|Overall Study||8
9926515|NCT01272011|11044011|FG002|COMPLETED|Overall Study||3
9926516|NCT01272011|11044009|FG000|NOT COMPLETED|Overall Study||0
9926517|NCT01272011|11044010|FG001|NOT COMPLETED|Overall Study||2
9926518|NCT01272011|11044011|FG002|NOT COMPLETED|Overall Study||0
9926519|NCT01272076|11044019|FG000|STARTED|Overall Study||52
9926520|NCT01272076|11044019|FG000|COMPLETED|Overall Study||52
9926521|NCT01272076|11044019|FG000|NOT COMPLETED|Overall Study||0
9926522|NCT01272180|11044027|FG000|STARTED|Overall Study||120
9926523|NCT01272180|11044028|FG001|STARTED|Overall Study||121
9926524|NCT01272180|11044029|FG002|STARTED|Overall Study||122
9926525|NCT01272180|11044030|FG003|STARTED|Overall Study||121
9926526|NCT01272180|11044027|FG000|COMPLETED|Overall Study||103
9926527|NCT01272180|11044028|FG001|COMPLETED|Overall Study||100
9926528|NCT01272180|11044029|FG002|COMPLETED|Overall Study||109
9926529|NCT01272180|11044030|FG003|COMPLETED|Overall Study||107
9926530|NCT01272180|11044027|FG000|NOT COMPLETED|Overall Study||17
9926531|NCT01272180|11044028|FG001|NOT COMPLETED|Overall Study||21
9926532|NCT01272180|11044029|FG002|NOT COMPLETED|Overall Study||13
9926533|NCT01272180|11044030|FG003|NOT COMPLETED|Overall Study||14
9926534|NCT01272193|11044046|FG000|STARTED|Overall Study||147
9926535|NCT01272193|11044047|FG001|STARTED|Overall Study||149
9926536|NCT01272193|11044046|FG000|COMPLETED|Overall Study||137
9926537|NCT01272193|11044047|FG001|COMPLETED|Overall Study||137
9926538|NCT01272193|11044046|FG000|NOT COMPLETED|Overall Study||10
9926539|NCT01272193|11044047|FG001|NOT COMPLETED|Overall Study||12
9926540|NCT01272219|11044057|FG000|STARTED|Main Period: Week 0 to Week 56||959
10205397|NCT03491800|11332198|FG002|COMPLETED|Overall Study||7
10205398|NCT03491800|11332196|FG000|NOT COMPLETED|Overall Study||0
10205399|NCT03491800|11332197|FG001|NOT COMPLETED|Overall Study||0
10205400|NCT03491800|11332198|FG002|NOT COMPLETED|Overall Study||0
9926541|NCT01272219|11044058|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
9926542|NCT01272219|11044059|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
9926543|NCT01272219|11044060|FG003|STARTED|Main Period: Week 0 to Week 56||487
9926544|NCT01272219|11044061|FG004|STARTED|Main Period: Week 0 to Week 56||1528
9926545|NCT01272219|11044062|FG005|STARTED|Main Period: Week 0 to Week 56||757
9926546|NCT01272219|11044057|FG000|Exposed|Main Period: Week 0 to Week 56||957
9926547|NCT01272219|11044058|FG001|Exposed|Main Period: Week 0 to Week 56||0
9926548|NCT01272219|11044059|FG002|Exposed|Main Period: Week 0 to Week 56||0
9926549|NCT01272219|11044060|FG003|Exposed|Main Period: Week 0 to Week 56||487
9926550|NCT01272219|11044061|FG004|Exposed|Main Period: Week 0 to Week 56||1524
9926551|NCT01272219|11044062|FG005|Exposed|Main Period: Week 0 to Week 56||755
9926552|NCT01272219|11044057|FG000|COMPLETED|Main Period: Week 0 to Week 56||679
9926553|NCT01272219|11044058|FG001|COMPLETED|Main Period: Week 0 to Week 56||0
9926554|NCT01272219|11044059|FG002|COMPLETED|Main Period: Week 0 to Week 56||0
9926555|NCT01272219|11044060|FG003|COMPLETED|Main Period: Week 0 to Week 56||296
9926556|NCT01272219|11044061|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110
9926557|NCT01272219|11044062|FG005|COMPLETED|Main Period: Week 0 to Week 56||505
9926558|NCT01272219|11044057|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280
9926559|NCT01272219|11044058|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0
9926560|NCT01272219|11044059|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0
9926561|NCT01272219|11044060|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191
9926562|NCT01272219|11044061|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418
9926563|NCT01272219|11044062|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252
9926564|NCT01272219|11044057|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
9926565|NCT01272219|11044058|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
9926566|NCT01272219|11044059|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
9926567|NCT01272219|11044060|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
9926568|NCT01272219|11044061|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
9926569|NCT01272219|11044062|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
9926570|NCT01272219|11044057|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
9926571|NCT01272219|11044058|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
9926572|NCT01272219|11044059|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
9926573|NCT01272219|11044060|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
9926574|NCT01272219|11044061|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
9926575|NCT01272219|11044062|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
9926576|NCT01272219|11044057|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
9926577|NCT01272219|11044058|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
9926578|NCT01272219|11044059|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
9926579|NCT01272219|11044060|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
9926580|NCT01272219|11044061|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
9926581|NCT01272219|11044062|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
9926582|NCT01272219|11044057|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
9926583|NCT01272219|11044058|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
9926584|NCT01272219|11044059|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
9926585|NCT01272219|11044060|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
9926586|NCT01272219|11044061|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
9926587|NCT01272219|11044062|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
9926588|NCT01272219|11044057|FG000|Exposed|Main + Extension Period: Week 0-172||0
9926589|NCT01272219|11044058|FG001|Exposed|Main + Extension Period: Week 0-172||0
9926590|NCT01272219|11044059|FG002|Exposed|Main + Extension Period: Week 0-172||0
9926591|NCT01272219|11044060|FG003|Exposed|Main + Extension Period: Week 0-172||0
9926592|NCT01272219|11044061|FG004|Exposed|Main + Extension Period: Week 0-172||1501
9926593|NCT01272219|11044062|FG005|Exposed|Main + Extension Period: Week 0-172||747
9926594|NCT01272219|11044057|FG000|COMPLETED|Main + Extension Period: Week 0-172||0
9926595|NCT01272219|11044058|FG001|COMPLETED|Main + Extension Period: Week 0-172||0
9926596|NCT01272219|11044059|FG002|COMPLETED|Main + Extension Period: Week 0-172||0
9926597|NCT01272219|11044060|FG003|COMPLETED|Main + Extension Period: Week 0-172||0
9926598|NCT01272219|11044061|FG004|COMPLETED|Main + Extension Period: Week 0-172||783
9926599|NCT01272219|11044062|FG005|COMPLETED|Main + Extension Period: Week 0-172||327
10205401|NCT03491891|11332209|FG000|STARTED|Overall Study||6038
9926600|NCT01272219|11044057|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0
9926601|NCT01272219|11044058|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0
9926602|NCT01272219|11044059|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0
9926603|NCT01272219|11044060|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0
9926604|NCT01272219|11044061|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722
9926605|NCT01272219|11044062|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422
9926606|NCT01272232|11044078|FG000|STARTED|Weeks 0-56||423
9926607|NCT01272232|11044079|FG001|STARTED|Weeks 0-56||211
9926608|NCT01272232|11044080|FG002|STARTED|Weeks 0-56||212
9926609|NCT01272232|11044078|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
9926610|NCT01272232|11044079|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
9926611|NCT01272232|11044080|FG002|Exposed|Weeks 0-56||212
9926612|NCT01272232|11044078|FG000|COMPLETED|Weeks 0-56||324
9926613|NCT01272232|11044079|FG001|COMPLETED|Weeks 0-56||164
9926614|NCT01272232|11044080|FG002|COMPLETED|Weeks 0-56||140
10205402|NCT03491891|11332210|FG001|STARTED|Overall Study||2438
10205403|NCT03491891|11332209|FG000|COMPLETED|Overall Study||5185
10205404|NCT03491891|11332210|FG001|COMPLETED|Overall Study||2058
10205405|NCT03491891|11332209|FG000|NOT COMPLETED|Overall Study||853
10205406|NCT03491891|11332210|FG001|NOT COMPLETED|Overall Study||380
10205407|NCT03491917|11332216|FG000|STARTED|First Reading Session||50
10205408|NCT03491917|11332217|FG001|STARTED|First Reading Session||50
10205409|NCT03491917|11332216|FG000|COMPLETED|First Reading Session||50
9926615|NCT01272232|11044078|FG000|NOT COMPLETED|Weeks 0-56||99
9926616|NCT01272232|11044079|FG001|NOT COMPLETED|Weeks 0-56||47
9926617|NCT01272232|11044080|FG002|NOT COMPLETED|Weeks 0-56||72
9926618|NCT01272232|11044078|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
9926619|NCT01272232|11044079|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
9926620|NCT01272232|11044080|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
9926621|NCT01272232|11044078|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
9926622|NCT01272232|11044079|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
9926623|NCT01272232|11044080|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
9926624|NCT01272232|11044078|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
9926625|NCT01272232|11044079|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
9926626|NCT01272232|11044080|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
9926627|NCT01272245|11044088|FG000|STARTED|Overall Study||36
9926628|NCT01272245|11044088|FG000|COMPLETED|Overall Study||36
9926629|NCT01272245|11044088|FG000|NOT COMPLETED|Overall Study||0
9926630|NCT01272284|11044092|FG000|STARTED|3-month Follow-up Visit||113
9926631|NCT01272284|11044092|FG000|COMPLETED|3-month Follow-up Visit||112
9926632|NCT01272284|11044092|FG000|NOT COMPLETED|3-month Follow-up Visit||1
9926633|NCT01272284|11044092|FG000|STARTED|6-month Follow-up Visit||112
9926634|NCT01272284|11044092|FG000|COMPLETED|6-month Follow-up Visit||109
9926635|NCT01272284|11044092|FG000|NOT COMPLETED|6-month Follow-up Visit||3
9926636|NCT01272284|11044092|FG000|STARTED|12-month Follow-up Visit||109
9926637|NCT01272284|11044092|FG000|COMPLETED|12-month Follow-up Visit||105
9926638|NCT01272284|11044092|FG000|NOT COMPLETED|12-month Follow-up Visit||4
9926639|NCT01272388|11044099|FG000|STARTED|Overall Study||1
9926640|NCT01272388|11044100|FG001|STARTED|Overall Study||0
9926641|NCT01272388|11044099|FG000|COMPLETED|Overall Study||1
9926642|NCT01272388|11044100|FG001|COMPLETED|Overall Study||0
9926643|NCT01272388|11044099|FG000|NOT COMPLETED|Overall Study||0
9926644|NCT01272388|11044100|FG001|NOT COMPLETED|Overall Study||0
9926645|NCT01272583|11044108|FG000|STARTED|Overall Study||8
9926646|NCT01272583|11044109|FG001|STARTED|Overall Study||8
9926647|NCT01272583|11044108|FG000|COMPLETED|Overall Study||8
9926648|NCT01272583|11044109|FG001|COMPLETED|Overall Study||8
9926649|NCT01272583|11044108|FG000|NOT COMPLETED|Overall Study||0
9926650|NCT01272583|11044109|FG001|NOT COMPLETED|Overall Study||0
10205410|NCT03491917|11332217|FG001|COMPLETED|First Reading Session||50
10205411|NCT03491917|11332216|FG000|NOT COMPLETED|First Reading Session||0
9956095|NCT01442181|11075190|FG001|NOT COMPLETED|Overall Study||3
9956096|NCT01442376|11075200|FG000|STARTED|Overall Study|Randomized patients|169
9956097|NCT01442376|11075201|FG001|STARTED|Overall Study|Randomized patients|169
9956098|NCT01442376|11075202|FG002|STARTED|Overall Study|Randomized patients|164
9956099|NCT01442376|11075200|FG000|COMPLETED|Overall Study||166
9956100|NCT01442376|11075201|FG001|COMPLETED|Overall Study||160
9956101|NCT01442376|11075202|FG002|COMPLETED|Overall Study||159
9956102|NCT01442376|11075200|FG000|NOT COMPLETED|Overall Study||3
9956103|NCT01442376|11075201|FG001|NOT COMPLETED|Overall Study||9
9956104|NCT01442376|11075202|FG002|NOT COMPLETED|Overall Study||5
9956105|NCT01442493|11075212|FG000|STARTED|Overall Study||149
9956106|NCT01442493|11075213|FG001|STARTED|Overall Study||151
9956107|NCT01442493|11075212|FG000|COMPLETED|Overall Study||146
9956108|NCT01442493|11075213|FG001|COMPLETED|Overall Study||149
9956109|NCT01442493|11075212|FG000|NOT COMPLETED|Overall Study||3
9956110|NCT01442493|11075213|FG001|NOT COMPLETED|Overall Study||2
9956111|NCT01442675|11075219|FG000|STARTED|Overall Study||834
9956112|NCT01442675|11075219|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
9956113|NCT01442675|11075219|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
9956114|NCT01442675|11075219|FG000|COMPLETED|Overall Study||822
10205412|NCT03491917|11332217|FG001|NOT COMPLETED|First Reading Session||0
10205413|NCT03491917|11332216|FG000|STARTED|4 Week Memory Washout Period||50
9926651|NCT01272635|11044119|FG000|STARTED|Overall Study||153
9926652|NCT01272635|11044120|FG001|STARTED|Overall Study||154
9926653|NCT01272635|11044121|FG002|STARTED|Overall Study||148
9926654|NCT01272635|11044122|FG003|STARTED|Overall Study||152
9926655|NCT01272635|11044119|FG000|COMPLETED|Overall Study||122
9926656|NCT01272635|11044120|FG001|COMPLETED|Overall Study||134
9926657|NCT01272635|11044121|FG002|COMPLETED|Overall Study||117
9926658|NCT01272635|11044122|FG003|COMPLETED|Overall Study||129
9926659|NCT01272635|11044119|FG000|NOT COMPLETED|Overall Study||31
9926660|NCT01272635|11044120|FG001|NOT COMPLETED|Overall Study||20
9926661|NCT01272635|11044121|FG002|NOT COMPLETED|Overall Study||31
9926662|NCT01272635|11044122|FG003|NOT COMPLETED|Overall Study||23
9926663|NCT01272661|11044133|FG000|STARTED|Overall Study||413
9926664|NCT01272661|11044134|FG001|STARTED|Overall Study||497
9926665|NCT01272661|11044135|FG002|STARTED|Overall Study||386
9926666|NCT01272661|11044133|FG000|COMPLETED|Overall Study||287
9926667|NCT01272661|11044134|FG001|COMPLETED|Overall Study||288
9926668|NCT01272661|11044135|FG002|COMPLETED|Overall Study||314
9926669|NCT01272661|11044133|FG000|NOT COMPLETED|Overall Study||126
9926670|NCT01272661|11044134|FG001|NOT COMPLETED|Overall Study||209
9926671|NCT01272661|11044135|FG002|NOT COMPLETED|Overall Study||72
9926672|NCT01272804|11044149|FG000|STARTED|Overall Study||9
9926673|NCT01272804|11044150|FG001|STARTED|Overall Study||9
9926674|NCT01272804|11044151|FG002|STARTED|Overall Study||9
9926675|NCT01272804|11044152|FG003|STARTED|Overall Study||9
9926676|NCT01272804|11044153|FG004|STARTED|Overall Study||9
9926677|NCT01272804|11044154|FG005|STARTED|Overall Study||16
9926678|NCT01272804|11044149|FG000|COMPLETED|Overall Study||8
9926679|NCT01272804|11044150|FG001|COMPLETED|Overall Study||9
9926680|NCT01272804|11044151|FG002|COMPLETED|Overall Study||9
9926681|NCT01272804|11044152|FG003|COMPLETED|Overall Study||9
9926682|NCT01272804|11044153|FG004|COMPLETED|Overall Study||7
9926683|NCT01272804|11044154|FG005|COMPLETED|Overall Study||15
9926684|NCT01272804|11044149|FG000|NOT COMPLETED|Overall Study||1
9926685|NCT01272804|11044150|FG001|NOT COMPLETED|Overall Study||0
9926686|NCT01272804|11044151|FG002|NOT COMPLETED|Overall Study||0
9926687|NCT01272804|11044152|FG003|NOT COMPLETED|Overall Study||0
9926688|NCT01272804|11044153|FG004|NOT COMPLETED|Overall Study||2
9926689|NCT01272804|11044154|FG005|NOT COMPLETED|Overall Study||1
9926690|NCT01272830|11044170|FG000|STARTED|Overall Study||25
9926691|NCT01272830|11044171|FG001|STARTED|Overall Study||26
9926692|NCT01272830|11044170|FG000|COMPLETED|Overall Study||17
9926693|NCT01272830|11044171|FG001|COMPLETED|Overall Study||21
9926694|NCT01272830|11044170|FG000|NOT COMPLETED|Overall Study||8
9926695|NCT01272830|11044171|FG001|NOT COMPLETED|Overall Study||5
9926696|NCT01272869|11044179|FG000|STARTED|Period 1 (14 Days)||10
10010747|NCT01775189|11133363|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10010748|NCT01775189|11133364|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
9926697|NCT01272869|11044180|FG001|STARTED|Period 1 (14 Days)||10
9926698|NCT01272869|11044179|FG000|COMPLETED|Period 1 (14 Days)||10
9926699|NCT01272869|11044180|FG001|COMPLETED|Period 1 (14 Days)||10
9926700|NCT01272869|11044179|FG000|NOT COMPLETED|Period 1 (14 Days)||0
9926701|NCT01272869|11044180|FG001|NOT COMPLETED|Period 1 (14 Days)||0
9926702|NCT01272869|11044179|FG000|STARTED|Period 2 (14 Days)||10
9926703|NCT01272869|11044180|FG001|STARTED|Period 2 (14 Days)||10
9926704|NCT01272869|11044179|FG000|COMPLETED|Period 2 (14 Days)||9
9926705|NCT01272869|11044180|FG001|COMPLETED|Period 2 (14 Days)||10
9926706|NCT01272869|11044179|FG000|NOT COMPLETED|Period 2 (14 Days)||1
9926707|NCT01272869|11044180|FG001|NOT COMPLETED|Period 2 (14 Days)||0
9926708|NCT01272882|11044186|FG000|STARTED|Overall Study||13
9926709|NCT01272882|11044186|FG000|COMPLETED|Overall Study||13
9926710|NCT01272882|11044186|FG000|NOT COMPLETED|Overall Study||0
9926711|NCT01272908|11044190|FG000|STARTED|Initial Treatment Period||120
9926712|NCT01272908|11044190|FG000|COMPLETED|Initial Treatment Period||112
9926713|NCT01272908|11044190|FG000|NOT COMPLETED|Initial Treatment Period||8
9926714|NCT01272908|11044190|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
9926715|NCT01272908|11044190|FG000|COMPLETED|Re-Treatment Period||71
9926716|NCT01272908|11044190|FG000|NOT COMPLETED|Re-Treatment Period||6
9926717|NCT01272921|11044198|FG000|STARTED|Overall Study||71
9926718|NCT01272921|11044199|FG001|STARTED|Overall Study||71
9926719|NCT01272921|11044198|FG000|COMPLETED|Overall Study||69
9926720|NCT01272921|11044199|FG001|COMPLETED|Overall Study||70
9926721|NCT01272921|11044198|FG000|NOT COMPLETED|Overall Study||2
9926722|NCT01272921|11044199|FG001|NOT COMPLETED|Overall Study||1
9926723|NCT01272934|11044209|FG000|STARTED|Overall Study||102
9926724|NCT01272934|11044210|FG001|STARTED|Overall Study||103
9926725|NCT01272934|11044209|FG000|COMPLETED|Overall Study||102
9926726|NCT01272934|11044210|FG001|COMPLETED|Overall Study||101
10010749|NCT01775189|11133365|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10010750|NCT01775189|11133366|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
9926727|NCT01272934|11044209|FG000|NOT COMPLETED|Overall Study||0
9926728|NCT01272934|11044210|FG001|NOT COMPLETED|Overall Study||2
9926729|NCT01272947|11044219|FG000|STARTED|Overall Study||104
9926730|NCT01272947|11044220|FG001|STARTED|Overall Study||100
9926731|NCT01272947|11044219|FG000|COMPLETED|Overall Study||102
9926732|NCT01272947|11044220|FG001|COMPLETED|Overall Study||98
9926733|NCT01272947|11044219|FG000|NOT COMPLETED|Overall Study||2
9926734|NCT01272947|11044220|FG001|NOT COMPLETED|Overall Study||2
9926735|NCT01272960|11044228|FG000|STARTED|Overall Study||14
9926736|NCT01272960|11044229|FG001|STARTED|Overall Study||15
9926737|NCT01272960|11044228|FG000|COMPLETED|Overall Study||14
9926738|NCT01272960|11044229|FG001|COMPLETED|Overall Study||15
9926739|NCT01272960|11044228|FG000|NOT COMPLETED|Overall Study||0
9926740|NCT01272960|11044229|FG001|NOT COMPLETED|Overall Study||0
9926741|NCT01272999|11044240|FG000|STARTED|Overall Study||357
9926742|NCT01272999|11044241|FG001|STARTED|Overall Study||34
9926743|NCT01272999|11044240|FG000|COMPLETED|Overall Study||357
9926744|NCT01272999|11044241|FG001|COMPLETED|Overall Study||34
9926745|NCT01272999|11044240|FG000|NOT COMPLETED|Overall Study||0
9926746|NCT01272999|11044241|FG001|NOT COMPLETED|Overall Study||0
9926747|NCT01273038|11044249|FG000|STARTED|First Intervention (14 Days)||10
9926748|NCT01273038|11044250|FG001|STARTED|First Intervention (14 Days)||10
9926749|NCT01273038|11044249|FG000|COMPLETED|First Intervention (14 Days)||10
9926750|NCT01273038|11044250|FG001|COMPLETED|First Intervention (14 Days)||10
9926751|NCT01273038|11044249|FG000|NOT COMPLETED|First Intervention (14 Days)||0
9926752|NCT01273038|11044250|FG001|NOT COMPLETED|First Intervention (14 Days)||0
9926753|NCT01273038|11044249|FG000|STARTED|Second Intervention (14 Days)||10
9926754|NCT01273038|11044250|FG001|STARTED|Second Intervention (14 Days)||10
9926755|NCT01273038|11044249|FG000|COMPLETED|Second Intervention (14 Days)||10
9926756|NCT01273038|11044250|FG001|COMPLETED|Second Intervention (14 Days)||8
9926757|NCT01273038|11044249|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
9926758|NCT01273038|11044250|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
9926759|NCT01273155|11044260|FG000|STARTED|Overall Study||14
9926760|NCT01273155|11044261|FG001|STARTED|Overall Study||12
9926761|NCT01273155|11044262|FG002|STARTED|Overall Study||18
9926762|NCT01273155|11044263|FG003|STARTED|Overall Study||5
9926763|NCT01273155|11044264|FG004|STARTED|Overall Study||5
9926764|NCT01273155|11044265|FG005|STARTED|Overall Study||10
9926765|NCT01273155|11044266|FG006|STARTED|Overall Study||8
9926766|NCT01273155|11044260|FG000|COMPLETED|Overall Study||12
9926767|NCT01273155|11044261|FG001|COMPLETED|Overall Study||8
9926768|NCT01273155|11044262|FG002|COMPLETED|Overall Study||6
9926769|NCT01273155|11044263|FG003|COMPLETED|Overall Study||4
9926770|NCT01273155|11044264|FG004|COMPLETED|Overall Study||3
9926771|NCT01273155|11044265|FG005|COMPLETED|Overall Study||5
9926772|NCT01273155|11044266|FG006|COMPLETED|Overall Study||2
9926773|NCT01273155|11044260|FG000|NOT COMPLETED|Overall Study||2
9926774|NCT01273155|11044261|FG001|NOT COMPLETED|Overall Study||4
9926775|NCT01273155|11044262|FG002|NOT COMPLETED|Overall Study||12
9926776|NCT01273155|11044263|FG003|NOT COMPLETED|Overall Study||1
9926777|NCT01273155|11044264|FG004|NOT COMPLETED|Overall Study||2
9926778|NCT01273155|11044265|FG005|NOT COMPLETED|Overall Study||5
9926779|NCT01273155|11044266|FG006|NOT COMPLETED|Overall Study||6
9926780|NCT01273181|11044293|FG000|STARTED|Phase I, Dose 1||3
9926781|NCT01273181|11044294|FG001|STARTED|Phase I, Dose 1||0
9926782|NCT01273181|11044295|FG002|STARTED|Phase I, Dose 1||0
9926783|NCT01273181|11044296|FG003|STARTED|Phase I, Dose 1||0
9926784|NCT01273181|11044293|FG000|COMPLETED|Phase I, Dose 1||2
9926785|NCT01273181|11044294|FG001|COMPLETED|Phase I, Dose 1||0
9926786|NCT01273181|11044295|FG002|COMPLETED|Phase I, Dose 1||0
9926787|NCT01273181|11044296|FG003|COMPLETED|Phase I, Dose 1||0
9926788|NCT01273181|11044293|FG000|NOT COMPLETED|Phase I, Dose 1||1
9926789|NCT01273181|11044294|FG001|NOT COMPLETED|Phase I, Dose 1||0
9926790|NCT01273181|11044295|FG002|NOT COMPLETED|Phase I, Dose 1||0
9926791|NCT01273181|11044296|FG003|NOT COMPLETED|Phase I, Dose 1||0
9926792|NCT01273181|11044293|FG000|STARTED|Phase I, Dose 2||0
9926793|NCT01273181|11044294|FG001|STARTED|Phase I, Dose 2||3
9926794|NCT01273181|11044295|FG002|STARTED|Phase I, Dose 2||0
9926795|NCT01273181|11044296|FG003|STARTED|Phase I, Dose 2||0
9926796|NCT01273181|11044293|FG000|COMPLETED|Phase I, Dose 2||0
9926797|NCT01273181|11044294|FG001|COMPLETED|Phase I, Dose 2||2
9926798|NCT01273181|11044295|FG002|COMPLETED|Phase I, Dose 2||0
9926799|NCT01273181|11044296|FG003|COMPLETED|Phase I, Dose 2||0
9926800|NCT01273181|11044293|FG000|NOT COMPLETED|Phase I, Dose 2||0
9926801|NCT01273181|11044294|FG001|NOT COMPLETED|Phase I, Dose 2||1
9926802|NCT01273181|11044295|FG002|NOT COMPLETED|Phase I, Dose 2||0
9926803|NCT01273181|11044296|FG003|NOT COMPLETED|Phase I, Dose 2||0
9926804|NCT01273181|11044293|FG000|STARTED|Phase 2, Dose 1||0
9926805|NCT01273181|11044294|FG001|STARTED|Phase 2, Dose 1||0
9926806|NCT01273181|11044295|FG002|STARTED|Phase 2, Dose 1||2
9926807|NCT01273181|11044296|FG003|STARTED|Phase 2, Dose 1||0
9926808|NCT01273181|11044293|FG000|COMPLETED|Phase 2, Dose 1||0
9926809|NCT01273181|11044294|FG001|COMPLETED|Phase 2, Dose 1||0
9926810|NCT01273181|11044295|FG002|COMPLETED|Phase 2, Dose 1||1
9926811|NCT01273181|11044296|FG003|COMPLETED|Phase 2, Dose 1||0
9926812|NCT01273181|11044293|FG000|NOT COMPLETED|Phase 2, Dose 1||0
9926813|NCT01273181|11044294|FG001|NOT COMPLETED|Phase 2, Dose 1||0
9926814|NCT01273181|11044295|FG002|NOT COMPLETED|Phase 2, Dose 1||1
9926815|NCT01273181|11044296|FG003|NOT COMPLETED|Phase 2, Dose 1||0
9926816|NCT01273181|11044293|FG000|STARTED|Phase 2, Dose 2||0
9926817|NCT01273181|11044294|FG001|STARTED|Phase 2, Dose 2||0
9926818|NCT01273181|11044295|FG002|STARTED|Phase 2, Dose 2||0
9926819|NCT01273181|11044296|FG003|STARTED|Phase 2, Dose 2||1
9926820|NCT01273181|11044293|FG000|COMPLETED|Phase 2, Dose 2||0
9926821|NCT01273181|11044294|FG001|COMPLETED|Phase 2, Dose 2||0
9926822|NCT01273181|11044295|FG002|COMPLETED|Phase 2, Dose 2||0
9926823|NCT01273181|11044296|FG003|COMPLETED|Phase 2, Dose 2||0
9926824|NCT01273181|11044293|FG000|NOT COMPLETED|Phase 2, Dose 2||0
9926825|NCT01273181|11044294|FG001|NOT COMPLETED|Phase 2, Dose 2||0
9926826|NCT01273181|11044295|FG002|NOT COMPLETED|Phase 2, Dose 2||0
9926827|NCT01273181|11044296|FG003|NOT COMPLETED|Phase 2, Dose 2||1
10111440|NCT02496221|11242521|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0
10010751|NCT01775371|11133396|FG000|STARTED|Overall Study||306
10010752|NCT01775371|11133397|FG001|STARTED|Overall Study||330
10010753|NCT01775371|11133396|FG000|COMPLETED|Overall Study||306
10111441|NCT02496221|11242522|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0
10111442|NCT02496221|11242521|FG000|STARTED|Treatment Period 2 - 4 Days||10
10111443|NCT02496221|11242522|FG001|STARTED|Treatment Period 2 - 4 Days||10
10111444|NCT02496221|11242521|FG000|COMPLETED|Treatment Period 2 - 4 Days||8
9926828|NCT01273207|11044310|FG000|STARTED|Overall Study||7
9926829|NCT01273207|11044310|FG000|COMPLETED|Overall Study||2
10205414|NCT03491917|11332217|FG001|STARTED|4 Week Memory Washout Period||50
10205415|NCT03491917|11332216|FG000|COMPLETED|4 Week Memory Washout Period||50
10205416|NCT03491917|11332217|FG001|COMPLETED|4 Week Memory Washout Period||50
10205417|NCT03491917|11332216|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10205418|NCT03491917|11332217|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
9926830|NCT01273207|11044310|FG000|NOT COMPLETED|Overall Study||5
9926831|NCT01273519|11044317|FG000|STARTED|Overall Study||78
9926832|NCT01273519|11044318|FG001|STARTED|Overall Study||30
9926833|NCT01273519|11044319|FG002|STARTED|Overall Study||47
9926834|NCT01273519|11044317|FG000|COMPLETED|Overall Study||59
9926835|NCT01273519|11044318|FG001|COMPLETED|Overall Study||25
9926836|NCT01273519|11044319|FG002|COMPLETED|Overall Study||39
9926837|NCT01273519|11044317|FG000|NOT COMPLETED|Overall Study||19
9926838|NCT01273519|11044318|FG001|NOT COMPLETED|Overall Study||5
9926839|NCT01273519|11044319|FG002|NOT COMPLETED|Overall Study||8
9926840|NCT01273597|11044330|FG000|STARTED|Overall Study||60
9926841|NCT01273597|11044330|FG000|COMPLETED|Overall Study||52
10010754|NCT01775371|11133397|FG001|COMPLETED|Overall Study||330
10010755|NCT01775371|11133396|FG000|NOT COMPLETED|Overall Study||0
10010756|NCT01775371|11133397|FG001|NOT COMPLETED|Overall Study||0
10010757|NCT01775410|11133405|FG000|STARTED|Overall Study||4
10010758|NCT01775410|11133405|FG000|COMPLETED|Overall Study||4
10010759|NCT01775410|11133405|FG000|NOT COMPLETED|Overall Study||0
10010760|NCT01775501|11133409|FG000|STARTED|Overall Study||40
10010761|NCT01775501|11133409|FG000|COMPLETED|Overall Study||39
10010762|NCT01775501|11133409|FG000|NOT COMPLETED|Overall Study||1
10010763|NCT01775553|11133413|FG000|STARTED|Overall Study||13
10010764|NCT01775553|11133413|FG000|COMPLETED|Overall Study||0
10010765|NCT01775553|11133413|FG000|NOT COMPLETED|Overall Study||13
10010766|NCT01775670|11133419|FG000|STARTED|Overall Study||1
10010767|NCT01775670|11133420|FG001|STARTED|Overall Study||3
10010768|NCT01775670|11133419|FG000|COMPLETED|Overall Study||0
10010769|NCT01775670|11133420|FG001|COMPLETED|Overall Study||2
10010770|NCT01775670|11133419|FG000|NOT COMPLETED|Overall Study||1
10010771|NCT01775670|11133420|FG001|NOT COMPLETED|Overall Study||1
10010772|NCT01775722|11133426|FG000|STARTED|Overall Study||22
10010773|NCT01775722|11133426|FG000|COMPLETED|Overall Study||20
10010774|NCT01775722|11133426|FG000|NOT COMPLETED|Overall Study||2
10010775|NCT01775735|11133434|FG000|STARTED|Intervention (6 Months)||8
10010776|NCT01775735|11133435|FG001|STARTED|Intervention (6 Months)||7
10010777|NCT01775735|11133434|FG000|COMPLETED|Intervention (6 Months)||8
10010778|NCT01775735|11133435|FG001|COMPLETED|Intervention (6 Months)||7
10010779|NCT01775735|11133434|FG000|NOT COMPLETED|Intervention (6 Months)||0
10010780|NCT01775735|11133435|FG001|NOT COMPLETED|Intervention (6 Months)||0
10010781|NCT01775735|11133434|FG000|STARTED|Open Label (24 Months)||8
10010782|NCT01775735|11133435|FG001|STARTED|Open Label (24 Months)||7
10010783|NCT01775735|11133434|FG000|COMPLETED|Open Label (24 Months)||7
10010784|NCT01775735|11133435|FG001|COMPLETED|Open Label (24 Months)||3
10010785|NCT01775735|11133434|FG000|NOT COMPLETED|Open Label (24 Months)||1
10010786|NCT01775735|11133435|FG001|NOT COMPLETED|Open Label (24 Months)||4
10010787|NCT01775774|11133444|FG000|STARTED|Overall Study||3
10010788|NCT01775774|11133445|FG001|STARTED|Overall Study||3
10010789|NCT01775774|11133446|FG002|STARTED|Overall Study||3
10010790|NCT01775774|11133444|FG000|COMPLETED|Overall Study||3
10010791|NCT01775774|11133445|FG001|COMPLETED|Overall Study||3
10010792|NCT01775774|11133446|FG002|COMPLETED|Overall Study||3
10010793|NCT01775774|11133444|FG000|NOT COMPLETED|Overall Study||0
10010794|NCT01775774|11133445|FG001|NOT COMPLETED|Overall Study||0
10111445|NCT02496221|11242522|FG001|COMPLETED|Treatment Period 2 - 4 Days||9
10111446|NCT02496221|11242521|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2
10111447|NCT02496221|11242522|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1
10111448|NCT02496533|11242532|FG000|STARTED|Overall Study||105
10111449|NCT02496533|11242533|FG001|STARTED|Overall Study||112
10111450|NCT02496533|11242532|FG000|COMPLETED|Overall Study||102
10111451|NCT02496533|11242533|FG001|COMPLETED|Overall Study||106
10111452|NCT02496533|11242532|FG000|NOT COMPLETED|Overall Study||3
10111453|NCT02496533|11242533|FG001|NOT COMPLETED|Overall Study||6
10010795|NCT01775774|11133446|FG002|NOT COMPLETED|Overall Study||0
10010796|NCT01775787|11133454|FG000|STARTED|First 7-10 Days||13
10111454|NCT02496702|11242541|FG000|STARTED|Overall Study||30
10111455|NCT02496702|11242542|FG001|STARTED|Overall Study||30
9926842|NCT01273597|11044330|FG000|NOT COMPLETED|Overall Study||8
9926843|NCT01273623|11044334|FG000|STARTED|Overall Study|met angiographic criteria|55
9926844|NCT01273623|11044334|FG000|COMPLETED|Overall Study|met IVUS criteria|26
9926845|NCT01273623|11044334|FG000|NOT COMPLETED|Overall Study||29
10010797|NCT01775787|11133455|FG001|STARTED|First 7-10 Days||14
10010798|NCT01775787|11133454|FG000|COMPLETED|First 7-10 Days||12
10010799|NCT01775787|11133455|FG001|COMPLETED|First 7-10 Days||8
10111456|NCT02496702|11242541|FG000|Received Allocated Intervention|Overall Study||21
9926846|NCT01273766|11044343|FG000|STARTED|Overall Study||4
9926847|NCT01273766|11044344|FG001|STARTED|Overall Study||7
9926848|NCT01273766|11044345|FG002|STARTED|Overall Study||5
9926849|NCT01273766|11044343|FG000|COMPLETED|Overall Study||4
9926850|NCT01273766|11044344|FG001|COMPLETED|Overall Study||7
9926851|NCT01273766|11044345|FG002|COMPLETED|Overall Study||5
9926852|NCT01273766|11044343|FG000|NOT COMPLETED|Overall Study||0
9926853|NCT01273766|11044344|FG001|NOT COMPLETED|Overall Study||0
9926854|NCT01273766|11044345|FG002|NOT COMPLETED|Overall Study||0
9926855|NCT01273805|11044354|FG000|STARTED|Overall Study||10
9926856|NCT01273805|11044355|FG001|STARTED|Overall Study||10
9926857|NCT01273805|11044354|FG000|COMPLETED|Overall Study||0
9926858|NCT01273805|11044355|FG001|COMPLETED|Overall Study||0
9926859|NCT01273805|11044354|FG000|NOT COMPLETED|Overall Study||10
9926860|NCT01273805|11044355|FG001|NOT COMPLETED|Overall Study||10
9926861|NCT01273818|11044364|FG000|STARTED|Overall Study||100
9926862|NCT01273818|11044365|FG001|STARTED|Overall Study||100
9926863|NCT01273818|11044366|FG002|STARTED|Overall Study||100
9926864|NCT01273818|11044364|FG000|COMPLETED|Overall Study||87
9926865|NCT01273818|11044365|FG001|COMPLETED|Overall Study||98
9926866|NCT01273818|11044366|FG002|COMPLETED|Overall Study||91
9926867|NCT01273818|11044364|FG000|NOT COMPLETED|Overall Study||13
9926868|NCT01273818|11044365|FG001|NOT COMPLETED|Overall Study||2
9926869|NCT01273818|11044366|FG002|NOT COMPLETED|Overall Study||9
10205419|NCT03491917|11332216|FG000|STARTED|Second Reading Session||50
10205420|NCT03491917|11332217|FG001|STARTED|Second Reading Session||50
10205421|NCT03491917|11332216|FG000|COMPLETED|Second Reading Session||50
10205422|NCT03491917|11332217|FG001|COMPLETED|Second Reading Session||50
10205423|NCT03491917|11332216|FG000|NOT COMPLETED|Second Reading Session||0
10205424|NCT03491917|11332217|FG001|NOT COMPLETED|Second Reading Session||0
9926870|NCT01273857|11044376|FG000|STARTED|Overall Study||7
9926871|NCT01273857|11044377|FG001|STARTED|Overall Study||7
9926872|NCT01273857|11044376|FG000|COMPLETED|Overall Study||7
9926873|NCT01273857|11044377|FG001|COMPLETED|Overall Study||7
9926874|NCT01273857|11044376|FG000|NOT COMPLETED|Overall Study||0
9926875|NCT01273857|11044377|FG001|NOT COMPLETED|Overall Study||0
9926876|NCT01273883|11044383|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19
9926877|NCT01273883|11044384|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19
9926878|NCT01273883|11044383|FG000|COMPLETED|First Intervention||17
9926879|NCT01273883|11044384|FG001|COMPLETED|First Intervention||18
9926880|NCT01273883|11044383|FG000|NOT COMPLETED|First Intervention||2
9926881|NCT01273883|11044384|FG001|NOT COMPLETED|First Intervention||1
9926882|NCT01273883|11044383|FG000|STARTED|Washout Period of 2 Weeks||17
9926883|NCT01273883|11044384|FG001|STARTED|Washout Period of 2 Weeks||18
9926884|NCT01273883|11044383|FG000|COMPLETED|Washout Period of 2 Weeks||17
9926885|NCT01273883|11044384|FG001|COMPLETED|Washout Period of 2 Weeks||18
9926886|NCT01273883|11044383|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9926887|NCT01273883|11044384|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9926888|NCT01273883|11044383|FG000|STARTED|Second Intervention||17
9926889|NCT01273883|11044384|FG001|STARTED|Second Intervention||18
9926890|NCT01273883|11044383|FG000|COMPLETED|Second Intervention||15
9926891|NCT01273883|11044384|FG001|COMPLETED|Second Intervention||17
9926892|NCT01273883|11044383|FG000|NOT COMPLETED|Second Intervention||2
9926893|NCT01273883|11044384|FG001|NOT COMPLETED|Second Intervention||1
9926894|NCT01273896|11044390|FG000|STARTED|Overall Study||22
9926895|NCT01273896|11044390|FG000|COMPLETED|Overall Study||22
9926896|NCT01273896|11044390|FG000|NOT COMPLETED|Overall Study||0
9926897|NCT01274182|11044397|FG000|STARTED|Overall Study||133
9926898|NCT01274182|11044398|FG001|STARTED|Overall Study||87
9926899|NCT01274182|11044399|FG002|STARTED|Overall Study||92
9926900|NCT01274182|11044397|FG000|24 Weeks|Overall Study||123
9926901|NCT01274182|11044398|FG001|24 Weeks|Overall Study||83
9926902|NCT01274182|11044399|FG002|24 Weeks|Overall Study||84
9926903|NCT01274182|11044397|FG000|COMPLETED|Overall Study||112
9926904|NCT01274182|11044398|FG001|COMPLETED|Overall Study||69
9926905|NCT01274182|11044399|FG002|COMPLETED|Overall Study||80
10205425|NCT03492281|11332226|FG000|STARTED|Overall Study||540
9926906|NCT01274182|11044397|FG000|NOT COMPLETED|Overall Study||21
9926907|NCT01274182|11044398|FG001|NOT COMPLETED|Overall Study||18
9926908|NCT01274182|11044399|FG002|NOT COMPLETED|Overall Study||12
9926909|NCT01274338|11044417|FG000|STARTED|Overall Study||511
9926910|NCT01274338|11044418|FG001|STARTED|Overall Study||636
9926911|NCT01274338|11044419|FG002|STARTED|Overall Study||523
9926912|NCT01274338|11044420|FG003|STARTED|Overall Study||1
9926913|NCT01274338|11044421|FG004|STARTED|Overall Study||1
9926914|NCT01274338|11044422|FG005|STARTED|Overall Study||1
9926915|NCT01274338|11044417|FG000|Received Treatment|Overall Study||503
9926916|NCT01274338|11044418|FG001|Received Treatment|Overall Study||520
9926917|NCT01274338|11044419|FG002|Received Treatment|Overall Study||516
9926918|NCT01274338|11044420|FG003|Received Treatment|Overall Study||1
9926919|NCT01274338|11044421|FG004|Received Treatment|Overall Study||1
9926920|NCT01274338|11044422|FG005|Received Treatment|Overall Study||1
9926921|NCT01274338|11044417|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
9926922|NCT01274338|11044418|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
9926923|NCT01274338|11044419|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
10205426|NCT03492281|11332227|FG001|STARTED|Overall Study||547
10205427|NCT03492281|11332228|FG002|STARTED|Overall Study||431
10205428|NCT03492281|11332226|FG000|COMPLETED|Overall Study||486
9926924|NCT01274338|11044420|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
9926925|NCT01274338|11044421|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
9926926|NCT01274338|11044422|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
9926927|NCT01274338|11044417|FG000|Data Available for FACIT-D Analysis|Overall Study||109
9926928|NCT01274338|11044418|FG001|Data Available for FACIT-D Analysis|Overall Study||114
9926929|NCT01274338|11044419|FG002|Data Available for FACIT-D Analysis|Overall Study||97
9926930|NCT01274338|11044420|FG003|Data Available for FACIT-D Analysis|Overall Study||0
9926931|NCT01274338|11044421|FG004|Data Available for FACIT-D Analysis|Overall Study||0
9926932|NCT01274338|11044422|FG005|Data Available for FACIT-D Analysis|Overall Study||0
9926933|NCT01274338|11044417|FG000|COMPLETED|Overall Study||108
9926934|NCT01274338|11044418|FG001|COMPLETED|Overall Study||182
9926935|NCT01274338|11044419|FG002|COMPLETED|Overall Study||198
9926936|NCT01274338|11044420|FG003|COMPLETED|Overall Study||0
9926937|NCT01274338|11044421|FG004|COMPLETED|Overall Study||0
9926938|NCT01274338|11044422|FG005|COMPLETED|Overall Study||1
9926939|NCT01274338|11044417|FG000|NOT COMPLETED|Overall Study||403
9926940|NCT01274338|11044418|FG001|NOT COMPLETED|Overall Study||454
9926941|NCT01274338|11044419|FG002|NOT COMPLETED|Overall Study||325
9926942|NCT01274338|11044420|FG003|NOT COMPLETED|Overall Study||1
9926943|NCT01274338|11044421|FG004|NOT COMPLETED|Overall Study||1
9926944|NCT01274338|11044422|FG005|NOT COMPLETED|Overall Study||0
9926945|NCT01274351|11044435|FG000|STARTED|Overall Study||112
9926946|NCT01274351|11044435|FG000|COMPLETED|Overall Study||92
9926947|NCT01274351|11044435|FG000|NOT COMPLETED|Overall Study||20
9926948|NCT01274520|11044441|FG000|STARTED|Overall Study||25
9926949|NCT01274520|11044442|FG001|STARTED|Overall Study||24
9926950|NCT01274520|11044441|FG000|COMPLETED|Overall Study||25
9926951|NCT01274520|11044442|FG001|COMPLETED|Overall Study||24
9926952|NCT01274520|11044441|FG000|NOT COMPLETED|Overall Study||0
9926953|NCT01274520|11044442|FG001|NOT COMPLETED|Overall Study||0
9926954|NCT01274585|11044453|FG000|STARTED|Overall Study||2
9926955|NCT01274585|11044454|FG001|STARTED|Overall Study||3
9926956|NCT01274585|11044453|FG000|COMPLETED|Overall Study||2
9926957|NCT01274585|11044454|FG001|COMPLETED|Overall Study||3
9926958|NCT01274585|11044453|FG000|NOT COMPLETED|Overall Study||0
9926959|NCT01274585|11044454|FG001|NOT COMPLETED|Overall Study||0
9926960|NCT01274637|11044462|FG000|STARTED|Overall Study||30
9926961|NCT01274637|11044463|FG001|STARTED|Overall Study||32
9926962|NCT01274637|11044462|FG000|COMPLETED|Overall Study||30
9926963|NCT01274637|11044463|FG001|COMPLETED|Overall Study||30
9926964|NCT01274637|11044462|FG000|NOT COMPLETED|Overall Study||0
9926965|NCT01274637|11044463|FG001|NOT COMPLETED|Overall Study||2
9926966|NCT01274715|11044469|FG000|STARTED|Overall Study||12
9926967|NCT01274715|11044469|FG000|Screened Out at Baseline|Overall Study||3
9926968|NCT01274715|11044469|FG000|COMPLETED|Overall Study||8
9926969|NCT01274715|11044469|FG000|NOT COMPLETED|Overall Study||4
9926970|NCT01274897|11044475|FG000|STARTED|Overall Study||297
9926971|NCT01274897|11044476|FG001|STARTED|Overall Study||153
9926972|NCT01274897|11044475|FG000|COMPLETED|Overall Study||297
9926973|NCT01274897|11044476|FG001|COMPLETED|Overall Study||153
9926974|NCT01274897|11044475|FG000|NOT COMPLETED|Overall Study||0
9926975|NCT01274897|11044476|FG001|NOT COMPLETED|Overall Study||0
9926976|NCT01275053|11044482|FG000|STARTED|Overall Study||12
9926977|NCT01275053|11044482|FG000|COMPLETED|Overall Study||12
9926978|NCT01275053|11044482|FG000|NOT COMPLETED|Overall Study||0
9926979|NCT01275066|11044489|FG000|STARTED|Overall Study||60
9926980|NCT01275066|11044490|FG001|STARTED|Overall Study||59
9926981|NCT01275066|11044491|FG002|STARTED|Overall Study||58
9926982|NCT01275066|11044489|FG000|Treated|Overall Study||59
9926983|NCT01275066|11044490|FG001|Treated|Overall Study||59
9926984|NCT01275066|11044491|FG002|Treated|Overall Study||58
9926985|NCT01275066|11044489|FG000|COMPLETED|Overall Study||59
9926986|NCT01275066|11044490|FG001|COMPLETED|Overall Study||59
9926987|NCT01275066|11044491|FG002|COMPLETED|Overall Study||57
9926988|NCT01275066|11044489|FG000|NOT COMPLETED|Overall Study||1
9926989|NCT01275066|11044490|FG001|NOT COMPLETED|Overall Study||0
9926990|NCT01275066|11044491|FG002|NOT COMPLETED|Overall Study||1
9926991|NCT01275092|11044499|FG000|STARTED|Overall Study||164
9926992|NCT01275092|11044499|FG000|COMPLETED|Overall Study||164
9926993|NCT01275092|11044499|FG000|NOT COMPLETED|Overall Study||0
9926994|NCT01275131|11044507|FG000|STARTED|Period 1||11
9926995|NCT01275131|11044508|FG001|STARTED|Period 1||9
9926996|NCT01275131|11044509|FG002|STARTED|Period 1||13
9926997|NCT01275131|11044510|FG003|STARTED|Period 1||12
9926998|NCT01275131|11044507|FG000|Received at Least One Dose of Study Drug|Period 1||11
9926999|NCT01275131|11044508|FG001|Received at Least One Dose of Study Drug|Period 1||9
9927000|NCT01275131|11044509|FG002|Received at Least One Dose of Study Drug|Period 1||13
9927001|NCT01275131|11044510|FG003|Received at Least One Dose of Study Drug|Period 1||12
9927002|NCT01275131|11044507|FG000|COMPLETED|Period 1||9
9927003|NCT01275131|11044508|FG001|COMPLETED|Period 1||9
9927004|NCT01275131|11044509|FG002|COMPLETED|Period 1||10
9927005|NCT01275131|11044510|FG003|COMPLETED|Period 1||10
9927006|NCT01275131|11044507|FG000|NOT COMPLETED|Period 1||2
9927007|NCT01275131|11044508|FG001|NOT COMPLETED|Period 1||0
9927008|NCT01275131|11044509|FG002|NOT COMPLETED|Period 1||3
9927009|NCT01275131|11044510|FG003|NOT COMPLETED|Period 1||2
9927010|NCT01275131|11044507|FG000|STARTED|5- to 14-Day Washout Period||9
9927011|NCT01275131|11044508|FG001|STARTED|5- to 14-Day Washout Period||9
9927012|NCT01275131|11044509|FG002|STARTED|5- to 14-Day Washout Period||10
9927013|NCT01275131|11044510|FG003|STARTED|5- to 14-Day Washout Period||10
9927014|NCT01275131|11044507|FG000|COMPLETED|5- to 14-Day Washout Period||9
9927015|NCT01275131|11044508|FG001|COMPLETED|5- to 14-Day Washout Period||9
9927016|NCT01275131|11044509|FG002|COMPLETED|5- to 14-Day Washout Period||10
9927017|NCT01275131|11044510|FG003|COMPLETED|5- to 14-Day Washout Period||10
9927018|NCT01275131|11044507|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0
9927019|NCT01275131|11044508|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0
9927020|NCT01275131|11044509|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0
9927021|NCT01275131|11044510|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0
9927022|NCT01275131|11044507|FG000|STARTED|Period 2 (Crossover)||9
9927023|NCT01275131|11044508|FG001|STARTED|Period 2 (Crossover)||9
9927024|NCT01275131|11044509|FG002|STARTED|Period 2 (Crossover)||10
9927025|NCT01275131|11044510|FG003|STARTED|Period 2 (Crossover)||10
9927026|NCT01275131|11044507|FG000|COMPLETED|Period 2 (Crossover)||8
9927027|NCT01275131|11044508|FG001|COMPLETED|Period 2 (Crossover)||8
9927028|NCT01275131|11044509|FG002|COMPLETED|Period 2 (Crossover)||9
9927029|NCT01275131|11044510|FG003|COMPLETED|Period 2 (Crossover)||8
9927030|NCT01275131|11044507|FG000|NOT COMPLETED|Period 2 (Crossover)||1
9927031|NCT01275131|11044508|FG001|NOT COMPLETED|Period 2 (Crossover)||1
9927032|NCT01275131|11044509|FG002|NOT COMPLETED|Period 2 (Crossover)||1
9927033|NCT01275131|11044510|FG003|NOT COMPLETED|Period 2 (Crossover)||2
9927034|NCT01275144|11044528|FG000|STARTED|First Intervention (6 Days)||14
9927035|NCT01275144|11044529|FG001|STARTED|First Intervention (6 Days)||14
9927036|NCT01275144|11044528|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
9927037|NCT01275144|11044529|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
9927038|NCT01275144|11044528|FG000|COMPLETED|First Intervention (6 Days)||14
9927039|NCT01275144|11044529|FG001|COMPLETED|First Intervention (6 Days)||14
9927040|NCT01275144|11044528|FG000|NOT COMPLETED|First Intervention (6 Days)||0
9927041|NCT01275144|11044529|FG001|NOT COMPLETED|First Intervention (6 Days)||0
9927042|NCT01275144|11044528|FG000|STARTED|Washout (7 Days)||14
9927043|NCT01275144|11044529|FG001|STARTED|Washout (7 Days)||14
9927044|NCT01275144|11044528|FG000|COMPLETED|Washout (7 Days)||14
9927045|NCT01275144|11044529|FG001|COMPLETED|Washout (7 Days)||14
9927046|NCT01275144|11044528|FG000|NOT COMPLETED|Washout (7 Days)||0
9927047|NCT01275144|11044529|FG001|NOT COMPLETED|Washout (7 Days)||0
9927048|NCT01275144|11044528|FG000|STARTED|Second Intervention (6 Days)||14
9927049|NCT01275144|11044529|FG001|STARTED|Second Intervention (6 Days)||14
9927050|NCT01275144|11044528|FG000|COMPLETED|Second Intervention (6 Days)||13
9927051|NCT01275144|11044529|FG001|COMPLETED|Second Intervention (6 Days)||14
9927052|NCT01275144|11044528|FG000|NOT COMPLETED|Second Intervention (6 Days)||1
9927053|NCT01275144|11044529|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
9927054|NCT01275170|11044545|FG000|STARTED|Part 1: Period 1||7
9927055|NCT01275170|11044546|FG001|STARTED|Part 1: Period 1||6
9927056|NCT01275170|11044547|FG002|STARTED|Part 1: Period 1||6
9927057|NCT01275170|11044548|FG003|STARTED|Part 1: Period 1||6
9927058|NCT01275170|11044549|FG004|STARTED|Part 1: Period 1||6
9927059|NCT01275170|11044550|FG005|STARTED|Part 1: Period 1||6
9927060|NCT01275170|11044551|FG006|STARTED|Part 1: Period 1||6
9927061|NCT01275170|11044552|FG007|STARTED|Part 1: Period 1||6
9927062|NCT01275170|11044545|FG000|Treated|Part 1: Period 1||6
9927063|NCT01275170|11044546|FG001|Treated|Part 1: Period 1||6
9927064|NCT01275170|11044547|FG002|Treated|Part 1: Period 1||6
9927065|NCT01275170|11044548|FG003|Treated|Part 1: Period 1||6
9927066|NCT01275170|11044549|FG004|Treated|Part 1: Period 1||6
9927067|NCT01275170|11044550|FG005|Treated|Part 1: Period 1||6
9927068|NCT01275170|11044551|FG006|Treated|Part 1: Period 1||6
9927069|NCT01275170|11044552|FG007|Treated|Part 1: Period 1||6
9927070|NCT01275170|11044545|FG000|COMPLETED|Part 1: Period 1||6
9927071|NCT01275170|11044546|FG001|COMPLETED|Part 1: Period 1||6
9927072|NCT01275170|11044547|FG002|COMPLETED|Part 1: Period 1||6
9927073|NCT01275170|11044548|FG003|COMPLETED|Part 1: Period 1||6
9927074|NCT01275170|11044549|FG004|COMPLETED|Part 1: Period 1||6
9927075|NCT01275170|11044550|FG005|COMPLETED|Part 1: Period 1||6
9927076|NCT01275170|11044551|FG006|COMPLETED|Part 1: Period 1||6
9927077|NCT01275170|11044552|FG007|COMPLETED|Part 1: Period 1||6
9927078|NCT01275170|11044545|FG000|NOT COMPLETED|Part 1: Period 1||1
9927079|NCT01275170|11044546|FG001|NOT COMPLETED|Part 1: Period 1||0
9927080|NCT01275170|11044547|FG002|NOT COMPLETED|Part 1: Period 1||0
9927081|NCT01275170|11044548|FG003|NOT COMPLETED|Part 1: Period 1||0
9927082|NCT01275170|11044549|FG004|NOT COMPLETED|Part 1: Period 1||0
9927083|NCT01275170|11044550|FG005|NOT COMPLETED|Part 1: Period 1||0
9927084|NCT01275170|11044551|FG006|NOT COMPLETED|Part 1: Period 1||0
9927085|NCT01275170|11044552|FG007|NOT COMPLETED|Part 1: Period 1||0
9927086|NCT01275170|11044545|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
9927087|NCT01275170|11044546|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
9927088|NCT01275170|11044547|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
9927089|NCT01275170|11044548|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
9927090|NCT01275170|11044549|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
9927091|NCT01275170|11044550|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
9927092|NCT01275170|11044551|FG006|STARTED|Part 1: Period 2||6
9927093|NCT01275170|11044552|FG007|STARTED|Part 1: Period 2||6
9927094|NCT01275170|11044545|FG000|COMPLETED|Part 1: Period 2||0
9927095|NCT01275170|11044546|FG001|COMPLETED|Part 1: Period 2||0
9927096|NCT01275170|11044547|FG002|COMPLETED|Part 1: Period 2||0
9927097|NCT01275170|11044548|FG003|COMPLETED|Part 1: Period 2||0
9927098|NCT01275170|11044549|FG004|COMPLETED|Part 1: Period 2||0
9927099|NCT01275170|11044550|FG005|COMPLETED|Part 1: Period 2||0
9927100|NCT01275170|11044551|FG006|COMPLETED|Part 1: Period 2||6
9927101|NCT01275170|11044552|FG007|COMPLETED|Part 1: Period 2||6
9927102|NCT01275170|11044545|FG000|NOT COMPLETED|Part 1: Period 2||0
9927103|NCT01275170|11044546|FG001|NOT COMPLETED|Part 1: Period 2||0
9927104|NCT01275170|11044547|FG002|NOT COMPLETED|Part 1: Period 2||0
9927105|NCT01275170|11044548|FG003|NOT COMPLETED|Part 1: Period 2||0
9927106|NCT01275170|11044549|FG004|NOT COMPLETED|Part 1: Period 2||0
9927107|NCT01275170|11044550|FG005|NOT COMPLETED|Part 1: Period 2||0
9927108|NCT01275170|11044551|FG006|NOT COMPLETED|Part 1: Period 2||0
9927109|NCT01275170|11044552|FG007|NOT COMPLETED|Part 1: Period 2||0
9927110|NCT01275170|11044545|FG000|STARTED|Part 2: Period 1||0
9927111|NCT01275170|11044546|FG001|STARTED|Part 2: Period 1||0
9927112|NCT01275170|11044547|FG002|STARTED|Part 2: Period 1||0
9927113|NCT01275170|11044548|FG003|STARTED|Part 2: Period 1||0
9927114|NCT01275170|11044549|FG004|STARTED|Part 2: Period 1||6
9927115|NCT01275170|11044550|FG005|STARTED|Part 2: Period 1||6
9927116|NCT01275170|11044551|FG006|STARTED|Part 2: Period 1||6
9927117|NCT01275170|11044552|FG007|STARTED|Part 2: Period 1||6
9927118|NCT01275170|11044545|FG000|COMPLETED|Part 2: Period 1||0
9927119|NCT01275170|11044546|FG001|COMPLETED|Part 2: Period 1||0
9927120|NCT01275170|11044547|FG002|COMPLETED|Part 2: Period 1||0
9927121|NCT01275170|11044548|FG003|COMPLETED|Part 2: Period 1||0
9927122|NCT01275170|11044549|FG004|COMPLETED|Part 2: Period 1||6
9927123|NCT01275170|11044550|FG005|COMPLETED|Part 2: Period 1||6
9927124|NCT01275170|11044551|FG006|COMPLETED|Part 2: Period 1||6
9927125|NCT01275170|11044552|FG007|COMPLETED|Part 2: Period 1||6
9927126|NCT01275170|11044545|FG000|NOT COMPLETED|Part 2: Period 1||0
9927127|NCT01275170|11044546|FG001|NOT COMPLETED|Part 2: Period 1||0
9927128|NCT01275170|11044547|FG002|NOT COMPLETED|Part 2: Period 1||0
9927129|NCT01275170|11044548|FG003|NOT COMPLETED|Part 2: Period 1||0
9927130|NCT01275170|11044549|FG004|NOT COMPLETED|Part 2: Period 1||0
9927131|NCT01275170|11044550|FG005|NOT COMPLETED|Part 2: Period 1||0
9927132|NCT01275170|11044551|FG006|NOT COMPLETED|Part 2: Period 1||0
10205429|NCT03492281|11332227|FG001|COMPLETED|Overall Study||502
10205430|NCT03492281|11332228|FG002|COMPLETED|Overall Study||385
10205431|NCT03492281|11332226|FG000|NOT COMPLETED|Overall Study||54
10205432|NCT03492281|11332227|FG001|NOT COMPLETED|Overall Study||45
10205433|NCT03492281|11332228|FG002|NOT COMPLETED|Overall Study||46
10205434|NCT03492398|11332248|FG000|STARTED|Overall Study||8
10205435|NCT03492398|11332249|FG001|STARTED|Overall Study||6
10205436|NCT03492398|11332250|FG002|STARTED|Overall Study||6
10205437|NCT03492398|11332251|FG003|STARTED|Overall Study||6
10205438|NCT03492398|11332252|FG004|STARTED|Overall Study||6
10205439|NCT03492398|11332253|FG005|STARTED|Overall Study||6
10205440|NCT03492398|11332254|FG006|STARTED|Overall Study||6
10205441|NCT03492398|11332255|FG007|STARTED|Overall Study||6
10205442|NCT03492398|11332256|FG008|STARTED|Overall Study||6
10205443|NCT03492398|11332248|FG000|COMPLETED|Overall Study||8
10205444|NCT03492398|11332249|FG001|COMPLETED|Overall Study||6
10205445|NCT03492398|11332250|FG002|COMPLETED|Overall Study||6
10205446|NCT03492398|11332251|FG003|COMPLETED|Overall Study||6
10205447|NCT03492398|11332252|FG004|COMPLETED|Overall Study||6
10205448|NCT03492398|11332253|FG005|COMPLETED|Overall Study||6
10205449|NCT03492398|11332254|FG006|COMPLETED|Overall Study||5
10205450|NCT03492398|11332255|FG007|COMPLETED|Overall Study||5
10205451|NCT03492398|11332256|FG008|COMPLETED|Overall Study||6
10205452|NCT03492398|11332248|FG000|NOT COMPLETED|Overall Study||0
10205453|NCT03492398|11332249|FG001|NOT COMPLETED|Overall Study||0
10205454|NCT03492398|11332250|FG002|NOT COMPLETED|Overall Study||0
10205455|NCT03492398|11332251|FG003|NOT COMPLETED|Overall Study||0
10205456|NCT03492398|11332252|FG004|NOT COMPLETED|Overall Study||0
10205457|NCT03492398|11332253|FG005|NOT COMPLETED|Overall Study||0
10205458|NCT03492398|11332254|FG006|NOT COMPLETED|Overall Study||1
10205459|NCT03492398|11332255|FG007|NOT COMPLETED|Overall Study||1
10205460|NCT03492398|11332256|FG008|NOT COMPLETED|Overall Study||0
10205461|NCT03492554|11332278|FG000|STARTED|Overall Study||301
10205462|NCT03492554|11332279|FG001|STARTED|Overall Study||301
10205463|NCT03492554|11332278|FG000|COMPLETED|Overall Study||301
10205464|NCT03492554|11332279|FG001|COMPLETED|Overall Study||287
10205465|NCT03492554|11332278|FG000|NOT COMPLETED|Overall Study||0
10205466|NCT03492554|11332279|FG001|NOT COMPLETED|Overall Study||14
10205467|NCT03493386|11332288|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26
10205468|NCT03493386|11332289|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26
10205469|NCT03493386|11332290|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0
10205470|NCT03493386|11332291|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0
10205471|NCT03493386|11332288|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
10205472|NCT03493386|11332289|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
10205473|NCT03493386|11332290|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10205474|NCT03493386|11332291|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10205475|NCT03493386|11332288|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10205476|NCT03493386|11332289|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9927133|NCT01275170|11044552|FG007|NOT COMPLETED|Part 2: Period 1||0
9927134|NCT01275170|11044545|FG000|STARTED|Part 2: Period 2||0
9927135|NCT01275170|11044546|FG001|STARTED|Part 2: Period 2||0
10205477|NCT03493386|11332290|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10205478|NCT03493386|11332291|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9927136|NCT01275170|11044547|FG002|STARTED|Part 2: Period 2||0
9927137|NCT01275170|11044548|FG003|STARTED|Part 2: Period 2||0
9927138|NCT01275170|11044549|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
9927139|NCT01275170|11044550|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
9927140|NCT01275170|11044551|FG006|STARTED|Part 2: Period 2||6
9927141|NCT01275170|11044552|FG007|STARTED|Part 2: Period 2||6
9927142|NCT01275170|11044545|FG000|COMPLETED|Part 2: Period 2||0
9927143|NCT01275170|11044546|FG001|COMPLETED|Part 2: Period 2||0
9927144|NCT01275170|11044547|FG002|COMPLETED|Part 2: Period 2||0
9927145|NCT01275170|11044548|FG003|COMPLETED|Part 2: Period 2||0
9927146|NCT01275170|11044549|FG004|COMPLETED|Part 2: Period 2||0
9927147|NCT01275170|11044550|FG005|COMPLETED|Part 2: Period 2||0
9927148|NCT01275170|11044551|FG006|COMPLETED|Part 2: Period 2||6
9927149|NCT01275170|11044552|FG007|COMPLETED|Part 2: Period 2||6
9927150|NCT01275170|11044545|FG000|NOT COMPLETED|Part 2: Period 2||0
9927151|NCT01275170|11044546|FG001|NOT COMPLETED|Part 2: Period 2||0
9927152|NCT01275170|11044547|FG002|NOT COMPLETED|Part 2: Period 2||0
9927153|NCT01275170|11044548|FG003|NOT COMPLETED|Part 2: Period 2||0
9927154|NCT01275170|11044549|FG004|NOT COMPLETED|Part 2: Period 2||0
9927155|NCT01275170|11044550|FG005|NOT COMPLETED|Part 2: Period 2||0
9927156|NCT01275170|11044551|FG006|NOT COMPLETED|Part 2: Period 2||0
9927157|NCT01275170|11044552|FG007|NOT COMPLETED|Part 2: Period 2||0
10010800|NCT01775787|11133454|FG000|NOT COMPLETED|First 7-10 Days||1
10010801|NCT01775787|11133455|FG001|NOT COMPLETED|First 7-10 Days||6
10010802|NCT01775787|11133454|FG000|STARTED|Second 7-10 Days||12
10010803|NCT01775787|11133455|FG001|STARTED|Second 7-10 Days||8
10010804|NCT01775787|11133454|FG000|COMPLETED|Second 7-10 Days||12
10010805|NCT01775787|11133455|FG001|COMPLETED|Second 7-10 Days||6
10010806|NCT01775787|11133454|FG000|NOT COMPLETED|Second 7-10 Days||0
10010807|NCT01775787|11133455|FG001|NOT COMPLETED|Second 7-10 Days||2
10010808|NCT01775800|11133465|FG000|STARTED|Overall Study||8
10010809|NCT01775800|11133466|FG001|STARTED|Overall Study||8
10010810|NCT01775800|11133465|FG000|COMPLETED|Overall Study||8
9927158|NCT01275196|11044587|FG000|STARTED|Overall Study||133
9927159|NCT01275196|11044588|FG001|STARTED|Overall Study||134
9927160|NCT01275196|11044587|FG000|Intended to Continue Into Extension|Overall Study||112
9927161|NCT01275196|11044588|FG001|Intended to Continue Into Extension|Overall Study||113
9927162|NCT01275196|11044587|FG000|COMPLETED|Overall Study||113
9927163|NCT01275196|11044588|FG001|COMPLETED|Overall Study||113
9927164|NCT01275196|11044587|FG000|NOT COMPLETED|Overall Study||20
9927165|NCT01275196|11044588|FG001|NOT COMPLETED|Overall Study||21
9927166|NCT01275222|11044602|FG000|STARTED|Phase l by Treatment||13
9927167|NCT01275222|11044603|FG001|STARTED|Phase l by Treatment||13
9927168|NCT01275222|11044604|FG002|STARTED|Phase l by Treatment||5
9927169|NCT01275222|11044605|FG003|STARTED|Phase l by Treatment||11
9927170|NCT01275222|11044606|FG004|STARTED|Phase l by Treatment||0
9927171|NCT01275222|11044607|FG005|STARTED|Phase l by Treatment||0
9927172|NCT01275222|11044602|FG000|COMPLETED|Phase l by Treatment||0
9927173|NCT01275222|11044603|FG001|COMPLETED|Phase l by Treatment||0
9927174|NCT01275222|11044604|FG002|COMPLETED|Phase l by Treatment||0
9927175|NCT01275222|11044605|FG003|COMPLETED|Phase l by Treatment||0
9927176|NCT01275222|11044606|FG004|COMPLETED|Phase l by Treatment||0
9927177|NCT01275222|11044607|FG005|COMPLETED|Phase l by Treatment||0
9927178|NCT01275222|11044602|FG000|NOT COMPLETED|Phase l by Treatment||13
9927179|NCT01275222|11044603|FG001|NOT COMPLETED|Phase l by Treatment||13
9927180|NCT01275222|11044604|FG002|NOT COMPLETED|Phase l by Treatment||5
9927181|NCT01275222|11044605|FG003|NOT COMPLETED|Phase l by Treatment||11
9927182|NCT01275222|11044606|FG004|NOT COMPLETED|Phase l by Treatment||0
9927183|NCT01275222|11044607|FG005|NOT COMPLETED|Phase l by Treatment||0
9927184|NCT01275222|11044602|FG000|STARTED|Phase ll by Stratum||0
9927185|NCT01275222|11044603|FG001|STARTED|Phase ll by Stratum||0
9927186|NCT01275222|11044604|FG002|STARTED|Phase ll by Stratum||0
9927187|NCT01275222|11044605|FG003|STARTED|Phase ll by Stratum||0
9927188|NCT01275222|11044606|FG004|STARTED|Phase ll by Stratum||28
9927189|NCT01275222|11044607|FG005|STARTED|Phase ll by Stratum||47
9927190|NCT01275222|11044602|FG000|COMPLETED|Phase ll by Stratum||0
9927191|NCT01275222|11044603|FG001|COMPLETED|Phase ll by Stratum||0
9927192|NCT01275222|11044604|FG002|COMPLETED|Phase ll by Stratum||0
9927193|NCT01275222|11044605|FG003|COMPLETED|Phase ll by Stratum||0
9927194|NCT01275222|11044606|FG004|COMPLETED|Phase ll by Stratum||0
9927195|NCT01275222|11044607|FG005|COMPLETED|Phase ll by Stratum||1
9927196|NCT01275222|11044602|FG000|NOT COMPLETED|Phase ll by Stratum||0
9927197|NCT01275222|11044603|FG001|NOT COMPLETED|Phase ll by Stratum||0
9927198|NCT01275222|11044604|FG002|NOT COMPLETED|Phase ll by Stratum||0
9927199|NCT01275222|11044605|FG003|NOT COMPLETED|Phase ll by Stratum||0
9927200|NCT01275222|11044606|FG004|NOT COMPLETED|Phase ll by Stratum||28
9927201|NCT01275222|11044607|FG005|NOT COMPLETED|Phase ll by Stratum||46
9927202|NCT01275300|11044625|FG000|STARTED|1st Intervention (5 Days)||5
9927203|NCT01275300|11044626|FG001|STARTED|1st Intervention (5 Days)||4
9927204|NCT01275300|11044625|FG000|COMPLETED|1st Intervention (5 Days)||5
9927205|NCT01275300|11044626|FG001|COMPLETED|1st Intervention (5 Days)||4
9927206|NCT01275300|11044625|FG000|NOT COMPLETED|1st Intervention (5 Days)||0
9927207|NCT01275300|11044626|FG001|NOT COMPLETED|1st Intervention (5 Days)||0
9927208|NCT01275300|11044625|FG000|STARTED|Washout (14 Days)||5
9927209|NCT01275300|11044626|FG001|STARTED|Washout (14 Days)||4
9927210|NCT01275300|11044625|FG000|COMPLETED|Washout (14 Days)||5
10010811|NCT01775800|11133466|FG001|COMPLETED|Overall Study||8
10010812|NCT01775800|11133465|FG000|NOT COMPLETED|Overall Study||0
9927211|NCT01275300|11044626|FG001|COMPLETED|Washout (14 Days)||4
9927212|NCT01275300|11044625|FG000|NOT COMPLETED|Washout (14 Days)||0
9927213|NCT01275300|11044626|FG001|NOT COMPLETED|Washout (14 Days)||0
9927214|NCT01275300|11044625|FG000|STARTED|2nd Intervention(5 Days)||5
9927215|NCT01275300|11044626|FG001|STARTED|2nd Intervention(5 Days)||4
9927216|NCT01275300|11044625|FG000|COMPLETED|2nd Intervention(5 Days)||5
9927217|NCT01275300|11044626|FG001|COMPLETED|2nd Intervention(5 Days)||4
9927218|NCT01275300|11044625|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0
9927219|NCT01275300|11044626|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0
9927220|NCT01275300|11044625|FG000|STARTED|Washout (14 Days)||5
9927221|NCT01275300|11044626|FG001|STARTED|Washout (14 Days)||4
9927222|NCT01275300|11044625|FG000|COMPLETED|Washout (14 Days)||5
9927223|NCT01275300|11044626|FG001|COMPLETED|Washout (14 Days)||4
9927224|NCT01275300|11044625|FG000|NOT COMPLETED|Washout (14 Days)||0
9927225|NCT01275300|11044626|FG001|NOT COMPLETED|Washout (14 Days)||0
9927226|NCT01275300|11044625|FG000|STARTED|Phase 2: Open-label 6days)||5
9927227|NCT01275300|11044626|FG001|STARTED|Phase 2: Open-label 6days)||4
9927228|NCT01275300|11044625|FG000|COMPLETED|Phase 2: Open-label 6days)||5
9927229|NCT01275300|11044626|FG001|COMPLETED|Phase 2: Open-label 6days)||4
9927230|NCT01275300|11044625|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0
9927231|NCT01275300|11044626|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0
9927238|NCT01275339|11044645|FG000|STARTED|Overall Study||2
9927239|NCT01275339|11044646|FG001|STARTED|Overall Study||0
9927240|NCT01275339|11044647|FG002|STARTED|Overall Study||4
9927241|NCT01275339|11044648|FG003|STARTED|Overall Study||4
9927242|NCT01275339|11044645|FG000|COMPLETED|Overall Study||1
9927243|NCT01275339|11044646|FG001|COMPLETED|Overall Study||0
9927244|NCT01275339|11044647|FG002|COMPLETED|Overall Study||3
9927245|NCT01275339|11044648|FG003|COMPLETED|Overall Study||4
9927246|NCT01275339|11044645|FG000|NOT COMPLETED|Overall Study||1
9927247|NCT01275339|11044646|FG001|NOT COMPLETED|Overall Study||0
9927248|NCT01275339|11044647|FG002|NOT COMPLETED|Overall Study||1
9927249|NCT01275339|11044648|FG003|NOT COMPLETED|Overall Study||0
9927250|NCT01275365|11044662|FG000|STARTED|Overall Study||24
9927251|NCT01275365|11044663|FG001|STARTED|Overall Study||24
9927252|NCT01275365|11044664|FG002|STARTED|Overall Study||22
9927253|NCT01275365|11044665|FG003|STARTED|Overall Study||22
9927254|NCT01275365|11044662|FG000|COMPLETED|Overall Study||21
9927255|NCT01275365|11044663|FG001|COMPLETED|Overall Study||21
9927256|NCT01275365|11044664|FG002|COMPLETED|Overall Study||17
9927257|NCT01275365|11044665|FG003|COMPLETED|Overall Study||19
9927258|NCT01275365|11044662|FG000|NOT COMPLETED|Overall Study||3
9927259|NCT01275365|11044663|FG001|NOT COMPLETED|Overall Study||3
9927260|NCT01275365|11044664|FG002|NOT COMPLETED|Overall Study||5
9927261|NCT01275365|11044665|FG003|NOT COMPLETED|Overall Study||3
9927262|NCT01275430|11044675|FG000|STARTED|Overall Study||27
9927263|NCT01275430|11044675|FG000|COMPLETED|Overall Study||18
9927264|NCT01275430|11044675|FG000|NOT COMPLETED|Overall Study||9
9927265|NCT01275586|11044680|FG000|STARTED|Overall Study||6
9927266|NCT01275586|11044680|FG000|COMPLETED|Overall Study||3
9927267|NCT01275586|11044680|FG000|NOT COMPLETED|Overall Study||3
9927268|NCT01275625|11044684|FG000|STARTED|Overall Study||77
9927269|NCT01275625|11044684|FG000|Treated|Overall Study||77
9927270|NCT01275625|11044684|FG000|COMPLETED|Overall Study||64
9927271|NCT01275625|11044684|FG000|NOT COMPLETED|Overall Study||13
9927272|NCT01275664|11044688|FG000|STARTED|Overall Study||4
9927273|NCT01275664|11044688|FG000|COMPLETED|Overall Study||4
10010813|NCT01775800|11133466|FG001|NOT COMPLETED|Overall Study||0
10010814|NCT01775852|11133475|FG000|STARTED|Overall Study||31
10010815|NCT01775852|11133476|FG001|STARTED|Overall Study||14
10010816|NCT01775852|11133475|FG000|COMPLETED|Overall Study||31
10111457|NCT02496702|11242542|FG001|Received Allocated Intervention|Overall Study||0
10010817|NCT01775852|11133476|FG001|COMPLETED|Overall Study||13
9927274|NCT01275664|11044688|FG000|NOT COMPLETED|Overall Study||0
9927275|NCT01275755|11044694|FG000|STARTED|Run-in Placebo Period||41
9927276|NCT01275755|11044695|FG001|STARTED|Run-in Placebo Period||40
9927277|NCT01275755|11044694|FG000|COMPLETED|Run-in Placebo Period||41
9927278|NCT01275755|11044695|FG001|COMPLETED|Run-in Placebo Period||40
9927279|NCT01275755|11044694|FG000|NOT COMPLETED|Run-in Placebo Period||0
9927280|NCT01275755|11044695|FG001|NOT COMPLETED|Run-in Placebo Period||0
9927281|NCT01275755|11044694|FG000|STARTED|Double-blind Treatment Period||41
9927282|NCT01275755|11044695|FG001|STARTED|Double-blind Treatment Period||40
9927283|NCT01275755|11044694|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
9927284|NCT01275755|11044695|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
9927285|NCT01275755|11044694|FG000|COMPLETED|Double-blind Treatment Period||39
9927286|NCT01275755|11044695|FG001|COMPLETED|Double-blind Treatment Period||37
9927287|NCT01275755|11044694|FG000|NOT COMPLETED|Double-blind Treatment Period||2
9927288|NCT01275755|11044695|FG001|NOT COMPLETED|Double-blind Treatment Period||3
9927289|NCT01275755|11044694|FG000|STARTED|Run-out Placebo Period||39
9927290|NCT01275755|11044695|FG001|STARTED|Run-out Placebo Period||37
10010818|NCT01775852|11133475|FG000|NOT COMPLETED|Overall Study||0
10010819|NCT01775852|11133476|FG001|NOT COMPLETED|Overall Study||1
9927291|NCT01275755|11044694|FG000|COMPLETED|Run-out Placebo Period||38
9927292|NCT01275755|11044695|FG001|COMPLETED|Run-out Placebo Period||37
9927293|NCT01275755|11044694|FG000|NOT COMPLETED|Run-out Placebo Period||1
9927294|NCT01275755|11044695|FG001|NOT COMPLETED|Run-out Placebo Period||0
9927295|NCT01275833|11044703|FG000|STARTED|Overall Study||1
9927296|NCT01275833|11044704|FG001|STARTED|Overall Study||1
9927297|NCT01275833|11044703|FG000|COMPLETED|Overall Study||0
9927298|NCT01275833|11044704|FG001|COMPLETED|Overall Study||0
9927299|NCT01275833|11044703|FG000|NOT COMPLETED|Overall Study||1
9927300|NCT01275833|11044704|FG001|NOT COMPLETED|Overall Study||1
9927301|NCT01276041|11044710|FG000|STARTED|Overall Study||70
9927302|NCT01276041|11044710|FG000|COMPLETED|Overall Study||67
9927303|NCT01276041|11044710|FG000|NOT COMPLETED|Overall Study||3
9927304|NCT01276106|11044718|FG000|STARTED|Overall Study||65
9927305|NCT01276106|11044719|FG001|STARTED|Overall Study||64
9927306|NCT01276106|11044720|FG002|STARTED|Overall Study||65
9927307|NCT01276106|11044721|FG003|STARTED|Overall Study||65
9927308|NCT01276106|11044718|FG000|COMPLETED|Overall Study||53
9927309|NCT01276106|11044719|FG001|COMPLETED|Overall Study||55
9927310|NCT01276106|11044720|FG002|COMPLETED|Overall Study||49
9927311|NCT01276106|11044721|FG003|COMPLETED|Overall Study||52
9927312|NCT01276106|11044718|FG000|NOT COMPLETED|Overall Study||12
9927313|NCT01276106|11044719|FG001|NOT COMPLETED|Overall Study||9
9927314|NCT01276106|11044720|FG002|NOT COMPLETED|Overall Study||16
9927315|NCT01276106|11044721|FG003|NOT COMPLETED|Overall Study||13
9927316|NCT01276171|11044734|FG000|STARTED|Overall Study||249
9927317|NCT01276171|11044735|FG001|STARTED|Overall Study||244
9927318|NCT01276171|11044736|FG002|STARTED|Overall Study||256
9927319|NCT01276171|11044734|FG000|COMPLETED|Overall Study||249
9927320|NCT01276171|11044735|FG001|COMPLETED|Overall Study||244
9927321|NCT01276171|11044736|FG002|COMPLETED|Overall Study||256
9927322|NCT01276171|11044734|FG000|NOT COMPLETED|Overall Study||0
9927323|NCT01276171|11044735|FG001|NOT COMPLETED|Overall Study||0
9927324|NCT01276171|11044736|FG002|NOT COMPLETED|Overall Study||0
9927325|NCT01276184|11044746|FG000|STARTED|Overall Study||13
9927326|NCT01276184|11044747|FG001|STARTED|Overall Study||9
9927327|NCT01276184|11044746|FG000|COMPLETED|Overall Study||13
9927328|NCT01276184|11044747|FG001|COMPLETED|Overall Study||9
9927329|NCT01276184|11044746|FG000|NOT COMPLETED|Overall Study||0
9927330|NCT01276184|11044747|FG001|NOT COMPLETED|Overall Study||0
9927331|NCT01276197|11044755|FG000|STARTED|Overall Study||308
9927332|NCT01276197|11044756|FG001|STARTED|Overall Study||310
9927333|NCT01276197|11044755|FG000|COMPLETED|Overall Study||200
9927334|NCT01276197|11044756|FG001|COMPLETED|Overall Study||200
9927335|NCT01276197|11044755|FG000|NOT COMPLETED|Overall Study||108
9927336|NCT01276197|11044756|FG001|NOT COMPLETED|Overall Study||110
9927337|NCT01276223|11044765|FG000|STARTED|Overall Study||78
9927338|NCT01276223|11044766|FG001|STARTED|Overall Study||107
9927339|NCT01276223|11044767|FG002|STARTED|Overall Study||104
9927340|NCT01276223|11044765|FG000|COMPLETED|Overall Study||67
9927341|NCT01276223|11044766|FG001|COMPLETED|Overall Study||103
9927342|NCT01276223|11044767|FG002|COMPLETED|Overall Study||101
9927343|NCT01276223|11044765|FG000|NOT COMPLETED|Overall Study||11
9927344|NCT01276223|11044766|FG001|NOT COMPLETED|Overall Study||4
9927345|NCT01276223|11044767|FG002|NOT COMPLETED|Overall Study||3
9927346|NCT01276236|11044774|FG000|STARTED|Overall Study||13
9927347|NCT01276236|11044774|FG000|Week 36 Visit|Overall Study||13
9927348|NCT01276236|11044774|FG000|Week 56 Visit|Overall Study||9
9927349|NCT01276236|11044774|FG000|Week 76 Visit|Overall Study||8
9927350|NCT01276236|11044774|FG000|COMPLETED|Overall Study||7
9927351|NCT01276236|11044774|FG000|NOT COMPLETED|Overall Study||6
9927352|NCT01276288|11044778|FG000|STARTED|Overall Study||7
9927353|NCT01276288|11044779|FG001|STARTED|Overall Study||6
9927354|NCT01276288|11044780|FG002|STARTED|Overall Study||5
9927355|NCT01276288|11044781|FG003|STARTED|Overall Study||5
9927356|NCT01276288|11044778|FG000|Received EMPA|Overall Study||6
9927357|NCT01276288|11044779|FG001|Received EMPA|Overall Study||5
9927358|NCT01276288|11044780|FG002|Received EMPA|Overall Study||5
9927359|NCT01276288|11044781|FG003|Received EMPA|Overall Study||5
9927360|NCT01276288|11044778|FG000|Received EMPA+HCT|Overall Study||5
9927361|NCT01276288|11044779|FG001|Received EMPA+HCT|Overall Study||5
9927362|NCT01276288|11044780|FG002|Received EMPA+HCT|Overall Study||0
9927363|NCT01276288|11044781|FG003|Received EMPA+HCT|Overall Study||0
9927364|NCT01276288|11044778|FG000|Received EMPA+TOR|Overall Study||0
9927365|NCT01276288|11044779|FG001|Received EMPA+TOR|Overall Study||0
9927366|NCT01276288|11044780|FG002|Received EMPA+TOR|Overall Study||5
9927367|NCT01276288|11044781|FG003|Received EMPA+TOR|Overall Study||5
9927368|NCT01276288|11044778|FG000|COMPLETED|Overall Study||5
9927369|NCT01276288|11044779|FG001|COMPLETED|Overall Study||5
9927370|NCT01276288|11044780|FG002|COMPLETED|Overall Study||5
9927371|NCT01276288|11044781|FG003|COMPLETED|Overall Study||5
9927372|NCT01276288|11044778|FG000|NOT COMPLETED|Overall Study||2
9927373|NCT01276288|11044779|FG001|NOT COMPLETED|Overall Study||1
9927374|NCT01276288|11044780|FG002|NOT COMPLETED|Overall Study||0
9927375|NCT01276288|11044781|FG003|NOT COMPLETED|Overall Study||0
9927376|NCT01276301|11044803|FG000|STARTED|First Intervention||8
9927377|NCT01276301|11044804|FG001|STARTED|First Intervention||8
9927378|NCT01276301|11044803|FG000|COMPLETED|First Intervention||8
9927379|NCT01276301|11044804|FG001|COMPLETED|First Intervention||8
9927380|NCT01276301|11044803|FG000|NOT COMPLETED|First Intervention||0
9927381|NCT01276301|11044804|FG001|NOT COMPLETED|First Intervention||0
9927382|NCT01276301|11044803|FG000|STARTED|Washout Period of 7 Days||8
10205479|NCT03493386|11332288|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26
10205480|NCT03493386|11332289|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26
10205481|NCT03493386|11332290|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0
10205482|NCT03493386|11332291|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0
10205483|NCT03493386|11332288|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
10010820|NCT01775865|11133485|FG000|STARTED|Overall Study||14
10010821|NCT01775865|11133486|FG001|STARTED|Overall Study||14
10010822|NCT01775865|11133487|FG002|STARTED|Overall Study||17
10205484|NCT03493386|11332289|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
9927383|NCT01276301|11044804|FG001|STARTED|Washout Period of 7 Days||8
9927384|NCT01276301|11044803|FG000|COMPLETED|Washout Period of 7 Days||8
9927385|NCT01276301|11044804|FG001|COMPLETED|Washout Period of 7 Days||8
9927386|NCT01276301|11044803|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9927387|NCT01276301|11044804|FG001|NOT COMPLETED|Washout Period of 7 Days||0
9927388|NCT01276301|11044803|FG000|STARTED|Second Intervention||8
9927389|NCT01276301|11044804|FG001|STARTED|Second Intervention||8
9927390|NCT01276301|11044803|FG000|COMPLETED|Second Intervention||8
9927391|NCT01276301|11044804|FG001|COMPLETED|Second Intervention||8
9927392|NCT01276301|11044803|FG000|NOT COMPLETED|Second Intervention||0
9927393|NCT01276301|11044804|FG001|NOT COMPLETED|Second Intervention||0
9927394|NCT01276314|11044815|FG000|STARTED|Overall Study||48
9927395|NCT01276314|11044816|FG001|STARTED|Overall Study||43
9927396|NCT01276314|11044817|FG002|STARTED|Overall Study||22
9927397|NCT01276314|11044818|FG003|STARTED|Overall Study||22
9927398|NCT01276314|11044815|FG000|COMPLETED|Overall Study||38
9927399|NCT01276314|11044816|FG001|COMPLETED|Overall Study||33
9927400|NCT01276314|11044817|FG002|COMPLETED|Overall Study||18
9927401|NCT01276314|11044818|FG003|COMPLETED|Overall Study||17
9927402|NCT01276314|11044815|FG000|NOT COMPLETED|Overall Study||10
9927403|NCT01276314|11044816|FG001|NOT COMPLETED|Overall Study||10
9927404|NCT01276314|11044817|FG002|NOT COMPLETED|Overall Study||4
9927405|NCT01276314|11044818|FG003|NOT COMPLETED|Overall Study||5
9927406|NCT01276327|11044830|FG000|STARTED|Overall Study||32
9927407|NCT01276327|11044831|FG001|STARTED|Overall Study||32
9927408|NCT01276327|11044830|FG000|COMPLETED|Overall Study||30
9927409|NCT01276327|11044831|FG001|COMPLETED|Overall Study||29
9927410|NCT01276327|11044830|FG000|NOT COMPLETED|Overall Study||2
9927411|NCT01276327|11044831|FG001|NOT COMPLETED|Overall Study||3
9927412|NCT01276353|11044839|FG000|STARTED|Double-blind||22
9927413|NCT01276353|11044840|FG001|STARTED|Double-blind||23
9927414|NCT01276353|11044839|FG000|COMPLETED|Double-blind||19
10010823|NCT01775865|11133485|FG000|COMPLETED|Overall Study||11
10010824|NCT01775865|11133486|FG001|COMPLETED|Overall Study||13
10010825|NCT01775865|11133487|FG002|COMPLETED|Overall Study||17
10010826|NCT01775865|11133485|FG000|NOT COMPLETED|Overall Study||3
10010827|NCT01775865|11133486|FG001|NOT COMPLETED|Overall Study||1
10010828|NCT01775865|11133487|FG002|NOT COMPLETED|Overall Study||0
9927415|NCT01276353|11044840|FG001|COMPLETED|Double-blind||23
9927416|NCT01276353|11044839|FG000|NOT COMPLETED|Double-blind||3
9927417|NCT01276353|11044840|FG001|NOT COMPLETED|Double-blind||0
9927418|NCT01276353|11044839|FG000|STARTED|Extension||19
9927419|NCT01276353|11044840|FG001|STARTED|Extension||23
9927420|NCT01276353|11044839|FG000|COMPLETED|Extension||12
9927421|NCT01276353|11044840|FG001|COMPLETED|Extension||14
9927422|NCT01276353|11044839|FG000|NOT COMPLETED|Extension||7
9927423|NCT01276353|11044840|FG001|NOT COMPLETED|Extension||9
9927424|NCT01276379|11044852|FG000|STARTED|Overall Study||221
9927425|NCT01276379|11044852|FG000|COMPLETED|Overall Study||181
9927426|NCT01276379|11044852|FG000|NOT COMPLETED|Overall Study||40
9927427|NCT01276457|11044860|FG000|STARTED|Core Study||142
9927428|NCT01276457|11044861|FG001|STARTED|Core Study||143
9927429|NCT01276457|11044860|FG000|COMPLETED|Core Study||129
9927430|NCT01276457|11044861|FG001|COMPLETED|Core Study||123
9927431|NCT01276457|11044860|FG000|NOT COMPLETED|Core Study||13
9927432|NCT01276457|11044861|FG001|NOT COMPLETED|Core Study||20
9927433|NCT01276457|11044860|FG000|STARTED|Extension Study||111
9927434|NCT01276457|11044861|FG001|STARTED|Extension Study||112
9927435|NCT01276457|11044860|FG000|COMPLETED|Extension Study||105
9927436|NCT01276457|11044861|FG001|COMPLETED|Extension Study||110
10010829|NCT01775904|11133500|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26
10010830|NCT01775904|11133500|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
10010831|NCT01775904|11133500|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
10010832|NCT01775904|11133500|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
9927437|NCT01276457|11044860|FG000|NOT COMPLETED|Extension Study||6
9927438|NCT01276457|11044861|FG001|NOT COMPLETED|Extension Study||2
9927439|NCT01276509|11044871|FG000|STARTED|Overall Study||66
9927440|NCT01276509|11044872|FG001|STARTED|Overall Study||65
9927441|NCT01276509|11044873|FG002|STARTED|Overall Study||68
9927442|NCT01276509|11044874|FG003|STARTED|Overall Study||63
9927443|NCT01276509|11044871|FG000|COMPLETED|Overall Study||53
9927444|NCT01276509|11044872|FG001|COMPLETED|Overall Study||53
10010833|NCT01775904|11133500|FG000|STARTED|First Washout (7 Days)||26
10010834|NCT01775904|11133500|FG000|COMPLETED|First Washout (7 Days)||26
9927445|NCT01276509|11044873|FG002|COMPLETED|Overall Study||63
9927446|NCT01276509|11044874|FG003|COMPLETED|Overall Study||58
9927447|NCT01276509|11044871|FG000|NOT COMPLETED|Overall Study||13
9927448|NCT01276509|11044872|FG001|NOT COMPLETED|Overall Study||12
9927449|NCT01276509|11044873|FG002|NOT COMPLETED|Overall Study||5
9927450|NCT01276509|11044874|FG003|NOT COMPLETED|Overall Study||5
9927451|NCT01276535|11044884|FG000|STARTED|Overall Study||12
9927452|NCT01276535|11044884|FG000|COMPLETED|Overall Study||12
9927453|NCT01276535|11044884|FG000|NOT COMPLETED|Overall Study||0
9927454|NCT01276639|11044891|FG000|STARTED|Week 0 to 16||363
9927455|NCT01276639|11044892|FG001|STARTED|Week 0 to 16||361
9927456|NCT01276639|11044893|FG002|STARTED|Week 0 to 16||177
9927457|NCT01276639|11044894|FG003|STARTED|Week 0 to 16||0
9927458|NCT01276639|11044895|FG004|STARTED|Week 0 to 16||0
9927459|NCT01276639|11044891|FG000|Treated|Week 0 to 16||363
9927460|NCT01276639|11044892|FG001|Treated|Week 0 to 16||360
9927461|NCT01276639|11044893|FG002|Treated|Week 0 to 16||177
9927462|NCT01276639|11044894|FG003|Treated|Week 0 to 16||0
9927463|NCT01276639|11044895|FG004|Treated|Week 0 to 16||0
9927464|NCT01276639|11044891|FG000|COMPLETED|Week 0 to 16||313
9927465|NCT01276639|11044892|FG001|COMPLETED|Week 0 to 16||320
9927466|NCT01276639|11044893|FG002|COMPLETED|Week 0 to 16||132
9927467|NCT01276639|11044894|FG003|COMPLETED|Week 0 to 16||0
9927468|NCT01276639|11044895|FG004|COMPLETED|Week 0 to 16||0
9927469|NCT01276639|11044891|FG000|NOT COMPLETED|Week 0 to 16||50
9927470|NCT01276639|11044892|FG001|NOT COMPLETED|Week 0 to 16||41
9927471|NCT01276639|11044893|FG002|NOT COMPLETED|Week 0 to 16||45
9927472|NCT01276639|11044894|FG003|NOT COMPLETED|Week 0 to 16||0
9927473|NCT01276639|11044895|FG004|NOT COMPLETED|Week 0 to 16||0
9927474|NCT01276639|11044891|FG000|STARTED|Week 16 to 52||313
9927475|NCT01276639|11044892|FG001|STARTED|Week 16 to 52||320
9927476|NCT01276639|11044893|FG002|STARTED|Week 16 to 52||0
9927477|NCT01276639|11044894|FG003|STARTED|Week 16 to 52||66
9927478|NCT01276639|11044895|FG004|STARTED|Week 16 to 52||66
9927479|NCT01276639|11044891|FG000|COMPLETED|Week 16 to 52||186
9927480|NCT01276639|11044892|FG001|COMPLETED|Week 16 to 52||219
9927481|NCT01276639|11044893|FG002|COMPLETED|Week 16 to 52||0
9927482|NCT01276639|11044894|FG003|COMPLETED|Week 16 to 52||50
9927483|NCT01276639|11044895|FG004|COMPLETED|Week 16 to 52||45
9927484|NCT01276639|11044891|FG000|NOT COMPLETED|Week 16 to 52||127
9927485|NCT01276639|11044892|FG001|NOT COMPLETED|Week 16 to 52||101
9927486|NCT01276639|11044893|FG002|NOT COMPLETED|Week 16 to 52||0
9927487|NCT01276639|11044894|FG003|NOT COMPLETED|Week 16 to 52||16
9927488|NCT01276639|11044895|FG004|NOT COMPLETED|Week 16 to 52||21
10010835|NCT01775904|11133500|FG000|NOT COMPLETED|First Washout (7 Days)||0
10010836|NCT01775904|11133500|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26
10010837|NCT01775904|11133500|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
10010838|NCT01775904|11133500|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
10010839|NCT01775904|11133500|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
10010840|NCT01775904|11133500|FG000|STARTED|Second Washout (7 Days)||25
9927489|NCT01276652|11044913|FG000|STARTED|Period 1: Randomization||9
9927490|NCT01276652|11044914|FG001|STARTED|Period 1: Randomization||8
9927491|NCT01276652|11044915|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
9927492|NCT01276652|11044913|FG000|COMPLETED|Period 1: Randomization||9
9927493|NCT01276652|11044914|FG001|COMPLETED|Period 1: Randomization||8
9927494|NCT01276652|11044915|FG002|COMPLETED|Period 1: Randomization||0
9927495|NCT01276652|11044913|FG000|NOT COMPLETED|Period 1: Randomization||0
9927496|NCT01276652|11044914|FG001|NOT COMPLETED|Period 1: Randomization||0
9927497|NCT01276652|11044915|FG002|NOT COMPLETED|Period 1: Randomization||0
9927498|NCT01276652|11044913|FG000|STARTED|Period 2: Observational||9
9927499|NCT01276652|11044914|FG001|STARTED|Period 2: Observational||8
9927500|NCT01276652|11044915|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
9927501|NCT01276652|11044913|FG000|COMPLETED|Period 2: Observational||9
9927502|NCT01276652|11044914|FG001|COMPLETED|Period 2: Observational||8
9927503|NCT01276652|11044915|FG002|COMPLETED|Period 2: Observational||5
9927504|NCT01276652|11044913|FG000|NOT COMPLETED|Period 2: Observational||0
9927505|NCT01276652|11044914|FG001|NOT COMPLETED|Period 2: Observational||0
9927506|NCT01276652|11044915|FG002|NOT COMPLETED|Period 2: Observational||0
9927507|NCT01276756|11044930|FG000|STARTED|Overall Study||50
9927508|NCT01276756|11044931|FG001|STARTED|Overall Study||50
9927509|NCT01276756|11044930|FG000|COMPLETED|Overall Study||45
10010841|NCT01775904|11133500|FG000|COMPLETED|Second Washout (7 Days)||25
10010842|NCT01775904|11133500|FG000|NOT COMPLETED|Second Washout (7 Days)||0
10010843|NCT01775904|11133500|FG000|STARTED|LY2886721 ODT (Water, Fed)||25
9927510|NCT01276756|11044931|FG001|COMPLETED|Overall Study||48
9927511|NCT01276756|11044930|FG000|NOT COMPLETED|Overall Study||5
9927512|NCT01276756|11044931|FG001|NOT COMPLETED|Overall Study||2
9927513|NCT01276821|11044939|FG000|STARTED|Overall Study||50
9927514|NCT01276821|11044940|FG001|STARTED|Overall Study||50
9927515|NCT01276821|11044939|FG000|COMPLETED|Overall Study||50
9927516|NCT01276821|11044940|FG001|COMPLETED|Overall Study||49
9927517|NCT01276821|11044939|FG000|NOT COMPLETED|Overall Study||0
9927518|NCT01276821|11044940|FG001|NOT COMPLETED|Overall Study||1
9927519|NCT01276847|11044949|FG000|STARTED|Overall Study||10
9927520|NCT01276847|11044950|FG001|STARTED|Overall Study||10
9927521|NCT01276847|11044951|FG002|STARTED|Overall Study||20
9927522|NCT01276847|11044949|FG000|COMPLETED|Overall Study||9
9927523|NCT01276847|11044950|FG001|COMPLETED|Overall Study||10
9927524|NCT01276847|11044951|FG002|COMPLETED|Overall Study||20
9927525|NCT01276847|11044949|FG000|NOT COMPLETED|Overall Study||1
9927526|NCT01276847|11044950|FG001|NOT COMPLETED|Overall Study||0
9927527|NCT01276847|11044951|FG002|NOT COMPLETED|Overall Study||0
9927528|NCT01276860|11044960|FG000|STARTED|Overall Study||5
9927529|NCT01276860|11044961|FG001|STARTED|Overall Study||2
9927530|NCT01276860|11044960|FG000|COMPLETED|Overall Study||5
9927531|NCT01276860|11044961|FG001|COMPLETED|Overall Study||2
10010844|NCT01775904|11133500|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
10010845|NCT01775904|11133500|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25
10010846|NCT01775904|11133500|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
10010847|NCT01775904|11133500|FG000|STARTED|Third Washout (7 Days)||25
10010848|NCT01775904|11133500|FG000|COMPLETED|Third Washout (7 Days)||25
10010849|NCT01775904|11133500|FG000|NOT COMPLETED|Third Washout (7 Days)||0
10010850|NCT01775904|11133500|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25
9927532|NCT01276860|11044960|FG000|NOT COMPLETED|Overall Study||0
9927533|NCT01276860|11044961|FG001|NOT COMPLETED|Overall Study||0
9927534|NCT01277042|11044969|FG000|STARTED|Overall Study||606
9927535|NCT01277042|11044970|FG001|STARTED|Overall Study||606
9927536|NCT01277042|11044969|FG000|COMPLETED|Overall Study||598
9927537|NCT01277042|11044970|FG001|COMPLETED|Overall Study||601
9927538|NCT01277042|11044969|FG000|NOT COMPLETED|Overall Study||8
9927539|NCT01277042|11044970|FG001|NOT COMPLETED|Overall Study||5
9927540|NCT01277081|11044979|FG000|STARTED|Overall Study||100
9927541|NCT01277081|11044980|FG001|STARTED|Overall Study||100
9927542|NCT01277081|11044979|FG000|COMPLETED|Overall Study||100
9927543|NCT01277081|11044980|FG001|COMPLETED|Overall Study||100
9927544|NCT01277081|11044979|FG000|NOT COMPLETED|Overall Study||0
9927545|NCT01277081|11044980|FG001|NOT COMPLETED|Overall Study||0
9927546|NCT01277159|11044991|FG000|STARTED|Overall Study||21
9927547|NCT01277159|11044992|FG001|STARTED|Overall Study||22
9927548|NCT01277159|11044993|FG002|STARTED|Overall Study||22
9927549|NCT01277159|11044994|FG003|STARTED|Overall Study||22
9927550|NCT01277159|11044995|FG004|STARTED|Overall Study||21
9927551|NCT01277159|11044991|FG000|COMPLETED|Overall Study||17
9927552|NCT01277159|11044992|FG001|COMPLETED|Overall Study||21
9927553|NCT01277159|11044993|FG002|COMPLETED|Overall Study||19
9927554|NCT01277159|11044994|FG003|COMPLETED|Overall Study||19
9927555|NCT01277159|11044995|FG004|COMPLETED|Overall Study||16
9927556|NCT01277159|11044991|FG000|NOT COMPLETED|Overall Study||4
9927557|NCT01277159|11044992|FG001|NOT COMPLETED|Overall Study||1
9927558|NCT01277159|11044993|FG002|NOT COMPLETED|Overall Study||3
9927559|NCT01277159|11044994|FG003|NOT COMPLETED|Overall Study||3
9927560|NCT01277159|11044995|FG004|NOT COMPLETED|Overall Study||5
9927561|NCT01277302|11045010|FG000|STARTED|7-Month Fixed Treatment Period||85
9927562|NCT01277302|11045011|FG001|STARTED|7-Month Fixed Treatment Period||86
9927563|NCT01277302|11045012|FG002|STARTED|7-Month Fixed Treatment Period||31
9927564|NCT01277302|11045010|FG000|COMPLETED|7-Month Fixed Treatment Period||85
9927565|NCT01277302|11045011|FG001|COMPLETED|7-Month Fixed Treatment Period||86
9927566|NCT01277302|11045012|FG002|COMPLETED|7-Month Fixed Treatment Period||19
9927567|NCT01277302|11045010|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0
9927568|NCT01277302|11045011|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0
9927569|NCT01277302|11045012|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12
9927570|NCT01277302|11045010|FG000|STARTED|8-Month Alternate Dose Regimen Period||85
9927571|NCT01277302|11045011|FG001|STARTED|8-Month Alternate Dose Regimen Period||86
9927572|NCT01277302|11045012|FG002|STARTED|8-Month Alternate Dose Regimen Period||19
9927573|NCT01277302|11045010|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80
9927574|NCT01277302|11045011|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82
9927575|NCT01277302|11045012|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13
9927576|NCT01277302|11045010|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
9927577|NCT01277302|11045011|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
9927578|NCT01277302|11045012|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
9927579|NCT01277341|11045024|FG000|STARTED|Overall Study||150
9927580|NCT01277341|11045025|FG001|STARTED|Overall Study||150
9927581|NCT01277341|11045026|FG002|STARTED|Overall Study||149
9927582|NCT01277341|11045027|FG003|STARTED|Overall Study||152
9927583|NCT01277341|11045024|FG000|COMPLETED|Overall Study||146
9927584|NCT01277341|11045025|FG001|COMPLETED|Overall Study||145
9927585|NCT01277341|11045026|FG002|COMPLETED|Overall Study||145
9927586|NCT01277341|11045027|FG003|COMPLETED|Overall Study||146
9927587|NCT01277341|11045024|FG000|NOT COMPLETED|Overall Study||4
9927588|NCT01277341|11045025|FG001|NOT COMPLETED|Overall Study||5
9927589|NCT01277341|11045026|FG002|NOT COMPLETED|Overall Study||4
9927590|NCT01277341|11045027|FG003|NOT COMPLETED|Overall Study||6
9927591|NCT01277354|11045039|FG000|STARTED|Overall Study||1
9927592|NCT01277354|11045040|FG001|STARTED|Overall Study||1
9927593|NCT01277354|11045039|FG000|COMPLETED|Overall Study||1
9927594|NCT01277354|11045040|FG001|COMPLETED|Overall Study||1
9927595|NCT01277354|11045039|FG000|NOT COMPLETED|Overall Study||0
9927596|NCT01277354|11045040|FG001|NOT COMPLETED|Overall Study||0
9927597|NCT01277510|11045048|FG000|STARTED|Double-blind Phase||21
9927598|NCT01277510|11045049|FG001|STARTED|Double-blind Phase||22
9927599|NCT01277510|11045048|FG000|Received Investigational Product|Double-blind Phase||21
9927600|NCT01277510|11045049|FG001|Received Investigational Product|Double-blind Phase||22
9927601|NCT01277510|11045048|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8
9927602|NCT01277510|11045049|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4
9927603|NCT01277510|11045048|FG000|NOT COMPLETED|Double-blind Phase||13
9927604|NCT01277510|11045049|FG001|NOT COMPLETED|Double-blind Phase||18
9927605|NCT01277510|11045048|FG000|STARTED|Open-label Phase||8
9927606|NCT01277510|11045049|FG001|STARTED|Open-label Phase||4
9927607|NCT01277510|11045048|FG000|Received Investigational Product|Open-label Phase||6
9927608|NCT01277510|11045049|FG001|Received Investigational Product|Open-label Phase||4
10019014|NCT01826981|11142056|FG005|NOT COMPLETED|Overall Study||1
9927609|NCT01277510|11045048|FG000|COMPLETED|Open-label Phase|Completed investigational product|1
9927610|NCT01277510|11045049|FG001|COMPLETED|Open-label Phase|Completed investigational product|1
9927611|NCT01277510|11045048|FG000|NOT COMPLETED|Open-label Phase||7
9927612|NCT01277510|11045049|FG001|NOT COMPLETED|Open-label Phase||3
9927613|NCT01277523|11045060|FG000|STARTED|Overall Study||135
9927614|NCT01277523|11045061|FG001|STARTED|Overall Study||127
9927615|NCT01277523|11045062|FG002|STARTED|Overall Study||130
9927616|NCT01277523|11045060|FG000|COMPLETED|Overall Study||132
9927617|NCT01277523|11045061|FG001|COMPLETED|Overall Study||126
9927618|NCT01277523|11045062|FG002|COMPLETED|Overall Study||130
9927619|NCT01277523|11045060|FG000|NOT COMPLETED|Overall Study||3
9927620|NCT01277523|11045061|FG001|NOT COMPLETED|Overall Study||1
9927621|NCT01277523|11045062|FG002|NOT COMPLETED|Overall Study||0
9927622|NCT01277549|11045072|FG000|STARTED|Overall Study||41
9927623|NCT01277549|11045073|FG001|STARTED|Overall Study||29
9927624|NCT01277549|11045072|FG000|COMPLETED|Overall Study||15
9927625|NCT01277549|11045073|FG001|COMPLETED|Overall Study||15
9927626|NCT01277549|11045072|FG000|NOT COMPLETED|Overall Study||26
9927627|NCT01277549|11045073|FG001|NOT COMPLETED|Overall Study||14
9927628|NCT01277601|11045086|FG000|STARTED|Overall Study||188
9927629|NCT01277601|11045087|FG001|STARTED|Overall Study||187
9927630|NCT01277601|11045088|FG002|STARTED|Overall Study||190
9927631|NCT01277601|11045089|FG003|STARTED|Overall Study||186
9927632|NCT01277601|11045086|FG000|COMPLETED|Overall Study||151
9927633|NCT01277601|11045087|FG001|COMPLETED|Overall Study||139
9927634|NCT01277601|11045088|FG002|COMPLETED|Overall Study||163
9927635|NCT01277601|11045089|FG003|COMPLETED|Overall Study||150
9927636|NCT01277601|11045086|FG000|NOT COMPLETED|Overall Study||37
9927637|NCT01277601|11045087|FG001|NOT COMPLETED|Overall Study||48
9927638|NCT01277601|11045088|FG002|NOT COMPLETED|Overall Study||27
9927639|NCT01277601|11045089|FG003|NOT COMPLETED|Overall Study||36
9927640|NCT01277666|11045119|FG000|STARTED|Overall Study||203
9927641|NCT01277666|11045120|FG001|STARTED|Overall Study||203
9927642|NCT01277666|11045121|FG002|STARTED|Overall Study||202
9927643|NCT01277666|11045119|FG000|COMPLETED|Overall Study||158
9927644|NCT01277666|11045120|FG001|COMPLETED|Overall Study||144
9927645|NCT01277666|11045121|FG002|COMPLETED|Overall Study||153
9927646|NCT01277666|11045119|FG000|NOT COMPLETED|Overall Study||45
9927647|NCT01277666|11045120|FG001|NOT COMPLETED|Overall Study||59
9927648|NCT01277666|11045121|FG002|NOT COMPLETED|Overall Study||49
9927649|NCT01277718|11045129|FG000|STARTED|Period 1 - First Intervention||10
9927650|NCT01277718|11045130|FG001|STARTED|Period 1 - First Intervention||10
9927651|NCT01277718|11045129|FG000|COMPLETED|Period 1 - First Intervention||10
9927652|NCT01277718|11045130|FG001|COMPLETED|Period 1 - First Intervention||10
9927653|NCT01277718|11045129|FG000|NOT COMPLETED|Period 1 - First Intervention||0
9927654|NCT01277718|11045130|FG001|NOT COMPLETED|Period 1 - First Intervention||0
9927655|NCT01277718|11045129|FG000|STARTED|Washout Period of 13 Days||10
9927656|NCT01277718|11045130|FG001|STARTED|Washout Period of 13 Days||10
9927657|NCT01277718|11045129|FG000|COMPLETED|Washout Period of 13 Days||10
9927658|NCT01277718|11045130|FG001|COMPLETED|Washout Period of 13 Days||10
9927659|NCT01277718|11045129|FG000|NOT COMPLETED|Washout Period of 13 Days||0
9927660|NCT01277718|11045130|FG001|NOT COMPLETED|Washout Period of 13 Days||0
9927661|NCT01277718|11045129|FG000|STARTED|Period 2 - Second Intervention||10
9927662|NCT01277718|11045130|FG001|STARTED|Period 2 - Second Intervention||10
9927663|NCT01277718|11045129|FG000|COMPLETED|Period 2 - Second Intervention||10
9927664|NCT01277718|11045130|FG001|COMPLETED|Period 2 - Second Intervention||7
9927665|NCT01277718|11045129|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
9927666|NCT01277718|11045130|FG001|NOT COMPLETED|Period 2 - Second Intervention||3
9927667|NCT01277718|11045129|FG000|STARTED|Washout Period of 13 Days||10
9927668|NCT01277718|11045130|FG001|STARTED|Washout Period of 13 Days||7
9927669|NCT01277718|11045129|FG000|COMPLETED|Washout Period of 13 Days||10
9927670|NCT01277718|11045130|FG001|COMPLETED|Washout Period of 13 Days||7
9927671|NCT01277718|11045129|FG000|NOT COMPLETED|Washout Period of 13 Days||0
9927672|NCT01277718|11045130|FG001|NOT COMPLETED|Washout Period of 13 Days||0
9927673|NCT01277718|11045129|FG000|STARTED|Period 3 - Third Intervention||10
9927674|NCT01277718|11045130|FG001|STARTED|Period 3 - Third Intervention||7
9927675|NCT01277718|11045129|FG000|COMPLETED|Period 3 - Third Intervention||10
9927676|NCT01277718|11045130|FG001|COMPLETED|Period 3 - Third Intervention||7
9927677|NCT01277718|11045129|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
9927678|NCT01277718|11045130|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
9927679|NCT01277744|11045138|FG000|STARTED|Overall Study||22
9927680|NCT01277744|11045138|FG000|COMPLETED|Overall Study||20
9927681|NCT01277744|11045138|FG000|NOT COMPLETED|Overall Study||2
9927682|NCT01277757|11045142|FG000|STARTED|Overall Study||30
9927683|NCT01277757|11045142|FG000|COMPLETED|Overall Study||28
9927684|NCT01277757|11045142|FG000|NOT COMPLETED|Overall Study||2
9927685|NCT01277783|11045146|FG000|STARTED|Overall Study||138
9927686|NCT01277783|11045146|FG000|COMPLETED|Overall Study||138
9927687|NCT01277783|11045146|FG000|NOT COMPLETED|Overall Study||0
9927688|NCT01277861|11045153|FG000|STARTED|Overall Study||51
9927689|NCT01277861|11045154|FG001|STARTED|Overall Study||49
9927690|NCT01277861|11045153|FG000|COMPLETED|Overall Study||49
9927691|NCT01277861|11045154|FG001|COMPLETED|Overall Study||47
9927692|NCT01277861|11045153|FG000|NOT COMPLETED|Overall Study||2
9927693|NCT01277861|11045154|FG001|NOT COMPLETED|Overall Study||2
9927694|NCT01277887|11045164|FG000|STARTED|Pre-Quit Treatment Phase||9
9927695|NCT01277887|11045165|FG001|STARTED|Pre-Quit Treatment Phase||10
9927696|NCT01277887|11045164|FG000|Entered Study|Pre-Quit Treatment Phase||7
9927697|NCT01277887|11045165|FG001|Entered Study|Pre-Quit Treatment Phase||10
9927698|NCT01277887|11045164|FG000|COMPLETED|Pre-Quit Treatment Phase||6
9927699|NCT01277887|11045165|FG001|COMPLETED|Pre-Quit Treatment Phase||10
9927700|NCT01277887|11045164|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3
9927701|NCT01277887|11045165|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0
9927702|NCT01277887|11045164|FG000|STARTED|Post-Quit Treatment Phase||6
9927703|NCT01277887|11045165|FG001|STARTED|Post-Quit Treatment Phase||10
9927704|NCT01277887|11045164|FG000|COMPLETED|Post-Quit Treatment Phase||3
9927705|NCT01277887|11045165|FG001|COMPLETED|Post-Quit Treatment Phase||5
9927706|NCT01277887|11045164|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3
9927707|NCT01277887|11045165|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5
9927708|NCT01278030|11045173|FG000|STARTED|Overall Study||43
9927709|NCT01278030|11045174|FG001|STARTED|Overall Study||35
9927710|NCT01278030|11045173|FG000|COMPLETED|Overall Study||35
9927711|NCT01278030|11045174|FG001|COMPLETED|Overall Study||31
9927712|NCT01278030|11045173|FG000|NOT COMPLETED|Overall Study||8
9927713|NCT01278030|11045174|FG001|NOT COMPLETED|Overall Study||4
9927714|NCT01278160|11045182|FG000|STARTED|Overall Study||89
9927715|NCT01278160|11045183|FG001|STARTED|Overall Study||90
9927716|NCT01278160|11045182|FG000|COMPLETED|Overall Study||84
9927717|NCT01278160|11045183|FG001|COMPLETED|Overall Study||84
9927718|NCT01278160|11045182|FG000|NOT COMPLETED|Overall Study||5
9927719|NCT01278160|11045183|FG001|NOT COMPLETED|Overall Study||6
9927720|NCT01278173|11045189|FG000|STARTED|Overall Study||65
9927721|NCT01278173|11045189|FG000|COMPLETED|Overall Study||38
9927722|NCT01278173|11045189|FG000|NOT COMPLETED|Overall Study||27
9927723|NCT01278303|11045193|FG000|STARTED|Overall Study||82
9927724|NCT01278303|11045193|FG000|COMPLETED|Overall Study||82
9927725|NCT01278303|11045193|FG000|NOT COMPLETED|Overall Study||0
9927726|NCT01278342|11045200|FG000|STARTED|Overall Study||7
9927727|NCT01278342|11045201|FG001|STARTED|Overall Study||31
9927728|NCT01278342|11045202|FG002|STARTED|Overall Study||32
9927729|NCT01278342|11045200|FG000|COMPLETED|Overall Study||3
9927730|NCT01278342|11045201|FG001|COMPLETED|Overall Study||30
9927731|NCT01278342|11045202|FG002|COMPLETED|Overall Study||32
9927732|NCT01278342|11045200|FG000|NOT COMPLETED|Overall Study||4
9927733|NCT01278342|11045201|FG001|NOT COMPLETED|Overall Study||1
9927734|NCT01278342|11045202|FG002|NOT COMPLETED|Overall Study||0
9927735|NCT01278394|11045210|FG000|STARTED|Overall Study||29
9927736|NCT01278394|11045210|FG000|COMPLETED|Overall Study||28
9927737|NCT01278394|11045210|FG000|NOT COMPLETED|Overall Study||1
9927738|NCT01278407|11045217|FG000|STARTED|Confirmatory Phase||46
9927739|NCT01278407|11045218|FG001|STARTED|Confirmatory Phase||47
9927740|NCT01278407|11045219|FG002|STARTED|Confirmatory Phase||49
9927741|NCT01278407|11045220|FG003|STARTED|Confirmatory Phase||0
9927742|NCT01278407|11045221|FG004|STARTED|Confirmatory Phase||0
9927743|NCT01278407|11045217|FG000|COMPLETED|Confirmatory Phase||37
9927744|NCT01278407|11045218|FG001|COMPLETED|Confirmatory Phase||31
9927745|NCT01278407|11045219|FG002|COMPLETED|Confirmatory Phase||43
9927746|NCT01278407|11045220|FG003|COMPLETED|Confirmatory Phase||0
9927747|NCT01278407|11045221|FG004|COMPLETED|Confirmatory Phase||0
9927748|NCT01278407|11045217|FG000|NOT COMPLETED|Confirmatory Phase||9
9927749|NCT01278407|11045218|FG001|NOT COMPLETED|Confirmatory Phase||16
9927750|NCT01278407|11045219|FG002|NOT COMPLETED|Confirmatory Phase||6
9927751|NCT01278407|11045220|FG003|NOT COMPLETED|Confirmatory Phase||0
9927752|NCT01278407|11045221|FG004|NOT COMPLETED|Confirmatory Phase||0
9927753|NCT01278407|11045217|FG000|STARTED|Extension Phase||0
9927754|NCT01278407|11045218|FG001|STARTED|Extension Phase||0
9927755|NCT01278407|11045219|FG002|STARTED|Extension Phase||0
9927756|NCT01278407|11045220|FG003|STARTED|Extension Phase||46
9927757|NCT01278407|11045221|FG004|STARTED|Extension Phase||96
9927758|NCT01278407|11045217|FG000|COMPLETED|Extension Phase||0
9927759|NCT01278407|11045218|FG001|COMPLETED|Extension Phase||0
9927760|NCT01278407|11045219|FG002|COMPLETED|Extension Phase||0
9927761|NCT01278407|11045220|FG003|COMPLETED|Extension Phase||34
9927762|NCT01278407|11045221|FG004|COMPLETED|Extension Phase||66
9927763|NCT01278407|11045217|FG000|NOT COMPLETED|Extension Phase||0
9927764|NCT01278407|11045218|FG001|NOT COMPLETED|Extension Phase||0
9927765|NCT01278407|11045219|FG002|NOT COMPLETED|Extension Phase||0
9927766|NCT01278407|11045220|FG003|NOT COMPLETED|Extension Phase||12
9927767|NCT01278407|11045221|FG004|NOT COMPLETED|Extension Phase||30
9927768|NCT01278485|11045231|FG000|STARTED|Overall Study||719
9927769|NCT01278485|11045231|FG000|COMPLETED|Overall Study||719
9927770|NCT01278485|11045231|FG000|NOT COMPLETED|Overall Study||0
9927771|NCT01278615|11045235|FG000|STARTED|Overall Study||16
9927772|NCT01278615|11045235|FG000|COMPLETED|Overall Study||14
9927773|NCT01278615|11045235|FG000|NOT COMPLETED|Overall Study||2
9927774|NCT01278745|11045241|FG000|STARTED|Overall Study||89
9927775|NCT01278745|11045242|FG001|STARTED|Overall Study||74
9927776|NCT01278745|11045243|FG002|STARTED|Overall Study||121
9927777|NCT01278745|11045244|FG003|STARTED|Overall Study||78
9927778|NCT01278745|11045241|FG000|COMPLETED|Overall Study||84
9927779|NCT01278745|11045242|FG001|COMPLETED|Overall Study||68
9927780|NCT01278745|11045243|FG002|COMPLETED|Overall Study||0
9927781|NCT01278745|11045244|FG003|COMPLETED|Overall Study||0
9927782|NCT01278745|11045241|FG000|NOT COMPLETED|Overall Study||5
9927783|NCT01278745|11045242|FG001|NOT COMPLETED|Overall Study||6
9927784|NCT01278745|11045243|FG002|NOT COMPLETED|Overall Study||121
9927785|NCT01278745|11045244|FG003|NOT COMPLETED|Overall Study||78
9956115|NCT01442675|11075219|FG000|NOT COMPLETED|Overall Study||12
9927786|NCT01278797|11045252|FG000|STARTED|Period 1||14
9927787|NCT01278797|11045253|FG001|STARTED|Period 1||14
9927788|NCT01278797|11045252|FG000|COMPLETED|Period 1||13
9927789|NCT01278797|11045253|FG001|COMPLETED|Period 1||13
9927790|NCT01278797|11045252|FG000|NOT COMPLETED|Period 1||1
9927791|NCT01278797|11045253|FG001|NOT COMPLETED|Period 1||1
9927792|NCT01278797|11045252|FG000|STARTED|Washout Period of 21 Days||13
9927793|NCT01278797|11045253|FG001|STARTED|Washout Period of 21 Days||13
9927794|NCT01278797|11045252|FG000|COMPLETED|Washout Period of 21 Days||13
9927795|NCT01278797|11045253|FG001|COMPLETED|Washout Period of 21 Days||13
9927796|NCT01278797|11045252|FG000|NOT COMPLETED|Washout Period of 21 Days||0
9927797|NCT01278797|11045253|FG001|NOT COMPLETED|Washout Period of 21 Days||0
9927798|NCT01278797|11045252|FG000|STARTED|Period 2||13
9927799|NCT01278797|11045253|FG001|STARTED|Period 2||13
9927800|NCT01278797|11045252|FG000|COMPLETED|Period 2||13
9927801|NCT01278797|11045253|FG001|COMPLETED|Period 2||13
9927802|NCT01278797|11045252|FG000|NOT COMPLETED|Period 2||0
9927803|NCT01278797|11045253|FG001|NOT COMPLETED|Period 2||0
9927804|NCT01278862|11045261|FG000|STARTED|Overall Study||45
9927805|NCT01278862|11045262|FG001|STARTED|Overall Study||43
9927806|NCT01278862|11045261|FG000|COMPLETED|Overall Study||44
9927807|NCT01278862|11045262|FG001|COMPLETED|Overall Study||42
9927808|NCT01278862|11045261|FG000|NOT COMPLETED|Overall Study||1
9927809|NCT01278862|11045262|FG001|NOT COMPLETED|Overall Study||1
9927810|NCT01278927|11045272|FG000|STARTED|Overall Study||180
9927811|NCT01278927|11045273|FG001|STARTED|Overall Study||178
9927812|NCT01278927|11045274|FG002|STARTED|Overall Study||178
9927813|NCT01278927|11045275|FG003|STARTED|Overall Study||175
9927814|NCT01278927|11045272|FG000|COMPLETED|Overall Study||180
9927815|NCT01278927|11045273|FG001|COMPLETED|Overall Study||178
9927816|NCT01278927|11045274|FG002|COMPLETED|Overall Study||178
9927817|NCT01278927|11045275|FG003|COMPLETED|Overall Study||175
9927818|NCT01278927|11045272|FG000|NOT COMPLETED|Overall Study||0
9927819|NCT01278927|11045273|FG001|NOT COMPLETED|Overall Study||0
9927820|NCT01278927|11045274|FG002|NOT COMPLETED|Overall Study||0
9927821|NCT01278927|11045275|FG003|NOT COMPLETED|Overall Study||0
9927822|NCT01278953|11045288|FG000|STARTED|Overall Study||155
9927823|NCT01278953|11045289|FG001|STARTED|Overall Study||145
9927824|NCT01278953|11045288|FG000|COMPLETED|Overall Study||146
9927825|NCT01278953|11045289|FG001|COMPLETED|Overall Study||134
9927826|NCT01278953|11045288|FG000|NOT COMPLETED|Overall Study||9
9927827|NCT01278953|11045289|FG001|NOT COMPLETED|Overall Study||11
9927828|NCT01279044|11045298|FG000|STARTED|PHASE 1 - Formative||59
9927829|NCT01279044|11045299|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
9927830|NCT01279044|11045300|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
9927831|NCT01279044|11045298|FG000|COMPLETED|PHASE 1 - Formative||59
9927832|NCT01279044|11045299|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
9927833|NCT01279044|11045300|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
9927834|NCT01279044|11045298|FG000|NOT COMPLETED|PHASE 1 - Formative||0
9927835|NCT01279044|11045299|FG001|NOT COMPLETED|PHASE 1 - Formative||0
9927836|NCT01279044|11045300|FG002|NOT COMPLETED|PHASE 1 - Formative||0
9927837|NCT01279044|11045298|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
9927838|NCT01279044|11045299|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162
9927839|NCT01279044|11045300|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164
9927840|NCT01279044|11045298|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
9927841|NCT01279044|11045299|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
9927842|NCT01279044|11045300|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
9927843|NCT01279044|11045298|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
9927844|NCT01279044|11045299|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
9927845|NCT01279044|11045300|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
9927846|NCT01279057|11045309|FG000|STARTED|Overall Study||288
9927847|NCT01279057|11045310|FG001|STARTED|Overall Study||292
9927848|NCT01279057|11045311|FG002|STARTED|Overall Study||147
9927849|NCT01279057|11045309|FG000|Per-Protocol (PPP) Population|Overall Study||257
9927850|NCT01279057|11045310|FG001|Per-Protocol (PPP) Population|Overall Study||245
9927851|NCT01279057|11045311|FG002|Per-Protocol (PPP) Population|Overall Study||126
9927852|NCT01279057|11045309|FG000|Intent-to-Treat (ITT) Population|Overall Study||284
9927853|NCT01279057|11045310|FG001|Intent-to-Treat (ITT) Population|Overall Study||285
9927854|NCT01279057|11045311|FG002|Intent-to-Treat (ITT) Population|Overall Study||144
9927855|NCT01279057|11045309|FG000|COMPLETED|Overall Study||282
9927856|NCT01279057|11045310|FG001|COMPLETED|Overall Study||287
9927857|NCT01279057|11045311|FG002|COMPLETED|Overall Study||144
9927858|NCT01279057|11045309|FG000|NOT COMPLETED|Overall Study||6
9927859|NCT01279057|11045310|FG001|NOT COMPLETED|Overall Study||5
9927860|NCT01279057|11045311|FG002|NOT COMPLETED|Overall Study||3
9927861|NCT01279070|11045321|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
9927862|NCT01279070|11045322|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
9927863|NCT01279070|11045321|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
9927864|NCT01279070|11045322|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
9927865|NCT01279070|11045321|FG000|NOT COMPLETED|Overall Study||5
9927866|NCT01279070|11045322|FG001|NOT COMPLETED|Overall Study||4
9927867|NCT01279109|11045334|FG000|STARTED|Overall Study||68
9927868|NCT01279109|11045335|FG001|STARTED|Overall Study||67
9927869|NCT01279109|11045334|FG000|COMPLETED|Overall Study||55
9927870|NCT01279109|11045335|FG001|COMPLETED|Overall Study||55
9927871|NCT01279109|11045334|FG000|NOT COMPLETED|Overall Study||13
9927872|NCT01279109|11045335|FG001|NOT COMPLETED|Overall Study||12
9927873|NCT01279187|11045343|FG000|STARTED|Overall Study||14
9927874|NCT01279187|11045344|FG001|STARTED|Overall Study||13
9927875|NCT01279187|11045343|FG000|COMPLETED|Overall Study||14
9927876|NCT01279187|11045344|FG001|COMPLETED|Overall Study||13
9927877|NCT01279187|11045343|FG000|NOT COMPLETED|Overall Study||0
9927878|NCT01279187|11045344|FG001|NOT COMPLETED|Overall Study||0
9927879|NCT01279200|11045352|FG000|STARTED|Overall Study||10
9927880|NCT01279200|11045353|FG001|STARTED|Overall Study||11
9927881|NCT01279200|11045352|FG000|COMPLETED|Overall Study||8
9927882|NCT01279200|11045353|FG001|COMPLETED|Overall Study||4
9927883|NCT01279200|11045352|FG000|NOT COMPLETED|Overall Study||2
9927884|NCT01279200|11045353|FG001|NOT COMPLETED|Overall Study||7
9927885|NCT01279265|11045361|FG000|STARTED|Overall Study||13
9927886|NCT01279265|11045362|FG001|STARTED|Overall Study||17
9927887|NCT01279265|11045361|FG000|COMPLETED|Overall Study||9
9927888|NCT01279265|11045362|FG001|COMPLETED|Overall Study||11
9927889|NCT01279265|11045361|FG000|NOT COMPLETED|Overall Study||4
9927890|NCT01279265|11045362|FG001|NOT COMPLETED|Overall Study||6
9927891|NCT01279317|11045370|FG000|STARTED|Period 1||6
9927892|NCT01279317|11045371|FG001|STARTED|Period 1||6
9927893|NCT01279317|11045370|FG000|COMPLETED|Period 1||6
9927894|NCT01279317|11045371|FG001|COMPLETED|Period 1||6
9927895|NCT01279317|11045370|FG000|NOT COMPLETED|Period 1||0
9927896|NCT01279317|11045371|FG001|NOT COMPLETED|Period 1||0
9927897|NCT01279317|11045370|FG000|STARTED|Washout||6
9927898|NCT01279317|11045371|FG001|STARTED|Washout||6
9927899|NCT01279317|11045370|FG000|COMPLETED|Washout||6
9927900|NCT01279317|11045371|FG001|COMPLETED|Washout||6
9927901|NCT01279317|11045370|FG000|NOT COMPLETED|Washout||0
9927902|NCT01279317|11045371|FG001|NOT COMPLETED|Washout||0
9927903|NCT01279317|11045370|FG000|STARTED|Period 2||6
9927904|NCT01279317|11045371|FG001|STARTED|Period 2||6
9927905|NCT01279317|11045370|FG000|COMPLETED|Period 2||6
9927906|NCT01279317|11045371|FG001|COMPLETED|Period 2||6
9927907|NCT01279317|11045370|FG000|NOT COMPLETED|Period 2||0
9927908|NCT01279317|11045371|FG001|NOT COMPLETED|Period 2||0
9927909|NCT01279343|11045378|FG000|STARTED|Overall Study||59
9927910|NCT01279343|11045379|FG001|STARTED|Overall Study||64
9927911|NCT01279343|11045378|FG000|COMPLETED|Overall Study||57
9927912|NCT01279343|11045379|FG001|COMPLETED|Overall Study||58
9927913|NCT01279343|11045378|FG000|NOT COMPLETED|Overall Study||2
9927914|NCT01279343|11045379|FG001|NOT COMPLETED|Overall Study||6
9927915|NCT01279447|11045387|FG000|STARTED|Overall Study||34
9927916|NCT01279447|11045388|FG001|STARTED|Overall Study||34
9927917|NCT01279447|11045387|FG000|COMPLETED|Overall Study||31
9927918|NCT01279447|11045388|FG001|COMPLETED|Overall Study||33
9927919|NCT01279447|11045387|FG000|NOT COMPLETED|Overall Study||3
9927920|NCT01279447|11045388|FG001|NOT COMPLETED|Overall Study||1
9927921|NCT01279486|11045394|FG000|STARTED|Overall Study||120
9927922|NCT01279486|11045394|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
9927923|NCT01279486|11045394|FG000|NOT COMPLETED|Overall Study||1
9927924|NCT01279564|11045400|FG000|STARTED|Overall Study||40
9927925|NCT01279564|11045401|FG001|STARTED|Overall Study||32
9927926|NCT01279564|11045400|FG000|COMPLETED|Overall Study||40
9927927|NCT01279564|11045401|FG001|COMPLETED|Overall Study||32
9927928|NCT01279564|11045400|FG000|NOT COMPLETED|Overall Study||0
9927929|NCT01279564|11045401|FG001|NOT COMPLETED|Overall Study||0
9927930|NCT01279681|11045409|FG000|STARTED|Overall Study||15
9927931|NCT01279681|11045410|FG001|STARTED|Overall Study||17
9927932|NCT01279681|11045409|FG000|COMPLETED|Overall Study||0
9927933|NCT01279681|11045410|FG001|COMPLETED|Overall Study||0
9927934|NCT01279681|11045409|FG000|NOT COMPLETED|Overall Study||15
9927935|NCT01279681|11045410|FG001|NOT COMPLETED|Overall Study||17
9927936|NCT01279850|11045416|FG000|STARTED|Overall Study||891
9927937|NCT01279850|11045416|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
9927938|NCT01279850|11045416|FG000|NOT COMPLETED|Overall Study||91
9927939|NCT01279954|11045422|FG000|STARTED|Overall Study||5
9927940|NCT01279954|11045423|FG001|STARTED|Overall Study||5
9927941|NCT01279954|11045422|FG000|COMPLETED|Overall Study||2
9927942|NCT01279954|11045423|FG001|COMPLETED|Overall Study||1
9927943|NCT01279954|11045422|FG000|NOT COMPLETED|Overall Study||3
9927944|NCT01279954|11045423|FG001|NOT COMPLETED|Overall Study||4
9927945|NCT01280058|11045434|FG000|STARTED|Overall Study||36
9927946|NCT01280058|11045435|FG001|STARTED|Overall Study||37
9927947|NCT01280058|11045434|FG000|COMPLETED|Overall Study||36
9927948|NCT01280058|11045435|FG001|COMPLETED|Overall Study||37
9927949|NCT01280058|11045434|FG000|NOT COMPLETED|Overall Study||0
9927950|NCT01280058|11045435|FG001|NOT COMPLETED|Overall Study||0
9927951|NCT01280110|11045445|FG000|STARTED|Overall Study||22
9927952|NCT01280110|11045446|FG001|STARTED|Overall Study||22
9927953|NCT01280110|11045445|FG000|COMPLETED|Overall Study||22
9927954|NCT01280110|11045446|FG001|COMPLETED|Overall Study||22
9927955|NCT01280110|11045445|FG000|NOT COMPLETED|Overall Study||0
9927956|NCT01280110|11045446|FG001|NOT COMPLETED|Overall Study||0
9927957|NCT01280123|11045457|FG000|STARTED|Overall Study||72
9927958|NCT01280123|11045458|FG001|STARTED|Overall Study||67
9927959|NCT01280123|11045459|FG002|STARTED|Overall Study||71
9927960|NCT01280123|11045457|FG000|COMPLETED|Overall Study||71
9927961|NCT01280123|11045458|FG001|COMPLETED|Overall Study||63
9927962|NCT01280123|11045459|FG002|COMPLETED|Overall Study||70
9927963|NCT01280123|11045457|FG000|NOT COMPLETED|Overall Study||1
9927964|NCT01280123|11045458|FG001|NOT COMPLETED|Overall Study||4
9927965|NCT01280123|11045459|FG002|NOT COMPLETED|Overall Study||1
9927966|NCT01280201|11045467|FG000|STARTED|Overall Study||44
9927967|NCT01280201|11045467|FG000|COMPLETED|Overall Study||44
9927968|NCT01280201|11045467|FG000|NOT COMPLETED|Overall Study||0
9927969|NCT01280266|11045473|FG000|STARTED|First Intervention (Week 1-4)||15
9927970|NCT01280266|11045474|FG001|STARTED|First Intervention (Week 1-4)||14
9927971|NCT01280266|11045473|FG000|COMPLETED|First Intervention (Week 1-4)||14
9927972|NCT01280266|11045474|FG001|COMPLETED|First Intervention (Week 1-4)||12
9927973|NCT01280266|11045473|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1
9927974|NCT01280266|11045474|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2
9927975|NCT01280266|11045473|FG000|STARTED|Washout Period (Week 4-5)||14
9927976|NCT01280266|11045474|FG001|STARTED|Washout Period (Week 4-5)||12
9927977|NCT01280266|11045473|FG000|COMPLETED|Washout Period (Week 4-5)||14
9927978|NCT01280266|11045474|FG001|COMPLETED|Washout Period (Week 4-5)||12
9927979|NCT01280266|11045473|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0
9927980|NCT01280266|11045474|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0
9927981|NCT01280266|11045473|FG000|STARTED|Second Intervention (Week 5-9)||14
9927982|NCT01280266|11045474|FG001|STARTED|Second Intervention (Week 5-9)||12
9927983|NCT01280266|11045473|FG000|COMPLETED|Second Intervention (Week 5-9)||14
9927984|NCT01280266|11045474|FG001|COMPLETED|Second Intervention (Week 5-9)||12
9927985|NCT01280266|11045473|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0
9927986|NCT01280266|11045474|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0
9927987|NCT01280357|11045484|FG000|STARTED|Overall Study||60
9927988|NCT01280357|11045484|FG000|COMPLETED|Overall Study||34
9927989|NCT01280357|11045484|FG000|NOT COMPLETED|Overall Study||26
9927990|NCT01280409|11045493|FG000|STARTED|Overall Study||59
9927991|NCT01280409|11045494|FG001|STARTED|Overall Study||55
9927992|NCT01280409|11045493|FG000|COMPLETED|Overall Study||43
9927993|NCT01280409|11045494|FG001|COMPLETED|Overall Study||36
9927994|NCT01280409|11045493|FG000|NOT COMPLETED|Overall Study||16
9927995|NCT01280409|11045494|FG001|NOT COMPLETED|Overall Study||19
9927996|NCT01280552|11045502|FG000|STARTED|Overall Study||81
9927997|NCT01280552|11045503|FG001|STARTED|Overall Study||43
9927998|NCT01280552|11045502|FG000|COMPLETED|Overall Study|Survival is still being assessed|75
9927999|NCT01280552|11045503|FG001|COMPLETED|Overall Study||42
9928000|NCT01280552|11045502|FG000|NOT COMPLETED|Overall Study||6
9928001|NCT01280552|11045503|FG001|NOT COMPLETED|Overall Study||1
9928002|NCT01280591|11045516|FG000|STARTED|Overall Study||203
9928003|NCT01280591|11045517|FG001|STARTED|Overall Study||204
9928004|NCT01280591|11045518|FG002|STARTED|Overall Study||203
9928005|NCT01280591|11045519|FG003|STARTED|Overall Study||102
9928006|NCT01280591|11045516|FG000|COMPLETED|Overall Study||203
9928007|NCT01280591|11045517|FG001|COMPLETED|Overall Study||204
9928008|NCT01280591|11045518|FG002|COMPLETED|Overall Study||203
9928009|NCT01280591|11045519|FG003|COMPLETED|Overall Study||99
9928010|NCT01280591|11045516|FG000|NOT COMPLETED|Overall Study||0
9928011|NCT01280591|11045517|FG001|NOT COMPLETED|Overall Study||0
9928012|NCT01280591|11045518|FG002|NOT COMPLETED|Overall Study||0
9928013|NCT01280591|11045519|FG003|NOT COMPLETED|Overall Study||3
9928014|NCT01280604|11045531|FG000|STARTED|Overall Study||33
9928015|NCT01280604|11045532|FG001|STARTED|Overall Study||33
9928016|NCT01280604|11045531|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25
9928017|NCT01280604|11045532|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29
9928018|NCT01280604|11045531|FG000|COMPLETED|Overall Study||24
9928019|NCT01280604|11045532|FG001|COMPLETED|Overall Study||28
9928020|NCT01280604|11045531|FG000|NOT COMPLETED|Overall Study||9
9928021|NCT01280604|11045532|FG001|NOT COMPLETED|Overall Study||5
9928022|NCT01280617|11045540|FG000|STARTED|Overall Study||23
9928023|NCT01280617|11045541|FG001|STARTED|Overall Study||21
9928024|NCT01280617|11045540|FG000|COMPLETED|Overall Study||23
9928025|NCT01280617|11045541|FG001|COMPLETED|Overall Study||20
9928026|NCT01280617|11045540|FG000|NOT COMPLETED|Overall Study||0
9928027|NCT01280617|11045541|FG001|NOT COMPLETED|Overall Study||1
9928028|NCT01280656|11045550|FG000|STARTED|Overall Study||62
9928029|NCT01280656|11045551|FG001|STARTED|Overall Study||312
9928030|NCT01280656|11045552|FG002|STARTED|Overall Study||286
9928031|NCT01280656|11045550|FG000|COMPLETED|Overall Study||59
9928032|NCT01280656|11045551|FG001|COMPLETED|Overall Study||265
9928033|NCT01280656|11045552|FG002|COMPLETED|Overall Study||223
9928034|NCT01280656|11045550|FG000|NOT COMPLETED|Overall Study||3
9928035|NCT01280656|11045551|FG001|NOT COMPLETED|Overall Study||47
9928036|NCT01280656|11045552|FG002|NOT COMPLETED|Overall Study||63
9928037|NCT01280695|11045565|FG000|STARTED|Overall Study||26
9928038|NCT01280695|11045566|FG001|STARTED|Overall Study||25
9928039|NCT01280695|11045567|FG002|STARTED|Overall Study||26
9928040|NCT01280695|11045568|FG003|STARTED|Overall Study||26
9928041|NCT01280695|11045569|FG004|STARTED|Overall Study||26
9928042|NCT01280695|11045565|FG000|COMPLETED|Overall Study||26
9928043|NCT01280695|11045566|FG001|COMPLETED|Overall Study||24
9928044|NCT01280695|11045567|FG002|COMPLETED|Overall Study||21
9928045|NCT01280695|11045568|FG003|COMPLETED|Overall Study||22
9928046|NCT01280695|11045569|FG004|COMPLETED|Overall Study||24
9928047|NCT01280695|11045565|FG000|NOT COMPLETED|Overall Study||0
9928048|NCT01280695|11045566|FG001|NOT COMPLETED|Overall Study||1
9928049|NCT01280695|11045567|FG002|NOT COMPLETED|Overall Study||5
9928050|NCT01280695|11045568|FG003|NOT COMPLETED|Overall Study||4
9928051|NCT01280695|11045569|FG004|NOT COMPLETED|Overall Study||2
9928052|NCT01280721|11045581|FG000|STARTED|Overall Study||135
9928053|NCT01280721|11045581|FG000|COMPLETED|Overall Study||113
9928054|NCT01280721|11045581|FG000|NOT COMPLETED|Overall Study||22
9928055|NCT01280812|11045599|FG000|STARTED|Overall Study||70
9928056|NCT01280812|11045600|FG001|STARTED|Overall Study||71
9928057|NCT01280812|11045601|FG002|STARTED|Overall Study||69
9928058|NCT01280812|11045599|FG000|COMPLETED|Overall Study||67
9928059|NCT01280812|11045600|FG001|COMPLETED|Overall Study||69
9928060|NCT01280812|11045601|FG002|COMPLETED|Overall Study||68
9928061|NCT01280812|11045599|FG000|NOT COMPLETED|Overall Study||3
9928062|NCT01280812|11045600|FG001|NOT COMPLETED|Overall Study||2
9928063|NCT01280812|11045601|FG002|NOT COMPLETED|Overall Study||1
9928064|NCT01280903|11045612|FG000|STARTED|Overall Study||91
9928065|NCT01280903|11045613|FG001|STARTED|Overall Study||91
9928066|NCT01280903|11045612|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
9928067|NCT01280903|11045613|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
9928068|NCT01280903|11045612|FG000|NOT COMPLETED|Overall Study||23
9928069|NCT01280903|11045613|FG001|NOT COMPLETED|Overall Study||16
9928070|NCT01280942|11045621|FG000|STARTED|Overall Study||10120
9928071|NCT01280942|11045622|FG001|STARTED|Overall Study||9911
9928072|NCT01280942|11045621|FG000|COMPLETED|Overall Study||10120
9928073|NCT01280942|11045622|FG001|COMPLETED|Overall Study||9911
9928074|NCT01280942|11045621|FG000|NOT COMPLETED|Overall Study||0
9928075|NCT01280942|11045622|FG001|NOT COMPLETED|Overall Study||0
9928076|NCT01280955|11045628|FG000|STARTED|Overall Study||30
9928077|NCT01280955|11045628|FG000|COMPLETED|Overall Study||27
9928078|NCT01280955|11045628|FG000|NOT COMPLETED|Overall Study||3
9928079|NCT01280968|11045636|FG000|STARTED|Overall Study||45
9928080|NCT01280968|11045637|FG001|STARTED|Overall Study||7
9928081|NCT01280968|11045636|FG000|COMPLETED|Overall Study||27
9928082|NCT01280968|11045637|FG001|COMPLETED|Overall Study||4
9928083|NCT01280968|11045636|FG000|NOT COMPLETED|Overall Study||18
9928084|NCT01280968|11045637|FG001|NOT COMPLETED|Overall Study||3
9928085|NCT01280981|11045644|FG000|STARTED|Overall Study||288
9928086|NCT01280981|11045644|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
9928087|NCT01280981|11045644|FG000|COMPLETED|Overall Study||196
9928088|NCT01280981|11045644|FG000|NOT COMPLETED|Overall Study||92
9928089|NCT01281007|11045650|FG000|STARTED|Overall Study||75
9928090|NCT01281007|11045651|FG001|STARTED|Overall Study||75
9928091|NCT01281007|11045650|FG000|COMPLETED|Overall Study||71
9928092|NCT01281007|11045651|FG001|COMPLETED|Overall Study||67
9928093|NCT01281007|11045650|FG000|NOT COMPLETED|Overall Study||4
9928094|NCT01281007|11045651|FG001|NOT COMPLETED|Overall Study||8
9928095|NCT01281137|11045659|FG000|STARTED|Baseline Population||25
9928096|NCT01281137|11045660|FG001|STARTED|Baseline Population||79
9928097|NCT01281137|11045659|FG000|COMPLETED|Baseline Population||25
9928098|NCT01281137|11045660|FG001|COMPLETED|Baseline Population||78
9928099|NCT01281137|11045659|FG000|NOT COMPLETED|Baseline Population||0
9928100|NCT01281137|11045660|FG001|NOT COMPLETED|Baseline Population||1
9928101|NCT01281137|11045659|FG000|STARTED|Analysis Population (Baseline)||25
9928102|NCT01281137|11045660|FG001|STARTED|Analysis Population (Baseline)||78
9928103|NCT01281137|11045659|FG000|COMPLETED|Analysis Population (Baseline)||21
9928104|NCT01281137|11045660|FG001|COMPLETED|Analysis Population (Baseline)||69
9928105|NCT01281137|11045659|FG000|NOT COMPLETED|Analysis Population (Baseline)||4
9928106|NCT01281137|11045660|FG001|NOT COMPLETED|Analysis Population (Baseline)||9
9928107|NCT01281137|11045659|FG000|STARTED|Analysis Population (9 Months)||21
9928108|NCT01281137|11045660|FG001|STARTED|Analysis Population (9 Months)||69
9928109|NCT01281137|11045659|FG000|COMPLETED|Analysis Population (9 Months)||21
9928110|NCT01281137|11045660|FG001|COMPLETED|Analysis Population (9 Months)||64
9928111|NCT01281137|11045659|FG000|NOT COMPLETED|Analysis Population (9 Months)||0
9928112|NCT01281137|11045660|FG001|NOT COMPLETED|Analysis Population (9 Months)||5
9928113|NCT01281137|11045659|FG000|STARTED|Analysis Population (10.5 Months)||21
9928114|NCT01281137|11045660|FG001|STARTED|Analysis Population (10.5 Months)||64
9928115|NCT01281137|11045659|FG000|COMPLETED|Analysis Population (10.5 Months)||20
9928116|NCT01281137|11045660|FG001|COMPLETED|Analysis Population (10.5 Months)||64
9928117|NCT01281137|11045659|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1
9928118|NCT01281137|11045660|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0
9928119|NCT01281137|11045659|FG000|STARTED|Analysis Population (12 Months)||20
9928120|NCT01281137|11045660|FG001|STARTED|Analysis Population (12 Months)||64
9928121|NCT01281137|11045659|FG000|COMPLETED|Analysis Population (12 Months)||19
9928122|NCT01281137|11045660|FG001|COMPLETED|Analysis Population (12 Months)||62
9928123|NCT01281137|11045659|FG000|NOT COMPLETED|Analysis Population (12 Months)||1
9928124|NCT01281137|11045660|FG001|NOT COMPLETED|Analysis Population (12 Months)||2
9928125|NCT01281189|11045686|FG000|STARTED|Overall Study||468
9928126|NCT01281189|11045687|FG001|STARTED|Overall Study||474
9928127|NCT01281189|11045686|FG000|COMPLETED|Overall Study||321
9928128|NCT01281189|11045687|FG001|COMPLETED|Overall Study||331
9928129|NCT01281189|11045686|FG000|NOT COMPLETED|Overall Study||147
9928130|NCT01281189|11045687|FG001|NOT COMPLETED|Overall Study||143
9928131|NCT01281202|11045695|FG000|STARTED|Overall Study||103
9928132|NCT01281202|11045696|FG001|STARTED|Overall Study||104
9928133|NCT01281202|11045695|FG000|COMPLETED|Overall Study||75
9928134|NCT01281202|11045696|FG001|COMPLETED|Overall Study||68
9928135|NCT01281202|11045695|FG000|NOT COMPLETED|Overall Study||28
9928136|NCT01281202|11045696|FG001|NOT COMPLETED|Overall Study||36
9928137|NCT01281306|11045711|FG000|STARTED|Overall Study||144
9928138|NCT01281306|11045712|FG001|STARTED|Overall Study||145
9928139|NCT01281306|11045713|FG002|STARTED|Overall Study||141
9928140|NCT01281306|11045714|FG003|STARTED|Overall Study||134
9928141|NCT01281306|11045715|FG004|STARTED|Overall Study||143
9928142|NCT01281306|11045716|FG005|STARTED|Overall Study||142
9928143|NCT01281306|11045717|FG006|STARTED|Overall Study||58
9928144|NCT01281306|11045711|FG000|Full Analysis Set|Overall Study||143
9928145|NCT01281306|11045712|FG001|Full Analysis Set|Overall Study||145
9928146|NCT01281306|11045713|FG002|Full Analysis Set|Overall Study||141
9928147|NCT01281306|11045714|FG003|Full Analysis Set|Overall Study||133
9928148|NCT01281306|11045715|FG004|Full Analysis Set|Overall Study||143
9928149|NCT01281306|11045716|FG005|Full Analysis Set|Overall Study||142
9928150|NCT01281306|11045717|FG006|Full Analysis Set|Overall Study||58
9928151|NCT01281306|11045711|FG000|Safety Set|Overall Study||143
9928152|NCT01281306|11045712|FG001|Safety Set|Overall Study||145
9928153|NCT01281306|11045713|FG002|Safety Set|Overall Study||141
9928154|NCT01281306|11045714|FG003|Safety Set|Overall Study||133
9928155|NCT01281306|11045715|FG004|Safety Set|Overall Study||143
9928156|NCT01281306|11045716|FG005|Safety Set|Overall Study||142
9928157|NCT01281306|11045717|FG006|Safety Set|Overall Study||58
9928158|NCT01281306|11045711|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
9928159|NCT01281306|11045712|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
9928160|NCT01281306|11045713|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
10010851|NCT01775904|11133500|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
10205485|NCT03493386|11332290|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10205486|NCT03493386|11332291|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10205487|NCT03493386|11332288|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
9928161|NCT01281306|11045714|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
9928162|NCT01281306|11045715|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
9928163|NCT01281306|11045716|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
9928164|NCT01281306|11045717|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
9928165|NCT01281306|11045711|FG000|COMPLETED|Overall Study||136
9928166|NCT01281306|11045712|FG001|COMPLETED|Overall Study||141
9928167|NCT01281306|11045713|FG002|COMPLETED|Overall Study||133
9928168|NCT01281306|11045714|FG003|COMPLETED|Overall Study||123
9928169|NCT01281306|11045715|FG004|COMPLETED|Overall Study||134
9928170|NCT01281306|11045716|FG005|COMPLETED|Overall Study||135
9928171|NCT01281306|11045717|FG006|COMPLETED|Overall Study||51
9928172|NCT01281306|11045711|FG000|NOT COMPLETED|Overall Study||8
9928173|NCT01281306|11045712|FG001|NOT COMPLETED|Overall Study||4
9928174|NCT01281306|11045713|FG002|NOT COMPLETED|Overall Study||8
9928175|NCT01281306|11045714|FG003|NOT COMPLETED|Overall Study||11
10205488|NCT03493386|11332289|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
10205489|NCT03493386|11332290|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10205490|NCT03493386|11332291|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10205491|NCT03493386|11332288|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26
10205492|NCT03493386|11332289|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25
10205493|NCT03493386|11332290|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0
10205494|NCT03493386|11332291|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0
10205495|NCT03493386|11332288|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
10205496|NCT03493386|11332289|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
10205497|NCT03493386|11332290|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10205498|NCT03493386|11332291|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10205499|NCT03493386|11332288|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10205500|NCT03493386|11332289|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10205501|NCT03493386|11332290|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10205502|NCT03493386|11332291|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10205503|NCT03493386|11332288|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0
10205504|NCT03493386|11332289|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0
10205505|NCT03493386|11332290|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6
10205506|NCT03493386|11332291|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6
10205507|NCT03493386|11332288|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10205508|NCT03493386|11332289|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10205509|NCT03493386|11332290|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
10205510|NCT03493386|11332291|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
9928176|NCT01281306|11045715|FG004|NOT COMPLETED|Overall Study||9
9928177|NCT01281306|11045716|FG005|NOT COMPLETED|Overall Study||7
9928178|NCT01281306|11045717|FG006|NOT COMPLETED|Overall Study||7
9928179|NCT01281475|11045735|FG000|STARTED|Overall Study||33
9928180|NCT01281475|11045736|FG001|STARTED|Overall Study||34
9928181|NCT01281475|11045735|FG000|COMPLETED|Overall Study||29
9928182|NCT01281475|11045736|FG001|COMPLETED|Overall Study||26
9928183|NCT01281475|11045735|FG000|NOT COMPLETED|Overall Study||4
9928184|NCT01281475|11045736|FG001|NOT COMPLETED|Overall Study||8
9928185|NCT01281501|11045746|FG000|STARTED|Overall Study||44
9928186|NCT01281501|11045747|FG001|STARTED|Overall Study||43
9928187|NCT01281501|11045746|FG000|COMPLETED|Overall Study||44
9928188|NCT01281501|11045747|FG001|COMPLETED|Overall Study||43
9928189|NCT01281501|11045746|FG000|NOT COMPLETED|Overall Study||0
9928190|NCT01281501|11045747|FG001|NOT COMPLETED|Overall Study||0
9928191|NCT01281839|11045755|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
9928192|NCT01281839|11045756|FG001|STARTED|Overall Study||133
9928193|NCT01281839|11045755|FG000|COMPLETED|Overall Study||250
9928194|NCT01281839|11045756|FG001|COMPLETED|Overall Study||119
9928195|NCT01281839|11045755|FG000|NOT COMPLETED|Overall Study||10
9928196|NCT01281839|11045756|FG001|NOT COMPLETED|Overall Study||14
9928197|NCT01281865|11045764|FG000|STARTED|Overall Study||12
9928198|NCT01281865|11045765|FG001|STARTED|Overall Study||2
9928199|NCT01281865|11045764|FG000|COMPLETED|Overall Study||9
9928200|NCT01281865|11045765|FG001|COMPLETED|Overall Study||1
9928201|NCT01281865|11045764|FG000|NOT COMPLETED|Overall Study||3
9928202|NCT01281865|11045765|FG001|NOT COMPLETED|Overall Study||1
9928203|NCT01281917|11045771|FG000|STARTED|Overall Study||40
9928204|NCT01281917|11045771|FG000|COMPLETED|Overall Study||39
9928205|NCT01281917|11045771|FG000|NOT COMPLETED|Overall Study||1
9928206|NCT01281956|11045775|FG000|STARTED|1st Intervention (3 Months)||5
9928207|NCT01281956|11045776|FG001|STARTED|1st Intervention (3 Months)||5
9928208|NCT01281956|11045775|FG000|COMPLETED|1st Intervention (3 Months)||5
9928209|NCT01281956|11045776|FG001|COMPLETED|1st Intervention (3 Months)||5
9928210|NCT01281956|11045775|FG000|NOT COMPLETED|1st Intervention (3 Months)||0
9928211|NCT01281956|11045776|FG001|NOT COMPLETED|1st Intervention (3 Months)||0
9928212|NCT01281956|11045775|FG000|STARTED|2nd Intervention (3 Months)||5
9928213|NCT01281956|11045776|FG001|STARTED|2nd Intervention (3 Months)||5
9928214|NCT01281956|11045775|FG000|COMPLETED|2nd Intervention (3 Months)||4
9928215|NCT01281956|11045776|FG001|COMPLETED|2nd Intervention (3 Months)||5
9928216|NCT01281956|11045775|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1
9928217|NCT01281956|11045776|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0
9928218|NCT01281969|11045787|FG000|STARTED|Overall Study||18
9928219|NCT01281969|11045788|FG001|STARTED|Overall Study||18
9928220|NCT01281969|11045789|FG002|STARTED|Overall Study||12
9928221|NCT01281969|11045787|FG000|COMPLETED|Overall Study||17
9928222|NCT01281969|11045788|FG001|COMPLETED|Overall Study||18
9928223|NCT01281969|11045789|FG002|COMPLETED|Overall Study||0
9928224|NCT01281969|11045787|FG000|NOT COMPLETED|Overall Study||1
9928225|NCT01281969|11045788|FG001|NOT COMPLETED|Overall Study||0
9928226|NCT01281969|11045789|FG002|NOT COMPLETED|Overall Study||12
9928227|NCT01282086|11045797|FG000|STARTED|Overall Study||1365
9928228|NCT01282086|11045797|FG000|COMPLETED|Overall Study||1365
9928229|NCT01282086|11045797|FG000|NOT COMPLETED|Overall Study||0
9928230|NCT01282138|11045804|FG000|STARTED|EEC||6
9928231|NCT01282138|11045805|FG001|STARTED|EEC||7
9928232|NCT01282138|11045804|FG000|COMPLETED|EEC||6
9928233|NCT01282138|11045805|FG001|COMPLETED|EEC||7
9928234|NCT01282138|11045804|FG000|NOT COMPLETED|EEC||0
9928235|NCT01282138|11045805|FG001|NOT COMPLETED|EEC||0
9928236|NCT01282138|11045804|FG000|STARTED|CAPT||6
9928237|NCT01282138|11045805|FG001|STARTED|CAPT||7
9928238|NCT01282138|11045804|FG000|COMPLETED|CAPT||6
9928239|NCT01282138|11045805|FG001|COMPLETED|CAPT||7
9928240|NCT01282138|11045804|FG000|NOT COMPLETED|CAPT||0
9928241|NCT01282138|11045805|FG001|NOT COMPLETED|CAPT||0
9928242|NCT01282164|11045813|FG000|STARTED|Overall Study||29
9928243|NCT01282164|11045814|FG001|STARTED|Overall Study||14
9928244|NCT01282164|11045813|FG000|COMPLETED|Overall Study||28
9928245|NCT01282164|11045814|FG001|COMPLETED|Overall Study||14
9928246|NCT01282164|11045813|FG000|NOT COMPLETED|Overall Study||1
9928247|NCT01282164|11045814|FG001|NOT COMPLETED|Overall Study||0
9928248|NCT01282203|11045828|FG000|STARTED|Overall Study||1122
9928249|NCT01282203|11045828|FG000|COMPLETED|Overall Study||1121
9928250|NCT01282203|11045828|FG000|NOT COMPLETED|Overall Study||1
9928251|NCT01282229|11045835|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
9928252|NCT01282229|11045835|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
9928253|NCT01282229|11045835|FG000|NOT COMPLETED|Overall Study||2
9928254|NCT01282242|11045855|FG000|STARTED|Overall Study||80
9928255|NCT01282242|11045856|FG001|STARTED|Overall Study||8
9928256|NCT01282242|11045855|FG000|COMPLETED|Overall Study||80
9928257|NCT01282242|11045856|FG001|COMPLETED|Overall Study||8
9928258|NCT01282242|11045855|FG000|NOT COMPLETED|Overall Study||0
9928259|NCT01282242|11045856|FG001|NOT COMPLETED|Overall Study||0
9928260|NCT01282294|11045862|FG000|STARTED|Overall Study||100
9928261|NCT01282294|11045862|FG000|Intra-operative|Overall Study||99
9928262|NCT01282294|11045862|FG000|Post-operative|Overall Study||99
9928263|NCT01282294|11045862|FG000|6 Weeks|Overall Study||95
9928264|NCT01282294|11045862|FG000|3 Months|Overall Study||95
9928265|NCT01282294|11045862|FG000|6 Months|Overall Study||94
9928266|NCT01282294|11045862|FG000|12 Months|Overall Study||86
9928267|NCT01282294|11045862|FG000|COMPLETED|Overall Study||81
9928268|NCT01282294|11045862|FG000|NOT COMPLETED|Overall Study||19
9928269|NCT01282372|11045866|FG000|STARTED|Overall Study||500
9928270|NCT01282372|11045866|FG000|COMPLETED|Overall Study||421
9928271|NCT01282372|11045866|FG000|NOT COMPLETED|Overall Study||79
9928272|NCT01282424|11045877|FG000|STARTED|Treatment Period (TP) (81 Months)||125
9928273|NCT01282424|11045877|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
9928274|NCT01282424|11045877|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9
9928275|NCT01282424|11045877|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79
9928276|NCT01282424|11045877|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
9956116|NCT01442688|11075226|FG000|STARTED|First Intervention||31
9928277|NCT01282424|11045877|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
9928278|NCT01282424|11045877|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20
9928279|NCT01282424|11045877|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
9928280|NCT01282463|11045884|FG000|STARTED|Overall Study||49
9928281|NCT01282463|11045885|FG001|STARTED|Overall Study||49
9928282|NCT01282463|11045886|FG002|STARTED|Overall Study||50
9928283|NCT01282463|11045884|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
9928284|NCT01282463|11045885|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46
9928285|NCT01282463|11045886|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
9928286|NCT01282463|11045884|FG000|COMPLETED|Overall Study||41
9928287|NCT01282463|11045885|FG001|COMPLETED|Overall Study||45
9928288|NCT01282463|11045886|FG002|COMPLETED|Overall Study||46
9928289|NCT01282463|11045884|FG000|NOT COMPLETED|Overall Study||8
9928290|NCT01282463|11045885|FG001|NOT COMPLETED|Overall Study||4
9928291|NCT01282463|11045886|FG002|NOT COMPLETED|Overall Study||4
9928292|NCT01282476|11045902|FG000|STARTED|Overall Study||18
9928293|NCT01282476|11045902|FG000|COMPLETED|Overall Study||7
9928294|NCT01282476|11045902|FG000|NOT COMPLETED|Overall Study||11
9928295|NCT01282710|11045906|FG000|STARTED|Overall Study||20
9928296|NCT01282710|11045906|FG000|COMPLETED|Overall Study||20
9928297|NCT01282710|11045906|FG000|NOT COMPLETED|Overall Study||0
9928298|NCT01282723|11045910|FG000|STARTED|Overall Study||20
9928299|NCT01282723|11045910|FG000|COMPLETED|Overall Study||20
9928300|NCT01282723|11045910|FG000|NOT COMPLETED|Overall Study||0
9928301|NCT01282801|11045916|FG000|STARTED|First Intervention||9
9928302|NCT01282801|11045917|FG001|STARTED|First Intervention||9
9928303|NCT01282801|11045916|FG000|COMPLETED|First Intervention||9
9928304|NCT01282801|11045917|FG001|COMPLETED|First Intervention||9
9928305|NCT01282801|11045916|FG000|NOT COMPLETED|First Intervention||0
9928306|NCT01282801|11045917|FG001|NOT COMPLETED|First Intervention||0
9928307|NCT01282801|11045916|FG000|STARTED|Washout of 7 Days||9
9928308|NCT01282801|11045917|FG001|STARTED|Washout of 7 Days||9
9928309|NCT01282801|11045916|FG000|COMPLETED|Washout of 7 Days||9
9928310|NCT01282801|11045917|FG001|COMPLETED|Washout of 7 Days||9
9928311|NCT01282801|11045916|FG000|NOT COMPLETED|Washout of 7 Days||0
9928312|NCT01282801|11045917|FG001|NOT COMPLETED|Washout of 7 Days||0
9928313|NCT01282801|11045916|FG000|STARTED|Second Intervention||9
9928314|NCT01282801|11045917|FG001|STARTED|Second Intervention||9
9928315|NCT01282801|11045916|FG000|COMPLETED|Second Intervention||9
9928316|NCT01282801|11045917|FG001|COMPLETED|Second Intervention||8
9928317|NCT01282801|11045916|FG000|NOT COMPLETED|Second Intervention||0
9928318|NCT01282801|11045917|FG001|NOT COMPLETED|Second Intervention||1
9928319|NCT01282814|11045925|FG000|STARTED|First Intervention||12
10111458|NCT02496702|11242541|FG000|Did Not Receive Allocated Intervention|Overall Study||9
10111459|NCT02496702|11242542|FG001|Did Not Receive Allocated Intervention|Overall Study||0
10111460|NCT02496702|11242541|FG000|COMPLETED|Overall Study||22
10111461|NCT02496702|11242542|FG001|COMPLETED|Overall Study||22
10111462|NCT02496702|11242541|FG000|NOT COMPLETED|Overall Study||8
10111463|NCT02496702|11242542|FG001|NOT COMPLETED|Overall Study||8
10111464|NCT02496767|11242552|FG000|STARTED|Open-label Lead-in Phase||744
10111465|NCT02496767|11242553|FG001|STARTED|Open-label Lead-in Phase||0
10111466|NCT02496767|11242554|FG002|STARTED|Open-label Lead-in Phase||0
10111467|NCT02496767|11242555|FG003|STARTED|Open-label Lead-in Phase||0
9928320|NCT01282814|11045926|FG001|STARTED|First Intervention||12
9928321|NCT01282814|11045925|FG000|COMPLETED|First Intervention||12
9928322|NCT01282814|11045926|FG001|COMPLETED|First Intervention||9
9928323|NCT01282814|11045925|FG000|NOT COMPLETED|First Intervention||0
9928324|NCT01282814|11045926|FG001|NOT COMPLETED|First Intervention||3
9928325|NCT01282814|11045925|FG000|STARTED|Washout of 7 Days||12
9928326|NCT01282814|11045926|FG001|STARTED|Washout of 7 Days||9
9928327|NCT01282814|11045925|FG000|COMPLETED|Washout of 7 Days||10
9928328|NCT01282814|11045926|FG001|COMPLETED|Washout of 7 Days||9
9928329|NCT01282814|11045925|FG000|NOT COMPLETED|Washout of 7 Days||2
9928330|NCT01282814|11045926|FG001|NOT COMPLETED|Washout of 7 Days||0
9928331|NCT01282814|11045925|FG000|STARTED|Second Intervention||10
9928332|NCT01282814|11045926|FG001|STARTED|Second Intervention||9
9928333|NCT01282814|11045925|FG000|COMPLETED|Second Intervention||10
9928334|NCT01282814|11045926|FG001|COMPLETED|Second Intervention||9
9928335|NCT01282814|11045925|FG000|NOT COMPLETED|Second Intervention||0
9928336|NCT01282814|11045926|FG001|NOT COMPLETED|Second Intervention||0
9928337|NCT01282866|11045932|FG000|STARTED|Overall Study||35
9928338|NCT01282866|11045932|FG000|COMPLETED|Overall Study||34
9928339|NCT01282866|11045932|FG000|NOT COMPLETED|Overall Study||1
9928340|NCT01283009|11045938|FG000|STARTED|Overall Study||287
9928341|NCT01283009|11045939|FG001|STARTED|Overall Study||297
9928342|NCT01283009|11045938|FG000|COMPLETED|Overall Study||169
9928343|NCT01283009|11045939|FG001|COMPLETED|Overall Study||180
9928344|NCT01283009|11045938|FG000|NOT COMPLETED|Overall Study||118
9928345|NCT01283009|11045939|FG001|NOT COMPLETED|Overall Study||117
9928346|NCT01283022|11045945|FG000|STARTED|Overall Study||24
9928347|NCT01283022|11045945|FG000|COMPLETED|Overall Study||24
9928348|NCT01283022|11045945|FG000|NOT COMPLETED|Overall Study||0
9928349|NCT01283035|11045950|FG000|STARTED|Overall Study||6
9928350|NCT01283035|11045950|FG000|COMPLETED|Overall Study||5
9928351|NCT01283035|11045950|FG000|NOT COMPLETED|Overall Study||1
9928352|NCT01283139|11045958|FG000|STARTED|Overall Study||108
9928353|NCT01283139|11045959|FG001|STARTED|Overall Study||108
9928354|NCT01283139|11045960|FG002|STARTED|Overall Study||109
9928355|NCT01283139|11045961|FG003|STARTED|Overall Study||107
9928356|NCT01283139|11045958|FG000|COMPLETED|Overall Study||91
9928357|NCT01283139|11045959|FG001|COMPLETED|Overall Study||90
9928358|NCT01283139|11045960|FG002|COMPLETED|Overall Study||91
9928359|NCT01283139|11045961|FG003|COMPLETED|Overall Study||92
9928360|NCT01283139|11045958|FG000|NOT COMPLETED|Overall Study||17
9928361|NCT01283139|11045959|FG001|NOT COMPLETED|Overall Study||18
9928362|NCT01283139|11045960|FG002|NOT COMPLETED|Overall Study||18
9928363|NCT01283139|11045961|FG003|NOT COMPLETED|Overall Study||15
9928364|NCT01283152|11045973|FG000|STARTED|Overall Study||25
9928365|NCT01283152|11045974|FG001|STARTED|Overall Study||25
9928366|NCT01283152|11045973|FG000|ITT Population|Overall Study||25
9928367|NCT01283152|11045974|FG001|ITT Population|Overall Study||25
9928368|NCT01283152|11045973|FG000|Study Treatment Received|Overall Study||25
9928369|NCT01283152|11045974|FG001|Study Treatment Received|Overall Study||25
9928370|NCT01283152|11045973|FG000|24-hr HESA Attempted|Overall Study||25
9928371|NCT01283152|11045974|FG001|24-hr HESA Attempted|Overall Study||25
9928372|NCT01283152|11045973|FG000|COMPLETED|Overall Study||23
9928373|NCT01283152|11045974|FG001|COMPLETED|Overall Study||25
9928374|NCT01283152|11045973|FG000|NOT COMPLETED|Overall Study||2
9928375|NCT01283152|11045974|FG001|NOT COMPLETED|Overall Study||0
9928376|NCT01283282|11045980|FG000|STARTED|First Intervention (6 Weeks)||25
9928377|NCT01283282|11045981|FG001|STARTED|First Intervention (6 Weeks)||23
9928378|NCT01283282|11045980|FG000|COMPLETED|First Intervention (6 Weeks)||22
9928379|NCT01283282|11045981|FG001|COMPLETED|First Intervention (6 Weeks)||19
9928380|NCT01283282|11045980|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3
9928381|NCT01283282|11045981|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4
9928382|NCT01283282|11045980|FG000|STARTED|Second Intervention (6 Weeks)||22
9928383|NCT01283282|11045981|FG001|STARTED|Second Intervention (6 Weeks)||19
9928384|NCT01283282|11045980|FG000|COMPLETED|Second Intervention (6 Weeks)||22
9928385|NCT01283282|11045981|FG001|COMPLETED|Second Intervention (6 Weeks)||19
9928386|NCT01283282|11045980|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9928387|NCT01283282|11045981|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9928388|NCT01283321|11045990|FG000|STARTED|Overall Study||10
9928389|NCT01283321|11045991|FG001|STARTED|Overall Study||10
9928390|NCT01283321|11045990|FG000|COMPLETED|Overall Study||10
9928391|NCT01283321|11045991|FG001|COMPLETED|Overall Study||10
9928392|NCT01283321|11045990|FG000|NOT COMPLETED|Overall Study||0
9928393|NCT01283321|11045991|FG001|NOT COMPLETED|Overall Study||0
9928394|NCT01283334|11045999|FG000|STARTED|Overall Study||20
9928395|NCT01283334|11045999|FG000|COMPLETED|Overall Study||13
9928396|NCT01283334|11045999|FG000|NOT COMPLETED|Overall Study||7
9928397|NCT01283386|11046007|FG000|STARTED|Overall Study||10
9928398|NCT01283386|11046008|FG001|STARTED|Overall Study||16
9928399|NCT01283386|11046007|FG000|COMPLETED|Overall Study||2
9928400|NCT01283386|11046008|FG001|COMPLETED|Overall Study||4
9928401|NCT01283386|11046007|FG000|NOT COMPLETED|Overall Study||8
9928402|NCT01283386|11046008|FG001|NOT COMPLETED|Overall Study||12
9928403|NCT01283464|11046016|FG000|STARTED|Overall Study||12
9928404|NCT01283464|11046017|FG001|STARTED|Overall Study||12
9928405|NCT01283464|11046016|FG000|COMPLETED|Overall Study||10
9928406|NCT01283464|11046017|FG001|COMPLETED|Overall Study||11
9928407|NCT01283464|11046016|FG000|NOT COMPLETED|Overall Study||2
9928408|NCT01283464|11046017|FG001|NOT COMPLETED|Overall Study||1
9928409|NCT01283516|11046032|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
9928410|NCT01283516|11046033|FG001|STARTED|Overall Study||2
9928411|NCT01283516|11046034|FG002|STARTED|Overall Study||3
9928412|NCT01283516|11046035|FG003|STARTED|Overall Study||3
9928413|NCT01283516|11046036|FG004|STARTED|Overall Study||14
9928414|NCT01283516|11046037|FG005|STARTED|Overall Study||10
9928415|NCT01283516|11046038|FG006|STARTED|Overall Study||10
9928416|NCT01283516|11046039|FG007|STARTED|Overall Study||5
9928417|NCT01283516|11046040|FG008|STARTED|Overall Study||255
9928418|NCT01283516|11046032|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
9928419|NCT01283516|11046033|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
9928420|NCT01283516|11046034|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
9928421|NCT01283516|11046035|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
9928422|NCT01283516|11046036|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
9928423|NCT01283516|11046037|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
9928424|NCT01283516|11046038|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
9928425|NCT01283516|11046039|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
9928426|NCT01283516|11046040|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
9928427|NCT01283516|11046032|FG000|Dose-Determining Set (DDS)|Overall Study||2
9928428|NCT01283516|11046033|FG001|Dose-Determining Set (DDS)|Overall Study||1
9928429|NCT01283516|11046034|FG002|Dose-Determining Set (DDS)|Overall Study||3
9928430|NCT01283516|11046035|FG003|Dose-Determining Set (DDS)|Overall Study||3
9928431|NCT01283516|11046036|FG004|Dose-Determining Set (DDS)|Overall Study||14
9928432|NCT01283516|11046037|FG005|Dose-Determining Set (DDS)|Overall Study||8
9928433|NCT01283516|11046038|FG006|Dose-Determining Set (DDS)|Overall Study||10
9928434|NCT01283516|11046039|FG007|Dose-Determining Set (DDS)|Overall Study||5
9928435|NCT01283516|11046040|FG008|Dose-Determining Set (DDS)|Overall Study||8
9928436|NCT01283516|11046032|FG000|Non-NSCLC|Overall Study||0
9928437|NCT01283516|11046033|FG001|Non-NSCLC|Overall Study||1
9928438|NCT01283516|11046034|FG002|Non-NSCLC|Overall Study||1
9928439|NCT01283516|11046035|FG003|Non-NSCLC|Overall Study||0
9928440|NCT01283516|11046036|FG004|Non-NSCLC|Overall Study||2
9928441|NCT01283516|11046037|FG005|Non-NSCLC|Overall Study||0
9928442|NCT01283516|11046038|FG006|Non-NSCLC|Overall Study||1
9928443|NCT01283516|11046039|FG007|Non-NSCLC|Overall Study||0
9928444|NCT01283516|11046040|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
9928445|NCT01283516|11046032|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
9928446|NCT01283516|11046033|FG001|COMPLETED|Overall Study||0
9928447|NCT01283516|11046034|FG002|COMPLETED|Overall Study||0
9928448|NCT01283516|11046035|FG003|COMPLETED|Overall Study||0
9928449|NCT01283516|11046036|FG004|COMPLETED|Overall Study||0
9928450|NCT01283516|11046037|FG005|COMPLETED|Overall Study||0
9928451|NCT01283516|11046038|FG006|COMPLETED|Overall Study||0
10010852|NCT01775904|11133500|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24
10010853|NCT01775904|11133500|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
10010854|NCT01775930|11133510|FG000|STARTED|Overall Study||10
9928452|NCT01283516|11046039|FG007|COMPLETED|Overall Study||0
9928453|NCT01283516|11046040|FG008|COMPLETED|Overall Study||0
9928454|NCT01283516|11046032|FG000|NOT COMPLETED|Overall Study||2
9928455|NCT01283516|11046033|FG001|NOT COMPLETED|Overall Study||2
9928456|NCT01283516|11046034|FG002|NOT COMPLETED|Overall Study||3
9928457|NCT01283516|11046035|FG003|NOT COMPLETED|Overall Study||3
9928458|NCT01283516|11046036|FG004|NOT COMPLETED|Overall Study||14
9928459|NCT01283516|11046037|FG005|NOT COMPLETED|Overall Study||10
9928460|NCT01283516|11046038|FG006|NOT COMPLETED|Overall Study||10
9928461|NCT01283516|11046039|FG007|NOT COMPLETED|Overall Study||5
9928462|NCT01283516|11046040|FG008|NOT COMPLETED|Overall Study||255
9928463|NCT01283542|11046068|FG000|STARTED|Main Phase||20
9928464|NCT01283542|11046068|FG000|Full Analysis Set (FAS)|Main Phase||20
9928465|NCT01283542|11046068|FG000|Safety Analysis Set|Main Phase||20
9928466|NCT01283542|11046068|FG000|COMPLETED|Main Phase||13
9928467|NCT01283542|11046068|FG000|NOT COMPLETED|Main Phase||7
9928468|NCT01283542|11046068|FG000|STARTED|Extension Phase||13
9928469|NCT01283542|11046068|FG000|Full Analysis Set (FAS)|Extension Phase||13
9928470|NCT01283542|11046068|FG000|Safety Analysis Set|Extension Phase||13
9928471|NCT01283542|11046068|FG000|COMPLETED|Extension Phase||10
9928472|NCT01283542|11046068|FG000|NOT COMPLETED|Extension Phase||3
9928473|NCT01283555|11046090|FG000|STARTED|First Intervention||13
9928474|NCT01283555|11046091|FG001|STARTED|First Intervention||12
9928475|NCT01283555|11046090|FG000|COMPLETED|First Intervention||13
9928476|NCT01283555|11046091|FG001|COMPLETED|First Intervention||12
9928477|NCT01283555|11046090|FG000|NOT COMPLETED|First Intervention||0
9928478|NCT01283555|11046091|FG001|NOT COMPLETED|First Intervention||0
9928479|NCT01283555|11046090|FG000|STARTED|Washout Period of at Least 21 Days||13
9928480|NCT01283555|11046091|FG001|STARTED|Washout Period of at Least 21 Days||12
9928481|NCT01283555|11046090|FG000|COMPLETED|Washout Period of at Least 21 Days||13
9928482|NCT01283555|11046091|FG001|COMPLETED|Washout Period of at Least 21 Days||12
9928483|NCT01283555|11046090|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0
9928484|NCT01283555|11046091|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0
9928485|NCT01283555|11046090|FG000|STARTED|Second Intervention||13
9928486|NCT01283555|11046091|FG001|STARTED|Second Intervention||12
9928487|NCT01283555|11046090|FG000|COMPLETED|Second Intervention||13
9928488|NCT01283555|11046091|FG001|COMPLETED|Second Intervention||12
9928489|NCT01283555|11046090|FG000|NOT COMPLETED|Second Intervention||0
9928490|NCT01283555|11046091|FG001|NOT COMPLETED|Second Intervention||0
9928491|NCT01283581|11046104|FG000|STARTED|Overall Study||81
9928492|NCT01283581|11046105|FG001|STARTED|Overall Study||77
9928493|NCT01283581|11046106|FG002|STARTED|Overall Study||98
9928494|NCT01283581|11046104|FG000|COMPLETED|Overall Study||69
9928495|NCT01283581|11046105|FG001|COMPLETED|Overall Study||63
9928496|NCT01283581|11046106|FG002|COMPLETED|Overall Study||78
9928497|NCT01283581|11046104|FG000|NOT COMPLETED|Overall Study||12
9928498|NCT01283581|11046105|FG001|NOT COMPLETED|Overall Study||14
9928499|NCT01283581|11046106|FG002|NOT COMPLETED|Overall Study||20
9928500|NCT01283971|11046119|FG000|STARTED|Overall Study||48
9928501|NCT01283971|11046120|FG001|STARTED|Overall Study||48
9928502|NCT01283971|11046119|FG000|Intent to Treat Population|Overall Study||46
9928503|NCT01283971|11046120|FG001|Intent to Treat Population|Overall Study||48
9928504|NCT01283971|11046119|FG000|COMPLETED|Overall Study||33
9928505|NCT01283971|11046120|FG001|COMPLETED|Overall Study||36
9928506|NCT01283971|11046119|FG000|NOT COMPLETED|Overall Study||15
9928507|NCT01283971|11046120|FG001|NOT COMPLETED|Overall Study||12
9928508|NCT01284062|11046130|FG000|STARTED|Overall Study||21
9928509|NCT01284062|11046131|FG001|STARTED|Overall Study||21
9928510|NCT01284062|11046132|FG002|STARTED|Overall Study||21
9928511|NCT01284062|11046133|FG003|STARTED|Overall Study||21
9928512|NCT01284062|11046130|FG000|COMPLETED|Overall Study||10
9928513|NCT01284062|11046131|FG001|COMPLETED|Overall Study||13
9928514|NCT01284062|11046132|FG002|COMPLETED|Overall Study||15
9928515|NCT01284062|11046133|FG003|COMPLETED|Overall Study||7
9928516|NCT01284062|11046130|FG000|NOT COMPLETED|Overall Study||11
9928517|NCT01284062|11046131|FG001|NOT COMPLETED|Overall Study||8
9928518|NCT01284062|11046132|FG002|NOT COMPLETED|Overall Study||6
9928519|NCT01284062|11046133|FG003|NOT COMPLETED|Overall Study||14
9928520|NCT01284114|11046146|FG000|STARTED|Overall Study||23
9928521|NCT01284114|11046146|FG000|COMPLETED|Overall Study||19
9928522|NCT01284114|11046146|FG000|NOT COMPLETED|Overall Study||4
9928523|NCT01284127|11046151|FG000|STARTED|Overall Study||38
9928524|NCT01284127|11046151|FG000|COMPLETED|Overall Study||31
9928525|NCT01284127|11046151|FG000|NOT COMPLETED|Overall Study||7
9928526|NCT01284140|11046157|FG000|STARTED|Randomization and Intervention||11
9928527|NCT01284140|11046158|FG001|STARTED|Randomization and Intervention||11
9928528|NCT01284140|11046157|FG000|COMPLETED|Randomization and Intervention||11
9928529|NCT01284140|11046158|FG001|COMPLETED|Randomization and Intervention||11
9928530|NCT01284140|11046157|FG000|NOT COMPLETED|Randomization and Intervention||0
9928531|NCT01284140|11046158|FG001|NOT COMPLETED|Randomization and Intervention||0
9928532|NCT01284140|11046157|FG000|STARTED|Subjects With Paired 24hr Collections||11
9928533|NCT01284140|11046158|FG001|STARTED|Subjects With Paired 24hr Collections||11
9928534|NCT01284140|11046157|FG000|COMPLETED|Subjects With Paired 24hr Collections||6
9928535|NCT01284140|11046158|FG001|COMPLETED|Subjects With Paired 24hr Collections||5
9928536|NCT01284140|11046157|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5
9928537|NCT01284140|11046158|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6
9928538|NCT01284244|11046166|FG000|STARTED|Overall Study||18
9928539|NCT01284244|11046167|FG001|STARTED|Overall Study||18
9928540|NCT01284244|11046166|FG000|COMPLETED|Overall Study||18
9928541|NCT01284244|11046167|FG001|COMPLETED|Overall Study||18
9928542|NCT01284244|11046166|FG000|NOT COMPLETED|Overall Study||0
9928543|NCT01284244|11046167|FG001|NOT COMPLETED|Overall Study||0
9928544|NCT01284296|11046173|FG000|STARTED|Overall Study||20
9928545|NCT01284296|11046173|FG000|COMPLETED|Overall Study||20
9928546|NCT01284296|11046173|FG000|NOT COMPLETED|Overall Study||0
9928547|NCT01284335|11046191|FG000|STARTED|Overall Study||25
9928548|NCT01284335|11046192|FG001|STARTED|Overall Study||33
9928549|NCT01284335|11046193|FG002|STARTED|Overall Study||5
9928550|NCT01284335|11046194|FG003|STARTED|Overall Study||5
9928551|NCT01284335|11046195|FG004|STARTED|Overall Study||24
9928552|NCT01284335|11046196|FG005|STARTED|Overall Study||26
9928553|NCT01284335|11046197|FG006|STARTED|Overall Study||19
9928554|NCT01284335|11046198|FG007|STARTED|Overall Study||6
9928555|NCT01284335|11046199|FG008|STARTED|Overall Study||4
9928556|NCT01284335|11046200|FG009|STARTED|Overall Study||14
9928557|NCT01284335|11046201|FG010|STARTED|Overall Study||45
9928558|NCT01284335|11046202|FG011|STARTED|Overall Study||16
9928559|NCT01284335|11046203|FG012|STARTED|Overall Study||12
9928560|NCT01284335|11046191|FG000|Received at Least One Dose of Study Drug|Overall Study||25
9928561|NCT01284335|11046192|FG001|Received at Least One Dose of Study Drug|Overall Study||33
9928562|NCT01284335|11046193|FG002|Received at Least One Dose of Study Drug|Overall Study||5
9928563|NCT01284335|11046194|FG003|Received at Least One Dose of Study Drug|Overall Study||5
9928564|NCT01284335|11046195|FG004|Received at Least One Dose of Study Drug|Overall Study||24
9928565|NCT01284335|11046196|FG005|Received at Least One Dose of Study Drug|Overall Study||26
9928566|NCT01284335|11046197|FG006|Received at Least One Dose of Study Drug|Overall Study||19
9928567|NCT01284335|11046198|FG007|Received at Least One Dose of Study Drug|Overall Study||6
9928568|NCT01284335|11046199|FG008|Received at Least One Dose of Study Drug|Overall Study||4
9928569|NCT01284335|11046200|FG009|Received at Least One Dose of Study Drug|Overall Study||14
9928570|NCT01284335|11046201|FG010|Received at Least One Dose of Study Drug|Overall Study||45
9928571|NCT01284335|11046202|FG011|Received at Least One Dose of Study Drug|Overall Study||16
9928572|NCT01284335|11046203|FG012|Received at Least One Dose of Study Drug|Overall Study||12
9928573|NCT01284335|11046191|FG000|COMPLETED|Overall Study||25
9928574|NCT01284335|11046192|FG001|COMPLETED|Overall Study||33
9928575|NCT01284335|11046193|FG002|COMPLETED|Overall Study||5
9928576|NCT01284335|11046194|FG003|COMPLETED|Overall Study||5
9928577|NCT01284335|11046195|FG004|COMPLETED|Overall Study||24
9928578|NCT01284335|11046196|FG005|COMPLETED|Overall Study||26
9928579|NCT01284335|11046197|FG006|COMPLETED|Overall Study||19
9928580|NCT01284335|11046198|FG007|COMPLETED|Overall Study||6
9928581|NCT01284335|11046199|FG008|COMPLETED|Overall Study||4
9928582|NCT01284335|11046200|FG009|COMPLETED|Overall Study||14
9928583|NCT01284335|11046201|FG010|COMPLETED|Overall Study||45
9928584|NCT01284335|11046202|FG011|COMPLETED|Overall Study||16
9928585|NCT01284335|11046203|FG012|COMPLETED|Overall Study||12
9928586|NCT01284335|11046191|FG000|NOT COMPLETED|Overall Study||0
9928587|NCT01284335|11046192|FG001|NOT COMPLETED|Overall Study||0
9928588|NCT01284335|11046193|FG002|NOT COMPLETED|Overall Study||0
9928589|NCT01284335|11046194|FG003|NOT COMPLETED|Overall Study||0
9928590|NCT01284335|11046195|FG004|NOT COMPLETED|Overall Study||0
9928591|NCT01284335|11046196|FG005|NOT COMPLETED|Overall Study||0
9928592|NCT01284335|11046197|FG006|NOT COMPLETED|Overall Study||0
9928593|NCT01284335|11046198|FG007|NOT COMPLETED|Overall Study||0
9928594|NCT01284335|11046199|FG008|NOT COMPLETED|Overall Study||0
9928595|NCT01284335|11046200|FG009|NOT COMPLETED|Overall Study||0
9928596|NCT01284335|11046201|FG010|NOT COMPLETED|Overall Study||0
9928597|NCT01284335|11046202|FG011|NOT COMPLETED|Overall Study||0
9928598|NCT01284335|11046203|FG012|NOT COMPLETED|Overall Study||0
9928599|NCT01284361|11046243|FG000|STARTED|Overall Study||91
9928600|NCT01284361|11046243|FG000|COMPLETED|Overall Study||82
9928601|NCT01284361|11046243|FG000|NOT COMPLETED|Overall Study||9
9928602|NCT01284426|11046250|FG000|STARTED|Overall Study||94
9928603|NCT01284426|11046250|FG000|COMPLETED|Overall Study||92
9928604|NCT01284426|11046250|FG000|NOT COMPLETED|Overall Study||2
9928605|NCT01284517|11046256|FG000|STARTED|Overall Study||180
9928606|NCT01284517|11046257|FG001|STARTED|Overall Study||176
9928607|NCT01284517|11046256|FG000|COMPLETED|Overall Study||148
9928608|NCT01284517|11046257|FG001|COMPLETED|Overall Study||140
9928609|NCT01284517|11046256|FG000|NOT COMPLETED|Overall Study||32
9928610|NCT01284517|11046257|FG001|NOT COMPLETED|Overall Study||36
9928611|NCT01284621|11046263|FG000|STARTED|First Intervention (8 Days)||3
9928612|NCT01284621|11046264|FG001|STARTED|First Intervention (8 Days)||4
9928613|NCT01284621|11046265|FG002|STARTED|First Intervention (8 Days)||4
9928614|NCT01284621|11046266|FG003|STARTED|First Intervention (8 Days)||4
9928615|NCT01284621|11046267|FG004|STARTED|First Intervention (8 Days)||4
9928616|NCT01284621|11046268|FG005|STARTED|First Intervention (8 Days)||4
9928617|NCT01284621|11046263|FG000|COMPLETED|First Intervention (8 Days)||3
9928618|NCT01284621|11046264|FG001|COMPLETED|First Intervention (8 Days)||4
9928619|NCT01284621|11046265|FG002|COMPLETED|First Intervention (8 Days)||4
9928620|NCT01284621|11046266|FG003|COMPLETED|First Intervention (8 Days)||4
9928621|NCT01284621|11046267|FG004|COMPLETED|First Intervention (8 Days)||4
9928622|NCT01284621|11046268|FG005|COMPLETED|First Intervention (8 Days)||4
9928623|NCT01284621|11046263|FG000|NOT COMPLETED|First Intervention (8 Days)||0
9928624|NCT01284621|11046264|FG001|NOT COMPLETED|First Intervention (8 Days)||0
9928625|NCT01284621|11046265|FG002|NOT COMPLETED|First Intervention (8 Days)||0
9928626|NCT01284621|11046266|FG003|NOT COMPLETED|First Intervention (8 Days)||0
9928627|NCT01284621|11046267|FG004|NOT COMPLETED|First Intervention (8 Days)||0
9928628|NCT01284621|11046268|FG005|NOT COMPLETED|First Intervention (8 Days)||0
9928629|NCT01284621|11046263|FG000|STARTED|Washout Period 1 (7 Days)||3
9928630|NCT01284621|11046264|FG001|STARTED|Washout Period 1 (7 Days)||4
9928631|NCT01284621|11046265|FG002|STARTED|Washout Period 1 (7 Days)||4
9928632|NCT01284621|11046266|FG003|STARTED|Washout Period 1 (7 Days)||4
9928633|NCT01284621|11046267|FG004|STARTED|Washout Period 1 (7 Days)||4
9928634|NCT01284621|11046268|FG005|STARTED|Washout Period 1 (7 Days)||4
9928635|NCT01284621|11046263|FG000|COMPLETED|Washout Period 1 (7 Days)||3
9928636|NCT01284621|11046264|FG001|COMPLETED|Washout Period 1 (7 Days)||4
9928637|NCT01284621|11046265|FG002|COMPLETED|Washout Period 1 (7 Days)||4
9928638|NCT01284621|11046266|FG003|COMPLETED|Washout Period 1 (7 Days)||4
9928639|NCT01284621|11046267|FG004|COMPLETED|Washout Period 1 (7 Days)||3
9928640|NCT01284621|11046268|FG005|COMPLETED|Washout Period 1 (7 Days)||4
9928641|NCT01284621|11046263|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9928642|NCT01284621|11046264|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9928643|NCT01284621|11046265|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9928644|NCT01284621|11046266|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
9928645|NCT01284621|11046267|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1
9928646|NCT01284621|11046268|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
9928647|NCT01284621|11046263|FG000|STARTED|Second Intervention (8 Days)||3
9928648|NCT01284621|11046264|FG001|STARTED|Second Intervention (8 Days)||4
9928649|NCT01284621|11046265|FG002|STARTED|Second Intervention (8 Days)||4
9928650|NCT01284621|11046266|FG003|STARTED|Second Intervention (8 Days)||4
9928651|NCT01284621|11046267|FG004|STARTED|Second Intervention (8 Days)||3
9928652|NCT01284621|11046268|FG005|STARTED|Second Intervention (8 Days)||4
9928653|NCT01284621|11046263|FG000|COMPLETED|Second Intervention (8 Days)||3
9928654|NCT01284621|11046264|FG001|COMPLETED|Second Intervention (8 Days)||4
9928655|NCT01284621|11046265|FG002|COMPLETED|Second Intervention (8 Days)||4
9928656|NCT01284621|11046266|FG003|COMPLETED|Second Intervention (8 Days)||4
9928657|NCT01284621|11046267|FG004|COMPLETED|Second Intervention (8 Days)||3
9928658|NCT01284621|11046268|FG005|COMPLETED|Second Intervention (8 Days)||4
9928659|NCT01284621|11046263|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
9928660|NCT01284621|11046264|FG001|NOT COMPLETED|Second Intervention (8 Days)||0
9928661|NCT01284621|11046265|FG002|NOT COMPLETED|Second Intervention (8 Days)||0
9928662|NCT01284621|11046266|FG003|NOT COMPLETED|Second Intervention (8 Days)||0
9928663|NCT01284621|11046267|FG004|NOT COMPLETED|Second Intervention (8 Days)||0
9928664|NCT01284621|11046268|FG005|NOT COMPLETED|Second Intervention (8 Days)||0
9928665|NCT01284621|11046263|FG000|STARTED|Washout Period 2 (7 Days)||3
9928666|NCT01284621|11046264|FG001|STARTED|Washout Period 2 (7 Days)||4
9928667|NCT01284621|11046265|FG002|STARTED|Washout Period 2 (7 Days)||4
9928668|NCT01284621|11046266|FG003|STARTED|Washout Period 2 (7 Days)||4
9928669|NCT01284621|11046267|FG004|STARTED|Washout Period 2 (7 Days)||3
9928670|NCT01284621|11046268|FG005|STARTED|Washout Period 2 (7 Days)||4
9928671|NCT01284621|11046263|FG000|COMPLETED|Washout Period 2 (7 Days)||3
9928672|NCT01284621|11046264|FG001|COMPLETED|Washout Period 2 (7 Days)||4
9928673|NCT01284621|11046265|FG002|COMPLETED|Washout Period 2 (7 Days)||4
9928674|NCT01284621|11046266|FG003|COMPLETED|Washout Period 2 (7 Days)||4
9928675|NCT01284621|11046267|FG004|COMPLETED|Washout Period 2 (7 Days)||3
9928676|NCT01284621|11046268|FG005|COMPLETED|Washout Period 2 (7 Days)||4
9928677|NCT01284621|11046263|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9928678|NCT01284621|11046264|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9928679|NCT01284621|11046265|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9928680|NCT01284621|11046266|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9928681|NCT01284621|11046267|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
9928682|NCT01284621|11046268|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
9928683|NCT01284621|11046263|FG000|STARTED|Third Intervention (8 Days)||3
9928684|NCT01284621|11046264|FG001|STARTED|Third Intervention (8 Days)||4
9928685|NCT01284621|11046265|FG002|STARTED|Third Intervention (8 Days)||4
9928686|NCT01284621|11046266|FG003|STARTED|Third Intervention (8 Days)||4
9928687|NCT01284621|11046267|FG004|STARTED|Third Intervention (8 Days)||3
9928688|NCT01284621|11046268|FG005|STARTED|Third Intervention (8 Days)||4
9928689|NCT01284621|11046263|FG000|COMPLETED|Third Intervention (8 Days)||3
9928690|NCT01284621|11046264|FG001|COMPLETED|Third Intervention (8 Days)||4
9928691|NCT01284621|11046265|FG002|COMPLETED|Third Intervention (8 Days)||4
9928692|NCT01284621|11046266|FG003|COMPLETED|Third Intervention (8 Days)||4
9928693|NCT01284621|11046267|FG004|COMPLETED|Third Intervention (8 Days)||3
9928694|NCT01284621|11046268|FG005|COMPLETED|Third Intervention (8 Days)||4
9928695|NCT01284621|11046263|FG000|NOT COMPLETED|Third Intervention (8 Days)||0
9928696|NCT01284621|11046264|FG001|NOT COMPLETED|Third Intervention (8 Days)||0
9928697|NCT01284621|11046265|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
9928698|NCT01284621|11046266|FG003|NOT COMPLETED|Third Intervention (8 Days)||0
9928699|NCT01284621|11046267|FG004|NOT COMPLETED|Third Intervention (8 Days)||0
9928700|NCT01284621|11046268|FG005|NOT COMPLETED|Third Intervention (8 Days)||0
9928701|NCT01284634|11046282|FG000|STARTED|Overall Study||7
9928702|NCT01284634|11046283|FG001|STARTED|Overall Study||6
9928703|NCT01284634|11046284|FG002|STARTED|Overall Study||7
9928704|NCT01284634|11046285|FG003|STARTED|Overall Study||5
9928705|NCT01284634|11046282|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
9928706|NCT01284634|11046283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9928707|NCT01284634|11046284|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
9928708|NCT01284634|11046285|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
9928709|NCT01284634|11046282|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7
9928710|NCT01284634|11046283|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6
9928711|NCT01284634|11046284|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7
9928712|NCT01284634|11046285|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5
9928713|NCT01284634|11046282|FG000|COMPLETED|Overall Study||6
9928714|NCT01284634|11046283|FG001|COMPLETED|Overall Study||6
9928715|NCT01284634|11046284|FG002|COMPLETED|Overall Study||5
9928716|NCT01284634|11046285|FG003|COMPLETED|Overall Study||4
9928717|NCT01284634|11046282|FG000|NOT COMPLETED|Overall Study||1
9928718|NCT01284634|11046283|FG001|NOT COMPLETED|Overall Study||0
9928719|NCT01284634|11046284|FG002|NOT COMPLETED|Overall Study||2
9928720|NCT01284634|11046285|FG003|NOT COMPLETED|Overall Study||1
9928721|NCT01284959|11046298|FG000|STARTED|Overall Study||11
9928722|NCT01284959|11046299|FG001|STARTED|Overall Study||12
9928723|NCT01284959|11046300|FG002|STARTED|Overall Study||11
9928724|NCT01284959|11046298|FG000|COMPLETED|Overall Study||10
9928725|NCT01284959|11046299|FG001|COMPLETED|Overall Study||12
9928726|NCT01284959|11046300|FG002|COMPLETED|Overall Study||10
9928727|NCT01284959|11046298|FG000|NOT COMPLETED|Overall Study||1
9928728|NCT01284959|11046299|FG001|NOT COMPLETED|Overall Study||0
9928729|NCT01284959|11046300|FG002|NOT COMPLETED|Overall Study||1
9928730|NCT01285024|11046310|FG000|STARTED|Overall Study||49
9928731|NCT01285024|11046311|FG001|STARTED|Overall Study||60
9928732|NCT01285024|11046310|FG000|COMPLETED|Overall Study||49
9928733|NCT01285024|11046311|FG001|COMPLETED|Overall Study||60
9928734|NCT01285024|11046310|FG000|NOT COMPLETED|Overall Study||0
9928735|NCT01285024|11046311|FG001|NOT COMPLETED|Overall Study||0
9928736|NCT01285050|11046317|FG000|STARTED|Overall Study||20
9928737|NCT01285050|11046317|FG000|COMPLETED|Overall Study||19
9928738|NCT01285050|11046317|FG000|NOT COMPLETED|Overall Study||1
9928739|NCT01285076|11046322|FG000|STARTED|Overall Study||834
9928740|NCT01285076|11046322|FG000|COMPLETED|Overall Study||834
9928741|NCT01285076|11046322|FG000|NOT COMPLETED|Overall Study||0
9928742|NCT01285310|11046329|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79
9928743|NCT01285310|11046330|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82
9928744|NCT01285310|11046331|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76
9928745|NCT01285310|11046332|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0
9928746|NCT01285310|11046333|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0
9928747|NCT01285310|11046329|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
9928748|NCT01285310|11046330|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
9928749|NCT01285310|11046331|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
9928750|NCT01285310|11046332|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
9928751|NCT01285310|11046333|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
9928752|NCT01285310|11046329|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
9928753|NCT01285310|11046330|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
9928754|NCT01285310|11046331|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
9928755|NCT01285310|11046332|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
9928756|NCT01285310|11046333|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
9928757|NCT01285310|11046329|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0
9928758|NCT01285310|11046330|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63
9928759|NCT01285310|11046331|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60
9928760|NCT01285310|11046332|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27
9928761|NCT01285310|11046333|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42
9928762|NCT01285310|11046329|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0
9928763|NCT01285310|11046330|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31
9928764|NCT01285310|11046331|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34
9928765|NCT01285310|11046332|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17
10010855|NCT01775930|11133510|FG000|COMPLETED|Overall Study||9
9928766|NCT01285310|11046333|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23
9928767|NCT01285310|11046329|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
9928768|NCT01285310|11046330|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
9928769|NCT01285310|11046331|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
9928770|NCT01285310|11046332|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
9928771|NCT01285310|11046333|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
9928772|NCT01285323|11046373|FG000|STARTED|Overall Study||232
9928773|NCT01285323|11046374|FG001|STARTED|Overall Study||232
9928774|NCT01285323|11046373|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
9928775|NCT01285323|11046374|FG001|Full Analysis Set|Overall Study||232
9928776|NCT01285323|11046373|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
9928777|NCT01285323|11046374|FG001|Safety Analysis Set|Overall Study||232
9928778|NCT01285323|11046373|FG000|COMPLETED|Overall Study||199
9928779|NCT01285323|11046374|FG001|COMPLETED|Overall Study||202
9928780|NCT01285323|11046373|FG000|NOT COMPLETED|Overall Study||33
9928781|NCT01285323|11046374|FG001|NOT COMPLETED|Overall Study||30
9956117|NCT01442688|11075227|FG001|STARTED|First Intervention||31
9956118|NCT01442688|11075226|FG000|COMPLETED|First Intervention||29
9956119|NCT01442688|11075227|FG001|COMPLETED|First Intervention||31
9956120|NCT01442688|11075226|FG000|NOT COMPLETED|First Intervention||2
9956121|NCT01442688|11075227|FG001|NOT COMPLETED|First Intervention||0
9956122|NCT01442688|11075226|FG000|STARTED|Second Intervention||29
9956123|NCT01442688|11075227|FG001|STARTED|Second Intervention||31
9956124|NCT01442688|11075226|FG000|COMPLETED|Second Intervention||28
9956125|NCT01442688|11075227|FG001|COMPLETED|Second Intervention||31
9956126|NCT01442688|11075226|FG000|NOT COMPLETED|Second Intervention||1
9956127|NCT01442688|11075227|FG001|NOT COMPLETED|Second Intervention||0
9956128|NCT01442714|11075233|FG000|STARTED|Overall Study||33
9956129|NCT01442714|11075233|FG000|COMPLETED|Overall Study||21
9956130|NCT01442714|11075233|FG000|NOT COMPLETED|Overall Study||12
9956131|NCT01442779|11075239|FG000|STARTED|Overall Study||18
9956132|NCT01442779|11075239|FG000|COMPLETED|Overall Study||11
9956133|NCT01442779|11075239|FG000|NOT COMPLETED|Overall Study||7
9956134|NCT01442844|11075245|FG000|STARTED|Overall Study||1
9956135|NCT01442844|11075246|FG001|STARTED|Overall Study||2
9956136|NCT01442844|11075245|FG000|COMPLETED|Overall Study||1
9956137|NCT01442844|11075246|FG001|COMPLETED|Overall Study||2
9956138|NCT01442844|11075245|FG000|NOT COMPLETED|Overall Study||0
9956139|NCT01442844|11075246|FG001|NOT COMPLETED|Overall Study||0
9956140|NCT01443026|11075254|FG000|STARTED|Overall Study||29
9956141|NCT01443026|11075255|FG001|STARTED|Overall Study||37
9956142|NCT01443026|11075254|FG000|COMPLETED|Overall Study||26
9956143|NCT01443026|11075255|FG001|COMPLETED|Overall Study||32
9956144|NCT01443026|11075254|FG000|NOT COMPLETED|Overall Study||3
9956145|NCT01443026|11075255|FG001|NOT COMPLETED|Overall Study||5
9956146|NCT01443078|11075261|FG000|STARTED|Overall Study||42
10111468|NCT02496767|11242556|FG004|STARTED|Open-label Lead-in Phase||0
10111469|NCT02496767|11242557|FG005|STARTED|Open-label Lead-in Phase||0
10111470|NCT02496767|11242558|FG006|STARTED|Open-label Lead-in Phase||0
10111471|NCT02496767|11242559|FG007|STARTED|Open-label Lead-in Phase||0
9956147|NCT01443078|11075261|FG000|COMPLETED|Overall Study||13
9956148|NCT01443078|11075261|FG000|NOT COMPLETED|Overall Study||29
9956149|NCT01443130|11075271|FG000|STARTED|Overall Study||300
9956150|NCT01443130|11075272|FG001|STARTED|Overall Study||300
9956151|NCT01443130|11075273|FG002|STARTED|Overall Study||300
9956152|NCT01443130|11075274|FG003|STARTED|Overall Study||270
9956153|NCT01443130|11075275|FG004|STARTED|Overall Study||274
9956154|NCT01443130|11075276|FG005|STARTED|Overall Study||259
9956155|NCT01443130|11075271|FG000|COMPLETED|Overall Study||232
9956156|NCT01443130|11075272|FG001|COMPLETED|Overall Study||231
9956157|NCT01443130|11075273|FG002|COMPLETED|Overall Study||223
9956158|NCT01443130|11075274|FG003|COMPLETED|Overall Study||231
9956159|NCT01443130|11075275|FG004|COMPLETED|Overall Study||230
9956160|NCT01443130|11075276|FG005|COMPLETED|Overall Study||225
9956161|NCT01443130|11075271|FG000|NOT COMPLETED|Overall Study||68
9956162|NCT01443130|11075272|FG001|NOT COMPLETED|Overall Study||69
9956163|NCT01443130|11075273|FG002|NOT COMPLETED|Overall Study||77
9956164|NCT01443130|11075274|FG003|NOT COMPLETED|Overall Study||39
9956165|NCT01443130|11075275|FG004|NOT COMPLETED|Overall Study||44
9956166|NCT01443130|11075276|FG005|NOT COMPLETED|Overall Study||34
9956167|NCT01443364|11075290|FG000|STARTED|Overall Study||132
9956168|NCT01443364|11075290|FG000|COMPLETED|Overall Study||91
9956169|NCT01443364|11075290|FG000|NOT COMPLETED|Overall Study||41
9956170|NCT01443403|11075298|FG000|STARTED|Overall Study||61
9956171|NCT01443403|11075299|FG001|STARTED|Overall Study||61
9956172|NCT01443403|11075300|FG002|STARTED|Overall Study||61
9956173|NCT01443403|11075301|FG003|STARTED|Overall Study||61
9956174|NCT01443403|11075298|FG000|Received Treatment|Overall Study||61
9956175|NCT01443403|11075299|FG001|Received Treatment|Overall Study||61
9956176|NCT01443403|11075300|FG002|Received Treatment|Overall Study||60
9956177|NCT01443403|11075301|FG003|Received Treatment|Overall Study||61
9956178|NCT01443403|11075298|FG000|COMPLETED|Overall Study||55
9956179|NCT01443403|11075299|FG001|COMPLETED|Overall Study||55
9956180|NCT01443403|11075300|FG002|COMPLETED|Overall Study||54
9956181|NCT01443403|11075301|FG003|COMPLETED|Overall Study||52
9956182|NCT01443403|11075298|FG000|NOT COMPLETED|Overall Study||6
9956183|NCT01443403|11075299|FG001|NOT COMPLETED|Overall Study||6
9956184|NCT01443403|11075300|FG002|NOT COMPLETED|Overall Study||7
9956185|NCT01443403|11075301|FG003|NOT COMPLETED|Overall Study||9
9956186|NCT01443442|11075316|FG000|STARTED|Overall Study||12
9956187|NCT01443442|11075317|FG001|STARTED|Overall Study||11
9956188|NCT01443442|11075316|FG000|COMPLETED|Overall Study||12
9956189|NCT01443442|11075317|FG001|COMPLETED|Overall Study||11
10111472|NCT02496767|11242552|FG000|COMPLETED|Open-label Lead-in Phase||565
9956190|NCT01443442|11075316|FG000|NOT COMPLETED|Overall Study||0
9956191|NCT01443442|11075317|FG001|NOT COMPLETED|Overall Study||0
10205511|NCT03493386|11332288|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10205512|NCT03493386|11332289|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10205513|NCT03493386|11332290|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
9928782|NCT01285349|11046383|FG000|STARTED|Overall Study||190
9928783|NCT01285349|11046384|FG001|STARTED|Overall Study||190
9928784|NCT01285349|11046385|FG002|STARTED|Overall Study||184
9928785|NCT01285349|11046383|FG000|COMPLETED|Overall Study||163
9928786|NCT01285349|11046384|FG001|COMPLETED|Overall Study||170
9928787|NCT01285349|11046385|FG002|COMPLETED|Overall Study||157
9928788|NCT01285349|11046383|FG000|NOT COMPLETED|Overall Study||27
9928789|NCT01285349|11046384|FG001|NOT COMPLETED|Overall Study||20
9928790|NCT01285349|11046385|FG002|NOT COMPLETED|Overall Study||27
9928791|NCT01285401|11046396|FG000|STARTED|Overall Study||115
9928792|NCT01285401|11046397|FG001|STARTED|Overall Study||117
9928793|NCT01285401|11046396|FG000|Treated|Overall Study||113
9928794|NCT01285401|11046397|FG001|Treated|Overall Study||116
9928795|NCT01285401|11046396|FG000|COMPLETED|Overall Study||98
9928796|NCT01285401|11046397|FG001|COMPLETED|Overall Study||88
9928797|NCT01285401|11046396|FG000|NOT COMPLETED|Overall Study||17
9928798|NCT01285401|11046397|FG001|NOT COMPLETED|Overall Study||29
9928799|NCT01285427|11046403|FG000|STARTED|Overall Study||300
9928800|NCT01285427|11046403|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
9928801|NCT01285427|11046403|FG000|NOT COMPLETED|Overall Study||1
9928802|NCT01285492|11046417|FG000|STARTED|Overall Study|All patients randomized to this group|121
9928803|NCT01285492|11046418|FG001|STARTED|Overall Study|All patients randomized to this group|39
9928804|NCT01285492|11046417|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
9928805|NCT01285492|11046418|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
9928806|NCT01285492|11046417|FG000|COMPLETED|Overall Study||104
9928807|NCT01285492|11046418|FG001|COMPLETED|Overall Study||38
9928808|NCT01285492|11046417|FG000|NOT COMPLETED|Overall Study||17
9928809|NCT01285492|11046418|FG001|NOT COMPLETED|Overall Study||1
9928810|NCT01285518|11046432|FG000|STARTED|Overall Study||10
9928811|NCT01285518|11046433|FG001|STARTED|Overall Study||10
9928812|NCT01285518|11046434|FG002|STARTED|Overall Study||10
9928813|NCT01285518|11046435|FG003|STARTED|Overall Study||10
9928814|NCT01285518|11046436|FG004|STARTED|Overall Study||10
9928815|NCT01285518|11046437|FG005|STARTED|Overall Study||10
9928816|NCT01285518|11046438|FG006|STARTED|Overall Study||10
9928817|NCT01285518|11046439|FG007|STARTED|Overall Study||14
9928818|NCT01285518|11046432|FG000|COMPLETED|Overall Study||10
9928819|NCT01285518|11046433|FG001|COMPLETED|Overall Study||10
9928820|NCT01285518|11046434|FG002|COMPLETED|Overall Study||10
9928821|NCT01285518|11046435|FG003|COMPLETED|Overall Study||10
9928822|NCT01285518|11046436|FG004|COMPLETED|Overall Study||10
9928823|NCT01285518|11046437|FG005|COMPLETED|Overall Study||9
9928824|NCT01285518|11046438|FG006|COMPLETED|Overall Study||10
9928825|NCT01285518|11046439|FG007|COMPLETED|Overall Study||14
9928826|NCT01285518|11046432|FG000|NOT COMPLETED|Overall Study||0
9928827|NCT01285518|11046433|FG001|NOT COMPLETED|Overall Study||0
9928828|NCT01285518|11046434|FG002|NOT COMPLETED|Overall Study||0
9928829|NCT01285518|11046435|FG003|NOT COMPLETED|Overall Study||0
9928830|NCT01285518|11046436|FG004|NOT COMPLETED|Overall Study||0
9928831|NCT01285518|11046437|FG005|NOT COMPLETED|Overall Study||1
9928832|NCT01285518|11046438|FG006|NOT COMPLETED|Overall Study||0
10010856|NCT01775930|11133510|FG000|NOT COMPLETED|Overall Study||1
10010857|NCT01775995|11133516|FG000|STARTED|Overall Study||21
10010858|NCT01775995|11133517|FG001|STARTED|Overall Study||14
9928833|NCT01285518|11046439|FG007|NOT COMPLETED|Overall Study||0
9928834|NCT01285609|11046460|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
9928835|NCT01285609|11046461|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
9928836|NCT01285609|11046460|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475
9928837|NCT01285609|11046461|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473
9928838|NCT01285609|11046460|FG000|COMPLETED|Randomized||388
9928839|NCT01285609|11046461|FG001|COMPLETED|Randomized||361
10010859|NCT01775995|11133516|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
10010860|NCT01775995|11133517|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
9928840|NCT01285609|11046460|FG000|NOT COMPLETED|Randomized||91
9928841|NCT01285609|11046461|FG001|NOT COMPLETED|Randomized||116
9928842|NCT01285609|11046460|FG000|STARTED|Treated With Blinded Therapy||388
9928843|NCT01285609|11046461|FG001|STARTED|Treated With Blinded Therapy||361
9928844|NCT01285609|11046460|FG000|COMPLETED|Treated With Blinded Therapy||1
9928845|NCT01285609|11046461|FG001|COMPLETED|Treated With Blinded Therapy||2
9928846|NCT01285609|11046460|FG000|NOT COMPLETED|Treated With Blinded Therapy||387
9928847|NCT01285609|11046461|FG001|NOT COMPLETED|Treated With Blinded Therapy||359
9928848|NCT01285635|11046472|FG000|STARTED|First Intervention (2 Weeks)||13
9928849|NCT01285635|11046473|FG001|STARTED|First Intervention (2 Weeks)||11
9928850|NCT01285635|11046474|FG002|STARTED|First Intervention (2 Weeks)||11
9928851|NCT01285635|11046472|FG000|COMPLETED|First Intervention (2 Weeks)||13
9928852|NCT01285635|11046473|FG001|COMPLETED|First Intervention (2 Weeks)||11
9928853|NCT01285635|11046474|FG002|COMPLETED|First Intervention (2 Weeks)||11
9928854|NCT01285635|11046472|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
9928855|NCT01285635|11046473|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
9928856|NCT01285635|11046474|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
9928857|NCT01285635|11046472|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13
9928858|NCT01285635|11046473|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11
9928859|NCT01285635|11046474|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11
9928860|NCT01285635|11046472|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
9928861|NCT01285635|11046473|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
9928862|NCT01285635|11046474|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
9928863|NCT01285635|11046472|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
9928864|NCT01285635|11046473|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
9928865|NCT01285635|11046474|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
9928866|NCT01285713|11046487|FG000|STARTED|Overall Study||42
9928867|NCT01285713|11046488|FG001|STARTED|Overall Study||41
9928868|NCT01285713|11046487|FG000|COMPLETED|Overall Study||42
9928869|NCT01285713|11046488|FG001|COMPLETED|Overall Study||41
9928870|NCT01285713|11046487|FG000|NOT COMPLETED|Overall Study||0
9928871|NCT01285713|11046488|FG001|NOT COMPLETED|Overall Study||0
9928872|NCT01285791|11046497|FG000|STARTED|Overall Study||11
9928873|NCT01285791|11046498|FG001|STARTED|Overall Study||15
9928874|NCT01285791|11046499|FG002|STARTED|Overall Study||13
9928875|NCT01285791|11046497|FG000|COMPLETED|Overall Study||11
9928876|NCT01285791|11046498|FG001|COMPLETED|Overall Study||15
9928877|NCT01285791|11046499|FG002|COMPLETED|Overall Study||13
9928878|NCT01285791|11046497|FG000|NOT COMPLETED|Overall Study||0
9928879|NCT01285791|11046498|FG001|NOT COMPLETED|Overall Study||0
9928880|NCT01285791|11046499|FG002|NOT COMPLETED|Overall Study||0
9928881|NCT01285843|11046509|FG000|STARTED|Overall Study||20
9928882|NCT01285843|11046510|FG001|STARTED|Overall Study||20
9928883|NCT01285843|11046509|FG000|COMPLETED|Overall Study||18
9928884|NCT01285843|11046510|FG001|COMPLETED|Overall Study||18
9928885|NCT01285843|11046509|FG000|NOT COMPLETED|Overall Study||2
9928886|NCT01285843|11046510|FG001|NOT COMPLETED|Overall Study||2
9928887|NCT01285908|11046516|FG000|STARTED|Baseline Measurement||6
9928888|NCT01285908|11046517|FG001|STARTED|Baseline Measurement||0
9928889|NCT01285908|11046518|FG002|STARTED|Baseline Measurement||0
9928890|NCT01285908|11046516|FG000|COMPLETED|Baseline Measurement||3
9928891|NCT01285908|11046517|FG001|COMPLETED|Baseline Measurement||0
9928892|NCT01285908|11046518|FG002|COMPLETED|Baseline Measurement||0
9928893|NCT01285908|11046516|FG000|NOT COMPLETED|Baseline Measurement||3
9928894|NCT01285908|11046517|FG001|NOT COMPLETED|Baseline Measurement||0
9928895|NCT01285908|11046518|FG002|NOT COMPLETED|Baseline Measurement||0
9928896|NCT01285908|11046516|FG000|STARTED|Treatment Crossover||0
9928897|NCT01285908|11046517|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
9928898|NCT01285908|11046518|FG002|STARTED|Treatment Crossover||2
9928899|NCT01285908|11046516|FG000|COMPLETED|Treatment Crossover||0
9928900|NCT01285908|11046517|FG001|COMPLETED|Treatment Crossover||2
9928901|NCT01285908|11046518|FG002|COMPLETED|Treatment Crossover||2
9928902|NCT01285908|11046516|FG000|NOT COMPLETED|Treatment Crossover||0
9928903|NCT01285908|11046517|FG001|NOT COMPLETED|Treatment Crossover||0
9928904|NCT01285908|11046518|FG002|NOT COMPLETED|Treatment Crossover||0
9928905|NCT01285960|11046548|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
9928906|NCT01285960|11046548|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
9928907|NCT01285960|11046548|FG000|NOT COMPLETED|Overall Study||6
9928908|NCT01286012|11046554|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
9928909|NCT01286012|11046555|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
9928910|NCT01286012|11046554|FG000|COMPLETED|Overall Study||41
9928911|NCT01286012|11046555|FG001|COMPLETED|Overall Study||40
9928912|NCT01286012|11046554|FG000|NOT COMPLETED|Overall Study||13
9928913|NCT01286012|11046555|FG001|NOT COMPLETED|Overall Study||14
9928914|NCT01286077|11046564|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
9928915|NCT01286077|11046565|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
9928916|NCT01286077|11046564|FG000|COMPLETED|Overall Study||41
9928917|NCT01286077|11046565|FG001|COMPLETED|Overall Study||46
9928918|NCT01286077|11046564|FG000|NOT COMPLETED|Overall Study||10
9928919|NCT01286077|11046565|FG001|NOT COMPLETED|Overall Study||7
9928920|NCT01286129|11046573|FG000|STARTED|Overall Study||27
9928921|NCT01286129|11046574|FG001|STARTED|Overall Study||18
9928922|NCT01286129|11046573|FG000|COMPLETED|Overall Study||19
9928923|NCT01286129|11046574|FG001|COMPLETED|Overall Study||13
9928924|NCT01286129|11046573|FG000|NOT COMPLETED|Overall Study||8
9928925|NCT01286129|11046574|FG001|NOT COMPLETED|Overall Study||5
9928926|NCT01286168|11046582|FG000|STARTED|Overall Study||104
9928927|NCT01286168|11046582|FG000|COMPLETED|Overall Study||101
9928928|NCT01286168|11046582|FG000|NOT COMPLETED|Overall Study||3
9928929|NCT01286259|11046587|FG000|STARTED|Overall Study||16
9928930|NCT01286259|11046587|FG000|COMPLETED|Overall Study||16
9928931|NCT01286259|11046587|FG000|NOT COMPLETED|Overall Study||0
9928932|NCT01286311|11046593|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
9928933|NCT01286311|11046594|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
9928934|NCT01286311|11046593|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
9928935|NCT01286311|11046594|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
9928936|NCT01286311|11046593|FG000|NOT COMPLETED|Overall Study||14
9928937|NCT01286311|11046594|FG001|NOT COMPLETED|Overall Study||0
9928938|NCT01286324|11046602|FG000|STARTED|Overall Study||17
9928939|NCT01286324|11046603|FG001|STARTED|Overall Study||17
9928940|NCT01286324|11046602|FG000|COMPLETED|Overall Study||17
9928941|NCT01286324|11046603|FG001|COMPLETED|Overall Study||17
9928942|NCT01286324|11046602|FG000|NOT COMPLETED|Overall Study||0
9928943|NCT01286324|11046603|FG001|NOT COMPLETED|Overall Study||0
9928944|NCT01286402|11046611|FG000|STARTED|Overall Study||5
9928945|NCT01286402|11046612|FG001|STARTED|Overall Study||6
9928946|NCT01286402|11046611|FG000|COMPLETED|Overall Study||5
9928947|NCT01286402|11046612|FG001|COMPLETED|Overall Study||6
9928948|NCT01286402|11046611|FG000|NOT COMPLETED|Overall Study||0
9928949|NCT01286402|11046612|FG001|NOT COMPLETED|Overall Study||0
9928950|NCT01286441|11046622|FG000|STARTED|Overall Study||45
9928951|NCT01286441|11046623|FG001|STARTED|Overall Study||44
9928952|NCT01286441|11046624|FG002|STARTED|Overall Study||46
9928953|NCT01286441|11046625|FG003|STARTED|Overall Study||48
9928954|NCT01286441|11046622|FG000|COMPLETED|Overall Study||38
9928955|NCT01286441|11046623|FG001|COMPLETED|Overall Study||37
9928956|NCT01286441|11046624|FG002|COMPLETED|Overall Study||39
9928957|NCT01286441|11046625|FG003|COMPLETED|Overall Study||37
9928958|NCT01286441|11046622|FG000|NOT COMPLETED|Overall Study||7
9928959|NCT01286441|11046623|FG001|NOT COMPLETED|Overall Study||7
9928960|NCT01286441|11046624|FG002|NOT COMPLETED|Overall Study||7
9928961|NCT01286441|11046625|FG003|NOT COMPLETED|Overall Study||11
9928962|NCT01286454|11046635|FG000|STARTED|Part I- First Intervention Period||2
9928963|NCT01286454|11046636|FG001|STARTED|Part I- First Intervention Period||2
9928964|NCT01286454|11046637|FG002|STARTED|Part I- First Intervention Period||2
9928965|NCT01286454|11046638|FG003|STARTED|Part I- First Intervention Period||2
9928966|NCT01286454|11046639|FG004|STARTED|Part I- First Intervention Period||2
9928967|NCT01286454|11046640|FG005|STARTED|Part I- First Intervention Period||2
9928968|NCT01286454|11046641|FG006|STARTED|Part I- First Intervention Period||2
9928969|NCT01286454|11046642|FG007|STARTED|Part I- First Intervention Period||2
9928970|NCT01286454|11046643|FG008|STARTED|Part I- First Intervention Period||2
9928971|NCT01286454|11046644|FG009|STARTED|Part I- First Intervention Period||2
9928972|NCT01286454|11046645|FG010|STARTED|Part I- First Intervention Period||0
9928973|NCT01286454|11046635|FG000|COMPLETED|Part I- First Intervention Period||2
9928974|NCT01286454|11046636|FG001|COMPLETED|Part I- First Intervention Period||2
9928975|NCT01286454|11046637|FG002|COMPLETED|Part I- First Intervention Period||2
9928976|NCT01286454|11046638|FG003|COMPLETED|Part I- First Intervention Period||2
9928977|NCT01286454|11046639|FG004|COMPLETED|Part I- First Intervention Period||2
9928978|NCT01286454|11046640|FG005|COMPLETED|Part I- First Intervention Period||2
9928979|NCT01286454|11046641|FG006|COMPLETED|Part I- First Intervention Period||2
9928980|NCT01286454|11046642|FG007|COMPLETED|Part I- First Intervention Period||2
9928981|NCT01286454|11046643|FG008|COMPLETED|Part I- First Intervention Period||2
9928982|NCT01286454|11046644|FG009|COMPLETED|Part I- First Intervention Period||2
9928983|NCT01286454|11046645|FG010|COMPLETED|Part I- First Intervention Period||0
9928984|NCT01286454|11046635|FG000|NOT COMPLETED|Part I- First Intervention Period||0
9928985|NCT01286454|11046636|FG001|NOT COMPLETED|Part I- First Intervention Period||0
9928986|NCT01286454|11046637|FG002|NOT COMPLETED|Part I- First Intervention Period||0
9928987|NCT01286454|11046638|FG003|NOT COMPLETED|Part I- First Intervention Period||0
9928988|NCT01286454|11046639|FG004|NOT COMPLETED|Part I- First Intervention Period||0
9928989|NCT01286454|11046640|FG005|NOT COMPLETED|Part I- First Intervention Period||0
9928990|NCT01286454|11046641|FG006|NOT COMPLETED|Part I- First Intervention Period||0
9928991|NCT01286454|11046642|FG007|NOT COMPLETED|Part I- First Intervention Period||0
9928992|NCT01286454|11046643|FG008|NOT COMPLETED|Part I- First Intervention Period||0
9928993|NCT01286454|11046644|FG009|NOT COMPLETED|Part I- First Intervention Period||0
9928994|NCT01286454|11046645|FG010|NOT COMPLETED|Part I- First Intervention Period||0
9928995|NCT01286454|11046635|FG000|STARTED|Washout Period (At Least 3 Days)||2
9928996|NCT01286454|11046636|FG001|STARTED|Washout Period (At Least 3 Days)||2
9928997|NCT01286454|11046637|FG002|STARTED|Washout Period (At Least 3 Days)||2
9928998|NCT01286454|11046638|FG003|STARTED|Washout Period (At Least 3 Days)||2
9928999|NCT01286454|11046639|FG004|STARTED|Washout Period (At Least 3 Days)||2
9929000|NCT01286454|11046640|FG005|STARTED|Washout Period (At Least 3 Days)||2
9929001|NCT01286454|11046641|FG006|STARTED|Washout Period (At Least 3 Days)||2
9929002|NCT01286454|11046642|FG007|STARTED|Washout Period (At Least 3 Days)||2
9929003|NCT01286454|11046643|FG008|STARTED|Washout Period (At Least 3 Days)||2
9929004|NCT01286454|11046644|FG009|STARTED|Washout Period (At Least 3 Days)||2
9929005|NCT01286454|11046645|FG010|STARTED|Washout Period (At Least 3 Days)||0
9929006|NCT01286454|11046635|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
10205514|NCT03493386|11332291|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10205515|NCT03493386|11332288|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0
10205516|NCT03493386|11332289|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0
10205517|NCT03493386|11332290|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6
9929007|NCT01286454|11046636|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
9929008|NCT01286454|11046637|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
9929009|NCT01286454|11046638|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
9929010|NCT01286454|11046639|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
9929011|NCT01286454|11046640|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
9929012|NCT01286454|11046641|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
9929013|NCT01286454|11046642|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
9929014|NCT01286454|11046643|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
9929015|NCT01286454|11046644|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
9929016|NCT01286454|11046645|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
9929017|NCT01286454|11046635|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929018|NCT01286454|11046636|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929019|NCT01286454|11046637|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929020|NCT01286454|11046638|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929021|NCT01286454|11046639|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929022|NCT01286454|11046640|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929023|NCT01286454|11046641|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929024|NCT01286454|11046642|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929025|NCT01286454|11046643|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929026|NCT01286454|11046644|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929027|NCT01286454|11046645|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929028|NCT01286454|11046635|FG000|STARTED|Second Intervention Period||2
9929029|NCT01286454|11046636|FG001|STARTED|Second Intervention Period||2
9929030|NCT01286454|11046637|FG002|STARTED|Second Intervention Period||2
9929031|NCT01286454|11046638|FG003|STARTED|Second Intervention Period||2
9929032|NCT01286454|11046639|FG004|STARTED|Second Intervention Period||2
9929033|NCT01286454|11046640|FG005|STARTED|Second Intervention Period||2
9929034|NCT01286454|11046641|FG006|STARTED|Second Intervention Period||2
9929035|NCT01286454|11046642|FG007|STARTED|Second Intervention Period||2
9929036|NCT01286454|11046643|FG008|STARTED|Second Intervention Period||2
9929037|NCT01286454|11046644|FG009|STARTED|Second Intervention Period||2
9929038|NCT01286454|11046645|FG010|STARTED|Second Intervention Period||0
9929039|NCT01286454|11046635|FG000|COMPLETED|Second Intervention Period||2
9929040|NCT01286454|11046636|FG001|COMPLETED|Second Intervention Period||2
9929041|NCT01286454|11046637|FG002|COMPLETED|Second Intervention Period||2
9929042|NCT01286454|11046638|FG003|COMPLETED|Second Intervention Period||2
9929043|NCT01286454|11046639|FG004|COMPLETED|Second Intervention Period||2
9929044|NCT01286454|11046640|FG005|COMPLETED|Second Intervention Period||2
9929045|NCT01286454|11046641|FG006|COMPLETED|Second Intervention Period||2
9929046|NCT01286454|11046642|FG007|COMPLETED|Second Intervention Period||2
9929047|NCT01286454|11046643|FG008|COMPLETED|Second Intervention Period||2
9929048|NCT01286454|11046644|FG009|COMPLETED|Second Intervention Period||2
9929049|NCT01286454|11046645|FG010|COMPLETED|Second Intervention Period||0
9929050|NCT01286454|11046635|FG000|NOT COMPLETED|Second Intervention Period||0
9929051|NCT01286454|11046636|FG001|NOT COMPLETED|Second Intervention Period||0
9929052|NCT01286454|11046637|FG002|NOT COMPLETED|Second Intervention Period||0
9929053|NCT01286454|11046638|FG003|NOT COMPLETED|Second Intervention Period||0
9929054|NCT01286454|11046639|FG004|NOT COMPLETED|Second Intervention Period||0
9929055|NCT01286454|11046640|FG005|NOT COMPLETED|Second Intervention Period||0
9929056|NCT01286454|11046641|FG006|NOT COMPLETED|Second Intervention Period||0
9929057|NCT01286454|11046642|FG007|NOT COMPLETED|Second Intervention Period||0
9929058|NCT01286454|11046643|FG008|NOT COMPLETED|Second Intervention Period||0
9929059|NCT01286454|11046644|FG009|NOT COMPLETED|Second Intervention Period||0
9929060|NCT01286454|11046645|FG010|NOT COMPLETED|Second Intervention Period||0
9929061|NCT01286454|11046635|FG000|STARTED|Washout Period (At Least 3 Days)||2
9929062|NCT01286454|11046636|FG001|STARTED|Washout Period (At Least 3 Days)||2
9929063|NCT01286454|11046637|FG002|STARTED|Washout Period (At Least 3 Days)||2
9929064|NCT01286454|11046638|FG003|STARTED|Washout Period (At Least 3 Days)||2
9929065|NCT01286454|11046639|FG004|STARTED|Washout Period (At Least 3 Days)||2
9929066|NCT01286454|11046640|FG005|STARTED|Washout Period (At Least 3 Days)||2
9929067|NCT01286454|11046641|FG006|STARTED|Washout Period (At Least 3 Days)||2
9929068|NCT01286454|11046642|FG007|STARTED|Washout Period (At Least 3 Days)||2
9929069|NCT01286454|11046643|FG008|STARTED|Washout Period (At Least 3 Days)||2
9929070|NCT01286454|11046644|FG009|STARTED|Washout Period (At Least 3 Days)||2
9929071|NCT01286454|11046645|FG010|STARTED|Washout Period (At Least 3 Days)||0
10010861|NCT01775995|11133516|FG000|NOT COMPLETED|Overall Study||1
10010862|NCT01775995|11133517|FG001|NOT COMPLETED|Overall Study||1
10010863|NCT01776008|11133523|FG000|STARTED|Overall Study||16
10010864|NCT01776008|11133523|FG000|COMPLETED|Overall Study||14
10010865|NCT01776008|11133523|FG000|NOT COMPLETED|Overall Study||2
10010866|NCT01776268|11133529|FG000|STARTED|Overall Study||48
10010867|NCT01776268|11133530|FG001|STARTED|Overall Study||51
10010868|NCT01776268|11133529|FG000|COMPLETED|Overall Study||48
10010869|NCT01776268|11133530|FG001|COMPLETED|Overall Study||51
10010870|NCT01776268|11133529|FG000|NOT COMPLETED|Overall Study||0
10205518|NCT03493386|11332291|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6
9929072|NCT01286454|11046635|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
9929073|NCT01286454|11046636|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
9929074|NCT01286454|11046637|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
9929075|NCT01286454|11046638|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
9929076|NCT01286454|11046639|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
9929077|NCT01286454|11046640|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
9929078|NCT01286454|11046641|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
9929079|NCT01286454|11046642|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
9929080|NCT01286454|11046643|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
9929081|NCT01286454|11046644|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
9929082|NCT01286454|11046645|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
9929083|NCT01286454|11046635|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929084|NCT01286454|11046636|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929085|NCT01286454|11046637|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929086|NCT01286454|11046638|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929087|NCT01286454|11046639|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929088|NCT01286454|11046640|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929089|NCT01286454|11046641|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929090|NCT01286454|11046642|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929091|NCT01286454|11046643|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929092|NCT01286454|11046644|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10010871|NCT01776268|11133530|FG001|NOT COMPLETED|Overall Study||0
10010872|NCT01776424|11133540|FG000|STARTED|Overall Study||9152
10010873|NCT01776424|11133541|FG001|STARTED|Overall Study||9117
10010874|NCT01776424|11133542|FG002|STARTED|Overall Study||9126
10205519|NCT03493386|11332288|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10205520|NCT03493386|11332289|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10205521|NCT03493386|11332290|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
10205522|NCT03493386|11332291|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
10205523|NCT03493386|11332288|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10205524|NCT03493386|11332289|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10205525|NCT03493386|11332290|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10205526|NCT03493386|11332291|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10205527|NCT03493386|11332288|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0
10205528|NCT03493386|11332289|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0
10205529|NCT03493386|11332290|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6
10205530|NCT03493386|11332291|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6
10205531|NCT03493386|11332288|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10205532|NCT03493386|11332289|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10205533|NCT03493386|11332290|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
10205534|NCT03493386|11332291|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
10205535|NCT03493386|11332288|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10205536|NCT03493386|11332289|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10205537|NCT03493386|11332290|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10205538|NCT03493386|11332291|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10205539|NCT03493542|11332310|FG000|STARTED|Overall Study||383
10205540|NCT03493542|11332311|FG001|STARTED|Overall Study||383
10205541|NCT03493542|11332310|FG000|Vaccination 1|Overall Study||383
10205542|NCT03493542|11332311|FG001|Vaccination 1|Overall Study||383
10205543|NCT03493542|11332310|FG000|Vaccination 2|Overall Study||379
10205544|NCT03493542|11332311|FG001|Vaccination 2|Overall Study||378
10205545|NCT03493542|11332310|FG000|Vaccination 3|Overall Study||376
10205546|NCT03493542|11332311|FG001|Vaccination 3|Overall Study||374
10205547|NCT03493542|11332310|FG000|COMPLETED|Overall Study||376
10205548|NCT03493542|11332311|FG001|COMPLETED|Overall Study||374
10205549|NCT03493542|11332310|FG000|NOT COMPLETED|Overall Study||7
10205550|NCT03493542|11332311|FG001|NOT COMPLETED|Overall Study||9
10205551|NCT03493607|11332317|FG000|STARTED|Overall Study||6
10205552|NCT03493607|11332317|FG000|COMPLETED|Overall Study||6
10205553|NCT03493607|11332317|FG000|NOT COMPLETED|Overall Study||0
10205554|NCT03493698|11332321|FG000|STARTED|Treatment Period A||17
10205555|NCT03493698|11332321|FG000|COMPLETED|Treatment Period A||17
10205556|NCT03493698|11332321|FG000|NOT COMPLETED|Treatment Period A||0
10205557|NCT03493698|11332321|FG000|STARTED|Treatment Period B||17
10205558|NCT03493698|11332321|FG000|COMPLETED|Treatment Period B||17
10205559|NCT03493698|11332321|FG000|NOT COMPLETED|Treatment Period B||0
10205560|NCT03493698|11332321|FG000|STARTED|Treatment Period C||17
10205561|NCT03493698|11332321|FG000|COMPLETED|Treatment Period C||15
10205562|NCT03493698|11332321|FG000|NOT COMPLETED|Treatment Period C||2
10205563|NCT03493698|11332321|FG000|STARTED|Treatment Period D||15
9929093|NCT01286454|11046645|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929094|NCT01286454|11046635|FG000|STARTED|Third Intervention Period||2
9929095|NCT01286454|11046636|FG001|STARTED|Third Intervention Period||2
10010875|NCT01776424|11133540|FG000|Treated|Overall Study||9134
10010876|NCT01776424|11133541|FG001|Treated|Overall Study||9110
10205564|NCT03493698|11332321|FG000|COMPLETED|Treatment Period D||15
10205565|NCT03493698|11332321|FG000|NOT COMPLETED|Treatment Period D||0
10205566|NCT03493815|11332337|FG000|STARTED|Overall Study||42
10205567|NCT03493815|11332338|FG001|STARTED|Overall Study||43
10205568|NCT03493815|11332337|FG000|COMPLETED|Overall Study||33
10205569|NCT03493815|11332338|FG001|COMPLETED|Overall Study||32
9929096|NCT01286454|11046637|FG002|STARTED|Third Intervention Period||2
9929097|NCT01286454|11046638|FG003|STARTED|Third Intervention Period||2
9929098|NCT01286454|11046639|FG004|STARTED|Third Intervention Period||2
9929099|NCT01286454|11046640|FG005|STARTED|Third Intervention Period||2
9929100|NCT01286454|11046641|FG006|STARTED|Third Intervention Period||2
9929101|NCT01286454|11046642|FG007|STARTED|Third Intervention Period||2
9929102|NCT01286454|11046643|FG008|STARTED|Third Intervention Period||2
9929103|NCT01286454|11046644|FG009|STARTED|Third Intervention Period||2
9929104|NCT01286454|11046645|FG010|STARTED|Third Intervention Period||0
9929105|NCT01286454|11046635|FG000|COMPLETED|Third Intervention Period||2
9929106|NCT01286454|11046636|FG001|COMPLETED|Third Intervention Period||2
9929107|NCT01286454|11046637|FG002|COMPLETED|Third Intervention Period||2
9929108|NCT01286454|11046638|FG003|COMPLETED|Third Intervention Period||2
9929109|NCT01286454|11046639|FG004|COMPLETED|Third Intervention Period||2
9929110|NCT01286454|11046640|FG005|COMPLETED|Third Intervention Period||2
9929111|NCT01286454|11046641|FG006|COMPLETED|Third Intervention Period||2
9929112|NCT01286454|11046642|FG007|COMPLETED|Third Intervention Period||2
9929113|NCT01286454|11046643|FG008|COMPLETED|Third Intervention Period||2
9929114|NCT01286454|11046644|FG009|COMPLETED|Third Intervention Period||2
9929115|NCT01286454|11046645|FG010|COMPLETED|Third Intervention Period||0
9929116|NCT01286454|11046635|FG000|NOT COMPLETED|Third Intervention Period||0
9929117|NCT01286454|11046636|FG001|NOT COMPLETED|Third Intervention Period||0
9929118|NCT01286454|11046637|FG002|NOT COMPLETED|Third Intervention Period||0
9929119|NCT01286454|11046638|FG003|NOT COMPLETED|Third Intervention Period||0
9929120|NCT01286454|11046639|FG004|NOT COMPLETED|Third Intervention Period||0
9929121|NCT01286454|11046640|FG005|NOT COMPLETED|Third Intervention Period||0
9929122|NCT01286454|11046641|FG006|NOT COMPLETED|Third Intervention Period||0
9929123|NCT01286454|11046642|FG007|NOT COMPLETED|Third Intervention Period||0
9929124|NCT01286454|11046643|FG008|NOT COMPLETED|Third Intervention Period||0
9929125|NCT01286454|11046644|FG009|NOT COMPLETED|Third Intervention Period||0
9929126|NCT01286454|11046645|FG010|NOT COMPLETED|Third Intervention Period||0
9929127|NCT01286454|11046635|FG000|STARTED|Washout Period (At Least 3 Days)||2
9929128|NCT01286454|11046636|FG001|STARTED|Washout Period (At Least 3 Days)||2
9929129|NCT01286454|11046637|FG002|STARTED|Washout Period (At Least 3 Days)||2
9929130|NCT01286454|11046638|FG003|STARTED|Washout Period (At Least 3 Days)||2
9929131|NCT01286454|11046639|FG004|STARTED|Washout Period (At Least 3 Days)||2
9929132|NCT01286454|11046640|FG005|STARTED|Washout Period (At Least 3 Days)||2
9929133|NCT01286454|11046641|FG006|STARTED|Washout Period (At Least 3 Days)||2
9929134|NCT01286454|11046642|FG007|STARTED|Washout Period (At Least 3 Days)||2
9929135|NCT01286454|11046643|FG008|STARTED|Washout Period (At Least 3 Days)||2
9929136|NCT01286454|11046644|FG009|STARTED|Washout Period (At Least 3 Days)||2
9929137|NCT01286454|11046645|FG010|STARTED|Washout Period (At Least 3 Days)||0
9929138|NCT01286454|11046635|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
9929139|NCT01286454|11046636|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
9929140|NCT01286454|11046637|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
9929141|NCT01286454|11046638|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
9929142|NCT01286454|11046639|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
9929143|NCT01286454|11046640|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
9929144|NCT01286454|11046641|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
9929145|NCT01286454|11046642|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
9929146|NCT01286454|11046643|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
9929147|NCT01286454|11046644|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
9929148|NCT01286454|11046645|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
9929149|NCT01286454|11046635|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929150|NCT01286454|11046636|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929151|NCT01286454|11046637|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929152|NCT01286454|11046638|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929153|NCT01286454|11046639|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10010877|NCT01776424|11133542|FG002|Treated|Overall Study||9107
10010878|NCT01776424|11133540|FG000|COMPLETED|Overall Study||9132
10010879|NCT01776424|11133541|FG001|COMPLETED|Overall Study||9098
10010880|NCT01776424|11133542|FG002|COMPLETED|Overall Study||9102
10010881|NCT01776424|11133540|FG000|NOT COMPLETED|Overall Study||20
9929154|NCT01286454|11046640|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929155|NCT01286454|11046641|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929156|NCT01286454|11046642|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929157|NCT01286454|11046643|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929158|NCT01286454|11046644|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929159|NCT01286454|11046645|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929160|NCT01286454|11046635|FG000|STARTED|Fourth Intervention Period||2
9929161|NCT01286454|11046636|FG001|STARTED|Fourth Intervention Period||2
9929162|NCT01286454|11046637|FG002|STARTED|Fourth Intervention Period||2
9929163|NCT01286454|11046638|FG003|STARTED|Fourth Intervention Period||2
9929164|NCT01286454|11046639|FG004|STARTED|Fourth Intervention Period||2
9929165|NCT01286454|11046640|FG005|STARTED|Fourth Intervention Period||2
9929166|NCT01286454|11046641|FG006|STARTED|Fourth Intervention Period||2
9929167|NCT01286454|11046642|FG007|STARTED|Fourth Intervention Period||2
9929168|NCT01286454|11046643|FG008|STARTED|Fourth Intervention Period||2
10010882|NCT01776424|11133541|FG001|NOT COMPLETED|Overall Study||19
10010883|NCT01776424|11133542|FG002|NOT COMPLETED|Overall Study||24
10010884|NCT01776541|11133552|FG000|STARTED|Overall Study||488
9929169|NCT01286454|11046644|FG009|STARTED|Fourth Intervention Period||2
9929170|NCT01286454|11046645|FG010|STARTED|Fourth Intervention Period||0
9929171|NCT01286454|11046635|FG000|COMPLETED|Fourth Intervention Period||2
9929172|NCT01286454|11046636|FG001|COMPLETED|Fourth Intervention Period||2
9929173|NCT01286454|11046637|FG002|COMPLETED|Fourth Intervention Period||2
9929174|NCT01286454|11046638|FG003|COMPLETED|Fourth Intervention Period||2
9929175|NCT01286454|11046639|FG004|COMPLETED|Fourth Intervention Period||2
9929176|NCT01286454|11046640|FG005|COMPLETED|Fourth Intervention Period||2
9929177|NCT01286454|11046641|FG006|COMPLETED|Fourth Intervention Period||2
9929178|NCT01286454|11046642|FG007|COMPLETED|Fourth Intervention Period||2
9929179|NCT01286454|11046643|FG008|COMPLETED|Fourth Intervention Period||2
9929180|NCT01286454|11046644|FG009|COMPLETED|Fourth Intervention Period||2
9929181|NCT01286454|11046645|FG010|COMPLETED|Fourth Intervention Period||0
9929182|NCT01286454|11046635|FG000|NOT COMPLETED|Fourth Intervention Period||0
9929183|NCT01286454|11046636|FG001|NOT COMPLETED|Fourth Intervention Period||0
9929184|NCT01286454|11046637|FG002|NOT COMPLETED|Fourth Intervention Period||0
9929185|NCT01286454|11046638|FG003|NOT COMPLETED|Fourth Intervention Period||0
9929186|NCT01286454|11046639|FG004|NOT COMPLETED|Fourth Intervention Period||0
9929187|NCT01286454|11046640|FG005|NOT COMPLETED|Fourth Intervention Period||0
9929188|NCT01286454|11046641|FG006|NOT COMPLETED|Fourth Intervention Period||0
9929189|NCT01286454|11046642|FG007|NOT COMPLETED|Fourth Intervention Period||0
9929190|NCT01286454|11046643|FG008|NOT COMPLETED|Fourth Intervention Period||0
9929191|NCT01286454|11046644|FG009|NOT COMPLETED|Fourth Intervention Period||0
9929192|NCT01286454|11046645|FG010|NOT COMPLETED|Fourth Intervention Period||0
9929193|NCT01286454|11046635|FG000|STARTED|Washout Period (At Least 3 Days)||2
9929194|NCT01286454|11046636|FG001|STARTED|Washout Period (At Least 3 Days)||2
9929195|NCT01286454|11046637|FG002|STARTED|Washout Period (At Least 3 Days)||2
9929196|NCT01286454|11046638|FG003|STARTED|Washout Period (At Least 3 Days)||2
9929197|NCT01286454|11046639|FG004|STARTED|Washout Period (At Least 3 Days)||2
9929198|NCT01286454|11046640|FG005|STARTED|Washout Period (At Least 3 Days)||2
9929199|NCT01286454|11046641|FG006|STARTED|Washout Period (At Least 3 Days)||2
9929200|NCT01286454|11046642|FG007|STARTED|Washout Period (At Least 3 Days)||2
9929201|NCT01286454|11046643|FG008|STARTED|Washout Period (At Least 3 Days)||2
9929202|NCT01286454|11046644|FG009|STARTED|Washout Period (At Least 3 Days)||2
9929203|NCT01286454|11046645|FG010|STARTED|Washout Period (At Least 3 Days)||0
9929204|NCT01286454|11046635|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
9929205|NCT01286454|11046636|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
9929206|NCT01286454|11046637|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
9929207|NCT01286454|11046638|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
9929208|NCT01286454|11046639|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
9929209|NCT01286454|11046640|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
9929210|NCT01286454|11046641|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
9929211|NCT01286454|11046642|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
9929212|NCT01286454|11046643|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
9929213|NCT01286454|11046644|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
9929214|NCT01286454|11046645|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
9929215|NCT01286454|11046635|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929216|NCT01286454|11046636|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929217|NCT01286454|11046637|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929218|NCT01286454|11046638|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929219|NCT01286454|11046639|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929220|NCT01286454|11046640|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929221|NCT01286454|11046641|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929222|NCT01286454|11046642|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929223|NCT01286454|11046643|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929224|NCT01286454|11046644|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929225|NCT01286454|11046645|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
9929226|NCT01286454|11046635|FG000|STARTED|Fifth Intervention Period||2
9929227|NCT01286454|11046636|FG001|STARTED|Fifth Intervention Period||2
9929228|NCT01286454|11046637|FG002|STARTED|Fifth Intervention Period||2
9929229|NCT01286454|11046638|FG003|STARTED|Fifth Intervention Period||2
10111473|NCT02496767|11242553|FG001|COMPLETED|Open-label Lead-in Phase||0
10111474|NCT02496767|11242554|FG002|COMPLETED|Open-label Lead-in Phase||0
10111475|NCT02496767|11242555|FG003|COMPLETED|Open-label Lead-in Phase||0
10111476|NCT02496767|11242556|FG004|COMPLETED|Open-label Lead-in Phase||0
10111477|NCT02496767|11242557|FG005|COMPLETED|Open-label Lead-in Phase||0
10111478|NCT02496767|11242558|FG006|COMPLETED|Open-label Lead-in Phase||0
10111479|NCT02496767|11242559|FG007|COMPLETED|Open-label Lead-in Phase||0
10111480|NCT02496767|11242552|FG000|NOT COMPLETED|Open-label Lead-in Phase||179
10111481|NCT02496767|11242553|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
10111482|NCT02496767|11242554|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
10111483|NCT02496767|11242555|FG003|NOT COMPLETED|Open-label Lead-in Phase||0
10111484|NCT02496767|11242556|FG004|NOT COMPLETED|Open-label Lead-in Phase||0
10111485|NCT02496767|11242557|FG005|NOT COMPLETED|Open-label Lead-in Phase||0
9929230|NCT01286454|11046639|FG004|STARTED|Fifth Intervention Period||2
9929231|NCT01286454|11046640|FG005|STARTED|Fifth Intervention Period||2
9929232|NCT01286454|11046641|FG006|STARTED|Fifth Intervention Period||2
9929233|NCT01286454|11046642|FG007|STARTED|Fifth Intervention Period||2
9929234|NCT01286454|11046643|FG008|STARTED|Fifth Intervention Period||2
9929235|NCT01286454|11046644|FG009|STARTED|Fifth Intervention Period||2
10205570|NCT03493815|11332337|FG000|NOT COMPLETED|Overall Study||9
10205571|NCT03493815|11332338|FG001|NOT COMPLETED|Overall Study||11
10205572|NCT03493828|11332347|FG000|STARTED|Overall Study||20
10205573|NCT03493828|11332348|FG001|STARTED|Overall Study||20
10205574|NCT03493828|11332349|FG002|STARTED|Overall Study||20
10205575|NCT03493828|11332347|FG000|COMPLETED|Overall Study||20
10205576|NCT03493828|11332348|FG001|COMPLETED|Overall Study||20
10205577|NCT03493828|11332349|FG002|COMPLETED|Overall Study||20
10205578|NCT03493828|11332347|FG000|NOT COMPLETED|Overall Study||0
10205579|NCT03493828|11332348|FG001|NOT COMPLETED|Overall Study||0
10205580|NCT03493828|11332349|FG002|NOT COMPLETED|Overall Study||0
10205581|NCT03494725|11332359|FG000|STARTED|Overall Study||60
10205582|NCT03494725|11332360|FG001|STARTED|Overall Study||60
10205583|NCT03494725|11332359|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59
10205584|NCT03494725|11332360|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59
10205585|NCT03494725|11332359|FG000|COMPLETED|Overall Study||59
10205586|NCT03494725|11332360|FG001|COMPLETED|Overall Study||58
10205587|NCT03494725|11332359|FG000|NOT COMPLETED|Overall Study||1
10205588|NCT03494725|11332360|FG001|NOT COMPLETED|Overall Study||2
10205589|NCT03494816|11332372|FG000|STARTED|Overall Study||24
10205590|NCT03494816|11332372|FG000|COMPLETED|Overall Study||18
10205591|NCT03494816|11332372|FG000|NOT COMPLETED|Overall Study||6
10205592|NCT03494985|11332384|FG000|STARTED|Overall Study||101
10205593|NCT03494985|11332385|FG001|STARTED|Overall Study||98
10205594|NCT03494985|11332386|FG002|STARTED|Overall Study||98
10205595|NCT03494985|11332387|FG003|STARTED|Overall Study||99
10205596|NCT03494985|11332384|FG000|COMPLETED|Overall Study||96
10205597|NCT03494985|11332385|FG001|COMPLETED|Overall Study||92
10205598|NCT03494985|11332386|FG002|COMPLETED|Overall Study||92
10205599|NCT03494985|11332387|FG003|COMPLETED|Overall Study||94
10205600|NCT03494985|11332384|FG000|NOT COMPLETED|Overall Study||5
10205601|NCT03494985|11332385|FG001|NOT COMPLETED|Overall Study||6
10205602|NCT03494985|11332386|FG002|NOT COMPLETED|Overall Study||6
10205603|NCT03494985|11332387|FG003|NOT COMPLETED|Overall Study||5
10205604|NCT03495102|11332400|FG000|STARTED|Overall Study||612
10205605|NCT03495102|11332401|FG001|STARTED|Overall Study||616
10205606|NCT03495102|11332402|FG002|STARTED|Overall Study||614
10205607|NCT03495102|11332400|FG000|Received at Least One Dose of Study Drug|Overall Study||612
10205608|NCT03495102|11332401|FG001|Received at Least One Dose of Study Drug|Overall Study||616
10205609|NCT03495102|11332402|FG002|Received at Least One Dose of Study Drug|Overall Study||614
10205610|NCT03495102|11332400|FG000|COMPLETED|Overall Study||556
10205611|NCT03495102|11332401|FG001|COMPLETED|Overall Study||549
10205612|NCT03495102|11332402|FG002|COMPLETED|Overall Study||560
10205613|NCT03495102|11332400|FG000|NOT COMPLETED|Overall Study||56
10205614|NCT03495102|11332401|FG001|NOT COMPLETED|Overall Study||67
10205615|NCT03495102|11332402|FG002|NOT COMPLETED|Overall Study||54
10205616|NCT03495648|11332412|FG000|STARTED|Overall Study||60
10111486|NCT02496767|11242558|FG006|NOT COMPLETED|Open-label Lead-in Phase||0
10111487|NCT02496767|11242559|FG007|NOT COMPLETED|Open-label Lead-in Phase||0
10111488|NCT02496767|11242552|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
10111489|NCT02496767|11242553|FG001|STARTED|Double-blind, Placebo-controlled Phase||188
10111490|NCT02496767|11242554|FG002|STARTED|Double-blind, Placebo-controlled Phase||126
10111491|NCT02496767|11242555|FG003|STARTED|Double-blind, Placebo-controlled Phase||126
10111492|NCT02496767|11242556|FG004|STARTED|Double-blind, Placebo-controlled Phase||125
10111493|NCT02496767|11242557|FG005|STARTED|Double-blind, Placebo-controlled Phase||0
10111494|NCT02496767|11242558|FG006|STARTED|Double-blind, Placebo-controlled Phase||0
10111495|NCT02496767|11242559|FG007|STARTED|Double-blind, Placebo-controlled Phase||0
10111496|NCT02496767|11242552|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
10111497|NCT02496767|11242553|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132
10111498|NCT02496767|11242554|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80
10111499|NCT02496767|11242555|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65
10111500|NCT02496767|11242556|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59
10111501|NCT02496767|11242557|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0
10111502|NCT02496767|11242558|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0
10111503|NCT02496767|11242559|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0
10111504|NCT02496767|11242552|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10111505|NCT02496767|11242553|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
10111506|NCT02496767|11242554|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
10111507|NCT02496767|11242555|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
10111508|NCT02496767|11242556|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
10111509|NCT02496767|11242557|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10111510|NCT02496767|11242558|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10111511|NCT02496767|11242559|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10111512|NCT02496767|11242552|FG000|STARTED|Double-blind, Withdrawal Phase||0
10205617|NCT03495648|11332413|FG001|STARTED|Overall Study||61
10205618|NCT03495648|11332412|FG000|COMPLETED|Overall Study||60
10205619|NCT03495648|11332413|FG001|COMPLETED|Overall Study||61
10205620|NCT03495648|11332412|FG000|NOT COMPLETED|Overall Study||0
10205621|NCT03495648|11332413|FG001|NOT COMPLETED|Overall Study||0
10205622|NCT03495817|11332419|FG000|STARTED|26 Week Open Label||31
10205623|NCT03495817|11332419|FG000|COMPLETED|26 Week Open Label||23
10205624|NCT03495817|11332419|FG000|NOT COMPLETED|26 Week Open Label||8
10205625|NCT03495817|11332419|FG000|STARTED|26 Week Extension||19
10205626|NCT03495817|11332419|FG000|COMPLETED|26 Week Extension||17
10111513|NCT02496767|11242553|FG001|STARTED|Double-blind, Withdrawal Phase||0
10111514|NCT02496767|11242554|FG002|STARTED|Double-blind, Withdrawal Phase||0
10111515|NCT02496767|11242555|FG003|STARTED|Double-blind, Withdrawal Phase||0
10111516|NCT02496767|11242556|FG004|STARTED|Double-blind, Withdrawal Phase||0
10111517|NCT02496767|11242557|FG005|STARTED|Double-blind, Withdrawal Phase||132
10111518|NCT02496767|11242558|FG006|STARTED|Double-blind, Withdrawal Phase||103
10111519|NCT02496767|11242559|FG007|STARTED|Double-blind, Withdrawal Phase||101
10111520|NCT02496767|11242552|FG000|COMPLETED|Double-blind, Withdrawal Phase||0
10111521|NCT02496767|11242553|FG001|COMPLETED|Double-blind, Withdrawal Phase||0
10111522|NCT02496767|11242554|FG002|COMPLETED|Double-blind, Withdrawal Phase||0
10111523|NCT02496767|11242555|FG003|COMPLETED|Double-blind, Withdrawal Phase||0
10111524|NCT02496767|11242556|FG004|COMPLETED|Double-blind, Withdrawal Phase||0
10111525|NCT02496767|11242557|FG005|COMPLETED|Double-blind, Withdrawal Phase||126
10111526|NCT02496767|11242558|FG006|COMPLETED|Double-blind, Withdrawal Phase||99
10111527|NCT02496767|11242559|FG007|COMPLETED|Double-blind, Withdrawal Phase||96
10111528|NCT02496767|11242552|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10111529|NCT02496767|11242553|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10111530|NCT02496767|11242554|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10111531|NCT02496767|11242555|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10111532|NCT02496767|11242556|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10111533|NCT02496767|11242557|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6
10111534|NCT02496767|11242558|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4
10111535|NCT02496767|11242559|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5
10111536|NCT02496884|11242577|FG000|STARTED|Overall Study||17
10111537|NCT02496884|11242578|FG001|STARTED|Overall Study||34
10111538|NCT02496884|11242579|FG002|STARTED|Overall Study||1
10111539|NCT02496884|11242580|FG003|STARTED|Overall Study||4
10111540|NCT02496884|11242577|FG000|Safety Analysis Set|Overall Study||17
10111541|NCT02496884|11242578|FG001|Safety Analysis Set|Overall Study||34
10111542|NCT02496884|11242579|FG002|Safety Analysis Set|Overall Study||1
10111543|NCT02496884|11242580|FG003|Safety Analysis Set|Overall Study||4
10111544|NCT02496884|11242577|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17
10111545|NCT02496884|11242578|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34
10111546|NCT02496884|11242579|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1
10111547|NCT02496884|11242580|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4
10111548|NCT02496884|11242577|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10111549|NCT02496884|11242578|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33
10111550|NCT02496884|11242579|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10205627|NCT03495817|11332419|FG000|NOT COMPLETED|26 Week Extension||2
10205628|NCT03495856|11332423|FG000|STARTED|Overall Study||23
10205629|NCT03495856|11332423|FG000|COMPLETED|Overall Study||22
10205630|NCT03495856|11332423|FG000|NOT COMPLETED|Overall Study||1
10205631|NCT03495869|11332431|FG000|STARTED|Overall Study||54
10205632|NCT03495869|11332432|FG001|STARTED|Overall Study||124
10205633|NCT03495869|11332433|FG002|STARTED|Overall Study||61
10205634|NCT03495869|11332434|FG003|STARTED|Overall Study||129
10205635|NCT03495869|11332431|FG000|COMPLETED|Overall Study||50
10205636|NCT03495869|11332432|FG001|COMPLETED|Overall Study||97
10205637|NCT03495869|11332433|FG002|COMPLETED|Overall Study||51
10205638|NCT03495869|11332434|FG003|COMPLETED|Overall Study||108
10205639|NCT03495869|11332431|FG000|NOT COMPLETED|Overall Study||4
10205640|NCT03495869|11332432|FG001|NOT COMPLETED|Overall Study||27
10205641|NCT03495869|11332433|FG002|NOT COMPLETED|Overall Study||10
10205642|NCT03495869|11332434|FG003|NOT COMPLETED|Overall Study||21
9929236|NCT01286454|11046645|FG010|STARTED|Fifth Intervention Period||0
10111551|NCT02496884|11242580|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10111552|NCT02496884|11242577|FG000|Completed Treatment Per Protocol|Overall Study||16
10111553|NCT02496884|11242578|FG001|Completed Treatment Per Protocol|Overall Study||27
10111554|NCT02496884|11242579|FG002|Completed Treatment Per Protocol|Overall Study||1
10111555|NCT02496884|11242580|FG003|Completed Treatment Per Protocol|Overall Study||3
10111556|NCT02496884|11242577|FG000|COMPLETED|Overall Study||15
10111557|NCT02496884|11242578|FG001|COMPLETED|Overall Study||31
10111558|NCT02496884|11242579|FG002|COMPLETED|Overall Study||1
10111559|NCT02496884|11242580|FG003|COMPLETED|Overall Study||4
10111560|NCT02496884|11242577|FG000|NOT COMPLETED|Overall Study||2
10111561|NCT02496884|11242578|FG001|NOT COMPLETED|Overall Study||3
10111562|NCT02496884|11242579|FG002|NOT COMPLETED|Overall Study||0
10111563|NCT02496884|11242580|FG003|NOT COMPLETED|Overall Study||0
10111564|NCT02497001|11242594|FG000|STARTED|Overall Study||640
10111565|NCT02497001|11242595|FG001|STARTED|Overall Study||627
10111566|NCT02497001|11242596|FG002|STARTED|Overall Study||316
10111567|NCT02497001|11242597|FG003|STARTED|Overall Study||319
10111568|NCT02497001|11242594|FG000|COMPLETED|Overall Study||566
10111569|NCT02497001|11242595|FG001|COMPLETED|Overall Study||524
10111570|NCT02497001|11242596|FG002|COMPLETED|Overall Study||266
10111571|NCT02497001|11242597|FG003|COMPLETED|Overall Study||278
10111572|NCT02497001|11242594|FG000|NOT COMPLETED|Overall Study||74
10111573|NCT02497001|11242595|FG001|NOT COMPLETED|Overall Study||103
10111574|NCT02497001|11242596|FG002|NOT COMPLETED|Overall Study||50
10111575|NCT02497001|11242597|FG003|NOT COMPLETED|Overall Study||41
10111576|NCT02497040|11242613|FG000|STARTED|Overall Study||30
10111577|NCT02497040|11242614|FG001|STARTED|Overall Study||30
10111578|NCT02497040|11242615|FG002|STARTED|Overall Study||30
10111579|NCT02497040|11242613|FG000|COMPLETED|Overall Study||30
10205643|NCT03495908|11332446|FG000|STARTED|Overall Study||69
10205644|NCT03495908|11332447|FG001|STARTED|Overall Study||67
10111580|NCT02497040|11242614|FG001|COMPLETED|Overall Study||30
10111581|NCT02497040|11242615|FG002|COMPLETED|Overall Study||30
10111582|NCT02497040|11242613|FG000|NOT COMPLETED|Overall Study||0
10111583|NCT02497040|11242614|FG001|NOT COMPLETED|Overall Study||0
10111584|NCT02497040|11242615|FG002|NOT COMPLETED|Overall Study||0
10111585|NCT02497235|11242628|FG000|STARTED|Overall Study||2
10111586|NCT02497235|11242629|FG001|STARTED|Overall Study||2
10111587|NCT02497235|11242630|FG002|STARTED|Overall Study||2
10111588|NCT02497235|11242631|FG003|STARTED|Overall Study||2
9929237|NCT01286454|11046635|FG000|COMPLETED|Fifth Intervention Period||2
9929238|NCT01286454|11046636|FG001|COMPLETED|Fifth Intervention Period||2
9929239|NCT01286454|11046637|FG002|COMPLETED|Fifth Intervention Period||2
9929240|NCT01286454|11046638|FG003|COMPLETED|Fifth Intervention Period||2
9929241|NCT01286454|11046639|FG004|COMPLETED|Fifth Intervention Period||2
9929242|NCT01286454|11046640|FG005|COMPLETED|Fifth Intervention Period||2
9929243|NCT01286454|11046641|FG006|COMPLETED|Fifth Intervention Period||2
9929244|NCT01286454|11046642|FG007|COMPLETED|Fifth Intervention Period||2
9929245|NCT01286454|11046643|FG008|COMPLETED|Fifth Intervention Period||2
9929246|NCT01286454|11046644|FG009|COMPLETED|Fifth Intervention Period||2
9929247|NCT01286454|11046645|FG010|COMPLETED|Fifth Intervention Period||0
9929248|NCT01286454|11046635|FG000|NOT COMPLETED|Fifth Intervention Period||0
9929249|NCT01286454|11046636|FG001|NOT COMPLETED|Fifth Intervention Period||0
9929250|NCT01286454|11046637|FG002|NOT COMPLETED|Fifth Intervention Period||0
9929251|NCT01286454|11046638|FG003|NOT COMPLETED|Fifth Intervention Period||0
9929252|NCT01286454|11046639|FG004|NOT COMPLETED|Fifth Intervention Period||0
9929253|NCT01286454|11046640|FG005|NOT COMPLETED|Fifth Intervention Period||0
9929254|NCT01286454|11046641|FG006|NOT COMPLETED|Fifth Intervention Period||0
9929255|NCT01286454|11046642|FG007|NOT COMPLETED|Fifth Intervention Period||0
9929256|NCT01286454|11046643|FG008|NOT COMPLETED|Fifth Intervention Period||0
9929257|NCT01286454|11046644|FG009|NOT COMPLETED|Fifth Intervention Period||0
9929258|NCT01286454|11046645|FG010|NOT COMPLETED|Fifth Intervention Period||0
9929259|NCT01286454|11046635|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2
9929260|NCT01286454|11046636|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2
9929261|NCT01286454|11046637|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2
9929262|NCT01286454|11046638|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2
9929263|NCT01286454|11046639|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2
9929264|NCT01286454|11046640|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2
9929265|NCT01286454|11046641|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2
9929266|NCT01286454|11046642|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2
9929267|NCT01286454|11046643|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2
9929268|NCT01286454|11046644|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2
9929269|NCT01286454|11046645|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0
9929270|NCT01286454|11046635|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929271|NCT01286454|11046636|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929272|NCT01286454|11046637|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929273|NCT01286454|11046638|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929274|NCT01286454|11046639|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929275|NCT01286454|11046640|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929276|NCT01286454|11046641|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929277|NCT01286454|11046642|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929278|NCT01286454|11046643|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929279|NCT01286454|11046644|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2
9929280|NCT01286454|11046645|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929281|NCT01286454|11046635|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929282|NCT01286454|11046636|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929283|NCT01286454|11046637|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929284|NCT01286454|11046638|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929285|NCT01286454|11046639|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929286|NCT01286454|11046640|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929287|NCT01286454|11046641|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929288|NCT01286454|11046642|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929289|NCT01286454|11046643|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929290|NCT01286454|11046644|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929291|NCT01286454|11046645|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
9929292|NCT01286454|11046635|FG000|STARTED|Part II- Sixth Intervention Period||0
9929293|NCT01286454|11046636|FG001|STARTED|Part II- Sixth Intervention Period||0
9929294|NCT01286454|11046637|FG002|STARTED|Part II- Sixth Intervention Period||0
9929295|NCT01286454|11046638|FG003|STARTED|Part II- Sixth Intervention Period||0
9929296|NCT01286454|11046639|FG004|STARTED|Part II- Sixth Intervention Period||0
9929297|NCT01286454|11046640|FG005|STARTED|Part II- Sixth Intervention Period||0
9929298|NCT01286454|11046641|FG006|STARTED|Part II- Sixth Intervention Period||0
9929299|NCT01286454|11046642|FG007|STARTED|Part II- Sixth Intervention Period||0
9929300|NCT01286454|11046643|FG008|STARTED|Part II- Sixth Intervention Period||0
9929301|NCT01286454|11046644|FG009|STARTED|Part II- Sixth Intervention Period||0
9929302|NCT01286454|11046645|FG010|STARTED|Part II- Sixth Intervention Period||20
10111589|NCT02497235|11242632|FG004|STARTED|Overall Study||3
10111590|NCT02497235|11242628|FG000|COMPLETED|Overall Study||2
10111591|NCT02497235|11242629|FG001|COMPLETED|Overall Study||2
9929303|NCT01286454|11046635|FG000|COMPLETED|Part II- Sixth Intervention Period||0
9929304|NCT01286454|11046636|FG001|COMPLETED|Part II- Sixth Intervention Period||0
9929305|NCT01286454|11046637|FG002|COMPLETED|Part II- Sixth Intervention Period||0
9929306|NCT01286454|11046638|FG003|COMPLETED|Part II- Sixth Intervention Period||0
9929307|NCT01286454|11046639|FG004|COMPLETED|Part II- Sixth Intervention Period||0
9929308|NCT01286454|11046640|FG005|COMPLETED|Part II- Sixth Intervention Period||0
9929309|NCT01286454|11046641|FG006|COMPLETED|Part II- Sixth Intervention Period||0
9929310|NCT01286454|11046642|FG007|COMPLETED|Part II- Sixth Intervention Period||0
9929311|NCT01286454|11046643|FG008|COMPLETED|Part II- Sixth Intervention Period||0
9929312|NCT01286454|11046644|FG009|COMPLETED|Part II- Sixth Intervention Period||0
9929313|NCT01286454|11046645|FG010|COMPLETED|Part II- Sixth Intervention Period||20
9929314|NCT01286454|11046635|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929315|NCT01286454|11046636|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929316|NCT01286454|11046637|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929317|NCT01286454|11046638|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929318|NCT01286454|11046639|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929319|NCT01286454|11046640|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929320|NCT01286454|11046641|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929321|NCT01286454|11046642|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929322|NCT01286454|11046643|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929323|NCT01286454|11046644|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929324|NCT01286454|11046645|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0
9929325|NCT01286480|11046661|FG000|STARTED|Overall Study||32
9929326|NCT01286480|11046662|FG001|STARTED|Overall Study||34
9929327|NCT01286480|11046661|FG000|COMPLETED|Overall Study||27
9929328|NCT01286480|11046662|FG001|COMPLETED|Overall Study||31
9929329|NCT01286480|11046661|FG000|NOT COMPLETED|Overall Study||5
9929330|NCT01286480|11046662|FG001|NOT COMPLETED|Overall Study||3
9929331|NCT01286493|11046668|FG000|STARTED|Overall Study||33
9929332|NCT01286493|11046668|FG000|COMPLETED|Overall Study||30
9929333|NCT01286493|11046668|FG000|NOT COMPLETED|Overall Study||3
9929334|NCT01286558|11046674|FG000|STARTED|Overall Study||112
9929335|NCT01286558|11046675|FG001|STARTED|Overall Study||113
9929336|NCT01286558|11046674|FG000|COMPLETED|Overall Study||111
9929337|NCT01286558|11046675|FG001|COMPLETED|Overall Study||111
9929338|NCT01286558|11046674|FG000|NOT COMPLETED|Overall Study||1
9929339|NCT01286558|11046675|FG001|NOT COMPLETED|Overall Study||2
9929340|NCT01286740|11046681|FG000|STARTED|Overall Study||50
9929341|NCT01286740|11046681|FG000|Enrolled and Treated|Overall Study||49
9929342|NCT01286740|11046681|FG000|Week 12 (Primary Endpoint)|Overall Study||49
9929343|NCT01286740|11046681|FG000|COMPLETED|Overall Study||48
9929344|NCT01286740|11046681|FG000|NOT COMPLETED|Overall Study||2
9929345|NCT01286753|11046687|FG000|STARTED|Overall Study||26
9929346|NCT01286753|11046688|FG001|STARTED|Overall Study||25
9929347|NCT01286753|11046687|FG000|COMPLETED|Overall Study||0
9929348|NCT01286753|11046688|FG001|COMPLETED|Overall Study||0
9929349|NCT01286753|11046687|FG000|NOT COMPLETED|Overall Study||26
9929350|NCT01286753|11046688|FG001|NOT COMPLETED|Overall Study||25
9929351|NCT01286779|11046695|FG000|STARTED|Overall Study||115
9929352|NCT01286779|11046695|FG000|COMPLETED|Overall Study||96
9929353|NCT01286779|11046695|FG000|NOT COMPLETED|Overall Study||19
9929354|NCT01286805|11046711|FG000|STARTED|Overall Study||41
9929355|NCT01286805|11046712|FG001|STARTED|Overall Study||42
9929356|NCT01286805|11046711|FG000|COMPLETED|Overall Study||41
9929357|NCT01286805|11046712|FG001|COMPLETED|Overall Study||41
9929358|NCT01286805|11046711|FG000|NOT COMPLETED|Overall Study||0
9929359|NCT01286805|11046712|FG001|NOT COMPLETED|Overall Study||1
9929360|NCT01286818|11046718|FG000|STARTED|Overall Study||6
9929361|NCT01286818|11046718|FG000|Completed DLT Assessment Period|Overall Study||5
9929362|NCT01286818|11046718|FG000|COMPLETED|Overall Study||6
9929363|NCT01286818|11046718|FG000|NOT COMPLETED|Overall Study||0
9929364|NCT01286870|11046722|FG000|STARTED|Overall Study||11
9929365|NCT01286870|11046722|FG000|COMPLETED|Overall Study||11
9929366|NCT01286870|11046722|FG000|NOT COMPLETED|Overall Study||0
9929367|NCT01286987|11046741|FG000|STARTED|Part 1: Dose Escalation||3
9929368|NCT01286987|11046742|FG001|STARTED|Part 1: Dose Escalation||3
9929369|NCT01286987|11046743|FG002|STARTED|Part 1: Dose Escalation||3
9929370|NCT01286987|11046744|FG003|STARTED|Part 1: Dose Escalation||3
9929371|NCT01286987|11046745|FG004|STARTED|Part 1: Dose Escalation||3
9929372|NCT01286987|11046746|FG005|STARTED|Part 1: Dose Escalation||6
9929373|NCT01286987|11046747|FG006|STARTED|Part 1: Dose Escalation||6
9929374|NCT01286987|11046748|FG007|STARTED|Part 1: Dose Escalation||6
9929375|NCT01286987|11046749|FG008|STARTED|Part 1: Dose Escalation||6
9929376|NCT01286987|11046750|FG009|STARTED|Part 1: Dose Escalation||0
9929377|NCT01286987|11046751|FG010|STARTED|Part 1: Dose Escalation||0
9929378|NCT01286987|11046752|FG011|STARTED|Part 1: Dose Escalation||0
9929379|NCT01286987|11046753|FG012|STARTED|Part 1: Dose Escalation||0
9929380|NCT01286987|11046754|FG013|STARTED|Part 1: Dose Escalation||0
9929381|NCT01286987|11046755|FG014|STARTED|Part 1: Dose Escalation||0
9929382|NCT01286987|11046741|FG000|Colorectal Cancer|Part 1: Dose Escalation||1
9929383|NCT01286987|11046742|FG001|Colorectal Cancer|Part 1: Dose Escalation||0
9929384|NCT01286987|11046743|FG002|Colorectal Cancer|Part 1: Dose Escalation||1
9929385|NCT01286987|11046744|FG003|Colorectal Cancer|Part 1: Dose Escalation||0
9929386|NCT01286987|11046745|FG004|Colorectal Cancer|Part 1: Dose Escalation||0
9929387|NCT01286987|11046746|FG005|Colorectal Cancer|Part 1: Dose Escalation||0
9929388|NCT01286987|11046747|FG006|Colorectal Cancer|Part 1: Dose Escalation||0
9929389|NCT01286987|11046748|FG007|Colorectal Cancer|Part 1: Dose Escalation||0
9929390|NCT01286987|11046749|FG008|Colorectal Cancer|Part 1: Dose Escalation||0
9929391|NCT01286987|11046750|FG009|Colorectal Cancer|Part 1: Dose Escalation||0
9929392|NCT01286987|11046751|FG010|Colorectal Cancer|Part 1: Dose Escalation||0
9929393|NCT01286987|11046752|FG011|Colorectal Cancer|Part 1: Dose Escalation||0
9929394|NCT01286987|11046753|FG012|Colorectal Cancer|Part 1: Dose Escalation||0
9929395|NCT01286987|11046754|FG013|Colorectal Cancer|Part 1: Dose Escalation||0
9929396|NCT01286987|11046755|FG014|Colorectal Cancer|Part 1: Dose Escalation||0
9929397|NCT01286987|11046741|FG000|Prostate Cancer|Part 1: Dose Escalation||0
9929398|NCT01286987|11046742|FG001|Prostate Cancer|Part 1: Dose Escalation||0
9929399|NCT01286987|11046743|FG002|Prostate Cancer|Part 1: Dose Escalation||0
9929400|NCT01286987|11046744|FG003|Prostate Cancer|Part 1: Dose Escalation||0
9929401|NCT01286987|11046745|FG004|Prostate Cancer|Part 1: Dose Escalation||0
9929402|NCT01286987|11046746|FG005|Prostate Cancer|Part 1: Dose Escalation||1
9929403|NCT01286987|11046747|FG006|Prostate Cancer|Part 1: Dose Escalation||0
9929404|NCT01286987|11046748|FG007|Prostate Cancer|Part 1: Dose Escalation||0
9929405|NCT01286987|11046749|FG008|Prostate Cancer|Part 1: Dose Escalation||0
9929406|NCT01286987|11046750|FG009|Prostate Cancer|Part 1: Dose Escalation||0
9929407|NCT01286987|11046751|FG010|Prostate Cancer|Part 1: Dose Escalation||0
9929408|NCT01286987|11046752|FG011|Prostate Cancer|Part 1: Dose Escalation||0
9929409|NCT01286987|11046753|FG012|Prostate Cancer|Part 1: Dose Escalation||0
9929410|NCT01286987|11046754|FG013|Prostate Cancer|Part 1: Dose Escalation||0
9929411|NCT01286987|11046755|FG014|Prostate Cancer|Part 1: Dose Escalation||0
9929412|NCT01286987|11046741|FG000|Ewing Cancer|Part 1: Dose Escalation||0
9929413|NCT01286987|11046742|FG001|Ewing Cancer|Part 1: Dose Escalation||0
9929414|NCT01286987|11046743|FG002|Ewing Cancer|Part 1: Dose Escalation||0
9929415|NCT01286987|11046744|FG003|Ewing Cancer|Part 1: Dose Escalation||0
9929416|NCT01286987|11046745|FG004|Ewing Cancer|Part 1: Dose Escalation||0
9929417|NCT01286987|11046746|FG005|Ewing Cancer|Part 1: Dose Escalation||0
9929418|NCT01286987|11046747|FG006|Ewing Cancer|Part 1: Dose Escalation||0
9929419|NCT01286987|11046748|FG007|Ewing Cancer|Part 1: Dose Escalation||1
9929420|NCT01286987|11046749|FG008|Ewing Cancer|Part 1: Dose Escalation||1
9929421|NCT01286987|11046750|FG009|Ewing Cancer|Part 1: Dose Escalation||0
9929422|NCT01286987|11046751|FG010|Ewing Cancer|Part 1: Dose Escalation||0
9929423|NCT01286987|11046752|FG011|Ewing Cancer|Part 1: Dose Escalation||0
9929424|NCT01286987|11046753|FG012|Ewing Cancer|Part 1: Dose Escalation||0
9929425|NCT01286987|11046754|FG013|Ewing Cancer|Part 1: Dose Escalation||0
9929426|NCT01286987|11046755|FG014|Ewing Cancer|Part 1: Dose Escalation||0
9929427|NCT01286987|11046741|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1
9929428|NCT01286987|11046742|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2
9929429|NCT01286987|11046743|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0
9929430|NCT01286987|11046744|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0
9929431|NCT01286987|11046745|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0
9929432|NCT01286987|11046746|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0
9929433|NCT01286987|11046747|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0
9929434|NCT01286987|11046748|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0
9929435|NCT01286987|11046749|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0
9929436|NCT01286987|11046750|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0
9929437|NCT01286987|11046751|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0
9929438|NCT01286987|11046752|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0
9929439|NCT01286987|11046753|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0
9929440|NCT01286987|11046754|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0
9929441|NCT01286987|11046755|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0
9929442|NCT01286987|11046741|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
9929443|NCT01286987|11046742|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
9929444|NCT01286987|11046743|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
9929445|NCT01286987|11046744|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
9929446|NCT01286987|11046745|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
9929447|NCT01286987|11046746|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
9929448|NCT01286987|11046747|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
9929449|NCT01286987|11046748|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
9929450|NCT01286987|11046749|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
9929451|NCT01286987|11046750|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
9929452|NCT01286987|11046751|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
9929453|NCT01286987|11046752|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
9929454|NCT01286987|11046753|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
9929455|NCT01286987|11046754|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
9929456|NCT01286987|11046755|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
9929457|NCT01286987|11046741|FG000|Breast Cancer|Part 1: Dose Escalation||0
9929458|NCT01286987|11046742|FG001|Breast Cancer|Part 1: Dose Escalation||0
9929459|NCT01286987|11046743|FG002|Breast Cancer|Part 1: Dose Escalation||0
9929460|NCT01286987|11046744|FG003|Breast Cancer|Part 1: Dose Escalation||0
9929461|NCT01286987|11046745|FG004|Breast Cancer|Part 1: Dose Escalation||0
9929462|NCT01286987|11046746|FG005|Breast Cancer|Part 1: Dose Escalation||1
9929463|NCT01286987|11046747|FG006|Breast Cancer|Part 1: Dose Escalation||2
9929464|NCT01286987|11046748|FG007|Breast Cancer|Part 1: Dose Escalation||2
9929465|NCT01286987|11046749|FG008|Breast Cancer|Part 1: Dose Escalation||3
9929466|NCT01286987|11046750|FG009|Breast Cancer|Part 1: Dose Escalation||0
9929467|NCT01286987|11046751|FG010|Breast Cancer|Part 1: Dose Escalation||0
9929468|NCT01286987|11046752|FG011|Breast Cancer|Part 1: Dose Escalation||0
9929469|NCT01286987|11046753|FG012|Breast Cancer|Part 1: Dose Escalation||0
9929470|NCT01286987|11046754|FG013|Breast Cancer|Part 1: Dose Escalation||0
9929471|NCT01286987|11046755|FG014|Breast Cancer|Part 1: Dose Escalation||0
9929472|NCT01286987|11046741|FG000|COMPLETED|Part 1: Dose Escalation||0
9929473|NCT01286987|11046742|FG001|COMPLETED|Part 1: Dose Escalation||0
9929474|NCT01286987|11046743|FG002|COMPLETED|Part 1: Dose Escalation||0
9929475|NCT01286987|11046744|FG003|COMPLETED|Part 1: Dose Escalation||0
9929476|NCT01286987|11046745|FG004|COMPLETED|Part 1: Dose Escalation||0
9929477|NCT01286987|11046746|FG005|COMPLETED|Part 1: Dose Escalation||0
9929478|NCT01286987|11046747|FG006|COMPLETED|Part 1: Dose Escalation||1
9929479|NCT01286987|11046748|FG007|COMPLETED|Part 1: Dose Escalation||1
9929480|NCT01286987|11046749|FG008|COMPLETED|Part 1: Dose Escalation||0
9929481|NCT01286987|11046750|FG009|COMPLETED|Part 1: Dose Escalation||0
9929482|NCT01286987|11046751|FG010|COMPLETED|Part 1: Dose Escalation||0
9929483|NCT01286987|11046752|FG011|COMPLETED|Part 1: Dose Escalation||0
9929484|NCT01286987|11046753|FG012|COMPLETED|Part 1: Dose Escalation||0
9929485|NCT01286987|11046754|FG013|COMPLETED|Part 1: Dose Escalation||0
9929486|NCT01286987|11046755|FG014|COMPLETED|Part 1: Dose Escalation||0
9929487|NCT01286987|11046741|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
9929488|NCT01286987|11046742|FG001|NOT COMPLETED|Part 1: Dose Escalation||3
9929489|NCT01286987|11046743|FG002|NOT COMPLETED|Part 1: Dose Escalation||3
9929490|NCT01286987|11046744|FG003|NOT COMPLETED|Part 1: Dose Escalation||3
9929491|NCT01286987|11046745|FG004|NOT COMPLETED|Part 1: Dose Escalation||3
9929492|NCT01286987|11046746|FG005|NOT COMPLETED|Part 1: Dose Escalation||6
9929493|NCT01286987|11046747|FG006|NOT COMPLETED|Part 1: Dose Escalation||5
9929494|NCT01286987|11046748|FG007|NOT COMPLETED|Part 1: Dose Escalation||5
9929495|NCT01286987|11046749|FG008|NOT COMPLETED|Part 1: Dose Escalation||6
9929496|NCT01286987|11046750|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
9929497|NCT01286987|11046751|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
9929498|NCT01286987|11046752|FG011|NOT COMPLETED|Part 1: Dose Escalation||0
10205645|NCT03495908|11332446|FG000|COMPLETED|Overall Study||59
10205646|NCT03495908|11332447|FG001|COMPLETED|Overall Study||54
10205647|NCT03495908|11332446|FG000|NOT COMPLETED|Overall Study||10
10205648|NCT03495908|11332447|FG001|NOT COMPLETED|Overall Study||13
10205649|NCT03496220|11332455|FG000|STARTED|First Intervention||15
10205650|NCT03496220|11332456|FG001|STARTED|First Intervention||4
10205651|NCT03496220|11332457|FG002|STARTED|First Intervention||10
10205652|NCT03496220|11332455|FG000|COMPLETED|First Intervention||15
10205653|NCT03496220|11332456|FG001|COMPLETED|First Intervention||4
10205654|NCT03496220|11332457|FG002|COMPLETED|First Intervention||10
10205655|NCT03496220|11332455|FG000|NOT COMPLETED|First Intervention||0
10205656|NCT03496220|11332456|FG001|NOT COMPLETED|First Intervention||0
10205657|NCT03496220|11332457|FG002|NOT COMPLETED|First Intervention||0
10205658|NCT03496220|11332455|FG000|STARTED|Second Intervention||17
10205659|NCT03496220|11332456|FG001|STARTED|Second Intervention||9
10205660|NCT03496220|11332457|FG002|STARTED|Second Intervention||11
10205661|NCT03496220|11332455|FG000|COMPLETED|Second Intervention||17
10205662|NCT03496220|11332456|FG001|COMPLETED|Second Intervention||9
10205663|NCT03496220|11332457|FG002|COMPLETED|Second Intervention||11
10205664|NCT03496220|11332455|FG000|NOT COMPLETED|Second Intervention||0
10205665|NCT03496220|11332456|FG001|NOT COMPLETED|Second Intervention||0
10205666|NCT03496220|11332457|FG002|NOT COMPLETED|Second Intervention||0
10205667|NCT03496220|11332455|FG000|STARTED|Third Intervention||11
10205668|NCT03496220|11332456|FG001|STARTED|Third Intervention||8
10205669|NCT03496220|11332457|FG002|STARTED|Third Intervention||5
10205670|NCT03496220|11332455|FG000|COMPLETED|Third Intervention||11
10205671|NCT03496220|11332456|FG001|COMPLETED|Third Intervention||8
10205672|NCT03496220|11332457|FG002|COMPLETED|Third Intervention||5
10205673|NCT03496220|11332455|FG000|NOT COMPLETED|Third Intervention||0
10205674|NCT03496220|11332456|FG001|NOT COMPLETED|Third Intervention||0
10205675|NCT03496220|11332457|FG002|NOT COMPLETED|Third Intervention||0
10205676|NCT03496298|11332466|FG000|STARTED|Overall Study||1359
10205677|NCT03496298|11332467|FG001|STARTED|Overall Study||1359
10205678|NCT03496298|11332468|FG002|STARTED|Overall Study||1358
10205679|NCT03496298|11332466|FG000|Randomized and Treated|Overall Study||1358
10205680|NCT03496298|11332467|FG001|Randomized and Treated|Overall Study||1358
10205681|NCT03496298|11332468|FG002|Randomized and Treated|Overall Study||1357
10205682|NCT03496298|11332466|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355
10205683|NCT03496298|11332467|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360
10205684|NCT03496298|11332468|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358
10205685|NCT03496298|11332466|FG000|COMPLETED|Overall Study||42
10205686|NCT03496298|11332467|FG001|COMPLETED|Overall Study||36
9929499|NCT01286987|11046753|FG012|NOT COMPLETED|Part 1: Dose Escalation||0
9929500|NCT01286987|11046754|FG013|NOT COMPLETED|Part 1: Dose Escalation||0
9929501|NCT01286987|11046755|FG014|NOT COMPLETED|Part 1: Dose Escalation||0
9929502|NCT01286987|11046741|FG000|STARTED|Part 2: Dose Expansion||0
9929503|NCT01286987|11046742|FG001|STARTED|Part 2: Dose Expansion||0
9929504|NCT01286987|11046743|FG002|STARTED|Part 2: Dose Expansion||0
9929505|NCT01286987|11046744|FG003|STARTED|Part 2: Dose Expansion||0
9929506|NCT01286987|11046745|FG004|STARTED|Part 2: Dose Expansion||0
9929507|NCT01286987|11046746|FG005|STARTED|Part 2: Dose Expansion||0
9929508|NCT01286987|11046747|FG006|STARTED|Part 2: Dose Expansion||0
9929509|NCT01286987|11046748|FG007|STARTED|Part 2: Dose Expansion||0
9929510|NCT01286987|11046749|FG008|STARTED|Part 2: Dose Expansion||0
9929511|NCT01286987|11046750|FG009|STARTED|Part 2: Dose Expansion||12
9929512|NCT01286987|11046751|FG010|STARTED|Part 2: Dose Expansion||12
9929513|NCT01286987|11046752|FG011|STARTED|Part 2: Dose Expansion||11
9929514|NCT01286987|11046753|FG012|STARTED|Part 2: Dose Expansion||12
9929515|NCT01286987|11046754|FG013|STARTED|Part 2: Dose Expansion||24
9929516|NCT01286987|11046755|FG014|STARTED|Part 2: Dose Expansion||3
9929517|NCT01286987|11046741|FG000|Treated|Part 2: Dose Expansion||0
9929518|NCT01286987|11046742|FG001|Treated|Part 2: Dose Expansion||0
9929519|NCT01286987|11046743|FG002|Treated|Part 2: Dose Expansion||0
9929520|NCT01286987|11046744|FG003|Treated|Part 2: Dose Expansion||0
9929521|NCT01286987|11046745|FG004|Treated|Part 2: Dose Expansion||0
9929522|NCT01286987|11046746|FG005|Treated|Part 2: Dose Expansion||0
9929523|NCT01286987|11046747|FG006|Treated|Part 2: Dose Expansion||0
9929524|NCT01286987|11046748|FG007|Treated|Part 2: Dose Expansion||0
9929525|NCT01286987|11046749|FG008|Treated|Part 2: Dose Expansion||0
9929526|NCT01286987|11046750|FG009|Treated|Part 2: Dose Expansion||12
9929527|NCT01286987|11046751|FG010|Treated|Part 2: Dose Expansion||11
9929528|NCT01286987|11046752|FG011|Treated|Part 2: Dose Expansion||10
9929529|NCT01286987|11046753|FG012|Treated|Part 2: Dose Expansion||12
9929530|NCT01286987|11046754|FG013|Treated|Part 2: Dose Expansion||23
9929531|NCT01286987|11046755|FG014|Treated|Part 2: Dose Expansion||3
9929532|NCT01286987|11046741|FG000|COMPLETED|Part 2: Dose Expansion||0
9929533|NCT01286987|11046742|FG001|COMPLETED|Part 2: Dose Expansion||0
9929534|NCT01286987|11046743|FG002|COMPLETED|Part 2: Dose Expansion||0
9929535|NCT01286987|11046744|FG003|COMPLETED|Part 2: Dose Expansion||0
9929536|NCT01286987|11046745|FG004|COMPLETED|Part 2: Dose Expansion||0
9929537|NCT01286987|11046746|FG005|COMPLETED|Part 2: Dose Expansion||0
9929538|NCT01286987|11046747|FG006|COMPLETED|Part 2: Dose Expansion||0
9929539|NCT01286987|11046748|FG007|COMPLETED|Part 2: Dose Expansion||0
9929540|NCT01286987|11046749|FG008|COMPLETED|Part 2: Dose Expansion||0
9929541|NCT01286987|11046750|FG009|COMPLETED|Part 2: Dose Expansion||1
9929542|NCT01286987|11046751|FG010|COMPLETED|Part 2: Dose Expansion||2
9929543|NCT01286987|11046752|FG011|COMPLETED|Part 2: Dose Expansion||1
9929544|NCT01286987|11046753|FG012|COMPLETED|Part 2: Dose Expansion||0
9929545|NCT01286987|11046754|FG013|COMPLETED|Part 2: Dose Expansion||0
10010885|NCT01776541|11133553|FG001|STARTED|Overall Study||491
10010886|NCT01776541|11133552|FG000|COMPLETED|Overall Study||432
10010887|NCT01776541|11133553|FG001|COMPLETED|Overall Study||416
10010888|NCT01776541|11133552|FG000|NOT COMPLETED|Overall Study||56
9929546|NCT01286987|11046755|FG014|COMPLETED|Part 2: Dose Expansion||1
9929547|NCT01286987|11046741|FG000|NOT COMPLETED|Part 2: Dose Expansion||0
9929548|NCT01286987|11046742|FG001|NOT COMPLETED|Part 2: Dose Expansion||0
9929549|NCT01286987|11046743|FG002|NOT COMPLETED|Part 2: Dose Expansion||0
9929550|NCT01286987|11046744|FG003|NOT COMPLETED|Part 2: Dose Expansion||0
9929551|NCT01286987|11046745|FG004|NOT COMPLETED|Part 2: Dose Expansion||0
9929552|NCT01286987|11046746|FG005|NOT COMPLETED|Part 2: Dose Expansion||0
9929553|NCT01286987|11046747|FG006|NOT COMPLETED|Part 2: Dose Expansion||0
9929554|NCT01286987|11046748|FG007|NOT COMPLETED|Part 2: Dose Expansion||0
9929555|NCT01286987|11046749|FG008|NOT COMPLETED|Part 2: Dose Expansion||0
9929556|NCT01286987|11046750|FG009|NOT COMPLETED|Part 2: Dose Expansion||11
9929557|NCT01286987|11046751|FG010|NOT COMPLETED|Part 2: Dose Expansion||10
9929558|NCT01286987|11046752|FG011|NOT COMPLETED|Part 2: Dose Expansion||10
9929559|NCT01286987|11046753|FG012|NOT COMPLETED|Part 2: Dose Expansion||12
9929560|NCT01286987|11046754|FG013|NOT COMPLETED|Part 2: Dose Expansion||24
9929561|NCT01286987|11046755|FG014|NOT COMPLETED|Part 2: Dose Expansion||2
9929562|NCT01287013|11046799|FG000|STARTED|Overall Study||32
9929563|NCT01287013|11046800|FG001|STARTED|Overall Study||34
9929564|NCT01287013|11046801|FG002|STARTED|Overall Study||21
9929565|NCT01287013|11046799|FG000|COMPLETED|Overall Study||29
9929566|NCT01287013|11046800|FG001|COMPLETED|Overall Study||29
9929567|NCT01287013|11046801|FG002|COMPLETED|Overall Study||0
9929568|NCT01287013|11046799|FG000|NOT COMPLETED|Overall Study||3
9929569|NCT01287013|11046800|FG001|NOT COMPLETED|Overall Study||5
9929570|NCT01287013|11046801|FG002|NOT COMPLETED|Overall Study||21
9929571|NCT01287039|11046811|FG000|STARTED|Overall Study||244
9929572|NCT01287039|11046812|FG001|STARTED|Overall Study||245
9929573|NCT01287039|11046811|FG000|COMPLETED|Overall Study||215
9929574|NCT01287039|11046812|FG001|COMPLETED|Overall Study||218
9929575|NCT01287039|11046811|FG000|NOT COMPLETED|Overall Study||29
9929576|NCT01287039|11046812|FG001|NOT COMPLETED|Overall Study||27
9929577|NCT01287065|11046818|FG000|STARTED|Treatment Period 1||4
9929578|NCT01287065|11046819|FG001|STARTED|Treatment Period 1||4
9929579|NCT01287065|11046820|FG002|STARTED|Treatment Period 1||4
9929580|NCT01287065|11046821|FG003|STARTED|Treatment Period 1||4
9929581|NCT01287065|11046822|FG004|STARTED|Treatment Period 1||5
9929582|NCT01287065|11046823|FG005|STARTED|Treatment Period 1||5
9929583|NCT01287065|11046818|FG000|COMPLETED|Treatment Period 1||4
9929584|NCT01287065|11046819|FG001|COMPLETED|Treatment Period 1||4
9929585|NCT01287065|11046820|FG002|COMPLETED|Treatment Period 1||4
10010889|NCT01776541|11133553|FG001|NOT COMPLETED|Overall Study||75
10010890|NCT01776554|11133562|FG000|STARTED|Overall Study||332
10010891|NCT01776554|11133563|FG001|STARTED|Overall Study||330
9929586|NCT01287065|11046821|FG003|COMPLETED|Treatment Period 1||4
9929587|NCT01287065|11046822|FG004|COMPLETED|Treatment Period 1||4
9929588|NCT01287065|11046823|FG005|COMPLETED|Treatment Period 1||4
9929589|NCT01287065|11046818|FG000|NOT COMPLETED|Treatment Period 1||0
9929590|NCT01287065|11046819|FG001|NOT COMPLETED|Treatment Period 1||0
9929591|NCT01287065|11046820|FG002|NOT COMPLETED|Treatment Period 1||0
9929592|NCT01287065|11046821|FG003|NOT COMPLETED|Treatment Period 1||0
9929593|NCT01287065|11046822|FG004|NOT COMPLETED|Treatment Period 1||1
9929594|NCT01287065|11046823|FG005|NOT COMPLETED|Treatment Period 1||1
9929595|NCT01287065|11046818|FG000|STARTED|Washout Period 1||4
9929596|NCT01287065|11046819|FG001|STARTED|Washout Period 1||4
9929597|NCT01287065|11046820|FG002|STARTED|Washout Period 1||4
9929598|NCT01287065|11046821|FG003|STARTED|Washout Period 1||4
9929599|NCT01287065|11046822|FG004|STARTED|Washout Period 1||4
9929600|NCT01287065|11046823|FG005|STARTED|Washout Period 1||4
9929601|NCT01287065|11046818|FG000|COMPLETED|Washout Period 1||4
9929602|NCT01287065|11046819|FG001|COMPLETED|Washout Period 1||4
9929603|NCT01287065|11046820|FG002|COMPLETED|Washout Period 1||4
9929604|NCT01287065|11046821|FG003|COMPLETED|Washout Period 1||4
9929605|NCT01287065|11046822|FG004|COMPLETED|Washout Period 1||4
9929606|NCT01287065|11046823|FG005|COMPLETED|Washout Period 1||4
9929607|NCT01287065|11046818|FG000|NOT COMPLETED|Washout Period 1||0
9929608|NCT01287065|11046819|FG001|NOT COMPLETED|Washout Period 1||0
9929609|NCT01287065|11046820|FG002|NOT COMPLETED|Washout Period 1||0
9929610|NCT01287065|11046821|FG003|NOT COMPLETED|Washout Period 1||0
9929611|NCT01287065|11046822|FG004|NOT COMPLETED|Washout Period 1||0
9929612|NCT01287065|11046823|FG005|NOT COMPLETED|Washout Period 1||0
9929613|NCT01287065|11046818|FG000|STARTED|Treatment Period 2||4
9929614|NCT01287065|11046819|FG001|STARTED|Treatment Period 2||4
9929615|NCT01287065|11046820|FG002|STARTED|Treatment Period 2||4
9929616|NCT01287065|11046821|FG003|STARTED|Treatment Period 2||4
9929617|NCT01287065|11046822|FG004|STARTED|Treatment Period 2||4
9929618|NCT01287065|11046823|FG005|STARTED|Treatment Period 2||4
9929619|NCT01287065|11046818|FG000|COMPLETED|Treatment Period 2||4
9929620|NCT01287065|11046819|FG001|COMPLETED|Treatment Period 2||4
9929621|NCT01287065|11046820|FG002|COMPLETED|Treatment Period 2||4
9929622|NCT01287065|11046821|FG003|COMPLETED|Treatment Period 2||4
9929623|NCT01287065|11046822|FG004|COMPLETED|Treatment Period 2||4
9929624|NCT01287065|11046823|FG005|COMPLETED|Treatment Period 2||4
9929625|NCT01287065|11046818|FG000|NOT COMPLETED|Treatment Period 2||0
9929626|NCT01287065|11046819|FG001|NOT COMPLETED|Treatment Period 2||0
9929627|NCT01287065|11046820|FG002|NOT COMPLETED|Treatment Period 2||0
9929628|NCT01287065|11046821|FG003|NOT COMPLETED|Treatment Period 2||0
9929629|NCT01287065|11046822|FG004|NOT COMPLETED|Treatment Period 2||0
9929630|NCT01287065|11046823|FG005|NOT COMPLETED|Treatment Period 2||0
9929631|NCT01287065|11046818|FG000|STARTED|Washout Period 2||4
9929632|NCT01287065|11046819|FG001|STARTED|Washout Period 2||4
9929633|NCT01287065|11046820|FG002|STARTED|Washout Period 2||4
9929634|NCT01287065|11046821|FG003|STARTED|Washout Period 2||4
9929635|NCT01287065|11046822|FG004|STARTED|Washout Period 2||4
9929636|NCT01287065|11046823|FG005|STARTED|Washout Period 2||4
9929637|NCT01287065|11046818|FG000|COMPLETED|Washout Period 2||4
9929638|NCT01287065|11046819|FG001|COMPLETED|Washout Period 2||4
9929639|NCT01287065|11046820|FG002|COMPLETED|Washout Period 2||4
9929640|NCT01287065|11046821|FG003|COMPLETED|Washout Period 2||4
9929641|NCT01287065|11046822|FG004|COMPLETED|Washout Period 2||4
9929642|NCT01287065|11046823|FG005|COMPLETED|Washout Period 2||4
9929643|NCT01287065|11046818|FG000|NOT COMPLETED|Washout Period 2||0
9929644|NCT01287065|11046819|FG001|NOT COMPLETED|Washout Period 2||0
9929645|NCT01287065|11046820|FG002|NOT COMPLETED|Washout Period 2||0
9929646|NCT01287065|11046821|FG003|NOT COMPLETED|Washout Period 2||0
9929647|NCT01287065|11046822|FG004|NOT COMPLETED|Washout Period 2||0
9929648|NCT01287065|11046823|FG005|NOT COMPLETED|Washout Period 2||0
9929649|NCT01287065|11046818|FG000|STARTED|Treatment Period 3||4
9929650|NCT01287065|11046819|FG001|STARTED|Treatment Period 3||4
9929651|NCT01287065|11046820|FG002|STARTED|Treatment Period 3||4
9929652|NCT01287065|11046821|FG003|STARTED|Treatment Period 3||4
9929653|NCT01287065|11046822|FG004|STARTED|Treatment Period 3||4
9929654|NCT01287065|11046823|FG005|STARTED|Treatment Period 3||4
9929655|NCT01287065|11046818|FG000|COMPLETED|Treatment Period 3||4
9929656|NCT01287065|11046819|FG001|COMPLETED|Treatment Period 3||4
9929657|NCT01287065|11046820|FG002|COMPLETED|Treatment Period 3||4
9929658|NCT01287065|11046821|FG003|COMPLETED|Treatment Period 3||4
9929659|NCT01287065|11046822|FG004|COMPLETED|Treatment Period 3||4
9929660|NCT01287065|11046823|FG005|COMPLETED|Treatment Period 3||4
9929661|NCT01287065|11046818|FG000|NOT COMPLETED|Treatment Period 3||0
9929662|NCT01287065|11046819|FG001|NOT COMPLETED|Treatment Period 3||0
9929663|NCT01287065|11046820|FG002|NOT COMPLETED|Treatment Period 3||0
9929664|NCT01287065|11046821|FG003|NOT COMPLETED|Treatment Period 3||0
9929665|NCT01287065|11046822|FG004|NOT COMPLETED|Treatment Period 3||0
9929666|NCT01287065|11046823|FG005|NOT COMPLETED|Treatment Period 3||0
9929667|NCT01287078|11046833|FG000|STARTED|Overall Study||20
9929668|NCT01287078|11046834|FG001|STARTED|Overall Study||3
9929669|NCT01287078|11046833|FG000|COMPLETED|Overall Study||10
9929670|NCT01287078|11046834|FG001|COMPLETED|Overall Study||1
9929671|NCT01287078|11046833|FG000|NOT COMPLETED|Overall Study||10
9929672|NCT01287078|11046834|FG001|NOT COMPLETED|Overall Study||2
9929673|NCT01287104|11046844|FG000|STARTED|Overall Study||4
9929674|NCT01287104|11046845|FG001|STARTED|Overall Study||7
9929675|NCT01287104|11046846|FG002|STARTED|Overall Study||12
10010892|NCT01776554|11133562|FG000|COMPLETED|Overall Study||315
10010893|NCT01776554|11133563|FG001|COMPLETED|Overall Study||307
10010894|NCT01776554|11133562|FG000|NOT COMPLETED|Overall Study||17
10010895|NCT01776554|11133563|FG001|NOT COMPLETED|Overall Study||23
10010896|NCT01776632|11133572|FG000|STARTED|Overall Study||217
10010897|NCT01776632|11133573|FG001|STARTED|Overall Study||219
10010898|NCT01776632|11133572|FG000|COMPLETED|Overall Study||190
10010899|NCT01776632|11133573|FG001|COMPLETED|Overall Study||190
10010900|NCT01776632|11133572|FG000|NOT COMPLETED|Overall Study||27
10010901|NCT01776632|11133573|FG001|NOT COMPLETED|Overall Study||29
10010902|NCT01776645|11133581|FG000|STARTED|Overall Study||28
10010903|NCT01776645|11133582|FG001|STARTED|Overall Study||28
10010904|NCT01776645|11133581|FG000|COMPLETED|Overall Study||14
10010905|NCT01776645|11133582|FG001|COMPLETED|Overall Study||14
10010906|NCT01776645|11133581|FG000|NOT COMPLETED|Overall Study||14
10010907|NCT01776645|11133582|FG001|NOT COMPLETED|Overall Study||14
10010908|NCT01777126|11133589|FG000|STARTED|Overall Study||48
10010909|NCT01777126|11133590|FG001|STARTED|Overall Study||46
10010910|NCT01777126|11133589|FG000|COMPLETED|Overall Study||48
10205687|NCT03496298|11332468|FG002|COMPLETED|Overall Study||23
10205688|NCT03496298|11332466|FG000|NOT COMPLETED|Overall Study||1317
9929676|NCT01287104|11046847|FG003|STARTED|Overall Study||11
9929677|NCT01287104|11046844|FG000|COMPLETED|Overall Study||3
9929678|NCT01287104|11046845|FG001|COMPLETED|Overall Study||2
9929679|NCT01287104|11046846|FG002|COMPLETED|Overall Study||5
9929680|NCT01287104|11046847|FG003|COMPLETED|Overall Study||8
9929681|NCT01287104|11046844|FG000|NOT COMPLETED|Overall Study||1
9929682|NCT01287104|11046845|FG001|NOT COMPLETED|Overall Study||5
9929683|NCT01287104|11046846|FG002|NOT COMPLETED|Overall Study||7
9929684|NCT01287104|11046847|FG003|NOT COMPLETED|Overall Study||3
9929685|NCT01287117|11046868|FG000|STARTED|Overall Study||80
9929686|NCT01287117|11046869|FG001|STARTED|Overall Study||78
9929687|NCT01287117|11046870|FG002|STARTED|Overall Study||80
9929688|NCT01287117|11046871|FG003|STARTED|Overall Study||81
9929689|NCT01287117|11046868|FG000|Received Treatment|Overall Study||80
9929690|NCT01287117|11046869|FG001|Received Treatment|Overall Study||77
9929691|NCT01287117|11046870|FG002|Received Treatment|Overall Study||80
9929692|NCT01287117|11046871|FG003|Received Treatment|Overall Study||81
9929693|NCT01287117|11046868|FG000|COMPLETED|Overall Study||65
9929694|NCT01287117|11046869|FG001|COMPLETED|Overall Study||64
9929695|NCT01287117|11046870|FG002|COMPLETED|Overall Study||64
9929696|NCT01287117|11046871|FG003|COMPLETED|Overall Study||69
9929697|NCT01287117|11046868|FG000|NOT COMPLETED|Overall Study||15
9929698|NCT01287117|11046869|FG001|NOT COMPLETED|Overall Study||14
9929699|NCT01287117|11046870|FG002|NOT COMPLETED|Overall Study||16
9929700|NCT01287117|11046871|FG003|NOT COMPLETED|Overall Study||12
9929701|NCT01287195|11046881|FG000|STARTED|Overall Study||6
9929702|NCT01287195|11046881|FG000|COMPLETED|Overall Study||4
9929703|NCT01287195|11046881|FG000|NOT COMPLETED|Overall Study||2
9929704|NCT01287208|11046887|FG000|STARTED|Phase 1: Randomized Phase||52
9929705|NCT01287208|11046888|FG001|STARTED|Phase 1: Randomized Phase||52
9929706|NCT01287208|11046887|FG000|COMPLETED|Phase 1: Randomized Phase||50
9929707|NCT01287208|11046888|FG001|COMPLETED|Phase 1: Randomized Phase||49
9929708|NCT01287208|11046887|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2
9929709|NCT01287208|11046888|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3
9929710|NCT01287208|11046887|FG000|STARTED|Phase 2: Team Competition||50
9929711|NCT01287208|11046888|FG001|STARTED|Phase 2: Team Competition||49
10010911|NCT01777126|11133590|FG001|COMPLETED|Overall Study||46
10010912|NCT01777126|11133589|FG000|NOT COMPLETED|Overall Study||0
10205689|NCT03496298|11332467|FG001|NOT COMPLETED|Overall Study||1323
10205690|NCT03496298|11332468|FG002|NOT COMPLETED|Overall Study||1335
10205691|NCT03496324|11332475|FG000|STARTED|Period 1||6
10205692|NCT03496324|11332476|FG001|STARTED|Period 1||6
10205693|NCT03496324|11332477|FG002|STARTED|Period 1||6
10205694|NCT03496324|11332478|FG003|STARTED|Period 1||6
10205695|NCT03496324|11332475|FG000|COMPLETED|Period 1||6
10205696|NCT03496324|11332476|FG001|COMPLETED|Period 1||6
10205697|NCT03496324|11332477|FG002|COMPLETED|Period 1||6
10205698|NCT03496324|11332478|FG003|COMPLETED|Period 1||6
10205699|NCT03496324|11332475|FG000|NOT COMPLETED|Period 1||0
10205700|NCT03496324|11332476|FG001|NOT COMPLETED|Period 1||0
10205701|NCT03496324|11332477|FG002|NOT COMPLETED|Period 1||0
10205702|NCT03496324|11332478|FG003|NOT COMPLETED|Period 1||0
10205703|NCT03496324|11332475|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6
10205704|NCT03496324|11332476|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6
10205705|NCT03496324|11332477|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6
10205706|NCT03496324|11332478|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6
10205707|NCT03496324|11332475|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6
10205708|NCT03496324|11332476|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6
10205709|NCT03496324|11332477|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6
9929712|NCT01287208|11046887|FG000|COMPLETED|Phase 2: Team Competition||50
9929713|NCT01287208|11046888|FG001|COMPLETED|Phase 2: Team Competition||49
9929714|NCT01287208|11046887|FG000|NOT COMPLETED|Phase 2: Team Competition||0
9929715|NCT01287208|11046888|FG001|NOT COMPLETED|Phase 2: Team Competition||0
9929716|NCT01287221|11046898|FG000|STARTED|Overall Study||50
9929717|NCT01287221|11046899|FG001|STARTED|Overall Study||50
10010913|NCT01777126|11133590|FG001|NOT COMPLETED|Overall Study||0
10010914|NCT01777139|11133598|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30
10205710|NCT03496324|11332478|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6
9956192|NCT01443494|11075323|FG000|STARTED|Overall Study||19
10205711|NCT03496324|11332475|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
9929718|NCT01287221|11046898|FG000|Completed 3 Months Follow-up|Overall Study||49
9929719|NCT01287221|11046899|FG001|Completed 3 Months Follow-up|Overall Study||50
9929720|NCT01287221|11046898|FG000|Completed 6 Months Follow-up|Overall Study||47
9929721|NCT01287221|11046899|FG001|Completed 6 Months Follow-up|Overall Study||43
9929722|NCT01287221|11046898|FG000|Completed 9 Months Follow-up|Overall Study||42
9929723|NCT01287221|11046899|FG001|Completed 9 Months Follow-up|Overall Study||40
9929724|NCT01287221|11046898|FG000|Completed 12 Months Follow-up|Overall Study||40
9929725|NCT01287221|11046899|FG001|Completed 12 Months Follow-up|Overall Study||39
9929726|NCT01287221|11046898|FG000|COMPLETED|Overall Study||46
9929727|NCT01287221|11046899|FG001|COMPLETED|Overall Study||45
9929728|NCT01287221|11046898|FG000|NOT COMPLETED|Overall Study||4
9929729|NCT01287221|11046899|FG001|NOT COMPLETED|Overall Study||5
9929730|NCT01287364|11046907|FG000|STARTED|Overall Study||94
9929731|NCT01287364|11046908|FG001|STARTED|Overall Study||91
9929732|NCT01287364|11046907|FG000|COMPLETED|Overall Study||85
9929733|NCT01287364|11046908|FG001|COMPLETED|Overall Study||81
9929734|NCT01287364|11046907|FG000|NOT COMPLETED|Overall Study||9
9929735|NCT01287364|11046908|FG001|NOT COMPLETED|Overall Study||10
9929736|NCT01287377|11046930|FG000|STARTED|Overall Study||80
9929737|NCT01287377|11046931|FG001|STARTED|Overall Study||81
9929738|NCT01287377|11046932|FG002|STARTED|Overall Study||82
9929739|NCT01287377|11046930|FG000|COMPLETED|Overall Study|Study Complete|80
9929740|NCT01287377|11046931|FG001|COMPLETED|Overall Study|Study Complete|81
9929741|NCT01287377|11046932|FG002|COMPLETED|Overall Study|Study Complete|82
9929742|NCT01287377|11046930|FG000|NOT COMPLETED|Overall Study||0
9929743|NCT01287377|11046931|FG001|NOT COMPLETED|Overall Study||0
9929744|NCT01287377|11046932|FG002|NOT COMPLETED|Overall Study||0
9929745|NCT01287403|11046940|FG000|STARTED|Diet Restriction (7 Days)||14
9929746|NCT01287403|11046940|FG000|COMPLETED|Diet Restriction (7 Days)||14
9929747|NCT01287403|11046940|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0
9929748|NCT01287403|11046940|FG000|STARTED|1st Intervention (1 Day)||14
9929749|NCT01287403|11046940|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
9929750|NCT01287403|11046940|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
9929751|NCT01287403|11046940|FG000|STARTED|Washout 7 Days||13
9929752|NCT01287403|11046940|FG000|COMPLETED|Washout 7 Days||13
9929753|NCT01287403|11046940|FG000|NOT COMPLETED|Washout 7 Days||0
9929754|NCT01287403|11046940|FG000|STARTED|2nd Intervention (1 Day)||13
10205712|NCT03496324|11332476|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10205713|NCT03496324|11332477|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10205714|NCT03496324|11332478|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10205715|NCT03496324|11332475|FG000|STARTED|Period 2||6
10205716|NCT03496324|11332476|FG001|STARTED|Period 2||6
10205717|NCT03496324|11332477|FG002|STARTED|Period 2||6
10205718|NCT03496324|11332478|FG003|STARTED|Period 2||6
10205719|NCT03496324|11332475|FG000|COMPLETED|Period 2||6
10205720|NCT03496324|11332476|FG001|COMPLETED|Period 2||6
10205721|NCT03496324|11332477|FG002|COMPLETED|Period 2||6
10205722|NCT03496324|11332478|FG003|COMPLETED|Period 2||6
10205723|NCT03496324|11332475|FG000|NOT COMPLETED|Period 2||0
10205724|NCT03496324|11332476|FG001|NOT COMPLETED|Period 2||0
10205725|NCT03496324|11332477|FG002|NOT COMPLETED|Period 2||0
10205726|NCT03496324|11332478|FG003|NOT COMPLETED|Period 2||0
10205727|NCT03496324|11332475|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6
10205728|NCT03496324|11332476|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6
10205729|NCT03496324|11332477|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6
10205730|NCT03496324|11332478|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6
10205731|NCT03496324|11332475|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10205732|NCT03496324|11332476|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10205733|NCT03496324|11332477|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10205734|NCT03496324|11332478|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10205735|NCT03496324|11332475|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10205736|NCT03496324|11332476|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10205737|NCT03496324|11332477|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10205738|NCT03496324|11332478|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10205739|NCT03496324|11332475|FG000|STARTED|Period 3||6
10205740|NCT03496324|11332476|FG001|STARTED|Period 3||6
10205741|NCT03496324|11332477|FG002|STARTED|Period 3||6
10205742|NCT03496324|11332478|FG003|STARTED|Period 3||6
10205743|NCT03496324|11332475|FG000|COMPLETED|Period 3||6
10205744|NCT03496324|11332476|FG001|COMPLETED|Period 3||6
10205745|NCT03496324|11332477|FG002|COMPLETED|Period 3||6
9929755|NCT01287403|11046940|FG000|COMPLETED|2nd Intervention (1 Day)||13
9929756|NCT01287403|11046940|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
9929757|NCT01287403|11046940|FG000|STARTED|Washout (7 Days)||13
10205746|NCT03496324|11332478|FG003|COMPLETED|Period 3||6
10205747|NCT03496324|11332475|FG000|NOT COMPLETED|Period 3||0
10205748|NCT03496324|11332476|FG001|NOT COMPLETED|Period 3||0
10205749|NCT03496324|11332477|FG002|NOT COMPLETED|Period 3||0
10205750|NCT03496324|11332478|FG003|NOT COMPLETED|Period 3||0
10205751|NCT03496324|11332475|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
10205752|NCT03496324|11332476|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6
10205753|NCT03496324|11332477|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
9929758|NCT01287403|11046940|FG000|COMPLETED|Washout (7 Days)||13
9929759|NCT01287403|11046940|FG000|NOT COMPLETED|Washout (7 Days)||0
10205754|NCT03496324|11332478|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6
10205755|NCT03496324|11332475|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
9929760|NCT01287403|11046940|FG000|STARTED|3rd Intervention (1 Day)||13
9929761|NCT01287403|11046940|FG000|COMPLETED|3rd Intervention (1 Day)||13
9929762|NCT01287403|11046940|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0
9929763|NCT01287403|11046940|FG000|STARTED|Washout (7 Days)||13
9929764|NCT01287403|11046940|FG000|COMPLETED|Washout (7 Days)||13
9929765|NCT01287403|11046940|FG000|NOT COMPLETED|Washout (7 Days)||0
9929766|NCT01287403|11046940|FG000|STARTED|4th Intervention (1 Day)||13
9929767|NCT01287403|11046940|FG000|COMPLETED|4th Intervention (1 Day)||13
9929768|NCT01287403|11046940|FG000|NOT COMPLETED|4th Intervention (1 Day)||0
9929769|NCT01287403|11046940|FG000|STARTED|Washout (7 Days)||13
9929770|NCT01287403|11046940|FG000|COMPLETED|Washout (7 Days)||13
9929771|NCT01287403|11046940|FG000|NOT COMPLETED|Washout (7 Days)||0
9929772|NCT01287403|11046940|FG000|STARTED|5th Intervention (1 Day)||13
9929773|NCT01287403|11046940|FG000|COMPLETED|5th Intervention (1 Day)||13
9929774|NCT01287403|11046940|FG000|NOT COMPLETED|5th Intervention (1 Day)||0
9929775|NCT01287403|11046940|FG000|STARTED|Washout (7 Days)||13
9929776|NCT01287403|11046940|FG000|COMPLETED|Washout (7 Days)||13
9929777|NCT01287403|11046940|FG000|NOT COMPLETED|Washout (7 Days)||0
9929778|NCT01287403|11046940|FG000|STARTED|6th and Last Intervention (1 Day)||13
9929779|NCT01287403|11046940|FG000|COMPLETED|6th and Last Intervention (1 Day)||13
9929780|NCT01287403|11046940|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0
9929781|NCT01287416|11046956|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
9929782|NCT01287416|11046957|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
9929783|NCT01287416|11046956|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
9929784|NCT01287416|11046957|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
9929785|NCT01287416|11046956|FG000|Post Training Questionnaire|Pre-post Training||26
9929786|NCT01287416|11046957|FG001|Post Training Questionnaire|Pre-post Training||23
9929787|NCT01287416|11046956|FG000|COMPLETED|Pre-post Training||26
9929788|NCT01287416|11046957|FG001|COMPLETED|Pre-post Training||23
9929789|NCT01287416|11046956|FG000|NOT COMPLETED|Pre-post Training||22
9929790|NCT01287416|11046957|FG001|NOT COMPLETED|Pre-post Training||25
9929791|NCT01287416|11046956|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
9929792|NCT01287416|11046957|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
9929793|NCT01287416|11046956|FG000|COMPLETED|6 Month Follow-up||28
9929794|NCT01287416|11046957|FG001|COMPLETED|6 Month Follow-up||22
9929795|NCT01287416|11046956|FG000|NOT COMPLETED|6 Month Follow-up||3
9929796|NCT01287416|11046957|FG001|NOT COMPLETED|6 Month Follow-up||2
9929797|NCT01287520|11046972|FG000|STARTED|Overall Study||3
9929798|NCT01287520|11046973|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
9929799|NCT01287520|11046974|FG002|STARTED|Overall Study||5
9929800|NCT01287520|11046975|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
9929801|NCT01287520|11046976|FG004|STARTED|Overall Study||3
9929802|NCT01287520|11046977|FG005|STARTED|Overall Study||4
9929803|NCT01287520|11046978|FG006|STARTED|Overall Study||2
9929804|NCT01287520|11046979|FG007|STARTED|Overall Study||5
9929805|NCT01287520|11046980|FG008|STARTED|Overall Study||5
9929806|NCT01287520|11046972|FG000|COMPLETED|Overall Study||0
9929807|NCT01287520|11046973|FG001|COMPLETED|Overall Study||0
9929808|NCT01287520|11046974|FG002|COMPLETED|Overall Study||0
9929809|NCT01287520|11046975|FG003|COMPLETED|Overall Study||0
9929810|NCT01287520|11046976|FG004|COMPLETED|Overall Study||0
9929811|NCT01287520|11046977|FG005|COMPLETED|Overall Study||0
9929812|NCT01287520|11046978|FG006|COMPLETED|Overall Study||0
9929813|NCT01287520|11046979|FG007|COMPLETED|Overall Study||0
9929814|NCT01287520|11046980|FG008|COMPLETED|Overall Study||0
9929815|NCT01287520|11046972|FG000|NOT COMPLETED|Overall Study||3
9929816|NCT01287520|11046973|FG001|NOT COMPLETED|Overall Study||7
9929817|NCT01287520|11046974|FG002|NOT COMPLETED|Overall Study||5
9929818|NCT01287520|11046975|FG003|NOT COMPLETED|Overall Study||7
9929819|NCT01287520|11046976|FG004|NOT COMPLETED|Overall Study||3
9929820|NCT01287520|11046977|FG005|NOT COMPLETED|Overall Study||4
9929821|NCT01287520|11046978|FG006|NOT COMPLETED|Overall Study||2
9929822|NCT01287520|11046979|FG007|NOT COMPLETED|Overall Study||5
9929823|NCT01287520|11046980|FG008|NOT COMPLETED|Overall Study||5
9929824|NCT01287754|11047031|FG000|STARTED|Overall Study||3
9929825|NCT01287754|11047032|FG001|STARTED|Overall Study||21
9929826|NCT01287754|11047031|FG000|COMPLETED|Overall Study||0
9929827|NCT01287754|11047032|FG001|COMPLETED|Overall Study||0
9929828|NCT01287754|11047031|FG000|NOT COMPLETED|Overall Study||3
9929829|NCT01287754|11047032|FG001|NOT COMPLETED|Overall Study||21
9929830|NCT01287832|11047040|FG000|STARTED|Overall Study||6
9929831|NCT01287832|11047041|FG001|STARTED|Overall Study||5
9929832|NCT01287832|11047040|FG000|COMPLETED|Overall Study||5
9929833|NCT01287832|11047041|FG001|COMPLETED|Overall Study||4
9929834|NCT01287832|11047040|FG000|NOT COMPLETED|Overall Study||1
9929835|NCT01287832|11047041|FG001|NOT COMPLETED|Overall Study||1
9929836|NCT01287897|11047051|FG000|STARTED|Overall Study||70
9929837|NCT01287897|11047052|FG001|STARTED|Overall Study||69
9929838|NCT01287897|11047053|FG002|STARTED|Overall Study||71
9929839|NCT01287897|11047054|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
9929840|NCT01287897|11047051|FG000|Treated|Overall Study||69
9929841|NCT01287897|11047052|FG001|Treated|Overall Study||67
9929842|NCT01287897|11047053|FG002|Treated|Overall Study||71
9929843|NCT01287897|11047054|FG003|Treated|Overall Study||40
9929844|NCT01287897|11047051|FG000|Completed Treatment Period|Overall Study||58
9929845|NCT01287897|11047052|FG001|Completed Treatment Period|Overall Study||52
9929846|NCT01287897|11047053|FG002|Completed Treatment Period|Overall Study||58
9929847|NCT01287897|11047054|FG003|Completed Treatment Period|Overall Study||29
9929848|NCT01287897|11047051|FG000|Completed Follow-up Period|Overall Study||3
9929849|NCT01287897|11047052|FG001|Completed Follow-up Period|Overall Study||8
10205756|NCT03496324|11332476|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10205757|NCT03496324|11332477|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10205758|NCT03496324|11332478|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6
9929850|NCT01287897|11047053|FG002|Completed Follow-up Period|Overall Study||3
9929851|NCT01287897|11047054|FG003|Completed Follow-up Period|Overall Study||4
9929852|NCT01287897|11047051|FG000|Enrolled in NCT01345318|Overall Study||56
9929853|NCT01287897|11047052|FG001|Enrolled in NCT01345318|Overall Study||50
9929854|NCT01287897|11047053|FG002|Enrolled in NCT01345318|Overall Study||56
9929855|NCT01287897|11047054|FG003|Enrolled in NCT01345318|Overall Study||29
9929856|NCT01287897|11047051|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
9929857|NCT01287897|11047052|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
9929858|NCT01287897|11047053|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
10010915|NCT01777139|11133599|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0
10010916|NCT01777139|11133598|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
10010917|NCT01777139|11133599|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
10010918|NCT01777139|11133598|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
10205759|NCT03496324|11332475|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10205760|NCT03496324|11332476|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10205761|NCT03496324|11332477|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10205762|NCT03496324|11332478|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10205763|NCT03496324|11332475|FG000|STARTED|Period 7: Period 4||6
9929859|NCT01287897|11047054|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
9929860|NCT01287897|11047051|FG000|NOT COMPLETED|Overall Study||11
9929861|NCT01287897|11047052|FG001|NOT COMPLETED|Overall Study||11
9929862|NCT01287897|11047053|FG002|NOT COMPLETED|Overall Study||12
9929863|NCT01287897|11047054|FG003|NOT COMPLETED|Overall Study||7
9929864|NCT01288027|11047068|FG000|STARTED|Overall Study||16
9929865|NCT01288027|11047068|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
9929866|NCT01288027|11047068|FG000|COMPLETED|Overall Study||16
9929867|NCT01288027|11047068|FG000|NOT COMPLETED|Overall Study||0
9929868|NCT01288053|11047072|FG000|STARTED|Overall Study||9
9929869|NCT01288053|11047072|FG000|COMPLETED|Overall Study||8
9929870|NCT01288053|11047072|FG000|NOT COMPLETED|Overall Study||1
9929871|NCT01288079|11047080|FG000|STARTED|Overall Study||37
9929872|NCT01288079|11047081|FG001|STARTED|Overall Study||36
9929873|NCT01288079|11047082|FG002|STARTED|Overall Study||37
9929874|NCT01288079|11047083|FG003|STARTED|Overall Study||35
9929875|NCT01288079|11047080|FG000|COMPLETED|Overall Study||17
9929876|NCT01288079|11047081|FG001|COMPLETED|Overall Study||9
9929877|NCT01288079|11047082|FG002|COMPLETED|Overall Study||18
9929878|NCT01288079|11047083|FG003|COMPLETED|Overall Study||18
9929879|NCT01288079|11047080|FG000|NOT COMPLETED|Overall Study||20
9929880|NCT01288079|11047081|FG001|NOT COMPLETED|Overall Study||27
9929881|NCT01288079|11047082|FG002|NOT COMPLETED|Overall Study||19
9929882|NCT01288079|11047083|FG003|NOT COMPLETED|Overall Study||17
9929883|NCT01288209|11047095|FG000|STARTED|Overall Study||53
9929884|NCT01288209|11047096|FG001|STARTED|Overall Study||53
9929885|NCT01288209|11047095|FG000|COMPLETED|Overall Study||51
9929886|NCT01288209|11047096|FG001|COMPLETED|Overall Study||50
9929887|NCT01288209|11047095|FG000|NOT COMPLETED|Overall Study||2
9929888|NCT01288209|11047096|FG001|NOT COMPLETED|Overall Study||3
9929889|NCT01288287|11047102|FG000|STARTED|Overall Study||149
10010919|NCT01777139|11133599|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
10010920|NCT01777139|11133598|FG000|STARTED|SFUCP (Up to 1.4 Years)||0
10010921|NCT01777139|11133599|FG001|STARTED|SFUCP (Up to 1.4 Years)||4
10010922|NCT01777139|11133598|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0
10205764|NCT03496324|11332476|FG001|STARTED|Period 7: Period 4||6
10205765|NCT03496324|11332477|FG002|STARTED|Period 7: Period 4||6
10205766|NCT03496324|11332478|FG003|STARTED|Period 7: Period 4||6
10205767|NCT03496324|11332475|FG000|COMPLETED|Period 7: Period 4||6
10205768|NCT03496324|11332476|FG001|COMPLETED|Period 7: Period 4||6
10205769|NCT03496324|11332477|FG002|COMPLETED|Period 7: Period 4||6
10205770|NCT03496324|11332478|FG003|COMPLETED|Period 7: Period 4||6
10205771|NCT03496324|11332475|FG000|NOT COMPLETED|Period 7: Period 4||0
10205772|NCT03496324|11332476|FG001|NOT COMPLETED|Period 7: Period 4||0
10205773|NCT03496324|11332477|FG002|NOT COMPLETED|Period 7: Period 4||0
10205774|NCT03496324|11332478|FG003|NOT COMPLETED|Period 7: Period 4||0
10205775|NCT03496428|11332488|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
10205776|NCT03496428|11332488|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
10205777|NCT03496428|11332488|FG000|NOT COMPLETED|Overall Study||0
10205778|NCT03496467|11332494|FG000|STARTED|Overall Study||38
10205779|NCT03496467|11332495|FG001|STARTED|Overall Study||18
9929890|NCT01288287|11047102|FG000|Safety Set|Overall Study||147
9929891|NCT01288287|11047102|FG000|Full Analysis Set|Overall Study||111
9929892|NCT01288287|11047102|FG000|COMPLETED|Overall Study||103
9929893|NCT01288287|11047102|FG000|NOT COMPLETED|Overall Study||46
9929894|NCT01288430|11047117|FG000|STARTED|Part 1||2
9929895|NCT01288430|11047118|FG001|STARTED|Part 1||3
9929896|NCT01288430|11047119|FG002|STARTED|Part 1||5
9929897|NCT01288430|11047120|FG003|STARTED|Part 1||7
9929898|NCT01288430|11047121|FG004|STARTED|Part 1||3
9929899|NCT01288430|11047122|FG005|STARTED|Part 1||6
9929900|NCT01288430|11047123|FG006|STARTED|Part 1||7
9929901|NCT01288430|11047124|FG007|STARTED|Part 1||0
9929902|NCT01288430|11047125|FG008|STARTED|Part 1||0
9929903|NCT01288430|11047126|FG009|STARTED|Part 1||0
9929904|NCT01288430|11047117|FG000|COMPLETED|Part 1||0
9929905|NCT01288430|11047118|FG001|COMPLETED|Part 1||0
9929906|NCT01288430|11047119|FG002|COMPLETED|Part 1||0
9929907|NCT01288430|11047120|FG003|COMPLETED|Part 1||0
9929908|NCT01288430|11047121|FG004|COMPLETED|Part 1||0
9929909|NCT01288430|11047122|FG005|COMPLETED|Part 1||0
9929910|NCT01288430|11047123|FG006|COMPLETED|Part 1||0
9929911|NCT01288430|11047124|FG007|COMPLETED|Part 1||0
9929912|NCT01288430|11047125|FG008|COMPLETED|Part 1||0
9929913|NCT01288430|11047126|FG009|COMPLETED|Part 1||0
9929914|NCT01288430|11047117|FG000|NOT COMPLETED|Part 1||2
9929915|NCT01288430|11047118|FG001|NOT COMPLETED|Part 1||3
9929916|NCT01288430|11047119|FG002|NOT COMPLETED|Part 1||5
9929917|NCT01288430|11047120|FG003|NOT COMPLETED|Part 1||7
9929918|NCT01288430|11047121|FG004|NOT COMPLETED|Part 1||3
9929919|NCT01288430|11047122|FG005|NOT COMPLETED|Part 1||6
9929920|NCT01288430|11047123|FG006|NOT COMPLETED|Part 1||7
9929921|NCT01288430|11047124|FG007|NOT COMPLETED|Part 1||0
9929922|NCT01288430|11047125|FG008|NOT COMPLETED|Part 1||0
9929923|NCT01288430|11047126|FG009|NOT COMPLETED|Part 1||0
9929924|NCT01288430|11047117|FG000|STARTED|Part 2||0
9929925|NCT01288430|11047118|FG001|STARTED|Part 2||0
9929926|NCT01288430|11047119|FG002|STARTED|Part 2||0
9929927|NCT01288430|11047120|FG003|STARTED|Part 2||0
9929928|NCT01288430|11047121|FG004|STARTED|Part 2||0
9929929|NCT01288430|11047122|FG005|STARTED|Part 2||0
9929930|NCT01288430|11047123|FG006|STARTED|Part 2||0
9929931|NCT01288430|11047124|FG007|STARTED|Part 2||12
9929932|NCT01288430|11047125|FG008|STARTED|Part 2||12
9929933|NCT01288430|11047126|FG009|STARTED|Part 2||3
9929934|NCT01288430|11047117|FG000|COMPLETED|Part 2||0
9929935|NCT01288430|11047118|FG001|COMPLETED|Part 2||0
9929936|NCT01288430|11047119|FG002|COMPLETED|Part 2||0
9929937|NCT01288430|11047120|FG003|COMPLETED|Part 2||0
9929938|NCT01288430|11047121|FG004|COMPLETED|Part 2||0
9929939|NCT01288430|11047122|FG005|COMPLETED|Part 2||0
9929940|NCT01288430|11047123|FG006|COMPLETED|Part 2||0
9929941|NCT01288430|11047124|FG007|COMPLETED|Part 2||0
9929942|NCT01288430|11047125|FG008|COMPLETED|Part 2||0
9929943|NCT01288430|11047126|FG009|COMPLETED|Part 2||0
9929944|NCT01288430|11047117|FG000|NOT COMPLETED|Part 2||0
9929945|NCT01288430|11047118|FG001|NOT COMPLETED|Part 2||0
9929946|NCT01288430|11047119|FG002|NOT COMPLETED|Part 2||0
9929947|NCT01288430|11047120|FG003|NOT COMPLETED|Part 2||0
9929948|NCT01288430|11047121|FG004|NOT COMPLETED|Part 2||0
9929949|NCT01288430|11047122|FG005|NOT COMPLETED|Part 2||0
9929950|NCT01288430|11047123|FG006|NOT COMPLETED|Part 2||0
10010923|NCT01777139|11133599|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0
10010924|NCT01777139|11133598|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
10010925|NCT01777139|11133599|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
10010926|NCT01777152|11133608|FG000|STARTED|Overall Study||226
10111592|NCT02497235|11242630|FG002|COMPLETED|Overall Study||2
9929951|NCT01288430|11047124|FG007|NOT COMPLETED|Part 2||12
9929952|NCT01288430|11047125|FG008|NOT COMPLETED|Part 2||12
9929953|NCT01288430|11047126|FG009|NOT COMPLETED|Part 2||3
9929954|NCT01288443|11047159|FG000|STARTED|Overall Study|Randomized|31
9929955|NCT01288443|11047160|FG001|STARTED|Overall Study|Randomized|30
9929956|NCT01288443|11047161|FG002|STARTED|Overall Study|Randomized|31
9929957|NCT01288443|11047162|FG003|STARTED|Overall Study|Randomized|31
9929958|NCT01288443|11047163|FG004|STARTED|Overall Study|Randomized|30
9929959|NCT01288443|11047164|FG005|STARTED|Overall Study|Randomized|30
9929960|NCT01288443|11047159|FG000|Treated|Overall Study||31
9929961|NCT01288443|11047160|FG001|Treated|Overall Study||30
9929962|NCT01288443|11047161|FG002|Treated|Overall Study||31
9929963|NCT01288443|11047162|FG003|Treated|Overall Study||31
9929964|NCT01288443|11047163|FG004|Treated|Overall Study||29
9929965|NCT01288443|11047164|FG005|Treated|Overall Study||30
10010927|NCT01777152|11133609|FG001|STARTED|Overall Study||226
9929966|NCT01288443|11047159|FG000|COMPLETED|Overall Study||31
9929967|NCT01288443|11047160|FG001|COMPLETED|Overall Study||29
9929968|NCT01288443|11047161|FG002|COMPLETED|Overall Study||30
9929969|NCT01288443|11047162|FG003|COMPLETED|Overall Study||27
10010928|NCT01777152|11133608|FG000|COMPLETED|Overall Study||131
9929970|NCT01288443|11047163|FG004|COMPLETED|Overall Study||23
9929971|NCT01288443|11047164|FG005|COMPLETED|Overall Study||25
9929972|NCT01288443|11047159|FG000|NOT COMPLETED|Overall Study||0
9929973|NCT01288443|11047160|FG001|NOT COMPLETED|Overall Study||1
9929974|NCT01288443|11047161|FG002|NOT COMPLETED|Overall Study||1
9929975|NCT01288443|11047162|FG003|NOT COMPLETED|Overall Study||4
9929976|NCT01288443|11047163|FG004|NOT COMPLETED|Overall Study||7
9929977|NCT01288443|11047164|FG005|NOT COMPLETED|Overall Study||5
9929978|NCT01288469|11047181|FG000|STARTED|Overall Study|Randomized|31
9929979|NCT01288469|11047182|FG001|STARTED|Overall Study|Randomized|31
10010929|NCT01777152|11133609|FG001|COMPLETED|Overall Study||116
10111593|NCT02497235|11242631|FG003|COMPLETED|Overall Study||2
9929980|NCT01288469|11047183|FG002|STARTED|Overall Study|Randomized|30
9929981|NCT01288469|11047181|FG000|Treated|Overall Study||31
9929982|NCT01288469|11047182|FG001|Treated|Overall Study||31
9929983|NCT01288469|11047183|FG002|Treated|Overall Study||30
9929984|NCT01288469|11047181|FG000|COMPLETED|Overall Study||24
9929985|NCT01288469|11047182|FG001|COMPLETED|Overall Study||28
9929986|NCT01288469|11047183|FG002|COMPLETED|Overall Study||28
9929987|NCT01288469|11047181|FG000|NOT COMPLETED|Overall Study||7
9929988|NCT01288469|11047182|FG001|NOT COMPLETED|Overall Study||3
9929989|NCT01288469|11047183|FG002|NOT COMPLETED|Overall Study||2
9929990|NCT01288521|11047193|FG000|STARTED|Overall Study||3
9929991|NCT01288521|11047194|FG001|STARTED|Overall Study||5
9929992|NCT01288521|11047193|FG000|COMPLETED|Overall Study||3
9929993|NCT01288521|11047194|FG001|COMPLETED|Overall Study||5
9929994|NCT01288521|11047193|FG000|NOT COMPLETED|Overall Study||0
9929995|NCT01288521|11047194|FG001|NOT COMPLETED|Overall Study||0
9929996|NCT01288534|11047200|FG000|STARTED|Overall Study||68
9929997|NCT01288534|11047200|FG000|COMPLETED|Overall Study||68
9929998|NCT01288534|11047200|FG000|NOT COMPLETED|Overall Study||0
9929999|NCT01288612|11047207|FG000|STARTED|Overall Study||150
9930000|NCT01288612|11047208|FG001|STARTED|Overall Study||151
9930001|NCT01288612|11047209|FG002|STARTED|Overall Study||158
9930002|NCT01288612|11047207|FG000|Contacted|Overall Study||139
9930003|NCT01288612|11047208|FG001|Contacted|Overall Study||135
9930004|NCT01288612|11047209|FG002|Contacted|Overall Study||138
9930005|NCT01288612|11047207|FG000|Agreed to Take Part|Overall Study||61
9930006|NCT01288612|11047208|FG001|Agreed to Take Part|Overall Study||72
9930007|NCT01288612|11047209|FG002|Agreed to Take Part|Overall Study||76
9930008|NCT01288612|11047207|FG000|COMPLETED|Overall Study||61
9930009|NCT01288612|11047208|FG001|COMPLETED|Overall Study||69
9930010|NCT01288612|11047209|FG002|COMPLETED|Overall Study||76
9930011|NCT01288612|11047207|FG000|NOT COMPLETED|Overall Study||89
9930012|NCT01288612|11047208|FG001|NOT COMPLETED|Overall Study||82
9930013|NCT01288612|11047209|FG002|NOT COMPLETED|Overall Study||82
9930014|NCT01288729|11047219|FG000|STARTED|Overall Study||10
9930015|NCT01288729|11047220|FG001|STARTED|Overall Study||10
9930016|NCT01288729|11047219|FG000|COMPLETED|Overall Study||9
9930017|NCT01288729|11047220|FG001|COMPLETED|Overall Study||10
9930018|NCT01288729|11047219|FG000|NOT COMPLETED|Overall Study||1
9930019|NCT01288729|11047220|FG001|NOT COMPLETED|Overall Study||0
9930020|NCT01288781|11047228|FG000|STARTED|Overall Study||11
9930021|NCT01288781|11047229|FG001|STARTED|Overall Study||12
9930022|NCT01288781|11047228|FG000|COMPLETED|Overall Study||11
9930023|NCT01288781|11047229|FG001|COMPLETED|Overall Study||12
9930024|NCT01288781|11047228|FG000|NOT COMPLETED|Overall Study||0
9930025|NCT01288781|11047229|FG001|NOT COMPLETED|Overall Study||0
9930026|NCT01288807|11047235|FG000|STARTED|Overall Study||8
9930027|NCT01288807|11047235|FG000|COMPLETED|Overall Study||8
9930028|NCT01288807|11047235|FG000|NOT COMPLETED|Overall Study||0
10205780|NCT03496467|11332494|FG000|COMPLETED|Overall Study||34
10205781|NCT03496467|11332495|FG001|COMPLETED|Overall Study||14
10205782|NCT03496467|11332494|FG000|NOT COMPLETED|Overall Study||4
10205783|NCT03496467|11332495|FG001|NOT COMPLETED|Overall Study||4
10205784|NCT03496545|11332503|FG000|STARTED|Overall Study||21
10205785|NCT03496545|11332504|FG001|STARTED|Overall Study||26
10205786|NCT03496545|11332503|FG000|COMPLETED|Overall Study||20
10205787|NCT03496545|11332504|FG001|COMPLETED|Overall Study||24
10205788|NCT03496545|11332503|FG000|NOT COMPLETED|Overall Study||1
10205789|NCT03496545|11332504|FG001|NOT COMPLETED|Overall Study||2
10205790|NCT03496701|11332510|FG000|STARTED|Overall Study||77
10205791|NCT03496701|11332510|FG000|COMPLETED|Overall Study||77
10205792|NCT03496701|11332510|FG000|NOT COMPLETED|Overall Study||0
10205793|NCT03496974|11332518|FG000|STARTED|Overall Study||10
10205794|NCT03496974|11332519|FG001|STARTED|Overall Study||28
10205795|NCT03496974|11332518|FG000|COMPLETED|Overall Study||9
10205796|NCT03496974|11332519|FG001|COMPLETED|Overall Study||20
10205797|NCT03496974|11332518|FG000|NOT COMPLETED|Overall Study||1
10205798|NCT03496974|11332519|FG001|NOT COMPLETED|Overall Study||8
10205799|NCT03496987|11332527|FG000|STARTED|Overall Study||49
10205800|NCT03496987|11332528|FG001|STARTED|Overall Study||51
10205801|NCT03496987|11332527|FG000|COMPLETED|Overall Study||49
10205802|NCT03496987|11332528|FG001|COMPLETED|Overall Study||51
10205803|NCT03496987|11332527|FG000|NOT COMPLETED|Overall Study||0
10205804|NCT03496987|11332528|FG001|NOT COMPLETED|Overall Study||0
10205805|NCT03497026|11332534|FG000|STARTED|Overall Study||4
10205806|NCT03497026|11332534|FG000|COMPLETED|Overall Study||4
10205807|NCT03497026|11332534|FG000|NOT COMPLETED|Overall Study||0
10205808|NCT03497039|11332540|FG000|STARTED|Overall Study||30
10205809|NCT03497039|11332541|FG001|STARTED|Overall Study||17
10205810|NCT03497039|11332540|FG000|Treated|Overall Study||29
10205811|NCT03497039|11332541|FG001|Treated|Overall Study||17
10205812|NCT03497039|11332540|FG000|COMPLETED|Overall Study||29
9930029|NCT01288833|11047241|FG000|STARTED|Overall Study||277
9930030|NCT01288833|11047242|FG001|STARTED|Overall Study||281
9930031|NCT01288833|11047241|FG000|COMPLETED|Overall Study||277
9930032|NCT01288833|11047242|FG001|COMPLETED|Overall Study||281
9930033|NCT01288833|11047241|FG000|NOT COMPLETED|Overall Study||0
9930034|NCT01288833|11047242|FG001|NOT COMPLETED|Overall Study||0
9930035|NCT01288859|11047248|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
10205813|NCT03497039|11332541|FG001|COMPLETED|Overall Study||16
10205814|NCT03497039|11332540|FG000|NOT COMPLETED|Overall Study||1
10205815|NCT03497039|11332541|FG001|NOT COMPLETED|Overall Study||1
10205816|NCT03497130|11332549|FG000|STARTED|Overall Study||40
9930036|NCT01288859|11047249|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
9930037|NCT01288859|11047250|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
9930038|NCT01288859|11047251|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
9930039|NCT01288859|11047252|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
9930040|NCT01288859|11047253|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
9930041|NCT01288859|11047248|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
9930042|NCT01288859|11047249|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930043|NCT01288859|11047250|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930044|NCT01288859|11047251|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930045|NCT01288859|11047252|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930046|NCT01288859|11047253|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
9930047|NCT01288859|11047248|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930048|NCT01288859|11047249|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930049|NCT01288859|11047250|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930050|NCT01288859|11047251|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930051|NCT01288859|11047252|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930052|NCT01288859|11047253|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
9930053|NCT01288859|11047248|FG000|STARTED|Washout Period of 1 Week||5
9930054|NCT01288859|11047249|FG001|STARTED|Washout Period of 1 Week||0
9930055|NCT01288859|11047250|FG002|STARTED|Washout Period of 1 Week||0
9930056|NCT01288859|11047251|FG003|STARTED|Washout Period of 1 Week||0
9930057|NCT01288859|11047252|FG004|STARTED|Washout Period of 1 Week||0
9930058|NCT01288859|11047253|FG005|STARTED|Washout Period of 1 Week||5
9930059|NCT01288859|11047248|FG000|COMPLETED|Washout Period of 1 Week||5
9930060|NCT01288859|11047249|FG001|COMPLETED|Washout Period of 1 Week||0
9930061|NCT01288859|11047250|FG002|COMPLETED|Washout Period of 1 Week||0
9930062|NCT01288859|11047251|FG003|COMPLETED|Washout Period of 1 Week||0
9930063|NCT01288859|11047252|FG004|COMPLETED|Washout Period of 1 Week||0
9930064|NCT01288859|11047253|FG005|COMPLETED|Washout Period of 1 Week||5
9930065|NCT01288859|11047248|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9930066|NCT01288859|11047249|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9930067|NCT01288859|11047250|FG002|NOT COMPLETED|Washout Period of 1 Week||0
9930068|NCT01288859|11047251|FG003|NOT COMPLETED|Washout Period of 1 Week||0
9930069|NCT01288859|11047252|FG004|NOT COMPLETED|Washout Period of 1 Week||0
9930070|NCT01288859|11047253|FG005|NOT COMPLETED|Washout Period of 1 Week||0
9930071|NCT01288859|11047248|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
9930072|NCT01288859|11047249|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
9930073|NCT01288859|11047250|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
10205817|NCT03497130|11332550|FG001|STARTED|Overall Study||14
10205818|NCT03497130|11332549|FG000|COMPLETED|Overall Study||39
10205819|NCT03497130|11332550|FG001|COMPLETED|Overall Study||13
10205820|NCT03497130|11332549|FG000|NOT COMPLETED|Overall Study||1
10205821|NCT03497130|11332550|FG001|NOT COMPLETED|Overall Study||1
10205822|NCT03497429|11332558|FG000|STARTED|Overall Study||3
10205823|NCT03497429|11332559|FG001|STARTED|Overall Study||6
10205824|NCT03497429|11332558|FG000|Started|Overall Study||3
10205825|NCT03497429|11332559|FG001|Started|Overall Study||6
10205826|NCT03497429|11332558|FG000|Completed|Overall Study||0
10205827|NCT03497429|11332559|FG001|Completed|Overall Study||0
10205828|NCT03497429|11332558|FG000|COMPLETED|Overall Study||0
10205829|NCT03497429|11332559|FG001|COMPLETED|Overall Study||0
10205830|NCT03497429|11332558|FG000|NOT COMPLETED|Overall Study||3
10205831|NCT03497429|11332559|FG001|NOT COMPLETED|Overall Study||6
10238742|NCT00484718|11370188|FG001|STARTED|Treatment Period 2 (2 Weeks)||1
10238743|NCT00484718|11370189|FG002|STARTED|Treatment Period 2 (2 Weeks)||1
10238744|NCT00484718|11370190|FG003|STARTED|Treatment Period 2 (2 Weeks)||1
10238745|NCT00484718|11370191|FG004|STARTED|Treatment Period 2 (2 Weeks)||1
10238746|NCT00484718|11370192|FG005|STARTED|Treatment Period 2 (2 Weeks)||1
10238747|NCT00484718|11370187|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1
10238748|NCT00484718|11370188|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1
10238749|NCT00484718|11370189|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1
10238750|NCT00484718|11370190|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1
10238751|NCT00484718|11370191|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1
10238752|NCT00484718|11370192|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1
10238753|NCT00484718|11370187|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10238754|NCT00484718|11370188|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10238755|NCT00484718|11370189|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10238756|NCT00484718|11370190|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10238757|NCT00484718|11370191|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10238758|NCT00484718|11370192|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10238759|NCT00484718|11370187|FG000|STARTED|Washout Period (2 Weeks)||1
10238760|NCT00484718|11370188|FG001|STARTED|Washout Period (2 Weeks)||1
10238761|NCT00484718|11370189|FG002|STARTED|Washout Period (2 Weeks)||1
10238762|NCT00484718|11370190|FG003|STARTED|Washout Period (2 Weeks)||1
10238763|NCT00484718|11370191|FG004|STARTED|Washout Period (2 Weeks)||1
10238764|NCT00484718|11370192|FG005|STARTED|Washout Period (2 Weeks)||1
9930074|NCT01288859|11047251|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
9930075|NCT01288859|11047252|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
9930076|NCT01288859|11047253|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
9930077|NCT01288859|11047248|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
10238765|NCT00484718|11370187|FG000|COMPLETED|Washout Period (2 Weeks)||1
9930078|NCT01288859|11047249|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930079|NCT01288859|11047250|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930080|NCT01288859|11047251|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930081|NCT01288859|11047252|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930082|NCT01288859|11047253|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
9930083|NCT01288859|11047248|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930084|NCT01288859|11047249|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930085|NCT01288859|11047250|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930086|NCT01288859|11047251|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930087|NCT01288859|11047252|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930088|NCT01288859|11047253|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
9930089|NCT01288859|11047248|FG000|STARTED|Washout Period of 1 Week||5
9930090|NCT01288859|11047249|FG001|STARTED|Washout Period of 1 Week||0
9930091|NCT01288859|11047250|FG002|STARTED|Washout Period of 1 Week||0
9930092|NCT01288859|11047251|FG003|STARTED|Washout Period of 1 Week||0
9930093|NCT01288859|11047252|FG004|STARTED|Washout Period of 1 Week||0
9930094|NCT01288859|11047253|FG005|STARTED|Washout Period of 1 Week||5
9930095|NCT01288859|11047248|FG000|COMPLETED|Washout Period of 1 Week||5
9930096|NCT01288859|11047249|FG001|COMPLETED|Washout Period of 1 Week||0
9930097|NCT01288859|11047250|FG002|COMPLETED|Washout Period of 1 Week||0
9930098|NCT01288859|11047251|FG003|COMPLETED|Washout Period of 1 Week||0
9930099|NCT01288859|11047252|FG004|COMPLETED|Washout Period of 1 Week||0
9930100|NCT01288859|11047253|FG005|COMPLETED|Washout Period of 1 Week||5
9930101|NCT01288859|11047248|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9930102|NCT01288859|11047249|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9930103|NCT01288859|11047250|FG002|NOT COMPLETED|Washout Period of 1 Week||0
9930104|NCT01288859|11047251|FG003|NOT COMPLETED|Washout Period of 1 Week||0
9930105|NCT01288859|11047252|FG004|NOT COMPLETED|Washout Period of 1 Week||0
9930106|NCT01288859|11047253|FG005|NOT COMPLETED|Washout Period of 1 Week||0
9930107|NCT01288859|11047248|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930108|NCT01288859|11047249|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
9930109|NCT01288859|11047250|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
9930110|NCT01288859|11047251|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930111|NCT01288859|11047252|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930112|NCT01288859|11047253|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930113|NCT01288859|11047248|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930114|NCT01288859|11047249|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
9930115|NCT01288859|11047250|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
9930116|NCT01288859|11047251|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930117|NCT01288859|11047252|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930118|NCT01288859|11047253|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930119|NCT01288859|11047248|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930120|NCT01288859|11047249|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930121|NCT01288859|11047250|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930122|NCT01288859|11047251|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930123|NCT01288859|11047252|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930124|NCT01288859|11047253|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
9930125|NCT01288859|11047248|FG000|STARTED|Washout Period of 1 Week||0
9930126|NCT01288859|11047249|FG001|STARTED|Washout Period of 1 Week||5
9930127|NCT01288859|11047250|FG002|STARTED|Washout Period of 1 Week||5
9930128|NCT01288859|11047251|FG003|STARTED|Washout Period of 1 Week||0
9930129|NCT01288859|11047252|FG004|STARTED|Washout Period of 1 Week||0
9930130|NCT01288859|11047253|FG005|STARTED|Washout Period of 1 Week||0
9930131|NCT01288859|11047248|FG000|COMPLETED|Washout Period of 1 Week||0
9930132|NCT01288859|11047249|FG001|COMPLETED|Washout Period of 1 Week||5
9930133|NCT01288859|11047250|FG002|COMPLETED|Washout Period of 1 Week||5
9930134|NCT01288859|11047251|FG003|COMPLETED|Washout Period of 1 Week||0
9930135|NCT01288859|11047252|FG004|COMPLETED|Washout Period of 1 Week||0
9930136|NCT01288859|11047253|FG005|COMPLETED|Washout Period of 1 Week||0
9930137|NCT01288859|11047248|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9930138|NCT01288859|11047249|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9930139|NCT01288859|11047250|FG002|NOT COMPLETED|Washout Period of 1 Week||0
9930140|NCT01288859|11047251|FG003|NOT COMPLETED|Washout Period of 1 Week||0
9930141|NCT01288859|11047252|FG004|NOT COMPLETED|Washout Period of 1 Week||0
9930142|NCT01288859|11047253|FG005|NOT COMPLETED|Washout Period of 1 Week||0
9930143|NCT01288859|11047248|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930144|NCT01288859|11047249|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
9930145|NCT01288859|11047250|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
9930146|NCT01288859|11047251|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930147|NCT01288859|11047252|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930148|NCT01288859|11047253|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930149|NCT01288859|11047248|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930150|NCT01288859|11047249|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
9930151|NCT01288859|11047250|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
9930152|NCT01288859|11047251|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930153|NCT01288859|11047252|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930154|NCT01288859|11047253|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930155|NCT01288859|11047248|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930156|NCT01288859|11047249|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930157|NCT01288859|11047250|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930158|NCT01288859|11047251|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930159|NCT01288859|11047252|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930160|NCT01288859|11047253|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
9930161|NCT01288859|11047248|FG000|STARTED|Washout Period of 1 Week||0
9930162|NCT01288859|11047249|FG001|STARTED|Washout Period of 1 Week||0
9930163|NCT01288859|11047250|FG002|STARTED|Washout Period of 1 Week||0
9930164|NCT01288859|11047251|FG003|STARTED|Washout Period of 1 Week||5
9930165|NCT01288859|11047252|FG004|STARTED|Washout Period of 1 Week||5
9930166|NCT01288859|11047253|FG005|STARTED|Washout Period of 1 Week||0
9930167|NCT01288859|11047248|FG000|COMPLETED|Washout Period of 1 Week||0
9930168|NCT01288859|11047249|FG001|COMPLETED|Washout Period of 1 Week||0
9930169|NCT01288859|11047250|FG002|COMPLETED|Washout Period of 1 Week||0
9930170|NCT01288859|11047251|FG003|COMPLETED|Washout Period of 1 Week||5
9930171|NCT01288859|11047252|FG004|COMPLETED|Washout Period of 1 Week||5
9930172|NCT01288859|11047253|FG005|COMPLETED|Washout Period of 1 Week||0
9930173|NCT01288859|11047248|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9930174|NCT01288859|11047249|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9930175|NCT01288859|11047250|FG002|NOT COMPLETED|Washout Period of 1 Week||0
9930176|NCT01288859|11047251|FG003|NOT COMPLETED|Washout Period of 1 Week||0
9930177|NCT01288859|11047252|FG004|NOT COMPLETED|Washout Period of 1 Week||0
9930178|NCT01288859|11047253|FG005|NOT COMPLETED|Washout Period of 1 Week||0
9930179|NCT01288859|11047248|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
9930180|NCT01288859|11047249|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
9930181|NCT01288859|11047250|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
9930182|NCT01288859|11047251|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
9930183|NCT01288859|11047252|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
9930184|NCT01288859|11047253|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
9930185|NCT01288859|11047248|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930186|NCT01288859|11047249|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930187|NCT01288859|11047250|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930188|NCT01288859|11047251|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
9930189|NCT01288859|11047252|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
9930190|NCT01288859|11047253|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930191|NCT01288859|11047248|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930192|NCT01288859|11047249|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930193|NCT01288859|11047250|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930194|NCT01288859|11047251|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930195|NCT01288859|11047252|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930196|NCT01288859|11047253|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
9930197|NCT01288859|11047248|FG000|STARTED|Washout Period of 1 Week||0
9930198|NCT01288859|11047249|FG001|STARTED|Washout Period of 1 Week||0
9930199|NCT01288859|11047250|FG002|STARTED|Washout Period of 1 Week||0
9930200|NCT01288859|11047251|FG003|STARTED|Washout Period of 1 Week||5
9930201|NCT01288859|11047252|FG004|STARTED|Washout Period of 1 Week||5
9930202|NCT01288859|11047253|FG005|STARTED|Washout Period of 1 Week||0
9930203|NCT01288859|11047248|FG000|COMPLETED|Washout Period of 1 Week||0
9930204|NCT01288859|11047249|FG001|COMPLETED|Washout Period of 1 Week||0
9930205|NCT01288859|11047250|FG002|COMPLETED|Washout Period of 1 Week||0
9930206|NCT01288859|11047251|FG003|COMPLETED|Washout Period of 1 Week||5
9930207|NCT01288859|11047252|FG004|COMPLETED|Washout Period of 1 Week||5
9930208|NCT01288859|11047253|FG005|COMPLETED|Washout Period of 1 Week||0
9930209|NCT01288859|11047248|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9930210|NCT01288859|11047249|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9930211|NCT01288859|11047250|FG002|NOT COMPLETED|Washout Period of 1 Week||0
9930212|NCT01288859|11047251|FG003|NOT COMPLETED|Washout Period of 1 Week||0
9930213|NCT01288859|11047252|FG004|NOT COMPLETED|Washout Period of 1 Week||0
9930214|NCT01288859|11047253|FG005|NOT COMPLETED|Washout Period of 1 Week||0
9930215|NCT01288859|11047248|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
9930216|NCT01288859|11047249|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
9930217|NCT01288859|11047250|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
9930218|NCT01288859|11047251|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
9930219|NCT01288859|11047252|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
9930220|NCT01288859|11047253|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
9930221|NCT01288859|11047248|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930222|NCT01288859|11047249|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930223|NCT01288859|11047250|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930224|NCT01288859|11047251|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
9930225|NCT01288859|11047252|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
9930226|NCT01288859|11047253|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930227|NCT01288859|11047248|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930228|NCT01288859|11047249|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930229|NCT01288859|11047250|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930230|NCT01288859|11047251|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930231|NCT01288859|11047252|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930232|NCT01288859|11047253|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
9930233|NCT01288911|11047275|FG000|STARTED|Double-blind Period||184
9930234|NCT01288911|11047276|FG001|STARTED|Double-blind Period||191
9930235|NCT01288911|11047275|FG000|Received Treatment|Double-blind Period||183
9930236|NCT01288911|11047276|FG001|Received Treatment|Double-blind Period||189
9930237|NCT01288911|11047275|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
9930238|NCT01288911|11047276|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
9930239|NCT01288911|11047275|FG000|NOT COMPLETED|Double-blind Period||142
9930240|NCT01288911|11047276|FG001|NOT COMPLETED|Double-blind Period||182
9930241|NCT01288911|11047275|FG000|STARTED|Open-label Period (All Enzalutamide)||42
9930242|NCT01288911|11047276|FG001|STARTED|Open-label Period (All Enzalutamide)||9
9930243|NCT01288911|11047275|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42
9930244|NCT01288911|11047276|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9
9930245|NCT01288911|11047275|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0
9930246|NCT01288911|11047276|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0
9930247|NCT01288911|11047275|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
9930248|NCT01288911|11047276|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
9930249|NCT01288937|11047287|FG000|STARTED|Overall Study||4
9930250|NCT01288937|11047288|FG001|STARTED|Overall Study||2
9930251|NCT01288937|11047287|FG000|COMPLETED|Overall Study||3
9930252|NCT01288937|11047288|FG001|COMPLETED|Overall Study||2
9930253|NCT01288937|11047287|FG000|NOT COMPLETED|Overall Study||1
9930254|NCT01288937|11047288|FG001|NOT COMPLETED|Overall Study||0
9930255|NCT01288976|11047297|FG000|STARTED|Overall Study||567
9930256|NCT01288976|11047298|FG001|STARTED|Overall Study||49
9930257|NCT01288976|11047299|FG002|STARTED|Overall Study||105
9930258|NCT01288976|11047297|FG000|COMPLETED|Overall Study||389
9930259|NCT01288976|11047298|FG001|COMPLETED|Overall Study||22
9930260|NCT01288976|11047299|FG002|COMPLETED|Overall Study||85
9930261|NCT01288976|11047297|FG000|NOT COMPLETED|Overall Study||178
9930262|NCT01288976|11047298|FG001|NOT COMPLETED|Overall Study||27
9930263|NCT01288976|11047299|FG002|NOT COMPLETED|Overall Study||20
9930264|NCT01288989|11047310|FG000|STARTED|Overall Study||6
9930265|NCT01288989|11047311|FG001|STARTED|Overall Study||3
9930266|NCT01288989|11047312|FG002|STARTED|Overall Study||3
9930267|NCT01288989|11047313|FG003|STARTED|Overall Study||11
9930268|NCT01288989|11047314|FG004|STARTED|Overall Study||21
9930269|NCT01288989|11047310|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9930270|NCT01288989|11047311|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9930271|NCT01288989|11047312|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9930272|NCT01288989|11047313|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11
9930273|NCT01288989|11047314|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21
9930274|NCT01288989|11047310|FG000|COMPLETED|Overall Study||5
9930275|NCT01288989|11047311|FG001|COMPLETED|Overall Study||3
9930276|NCT01288989|11047312|FG002|COMPLETED|Overall Study||3
9930277|NCT01288989|11047313|FG003|COMPLETED|Overall Study||10
9930278|NCT01288989|11047314|FG004|COMPLETED|Overall Study||15
9930279|NCT01288989|11047310|FG000|NOT COMPLETED|Overall Study||1
9930280|NCT01288989|11047311|FG001|NOT COMPLETED|Overall Study||0
9930281|NCT01288989|11047312|FG002|NOT COMPLETED|Overall Study||0
9930282|NCT01288989|11047313|FG003|NOT COMPLETED|Overall Study||1
9930283|NCT01288989|11047314|FG004|NOT COMPLETED|Overall Study||6
9930284|NCT01289015|11047334|FG000|STARTED|Overall Study||571
9930285|NCT01289015|11047335|FG001|STARTED|Overall Study||284
9930286|NCT01289015|11047334|FG000|COMPLETED|Overall Study||472
9930287|NCT01289015|11047335|FG001|COMPLETED|Overall Study||230
9930288|NCT01289015|11047334|FG000|NOT COMPLETED|Overall Study||99
9930289|NCT01289015|11047335|FG001|NOT COMPLETED|Overall Study||54
9930290|NCT01289028|11047341|FG000|STARTED|Overall Study||125
9930291|NCT01289028|11047341|FG000|COMPLETED|Overall Study||42
9930292|NCT01289028|11047341|FG000|NOT COMPLETED|Overall Study||83
9930293|NCT01289041|11047347|FG000|STARTED|Overall Study||70
9930294|NCT01289041|11047347|FG000|COMPLETED|Overall Study||0
9930295|NCT01289041|11047347|FG000|NOT COMPLETED|Overall Study||70
9930296|NCT01289067|11047353|FG000|STARTED|Overall Study||13
9930297|NCT01289067|11047353|FG000|COMPLETED|Overall Study||13
9930298|NCT01289067|11047353|FG000|NOT COMPLETED|Overall Study||0
9930299|NCT01289080|11047359|FG000|STARTED|Overall Study||9
9930300|NCT01289080|11047360|FG001|STARTED|Overall Study||10
9930301|NCT01289080|11047359|FG000|COMPLETED|Overall Study||9
9930302|NCT01289080|11047360|FG001|COMPLETED|Overall Study||10
9930303|NCT01289080|11047359|FG000|NOT COMPLETED|Overall Study||0
9930304|NCT01289080|11047360|FG001|NOT COMPLETED|Overall Study||0
9930305|NCT01289119|11047373|FG000|STARTED|Overall Study||93
9930306|NCT01289119|11047374|FG001|STARTED|Overall Study||92
9930307|NCT01289119|11047375|FG002|STARTED|Overall Study||98
9930308|NCT01289119|11047376|FG003|STARTED|Overall Study||99
9930309|NCT01289119|11047377|FG004|STARTED|Overall Study||63
9930310|NCT01289119|11047378|FG005|STARTED|Overall Study||61
9930311|NCT01289119|11047373|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
9930312|NCT01289119|11047374|FG001|Treated|Overall Study||92
9930313|NCT01289119|11047375|FG002|Treated|Overall Study||98
9930314|NCT01289119|11047376|FG003|Treated|Overall Study||99
9930315|NCT01289119|11047377|FG004|Treated|Overall Study||63
9930316|NCT01289119|11047378|FG005|Treated|Overall Study||61
9930317|NCT01289119|11047373|FG000|COMPLETED|Overall Study||84
9930318|NCT01289119|11047374|FG001|COMPLETED|Overall Study||83
9930319|NCT01289119|11047375|FG002|COMPLETED|Overall Study||89
9930320|NCT01289119|11047376|FG003|COMPLETED|Overall Study||93
9930321|NCT01289119|11047377|FG004|COMPLETED|Overall Study||58
9930322|NCT01289119|11047378|FG005|COMPLETED|Overall Study||57
9930323|NCT01289119|11047373|FG000|NOT COMPLETED|Overall Study||9
9930324|NCT01289119|11047374|FG001|NOT COMPLETED|Overall Study||9
9930325|NCT01289119|11047375|FG002|NOT COMPLETED|Overall Study||9
9930326|NCT01289119|11047376|FG003|NOT COMPLETED|Overall Study||6
9930327|NCT01289119|11047377|FG004|NOT COMPLETED|Overall Study||5
9930328|NCT01289119|11047378|FG005|NOT COMPLETED|Overall Study||4
9930329|NCT01289210|11047392|FG000|STARTED|Overall Study||2
9930330|NCT01289210|11047392|FG000|COMPLETED|Overall Study||1
9930331|NCT01289210|11047392|FG000|NOT COMPLETED|Overall Study||1
9930332|NCT01289275|11047400|FG000|STARTED|Overall Study||317
9930333|NCT01289275|11047401|FG001|STARTED|Overall Study||320
9930334|NCT01289275|11047402|FG002|STARTED|Overall Study||317
9930335|NCT01289275|11047403|FG003|STARTED|Overall Study||316
9930336|NCT01289275|11047400|FG000|COMPLETED|Overall Study||317
9930337|NCT01289275|11047401|FG001|COMPLETED|Overall Study||320
9930338|NCT01289275|11047402|FG002|COMPLETED|Overall Study||317
9930339|NCT01289275|11047403|FG003|COMPLETED|Overall Study||316
9930340|NCT01289275|11047400|FG000|NOT COMPLETED|Overall Study||0
9930341|NCT01289275|11047401|FG001|NOT COMPLETED|Overall Study||0
9930342|NCT01289275|11047402|FG002|NOT COMPLETED|Overall Study||0
9930343|NCT01289275|11047403|FG003|NOT COMPLETED|Overall Study||0
9930344|NCT01289353|11047417|FG000|STARTED|Overall Study||92
9930345|NCT01289353|11047417|FG000|COMPLETED|Overall Study||90
9930346|NCT01289353|11047417|FG000|NOT COMPLETED|Overall Study||2
9930347|NCT01289392|11047424|FG000|STARTED|Overall Study||9
9930348|NCT01289392|11047425|FG001|STARTED|Overall Study||9
9930349|NCT01289392|11047426|FG002|STARTED|Overall Study||7
9930350|NCT01289392|11047424|FG000|COMPLETED|Overall Study||9
9930351|NCT01289392|11047425|FG001|COMPLETED|Overall Study||9
9930352|NCT01289392|11047426|FG002|COMPLETED|Overall Study||7
9930353|NCT01289392|11047424|FG000|NOT COMPLETED|Overall Study||0
9930354|NCT01289392|11047425|FG001|NOT COMPLETED|Overall Study||0
9930355|NCT01289392|11047426|FG002|NOT COMPLETED|Overall Study||0
9930356|NCT01289418|11047437|FG000|STARTED|Day 8 Survey||6525
9930357|NCT01289418|11047437|FG000|COMPLETED|Day 8 Survey||4307
9930358|NCT01289418|11047437|FG000|NOT COMPLETED|Day 8 Survey||2218
9930359|NCT01289418|11047437|FG000|STARTED|Day 29 Survey||6525
9930360|NCT01289418|11047437|FG000|COMPLETED|Day 29 Survey||4057
9930361|NCT01289418|11047437|FG000|NOT COMPLETED|Day 29 Survey||2468
9930362|NCT01289431|11047450|FG000|STARTED|Overall Study||34
9930363|NCT01289431|11047451|FG001|STARTED|Overall Study||34
9930364|NCT01289431|11047452|FG002|STARTED|Overall Study||34
9930365|NCT01289431|11047453|FG003|STARTED|Overall Study||33
9930366|NCT01289431|11047454|FG004|STARTED|Overall Study||34
9930367|NCT01289431|11047455|FG005|STARTED|Overall Study||33
9930368|NCT01289431|11047456|FG006|STARTED|Overall Study||34
9930369|NCT01289431|11047450|FG000|COMPLETED|Overall Study||29
9930370|NCT01289431|11047451|FG001|COMPLETED|Overall Study||32
9930371|NCT01289431|11047452|FG002|COMPLETED|Overall Study||30
9930372|NCT01289431|11047453|FG003|COMPLETED|Overall Study||28
9930373|NCT01289431|11047454|FG004|COMPLETED|Overall Study||32
9930374|NCT01289431|11047455|FG005|COMPLETED|Overall Study||31
9930375|NCT01289431|11047456|FG006|COMPLETED|Overall Study||33
9930376|NCT01289431|11047450|FG000|NOT COMPLETED|Overall Study||5
9930377|NCT01289431|11047451|FG001|NOT COMPLETED|Overall Study||2
9930378|NCT01289431|11047452|FG002|NOT COMPLETED|Overall Study||4
9930379|NCT01289431|11047453|FG003|NOT COMPLETED|Overall Study||5
9930380|NCT01289431|11047454|FG004|NOT COMPLETED|Overall Study||2
9930381|NCT01289431|11047455|FG005|NOT COMPLETED|Overall Study||2
9930382|NCT01289431|11047456|FG006|NOT COMPLETED|Overall Study||1
9930383|NCT01289457|11047475|FG000|STARTED|Overall Study||12
9930384|NCT01289457|11047476|FG001|STARTED|Overall Study||157
9930385|NCT01289457|11047477|FG002|STARTED|Overall Study||113
9930386|NCT01289457|11047475|FG000|COMPLETED|Overall Study||12
9930387|NCT01289457|11047476|FG001|COMPLETED|Overall Study||157
9930388|NCT01289457|11047477|FG002|COMPLETED|Overall Study||113
9930389|NCT01289457|11047475|FG000|NOT COMPLETED|Overall Study||0
9930390|NCT01289457|11047476|FG001|NOT COMPLETED|Overall Study||0
9930391|NCT01289457|11047477|FG002|NOT COMPLETED|Overall Study||0
9930392|NCT01289522|11047485|FG000|STARTED|Overall Study||54
9930393|NCT01289522|11047485|FG000|COMPLETED|Overall Study||43
9930394|NCT01289522|11047485|FG000|NOT COMPLETED|Overall Study||11
9930395|NCT01289548|11047492|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
9930396|NCT01289548|11047493|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
9930397|NCT01289548|11047494|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
9930398|NCT01289548|11047492|FG000|Donors|Overall Study||20
9930399|NCT01289548|11047493|FG001|Donors|Overall Study||20
9930400|NCT01289548|11047494|FG002|Donors|Overall Study||20
9930401|NCT01289548|11047492|FG000|Recipients|Overall Study||20
9930402|NCT01289548|11047493|FG001|Recipients|Overall Study||20
9930403|NCT01289548|11047494|FG002|Recipients|Overall Study||20
9930404|NCT01289548|11047492|FG000|COMPLETED|Overall Study||40
9930405|NCT01289548|11047493|FG001|COMPLETED|Overall Study||40
9930406|NCT01289548|11047494|FG002|COMPLETED|Overall Study||40
9930407|NCT01289548|11047492|FG000|NOT COMPLETED|Overall Study||0
9930408|NCT01289548|11047493|FG001|NOT COMPLETED|Overall Study||0
9930409|NCT01289548|11047494|FG002|NOT COMPLETED|Overall Study||0
9930410|NCT01289574|11047505|FG000|STARTED|Overall Study||58
9930411|NCT01289574|11047506|FG001|STARTED|Overall Study||60
9930412|NCT01289574|11047507|FG002|STARTED|Overall Study||63
9930413|NCT01289574|11047505|FG000|COMPLETED|Overall Study||51
9930414|NCT01289574|11047506|FG001|COMPLETED|Overall Study||57
9930415|NCT01289574|11047507|FG002|COMPLETED|Overall Study||60
9930416|NCT01289574|11047505|FG000|NOT COMPLETED|Overall Study||7
9930417|NCT01289574|11047506|FG001|NOT COMPLETED|Overall Study||3
9930418|NCT01289574|11047507|FG002|NOT COMPLETED|Overall Study||3
9930419|NCT01289639|11047519|FG000|STARTED|Overall Study||5
9930420|NCT01289639|11047520|FG001|STARTED|Overall Study||6
9930421|NCT01289639|11047521|FG002|STARTED|Overall Study||0
9930422|NCT01289639|11047519|FG000|COMPLETED|Overall Study||4
9930423|NCT01289639|11047520|FG001|COMPLETED|Overall Study||6
9930424|NCT01289639|11047521|FG002|COMPLETED|Overall Study||0
9930425|NCT01289639|11047519|FG000|NOT COMPLETED|Overall Study||1
9930426|NCT01289639|11047520|FG001|NOT COMPLETED|Overall Study||0
9930427|NCT01289639|11047521|FG002|NOT COMPLETED|Overall Study||0
9930428|NCT01289665|11047531|FG000|STARTED|Overall Study||60
9930429|NCT01289665|11047532|FG001|STARTED|Overall Study||60
9930430|NCT01289665|11047531|FG000|COMPLETED|Overall Study||59
9930431|NCT01289665|11047532|FG001|COMPLETED|Overall Study||60
9930432|NCT01289665|11047531|FG000|NOT COMPLETED|Overall Study||1
9930433|NCT01289665|11047532|FG001|NOT COMPLETED|Overall Study||0
9930434|NCT01289678|11047538|FG000|STARTED|Overall Study||18
9930435|NCT01289678|11047538|FG000|COMPLETED|Overall Study||12
9930436|NCT01289678|11047538|FG000|NOT COMPLETED|Overall Study||6
9930437|NCT01289782|11047544|FG000|STARTED|Overall Study||264
9930438|NCT01289782|11047545|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
9930439|NCT01289782|11047544|FG000|COMPLETED|Overall Study||239
9930440|NCT01289782|11047545|FG001|COMPLETED|Overall Study||118
9930441|NCT01289782|11047544|FG000|NOT COMPLETED|Overall Study||25
9930442|NCT01289782|11047545|FG001|NOT COMPLETED|Overall Study||12
9930443|NCT01289821|11047551|FG000|STARTED|Treatment Period||54
9930444|NCT01289821|11047551|FG000|Participants Received Regorafenib|Treatment Period||54
9930445|NCT01289821|11047551|FG000|COMPLETED|Treatment Period||0
9930446|NCT01289821|11047551|FG000|NOT COMPLETED|Treatment Period||54
9930447|NCT01289821|11047551|FG000|STARTED|Safety Follow-up Period||54
9930448|NCT01289821|11047551|FG000|COMPLETED|Safety Follow-up Period||49
9930449|NCT01289821|11047551|FG000|NOT COMPLETED|Safety Follow-up Period||5
9930450|NCT01289821|11047551|FG000|STARTED|Survival Follow-up Period||52
9930451|NCT01289821|11047551|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
9930452|NCT01289821|11047551|FG000|NOT COMPLETED|Survival Follow-up Period||18
9930453|NCT01289847|11047555|FG000|STARTED|Overall Study||25
9930454|NCT01289847|11047555|FG000|COMPLETED|Overall Study||24
9930455|NCT01289847|11047555|FG000|NOT COMPLETED|Overall Study||1
9930456|NCT01289912|11047561|FG000|STARTED|Overall Study||32
9930457|NCT01289912|11047562|FG001|STARTED|Overall Study||15
9930458|NCT01289912|11047561|FG000|COMPLETED|Overall Study||29
9930459|NCT01289912|11047562|FG001|COMPLETED|Overall Study||13
9930460|NCT01289912|11047561|FG000|NOT COMPLETED|Overall Study||3
9930461|NCT01289912|11047562|FG001|NOT COMPLETED|Overall Study||2
9930462|NCT01289990|11047591|FG000|STARTED|Overall Study||224
9930463|NCT01289990|11047592|FG001|STARTED|Overall Study||224
9930464|NCT01289990|11047593|FG002|STARTED|Overall Study||228
9930465|NCT01289990|11047594|FG003|STARTED|Overall Study||223
9930466|NCT01289990|11047595|FG004|STARTED|Overall Study||165
9930467|NCT01289990|11047596|FG005|STARTED|Overall Study||168
9930468|NCT01289990|11047597|FG006|STARTED|Overall Study||166
9930469|NCT01289990|11047598|FG007|STARTED|Overall Study||217
9930470|NCT01289990|11047599|FG008|STARTED|Overall Study||214
9930471|NCT01289990|11047600|FG009|STARTED|Overall Study||207
9930472|NCT01289990|11047601|FG010|STARTED|Overall Study||226
9930473|NCT01289990|11047602|FG011|STARTED|Overall Study||218
9930474|NCT01289990|11047603|FG012|STARTED|Overall Study||225
9930475|NCT01289990|11047591|FG000|COMPLETED|Overall Study||147
9930476|NCT01289990|11047592|FG001|COMPLETED|Overall Study||143
9930477|NCT01289990|11047593|FG002|COMPLETED|Overall Study||119
9930478|NCT01289990|11047594|FG003|COMPLETED|Overall Study||136
9930479|NCT01289990|11047595|FG004|COMPLETED|Overall Study||93
9930480|NCT01289990|11047596|FG005|COMPLETED|Overall Study||94
9930481|NCT01289990|11047597|FG006|COMPLETED|Overall Study||78
9930482|NCT01289990|11047598|FG007|COMPLETED|Overall Study||162
9930483|NCT01289990|11047599|FG008|COMPLETED|Overall Study||139
9930484|NCT01289990|11047600|FG009|COMPLETED|Overall Study||121
9930485|NCT01289990|11047601|FG010|COMPLETED|Overall Study||150
9930486|NCT01289990|11047602|FG011|COMPLETED|Overall Study||150
9930487|NCT01289990|11047603|FG012|COMPLETED|Overall Study||127
9930488|NCT01289990|11047591|FG000|NOT COMPLETED|Overall Study||77
9930489|NCT01289990|11047592|FG001|NOT COMPLETED|Overall Study||81
9930490|NCT01289990|11047593|FG002|NOT COMPLETED|Overall Study||109
9930491|NCT01289990|11047594|FG003|NOT COMPLETED|Overall Study||87
9930492|NCT01289990|11047595|FG004|NOT COMPLETED|Overall Study||72
9930493|NCT01289990|11047596|FG005|NOT COMPLETED|Overall Study||74
9930494|NCT01289990|11047597|FG006|NOT COMPLETED|Overall Study||88
9930495|NCT01289990|11047598|FG007|NOT COMPLETED|Overall Study||55
9930496|NCT01289990|11047599|FG008|NOT COMPLETED|Overall Study||75
9930497|NCT01289990|11047600|FG009|NOT COMPLETED|Overall Study||86
9930498|NCT01289990|11047601|FG010|NOT COMPLETED|Overall Study||76
9930499|NCT01289990|11047602|FG011|NOT COMPLETED|Overall Study||68
9930500|NCT01289990|11047603|FG012|NOT COMPLETED|Overall Study||98
9930501|NCT01290029|11047631|FG000|STARTED|Overall Study||14
9930502|NCT01290029|11047631|FG000|Received Study Treatment|Overall Study||12
9930503|NCT01290029|11047631|FG000|COMPLETED|Overall Study||12
9930504|NCT01290029|11047631|FG000|NOT COMPLETED|Overall Study||2
9930505|NCT01290068|11047637|FG000|STARTED|Overall Study||108
9930506|NCT01290068|11047638|FG001|STARTED|Overall Study||100
9930507|NCT01290068|11047637|FG000|Implanted|Overall Study||108
9930508|NCT01290068|11047638|FG001|Implanted|Overall Study||98
9930509|NCT01290068|11047637|FG000|COMPLETED|Overall Study||101
9930510|NCT01290068|11047638|FG001|COMPLETED|Overall Study||94
9930511|NCT01290068|11047637|FG000|NOT COMPLETED|Overall Study||7
9930512|NCT01290068|11047638|FG001|NOT COMPLETED|Overall Study||6
9930513|NCT01290094|11047644|FG000|STARTED|Overall Study||41
9930514|NCT01290094|11047644|FG000|COMPLETED|Overall Study||35
9930515|NCT01290094|11047644|FG000|NOT COMPLETED|Overall Study||6
9930516|NCT01290224|11047648|FG000|STARTED|Overall Study||10
9930517|NCT01290224|11047648|FG000|COMPLETED|Overall Study||5
9930518|NCT01290224|11047648|FG000|NOT COMPLETED|Overall Study||5
9930519|NCT01290237|11047656|FG000|STARTED|Overall Study||30
9930520|NCT01290237|11047657|FG001|STARTED|Overall Study||29
9930521|NCT01290237|11047656|FG000|COMPLETED|Overall Study||19
9930522|NCT01290237|11047657|FG001|COMPLETED|Overall Study||27
9930523|NCT01290237|11047656|FG000|NOT COMPLETED|Overall Study||11
9930524|NCT01290237|11047657|FG001|NOT COMPLETED|Overall Study||2
9930525|NCT01290263|11047667|FG000|STARTED|Overall Study||11
9930526|NCT01290263|11047668|FG001|STARTED|Overall Study||3
9930527|NCT01290263|11047669|FG002|STARTED|Overall Study||7
9930528|NCT01290263|11047670|FG003|STARTED|Overall Study||27
9930529|NCT01290263|11047671|FG004|STARTED|Overall Study||37
9930530|NCT01290263|11047667|FG000|COMPLETED|Overall Study||0
9930531|NCT01290263|11047668|FG001|COMPLETED|Overall Study||0
9930532|NCT01290263|11047669|FG002|COMPLETED|Overall Study||0
9930533|NCT01290263|11047670|FG003|COMPLETED|Overall Study||0
9930534|NCT01290263|11047671|FG004|COMPLETED|Overall Study||0
9930535|NCT01290263|11047667|FG000|NOT COMPLETED|Overall Study||11
9930536|NCT01290263|11047668|FG001|NOT COMPLETED|Overall Study||3
9930537|NCT01290263|11047669|FG002|NOT COMPLETED|Overall Study||7
9930538|NCT01290263|11047670|FG003|NOT COMPLETED|Overall Study||27
9930539|NCT01290263|11047671|FG004|NOT COMPLETED|Overall Study||37
9930540|NCT01290315|11047683|FG000|STARTED|Overall Study||14
9930541|NCT01290315|11047684|FG001|STARTED|Overall Study||12
9930542|NCT01290315|11047685|FG002|STARTED|Overall Study||10
9930543|NCT01290315|11047686|FG003|STARTED|Overall Study||13
9930544|NCT01290315|11047683|FG000|COMPLETED|Overall Study||11
9930545|NCT01290315|11047684|FG001|COMPLETED|Overall Study||9
9930546|NCT01290315|11047685|FG002|COMPLETED|Overall Study||10
9930547|NCT01290315|11047686|FG003|COMPLETED|Overall Study||8
9930548|NCT01290315|11047683|FG000|NOT COMPLETED|Overall Study||3
9930549|NCT01290315|11047684|FG001|NOT COMPLETED|Overall Study||3
9930550|NCT01290315|11047685|FG002|NOT COMPLETED|Overall Study||0
9930551|NCT01290315|11047686|FG003|NOT COMPLETED|Overall Study||5
9956193|NCT01443494|11075323|FG000|COMPLETED|Overall Study||19
9956194|NCT01443494|11075323|FG000|NOT COMPLETED|Overall Study||0
9956195|NCT01443546|11075330|FG000|STARTED|Overall Study||9
9956196|NCT01443546|11075331|FG001|STARTED|Overall Study||9
9956197|NCT01443546|11075332|FG002|STARTED|Overall Study||8
9956198|NCT01443546|11075330|FG000|COMPLETED|Overall Study||9
9956199|NCT01443546|11075331|FG001|COMPLETED|Overall Study||9
9956200|NCT01443546|11075332|FG002|COMPLETED|Overall Study||8
9956201|NCT01443546|11075330|FG000|NOT COMPLETED|Overall Study||0
9956202|NCT01443546|11075331|FG001|NOT COMPLETED|Overall Study||0
9956203|NCT01443546|11075332|FG002|NOT COMPLETED|Overall Study||0
9956204|NCT01443845|11075344|FG000|STARTED|Overall Study||1176
9956205|NCT01443845|11075345|FG001|STARTED|Overall Study||1178
9956206|NCT01443845|11075344|FG000|COMPLETED|Overall Study||922
9956207|NCT01443845|11075345|FG001|COMPLETED|Overall Study||841
9956208|NCT01443845|11075344|FG000|NOT COMPLETED|Overall Study||254
9956209|NCT01443845|11075345|FG001|NOT COMPLETED|Overall Study||337
9956210|NCT01443858|11075354|FG000|STARTED|Overall Study||25
9956211|NCT01443858|11075355|FG001|STARTED|Overall Study||25
9956212|NCT01443858|11075356|FG002|STARTED|Overall Study||25
9956213|NCT01443858|11075354|FG000|COMPLETED|Overall Study||10
10205832|NCT03497585|11332565|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
10205833|NCT03497585|11332565|FG000|COMPLETED|Overall Study||57
9956214|NCT01443858|11075355|FG001|COMPLETED|Overall Study||12
9956215|NCT01443858|11075356|FG002|COMPLETED|Overall Study||18
9956216|NCT01443858|11075354|FG000|NOT COMPLETED|Overall Study||15
9956217|NCT01443858|11075355|FG001|NOT COMPLETED|Overall Study||13
9956218|NCT01443858|11075356|FG002|NOT COMPLETED|Overall Study||7
9956219|NCT01444027|11075367|FG000|STARTED|Overall Study||172
9956220|NCT01444027|11075368|FG001|STARTED|Overall Study||171
9956221|NCT01444027|11075369|FG002|STARTED|Overall Study||171
9956222|NCT01444027|11075367|FG000|Received Intervention as Assigned|Overall Study||168
9956223|NCT01444027|11075368|FG001|Received Intervention as Assigned|Overall Study||161
9956224|NCT01444027|11075369|FG002|Received Intervention as Assigned|Overall Study||147
9956225|NCT01444027|11075367|FG000|1 Month Follow-up|Overall Study||160
9956226|NCT01444027|11075368|FG001|1 Month Follow-up|Overall Study||159
9956227|NCT01444027|11075369|FG002|1 Month Follow-up|Overall Study||141
9956228|NCT01444027|11075367|FG000|3 Month Follow-up|Overall Study||142
9930552|NCT01290341|11047697|FG000|STARTED|Overall Study||573
9930553|NCT01290341|11047698|FG001|STARTED|Overall Study||287
9930554|NCT01290341|11047697|FG000|COMPLETED|Overall Study||481
9930555|NCT01290341|11047698|FG001|COMPLETED|Overall Study||258
9930556|NCT01290341|11047697|FG000|NOT COMPLETED|Overall Study||92
9930557|NCT01290341|11047698|FG001|NOT COMPLETED|Overall Study||29
9930558|NCT01290445|11047707|FG000|STARTED|Overall Study||335
9930559|NCT01290445|11047708|FG001|STARTED|Overall Study||78412
9930560|NCT01290445|11047709|FG002|STARTED|Overall Study||806438
9930561|NCT01290445|11047707|FG000|COMPLETED|Overall Study||335
9930562|NCT01290445|11047708|FG001|COMPLETED|Overall Study||78412
9930563|NCT01290445|11047709|FG002|COMPLETED|Overall Study||806438
10205834|NCT03497585|11332565|FG000|NOT COMPLETED|Overall Study||55
10205835|NCT03497845|11332581|FG000|STARTED|Overall Study||60
10205836|NCT03497845|11332582|FG001|STARTED|Overall Study||58
10205837|NCT03497845|11332583|FG002|STARTED|Overall Study||61
10205838|NCT03497845|11332584|FG003|STARTED|Overall Study||60
10205839|NCT03497845|11332585|FG004|STARTED|Overall Study||59
10205840|NCT03497845|11332586|FG005|STARTED|Overall Study||62
10205841|NCT03497845|11332587|FG006|STARTED|Overall Study||59
10205842|NCT03497845|11332588|FG007|STARTED|Overall Study||60
10205843|NCT03497845|11332589|FG008|STARTED|Overall Study||61
10205844|NCT03497845|11332590|FG009|STARTED|Overall Study||59
10205845|NCT03497845|11332591|FG010|STARTED|Overall Study||61
10205846|NCT03497845|11332592|FG011|STARTED|Overall Study||60
10205847|NCT03497845|11332581|FG000|COMPLETED|Overall Study|Day 142|55
10205848|NCT03497845|11332582|FG001|COMPLETED|Overall Study|Day 142|45
10205849|NCT03497845|11332583|FG002|COMPLETED|Overall Study|Day 142|50
10205850|NCT03497845|11332584|FG003|COMPLETED|Overall Study|Day 142|50
10205851|NCT03497845|11332585|FG004|COMPLETED|Overall Study|Day 262|38
10205852|NCT03497845|11332586|FG005|COMPLETED|Overall Study|Day 262|44
10205853|NCT03497845|11332587|FG006|COMPLETED|Overall Study|Day 142|51
10205854|NCT03497845|11332588|FG007|COMPLETED|Overall Study|Day 142|50
10205855|NCT03497845|11332589|FG008|COMPLETED|Overall Study|Day 142|47
10205856|NCT03497845|11332590|FG009|COMPLETED|Overall Study|Day 142|53
10205857|NCT03497845|11332591|FG010|COMPLETED|Overall Study|Day 262|46
10205858|NCT03497845|11332592|FG011|COMPLETED|Overall Study|Day 262|38
10205859|NCT03497845|11332581|FG000|NOT COMPLETED|Overall Study||5
10205860|NCT03497845|11332582|FG001|NOT COMPLETED|Overall Study||13
10205861|NCT03497845|11332583|FG002|NOT COMPLETED|Overall Study||11
10205862|NCT03497845|11332584|FG003|NOT COMPLETED|Overall Study||10
10205863|NCT03497845|11332585|FG004|NOT COMPLETED|Overall Study||21
10205864|NCT03497845|11332586|FG005|NOT COMPLETED|Overall Study||18
10205865|NCT03497845|11332587|FG006|NOT COMPLETED|Overall Study||8
10205866|NCT03497845|11332588|FG007|NOT COMPLETED|Overall Study||10
10205867|NCT03497845|11332589|FG008|NOT COMPLETED|Overall Study||14
10205868|NCT03497845|11332590|FG009|NOT COMPLETED|Overall Study||6
10205869|NCT03497845|11332591|FG010|NOT COMPLETED|Overall Study||15
10205870|NCT03497845|11332592|FG011|NOT COMPLETED|Overall Study||22
10205871|NCT03498196|11332624|FG000|STARTED|Overall Study||1
10205872|NCT03498196|11332624|FG000|COMPLETED|Overall Study||1
10205873|NCT03498196|11332624|FG000|NOT COMPLETED|Overall Study||0
10205874|NCT03498287|11332630|FG000|STARTED|Overall Study||45
10205875|NCT03498287|11332631|FG001|STARTED|Overall Study||43
10205876|NCT03498287|11332630|FG000|COMPLETED|Overall Study||42
10205877|NCT03498287|11332631|FG001|COMPLETED|Overall Study||38
10205878|NCT03498287|11332630|FG000|NOT COMPLETED|Overall Study||3
10205879|NCT03498287|11332631|FG001|NOT COMPLETED|Overall Study||5
10205880|NCT03498300|11332639|FG000|STARTED|Overall Study||21
10205881|NCT03498300|11332640|FG001|STARTED|Overall Study||21
10205882|NCT03498300|11332639|FG000|COMPLETED|Overall Study||18
10205883|NCT03498300|11332640|FG001|COMPLETED|Overall Study||13
10205884|NCT03498300|11332639|FG000|NOT COMPLETED|Overall Study||3
10205885|NCT03498300|11332640|FG001|NOT COMPLETED|Overall Study||8
10205886|NCT03499028|11332649|FG000|STARTED|Overall Study||226
10205887|NCT03499028|11332650|FG001|STARTED|Overall Study||220
10205888|NCT03499028|11332649|FG000|COMPLETED|Overall Study||204
10205889|NCT03499028|11332650|FG001|COMPLETED|Overall Study||195
10205890|NCT03499028|11332649|FG000|NOT COMPLETED|Overall Study||22
10205891|NCT03499028|11332650|FG001|NOT COMPLETED|Overall Study||25
10205892|NCT03499067|11332658|FG000|STARTED|First Intervention||27
10205893|NCT03499067|11332659|FG001|STARTED|First Intervention||31
10205894|NCT03499067|11332658|FG000|COMPLETED|First Intervention||22
10205895|NCT03499067|11332659|FG001|COMPLETED|First Intervention||24
10205896|NCT03499067|11332658|FG000|NOT COMPLETED|First Intervention||5
10205897|NCT03499067|11332659|FG001|NOT COMPLETED|First Intervention||7
10205898|NCT03499067|11332658|FG000|STARTED|Second Intervention||22
10205899|NCT03499067|11332659|FG001|STARTED|Second Intervention||24
10205900|NCT03499067|11332658|FG000|COMPLETED|Second Intervention||22
10205901|NCT03499067|11332659|FG001|COMPLETED|Second Intervention||24
10205902|NCT03499067|11332658|FG000|NOT COMPLETED|Second Intervention||0
10205903|NCT03499067|11332659|FG001|NOT COMPLETED|Second Intervention||0
10205904|NCT03499353|11332665|FG000|STARTED|Treatment||61
10205905|NCT03499353|11332665|FG000|COMPLETED|Treatment||45
9930564|NCT01290445|11047707|FG000|NOT COMPLETED|Overall Study||0
9930565|NCT01290445|11047708|FG001|NOT COMPLETED|Overall Study||0
9930566|NCT01290445|11047709|FG002|NOT COMPLETED|Overall Study||0
9930567|NCT01290484|11047717|FG000|STARTED|Overall Study||7
9930568|NCT01290484|11047717|FG000|COMPLETED|Overall Study||7
9930569|NCT01290484|11047717|FG000|NOT COMPLETED|Overall Study||0
9930570|NCT01290523|11047721|FG000|STARTED|Overall Study||14
9930571|NCT01290523|11047721|FG000|COMPLETED|Overall Study||11
9930572|NCT01290523|11047721|FG000|NOT COMPLETED|Overall Study||3
9930573|NCT01290536|11047725|FG000|STARTED|Overall Study||42
9930574|NCT01290536|11047725|FG000|COMPLETED|Overall Study||42
9930575|NCT01290536|11047725|FG000|NOT COMPLETED|Overall Study||0
9930576|NCT01290601|11047734|FG000|STARTED|Overall Study||46
9930577|NCT01290601|11047735|FG001|STARTED|Overall Study||24
9930578|NCT01290601|11047736|FG002|STARTED|Overall Study||0
9930579|NCT01290601|11047737|FG003|STARTED|Overall Study||0
9930580|NCT01290601|11047734|FG000|COMPLETED|Overall Study||35
9930581|NCT01290601|11047735|FG001|COMPLETED|Overall Study||19
9930582|NCT01290601|11047736|FG002|COMPLETED|Overall Study||0
9930583|NCT01290601|11047737|FG003|COMPLETED|Overall Study||0
9930584|NCT01290601|11047734|FG000|NOT COMPLETED|Overall Study||11
9930585|NCT01290601|11047735|FG001|NOT COMPLETED|Overall Study||5
10205906|NCT03499353|11332665|FG000|NOT COMPLETED|Treatment||16
10205907|NCT03499353|11332665|FG000|STARTED|Safety Follow-up||49
10205908|NCT03499353|11332665|FG000|Received Treatment|Safety Follow-up||0
10205909|NCT03499353|11332665|FG000|COMPLETED|Safety Follow-up||49
10205910|NCT03499353|11332665|FG000|NOT COMPLETED|Safety Follow-up||0
10205911|NCT03499353|11332665|FG000|STARTED|Long-Term Follow-up||58
10205912|NCT03499353|11332665|FG000|Received Treatment|Long-Term Follow-up||0
10205913|NCT03499353|11332665|FG000|COMPLETED|Long-Term Follow-up||0
9930586|NCT01290601|11047736|FG002|NOT COMPLETED|Overall Study||0
9930587|NCT01290601|11047737|FG003|NOT COMPLETED|Overall Study||0
9930588|NCT01290614|11047745|FG000|STARTED|Overall Study||1070
9930589|NCT01290614|11047746|FG001|STARTED|Overall Study||1129
9930590|NCT01290614|11047745|FG000|COMPLETED|Overall Study||518
9930591|NCT01290614|11047746|FG001|COMPLETED|Overall Study||1129
9930592|NCT01290614|11047745|FG000|NOT COMPLETED|Overall Study||552
9930593|NCT01290614|11047746|FG001|NOT COMPLETED|Overall Study||0
9930594|NCT01290627|11047755|FG000|STARTED|Overall Study||10
9930595|NCT01290627|11047756|FG001|STARTED|Overall Study||10
9930596|NCT01290627|11047757|FG002|STARTED|Overall Study||10
9930597|NCT01290627|11047755|FG000|COMPLETED|Overall Study||10
9930598|NCT01290627|11047756|FG001|COMPLETED|Overall Study||10
9930599|NCT01290627|11047757|FG002|COMPLETED|Overall Study||10
9930600|NCT01290627|11047755|FG000|NOT COMPLETED|Overall Study||0
9930601|NCT01290627|11047756|FG001|NOT COMPLETED|Overall Study||0
9930602|NCT01290627|11047757|FG002|NOT COMPLETED|Overall Study||0
9930603|NCT01290640|11047767|FG000|STARTED|Overall Study||12
9930604|NCT01290640|11047768|FG001|STARTED|Overall Study||10
9930605|NCT01290640|11047767|FG000|COMPLETED|Overall Study||12
9930606|NCT01290640|11047768|FG001|COMPLETED|Overall Study||10
9930607|NCT01290640|11047767|FG000|NOT COMPLETED|Overall Study||0
9930608|NCT01290640|11047768|FG001|NOT COMPLETED|Overall Study||0
9930609|NCT01290666|11047774|FG000|STARTED|Overall Study||93
9930610|NCT01290666|11047774|FG000|COMPLETED|Overall Study||55
9930611|NCT01290666|11047774|FG000|NOT COMPLETED|Overall Study||38
9930612|NCT01290679|11047780|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
9930613|NCT01290679|11047781|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
9930614|NCT01290679|11047780|FG000|COMPLETED|Overall Study||241
9930615|NCT01290679|11047781|FG001|COMPLETED|Overall Study||113
9930616|NCT01290679|11047780|FG000|NOT COMPLETED|Overall Study||16
9930617|NCT01290679|11047781|FG001|NOT COMPLETED|Overall Study||21
9930618|NCT01290731|11047787|FG000|STARTED|Overall Study||49
9930619|NCT01290731|11047787|FG000|COMPLETED|Overall Study||48
9930620|NCT01290731|11047787|FG000|NOT COMPLETED|Overall Study||1
9930621|NCT01290757|11047793|FG000|STARTED|Overall Study||90
9930622|NCT01290757|11047794|FG001|STARTED|Overall Study||90
9930623|NCT01290757|11047793|FG000|COMPLETED|Overall Study||88
9930624|NCT01290757|11047794|FG001|COMPLETED|Overall Study||88
9930625|NCT01290757|11047793|FG000|NOT COMPLETED|Overall Study||2
9930626|NCT01290757|11047794|FG001|NOT COMPLETED|Overall Study||2
9930627|NCT01290796|11047800|FG000|STARTED|Overall Study||153
9930628|NCT01290796|11047800|FG000|COMPLETED|Overall Study||123
9930629|NCT01290796|11047800|FG000|NOT COMPLETED|Overall Study||30
9930630|NCT01290874|11047806|FG000|STARTED|Overall Study||532
10205914|NCT03499353|11332665|FG000|NOT COMPLETED|Long-Term Follow-up||58
10205915|NCT03499873|11332672|FG000|STARTED|Overall Study||183
10205916|NCT03499873|11332673|FG001|STARTED|Overall Study||182
10205917|NCT03499873|11332674|FG002|STARTED|Overall Study||83
9930631|NCT01290874|11047807|FG001|STARTED|Overall Study||538
9930632|NCT01290874|11047806|FG000|COMPLETED|Overall Study||122
9930633|NCT01290874|11047807|FG001|COMPLETED|Overall Study||134
9930634|NCT01290874|11047806|FG000|NOT COMPLETED|Overall Study||410
9930635|NCT01290874|11047807|FG001|NOT COMPLETED|Overall Study||404
9930636|NCT01290887|11047816|FG000|STARTED|Overall Study||481
9930637|NCT01290887|11047817|FG001|STARTED|Overall Study||571
9930638|NCT01290887|11047816|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
9930639|NCT01290887|11047817|FG001|Safety Analysis Set|Overall Study||571
9930640|NCT01290887|11047816|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
9930641|NCT01290887|11047817|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
9930642|NCT01290887|11047816|FG000|NOT COMPLETED|Overall Study||466
9930643|NCT01290887|11047817|FG001|NOT COMPLETED|Overall Study||536
9930644|NCT01290913|11047823|FG000|STARTED|Overall Study||13
9930645|NCT01290913|11047823|FG000|COMPLETED|Overall Study||12
9930646|NCT01290913|11047823|FG000|NOT COMPLETED|Overall Study||1
9930647|NCT01290952|11047829|FG000|STARTED|Overall Study||204
9930648|NCT01290952|11047830|FG001|STARTED|Overall Study||207
9930649|NCT01290952|11047829|FG000|COMPLETED|Overall Study||192
9930650|NCT01290952|11047830|FG001|COMPLETED|Overall Study||193
9930651|NCT01290952|11047829|FG000|NOT COMPLETED|Overall Study||12
9930652|NCT01290952|11047830|FG001|NOT COMPLETED|Overall Study||14
9930653|NCT01290978|11047838|FG000|STARTED|Overall Study||22
9930654|NCT01290978|11047838|FG000|COMPLETED|Overall Study||22
9930655|NCT01290978|11047838|FG000|NOT COMPLETED|Overall Study||0
9930656|NCT01291017|11047843|FG000|STARTED|Overall Study||19
9930657|NCT01291017|11047843|FG000|COMPLETED|Overall Study||14
9930658|NCT01291017|11047843|FG000|NOT COMPLETED|Overall Study||5
9930659|NCT01291056|11047849|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10
9930660|NCT01291056|11047850|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10
9930661|NCT01291056|11047849|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10
9930662|NCT01291056|11047850|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10
9930663|NCT01291056|11047849|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
9930664|NCT01291056|11047850|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
9930665|NCT01291056|11047849|FG000|STARTED|Washout||10
9930666|NCT01291056|11047850|FG001|STARTED|Washout||10
9930667|NCT01291056|11047849|FG000|COMPLETED|Washout||10
9930668|NCT01291056|11047850|FG001|COMPLETED|Washout||10
9930669|NCT01291056|11047849|FG000|NOT COMPLETED|Washout||0
9930670|NCT01291056|11047850|FG001|NOT COMPLETED|Washout||0
9930671|NCT01291056|11047849|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10
9930672|NCT01291056|11047850|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10
9930673|NCT01291056|11047849|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10
9930674|NCT01291056|11047850|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10
9930675|NCT01291056|11047849|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
9930676|NCT01291056|11047850|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
9930677|NCT01291108|11047860|FG000|STARTED|Month 1 (Monotherapy)||65
9930678|NCT01291108|11047861|FG001|STARTED|Month 1 (Monotherapy)||0
9930679|NCT01291108|11047862|FG002|STARTED|Month 1 (Monotherapy)||0
9930680|NCT01291108|11047863|FG003|STARTED|Month 1 (Monotherapy)||60
9930681|NCT01291108|11047864|FG004|STARTED|Month 1 (Monotherapy)||0
9930682|NCT01291108|11047865|FG005|STARTED|Month 1 (Monotherapy)||0
9930683|NCT01291108|11047860|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
9930684|NCT01291108|11047861|FG001|COMPLETED|Month 1 (Monotherapy)||0
9930685|NCT01291108|11047862|FG002|COMPLETED|Month 1 (Monotherapy)||0
9930686|NCT01291108|11047863|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
9930687|NCT01291108|11047864|FG004|COMPLETED|Month 1 (Monotherapy)||0
9930688|NCT01291108|11047865|FG005|COMPLETED|Month 1 (Monotherapy)||0
9930689|NCT01291108|11047860|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1
9930690|NCT01291108|11047861|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0
9930691|NCT01291108|11047862|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0
9930692|NCT01291108|11047863|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0
9930693|NCT01291108|11047864|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0
9930694|NCT01291108|11047865|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0
9930695|NCT01291108|11047860|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
9930696|NCT01291108|11047861|FG001|STARTED|Month 2 (Adjunctive Therapy)||40
9930697|NCT01291108|11047862|FG002|STARTED|Month 2 (Adjunctive Therapy)||24
9930698|NCT01291108|11047863|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
9930699|NCT01291108|11047864|FG004|STARTED|Month 2 (Adjunctive Therapy)||34
9930700|NCT01291108|11047865|FG005|STARTED|Month 2 (Adjunctive Therapy)||26
9930701|NCT01291108|11047860|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0
9930702|NCT01291108|11047861|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38
9930703|NCT01291108|11047862|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24
9930704|NCT01291108|11047863|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0
9930705|NCT01291108|11047864|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34
9930706|NCT01291108|11047865|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25
9930707|NCT01291108|11047860|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
9930708|NCT01291108|11047861|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
9930709|NCT01291108|11047862|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
9930710|NCT01291108|11047863|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
9930711|NCT01291108|11047864|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
9930712|NCT01291108|11047865|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
9930713|NCT01291160|11047878|FG000|STARTED|Overall Study||66
9930714|NCT01291160|11047879|FG001|STARTED|Overall Study||64
9930715|NCT01291160|11047878|FG000|COMPLETED|Overall Study||48
9930716|NCT01291160|11047879|FG001|COMPLETED|Overall Study||48
9930717|NCT01291160|11047878|FG000|NOT COMPLETED|Overall Study||18
9930718|NCT01291160|11047879|FG001|NOT COMPLETED|Overall Study||16
9930719|NCT01291173|11047889|FG000|STARTED|Overall Study||64
9930720|NCT01291173|11047890|FG001|STARTED|Overall Study||66
9930721|NCT01291173|11047891|FG002|STARTED|Overall Study||65
9930722|NCT01291173|11047892|FG003|STARTED|Overall Study||65
9930723|NCT01291173|11047889|FG000|COMPLETED|Overall Study||47
9930724|NCT01291173|11047890|FG001|COMPLETED|Overall Study||51
9930725|NCT01291173|11047891|FG002|COMPLETED|Overall Study||52
9930726|NCT01291173|11047892|FG003|COMPLETED|Overall Study||52
9930727|NCT01291173|11047889|FG000|NOT COMPLETED|Overall Study||17
9930728|NCT01291173|11047890|FG001|NOT COMPLETED|Overall Study||15
9930729|NCT01291173|11047891|FG002|NOT COMPLETED|Overall Study||13
9930730|NCT01291173|11047892|FG003|NOT COMPLETED|Overall Study||13
9930731|NCT01291225|11047904|FG000|STARTED|Overall Study||151
9930732|NCT01291225|11047905|FG001|STARTED|Overall Study||160
9930733|NCT01291225|11047904|FG000|COMPLETED|Overall Study||66
9930734|NCT01291225|11047905|FG001|COMPLETED|Overall Study||121
9930735|NCT01291225|11047904|FG000|NOT COMPLETED|Overall Study||85
9930736|NCT01291225|11047905|FG001|NOT COMPLETED|Overall Study||39
10010930|NCT01777152|11133608|FG000|NOT COMPLETED|Overall Study||95
10010931|NCT01777152|11133609|FG001|NOT COMPLETED|Overall Study||110
10010932|NCT01777191|11133618|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
10010933|NCT01777191|11133619|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
10010934|NCT01777191|11133618|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
10010935|NCT01777191|11133619|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
10010936|NCT01777191|11133618|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
10010937|NCT01777191|11133619|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
9930737|NCT01291264|11047915|FG000|STARTED|Overall Study||260
9930738|NCT01291264|11047915|FG000|COMPLETED|Overall Study||260
9930739|NCT01291264|11047915|FG000|NOT COMPLETED|Overall Study||0
9930740|NCT01291277|11047921|FG000|STARTED|Overall Study||45
9930741|NCT01291277|11047922|FG001|STARTED|Overall Study||45
9930742|NCT01291277|11047921|FG000|COMPLETED|Overall Study||40
9930743|NCT01291277|11047922|FG001|COMPLETED|Overall Study||42
9930744|NCT01291277|11047921|FG000|NOT COMPLETED|Overall Study||5
9930745|NCT01291277|11047922|FG001|NOT COMPLETED|Overall Study||3
9930746|NCT01291498|11047928|FG000|STARTED|Overall Study||1
9930747|NCT01291498|11047928|FG000|COMPLETED|Overall Study||0
9930748|NCT01291498|11047928|FG000|NOT COMPLETED|Overall Study||1
9930749|NCT01291784|11047934|FG000|STARTED|Overall Study||1
9930750|NCT01291784|11047935|FG001|STARTED|Overall Study||1
9930751|NCT01291784|11047936|FG002|STARTED|Overall Study||1
9930752|NCT01291784|11047934|FG000|COMPLETED|Overall Study||1
9930753|NCT01291784|11047935|FG001|COMPLETED|Overall Study||0
9930754|NCT01291784|11047936|FG002|COMPLETED|Overall Study||1
9930755|NCT01291784|11047934|FG000|NOT COMPLETED|Overall Study||0
9930756|NCT01291784|11047935|FG001|NOT COMPLETED|Overall Study||1
9930757|NCT01291784|11047936|FG002|NOT COMPLETED|Overall Study||0
9930758|NCT01291836|11047944|FG000|STARTED|Overall Study||930
9930759|NCT01291836|11047945|FG001|STARTED|Overall Study||71
9930760|NCT01291836|11047944|FG000|COMPLETED|Overall Study||930
9930761|NCT01291836|11047945|FG001|COMPLETED|Overall Study||71
9930762|NCT01291836|11047944|FG000|NOT COMPLETED|Overall Study||0
9930763|NCT01291836|11047945|FG001|NOT COMPLETED|Overall Study||0
9930764|NCT01292005|11047953|FG000|STARTED|Overall Study||14
9930765|NCT01292005|11047954|FG001|STARTED|Overall Study||14
9930766|NCT01292005|11047953|FG000|COMPLETED|Overall Study||14
9930767|NCT01292005|11047954|FG001|COMPLETED|Overall Study||14
9930768|NCT01292005|11047953|FG000|NOT COMPLETED|Overall Study||0
9930769|NCT01292005|11047954|FG001|NOT COMPLETED|Overall Study||0
9930770|NCT01292057|11047962|FG000|STARTED|Overall Study||49
9930771|NCT01292057|11047963|FG001|STARTED|Overall Study||50
9930772|NCT01292057|11047962|FG000|COMPLETED|Overall Study||47
9930773|NCT01292057|11047963|FG001|COMPLETED|Overall Study||48
9930774|NCT01292057|11047962|FG000|NOT COMPLETED|Overall Study||2
9930775|NCT01292057|11047963|FG001|NOT COMPLETED|Overall Study||2
9930776|NCT01292135|11047971|FG000|STARTED|Overall Study||3
9930777|NCT01292135|11047972|FG001|STARTED|Overall Study||30
9930778|NCT01292135|11047971|FG000|COMPLETED|Overall Study||3
9930779|NCT01292135|11047972|FG001|COMPLETED|Overall Study||21
9930780|NCT01292135|11047971|FG000|NOT COMPLETED|Overall Study||0
9930781|NCT01292135|11047972|FG001|NOT COMPLETED|Overall Study||9
9930782|NCT01292187|11047982|FG000|STARTED|Overall Study||86
9930783|NCT01292187|11047983|FG001|STARTED|Overall Study||43
9930784|NCT01292187|11047982|FG000|COMPLETED|Overall Study||69
9930785|NCT01292187|11047983|FG001|COMPLETED|Overall Study||30
9930786|NCT01292187|11047982|FG000|NOT COMPLETED|Overall Study||17
9930787|NCT01292187|11047983|FG001|NOT COMPLETED|Overall Study||13
10019015|NCT01826981|11142057|FG006|NOT COMPLETED|Overall Study||1
9930788|NCT01292226|11047990|FG000|STARTED|Overall Study||45
9930789|NCT01292226|11047990|FG000|COMPLETED|Overall Study||32
9930790|NCT01292226|11047990|FG000|NOT COMPLETED|Overall Study||13
9930791|NCT01292239|11047996|FG000|STARTED|Overall Study||123
9930792|NCT01292239|11047997|FG001|STARTED|Overall Study||60
9930793|NCT01292239|11047996|FG000|COMPLETED|Overall Study||119
9930794|NCT01292239|11047997|FG001|COMPLETED|Overall Study||53
9930795|NCT01292239|11047996|FG000|NOT COMPLETED|Overall Study||4
9930796|NCT01292239|11047997|FG001|NOT COMPLETED|Overall Study||7
9930797|NCT01292252|11048005|FG000|STARTED|Overall Study||21
9930798|NCT01292252|11048006|FG001|STARTED|Overall Study||15
9930799|NCT01292252|11048005|FG000|COMPLETED|Overall Study||21
9930800|NCT01292252|11048006|FG001|COMPLETED|Overall Study||14
9930801|NCT01292252|11048005|FG000|NOT COMPLETED|Overall Study||0
9930802|NCT01292252|11048006|FG001|NOT COMPLETED|Overall Study||1
9930803|NCT01292304|11048012|FG000|STARTED|Overall Study||10
9930804|NCT01292304|11048012|FG000|COMPLETED|Overall Study||10
9930805|NCT01292304|11048012|FG000|NOT COMPLETED|Overall Study||0
9930806|NCT01292447|11048018|FG000|STARTED|Overall Study||75
9930807|NCT01292447|11048019|FG001|STARTED|Overall Study||75
9930808|NCT01292447|11048018|FG000|COMPLETED|Overall Study||73
9930809|NCT01292447|11048019|FG001|COMPLETED|Overall Study||72
9930810|NCT01292447|11048018|FG000|NOT COMPLETED|Overall Study||2
9930811|NCT01292447|11048019|FG001|NOT COMPLETED|Overall Study||3
9930812|NCT01292473|11048029|FG000|STARTED|Overall Study||79
9930813|NCT01292473|11048030|FG001|STARTED|Overall Study||82
9930814|NCT01292473|11048031|FG002|STARTED|Overall Study||83
9930815|NCT01292473|11048032|FG003|STARTED|Overall Study||79
9930816|NCT01292473|11048029|FG000|COMPLETED|Overall Study||74
9930817|NCT01292473|11048030|FG001|COMPLETED|Overall Study||75
9930818|NCT01292473|11048031|FG002|COMPLETED|Overall Study||74
9930819|NCT01292473|11048032|FG003|COMPLETED|Overall Study||67
9930820|NCT01292473|11048029|FG000|NOT COMPLETED|Overall Study||5
9930821|NCT01292473|11048030|FG001|NOT COMPLETED|Overall Study||7
9930822|NCT01292473|11048031|FG002|NOT COMPLETED|Overall Study||9
9930823|NCT01292473|11048032|FG003|NOT COMPLETED|Overall Study||12
9930824|NCT01292486|11048046|FG000|STARTED|Overall Study||32
9930825|NCT01292486|11048046|FG000|COMPLETED|Overall Study||26
9930826|NCT01292486|11048046|FG000|NOT COMPLETED|Overall Study||6
9930827|NCT01292538|11048053|FG000|STARTED|Overall Study||35
9930828|NCT01292538|11048054|FG001|STARTED|Overall Study||32
9930829|NCT01292538|11048053|FG000|COMPLETED|Overall Study||35
9930830|NCT01292538|11048054|FG001|COMPLETED|Overall Study||32
9930831|NCT01292538|11048053|FG000|NOT COMPLETED|Overall Study||0
9930832|NCT01292538|11048054|FG001|NOT COMPLETED|Overall Study||0
9930833|NCT01292603|11048065|FG000|STARTED|Part 1: Pilot Dose Selection Period||16
9930834|NCT01292603|11048066|FG001|STARTED|Part 1: Pilot Dose Selection Period||17
9930835|NCT01292603|11048067|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
9930836|NCT01292603|11048068|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
9930837|NCT01292603|11048069|FG004|STARTED|Part 1: Pilot Dose Selection Period||0
9930838|NCT01292603|11048070|FG005|STARTED|Part 1: Pilot Dose Selection Period||0
9930839|NCT01292603|11048065|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16
10205918|NCT03499873|11332672|FG000|Safety Population|Overall Study||175
10205919|NCT03499873|11332673|FG001|Safety Population|Overall Study||174
10205920|NCT03499873|11332674|FG002|Safety Population|Overall Study||80
10205921|NCT03499873|11332672|FG000|Per-Protocol Population|Overall Study||144
10205922|NCT03499873|11332673|FG001|Per-Protocol Population|Overall Study||143
10205923|NCT03499873|11332674|FG002|Per-Protocol Population|Overall Study||58
10205924|NCT03499873|11332672|FG000|Modified-Intent-to-Treat|Overall Study||170
10205925|NCT03499873|11332673|FG001|Modified-Intent-to-Treat|Overall Study||168
10205926|NCT03499873|11332674|FG002|Modified-Intent-to-Treat|Overall Study||77
10205927|NCT03499873|11332672|FG000|COMPLETED|Overall Study||163
10205928|NCT03499873|11332673|FG001|COMPLETED|Overall Study||162
10205929|NCT03499873|11332674|FG002|COMPLETED|Overall Study||56
10205930|NCT03499873|11332672|FG000|NOT COMPLETED|Overall Study||20
10205931|NCT03499873|11332673|FG001|NOT COMPLETED|Overall Study||20
10205932|NCT03499873|11332674|FG002|NOT COMPLETED|Overall Study||27
10205933|NCT03500094|11332682|FG000|STARTED|Overall Study||22
10205934|NCT03500094|11332682|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21
10205935|NCT03500094|11332682|FG000|COMPLETED|Overall Study||19
10205936|NCT03500094|11332682|FG000|NOT COMPLETED|Overall Study||3
10205937|NCT03500198|11332690|FG000|STARTED|Overall Study||110
10205938|NCT03500198|11332691|FG001|STARTED|Overall Study||108
10205939|NCT03500198|11332690|FG000|First Eye|Overall Study||110
10205940|NCT03500198|11332691|FG001|First Eye|Overall Study||108
10205941|NCT03500198|11332690|FG000|Second Eye|Overall Study||109
10205942|NCT03500198|11332691|FG001|Second Eye|Overall Study||108
10205943|NCT03500198|11332690|FG000|COMPLETED|Overall Study||110
10205944|NCT03500198|11332691|FG001|COMPLETED|Overall Study||107
10205945|NCT03500198|11332690|FG000|NOT COMPLETED|Overall Study||0
10205946|NCT03500198|11332691|FG001|NOT COMPLETED|Overall Study||1
10205947|NCT03500211|11332701|FG000|STARTED|Overall Study||25
10205948|NCT03500211|11332702|FG001|STARTED|Overall Study||25
10205949|NCT03500211|11332701|FG000|COMPLETED|Overall Study||24
10205950|NCT03500211|11332702|FG001|COMPLETED|Overall Study||24
10205951|NCT03500211|11332701|FG000|NOT COMPLETED|Overall Study||1
10205952|NCT03500211|11332702|FG001|NOT COMPLETED|Overall Study||1
10205953|NCT03500224|11332708|FG000|STARTED|Overall Study||6
10205954|NCT03500224|11332708|FG000|COMPLETED|Overall Study||4
10205955|NCT03500224|11332708|FG000|NOT COMPLETED|Overall Study||2
10205956|NCT03500289|11332714|FG000|STARTED|Overall Study||12
10205957|NCT03500289|11332715|FG001|STARTED|Overall Study||6
10205958|NCT03500289|11332714|FG000|COMPLETED|Overall Study||12
10205959|NCT03500289|11332715|FG001|COMPLETED|Overall Study||6
10205960|NCT03500289|11332714|FG000|NOT COMPLETED|Overall Study||0
10205961|NCT03500289|11332715|FG001|NOT COMPLETED|Overall Study||0
10205962|NCT03500302|11332721|FG000|STARTED|Overall Study||19
9930840|NCT01292603|11048066|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17
9930841|NCT01292603|11048067|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23
9930842|NCT01292603|11048068|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0
9930843|NCT01292603|11048069|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0
9930844|NCT01292603|11048070|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0
9930845|NCT01292603|11048065|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
9930846|NCT01292603|11048066|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
9930847|NCT01292603|11048067|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
9930848|NCT01292603|11048068|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
9930849|NCT01292603|11048069|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
10205963|NCT03500302|11332721|FG000|COMPLETED|Overall Study||19
10205964|NCT03500302|11332721|FG000|NOT COMPLETED|Overall Study||0
10205965|NCT03500419|11332727|FG000|STARTED|Overall Study||27
9930850|NCT01292603|11048070|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
9930851|NCT01292603|11048065|FG000|STARTED|Part 1: Regular Follow-Up Period||16
9930852|NCT01292603|11048066|FG001|STARTED|Part 1: Regular Follow-Up Period||17
9930853|NCT01292603|11048067|FG002|STARTED|Part 1: Regular Follow-Up Period||23
9930854|NCT01292603|11048068|FG003|STARTED|Part 1: Regular Follow-Up Period||8
9930855|NCT01292603|11048069|FG004|STARTED|Part 1: Regular Follow-Up Period||0
9930856|NCT01292603|11048070|FG005|STARTED|Part 1: Regular Follow-Up Period||0
9930857|NCT01292603|11048065|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
9930858|NCT01292603|11048066|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
9930859|NCT01292603|11048067|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
9930860|NCT01292603|11048068|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7
9930861|NCT01292603|11048069|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0
9930862|NCT01292603|11048070|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0
9930863|NCT01292603|11048065|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
9930864|NCT01292603|11048066|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
9930865|NCT01292603|11048067|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
9930866|NCT01292603|11048068|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
9930867|NCT01292603|11048069|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
9930868|NCT01292603|11048070|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
9930869|NCT01292603|11048065|FG000|STARTED|Part 2: Dose Confirmation Period||0
9930870|NCT01292603|11048066|FG001|STARTED|Part 2: Dose Confirmation Period||0
9930871|NCT01292603|11048067|FG002|STARTED|Part 2: Dose Confirmation Period||0
9930872|NCT01292603|11048068|FG003|STARTED|Part 2: Dose Confirmation Period||0
9930873|NCT01292603|11048069|FG004|STARTED|Part 2: Dose Confirmation Period||88
9930874|NCT01292603|11048070|FG005|STARTED|Part 2: Dose Confirmation Period||88
9930875|NCT01292603|11048065|FG000|COMPLETED|Part 2: Dose Confirmation Period||0
9930876|NCT01292603|11048066|FG001|COMPLETED|Part 2: Dose Confirmation Period||0
9930877|NCT01292603|11048067|FG002|COMPLETED|Part 2: Dose Confirmation Period||0
9930878|NCT01292603|11048068|FG003|COMPLETED|Part 2: Dose Confirmation Period||0
9930879|NCT01292603|11048069|FG004|COMPLETED|Part 2: Dose Confirmation Period||72
9930880|NCT01292603|11048070|FG005|COMPLETED|Part 2: Dose Confirmation Period||73
9930881|NCT01292603|11048065|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0
9930882|NCT01292603|11048066|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0
9930883|NCT01292603|11048067|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0
9930884|NCT01292603|11048068|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0
9930885|NCT01292603|11048069|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16
9930886|NCT01292603|11048070|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15
9930887|NCT01292603|11048065|FG000|STARTED|Part 2: Regular Follow-Up||0
9930888|NCT01292603|11048066|FG001|STARTED|Part 2: Regular Follow-Up||0
9930889|NCT01292603|11048067|FG002|STARTED|Part 2: Regular Follow-Up||0
9930890|NCT01292603|11048068|FG003|STARTED|Part 2: Regular Follow-Up||0
9930891|NCT01292603|11048069|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
9930892|NCT01292603|11048070|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
9930893|NCT01292603|11048065|FG000|COMPLETED|Part 2: Regular Follow-Up||0
9930894|NCT01292603|11048066|FG001|COMPLETED|Part 2: Regular Follow-Up||0
9930895|NCT01292603|11048067|FG002|COMPLETED|Part 2: Regular Follow-Up||0
9930896|NCT01292603|11048068|FG003|COMPLETED|Part 2: Regular Follow-Up||0
9930897|NCT01292603|11048069|FG004|COMPLETED|Part 2: Regular Follow-Up||68
9930898|NCT01292603|11048070|FG005|COMPLETED|Part 2: Regular Follow-Up||75
10205966|NCT03500419|11332728|FG001|STARTED|Overall Study||55
10205967|NCT03500419|11332727|FG000|COMPLETED|Overall Study||25
10205968|NCT03500419|11332728|FG001|COMPLETED|Overall Study||30
10205969|NCT03500419|11332727|FG000|NOT COMPLETED|Overall Study||2
10205970|NCT03500419|11332728|FG001|NOT COMPLETED|Overall Study||25
10205971|NCT03500679|11332736|FG000|STARTED|Overall Study||75
10205972|NCT03500679|11332737|FG001|STARTED|Overall Study||25
10205973|NCT03500679|11332736|FG000|COMPLETED|Overall Study||66
10205974|NCT03500679|11332737|FG001|COMPLETED|Overall Study||22
10205975|NCT03500679|11332736|FG000|NOT COMPLETED|Overall Study||9
10205976|NCT03500679|11332737|FG001|NOT COMPLETED|Overall Study||3
10205977|NCT03501043|11332743|FG000|STARTED|Overall Study||11
10205978|NCT03501043|11332743|FG000|COMPLETED|Overall Study||10
10205979|NCT03501043|11332743|FG000|NOT COMPLETED|Overall Study||1
10205980|NCT03501069|11332767|FG000|STARTED|Period A||2
10205981|NCT03501069|11332768|FG001|STARTED|Period A||4
10205982|NCT03501069|11332769|FG002|STARTED|Period A||2
10205983|NCT03501069|11332770|FG003|STARTED|Period A||5
10205984|NCT03501069|11332771|FG004|STARTED|Period A||1
10205985|NCT03501069|11332772|FG005|STARTED|Period A||6
10205986|NCT03501069|11332773|FG006|STARTED|Period A||6
10205987|NCT03501069|11332774|FG007|STARTED|Period A||3
9930899|NCT01292603|11048065|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0
9930900|NCT01292603|11048066|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0
9930901|NCT01292603|11048067|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0
10205988|NCT03501069|11332775|FG008|STARTED|Period A||3
10205989|NCT03501069|11332767|FG000|COMPLETED|Period A||2
10205990|NCT03501069|11332768|FG001|COMPLETED|Period A||4
10205991|NCT03501069|11332769|FG002|COMPLETED|Period A||2
10205992|NCT03501069|11332770|FG003|COMPLETED|Period A||5
9930902|NCT01292603|11048068|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0
9930903|NCT01292603|11048069|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19
9930904|NCT01292603|11048070|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12
9930905|NCT01292603|11048065|FG000|STARTED|Overall Survival Status||16
9930906|NCT01292603|11048066|FG001|STARTED|Overall Survival Status||17
9930907|NCT01292603|11048067|FG002|STARTED|Overall Survival Status||23
9930908|NCT01292603|11048068|FG003|STARTED|Overall Survival Status||8
9930909|NCT01292603|11048069|FG004|STARTED|Overall Survival Status||88
9930910|NCT01292603|11048070|FG005|STARTED|Overall Survival Status||88
9930911|NCT01292603|11048065|FG000|COMPLETED|Overall Survival Status||13
9930912|NCT01292603|11048066|FG001|COMPLETED|Overall Survival Status||16
9930913|NCT01292603|11048067|FG002|COMPLETED|Overall Survival Status||20
9930914|NCT01292603|11048068|FG003|COMPLETED|Overall Survival Status||7
9930915|NCT01292603|11048069|FG004|COMPLETED|Overall Survival Status||72
9930916|NCT01292603|11048070|FG005|COMPLETED|Overall Survival Status||78
9930917|NCT01292603|11048065|FG000|NOT COMPLETED|Overall Survival Status||3
9930918|NCT01292603|11048066|FG001|NOT COMPLETED|Overall Survival Status||1
9930919|NCT01292603|11048067|FG002|NOT COMPLETED|Overall Survival Status||3
9930920|NCT01292603|11048068|FG003|NOT COMPLETED|Overall Survival Status||1
9930921|NCT01292603|11048069|FG004|NOT COMPLETED|Overall Survival Status||16
9930922|NCT01292603|11048070|FG005|NOT COMPLETED|Overall Survival Status||10
9930923|NCT01292629|11048091|FG000|STARTED|Overall Study||125
9930924|NCT01292629|11048091|FG000|COMPLETED|Overall Study||125
9930925|NCT01292629|11048091|FG000|NOT COMPLETED|Overall Study||0
9930926|NCT01292642|11048096|FG000|STARTED|Overall Study||12
9930927|NCT01292642|11048096|FG000|COMPLETED|Overall Study||7
9930928|NCT01292642|11048096|FG000|NOT COMPLETED|Overall Study||5
9930929|NCT01292746|11048104|FG000|STARTED|Overall Study||14
9930930|NCT01292746|11048104|FG000|COMPLETED|Overall Study||14
9930931|NCT01292746|11048104|FG000|NOT COMPLETED|Overall Study||0
9930932|NCT01292798|11048108|FG000|STARTED|Overall Study||43
9930933|NCT01292798|11048108|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
9930934|NCT01292798|11048108|FG000|COMPLETED|Overall Study||43
9930935|NCT01292798|11048108|FG000|NOT COMPLETED|Overall Study||0
9930936|NCT01292837|11048112|FG000|STARTED|Overall Study||13
9930937|NCT01292837|11048112|FG000|COMPLETED|Overall Study||11
9930938|NCT01292837|11048112|FG000|NOT COMPLETED|Overall Study||2
9930939|NCT01292876|11048116|FG000|STARTED|Overall Study||17
9930940|NCT01292876|11048116|FG000|COMPLETED|Overall Study||13
9930941|NCT01292876|11048116|FG000|NOT COMPLETED|Overall Study||4
9930942|NCT01292928|11048122|FG000|STARTED|Overall Study||299
9930943|NCT01292928|11048122|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266
9930944|NCT01292928|11048122|FG000|COMPLETED|Overall Study||275
9930945|NCT01292928|11048122|FG000|NOT COMPLETED|Overall Study||24
9930946|NCT01293006|11048132|FG000|STARTED|Period 1||11
9930947|NCT01293006|11048133|FG001|STARTED|Period 1||2
9930948|NCT01293006|11048134|FG002|STARTED|Period 1||9
9930949|NCT01293006|11048135|FG003|STARTED|Period 1||3
9930950|NCT01293006|11048132|FG000|COMPLETED|Period 1||11
10205993|NCT03501069|11332771|FG004|COMPLETED|Period A||1
10205994|NCT03501069|11332772|FG005|COMPLETED|Period A||6
10205995|NCT03501069|11332773|FG006|COMPLETED|Period A||6
10205996|NCT03501069|11332774|FG007|COMPLETED|Period A||3
10205997|NCT03501069|11332775|FG008|COMPLETED|Period A||3
10205998|NCT03501069|11332767|FG000|NOT COMPLETED|Period A||0
10205999|NCT03501069|11332768|FG001|NOT COMPLETED|Period A||0
10206000|NCT03501069|11332769|FG002|NOT COMPLETED|Period A||0
10206001|NCT03501069|11332770|FG003|NOT COMPLETED|Period A||0
10206002|NCT03501069|11332771|FG004|NOT COMPLETED|Period A||0
10206003|NCT03501069|11332772|FG005|NOT COMPLETED|Period A||0
10206004|NCT03501069|11332773|FG006|NOT COMPLETED|Period A||0
10206005|NCT03501069|11332774|FG007|NOT COMPLETED|Period A||0
10206006|NCT03501069|11332775|FG008|NOT COMPLETED|Period A||0
10206007|NCT03501069|11332767|FG000|STARTED|Washout Period (at Least 14 Days)||2
10206008|NCT03501069|11332768|FG001|STARTED|Washout Period (at Least 14 Days)||4
9930951|NCT01293006|11048133|FG001|COMPLETED|Period 1||2
9930952|NCT01293006|11048134|FG002|COMPLETED|Period 1||9
9930953|NCT01293006|11048135|FG003|COMPLETED|Period 1||3
9930954|NCT01293006|11048132|FG000|NOT COMPLETED|Period 1||0
10206009|NCT03501069|11332769|FG002|STARTED|Washout Period (at Least 14 Days)||2
10206010|NCT03501069|11332770|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206011|NCT03501069|11332771|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9930955|NCT01293006|11048133|FG001|NOT COMPLETED|Period 1||0
9930956|NCT01293006|11048134|FG002|NOT COMPLETED|Period 1||0
9930957|NCT01293006|11048135|FG003|NOT COMPLETED|Period 1||0
9930958|NCT01293006|11048132|FG000|STARTED|Washout||11
9930959|NCT01293006|11048133|FG001|STARTED|Washout||2
9930960|NCT01293006|11048134|FG002|STARTED|Washout||9
10206012|NCT03501069|11332772|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10238766|NCT00484718|11370188|FG001|COMPLETED|Washout Period (2 Weeks)||1
9930961|NCT01293006|11048135|FG003|STARTED|Washout||3
9930962|NCT01293006|11048132|FG000|COMPLETED|Washout||11
9930963|NCT01293006|11048133|FG001|COMPLETED|Washout||2
9930964|NCT01293006|11048134|FG002|COMPLETED|Washout||9
9930965|NCT01293006|11048135|FG003|COMPLETED|Washout||3
9930966|NCT01293006|11048132|FG000|NOT COMPLETED|Washout||0
9930967|NCT01293006|11048133|FG001|NOT COMPLETED|Washout||0
9930968|NCT01293006|11048134|FG002|NOT COMPLETED|Washout||0
9930969|NCT01293006|11048135|FG003|NOT COMPLETED|Washout||0
9930970|NCT01293006|11048132|FG000|STARTED|Period 2||11
9930971|NCT01293006|11048133|FG001|STARTED|Period 2||2
9930972|NCT01293006|11048134|FG002|STARTED|Period 2||9
9930973|NCT01293006|11048135|FG003|STARTED|Period 2||3
9930974|NCT01293006|11048132|FG000|COMPLETED|Period 2||10
9930975|NCT01293006|11048133|FG001|COMPLETED|Period 2||2
9930976|NCT01293006|11048134|FG002|COMPLETED|Period 2||9
9930977|NCT01293006|11048135|FG003|COMPLETED|Period 2||3
9930978|NCT01293006|11048132|FG000|NOT COMPLETED|Period 2||1
9930979|NCT01293006|11048133|FG001|NOT COMPLETED|Period 2||0
9930980|NCT01293006|11048134|FG002|NOT COMPLETED|Period 2||0
9930981|NCT01293006|11048135|FG003|NOT COMPLETED|Period 2||0
9930982|NCT01293032|11048154|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12
9930983|NCT01293032|11048155|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17
9930984|NCT01293032|11048156|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16
9930985|NCT01293032|11048157|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14
10206013|NCT03501069|11332773|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206014|NCT03501069|11332774|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206015|NCT03501069|11332775|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206016|NCT03501069|11332767|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
10206017|NCT03501069|11332768|FG001|COMPLETED|Washout Period (at Least 14 Days)||4
10206018|NCT03501069|11332769|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
10206019|NCT03501069|11332770|FG003|COMPLETED|Washout Period (at Least 14 Days)||0
10206020|NCT03501069|11332771|FG004|COMPLETED|Washout Period (at Least 14 Days)||0
10206021|NCT03501069|11332772|FG005|COMPLETED|Washout Period (at Least 14 Days)||0
10206022|NCT03501069|11332773|FG006|COMPLETED|Washout Period (at Least 14 Days)||0
10206023|NCT03501069|11332774|FG007|COMPLETED|Washout Period (at Least 14 Days)||0
10206024|NCT03501069|11332775|FG008|COMPLETED|Washout Period (at Least 14 Days)||0
10206025|NCT03501069|11332767|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206026|NCT03501069|11332768|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206027|NCT03501069|11332769|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206028|NCT03501069|11332770|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206029|NCT03501069|11332771|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206030|NCT03501069|11332772|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206031|NCT03501069|11332773|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206032|NCT03501069|11332774|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206033|NCT03501069|11332775|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10206034|NCT03501069|11332767|FG000|STARTED|Period B||2
10206035|NCT03501069|11332768|FG001|STARTED|Period B||4
10206036|NCT03501069|11332769|FG002|STARTED|Period B||2
9930986|NCT01293032|11048154|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
10206037|NCT03501069|11332770|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206038|NCT03501069|11332771|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206039|NCT03501069|11332772|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206040|NCT03501069|11332773|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206041|NCT03501069|11332774|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206042|NCT03501069|11332775|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10206043|NCT03501069|11332767|FG000|COMPLETED|Period B||2
10206044|NCT03501069|11332768|FG001|COMPLETED|Period B||4
10206045|NCT03501069|11332769|FG002|COMPLETED|Period B||2
10206046|NCT03501069|11332770|FG003|COMPLETED|Period B||0
10206047|NCT03501069|11332771|FG004|COMPLETED|Period B||0
10206048|NCT03501069|11332772|FG005|COMPLETED|Period B||0
10206049|NCT03501069|11332773|FG006|COMPLETED|Period B||0
10206050|NCT03501069|11332774|FG007|COMPLETED|Period B||0
10206051|NCT03501069|11332775|FG008|COMPLETED|Period B||0
10206052|NCT03501069|11332767|FG000|NOT COMPLETED|Period B||0
10206053|NCT03501069|11332768|FG001|NOT COMPLETED|Period B||0
10206054|NCT03501069|11332769|FG002|NOT COMPLETED|Period B||0
10206055|NCT03501069|11332770|FG003|NOT COMPLETED|Period B||0
10206056|NCT03501069|11332771|FG004|NOT COMPLETED|Period B||0
10206057|NCT03501069|11332772|FG005|NOT COMPLETED|Period B||0
10206058|NCT03501069|11332773|FG006|NOT COMPLETED|Period B||0
10206059|NCT03501069|11332774|FG007|NOT COMPLETED|Period B||0
10206060|NCT03501069|11332775|FG008|NOT COMPLETED|Period B||0
10206061|NCT03501264|11332805|FG000|STARTED|Overall Study||120
10206062|NCT03501264|11332806|FG001|STARTED|Overall Study||120
10206063|NCT03501264|11332805|FG000|COMPLETED|Overall Study||120
10206064|NCT03501264|11332806|FG001|COMPLETED|Overall Study||120
10206065|NCT03501264|11332805|FG000|NOT COMPLETED|Overall Study||0
10206066|NCT03501264|11332806|FG001|NOT COMPLETED|Overall Study||0
10206067|NCT03501277|11332816|FG000|STARTED|Intervention Period 1 (4 Days)||18
10206068|NCT03501277|11332817|FG001|STARTED|Intervention Period 1 (4 Days)||18
9930987|NCT01293032|11048155|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
9930988|NCT01293032|11048156|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
9930989|NCT01293032|11048157|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
9930990|NCT01293032|11048154|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
9930991|NCT01293032|11048155|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
9930992|NCT01293032|11048156|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
9930993|NCT01293032|11048157|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
9930994|NCT01293032|11048154|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
9930995|NCT01293032|11048155|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
9930996|NCT01293032|11048156|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
9930997|NCT01293032|11048157|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
9930998|NCT01293032|11048154|FG000|STARTED|Treatment||12
9930999|NCT01293032|11048155|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
9931000|NCT01293032|11048156|FG002|STARTED|Treatment||11
9931001|NCT01293032|11048157|FG003|STARTED|Treatment||14
9931002|NCT01293032|11048154|FG000|COMPLETED|Treatment||10
9931003|NCT01293032|11048155|FG001|COMPLETED|Treatment||14
9931004|NCT01293032|11048156|FG002|COMPLETED|Treatment||10
9931005|NCT01293032|11048157|FG003|COMPLETED|Treatment||13
9931006|NCT01293032|11048154|FG000|NOT COMPLETED|Treatment||2
9931007|NCT01293032|11048155|FG001|NOT COMPLETED|Treatment||5
9931008|NCT01293032|11048156|FG002|NOT COMPLETED|Treatment||1
9931009|NCT01293032|11048157|FG003|NOT COMPLETED|Treatment||1
9931010|NCT01293084|11048164|FG000|STARTED|Overall Study||17
9931011|NCT01293084|11048164|FG000|COMPLETED|Overall Study||12
9931012|NCT01293084|11048164|FG000|NOT COMPLETED|Overall Study||5
9931013|NCT01293240|11048170|FG000|STARTED|Overall Study||117
9931014|NCT01293240|11048170|FG000|COMPLETED|Overall Study||115
9931015|NCT01293240|11048170|FG000|NOT COMPLETED|Overall Study||2
9931016|NCT01293396|11048174|FG000|STARTED|First Intervention||6
9931017|NCT01293396|11048175|FG001|STARTED|First Intervention||7
9931018|NCT01293396|11048176|FG002|STARTED|First Intervention||7
9931019|NCT01293396|11048174|FG000|COMPLETED|First Intervention||6
9931020|NCT01293396|11048175|FG001|COMPLETED|First Intervention||7
9931021|NCT01293396|11048176|FG002|COMPLETED|First Intervention||7
9931022|NCT01293396|11048174|FG000|NOT COMPLETED|First Intervention||0
9931023|NCT01293396|11048175|FG001|NOT COMPLETED|First Intervention||0
9931024|NCT01293396|11048176|FG002|NOT COMPLETED|First Intervention||0
9931025|NCT01293396|11048174|FG000|STARTED|Wash Out Period 1 (3 Days)||6
9931026|NCT01293396|11048175|FG001|STARTED|Wash Out Period 1 (3 Days)||7
9931027|NCT01293396|11048176|FG002|STARTED|Wash Out Period 1 (3 Days)||7
9931028|NCT01293396|11048174|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6
9931029|NCT01293396|11048175|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7
9931030|NCT01293396|11048176|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7
9931031|NCT01293396|11048174|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
9931032|NCT01293396|11048175|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
9931033|NCT01293396|11048176|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
9931034|NCT01293396|11048174|FG000|STARTED|Second Intervention||5
9931035|NCT01293396|11048175|FG001|STARTED|Second Intervention||5
9931036|NCT01293396|11048176|FG002|STARTED|Second Intervention||10
9931037|NCT01293396|11048174|FG000|COMPLETED|Second Intervention||5
9931038|NCT01293396|11048175|FG001|COMPLETED|Second Intervention||5
10206069|NCT03501277|11332818|FG002|STARTED|Intervention Period 1 (4 Days)||18
10206070|NCT03501277|11332819|FG003|STARTED|Intervention Period 1 (4 Days)||18
10206071|NCT03501277|11332816|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18
10206072|NCT03501277|11332817|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18
10206073|NCT03501277|11332818|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17
10206074|NCT03501277|11332819|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17
10206075|NCT03501277|11332816|FG000|COMPLETED|Intervention Period 1 (4 Days)||18
10206076|NCT03501277|11332817|FG001|COMPLETED|Intervention Period 1 (4 Days)||18
10206077|NCT03501277|11332818|FG002|COMPLETED|Intervention Period 1 (4 Days)||17
10206078|NCT03501277|11332819|FG003|COMPLETED|Intervention Period 1 (4 Days)||17
10206079|NCT03501277|11332816|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0
10206080|NCT03501277|11332817|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0
10206081|NCT03501277|11332818|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1
10206082|NCT03501277|11332819|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1
10206083|NCT03501277|11332816|FG000|STARTED|Washout Period 1 (7 Days)||18
10206084|NCT03501277|11332817|FG001|STARTED|Washout Period 1 (7 Days)||18
10206085|NCT03501277|11332818|FG002|STARTED|Washout Period 1 (7 Days)||17
10206086|NCT03501277|11332819|FG003|STARTED|Washout Period 1 (7 Days)||17
10206087|NCT03501277|11332816|FG000|COMPLETED|Washout Period 1 (7 Days)||18
10206088|NCT03501277|11332817|FG001|COMPLETED|Washout Period 1 (7 Days)||18
10206089|NCT03501277|11332818|FG002|COMPLETED|Washout Period 1 (7 Days)||17
10206090|NCT03501277|11332819|FG003|COMPLETED|Washout Period 1 (7 Days)||17
10206091|NCT03501277|11332816|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9931039|NCT01293396|11048176|FG002|COMPLETED|Second Intervention||10
9931040|NCT01293396|11048174|FG000|NOT COMPLETED|Second Intervention||0
9931041|NCT01293396|11048175|FG001|NOT COMPLETED|Second Intervention||0
9931042|NCT01293396|11048176|FG002|NOT COMPLETED|Second Intervention||0
9931043|NCT01293396|11048174|FG000|STARTED|Wash Out Period 2 (3 Days)||5
9931044|NCT01293396|11048175|FG001|STARTED|Wash Out Period 2 (3 Days)||5
9931045|NCT01293396|11048176|FG002|STARTED|Wash Out Period 2 (3 Days)||10
9931046|NCT01293396|11048174|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5
9931047|NCT01293396|11048175|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5
9931048|NCT01293396|11048176|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10
9931049|NCT01293396|11048174|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
9931050|NCT01293396|11048175|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
9931051|NCT01293396|11048176|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
9931052|NCT01293396|11048174|FG000|STARTED|Third Intervention||9
9931053|NCT01293396|11048175|FG001|STARTED|Third Intervention||8
9931054|NCT01293396|11048176|FG002|STARTED|Third Intervention||3
9931055|NCT01293396|11048174|FG000|COMPLETED|Third Intervention||9
9931056|NCT01293396|11048175|FG001|COMPLETED|Third Intervention||8
9931057|NCT01293396|11048176|FG002|COMPLETED|Third Intervention||3
9931058|NCT01293396|11048174|FG000|NOT COMPLETED|Third Intervention||0
9931059|NCT01293396|11048175|FG001|NOT COMPLETED|Third Intervention||0
9931060|NCT01293396|11048176|FG002|NOT COMPLETED|Third Intervention||0
9931061|NCT01293539|11048184|FG000|STARTED|Overall Study||10
9931062|NCT01293539|11048184|FG000|COMPLETED|Overall Study||9
9931063|NCT01293539|11048184|FG000|NOT COMPLETED|Overall Study||1
9931064|NCT01293695|11048190|FG000|STARTED|Overall Study||93
9931065|NCT01293695|11048191|FG001|STARTED|Overall Study||94
9931066|NCT01293695|11048190|FG000|COMPLETED|Overall Study||78
9931067|NCT01293695|11048191|FG001|COMPLETED|Overall Study||87
9931068|NCT01293695|11048190|FG000|NOT COMPLETED|Overall Study||15
9931069|NCT01293695|11048191|FG001|NOT COMPLETED|Overall Study||7
9931070|NCT01293825|11048200|FG000|STARTED|Overall Study||30
9931071|NCT01293825|11048200|FG000|COMPLETED|Overall Study||20
9931072|NCT01293825|11048200|FG000|NOT COMPLETED|Overall Study||10
9931073|NCT01293968|11048206|FG000|STARTED|Overall Study||20
10206092|NCT03501277|11332817|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10206093|NCT03501277|11332818|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10206094|NCT03501277|11332819|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10206095|NCT03501277|11332816|FG000|STARTED|Intervention Period 2 (4 Days)||18
10206096|NCT03501277|11332817|FG001|STARTED|Intervention Period 2 (4 Days)||18
10206097|NCT03501277|11332818|FG002|STARTED|Intervention Period 2 (4 Days)||17
10206098|NCT03501277|11332819|FG003|STARTED|Intervention Period 2 (4 Days)||17
10206099|NCT03501277|11332816|FG000|COMPLETED|Intervention Period 2 (4 Days)||18
10206100|NCT03501277|11332817|FG001|COMPLETED|Intervention Period 2 (4 Days)||18
10206101|NCT03501277|11332818|FG002|COMPLETED|Intervention Period 2 (4 Days)||17
10206102|NCT03501277|11332819|FG003|COMPLETED|Intervention Period 2 (4 Days)||16
10206103|NCT03501277|11332816|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0
10206104|NCT03501277|11332817|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0
10206105|NCT03501277|11332818|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0
10206106|NCT03501277|11332819|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1
10206107|NCT03501277|11332816|FG000|STARTED|Washout Period 2 (7 Days)||18
10206108|NCT03501277|11332817|FG001|STARTED|Washout Period 2 (7 Days)||18
10206109|NCT03501277|11332818|FG002|STARTED|Washout Period 2 (7 Days)||17
10206110|NCT03501277|11332819|FG003|STARTED|Washout Period 2 (7 Days)||16
10206111|NCT03501277|11332816|FG000|COMPLETED|Washout Period 2 (7 Days)||18
10206112|NCT03501277|11332817|FG001|COMPLETED|Washout Period 2 (7 Days)||18
10206113|NCT03501277|11332818|FG002|COMPLETED|Washout Period 2 (7 Days)||17
10206114|NCT03501277|11332819|FG003|COMPLETED|Washout Period 2 (7 Days)||16
10206115|NCT03501277|11332816|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10206116|NCT03501277|11332817|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10206117|NCT03501277|11332818|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10206118|NCT03501277|11332819|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10206119|NCT03501277|11332816|FG000|STARTED|Intervention Period 3 (4 Days)||18
10206120|NCT03501277|11332817|FG001|STARTED|Intervention Period 3 (4 Days)||18
10206121|NCT03501277|11332818|FG002|STARTED|Intervention Period 3 (4 Days)||17
10206122|NCT03501277|11332819|FG003|STARTED|Intervention Period 3 (4 Days)||16
10206123|NCT03501277|11332816|FG000|COMPLETED|Intervention Period 3 (4 Days)||18
10206124|NCT03501277|11332817|FG001|COMPLETED|Intervention Period 3 (4 Days)||18
10206125|NCT03501277|11332818|FG002|COMPLETED|Intervention Period 3 (4 Days)||17
10206126|NCT03501277|11332819|FG003|COMPLETED|Intervention Period 3 (4 Days)||15
10206127|NCT03501277|11332816|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0
10206128|NCT03501277|11332817|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0
10206129|NCT03501277|11332818|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0
10206130|NCT03501277|11332819|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1
10206131|NCT03501277|11332816|FG000|STARTED|Washout Period 3 (7 Days)||18
10206132|NCT03501277|11332817|FG001|STARTED|Washout Period 3 (7 Days)||18
10206133|NCT03501277|11332818|FG002|STARTED|Washout Period 3 (7 Days)||17
10206134|NCT03501277|11332819|FG003|STARTED|Washout Period 3 (7 Days)||15
10206135|NCT03501277|11332816|FG000|COMPLETED|Washout Period 3 (7 Days)||18
10206136|NCT03501277|11332817|FG001|COMPLETED|Washout Period 3 (7 Days)||18
10206137|NCT03501277|11332818|FG002|COMPLETED|Washout Period 3 (7 Days)||17
9931074|NCT01293968|11048207|FG001|STARTED|Overall Study||17
9931075|NCT01293968|11048206|FG000|COMPLETED|Overall Study||17
9931076|NCT01293968|11048207|FG001|COMPLETED|Overall Study||14
9931077|NCT01293968|11048206|FG000|NOT COMPLETED|Overall Study||3
9931078|NCT01293968|11048207|FG001|NOT COMPLETED|Overall Study||3
9931079|NCT01294098|11048216|FG000|STARTED|Overall Study||0
9931080|NCT01294098|11048217|FG001|STARTED|Overall Study||1
9931081|NCT01294098|11048218|FG002|STARTED|Overall Study||1
9931082|NCT01294098|11048216|FG000|COMPLETED|Overall Study||0
9931083|NCT01294098|11048217|FG001|COMPLETED|Overall Study||0
9931084|NCT01294098|11048218|FG002|COMPLETED|Overall Study||0
9931085|NCT01294098|11048216|FG000|NOT COMPLETED|Overall Study||0
9931086|NCT01294098|11048217|FG001|NOT COMPLETED|Overall Study||1
10206138|NCT03501277|11332819|FG003|COMPLETED|Washout Period 3 (7 Days)||15
10206139|NCT03501277|11332816|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10206140|NCT03501277|11332817|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10206141|NCT03501277|11332818|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10206142|NCT03501277|11332819|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10206143|NCT03501277|11332816|FG000|STARTED|Intervention Period 4 (4 Days)||18
10206144|NCT03501277|11332817|FG001|STARTED|Intervention Period 4 (4 Days)||18
10206145|NCT03501277|11332818|FG002|STARTED|Intervention Period 4 (4 Days)||17
10206146|NCT03501277|11332819|FG003|STARTED|Intervention Period 4 (4 Days)||15
10206147|NCT03501277|11332816|FG000|COMPLETED|Intervention Period 4 (4 Days)||18
10206148|NCT03501277|11332817|FG001|COMPLETED|Intervention Period 4 (4 Days)||18
10206149|NCT03501277|11332818|FG002|COMPLETED|Intervention Period 4 (4 Days)||17
10206150|NCT03501277|11332819|FG003|COMPLETED|Intervention Period 4 (4 Days)||15
10206151|NCT03501277|11332816|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10206152|NCT03501277|11332817|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10206153|NCT03501277|11332818|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10206154|NCT03501277|11332819|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10206155|NCT03501550|11332829|FG000|STARTED|Overall Study||12
10206156|NCT03501550|11332829|FG000|COMPLETED|Overall Study||12
10206157|NCT03501550|11332829|FG000|NOT COMPLETED|Overall Study||0
10206158|NCT03501693|11332833|FG000|STARTED|First Reading Session||75
10206159|NCT03501693|11332834|FG001|STARTED|First Reading Session||75
10206160|NCT03501693|11332833|FG000|COMPLETED|First Reading Session||75
10206161|NCT03501693|11332834|FG001|COMPLETED|First Reading Session||75
10206162|NCT03501693|11332833|FG000|NOT COMPLETED|First Reading Session||0
10206163|NCT03501693|11332834|FG001|NOT COMPLETED|First Reading Session||0
10206164|NCT03501693|11332833|FG000|STARTED|4 Week Memory Washout Period||75
10206165|NCT03501693|11332834|FG001|STARTED|4 Week Memory Washout Period||75
10206166|NCT03501693|11332833|FG000|COMPLETED|4 Week Memory Washout Period||75
10206167|NCT03501693|11332834|FG001|COMPLETED|4 Week Memory Washout Period||75
10206168|NCT03501693|11332833|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10206169|NCT03501693|11332834|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
10206170|NCT03501693|11332833|FG000|STARTED|Second Reading Session||75
10206171|NCT03501693|11332834|FG001|STARTED|Second Reading Session||75
10206172|NCT03501693|11332833|FG000|COMPLETED|Second Reading Session||75
10206173|NCT03501693|11332834|FG001|COMPLETED|Second Reading Session||75
10206174|NCT03501693|11332833|FG000|NOT COMPLETED|Second Reading Session||0
10206175|NCT03501693|11332834|FG001|NOT COMPLETED|Second Reading Session||0
10206176|NCT03502265|11332840|FG000|STARTED|Overall Study||4
10206177|NCT03502265|11332840|FG000|COMPLETED|Overall Study||4
10206178|NCT03502265|11332840|FG000|NOT COMPLETED|Overall Study||0
10206179|NCT03502616|11332846|FG000|STARTED|Up to Week 16||134
10206180|NCT03502616|11332847|FG001|STARTED|Up to Week 16||136
10206181|NCT03502616|11332846|FG000|Treated|Up to Week 16||133
10206182|NCT03502616|11332847|FG001|Treated|Up to Week 16||136
10206183|NCT03502616|11332846|FG000|COMPLETED|Up to Week 16||132
10206184|NCT03502616|11332847|FG001|COMPLETED|Up to Week 16||133
10206185|NCT03502616|11332846|FG000|NOT COMPLETED|Up to Week 16||2
10206186|NCT03502616|11332847|FG001|NOT COMPLETED|Up to Week 16||3
10206187|NCT03502616|11332846|FG000|STARTED|Week 16 to Week 48||132
10206188|NCT03502616|11332847|FG001|STARTED|Week 16 to Week 48||133
10206189|NCT03502616|11332846|FG000|Treated|Week 16 to Week 48||132
10206190|NCT03502616|11332847|FG001|Treated|Week 16 to Week 48||133
10206191|NCT03502616|11332846|FG000|COMPLETED|Week 16 to Week 48||125
10206192|NCT03502616|11332847|FG001|COMPLETED|Week 16 to Week 48||127
10206193|NCT03502616|11332846|FG000|NOT COMPLETED|Week 16 to Week 48||7
10206194|NCT03502616|11332847|FG001|NOT COMPLETED|Week 16 to Week 48||6
10206195|NCT03502681|11332857|FG000|STARTED|Overall Study||3
10206196|NCT03502681|11332858|FG001|STARTED|Overall Study||3
10206197|NCT03502681|11332857|FG000|COMPLETED|Overall Study||0
10206198|NCT03502681|11332858|FG001|COMPLETED|Overall Study||1
10206199|NCT03502681|11332857|FG000|NOT COMPLETED|Overall Study||3
9931087|NCT01294098|11048218|FG002|NOT COMPLETED|Overall Study||1
9931088|NCT01294150|11048228|FG000|STARTED|Overall Study||140
9931089|NCT01294150|11048229|FG001|STARTED|Overall Study||66
9931090|NCT01294150|11048228|FG000|COMPLETED|Overall Study||138
9931091|NCT01294150|11048229|FG001|COMPLETED|Overall Study||64
9931092|NCT01294150|11048228|FG000|NOT COMPLETED|Overall Study||2
9931093|NCT01294150|11048229|FG001|NOT COMPLETED|Overall Study||2
9931094|NCT01294163|11048240|FG000|STARTED|Overall Study||178
9931095|NCT01294163|11048241|FG001|STARTED|Overall Study||165
9931096|NCT01294163|11048242|FG002|STARTED|Overall Study||166
10206200|NCT03502681|11332858|FG001|NOT COMPLETED|Overall Study||2
10206201|NCT03502798|11332865|FG000|STARTED|Overall Study||5
10206202|NCT03502798|11332866|FG001|STARTED|Overall Study||40
10206203|NCT03502798|11332865|FG000|COMPLETED|Overall Study||5
10206204|NCT03502798|11332866|FG001|COMPLETED|Overall Study||33
10206205|NCT03502798|11332865|FG000|NOT COMPLETED|Overall Study||0
10206206|NCT03502798|11332866|FG001|NOT COMPLETED|Overall Study||7
10206207|NCT03502915|11332874|FG000|STARTED|Overall Study||24
10206208|NCT03502915|11332875|FG001|STARTED|Overall Study||24
10206209|NCT03502915|11332874|FG000|COMPLETED|Overall Study||24
10206210|NCT03502915|11332875|FG001|COMPLETED|Overall Study||24
10206211|NCT03502915|11332874|FG000|NOT COMPLETED|Overall Study||0
10206212|NCT03502915|11332875|FG001|NOT COMPLETED|Overall Study||0
10206213|NCT03502941|11332884|FG000|STARTED|Overall Study||3
9931097|NCT01294163|11048240|FG000|COMPLETED|Overall Study||177
9931098|NCT01294163|11048241|FG001|COMPLETED|Overall Study||165
9931099|NCT01294163|11048242|FG002|COMPLETED|Overall Study||163
9931100|NCT01294163|11048240|FG000|NOT COMPLETED|Overall Study||1
9931101|NCT01294163|11048241|FG001|NOT COMPLETED|Overall Study||0
9931102|NCT01294163|11048242|FG002|NOT COMPLETED|Overall Study||3
9931103|NCT01294228|11048249|FG000|STARTED|Overall Study||1001
9931104|NCT01294228|11048249|FG000|COMPLETED|Overall Study||1001
9931105|NCT01294228|11048249|FG000|NOT COMPLETED|Overall Study||0
9931106|NCT01294241|11048253|FG000|STARTED|Overall Study||10
9931107|NCT01294241|11048253|FG000|COMPLETED|Overall Study||10
9931108|NCT01294241|11048253|FG000|NOT COMPLETED|Overall Study||0
9931109|NCT01294267|11048259|FG000|STARTED|Overall Study||20
9931110|NCT01294267|11048259|FG000|COMPLETED|Overall Study||20
9931111|NCT01294267|11048259|FG000|NOT COMPLETED|Overall Study||0
9931112|NCT01294306|11048265|FG000|STARTED|Overall Study||45
9931113|NCT01294306|11048266|FG001|STARTED|Overall Study||35
9931114|NCT01294306|11048265|FG000|COMPLETED|Overall Study||45
9931115|NCT01294306|11048266|FG001|COMPLETED|Overall Study||35
9931116|NCT01294306|11048265|FG000|NOT COMPLETED|Overall Study||0
9931117|NCT01294306|11048266|FG001|NOT COMPLETED|Overall Study||0
9931118|NCT01294319|11048280|FG000|STARTED|Overall Study||4
9931119|NCT01294319|11048281|FG001|STARTED|Overall Study||6
9931120|NCT01294319|11048282|FG002|STARTED|Overall Study||5
9931121|NCT01294319|11048283|FG003|STARTED|Overall Study||5
9931122|NCT01294319|11048284|FG004|STARTED|Overall Study||5
9931123|NCT01294319|11048285|FG005|STARTED|Overall Study||4
9931124|NCT01294319|11048286|FG006|STARTED|Overall Study||5
9931125|NCT01294319|11048287|FG007|STARTED|Overall Study||5
9931126|NCT01294319|11048280|FG000|COMPLETED|Overall Study||4
9931127|NCT01294319|11048281|FG001|COMPLETED|Overall Study||6
9931128|NCT01294319|11048282|FG002|COMPLETED|Overall Study||5
9931129|NCT01294319|11048283|FG003|COMPLETED|Overall Study||5
9931130|NCT01294319|11048284|FG004|COMPLETED|Overall Study||5
9931131|NCT01294319|11048285|FG005|COMPLETED|Overall Study||4
9931132|NCT01294319|11048286|FG006|COMPLETED|Overall Study||5
9931133|NCT01294319|11048287|FG007|COMPLETED|Overall Study||5
9931134|NCT01294319|11048280|FG000|NOT COMPLETED|Overall Study||0
9931135|NCT01294319|11048281|FG001|NOT COMPLETED|Overall Study||0
9931136|NCT01294319|11048282|FG002|NOT COMPLETED|Overall Study||0
9931137|NCT01294319|11048283|FG003|NOT COMPLETED|Overall Study||0
9931138|NCT01294319|11048284|FG004|NOT COMPLETED|Overall Study||0
9931139|NCT01294319|11048285|FG005|NOT COMPLETED|Overall Study||0
9931140|NCT01294319|11048286|FG006|NOT COMPLETED|Overall Study||0
9931141|NCT01294319|11048287|FG007|NOT COMPLETED|Overall Study||0
9931142|NCT01294358|11048294|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4
9931143|NCT01294358|11048295|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0
9931144|NCT01294358|11048296|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0
9931145|NCT01294358|11048297|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0
9931146|NCT01294358|11048298|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0
9931147|NCT01294358|11048294|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
9931148|NCT01294358|11048295|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931149|NCT01294358|11048296|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931150|NCT01294358|11048297|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931151|NCT01294358|11048298|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931152|NCT01294358|11048294|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931153|NCT01294358|11048295|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931154|NCT01294358|11048296|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931155|NCT01294358|11048297|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931156|NCT01294358|11048298|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9931157|NCT01294358|11048294|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0
9931158|NCT01294358|11048295|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
9931159|NCT01294358|11048296|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0
9931160|NCT01294358|11048297|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0
9931161|NCT01294358|11048298|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0
9931162|NCT01294358|11048294|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931163|NCT01294358|11048295|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
9931164|NCT01294358|11048296|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931165|NCT01294358|11048297|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931166|NCT01294358|11048298|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931167|NCT01294358|11048294|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931168|NCT01294358|11048295|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
9931169|NCT01294358|11048296|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931170|NCT01294358|11048297|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931171|NCT01294358|11048298|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
9931172|NCT01294358|11048294|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0
9931173|NCT01294358|11048295|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0
9931174|NCT01294358|11048296|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
9931175|NCT01294358|11048297|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0
9931176|NCT01294358|11048298|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0
9931177|NCT01294358|11048294|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931178|NCT01294358|11048295|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931179|NCT01294358|11048296|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
9931180|NCT01294358|11048297|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931181|NCT01294358|11048298|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931182|NCT01294358|11048294|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931183|NCT01294358|11048295|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931184|NCT01294358|11048296|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
9931185|NCT01294358|11048297|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931186|NCT01294358|11048298|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
9931187|NCT01294358|11048294|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0
9931188|NCT01294358|11048295|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0
9931189|NCT01294358|11048296|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0
9931190|NCT01294358|11048297|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
9931191|NCT01294358|11048298|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0
9931192|NCT01294358|11048294|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931193|NCT01294358|11048295|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931194|NCT01294358|11048296|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931195|NCT01294358|11048297|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
9931196|NCT01294358|11048298|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931197|NCT01294358|11048294|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931198|NCT01294358|11048295|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931199|NCT01294358|11048296|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931200|NCT01294358|11048297|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
9931201|NCT01294358|11048298|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
9931202|NCT01294358|11048294|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0
9931203|NCT01294358|11048295|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0
9931204|NCT01294358|11048296|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0
9931205|NCT01294358|11048297|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0
9931206|NCT01294358|11048298|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
9931207|NCT01294358|11048294|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931208|NCT01294358|11048295|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931209|NCT01294358|11048296|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931210|NCT01294358|11048297|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931211|NCT01294358|11048298|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931212|NCT01294358|11048294|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931213|NCT01294358|11048295|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931214|NCT01294358|11048296|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931215|NCT01294358|11048297|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
9931216|NCT01294358|11048298|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
9931217|NCT01294371|11048315|FG000|STARTED|Overall Study||391
10206214|NCT03502941|11332885|FG001|STARTED|Overall Study||5
10206215|NCT03502941|11332886|FG002|STARTED|Overall Study||8
10206216|NCT03502941|11332884|FG000|COMPLETED|Overall Study||3
10206217|NCT03502941|11332885|FG001|COMPLETED|Overall Study||5
10206218|NCT03502941|11332886|FG002|COMPLETED|Overall Study||8
10206219|NCT03502941|11332884|FG000|NOT COMPLETED|Overall Study||0
10206220|NCT03502941|11332885|FG001|NOT COMPLETED|Overall Study||0
10206221|NCT03502941|11332886|FG002|NOT COMPLETED|Overall Study||0
10206222|NCT03503162|11332894|FG000|STARTED|Overall Study||95
10206223|NCT03503162|11332894|FG000|COMPLETED|Overall Study||94
10206224|NCT03503162|11332894|FG000|NOT COMPLETED|Overall Study||1
10206225|NCT03503188|11332900|FG000|STARTED|Overall Study||128
10206226|NCT03503188|11332901|FG001|STARTED|Overall Study||146
10206227|NCT03503188|11332900|FG000|Entered in the Entire Study|Overall Study||128
10206228|NCT03503188|11332901|FG001|Entered in the Entire Study|Overall Study||145
10206229|NCT03503188|11332900|FG000|Main Study|Overall Study||99
10206230|NCT03503188|11332901|FG001|Main Study|Overall Study||101
10206231|NCT03503188|11332900|FG000|Sub-study|Overall Study||29
10206232|NCT03503188|11332901|FG001|Sub-study|Overall Study||44
10206233|NCT03503188|11332900|FG000|COMPLETED|Overall Study||128
10206234|NCT03503188|11332901|FG001|COMPLETED|Overall Study||145
10206235|NCT03503188|11332900|FG000|NOT COMPLETED|Overall Study||0
10206236|NCT03503188|11332901|FG001|NOT COMPLETED|Overall Study||1
10206237|NCT03503292|11332909|FG000|STARTED|Overall Study||2
10206238|NCT03503292|11332910|FG001|STARTED|Overall Study||90
10206239|NCT03503292|11332909|FG000|COMPLETED|Overall Study||2
10206240|NCT03503292|11332910|FG001|COMPLETED|Overall Study||90
10206241|NCT03503292|11332909|FG000|NOT COMPLETED|Overall Study||0
10206242|NCT03503292|11332910|FG001|NOT COMPLETED|Overall Study||0
10206243|NCT03503565|11332918|FG000|STARTED|Overall Study||59
10206244|NCT03503565|11332919|FG001|STARTED|Overall Study||58
10206245|NCT03503565|11332918|FG000|COMPLETED|Overall Study||59
10206246|NCT03503565|11332919|FG001|COMPLETED|Overall Study||58
10206247|NCT03503565|11332918|FG000|NOT COMPLETED|Overall Study||0
10206248|NCT03503565|11332919|FG001|NOT COMPLETED|Overall Study||0
10206249|NCT03503578|11332925|FG000|STARTED|Overall Study||12
10206250|NCT03503578|11332925|FG000|COMPLETED|Overall Study||12
9931218|NCT01294371|11048315|FG000|Treated|Overall Study||390
9931219|NCT01294371|11048315|FG000|COMPLETED|Overall Study||357
9931220|NCT01294371|11048315|FG000|NOT COMPLETED|Overall Study||34
9931221|NCT01294384|11048325|FG000|STARTED|Overall Study||101
9931222|NCT01294384|11048326|FG001|STARTED|Overall Study||100
9931223|NCT01294384|11048327|FG002|STARTED|Overall Study||104
9931224|NCT01294384|11048325|FG000|COMPLETED|Overall Study||97
9931225|NCT01294384|11048326|FG001|COMPLETED|Overall Study||94
9931226|NCT01294384|11048327|FG002|COMPLETED|Overall Study||95
9931227|NCT01294384|11048325|FG000|NOT COMPLETED|Overall Study||4
10206251|NCT03503578|11332925|FG000|NOT COMPLETED|Overall Study||0
10206252|NCT03504189|11332929|FG000|STARTED|Overall Study||151
10206253|NCT03504189|11332929|FG000|COMPLETED|Overall Study||147
10206254|NCT03504189|11332929|FG000|NOT COMPLETED|Overall Study||4
10206255|NCT03504839|11332938|FG000|STARTED|Overall Study||53
10206256|NCT03504839|11332938|FG000|COMPLETED|Overall Study||49
10206257|NCT03504839|11332938|FG000|NOT COMPLETED|Overall Study||4
9931228|NCT01294384|11048326|FG001|NOT COMPLETED|Overall Study||6
9931229|NCT01294384|11048327|FG002|NOT COMPLETED|Overall Study||9
9931230|NCT01294397|11048335|FG000|STARTED|Overall Study||19
9931231|NCT01294397|11048335|FG000|COMPLETED|Overall Study||17
9931232|NCT01294397|11048335|FG000|NOT COMPLETED|Overall Study||2
9931233|NCT01294423|11048344|FG000|STARTED|Overall Study||86
9931234|NCT01294423|11048345|FG001|STARTED|Overall Study||88
9931235|NCT01294423|11048346|FG002|STARTED|Overall Study||87
9931236|NCT01294423|11048344|FG000|COMPLETED|Overall Study||81
9931237|NCT01294423|11048345|FG001|COMPLETED|Overall Study||79
9931238|NCT01294423|11048346|FG002|COMPLETED|Overall Study||79
9931239|NCT01294423|11048344|FG000|NOT COMPLETED|Overall Study||5
9931240|NCT01294423|11048345|FG001|NOT COMPLETED|Overall Study||9
9931241|NCT01294423|11048346|FG002|NOT COMPLETED|Overall Study||8
9931242|NCT01294436|11048356|FG000|STARTED|Overall Study||249
9931243|NCT01294436|11048357|FG001|STARTED|Overall Study||479
9931244|NCT01294436|11048356|FG000|COMPLETED|Overall Study||221
9931245|NCT01294436|11048357|FG001|COMPLETED|Overall Study||409
9931246|NCT01294436|11048356|FG000|NOT COMPLETED|Overall Study||28
9931247|NCT01294436|11048357|FG001|NOT COMPLETED|Overall Study||70
9931248|NCT01294449|11048365|FG000|STARTED|Overall Study||156
9931249|NCT01294449|11048366|FG001|STARTED|Overall Study||252
9931250|NCT01294449|11048365|FG000|Consent to Registry|Overall Study||149
9931251|NCT01294449|11048366|FG001|Consent to Registry|Overall Study||245
9931252|NCT01294449|11048365|FG000|COMPLETED|Overall Study||144
9931253|NCT01294449|11048366|FG001|COMPLETED|Overall Study||237
9931254|NCT01294449|11048365|FG000|NOT COMPLETED|Overall Study||12
9931255|NCT01294449|11048366|FG001|NOT COMPLETED|Overall Study||15
9931256|NCT01294462|11048374|FG000|STARTED|Overall Study||401
9931257|NCT01294462|11048375|FG001|STARTED|Overall Study||400
9931258|NCT01294462|11048374|FG000|Received Randomized Treatment|Overall Study||387
9931259|NCT01294462|11048375|FG001|Received Randomized Treatment|Overall Study||380
9931260|NCT01294462|11048374|FG000|COMPLETED|Overall Study||335
9931261|NCT01294462|11048375|FG001|COMPLETED|Overall Study||337
9931262|NCT01294462|11048374|FG000|NOT COMPLETED|Overall Study||66
9931263|NCT01294462|11048375|FG001|NOT COMPLETED|Overall Study||63
9931264|NCT01294514|11048381|FG000|STARTED|Overall Study||27
9931265|NCT01294514|11048381|FG000|COMPLETED|Overall Study||26
9931266|NCT01294514|11048381|FG000|NOT COMPLETED|Overall Study||1
9931267|NCT01294553|11048389|FG000|STARTED|Overall Study||982
9931268|NCT01294553|11048389|FG000|COMPLETED|Overall Study||713
9931269|NCT01294553|11048389|FG000|NOT COMPLETED|Overall Study||269
9931270|NCT01294579|11048394|FG000|STARTED|Overall Study||49
9931271|NCT01294579|11048394|FG000|COMPLETED|Overall Study||14
9931272|NCT01294579|11048394|FG000|NOT COMPLETED|Overall Study||35
9931273|NCT01294592|11048400|FG000|STARTED|Overall Study||369
9931274|NCT01294592|11048401|FG001|STARTED|Overall Study||373
9931275|NCT01294592|11048400|FG000|COMPLETED|Overall Study||292
9931276|NCT01294592|11048401|FG001|COMPLETED|Overall Study||300
9931277|NCT01294592|11048400|FG000|NOT COMPLETED|Overall Study||77
9931278|NCT01294592|11048401|FG001|NOT COMPLETED|Overall Study||73
9931279|NCT01294644|11048413|FG000|STARTED|Overall Study||121
9931280|NCT01294644|11048414|FG001|STARTED|Overall Study||122
9931281|NCT01294644|11048415|FG002|STARTED|Overall Study||117
9931282|NCT01294644|11048413|FG000|Received Treatment|Overall Study||118
9931283|NCT01294644|11048414|FG001|Received Treatment|Overall Study||122
10206258|NCT03504852|11332945|FG000|STARTED|Overall Study||165
10206259|NCT03504852|11332946|FG001|STARTED|Overall Study||135
10206260|NCT03504852|11332947|FG002|STARTED|Overall Study||31
10206261|NCT03504852|11332945|FG000|COMPLETED|Overall Study||148
10206262|NCT03504852|11332946|FG001|COMPLETED|Overall Study||117
10206263|NCT03504852|11332947|FG002|COMPLETED|Overall Study||28
10206264|NCT03504852|11332945|FG000|NOT COMPLETED|Overall Study||17
10206265|NCT03504852|11332946|FG001|NOT COMPLETED|Overall Study||18
10206266|NCT03504852|11332947|FG002|NOT COMPLETED|Overall Study||3
10206267|NCT03504917|11332959|FG000|STARTED|Blinded Treatment Period||163
10206268|NCT03504917|11332960|FG001|STARTED|Blinded Treatment Period||158
10206269|NCT03504917|11332959|FG000|COMPLETED|Blinded Treatment Period||103
10206270|NCT03504917|11332960|FG001|COMPLETED|Blinded Treatment Period||102
10206271|NCT03504917|11332959|FG000|NOT COMPLETED|Blinded Treatment Period||60
10206272|NCT03504917|11332960|FG001|NOT COMPLETED|Blinded Treatment Period||56
10206273|NCT03504917|11332959|FG000|STARTED|Open Label Extension Treatment Period||100
10206274|NCT03504917|11332960|FG001|STARTED|Open Label Extension Treatment Period||97
10206275|NCT03504917|11332959|FG000|COMPLETED|Open Label Extension Treatment Period||0
9931284|NCT01294644|11048415|FG002|Received Treatment|Overall Study||114
9931285|NCT01294644|11048413|FG000|COMPLETED|Overall Study||111
9931286|NCT01294644|11048414|FG001|COMPLETED|Overall Study||112
9931287|NCT01294644|11048415|FG002|COMPLETED|Overall Study||103
9931288|NCT01294644|11048413|FG000|NOT COMPLETED|Overall Study||10
9931289|NCT01294644|11048414|FG001|NOT COMPLETED|Overall Study||10
9931290|NCT01294644|11048415|FG002|NOT COMPLETED|Overall Study||14
9931291|NCT01294683|11048425|FG000|STARTED|Precrossover (Periods I/II)||489
9931292|NCT01294683|11048426|FG001|STARTED|Precrossover (Periods I/II)||488
9931293|NCT01294683|11048425|FG000|Treated|Precrossover (Periods I/II)||486
9931294|NCT01294683|11048426|FG001|Treated|Precrossover (Periods I/II)||486
10206276|NCT03504917|11332960|FG001|COMPLETED|Open Label Extension Treatment Period||0
10206277|NCT03504917|11332959|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100
9931295|NCT01294683|11048425|FG000|COMPLETED|Precrossover (Periods I/II)||232
10206278|NCT03504917|11332960|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97
9931296|NCT01294683|11048426|FG001|COMPLETED|Precrossover (Periods I/II)||222
9931297|NCT01294683|11048425|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257
9931298|NCT01294683|11048426|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266
9931299|NCT01294683|11048425|FG000|STARTED|Post Crossover (Period III)||232
9931300|NCT01294683|11048426|FG001|STARTED|Post Crossover (Period III)||222
9931301|NCT01294683|11048425|FG000|COMPLETED|Post Crossover (Period III)||199
9931302|NCT01294683|11048426|FG001|COMPLETED|Post Crossover (Period III)||190
9931303|NCT01294683|11048425|FG000|NOT COMPLETED|Post Crossover (Period III)||33
9931304|NCT01294683|11048426|FG001|NOT COMPLETED|Post Crossover (Period III)||32
9931305|NCT01294709|11048438|FG000|STARTED|Period 1||31
9931306|NCT01294709|11048439|FG001|STARTED|Period 1||33
10206279|NCT03505190|11332977|FG000|STARTED|Overall Study||9
10206280|NCT03505190|11332978|FG001|STARTED|Overall Study||8
10206281|NCT03505190|11332979|FG002|STARTED|Overall Study||8
10206282|NCT03505190|11332980|FG003|STARTED|Overall Study||8
10206283|NCT03505190|11332981|FG004|STARTED|Overall Study||8
10206284|NCT03505190|11332977|FG000|COMPLETED|Overall Study||9
10206285|NCT03505190|11332978|FG001|COMPLETED|Overall Study||8
10206286|NCT03505190|11332979|FG002|COMPLETED|Overall Study||8
10206287|NCT03505190|11332980|FG003|COMPLETED|Overall Study||8
10206288|NCT03505190|11332981|FG004|COMPLETED|Overall Study||8
10206289|NCT03505190|11332977|FG000|NOT COMPLETED|Overall Study||0
10206290|NCT03505190|11332978|FG001|NOT COMPLETED|Overall Study||0
10206291|NCT03505190|11332979|FG002|NOT COMPLETED|Overall Study||0
10206292|NCT03505190|11332980|FG003|NOT COMPLETED|Overall Study||0
10206293|NCT03505190|11332981|FG004|NOT COMPLETED|Overall Study||0
10206294|NCT03505593|11332993|FG000|STARTED|Overall Study||48
10206295|NCT03505593|11332993|FG000|COMPLETED|Overall Study||43
10206296|NCT03505593|11332993|FG000|NOT COMPLETED|Overall Study||5
10206297|NCT03506295|11332997|FG000|STARTED|Overall Study||10
10206298|NCT03506295|11332997|FG000|COMPLETED|Overall Study||10
10206299|NCT03506295|11332997|FG000|NOT COMPLETED|Overall Study||0
10206300|NCT03506347|11333005|FG000|STARTED|Overall Study||12
10206301|NCT03506347|11333006|FG001|STARTED|Overall Study||12
10206302|NCT03506347|11333005|FG000|COMPLETED|Overall Study||12
10206303|NCT03506347|11333006|FG001|COMPLETED|Overall Study||12
10206304|NCT03506347|11333005|FG000|NOT COMPLETED|Overall Study||0
10206305|NCT03506347|11333006|FG001|NOT COMPLETED|Overall Study||0
10206306|NCT03506386|11333012|FG000|STARTED|Overall Study||943
10206307|NCT03506386|11333012|FG000|COMPLETED|Overall Study||943
10206308|NCT03506386|11333012|FG000|NOT COMPLETED|Overall Study||0
10206309|NCT03506425|11333019|FG000|STARTED|Overall Study||5
10206310|NCT03506425|11333020|FG001|STARTED|Overall Study||5
10206311|NCT03506425|11333021|FG002|STARTED|Overall Study||5
10206312|NCT03506425|11333019|FG000|COMPLETED|Overall Study||3
10206313|NCT03506425|11333020|FG001|COMPLETED|Overall Study||2
10206314|NCT03506425|11333021|FG002|COMPLETED|Overall Study||4
10206315|NCT03506425|11333019|FG000|NOT COMPLETED|Overall Study||2
10206316|NCT03506425|11333020|FG001|NOT COMPLETED|Overall Study||3
10206317|NCT03506425|11333021|FG002|NOT COMPLETED|Overall Study||1
10206318|NCT03506477|11333032|FG000|STARTED|Overall Study||20
10206319|NCT03506477|11333033|FG001|STARTED|Overall Study||5
10206320|NCT03506477|11333032|FG000|COMPLETED|Overall Study||19
10206321|NCT03506477|11333033|FG001|COMPLETED|Overall Study||5
10206322|NCT03506477|11333032|FG000|NOT COMPLETED|Overall Study||1
10206323|NCT03506477|11333033|FG001|NOT COMPLETED|Overall Study||0
10206324|NCT03506724|11333041|FG000|STARTED|Overall Study||54
10206325|NCT03506724|11333042|FG001|STARTED|Overall Study||55
10206326|NCT03506724|11333041|FG000|COMPLETED|Overall Study||54
10206327|NCT03506724|11333042|FG001|COMPLETED|Overall Study||55
10206328|NCT03506724|11333041|FG000|NOT COMPLETED|Overall Study||0
10206329|NCT03506724|11333042|FG001|NOT COMPLETED|Overall Study||0
10206330|NCT03507036|11333048|FG000|STARTED|Overall Study||20
10206331|NCT03507036|11333048|FG000|COMPLETED|Overall Study||15
10206332|NCT03507036|11333048|FG000|NOT COMPLETED|Overall Study||5
10206333|NCT03507569|11333059|FG000|STARTED|Overall Study||2
10206334|NCT03507569|11333060|FG001|STARTED|Overall Study||1
10206335|NCT03507569|11333061|FG002|STARTED|Overall Study||2
10206336|NCT03507569|11333062|FG003|STARTED|Overall Study||1
10206337|NCT03507569|11333059|FG000|COMPLETED|Overall Study||2
9931307|NCT01294709|11048438|FG000|COMPLETED|Period 1||30
10206338|NCT03507569|11333060|FG001|COMPLETED|Overall Study||1
10206339|NCT03507569|11333061|FG002|COMPLETED|Overall Study||2
10206340|NCT03507569|11333062|FG003|COMPLETED|Overall Study||1
10206341|NCT03507569|11333059|FG000|NOT COMPLETED|Overall Study||0
10206342|NCT03507569|11333060|FG001|NOT COMPLETED|Overall Study||0
10206343|NCT03507569|11333061|FG002|NOT COMPLETED|Overall Study||0
10206344|NCT03507569|11333062|FG003|NOT COMPLETED|Overall Study||0
9931308|NCT01294709|11048439|FG001|COMPLETED|Period 1||32
9931309|NCT01294709|11048438|FG000|NOT COMPLETED|Period 1||1
9931310|NCT01294709|11048439|FG001|NOT COMPLETED|Period 1||1
10206345|NCT03508050|11333074|FG000|STARTED|Overall Study||20
10206346|NCT03508050|11333075|FG001|STARTED|Overall Study||17
10206347|NCT03508050|11333074|FG000|COMPLETED|Overall Study||15
10206348|NCT03508050|11333075|FG001|COMPLETED|Overall Study||15
10206349|NCT03508050|11333074|FG000|NOT COMPLETED|Overall Study||5
10206350|NCT03508050|11333075|FG001|NOT COMPLETED|Overall Study||2
10206351|NCT03508609|11333082|FG000|STARTED|Overall Study||20
10206352|NCT03508609|11333082|FG000|COMPLETED|Overall Study||19
10206353|NCT03508609|11333082|FG000|NOT COMPLETED|Overall Study||1
10206354|NCT03508661|11333086|FG000|STARTED|Overall Study||10
10206355|NCT03508661|11333086|FG000|COMPLETED|Overall Study||10
10206356|NCT03508661|11333086|FG000|NOT COMPLETED|Overall Study||0
9931311|NCT01294709|11048438|FG000|STARTED|Washout Period||30
9931312|NCT01294709|11048439|FG001|STARTED|Washout Period||32
10206357|NCT03508687|11333092|FG000|STARTED|Overall Study||2
10206358|NCT03508687|11333093|FG001|STARTED|Overall Study||3
10206359|NCT03508687|11333092|FG000|COMPLETED|Overall Study||2
10206360|NCT03508687|11333093|FG001|COMPLETED|Overall Study||3
10206361|NCT03508687|11333092|FG000|NOT COMPLETED|Overall Study||0
10206362|NCT03508687|11333093|FG001|NOT COMPLETED|Overall Study||0
10206363|NCT03508830|11333103|FG000|STARTED|Overall Study||46
10206364|NCT03508830|11333104|FG001|STARTED|Overall Study||45
10206365|NCT03508830|11333103|FG000|COMPLETED|Overall Study||41
10206366|NCT03508830|11333104|FG001|COMPLETED|Overall Study||39
10206367|NCT03508830|11333103|FG000|NOT COMPLETED|Overall Study||5
10206368|NCT03508830|11333104|FG001|NOT COMPLETED|Overall Study||6
10206369|NCT03508843|11333110|FG000|STARTED|Overall Study||150
10206370|NCT03508843|11333110|FG000|COMPLETED|Overall Study||147
10206371|NCT03508843|11333110|FG000|NOT COMPLETED|Overall Study||3
10206372|NCT03509350|11333116|FG000|STARTED|Overall Study||252
10206373|NCT03509350|11333117|FG001|STARTED|Overall Study||249
10206374|NCT03509350|11333116|FG000|COMPLETED|Overall Study||252
10206375|NCT03509350|11333117|FG001|COMPLETED|Overall Study||247
10206376|NCT03509350|11333116|FG000|NOT COMPLETED|Overall Study||0
10206377|NCT03509350|11333117|FG001|NOT COMPLETED|Overall Study||2
10206378|NCT03509675|11333125|FG000|STARTED|First Intervention (7 Days)||11
10206379|NCT03509675|11333126|FG001|STARTED|First Intervention (7 Days)||12
10206380|NCT03509675|11333125|FG000|COMPLETED|First Intervention (7 Days)||6
10206381|NCT03509675|11333126|FG001|COMPLETED|First Intervention (7 Days)||8
10206382|NCT03509675|11333125|FG000|NOT COMPLETED|First Intervention (7 Days)||5
10206383|NCT03509675|11333126|FG001|NOT COMPLETED|First Intervention (7 Days)||4
10206384|NCT03509675|11333125|FG000|STARTED|Washout Period (7 Days)||6
10206385|NCT03509675|11333126|FG001|STARTED|Washout Period (7 Days)||8
10206386|NCT03509675|11333125|FG000|COMPLETED|Washout Period (7 Days)||6
10206387|NCT03509675|11333126|FG001|COMPLETED|Washout Period (7 Days)||8
10206388|NCT03509675|11333125|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10206389|NCT03509675|11333126|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10206390|NCT03509675|11333125|FG000|STARTED|Second Intervention )7 Days)||6
10206391|NCT03509675|11333126|FG001|STARTED|Second Intervention )7 Days)||8
10206392|NCT03509675|11333125|FG000|COMPLETED|Second Intervention )7 Days)||4
10206393|NCT03509675|11333126|FG001|COMPLETED|Second Intervention )7 Days)||8
10206394|NCT03509675|11333125|FG000|NOT COMPLETED|Second Intervention )7 Days)||2
10206395|NCT03509675|11333126|FG001|NOT COMPLETED|Second Intervention )7 Days)||0
10206396|NCT03509766|11333132|FG000|STARTED|Overall Study||24
10206397|NCT03509766|11333132|FG000|COMPLETED|Overall Study||24
10206398|NCT03509766|11333132|FG000|NOT COMPLETED|Overall Study||0
10206399|NCT03509883|11333139|FG000|STARTED|Initial Treatment||15
10206400|NCT03509883|11333140|FG001|STARTED|Initial Treatment||15
10206401|NCT03509883|11333139|FG000|COMPLETED|Initial Treatment||15
10206402|NCT03509883|11333140|FG001|COMPLETED|Initial Treatment||15
10206403|NCT03509883|11333139|FG000|NOT COMPLETED|Initial Treatment||0
10206404|NCT03509883|11333140|FG001|NOT COMPLETED|Initial Treatment||0
10206405|NCT03509883|11333139|FG000|STARTED|Initial Treatment Washout||15
10206406|NCT03509883|11333140|FG001|STARTED|Initial Treatment Washout||15
10206407|NCT03509883|11333139|FG000|COMPLETED|Initial Treatment Washout||15
10206408|NCT03509883|11333140|FG001|COMPLETED|Initial Treatment Washout||15
10206409|NCT03509883|11333139|FG000|NOT COMPLETED|Initial Treatment Washout||0
10206410|NCT03509883|11333140|FG001|NOT COMPLETED|Initial Treatment Washout||0
10206411|NCT03509883|11333139|FG000|STARTED|Cross-over and Treatment||15
10206412|NCT03509883|11333140|FG001|STARTED|Cross-over and Treatment||15
10206413|NCT03509883|11333139|FG000|COMPLETED|Cross-over and Treatment||15
10206414|NCT03509883|11333140|FG001|COMPLETED|Cross-over and Treatment||15
10206415|NCT03509883|11333139|FG000|NOT COMPLETED|Cross-over and Treatment||0
10206416|NCT03509883|11333140|FG001|NOT COMPLETED|Cross-over and Treatment||0
10206417|NCT03509948|11333147|FG000|STARTED|Overall Study||6
10206418|NCT03509948|11333148|FG001|STARTED|Overall Study||7
10206419|NCT03509948|11333147|FG000|COMPLETED|Overall Study||6
10206420|NCT03509948|11333148|FG001|COMPLETED|Overall Study||6
10206421|NCT03509948|11333147|FG000|NOT COMPLETED|Overall Study||0
10206422|NCT03509948|11333148|FG001|NOT COMPLETED|Overall Study||1
10206423|NCT03509974|11333154|FG000|STARTED|Overall Study||14
10206424|NCT03509974|11333154|FG000|COMPLETED|Overall Study||14
10206425|NCT03509974|11333154|FG000|NOT COMPLETED|Overall Study||0
10206426|NCT03510182|11333158|FG000|STARTED|Overall Study||25
10206427|NCT03510182|11333158|FG000|COMPLETED|Overall Study||23
10206428|NCT03510182|11333158|FG000|NOT COMPLETED|Overall Study||2
10206429|NCT03510195|11333162|FG000|STARTED|Overall Study||267
10206430|NCT03510195|11333162|FG000|COMPLETED|Overall Study||101
10206431|NCT03510195|11333162|FG000|NOT COMPLETED|Overall Study||166
10206432|NCT03510273|11333176|FG000|STARTED|Overall Study||319
10206433|NCT03510273|11333176|FG000|Treated With Thermal Coagulation|Overall Study||319
10206434|NCT03510273|11333176|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
10206435|NCT03510273|11333176|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
10206436|NCT03510273|11333176|FG000|Completed All One-year Follow up Visits|Overall Study||118
10206437|NCT03510273|11333176|FG000|COMPLETED|Overall Study||310
10206438|NCT03510273|11333176|FG000|NOT COMPLETED|Overall Study||9
10206439|NCT03510455|11333184|FG000|STARTED|Overall Study||4
10206440|NCT03510455|11333184|FG000|Treated|Overall Study||4
10206441|NCT03510455|11333184|FG000|Extension Phase|Overall Study||1
10206442|NCT03510455|11333184|FG000|Screening Failures|Overall Study||0
9931313|NCT01294709|11048438|FG000|COMPLETED|Washout Period||29
9931314|NCT01294709|11048439|FG001|COMPLETED|Washout Period||31
9931315|NCT01294709|11048438|FG000|NOT COMPLETED|Washout Period||1
9931316|NCT01294709|11048439|FG001|NOT COMPLETED|Washout Period||1
9931317|NCT01294709|11048438|FG000|STARTED|Period 2||29
9931318|NCT01294709|11048439|FG001|STARTED|Period 2||31
9931319|NCT01294709|11048438|FG000|COMPLETED|Period 2||28
9931320|NCT01294709|11048439|FG001|COMPLETED|Period 2||31
9931321|NCT01294709|11048438|FG000|NOT COMPLETED|Period 2||1
9931322|NCT01294709|11048439|FG001|NOT COMPLETED|Period 2||0
9931323|NCT01294748|11048452|FG000|STARTED|Overall Study||123
9931324|NCT01294748|11048453|FG001|STARTED|Overall Study||61
9931325|NCT01294748|11048452|FG000|COMPLETED|Overall Study|At 270 days|118
9931326|NCT01294748|11048453|FG001|COMPLETED|Overall Study|At 270 days|59
9931327|NCT01294748|11048452|FG000|NOT COMPLETED|Overall Study||5
9931328|NCT01294748|11048453|FG001|NOT COMPLETED|Overall Study||2
9931329|NCT01294787|11048459|FG000|STARTED|Period 1||12
9931330|NCT01294787|11048460|FG001|STARTED|Period 1||16
9931331|NCT01294787|11048461|FG002|STARTED|Period 1||14
9931332|NCT01294787|11048462|FG003|STARTED|Period 1||12
9931333|NCT01294787|11048463|FG004|STARTED|Period 1||16
9931334|NCT01294787|11048464|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15
9931335|NCT01294787|11048459|FG000|COMPLETED|Period 1||12
9931336|NCT01294787|11048460|FG001|COMPLETED|Period 1||16
9931337|NCT01294787|11048461|FG002|COMPLETED|Period 1||13
9931338|NCT01294787|11048462|FG003|COMPLETED|Period 1||11
9931339|NCT01294787|11048463|FG004|COMPLETED|Period 1||14
9931340|NCT01294787|11048464|FG005|COMPLETED|Period 1||13
9931341|NCT01294787|11048459|FG000|NOT COMPLETED|Period 1||0
9931342|NCT01294787|11048460|FG001|NOT COMPLETED|Period 1||0
9931343|NCT01294787|11048461|FG002|NOT COMPLETED|Period 1||1
10206443|NCT03510455|11333184|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
10206444|NCT03510455|11333184|FG000|NOT COMPLETED|Overall Study||1
10206445|NCT03510481|11333194|FG000|STARTED|Year 1||69
10206446|NCT03510481|11333195|FG001|STARTED|Year 1||70
10206447|NCT03510481|11333196|FG002|STARTED|Year 1||36
10206448|NCT03510481|11333197|FG003|STARTED|Year 1||35
10206449|NCT03510481|11333194|FG000|COMPLETED|Year 1||56
10206450|NCT03510481|11333195|FG001|COMPLETED|Year 1||61
10206451|NCT03510481|11333196|FG002|COMPLETED|Year 1||34
10206452|NCT03510481|11333197|FG003|COMPLETED|Year 1||31
10206453|NCT03510481|11333194|FG000|NOT COMPLETED|Year 1||13
10206454|NCT03510481|11333195|FG001|NOT COMPLETED|Year 1||9
10206455|NCT03510481|11333196|FG002|NOT COMPLETED|Year 1||2
10206456|NCT03510481|11333197|FG003|NOT COMPLETED|Year 1||4
10206457|NCT03510481|11333194|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
10206458|NCT03510481|11333195|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
10206459|NCT03510481|11333196|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
10206460|NCT03510481|11333197|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
10206461|NCT03510481|11333194|FG000|COMPLETED|Year 2 - Booster Dose||42
10206462|NCT03510481|11333195|FG001|COMPLETED|Year 2 - Booster Dose||49
10206463|NCT03510481|11333196|FG002|COMPLETED|Year 2 - Booster Dose||23
10206464|NCT03510481|11333197|FG003|COMPLETED|Year 2 - Booster Dose||18
10206465|NCT03510481|11333194|FG000|NOT COMPLETED|Year 2 - Booster Dose||4
10206466|NCT03510481|11333195|FG001|NOT COMPLETED|Year 2 - Booster Dose||3
10206467|NCT03510481|11333196|FG002|NOT COMPLETED|Year 2 - Booster Dose||2
10206468|NCT03510481|11333197|FG003|NOT COMPLETED|Year 2 - Booster Dose||1
10206469|NCT03510663|11333217|FG000|STARTED|Overall Study||6
10206470|NCT03510663|11333218|FG001|STARTED|Overall Study||6
10206471|NCT03510663|11333219|FG002|STARTED|Overall Study||6
10206472|NCT03510663|11333220|FG003|STARTED|Overall Study||6
10206473|NCT03510663|11333221|FG004|STARTED|Overall Study||6
10206474|NCT03510663|11333222|FG005|STARTED|Overall Study||6
10206475|NCT03510663|11333223|FG006|STARTED|Overall Study||6
10206476|NCT03510663|11333224|FG007|STARTED|Overall Study||6
10206477|NCT03510663|11333217|FG000|COMPLETED|Overall Study||6
10206478|NCT03510663|11333218|FG001|COMPLETED|Overall Study||5
10206479|NCT03510663|11333219|FG002|COMPLETED|Overall Study||6
10206480|NCT03510663|11333220|FG003|COMPLETED|Overall Study||6
10206481|NCT03510663|11333221|FG004|COMPLETED|Overall Study||6
10206482|NCT03510663|11333222|FG005|COMPLETED|Overall Study||6
10206483|NCT03510663|11333223|FG006|COMPLETED|Overall Study||6
9931344|NCT01294787|11048462|FG003|NOT COMPLETED|Period 1||1
9931345|NCT01294787|11048463|FG004|NOT COMPLETED|Period 1||2
9931346|NCT01294787|11048464|FG005|NOT COMPLETED|Period 1||2
9931347|NCT01294787|11048459|FG000|STARTED|Period 2||12
9931348|NCT01294787|11048460|FG001|STARTED|Period 2||16
10206484|NCT03510663|11333224|FG007|COMPLETED|Overall Study||6
10206485|NCT03510663|11333217|FG000|NOT COMPLETED|Overall Study||0
10206486|NCT03510663|11333218|FG001|NOT COMPLETED|Overall Study||1
9931349|NCT01294787|11048461|FG002|STARTED|Period 2||13
9931350|NCT01294787|11048462|FG003|STARTED|Period 2||11
9931351|NCT01294787|11048463|FG004|STARTED|Period 2||14
9931352|NCT01294787|11048464|FG005|STARTED|Period 2||13
10206487|NCT03510663|11333219|FG002|NOT COMPLETED|Overall Study||0
10206488|NCT03510663|11333220|FG003|NOT COMPLETED|Overall Study||0
10206489|NCT03510663|11333221|FG004|NOT COMPLETED|Overall Study||0
10206490|NCT03510663|11333222|FG005|NOT COMPLETED|Overall Study||0
10206491|NCT03510663|11333223|FG006|NOT COMPLETED|Overall Study||0
9931353|NCT01294787|11048459|FG000|COMPLETED|Period 2||12
9931354|NCT01294787|11048460|FG001|COMPLETED|Period 2||13
10206492|NCT03510663|11333224|FG007|NOT COMPLETED|Overall Study||0
10206493|NCT03510715|11333236|FG000|STARTED|Overall Study||9
10206494|NCT03510715|11333237|FG001|STARTED|Overall Study||9
10206495|NCT03510715|11333236|FG000|COMPLETED|Overall Study||8
10206496|NCT03510715|11333237|FG001|COMPLETED|Overall Study||9
10206497|NCT03510715|11333236|FG000|NOT COMPLETED|Overall Study||1
10206498|NCT03510715|11333237|FG001|NOT COMPLETED|Overall Study||0
10206499|NCT03510910|11333246|FG000|STARTED|Overall Study||42
10206500|NCT03510910|11333247|FG001|STARTED|Overall Study||43
10206501|NCT03510910|11333246|FG000|COMPLETED|Overall Study||40
10206502|NCT03510910|11333247|FG001|COMPLETED|Overall Study||40
10206503|NCT03510910|11333246|FG000|NOT COMPLETED|Overall Study||2
10206504|NCT03510910|11333247|FG001|NOT COMPLETED|Overall Study||3
10206505|NCT03511001|11333255|FG000|STARTED|Overall Study||126
10206506|NCT03511001|11333256|FG001|STARTED|Overall Study||61
10206507|NCT03511001|11333255|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114
10206508|NCT03511001|11333256|FG001|Completers Analyzed|Overall Study||61
10206509|NCT03511001|11333255|FG000|COMPLETED|Overall Study||115
10206510|NCT03511001|11333256|FG001|COMPLETED|Overall Study||54
10206511|NCT03511001|11333255|FG000|NOT COMPLETED|Overall Study||11
10206512|NCT03511001|11333256|FG001|NOT COMPLETED|Overall Study||7
10206513|NCT03511053|11333262|FG000|STARTED|Overall Study||11
10206514|NCT03511053|11333262|FG000|COMPLETED|Overall Study||10
10206515|NCT03511053|11333262|FG000|NOT COMPLETED|Overall Study||1
10206516|NCT03511105|11333268|FG000|STARTED|Overall Study||25
10206517|NCT03511105|11333269|FG001|STARTED|Overall Study||22
10206518|NCT03511105|11333268|FG000|COMPLETED|Overall Study||23
10206519|NCT03511105|11333269|FG001|COMPLETED|Overall Study||22
10206520|NCT03511105|11333268|FG000|NOT COMPLETED|Overall Study||2
10206521|NCT03511105|11333269|FG001|NOT COMPLETED|Overall Study||0
10206522|NCT03511326|11333276|FG000|STARTED|Overall Study||50
10206523|NCT03511326|11333276|FG000|COMPLETED|Overall Study||49
10206524|NCT03511326|11333276|FG000|NOT COMPLETED|Overall Study||1
10206525|NCT03511378|11333282|FG000|STARTED|Overall Study||70
10206526|NCT03511378|11333283|FG001|STARTED|Overall Study||68
10206527|NCT03511378|11333282|FG000|COMPLETED|Overall Study||67
10206528|NCT03511378|11333283|FG001|COMPLETED|Overall Study||66
10206529|NCT03511378|11333282|FG000|NOT COMPLETED|Overall Study||3
10206530|NCT03511378|11333283|FG001|NOT COMPLETED|Overall Study||2
10206531|NCT03511521|11333291|FG000|STARTED|Overall Study||2
10206532|NCT03511521|11333292|FG001|STARTED|Overall Study||1
10206533|NCT03511521|11333291|FG000|COMPLETED|Overall Study||2
10206534|NCT03511521|11333292|FG001|COMPLETED|Overall Study||1
10206535|NCT03511521|11333291|FG000|NOT COMPLETED|Overall Study||0
10206536|NCT03511521|11333292|FG001|NOT COMPLETED|Overall Study||0
10206537|NCT03511638|11333300|FG000|STARTED|Overall Study||184
10206538|NCT03511638|11333301|FG001|STARTED|Overall Study||188
10206539|NCT03511638|11333300|FG000|COMPLETED|Overall Study||182
10206540|NCT03511638|11333301|FG001|COMPLETED|Overall Study||187
10206541|NCT03511638|11333300|FG000|NOT COMPLETED|Overall Study||2
10206542|NCT03511638|11333301|FG001|NOT COMPLETED|Overall Study||1
10206543|NCT03511937|11333309|FG000|STARTED|Overall Study||200
10206544|NCT03511937|11333310|FG001|STARTED|Overall Study||200
10206545|NCT03511937|11333309|FG000|COMPLETED|Overall Study||200
10206546|NCT03511937|11333310|FG001|COMPLETED|Overall Study||200
10206547|NCT03511937|11333309|FG000|NOT COMPLETED|Overall Study||0
10206548|NCT03511937|11333310|FG001|NOT COMPLETED|Overall Study||0
10206549|NCT03512028|11333320|FG000|STARTED|Overall Study||19
10206550|NCT03512028|11333321|FG001|STARTED|Overall Study||15
10206551|NCT03512028|11333320|FG000|COMPLETED|Overall Study||15
10206552|NCT03512028|11333321|FG001|COMPLETED|Overall Study||15
10206553|NCT03512028|11333320|FG000|NOT COMPLETED|Overall Study||4
10206554|NCT03512028|11333321|FG001|NOT COMPLETED|Overall Study||0
10206555|NCT03512041|11333331|FG000|STARTED|Overall Study||10
10206556|NCT03512041|11333332|FG001|STARTED|Overall Study||10
10206557|NCT03512041|11333333|FG002|STARTED|Overall Study||11
10206558|NCT03512041|11333334|FG003|STARTED|Overall Study||9
10206559|NCT03512041|11333331|FG000|COMPLETED|Overall Study||10
10206560|NCT03512041|11333332|FG001|COMPLETED|Overall Study||10
10206561|NCT03512041|11333333|FG002|COMPLETED|Overall Study||11
10206562|NCT03512041|11333334|FG003|COMPLETED|Overall Study||9
10206563|NCT03512041|11333331|FG000|NOT COMPLETED|Overall Study||0
10206564|NCT03512041|11333332|FG001|NOT COMPLETED|Overall Study||0
10206565|NCT03512041|11333333|FG002|NOT COMPLETED|Overall Study||0
10206566|NCT03512041|11333334|FG003|NOT COMPLETED|Overall Study||0
10206567|NCT03512067|11333344|FG000|STARTED|Overall Study||1
10206568|NCT03512067|11333344|FG000|COMPLETED|Overall Study||1
10206569|NCT03512067|11333344|FG000|NOT COMPLETED|Overall Study||0
10206570|NCT03512288|11333350|FG000|STARTED|Overall Study||232
10206571|NCT03512288|11333351|FG001|STARTED|Overall Study||228
10206572|NCT03512288|11333350|FG000|Vaccination 1|Overall Study||231
10206573|NCT03512288|11333351|FG001|Vaccination 1|Overall Study||227
10206574|NCT03512288|11333350|FG000|Vaccination 2|Overall Study||222
10206575|NCT03512288|11333351|FG001|Vaccination 2|Overall Study||213
10206576|NCT03512288|11333350|FG000|Vaccination 3|Overall Study||210
10206577|NCT03512288|11333351|FG001|Vaccination 3|Overall Study||206
10206578|NCT03512288|11333350|FG000|Vaccination 4|Overall Study||197
10206579|NCT03512288|11333351|FG001|Vaccination 4|Overall Study||194
10206580|NCT03512288|11333350|FG000|COMPLETED|Overall Study||191
10206581|NCT03512288|11333351|FG001|COMPLETED|Overall Study||185
10206582|NCT03512288|11333350|FG000|NOT COMPLETED|Overall Study||41
10206583|NCT03512288|11333351|FG001|NOT COMPLETED|Overall Study||43
9931355|NCT01294787|11048461|FG002|COMPLETED|Period 2||13
9931356|NCT01294787|11048462|FG003|COMPLETED|Period 2||9
9931357|NCT01294787|11048463|FG004|COMPLETED|Period 2||14
9931358|NCT01294787|11048464|FG005|COMPLETED|Period 2||13
9931359|NCT01294787|11048459|FG000|NOT COMPLETED|Period 2||0
9931360|NCT01294787|11048460|FG001|NOT COMPLETED|Period 2||3
9931361|NCT01294787|11048461|FG002|NOT COMPLETED|Period 2||0
9931362|NCT01294787|11048462|FG003|NOT COMPLETED|Period 2||2
9931363|NCT01294787|11048463|FG004|NOT COMPLETED|Period 2||0
9931364|NCT01294787|11048464|FG005|NOT COMPLETED|Period 2||0
9931365|NCT01294787|11048459|FG000|STARTED|Period 3||12
9931366|NCT01294787|11048460|FG001|STARTED|Period 3||13
9931367|NCT01294787|11048461|FG002|STARTED|Period 3||13
9931368|NCT01294787|11048462|FG003|STARTED|Period 3||9
9931369|NCT01294787|11048463|FG004|STARTED|Period 3||14
9931370|NCT01294787|11048464|FG005|STARTED|Period 3||13
9931371|NCT01294787|11048459|FG000|COMPLETED|Period 3||12
9931372|NCT01294787|11048460|FG001|COMPLETED|Period 3||13
9931373|NCT01294787|11048461|FG002|COMPLETED|Period 3||13
9931374|NCT01294787|11048462|FG003|COMPLETED|Period 3||9
9931375|NCT01294787|11048463|FG004|COMPLETED|Period 3||13
9931376|NCT01294787|11048464|FG005|COMPLETED|Period 3||13
9931377|NCT01294787|11048459|FG000|NOT COMPLETED|Period 3||0
9931378|NCT01294787|11048460|FG001|NOT COMPLETED|Period 3||0
9931379|NCT01294787|11048461|FG002|NOT COMPLETED|Period 3||0
9931380|NCT01294787|11048462|FG003|NOT COMPLETED|Period 3||0
9931381|NCT01294787|11048463|FG004|NOT COMPLETED|Period 3||1
9931382|NCT01294787|11048464|FG005|NOT COMPLETED|Period 3||0
9931383|NCT01294800|11048479|FG000|STARTED|Overall Study||111
9931384|NCT01294800|11048480|FG001|STARTED|Overall Study||113
9931385|NCT01294800|11048481|FG002|STARTED|Overall Study||113
9931386|NCT01294800|11048482|FG003|STARTED|Overall Study||113
9931387|NCT01294800|11048479|FG000|COMPLETED|Overall Study||100
9931388|NCT01294800|11048480|FG001|COMPLETED|Overall Study||103
9931389|NCT01294800|11048481|FG002|COMPLETED|Overall Study||96
10206584|NCT03512353|11333357|FG000|STARTED|Overall Study||7
10206585|NCT03512353|11333357|FG000|Received Treatment|Overall Study||6
10206586|NCT03512353|11333357|FG000|COMPLETED|Overall Study||3
10206587|NCT03512353|11333357|FG000|NOT COMPLETED|Overall Study||4
10206588|NCT03512457|11333365|FG000|STARTED|Overall Study||195
10206589|NCT03512457|11333366|FG001|STARTED|Overall Study||225
10206590|NCT03512457|11333365|FG000|COMPLETED|Overall Study||161
10206591|NCT03512457|11333366|FG001|COMPLETED|Overall Study||185
10206592|NCT03512457|11333365|FG000|NOT COMPLETED|Overall Study||34
10206593|NCT03512457|11333366|FG001|NOT COMPLETED|Overall Study||40
10206594|NCT03513588|11333377|FG000|STARTED|Overall Study||16
10206595|NCT03513588|11333378|FG001|STARTED|Overall Study||17
10206596|NCT03513588|11333379|FG002|STARTED|Overall Study||15
10206597|NCT03513588|11333377|FG000|COMPLETED|Overall Study||15
10206598|NCT03513588|11333378|FG001|COMPLETED|Overall Study||15
10206599|NCT03513588|11333379|FG002|COMPLETED|Overall Study||13
10206600|NCT03513588|11333377|FG000|NOT COMPLETED|Overall Study||1
10206601|NCT03513588|11333378|FG001|NOT COMPLETED|Overall Study||2
10206602|NCT03513588|11333379|FG002|NOT COMPLETED|Overall Study||2
10206603|NCT03513757|11333391|FG000|STARTED|Overall Study||22
10206604|NCT03513757|11333392|FG001|STARTED|Overall Study||18
10206605|NCT03513757|11333391|FG000|COMPLETED|Overall Study||22
10206606|NCT03513757|11333392|FG001|COMPLETED|Overall Study||18
10206607|NCT03513757|11333391|FG000|NOT COMPLETED|Overall Study||0
10206608|NCT03513757|11333392|FG001|NOT COMPLETED|Overall Study||0
10206609|NCT03513848|11333403|FG000|STARTED|Overall Study||9
10206610|NCT03513848|11333404|FG001|STARTED|Overall Study||6
10206611|NCT03513848|11333403|FG000|COMPLETED|Overall Study||9
10206612|NCT03513848|11333404|FG001|COMPLETED|Overall Study||6
10206613|NCT03513848|11333403|FG000|NOT COMPLETED|Overall Study||0
10206614|NCT03513848|11333404|FG001|NOT COMPLETED|Overall Study||0
10206615|NCT03514277|11333413|FG000|STARTED|Overall Study||11
10206616|NCT03514277|11333414|FG001|STARTED|Overall Study||4
10206617|NCT03514277|11333415|FG002|STARTED|Overall Study||4
10206618|NCT03514277|11333413|FG000|COMPLETED|Overall Study||11
9931390|NCT01294800|11048482|FG003|COMPLETED|Overall Study||97
10206619|NCT03514277|11333414|FG001|COMPLETED|Overall Study||4
10206620|NCT03514277|11333415|FG002|COMPLETED|Overall Study||4
10206621|NCT03514277|11333413|FG000|NOT COMPLETED|Overall Study||0
10206622|NCT03514277|11333414|FG001|NOT COMPLETED|Overall Study||0
9931391|NCT01294800|11048479|FG000|NOT COMPLETED|Overall Study||11
9931392|NCT01294800|11048480|FG001|NOT COMPLETED|Overall Study||10
9931393|NCT01294800|11048481|FG002|NOT COMPLETED|Overall Study||17
9931394|NCT01294800|11048482|FG003|NOT COMPLETED|Overall Study||16
9931395|NCT01294917|11048492|FG000|STARTED|Overall Study||42
9931396|NCT01294917|11048492|FG000|Received Investigational MPS|Overall Study||36
9931397|NCT01294917|11048492|FG000|Received Clear Care|Overall Study||36
10206623|NCT03514277|11333415|FG002|NOT COMPLETED|Overall Study||0
10206624|NCT03514420|11333423|FG000|STARTED|Overall Study||4
9931398|NCT01294917|11048492|FG000|Received OptiFree RepleniSH MPS|Overall Study||36
9931399|NCT01294917|11048492|FG000|COMPLETED|Overall Study||36
10206625|NCT03514420|11333423|FG000|COMPLETED|Overall Study||4
10206626|NCT03514420|11333423|FG000|NOT COMPLETED|Overall Study||0
10206627|NCT03514641|11333431|FG000|STARTED|603A: 0-12 Week Study Period||334
9931400|NCT01294917|11048492|FG000|NOT COMPLETED|Overall Study||6
9931401|NCT01295034|11048500|FG000|STARTED|Overall Study||32
9931402|NCT01295034|11048501|FG001|STARTED|Overall Study||30
9931403|NCT01295034|11048500|FG000|COMPLETED|Overall Study||27
9931404|NCT01295034|11048501|FG001|COMPLETED|Overall Study||25
9931405|NCT01295034|11048500|FG000|NOT COMPLETED|Overall Study||5
9931406|NCT01295034|11048501|FG001|NOT COMPLETED|Overall Study||5
9931407|NCT01295112|11048510|FG000|STARTED|Overall Study||35
9931408|NCT01295112|11048511|FG001|STARTED|Overall Study||33
9931409|NCT01295112|11048510|FG000|COMPLETED|Overall Study||35
9931410|NCT01295112|11048511|FG001|COMPLETED|Overall Study||33
9931411|NCT01295112|11048510|FG000|NOT COMPLETED|Overall Study||0
9931412|NCT01295112|11048511|FG001|NOT COMPLETED|Overall Study||0
9931413|NCT01295216|11048519|FG000|STARTED|Overall Study||316
10206628|NCT03514641|11333432|FG001|STARTED|603A: 0-12 Week Study Period||339
10206629|NCT03514641|11333433|FG002|STARTED|603A: 0-12 Week Study Period||0
10206630|NCT03514641|11333434|FG003|STARTED|603A: 0-12 Week Study Period||0
10206631|NCT03514641|11333431|FG000|COMPLETED|603A: 0-12 Week Study Period||307
10206632|NCT03514641|11333432|FG001|COMPLETED|603A: 0-12 Week Study Period||319
10206633|NCT03514641|11333433|FG002|COMPLETED|603A: 0-12 Week Study Period||0
10206634|NCT03514641|11333434|FG003|COMPLETED|603A: 0-12 Week Study Period||0
10206635|NCT03514641|11333431|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27
10206636|NCT03514641|11333432|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20
10206637|NCT03514641|11333433|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0
10206638|NCT03514641|11333434|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0
10206639|NCT03514641|11333431|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
10206640|NCT03514641|11333432|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
10206641|NCT03514641|11333433|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
10206642|NCT03514641|11333434|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
10206643|NCT03514641|11333431|FG000|COMPLETED|603B: 24-36 Week Study Period||0
10206644|NCT03514641|11333432|FG001|COMPLETED|603B: 24-36 Week Study Period||0
10206645|NCT03514641|11333433|FG002|COMPLETED|603B: 24-36 Week Study Period||267
10206646|NCT03514641|11333434|FG003|COMPLETED|603B: 24-36 Week Study Period||266
10206647|NCT03514641|11333431|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0
10206648|NCT03514641|11333432|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0
10206649|NCT03514641|11333433|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14
10206650|NCT03514641|11333434|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15
10206651|NCT03514966|11333448|FG000|STARTED|Overall Study||40
10206652|NCT03514966|11333449|FG001|STARTED|Overall Study||43
10206653|NCT03514966|11333448|FG000|COMPLETED|Overall Study||40
10206654|NCT03514966|11333449|FG001|COMPLETED|Overall Study||43
10206655|NCT03514966|11333448|FG000|NOT COMPLETED|Overall Study||0
10206656|NCT03514966|11333449|FG001|NOT COMPLETED|Overall Study||0
10206657|NCT03515681|11333457|FG000|STARTED|Overall Study||70
10206658|NCT03515681|11333458|FG001|STARTED|Overall Study||70
10206659|NCT03515681|11333457|FG000|Randomized|Overall Study||70
10206660|NCT03515681|11333458|FG001|Randomized|Overall Study||70
10206661|NCT03515681|11333457|FG000|Completed at 6 Months|Overall Study||61
10206662|NCT03515681|11333458|FG001|Completed at 6 Months|Overall Study||62
10206663|NCT03515681|11333457|FG000|COMPLETED|Overall Study||37
10206664|NCT03515681|11333458|FG001|COMPLETED|Overall Study||25
10206665|NCT03515681|11333457|FG000|NOT COMPLETED|Overall Study||33
10206666|NCT03515681|11333458|FG001|NOT COMPLETED|Overall Study||45
10206667|NCT03515824|11333467|FG000|STARTED|Overall Study||3
10206668|NCT03515824|11333468|FG001|STARTED|Overall Study||4
10206669|NCT03515824|11333469|FG002|STARTED|Overall Study||15
10206670|NCT03515824|11333470|FG003|STARTED|Overall Study||0
10206671|NCT03515824|11333467|FG000|COMPLETED|Overall Study||0
10206672|NCT03515824|11333468|FG001|COMPLETED|Overall Study||0
10206673|NCT03515824|11333469|FG002|COMPLETED|Overall Study||0
10206674|NCT03515824|11333470|FG003|COMPLETED|Overall Study||0
10206675|NCT03515824|11333467|FG000|NOT COMPLETED|Overall Study||3
10206676|NCT03515824|11333468|FG001|NOT COMPLETED|Overall Study||4
10206677|NCT03515824|11333469|FG002|NOT COMPLETED|Overall Study||15
10206678|NCT03515824|11333470|FG003|NOT COMPLETED|Overall Study||0
10206679|NCT03515941|11333480|FG000|STARTED|Overall Study||4
10206680|NCT03515941|11333481|FG001|STARTED|Overall Study||2
10206681|NCT03515941|11333480|FG000|COMPLETED|Overall Study||3
10206682|NCT03515941|11333481|FG001|COMPLETED|Overall Study||2
10206683|NCT03515941|11333480|FG000|NOT COMPLETED|Overall Study||1
10206684|NCT03515941|11333481|FG001|NOT COMPLETED|Overall Study||0
10206685|NCT03516227|11333489|FG000|STARTED|Overall Study||20
10206686|NCT03516227|11333490|FG001|STARTED|Overall Study||20
10206687|NCT03516227|11333489|FG000|COMPLETED|Overall Study||19
10206688|NCT03516227|11333490|FG001|COMPLETED|Overall Study||16
10206689|NCT03516227|11333489|FG000|NOT COMPLETED|Overall Study||1
9931414|NCT01295216|11048520|FG001|STARTED|Overall Study||321
10206690|NCT03516227|11333490|FG001|NOT COMPLETED|Overall Study||4
10206691|NCT03517436|11333497|FG000|STARTED|Overall Study||101
10206692|NCT03517436|11333497|FG000|COMPLETED|Overall Study||93
10206693|NCT03517436|11333497|FG000|NOT COMPLETED|Overall Study||8
10206694|NCT03517566|11333506|FG000|STARTED|Overall Study||74
10206695|NCT03517566|11333507|FG001|STARTED|Overall Study||37
10206696|NCT03517566|11333508|FG002|STARTED|Overall Study||36
10206697|NCT03517566|11333509|FG003|STARTED|Overall Study||73
10206698|NCT03517566|11333510|FG004|STARTED|Overall Study||73
9931415|NCT01295216|11048519|FG000|COMPLETED|Overall Study||266
9931416|NCT01295216|11048520|FG001|COMPLETED|Overall Study||287
10206699|NCT03517566|11333506|FG000|COMPLETED|Overall Study||42
10206700|NCT03517566|11333507|FG001|COMPLETED|Overall Study||16
10206701|NCT03517566|11333508|FG002|COMPLETED|Overall Study||21
10206702|NCT03517566|11333509|FG003|COMPLETED|Overall Study||39
9931417|NCT01295216|11048519|FG000|NOT COMPLETED|Overall Study||50
9931418|NCT01295216|11048520|FG001|NOT COMPLETED|Overall Study||34
9931419|NCT01295281|11048528|FG000|STARTED|First Intervention (7 Days)||53
9931420|NCT01295281|11048529|FG001|STARTED|First Intervention (7 Days)||52
9931421|NCT01295281|11048528|FG000|COMPLETED|First Intervention (7 Days)||53
9931422|NCT01295281|11048529|FG001|COMPLETED|First Intervention (7 Days)||51
10206703|NCT03517566|11333510|FG004|COMPLETED|Overall Study||41
10206704|NCT03517566|11333506|FG000|NOT COMPLETED|Overall Study||32
10206705|NCT03517566|11333507|FG001|NOT COMPLETED|Overall Study||21
10206706|NCT03517566|11333508|FG002|NOT COMPLETED|Overall Study||15
10206707|NCT03517566|11333509|FG003|NOT COMPLETED|Overall Study||34
10206708|NCT03517566|11333510|FG004|NOT COMPLETED|Overall Study||32
10206709|NCT03518008|11333523|FG000|STARTED|Period 1, First Week of Wear||11
10206710|NCT03518008|11333524|FG001|STARTED|Period 1, First Week of Wear||11
10206711|NCT03518008|11333523|FG000|COMPLETED|Period 1, First Week of Wear||11
10206712|NCT03518008|11333524|FG001|COMPLETED|Period 1, First Week of Wear||11
10206713|NCT03518008|11333523|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10206714|NCT03518008|11333524|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
10206715|NCT03518008|11333523|FG000|STARTED|Period 2, Second Week of Wear||11
10206716|NCT03518008|11333524|FG001|STARTED|Period 2, Second Week of Wear||11
10206717|NCT03518008|11333523|FG000|COMPLETED|Period 2, Second Week of Wear||11
10206718|NCT03518008|11333524|FG001|COMPLETED|Period 2, Second Week of Wear||10
10206719|NCT03518008|11333523|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
10206720|NCT03518008|11333524|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1
10206721|NCT03518125|11333536|FG000|STARTED|Overall Study||50
10206722|NCT03518125|11333537|FG001|STARTED|Overall Study||50
10206723|NCT03518125|11333538|FG002|STARTED|Overall Study||49
10206724|NCT03518125|11333539|FG003|STARTED|Overall Study||52
10206725|NCT03518125|11333540|FG004|STARTED|Overall Study||52
10206726|NCT03518125|11333541|FG005|STARTED|Overall Study||52
10206727|NCT03518125|11333536|FG000|COMPLETED|Overall Study||48
10206728|NCT03518125|11333537|FG001|COMPLETED|Overall Study||46
10206729|NCT03518125|11333538|FG002|COMPLETED|Overall Study||49
10206730|NCT03518125|11333539|FG003|COMPLETED|Overall Study||51
10206731|NCT03518125|11333540|FG004|COMPLETED|Overall Study||48
10206732|NCT03518125|11333541|FG005|COMPLETED|Overall Study||44
10206733|NCT03518125|11333536|FG000|NOT COMPLETED|Overall Study||2
10206734|NCT03518125|11333537|FG001|NOT COMPLETED|Overall Study||4
10206735|NCT03518125|11333538|FG002|NOT COMPLETED|Overall Study||0
10206736|NCT03518125|11333539|FG003|NOT COMPLETED|Overall Study||1
10206737|NCT03518125|11333540|FG004|NOT COMPLETED|Overall Study||4
10206738|NCT03518125|11333541|FG005|NOT COMPLETED|Overall Study||8
10206739|NCT03518658|11333558|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257
10206740|NCT03518658|11333559|FG001|STARTED|Overall Study||128607
10206741|NCT03518658|11333558|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206
10206742|NCT03518658|11333559|FG001|COMPLETED|Overall Study||128607
10206743|NCT03518658|11333558|FG000|NOT COMPLETED|Overall Study||51
10206744|NCT03518658|11333559|FG001|NOT COMPLETED|Overall Study||0
10206745|NCT03518840|11333567|FG000|STARTED|Overall Study||63
10206746|NCT03518840|11333567|FG000|COMPLETED|Overall Study||57
10206747|NCT03518840|11333567|FG000|NOT COMPLETED|Overall Study||6
10206748|NCT03519087|11333576|FG000|STARTED|Clinic Evaluation||55
10206749|NCT03519087|11333577|FG001|STARTED|Clinic Evaluation||57
10206750|NCT03519087|11333578|FG002|STARTED|Clinic Evaluation||0
10206751|NCT03519087|11333579|FG003|STARTED|Clinic Evaluation||0
10206752|NCT03519087|11333580|FG004|STARTED|Clinic Evaluation||0
10206753|NCT03519087|11333576|FG000|Received Assigned Intervention|Clinic Evaluation||54
10206754|NCT03519087|11333577|FG001|Received Assigned Intervention|Clinic Evaluation||57
10206755|NCT03519087|11333578|FG002|Received Assigned Intervention|Clinic Evaluation||0
10206756|NCT03519087|11333579|FG003|Received Assigned Intervention|Clinic Evaluation||0
10206757|NCT03519087|11333580|FG004|Received Assigned Intervention|Clinic Evaluation||0
10206758|NCT03519087|11333576|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39
10206759|NCT03519087|11333577|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39
10206760|NCT03519087|11333578|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0
10206761|NCT03519087|11333579|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0
10206762|NCT03519087|11333580|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0
10206763|NCT03519087|11333576|FG000|COMPLETED|Clinic Evaluation||39
10206764|NCT03519087|11333577|FG001|COMPLETED|Clinic Evaluation||39
10206765|NCT03519087|11333578|FG002|COMPLETED|Clinic Evaluation||0
10206766|NCT03519087|11333579|FG003|COMPLETED|Clinic Evaluation||0
10206767|NCT03519087|11333580|FG004|COMPLETED|Clinic Evaluation||0
10206768|NCT03519087|11333576|FG000|NOT COMPLETED|Clinic Evaluation||16
10206769|NCT03519087|11333577|FG001|NOT COMPLETED|Clinic Evaluation||18
10206770|NCT03519087|11333578|FG002|NOT COMPLETED|Clinic Evaluation||0
10206771|NCT03519087|11333579|FG003|NOT COMPLETED|Clinic Evaluation||0
10206772|NCT03519087|11333580|FG004|NOT COMPLETED|Clinic Evaluation||0
10206773|NCT03519087|11333576|FG000|STARTED|Re-randomization for Treatment||39
9931423|NCT01295281|11048528|FG000|NOT COMPLETED|First Intervention (7 Days)||0
9931424|NCT01295281|11048529|FG001|NOT COMPLETED|First Intervention (7 Days)||1
10206774|NCT03519087|11333577|FG001|STARTED|Re-randomization for Treatment||39
10206775|NCT03519087|11333578|FG002|STARTED|Re-randomization for Treatment||0
10206776|NCT03519087|11333579|FG003|STARTED|Re-randomization for Treatment||0
10206777|NCT03519087|11333580|FG004|STARTED|Re-randomization for Treatment||0
10206778|NCT03519087|11333576|FG000|COMPLETED|Re-randomization for Treatment||12
9931425|NCT01295281|11048528|FG000|STARTED|Second Intervention (7days)||53
9931426|NCT01295281|11048529|FG001|STARTED|Second Intervention (7days)||51
9931427|NCT01295281|11048528|FG000|COMPLETED|Second Intervention (7days)||53
9931428|NCT01295281|11048529|FG001|COMPLETED|Second Intervention (7days)||51
9931429|NCT01295281|11048528|FG000|NOT COMPLETED|Second Intervention (7days)||0
9931430|NCT01295281|11048529|FG001|NOT COMPLETED|Second Intervention (7days)||0
9931431|NCT01295320|11048535|FG000|STARTED|Overall Study||129
9931432|NCT01295320|11048535|FG000|COMPLETED|Overall Study||119
9931433|NCT01295320|11048535|FG000|NOT COMPLETED|Overall Study||10
9931434|NCT01295515|11048539|FG000|STARTED|Overall Study||7
9931435|NCT01295515|11048539|FG000|COMPLETED|Overall Study||7
9931436|NCT01295515|11048539|FG000|NOT COMPLETED|Overall Study||0
9931437|NCT01295580|11048545|FG000|STARTED|Overall Study||174
9931438|NCT01295580|11048546|FG001|STARTED|Overall Study||175
9931439|NCT01295580|11048545|FG000|COMPLETED|Overall Study||164
10206779|NCT03519087|11333577|FG001|COMPLETED|Re-randomization for Treatment||7
10206780|NCT03519087|11333578|FG002|COMPLETED|Re-randomization for Treatment||0
10206781|NCT03519087|11333579|FG003|COMPLETED|Re-randomization for Treatment||0
10206782|NCT03519087|11333580|FG004|COMPLETED|Re-randomization for Treatment||0
10206783|NCT03519087|11333576|FG000|NOT COMPLETED|Re-randomization for Treatment||27
10206784|NCT03519087|11333577|FG001|NOT COMPLETED|Re-randomization for Treatment||32
10206785|NCT03519087|11333578|FG002|NOT COMPLETED|Re-randomization for Treatment||0
10206786|NCT03519087|11333579|FG003|NOT COMPLETED|Re-randomization for Treatment||0
10206787|NCT03519087|11333580|FG004|NOT COMPLETED|Re-randomization for Treatment||0
10206788|NCT03519087|11333576|FG000|STARTED|Laboratory Testing||0
10206789|NCT03519087|11333577|FG001|STARTED|Laboratory Testing||0
10206790|NCT03519087|11333578|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
10206791|NCT03519087|11333579|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
10206792|NCT03519087|11333580|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
10206793|NCT03519087|11333576|FG000|Baseline Lab Testing|Laboratory Testing||0
10206794|NCT03519087|11333577|FG001|Baseline Lab Testing|Laboratory Testing||0
10206795|NCT03519087|11333578|FG002|Baseline Lab Testing|Laboratory Testing||5
10206796|NCT03519087|11333579|FG003|Baseline Lab Testing|Laboratory Testing||4
10206797|NCT03519087|11333580|FG004|Baseline Lab Testing|Laboratory Testing||3
10206798|NCT03519087|11333576|FG000|COMPLETED|Laboratory Testing||0
10206799|NCT03519087|11333577|FG001|COMPLETED|Laboratory Testing||0
10206800|NCT03519087|11333578|FG002|COMPLETED|Laboratory Testing||4
10206801|NCT03519087|11333579|FG003|COMPLETED|Laboratory Testing||2
10206802|NCT03519087|11333580|FG004|COMPLETED|Laboratory Testing||1
10206803|NCT03519087|11333576|FG000|NOT COMPLETED|Laboratory Testing||0
10206804|NCT03519087|11333577|FG001|NOT COMPLETED|Laboratory Testing||0
10206805|NCT03519087|11333578|FG002|NOT COMPLETED|Laboratory Testing||2
10206806|NCT03519087|11333579|FG003|NOT COMPLETED|Laboratory Testing||4
10206807|NCT03519087|11333580|FG004|NOT COMPLETED|Laboratory Testing||6
10238767|NCT00484718|11370189|FG002|COMPLETED|Washout Period (2 Weeks)||1
10238768|NCT00484718|11370190|FG003|COMPLETED|Washout Period (2 Weeks)||1
10238769|NCT00484718|11370191|FG004|COMPLETED|Washout Period (2 Weeks)||1
10238770|NCT00484718|11370192|FG005|COMPLETED|Washout Period (2 Weeks)||1
10238771|NCT00484718|11370187|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10238772|NCT00484718|11370188|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10238773|NCT00484718|11370189|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
10238774|NCT00484718|11370190|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
10238775|NCT00484718|11370191|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
10238776|NCT00484718|11370192|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
10238777|NCT00484718|11370187|FG000|STARTED|Treatment Period 3 (2 Weeks)||1
10238778|NCT00484718|11370188|FG001|STARTED|Treatment Period 3 (2 Weeks)||1
10238779|NCT00484718|11370189|FG002|STARTED|Treatment Period 3 (2 Weeks)||1
10238780|NCT00484718|11370190|FG003|STARTED|Treatment Period 3 (2 Weeks)||1
10238781|NCT00484718|11370191|FG004|STARTED|Treatment Period 3 (2 Weeks)||1
10238782|NCT00484718|11370192|FG005|STARTED|Treatment Period 3 (2 Weeks)||1
10238783|NCT00484718|11370187|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1
10238784|NCT00484718|11370188|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1
10238785|NCT00484718|11370189|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1
10238786|NCT00484718|11370190|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1
10238787|NCT00484718|11370191|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1
10238788|NCT00484718|11370192|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1
10238789|NCT00484718|11370187|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10238790|NCT00484718|11370188|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10238791|NCT00484718|11370189|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10238792|NCT00484718|11370190|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10238793|NCT00484718|11370191|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10238794|NCT00484718|11370192|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10238795|NCT00477230|11370202|FG000|STARTED|Overall Study||32
10238796|NCT00477230|11370203|FG001|STARTED|Overall Study||32
10238797|NCT00477230|11370202|FG000|COMPLETED|Overall Study||12
9931440|NCT01295580|11048546|FG001|COMPLETED|Overall Study||167
9931441|NCT01295580|11048545|FG000|NOT COMPLETED|Overall Study||10
9931442|NCT01295580|11048546|FG001|NOT COMPLETED|Overall Study||8
9931443|NCT01295671|11048555|FG000|STARTED|Overall Study||67
9931444|NCT01295671|11048556|FG001|STARTED|Overall Study||67
10238798|NCT00477230|11370203|FG001|COMPLETED|Overall Study||1
10238799|NCT00477230|11370202|FG000|NOT COMPLETED|Overall Study||20
10206808|NCT03519204|11333598|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
10206809|NCT03519204|11333599|FG001|STARTED|Overall Study||133
10206810|NCT03519204|11333598|FG000|mITT Population|Overall Study||33
10206811|NCT03519204|11333599|FG001|mITT Population|Overall Study||130
10206812|NCT03519204|11333598|FG000|Safety Population|Overall Study||40
10206813|NCT03519204|11333599|FG001|Safety Population|Overall Study||136
10206814|NCT03519204|11333598|FG000|COMPLETED|Overall Study||30
10206815|NCT03519204|11333599|FG001|COMPLETED|Overall Study||118
10206816|NCT03519204|11333598|FG000|NOT COMPLETED|Overall Study||13
10206817|NCT03519204|11333599|FG001|NOT COMPLETED|Overall Study||15
10206818|NCT03519243|11333612|FG000|STARTED|Overall Study||25
10206819|NCT03519243|11333613|FG001|STARTED|Overall Study||25
10206820|NCT03519243|11333614|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
10206821|NCT03519243|11333615|FG003|STARTED|Overall Study||25
10206822|NCT03519243|11333612|FG000|COMPLETED|Overall Study||20
10206823|NCT03519243|11333613|FG001|COMPLETED|Overall Study||21
10206824|NCT03519243|11333614|FG002|COMPLETED|Overall Study||0
10206825|NCT03519243|11333615|FG003|COMPLETED|Overall Study||24
10206826|NCT03519243|11333612|FG000|NOT COMPLETED|Overall Study||5
10206827|NCT03519243|11333613|FG001|NOT COMPLETED|Overall Study||4
10206828|NCT03519243|11333614|FG002|NOT COMPLETED|Overall Study||0
10206829|NCT03519243|11333615|FG003|NOT COMPLETED|Overall Study||1
10206830|NCT03519282|11333623|FG000|STARTED|First Intervention||5
10206831|NCT03519282|11333624|FG001|STARTED|First Intervention||5
10206832|NCT03519282|11333623|FG000|COMPLETED|First Intervention||5
10206833|NCT03519282|11333624|FG001|COMPLETED|First Intervention||5
10206834|NCT03519282|11333623|FG000|NOT COMPLETED|First Intervention||0
10206835|NCT03519282|11333624|FG001|NOT COMPLETED|First Intervention||0
10206836|NCT03519282|11333623|FG000|STARTED|Second Intervention||5
10206837|NCT03519282|11333624|FG001|STARTED|Second Intervention||5
10206838|NCT03519282|11333623|FG000|COMPLETED|Second Intervention||5
10206839|NCT03519282|11333624|FG001|COMPLETED|Second Intervention||5
10206840|NCT03519282|11333623|FG000|NOT COMPLETED|Second Intervention||0
10206841|NCT03519282|11333624|FG001|NOT COMPLETED|Second Intervention||0
10206842|NCT03519516|11333632|FG000|STARTED|Overall Study||15
10206843|NCT03519516|11333633|FG001|STARTED|Overall Study||15
10206844|NCT03519516|11333632|FG000|COMPLETED|Overall Study||15
10206845|NCT03519516|11333633|FG001|COMPLETED|Overall Study||14
10206846|NCT03519516|11333632|FG000|NOT COMPLETED|Overall Study||0
10206847|NCT03519516|11333633|FG001|NOT COMPLETED|Overall Study||1
10206848|NCT03519854|11333657|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
10206849|NCT03519854|11333658|FG001|STARTED|Overall Study||6
10206850|NCT03519854|11333659|FG002|STARTED|Overall Study||5
10206851|NCT03519854|11333660|FG003|STARTED|Overall Study||6
10206852|NCT03519854|11333661|FG004|STARTED|Overall Study||6
10206853|NCT03519854|11333662|FG005|STARTED|Overall Study||6
10206854|NCT03519854|11333663|FG006|STARTED|Overall Study||3
10206855|NCT03519854|11333664|FG007|STARTED|Overall Study||6
10206856|NCT03519854|11333665|FG008|STARTED|Overall Study||6
10206857|NCT03519854|11333666|FG009|STARTED|Overall Study||6
10206858|NCT03519854|11333667|FG010|STARTED|Overall Study||6
10206859|NCT03519854|11333668|FG011|STARTED|Overall Study||6
10206860|NCT03519854|11333669|FG012|STARTED|Overall Study||3
10206861|NCT03519854|11333670|FG013|STARTED|Overall Study||6
10206862|NCT03519854|11333671|FG014|STARTED|Overall Study||6
10206863|NCT03519854|11333672|FG015|STARTED|Overall Study||6
10206864|NCT03519854|11333673|FG016|STARTED|Overall Study||6
10206865|NCT03519854|11333674|FG017|STARTED|Overall Study||6
10206866|NCT03519854|11333657|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
10206867|NCT03519854|11333658|FG001|Treated|Overall Study||6
10206868|NCT03519854|11333659|FG002|Treated|Overall Study||4
10206869|NCT03519854|11333660|FG003|Treated|Overall Study||6
10206870|NCT03519854|11333661|FG004|Treated|Overall Study||6
10206871|NCT03519854|11333662|FG005|Treated|Overall Study||6
10206872|NCT03519854|11333663|FG006|Treated|Overall Study||3
10206873|NCT03519854|11333664|FG007|Treated|Overall Study||6
10206874|NCT03519854|11333665|FG008|Treated|Overall Study||6
10206875|NCT03519854|11333666|FG009|Treated|Overall Study||6
10206876|NCT03519854|11333667|FG010|Treated|Overall Study||6
10206877|NCT03519854|11333668|FG011|Treated|Overall Study||6
10206878|NCT03519854|11333669|FG012|Treated|Overall Study||3
10206879|NCT03519854|11333670|FG013|Treated|Overall Study||6
10206880|NCT03519854|11333671|FG014|Treated|Overall Study||6
10206881|NCT03519854|11333672|FG015|Treated|Overall Study||6
10206882|NCT03519854|11333673|FG016|Treated|Overall Study||6
10206883|NCT03519854|11333674|FG017|Treated|Overall Study||6
10206884|NCT03519854|11333657|FG000|COMPLETED|Overall Study||4
10206885|NCT03519854|11333658|FG001|COMPLETED|Overall Study||6
10206886|NCT03519854|11333659|FG002|COMPLETED|Overall Study||4
10206887|NCT03519854|11333660|FG003|COMPLETED|Overall Study||6
10206888|NCT03519854|11333661|FG004|COMPLETED|Overall Study||6
10206889|NCT03519854|11333662|FG005|COMPLETED|Overall Study||6
10206890|NCT03519854|11333663|FG006|COMPLETED|Overall Study||3
10206891|NCT03519854|11333664|FG007|COMPLETED|Overall Study||6
10206892|NCT03519854|11333665|FG008|COMPLETED|Overall Study||6
10206893|NCT03519854|11333666|FG009|COMPLETED|Overall Study||6
10206894|NCT03519854|11333667|FG010|COMPLETED|Overall Study||6
10206895|NCT03519854|11333668|FG011|COMPLETED|Overall Study||6
10206896|NCT03519854|11333669|FG012|COMPLETED|Overall Study||3
10206897|NCT03519854|11333670|FG013|COMPLETED|Overall Study||6
9931445|NCT01295671|11048557|FG002|STARTED|Overall Study||69
10010938|NCT01777191|11133618|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
10010939|NCT01777191|11133619|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
9931446|NCT01295671|11048555|FG000|COMPLETED|Overall Study||60
9931447|NCT01295671|11048556|FG001|COMPLETED|Overall Study||60
9931448|NCT01295671|11048557|FG002|COMPLETED|Overall Study||66
9931449|NCT01295671|11048555|FG000|NOT COMPLETED|Overall Study||7
9931450|NCT01295671|11048556|FG001|NOT COMPLETED|Overall Study||7
9931451|NCT01295671|11048557|FG002|NOT COMPLETED|Overall Study||3
9931452|NCT01295710|11048567|FG000|STARTED|Overall Study|Randomized and treated|126
9931453|NCT01295710|11048568|FG001|STARTED|Overall Study|Randomized and treated|128
9931454|NCT01295710|11048567|FG000|COMPLETED|Overall Study||48
9931455|NCT01295710|11048568|FG001|COMPLETED|Overall Study||78
9931456|NCT01295710|11048567|FG000|NOT COMPLETED|Overall Study||78
9931457|NCT01295710|11048568|FG001|NOT COMPLETED|Overall Study||50
9931458|NCT01295814|11048576|FG000|STARTED|Overall Study||22
9931459|NCT01295814|11048577|FG001|STARTED|Overall Study||21
9931460|NCT01295814|11048576|FG000|COMPLETED|Overall Study||20
9931461|NCT01295814|11048577|FG001|COMPLETED|Overall Study||19
9931462|NCT01295814|11048576|FG000|NOT COMPLETED|Overall Study||2
9931463|NCT01295814|11048577|FG001|NOT COMPLETED|Overall Study||2
9931464|NCT01295827|11048595|FG000|STARTED|Overall Study||4
9931465|NCT01295827|11048596|FG001|STARTED|Overall Study||3
9931466|NCT01295827|11048597|FG002|STARTED|Overall Study||12
9931467|NCT01295827|11048598|FG003|STARTED|Overall Study||4
9931468|NCT01295827|11048599|FG004|STARTED|Overall Study||3
9931469|NCT01295827|11048600|FG005|STARTED|Overall Study||6
9931470|NCT01295827|11048601|FG006|STARTED|Overall Study||164
9931471|NCT01295827|11048602|FG007|STARTED|Overall Study||321
9931472|NCT01295827|11048603|FG008|STARTED|Overall Study||183
9931473|NCT01295827|11048604|FG009|STARTED|Overall Study||61
9931474|NCT01295827|11048605|FG010|STARTED|Overall Study||296
9931475|NCT01295827|11048606|FG011|STARTED|Overall Study||203
9931476|NCT01295827|11048607|FG012|STARTED|Overall Study||0
9931477|NCT01295827|11048608|FG013|STARTED|Overall Study||0
9931478|NCT01295827|11048609|FG014|STARTED|Overall Study||0
9931479|NCT01295827|11048595|FG000|Treated (All Treated Population)|Overall Study||4
9931480|NCT01295827|11048596|FG001|Treated (All Treated Population)|Overall Study||3
9931481|NCT01295827|11048597|FG002|Treated (All Treated Population)|Overall Study||10
9931482|NCT01295827|11048598|FG003|Treated (All Treated Population)|Overall Study||4
9931483|NCT01295827|11048599|FG004|Treated (All Treated Population)|Overall Study||3
9931484|NCT01295827|11048600|FG005|Treated (All Treated Population)|Overall Study||6
9931485|NCT01295827|11048601|FG006|Treated (All Treated Population)|Overall Study||162
9931486|NCT01295827|11048602|FG007|Treated (All Treated Population)|Overall Study||313
9931487|NCT01295827|11048603|FG008|Treated (All Treated Population)|Overall Study||180
9931488|NCT01295827|11048604|FG009|Treated (All Treated Population)|Overall Study||61
9931489|NCT01295827|11048605|FG010|Treated (All Treated Population)|Overall Study||287
9931490|NCT01295827|11048606|FG011|Treated (All Treated Population)|Overall Study||202
9931491|NCT01295827|11048607|FG012|Treated (All Treated Population)|Overall Study||0
9931492|NCT01295827|11048608|FG013|Treated (All Treated Population)|Overall Study||0
9931493|NCT01295827|11048609|FG014|Treated (All Treated Population)|Overall Study||0
9931494|NCT01295827|11048595|FG000|COMPLETED|Overall Study||0
9931495|NCT01295827|11048596|FG001|COMPLETED|Overall Study||0
9931496|NCT01295827|11048597|FG002|COMPLETED|Overall Study||0
9931497|NCT01295827|11048598|FG003|COMPLETED|Overall Study||0
9931498|NCT01295827|11048599|FG004|COMPLETED|Overall Study||1
9931499|NCT01295827|11048600|FG005|COMPLETED|Overall Study||0
9931500|NCT01295827|11048601|FG006|COMPLETED|Overall Study||18
9931501|NCT01295827|11048602|FG007|COMPLETED|Overall Study||24
9931502|NCT01295827|11048603|FG008|COMPLETED|Overall Study||14
9931503|NCT01295827|11048604|FG009|COMPLETED|Overall Study||6
9931504|NCT01295827|11048605|FG010|COMPLETED|Overall Study||20
9931505|NCT01295827|11048606|FG011|COMPLETED|Overall Study||17
9931506|NCT01295827|11048607|FG012|COMPLETED|Overall Study||0
9931507|NCT01295827|11048608|FG013|COMPLETED|Overall Study||0
9931508|NCT01295827|11048609|FG014|COMPLETED|Overall Study||0
9931509|NCT01295827|11048595|FG000|NOT COMPLETED|Overall Study||4
9931510|NCT01295827|11048596|FG001|NOT COMPLETED|Overall Study||3
9931511|NCT01295827|11048597|FG002|NOT COMPLETED|Overall Study||12
9931512|NCT01295827|11048598|FG003|NOT COMPLETED|Overall Study||4
9931513|NCT01295827|11048599|FG004|NOT COMPLETED|Overall Study||2
9931514|NCT01295827|11048600|FG005|NOT COMPLETED|Overall Study||6
9931515|NCT01295827|11048601|FG006|NOT COMPLETED|Overall Study||146
9931516|NCT01295827|11048602|FG007|NOT COMPLETED|Overall Study||297
9931517|NCT01295827|11048603|FG008|NOT COMPLETED|Overall Study||169
9931518|NCT01295827|11048604|FG009|NOT COMPLETED|Overall Study||55
9931519|NCT01295827|11048605|FG010|NOT COMPLETED|Overall Study||276
9931520|NCT01295827|11048606|FG011|NOT COMPLETED|Overall Study||186
9931521|NCT01295827|11048607|FG012|NOT COMPLETED|Overall Study||0
9931522|NCT01295827|11048608|FG013|NOT COMPLETED|Overall Study||0
9931523|NCT01295827|11048609|FG014|NOT COMPLETED|Overall Study||0
9931524|NCT01295840|11048662|FG000|STARTED|Overall Study||51
9931525|NCT01295840|11048662|FG000|COMPLETED|Overall Study||50
9931526|NCT01295840|11048662|FG000|NOT COMPLETED|Overall Study||1
9931527|NCT01295879|11048668|FG000|STARTED|Overall Study||29
9931528|NCT01295879|11048668|FG000|COMPLETED|Overall Study||29
9931529|NCT01295879|11048668|FG000|NOT COMPLETED|Overall Study||0
9931530|NCT01295905|11048674|FG000|STARTED|Overall Study||60
9931531|NCT01295905|11048675|FG001|STARTED|Overall Study||30
9931532|NCT01295905|11048674|FG000|COMPLETED|Overall Study||58
9931533|NCT01295905|11048675|FG001|COMPLETED|Overall Study||30
9931534|NCT01295905|11048674|FG000|NOT COMPLETED|Overall Study||2
9931535|NCT01295905|11048675|FG001|NOT COMPLETED|Overall Study||0
9956229|NCT01444027|11075368|FG001|3 Month Follow-up|Overall Study||141
9956230|NCT01444027|11075369|FG002|3 Month Follow-up|Overall Study||133
9956231|NCT01444027|11075367|FG000|COMPLETED|Overall Study||142
9956232|NCT01444027|11075368|FG001|COMPLETED|Overall Study||141
9956233|NCT01444027|11075369|FG002|COMPLETED|Overall Study||133
9956234|NCT01444027|11075367|FG000|NOT COMPLETED|Overall Study||30
9956235|NCT01444027|11075368|FG001|NOT COMPLETED|Overall Study||30
9956236|NCT01444027|11075369|FG002|NOT COMPLETED|Overall Study||38
9956237|NCT01444287|11075377|FG000|STARTED|Period 1||22
9956238|NCT01444287|11075377|FG000|COMPLETED|Period 1||22
9956239|NCT01444287|11075377|FG000|NOT COMPLETED|Period 1||0
9956240|NCT01444287|11075377|FG000|STARTED|Period 2||22
9956241|NCT01444287|11075377|FG000|COMPLETED|Period 2||22
9956242|NCT01444287|11075377|FG000|NOT COMPLETED|Period 2||0
9956243|NCT01444287|11075377|FG000|STARTED|Period 3||22
10206898|NCT03519854|11333671|FG014|COMPLETED|Overall Study||6
10206899|NCT03519854|11333672|FG015|COMPLETED|Overall Study||6
10206900|NCT03519854|11333673|FG016|COMPLETED|Overall Study||6
10206901|NCT03519854|11333674|FG017|COMPLETED|Overall Study||6
10206902|NCT03519854|11333657|FG000|NOT COMPLETED|Overall Study||0
10206903|NCT03519854|11333658|FG001|NOT COMPLETED|Overall Study||0
10206904|NCT03519854|11333659|FG002|NOT COMPLETED|Overall Study||1
10206905|NCT03519854|11333660|FG003|NOT COMPLETED|Overall Study||0
10206906|NCT03519854|11333661|FG004|NOT COMPLETED|Overall Study||0
10206907|NCT03519854|11333662|FG005|NOT COMPLETED|Overall Study||0
10206908|NCT03519854|11333663|FG006|NOT COMPLETED|Overall Study||0
10206909|NCT03519854|11333664|FG007|NOT COMPLETED|Overall Study||0
10206910|NCT03519854|11333665|FG008|NOT COMPLETED|Overall Study||0
10206911|NCT03519854|11333666|FG009|NOT COMPLETED|Overall Study||0
10206912|NCT03519854|11333667|FG010|NOT COMPLETED|Overall Study||0
10206913|NCT03519854|11333668|FG011|NOT COMPLETED|Overall Study||0
10206914|NCT03519854|11333669|FG012|NOT COMPLETED|Overall Study||0
10206915|NCT03519854|11333670|FG013|NOT COMPLETED|Overall Study||0
10206916|NCT03519854|11333671|FG014|NOT COMPLETED|Overall Study||0
10206917|NCT03519854|11333672|FG015|NOT COMPLETED|Overall Study||0
10206918|NCT03519854|11333673|FG016|NOT COMPLETED|Overall Study||0
10206919|NCT03519854|11333674|FG017|NOT COMPLETED|Overall Study||0
10206920|NCT03519867|11333722|FG000|STARTED|Overall Study||6
10206921|NCT03519867|11333723|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
10206922|NCT03519867|11333724|FG002|STARTED|Overall Study||6
10206923|NCT03519867|11333725|FG003|STARTED|Overall Study||4
10206924|NCT03519867|11333726|FG004|STARTED|Overall Study||5
9956244|NCT01444287|11075377|FG000|COMPLETED|Period 3||22
9956245|NCT01444287|11075377|FG000|NOT COMPLETED|Period 3||0
9956246|NCT01444287|11075377|FG000|STARTED|Period 4||22
9956247|NCT01444287|11075377|FG000|COMPLETED|Period 4||22
9956248|NCT01444287|11075377|FG000|NOT COMPLETED|Period 4||0
9956249|NCT01444300|11075393|FG000|STARTED|Overall Study||12
9956250|NCT01444300|11075394|FG001|STARTED|Overall Study||12
9956251|NCT01444300|11075393|FG000|COMPLETED|Overall Study||8
9956252|NCT01444300|11075394|FG001|COMPLETED|Overall Study||12
9956253|NCT01444300|11075393|FG000|NOT COMPLETED|Overall Study||4
9956254|NCT01444300|11075394|FG001|NOT COMPLETED|Overall Study||0
9956255|NCT01444378|11075401|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
9956256|NCT01444378|11075401|FG000|COMPLETED|Overall Study||124
9956257|NCT01444378|11075401|FG000|NOT COMPLETED|Overall Study||17
9956258|NCT01444391|11075408|FG000|STARTED|Overall Study||42
9956259|NCT01444391|11075408|FG000|COMPLETED|Overall Study||41
9956260|NCT01444391|11075408|FG000|NOT COMPLETED|Overall Study||1
9956261|NCT01444417|11075414|FG000|STARTED|Overall Study||20
9956262|NCT01444417|11075415|FG001|STARTED|Overall Study||42
9956263|NCT01444417|11075414|FG000|Received Treatment|Overall Study||19
9956264|NCT01444417|11075415|FG001|Received Treatment|Overall Study||42
9956265|NCT01444417|11075414|FG000|COMPLETED|Overall Study||18
9956266|NCT01444417|11075415|FG001|COMPLETED|Overall Study||41
9956267|NCT01444417|11075414|FG000|NOT COMPLETED|Overall Study||2
9956268|NCT01444417|11075415|FG001|NOT COMPLETED|Overall Study||1
9956269|NCT01444430|11075423|FG000|STARTED|Overall Study||5846
9956270|NCT01444430|11075424|FG001|STARTED|Overall Study||5847
9956271|NCT01444430|11075423|FG000|COMPLETED|Overall Study||5785
10206925|NCT03519867|11333727|FG005|STARTED|Overall Study||5
10206926|NCT03519867|11333728|FG006|STARTED|Overall Study||4
10206927|NCT03519867|11333729|FG007|STARTED|Overall Study||5
10206928|NCT03519867|11333730|FG008|STARTED|Overall Study||4
9956272|NCT01444430|11075424|FG001|COMPLETED|Overall Study||5766
9956273|NCT01444430|11075423|FG000|NOT COMPLETED|Overall Study||61
9956274|NCT01444430|11075424|FG001|NOT COMPLETED|Overall Study||81
9956275|NCT01444456|11075430|FG000|STARTED|Overall Study||1262
9956276|NCT01444456|11075430|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
9956277|NCT01444456|11075430|FG000|Received Darbepoetin Alfa|Overall Study||1134
10206929|NCT03519867|11333731|FG009|STARTED|Overall Study||4
9956278|NCT01444456|11075430|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
9956279|NCT01444456|11075430|FG000|NOT COMPLETED|Overall Study||285
9957077|NCT01449370|11076252|FG017|COMPLETED|Overall Study||0
10010940|NCT01777191|11133618|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
10010941|NCT01777191|11133619|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
9931536|NCT01296035|11048681|FG000|STARTED|Overall Study||8
9931537|NCT01296035|11048681|FG000|COMPLETED|Overall Study||7
9931538|NCT01296035|11048681|FG000|NOT COMPLETED|Overall Study||1
9931539|NCT01296152|11048685|FG000|STARTED|Overall Study||25
9931540|NCT01296152|11048685|FG000|COMPLETED|Overall Study||24
9931541|NCT01296152|11048685|FG000|NOT COMPLETED|Overall Study||1
9931542|NCT01296191|11048691|FG000|STARTED|Overall Study||60
9931543|NCT01296191|11048692|FG001|STARTED|Overall Study||60
9931544|NCT01296191|11048691|FG000|COMPLETED|Overall Study||57
9931545|NCT01296191|11048692|FG001|COMPLETED|Overall Study||59
9931546|NCT01296191|11048691|FG000|NOT COMPLETED|Overall Study||3
9931547|NCT01296191|11048692|FG001|NOT COMPLETED|Overall Study||1
9931548|NCT01296347|11048700|FG000|STARTED|Allocation||38
9931549|NCT01296347|11048701|FG001|STARTED|Allocation||39
9931550|NCT01296347|11048700|FG000|COMPLETED|Allocation||35
9931551|NCT01296347|11048701|FG001|COMPLETED|Allocation||35
9931552|NCT01296347|11048700|FG000|NOT COMPLETED|Allocation||3
9931553|NCT01296347|11048701|FG001|NOT COMPLETED|Allocation||4
9931554|NCT01296347|11048700|FG000|STARTED|6 Week Follow up||35
9931555|NCT01296347|11048701|FG001|STARTED|6 Week Follow up||35
9931556|NCT01296347|11048700|FG000|COMPLETED|6 Week Follow up||35
9931557|NCT01296347|11048701|FG001|COMPLETED|6 Week Follow up||34
9931558|NCT01296347|11048700|FG000|NOT COMPLETED|6 Week Follow up||0
9931559|NCT01296347|11048701|FG001|NOT COMPLETED|6 Week Follow up||1
9931560|NCT01296347|11048700|FG000|STARTED|3 Month Follow up||35
9931561|NCT01296347|11048701|FG001|STARTED|3 Month Follow up||34
9931562|NCT01296347|11048700|FG000|COMPLETED|3 Month Follow up||34
9931563|NCT01296347|11048701|FG001|COMPLETED|3 Month Follow up||33
9931564|NCT01296347|11048700|FG000|NOT COMPLETED|3 Month Follow up||1
9931565|NCT01296347|11048701|FG001|NOT COMPLETED|3 Month Follow up||1
9931566|NCT01296347|11048700|FG000|STARTED|6 Month Follow up||34
9931567|NCT01296347|11048701|FG001|STARTED|6 Month Follow up||33
9931568|NCT01296347|11048700|FG000|COMPLETED|6 Month Follow up||32
9931569|NCT01296347|11048701|FG001|COMPLETED|6 Month Follow up||31
9931570|NCT01296347|11048700|FG000|NOT COMPLETED|6 Month Follow up||2
9931571|NCT01296347|11048701|FG001|NOT COMPLETED|6 Month Follow up||2
9931572|NCT01296347|11048700|FG000|STARTED|12 Month Follow up||32
9931573|NCT01296347|11048701|FG001|STARTED|12 Month Follow up||31
9931574|NCT01296347|11048700|FG000|COMPLETED|12 Month Follow up||28
9931575|NCT01296347|11048701|FG001|COMPLETED|12 Month Follow up||28
9931576|NCT01296347|11048700|FG000|NOT COMPLETED|12 Month Follow up||4
9931577|NCT01296347|11048701|FG001|NOT COMPLETED|12 Month Follow up||3
9931578|NCT01296360|11048712|FG000|STARTED|Overall Study||150
9931579|NCT01296360|11048713|FG001|STARTED|Overall Study||150
9931580|NCT01296360|11048712|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148
9931581|NCT01296360|11048713|FG001|Visit 2 (Month 12)|Overall Study||149
9931582|NCT01296360|11048712|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
9931583|NCT01296360|11048713|FG001|Visit 2a (Month 13)|Overall Study||0
9931584|NCT01296360|11048712|FG000|COMPLETED|Overall Study||144
9931585|NCT01296360|11048713|FG001|COMPLETED|Overall Study||142
9931586|NCT01296360|11048712|FG000|NOT COMPLETED|Overall Study||6
9931587|NCT01296360|11048713|FG001|NOT COMPLETED|Overall Study||8
9931588|NCT01296412|11048721|FG000|STARTED|Overall Study||326
9931589|NCT01296412|11048722|FG001|STARTED|Overall Study||327
9931590|NCT01296412|11048721|FG000|COMPLETED|Overall Study||275
9931591|NCT01296412|11048722|FG001|COMPLETED|Overall Study||257
9931592|NCT01296412|11048721|FG000|NOT COMPLETED|Overall Study||51
9931593|NCT01296412|11048722|FG001|NOT COMPLETED|Overall Study||70
9931594|NCT01296542|11048730|FG000|STARTED|Overall Study||30
9931595|NCT01296542|11048731|FG001|STARTED|Overall Study||30
9931596|NCT01296542|11048730|FG000|COMPLETED|Overall Study||30
9931597|NCT01296542|11048731|FG001|COMPLETED|Overall Study||28
9931598|NCT01296542|11048730|FG000|NOT COMPLETED|Overall Study||0
9931599|NCT01296542|11048731|FG001|NOT COMPLETED|Overall Study||2
9931600|NCT01296568|11048737|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3
9931601|NCT01296568|11048737|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
9931602|NCT01296568|11048737|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
9931603|NCT01296568|11048737|FG000|STARTED|Continued Access Phase||3
9931604|NCT01296568|11048737|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
9931605|NCT01296568|11048737|FG000|NOT COMPLETED|Continued Access Phase||3
9931606|NCT01296646|11048745|FG000|STARTED|Overall Study||40
9931607|NCT01296646|11048746|FG001|STARTED|Overall Study||40
9931608|NCT01296646|11048745|FG000|COMPLETED|Overall Study||29
9931609|NCT01296646|11048746|FG001|COMPLETED|Overall Study||29
9931610|NCT01296646|11048745|FG000|NOT COMPLETED|Overall Study||11
9931611|NCT01296646|11048746|FG001|NOT COMPLETED|Overall Study||11
9931612|NCT01296672|11048754|FG000|STARTED|Overall Study||306
9931613|NCT01296672|11048755|FG001|STARTED|Overall Study||77
9931614|NCT01296672|11048754|FG000|COMPLETED|Overall Study||233
9931615|NCT01296672|11048755|FG001|COMPLETED|Overall Study||59
9931616|NCT01296672|11048754|FG000|NOT COMPLETED|Overall Study||73
9931617|NCT01296672|11048755|FG001|NOT COMPLETED|Overall Study||18
9931618|NCT01296698|11048765|FG000|STARTED|Overall Study||244
9931619|NCT01296698|11048766|FG001|STARTED|Overall Study||13
9931620|NCT01296698|11048765|FG000|COMPLETED|Overall Study||0
9931621|NCT01296698|11048766|FG001|COMPLETED|Overall Study||0
9931622|NCT01296698|11048765|FG000|NOT COMPLETED|Overall Study||244
9931623|NCT01296698|11048766|FG001|NOT COMPLETED|Overall Study||13
9931624|NCT01296763|11048775|FG000|STARTED|Overall Study||7
9931625|NCT01296763|11048776|FG001|STARTED|Overall Study||5
9931626|NCT01296763|11048777|FG002|STARTED|Overall Study||6
9931627|NCT01296763|11048775|FG000|COMPLETED|Overall Study||7
9931628|NCT01296763|11048776|FG001|COMPLETED|Overall Study||5
9931629|NCT01296763|11048777|FG002|COMPLETED|Overall Study||6
9931630|NCT01296763|11048775|FG000|NOT COMPLETED|Overall Study||0
9931631|NCT01296763|11048776|FG001|NOT COMPLETED|Overall Study||0
9931632|NCT01296763|11048777|FG002|NOT COMPLETED|Overall Study||0
9931633|NCT01296815|11048787|FG000|STARTED|Overall Study||7
9931634|NCT01296815|11048788|FG001|STARTED|Overall Study||7
9931635|NCT01296815|11048787|FG000|COMPLETED|Overall Study||7
9931636|NCT01296815|11048788|FG001|COMPLETED|Overall Study||7
10010942|NCT01777191|11133618|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
10010943|NCT01777191|11133619|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
10010944|NCT01777217|11133630|FG000|STARTED|Overall Study||4
9931637|NCT01296815|11048787|FG000|NOT COMPLETED|Overall Study||0
9931638|NCT01296815|11048788|FG001|NOT COMPLETED|Overall Study||0
9931639|NCT01296841|11048796|FG000|STARTED|Overall Study||19
9931640|NCT01296841|11048797|FG001|STARTED|Overall Study||15
9931641|NCT01296841|11048796|FG000|COMPLETED|Overall Study||19
9931642|NCT01296841|11048797|FG001|COMPLETED|Overall Study||15
9931643|NCT01296841|11048796|FG000|NOT COMPLETED|Overall Study||0
9931644|NCT01296841|11048797|FG001|NOT COMPLETED|Overall Study||0
9931645|NCT01296932|11048814|FG000|STARTED|Overall Study||3
9931646|NCT01296932|11048815|FG001|STARTED|Overall Study||3
9931647|NCT01296932|11048816|FG002|STARTED|Overall Study||6
9931648|NCT01296932|11048817|FG003|STARTED|Overall Study||6
9931649|NCT01296932|11048818|FG004|STARTED|Overall Study||3
9931650|NCT01296932|11048819|FG005|STARTED|Overall Study||3
9931651|NCT01296932|11048820|FG006|STARTED|Overall Study||6
9931652|NCT01296932|11048821|FG007|STARTED|Overall Study||3
9931653|NCT01296932|11048822|FG008|STARTED|Overall Study||4
9931654|NCT01296932|11048814|FG000|COMPLETED|Overall Study||0
9931655|NCT01296932|11048815|FG001|COMPLETED|Overall Study||0
9931656|NCT01296932|11048816|FG002|COMPLETED|Overall Study||0
9931657|NCT01296932|11048817|FG003|COMPLETED|Overall Study||0
9931658|NCT01296932|11048818|FG004|COMPLETED|Overall Study||0
9931659|NCT01296932|11048819|FG005|COMPLETED|Overall Study||0
9931660|NCT01296932|11048820|FG006|COMPLETED|Overall Study||0
9931661|NCT01296932|11048821|FG007|COMPLETED|Overall Study||1
9931662|NCT01296932|11048822|FG008|COMPLETED|Overall Study||0
9931663|NCT01296932|11048814|FG000|NOT COMPLETED|Overall Study||3
9931664|NCT01296932|11048815|FG001|NOT COMPLETED|Overall Study||3
9931665|NCT01296932|11048816|FG002|NOT COMPLETED|Overall Study||6
9931666|NCT01296932|11048817|FG003|NOT COMPLETED|Overall Study||6
9931667|NCT01296932|11048818|FG004|NOT COMPLETED|Overall Study||3
9931668|NCT01296932|11048819|FG005|NOT COMPLETED|Overall Study||3
9931669|NCT01296932|11048820|FG006|NOT COMPLETED|Overall Study||6
10010945|NCT01777217|11133631|FG001|STARTED|Overall Study||4
10010946|NCT01777217|11133630|FG000|COMPLETED|Overall Study||4
10010947|NCT01777217|11133631|FG001|COMPLETED|Overall Study||4
10010948|NCT01777217|11133630|FG000|NOT COMPLETED|Overall Study||0
10010949|NCT01777217|11133631|FG001|NOT COMPLETED|Overall Study||0
10010950|NCT01777269|11133639|FG000|STARTED|Overall Study||246
10010951|NCT01777269|11133640|FG001|STARTED|Overall Study||243
10206930|NCT03519867|11333722|FG000|Treated|Overall Study||5
10206931|NCT03519867|11333723|FG001|Treated|Overall Study||6
10206932|NCT03519867|11333724|FG002|Treated|Overall Study||5
10206933|NCT03519867|11333725|FG003|Treated|Overall Study||3
10206934|NCT03519867|11333726|FG004|Treated|Overall Study||5
10206935|NCT03519867|11333727|FG005|Treated|Overall Study||4
10206936|NCT03519867|11333728|FG006|Treated|Overall Study||4
10206937|NCT03519867|11333729|FG007|Treated|Overall Study||4
10206938|NCT03519867|11333730|FG008|Treated|Overall Study||3
10206939|NCT03519867|11333731|FG009|Treated|Overall Study||4
10206940|NCT03519867|11333722|FG000|COMPLETED|Overall Study||3
10010952|NCT01777269|11133639|FG000|COMPLETED|Overall Study||191
10010953|NCT01777269|11133640|FG001|COMPLETED|Overall Study||184
10010954|NCT01777269|11133639|FG000|NOT COMPLETED|Overall Study||55
10010955|NCT01777269|11133640|FG001|NOT COMPLETED|Overall Study||59
10206941|NCT03519867|11333723|FG001|COMPLETED|Overall Study||4
10206942|NCT03519867|11333724|FG002|COMPLETED|Overall Study||5
9931670|NCT01296932|11048821|FG007|NOT COMPLETED|Overall Study||2
9931671|NCT01296932|11048822|FG008|NOT COMPLETED|Overall Study||4
9931672|NCT01297062|11048849|FG000|STARTED|Overall Study||15
9931673|NCT01297062|11048850|FG001|STARTED|Overall Study||14
9931674|NCT01297062|11048851|FG002|STARTED|Overall Study||14
9931675|NCT01297062|11048852|FG003|STARTED|Overall Study||14
9931676|NCT01297062|11048853|FG004|STARTED|Overall Study||15
9931677|NCT01297062|11048854|FG005|STARTED|Overall Study||14
9931678|NCT01297062|11048855|FG006|STARTED|Overall Study||8
9931679|NCT01297062|11048849|FG000|Intent to Treat (ITT)|Overall Study||15
9931680|NCT01297062|11048850|FG001|Intent to Treat (ITT)|Overall Study||14
9931681|NCT01297062|11048851|FG002|Intent to Treat (ITT)|Overall Study||14
9931682|NCT01297062|11048852|FG003|Intent to Treat (ITT)|Overall Study||14
9931683|NCT01297062|11048853|FG004|Intent to Treat (ITT)|Overall Study||15
9931684|NCT01297062|11048854|FG005|Intent to Treat (ITT)|Overall Study||14
10010956|NCT01777282|11133651|FG000|STARTED|Overall Study||120
10010957|NCT01777282|11133652|FG001|STARTED|Overall Study||67
10206943|NCT03519867|11333725|FG003|COMPLETED|Overall Study||3
10206944|NCT03519867|11333726|FG004|COMPLETED|Overall Study||5
10206945|NCT03519867|11333727|FG005|COMPLETED|Overall Study||2
9931685|NCT01297062|11048855|FG006|Intent to Treat (ITT)|Overall Study||0
9931686|NCT01297062|11048849|FG000|Evaluable Population|Overall Study||11
9931687|NCT01297062|11048850|FG001|Evaluable Population|Overall Study||12
9931688|NCT01297062|11048851|FG002|Evaluable Population|Overall Study||12
9931689|NCT01297062|11048852|FG003|Evaluable Population|Overall Study||13
9931690|NCT01297062|11048853|FG004|Evaluable Population|Overall Study||13
9931691|NCT01297062|11048854|FG005|Evaluable Population|Overall Study||13
9931692|NCT01297062|11048855|FG006|Evaluable Population|Overall Study||0
9931693|NCT01297062|11048849|FG000|COMPLETED|Overall Study||11
9931694|NCT01297062|11048850|FG001|COMPLETED|Overall Study||13
9931695|NCT01297062|11048851|FG002|COMPLETED|Overall Study||12
9931696|NCT01297062|11048852|FG003|COMPLETED|Overall Study||13
9931697|NCT01297062|11048853|FG004|COMPLETED|Overall Study||13
9931698|NCT01297062|11048854|FG005|COMPLETED|Overall Study||13
9931699|NCT01297062|11048855|FG006|COMPLETED|Overall Study||0
9931700|NCT01297062|11048849|FG000|NOT COMPLETED|Overall Study||4
9931701|NCT01297062|11048850|FG001|NOT COMPLETED|Overall Study||1
9931702|NCT01297062|11048851|FG002|NOT COMPLETED|Overall Study||2
9931703|NCT01297062|11048852|FG003|NOT COMPLETED|Overall Study||1
9931704|NCT01297062|11048853|FG004|NOT COMPLETED|Overall Study||2
9931705|NCT01297062|11048854|FG005|NOT COMPLETED|Overall Study||1
9931706|NCT01297062|11048855|FG006|NOT COMPLETED|Overall Study||8
9931707|NCT01297244|11048865|FG000|STARTED|Overall Study||90
9931708|NCT01297244|11048866|FG001|STARTED|Overall Study||15
9931709|NCT01297244|11048865|FG000|COMPLETED|Overall Study||55
9931710|NCT01297244|11048866|FG001|COMPLETED|Overall Study||9
9931711|NCT01297244|11048865|FG000|NOT COMPLETED|Overall Study||35
9931712|NCT01297244|11048866|FG001|NOT COMPLETED|Overall Study||6
9931713|NCT01297257|11048873|FG000|STARTED|Overall Study||7740
9931714|NCT01297257|11048873|FG000|COMPLETED|Overall Study||7740
9931715|NCT01297257|11048873|FG000|NOT COMPLETED|Overall Study||0
9931716|NCT01297270|11048881|FG000|STARTED|Overall Study||262
9931717|NCT01297270|11048882|FG001|STARTED|Overall Study||264
9931718|NCT01297270|11048883|FG002|STARTED|Overall Study||132
9931719|NCT01297270|11048881|FG000|COMPLETED|Overall Study||217
9931720|NCT01297270|11048882|FG001|COMPLETED|Overall Study||192
9931721|NCT01297270|11048883|FG002|COMPLETED|Overall Study||103
9931722|NCT01297270|11048881|FG000|NOT COMPLETED|Overall Study||45
9931723|NCT01297270|11048882|FG001|NOT COMPLETED|Overall Study||72
9931724|NCT01297270|11048883|FG002|NOT COMPLETED|Overall Study||29
9931725|NCT01297283|11048891|FG000|STARTED|Overall Study||195
9931726|NCT01297283|11048891|FG000|COMPLETED|Overall Study||176
9931727|NCT01297283|11048891|FG000|NOT COMPLETED|Overall Study||19
9931728|NCT01297309|11048895|FG000|STARTED|Overall Study||51
9931729|NCT01297309|11048895|FG000|Treated|Overall Study||49
9931730|NCT01297309|11048895|FG000|Started Extension Period|Overall Study||46
9931731|NCT01297309|11048895|FG000|COMPLETED|Overall Study||37
9931732|NCT01297309|11048895|FG000|NOT COMPLETED|Overall Study||14
9931733|NCT01297322|11048901|FG000|STARTED|Overall Study||142
9931734|NCT01297322|11048902|FG001|STARTED|Overall Study||278
9931735|NCT01297322|11048901|FG000|COMPLETED|Overall Study||141
9931736|NCT01297322|11048902|FG001|COMPLETED|Overall Study||274
9931737|NCT01297322|11048901|FG000|NOT COMPLETED|Overall Study||1
9931738|NCT01297322|11048902|FG001|NOT COMPLETED|Overall Study||4
9931739|NCT01297335|11048909|FG000|STARTED|Overall Study||10
9931740|NCT01297335|11048909|FG000|COMPLETED|Overall Study||10
9931741|NCT01297335|11048909|FG000|NOT COMPLETED|Overall Study||0
9931742|NCT01297348|11048917|FG000|STARTED|Overall Study||12281
9931743|NCT01297348|11048918|FG001|STARTED|Overall Study||586401
9931744|NCT01297348|11048917|FG000|COMPLETED|Overall Study||12281
9931745|NCT01297348|11048918|FG001|COMPLETED|Overall Study||586401
9931746|NCT01297348|11048917|FG000|NOT COMPLETED|Overall Study||0
9931747|NCT01297348|11048918|FG001|NOT COMPLETED|Overall Study||0
9931748|NCT01297465|11048927|FG000|STARTED|Overall Study||99
9931749|NCT01297465|11048928|FG001|STARTED|Overall Study||103
9931750|NCT01297465|11048927|FG000|COMPLETED|Overall Study||91
9931751|NCT01297465|11048928|FG001|COMPLETED|Overall Study||93
9931752|NCT01297465|11048927|FG000|NOT COMPLETED|Overall Study||8
9931753|NCT01297465|11048928|FG001|NOT COMPLETED|Overall Study||10
9931754|NCT01297491|11048936|FG000|STARTED|Overall Study||30
10206946|NCT03519867|11333728|FG006|COMPLETED|Overall Study||3
9931755|NCT01297491|11048937|FG001|STARTED|Overall Study||33
9931756|NCT01297491|11048936|FG000|COMPLETED|Overall Study||0
9931757|NCT01297491|11048937|FG001|COMPLETED|Overall Study||0
9931758|NCT01297491|11048936|FG000|NOT COMPLETED|Overall Study||30
9931759|NCT01297491|11048937|FG001|NOT COMPLETED|Overall Study||33
9931760|NCT01297504|11048943|FG000|STARTED|Overall Study||464
9931761|NCT01297504|11048943|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
9931762|NCT01297504|11048943|FG000|COMPLETED|Overall Study||397
9931763|NCT01297504|11048943|FG000|NOT COMPLETED|Overall Study||67
9931764|NCT01297517|11048954|FG000|STARTED|Overall Study||214
9931765|NCT01297517|11048955|FG001|STARTED|Overall Study||226
9931766|NCT01297517|11048956|FG002|STARTED|Overall Study||220
9931767|NCT01297517|11048954|FG000|COMPLETED|Overall Study||187
9931768|NCT01297517|11048955|FG001|COMPLETED|Overall Study||214
9931769|NCT01297517|11048956|FG002|COMPLETED|Overall Study||193
9931770|NCT01297517|11048954|FG000|NOT COMPLETED|Overall Study||27
9931771|NCT01297517|11048955|FG001|NOT COMPLETED|Overall Study||12
10206947|NCT03519867|11333729|FG007|COMPLETED|Overall Study||4
9931772|NCT01297517|11048956|FG002|NOT COMPLETED|Overall Study||27
9931773|NCT01297595|11048964|FG000|STARTED|First Intervention Period||11
9931774|NCT01297595|11048965|FG001|STARTED|First Intervention Period||11
9931775|NCT01297595|11048964|FG000|COMPLETED|First Intervention Period||11
9931776|NCT01297595|11048965|FG001|COMPLETED|First Intervention Period||11
9931777|NCT01297595|11048964|FG000|NOT COMPLETED|First Intervention Period||0
9931778|NCT01297595|11048965|FG001|NOT COMPLETED|First Intervention Period||0
9931779|NCT01297595|11048964|FG000|STARTED|Washout Period (At Least 14 Days)||11
9931780|NCT01297595|11048965|FG001|STARTED|Washout Period (At Least 14 Days)||11
9931781|NCT01297595|11048964|FG000|COMPLETED|Washout Period (At Least 14 Days)||11
9931782|NCT01297595|11048965|FG001|COMPLETED|Washout Period (At Least 14 Days)||11
9931783|NCT01297595|11048964|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0
9931784|NCT01297595|11048965|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0
9931785|NCT01297595|11048964|FG000|STARTED|Second Intervention Period||11
9931786|NCT01297595|11048965|FG001|STARTED|Second Intervention Period||11
9931787|NCT01297595|11048964|FG000|COMPLETED|Second Intervention Period||11
9931788|NCT01297595|11048965|FG001|COMPLETED|Second Intervention Period||11
9931789|NCT01297595|11048964|FG000|NOT COMPLETED|Second Intervention Period||0
9931790|NCT01297595|11048965|FG001|NOT COMPLETED|Second Intervention Period||0
9931791|NCT01297920|11048974|FG000|STARTED|Overall Study||221
9931792|NCT01297920|11048975|FG001|STARTED|Overall Study||234
9931793|NCT01297920|11048976|FG002|STARTED|Overall Study||235
9931794|NCT01297920|11048974|FG000|COMPLETED|Overall Study||163
9931795|NCT01297920|11048975|FG001|COMPLETED|Overall Study||207
9931796|NCT01297920|11048976|FG002|COMPLETED|Overall Study||178
9931797|NCT01297920|11048974|FG000|NOT COMPLETED|Overall Study||58
9931798|NCT01297920|11048975|FG001|NOT COMPLETED|Overall Study||27
9931799|NCT01297920|11048976|FG002|NOT COMPLETED|Overall Study||57
9931800|NCT01297959|11048986|FG000|STARTED|Overall Study||261
9931801|NCT01297959|11048987|FG001|STARTED|Overall Study||242
9931802|NCT01297959|11048986|FG000|COMPLETED|Overall Study||241
9931803|NCT01297959|11048987|FG001|COMPLETED|Overall Study||226
9931804|NCT01297959|11048986|FG000|NOT COMPLETED|Overall Study||20
9931805|NCT01297959|11048987|FG001|NOT COMPLETED|Overall Study||16
9931806|NCT01297985|11048995|FG000|STARTED|Overall Study||212
9931807|NCT01297985|11048996|FG001|STARTED|Overall Study||216
9931808|NCT01297985|11048995|FG000|COMPLETED|Overall Study||157
9931809|NCT01297985|11048996|FG001|COMPLETED|Overall Study||163
9931810|NCT01297985|11048995|FG000|NOT COMPLETED|Overall Study||55
9931811|NCT01297985|11048996|FG001|NOT COMPLETED|Overall Study||53
9931812|NCT01298063|11049007|FG000|STARTED|Overall Study||8
9931813|NCT01298063|11049008|FG001|STARTED|Overall Study||3
9931814|NCT01298063|11049009|FG002|STARTED|Overall Study||8
9931815|NCT01298063|11049010|FG003|STARTED|Overall Study||8
9931816|NCT01298063|11049011|FG004|STARTED|Overall Study||8
9931817|NCT01298063|11049007|FG000|COMPLETED|Overall Study||8
9931818|NCT01298063|11049008|FG001|COMPLETED|Overall Study||3
9931819|NCT01298063|11049009|FG002|COMPLETED|Overall Study||8
9931820|NCT01298063|11049010|FG003|COMPLETED|Overall Study||8
9931821|NCT01298063|11049011|FG004|COMPLETED|Overall Study||8
9931822|NCT01298063|11049007|FG000|NOT COMPLETED|Overall Study||0
9931823|NCT01298063|11049008|FG001|NOT COMPLETED|Overall Study||0
9931824|NCT01298063|11049009|FG002|NOT COMPLETED|Overall Study||0
9931825|NCT01298063|11049010|FG003|NOT COMPLETED|Overall Study||0
9931826|NCT01298063|11049011|FG004|NOT COMPLETED|Overall Study||0
9931827|NCT01298128|11049026|FG000|STARTED|Overall Study||35
9931828|NCT01298128|11049027|FG001|STARTED|Overall Study||35
9931829|NCT01298128|11049026|FG000|COMPLETED|Overall Study||26
9931830|NCT01298128|11049027|FG001|COMPLETED|Overall Study||27
9931831|NCT01298128|11049026|FG000|NOT COMPLETED|Overall Study||9
9931832|NCT01298128|11049027|FG001|NOT COMPLETED|Overall Study||8
9931833|NCT01298141|11049033|FG000|STARTED|Overall Study||171
9931834|NCT01298141|11049033|FG000|Treated|Overall Study||167
9931835|NCT01298141|11049033|FG000|COMPLETED|Overall Study||140
9931836|NCT01298141|11049033|FG000|NOT COMPLETED|Overall Study||31
9931837|NCT01298167|11049039|FG000|STARTED|Overall Study||6
9931838|NCT01298167|11049040|FG001|STARTED|Overall Study||8
9931839|NCT01298167|11049039|FG000|COMPLETED|Overall Study||5
9931840|NCT01298167|11049040|FG001|COMPLETED|Overall Study||8
9931841|NCT01298167|11049039|FG000|NOT COMPLETED|Overall Study||1
9931842|NCT01298167|11049040|FG001|NOT COMPLETED|Overall Study||0
9931843|NCT01298193|11049046|FG000|STARTED|Observational Phase (First Cycle)||212
9931844|NCT01298193|11049046|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
9931845|NCT01298193|11049046|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27
9931846|NCT01298193|11049046|FG000|STARTED|Efficacy Phase (Second Cycle)||24
9931847|NCT01298193|11049046|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23
9931848|NCT01298193|11049046|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
9931849|NCT01298219|11049055|FG000|STARTED|Overall Study||219
9931850|NCT01298219|11049056|FG001|STARTED|Overall Study||220
9931851|NCT01298219|11049055|FG000|Intention to Treat (ITT)|Overall Study||219
9931852|NCT01298219|11049056|FG001|Intention to Treat (ITT)|Overall Study||220
9931853|NCT01298219|11049055|FG000|Safety Analysis Set|Overall Study||219
9931854|NCT01298219|11049056|FG001|Safety Analysis Set|Overall Study||220
9931855|NCT01298219|11049055|FG000|COMPLETED|Overall Study||169
9931856|NCT01298219|11049056|FG001|COMPLETED|Overall Study||184
9931857|NCT01298219|11049055|FG000|NOT COMPLETED|Overall Study||50
9931858|NCT01298219|11049056|FG001|NOT COMPLETED|Overall Study||36
9931859|NCT01298323|11049064|FG000|STARTED|Overall Study||102
9931860|NCT01298323|11049065|FG001|STARTED|Overall Study||103
9931861|NCT01298323|11049064|FG000|Ongoing|Overall Study||55
9931862|NCT01298323|11049065|FG001|Ongoing|Overall Study||55
9931863|NCT01298323|11049064|FG000|COMPLETED|Overall Study||16
9931864|NCT01298323|11049065|FG001|COMPLETED|Overall Study||15
9931865|NCT01298323|11049064|FG000|NOT COMPLETED|Overall Study||86
9931866|NCT01298323|11049065|FG001|NOT COMPLETED|Overall Study||88
9931867|NCT01298362|11049073|FG000|STARTED|Overall Study||124
9931868|NCT01298362|11049074|FG001|STARTED|Overall Study||166
9931869|NCT01298362|11049073|FG000|COMPLETED|Overall Study||86
9931870|NCT01298362|11049074|FG001|COMPLETED|Overall Study||123
9931871|NCT01298362|11049073|FG000|NOT COMPLETED|Overall Study||38
9931872|NCT01298362|11049074|FG001|NOT COMPLETED|Overall Study||43
9931873|NCT01298492|11049082|FG000|STARTED|Overall Study||268
9931874|NCT01298492|11049082|FG000|COMPLETED|Overall Study||149
9931875|NCT01298492|11049082|FG000|NOT COMPLETED|Overall Study||119
9931876|NCT01298518|11049089|FG000|STARTED|Overall Study||16
9931877|NCT01298518|11049090|FG001|STARTED|Overall Study||16
9931878|NCT01298518|11049091|FG002|STARTED|Overall Study||16
9931879|NCT01298518|11049089|FG000|COMPLETED|Overall Study||16
9931880|NCT01298518|11049090|FG001|COMPLETED|Overall Study||16
9931881|NCT01298518|11049091|FG002|COMPLETED|Overall Study||15
9931882|NCT01298518|11049089|FG000|NOT COMPLETED|Overall Study||0
9931883|NCT01298518|11049090|FG001|NOT COMPLETED|Overall Study||0
9931884|NCT01298518|11049091|FG002|NOT COMPLETED|Overall Study||1
9931885|NCT01298531|11049101|FG000|STARTED|Overall Study||42
9931886|NCT01298531|11049102|FG001|STARTED|Overall Study||48
9931887|NCT01298531|11049101|FG000|COMPLETED|Overall Study||33
9931888|NCT01298531|11049102|FG001|COMPLETED|Overall Study||41
9931889|NCT01298531|11049101|FG000|NOT COMPLETED|Overall Study||9
9931890|NCT01298531|11049102|FG001|NOT COMPLETED|Overall Study||7
9931891|NCT01298544|11049109|FG000|STARTED|Overall Study||335
9931892|NCT01298544|11049109|FG000|COMPLETED|Overall Study||335
9931893|NCT01298544|11049109|FG000|NOT COMPLETED|Overall Study||0
9931894|NCT01298570|11049117|FG000|STARTED|Overall Study||120
9931895|NCT01298570|11049118|FG001|STARTED|Overall Study||61
9931896|NCT01298570|11049117|FG000|COMPLETED|Overall Study||0
9931897|NCT01298570|11049118|FG001|COMPLETED|Overall Study||0
9931898|NCT01298570|11049117|FG000|NOT COMPLETED|Overall Study||120
9931899|NCT01298570|11049118|FG001|NOT COMPLETED|Overall Study||61
9931900|NCT01298596|11049126|FG000|STARTED|Overall Study||200
9931901|NCT01298596|11049127|FG001|STARTED|Overall Study||200
9931902|NCT01298596|11049126|FG000|COMPLETED|Overall Study||172
9931903|NCT01298596|11049127|FG001|COMPLETED|Overall Study||167
9931904|NCT01298596|11049126|FG000|NOT COMPLETED|Overall Study||28
9931905|NCT01298596|11049127|FG001|NOT COMPLETED|Overall Study||33
9931906|NCT01298648|11049133|FG000|STARTED|Overall Study||1716
9931907|NCT01298648|11049133|FG000|COMPLETED|Overall Study||1693
9931908|NCT01298648|11049133|FG000|NOT COMPLETED|Overall Study||23
9931909|NCT01298661|11049140|FG000|STARTED|Overall Study||33
9931910|NCT01298661|11049141|FG001|STARTED|Overall Study||24
9931911|NCT01298661|11049142|FG002|STARTED|Overall Study||34
9931912|NCT01298661|11049140|FG000|COMPLETED|Overall Study||31
9931913|NCT01298661|11049141|FG001|COMPLETED|Overall Study||24
9931914|NCT01298661|11049142|FG002|COMPLETED|Overall Study||32
9931915|NCT01298661|11049140|FG000|NOT COMPLETED|Overall Study||2
9931916|NCT01298661|11049141|FG001|NOT COMPLETED|Overall Study||0
9931917|NCT01298661|11049142|FG002|NOT COMPLETED|Overall Study||2
9931918|NCT01298700|11049153|FG000|STARTED|Overall Study||403
9931919|NCT01298700|11049154|FG001|STARTED|Overall Study||403
9931920|NCT01298700|11049153|FG000|Safety Population: Received Study Drug|Overall Study||400
9931921|NCT01298700|11049154|FG001|Safety Population: Received Study Drug|Overall Study||398
9931922|NCT01298700|11049153|FG000|COMPLETED|Overall Study||302
9931923|NCT01298700|11049154|FG001|COMPLETED|Overall Study||303
9931924|NCT01298700|11049153|FG000|NOT COMPLETED|Overall Study||101
9931925|NCT01298700|11049154|FG001|NOT COMPLETED|Overall Study||100
9931926|NCT01298752|11049162|FG000|STARTED|Overall Study||120
9931927|NCT01298752|11049163|FG001|STARTED|Overall Study||57
9931928|NCT01298752|11049162|FG000|COMPLETED|Overall Study||77
9931929|NCT01298752|11049163|FG001|COMPLETED|Overall Study||31
9931930|NCT01298752|11049162|FG000|NOT COMPLETED|Overall Study||43
9931931|NCT01298752|11049163|FG001|NOT COMPLETED|Overall Study||26
9931932|NCT01298765|11049169|FG000|STARTED|Titration Period||302
9931933|NCT01298765|11049169|FG000|COMPLETED|Titration Period||226
9931934|NCT01298765|11049169|FG000|NOT COMPLETED|Titration Period||76
9931935|NCT01298765|11049169|FG000|STARTED|Long-Term Treatment Period||226
9931936|NCT01298765|11049169|FG000|COMPLETED|Long-Term Treatment Period||127
9931937|NCT01298765|11049169|FG000|NOT COMPLETED|Long-Term Treatment Period||99
9931938|NCT01298778|11049175|FG000|STARTED|Overall Study||33
9931939|NCT01298778|11049176|FG001|STARTED|Overall Study||36
9931940|NCT01298778|11049175|FG000|COMPLETED|Overall Study||30
9931941|NCT01298778|11049176|FG001|COMPLETED|Overall Study||30
9931942|NCT01298778|11049175|FG000|NOT COMPLETED|Overall Study||3
9931943|NCT01298778|11049176|FG001|NOT COMPLETED|Overall Study||6
9931944|NCT01298999|11049186|FG000|STARTED|Overall Study||13
9931945|NCT01298999|11049187|FG001|STARTED|Overall Study||11
9931946|NCT01298999|11049186|FG000|COMPLETED|Overall Study||10
9931947|NCT01298999|11049187|FG001|COMPLETED|Overall Study||10
9931948|NCT01298999|11049186|FG000|NOT COMPLETED|Overall Study||3
9931949|NCT01298999|11049187|FG001|NOT COMPLETED|Overall Study||1
9931950|NCT01299025|11049195|FG000|STARTED|Overall Study||42
9931951|NCT01299025|11049196|FG001|STARTED|Overall Study||42
9931952|NCT01299025|11049195|FG000|COMPLETED|Overall Study||39
9931953|NCT01299025|11049196|FG001|COMPLETED|Overall Study||41
9931954|NCT01299025|11049195|FG000|NOT COMPLETED|Overall Study||3
9931955|NCT01299025|11049196|FG001|NOT COMPLETED|Overall Study||1
9931956|NCT01299038|11049204|FG000|STARTED|Overall Study|Consented|10
9931957|NCT01299038|11049205|FG001|STARTED|Overall Study|Consented|10
9931958|NCT01299038|11049204|FG000|COMPLETED|Overall Study|Evaluable|9
9931959|NCT01299038|11049205|FG001|COMPLETED|Overall Study|Evaluable|10
9931960|NCT01299038|11049204|FG000|NOT COMPLETED|Overall Study||1
9931961|NCT01299038|11049205|FG001|NOT COMPLETED|Overall Study||0
9931962|NCT01299077|11049211|FG000|STARTED|Overall Study||478
9931963|NCT01299077|11049211|FG000|COMPLETED|Overall Study||478
9931964|NCT01299077|11049211|FG000|NOT COMPLETED|Overall Study||0
9931965|NCT01299090|11049215|FG000|STARTED|Overall Study||49
9931966|NCT01299090|11049215|FG000|COMPLETED|Overall Study||49
9931967|NCT01299090|11049215|FG000|NOT COMPLETED|Overall Study||0
9931968|NCT01299103|11049222|FG000|STARTED|Overall Study||15
9931969|NCT01299103|11049223|FG001|STARTED|Overall Study||15
9931970|NCT01299103|11049224|FG002|STARTED|Overall Study||10
9931971|NCT01299103|11049222|FG000|COMPLETED|Overall Study||15
9931972|NCT01299103|11049223|FG001|COMPLETED|Overall Study||13
9931973|NCT01299103|11049224|FG002|COMPLETED|Overall Study||8
9931974|NCT01299103|11049222|FG000|NOT COMPLETED|Overall Study||0
9931975|NCT01299103|11049223|FG001|NOT COMPLETED|Overall Study||2
9931976|NCT01299103|11049224|FG002|NOT COMPLETED|Overall Study||2
9931977|NCT01299116|11049235|FG000|STARTED|Overall Study||522
9931978|NCT01299116|11049236|FG001|STARTED|Overall Study||177
9931979|NCT01299116|11049237|FG002|STARTED|Overall Study||195
9931980|NCT01299116|11049235|FG000|COMPLETED|Overall Study||457
9931981|NCT01299116|11049236|FG001|COMPLETED|Overall Study||168
9931982|NCT01299116|11049237|FG002|COMPLETED|Overall Study||184
9931983|NCT01299116|11049235|FG000|NOT COMPLETED|Overall Study||65
9931984|NCT01299116|11049236|FG001|NOT COMPLETED|Overall Study||9
9931985|NCT01299116|11049237|FG002|NOT COMPLETED|Overall Study||11
9931986|NCT01299272|11049248|FG000|STARTED|Acute Open-label (OL) Period||1249
9931987|NCT01299272|11049249|FG001|STARTED|Acute Open-label (OL) Period||0
9931988|NCT01299272|11049250|FG002|STARTED|Acute Open-label (OL) Period||0
9931989|NCT01299272|11049251|FG003|STARTED|Acute Open-label (OL) Period||0
9931990|NCT01299272|11049248|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
9931991|NCT01299272|11049249|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
9931992|NCT01299272|11049250|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
9931993|NCT01299272|11049251|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
9931994|NCT01299272|11049248|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
9931995|NCT01299272|11049249|FG001|COMPLETED|Acute Open-label (OL) Period||0
9931996|NCT01299272|11049250|FG002|COMPLETED|Acute Open-label (OL) Period||0
9931997|NCT01299272|11049251|FG003|COMPLETED|Acute Open-label (OL) Period||0
9931998|NCT01299272|11049248|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414
9931999|NCT01299272|11049249|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0
9932000|NCT01299272|11049250|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0
9932001|NCT01299272|11049251|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0
9932002|NCT01299272|11049248|FG000|STARTED|Stabilization Open-label (OL) Period||0
9932003|NCT01299272|11049249|FG001|STARTED|Stabilization Open-label (OL) Period||835
9932004|NCT01299272|11049250|FG002|STARTED|Stabilization Open-label (OL) Period||0
9932005|NCT01299272|11049251|FG003|STARTED|Stabilization Open-label (OL) Period||0
9932006|NCT01299272|11049248|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
9932007|NCT01299272|11049249|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
9932008|NCT01299272|11049250|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
9932009|NCT01299272|11049251|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
9932010|NCT01299272|11049248|FG000|COMPLETED|Stabilization Open-label (OL) Period||0
10206948|NCT03519867|11333730|FG008|COMPLETED|Overall Study||3
10206949|NCT03519867|11333731|FG009|COMPLETED|Overall Study||4
10206950|NCT03519867|11333722|FG000|NOT COMPLETED|Overall Study||3
10206951|NCT03519867|11333723|FG001|NOT COMPLETED|Overall Study||3
10206952|NCT03519867|11333724|FG002|NOT COMPLETED|Overall Study||1
9932011|NCT01299272|11049249|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
9932012|NCT01299272|11049250|FG002|COMPLETED|Stabilization Open-label (OL) Period||0
9932013|NCT01299272|11049251|FG003|COMPLETED|Stabilization Open-label (OL) Period||0
9932014|NCT01299272|11049248|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0
9932015|NCT01299272|11049249|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249
9932016|NCT01299272|11049250|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0
9932017|NCT01299272|11049251|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0
9932018|NCT01299272|11049248|FG000|STARTED|Double-blind (DB) Randomized Period||0
9932019|NCT01299272|11049249|FG001|STARTED|Double-blind (DB) Randomized Period||0
9932020|NCT01299272|11049250|FG002|STARTED|Double-blind (DB) Randomized Period||294
9932021|NCT01299272|11049251|FG003|STARTED|Double-blind (DB) Randomized Period||292
10206953|NCT03519867|11333725|FG003|NOT COMPLETED|Overall Study||1
10206954|NCT03519867|11333726|FG004|NOT COMPLETED|Overall Study||0
10206955|NCT03519867|11333727|FG005|NOT COMPLETED|Overall Study||3
9932022|NCT01299272|11049248|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
9932023|NCT01299272|11049249|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
9932024|NCT01299272|11049250|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
9932025|NCT01299272|11049251|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
9932026|NCT01299272|11049248|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
9932027|NCT01299272|11049249|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
9932028|NCT01299272|11049250|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
9932029|NCT01299272|11049251|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
9932030|NCT01299272|11049248|FG000|COMPLETED|Double-blind (DB) Randomized Period||0
9932031|NCT01299272|11049249|FG001|COMPLETED|Double-blind (DB) Randomized Period||0
9932032|NCT01299272|11049250|FG002|COMPLETED|Double-blind (DB) Randomized Period||224
9932033|NCT01299272|11049251|FG003|COMPLETED|Double-blind (DB) Randomized Period||234
9932034|NCT01299272|11049248|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0
9932035|NCT01299272|11049249|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0
9932036|NCT01299272|11049250|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70
9932037|NCT01299272|11049251|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58
9932038|NCT01299285|11049265|FG000|STARTED|Overall Study||6
9932039|NCT01299285|11049265|FG000|COMPLETED|Overall Study||6
9932040|NCT01299285|11049265|FG000|NOT COMPLETED|Overall Study||0
10111594|NCT02497235|11242632|FG004|COMPLETED|Overall Study||3
10010958|NCT01777282|11133653|FG002|STARTED|Overall Study||65
10010959|NCT01777282|11133654|FG003|STARTED|Overall Study||61
10010960|NCT01777282|11133655|FG004|STARTED|Overall Study||61
10010961|NCT01777282|11133651|FG000|Completing Treatment Period|Overall Study||109
10010962|NCT01777282|11133652|FG001|Completing Treatment Period|Overall Study||63
9932041|NCT01299376|11049273|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
9932042|NCT01299376|11049274|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
9932043|NCT01299376|11049273|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
9932044|NCT01299376|11049274|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
9932045|NCT01299376|11049273|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
9932046|NCT01299376|11049274|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
9932047|NCT01299376|11049273|FG000|STARTED|Extension (Weeks 9 to 52)||134
9932048|NCT01299376|11049274|FG001|STARTED|Extension (Weeks 9 to 52)||133
9932049|NCT01299376|11049273|FG000|COMPLETED|Extension (Weeks 9 to 52)||124
9932050|NCT01299376|11049274|FG001|COMPLETED|Extension (Weeks 9 to 52)||118
9932051|NCT01299376|11049273|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10
9932052|NCT01299376|11049274|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15
9932053|NCT01299389|11049286|FG000|STARTED|Double-blind||164
9932054|NCT01299389|11049287|FG001|STARTED|Double-blind||159
9932055|NCT01299389|11049288|FG002|STARTED|Double-blind||0
9932056|NCT01299389|11049289|FG003|STARTED|Double-blind||0
9932057|NCT01299389|11049286|FG000|COMPLETED|Double-blind||55
9932058|NCT01299389|11049287|FG001|COMPLETED|Double-blind||95
9932059|NCT01299389|11049288|FG002|COMPLETED|Double-blind||0
9932060|NCT01299389|11049289|FG003|COMPLETED|Double-blind||0
9932061|NCT01299389|11049286|FG000|NOT COMPLETED|Double-blind||109
9932062|NCT01299389|11049287|FG001|NOT COMPLETED|Double-blind||64
9932063|NCT01299389|11049288|FG002|NOT COMPLETED|Double-blind||0
9932064|NCT01299389|11049289|FG003|NOT COMPLETED|Double-blind||0
9932065|NCT01299389|11049286|FG000|STARTED|Post-observational||0
9932066|NCT01299389|11049287|FG001|STARTED|Post-observational||0
9932067|NCT01299389|11049288|FG002|STARTED|Post-observational||156
9932068|NCT01299389|11049289|FG003|STARTED|Post-observational||155
9932069|NCT01299389|11049286|FG000|COMPLETED|Post-observational||0
9932070|NCT01299389|11049287|FG001|COMPLETED|Post-observational||0
9932071|NCT01299389|11049288|FG002|COMPLETED|Post-observational||144
9932072|NCT01299389|11049289|FG003|COMPLETED|Post-observational||149
9932073|NCT01299389|11049286|FG000|NOT COMPLETED|Post-observational||0
9932074|NCT01299389|11049287|FG001|NOT COMPLETED|Post-observational||0
9932075|NCT01299389|11049288|FG002|NOT COMPLETED|Post-observational||12
9932076|NCT01299389|11049289|FG003|NOT COMPLETED|Post-observational||6
9932077|NCT01299454|11049302|FG000|STARTED|Overall Study||8
9932078|NCT01299454|11049303|FG001|STARTED|Overall Study||8
9932079|NCT01299454|11049304|FG002|STARTED|Overall Study||6
9932080|NCT01299454|11049305|FG003|STARTED|Overall Study||23
9932081|NCT01299454|11049302|FG000|COMPLETED|Overall Study||8
9932082|NCT01299454|11049303|FG001|COMPLETED|Overall Study||8
10010963|NCT01777282|11133653|FG002|Completing Treatment Period|Overall Study||59
10010964|NCT01777282|11133654|FG003|Completing Treatment Period|Overall Study||59
10010965|NCT01777282|11133655|FG004|Completing Treatment Period|Overall Study||54
10010966|NCT01777282|11133651|FG000|Completing Follow-up Period|Overall Study||109
10010967|NCT01777282|11133652|FG001|Completing Follow-up Period|Overall Study||63
10111595|NCT02497235|11242628|FG000|NOT COMPLETED|Overall Study||0
9932083|NCT01299454|11049304|FG002|COMPLETED|Overall Study||6
9932084|NCT01299454|11049305|FG003|COMPLETED|Overall Study||23
10010968|NCT01777282|11133653|FG002|Completing Follow-up Period|Overall Study||59
10010969|NCT01777282|11133654|FG003|Completing Follow-up Period|Overall Study||59
10010970|NCT01777282|11133655|FG004|Completing Follow-up Period|Overall Study||54
10010971|NCT01777282|11133651|FG000|COMPLETED|Overall Study||109
9932085|NCT01299454|11049302|FG000|NOT COMPLETED|Overall Study||0
9932086|NCT01299454|11049303|FG001|NOT COMPLETED|Overall Study||0
9932087|NCT01299454|11049304|FG002|NOT COMPLETED|Overall Study||0
9932088|NCT01299454|11049305|FG003|NOT COMPLETED|Overall Study||0
9932089|NCT01299480|11049346|FG000|STARTED|Overall Study||427
9932090|NCT01299480|11049347|FG001|STARTED|Overall Study||430
9932091|NCT01299480|11049348|FG002|STARTED|Overall Study||427
9932092|NCT01299480|11049349|FG003|STARTED|Overall Study||286
9932093|NCT01299480|11049350|FG004|STARTED|Overall Study||143
9932094|NCT01299480|11049346|FG000|COMPLETED|Overall Study||385
9932095|NCT01299480|11049347|FG001|COMPLETED|Overall Study||395
9932096|NCT01299480|11049348|FG002|COMPLETED|Overall Study||386
9932097|NCT01299480|11049349|FG003|COMPLETED|Overall Study||261
9932098|NCT01299480|11049350|FG004|COMPLETED|Overall Study||123
9932099|NCT01299480|11049346|FG000|NOT COMPLETED|Overall Study||42
9932100|NCT01299480|11049347|FG001|NOT COMPLETED|Overall Study||35
9932101|NCT01299480|11049348|FG002|NOT COMPLETED|Overall Study||41
9932102|NCT01299480|11049349|FG003|NOT COMPLETED|Overall Study||25
9932103|NCT01299480|11049350|FG004|NOT COMPLETED|Overall Study||20
9932104|NCT01299571|11049363|FG000|STARTED|Overall Study||3977
9932105|NCT01299571|11049363|FG000|COMPLETED|Overall Study||3870
9932106|NCT01299571|11049363|FG000|NOT COMPLETED|Overall Study||107
9932107|NCT01299584|11049368|FG000|STARTED|Overall Study||775
9932108|NCT01299584|11049368|FG000|COMPLETED|Overall Study||766
9932109|NCT01299584|11049368|FG000|NOT COMPLETED|Overall Study||9
9932110|NCT01299610|11049375|FG000|STARTED|Overall Study||10
9932111|NCT01299610|11049376|FG001|STARTED|Overall Study||5
9932112|NCT01299610|11049377|FG002|STARTED|Overall Study||10
9932113|NCT01299610|11049375|FG000|COMPLETED|Overall Study||10
9932114|NCT01299610|11049376|FG001|COMPLETED|Overall Study||5
9932115|NCT01299610|11049377|FG002|COMPLETED|Overall Study||10
9932116|NCT01299610|11049375|FG000|NOT COMPLETED|Overall Study||0
9932117|NCT01299610|11049376|FG001|NOT COMPLETED|Overall Study||0
9932118|NCT01299610|11049377|FG002|NOT COMPLETED|Overall Study||0
9932119|NCT01299727|11049392|FG000|STARTED|Overall Study||4
9932120|NCT01299727|11049393|FG001|STARTED|Overall Study||4
9932121|NCT01299727|11049394|FG002|STARTED|Overall Study||4
9932122|NCT01299727|11049392|FG000|COMPLETED|Overall Study||0
9932123|NCT01299727|11049393|FG001|COMPLETED|Overall Study||0
9932124|NCT01299727|11049394|FG002|COMPLETED|Overall Study||0
9932125|NCT01299727|11049392|FG000|NOT COMPLETED|Overall Study||4
9932126|NCT01299727|11049393|FG001|NOT COMPLETED|Overall Study||4
9932127|NCT01299727|11049394|FG002|NOT COMPLETED|Overall Study||4
9932128|NCT01299766|11049404|FG000|STARTED|Overall Study||111
9932129|NCT01299766|11049405|FG001|STARTED|Overall Study||110
9932130|NCT01299766|11049404|FG000|COMPLETED|Overall Study||77
9932131|NCT01299766|11049405|FG001|COMPLETED|Overall Study||87
9932132|NCT01299766|11049404|FG000|NOT COMPLETED|Overall Study||34
9932133|NCT01299766|11049405|FG001|NOT COMPLETED|Overall Study||23
9932134|NCT01299805|11049413|FG000|STARTED|Overall Study||12
9932135|NCT01299805|11049414|FG001|STARTED|Overall Study||5
9932136|NCT01299805|11049413|FG000|COMPLETED|Overall Study||10
9932137|NCT01299805|11049414|FG001|COMPLETED|Overall Study||5
9932138|NCT01299805|11049413|FG000|NOT COMPLETED|Overall Study||2
9932139|NCT01299805|11049414|FG001|NOT COMPLETED|Overall Study||0
9932140|NCT01299896|11049422|FG000|STARTED|Overall Study||319
9932141|NCT01299896|11049423|FG001|STARTED|Overall Study||314
9932142|NCT01299896|11049422|FG000|COMPLETED|Overall Study||318
9932143|NCT01299896|11049423|FG001|COMPLETED|Overall Study||296
9932144|NCT01299896|11049422|FG000|NOT COMPLETED|Overall Study||1
9932145|NCT01299896|11049423|FG001|NOT COMPLETED|Overall Study||18
9932146|NCT01299909|11049432|FG000|STARTED|Overall Study||68
9932147|NCT01299909|11049433|FG001|STARTED|Overall Study||67
9932148|NCT01299909|11049434|FG002|STARTED|Overall Study||40
9932149|NCT01299909|11049432|FG000|COMPLETED|Overall Study||46
9932150|NCT01299909|11049433|FG001|COMPLETED|Overall Study||49
9932151|NCT01299909|11049434|FG002|COMPLETED|Overall Study||23
9932152|NCT01299909|11049432|FG000|NOT COMPLETED|Overall Study||22
9932153|NCT01299909|11049433|FG001|NOT COMPLETED|Overall Study||18
9932154|NCT01299909|11049434|FG002|NOT COMPLETED|Overall Study||17
9932155|NCT01299961|11049441|FG000|STARTED|Overall Study||25
9932156|NCT01299961|11049441|FG000|COMPLETED|Overall Study||19
9932157|NCT01299961|11049441|FG000|NOT COMPLETED|Overall Study||6
9932158|NCT01300052|11049447|FG000|STARTED|Overall Study||46
9932159|NCT01300052|11049448|FG001|STARTED|Overall Study||22
9932160|NCT01300052|11049447|FG000|COMPLETED|Overall Study||40
9932161|NCT01300052|11049448|FG001|COMPLETED|Overall Study||19
9932162|NCT01300052|11049447|FG000|NOT COMPLETED|Overall Study||6
9932163|NCT01300052|11049448|FG001|NOT COMPLETED|Overall Study||3
9932164|NCT01300065|11049456|FG000|STARTED|Overall Study||221
9932165|NCT01300065|11049457|FG001|STARTED|Overall Study||220
9932166|NCT01300065|11049456|FG000|COMPLETED|Overall Study||215
9932167|NCT01300065|11049457|FG001|COMPLETED|Overall Study||217
9932168|NCT01300065|11049456|FG000|NOT COMPLETED|Overall Study||6
9932169|NCT01300065|11049457|FG001|NOT COMPLETED|Overall Study||3
9932170|NCT01300234|11049465|FG000|STARTED|Overall Study||257
9932171|NCT01300234|11049466|FG001|STARTED|Overall Study||255
9932172|NCT01300234|11049465|FG000|COMPLETED|Overall Study||229
9932173|NCT01300234|11049466|FG001|COMPLETED|Overall Study||228
9932174|NCT01300234|11049465|FG000|NOT COMPLETED|Overall Study||28
9932175|NCT01300234|11049466|FG001|NOT COMPLETED|Overall Study||27
9932176|NCT01300247|11049485|FG000|STARTED|Overall Study||21
9932177|NCT01300247|11049486|FG001|STARTED|Overall Study||20
9932178|NCT01300247|11049485|FG000|COMPLETED|Overall Study||17
9932179|NCT01300247|11049486|FG001|COMPLETED|Overall Study||18
9932180|NCT01300247|11049485|FG000|NOT COMPLETED|Overall Study||4
9932181|NCT01300247|11049486|FG001|NOT COMPLETED|Overall Study||2
9932182|NCT01300260|11049494|FG000|STARTED|Period 1 of Study: First Intervention||15
9932183|NCT01300260|11049495|FG001|STARTED|Period 1 of Study: First Intervention||17
9932184|NCT01300260|11049494|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
9932185|NCT01300260|11049495|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
9932186|NCT01300260|11049494|FG000|COMPLETED|Period 1 of Study: First Intervention||14
9932187|NCT01300260|11049495|FG001|COMPLETED|Period 1 of Study: First Intervention||16
9932188|NCT01300260|11049494|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1
9932189|NCT01300260|11049495|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1
9932190|NCT01300260|11049494|FG000|STARTED|Washout Period of at Least 28 Days||14
9932191|NCT01300260|11049495|FG001|STARTED|Washout Period of at Least 28 Days||16
9932192|NCT01300260|11049494|FG000|COMPLETED|Washout Period of at Least 28 Days||14
9932193|NCT01300260|11049495|FG001|COMPLETED|Washout Period of at Least 28 Days||16
9932194|NCT01300260|11049494|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
9932195|NCT01300260|11049495|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
9932196|NCT01300260|11049494|FG000|STARTED|Period 2 of Study: Second Intervention||14
9932197|NCT01300260|11049495|FG001|STARTED|Period 2 of Study: Second Intervention||16
9932198|NCT01300260|11049494|FG000|COMPLETED|Period 2 of Study: Second Intervention||14
9932199|NCT01300260|11049495|FG001|COMPLETED|Period 2 of Study: Second Intervention||15
9932200|NCT01300260|11049494|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0
9932201|NCT01300260|11049495|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1
9932202|NCT01300286|11049512|FG000|STARTED|Overall Study||23
9932203|NCT01300286|11049512|FG000|COMPLETED|Overall Study||22
9932204|NCT01300286|11049512|FG000|NOT COMPLETED|Overall Study||1
9932205|NCT01300338|11049519|FG000|STARTED|Overall Study||25
9932206|NCT01300338|11049520|FG001|STARTED|Overall Study||25
9932207|NCT01300338|11049519|FG000|COMPLETED|Overall Study||20
9932208|NCT01300338|11049520|FG001|COMPLETED|Overall Study||25
9932209|NCT01300338|11049519|FG000|NOT COMPLETED|Overall Study||5
9932210|NCT01300338|11049520|FG001|NOT COMPLETED|Overall Study||0
9932211|NCT01300351|11049528|FG000|STARTED|Overall Study||111
9932212|NCT01300351|11049529|FG001|STARTED|Overall Study||110
9932213|NCT01300351|11049528|FG000|Received Study Treatment|Overall Study||109
9932214|NCT01300351|11049529|FG001|Received Study Treatment|Overall Study||110
9932215|NCT01300351|11049528|FG000|COMPLETED|Overall Study||75
9932216|NCT01300351|11049529|FG001|COMPLETED|Overall Study||72
9932217|NCT01300351|11049528|FG000|NOT COMPLETED|Overall Study||36
9932218|NCT01300351|11049529|FG001|NOT COMPLETED|Overall Study||38
9932219|NCT01300455|11049537|FG000|STARTED|Period 1||13
9932220|NCT01300455|11049538|FG001|STARTED|Period 1||13
9932221|NCT01300455|11049537|FG000|COMPLETED|Period 1||13
9932222|NCT01300455|11049538|FG001|COMPLETED|Period 1||13
9932223|NCT01300455|11049537|FG000|NOT COMPLETED|Period 1||0
9932224|NCT01300455|11049538|FG001|NOT COMPLETED|Period 1||0
9932225|NCT01300455|11049537|FG000|STARTED|Washout||13
9932226|NCT01300455|11049538|FG001|STARTED|Washout||13
9932227|NCT01300455|11049537|FG000|COMPLETED|Washout||12
9932228|NCT01300455|11049538|FG001|COMPLETED|Washout||13
9932229|NCT01300455|11049537|FG000|NOT COMPLETED|Washout||1
9932230|NCT01300455|11049538|FG001|NOT COMPLETED|Washout||0
9932231|NCT01300455|11049537|FG000|STARTED|Period 2||12
9932232|NCT01300455|11049538|FG001|STARTED|Period 2||13
9932233|NCT01300455|11049537|FG000|COMPLETED|Period 2||12
9932234|NCT01300455|11049538|FG001|COMPLETED|Period 2||13
9932235|NCT01300455|11049537|FG000|NOT COMPLETED|Period 2||0
9932236|NCT01300455|11049538|FG001|NOT COMPLETED|Period 2||0
9932237|NCT01300546|11049546|FG000|STARTED|Overall Study||19
9932238|NCT01300546|11049547|FG001|STARTED|Overall Study||20
9932239|NCT01300546|11049546|FG000|COMPLETED|Overall Study||18
9932240|NCT01300546|11049547|FG001|COMPLETED|Overall Study||14
9932241|NCT01300546|11049546|FG000|NOT COMPLETED|Overall Study||1
9932242|NCT01300546|11049547|FG001|NOT COMPLETED|Overall Study||6
9932243|NCT01300559|11049555|FG000|STARTED|Overall Study||30
9932244|NCT01300559|11049556|FG001|STARTED|Overall Study||30
9932245|NCT01300559|11049555|FG000|COMPLETED|Overall Study||30
9932246|NCT01300559|11049556|FG001|COMPLETED|Overall Study||30
9932247|NCT01300559|11049555|FG000|NOT COMPLETED|Overall Study||0
9932248|NCT01300559|11049556|FG001|NOT COMPLETED|Overall Study||0
9932249|NCT01300572|11049562|FG000|STARTED|Overall Study||16
9932250|NCT01300572|11049562|FG000|COMPLETED|Overall Study||15
9932251|NCT01300572|11049562|FG000|NOT COMPLETED|Overall Study||1
9932252|NCT01300624|11049567|FG000|STARTED|Overall Study||11
9932253|NCT01300624|11049567|FG000|COMPLETED|Overall Study||11
9932254|NCT01300624|11049567|FG000|NOT COMPLETED|Overall Study||0
9932255|NCT01300650|11049572|FG000|STARTED|Overall Study||8
9932256|NCT01300650|11049572|FG000|COMPLETED|Overall Study||7
9932257|NCT01300650|11049572|FG000|NOT COMPLETED|Overall Study||1
9932258|NCT01300728|11049579|FG000|STARTED|Overall Study||26
9932259|NCT01300728|11049580|FG001|STARTED|Overall Study||26
9932260|NCT01300728|11049579|FG000|COMPLETED|Overall Study||24
9932261|NCT01300728|11049580|FG001|COMPLETED|Overall Study||25
9932262|NCT01300728|11049579|FG000|NOT COMPLETED|Overall Study||2
9932263|NCT01300728|11049580|FG001|NOT COMPLETED|Overall Study||1
9932264|NCT01300741|11049586|FG000|STARTED|Overall Study||75
9932265|NCT01300741|11049586|FG000|COMPLETED|Overall Study||72
9932266|NCT01300741|11049586|FG000|NOT COMPLETED|Overall Study||3
9932267|NCT01300767|11049592|FG000|STARTED|Overall Study||74
9932268|NCT01300767|11049592|FG000|COMPLETED|Overall Study||70
9932269|NCT01300767|11049592|FG000|NOT COMPLETED|Overall Study||4
9932270|NCT01300819|11049600|FG000|STARTED|Overall Study||125
9932271|NCT01300819|11049601|FG001|STARTED|Overall Study||224
9932272|NCT01300819|11049600|FG000|COMPLETED|Overall Study||103
9932273|NCT01300819|11049601|FG001|COMPLETED|Overall Study||180
9932274|NCT01300819|11049600|FG000|NOT COMPLETED|Overall Study||22
9932275|NCT01300819|11049601|FG001|NOT COMPLETED|Overall Study||44
9932276|NCT01300923|11049607|FG000|STARTED|Overall Study||12
9932277|NCT01300923|11049608|FG001|STARTED|Overall Study||2
9932278|NCT01300923|11049607|FG000|COMPLETED|Overall Study||12
9932279|NCT01300923|11049608|FG001|COMPLETED|Overall Study||0
9932280|NCT01300923|11049607|FG000|NOT COMPLETED|Overall Study||0
9932281|NCT01300923|11049608|FG001|NOT COMPLETED|Overall Study||2
9932282|NCT01300949|11049616|FG000|STARTED|Overall Study||154
9932283|NCT01300949|11049617|FG001|STARTED|Overall Study||125
9932284|NCT01300949|11049618|FG002|STARTED|Overall Study||35
9932285|NCT01300949|11049616|FG000|COMPLETED|Overall Study||154
9932286|NCT01300949|11049617|FG001|COMPLETED|Overall Study||125
9932287|NCT01300949|11049618|FG002|COMPLETED|Overall Study||35
9932288|NCT01300949|11049616|FG000|NOT COMPLETED|Overall Study||0
9932289|NCT01300949|11049617|FG001|NOT COMPLETED|Overall Study||0
9932290|NCT01300949|11049618|FG002|NOT COMPLETED|Overall Study||0
9932291|NCT01301001|11049626|FG000|STARTED|First Intervention||44
9932292|NCT01301001|11049627|FG001|STARTED|First Intervention||45
9932293|NCT01301001|11049626|FG000|COMPLETED|First Intervention||34
9932294|NCT01301001|11049627|FG001|COMPLETED|First Intervention||36
9932295|NCT01301001|11049626|FG000|NOT COMPLETED|First Intervention||10
9932296|NCT01301001|11049627|FG001|NOT COMPLETED|First Intervention||9
9932297|NCT01301001|11049626|FG000|STARTED|Washout (2 Weeks)||34
9932298|NCT01301001|11049627|FG001|STARTED|Washout (2 Weeks)||36
9932299|NCT01301001|11049626|FG000|COMPLETED|Washout (2 Weeks)||34
9932300|NCT01301001|11049627|FG001|COMPLETED|Washout (2 Weeks)||36
9932301|NCT01301001|11049626|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9932302|NCT01301001|11049627|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9932303|NCT01301001|11049626|FG000|STARTED|Second Intervention||34
9932304|NCT01301001|11049627|FG001|STARTED|Second Intervention||36
9932305|NCT01301001|11049626|FG000|COMPLETED|Second Intervention||30
9932306|NCT01301001|11049627|FG001|COMPLETED|Second Intervention||36
9932307|NCT01301001|11049626|FG000|NOT COMPLETED|Second Intervention||4
9932308|NCT01301001|11049627|FG001|NOT COMPLETED|Second Intervention||0
9932309|NCT01301027|11049636|FG000|STARTED|Overall Study||48
9932310|NCT01301027|11049637|FG001|STARTED|Overall Study||47
9932311|NCT01301027|11049636|FG000|COMPLETED|Overall Study||40
9932312|NCT01301027|11049637|FG001|COMPLETED|Overall Study||37
9932313|NCT01301027|11049636|FG000|NOT COMPLETED|Overall Study||8
9932314|NCT01301027|11049637|FG001|NOT COMPLETED|Overall Study||10
9932315|NCT01301066|11049645|FG000|STARTED|Overall Study||126
9932316|NCT01301066|11049646|FG001|STARTED|Overall Study||126
9932317|NCT01301066|11049645|FG000|COMPLETED|Overall Study||99
9932318|NCT01301066|11049646|FG001|COMPLETED|Overall Study||91
9932319|NCT01301066|11049645|FG000|NOT COMPLETED|Overall Study||27
9932320|NCT01301066|11049646|FG001|NOT COMPLETED|Overall Study||35
9932321|NCT01301079|11049654|FG000|STARTED|Overall Study||30
9932322|NCT01301079|11049655|FG001|STARTED|Overall Study||30
9932323|NCT01301079|11049654|FG000|COMPLETED|Overall Study||28
9932324|NCT01301079|11049655|FG001|COMPLETED|Overall Study||28
9932325|NCT01301079|11049654|FG000|NOT COMPLETED|Overall Study||2
9932326|NCT01301079|11049655|FG001|NOT COMPLETED|Overall Study||2
9932327|NCT01301092|11049668|FG000|STARTED|Overall Study||6
9932328|NCT01301092|11049669|FG001|STARTED|Overall Study||16
9932329|NCT01301092|11049670|FG002|STARTED|Overall Study||8
9932330|NCT01301092|11049668|FG000|COMPLETED|Overall Study||6
9932331|NCT01301092|11049669|FG001|COMPLETED|Overall Study||16
9932332|NCT01301092|11049670|FG002|COMPLETED|Overall Study||7
9932333|NCT01301092|11049668|FG000|NOT COMPLETED|Overall Study||0
9932334|NCT01301092|11049669|FG001|NOT COMPLETED|Overall Study||0
9932335|NCT01301092|11049670|FG002|NOT COMPLETED|Overall Study||1
9932336|NCT01301183|11049685|FG000|STARTED|Overall Study||38
9932337|NCT01301183|11049686|FG001|STARTED|Overall Study||37
9932338|NCT01301183|11049685|FG000|COMPLETED|Overall Study||12
9932339|NCT01301183|11049686|FG001|COMPLETED|Overall Study||21
9932340|NCT01301183|11049685|FG000|NOT COMPLETED|Overall Study||26
9932341|NCT01301183|11049686|FG001|NOT COMPLETED|Overall Study||16
9956280|NCT01444651|11075436|FG000|STARTED|Overall Study||36
9956281|NCT01444651|11075437|FG001|STARTED|Overall Study||37
9956282|NCT01444651|11075436|FG000|COMPLETED|Overall Study||25
9956283|NCT01444651|11075437|FG001|COMPLETED|Overall Study||28
9956284|NCT01444651|11075436|FG000|NOT COMPLETED|Overall Study||11
9956285|NCT01444651|11075437|FG001|NOT COMPLETED|Overall Study||9
9956286|NCT01444716|11075443|FG000|STARTED|Overall Study||34
9956287|NCT01444716|11075443|FG000|COMPLETED|Overall Study||34
9956288|NCT01444716|11075443|FG000|NOT COMPLETED|Overall Study||0
9956289|NCT01444742|11075447|FG000|STARTED|Overall Study||81
9956290|NCT01444742|11075447|FG000|COMPLETED|Overall Study||80
9956291|NCT01444742|11075447|FG000|NOT COMPLETED|Overall Study||1
9956292|NCT01444781|11075454|FG000|STARTED|Overall Study||416
9956293|NCT01444781|11075455|FG001|STARTED|Overall Study||415
9956294|NCT01444781|11075456|FG002|STARTED|Overall Study||275
9956295|NCT01444781|11075454|FG000|COMPLETED|Overall Study||413
9956296|NCT01444781|11075455|FG001|COMPLETED|Overall Study||411
9956297|NCT01444781|11075456|FG002|COMPLETED|Overall Study||272
9932342|NCT01301274|11049694|FG000|STARTED|Overall Study||34
9932343|NCT01301274|11049695|FG001|STARTED|Overall Study||32
9932344|NCT01301274|11049694|FG000|COMPLETED|Overall Study||32
9932345|NCT01301274|11049695|FG001|COMPLETED|Overall Study||31
9932346|NCT01301274|11049694|FG000|NOT COMPLETED|Overall Study||2
9932347|NCT01301274|11049695|FG001|NOT COMPLETED|Overall Study||1
9932348|NCT01301391|11049706|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
9932349|NCT01301391|11049706|FG000|COMPLETED|Overall Study||4
9932350|NCT01301391|11049706|FG000|NOT COMPLETED|Overall Study||26
9932351|NCT01301456|11049722|FG000|STARTED|Stage 1||15
9932352|NCT01301456|11049723|FG001|STARTED|Stage 1||5
9932353|NCT01301456|11049724|FG002|STARTED|Stage 1||6
9932354|NCT01301456|11049725|FG003|STARTED|Stage 1||6
9932355|NCT01301456|11049726|FG004|STARTED|Stage 1||7
9932356|NCT01301456|11049727|FG005|STARTED|Stage 1||5
9932357|NCT01301456|11049728|FG006|STARTED|Stage 1||8
9932358|NCT01301456|11049729|FG007|STARTED|Stage 1||0
9932359|NCT01301456|11049730|FG008|STARTED|Stage 1||0
9932360|NCT01301456|11049731|FG009|STARTED|Stage 1||0
9932361|NCT01301456|11049732|FG010|STARTED|Stage 1||0
9932362|NCT01301456|11049733|FG011|STARTED|Stage 1||0
9932363|NCT01301456|11049722|FG000|Received Treatment|Stage 1||15
9932364|NCT01301456|11049723|FG001|Received Treatment|Stage 1||5
9932365|NCT01301456|11049724|FG002|Received Treatment|Stage 1||6
9932366|NCT01301456|11049725|FG003|Received Treatment|Stage 1||6
9932367|NCT01301456|11049726|FG004|Received Treatment|Stage 1||7
9932368|NCT01301456|11049727|FG005|Received Treatment|Stage 1||5
9932369|NCT01301456|11049728|FG006|Received Treatment|Stage 1||7
9932370|NCT01301456|11049729|FG007|Received Treatment|Stage 1||0
9932371|NCT01301456|11049730|FG008|Received Treatment|Stage 1||0
9932372|NCT01301456|11049731|FG009|Received Treatment|Stage 1||0
9932373|NCT01301456|11049732|FG010|Received Treatment|Stage 1||0
9932374|NCT01301456|11049733|FG011|Received Treatment|Stage 1||0
9932375|NCT01301456|11049722|FG000|COMPLETED|Stage 1||15
9932376|NCT01301456|11049723|FG001|COMPLETED|Stage 1||5
9932377|NCT01301456|11049724|FG002|COMPLETED|Stage 1||5
9932378|NCT01301456|11049725|FG003|COMPLETED|Stage 1||6
9932379|NCT01301456|11049726|FG004|COMPLETED|Stage 1||6
9932380|NCT01301456|11049727|FG005|COMPLETED|Stage 1||5
9932381|NCT01301456|11049728|FG006|COMPLETED|Stage 1||7
9932382|NCT01301456|11049729|FG007|COMPLETED|Stage 1||0
9932383|NCT01301456|11049730|FG008|COMPLETED|Stage 1||0
9932384|NCT01301456|11049731|FG009|COMPLETED|Stage 1||0
9932385|NCT01301456|11049732|FG010|COMPLETED|Stage 1||0
9932386|NCT01301456|11049733|FG011|COMPLETED|Stage 1||0
9932387|NCT01301456|11049722|FG000|NOT COMPLETED|Stage 1||0
9932388|NCT01301456|11049723|FG001|NOT COMPLETED|Stage 1||0
9932389|NCT01301456|11049724|FG002|NOT COMPLETED|Stage 1||1
9932390|NCT01301456|11049725|FG003|NOT COMPLETED|Stage 1||0
9932391|NCT01301456|11049726|FG004|NOT COMPLETED|Stage 1||1
9932392|NCT01301456|11049727|FG005|NOT COMPLETED|Stage 1||0
9932393|NCT01301456|11049728|FG006|NOT COMPLETED|Stage 1||1
9932394|NCT01301456|11049729|FG007|NOT COMPLETED|Stage 1||0
9932395|NCT01301456|11049730|FG008|NOT COMPLETED|Stage 1||0
9932396|NCT01301456|11049731|FG009|NOT COMPLETED|Stage 1||0
9932397|NCT01301456|11049732|FG010|NOT COMPLETED|Stage 1||0
9932398|NCT01301456|11049733|FG011|NOT COMPLETED|Stage 1||0
9932399|NCT01301456|11049722|FG000|STARTED|Stage 2||0
9932400|NCT01301456|11049723|FG001|STARTED|Stage 2||0
9932401|NCT01301456|11049724|FG002|STARTED|Stage 2||0
9932402|NCT01301456|11049725|FG003|STARTED|Stage 2||0
9932403|NCT01301456|11049726|FG004|STARTED|Stage 2||0
9932404|NCT01301456|11049727|FG005|STARTED|Stage 2||0
9932405|NCT01301456|11049728|FG006|STARTED|Stage 2||0
9932406|NCT01301456|11049729|FG007|STARTED|Stage 2||7
9932407|NCT01301456|11049730|FG008|STARTED|Stage 2||5
9932408|NCT01301456|11049731|FG009|STARTED|Stage 2||7
9932409|NCT01301456|11049732|FG010|STARTED|Stage 2||7
9932410|NCT01301456|11049733|FG011|STARTED|Stage 2||6
9932411|NCT01301456|11049722|FG000|Received Treatment|Stage 2||0
9932412|NCT01301456|11049723|FG001|Received Treatment|Stage 2||0
9932413|NCT01301456|11049724|FG002|Received Treatment|Stage 2||0
9932414|NCT01301456|11049725|FG003|Received Treatment|Stage 2||0
9932415|NCT01301456|11049726|FG004|Received Treatment|Stage 2||0
9932416|NCT01301456|11049727|FG005|Received Treatment|Stage 2||0
9932417|NCT01301456|11049728|FG006|Received Treatment|Stage 2||0
9932418|NCT01301456|11049729|FG007|Received Treatment|Stage 2||7
9932419|NCT01301456|11049730|FG008|Received Treatment|Stage 2||5
9932420|NCT01301456|11049731|FG009|Received Treatment|Stage 2||7
9932421|NCT01301456|11049732|FG010|Received Treatment|Stage 2||7
9932422|NCT01301456|11049733|FG011|Received Treatment|Stage 2||6
9932423|NCT01301456|11049722|FG000|COMPLETED|Stage 2||0
9932424|NCT01301456|11049723|FG001|COMPLETED|Stage 2||0
9932425|NCT01301456|11049724|FG002|COMPLETED|Stage 2||0
9932426|NCT01301456|11049725|FG003|COMPLETED|Stage 2||0
9932427|NCT01301456|11049726|FG004|COMPLETED|Stage 2||0
9932428|NCT01301456|11049727|FG005|COMPLETED|Stage 2||0
9932429|NCT01301456|11049728|FG006|COMPLETED|Stage 2||0
9932430|NCT01301456|11049729|FG007|COMPLETED|Stage 2||7
9932431|NCT01301456|11049730|FG008|COMPLETED|Stage 2||5
9932432|NCT01301456|11049731|FG009|COMPLETED|Stage 2||7
9932433|NCT01301456|11049732|FG010|COMPLETED|Stage 2||6
9932434|NCT01301456|11049733|FG011|COMPLETED|Stage 2||6
9932435|NCT01301456|11049722|FG000|NOT COMPLETED|Stage 2||0
9932436|NCT01301456|11049723|FG001|NOT COMPLETED|Stage 2||0
9932437|NCT01301456|11049724|FG002|NOT COMPLETED|Stage 2||0
9932438|NCT01301456|11049725|FG003|NOT COMPLETED|Stage 2||0
9932439|NCT01301456|11049726|FG004|NOT COMPLETED|Stage 2||0
9932440|NCT01301456|11049727|FG005|NOT COMPLETED|Stage 2||0
9932441|NCT01301456|11049728|FG006|NOT COMPLETED|Stage 2||0
9932442|NCT01301456|11049729|FG007|NOT COMPLETED|Stage 2||0
9932443|NCT01301456|11049730|FG008|NOT COMPLETED|Stage 2||0
9932444|NCT01301456|11049731|FG009|NOT COMPLETED|Stage 2||0
9932445|NCT01301456|11049732|FG010|NOT COMPLETED|Stage 2||1
9932446|NCT01301456|11049733|FG011|NOT COMPLETED|Stage 2||0
9932447|NCT01301508|11049779|FG000|STARTED|Overall Study||21
9932448|NCT01301508|11049780|FG001|STARTED|Overall Study||25
9932449|NCT01301508|11049779|FG000|COMPLETED|Overall Study||20
9932450|NCT01301508|11049780|FG001|COMPLETED|Overall Study||22
9932451|NCT01301508|11049779|FG000|NOT COMPLETED|Overall Study||1
9932452|NCT01301508|11049780|FG001|NOT COMPLETED|Overall Study||3
9932453|NCT01301625|11049786|FG000|STARTED|Overall Study||78
9932454|NCT01301625|11049786|FG000|COMPLETED|Overall Study||43
9932455|NCT01301625|11049786|FG000|NOT COMPLETED|Overall Study||35
9932456|NCT01301729|11049790|FG000|STARTED|Overall Study||32
9932457|NCT01301729|11049790|FG000|COMPLETED|Overall Study||28
9932458|NCT01301729|11049790|FG000|NOT COMPLETED|Overall Study||4
9932459|NCT01301742|11049795|FG000|STARTED|First Intervention||9
9932460|NCT01301742|11049796|FG001|STARTED|First Intervention||9
9932461|NCT01301742|11049795|FG000|COMPLETED|First Intervention||9
9932462|NCT01301742|11049796|FG001|COMPLETED|First Intervention||9
9932463|NCT01301742|11049795|FG000|NOT COMPLETED|First Intervention||0
9932464|NCT01301742|11049796|FG001|NOT COMPLETED|First Intervention||0
9932465|NCT01301742|11049795|FG000|STARTED|Washout Period of at Least 7 Days||9
9932466|NCT01301742|11049796|FG001|STARTED|Washout Period of at Least 7 Days||9
9932467|NCT01301742|11049795|FG000|COMPLETED|Washout Period of at Least 7 Days||9
9932468|NCT01301742|11049796|FG001|COMPLETED|Washout Period of at Least 7 Days||9
9932469|NCT01301742|11049795|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
9932470|NCT01301742|11049796|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
9932471|NCT01301742|11049795|FG000|STARTED|Second Intervention||9
9932472|NCT01301742|11049796|FG001|STARTED|Second Intervention||9
9932473|NCT01301742|11049795|FG000|COMPLETED|Second Intervention||9
9932474|NCT01301742|11049796|FG001|COMPLETED|Second Intervention||9
9932475|NCT01301742|11049795|FG000|NOT COMPLETED|Second Intervention||0
9932476|NCT01301742|11049796|FG001|NOT COMPLETED|Second Intervention||0
10206956|NCT03519867|11333728|FG006|NOT COMPLETED|Overall Study||1
9932477|NCT01301833|11049807|FG000|STARTED|Overall Study||212
9932478|NCT01301833|11049808|FG001|STARTED|Overall Study||80
9932479|NCT01301833|11049809|FG002|STARTED|Overall Study||95
9932480|NCT01301833|11049810|FG003|STARTED|Overall Study||75
9932481|NCT01301833|11049807|FG000|COMPLETED|Overall Study||197
9932482|NCT01301833|11049808|FG001|COMPLETED|Overall Study||72
9932483|NCT01301833|11049809|FG002|COMPLETED|Overall Study||88
9932484|NCT01301833|11049810|FG003|COMPLETED|Overall Study||68
9932485|NCT01301833|11049807|FG000|NOT COMPLETED|Overall Study||15
9932486|NCT01301833|11049808|FG001|NOT COMPLETED|Overall Study||8
10111596|NCT02497235|11242629|FG001|NOT COMPLETED|Overall Study||0
10111597|NCT02497235|11242630|FG002|NOT COMPLETED|Overall Study||0
10111598|NCT02497235|11242631|FG003|NOT COMPLETED|Overall Study||0
9932487|NCT01301833|11049809|FG002|NOT COMPLETED|Overall Study||7
9932488|NCT01301833|11049810|FG003|NOT COMPLETED|Overall Study||7
9932489|NCT01301950|11049822|FG000|STARTED|Overall Study||15
9932490|NCT01301950|11049823|FG001|STARTED|Overall Study||15
9932491|NCT01301950|11049822|FG000|COMPLETED|Overall Study||15
9932492|NCT01301950|11049823|FG001|COMPLETED|Overall Study||14
9932493|NCT01301950|11049822|FG000|NOT COMPLETED|Overall Study||0
9932494|NCT01301950|11049823|FG001|NOT COMPLETED|Overall Study||1
9932495|NCT01302041|11049829|FG000|STARTED|Overall Study||67
9932496|NCT01302041|11049829|FG000|Treatment Received|Overall Study||67
9932497|NCT01302041|11049829|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
9932498|NCT01302041|11049829|FG000|NOT COMPLETED|Overall Study||40
9932499|NCT01302054|11049834|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990
9932500|NCT01302054|11049835|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0
9932501|NCT01302054|11049836|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0
10111599|NCT02497235|11242632|FG004|NOT COMPLETED|Overall Study||0
10111600|NCT02497287|11242647|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
10111601|NCT02497287|11242647|FG000|COMPLETED|Induction Phase (4 Weeks)||580
10111602|NCT02497287|11242647|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199
10111603|NCT02497287|11242647|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
10111604|NCT02497287|11242647|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150
10111605|NCT02497287|11242647|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
10111606|NCT02497287|11242647|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
10206957|NCT03519867|11333729|FG007|NOT COMPLETED|Overall Study||1
10206958|NCT03519867|11333730|FG008|NOT COMPLETED|Overall Study||1
9932502|NCT01302054|11049834|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611
9932503|NCT01302054|11049835|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0
9932504|NCT01302054|11049836|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0
9932505|NCT01302054|11049834|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
9932506|NCT01302054|11049835|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
9932507|NCT01302054|11049836|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
9956298|NCT01444781|11075454|FG000|NOT COMPLETED|Overall Study||3
9932508|NCT01302054|11049834|FG000|STARTED|Between Open-Label and Double Blind||611
9932509|NCT01302054|11049835|FG001|STARTED|Between Open-Label and Double Blind||0
9932510|NCT01302054|11049836|FG002|STARTED|Between Open-Label and Double Blind||0
9932511|NCT01302054|11049834|FG000|COMPLETED|Between Open-Label and Double Blind||609
9932512|NCT01302054|11049835|FG001|COMPLETED|Between Open-Label and Double Blind||0
9932513|NCT01302054|11049836|FG002|COMPLETED|Between Open-Label and Double Blind||0
9932514|NCT01302054|11049834|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2
9932515|NCT01302054|11049835|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0
9932516|NCT01302054|11049836|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0
9932517|NCT01302054|11049834|FG000|STARTED|Double-Blind Treatment Phase||0
9932518|NCT01302054|11049835|FG001|STARTED|Double-Blind Treatment Phase||308
9932519|NCT01302054|11049836|FG002|STARTED|Double-Blind Treatment Phase||301
9932520|NCT01302054|11049834|FG000|COMPLETED|Double-Blind Treatment Phase||0
9932521|NCT01302054|11049835|FG001|COMPLETED|Double-Blind Treatment Phase||281
9932522|NCT01302054|11049836|FG002|COMPLETED|Double-Blind Treatment Phase||255
9932523|NCT01302054|11049834|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
9932524|NCT01302054|11049835|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27
9932525|NCT01302054|11049836|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46
9932526|NCT01302067|11049848|FG000|STARTED|Overall Study||790
9932527|NCT01302067|11049849|FG001|STARTED|Overall Study||386
9932528|NCT01302067|11049850|FG002|STARTED|Overall Study||779
9932529|NCT01302067|11049848|FG000|COMPLETED|Overall Study||712
9932530|NCT01302067|11049849|FG001|COMPLETED|Overall Study||352
9932531|NCT01302067|11049850|FG002|COMPLETED|Overall Study||681
9932532|NCT01302067|11049848|FG000|NOT COMPLETED|Overall Study||78
9932533|NCT01302067|11049849|FG001|NOT COMPLETED|Overall Study||34
9932534|NCT01302067|11049850|FG002|NOT COMPLETED|Overall Study||98
9932535|NCT01302080|11049861|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696
9932536|NCT01302080|11049862|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245
9932537|NCT01302080|11049861|FG000|COMPLETED|Overall Study||330
9932538|NCT01302080|11049862|FG001|COMPLETED|Overall Study||102
9932539|NCT01302080|11049861|FG000|NOT COMPLETED|Overall Study||366
10010972|NCT01777282|11133652|FG001|COMPLETED|Overall Study||63
10010973|NCT01777282|11133653|FG002|COMPLETED|Overall Study||59
10010974|NCT01777282|11133654|FG003|COMPLETED|Overall Study||59
10010975|NCT01777282|11133655|FG004|COMPLETED|Overall Study||54
10010976|NCT01777282|11133651|FG000|NOT COMPLETED|Overall Study||11
10010977|NCT01777282|11133652|FG001|NOT COMPLETED|Overall Study||4
9932540|NCT01302080|11049862|FG001|NOT COMPLETED|Overall Study||143
9932541|NCT01302119|11049894|FG000|STARTED|Overall Study||399
9932542|NCT01302119|11049895|FG001|STARTED|Overall Study||205
9932543|NCT01302119|11049894|FG000|COMPLETED|Overall Study||349
9932544|NCT01302119|11049895|FG001|COMPLETED|Overall Study||177
9932545|NCT01302119|11049894|FG000|NOT COMPLETED|Overall Study||50
9932546|NCT01302119|11049895|FG001|NOT COMPLETED|Overall Study||28
9932547|NCT01302366|11049901|FG000|STARTED|Overall Study||20
10010978|NCT01777282|11133653|FG002|NOT COMPLETED|Overall Study||6
10010979|NCT01777282|11133654|FG003|NOT COMPLETED|Overall Study||2
10010980|NCT01777282|11133655|FG004|NOT COMPLETED|Overall Study||7
10010981|NCT01777308|11133669|FG000|STARTED|Overall Study||119
10010982|NCT01777308|11133670|FG001|STARTED|Overall Study||37
10010983|NCT01777308|11133669|FG000|Completed up to Month 73|Overall Study||118
10010984|NCT01777308|11133670|FG001|Completed up to Month 73|Overall Study||37
10010985|NCT01777308|11133669|FG000|COMPLETED|Overall Study||105
9932548|NCT01302366|11049901|FG000|COMPLETED|Overall Study||15
9932549|NCT01302366|11049901|FG000|NOT COMPLETED|Overall Study||5
9932550|NCT01302379|11049909|FG000|STARTED|Overall Study||83
9932551|NCT01302379|11049910|FG001|STARTED|Overall Study||83
9932552|NCT01302379|11049911|FG002|STARTED|Overall Study||84
9932553|NCT01302379|11049912|FG003|STARTED|Overall Study||83
9932554|NCT01302379|11049909|FG000|COMPLETED|Overall Study||76
9932555|NCT01302379|11049910|FG001|COMPLETED|Overall Study||78
9932556|NCT01302379|11049911|FG002|COMPLETED|Overall Study||80
10010986|NCT01777308|11133670|FG001|COMPLETED|Overall Study||34
10010987|NCT01777308|11133669|FG000|NOT COMPLETED|Overall Study||14
10010988|NCT01777308|11133670|FG001|NOT COMPLETED|Overall Study||3
10010989|NCT01777321|11133679|FG000|STARTED|Overall Study||30
10010990|NCT01777321|11133680|FG001|STARTED|Overall Study||30
10010991|NCT01777321|11133679|FG000|COMPLETED|Overall Study||30
10010992|NCT01777321|11133680|FG001|COMPLETED|Overall Study||29
10010993|NCT01777321|11133679|FG000|NOT COMPLETED|Overall Study||0
9932557|NCT01302379|11049912|FG003|COMPLETED|Overall Study||79
9932558|NCT01302379|11049909|FG000|NOT COMPLETED|Overall Study||7
9932559|NCT01302379|11049910|FG001|NOT COMPLETED|Overall Study||5
9932560|NCT01302379|11049911|FG002|NOT COMPLETED|Overall Study||4
9932561|NCT01302379|11049912|FG003|NOT COMPLETED|Overall Study||4
9932562|NCT01302392|11049922|FG000|STARTED|Overall Study||158
9932563|NCT01302392|11049923|FG001|STARTED|Overall Study||157
9932564|NCT01302392|11049922|FG000|Treated|Overall Study||153
9932565|NCT01302392|11049923|FG001|Treated|Overall Study||157
9932566|NCT01302392|11049922|FG000|COMPLETED|Overall Study||151
9932567|NCT01302392|11049923|FG001|COMPLETED|Overall Study||156
9932568|NCT01302392|11049922|FG000|NOT COMPLETED|Overall Study||7
10010994|NCT01777321|11133680|FG001|NOT COMPLETED|Overall Study||1
10010995|NCT01777334|11133688|FG000|STARTED|Overall Study||454
10010996|NCT01777334|11133689|FG001|STARTED|Overall Study||451
9932569|NCT01302392|11049923|FG001|NOT COMPLETED|Overall Study||1
9932570|NCT01302418|11049929|FG000|STARTED|Overall Study||272
9932571|NCT01302418|11049929|FG000|COMPLETED|Overall Study||254
9932572|NCT01302418|11049929|FG000|NOT COMPLETED|Overall Study||18
9932573|NCT01302483|11049935|FG000|STARTED|Overall Study||30
9932574|NCT01302483|11049936|FG001|STARTED|Overall Study||15
9932575|NCT01302483|11049935|FG000|COMPLETED|Overall Study||30
9932576|NCT01302483|11049936|FG001|COMPLETED|Overall Study||15
9932577|NCT01302483|11049935|FG000|NOT COMPLETED|Overall Study||0
9932578|NCT01302483|11049936|FG001|NOT COMPLETED|Overall Study||0
9932579|NCT01302548|11049950|FG000|STARTED|Overall Study||14
9932580|NCT01302548|11049951|FG001|STARTED|Overall Study||19
9932581|NCT01302548|11049950|FG000|COMPLETED|Overall Study||12
9932582|NCT01302548|11049951|FG001|COMPLETED|Overall Study||18
9932583|NCT01302548|11049950|FG000|NOT COMPLETED|Overall Study||2
9932584|NCT01302548|11049951|FG001|NOT COMPLETED|Overall Study||1
9932585|NCT01302691|11049959|FG000|STARTED|Overall Study||164
9932586|NCT01302691|11049960|FG001|STARTED|Overall Study||163
9932587|NCT01302691|11049959|FG000|COMPLETED|Overall Study||154
9932588|NCT01302691|11049960|FG001|COMPLETED|Overall Study||157
9932589|NCT01302691|11049959|FG000|NOT COMPLETED|Overall Study||10
9932590|NCT01302691|11049960|FG001|NOT COMPLETED|Overall Study||6
9932591|NCT01302743|11049969|FG000|STARTED|Overall Study||7
9932592|NCT01302743|11049970|FG001|STARTED|Overall Study||8
9932593|NCT01302743|11049971|FG002|STARTED|Overall Study||10
9932594|NCT01302743|11049969|FG000|COMPLETED|Overall Study||6
9932595|NCT01302743|11049970|FG001|COMPLETED|Overall Study||7
9932596|NCT01302743|11049971|FG002|COMPLETED|Overall Study||8
9932597|NCT01302743|11049969|FG000|NOT COMPLETED|Overall Study||1
9932598|NCT01302743|11049970|FG001|NOT COMPLETED|Overall Study||1
9932599|NCT01302743|11049971|FG002|NOT COMPLETED|Overall Study||2
9932600|NCT01302808|11049983|FG000|STARTED|Overall Study||3
9932601|NCT01302808|11049984|FG001|STARTED|Overall Study||7
9932602|NCT01302808|11049985|FG002|STARTED|Overall Study||4
9932603|NCT01302808|11049986|FG003|STARTED|Overall Study||3
9932604|NCT01302808|11049983|FG000|COMPLETED|Overall Study||3
9932605|NCT01302808|11049984|FG001|COMPLETED|Overall Study||7
9932606|NCT01302808|11049985|FG002|COMPLETED|Overall Study||4
9932607|NCT01302808|11049986|FG003|COMPLETED|Overall Study||3
9932608|NCT01302808|11049983|FG000|NOT COMPLETED|Overall Study||0
9932609|NCT01302808|11049984|FG001|NOT COMPLETED|Overall Study||0
9932610|NCT01302808|11049985|FG002|NOT COMPLETED|Overall Study||0
9932611|NCT01302808|11049986|FG003|NOT COMPLETED|Overall Study||0
10010997|NCT01777334|11133688|FG000|COMPLETED|Overall Study||401
10010998|NCT01777334|11133689|FG001|COMPLETED|Overall Study||388
10010999|NCT01777334|11133688|FG000|NOT COMPLETED|Overall Study||53
10011000|NCT01777334|11133689|FG001|NOT COMPLETED|Overall Study||63
10011001|NCT01777412|11133695|FG000|STARTED|Overall Study||10
10011002|NCT01777412|11133695|FG000|COMPLETED|Overall Study||10
10011003|NCT01777412|11133695|FG000|NOT COMPLETED|Overall Study||0
10011004|NCT01777425|11133699|FG000|STARTED|Overall Study||389
10011005|NCT01777425|11133699|FG000|COMPLETED|Overall Study||389
10011006|NCT01777425|11133699|FG000|NOT COMPLETED|Overall Study||0
10011007|NCT01777438|11133706|FG000|STARTED|Overall Study||352
10011008|NCT01777438|11133707|FG001|STARTED|Overall Study||82
10011009|NCT01777438|11133706|FG000|COMPLETED|Overall Study||352
9932644|NCT01302860|11050007|FG000|STARTED|Overall Study||17
9932645|NCT01302860|11050007|FG000|COMPLETED|Overall Study||17
9932646|NCT01302860|11050007|FG000|NOT COMPLETED|Overall Study||0
9932647|NCT01302899|11050013|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4
9932648|NCT01302899|11050014|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4
9932649|NCT01302899|11050013|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
9932650|NCT01302899|11050014|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
9932651|NCT01302899|11050013|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
9932652|NCT01302899|11050014|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
9932653|NCT01302899|11050013|FG000|STARTED|Period 2 (Weeks 7 to 12)||4
9932654|NCT01302899|11050014|FG001|STARTED|Period 2 (Weeks 7 to 12)||4
9932655|NCT01302899|11050013|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3
9932656|NCT01302899|11050014|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3
9932657|NCT01302899|11050013|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
9932658|NCT01302899|11050014|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
9932659|NCT01302899|11050013|FG000|STARTED|Period 3 (Weeks 13 to 18)||3
9932660|NCT01302899|11050014|FG001|STARTED|Period 3 (Weeks 13 to 18)||3
9932661|NCT01302899|11050013|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3
9932662|NCT01302899|11050014|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3
9932663|NCT01302899|11050013|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
9932664|NCT01302899|11050014|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
9932665|NCT01302899|11050013|FG000|STARTED|Period 4 (Weeks 19 to 26)||3
9932666|NCT01302899|11050014|FG001|STARTED|Period 4 (Weeks 19 to 26)||3
9932667|NCT01302899|11050013|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3
9932668|NCT01302899|11050014|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3
9932669|NCT01302899|11050013|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
9932670|NCT01302899|11050014|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
9932671|NCT01302938|11050026|FG000|STARTED|Overall Study||12
9932672|NCT01302938|11050027|FG001|STARTED|Overall Study||6
9932673|NCT01302938|11050026|FG000|COMPLETED|Overall Study||10
9932674|NCT01302938|11050027|FG001|COMPLETED|Overall Study||6
9932675|NCT01302938|11050026|FG000|NOT COMPLETED|Overall Study||2
9932676|NCT01302938|11050027|FG001|NOT COMPLETED|Overall Study||0
9932677|NCT01302964|11050036|FG000|STARTED|Overall Study||20
9932678|NCT01302964|11050037|FG001|STARTED|Overall Study||10
9932679|NCT01302964|11050036|FG000|COMPLETED|Overall Study||19
9932680|NCT01302964|11050037|FG001|COMPLETED|Overall Study||10
9932681|NCT01302964|11050036|FG000|NOT COMPLETED|Overall Study||1
9932682|NCT01302964|11050037|FG001|NOT COMPLETED|Overall Study||0
9932683|NCT01303068|11050045|FG000|STARTED|Overall Study||6
9932684|NCT01303068|11050046|FG001|STARTED|Overall Study||6
9932685|NCT01303068|11050045|FG000|COMPLETED|Overall Study||6
9932686|NCT01303068|11050046|FG001|COMPLETED|Overall Study||6
9932687|NCT01303068|11050045|FG000|NOT COMPLETED|Overall Study||0
9932688|NCT01303068|11050046|FG001|NOT COMPLETED|Overall Study||0
9932689|NCT01303159|11050052|FG000|STARTED|Overall Study||29
9932690|NCT01303159|11050052|FG000|COMPLETED|Overall Study||6
9932691|NCT01303159|11050052|FG000|NOT COMPLETED|Overall Study||23
9932692|NCT01303172|11050058|FG000|STARTED|Overall Study||75
9932693|NCT01303172|11050059|FG001|STARTED|Overall Study||35
9932694|NCT01303172|11050058|FG000|COMPLETED|Overall Study||12
9932695|NCT01303172|11050059|FG001|COMPLETED|Overall Study||1
9932696|NCT01303172|11050058|FG000|NOT COMPLETED|Overall Study||63
9932697|NCT01303172|11050059|FG001|NOT COMPLETED|Overall Study||34
9932698|NCT01303224|11050070|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
9932699|NCT01303224|11050071|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
9932700|NCT01303224|11050072|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
10011010|NCT01777438|11133707|FG001|COMPLETED|Overall Study||82
10011011|NCT01777438|11133706|FG000|NOT COMPLETED|Overall Study||0
10011012|NCT01777438|11133707|FG001|NOT COMPLETED|Overall Study||0
10011013|NCT01777490|11133717|FG000|STARTED|Overall Study||123
10011014|NCT01777490|11133718|FG001|STARTED|Overall Study||123
10011015|NCT01777490|11133719|FG002|STARTED|Overall Study||119
10011016|NCT01777490|11133720|FG003|STARTED|Overall Study||119
10011017|NCT01777490|11133717|FG000|COMPLETED|Overall Study||123
10011018|NCT01777490|11133718|FG001|COMPLETED|Overall Study||123
10011019|NCT01777490|11133719|FG002|COMPLETED|Overall Study||118
10011020|NCT01777490|11133720|FG003|COMPLETED|Overall Study||118
10011021|NCT01777490|11133717|FG000|NOT COMPLETED|Overall Study||0
10011022|NCT01777490|11133718|FG001|NOT COMPLETED|Overall Study||0
10011023|NCT01777490|11133719|FG002|NOT COMPLETED|Overall Study||1
10011024|NCT01777490|11133720|FG003|NOT COMPLETED|Overall Study||1
10011025|NCT01777542|11133732|FG000|STARTED|First Intervention (20 Weeks)||15
10011026|NCT01777542|11133733|FG001|STARTED|First Intervention (20 Weeks)||15
10011027|NCT01777542|11133732|FG000|COMPLETED|First Intervention (20 Weeks)||15
10011028|NCT01777542|11133733|FG001|COMPLETED|First Intervention (20 Weeks)||15
10011029|NCT01777542|11133732|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0
10011030|NCT01777542|11133733|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0
10011031|NCT01777542|11133732|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15
10011032|NCT01777542|11133733|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15
10011033|NCT01777542|11133732|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
9932701|NCT01303224|11050073|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
9932702|NCT01303224|11050070|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
9956299|NCT01444781|11075455|FG001|NOT COMPLETED|Overall Study||4
10011034|NCT01777542|11133733|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
10011035|NCT01777542|11133732|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
9932703|NCT01303224|11050071|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
9932704|NCT01303224|11050072|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
9932705|NCT01303224|11050073|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
9932706|NCT01303224|11050070|FG000|COMPLETED|Overall Study||130
9932707|NCT01303224|11050071|FG001|COMPLETED|Overall Study||131
9932708|NCT01303224|11050072|FG002|COMPLETED|Overall Study||133
9932709|NCT01303224|11050073|FG003|COMPLETED|Overall Study||133
9932710|NCT01303224|11050070|FG000|NOT COMPLETED|Overall Study||11
9932711|NCT01303224|11050071|FG001|NOT COMPLETED|Overall Study||11
9932712|NCT01303224|11050072|FG002|NOT COMPLETED|Overall Study||6
9932713|NCT01303224|11050073|FG003|NOT COMPLETED|Overall Study||10
9932714|NCT01303380|11050083|FG000|STARTED|Overall Study||9
9932715|NCT01303380|11050083|FG000|COMPLETED|Overall Study||8
9932716|NCT01303380|11050083|FG000|NOT COMPLETED|Overall Study||1
9932717|NCT01303406|11050089|FG000|STARTED|Overall Study||13
9932718|NCT01303406|11050090|FG001|STARTED|Overall Study||16
9932719|NCT01303406|11050089|FG000|COMPLETED|Overall Study||13
9932720|NCT01303406|11050090|FG001|COMPLETED|Overall Study||15
9932721|NCT01303406|11050089|FG000|NOT COMPLETED|Overall Study||0
9932722|NCT01303406|11050090|FG001|NOT COMPLETED|Overall Study||1
9932723|NCT01303419|11050096|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
9932724|NCT01303419|11050096|FG000|COMPLETED|Overall Study||128
9932725|NCT01303419|11050096|FG000|NOT COMPLETED|Overall Study||96
9932726|NCT01303445|11050100|FG000|STARTED|First Intervention (7 Days)||30
9932727|NCT01303445|11050101|FG001|STARTED|First Intervention (7 Days)||30
9932728|NCT01303445|11050100|FG000|COMPLETED|First Intervention (7 Days)||29
9932729|NCT01303445|11050101|FG001|COMPLETED|First Intervention (7 Days)||30
9932730|NCT01303445|11050100|FG000|NOT COMPLETED|First Intervention (7 Days)||1
9932731|NCT01303445|11050101|FG001|NOT COMPLETED|First Intervention (7 Days)||0
9932732|NCT01303445|11050100|FG000|STARTED|Second Intervention (7 Days)||29
9932733|NCT01303445|11050101|FG001|STARTED|Second Intervention (7 Days)||30
9932734|NCT01303445|11050100|FG000|COMPLETED|Second Intervention (7 Days)||28
9932735|NCT01303445|11050101|FG001|COMPLETED|Second Intervention (7 Days)||28
9932736|NCT01303445|11050100|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
9932737|NCT01303445|11050101|FG001|NOT COMPLETED|Second Intervention (7 Days)||2
9932738|NCT01303445|11050100|FG000|STARTED|Washout (14 Days)||28
9932739|NCT01303445|11050101|FG001|STARTED|Washout (14 Days)||28
9932740|NCT01303445|11050100|FG000|COMPLETED|Washout (14 Days)||27
9932741|NCT01303445|11050101|FG001|COMPLETED|Washout (14 Days)||26
9932742|NCT01303445|11050100|FG000|NOT COMPLETED|Washout (14 Days)||1
9932743|NCT01303445|11050101|FG001|NOT COMPLETED|Washout (14 Days)||2
9932744|NCT01303445|11050100|FG000|STARTED|Third Intervention (7 Days)||27
9932745|NCT01303445|11050101|FG001|STARTED|Third Intervention (7 Days)||26
9932746|NCT01303445|11050100|FG000|COMPLETED|Third Intervention (7 Days)||27
9932747|NCT01303445|11050101|FG001|COMPLETED|Third Intervention (7 Days)||26
9932748|NCT01303445|11050100|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
9932749|NCT01303445|11050101|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
9932750|NCT01303445|11050100|FG000|STARTED|Fourth Intervention (7 Days)||27
9932751|NCT01303445|11050101|FG001|STARTED|Fourth Intervention (7 Days)||26
9932752|NCT01303445|11050100|FG000|COMPLETED|Fourth Intervention (7 Days)||26
9932753|NCT01303445|11050101|FG001|COMPLETED|Fourth Intervention (7 Days)||26
9932754|NCT01303445|11050100|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1
9932755|NCT01303445|11050101|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0
9932756|NCT01303445|11050100|FG000|STARTED|Follow-up Period (14 Days)||26
9932757|NCT01303445|11050101|FG001|STARTED|Follow-up Period (14 Days)||26
9932758|NCT01303445|11050100|FG000|COMPLETED|Follow-up Period (14 Days)||26
9932759|NCT01303445|11050101|FG001|COMPLETED|Follow-up Period (14 Days)||25
9932760|NCT01303445|11050100|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
9932761|NCT01303445|11050101|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1
9932762|NCT01303510|11050113|FG000|STARTED|Overall Study||55
9932763|NCT01303510|11050114|FG001|STARTED|Overall Study||56
9932764|NCT01303510|11050113|FG000|COMPLETED|Overall Study||54
9932765|NCT01303510|11050114|FG001|COMPLETED|Overall Study||56
9932766|NCT01303510|11050113|FG000|NOT COMPLETED|Overall Study||1
9932767|NCT01303510|11050114|FG001|NOT COMPLETED|Overall Study||0
9932768|NCT01303627|11050122|FG000|STARTED|Overall Study||21
9932769|NCT01303627|11050123|FG001|STARTED|Overall Study||21
9932770|NCT01303627|11050122|FG000|COMPLETED|Overall Study||21
9932771|NCT01303627|11050123|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
9932772|NCT01303627|11050122|FG000|NOT COMPLETED|Overall Study||0
9932773|NCT01303627|11050123|FG001|NOT COMPLETED|Overall Study||1
9932774|NCT01303744|11050133|FG000|STARTED|Overall Study||24
9932775|NCT01303744|11050134|FG001|STARTED|Overall Study||24
9932776|NCT01303744|11050135|FG002|STARTED|Overall Study||24
9932777|NCT01303744|11050136|FG003|STARTED|Overall Study||24
9932778|NCT01303744|11050133|FG000|COMPLETED|Overall Study||24
9932779|NCT01303744|11050134|FG001|COMPLETED|Overall Study||24
9932780|NCT01303744|11050135|FG002|COMPLETED|Overall Study||24
9932781|NCT01303744|11050136|FG003|COMPLETED|Overall Study||24
9932782|NCT01303744|11050133|FG000|NOT COMPLETED|Overall Study||0
9932783|NCT01303744|11050134|FG001|NOT COMPLETED|Overall Study||0
9932784|NCT01303744|11050135|FG002|NOT COMPLETED|Overall Study||0
9932785|NCT01303744|11050136|FG003|NOT COMPLETED|Overall Study||0
9932786|NCT01303835|11050148|FG000|STARTED|Overall Study||54
9932787|NCT01303835|11050149|FG001|STARTED|Overall Study||56
9932788|NCT01303835|11050148|FG000|COMPLETED|Overall Study||35
9932789|NCT01303835|11050149|FG001|COMPLETED|Overall Study||31
9932790|NCT01303835|11050148|FG000|NOT COMPLETED|Overall Study||19
9932791|NCT01303835|11050149|FG001|NOT COMPLETED|Overall Study||25
9932792|NCT01303861|11050160|FG000|STARTED|Overall Study||109
9932793|NCT01303861|11050161|FG001|STARTED|Overall Study||50
9932794|NCT01303861|11050162|FG002|STARTED|Overall Study||55
9932795|NCT01303861|11050163|FG003|STARTED|Overall Study||113
9932796|NCT01303861|11050160|FG000|Finished Treatment Phase|Overall Study||71
9932797|NCT01303861|11050161|FG001|Finished Treatment Phase|Overall Study||34
9932798|NCT01303861|11050162|FG002|Finished Treatment Phase|Overall Study||39
9932799|NCT01303861|11050163|FG003|Finished Treatment Phase|Overall Study||72
9932800|NCT01303861|11050160|FG000|COMPLETED|Overall Study||51
9932801|NCT01303861|11050161|FG001|COMPLETED|Overall Study||25
9932802|NCT01303861|11050162|FG002|COMPLETED|Overall Study||19
9932803|NCT01303861|11050163|FG003|COMPLETED|Overall Study||54
9932804|NCT01303861|11050160|FG000|NOT COMPLETED|Overall Study||58
9932805|NCT01303861|11050161|FG001|NOT COMPLETED|Overall Study||25
9932806|NCT01303861|11050162|FG002|NOT COMPLETED|Overall Study||36
9932807|NCT01303861|11050163|FG003|NOT COMPLETED|Overall Study||59
9932808|NCT01303939|11050176|FG000|STARTED|Overall Study||22
9932809|NCT01303939|11050177|FG001|STARTED|Overall Study||15
9932810|NCT01303939|11050176|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
9932811|NCT01303939|11050177|FG001|COMPLETED|Overall Study||15
9932812|NCT01303939|11050176|FG000|NOT COMPLETED|Overall Study||7
9932813|NCT01303939|11050177|FG001|NOT COMPLETED|Overall Study||0
9932814|NCT01303965|11050187|FG000|STARTED|Overall Study||3
9932815|NCT01303965|11050188|FG001|STARTED|Overall Study||11
9932816|NCT01303965|11050187|FG000|COMPLETED|Overall Study||0
9932817|NCT01303965|11050188|FG001|COMPLETED|Overall Study||1
9932818|NCT01303965|11050187|FG000|NOT COMPLETED|Overall Study||3
9932819|NCT01303965|11050188|FG001|NOT COMPLETED|Overall Study||10
9932820|NCT01304082|11050194|FG000|STARTED|Overall Study||3
9932821|NCT01304082|11050195|FG001|STARTED|Overall Study||2
9932822|NCT01304082|11050196|FG002|STARTED|Overall Study||11
9932823|NCT01304082|11050197|FG003|STARTED|Overall Study||8
9932824|NCT01304082|11050198|FG004|STARTED|Overall Study||5
9932825|NCT01304082|11050194|FG000|First Intervention|Overall Study||3
9932826|NCT01304082|11050195|FG001|First Intervention|Overall Study||2
9932827|NCT01304082|11050196|FG002|First Intervention|Overall Study||11
9932828|NCT01304082|11050197|FG003|First Intervention|Overall Study||8
9932829|NCT01304082|11050198|FG004|First Intervention|Overall Study||5
9932830|NCT01304082|11050194|FG000|Second Intervention|Overall Study||3
9932831|NCT01304082|11050195|FG001|Second Intervention|Overall Study||2
9932832|NCT01304082|11050196|FG002|Second Intervention|Overall Study||11
9932833|NCT01304082|11050197|FG003|Second Intervention|Overall Study||8
9932834|NCT01304082|11050198|FG004|Second Intervention|Overall Study||5
9932835|NCT01304082|11050194|FG000|Third Intervention|Overall Study||3
9932836|NCT01304082|11050195|FG001|Third Intervention|Overall Study||2
9932837|NCT01304082|11050196|FG002|Third Intervention|Overall Study||11
9932838|NCT01304082|11050197|FG003|Third Intervention|Overall Study||8
9932839|NCT01304082|11050198|FG004|Third Intervention|Overall Study||5
9932840|NCT01304082|11050194|FG000|COMPLETED|Overall Study||3
9932841|NCT01304082|11050195|FG001|COMPLETED|Overall Study||2
9932842|NCT01304082|11050196|FG002|COMPLETED|Overall Study||11
9932843|NCT01304082|11050197|FG003|COMPLETED|Overall Study||8
9932844|NCT01304082|11050198|FG004|COMPLETED|Overall Study||5
9932845|NCT01304082|11050194|FG000|NOT COMPLETED|Overall Study||0
9932846|NCT01304082|11050195|FG001|NOT COMPLETED|Overall Study||0
9932847|NCT01304082|11050196|FG002|NOT COMPLETED|Overall Study||0
9932848|NCT01304082|11050197|FG003|NOT COMPLETED|Overall Study||0
9932849|NCT01304082|11050198|FG004|NOT COMPLETED|Overall Study||0
9932850|NCT01304147|11050206|FG000|STARTED|First Intervention (7days)||10
9932851|NCT01304147|11050207|FG001|STARTED|First Intervention (7days)||10
9932852|NCT01304147|11050206|FG000|COMPLETED|First Intervention (7days)||10
9932853|NCT01304147|11050207|FG001|COMPLETED|First Intervention (7days)||10
9932854|NCT01304147|11050206|FG000|NOT COMPLETED|First Intervention (7days)||0
9932855|NCT01304147|11050207|FG001|NOT COMPLETED|First Intervention (7days)||0
9932856|NCT01304147|11050206|FG000|STARTED|Washout (1 Day)||10
9932857|NCT01304147|11050207|FG001|STARTED|Washout (1 Day)||10
9932858|NCT01304147|11050206|FG000|COMPLETED|Washout (1 Day)||10
9932859|NCT01304147|11050207|FG001|COMPLETED|Washout (1 Day)||10
9932860|NCT01304147|11050206|FG000|NOT COMPLETED|Washout (1 Day)||0
9932861|NCT01304147|11050207|FG001|NOT COMPLETED|Washout (1 Day)||0
9932862|NCT01304147|11050206|FG000|STARTED|Second Intervention (7days)||10
9932863|NCT01304147|11050207|FG001|STARTED|Second Intervention (7days)||10
9932864|NCT01304147|11050206|FG000|COMPLETED|Second Intervention (7days)||9
9932865|NCT01304147|11050207|FG001|COMPLETED|Second Intervention (7days)||9
9932866|NCT01304147|11050206|FG000|NOT COMPLETED|Second Intervention (7days)||1
9932867|NCT01304147|11050207|FG001|NOT COMPLETED|Second Intervention (7days)||1
9932868|NCT01304238|11050223|FG000|STARTED|Overall Study||32
9932869|NCT01304238|11050224|FG001|STARTED|Overall Study||4
9932870|NCT01304238|11050225|FG002|STARTED|Overall Study||46
9932871|NCT01304238|11050226|FG003|STARTED|Overall Study||78
9932872|NCT01304238|11050227|FG004|STARTED|Overall Study||11
9932873|NCT01304238|11050228|FG005|STARTED|Overall Study||11
9932874|NCT01304238|11050229|FG006|STARTED|Overall Study||5
9932875|NCT01304238|11050230|FG007|STARTED|Overall Study||4
9932876|NCT01304238|11050231|FG008|STARTED|Overall Study||1
9932877|NCT01304238|11050232|FG009|STARTED|Overall Study||3
9932878|NCT01304238|11050223|FG000|COMPLETED|Overall Study||32
9932879|NCT01304238|11050224|FG001|COMPLETED|Overall Study||4
9932880|NCT01304238|11050225|FG002|COMPLETED|Overall Study||46
9932881|NCT01304238|11050226|FG003|COMPLETED|Overall Study||78
9932882|NCT01304238|11050227|FG004|COMPLETED|Overall Study||11
9932883|NCT01304238|11050228|FG005|COMPLETED|Overall Study||11
9932884|NCT01304238|11050229|FG006|COMPLETED|Overall Study||5
9932885|NCT01304238|11050230|FG007|COMPLETED|Overall Study||4
9932886|NCT01304238|11050231|FG008|COMPLETED|Overall Study||1
9932887|NCT01304238|11050232|FG009|COMPLETED|Overall Study||3
9932888|NCT01304238|11050223|FG000|NOT COMPLETED|Overall Study||0
9932889|NCT01304238|11050224|FG001|NOT COMPLETED|Overall Study||0
9932890|NCT01304238|11050225|FG002|NOT COMPLETED|Overall Study||0
9932891|NCT01304238|11050226|FG003|NOT COMPLETED|Overall Study||0
9932892|NCT01304238|11050227|FG004|NOT COMPLETED|Overall Study||0
9932893|NCT01304238|11050228|FG005|NOT COMPLETED|Overall Study||0
9932894|NCT01304238|11050229|FG006|NOT COMPLETED|Overall Study||0
9932895|NCT01304238|11050230|FG007|NOT COMPLETED|Overall Study||0
9932896|NCT01304238|11050231|FG008|NOT COMPLETED|Overall Study||0
9932897|NCT01304238|11050232|FG009|NOT COMPLETED|Overall Study||0
9932898|NCT01304277|11050254|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
9932899|NCT01304277|11050254|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
9932900|NCT01304277|11050254|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
9932901|NCT01304277|11050254|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
9932902|NCT01304277|11050254|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
9932903|NCT01304277|11050254|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
9932904|NCT01304329|11050261|FG000|STARTED|First Intervention (3 Days)||3
9932905|NCT01304329|11050262|FG001|STARTED|First Intervention (3 Days)||3
9932906|NCT01304329|11050263|FG002|STARTED|First Intervention (3 Days)||3
9932907|NCT01304329|11050264|FG003|STARTED|First Intervention (3 Days)||3
9932908|NCT01304329|11050265|FG004|STARTED|First Intervention (3 Days)||3
9932909|NCT01304329|11050266|FG005|STARTED|First Intervention (3 Days)||3
9932910|NCT01304329|11050261|FG000|COMPLETED|First Intervention (3 Days)||3
9932911|NCT01304329|11050262|FG001|COMPLETED|First Intervention (3 Days)||3
9932912|NCT01304329|11050263|FG002|COMPLETED|First Intervention (3 Days)||3
9932913|NCT01304329|11050264|FG003|COMPLETED|First Intervention (3 Days)||3
9932914|NCT01304329|11050265|FG004|COMPLETED|First Intervention (3 Days)||3
9932915|NCT01304329|11050266|FG005|COMPLETED|First Intervention (3 Days)||3
9932916|NCT01304329|11050261|FG000|NOT COMPLETED|First Intervention (3 Days)||0
9932917|NCT01304329|11050262|FG001|NOT COMPLETED|First Intervention (3 Days)||0
9932918|NCT01304329|11050263|FG002|NOT COMPLETED|First Intervention (3 Days)||0
9932919|NCT01304329|11050264|FG003|NOT COMPLETED|First Intervention (3 Days)||0
9932920|NCT01304329|11050265|FG004|NOT COMPLETED|First Intervention (3 Days)||0
9932921|NCT01304329|11050266|FG005|NOT COMPLETED|First Intervention (3 Days)||0
9932922|NCT01304329|11050261|FG000|STARTED|Second Intervention (3 Days)||3
9932923|NCT01304329|11050262|FG001|STARTED|Second Intervention (3 Days)||3
9932924|NCT01304329|11050263|FG002|STARTED|Second Intervention (3 Days)||3
9932925|NCT01304329|11050264|FG003|STARTED|Second Intervention (3 Days)||3
9932926|NCT01304329|11050265|FG004|STARTED|Second Intervention (3 Days)||3
9932927|NCT01304329|11050266|FG005|STARTED|Second Intervention (3 Days)||3
9932928|NCT01304329|11050261|FG000|COMPLETED|Second Intervention (3 Days)||3
9932929|NCT01304329|11050262|FG001|COMPLETED|Second Intervention (3 Days)||3
9932930|NCT01304329|11050263|FG002|COMPLETED|Second Intervention (3 Days)||3
9932931|NCT01304329|11050264|FG003|COMPLETED|Second Intervention (3 Days)||3
9932932|NCT01304329|11050265|FG004|COMPLETED|Second Intervention (3 Days)||3
9932933|NCT01304329|11050266|FG005|COMPLETED|Second Intervention (3 Days)||3
9932934|NCT01304329|11050261|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
9932935|NCT01304329|11050262|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
9932936|NCT01304329|11050263|FG002|NOT COMPLETED|Second Intervention (3 Days)||0
9932937|NCT01304329|11050264|FG003|NOT COMPLETED|Second Intervention (3 Days)||0
9932938|NCT01304329|11050265|FG004|NOT COMPLETED|Second Intervention (3 Days)||0
9932939|NCT01304329|11050266|FG005|NOT COMPLETED|Second Intervention (3 Days)||0
9932940|NCT01304329|11050261|FG000|STARTED|Third Intervention (3 Days)||3
9932941|NCT01304329|11050262|FG001|STARTED|Third Intervention (3 Days)||3
9932942|NCT01304329|11050263|FG002|STARTED|Third Intervention (3 Days)||3
9932943|NCT01304329|11050264|FG003|STARTED|Third Intervention (3 Days)||3
9932944|NCT01304329|11050265|FG004|STARTED|Third Intervention (3 Days)||3
9932945|NCT01304329|11050266|FG005|STARTED|Third Intervention (3 Days)||3
9932946|NCT01304329|11050261|FG000|COMPLETED|Third Intervention (3 Days)||3
9932947|NCT01304329|11050262|FG001|COMPLETED|Third Intervention (3 Days)||2
9932948|NCT01304329|11050263|FG002|COMPLETED|Third Intervention (3 Days)||3
9932949|NCT01304329|11050264|FG003|COMPLETED|Third Intervention (3 Days)||3
9932950|NCT01304329|11050265|FG004|COMPLETED|Third Intervention (3 Days)||3
9932951|NCT01304329|11050266|FG005|COMPLETED|Third Intervention (3 Days)||3
9932952|NCT01304329|11050261|FG000|NOT COMPLETED|Third Intervention (3 Days)||0
9932953|NCT01304329|11050262|FG001|NOT COMPLETED|Third Intervention (3 Days)||1
9932954|NCT01304329|11050263|FG002|NOT COMPLETED|Third Intervention (3 Days)||0
9932955|NCT01304329|11050264|FG003|NOT COMPLETED|Third Intervention (3 Days)||0
9932956|NCT01304329|11050265|FG004|NOT COMPLETED|Third Intervention (3 Days)||0
9932957|NCT01304329|11050266|FG005|NOT COMPLETED|Third Intervention (3 Days)||0
9932958|NCT01304407|11050274|FG000|STARTED|Overall Study||29
9932959|NCT01304407|11050274|FG000|COMPLETED|Overall Study||29
9932960|NCT01304407|11050274|FG000|NOT COMPLETED|Overall Study||0
9932961|NCT01304498|11050280|FG000|STARTED|Overall Study||300
9932962|NCT01304498|11050281|FG001|STARTED|Overall Study||300
9932963|NCT01304498|11050280|FG000|Received ≥1 Dose|Overall Study||300
9932964|NCT01304498|11050281|FG001|Received ≥1 Dose|Overall Study||300
9932965|NCT01304498|11050280|FG000|COMPLETED|Overall Study||294
9932966|NCT01304498|11050281|FG001|COMPLETED|Overall Study||295
9932967|NCT01304498|11050280|FG000|NOT COMPLETED|Overall Study||6
9932968|NCT01304498|11050281|FG001|NOT COMPLETED|Overall Study||5
9932969|NCT01304589|11050287|FG000|STARTED|Overall Study||31
9932970|NCT01304589|11050287|FG000|COMPLETED|Overall Study||18
9932971|NCT01304589|11050287|FG000|NOT COMPLETED|Overall Study||13
9932972|NCT01304641|11050294|FG000|STARTED|Overall Study||11470
9932973|NCT01304641|11050295|FG001|STARTED|Overall Study||20132
9932974|NCT01304641|11050294|FG000|COMPLETED|Overall Study||11470
9932975|NCT01304641|11050295|FG001|COMPLETED|Overall Study||20132
9932976|NCT01304641|11050294|FG000|NOT COMPLETED|Overall Study||0
9932977|NCT01304641|11050295|FG001|NOT COMPLETED|Overall Study||0
9932978|NCT01304693|11050306|FG000|STARTED|Overall Study||10
9932979|NCT01304693|11050307|FG001|STARTED|Overall Study||35
9932980|NCT01304693|11050308|FG002|STARTED|Overall Study||48
9932981|NCT01304693|11050309|FG003|STARTED|Overall Study||40
9932982|NCT01304693|11050310|FG004|STARTED|Overall Study||61
9932983|NCT01304693|11050306|FG000|COMPLETED|Overall Study||10
9932984|NCT01304693|11050307|FG001|COMPLETED|Overall Study||35
9932985|NCT01304693|11050308|FG002|COMPLETED|Overall Study||47
9932986|NCT01304693|11050309|FG003|COMPLETED|Overall Study||39
9932987|NCT01304693|11050310|FG004|COMPLETED|Overall Study||60
9932988|NCT01304693|11050306|FG000|NOT COMPLETED|Overall Study||0
9932989|NCT01304693|11050307|FG001|NOT COMPLETED|Overall Study||0
9932990|NCT01304693|11050308|FG002|NOT COMPLETED|Overall Study||1
9932991|NCT01304693|11050309|FG003|NOT COMPLETED|Overall Study||1
9932992|NCT01304693|11050310|FG004|NOT COMPLETED|Overall Study||1
9932993|NCT01304706|11050322|FG000|STARTED|Overall Study||121
9932994|NCT01304706|11050322|FG000|COMPLETED|Overall Study||104
9932995|NCT01304706|11050322|FG000|NOT COMPLETED|Overall Study||17
9932996|NCT01304940|11050328|FG000|STARTED|Overall Study||25
9932997|NCT01304940|11050329|FG001|STARTED|Overall Study||25
9932998|NCT01304940|11050328|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
9932999|NCT01304940|11050329|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
9933000|NCT01304940|11050328|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
9933001|NCT01304940|11050329|FG001|COMPLETED|Overall Study||25
9933002|NCT01304940|11050328|FG000|NOT COMPLETED|Overall Study||3
9933003|NCT01304940|11050329|FG001|NOT COMPLETED|Overall Study||0
9933004|NCT01304966|11050335|FG000|STARTED|Overall Study||15
9933005|NCT01304966|11050335|FG000|COMPLETED|Overall Study||15
9933006|NCT01304966|11050335|FG000|NOT COMPLETED|Overall Study||0
9933007|NCT01305044|11050343|FG000|STARTED|Overall Study||32
9933008|NCT01305044|11050344|FG001|STARTED|Overall Study||31
9933009|NCT01305044|11050343|FG000|COMPLETED|Overall Study||29
9933010|NCT01305044|11050344|FG001|COMPLETED|Overall Study||25
9933011|NCT01305044|11050343|FG000|NOT COMPLETED|Overall Study||3
9933012|NCT01305044|11050344|FG001|NOT COMPLETED|Overall Study||6
9933013|NCT01305200|11050353|FG000|STARTED|Overall Study||111
9933014|NCT01305200|11050354|FG001|STARTED|Overall Study||112
9933015|NCT01305200|11050355|FG002|STARTED|Overall Study||3
9933016|NCT01305200|11050353|FG000|COMPLETED|Overall Study||82
9933017|NCT01305200|11050354|FG001|COMPLETED|Overall Study||81
9933018|NCT01305200|11050355|FG002|COMPLETED|Overall Study||0
9933019|NCT01305200|11050353|FG000|NOT COMPLETED|Overall Study||29
9933020|NCT01305200|11050354|FG001|NOT COMPLETED|Overall Study||31
9933021|NCT01305200|11050355|FG002|NOT COMPLETED|Overall Study||3
9933022|NCT01305213|11050363|FG000|STARTED|Overall Study||53
9933023|NCT01305213|11050364|FG001|STARTED|Overall Study||54
9933024|NCT01305213|11050363|FG000|COMPLETED|Overall Study||53
9933025|NCT01305213|11050364|FG001|COMPLETED|Overall Study||54
9933026|NCT01305213|11050363|FG000|NOT COMPLETED|Overall Study||0
9933027|NCT01305213|11050364|FG001|NOT COMPLETED|Overall Study||0
9933028|NCT01305239|11050373|FG000|STARTED|Overall Study||398
9933029|NCT01305239|11050373|FG000|Safety Set|Overall Study||397
9933030|NCT01305239|11050373|FG000|Intent to Treat Population|Overall Study||287
9933031|NCT01305239|11050373|FG000|COMPLETED|Overall Study||375
9933032|NCT01305239|11050373|FG000|NOT COMPLETED|Overall Study||23
9933033|NCT01305252|11050379|FG000|STARTED|Overall Study||10
9933034|NCT01305252|11050380|FG001|STARTED|Overall Study||11
9933035|NCT01305252|11050379|FG000|COMPLETED|Overall Study||9
9933036|NCT01305252|11050380|FG001|COMPLETED|Overall Study||11
9933037|NCT01305252|11050379|FG000|NOT COMPLETED|Overall Study||1
9933038|NCT01305252|11050380|FG001|NOT COMPLETED|Overall Study||0
9933039|NCT01305265|11050392|FG000|STARTED|Overall Study||71
9933040|NCT01305265|11050393|FG001|STARTED|Overall Study||70
9933041|NCT01305265|11050392|FG000|COMPLETED|Overall Study||69
9933042|NCT01305265|11050393|FG001|COMPLETED|Overall Study||64
9933043|NCT01305265|11050392|FG000|NOT COMPLETED|Overall Study||2
9933044|NCT01305265|11050393|FG001|NOT COMPLETED|Overall Study||6
9933045|NCT01305356|11050401|FG000|STARTED|Overall Study||132
9933046|NCT01305356|11050402|FG001|STARTED|Overall Study||167
9933047|NCT01305356|11050401|FG000|COMPLETED|Overall Study||132
9933048|NCT01305356|11050402|FG001|COMPLETED|Overall Study||167
9933049|NCT01305356|11050401|FG000|NOT COMPLETED|Overall Study||0
9933050|NCT01305356|11050402|FG001|NOT COMPLETED|Overall Study||0
9933051|NCT01305408|11050410|FG000|STARTED|Overall Study||199
9933052|NCT01305408|11050411|FG001|STARTED|Overall Study||200
9933053|NCT01305408|11050410|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
9933054|NCT01305408|11050411|FG001|Safety Population|Overall Study|Treated participants.|200
9933055|NCT01305408|11050410|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
9933056|NCT01305408|11050411|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
9933057|NCT01305408|11050410|FG000|COMPLETED|Overall Study||167
9933058|NCT01305408|11050411|FG001|COMPLETED|Overall Study||169
9933059|NCT01305408|11050410|FG000|NOT COMPLETED|Overall Study||32
9933060|NCT01305408|11050411|FG001|NOT COMPLETED|Overall Study||31
9933061|NCT01305473|11050417|FG000|STARTED|Overall Study||90
9933062|NCT01305473|11050417|FG000|COMPLETED|Overall Study||90
9933063|NCT01305473|11050417|FG000|NOT COMPLETED|Overall Study||0
9933064|NCT01305564|11050421|FG000|STARTED|Overall Study||200
9933065|NCT01305564|11050421|FG000|COMPLETED|Overall Study||163
9933066|NCT01305564|11050421|FG000|NOT COMPLETED|Overall Study||37
9933067|NCT01305577|11050439|FG000|STARTED|Overall Study||120
9933068|NCT01305577|11050440|FG001|STARTED|Overall Study||121
9933069|NCT01305577|11050441|FG002|STARTED|Overall Study||122
9933070|NCT01305577|11050439|FG000|Received Treatment|Overall Study||119
9933071|NCT01305577|11050440|FG001|Received Treatment|Overall Study||121
9933072|NCT01305577|11050441|FG002|Received Treatment|Overall Study||122
9933073|NCT01305577|11050439|FG000|COMPLETED|Overall Study||107
9933074|NCT01305577|11050440|FG001|COMPLETED|Overall Study||110
9933075|NCT01305577|11050441|FG002|COMPLETED|Overall Study||112
9933076|NCT01305577|11050439|FG000|NOT COMPLETED|Overall Study||13
9933077|NCT01305577|11050440|FG001|NOT COMPLETED|Overall Study||11
9933078|NCT01305577|11050441|FG002|NOT COMPLETED|Overall Study||10
9933079|NCT01305655|11050449|FG000|STARTED|Overall Study|July 2008|47
9933080|NCT01305655|11050449|FG000|COMPLETED|Overall Study|December 31, 2014|47
9933081|NCT01305655|11050449|FG000|NOT COMPLETED|Overall Study||0
9933082|NCT01305772|11050455|FG000|STARTED|Overall Study||5
9933083|NCT01305772|11050456|FG001|STARTED|Overall Study||1
9933084|NCT01305772|11050455|FG000|Genomic Screening + Biopsy #1|Overall Study||5
9933085|NCT01305772|11050456|FG001|Genomic Screening + Biopsy #1|Overall Study||1
9933086|NCT01305772|11050455|FG000|Research PET/CT #1|Overall Study||5
9933087|NCT01305772|11050456|FG001|Research PET/CT #1|Overall Study||1
9933088|NCT01305772|11050455|FG000|Panitumumab Dose #1|Overall Study||5
9933089|NCT01305772|11050456|FG001|Panitumumab Dose #1|Overall Study||1
9933090|NCT01305772|11050455|FG000|Research PET/CT #2|Overall Study||5
9933091|NCT01305772|11050456|FG001|Research PET/CT #2|Overall Study||1
9933092|NCT01305772|11050455|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
9933093|NCT01305772|11050456|FG001|Surgery/Biopsy #2|Overall Study||1
9933094|NCT01305772|11050455|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
9933095|NCT01305772|11050456|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1
9933096|NCT01305772|11050455|FG000|COMPLETED|Overall Study||5
9933097|NCT01305772|11050456|FG001|COMPLETED|Overall Study||1
9933098|NCT01305772|11050455|FG000|NOT COMPLETED|Overall Study||0
9933099|NCT01305772|11050456|FG001|NOT COMPLETED|Overall Study||0
9933100|NCT01305811|11050463|FG000|STARTED|Overall Study||52
9933101|NCT01305811|11050464|FG001|STARTED|Overall Study||52
9933102|NCT01305811|11050463|FG000|COMPLETED|Overall Study||44
9933103|NCT01305811|11050464|FG001|COMPLETED|Overall Study||41
9933104|NCT01305811|11050463|FG000|NOT COMPLETED|Overall Study||8
9933105|NCT01305811|11050464|FG001|NOT COMPLETED|Overall Study||11
9933106|NCT01305941|11050472|FG000|STARTED|Overall Study||32
9933107|NCT01305941|11050472|FG000|COMPLETED|Overall Study||22
9933108|NCT01305941|11050472|FG000|NOT COMPLETED|Overall Study||10
9933109|NCT01306032|11050482|FG000|STARTED|First Intervention||22
9933110|NCT01306032|11050483|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
9933111|NCT01306032|11050484|FG002|STARTED|First Intervention||37
9933112|NCT01306032|11050485|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
9933113|NCT01306032|11050486|FG004|STARTED|First Intervention||2
9933114|NCT01306032|11050487|FG005|STARTED|First Intervention||2
9933115|NCT01306032|11050482|FG000|COMPLETED|First Intervention||21
9933116|NCT01306032|11050483|FG001|COMPLETED|First Intervention||18
9933117|NCT01306032|11050484|FG002|COMPLETED|First Intervention||35
9933118|NCT01306032|11050485|FG003|COMPLETED|First Intervention||37
9933119|NCT01306032|11050486|FG004|COMPLETED|First Intervention||0
9933120|NCT01306032|11050487|FG005|COMPLETED|First Intervention||0
9933121|NCT01306032|11050482|FG000|NOT COMPLETED|First Intervention||1
9933122|NCT01306032|11050483|FG001|NOT COMPLETED|First Intervention||2
9933123|NCT01306032|11050484|FG002|NOT COMPLETED|First Intervention||2
9933124|NCT01306032|11050485|FG003|NOT COMPLETED|First Intervention||1
9933125|NCT01306032|11050486|FG004|NOT COMPLETED|First Intervention||2
9933126|NCT01306032|11050487|FG005|NOT COMPLETED|First Intervention||2
9933127|NCT01306032|11050482|FG000|STARTED|Disease Progression/Crossover||0
9933128|NCT01306032|11050483|FG001|STARTED|Disease Progression/Crossover||16
9933129|NCT01306032|11050484|FG002|STARTED|Disease Progression/Crossover||0
9933130|NCT01306032|11050485|FG003|STARTED|Disease Progression/Crossover||29
9933131|NCT01306032|11050486|FG004|STARTED|Disease Progression/Crossover||0
9933132|NCT01306032|11050487|FG005|STARTED|Disease Progression/Crossover||0
9933133|NCT01306032|11050482|FG000|COMPLETED|Disease Progression/Crossover||0
9933134|NCT01306032|11050483|FG001|COMPLETED|Disease Progression/Crossover||14
9933135|NCT01306032|11050484|FG002|COMPLETED|Disease Progression/Crossover||0
9933136|NCT01306032|11050485|FG003|COMPLETED|Disease Progression/Crossover||26
9933137|NCT01306032|11050486|FG004|COMPLETED|Disease Progression/Crossover||0
9933138|NCT01306032|11050487|FG005|COMPLETED|Disease Progression/Crossover||0
10011036|NCT01777542|11133733|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
10011037|NCT01777542|11133732|FG000|STARTED|Second Intervention (20 Weeks)||15
10011038|NCT01777542|11133733|FG001|STARTED|Second Intervention (20 Weeks)||15
9933139|NCT01306032|11050482|FG000|NOT COMPLETED|Disease Progression/Crossover||0
9933140|NCT01306032|11050483|FG001|NOT COMPLETED|Disease Progression/Crossover||2
9933141|NCT01306032|11050484|FG002|NOT COMPLETED|Disease Progression/Crossover||0
9933142|NCT01306032|11050485|FG003|NOT COMPLETED|Disease Progression/Crossover||3
9933143|NCT01306032|11050486|FG004|NOT COMPLETED|Disease Progression/Crossover||0
9933144|NCT01306032|11050487|FG005|NOT COMPLETED|Disease Progression/Crossover||0
9933145|NCT01306058|11050513|FG000|STARTED|Overall Study||27
9933146|NCT01306058|11050513|FG000|COMPLETED|Overall Study||25
9933147|NCT01306058|11050513|FG000|NOT COMPLETED|Overall Study||2
9933148|NCT01306162|11050521|FG000|STARTED|Period 1||9
9933149|NCT01306162|11050522|FG001|STARTED|Period 1||9
9933150|NCT01306162|11050523|FG002|STARTED|Period 1||9
9933151|NCT01306162|11050524|FG003|STARTED|Period 1||9
9933152|NCT01306162|11050521|FG000|COMPLETED|Period 1||9
9933153|NCT01306162|11050522|FG001|COMPLETED|Period 1||9
9933154|NCT01306162|11050523|FG002|COMPLETED|Period 1||9
9933155|NCT01306162|11050524|FG003|COMPLETED|Period 1||8
9933156|NCT01306162|11050521|FG000|NOT COMPLETED|Period 1||0
9933157|NCT01306162|11050522|FG001|NOT COMPLETED|Period 1||0
9933158|NCT01306162|11050523|FG002|NOT COMPLETED|Period 1||0
9933159|NCT01306162|11050524|FG003|NOT COMPLETED|Period 1||1
9933160|NCT01306162|11050521|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
9933161|NCT01306162|11050522|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
9933162|NCT01306162|11050523|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
9933163|NCT01306162|11050524|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
9933164|NCT01306162|11050521|FG000|COMPLETED|Washout 1||9
9933165|NCT01306162|11050522|FG001|COMPLETED|Washout 1||8
9933166|NCT01306162|11050523|FG002|COMPLETED|Washout 1||9
9933167|NCT01306162|11050524|FG003|COMPLETED|Washout 1||8
9933168|NCT01306162|11050521|FG000|NOT COMPLETED|Washout 1||0
9933169|NCT01306162|11050522|FG001|NOT COMPLETED|Washout 1||1
9933170|NCT01306162|11050523|FG002|NOT COMPLETED|Washout 1||0
9933171|NCT01306162|11050524|FG003|NOT COMPLETED|Washout 1||0
9933172|NCT01306162|11050521|FG000|STARTED|Period 2|No washout phase after Period 2.|9
9933173|NCT01306162|11050522|FG001|STARTED|Period 2|No washout phase after Period 2.|8
9933174|NCT01306162|11050523|FG002|STARTED|Period 2|No washout phase after Period 2.|9
9933175|NCT01306162|11050524|FG003|STARTED|Period 2|No washout phase after Period 2.|8
9933176|NCT01306162|11050521|FG000|COMPLETED|Period 2||9
9933177|NCT01306162|11050522|FG001|COMPLETED|Period 2||8
9933178|NCT01306162|11050523|FG002|COMPLETED|Period 2||9
9933179|NCT01306162|11050524|FG003|COMPLETED|Period 2||8
9933180|NCT01306162|11050521|FG000|NOT COMPLETED|Period 2||0
9933181|NCT01306162|11050522|FG001|NOT COMPLETED|Period 2||0
9933182|NCT01306162|11050523|FG002|NOT COMPLETED|Period 2||0
9933183|NCT01306162|11050524|FG003|NOT COMPLETED|Period 2||0
9933184|NCT01306162|11050521|FG000|STARTED|Period 3||9
9933185|NCT01306162|11050522|FG001|STARTED|Period 3||8
9933186|NCT01306162|11050523|FG002|STARTED|Period 3||9
9933187|NCT01306162|11050524|FG003|STARTED|Period 3||8
9933188|NCT01306162|11050521|FG000|COMPLETED|Period 3||9
9933189|NCT01306162|11050522|FG001|COMPLETED|Period 3||8
9933190|NCT01306162|11050523|FG002|COMPLETED|Period 3||9
9933191|NCT01306162|11050524|FG003|COMPLETED|Period 3||8
9933192|NCT01306162|11050521|FG000|NOT COMPLETED|Period 3||0
9933193|NCT01306162|11050522|FG001|NOT COMPLETED|Period 3||0
9933194|NCT01306162|11050523|FG002|NOT COMPLETED|Period 3||0
9933195|NCT01306162|11050524|FG003|NOT COMPLETED|Period 3||0
9933196|NCT01306162|11050521|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
9933197|NCT01306162|11050522|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
9933198|NCT01306162|11050523|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
9933199|NCT01306162|11050524|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
9933200|NCT01306162|11050521|FG000|COMPLETED|Washout 2||9
9933201|NCT01306162|11050522|FG001|COMPLETED|Washout 2||8
9933202|NCT01306162|11050523|FG002|COMPLETED|Washout 2||9
9933203|NCT01306162|11050524|FG003|COMPLETED|Washout 2||8
9933204|NCT01306162|11050521|FG000|NOT COMPLETED|Washout 2||0
9933205|NCT01306162|11050522|FG001|NOT COMPLETED|Washout 2||0
9933206|NCT01306162|11050523|FG002|NOT COMPLETED|Washout 2||0
9933207|NCT01306162|11050524|FG003|NOT COMPLETED|Washout 2||0
9933208|NCT01306162|11050521|FG000|STARTED|Period 4||9
9933209|NCT01306162|11050522|FG001|STARTED|Period 4||8
10011039|NCT01777542|11133732|FG000|COMPLETED|Second Intervention (20 Weeks)||15
10011040|NCT01777542|11133733|FG001|COMPLETED|Second Intervention (20 Weeks)||14
9933210|NCT01306162|11050523|FG002|STARTED|Period 4||9
9933211|NCT01306162|11050524|FG003|STARTED|Period 4||8
9933212|NCT01306162|11050521|FG000|COMPLETED|Period 4||9
9933213|NCT01306162|11050522|FG001|COMPLETED|Period 4||8
9933214|NCT01306162|11050523|FG002|COMPLETED|Period 4||9
9933215|NCT01306162|11050524|FG003|COMPLETED|Period 4||8
9933216|NCT01306162|11050521|FG000|NOT COMPLETED|Period 4||0
9933217|NCT01306162|11050522|FG001|NOT COMPLETED|Period 4||0
9933218|NCT01306162|11050523|FG002|NOT COMPLETED|Period 4||0
9933219|NCT01306162|11050524|FG003|NOT COMPLETED|Period 4||0
9933220|NCT01306175|11050537|FG000|STARTED|First Intervention||20
9933221|NCT01306175|11050537|FG000|COMPLETED|First Intervention||20
9933222|NCT01306175|11050537|FG000|NOT COMPLETED|First Intervention||0
9933223|NCT01306175|11050537|FG000|STARTED|Washout Period of at Least 14 Days||20
9933224|NCT01306175|11050537|FG000|COMPLETED|Washout Period of at Least 14 Days||20
9933225|NCT01306175|11050537|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
9933226|NCT01306175|11050537|FG000|STARTED|Second Intervention||20
9933227|NCT01306175|11050537|FG000|COMPLETED|Second Intervention||20
9933228|NCT01306175|11050537|FG000|NOT COMPLETED|Second Intervention||0
9933229|NCT01306201|11050543|FG000|STARTED|Overall Study||63
9933230|NCT01306201|11050543|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
9933231|NCT01306201|11050543|FG000|NOT COMPLETED|Overall Study||10
9933232|NCT01306214|11050554|FG000|STARTED|Overall Study||189
9933233|NCT01306214|11050555|FG001|STARTED|Overall Study||187
9933234|NCT01306214|11050556|FG002|STARTED|Overall Study||190
9933235|NCT01306214|11050554|FG000|COMPLETED|Overall Study||161
9933236|NCT01306214|11050555|FG001|COMPLETED|Overall Study||159
9933237|NCT01306214|11050556|FG002|COMPLETED|Overall Study||168
9933238|NCT01306214|11050554|FG000|NOT COMPLETED|Overall Study||28
9933239|NCT01306214|11050555|FG001|NOT COMPLETED|Overall Study||28
9933240|NCT01306214|11050556|FG002|NOT COMPLETED|Overall Study||22
9933241|NCT01306253|11050566|FG000|STARTED|Overall Study||57
9933242|NCT01306253|11050567|FG001|STARTED|Overall Study||57
9933243|NCT01306253|11050566|FG000|COMPLETED|Overall Study||56
9933244|NCT01306253|11050567|FG001|COMPLETED|Overall Study||56
9933245|NCT01306253|11050566|FG000|NOT COMPLETED|Overall Study||1
9933246|NCT01306253|11050567|FG001|NOT COMPLETED|Overall Study||1
9933247|NCT01306292|11050575|FG000|STARTED|First Injection||10
9933248|NCT01306292|11050576|FG001|STARTED|First Injection||8
9933249|NCT01306292|11050577|FG002|STARTED|First Injection||8
9933250|NCT01306292|11050578|FG003|STARTED|First Injection||10
9933251|NCT01306292|11050575|FG000|COMPLETED|First Injection||10
9933252|NCT01306292|11050576|FG001|COMPLETED|First Injection||8
9933253|NCT01306292|11050577|FG002|COMPLETED|First Injection||8
9933254|NCT01306292|11050578|FG003|COMPLETED|First Injection||10
9933255|NCT01306292|11050575|FG000|NOT COMPLETED|First Injection||0
9933256|NCT01306292|11050576|FG001|NOT COMPLETED|First Injection||0
9933257|NCT01306292|11050577|FG002|NOT COMPLETED|First Injection||0
9933258|NCT01306292|11050578|FG003|NOT COMPLETED|First Injection||0
9933259|NCT01306292|11050575|FG000|STARTED|Washout (at Least 10 Minutes)||10
9933260|NCT01306292|11050576|FG001|STARTED|Washout (at Least 10 Minutes)||8
9933261|NCT01306292|11050577|FG002|STARTED|Washout (at Least 10 Minutes)||8
9933262|NCT01306292|11050578|FG003|STARTED|Washout (at Least 10 Minutes)||10
9933263|NCT01306292|11050575|FG000|COMPLETED|Washout (at Least 10 Minutes)||10
9933264|NCT01306292|11050576|FG001|COMPLETED|Washout (at Least 10 Minutes)||8
9933265|NCT01306292|11050577|FG002|COMPLETED|Washout (at Least 10 Minutes)||8
9933266|NCT01306292|11050578|FG003|COMPLETED|Washout (at Least 10 Minutes)||10
9933267|NCT01306292|11050575|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0
9933268|NCT01306292|11050576|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0
9933269|NCT01306292|11050577|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0
9933270|NCT01306292|11050578|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0
9933271|NCT01306292|11050575|FG000|STARTED|Second Injection||10
9933272|NCT01306292|11050576|FG001|STARTED|Second Injection||8
9933273|NCT01306292|11050577|FG002|STARTED|Second Injection||8
9933274|NCT01306292|11050578|FG003|STARTED|Second Injection||10
9933275|NCT01306292|11050575|FG000|COMPLETED|Second Injection||10
9933276|NCT01306292|11050576|FG001|COMPLETED|Second Injection||8
9933277|NCT01306292|11050577|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
9933278|NCT01306292|11050578|FG003|COMPLETED|Second Injection||10
9933279|NCT01306292|11050575|FG000|NOT COMPLETED|Second Injection||0
9933280|NCT01306292|11050576|FG001|NOT COMPLETED|Second Injection||0
9933281|NCT01306292|11050577|FG002|NOT COMPLETED|Second Injection||1
9933282|NCT01306292|11050578|FG003|NOT COMPLETED|Second Injection||0
9933283|NCT01306305|11050588|FG000|STARTED|Overall Study||55
9933284|NCT01306305|11050589|FG001|STARTED|Overall Study||55
9933285|NCT01306305|11050588|FG000|COMPLETED|Overall Study||53
9933286|NCT01306305|11050589|FG001|COMPLETED|Overall Study||55
9933287|NCT01306305|11050588|FG000|NOT COMPLETED|Overall Study||2
9933288|NCT01306305|11050589|FG001|NOT COMPLETED|Overall Study||0
9933289|NCT01306331|11050597|FG000|STARTED|Overall Study||1659
9933290|NCT01306331|11050598|FG001|STARTED|Overall Study||1665
9933291|NCT01306331|11050597|FG000|COMPLETED|Overall Study||758
9933292|NCT01306331|11050598|FG001|COMPLETED|Overall Study||788
9933293|NCT01306331|11050597|FG000|NOT COMPLETED|Overall Study||901
9933294|NCT01306331|11050598|FG001|NOT COMPLETED|Overall Study||877
9933295|NCT01306617|11050607|FG000|STARTED|Overall Study||19
9933296|NCT01306617|11050608|FG001|STARTED|Overall Study||14
9933297|NCT01306617|11050609|FG002|STARTED|Overall Study||17
9956300|NCT01444781|11075456|FG002|NOT COMPLETED|Overall Study||3
9933298|NCT01306617|11050607|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18
9933299|NCT01306617|11050608|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13
9933300|NCT01306617|11050609|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12
9933301|NCT01306617|11050607|FG000|NOT COMPLETED|Overall Study||1
9933302|NCT01306617|11050608|FG001|NOT COMPLETED|Overall Study||1
9933303|NCT01306617|11050609|FG002|NOT COMPLETED|Overall Study||5
9933304|NCT01306643|11050617|FG000|STARTED|Overall Study||18
9933305|NCT01306643|11050617|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
9933306|NCT01306643|11050617|FG000|NOT COMPLETED|Overall Study||13
9933307|NCT01306656|11050623|FG000|STARTED|Overall Study||7
9933308|NCT01306656|11050624|FG001|STARTED|Overall Study||2
9933309|NCT01306656|11050623|FG000|COMPLETED|Overall Study||6
10011041|NCT01777542|11133732|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0
10011042|NCT01777542|11133733|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1
10011043|NCT01777568|11133742|FG000|STARTED|Overall Study||2853
9933310|NCT01306656|11050624|FG001|COMPLETED|Overall Study||2
9933311|NCT01306656|11050623|FG000|NOT COMPLETED|Overall Study||1
9933312|NCT01306656|11050624|FG001|NOT COMPLETED|Overall Study||0
9933313|NCT01306877|11050634|FG000|STARTED|Overall Study||78
9933314|NCT01306877|11050635|FG001|STARTED|Overall Study||71
9933315|NCT01306877|11050634|FG000|COMPLETED|Overall Study||75
9933316|NCT01306877|11050635|FG001|COMPLETED|Overall Study||67
9933317|NCT01306877|11050634|FG000|NOT COMPLETED|Overall Study||3
9933318|NCT01306877|11050635|FG001|NOT COMPLETED|Overall Study||4
9933319|NCT01306890|11050641|FG000|STARTED|Overall Study||1976
9933320|NCT01306890|11050641|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
9933321|NCT01306890|11050641|FG000|NOT COMPLETED|Overall Study||1519
9933322|NCT01306942|11050648|FG000|STARTED|Phase I||6
9933323|NCT01306942|11050649|FG001|STARTED|Phase I||4
9933324|NCT01306942|11050650|FG002|STARTED|Phase I||0
9933325|NCT01306942|11050651|FG003|STARTED|Phase I||0
9933326|NCT01306942|11050648|FG000|COMPLETED|Phase I||1
9933327|NCT01306942|11050649|FG001|COMPLETED|Phase I||1
9933328|NCT01306942|11050650|FG002|COMPLETED|Phase I||0
9933329|NCT01306942|11050651|FG003|COMPLETED|Phase I||0
9933330|NCT01306942|11050648|FG000|NOT COMPLETED|Phase I||5
9933331|NCT01306942|11050649|FG001|NOT COMPLETED|Phase I||3
9933332|NCT01306942|11050650|FG002|NOT COMPLETED|Phase I||0
9933333|NCT01306942|11050651|FG003|NOT COMPLETED|Phase I||0
9933334|NCT01306942|11050648|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
9933335|NCT01306942|11050649|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
9933336|NCT01306942|11050650|FG002|STARTED|Phase II||0
9933337|NCT01306942|11050651|FG003|STARTED|Phase II||27
9933338|NCT01306942|11050648|FG000|COMPLETED|Phase II||0
9933339|NCT01306942|11050649|FG001|COMPLETED|Phase II||0
9933340|NCT01306942|11050650|FG002|COMPLETED|Phase II||0
9933341|NCT01306942|11050651|FG003|COMPLETED|Phase II||11
9933342|NCT01306942|11050648|FG000|NOT COMPLETED|Phase II||2
9933343|NCT01306942|11050649|FG001|NOT COMPLETED|Phase II||0
9933344|NCT01306942|11050650|FG002|NOT COMPLETED|Phase II||0
9933345|NCT01306942|11050651|FG003|NOT COMPLETED|Phase II||16
9933346|NCT01306968|11050667|FG000|STARTED|Overall Study||7
9933347|NCT01306968|11050668|FG001|STARTED|Overall Study||23
9933348|NCT01306968|11050669|FG002|STARTED|Overall Study||24
9933349|NCT01306968|11050670|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
9933350|NCT01306968|11050667|FG000|COMPLETED|Overall Study||6
9933351|NCT01306968|11050668|FG001|COMPLETED|Overall Study||20
9933352|NCT01306968|11050669|FG002|COMPLETED|Overall Study||23
9933353|NCT01306968|11050670|FG003|COMPLETED|Overall Study||21
9933354|NCT01306968|11050667|FG000|NOT COMPLETED|Overall Study||1
9933355|NCT01306968|11050668|FG001|NOT COMPLETED|Overall Study||3
9933356|NCT01306968|11050669|FG002|NOT COMPLETED|Overall Study||1
9933357|NCT01306968|11050670|FG003|NOT COMPLETED|Overall Study||4
9933358|NCT01307007|11050684|FG000|STARTED|Overall Study||25
9933359|NCT01307007|11050685|FG001|STARTED|Overall Study||30
9933360|NCT01307007|11050684|FG000|COMPLETED|Overall Study||25
9933361|NCT01307007|11050685|FG001|COMPLETED|Overall Study||30
9933362|NCT01307007|11050684|FG000|NOT COMPLETED|Overall Study||0
9933363|NCT01307007|11050685|FG001|NOT COMPLETED|Overall Study||0
9933364|NCT01307020|11050701|FG000|STARTED|Overall Study||61
9933365|NCT01307020|11050702|FG001|STARTED|Overall Study||63
9933366|NCT01307020|11050703|FG002|STARTED|Overall Study||63
9933367|NCT01307020|11050704|FG003|STARTED|Overall Study||61
9933368|NCT01307020|11050705|FG004|STARTED|Overall Study||60
9933369|NCT01307020|11050706|FG005|STARTED|Overall Study||61
9933370|NCT01307020|11050707|FG006|STARTED|Overall Study||59
9933371|NCT01307020|11050708|FG007|STARTED|Overall Study||60
9933372|NCT01307020|11050709|FG008|STARTED|Overall Study||61
9933373|NCT01307020|11050710|FG009|STARTED|Overall Study||62
9933374|NCT01307020|11050701|FG000|Safety Population|Overall Study||61
9933375|NCT01307020|11050702|FG001|Safety Population|Overall Study||63
9933376|NCT01307020|11050703|FG002|Safety Population|Overall Study||63
9933377|NCT01307020|11050704|FG003|Safety Population|Overall Study||61
9933378|NCT01307020|11050705|FG004|Safety Population|Overall Study||60
9933379|NCT01307020|11050706|FG005|Safety Population|Overall Study||61
9933380|NCT01307020|11050707|FG006|Safety Population|Overall Study||59
9933381|NCT01307020|11050708|FG007|Safety Population|Overall Study||60
9933382|NCT01307020|11050709|FG008|Safety Population|Overall Study||61
9933383|NCT01307020|11050710|FG009|Safety Population|Overall Study||62
9933384|NCT01307020|11050701|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
9933385|NCT01307020|11050702|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
9933386|NCT01307020|11050703|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
9933387|NCT01307020|11050704|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
9933388|NCT01307020|11050705|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
9933389|NCT01307020|11050706|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
9933390|NCT01307020|11050707|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
9933391|NCT01307020|11050708|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
9933392|NCT01307020|11050709|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
9933393|NCT01307020|11050710|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
9933394|NCT01307020|11050701|FG000|COMPLETED|Overall Study||61
9933395|NCT01307020|11050702|FG001|COMPLETED|Overall Study||62
9933396|NCT01307020|11050703|FG002|COMPLETED|Overall Study||62
9933397|NCT01307020|11050704|FG003|COMPLETED|Overall Study||60
9933398|NCT01307020|11050705|FG004|COMPLETED|Overall Study||60
9933399|NCT01307020|11050706|FG005|COMPLETED|Overall Study||61
9933400|NCT01307020|11050707|FG006|COMPLETED|Overall Study||58
9933401|NCT01307020|11050708|FG007|COMPLETED|Overall Study||60
9933402|NCT01307020|11050709|FG008|COMPLETED|Overall Study||61
9933403|NCT01307020|11050710|FG009|COMPLETED|Overall Study||62
9933404|NCT01307020|11050701|FG000|NOT COMPLETED|Overall Study||0
9933405|NCT01307020|11050702|FG001|NOT COMPLETED|Overall Study||1
9933406|NCT01307020|11050703|FG002|NOT COMPLETED|Overall Study||1
9933407|NCT01307020|11050704|FG003|NOT COMPLETED|Overall Study||1
9933408|NCT01307020|11050705|FG004|NOT COMPLETED|Overall Study||0
9933409|NCT01307020|11050706|FG005|NOT COMPLETED|Overall Study||0
9933410|NCT01307020|11050707|FG006|NOT COMPLETED|Overall Study||1
9933411|NCT01307020|11050708|FG007|NOT COMPLETED|Overall Study||0
9933412|NCT01307020|11050709|FG008|NOT COMPLETED|Overall Study||0
9933413|NCT01307020|11050710|FG009|NOT COMPLETED|Overall Study||0
9933414|NCT01307098|11050735|FG000|STARTED|Overall Study||3
9933415|NCT01307098|11050736|FG001|STARTED|Overall Study||3
9933416|NCT01307098|11050737|FG002|STARTED|Overall Study||3
9933417|NCT01307098|11050735|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9933418|NCT01307098|11050736|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9933419|NCT01307098|11050737|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9933420|NCT01307098|11050735|FG000|COMPLETED|Overall Study||3
9933421|NCT01307098|11050736|FG001|COMPLETED|Overall Study||3
9933422|NCT01307098|11050737|FG002|COMPLETED|Overall Study||3
10206959|NCT03519867|11333731|FG009|NOT COMPLETED|Overall Study||0
10206960|NCT03519919|11333753|FG000|STARTED|Overall Study||51
10206961|NCT03519919|11333753|FG000|COMPLETED|Overall Study||48
9933423|NCT01307098|11050735|FG000|NOT COMPLETED|Overall Study||0
9933424|NCT01307098|11050736|FG001|NOT COMPLETED|Overall Study||0
9933425|NCT01307098|11050737|FG002|NOT COMPLETED|Overall Study||0
9933426|NCT01307111|11050748|FG000|STARTED|IUD Insertion||42
9933427|NCT01307111|11050749|FG001|STARTED|IUD Insertion||40
9933428|NCT01307111|11050748|FG000|COMPLETED|IUD Insertion||40
9933429|NCT01307111|11050749|FG001|COMPLETED|IUD Insertion||40
9933430|NCT01307111|11050748|FG000|NOT COMPLETED|IUD Insertion||2
9933431|NCT01307111|11050749|FG001|NOT COMPLETED|IUD Insertion||0
9933432|NCT01307111|11050748|FG000|STARTED|1-2 Week IUD Check up||40
9933433|NCT01307111|11050749|FG001|STARTED|1-2 Week IUD Check up||40
9933434|NCT01307111|11050748|FG000|COMPLETED|1-2 Week IUD Check up||38
9933435|NCT01307111|11050749|FG001|COMPLETED|1-2 Week IUD Check up||38
9933436|NCT01307111|11050748|FG000|NOT COMPLETED|1-2 Week IUD Check up||2
9933437|NCT01307111|11050749|FG001|NOT COMPLETED|1-2 Week IUD Check up||2
9933438|NCT01307267|11050778|FG000|STARTED|Overall Study||4
9933439|NCT01307267|11050779|FG001|STARTED|Overall Study||3
9933440|NCT01307267|11050780|FG002|STARTED|Overall Study||6
9933441|NCT01307267|11050781|FG003|STARTED|Overall Study||4
9933442|NCT01307267|11050782|FG004|STARTED|Overall Study||3
9933443|NCT01307267|11050783|FG005|STARTED|Overall Study||42
9933444|NCT01307267|11050784|FG006|STARTED|Overall Study||3
9933445|NCT01307267|11050785|FG007|STARTED|Overall Study||4
9933446|NCT01307267|11050786|FG008|STARTED|Overall Study||31
9933447|NCT01307267|11050787|FG009|STARTED|Overall Study||5
9933448|NCT01307267|11050788|FG010|STARTED|Overall Study||6
9933449|NCT01307267|11050789|FG011|STARTED|Overall Study||11
9933450|NCT01307267|11050790|FG012|STARTED|Overall Study||3
9933451|NCT01307267|11050791|FG013|STARTED|Overall Study||3
9933452|NCT01307267|11050792|FG014|STARTED|Overall Study||4
9933453|NCT01307267|11050793|FG015|STARTED|Overall Study||3
9933454|NCT01307267|11050794|FG016|STARTED|Overall Study||3
9933455|NCT01307267|11050795|FG017|STARTED|Overall Study||3
9933456|NCT01307267|11050796|FG018|STARTED|Overall Study||4
10206962|NCT03519919|11333753|FG000|NOT COMPLETED|Overall Study||3
10206963|NCT03519932|11333783|FG000|STARTED|First Intervention||24
9933457|NCT01307267|11050797|FG019|STARTED|Overall Study||32
9933458|NCT01307267|11050798|FG020|STARTED|Overall Study||3
10206964|NCT03519932|11333784|FG001|STARTED|First Intervention||25
9933459|NCT01307267|11050799|FG021|STARTED|Overall Study||5
9933460|NCT01307267|11050800|FG022|STARTED|Overall Study||4
9933461|NCT01307267|11050778|FG000|COMPLETED|Overall Study||0
9933462|NCT01307267|11050779|FG001|COMPLETED|Overall Study||0
9933463|NCT01307267|11050780|FG002|COMPLETED|Overall Study||1
10238800|NCT00477230|11370203|FG001|NOT COMPLETED|Overall Study||31
9933464|NCT01307267|11050781|FG003|COMPLETED|Overall Study||1
9933465|NCT01307267|11050782|FG004|COMPLETED|Overall Study||2
9933466|NCT01307267|11050783|FG005|COMPLETED|Overall Study||1
9933467|NCT01307267|11050784|FG006|COMPLETED|Overall Study||1
9933468|NCT01307267|11050785|FG007|COMPLETED|Overall Study||0
9933469|NCT01307267|11050786|FG008|COMPLETED|Overall Study||1
9933470|NCT01307267|11050787|FG009|COMPLETED|Overall Study||0
9933471|NCT01307267|11050788|FG010|COMPLETED|Overall Study||0
9933472|NCT01307267|11050789|FG011|COMPLETED|Overall Study||0
9933473|NCT01307267|11050790|FG012|COMPLETED|Overall Study||2
9933474|NCT01307267|11050791|FG013|COMPLETED|Overall Study||3
9933475|NCT01307267|11050792|FG014|COMPLETED|Overall Study||2
9933476|NCT01307267|11050793|FG015|COMPLETED|Overall Study||2
9933477|NCT01307267|11050794|FG016|COMPLETED|Overall Study||2
9933478|NCT01307267|11050795|FG017|COMPLETED|Overall Study||2
9933479|NCT01307267|11050796|FG018|COMPLETED|Overall Study||2
9933480|NCT01307267|11050797|FG019|COMPLETED|Overall Study||0
9933481|NCT01307267|11050798|FG020|COMPLETED|Overall Study||0
9933482|NCT01307267|11050799|FG021|COMPLETED|Overall Study||0
9933483|NCT01307267|11050800|FG022|COMPLETED|Overall Study||0
9933484|NCT01307267|11050778|FG000|NOT COMPLETED|Overall Study||4
9933485|NCT01307267|11050779|FG001|NOT COMPLETED|Overall Study||3
9933486|NCT01307267|11050780|FG002|NOT COMPLETED|Overall Study||5
9933487|NCT01307267|11050781|FG003|NOT COMPLETED|Overall Study||3
9933488|NCT01307267|11050782|FG004|NOT COMPLETED|Overall Study||1
9933489|NCT01307267|11050783|FG005|NOT COMPLETED|Overall Study||41
9933490|NCT01307267|11050784|FG006|NOT COMPLETED|Overall Study||2
9933491|NCT01307267|11050785|FG007|NOT COMPLETED|Overall Study||4
9933492|NCT01307267|11050786|FG008|NOT COMPLETED|Overall Study||30
9933493|NCT01307267|11050787|FG009|NOT COMPLETED|Overall Study||5
9933494|NCT01307267|11050788|FG010|NOT COMPLETED|Overall Study||6
9933495|NCT01307267|11050789|FG011|NOT COMPLETED|Overall Study||11
9933496|NCT01307267|11050790|FG012|NOT COMPLETED|Overall Study||1
9933497|NCT01307267|11050791|FG013|NOT COMPLETED|Overall Study||0
9933498|NCT01307267|11050792|FG014|NOT COMPLETED|Overall Study||2
9933499|NCT01307267|11050793|FG015|NOT COMPLETED|Overall Study||1
9933500|NCT01307267|11050794|FG016|NOT COMPLETED|Overall Study||1
9933501|NCT01307267|11050795|FG017|NOT COMPLETED|Overall Study||1
9933502|NCT01307267|11050796|FG018|NOT COMPLETED|Overall Study||2
9933503|NCT01307267|11050797|FG019|NOT COMPLETED|Overall Study||32
9933504|NCT01307267|11050798|FG020|NOT COMPLETED|Overall Study||3
9933505|NCT01307267|11050799|FG021|NOT COMPLETED|Overall Study||5
9933506|NCT01307267|11050800|FG022|NOT COMPLETED|Overall Study||4
9933507|NCT01307319|11050862|FG000|STARTED|Overall Study|Randomized|239
9933508|NCT01307319|11050863|FG001|STARTED|Overall Study|Randomized|242
9933509|NCT01307319|11050864|FG002|STARTED|Overall Study|Randomized|234
9933510|NCT01307319|11050862|FG000|Safety Population|Overall Study||239
9933511|NCT01307319|11050863|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
9933512|NCT01307319|11050864|FG002|Safety Population|Overall Study||234
9933513|NCT01307319|11050862|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
9933514|NCT01307319|11050863|FG001|ITT Population|Overall Study||241
9933515|NCT01307319|11050864|FG002|ITT Population|Overall Study||234
9933516|NCT01307319|11050862|FG000|COMPLETED|Overall Study||235
9933517|NCT01307319|11050863|FG001|COMPLETED|Overall Study||234
9933518|NCT01307319|11050864|FG002|COMPLETED|Overall Study||227
9933519|NCT01307319|11050862|FG000|NOT COMPLETED|Overall Study||4
9933520|NCT01307319|11050863|FG001|NOT COMPLETED|Overall Study||8
9933521|NCT01307319|11050864|FG002|NOT COMPLETED|Overall Study||7
9933522|NCT01307397|11050872|FG000|STARTED|Overall Study||3219
9933523|NCT01307397|11050872|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
9933524|NCT01307397|11050872|FG000|NOT COMPLETED|Overall Study||0
9933525|NCT01307449|11050880|FG000|STARTED|Overall Study||33
9933526|NCT01307449|11050881|FG001|STARTED|Overall Study||33
9933527|NCT01307449|11050882|FG002|STARTED|Overall Study||11
9933528|NCT01307449|11050883|FG003|STARTED|Overall Study||11
9933529|NCT01307449|11050880|FG000|COMPLETED|Overall Study||32
9933530|NCT01307449|11050881|FG001|COMPLETED|Overall Study||33
9933531|NCT01307449|11050882|FG002|COMPLETED|Overall Study||11
9933532|NCT01307449|11050883|FG003|COMPLETED|Overall Study||11
9933533|NCT01307449|11050880|FG000|NOT COMPLETED|Overall Study||1
9933534|NCT01307449|11050881|FG001|NOT COMPLETED|Overall Study||0
9933535|NCT01307449|11050882|FG002|NOT COMPLETED|Overall Study||0
9933536|NCT01307449|11050883|FG003|NOT COMPLETED|Overall Study||0
9933537|NCT01307462|11050893|FG000|STARTED|Overall Study||36
9933538|NCT01307462|11050893|FG000|COMPLETED|Overall Study||35
9933539|NCT01307462|11050893|FG000|NOT COMPLETED|Overall Study||1
9933540|NCT01307501|11050897|FG000|STARTED|Overall Study||40
9933541|NCT01307501|11050897|FG000|Intent-to-Treat (ITT) Population|Overall Study||40
9933542|NCT01307501|11050897|FG000|COMPLETED|Overall Study||17
9933543|NCT01307501|11050897|FG000|NOT COMPLETED|Overall Study||23
9933544|NCT01307579|11050903|FG000|STARTED|Overall Study||257
9933545|NCT01307579|11050904|FG001|STARTED|Overall Study||260
9933546|NCT01307579|11050903|FG000|COMPLETED|Overall Study||117
9933547|NCT01307579|11050904|FG001|COMPLETED|Overall Study||115
9933548|NCT01307579|11050903|FG000|NOT COMPLETED|Overall Study||140
9933549|NCT01307579|11050904|FG001|NOT COMPLETED|Overall Study||145
9933550|NCT01307618|11050912|FG000|STARTED|Overall Study||5
9933551|NCT01307618|11050913|FG001|STARTED|Overall Study||5
9933552|NCT01307618|11050912|FG000|COMPLETED|Overall Study||5
9933553|NCT01307618|11050913|FG001|COMPLETED|Overall Study||5
9933554|NCT01307618|11050912|FG000|NOT COMPLETED|Overall Study||0
9933555|NCT01307618|11050913|FG001|NOT COMPLETED|Overall Study||0
9956301|NCT01444898|11075471|FG000|STARTED|Overall Study||10
9956302|NCT01444898|11075471|FG000|COMPLETED|Overall Study||9
9956303|NCT01444898|11075471|FG000|NOT COMPLETED|Overall Study||1
9956304|NCT01444911|11075477|FG000|STARTED|Overall Study||16
9956305|NCT01444911|11075478|FG001|STARTED|Overall Study||13
9956306|NCT01444911|11075477|FG000|COMPLETED|Overall Study||8
9956307|NCT01444911|11075478|FG001|COMPLETED|Overall Study||13
9956308|NCT01444911|11075477|FG000|NOT COMPLETED|Overall Study||8
9956309|NCT01444911|11075478|FG001|NOT COMPLETED|Overall Study||0
9956310|NCT01444924|11075486|FG000|STARTED|Overall Study||31
9956311|NCT01444924|11075487|FG001|STARTED|Overall Study||33
9956312|NCT01444924|11075486|FG000|COMPLETED|Overall Study||31
9956313|NCT01444924|11075487|FG001|COMPLETED|Overall Study||33
9956314|NCT01444924|11075486|FG000|NOT COMPLETED|Overall Study||0
9956315|NCT01444924|11075487|FG001|NOT COMPLETED|Overall Study||0
9956316|NCT01445028|11075495|FG000|STARTED|Overall Study||58
9956317|NCT01445028|11075496|FG001|STARTED|Overall Study||54
9956318|NCT01445028|11075495|FG000|COMPLETED|Overall Study||58
9956319|NCT01445028|11075496|FG001|COMPLETED|Overall Study||51
9956320|NCT01445028|11075495|FG000|NOT COMPLETED|Overall Study||0
9956321|NCT01445028|11075496|FG001|NOT COMPLETED|Overall Study||3
9956322|NCT01445080|11075511|FG000|STARTED|Overall Study||7
9956323|NCT01445080|11075512|FG001|STARTED|Overall Study||5
9956324|NCT01445080|11075513|FG002|STARTED|Overall Study||12
9956325|NCT01445080|11075514|FG003|STARTED|Overall Study||8
9956326|NCT01445080|11075515|FG004|STARTED|Overall Study||4
9956327|NCT01445080|11075516|FG005|STARTED|Overall Study||9
9956328|NCT01445080|11075517|FG006|STARTED|Overall Study||2
9956329|NCT01445080|11075518|FG007|STARTED|Overall Study||5
9956330|NCT01445080|11075519|FG008|STARTED|Overall Study||18
9956331|NCT01445080|11075511|FG000|COMPLETED|Overall Study||0
9956332|NCT01445080|11075512|FG001|COMPLETED|Overall Study||0
9956333|NCT01445080|11075513|FG002|COMPLETED|Overall Study||0
9956334|NCT01445080|11075514|FG003|COMPLETED|Overall Study||0
9956335|NCT01445080|11075515|FG004|COMPLETED|Overall Study||0
9956336|NCT01445080|11075516|FG005|COMPLETED|Overall Study||0
9956337|NCT01445080|11075517|FG006|COMPLETED|Overall Study||0
9956338|NCT01445080|11075518|FG007|COMPLETED|Overall Study||0
9956339|NCT01445080|11075519|FG008|COMPLETED|Overall Study||0
9956340|NCT01445080|11075511|FG000|NOT COMPLETED|Overall Study||7
9956341|NCT01445080|11075512|FG001|NOT COMPLETED|Overall Study||5
9956342|NCT01445080|11075513|FG002|NOT COMPLETED|Overall Study||12
9956343|NCT01445080|11075514|FG003|NOT COMPLETED|Overall Study||8
9956344|NCT01445080|11075515|FG004|NOT COMPLETED|Overall Study||4
9956345|NCT01445080|11075516|FG005|NOT COMPLETED|Overall Study||9
9956346|NCT01445080|11075517|FG006|NOT COMPLETED|Overall Study||2
9956347|NCT01445080|11075518|FG007|NOT COMPLETED|Overall Study||5
9956348|NCT01445080|11075519|FG008|NOT COMPLETED|Overall Study||18
9956349|NCT01445171|11075554|FG000|STARTED|Overall Study||295
9956350|NCT01445171|11075554|FG000|Implanted With Study Device|Overall Study||287
9956351|NCT01445171|11075554|FG000|COMPLETED|Overall Study||200
9956352|NCT01445171|11075554|FG000|NOT COMPLETED|Overall Study||95
9956353|NCT01445301|11075563|FG000|STARTED|Overall Study||204
10011044|NCT01777568|11133743|FG001|STARTED|Overall Study||2896
10011045|NCT01777568|11133742|FG000|COMPLETED|Overall Study||2853
10011046|NCT01777568|11133743|FG001|COMPLETED|Overall Study||2896
9956354|NCT01445301|11075564|FG001|STARTED|Overall Study||297
9956355|NCT01445301|11075565|FG002|STARTED|Overall Study||299
9956356|NCT01445301|11075563|FG000|COMPLETED|Overall Study||183
9956357|NCT01445301|11075564|FG001|COMPLETED|Overall Study||262
9956358|NCT01445301|11075565|FG002|COMPLETED|Overall Study||290
9956359|NCT01445301|11075563|FG000|NOT COMPLETED|Overall Study||21
9956360|NCT01445301|11075564|FG001|NOT COMPLETED|Overall Study||35
9956361|NCT01445301|11075565|FG002|NOT COMPLETED|Overall Study||9
9956362|NCT01445535|11075577|FG000|STARTED|Overall Study||3
9956363|NCT01445535|11075578|FG001|STARTED|Overall Study||3
9956364|NCT01445535|11075579|FG002|STARTED|Overall Study||3
9956365|NCT01445535|11075580|FG003|STARTED|Overall Study||6
9956366|NCT01445535|11075577|FG000|COMPLETED|Overall Study||2
9956367|NCT01445535|11075578|FG001|COMPLETED|Overall Study||3
9956368|NCT01445535|11075579|FG002|COMPLETED|Overall Study||2
9956369|NCT01445535|11075580|FG003|COMPLETED|Overall Study||4
9956370|NCT01445535|11075577|FG000|NOT COMPLETED|Overall Study||1
9956371|NCT01445535|11075578|FG001|NOT COMPLETED|Overall Study||0
10011047|NCT01777568|11133742|FG000|NOT COMPLETED|Overall Study||0
9956372|NCT01445535|11075579|FG002|NOT COMPLETED|Overall Study||1
9956373|NCT01445535|11075580|FG003|NOT COMPLETED|Overall Study||2
9956374|NCT01445548|11075591|FG000|STARTED|Overall Study||6
9956375|NCT01445548|11075591|FG000|COMPLETED|Overall Study||5
9956376|NCT01445548|11075591|FG000|NOT COMPLETED|Overall Study||1
9956377|NCT01445613|11075595|FG000|STARTED|30-day Follow-up||1200
9956378|NCT01445613|11075595|FG000|COMPLETED|30-day Follow-up||1165
9956379|NCT01445613|11075595|FG000|NOT COMPLETED|30-day Follow-up||35
9956380|NCT01445613|11075595|FG000|STARTED|1-year Follow-up||1165
9956381|NCT01445613|11075595|FG000|COMPLETED|1-year Follow-up||1088
9956382|NCT01445613|11075595|FG000|NOT COMPLETED|1-year Follow-up||77
9956383|NCT01445626|11075605|FG000|STARTED|Overall Study||87
9956384|NCT01445626|11075605|FG000|COMPLETED|Overall Study||87
9956385|NCT01445626|11075605|FG000|NOT COMPLETED|Overall Study||0
9956386|NCT01445652|11075611|FG000|STARTED|Overall Study||57
9933556|NCT01307748|11050922|FG000|STARTED|Overall Study||31
9933557|NCT01307748|11050923|FG001|STARTED|Overall Study||31
9933558|NCT01307748|11050924|FG002|STARTED|Overall Study||30
9933559|NCT01307748|11050922|FG000|COMPLETED|Overall Study||31
9933560|NCT01307748|11050923|FG001|COMPLETED|Overall Study||31
9933561|NCT01307748|11050924|FG002|COMPLETED|Overall Study||30
9933562|NCT01307748|11050922|FG000|NOT COMPLETED|Overall Study||0
9933563|NCT01307748|11050923|FG001|NOT COMPLETED|Overall Study||0
9933564|NCT01307748|11050924|FG002|NOT COMPLETED|Overall Study||0
9933565|NCT01307891|11050940|FG000|STARTED|Overall Study||42
9933566|NCT01307891|11050941|FG001|STARTED|Overall Study||22
9933567|NCT01307891|11050940|FG000|COMPLETED|Overall Study||39
9933568|NCT01307891|11050941|FG001|COMPLETED|Overall Study||21
9933569|NCT01307891|11050940|FG000|NOT COMPLETED|Overall Study||3
9933570|NCT01307891|11050941|FG001|NOT COMPLETED|Overall Study||1
9933571|NCT01307930|11050947|FG000|STARTED|Overall Study||20
9933572|NCT01307930|11050947|FG000|COMPLETED|Overall Study||18
9933573|NCT01307930|11050947|FG000|NOT COMPLETED|Overall Study||2
9933574|NCT01307956|11050951|FG000|STARTED|Overall Study||11
9933575|NCT01307956|11050951|FG000|COMPLETED|Overall Study||11
9933576|NCT01307956|11050951|FG000|NOT COMPLETED|Overall Study||0
9933577|NCT01308008|11050957|FG000|STARTED|4 Weeks||71
9933578|NCT01308008|11050958|FG001|STARTED|4 Weeks||73
9933579|NCT01308008|11050957|FG000|COMPLETED|4 Weeks||62
9933580|NCT01308008|11050958|FG001|COMPLETED|4 Weeks||71
9933581|NCT01308008|11050957|FG000|NOT COMPLETED|4 Weeks||9
9933582|NCT01308008|11050958|FG001|NOT COMPLETED|4 Weeks||2
9933583|NCT01308008|11050957|FG000|STARTED|6 Months||62
9933584|NCT01308008|11050958|FG001|STARTED|6 Months||71
9933585|NCT01308008|11050957|FG000|COMPLETED|6 Months||54
9933586|NCT01308008|11050958|FG001|COMPLETED|6 Months||62
9933587|NCT01308008|11050957|FG000|NOT COMPLETED|6 Months||8
9933588|NCT01308008|11050958|FG001|NOT COMPLETED|6 Months||9
9933589|NCT01308008|11050957|FG000|STARTED|12 Months||54
9933590|NCT01308008|11050958|FG001|STARTED|12 Months||62
9933591|NCT01308008|11050957|FG000|COMPLETED|12 Months||46
9933592|NCT01308008|11050958|FG001|COMPLETED|12 Months||58
9933593|NCT01308008|11050957|FG000|NOT COMPLETED|12 Months||8
9933594|NCT01308008|11050958|FG001|NOT COMPLETED|12 Months||4
9933595|NCT01308060|11050966|FG000|STARTED|Part A||252
9933596|NCT01308060|11050967|FG001|STARTED|Part A||83
9933597|NCT01308060|11050966|FG000|COMPLETED|Part A||238
9933598|NCT01308060|11050967|FG001|COMPLETED|Part A||77
9933599|NCT01308060|11050966|FG000|NOT COMPLETED|Part A||14
9933600|NCT01308060|11050967|FG001|NOT COMPLETED|Part A||6
9933601|NCT01308060|11050966|FG000|STARTED|Part B||238
9933602|NCT01308060|11050967|FG001|STARTED|Part B||77
9933603|NCT01308060|11050966|FG000|COMPLETED|Part B||219
9933604|NCT01308060|11050967|FG001|COMPLETED|Part B||69
9933605|NCT01308060|11050966|FG000|NOT COMPLETED|Part B||19
9933606|NCT01308060|11050967|FG001|NOT COMPLETED|Part B||8
9933607|NCT01308294|11050977|FG000|STARTED|Cycle 1||10
9933608|NCT01308294|11050978|FG001|STARTED|Cycle 1||6
9933609|NCT01308294|11050979|FG002|STARTED|Cycle 1||0
9933610|NCT01308294|11050977|FG000|COMPLETED|Cycle 1||10
9933611|NCT01308294|11050978|FG001|COMPLETED|Cycle 1||6
9933612|NCT01308294|11050979|FG002|COMPLETED|Cycle 1||0
9933613|NCT01308294|11050977|FG000|NOT COMPLETED|Cycle 1||0
9933614|NCT01308294|11050978|FG001|NOT COMPLETED|Cycle 1||0
9933615|NCT01308294|11050979|FG002|NOT COMPLETED|Cycle 1||0
9933616|NCT01308294|11050977|FG000|STARTED|Cycle 2||10
9933617|NCT01308294|11050978|FG001|STARTED|Cycle 2||6
9933618|NCT01308294|11050979|FG002|STARTED|Cycle 2||0
9933619|NCT01308294|11050977|FG000|COMPLETED|Cycle 2||10
9933620|NCT01308294|11050978|FG001|COMPLETED|Cycle 2||5
9933621|NCT01308294|11050979|FG002|COMPLETED|Cycle 2||0
9933622|NCT01308294|11050977|FG000|NOT COMPLETED|Cycle 2||0
9933623|NCT01308294|11050978|FG001|NOT COMPLETED|Cycle 2||1
9933624|NCT01308294|11050979|FG002|NOT COMPLETED|Cycle 2||0
9933625|NCT01308294|11050977|FG000|STARTED|Cycle 3||10
9933626|NCT01308294|11050978|FG001|STARTED|Cycle 3||5
9933627|NCT01308294|11050979|FG002|STARTED|Cycle 3||0
9933628|NCT01308294|11050977|FG000|COMPLETED|Cycle 3||10
9933629|NCT01308294|11050978|FG001|COMPLETED|Cycle 3||4
9933630|NCT01308294|11050979|FG002|COMPLETED|Cycle 3||0
9933631|NCT01308294|11050977|FG000|NOT COMPLETED|Cycle 3||0
9933632|NCT01308294|11050978|FG001|NOT COMPLETED|Cycle 3||1
9933633|NCT01308294|11050979|FG002|NOT COMPLETED|Cycle 3||0
9933634|NCT01308424|11050992|FG000|STARTED|Baseline Eligibility||242
9933635|NCT01308424|11050993|FG001|STARTED|Baseline Eligibility||0
9933636|NCT01308424|11050994|FG002|STARTED|Baseline Eligibility||0
9933637|NCT01308424|11050992|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
9933638|NCT01308424|11050993|FG001|COMPLETED|Baseline Eligibility||0
9933639|NCT01308424|11050994|FG002|COMPLETED|Baseline Eligibility||0
9933640|NCT01308424|11050992|FG000|NOT COMPLETED|Baseline Eligibility||71
9933641|NCT01308424|11050993|FG001|NOT COMPLETED|Baseline Eligibility||0
9933642|NCT01308424|11050994|FG002|NOT COMPLETED|Baseline Eligibility||0
9933643|NCT01308424|11050992|FG000|STARTED|Randomization||0
9933644|NCT01308424|11050993|FG001|STARTED|Randomization||87
9933645|NCT01308424|11050994|FG002|STARTED|Randomization||84
9933646|NCT01308424|11050992|FG000|COMPLETED|Randomization||0
9933647|NCT01308424|11050993|FG001|COMPLETED|Randomization||84
9933648|NCT01308424|11050994|FG002|COMPLETED|Randomization||82
9933649|NCT01308424|11050992|FG000|NOT COMPLETED|Randomization||0
9933650|NCT01308424|11050993|FG001|NOT COMPLETED|Randomization||3
9933651|NCT01308424|11050994|FG002|NOT COMPLETED|Randomization||2
9956387|NCT01445652|11075612|FG001|STARTED|Overall Study||53
9933652|NCT01308450|11051001|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
9933653|NCT01308450|11051001|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
9933654|NCT01308450|11051001|FG000|NOT COMPLETED|Overall Study||2
9933655|NCT01308463|11051005|FG000|STARTED|Overall Study||29
9933656|NCT01308463|11051005|FG000|6 Months|Overall Study||23
9933657|NCT01308463|11051005|FG000|1 Year|Overall Study||21
9933658|NCT01308463|11051005|FG000|2 Years|Overall Study||18
9933659|NCT01308463|11051005|FG000|3 Years|Overall Study||17
9933660|NCT01308463|11051005|FG000|4 Years|Overall Study||20
9933661|NCT01308463|11051005|FG000|5 Years|Overall Study||20
9933662|NCT01308463|11051005|FG000|6 Years|Overall Study||11
9933663|NCT01308463|11051005|FG000|7 Years|Overall Study||12
9933664|NCT01308463|11051005|FG000|8 Years|Overall Study||14
9933665|NCT01308463|11051005|FG000|9 Years|Overall Study||11
10011048|NCT01777568|11133743|FG001|NOT COMPLETED|Overall Study||0
9933666|NCT01308463|11051005|FG000|10 Years|Overall Study||8
9933667|NCT01308463|11051005|FG000|11 Years|Overall Study||8
9933668|NCT01308463|11051005|FG000|12 Years|Overall Study||2
9933669|NCT01308463|11051005|FG000|COMPLETED|Overall Study||0
9933670|NCT01308463|11051005|FG000|NOT COMPLETED|Overall Study||29
9933671|NCT01308476|11051011|FG000|STARTED|Overall Study|Entered and treated.|48
9933672|NCT01308476|11051012|FG001|STARTED|Overall Study|Entered and treated.|47
9933673|NCT01308476|11051011|FG000|COMPLETED|Overall Study||45
9933674|NCT01308476|11051012|FG001|COMPLETED|Overall Study||45
9933675|NCT01308476|11051011|FG000|NOT COMPLETED|Overall Study||3
9933676|NCT01308476|11051012|FG001|NOT COMPLETED|Overall Study||2
9933677|NCT01308567|11051021|FG000|STARTED|Overall Study|Randomized|391
9933678|NCT01308567|11051022|FG001|STARTED|Overall Study|Randomized|389
9933679|NCT01308567|11051023|FG002|STARTED|Overall Study|Randomized|388
9933680|NCT01308567|11051021|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
9933681|NCT01308567|11051022|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
9933682|NCT01308567|11051023|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
9933683|NCT01308567|11051021|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
9933684|NCT01308567|11051022|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
9933685|NCT01308567|11051023|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
9933686|NCT01308567|11051021|FG000|NOT COMPLETED|Overall Study||2
9933687|NCT01308567|11051022|FG001|NOT COMPLETED|Overall Study||4
9933688|NCT01308567|11051023|FG002|NOT COMPLETED|Overall Study||4
9933689|NCT01308580|11051033|FG000|STARTED|Overall Study||598
9933690|NCT01308580|11051034|FG001|STARTED|Overall Study||602
9933691|NCT01308580|11051033|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
9933692|NCT01308580|11051034|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
9933693|NCT01308580|11051033|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
9933694|NCT01308580|11051034|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
9933695|NCT01308580|11051033|FG000|NOT COMPLETED|Overall Study||12
9933696|NCT01308580|11051034|FG001|NOT COMPLETED|Overall Study||7
9933697|NCT01308619|11051043|FG000|STARTED|Overall Study||84
9933698|NCT01308619|11051044|FG001|STARTED|Overall Study||86
9933699|NCT01308619|11051043|FG000|COMPLETED|Overall Study||77
9933700|NCT01308619|11051044|FG001|COMPLETED|Overall Study||83
9933701|NCT01308619|11051043|FG000|NOT COMPLETED|Overall Study||7
9933702|NCT01308619|11051044|FG001|NOT COMPLETED|Overall Study||3
9933703|NCT01308736|11051054|FG000|STARTED|Overall Study||31
9933704|NCT01308736|11051055|FG001|STARTED|Overall Study||32
9933705|NCT01308736|11051054|FG000|COMPLETED|Overall Study||25
9933706|NCT01308736|11051055|FG001|COMPLETED|Overall Study||27
9933707|NCT01308736|11051054|FG000|NOT COMPLETED|Overall Study||6
9933708|NCT01308736|11051055|FG001|NOT COMPLETED|Overall Study||5
9933709|NCT01308749|11051063|FG000|STARTED|Period 1: Double Blind Treatment||12
9933710|NCT01308749|11051064|FG001|STARTED|Period 1: Double Blind Treatment||13
9933711|NCT01308749|11051063|FG000|COMPLETED|Period 1: Double Blind Treatment||11
9933712|NCT01308749|11051064|FG001|COMPLETED|Period 1: Double Blind Treatment||13
9933713|NCT01308749|11051063|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1
9933714|NCT01308749|11051064|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0
9933715|NCT01308749|11051063|FG000|STARTED|Period 2: Open Label Treatment||11
9933716|NCT01308749|11051064|FG001|STARTED|Period 2: Open Label Treatment||13
9933717|NCT01308749|11051063|FG000|COMPLETED|Period 2: Open Label Treatment||11
9933718|NCT01308749|11051064|FG001|COMPLETED|Period 2: Open Label Treatment||11
9933719|NCT01308749|11051063|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0
9933720|NCT01308749|11051064|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2
9933721|NCT01308762|11051087|FG000|STARTED|Overall Study||6
9933722|NCT01308762|11051088|FG001|STARTED|Overall Study||7
9933723|NCT01308762|11051089|FG002|STARTED|Overall Study||6
9933724|NCT01308762|11051087|FG000|COMPLETED|Overall Study||6
9933725|NCT01308762|11051088|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
9933726|NCT01308762|11051089|FG002|COMPLETED|Overall Study||6
9933727|NCT01308762|11051087|FG000|NOT COMPLETED|Overall Study||0
10019016|NCT01826981|11142058|FG007|NOT COMPLETED|Overall Study||11
9933728|NCT01308762|11051088|FG001|NOT COMPLETED|Overall Study||1
9933729|NCT01308762|11051089|FG002|NOT COMPLETED|Overall Study||0
9933730|NCT01308788|11051102|FG000|STARTED|6-month Treatment||14
9933731|NCT01308788|11051103|FG001|STARTED|6-month Treatment||21
9933732|NCT01308788|11051102|FG000|COMPLETED|6-month Treatment||14
9933733|NCT01308788|11051103|FG001|COMPLETED|6-month Treatment||21
9933734|NCT01308788|11051102|FG000|NOT COMPLETED|6-month Treatment||0
9933735|NCT01308788|11051103|FG001|NOT COMPLETED|6-month Treatment||0
9933736|NCT01308788|11051102|FG000|STARTED|2-year Treatment||14
9933737|NCT01308788|11051103|FG001|STARTED|2-year Treatment||21
9933738|NCT01308788|11051102|FG000|COMPLETED|2-year Treatment||10
9933739|NCT01308788|11051103|FG001|COMPLETED|2-year Treatment||10
9933740|NCT01308788|11051102|FG000|NOT COMPLETED|2-year Treatment||4
9933741|NCT01308788|11051103|FG001|NOT COMPLETED|2-year Treatment||11
9933742|NCT01308814|11051111|FG000|STARTED|Overall Study||86
9933743|NCT01308814|11051112|FG001|STARTED|Overall Study||86
9933744|NCT01308814|11051111|FG000|COMPLETED|Overall Study||69
9933745|NCT01308814|11051112|FG001|COMPLETED|Overall Study||63
9933746|NCT01308814|11051111|FG000|NOT COMPLETED|Overall Study||17
9933747|NCT01308814|11051112|FG001|NOT COMPLETED|Overall Study||23
9933748|NCT01308840|11051118|FG000|STARTED|Overall Study||31
9933749|NCT01308840|11051118|FG000|COMPLETED|Overall Study||31
9933750|NCT01308840|11051118|FG000|NOT COMPLETED|Overall Study||0
9933751|NCT01308853|11051122|FG000|STARTED|Overall Study||24
9933752|NCT01308853|11051122|FG000|COMPLETED|Overall Study||20
9933753|NCT01308853|11051122|FG000|NOT COMPLETED|Overall Study||4
9933754|NCT01308918|11051126|FG000|STARTED|Overall Study||50
9933755|NCT01308918|11051126|FG000|COMPLETED|Overall Study||50
9933756|NCT01308918|11051126|FG000|NOT COMPLETED|Overall Study||0
9933757|NCT01309100|11051130|FG000|STARTED|Overall Study||144
9933758|NCT01309100|11051130|FG000|COMPLETED|Overall Study||142
9933759|NCT01309100|11051130|FG000|NOT COMPLETED|Overall Study||2
9933760|NCT01309165|11051139|FG000|STARTED|Overall Study||19
9933761|NCT01309165|11051140|FG001|STARTED|Overall Study||16
9933762|NCT01309165|11051139|FG000|Received Allocated Intervention|Overall Study||16
9933763|NCT01309165|11051140|FG001|Received Allocated Intervention|Overall Study||14
9933764|NCT01309165|11051139|FG000|Included in Primary Analysis|Overall Study||14
9933765|NCT01309165|11051140|FG001|Included in Primary Analysis|Overall Study||12
9933766|NCT01309165|11051139|FG000|COMPLETED|Overall Study||13
9933767|NCT01309165|11051140|FG001|COMPLETED|Overall Study||9
9933768|NCT01309165|11051139|FG000|NOT COMPLETED|Overall Study||6
9933769|NCT01309165|11051140|FG001|NOT COMPLETED|Overall Study||7
9933770|NCT01309204|11051149|FG000|STARTED|Overall Study||452
9933771|NCT01309204|11051150|FG001|STARTED|Overall Study||436
9933772|NCT01309204|11051149|FG000|COMPLETED|Overall Study||385
9933773|NCT01309204|11051150|FG001|COMPLETED|Overall Study||361
9933774|NCT01309204|11051149|FG000|NOT COMPLETED|Overall Study||67
9933775|NCT01309204|11051150|FG001|NOT COMPLETED|Overall Study||75
9933776|NCT01309243|11051158|FG000|STARTED|Randomized Phase Through Week 96||400
9933777|NCT01309243|11051159|FG001|STARTED|Randomized Phase Through Week 96||399
9933778|NCT01309243|11051158|FG000|Randomized and Treated|Randomized Phase Through Week 96||394
9933779|NCT01309243|11051159|FG001|Randomized and Treated|Randomized Phase Through Week 96||392
9933780|NCT01309243|11051158|FG000|COMPLETED|Randomized Phase Through Week 96||316
9933781|NCT01309243|11051159|FG001|COMPLETED|Randomized Phase Through Week 96||290
9933782|NCT01309243|11051158|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84
9933783|NCT01309243|11051159|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109
9933784|NCT01309243|11051158|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
9933785|NCT01309243|11051159|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
9933786|NCT01309243|11051158|FG000|COMPLETED|Extension Phase||34
9933787|NCT01309243|11051159|FG001|COMPLETED|Extension Phase||117
9933788|NCT01309243|11051158|FG000|NOT COMPLETED|Extension Phase||6
9933789|NCT01309243|11051159|FG001|NOT COMPLETED|Extension Phase||0
9933790|NCT01309269|11051165|FG000|STARTED|Overall Study||1085
9933791|NCT01309269|11051165|FG000|Treated|Overall Study||978
9933792|NCT01309269|11051165|FG000|COMPLETED|Overall Study||245
9933793|NCT01309269|11051165|FG000|NOT COMPLETED|Overall Study||840
9933794|NCT01309282|11051169|FG000|STARTED|Overall Study||9
9933795|NCT01309282|11051169|FG000|COMPLETED|Overall Study||8
9933796|NCT01309282|11051169|FG000|NOT COMPLETED|Overall Study||1
9933797|NCT01309308|11051175|FG000|STARTED|Overall Study||75
9933798|NCT01309308|11051176|FG001|STARTED|Overall Study||75
9933799|NCT01309308|11051175|FG000|COMPLETED|Overall Study||69
9933800|NCT01309308|11051176|FG001|COMPLETED|Overall Study||71
9933801|NCT01309308|11051175|FG000|NOT COMPLETED|Overall Study||6
9933802|NCT01309308|11051176|FG001|NOT COMPLETED|Overall Study||4
9933803|NCT01309360|11051185|FG000|STARTED|Overall Study||40
9933804|NCT01309360|11051186|FG001|STARTED|Overall Study||40
9933805|NCT01309360|11051187|FG002|STARTED|Overall Study||40
9933806|NCT01309360|11051185|FG000|COMPLETED|Overall Study||40
9933807|NCT01309360|11051186|FG001|COMPLETED|Overall Study||40
9933808|NCT01309360|11051187|FG002|COMPLETED|Overall Study||40
9933809|NCT01309360|11051185|FG000|NOT COMPLETED|Overall Study||0
9933810|NCT01309360|11051186|FG001|NOT COMPLETED|Overall Study||0
9933811|NCT01309360|11051187|FG002|NOT COMPLETED|Overall Study||0
9933812|NCT01309386|11051197|FG000|STARTED|Overall Study||50
9933813|NCT01309386|11051198|FG001|STARTED|Overall Study||50
9933814|NCT01309386|11051197|FG000|COMPLETED|Overall Study||28
9933815|NCT01309386|11051198|FG001|COMPLETED|Overall Study||29
9933816|NCT01309386|11051197|FG000|NOT COMPLETED|Overall Study||22
9933817|NCT01309386|11051198|FG001|NOT COMPLETED|Overall Study||21
9933818|NCT01309451|11051206|FG000|STARTED|Overall Study|unit of measure is number of eyes|19
9933819|NCT01309451|11051207|FG001|STARTED|Overall Study|unit of measure is number of eyes|21
9933820|NCT01309451|11051206|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17
9933821|NCT01309451|11051207|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18
9933822|NCT01309451|11051206|FG000|NOT COMPLETED|Overall Study||2
9933823|NCT01309451|11051207|FG001|NOT COMPLETED|Overall Study||3
9933824|NCT01309646|11051217|FG000|STARTED|Overall Study||224
9933825|NCT01309646|11051218|FG001|STARTED|Overall Study||227
9933826|NCT01309646|11051217|FG000|COMPLETED|Overall Study||224
9933827|NCT01309646|11051218|FG001|COMPLETED|Overall Study||227
9933828|NCT01309646|11051217|FG000|NOT COMPLETED|Overall Study||0
9933829|NCT01309646|11051218|FG001|NOT COMPLETED|Overall Study||0
9933830|NCT01309659|11051226|FG000|STARTED|Overall Study||9
9933831|NCT01309659|11051227|FG001|STARTED|Overall Study||10
9933832|NCT01309659|11051226|FG000|COMPLETED|Overall Study||9
9933833|NCT01309659|11051227|FG001|COMPLETED|Overall Study||9
9933834|NCT01309659|11051226|FG000|NOT COMPLETED|Overall Study||0
9933835|NCT01309659|11051227|FG001|NOT COMPLETED|Overall Study||1
9933836|NCT01309737|11051236|FG000|STARTED|Week 0 to 16||383
9933837|NCT01309737|11051237|FG001|STARTED|Week 0 to 16||381
9933838|NCT01309737|11051238|FG002|STARTED|Week 0 to 16||196
9933839|NCT01309737|11051239|FG003|STARTED|Week 0 to 16||0
9933840|NCT01309737|11051240|FG004|STARTED|Week 0 to 16||0
9933841|NCT01309737|11051236|FG000|Treated|Week 0 to 16||382
9933842|NCT01309737|11051237|FG001|Treated|Week 0 to 16||381
9933843|NCT01309737|11051238|FG002|Treated|Week 0 to 16||196
9933844|NCT01309737|11051239|FG003|Treated|Week 0 to 16||0
9933845|NCT01309737|11051240|FG004|Treated|Week 0 to 16||0
9933846|NCT01309737|11051236|FG000|COMPLETED|Week 0 to 16||331
9933847|NCT01309737|11051237|FG001|COMPLETED|Week 0 to 16||341
9933848|NCT01309737|11051238|FG002|COMPLETED|Week 0 to 16||152
9933849|NCT01309737|11051239|FG003|COMPLETED|Week 0 to 16||0
9933850|NCT01309737|11051240|FG004|COMPLETED|Week 0 to 16||0
9933851|NCT01309737|11051236|FG000|NOT COMPLETED|Week 0 to 16||52
9933852|NCT01309737|11051237|FG001|NOT COMPLETED|Week 0 to 16||40
9933853|NCT01309737|11051238|FG002|NOT COMPLETED|Week 0 to 16||44
9933854|NCT01309737|11051239|FG003|NOT COMPLETED|Week 0 to 16||0
9933855|NCT01309737|11051240|FG004|NOT COMPLETED|Week 0 to 16||0
9933856|NCT01309737|11051236|FG000|STARTED|Week 16 to 52||331
9933857|NCT01309737|11051237|FG001|STARTED|Week 16 to 52||341
9933858|NCT01309737|11051238|FG002|STARTED|Week 16 to 52||0
9933859|NCT01309737|11051239|FG003|STARTED|Week 16 to 52||75
9933860|NCT01309737|11051240|FG004|STARTED|Week 16 to 52||77
9933861|NCT01309737|11051236|FG000|COMPLETED|Week 16 to 52||198
9933862|NCT01309737|11051237|FG001|COMPLETED|Week 16 to 52||238
9933863|NCT01309737|11051238|FG002|COMPLETED|Week 16 to 52||0
9933864|NCT01309737|11051239|FG003|COMPLETED|Week 16 to 52||41
9933865|NCT01309737|11051240|FG004|COMPLETED|Week 16 to 52||44
9933866|NCT01309737|11051236|FG000|NOT COMPLETED|Week 16 to 52||133
9933867|NCT01309737|11051237|FG001|NOT COMPLETED|Week 16 to 52||103
9933868|NCT01309737|11051238|FG002|NOT COMPLETED|Week 16 to 52||0
9933869|NCT01309737|11051239|FG003|NOT COMPLETED|Week 16 to 52||34
9933870|NCT01309737|11051240|FG004|NOT COMPLETED|Week 16 to 52||33
9933871|NCT01309802|11051265|FG000|STARTED|Overall Study||25
9933872|NCT01309802|11051266|FG001|STARTED|Overall Study||23
9933873|NCT01309802|11051265|FG000|COMPLETED|Overall Study||13
9933874|NCT01309802|11051266|FG001|COMPLETED|Overall Study||14
9933875|NCT01309802|11051265|FG000|NOT COMPLETED|Overall Study||12
9933876|NCT01309802|11051266|FG001|NOT COMPLETED|Overall Study||9
9933877|NCT01309828|11051274|FG000|STARTED|Overall Study||77
9933878|NCT01309828|11051275|FG001|STARTED|Overall Study||76
9933879|NCT01309828|11051274|FG000|COMPLETED|Overall Study||61
9933880|NCT01309828|11051275|FG001|COMPLETED|Overall Study||60
9933881|NCT01309828|11051274|FG000|NOT COMPLETED|Overall Study||16
9933882|NCT01309828|11051275|FG001|NOT COMPLETED|Overall Study||16
9933883|NCT01309841|11051284|FG000|STARTED|Overall Study||217
9933884|NCT01309841|11051285|FG001|STARTED|Overall Study||218
9933885|NCT01309841|11051286|FG002|STARTED|Overall Study||217
9933886|NCT01309841|11051284|FG000|COMPLETED|Overall Study||178
9933887|NCT01309841|11051285|FG001|COMPLETED|Overall Study||177
9933888|NCT01309841|11051286|FG002|COMPLETED|Overall Study||180
9933889|NCT01309841|11051284|FG000|NOT COMPLETED|Overall Study||39
9933890|NCT01309841|11051285|FG001|NOT COMPLETED|Overall Study||41
9933891|NCT01309841|11051286|FG002|NOT COMPLETED|Overall Study||37
9933892|NCT01309867|11051294|FG000|STARTED|Overall Study||151
9933893|NCT01309867|11051295|FG001|STARTED|Overall Study||151
9933894|NCT01309867|11051294|FG000|COMPLETED|Overall Study||148
9933895|NCT01309867|11051295|FG001|COMPLETED|Overall Study||139
10206965|NCT03519932|11333783|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
10206966|NCT03519932|11333784|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
10206967|NCT03519932|11333783|FG000|NOT COMPLETED|First Intervention||1
9933896|NCT01309867|11051294|FG000|NOT COMPLETED|Overall Study||3
9933897|NCT01309867|11051295|FG001|NOT COMPLETED|Overall Study||12
9933898|NCT01309880|11051301|FG000|STARTED|Overall Study||33
9933899|NCT01309880|11051302|FG001|STARTED|Overall Study||33
9933900|NCT01309880|11051301|FG000|COMPLETED|Overall Study||33
9933901|NCT01309880|11051302|FG001|COMPLETED|Overall Study||33
9933902|NCT01309880|11051301|FG000|NOT COMPLETED|Overall Study||0
10206968|NCT03519932|11333784|FG001|NOT COMPLETED|First Intervention||3
9933903|NCT01309880|11051302|FG001|NOT COMPLETED|Overall Study||0
9933904|NCT01309893|11051308|FG000|STARTED|Week 1 - First Intervention||33
9933905|NCT01309893|11051309|FG001|STARTED|Week 1 - First Intervention||33
9933906|NCT01309893|11051308|FG000|COMPLETED|Week 1 - First Intervention||33
9933907|NCT01309893|11051309|FG001|COMPLETED|Week 1 - First Intervention||33
9933908|NCT01309893|11051308|FG000|NOT COMPLETED|Week 1 - First Intervention||0
9933909|NCT01309893|11051309|FG001|NOT COMPLETED|Week 1 - First Intervention||0
9933910|NCT01309893|11051308|FG000|STARTED|Week 2 - Crossover Intervention||33
9933911|NCT01309893|11051309|FG001|STARTED|Week 2 - Crossover Intervention||33
9933912|NCT01309893|11051308|FG000|COMPLETED|Week 2 - Crossover Intervention||32
9933913|NCT01309893|11051309|FG001|COMPLETED|Week 2 - Crossover Intervention||32
9933914|NCT01309893|11051308|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1
9933915|NCT01309893|11051309|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1
9933916|NCT01309906|11051315|FG000|STARTED|Overall Study||33
9933917|NCT01309906|11051316|FG001|STARTED|Overall Study||33
9933918|NCT01309906|11051315|FG000|COMPLETED|Overall Study||32
9933919|NCT01309906|11051316|FG001|COMPLETED|Overall Study||32
9933920|NCT01309906|11051315|FG000|NOT COMPLETED|Overall Study||1
9933921|NCT01309906|11051316|FG001|NOT COMPLETED|Overall Study||1
9933922|NCT01309919|11051324|FG000|STARTED|Overall Study||75
9933923|NCT01309919|11051325|FG001|STARTED|Overall Study||75
9933924|NCT01309919|11051324|FG000|COMPLETED|Overall Study||58
9933925|NCT01309919|11051325|FG001|COMPLETED|Overall Study||27
9933926|NCT01309919|11051324|FG000|NOT COMPLETED|Overall Study||17
9933927|NCT01309919|11051325|FG001|NOT COMPLETED|Overall Study||48
9933928|NCT01309997|11051333|FG000|STARTED|Overall Study||35
10011049|NCT01777581|11133751|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
10011050|NCT01777581|11133752|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
10011051|NCT01777581|11133751|FG000|COMPLETED|Overall Study||5
10011052|NCT01777581|11133752|FG001|COMPLETED|Overall Study||3
10011053|NCT01777581|11133751|FG000|NOT COMPLETED|Overall Study||3
10011054|NCT01777581|11133752|FG001|NOT COMPLETED|Overall Study||2
10011055|NCT01777620|11133760|FG000|STARTED|Overall Study||63
10011056|NCT01777620|11133761|FG001|STARTED|Overall Study||62
10011057|NCT01777620|11133760|FG000|COMPLETED|Overall Study||62
10011058|NCT01777620|11133761|FG001|COMPLETED|Overall Study||62
10011059|NCT01777620|11133760|FG000|NOT COMPLETED|Overall Study||1
10011060|NCT01777620|11133761|FG001|NOT COMPLETED|Overall Study||0
10011061|NCT01777763|11133769|FG000|STARTED|Overall Study||20
10011062|NCT01777763|11133770|FG001|STARTED|Overall Study||210
10011063|NCT01777763|11133769|FG000|COMPLETED|Overall Study||16
10011064|NCT01777763|11133770|FG001|COMPLETED|Overall Study||163
10011065|NCT01777763|11133769|FG000|NOT COMPLETED|Overall Study||4
10011066|NCT01777763|11133770|FG001|NOT COMPLETED|Overall Study||47
10011067|NCT01777776|11133780|FG000|STARTED|Overall Study||6
10011068|NCT01777776|11133781|FG001|STARTED|Overall Study||12
10011069|NCT01777776|11133782|FG002|STARTED|Overall Study||6
10011070|NCT01777776|11133783|FG003|STARTED|Overall Study||4
9933929|NCT01309997|11051334|FG001|STARTED|Overall Study||37
9933930|NCT01309997|11051333|FG000|Remained on First Arm Only|Overall Study||16
9933931|NCT01309997|11051334|FG001|Remained on First Arm Only|Overall Study||14
9933932|NCT01309997|11051333|FG000|Crossed Over to Second Arm|Overall Study||19
9933933|NCT01309997|11051334|FG001|Crossed Over to Second Arm|Overall Study||23
9933934|NCT01309997|11051333|FG000|COMPLETED|Overall Study||30
9933935|NCT01309997|11051334|FG001|COMPLETED|Overall Study||31
9933936|NCT01309997|11051333|FG000|NOT COMPLETED|Overall Study||5
9933937|NCT01309997|11051334|FG001|NOT COMPLETED|Overall Study||6
9933938|NCT01310036|11051351|FG000|STARTED|Overall Study||208
9933939|NCT01310036|11051351|FG000|COMPLETED|Overall Study||6
9933940|NCT01310036|11051351|FG000|NOT COMPLETED|Overall Study||202
9933941|NCT01310075|11051357|FG000|STARTED|Overall Study||45
10011071|NCT01777776|11133780|FG000|COMPLETED|Overall Study||0
10011072|NCT01777776|11133781|FG001|COMPLETED|Overall Study||0
10011073|NCT01777776|11133782|FG002|COMPLETED|Overall Study||0
9933942|NCT01310075|11051358|FG001|STARTED|Overall Study||45
9933943|NCT01310075|11051357|FG000|COMPLETED|Overall Study||31
9933944|NCT01310075|11051358|FG001|COMPLETED|Overall Study||35
10011074|NCT01777776|11133783|FG003|COMPLETED|Overall Study||0
10011075|NCT01777776|11133780|FG000|NOT COMPLETED|Overall Study||6
10206969|NCT03519932|11333783|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
10011076|NCT01777776|11133781|FG001|NOT COMPLETED|Overall Study||12
10011077|NCT01777776|11133782|FG002|NOT COMPLETED|Overall Study||6
10011078|NCT01777776|11133783|FG003|NOT COMPLETED|Overall Study||4
10011079|NCT01777932|11133802|FG000|STARTED|Overall Study||220
10011080|NCT01777932|11133802|FG000|COMPLETED|Overall Study||15
10206970|NCT03519932|11333784|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
10206971|NCT03519932|11333783|FG000|COMPLETED|Second Intervention||22
10206972|NCT03519932|11333784|FG001|COMPLETED|Second Intervention||23
9933945|NCT01310075|11051357|FG000|NOT COMPLETED|Overall Study||14
9933946|NCT01310075|11051358|FG001|NOT COMPLETED|Overall Study||10
9933947|NCT01310127|11051366|FG000|STARTED|Overall Study||12
9933948|NCT01310127|11051367|FG001|STARTED|Overall Study||11
9933949|NCT01310127|11051366|FG000|COMPLETED|Overall Study||10
9933950|NCT01310127|11051367|FG001|COMPLETED|Overall Study||10
9933951|NCT01310127|11051366|FG000|NOT COMPLETED|Overall Study||2
10011081|NCT01777932|11133802|FG000|NOT COMPLETED|Overall Study||205
10011082|NCT01777945|11133806|FG000|STARTED|Overall Study||46
10011083|NCT01777945|11133806|FG000|Evaluable Participants|Overall Study||45
9933952|NCT01310127|11051367|FG001|NOT COMPLETED|Overall Study||1
9933953|NCT01310179|11051373|FG000|STARTED|Overall Study||12
9933954|NCT01310179|11051373|FG000|COMPLETED|Overall Study||12
9933955|NCT01310179|11051373|FG000|NOT COMPLETED|Overall Study||0
9933956|NCT01310231|11051379|FG000|STARTED|Overall Study||22
9933957|NCT01310231|11051380|FG001|STARTED|Overall Study||18
9933958|NCT01310231|11051379|FG000|Received Intervention|Overall Study||22
9933959|NCT01310231|11051380|FG001|Received Intervention|Overall Study||17
9933960|NCT01310231|11051379|FG000|Discontinued Intervention|Overall Study||0
9933961|NCT01310231|11051380|FG001|Discontinued Intervention|Overall Study||1
9933962|NCT01310231|11051379|FG000|Analyzed for Survival|Overall Study||22
9933963|NCT01310231|11051380|FG001|Analyzed for Survival|Overall Study||18
9933964|NCT01310231|11051379|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22
9933965|NCT01310231|11051380|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17
9933966|NCT01310231|11051379|FG000|COMPLETED|Overall Study||22
9933967|NCT01310231|11051380|FG001|COMPLETED|Overall Study||17
9933968|NCT01310231|11051379|FG000|NOT COMPLETED|Overall Study||0
9933969|NCT01310231|11051380|FG001|NOT COMPLETED|Overall Study||1
9933970|NCT01310400|11051389|FG000|STARTED|Overall Study||452
9933971|NCT01310400|11051390|FG001|STARTED|Overall Study||452
9933972|NCT01310400|11051391|FG002|STARTED|Overall Study||452
9933973|NCT01310400|11051389|FG000|COMPLETED|Overall Study||424
9933974|NCT01310400|11051390|FG001|COMPLETED|Overall Study||420
9933975|NCT01310400|11051391|FG002|COMPLETED|Overall Study||422
9933976|NCT01310400|11051389|FG000|NOT COMPLETED|Overall Study||28
9933977|NCT01310400|11051390|FG001|NOT COMPLETED|Overall Study||32
9933978|NCT01310400|11051391|FG002|NOT COMPLETED|Overall Study||30
9933979|NCT01310413|11051408|FG000|STARTED|Day 0 to Day 385||199
9933980|NCT01310413|11051409|FG001|STARTED|Day 0 to Day 385||198
9933981|NCT01310413|11051410|FG002|STARTED|Day 0 to Day 385||210
9933982|NCT01310413|11051411|FG003|STARTED|Day 0 to Day 385||75
9933983|NCT01310413|11051412|FG004|STARTED|Day 0 to Day 385||76
9933984|NCT01310413|11051413|FG005|STARTED|Day 0 to Day 385||80
9933985|NCT01310413|11051414|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
9933986|NCT01310413|11051408|FG000|COMPLETED|Day 0 to Day 385||172
9933987|NCT01310413|11051409|FG001|COMPLETED|Day 0 to Day 385||190
9933988|NCT01310413|11051410|FG002|COMPLETED|Day 0 to Day 385||203
9933989|NCT01310413|11051411|FG003|COMPLETED|Day 0 to Day 385||67
9933990|NCT01310413|11051412|FG004|COMPLETED|Day 0 to Day 385||73
9933991|NCT01310413|11051413|FG005|COMPLETED|Day 0 to Day 385||77
9933992|NCT01310413|11051414|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
9933993|NCT01310413|11051408|FG000|NOT COMPLETED|Day 0 to Day 385||27
9933994|NCT01310413|11051409|FG001|NOT COMPLETED|Day 0 to Day 385||8
9933995|NCT01310413|11051410|FG002|NOT COMPLETED|Day 0 to Day 385||7
9933996|NCT01310413|11051411|FG003|NOT COMPLETED|Day 0 to Day 385||8
9933997|NCT01310413|11051412|FG004|NOT COMPLETED|Day 0 to Day 385||3
9933998|NCT01310413|11051413|FG005|NOT COMPLETED|Day 0 to Day 385||3
9933999|NCT01310413|11051414|FG006|NOT COMPLETED|Day 0 to Day 385||0
9934000|NCT01310413|11051408|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
9934001|NCT01310413|11051409|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
9934002|NCT01310413|11051410|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
9934003|NCT01310413|11051411|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
9934004|NCT01310413|11051412|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
9934005|NCT01310413|11051413|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
9934006|NCT01310413|11051414|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155
9934007|NCT01310413|11051408|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
9934008|NCT01310413|11051409|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
9934009|NCT01310413|11051410|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
9934010|NCT01310413|11051411|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
9934011|NCT01310413|11051412|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
9956388|NCT01445652|11075611|FG000|COMPLETED|Overall Study||47
9956389|NCT01445652|11075612|FG001|COMPLETED|Overall Study||50
10011084|NCT01777945|11133806|FG000|COMPLETED|Overall Study||46
10011085|NCT01777945|11133806|FG000|NOT COMPLETED|Overall Study||0
10011086|NCT01777997|11133810|FG000|STARTED|12 Week lead-in of no ART||38
10011087|NCT01777997|11133810|FG000|COMPLETED|12 Week lead-in of no ART||36
10011088|NCT01777997|11133810|FG000|NOT COMPLETED|12 Week lead-in of no ART||2
10011089|NCT01777997|11133810|FG000|STARTED|Weeks 0 to 24/48 on ART||36
10019017|NCT01826981|11142059|FG008|NOT COMPLETED|Overall Study||7
10111607|NCT02497287|11242647|FG000|COMPLETED|Follow-up Phase (4 Week)||326
10111608|NCT02497287|11242647|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31
9934012|NCT01310413|11051413|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
9934013|NCT01310413|11051414|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
9934014|NCT01310413|11051408|FG000|NOT COMPLETED|From Day U0 to Day U385||0
9934015|NCT01310413|11051409|FG001|NOT COMPLETED|From Day U0 to Day U385||0
9934016|NCT01310413|11051410|FG002|NOT COMPLETED|From Day U0 to Day U385||0
9934017|NCT01310413|11051411|FG003|NOT COMPLETED|From Day U0 to Day U385||0
9934018|NCT01310413|11051412|FG004|NOT COMPLETED|From Day U0 to Day U385||0
9934019|NCT01310413|11051413|FG005|NOT COMPLETED|From Day U0 to Day U385||0
9934020|NCT01310413|11051414|FG006|NOT COMPLETED|From Day U0 to Day U385||3
9934021|NCT01310582|11051445|FG000|STARTED|Overall Study||31
9934022|NCT01310582|11051446|FG001|STARTED|Overall Study||26
9934023|NCT01310582|11051445|FG000|COMPLETED|Overall Study||31
9934024|NCT01310582|11051446|FG001|COMPLETED|Overall Study||26
9934025|NCT01310582|11051445|FG000|NOT COMPLETED|Overall Study||0
9934026|NCT01310582|11051446|FG001|NOT COMPLETED|Overall Study||0
9934027|NCT01310699|11051454|FG000|STARTED|Overall Study||132
9934028|NCT01310699|11051455|FG001|STARTED|Overall Study||149
9934029|NCT01310699|11051454|FG000|COMPLETED|Overall Study||128
9934030|NCT01310699|11051455|FG001|COMPLETED|Overall Study||143
9934031|NCT01310699|11051454|FG000|NOT COMPLETED|Overall Study||4
9934032|NCT01310699|11051455|FG001|NOT COMPLETED|Overall Study||6
9934033|NCT01310777|11051466|FG000|STARTED|Overall Study||193
9934034|NCT01310777|11051467|FG001|STARTED|Overall Study||192
9934035|NCT01310777|11051468|FG002|STARTED|Overall Study||175
9934036|NCT01310777|11051466|FG000|COMPLETED|Overall Study||160
9934037|NCT01310777|11051467|FG001|COMPLETED|Overall Study||178
9934038|NCT01310777|11051468|FG002|COMPLETED|Overall Study||145
9934039|NCT01310777|11051466|FG000|NOT COMPLETED|Overall Study||33
9934040|NCT01310777|11051467|FG001|NOT COMPLETED|Overall Study||14
9934041|NCT01310777|11051468|FG002|NOT COMPLETED|Overall Study||30
9934042|NCT01310855|11051478|FG000|STARTED|Overall Study||19
9934043|NCT01310855|11051479|FG001|STARTED|Overall Study||19
9934044|NCT01310855|11051478|FG000|COMPLETED|Overall Study||19
9934045|NCT01310855|11051479|FG001|COMPLETED|Overall Study||19
9934046|NCT01310855|11051478|FG000|NOT COMPLETED|Overall Study||0
9934047|NCT01310855|11051479|FG001|NOT COMPLETED|Overall Study||0
9934048|NCT01310868|11051485|FG000|STARTED|Overall Study||72
9934049|NCT01310868|11051485|FG000|COMPLETED|Overall Study||59
9934050|NCT01310868|11051485|FG000|NOT COMPLETED|Overall Study||13
9934051|NCT01311024|11051491|FG000|STARTED|Overall Study||1530
9934052|NCT01311024|11051492|FG001|STARTED|Overall Study||811
9934053|NCT01311024|11051491|FG000|COMPLETED|Overall Study||1495
9934054|NCT01311024|11051492|FG001|COMPLETED|Overall Study||789
9934055|NCT01311024|11051491|FG000|NOT COMPLETED|Overall Study||35
9934056|NCT01311024|11051492|FG001|NOT COMPLETED|Overall Study||22
9934057|NCT01311102|11051500|FG000|STARTED|Overall Study||20
9934058|NCT01311102|11051501|FG001|STARTED|Overall Study||20
9934059|NCT01311102|11051500|FG000|COMPLETED|Overall Study||20
9934060|NCT01311102|11051501|FG001|COMPLETED|Overall Study||20
9934061|NCT01311102|11051500|FG000|NOT COMPLETED|Overall Study||0
9934062|NCT01311102|11051501|FG001|NOT COMPLETED|Overall Study||0
9934063|NCT01311362|11051509|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
9934064|NCT01311362|11051509|FG000|COMPLETED|Ambrisentan Single Dose||20
9934065|NCT01311362|11051509|FG000|NOT COMPLETED|Ambrisentan Single Dose||0
9934066|NCT01311362|11051509|FG000|STARTED|Ambrisentan Steady-state||20
9934067|NCT01311362|11051509|FG000|COMPLETED|Ambrisentan Steady-state||20
9934068|NCT01311362|11051509|FG000|NOT COMPLETED|Ambrisentan Steady-state||0
9934069|NCT01311362|11051509|FG000|STARTED|Ambrisentan and SJW||20
9934070|NCT01311362|11051509|FG000|COMPLETED|Ambrisentan and SJW||20
9934071|NCT01311362|11051509|FG000|NOT COMPLETED|Ambrisentan and SJW||0
9934072|NCT01311505|11051518|FG000|STARTED|First Intervention Period||10
9934073|NCT01311505|11051519|FG001|STARTED|First Intervention Period||11
9934074|NCT01311505|11051518|FG000|COMPLETED|First Intervention Period||10
9934075|NCT01311505|11051519|FG001|COMPLETED|First Intervention Period||10
9934076|NCT01311505|11051518|FG000|NOT COMPLETED|First Intervention Period||0
9934077|NCT01311505|11051519|FG001|NOT COMPLETED|First Intervention Period||1
9934078|NCT01311505|11051518|FG000|STARTED|Washout Period (at Least 7 Days)||10
9934079|NCT01311505|11051519|FG001|STARTED|Washout Period (at Least 7 Days)||10
9934080|NCT01311505|11051518|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
9934081|NCT01311505|11051519|FG001|COMPLETED|Washout Period (at Least 7 Days)||10
9934082|NCT01311505|11051518|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9934083|NCT01311505|11051519|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9934084|NCT01311505|11051518|FG000|STARTED|Second Intervention Period||10
9934085|NCT01311505|11051519|FG001|STARTED|Second Intervention Period||10
9934086|NCT01311505|11051518|FG000|COMPLETED|Second Intervention Period||10
9934087|NCT01311505|11051519|FG001|COMPLETED|Second Intervention Period||10
9934088|NCT01311505|11051518|FG000|NOT COMPLETED|Second Intervention Period||0
9934089|NCT01311505|11051519|FG001|NOT COMPLETED|Second Intervention Period||0
9934090|NCT01311557|11051530|FG000|STARTED|Overall Study||651
9934091|NCT01311557|11051531|FG001|STARTED|Overall Study||651
9934092|NCT01311557|11051530|FG000|COMPLETED|Overall Study||646
9934093|NCT01311557|11051531|FG001|COMPLETED|Overall Study||645
9934094|NCT01311557|11051530|FG000|NOT COMPLETED|Overall Study||5
9934095|NCT01311557|11051531|FG001|NOT COMPLETED|Overall Study||6
9934096|NCT01311648|11051540|FG000|STARTED|Main Study||51
9934097|NCT01311648|11051541|FG001|STARTED|Main Study||43
9934098|NCT01311648|11051540|FG000|Started 0-<6 Years|Main Study||25
9934099|NCT01311648|11051541|FG001|Started 0-<6 Years|Main Study||43
9934100|NCT01311648|11051540|FG000|Started 6-12 Years|Main Study||26
9934101|NCT01311648|11051541|FG001|Started 6-12 Years|Main Study||0
9934102|NCT01311648|11051540|FG000|COMPLETED|Main Study||51
9934103|NCT01311648|11051541|FG001|COMPLETED|Main Study||22
9934104|NCT01311648|11051540|FG000|NOT COMPLETED|Main Study||0
9934105|NCT01311648|11051541|FG001|NOT COMPLETED|Main Study||21
9934106|NCT01311648|11051540|FG000|STARTED|Extension Study||46
9934107|NCT01311648|11051541|FG001|STARTED|Extension Study||36
9934108|NCT01311648|11051540|FG000|COMPLETED|Extension Study||45
9934109|NCT01311648|11051541|FG001|COMPLETED|Extension Study||25
9934110|NCT01311648|11051540|FG000|NOT COMPLETED|Extension Study||1
9934111|NCT01311648|11051541|FG001|NOT COMPLETED|Extension Study||11
9934112|NCT01311661|11051554|FG000|STARTED|Overall Study|Entered and treated|206
9934113|NCT01311661|11051554|FG000|Received Placebo|Overall Study||201
9934114|NCT01311661|11051554|FG000|Received Olo 2.5 mcg Bid|Overall Study||101
9934115|NCT01311661|11051554|FG000|Received Olo 5 mcg qd|Overall Study||101
9934116|NCT01311661|11051554|FG000|Received Olo 5 mcg Bid|Overall Study||101
9934117|NCT01311661|11051554|FG000|Received Olo 10 mcg qd|Overall Study||102
9934118|NCT01311661|11051554|FG000|COMPLETED|Overall Study||199
9934119|NCT01311661|11051554|FG000|NOT COMPLETED|Overall Study||7
9934120|NCT01311674|11051568|FG000|STARTED|Overall Study||72
9934121|NCT01311674|11051569|FG001|STARTED|Overall Study||69
9934122|NCT01311674|11051568|FG000|COMPLETED|Overall Study||28
9934123|NCT01311674|11051569|FG001|COMPLETED|Overall Study||29
9934124|NCT01311674|11051568|FG000|NOT COMPLETED|Overall Study||44
9934125|NCT01311674|11051569|FG001|NOT COMPLETED|Overall Study||40
9934126|NCT01311687|11051578|FG000|STARTED|Treatment Phase||302
9934127|NCT01311687|11051579|FG001|STARTED|Treatment Phase||153
9934128|NCT01311687|11051578|FG000|Received Study Drug|Treatment Phase||300
9934129|NCT01311687|11051579|FG001|Received Study Drug|Treatment Phase||150
9934130|NCT01311687|11051578|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
9934131|NCT01311687|11051579|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
9934132|NCT01311687|11051578|FG000|COMPLETED|Treatment Phase||302
9934133|NCT01311687|11051579|FG001|COMPLETED|Treatment Phase||153
9934134|NCT01311687|11051578|FG000|NOT COMPLETED|Treatment Phase||0
9934135|NCT01311687|11051579|FG001|NOT COMPLETED|Treatment Phase||0
9934136|NCT01311687|11051578|FG000|STARTED|PFS Follow-up Phase||11
9934137|NCT01311687|11051579|FG001|STARTED|PFS Follow-up Phase||8
9934138|NCT01311687|11051578|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
9934139|NCT01311687|11051579|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
9934140|NCT01311687|11051578|FG000|COMPLETED|PFS Follow-up Phase||11
9934141|NCT01311687|11051579|FG001|COMPLETED|PFS Follow-up Phase||8
9934142|NCT01311687|11051578|FG000|NOT COMPLETED|PFS Follow-up Phase||0
9934143|NCT01311687|11051579|FG001|NOT COMPLETED|PFS Follow-up Phase||0
9934144|NCT01311895|11051590|FG000|STARTED|Overall Study||175
9934145|NCT01311895|11051591|FG001|STARTED|Overall Study||175
9934146|NCT01311895|11051590|FG000|COMPLETED|Overall Study||175
9934147|NCT01311895|11051591|FG001|COMPLETED|Overall Study||175
9934148|NCT01311895|11051590|FG000|NOT COMPLETED|Overall Study||0
9934149|NCT01311895|11051591|FG001|NOT COMPLETED|Overall Study||0
9934150|NCT01312038|11051599|FG000|STARTED|Overall Study||13
9934151|NCT01312038|11051600|FG001|STARTED|Overall Study||12
9934152|NCT01312038|11051599|FG000|COMPLETED|Overall Study||13
9934153|NCT01312038|11051600|FG001|COMPLETED|Overall Study||12
9934154|NCT01312038|11051599|FG000|NOT COMPLETED|Overall Study||0
9934155|NCT01312038|11051600|FG001|NOT COMPLETED|Overall Study||0
9934156|NCT01312129|11051608|FG000|STARTED|First Intervention (24 Hours)||6
9934157|NCT01312129|11051609|FG001|STARTED|First Intervention (24 Hours)||7
9934158|NCT01312129|11051608|FG000|Control Cue|First Intervention (24 Hours)||6
9934159|NCT01312129|11051609|FG001|Control Cue|First Intervention (24 Hours)||7
9934160|NCT01312129|11051608|FG000|Alcohol Cue|First Intervention (24 Hours)||6
9934161|NCT01312129|11051609|FG001|Alcohol Cue|First Intervention (24 Hours)||7
9934162|NCT01312129|11051608|FG000|COMPLETED|First Intervention (24 Hours)||6
10206973|NCT03519932|11333783|FG000|NOT COMPLETED|Second Intervention||0
10206974|NCT03519932|11333784|FG001|NOT COMPLETED|Second Intervention||0
10206975|NCT03520283|11333797|FG000|STARTED|Overall Study||24
10206976|NCT03520283|11333798|FG001|STARTED|Overall Study||42
10206977|NCT03520283|11333797|FG000|COMPLETED|Overall Study||24
10206978|NCT03520283|11333798|FG001|COMPLETED|Overall Study||42
10206979|NCT03520283|11333797|FG000|NOT COMPLETED|Overall Study||0
9934163|NCT01312129|11051609|FG001|COMPLETED|First Intervention (24 Hours)||7
9934164|NCT01312129|11051608|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
9934165|NCT01312129|11051609|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
10206980|NCT03520283|11333798|FG001|NOT COMPLETED|Overall Study||0
10206981|NCT03520348|11333815|FG000|STARTED|Overall Study||12
10206982|NCT03520348|11333816|FG001|STARTED|Overall Study||12
9934166|NCT01312129|11051608|FG000|STARTED|Washout (1 Week)||6
9934167|NCT01312129|11051609|FG001|STARTED|Washout (1 Week)||7
9934168|NCT01312129|11051608|FG000|COMPLETED|Washout (1 Week)||6
9934169|NCT01312129|11051609|FG001|COMPLETED|Washout (1 Week)||7
9934170|NCT01312129|11051608|FG000|NOT COMPLETED|Washout (1 Week)||0
9934171|NCT01312129|11051609|FG001|NOT COMPLETED|Washout (1 Week)||0
9934172|NCT01312129|11051608|FG000|STARTED|Second Intervention (24 Hours)||6
9934173|NCT01312129|11051609|FG001|STARTED|Second Intervention (24 Hours)||7
9934174|NCT01312129|11051608|FG000|Control Cue|Second Intervention (24 Hours)||6
9934175|NCT01312129|11051609|FG001|Control Cue|Second Intervention (24 Hours)||6
9934176|NCT01312129|11051608|FG000|Alcohol Cue|Second Intervention (24 Hours)||6
10206983|NCT03520348|11333815|FG000|COMPLETED|Overall Study||12
10206984|NCT03520348|11333816|FG001|COMPLETED|Overall Study||12
10206985|NCT03520348|11333815|FG000|NOT COMPLETED|Overall Study||0
10011090|NCT01777997|11133810|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
10011091|NCT01777997|11133810|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
10011092|NCT01777997|11133810|FG000|STARTED|Weeks 48 to 72/96 on ART||28
10011093|NCT01777997|11133810|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26
10011094|NCT01777997|11133810|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
10011095|NCT01778010|11133814|FG000|STARTED|Overall Study||13
10011096|NCT01778010|11133814|FG000|COMPLETED|Overall Study||8
10011097|NCT01778010|11133814|FG000|NOT COMPLETED|Overall Study||5
10011098|NCT01778023|11133833|FG000|STARTED|Overall Study||36
10011099|NCT01778023|11133834|FG001|STARTED|Overall Study||18
10011100|NCT01778023|11133833|FG000|Exposed|Overall Study||36
10011101|NCT01778023|11133834|FG001|Exposed|Overall Study||15
10011102|NCT01778023|11133833|FG000|COMPLETED|Overall Study||36
10011103|NCT01778023|11133834|FG001|COMPLETED|Overall Study||15
10011104|NCT01778023|11133833|FG000|NOT COMPLETED|Overall Study||0
9934177|NCT01312129|11051609|FG001|Alcohol Cue|Second Intervention (24 Hours)||6
9934178|NCT01312129|11051608|FG000|COMPLETED|Second Intervention (24 Hours)||6
9934179|NCT01312129|11051609|FG001|COMPLETED|Second Intervention (24 Hours)||6
9934180|NCT01312129|11051608|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
9934181|NCT01312129|11051609|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1
9934182|NCT01312181|11051618|FG000|STARTED|Overall Study||80
9934183|NCT01312181|11051619|FG001|STARTED|Overall Study||77
9934184|NCT01312181|11051620|FG002|STARTED|Overall Study||83
9934185|NCT01312181|11051618|FG000|COMPLETED|Overall Study||78
9934186|NCT01312181|11051619|FG001|COMPLETED|Overall Study||71
9934187|NCT01312181|11051620|FG002|COMPLETED|Overall Study||75
9934188|NCT01312181|11051618|FG000|NOT COMPLETED|Overall Study||2
9934189|NCT01312181|11051619|FG001|NOT COMPLETED|Overall Study||6
9934190|NCT01312181|11051620|FG002|NOT COMPLETED|Overall Study||8
9934191|NCT01312233|11051631|FG000|STARTED|Overall Study||44
9934192|NCT01312233|11051632|FG001|STARTED|Overall Study||44
9934193|NCT01312233|11051633|FG002|STARTED|Overall Study||43
9934194|NCT01312233|11051631|FG000|COMPLETED|Overall Study||42
9934195|NCT01312233|11051632|FG001|COMPLETED|Overall Study||44
9934196|NCT01312233|11051633|FG002|COMPLETED|Overall Study||36
9934197|NCT01312233|11051631|FG000|NOT COMPLETED|Overall Study||2
9934198|NCT01312233|11051632|FG001|NOT COMPLETED|Overall Study||0
9934199|NCT01312233|11051633|FG002|NOT COMPLETED|Overall Study||7
9934200|NCT01312272|11051643|FG000|STARTED|Overall Study||12
9934201|NCT01312272|11051644|FG001|STARTED|Overall Study||12
9934202|NCT01312272|11051643|FG000|COMPLETED|Overall Study||12
9934203|NCT01312272|11051644|FG001|COMPLETED|Overall Study||11
9934204|NCT01312272|11051643|FG000|NOT COMPLETED|Overall Study||0
9934205|NCT01312272|11051644|FG001|NOT COMPLETED|Overall Study||1
9934206|NCT01312389|11051653|FG000|STARTED|Phase 1||3
9934207|NCT01312389|11051654|FG001|STARTED|Phase 1||0
9934208|NCT01312389|11051655|FG002|STARTED|Phase 1||0
9934209|NCT01312389|11051653|FG000|COMPLETED|Phase 1||3
9934210|NCT01312389|11051654|FG001|COMPLETED|Phase 1||0
9934211|NCT01312389|11051655|FG002|COMPLETED|Phase 1||0
9934212|NCT01312389|11051653|FG000|NOT COMPLETED|Phase 1||0
9934213|NCT01312389|11051654|FG001|NOT COMPLETED|Phase 1||0
9934214|NCT01312389|11051655|FG002|NOT COMPLETED|Phase 1||0
9934215|NCT01312389|11051653|FG000|STARTED|Phase 2||0
9934216|NCT01312389|11051654|FG001|STARTED|Phase 2||0
9934217|NCT01312389|11051655|FG002|STARTED|Phase 2||0
9934218|NCT01312389|11051653|FG000|COMPLETED|Phase 2||0
9934219|NCT01312389|11051654|FG001|COMPLETED|Phase 2||0
9934220|NCT01312389|11051655|FG002|COMPLETED|Phase 2||0
9934221|NCT01312389|11051653|FG000|NOT COMPLETED|Phase 2||0
9934222|NCT01312389|11051654|FG001|NOT COMPLETED|Phase 2||0
9934223|NCT01312389|11051655|FG002|NOT COMPLETED|Phase 2||0
9934224|NCT01312467|11051663|FG000|STARTED|Overall Study||45
9934225|NCT01312467|11051663|FG000|COMPLETED|Overall Study||32
9934226|NCT01312467|11051663|FG000|NOT COMPLETED|Overall Study||13
9934227|NCT01312519|11051670|FG000|STARTED|Overall Study||26
9934228|NCT01312519|11051671|FG001|STARTED|Overall Study||24
9934229|NCT01312519|11051670|FG000|COMPLETED|Overall Study||26
9934230|NCT01312519|11051671|FG001|COMPLETED|Overall Study||24
9934231|NCT01312519|11051670|FG000|NOT COMPLETED|Overall Study||0
9934232|NCT01312519|11051671|FG001|NOT COMPLETED|Overall Study||0
10011105|NCT01778023|11133834|FG001|NOT COMPLETED|Overall Study||3
10011106|NCT01778049|11133842|FG000|STARTED|Open Label Treatment Period||354
9934233|NCT01312675|11051679|FG000|STARTED|Overall Study||9
10011107|NCT01778049|11133843|FG001|STARTED|Open Label Treatment Period||355
9934234|NCT01312675|11051680|FG001|STARTED|Overall Study||7
9934235|NCT01312675|11051679|FG000|COMPLETED|Overall Study||9
9934236|NCT01312675|11051680|FG001|COMPLETED|Overall Study||7
9934237|NCT01312675|11051679|FG000|NOT COMPLETED|Overall Study||0
9934238|NCT01312675|11051680|FG001|NOT COMPLETED|Overall Study||0
9934239|NCT01312766|11051688|FG000|STARTED|Overall Study||135
9934240|NCT01312766|11051689|FG001|STARTED|Overall Study||135
9934241|NCT01312766|11051688|FG000|COMPLETED|Overall Study||129
9934242|NCT01312766|11051689|FG001|COMPLETED|Overall Study||130
9934243|NCT01312766|11051688|FG000|NOT COMPLETED|Overall Study||6
10206986|NCT03520348|11333816|FG001|NOT COMPLETED|Overall Study||0
9934244|NCT01312766|11051689|FG001|NOT COMPLETED|Overall Study||5
9934245|NCT01312779|11051695|FG000|STARTED|Overall Study||39
9934246|NCT01312779|11051695|FG000|Implanted With Device|Overall Study||12
9934247|NCT01312779|11051695|FG000|COMPLETED|Overall Study||7
9934248|NCT01312779|11051695|FG000|NOT COMPLETED|Overall Study||32
9934249|NCT01312805|11051710|FG000|STARTED|Overall Study||1016
9934250|NCT01312805|11051711|FG001|STARTED|Overall Study||1082
9934251|NCT01312805|11051710|FG000|COMPLETED|Overall Study||1016
9934252|NCT01312805|11051711|FG001|COMPLETED|Overall Study||1082
9934253|NCT01312805|11051710|FG000|NOT COMPLETED|Overall Study||0
9934254|NCT01312805|11051711|FG001|NOT COMPLETED|Overall Study||0
9934255|NCT01312818|11051717|FG000|STARTED|Overall Study||2
9934256|NCT01312818|11051717|FG000|COMPLETED|Overall Study||2
9934257|NCT01312818|11051717|FG000|NOT COMPLETED|Overall Study||0
9934258|NCT01312844|11051725|FG000|STARTED|Overall Study||4
9934259|NCT01312844|11051726|FG001|STARTED|Overall Study||3
9934260|NCT01312844|11051725|FG000|COMPLETED|Overall Study||4
9934261|NCT01312844|11051726|FG001|COMPLETED|Overall Study||3
9934262|NCT01312844|11051725|FG000|NOT COMPLETED|Overall Study||0
9934263|NCT01312844|11051726|FG001|NOT COMPLETED|Overall Study||0
9934264|NCT01312909|11051735|FG000|STARTED|Overall Study||109
9934265|NCT01312909|11051736|FG001|STARTED|Overall Study||103
9934266|NCT01312909|11051737|FG002|STARTED|Overall Study||100
9934267|NCT01312909|11051735|FG000|Treated|Overall Study||108
9934268|NCT01312909|11051736|FG001|Treated|Overall Study||100
9934269|NCT01312909|11051737|FG002|Treated|Overall Study||99
9934270|NCT01312909|11051735|FG000|COMPLETED|Overall Study||67
9934271|NCT01312909|11051736|FG001|COMPLETED|Overall Study||67
9934272|NCT01312909|11051737|FG002|COMPLETED|Overall Study||53
9934273|NCT01312909|11051735|FG000|NOT COMPLETED|Overall Study||42
9934274|NCT01312909|11051736|FG001|NOT COMPLETED|Overall Study||36
9934275|NCT01312909|11051737|FG002|NOT COMPLETED|Overall Study||47
9934276|NCT01312948|11051745|FG000|STARTED|Overall Study||6
9934277|NCT01312948|11051745|FG000|COMPLETED|Overall Study||6
9934278|NCT01312948|11051745|FG000|NOT COMPLETED|Overall Study||0
9934279|NCT01312961|11051754|FG000|STARTED|Overall Study||52
9934280|NCT01312961|11051755|FG001|STARTED|Overall Study||52
9934281|NCT01312961|11051754|FG000|Treated|Overall Study||52
9934282|NCT01312961|11051755|FG001|Treated|Overall Study||52
9934283|NCT01312961|11051754|FG000|COMPLETED|Overall Study||35
9934284|NCT01312961|11051755|FG001|COMPLETED|Overall Study||45
9934285|NCT01312961|11051754|FG000|NOT COMPLETED|Overall Study||17
9934286|NCT01312961|11051755|FG001|NOT COMPLETED|Overall Study||7
9934287|NCT01313039|11051762|FG000|STARTED|Overall Study||4
9934288|NCT01313039|11051762|FG000|COMPLETED|Overall Study||2
9934289|NCT01313039|11051762|FG000|NOT COMPLETED|Overall Study||2
9934290|NCT01313078|11051766|FG000|STARTED|Overall Study||4
9934291|NCT01313078|11051766|FG000|COMPLETED|Overall Study||1
9934292|NCT01313078|11051766|FG000|NOT COMPLETED|Overall Study||3
9934293|NCT01313117|11051770|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
9934294|NCT01313117|11051770|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
9934295|NCT01313117|11051770|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
9934296|NCT01313117|11051770|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
9934297|NCT01313117|11051770|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
9934298|NCT01313117|11051770|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
9934299|NCT01313117|11051770|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
9934300|NCT01313117|11051770|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
9934301|NCT01313117|11051770|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
9934302|NCT01313117|11051770|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
9934303|NCT01313117|11051770|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
9934304|NCT01313117|11051770|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
9934305|NCT01313117|11051770|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
9934306|NCT01313117|11051770|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
9934307|NCT01313117|11051770|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
9934308|NCT01313182|11051777|FG000|STARTED|Overall Study||842
9934309|NCT01313182|11051778|FG001|STARTED|Overall Study||855
9934310|NCT01313182|11051777|FG000|COMPLETED|Overall Study||776
9934311|NCT01313182|11051778|FG001|COMPLETED|Overall Study||763
9934312|NCT01313182|11051777|FG000|NOT COMPLETED|Overall Study||66
9934313|NCT01313182|11051778|FG001|NOT COMPLETED|Overall Study||92
9934314|NCT01313208|11051786|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104
9934315|NCT01313208|11051787|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106
9934316|NCT01313208|11051786|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
9934317|NCT01313208|11051787|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
9934318|NCT01313208|11051786|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
9934319|NCT01313208|11051787|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
9934320|NCT01313208|11051786|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98
9934321|NCT01313208|11051787|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101
9934322|NCT01313208|11051786|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
9934323|NCT01313208|11051787|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
9934324|NCT01313208|11051786|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
9934325|NCT01313208|11051787|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
9934326|NCT01313221|11051798|FG000|STARTED|Overall Study||144
9934327|NCT01313221|11051799|FG001|STARTED|Overall Study||143
9934328|NCT01313221|11051800|FG002|STARTED|Overall Study||23
9934329|NCT01313221|11051798|FG000|Randomized|Overall Study||144
9934330|NCT01313221|11051799|FG001|Randomized|Overall Study||143
9934331|NCT01313221|11051800|FG002|Randomized|Overall Study||0
9934332|NCT01313221|11051798|FG000|COMPLETED|Overall Study||132
9934333|NCT01313221|11051799|FG001|COMPLETED|Overall Study||135
9934334|NCT01313221|11051800|FG002|COMPLETED|Overall Study||0
9934335|NCT01313221|11051798|FG000|NOT COMPLETED|Overall Study||12
9934336|NCT01313221|11051799|FG001|NOT COMPLETED|Overall Study||8
9934337|NCT01313221|11051800|FG002|NOT COMPLETED|Overall Study||23
9934338|NCT01313286|11051808|FG000|STARTED|Period 1||8
9934339|NCT01313286|11051809|FG001|STARTED|Period 1||8
9934340|NCT01313286|11051808|FG000|COMPLETED|Period 1||6
9934341|NCT01313286|11051809|FG001|COMPLETED|Period 1||8
9934342|NCT01313286|11051808|FG000|NOT COMPLETED|Period 1||2
9934343|NCT01313286|11051809|FG001|NOT COMPLETED|Period 1||0
9934344|NCT01313286|11051808|FG000|STARTED|Period 2||6
9934345|NCT01313286|11051809|FG001|STARTED|Period 2||8
9934346|NCT01313286|11051808|FG000|COMPLETED|Period 2||6
9934347|NCT01313286|11051809|FG001|COMPLETED|Period 2||8
9934348|NCT01313286|11051808|FG000|NOT COMPLETED|Period 2||0
9934349|NCT01313286|11051809|FG001|NOT COMPLETED|Period 2||0
9934350|NCT01313299|11051818|FG000|STARTED|Overall Study||81
9934351|NCT01313299|11051819|FG001|STARTED|Overall Study||81
9934352|NCT01313299|11051820|FG002|STARTED|Overall Study||81
9934353|NCT01313299|11051818|FG000|COMPLETED|Overall Study||74
9934354|NCT01313299|11051819|FG001|COMPLETED|Overall Study||78
9934355|NCT01313299|11051820|FG002|COMPLETED|Overall Study||77
9934356|NCT01313299|11051818|FG000|NOT COMPLETED|Overall Study||7
9934357|NCT01313299|11051819|FG001|NOT COMPLETED|Overall Study||3
9934358|NCT01313299|11051820|FG002|NOT COMPLETED|Overall Study||4
9934359|NCT01313312|11051828|FG000|STARTED|Overall Study||258
9934360|NCT01313312|11051828|FG000|Cycle 1|Overall Study||254
9934361|NCT01313312|11051828|FG000|Cycle 2|Overall Study||229
9934362|NCT01313312|11051828|FG000|Cycle 3|Overall Study||175
9934363|NCT01313312|11051828|FG000|Cycle 4|Overall Study||81
9934364|NCT01313312|11051828|FG000|Cycle 5|Overall Study||11
9934365|NCT01313312|11051828|FG000|COMPLETED|Overall Study||222
9934366|NCT01313312|11051828|FG000|NOT COMPLETED|Overall Study||36
9934367|NCT01313494|11051834|FG000|STARTED|Overall Study||313
9934368|NCT01313494|11051835|FG001|STARTED|Overall Study||313
9934369|NCT01313494|11051834|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
9934370|NCT01313494|11051835|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
9934371|NCT01313494|11051834|FG000|COMPLETED|Overall Study||246
9934372|NCT01313494|11051835|FG001|COMPLETED|Overall Study||263
9934373|NCT01313494|11051834|FG000|NOT COMPLETED|Overall Study||67
9934374|NCT01313494|11051835|FG001|NOT COMPLETED|Overall Study||50
9934375|NCT01313507|11051841|FG000|STARTED|Overall Study||21
9934376|NCT01313507|11051841|FG000|COMPLETED|Overall Study||21
9934377|NCT01313507|11051841|FG000|NOT COMPLETED|Overall Study||0
9934378|NCT01313520|11051847|FG000|STARTED|Overall Study||30
9934379|NCT01313520|11051848|FG001|STARTED|Overall Study||31
9934380|NCT01313520|11051847|FG000|COMPLETED|Overall Study||30
9934381|NCT01313520|11051848|FG001|COMPLETED|Overall Study||31
9934382|NCT01313520|11051847|FG000|NOT COMPLETED|Overall Study||0
9934383|NCT01313520|11051848|FG001|NOT COMPLETED|Overall Study||0
9934384|NCT01313559|11051858|FG000|STARTED|Overall Study||4
9934385|NCT01313559|11051859|FG001|STARTED|Overall Study||2
9934386|NCT01313559|11051858|FG000|COMPLETED|Overall Study||0
9934387|NCT01313559|11051859|FG001|COMPLETED|Overall Study||0
9934388|NCT01313559|11051858|FG000|NOT COMPLETED|Overall Study||4
9934389|NCT01313559|11051859|FG001|NOT COMPLETED|Overall Study||2
9934390|NCT01313624|11051867|FG000|STARTED|Double-Blind Phase||134
9934391|NCT01313624|11051868|FG001|STARTED|Double-Blind Phase||132
9934392|NCT01313624|11051867|FG000|COMPLETED|Double-Blind Phase||96
9934393|NCT01313624|11051868|FG001|COMPLETED|Double-Blind Phase||122
9934394|NCT01313624|11051867|FG000|NOT COMPLETED|Double-Blind Phase||38
9934395|NCT01313624|11051868|FG001|NOT COMPLETED|Double-Blind Phase||10
9934396|NCT01313624|11051867|FG000|STARTED|Open-Label Phase||96
9934397|NCT01313624|11051868|FG001|STARTED|Open-Label Phase||122
9934398|NCT01313624|11051867|FG000|COMPLETED|Open-Label Phase||92
9934399|NCT01313624|11051868|FG001|COMPLETED|Open-Label Phase||109
10011108|NCT01778049|11133844|FG002|STARTED|Open Label Treatment Period||0
10011109|NCT01778049|11133845|FG003|STARTED|Open Label Treatment Period||0
10011110|NCT01778049|11133846|FG004|STARTED|Open Label Treatment Period||0
9934400|NCT01313624|11051867|FG000|NOT COMPLETED|Open-Label Phase||4
9934401|NCT01313624|11051868|FG001|NOT COMPLETED|Open-Label Phase||13
9934402|NCT01313637|11051880|FG000|STARTED|Overall Study||275
9934403|NCT01313637|11051881|FG001|STARTED|Overall Study||407
9934404|NCT01313637|11051882|FG002|STARTED|Overall Study||404
9934405|NCT01313637|11051883|FG003|STARTED|Overall Study||403
9934406|NCT01313637|11051880|FG000|COMPLETED|Overall Study||183
9934407|NCT01313637|11051881|FG001|COMPLETED|Overall Study||312
9934408|NCT01313637|11051882|FG002|COMPLETED|Overall Study||298
9934409|NCT01313637|11051883|FG003|COMPLETED|Overall Study||325
9934410|NCT01313637|11051880|FG000|NOT COMPLETED|Overall Study||92
9934411|NCT01313637|11051881|FG001|NOT COMPLETED|Overall Study||95
9934412|NCT01313637|11051882|FG002|NOT COMPLETED|Overall Study||106
9934413|NCT01313637|11051883|FG003|NOT COMPLETED|Overall Study||78
9934414|NCT01313650|11051897|FG000|STARTED|Overall Study||280
9934415|NCT01313650|11051898|FG001|STARTED|Overall Study||418
9934416|NCT01313650|11051899|FG002|STARTED|Overall Study||421
9934417|NCT01313650|11051900|FG003|STARTED|Overall Study||413
9934418|NCT01313650|11051897|FG000|COMPLETED|Overall Study||204
9934419|NCT01313650|11051898|FG001|COMPLETED|Overall Study||324
9934420|NCT01313650|11051899|FG002|COMPLETED|Overall Study||318
9934421|NCT01313650|11051900|FG003|COMPLETED|Overall Study||332
9934422|NCT01313650|11051897|FG000|NOT COMPLETED|Overall Study||76
9934423|NCT01313650|11051898|FG001|NOT COMPLETED|Overall Study||94
9934424|NCT01313650|11051899|FG002|NOT COMPLETED|Overall Study||103
9934425|NCT01313650|11051900|FG003|NOT COMPLETED|Overall Study||81
9934426|NCT01313663|11051912|FG000|STARTED|Overall Study||9
9934427|NCT01313663|11051913|FG001|STARTED|Overall Study||11
9934428|NCT01313663|11051912|FG000|COMPLETED|Overall Study||5
9934429|NCT01313663|11051913|FG001|COMPLETED|Overall Study||3
9934430|NCT01313663|11051912|FG000|NOT COMPLETED|Overall Study||4
9934431|NCT01313663|11051913|FG001|NOT COMPLETED|Overall Study||8
9956390|NCT01445652|11075611|FG000|NOT COMPLETED|Overall Study||10
9956391|NCT01445652|11075612|FG001|NOT COMPLETED|Overall Study||3
9956392|NCT01445678|11075620|FG000|STARTED|Overall Study||482
9956393|NCT01445678|11075621|FG001|STARTED|Overall Study||497
9956394|NCT01445678|11075620|FG000|COMPLETED|Overall Study||452
9956395|NCT01445678|11075621|FG001|COMPLETED|Overall Study||476
9956396|NCT01445678|11075620|FG000|NOT COMPLETED|Overall Study||30
9956397|NCT01445678|11075621|FG001|NOT COMPLETED|Overall Study||21
9956398|NCT01445730|11075627|FG000|STARTED|Overall Study||82
9956399|NCT01445730|11075627|FG000|COMPLETED|Overall Study||71
9956400|NCT01445730|11075627|FG000|NOT COMPLETED|Overall Study||11
9956401|NCT01445769|11075631|FG000|STARTED|Overall Study||45
9956402|NCT01445769|11075631|FG000|COMPLETED|Overall Study||37
9956403|NCT01445769|11075631|FG000|NOT COMPLETED|Overall Study||8
9956404|NCT01445821|11075639|FG000|STARTED|Overall Study||22
9956405|NCT01445821|11075640|FG001|STARTED|Overall Study||22
9956406|NCT01445821|11075639|FG000|COMPLETED|Overall Study||22
9956407|NCT01445821|11075640|FG001|COMPLETED|Overall Study||22
9956408|NCT01445821|11075639|FG000|NOT COMPLETED|Overall Study||0
9956409|NCT01445821|11075640|FG001|NOT COMPLETED|Overall Study||0
9956410|NCT01445847|11075648|FG000|STARTED|Overall Study||50
9956411|NCT01445847|11075649|FG001|STARTED|Overall Study||50
9956412|NCT01445847|11075648|FG000|COMPLETED|Overall Study||36
9956413|NCT01445847|11075649|FG001|COMPLETED|Overall Study||36
9956414|NCT01445847|11075648|FG000|NOT COMPLETED|Overall Study||14
9956415|NCT01445847|11075649|FG001|NOT COMPLETED|Overall Study||14
9956416|NCT01445873|11075655|FG000|STARTED|Overall Study||36
9956417|NCT01445873|11075655|FG000|COMPLETED|Overall Study||36
9956418|NCT01445873|11075655|FG000|NOT COMPLETED|Overall Study||0
9956419|NCT01445886|11075659|FG000|STARTED|Overall Study||33
9956420|NCT01445886|11075659|FG000|COMPLETED|Overall Study||28
9956421|NCT01445886|11075659|FG000|NOT COMPLETED|Overall Study||5
9956422|NCT01445951|11075668|FG000|STARTED|Overall Study||174
9956423|NCT01445951|11075669|FG001|STARTED|Overall Study||174
9956424|NCT01445951|11075670|FG002|STARTED|Overall Study||170
9956425|NCT01445951|11075668|FG000|COMPLETED|Overall Study||130
10011111|NCT01778049|11133847|FG005|STARTED|Open Label Treatment Period||0
10011112|NCT01778049|11133842|FG000|COMPLETED|Open Label Treatment Period||256
10011113|NCT01778049|11133843|FG001|COMPLETED|Open Label Treatment Period||226
10011114|NCT01778049|11133844|FG002|COMPLETED|Open Label Treatment Period||0
10011115|NCT01778049|11133845|FG003|COMPLETED|Open Label Treatment Period||0
10011116|NCT01778049|11133846|FG004|COMPLETED|Open Label Treatment Period||0
10011117|NCT01778049|11133847|FG005|COMPLETED|Open Label Treatment Period||0
9956426|NCT01445951|11075669|FG001|COMPLETED|Overall Study||138
9956427|NCT01445951|11075670|FG002|COMPLETED|Overall Study||151
9956428|NCT01445951|11075668|FG000|NOT COMPLETED|Overall Study||44
9956429|NCT01445951|11075669|FG001|NOT COMPLETED|Overall Study||36
9956430|NCT01445951|11075670|FG002|NOT COMPLETED|Overall Study||19
9956431|NCT01446003|11075678|FG000|STARTED|Period 1||16
9956432|NCT01446003|11075679|FG001|STARTED|Period 1||15
9956433|NCT01446003|11075678|FG000|COMPLETED|Period 1||14
9956434|NCT01446003|11075679|FG001|COMPLETED|Period 1||15
9956435|NCT01446003|11075678|FG000|NOT COMPLETED|Period 1||2
9956436|NCT01446003|11075679|FG001|NOT COMPLETED|Period 1||0
9956437|NCT01446003|11075678|FG000|STARTED|Period 2||14
9956438|NCT01446003|11075679|FG001|STARTED|Period 2||15
9956439|NCT01446003|11075678|FG000|COMPLETED|Period 2||13
9956440|NCT01446003|11075679|FG001|COMPLETED|Period 2||15
9956441|NCT01446003|11075678|FG000|NOT COMPLETED|Period 2||1
9956442|NCT01446003|11075679|FG001|NOT COMPLETED|Period 2||0
9956443|NCT01446042|11075688|FG000|STARTED|Overall Study||142
9956444|NCT01446042|11075689|FG001|STARTED|Overall Study||86
9956445|NCT01446042|11075690|FG002|STARTED|Overall Study||78
9956446|NCT01446042|11075688|FG000|COMPLETED|Overall Study||122
9956447|NCT01446042|11075689|FG001|COMPLETED|Overall Study||83
10011118|NCT01778049|11133842|FG000|NOT COMPLETED|Open Label Treatment Period||98
9956448|NCT01446042|11075690|FG002|COMPLETED|Overall Study||69
9956449|NCT01446042|11075688|FG000|NOT COMPLETED|Overall Study||20
9956450|NCT01446042|11075689|FG001|NOT COMPLETED|Overall Study||3
9956451|NCT01446042|11075690|FG002|NOT COMPLETED|Overall Study||9
9956452|NCT01446159|11075702|FG000|STARTED|Overall Study||3
9956453|NCT01446159|11075703|FG001|STARTED|Overall Study||3
9956454|NCT01446159|11075704|FG002|STARTED|Overall Study||92
9956455|NCT01446159|11075705|FG003|STARTED|Overall Study||85
9956456|NCT01446159|11075702|FG000|COMPLETED|Overall Study||0
9956457|NCT01446159|11075703|FG001|COMPLETED|Overall Study||0
9956458|NCT01446159|11075704|FG002|COMPLETED|Overall Study||21
9956459|NCT01446159|11075705|FG003|COMPLETED|Overall Study||23
9956460|NCT01446159|11075702|FG000|NOT COMPLETED|Overall Study||3
9934432|NCT01313676|11051923|FG000|STARTED|Overall Study||4131
9934433|NCT01313676|11051924|FG001|STARTED|Overall Study||4157
9934434|NCT01313676|11051925|FG002|STARTED|Overall Study||4140
9934435|NCT01313676|11051926|FG003|STARTED|Overall Study||4140
9934436|NCT01313676|11051923|FG000|COMPLETED|Overall Study||2881
9934437|NCT01313676|11051924|FG001|COMPLETED|Overall Study||3044
9934438|NCT01313676|11051925|FG002|COMPLETED|Overall Study||3052
9934439|NCT01313676|11051926|FG003|COMPLETED|Overall Study||3146
9934440|NCT01313676|11051923|FG000|NOT COMPLETED|Overall Study||1250
9934441|NCT01313676|11051924|FG001|NOT COMPLETED|Overall Study||1113
9934442|NCT01313676|11051925|FG002|NOT COMPLETED|Overall Study||1088
9934443|NCT01313676|11051926|FG003|NOT COMPLETED|Overall Study||994
9934444|NCT01313728|11051937|FG000|STARTED|Informed Consent to Baseline||26
9934445|NCT01313728|11051937|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
9934446|NCT01313728|11051937|FG000|NOT COMPLETED|Informed Consent to Baseline||1
9934447|NCT01313728|11051937|FG000|STARTED|Baseline to Completion||25
9934448|NCT01313728|11051937|FG000|COMPLETED|Baseline to Completion||25
9934449|NCT01313728|11051937|FG000|NOT COMPLETED|Baseline to Completion||0
9934450|NCT01313767|11051944|FG000|STARTED|Overall Study||98
9934451|NCT01313767|11051945|FG001|STARTED|Overall Study||98
9934452|NCT01313767|11051944|FG000|COMPLETED|Overall Study||91
9934453|NCT01313767|11051945|FG001|COMPLETED|Overall Study||96
9934454|NCT01313767|11051944|FG000|NOT COMPLETED|Overall Study||7
9934455|NCT01313767|11051945|FG001|NOT COMPLETED|Overall Study||2
9934456|NCT01313780|11051953|FG000|STARTED|Overall Study|FAS|58
9934457|NCT01313780|11051954|FG001|STARTED|Overall Study|FAS|59
9934458|NCT01313780|11051953|FG000|COMPLETED|Overall Study|PPS|33
9934459|NCT01313780|11051954|FG001|COMPLETED|Overall Study|PPS|31
9934460|NCT01313780|11051953|FG000|NOT COMPLETED|Overall Study||25
9934461|NCT01313780|11051954|FG001|NOT COMPLETED|Overall Study||28
9934462|NCT01313858|11051963|FG000|STARTED|Overall Study||524
9934463|NCT01313858|11051964|FG001|STARTED|Overall Study||546
9934464|NCT01313858|11051965|FG002|STARTED|Overall Study||543
9934465|NCT01313858|11051963|FG000|COMPLETED|Overall Study||238
9934466|NCT01313858|11051964|FG001|COMPLETED|Overall Study||276
9934467|NCT01313858|11051965|FG002|COMPLETED|Overall Study||305
9934468|NCT01313858|11051963|FG000|NOT COMPLETED|Overall Study||286
9934469|NCT01313858|11051964|FG001|NOT COMPLETED|Overall Study||270
9934470|NCT01313858|11051965|FG002|NOT COMPLETED|Overall Study||238
9934471|NCT01313884|11051971|FG000|STARTED|Overall Study||3
9934472|NCT01313884|11051971|FG000|COMPLETED|Overall Study||2
9934473|NCT01313884|11051971|FG000|NOT COMPLETED|Overall Study||1
9934474|NCT01313897|11051975|FG000|STARTED|Overall Study||10
9934475|NCT01313897|11051975|FG000|COMPLETED|Overall Study||8
9934476|NCT01313897|11051975|FG000|NOT COMPLETED|Overall Study||2
9934477|NCT01313910|11051979|FG000|STARTED|Overall Study||8
9934478|NCT01313910|11051979|FG000|COMPLETED|Overall Study||8
9934479|NCT01313910|11051979|FG000|NOT COMPLETED|Overall Study||0
9934480|NCT01313936|11051985|FG000|STARTED|Overall Study||6
9934481|NCT01313936|11051986|FG001|STARTED|Overall Study||26
9934482|NCT01313936|11051985|FG000|COMPLETED|Overall Study||6
9934483|NCT01313936|11051986|FG001|COMPLETED|Overall Study||26
9934484|NCT01313936|11051985|FG000|NOT COMPLETED|Overall Study||0
9934485|NCT01313936|11051986|FG001|NOT COMPLETED|Overall Study||0
9934486|NCT01314001|11052001|FG000|STARTED|Overall Study||215
9934487|NCT01314001|11052002|FG001|STARTED|Overall Study||193
9934488|NCT01314001|11052003|FG002|STARTED|Overall Study||227
9934489|NCT01314001|11052004|FG003|STARTED|Overall Study||191
9934490|NCT01314001|11052005|FG004|STARTED|Overall Study||220
9934491|NCT01314001|11052006|FG005|STARTED|Overall Study||200
9934492|NCT01314001|11052001|FG000|End-of-Treatment Visit|Overall Study||156
9934493|NCT01314001|11052002|FG001|End-of-Treatment Visit|Overall Study||141
9934494|NCT01314001|11052003|FG002|End-of-Treatment Visit|Overall Study||179
9934495|NCT01314001|11052004|FG003|End-of-Treatment Visit|Overall Study||146
9934496|NCT01314001|11052005|FG004|End-of-Treatment Visit|Overall Study||174
9934497|NCT01314001|11052006|FG005|End-of-Treatment Visit|Overall Study||160
9934498|NCT01314001|11052001|FG000|6-Month Follow Up Survey|Overall Study||146
9934499|NCT01314001|11052002|FG001|6-Month Follow Up Survey|Overall Study||137
9934500|NCT01314001|11052003|FG002|6-Month Follow Up Survey|Overall Study||165
9934501|NCT01314001|11052004|FG003|6-Month Follow Up Survey|Overall Study||135
9934502|NCT01314001|11052005|FG004|6-Month Follow Up Survey|Overall Study||157
9934503|NCT01314001|11052006|FG005|6-Month Follow Up Survey|Overall Study||139
9934504|NCT01314001|11052001|FG000|COMPLETED|Overall Study||140
9934505|NCT01314001|11052002|FG001|COMPLETED|Overall Study||124
9934506|NCT01314001|11052003|FG002|COMPLETED|Overall Study||158
9934507|NCT01314001|11052004|FG003|COMPLETED|Overall Study||122
9934508|NCT01314001|11052005|FG004|COMPLETED|Overall Study||148
9934509|NCT01314001|11052006|FG005|COMPLETED|Overall Study||129
9934510|NCT01314001|11052001|FG000|NOT COMPLETED|Overall Study||75
9934511|NCT01314001|11052002|FG001|NOT COMPLETED|Overall Study||69
9934512|NCT01314001|11052003|FG002|NOT COMPLETED|Overall Study||69
9934513|NCT01314001|11052004|FG003|NOT COMPLETED|Overall Study||69
9934514|NCT01314001|11052005|FG004|NOT COMPLETED|Overall Study||72
9934515|NCT01314001|11052006|FG005|NOT COMPLETED|Overall Study||71
9934516|NCT01314014|11052020|FG000|STARTED|Overall Study||22
9934517|NCT01314014|11052020|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
9934518|NCT01314014|11052020|FG000|NOT COMPLETED|Overall Study||0
9934519|NCT01314105|11052026|FG000|STARTED|Overall Study||7
9934520|NCT01314105|11052027|FG001|STARTED|Overall Study||12
9934521|NCT01314105|11052026|FG000|COMPLETED|Overall Study||0
9934522|NCT01314105|11052027|FG001|COMPLETED|Overall Study||0
9934523|NCT01314105|11052026|FG000|NOT COMPLETED|Overall Study||7
9934524|NCT01314105|11052027|FG001|NOT COMPLETED|Overall Study||12
9934525|NCT01314261|11052039|FG000|STARTED|Overall Study||9
9934526|NCT01314261|11052040|FG001|STARTED|Overall Study||9
9934527|NCT01314261|11052041|FG002|STARTED|Overall Study||10
9934528|NCT01314261|11052042|FG003|STARTED|Overall Study||9
9934529|NCT01314261|11052039|FG000|Discontinued ABT-267 or Placebo|Overall Study||1
9934530|NCT01314261|11052040|FG001|Discontinued ABT-267 or Placebo|Overall Study||0
9934531|NCT01314261|11052041|FG002|Discontinued ABT-267 or Placebo|Overall Study||1
9934532|NCT01314261|11052042|FG003|Discontinued ABT-267 or Placebo|Overall Study||0
9934533|NCT01314261|11052039|FG000|Discontinued pegIFN/RBV|Overall Study||1
9934534|NCT01314261|11052040|FG001|Discontinued pegIFN/RBV|Overall Study||4
9934535|NCT01314261|11052041|FG002|Discontinued pegIFN/RBV|Overall Study||5
9934536|NCT01314261|11052042|FG003|Discontinued pegIFN/RBV|Overall Study||1
9934537|NCT01314261|11052039|FG000|COMPLETED|Overall Study||7
9934538|NCT01314261|11052040|FG001|COMPLETED|Overall Study||5
9934539|NCT01314261|11052041|FG002|COMPLETED|Overall Study||7
9934540|NCT01314261|11052042|FG003|COMPLETED|Overall Study||6
9934541|NCT01314261|11052039|FG000|NOT COMPLETED|Overall Study||2
9934542|NCT01314261|11052040|FG001|NOT COMPLETED|Overall Study||4
9934543|NCT01314261|11052041|FG002|NOT COMPLETED|Overall Study||3
9934544|NCT01314261|11052042|FG003|NOT COMPLETED|Overall Study||3
9934545|NCT01314313|11052054|FG000|STARTED|Overall Study||1011
9934546|NCT01314313|11052055|FG001|STARTED|Overall Study||1021
9934547|NCT01314313|11052054|FG000|As Treated|Overall Study||994
9934548|NCT01314313|11052055|FG001|As Treated|Overall Study||944
9934549|NCT01314313|11052054|FG000|Valve Implanted|Overall Study||974
9934550|NCT01314313|11052055|FG001|Valve Implanted|Overall Study||936
9934551|NCT01314313|11052054|FG000|COMPLETED|Overall Study||784
9934552|NCT01314313|11052055|FG001|COMPLETED|Overall Study||710
9934553|NCT01314313|11052054|FG000|NOT COMPLETED|Overall Study||227
9934554|NCT01314313|11052055|FG001|NOT COMPLETED|Overall Study||311
9934555|NCT01314417|11052063|FG000|STARTED|Overall Study||2
9934556|NCT01314417|11052063|FG000|COMPLETED|Overall Study||2
9934557|NCT01314417|11052063|FG000|NOT COMPLETED|Overall Study||0
9934558|NCT01314443|11052071|FG000|STARTED|Overall Study||18
9934559|NCT01314443|11052072|FG001|STARTED|Overall Study||19
9934560|NCT01314443|11052073|FG002|STARTED|Overall Study||15
9934561|NCT01314443|11052074|FG003|STARTED|Overall Study||15
9934562|NCT01314443|11052071|FG000|COMPLETED|Overall Study||14
9934563|NCT01314443|11052072|FG001|COMPLETED|Overall Study||16
9934564|NCT01314443|11052073|FG002|COMPLETED|Overall Study||13
9934565|NCT01314443|11052074|FG003|COMPLETED|Overall Study||13
9934566|NCT01314443|11052071|FG000|NOT COMPLETED|Overall Study||4
9934567|NCT01314443|11052072|FG001|NOT COMPLETED|Overall Study||3
9934568|NCT01314443|11052073|FG002|NOT COMPLETED|Overall Study||2
9934569|NCT01314443|11052074|FG003|NOT COMPLETED|Overall Study||2
10206987|NCT03520387|11333827|FG000|STARTED|Pre-Randomization||16
10206988|NCT03520387|11333828|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10206989|NCT03520387|11333829|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10206990|NCT03520387|11333830|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10206991|NCT03520387|11333831|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10206992|NCT03520387|11333827|FG000|COMPLETED|Pre-Randomization||13
10206993|NCT03520387|11333828|FG001|COMPLETED|Pre-Randomization||0
10206994|NCT03520387|11333829|FG002|COMPLETED|Pre-Randomization||0
10206995|NCT03520387|11333830|FG003|COMPLETED|Pre-Randomization||0
10206996|NCT03520387|11333831|FG004|COMPLETED|Pre-Randomization||0
10206997|NCT03520387|11333827|FG000|NOT COMPLETED|Pre-Randomization||3
10206998|NCT03520387|11333828|FG001|NOT COMPLETED|Pre-Randomization||0
10206999|NCT03520387|11333829|FG002|NOT COMPLETED|Pre-Randomization||0
9934570|NCT01314703|11052084|FG000|STARTED|Overall Study||35
9934571|NCT01314703|11052084|FG000|Signed Informed Consent|Overall Study||35
9934572|NCT01314703|11052084|FG000|Completed Screen Visit|Overall Study||33
9934573|NCT01314703|11052084|FG000|Completed Treatment Visit|Overall Study||27
9934574|NCT01314703|11052084|FG000|Completed Study|Overall Study||27
9934575|NCT01314703|11052084|FG000|Excluded Prior to Screening Baseline|Overall Study||2
9934576|NCT01314703|11052084|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3
9934577|NCT01314703|11052084|FG000|Discontinued When Enrollment Completed|Overall Study||3
9934578|NCT01314703|11052084|FG000|COMPLETED|Overall Study||27
9934579|NCT01314703|11052084|FG000|NOT COMPLETED|Overall Study||8
9934580|NCT01314716|11052091|FG000|STARTED|Double-Blind Phase||136
9934581|NCT01314716|11052092|FG001|STARTED|Double-Blind Phase||138
9934582|NCT01314716|11052091|FG000|Randomized and Treated|Double-Blind Phase||135
9934583|NCT01314716|11052092|FG001|Randomized and Treated|Double-Blind Phase||137
9934584|NCT01314716|11052091|FG000|COMPLETED|Double-Blind Phase||119
9934585|NCT01314716|11052092|FG001|COMPLETED|Double-Blind Phase||123
9934586|NCT01314716|11052091|FG000|NOT COMPLETED|Double-Blind Phase||17
9934587|NCT01314716|11052092|FG001|NOT COMPLETED|Double-Blind Phase||15
9934588|NCT01314716|11052091|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
9934589|NCT01314716|11052092|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
9934590|NCT01314716|11052091|FG000|COMPLETED|Open-Label Phase||102
9934591|NCT01314716|11052092|FG001|COMPLETED|Open-Label Phase||98
9934592|NCT01314716|11052091|FG000|NOT COMPLETED|Open-Label Phase||10
9934593|NCT01314716|11052092|FG001|NOT COMPLETED|Open-Label Phase||12
9934594|NCT01314742|11052102|FG000|STARTED|Overall Study||20
9934595|NCT01314742|11052103|FG001|STARTED|Overall Study||21
9934596|NCT01314742|11052102|FG000|COMPLETED|Overall Study||20
9934597|NCT01314742|11052103|FG001|COMPLETED|Overall Study||21
9934598|NCT01314742|11052102|FG000|NOT COMPLETED|Overall Study||0
9934599|NCT01314742|11052103|FG001|NOT COMPLETED|Overall Study||0
9934600|NCT01314872|11052122|FG000|STARTED|Treatment Period 1||141
9934601|NCT01314872|11052123|FG001|STARTED|Treatment Period 1||144
9934602|NCT01314872|11052124|FG002|STARTED|Treatment Period 1||134
9934603|NCT01314872|11052125|FG003|STARTED|Treatment Period 1||150
9934604|NCT01314872|11052126|FG004|STARTED|Treatment Period 1||149
9934605|NCT01314872|11052127|FG005|STARTED|Treatment Period 1||135
10207000|NCT03520387|11333830|FG003|NOT COMPLETED|Pre-Randomization||0
10207001|NCT03520387|11333831|FG004|NOT COMPLETED|Pre-Randomization||0
10207002|NCT03520387|11333827|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0
10238801|NCT00470067|11370209|FG000|STARTED|Overall Study||9
9934606|NCT01314872|11052128|FG006|STARTED|Treatment Period 1||134
9934607|NCT01314872|11052129|FG007|STARTED|Treatment Period 1||64
9934608|NCT01314872|11052130|FG008|STARTED|Treatment Period 1||112
9934609|NCT01314872|11052131|FG009|STARTED|Treatment Period 1||122
9934610|NCT01314872|11052132|FG010|STARTED|Treatment Period 1||110
9934611|NCT01314872|11052133|FG011|STARTED|Treatment Period 1||0
9934612|NCT01314872|11052134|FG012|STARTED|Treatment Period 1||0
9934613|NCT01314872|11052135|FG013|STARTED|Treatment Period 1||0
9934614|NCT01314872|11052136|FG014|STARTED|Treatment Period 1||0
9934615|NCT01314872|11052122|FG000|COMPLETED|Treatment Period 1||131
9934616|NCT01314872|11052123|FG001|COMPLETED|Treatment Period 1||138
9934617|NCT01314872|11052124|FG002|COMPLETED|Treatment Period 1||128
9934618|NCT01314872|11052125|FG003|COMPLETED|Treatment Period 1||143
9934619|NCT01314872|11052126|FG004|COMPLETED|Treatment Period 1||142
9934620|NCT01314872|11052127|FG005|COMPLETED|Treatment Period 1||128
9934621|NCT01314872|11052128|FG006|COMPLETED|Treatment Period 1||126
9934622|NCT01314872|11052129|FG007|COMPLETED|Treatment Period 1||57
9934623|NCT01314872|11052130|FG008|COMPLETED|Treatment Period 1||106
9934624|NCT01314872|11052131|FG009|COMPLETED|Treatment Period 1||118
9934625|NCT01314872|11052132|FG010|COMPLETED|Treatment Period 1||107
9934626|NCT01314872|11052133|FG011|COMPLETED|Treatment Period 1||0
9934627|NCT01314872|11052134|FG012|COMPLETED|Treatment Period 1||0
9934628|NCT01314872|11052135|FG013|COMPLETED|Treatment Period 1||0
9934629|NCT01314872|11052136|FG014|COMPLETED|Treatment Period 1||0
9934630|NCT01314872|11052122|FG000|NOT COMPLETED|Treatment Period 1||10
9934631|NCT01314872|11052123|FG001|NOT COMPLETED|Treatment Period 1||6
9934632|NCT01314872|11052124|FG002|NOT COMPLETED|Treatment Period 1||6
9934633|NCT01314872|11052125|FG003|NOT COMPLETED|Treatment Period 1||7
9934634|NCT01314872|11052126|FG004|NOT COMPLETED|Treatment Period 1||7
9934635|NCT01314872|11052127|FG005|NOT COMPLETED|Treatment Period 1||7
9934636|NCT01314872|11052128|FG006|NOT COMPLETED|Treatment Period 1||8
9934637|NCT01314872|11052129|FG007|NOT COMPLETED|Treatment Period 1||7
9934638|NCT01314872|11052130|FG008|NOT COMPLETED|Treatment Period 1||6
10238802|NCT00470067|11370209|FG000|COMPLETED|Overall Study||2
9934639|NCT01314872|11052131|FG009|NOT COMPLETED|Treatment Period 1||4
9934640|NCT01314872|11052132|FG010|NOT COMPLETED|Treatment Period 1||3
9934641|NCT01314872|11052133|FG011|NOT COMPLETED|Treatment Period 1||0
9934642|NCT01314872|11052134|FG012|NOT COMPLETED|Treatment Period 1||0
9934643|NCT01314872|11052135|FG013|NOT COMPLETED|Treatment Period 1||0
9934644|NCT01314872|11052136|FG014|NOT COMPLETED|Treatment Period 1||0
9934645|NCT01314872|11052122|FG000|STARTED|Period 2||0
9934646|NCT01314872|11052123|FG001|STARTED|Period 2||0
9934647|NCT01314872|11052124|FG002|STARTED|Period 2||0
9934648|NCT01314872|11052125|FG003|STARTED|Period 2||0
9934649|NCT01314872|11052126|FG004|STARTED|Period 2||0
9934650|NCT01314872|11052127|FG005|STARTED|Period 2||0
9934651|NCT01314872|11052128|FG006|STARTED|Period 2||0
9934652|NCT01314872|11052129|FG007|STARTED|Period 2||0
9934653|NCT01314872|11052130|FG008|STARTED|Period 2||0
9934654|NCT01314872|11052131|FG009|STARTED|Period 2||0
9934655|NCT01314872|11052132|FG010|STARTED|Period 2||0
10238803|NCT00470067|11370209|FG000|NOT COMPLETED|Overall Study||7
10238804|NCT00476827|11370219|FG000|STARTED|Overall Study||3
9934656|NCT01314872|11052133|FG011|STARTED|Period 2||223
9934657|NCT01314872|11052134|FG012|STARTED|Period 2||248
9934658|NCT01314872|11052135|FG013|STARTED|Period 2||240
9934659|NCT01314872|11052136|FG014|STARTED|Period 2||134
9934660|NCT01314872|11052122|FG000|COMPLETED|Period 2||0
9934661|NCT01314872|11052123|FG001|COMPLETED|Period 2||0
9934662|NCT01314872|11052124|FG002|COMPLETED|Period 2||0
9934663|NCT01314872|11052125|FG003|COMPLETED|Period 2||0
9934664|NCT01314872|11052126|FG004|COMPLETED|Period 2||0
9934665|NCT01314872|11052127|FG005|COMPLETED|Period 2||0
9934666|NCT01314872|11052128|FG006|COMPLETED|Period 2||0
9934667|NCT01314872|11052129|FG007|COMPLETED|Period 2||0
9934668|NCT01314872|11052130|FG008|COMPLETED|Period 2||0
9934669|NCT01314872|11052131|FG009|COMPLETED|Period 2||0
9934670|NCT01314872|11052132|FG010|COMPLETED|Period 2||0
9934671|NCT01314872|11052133|FG011|COMPLETED|Period 2||175
9934672|NCT01314872|11052134|FG012|COMPLETED|Period 2||188
9934673|NCT01314872|11052135|FG013|COMPLETED|Period 2||187
9934674|NCT01314872|11052136|FG014|COMPLETED|Period 2||110
9934675|NCT01314872|11052122|FG000|NOT COMPLETED|Period 2||0
9934676|NCT01314872|11052123|FG001|NOT COMPLETED|Period 2||0
9934677|NCT01314872|11052124|FG002|NOT COMPLETED|Period 2||0
9934678|NCT01314872|11052125|FG003|NOT COMPLETED|Period 2||0
9934679|NCT01314872|11052126|FG004|NOT COMPLETED|Period 2||0
9934680|NCT01314872|11052127|FG005|NOT COMPLETED|Period 2||0
9934681|NCT01314872|11052128|FG006|NOT COMPLETED|Period 2||0
9934682|NCT01314872|11052129|FG007|NOT COMPLETED|Period 2||0
9934683|NCT01314872|11052130|FG008|NOT COMPLETED|Period 2||0
9934684|NCT01314872|11052131|FG009|NOT COMPLETED|Period 2||0
9934685|NCT01314872|11052132|FG010|NOT COMPLETED|Period 2||0
9934686|NCT01314872|11052133|FG011|NOT COMPLETED|Period 2||48
9934687|NCT01314872|11052134|FG012|NOT COMPLETED|Period 2||60
9934688|NCT01314872|11052135|FG013|NOT COMPLETED|Period 2||53
9934689|NCT01314872|11052136|FG014|NOT COMPLETED|Period 2||24
9934690|NCT01314911|11052170|FG000|STARTED|Overall Study||278
9934691|NCT01314911|11052171|FG001|STARTED|Overall Study||280
9934692|NCT01314911|11052170|FG000|COMPLETED|Overall Study||273
9934693|NCT01314911|11052171|FG001|COMPLETED|Overall Study||274
9934694|NCT01314911|11052170|FG000|NOT COMPLETED|Overall Study||5
9934695|NCT01314911|11052171|FG001|NOT COMPLETED|Overall Study||6
9934696|NCT01314963|11052177|FG000|STARTED|Overall Study||50
9934697|NCT01314963|11052177|FG000|COMPLETED|Overall Study||50
9934698|NCT01314963|11052177|FG000|NOT COMPLETED|Overall Study||0
9934699|NCT01315002|11052183|FG000|STARTED|Overall Study||61
9934700|NCT01315002|11052184|FG001|STARTED|Overall Study||60
9934701|NCT01315002|11052183|FG000|COMPLETED|Overall Study||56
9934702|NCT01315002|11052184|FG001|COMPLETED|Overall Study||55
9934703|NCT01315002|11052183|FG000|NOT COMPLETED|Overall Study||5
9934704|NCT01315002|11052184|FG001|NOT COMPLETED|Overall Study||5
9934705|NCT01315028|11052192|FG000|STARTED|Overall Study||10
9934706|NCT01315028|11052193|FG001|STARTED|Overall Study||10
9934707|NCT01315028|11052192|FG000|COMPLETED|Overall Study||9
9934708|NCT01315028|11052193|FG001|COMPLETED|Overall Study||9
9934709|NCT01315028|11052192|FG000|NOT COMPLETED|Overall Study||1
9934710|NCT01315028|11052193|FG001|NOT COMPLETED|Overall Study||1
9934711|NCT01315132|11052199|FG000|STARTED|Overall Study||47
9934712|NCT01315132|11052199|FG000|COMPLETED|Overall Study||46
9934713|NCT01315132|11052199|FG000|NOT COMPLETED|Overall Study||1
9934714|NCT01315145|11052205|FG000|STARTED|Overall Study||122
9934715|NCT01315145|11052206|FG001|STARTED|Overall Study||16
9934716|NCT01315145|11052205|FG000|COMPLETED|Overall Study||105
9934717|NCT01315145|11052206|FG001|COMPLETED|Overall Study||11
9934718|NCT01315145|11052205|FG000|NOT COMPLETED|Overall Study||17
10207003|NCT03520387|11333828|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4
9934719|NCT01315145|11052206|FG001|NOT COMPLETED|Overall Study||5
9934720|NCT01315158|11052214|FG000|STARTED|Overall Study||17
9934721|NCT01315158|11052215|FG001|STARTED|Overall Study||19
9934722|NCT01315158|11052214|FG000|COMPLETED|Overall Study||17
9934723|NCT01315158|11052215|FG001|COMPLETED|Overall Study||19
9934724|NCT01315158|11052214|FG000|NOT COMPLETED|Overall Study||0
9934725|NCT01315158|11052215|FG001|NOT COMPLETED|Overall Study||0
9934726|NCT01315236|11052223|FG000|STARTED|Double-blind Phase||44
9934727|NCT01315236|11052224|FG001|STARTED|Double-blind Phase||45
9934728|NCT01315236|11052223|FG000|COMPLETED|Double-blind Phase||40
9934729|NCT01315236|11052224|FG001|COMPLETED|Double-blind Phase||45
9934730|NCT01315236|11052223|FG000|NOT COMPLETED|Double-blind Phase||4
9934731|NCT01315236|11052224|FG001|NOT COMPLETED|Double-blind Phase||0
9934732|NCT01315236|11052223|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
9934733|NCT01315236|11052224|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
9934734|NCT01315236|11052223|FG000|COMPLETED|Open-label Phase||34
9934735|NCT01315236|11052224|FG001|COMPLETED|Open-label Phase||41
9934736|NCT01315236|11052223|FG000|NOT COMPLETED|Open-label Phase||1
9934737|NCT01315236|11052224|FG001|NOT COMPLETED|Open-label Phase||2
9934738|NCT01315236|11052223|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
9934739|NCT01315236|11052224|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
9934740|NCT01315236|11052223|FG000|COMPLETED|12-Month Follow-up Period||26
9934741|NCT01315236|11052224|FG001|COMPLETED|12-Month Follow-up Period||31
9934742|NCT01315236|11052223|FG000|NOT COMPLETED|12-Month Follow-up Period||1
9934743|NCT01315236|11052224|FG001|NOT COMPLETED|12-Month Follow-up Period||1
9934744|NCT01315249|11052234|FG000|STARTED|Overall Study||259
9934745|NCT01315249|11052235|FG001|STARTED|Overall Study||264
9934746|NCT01315249|11052234|FG000|COMPLETED|Overall Study||215
9934747|NCT01315249|11052235|FG001|COMPLETED|Overall Study||217
9934748|NCT01315249|11052234|FG000|NOT COMPLETED|Overall Study||44
9934749|NCT01315249|11052235|FG001|NOT COMPLETED|Overall Study||47
9934750|NCT01315574|11052243|FG000|STARTED|Overall Study||7
9934751|NCT01315574|11052244|FG001|STARTED|Overall Study||7
9934752|NCT01315574|11052243|FG000|COMPLETED|Overall Study||7
9934753|NCT01315574|11052244|FG001|COMPLETED|Overall Study||7
9934754|NCT01315574|11052243|FG000|NOT COMPLETED|Overall Study||0
9934755|NCT01315574|11052244|FG001|NOT COMPLETED|Overall Study||0
9934756|NCT01315665|11052252|FG000|STARTED|Overall Study||10
9934757|NCT01315665|11052253|FG001|STARTED|Overall Study||5
9934758|NCT01315665|11052252|FG000|COMPLETED|Overall Study||10
9934759|NCT01315665|11052253|FG001|COMPLETED|Overall Study||5
9934760|NCT01315665|11052252|FG000|NOT COMPLETED|Overall Study||0
9934761|NCT01315665|11052253|FG001|NOT COMPLETED|Overall Study||0
9934762|NCT01315678|11052263|FG000|STARTED|Overall Study||148
9934763|NCT01315678|11052264|FG001|STARTED|Overall Study||146
9934764|NCT01315678|11052263|FG000|COMPLETED|Overall Study||134
9934765|NCT01315678|11052264|FG001|COMPLETED|Overall Study||140
9934766|NCT01315678|11052263|FG000|NOT COMPLETED|Overall Study||14
9934767|NCT01315678|11052264|FG001|NOT COMPLETED|Overall Study||6
9934768|NCT01315847|11052274|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
9934769|NCT01315847|11052275|FG001|STARTED|Part I, Period 1||0
9934770|NCT01315847|11052274|FG000|Received Telcagepant|Part I, Period 1||5
9934771|NCT01315847|11052275|FG001|Received Telcagepant|Part I, Period 1||0
9934772|NCT01315847|11052274|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
9934773|NCT01315847|11052275|FG001|Received [11C]MK-4232|Part I, Period 1||0
9934774|NCT01315847|11052274|FG000|COMPLETED|Part I, Period 1||2
9934775|NCT01315847|11052275|FG001|COMPLETED|Part I, Period 1||0
9934776|NCT01315847|11052274|FG000|NOT COMPLETED|Part I, Period 1||3
9934777|NCT01315847|11052275|FG001|NOT COMPLETED|Part I, Period 1||0
9934778|NCT01315847|11052274|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
9934779|NCT01315847|11052275|FG001|STARTED|Part I, Period 2||0
9934780|NCT01315847|11052274|FG000|Received Telcagepant|Part I, Period 2||3
9934781|NCT01315847|11052275|FG001|Received Telcagepant|Part I, Period 2||0
9934782|NCT01315847|11052274|FG000|Received [11C]MK-4232|Part I, Period 2||3
9934783|NCT01315847|11052275|FG001|Received [11C]MK-4232|Part I, Period 2||0
9934784|NCT01315847|11052274|FG000|COMPLETED|Part I, Period 2||3
9934785|NCT01315847|11052275|FG001|COMPLETED|Part I, Period 2||0
9934786|NCT01315847|11052274|FG000|NOT COMPLETED|Part I, Period 2||0
9934787|NCT01315847|11052275|FG001|NOT COMPLETED|Part I, Period 2||0
9934788|NCT01315847|11052274|FG000|STARTED|Part III, Period 1||0
9934789|NCT01315847|11052275|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
9934790|NCT01315847|11052274|FG000|Received Telcagepant|Part III, Period 1||0
9934791|NCT01315847|11052275|FG001|Received Telcagepant|Part III, Period 1||4
9934792|NCT01315847|11052274|FG000|Received [11C]MK-4232|Part III, Period 1||0
9934793|NCT01315847|11052275|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
9934794|NCT01315847|11052274|FG000|COMPLETED|Part III, Period 1||0
9934795|NCT01315847|11052275|FG001|COMPLETED|Part III, Period 1||3
9934796|NCT01315847|11052274|FG000|NOT COMPLETED|Part III, Period 1||0
9934797|NCT01315847|11052275|FG001|NOT COMPLETED|Part III, Period 1||1
9934798|NCT01315847|11052274|FG000|STARTED|Part III, Period 2||0
9934799|NCT01315847|11052275|FG001|STARTED|Part III, Period 2||3
9934800|NCT01315847|11052274|FG000|Received Telcagepant|Part III, Period 2||0
9934801|NCT01315847|11052275|FG001|Received Telcagepant|Part III, Period 2||3
9934802|NCT01315847|11052274|FG000|Received [11C]MK-4232|Part III, Period 2||0
9934803|NCT01315847|11052275|FG001|Received [11C]MK-4232|Part III, Period 2||3
9934804|NCT01315847|11052274|FG000|COMPLETED|Part III, Period 2||0
9934805|NCT01315847|11052275|FG001|COMPLETED|Part III, Period 2||3
9934806|NCT01315847|11052274|FG000|NOT COMPLETED|Part III, Period 2||0
9934807|NCT01315847|11052275|FG001|NOT COMPLETED|Part III, Period 2||0
9934808|NCT01316042|11052283|FG000|STARTED|Overall Study||2
9934809|NCT01316042|11052284|FG001|STARTED|Overall Study||2
9934810|NCT01316042|11052283|FG000|COMPLETED|Overall Study||2
9934811|NCT01316042|11052284|FG001|COMPLETED|Overall Study||1
9934812|NCT01316042|11052283|FG000|NOT COMPLETED|Overall Study||0
9934813|NCT01316042|11052284|FG001|NOT COMPLETED|Overall Study||1
9934814|NCT01316055|11052293|FG000|STARTED|Overall Study||13
9934815|NCT01316055|11052294|FG001|STARTED|Overall Study||17
9934816|NCT01316055|11052295|FG002|STARTED|Overall Study||12
9934817|NCT01316055|11052293|FG000|COMPLETED|Overall Study||12
9934818|NCT01316055|11052294|FG001|COMPLETED|Overall Study||17
9934819|NCT01316055|11052295|FG002|COMPLETED|Overall Study||12
9934820|NCT01316055|11052293|FG000|NOT COMPLETED|Overall Study||1
9934821|NCT01316055|11052294|FG001|NOT COMPLETED|Overall Study||0
9934822|NCT01316055|11052295|FG002|NOT COMPLETED|Overall Study||0
9934823|NCT01316211|11052308|FG000|STARTED|Overall Study||116
9934824|NCT01316211|11052309|FG001|STARTED|Overall Study||123
9934825|NCT01316211|11052308|FG000|COMPLETED|Overall Study||105
9934826|NCT01316211|11052309|FG001|COMPLETED|Overall Study||111
9934827|NCT01316211|11052308|FG000|NOT COMPLETED|Overall Study||11
9934828|NCT01316211|11052309|FG001|NOT COMPLETED|Overall Study||12
9934829|NCT01316224|11052315|FG000|STARTED|Overall Study||52
9934830|NCT01316224|11052315|FG000|Completed Visit 1 to Dermatologist|Overall Study||52
9934831|NCT01316224|11052315|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49
9934832|NCT01316224|11052315|FG000|Completed Visit 2 to Dermatologist|Overall Study||51
9934833|NCT01316224|11052315|FG000|Completed Visit 3 to Dermatologist|Overall Study||48
9934834|NCT01316224|11052315|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39
9934835|NCT01316224|11052315|FG000|Completed Visit 4 to Dermatologist|Overall Study||42
9934836|NCT01316224|11052315|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28
9934837|NCT01316224|11052315|FG000|COMPLETED|Overall Study||42
9934838|NCT01316224|11052315|FG000|NOT COMPLETED|Overall Study||10
9934839|NCT01316263|11052321|FG000|STARTED|Overall Study||7
9934840|NCT01316263|11052322|FG001|STARTED|Overall Study||14
9934841|NCT01316263|11052321|FG000|Received Any Study Drug|Overall Study||7
9934842|NCT01316263|11052322|FG001|Received Any Study Drug|Overall Study||14
9934843|NCT01316263|11052321|FG000|COMPLETED|Overall Study||7
10011119|NCT01778049|11133843|FG001|NOT COMPLETED|Open Label Treatment Period||129
10011120|NCT01778049|11133844|FG002|NOT COMPLETED|Open Label Treatment Period||0
9934844|NCT01316263|11052322|FG001|COMPLETED|Overall Study||14
9934845|NCT01316263|11052321|FG000|NOT COMPLETED|Overall Study||0
9934846|NCT01316263|11052322|FG001|NOT COMPLETED|Overall Study||0
9934847|NCT01316276|11052330|FG000|STARTED|Overall Study||206
9934848|NCT01316276|11052330|FG000|COMPLETED|Overall Study||139
9934849|NCT01316276|11052330|FG000|NOT COMPLETED|Overall Study||67
9934850|NCT01316302|11052337|FG000|STARTED|Overall Study||30
9934851|NCT01316302|11052338|FG001|STARTED|Overall Study||33
9934852|NCT01316302|11052337|FG000|COMPLETED|Overall Study||20
9934853|NCT01316302|11052338|FG001|COMPLETED|Overall Study||22
9934854|NCT01316302|11052337|FG000|NOT COMPLETED|Overall Study||10
9934855|NCT01316302|11052338|FG001|NOT COMPLETED|Overall Study||11
9934856|NCT01316315|11052348|FG000|STARTED|Sequence 1||7
9934857|NCT01316315|11052349|FG001|STARTED|Sequence 1||7
9934858|NCT01316315|11052348|FG000|COMPLETED|Sequence 1||7
9934859|NCT01316315|11052349|FG001|COMPLETED|Sequence 1||7
9934860|NCT01316315|11052348|FG000|NOT COMPLETED|Sequence 1||0
9934861|NCT01316315|11052349|FG001|NOT COMPLETED|Sequence 1||0
9934862|NCT01316315|11052348|FG000|STARTED|Sequence 2||7
9934863|NCT01316315|11052349|FG001|STARTED|Sequence 2||7
9934864|NCT01316315|11052348|FG000|COMPLETED|Sequence 2||7
9934865|NCT01316315|11052349|FG001|COMPLETED|Sequence 2||7
9934866|NCT01316315|11052348|FG000|NOT COMPLETED|Sequence 2||0
9934867|NCT01316315|11052349|FG001|NOT COMPLETED|Sequence 2||0
9934868|NCT01316341|11052360|FG000|STARTED|Overall Study||6
9934869|NCT01316341|11052361|FG001|STARTED|Overall Study||9
9934870|NCT01316341|11052362|FG002|STARTED|Overall Study||9
9934871|NCT01316341|11052360|FG000|COMPLETED|Overall Study||6
9934872|NCT01316341|11052361|FG001|COMPLETED|Overall Study||9
9934873|NCT01316341|11052362|FG002|COMPLETED|Overall Study||9
9934874|NCT01316341|11052360|FG000|NOT COMPLETED|Overall Study||0
9934875|NCT01316341|11052361|FG001|NOT COMPLETED|Overall Study||0
9934876|NCT01316341|11052362|FG002|NOT COMPLETED|Overall Study||0
9934877|NCT01316380|11052382|FG000|STARTED|Overall Study||156
9934878|NCT01316380|11052383|FG001|STARTED|Overall Study||154
9934879|NCT01316380|11052384|FG002|STARTED|Overall Study||155
9934880|NCT01316380|11052382|FG000|COMPLETED|Overall Study||154
9934881|NCT01316380|11052383|FG001|COMPLETED|Overall Study||149
9934882|NCT01316380|11052384|FG002|COMPLETED|Overall Study||152
9934883|NCT01316380|11052382|FG000|NOT COMPLETED|Overall Study||2
9934884|NCT01316380|11052383|FG001|NOT COMPLETED|Overall Study||5
9934885|NCT01316380|11052384|FG002|NOT COMPLETED|Overall Study||3
9934886|NCT01316419|11052392|FG000|STARTED|Overall Study||2089
9934887|NCT01316419|11052392|FG000|COMPLETED|Overall Study||1824
9934888|NCT01316419|11052392|FG000|NOT COMPLETED|Overall Study||265
9934889|NCT01316510|11052398|FG000|STARTED|Overall Study||12
9934890|NCT01316510|11052399|FG001|STARTED|Overall Study||12
9934891|NCT01316510|11052398|FG000|COMPLETED|Overall Study||12
9934892|NCT01316510|11052399|FG001|COMPLETED|Overall Study||12
9934893|NCT01316510|11052398|FG000|NOT COMPLETED|Overall Study||0
9934894|NCT01316510|11052399|FG001|NOT COMPLETED|Overall Study||0
10011121|NCT01778049|11133845|FG003|NOT COMPLETED|Open Label Treatment Period||0
9934895|NCT01316575|11052407|FG000|STARTED|Overall Study||20
9934896|NCT01316575|11052408|FG001|STARTED|Overall Study||20
9934897|NCT01316575|11052407|FG000|COMPLETED|Overall Study||18
9934898|NCT01316575|11052408|FG001|COMPLETED|Overall Study||19
9934899|NCT01316575|11052407|FG000|NOT COMPLETED|Overall Study||2
9934900|NCT01316575|11052408|FG001|NOT COMPLETED|Overall Study||1
9934901|NCT01316614|11052414|FG000|STARTED|Overall Study||137
9934902|NCT01316614|11052414|FG000|COMPLETED|Overall Study||100
9934903|NCT01316614|11052414|FG000|NOT COMPLETED|Overall Study||37
9934904|NCT01316692|11052419|FG000|STARTED|Overall Study||12
9934905|NCT01316692|11052419|FG000|COMPLETED|Overall Study||0
9934906|NCT01316692|11052419|FG000|NOT COMPLETED|Overall Study||12
9934907|NCT01316770|11052423|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
9934908|NCT01316770|11052424|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
9934909|NCT01316770|11052423|FG000|COMPLETED|Overall Study||9
9934910|NCT01316770|11052424|FG001|COMPLETED|Overall Study||9
9934911|NCT01316770|11052423|FG000|NOT COMPLETED|Overall Study||0
9934912|NCT01316770|11052424|FG001|NOT COMPLETED|Overall Study||0
9934913|NCT01316887|11052437|FG000|STARTED|Overall Study||109
9934914|NCT01316887|11052438|FG001|STARTED|Overall Study||227
9934915|NCT01316887|11052439|FG002|STARTED|Overall Study||226
9934916|NCT01316887|11052437|FG000|COMPLETED|Overall Study||66
9934917|NCT01316887|11052438|FG001|COMPLETED|Overall Study||133
9934918|NCT01316887|11052439|FG002|COMPLETED|Overall Study||143
9934919|NCT01316887|11052437|FG000|NOT COMPLETED|Overall Study||43
9934920|NCT01316887|11052438|FG001|NOT COMPLETED|Overall Study||94
9934921|NCT01316887|11052439|FG002|NOT COMPLETED|Overall Study||83
9934922|NCT01316900|11052452|FG000|STARTED|Overall Study||209
9934923|NCT01316900|11052453|FG001|STARTED|Overall Study||212
9934924|NCT01316900|11052454|FG002|STARTED|Overall Study||214
9934925|NCT01316900|11052455|FG003|STARTED|Overall Study||208
9934926|NCT01316900|11052452|FG000|COMPLETED|Overall Study||165
9934927|NCT01316900|11052453|FG001|COMPLETED|Overall Study||181
9934928|NCT01316900|11052454|FG002|COMPLETED|Overall Study||173
9934929|NCT01316900|11052455|FG003|COMPLETED|Overall Study||177
9934930|NCT01316900|11052452|FG000|NOT COMPLETED|Overall Study||44
9934931|NCT01316900|11052453|FG001|NOT COMPLETED|Overall Study||31
9934932|NCT01316900|11052454|FG002|NOT COMPLETED|Overall Study||41
9934933|NCT01316900|11052455|FG003|NOT COMPLETED|Overall Study||31
9934934|NCT01316913|11052469|FG000|STARTED|Overall Study||222
9934935|NCT01316913|11052470|FG001|STARTED|Overall Study||217
9934936|NCT01316913|11052471|FG002|STARTED|Overall Study||215
9934937|NCT01316913|11052472|FG003|STARTED|Overall Study||215
9934938|NCT01316913|11052469|FG000|COMPLETED|Overall Study||165
9934939|NCT01316913|11052470|FG001|COMPLETED|Overall Study||163
9934940|NCT01316913|11052471|FG002|COMPLETED|Overall Study||166
9934941|NCT01316913|11052472|FG003|COMPLETED|Overall Study||176
9934942|NCT01316913|11052469|FG000|NOT COMPLETED|Overall Study||57
9934943|NCT01316913|11052470|FG001|NOT COMPLETED|Overall Study||54
9934944|NCT01316913|11052471|FG002|NOT COMPLETED|Overall Study||49
9934945|NCT01316913|11052472|FG003|NOT COMPLETED|Overall Study||39
9934946|NCT01316926|11052483|FG000|STARTED|Period 1||30
9934947|NCT01316926|11052484|FG001|STARTED|Period 1||30
9934948|NCT01316926|11052483|FG000|COMPLETED|Period 1||30
9934949|NCT01316926|11052484|FG001|COMPLETED|Period 1||30
9934950|NCT01316926|11052483|FG000|NOT COMPLETED|Period 1||0
9934951|NCT01316926|11052484|FG001|NOT COMPLETED|Period 1||0
9934952|NCT01316926|11052483|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
9934953|NCT01316926|11052484|FG001|STARTED|Period 2||30
9934954|NCT01316926|11052483|FG000|COMPLETED|Period 2||29
9934955|NCT01316926|11052484|FG001|COMPLETED|Period 2||30
9934956|NCT01316926|11052483|FG000|NOT COMPLETED|Period 2||0
9934957|NCT01316926|11052484|FG001|NOT COMPLETED|Period 2||0
9934958|NCT01316939|11052494|FG000|STARTED|Overall Study||76
9934959|NCT01316939|11052495|FG001|STARTED|Overall Study||77
9934960|NCT01316939|11052496|FG002|STARTED|Overall Study||76
9934961|NCT01316939|11052494|FG000|COMPLETED|Overall Study||13
9934962|NCT01316939|11052495|FG001|COMPLETED|Overall Study||9
9934963|NCT01316939|11052496|FG002|COMPLETED|Overall Study||7
9934964|NCT01316939|11052494|FG000|NOT COMPLETED|Overall Study||63
9934965|NCT01316939|11052495|FG001|NOT COMPLETED|Overall Study||68
9934966|NCT01316939|11052496|FG002|NOT COMPLETED|Overall Study||69
9934967|NCT01317004|11052506|FG000|STARTED|Overall Study||51
10011122|NCT01778049|11133846|FG004|NOT COMPLETED|Open Label Treatment Period||0
10011123|NCT01778049|11133847|FG005|NOT COMPLETED|Open Label Treatment Period||0
10011124|NCT01778049|11133842|FG000|STARTED|Double Blind Treatment Period||0
10011125|NCT01778049|11133843|FG001|STARTED|Double Blind Treatment Period||0
10011126|NCT01778049|11133844|FG002|STARTED|Double Blind Treatment Period||126
10011127|NCT01778049|11133845|FG003|STARTED|Double Blind Treatment Period||130
10011128|NCT01778049|11133846|FG004|STARTED|Double Blind Treatment Period||114
10011129|NCT01778049|11133847|FG005|STARTED|Double Blind Treatment Period||112
10011130|NCT01778049|11133842|FG000|COMPLETED|Double Blind Treatment Period||0
10011131|NCT01778049|11133843|FG001|COMPLETED|Double Blind Treatment Period||0
10011132|NCT01778049|11133844|FG002|COMPLETED|Double Blind Treatment Period||111
10011133|NCT01778049|11133845|FG003|COMPLETED|Double Blind Treatment Period||118
10011134|NCT01778049|11133846|FG004|COMPLETED|Double Blind Treatment Period||102
10011135|NCT01778049|11133847|FG005|COMPLETED|Double Blind Treatment Period||105
10011136|NCT01778049|11133842|FG000|NOT COMPLETED|Double Blind Treatment Period||0
10011137|NCT01778049|11133843|FG001|NOT COMPLETED|Double Blind Treatment Period||0
10011138|NCT01778049|11133844|FG002|NOT COMPLETED|Double Blind Treatment Period||15
9934968|NCT01317004|11052507|FG001|STARTED|Overall Study||14
9934969|NCT01317004|11052506|FG000|Safety Set|Overall Study||50
9934970|NCT01317004|11052507|FG001|Safety Set|Overall Study||11
9934971|NCT01317004|11052506|FG000|COMPLETED|Overall Study||47
9934972|NCT01317004|11052507|FG001|COMPLETED|Overall Study||5
9934973|NCT01317004|11052506|FG000|NOT COMPLETED|Overall Study||4
9934974|NCT01317004|11052507|FG001|NOT COMPLETED|Overall Study||9
9934975|NCT01317030|11052515|FG000|STARTED|Overall Study||12
9934976|NCT01317030|11052516|FG001|STARTED|Overall Study||13
9934977|NCT01317030|11052515|FG000|COMPLETED|Overall Study||12
9934978|NCT01317030|11052516|FG001|COMPLETED|Overall Study||13
9934979|NCT01317030|11052515|FG000|NOT COMPLETED|Overall Study||0
9934980|NCT01317030|11052516|FG001|NOT COMPLETED|Overall Study||0
9934981|NCT01317095|11052524|FG000|STARTED|Overall Study||39
9934982|NCT01317095|11052525|FG001|STARTED|Overall Study||41
9934983|NCT01317095|11052524|FG000|COMPLETED|Overall Study||39
9934984|NCT01317095|11052525|FG001|COMPLETED|Overall Study||41
9934985|NCT01317095|11052524|FG000|NOT COMPLETED|Overall Study||0
9934986|NCT01317095|11052525|FG001|NOT COMPLETED|Overall Study||0
9934987|NCT01317199|11052535|FG000|STARTED|Dose-escalation Phase 1||14
9934988|NCT01317199|11052536|FG001|STARTED|Dose-escalation Phase 1||0
9934989|NCT01317199|11052537|FG002|STARTED|Dose-escalation Phase 1||0
9934990|NCT01317199|11052538|FG003|STARTED|Dose-escalation Phase 1||0
9934991|NCT01317199|11052535|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
9934992|NCT01317199|11052536|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
9934993|NCT01317199|11052537|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
9934994|NCT01317199|11052538|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
9934995|NCT01317199|11052535|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
9934996|NCT01317199|11052536|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9934997|NCT01317199|11052537|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9934998|NCT01317199|11052538|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9934999|NCT01317199|11052535|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
9935000|NCT01317199|11052536|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935001|NCT01317199|11052537|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935002|NCT01317199|11052538|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935003|NCT01317199|11052535|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
9935004|NCT01317199|11052536|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935005|NCT01317199|11052537|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935006|NCT01317199|11052538|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935007|NCT01317199|11052535|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
9935008|NCT01317199|11052536|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935009|NCT01317199|11052537|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935010|NCT01317199|11052538|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
9935011|NCT01317199|11052535|FG000|COMPLETED|Dose-escalation Phase 1||7
9935012|NCT01317199|11052536|FG001|COMPLETED|Dose-escalation Phase 1||0
9935013|NCT01317199|11052537|FG002|COMPLETED|Dose-escalation Phase 1||0
9935014|NCT01317199|11052538|FG003|COMPLETED|Dose-escalation Phase 1||0
9935015|NCT01317199|11052535|FG000|NOT COMPLETED|Dose-escalation Phase 1||7
9935016|NCT01317199|11052536|FG001|NOT COMPLETED|Dose-escalation Phase 1||0
9935017|NCT01317199|11052537|FG002|NOT COMPLETED|Dose-escalation Phase 1||0
9935018|NCT01317199|11052538|FG003|NOT COMPLETED|Dose-escalation Phase 1||0
9935019|NCT01317199|11052535|FG000|STARTED|Randomized Phase 2||0
9935020|NCT01317199|11052536|FG001|STARTED|Randomized Phase 2||24
9935021|NCT01317199|11052537|FG002|STARTED|Randomized Phase 2||56
9935022|NCT01317199|11052538|FG003|STARTED|Randomized Phase 2||49
9935023|NCT01317199|11052535|FG000|COMPLETED|Randomized Phase 2||0
9935024|NCT01317199|11052536|FG001|COMPLETED|Randomized Phase 2||13
9935025|NCT01317199|11052537|FG002|COMPLETED|Randomized Phase 2||35
9935026|NCT01317199|11052538|FG003|COMPLETED|Randomized Phase 2||32
9935027|NCT01317199|11052535|FG000|NOT COMPLETED|Randomized Phase 2||0
9935028|NCT01317199|11052536|FG001|NOT COMPLETED|Randomized Phase 2||11
9935029|NCT01317199|11052537|FG002|NOT COMPLETED|Randomized Phase 2||21
9935030|NCT01317199|11052538|FG003|NOT COMPLETED|Randomized Phase 2||17
9935031|NCT01317277|11052557|FG000|STARTED|Overall Study||50
9935032|NCT01317277|11052558|FG001|STARTED|Overall Study||25
9935033|NCT01317277|11052557|FG000|COMPLETED|Overall Study||43
9935034|NCT01317277|11052558|FG001|COMPLETED|Overall Study||23
9935035|NCT01317277|11052557|FG000|NOT COMPLETED|Overall Study||7
9935036|NCT01317277|11052558|FG001|NOT COMPLETED|Overall Study||2
9935037|NCT01317472|11052566|FG000|STARTED|Overall Study||9
9935038|NCT01317472|11052567|FG001|STARTED|Overall Study||2
9935039|NCT01317472|11052566|FG000|COMPLETED|Overall Study||7
9935040|NCT01317472|11052567|FG001|COMPLETED|Overall Study||2
9935041|NCT01317472|11052566|FG000|NOT COMPLETED|Overall Study||2
9935042|NCT01317472|11052567|FG001|NOT COMPLETED|Overall Study||0
9935043|NCT01317550|11052577|FG000|STARTED|Overall Study||5
9935044|NCT01317550|11052578|FG001|STARTED|Overall Study||3
9935045|NCT01317550|11052579|FG002|STARTED|Overall Study||3
9935046|NCT01317550|11052580|FG003|STARTED|Overall Study||3
9935047|NCT01317550|11052577|FG000|COMPLETED|Overall Study||3
9935048|NCT01317550|11052578|FG001|COMPLETED|Overall Study||3
9935049|NCT01317550|11052579|FG002|COMPLETED|Overall Study||3
9935050|NCT01317550|11052580|FG003|COMPLETED|Overall Study||3
9935051|NCT01317550|11052577|FG000|NOT COMPLETED|Overall Study||2
9935052|NCT01317550|11052578|FG001|NOT COMPLETED|Overall Study||0
9935053|NCT01317550|11052579|FG002|NOT COMPLETED|Overall Study||0
9935054|NCT01317550|11052580|FG003|NOT COMPLETED|Overall Study||0
9935055|NCT01317615|11052590|FG000|STARTED|Overall Study||49
9935056|NCT01317615|11052590|FG000|COMPLETED|Overall Study||0
9935057|NCT01317615|11052590|FG000|NOT COMPLETED|Overall Study||49
9935058|NCT01317641|11052603|FG000|STARTED|Overall Study||4
9935059|NCT01317641|11052604|FG001|STARTED|Overall Study||7
9935060|NCT01317641|11052605|FG002|STARTED|Overall Study||3
9935061|NCT01317641|11052606|FG003|STARTED|Overall Study||4
9935062|NCT01317641|11052607|FG004|STARTED|Overall Study||3
9935063|NCT01317641|11052608|FG005|STARTED|Overall Study||3
9935064|NCT01317641|11052609|FG006|STARTED|Overall Study||38
9935065|NCT01317641|11052610|FG007|STARTED|Overall Study||38
9935066|NCT01317641|11052611|FG008|STARTED|Overall Study||36
9935067|NCT01317641|11052603|FG000|COMPLETED|Overall Study||3
9935068|NCT01317641|11052604|FG001|COMPLETED|Overall Study||6
9935069|NCT01317641|11052605|FG002|COMPLETED|Overall Study||3
9935070|NCT01317641|11052606|FG003|COMPLETED|Overall Study||3
9935071|NCT01317641|11052607|FG004|COMPLETED|Overall Study||3
9935072|NCT01317641|11052608|FG005|COMPLETED|Overall Study||3
9935073|NCT01317641|11052609|FG006|COMPLETED|Overall Study||35
9935074|NCT01317641|11052610|FG007|COMPLETED|Overall Study||33
9935075|NCT01317641|11052611|FG008|COMPLETED|Overall Study||31
9935076|NCT01317641|11052603|FG000|NOT COMPLETED|Overall Study||1
9935077|NCT01317641|11052604|FG001|NOT COMPLETED|Overall Study||1
9935078|NCT01317641|11052605|FG002|NOT COMPLETED|Overall Study||0
9935079|NCT01317641|11052606|FG003|NOT COMPLETED|Overall Study||1
9935080|NCT01317641|11052607|FG004|NOT COMPLETED|Overall Study||0
9935081|NCT01317641|11052608|FG005|NOT COMPLETED|Overall Study||0
9935082|NCT01317641|11052609|FG006|NOT COMPLETED|Overall Study||3
9935083|NCT01317641|11052610|FG007|NOT COMPLETED|Overall Study||5
9935084|NCT01317641|11052611|FG008|NOT COMPLETED|Overall Study||5
9935085|NCT01317667|11052650|FG000|STARTED|Overall Study||10
9935086|NCT01317667|11052651|FG001|STARTED|Overall Study||10
9935087|NCT01317667|11052652|FG002|STARTED|Overall Study||10
9935088|NCT01317667|11052650|FG000|COMPLETED|Overall Study||10
9935089|NCT01317667|11052651|FG001|COMPLETED|Overall Study||10
9935090|NCT01317667|11052652|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
9935091|NCT01317667|11052650|FG000|NOT COMPLETED|Overall Study||0
9935092|NCT01317667|11052651|FG001|NOT COMPLETED|Overall Study||0
9935093|NCT01317667|11052652|FG002|NOT COMPLETED|Overall Study||0
9935094|NCT01317797|11052663|FG000|STARTED|Overall Study||8
9935095|NCT01317797|11052664|FG001|STARTED|Overall Study||7
9935096|NCT01317797|11052665|FG002|STARTED|Overall Study||9
9935097|NCT01317797|11052663|FG000|COMPLETED|Overall Study||8
9935098|NCT01317797|11052664|FG001|COMPLETED|Overall Study||6
9935099|NCT01317797|11052665|FG002|COMPLETED|Overall Study||8
9935100|NCT01317797|11052663|FG000|NOT COMPLETED|Overall Study||0
9935101|NCT01317797|11052664|FG001|NOT COMPLETED|Overall Study||1
9935102|NCT01317797|11052665|FG002|NOT COMPLETED|Overall Study||1
9935103|NCT01317901|11052675|FG000|STARTED|Overall Study||6
9935104|NCT01317901|11052676|FG001|STARTED|Overall Study||6
9935105|NCT01317901|11052675|FG000|COMPLETED|Overall Study||6
9935106|NCT01317901|11052676|FG001|COMPLETED|Overall Study||6
9935107|NCT01317901|11052675|FG000|NOT COMPLETED|Overall Study||0
9935108|NCT01317901|11052676|FG001|NOT COMPLETED|Overall Study||0
9935109|NCT01317940|11052688|FG000|STARTED|Overall Study||19
9935110|NCT01317940|11052689|FG001|STARTED|Overall Study||10
9935111|NCT01317940|11052690|FG002|STARTED|Overall Study||20
9935112|NCT01317940|11052691|FG003|STARTED|Overall Study||6
9935113|NCT01317940|11052692|FG004|STARTED|Overall Study||13
9935114|NCT01317940|11052693|FG005|STARTED|Overall Study||4
9935115|NCT01317940|11052688|FG000|COMPLETED|Overall Study||18
9935116|NCT01317940|11052689|FG001|COMPLETED|Overall Study||10
9935117|NCT01317940|11052690|FG002|COMPLETED|Overall Study||15
9935118|NCT01317940|11052691|FG003|COMPLETED|Overall Study||5
9935119|NCT01317940|11052692|FG004|COMPLETED|Overall Study||12
9935120|NCT01317940|11052693|FG005|COMPLETED|Overall Study||4
9935121|NCT01317940|11052688|FG000|NOT COMPLETED|Overall Study||1
9935122|NCT01317940|11052689|FG001|NOT COMPLETED|Overall Study||0
9935123|NCT01317940|11052690|FG002|NOT COMPLETED|Overall Study||5
9935124|NCT01317940|11052691|FG003|NOT COMPLETED|Overall Study||1
9935125|NCT01317940|11052692|FG004|NOT COMPLETED|Overall Study||1
9935126|NCT01317940|11052693|FG005|NOT COMPLETED|Overall Study||0
9935127|NCT01318018|11052710|FG000|STARTED|Overall Study||10
9935128|NCT01318018|11052711|FG001|STARTED|Overall Study||10
9935129|NCT01318018|11052710|FG000|COMPLETED|Overall Study||10
9935130|NCT01318018|11052711|FG001|COMPLETED|Overall Study||10
9935131|NCT01318018|11052710|FG000|NOT COMPLETED|Overall Study||0
9935132|NCT01318018|11052711|FG001|NOT COMPLETED|Overall Study||0
9935133|NCT01318070|11052720|FG000|STARTED|Overall Study||111
9935134|NCT01318070|11052721|FG001|STARTED|Overall Study||113
9935135|NCT01318070|11052722|FG002|STARTED|Overall Study||115
9935136|NCT01318070|11052720|FG000|COMPLETED|Overall Study||109
9935137|NCT01318070|11052721|FG001|COMPLETED|Overall Study||111
9935138|NCT01318070|11052722|FG002|COMPLETED|Overall Study||108
9935139|NCT01318070|11052720|FG000|NOT COMPLETED|Overall Study||2
9935140|NCT01318070|11052721|FG001|NOT COMPLETED|Overall Study||2
9935141|NCT01318070|11052722|FG002|NOT COMPLETED|Overall Study||7
9935142|NCT01318083|11052733|FG000|STARTED|Overall Study||105
9935143|NCT01318083|11052734|FG001|STARTED|Overall Study||104
9935144|NCT01318083|11052735|FG002|STARTED|Overall Study||103
9935145|NCT01318083|11052733|FG000|COMPLETED|Overall Study||99
9935146|NCT01318083|11052734|FG001|COMPLETED|Overall Study||102
9935147|NCT01318083|11052735|FG002|COMPLETED|Overall Study||98
9935148|NCT01318083|11052733|FG000|NOT COMPLETED|Overall Study||6
9935149|NCT01318083|11052734|FG001|NOT COMPLETED|Overall Study||2
9935150|NCT01318083|11052735|FG002|NOT COMPLETED|Overall Study||5
9935151|NCT01318109|11052746|FG000|STARTED|Overall Study||92
9935152|NCT01318109|11052747|FG001|STARTED|Overall Study||96
9935153|NCT01318109|11052748|FG002|STARTED|Overall Study||100
9935154|NCT01318109|11052746|FG000|COMPLETED|Overall Study||91
9935155|NCT01318109|11052747|FG001|COMPLETED|Overall Study||93
9935156|NCT01318109|11052748|FG002|COMPLETED|Overall Study||100
9935157|NCT01318109|11052746|FG000|NOT COMPLETED|Overall Study||1
9935158|NCT01318109|11052747|FG001|NOT COMPLETED|Overall Study||3
9935159|NCT01318109|11052748|FG002|NOT COMPLETED|Overall Study||0
9935160|NCT01318122|11052758|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
9935161|NCT01318122|11052759|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
9935162|NCT01318122|11052760|FG002|STARTED|Enrolled - Long-Term Extension Study||57
9935163|NCT01318122|11052761|FG003|STARTED|Enrolled - Long-Term Extension Study||53
9935164|NCT01318122|11052758|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105
9935165|NCT01318122|11052759|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110
9935166|NCT01318122|11052760|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55
9935167|NCT01318122|11052761|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52
9935168|NCT01318122|11052758|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
9935169|NCT01318122|11052759|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935170|NCT01318122|11052760|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
9935171|NCT01318122|11052761|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
9935172|NCT01318122|11052758|FG000|STARTED|Entered - Long-Term Extension Study||105
9935173|NCT01318122|11052759|FG001|STARTED|Entered - Long-Term Extension Study||110
9935174|NCT01318122|11052760|FG002|STARTED|Entered - Long-Term Extension Study||55
9935175|NCT01318122|11052761|FG003|STARTED|Entered - Long-Term Extension Study||52
9935176|NCT01318122|11052758|FG000|COMPLETED|Entered - Long-Term Extension Study||96
9935177|NCT01318122|11052759|FG001|COMPLETED|Entered - Long-Term Extension Study||99
9935178|NCT01318122|11052760|FG002|COMPLETED|Entered - Long-Term Extension Study||49
9935179|NCT01318122|11052761|FG003|COMPLETED|Entered - Long-Term Extension Study||48
9935180|NCT01318122|11052758|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
9935181|NCT01318122|11052759|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11
9935182|NCT01318122|11052760|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6
9935183|NCT01318122|11052761|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4
9935184|NCT01318135|11052771|FG000|STARTED|Enrolled - Long-Term Extension Study||99
9935185|NCT01318135|11052772|FG001|STARTED|Enrolled - Long-Term Extension Study||102
9935186|NCT01318135|11052773|FG002|STARTED|Enrolled - Long-Term Extension Study||46
9935187|NCT01318135|11052774|FG003|STARTED|Enrolled - Long-Term Extension Study||49
9935188|NCT01318135|11052775|FG004|STARTED|Enrolled - Long-Term Extension Study||91
9935189|NCT01318135|11052776|FG005|STARTED|Enrolled - Long-Term Extension Study||90
9935190|NCT01318135|11052777|FG006|STARTED|Enrolled - Long-Term Extension Study||50
9935191|NCT01318135|11052778|FG007|STARTED|Enrolled - Long-Term Extension Study||49
9935192|NCT01318135|11052771|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97
9935193|NCT01318135|11052772|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102
9935194|NCT01318135|11052773|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46
9935195|NCT01318135|11052774|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49
9935196|NCT01318135|11052775|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91
9935197|NCT01318135|11052776|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90
9935198|NCT01318135|11052777|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50
9935199|NCT01318135|11052778|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49
9935200|NCT01318135|11052771|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
9935201|NCT01318135|11052772|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935202|NCT01318135|11052773|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935203|NCT01318135|11052774|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935204|NCT01318135|11052775|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935205|NCT01318135|11052776|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935206|NCT01318135|11052777|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935207|NCT01318135|11052778|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
9935208|NCT01318135|11052771|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
9935209|NCT01318135|11052772|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
9935210|NCT01318135|11052773|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
9935211|NCT01318135|11052774|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
9935212|NCT01318135|11052775|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
9935213|NCT01318135|11052776|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
9935214|NCT01318135|11052777|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
9935215|NCT01318135|11052778|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
9935216|NCT01318135|11052771|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
9935217|NCT01318135|11052772|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
9935218|NCT01318135|11052773|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
9935219|NCT01318135|11052774|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
9935220|NCT01318135|11052775|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
9956461|NCT01446159|11075703|FG001|NOT COMPLETED|Overall Study||3
9935221|NCT01318135|11052776|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
9935222|NCT01318135|11052777|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
9935223|NCT01318135|11052778|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
9935224|NCT01318135|11052771|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17
9935225|NCT01318135|11052772|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
9935226|NCT01318135|11052773|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8
9935227|NCT01318135|11052774|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7
9935228|NCT01318135|11052775|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9
9935229|NCT01318135|11052776|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4
9935230|NCT01318135|11052777|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
9935231|NCT01318135|11052778|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3
9935232|NCT01318278|11052791|FG000|STARTED|Overall Study||10
9935233|NCT01318278|11052792|FG001|STARTED|Overall Study||10
9935234|NCT01318278|11052793|FG002|STARTED|Overall Study||50
9935235|NCT01318278|11052791|FG000|COMPLETED|Overall Study||10
9935236|NCT01318278|11052792|FG001|COMPLETED|Overall Study||10
9935237|NCT01318278|11052793|FG002|COMPLETED|Overall Study||50
9935238|NCT01318278|11052791|FG000|NOT COMPLETED|Overall Study||0
9935239|NCT01318278|11052792|FG001|NOT COMPLETED|Overall Study||0
9935240|NCT01318278|11052793|FG002|NOT COMPLETED|Overall Study||0
9935241|NCT01318356|11052805|FG000|STARTED|Overall Study||51
9935242|NCT01318356|11052806|FG001|STARTED|Overall Study||52
9935243|NCT01318356|11052807|FG002|STARTED|Overall Study||52
9935244|NCT01318356|11052805|FG000|COMPLETED|Overall Study||43
9935245|NCT01318356|11052806|FG001|COMPLETED|Overall Study||49
9935246|NCT01318356|11052807|FG002|COMPLETED|Overall Study||50
9935247|NCT01318356|11052805|FG000|NOT COMPLETED|Overall Study||8
9935248|NCT01318356|11052806|FG001|NOT COMPLETED|Overall Study||3
9935249|NCT01318356|11052807|FG002|NOT COMPLETED|Overall Study||2
9935250|NCT01318382|11052815|FG000|STARTED|Overall Study||302
9935251|NCT01318382|11052815|FG000|COMPLETED|Overall Study||289
9935252|NCT01318382|11052815|FG000|NOT COMPLETED|Overall Study||13
9935253|NCT01318408|11052820|FG000|STARTED|Overall Study||24
9935254|NCT01318408|11052820|FG000|COMPLETED|Overall Study||16
9935255|NCT01318408|11052820|FG000|NOT COMPLETED|Overall Study||8
9935256|NCT01318499|11052827|FG000|STARTED|Overall Study||540
9935257|NCT01318499|11052828|FG001|STARTED|Overall Study||534
9935258|NCT01318499|11052829|FG002|STARTED|Overall Study||268
9935259|NCT01318499|11052827|FG000|COMPLETED|Overall Study||475
9935260|NCT01318499|11052828|FG001|COMPLETED|Overall Study||458
9935261|NCT01318499|11052829|FG002|COMPLETED|Overall Study||121
9935262|NCT01318499|11052827|FG000|NOT COMPLETED|Overall Study||65
9935263|NCT01318499|11052828|FG001|NOT COMPLETED|Overall Study||76
9935264|NCT01318499|11052829|FG002|NOT COMPLETED|Overall Study||147
9935265|NCT01318512|11052839|FG000|STARTED|Titration Period (4 Months)||340
9935266|NCT01318512|11052839|FG000|COMPLETED|Titration Period (4 Months)||340
9935267|NCT01318512|11052839|FG000|NOT COMPLETED|Titration Period (4 Months)||0
9935268|NCT01318512|11052839|FG000|STARTED|Maintenance Period (6 Months)||340
9935269|NCT01318512|11052839|FG000|COMPLETED|Maintenance Period (6 Months)||329
9935270|NCT01318512|11052839|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11
9935271|NCT01318538|11052847|FG000|STARTED|Overall Study||52
9935272|NCT01318538|11052848|FG001|STARTED|Overall Study||106
9935273|NCT01318538|11052849|FG002|STARTED|Overall Study||8
9935274|NCT01318538|11052847|FG000|COMPLETED|Overall Study||52
9935275|NCT01318538|11052848|FG001|COMPLETED|Overall Study||106
9935276|NCT01318538|11052849|FG002|COMPLETED|Overall Study||8
9935277|NCT01318538|11052847|FG000|NOT COMPLETED|Overall Study||0
9935278|NCT01318538|11052848|FG001|NOT COMPLETED|Overall Study||0
9935279|NCT01318538|11052849|FG002|NOT COMPLETED|Overall Study||0
9935280|NCT01318577|11052859|FG000|STARTED|Overall Study||224
9935281|NCT01318577|11052860|FG001|STARTED|Overall Study||220
9935282|NCT01318577|11052859|FG000|COMPLETED|Overall Study||211
9935283|NCT01318577|11052860|FG001|COMPLETED|Overall Study||212
9935284|NCT01318577|11052859|FG000|NOT COMPLETED|Overall Study||13
9935285|NCT01318577|11052860|FG001|NOT COMPLETED|Overall Study||8
9935286|NCT01318694|11052870|FG000|STARTED|Overall Study||275
9935287|NCT01318694|11052871|FG001|STARTED|Overall Study||270
9935288|NCT01318694|11052872|FG002|STARTED|Overall Study||268
9935289|NCT01318694|11052873|FG003|STARTED|Overall Study||268
9935290|NCT01318694|11052870|FG000|Full Analysis Set|Overall Study||274
9935291|NCT01318694|11052871|FG001|Full Analysis Set|Overall Study||270
9935292|NCT01318694|11052872|FG002|Full Analysis Set|Overall Study||265
9935293|NCT01318694|11052873|FG003|Full Analysis Set|Overall Study||268
9935294|NCT01318694|11052870|FG000|Safety Set|Overall Study||273
9935295|NCT01318694|11052871|FG001|Safety Set|Overall Study||268
9935296|NCT01318694|11052872|FG002|Safety Set|Overall Study||265
9935297|NCT01318694|11052873|FG003|Safety Set|Overall Study||265
9935298|NCT01318694|11052870|FG000|COMPLETED|Overall Study||223
9935299|NCT01318694|11052871|FG001|COMPLETED|Overall Study||212
9935300|NCT01318694|11052872|FG002|COMPLETED|Overall Study||225
9935301|NCT01318694|11052873|FG003|COMPLETED|Overall Study||200
9935302|NCT01318694|11052870|FG000|NOT COMPLETED|Overall Study||52
9935303|NCT01318694|11052871|FG001|NOT COMPLETED|Overall Study||58
9935304|NCT01318694|11052872|FG002|NOT COMPLETED|Overall Study||43
9935305|NCT01318694|11052873|FG003|NOT COMPLETED|Overall Study||68
9935306|NCT01318733|11052883|FG000|STARTED|Overall Study||449
9935307|NCT01318733|11052883|FG000|COMPLETED|Overall Study||279
9935308|NCT01318733|11052883|FG000|NOT COMPLETED|Overall Study||170
9935309|NCT01318811|11052889|FG000|STARTED|Overall Study||4
9935310|NCT01318811|11052890|FG001|STARTED|Overall Study||8
9935311|NCT01318811|11052889|FG000|COMPLETED|Overall Study||3
9935312|NCT01318811|11052890|FG001|COMPLETED|Overall Study||4
9935313|NCT01318811|11052889|FG000|NOT COMPLETED|Overall Study||1
9935314|NCT01318811|11052890|FG001|NOT COMPLETED|Overall Study||4
9935315|NCT01318876|11052896|FG000|STARTED|Day 8 Survey||7645
9935316|NCT01318876|11052896|FG000|COMPLETED|Day 8 Survey||5825
9935317|NCT01318876|11052896|FG000|NOT COMPLETED|Day 8 Survey||1820
9935318|NCT01318876|11052896|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
9935319|NCT01318876|11052896|FG000|COMPLETED|Day 29 Survey||5724
9935320|NCT01318876|11052896|FG000|NOT COMPLETED|Day 29 Survey||1825
9935321|NCT01318902|11052904|FG000|STARTED|Overall Study||6
9935322|NCT01318902|11052905|FG001|STARTED|Overall Study||5
9935323|NCT01318902|11052906|FG002|STARTED|Overall Study||5
9935324|NCT01318902|11052907|FG003|STARTED|Overall Study||11
9935325|NCT01318902|11052904|FG000|COMPLETED|Overall Study||5
9935326|NCT01318902|11052905|FG001|COMPLETED|Overall Study||2
9935327|NCT01318902|11052906|FG002|COMPLETED|Overall Study||3
9935328|NCT01318902|11052907|FG003|COMPLETED|Overall Study||5
9935329|NCT01318902|11052904|FG000|NOT COMPLETED|Overall Study||1
9935330|NCT01318902|11052905|FG001|NOT COMPLETED|Overall Study||3
9935331|NCT01318902|11052906|FG002|NOT COMPLETED|Overall Study||2
9935332|NCT01318902|11052907|FG003|NOT COMPLETED|Overall Study||6
9935333|NCT01318915|11052919|FG000|STARTED|Overall Study||10
9935334|NCT01318915|11052919|FG000|COMPLETED|Overall Study||9
9935335|NCT01318915|11052919|FG000|NOT COMPLETED|Overall Study||1
9935336|NCT01318967|11052925|FG000|STARTED|Overall Study||10
9935337|NCT01318967|11052925|FG000|COMPLETED|Overall Study||10
9935338|NCT01318967|11052925|FG000|NOT COMPLETED|Overall Study||0
9935339|NCT01319045|11052930|FG000|STARTED|Overall Study||5
9935340|NCT01319045|11052930|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
9935341|NCT01319045|11052930|FG000|NOT COMPLETED|Overall Study||2
9935342|NCT01319110|11052936|FG000|STARTED|Overall Study||5
9935343|NCT01319110|11052937|FG001|STARTED|Overall Study||5
9935344|NCT01319110|11052936|FG000|COMPLETED|Overall Study||5
9935345|NCT01319110|11052937|FG001|COMPLETED|Overall Study||5
9935346|NCT01319110|11052936|FG000|NOT COMPLETED|Overall Study||0
9935347|NCT01319110|11052937|FG001|NOT COMPLETED|Overall Study||0
9935348|NCT01319318|11052943|FG000|STARTED|Overall Study||25
9935349|NCT01319318|11052943|FG000|COMPLETED|Overall Study||25
9935350|NCT01319318|11052943|FG000|NOT COMPLETED|Overall Study||0
9935351|NCT01319383|11052947|FG000|STARTED|Overall Study||12
9935352|NCT01319383|11052948|FG001|STARTED|Overall Study||13
9935353|NCT01319383|11052947|FG000|Step 1|Overall Study||8
9935354|NCT01319383|11052948|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
9935355|NCT01319383|11052947|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
9935356|NCT01319383|11052948|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
9935357|NCT01319383|11052947|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
9935358|NCT01319383|11052948|FG001|Step 2|Overall Study||0
9935359|NCT01319383|11052947|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
9935360|NCT01319383|11052948|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
9935361|NCT01319383|11052947|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0
9935362|NCT01319383|11052948|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3
9935363|NCT01319383|11052947|FG000|COMPLETED|Overall Study||0
9935364|NCT01319383|11052948|FG001|COMPLETED|Overall Study||3
9935365|NCT01319383|11052947|FG000|NOT COMPLETED|Overall Study||12
9935366|NCT01319383|11052948|FG001|NOT COMPLETED|Overall Study||10
9935367|NCT01319396|11052965|FG000|STARTED|Overall Study||24
9935368|NCT01319396|11052965|FG000|COMPLETED|Overall Study||24
9935369|NCT01319396|11052965|FG000|NOT COMPLETED|Overall Study||0
9935370|NCT01319422|11052971|FG000|STARTED|Overall Study||20
9935371|NCT01319422|11052972|FG001|STARTED|Overall Study||20
9935372|NCT01319422|11052971|FG000|COMPLETED|Overall Study||19
9935373|NCT01319422|11052972|FG001|COMPLETED|Overall Study||20
9935374|NCT01319422|11052971|FG000|NOT COMPLETED|Overall Study||1
9935375|NCT01319422|11052972|FG001|NOT COMPLETED|Overall Study||0
9935376|NCT01319500|11052980|FG000|STARTED|Overall Study||1187
9935377|NCT01319500|11052981|FG001|STARTED|Overall Study||2589
9935378|NCT01319500|11052980|FG000|COMPLETED|Overall Study||1187
9935379|NCT01319500|11052981|FG001|COMPLETED|Overall Study||2589
9935380|NCT01319500|11052980|FG000|NOT COMPLETED|Overall Study||0
9935381|NCT01319500|11052981|FG001|NOT COMPLETED|Overall Study||0
9935382|NCT01319539|11052992|FG000|STARTED|Overall Study||12
9935383|NCT01319539|11052992|FG000|COMPLETED|Overall Study||12
9935384|NCT01319539|11052992|FG000|NOT COMPLETED|Overall Study||0
9935385|NCT01319552|11052998|FG000|STARTED|Overall Study||14
9935386|NCT01319552|11052998|FG000|COMPLETED|Overall Study||14
9935387|NCT01319552|11052998|FG000|NOT COMPLETED|Overall Study||0
9935388|NCT01319617|11053003|FG000|STARTED|Overall Study||41
9935389|NCT01319617|11053003|FG000|COMPLETED|Overall Study||40
9935390|NCT01319617|11053003|FG000|NOT COMPLETED|Overall Study||1
9935391|NCT01319721|11053009|FG000|STARTED|Overall Study|The unit of measure is eyes.|48
9935392|NCT01319721|11053010|FG001|STARTED|Overall Study|The unit of measure is eyes.|48
9935393|NCT01319721|11053009|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47
9935394|NCT01319721|11053010|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42
9935395|NCT01319721|11053009|FG000|NOT COMPLETED|Overall Study||1
9935396|NCT01319721|11053010|FG001|NOT COMPLETED|Overall Study||6
9935397|NCT01319773|11053021|FG000|STARTED|Overall Study||10
9935398|NCT01319773|11053022|FG001|STARTED|Overall Study||10
9935399|NCT01319773|11053023|FG002|STARTED|Overall Study||8
9935400|NCT01319773|11053024|FG003|STARTED|Overall Study||8
9935401|NCT01319773|11053025|FG004|STARTED|Overall Study||8
9935402|NCT01319773|11053021|FG000|COMPLETED|Overall Study||10
9935403|NCT01319773|11053022|FG001|COMPLETED|Overall Study||10
9935404|NCT01319773|11053023|FG002|COMPLETED|Overall Study||8
9935405|NCT01319773|11053024|FG003|COMPLETED|Overall Study||8
9935406|NCT01319773|11053025|FG004|COMPLETED|Overall Study||8
9935407|NCT01319773|11053021|FG000|NOT COMPLETED|Overall Study||0
9935408|NCT01319773|11053022|FG001|NOT COMPLETED|Overall Study||0
9935409|NCT01319773|11053023|FG002|NOT COMPLETED|Overall Study||0
9935410|NCT01319773|11053024|FG003|NOT COMPLETED|Overall Study||0
9935411|NCT01319773|11053025|FG004|NOT COMPLETED|Overall Study||0
9956462|NCT01446159|11075704|FG002|NOT COMPLETED|Overall Study||71
9956463|NCT01446159|11075705|FG003|NOT COMPLETED|Overall Study||62
9956464|NCT01446237|11075717|FG000|STARTED|Overall Study||125
9956465|NCT01446237|11075717|FG000|COMPLETED|Overall Study||115
9956466|NCT01446237|11075717|FG000|NOT COMPLETED|Overall Study||10
9956467|NCT01446289|11075725|FG000|STARTED|Overall Study||51
10011139|NCT01778049|11133845|FG003|NOT COMPLETED|Double Blind Treatment Period||12
10011140|NCT01778049|11133846|FG004|NOT COMPLETED|Double Blind Treatment Period||12
10011141|NCT01778049|11133847|FG005|NOT COMPLETED|Double Blind Treatment Period||7
9956468|NCT01446289|11075726|FG001|STARTED|Overall Study||35
9956469|NCT01446289|11075727|FG002|STARTED|Overall Study||51
9956470|NCT01446289|11075728|FG003|STARTED|Overall Study||35
9956471|NCT01446289|11075725|FG000|COMPLETED|Overall Study||50
9956472|NCT01446289|11075726|FG001|COMPLETED|Overall Study||35
9956473|NCT01446289|11075727|FG002|COMPLETED|Overall Study||50
9956474|NCT01446289|11075728|FG003|COMPLETED|Overall Study||35
9956475|NCT01446289|11075725|FG000|NOT COMPLETED|Overall Study||1
9956476|NCT01446289|11075726|FG001|NOT COMPLETED|Overall Study||0
9956477|NCT01446289|11075727|FG002|NOT COMPLETED|Overall Study||1
9956478|NCT01446289|11075728|FG003|NOT COMPLETED|Overall Study||0
9956479|NCT01446419|11075742|FG000|STARTED|Overall Study||147
9956480|NCT01446419|11075743|FG001|STARTED|Overall Study||78
9956481|NCT01446419|11075742|FG000|3 Month Follow-up|Overall Study||146
9956482|NCT01446419|11075743|FG001|3 Month Follow-up|Overall Study||77
9956483|NCT01446419|11075742|FG000|6 Month Follow-up|Overall Study||144
9956484|NCT01446419|11075743|FG001|6 Month Follow-up|Overall Study||77
9956485|NCT01446419|11075742|FG000|12 Month Follow-up|Overall Study||142
9956486|NCT01446419|11075743|FG001|12 Month Follow-up|Overall Study||77
9956487|NCT01446419|11075742|FG000|COMPLETED|Overall Study||142
9956488|NCT01446419|11075743|FG001|COMPLETED|Overall Study||77
9956489|NCT01446419|11075742|FG000|NOT COMPLETED|Overall Study||5
10011142|NCT01778062|11133861|FG000|STARTED|Overall Study||68
10011143|NCT01778062|11133862|FG001|STARTED|Overall Study||68
10011144|NCT01778062|11133861|FG000|Safety Set|Overall Study||68
10011145|NCT01778062|11133862|FG001|Safety Set|Overall Study||68
10011146|NCT01778062|11133861|FG000|Intent to Treat (ITT)|Overall Study||68
9956490|NCT01446419|11075743|FG001|NOT COMPLETED|Overall Study||1
9956491|NCT01446666|11075749|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
9956492|NCT01446666|11075749|FG000|COMPLETED|Overall Study||326
9956493|NCT01446666|11075749|FG000|NOT COMPLETED|Overall Study||81
9956494|NCT01446705|11075756|FG000|STARTED|Overall Study||50446
9956495|NCT01446705|11075757|FG001|STARTED|Overall Study||6627
9956496|NCT01446705|11075756|FG000|COMPLETED|Overall Study||50446
9956497|NCT01446705|11075757|FG001|COMPLETED|Overall Study||6627
9956498|NCT01446705|11075756|FG000|NOT COMPLETED|Overall Study||0
9956499|NCT01446705|11075757|FG001|NOT COMPLETED|Overall Study||0
9956500|NCT01446809|11075775|FG000|STARTED|Overall Study||14
9956501|NCT01446809|11075776|FG001|STARTED|Overall Study||7
9956502|NCT01446809|11075777|FG002|STARTED|Overall Study||2
9956503|NCT01446809|11075775|FG000|COMPLETED|Overall Study||14
9956504|NCT01446809|11075776|FG001|COMPLETED|Overall Study||7
9956505|NCT01446809|11075777|FG002|COMPLETED|Overall Study||0
9956506|NCT01446809|11075775|FG000|NOT COMPLETED|Overall Study||0
10019018|NCT01826981|11142060|FG009|NOT COMPLETED|Overall Study||1
9956507|NCT01446809|11075776|FG001|NOT COMPLETED|Overall Study||0
9956508|NCT01446809|11075777|FG002|NOT COMPLETED|Overall Study||2
9956509|NCT01446874|11075789|FG000|STARTED|Overall Study||20
9956510|NCT01446874|11075790|FG001|STARTED|Overall Study||50
9956511|NCT01446874|11075791|FG002|STARTED|Overall Study||80
9956512|NCT01446874|11075789|FG000|COMPLETED|Overall Study||18
9956513|NCT01446874|11075790|FG001|COMPLETED|Overall Study||46
9956514|NCT01446874|11075791|FG002|COMPLETED|Overall Study||62
9956515|NCT01446874|11075789|FG000|NOT COMPLETED|Overall Study||2
9956516|NCT01446874|11075790|FG001|NOT COMPLETED|Overall Study||4
9956517|NCT01446874|11075791|FG002|NOT COMPLETED|Overall Study||18
9956518|NCT01446913|11075802|FG000|STARTED|Overall Study||86
9956519|NCT01446913|11075803|FG001|STARTED|Overall Study||82
9956520|NCT01446913|11075804|FG002|STARTED|Overall Study||84
9956521|NCT01446913|11075802|FG000|Patients With Sleep Study|Overall Study||53
9956522|NCT01446913|11075803|FG001|Patients With Sleep Study|Overall Study||56
9935412|NCT01319799|11053035|FG000|STARTED|Overall Study||10
9935413|NCT01319799|11053035|FG000|COMPLETED|Overall Study||10
9935414|NCT01319799|11053035|FG000|NOT COMPLETED|Overall Study||0
9935415|NCT01319812|11053041|FG000|STARTED|Overall Study||161
9935416|NCT01319812|11053042|FG001|STARTED|Overall Study||302
9935417|NCT01319812|11053041|FG000|COMPLETED|Overall Study||145
9935418|NCT01319812|11053042|FG001|COMPLETED|Overall Study||280
9935419|NCT01319812|11053041|FG000|NOT COMPLETED|Overall Study||16
9935420|NCT01319812|11053042|FG001|NOT COMPLETED|Overall Study||22
9935421|NCT01319851|11053055|FG000|STARTED|Overall Study||3
9935422|NCT01319851|11053055|FG000|COMPLETED|Overall Study||3
9935423|NCT01319851|11053055|FG000|NOT COMPLETED|Overall Study||0
9935424|NCT01319877|11053061|FG000|STARTED|Overall Study||453
9935425|NCT01319877|11053062|FG001|STARTED|Overall Study||153
9935426|NCT01319877|11053061|FG000|COMPLETED|Overall Study||345
9935427|NCT01319877|11053062|FG001|COMPLETED|Overall Study||108
9935428|NCT01319877|11053061|FG000|NOT COMPLETED|Overall Study||108
9935429|NCT01319877|11053062|FG001|NOT COMPLETED|Overall Study||45
9935430|NCT01319929|11053069|FG000|STARTED|First Treatment Period (4 Weeks)||20
9935431|NCT01319929|11053070|FG001|STARTED|First Treatment Period (4 Weeks)||19
9935432|NCT01319929|11053069|FG000|COMPLETED|First Treatment Period (4 Weeks)||17
9935433|NCT01319929|11053070|FG001|COMPLETED|First Treatment Period (4 Weeks)||17
9935434|NCT01319929|11053069|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3
9935435|NCT01319929|11053070|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2
9935436|NCT01319929|11053069|FG000|STARTED|Washout Period (3 Weeks)||17
9935437|NCT01319929|11053070|FG001|STARTED|Washout Period (3 Weeks)||17
9935438|NCT01319929|11053069|FG000|COMPLETED|Washout Period (3 Weeks)||17
9935439|NCT01319929|11053070|FG001|COMPLETED|Washout Period (3 Weeks)||17
9935440|NCT01319929|11053069|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
9935441|NCT01319929|11053070|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
9935442|NCT01319929|11053069|FG000|STARTED|Second Treatment Period (4 Weeks)||17
9935443|NCT01319929|11053070|FG001|STARTED|Second Treatment Period (4 Weeks)||17
9935444|NCT01319929|11053069|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16
9935445|NCT01319929|11053070|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16
9935446|NCT01319929|11053069|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
9935447|NCT01319929|11053070|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
9935448|NCT01319994|11053079|FG000|STARTED|Overall Study||26
9935449|NCT01319994|11053080|FG001|STARTED|Overall Study||27
9935450|NCT01319994|11053079|FG000|Abto Keep Appoinment Shedule|Overall Study||23
9935451|NCT01319994|11053080|FG001|Abto Keep Appoinment Shedule|Overall Study||24
9935452|NCT01319994|11053079|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19
9935453|NCT01319994|11053080|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24
9935454|NCT01319994|11053079|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19
9935455|NCT01319994|11053080|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22
9935456|NCT01319994|11053079|FG000|Did Not Develop Overt Diabetes|Overall Study||19
9935457|NCT01319994|11053080|FG001|Did Not Develop Overt Diabetes|Overall Study||21
9935458|NCT01319994|11053079|FG000|COMPLETED|Overall Study||19
9935459|NCT01319994|11053080|FG001|COMPLETED|Overall Study||21
9935460|NCT01319994|11053079|FG000|NOT COMPLETED|Overall Study||7
9935461|NCT01319994|11053080|FG001|NOT COMPLETED|Overall Study||6
9935462|NCT01320033|11053089|FG000|STARTED|Overall Study||216
9935463|NCT01320033|11053090|FG001|STARTED|Overall Study||224
9935464|NCT01320033|11053091|FG002|STARTED|Overall Study||222
9935465|NCT01320033|11053089|FG000|COMPLETED|Overall Study||158
9935466|NCT01320033|11053090|FG001|COMPLETED|Overall Study||160
9935467|NCT01320033|11053091|FG002|COMPLETED|Overall Study||169
9935468|NCT01320033|11053089|FG000|NOT COMPLETED|Overall Study||58
9935469|NCT01320033|11053090|FG001|NOT COMPLETED|Overall Study||64
9935470|NCT01320033|11053091|FG002|NOT COMPLETED|Overall Study||53
9935471|NCT01320085|11053102|FG000|STARTED|Overall Study||41
9935472|NCT01320085|11053103|FG001|STARTED|Overall Study||117
9935473|NCT01320085|11053104|FG002|STARTED|Overall Study||25
9935474|NCT01320085|11053102|FG000|COMPLETED|Overall Study||0
9935475|NCT01320085|11053103|FG001|COMPLETED|Overall Study||0
9935476|NCT01320085|11053104|FG002|COMPLETED|Overall Study||0
9935477|NCT01320085|11053102|FG000|NOT COMPLETED|Overall Study||41
9935478|NCT01320085|11053103|FG001|NOT COMPLETED|Overall Study||117
9935479|NCT01320085|11053104|FG002|NOT COMPLETED|Overall Study||25
9935480|NCT01320137|11053114|FG000|STARTED|Overall Study||40
9935481|NCT01320137|11053115|FG001|STARTED|Overall Study||40
9935482|NCT01320137|11053114|FG000|COMPLETED|Overall Study||40
9935483|NCT01320137|11053115|FG001|COMPLETED|Overall Study||40
9935484|NCT01320137|11053114|FG000|NOT COMPLETED|Overall Study||0
9935485|NCT01320137|11053115|FG001|NOT COMPLETED|Overall Study||0
9935486|NCT01320150|11053123|FG000|STARTED|Overall Study||311
9935487|NCT01320150|11053123|FG000|PPP|Overall Study||34
9935488|NCT01320150|11053123|FG000|Non-PPP|Overall Study||211
9935489|NCT01320150|11053123|FG000|COMPLETED|Overall Study||245
9935490|NCT01320150|11053123|FG000|NOT COMPLETED|Overall Study||66
9935491|NCT01320202|11053129|FG000|STARTED|Overall Study||152
9935492|NCT01320202|11053130|FG001|STARTED|Overall Study||153
9935493|NCT01320202|11053129|FG000|Comp 48 Wks in St 2|Overall Study||27
9935494|NCT01320202|11053130|FG001|Comp 48 Wks in St 2|Overall Study||27
9935495|NCT01320202|11053129|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
9935496|NCT01320202|11053130|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
9935497|NCT01320202|11053129|FG000|Enrolled in St 3|Overall Study||98
9935498|NCT01320202|11053130|FG001|Enrolled in St 3|Overall Study||109
9935499|NCT01320202|11053129|FG000|Completed St 3|Overall Study||79
9935500|NCT01320202|11053130|FG001|Completed St 3|Overall Study||82
9935501|NCT01320202|11053129|FG000|COMPLETED|Overall Study||96
9935502|NCT01320202|11053130|FG001|COMPLETED|Overall Study||109
9935503|NCT01320202|11053129|FG000|NOT COMPLETED|Overall Study||56
9935504|NCT01320202|11053130|FG001|NOT COMPLETED|Overall Study||44
9935505|NCT01320293|11053139|FG000|STARTED|Overall Study||18
9935506|NCT01320293|11053139|FG000|COMPLETED|Overall Study||16
9935507|NCT01320293|11053139|FG000|NOT COMPLETED|Overall Study||2
9935508|NCT01320553|11053147|FG000|STARTED|Overall Study||31
9935509|NCT01320553|11053148|FG001|STARTED|Overall Study||30
9935510|NCT01320553|11053149|FG002|STARTED|Overall Study||31
9935511|NCT01320553|11053150|FG003|STARTED|Overall Study||30
9935512|NCT01320553|11053147|FG000|COMPLETED|Overall Study||30
9935513|NCT01320553|11053148|FG001|COMPLETED|Overall Study||26
9935514|NCT01320553|11053149|FG002|COMPLETED|Overall Study||29
9935515|NCT01320553|11053150|FG003|COMPLETED|Overall Study||29
9935516|NCT01320553|11053147|FG000|NOT COMPLETED|Overall Study||1
9935517|NCT01320553|11053148|FG001|NOT COMPLETED|Overall Study||4
9935518|NCT01320553|11053149|FG002|NOT COMPLETED|Overall Study||2
9935519|NCT01320553|11053150|FG003|NOT COMPLETED|Overall Study||1
9935520|NCT01320722|11053165|FG000|STARTED|Overall Study||46
9935521|NCT01320722|11053166|FG001|STARTED|Overall Study||47
9935522|NCT01320722|11053167|FG002|STARTED|Overall Study||47
9935523|NCT01320722|11053168|FG003|STARTED|Overall Study||49
9935524|NCT01320722|11053169|FG004|STARTED|Overall Study||53
9935525|NCT01320722|11053165|FG000|Received Intervention|Overall Study||43
9935526|NCT01320722|11053166|FG001|Received Intervention|Overall Study||45
9935527|NCT01320722|11053167|FG002|Received Intervention|Overall Study||46
9935528|NCT01320722|11053168|FG003|Received Intervention|Overall Study||48
9935529|NCT01320722|11053169|FG004|Received Intervention|Overall Study||51
9935530|NCT01320722|11053165|FG000|COMPLETED|Overall Study||43
9935531|NCT01320722|11053166|FG001|COMPLETED|Overall Study||41
9935532|NCT01320722|11053167|FG002|COMPLETED|Overall Study||40
9935533|NCT01320722|11053168|FG003|COMPLETED|Overall Study||35
9935534|NCT01320722|11053169|FG004|COMPLETED|Overall Study||45
9935535|NCT01320722|11053165|FG000|NOT COMPLETED|Overall Study||3
9935536|NCT01320722|11053166|FG001|NOT COMPLETED|Overall Study||6
9935537|NCT01320722|11053167|FG002|NOT COMPLETED|Overall Study||7
9935538|NCT01320722|11053168|FG003|NOT COMPLETED|Overall Study||14
9935539|NCT01320722|11053169|FG004|NOT COMPLETED|Overall Study||8
9935540|NCT01320735|11053184|FG000|STARTED|Overall Study||300
9935541|NCT01320735|11053184|FG000|COMPLETED|Overall Study||194
9935542|NCT01320735|11053184|FG000|NOT COMPLETED|Overall Study||106
9935543|NCT01320826|11053188|FG000|STARTED|Overall Study||577
9935544|NCT01320826|11053188|FG000|COMPLETED|Overall Study||577
9935545|NCT01320826|11053188|FG000|NOT COMPLETED|Overall Study||0
9935546|NCT01320943|11053205|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
9935547|NCT01320943|11053206|FG001|STARTED|Overall Study||22
9935548|NCT01320943|11053205|FG000|COMPLETED|Overall Study||20
9935549|NCT01320943|11053206|FG001|COMPLETED|Overall Study||20
9935550|NCT01320943|11053205|FG000|NOT COMPLETED|Overall Study||1
10011147|NCT01778062|11133862|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
10011148|NCT01778062|11133861|FG000|COMPLETED|Overall Study||62
10011149|NCT01778062|11133862|FG001|COMPLETED|Overall Study||57
10011150|NCT01778062|11133861|FG000|NOT COMPLETED|Overall Study||6
9935551|NCT01320943|11053206|FG001|NOT COMPLETED|Overall Study||2
9935552|NCT01321073|11053219|FG000|STARTED|Overall Study||64
9935553|NCT01321073|11053219|FG000|COMPLETED|Overall Study||57
9935554|NCT01321073|11053219|FG000|NOT COMPLETED|Overall Study||7
9935555|NCT01321151|11053225|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
9935556|NCT01321151|11053226|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
9935557|NCT01321151|11053225|FG000|COMPLETED|Overall Study||6
9935558|NCT01321151|11053226|FG001|COMPLETED|Overall Study||6
9935559|NCT01321151|11053225|FG000|NOT COMPLETED|Overall Study||0
9935560|NCT01321151|11053226|FG001|NOT COMPLETED|Overall Study||0
9935561|NCT01321177|11053234|FG000|STARTED|Overall Study||223
9935562|NCT01321177|11053235|FG001|STARTED|Overall Study||181
9935563|NCT01321177|11053234|FG000|COMPLETED|Overall Study||147
9935564|NCT01321177|11053235|FG001|COMPLETED|Overall Study||84
9935565|NCT01321177|11053234|FG000|NOT COMPLETED|Overall Study||76
9935566|NCT01321177|11053235|FG001|NOT COMPLETED|Overall Study||97
10011151|NCT01778062|11133862|FG001|NOT COMPLETED|Overall Study||11
9935567|NCT01321437|11053241|FG000|STARTED|Overall Study||11
9935568|NCT01321437|11053241|FG000|COMPLETED|Overall Study||11
9935569|NCT01321437|11053241|FG000|NOT COMPLETED|Overall Study||0
9935570|NCT01321541|11053247|FG000|STARTED|Overall Study||155
9935571|NCT01321541|11053248|FG001|STARTED|Overall Study||157
9935572|NCT01321541|11053247|FG000|COMPLETED|Overall Study||72
9935573|NCT01321541|11053248|FG001|COMPLETED|Overall Study||61
9935574|NCT01321541|11053247|FG000|NOT COMPLETED|Overall Study||83
9935575|NCT01321541|11053248|FG001|NOT COMPLETED|Overall Study||96
9935576|NCT01321554|11053256|FG000|STARTED|Randomization Phase||261
9935577|NCT01321554|11053257|FG001|STARTED|Randomization Phase||131
9935578|NCT01321554|11053258|FG002|STARTED|Randomization Phase||0
9935579|NCT01321554|11053259|FG003|STARTED|Randomization Phase||0
9935580|NCT01321554|11053256|FG000|COMPLETED|Randomization Phase||261
9935581|NCT01321554|11053257|FG001|COMPLETED|Randomization Phase||131
9935582|NCT01321554|11053258|FG002|COMPLETED|Randomization Phase||0
9935583|NCT01321554|11053259|FG003|COMPLETED|Randomization Phase||0
9935584|NCT01321554|11053256|FG000|NOT COMPLETED|Randomization Phase||0
9935585|NCT01321554|11053257|FG001|NOT COMPLETED|Randomization Phase||0
9935586|NCT01321554|11053258|FG002|NOT COMPLETED|Randomization Phase||0
9935587|NCT01321554|11053259|FG003|NOT COMPLETED|Randomization Phase||0
9935588|NCT01321554|11053256|FG000|STARTED|OOL Lenvatinib Treatment Period||0
9935589|NCT01321554|11053257|FG001|STARTED|OOL Lenvatinib Treatment Period||0
9935590|NCT01321554|11053258|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
9935591|NCT01321554|11053259|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
9935592|NCT01321554|11053256|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0
9935593|NCT01321554|11053257|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0
9935594|NCT01321554|11053258|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85
9935595|NCT01321554|11053259|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30
9935596|NCT01321554|11053256|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
9935597|NCT01321554|11053257|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
9935598|NCT01321554|11053258|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
9935599|NCT01321554|11053259|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
9935600|NCT01321606|11053269|FG000|STARTED|Overall Study||18
9935601|NCT01321606|11053270|FG001|STARTED|Overall Study||32
9935602|NCT01321606|11053271|FG002|STARTED|Overall Study||34
9935603|NCT01321606|11053272|FG003|STARTED|Overall Study||29
9935604|NCT01321606|11053269|FG000|COMPLETED|Overall Study||18
9935605|NCT01321606|11053270|FG001|COMPLETED|Overall Study||32
9935606|NCT01321606|11053271|FG002|COMPLETED|Overall Study||34
9935607|NCT01321606|11053272|FG003|COMPLETED|Overall Study||28
9935608|NCT01321606|11053269|FG000|NOT COMPLETED|Overall Study||0
9935609|NCT01321606|11053270|FG001|NOT COMPLETED|Overall Study||0
9935610|NCT01321606|11053271|FG002|NOT COMPLETED|Overall Study||0
9935611|NCT01321606|11053272|FG003|NOT COMPLETED|Overall Study||1
9935612|NCT01321710|11053285|FG000|STARTED|Overall Study||50
9935613|NCT01321710|11053286|FG001|STARTED|Overall Study||58
9935614|NCT01321710|11053287|FG002|STARTED|Overall Study||44
9935615|NCT01321710|11053285|FG000|COMPLETED|Overall Study||46
9935616|NCT01321710|11053286|FG001|COMPLETED|Overall Study||53
9935617|NCT01321710|11053287|FG002|COMPLETED|Overall Study||44
9935618|NCT01321710|11053285|FG000|NOT COMPLETED|Overall Study||4
9935619|NCT01321710|11053286|FG001|NOT COMPLETED|Overall Study||5
9935620|NCT01321710|11053287|FG002|NOT COMPLETED|Overall Study||0
10207004|NCT03520387|11333829|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
10207005|NCT03520387|11333830|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
10207006|NCT03520387|11333831|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
10207007|NCT03520387|11333827|FG000|COMPLETED|Randomized||0
10207008|NCT03520387|11333828|FG001|COMPLETED|Randomized||4
10207009|NCT03520387|11333829|FG002|COMPLETED|Randomized||3
10207010|NCT03520387|11333830|FG003|COMPLETED|Randomized||3
10207011|NCT03520387|11333831|FG004|COMPLETED|Randomized||3
10207012|NCT03520387|11333827|FG000|NOT COMPLETED|Randomized||0
10207013|NCT03520387|11333828|FG001|NOT COMPLETED|Randomized||0
10207014|NCT03520387|11333829|FG002|NOT COMPLETED|Randomized||0
10207015|NCT03520387|11333830|FG003|NOT COMPLETED|Randomized||0
10207016|NCT03520387|11333831|FG004|NOT COMPLETED|Randomized||0
10207017|NCT03520400|11333844|FG000|STARTED|Overall Study||37
10207018|NCT03520400|11333845|FG001|STARTED|Overall Study||14
10207019|NCT03520400|11333844|FG000|COMPLETED|Overall Study||22
10207020|NCT03520400|11333845|FG001|COMPLETED|Overall Study||7
10207021|NCT03520400|11333844|FG000|NOT COMPLETED|Overall Study||15
10207022|NCT03520400|11333845|FG001|NOT COMPLETED|Overall Study||7
10207023|NCT03520920|11333854|FG000|STARTED|Overall Study||20
10207024|NCT03520920|11333855|FG001|STARTED|Overall Study||16
10207025|NCT03520920|11333856|FG002|STARTED|Overall Study||5
10207026|NCT03520920|11333854|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10207027|NCT03520920|11333855|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10207028|NCT03520920|11333856|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
10207029|NCT03520920|11333854|FG000|COMPLETED|Overall Study||0
10207030|NCT03520920|11333855|FG001|COMPLETED|Overall Study||0
10207031|NCT03520920|11333856|FG002|COMPLETED|Overall Study||0
10207032|NCT03520920|11333854|FG000|NOT COMPLETED|Overall Study||20
10207033|NCT03520920|11333855|FG001|NOT COMPLETED|Overall Study||16
10207034|NCT03520920|11333856|FG002|NOT COMPLETED|Overall Study||5
10207035|NCT03520959|11333872|FG000|STARTED|Overall Study||0
10207036|NCT03520959|11333873|FG001|STARTED|Overall Study||1
10207037|NCT03520959|11333872|FG000|COMPLETED|Overall Study||0
10207038|NCT03520959|11333873|FG001|COMPLETED|Overall Study||0
9935621|NCT01321723|11053300|FG000|STARTED|Overall Study||32
9935622|NCT01321723|11053301|FG001|STARTED|Overall Study||33
9935623|NCT01321723|11053302|FG002|STARTED|Overall Study||32
9935624|NCT01321723|11053300|FG000|COMPLETED|Overall Study||27
9935625|NCT01321723|11053301|FG001|COMPLETED|Overall Study||28
9935626|NCT01321723|11053302|FG002|COMPLETED|Overall Study||28
9935627|NCT01321723|11053300|FG000|NOT COMPLETED|Overall Study||5
9935628|NCT01321723|11053301|FG001|NOT COMPLETED|Overall Study||5
9935629|NCT01321723|11053302|FG002|NOT COMPLETED|Overall Study||4
9935630|NCT01321749|11053312|FG000|STARTED|Overall Study||51
10207039|NCT03520959|11333872|FG000|NOT COMPLETED|Overall Study||0
10207040|NCT03520959|11333873|FG001|NOT COMPLETED|Overall Study||1
10207041|NCT03520998|11333881|FG000|STARTED|Overall Study||24
10207042|NCT03520998|11333882|FG001|STARTED|Overall Study||23
10207043|NCT03520998|11333881|FG000|COMPLETED|Overall Study||18
9935631|NCT01321749|11053313|FG001|STARTED|Overall Study||52
9935632|NCT01321749|11053312|FG000|COMPLETED|Overall Study||38
9935633|NCT01321749|11053313|FG001|COMPLETED|Overall Study||30
9935634|NCT01321749|11053312|FG000|NOT COMPLETED|Overall Study||13
9935635|NCT01321749|11053313|FG001|NOT COMPLETED|Overall Study||22
9935636|NCT01321879|11053319|FG000|STARTED|Overall Study||39
9935637|NCT01321879|11053319|FG000|COMPLETED|Overall Study||25
9935638|NCT01321879|11053319|FG000|NOT COMPLETED|Overall Study||14
9935639|NCT01322009|11053325|FG000|STARTED|Overall Study||7
9935640|NCT01322009|11053326|FG001|STARTED|Overall Study||7
9935641|NCT01322009|11053325|FG000|COMPLETED|Overall Study||7
9935642|NCT01322009|11053326|FG001|COMPLETED|Overall Study||4
9935643|NCT01322009|11053325|FG000|NOT COMPLETED|Overall Study||0
9935644|NCT01322009|11053326|FG001|NOT COMPLETED|Overall Study||3
9935645|NCT01322022|11053334|FG000|STARTED|Overall Study||20
9935646|NCT01322022|11053335|FG001|STARTED|Overall Study||20
9935647|NCT01322022|11053334|FG000|Week 4|Overall Study||15
9935648|NCT01322022|11053335|FG001|Week 4|Overall Study||18
9935649|NCT01322022|11053334|FG000|COMPLETED|Overall Study||15
9935650|NCT01322022|11053335|FG001|COMPLETED|Overall Study||18
9935651|NCT01322022|11053334|FG000|NOT COMPLETED|Overall Study||5
9935652|NCT01322022|11053335|FG001|NOT COMPLETED|Overall Study||2
9935653|NCT01322048|11053343|FG000|STARTED|Overall Study||21
9935654|NCT01322048|11053344|FG001|STARTED|Overall Study||26
9935655|NCT01322048|11053343|FG000|COMPLETED|Overall Study||21
9935656|NCT01322048|11053344|FG001|COMPLETED|Overall Study||26
9935657|NCT01322048|11053343|FG000|NOT COMPLETED|Overall Study||0
9935658|NCT01322048|11053344|FG001|NOT COMPLETED|Overall Study||0
9935659|NCT01322347|11053352|FG000|STARTED|Overall Study||147
9935660|NCT01322347|11053353|FG001|STARTED|Overall Study||147
9935661|NCT01322347|11053352|FG000|Completed 48 Wks in St 2|Overall Study||28
9935662|NCT01322347|11053353|FG001|Completed 48 Wks in St 2|Overall Study||22
9935663|NCT01322347|11053352|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
9935664|NCT01322347|11053353|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
9935665|NCT01322347|11053352|FG000|Enrolled in St 3|Overall Study||101
9935666|NCT01322347|11053353|FG001|Enrolled in St 3|Overall Study||113
9935667|NCT01322347|11053352|FG000|Completed St 3|Overall Study||82
9935668|NCT01322347|11053353|FG001|Completed St 3|Overall Study||86
9935669|NCT01322347|11053352|FG000|COMPLETED|Overall Study||96
9935670|NCT01322347|11053353|FG001|COMPLETED|Overall Study||112
9935671|NCT01322347|11053352|FG000|NOT COMPLETED|Overall Study||51
9935672|NCT01322347|11053353|FG001|NOT COMPLETED|Overall Study||35
9935673|NCT01322360|11053360|FG000|STARTED|Overall Study||50
10207044|NCT03520998|11333882|FG001|COMPLETED|Overall Study||21
10207045|NCT03520998|11333881|FG000|NOT COMPLETED|Overall Study||6
10207046|NCT03520998|11333882|FG001|NOT COMPLETED|Overall Study||2
10207047|NCT03521089|11333890|FG000|STARTED|Overall Study||8
10207048|NCT03521089|11333891|FG001|STARTED|Overall Study||8
10207049|NCT03521089|11333890|FG000|COMPLETED|Overall Study||8
10207050|NCT03521089|11333891|FG001|COMPLETED|Overall Study||8
10207051|NCT03521089|11333890|FG000|NOT COMPLETED|Overall Study||0
10207052|NCT03521089|11333891|FG001|NOT COMPLETED|Overall Study||0
10207053|NCT03521115|11333899|FG000|STARTED|Time 0 Baseline Surveys||206
10207054|NCT03521115|11333900|FG001|STARTED|Time 0 Baseline Surveys||205
10207055|NCT03521115|11333899|FG000|COMPLETED|Time 0 Baseline Surveys||206
10207056|NCT03521115|11333900|FG001|COMPLETED|Time 0 Baseline Surveys||205
10207057|NCT03521115|11333899|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0
10207058|NCT03521115|11333900|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0
10207059|NCT03521115|11333899|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206
10207060|NCT03521115|11333900|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205
10207061|NCT03521115|11333899|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150
10207062|NCT03521115|11333900|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165
10207063|NCT03521115|11333899|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56
9935674|NCT01322360|11053360|FG000|COMPLETED|Overall Study||50
9935675|NCT01322360|11053360|FG000|NOT COMPLETED|Overall Study||0
9935676|NCT01322386|11053367|FG000|STARTED|Overall Study||10
9935677|NCT01322386|11053368|FG001|STARTED|Overall Study||11
9935678|NCT01322386|11053367|FG000|COMPLETED|Overall Study||10
9935679|NCT01322386|11053368|FG001|COMPLETED|Overall Study||9
9935680|NCT01322386|11053367|FG000|NOT COMPLETED|Overall Study||0
9935681|NCT01322386|11053368|FG001|NOT COMPLETED|Overall Study||2
9935682|NCT01322490|11053379|FG000|STARTED|Treatment Period||432
9935683|NCT01322490|11053380|FG001|STARTED|Treatment Period||432
10207064|NCT03521115|11333900|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40
10207065|NCT03521115|11333899|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150
10207066|NCT03521115|11333900|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165
10207067|NCT03521115|11333899|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147
9935684|NCT01322490|11053381|FG002|STARTED|Treatment Period||433
9935685|NCT01322490|11053379|FG000|Treated|Treatment Period||429
9935686|NCT01322490|11053380|FG001|Treated|Treatment Period||429
9935687|NCT01322490|11053381|FG002|Treated|Treatment Period||428
9935688|NCT01322490|11053379|FG000|COMPLETED|Treatment Period||300
9935689|NCT01322490|11053380|FG001|COMPLETED|Treatment Period||279
9935690|NCT01322490|11053381|FG002|COMPLETED|Treatment Period||280
9935691|NCT01322490|11053379|FG000|NOT COMPLETED|Treatment Period||132
9935692|NCT01322490|11053380|FG001|NOT COMPLETED|Treatment Period||153
9935693|NCT01322490|11053381|FG002|NOT COMPLETED|Treatment Period||153
9935694|NCT01322490|11053379|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
9935695|NCT01322490|11053380|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
9935696|NCT01322490|11053381|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
9935697|NCT01322490|11053379|FG000|COMPLETED|Long Term Follow-up Period||0
9935698|NCT01322490|11053380|FG001|COMPLETED|Long Term Follow-up Period||0
9935699|NCT01322490|11053381|FG002|COMPLETED|Long Term Follow-up Period||0
9935700|NCT01322490|11053379|FG000|NOT COMPLETED|Long Term Follow-up Period||409
9935701|NCT01322490|11053380|FG001|NOT COMPLETED|Long Term Follow-up Period||408
9935702|NCT01322490|11053381|FG002|NOT COMPLETED|Long Term Follow-up Period||413
9935703|NCT01322594|11053395|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
9935704|NCT01322594|11053396|FG001|STARTED|Overall Study||3
9935705|NCT01322594|11053397|FG002|STARTED|Overall Study||3
9935706|NCT01322594|11053398|FG003|STARTED|Overall Study||6
9935707|NCT01322594|11053399|FG004|STARTED|Overall Study||7
9935708|NCT01322594|11053400|FG005|STARTED|Overall Study||6
9935709|NCT01322594|11053395|FG000|COMPLETED|Overall Study||6
9935710|NCT01322594|11053396|FG001|COMPLETED|Overall Study||3
9935711|NCT01322594|11053397|FG002|COMPLETED|Overall Study||3
9935712|NCT01322594|11053398|FG003|COMPLETED|Overall Study||6
9935713|NCT01322594|11053399|FG004|COMPLETED|Overall Study||7
9935714|NCT01322594|11053400|FG005|COMPLETED|Overall Study||6
9935715|NCT01322594|11053395|FG000|NOT COMPLETED|Overall Study||0
9935716|NCT01322594|11053396|FG001|NOT COMPLETED|Overall Study||0
9935717|NCT01322594|11053397|FG002|NOT COMPLETED|Overall Study||0
9935718|NCT01322594|11053398|FG003|NOT COMPLETED|Overall Study||0
9935719|NCT01322594|11053399|FG004|NOT COMPLETED|Overall Study||0
9935720|NCT01322594|11053400|FG005|NOT COMPLETED|Overall Study||0
9935721|NCT01322607|11053416|FG000|STARTED|Overall Study||11
9935722|NCT01322607|11053417|FG001|STARTED|Overall Study||9
9935723|NCT01322607|11053416|FG000|COMPLETED|Overall Study||10
9935724|NCT01322607|11053417|FG001|COMPLETED|Overall Study||9
9935725|NCT01322607|11053416|FG000|NOT COMPLETED|Overall Study||1
9935726|NCT01322607|11053417|FG001|NOT COMPLETED|Overall Study||0
9935727|NCT01322633|11053425|FG000|STARTED|Overall Study||34178
9935728|NCT01322633|11053426|FG001|STARTED|Overall Study||27686
9935729|NCT01322633|11053425|FG000|COMPLETED|Overall Study||34178
9935730|NCT01322633|11053426|FG001|COMPLETED|Overall Study||27686
9935731|NCT01322633|11053425|FG000|NOT COMPLETED|Overall Study||0
9935732|NCT01322633|11053426|FG001|NOT COMPLETED|Overall Study||0
9935733|NCT01322815|11053434|FG000|STARTED|Overall Study||7
9935734|NCT01322815|11053435|FG001|STARTED|Overall Study||4
9935735|NCT01322815|11053434|FG000|COMPLETED|Overall Study||7
9935736|NCT01322815|11053435|FG001|COMPLETED|Overall Study||4
9935737|NCT01322815|11053434|FG000|NOT COMPLETED|Overall Study||0
9935738|NCT01322815|11053435|FG001|NOT COMPLETED|Overall Study||0
9935739|NCT01322841|11053443|FG000|STARTED|Overall Study||1116
9935740|NCT01322841|11053444|FG001|STARTED|Overall Study||1123
9935741|NCT01322841|11053443|FG000|COMPLETED|Overall Study||1116
9935742|NCT01322841|11053444|FG001|COMPLETED|Overall Study||1123
9935743|NCT01322841|11053443|FG000|NOT COMPLETED|Overall Study||0
9935744|NCT01322841|11053444|FG001|NOT COMPLETED|Overall Study||0
9935745|NCT01322945|11053452|FG000|STARTED|Overall Study||52
9935746|NCT01322945|11053453|FG001|STARTED|Overall Study||42
9935747|NCT01322945|11053452|FG000|COMPLETED|Overall Study||52
9935748|NCT01322945|11053453|FG001|COMPLETED|Overall Study||42
9935749|NCT01322945|11053452|FG000|NOT COMPLETED|Overall Study||0
9935750|NCT01322945|11053453|FG001|NOT COMPLETED|Overall Study||0
9935751|NCT01323010|11053463|FG000|STARTED|Overall Study||60
9935752|NCT01323010|11053464|FG001|STARTED|Overall Study||59
9935753|NCT01323010|11053463|FG000|COMPLETED|Overall Study||60
9935754|NCT01323010|11053464|FG001|COMPLETED|Overall Study||59
9935755|NCT01323010|11053463|FG000|NOT COMPLETED|Overall Study||0
9935756|NCT01323010|11053464|FG001|NOT COMPLETED|Overall Study||0
9935757|NCT01323140|11053482|FG000|STARTED|Overall Study||40
9935758|NCT01323140|11053482|FG000|COMPLETED|Overall Study||38
9935759|NCT01323140|11053482|FG000|NOT COMPLETED|Overall Study||2
9935760|NCT01323153|11053488|FG000|STARTED|Overall Study||150
9935761|NCT01323153|11053489|FG001|STARTED|Overall Study||150
9935762|NCT01323153|11053488|FG000|COMPLETED|Overall Study||133
9935763|NCT01323153|11053489|FG001|COMPLETED|Overall Study||142
9935764|NCT01323153|11053488|FG000|NOT COMPLETED|Overall Study||17
9935765|NCT01323153|11053489|FG001|NOT COMPLETED|Overall Study||8
9935766|NCT01323192|11053497|FG000|STARTED|Overall Study||143
9935767|NCT01323192|11053498|FG001|STARTED|Overall Study||141
9935768|NCT01323192|11053497|FG000|COMPLETED|Overall Study||134
9935769|NCT01323192|11053498|FG001|COMPLETED|Overall Study||135
9935770|NCT01323192|11053497|FG000|NOT COMPLETED|Overall Study||9
9935771|NCT01323192|11053498|FG001|NOT COMPLETED|Overall Study||6
9935772|NCT01323270|11053506|FG000|STARTED|Overall Study||373
9935773|NCT01323270|11053507|FG001|STARTED|Overall Study||376
10207068|NCT03521115|11333900|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164
10207069|NCT03521115|11333899|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3
10207070|NCT03521115|11333900|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1
10207071|NCT03521115|11333899|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147
10207072|NCT03521115|11333900|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164
9935774|NCT01323270|11053506|FG000|COMPLETED|Overall Study||330
9935775|NCT01323270|11053507|FG001|COMPLETED|Overall Study||347
9935776|NCT01323270|11053506|FG000|NOT COMPLETED|Overall Study||43
9935777|NCT01323270|11053507|FG001|NOT COMPLETED|Overall Study||29
9935778|NCT01323387|11053514|FG000|STARTED|Overall Study||178
9935779|NCT01323387|11053514|FG000|COMPLETED|Overall Study||94
9935780|NCT01323387|11053514|FG000|NOT COMPLETED|Overall Study||84
9935781|NCT01323478|11053520|FG000|STARTED|Overall Study||71
9935782|NCT01323478|11053520|FG000|COMPLETED|Overall Study||47
9935783|NCT01323478|11053520|FG000|NOT COMPLETED|Overall Study||24
9935784|NCT01323517|11053524|FG000|STARTED|Overall Study||26
9935785|NCT01323517|11053524|FG000|COMPLETED|Overall Study||26
9935786|NCT01323517|11053524|FG000|NOT COMPLETED|Overall Study||0
9935787|NCT01323530|11053535|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8
9935788|NCT01323530|11053536|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6
9935789|NCT01323530|11053537|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5
9935790|NCT01323530|11053538|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3
9935791|NCT01323530|11053539|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6
9935792|NCT01323530|11053540|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6
9935793|NCT01323530|11053541|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0
9935794|NCT01323530|11053535|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5
9935795|NCT01323530|11053536|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4
9935796|NCT01323530|11053537|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4
9935797|NCT01323530|11053538|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3
9935798|NCT01323530|11053539|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3
9935799|NCT01323530|11053540|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3
9935800|NCT01323530|11053541|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0
9935801|NCT01323530|11053535|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
9935802|NCT01323530|11053536|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
9935803|NCT01323530|11053537|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
9935804|NCT01323530|11053538|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
9935805|NCT01323530|11053539|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
9935806|NCT01323530|11053540|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
9935807|NCT01323530|11053541|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
9935808|NCT01323530|11053535|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0
9935809|NCT01323530|11053536|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0
9935810|NCT01323530|11053537|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0
9935811|NCT01323530|11053538|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0
9935812|NCT01323530|11053539|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0
9935813|NCT01323530|11053540|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0
9935814|NCT01323530|11053541|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42
9935815|NCT01323530|11053535|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935816|NCT01323530|11053536|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935817|NCT01323530|11053537|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935818|NCT01323530|11053538|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935819|NCT01323530|11053539|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935820|NCT01323530|11053540|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935821|NCT01323530|11053541|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
9935822|NCT01323530|11053535|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935823|NCT01323530|11053536|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935824|NCT01323530|11053537|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935825|NCT01323530|11053538|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935826|NCT01323530|11053539|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935827|NCT01323530|11053540|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
9935828|NCT01323530|11053541|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
9935829|NCT01323582|11053560|FG000|STARTED|Weeks 1-4 (First Period)||12
9935830|NCT01323582|11053561|FG001|STARTED|Weeks 1-4 (First Period)||14
9935831|NCT01323582|11053560|FG000|COMPLETED|Weeks 1-4 (First Period)||10
9935832|NCT01323582|11053561|FG001|COMPLETED|Weeks 1-4 (First Period)||12
9935833|NCT01323582|11053560|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2
9935834|NCT01323582|11053561|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2
9935835|NCT01323582|11053560|FG000|STARTED|Weeks 5-7 (Washout)||10
10207073|NCT03521115|11333899|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145
10207074|NCT03521115|11333900|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164
10207075|NCT03521115|11333899|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2
10207076|NCT03521115|11333900|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0
10207077|NCT03521141|11333915|FG000|STARTED|Overall Study||19
10207078|NCT03521141|11333916|FG001|STARTED|Overall Study||19
9935836|NCT01323582|11053561|FG001|STARTED|Weeks 5-7 (Washout)||12
9935837|NCT01323582|11053560|FG000|COMPLETED|Weeks 5-7 (Washout)||10
9935838|NCT01323582|11053561|FG001|COMPLETED|Weeks 5-7 (Washout)||11
9935839|NCT01323582|11053560|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0
10207079|NCT03521141|11333917|FG002|STARTED|Overall Study||20
10207080|NCT03521141|11333915|FG000|COMPLETED|Overall Study||18
10207081|NCT03521141|11333916|FG001|COMPLETED|Overall Study||19
9935840|NCT01323582|11053561|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1
9935841|NCT01323582|11053560|FG000|STARTED|Weeks 8-11 (Period 2)||10
9935842|NCT01323582|11053561|FG001|STARTED|Weeks 8-11 (Period 2)||11
9935843|NCT01323582|11053560|FG000|COMPLETED|Weeks 8-11 (Period 2)||10
9935844|NCT01323582|11053561|FG001|COMPLETED|Weeks 8-11 (Period 2)||10
9935845|NCT01323582|11053560|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0
9935846|NCT01323582|11053561|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1
9935847|NCT01323595|11053571|FG000|STARTED|Overall Study||39
9935848|NCT01323595|11053572|FG001|STARTED|Overall Study||39
9935849|NCT01323595|11053571|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
9935850|NCT01323595|11053572|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
9935851|NCT01323595|11053571|FG000|NOT COMPLETED|Overall Study||23
9935852|NCT01323595|11053572|FG001|NOT COMPLETED|Overall Study||21
9935853|NCT01323621|11053582|FG000|STARTED|2-week, Single-blind Run In Period||739
9935854|NCT01323621|11053583|FG001|STARTED|2-week, Single-blind Run In Period||0
9935855|NCT01323621|11053584|FG002|STARTED|2-week, Single-blind Run In Period||0
9935856|NCT01323621|11053582|FG000|COMPLETED|2-week, Single-blind Run In Period||511
9935857|NCT01323621|11053583|FG001|COMPLETED|2-week, Single-blind Run In Period||0
9935858|NCT01323621|11053584|FG002|COMPLETED|2-week, Single-blind Run In Period||0
10011152|NCT01778127|11133871|FG000|STARTED|Overall Study||33
10011153|NCT01778127|11133872|FG001|STARTED|Overall Study||33
10011154|NCT01778127|11133873|FG002|STARTED|Overall Study||32
10011155|NCT01778127|11133871|FG000|COMPLETED|Overall Study||25
9935859|NCT01323621|11053582|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228
9935860|NCT01323621|11053583|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0
9935861|NCT01323621|11053584|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0
9935862|NCT01323621|11053582|FG000|STARTED|12-week, Double-blind Treatment Period||0
9935863|NCT01323621|11053583|FG001|STARTED|12-week, Double-blind Treatment Period||252
9935864|NCT01323621|11053584|FG002|STARTED|12-week, Double-blind Treatment Period||259
9935865|NCT01323621|11053582|FG000|COMPLETED|12-week, Double-blind Treatment Period||0
9935866|NCT01323621|11053583|FG001|COMPLETED|12-week, Double-blind Treatment Period||237
9935867|NCT01323621|11053584|FG002|COMPLETED|12-week, Double-blind Treatment Period||239
9935868|NCT01323621|11053582|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0
9935869|NCT01323621|11053583|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15
9935870|NCT01323621|11053584|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20
9935871|NCT01323634|11053592|FG000|STARTED|2-week Run-in Period||733
9935872|NCT01323634|11053593|FG001|STARTED|2-week Run-in Period||0
9935873|NCT01323634|11053594|FG002|STARTED|2-week Run-in Period||0
9935874|NCT01323634|11053592|FG000|COMPLETED|2-week Run-in Period||521
9935875|NCT01323634|11053593|FG001|COMPLETED|2-week Run-in Period||0
9935876|NCT01323634|11053594|FG002|COMPLETED|2-week Run-in Period||0
9935877|NCT01323634|11053592|FG000|NOT COMPLETED|2-week Run-in Period||212
9935878|NCT01323634|11053593|FG001|NOT COMPLETED|2-week Run-in Period||0
9935879|NCT01323634|11053594|FG002|NOT COMPLETED|2-week Run-in Period||0
9935880|NCT01323634|11053592|FG000|STARTED|Double-Blind (DB) Treatment Period||0
9935881|NCT01323634|11053593|FG001|STARTED|Double-Blind (DB) Treatment Period||260
9935882|NCT01323634|11053594|FG002|STARTED|Double-Blind (DB) Treatment Period||261
9935883|NCT01323634|11053592|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0
9935884|NCT01323634|11053593|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235
9935885|NCT01323634|11053594|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239
9935886|NCT01323634|11053592|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
9935887|NCT01323634|11053593|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
9935888|NCT01323634|11053594|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
9935889|NCT01323647|11053602|FG000|STARTED|Overall Study||470
9935890|NCT01323647|11053603|FG001|STARTED|Overall Study||487
9935891|NCT01323647|11053602|FG000|COMPLETED|Overall Study||461
9935892|NCT01323647|11053603|FG001|COMPLETED|Overall Study||487
9935893|NCT01323647|11053602|FG000|NOT COMPLETED|Overall Study||9
9935894|NCT01323647|11053603|FG001|NOT COMPLETED|Overall Study||0
9935895|NCT01323660|11053609|FG000|STARTED|Treatment Period 1 (12 Weeks)||84
9935896|NCT01323660|11053610|FG001|STARTED|Treatment Period 1 (12 Weeks)||22
9935897|NCT01323660|11053611|FG002|STARTED|Treatment Period 1 (12 Weeks)||24
9935898|NCT01323660|11053612|FG003|STARTED|Treatment Period 1 (12 Weeks)||36
9935899|NCT01323660|11053613|FG004|STARTED|Treatment Period 1 (12 Weeks)||71
9935900|NCT01323660|11053614|FG005|STARTED|Treatment Period 1 (12 Weeks)||70
9935901|NCT01323660|11053609|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65
9935902|NCT01323660|11053610|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
9935903|NCT01323660|11053611|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19
9935904|NCT01323660|11053612|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31
9935905|NCT01323660|11053613|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61
9935906|NCT01323660|11053614|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61
9935907|NCT01323660|11053609|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
9935908|NCT01323660|11053610|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
9935909|NCT01323660|11053611|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
9935910|NCT01323660|11053612|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
9935911|NCT01323660|11053613|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
9935912|NCT01323660|11053614|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
9935913|NCT01323660|11053609|FG000|STARTED|Washout Period (14 Days)||65
10011156|NCT01778127|11133872|FG001|COMPLETED|Overall Study||31
10011157|NCT01778127|11133873|FG002|COMPLETED|Overall Study||26
9935914|NCT01323660|11053610|FG001|STARTED|Washout Period (14 Days)||21
10011158|NCT01778127|11133871|FG000|NOT COMPLETED|Overall Study||8
10011159|NCT01778127|11133872|FG001|NOT COMPLETED|Overall Study||2
10011160|NCT01778127|11133873|FG002|NOT COMPLETED|Overall Study||6
10011161|NCT01778179|11133883|FG000|STARTED|Overall Study||25
10011162|NCT01778179|11133884|FG001|STARTED|Overall Study||25
10011163|NCT01778179|11133883|FG000|COMPLETED|Overall Study||23
10011164|NCT01778179|11133884|FG001|COMPLETED|Overall Study||22
10011165|NCT01778179|11133883|FG000|NOT COMPLETED|Overall Study||2
10011166|NCT01778179|11133884|FG001|NOT COMPLETED|Overall Study||3
9935915|NCT01323660|11053611|FG002|STARTED|Washout Period (14 Days)||19
9935916|NCT01323660|11053612|FG003|STARTED|Washout Period (14 Days)||31
9935917|NCT01323660|11053613|FG004|STARTED|Washout Period (14 Days)||61
9935918|NCT01323660|11053614|FG005|STARTED|Washout Period (14 Days)||61
9935919|NCT01323660|11053609|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
9935920|NCT01323660|11053610|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
9935921|NCT01323660|11053611|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
9935922|NCT01323660|11053612|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
9935923|NCT01323660|11053613|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
9935924|NCT01323660|11053614|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
9935925|NCT01323660|11053609|FG000|NOT COMPLETED|Washout Period (14 Days)||0
9935926|NCT01323660|11053610|FG001|NOT COMPLETED|Washout Period (14 Days)||0
9935927|NCT01323660|11053611|FG002|NOT COMPLETED|Washout Period (14 Days)||1
9935928|NCT01323660|11053612|FG003|NOT COMPLETED|Washout Period (14 Days)||3
9935929|NCT01323660|11053613|FG004|NOT COMPLETED|Washout Period (14 Days)||3
9935930|NCT01323660|11053614|FG005|NOT COMPLETED|Washout Period (14 Days)||2
9935931|NCT01323660|11053609|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
9935932|NCT01323660|11053610|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
9935933|NCT01323660|11053611|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
9935934|NCT01323660|11053612|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
9935935|NCT01323660|11053613|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
9935936|NCT01323660|11053614|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
9935937|NCT01323660|11053609|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55
10011167|NCT01778296|11133890|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
10011168|NCT01778296|11133890|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12
10011169|NCT01778296|11133890|FG000|NOT COMPLETED|Overall Study||0
10011170|NCT01778426|11133896|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264
10011171|NCT01778426|11133897|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138
10011172|NCT01778426|11133896|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
10011173|NCT01778426|11133897|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
10011174|NCT01778426|11133896|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
10011175|NCT01778426|11133897|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
10011176|NCT01778426|11133896|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198
10011177|NCT01778426|11133897|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
10011178|NCT01778426|11133896|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198
10011179|NCT01778426|11133897|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
10011180|NCT01778426|11133896|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
9935938|NCT01323660|11053610|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17
9935939|NCT01323660|11053611|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14
9935940|NCT01323660|11053612|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25
9935941|NCT01323660|11053613|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55
9935942|NCT01323660|11053614|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51
9935943|NCT01323660|11053609|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
9935944|NCT01323660|11053610|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
9935945|NCT01323660|11053611|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
9935946|NCT01323660|11053612|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
9935947|NCT01323660|11053613|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
9935948|NCT01323660|11053614|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
9935949|NCT01323673|11053630|FG000|STARTED|Overall Study||62
9935950|NCT01323673|11053631|FG001|STARTED|Overall Study||63
9935951|NCT01323673|11053630|FG000|COMPLETED|Overall Study||59
9935952|NCT01323673|11053631|FG001|COMPLETED|Overall Study||58
9935953|NCT01323673|11053630|FG000|NOT COMPLETED|Overall Study||3
9935954|NCT01323673|11053631|FG001|NOT COMPLETED|Overall Study||5
9935955|NCT01323777|11053637|FG000|STARTED|Overall Study||65
9935956|NCT01323777|11053637|FG000|COMPLETED|Overall Study||65
9935957|NCT01323777|11053637|FG000|NOT COMPLETED|Overall Study||0
9935958|NCT01323790|11053651|FG000|STARTED|Overall Study||233
10019019|NCT01826981|11142061|FG010|NOT COMPLETED|Overall Study||2
9935959|NCT01323790|11053652|FG001|STARTED|Overall Study||234
9935960|NCT01323790|11053653|FG002|STARTED|Overall Study||233
9935961|NCT01323790|11053651|FG000|COMPLETED|Overall Study||178
9935962|NCT01323790|11053652|FG001|COMPLETED|Overall Study||174
9935963|NCT01323790|11053653|FG002|COMPLETED|Overall Study||188
9935964|NCT01323790|11053651|FG000|NOT COMPLETED|Overall Study||55
9935965|NCT01323790|11053652|FG001|NOT COMPLETED|Overall Study||60
9935966|NCT01323790|11053653|FG002|NOT COMPLETED|Overall Study||45
9935967|NCT01323855|11053666|FG000|STARTED|Overall Study||9
9935968|NCT01323855|11053667|FG001|STARTED|Overall Study||9
9935969|NCT01323855|11053668|FG002|STARTED|Overall Study||8
9935970|NCT01323855|11053669|FG003|STARTED|Overall Study||9
9935971|NCT01323855|11053670|FG004|STARTED|Overall Study||11
9935972|NCT01323855|11053666|FG000|COMPLETED|Overall Study||9
9935973|NCT01323855|11053667|FG001|COMPLETED|Overall Study||9
9935974|NCT01323855|11053668|FG002|COMPLETED|Overall Study||8
9935975|NCT01323855|11053669|FG003|COMPLETED|Overall Study||9
9935976|NCT01323855|11053670|FG004|COMPLETED|Overall Study||11
9935977|NCT01323855|11053666|FG000|NOT COMPLETED|Overall Study||0
9935978|NCT01323855|11053667|FG001|NOT COMPLETED|Overall Study||0
9935979|NCT01323855|11053668|FG002|NOT COMPLETED|Overall Study||0
9935980|NCT01323855|11053669|FG003|NOT COMPLETED|Overall Study||0
9935981|NCT01323855|11053670|FG004|NOT COMPLETED|Overall Study||0
9935982|NCT01323920|11053682|FG000|STARTED|Overall Study||35
9935983|NCT01323920|11053682|FG000|COMPLETED|Overall Study||29
10011181|NCT01778426|11133897|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
10011182|NCT01778465|11133906|FG000|STARTED|First Intervention (7 Days)||3
10011183|NCT01778465|11133907|FG001|STARTED|First Intervention (7 Days)||4
10011184|NCT01778465|11133906|FG000|COMPLETED|First Intervention (7 Days)||3
9935984|NCT01323920|11053682|FG000|NOT COMPLETED|Overall Study||6
9935985|NCT01323946|11053689|FG000|STARTED|Overall Study||46
9935986|NCT01323946|11053690|FG001|STARTED|Overall Study||34
9935987|NCT01323946|11053691|FG002|STARTED|Overall Study||33
9935988|NCT01323946|11053689|FG000|COMPLETED|Overall Study||43
9935989|NCT01323946|11053690|FG001|COMPLETED|Overall Study||31
9935990|NCT01323946|11053691|FG002|COMPLETED|Overall Study||33
9935991|NCT01323946|11053689|FG000|NOT COMPLETED|Overall Study||3
9935992|NCT01323946|11053690|FG001|NOT COMPLETED|Overall Study||3
9935993|NCT01323946|11053691|FG002|NOT COMPLETED|Overall Study||0
9935994|NCT01323959|11053704|FG000|STARTED|Overall Study||67
9935995|NCT01323959|11053705|FG001|STARTED|Overall Study||72
9935996|NCT01323959|11053706|FG002|STARTED|Overall Study||72
9935997|NCT01323959|11053704|FG000|COMPLETED|Overall Study||67
9935998|NCT01323959|11053705|FG001|COMPLETED|Overall Study||72
9935999|NCT01323959|11053706|FG002|COMPLETED|Overall Study||72
9936000|NCT01323959|11053704|FG000|NOT COMPLETED|Overall Study||0
9936001|NCT01323959|11053705|FG001|NOT COMPLETED|Overall Study||0
9936002|NCT01323959|11053706|FG002|NOT COMPLETED|Overall Study||0
9936003|NCT01323972|11053718|FG000|STARTED|Overall Study||81
9936004|NCT01323972|11053719|FG001|STARTED|Overall Study||79
9936005|NCT01323972|11053720|FG002|STARTED|Overall Study||80
9936006|NCT01323972|11053721|FG003|STARTED|Overall Study||80
9936007|NCT01323972|11053718|FG000|COMPLETED|Overall Study||79
9936008|NCT01323972|11053719|FG001|COMPLETED|Overall Study||76
9936009|NCT01323972|11053720|FG002|COMPLETED|Overall Study||78
9936010|NCT01323972|11053721|FG003|COMPLETED|Overall Study||79
9936011|NCT01323972|11053718|FG000|NOT COMPLETED|Overall Study||2
9936012|NCT01323972|11053719|FG001|NOT COMPLETED|Overall Study||3
9936013|NCT01323972|11053720|FG002|NOT COMPLETED|Overall Study||2
9936014|NCT01323972|11053721|FG003|NOT COMPLETED|Overall Study||1
9936015|NCT01323998|11053738|FG000|STARTED|Overall Study||200631
9936016|NCT01323998|11053739|FG001|STARTED|Overall Study||18681
9936017|NCT01323998|11053740|FG002|STARTED|Overall Study||10294
9936018|NCT01323998|11053741|FG003|STARTED|Overall Study||12052
9936019|NCT01323998|11053742|FG004|STARTED|Overall Study||6735
9936020|NCT01323998|11053738|FG000|COMPLETED|Overall Study||200631
9936021|NCT01323998|11053739|FG001|COMPLETED|Overall Study||18681
9936022|NCT01323998|11053740|FG002|COMPLETED|Overall Study||10294
9936023|NCT01323998|11053741|FG003|COMPLETED|Overall Study||12052
9936024|NCT01323998|11053742|FG004|COMPLETED|Overall Study||6735
9936025|NCT01323998|11053738|FG000|NOT COMPLETED|Overall Study||0
9936026|NCT01323998|11053739|FG001|NOT COMPLETED|Overall Study||0
9936027|NCT01323998|11053740|FG002|NOT COMPLETED|Overall Study||0
9936028|NCT01323998|11053741|FG003|NOT COMPLETED|Overall Study||0
9936029|NCT01323998|11053742|FG004|NOT COMPLETED|Overall Study||0
10011185|NCT01778465|11133907|FG001|COMPLETED|First Intervention (7 Days)||4
9936030|NCT01324024|11053754|FG000|STARTED|First Intervention (4 Weeks)||18
9936031|NCT01324024|11053755|FG001|STARTED|First Intervention (4 Weeks)||17
9936032|NCT01324024|11053754|FG000|COMPLETED|First Intervention (4 Weeks)||18
9936033|NCT01324024|11053755|FG001|COMPLETED|First Intervention (4 Weeks)||17
9936034|NCT01324024|11053754|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
9936035|NCT01324024|11053755|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
9936036|NCT01324024|11053754|FG000|STARTED|Washout (2 Weeks)||18
9936037|NCT01324024|11053755|FG001|STARTED|Washout (2 Weeks)||17
9936038|NCT01324024|11053754|FG000|COMPLETED|Washout (2 Weeks)||18
9936039|NCT01324024|11053755|FG001|COMPLETED|Washout (2 Weeks)||17
9936040|NCT01324024|11053754|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9936041|NCT01324024|11053755|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9936042|NCT01324024|11053754|FG000|STARTED|Second Intervention (4 Weeks)||18
9936043|NCT01324024|11053755|FG001|STARTED|Second Intervention (4 Weeks)||17
9936044|NCT01324024|11053754|FG000|COMPLETED|Second Intervention (4 Weeks)||16
9936045|NCT01324024|11053755|FG001|COMPLETED|Second Intervention (4 Weeks)||16
9936046|NCT01324024|11053754|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
9936047|NCT01324024|11053755|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
9936048|NCT01324102|11053767|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
9936049|NCT01324102|11053768|FG001|STARTED|Overall Study|Yoga group 4 and 6|12
9936050|NCT01324102|11053767|FG000|COMPLETED|Overall Study||10
9936051|NCT01324102|11053768|FG001|COMPLETED|Overall Study||6
9936052|NCT01324102|11053767|FG000|NOT COMPLETED|Overall Study||1
9936053|NCT01324102|11053768|FG001|NOT COMPLETED|Overall Study||6
9936054|NCT01324128|11053777|FG000|STARTED|Stage 1||710
9936055|NCT01324128|11053778|FG001|STARTED|Stage 1||349
9936056|NCT01324128|11053779|FG002|STARTED|Stage 1||0
9936057|NCT01324128|11053780|FG003|STARTED|Stage 1||0
9936058|NCT01324128|11053777|FG000|COMPLETED|Stage 1||515
9936059|NCT01324128|11053778|FG001|COMPLETED|Stage 1||293
9936060|NCT01324128|11053779|FG002|COMPLETED|Stage 1||0
9936061|NCT01324128|11053780|FG003|COMPLETED|Stage 1||0
9936062|NCT01324128|11053777|FG000|NOT COMPLETED|Stage 1||195
9936063|NCT01324128|11053778|FG001|NOT COMPLETED|Stage 1||56
9936064|NCT01324128|11053779|FG002|NOT COMPLETED|Stage 1||0
9936065|NCT01324128|11053780|FG003|NOT COMPLETED|Stage 1||0
9936066|NCT01324128|11053777|FG000|STARTED|Stage 2||0
9936067|NCT01324128|11053778|FG001|STARTED|Stage 2||0
9936068|NCT01324128|11053779|FG002|STARTED|Stage 2||50
9936069|NCT01324128|11053780|FG003|STARTED|Stage 2||49
10207082|NCT03521141|11333917|FG002|COMPLETED|Overall Study||19
10207083|NCT03521141|11333915|FG000|NOT COMPLETED|Overall Study||1
9936070|NCT01324128|11053777|FG000|COMPLETED|Stage 2||0
9936071|NCT01324128|11053778|FG001|COMPLETED|Stage 2||0
9936072|NCT01324128|11053779|FG002|COMPLETED|Stage 2||42
9936073|NCT01324128|11053780|FG003|COMPLETED|Stage 2||46
9936074|NCT01324128|11053777|FG000|NOT COMPLETED|Stage 2||0
9936075|NCT01324128|11053778|FG001|NOT COMPLETED|Stage 2||0
9936076|NCT01324128|11053779|FG002|NOT COMPLETED|Stage 2||8
9936077|NCT01324128|11053780|FG003|NOT COMPLETED|Stage 2||3
9936078|NCT01324141|11053790|FG000|STARTED|Overall Study||6
9936079|NCT01324141|11053790|FG000|COMPLETED|Overall Study||4
9936080|NCT01324141|11053790|FG000|NOT COMPLETED|Overall Study||2
9936081|NCT01324232|11053808|FG000|STARTED|Overall Study||49
9936082|NCT01324232|11053809|FG001|STARTED|Overall Study||53
9936083|NCT01324232|11053810|FG002|STARTED|Overall Study||54
9936084|NCT01324232|11053811|FG003|STARTED|Overall Study||53
9936085|NCT01324232|11053808|FG000|COMPLETED|Overall Study||44
9936086|NCT01324232|11053809|FG001|COMPLETED|Overall Study||42
9936087|NCT01324232|11053810|FG002|COMPLETED|Overall Study||41
9936088|NCT01324232|11053811|FG003|COMPLETED|Overall Study||42
9936089|NCT01324232|11053808|FG000|NOT COMPLETED|Overall Study||5
9936090|NCT01324232|11053809|FG001|NOT COMPLETED|Overall Study||11
9936091|NCT01324232|11053810|FG002|NOT COMPLETED|Overall Study||13
9936092|NCT01324232|11053811|FG003|NOT COMPLETED|Overall Study||11
9936093|NCT01324271|11053826|FG000|STARTED|Overall Study||57
9936094|NCT01324271|11053827|FG001|STARTED|Overall Study||28
9936095|NCT01324271|11053826|FG000|COMPLETED|Overall Study||53
9936096|NCT01324271|11053827|FG001|COMPLETED|Overall Study||28
9936097|NCT01324271|11053826|FG000|NOT COMPLETED|Overall Study||4
9936098|NCT01324271|11053827|FG001|NOT COMPLETED|Overall Study||0
9936099|NCT01324310|11053833|FG000|STARTED|Overall Study||15
9936100|NCT01324310|11053833|FG000|COMPLETED|Overall Study||13
9936101|NCT01324310|11053833|FG000|NOT COMPLETED|Overall Study||2
9936102|NCT01324323|11053839|FG000|STARTED|Overall Study||14
9936103|NCT01324323|11053839|FG000|COMPLETED|Overall Study||13
9936104|NCT01324323|11053839|FG000|NOT COMPLETED|Overall Study||1
9936105|NCT01324349|11053853|FG000|STARTED|Overall Study||32
9936106|NCT01324349|11053854|FG001|STARTED|Overall Study||18
9936107|NCT01324349|11053853|FG000|COMPLETED|Overall Study||31
9936108|NCT01324349|11053854|FG001|COMPLETED|Overall Study||16
9936109|NCT01324349|11053853|FG000|NOT COMPLETED|Overall Study||1
9936110|NCT01324349|11053854|FG001|NOT COMPLETED|Overall Study||2
9936111|NCT01324388|11053863|FG000|STARTED|Part 1 of Study||23
9936112|NCT01324388|11053864|FG001|STARTED|Part 1 of Study||8
9936113|NCT01324388|11053865|FG002|STARTED|Part 1 of Study||0
9936114|NCT01324388|11053866|FG003|STARTED|Part 1 of Study||0
9936115|NCT01324388|11053863|FG000|Received at Least 1 Dose|Part 1 of Study||23
9936116|NCT01324388|11053864|FG001|Received at Least 1 Dose|Part 1 of Study||8
9936117|NCT01324388|11053865|FG002|Received at Least 1 Dose|Part 1 of Study||0
9936118|NCT01324388|11053866|FG003|Received at Least 1 Dose|Part 1 of Study||0
9936119|NCT01324388|11053863|FG000|COMPLETED|Part 1 of Study||19
9936120|NCT01324388|11053864|FG001|COMPLETED|Part 1 of Study||6
9936121|NCT01324388|11053865|FG002|COMPLETED|Part 1 of Study||0
9936122|NCT01324388|11053866|FG003|COMPLETED|Part 1 of Study||0
9936123|NCT01324388|11053863|FG000|NOT COMPLETED|Part 1 of Study||4
9936124|NCT01324388|11053864|FG001|NOT COMPLETED|Part 1 of Study||2
9936125|NCT01324388|11053865|FG002|NOT COMPLETED|Part 1 of Study||0
9936126|NCT01324388|11053866|FG003|NOT COMPLETED|Part 1 of Study||0
9936127|NCT01324388|11053863|FG000|STARTED|Part 2 of Study: First Intervention||0
9936128|NCT01324388|11053864|FG001|STARTED|Part 2 of Study: First Intervention||0
9936129|NCT01324388|11053865|FG002|STARTED|Part 2 of Study: First Intervention||10
9936130|NCT01324388|11053866|FG003|STARTED|Part 2 of Study: First Intervention||10
9936131|NCT01324388|11053863|FG000|COMPLETED|Part 2 of Study: First Intervention||0
9936132|NCT01324388|11053864|FG001|COMPLETED|Part 2 of Study: First Intervention||0
9936133|NCT01324388|11053865|FG002|COMPLETED|Part 2 of Study: First Intervention||10
10207084|NCT03521141|11333916|FG001|NOT COMPLETED|Overall Study||0
9936134|NCT01324388|11053866|FG003|COMPLETED|Part 2 of Study: First Intervention||9
9936135|NCT01324388|11053863|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0
9936136|NCT01324388|11053864|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0
9936137|NCT01324388|11053865|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0
9936138|NCT01324388|11053866|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1
9936139|NCT01324388|11053863|FG000|STARTED|Part 2: Washout of at Least 21 Days||0
9936140|NCT01324388|11053864|FG001|STARTED|Part 2: Washout of at Least 21 Days||0
9936141|NCT01324388|11053865|FG002|STARTED|Part 2: Washout of at Least 21 Days||10
9936142|NCT01324388|11053866|FG003|STARTED|Part 2: Washout of at Least 21 Days||9
9936143|NCT01324388|11053863|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0
9936144|NCT01324388|11053864|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0
9936145|NCT01324388|11053865|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10
9936146|NCT01324388|11053866|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9
9936147|NCT01324388|11053863|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
10011186|NCT01778465|11133906|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10011187|NCT01778465|11133907|FG001|NOT COMPLETED|First Intervention (7 Days)||0
9936148|NCT01324388|11053864|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
9936149|NCT01324388|11053865|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
9936150|NCT01324388|11053866|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
9936151|NCT01324388|11053863|FG000|STARTED|Part 2 of Study: Second Intervention||0
9936152|NCT01324388|11053864|FG001|STARTED|Part 2 of Study: Second Intervention||0
9936153|NCT01324388|11053865|FG002|STARTED|Part 2 of Study: Second Intervention||10
9936154|NCT01324388|11053866|FG003|STARTED|Part 2 of Study: Second Intervention||9
9936155|NCT01324388|11053863|FG000|COMPLETED|Part 2 of Study: Second Intervention||0
9936156|NCT01324388|11053864|FG001|COMPLETED|Part 2 of Study: Second Intervention||0
9936157|NCT01324388|11053865|FG002|COMPLETED|Part 2 of Study: Second Intervention||9
9936158|NCT01324388|11053866|FG003|COMPLETED|Part 2 of Study: Second Intervention||9
9936159|NCT01324388|11053863|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0
9936160|NCT01324388|11053864|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0
9936161|NCT01324388|11053865|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1
9936162|NCT01324388|11053866|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0
9936163|NCT01324401|11053880|FG000|STARTED|Overall Study||4
9936164|NCT01324401|11053881|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
9936165|NCT01324401|11053880|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
9936166|NCT01324401|11053881|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
9936167|NCT01324401|11053880|FG000|NOT COMPLETED|Overall Study||1
9936168|NCT01324401|11053881|FG001|NOT COMPLETED|Overall Study||6
9936169|NCT01324440|11053889|FG000|STARTED|Overall Study||32
9936170|NCT01324440|11053890|FG001|STARTED|Overall Study||32
9936171|NCT01324440|11053889|FG000|COMPLETED|Overall Study||32
9936172|NCT01324440|11053890|FG001|COMPLETED|Overall Study||31
9936173|NCT01324440|11053889|FG000|NOT COMPLETED|Overall Study||0
9936174|NCT01324440|11053890|FG001|NOT COMPLETED|Overall Study||1
9936175|NCT01324453|11053898|FG000|STARTED|Overall Study||54
9936176|NCT01324453|11053899|FG001|STARTED|Overall Study||49
9936177|NCT01324453|11053898|FG000|COMPLETED|Overall Study||54
9936178|NCT01324453|11053899|FG001|COMPLETED|Overall Study||49
9936179|NCT01324453|11053898|FG000|NOT COMPLETED|Overall Study||0
9936180|NCT01324453|11053899|FG001|NOT COMPLETED|Overall Study||0
9936181|NCT01324518|11053908|FG000|STARTED|Overall Study||33
9936182|NCT01324518|11053909|FG001|STARTED|Overall Study||33
9936183|NCT01324518|11053910|FG002|STARTED|Overall Study||34
9936184|NCT01324518|11053908|FG000|COMPLETED|Overall Study||28
9936185|NCT01324518|11053909|FG001|COMPLETED|Overall Study||30
9936186|NCT01324518|11053910|FG002|COMPLETED|Overall Study||33
9936187|NCT01324518|11053908|FG000|NOT COMPLETED|Overall Study||5
9936188|NCT01324518|11053909|FG001|NOT COMPLETED|Overall Study||3
9936189|NCT01324518|11053910|FG002|NOT COMPLETED|Overall Study||1
9936190|NCT01324570|11053920|FG000|STARTED|Overall Study||6
9936191|NCT01324570|11053921|FG001|STARTED|Overall Study||35
9936192|NCT01324570|11053920|FG000|COMPLETED|Overall Study||2
9936193|NCT01324570|11053921|FG001|COMPLETED|Overall Study||21
9936194|NCT01324570|11053920|FG000|NOT COMPLETED|Overall Study||4
9936195|NCT01324570|11053921|FG001|NOT COMPLETED|Overall Study||14
9936196|NCT01324622|11053931|FG000|STARTED|Overall Study||13
9936197|NCT01324622|11053932|FG001|STARTED|Overall Study||11
9936198|NCT01324622|11053931|FG000|COMPLETED|Overall Study||4
9936199|NCT01324622|11053932|FG001|COMPLETED|Overall Study||4
9936200|NCT01324622|11053931|FG000|NOT COMPLETED|Overall Study||9
9936201|NCT01324622|11053932|FG001|NOT COMPLETED|Overall Study||7
9936202|NCT01324687|11053941|FG000|STARTED|Overall Study||1058
9936203|NCT01324687|11053942|FG001|STARTED|Overall Study||494
9936204|NCT01324687|11053941|FG000|COMPLETED|Overall Study||1058
9936205|NCT01324687|11053942|FG001|COMPLETED|Overall Study||479
9936206|NCT01324687|11053941|FG000|NOT COMPLETED|Overall Study||0
9936207|NCT01324687|11053942|FG001|NOT COMPLETED|Overall Study||15
9936208|NCT01324700|11053952|FG000|STARTED|Overall Study||22
9936209|NCT01324700|11053953|FG001|STARTED|Overall Study||20
9936210|NCT01324700|11053954|FG002|STARTED|Overall Study||49
9936211|NCT01324700|11053955|FG003|STARTED|Overall Study||48
9936212|NCT01324700|11053952|FG000|COMPLETED|Overall Study||13
9936213|NCT01324700|11053953|FG001|COMPLETED|Overall Study||16
9936214|NCT01324700|11053954|FG002|COMPLETED|Overall Study||33
9936215|NCT01324700|11053955|FG003|COMPLETED|Overall Study||37
9936216|NCT01324700|11053952|FG000|NOT COMPLETED|Overall Study||9
9936217|NCT01324700|11053953|FG001|NOT COMPLETED|Overall Study||4
9936218|NCT01324700|11053954|FG002|NOT COMPLETED|Overall Study||16
9936219|NCT01324700|11053955|FG003|NOT COMPLETED|Overall Study||11
9936220|NCT01324830|11053984|FG000|STARTED|Overall Study||3
9936221|NCT01324830|11053985|FG001|STARTED|Overall Study||3
9936222|NCT01324830|11053986|FG002|STARTED|Overall Study||3
9936223|NCT01324830|11053987|FG003|STARTED|Overall Study||3
9936224|NCT01324830|11053988|FG004|STARTED|Overall Study||7
9936225|NCT01324830|11053989|FG005|STARTED|Overall Study||7
9936226|NCT01324830|11053990|FG006|STARTED|Overall Study||3
9936227|NCT01324830|11053991|FG007|STARTED|Overall Study||3
9936228|NCT01324830|11053992|FG008|STARTED|Overall Study||5
9936229|NCT01324830|11053993|FG009|STARTED|Overall Study||6
9936230|NCT01324830|11053994|FG010|STARTED|Overall Study||4
9936231|NCT01324830|11053995|FG011|STARTED|Overall Study||1
9936232|NCT01324830|11053996|FG012|STARTED|Overall Study||1
9936233|NCT01324830|11053997|FG013|STARTED|Overall Study||1
9936234|NCT01324830|11053998|FG014|STARTED|Overall Study||1
9936235|NCT01324830|11053999|FG015|STARTED|Overall Study||3
9936236|NCT01324830|11054000|FG016|STARTED|Overall Study||3
9936237|NCT01324830|11054001|FG017|STARTED|Overall Study||6
9936238|NCT01324830|11054002|FG018|STARTED|Overall Study||6
9936239|NCT01324830|11053984|FG000|COMPLETED|Overall Study||0
9936240|NCT01324830|11053985|FG001|COMPLETED|Overall Study||0
9936241|NCT01324830|11053986|FG002|COMPLETED|Overall Study||0
9936242|NCT01324830|11053987|FG003|COMPLETED|Overall Study||0
9936243|NCT01324830|11053988|FG004|COMPLETED|Overall Study||0
9936244|NCT01324830|11053989|FG005|COMPLETED|Overall Study||0
9936245|NCT01324830|11053990|FG006|COMPLETED|Overall Study||0
9936246|NCT01324830|11053991|FG007|COMPLETED|Overall Study||0
9936247|NCT01324830|11053992|FG008|COMPLETED|Overall Study||0
9936248|NCT01324830|11053993|FG009|COMPLETED|Overall Study||0
9936249|NCT01324830|11053994|FG010|COMPLETED|Overall Study||0
9936250|NCT01324830|11053995|FG011|COMPLETED|Overall Study||0
9936251|NCT01324830|11053996|FG012|COMPLETED|Overall Study||0
9936252|NCT01324830|11053997|FG013|COMPLETED|Overall Study||0
9936253|NCT01324830|11053998|FG014|COMPLETED|Overall Study||0
9936254|NCT01324830|11053999|FG015|COMPLETED|Overall Study||0
9936255|NCT01324830|11054000|FG016|COMPLETED|Overall Study||0
9936256|NCT01324830|11054001|FG017|COMPLETED|Overall Study||0
9936257|NCT01324830|11054002|FG018|COMPLETED|Overall Study||0
9936258|NCT01324830|11053984|FG000|NOT COMPLETED|Overall Study||3
9936259|NCT01324830|11053985|FG001|NOT COMPLETED|Overall Study||3
9936260|NCT01324830|11053986|FG002|NOT COMPLETED|Overall Study||3
9936261|NCT01324830|11053987|FG003|NOT COMPLETED|Overall Study||3
9936262|NCT01324830|11053988|FG004|NOT COMPLETED|Overall Study||7
9936263|NCT01324830|11053989|FG005|NOT COMPLETED|Overall Study||7
9936264|NCT01324830|11053990|FG006|NOT COMPLETED|Overall Study||3
9936265|NCT01324830|11053991|FG007|NOT COMPLETED|Overall Study||3
9936266|NCT01324830|11053992|FG008|NOT COMPLETED|Overall Study||5
9936267|NCT01324830|11053993|FG009|NOT COMPLETED|Overall Study||6
9936268|NCT01324830|11053994|FG010|NOT COMPLETED|Overall Study||4
9936269|NCT01324830|11053995|FG011|NOT COMPLETED|Overall Study||1
9936270|NCT01324830|11053996|FG012|NOT COMPLETED|Overall Study||1
9936271|NCT01324830|11053997|FG013|NOT COMPLETED|Overall Study||1
9936272|NCT01324830|11053998|FG014|NOT COMPLETED|Overall Study||1
9936273|NCT01324830|11053999|FG015|NOT COMPLETED|Overall Study||3
9936274|NCT01324830|11054000|FG016|NOT COMPLETED|Overall Study||3
9936275|NCT01324830|11054001|FG017|NOT COMPLETED|Overall Study||6
9936276|NCT01324830|11054002|FG018|NOT COMPLETED|Overall Study||6
9936277|NCT01324882|11054050|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27
9936278|NCT01324882|11054051|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30
9936279|NCT01324882|11054050|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27
9936280|NCT01324882|11054051|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30
9936281|NCT01324882|11054050|FG000|NOT COMPLETED|Overall Study||0
9936282|NCT01324882|11054051|FG001|NOT COMPLETED|Overall Study||0
9936283|NCT01324947|11054059|FG000|STARTED|Overall Study||74
9936284|NCT01324947|11054059|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
10011188|NCT01778465|11133906|FG000|STARTED|Second Intervention (7 Days)||3
10011189|NCT01778465|11133907|FG001|STARTED|Second Intervention (7 Days)||4
9936285|NCT01324947|11054059|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
9936286|NCT01324947|11054059|FG000|COMPLETED|Overall Study||0
10011190|NCT01778465|11133906|FG000|COMPLETED|Second Intervention (7 Days)||3
9936287|NCT01324947|11054059|FG000|NOT COMPLETED|Overall Study||74
9936288|NCT01324999|11054065|FG000|STARTED|Overall Study||12
9936289|NCT01324999|11054065|FG000|COMPLETED|Overall Study||7
9936290|NCT01324999|11054065|FG000|NOT COMPLETED|Overall Study||5
9936291|NCT01325181|11054071|FG000|STARTED|Overall Study||18
9936292|NCT01325181|11054072|FG001|STARTED|Overall Study||16
9936293|NCT01325181|11054071|FG000|COMPLETED|Overall Study||18
9936294|NCT01325181|11054072|FG001|COMPLETED|Overall Study||14
9936295|NCT01325181|11054071|FG000|NOT COMPLETED|Overall Study||0
9936296|NCT01325181|11054072|FG001|NOT COMPLETED|Overall Study||2
9936297|NCT01325207|11054084|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
9936298|NCT01325207|11054085|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
9936299|NCT01325207|11054086|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
9936300|NCT01325207|11054087|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
9936301|NCT01325207|11054088|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
9936302|NCT01325207|11054089|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
9936303|NCT01325207|11054084|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
9936304|NCT01325207|11054085|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
10011191|NCT01778465|11133907|FG001|COMPLETED|Second Intervention (7 Days)||4
10011192|NCT01778465|11133906|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10011193|NCT01778465|11133907|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
9936305|NCT01325207|11054086|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
9936306|NCT01325207|11054087|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
9936307|NCT01325207|11054088|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
9936308|NCT01325207|11054089|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
9936309|NCT01325207|11054084|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
10207085|NCT03521141|11333917|FG002|NOT COMPLETED|Overall Study||1
10207086|NCT03521193|11333927|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78
10207087|NCT03521193|11333928|FG001|STARTED|Overall Study||12
10207088|NCT03521193|11333927|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62
10207089|NCT03521193|11333928|FG001|COMPLETED|Overall Study||12
10207090|NCT03521193|11333927|FG000|NOT COMPLETED|Overall Study||16
10207091|NCT03521193|11333928|FG001|NOT COMPLETED|Overall Study||0
9936310|NCT01325207|11054085|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
9936311|NCT01325207|11054086|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
9936312|NCT01325207|11054087|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
9936313|NCT01325207|11054088|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
9936314|NCT01325207|11054089|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
9936315|NCT01325207|11054084|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
9936316|NCT01325207|11054085|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
9936317|NCT01325207|11054086|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
9936318|NCT01325207|11054087|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
9936319|NCT01325207|11054088|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
9936320|NCT01325207|11054089|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
9936321|NCT01325207|11054084|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
9936322|NCT01325207|11054085|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
9936323|NCT01325207|11054086|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
9936324|NCT01325207|11054087|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
9936325|NCT01325207|11054088|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
9936326|NCT01325207|11054089|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
9936327|NCT01325207|11054084|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
9936328|NCT01325207|11054085|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
9936329|NCT01325207|11054086|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
9936330|NCT01325207|11054087|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
9936331|NCT01325207|11054088|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
9936332|NCT01325207|11054089|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
9936333|NCT01325207|11054084|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2
9936334|NCT01325207|11054085|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2
9936335|NCT01325207|11054086|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1
9936336|NCT01325207|11054087|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1
9936337|NCT01325207|11054088|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3
9936338|NCT01325207|11054089|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14
9936339|NCT01325207|11054084|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
9936340|NCT01325207|11054085|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
9936341|NCT01325207|11054086|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
9936342|NCT01325207|11054087|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
9936343|NCT01325207|11054088|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
9936344|NCT01325207|11054089|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
9936345|NCT01325207|11054084|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
9936346|NCT01325207|11054085|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
9936347|NCT01325207|11054086|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
9936348|NCT01325207|11054087|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
9936349|NCT01325207|11054088|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
9936350|NCT01325207|11054089|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
9936351|NCT01325207|11054084|FG000|STARTED|Follow-up Every 3 Months Until Death||3
9936352|NCT01325207|11054085|FG001|STARTED|Follow-up Every 3 Months Until Death||3
9936353|NCT01325207|11054086|FG002|STARTED|Follow-up Every 3 Months Until Death||1
9936354|NCT01325207|11054087|FG003|STARTED|Follow-up Every 3 Months Until Death||1
9936355|NCT01325207|11054088|FG004|STARTED|Follow-up Every 3 Months Until Death||7
9936356|NCT01325207|11054089|FG005|STARTED|Follow-up Every 3 Months Until Death||19
9936357|NCT01325207|11054084|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3
10011194|NCT01778530|11133916|FG000|STARTED|Overall Study||2
10011195|NCT01778530|11133916|FG000|COMPLETED|Overall Study||0
10011196|NCT01778530|11133916|FG000|NOT COMPLETED|Overall Study||2
10011197|NCT01778556|11133922|FG000|STARTED|Intervention 1 (5 Days)||15
10207092|NCT03521479|11333939|FG000|STARTED|Overall Study||10
10207093|NCT03521479|11333940|FG001|STARTED|Overall Study||10
10207094|NCT03521479|11333941|FG002|STARTED|Overall Study||10
9936358|NCT01325207|11054085|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3
9936359|NCT01325207|11054086|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1
9936360|NCT01325207|11054087|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1
9936361|NCT01325207|11054088|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6
9936362|NCT01325207|11054089|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18
9936363|NCT01325207|11054084|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
9936364|NCT01325207|11054085|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
9936365|NCT01325207|11054086|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
9936366|NCT01325207|11054087|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
9936367|NCT01325207|11054088|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
9936368|NCT01325207|11054089|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
9936369|NCT01325311|11054106|FG000|STARTED|Overall Study||8
9936370|NCT01325311|11054107|FG001|STARTED|Overall Study||7
9936371|NCT01325311|11054106|FG000|COMPLETED|Overall Study||8
9936372|NCT01325311|11054107|FG001|COMPLETED|Overall Study||7
9936373|NCT01325311|11054106|FG000|NOT COMPLETED|Overall Study||0
9936374|NCT01325311|11054107|FG001|NOT COMPLETED|Overall Study||0
9936375|NCT01325337|11054118|FG000|STARTED|Overall Study||61
9936376|NCT01325337|11054119|FG001|STARTED|Overall Study||61
9936377|NCT01325337|11054120|FG002|STARTED|Overall Study||62
9936378|NCT01325337|11054121|FG003|STARTED|Overall Study||62
9936379|NCT01325337|11054122|FG004|STARTED|Overall Study||61
9936380|NCT01325337|11054118|FG000|COMPLETED|Overall Study||56
9936381|NCT01325337|11054119|FG001|COMPLETED|Overall Study||52
9936382|NCT01325337|11054120|FG002|COMPLETED|Overall Study||53
9936383|NCT01325337|11054121|FG003|COMPLETED|Overall Study||52
9936384|NCT01325337|11054122|FG004|COMPLETED|Overall Study||53
9936385|NCT01325337|11054118|FG000|NOT COMPLETED|Overall Study||5
9936386|NCT01325337|11054119|FG001|NOT COMPLETED|Overall Study||9
9936387|NCT01325337|11054120|FG002|NOT COMPLETED|Overall Study||9
9936388|NCT01325337|11054121|FG003|NOT COMPLETED|Overall Study||10
9936389|NCT01325337|11054122|FG004|NOT COMPLETED|Overall Study||8
9936390|NCT01325350|11054139|FG000|STARTED|Overall Study||61
9936391|NCT01325350|11054140|FG001|STARTED|Overall Study||61
9936392|NCT01325350|11054141|FG002|STARTED|Overall Study||61
9936393|NCT01325350|11054142|FG003|STARTED|Overall Study||61
9936394|NCT01325350|11054143|FG004|STARTED|Overall Study||62
9936395|NCT01325350|11054139|FG000|COMPLETED|Overall Study||55
9936396|NCT01325350|11054140|FG001|COMPLETED|Overall Study||56
9936397|NCT01325350|11054141|FG002|COMPLETED|Overall Study||44
9936398|NCT01325350|11054142|FG003|COMPLETED|Overall Study||52
10011198|NCT01778556|11133923|FG001|STARTED|Intervention 1 (5 Days)||10
10011199|NCT01778556|11133922|FG000|COMPLETED|Intervention 1 (5 Days)||15
10011200|NCT01778556|11133923|FG001|COMPLETED|Intervention 1 (5 Days)||8
10011201|NCT01778556|11133922|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0
10011202|NCT01778556|11133923|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2
10011203|NCT01778556|11133922|FG000|STARTED|Intervention 2 (14 Days)||15
10011204|NCT01778556|11133923|FG001|STARTED|Intervention 2 (14 Days)||8
10011205|NCT01778556|11133922|FG000|COMPLETED|Intervention 2 (14 Days)||14
10011206|NCT01778556|11133923|FG001|COMPLETED|Intervention 2 (14 Days)||8
10011207|NCT01778556|11133922|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1
10011208|NCT01778556|11133923|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0
10011209|NCT01778556|11133922|FG000|STARTED|Long-term Follow-up||15
10011210|NCT01778556|11133923|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
10011211|NCT01778556|11133922|FG000|COMPLETED|Long-term Follow-up||14
10011212|NCT01778556|11133923|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
10011213|NCT01778556|11133922|FG000|NOT COMPLETED|Long-term Follow-up||1
10011214|NCT01778556|11133923|FG001|NOT COMPLETED|Long-term Follow-up||0
10011215|NCT01778634|11133934|FG000|STARTED|Overall Study||61
10011216|NCT01778634|11133935|FG001|STARTED|Overall Study||60
10011217|NCT01778634|11133934|FG000|COMPLETED|Overall Study||61
10011218|NCT01778634|11133935|FG001|COMPLETED|Overall Study||60
10011219|NCT01778634|11133934|FG000|NOT COMPLETED|Overall Study||0
10011220|NCT01778634|11133935|FG001|NOT COMPLETED|Overall Study||0
10011221|NCT01778751|11133944|FG000|STARTED|Overall Study||25
10011222|NCT01778751|11133945|FG001|STARTED|Overall Study||25
10011223|NCT01778751|11133944|FG000|COMPLETED|Overall Study||23
10011224|NCT01778751|11133945|FG001|COMPLETED|Overall Study||23
10011225|NCT01778751|11133944|FG000|NOT COMPLETED|Overall Study||2
10011226|NCT01778751|11133945|FG001|NOT COMPLETED|Overall Study||2
10011227|NCT01778855|11133953|FG000|STARTED|Overall Study||2
10011228|NCT01778855|11133954|FG001|STARTED|Overall Study||4
10011229|NCT01778855|11133953|FG000|COMPLETED|Overall Study||2
10011230|NCT01778855|11133954|FG001|COMPLETED|Overall Study||3
9936399|NCT01325350|11054143|FG004|COMPLETED|Overall Study||50
9936400|NCT01325350|11054139|FG000|NOT COMPLETED|Overall Study||6
9936401|NCT01325350|11054140|FG001|NOT COMPLETED|Overall Study||5
9936402|NCT01325350|11054141|FG002|NOT COMPLETED|Overall Study||17
9936403|NCT01325350|11054142|FG003|NOT COMPLETED|Overall Study||9
9936404|NCT01325350|11054143|FG004|NOT COMPLETED|Overall Study||12
9936405|NCT01325428|11054155|FG000|STARTED|Part A||26
10011231|NCT01778855|11133953|FG000|NOT COMPLETED|Overall Study||0
10011232|NCT01778855|11133954|FG001|NOT COMPLETED|Overall Study||1
10011233|NCT01778985|11133962|FG000|STARTED|Overall Study||15
10011234|NCT01778985|11133963|FG001|STARTED|Overall Study||15
10011235|NCT01778985|11133962|FG000|COMPLETED|Overall Study||8
10011236|NCT01778985|11133963|FG001|COMPLETED|Overall Study||12
10011237|NCT01778985|11133962|FG000|NOT COMPLETED|Overall Study||7
9760542|NCT00381810|10864270|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
9936406|NCT01325428|11054155|FG000|COMPLETED|Part A||10
9936407|NCT01325428|11054155|FG000|NOT COMPLETED|Part A||16
9936408|NCT01325428|11054155|FG000|STARTED|Part B||10
9936409|NCT01325428|11054155|FG000|COMPLETED|Part B||7
9936410|NCT01325428|11054155|FG000|NOT COMPLETED|Part B||3
9936411|NCT01325493|11054166|FG000|STARTED|Overall Study||30
9936412|NCT01325493|11054167|FG001|STARTED|Overall Study||24
9936413|NCT01325493|11054166|FG000|COMPLETED|Overall Study||29
9936414|NCT01325493|11054167|FG001|COMPLETED|Overall Study||21
9936415|NCT01325493|11054166|FG000|NOT COMPLETED|Overall Study||1
9936416|NCT01325493|11054167|FG001|NOT COMPLETED|Overall Study||3
9936417|NCT01325532|11054175|FG000|STARTED|Overall Study||17
9936418|NCT01325532|11054176|FG001|STARTED|Overall Study||13
9936419|NCT01325532|11054175|FG000|COMPLETED|Overall Study||15
9936420|NCT01325532|11054176|FG001|COMPLETED|Overall Study||13
9936421|NCT01325532|11054175|FG000|NOT COMPLETED|Overall Study||2
9936422|NCT01325532|11054176|FG001|NOT COMPLETED|Overall Study||0
9936423|NCT01325584|11054182|FG000|STARTED|Overall Study||12
9936424|NCT01325584|11054182|FG000|COMPLETED|Overall Study||11
9936425|NCT01325584|11054182|FG000|NOT COMPLETED|Overall Study||1
9936426|NCT01325623|11054186|FG000|STARTED|Overall Study||31
9936427|NCT01325623|11054186|FG000|COMPLETED|Overall Study||28
9936428|NCT01325623|11054186|FG000|NOT COMPLETED|Overall Study||3
9936429|NCT01325701|11054225|FG000|STARTED|Overall Study||70
9936430|NCT01325701|11054226|FG001|STARTED|Overall Study||8
9760543|NCT00381810|10864270|FG000|COMPLETED|B Cell Follow-up||0
9760544|NCT00381810|10864270|FG000|NOT COMPLETED|B Cell Follow-up||7
9760545|NCT00381849|10864276|FG000|STARTED|First Intervention||10
9760546|NCT00381849|10864277|FG001|STARTED|First Intervention||10
9760547|NCT00381849|10864276|FG000|COMPLETED|First Intervention||10
9760548|NCT00381849|10864277|FG001|COMPLETED|First Intervention||10
9760549|NCT00381849|10864276|FG000|NOT COMPLETED|First Intervention||0
9760550|NCT00381849|10864277|FG001|NOT COMPLETED|First Intervention||0
9760551|NCT00381849|10864276|FG000|STARTED|Wash Out||10
9760552|NCT00381849|10864277|FG001|STARTED|Wash Out||10
9760553|NCT00381849|10864276|FG000|COMPLETED|Wash Out||10
9760554|NCT00381849|10864277|FG001|COMPLETED|Wash Out||9
9760555|NCT00381849|10864276|FG000|NOT COMPLETED|Wash Out||0
9760556|NCT00381849|10864277|FG001|NOT COMPLETED|Wash Out||1
9760557|NCT00381849|10864276|FG000|STARTED|Second Intervention||10
9760558|NCT00381849|10864277|FG001|STARTED|Second Intervention||9
9760559|NCT00381849|10864276|FG000|COMPLETED|Second Intervention||10
9760560|NCT00381849|10864277|FG001|COMPLETED|Second Intervention||9
9760561|NCT00381849|10864276|FG000|NOT COMPLETED|Second Intervention||0
9760562|NCT00381849|10864277|FG001|NOT COMPLETED|Second Intervention||0
9760563|NCT00381849|10864276|FG000|STARTED|Open-label||10
9760564|NCT00381849|10864277|FG001|STARTED|Open-label||9
9760565|NCT00381849|10864276|FG000|COMPLETED|Open-label||10
9760566|NCT00381849|10864277|FG001|COMPLETED|Open-label||9
9936431|NCT01325701|11054225|FG000|COMPLETED|Overall Study||49
9936432|NCT01325701|11054226|FG001|COMPLETED|Overall Study||5
9936433|NCT01325701|11054225|FG000|NOT COMPLETED|Overall Study||21
9936434|NCT01325701|11054226|FG001|NOT COMPLETED|Overall Study||3
9936435|NCT01325714|11054235|FG000|STARTED|Overall Study||101
9936436|NCT01325714|11054236|FG001|STARTED|Overall Study||102
9936437|NCT01325714|11054235|FG000|3 Month Assessment|Overall Study||82
9936438|NCT01325714|11054236|FG001|3 Month Assessment|Overall Study||86
9936439|NCT01325714|11054235|FG000|6 Month Asessment|Overall Study||75
9936440|NCT01325714|11054236|FG001|6 Month Asessment|Overall Study||82
9760567|NCT00381849|10864276|FG000|NOT COMPLETED|Open-label||0
9760568|NCT00381849|10864277|FG001|NOT COMPLETED|Open-label||0
9760569|NCT00381862|10864283|FG000|STARTED|Overall Study||54
9760570|NCT00381862|10864283|FG000|COMPLETED|Overall Study||44
9760571|NCT00381862|10864283|FG000|NOT COMPLETED|Overall Study||10
9760572|NCT00381888|10864287|FG000|STARTED|Overall Study||44
9760573|NCT00381888|10864287|FG000|COMPLETED|Overall Study||27
9760574|NCT00381888|10864287|FG000|NOT COMPLETED|Overall Study||17
9760575|NCT00381940|10864291|FG000|STARTED|Overall Study||26
9760576|NCT00381940|10864291|FG000|COMPLETED|Overall Study||21
9760577|NCT00381940|10864291|FG000|NOT COMPLETED|Overall Study||5
9760578|NCT00381966|10864295|FG000|STARTED|Overall Study||5
9760579|NCT00381966|10864295|FG000|COMPLETED|Overall Study||5
9760580|NCT00381966|10864295|FG000|NOT COMPLETED|Overall Study||0
9760581|NCT00382018|10864303|FG000|STARTED|Overall Study||276
9760582|NCT00382018|10864304|FG001|STARTED|Overall Study||165
9760583|NCT00382018|10864305|FG002|STARTED|Overall Study||64
9760584|NCT00382018|10864306|FG003|STARTED|Overall Study||59
9832539|NCT00773513|10943310|FG001|NOT COMPLETED|Overall Study||1109
9832540|NCT00773604|10943316|FG000|STARTED|Overall Study||9
9832541|NCT00773604|10943316|FG000|COMPLETED|Overall Study||9
9832542|NCT00773604|10943316|FG000|NOT COMPLETED|Overall Study||0
9832543|NCT00773734|10943324|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88
9832544|NCT00773734|10943325|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89
9832545|NCT00773734|10943326|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87
9832546|NCT00773734|10943327|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88
9832547|NCT00773734|10943328|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0
9832548|NCT00773734|10943329|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0
9832549|NCT00773734|10943324|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
9936441|NCT01325714|11054235|FG000|12 Month Assessment|Overall Study||67
9936442|NCT01325714|11054236|FG001|12 Month Assessment|Overall Study||71
9936443|NCT01325714|11054235|FG000|COMPLETED|Overall Study||67
9936444|NCT01325714|11054236|FG001|COMPLETED|Overall Study||71
9936445|NCT01325714|11054235|FG000|NOT COMPLETED|Overall Study||34
9936446|NCT01325714|11054236|FG001|NOT COMPLETED|Overall Study||31
9936447|NCT01325792|11054244|FG000|STARTED|Overall Study||104
9936448|NCT01325792|11054244|FG000|COMPLETED|Overall Study||87
9936449|NCT01325792|11054244|FG000|NOT COMPLETED|Overall Study||17
9956523|NCT01446913|11075804|FG002|Patients With Sleep Study|Overall Study||29
9956524|NCT01446913|11075802|FG000|Patients With Sleep Apnea|Overall Study||39
9956525|NCT01446913|11075803|FG001|Patients With Sleep Apnea|Overall Study||45
9956526|NCT01446913|11075804|FG002|Patients With Sleep Apnea|Overall Study||21
9956527|NCT01446913|11075802|FG000|COMPLETED|Overall Study||77
9956528|NCT01446913|11075803|FG001|COMPLETED|Overall Study||73
9956529|NCT01446913|11075804|FG002|COMPLETED|Overall Study||73
9956530|NCT01446913|11075802|FG000|NOT COMPLETED|Overall Study||9
9956531|NCT01446913|11075803|FG001|NOT COMPLETED|Overall Study||9
9956532|NCT01446913|11075804|FG002|NOT COMPLETED|Overall Study||11
9956533|NCT01446965|11075820|FG000|STARTED|Randominization||1554
9956534|NCT01446965|11075821|FG001|STARTED|Randominization||794
9956535|NCT01446965|11075820|FG000|COMPLETED|Randominization||1524
9956536|NCT01446965|11075821|FG001|COMPLETED|Randominization||778
9956537|NCT01446965|11075820|FG000|NOT COMPLETED|Randominization||30
9956538|NCT01446965|11075821|FG001|NOT COMPLETED|Randominization||16
9956539|NCT01446965|11075820|FG000|STARTED|Participants Followed and Analyzed||1524
9956540|NCT01446965|11075821|FG001|STARTED|Participants Followed and Analyzed||778
9956541|NCT01446965|11075820|FG000|Received WCD|Participants Followed and Analyzed||1481
9956542|NCT01446965|11075821|FG001|Received WCD|Participants Followed and Analyzed||0
9956543|NCT01446965|11075820|FG000|Never Wore WCD|Participants Followed and Analyzed||43
9956544|NCT01446965|11075821|FG001|Never Wore WCD|Participants Followed and Analyzed||0
9956545|NCT01446965|11075820|FG000|Never Given WCD|Participants Followed and Analyzed||0
9956546|NCT01446965|11075821|FG001|Never Given WCD|Participants Followed and Analyzed||758
9956547|NCT01446965|11075820|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0
9956548|NCT01446965|11075821|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20
9956549|NCT01446965|11075820|FG000|COMPLETED|Participants Followed and Analyzed||1514
9956550|NCT01446965|11075821|FG001|COMPLETED|Participants Followed and Analyzed||766
9956551|NCT01446965|11075820|FG000|NOT COMPLETED|Participants Followed and Analyzed||10
9956552|NCT01446965|11075821|FG001|NOT COMPLETED|Participants Followed and Analyzed||12
9956553|NCT01447017|11075829|FG000|STARTED|Overall Study||45
9956554|NCT01447017|11075830|FG001|STARTED|Overall Study||24
9956555|NCT01447017|11075829|FG000|Performed Visit 2|Overall Study||43
9956556|NCT01447017|11075830|FG001|Performed Visit 2|Overall Study||24
9956557|NCT01447017|11075829|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
9956558|NCT01447017|11075830|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
9956559|NCT01447017|11075829|FG000|NOT COMPLETED|Overall Study||10
9956560|NCT01447017|11075830|FG001|NOT COMPLETED|Overall Study||10
9956561|NCT01447121|11075836|FG000|STARTED|Overall Study||118
9956562|NCT01447121|11075836|FG000|COMPLETED|Overall Study||118
9956563|NCT01447121|11075836|FG000|NOT COMPLETED|Overall Study||0
9956564|NCT01447225|11075845|FG000|STARTED|Overall Study||3
9956565|NCT01447225|11075846|FG001|STARTED|Overall Study||8
9956566|NCT01447225|11075847|FG002|STARTED|Overall Study||5
9956567|NCT01447225|11075848|FG003|STARTED|Overall Study||3
9956568|NCT01447225|11075849|FG004|STARTED|Overall Study||3
9956569|NCT01447225|11075850|FG005|STARTED|Overall Study||3
9956570|NCT01447225|11075851|FG006|STARTED|Overall Study||7
9956571|NCT01447225|11075852|FG007|STARTED|Overall Study||4
9956572|NCT01447225|11075853|FG008|STARTED|Overall Study||3
9956573|NCT01447225|11075854|FG009|STARTED|Overall Study||4
9956574|NCT01447225|11075845|FG000|COMPLETED|Overall Study||3
9956575|NCT01447225|11075846|FG001|COMPLETED|Overall Study||8
9956576|NCT01447225|11075847|FG002|COMPLETED|Overall Study||5
9956577|NCT01447225|11075848|FG003|COMPLETED|Overall Study||3
9956578|NCT01447225|11075849|FG004|COMPLETED|Overall Study||3
9956579|NCT01447225|11075850|FG005|COMPLETED|Overall Study||3
9956580|NCT01447225|11075851|FG006|COMPLETED|Overall Study||7
9956581|NCT01447225|11075852|FG007|COMPLETED|Overall Study||4
9956582|NCT01447225|11075853|FG008|COMPLETED|Overall Study||3
9956583|NCT01447225|11075854|FG009|COMPLETED|Overall Study||4
9956584|NCT01447225|11075845|FG000|NOT COMPLETED|Overall Study||0
9956585|NCT01447225|11075846|FG001|NOT COMPLETED|Overall Study||0
9956586|NCT01447225|11075847|FG002|NOT COMPLETED|Overall Study||0
9956587|NCT01447225|11075848|FG003|NOT COMPLETED|Overall Study||0
9956588|NCT01447225|11075849|FG004|NOT COMPLETED|Overall Study||0
9956589|NCT01447225|11075850|FG005|NOT COMPLETED|Overall Study||0
9956590|NCT01447225|11075851|FG006|NOT COMPLETED|Overall Study||0
9956591|NCT01447225|11075852|FG007|NOT COMPLETED|Overall Study||0
9956592|NCT01447225|11075853|FG008|NOT COMPLETED|Overall Study||0
9956593|NCT01447225|11075854|FG009|NOT COMPLETED|Overall Study||0
9956594|NCT01447407|11075890|FG000|STARTED|Overall Study||41
9956595|NCT01447407|11075891|FG001|STARTED|Overall Study||40
9956596|NCT01447407|11075892|FG002|STARTED|Overall Study||41
9956597|NCT01447407|11075893|FG003|STARTED|Overall Study||42
9956598|NCT01447407|11075890|FG000|COMPLETED|Overall Study||39
9956599|NCT01447407|11075891|FG001|COMPLETED|Overall Study||40
9936450|NCT01325870|11054251|FG000|STARTED|Overall Study||18
9936451|NCT01325870|11054252|FG001|STARTED|Overall Study||16
9936452|NCT01325870|11054253|FG002|STARTED|Overall Study||14
9936453|NCT01325870|11054251|FG000|COMPLETED|Overall Study||7
9936454|NCT01325870|11054252|FG001|COMPLETED|Overall Study||3
9936455|NCT01325870|11054253|FG002|COMPLETED|Overall Study||6
9936456|NCT01325870|11054251|FG000|NOT COMPLETED|Overall Study||11
9936457|NCT01325870|11054252|FG001|NOT COMPLETED|Overall Study||13
9936458|NCT01325870|11054253|FG002|NOT COMPLETED|Overall Study||8
9936459|NCT01326026|11054263|FG000|STARTED|Overall Study||111
9936460|NCT01326026|11054264|FG001|STARTED|Overall Study||111
9936461|NCT01326026|11054263|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
9936462|NCT01326026|11054264|FG001|Exposed|Overall Study||111
9936463|NCT01326026|11054263|FG000|COMPLETED|Overall Study||99
9936464|NCT01326026|11054264|FG001|COMPLETED|Overall Study||98
10011238|NCT01778985|11133963|FG001|NOT COMPLETED|Overall Study||3
10011239|NCT01779024|11133969|FG000|STARTED|1st Visit - Alcohol Self-Administration||8
10011240|NCT01779024|11133970|FG001|STARTED|1st Visit - Alcohol Self-Administration||9
9936465|NCT01326026|11054263|FG000|NOT COMPLETED|Overall Study||12
9936466|NCT01326026|11054264|FG001|NOT COMPLETED|Overall Study||13
9936467|NCT01326481|11054270|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
9936468|NCT01326481|11054270|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
9936469|NCT01326481|11054270|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
9936470|NCT01326481|11054270|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
9936471|NCT01326481|11054270|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
9936472|NCT01326481|11054270|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
9936473|NCT01326533|11054278|FG000|STARTED|Overall Study||17
9936474|NCT01326533|11054279|FG001|STARTED|Overall Study||15
9936475|NCT01326533|11054278|FG000|COMPLETED|Overall Study||13
9936476|NCT01326533|11054279|FG001|COMPLETED|Overall Study||15
9936477|NCT01326533|11054278|FG000|NOT COMPLETED|Overall Study||4
9936478|NCT01326533|11054279|FG001|NOT COMPLETED|Overall Study||0
9936479|NCT01326546|11054287|FG000|STARTED|Overall Study||189
9936480|NCT01326546|11054288|FG001|STARTED|Overall Study||189
9936481|NCT01326546|11054287|FG000|COMPLETED|Overall Study||172
9936482|NCT01326546|11054288|FG001|COMPLETED|Overall Study||176
9936483|NCT01326546|11054287|FG000|NOT COMPLETED|Overall Study||17
9936484|NCT01326546|11054288|FG001|NOT COMPLETED|Overall Study||13
9936485|NCT01326702|11054301|FG000|STARTED|Overall Study||3
9936486|NCT01326702|11054302|FG001|STARTED|Overall Study||3
9936487|NCT01326702|11054303|FG002|STARTED|Overall Study||6
9936488|NCT01326702|11054304|FG003|STARTED|Overall Study||4
9936489|NCT01326702|11054305|FG004|STARTED|Overall Study||5
9936490|NCT01326702|11054306|FG005|STARTED|Overall Study||15
9936491|NCT01326702|11054307|FG006|STARTED|Overall Study||7
9936492|NCT01326702|11054301|FG000|COMPLETED|Overall Study||1
9936493|NCT01326702|11054302|FG001|COMPLETED|Overall Study||1
9936494|NCT01326702|11054303|FG002|COMPLETED|Overall Study||1
9936495|NCT01326702|11054304|FG003|COMPLETED|Overall Study||1
9936496|NCT01326702|11054305|FG004|COMPLETED|Overall Study||1
9936497|NCT01326702|11054306|FG005|COMPLETED|Overall Study||7
9936498|NCT01326702|11054307|FG006|COMPLETED|Overall Study||0
9936499|NCT01326702|11054301|FG000|NOT COMPLETED|Overall Study||2
9936500|NCT01326702|11054302|FG001|NOT COMPLETED|Overall Study||2
9936501|NCT01326702|11054303|FG002|NOT COMPLETED|Overall Study||5
9936502|NCT01326702|11054304|FG003|NOT COMPLETED|Overall Study||3
9936503|NCT01326702|11054305|FG004|NOT COMPLETED|Overall Study||4
9936504|NCT01326702|11054306|FG005|NOT COMPLETED|Overall Study||8
9936505|NCT01326702|11054307|FG006|NOT COMPLETED|Overall Study||7
9936506|NCT01326728|11054328|FG000|STARTED|Overall Study||47
9936507|NCT01326728|11054329|FG001|STARTED|Overall Study||9
9936508|NCT01326728|11054328|FG000|COMPLETED|Overall Study||0
9936509|NCT01326728|11054329|FG001|COMPLETED|Overall Study||0
9936510|NCT01326728|11054328|FG000|NOT COMPLETED|Overall Study||47
9936511|NCT01326728|11054329|FG001|NOT COMPLETED|Overall Study||9
9936512|NCT01326780|11054338|FG000|STARTED|Overall Study||106
9936513|NCT01326780|11054339|FG001|STARTED|Overall Study||109
9936514|NCT01326780|11054340|FG002|STARTED|Overall Study||109
9936515|NCT01326780|11054341|FG003|STARTED|Overall Study||107
9936516|NCT01326780|11054338|FG000|COMPLETED|Overall Study||93
9936517|NCT01326780|11054339|FG001|COMPLETED|Overall Study||100
9936518|NCT01326780|11054340|FG002|COMPLETED|Overall Study||103
9936519|NCT01326780|11054341|FG003|COMPLETED|Overall Study||94
9936520|NCT01326780|11054338|FG000|NOT COMPLETED|Overall Study||13
9936521|NCT01326780|11054339|FG001|NOT COMPLETED|Overall Study||9
9936522|NCT01326780|11054340|FG002|NOT COMPLETED|Overall Study||6
9936523|NCT01326780|11054341|FG003|NOT COMPLETED|Overall Study||13
9936524|NCT01326910|11054353|FG000|STARTED|Overall Study||45
9936525|NCT01326910|11054354|FG001|STARTED|Overall Study||45
9936526|NCT01326910|11054353|FG000|COMPLETED|Overall Study||41
9936527|NCT01326910|11054354|FG001|COMPLETED|Overall Study||42
9936528|NCT01326910|11054353|FG000|NOT COMPLETED|Overall Study||4
9936529|NCT01326910|11054354|FG001|NOT COMPLETED|Overall Study||3
10011241|NCT01779024|11133969|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8
10011242|NCT01779024|11133970|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9
10011243|NCT01779024|11133969|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
10011244|NCT01779024|11133970|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
10011245|NCT01779024|11133969|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8
10011246|NCT01779024|11133970|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9
10011247|NCT01779024|11133969|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6
10011248|NCT01779024|11133970|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9
10011249|NCT01779024|11133969|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
10011250|NCT01779024|11133970|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
10011251|NCT01779024|11133969|FG000|STARTED|1st Visit - Functional MRI||6
10011252|NCT01779024|11133970|FG001|STARTED|1st Visit - Functional MRI||7
10011253|NCT01779024|11133969|FG000|COMPLETED|1st Visit - Functional MRI||4
10011254|NCT01779024|11133970|FG001|COMPLETED|1st Visit - Functional MRI||5
10011255|NCT01779024|11133969|FG000|NOT COMPLETED|1st Visit - Functional MRI||2
10011256|NCT01779024|11133970|FG001|NOT COMPLETED|1st Visit - Functional MRI||2
10011257|NCT01779024|11133969|FG000|STARTED|2nd Visit - Functional MRI||5
10011258|NCT01779024|11133970|FG001|STARTED|2nd Visit - Functional MRI||6
10011259|NCT01779024|11133969|FG000|COMPLETED|2nd Visit - Functional MRI||5
10011260|NCT01779024|11133970|FG001|COMPLETED|2nd Visit - Functional MRI||6
10011261|NCT01779024|11133969|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0
9936530|NCT01326962|11054360|FG000|STARTED|Overall Study||28
9936531|NCT01326962|11054360|FG000|COMPLETED|Overall Study||21
9936532|NCT01326962|11054360|FG000|NOT COMPLETED|Overall Study||7
9936533|NCT01327053|11054366|FG000|STARTED|Overall Study||79
9936534|NCT01327053|11054367|FG001|STARTED|Overall Study||151
9936535|NCT01327053|11054366|FG000|Untreated|Overall Study||0
9936536|NCT01327053|11054367|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
9936537|NCT01327053|11054366|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52
9936538|NCT01327053|11054367|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89
9936539|NCT01327053|11054366|FG000|Survival Follow-up|Overall Study||33
9936540|NCT01327053|11054367|FG001|Survival Follow-up|Overall Study||49
9936541|NCT01327053|11054366|FG000|Post-treatment Follow-up|Overall Study||19
9936542|NCT01327053|11054367|FG001|Post-treatment Follow-up|Overall Study||40
9936543|NCT01327053|11054366|FG000|COMPLETED|Overall Study||0
9936544|NCT01327053|11054367|FG001|COMPLETED|Overall Study||0
9936545|NCT01327053|11054366|FG000|NOT COMPLETED|Overall Study||79
9936546|NCT01327053|11054367|FG001|NOT COMPLETED|Overall Study||151
9936547|NCT01327157|11054379|FG000|STARTED|01-90||7
9936548|NCT01327157|11054380|FG001|STARTED|01-90||7
9936549|NCT01327157|11054379|FG000|COMPLETED|01-90||7
9936550|NCT01327157|11054380|FG001|COMPLETED|01-90||7
9936551|NCT01327157|11054379|FG000|NOT COMPLETED|01-90||0
9936552|NCT01327157|11054380|FG001|NOT COMPLETED|01-90||0
9936553|NCT01327157|11054379|FG000|STARTED|91-180||7
9936554|NCT01327157|11054380|FG001|STARTED|91-180||0
9936555|NCT01327157|11054379|FG000|COMPLETED|91-180||7
9936556|NCT01327157|11054380|FG001|COMPLETED|91-180||0
9936557|NCT01327157|11054379|FG000|NOT COMPLETED|91-180||0
9936558|NCT01327157|11054380|FG001|NOT COMPLETED|91-180||0
9936559|NCT01327274|11054391|FG000|STARTED|Overall Study||15
9936560|NCT01327274|11054391|FG000|COMPLETED|Overall Study||15
9936561|NCT01327274|11054391|FG000|NOT COMPLETED|Overall Study||0
9936562|NCT01327300|11054396|FG000|STARTED|First Intervention (12 Weeks)||5
9936563|NCT01327300|11054397|FG001|STARTED|First Intervention (12 Weeks)||2
9936564|NCT01327300|11054396|FG000|COMPLETED|First Intervention (12 Weeks)||5
9936565|NCT01327300|11054397|FG001|COMPLETED|First Intervention (12 Weeks)||2
9936566|NCT01327300|11054396|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
9936567|NCT01327300|11054397|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
9936568|NCT01327300|11054396|FG000|STARTED|Washout (3 Weeks)||5
9936569|NCT01327300|11054397|FG001|STARTED|Washout (3 Weeks)||2
9936570|NCT01327300|11054396|FG000|COMPLETED|Washout (3 Weeks)||4
9936571|NCT01327300|11054397|FG001|COMPLETED|Washout (3 Weeks)||2
9936572|NCT01327300|11054396|FG000|NOT COMPLETED|Washout (3 Weeks)||1
9936573|NCT01327300|11054397|FG001|NOT COMPLETED|Washout (3 Weeks)||0
9936574|NCT01327300|11054396|FG000|STARTED|Second Intervention (12 Weeks)||4
9936575|NCT01327300|11054397|FG001|STARTED|Second Intervention (12 Weeks)||2
9936576|NCT01327300|11054396|FG000|COMPLETED|Second Intervention (12 Weeks)||4
9936577|NCT01327300|11054397|FG001|COMPLETED|Second Intervention (12 Weeks)||2
9936578|NCT01327300|11054396|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
9936579|NCT01327300|11054397|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
9936580|NCT01327313|11054417|FG000|STARTED|Overall Study||8
9936581|NCT01327313|11054418|FG001|STARTED|Overall Study||6
9936582|NCT01327313|11054419|FG002|STARTED|Overall Study||6
9936583|NCT01327313|11054420|FG003|STARTED|Overall Study||7
9936584|NCT01327313|11054417|FG000|COMPLETED|Overall Study||8
9936585|NCT01327313|11054418|FG001|COMPLETED|Overall Study||6
9936586|NCT01327313|11054419|FG002|COMPLETED|Overall Study||6
9936587|NCT01327313|11054420|FG003|COMPLETED|Overall Study||7
9936588|NCT01327313|11054417|FG000|NOT COMPLETED|Overall Study||0
9936589|NCT01327313|11054418|FG001|NOT COMPLETED|Overall Study||0
9936590|NCT01327313|11054419|FG002|NOT COMPLETED|Overall Study||0
9936591|NCT01327313|11054420|FG003|NOT COMPLETED|Overall Study||0
9936592|NCT01327339|11054430|FG000|STARTED|Overall Study||755
9936593|NCT01327339|11054430|FG000|COMPLETED|Overall Study||747
9936594|NCT01327339|11054430|FG000|NOT COMPLETED|Overall Study||8
9936595|NCT01327482|11054434|FG000|STARTED|Overall Study||10
9936596|NCT01327482|11054434|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
9936597|NCT01327482|11054434|FG000|NOT COMPLETED|Overall Study||1
9936598|NCT01327495|11054444|FG000|STARTED|Overall Study||10
9936599|NCT01327495|11054445|FG001|STARTED|Overall Study||11
9936600|NCT01327495|11054446|FG002|STARTED|Overall Study||10
9936601|NCT01327495|11054447|FG003|STARTED|Overall Study||9
9936602|NCT01327495|11054448|FG004|STARTED|Overall Study||11
9936603|NCT01327495|11054449|FG005|STARTED|Overall Study||11
9936604|NCT01327495|11054444|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
9936605|NCT01327495|11054445|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
9936606|NCT01327495|11054446|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
9936607|NCT01327495|11054447|FG003|COMPLETED|Overall Study||9
9936608|NCT01327495|11054448|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
9936609|NCT01327495|11054449|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
9936610|NCT01327495|11054444|FG000|NOT COMPLETED|Overall Study||2
9936611|NCT01327495|11054445|FG001|NOT COMPLETED|Overall Study||2
9936612|NCT01327495|11054446|FG002|NOT COMPLETED|Overall Study||2
9936613|NCT01327495|11054447|FG003|NOT COMPLETED|Overall Study||0
9936614|NCT01327495|11054448|FG004|NOT COMPLETED|Overall Study||3
9936615|NCT01327495|11054449|FG005|NOT COMPLETED|Overall Study||2
9936616|NCT01327508|11054471|FG000|STARTED|Overall Study||30
9936617|NCT01327508|11054472|FG001|STARTED|Overall Study||30
9936618|NCT01327508|11054471|FG000|COMPLETED|Overall Study||30
9936619|NCT01327508|11054472|FG001|COMPLETED|Overall Study||30
9936620|NCT01327508|11054471|FG000|NOT COMPLETED|Overall Study||0
9936621|NCT01327508|11054472|FG001|NOT COMPLETED|Overall Study||0
9936622|NCT01327547|11054480|FG000|STARTED|Overall Study||70
9936623|NCT01327547|11054481|FG001|STARTED|Overall Study||67
9936624|NCT01327547|11054480|FG000|Randomized and Not Treated|Overall Study||0
9936625|NCT01327547|11054481|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
9936626|NCT01327547|11054480|FG000|COMPLETED|Overall Study||50
9936627|NCT01327547|11054481|FG001|COMPLETED|Overall Study||45
9936628|NCT01327547|11054480|FG000|NOT COMPLETED|Overall Study||20
9936629|NCT01327547|11054481|FG001|NOT COMPLETED|Overall Study||22
9936630|NCT01327573|11054498|FG000|STARTED|Overall Study||11
9936631|NCT01327573|11054499|FG001|STARTED|Overall Study||5
9936632|NCT01327573|11054498|FG000|Received Treatment/Control as Allocated|Overall Study||10
9936633|NCT01327573|11054499|FG001|Received Treatment/Control as Allocated|Overall Study||5
9936634|NCT01327573|11054498|FG000|COMPLETED|Overall Study||8
9936635|NCT01327573|11054499|FG001|COMPLETED|Overall Study||4
9936636|NCT01327573|11054498|FG000|NOT COMPLETED|Overall Study||3
9936637|NCT01327573|11054499|FG001|NOT COMPLETED|Overall Study||1
9936638|NCT01327599|11054506|FG000|STARTED|Overall Study||60
9936639|NCT01327599|11054506|FG000|COMPLETED|Overall Study||57
9936640|NCT01327599|11054506|FG000|NOT COMPLETED|Overall Study||3
9936641|NCT01327612|11054517|FG000|STARTED|Overall Study||2
9936642|NCT01327612|11054518|FG001|STARTED|Overall Study||1
9936643|NCT01327612|11054519|FG002|STARTED|Overall Study||1
9936644|NCT01327612|11054520|FG003|STARTED|Overall Study||1
9936645|NCT01327612|11054521|FG004|STARTED|Overall Study||2
9936646|NCT01327612|11054522|FG005|STARTED|Overall Study||3
9936647|NCT01327612|11054523|FG006|STARTED|Overall Study||2
9936648|NCT01327612|11054517|FG000|COMPLETED|Overall Study||1
9936649|NCT01327612|11054518|FG001|COMPLETED|Overall Study||0
9936650|NCT01327612|11054519|FG002|COMPLETED|Overall Study||0
9936651|NCT01327612|11054520|FG003|COMPLETED|Overall Study||0
9936652|NCT01327612|11054521|FG004|COMPLETED|Overall Study||0
9936653|NCT01327612|11054522|FG005|COMPLETED|Overall Study||0
9936654|NCT01327612|11054523|FG006|COMPLETED|Overall Study||0
9936655|NCT01327612|11054517|FG000|NOT COMPLETED|Overall Study||1
9936656|NCT01327612|11054518|FG001|NOT COMPLETED|Overall Study||1
9936657|NCT01327612|11054519|FG002|NOT COMPLETED|Overall Study||1
9936658|NCT01327612|11054520|FG003|NOT COMPLETED|Overall Study||1
9936659|NCT01327612|11054521|FG004|NOT COMPLETED|Overall Study||2
9936660|NCT01327612|11054522|FG005|NOT COMPLETED|Overall Study||3
9936661|NCT01327612|11054523|FG006|NOT COMPLETED|Overall Study||2
9936662|NCT01327651|11054549|FG000|STARTED|Self-administered Dosing Period||60
9936663|NCT01327651|11054550|FG001|STARTED|Self-administered Dosing Period||59
9936664|NCT01327651|11054551|FG002|STARTED|Self-administered Dosing Period||60
9936665|NCT01327651|11054552|FG003|STARTED|Self-administered Dosing Period||60
9936666|NCT01327651|11054553|FG004|STARTED|Self-administered Dosing Period||59
9936667|NCT01327651|11054554|FG005|STARTED|Self-administered Dosing Period||59
9936668|NCT01327651|11054555|FG006|STARTED|Self-administered Dosing Period||59
9936669|NCT01327651|11054556|FG007|STARTED|Self-administered Dosing Period||60
9936670|NCT01327651|11054557|FG008|STARTED|Self-administered Dosing Period||60
9936671|NCT01327651|11054549|FG000|Week 10|Self-administered Dosing Period||59
9936672|NCT01327651|11054550|FG001|Week 10|Self-administered Dosing Period||58
9936673|NCT01327651|11054551|FG002|Week 10|Self-administered Dosing Period||60
9936674|NCT01327651|11054552|FG003|Week 10|Self-administered Dosing Period||60
9936675|NCT01327651|11054553|FG004|Week 10|Self-administered Dosing Period||59
9936676|NCT01327651|11054554|FG005|Week 10|Self-administered Dosing Period||59
9936677|NCT01327651|11054555|FG006|Week 10|Self-administered Dosing Period||57
9936678|NCT01327651|11054556|FG007|Week 10|Self-administered Dosing Period||57
9936679|NCT01327651|11054557|FG008|Week 10|Self-administered Dosing Period||56
9936680|NCT01327651|11054549|FG000|Week 14|Self-administered Dosing Period||59
9936681|NCT01327651|11054550|FG001|Week 14|Self-administered Dosing Period||55
9936682|NCT01327651|11054551|FG002|Week 14|Self-administered Dosing Period||57
9936683|NCT01327651|11054552|FG003|Week 14|Self-administered Dosing Period||60
9936684|NCT01327651|11054553|FG004|Week 14|Self-administered Dosing Period||58
9936685|NCT01327651|11054554|FG005|Week 14|Self-administered Dosing Period||59
9936686|NCT01327651|11054555|FG006|Week 14|Self-administered Dosing Period||54
9936687|NCT01327651|11054556|FG007|Week 14|Self-administered Dosing Period||51
9936688|NCT01327651|11054557|FG008|Week 14|Self-administered Dosing Period||54
9936689|NCT01327651|11054549|FG000|Week 18|Self-administered Dosing Period||57
9936690|NCT01327651|11054550|FG001|Week 18|Self-administered Dosing Period||56
9936691|NCT01327651|11054551|FG002|Week 18|Self-administered Dosing Period||56
9936692|NCT01327651|11054552|FG003|Week 18|Self-administered Dosing Period||60
9936693|NCT01327651|11054553|FG004|Week 18|Self-administered Dosing Period||57
9936694|NCT01327651|11054554|FG005|Week 18|Self-administered Dosing Period||59
9936695|NCT01327651|11054555|FG006|Week 18|Self-administered Dosing Period||53
9936696|NCT01327651|11054556|FG007|Week 18|Self-administered Dosing Period||49
9936697|NCT01327651|11054557|FG008|Week 18|Self-administered Dosing Period||53
9936698|NCT01327651|11054549|FG000|Week 22|Self-administered Dosing Period||59
9936699|NCT01327651|11054550|FG001|Week 22|Self-administered Dosing Period||56
9936700|NCT01327651|11054551|FG002|Week 22|Self-administered Dosing Period||55
9936701|NCT01327651|11054552|FG003|Week 22|Self-administered Dosing Period||58
9936702|NCT01327651|11054553|FG004|Week 22|Self-administered Dosing Period||56
9936703|NCT01327651|11054554|FG005|Week 22|Self-administered Dosing Period||59
9936704|NCT01327651|11054555|FG006|Week 22|Self-administered Dosing Period||50
9936705|NCT01327651|11054556|FG007|Week 22|Self-administered Dosing Period||50
9936706|NCT01327651|11054557|FG008|Week 22|Self-administered Dosing Period||51
9936707|NCT01327651|11054549|FG000|Week 26|Self-administered Dosing Period||58
9936708|NCT01327651|11054550|FG001|Week 26|Self-administered Dosing Period||56
9936709|NCT01327651|11054551|FG002|Week 26|Self-administered Dosing Period||53
9936710|NCT01327651|11054552|FG003|Week 26|Self-administered Dosing Period||57
9936711|NCT01327651|11054553|FG004|Week 26|Self-administered Dosing Period||56
9936712|NCT01327651|11054554|FG005|Week 26|Self-administered Dosing Period||58
9936713|NCT01327651|11054555|FG006|Week 26|Self-administered Dosing Period||50
9936714|NCT01327651|11054556|FG007|Week 26|Self-administered Dosing Period||51
9936715|NCT01327651|11054557|FG008|Week 26|Self-administered Dosing Period||49
9936716|NCT01327651|11054549|FG000|COMPLETED|Self-administered Dosing Period||56
9936717|NCT01327651|11054550|FG001|COMPLETED|Self-administered Dosing Period||56
9936718|NCT01327651|11054551|FG002|COMPLETED|Self-administered Dosing Period||56
9936719|NCT01327651|11054552|FG003|COMPLETED|Self-administered Dosing Period||57
9936720|NCT01327651|11054553|FG004|COMPLETED|Self-administered Dosing Period||56
9936721|NCT01327651|11054554|FG005|COMPLETED|Self-administered Dosing Period||59
9936722|NCT01327651|11054555|FG006|COMPLETED|Self-administered Dosing Period||49
9936723|NCT01327651|11054556|FG007|COMPLETED|Self-administered Dosing Period||50
9936724|NCT01327651|11054557|FG008|COMPLETED|Self-administered Dosing Period||49
9936725|NCT01327651|11054549|FG000|NOT COMPLETED|Self-administered Dosing Period||4
9936726|NCT01327651|11054550|FG001|NOT COMPLETED|Self-administered Dosing Period||3
9936727|NCT01327651|11054551|FG002|NOT COMPLETED|Self-administered Dosing Period||4
9936728|NCT01327651|11054552|FG003|NOT COMPLETED|Self-administered Dosing Period||3
9936729|NCT01327651|11054553|FG004|NOT COMPLETED|Self-administered Dosing Period||3
9936730|NCT01327651|11054554|FG005|NOT COMPLETED|Self-administered Dosing Period||0
9936731|NCT01327651|11054555|FG006|NOT COMPLETED|Self-administered Dosing Period||10
9936732|NCT01327651|11054556|FG007|NOT COMPLETED|Self-administered Dosing Period||10
9936733|NCT01327651|11054557|FG008|NOT COMPLETED|Self-administered Dosing Period||11
9936734|NCT01327651|11054549|FG000|STARTED|Post Study Follow-up||56
9936735|NCT01327651|11054550|FG001|STARTED|Post Study Follow-up||56
9936736|NCT01327651|11054551|FG002|STARTED|Post Study Follow-up||56
9936737|NCT01327651|11054552|FG003|STARTED|Post Study Follow-up||57
9936738|NCT01327651|11054553|FG004|STARTED|Post Study Follow-up||56
9936739|NCT01327651|11054554|FG005|STARTED|Post Study Follow-up||59
9936740|NCT01327651|11054555|FG006|STARTED|Post Study Follow-up||49
9936741|NCT01327651|11054556|FG007|STARTED|Post Study Follow-up||50
9936742|NCT01327651|11054557|FG008|STARTED|Post Study Follow-up||49
9936743|NCT01327651|11054549|FG000|COMPLETED|Post Study Follow-up||56
9936744|NCT01327651|11054550|FG001|COMPLETED|Post Study Follow-up||55
9936745|NCT01327651|11054551|FG002|COMPLETED|Post Study Follow-up||55
9936746|NCT01327651|11054552|FG003|COMPLETED|Post Study Follow-up||57
9936747|NCT01327651|11054553|FG004|COMPLETED|Post Study Follow-up||56
9936748|NCT01327651|11054554|FG005|COMPLETED|Post Study Follow-up||59
9936749|NCT01327651|11054555|FG006|COMPLETED|Post Study Follow-up||45
9936750|NCT01327651|11054556|FG007|COMPLETED|Post Study Follow-up||49
9936751|NCT01327651|11054557|FG008|COMPLETED|Post Study Follow-up||47
9936752|NCT01327651|11054549|FG000|NOT COMPLETED|Post Study Follow-up||0
9936753|NCT01327651|11054550|FG001|NOT COMPLETED|Post Study Follow-up||1
9936754|NCT01327651|11054551|FG002|NOT COMPLETED|Post Study Follow-up||1
9936755|NCT01327651|11054552|FG003|NOT COMPLETED|Post Study Follow-up||0
9936756|NCT01327651|11054553|FG004|NOT COMPLETED|Post Study Follow-up||0
9936757|NCT01327651|11054554|FG005|NOT COMPLETED|Post Study Follow-up||0
9936758|NCT01327651|11054555|FG006|NOT COMPLETED|Post Study Follow-up||4
9936759|NCT01327651|11054556|FG007|NOT COMPLETED|Post Study Follow-up||1
9936760|NCT01327651|11054557|FG008|NOT COMPLETED|Post Study Follow-up||2
9936761|NCT01327677|11054598|FG000|STARTED|Overall Study||68
9936762|NCT01327677|11054599|FG001|STARTED|Overall Study||69
9936763|NCT01327677|11054598|FG000|COMPLETED|Overall Study||48
9936764|NCT01327677|11054599|FG001|COMPLETED|Overall Study||56
9936765|NCT01327677|11054598|FG000|NOT COMPLETED|Overall Study||20
9936766|NCT01327677|11054599|FG001|NOT COMPLETED|Overall Study||13
9936767|NCT01327703|11054607|FG000|STARTED|First Treatment Period||42
9936768|NCT01327703|11054608|FG001|STARTED|First Treatment Period||45
9936769|NCT01327703|11054607|FG000|COMPLETED|First Treatment Period||42
9936770|NCT01327703|11054608|FG001|COMPLETED|First Treatment Period||45
9936771|NCT01327703|11054607|FG000|NOT COMPLETED|First Treatment Period||0
9936772|NCT01327703|11054608|FG001|NOT COMPLETED|First Treatment Period||0
9936773|NCT01327703|11054607|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
9936774|NCT01327703|11054608|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
9936775|NCT01327703|11054607|FG000|COMPLETED|Second Treatment Period||39
9936776|NCT01327703|11054608|FG001|COMPLETED|Second Treatment Period||42
9936777|NCT01327703|11054607|FG000|NOT COMPLETED|Second Treatment Period||1
9936778|NCT01327703|11054608|FG001|NOT COMPLETED|Second Treatment Period||2
9936779|NCT01327846|11054621|FG000|STARTED|Core Phase||2263
9936780|NCT01327846|11054622|FG001|STARTED|Core Phase||2284
9936781|NCT01327846|11054623|FG002|STARTED|Core Phase||2170
9936782|NCT01327846|11054624|FG003|STARTED|Core Phase||3344
9936783|NCT01327846|11054621|FG000|COMPLETED|Core Phase||2235
9936784|NCT01327846|11054622|FG001|COMPLETED|Core Phase||2252
9936785|NCT01327846|11054623|FG002|COMPLETED|Core Phase||2144
9936786|NCT01327846|11054624|FG003|COMPLETED|Core Phase||3311
9936787|NCT01327846|11054621|FG000|NOT COMPLETED|Core Phase||28
10207095|NCT03521479|11333942|FG003|STARTED|Overall Study||10
10207096|NCT03521479|11333939|FG000|COMPLETED|Overall Study||10
10207097|NCT03521479|11333940|FG001|COMPLETED|Overall Study||10
10207098|NCT03521479|11333941|FG002|COMPLETED|Overall Study||10
10207099|NCT03521479|11333942|FG003|COMPLETED|Overall Study||10
10011262|NCT01779024|11133970|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0
10011263|NCT01779141|11133976|FG000|STARTED|Overall Study||481
9936788|NCT01327846|11054622|FG001|NOT COMPLETED|Core Phase||32
9936789|NCT01327846|11054623|FG002|NOT COMPLETED|Core Phase||26
9936790|NCT01327846|11054624|FG003|NOT COMPLETED|Core Phase||33
9936791|NCT01327846|11054621|FG000|STARTED|Extension Phase||1267
9936792|NCT01327846|11054622|FG001|STARTED|Extension Phase||1287
9936793|NCT01327846|11054623|FG002|STARTED|Extension Phase||1279
9936794|NCT01327846|11054624|FG003|STARTED|Extension Phase||1944
9936795|NCT01327846|11054621|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127
9936796|NCT01327846|11054622|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97
9936797|NCT01327846|11054623|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137
9936798|NCT01327846|11054624|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178
9936799|NCT01327846|11054621|FG000|Completed Treatment Period|Extension Phase||41
9936800|NCT01327846|11054622|FG001|Completed Treatment Period|Extension Phase||45
9936801|NCT01327846|11054623|FG002|Completed Treatment Period|Extension Phase||49
9936802|NCT01327846|11054624|FG003|Completed Treatment Period|Extension Phase||60
9936803|NCT01327846|11054621|FG000|Details Missing|Extension Phase||0
9936804|NCT01327846|11054622|FG001|Details Missing|Extension Phase||1
9936805|NCT01327846|11054623|FG002|Details Missing|Extension Phase||1
9936806|NCT01327846|11054624|FG003|Details Missing|Extension Phase||0
9936807|NCT01327846|11054621|FG000|COMPLETED|Extension Phase||168
9936808|NCT01327846|11054622|FG001|COMPLETED|Extension Phase||143
9936809|NCT01327846|11054623|FG002|COMPLETED|Extension Phase||187
9936810|NCT01327846|11054624|FG003|COMPLETED|Extension Phase||238
9936811|NCT01327846|11054621|FG000|NOT COMPLETED|Extension Phase||1099
9936812|NCT01327846|11054622|FG001|NOT COMPLETED|Extension Phase||1144
9936813|NCT01327846|11054623|FG002|NOT COMPLETED|Extension Phase||1092
9936814|NCT01327846|11054624|FG003|NOT COMPLETED|Extension Phase||1706
9936815|NCT01327885|11054637|FG000|STARTED|Overall Study||228
9936816|NCT01327885|11054638|FG001|STARTED|Overall Study||224
9936817|NCT01327885|11054637|FG000|COMPLETED|Overall Study||0
9936818|NCT01327885|11054638|FG001|COMPLETED|Overall Study||0
9936819|NCT01327885|11054637|FG000|NOT COMPLETED|Overall Study||228
9936820|NCT01327885|11054638|FG001|NOT COMPLETED|Overall Study||224
9936821|NCT01327963|11054645|FG000|STARTED|Overall Study||110
9936822|NCT01327963|11054645|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
9936823|NCT01327963|11054645|FG000|NOT COMPLETED|Overall Study||0
9936824|NCT01327976|11054653|FG000|STARTED|Overall Study||162
9936825|NCT01327976|11054654|FG001|STARTED|Overall Study||77
9936826|NCT01327976|11054653|FG000|COMPLETED|Overall Study||154
9936827|NCT01327976|11054654|FG001|COMPLETED|Overall Study||70
9936828|NCT01327976|11054653|FG000|NOT COMPLETED|Overall Study||8
9936829|NCT01327976|11054654|FG001|NOT COMPLETED|Overall Study||7
9936830|NCT01327989|11054662|FG000|STARTED|Overall Study||202
9936831|NCT01327989|11054662|FG000|COMPLETED|Overall Study||188
9936832|NCT01327989|11054662|FG000|NOT COMPLETED|Overall Study||14
9936833|NCT01328002|11054666|FG000|STARTED|Open-Label Period||116
9936834|NCT01328002|11054667|FG001|STARTED|Open-Label Period||0
9936835|NCT01328002|11054666|FG000|COMPLETED|Open-Label Period||20
10207100|NCT03521479|11333939|FG000|NOT COMPLETED|Overall Study||0
9936836|NCT01328002|11054667|FG001|COMPLETED|Open-Label Period||0
9936837|NCT01328002|11054666|FG000|NOT COMPLETED|Open-Label Period||96
9936838|NCT01328002|11054667|FG001|NOT COMPLETED|Open-Label Period||0
9936839|NCT01328002|11054666|FG000|STARTED|Double-Blind Period||14
9936840|NCT01328002|11054667|FG001|STARTED|Double-Blind Period||6
9936841|NCT01328002|11054666|FG000|COMPLETED|Double-Blind Period||12
9936842|NCT01328002|11054667|FG001|COMPLETED|Double-Blind Period||6
9936843|NCT01328002|11054666|FG000|NOT COMPLETED|Double-Blind Period||2
9936844|NCT01328002|11054667|FG001|NOT COMPLETED|Double-Blind Period||0
9936845|NCT01328041|11054674|FG000|STARTED|Overall Study||183
9936846|NCT01328041|11054674|FG000|COMPLETED|Overall Study||126
9936847|NCT01328041|11054674|FG000|NOT COMPLETED|Overall Study||57
9936848|NCT01328054|11054678|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
9936849|NCT01328054|11054679|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
9936850|NCT01328054|11054678|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
9936851|NCT01328054|11054679|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
9936852|NCT01328054|11054678|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
9936853|NCT01328054|11054679|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
9936854|NCT01328054|11054678|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
9936855|NCT01328054|11054679|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
9936856|NCT01328054|11054678|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
9936857|NCT01328054|11054679|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
9936858|NCT01328054|11054678|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
9936859|NCT01328054|11054679|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
9936860|NCT01328080|11054691|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
9936861|NCT01328080|11054691|FG000|COMPLETED|Overall Study||6
9936862|NCT01328080|11054691|FG000|NOT COMPLETED|Overall Study||5
9936863|NCT01328158|11054695|FG000|STARTED|Overall Study||220
9936864|NCT01328158|11054695|FG000|COMPLETED|Overall Study||220
9936865|NCT01328158|11054695|FG000|NOT COMPLETED|Overall Study||0
9936866|NCT01328184|11054702|FG000|STARTED|Overall Study||18
9936867|NCT01328184|11054702|FG000|COMPLETED|Overall Study||18
9936868|NCT01328184|11054702|FG000|NOT COMPLETED|Overall Study||0
9936869|NCT01328249|11054710|FG000|STARTED|Overall Study||55
9936870|NCT01328249|11054711|FG001|STARTED|Overall Study||26
9936871|NCT01328249|11054710|FG000|COMPLETED|Overall Study||48
9936872|NCT01328249|11054711|FG001|COMPLETED|Overall Study||23
9936873|NCT01328249|11054710|FG000|NOT COMPLETED|Overall Study||7
9936874|NCT01328249|11054711|FG001|NOT COMPLETED|Overall Study||3
9936875|NCT01328366|11054719|FG000|STARTED|Overall Study||153
9936876|NCT01328366|11054719|FG000|COMPLETED|Overall Study||143
9936877|NCT01328366|11054719|FG000|NOT COMPLETED|Overall Study||10
9936878|NCT01328379|11054726|FG000|STARTED|Overall Study||143
9936879|NCT01328379|11054727|FG001|STARTED|Overall Study||144
9936880|NCT01328379|11054728|FG002|STARTED|Overall Study||143
9936881|NCT01328379|11054726|FG000|COMPLETED|Overall Study||142
9936882|NCT01328379|11054727|FG001|COMPLETED|Overall Study||144
9936883|NCT01328379|11054728|FG002|COMPLETED|Overall Study||143
9936884|NCT01328379|11054726|FG000|NOT COMPLETED|Overall Study||1
9936885|NCT01328379|11054727|FG001|NOT COMPLETED|Overall Study||0
9936886|NCT01328379|11054728|FG002|NOT COMPLETED|Overall Study||0
9936887|NCT01328405|11054738|FG000|STARTED|Overall Study||52
9936888|NCT01328405|11054739|FG001|STARTED|Overall Study||48
9936889|NCT01328405|11054738|FG000|COMPLETED|Overall Study||52
9936890|NCT01328405|11054739|FG001|COMPLETED|Overall Study||48
9936891|NCT01328405|11054738|FG000|NOT COMPLETED|Overall Study||0
9936892|NCT01328405|11054739|FG001|NOT COMPLETED|Overall Study||0
9936893|NCT01328431|11054747|FG000|STARTED|Baseline||390
9936894|NCT01328431|11054748|FG001|STARTED|Baseline||390
9936895|NCT01328431|11054747|FG000|COMPLETED|Baseline||390
9936896|NCT01328431|11054748|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
9936897|NCT01328431|11054747|FG000|NOT COMPLETED|Baseline||0
9936898|NCT01328431|11054748|FG001|NOT COMPLETED|Baseline||2
9936899|NCT01328431|11054747|FG000|STARTED|1 Month (1M)||390
9936900|NCT01328431|11054748|FG001|STARTED|1 Month (1M)||388
9936901|NCT01328431|11054747|FG000|COMPLETED|1 Month (1M)||335
9936902|NCT01328431|11054748|FG001|COMPLETED|1 Month (1M)||330
9936903|NCT01328431|11054747|FG000|NOT COMPLETED|1 Month (1M)||55
9936904|NCT01328431|11054748|FG001|NOT COMPLETED|1 Month (1M)||58
9936905|NCT01328431|11054747|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
9936906|NCT01328431|11054748|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
9936907|NCT01328431|11054747|FG000|COMPLETED|3 Month (3M)||313
9936908|NCT01328431|11054748|FG001|COMPLETED|3 Month (3M)||316
9936909|NCT01328431|11054747|FG000|NOT COMPLETED|3 Month (3M)||77
9936910|NCT01328431|11054748|FG001|NOT COMPLETED|3 Month (3M)||72
9936911|NCT01328431|11054747|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
9936912|NCT01328431|11054748|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
9936913|NCT01328431|11054747|FG000|COMPLETED|12 Month (12M)||304
9936914|NCT01328431|11054748|FG001|COMPLETED|12 Month (12M)||289
9936915|NCT01328431|11054747|FG000|NOT COMPLETED|12 Month (12M)||84
9936916|NCT01328431|11054748|FG001|NOT COMPLETED|12 Month (12M)||97
9936917|NCT01328444|11054754|FG000|STARTED|Treatment Period 1 (12 Weeks)||94
9936918|NCT01328444|11054755|FG001|STARTED|Treatment Period 1 (12 Weeks)||26
9936919|NCT01328444|11054756|FG002|STARTED|Treatment Period 1 (12 Weeks)||28
9936920|NCT01328444|11054757|FG003|STARTED|Treatment Period 1 (12 Weeks)||41
9936921|NCT01328444|11054758|FG004|STARTED|Treatment Period 1 (12 Weeks)||81
9936922|NCT01328444|11054759|FG005|STARTED|Treatment Period 1 (12 Weeks)||78
9936923|NCT01328444|11054754|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83
9936924|NCT01328444|11054755|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
9936925|NCT01328444|11054756|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25
9936926|NCT01328444|11054757|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33
9936927|NCT01328444|11054758|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67
9936928|NCT01328444|11054759|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72
9936929|NCT01328444|11054754|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
9936930|NCT01328444|11054755|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
9936931|NCT01328444|11054756|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
9936932|NCT01328444|11054757|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
9936933|NCT01328444|11054758|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
9936934|NCT01328444|11054759|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
9936935|NCT01328444|11054754|FG000|STARTED|Washout Period (14 Days)||83
9936936|NCT01328444|11054755|FG001|STARTED|Washout Period (14 Days)||21
9936937|NCT01328444|11054756|FG002|STARTED|Washout Period (14 Days)||25
9936938|NCT01328444|11054757|FG003|STARTED|Washout Period (14 Days)||33
9936939|NCT01328444|11054758|FG004|STARTED|Washout Period (14 Days)||67
9936940|NCT01328444|11054759|FG005|STARTED|Washout Period (14 Days)||72
9936941|NCT01328444|11054754|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
9936942|NCT01328444|11054755|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
9936943|NCT01328444|11054756|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
9936944|NCT01328444|11054757|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
9936945|NCT01328444|11054758|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
9936946|NCT01328444|11054759|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
9936947|NCT01328444|11054754|FG000|NOT COMPLETED|Washout Period (14 Days)||1
9936948|NCT01328444|11054755|FG001|NOT COMPLETED|Washout Period (14 Days)||1
9936949|NCT01328444|11054756|FG002|NOT COMPLETED|Washout Period (14 Days)||0
9936950|NCT01328444|11054757|FG003|NOT COMPLETED|Washout Period (14 Days)||1
9936951|NCT01328444|11054758|FG004|NOT COMPLETED|Washout Period (14 Days)||1
9936952|NCT01328444|11054759|FG005|NOT COMPLETED|Washout Period (14 Days)||4
9936953|NCT01328444|11054754|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
9936954|NCT01328444|11054755|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
9936955|NCT01328444|11054756|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
9936956|NCT01328444|11054757|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
9936957|NCT01328444|11054758|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
9936958|NCT01328444|11054759|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
9936959|NCT01328444|11054754|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65
9936960|NCT01328444|11054755|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22
9936961|NCT01328444|11054756|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19
9936962|NCT01328444|11054757|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30
9936963|NCT01328444|11054758|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63
9936964|NCT01328444|11054759|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59
9936965|NCT01328444|11054754|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
9936966|NCT01328444|11054755|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
9936967|NCT01328444|11054756|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
9936968|NCT01328444|11054757|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
9936969|NCT01328444|11054758|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
9936970|NCT01328444|11054759|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
9936971|NCT01328496|11054775|FG000|STARTED|Overall Study||10
9936972|NCT01328496|11054776|FG001|STARTED|Overall Study||4
9936973|NCT01328496|11054775|FG000|COMPLETED|Overall Study||9
9936974|NCT01328496|11054776|FG001|COMPLETED|Overall Study||4
9936975|NCT01328496|11054775|FG000|NOT COMPLETED|Overall Study||1
9936976|NCT01328496|11054776|FG001|NOT COMPLETED|Overall Study||0
9936977|NCT01328535|11054785|FG000|STARTED|Overall Study||25
9936978|NCT01328535|11054785|FG000|COMPLETED|Overall Study||24
9936979|NCT01328535|11054785|FG000|NOT COMPLETED|Overall Study||1
9936980|NCT01328548|11054793|FG000|STARTED|Overall Study||191
9936981|NCT01328548|11054794|FG001|STARTED|Overall Study||50
9936982|NCT01328548|11054793|FG000|COMPLETED|Overall Study||187
9936983|NCT01328548|11054794|FG001|COMPLETED|Overall Study||50
9936984|NCT01328548|11054793|FG000|NOT COMPLETED|Overall Study||4
9936985|NCT01328548|11054794|FG001|NOT COMPLETED|Overall Study||0
9936986|NCT01328574|11054800|FG000|STARTED|Overall Study||13
9936987|NCT01328574|11054800|FG000|COMPLETED|Overall Study||12
9936988|NCT01328574|11054800|FG000|NOT COMPLETED|Overall Study||1
9936989|NCT01328717|11054809|FG000|STARTED|Overall Study||78
9936990|NCT01328717|11054809|FG000|COMPLETED|Overall Study||77
9936991|NCT01328717|11054809|FG000|NOT COMPLETED|Overall Study||1
9936992|NCT01328743|11054815|FG000|STARTED|Overall Study||91
9936993|NCT01328743|11054816|FG001|STARTED|Overall Study||89
9936994|NCT01328743|11054815|FG000|COMPLETED|Overall Study||82
9936995|NCT01328743|11054816|FG001|COMPLETED|Overall Study||79
9936996|NCT01328743|11054815|FG000|NOT COMPLETED|Overall Study||9
9936997|NCT01328743|11054816|FG001|NOT COMPLETED|Overall Study||10
9936998|NCT01328756|11054822|FG000|STARTED|Overall Study||314
9936999|NCT01328756|11054822|FG000|COMPLETED|Overall Study||191
9937000|NCT01328756|11054822|FG000|NOT COMPLETED|Overall Study||123
9937001|NCT01328769|11054828|FG000|STARTED|Overall Study||25
9937002|NCT01328769|11054829|FG001|STARTED|Overall Study||24
9937003|NCT01328769|11054828|FG000|COMPLETED|Overall Study||25
9937004|NCT01328769|11054829|FG001|COMPLETED|Overall Study||23
9937005|NCT01328769|11054828|FG000|NOT COMPLETED|Overall Study||0
9937006|NCT01328769|11054829|FG001|NOT COMPLETED|Overall Study||1
9937007|NCT01328782|11054838|FG000|STARTED|Overall Study||43
9937008|NCT01328782|11054839|FG001|STARTED|Overall Study||42
9937009|NCT01328782|11054840|FG002|STARTED|Overall Study||39
9937010|NCT01328782|11054838|FG000|COMPLETED|Overall Study||43
9937011|NCT01328782|11054839|FG001|COMPLETED|Overall Study||42
9937012|NCT01328782|11054840|FG002|COMPLETED|Overall Study||39
9937013|NCT01328782|11054838|FG000|NOT COMPLETED|Overall Study||0
9937014|NCT01328782|11054839|FG001|NOT COMPLETED|Overall Study||0
9937015|NCT01328782|11054840|FG002|NOT COMPLETED|Overall Study||0
9937016|NCT01328873|11054848|FG000|STARTED|Overall Study||49
9937017|NCT01328873|11054848|FG000|COMPLETED|Overall Study||49
9937018|NCT01328873|11054848|FG000|NOT COMPLETED|Overall Study||0
10011264|NCT01779141|11133976|FG000|COMPLETED|Overall Study||300
10011265|NCT01779141|11133976|FG000|NOT COMPLETED|Overall Study||181
10019020|NCT01826981|11142062|FG011|NOT COMPLETED|Overall Study||2
10019021|NCT01826981|11142063|FG012|NOT COMPLETED|Overall Study||1
10019022|NCT01826981|11142064|FG013|NOT COMPLETED|Overall Study||5
9937019|NCT01328951|11054856|FG000|STARTED|Overall Study||321
9937020|NCT01328951|11054857|FG001|STARTED|Overall Study||322
9937021|NCT01328951|11054856|FG000|COMPLETED|Overall Study||0
9937022|NCT01328951|11054857|FG001|COMPLETED|Overall Study||0
9937023|NCT01328951|11054856|FG000|NOT COMPLETED|Overall Study||321
9937024|NCT01328951|11054857|FG001|NOT COMPLETED|Overall Study||322
9937025|NCT01328964|11054870|FG000|STARTED|Overall Study||2212
9937026|NCT01328964|11054871|FG001|STARTED|Overall Study||3270
9937027|NCT01328964|11054872|FG002|STARTED|Overall Study||4424
9937028|NCT01328964|11054870|FG000|COMPLETED|Overall Study||2212
9937029|NCT01328964|11054871|FG001|COMPLETED|Overall Study||3270
9937030|NCT01328964|11054872|FG002|COMPLETED|Overall Study||4424
9937031|NCT01328964|11054870|FG000|NOT COMPLETED|Overall Study||0
9937032|NCT01328964|11054871|FG001|NOT COMPLETED|Overall Study||0
9937033|NCT01328964|11054872|FG002|NOT COMPLETED|Overall Study||0
9937034|NCT01329029|11054882|FG000|STARTED|Overall Study||973
9937035|NCT01329029|11054883|FG001|STARTED|Overall Study||972
9937036|NCT01329029|11054882|FG000|Full Analysis Set (FAS)|Overall Study||969
9937037|NCT01329029|11054883|FG001|Full Analysis Set (FAS)|Overall Study||966
9937038|NCT01329029|11054882|FG000|Safety Population|Overall Study||968
9937039|NCT01329029|11054883|FG001|Safety Population|Overall Study||967
9937040|NCT01329029|11054882|FG000|COMPLETED|Overall Study||704
9937041|NCT01329029|11054883|FG001|COMPLETED|Overall Study||780
9937042|NCT01329029|11054882|FG000|NOT COMPLETED|Overall Study||269
9937043|NCT01329029|11054883|FG001|NOT COMPLETED|Overall Study||192
9937044|NCT01329185|11054891|FG000|STARTED|Overall Study||10
9937045|NCT01329185|11054892|FG001|STARTED|Overall Study||7
9937046|NCT01329185|11054891|FG000|CMV Disease|Overall Study||1
9937047|NCT01329185|11054892|FG001|CMV Disease|Overall Study||0
9937048|NCT01329185|11054891|FG000|PTLD|Overall Study||1
9937049|NCT01329185|11054892|FG001|PTLD|Overall Study||0
9937050|NCT01329185|11054891|FG000|COMPLETED|Overall Study||10
9937051|NCT01329185|11054892|FG001|COMPLETED|Overall Study||7
9937052|NCT01329185|11054891|FG000|NOT COMPLETED|Overall Study||0
9937053|NCT01329185|11054892|FG001|NOT COMPLETED|Overall Study||0
9937054|NCT01329198|11054900|FG000|STARTED|Overall Study||3
9937055|NCT01329198|11054901|FG001|STARTED|Overall Study||2
9937056|NCT01329198|11054900|FG000|COMPLETED|Overall Study||3
9937057|NCT01329198|11054901|FG001|COMPLETED|Overall Study||2
9937058|NCT01329198|11054900|FG000|NOT COMPLETED|Overall Study||0
9937059|NCT01329198|11054901|FG001|NOT COMPLETED|Overall Study||0
9937060|NCT01329263|11054914|FG000|STARTED|Overall Study||15
9937061|NCT01329263|11054915|FG001|STARTED|Overall Study||45
9937062|NCT01329263|11054914|FG000|Completed Period 1 Own Menthol|Overall Study||15
9937063|NCT01329263|11054915|FG001|Completed Period 1 Own Menthol|Overall Study||45
9937064|NCT01329263|11054914|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10
9937065|NCT01329263|11054915|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30
9937066|NCT01329263|11054914|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
9937067|NCT01329263|11054915|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
9937068|NCT01329263|11054914|FG000|COMPLETED|Overall Study||10
9937069|NCT01329263|11054915|FG001|COMPLETED|Overall Study||22
9937070|NCT01329263|11054914|FG000|NOT COMPLETED|Overall Study||5
9937071|NCT01329263|11054915|FG001|NOT COMPLETED|Overall Study||23
9937072|NCT01329328|11054926|FG000|STARTED|Overall Study||15
9937073|NCT01329328|11054927|FG001|STARTED|Overall Study||17
9937074|NCT01329328|11054928|FG002|STARTED|Overall Study||18
9937075|NCT01329328|11054926|FG000|COMPLETED|Overall Study||13
10019023|NCT01826981|11142065|FG014|NOT COMPLETED|Overall Study||0
9937076|NCT01329328|11054927|FG001|COMPLETED|Overall Study||13
9937077|NCT01329328|11054928|FG002|COMPLETED|Overall Study||15
9937078|NCT01329328|11054926|FG000|NOT COMPLETED|Overall Study||2
9937079|NCT01329328|11054927|FG001|NOT COMPLETED|Overall Study||4
9937080|NCT01329328|11054928|FG002|NOT COMPLETED|Overall Study||3
9937081|NCT01329380|11054936|FG000|STARTED|Overall Study||403
9937082|NCT01329380|11054936|FG000|Safety Population|Overall Study||396
9937083|NCT01329380|11054936|FG000|COMPLETED|Overall Study||374
9937084|NCT01329380|11054936|FG000|NOT COMPLETED|Overall Study||29
9937085|NCT01329419|11054940|FG000|STARTED|Overall Study||4393
9937086|NCT01329419|11054940|FG000|COMPLETED|Overall Study||4158
9937087|NCT01329419|11054940|FG000|NOT COMPLETED|Overall Study||235
9937088|NCT01329562|11054947|FG000|STARTED|Overall Study||20
9937089|NCT01329562|11054948|FG001|STARTED|Overall Study||21
9937090|NCT01329562|11054947|FG000|COMPLETED|Overall Study||11
9937091|NCT01329562|11054948|FG001|COMPLETED|Overall Study||14
9937092|NCT01329562|11054947|FG000|NOT COMPLETED|Overall Study||9
9937093|NCT01329562|11054948|FG001|NOT COMPLETED|Overall Study||7
9937094|NCT01329679|11054956|FG000|STARTED|Overall Study||13
9937095|NCT01329679|11054957|FG001|STARTED|Overall Study||13
9937096|NCT01329679|11054956|FG000|COMPLETED|Overall Study||13
9937097|NCT01329679|11054957|FG001|COMPLETED|Overall Study||13
9937098|NCT01329679|11054956|FG000|NOT COMPLETED|Overall Study||0
9937099|NCT01329679|11054957|FG001|NOT COMPLETED|Overall Study||0
9937100|NCT01329848|11054965|FG000|STARTED|Overall Study||83
9937101|NCT01329848|11054965|FG000|COMPLETED|Overall Study||54
9937102|NCT01329848|11054965|FG000|NOT COMPLETED|Overall Study||29
9937103|NCT01329900|11054969|FG000|STARTED|Overall Study||50
9937104|NCT01329900|11054969|FG000|COMPLETED|Overall Study||49
9937105|NCT01329900|11054969|FG000|NOT COMPLETED|Overall Study||1
9937106|NCT01329939|11054977|FG000|STARTED|Overall Study||7
9937107|NCT01329939|11054978|FG001|STARTED|Overall Study||5
9937108|NCT01329939|11054979|FG002|STARTED|Overall Study||5
9937109|NCT01329939|11054980|FG003|STARTED|Overall Study||9
9937110|NCT01329939|11054977|FG000|COMPLETED|Overall Study||4
9937111|NCT01329939|11054978|FG001|COMPLETED|Overall Study||4
9937112|NCT01329939|11054979|FG002|COMPLETED|Overall Study||4
9937113|NCT01329939|11054980|FG003|COMPLETED|Overall Study||4
9937114|NCT01329939|11054977|FG000|NOT COMPLETED|Overall Study||3
9937115|NCT01329939|11054978|FG001|NOT COMPLETED|Overall Study||1
9937116|NCT01329939|11054979|FG002|NOT COMPLETED|Overall Study||1
9937117|NCT01329939|11054980|FG003|NOT COMPLETED|Overall Study||5
9937118|NCT01329978|11054993|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
9937119|NCT01329978|11054994|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
9937120|NCT01329978|11054995|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
9937121|NCT01329978|11054996|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
9937122|NCT01329978|11054997|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
9937123|NCT01329978|11054993|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
9937124|NCT01329978|11054994|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
9937125|NCT01329978|11054995|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
9937126|NCT01329978|11054996|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
9937127|NCT01329978|11054997|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
9937128|NCT01329978|11054993|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
9937129|NCT01329978|11054994|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
9937130|NCT01329978|11054995|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
9937131|NCT01329978|11054996|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
9937132|NCT01329978|11054997|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
9937133|NCT01329978|11054993|FG000|STARTED|Rerandomization Treatment Period||0
9937134|NCT01329978|11054994|FG001|STARTED|Rerandomization Treatment Period||0
9937135|NCT01329978|11054995|FG002|STARTED|Rerandomization Treatment Period||0
9937136|NCT01329978|11054996|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
9937137|NCT01329978|11054997|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
9937138|NCT01329978|11054993|FG000|COMPLETED|Rerandomization Treatment Period||0
9937139|NCT01329978|11054994|FG001|COMPLETED|Rerandomization Treatment Period||0
9937140|NCT01329978|11054995|FG002|COMPLETED|Rerandomization Treatment Period||0
9937141|NCT01329978|11054996|FG003|COMPLETED|Rerandomization Treatment Period||70
9937142|NCT01329978|11054997|FG004|COMPLETED|Rerandomization Treatment Period||71
9937143|NCT01329978|11054993|FG000|NOT COMPLETED|Rerandomization Treatment Period||0
9937144|NCT01329978|11054994|FG001|NOT COMPLETED|Rerandomization Treatment Period||0
9937145|NCT01329978|11054995|FG002|NOT COMPLETED|Rerandomization Treatment Period||0
9937146|NCT01329978|11054996|FG003|NOT COMPLETED|Rerandomization Treatment Period||5
9937147|NCT01329978|11054997|FG004|NOT COMPLETED|Rerandomization Treatment Period||4
9937148|NCT01330017|11055014|FG000|STARTED|Overall Study||109
9937149|NCT01330017|11055015|FG001|STARTED|Overall Study||108
9937150|NCT01330017|11055016|FG002|STARTED|Overall Study||107
9937151|NCT01330017|11055017|FG003|STARTED|Overall Study||112
9937152|NCT01330017|11055018|FG004|STARTED|Overall Study||103
9937153|NCT01330017|11055014|FG000|COMPLETED|Overall Study||104
9937154|NCT01330017|11055015|FG001|COMPLETED|Overall Study||104
9937155|NCT01330017|11055016|FG002|COMPLETED|Overall Study||99
9937156|NCT01330017|11055017|FG003|COMPLETED|Overall Study||100
9937157|NCT01330017|11055018|FG004|COMPLETED|Overall Study||100
9937158|NCT01330017|11055014|FG000|NOT COMPLETED|Overall Study||5
9937159|NCT01330017|11055015|FG001|NOT COMPLETED|Overall Study||4
9937160|NCT01330017|11055016|FG002|NOT COMPLETED|Overall Study||8
9937161|NCT01330017|11055017|FG003|NOT COMPLETED|Overall Study||12
9937162|NCT01330017|11055018|FG004|NOT COMPLETED|Overall Study||3
9937163|NCT01330030|11055032|FG000|STARTED|Overall Study||121
10011266|NCT01779167|11133980|FG000|STARTED|Overall Study||4
10011267|NCT01779167|11133980|FG000|COMPLETED|Overall Study||3
9937164|NCT01330030|11055033|FG001|STARTED|Overall Study||122
9937165|NCT01330030|11055032|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
9937166|NCT01330030|11055033|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
9937167|NCT01330030|11055032|FG000|NOT COMPLETED|Overall Study||16
9937168|NCT01330030|11055033|FG001|NOT COMPLETED|Overall Study||17
9937169|NCT01330043|11055041|FG000|STARTED|Overall Study||111
9937170|NCT01330043|11055042|FG001|STARTED|Overall Study||112
9937171|NCT01330043|11055041|FG000|COMPLETED|Overall Study||111
9937172|NCT01330043|11055042|FG001|COMPLETED|Overall Study||108
9937173|NCT01330043|11055041|FG000|NOT COMPLETED|Overall Study||0
9937174|NCT01330043|11055042|FG001|NOT COMPLETED|Overall Study||4
9937175|NCT01330108|11055048|FG000|STARTED|Overall Study||32
9937176|NCT01330108|11055048|FG000|COMPLETED|Overall Study||28
9937177|NCT01330108|11055048|FG000|NOT COMPLETED|Overall Study||4
9937178|NCT01330134|11055054|FG000|STARTED|Overall Study||244
9937179|NCT01330134|11055055|FG001|STARTED|Overall Study||237
9937180|NCT01330134|11055054|FG000|COMPLETED|Overall Study||244
9937181|NCT01330134|11055055|FG001|COMPLETED|Overall Study||237
9937182|NCT01330134|11055054|FG000|NOT COMPLETED|Overall Study||0
9937183|NCT01330134|11055055|FG001|NOT COMPLETED|Overall Study||0
9937184|NCT01330290|11055061|FG000|STARTED|Overall Study||148
9937185|NCT01330290|11055061|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
9937186|NCT01330290|11055061|FG000|NOT COMPLETED|Overall Study||0
9937187|NCT01330303|11055065|FG000|STARTED|Period 1||20
9937188|NCT01330303|11055066|FG001|STARTED|Period 1||20
9937189|NCT01330303|11055065|FG000|COMPLETED|Period 1||19
9937190|NCT01330303|11055066|FG001|COMPLETED|Period 1||18
9937191|NCT01330303|11055065|FG000|NOT COMPLETED|Period 1||1
9937192|NCT01330303|11055066|FG001|NOT COMPLETED|Period 1||2
9937193|NCT01330303|11055065|FG000|STARTED|7-Day Washout Period||19
9937194|NCT01330303|11055066|FG001|STARTED|7-Day Washout Period||18
9937195|NCT01330303|11055065|FG000|COMPLETED|7-Day Washout Period||19
9937196|NCT01330303|11055066|FG001|COMPLETED|7-Day Washout Period||18
9937197|NCT01330303|11055065|FG000|NOT COMPLETED|7-Day Washout Period||0
9937198|NCT01330303|11055066|FG001|NOT COMPLETED|7-Day Washout Period||0
9937199|NCT01330303|11055065|FG000|STARTED|Period 2||19
10011268|NCT01779167|11133980|FG000|NOT COMPLETED|Overall Study||1
10011269|NCT01779219|11133986|FG000|STARTED|Overall Study|First interim analysis|21
9760585|NCT00382018|10864303|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
9760586|NCT00382018|10864304|FG001|COMPLETED|Overall Study||0
9760587|NCT00382018|10864305|FG002|COMPLETED|Overall Study||0
9760588|NCT00382018|10864306|FG003|COMPLETED|Overall Study||0
9760589|NCT00382018|10864303|FG000|NOT COMPLETED|Overall Study||0
9760590|NCT00382018|10864304|FG001|NOT COMPLETED|Overall Study||165
9760591|NCT00382018|10864305|FG002|NOT COMPLETED|Overall Study||64
9760592|NCT00382018|10864306|FG003|NOT COMPLETED|Overall Study||59
9760593|NCT00382031|10864321|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
9760594|NCT00382031|10864322|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
9760595|NCT00382031|10864321|FG000|COMPLETED|Overall Study||191
9760596|NCT00382031|10864322|FG001|COMPLETED|Overall Study||95
9760597|NCT00382031|10864321|FG000|NOT COMPLETED|Overall Study||0
9760598|NCT00382031|10864322|FG001|NOT COMPLETED|Overall Study||0
9760599|NCT00382070|10864330|FG000|STARTED|Overall Study||1983
9760600|NCT00382070|10864331|FG001|STARTED|Overall Study||1983
9760601|NCT00382070|10864330|FG000|COMPLETED|Overall Study||1950
9760602|NCT00382070|10864331|FG001|COMPLETED|Overall Study||1953
9760603|NCT00382070|10864330|FG000|NOT COMPLETED|Overall Study||33
9760604|NCT00382070|10864331|FG001|NOT COMPLETED|Overall Study||30
9760605|NCT00382109|10864339|FG000|STARTED|Overall Study||76
9760606|NCT00382109|10864340|FG001|STARTED|Overall Study||70
9760607|NCT00382109|10864339|FG000|COMPLETED|Overall Study||64
9760608|NCT00382109|10864340|FG001|COMPLETED|Overall Study||66
9760609|NCT00382109|10864339|FG000|NOT COMPLETED|Overall Study||12
9760610|NCT00382109|10864340|FG001|NOT COMPLETED|Overall Study||4
9760611|NCT00382148|10864351|FG000|STARTED|Overall Study||4
9760612|NCT00382148|10864352|FG001|STARTED|Overall Study||7
9760613|NCT00382148|10864351|FG000|COMPLETED|Overall Study||3
9760614|NCT00382148|10864352|FG001|COMPLETED|Overall Study||7
9760615|NCT00382148|10864351|FG000|NOT COMPLETED|Overall Study||1
9760616|NCT00382148|10864352|FG001|NOT COMPLETED|Overall Study||0
9760617|NCT00382174|10864360|FG000|STARTED|Overall Study||18
9760618|NCT00382174|10864361|FG001|STARTED|Overall Study||54
9937200|NCT01330303|11055066|FG001|STARTED|Period 2||18
9937201|NCT01330303|11055065|FG000|COMPLETED|Period 2||19
9937202|NCT01330303|11055066|FG001|COMPLETED|Period 2||18
10011270|NCT01779219|11133987|FG001|STARTED|Overall Study|First interim analysis|21
10011271|NCT01779219|11133986|FG000|COMPLETED|Overall Study|First interim analysis|21
10011272|NCT01779219|11133987|FG001|COMPLETED|Overall Study|First interim analysis|21
10011273|NCT01779219|11133986|FG000|NOT COMPLETED|Overall Study||0
9937203|NCT01330303|11055065|FG000|NOT COMPLETED|Period 2||0
10011274|NCT01779219|11133987|FG001|NOT COMPLETED|Overall Study||0
10011275|NCT01779375|11133995|FG000|STARTED|Overall Study||47
10011276|NCT01779375|11133996|FG001|STARTED|Overall Study||44
10011277|NCT01779375|11133995|FG000|COMPLETED|Overall Study||45
10011278|NCT01779375|11133996|FG001|COMPLETED|Overall Study||41
10011279|NCT01779375|11133995|FG000|NOT COMPLETED|Overall Study||2
10011280|NCT01779375|11133996|FG001|NOT COMPLETED|Overall Study||3
10011281|NCT01779440|11134006|FG000|STARTED|Overall Study||30
10011282|NCT01779440|11134007|FG001|STARTED|Overall Study||28
10011283|NCT01779440|11134006|FG000|COMPLETED|Overall Study||27
10011284|NCT01779440|11134007|FG001|COMPLETED|Overall Study||23
10011285|NCT01779440|11134006|FG000|NOT COMPLETED|Overall Study||3
10011286|NCT01779440|11134007|FG001|NOT COMPLETED|Overall Study||5
10011287|NCT01779648|11134015|FG000|STARTED|Overall Study||28
10011288|NCT01779648|11134016|FG001|STARTED|Overall Study||27
10011289|NCT01779648|11134015|FG000|COMPLETED|Overall Study||27
9760619|NCT00382174|10864362|FG002|STARTED|Overall Study||72
9760620|NCT00382174|10864360|FG000|COMPLETED|Overall Study||14
9760621|NCT00382174|10864361|FG001|COMPLETED|Overall Study||37
9760622|NCT00382174|10864362|FG002|COMPLETED|Overall Study||51
9760623|NCT00382174|10864360|FG000|NOT COMPLETED|Overall Study||4
9760624|NCT00382174|10864361|FG001|NOT COMPLETED|Overall Study||17
9937204|NCT01330303|11055066|FG001|NOT COMPLETED|Period 2||0
9937205|NCT01330316|11055075|FG000|STARTED|Overall Study||43
9937206|NCT01330316|11055076|FG001|STARTED|Overall Study||75
9937207|NCT01330316|11055075|FG000|COMPLETED|Overall Study||41
9937208|NCT01330316|11055076|FG001|COMPLETED|Overall Study||60
9937209|NCT01330316|11055075|FG000|NOT COMPLETED|Overall Study||2
9937210|NCT01330316|11055076|FG001|NOT COMPLETED|Overall Study||15
9937211|NCT01330355|11055084|FG000|STARTED|Overall Study||16
9937212|NCT01330355|11055085|FG001|STARTED|Overall Study||17
9937213|NCT01330355|11055084|FG000|COMPLETED|Overall Study||16
9937214|NCT01330355|11055085|FG001|COMPLETED|Overall Study||17
9937215|NCT01330355|11055084|FG000|NOT COMPLETED|Overall Study||0
9937216|NCT01330355|11055085|FG001|NOT COMPLETED|Overall Study||0
9937217|NCT01330381|11055093|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107
9937218|NCT01330381|11055094|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108
9937219|NCT01330381|11055095|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0
9937220|NCT01330381|11055093|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
9937221|NCT01330381|11055094|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
9937222|NCT01330381|11055095|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
9937223|NCT01330381|11055093|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
9937224|NCT01330381|11055094|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
9760625|NCT00382174|10864362|FG002|NOT COMPLETED|Overall Study||21
9760626|NCT00382265|10864372|FG000|STARTED|Overall Study||267
9760627|NCT00382265|10864373|FG001|STARTED|Overall Study||245
9760628|NCT00382265|10864372|FG000|COMPLETED|Overall Study||258
9760629|NCT00382265|10864373|FG001|COMPLETED|Overall Study||239
9760630|NCT00382265|10864372|FG000|NOT COMPLETED|Overall Study||9
9760631|NCT00382265|10864373|FG001|NOT COMPLETED|Overall Study||6
9829275|NCT00759031|10939867|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
9937225|NCT01330381|11055095|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
9937226|NCT01330381|11055093|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
9937227|NCT01330381|11055094|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
9937228|NCT01330381|11055095|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
9937229|NCT01330381|11055093|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98
9937230|NCT01330381|11055094|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0
9937231|NCT01330381|11055095|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99
9937232|NCT01330381|11055093|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88
9937233|NCT01330381|11055094|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0
9937234|NCT01330381|11055095|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81
9937235|NCT01330381|11055093|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
10011290|NCT01779648|11134016|FG001|COMPLETED|Overall Study||27
10011291|NCT01779648|11134015|FG000|NOT COMPLETED|Overall Study||1
10011292|NCT01779648|11134016|FG001|NOT COMPLETED|Overall Study||0
10011293|NCT01779700|11134024|FG000|STARTED|Overall Study||18
10011294|NCT01779700|11134025|FG001|STARTED|Overall Study||22
9829276|NCT00759031|10939868|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
9829277|NCT00759031|10939867|FG000|STARTED|Second Intervention (1 Day)||8
9829278|NCT00759031|10939868|FG001|STARTED|Second Intervention (1 Day)||8
9829279|NCT00759031|10939867|FG000|COMPLETED|Second Intervention (1 Day)||8
9829280|NCT00759031|10939868|FG001|COMPLETED|Second Intervention (1 Day)||8
9829281|NCT00759031|10939867|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9829282|NCT00759031|10939868|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9829283|NCT00759096|10939874|FG000|STARTED|Overall Study||30
9829284|NCT00759096|10939874|FG000|COMPLETED|Overall Study||30
9829285|NCT00759096|10939874|FG000|NOT COMPLETED|Overall Study||0
9829286|NCT00759109|10939880|FG000|STARTED|Overall Study||74
9829287|NCT00759109|10939881|FG001|STARTED|Overall Study||76
9829288|NCT00759109|10939880|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
9829289|NCT00759109|10939881|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
9829290|NCT00759109|10939880|FG000|NOT COMPLETED|Overall Study||39
9829291|NCT00759109|10939881|FG001|NOT COMPLETED|Overall Study||35
9937236|NCT01330381|11055094|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
9937237|NCT01330381|11055095|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
9937238|NCT01330394|11055106|FG000|STARTED|Overall Study||17
9937239|NCT01330394|11055107|FG001|STARTED|Overall Study||16
9937240|NCT01330394|11055106|FG000|COMPLETED|Overall Study||17
9937241|NCT01330394|11055107|FG001|COMPLETED|Overall Study||16
9937242|NCT01330394|11055106|FG000|NOT COMPLETED|Overall Study||0
9937243|NCT01330394|11055107|FG001|NOT COMPLETED|Overall Study||0
9937244|NCT01330420|11055113|FG000|STARTED|Overall Study||28
9937245|NCT01330420|11055113|FG000|COMPLETED|Overall Study||24
9937246|NCT01330420|11055113|FG000|NOT COMPLETED|Overall Study||4
9937247|NCT01330433|11055119|FG000|STARTED|Overall Study||16
9937248|NCT01330433|11055120|FG001|STARTED|Overall Study||19
9937249|NCT01330433|11055119|FG000|COMPLETED|Overall Study||14
9937250|NCT01330433|11055120|FG001|COMPLETED|Overall Study||16
9937251|NCT01330433|11055119|FG000|NOT COMPLETED|Overall Study||2
9937252|NCT01330433|11055120|FG001|NOT COMPLETED|Overall Study||3
9937253|NCT01330459|11055128|FG000|STARTED|Overall Study||61
9937254|NCT01330459|11055129|FG001|STARTED|Overall Study||60
9937255|NCT01330459|11055128|FG000|COMPLETED|Overall Study||61
9937256|NCT01330459|11055129|FG001|COMPLETED|Overall Study||58
9937257|NCT01330459|11055128|FG000|NOT COMPLETED|Overall Study||0
9937258|NCT01330459|11055129|FG001|NOT COMPLETED|Overall Study||2
10207101|NCT03521479|11333940|FG001|NOT COMPLETED|Overall Study||0
10207102|NCT03521479|11333941|FG002|NOT COMPLETED|Overall Study||0
10207103|NCT03521479|11333942|FG003|NOT COMPLETED|Overall Study||0
10207104|NCT03521505|11333954|FG000|STARTED|Overall Study||25
10207105|NCT03521505|11333955|FG001|STARTED|Overall Study||25
10207106|NCT03521505|11333954|FG000|COMPLETED|Overall Study||25
10207107|NCT03521505|11333955|FG001|COMPLETED|Overall Study||25
10207108|NCT03521505|11333954|FG000|NOT COMPLETED|Overall Study||0
10207109|NCT03521505|11333955|FG001|NOT COMPLETED|Overall Study||0
10207110|NCT03521635|11333963|FG000|STARTED|Overall Study||49
10207111|NCT03521635|11333964|FG001|STARTED|Overall Study||49
10207112|NCT03521635|11333963|FG000|COMPLETED|Overall Study||45
10207113|NCT03521635|11333964|FG001|COMPLETED|Overall Study||43
10207114|NCT03521635|11333963|FG000|NOT COMPLETED|Overall Study||4
10207115|NCT03521635|11333964|FG001|NOT COMPLETED|Overall Study||6
10207116|NCT03521791|11333972|FG000|STARTED|Overall Study||76
10207117|NCT03521791|11333973|FG001|STARTED|Overall Study||90
10207118|NCT03521791|11333972|FG000|COMPLETED|Overall Study||69
10207119|NCT03521791|11333973|FG001|COMPLETED|Overall Study||73
10207120|NCT03521791|11333972|FG000|NOT COMPLETED|Overall Study||7
10207121|NCT03521791|11333973|FG001|NOT COMPLETED|Overall Study||17
10207122|NCT03521817|11333981|FG000|STARTED|Overall Study||7
10207123|NCT03521817|11333982|FG001|STARTED|Overall Study||5
10207124|NCT03521817|11333981|FG000|COMPLETED|Overall Study||7
10207125|NCT03521817|11333982|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
10207126|NCT03521817|11333981|FG000|NOT COMPLETED|Overall Study||0
10207127|NCT03521817|11333982|FG001|NOT COMPLETED|Overall Study||1
10207128|NCT03522350|11333988|FG000|STARTED|Overall Study||18
10207129|NCT03522350|11333989|FG001|STARTED|Overall Study||18
10207130|NCT03522350|11333988|FG000|COMPLETED|Overall Study||18
10207131|NCT03522350|11333989|FG001|COMPLETED|Overall Study||18
10207132|NCT03522350|11333988|FG000|NOT COMPLETED|Overall Study||0
10207133|NCT03522350|11333989|FG001|NOT COMPLETED|Overall Study||0
10207134|NCT03522441|11333997|FG000|STARTED|Overall Study||450
10207135|NCT03522441|11333998|FG001|STARTED|Overall Study||450
10207136|NCT03522441|11333999|FG002|STARTED|Overall Study||225
10207137|NCT03522441|11333997|FG000|COMPLETED|Overall Study||424
10207138|NCT03522441|11333998|FG001|COMPLETED|Overall Study||431
10207139|NCT03522441|11333999|FG002|COMPLETED|Overall Study||214
10207140|NCT03522441|11333997|FG000|NOT COMPLETED|Overall Study||26
10207141|NCT03522441|11333998|FG001|NOT COMPLETED|Overall Study||19
10207142|NCT03522441|11333999|FG002|NOT COMPLETED|Overall Study||11
10207143|NCT03522506|11334011|FG000|STARTED|Treatment Period 1 (2 Days)||5
10207144|NCT03522506|11334012|FG001|STARTED|Treatment Period 1 (2 Days)||5
10207145|NCT03522506|11334013|FG002|STARTED|Treatment Period 1 (2 Days)||5
10207146|NCT03522506|11334014|FG003|STARTED|Treatment Period 1 (2 Days)||5
10207147|NCT03522506|11334011|FG000|COMPLETED|Treatment Period 1 (2 Days)||5
10207148|NCT03522506|11334012|FG001|COMPLETED|Treatment Period 1 (2 Days)||5
9937259|NCT01330628|11055139|FG000|STARTED|Overall Study||170
9937260|NCT01330628|11055140|FG001|STARTED|Overall Study||82
9937261|NCT01330628|11055139|FG000|30 Day Follow-up|Overall Study||165
9937262|NCT01330628|11055140|FG001|30 Day Follow-up|Overall Study||73
9937263|NCT01330628|11055139|FG000|6 Month Follow-up|Overall Study||135
9937264|NCT01330628|11055140|FG001|6 Month Follow-up|Overall Study||60
9937265|NCT01330628|11055139|FG000|COMPLETED|Overall Study||100
9937266|NCT01330628|11055140|FG001|COMPLETED|Overall Study||42
10207149|NCT03522506|11334013|FG002|COMPLETED|Treatment Period 1 (2 Days)||5
10207150|NCT03522506|11334014|FG003|COMPLETED|Treatment Period 1 (2 Days)||5
10207151|NCT03522506|11334011|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10207152|NCT03522506|11334012|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10207153|NCT03522506|11334013|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10207154|NCT03522506|11334014|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10207155|NCT03522506|11334011|FG000|STARTED|Washout Period 1 (7 Days)||5
10207156|NCT03522506|11334012|FG001|STARTED|Washout Period 1 (7 Days)||5
10207157|NCT03522506|11334013|FG002|STARTED|Washout Period 1 (7 Days)||5
10207158|NCT03522506|11334014|FG003|STARTED|Washout Period 1 (7 Days)||5
9937267|NCT01330628|11055139|FG000|NOT COMPLETED|Overall Study||70
9937268|NCT01330628|11055140|FG001|NOT COMPLETED|Overall Study||40
9937269|NCT01330914|11055146|FG000|STARTED|Overall Study||55
9937270|NCT01330914|11055146|FG000|COMPLETED|Overall Study||48
9937271|NCT01330914|11055146|FG000|NOT COMPLETED|Overall Study||7
9937272|NCT01330953|11055155|FG000|STARTED|Overall Study||8
9937273|NCT01330953|11055156|FG001|STARTED|Overall Study||6
9937274|NCT01330953|11055157|FG002|STARTED|Overall Study||6
9937275|NCT01330953|11055158|FG003|STARTED|Overall Study||6
9937276|NCT01330953|11055159|FG004|STARTED|Overall Study||6
9937277|NCT01330953|11055155|FG000|COMPLETED|Overall Study||8
9937278|NCT01330953|11055156|FG001|COMPLETED|Overall Study||6
9937279|NCT01330953|11055157|FG002|COMPLETED|Overall Study||6
9937280|NCT01330953|11055158|FG003|COMPLETED|Overall Study||6
9937281|NCT01330953|11055159|FG004|COMPLETED|Overall Study||6
9937282|NCT01330953|11055155|FG000|NOT COMPLETED|Overall Study||0
9937283|NCT01330953|11055156|FG001|NOT COMPLETED|Overall Study||0
9937284|NCT01330953|11055157|FG002|NOT COMPLETED|Overall Study||0
9937285|NCT01330953|11055158|FG003|NOT COMPLETED|Overall Study||0
9937286|NCT01330953|11055159|FG004|NOT COMPLETED|Overall Study||0
9937287|NCT01330966|11055176|FG000|STARTED|Overall Study||47
9937288|NCT01330966|11055176|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
9937289|NCT01330966|11055176|FG000|NOT COMPLETED|Overall Study||5
9937290|NCT01331005|11055182|FG000|STARTED|Overall Study||64
9937291|NCT01331005|11055183|FG001|STARTED|Overall Study||61
9937292|NCT01331005|11055182|FG000|COMPLETED|Overall Study||60
10011295|NCT01779700|11134024|FG000|COMPLETED|Overall Study||14
10011296|NCT01779700|11134025|FG001|COMPLETED|Overall Study||17
10011297|NCT01779700|11134024|FG000|NOT COMPLETED|Overall Study||4
9937293|NCT01331005|11055183|FG001|COMPLETED|Overall Study||57
9937294|NCT01331005|11055182|FG000|NOT COMPLETED|Overall Study||4
9937295|NCT01331005|11055183|FG001|NOT COMPLETED|Overall Study||4
9937296|NCT01331083|11055191|FG000|STARTED|Overall Study||43
9937297|NCT01331083|11055192|FG001|STARTED|Overall Study||25
9937298|NCT01331083|11055191|FG000|COMPLETED|Overall Study||43
9937299|NCT01331083|11055192|FG001|COMPLETED|Overall Study||25
9937300|NCT01331083|11055191|FG000|NOT COMPLETED|Overall Study||0
9937301|NCT01331083|11055192|FG001|NOT COMPLETED|Overall Study||0
9937302|NCT01331109|11055198|FG000|STARTED|Overall Study||57
9937303|NCT01331109|11055198|FG000|COMPLETED|Overall Study||0
9937304|NCT01331109|11055198|FG000|NOT COMPLETED|Overall Study||57
9937305|NCT01331161|11055204|FG000|STARTED|Overall Study||44
9937306|NCT01331161|11055205|FG001|STARTED|Overall Study||33
9937307|NCT01331161|11055204|FG000|COMPLETED|Overall Study||43
9937308|NCT01331161|11055205|FG001|COMPLETED|Overall Study||31
9937309|NCT01331161|11055204|FG000|NOT COMPLETED|Overall Study||1
9937310|NCT01331161|11055205|FG001|NOT COMPLETED|Overall Study||2
9937311|NCT01331213|11055215|FG000|STARTED|Overall Study||8
9937312|NCT01331213|11055216|FG001|STARTED|Overall Study||10
9937313|NCT01331213|11055215|FG000|COMPLETED|Overall Study||8
9937314|NCT01331213|11055216|FG001|COMPLETED|Overall Study||10
9937315|NCT01331213|11055215|FG000|NOT COMPLETED|Overall Study||0
9937316|NCT01331213|11055216|FG001|NOT COMPLETED|Overall Study||0
9937317|NCT01331239|11055224|FG000|STARTED|Part I: Core Study||12
9937318|NCT01331239|11055225|FG001|STARTED|Part I: Core Study||0
9937319|NCT01331239|11055226|FG002|STARTED|Part I: Core Study||0
9937320|NCT01331239|11055224|FG000|COMPLETED|Part I: Core Study||12
9937321|NCT01331239|11055225|FG001|COMPLETED|Part I: Core Study||0
9937322|NCT01331239|11055226|FG002|COMPLETED|Part I: Core Study||0
9937323|NCT01331239|11055224|FG000|NOT COMPLETED|Part I: Core Study||0
9937324|NCT01331239|11055225|FG001|NOT COMPLETED|Part I: Core Study||0
9937325|NCT01331239|11055226|FG002|NOT COMPLETED|Part I: Core Study||0
10207159|NCT03522506|11334011|FG000|COMPLETED|Washout Period 1 (7 Days)||5
10207160|NCT03522506|11334012|FG001|COMPLETED|Washout Period 1 (7 Days)||5
10207161|NCT03522506|11334013|FG002|COMPLETED|Washout Period 1 (7 Days)||5
10207162|NCT03522506|11334014|FG003|COMPLETED|Washout Period 1 (7 Days)||4
10207163|NCT03522506|11334011|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10207164|NCT03522506|11334012|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10207165|NCT03522506|11334013|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9937326|NCT01331239|11055224|FG000|STARTED|Part II: Core Study||0
9937327|NCT01331239|11055225|FG001|STARTED|Part II: Core Study||15
9937328|NCT01331239|11055226|FG002|STARTED|Part II: Core Study||4
9937329|NCT01331239|11055224|FG000|COMPLETED|Part II: Core Study||0
9937330|NCT01331239|11055225|FG001|COMPLETED|Part II: Core Study||7
9937331|NCT01331239|11055226|FG002|COMPLETED|Part II: Core Study||3
9937332|NCT01331239|11055224|FG000|NOT COMPLETED|Part II: Core Study||0
10011298|NCT01779700|11134025|FG001|NOT COMPLETED|Overall Study||5
10207166|NCT03522506|11334014|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
9937333|NCT01331239|11055225|FG001|NOT COMPLETED|Part II: Core Study||8
9937334|NCT01331239|11055226|FG002|NOT COMPLETED|Part II: Core Study||1
9937335|NCT01331291|11055244|FG000|STARTED|Overall Study||2
9937336|NCT01331291|11055245|FG001|STARTED|Overall Study||9
9937337|NCT01331291|11055244|FG000|COMPLETED|Overall Study||0
9937338|NCT01331291|11055245|FG001|COMPLETED|Overall Study||0
9937339|NCT01331291|11055244|FG000|NOT COMPLETED|Overall Study||2
10011299|NCT01779856|11134031|FG000|STARTED|Overall Study||81
9937340|NCT01331291|11055245|FG001|NOT COMPLETED|Overall Study||9
9937341|NCT01331304|11055252|FG000|STARTED|Overall Study||240
9937342|NCT01331304|11055253|FG001|STARTED|Overall Study||242
9937343|NCT01331304|11055252|FG000|COMPLETED|Overall Study||182
10207167|NCT03522506|11334011|FG000|STARTED|Treatment Period 2 (2 Days)||5
10207168|NCT03522506|11334012|FG001|STARTED|Treatment Period 2 (2 Days)||5
10207169|NCT03522506|11334013|FG002|STARTED|Treatment Period 2 (2 Days)||5
10207170|NCT03522506|11334014|FG003|STARTED|Treatment Period 2 (2 Days)||4
10207171|NCT03522506|11334011|FG000|COMPLETED|Treatment Period 2 (2 Days)||5
9937344|NCT01331304|11055253|FG001|COMPLETED|Overall Study||182
9937345|NCT01331304|11055252|FG000|NOT COMPLETED|Overall Study||58
9937346|NCT01331304|11055253|FG001|NOT COMPLETED|Overall Study||60
9937347|NCT01331408|11055260|FG000|STARTED|Overall Study||61
9937348|NCT01331408|11055260|FG000|COMPLETED|Overall Study||50
9937349|NCT01331408|11055260|FG000|NOT COMPLETED|Overall Study||11
9937350|NCT01331681|11055267|FG000|STARTED|Overall Study|randomized|136
9937351|NCT01331681|11055268|FG001|STARTED|Overall Study|randomized|135
9937352|NCT01331681|11055269|FG002|STARTED|Overall Study|randomized|135
9937353|NCT01331681|11055267|FG000|Participants Received Treatment|Overall Study|safety population|136
9937354|NCT01331681|11055268|FG001|Participants Received Treatment|Overall Study|safety population|135
9937355|NCT01331681|11055269|FG002|Participants Received Treatment|Overall Study|safety population|133
9937356|NCT01331681|11055267|FG000|Completed Week 52|Overall Study||125
9937357|NCT01331681|11055268|FG001|Completed Week 52|Overall Study||121
9937358|NCT01331681|11055269|FG002|Completed Week 52|Overall Study||115
9937359|NCT01331681|11055267|FG000|Completed Week 100|Overall Study||115
9937360|NCT01331681|11055268|FG001|Completed Week 100|Overall Study||110
9937361|NCT01331681|11055269|FG002|Completed Week 100|Overall Study||105
9937362|NCT01331681|11055267|FG000|Completed Week 148|Overall Study||101
9937363|NCT01331681|11055268|FG001|Completed Week 148|Overall Study||101
9937364|NCT01331681|11055269|FG002|Completed Week 148|Overall Study||100
9937365|NCT01331681|11055267|FG000|COMPLETED|Overall Study|Completed Week 148|101
9937366|NCT01331681|11055268|FG001|COMPLETED|Overall Study|Completed Week 148|101
9937367|NCT01331681|11055269|FG002|COMPLETED|Overall Study|Completed Week 148|100
9937368|NCT01331681|11055267|FG000|NOT COMPLETED|Overall Study||35
9937369|NCT01331681|11055268|FG001|NOT COMPLETED|Overall Study||34
9937370|NCT01331681|11055269|FG002|NOT COMPLETED|Overall Study||35
9937371|NCT01331694|11055283|FG000|STARTED|Overall Study||16684
9937372|NCT01331694|11055284|FG001|STARTED|Overall Study||14449
9937373|NCT01331694|11055285|FG002|STARTED|Overall Study||12659
9937374|NCT01331694|11055286|FG003|STARTED|Overall Study||12595
9937375|NCT01331694|11055287|FG004|STARTED|Overall Study||10617
9937376|NCT01331694|11055288|FG005|STARTED|Overall Study||9126
9937377|NCT01331694|11055283|FG000|COMPLETED|Overall Study||16684
9937378|NCT01331694|11055284|FG001|COMPLETED|Overall Study||14449
9937379|NCT01331694|11055285|FG002|COMPLETED|Overall Study||12659
9937380|NCT01331694|11055286|FG003|COMPLETED|Overall Study||12595
9937381|NCT01331694|11055287|FG004|COMPLETED|Overall Study||10617
9937382|NCT01331694|11055288|FG005|COMPLETED|Overall Study||9126
9937383|NCT01331694|11055283|FG000|NOT COMPLETED|Overall Study||0
9937384|NCT01331694|11055284|FG001|NOT COMPLETED|Overall Study||0
9937385|NCT01331694|11055285|FG002|NOT COMPLETED|Overall Study||0
9937386|NCT01331694|11055286|FG003|NOT COMPLETED|Overall Study||0
9937387|NCT01331694|11055287|FG004|NOT COMPLETED|Overall Study||0
9937388|NCT01331694|11055288|FG005|NOT COMPLETED|Overall Study||0
9937389|NCT01331824|11055302|FG000|STARTED|Overall Study||22
9937390|NCT01331824|11055302|FG000|COMPLETED|Overall Study||9
9937391|NCT01331824|11055302|FG000|NOT COMPLETED|Overall Study||13
9937392|NCT01331837|11055308|FG000|STARTED|Overall Study||1538
9937393|NCT01331837|11055309|FG001|STARTED|Overall Study||1542
9937394|NCT01331837|11055308|FG000|COMPLETED|Overall Study||1482
9937395|NCT01331837|11055309|FG001|COMPLETED|Overall Study||1475
9937396|NCT01331837|11055308|FG000|NOT COMPLETED|Overall Study||56
9937397|NCT01331837|11055309|FG001|NOT COMPLETED|Overall Study||67
9937398|NCT01332019|11055317|FG000|STARTED|Overall Study||530
9937399|NCT01332019|11055318|FG001|STARTED|Overall Study||547
9937400|NCT01332019|11055317|FG000|COMPLETED|Overall Study||417
9937401|NCT01332019|11055318|FG001|COMPLETED|Overall Study||425
9937402|NCT01332019|11055317|FG000|NOT COMPLETED|Overall Study||113
9937403|NCT01332019|11055318|FG001|NOT COMPLETED|Overall Study||122
9956600|NCT01447407|11075892|FG002|COMPLETED|Overall Study||40
9956601|NCT01447407|11075893|FG003|COMPLETED|Overall Study||40
10207172|NCT03522506|11334012|FG001|COMPLETED|Treatment Period 2 (2 Days)||5
9956602|NCT01447407|11075890|FG000|NOT COMPLETED|Overall Study||2
9956603|NCT01447407|11075891|FG001|NOT COMPLETED|Overall Study||0
9956604|NCT01447407|11075892|FG002|NOT COMPLETED|Overall Study||1
9956605|NCT01447407|11075893|FG003|NOT COMPLETED|Overall Study||2
9956606|NCT01447420|11075906|FG000|STARTED|Overall Study||39
9956607|NCT01447420|11075907|FG001|STARTED|Overall Study||72
9956608|NCT01447420|11075908|FG002|STARTED|Overall Study||18
9956609|NCT01447420|11075906|FG000|COMPLETED|Overall Study||29
9956610|NCT01447420|11075907|FG001|COMPLETED|Overall Study||45
9956611|NCT01447420|11075908|FG002|COMPLETED|Overall Study||8
9956612|NCT01447420|11075906|FG000|NOT COMPLETED|Overall Study||10
9956613|NCT01447420|11075907|FG001|NOT COMPLETED|Overall Study||27
9956614|NCT01447420|11075908|FG002|NOT COMPLETED|Overall Study||10
9956615|NCT01447433|11075917|FG000|STARTED|Overall Study||26
9956616|NCT01447433|11075918|FG001|STARTED|Overall Study||27
9956617|NCT01447433|11075917|FG000|COMPLETED|Overall Study||22
9956618|NCT01447433|11075918|FG001|COMPLETED|Overall Study||21
9956619|NCT01447433|11075917|FG000|NOT COMPLETED|Overall Study||4
9956620|NCT01447433|11075918|FG001|NOT COMPLETED|Overall Study||6
9957078|NCT01449370|11076253|FG018|COMPLETED|Overall Study||0
10207173|NCT03522506|11334013|FG002|COMPLETED|Treatment Period 2 (2 Days)||5
10111609|NCT02497391|11242653|FG000|STARTED|Period 1 (14 Days)||16
10111610|NCT02497391|11242654|FG001|STARTED|Period 1 (14 Days)||15
10111611|NCT02497391|11242655|FG002|STARTED|Period 1 (14 Days)||16
10111612|NCT02497391|11242656|FG003|STARTED|Period 1 (14 Days)||16
10111613|NCT02497391|11242657|FG004|STARTED|Period 1 (14 Days)||16
10207174|NCT03522506|11334014|FG003|COMPLETED|Treatment Period 2 (2 Days)||4
9937404|NCT01332071|11055324|FG000|STARTED|Period 1||13
9937405|NCT01332071|11055325|FG001|STARTED|Period 1||13
9937406|NCT01332071|11055324|FG000|COMPLETED|Period 1||13
9937407|NCT01332071|11055325|FG001|COMPLETED|Period 1||13
9937408|NCT01332071|11055324|FG000|NOT COMPLETED|Period 1||0
9937409|NCT01332071|11055325|FG001|NOT COMPLETED|Period 1||0
9937410|NCT01332071|11055324|FG000|STARTED|7-Day Washout Period||13
9937411|NCT01332071|11055325|FG001|STARTED|7-Day Washout Period||13
9937412|NCT01332071|11055324|FG000|COMPLETED|7-Day Washout Period||13
9937413|NCT01332071|11055325|FG001|COMPLETED|7-Day Washout Period||13
9937414|NCT01332071|11055324|FG000|NOT COMPLETED|7-Day Washout Period||0
9937415|NCT01332071|11055325|FG001|NOT COMPLETED|7-Day Washout Period||0
9937416|NCT01332071|11055324|FG000|STARTED|Period 2||13
9937417|NCT01332071|11055325|FG001|STARTED|Period 2||13
10207175|NCT03522506|11334011|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9937418|NCT01332071|11055324|FG000|COMPLETED|Period 2||13
9937419|NCT01332071|11055325|FG001|COMPLETED|Period 2||13
9937420|NCT01332071|11055324|FG000|NOT COMPLETED|Period 2||0
9937421|NCT01332071|11055325|FG001|NOT COMPLETED|Period 2||0
9937422|NCT01332123|11055333|FG000|STARTED|Overall Study||10
9937423|NCT01332123|11055333|FG000|COMPLETED|Overall Study||10
9937424|NCT01332123|11055333|FG000|NOT COMPLETED|Overall Study||0
9937425|NCT01332149|11055340|FG000|STARTED|Overall Study|Assigned to study treatment.|314
9937426|NCT01332149|11055341|FG001|STARTED|Overall Study|Assigned to study treatment.|309
9937427|NCT01332149|11055340|FG000|Treated|Overall Study||313
9937428|NCT01332149|11055341|FG001|Treated|Overall Study||307
9937429|NCT01332149|11055340|FG000|COMPLETED|Overall Study||284
9937430|NCT01332149|11055341|FG001|COMPLETED|Overall Study||271
9937431|NCT01332149|11055340|FG000|NOT COMPLETED|Overall Study||30
9937432|NCT01332149|11055341|FG001|NOT COMPLETED|Overall Study||38
9937433|NCT01332188|11055351|FG000|STARTED|Overall Study||25
9937434|NCT01332188|11055352|FG001|STARTED|Overall Study||26
9937435|NCT01332188|11055353|FG002|STARTED|Overall Study||25
9937436|NCT01332188|11055354|FG003|STARTED|Overall Study||25
9937437|NCT01332188|11055351|FG000|COMPLETED|Overall Study||23
9937438|NCT01332188|11055352|FG001|COMPLETED|Overall Study||25
9937439|NCT01332188|11055353|FG002|COMPLETED|Overall Study||21
9937440|NCT01332188|11055354|FG003|COMPLETED|Overall Study||25
9937441|NCT01332188|11055351|FG000|NOT COMPLETED|Overall Study||2
9937442|NCT01332188|11055352|FG001|NOT COMPLETED|Overall Study||1
9937443|NCT01332188|11055353|FG002|NOT COMPLETED|Overall Study||4
9937444|NCT01332188|11055354|FG003|NOT COMPLETED|Overall Study||0
9937445|NCT01332227|11055366|FG000|STARTED|Overall Study|Participants who received treatment|72
9937446|NCT01332227|11055367|FG001|STARTED|Overall Study|Participants who received treatment|37
9937447|NCT01332227|11055366|FG000|COMPLETED|Overall Study||56
9937448|NCT01332227|11055367|FG001|COMPLETED|Overall Study||32
9937449|NCT01332227|11055366|FG000|NOT COMPLETED|Overall Study||16
9937450|NCT01332227|11055367|FG001|NOT COMPLETED|Overall Study||5
9937451|NCT01332253|11055375|FG000|STARTED|Overall Study||82
9937452|NCT01332253|11055376|FG001|STARTED|Overall Study||79
9937453|NCT01332253|11055375|FG000|COMPLETED|Overall Study||82
9937454|NCT01332253|11055376|FG001|COMPLETED|Overall Study||79
9937455|NCT01332253|11055375|FG000|NOT COMPLETED|Overall Study||0
9937456|NCT01332253|11055376|FG001|NOT COMPLETED|Overall Study||0
9937457|NCT01332292|11055382|FG000|STARTED|Treatment Period 1 (14 Days)||14
9937458|NCT01332292|11055383|FG001|STARTED|Treatment Period 1 (14 Days)||13
9937459|NCT01332292|11055382|FG000|COMPLETED|Treatment Period 1 (14 Days)||12
9937460|NCT01332292|11055383|FG001|COMPLETED|Treatment Period 1 (14 Days)||12
9937461|NCT01332292|11055382|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
9937462|NCT01332292|11055383|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
9937463|NCT01332292|11055382|FG000|STARTED|Washout Period (>=7 Days)||12
9937464|NCT01332292|11055383|FG001|STARTED|Washout Period (>=7 Days)||12
9937465|NCT01332292|11055382|FG000|COMPLETED|Washout Period (>=7 Days)||12
9937466|NCT01332292|11055383|FG001|COMPLETED|Washout Period (>=7 Days)||12
9937467|NCT01332292|11055382|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0
9937468|NCT01332292|11055383|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0
9937469|NCT01332292|11055382|FG000|STARTED|Treatment Period 2 (14 Days)||12
9937470|NCT01332292|11055383|FG001|STARTED|Treatment Period 2 (14 Days)||12
9937471|NCT01332292|11055382|FG000|COMPLETED|Treatment Period 2 (14 Days)||11
10111614|NCT02497391|11242658|FG005|STARTED|Period 1 (14 Days)||16
10111615|NCT02497391|11242653|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10111616|NCT02497391|11242654|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
9937472|NCT01332292|11055383|FG001|COMPLETED|Treatment Period 2 (14 Days)||11
9937473|NCT01332292|11055382|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
9937474|NCT01332292|11055383|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
9937475|NCT01332305|11055396|FG000|STARTED|Overall Study||41
9937476|NCT01332305|11055397|FG001|STARTED|Overall Study||48
9937477|NCT01332305|11055398|FG002|STARTED|Overall Study||45
9937478|NCT01332305|11055399|FG003|STARTED|Overall Study||38
9937479|NCT01332305|11055400|FG004|STARTED|Overall Study||45
9937480|NCT01332305|11055396|FG000|COMPLETED|Overall Study||31
10113430|NCT02509117|11244196|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0
9937481|NCT01332305|11055397|FG001|COMPLETED|Overall Study||34
9937482|NCT01332305|11055398|FG002|COMPLETED|Overall Study||31
9937483|NCT01332305|11055399|FG003|COMPLETED|Overall Study||30
9937484|NCT01332305|11055400|FG004|COMPLETED|Overall Study||33
9937485|NCT01332305|11055396|FG000|NOT COMPLETED|Overall Study||10
9937486|NCT01332305|11055397|FG001|NOT COMPLETED|Overall Study||14
9937487|NCT01332305|11055398|FG002|NOT COMPLETED|Overall Study||14
9937488|NCT01332305|11055399|FG003|NOT COMPLETED|Overall Study||8
9937489|NCT01332305|11055400|FG004|NOT COMPLETED|Overall Study||12
9937490|NCT01332318|11055416|FG000|STARTED|Overall Study||34
9937491|NCT01332318|11055417|FG001|STARTED|Overall Study||32
9937492|NCT01332318|11055418|FG002|STARTED|Overall Study||34
9937493|NCT01332318|11055419|FG003|STARTED|Overall Study||30
9937494|NCT01332318|11055416|FG000|COMPLETED|Overall Study||32
9937495|NCT01332318|11055417|FG001|COMPLETED|Overall Study||28
9937496|NCT01332318|11055418|FG002|COMPLETED|Overall Study||33
9937497|NCT01332318|11055419|FG003|COMPLETED|Overall Study||28
9937498|NCT01332318|11055416|FG000|NOT COMPLETED|Overall Study||2
9937499|NCT01332318|11055417|FG001|NOT COMPLETED|Overall Study||4
9937500|NCT01332318|11055418|FG002|NOT COMPLETED|Overall Study||1
9937501|NCT01332318|11055419|FG003|NOT COMPLETED|Overall Study||2
9937502|NCT01332331|11055432|FG000|STARTED|Overall Study||21
9937503|NCT01332331|11055433|FG001|STARTED|Overall Study||20
9937504|NCT01332331|11055432|FG000|COMPLETED|Overall Study||19
9937505|NCT01332331|11055433|FG001|COMPLETED|Overall Study||18
9937506|NCT01332331|11055432|FG000|NOT COMPLETED|Overall Study||2
9937507|NCT01332331|11055433|FG001|NOT COMPLETED|Overall Study||2
9937508|NCT01332357|11055440|FG000|STARTED|Overall Study||6139
9937509|NCT01332357|11055440|FG000|COMPLETED|Overall Study||6139
9937510|NCT01332357|11055440|FG000|NOT COMPLETED|Overall Study||0
9937511|NCT01332435|11055448|FG000|STARTED|Overall Study||1572
9937512|NCT01332435|11055449|FG001|STARTED|Overall Study||1064
9937513|NCT01332435|11055450|FG002|STARTED|Overall Study||2604
9937514|NCT01332435|11055451|FG003|STARTED|Overall Study||1656
9937515|NCT01332435|11055448|FG000|COMPLETED|Overall Study||1572
9937516|NCT01332435|11055449|FG001|COMPLETED|Overall Study||1064
9937517|NCT01332435|11055450|FG002|COMPLETED|Overall Study||2604
9937518|NCT01332435|11055451|FG003|COMPLETED|Overall Study||1656
9937519|NCT01332435|11055448|FG000|NOT COMPLETED|Overall Study||0
9937520|NCT01332435|11055449|FG001|NOT COMPLETED|Overall Study||0
9937521|NCT01332435|11055450|FG002|NOT COMPLETED|Overall Study||0
9937522|NCT01332435|11055451|FG003|NOT COMPLETED|Overall Study||0
9937523|NCT01332461|11055464|FG000|STARTED|Overall Study||1291
9937524|NCT01332461|11055465|FG001|STARTED|Overall Study||4386
9937525|NCT01332461|11055464|FG000|COMPLETED|Overall Study||1291
9937526|NCT01332461|11055465|FG001|COMPLETED|Overall Study||4386
9937527|NCT01332461|11055464|FG000|NOT COMPLETED|Overall Study||0
9937528|NCT01332461|11055465|FG001|NOT COMPLETED|Overall Study||0
9937529|NCT01332487|11055473|FG000|STARTED|Overall Study||5554
9937530|NCT01332487|11055474|FG001|STARTED|Overall Study||3063
9937531|NCT01332487|11055473|FG000|COMPLETED|Overall Study||5554
9937532|NCT01332487|11055474|FG001|COMPLETED|Overall Study||3063
9937533|NCT01332487|11055473|FG000|NOT COMPLETED|Overall Study||0
9937534|NCT01332487|11055474|FG001|NOT COMPLETED|Overall Study||0
9937535|NCT01332500|11055484|FG000|STARTED|Overall Study||13257
9937536|NCT01332500|11055485|FG001|STARTED|Overall Study||39771
9937537|NCT01332500|11055486|FG002|STARTED|Overall Study||2903
9937538|NCT01332500|11055487|FG003|STARTED|Overall Study||5806
9937539|NCT01332500|11055484|FG000|COMPLETED|Overall Study||13257
9937540|NCT01332500|11055485|FG001|COMPLETED|Overall Study||39771
9937541|NCT01332500|11055486|FG002|COMPLETED|Overall Study||2903
9937542|NCT01332500|11055487|FG003|COMPLETED|Overall Study||5806
9937543|NCT01332500|11055484|FG000|NOT COMPLETED|Overall Study||0
9937544|NCT01332500|11055485|FG001|NOT COMPLETED|Overall Study||0
9937545|NCT01332500|11055486|FG002|NOT COMPLETED|Overall Study||0
9937546|NCT01332500|11055487|FG003|NOT COMPLETED|Overall Study||0
9937547|NCT01332578|11055497|FG000|STARTED|Period I||12
9937548|NCT01332578|11055498|FG001|STARTED|Period I||13
9937549|NCT01332578|11055497|FG000|COMPLETED|Period I||12
9937550|NCT01332578|11055498|FG001|COMPLETED|Period I||13
9937551|NCT01332578|11055497|FG000|NOT COMPLETED|Period I||0
9937552|NCT01332578|11055498|FG001|NOT COMPLETED|Period I||0
9937553|NCT01332578|11055497|FG000|STARTED|Washout Period||12
9937554|NCT01332578|11055498|FG001|STARTED|Washout Period||13
9937555|NCT01332578|11055497|FG000|COMPLETED|Washout Period||12
9937556|NCT01332578|11055498|FG001|COMPLETED|Washout Period||13
9937557|NCT01332578|11055497|FG000|NOT COMPLETED|Washout Period||0
9937558|NCT01332578|11055498|FG001|NOT COMPLETED|Washout Period||0
9937559|NCT01332578|11055497|FG000|STARTED|Period II||12
9937560|NCT01332578|11055498|FG001|STARTED|Period II||13
9937561|NCT01332578|11055497|FG000|COMPLETED|Period II||12
9937562|NCT01332578|11055498|FG001|COMPLETED|Period II||13
9937563|NCT01332578|11055497|FG000|NOT COMPLETED|Period II||0
9937564|NCT01332578|11055498|FG001|NOT COMPLETED|Period II||0
9937565|NCT01332630|11055505|FG000|STARTED|Overall Study||24
9937566|NCT01332630|11055505|FG000|COMPLETED|Overall Study||21
9937567|NCT01332630|11055505|FG000|NOT COMPLETED|Overall Study||3
9937568|NCT01332721|11055509|FG000|STARTED|Overall Study||38
9937569|NCT01332721|11055509|FG000|COMPLETED|Overall Study||38
9937570|NCT01332721|11055509|FG000|NOT COMPLETED|Overall Study||0
9937571|NCT01332851|11055515|FG000|STARTED|Overall Study||124
9937572|NCT01332851|11055516|FG001|STARTED|Overall Study||123
9937573|NCT01332851|11055515|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
9937574|NCT01332851|11055516|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
9937575|NCT01332851|11055515|FG000|Completed Follow up 1|Overall Study||116
9937576|NCT01332851|11055516|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
9937577|NCT01332851|11055515|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
9937578|NCT01332851|11055516|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
9937579|NCT01332851|11055515|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
9937580|NCT01332851|11055516|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
9937581|NCT01332851|11055515|FG000|COMPLETED|Overall Study||113
9937582|NCT01332851|11055516|FG001|COMPLETED|Overall Study||110
9937583|NCT01332851|11055515|FG000|NOT COMPLETED|Overall Study||11
9937584|NCT01332851|11055516|FG001|NOT COMPLETED|Overall Study||13
9937585|NCT01332981|11055526|FG000|STARTED|Overall Study||220
9937586|NCT01332981|11055526|FG000|COMPLETED|Overall Study||220
9937587|NCT01332981|11055526|FG000|NOT COMPLETED|Overall Study||0
9937588|NCT01332994|11055533|FG000|STARTED|Overall Study||519
9937589|NCT01332994|11055533|FG000|Completed Week 16|Overall Study||463
9937590|NCT01332994|11055533|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200
9937591|NCT01332994|11055533|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26
9937592|NCT01332994|11055533|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25
9937593|NCT01332994|11055533|FG000|COMPLETED|Overall Study||448
9937594|NCT01332994|11055533|FG000|NOT COMPLETED|Overall Study||71
9937595|NCT01333033|11055539|FG000|STARTED|Overall Study||72
9937596|NCT01333033|11055540|FG001|STARTED|Overall Study||39
9937597|NCT01333033|11055541|FG002|STARTED|Overall Study||64
9937598|NCT01333033|11055542|FG003|STARTED|Overall Study||50
9937599|NCT01333033|11055543|FG004|STARTED|Overall Study||14
9937600|NCT01333033|11055544|FG005|STARTED|Overall Study||18
9937601|NCT01333033|11055539|FG000|COMPLETED|Overall Study||72
9937602|NCT01333033|11055540|FG001|COMPLETED|Overall Study||39
9937603|NCT01333033|11055541|FG002|COMPLETED|Overall Study||64
9937604|NCT01333033|11055542|FG003|COMPLETED|Overall Study||50
9937605|NCT01333033|11055543|FG004|COMPLETED|Overall Study||0
9937606|NCT01333033|11055544|FG005|COMPLETED|Overall Study||0
9937607|NCT01333033|11055539|FG000|NOT COMPLETED|Overall Study||0
9937608|NCT01333033|11055540|FG001|NOT COMPLETED|Overall Study||0
9937609|NCT01333033|11055541|FG002|NOT COMPLETED|Overall Study||0
9937610|NCT01333033|11055542|FG003|NOT COMPLETED|Overall Study||0
9937611|NCT01333033|11055543|FG004|NOT COMPLETED|Overall Study||14
9937612|NCT01333033|11055544|FG005|NOT COMPLETED|Overall Study||18
9937613|NCT01333059|11055564|FG000|STARTED|Overall Study||14
9937614|NCT01333059|11055565|FG001|STARTED|Overall Study||11
9937615|NCT01333059|11055564|FG000|COMPLETED|Overall Study||8
9937616|NCT01333059|11055565|FG001|COMPLETED|Overall Study||8
9937617|NCT01333059|11055564|FG000|NOT COMPLETED|Overall Study||6
9937618|NCT01333059|11055565|FG001|NOT COMPLETED|Overall Study||3
9937619|NCT01333072|11055575|FG000|STARTED|Overall Study||30
9937620|NCT01333072|11055576|FG001|STARTED|Overall Study||31
9937621|NCT01333072|11055575|FG000|COMPLETED|Overall Study||24
9937622|NCT01333072|11055576|FG001|COMPLETED|Overall Study||27
9937623|NCT01333072|11055575|FG000|NOT COMPLETED|Overall Study||6
9937624|NCT01333072|11055576|FG001|NOT COMPLETED|Overall Study||4
9937625|NCT01333098|11055582|FG000|STARTED|Overall Study||15
9937626|NCT01333098|11055582|FG000|COMPLETED|Overall Study||12
9937627|NCT01333098|11055582|FG000|NOT COMPLETED|Overall Study||3
9937628|NCT01333111|11055591|FG000|STARTED|Overall Study||30
9937629|NCT01333111|11055592|FG001|STARTED|Overall Study||29
9937630|NCT01333111|11055593|FG002|STARTED|Overall Study||15
9937631|NCT01333111|11055591|FG000|COMPLETED|Overall Study||28
9937632|NCT01333111|11055592|FG001|COMPLETED|Overall Study||26
9937633|NCT01333111|11055593|FG002|COMPLETED|Overall Study||13
9937634|NCT01333111|11055591|FG000|NOT COMPLETED|Overall Study||2
9937635|NCT01333111|11055592|FG001|NOT COMPLETED|Overall Study||3
9937636|NCT01333111|11055593|FG002|NOT COMPLETED|Overall Study||2
9937637|NCT01333189|11055603|FG000|STARTED|Overall Study||13
9937638|NCT01333189|11055604|FG001|STARTED|Overall Study||13
9937639|NCT01333189|11055603|FG000|COMPLETED|Overall Study||11
9937640|NCT01333189|11055604|FG001|COMPLETED|Overall Study||11
9937641|NCT01333189|11055603|FG000|NOT COMPLETED|Overall Study||2
9937642|NCT01333189|11055604|FG001|NOT COMPLETED|Overall Study||2
9937643|NCT01333397|11055615|FG000|STARTED|Overall Study||35
9937644|NCT01333397|11055616|FG001|STARTED|Overall Study||36
9937645|NCT01333397|11055617|FG002|STARTED|Overall Study||35
9937646|NCT01333397|11055618|FG003|STARTED|Overall Study||35
9937647|NCT01333397|11055619|FG004|STARTED|Overall Study||35
9937648|NCT01333397|11055615|FG000|COMPLETED|Overall Study||34
9937649|NCT01333397|11055616|FG001|COMPLETED|Overall Study||36
9937650|NCT01333397|11055617|FG002|COMPLETED|Overall Study||35
9937651|NCT01333397|11055618|FG003|COMPLETED|Overall Study||34
9937652|NCT01333397|11055619|FG004|COMPLETED|Overall Study||35
9937653|NCT01333397|11055615|FG000|NOT COMPLETED|Overall Study||1
9937654|NCT01333397|11055616|FG001|NOT COMPLETED|Overall Study||0
9937655|NCT01333397|11055617|FG002|NOT COMPLETED|Overall Study||0
9937656|NCT01333397|11055618|FG003|NOT COMPLETED|Overall Study||1
9937657|NCT01333397|11055619|FG004|NOT COMPLETED|Overall Study||0
9937658|NCT01333475|11055642|FG000|STARTED|Overall Study||12
9937659|NCT01333475|11055643|FG001|STARTED|Overall Study||9
9937660|NCT01333475|11055642|FG000|COMPLETED|Overall Study||10
9937661|NCT01333475|11055643|FG001|COMPLETED|Overall Study||6
9937662|NCT01333475|11055642|FG000|NOT COMPLETED|Overall Study||2
9937663|NCT01333475|11055643|FG001|NOT COMPLETED|Overall Study||3
9937664|NCT01333488|11055653|FG000|STARTED|Overall Study||2
9937665|NCT01333488|11055654|FG001|STARTED|Overall Study||1
9937666|NCT01333488|11055655|FG002|STARTED|Overall Study||3
9937667|NCT01333488|11055653|FG000|COMPLETED|Overall Study||2
9937668|NCT01333488|11055654|FG001|COMPLETED|Overall Study||1
9937669|NCT01333488|11055655|FG002|COMPLETED|Overall Study||3
9937670|NCT01333488|11055653|FG000|NOT COMPLETED|Overall Study||0
9937671|NCT01333488|11055654|FG001|NOT COMPLETED|Overall Study||0
9937672|NCT01333488|11055655|FG002|NOT COMPLETED|Overall Study||0
9937673|NCT01333501|11055666|FG000|STARTED|Overall Study||106
9937674|NCT01333501|11055667|FG001|STARTED|Overall Study||51
9937675|NCT01333501|11055666|FG000|Full Analysis Set (FAS)|Overall Study||80
9937676|NCT01333501|11055667|FG001|Full Analysis Set (FAS)|Overall Study||28
9937677|NCT01333501|11055666|FG000|Safety Population|Overall Study||104
9937678|NCT01333501|11055667|FG001|Safety Population|Overall Study||47
9937679|NCT01333501|11055666|FG000|COMPLETED|Overall Study||97
9937680|NCT01333501|11055667|FG001|COMPLETED|Overall Study||30
9937681|NCT01333501|11055666|FG000|NOT COMPLETED|Overall Study||9
9937682|NCT01333501|11055667|FG001|NOT COMPLETED|Overall Study||21
9937683|NCT01333527|11055675|FG000|STARTED|Overall Study||105
9937684|NCT01333527|11055676|FG001|STARTED|Overall Study||106
9937685|NCT01333527|11055675|FG000|COMPLETED|Overall Study||87
9937686|NCT01333527|11055676|FG001|COMPLETED|Overall Study||89
9937687|NCT01333527|11055675|FG000|NOT COMPLETED|Overall Study||18
9937688|NCT01333527|11055676|FG001|NOT COMPLETED|Overall Study||17
9937689|NCT01333592|11055684|FG000|STARTED|Overall Study||67
9937690|NCT01333592|11055685|FG001|STARTED|Overall Study||69
9937691|NCT01333592|11055684|FG000|COMPLETED|Overall Study||58
9937692|NCT01333592|11055685|FG001|COMPLETED|Overall Study||52
9937693|NCT01333592|11055684|FG000|NOT COMPLETED|Overall Study||9
9937694|NCT01333592|11055685|FG001|NOT COMPLETED|Overall Study||17
9937695|NCT01333722|11055693|FG000|STARTED|Overall Study||51
9937696|NCT01333722|11055694|FG001|STARTED|Overall Study||49
9937697|NCT01333722|11055693|FG000|COMPLETED|Overall Study||51
9937698|NCT01333722|11055694|FG001|COMPLETED|Overall Study||46
9937699|NCT01333722|11055693|FG000|NOT COMPLETED|Overall Study||0
9937700|NCT01333722|11055694|FG001|NOT COMPLETED|Overall Study||3
9937701|NCT01333813|11055702|FG000|STARTED|Overall Study||297
9937702|NCT01333813|11055702|FG000|COMPLETED|Overall Study||297
9937703|NCT01333813|11055702|FG000|NOT COMPLETED|Overall Study||0
9937704|NCT01333865|11055706|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
9937705|NCT01333865|11055706|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
9937706|NCT01333865|11055706|FG000|NOT COMPLETED|Overall Study||2
9937707|NCT01333956|11055714|FG000|STARTED|Overall Study||30
9937708|NCT01333956|11055715|FG001|STARTED|Overall Study||30
9937709|NCT01333956|11055716|FG002|STARTED|Overall Study||30
9937710|NCT01333956|11055717|FG003|STARTED|Overall Study||30
9937711|NCT01333956|11055714|FG000|COMPLETED|Overall Study||28
9937712|NCT01333956|11055715|FG001|COMPLETED|Overall Study||26
9937713|NCT01333956|11055716|FG002|COMPLETED|Overall Study||29
9937714|NCT01333956|11055717|FG003|COMPLETED|Overall Study||28
9937715|NCT01333956|11055714|FG000|NOT COMPLETED|Overall Study||2
9937716|NCT01333956|11055715|FG001|NOT COMPLETED|Overall Study||4
9937717|NCT01333956|11055716|FG002|NOT COMPLETED|Overall Study||1
9937718|NCT01333956|11055717|FG003|NOT COMPLETED|Overall Study||2
9937719|NCT01334086|11055728|FG000|STARTED|Overall Study||41
9937720|NCT01334086|11055728|FG000|COMPLETED|Overall Study||41
9937721|NCT01334086|11055728|FG000|NOT COMPLETED|Overall Study||0
9937722|NCT01334125|11055734|FG000|STARTED|Overall Study||15
9937723|NCT01334125|11055735|FG001|STARTED|Overall Study||13
9937724|NCT01334125|11055734|FG000|COMPLETED|Overall Study|3 subjects move to another city|12
9937725|NCT01334125|11055735|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
9937726|NCT01334125|11055734|FG000|NOT COMPLETED|Overall Study||3
9937727|NCT01334125|11055735|FG001|NOT COMPLETED|Overall Study||3
9937728|NCT01334216|11055744|FG000|STARTED|Overall Study||168
9937729|NCT01334216|11055745|FG001|STARTED|Overall Study||194
9937730|NCT01334216|11055744|FG000|COMPLETED|Overall Study||168
9937731|NCT01334216|11055745|FG001|COMPLETED|Overall Study||194
10011300|NCT01779856|11134031|FG000|COMPLETED|Overall Study||57
10011301|NCT01779856|11134031|FG000|NOT COMPLETED|Overall Study||24
10011302|NCT01779869|11134042|FG000|STARTED|Overall Study||16
10011303|NCT01779869|11134042|FG000|COMPLETED|Overall Study||14
10011304|NCT01779869|11134042|FG000|NOT COMPLETED|Overall Study||2
10011305|NCT01780324|11134048|FG000|STARTED|Overall Study||41
10011306|NCT01780324|11134049|FG001|STARTED|Overall Study||39
9937732|NCT01334216|11055744|FG000|NOT COMPLETED|Overall Study||0
9937733|NCT01334216|11055745|FG001|NOT COMPLETED|Overall Study||0
9937734|NCT01334229|11055753|FG000|STARTED|Overall Study||11
9937735|NCT01334229|11055754|FG001|STARTED|Overall Study||11
9937736|NCT01334229|11055753|FG000|COMPLETED|Overall Study||11
9937737|NCT01334229|11055754|FG001|COMPLETED|Overall Study||11
9937738|NCT01334229|11055753|FG000|NOT COMPLETED|Overall Study||0
9937739|NCT01334229|11055754|FG001|NOT COMPLETED|Overall Study||0
10011307|NCT01780324|11134048|FG000|COMPLETED|Overall Study||40
9937740|NCT01334515|11055762|FG000|STARTED|Overall Study||16
10011308|NCT01780324|11134049|FG001|COMPLETED|Overall Study||33
10011309|NCT01780324|11134048|FG000|NOT COMPLETED|Overall Study||1
10011310|NCT01780324|11134049|FG001|NOT COMPLETED|Overall Study||6
10011311|NCT01780337|11134057|FG000|STARTED|Overall Study||6
10011312|NCT01780337|11134058|FG001|STARTED|Overall Study||6
9937741|NCT01334515|11055763|FG001|STARTED|Overall Study||36
9937742|NCT01334515|11055762|FG000|COMPLETED|Overall Study||4
9937743|NCT01334515|11055763|FG001|COMPLETED|Overall Study||7
9937744|NCT01334515|11055762|FG000|NOT COMPLETED|Overall Study||12
9937745|NCT01334515|11055763|FG001|NOT COMPLETED|Overall Study||29
9937746|NCT01334554|11055771|FG000|STARTED|Overall Study||23
9937747|NCT01334554|11055772|FG001|STARTED|Overall Study||23
9937748|NCT01334554|11055771|FG000|COMPLETED|Overall Study||19
9937749|NCT01334554|11055772|FG001|COMPLETED|Overall Study||21
9937750|NCT01334554|11055771|FG000|NOT COMPLETED|Overall Study||4
9937751|NCT01334554|11055772|FG001|NOT COMPLETED|Overall Study||2
9937752|NCT01334710|11055780|FG000|STARTED|Overall Study||3
9937753|NCT01334710|11055780|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
9937754|NCT01334710|11055780|FG000|NOT COMPLETED|Overall Study||3
9937755|NCT01334723|11055787|FG000|STARTED|Overall Study||17293
9937756|NCT01334723|11055788|FG001|STARTED|Overall Study||17739
9937757|NCT01334723|11055787|FG000|COMPLETED|Overall Study||17293
9937758|NCT01334723|11055788|FG001|COMPLETED|Overall Study||17739
9937759|NCT01334723|11055787|FG000|NOT COMPLETED|Overall Study||0
9937760|NCT01334723|11055788|FG001|NOT COMPLETED|Overall Study||0
9937761|NCT01334827|11055808|FG000|STARTED|Overall Study||48
9937762|NCT01334827|11055808|FG000|COMPLETED|Overall Study||48
9937763|NCT01334827|11055808|FG000|NOT COMPLETED|Overall Study||0
9937764|NCT01334866|11055814|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
9937765|NCT01334866|11055814|FG000|COMPLETED|Overall Study||72
9937766|NCT01334866|11055814|FG000|NOT COMPLETED|Overall Study||19
9937767|NCT01334918|11055822|FG000|STARTED|Overall Study||63
9937768|NCT01334918|11055823|FG001|STARTED|Overall Study||61
9937769|NCT01334918|11055822|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
9937770|NCT01334918|11055823|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
9937771|NCT01334918|11055822|FG000|COMPLETED|Overall Study||55
9937772|NCT01334918|11055823|FG001|COMPLETED|Overall Study||60
9937773|NCT01334918|11055822|FG000|NOT COMPLETED|Overall Study||8
9937774|NCT01334918|11055823|FG001|NOT COMPLETED|Overall Study||1
9937775|NCT01334944|11055840|FG000|STARTED|Overall Study||11
9937776|NCT01334944|11055841|FG001|STARTED|Overall Study||139
9937777|NCT01334944|11055840|FG000|Received Singel Dose|Overall Study||1
9937778|NCT01334944|11055841|FG001|Received Singel Dose|Overall Study||96
9937779|NCT01334944|11055840|FG000|Received Multiple Doses|Overall Study||10
9937780|NCT01334944|11055841|FG001|Received Multiple Doses|Overall Study||43
9937781|NCT01334944|11055840|FG000|COMPLETED|Overall Study||11
9937782|NCT01334944|11055841|FG001|COMPLETED|Overall Study||139
9937783|NCT01334944|11055840|FG000|NOT COMPLETED|Overall Study||0
9937784|NCT01334944|11055841|FG001|NOT COMPLETED|Overall Study||0
9937785|NCT01334957|11055850|FG000|STARTED|Overall Study||300
9937786|NCT01334957|11055850|FG000|Received Single Dose|Overall Study||252
9937787|NCT01334957|11055850|FG000|Received Multiple Doses|Overall Study||48
9937788|NCT01334957|11055850|FG000|COMPLETED|Overall Study||300
9937789|NCT01334957|11055850|FG000|NOT COMPLETED|Overall Study||0
9937790|NCT01335009|11055856|FG000|STARTED|Overall Study||40
9937791|NCT01335009|11055857|FG001|STARTED|Overall Study||36
9937792|NCT01335009|11055856|FG000|COMPLETED|Overall Study||9
9937793|NCT01335009|11055857|FG001|COMPLETED|Overall Study||3
9937794|NCT01335009|11055856|FG000|NOT COMPLETED|Overall Study||31
9937795|NCT01335009|11055857|FG001|NOT COMPLETED|Overall Study||33
9937796|NCT01335061|11055863|FG000|STARTED|Overall Study||25
9937797|NCT01335061|11055863|FG000|COMPLETED|Overall Study||25
9937798|NCT01335061|11055863|FG000|NOT COMPLETED|Overall Study||0
9937799|NCT01335191|11055876|FG000|STARTED|Overall Study||16
9937800|NCT01335191|11055877|FG001|STARTED|Overall Study||11
9937801|NCT01335191|11055876|FG000|COMPLETED|Overall Study||16
9937802|NCT01335191|11055877|FG001|COMPLETED|Overall Study||11
9937803|NCT01335191|11055876|FG000|NOT COMPLETED|Overall Study||0
9937804|NCT01335191|11055877|FG001|NOT COMPLETED|Overall Study||0
9937805|NCT01335204|11055883|FG000|STARTED|Overall Study||4
9937806|NCT01335204|11055883|FG000|COMPLETED|Overall Study||4
9937807|NCT01335204|11055883|FG000|NOT COMPLETED|Overall Study||0
9937808|NCT01335230|11055891|FG000|STARTED|Overall Study|subjects|10
9937809|NCT01335230|11055892|FG001|STARTED|Overall Study|subjects|10
9937810|NCT01335230|11055893|FG002|STARTED|Overall Study|subjects|10
9937811|NCT01335230|11055894|FG003|STARTED|Overall Study|subjects|10
9937812|NCT01335230|11055891|FG000|COMPLETED|Overall Study|subjects|10
9937813|NCT01335230|11055892|FG001|COMPLETED|Overall Study|subjects|10
9937814|NCT01335230|11055893|FG002|COMPLETED|Overall Study|subjects|10
9937815|NCT01335230|11055894|FG003|COMPLETED|Overall Study|subjects|10
9937816|NCT01335230|11055891|FG000|NOT COMPLETED|Overall Study||0
9937817|NCT01335230|11055892|FG001|NOT COMPLETED|Overall Study||0
9937818|NCT01335230|11055893|FG002|NOT COMPLETED|Overall Study||0
9937819|NCT01335230|11055894|FG003|NOT COMPLETED|Overall Study||0
9937820|NCT01335308|11055907|FG000|STARTED|Overall Study||198
9937821|NCT01335308|11055908|FG001|STARTED|Overall Study||212
9937822|NCT01335308|11055909|FG002|STARTED|Overall Study||235
9937823|NCT01335308|11055907|FG000|COMPLETED|Overall Study||158
10011313|NCT01780337|11134057|FG000|COMPLETED|Overall Study||6
9937824|NCT01335308|11055908|FG001|COMPLETED|Overall Study||145
9937825|NCT01335308|11055909|FG002|COMPLETED|Overall Study||154
9937826|NCT01335308|11055907|FG000|NOT COMPLETED|Overall Study||40
9937827|NCT01335308|11055908|FG001|NOT COMPLETED|Overall Study||67
9937828|NCT01335308|11055909|FG002|NOT COMPLETED|Overall Study||81
9937829|NCT01335464|11055919|FG000|STARTED|Overall Study||206
9937830|NCT01335464|11055920|FG001|STARTED|Overall Study||309
9937831|NCT01335464|11055919|FG000|COMPLETED|Overall Study||174
9937832|NCT01335464|11055920|FG001|COMPLETED|Overall Study||260
9937833|NCT01335464|11055919|FG000|NOT COMPLETED|Overall Study||32
9937834|NCT01335464|11055920|FG001|NOT COMPLETED|Overall Study||49
9937835|NCT01335477|11055928|FG000|STARTED|Overall Study||220
9937836|NCT01335477|11055929|FG001|STARTED|Overall Study||331
9937837|NCT01335477|11055928|FG000|COMPLETED|Overall Study||179
9937838|NCT01335477|11055929|FG001|COMPLETED|Overall Study||272
9937839|NCT01335477|11055928|FG000|NOT COMPLETED|Overall Study||41
9937840|NCT01335477|11055929|FG001|NOT COMPLETED|Overall Study||59
9937841|NCT01335542|11055937|FG000|STARTED|Overall Study||45
9937842|NCT01335542|11055938|FG001|STARTED|Overall Study||45
9937843|NCT01335542|11055937|FG000|COMPLETED|Overall Study||45
9937844|NCT01335542|11055938|FG001|COMPLETED|Overall Study||45
9937845|NCT01335542|11055937|FG000|NOT COMPLETED|Overall Study||0
9937846|NCT01335542|11055938|FG001|NOT COMPLETED|Overall Study||0
9937847|NCT01335620|11055944|FG000|STARTED|Overall Study||19
9937848|NCT01335620|11055944|FG000|COMPLETED|Overall Study||19
9937849|NCT01335620|11055944|FG000|NOT COMPLETED|Overall Study||0
9937850|NCT01335698|11055953|FG000|STARTED|Treatment Stage 1||23
9937851|NCT01335698|11055954|FG001|STARTED|Treatment Stage 1||12
9937852|NCT01335698|11055955|FG002|STARTED|Treatment Stage 1||21
9937853|NCT01335698|11055956|FG003|STARTED|Treatment Stage 1||35
9937854|NCT01335698|11055957|FG004|STARTED|Treatment Stage 1||8
9937855|NCT01335698|11055953|FG000|COMPLETED|Treatment Stage 1||15
9937856|NCT01335698|11055954|FG001|COMPLETED|Treatment Stage 1||4
9937857|NCT01335698|11055955|FG002|COMPLETED|Treatment Stage 1||16
9937858|NCT01335698|11055956|FG003|COMPLETED|Treatment Stage 1||26
9937859|NCT01335698|11055957|FG004|COMPLETED|Treatment Stage 1||6
9937860|NCT01335698|11055953|FG000|NOT COMPLETED|Treatment Stage 1||8
9937861|NCT01335698|11055954|FG001|NOT COMPLETED|Treatment Stage 1||8
9937862|NCT01335698|11055955|FG002|NOT COMPLETED|Treatment Stage 1||5
9937863|NCT01335698|11055956|FG003|NOT COMPLETED|Treatment Stage 1||9
9937864|NCT01335698|11055957|FG004|NOT COMPLETED|Treatment Stage 1||2
9937865|NCT01335698|11055953|FG000|STARTED|Treatment Stage 2||15
9937866|NCT01335698|11055954|FG001|STARTED|Treatment Stage 2||4
9937867|NCT01335698|11055955|FG002|STARTED|Treatment Stage 2||16
9937868|NCT01335698|11055956|FG003|STARTED|Treatment Stage 2||26
9937869|NCT01335698|11055957|FG004|STARTED|Treatment Stage 2||6
9937870|NCT01335698|11055953|FG000|COMPLETED|Treatment Stage 2||4
9937871|NCT01335698|11055954|FG001|COMPLETED|Treatment Stage 2||1
9937872|NCT01335698|11055955|FG002|COMPLETED|Treatment Stage 2||11
9937873|NCT01335698|11055956|FG003|COMPLETED|Treatment Stage 2||18
9937874|NCT01335698|11055957|FG004|COMPLETED|Treatment Stage 2||5
9937875|NCT01335698|11055953|FG000|NOT COMPLETED|Treatment Stage 2||11
9937876|NCT01335698|11055954|FG001|NOT COMPLETED|Treatment Stage 2||3
9937877|NCT01335698|11055955|FG002|NOT COMPLETED|Treatment Stage 2||5
9937878|NCT01335698|11055956|FG003|NOT COMPLETED|Treatment Stage 2||8
9937879|NCT01335698|11055957|FG004|NOT COMPLETED|Treatment Stage 2||1
9937880|NCT01335724|11055973|FG000|STARTED|Overall Study||36
9937881|NCT01335724|11055974|FG001|STARTED|Overall Study||36
9937882|NCT01335724|11055973|FG000|COMPLETED|Overall Study||36
9937883|NCT01335724|11055974|FG001|COMPLETED|Overall Study||36
9937884|NCT01335724|11055973|FG000|NOT COMPLETED|Overall Study||0
9937885|NCT01335724|11055974|FG001|NOT COMPLETED|Overall Study||0
9937886|NCT01335750|11055980|FG000|STARTED|Overall Study||32
9937887|NCT01335750|11055980|FG000|COMPLETED|Overall Study||32
9937888|NCT01335750|11055980|FG000|NOT COMPLETED|Overall Study||0
9937889|NCT01335789|11055994|FG000|STARTED|Overall Study||8
9937890|NCT01335789|11055995|FG001|STARTED|Overall Study||8
9937891|NCT01335789|11055994|FG000|COMPLETED|Overall Study||8
9937892|NCT01335789|11055995|FG001|COMPLETED|Overall Study||8
9937893|NCT01335789|11055994|FG000|NOT COMPLETED|Overall Study||0
9937894|NCT01335789|11055995|FG001|NOT COMPLETED|Overall Study||0
9937895|NCT01335867|11056003|FG000|STARTED|Overall Study||16
9937896|NCT01335867|11056004|FG001|STARTED|Overall Study||16
9937897|NCT01335867|11056003|FG000|COMPLETED|Overall Study||9
9937898|NCT01335867|11056004|FG001|COMPLETED|Overall Study||12
10207176|NCT03522506|11334012|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10207177|NCT03522506|11334013|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10207178|NCT03522506|11334014|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10207179|NCT03522506|11334011|FG000|STARTED|Washout Period 2 (7 Days)||5
10207180|NCT03522506|11334012|FG001|STARTED|Washout Period 2 (7 Days)||5
9937899|NCT01335867|11056003|FG000|NOT COMPLETED|Overall Study||7
9937900|NCT01335867|11056004|FG001|NOT COMPLETED|Overall Study||4
9937901|NCT01335932|11056019|FG000|STARTED|Overall Study||84
9937902|NCT01335932|11056020|FG001|STARTED|Overall Study||76
9937903|NCT01335932|11056019|FG000|COMPLETED|Overall Study||84
9937904|NCT01335932|11056020|FG001|COMPLETED|Overall Study||72
9937905|NCT01335932|11056019|FG000|NOT COMPLETED|Overall Study||0
9937906|NCT01335932|11056020|FG001|NOT COMPLETED|Overall Study||4
9937907|NCT01335971|11056029|FG000|STARTED|Overall Study||31
9937908|NCT01335971|11056030|FG001|STARTED|Overall Study||29
9937909|NCT01335971|11056031|FG002|STARTED|Overall Study||29
10207181|NCT03522506|11334013|FG002|STARTED|Washout Period 2 (7 Days)||5
9937910|NCT01335971|11056029|FG000|COMPLETED|Overall Study||29
9937911|NCT01335971|11056030|FG001|COMPLETED|Overall Study||28
9937912|NCT01335971|11056031|FG002|COMPLETED|Overall Study||28
9937913|NCT01335971|11056029|FG000|NOT COMPLETED|Overall Study||2
9937914|NCT01335971|11056030|FG001|NOT COMPLETED|Overall Study||1
9937915|NCT01335971|11056031|FG002|NOT COMPLETED|Overall Study||1
9937916|NCT01336023|11056042|FG000|STARTED|Week 0 to Week 26||414
9937917|NCT01336023|11056043|FG001|STARTED|Week 0 to Week 26||834
9937918|NCT01336023|11056044|FG002|STARTED|Week 0 to Week 26||415
9937919|NCT01336023|11056042|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
9937920|NCT01336023|11056043|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
9937921|NCT01336023|11056044|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
9937922|NCT01336023|11056042|FG000|COMPLETED|Week 0 to Week 26||366
9937923|NCT01336023|11056043|FG001|COMPLETED|Week 0 to Week 26||736
9937924|NCT01336023|11056044|FG002|COMPLETED|Week 0 to Week 26||342
9937925|NCT01336023|11056042|FG000|NOT COMPLETED|Week 0 to Week 26||48
9937926|NCT01336023|11056043|FG001|NOT COMPLETED|Week 0 to Week 26||98
9937927|NCT01336023|11056044|FG002|NOT COMPLETED|Week 0 to Week 26||73
9937928|NCT01336023|11056042|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
9937929|NCT01336023|11056043|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
9937930|NCT01336023|11056044|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
9937931|NCT01336023|11056042|FG000|COMPLETED|Week 27 to 52||305
9937932|NCT01336023|11056043|FG001|COMPLETED|Week 27 to 52||621
9937933|NCT01336023|11056044|FG002|COMPLETED|Week 27 to 52||285
9937934|NCT01336023|11056042|FG000|NOT COMPLETED|Week 27 to 52||28
9937935|NCT01336023|11056043|FG001|NOT COMPLETED|Week 27 to 52||44
9937936|NCT01336023|11056044|FG002|NOT COMPLETED|Week 27 to 52||28
9937937|NCT01336140|11056054|FG000|STARTED|Overall Study||150
9937938|NCT01336140|11056055|FG001|STARTED|Overall Study||150
9937939|NCT01336140|11056054|FG000|COMPLETED|Overall Study||150
9937940|NCT01336140|11056055|FG001|COMPLETED|Overall Study||150
9937941|NCT01336140|11056054|FG000|NOT COMPLETED|Overall Study||0
9937942|NCT01336140|11056055|FG001|NOT COMPLETED|Overall Study||0
9937943|NCT01336205|11056063|FG000|STARTED|Overall Study||563
10111617|NCT02497391|11242655|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10111618|NCT02497391|11242656|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10111619|NCT02497391|11242657|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10111620|NCT02497391|11242658|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10111621|NCT02497391|11242653|FG000|COMPLETED|Period 1 (14 Days)||16
10111622|NCT02497391|11242654|FG001|COMPLETED|Period 1 (14 Days)||15
9937944|NCT01336205|11056064|FG001|STARTED|Overall Study||281
9937945|NCT01336205|11056063|FG000|COMPLETED|Overall Study||330
9937946|NCT01336205|11056064|FG001|COMPLETED|Overall Study||192
9937947|NCT01336205|11056063|FG000|NOT COMPLETED|Overall Study||233
9937948|NCT01336205|11056064|FG001|NOT COMPLETED|Overall Study||89
9937949|NCT01336296|11056072|FG000|STARTED|Overall Study||40
9937950|NCT01336296|11056073|FG001|STARTED|Overall Study||21
9937951|NCT01336296|11056072|FG000|COMPLETED|Overall Study||35
9937952|NCT01336296|11056073|FG001|COMPLETED|Overall Study||17
9937953|NCT01336296|11056072|FG000|NOT COMPLETED|Overall Study||5
9937954|NCT01336296|11056073|FG001|NOT COMPLETED|Overall Study||4
9937955|NCT01336413|11056081|FG000|STARTED|Overall Study||27
9937956|NCT01336413|11056082|FG001|STARTED|Overall Study||26
9937957|NCT01336413|11056081|FG000|COMPLETED|Overall Study||26
9937958|NCT01336413|11056082|FG001|COMPLETED|Overall Study||18
9937959|NCT01336413|11056081|FG000|NOT COMPLETED|Overall Study||1
9937960|NCT01336413|11056082|FG001|NOT COMPLETED|Overall Study||8
9937961|NCT01336569|11056090|FG000|STARTED|Overall Study||49
9937962|NCT01336569|11056090|FG000|COMPLETED|Overall Study||45
9937963|NCT01336569|11056090|FG000|NOT COMPLETED|Overall Study||4
9937964|NCT01336608|11056097|FG000|STARTED|2-week, Single-blind Run-In Period||559
9937965|NCT01336608|11056098|FG001|STARTED|2-week, Single-blind Run-In Period||0
9937966|NCT01336608|11056099|FG002|STARTED|2-week, Single-blind Run-In Period||0
9937967|NCT01336608|11056100|FG003|STARTED|2-week, Single-blind Run-In Period||0
9937968|NCT01336608|11056097|FG000|COMPLETED|2-week, Single-blind Run-In Period||444
9937969|NCT01336608|11056098|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
9937970|NCT01336608|11056099|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
9937971|NCT01336608|11056100|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
9937972|NCT01336608|11056097|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115
9937973|NCT01336608|11056098|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9937974|NCT01336608|11056099|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9937975|NCT01336608|11056100|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
9937976|NCT01336608|11056097|FG000|STARTED|24-week, Double-blind Treatment Period||0
9937977|NCT01336608|11056098|FG001|STARTED|24-week, Double-blind Treatment Period||141
9937978|NCT01336608|11056099|FG002|STARTED|24-week, Double-blind Treatment Period||154
9937979|NCT01336608|11056100|FG003|STARTED|24-week, Double-blind Treatment Period||135
9937980|NCT01336608|11056097|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
9937981|NCT01336608|11056098|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
9956621|NCT01447446|11075930|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
9937982|NCT01336608|11056099|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
9937983|NCT01336608|11056100|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
9937984|NCT01336608|11056097|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
9937985|NCT01336608|11056098|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
9937986|NCT01336608|11056099|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
9937987|NCT01336608|11056100|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
9937988|NCT01336608|11056097|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
9937989|NCT01336608|11056098|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44
9937990|NCT01336608|11056099|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30
9937991|NCT01336608|11056100|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24
9937992|NCT01336647|11056111|FG000|STARTED|Overall Study||46
9937993|NCT01336647|11056112|FG001|STARTED|Overall Study||49
9937994|NCT01336647|11056113|FG002|STARTED|Overall Study||47
9937995|NCT01336647|11056111|FG000|COMPLETED|Overall Study||42
9937996|NCT01336647|11056112|FG001|COMPLETED|Overall Study||48
9937997|NCT01336647|11056113|FG002|COMPLETED|Overall Study||44
9937998|NCT01336647|11056111|FG000|NOT COMPLETED|Overall Study||4
9937999|NCT01336647|11056112|FG001|NOT COMPLETED|Overall Study||1
9938000|NCT01336647|11056113|FG002|NOT COMPLETED|Overall Study||3
9938001|NCT01336712|11056123|FG000|STARTED|Overall Study||30
9938002|NCT01336712|11056123|FG000|COMPLETED|Overall Study||27
9938003|NCT01336712|11056123|FG000|NOT COMPLETED|Overall Study||3
9938004|NCT01336738|11056132|FG000|STARTED|Overall Study||52
9938005|NCT01336738|11056133|FG001|STARTED|Overall Study||54
9938006|NCT01336738|11056134|FG002|STARTED|Overall Study||53
9938007|NCT01336738|11056135|FG003|STARTED|Overall Study||54
9938008|NCT01336738|11056136|FG004|STARTED|Overall Study||53
9938009|NCT01336738|11056132|FG000|COMPLETED|Overall Study||45
9938010|NCT01336738|11056133|FG001|COMPLETED|Overall Study||45
9938011|NCT01336738|11056134|FG002|COMPLETED|Overall Study||45
9938012|NCT01336738|11056135|FG003|COMPLETED|Overall Study||47
9938013|NCT01336738|11056136|FG004|COMPLETED|Overall Study||43
9938014|NCT01336738|11056132|FG000|NOT COMPLETED|Overall Study||7
9938015|NCT01336738|11056133|FG001|NOT COMPLETED|Overall Study||9
9938016|NCT01336738|11056134|FG002|NOT COMPLETED|Overall Study||8
9938017|NCT01336738|11056135|FG003|NOT COMPLETED|Overall Study||7
9938018|NCT01336738|11056136|FG004|NOT COMPLETED|Overall Study||10
9938019|NCT01336764|11056150|FG000|STARTED|Overall Study||12
9938020|NCT01336764|11056151|FG001|STARTED|Overall Study||10
9938021|NCT01336764|11056150|FG000|COMPLETED|Overall Study||7
9938022|NCT01336764|11056151|FG001|COMPLETED|Overall Study||5
9938023|NCT01336764|11056150|FG000|NOT COMPLETED|Overall Study||5
9938024|NCT01336764|11056151|FG001|NOT COMPLETED|Overall Study||5
9938025|NCT01336803|11056157|FG000|STARTED|Overall Study||21
9938026|NCT01336803|11056157|FG000|Bone Sarcoma|Overall Study||10
9938027|NCT01336803|11056157|FG000|Osteomyelitis|Overall Study||4
9938028|NCT01336803|11056157|FG000|Lymphoma|Overall Study||7
9938029|NCT01336803|11056157|FG000|COMPLETED|Overall Study||21
9938030|NCT01336803|11056157|FG000|NOT COMPLETED|Overall Study||0
9938031|NCT01336894|11056171|FG000|STARTED|Protocol Interventions||4
9938032|NCT01336894|11056172|FG001|STARTED|Protocol Interventions||7
9938033|NCT01336894|11056171|FG000|COMPLETED|Protocol Interventions||4
9938034|NCT01336894|11056172|FG001|COMPLETED|Protocol Interventions||7
9938035|NCT01336894|11056171|FG000|NOT COMPLETED|Protocol Interventions||0
9938036|NCT01336894|11056172|FG001|NOT COMPLETED|Protocol Interventions||0
9938037|NCT01336894|11056171|FG000|STARTED|Follow-up||4
9938038|NCT01336894|11056172|FG001|STARTED|Follow-up||7
9938039|NCT01336894|11056171|FG000|COMPLETED|Follow-up||2
9938040|NCT01336894|11056172|FG001|COMPLETED|Follow-up||0
9938041|NCT01336894|11056171|FG000|NOT COMPLETED|Follow-up||2
9938042|NCT01336894|11056172|FG001|NOT COMPLETED|Follow-up||7
9938043|NCT01336933|11056178|FG000|STARTED|Overall Study||34
9938044|NCT01336933|11056178|FG000|COMPLETED|Overall Study||33
9938045|NCT01336933|11056178|FG000|NOT COMPLETED|Overall Study||1
9938046|NCT01336959|11056186|FG000|STARTED|Overall Study||8
9938047|NCT01336959|11056187|FG001|STARTED|Overall Study||42
9938048|NCT01336959|11056188|FG002|STARTED|Overall Study||41
9938049|NCT01336959|11056186|FG000|COMPLETED|Overall Study||8
9938050|NCT01336959|11056187|FG001|COMPLETED|Overall Study||37
9938051|NCT01336959|11056188|FG002|COMPLETED|Overall Study||40
9938052|NCT01336959|11056186|FG000|NOT COMPLETED|Overall Study||0
9938053|NCT01336959|11056187|FG001|NOT COMPLETED|Overall Study||5
9938054|NCT01336959|11056188|FG002|NOT COMPLETED|Overall Study||1
9938055|NCT01336972|11056202|FG000|STARTED|Overall Study||10
9938056|NCT01336972|11056203|FG001|STARTED|Overall Study||10
9938057|NCT01336972|11056204|FG002|STARTED|Overall Study||9
9938058|NCT01336972|11056202|FG000|COMPLETED|Overall Study||9
9938059|NCT01336972|11056203|FG001|COMPLETED|Overall Study||9
9938060|NCT01336972|11056204|FG002|COMPLETED|Overall Study||9
9938061|NCT01336972|11056202|FG000|NOT COMPLETED|Overall Study||1
9938062|NCT01336972|11056203|FG001|NOT COMPLETED|Overall Study||1
9938063|NCT01336972|11056204|FG002|NOT COMPLETED|Overall Study||0
9938064|NCT01337050|11056216|FG000|STARTED|Overall Study||4
9938065|NCT01337050|11056217|FG001|STARTED|Overall Study||13
9938066|NCT01337050|11056218|FG002|STARTED|Overall Study||19
9938067|NCT01337050|11056216|FG000|COMPLETED|Overall Study||0
9938068|NCT01337050|11056217|FG001|COMPLETED|Overall Study||0
9938069|NCT01337050|11056218|FG002|COMPLETED|Overall Study||0
9938070|NCT01337050|11056216|FG000|NOT COMPLETED|Overall Study||4
9938071|NCT01337050|11056217|FG001|NOT COMPLETED|Overall Study||13
9938072|NCT01337050|11056218|FG002|NOT COMPLETED|Overall Study||19
9938073|NCT01337076|11056227|FG000|STARTED|Overall Study|subjects implanted|21
9938074|NCT01337076|11056227|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
9938075|NCT01337076|11056227|FG000|NOT COMPLETED|Overall Study||2
9938076|NCT01337089|11056231|FG000|STARTED|Overall Study||660
9938077|NCT01337089|11056231|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660
9938078|NCT01337089|11056231|FG000|Safety Population|Overall Study||660
9938079|NCT01337089|11056231|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
9938080|NCT01337089|11056231|FG000|COMPLETED|Overall Study||256
9938081|NCT01337089|11056231|FG000|NOT COMPLETED|Overall Study||404
9938082|NCT01337115|11056237|FG000|STARTED|Overall Study||25
9938083|NCT01337115|11056238|FG001|STARTED|Overall Study||25
9938084|NCT01337115|11056237|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
9938085|NCT01337115|11056238|FG001|COMPLETED|Overall Study||25
9938086|NCT01337115|11056237|FG000|NOT COMPLETED|Overall Study||2
9938087|NCT01337115|11056238|FG001|NOT COMPLETED|Overall Study||0
9938088|NCT01337167|11056248|FG000|STARTED|Infant Series||986
9938089|NCT01337167|11056249|FG001|STARTED|Infant Series||487
9938090|NCT01337167|11056248|FG000|COMPLETED|Infant Series||924
9938091|NCT01337167|11056249|FG001|COMPLETED|Infant Series||460
9938092|NCT01337167|11056248|FG000|NOT COMPLETED|Infant Series||62
9938093|NCT01337167|11056249|FG001|NOT COMPLETED|Infant Series||27
9938094|NCT01337167|11056248|FG000|STARTED|Interim Period||924
9938095|NCT01337167|11056249|FG001|STARTED|Interim Period||460
9938096|NCT01337167|11056248|FG000|COMPLETED|Interim Period||843
9938097|NCT01337167|11056249|FG001|COMPLETED|Interim Period||420
9938098|NCT01337167|11056248|FG000|NOT COMPLETED|Interim Period||81
9938099|NCT01337167|11056249|FG001|NOT COMPLETED|Interim Period||40
9938100|NCT01337167|11056248|FG000|STARTED|Toddler Vaccinations||843
9938101|NCT01337167|11056249|FG001|STARTED|Toddler Vaccinations||420
9938102|NCT01337167|11056248|FG000|COMPLETED|Toddler Vaccinations||829
9938103|NCT01337167|11056249|FG001|COMPLETED|Toddler Vaccinations||407
9938104|NCT01337167|11056248|FG000|NOT COMPLETED|Toddler Vaccinations||14
9938105|NCT01337167|11056249|FG001|NOT COMPLETED|Toddler Vaccinations||13
9938106|NCT01337297|11056257|FG000|STARTED|Overall Study||11
9938107|NCT01337297|11056258|FG001|STARTED|Overall Study||9
9938108|NCT01337297|11056257|FG000|COMPLETED|Overall Study||6
9938109|NCT01337297|11056258|FG001|COMPLETED|Overall Study||3
9938110|NCT01337297|11056257|FG000|NOT COMPLETED|Overall Study||5
9938111|NCT01337297|11056258|FG001|NOT COMPLETED|Overall Study||6
9938112|NCT01337336|11056266|FG000|STARTED|Overall Study||1078
9938113|NCT01337336|11056267|FG001|STARTED|Overall Study||2923
9938114|NCT01337336|11056266|FG000|COMPLETED|Overall Study||1078
9938115|NCT01337336|11056267|FG001|COMPLETED|Overall Study||2923
9938116|NCT01337336|11056266|FG000|NOT COMPLETED|Overall Study||0
9938117|NCT01337336|11056267|FG001|NOT COMPLETED|Overall Study||0
9938118|NCT01337596|11056282|FG000|STARTED|Overall Study||7
9938119|NCT01337596|11056283|FG001|STARTED|Overall Study||7
9938120|NCT01337596|11056284|FG002|STARTED|Overall Study||7
9938121|NCT01337596|11056285|FG003|STARTED|Overall Study||7
9938122|NCT01337596|11056286|FG004|STARTED|Overall Study||7
9938123|NCT01337596|11056287|FG005|STARTED|Overall Study||7
9938124|NCT01337596|11056288|FG006|STARTED|Overall Study||12
9938125|NCT01337596|11056289|FG007|STARTED|Overall Study||2
9938126|NCT01337596|11056290|FG008|STARTED|Overall Study||7
9938127|NCT01337596|11056282|FG000|Safety Population|Overall Study||7
9938128|NCT01337596|11056283|FG001|Safety Population|Overall Study||7
9938129|NCT01337596|11056284|FG002|Safety Population|Overall Study||7
9938130|NCT01337596|11056285|FG003|Safety Population|Overall Study||7
9938131|NCT01337596|11056286|FG004|Safety Population|Overall Study||7
9938132|NCT01337596|11056287|FG005|Safety Population|Overall Study||7
9938133|NCT01337596|11056288|FG006|Safety Population|Overall Study||12
9938134|NCT01337596|11056289|FG007|Safety Population|Overall Study||2
9938135|NCT01337596|11056290|FG008|Safety Population|Overall Study||7
9938136|NCT01337596|11056282|FG000|COMPLETED|Overall Study||7
9938137|NCT01337596|11056283|FG001|COMPLETED|Overall Study||7
9938138|NCT01337596|11056284|FG002|COMPLETED|Overall Study||7
9938139|NCT01337596|11056285|FG003|COMPLETED|Overall Study||7
9938140|NCT01337596|11056286|FG004|COMPLETED|Overall Study||5
9938141|NCT01337596|11056287|FG005|COMPLETED|Overall Study||7
9938142|NCT01337596|11056288|FG006|COMPLETED|Overall Study||12
9938143|NCT01337596|11056289|FG007|COMPLETED|Overall Study||2
9938144|NCT01337596|11056290|FG008|COMPLETED|Overall Study||7
9938145|NCT01337596|11056282|FG000|NOT COMPLETED|Overall Study||0
9938146|NCT01337596|11056283|FG001|NOT COMPLETED|Overall Study||0
9938147|NCT01337596|11056284|FG002|NOT COMPLETED|Overall Study||0
9938148|NCT01337596|11056285|FG003|NOT COMPLETED|Overall Study||0
9938149|NCT01337596|11056286|FG004|NOT COMPLETED|Overall Study||2
9938150|NCT01337596|11056287|FG005|NOT COMPLETED|Overall Study||0
9938151|NCT01337596|11056288|FG006|NOT COMPLETED|Overall Study||0
9938152|NCT01337596|11056289|FG007|NOT COMPLETED|Overall Study||0
9938153|NCT01337596|11056290|FG008|NOT COMPLETED|Overall Study||0
9938154|NCT01337635|11056315|FG000|STARTED|Overall Study||3
9938155|NCT01337635|11056316|FG001|STARTED|Overall Study||4
9938156|NCT01337635|11056315|FG000|COMPLETED|Overall Study||3
9938157|NCT01337635|11056316|FG001|COMPLETED|Overall Study||3
9938158|NCT01337635|11056315|FG000|NOT COMPLETED|Overall Study||0
9938159|NCT01337635|11056316|FG001|NOT COMPLETED|Overall Study||1
9938160|NCT01337674|11056324|FG000|STARTED|Treatment Period 1||6
9938161|NCT01337674|11056325|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7
9938162|NCT01337674|11056326|FG002|STARTED|Treatment Period 1||6
9938163|NCT01337674|11056327|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7
9938164|NCT01337674|11056324|FG000|COMPLETED|Treatment Period 1||6
9938165|NCT01337674|11056325|FG001|COMPLETED|Treatment Period 1||6
9938166|NCT01337674|11056326|FG002|COMPLETED|Treatment Period 1||6
9938167|NCT01337674|11056327|FG003|COMPLETED|Treatment Period 1||6
9938168|NCT01337674|11056324|FG000|NOT COMPLETED|Treatment Period 1||0
9938169|NCT01337674|11056325|FG001|NOT COMPLETED|Treatment Period 1||1
9938170|NCT01337674|11056326|FG002|NOT COMPLETED|Treatment Period 1||0
9938171|NCT01337674|11056327|FG003|NOT COMPLETED|Treatment Period 1||1
9938172|NCT01337674|11056324|FG000|STARTED|Two-week Washout Period||6
9938173|NCT01337674|11056325|FG001|STARTED|Two-week Washout Period||6
9938174|NCT01337674|11056326|FG002|STARTED|Two-week Washout Period||6
9938175|NCT01337674|11056327|FG003|STARTED|Two-week Washout Period||6
9938176|NCT01337674|11056324|FG000|COMPLETED|Two-week Washout Period||6
9938177|NCT01337674|11056325|FG001|COMPLETED|Two-week Washout Period||6
9938178|NCT01337674|11056326|FG002|COMPLETED|Two-week Washout Period||6
9938179|NCT01337674|11056327|FG003|COMPLETED|Two-week Washout Period||6
9938180|NCT01337674|11056324|FG000|NOT COMPLETED|Two-week Washout Period||0
9938181|NCT01337674|11056325|FG001|NOT COMPLETED|Two-week Washout Period||0
9938182|NCT01337674|11056326|FG002|NOT COMPLETED|Two-week Washout Period||0
9938183|NCT01337674|11056327|FG003|NOT COMPLETED|Two-week Washout Period||0
9938184|NCT01337674|11056324|FG000|STARTED|Treatment Period 2||6
9938185|NCT01337674|11056325|FG001|STARTED|Treatment Period 2||6
9938186|NCT01337674|11056326|FG002|STARTED|Treatment Period 2||6
9938187|NCT01337674|11056327|FG003|STARTED|Treatment Period 2||6
9938188|NCT01337674|11056324|FG000|COMPLETED|Treatment Period 2||6
9938189|NCT01337674|11056325|FG001|COMPLETED|Treatment Period 2||6
9938190|NCT01337674|11056326|FG002|COMPLETED|Treatment Period 2||5
9938191|NCT01337674|11056327|FG003|COMPLETED|Treatment Period 2||6
9938192|NCT01337674|11056324|FG000|NOT COMPLETED|Treatment Period 2||0
9938193|NCT01337674|11056325|FG001|NOT COMPLETED|Treatment Period 2||0
9938194|NCT01337674|11056326|FG002|NOT COMPLETED|Treatment Period 2||1
9938195|NCT01337674|11056327|FG003|NOT COMPLETED|Treatment Period 2||0
9938196|NCT01337687|11056342|FG000|STARTED|Overall Study||10
9938197|NCT01337687|11056343|FG001|STARTED|Overall Study||9
9938198|NCT01337687|11056342|FG000|COMPLETED|Overall Study||10
9938199|NCT01337687|11056343|FG001|COMPLETED|Overall Study||9
9938200|NCT01337687|11056342|FG000|NOT COMPLETED|Overall Study||0
9938201|NCT01337687|11056343|FG001|NOT COMPLETED|Overall Study||0
9938202|NCT01337700|11056351|FG000|STARTED|Overall Study||5
9938203|NCT01337700|11056352|FG001|STARTED|Overall Study||5
9938204|NCT01337700|11056351|FG000|COMPLETED|Overall Study||5
9938205|NCT01337700|11056352|FG001|COMPLETED|Overall Study||5
9938206|NCT01337700|11056351|FG000|NOT COMPLETED|Overall Study||0
9938207|NCT01337700|11056352|FG001|NOT COMPLETED|Overall Study||0
9938208|NCT01337739|11056360|FG000|STARTED|Overall Study||6
9938209|NCT01337739|11056361|FG001|STARTED|Overall Study||4
9938210|NCT01337739|11056360|FG000|COMPLETED|Overall Study||6
9938211|NCT01337739|11056361|FG001|COMPLETED|Overall Study||4
9938212|NCT01337739|11056360|FG000|NOT COMPLETED|Overall Study||0
9938213|NCT01337739|11056361|FG001|NOT COMPLETED|Overall Study||0
9938214|NCT01337960|11056370|FG000|STARTED|Overall Study||14
9938215|NCT01337960|11056371|FG001|STARTED|Overall Study||14
9938216|NCT01337960|11056372|FG002|STARTED|Overall Study||6
9938217|NCT01337960|11056370|FG000|COMPLETED|Overall Study||12
9938218|NCT01337960|11056371|FG001|COMPLETED|Overall Study||14
9938219|NCT01337960|11056372|FG002|COMPLETED|Overall Study||6
9938220|NCT01337960|11056370|FG000|NOT COMPLETED|Overall Study||2
9938221|NCT01337960|11056371|FG001|NOT COMPLETED|Overall Study||0
9938222|NCT01337960|11056372|FG002|NOT COMPLETED|Overall Study||0
9938223|NCT01337973|11056383|FG000|STARTED|Overall Study||60
9938224|NCT01337973|11056384|FG001|STARTED|Overall Study||60
9938225|NCT01337973|11056385|FG002|STARTED|Overall Study||60
9938226|NCT01337973|11056383|FG000|COMPLETED|Overall Study||44
9938227|NCT01337973|11056384|FG001|COMPLETED|Overall Study||45
9938228|NCT01337973|11056385|FG002|COMPLETED|Overall Study||49
9938229|NCT01337973|11056383|FG000|NOT COMPLETED|Overall Study||16
9938230|NCT01337973|11056384|FG001|NOT COMPLETED|Overall Study||15
9938231|NCT01337973|11056385|FG002|NOT COMPLETED|Overall Study||11
9938232|NCT01337986|11056395|FG000|STARTED|Overall Study||23
9938233|NCT01337986|11056396|FG001|STARTED|Overall Study||23
9938234|NCT01337986|11056395|FG000|COMPLETED|Overall Study||20
9938235|NCT01337986|11056396|FG001|COMPLETED|Overall Study||18
9938236|NCT01337986|11056395|FG000|NOT COMPLETED|Overall Study||3
9938237|NCT01337986|11056396|FG001|NOT COMPLETED|Overall Study||5
9938238|NCT01338012|11056418|FG000|STARTED|Overall Study||8
9938239|NCT01338012|11056418|FG000|COMPLETED|Overall Study||0
9938240|NCT01338012|11056418|FG000|NOT COMPLETED|Overall Study||8
9956622|NCT01447446|11075931|FG001|STARTED|Overall Study||496
9956623|NCT01447446|11075932|FG002|STARTED|Overall Study||292
9956624|NCT01447446|11075933|FG003|STARTED|Overall Study||93
9956625|NCT01447446|11075934|FG004|STARTED|Overall Study||821
9938241|NCT01338025|11056424|FG000|STARTED|Overall Study||16
9938242|NCT01338025|11056425|FG001|STARTED|Overall Study||17
9938243|NCT01338025|11056424|FG000|COMPLETED|Overall Study||5
9938244|NCT01338025|11056425|FG001|COMPLETED|Overall Study||6
9938245|NCT01338025|11056424|FG000|NOT COMPLETED|Overall Study||11
9938246|NCT01338025|11056425|FG001|NOT COMPLETED|Overall Study||11
9938247|NCT01338298|11056433|FG000|STARTED|Overall Study||24
9938248|NCT01338298|11056434|FG001|STARTED|Overall Study||18
9938249|NCT01338298|11056433|FG000|COMPLETED|Overall Study||20
9938250|NCT01338298|11056434|FG001|COMPLETED|Overall Study||15
9938251|NCT01338298|11056433|FG000|NOT COMPLETED|Overall Study||4
9938252|NCT01338298|11056434|FG001|NOT COMPLETED|Overall Study||3
9938253|NCT01338415|11056442|FG000|STARTED|Core + Extension||33
9938254|NCT01338415|11056443|FG001|STARTED|Core + Extension||31
9938255|NCT01338415|11056444|FG002|STARTED|Core + Extension||0
9938256|NCT01338415|11056442|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31
9938257|NCT01338415|11056443|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27
9938258|NCT01338415|11056444|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0
9938259|NCT01338415|11056442|FG000|COMPLETED|Core + Extension||23
9938260|NCT01338415|11056443|FG001|COMPLETED|Core + Extension||22
9938261|NCT01338415|11056444|FG002|COMPLETED|Core + Extension||0
9938262|NCT01338415|11056442|FG000|NOT COMPLETED|Core + Extension||10
9938263|NCT01338415|11056443|FG001|NOT COMPLETED|Core + Extension||9
9938264|NCT01338415|11056444|FG002|NOT COMPLETED|Core + Extension||0
9938265|NCT01338415|11056442|FG000|STARTED|Exceptional Use Treatment Period||0
9938266|NCT01338415|11056443|FG001|STARTED|Exceptional Use Treatment Period||0
9938267|NCT01338415|11056444|FG002|STARTED|Exceptional Use Treatment Period||10
9938268|NCT01338415|11056442|FG000|COMPLETED|Exceptional Use Treatment Period||0
9938269|NCT01338415|11056443|FG001|COMPLETED|Exceptional Use Treatment Period||0
9938270|NCT01338415|11056444|FG002|COMPLETED|Exceptional Use Treatment Period||4
9938271|NCT01338415|11056442|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0
9938272|NCT01338415|11056443|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0
9938273|NCT01338415|11056444|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6
9938274|NCT01338493|11056452|FG000|STARTED|Enrolled||139
9938275|NCT01338493|11056452|FG000|COMPLETED|Enrolled||134
9938276|NCT01338493|11056452|FG000|NOT COMPLETED|Enrolled||5
9938277|NCT01338493|11056452|FG000|STARTED|Implant||134
9938278|NCT01338493|11056452|FG000|COMPLETED|Implant||134
9938279|NCT01338493|11056452|FG000|NOT COMPLETED|Implant||0
9938280|NCT01338493|11056452|FG000|STARTED|Discharge||134
9938281|NCT01338493|11056452|FG000|COMPLETED|Discharge||132
9938282|NCT01338493|11056452|FG000|NOT COMPLETED|Discharge||2
9938283|NCT01338493|11056452|FG000|STARTED|6 Months Follow up||132
9938284|NCT01338493|11056452|FG000|COMPLETED|6 Months Follow up||113
9938285|NCT01338493|11056452|FG000|NOT COMPLETED|6 Months Follow up||19
9938286|NCT01338493|11056452|FG000|STARTED|12 Months Follow up||113
9938287|NCT01338493|11056452|FG000|COMPLETED|12 Months Follow up||104
9938288|NCT01338493|11056452|FG000|NOT COMPLETED|12 Months Follow up||9
9938289|NCT01338493|11056452|FG000|STARTED|24 Months Follow up||104
9938290|NCT01338493|11056452|FG000|COMPLETED|24 Months Follow up||104
9938291|NCT01338493|11056452|FG000|NOT COMPLETED|24 Months Follow up||0
9938292|NCT01338506|11056458|FG000|STARTED|Overall Study||54
9938293|NCT01338506|11056459|FG001|STARTED|Overall Study||27
9938294|NCT01338506|11056458|FG000|COMPLETED|Overall Study||29
9938295|NCT01338506|11056459|FG001|COMPLETED|Overall Study||13
9938296|NCT01338506|11056458|FG000|NOT COMPLETED|Overall Study||25
9938297|NCT01338506|11056459|FG001|NOT COMPLETED|Overall Study||14
9938298|NCT01338610|11056472|FG000|STARTED|Overall Study||39
9938299|NCT01338610|11056473|FG001|STARTED|Overall Study||56
9938300|NCT01338610|11056474|FG002|STARTED|Overall Study||29
9938301|NCT01338610|11056472|FG000|COMPLETED|Overall Study||34
9938302|NCT01338610|11056473|FG001|COMPLETED|Overall Study||55
9938303|NCT01338610|11056474|FG002|COMPLETED|Overall Study||28
9938304|NCT01338610|11056472|FG000|NOT COMPLETED|Overall Study||5
9938305|NCT01338610|11056473|FG001|NOT COMPLETED|Overall Study||1
9938306|NCT01338610|11056474|FG002|NOT COMPLETED|Overall Study||1
9938307|NCT01338649|11056483|FG000|STARTED|Overall Study||13
9938308|NCT01338649|11056484|FG001|STARTED|Overall Study||14
9938309|NCT01338649|11056483|FG000|COMPLETED|Overall Study||13
9938310|NCT01338649|11056484|FG001|COMPLETED|Overall Study||14
9938311|NCT01338649|11056483|FG000|NOT COMPLETED|Overall Study||0
9938312|NCT01338649|11056484|FG001|NOT COMPLETED|Overall Study||0
9938313|NCT01338792|11056490|FG000|STARTED|Overall Study||47
9938314|NCT01338792|11056490|FG000|COMPLETED|Overall Study||43
9938315|NCT01338792|11056490|FG000|NOT COMPLETED|Overall Study||4
9938316|NCT01338818|11056494|FG000|STARTED|Overall Study||298
9938317|NCT01338818|11056494|FG000|COMPLETED|Overall Study||262
9938318|NCT01338818|11056494|FG000|NOT COMPLETED|Overall Study||36
9938319|NCT01338857|11056498|FG000|STARTED|Overall Study||12
9938320|NCT01338857|11056498|FG000|COMPLETED|Overall Study||1
9938321|NCT01338857|11056498|FG000|NOT COMPLETED|Overall Study||11
9938322|NCT01338870|11056508|FG000|STARTED|Overall Study||50
9938323|NCT01338870|11056509|FG001|STARTED|Overall Study||49
9938324|NCT01338870|11056510|FG002|STARTED|Overall Study||50
9938325|NCT01338870|11056511|FG003|STARTED|Overall Study||50
9938326|NCT01338870|11056512|FG004|STARTED|Overall Study||52
9938327|NCT01338870|11056513|FG005|STARTED|Overall Study||50
9938328|NCT01338870|11056508|FG000|COMPLETED|Overall Study||41
9938329|NCT01338870|11056509|FG001|COMPLETED|Overall Study||37
9938330|NCT01338870|11056510|FG002|COMPLETED|Overall Study||39
9938331|NCT01338870|11056511|FG003|COMPLETED|Overall Study||41
9938332|NCT01338870|11056512|FG004|COMPLETED|Overall Study||46
9938333|NCT01338870|11056513|FG005|COMPLETED|Overall Study||44
9938334|NCT01338870|11056508|FG000|NOT COMPLETED|Overall Study||9
9938335|NCT01338870|11056509|FG001|NOT COMPLETED|Overall Study||12
9938336|NCT01338870|11056510|FG002|NOT COMPLETED|Overall Study||11
9938337|NCT01338870|11056511|FG003|NOT COMPLETED|Overall Study||9
9938338|NCT01338870|11056512|FG004|NOT COMPLETED|Overall Study||6
9938339|NCT01338870|11056513|FG005|NOT COMPLETED|Overall Study||6
9938340|NCT01338987|11056532|FG000|STARTED|Overall Study||12
9938341|NCT01338987|11056533|FG001|STARTED|Overall Study||9
9938342|NCT01338987|11056534|FG002|STARTED|Overall Study||22
9938343|NCT01338987|11056535|FG003|STARTED|Overall Study||31
9938344|NCT01338987|11056536|FG004|STARTED|Overall Study||2
9938345|NCT01338987|11056532|FG000|COMPLETED|Overall Study||10
9938346|NCT01338987|11056533|FG001|COMPLETED|Overall Study||8
9938347|NCT01338987|11056534|FG002|COMPLETED|Overall Study||20
9938348|NCT01338987|11056535|FG003|COMPLETED|Overall Study||31
9938349|NCT01338987|11056536|FG004|COMPLETED|Overall Study||2
9938350|NCT01338987|11056532|FG000|NOT COMPLETED|Overall Study||2
9938351|NCT01338987|11056533|FG001|NOT COMPLETED|Overall Study||1
9938352|NCT01338987|11056534|FG002|NOT COMPLETED|Overall Study||2
9938353|NCT01338987|11056535|FG003|NOT COMPLETED|Overall Study||0
9938354|NCT01338987|11056536|FG004|NOT COMPLETED|Overall Study||0
9938355|NCT01339000|11056552|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
9938356|NCT01339000|11056553|FG001|STARTED|Overall Study||0
9938357|NCT01339000|11056552|FG000|COMPLETED|Overall Study||0
9938358|NCT01339000|11056553|FG001|COMPLETED|Overall Study||0
9938359|NCT01339000|11056552|FG000|NOT COMPLETED|Overall Study||1
9938360|NCT01339000|11056553|FG001|NOT COMPLETED|Overall Study||0
9938361|NCT01339013|11056562|FG000|STARTED|Overall Study||6
9938362|NCT01339013|11056562|FG000|COMPLETED|Overall Study||6
9938363|NCT01339013|11056562|FG000|NOT COMPLETED|Overall Study||0
9938364|NCT01339052|11056568|FG000|STARTED|Overall Study||15
9938365|NCT01339052|11056569|FG001|STARTED|Overall Study||50
9938366|NCT01339052|11056568|FG000|Measurable Disease|Overall Study||11
9938367|NCT01339052|11056569|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
9938368|NCT01339052|11056568|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14
9938369|NCT01339052|11056569|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
9938370|NCT01339052|11056568|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13
9938371|NCT01339052|11056569|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
9938372|NCT01339052|11056568|FG000|COMPLETED|Overall Study||0
9938373|NCT01339052|11056569|FG001|COMPLETED|Overall Study||0
9938374|NCT01339052|11056568|FG000|NOT COMPLETED|Overall Study||15
9938375|NCT01339052|11056569|FG001|NOT COMPLETED|Overall Study||50
9938376|NCT01339091|11056580|FG000|STARTED|Overall Study||288
9938377|NCT01339091|11056581|FG001|STARTED|Overall Study||285
9938378|NCT01339091|11056580|FG000|Safety Population|Overall Study||284
9938379|NCT01339091|11056581|FG001|Safety Population|Overall Study||284
9938380|NCT01339091|11056580|FG000|COMPLETED|Overall Study||261
9938381|NCT01339091|11056581|FG001|COMPLETED|Overall Study||257
9938382|NCT01339091|11056580|FG000|NOT COMPLETED|Overall Study||27
9938383|NCT01339091|11056581|FG001|NOT COMPLETED|Overall Study||28
9938384|NCT01339247|11056587|FG000|STARTED|Period 1||30
9938385|NCT01339247|11056588|FG001|STARTED|Period 1||30
9938386|NCT01339247|11056587|FG000|COMPLETED|Period 1||30
9938387|NCT01339247|11056588|FG001|COMPLETED|Period 1||30
9938388|NCT01339247|11056587|FG000|NOT COMPLETED|Period 1||0
10011314|NCT01780337|11134058|FG001|COMPLETED|Overall Study||6
10011315|NCT01780337|11134057|FG000|NOT COMPLETED|Overall Study||0
10011316|NCT01780337|11134058|FG001|NOT COMPLETED|Overall Study||0
9938389|NCT01339247|11056588|FG001|NOT COMPLETED|Period 1||0
9938390|NCT01339247|11056587|FG000|STARTED|Period 2||30
9938391|NCT01339247|11056588|FG001|STARTED|Period 2||30
9938392|NCT01339247|11056587|FG000|COMPLETED|Period 2||30
9938393|NCT01339247|11056588|FG001|COMPLETED|Period 2||30
9938394|NCT01339247|11056587|FG000|NOT COMPLETED|Period 2||0
9938395|NCT01339247|11056588|FG001|NOT COMPLETED|Period 2||0
9938396|NCT01339260|11056596|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
9938397|NCT01339260|11056597|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
9938398|NCT01339260|11056596|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
9938399|NCT01339260|11056597|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725
9938400|NCT01339260|11056596|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
10011317|NCT01780350|11134064|FG000|STARTED|Overall Study||200
9938401|NCT01339260|11056597|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
9938402|NCT01339260|11056596|FG000|COMPLETED|Cycle 1||719
9938403|NCT01339260|11056597|FG001|COMPLETED|Cycle 1||719
9938404|NCT01339260|11056596|FG000|NOT COMPLETED|Cycle 1||7
9938405|NCT01339260|11056597|FG001|NOT COMPLETED|Cycle 1||10
9938406|NCT01339260|11056596|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
9938407|NCT01339260|11056597|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
9938408|NCT01339260|11056596|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
9938409|NCT01339260|11056597|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
10011318|NCT01780350|11134064|FG000|COMPLETED|Overall Study||200
9938410|NCT01339260|11056596|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
9938411|NCT01339260|11056597|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
9938412|NCT01339260|11056596|FG000|NOT COMPLETED|Multi-cycle Extension||186
9938413|NCT01339260|11056597|FG001|NOT COMPLETED|Multi-cycle Extension||193
9938414|NCT01339273|11056607|FG000|STARTED|Overall Study||36
9938415|NCT01339273|11056608|FG001|STARTED|Overall Study||36
9938416|NCT01339273|11056607|FG000|COMPLETED|Overall Study||28
9938417|NCT01339273|11056608|FG001|COMPLETED|Overall Study||28
9938418|NCT01339273|11056607|FG000|NOT COMPLETED|Overall Study||8
9938419|NCT01339273|11056608|FG001|NOT COMPLETED|Overall Study||8
9938420|NCT01339299|11056616|FG000|STARTED|Overall Study||50
9938421|NCT01339299|11056617|FG001|STARTED|Overall Study||50
9938422|NCT01339299|11056616|FG000|COMPLETED|Overall Study||50
9938423|NCT01339299|11056617|FG001|COMPLETED|Overall Study||50
9938424|NCT01339299|11056616|FG000|NOT COMPLETED|Overall Study||0
9938425|NCT01339299|11056617|FG001|NOT COMPLETED|Overall Study||0
9938426|NCT01339390|11056625|FG000|STARTED|Overall Study||1571
9938427|NCT01339390|11056626|FG001|STARTED|Overall Study||1598
9938428|NCT01339390|11056625|FG000|COMPLETED|Overall Study||1414
9938429|NCT01339390|11056626|FG001|COMPLETED|Overall Study||1442
9938430|NCT01339390|11056625|FG000|NOT COMPLETED|Overall Study||157
9938431|NCT01339390|11056626|FG001|NOT COMPLETED|Overall Study||156
9938432|NCT01339403|11056634|FG000|STARTED|Overall Study||24768
9938433|NCT01339403|11056635|FG001|STARTED|Overall Study||257600
9938434|NCT01339403|11056634|FG000|COMPLETED|Overall Study||24768
9938435|NCT01339403|11056635|FG001|COMPLETED|Overall Study||257600
9938436|NCT01339403|11056634|FG000|NOT COMPLETED|Overall Study||0
9938437|NCT01339403|11056635|FG001|NOT COMPLETED|Overall Study||0
9938438|NCT01339416|11056641|FG000|STARTED|Overall Study||8202
9938439|NCT01339416|11056641|FG000|COMPLETED|Overall Study||8202
9938440|NCT01339416|11056641|FG000|NOT COMPLETED|Overall Study||0
9938441|NCT01339429|11056645|FG000|STARTED|Overall Study||41
9938442|NCT01339429|11056645|FG000|COMPLETED|Overall Study||37
9938443|NCT01339429|11056645|FG000|NOT COMPLETED|Overall Study||4
9938444|NCT01339559|11056649|FG000|STARTED|Overall Study||766
9938445|NCT01339559|11056649|FG000|COMPLETED|Overall Study||368
9938446|NCT01339559|11056649|FG000|NOT COMPLETED|Overall Study||398
9938447|NCT01339832|11056654|FG000|STARTED|Overall Study||51
9938448|NCT01339832|11056654|FG000|COMPLETED|Overall Study||37
9938449|NCT01339832|11056654|FG000|NOT COMPLETED|Overall Study||14
9938450|NCT01339858|11056660|FG000|STARTED|Overall Study||30
9938451|NCT01339858|11056661|FG001|STARTED|Overall Study||30
9938452|NCT01339858|11056660|FG000|COMPLETED|Overall Study||14
9938453|NCT01339858|11056661|FG001|COMPLETED|Overall Study||18
9938454|NCT01339858|11056660|FG000|NOT COMPLETED|Overall Study||16
9938455|NCT01339858|11056661|FG001|NOT COMPLETED|Overall Study||12
9938456|NCT01339897|11056673|FG000|STARTED|Overall Study||7
9938457|NCT01339897|11056674|FG001|STARTED|Overall Study||6
9938458|NCT01339897|11056675|FG002|STARTED|Overall Study||6
9938459|NCT01339897|11056676|FG003|STARTED|Overall Study||6
9938460|NCT01339897|11056673|FG000|COMPLETED|Overall Study||6
9938461|NCT01339897|11056674|FG001|COMPLETED|Overall Study||6
9938462|NCT01339897|11056675|FG002|COMPLETED|Overall Study||6
9938463|NCT01339897|11056676|FG003|COMPLETED|Overall Study||5
9938464|NCT01339897|11056673|FG000|NOT COMPLETED|Overall Study||1
9938465|NCT01339897|11056674|FG001|NOT COMPLETED|Overall Study||0
9938466|NCT01339897|11056675|FG002|NOT COMPLETED|Overall Study||0
9938467|NCT01339897|11056676|FG003|NOT COMPLETED|Overall Study||1
9938468|NCT01339910|11056690|FG000|STARTED|Overall Study||135
9938469|NCT01339910|11056691|FG001|STARTED|Overall Study||137
9938470|NCT01339910|11056690|FG000|COMPLETED|Overall Study||132
9938471|NCT01339910|11056691|FG001|COMPLETED|Overall Study||133
9938472|NCT01339910|11056690|FG000|NOT COMPLETED|Overall Study||3
9938473|NCT01339910|11056691|FG001|NOT COMPLETED|Overall Study||4
9938474|NCT01339923|11056704|FG000|STARTED|Overall Study||253
9938475|NCT01339923|11056705|FG001|STARTED|Overall Study||250
9938476|NCT01339923|11056706|FG002|STARTED|Overall Study||251
9938477|NCT01339923|11056707|FG003|STARTED|Overall Study||104
9938478|NCT01339923|11056708|FG004|STARTED|Overall Study||300
9938479|NCT01339923|11056709|FG005|STARTED|Overall Study||126
9938480|NCT01339923|11056710|FG006|STARTED|Overall Study||125
9938481|NCT01339923|11056704|FG000|COMPLETED|Overall Study||239
9938482|NCT01339923|11056705|FG001|COMPLETED|Overall Study||234
9938483|NCT01339923|11056706|FG002|COMPLETED|Overall Study||243
9938484|NCT01339923|11056707|FG003|COMPLETED|Overall Study||100
9938485|NCT01339923|11056708|FG004|COMPLETED|Overall Study||295
9938486|NCT01339923|11056709|FG005|COMPLETED|Overall Study||117
9938487|NCT01339923|11056710|FG006|COMPLETED|Overall Study||111
9938488|NCT01339923|11056704|FG000|NOT COMPLETED|Overall Study||14
9938489|NCT01339923|11056705|FG001|NOT COMPLETED|Overall Study||16
9938490|NCT01339923|11056706|FG002|NOT COMPLETED|Overall Study||8
9938491|NCT01339923|11056707|FG003|NOT COMPLETED|Overall Study||4
9938492|NCT01339923|11056708|FG004|NOT COMPLETED|Overall Study||5
9938493|NCT01339923|11056709|FG005|NOT COMPLETED|Overall Study||9
9938494|NCT01339923|11056710|FG006|NOT COMPLETED|Overall Study||14
9938495|NCT01339936|11056739|FG000|STARTED|Overall Study|plus 2 screen failures|38
9938496|NCT01339936|11056739|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
9938497|NCT01339936|11056739|FG000|NOT COMPLETED|Overall Study||2
9938498|NCT01340014|11056745|FG000|STARTED|Period 1, First 7 Days||55
9938499|NCT01340014|11056746|FG001|STARTED|Period 1, First 7 Days||57
9938500|NCT01340014|11056745|FG000|COMPLETED|Period 1, First 7 Days||53
9938501|NCT01340014|11056746|FG001|COMPLETED|Period 1, First 7 Days||57
9938502|NCT01340014|11056745|FG000|NOT COMPLETED|Period 1, First 7 Days||2
9938503|NCT01340014|11056746|FG001|NOT COMPLETED|Period 1, First 7 Days||0
9938504|NCT01340014|11056745|FG000|STARTED|Period 2, Second 7 Days||53
9938505|NCT01340014|11056746|FG001|STARTED|Period 2, Second 7 Days||57
9938506|NCT01340014|11056745|FG000|COMPLETED|Period 2, Second 7 Days||53
9938507|NCT01340014|11056746|FG001|COMPLETED|Period 2, Second 7 Days||56
9938508|NCT01340014|11056745|FG000|NOT COMPLETED|Period 2, Second 7 Days||0
9938509|NCT01340014|11056746|FG001|NOT COMPLETED|Period 2, Second 7 Days||1
9938510|NCT01340027|11056764|FG000|STARTED|Overall Study||81
9938511|NCT01340027|11056765|FG001|STARTED|Overall Study||78
9938512|NCT01340027|11056766|FG002|STARTED|Overall Study||79
9938513|NCT01340027|11056767|FG003|STARTED|Overall Study||79
9938514|NCT01340027|11056768|FG004|STARTED|Overall Study||156
9938515|NCT01340027|11056769|FG005|STARTED|Overall Study||78
9938516|NCT01340027|11056770|FG006|STARTED|Overall Study||149
9938517|NCT01340027|11056771|FG007|STARTED|Overall Study||149
9938518|NCT01340027|11056772|FG008|STARTED|Overall Study||144
9938519|NCT01340027|11056773|FG009|STARTED|Overall Study||152
9938520|NCT01340027|11056774|FG010|STARTED|Overall Study||81
9938521|NCT01340027|11056775|FG011|STARTED|Overall Study||81
9938522|NCT01340027|11056764|FG000|Received Treatment|Overall Study||81
9938523|NCT01340027|11056765|FG001|Received Treatment|Overall Study||78
9938524|NCT01340027|11056766|FG002|Received Treatment|Overall Study||78
9938525|NCT01340027|11056767|FG003|Received Treatment|Overall Study||79
9938526|NCT01340027|11056768|FG004|Received Treatment|Overall Study||156
9938527|NCT01340027|11056769|FG005|Received Treatment|Overall Study||78
9938528|NCT01340027|11056770|FG006|Received Treatment|Overall Study||149
9938529|NCT01340027|11056771|FG007|Received Treatment|Overall Study||149
9938530|NCT01340027|11056772|FG008|Received Treatment|Overall Study||144
9938531|NCT01340027|11056773|FG009|Received Treatment|Overall Study||152
9938532|NCT01340027|11056774|FG010|Received Treatment|Overall Study||81
9938533|NCT01340027|11056775|FG011|Received Treatment|Overall Study||81
9938534|NCT01340027|11056764|FG000|COMPLETED|Overall Study||76
9938535|NCT01340027|11056765|FG001|COMPLETED|Overall Study||71
9938536|NCT01340027|11056766|FG002|COMPLETED|Overall Study||75
9938537|NCT01340027|11056767|FG003|COMPLETED|Overall Study||75
9938538|NCT01340027|11056768|FG004|COMPLETED|Overall Study||146
9938539|NCT01340027|11056769|FG005|COMPLETED|Overall Study||74
9938540|NCT01340027|11056770|FG006|COMPLETED|Overall Study||142
9938541|NCT01340027|11056771|FG007|COMPLETED|Overall Study||142
9938542|NCT01340027|11056772|FG008|COMPLETED|Overall Study||136
9938543|NCT01340027|11056773|FG009|COMPLETED|Overall Study||146
9938544|NCT01340027|11056774|FG010|COMPLETED|Overall Study||79
9938545|NCT01340027|11056775|FG011|COMPLETED|Overall Study||77
9938546|NCT01340027|11056764|FG000|NOT COMPLETED|Overall Study||5
9938547|NCT01340027|11056765|FG001|NOT COMPLETED|Overall Study||7
9938548|NCT01340027|11056766|FG002|NOT COMPLETED|Overall Study||4
9938549|NCT01340027|11056767|FG003|NOT COMPLETED|Overall Study||4
9938550|NCT01340027|11056768|FG004|NOT COMPLETED|Overall Study||10
9938551|NCT01340027|11056769|FG005|NOT COMPLETED|Overall Study||4
9938552|NCT01340027|11056770|FG006|NOT COMPLETED|Overall Study||7
9938553|NCT01340027|11056771|FG007|NOT COMPLETED|Overall Study||7
9938554|NCT01340027|11056772|FG008|NOT COMPLETED|Overall Study||8
9938555|NCT01340027|11056773|FG009|NOT COMPLETED|Overall Study||6
9938556|NCT01340027|11056774|FG010|NOT COMPLETED|Overall Study||2
9938557|NCT01340027|11056775|FG011|NOT COMPLETED|Overall Study||4
9938558|NCT01340053|11056805|FG000|STARTED|Overall Study||47
9938559|NCT01340053|11056806|FG001|STARTED|Overall Study||46
9938560|NCT01340053|11056807|FG002|STARTED|Overall Study||47
9938561|NCT01340053|11056808|FG003|STARTED|Overall Study||46
9938562|NCT01340053|11056805|FG000|COMPLETED|Overall Study||43
9938563|NCT01340053|11056806|FG001|COMPLETED|Overall Study||44
9938564|NCT01340053|11056807|FG002|COMPLETED|Overall Study||43
9938565|NCT01340053|11056808|FG003|COMPLETED|Overall Study||43
9938566|NCT01340053|11056805|FG000|NOT COMPLETED|Overall Study||4
9938567|NCT01340053|11056806|FG001|NOT COMPLETED|Overall Study||2
9938568|NCT01340053|11056807|FG002|NOT COMPLETED|Overall Study||4
9938569|NCT01340053|11056808|FG003|NOT COMPLETED|Overall Study||3
9938570|NCT01340066|11056820|FG000|STARTED|Placebo Run in Period||94
9938571|NCT01340066|11056821|FG001|STARTED|Placebo Run in Period||0
9938572|NCT01340066|11056822|FG002|STARTED|Placebo Run in Period||0
9938573|NCT01340066|11056820|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
9938574|NCT01340066|11056821|FG001|COMPLETED|Placebo Run in Period||0
9938575|NCT01340066|11056822|FG002|COMPLETED|Placebo Run in Period||0
9938576|NCT01340066|11056820|FG000|NOT COMPLETED|Placebo Run in Period||27
9938577|NCT01340066|11056821|FG001|NOT COMPLETED|Placebo Run in Period||0
9938578|NCT01340066|11056822|FG002|NOT COMPLETED|Placebo Run in Period||0
9938579|NCT01340066|11056820|FG000|STARTED|5 Week Double Blind Randomization Period||0
9938580|NCT01340066|11056821|FG001|STARTED|5 Week Double Blind Randomization Period||33
9938581|NCT01340066|11056822|FG002|STARTED|5 Week Double Blind Randomization Period||34
9938582|NCT01340066|11056820|FG000|COMPLETED|5 Week Double Blind Randomization Period||0
9938583|NCT01340066|11056821|FG001|COMPLETED|5 Week Double Blind Randomization Period||28
9938584|NCT01340066|11056822|FG002|COMPLETED|5 Week Double Blind Randomization Period||31
9938585|NCT01340066|11056820|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0
9938586|NCT01340066|11056821|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5
9938587|NCT01340066|11056822|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3
9938588|NCT01340144|11056831|FG000|STARTED|Overall Study||625
9938589|NCT01340144|11056832|FG001|STARTED|Overall Study||625
9938590|NCT01340144|11056831|FG000|COMPLETED|Overall Study||553
9938591|NCT01340144|11056832|FG001|COMPLETED|Overall Study||567
9938592|NCT01340144|11056831|FG000|NOT COMPLETED|Overall Study||72
9938593|NCT01340144|11056832|FG001|NOT COMPLETED|Overall Study||58
9938594|NCT01340196|11056838|FG000|STARTED|Treat. Period 1 (Tenofovir)||16
9938595|NCT01340196|11056838|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16
9938596|NCT01340196|11056838|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
9938597|NCT01340196|11056838|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
9938598|NCT01340196|11056838|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
9938599|NCT01340196|11056838|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
9938600|NCT01340196|11056838|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16
9938601|NCT01340196|11056838|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14
9938602|NCT01340196|11056838|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
9938603|NCT01340209|11056850|FG000|STARTED|Overall Study||57
9938604|NCT01340209|11056851|FG001|STARTED|Overall Study||114
9938605|NCT01340209|11056852|FG002|STARTED|Overall Study||114
9938606|NCT01340209|11056850|FG000|COMPLETED|Overall Study||52
9938607|NCT01340209|11056851|FG001|COMPLETED|Overall Study||106
9938608|NCT01340209|11056852|FG002|COMPLETED|Overall Study||106
9938609|NCT01340209|11056850|FG000|NOT COMPLETED|Overall Study||5
9938610|NCT01340209|11056851|FG001|NOT COMPLETED|Overall Study||8
9938611|NCT01340209|11056852|FG002|NOT COMPLETED|Overall Study||8
9938612|NCT01340300|11056864|FG000|STARTED|Overall Study||35
9938613|NCT01340300|11056865|FG001|STARTED|Overall Study||35
9938614|NCT01340300|11056866|FG002|STARTED|Overall Study||35
9938615|NCT01340300|11056867|FG003|STARTED|Overall Study||34
9938616|NCT01340300|11056864|FG000|Baseline Blood Sample|Overall Study||33
9938617|NCT01340300|11056865|FG001|Baseline Blood Sample|Overall Study||34
9938618|NCT01340300|11056866|FG002|Baseline Blood Sample|Overall Study||32
9938619|NCT01340300|11056867|FG003|Baseline Blood Sample|Overall Study||29
9938620|NCT01340300|11056864|FG000|Follow-up Blood Sample|Overall Study||25
9938621|NCT01340300|11056865|FG001|Follow-up Blood Sample|Overall Study||26
9938622|NCT01340300|11056866|FG002|Follow-up Blood Sample|Overall Study||19
9938623|NCT01340300|11056867|FG003|Follow-up Blood Sample|Overall Study||18
9938624|NCT01340300|11056864|FG000|COMPLETED|Overall Study||26
9938625|NCT01340300|11056865|FG001|COMPLETED|Overall Study||26
9938626|NCT01340300|11056866|FG002|COMPLETED|Overall Study||20
9938627|NCT01340300|11056867|FG003|COMPLETED|Overall Study||20
9938628|NCT01340300|11056864|FG000|NOT COMPLETED|Overall Study||9
9938629|NCT01340300|11056865|FG001|NOT COMPLETED|Overall Study||9
9938630|NCT01340300|11056866|FG002|NOT COMPLETED|Overall Study||15
9938631|NCT01340300|11056867|FG003|NOT COMPLETED|Overall Study||14
9938632|NCT01340482|11056880|FG000|STARTED|Overall Study||27
9938633|NCT01340482|11056881|FG001|STARTED|Overall Study||1
9938634|NCT01340482|11056882|FG002|STARTED|Overall Study||1
9938635|NCT01340482|11056880|FG000|COMPLETED|Overall Study||25
10011319|NCT01780350|11134064|FG000|NOT COMPLETED|Overall Study||0
10011320|NCT01780389|11134068|FG000|STARTED|Overall Study||5
10011321|NCT01780389|11134068|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
10011322|NCT01780389|11134068|FG000|NOT COMPLETED|Overall Study||1
10011323|NCT01780454|11134073|FG000|STARTED|Overall Study||2
9938636|NCT01340482|11056881|FG001|COMPLETED|Overall Study||1
9938637|NCT01340482|11056882|FG002|COMPLETED|Overall Study||1
9938638|NCT01340482|11056880|FG000|NOT COMPLETED|Overall Study||2
9938639|NCT01340482|11056881|FG001|NOT COMPLETED|Overall Study||0
9938640|NCT01340482|11056882|FG002|NOT COMPLETED|Overall Study||0
9938641|NCT01340495|11056892|FG000|STARTED|Overall Study||70
9938642|NCT01340495|11056892|FG000|COMPLETED|Overall Study||69
9938643|NCT01340495|11056892|FG000|NOT COMPLETED|Overall Study||1
9938644|NCT01340586|11056898|FG000|STARTED|Overall Study||8
9938645|NCT01340586|11056899|FG001|STARTED|Overall Study||8
9938646|NCT01340586|11056898|FG000|COMPLETED|Overall Study||8
9938647|NCT01340586|11056899|FG001|COMPLETED|Overall Study||8
9938648|NCT01340586|11056898|FG000|NOT COMPLETED|Overall Study||0
9938649|NCT01340586|11056899|FG001|NOT COMPLETED|Overall Study||0
9938650|NCT01340625|11056912|FG000|STARTED|First Intervention||18
9938651|NCT01340625|11056913|FG001|STARTED|First Intervention||18
9938652|NCT01340625|11056912|FG000|COMPLETED|First Intervention||17
9938653|NCT01340625|11056913|FG001|COMPLETED|First Intervention||18
9938654|NCT01340625|11056912|FG000|NOT COMPLETED|First Intervention||1
9938655|NCT01340625|11056913|FG001|NOT COMPLETED|First Intervention||0
9938656|NCT01340625|11056912|FG000|STARTED|Washout Period of 28 Days||17
9938657|NCT01340625|11056913|FG001|STARTED|Washout Period of 28 Days||18
9938658|NCT01340625|11056912|FG000|COMPLETED|Washout Period of 28 Days||16
9938659|NCT01340625|11056913|FG001|COMPLETED|Washout Period of 28 Days||18
9938660|NCT01340625|11056912|FG000|NOT COMPLETED|Washout Period of 28 Days||1
10011324|NCT01780454|11134073|FG000|COMPLETED|Overall Study||2
10011325|NCT01780454|11134073|FG000|NOT COMPLETED|Overall Study||0
9938661|NCT01340625|11056913|FG001|NOT COMPLETED|Washout Period of 28 Days||0
9938662|NCT01340625|11056912|FG000|STARTED|Second Intervention||16
9938663|NCT01340625|11056913|FG001|STARTED|Second Intervention||18
9938664|NCT01340625|11056912|FG000|COMPLETED|Second Intervention||16
9938665|NCT01340625|11056913|FG001|COMPLETED|Second Intervention||18
9938666|NCT01340625|11056912|FG000|NOT COMPLETED|Second Intervention||0
10011326|NCT01780506|11134079|FG000|STARTED|Double-Blind Phase||438
9938667|NCT01340625|11056913|FG001|NOT COMPLETED|Second Intervention||0
9938668|NCT01340651|11056919|FG000|STARTED|Overall Study||41
9938669|NCT01340651|11056919|FG000|COMPLETED|Overall Study||24
9938670|NCT01340651|11056919|FG000|NOT COMPLETED|Overall Study||17
9938671|NCT01340664|11056928|FG000|STARTED|Overall Study||93
9938672|NCT01340664|11056929|FG001|STARTED|Overall Study||93
9938673|NCT01340664|11056930|FG002|STARTED|Overall Study||93
9938674|NCT01340664|11056928|FG000|COMPLETED|Overall Study||86
9938675|NCT01340664|11056929|FG001|COMPLETED|Overall Study||85
9938676|NCT01340664|11056930|FG002|COMPLETED|Overall Study||80
9938677|NCT01340664|11056928|FG000|NOT COMPLETED|Overall Study||7
9938678|NCT01340664|11056929|FG001|NOT COMPLETED|Overall Study||8
9938679|NCT01340664|11056930|FG002|NOT COMPLETED|Overall Study||13
9938680|NCT01340768|11056940|FG000|STARTED|Overall Study||436
9938681|NCT01340768|11056941|FG001|STARTED|Overall Study||434
9938682|NCT01340768|11056940|FG000|COMPLETED|Overall Study||419
9938683|NCT01340768|11056941|FG001|COMPLETED|Overall Study||429
9938684|NCT01340768|11056940|FG000|NOT COMPLETED|Overall Study||17
9938685|NCT01340768|11056941|FG001|NOT COMPLETED|Overall Study||5
9938686|NCT01340794|11056949|FG000|STARTED|Overall Study||2
9938687|NCT01340794|11056950|FG001|STARTED|Overall Study||5
9938688|NCT01340794|11056949|FG000|COMPLETED|Overall Study||2
9938689|NCT01340794|11056950|FG001|COMPLETED|Overall Study||4
9938690|NCT01340794|11056949|FG000|NOT COMPLETED|Overall Study||0
9938691|NCT01340794|11056950|FG001|NOT COMPLETED|Overall Study||1
9938692|NCT01340872|11056960|FG000|STARTED|Double-blind Phase||64
9938693|NCT01340872|11056961|FG001|STARTED|Double-blind Phase||64
9938694|NCT01340872|11056962|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
9938695|NCT01340872|11056963|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
9938696|NCT01340872|11056960|FG000|COMPLETED|Double-blind Phase||55
9938697|NCT01340872|11056961|FG001|COMPLETED|Double-blind Phase||53
9938698|NCT01340872|11056962|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
9938699|NCT01340872|11056963|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
9938700|NCT01340872|11056960|FG000|NOT COMPLETED|Double-blind Phase||9
9938701|NCT01340872|11056961|FG001|NOT COMPLETED|Double-blind Phase||11
9938702|NCT01340872|11056962|FG002|NOT COMPLETED|Double-blind Phase||0
9938703|NCT01340872|11056963|FG003|NOT COMPLETED|Double-blind Phase||0
9938704|NCT01340872|11056960|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
9938705|NCT01340872|11056961|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
9938706|NCT01340872|11056962|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
9938707|NCT01340872|11056963|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
9938708|NCT01340872|11056960|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
9938709|NCT01340872|11056961|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
9938710|NCT01340872|11056962|FG002|COMPLETED|Open-label Phase||37
9938711|NCT01340872|11056963|FG003|COMPLETED|Open-label Phase||36
9938712|NCT01340872|11056960|FG000|NOT COMPLETED|Open-label Phase||0
9938713|NCT01340872|11056961|FG001|NOT COMPLETED|Open-label Phase||0
9938714|NCT01340872|11056962|FG002|NOT COMPLETED|Open-label Phase||13
9938715|NCT01340872|11056963|FG003|NOT COMPLETED|Open-label Phase||11
9938716|NCT01340898|11056978|FG000|STARTED|Primary Phase||376
9938717|NCT01340898|11056979|FG001|STARTED|Primary Phase||187
9938718|NCT01340898|11056980|FG002|STARTED|Primary Phase||187
9938719|NCT01340898|11056978|FG000|COMPLETED|Primary Phase||360
9938720|NCT01340898|11056979|FG001|COMPLETED|Primary Phase||178
9938721|NCT01340898|11056980|FG002|COMPLETED|Primary Phase||181
9938722|NCT01340898|11056978|FG000|NOT COMPLETED|Primary Phase||16
9938723|NCT01340898|11056979|FG001|NOT COMPLETED|Primary Phase||9
9938724|NCT01340898|11056980|FG002|NOT COMPLETED|Primary Phase||6
9938725|NCT01340898|11056978|FG000|STARTED|Booster Phase||342
9938726|NCT01340898|11056979|FG001|STARTED|Booster Phase||166
9938727|NCT01340898|11056980|FG002|STARTED|Booster Phase||170
9938728|NCT01340898|11056978|FG000|COMPLETED|Booster Phase||332
9938729|NCT01340898|11056979|FG001|COMPLETED|Booster Phase||164
9938730|NCT01340898|11056980|FG002|COMPLETED|Booster Phase||163
9938731|NCT01340898|11056978|FG000|NOT COMPLETED|Booster Phase||10
9938732|NCT01340898|11056979|FG001|NOT COMPLETED|Booster Phase||2
9938733|NCT01340898|11056980|FG002|NOT COMPLETED|Booster Phase||7
9938734|NCT01340937|11056994|FG000|STARTED|Period 1: Infant Series||800
9938735|NCT01340937|11056995|FG001|STARTED|Period 1: Infant Series||797
9938736|NCT01340937|11056996|FG002|STARTED|Period 1: Infant Series||809
9938737|NCT01340937|11056997|FG003|STARTED|Period 1: Infant Series||402
9938738|NCT01340937|11056994|FG000|COMPLETED|Period 1: Infant Series||742
9938739|NCT01340937|11056995|FG001|COMPLETED|Period 1: Infant Series||737
9938740|NCT01340937|11056996|FG002|COMPLETED|Period 1: Infant Series||753
9938741|NCT01340937|11056997|FG003|COMPLETED|Period 1: Infant Series||370
9938742|NCT01340937|11056994|FG000|NOT COMPLETED|Period 1: Infant Series||58
9938743|NCT01340937|11056995|FG001|NOT COMPLETED|Period 1: Infant Series||60
9938744|NCT01340937|11056996|FG002|NOT COMPLETED|Period 1: Infant Series||56
9938745|NCT01340937|11056997|FG003|NOT COMPLETED|Period 1: Infant Series||32
9938746|NCT01340937|11056994|FG000|STARTED|Period 2: Interim Period||742
9938747|NCT01340937|11056995|FG001|STARTED|Period 2: Interim Period||737
9938748|NCT01340937|11056996|FG002|STARTED|Period 2: Interim Period||753
9938749|NCT01340937|11056997|FG003|STARTED|Period 2: Interim Period||370
9938750|NCT01340937|11056994|FG000|COMPLETED|Period 2: Interim Period||675
9938751|NCT01340937|11056995|FG001|COMPLETED|Period 2: Interim Period||658
9938752|NCT01340937|11056996|FG002|COMPLETED|Period 2: Interim Period||669
10011327|NCT01780506|11134080|FG001|STARTED|Double-Blind Phase||434
10011328|NCT01780506|11134079|FG000|COMPLETED|Double-Blind Phase||368
10011329|NCT01780506|11134080|FG001|COMPLETED|Double-Blind Phase||356
10011330|NCT01780506|11134079|FG000|NOT COMPLETED|Double-Blind Phase||70
10011331|NCT01780506|11134080|FG001|NOT COMPLETED|Double-Blind Phase||78
10011332|NCT01780506|11134079|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
10011333|NCT01780506|11134080|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
10011334|NCT01780506|11134079|FG000|COMPLETED|Open-Label Extension Phase||90
10011335|NCT01780506|11134080|FG001|COMPLETED|Open-Label Extension Phase||94
9938753|NCT01340937|11056997|FG003|COMPLETED|Period 2: Interim Period||329
9938754|NCT01340937|11056994|FG000|NOT COMPLETED|Period 2: Interim Period||67
9938755|NCT01340937|11056995|FG001|NOT COMPLETED|Period 2: Interim Period||79
9938756|NCT01340937|11056996|FG002|NOT COMPLETED|Period 2: Interim Period||84
9938757|NCT01340937|11056997|FG003|NOT COMPLETED|Period 2: Interim Period||41
9938758|NCT01340937|11056994|FG000|STARTED|Period 3: Toddler Vaccinations||675
9938759|NCT01340937|11056995|FG001|STARTED|Period 3: Toddler Vaccinations||658
9938760|NCT01340937|11056996|FG002|STARTED|Period 3: Toddler Vaccinations||669
9938761|NCT01340937|11056997|FG003|STARTED|Period 3: Toddler Vaccinations||329
9938762|NCT01340937|11056994|FG000|COMPLETED|Period 3: Toddler Vaccinations||666
9938763|NCT01340937|11056995|FG001|COMPLETED|Period 3: Toddler Vaccinations||641
9938764|NCT01340937|11056996|FG002|COMPLETED|Period 3: Toddler Vaccinations||660
9938765|NCT01340937|11056997|FG003|COMPLETED|Period 3: Toddler Vaccinations||319
9938766|NCT01340937|11056994|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9
9938767|NCT01340937|11056995|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17
9938768|NCT01340937|11056996|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9
9938769|NCT01340937|11056997|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10
9938770|NCT01340976|11057019|FG000|STARTED|Overall Study||4
9938771|NCT01340976|11057020|FG001|STARTED|Overall Study||3
9938772|NCT01340976|11057021|FG002|STARTED|Overall Study||7
9938773|NCT01340976|11057022|FG003|STARTED|Overall Study||5
9938774|NCT01340976|11057023|FG004|STARTED|Overall Study||7
9938775|NCT01340976|11057024|FG005|STARTED|Overall Study||7
9938776|NCT01340976|11057019|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
9938777|NCT01340976|11057020|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9938778|NCT01340976|11057021|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
9938779|NCT01340976|11057022|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
9938780|NCT01340976|11057023|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7
9938781|NCT01340976|11057024|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
9938782|NCT01340976|11057019|FG000|COMPLETED|Overall Study||0
9938783|NCT01340976|11057020|FG001|COMPLETED|Overall Study||1
9938784|NCT01340976|11057021|FG002|COMPLETED|Overall Study||4
9938785|NCT01340976|11057022|FG003|COMPLETED|Overall Study||2
9938786|NCT01340976|11057023|FG004|COMPLETED|Overall Study||5
9938787|NCT01340976|11057024|FG005|COMPLETED|Overall Study||6
9938788|NCT01340976|11057019|FG000|NOT COMPLETED|Overall Study||4
9938789|NCT01340976|11057020|FG001|NOT COMPLETED|Overall Study||2
9938790|NCT01340976|11057021|FG002|NOT COMPLETED|Overall Study||3
9938791|NCT01340976|11057022|FG003|NOT COMPLETED|Overall Study||3
9938792|NCT01340976|11057023|FG004|NOT COMPLETED|Overall Study||2
9938793|NCT01340976|11057024|FG005|NOT COMPLETED|Overall Study||1
9938794|NCT01341067|11057044|FG000|STARTED|Overall Study||30
9938795|NCT01341067|11057044|FG000|COMPLETED|Overall Study||26
9938796|NCT01341067|11057044|FG000|NOT COMPLETED|Overall Study||4
9938797|NCT01341301|11057048|FG000|STARTED|Overall Study||25
9938798|NCT01341301|11057048|FG000|COMPLETED|Overall Study||25
9938799|NCT01341301|11057048|FG000|NOT COMPLETED|Overall Study||0
9938800|NCT01341444|11057056|FG000|STARTED|Overall Study||31
9938801|NCT01341444|11057057|FG001|STARTED|Overall Study||32
9938802|NCT01341444|11057056|FG000|COMPLETED|Overall Study||26
9938803|NCT01341444|11057057|FG001|COMPLETED|Overall Study||29
9938804|NCT01341444|11057056|FG000|NOT COMPLETED|Overall Study||5
9938805|NCT01341444|11057057|FG001|NOT COMPLETED|Overall Study||3
9938806|NCT01341457|11057065|FG000|STARTED|Overall Study||7
9938807|NCT01341457|11057066|FG001|STARTED|Overall Study||10
9938808|NCT01341457|11057065|FG000|Received at Least One Dose of Study Drug|Overall Study||7
9938809|NCT01341457|11057066|FG001|Received at Least One Dose of Study Drug|Overall Study||10
9938810|NCT01341457|11057065|FG000|COMPLETED|Overall Study||5
9938811|NCT01341457|11057066|FG001|COMPLETED|Overall Study||10
9938812|NCT01341457|11057065|FG000|NOT COMPLETED|Overall Study||2
9938813|NCT01341457|11057066|FG001|NOT COMPLETED|Overall Study||0
9938814|NCT01341470|11057079|FG000|STARTED|Overall Study||6
9938815|NCT01341470|11057080|FG001|STARTED|Overall Study||9
9938816|NCT01341470|11057081|FG002|STARTED|Overall Study||10
9938817|NCT01341470|11057082|FG003|STARTED|Overall Study||10
9938818|NCT01341470|11057083|FG004|STARTED|Overall Study||2
9938819|NCT01341470|11057084|FG005|STARTED|Overall Study||10
9938820|NCT01341470|11057079|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9938821|NCT01341470|11057080|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
9938822|NCT01341470|11057081|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
9938823|NCT01341470|11057082|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
9938824|NCT01341470|11057083|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
9956626|NCT01447446|11075935|FG005|STARTED|Overall Study||86
9938825|NCT01341470|11057084|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10
9938826|NCT01341470|11057079|FG000|COMPLETED|Overall Study||6
9938827|NCT01341470|11057080|FG001|COMPLETED|Overall Study||9
10207182|NCT03522506|11334014|FG003|STARTED|Washout Period 2 (7 Days)||4
10207183|NCT03522506|11334011|FG000|COMPLETED|Washout Period 2 (7 Days)||5
10207184|NCT03522506|11334012|FG001|COMPLETED|Washout Period 2 (7 Days)||5
10207185|NCT03522506|11334013|FG002|COMPLETED|Washout Period 2 (7 Days)||5
10207186|NCT03522506|11334014|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10207187|NCT03522506|11334011|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10207188|NCT03522506|11334012|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10207189|NCT03522506|11334013|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10207190|NCT03522506|11334014|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
10207191|NCT03522506|11334011|FG000|STARTED|Treatment Period 3 (2 Days)||5
10207192|NCT03522506|11334012|FG001|STARTED|Treatment Period 3 (2 Days)||5
10207193|NCT03522506|11334013|FG002|STARTED|Treatment Period 3 (2 Days)||5
10207194|NCT03522506|11334014|FG003|STARTED|Treatment Period 3 (2 Days)||3
10207195|NCT03522506|11334011|FG000|COMPLETED|Treatment Period 3 (2 Days)||5
10207196|NCT03522506|11334012|FG001|COMPLETED|Treatment Period 3 (2 Days)||5
10207197|NCT03522506|11334013|FG002|COMPLETED|Treatment Period 3 (2 Days)||5
10207198|NCT03522506|11334014|FG003|COMPLETED|Treatment Period 3 (2 Days)||3
10207199|NCT03522506|11334011|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10207200|NCT03522506|11334012|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10207201|NCT03522506|11334013|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10207202|NCT03522506|11334014|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10207203|NCT03522506|11334011|FG000|STARTED|Washout Period 3 (7 Days)||5
10207204|NCT03522506|11334012|FG001|STARTED|Washout Period 3 (7 Days)||5
10207205|NCT03522506|11334013|FG002|STARTED|Washout Period 3 (7 Days)||5
10207206|NCT03522506|11334014|FG003|STARTED|Washout Period 3 (7 Days)||3
10207207|NCT03522506|11334011|FG000|COMPLETED|Washout Period 3 (7 Days)||5
10207208|NCT03522506|11334012|FG001|COMPLETED|Washout Period 3 (7 Days)||5
10207209|NCT03522506|11334013|FG002|COMPLETED|Washout Period 3 (7 Days)||5
10207210|NCT03522506|11334014|FG003|COMPLETED|Washout Period 3 (7 Days)||3
9938828|NCT01341470|11057081|FG002|COMPLETED|Overall Study||9
9938829|NCT01341470|11057082|FG003|COMPLETED|Overall Study||9
9938830|NCT01341470|11057083|FG004|COMPLETED|Overall Study||2
9938831|NCT01341470|11057084|FG005|COMPLETED|Overall Study||9
9938832|NCT01341470|11057079|FG000|NOT COMPLETED|Overall Study||0
9938833|NCT01341470|11057080|FG001|NOT COMPLETED|Overall Study||0
9938834|NCT01341470|11057081|FG002|NOT COMPLETED|Overall Study||1
9938835|NCT01341470|11057082|FG003|NOT COMPLETED|Overall Study||1
9938836|NCT01341470|11057083|FG004|NOT COMPLETED|Overall Study||0
9938837|NCT01341470|11057084|FG005|NOT COMPLETED|Overall Study||1
9938838|NCT01341639|11057102|FG000|STARTED|Infant Series||628
9938839|NCT01341639|11057103|FG001|STARTED|Infant Series||622
9938840|NCT01341639|11057102|FG000|Site 0048 Excluded|Infant Series||611
9938841|NCT01341639|11057103|FG001|Site 0048 Excluded|Infant Series||606
9938842|NCT01341639|11057102|FG000|Treated|Infant Series||610
9938843|NCT01341639|11057103|FG001|Treated|Infant Series||605
9938844|NCT01341639|11057102|FG000|COMPLETED|Infant Series||599
9938845|NCT01341639|11057103|FG001|COMPLETED|Infant Series||590
9938846|NCT01341639|11057102|FG000|NOT COMPLETED|Infant Series||29
9938847|NCT01341639|11057103|FG001|NOT COMPLETED|Infant Series||32
9938848|NCT01341639|11057102|FG000|STARTED|Interim Period||599
9938849|NCT01341639|11057103|FG001|STARTED|Interim Period||590
9938850|NCT01341639|11057102|FG000|COMPLETED|Interim Period||591
9938851|NCT01341639|11057103|FG001|COMPLETED|Interim Period||581
9938852|NCT01341639|11057102|FG000|NOT COMPLETED|Interim Period||8
9938853|NCT01341639|11057103|FG001|NOT COMPLETED|Interim Period||9
9938854|NCT01341639|11057102|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
9938855|NCT01341639|11057103|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
9938856|NCT01341639|11057102|FG000|COMPLETED|Toddler Dose||539
9938857|NCT01341639|11057103|FG001|COMPLETED|Toddler Dose||548
9938858|NCT01341639|11057102|FG000|NOT COMPLETED|Toddler Dose||51
9938859|NCT01341639|11057103|FG001|NOT COMPLETED|Toddler Dose||34
9938860|NCT01341639|11057102|FG000|STARTED|Post-Treatment||539
9938861|NCT01341639|11057103|FG001|STARTED|Post-Treatment||548
9938862|NCT01341639|11057102|FG000|COMPLETED|Post-Treatment||539
9938863|NCT01341639|11057103|FG001|COMPLETED|Post-Treatment||545
9938864|NCT01341639|11057102|FG000|NOT COMPLETED|Post-Treatment||0
9938865|NCT01341639|11057103|FG001|NOT COMPLETED|Post-Treatment||3
9938866|NCT01341652|11057111|FG000|STARTED|Overall Study||49
9938867|NCT01341652|11057112|FG001|STARTED|Overall Study||50
9938868|NCT01341652|11057111|FG000|COMPLETED|Overall Study||49
9938869|NCT01341652|11057112|FG001|COMPLETED|Overall Study||48
9938870|NCT01341652|11057111|FG000|NOT COMPLETED|Overall Study||0
9938871|NCT01341652|11057112|FG001|NOT COMPLETED|Overall Study||2
9938872|NCT01341730|11057120|FG000|STARTED|Overall Study||20
9938873|NCT01341730|11057121|FG001|STARTED|Overall Study||21
9938874|NCT01341730|11057120|FG000|COMPLETED|Overall Study||16
9938875|NCT01341730|11057121|FG001|COMPLETED|Overall Study||17
9938876|NCT01341730|11057120|FG000|NOT COMPLETED|Overall Study||4
9938877|NCT01341730|11057121|FG001|NOT COMPLETED|Overall Study||4
10207211|NCT03522506|11334011|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10207212|NCT03522506|11334012|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10207213|NCT03522506|11334013|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10207214|NCT03522506|11334014|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
9938878|NCT01341782|11057131|FG000|STARTED|Overall Study||127
9938879|NCT01341782|11057132|FG001|STARTED|Overall Study||128
9938880|NCT01341782|11057131|FG000|COMPLETED|Overall Study||112
9938881|NCT01341782|11057132|FG001|COMPLETED|Overall Study||114
9938882|NCT01341782|11057131|FG000|NOT COMPLETED|Overall Study||15
9938883|NCT01341782|11057132|FG001|NOT COMPLETED|Overall Study||14
9938884|NCT01341912|11057138|FG000|STARTED|Overall Study||3
9938885|NCT01341912|11057138|FG000|COMPLETED|Overall Study||3
9938886|NCT01341912|11057138|FG000|NOT COMPLETED|Overall Study||0
9938887|NCT01341977|11057144|FG000|STARTED|Overall Study||288
9938888|NCT01341977|11057145|FG001|STARTED|Overall Study||285
9938889|NCT01341977|11057144|FG000|COMPLETED|Overall Study||274
9938890|NCT01341977|11057145|FG001|COMPLETED|Overall Study||270
9938891|NCT01341977|11057144|FG000|NOT COMPLETED|Overall Study||14
9938892|NCT01341977|11057145|FG001|NOT COMPLETED|Overall Study||15
9938893|NCT01341990|11057153|FG000|STARTED|Overall Study||35
9938894|NCT01341990|11057154|FG001|STARTED|Overall Study||33
9938895|NCT01341990|11057153|FG000|COMPLETED|Overall Study||32
9938896|NCT01341990|11057154|FG001|COMPLETED|Overall Study||32
9938897|NCT01341990|11057153|FG000|NOT COMPLETED|Overall Study||3
9938898|NCT01341990|11057154|FG001|NOT COMPLETED|Overall Study||1
9938899|NCT01342029|11057160|FG000|STARTED|Period 1||70
9938900|NCT01342029|11057161|FG001|STARTED|Period 1||72
10011336|NCT01780506|11134079|FG000|NOT COMPLETED|Open-Label Extension Phase||0
9938901|NCT01342029|11057160|FG000|Dropout|Period 1||3
9938902|NCT01342029|11057161|FG001|Dropout|Period 1||1
9938903|NCT01342029|11057160|FG000|COMPLETED|Period 1||67
9938904|NCT01342029|11057161|FG001|COMPLETED|Period 1||71
9938905|NCT01342029|11057160|FG000|NOT COMPLETED|Period 1||3
9938906|NCT01342029|11057161|FG001|NOT COMPLETED|Period 1||1
9938907|NCT01342029|11057160|FG000|STARTED|Washout||67
9938908|NCT01342029|11057161|FG001|STARTED|Washout||71
9938909|NCT01342029|11057160|FG000|COMPLETED|Washout||67
9938910|NCT01342029|11057161|FG001|COMPLETED|Washout||67
9938911|NCT01342029|11057160|FG000|NOT COMPLETED|Washout||0
9938912|NCT01342029|11057161|FG001|NOT COMPLETED|Washout||4
9938913|NCT01342029|11057160|FG000|STARTED|Period 2||67
9938914|NCT01342029|11057161|FG001|STARTED|Period 2||67
9938915|NCT01342029|11057160|FG000|Dropout|Period 2||2
9938916|NCT01342029|11057161|FG001|Dropout|Period 2||0
9938917|NCT01342029|11057160|FG000|COMPLETED|Period 2||65
9938918|NCT01342029|11057161|FG001|COMPLETED|Period 2||67
9938919|NCT01342029|11057160|FG000|NOT COMPLETED|Period 2||2
9938920|NCT01342029|11057161|FG001|NOT COMPLETED|Period 2||0
9938921|NCT01342081|11057172|FG000|STARTED|Overall Study||161
9938922|NCT01342081|11057173|FG001|STARTED|Overall Study||164
9938923|NCT01342081|11057174|FG002|STARTED|Overall Study||164
9938924|NCT01342081|11057172|FG000|COMPLETED|Overall Study||159
9938925|NCT01342081|11057173|FG001|COMPLETED|Overall Study||162
9938926|NCT01342081|11057174|FG002|COMPLETED|Overall Study||163
9938927|NCT01342081|11057172|FG000|NOT COMPLETED|Overall Study||2
9938928|NCT01342081|11057173|FG001|NOT COMPLETED|Overall Study||2
9938929|NCT01342081|11057174|FG002|NOT COMPLETED|Overall Study||1
9938930|NCT01342094|11057184|FG000|STARTED|Overall Study||82
9938931|NCT01342094|11057185|FG001|STARTED|Overall Study||84
9938932|NCT01342094|11057184|FG000|COMPLETED|Overall Study||77
9938933|NCT01342094|11057185|FG001|COMPLETED|Overall Study||81
9938934|NCT01342094|11057184|FG000|NOT COMPLETED|Overall Study||5
9938935|NCT01342094|11057185|FG001|NOT COMPLETED|Overall Study||3
9938936|NCT01342107|11057193|FG000|STARTED|Overall Study||34
9938937|NCT01342107|11057194|FG001|STARTED|Overall Study||32
9938938|NCT01342107|11057193|FG000|COMPLETED|Overall Study||34
9938939|NCT01342107|11057194|FG001|COMPLETED|Overall Study||32
9938940|NCT01342107|11057193|FG000|NOT COMPLETED|Overall Study||0
9938941|NCT01342107|11057194|FG001|NOT COMPLETED|Overall Study||0
9938942|NCT01342172|11057200|FG000|STARTED|Overall Study||9
9938943|NCT01342172|11057200|FG000|COMPLETED|Overall Study||9
9938944|NCT01342172|11057200|FG000|NOT COMPLETED|Overall Study||0
9938945|NCT01342211|11057210|FG000|STARTED|Overall Study||19
9938946|NCT01342211|11057211|FG001|STARTED|Overall Study||19
9938947|NCT01342211|11057212|FG002|STARTED|Overall Study||18
9938948|NCT01342211|11057213|FG003|STARTED|Overall Study||19
9938949|NCT01342211|11057214|FG004|STARTED|Overall Study||18
9938950|NCT01342211|11057210|FG000|Treated|Overall Study||19
9938951|NCT01342211|11057211|FG001|Treated|Overall Study||17
9938952|NCT01342211|11057212|FG002|Treated|Overall Study||18
9938953|NCT01342211|11057213|FG003|Treated|Overall Study||19
9938954|NCT01342211|11057214|FG004|Treated|Overall Study||17
9938955|NCT01342211|11057210|FG000|COMPLETED|Overall Study||19
9938956|NCT01342211|11057211|FG001|COMPLETED|Overall Study||17
9938957|NCT01342211|11057212|FG002|COMPLETED|Overall Study||18
9938958|NCT01342211|11057213|FG003|COMPLETED|Overall Study||17
9938959|NCT01342211|11057214|FG004|COMPLETED|Overall Study||16
9938960|NCT01342211|11057210|FG000|NOT COMPLETED|Overall Study||0
9938961|NCT01342211|11057211|FG001|NOT COMPLETED|Overall Study||2
9938962|NCT01342211|11057212|FG002|NOT COMPLETED|Overall Study||0
9938963|NCT01342211|11057213|FG003|NOT COMPLETED|Overall Study||2
9938964|NCT01342211|11057214|FG004|NOT COMPLETED|Overall Study||2
9938965|NCT01342341|11057232|FG000|STARTED|Overall Study||24
9938966|NCT01342341|11057233|FG001|STARTED|Overall Study||24
9938967|NCT01342341|11057232|FG000|COMPLETED|Overall Study||20
9938968|NCT01342341|11057233|FG001|COMPLETED|Overall Study||20
9938969|NCT01342341|11057232|FG000|NOT COMPLETED|Overall Study||4
9938970|NCT01342341|11057233|FG001|NOT COMPLETED|Overall Study||4
9938971|NCT01342367|11057241|FG000|STARTED|Overall Study||32
10207215|NCT03522506|11334011|FG000|STARTED|Treatment Period 4 (2 Days)||5
10207216|NCT03522506|11334012|FG001|STARTED|Treatment Period 4 (2 Days)||5
10207217|NCT03522506|11334013|FG002|STARTED|Treatment Period 4 (2 Days)||5
10207218|NCT03522506|11334014|FG003|STARTED|Treatment Period 4 (2 Days)||3
10207219|NCT03522506|11334011|FG000|COMPLETED|Treatment Period 4 (2 Days)||5
10207220|NCT03522506|11334012|FG001|COMPLETED|Treatment Period 4 (2 Days)||5
10207221|NCT03522506|11334013|FG002|COMPLETED|Treatment Period 4 (2 Days)||5
10207222|NCT03522506|11334014|FG003|COMPLETED|Treatment Period 4 (2 Days)||3
10207223|NCT03522506|11334011|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10207224|NCT03522506|11334012|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10207225|NCT03522506|11334013|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9938972|NCT01342367|11057242|FG001|STARTED|Overall Study||42
9938973|NCT01342367|11057241|FG000|COMPLETED|Overall Study||30
9938974|NCT01342367|11057242|FG001|COMPLETED|Overall Study||40
9938975|NCT01342367|11057241|FG000|NOT COMPLETED|Overall Study||2
9938976|NCT01342367|11057242|FG001|NOT COMPLETED|Overall Study||2
9938977|NCT01342445|11057250|FG000|STARTED|Overall Study||26
9938978|NCT01342445|11057251|FG001|STARTED|Overall Study||24
9938979|NCT01342445|11057250|FG000|COMPLETED|Overall Study||26
9938980|NCT01342445|11057251|FG001|COMPLETED|Overall Study||22
9938981|NCT01342445|11057250|FG000|NOT COMPLETED|Overall Study||0
9938982|NCT01342445|11057251|FG001|NOT COMPLETED|Overall Study||2
9938983|NCT01342458|11057263|FG000|STARTED|Overall Study||28
9938984|NCT01342458|11057264|FG001|STARTED|Overall Study||28
9938985|NCT01342458|11057263|FG000|COMPLETED|Overall Study||26
9938986|NCT01342458|11057264|FG001|COMPLETED|Overall Study||24
9938987|NCT01342458|11057263|FG000|NOT COMPLETED|Overall Study||2
9938988|NCT01342458|11057264|FG001|NOT COMPLETED|Overall Study||4
9938989|NCT01342471|11057286|FG000|STARTED|Overall Study||29
9938990|NCT01342471|11057287|FG001|STARTED|Overall Study||29
9938991|NCT01342471|11057286|FG000|COMPLETED|Overall Study||24
9938992|NCT01342471|11057287|FG001|COMPLETED|Overall Study||23
9938993|NCT01342471|11057286|FG000|NOT COMPLETED|Overall Study||5
9938994|NCT01342471|11057287|FG001|NOT COMPLETED|Overall Study||6
9938995|NCT01342484|11057296|FG000|STARTED|Overall Study||15
9938996|NCT01342484|11057297|FG001|STARTED|Overall Study||10
9938997|NCT01342484|11057298|FG002|STARTED|Overall Study||14
9938998|NCT01342484|11057296|FG000|COMPLETED|Overall Study||13
9938999|NCT01342484|11057297|FG001|COMPLETED|Overall Study||10
9939000|NCT01342484|11057298|FG002|COMPLETED|Overall Study||13
9939001|NCT01342484|11057296|FG000|NOT COMPLETED|Overall Study||2
9939002|NCT01342484|11057297|FG001|NOT COMPLETED|Overall Study||0
9939003|NCT01342484|11057298|FG002|NOT COMPLETED|Overall Study||1
9939004|NCT01342510|11057310|FG000|STARTED|Overall Study||50
9939005|NCT01342510|11057311|FG001|STARTED|Overall Study||50
9939006|NCT01342510|11057312|FG002|STARTED|Overall Study||50
9939007|NCT01342510|11057313|FG003|STARTED|Overall Study||50
9939008|NCT01342510|11057310|FG000|COMPLETED|Overall Study||38
9939009|NCT01342510|11057311|FG001|COMPLETED|Overall Study||44
9939010|NCT01342510|11057312|FG002|COMPLETED|Overall Study||37
9939011|NCT01342510|11057313|FG003|COMPLETED|Overall Study||39
9939012|NCT01342510|11057310|FG000|NOT COMPLETED|Overall Study||12
9939013|NCT01342510|11057311|FG001|NOT COMPLETED|Overall Study||6
9939014|NCT01342510|11057312|FG002|NOT COMPLETED|Overall Study||13
9939015|NCT01342510|11057313|FG003|NOT COMPLETED|Overall Study||11
9939016|NCT01342523|11057359|FG000|STARTED|Overall Study||35
9939017|NCT01342523|11057360|FG001|STARTED|Overall Study||32
9939018|NCT01342523|11057361|FG002|STARTED|Overall Study||36
9939019|NCT01342523|11057362|FG003|STARTED|Overall Study||33
9939020|NCT01342523|11057363|FG004|STARTED|Overall Study||36
9939021|NCT01342523|11057364|FG005|STARTED|Overall Study||36
9939022|NCT01342523|11057365|FG006|STARTED|Overall Study||22
9939023|NCT01342523|11057366|FG007|STARTED|Overall Study||27
9939024|NCT01342523|11057367|FG008|STARTED|Overall Study||28
9939025|NCT01342523|11057368|FG009|STARTED|Overall Study||28
9939026|NCT01342523|11057369|FG010|STARTED|Overall Study||38
9939027|NCT01342523|11057370|FG011|STARTED|Overall Study||38
9939028|NCT01342523|11057371|FG012|STARTED|Overall Study||39
9939029|NCT01342523|11057372|FG013|STARTED|Overall Study||38
9939030|NCT01342523|11057373|FG014|STARTED|Overall Study||38
9939031|NCT01342523|11057374|FG015|STARTED|Overall Study||32
9939032|NCT01342523|11057375|FG016|STARTED|Overall Study||29
9939033|NCT01342523|11057376|FG017|STARTED|Overall Study||27
9939034|NCT01342523|11057377|FG018|STARTED|Overall Study||21
9939035|NCT01342523|11057378|FG019|STARTED|Overall Study||27
9939036|NCT01342523|11057379|FG020|STARTED|Overall Study||29
9939037|NCT01342523|11057380|FG021|STARTED|Overall Study||30
9939038|NCT01342523|11057381|FG022|STARTED|Overall Study||36
9939039|NCT01342523|11057382|FG023|STARTED|Overall Study||36
9939040|NCT01342523|11057383|FG024|STARTED|Overall Study||37
9939041|NCT01342523|11057384|FG025|STARTED|Overall Study||38
9939042|NCT01342523|11057385|FG026|STARTED|Overall Study||34
9939043|NCT01342523|11057386|FG027|STARTED|Overall Study||31
9939044|NCT01342523|11057387|FG028|STARTED|Overall Study||35
9939045|NCT01342523|11057388|FG029|STARTED|Overall Study||29
9939046|NCT01342523|11057389|FG030|STARTED|Overall Study||31
9939047|NCT01342523|11057390|FG031|STARTED|Overall Study||28
9939048|NCT01342523|11057359|FG000|COMPLETED|Overall Study||34
9939049|NCT01342523|11057360|FG001|COMPLETED|Overall Study||32
10207226|NCT03522506|11334014|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10207227|NCT03522675|11334028|FG000|STARTED|Overall Study||22
10207228|NCT03522675|11334028|FG000|COMPLETED|Overall Study||20
10207229|NCT03522675|11334028|FG000|NOT COMPLETED|Overall Study||2
9939050|NCT01342523|11057361|FG002|COMPLETED|Overall Study||36
9939051|NCT01342523|11057362|FG003|COMPLETED|Overall Study||32
9939052|NCT01342523|11057363|FG004|COMPLETED|Overall Study||36
9939053|NCT01342523|11057364|FG005|COMPLETED|Overall Study||36
9939054|NCT01342523|11057365|FG006|COMPLETED|Overall Study||22
9939055|NCT01342523|11057366|FG007|COMPLETED|Overall Study||27
9939056|NCT01342523|11057367|FG008|COMPLETED|Overall Study||28
9939057|NCT01342523|11057368|FG009|COMPLETED|Overall Study||28
9939058|NCT01342523|11057369|FG010|COMPLETED|Overall Study||38
9939059|NCT01342523|11057370|FG011|COMPLETED|Overall Study||36
9939060|NCT01342523|11057371|FG012|COMPLETED|Overall Study||39
9939061|NCT01342523|11057372|FG013|COMPLETED|Overall Study||36
9939062|NCT01342523|11057373|FG014|COMPLETED|Overall Study||37
9939063|NCT01342523|11057374|FG015|COMPLETED|Overall Study||32
9939064|NCT01342523|11057375|FG016|COMPLETED|Overall Study||28
9939065|NCT01342523|11057376|FG017|COMPLETED|Overall Study||27
9939066|NCT01342523|11057377|FG018|COMPLETED|Overall Study||21
9939067|NCT01342523|11057378|FG019|COMPLETED|Overall Study||27
9939068|NCT01342523|11057379|FG020|COMPLETED|Overall Study||29
9939069|NCT01342523|11057380|FG021|COMPLETED|Overall Study||30
9939070|NCT01342523|11057381|FG022|COMPLETED|Overall Study||36
9939071|NCT01342523|11057382|FG023|COMPLETED|Overall Study||35
9939072|NCT01342523|11057383|FG024|COMPLETED|Overall Study||36
9939073|NCT01342523|11057384|FG025|COMPLETED|Overall Study||36
9939074|NCT01342523|11057385|FG026|COMPLETED|Overall Study||33
9939075|NCT01342523|11057386|FG027|COMPLETED|Overall Study||30
9939076|NCT01342523|11057387|FG028|COMPLETED|Overall Study||34
9939077|NCT01342523|11057388|FG029|COMPLETED|Overall Study||28
9939078|NCT01342523|11057389|FG030|COMPLETED|Overall Study||30
9939079|NCT01342523|11057390|FG031|COMPLETED|Overall Study||27
9939080|NCT01342523|11057359|FG000|NOT COMPLETED|Overall Study||1
9939081|NCT01342523|11057360|FG001|NOT COMPLETED|Overall Study||0
9939082|NCT01342523|11057361|FG002|NOT COMPLETED|Overall Study||0
9939083|NCT01342523|11057362|FG003|NOT COMPLETED|Overall Study||1
9939084|NCT01342523|11057363|FG004|NOT COMPLETED|Overall Study||0
9939085|NCT01342523|11057364|FG005|NOT COMPLETED|Overall Study||0
9939086|NCT01342523|11057365|FG006|NOT COMPLETED|Overall Study||0
9939087|NCT01342523|11057366|FG007|NOT COMPLETED|Overall Study||0
9939088|NCT01342523|11057367|FG008|NOT COMPLETED|Overall Study||0
9939089|NCT01342523|11057368|FG009|NOT COMPLETED|Overall Study||0
9939090|NCT01342523|11057369|FG010|NOT COMPLETED|Overall Study||0
9939091|NCT01342523|11057370|FG011|NOT COMPLETED|Overall Study||2
9939092|NCT01342523|11057371|FG012|NOT COMPLETED|Overall Study||0
9939093|NCT01342523|11057372|FG013|NOT COMPLETED|Overall Study||2
9939094|NCT01342523|11057373|FG014|NOT COMPLETED|Overall Study||1
9939095|NCT01342523|11057374|FG015|NOT COMPLETED|Overall Study||0
9939096|NCT01342523|11057375|FG016|NOT COMPLETED|Overall Study||1
9939097|NCT01342523|11057376|FG017|NOT COMPLETED|Overall Study||0
9939098|NCT01342523|11057377|FG018|NOT COMPLETED|Overall Study||0
9939099|NCT01342523|11057378|FG019|NOT COMPLETED|Overall Study||0
9939100|NCT01342523|11057379|FG020|NOT COMPLETED|Overall Study||0
9939101|NCT01342523|11057380|FG021|NOT COMPLETED|Overall Study||0
9939102|NCT01342523|11057381|FG022|NOT COMPLETED|Overall Study||0
9939103|NCT01342523|11057382|FG023|NOT COMPLETED|Overall Study||1
9939104|NCT01342523|11057383|FG024|NOT COMPLETED|Overall Study||1
9939105|NCT01342523|11057384|FG025|NOT COMPLETED|Overall Study||2
9939106|NCT01342523|11057385|FG026|NOT COMPLETED|Overall Study||1
9939107|NCT01342523|11057386|FG027|NOT COMPLETED|Overall Study||1
9939108|NCT01342523|11057387|FG028|NOT COMPLETED|Overall Study||1
9939109|NCT01342523|11057388|FG029|NOT COMPLETED|Overall Study||1
9939110|NCT01342523|11057389|FG030|NOT COMPLETED|Overall Study||1
9939111|NCT01342523|11057390|FG031|NOT COMPLETED|Overall Study||1
9939112|NCT01342549|11057405|FG000|STARTED|Overall Study||31
9939113|NCT01342549|11057406|FG001|STARTED|Overall Study||31
9939114|NCT01342549|11057405|FG000|COMPLETED|Overall Study||31
9939115|NCT01342549|11057406|FG001|COMPLETED|Overall Study||31
9939116|NCT01342549|11057405|FG000|NOT COMPLETED|Overall Study||0
9939117|NCT01342549|11057406|FG001|NOT COMPLETED|Overall Study||0
9939118|NCT01342640|11057412|FG000|STARTED|Overall Study||70
9939119|NCT01342640|11057412|FG000|COMPLETED|Overall Study||29
9939120|NCT01342640|11057412|FG000|NOT COMPLETED|Overall Study||41
9939121|NCT01342666|11057418|FG000|STARTED|Overall Study||26
9939122|NCT01342666|11057419|FG001|STARTED|Overall Study||24
9939123|NCT01342666|11057418|FG000|COMPLETED|Overall Study||26
9939124|NCT01342666|11057419|FG001|COMPLETED|Overall Study||24
9939125|NCT01342666|11057418|FG000|NOT COMPLETED|Overall Study||0
9939126|NCT01342666|11057419|FG001|NOT COMPLETED|Overall Study||0
9939127|NCT01342757|11057425|FG000|STARTED|Overall Study||12
9939128|NCT01342757|11057425|FG000|COMPLETED|Overall Study||12
9939129|NCT01342757|11057425|FG000|NOT COMPLETED|Overall Study||0
9939130|NCT01342770|11057429|FG000|STARTED|Overall Study||6
9939131|NCT01342770|11057429|FG000|COMPLETED|Overall Study||6
9939132|NCT01342770|11057429|FG000|NOT COMPLETED|Overall Study||0
9939133|NCT01342796|11057435|FG000|STARTED|Overall Study||43
9939134|NCT01342796|11057436|FG001|STARTED|Overall Study||41
9939135|NCT01342796|11057435|FG000|COMPLETED|Overall Study||40
9939136|NCT01342796|11057436|FG001|COMPLETED|Overall Study||38
9939137|NCT01342796|11057435|FG000|NOT COMPLETED|Overall Study||3
9939138|NCT01342796|11057436|FG001|NOT COMPLETED|Overall Study||3
9939139|NCT01342887|11057442|FG000|STARTED|Overall Study||6
9939140|NCT01342887|11057442|FG000|COMPLETED|Overall Study||4
9939141|NCT01342887|11057442|FG000|NOT COMPLETED|Overall Study||2
9939142|NCT01342913|11057448|FG000|STARTED|2-week Run-in Period||702
9939143|NCT01342913|11057449|FG001|STARTED|2-week Run-in Period||0
9939144|NCT01342913|11057450|FG002|STARTED|2-week Run-in Period||0
9939145|NCT01342913|11057448|FG000|COMPLETED|2-week Run-in Period||528
9939146|NCT01342913|11057449|FG001|COMPLETED|2-week Run-in Period||0
9939147|NCT01342913|11057450|FG002|COMPLETED|2-week Run-in Period||0
9939148|NCT01342913|11057448|FG000|NOT COMPLETED|2-week Run-in Period||174
9939149|NCT01342913|11057449|FG001|NOT COMPLETED|2-week Run-in Period||0
9939150|NCT01342913|11057450|FG002|NOT COMPLETED|2-week Run-in Period||0
9939151|NCT01342913|11057448|FG000|STARTED|Double-Blind Treatment Period||0
9939152|NCT01342913|11057449|FG001|STARTED|Double-Blind Treatment Period||262
9939153|NCT01342913|11057450|FG002|STARTED|Double-Blind Treatment Period||266
9939154|NCT01342913|11057448|FG000|COMPLETED|Double-Blind Treatment Period||0
9939155|NCT01342913|11057449|FG001|COMPLETED|Double-Blind Treatment Period||246
9939156|NCT01342913|11057450|FG002|COMPLETED|Double-Blind Treatment Period||243
9939157|NCT01342913|11057448|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
9939158|NCT01342913|11057449|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
9939159|NCT01342913|11057450|FG002|NOT COMPLETED|Double-Blind Treatment Period||23
9939160|NCT01342926|11057460|FG000|STARTED|Overall Study||46
9939161|NCT01342926|11057461|FG001|STARTED|Overall Study||46
9939162|NCT01342926|11057462|FG002|STARTED|Overall Study||48
9939163|NCT01342926|11057463|FG003|STARTED|Overall Study||51
9939164|NCT01342926|11057460|FG000|COMPLETED|Overall Study||37
9939165|NCT01342926|11057461|FG001|COMPLETED|Overall Study||31
9939166|NCT01342926|11057462|FG002|COMPLETED|Overall Study||34
9939167|NCT01342926|11057463|FG003|COMPLETED|Overall Study||39
9939168|NCT01342926|11057460|FG000|NOT COMPLETED|Overall Study||9
9939169|NCT01342926|11057461|FG001|NOT COMPLETED|Overall Study||15
9939170|NCT01342926|11057462|FG002|NOT COMPLETED|Overall Study||14
9939171|NCT01342926|11057463|FG003|NOT COMPLETED|Overall Study||12
9939172|NCT01342965|11057475|FG000|STARTED|Overall Study||110
9939173|NCT01342965|11057476|FG001|STARTED|Overall Study||107
9939174|NCT01342965|11057475|FG000|Received Treatment|Overall Study||110
9939175|NCT01342965|11057476|FG001|Received Treatment|Overall Study||104
9939176|NCT01342965|11057475|FG000|COMPLETED|Overall Study||1
9939177|NCT01342965|11057476|FG001|COMPLETED|Overall Study||0
10207230|NCT03522948|11334036|FG000|STARTED|Overall Study||8
10207231|NCT03522948|11334036|FG000|COMPLETED|Overall Study||7
10207232|NCT03522948|11334036|FG000|NOT COMPLETED|Overall Study||1
10207233|NCT03523715|11334042|FG000|STARTED|Overall Study||38
10207234|NCT03523715|11334043|FG001|STARTED|Overall Study||39
9939178|NCT01342965|11057475|FG000|NOT COMPLETED|Overall Study||109
9939179|NCT01342965|11057476|FG001|NOT COMPLETED|Overall Study||107
9939180|NCT01343004|11057485|FG000|STARTED|Overall Study||821
9939181|NCT01343004|11057486|FG001|STARTED|Overall Study||824
9939182|NCT01343004|11057487|FG002|STARTED|Overall Study||818
9939183|NCT01343004|11057485|FG000|COMPLETED|Overall Study||637
9939184|NCT01343004|11057486|FG001|COMPLETED|Overall Study||606
9939185|NCT01343004|11057487|FG002|COMPLETED|Overall Study||658
9939186|NCT01343004|11057485|FG000|NOT COMPLETED|Overall Study||184
9939187|NCT01343004|11057486|FG001|NOT COMPLETED|Overall Study||218
9939188|NCT01343004|11057487|FG002|NOT COMPLETED|Overall Study||160
9939189|NCT01343043|11057499|FG000|STARTED|Overall Study||15
9939190|NCT01343043|11057500|FG001|STARTED|Overall Study||14
9939191|NCT01343043|11057501|FG002|STARTED|Overall Study||5
9939192|NCT01343043|11057502|FG003|STARTED|Overall Study||16
9939193|NCT01343043|11057499|FG000|Received T-cell Infusion|Overall Study||12
9939194|NCT01343043|11057500|FG001|Received T-cell Infusion|Overall Study||13
9939195|NCT01343043|11057501|FG002|Received T-cell Infusion|Overall Study||5
9939196|NCT01343043|11057502|FG003|Received T-cell Infusion|Overall Study||15
9939197|NCT01343043|11057499|FG000|COMPLETED|Overall Study||12
9939198|NCT01343043|11057500|FG001|COMPLETED|Overall Study||13
9939199|NCT01343043|11057501|FG002|COMPLETED|Overall Study||5
9939200|NCT01343043|11057502|FG003|COMPLETED|Overall Study||15
9939201|NCT01343043|11057499|FG000|NOT COMPLETED|Overall Study||3
9939202|NCT01343043|11057500|FG001|NOT COMPLETED|Overall Study||1
9939203|NCT01343043|11057501|FG002|NOT COMPLETED|Overall Study||0
9939204|NCT01343043|11057502|FG003|NOT COMPLETED|Overall Study||1
9939205|NCT01343056|11057519|FG000|STARTED|Overall Study||35
9939206|NCT01343056|11057520|FG001|STARTED|Overall Study||36
9939207|NCT01343056|11057521|FG002|STARTED|Overall Study||32
10011337|NCT01780506|11134080|FG001|NOT COMPLETED|Open-Label Extension Phase||1
10011338|NCT01780545|11134090|FG000|STARTED|Overall Study||99
10011339|NCT01780545|11134091|FG001|STARTED|Overall Study||101
9939208|NCT01343056|11057522|FG003|STARTED|Overall Study||38
9939209|NCT01343056|11057519|FG000|COMPLETED|Overall Study||28
9939210|NCT01343056|11057520|FG001|COMPLETED|Overall Study||31
9939211|NCT01343056|11057521|FG002|COMPLETED|Overall Study||29
9939212|NCT01343056|11057522|FG003|COMPLETED|Overall Study||29
9939213|NCT01343056|11057519|FG000|NOT COMPLETED|Overall Study||7
9939214|NCT01343056|11057520|FG001|NOT COMPLETED|Overall Study||5
9939215|NCT01343056|11057521|FG002|NOT COMPLETED|Overall Study||3
9939216|NCT01343056|11057522|FG003|NOT COMPLETED|Overall Study||9
9939217|NCT01343082|11057536|FG000|STARTED|The run-in Period||51
9939218|NCT01343082|11057537|FG001|STARTED|The run-in Period||49
9939219|NCT01343082|11057538|FG002|STARTED|The run-in Period||48
9939220|NCT01343082|11057536|FG000|COMPLETED|The run-in Period||48
9939221|NCT01343082|11057537|FG001|COMPLETED|The run-in Period||45
10207235|NCT03523715|11334042|FG000|COMPLETED|Overall Study||26
10207236|NCT03523715|11334043|FG001|COMPLETED|Overall Study||23
10207237|NCT03523715|11334042|FG000|NOT COMPLETED|Overall Study||12
9939222|NCT01343082|11057538|FG002|COMPLETED|The run-in Period||43
9939223|NCT01343082|11057536|FG000|NOT COMPLETED|The run-in Period||3
9939224|NCT01343082|11057537|FG001|NOT COMPLETED|The run-in Period||4
9939225|NCT01343082|11057538|FG002|NOT COMPLETED|The run-in Period||5
9939226|NCT01343082|11057536|FG000|STARTED|Treatment Period , Switched to DE-111||48
9939227|NCT01343082|11057537|FG001|STARTED|Treatment Period , Switched to DE-111||45
9939228|NCT01343082|11057538|FG002|STARTED|Treatment Period , Switched to DE-111||43
9939229|NCT01343082|11057536|FG000|COMPLETED|Treatment Period , Switched to DE-111||43
9939230|NCT01343082|11057537|FG001|COMPLETED|Treatment Period , Switched to DE-111||36
9939231|NCT01343082|11057538|FG002|COMPLETED|Treatment Period , Switched to DE-111||31
9939232|NCT01343082|11057536|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5
9939233|NCT01343082|11057537|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9
9939234|NCT01343082|11057538|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12
9939235|NCT01343095|11057545|FG000|STARTED|Overall Study||2
9939236|NCT01343095|11057546|FG001|STARTED|Overall Study||3
9939237|NCT01343095|11057547|FG002|STARTED|Overall Study||3
9939238|NCT01343095|11057545|FG000|COMPLETED|Overall Study||2
9939239|NCT01343095|11057546|FG001|COMPLETED|Overall Study||3
9939240|NCT01343095|11057547|FG002|COMPLETED|Overall Study||3
9939241|NCT01343095|11057545|FG000|NOT COMPLETED|Overall Study||0
9939242|NCT01343095|11057546|FG001|NOT COMPLETED|Overall Study||0
9939243|NCT01343095|11057547|FG002|NOT COMPLETED|Overall Study||0
9939244|NCT01343160|11057557|FG000|STARTED|Overall Study||36
9939245|NCT01343160|11057557|FG000|COMPLETED|Overall Study||31
9939246|NCT01343160|11057557|FG000|NOT COMPLETED|Overall Study||5
9939247|NCT01343251|11057564|FG000|STARTED|Overall Study||16
9939248|NCT01343251|11057565|FG001|STARTED|Overall Study||17
9939249|NCT01343251|11057564|FG000|COMPLETED|Overall Study||16
9939250|NCT01343251|11057565|FG001|COMPLETED|Overall Study||17
9939251|NCT01343251|11057564|FG000|NOT COMPLETED|Overall Study||0
9939252|NCT01343251|11057565|FG001|NOT COMPLETED|Overall Study||0
9939253|NCT01343277|11057576|FG000|STARTED|Overall Study||384
9939254|NCT01343277|11057577|FG001|STARTED|Overall Study||193
9939255|NCT01343277|11057576|FG000|Treated|Overall Study||378
9939256|NCT01343277|11057577|FG001|Treated|Overall Study||172
9939257|NCT01343277|11057576|FG000|COMPLETED|Overall Study||0
9939258|NCT01343277|11057577|FG001|COMPLETED|Overall Study||0
9939259|NCT01343277|11057576|FG000|NOT COMPLETED|Overall Study||384
9939260|NCT01343277|11057577|FG001|NOT COMPLETED|Overall Study||193
9939261|NCT01343368|11057585|FG000|STARTED|Overall Study||9
9939262|NCT01343368|11057586|FG001|STARTED|Overall Study||10
9939263|NCT01343368|11057585|FG000|COMPLETED|Overall Study||7
9939264|NCT01343368|11057586|FG001|COMPLETED|Overall Study||10
9939265|NCT01343368|11057585|FG000|NOT COMPLETED|Overall Study||2
9939266|NCT01343368|11057586|FG001|NOT COMPLETED|Overall Study||0
9939267|NCT01343407|11057592|FG000|STARTED|First Treatment Period (Part 2)||2
9939268|NCT01343407|11057593|FG001|STARTED|First Treatment Period (Part 2)||2
9939269|NCT01343407|11057594|FG002|STARTED|First Treatment Period (Part 2)||3
9939270|NCT01343407|11057595|FG003|STARTED|First Treatment Period (Part 2)||3
9939271|NCT01343407|11057596|FG004|STARTED|First Treatment Period (Part 2)||3
9939272|NCT01343407|11057597|FG005|STARTED|First Treatment Period (Part 2)||3
9939273|NCT01343407|11057592|FG000|COMPLETED|First Treatment Period (Part 2)||2
9939274|NCT01343407|11057593|FG001|COMPLETED|First Treatment Period (Part 2)||2
9939275|NCT01343407|11057594|FG002|COMPLETED|First Treatment Period (Part 2)||3
9939276|NCT01343407|11057595|FG003|COMPLETED|First Treatment Period (Part 2)||3
9939277|NCT01343407|11057596|FG004|COMPLETED|First Treatment Period (Part 2)||3
9939278|NCT01343407|11057597|FG005|COMPLETED|First Treatment Period (Part 2)||3
9939279|NCT01343407|11057592|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0
9939280|NCT01343407|11057593|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0
9939281|NCT01343407|11057594|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0
9939282|NCT01343407|11057595|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0
9939283|NCT01343407|11057596|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0
9939284|NCT01343407|11057597|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0
9939285|NCT01343407|11057592|FG000|STARTED|First Washout (Part 2)||2
9939286|NCT01343407|11057593|FG001|STARTED|First Washout (Part 2)||2
9939287|NCT01343407|11057594|FG002|STARTED|First Washout (Part 2)||3
9939288|NCT01343407|11057595|FG003|STARTED|First Washout (Part 2)||3
9939289|NCT01343407|11057596|FG004|STARTED|First Washout (Part 2)||3
9939290|NCT01343407|11057597|FG005|STARTED|First Washout (Part 2)||3
9939291|NCT01343407|11057592|FG000|COMPLETED|First Washout (Part 2)||2
9939292|NCT01343407|11057593|FG001|COMPLETED|First Washout (Part 2)||2
9939293|NCT01343407|11057594|FG002|COMPLETED|First Washout (Part 2)||3
9939294|NCT01343407|11057595|FG003|COMPLETED|First Washout (Part 2)||3
9939295|NCT01343407|11057596|FG004|COMPLETED|First Washout (Part 2)||3
9939296|NCT01343407|11057597|FG005|COMPLETED|First Washout (Part 2)||3
9939297|NCT01343407|11057592|FG000|NOT COMPLETED|First Washout (Part 2)||0
9939298|NCT01343407|11057593|FG001|NOT COMPLETED|First Washout (Part 2)||0
9939299|NCT01343407|11057594|FG002|NOT COMPLETED|First Washout (Part 2)||0
9939300|NCT01343407|11057595|FG003|NOT COMPLETED|First Washout (Part 2)||0
9939301|NCT01343407|11057596|FG004|NOT COMPLETED|First Washout (Part 2)||0
9939302|NCT01343407|11057597|FG005|NOT COMPLETED|First Washout (Part 2)||0
9939303|NCT01343407|11057592|FG000|STARTED|Second Treatment Period (Part 2)||2
9939304|NCT01343407|11057593|FG001|STARTED|Second Treatment Period (Part 2)||2
9939305|NCT01343407|11057594|FG002|STARTED|Second Treatment Period (Part 2)||3
9939306|NCT01343407|11057595|FG003|STARTED|Second Treatment Period (Part 2)||3
9939307|NCT01343407|11057596|FG004|STARTED|Second Treatment Period (Part 2)||3
9939308|NCT01343407|11057597|FG005|STARTED|Second Treatment Period (Part 2)||3
9939309|NCT01343407|11057592|FG000|COMPLETED|Second Treatment Period (Part 2)||2
9939310|NCT01343407|11057593|FG001|COMPLETED|Second Treatment Period (Part 2)||2
9939311|NCT01343407|11057594|FG002|COMPLETED|Second Treatment Period (Part 2)||2
9939312|NCT01343407|11057595|FG003|COMPLETED|Second Treatment Period (Part 2)||3
9939313|NCT01343407|11057596|FG004|COMPLETED|Second Treatment Period (Part 2)||3
9939314|NCT01343407|11057597|FG005|COMPLETED|Second Treatment Period (Part 2)||3
9939315|NCT01343407|11057592|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0
9939316|NCT01343407|11057593|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0
9939317|NCT01343407|11057594|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1
9939318|NCT01343407|11057595|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0
9939319|NCT01343407|11057596|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0
9939320|NCT01343407|11057597|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0
9939321|NCT01343407|11057592|FG000|STARTED|Second Washout (Part 2)||2
9939322|NCT01343407|11057593|FG001|STARTED|Second Washout (Part 2)||2
9939323|NCT01343407|11057594|FG002|STARTED|Second Washout (Part 2)||2
9939324|NCT01343407|11057595|FG003|STARTED|Second Washout (Part 2)||3
9939325|NCT01343407|11057596|FG004|STARTED|Second Washout (Part 2)||3
9939326|NCT01343407|11057597|FG005|STARTED|Second Washout (Part 2)||3
9939327|NCT01343407|11057592|FG000|COMPLETED|Second Washout (Part 2)||2
9939328|NCT01343407|11057593|FG001|COMPLETED|Second Washout (Part 2)||2
9939329|NCT01343407|11057594|FG002|COMPLETED|Second Washout (Part 2)||1
9939330|NCT01343407|11057595|FG003|COMPLETED|Second Washout (Part 2)||3
9939331|NCT01343407|11057596|FG004|COMPLETED|Second Washout (Part 2)||3
9939332|NCT01343407|11057597|FG005|COMPLETED|Second Washout (Part 2)||3
9939333|NCT01343407|11057592|FG000|NOT COMPLETED|Second Washout (Part 2)||0
9939334|NCT01343407|11057593|FG001|NOT COMPLETED|Second Washout (Part 2)||0
9939335|NCT01343407|11057594|FG002|NOT COMPLETED|Second Washout (Part 2)||1
9939336|NCT01343407|11057595|FG003|NOT COMPLETED|Second Washout (Part 2)||0
10207238|NCT03523715|11334043|FG001|NOT COMPLETED|Overall Study||16
10207239|NCT03523871|11334049|FG000|STARTED|Overall Study||20
10207240|NCT03523871|11334049|FG000|COMPLETED|Overall Study||19
10207241|NCT03523871|11334049|FG000|NOT COMPLETED|Overall Study||1
10207242|NCT03523988|11334056|FG000|STARTED|Overall Study||24
9939337|NCT01343407|11057596|FG004|NOT COMPLETED|Second Washout (Part 2)||0
9939338|NCT01343407|11057597|FG005|NOT COMPLETED|Second Washout (Part 2)||0
9939339|NCT01343407|11057592|FG000|STARTED|Third Treatment Period (Part 2)||2
9939340|NCT01343407|11057593|FG001|STARTED|Third Treatment Period (Part 2)||2
9939341|NCT01343407|11057594|FG002|STARTED|Third Treatment Period (Part 2)||1
9939342|NCT01343407|11057595|FG003|STARTED|Third Treatment Period (Part 2)||3
9939343|NCT01343407|11057596|FG004|STARTED|Third Treatment Period (Part 2)||3
9939344|NCT01343407|11057597|FG005|STARTED|Third Treatment Period (Part 2)||3
9939345|NCT01343407|11057592|FG000|COMPLETED|Third Treatment Period (Part 2)||2
9939346|NCT01343407|11057593|FG001|COMPLETED|Third Treatment Period (Part 2)||2
9939347|NCT01343407|11057594|FG002|COMPLETED|Third Treatment Period (Part 2)||1
9939348|NCT01343407|11057595|FG003|COMPLETED|Third Treatment Period (Part 2)||3
9939349|NCT01343407|11057596|FG004|COMPLETED|Third Treatment Period (Part 2)||3
9939350|NCT01343407|11057597|FG005|COMPLETED|Third Treatment Period (Part 2)||3
9939351|NCT01343407|11057592|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0
9939352|NCT01343407|11057593|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0
9939353|NCT01343407|11057594|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0
9939354|NCT01343407|11057595|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0
9939355|NCT01343407|11057596|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0
9939356|NCT01343407|11057597|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0
9939357|NCT01343485|11057607|FG000|STARTED|Overall Study||185
9939358|NCT01343485|11057608|FG001|STARTED|Overall Study||180
9939359|NCT01343485|11057607|FG000|COMPLETED|Overall Study||36
9939360|NCT01343485|11057608|FG001|COMPLETED|Overall Study||46
9939361|NCT01343485|11057607|FG000|NOT COMPLETED|Overall Study||149
9939362|NCT01343485|11057608|FG001|NOT COMPLETED|Overall Study||134
9939363|NCT01343667|11057616|FG000|STARTED|Overall Study||425
9939364|NCT01343667|11057617|FG001|STARTED|Overall Study||972
9939365|NCT01343667|11057616|FG000|COMPLETED|Overall Study||413
9939366|NCT01343667|11057617|FG001|COMPLETED|Overall Study||916
9939367|NCT01343667|11057616|FG000|NOT COMPLETED|Overall Study||12
9939368|NCT01343667|11057617|FG001|NOT COMPLETED|Overall Study||56
9939369|NCT01343693|11057623|FG000|STARTED|Overall Study||119
9939370|NCT01343693|11057623|FG000|COMPLETED|Overall Study||110
9939371|NCT01343693|11057623|FG000|NOT COMPLETED|Overall Study||9
9956627|NCT01447446|11075930|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
9956628|NCT01447446|11075931|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
9956629|NCT01447446|11075932|FG002|COMPLETED|Overall Study||192
9956630|NCT01447446|11075933|FG003|COMPLETED|Overall Study||60
9956631|NCT01447446|11075934|FG004|COMPLETED|Overall Study||610
9956632|NCT01447446|11075935|FG005|COMPLETED|Overall Study||54
9956633|NCT01447446|11075930|FG000|NOT COMPLETED|Overall Study||722
9956634|NCT01447446|11075931|FG001|NOT COMPLETED|Overall Study||165
9956635|NCT01447446|11075932|FG002|NOT COMPLETED|Overall Study||100
9956636|NCT01447446|11075933|FG003|NOT COMPLETED|Overall Study||33
9956637|NCT01447446|11075934|FG004|NOT COMPLETED|Overall Study||211
10207243|NCT03523988|11334057|FG001|STARTED|Overall Study||24
10207244|NCT03523988|11334058|FG002|STARTED|Overall Study||25
9939372|NCT01343823|11057631|FG000|STARTED|Overall Study||20
9939373|NCT01343823|11057632|FG001|STARTED|Overall Study||20
9939374|NCT01343823|11057633|FG002|STARTED|Overall Study||19
9939375|NCT01343823|11057634|FG003|STARTED|Overall Study||20
9939376|NCT01343823|11057631|FG000|COMPLETED|Overall Study||18
9939377|NCT01343823|11057632|FG001|COMPLETED|Overall Study||20
9939378|NCT01343823|11057633|FG002|COMPLETED|Overall Study||19
9939379|NCT01343823|11057634|FG003|COMPLETED|Overall Study||19
9939380|NCT01343823|11057631|FG000|NOT COMPLETED|Overall Study||2
9939381|NCT01343823|11057632|FG001|NOT COMPLETED|Overall Study||0
9939382|NCT01343823|11057633|FG002|NOT COMPLETED|Overall Study||0
9939383|NCT01343823|11057634|FG003|NOT COMPLETED|Overall Study||1
9939384|NCT01343888|11057647|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
9939385|NCT01343888|11057648|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
9939386|NCT01343888|11057649|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
9939387|NCT01343888|11057647|FG000|COMPLETED|Overall Study||234
9939388|NCT01343888|11057648|FG001|COMPLETED|Overall Study||222
9939389|NCT01343888|11057649|FG002|COMPLETED|Overall Study||110
9939390|NCT01343888|11057647|FG000|NOT COMPLETED|Overall Study||25
9939391|NCT01343888|11057648|FG001|NOT COMPLETED|Overall Study||39
9939392|NCT01343888|11057649|FG002|NOT COMPLETED|Overall Study||22
9939393|NCT01343901|11057657|FG000|STARTED|Overall Study||210
9939394|NCT01343901|11057657|FG000|Efficacy Population|Overall Study||205
9939395|NCT01343901|11057657|FG000|COMPLETED|Overall Study||97
9939396|NCT01343901|11057657|FG000|NOT COMPLETED|Overall Study||113
9939397|NCT01344057|11057661|FG000|STARTED|Overall Study||63
9939398|NCT01344057|11057661|FG000|COMPLETED|Overall Study||62
9939399|NCT01344057|11057661|FG000|NOT COMPLETED|Overall Study||1
9939400|NCT01344161|11057667|FG000|STARTED|Overall Study||43
9939401|NCT01344161|11057668|FG001|STARTED|Overall Study||42
9939402|NCT01344161|11057667|FG000|COMPLETED|Overall Study||38
9939403|NCT01344161|11057668|FG001|COMPLETED|Overall Study||39
9939404|NCT01344161|11057667|FG000|NOT COMPLETED|Overall Study||5
9939405|NCT01344161|11057668|FG001|NOT COMPLETED|Overall Study||3
9939406|NCT01344226|11057674|FG000|STARTED|Overall Study||49
9939407|NCT01344226|11057674|FG000|COMPLETED|Overall Study||41
9939408|NCT01344226|11057674|FG000|NOT COMPLETED|Overall Study||8
9939409|NCT01344356|11057680|FG000|STARTED|Overall Study||1
9939410|NCT01344356|11057681|FG001|STARTED|Overall Study||18
9939411|NCT01344356|11057680|FG000|COMPLETED|Overall Study||1
9939412|NCT01344356|11057681|FG001|COMPLETED|Overall Study||9
9939413|NCT01344356|11057680|FG000|NOT COMPLETED|Overall Study||0
9939414|NCT01344356|11057681|FG001|NOT COMPLETED|Overall Study||9
9939415|NCT01344369|11057691|FG000|STARTED|First Intervention||18
9939416|NCT01344369|11057692|FG001|STARTED|First Intervention||18
9939417|NCT01344369|11057691|FG000|COMPLETED|First Intervention||18
9939418|NCT01344369|11057692|FG001|COMPLETED|First Intervention||18
9939419|NCT01344369|11057691|FG000|NOT COMPLETED|First Intervention||0
9939420|NCT01344369|11057692|FG001|NOT COMPLETED|First Intervention||0
9939421|NCT01344369|11057691|FG000|STARTED|Washout of 28 Days||18
9939422|NCT01344369|11057692|FG001|STARTED|Washout of 28 Days||18
9939423|NCT01344369|11057691|FG000|COMPLETED|Washout of 28 Days||17
9939424|NCT01344369|11057692|FG001|COMPLETED|Washout of 28 Days||17
9939425|NCT01344369|11057691|FG000|NOT COMPLETED|Washout of 28 Days||1
9939426|NCT01344369|11057692|FG001|NOT COMPLETED|Washout of 28 Days||1
9939427|NCT01344369|11057691|FG000|STARTED|Second Intervention||17
9939428|NCT01344369|11057692|FG001|STARTED|Second Intervention||17
9939429|NCT01344369|11057691|FG000|COMPLETED|Second Intervention||17
9939430|NCT01344369|11057692|FG001|COMPLETED|Second Intervention||16
9939431|NCT01344369|11057691|FG000|NOT COMPLETED|Second Intervention||0
9939432|NCT01344369|11057692|FG001|NOT COMPLETED|Second Intervention||1
9939433|NCT01344447|11057698|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
9939434|NCT01344447|11057698|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
9939435|NCT01344447|11057698|FG000|COMPLETED|Overall Study||471
9939436|NCT01344447|11057698|FG000|NOT COMPLETED|Overall Study||8
9939437|NCT01344460|11057706|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
9939438|NCT01344460|11057706|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
9939439|NCT01344460|11057706|FG000|COMPLETED|Overall Study||312
9939440|NCT01344460|11057706|FG000|NOT COMPLETED|Overall Study||3
9939441|NCT01344538|11057716|FG000|STARTED|Overall Study||16
9939442|NCT01344538|11057717|FG001|STARTED|Overall Study||17
9939443|NCT01344538|11057716|FG000|COMPLETED|Overall Study||14
9939444|NCT01344538|11057717|FG001|COMPLETED|Overall Study||16
9939445|NCT01344538|11057716|FG000|NOT COMPLETED|Overall Study||2
9939446|NCT01344538|11057717|FG001|NOT COMPLETED|Overall Study||1
9939447|NCT01344616|11057725|FG000|STARTED|Overall Study||244
9939448|NCT01344616|11057726|FG001|STARTED|Overall Study||238
9939449|NCT01344616|11057725|FG000|COMPLETED|Overall Study||209
9939450|NCT01344616|11057726|FG001|COMPLETED|Overall Study||194
9939451|NCT01344616|11057725|FG000|NOT COMPLETED|Overall Study||35
9939452|NCT01344616|11057726|FG001|NOT COMPLETED|Overall Study||44
9939453|NCT01344629|11057734|FG000|STARTED|Crossover Period 1||32
9939454|NCT01344629|11057735|FG001|STARTED|Crossover Period 1||32
9939455|NCT01344629|11057734|FG000|COMPLETED|Crossover Period 1||32
9939456|NCT01344629|11057735|FG001|COMPLETED|Crossover Period 1||32
9939457|NCT01344629|11057734|FG000|NOT COMPLETED|Crossover Period 1||0
9939458|NCT01344629|11057735|FG001|NOT COMPLETED|Crossover Period 1||0
9939459|NCT01344629|11057734|FG000|STARTED|Crossover Period 2||32
9939460|NCT01344629|11057735|FG001|STARTED|Crossover Period 2||32
9939461|NCT01344629|11057734|FG000|COMPLETED|Crossover Period 2||32
9939462|NCT01344629|11057735|FG001|COMPLETED|Crossover Period 2||31
9939463|NCT01344629|11057734|FG000|NOT COMPLETED|Crossover Period 2||0
9939464|NCT01344629|11057735|FG001|NOT COMPLETED|Crossover Period 2||1
9939465|NCT01344629|11057734|FG000|STARTED|Crossover Period 3||32
9939466|NCT01344629|11057735|FG001|STARTED|Crossover Period 3||31
9939467|NCT01344629|11057734|FG000|COMPLETED|Crossover Period 3||32
9939468|NCT01344629|11057735|FG001|COMPLETED|Crossover Period 3||31
9939469|NCT01344629|11057734|FG000|NOT COMPLETED|Crossover Period 3||0
9939470|NCT01344629|11057735|FG001|NOT COMPLETED|Crossover Period 3||0
9939471|NCT01344629|11057734|FG000|STARTED|Crossover Period 4||32
9939472|NCT01344629|11057735|FG001|STARTED|Crossover Period 4||31
9939473|NCT01344629|11057734|FG000|COMPLETED|Crossover Period 4||32
9939474|NCT01344629|11057735|FG001|COMPLETED|Crossover Period 4||31
9939475|NCT01344629|11057734|FG000|NOT COMPLETED|Crossover Period 4||0
9939476|NCT01344629|11057735|FG001|NOT COMPLETED|Crossover Period 4||0
9939477|NCT01344759|11057743|FG000|STARTED|Overall Study||30
9939478|NCT01344759|11057744|FG001|STARTED|Overall Study||30
9939479|NCT01344759|11057743|FG000|COMPLETED|Overall Study||30
9939480|NCT01344759|11057744|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
9939481|NCT01344759|11057743|FG000|NOT COMPLETED|Overall Study||0
9939482|NCT01344759|11057744|FG001|NOT COMPLETED|Overall Study||2
9939483|NCT01344824|11057756|FG000|STARTED|Overall Study||38
9939484|NCT01344824|11057756|FG000|COMPLETED|Overall Study||1
9939485|NCT01344824|11057756|FG000|NOT COMPLETED|Overall Study||37
9939486|NCT01344876|11057761|FG000|STARTED|Overall Study||4
9939487|NCT01344876|11057762|FG001|STARTED|Overall Study||3
9939488|NCT01344876|11057763|FG002|STARTED|Overall Study||4
9939489|NCT01344876|11057764|FG003|STARTED|Overall Study||6
9939490|NCT01344876|11057765|FG004|STARTED|Overall Study||3
9939491|NCT01344876|11057761|FG000|COMPLETED|Overall Study||3
9939492|NCT01344876|11057762|FG001|COMPLETED|Overall Study||3
9939493|NCT01344876|11057763|FG002|COMPLETED|Overall Study||3
9939494|NCT01344876|11057764|FG003|COMPLETED|Overall Study||3
9939495|NCT01344876|11057765|FG004|COMPLETED|Overall Study||2
9939496|NCT01344876|11057761|FG000|NOT COMPLETED|Overall Study||1
9939497|NCT01344876|11057762|FG001|NOT COMPLETED|Overall Study||0
9939498|NCT01344876|11057763|FG002|NOT COMPLETED|Overall Study||1
9939499|NCT01344876|11057764|FG003|NOT COMPLETED|Overall Study||3
9939500|NCT01344876|11057765|FG004|NOT COMPLETED|Overall Study||1
9939501|NCT01345019|11057780|FG000|STARTED|Blinded Treatment Phase||859
9939502|NCT01345019|11057781|FG001|STARTED|Blinded Treatment Phase||859
9939503|NCT01345019|11057780|FG000|Received Treatment|Blinded Treatment Phase||852
9939504|NCT01345019|11057781|FG001|Received Treatment|Blinded Treatment Phase||850
9939505|NCT01345019|11057780|FG000|COMPLETED|Blinded Treatment Phase||541
9939506|NCT01345019|11057781|FG001|COMPLETED|Blinded Treatment Phase||555
9939507|NCT01345019|11057780|FG000|NOT COMPLETED|Blinded Treatment Phase||318
9939508|NCT01345019|11057781|FG001|NOT COMPLETED|Blinded Treatment Phase||304
9939509|NCT01345019|11057780|FG000|STARTED|Open Label Treatment Phase||418
9939510|NCT01345019|11057781|FG001|STARTED|Open Label Treatment Phase||426
9939511|NCT01345019|11057780|FG000|COMPLETED|Open Label Treatment Phase||227
9939512|NCT01345019|11057781|FG001|COMPLETED|Open Label Treatment Phase||233
9939513|NCT01345019|11057780|FG000|NOT COMPLETED|Open Label Treatment Phase||191
9939514|NCT01345019|11057781|FG001|NOT COMPLETED|Open Label Treatment Phase||193
9939515|NCT01345058|11057791|FG000|STARTED|Overall Study||20
9939516|NCT01345058|11057792|FG001|STARTED|Overall Study||36
9939517|NCT01345058|11057791|FG000|Received Lacosamide|Overall Study||19
9939518|NCT01345058|11057792|FG001|Received Lacosamide|Overall Study||0
9939519|NCT01345058|11057791|FG000|COMPLETED|Overall Study||15
9939520|NCT01345058|11057792|FG001|COMPLETED|Overall Study||36
9939521|NCT01345058|11057791|FG000|NOT COMPLETED|Overall Study||5
10207245|NCT03523988|11334056|FG000|COMPLETED|Overall Study||7
10207246|NCT03523988|11334057|FG001|COMPLETED|Overall Study||8
10207247|NCT03523988|11334058|FG002|COMPLETED|Overall Study||7
9939522|NCT01345058|11057792|FG001|NOT COMPLETED|Overall Study||0
10011340|NCT01780545|11134090|FG000|COMPLETED|Overall Study||95
10011341|NCT01780545|11134091|FG001|COMPLETED|Overall Study||99
10011342|NCT01780545|11134090|FG000|NOT COMPLETED|Overall Study||4
10011343|NCT01780545|11134091|FG001|NOT COMPLETED|Overall Study||2
9939523|NCT01345123|11057801|FG000|STARTED|Overall Study||3323
9939524|NCT01345123|11057802|FG001|STARTED|Overall Study||3311
10011344|NCT01780584|11134103|FG000|STARTED|Overall Study||15
9939525|NCT01345123|11057803|FG002|STARTED|Overall Study||3291
9939526|NCT01345123|11057801|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
9939527|NCT01345123|11057802|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
9939528|NCT01345123|11057803|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
9939529|NCT01345123|11057801|FG000|NOT COMPLETED|Overall Study||79
9939530|NCT01345123|11057802|FG001|NOT COMPLETED|Overall Study||85
9939531|NCT01345123|11057803|FG002|NOT COMPLETED|Overall Study||88
10207248|NCT03523988|11334056|FG000|NOT COMPLETED|Overall Study||17
10207249|NCT03523988|11334057|FG001|NOT COMPLETED|Overall Study||16
10207250|NCT03523988|11334058|FG002|NOT COMPLETED|Overall Study||18
9939532|NCT01345162|11057814|FG000|STARTED|Overall Study||100
9939533|NCT01345162|11057815|FG001|STARTED|Overall Study||100
9939534|NCT01345162|11057814|FG000|COMPLETED|Overall Study||98
9939535|NCT01345162|11057815|FG001|COMPLETED|Overall Study||96
9939536|NCT01345162|11057814|FG000|NOT COMPLETED|Overall Study||2
9939537|NCT01345162|11057815|FG001|NOT COMPLETED|Overall Study||4
9939538|NCT01345188|11057821|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
9939539|NCT01345188|11057821|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
9939540|NCT01345188|11057821|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
9939541|NCT01345188|11057821|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
9939542|NCT01345188|11057821|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
9939543|NCT01345188|11057821|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
9939544|NCT01345253|11057830|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226
9939545|NCT01345253|11057831|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451
9939546|NCT01345253|11057830|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
9939547|NCT01345253|11057831|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
9939548|NCT01345253|11057830|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
9939549|NCT01345253|11057831|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
9939550|NCT01345253|11057830|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
9939551|NCT01345253|11057831|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
9939552|NCT01345253|11057830|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
9939553|NCT01345253|11057831|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
9939554|NCT01345253|11057830|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
9939555|NCT01345253|11057831|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
9939556|NCT01345292|11057842|FG000|STARTED|Overall Study||75
9939557|NCT01345292|11057843|FG001|STARTED|Overall Study||76
9939558|NCT01345292|11057844|FG002|STARTED|Overall Study||75
9939559|NCT01345292|11057842|FG000|COMPLETED|Overall Study||73
9939560|NCT01345292|11057843|FG001|COMPLETED|Overall Study||76
9939561|NCT01345292|11057844|FG002|COMPLETED|Overall Study||74
9939562|NCT01345292|11057842|FG000|NOT COMPLETED|Overall Study||2
9939563|NCT01345292|11057843|FG001|NOT COMPLETED|Overall Study||0
9939564|NCT01345292|11057844|FG002|NOT COMPLETED|Overall Study||1
9939565|NCT01345318|11057852|FG000|STARTED|Overall Study||191
9939566|NCT01345318|11057852|FG000|COMPLETED|Overall Study||111
9939567|NCT01345318|11057852|FG000|NOT COMPLETED|Overall Study||80
9939568|NCT01345513|11057857|FG000|STARTED|Overall Study||50
9939569|NCT01345513|11057857|FG000|COMPLETED|Overall Study||50
9939570|NCT01345513|11057857|FG000|NOT COMPLETED|Overall Study||0
9939571|NCT01345591|11057861|FG000|STARTED|Overall Study||20
9939572|NCT01345591|11057861|FG000|COMPLETED|Overall Study||19
9939573|NCT01345591|11057861|FG000|NOT COMPLETED|Overall Study||1
9939574|NCT01345630|11057872|FG000|STARTED|Overall Study||396
9939575|NCT01345630|11057873|FG001|STARTED|Overall Study||401
9939576|NCT01345630|11057872|FG000|COMPLETED|Overall Study||35
9939577|NCT01345630|11057873|FG001|COMPLETED|Overall Study||42
9939578|NCT01345630|11057872|FG000|NOT COMPLETED|Overall Study||361
9939579|NCT01345630|11057873|FG001|NOT COMPLETED|Overall Study||359
9939580|NCT01345669|11057885|FG000|STARTED|Overall Study||411
9939581|NCT01345669|11057886|FG001|STARTED|Overall Study||206
9939582|NCT01345669|11057885|FG000|COMPLETED|Overall Study||124
9939583|NCT01345669|11057886|FG001|COMPLETED|Overall Study||87
9939584|NCT01345669|11057885|FG000|NOT COMPLETED|Overall Study||287
9939585|NCT01345669|11057886|FG001|NOT COMPLETED|Overall Study||119
9939586|NCT01345682|11057894|FG000|STARTED|Overall Study|Randomised|322
9939587|NCT01345682|11057895|FG001|STARTED|Overall Study|Randomised|161
9939588|NCT01345682|11057894|FG000|COMPLETED|Overall Study||0
9939589|NCT01345682|11057895|FG001|COMPLETED|Overall Study||0
9939590|NCT01345682|11057894|FG000|NOT COMPLETED|Overall Study||322
9939591|NCT01345682|11057895|FG001|NOT COMPLETED|Overall Study||161
9939592|NCT01345721|11057904|FG000|STARTED|Overall Study||74
9939593|NCT01345721|11057905|FG001|STARTED|Overall Study||66
9939594|NCT01345721|11057906|FG002|STARTED|Overall Study||65
9939595|NCT01345721|11057904|FG000|COMPLETED|Overall Study||74
9939596|NCT01345721|11057905|FG001|COMPLETED|Overall Study||66
9939597|NCT01345721|11057906|FG002|COMPLETED|Overall Study||65
9939598|NCT01345721|11057904|FG000|NOT COMPLETED|Overall Study||0
9939599|NCT01345721|11057905|FG001|NOT COMPLETED|Overall Study||0
9939600|NCT01345721|11057906|FG002|NOT COMPLETED|Overall Study||0
9939601|NCT01345929|11057920|FG000|STARTED|Overall Study||533
9939602|NCT01345929|11057921|FG001|STARTED|Overall Study||535
9939603|NCT01345929|11057920|FG000|COMPLETED|Overall Study||512
9939604|NCT01345929|11057921|FG001|COMPLETED|Overall Study||516
9939605|NCT01345929|11057920|FG000|NOT COMPLETED|Overall Study||21
9939606|NCT01345929|11057921|FG001|NOT COMPLETED|Overall Study||19
9939607|NCT01346059|11057929|FG000|STARTED|Overall Study||1
9939608|NCT01346059|11057930|FG001|STARTED|Overall Study||1
9939609|NCT01346059|11057929|FG000|COMPLETED|Overall Study||0
9939610|NCT01346059|11057930|FG001|COMPLETED|Overall Study||1
9939611|NCT01346059|11057929|FG000|NOT COMPLETED|Overall Study||1
9939612|NCT01346059|11057930|FG001|NOT COMPLETED|Overall Study||0
9939613|NCT01346072|11057938|FG000|STARTED|Overall Study||11
9939614|NCT01346072|11057939|FG001|STARTED|Overall Study||10
9939615|NCT01346072|11057938|FG000|COMPLETED|Overall Study||11
9939616|NCT01346072|11057939|FG001|COMPLETED|Overall Study||10
9939617|NCT01346072|11057938|FG000|NOT COMPLETED|Overall Study||0
9939618|NCT01346072|11057939|FG001|NOT COMPLETED|Overall Study||0
9939619|NCT01346085|11057945|FG000|STARTED|Overall Study||10
9939620|NCT01346085|11057945|FG000|COMPLETED|Overall Study||10
9939621|NCT01346085|11057945|FG000|NOT COMPLETED|Overall Study||0
9939622|NCT01346176|11057952|FG000|STARTED|Recruited||49
9939623|NCT01346176|11057953|FG001|STARTED|Recruited||40
9939624|NCT01346176|11057954|FG002|STARTED|Recruited||43
9939625|NCT01346176|11057952|FG000|COMPLETED|Recruited||48
9939626|NCT01346176|11057953|FG001|COMPLETED|Recruited||40
9939627|NCT01346176|11057954|FG002|COMPLETED|Recruited||43
9939628|NCT01346176|11057952|FG000|NOT COMPLETED|Recruited||1
9939629|NCT01346176|11057953|FG001|NOT COMPLETED|Recruited||0
9939630|NCT01346176|11057954|FG002|NOT COMPLETED|Recruited||0
9939631|NCT01346176|11057952|FG000|STARTED|Completed Advance Directive||48
9939632|NCT01346176|11057953|FG001|STARTED|Completed Advance Directive||40
9939633|NCT01346176|11057954|FG002|STARTED|Completed Advance Directive||43
9939634|NCT01346176|11057952|FG000|COMPLETED|Completed Advance Directive||35
9939635|NCT01346176|11057953|FG001|COMPLETED|Completed Advance Directive||26
9939636|NCT01346176|11057954|FG002|COMPLETED|Completed Advance Directive||33
9939637|NCT01346176|11057952|FG000|NOT COMPLETED|Completed Advance Directive||13
9939638|NCT01346176|11057953|FG001|NOT COMPLETED|Completed Advance Directive||14
9939639|NCT01346176|11057954|FG002|NOT COMPLETED|Completed Advance Directive||10
9939640|NCT01346176|11057952|FG000|STARTED|Completed Satisfaction Survey||35
9939641|NCT01346176|11057953|FG001|STARTED|Completed Satisfaction Survey||26
9939642|NCT01346176|11057954|FG002|STARTED|Completed Satisfaction Survey||33
9939643|NCT01346176|11057952|FG000|COMPLETED|Completed Satisfaction Survey||29
9939644|NCT01346176|11057953|FG001|COMPLETED|Completed Satisfaction Survey||22
9939645|NCT01346176|11057954|FG002|COMPLETED|Completed Satisfaction Survey||27
9939646|NCT01346176|11057952|FG000|NOT COMPLETED|Completed Satisfaction Survey||6
9939647|NCT01346176|11057953|FG001|NOT COMPLETED|Completed Satisfaction Survey||4
9939648|NCT01346176|11057954|FG002|NOT COMPLETED|Completed Satisfaction Survey||6
9939649|NCT01346189|11057966|FG000|STARTED|Overall Study||433
9939650|NCT01346189|11057967|FG001|STARTED|Overall Study||358
9939651|NCT01346189|11057968|FG002|STARTED|Overall Study||346
9939652|NCT01346189|11057969|FG003|STARTED|Overall Study||366
9939653|NCT01346189|11057966|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
9939654|NCT01346189|11057967|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
9939655|NCT01346189|11057968|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
9939656|NCT01346189|11057969|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
9939657|NCT01346189|11057966|FG000|NOT COMPLETED|Overall Study||16
9939658|NCT01346189|11057967|FG001|NOT COMPLETED|Overall Study||17
9939659|NCT01346189|11057968|FG002|NOT COMPLETED|Overall Study||14
9939660|NCT01346189|11057969|FG003|NOT COMPLETED|Overall Study||11
9939661|NCT01346267|11057981|FG000|STARTED|Overall Study||93
9939662|NCT01346267|11057982|FG001|STARTED|Overall Study||94
9939663|NCT01346267|11057981|FG000|COMPLETED|Overall Study||70
9939664|NCT01346267|11057982|FG001|COMPLETED|Overall Study||67
9939665|NCT01346267|11057981|FG000|NOT COMPLETED|Overall Study||23
9939666|NCT01346267|11057982|FG001|NOT COMPLETED|Overall Study||27
9939667|NCT01346293|11057990|FG000|STARTED|Overall Study||2743
9939668|NCT01346293|11057991|FG001|STARTED|Overall Study||629
9939669|NCT01346293|11057990|FG000|COMPLETED|Overall Study||2676
9939670|NCT01346293|11057991|FG001|COMPLETED|Overall Study||608
9939671|NCT01346293|11057990|FG000|NOT COMPLETED|Overall Study||67
9939672|NCT01346293|11057991|FG001|NOT COMPLETED|Overall Study||21
9939673|NCT01346371|11058001|FG000|STARTED|Overall Study||20
9939674|NCT01346371|11058002|FG001|STARTED|Overall Study||20
9939675|NCT01346371|11058001|FG000|COMPLETED|Overall Study||18
9939676|NCT01346371|11058002|FG001|COMPLETED|Overall Study||20
9939677|NCT01346371|11058001|FG000|NOT COMPLETED|Overall Study||2
9939678|NCT01346371|11058002|FG001|NOT COMPLETED|Overall Study||0
9939679|NCT01346397|11058010|FG000|STARTED|Overall Study||85
9939680|NCT01346397|11058011|FG001|STARTED|Overall Study||85
9939681|NCT01346397|11058010|FG000|COMPLETED|Overall Study||85
9939682|NCT01346397|11058011|FG001|COMPLETED|Overall Study||85
9939683|NCT01346397|11058010|FG000|NOT COMPLETED|Overall Study||0
9939684|NCT01346397|11058011|FG001|NOT COMPLETED|Overall Study||0
9939685|NCT01346410|11058017|FG000|STARTED|Overall Study||1
9939686|NCT01346410|11058017|FG000|COMPLETED|Overall Study||0
9939687|NCT01346410|11058017|FG000|NOT COMPLETED|Overall Study||1
9939688|NCT01346475|11058023|FG000|STARTED|First Intervention||22
10207251|NCT03524157|11334069|FG000|STARTED|Overall Study||10
10207252|NCT03524157|11334070|FG001|STARTED|Overall Study||10
10207253|NCT03524157|11334071|FG002|STARTED|Overall Study||10
10207254|NCT03524157|11334069|FG000|COMPLETED|Overall Study||10
10207255|NCT03524157|11334070|FG001|COMPLETED|Overall Study||10
10207256|NCT03524157|11334071|FG002|COMPLETED|Overall Study||9
9939689|NCT01346475|11058024|FG001|STARTED|First Intervention||28
9939690|NCT01346475|11058023|FG000|COMPLETED|First Intervention||18
9939691|NCT01346475|11058024|FG001|COMPLETED|First Intervention||25
9939692|NCT01346475|11058023|FG000|NOT COMPLETED|First Intervention||4
9939693|NCT01346475|11058024|FG001|NOT COMPLETED|First Intervention||3
9939694|NCT01346475|11058023|FG000|STARTED|Second Intervention||18
9939695|NCT01346475|11058024|FG001|STARTED|Second Intervention||25
9939696|NCT01346475|11058023|FG000|COMPLETED|Second Intervention||18
9939697|NCT01346475|11058024|FG001|COMPLETED|Second Intervention||25
10207257|NCT03524157|11334069|FG000|NOT COMPLETED|Overall Study||0
9939698|NCT01346475|11058023|FG000|NOT COMPLETED|Second Intervention||0
9939699|NCT01346475|11058024|FG001|NOT COMPLETED|Second Intervention||0
9939700|NCT01346488|11058030|FG000|STARTED|Overall Study||1968
9939701|NCT01346488|11058030|FG000|COMPLETED|Overall Study||1262
9939702|NCT01346488|11058030|FG000|NOT COMPLETED|Overall Study||706
9939703|NCT01346501|11058036|FG000|STARTED|Overall Study||79
9939704|NCT01346501|11058037|FG001|STARTED|Overall Study||93
9939705|NCT01346501|11058036|FG000|COMPLETED|Overall Study||68
9939706|NCT01346501|11058037|FG001|COMPLETED|Overall Study||80
9939707|NCT01346501|11058036|FG000|NOT COMPLETED|Overall Study||11
9939708|NCT01346501|11058037|FG001|NOT COMPLETED|Overall Study||13
9939709|NCT01346514|11058047|FG000|STARTED|Overall Study||91
9939710|NCT01346514|11058048|FG001|STARTED|Overall Study||90
9939711|NCT01346514|11058047|FG000|3 Month Assessment|Overall Study||83
9939712|NCT01346514|11058048|FG001|3 Month Assessment|Overall Study||68
9939713|NCT01346514|11058047|FG000|6 Month Assessment|Overall Study||74
9939714|NCT01346514|11058048|FG001|6 Month Assessment|Overall Study||61
9939715|NCT01346514|11058047|FG000|9 Month Assessment|Overall Study||67
9939716|NCT01346514|11058048|FG001|9 Month Assessment|Overall Study||59
9939717|NCT01346514|11058047|FG000|12 Month Assessment|Overall Study||62
9939718|NCT01346514|11058048|FG001|12 Month Assessment|Overall Study||53
9939719|NCT01346514|11058047|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
9939720|NCT01346514|11058048|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
9939721|NCT01346514|11058047|FG000|NOT COMPLETED|Overall Study||29
9939722|NCT01346514|11058048|FG001|NOT COMPLETED|Overall Study||37
9939723|NCT01346540|11058058|FG000|STARTED|Overall Study||4
9939724|NCT01346540|11058059|FG001|STARTED|Overall Study||12
9939725|NCT01346540|11058058|FG000|COMPLETED|Overall Study||1
9939726|NCT01346540|11058059|FG001|COMPLETED|Overall Study||0
9939727|NCT01346540|11058058|FG000|NOT COMPLETED|Overall Study||3
9939728|NCT01346540|11058059|FG001|NOT COMPLETED|Overall Study||12
9939729|NCT01346592|11058069|FG000|STARTED|Overall Study||3136
9939730|NCT01346592|11058070|FG001|STARTED|Overall Study||1478
9939731|NCT01346592|11058071|FG002|STARTED|Overall Study||1486
9939732|NCT01346592|11058069|FG000|COMPLETED|Overall Study||2983
9939733|NCT01346592|11058070|FG001|COMPLETED|Overall Study||1389
9939734|NCT01346592|11058071|FG002|COMPLETED|Overall Study||1408
9939735|NCT01346592|11058069|FG000|NOT COMPLETED|Overall Study||153
9939736|NCT01346592|11058070|FG001|NOT COMPLETED|Overall Study||89
9939737|NCT01346592|11058071|FG002|NOT COMPLETED|Overall Study||78
9939738|NCT01346683|11058096|FG000|STARTED|Overall Study||45
9939739|NCT01346683|11058096|FG000|COMPLETED|Overall Study||45
9939740|NCT01346683|11058096|FG000|NOT COMPLETED|Overall Study||0
9939741|NCT01346696|11058100|FG000|STARTED|Overall Study||45
9939742|NCT01346696|11058100|FG000|COMPLETED|Overall Study||44
9939743|NCT01346696|11058100|FG000|NOT COMPLETED|Overall Study||1
9939744|NCT01346774|11058106|FG000|STARTED|Overall Study||80
9939745|NCT01346774|11058107|FG001|STARTED|Overall Study||80
9939746|NCT01346774|11058106|FG000|COMPLETED|Overall Study||67
9939747|NCT01346774|11058107|FG001|COMPLETED|Overall Study||63
9939748|NCT01346774|11058106|FG000|NOT COMPLETED|Overall Study||13
9939749|NCT01346774|11058107|FG001|NOT COMPLETED|Overall Study||17
9939750|NCT01346839|11058115|FG000|STARTED|Overall Study||683
9939751|NCT01346839|11058116|FG001|STARTED|Overall Study||573
9939752|NCT01346839|11058115|FG000|COMPLETED|Overall Study||369
9939753|NCT01346839|11058116|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
9939754|NCT01346839|11058115|FG000|NOT COMPLETED|Overall Study||314
9939755|NCT01346839|11058116|FG001|NOT COMPLETED|Overall Study||209
9939756|NCT01346852|11058124|FG000|STARTED|Overall Study||41753
9939757|NCT01346852|11058125|FG001|STARTED|Overall Study||59684
9939758|NCT01346852|11058124|FG000|COMPLETED|Overall Study||41753
9939759|NCT01346852|11058125|FG001|COMPLETED|Overall Study||59684
9939760|NCT01346852|11058124|FG000|NOT COMPLETED|Overall Study||0
9939761|NCT01346852|11058125|FG001|NOT COMPLETED|Overall Study||0
9939762|NCT01346969|11058135|FG000|STARTED|Overall Study||28
9939763|NCT01346969|11058136|FG001|STARTED|Overall Study||14
9939764|NCT01346969|11058137|FG002|STARTED|Overall Study||13
9939765|NCT01346969|11058138|FG003|STARTED|Overall Study||13
9939766|NCT01346969|11058135|FG000|Safety Population|Overall Study||27
9939767|NCT01346969|11058136|FG001|Safety Population|Overall Study||14
9939768|NCT01346969|11058137|FG002|Safety Population|Overall Study||13
9939769|NCT01346969|11058138|FG003|Safety Population|Overall Study||13
9939770|NCT01346969|11058135|FG000|COMPLETED|Overall Study||26
9939771|NCT01346969|11058136|FG001|COMPLETED|Overall Study||14
9939772|NCT01346969|11058137|FG002|COMPLETED|Overall Study||10
9939773|NCT01346969|11058138|FG003|COMPLETED|Overall Study||12
9939774|NCT01346969|11058135|FG000|NOT COMPLETED|Overall Study||2
9939775|NCT01346969|11058136|FG001|NOT COMPLETED|Overall Study||0
9939776|NCT01346969|11058137|FG002|NOT COMPLETED|Overall Study||3
9939777|NCT01346969|11058138|FG003|NOT COMPLETED|Overall Study||1
9939778|NCT01347008|11058150|FG000|STARTED|Overall Study||21
9939779|NCT01347008|11058151|FG001|STARTED|Overall Study||20
9939780|NCT01347008|11058150|FG000|COMPLETED|Overall Study||21
9939781|NCT01347008|11058151|FG001|COMPLETED|Overall Study||20
9939782|NCT01347008|11058150|FG000|NOT COMPLETED|Overall Study||0
9939783|NCT01347008|11058151|FG001|NOT COMPLETED|Overall Study||0
9939784|NCT01347034|11058159|FG000|STARTED|Overall Study||6
9939785|NCT01347034|11058160|FG001|STARTED|Overall Study||14
9939786|NCT01347034|11058159|FG000|COMPLETED|Overall Study||6
9939787|NCT01347034|11058160|FG001|COMPLETED|Overall Study||14
9939788|NCT01347034|11058159|FG000|NOT COMPLETED|Overall Study||0
9939789|NCT01347034|11058160|FG001|NOT COMPLETED|Overall Study||0
9939790|NCT01347060|11058168|FG000|STARTED|Overall Study||9868
9939791|NCT01347060|11058169|FG001|STARTED|Overall Study||7580
9939792|NCT01347060|11058168|FG000|COMPLETED|Overall Study||9868
9939793|NCT01347060|11058169|FG001|COMPLETED|Overall Study||7580
9939794|NCT01347060|11058168|FG000|NOT COMPLETED|Overall Study||0
9939795|NCT01347060|11058169|FG001|NOT COMPLETED|Overall Study||0
9939796|NCT01347073|11058175|FG000|STARTED|Overall Study||23
9939797|NCT01347073|11058175|FG000|COMPLETED|Overall Study||21
9939798|NCT01347073|11058175|FG000|NOT COMPLETED|Overall Study||2
9939799|NCT01347086|11058195|FG000|STARTED|Overall Study||2
9939800|NCT01347086|11058196|FG001|STARTED|Overall Study||6
9939801|NCT01347086|11058197|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
9939802|NCT01347086|11058198|FG003|STARTED|Overall Study||6
9939803|NCT01347086|11058199|FG004|STARTED|Overall Study||6
9939804|NCT01347086|11058200|FG005|STARTED|Overall Study||6
9939805|NCT01347086|11058201|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
9939806|NCT01347086|11058202|FG007|STARTED|Overall Study|One subject was not treated.|7
9939807|NCT01347086|11058203|FG008|STARTED|Overall Study||6
9939808|NCT01347086|11058204|FG009|STARTED|Overall Study|One subject was not treated.|7
9939809|NCT01347086|11058195|FG000|COMPLETED|Overall Study||2
9939810|NCT01347086|11058196|FG001|COMPLETED|Overall Study||6
9939811|NCT01347086|11058197|FG002|COMPLETED|Overall Study||6
9939812|NCT01347086|11058198|FG003|COMPLETED|Overall Study||6
9939813|NCT01347086|11058199|FG004|COMPLETED|Overall Study||6
9939814|NCT01347086|11058200|FG005|COMPLETED|Overall Study||6
9939815|NCT01347086|11058201|FG006|COMPLETED|Overall Study||6
9939816|NCT01347086|11058202|FG007|COMPLETED|Overall Study||6
9939817|NCT01347086|11058203|FG008|COMPLETED|Overall Study||6
9939818|NCT01347086|11058204|FG009|COMPLETED|Overall Study||6
9939819|NCT01347086|11058195|FG000|NOT COMPLETED|Overall Study||0
9939820|NCT01347086|11058196|FG001|NOT COMPLETED|Overall Study||0
9939821|NCT01347086|11058197|FG002|NOT COMPLETED|Overall Study||1
9939822|NCT01347086|11058198|FG003|NOT COMPLETED|Overall Study||0
9939823|NCT01347086|11058199|FG004|NOT COMPLETED|Overall Study||0
9939824|NCT01347086|11058200|FG005|NOT COMPLETED|Overall Study||0
9939825|NCT01347086|11058201|FG006|NOT COMPLETED|Overall Study||1
9939826|NCT01347086|11058202|FG007|NOT COMPLETED|Overall Study||1
9939827|NCT01347086|11058203|FG008|NOT COMPLETED|Overall Study||0
9939828|NCT01347086|11058204|FG009|NOT COMPLETED|Overall Study||1
9939829|NCT01347112|11058238|FG000|STARTED|Overall Study||16
9939830|NCT01347112|11058239|FG001|STARTED|Overall Study||17
9939831|NCT01347112|11058238|FG000|COMPLETED|Overall Study||12
9939832|NCT01347112|11058239|FG001|COMPLETED|Overall Study||5
9939833|NCT01347112|11058238|FG000|NOT COMPLETED|Overall Study||4
9939834|NCT01347112|11058239|FG001|NOT COMPLETED|Overall Study||12
9939835|NCT01347255|11058246|FG000|STARTED|Overall Study||24
9939836|NCT01347255|11058246|FG000|COMPLETED|Overall Study||24
9939837|NCT01347255|11058246|FG000|NOT COMPLETED|Overall Study||0
9939838|NCT01347307|11058255|FG000|STARTED|Overall Study||3
9939839|NCT01347307|11058256|FG001|STARTED|Overall Study||33
9939840|NCT01347307|11058255|FG000|COMPLETED|Overall Study||3
9939841|NCT01347307|11058256|FG001|COMPLETED|Overall Study||28
9939842|NCT01347307|11058255|FG000|NOT COMPLETED|Overall Study||0
9939843|NCT01347307|11058256|FG001|NOT COMPLETED|Overall Study||5
9939844|NCT01347333|11058264|FG000|STARTED|Overall Study||23
9939845|NCT01347333|11058265|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
9939846|NCT01347333|11058264|FG000|COMPLETED|Overall Study||23
9939847|NCT01347333|11058265|FG001|COMPLETED|Overall Study||0
9939848|NCT01347333|11058264|FG000|NOT COMPLETED|Overall Study||0
9939849|NCT01347333|11058265|FG001|NOT COMPLETED|Overall Study||0
9939850|NCT01347541|11058273|FG000|STARTED|Overall Study||3
9939851|NCT01347541|11058274|FG001|STARTED|Overall Study||1
9939852|NCT01347541|11058273|FG000|COMPLETED|Overall Study||3
9939853|NCT01347541|11058274|FG001|COMPLETED|Overall Study||1
9939854|NCT01347541|11058273|FG000|NOT COMPLETED|Overall Study||0
9939855|NCT01347541|11058274|FG001|NOT COMPLETED|Overall Study||0
9939856|NCT01347554|11058282|FG000|STARTED|Overall Study||237
9939857|NCT01347554|11058283|FG001|STARTED|Overall Study||242
9939858|NCT01347554|11058282|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
9939859|NCT01347554|11058283|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
9939860|NCT01347554|11058282|FG000|NOT COMPLETED|Overall Study||7
9939861|NCT01347554|11058283|FG001|NOT COMPLETED|Overall Study||11
9939862|NCT01347580|11058291|FG000|STARTED|Overall Study|based on randomized treatment|909
9939863|NCT01347580|11058292|FG001|STARTED|Overall Study|based on randomized treatment|953
9939864|NCT01347580|11058291|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
9939865|NCT01347580|11058292|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
9939866|NCT01347580|11058291|FG000|Safety Population|Overall Study|based on actual treatment|908
9939867|NCT01347580|11058292|FG001|Safety Population|Overall Study|based on actual treatment|950
9939868|NCT01347580|11058291|FG000|COMPLETED|Overall Study|based on randomized treatment|844
9939869|NCT01347580|11058292|FG001|COMPLETED|Overall Study|based on randomized treatment|897
9939870|NCT01347580|11058291|FG000|NOT COMPLETED|Overall Study||65
9939871|NCT01347580|11058292|FG001|NOT COMPLETED|Overall Study||56
9939872|NCT01347710|11058298|FG000|STARTED|Overall Study||795
9939873|NCT01347710|11058298|FG000|COMPLETED|Overall Study||764
9939874|NCT01347710|11058298|FG000|NOT COMPLETED|Overall Study||31
9939875|NCT01347762|11058310|FG000|STARTED|Overall Study||10
9939876|NCT01347762|11058311|FG001|STARTED|Overall Study||8
9939877|NCT01347762|11058312|FG002|STARTED|Overall Study||16
9939878|NCT01347762|11058313|FG003|STARTED|Overall Study||18
9939879|NCT01347762|11058310|FG000|COMPLETED|Overall Study||6
9939880|NCT01347762|11058311|FG001|COMPLETED|Overall Study||6
9939881|NCT01347762|11058312|FG002|COMPLETED|Overall Study||7
9939882|NCT01347762|11058313|FG003|COMPLETED|Overall Study||10
9939883|NCT01347762|11058310|FG000|NOT COMPLETED|Overall Study||4
9939884|NCT01347762|11058311|FG001|NOT COMPLETED|Overall Study||2
9939885|NCT01347762|11058312|FG002|NOT COMPLETED|Overall Study||9
9939886|NCT01347762|11058313|FG003|NOT COMPLETED|Overall Study||8
9939887|NCT01347788|11058323|FG000|STARTED|Overall Study||11
9939888|NCT01347788|11058324|FG001|STARTED|Overall Study||10
9939889|NCT01347788|11058325|FG002|STARTED|Overall Study||13
9939890|NCT01347788|11058323|FG000|COMPLETED|Overall Study||11
9939891|NCT01347788|11058324|FG001|COMPLETED|Overall Study||10
9939892|NCT01347788|11058325|FG002|COMPLETED|Overall Study||13
9939893|NCT01347788|11058323|FG000|NOT COMPLETED|Overall Study||0
9939894|NCT01347788|11058324|FG001|NOT COMPLETED|Overall Study||0
9939895|NCT01347788|11058325|FG002|NOT COMPLETED|Overall Study||0
9939896|NCT01347866|11058350|FG000|STARTED|Overall Study||5
9939897|NCT01347866|11058351|FG001|STARTED|Overall Study||1
9939898|NCT01347866|11058352|FG002|STARTED|Overall Study||1
9939899|NCT01347866|11058353|FG003|STARTED|Overall Study||7
9939900|NCT01347866|11058354|FG004|STARTED|Overall Study||7
9939901|NCT01347866|11058355|FG005|STARTED|Overall Study||3
9939902|NCT01347866|11058356|FG006|STARTED|Overall Study||6
9939903|NCT01347866|11058357|FG007|STARTED|Overall Study||4
9939904|NCT01347866|11058358|FG008|STARTED|Overall Study||31
9939905|NCT01347866|11058359|FG009|STARTED|Overall Study||7
9939906|NCT01347866|11058360|FG010|STARTED|Overall Study||3
9939907|NCT01347866|11058361|FG011|STARTED|Overall Study||4
9939908|NCT01347866|11058362|FG012|STARTED|Overall Study||7
9939909|NCT01347866|11058363|FG013|STARTED|Overall Study||7
9939910|NCT01347866|11058364|FG014|STARTED|Overall Study||3
9939911|NCT01347866|11058365|FG015|STARTED|Overall Study||4
9939912|NCT01347866|11058366|FG016|STARTED|Overall Study||2
9939913|NCT01347866|11058350|FG000|COMPLETED|Overall Study||0
9939914|NCT01347866|11058351|FG001|COMPLETED|Overall Study||0
9939915|NCT01347866|11058352|FG002|COMPLETED|Overall Study||0
9939916|NCT01347866|11058353|FG003|COMPLETED|Overall Study||0
9939917|NCT01347866|11058354|FG004|COMPLETED|Overall Study||0
9939918|NCT01347866|11058355|FG005|COMPLETED|Overall Study||0
9939919|NCT01347866|11058356|FG006|COMPLETED|Overall Study||0
9939920|NCT01347866|11058357|FG007|COMPLETED|Overall Study||0
9939921|NCT01347866|11058358|FG008|COMPLETED|Overall Study||0
9939922|NCT01347866|11058359|FG009|COMPLETED|Overall Study||0
9939923|NCT01347866|11058360|FG010|COMPLETED|Overall Study||0
9939924|NCT01347866|11058361|FG011|COMPLETED|Overall Study||0
9939925|NCT01347866|11058362|FG012|COMPLETED|Overall Study||0
9939926|NCT01347866|11058363|FG013|COMPLETED|Overall Study||0
9939927|NCT01347866|11058364|FG014|COMPLETED|Overall Study||0
9939928|NCT01347866|11058365|FG015|COMPLETED|Overall Study||0
9939929|NCT01347866|11058366|FG016|COMPLETED|Overall Study||0
9939930|NCT01347866|11058350|FG000|NOT COMPLETED|Overall Study||5
9939931|NCT01347866|11058351|FG001|NOT COMPLETED|Overall Study||1
9939932|NCT01347866|11058352|FG002|NOT COMPLETED|Overall Study||1
9939933|NCT01347866|11058353|FG003|NOT COMPLETED|Overall Study||7
9939934|NCT01347866|11058354|FG004|NOT COMPLETED|Overall Study||7
9939935|NCT01347866|11058355|FG005|NOT COMPLETED|Overall Study||3
9939936|NCT01347866|11058356|FG006|NOT COMPLETED|Overall Study||6
9939937|NCT01347866|11058357|FG007|NOT COMPLETED|Overall Study||4
9939938|NCT01347866|11058358|FG008|NOT COMPLETED|Overall Study||31
9939939|NCT01347866|11058359|FG009|NOT COMPLETED|Overall Study||7
9939940|NCT01347866|11058360|FG010|NOT COMPLETED|Overall Study||3
9939941|NCT01347866|11058361|FG011|NOT COMPLETED|Overall Study||4
9939942|NCT01347866|11058362|FG012|NOT COMPLETED|Overall Study||7
9939943|NCT01347866|11058363|FG013|NOT COMPLETED|Overall Study||7
9939944|NCT01347866|11058364|FG014|NOT COMPLETED|Overall Study||3
9939945|NCT01347866|11058365|FG015|NOT COMPLETED|Overall Study||4
9939946|NCT01347866|11058366|FG016|NOT COMPLETED|Overall Study||2
9939947|NCT01347879|11058439|FG000|STARTED|Overall Study||53
9939948|NCT01347879|11058440|FG001|STARTED|Overall Study||100
9939949|NCT01347879|11058439|FG000|COMPLETED|Overall Study||46
9939950|NCT01347879|11058440|FG001|COMPLETED|Overall Study||83
9939951|NCT01347879|11058439|FG000|NOT COMPLETED|Overall Study||7
9939952|NCT01347879|11058440|FG001|NOT COMPLETED|Overall Study||17
9939953|NCT01347931|11058446|FG000|STARTED|Standard Oxygen Therapy||30
9939954|NCT01347931|11058446|FG000|COMPLETED|Standard Oxygen Therapy||29
9939955|NCT01347931|11058446|FG000|NOT COMPLETED|Standard Oxygen Therapy||1
9939956|NCT01347931|11058446|FG000|STARTED|NIOV System||29
9939957|NCT01347931|11058446|FG000|COMPLETED|NIOV System||29
9939958|NCT01347931|11058446|FG000|NOT COMPLETED|NIOV System||0
9939959|NCT01348087|11058452|FG000|STARTED|Overall Study||148
9939960|NCT01348087|11058452|FG000|COMPLETED|Overall Study||0
9939961|NCT01348087|11058452|FG000|NOT COMPLETED|Overall Study||148
9939962|NCT01348100|11058473|FG000|STARTED|Overall Study||2
9939963|NCT01348100|11058474|FG001|STARTED|Overall Study||2
9939964|NCT01348100|11058475|FG002|STARTED|Overall Study||15
9939965|NCT01348100|11058476|FG003|STARTED|Overall Study||15
9939966|NCT01348100|11058477|FG004|STARTED|Overall Study||15
9939967|NCT01348100|11058478|FG005|STARTED|Overall Study||16
9939968|NCT01348100|11058479|FG006|STARTED|Overall Study||16
9939969|NCT01348100|11058473|FG000|COMPLETED|Overall Study||2
9939970|NCT01348100|11058474|FG001|COMPLETED|Overall Study||2
9939971|NCT01348100|11058475|FG002|COMPLETED|Overall Study||13
9939972|NCT01348100|11058476|FG003|COMPLETED|Overall Study||14
9939973|NCT01348100|11058477|FG004|COMPLETED|Overall Study||14
9939974|NCT01348100|11058478|FG005|COMPLETED|Overall Study||14
9939975|NCT01348100|11058479|FG006|COMPLETED|Overall Study||13
9939976|NCT01348100|11058473|FG000|NOT COMPLETED|Overall Study||0
9939977|NCT01348100|11058474|FG001|NOT COMPLETED|Overall Study||0
9939978|NCT01348100|11058475|FG002|NOT COMPLETED|Overall Study||2
9939979|NCT01348100|11058476|FG003|NOT COMPLETED|Overall Study||1
9939980|NCT01348100|11058477|FG004|NOT COMPLETED|Overall Study||1
9939981|NCT01348100|11058478|FG005|NOT COMPLETED|Overall Study||2
9939982|NCT01348100|11058479|FG006|NOT COMPLETED|Overall Study||3
9939983|NCT01348139|11058500|FG000|STARTED|Period 1||5
9939984|NCT01348139|11058501|FG001|STARTED|Period 1||4
9939985|NCT01348139|11058502|FG002|STARTED|Period 1||4
9939986|NCT01348139|11058503|FG003|STARTED|Period 1||4
9939987|NCT01348139|11058504|FG004|STARTED|Period 1||5
9939988|NCT01348139|11058505|FG005|STARTED|Period 1||4
9939989|NCT01348139|11058500|FG000|COMPLETED|Period 1||4
9939990|NCT01348139|11058501|FG001|COMPLETED|Period 1||4
9939991|NCT01348139|11058502|FG002|COMPLETED|Period 1||4
9939992|NCT01348139|11058503|FG003|COMPLETED|Period 1||4
9939993|NCT01348139|11058504|FG004|COMPLETED|Period 1||5
9939994|NCT01348139|11058505|FG005|COMPLETED|Period 1||4
9939995|NCT01348139|11058500|FG000|NOT COMPLETED|Period 1||1
9939996|NCT01348139|11058501|FG001|NOT COMPLETED|Period 1||0
9939997|NCT01348139|11058502|FG002|NOT COMPLETED|Period 1||0
9939998|NCT01348139|11058503|FG003|NOT COMPLETED|Period 1||0
9939999|NCT01348139|11058504|FG004|NOT COMPLETED|Period 1||0
9940000|NCT01348139|11058505|FG005|NOT COMPLETED|Period 1||0
9940001|NCT01348139|11058500|FG000|STARTED|Period 2||4
9940002|NCT01348139|11058501|FG001|STARTED|Period 2||4
9940003|NCT01348139|11058502|FG002|STARTED|Period 2||4
9940004|NCT01348139|11058503|FG003|STARTED|Period 2||4
9940005|NCT01348139|11058504|FG004|STARTED|Period 2||5
9940006|NCT01348139|11058505|FG005|STARTED|Period 2||4
9940007|NCT01348139|11058500|FG000|COMPLETED|Period 2||4
9940008|NCT01348139|11058501|FG001|COMPLETED|Period 2||4
9940009|NCT01348139|11058502|FG002|COMPLETED|Period 2||4
9940010|NCT01348139|11058503|FG003|COMPLETED|Period 2||4
9940011|NCT01348139|11058504|FG004|COMPLETED|Period 2||5
9940012|NCT01348139|11058505|FG005|COMPLETED|Period 2||4
9940013|NCT01348139|11058500|FG000|NOT COMPLETED|Period 2||0
9940014|NCT01348139|11058501|FG001|NOT COMPLETED|Period 2||0
9940015|NCT01348139|11058502|FG002|NOT COMPLETED|Period 2||0
9940016|NCT01348139|11058503|FG003|NOT COMPLETED|Period 2||0
9940017|NCT01348139|11058504|FG004|NOT COMPLETED|Period 2||0
9940018|NCT01348139|11058505|FG005|NOT COMPLETED|Period 2||0
9940019|NCT01348139|11058500|FG000|STARTED|Period 3||4
9940020|NCT01348139|11058501|FG001|STARTED|Period 3||4
9940021|NCT01348139|11058502|FG002|STARTED|Period 3||4
9940022|NCT01348139|11058503|FG003|STARTED|Period 3||4
9940023|NCT01348139|11058504|FG004|STARTED|Period 3||5
9940024|NCT01348139|11058505|FG005|STARTED|Period 3||4
9940025|NCT01348139|11058500|FG000|COMPLETED|Period 3||4
9940026|NCT01348139|11058501|FG001|COMPLETED|Period 3||4
9940027|NCT01348139|11058502|FG002|COMPLETED|Period 3||4
9940028|NCT01348139|11058503|FG003|COMPLETED|Period 3||4
9940029|NCT01348139|11058504|FG004|COMPLETED|Period 3||5
9940030|NCT01348139|11058505|FG005|COMPLETED|Period 3||4
9940031|NCT01348139|11058500|FG000|NOT COMPLETED|Period 3||0
9940032|NCT01348139|11058501|FG001|NOT COMPLETED|Period 3||0
9940033|NCT01348139|11058502|FG002|NOT COMPLETED|Period 3||0
9940034|NCT01348139|11058503|FG003|NOT COMPLETED|Period 3||0
9940035|NCT01348139|11058504|FG004|NOT COMPLETED|Period 3||0
9940036|NCT01348139|11058505|FG005|NOT COMPLETED|Period 3||0
9940037|NCT01348139|11058500|FG000|STARTED|Period 4||4
9940038|NCT01348139|11058501|FG001|STARTED|Period 4||4
9940039|NCT01348139|11058502|FG002|STARTED|Period 4||4
9940040|NCT01348139|11058503|FG003|STARTED|Period 4||4
9940041|NCT01348139|11058504|FG004|STARTED|Period 4||5
9940042|NCT01348139|11058505|FG005|STARTED|Period 4||4
9940043|NCT01348139|11058500|FG000|COMPLETED|Period 4||4
9940044|NCT01348139|11058501|FG001|COMPLETED|Period 4||4
9940045|NCT01348139|11058502|FG002|COMPLETED|Period 4||4
9940046|NCT01348139|11058503|FG003|COMPLETED|Period 4||4
9940047|NCT01348139|11058504|FG004|COMPLETED|Period 4||5
9940048|NCT01348139|11058505|FG005|COMPLETED|Period 4||4
9940049|NCT01348139|11058500|FG000|NOT COMPLETED|Period 4||0
9940050|NCT01348139|11058501|FG001|NOT COMPLETED|Period 4||0
9940051|NCT01348139|11058502|FG002|NOT COMPLETED|Period 4||0
9940052|NCT01348139|11058503|FG003|NOT COMPLETED|Period 4||0
9940053|NCT01348139|11058504|FG004|NOT COMPLETED|Period 4||0
9940054|NCT01348139|11058505|FG005|NOT COMPLETED|Period 4||0
9940055|NCT01348139|11058500|FG000|STARTED|Period 5||4
9940056|NCT01348139|11058501|FG001|STARTED|Period 5||4
9940057|NCT01348139|11058502|FG002|STARTED|Period 5||4
9940058|NCT01348139|11058503|FG003|STARTED|Period 5||4
9940059|NCT01348139|11058504|FG004|STARTED|Period 5||5
9940060|NCT01348139|11058505|FG005|STARTED|Period 5||4
9940061|NCT01348139|11058500|FG000|COMPLETED|Period 5||4
9940062|NCT01348139|11058501|FG001|COMPLETED|Period 5||4
9940063|NCT01348139|11058502|FG002|COMPLETED|Period 5||4
9940064|NCT01348139|11058503|FG003|COMPLETED|Period 5||4
9940065|NCT01348139|11058504|FG004|COMPLETED|Period 5||5
9940066|NCT01348139|11058505|FG005|COMPLETED|Period 5||4
9940067|NCT01348139|11058500|FG000|NOT COMPLETED|Period 5||0
9940068|NCT01348139|11058501|FG001|NOT COMPLETED|Period 5||0
9940069|NCT01348139|11058502|FG002|NOT COMPLETED|Period 5||0
9940070|NCT01348139|11058503|FG003|NOT COMPLETED|Period 5||0
9940071|NCT01348139|11058504|FG004|NOT COMPLETED|Period 5||0
9940072|NCT01348139|11058505|FG005|NOT COMPLETED|Period 5||0
9940073|NCT01348139|11058500|FG000|STARTED|Period 6||4
9940074|NCT01348139|11058501|FG001|STARTED|Period 6||4
9940075|NCT01348139|11058502|FG002|STARTED|Period 6||4
9940076|NCT01348139|11058503|FG003|STARTED|Period 6||4
9940077|NCT01348139|11058504|FG004|STARTED|Period 6||5
9940078|NCT01348139|11058505|FG005|STARTED|Period 6||4
9940079|NCT01348139|11058500|FG000|COMPLETED|Period 6||4
9940080|NCT01348139|11058501|FG001|COMPLETED|Period 6||4
9940081|NCT01348139|11058502|FG002|COMPLETED|Period 6||4
9940082|NCT01348139|11058503|FG003|COMPLETED|Period 6||4
9940083|NCT01348139|11058504|FG004|COMPLETED|Period 6||5
9940084|NCT01348139|11058505|FG005|COMPLETED|Period 6||4
9940085|NCT01348139|11058500|FG000|NOT COMPLETED|Period 6||0
9940086|NCT01348139|11058501|FG001|NOT COMPLETED|Period 6||0
9940087|NCT01348139|11058502|FG002|NOT COMPLETED|Period 6||0
9940088|NCT01348139|11058503|FG003|NOT COMPLETED|Period 6||0
9940089|NCT01348139|11058504|FG004|NOT COMPLETED|Period 6||0
9940090|NCT01348139|11058505|FG005|NOT COMPLETED|Period 6||0
9940091|NCT01348165|11058526|FG000|STARTED|Overall Study||10
9940092|NCT01348165|11058527|FG001|STARTED|Overall Study||5
9940093|NCT01348165|11058528|FG002|STARTED|Overall Study||6
9940094|NCT01348165|11058529|FG003|STARTED|Overall Study||6
9940095|NCT01348165|11058530|FG004|STARTED|Overall Study||6
9940096|NCT01348165|11058531|FG005|STARTED|Overall Study||1
9940097|NCT01348165|11058532|FG006|STARTED|Overall Study||6
9940098|NCT01348165|11058526|FG000|COMPLETED|Overall Study||10
9940099|NCT01348165|11058527|FG001|COMPLETED|Overall Study||5
9940100|NCT01348165|11058528|FG002|COMPLETED|Overall Study||6
9940101|NCT01348165|11058529|FG003|COMPLETED|Overall Study||6
9940102|NCT01348165|11058530|FG004|COMPLETED|Overall Study||6
9940103|NCT01348165|11058531|FG005|COMPLETED|Overall Study||1
9940104|NCT01348165|11058532|FG006|COMPLETED|Overall Study||5
9940105|NCT01348165|11058526|FG000|NOT COMPLETED|Overall Study||0
9940106|NCT01348165|11058527|FG001|NOT COMPLETED|Overall Study||0
9940107|NCT01348165|11058528|FG002|NOT COMPLETED|Overall Study||0
9940108|NCT01348165|11058529|FG003|NOT COMPLETED|Overall Study||0
9940109|NCT01348165|11058530|FG004|NOT COMPLETED|Overall Study||0
9940110|NCT01348165|11058531|FG005|NOT COMPLETED|Overall Study||0
9940111|NCT01348165|11058532|FG006|NOT COMPLETED|Overall Study||1
9940112|NCT01348347|11058555|FG000|STARTED|Overall Study||3
9940113|NCT01348347|11058556|FG001|STARTED|Overall Study||6
9940114|NCT01348347|11058557|FG002|STARTED|Overall Study||6
9940115|NCT01348347|11058555|FG000|COMPLETED|Overall Study||0
9940116|NCT01348347|11058556|FG001|COMPLETED|Overall Study||0
9940117|NCT01348347|11058557|FG002|COMPLETED|Overall Study||0
9940118|NCT01348347|11058555|FG000|NOT COMPLETED|Overall Study||3
9940119|NCT01348347|11058556|FG001|NOT COMPLETED|Overall Study||6
9940120|NCT01348347|11058557|FG002|NOT COMPLETED|Overall Study||6
9940121|NCT01348425|11058568|FG000|STARTED|Overall Study||31
9940122|NCT01348425|11058569|FG001|STARTED|Overall Study||14
9940123|NCT01348425|11058568|FG000|COMPLETED|Overall Study||30
9940124|NCT01348425|11058569|FG001|COMPLETED|Overall Study||13
9940125|NCT01348425|11058568|FG000|NOT COMPLETED|Overall Study||1
9940126|NCT01348425|11058569|FG001|NOT COMPLETED|Overall Study||1
9940127|NCT01348490|11058574|FG000|STARTED|Overall Study||66
9940128|NCT01348490|11058574|FG000|COMPLETED|Overall Study||42
9940129|NCT01348490|11058574|FG000|NOT COMPLETED|Overall Study||24
9940130|NCT01348542|11058597|FG000|STARTED|Overall Study||13
9940131|NCT01348542|11058598|FG001|STARTED|Overall Study||11
9940132|NCT01348542|11058597|FG000|COMPLETED|Overall Study||10
9940133|NCT01348542|11058598|FG001|COMPLETED|Overall Study||11
9940134|NCT01348542|11058597|FG000|NOT COMPLETED|Overall Study||3
9940135|NCT01348542|11058598|FG001|NOT COMPLETED|Overall Study||0
9940136|NCT01348607|11058607|FG000|STARTED|Overall Study||1
9940137|NCT01348607|11058608|FG001|STARTED|Overall Study||0
9940138|NCT01348607|11058609|FG002|STARTED|Overall Study||0
9940139|NCT01348607|11058607|FG000|COMPLETED|Overall Study||1
9940140|NCT01348607|11058608|FG001|COMPLETED|Overall Study||0
9940141|NCT01348607|11058609|FG002|COMPLETED|Overall Study||0
9940142|NCT01348607|11058607|FG000|NOT COMPLETED|Overall Study||0
9940143|NCT01348607|11058608|FG001|NOT COMPLETED|Overall Study||0
9940144|NCT01348607|11058609|FG002|NOT COMPLETED|Overall Study||0
9940145|NCT01348698|11058617|FG000|STARTED|Overall Study||74
9940146|NCT01348698|11058617|FG000|COMPLETED|Overall Study||2
9940147|NCT01348698|11058617|FG000|NOT COMPLETED|Overall Study||72
9940148|NCT01348763|11058621|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
9940149|NCT01348763|11058621|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
9940150|NCT01348763|11058621|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
9940151|NCT01348763|11058621|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
9940152|NCT01348763|11058621|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
9940153|NCT01348763|11058621|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
9940154|NCT01348776|11058625|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
9940155|NCT01348776|11058625|FG000|COMPLETED|Overall Study||84
9940156|NCT01348776|11058625|FG000|NOT COMPLETED|Overall Study||3
9940157|NCT01348789|11058638|FG000|STARTED|Overall Study||37
9940158|NCT01348789|11058638|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
9940159|NCT01348789|11058638|FG000|NOT COMPLETED|Overall Study||4
9940160|NCT01348828|11058649|FG000|STARTED|Overall Study||49
9940161|NCT01348828|11058649|FG000|COMPLETED|Overall Study||16
9940162|NCT01348828|11058649|FG000|NOT COMPLETED|Overall Study||33
9940163|NCT01348854|11058655|FG000|STARTED|Overall Study|53 eyes of 34 participants|34
9940164|NCT01348854|11058656|FG001|STARTED|Overall Study|10 eyes of 6 participants|6
9940165|NCT01348854|11058655|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31
9940166|NCT01348854|11058656|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5
9940167|NCT01348854|11058655|FG000|NOT COMPLETED|Overall Study||3
9940168|NCT01348854|11058656|FG001|NOT COMPLETED|Overall Study||1
9940169|NCT01349036|11058664|FG000|STARTED|Overall Study||14
9940170|NCT01349036|11058665|FG001|STARTED|Overall Study||24
9940171|NCT01349036|11058664|FG000|COMPLETED|Overall Study||0
9940172|NCT01349036|11058665|FG001|COMPLETED|Overall Study||0
9940173|NCT01349036|11058664|FG000|NOT COMPLETED|Overall Study||14
9940174|NCT01349036|11058665|FG001|NOT COMPLETED|Overall Study||24
9940175|NCT01349049|11058684|FG000|STARTED|Overall Study||3
9940176|NCT01349049|11058685|FG001|STARTED|Overall Study||7
9940177|NCT01349049|11058686|FG002|STARTED|Overall Study||3
9940178|NCT01349049|11058687|FG003|STARTED|Overall Study||3
9940179|NCT01349049|11058688|FG004|STARTED|Overall Study||3
9940180|NCT01349049|11058689|FG005|STARTED|Overall Study||6
9940181|NCT01349049|11058690|FG006|STARTED|Overall Study||5
9940182|NCT01349049|11058691|FG007|STARTED|Overall Study||4
9940183|NCT01349049|11058692|FG008|STARTED|Overall Study||56
9940184|NCT01349049|11058684|FG000|COMPLETED|Overall Study||0
9940185|NCT01349049|11058685|FG001|COMPLETED|Overall Study||0
9940186|NCT01349049|11058686|FG002|COMPLETED|Overall Study||0
9940187|NCT01349049|11058687|FG003|COMPLETED|Overall Study||0
9940188|NCT01349049|11058688|FG004|COMPLETED|Overall Study||0
9940189|NCT01349049|11058689|FG005|COMPLETED|Overall Study||0
9940190|NCT01349049|11058690|FG006|COMPLETED|Overall Study||0
9940191|NCT01349049|11058691|FG007|COMPLETED|Overall Study||0
9940192|NCT01349049|11058692|FG008|COMPLETED|Overall Study||1
9940193|NCT01349049|11058684|FG000|NOT COMPLETED|Overall Study||3
9940194|NCT01349049|11058685|FG001|NOT COMPLETED|Overall Study||7
9940195|NCT01349049|11058686|FG002|NOT COMPLETED|Overall Study||3
9940196|NCT01349049|11058687|FG003|NOT COMPLETED|Overall Study||3
9940197|NCT01349049|11058688|FG004|NOT COMPLETED|Overall Study||3
9940198|NCT01349049|11058689|FG005|NOT COMPLETED|Overall Study||6
9940199|NCT01349049|11058690|FG006|NOT COMPLETED|Overall Study||5
9940200|NCT01349049|11058691|FG007|NOT COMPLETED|Overall Study||4
9940201|NCT01349049|11058692|FG008|NOT COMPLETED|Overall Study||55
9940202|NCT01349114|11058726|FG000|STARTED|Overall Study||10
9940203|NCT01349114|11058727|FG001|STARTED|Overall Study||11
9940204|NCT01349114|11058726|FG000|COMPLETED|Overall Study||10
9940205|NCT01349114|11058727|FG001|COMPLETED|Overall Study||11
9940206|NCT01349114|11058726|FG000|NOT COMPLETED|Overall Study||0
9940207|NCT01349114|11058727|FG001|NOT COMPLETED|Overall Study||0
9940208|NCT01349140|11058735|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
9940209|NCT01349140|11058735|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
9940210|NCT01349140|11058735|FG000|NOT COMPLETED|Overall Study||0
9940211|NCT01349192|11058741|FG000|STARTED|Overall Study||24
10011345|NCT01780584|11134104|FG001|STARTED|Overall Study||15
10011346|NCT01780584|11134105|FG002|STARTED|Overall Study||15
9940212|NCT01349192|11058742|FG001|STARTED|Overall Study||23
9940213|NCT01349192|11058741|FG000|Evaluable for Primary Endpoint|Overall Study||22
9940214|NCT01349192|11058742|FG001|Evaluable for Primary Endpoint|Overall Study||19
9940215|NCT01349192|11058741|FG000|Withdrawals|Overall Study||3
9940216|NCT01349192|11058742|FG001|Withdrawals|Overall Study||6
9940217|NCT01349192|11058741|FG000|COMPLETED|Overall Study||21
9940218|NCT01349192|11058742|FG001|COMPLETED|Overall Study||17
9940219|NCT01349192|11058741|FG000|NOT COMPLETED|Overall Study||3
9940220|NCT01349192|11058742|FG001|NOT COMPLETED|Overall Study||6
9940221|NCT01349231|11058750|FG000|STARTED|Overall Study||10
9940222|NCT01349231|11058750|FG000|COMPLETED|Overall Study||10
9940223|NCT01349231|11058750|FG000|NOT COMPLETED|Overall Study||0
9940224|NCT01349465|11058756|FG000|STARTED|Overall Study||200
9940225|NCT01349465|11058757|FG001|STARTED|Overall Study||49
9940226|NCT01349465|11058756|FG000|COMPLETED|Overall Study||182
9940227|NCT01349465|11058757|FG001|COMPLETED|Overall Study||27
10011347|NCT01780584|11134103|FG000|COMPLETED|Overall Study||14
10011348|NCT01780584|11134104|FG001|COMPLETED|Overall Study||14
9940228|NCT01349465|11058756|FG000|NOT COMPLETED|Overall Study||18
9940229|NCT01349465|11058757|FG001|NOT COMPLETED|Overall Study||22
9940230|NCT01349491|11058767|FG000|STARTED|Overall Study||5
9940231|NCT01349491|11058768|FG001|STARTED|Overall Study||5
9940232|NCT01349491|11058767|FG000|COMPLETED|Overall Study||5
9940233|NCT01349491|11058768|FG001|COMPLETED|Overall Study||5
9940234|NCT01349491|11058767|FG000|NOT COMPLETED|Overall Study||0
9940235|NCT01349491|11058768|FG001|NOT COMPLETED|Overall Study||0
9940236|NCT01349569|11058774|FG000|STARTED|Overall Study||16
10011349|NCT01780584|11134105|FG002|COMPLETED|Overall Study||13
9940237|NCT01349569|11058774|FG000|COMPLETED|Overall Study||12
9940238|NCT01349569|11058774|FG000|NOT COMPLETED|Overall Study||4
9940239|NCT01349660|11058784|FG000|STARTED|Overall Study||6
9940240|NCT01349660|11058785|FG001|STARTED|Overall Study||6
9940241|NCT01349660|11058786|FG002|STARTED|Overall Study||76
9940242|NCT01349660|11058784|FG000|COMPLETED|Overall Study||0
9940243|NCT01349660|11058785|FG001|COMPLETED|Overall Study||0
9940244|NCT01349660|11058786|FG002|COMPLETED|Overall Study||0
9940245|NCT01349660|11058784|FG000|NOT COMPLETED|Overall Study||6
9940246|NCT01349660|11058785|FG001|NOT COMPLETED|Overall Study||6
9940247|NCT01349660|11058786|FG002|NOT COMPLETED|Overall Study||76
9940248|NCT01349673|11058801|FG000|STARTED|Overall Study||114
9940249|NCT01349673|11058801|FG000|Participants Entered Cycle 1|Overall Study||114
9940250|NCT01349673|11058801|FG000|Participants Entered Cycle 2|Overall Study||65
9940251|NCT01349673|11058801|FG000|Participants Entered Cycle 3|Overall Study||41
9940252|NCT01349673|11058801|FG000|Participants Entered Cycle 4|Overall Study||22
9940253|NCT01349673|11058801|FG000|Participants Entered Cycle 5|Overall Study||12
9940254|NCT01349673|11058801|FG000|Participants Entered Cycle 6|Overall Study||5
9940255|NCT01349673|11058801|FG000|Participants Entered Cycle 7|Overall Study||3
9940256|NCT01349673|11058801|FG000|Participants Entered Cycle 8|Overall Study||1
9940257|NCT01349673|11058801|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114
9940258|NCT01349673|11058801|FG000|COMPLETED|Overall Study||0
9940259|NCT01349673|11058801|FG000|NOT COMPLETED|Overall Study||114
9940260|NCT01349790|11058805|FG000|STARTED|Overall Study||40
9940261|NCT01349790|11058805|FG000|COMPLETED|Overall Study||31
9940262|NCT01349790|11058805|FG000|NOT COMPLETED|Overall Study||9
9940263|NCT01349803|11058813|FG000|STARTED|Overall Study||60
9940264|NCT01349803|11058814|FG001|STARTED|Overall Study||58
9940265|NCT01349803|11058815|FG002|STARTED|Overall Study||60
9940266|NCT01349803|11058816|FG003|STARTED|Overall Study||59
9940267|NCT01349803|11058813|FG000|COMPLETED|Overall Study||59
9940268|NCT01349803|11058814|FG001|COMPLETED|Overall Study||57
9940269|NCT01349803|11058815|FG002|COMPLETED|Overall Study||57
9940270|NCT01349803|11058816|FG003|COMPLETED|Overall Study||57
9940271|NCT01349803|11058813|FG000|NOT COMPLETED|Overall Study||1
9940272|NCT01349803|11058814|FG001|NOT COMPLETED|Overall Study||1
9940273|NCT01349803|11058815|FG002|NOT COMPLETED|Overall Study||3
9940274|NCT01349803|11058816|FG003|NOT COMPLETED|Overall Study||2
9940275|NCT01349816|11058834|FG000|STARTED|Overall Study||185
9940276|NCT01349816|11058834|FG000|GP MDI 36 µg|Overall Study||61
9940277|NCT01349816|11058834|FG000|GFF MDI 36/7.2 µg|Overall Study||58
9940278|NCT01349816|11058834|FG000|GFF MDI 36/9.6 µg|Overall Study||56
9940279|NCT01349816|11058834|FG000|GFF MDI 18/9.6 µg|Overall Study||57
9940280|NCT01349816|11058834|FG000|GFF MDI 9/9.6 µg|Overall Study||57
9940281|NCT01349816|11058834|FG000|FF MDI 9.6 µg|Overall Study||61
9940282|NCT01349816|11058834|FG000|COMPLETED|Overall Study||155
9940283|NCT01349816|11058834|FG000|NOT COMPLETED|Overall Study||30
9956638|NCT01447446|11075935|FG005|NOT COMPLETED|Overall Study||32
9956639|NCT01447511|11075960|FG000|STARTED|Control Period||8
9956640|NCT01447511|11075961|FG001|STARTED|Control Period||5
9956641|NCT01447511|11075962|FG002|STARTED|Control Period||9
9956642|NCT01447511|11075963|FG003|STARTED|Control Period||3
9956643|NCT01447511|11075964|FG004|STARTED|Control Period||4
9956644|NCT01447511|11075960|FG000|COMPLETED|Control Period||8
9956645|NCT01447511|11075961|FG001|COMPLETED|Control Period||5
9956646|NCT01447511|11075962|FG002|COMPLETED|Control Period||9
9956647|NCT01447511|11075963|FG003|COMPLETED|Control Period||3
9956648|NCT01447511|11075964|FG004|COMPLETED|Control Period||4
9956649|NCT01447511|11075960|FG000|NOT COMPLETED|Control Period||0
9956650|NCT01447511|11075961|FG001|NOT COMPLETED|Control Period||0
9956651|NCT01447511|11075962|FG002|NOT COMPLETED|Control Period||0
9956652|NCT01447511|11075963|FG003|NOT COMPLETED|Control Period||0
9956653|NCT01447511|11075964|FG004|NOT COMPLETED|Control Period||0
9956654|NCT01447511|11075960|FG000|STARTED|Fluconazole Period||8
9956655|NCT01447511|11075961|FG001|STARTED|Fluconazole Period||0
9956656|NCT01447511|11075962|FG002|STARTED|Fluconazole Period||9
9956657|NCT01447511|11075963|FG003|STARTED|Fluconazole Period||3
9956658|NCT01447511|11075964|FG004|STARTED|Fluconazole Period||4
9956659|NCT01447511|11075960|FG000|COMPLETED|Fluconazole Period||8
9956660|NCT01447511|11075961|FG001|COMPLETED|Fluconazole Period||0
9956661|NCT01447511|11075962|FG002|COMPLETED|Fluconazole Period||8
9956662|NCT01447511|11075963|FG003|COMPLETED|Fluconazole Period||3
9956663|NCT01447511|11075964|FG004|COMPLETED|Fluconazole Period||4
9956664|NCT01447511|11075960|FG000|NOT COMPLETED|Fluconazole Period||0
9956665|NCT01447511|11075961|FG001|NOT COMPLETED|Fluconazole Period||0
9956666|NCT01447511|11075962|FG002|NOT COMPLETED|Fluconazole Period||1
9956667|NCT01447511|11075963|FG003|NOT COMPLETED|Fluconazole Period||0
9956668|NCT01447511|11075964|FG004|NOT COMPLETED|Fluconazole Period||0
9956669|NCT01447511|11075960|FG000|STARTED|Rifampin Period||8
9956670|NCT01447511|11075961|FG001|STARTED|Rifampin Period||5
9956671|NCT01447511|11075962|FG002|STARTED|Rifampin Period||8
9956672|NCT01447511|11075963|FG003|STARTED|Rifampin Period||3
9956673|NCT01447511|11075964|FG004|STARTED|Rifampin Period||4
9956674|NCT01447511|11075960|FG000|COMPLETED|Rifampin Period||8
9956675|NCT01447511|11075961|FG001|COMPLETED|Rifampin Period||5
9956676|NCT01447511|11075962|FG002|COMPLETED|Rifampin Period||8
9956677|NCT01447511|11075963|FG003|COMPLETED|Rifampin Period||2
9956678|NCT01447511|11075964|FG004|COMPLETED|Rifampin Period||4
9956679|NCT01447511|11075960|FG000|NOT COMPLETED|Rifampin Period||0
9956680|NCT01447511|11075961|FG001|NOT COMPLETED|Rifampin Period||0
9940284|NCT01349829|11058850|FG000|STARTED|Overall Study||126
9940285|NCT01349829|11058851|FG001|STARTED|Overall Study||125
9940286|NCT01349829|11058850|FG000|COMPLETED|Overall Study||117
9940287|NCT01349829|11058851|FG001|COMPLETED|Overall Study||102
9940288|NCT01349829|11058850|FG000|NOT COMPLETED|Overall Study||9
9940289|NCT01349829|11058851|FG001|NOT COMPLETED|Overall Study||23
9940290|NCT01349920|11058859|FG000|STARTED|Overall Study||15
9940291|NCT01349920|11058859|FG000|COMPLETED|Overall Study||15
9940292|NCT01349920|11058859|FG000|NOT COMPLETED|Overall Study||0
9940293|NCT01349933|11058865|FG000|STARTED|Overall Study||21
9940294|NCT01349933|11058865|FG000|COMPLETED|Overall Study||21
9940295|NCT01349933|11058865|FG000|NOT COMPLETED|Overall Study||0
9940296|NCT01349972|11058871|FG000|STARTED|Overall Study||114
9940297|NCT01349972|11058872|FG001|STARTED|Overall Study||58
9940298|NCT01349972|11058871|FG000|COMPLETED|Overall Study||109
9940299|NCT01349972|11058872|FG001|COMPLETED|Overall Study||56
9940300|NCT01349972|11058871|FG000|NOT COMPLETED|Overall Study||5
9940301|NCT01349972|11058872|FG001|NOT COMPLETED|Overall Study||2
9940302|NCT01350102|11058882|FG000|STARTED|Overall Study||0
9940303|NCT01350102|11058883|FG001|STARTED|Overall Study||1
9940304|NCT01350102|11058884|FG002|STARTED|Overall Study||1
9940305|NCT01350102|11058885|FG003|STARTED|Overall Study||0
9940306|NCT01350102|11058882|FG000|COMPLETED|Overall Study||0
9940307|NCT01350102|11058883|FG001|COMPLETED|Overall Study||1
9940308|NCT01350102|11058884|FG002|COMPLETED|Overall Study||0
9940309|NCT01350102|11058885|FG003|COMPLETED|Overall Study||0
9940310|NCT01350102|11058882|FG000|NOT COMPLETED|Overall Study||0
9940311|NCT01350102|11058883|FG001|NOT COMPLETED|Overall Study||0
9940312|NCT01350102|11058884|FG002|NOT COMPLETED|Overall Study||1
9940313|NCT01350102|11058885|FG003|NOT COMPLETED|Overall Study||0
10011350|NCT01780584|11134103|FG000|NOT COMPLETED|Overall Study||1
10011351|NCT01780584|11134104|FG001|NOT COMPLETED|Overall Study||1
10011352|NCT01780584|11134105|FG002|NOT COMPLETED|Overall Study||2
9940314|NCT01350115|11058897|FG000|STARTED|Core Study (All Patients)||8
9940315|NCT01350115|11058898|FG001|STARTED|Core Study (All Patients)||2
9940316|NCT01350115|11058897|FG000|Safety Anlysis Set|Core Study (All Patients)||8
9940317|NCT01350115|11058898|FG001|Safety Anlysis Set|Core Study (All Patients)||2
9940318|NCT01350115|11058897|FG000|Pharmacodynamic Set|Core Study (All Patients)||7
9940319|NCT01350115|11058898|FG001|Pharmacodynamic Set|Core Study (All Patients)||2
9940320|NCT01350115|11058897|FG000|COMPLETED|Core Study (All Patients)||8
9940321|NCT01350115|11058898|FG001|COMPLETED|Core Study (All Patients)||2
9940322|NCT01350115|11058897|FG000|NOT COMPLETED|Core Study (All Patients)||0
9940323|NCT01350115|11058898|FG001|NOT COMPLETED|Core Study (All Patients)||0
9940324|NCT01350115|11058897|FG000|STARTED|Long Term Follow-Up (All Patients)||8
9940325|NCT01350115|11058898|FG001|STARTED|Long Term Follow-Up (All Patients)||2
9940326|NCT01350115|11058897|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7
9940327|NCT01350115|11058898|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0
9940328|NCT01350115|11058897|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
9940329|NCT01350115|11058898|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
9940330|NCT01350128|11058906|FG000|STARTED|Overall Study||103
9940331|NCT01350128|11058906|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
9940332|NCT01350128|11058906|FG000|GP MDI 18 µg BID|Overall Study||49
9940333|NCT01350128|11058906|FG000|GP MDI 9 µg BID|Overall Study||49
9940334|NCT01350128|11058906|FG000|GP MDI 4.6 µg BID|Overall Study||45
9940335|NCT01350128|11058906|FG000|Placebo MDI BID|Overall Study||48
9940336|NCT01350128|11058906|FG000|Atrovent HFA 34 µg BID|Overall Study||48
9940337|NCT01350128|11058906|FG000|COMPLETED|Overall Study||89
9940338|NCT01350128|11058906|FG000|NOT COMPLETED|Overall Study||14
9940339|NCT01350141|11058923|FG000|STARTED|Overall Study||15
9940340|NCT01350141|11058924|FG001|STARTED|Overall Study||15
9940341|NCT01350141|11058925|FG002|STARTED|Overall Study||16
9940342|NCT01350141|11058923|FG000|Treated|Overall Study||14
9940343|NCT01350141|11058924|FG001|Treated|Overall Study||15
9940344|NCT01350141|11058925|FG002|Treated|Overall Study||16
9940345|NCT01350141|11058923|FG000|COMPLETED|Overall Study||12
9940346|NCT01350141|11058924|FG001|COMPLETED|Overall Study||15
9940347|NCT01350141|11058925|FG002|COMPLETED|Overall Study||15
9940348|NCT01350141|11058923|FG000|NOT COMPLETED|Overall Study||3
9940349|NCT01350141|11058924|FG001|NOT COMPLETED|Overall Study||0
9940350|NCT01350141|11058925|FG002|NOT COMPLETED|Overall Study||1
9940351|NCT01350245|11058935|FG000|STARTED|Overall Study||28
9940352|NCT01350245|11058935|FG000|COMPLETED|Overall Study||28
9940353|NCT01350245|11058935|FG000|NOT COMPLETED|Overall Study||0
9940354|NCT01350271|11058942|FG000|STARTED|Overall Study||70
9940355|NCT01350271|11058943|FG001|STARTED|Overall Study||70
9940356|NCT01350271|11058944|FG002|STARTED|Overall Study||74
9940357|NCT01350271|11058942|FG000|COMPLETED|Overall Study||49
10011353|NCT01780662|11134116|FG000|STARTED|Overall Study||3
9940358|NCT01350271|11058943|FG001|COMPLETED|Overall Study||53
9940359|NCT01350271|11058944|FG002|COMPLETED|Overall Study||48
9940360|NCT01350271|11058942|FG000|NOT COMPLETED|Overall Study||21
9940361|NCT01350271|11058943|FG001|NOT COMPLETED|Overall Study||17
9940362|NCT01350271|11058944|FG002|NOT COMPLETED|Overall Study||26
9940363|NCT01350336|11058955|FG000|STARTED|Overall Study||284
9940364|NCT01350336|11058955|FG000|COMPLETED|Overall Study||227
9940365|NCT01350336|11058955|FG000|NOT COMPLETED|Overall Study||57
9940366|NCT01350388|11059006|FG000|STARTED|Overall Study||40
9940367|NCT01350388|11059007|FG001|STARTED|Overall Study||40
9940368|NCT01350388|11059006|FG000|COMPLETED|Overall Study||37
9940369|NCT01350388|11059007|FG001|COMPLETED|Overall Study||39
9940370|NCT01350388|11059006|FG000|NOT COMPLETED|Overall Study||3
9940371|NCT01350388|11059007|FG001|NOT COMPLETED|Overall Study||1
9940372|NCT01350401|11059013|FG000|STARTED|Overall Study||4
9940373|NCT01350401|11059013|FG000|COMPLETED|Overall Study||4
9940374|NCT01350401|11059013|FG000|NOT COMPLETED|Overall Study||0
9940375|NCT01350414|11059021|FG000|STARTED|Overall Study||181
9940376|NCT01350414|11059021|FG000|Year 2|Overall Study||165
9940377|NCT01350414|11059021|FG000|Year 3|Overall Study||162
9940378|NCT01350414|11059021|FG000|Year 4|Overall Study||159
9940379|NCT01350414|11059021|FG000|Year 5|Overall Study||162
9940380|NCT01350414|11059021|FG000|COMPLETED|Overall Study||162
9940381|NCT01350414|11059021|FG000|NOT COMPLETED|Overall Study||19
9940382|NCT01350453|11059033|FG000|STARTED|Overall Study||11
9940383|NCT01350453|11059034|FG001|STARTED|Overall Study||8
9940384|NCT01350453|11059033|FG000|COMPLETED|Overall Study||9
9940385|NCT01350453|11059034|FG001|COMPLETED|Overall Study||7
9940386|NCT01350453|11059033|FG000|NOT COMPLETED|Overall Study||2
9940387|NCT01350453|11059034|FG001|NOT COMPLETED|Overall Study||1
9940388|NCT01350479|11059044|FG000|STARTED|Overall Study||94
9940389|NCT01350479|11059045|FG001|STARTED|Overall Study||106
9940390|NCT01350479|11059044|FG000|COMPLETED|Overall Study||94
9940391|NCT01350479|11059045|FG001|COMPLETED|Overall Study||106
9940392|NCT01350479|11059044|FG000|NOT COMPLETED|Overall Study||0
9940393|NCT01350479|11059045|FG001|NOT COMPLETED|Overall Study||0
9940394|NCT01350492|11059053|FG000|STARTED|Intervention||28
9940395|NCT01350492|11059054|FG001|STARTED|Intervention||26
9940396|NCT01350492|11059053|FG000|6-week MRI Scan|Intervention||24
9940397|NCT01350492|11059054|FG001|6-week MRI Scan|Intervention||22
9940398|NCT01350492|11059053|FG000|11-week MRI Scan|Intervention||23
9940399|NCT01350492|11059054|FG001|11-week MRI Scan|Intervention||21
9940400|NCT01350492|11059053|FG000|COMPLETED|Intervention||23
9940401|NCT01350492|11059054|FG001|COMPLETED|Intervention||20
9940402|NCT01350492|11059053|FG000|NOT COMPLETED|Intervention||5
9940403|NCT01350492|11059054|FG001|NOT COMPLETED|Intervention||6
9940404|NCT01350492|11059053|FG000|STARTED|Post Intervention Follow-Up||23
9940405|NCT01350492|11059054|FG001|STARTED|Post Intervention Follow-Up||20
9940406|NCT01350492|11059053|FG000|6-month MRI Scan|Post Intervention Follow-Up||20
9940407|NCT01350492|11059054|FG001|6-month MRI Scan|Post Intervention Follow-Up||20
9940408|NCT01350492|11059053|FG000|COMPLETED|Post Intervention Follow-Up||17
9940409|NCT01350492|11059054|FG001|COMPLETED|Post Intervention Follow-Up||18
9940410|NCT01350492|11059053|FG000|NOT COMPLETED|Post Intervention Follow-Up||6
9940411|NCT01350492|11059054|FG001|NOT COMPLETED|Post Intervention Follow-Up||2
9940412|NCT01350505|11059060|FG000|STARTED|Overall Study||21
9940413|NCT01350505|11059060|FG000|COMPLETED|Overall Study||17
9940414|NCT01350505|11059060|FG000|NOT COMPLETED|Overall Study||4
9940415|NCT01350544|11059066|FG000|STARTED|Overall Study||108
9940416|NCT01350544|11059067|FG001|STARTED|Overall Study||108
9940417|NCT01350544|11059066|FG000|COMPLETED|Overall Study||85
9940418|NCT01350544|11059067|FG001|COMPLETED|Overall Study||86
9940419|NCT01350544|11059066|FG000|NOT COMPLETED|Overall Study||23
9940420|NCT01350544|11059067|FG001|NOT COMPLETED|Overall Study||22
9940421|NCT01350804|11059077|FG000|STARTED|Core Study||138
9940422|NCT01350804|11059078|FG001|STARTED|Core Study||137
9940423|NCT01350804|11059079|FG002|STARTED|Core Study||138
9940424|NCT01350804|11059080|FG003|STARTED|Core Study||138
9940425|NCT01350804|11059077|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
9940426|NCT01350804|11059078|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
9940427|NCT01350804|11059079|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
9940428|NCT01350804|11059080|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
9940429|NCT01350804|11059077|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0
9940430|NCT01350804|11059078|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0
9940431|NCT01350804|11059079|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
9940432|NCT01350804|11059080|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0
9940433|NCT01350804|11059077|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0
9940434|NCT01350804|11059078|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0
9940435|NCT01350804|11059079|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45
9940436|NCT01350804|11059080|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37
9940437|NCT01350804|11059077|FG000|Full Analysis Set|Core Study||138
9940438|NCT01350804|11059078|FG001|Full Analysis Set|Core Study||137
9940439|NCT01350804|11059079|FG002|Full Analysis Set|Core Study||138
9940440|NCT01350804|11059080|FG003|Full Analysis Set|Core Study||138
9940441|NCT01350804|11059077|FG000|COMPLETED|Core Study||97
9940442|NCT01350804|11059078|FG001|COMPLETED|Core Study||90
9940443|NCT01350804|11059079|FG002|COMPLETED|Core Study||91
9940444|NCT01350804|11059080|FG003|COMPLETED|Core Study||112
9940445|NCT01350804|11059077|FG000|NOT COMPLETED|Core Study||41
9940446|NCT01350804|11059078|FG001|NOT COMPLETED|Core Study||47
9940447|NCT01350804|11059079|FG002|NOT COMPLETED|Core Study||47
9940448|NCT01350804|11059080|FG003|NOT COMPLETED|Core Study||26
9940449|NCT01350804|11059077|FG000|STARTED|Extension Study, Weeks 52 - 260||80
9940450|NCT01350804|11059078|FG001|STARTED|Extension Study, Weeks 52 - 260||79
9940451|NCT01350804|11059079|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
9940452|NCT01350804|11059080|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
9940453|NCT01350804|11059077|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0
9940454|NCT01350804|11059078|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0
9940455|NCT01350804|11059079|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0
9940456|NCT01350804|11059080|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0
9940457|NCT01350804|11059077|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
9940458|NCT01350804|11059078|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
9940459|NCT01350804|11059079|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
9940460|NCT01350804|11059080|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
9940461|NCT01350947|11059100|FG000|STARTED|Overall Study||11
9940462|NCT01350947|11059100|FG000|COMPLETED|Overall Study||11
9940463|NCT01350947|11059100|FG000|NOT COMPLETED|Overall Study||0
9940464|NCT01350973|11059107|FG000|STARTED|Overall Study||206
9940465|NCT01350973|11059108|FG001|STARTED|Overall Study||210
9940466|NCT01350973|11059109|FG002|STARTED|Overall Study||195
9940467|NCT01350973|11059107|FG000|Received Treatment|Overall Study||205
9940468|NCT01350973|11059108|FG001|Received Treatment|Overall Study||210
9940469|NCT01350973|11059109|FG002|Received Treatment|Overall Study||195
9940470|NCT01350973|11059107|FG000|COMPLETED|Overall Study||200
9940471|NCT01350973|11059108|FG001|COMPLETED|Overall Study||202
9940472|NCT01350973|11059109|FG002|COMPLETED|Overall Study||187
9940473|NCT01350973|11059107|FG000|NOT COMPLETED|Overall Study||6
9940474|NCT01350973|11059108|FG001|NOT COMPLETED|Overall Study||8
9940475|NCT01350973|11059109|FG002|NOT COMPLETED|Overall Study||8
9940476|NCT01350999|11059120|FG000|STARTED|Overall Study||165
9940477|NCT01350999|11059121|FG001|STARTED|Overall Study||171
9940478|NCT01350999|11059122|FG002|STARTED|Overall Study||167
9940479|NCT01350999|11059120|FG000|Treated|Overall Study||165
9940480|NCT01350999|11059121|FG001|Treated|Overall Study||171
9940481|NCT01350999|11059122|FG002|Treated|Overall Study||167
9940482|NCT01350999|11059120|FG000|COMPLETED|Overall Study||157
9940483|NCT01350999|11059121|FG001|COMPLETED|Overall Study||157
9940484|NCT01350999|11059122|FG002|COMPLETED|Overall Study||146
9940485|NCT01350999|11059120|FG000|NOT COMPLETED|Overall Study||8
9940486|NCT01350999|11059121|FG001|NOT COMPLETED|Overall Study||14
9940487|NCT01350999|11059122|FG002|NOT COMPLETED|Overall Study||21
9940488|NCT01351025|11059132|FG000|STARTED|Week 0 - 20||46
9940489|NCT01351025|11059133|FG001|STARTED|Week 0 - 20||48
9940490|NCT01351025|11059132|FG000|COMPLETED|Week 0 - 20||43
9940491|NCT01351025|11059133|FG001|COMPLETED|Week 0 - 20||47
9940492|NCT01351025|11059132|FG000|NOT COMPLETED|Week 0 - 20||3
9940493|NCT01351025|11059133|FG001|NOT COMPLETED|Week 0 - 20||1
9940494|NCT01351025|11059132|FG000|STARTED|Week 20 - 24||43
9940495|NCT01351025|11059133|FG001|STARTED|Week 20 - 24||47
9940496|NCT01351025|11059132|FG000|COMPLETED|Week 20 - 24||43
9940497|NCT01351025|11059133|FG001|COMPLETED|Week 20 - 24||47
9940498|NCT01351025|11059132|FG000|NOT COMPLETED|Week 20 - 24||0
9940499|NCT01351025|11059133|FG001|NOT COMPLETED|Week 20 - 24||0
9940500|NCT01351025|11059132|FG000|STARTED|Week 24 - 44||43
9940501|NCT01351025|11059133|FG001|STARTED|Week 24 - 44||47
9940502|NCT01351025|11059132|FG000|COMPLETED|Week 24 - 44||42
9940503|NCT01351025|11059133|FG001|COMPLETED|Week 24 - 44||43
9940504|NCT01351025|11059132|FG000|NOT COMPLETED|Week 24 - 44||1
9940505|NCT01351025|11059133|FG001|NOT COMPLETED|Week 24 - 44||4
9940506|NCT01351025|11059132|FG000|STARTED|Week 44 - 48||42
9940507|NCT01351025|11059133|FG001|STARTED|Week 44 - 48||43
9940508|NCT01351025|11059132|FG000|COMPLETED|Week 44 - 48||42
9940509|NCT01351025|11059133|FG001|COMPLETED|Week 44 - 48||43
9940510|NCT01351025|11059132|FG000|NOT COMPLETED|Week 44 - 48||0
9940511|NCT01351025|11059133|FG001|NOT COMPLETED|Week 44 - 48||0
9940512|NCT01351064|11059147|FG000|STARTED|Overall Study||42
9940513|NCT01351064|11059148|FG001|STARTED|Overall Study||42
9940514|NCT01351064|11059147|FG000|COMPLETED|Overall Study||42
9940515|NCT01351064|11059148|FG001|COMPLETED|Overall Study||42
9940516|NCT01351064|11059147|FG000|NOT COMPLETED|Overall Study||0
9940517|NCT01351064|11059148|FG001|NOT COMPLETED|Overall Study||0
9940518|NCT01351077|11059156|FG000|STARTED|Overall Study||180
9940519|NCT01351077|11059157|FG001|STARTED|Overall Study||180
9940520|NCT01351077|11059156|FG000|COMPLETED|Overall Study||180
9940521|NCT01351077|11059157|FG001|COMPLETED|Overall Study||180
9940522|NCT01351077|11059156|FG000|NOT COMPLETED|Overall Study||0
9940523|NCT01351077|11059157|FG001|NOT COMPLETED|Overall Study||0
9940524|NCT01351090|11059166|FG000|STARTED|Overall Study||43
9940525|NCT01351090|11059167|FG001|STARTED|Overall Study||42
9940526|NCT01351090|11059168|FG002|STARTED|Overall Study||42
9940527|NCT01351090|11059166|FG000|COMPLETED|Overall Study||32
9940528|NCT01351090|11059167|FG001|COMPLETED|Overall Study||31
9940529|NCT01351090|11059168|FG002|COMPLETED|Overall Study||36
9940530|NCT01351090|11059166|FG000|NOT COMPLETED|Overall Study||11
9940531|NCT01351090|11059167|FG001|NOT COMPLETED|Overall Study||11
9940532|NCT01351090|11059168|FG002|NOT COMPLETED|Overall Study||6
9940533|NCT01351337|11059176|FG000|STARTED|Overall Study||58
9940534|NCT01351337|11059176|FG000|COMPLETED|Overall Study||58
9940535|NCT01351337|11059176|FG000|NOT COMPLETED|Overall Study||0
9940536|NCT01351350|11059186|FG000|STARTED|Overall Study||8
9940537|NCT01351350|11059187|FG001|STARTED|Overall Study||29
9940538|NCT01351350|11059188|FG002|STARTED|Overall Study||11
9940539|NCT01351350|11059189|FG003|STARTED|Overall Study||13
9940540|NCT01351350|11059190|FG004|STARTED|Overall Study||7
9940541|NCT01351350|11059186|FG000|Treated|Overall Study||8
9940542|NCT01351350|11059187|FG001|Treated|Overall Study||29
9940543|NCT01351350|11059188|FG002|Treated|Overall Study||10
9940544|NCT01351350|11059189|FG003|Treated|Overall Study||13
9940545|NCT01351350|11059190|FG004|Treated|Overall Study||7
9940546|NCT01351350|11059186|FG000|Dose-escalation Evaluable|Overall Study||7
9940547|NCT01351350|11059187|FG001|Dose-escalation Evaluable|Overall Study||23
9940548|NCT01351350|11059188|FG002|Dose-escalation Evaluable|Overall Study||10
9940549|NCT01351350|11059189|FG003|Dose-escalation Evaluable|Overall Study||0
9940550|NCT01351350|11059190|FG004|Dose-escalation Evaluable|Overall Study||0
9940551|NCT01351350|11059186|FG000|COMPLETED|Overall Study||0
9940552|NCT01351350|11059187|FG001|COMPLETED|Overall Study||0
9940553|NCT01351350|11059188|FG002|COMPLETED|Overall Study||0
9940554|NCT01351350|11059189|FG003|COMPLETED|Overall Study||0
9940555|NCT01351350|11059190|FG004|COMPLETED|Overall Study||0
9940556|NCT01351350|11059186|FG000|NOT COMPLETED|Overall Study||8
9940557|NCT01351350|11059187|FG001|NOT COMPLETED|Overall Study||29
9940558|NCT01351350|11059188|FG002|NOT COMPLETED|Overall Study||11
9940559|NCT01351350|11059189|FG003|NOT COMPLETED|Overall Study||13
9940560|NCT01351350|11059190|FG004|NOT COMPLETED|Overall Study||7
9940561|NCT01351376|11059217|FG000|STARTED|Overall Study||10
9940562|NCT01351376|11059218|FG001|STARTED|Overall Study||11
9940563|NCT01351376|11059217|FG000|COMPLETED|Overall Study||10
9940564|NCT01351376|11059218|FG001|COMPLETED|Overall Study||11
9940565|NCT01351376|11059217|FG000|NOT COMPLETED|Overall Study||0
9940566|NCT01351376|11059218|FG001|NOT COMPLETED|Overall Study||0
9940567|NCT01351415|11059226|FG000|STARTED|Overall Study||245
9940568|NCT01351415|11059227|FG001|STARTED|Overall Study||240
9940569|NCT01351415|11059226|FG000|Treated Participants|Overall Study||243
9940570|NCT01351415|11059227|FG001|Treated Participants|Overall Study||232
9940571|NCT01351415|11059226|FG000|COMPLETED|Overall Study||0
9940572|NCT01351415|11059227|FG001|COMPLETED|Overall Study||0
9940573|NCT01351415|11059226|FG000|NOT COMPLETED|Overall Study||245
9940574|NCT01351415|11059227|FG001|NOT COMPLETED|Overall Study||240
9940575|NCT01351480|11059233|FG000|STARTED|Overall Study||34
9940576|NCT01351480|11059233|FG000|COMPLETED|Overall Study||26
9940577|NCT01351480|11059233|FG000|NOT COMPLETED|Overall Study||8
9940578|NCT01351506|11059239|FG000|STARTED|Overall Study||602
9940579|NCT01351506|11059239|FG000|COMPLETED|Overall Study||465
9940580|NCT01351506|11059239|FG000|NOT COMPLETED|Overall Study||137
9940581|NCT01351623|11059245|FG000|STARTED|Overall Study||44
9940582|NCT01351623|11059245|FG000|COMPLETED|Overall Study||35
9940583|NCT01351623|11059245|FG000|NOT COMPLETED|Overall Study||9
9940584|NCT01351740|11059251|FG000|STARTED|Overall Study||25
9940585|NCT01351740|11059252|FG001|STARTED|Overall Study||25
9940586|NCT01351740|11059251|FG000|COMPLETED|Overall Study||23
9940587|NCT01351740|11059252|FG001|COMPLETED|Overall Study||19
9940588|NCT01351740|11059251|FG000|NOT COMPLETED|Overall Study||2
9940589|NCT01351740|11059252|FG001|NOT COMPLETED|Overall Study||6
9940590|NCT01351753|11059265|FG000|STARTED|Overall Study||22
9940591|NCT01351753|11059266|FG001|STARTED|Overall Study||20
9940592|NCT01351753|11059267|FG002|STARTED|Overall Study||21
9940593|NCT01351753|11059268|FG003|STARTED|Overall Study||21
9940594|NCT01351753|11059269|FG004|STARTED|Overall Study||21
9940595|NCT01351753|11059270|FG005|STARTED|Overall Study||23
9940596|NCT01351753|11059265|FG000|COMPLETED|Overall Study||15
9940597|NCT01351753|11059266|FG001|COMPLETED|Overall Study||13
9940598|NCT01351753|11059267|FG002|COMPLETED|Overall Study||14
9940599|NCT01351753|11059268|FG003|COMPLETED|Overall Study||21
9940600|NCT01351753|11059269|FG004|COMPLETED|Overall Study||14
9940601|NCT01351753|11059270|FG005|COMPLETED|Overall Study||22
9940602|NCT01351753|11059265|FG000|NOT COMPLETED|Overall Study||7
9940603|NCT01351753|11059266|FG001|NOT COMPLETED|Overall Study||7
10207258|NCT03524157|11334070|FG001|NOT COMPLETED|Overall Study||0
10207259|NCT03524157|11334071|FG002|NOT COMPLETED|Overall Study||1
9940604|NCT01351753|11059267|FG002|NOT COMPLETED|Overall Study||7
9940605|NCT01351753|11059268|FG003|NOT COMPLETED|Overall Study||0
9940606|NCT01351753|11059269|FG004|NOT COMPLETED|Overall Study||7
9940607|NCT01351753|11059270|FG005|NOT COMPLETED|Overall Study||1
9940608|NCT01351805|11059290|FG000|STARTED|Overall Study||6463
9940609|NCT01351805|11059291|FG001|STARTED|Overall Study||6464
9940610|NCT01351805|11059292|FG002|STARTED|Overall Study||6470
9940611|NCT01351805|11059293|FG003|STARTED|Overall Study||6474
9940612|NCT01351805|11059290|FG000|Knee Pain Cohort Within VITAL Trial|Overall Study||342
9940613|NCT01351805|11059291|FG001|Knee Pain Cohort Within VITAL Trial|Overall Study||332
9940614|NCT01351805|11059292|FG002|Knee Pain Cohort Within VITAL Trial|Overall Study||353
9940615|NCT01351805|11059293|FG003|Knee Pain Cohort Within VITAL Trial|Overall Study||371
9940616|NCT01351805|11059290|FG000|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
9940617|NCT01351805|11059291|FG001|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
9940618|NCT01351805|11059292|FG002|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
9940619|NCT01351805|11059293|FG003|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||385
9940620|NCT01351805|11059290|FG000|COMPLETED|Overall Study||6463
9940621|NCT01351805|11059291|FG001|COMPLETED|Overall Study||6464
9940622|NCT01351805|11059292|FG002|COMPLETED|Overall Study||6470
9940623|NCT01351805|11059293|FG003|COMPLETED|Overall Study||6474
9940624|NCT01351805|11059290|FG000|NOT COMPLETED|Overall Study||0
9940625|NCT01351805|11059291|FG001|NOT COMPLETED|Overall Study||0
9940626|NCT01351805|11059292|FG002|NOT COMPLETED|Overall Study||0
10207260|NCT03524339|11334081|FG000|STARTED|Overall Study||66
10207261|NCT03524339|11334082|FG001|STARTED|Overall Study||66
9940627|NCT01351805|11059293|FG003|NOT COMPLETED|Overall Study||0
10207262|NCT03524339|11334081|FG000|COMPLETED|Overall Study||57
9940628|NCT01352117|11059309|FG000|STARTED|Overall Study||96
9940629|NCT01352117|11059310|FG001|STARTED|Overall Study||96
9940630|NCT01352117|11059309|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32
9940631|NCT01352117|11059310|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
9940632|NCT01352117|11059309|FG000|Study Week 48 Data Potential|Overall Study||80
9940633|NCT01352117|11059310|FG001|Study Week 48 Data Potential|Overall Study||83
9940634|NCT01352117|11059309|FG000|Study Week 96 Data Potential|Overall Study||58
9940635|NCT01352117|11059310|FG001|Study Week 96 Data Potential|Overall Study||61
9940636|NCT01352117|11059309|FG000|COMPLETED|Overall Study||75
9940637|NCT01352117|11059310|FG001|COMPLETED|Overall Study||72
9940638|NCT01352117|11059309|FG000|NOT COMPLETED|Overall Study||21
9940639|NCT01352117|11059310|FG001|NOT COMPLETED|Overall Study||24
9940640|NCT01352182|11059321|FG000|STARTED|Overall Study||8
9940641|NCT01352182|11059322|FG001|STARTED|Overall Study||4
9940642|NCT01352182|11059321|FG000|COMPLETED|Overall Study||8
9940643|NCT01352182|11059322|FG001|COMPLETED|Overall Study||4
9940644|NCT01352182|11059321|FG000|NOT COMPLETED|Overall Study||0
9940645|NCT01352182|11059322|FG001|NOT COMPLETED|Overall Study||0
9940646|NCT01352221|11059332|FG000|STARTED|Double-blind Phase||64
9940647|NCT01352221|11059333|FG001|STARTED|Double-blind Phase||64
9940648|NCT01352221|11059334|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
9940649|NCT01352221|11059335|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
9940650|NCT01352221|11059332|FG000|COMPLETED|Double-blind Phase||55
9940651|NCT01352221|11059333|FG001|COMPLETED|Double-blind Phase||53
9940652|NCT01352221|11059334|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
9940653|NCT01352221|11059335|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
9940654|NCT01352221|11059332|FG000|NOT COMPLETED|Double-blind Phase||9
9940655|NCT01352221|11059333|FG001|NOT COMPLETED|Double-blind Phase||11
9940656|NCT01352221|11059334|FG002|NOT COMPLETED|Double-blind Phase||0
9940657|NCT01352221|11059335|FG003|NOT COMPLETED|Double-blind Phase||0
9940658|NCT01352221|11059332|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
9940659|NCT01352221|11059333|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
9940660|NCT01352221|11059334|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
9940661|NCT01352221|11059335|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
9940662|NCT01352221|11059332|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
9940663|NCT01352221|11059333|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
9940664|NCT01352221|11059334|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
9940665|NCT01352221|11059335|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
9940666|NCT01352221|11059332|FG000|NOT COMPLETED|Open-label Phase||0
9940667|NCT01352221|11059333|FG001|NOT COMPLETED|Open-label Phase||0
9940668|NCT01352221|11059334|FG002|NOT COMPLETED|Open-label Phase||13
9940669|NCT01352221|11059335|FG003|NOT COMPLETED|Open-label Phase||11
9940670|NCT01352286|11059347|FG000|STARTED|Overall Study||25
9940671|NCT01352286|11059347|FG000|Received T-cells|Overall Study||25
9940672|NCT01352286|11059347|FG000|COMPLETED|Overall Study||25
9940673|NCT01352286|11059347|FG000|NOT COMPLETED|Overall Study||0
9940674|NCT01352442|11059352|FG000|STARTED|Overall Study||151
9940675|NCT01352442|11059352|FG000|COMPLETED|Overall Study||139
9940676|NCT01352442|11059352|FG000|NOT COMPLETED|Overall Study||12
9940677|NCT01352468|11059358|FG000|STARTED|Overall Study||22
9940678|NCT01352468|11059359|FG001|STARTED|Overall Study||22
9940679|NCT01352468|11059358|FG000|COMPLETED|Overall Study||17
9940680|NCT01352468|11059359|FG001|COMPLETED|Overall Study||18
9940681|NCT01352468|11059358|FG000|NOT COMPLETED|Overall Study||5
9940682|NCT01352468|11059359|FG001|NOT COMPLETED|Overall Study||4
9940683|NCT01352507|11059367|FG000|STARTED|Treatment Period 1||190
9940684|NCT01352507|11059368|FG001|STARTED|Treatment Period 1||193
9940685|NCT01352507|11059367|FG000|Received Treatment|Treatment Period 1||182
9940686|NCT01352507|11059368|FG001|Received Treatment|Treatment Period 1||188
9940687|NCT01352507|11059367|FG000|COMPLETED|Treatment Period 1||176
9940688|NCT01352507|11059368|FG001|COMPLETED|Treatment Period 1||184
9940689|NCT01352507|11059367|FG000|NOT COMPLETED|Treatment Period 1||14
9940690|NCT01352507|11059368|FG001|NOT COMPLETED|Treatment Period 1||9
9940691|NCT01352507|11059367|FG000|STARTED|Washout Period||176
9940692|NCT01352507|11059368|FG001|STARTED|Washout Period||184
9940693|NCT01352507|11059367|FG000|COMPLETED|Washout Period||176
9940694|NCT01352507|11059368|FG001|COMPLETED|Washout Period||183
9940695|NCT01352507|11059367|FG000|NOT COMPLETED|Washout Period||0
9940696|NCT01352507|11059368|FG001|NOT COMPLETED|Washout Period||1
9940697|NCT01352507|11059367|FG000|STARTED|Treatment Period 2||176
9940698|NCT01352507|11059368|FG001|STARTED|Treatment Period 2||183
9940699|NCT01352507|11059367|FG000|Received Treatment|Treatment Period 2||173
9940700|NCT01352507|11059368|FG001|Received Treatment|Treatment Period 2||181
9940701|NCT01352507|11059367|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
9940702|NCT01352507|11059368|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
9940703|NCT01352507|11059367|FG000|NOT COMPLETED|Treatment Period 2||6
9940704|NCT01352507|11059368|FG001|NOT COMPLETED|Treatment Period 2||3
9940705|NCT01352507|11059367|FG000|STARTED|Extension Phase||164
9940706|NCT01352507|11059368|FG001|STARTED|Extension Phase||173
9940707|NCT01352507|11059367|FG000|COMPLETED|Extension Phase||164
9940708|NCT01352507|11059368|FG001|COMPLETED|Extension Phase||173
9940709|NCT01352507|11059367|FG000|NOT COMPLETED|Extension Phase||0
9940710|NCT01352507|11059368|FG001|NOT COMPLETED|Extension Phase||0
9940711|NCT01352546|11059380|FG000|STARTED|Overall Study||31
9940712|NCT01352546|11059380|FG000|COMPLETED|Overall Study||31
9940713|NCT01352546|11059380|FG000|NOT COMPLETED|Overall Study||0
9940714|NCT01352585|11059386|FG000|STARTED|Overall Study||23
9940715|NCT01352585|11059387|FG001|STARTED|Overall Study||24
9940716|NCT01352585|11059386|FG000|COMPLETED|Overall Study||15
9940717|NCT01352585|11059387|FG001|COMPLETED|Overall Study||21
9940718|NCT01352585|11059386|FG000|NOT COMPLETED|Overall Study||8
9940719|NCT01352585|11059387|FG001|NOT COMPLETED|Overall Study||3
9940720|NCT01352598|11059394|FG000|STARTED|Overall Study||84
9940721|NCT01352598|11059394|FG000|COMPLETED|Overall Study||72
9940722|NCT01352598|11059394|FG000|NOT COMPLETED|Overall Study||12
9940723|NCT01352637|11059402|FG000|STARTED|Exposure Therapy||97
9940724|NCT01352637|11059403|FG001|STARTED|Exposure Therapy||95
9940725|NCT01352637|11059404|FG002|STARTED|Exposure Therapy||0
9940726|NCT01352637|11059405|FG003|STARTED|Exposure Therapy||0
9940727|NCT01352637|11059402|FG000|COMPLETED|Exposure Therapy||70
9940728|NCT01352637|11059403|FG001|COMPLETED|Exposure Therapy||62
9940729|NCT01352637|11059404|FG002|COMPLETED|Exposure Therapy||0
9940730|NCT01352637|11059405|FG003|COMPLETED|Exposure Therapy||0
9940731|NCT01352637|11059402|FG000|NOT COMPLETED|Exposure Therapy||27
9940732|NCT01352637|11059403|FG001|NOT COMPLETED|Exposure Therapy||33
9940733|NCT01352637|11059404|FG002|NOT COMPLETED|Exposure Therapy||0
9940734|NCT01352637|11059405|FG003|NOT COMPLETED|Exposure Therapy||0
9940735|NCT01352637|11059402|FG000|STARTED|Drug||0
9940736|NCT01352637|11059403|FG001|STARTED|Drug||0
9940737|NCT01352637|11059404|FG002|STARTED|Drug||95
9940738|NCT01352637|11059405|FG003|STARTED|Drug||97
9940739|NCT01352637|11059402|FG000|COMPLETED|Drug||0
9940740|NCT01352637|11059403|FG001|COMPLETED|Drug||0
9940741|NCT01352637|11059404|FG002|COMPLETED|Drug||70
9940742|NCT01352637|11059405|FG003|COMPLETED|Drug||62
9940743|NCT01352637|11059402|FG000|NOT COMPLETED|Drug||0
9940744|NCT01352637|11059403|FG001|NOT COMPLETED|Drug||0
9940745|NCT01352637|11059404|FG002|NOT COMPLETED|Drug||25
9940746|NCT01352637|11059405|FG003|NOT COMPLETED|Drug||35
9940747|NCT01352715|11059417|FG000|STARTED|Overall Study||260
9940748|NCT01352715|11059418|FG001|STARTED|Overall Study||255
9940749|NCT01352715|11059417|FG000|COMPLETED|Overall Study||215
9940750|NCT01352715|11059418|FG001|COMPLETED|Overall Study||209
9940751|NCT01352715|11059417|FG000|NOT COMPLETED|Overall Study||45
9940752|NCT01352715|11059418|FG001|NOT COMPLETED|Overall Study||46
9940753|NCT01352741|11059424|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
9940754|NCT01352741|11059425|FG001|STARTED|Open-label Tapentadol Titration Period||0
9940755|NCT01352741|11059424|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
9940756|NCT01352741|11059425|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
9940757|NCT01352741|11059424|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436
9940758|NCT01352741|11059425|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0
9940759|NCT01352741|11059424|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
9940760|NCT01352741|11059425|FG001|COMPLETED|Open-label Tapentadol Titration Period||0
9940761|NCT01352741|11059424|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73
9940762|NCT01352741|11059425|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0
9940763|NCT01352741|11059424|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
9940764|NCT01352741|11059425|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
9940765|NCT01352741|11059424|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
9940766|NCT01352741|11059425|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
9940767|NCT01352741|11059424|FG000|No Pain Assessments Available|Double-blind Comparative Period||2
9940768|NCT01352741|11059425|FG001|No Pain Assessments Available|Double-blind Comparative Period||2
9940769|NCT01352741|11059424|FG000|Full Analysis Set|Double-blind Comparative Period||152
9940770|NCT01352741|11059425|FG001|Full Analysis Set|Double-blind Comparative Period||157
9940771|NCT01352741|11059424|FG000|Major Protocol Deviations|Double-blind Comparative Period||13
9940772|NCT01352741|11059425|FG001|Major Protocol Deviations|Double-blind Comparative Period||8
9940773|NCT01352741|11059424|FG000|Per Protocol Set|Double-blind Comparative Period||139
9940774|NCT01352741|11059425|FG001|Per Protocol Set|Double-blind Comparative Period||149
9940775|NCT01352741|11059424|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109
9940776|NCT01352741|11059425|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127
9940777|NCT01352741|11059424|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131
9940778|NCT01352741|11059425|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143
9940779|NCT01352741|11059424|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
9940780|NCT01352741|11059425|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
9940781|NCT01352741|11059424|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
9940782|NCT01352741|11059425|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
9940783|NCT01352741|11059424|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
9940784|NCT01352741|11059425|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
9940785|NCT01352741|11059424|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
9940786|NCT01352741|11059425|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
9940787|NCT01352741|11059424|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
9940788|NCT01352741|11059425|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
9940789|NCT01352741|11059424|FG000|COMPLETED|Double-blind Comparative Period||126
9940790|NCT01352741|11059425|FG001|COMPLETED|Double-blind Comparative Period||133
9940791|NCT01352741|11059424|FG000|NOT COMPLETED|Double-blind Comparative Period||28
9940792|NCT01352741|11059425|FG001|NOT COMPLETED|Double-blind Comparative Period||26
9940793|NCT01352741|11059424|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
9940794|NCT01352741|11059425|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
9940795|NCT01352741|11059424|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
9940796|NCT01352741|11059425|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
9940797|NCT01352741|11059424|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
9940798|NCT01352741|11059425|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
9940799|NCT01352741|11059424|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51
9940800|NCT01352741|11059425|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0
9940801|NCT01352741|11059424|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
9940802|NCT01352741|11059425|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
9940803|NCT01352741|11059424|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
9940804|NCT01352741|11059425|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
9940805|NCT01352741|11059424|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
9940806|NCT01352741|11059425|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
9940807|NCT01352741|11059424|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
9940808|NCT01352741|11059425|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
9940809|NCT01352793|11059447|FG000|STARTED|Overall Study||3804
9940810|NCT01352793|11059448|FG001|STARTED|Overall Study||1908
9940811|NCT01352793|11059447|FG000|Vaccination 1|Overall Study||3796
9940812|NCT01352793|11059448|FG001|Vaccination 1|Overall Study||1908
9940813|NCT01352793|11059447|FG000|Vaccination 2|Overall Study||3530
9940814|NCT01352793|11059448|FG001|Vaccination 2|Overall Study||1806
9940815|NCT01352793|11059447|FG000|Vaccination 3|Overall Study||3314
9940816|NCT01352793|11059448|FG001|Vaccination 3|Overall Study||1710
9940817|NCT01352793|11059447|FG000|COMPLETED|Overall Study||3219
9940818|NCT01352793|11059448|FG001|COMPLETED|Overall Study||1663
9940819|NCT01352793|11059447|FG000|NOT COMPLETED|Overall Study||585
9940820|NCT01352793|11059448|FG001|NOT COMPLETED|Overall Study||245
9940821|NCT01352845|11059456|FG000|STARTED|Overall Study||2471
9940822|NCT01352845|11059457|FG001|STARTED|Overall Study||822
9940823|NCT01352845|11059456|FG000|COMPLETED|Overall Study||1800
9940824|NCT01352845|11059457|FG001|COMPLETED|Overall Study||619
9940825|NCT01352845|11059456|FG000|NOT COMPLETED|Overall Study||671
9940826|NCT01352845|11059457|FG001|NOT COMPLETED|Overall Study||203
9940827|NCT01353079|11059465|FG000|STARTED|Overall Study||218
9940828|NCT01353079|11059466|FG001|STARTED|Overall Study||211
9940829|NCT01353079|11059465|FG000|COMPLETED|Overall Study||191
9940830|NCT01353079|11059466|FG001|COMPLETED|Overall Study||190
9940831|NCT01353079|11059465|FG000|NOT COMPLETED|Overall Study||27
9940832|NCT01353079|11059466|FG001|NOT COMPLETED|Overall Study||21
9940833|NCT01353144|11059476|FG000|STARTED|Overall Study||89
9940834|NCT01353144|11059477|FG001|STARTED|Overall Study||89
9940835|NCT01353144|11059476|FG000|COMPLETED|Overall Study||80
9940836|NCT01353144|11059477|FG001|COMPLETED|Overall Study||81
9940837|NCT01353144|11059476|FG000|NOT COMPLETED|Overall Study||9
9940838|NCT01353144|11059477|FG001|NOT COMPLETED|Overall Study||8
9940839|NCT01353196|11059487|FG000|STARTED|Overall Study||100
9940840|NCT01353196|11059488|FG001|STARTED|Overall Study||70
9940841|NCT01353196|11059487|FG000|COMPLETED|Overall Study||71
9940842|NCT01353196|11059488|FG001|COMPLETED|Overall Study||59
9940843|NCT01353196|11059487|FG000|NOT COMPLETED|Overall Study||29
9940844|NCT01353196|11059488|FG001|NOT COMPLETED|Overall Study||11
9940845|NCT01353222|11059496|FG000|STARTED|Overall Study||70
9940846|NCT01353222|11059497|FG001|STARTED|Overall Study||72
9940847|NCT01353222|11059496|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
9940848|NCT01353222|11059497|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
9940849|NCT01353222|11059496|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
9940850|NCT01353222|11059497|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
9940851|NCT01353222|11059496|FG000|COMPLETED|Overall Study||0
9940852|NCT01353222|11059497|FG001|COMPLETED|Overall Study||0
9940853|NCT01353222|11059496|FG000|NOT COMPLETED|Overall Study||70
9940854|NCT01353222|11059497|FG001|NOT COMPLETED|Overall Study||72
9940855|NCT01353274|11059503|FG000|STARTED|Overall Study||1157
9940856|NCT01353274|11059503|FG000|COMPLETED|Overall Study||1129
9940857|NCT01353274|11059503|FG000|NOT COMPLETED|Overall Study||28
9940858|NCT01353495|11059509|FG000|STARTED|Overall Study||19
9940859|NCT01353495|11059510|FG001|STARTED|Overall Study||20
9940860|NCT01353495|11059509|FG000|COMPLETED|Overall Study||19
9940861|NCT01353495|11059510|FG001|COMPLETED|Overall Study||20
9940862|NCT01353495|11059509|FG000|NOT COMPLETED|Overall Study||0
9940863|NCT01353495|11059510|FG001|NOT COMPLETED|Overall Study||0
9940864|NCT01353508|11059520|FG000|STARTED|Period 1 - First Intervention (7 Days)||8
9940865|NCT01353508|11059521|FG001|STARTED|Period 1 - First Intervention (7 Days)||8
9940866|NCT01353508|11059522|FG002|STARTED|Period 1 - First Intervention (7 Days)||8
9940867|NCT01353508|11059523|FG003|STARTED|Period 1 - First Intervention (7 Days)||8
9940868|NCT01353508|11059520|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8
9940869|NCT01353508|11059521|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8
9940870|NCT01353508|11059522|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8
9940871|NCT01353508|11059523|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7
9940872|NCT01353508|11059520|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
9940873|NCT01353508|11059521|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
9940874|NCT01353508|11059522|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
9940875|NCT01353508|11059523|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
9940876|NCT01353508|11059520|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8
9940877|NCT01353508|11059521|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8
9940878|NCT01353508|11059522|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8
9940879|NCT01353508|11059523|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7
10011354|NCT01780662|11134117|FG001|STARTED|Overall Study||13
10011355|NCT01780662|11134118|FG002|STARTED|Overall Study||30
10011356|NCT01780662|11134116|FG000|COMPLETED|Overall Study||2
10011357|NCT01780662|11134117|FG001|COMPLETED|Overall Study||7
10011358|NCT01780662|11134118|FG002|COMPLETED|Overall Study||20
10011359|NCT01780662|11134116|FG000|NOT COMPLETED|Overall Study||1
10011360|NCT01780662|11134117|FG001|NOT COMPLETED|Overall Study||6
9940880|NCT01353508|11059520|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7
9940881|NCT01353508|11059521|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8
9940882|NCT01353508|11059522|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8
9940883|NCT01353508|11059523|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7
9940884|NCT01353508|11059520|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
9940885|NCT01353508|11059521|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
9940886|NCT01353508|11059522|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
9940887|NCT01353508|11059523|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
9940888|NCT01353586|11059535|FG000|STARTED|Overall Study||167
9940889|NCT01353586|11059536|FG001|STARTED|Overall Study||19
9940890|NCT01353586|11059535|FG000|Participated in Workflow Phase|Overall Study||20
9940891|NCT01353586|11059536|FG001|Participated in Workflow Phase|Overall Study||0
9940892|NCT01353586|11059535|FG000|Participated in Roll-in Phase|Overall Study||22
9940893|NCT01353586|11059536|FG001|Participated in Roll-in Phase|Overall Study||0
9940894|NCT01353586|11059535|FG000|Participated in SNA Substudy|Overall Study||19
9940895|NCT01353586|11059536|FG001|Participated in SNA Substudy|Overall Study||19
9940896|NCT01353586|11059535|FG000|COMPLETED|Overall Study||160
9940897|NCT01353586|11059536|FG001|COMPLETED|Overall Study||17
9940898|NCT01353586|11059535|FG000|NOT COMPLETED|Overall Study||7
9940899|NCT01353586|11059536|FG001|NOT COMPLETED|Overall Study||2
9940900|NCT01353664|11059545|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
9940901|NCT01353664|11059545|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
9940902|NCT01353664|11059545|FG000|NOT COMPLETED|Overall Study||19
9940903|NCT01353703|11059551|FG000|STARTED|Overall Study||112
9940904|NCT01353703|11059552|FG001|STARTED|Overall Study||112
9940905|NCT01353703|11059551|FG000|COMPLETED|Overall Study||111
9940906|NCT01353703|11059552|FG001|COMPLETED|Overall Study||112
9940907|NCT01353703|11059551|FG000|NOT COMPLETED|Overall Study||1
9940908|NCT01353703|11059552|FG001|NOT COMPLETED|Overall Study||0
9940909|NCT01353859|11059560|FG000|STARTED|Overall Study||39
9940910|NCT01353859|11059560|FG000|COMPLETED|Overall Study||35
9940911|NCT01353859|11059560|FG000|NOT COMPLETED|Overall Study||4
9940912|NCT01353898|11059570|FG000|STARTED|Overall Study||2
9940913|NCT01353898|11059571|FG001|STARTED|Overall Study||2
9940914|NCT01353898|11059572|FG002|STARTED|Overall Study||2
9940915|NCT01353898|11059573|FG003|STARTED|Overall Study||2
9940916|NCT01353898|11059574|FG004|STARTED|Overall Study||2
9940917|NCT01353898|11059575|FG005|STARTED|Overall Study||2
9940918|NCT01353898|11059570|FG000|COMPLETED|Overall Study||2
9940919|NCT01353898|11059571|FG001|COMPLETED|Overall Study||2
9940920|NCT01353898|11059572|FG002|COMPLETED|Overall Study||2
9940921|NCT01353898|11059573|FG003|COMPLETED|Overall Study||2
9940922|NCT01353898|11059574|FG004|COMPLETED|Overall Study||2
9940923|NCT01353898|11059575|FG005|COMPLETED|Overall Study||1
9940924|NCT01353898|11059570|FG000|NOT COMPLETED|Overall Study||0
9940925|NCT01353898|11059571|FG001|NOT COMPLETED|Overall Study||0
9940926|NCT01353898|11059572|FG002|NOT COMPLETED|Overall Study||0
9940927|NCT01353898|11059573|FG003|NOT COMPLETED|Overall Study||0
9940928|NCT01353898|11059574|FG004|NOT COMPLETED|Overall Study||0
9940929|NCT01353898|11059575|FG005|NOT COMPLETED|Overall Study||1
9940930|NCT01353911|11059597|FG000|STARTED|Overall Study||36
9940931|NCT01353911|11059598|FG001|STARTED|Overall Study||66
9940932|NCT01353911|11059599|FG002|STARTED|Overall Study||68
9940933|NCT01353911|11059600|FG003|STARTED|Overall Study||24
9940934|NCT01353911|11059601|FG004|STARTED|Overall Study||29
9940935|NCT01353911|11059602|FG005|STARTED|Overall Study||43
10011361|NCT01780662|11134118|FG002|NOT COMPLETED|Overall Study||10
10011362|NCT01780831|11134131|FG000|STARTED|Overall Study||10
10011363|NCT01780831|11134132|FG001|STARTED|Overall Study||6
10011364|NCT01780831|11134133|FG002|STARTED|Overall Study||26
9940936|NCT01353911|11059603|FG006|STARTED|Overall Study||36
9940937|NCT01353911|11059604|FG007|STARTED|Overall Study||66
9940938|NCT01353911|11059597|FG000|COMPLETED|Overall Study||28
9940939|NCT01353911|11059598|FG001|COMPLETED|Overall Study||57
9940940|NCT01353911|11059599|FG002|COMPLETED|Overall Study||59
9940941|NCT01353911|11059600|FG003|COMPLETED|Overall Study||22
9940942|NCT01353911|11059601|FG004|COMPLETED|Overall Study||23
9940943|NCT01353911|11059602|FG005|COMPLETED|Overall Study||36
9940944|NCT01353911|11059603|FG006|COMPLETED|Overall Study||30
9940945|NCT01353911|11059604|FG007|COMPLETED|Overall Study||51
9940946|NCT01353911|11059597|FG000|NOT COMPLETED|Overall Study||8
9940947|NCT01353911|11059598|FG001|NOT COMPLETED|Overall Study||9
9940948|NCT01353911|11059599|FG002|NOT COMPLETED|Overall Study||9
9940949|NCT01353911|11059600|FG003|NOT COMPLETED|Overall Study||2
9940950|NCT01353911|11059601|FG004|NOT COMPLETED|Overall Study||6
9940951|NCT01353911|11059602|FG005|NOT COMPLETED|Overall Study||7
9940952|NCT01353911|11059603|FG006|NOT COMPLETED|Overall Study||6
9940953|NCT01353911|11059604|FG007|NOT COMPLETED|Overall Study||15
9940954|NCT01353963|11059622|FG000|STARTED|Overall Study||13
9940955|NCT01353963|11059622|FG000|COMPLETED|Overall Study||11
9940956|NCT01353963|11059622|FG000|NOT COMPLETED|Overall Study||2
9940957|NCT01353976|11059628|FG000|STARTED|Overall Study||130
9940958|NCT01353976|11059629|FG001|STARTED|Overall Study||134
9940959|NCT01353976|11059628|FG000|COMPLETED|Overall Study||82
9940960|NCT01353976|11059629|FG001|COMPLETED|Overall Study||83
9940961|NCT01353976|11059628|FG000|NOT COMPLETED|Overall Study||48
9940962|NCT01353976|11059629|FG001|NOT COMPLETED|Overall Study||51
9940963|NCT01354015|11059637|FG000|STARTED|Overall Study||50
9940964|NCT01354015|11059638|FG001|STARTED|Overall Study||48
9940965|NCT01354015|11059637|FG000|COMPLETED|Overall Study||44
9940966|NCT01354015|11059638|FG001|COMPLETED|Overall Study||43
9940967|NCT01354015|11059637|FG000|NOT COMPLETED|Overall Study||6
9940968|NCT01354015|11059638|FG001|NOT COMPLETED|Overall Study||5
9940969|NCT01354028|11059644|FG000|STARTED|Overall Study||15
9940970|NCT01354028|11059645|FG001|STARTED|Overall Study||15
9940971|NCT01354028|11059644|FG000|COMPLETED|Overall Study||13
9940972|NCT01354028|11059645|FG001|COMPLETED|Overall Study||10
9940973|NCT01354028|11059644|FG000|NOT COMPLETED|Overall Study||2
9940974|NCT01354028|11059645|FG001|NOT COMPLETED|Overall Study||5
9940975|NCT01354106|11059657|FG000|STARTED|Overall Study||26
9940976|NCT01354106|11059657|FG000|COMPLETED|Overall Study||24
9940977|NCT01354106|11059657|FG000|NOT COMPLETED|Overall Study||2
9940978|NCT01354132|11059665|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
9940979|NCT01354132|11059666|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
9940980|NCT01354132|11059665|FG000|COMPLETED|Randomization||31
9940981|NCT01354132|11059666|FG001|COMPLETED|Randomization||30
9940982|NCT01354132|11059665|FG000|NOT COMPLETED|Randomization||1
9940983|NCT01354132|11059666|FG001|NOT COMPLETED|Randomization||1
9940984|NCT01354132|11059665|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
9940985|NCT01354132|11059666|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
9940986|NCT01354132|11059665|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
9940987|NCT01354132|11059666|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
9940988|NCT01354132|11059665|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3
9940989|NCT01354132|11059666|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2
9940990|NCT01354132|11059665|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
9940991|NCT01354132|11059666|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
9940992|NCT01354132|11059665|FG000|COMPLETED|Double Blind (Visits 1-7)||22
9940993|NCT01354132|11059666|FG001|COMPLETED|Double Blind (Visits 1-7)||19
9940994|NCT01354132|11059665|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9
9940995|NCT01354132|11059666|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11
9940996|NCT01354132|11059665|FG000|STARTED|1 Month Post Study Medication||22
9940997|NCT01354132|11059666|FG001|STARTED|1 Month Post Study Medication||19
9940998|NCT01354132|11059665|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
9940999|NCT01354132|11059666|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
9941000|NCT01354132|11059665|FG000|COMPLETED|1 Month Post Study Medication||21
9941001|NCT01354132|11059666|FG001|COMPLETED|1 Month Post Study Medication||16
9941002|NCT01354132|11059665|FG000|NOT COMPLETED|1 Month Post Study Medication||1
9941003|NCT01354132|11059666|FG001|NOT COMPLETED|1 Month Post Study Medication||3
9941004|NCT01354145|11059677|FG000|STARTED|Overall Study||97
9941005|NCT01354145|11059678|FG001|STARTED|Overall Study||97
9941006|NCT01354145|11059677|FG000|COMPLETED|Overall Study||58
9941007|NCT01354145|11059678|FG001|COMPLETED|Overall Study||63
9941008|NCT01354145|11059677|FG000|NOT COMPLETED|Overall Study||39
9941009|NCT01354145|11059678|FG001|NOT COMPLETED|Overall Study||34
9941010|NCT01354197|11059686|FG000|STARTED|Overall Study||4652
9941011|NCT01354197|11059686|FG000|COMPLETED|Overall Study||4652
9941012|NCT01354197|11059686|FG000|NOT COMPLETED|Overall Study||0
9941013|NCT01354223|11059693|FG000|STARTED|Overall Study||60
9941014|NCT01354223|11059694|FG001|STARTED|Overall Study||30
9941015|NCT01354223|11059693|FG000|COMPLETED|Overall Study||57
9941016|NCT01354223|11059694|FG001|COMPLETED|Overall Study||29
9941017|NCT01354223|11059693|FG000|NOT COMPLETED|Overall Study||3
9941018|NCT01354223|11059694|FG001|NOT COMPLETED|Overall Study||1
9941019|NCT01354314|11059704|FG000|STARTED|Overall Study||12
9941020|NCT01354314|11059705|FG001|STARTED|Overall Study||11
9941021|NCT01354314|11059706|FG002|STARTED|Overall Study||11
9941022|NCT01354314|11059707|FG003|STARTED|Overall Study||11
9941023|NCT01354314|11059704|FG000|Completed (ITT)|Overall Study||11
9941024|NCT01354314|11059705|FG001|Completed (ITT)|Overall Study||11
9941025|NCT01354314|11059706|FG002|Completed (ITT)|Overall Study||9
9941026|NCT01354314|11059707|FG003|Completed (ITT)|Overall Study||10
9941027|NCT01354314|11059704|FG000|COMPLETED|Overall Study||6
10011365|NCT01780831|11134134|FG003|STARTED|Overall Study||10
10011366|NCT01780831|11134131|FG000|COMPLETED|Overall Study||10
10207263|NCT03524339|11334082|FG001|COMPLETED|Overall Study||62
10207264|NCT03524339|11334081|FG000|NOT COMPLETED|Overall Study||9
10207265|NCT03524339|11334082|FG001|NOT COMPLETED|Overall Study||4
9941028|NCT01354314|11059705|FG001|COMPLETED|Overall Study||8
10011367|NCT01780831|11134132|FG001|COMPLETED|Overall Study||6
10011368|NCT01780831|11134133|FG002|COMPLETED|Overall Study||22
10011369|NCT01780831|11134134|FG003|COMPLETED|Overall Study||9
10011370|NCT01780831|11134131|FG000|NOT COMPLETED|Overall Study||0
10011371|NCT01780831|11134132|FG001|NOT COMPLETED|Overall Study||0
10011372|NCT01780831|11134133|FG002|NOT COMPLETED|Overall Study||4
9941029|NCT01354314|11059706|FG002|COMPLETED|Overall Study||3
9941030|NCT01354314|11059707|FG003|COMPLETED|Overall Study||5
9941031|NCT01354314|11059704|FG000|NOT COMPLETED|Overall Study||6
9941032|NCT01354314|11059705|FG001|NOT COMPLETED|Overall Study||3
9941033|NCT01354314|11059706|FG002|NOT COMPLETED|Overall Study||8
9941034|NCT01354314|11059707|FG003|NOT COMPLETED|Overall Study||6
9941035|NCT01354353|11059725|FG000|STARTED|Overall Study||16
9941036|NCT01354353|11059726|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12
9941037|NCT01354353|11059727|FG002|STARTED|Overall Study||11
9941038|NCT01354353|11059728|FG003|STARTED|Overall Study||12
9941039|NCT01354353|11059729|FG004|STARTED|Overall Study||12
9941040|NCT01354353|11059730|FG005|STARTED|Overall Study||12
9941041|NCT01354353|11059725|FG000|Received at Least One Dose of Study Drug|Overall Study||16
9941042|NCT01354353|11059726|FG001|Received at Least One Dose of Study Drug|Overall Study||11
9941043|NCT01354353|11059727|FG002|Received at Least One Dose of Study Drug|Overall Study||10
9941044|NCT01354353|11059728|FG003|Received at Least One Dose of Study Drug|Overall Study||11
9941045|NCT01354353|11059729|FG004|Received at Least One Dose of Study Drug|Overall Study||11
9941046|NCT01354353|11059730|FG005|Received at Least One Dose of Study Drug|Overall Study||11
9941047|NCT01354353|11059725|FG000|COMPLETED|Overall Study||13
9941048|NCT01354353|11059726|FG001|COMPLETED|Overall Study||11
9941049|NCT01354353|11059727|FG002|COMPLETED|Overall Study||9
9941050|NCT01354353|11059728|FG003|COMPLETED|Overall Study||7
9941051|NCT01354353|11059729|FG004|COMPLETED|Overall Study||11
9941052|NCT01354353|11059730|FG005|COMPLETED|Overall Study||6
9941053|NCT01354353|11059725|FG000|NOT COMPLETED|Overall Study||3
9941054|NCT01354353|11059726|FG001|NOT COMPLETED|Overall Study||1
9941055|NCT01354353|11059727|FG002|NOT COMPLETED|Overall Study||2
9941056|NCT01354353|11059728|FG003|NOT COMPLETED|Overall Study||5
9941057|NCT01354353|11059729|FG004|NOT COMPLETED|Overall Study||1
9941058|NCT01354353|11059730|FG005|NOT COMPLETED|Overall Study||6
9941059|NCT01354444|11059753|FG000|STARTED|Overall Study||14
9941060|NCT01354444|11059754|FG001|STARTED|Overall Study||15
9941061|NCT01354444|11059753|FG000|COMPLETED|Overall Study||6
9941062|NCT01354444|11059754|FG001|COMPLETED|Overall Study||11
9941063|NCT01354444|11059753|FG000|NOT COMPLETED|Overall Study||8
9941064|NCT01354444|11059754|FG001|NOT COMPLETED|Overall Study||4
9941065|NCT01354496|11059764|FG000|STARTED|Period 1||6
9941066|NCT01354496|11059765|FG001|STARTED|Period 1||6
9941067|NCT01354496|11059766|FG002|STARTED|Period 1||6
9941068|NCT01354496|11059767|FG003|STARTED|Period 1||6
9941069|NCT01354496|11059768|FG004|STARTED|Period 1||5
9941070|NCT01354496|11059769|FG005|STARTED|Period 1||6
9941071|NCT01354496|11059764|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
9941072|NCT01354496|11059765|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
9941073|NCT01354496|11059766|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
10011373|NCT01780831|11134134|FG003|NOT COMPLETED|Overall Study||1
10011374|NCT01780870|11134193|FG000|STARTED|Overall Study||0
10011375|NCT01780870|11134194|FG001|STARTED|Overall Study||5
9941074|NCT01354496|11059767|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
9941075|NCT01354496|11059768|FG004|Received at Least 1 Dose of Study Drug|Period 1||5
9941076|NCT01354496|11059769|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
9941077|NCT01354496|11059764|FG000|COMPLETED|Period 1||6
9941078|NCT01354496|11059765|FG001|COMPLETED|Period 1||6
9941079|NCT01354496|11059766|FG002|COMPLETED|Period 1||4
9941080|NCT01354496|11059767|FG003|COMPLETED|Period 1||6
9941081|NCT01354496|11059768|FG004|COMPLETED|Period 1||5
9941082|NCT01354496|11059769|FG005|COMPLETED|Period 1||6
9941083|NCT01354496|11059764|FG000|NOT COMPLETED|Period 1||0
9941084|NCT01354496|11059765|FG001|NOT COMPLETED|Period 1||0
9941085|NCT01354496|11059766|FG002|NOT COMPLETED|Period 1||2
9941086|NCT01354496|11059767|FG003|NOT COMPLETED|Period 1||0
10011376|NCT01780870|11134193|FG000|COMPLETED|Overall Study||0
9941087|NCT01354496|11059768|FG004|NOT COMPLETED|Period 1||0
9941088|NCT01354496|11059769|FG005|NOT COMPLETED|Period 1||0
10011377|NCT01780870|11134194|FG001|COMPLETED|Overall Study||5
9941089|NCT01354496|11059764|FG000|STARTED|Washout (at Least 14 Days)||6
9941090|NCT01354496|11059765|FG001|STARTED|Washout (at Least 14 Days)||6
10011378|NCT01780870|11134193|FG000|NOT COMPLETED|Overall Study||0
10011379|NCT01780870|11134194|FG001|NOT COMPLETED|Overall Study||0
10011380|NCT01780922|11134200|FG000|STARTED|First Intervention (1 Day)||2
10207266|NCT03525119|11334091|FG000|STARTED|Overall Study||300
9941091|NCT01354496|11059766|FG002|STARTED|Washout (at Least 14 Days)||4
9941092|NCT01354496|11059767|FG003|STARTED|Washout (at Least 14 Days)||6
9941093|NCT01354496|11059768|FG004|STARTED|Washout (at Least 14 Days)||5
9941094|NCT01354496|11059769|FG005|STARTED|Washout (at Least 14 Days)||6
9941095|NCT01354496|11059764|FG000|COMPLETED|Washout (at Least 14 Days)||6
9941096|NCT01354496|11059765|FG001|COMPLETED|Washout (at Least 14 Days)||6
9941097|NCT01354496|11059766|FG002|COMPLETED|Washout (at Least 14 Days)||4
9941098|NCT01354496|11059767|FG003|COMPLETED|Washout (at Least 14 Days)||6
9941099|NCT01354496|11059768|FG004|COMPLETED|Washout (at Least 14 Days)||5
9941100|NCT01354496|11059769|FG005|COMPLETED|Washout (at Least 14 Days)||6
9941101|NCT01354496|11059764|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
9941102|NCT01354496|11059765|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
9941103|NCT01354496|11059766|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
9941104|NCT01354496|11059767|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
9941105|NCT01354496|11059768|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
9941106|NCT01354496|11059769|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
9941107|NCT01354496|11059764|FG000|STARTED|Period 2||6
9941108|NCT01354496|11059765|FG001|STARTED|Period 2||6
9941109|NCT01354496|11059766|FG002|STARTED|Period 2||4
9941110|NCT01354496|11059767|FG003|STARTED|Period 2||6
9941111|NCT01354496|11059768|FG004|STARTED|Period 2||5
9941112|NCT01354496|11059769|FG005|STARTED|Period 2||6
9941113|NCT01354496|11059764|FG000|COMPLETED|Period 2||6
9941114|NCT01354496|11059765|FG001|COMPLETED|Period 2||6
9941115|NCT01354496|11059766|FG002|COMPLETED|Period 2||4
9941116|NCT01354496|11059767|FG003|COMPLETED|Period 2||5
9941117|NCT01354496|11059768|FG004|COMPLETED|Period 2||5
9941118|NCT01354496|11059769|FG005|COMPLETED|Period 2||6
9941119|NCT01354496|11059764|FG000|NOT COMPLETED|Period 2||0
9941120|NCT01354496|11059765|FG001|NOT COMPLETED|Period 2||0
9941121|NCT01354496|11059766|FG002|NOT COMPLETED|Period 2||0
9941122|NCT01354496|11059767|FG003|NOT COMPLETED|Period 2||1
9941123|NCT01354496|11059768|FG004|NOT COMPLETED|Period 2||0
9941124|NCT01354496|11059769|FG005|NOT COMPLETED|Period 2||0
9941125|NCT01354496|11059764|FG000|STARTED|Washout (at Least 14 Days)||6
9941126|NCT01354496|11059765|FG001|STARTED|Washout (at Least 14 Days)||6
9941127|NCT01354496|11059766|FG002|STARTED|Washout (at Least 14 Days)||4
9941128|NCT01354496|11059767|FG003|STARTED|Washout (at Least 14 Days)||5
9941129|NCT01354496|11059768|FG004|STARTED|Washout (at Least 14 Days)||5
9941130|NCT01354496|11059769|FG005|STARTED|Washout (at Least 14 Days)||6
9941131|NCT01354496|11059764|FG000|COMPLETED|Washout (at Least 14 Days)||6
9941132|NCT01354496|11059765|FG001|COMPLETED|Washout (at Least 14 Days)||5
9941133|NCT01354496|11059766|FG002|COMPLETED|Washout (at Least 14 Days)||4
9941134|NCT01354496|11059767|FG003|COMPLETED|Washout (at Least 14 Days)||4
9941135|NCT01354496|11059768|FG004|COMPLETED|Washout (at Least 14 Days)||5
9941136|NCT01354496|11059769|FG005|COMPLETED|Washout (at Least 14 Days)||6
9941137|NCT01354496|11059764|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
9941138|NCT01354496|11059765|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1
9941139|NCT01354496|11059766|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
9941140|NCT01354496|11059767|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1
9941141|NCT01354496|11059768|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
9941142|NCT01354496|11059769|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
9941143|NCT01354496|11059764|FG000|STARTED|Period 3||6
9941144|NCT01354496|11059765|FG001|STARTED|Period 3||5
9941145|NCT01354496|11059766|FG002|STARTED|Period 3||4
9941146|NCT01354496|11059767|FG003|STARTED|Period 3||4
10011381|NCT01780922|11134201|FG001|STARTED|First Intervention (1 Day)||2
10011382|NCT01780922|11134202|FG002|STARTED|First Intervention (1 Day)||2
10011383|NCT01780922|11134203|FG003|STARTED|First Intervention (1 Day)||2
9941147|NCT01354496|11059768|FG004|STARTED|Period 3||5
9941148|NCT01354496|11059769|FG005|STARTED|Period 3||6
9941149|NCT01354496|11059764|FG000|COMPLETED|Period 3||6
9941150|NCT01354496|11059765|FG001|COMPLETED|Period 3||5
9941151|NCT01354496|11059766|FG002|COMPLETED|Period 3||4
9941152|NCT01354496|11059767|FG003|COMPLETED|Period 3||4
9941153|NCT01354496|11059768|FG004|COMPLETED|Period 3||5
9941154|NCT01354496|11059769|FG005|COMPLETED|Period 3||6
9941155|NCT01354496|11059764|FG000|NOT COMPLETED|Period 3||0
9941156|NCT01354496|11059765|FG001|NOT COMPLETED|Period 3||0
9941157|NCT01354496|11059766|FG002|NOT COMPLETED|Period 3||0
9941158|NCT01354496|11059767|FG003|NOT COMPLETED|Period 3||0
9941159|NCT01354496|11059768|FG004|NOT COMPLETED|Period 3||0
9941160|NCT01354496|11059769|FG005|NOT COMPLETED|Period 3||0
9941161|NCT01354652|11059793|FG000|STARTED|Overall Study||3
9941162|NCT01354652|11059794|FG001|STARTED|Overall Study||2
9941163|NCT01354652|11059795|FG002|STARTED|Overall Study||0
9941164|NCT01354652|11059793|FG000|COMPLETED|Overall Study||0
10111623|NCT02497391|11242655|FG002|COMPLETED|Period 1 (14 Days)||16
9941165|NCT01354652|11059794|FG001|COMPLETED|Overall Study||0
10011384|NCT01780922|11134204|FG004|STARTED|First Intervention (1 Day)||2
10111624|NCT02497391|11242656|FG003|COMPLETED|Period 1 (14 Days)||16
9941166|NCT01354652|11059795|FG002|COMPLETED|Overall Study||0
9941167|NCT01354652|11059793|FG000|NOT COMPLETED|Overall Study||3
9941168|NCT01354652|11059794|FG001|NOT COMPLETED|Overall Study||2
9941169|NCT01354652|11059795|FG002|NOT COMPLETED|Overall Study||0
9941170|NCT01354691|11059806|FG000|STARTED|Overall Study||101
9941171|NCT01354691|11059807|FG001|STARTED|Overall Study||99
9941172|NCT01354691|11059806|FG000|ITT|Overall Study||99
9941173|NCT01354691|11059807|FG001|ITT|Overall Study||96
10011385|NCT01780922|11134205|FG005|STARTED|First Intervention (1 Day)||2
10111625|NCT02497391|11242657|FG004|COMPLETED|Period 1 (14 Days)||16
10111626|NCT02497391|11242658|FG005|COMPLETED|Period 1 (14 Days)||16
10111627|NCT02497391|11242653|FG000|NOT COMPLETED|Period 1 (14 Days)||0
10111628|NCT02497391|11242654|FG001|NOT COMPLETED|Period 1 (14 Days)||0
10111629|NCT02497391|11242655|FG002|NOT COMPLETED|Period 1 (14 Days)||0
10111630|NCT02497391|11242656|FG003|NOT COMPLETED|Period 1 (14 Days)||0
10111631|NCT02497391|11242657|FG004|NOT COMPLETED|Period 1 (14 Days)||0
10111632|NCT02497391|11242658|FG005|NOT COMPLETED|Period 1 (14 Days)||0
10111633|NCT02497391|11242653|FG000|STARTED|Period 2 (14 Days)||16
9941174|NCT01354691|11059806|FG000|PP|Overall Study||79
9941175|NCT01354691|11059807|FG001|PP|Overall Study||75
9941176|NCT01354691|11059806|FG000|COMPLETED|Overall Study||80
9941177|NCT01354691|11059807|FG001|COMPLETED|Overall Study||77
9941178|NCT01354691|11059806|FG000|NOT COMPLETED|Overall Study||21
9941179|NCT01354691|11059807|FG001|NOT COMPLETED|Overall Study||22
9941180|NCT01354899|11059813|FG000|STARTED|Overall Study||24
9941181|NCT01354899|11059813|FG000|COMPLETED|Overall Study||21
9941182|NCT01354899|11059813|FG000|NOT COMPLETED|Overall Study||3
9941183|NCT01354938|11059817|FG000|STARTED|Overall Study||220
9941184|NCT01354938|11059817|FG000|COMPLETED|Overall Study||219
9941185|NCT01354938|11059817|FG000|NOT COMPLETED|Overall Study||1
9941186|NCT01354964|11059823|FG000|STARTED|Overall Study||11
9941187|NCT01354964|11059824|FG001|STARTED|Overall Study||8
9941188|NCT01354964|11059823|FG000|COMPLETED|Overall Study||7
9941189|NCT01354964|11059824|FG001|COMPLETED|Overall Study||7
9941190|NCT01354964|11059823|FG000|NOT COMPLETED|Overall Study||4
9941191|NCT01354964|11059824|FG001|NOT COMPLETED|Overall Study||1
9941192|NCT01354990|11059832|FG000|STARTED|Overall Study||2974
9941193|NCT01354990|11059832|FG000|COMPLETED|Overall Study||2974
9941194|NCT01354990|11059832|FG000|NOT COMPLETED|Overall Study||0
9941195|NCT01355068|11059836|FG000|STARTED|First Intervention Period||13
9941196|NCT01355068|11059837|FG001|STARTED|First Intervention Period||13
9941197|NCT01355068|11059836|FG000|COMPLETED|First Intervention Period||13
9941198|NCT01355068|11059837|FG001|COMPLETED|First Intervention Period||11
9941199|NCT01355068|11059836|FG000|NOT COMPLETED|First Intervention Period||0
9941200|NCT01355068|11059837|FG001|NOT COMPLETED|First Intervention Period||2
9941201|NCT01355068|11059836|FG000|STARTED|Washout Period (at Least 7 Days)||13
9941202|NCT01355068|11059837|FG001|STARTED|Washout Period (at Least 7 Days)||11
9941203|NCT01355068|11059836|FG000|COMPLETED|Washout Period (at Least 7 Days)||13
9941204|NCT01355068|11059837|FG001|COMPLETED|Washout Period (at Least 7 Days)||11
9941205|NCT01355068|11059836|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9941206|NCT01355068|11059837|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9941207|NCT01355068|11059836|FG000|STARTED|Second Intervention Period||13
9941208|NCT01355068|11059837|FG001|STARTED|Second Intervention Period||11
9941209|NCT01355068|11059836|FG000|COMPLETED|Second Intervention Period||13
9941210|NCT01355068|11059837|FG001|COMPLETED|Second Intervention Period||11
9941211|NCT01355068|11059836|FG000|NOT COMPLETED|Second Intervention Period||0
9941212|NCT01355068|11059837|FG001|NOT COMPLETED|Second Intervention Period||0
9941213|NCT01355081|11059846|FG000|STARTED|Overall Study||119
9941214|NCT01355081|11059847|FG001|STARTED|Overall Study||123
9941215|NCT01355081|11059848|FG002|STARTED|Overall Study||124
9941216|NCT01355081|11059846|FG000|COMPLETED|Overall Study||112
9941217|NCT01355081|11059847|FG001|COMPLETED|Overall Study||113
9941218|NCT01355081|11059848|FG002|COMPLETED|Overall Study||113
9941219|NCT01355081|11059846|FG000|NOT COMPLETED|Overall Study||7
9941220|NCT01355081|11059847|FG001|NOT COMPLETED|Overall Study||10
9941221|NCT01355081|11059848|FG002|NOT COMPLETED|Overall Study||11
9941222|NCT01355159|11059858|FG000|STARTED|Overall Study||1228
9941223|NCT01355159|11059859|FG001|STARTED|Overall Study||1236
9941224|NCT01355159|11059858|FG000|COMPLETED|Overall Study||1144
9941225|NCT01355159|11059859|FG001|COMPLETED|Overall Study||1157
9941226|NCT01355159|11059858|FG000|NOT COMPLETED|Overall Study||84
9941227|NCT01355159|11059859|FG001|NOT COMPLETED|Overall Study||79
9941228|NCT01355224|11059869|FG000|STARTED|Overall Study||198
9941229|NCT01355224|11059870|FG001|STARTED|Overall Study||203
9941230|NCT01355224|11059871|FG002|STARTED|Overall Study||196
9941231|NCT01355224|11059872|FG003|STARTED|Overall Study||201
9941232|NCT01355224|11059869|FG000|Competed Baseline|Overall Study||191
9941233|NCT01355224|11059870|FG001|Competed Baseline|Overall Study||200
9941234|NCT01355224|11059871|FG002|Competed Baseline|Overall Study||193
9941235|NCT01355224|11059872|FG003|Competed Baseline|Overall Study||193
9941236|NCT01355224|11059869|FG000|COMPLETED|Overall Study||167
9941237|NCT01355224|11059870|FG001|COMPLETED|Overall Study||180
9941238|NCT01355224|11059871|FG002|COMPLETED|Overall Study||177
9941239|NCT01355224|11059872|FG003|COMPLETED|Overall Study||172
9941240|NCT01355224|11059869|FG000|NOT COMPLETED|Overall Study||31
9941241|NCT01355224|11059870|FG001|NOT COMPLETED|Overall Study||23
9941242|NCT01355224|11059871|FG002|NOT COMPLETED|Overall Study||19
9941243|NCT01355224|11059872|FG003|NOT COMPLETED|Overall Study||29
9941244|NCT01355289|11059894|FG000|STARTED|Core Study||17
9941245|NCT01355289|11059895|FG001|STARTED|Core Study||16
9941246|NCT01355289|11059896|FG002|STARTED|Core Study||18
9941247|NCT01355289|11059897|FG003|STARTED|Core Study||14
9941248|NCT01355289|11059898|FG004|STARTED|Core Study||0
9941249|NCT01355289|11059894|FG000|COMPLETED|Core Study||16
9941250|NCT01355289|11059895|FG001|COMPLETED|Core Study||16
9941251|NCT01355289|11059896|FG002|COMPLETED|Core Study||18
9941252|NCT01355289|11059897|FG003|COMPLETED|Core Study||12
9941253|NCT01355289|11059898|FG004|COMPLETED|Core Study||0
9941254|NCT01355289|11059894|FG000|NOT COMPLETED|Core Study||1
9941255|NCT01355289|11059895|FG001|NOT COMPLETED|Core Study||0
9941256|NCT01355289|11059896|FG002|NOT COMPLETED|Core Study||0
9941257|NCT01355289|11059897|FG003|NOT COMPLETED|Core Study||2
9941258|NCT01355289|11059898|FG004|NOT COMPLETED|Core Study||0
9941259|NCT01355289|11059894|FG000|STARTED|Open Label Extension||0
9941260|NCT01355289|11059895|FG001|STARTED|Open Label Extension||0
9941261|NCT01355289|11059896|FG002|STARTED|Open Label Extension||0
9941262|NCT01355289|11059897|FG003|STARTED|Open Label Extension||0
9941263|NCT01355289|11059898|FG004|STARTED|Open Label Extension||62
9941264|NCT01355289|11059894|FG000|COMPLETED|Open Label Extension||0
9941265|NCT01355289|11059895|FG001|COMPLETED|Open Label Extension||0
9941266|NCT01355289|11059896|FG002|COMPLETED|Open Label Extension||0
9941267|NCT01355289|11059897|FG003|COMPLETED|Open Label Extension||0
9941268|NCT01355289|11059898|FG004|COMPLETED|Open Label Extension||28
9941269|NCT01355289|11059894|FG000|NOT COMPLETED|Open Label Extension||0
9941270|NCT01355289|11059895|FG001|NOT COMPLETED|Open Label Extension||0
9941271|NCT01355289|11059896|FG002|NOT COMPLETED|Open Label Extension||0
9941272|NCT01355289|11059897|FG003|NOT COMPLETED|Open Label Extension||0
9941273|NCT01355289|11059898|FG004|NOT COMPLETED|Open Label Extension||34
9941274|NCT01355302|11059911|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
9941275|NCT01355302|11059912|FG001|STARTED|Phase 1b||0
9941276|NCT01355302|11059913|FG002|STARTED|Phase 1b||0
9941277|NCT01355302|11059911|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
9941278|NCT01355302|11059912|FG001|COMPLETED|Phase 1b||0
9941279|NCT01355302|11059913|FG002|COMPLETED|Phase 1b||0
9941280|NCT01355302|11059911|FG000|NOT COMPLETED|Phase 1b||6
9941281|NCT01355302|11059912|FG001|NOT COMPLETED|Phase 1b||0
9941282|NCT01355302|11059913|FG002|NOT COMPLETED|Phase 1b||0
9941283|NCT01355302|11059911|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
9941284|NCT01355302|11059912|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0
9941285|NCT01355302|11059913|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0
9941286|NCT01355302|11059911|FG000|COMPLETED|Phase 2||0
9941287|NCT01355302|11059912|FG001|COMPLETED|Phase 2||0
9941288|NCT01355302|11059913|FG002|COMPLETED|Phase 2||0
9941289|NCT01355302|11059911|FG000|NOT COMPLETED|Phase 2||0
9941290|NCT01355302|11059912|FG001|NOT COMPLETED|Phase 2||0
9941291|NCT01355302|11059913|FG002|NOT COMPLETED|Phase 2||0
9941292|NCT01355419|11059921|FG000|STARTED|Overall Study||150
9941293|NCT01355419|11059921|FG000|COMPLETED|Overall Study||142
9941294|NCT01355419|11059921|FG000|NOT COMPLETED|Overall Study||8
9941295|NCT01355458|11059927|FG000|STARTED|Overall Study||129
9941296|NCT01355458|11059928|FG001|STARTED|Overall Study||131
9941297|NCT01355458|11059927|FG000|COMPLETED|Overall Study||127
9941298|NCT01355458|11059928|FG001|COMPLETED|Overall Study||127
9941299|NCT01355458|11059927|FG000|NOT COMPLETED|Overall Study||2
9941300|NCT01355458|11059928|FG001|NOT COMPLETED|Overall Study||4
9941301|NCT01355471|11059936|FG000|STARTED|Overall Study||148
9941302|NCT01355471|11059937|FG001|STARTED|Overall Study||145
9941303|NCT01355471|11059936|FG000|COMPLETED|Overall Study||141
9941304|NCT01355471|11059937|FG001|COMPLETED|Overall Study||142
9941305|NCT01355471|11059936|FG000|NOT COMPLETED|Overall Study||7
9941306|NCT01355471|11059937|FG001|NOT COMPLETED|Overall Study||3
9941307|NCT01355484|11059945|FG000|STARTED|Overall Study||160
9941308|NCT01355484|11059946|FG001|STARTED|Overall Study||161
9941309|NCT01355484|11059945|FG000|COMPLETED|Overall Study||109
9941310|NCT01355484|11059946|FG001|COMPLETED|Overall Study||107
9941311|NCT01355484|11059945|FG000|NOT COMPLETED|Overall Study||51
9941312|NCT01355484|11059946|FG001|NOT COMPLETED|Overall Study||54
9941313|NCT01355497|11059954|FG000|STARTED|Overall Study||165
9941314|NCT01355497|11059955|FG001|STARTED|Overall Study||165
9941315|NCT01355497|11059954|FG000|COMPLETED|Overall Study||99
9941316|NCT01355497|11059955|FG001|COMPLETED|Overall Study||102
9941317|NCT01355497|11059954|FG000|NOT COMPLETED|Overall Study||66
9941318|NCT01355497|11059955|FG001|NOT COMPLETED|Overall Study||63
9941319|NCT01355523|11059963|FG000|STARTED|Overall Study||28
9941320|NCT01355523|11059964|FG001|STARTED|Overall Study||26
9941321|NCT01355523|11059963|FG000|COMPLETED|Overall Study||27
9941322|NCT01355523|11059964|FG001|COMPLETED|Overall Study||16
9941323|NCT01355523|11059963|FG000|NOT COMPLETED|Overall Study||1
9941324|NCT01355523|11059964|FG001|NOT COMPLETED|Overall Study||10
9941325|NCT01355575|11059970|FG000|STARTED|Overall Study||15
9941326|NCT01355575|11059970|FG000|COMPLETED|Overall Study||13
9941327|NCT01355575|11059970|FG000|NOT COMPLETED|Overall Study||2
9941328|NCT01355588|11059982|FG000|STARTED|First Intervention (Day 1)||4
9941329|NCT01355588|11059983|FG001|STARTED|First Intervention (Day 1)||4
9941330|NCT01355588|11059984|FG002|STARTED|First Intervention (Day 1)||4
9941331|NCT01355588|11059985|FG003|STARTED|First Intervention (Day 1)||4
9941332|NCT01355588|11059982|FG000|COMPLETED|First Intervention (Day 1)||4
9941333|NCT01355588|11059983|FG001|COMPLETED|First Intervention (Day 1)||4
9941334|NCT01355588|11059984|FG002|COMPLETED|First Intervention (Day 1)||4
9941335|NCT01355588|11059985|FG003|COMPLETED|First Intervention (Day 1)||4
9941336|NCT01355588|11059982|FG000|NOT COMPLETED|First Intervention (Day 1)||0
9941337|NCT01355588|11059983|FG001|NOT COMPLETED|First Intervention (Day 1)||0
9941338|NCT01355588|11059984|FG002|NOT COMPLETED|First Intervention (Day 1)||0
9941339|NCT01355588|11059985|FG003|NOT COMPLETED|First Intervention (Day 1)||0
9941340|NCT01355588|11059982|FG000|STARTED|Washout (3-7 Days)||4
9941341|NCT01355588|11059983|FG001|STARTED|Washout (3-7 Days)||4
9941342|NCT01355588|11059984|FG002|STARTED|Washout (3-7 Days)||4
9941343|NCT01355588|11059985|FG003|STARTED|Washout (3-7 Days)||4
9941344|NCT01355588|11059982|FG000|COMPLETED|Washout (3-7 Days)||4
9941345|NCT01355588|11059983|FG001|COMPLETED|Washout (3-7 Days)||4
9941346|NCT01355588|11059984|FG002|COMPLETED|Washout (3-7 Days)||4
9941347|NCT01355588|11059985|FG003|COMPLETED|Washout (3-7 Days)||4
9941348|NCT01355588|11059982|FG000|NOT COMPLETED|Washout (3-7 Days)||0
9941349|NCT01355588|11059983|FG001|NOT COMPLETED|Washout (3-7 Days)||0
9941350|NCT01355588|11059984|FG002|NOT COMPLETED|Washout (3-7 Days)||0
9941351|NCT01355588|11059985|FG003|NOT COMPLETED|Washout (3-7 Days)||0
9941352|NCT01355588|11059982|FG000|STARTED|Second Intervention (After Washout)||4
9941353|NCT01355588|11059983|FG001|STARTED|Second Intervention (After Washout)||4
9941354|NCT01355588|11059984|FG002|STARTED|Second Intervention (After Washout)||4
9941355|NCT01355588|11059985|FG003|STARTED|Second Intervention (After Washout)||4
9941356|NCT01355588|11059982|FG000|COMPLETED|Second Intervention (After Washout)||4
9941357|NCT01355588|11059983|FG001|COMPLETED|Second Intervention (After Washout)||4
9941358|NCT01355588|11059984|FG002|COMPLETED|Second Intervention (After Washout)||4
9941359|NCT01355588|11059985|FG003|COMPLETED|Second Intervention (After Washout)||4
9941360|NCT01355588|11059982|FG000|NOT COMPLETED|Second Intervention (After Washout)||0
9941361|NCT01355588|11059983|FG001|NOT COMPLETED|Second Intervention (After Washout)||0
9941362|NCT01355588|11059984|FG002|NOT COMPLETED|Second Intervention (After Washout)||0
9941363|NCT01355588|11059985|FG003|NOT COMPLETED|Second Intervention (After Washout)||0
9941364|NCT01355588|11059982|FG000|STARTED|Washout (3-7 Days)||4
9941365|NCT01355588|11059983|FG001|STARTED|Washout (3-7 Days)||4
9941366|NCT01355588|11059984|FG002|STARTED|Washout (3-7 Days)||4
9941367|NCT01355588|11059985|FG003|STARTED|Washout (3-7 Days)||4
9941368|NCT01355588|11059982|FG000|COMPLETED|Washout (3-7 Days)||4
9941369|NCT01355588|11059983|FG001|COMPLETED|Washout (3-7 Days)||4
9941370|NCT01355588|11059984|FG002|COMPLETED|Washout (3-7 Days)||4
9941371|NCT01355588|11059985|FG003|COMPLETED|Washout (3-7 Days)||4
9941372|NCT01355588|11059982|FG000|NOT COMPLETED|Washout (3-7 Days)||0
9941373|NCT01355588|11059983|FG001|NOT COMPLETED|Washout (3-7 Days)||0
9941374|NCT01355588|11059984|FG002|NOT COMPLETED|Washout (3-7 Days)||0
9941375|NCT01355588|11059985|FG003|NOT COMPLETED|Washout (3-7 Days)||0
9941376|NCT01355588|11059982|FG000|STARTED|Third Intervention (After Washout)||4
9941377|NCT01355588|11059983|FG001|STARTED|Third Intervention (After Washout)||4
9941378|NCT01355588|11059984|FG002|STARTED|Third Intervention (After Washout)||4
9941379|NCT01355588|11059985|FG003|STARTED|Third Intervention (After Washout)||4
9941380|NCT01355588|11059982|FG000|COMPLETED|Third Intervention (After Washout)||4
9941381|NCT01355588|11059983|FG001|COMPLETED|Third Intervention (After Washout)||4
9941382|NCT01355588|11059984|FG002|COMPLETED|Third Intervention (After Washout)||4
9941383|NCT01355588|11059985|FG003|COMPLETED|Third Intervention (After Washout)||4
9941384|NCT01355588|11059982|FG000|NOT COMPLETED|Third Intervention (After Washout)||0
9941385|NCT01355588|11059983|FG001|NOT COMPLETED|Third Intervention (After Washout)||0
9941386|NCT01355588|11059984|FG002|NOT COMPLETED|Third Intervention (After Washout)||0
9941387|NCT01355588|11059985|FG003|NOT COMPLETED|Third Intervention (After Washout)||0
9941388|NCT01355588|11059982|FG000|STARTED|Washout (3-7 Days)||4
9941389|NCT01355588|11059983|FG001|STARTED|Washout (3-7 Days)||4
9941390|NCT01355588|11059984|FG002|STARTED|Washout (3-7 Days)||4
9941391|NCT01355588|11059985|FG003|STARTED|Washout (3-7 Days)||4
10207267|NCT03525119|11334092|FG001|STARTED|Overall Study||300
10207268|NCT03525119|11334093|FG002|STARTED|Overall Study||300
10207269|NCT03525119|11334091|FG000|Safety Population|Overall Study||299
10207270|NCT03525119|11334092|FG001|Safety Population|Overall Study||300
10207271|NCT03525119|11334093|FG002|Safety Population|Overall Study||298
10207272|NCT03525119|11334091|FG000|COMPLETED|Overall Study||260
10207273|NCT03525119|11334092|FG001|COMPLETED|Overall Study||261
10207274|NCT03525119|11334093|FG002|COMPLETED|Overall Study||257
10207275|NCT03525119|11334091|FG000|NOT COMPLETED|Overall Study||40
10207276|NCT03525119|11334092|FG001|NOT COMPLETED|Overall Study||39
10207277|NCT03525119|11334093|FG002|NOT COMPLETED|Overall Study||43
10207278|NCT03525210|11334103|FG000|STARTED|Overall Study||100
10207279|NCT03525210|11334104|FG001|STARTED|Overall Study||171
10207280|NCT03525210|11334103|FG000|COMPLETED|Overall Study||96
9941392|NCT01355588|11059982|FG000|COMPLETED|Washout (3-7 Days)||4
9941393|NCT01355588|11059983|FG001|COMPLETED|Washout (3-7 Days)||4
9941394|NCT01355588|11059984|FG002|COMPLETED|Washout (3-7 Days)||4
9941395|NCT01355588|11059985|FG003|COMPLETED|Washout (3-7 Days)||4
9941396|NCT01355588|11059982|FG000|NOT COMPLETED|Washout (3-7 Days)||0
9941397|NCT01355588|11059983|FG001|NOT COMPLETED|Washout (3-7 Days)||0
9941398|NCT01355588|11059984|FG002|NOT COMPLETED|Washout (3-7 Days)||0
9941399|NCT01355588|11059985|FG003|NOT COMPLETED|Washout (3-7 Days)||0
9941400|NCT01355588|11059982|FG000|STARTED|Fourth Intervention (After Washout)||4
9941401|NCT01355588|11059983|FG001|STARTED|Fourth Intervention (After Washout)||4
9941402|NCT01355588|11059984|FG002|STARTED|Fourth Intervention (After Washout)||4
9941403|NCT01355588|11059985|FG003|STARTED|Fourth Intervention (After Washout)||4
9941404|NCT01355588|11059982|FG000|COMPLETED|Fourth Intervention (After Washout)||4
9941405|NCT01355588|11059983|FG001|COMPLETED|Fourth Intervention (After Washout)||4
9941406|NCT01355588|11059984|FG002|COMPLETED|Fourth Intervention (After Washout)||4
9941407|NCT01355588|11059985|FG003|COMPLETED|Fourth Intervention (After Washout)||4
9956681|NCT01447511|11075962|FG002|NOT COMPLETED|Rifampin Period||0
10207281|NCT03525210|11334104|FG001|COMPLETED|Overall Study||169
10207282|NCT03525210|11334103|FG000|NOT COMPLETED|Overall Study||4
10207283|NCT03525210|11334104|FG001|NOT COMPLETED|Overall Study||2
9941408|NCT01355588|11059982|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0
9941409|NCT01355588|11059983|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0
9941410|NCT01355588|11059984|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0
9941411|NCT01355588|11059985|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0
9941412|NCT01355627|11059997|FG000|STARTED|Overall Study||362
9941413|NCT01355627|11059998|FG001|STARTED|Overall Study||364
9941414|NCT01355627|11059997|FG000|Safety Analysis Set|Overall Study||362
9941415|NCT01355627|11059998|FG001|Safety Analysis Set|Overall Study||364
9941416|NCT01355627|11059997|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
9941417|NCT01355627|11059998|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
9941418|NCT01355627|11059997|FG000|COMPLETED|Overall Study||329
9941419|NCT01355627|11059998|FG001|COMPLETED|Overall Study||326
9941420|NCT01355627|11059997|FG000|NOT COMPLETED|Overall Study||33
9941421|NCT01355627|11059998|FG001|NOT COMPLETED|Overall Study||38
9941422|NCT01355705|11060004|FG000|STARTED|Overall Study||14
9941423|NCT01355705|11060004|FG000|COMPLETED|Overall Study||14
9941424|NCT01355705|11060004|FG000|NOT COMPLETED|Overall Study||0
9956682|NCT01447511|11075963|FG003|NOT COMPLETED|Rifampin Period||1
9956683|NCT01447511|11075964|FG004|NOT COMPLETED|Rifampin Period||0
9956684|NCT01447576|11075976|FG000|STARTED|Overall Study||1036
9956685|NCT01447576|11075976|FG000|COMPLETED|Overall Study||560
9956686|NCT01447576|11075976|FG000|NOT COMPLETED|Overall Study||476
9956687|NCT01447706|11075982|FG000|STARTED|Overall Study||140
9956688|NCT01447706|11075983|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83
9956689|NCT01447706|11075982|FG000|COMPLETED|Overall Study||140
9956690|NCT01447706|11075983|FG001|COMPLETED|Overall Study||80
9956691|NCT01447706|11075982|FG000|NOT COMPLETED|Overall Study||0
9956692|NCT01447706|11075983|FG001|NOT COMPLETED|Overall Study||3
9956693|NCT01447719|11075993|FG000|STARTED|Overall Study||152
9956694|NCT01447719|11075993|FG000|Valid AV-45 Scan Acquired|Overall Study||147
9956695|NCT01447719|11075993|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66
9956696|NCT01447719|11075993|FG000|COMPLETED|Overall Study||59
9956697|NCT01447719|11075993|FG000|NOT COMPLETED|Overall Study||93
9956698|NCT01447849|11076006|FG000|STARTED|First Intervention||10
9956699|NCT01447849|11076007|FG001|STARTED|First Intervention||10
9956700|NCT01447849|11076008|FG002|STARTED|First Intervention||10
9956701|NCT01447849|11076009|FG003|STARTED|First Intervention||10
9956702|NCT01447849|11076006|FG000|COMPLETED|First Intervention||10
9956703|NCT01447849|11076007|FG001|COMPLETED|First Intervention||10
9956704|NCT01447849|11076008|FG002|COMPLETED|First Intervention||10
9956705|NCT01447849|11076009|FG003|COMPLETED|First Intervention||10
9956706|NCT01447849|11076006|FG000|NOT COMPLETED|First Intervention||0
9956707|NCT01447849|11076007|FG001|NOT COMPLETED|First Intervention||0
9956708|NCT01447849|11076008|FG002|NOT COMPLETED|First Intervention||0
9956709|NCT01447849|11076009|FG003|NOT COMPLETED|First Intervention||0
9956710|NCT01447849|11076006|FG000|STARTED|Washout Period for 1 Week||10
9956711|NCT01447849|11076007|FG001|STARTED|Washout Period for 1 Week||10
9956712|NCT01447849|11076008|FG002|STARTED|Washout Period for 1 Week||10
9956713|NCT01447849|11076009|FG003|STARTED|Washout Period for 1 Week||10
9956714|NCT01447849|11076006|FG000|COMPLETED|Washout Period for 1 Week||10
9956715|NCT01447849|11076007|FG001|COMPLETED|Washout Period for 1 Week||10
9956716|NCT01447849|11076008|FG002|COMPLETED|Washout Period for 1 Week||10
9956717|NCT01447849|11076009|FG003|COMPLETED|Washout Period for 1 Week||10
9956718|NCT01447849|11076006|FG000|NOT COMPLETED|Washout Period for 1 Week||0
9956719|NCT01447849|11076007|FG001|NOT COMPLETED|Washout Period for 1 Week||0
9956720|NCT01447849|11076008|FG002|NOT COMPLETED|Washout Period for 1 Week||0
9956721|NCT01447849|11076009|FG003|NOT COMPLETED|Washout Period for 1 Week||0
9956722|NCT01447849|11076006|FG000|STARTED|Second Intervention||10
9956723|NCT01447849|11076007|FG001|STARTED|Second Intervention||10
9956724|NCT01447849|11076008|FG002|STARTED|Second Intervention||10
9956725|NCT01447849|11076009|FG003|STARTED|Second Intervention||10
9956726|NCT01447849|11076006|FG000|COMPLETED|Second Intervention||10
9956727|NCT01447849|11076007|FG001|COMPLETED|Second Intervention||10
9956728|NCT01447849|11076008|FG002|COMPLETED|Second Intervention||10
9956729|NCT01447849|11076009|FG003|COMPLETED|Second Intervention||10
9956730|NCT01447849|11076006|FG000|NOT COMPLETED|Second Intervention||0
9956731|NCT01447849|11076007|FG001|NOT COMPLETED|Second Intervention||0
9956732|NCT01447849|11076008|FG002|NOT COMPLETED|Second Intervention||0
9956733|NCT01447849|11076009|FG003|NOT COMPLETED|Second Intervention||0
9956734|NCT01447888|11076021|FG000|STARTED|Overall Study||45
9956735|NCT01447888|11076022|FG001|STARTED|Overall Study||55
9956736|NCT01447888|11076021|FG000|COMPLETED|Overall Study||45
9956737|NCT01447888|11076022|FG001|COMPLETED|Overall Study||55
9956738|NCT01447888|11076021|FG000|NOT COMPLETED|Overall Study||0
9956739|NCT01447888|11076022|FG001|NOT COMPLETED|Overall Study||0
9956740|NCT01447914|11076028|FG000|STARTED|Overall Study||16
9956741|NCT01447914|11076028|FG000|COMPLETED|Overall Study||16
9956742|NCT01447914|11076028|FG000|NOT COMPLETED|Overall Study||0
9956743|NCT01447927|11076034|FG000|STARTED|Overall Study||38
9956744|NCT01447927|11076035|FG001|STARTED|Overall Study||36
9956745|NCT01447927|11076034|FG000|COMPLETED|Overall Study||33
9956746|NCT01447927|11076035|FG001|COMPLETED|Overall Study||33
9956747|NCT01447927|11076034|FG000|NOT COMPLETED|Overall Study||5
9956748|NCT01447927|11076035|FG001|NOT COMPLETED|Overall Study||3
9956749|NCT01448044|11076043|FG000|STARTED|Treatment Period||82
9956750|NCT01448044|11076044|FG001|STARTED|Treatment Period||42
9941425|NCT01355796|11060009|FG000|STARTED|Overall Study||15
9941426|NCT01355796|11060010|FG001|STARTED|Overall Study||15
9941427|NCT01355796|11060009|FG000|First Intervention for 14 Days|Overall Study||15
9941428|NCT01355796|11060010|FG001|First Intervention for 14 Days|Overall Study||15
9941429|NCT01355796|11060009|FG000|Washout Period for 7 Days|Overall Study||15
9941430|NCT01355796|11060010|FG001|Washout Period for 7 Days|Overall Study||15
9941431|NCT01355796|11060009|FG000|Second Intervention for 14 Days|Overall Study||15
9941432|NCT01355796|11060010|FG001|Second Intervention for 14 Days|Overall Study||15
10011386|NCT01780922|11134200|FG000|COMPLETED|First Intervention (1 Day)||2
9941433|NCT01355796|11060009|FG000|COMPLETED|Overall Study||15
9941434|NCT01355796|11060010|FG001|COMPLETED|Overall Study||15
9941435|NCT01355796|11060009|FG000|NOT COMPLETED|Overall Study||0
9941436|NCT01355796|11060010|FG001|NOT COMPLETED|Overall Study||0
9941437|NCT01355978|11060016|FG000|STARTED|Overall Study||22
9941438|NCT01355978|11060016|FG000|COMPLETED|Overall Study||18
9941439|NCT01355978|11060016|FG000|NOT COMPLETED|Overall Study||4
9941440|NCT01356147|11060022|FG000|STARTED|Overall Study||5
9941441|NCT01356147|11060023|FG001|STARTED|Overall Study||6
9941442|NCT01356147|11060022|FG000|COMPLETED|Overall Study||5
9941443|NCT01356147|11060023|FG001|COMPLETED|Overall Study||6
9941444|NCT01356147|11060022|FG000|NOT COMPLETED|Overall Study||0
9941445|NCT01356147|11060023|FG001|NOT COMPLETED|Overall Study||0
9941446|NCT01356277|11060031|FG000|STARTED|Run-in||81
9941447|NCT01356277|11060032|FG001|STARTED|Run-in||88
9941448|NCT01356277|11060031|FG000|COMPLETED|Run-in||76
9941449|NCT01356277|11060032|FG001|COMPLETED|Run-in||88
9941450|NCT01356277|11060031|FG000|NOT COMPLETED|Run-in||5
9941451|NCT01356277|11060032|FG001|NOT COMPLETED|Run-in||0
9941452|NCT01356277|11060031|FG000|STARTED|Intervention Interval||76
9941453|NCT01356277|11060032|FG001|STARTED|Intervention Interval||88
9941454|NCT01356277|11060031|FG000|COMPLETED|Intervention Interval||66
9941455|NCT01356277|11060032|FG001|COMPLETED|Intervention Interval||81
9941456|NCT01356277|11060031|FG000|NOT COMPLETED|Intervention Interval||10
9941457|NCT01356277|11060032|FG001|NOT COMPLETED|Intervention Interval||7
9941458|NCT01356407|11060042|FG000|STARTED|Overall Study||150
9941459|NCT01356407|11060043|FG001|STARTED|Overall Study||150
9941460|NCT01356407|11060042|FG000|COMPLETED|Overall Study||144
9941461|NCT01356407|11060043|FG001|COMPLETED|Overall Study||146
9941462|NCT01356407|11060042|FG000|NOT COMPLETED|Overall Study||6
9941463|NCT01356407|11060043|FG001|NOT COMPLETED|Overall Study||4
9941464|NCT01356498|11060055|FG000|STARTED|Overall Study||35
9941465|NCT01356498|11060056|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
9941466|NCT01356498|11060057|FG002|STARTED|Overall Study||23
9941467|NCT01356498|11060058|FG003|STARTED|Overall Study||22
9941468|NCT01356498|11060059|FG004|STARTED|Overall Study||28
9941469|NCT01356498|11060060|FG005|STARTED|Overall Study||16
9941470|NCT01356498|11060055|FG000|COMPLETED|Overall Study||24
9941471|NCT01356498|11060056|FG001|COMPLETED|Overall Study||17
9941472|NCT01356498|11060057|FG002|COMPLETED|Overall Study||11
9941473|NCT01356498|11060058|FG003|COMPLETED|Overall Study||8
9941474|NCT01356498|11060059|FG004|COMPLETED|Overall Study||8
9941475|NCT01356498|11060060|FG005|COMPLETED|Overall Study||2
9941476|NCT01356498|11060055|FG000|NOT COMPLETED|Overall Study||11
9941477|NCT01356498|11060056|FG001|NOT COMPLETED|Overall Study||8
9941478|NCT01356498|11060057|FG002|NOT COMPLETED|Overall Study||12
9941479|NCT01356498|11060058|FG003|NOT COMPLETED|Overall Study||14
9941480|NCT01356498|11060059|FG004|NOT COMPLETED|Overall Study||20
9941481|NCT01356498|11060060|FG005|NOT COMPLETED|Overall Study||14
9941482|NCT01356589|11060080|FG000|STARTED|Overall Study||1288
9941483|NCT01356589|11060080|FG000|Treated|Overall Study||1285
9941484|NCT01356589|11060080|FG000|COMPLETED|Overall Study||1283
9941485|NCT01356589|11060080|FG000|NOT COMPLETED|Overall Study||5
9941486|NCT01356602|11060087|FG000|STARTED|Overall Study||133
9941487|NCT01356602|11060088|FG001|STARTED|Overall Study||132
9941488|NCT01356602|11060089|FG002|STARTED|Overall Study||132
9941489|NCT01356602|11060087|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
9941490|NCT01356602|11060088|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
9941491|NCT01356602|11060089|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
9941492|NCT01356602|11060087|FG000|Full Analysis Set|Overall Study||131
9941493|NCT01356602|11060088|FG001|Full Analysis Set|Overall Study||129
9941494|NCT01356602|11060089|FG002|Full Analysis Set|Overall Study||129
9941495|NCT01356602|11060087|FG000|COMPLETED|Overall Study||124
9941496|NCT01356602|11060088|FG001|COMPLETED|Overall Study||117
9941497|NCT01356602|11060089|FG002|COMPLETED|Overall Study||108
9941498|NCT01356602|11060087|FG000|NOT COMPLETED|Overall Study||9
9941499|NCT01356602|11060088|FG001|NOT COMPLETED|Overall Study||15
9941500|NCT01356602|11060089|FG002|NOT COMPLETED|Overall Study||24
9941501|NCT01356628|11060097|FG000|STARTED|Overall Study||23
9941502|NCT01356628|11060097|FG000|COMPLETED|Overall Study||23
9941503|NCT01356628|11060097|FG000|NOT COMPLETED|Overall Study||0
9941504|NCT01356940|11060103|FG000|STARTED|First Intervention (28 Days)||22
9941505|NCT01356940|11060104|FG001|STARTED|First Intervention (28 Days)||21
9941506|NCT01356940|11060103|FG000|COMPLETED|First Intervention (28 Days)||21
10011387|NCT01780922|11134201|FG001|COMPLETED|First Intervention (1 Day)||2
9941507|NCT01356940|11060104|FG001|COMPLETED|First Intervention (28 Days)||21
9941508|NCT01356940|11060103|FG000|NOT COMPLETED|First Intervention (28 Days)||1
9941509|NCT01356940|11060104|FG001|NOT COMPLETED|First Intervention (28 Days)||0
9941510|NCT01356940|11060103|FG000|STARTED|Washout (14 Days)||21
9941511|NCT01356940|11060104|FG001|STARTED|Washout (14 Days)||21
9941512|NCT01356940|11060103|FG000|COMPLETED|Washout (14 Days)||21
9941513|NCT01356940|11060104|FG001|COMPLETED|Washout (14 Days)||21
9941514|NCT01356940|11060103|FG000|NOT COMPLETED|Washout (14 Days)||0
9941515|NCT01356940|11060104|FG001|NOT COMPLETED|Washout (14 Days)||0
9941516|NCT01356940|11060103|FG000|STARTED|Second Intervention (28 Days)||21
9941517|NCT01356940|11060104|FG001|STARTED|Second Intervention (28 Days)||21
9941518|NCT01356940|11060103|FG000|COMPLETED|Second Intervention (28 Days)||20
9941519|NCT01356940|11060104|FG001|COMPLETED|Second Intervention (28 Days)||21
9941520|NCT01356940|11060103|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
9941521|NCT01356940|11060104|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
9941522|NCT01356966|11060114|FG000|STARTED|Overall Study||18
9941523|NCT01356966|11060115|FG001|STARTED|Overall Study||14
9941524|NCT01356966|11060114|FG000|COMPLETED|Overall Study||16
9941525|NCT01356966|11060115|FG001|COMPLETED|Overall Study||12
9941526|NCT01356966|11060114|FG000|NOT COMPLETED|Overall Study||2
9941527|NCT01356966|11060115|FG001|NOT COMPLETED|Overall Study||2
9941528|NCT01357135|11060124|FG000|STARTED|Overall Study||1874
9941529|NCT01357135|11060125|FG001|STARTED|Overall Study||733
9941530|NCT01357135|11060126|FG002|STARTED|Overall Study||846
9941531|NCT01357135|11060124|FG000|COMPLETED|Overall Study||1276
9941532|NCT01357135|11060125|FG001|COMPLETED|Overall Study||510
9941533|NCT01357135|11060126|FG002|COMPLETED|Overall Study||583
9941534|NCT01357135|11060124|FG000|NOT COMPLETED|Overall Study||598
9941535|NCT01357135|11060125|FG001|NOT COMPLETED|Overall Study||223
9941536|NCT01357135|11060126|FG002|NOT COMPLETED|Overall Study||263
9941537|NCT01357148|11060133|FG000|STARTED|Overall Study||143
9941538|NCT01357148|11060133|FG000|COMPLETED|Overall Study||143
9941539|NCT01357148|11060133|FG000|NOT COMPLETED|Overall Study||0
9941540|NCT01357161|11060141|FG000|STARTED|Part 1 (Open Label Run-in)||15
9941541|NCT01357161|11060142|FG001|STARTED|Part 1 (Open Label Run-in)||0
9941542|NCT01357161|11060143|FG002|STARTED|Part 1 (Open Label Run-in)||0
9941543|NCT01357161|11060141|FG000|COMPLETED|Part 1 (Open Label Run-in)||0
9941544|NCT01357161|11060142|FG001|COMPLETED|Part 1 (Open Label Run-in)||0
9941545|NCT01357161|11060143|FG002|COMPLETED|Part 1 (Open Label Run-in)||0
9941546|NCT01357161|11060141|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15
9941547|NCT01357161|11060142|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0
9941548|NCT01357161|11060143|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0
9941549|NCT01357161|11060141|FG000|STARTED|Part 2 (Double-Blind Comparison)||0
9941550|NCT01357161|11060142|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
9941551|NCT01357161|11060143|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
10011388|NCT01780922|11134202|FG002|COMPLETED|First Intervention (1 Day)||2
10011389|NCT01780922|11134203|FG003|COMPLETED|First Intervention (1 Day)||2
10011390|NCT01780922|11134204|FG004|COMPLETED|First Intervention (1 Day)||2
10011391|NCT01780922|11134205|FG005|COMPLETED|First Intervention (1 Day)||2
10011392|NCT01780922|11134200|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10011393|NCT01780922|11134201|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10011394|NCT01780922|11134202|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10011395|NCT01780922|11134203|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10011396|NCT01780922|11134204|FG004|NOT COMPLETED|First Intervention (1 Day)||0
9941552|NCT01357161|11060141|FG000|Treated|Part 2 (Double-Blind Comparison)||0
9941553|NCT01357161|11060142|FG001|Treated|Part 2 (Double-Blind Comparison)||59
9941554|NCT01357161|11060143|FG002|Treated|Part 2 (Double-Blind Comparison)||60
9941555|NCT01357161|11060141|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0
9941556|NCT01357161|11060142|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0
9941557|NCT01357161|11060143|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0
10011397|NCT01780922|11134205|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10011398|NCT01780922|11134200|FG000|STARTED|Washout (7 Days)||2
10011399|NCT01780922|11134201|FG001|STARTED|Washout (7 Days)||2
10011400|NCT01780922|11134202|FG002|STARTED|Washout (7 Days)||2
10011401|NCT01780922|11134203|FG003|STARTED|Washout (7 Days)||2
10011402|NCT01780922|11134204|FG004|STARTED|Washout (7 Days)||2
10011403|NCT01780922|11134205|FG005|STARTED|Washout (7 Days)||2
9941558|NCT01357161|11060141|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
9941559|NCT01357161|11060142|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
9941560|NCT01357161|11060143|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
9941561|NCT01357239|11060155|FG000|STARTED|Stratum: All Patients||31
9941562|NCT01357239|11060156|FG001|STARTED|Stratum: All Patients||27
9941563|NCT01357239|11060157|FG002|STARTED|Stratum: All Patients||39
9941564|NCT01357239|11060158|FG003|STARTED|Stratum: All Patients||42
9941565|NCT01357239|11060155|FG000|COMPLETED|Stratum: All Patients||31
9941566|NCT01357239|11060156|FG001|COMPLETED|Stratum: All Patients||27
9941567|NCT01357239|11060157|FG002|COMPLETED|Stratum: All Patients||37
9941568|NCT01357239|11060158|FG003|COMPLETED|Stratum: All Patients||40
9941569|NCT01357239|11060155|FG000|NOT COMPLETED|Stratum: All Patients||0
9941570|NCT01357239|11060156|FG001|NOT COMPLETED|Stratum: All Patients||0
9941571|NCT01357239|11060157|FG002|NOT COMPLETED|Stratum: All Patients||2
9941572|NCT01357239|11060158|FG003|NOT COMPLETED|Stratum: All Patients||2
9941573|NCT01357239|11060155|FG000|STARTED|Stratum I: Fully-Methylated||8
9941574|NCT01357239|11060156|FG001|STARTED|Stratum I: Fully-Methylated||6
9941575|NCT01357239|11060157|FG002|STARTED|Stratum I: Fully-Methylated||17
10011404|NCT01780922|11134200|FG000|COMPLETED|Washout (7 Days)||2
10011405|NCT01780922|11134201|FG001|COMPLETED|Washout (7 Days)||2
9941576|NCT01357239|11060158|FG003|STARTED|Stratum I: Fully-Methylated||22
9941577|NCT01357239|11060155|FG000|COMPLETED|Stratum I: Fully-Methylated||8
9941578|NCT01357239|11060156|FG001|COMPLETED|Stratum I: Fully-Methylated||6
9941579|NCT01357239|11060157|FG002|COMPLETED|Stratum I: Fully-Methylated||16
9941580|NCT01357239|11060158|FG003|COMPLETED|Stratum I: Fully-Methylated||22
9941581|NCT01357239|11060155|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0
9941582|NCT01357239|11060156|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0
9941583|NCT01357239|11060157|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1
9941584|NCT01357239|11060158|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0
9941585|NCT01357239|11060155|FG000|STARTED|Stratum II: Partially-Methylated||23
9941586|NCT01357239|11060156|FG001|STARTED|Stratum II: Partially-Methylated||21
9941587|NCT01357239|11060157|FG002|STARTED|Stratum II: Partially-Methylated||22
9941588|NCT01357239|11060158|FG003|STARTED|Stratum II: Partially-Methylated||20
9941589|NCT01357239|11060155|FG000|COMPLETED|Stratum II: Partially-Methylated||23
9941590|NCT01357239|11060156|FG001|COMPLETED|Stratum II: Partially-Methylated||21
9941591|NCT01357239|11060157|FG002|COMPLETED|Stratum II: Partially-Methylated||21
9941592|NCT01357239|11060158|FG003|COMPLETED|Stratum II: Partially-Methylated||18
9941593|NCT01357239|11060155|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0
9941594|NCT01357239|11060156|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0
9941595|NCT01357239|11060157|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1
9941596|NCT01357239|11060158|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2
9941597|NCT01357356|11060175|FG000|STARTED|Overall Study||188
9941598|NCT01357356|11060176|FG001|STARTED|Overall Study||188
10011406|NCT01780922|11134202|FG002|COMPLETED|Washout (7 Days)||2
10011407|NCT01780922|11134203|FG003|COMPLETED|Washout (7 Days)||2
10207284|NCT03525444|11334114|FG000|STARTED|Overall Study||203
9941599|NCT01357356|11060177|FG002|STARTED|Overall Study||186
10011408|NCT01780922|11134204|FG004|COMPLETED|Washout (7 Days)||2
10011409|NCT01780922|11134205|FG005|COMPLETED|Washout (7 Days)||2
10011410|NCT01780922|11134200|FG000|NOT COMPLETED|Washout (7 Days)||0
10011411|NCT01780922|11134201|FG001|NOT COMPLETED|Washout (7 Days)||0
10011412|NCT01780922|11134202|FG002|NOT COMPLETED|Washout (7 Days)||0
10011413|NCT01780922|11134203|FG003|NOT COMPLETED|Washout (7 Days)||0
10011414|NCT01780922|11134204|FG004|NOT COMPLETED|Washout (7 Days)||0
10011415|NCT01780922|11134205|FG005|NOT COMPLETED|Washout (7 Days)||0
10011416|NCT01780922|11134200|FG000|STARTED|Second Intervention (1 Day)||2
10011417|NCT01780922|11134201|FG001|STARTED|Second Intervention (1 Day)||2
10011418|NCT01780922|11134202|FG002|STARTED|Second Intervention (1 Day)||2
10011419|NCT01780922|11134203|FG003|STARTED|Second Intervention (1 Day)||2
10011420|NCT01780922|11134204|FG004|STARTED|Second Intervention (1 Day)||2
10011421|NCT01780922|11134205|FG005|STARTED|Second Intervention (1 Day)||2
9941600|NCT01357356|11060178|FG003|STARTED|Overall Study||188
9941601|NCT01357356|11060175|FG000|COMPLETED|Overall Study||166
9941602|NCT01357356|11060176|FG001|COMPLETED|Overall Study||163
9941603|NCT01357356|11060177|FG002|COMPLETED|Overall Study||158
9941604|NCT01357356|11060178|FG003|COMPLETED|Overall Study||171
9941605|NCT01357356|11060175|FG000|NOT COMPLETED|Overall Study||22
9941606|NCT01357356|11060176|FG001|NOT COMPLETED|Overall Study||25
9941607|NCT01357356|11060177|FG002|NOT COMPLETED|Overall Study||28
9941608|NCT01357356|11060178|FG003|NOT COMPLETED|Overall Study||17
9941609|NCT01357512|11060192|FG000|STARTED|Overall Study||65
9941610|NCT01357512|11060193|FG001|STARTED|Overall Study||65
9941611|NCT01357512|11060192|FG000|COMPLETED|Overall Study||53
9941612|NCT01357512|11060193|FG001|COMPLETED|Overall Study||60
9941613|NCT01357512|11060192|FG000|NOT COMPLETED|Overall Study||12
9941614|NCT01357512|11060193|FG001|NOT COMPLETED|Overall Study||5
9941615|NCT01357525|11060199|FG000|STARTED|Overall Study||50
9941616|NCT01357525|11060199|FG000|COMPLETED|Overall Study||49
9941617|NCT01357525|11060199|FG000|NOT COMPLETED|Overall Study||1
9941618|NCT01357551|11060205|FG000|STARTED|Overall Study||110
9941619|NCT01357551|11060206|FG001|STARTED|Overall Study||112
9941620|NCT01357551|11060205|FG000|COMPLETED|Overall Study||88
9941621|NCT01357551|11060206|FG001|COMPLETED|Overall Study||101
9941622|NCT01357551|11060205|FG000|NOT COMPLETED|Overall Study||22
9941623|NCT01357551|11060206|FG001|NOT COMPLETED|Overall Study||11
9941624|NCT01357564|11060217|FG000|STARTED|Short-term (4-month) Follow up||154
9941625|NCT01357564|11060218|FG001|STARTED|Short-term (4-month) Follow up||168
9941626|NCT01357564|11060217|FG000|COMPLETED|Short-term (4-month) Follow up||106
9941627|NCT01357564|11060218|FG001|COMPLETED|Short-term (4-month) Follow up||118
9941628|NCT01357564|11060217|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48
9941629|NCT01357564|11060218|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50
9941630|NCT01357564|11060217|FG000|STARTED|Long-term (8-month) Follow-up||106
9941631|NCT01357564|11060218|FG001|STARTED|Long-term (8-month) Follow-up||118
9941632|NCT01357564|11060217|FG000|COMPLETED|Long-term (8-month) Follow-up||104
9941633|NCT01357564|11060218|FG001|COMPLETED|Long-term (8-month) Follow-up||102
9941634|NCT01357564|11060217|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2
9941635|NCT01357564|11060218|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16
10011422|NCT01780922|11134200|FG000|COMPLETED|Second Intervention (1 Day)||2
10011423|NCT01780922|11134201|FG001|COMPLETED|Second Intervention (1 Day)||2
10207285|NCT03525444|11334115|FG001|STARTED|Overall Study||200
9941636|NCT01357577|11060228|FG000|STARTED|Overall Study||64
9941637|NCT01357577|11060229|FG001|STARTED|Overall Study||65
9941638|NCT01357577|11060228|FG000|Post-Treatment Assessment Completed|Overall Study||24
9941639|NCT01357577|11060229|FG001|Post-Treatment Assessment Completed|Overall Study||39
9941640|NCT01357577|11060228|FG000|COMPLETED|Overall Study||27
9941641|NCT01357577|11060229|FG001|COMPLETED|Overall Study||39
10011424|NCT01780922|11134202|FG002|COMPLETED|Second Intervention (1 Day)||2
10011425|NCT01780922|11134203|FG003|COMPLETED|Second Intervention (1 Day)||2
10011426|NCT01780922|11134204|FG004|COMPLETED|Second Intervention (1 Day)||2
10011427|NCT01780922|11134205|FG005|COMPLETED|Second Intervention (1 Day)||2
10011428|NCT01780922|11134200|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10011429|NCT01780922|11134201|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10011430|NCT01780922|11134202|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10011431|NCT01780922|11134203|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9941642|NCT01357577|11060228|FG000|NOT COMPLETED|Overall Study||37
9941643|NCT01357577|11060229|FG001|NOT COMPLETED|Overall Study||26
9941644|NCT01357616|11060238|FG000|STARTED|Overall Study||166
9941645|NCT01357616|11060239|FG001|STARTED|Overall Study||162
9941646|NCT01357616|11060238|FG000|COMPLETED|Overall Study||156
9941647|NCT01357616|11060239|FG001|COMPLETED|Overall Study||153
9941648|NCT01357616|11060238|FG000|NOT COMPLETED|Overall Study||10
9941649|NCT01357616|11060239|FG001|NOT COMPLETED|Overall Study||9
9941650|NCT01357655|11060247|FG000|STARTED|Overall Study||66
9941651|NCT01357655|11060248|FG001|STARTED|Overall Study||0
9941652|NCT01357655|11060247|FG000|COMPLETED|Overall Study||0
9941653|NCT01357655|11060248|FG001|COMPLETED|Overall Study||0
9941654|NCT01357655|11060247|FG000|NOT COMPLETED|Overall Study||66
9941655|NCT01357655|11060248|FG001|NOT COMPLETED|Overall Study||0
9941656|NCT01357720|11060255|FG000|STARTED|Overall Study||200
9941657|NCT01357720|11060256|FG001|STARTED|Overall Study||200
9941658|NCT01357720|11060255|FG000|COMPLETED|Overall Study||198
9941659|NCT01357720|11060256|FG001|COMPLETED|Overall Study||195
9941660|NCT01357720|11060255|FG000|NOT COMPLETED|Overall Study||2
9941661|NCT01357720|11060256|FG001|NOT COMPLETED|Overall Study||5
9941662|NCT01357850|11060266|FG000|STARTED|Overall Study||30
9941663|NCT01357850|11060267|FG001|STARTED|Overall Study||12
9941664|NCT01357850|11060268|FG002|STARTED|Overall Study||13
9941665|NCT01357850|11060269|FG003|STARTED|Overall Study||27
9941666|NCT01357850|11060266|FG000|COMPLETED|Overall Study||29
9941667|NCT01357850|11060267|FG001|COMPLETED|Overall Study||12
9941668|NCT01357850|11060268|FG002|COMPLETED|Overall Study||13
9941669|NCT01357850|11060269|FG003|COMPLETED|Overall Study||27
9941670|NCT01357850|11060266|FG000|NOT COMPLETED|Overall Study||1
9941671|NCT01357850|11060267|FG001|NOT COMPLETED|Overall Study||0
9941672|NCT01357850|11060268|FG002|NOT COMPLETED|Overall Study||0
9941673|NCT01357850|11060269|FG003|NOT COMPLETED|Overall Study||0
9941674|NCT01357889|11060282|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
9941675|NCT01357889|11060283|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
9941676|NCT01357889|11060282|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
9941677|NCT01357889|11060283|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
9941678|NCT01357889|11060282|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
9941679|NCT01357889|11060283|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
9941680|NCT01357889|11060282|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
9941681|NCT01357889|11060283|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
9941682|NCT01357889|11060282|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
9941683|NCT01357889|11060283|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
9941684|NCT01357889|11060282|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
9941685|NCT01357889|11060283|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
9941686|NCT01357889|11060282|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
9941687|NCT01357889|11060283|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
9941688|NCT01357889|11060282|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
9941689|NCT01357889|11060283|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
9941690|NCT01357889|11060282|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
9941691|NCT01357889|11060283|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
9941692|NCT01357915|11060293|FG000|STARTED|Overall Study||30
9941693|NCT01357915|11060294|FG001|STARTED|Overall Study||17
9941694|NCT01357915|11060293|FG000|COMPLETED|Overall Study||27
9941695|NCT01357915|11060294|FG001|COMPLETED|Overall Study||17
9941696|NCT01357915|11060293|FG000|NOT COMPLETED|Overall Study||3
9941697|NCT01357915|11060294|FG001|NOT COMPLETED|Overall Study||0
9941698|NCT01357980|11060304|FG000|STARTED|Overall Study||16
9941699|NCT01357980|11060305|FG001|STARTED|Overall Study||7
9941700|NCT01357980|11060306|FG002|STARTED|Overall Study||17
9941701|NCT01357980|11060307|FG003|STARTED|Overall Study||7
9941702|NCT01357980|11060304|FG000|COMPLETED|Overall Study||16
9941703|NCT01357980|11060305|FG001|COMPLETED|Overall Study||6
9941704|NCT01357980|11060306|FG002|COMPLETED|Overall Study||16
9941705|NCT01357980|11060307|FG003|COMPLETED|Overall Study||7
9941706|NCT01357980|11060304|FG000|NOT COMPLETED|Overall Study||0
9941707|NCT01357980|11060305|FG001|NOT COMPLETED|Overall Study||1
9941708|NCT01357980|11060306|FG002|NOT COMPLETED|Overall Study||1
9941709|NCT01357980|11060307|FG003|NOT COMPLETED|Overall Study||0
9941710|NCT01358175|11060320|FG000|STARTED|Overall Study||124
9941711|NCT01358175|11060321|FG001|STARTED|Overall Study||125
9941712|NCT01358175|11060322|FG002|STARTED|Overall Study||122
9941713|NCT01358175|11060320|FG000|COMPLETED|Overall Study||103
9941714|NCT01358175|11060321|FG001|COMPLETED|Overall Study||97
9941715|NCT01358175|11060322|FG002|COMPLETED|Overall Study||90
9941716|NCT01358175|11060320|FG000|NOT COMPLETED|Overall Study||21
9941717|NCT01358175|11060321|FG001|NOT COMPLETED|Overall Study||28
9941718|NCT01358175|11060322|FG002|NOT COMPLETED|Overall Study||32
9941719|NCT01358266|11060337|FG000|STARTED|Double-Masked Period||208
9941720|NCT01358266|11060338|FG001|STARTED|Double-Masked Period||208
9941721|NCT01358266|11060339|FG002|STARTED|Double-Masked Period||176
9941722|NCT01358266|11060337|FG000|COMPLETED|Double-Masked Period||175
9941723|NCT01358266|11060338|FG001|COMPLETED|Double-Masked Period||162
10111634|NCT02497391|11242654|FG001|STARTED|Period 2 (14 Days)||15
10111635|NCT02497391|11242655|FG002|STARTED|Period 2 (14 Days)||16
10111636|NCT02497391|11242656|FG003|STARTED|Period 2 (14 Days)||16
10111637|NCT02497391|11242657|FG004|STARTED|Period 2 (14 Days)||16
10111638|NCT02497391|11242658|FG005|STARTED|Period 2 (14 Days)||16
9941724|NCT01358266|11060339|FG002|COMPLETED|Double-Masked Period||137
9941725|NCT01358266|11060337|FG000|NOT COMPLETED|Double-Masked Period||33
9941726|NCT01358266|11060338|FG001|NOT COMPLETED|Double-Masked Period||46
9941727|NCT01358266|11060339|FG002|NOT COMPLETED|Double-Masked Period||39
9941728|NCT01358266|11060337|FG000|STARTED|Open-Label Period||119
9941729|NCT01358266|11060338|FG001|STARTED|Open-Label Period||102
9941730|NCT01358266|11060339|FG002|STARTED|Open-Label Period||114
9941731|NCT01358266|11060337|FG000|COMPLETED|Open-Label Period||63
9941732|NCT01358266|11060338|FG001|COMPLETED|Open-Label Period||58
9941733|NCT01358266|11060339|FG002|COMPLETED|Open-Label Period||44
9941734|NCT01358266|11060337|FG000|NOT COMPLETED|Open-Label Period||56
9941735|NCT01358266|11060338|FG001|NOT COMPLETED|Open-Label Period||44
9941736|NCT01358266|11060339|FG002|NOT COMPLETED|Open-Label Period||70
9941737|NCT01358331|11060354|FG000|STARTED|Overall Study||2
9941738|NCT01358331|11060355|FG001|STARTED|Overall Study||3
9941739|NCT01358331|11060356|FG002|STARTED|Overall Study||4
9941740|NCT01358331|11060357|FG003|STARTED|Overall Study||3
9941741|NCT01358331|11060358|FG004|STARTED|Overall Study||7
9941742|NCT01358331|11060359|FG005|STARTED|Overall Study||6
9941743|NCT01358331|11060354|FG000|COMPLETED|Overall Study||0
9941744|NCT01358331|11060355|FG001|COMPLETED|Overall Study||0
9941745|NCT01358331|11060356|FG002|COMPLETED|Overall Study||0
9941746|NCT01358331|11060357|FG003|COMPLETED|Overall Study||0
9941747|NCT01358331|11060358|FG004|COMPLETED|Overall Study||0
9941748|NCT01358331|11060359|FG005|COMPLETED|Overall Study||0
9941749|NCT01358331|11060354|FG000|NOT COMPLETED|Overall Study||2
9941750|NCT01358331|11060355|FG001|NOT COMPLETED|Overall Study||3
9941751|NCT01358331|11060356|FG002|NOT COMPLETED|Overall Study||4
9941752|NCT01358331|11060357|FG003|NOT COMPLETED|Overall Study||3
9941753|NCT01358331|11060358|FG004|NOT COMPLETED|Overall Study||7
9941754|NCT01358331|11060359|FG005|NOT COMPLETED|Overall Study||6
9941755|NCT01358357|11060375|FG000|STARTED|Open Label Phase||0
9941756|NCT01358357|11060376|FG001|STARTED|Open Label Phase||0
9941757|NCT01358357|11060377|FG002|STARTED|Open Label Phase||965
9941758|NCT01358357|11060375|FG000|COMPLETED|Open Label Phase||0
9941759|NCT01358357|11060376|FG001|COMPLETED|Open Label Phase||0
9941760|NCT01358357|11060377|FG002|COMPLETED|Open Label Phase||503
9941761|NCT01358357|11060375|FG000|NOT COMPLETED|Open Label Phase||0
9941762|NCT01358357|11060376|FG001|NOT COMPLETED|Open Label Phase||0
9941763|NCT01358357|11060377|FG002|NOT COMPLETED|Open Label Phase||462
9941764|NCT01358357|11060375|FG000|STARTED|Double-Blind Phase||246
9941765|NCT01358357|11060376|FG001|STARTED|Double-Blind Phase||250
9941766|NCT01358357|11060377|FG002|STARTED|Double-Blind Phase||0
9941767|NCT01358357|11060375|FG000|COMPLETED|Double-Blind Phase||166
9941768|NCT01358357|11060376|FG001|COMPLETED|Double-Blind Phase||150
9941769|NCT01358357|11060377|FG002|COMPLETED|Double-Blind Phase||0
9941770|NCT01358357|11060375|FG000|NOT COMPLETED|Double-Blind Phase||80
9941771|NCT01358357|11060376|FG001|NOT COMPLETED|Double-Blind Phase||100
9941772|NCT01358357|11060377|FG002|NOT COMPLETED|Double-Blind Phase||0
9941773|NCT01358526|11060386|FG000|STARTED|Open-label Titration Period||1095
9941774|NCT01358526|11060387|FG001|STARTED|Open-label Titration Period||0
9941775|NCT01358526|11060388|FG002|STARTED|Open-label Titration Period||0
9941776|NCT01358526|11060386|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
9941777|NCT01358526|11060387|FG001|COMPLETED|Open-label Titration Period||0
9941778|NCT01358526|11060388|FG002|COMPLETED|Open-label Titration Period||0
9941779|NCT01358526|11060386|FG000|NOT COMPLETED|Open-label Titration Period||494
9941780|NCT01358526|11060387|FG001|NOT COMPLETED|Open-label Titration Period||0
9941781|NCT01358526|11060388|FG002|NOT COMPLETED|Open-label Titration Period||0
9941782|NCT01358526|11060386|FG000|STARTED|Double-blind Phase||0
9941783|NCT01358526|11060387|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
9941784|NCT01358526|11060388|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
9941785|NCT01358526|11060386|FG000|COMPLETED|Double-blind Phase||0
9941786|NCT01358526|11060387|FG001|COMPLETED|Double-blind Phase||218
9941787|NCT01358526|11060388|FG002|COMPLETED|Double-blind Phase||181
9941788|NCT01358526|11060386|FG000|NOT COMPLETED|Double-blind Phase||0
9941789|NCT01358526|11060387|FG001|NOT COMPLETED|Double-blind Phase||80
9941790|NCT01358526|11060388|FG002|NOT COMPLETED|Double-blind Phase||121
9941791|NCT01358578|11060399|FG000|STARTED|Induction Period||327
9941792|NCT01358578|11060400|FG001|STARTED|Induction Period||327
9941793|NCT01358578|11060401|FG002|STARTED|Induction Period||326
9941794|NCT01358578|11060402|FG003|STARTED|Induction Period||326
9956751|NCT01448044|11076043|FG000|COMPLETED|Treatment Period||59
9941795|NCT01358578|11060403|FG004|STARTED|Induction Period|These groups are populated after the induction period|0
9941796|NCT01358578|11060404|FG005|STARTED|Induction Period|These groups are populated after the induction period|0
9941797|NCT01358578|11060399|FG000|COMPLETED|Induction Period||315
9941798|NCT01358578|11060400|FG001|COMPLETED|Induction Period||312
9941799|NCT01358578|11060401|FG002|COMPLETED|Induction Period||301
9941800|NCT01358578|11060402|FG003|COMPLETED|Induction Period||305
9941801|NCT01358578|11060403|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0
9941802|NCT01358578|11060404|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0
9941803|NCT01358578|11060399|FG000|NOT COMPLETED|Induction Period||12
9941804|NCT01358578|11060400|FG001|NOT COMPLETED|Induction Period||15
9941805|NCT01358578|11060401|FG002|NOT COMPLETED|Induction Period||25
9941806|NCT01358578|11060402|FG003|NOT COMPLETED|Induction Period||21
9941807|NCT01358578|11060403|FG004|NOT COMPLETED|Induction Period||0
9941808|NCT01358578|11060404|FG005|NOT COMPLETED|Induction Period||0
9941809|NCT01358578|11060399|FG000|STARTED|Maintenance Period||315
9941810|NCT01358578|11060400|FG001|STARTED|Maintenance Period||312
9941811|NCT01358578|11060401|FG002|STARTED|Maintenance Period||17
9941812|NCT01358578|11060402|FG003|STARTED|Maintenance Period||305
9941813|NCT01358578|11060403|FG004|STARTED|Maintenance Period||142
9941814|NCT01358578|11060404|FG005|STARTED|Maintenance Period||142
9941815|NCT01358578|11060399|FG000|COMPLETED|Maintenance Period||276
9941816|NCT01358578|11060400|FG001|COMPLETED|Maintenance Period||290
9941817|NCT01358578|11060401|FG002|COMPLETED|Maintenance Period||15
9941818|NCT01358578|11060402|FG003|COMPLETED|Maintenance Period||263
9941819|NCT01358578|11060403|FG004|COMPLETED|Maintenance Period||125
9941820|NCT01358578|11060404|FG005|COMPLETED|Maintenance Period||131
9941821|NCT01358578|11060399|FG000|NOT COMPLETED|Maintenance Period||39
9941822|NCT01358578|11060400|FG001|NOT COMPLETED|Maintenance Period||22
9941823|NCT01358578|11060401|FG002|NOT COMPLETED|Maintenance Period||2
9941824|NCT01358578|11060402|FG003|NOT COMPLETED|Maintenance Period||42
9941825|NCT01358578|11060403|FG004|NOT COMPLETED|Maintenance Period||17
9941826|NCT01358578|11060404|FG005|NOT COMPLETED|Maintenance Period||11
9941827|NCT01358578|11060399|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
9941828|NCT01358578|11060400|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
9941829|NCT01358578|11060401|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
9941830|NCT01358578|11060402|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
9941831|NCT01358578|11060403|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
9941832|NCT01358578|11060404|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
9941833|NCT01358578|11060399|FG000|COMPLETED|Follow-up Period||138
9941834|NCT01358578|11060400|FG001|COMPLETED|Follow-up Period||119
9941835|NCT01358578|11060401|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
9941836|NCT01358578|11060402|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
9941837|NCT01358578|11060403|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
9941838|NCT01358578|11060404|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
9941839|NCT01358578|11060399|FG000|NOT COMPLETED|Follow-up Period||10
9941840|NCT01358578|11060400|FG001|NOT COMPLETED|Follow-up Period||6
9941841|NCT01358578|11060401|FG002|NOT COMPLETED|Follow-up Period||5
9941842|NCT01358578|11060402|FG003|NOT COMPLETED|Follow-up Period||19
9941843|NCT01358578|11060403|FG004|NOT COMPLETED|Follow-up Period||0
9941844|NCT01358578|11060404|FG005|NOT COMPLETED|Follow-up Period||0
9941845|NCT01358708|11060434|FG000|STARTED|Double-Blind Treatment Phase||13
9941846|NCT01358708|11060435|FG001|STARTED|Double-Blind Treatment Phase||13
9941847|NCT01358708|11060434|FG000|Randomized|Double-Blind Treatment Phase||13
9941848|NCT01358708|11060435|FG001|Randomized|Double-Blind Treatment Phase||13
9941849|NCT01358708|11060434|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
9941850|NCT01358708|11060435|FG001|Received Study Medication|Double-Blind Treatment Phase||13
9941851|NCT01358708|11060434|FG000|COMPLETED|Double-Blind Treatment Phase||10
9941852|NCT01358708|11060435|FG001|COMPLETED|Double-Blind Treatment Phase||13
9941853|NCT01358708|11060434|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3
9941854|NCT01358708|11060435|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
9941855|NCT01358708|11060434|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
9941856|NCT01358708|11060435|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
9941857|NCT01358708|11060434|FG000|COMPLETED|Open-Label Treatment Phase||5
9941858|NCT01358708|11060435|FG001|COMPLETED|Open-Label Treatment Phase||12
9941859|NCT01358708|11060434|FG000|NOT COMPLETED|Open-Label Treatment Phase||0
9941860|NCT01358708|11060435|FG001|NOT COMPLETED|Open-Label Treatment Phase||0
9941861|NCT01358721|11060449|FG000|STARTED|Overall Study||22
9941862|NCT01358721|11060450|FG001|STARTED|Overall Study||22
9941863|NCT01358721|11060451|FG002|STARTED|Overall Study||23
9941864|NCT01358721|11060452|FG003|STARTED|Overall Study||24
9941865|NCT01358721|11060449|FG000|COMPLETED|Overall Study||1
9941866|NCT01358721|11060450|FG001|COMPLETED|Overall Study||0
9941867|NCT01358721|11060451|FG002|COMPLETED|Overall Study||1
9941868|NCT01358721|11060452|FG003|COMPLETED|Overall Study||0
9941869|NCT01358721|11060449|FG000|NOT COMPLETED|Overall Study||21
9941870|NCT01358721|11060450|FG001|NOT COMPLETED|Overall Study||22
9941871|NCT01358721|11060451|FG002|NOT COMPLETED|Overall Study||22
9941872|NCT01358721|11060452|FG003|NOT COMPLETED|Overall Study||24
9941873|NCT01358734|11060465|FG000|STARTED|Overall Study||15
9941874|NCT01358734|11060466|FG001|STARTED|Overall Study||39
9941875|NCT01358734|11060467|FG002|STARTED|Overall Study||34
9941876|NCT01358734|11060465|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
9941877|NCT01358734|11060466|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
9941878|NCT01358734|11060467|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
9941879|NCT01358734|11060465|FG000|COMPLETED|Overall Study||0
9941880|NCT01358734|11060466|FG001|COMPLETED|Overall Study||0
9941881|NCT01358734|11060467|FG002|COMPLETED|Overall Study||0
9941882|NCT01358734|11060465|FG000|NOT COMPLETED|Overall Study||15
9941883|NCT01358734|11060466|FG001|NOT COMPLETED|Overall Study||39
9941884|NCT01358734|11060467|FG002|NOT COMPLETED|Overall Study||34
9941885|NCT01358760|11060478|FG000|STARTED|Overall Study||152
9941886|NCT01358760|11060479|FG001|STARTED|Overall Study||148
9941887|NCT01358760|11060480|FG002|STARTED|Overall Study||150
9941888|NCT01358760|11060478|FG000|Safety Population|Overall Study||150
9941889|NCT01358760|11060479|FG001|Safety Population|Overall Study||143
9941890|NCT01358760|11060480|FG002|Safety Population|Overall Study||148
9941891|NCT01358760|11060478|FG000|ITT Population|Overall Study||139
9941892|NCT01358760|11060479|FG001|ITT Population|Overall Study||134
9941893|NCT01358760|11060480|FG002|ITT Population|Overall Study||134
9941894|NCT01358760|11060478|FG000|COMPLETED|Overall Study||130
9941895|NCT01358760|11060479|FG001|COMPLETED|Overall Study||128
9941896|NCT01358760|11060480|FG002|COMPLETED|Overall Study||125
9941897|NCT01358760|11060478|FG000|NOT COMPLETED|Overall Study||22
9941898|NCT01358760|11060479|FG001|NOT COMPLETED|Overall Study||20
9941899|NCT01358760|11060480|FG002|NOT COMPLETED|Overall Study||25
9941900|NCT01358825|11060490|FG000|STARTED|Overall Study||12
9941901|NCT01358825|11060491|FG001|STARTED|Overall Study||46
9941902|NCT01358825|11060490|FG000|COMPLETED|Overall Study||12
9941903|NCT01358825|11060491|FG001|COMPLETED|Overall Study||45
9941904|NCT01358825|11060490|FG000|NOT COMPLETED|Overall Study||0
9941905|NCT01358825|11060491|FG001|NOT COMPLETED|Overall Study||1
9941906|NCT01358864|11060505|FG000|STARTED|Overall Study||49
9941907|NCT01358864|11060506|FG001|STARTED|Overall Study||99
9941908|NCT01358864|11060507|FG002|STARTED|Overall Study||103
9941909|NCT01358864|11060508|FG003|STARTED|Overall Study||29
9941910|NCT01358864|11060509|FG004|STARTED|Overall Study||57
9941911|NCT01358864|11060510|FG005|STARTED|Overall Study||55
9941912|NCT01358864|11060511|FG006|STARTED|Overall Study||146
9941913|NCT01358864|11060512|FG007|STARTED|Overall Study||140
9941914|NCT01358864|11060505|FG000|COMPLETED|Overall Study||18
9941915|NCT01358864|11060506|FG001|COMPLETED|Overall Study||86
9941916|NCT01358864|11060507|FG002|COMPLETED|Overall Study||87
9941917|NCT01358864|11060508|FG003|COMPLETED|Overall Study||10
9941918|NCT01358864|11060509|FG004|COMPLETED|Overall Study||46
9941919|NCT01358864|11060510|FG005|COMPLETED|Overall Study||42
9941920|NCT01358864|11060511|FG006|COMPLETED|Overall Study||81
9941921|NCT01358864|11060512|FG007|COMPLETED|Overall Study||85
9941922|NCT01358864|11060505|FG000|NOT COMPLETED|Overall Study||31
9941923|NCT01358864|11060506|FG001|NOT COMPLETED|Overall Study||13
9941924|NCT01358864|11060507|FG002|NOT COMPLETED|Overall Study||16
9941925|NCT01358864|11060508|FG003|NOT COMPLETED|Overall Study||19
9941926|NCT01358864|11060509|FG004|NOT COMPLETED|Overall Study||11
9941927|NCT01358864|11060510|FG005|NOT COMPLETED|Overall Study||13
9941928|NCT01358864|11060511|FG006|NOT COMPLETED|Overall Study||65
9941929|NCT01358864|11060512|FG007|NOT COMPLETED|Overall Study||55
9941930|NCT01358968|11060532|FG000|STARTED|Period 1||20
9941931|NCT01358968|11060533|FG001|STARTED|Period 1||0
9941932|NCT01358968|11060534|FG002|STARTED|Period 1||0
9941933|NCT01358968|11060535|FG003|STARTED|Period 1||0
9941934|NCT01358968|11060532|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
9941935|NCT01358968|11060533|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
9941936|NCT01358968|11060534|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
9941937|NCT01358968|11060535|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
9941938|NCT01358968|11060532|FG000|COMPLETED|Period 1||20
9941939|NCT01358968|11060533|FG001|COMPLETED|Period 1||0
9941940|NCT01358968|11060534|FG002|COMPLETED|Period 1||0
9941941|NCT01358968|11060535|FG003|COMPLETED|Period 1||0
9941942|NCT01358968|11060532|FG000|NOT COMPLETED|Period 1||0
9941943|NCT01358968|11060533|FG001|NOT COMPLETED|Period 1||0
9941944|NCT01358968|11060534|FG002|NOT COMPLETED|Period 1||0
9941945|NCT01358968|11060535|FG003|NOT COMPLETED|Period 1||0
9941946|NCT01358968|11060532|FG000|STARTED|Period 2||0
9941947|NCT01358968|11060533|FG001|STARTED|Period 2||20
9941948|NCT01358968|11060534|FG002|STARTED|Period 2||0
9941949|NCT01358968|11060535|FG003|STARTED|Period 2||0
9941950|NCT01358968|11060532|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
9941951|NCT01358968|11060533|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
9941952|NCT01358968|11060534|FG002|Received at Least 1 Dose of Study Drug|Period 2||0
9941953|NCT01358968|11060535|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
9941954|NCT01358968|11060532|FG000|COMPLETED|Period 2||0
9941955|NCT01358968|11060533|FG001|COMPLETED|Period 2||19
9941956|NCT01358968|11060534|FG002|COMPLETED|Period 2||0
9941957|NCT01358968|11060535|FG003|COMPLETED|Period 2||0
9941958|NCT01358968|11060532|FG000|NOT COMPLETED|Period 2||0
9941959|NCT01358968|11060533|FG001|NOT COMPLETED|Period 2||1
9941960|NCT01358968|11060534|FG002|NOT COMPLETED|Period 2||0
9941961|NCT01358968|11060535|FG003|NOT COMPLETED|Period 2||0
9941962|NCT01358968|11060532|FG000|STARTED|Continued Access Phase||0
9941963|NCT01358968|11060533|FG001|STARTED|Continued Access Phase||0
9941964|NCT01358968|11060534|FG002|STARTED|Continued Access Phase||12
9941965|NCT01358968|11060535|FG003|STARTED|Continued Access Phase||7
9941966|NCT01358968|11060532|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
9941967|NCT01358968|11060533|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
9941968|NCT01358968|11060534|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
9941969|NCT01358968|11060535|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
9941970|NCT01358968|11060532|FG000|COMPLETED|Continued Access Phase||0
9941971|NCT01358968|11060533|FG001|COMPLETED|Continued Access Phase||0
9941972|NCT01358968|11060534|FG002|COMPLETED|Continued Access Phase||0
9941973|NCT01358968|11060535|FG003|COMPLETED|Continued Access Phase||0
9941974|NCT01358968|11060532|FG000|NOT COMPLETED|Continued Access Phase||0
9941975|NCT01358968|11060533|FG001|NOT COMPLETED|Continued Access Phase||0
9941976|NCT01358968|11060534|FG002|NOT COMPLETED|Continued Access Phase||12
9941977|NCT01358968|11060535|FG003|NOT COMPLETED|Continued Access Phase||7
9941978|NCT01358981|11060552|FG000|STARTED|Period 1||2
9941979|NCT01358981|11060553|FG001|STARTED|Period 1||2
9941980|NCT01358981|11060554|FG002|STARTED|Period 1||2
9941981|NCT01358981|11060555|FG003|STARTED|Period 1||2
9941982|NCT01358981|11060556|FG004|STARTED|Period 1||3
9941983|NCT01358981|11060557|FG005|STARTED|Period 1||3
9941984|NCT01358981|11060558|FG006|STARTED|Period 1||3
9941985|NCT01358981|11060552|FG000|Received at Least 1dose of Study Drug|Period 1||2
9941986|NCT01358981|11060553|FG001|Received at Least 1dose of Study Drug|Period 1||2
9941987|NCT01358981|11060554|FG002|Received at Least 1dose of Study Drug|Period 1||2
9941988|NCT01358981|11060555|FG003|Received at Least 1dose of Study Drug|Period 1||2
9941989|NCT01358981|11060556|FG004|Received at Least 1dose of Study Drug|Period 1||3
9941990|NCT01358981|11060557|FG005|Received at Least 1dose of Study Drug|Period 1||3
9941991|NCT01358981|11060558|FG006|Received at Least 1dose of Study Drug|Period 1||3
9941992|NCT01358981|11060552|FG000|COMPLETED|Period 1||2
9941993|NCT01358981|11060553|FG001|COMPLETED|Period 1||2
9941994|NCT01358981|11060554|FG002|COMPLETED|Period 1||2
9941995|NCT01358981|11060555|FG003|COMPLETED|Period 1||1
9941996|NCT01358981|11060556|FG004|COMPLETED|Period 1||3
9941997|NCT01358981|11060557|FG005|COMPLETED|Period 1||3
9941998|NCT01358981|11060558|FG006|COMPLETED|Period 1||3
9941999|NCT01358981|11060552|FG000|NOT COMPLETED|Period 1||0
9942000|NCT01358981|11060553|FG001|NOT COMPLETED|Period 1||0
9942001|NCT01358981|11060554|FG002|NOT COMPLETED|Period 1||0
9942002|NCT01358981|11060555|FG003|NOT COMPLETED|Period 1||1
9942003|NCT01358981|11060556|FG004|NOT COMPLETED|Period 1||0
9942004|NCT01358981|11060557|FG005|NOT COMPLETED|Period 1||0
9942005|NCT01358981|11060558|FG006|NOT COMPLETED|Period 1||0
9942006|NCT01358981|11060552|FG000|STARTED|Period 2||2
9942007|NCT01358981|11060553|FG001|STARTED|Period 2||2
9942008|NCT01358981|11060554|FG002|STARTED|Period 2||2
9942009|NCT01358981|11060555|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
9942010|NCT01358981|11060556|FG004|STARTED|Period 2||3
9942011|NCT01358981|11060557|FG005|STARTED|Period 2||3
9942012|NCT01358981|11060558|FG006|STARTED|Period 2||3
9942013|NCT01358981|11060552|FG000|COMPLETED|Period 2||2
9942014|NCT01358981|11060553|FG001|COMPLETED|Period 2||2
9942015|NCT01358981|11060554|FG002|COMPLETED|Period 2||2
9942016|NCT01358981|11060555|FG003|COMPLETED|Period 2||2
9942017|NCT01358981|11060556|FG004|COMPLETED|Period 2||3
9942018|NCT01358981|11060557|FG005|COMPLETED|Period 2||3
9942019|NCT01358981|11060558|FG006|COMPLETED|Period 2||3
9942020|NCT01358981|11060552|FG000|NOT COMPLETED|Period 2||0
9942021|NCT01358981|11060553|FG001|NOT COMPLETED|Period 2||0
9942022|NCT01358981|11060554|FG002|NOT COMPLETED|Period 2||0
9942023|NCT01358981|11060555|FG003|NOT COMPLETED|Period 2||0
9942024|NCT01358981|11060556|FG004|NOT COMPLETED|Period 2||0
9942025|NCT01358981|11060557|FG005|NOT COMPLETED|Period 2||0
9942026|NCT01358981|11060558|FG006|NOT COMPLETED|Period 2||0
9942027|NCT01358981|11060552|FG000|STARTED|Period 3||2
9942028|NCT01358981|11060553|FG001|STARTED|Period 3||2
9942029|NCT01358981|11060554|FG002|STARTED|Period 3||2
9942030|NCT01358981|11060555|FG003|STARTED|Period 3||2
9942031|NCT01358981|11060556|FG004|STARTED|Period 3||3
9942032|NCT01358981|11060557|FG005|STARTED|Period 3||3
9942033|NCT01358981|11060558|FG006|STARTED|Period 3||3
9942034|NCT01358981|11060552|FG000|COMPLETED|Period 3||2
9942035|NCT01358981|11060553|FG001|COMPLETED|Period 3||2
9942036|NCT01358981|11060554|FG002|COMPLETED|Period 3||2
9942037|NCT01358981|11060555|FG003|COMPLETED|Period 3||2
9942038|NCT01358981|11060556|FG004|COMPLETED|Period 3||3
9942039|NCT01358981|11060557|FG005|COMPLETED|Period 3||3
9942040|NCT01358981|11060558|FG006|COMPLETED|Period 3||3
9942041|NCT01358981|11060552|FG000|NOT COMPLETED|Period 3||0
9942042|NCT01358981|11060553|FG001|NOT COMPLETED|Period 3||0
9942043|NCT01358981|11060554|FG002|NOT COMPLETED|Period 3||0
9942044|NCT01358981|11060555|FG003|NOT COMPLETED|Period 3||0
9942045|NCT01358981|11060556|FG004|NOT COMPLETED|Period 3||0
9942046|NCT01358981|11060557|FG005|NOT COMPLETED|Period 3||0
9942047|NCT01358981|11060558|FG006|NOT COMPLETED|Period 3||0
9942048|NCT01358981|11060552|FG000|STARTED|Period 4||2
9942049|NCT01358981|11060553|FG001|STARTED|Period 4||2
9942050|NCT01358981|11060554|FG002|STARTED|Period 4||2
9942051|NCT01358981|11060555|FG003|STARTED|Period 4||2
9942052|NCT01358981|11060556|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
9942053|NCT01358981|11060557|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
9942054|NCT01358981|11060558|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
9942055|NCT01358981|11060552|FG000|COMPLETED|Period 4||2
9942056|NCT01358981|11060553|FG001|COMPLETED|Period 4||2
9942057|NCT01358981|11060554|FG002|COMPLETED|Period 4||2
9942058|NCT01358981|11060555|FG003|COMPLETED|Period 4||2
9942059|NCT01358981|11060556|FG004|COMPLETED|Period 4||0
9942060|NCT01358981|11060557|FG005|COMPLETED|Period 4||0
9942061|NCT01358981|11060558|FG006|COMPLETED|Period 4||0
9942062|NCT01358981|11060552|FG000|NOT COMPLETED|Period 4||0
9942063|NCT01358981|11060553|FG001|NOT COMPLETED|Period 4||0
9942064|NCT01358981|11060554|FG002|NOT COMPLETED|Period 4||0
9942065|NCT01358981|11060555|FG003|NOT COMPLETED|Period 4||0
10011432|NCT01780922|11134204|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10011433|NCT01780922|11134205|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10011434|NCT01780922|11134200|FG000|STARTED|Washout (7 Days)||2
10011435|NCT01780922|11134201|FG001|STARTED|Washout (7 Days)||2
10011436|NCT01780922|11134202|FG002|STARTED|Washout (7 Days)||2
9942066|NCT01358981|11060556|FG004|NOT COMPLETED|Period 4||0
9942067|NCT01358981|11060557|FG005|NOT COMPLETED|Period 4||0
9942068|NCT01358981|11060558|FG006|NOT COMPLETED|Period 4||0
9942069|NCT01359007|11060583|FG000|STARTED|Overall Study||5
9942070|NCT01359007|11060583|FG000|COMPLETED|Overall Study||3
9942071|NCT01359007|11060583|FG000|NOT COMPLETED|Overall Study||2
9942072|NCT01359046|11060590|FG000|STARTED|Overall Study||144
9942073|NCT01359046|11060591|FG001|STARTED|Overall Study||144
9942074|NCT01359046|11060590|FG000|COMPLETED|Overall Study||137
9942075|NCT01359046|11060591|FG001|COMPLETED|Overall Study||127
9942076|NCT01359046|11060590|FG000|NOT COMPLETED|Overall Study||7
9942077|NCT01359046|11060591|FG001|NOT COMPLETED|Overall Study||17
9942078|NCT01359111|11060597|FG000|STARTED|Overall Study||20
9942079|NCT01359111|11060597|FG000|COMPLETED|Overall Study||20
9942080|NCT01359111|11060597|FG000|NOT COMPLETED|Overall Study||0
9942081|NCT01359150|11060605|FG000|STARTED|Overall Study||112
9942082|NCT01359150|11060606|FG001|STARTED|Overall Study||111
9942083|NCT01359150|11060605|FG000|COMPLETED|Overall Study||105
9942084|NCT01359150|11060606|FG001|COMPLETED|Overall Study||106
9942085|NCT01359150|11060605|FG000|NOT COMPLETED|Overall Study||7
9942086|NCT01359150|11060606|FG001|NOT COMPLETED|Overall Study||5
9942087|NCT01359371|11060612|FG000|STARTED|Overall Study||131
9942088|NCT01359371|11060612|FG000|COMPLETED|Overall Study||131
9942089|NCT01359371|11060612|FG000|NOT COMPLETED|Overall Study||0
9942090|NCT01359410|11060623|FG000|STARTED|Overall Study||54
9942091|NCT01359410|11060624|FG001|STARTED|Overall Study||46
9942092|NCT01359410|11060623|FG000|COMPLETED|Overall Study||54
9942093|NCT01359410|11060624|FG001|COMPLETED|Overall Study||46
9942094|NCT01359410|11060623|FG000|NOT COMPLETED|Overall Study||0
9942095|NCT01359410|11060624|FG001|NOT COMPLETED|Overall Study||0
9942096|NCT01359449|11060632|FG000|STARTED|Overall Study||61
9942097|NCT01359449|11060633|FG001|STARTED|Overall Study||62
9942098|NCT01359449|11060632|FG000|COMPLETED|Overall Study||57
9942099|NCT01359449|11060633|FG001|COMPLETED|Overall Study||58
9942100|NCT01359449|11060632|FG000|NOT COMPLETED|Overall Study||4
9942101|NCT01359449|11060633|FG001|NOT COMPLETED|Overall Study||4
9942102|NCT01359592|11060639|FG000|STARTED|Initial Registration||158
9942103|NCT01359592|11060640|FG001|STARTED|Initial Registration||1
9942104|NCT01359592|11060641|FG002|STARTED|Initial Registration||0
9942105|NCT01359592|11060642|FG003|STARTED|Initial Registration||0
9942106|NCT01359592|11060639|FG000|Eligible and Evaluable|Initial Registration||132
9942107|NCT01359592|11060640|FG001|Eligible and Evaluable|Initial Registration||1
9942108|NCT01359592|11060641|FG002|Eligible and Evaluable|Initial Registration||0
9942109|NCT01359592|11060642|FG003|Eligible and Evaluable|Initial Registration||0
9942110|NCT01359592|11060639|FG000|COMPLETED|Initial Registration||129
9942111|NCT01359592|11060640|FG001|COMPLETED|Initial Registration||1
9942112|NCT01359592|11060641|FG002|COMPLETED|Initial Registration||0
9942113|NCT01359592|11060642|FG003|COMPLETED|Initial Registration||0
9942114|NCT01359592|11060639|FG000|NOT COMPLETED|Initial Registration||29
9942115|NCT01359592|11060640|FG001|NOT COMPLETED|Initial Registration||0
9942116|NCT01359592|11060641|FG002|NOT COMPLETED|Initial Registration||0
9942117|NCT01359592|11060642|FG003|NOT COMPLETED|Initial Registration||0
9942118|NCT01359592|11060639|FG000|STARTED|PET-Directed Therapy||0
10011437|NCT01780922|11134203|FG003|STARTED|Washout (7 Days)||2
9942119|NCT01359592|11060640|FG001|STARTED|PET-Directed Therapy||0
9942120|NCT01359592|11060641|FG002|STARTED|PET-Directed Therapy||137
9942121|NCT01359592|11060642|FG003|STARTED|PET-Directed Therapy||12
9942122|NCT01359592|11060639|FG000|Eligible and Evaluable|PET-Directed Therapy||0
9942123|NCT01359592|11060640|FG001|Eligible and Evaluable|PET-Directed Therapy||0
9942124|NCT01359592|11060641|FG002|Eligible and Evaluable|PET-Directed Therapy||113
9942125|NCT01359592|11060642|FG003|Eligible and Evaluable|PET-Directed Therapy||12
9942126|NCT01359592|11060639|FG000|COMPLETED|PET-Directed Therapy||0
9942127|NCT01359592|11060640|FG001|COMPLETED|PET-Directed Therapy||0
9942128|NCT01359592|11060641|FG002|COMPLETED|PET-Directed Therapy||111
9942129|NCT01359592|11060642|FG003|COMPLETED|PET-Directed Therapy||12
9942130|NCT01359592|11060639|FG000|NOT COMPLETED|PET-Directed Therapy||0
9942131|NCT01359592|11060640|FG001|NOT COMPLETED|PET-Directed Therapy||0
9942132|NCT01359592|11060641|FG002|NOT COMPLETED|PET-Directed Therapy||26
9942133|NCT01359592|11060642|FG003|NOT COMPLETED|PET-Directed Therapy||0
9942134|NCT01359644|11060667|FG000|STARTED|Treatment Period||15
9942135|NCT01359644|11060668|FG001|STARTED|Treatment Period||16
9942136|NCT01359644|11060669|FG002|STARTED|Treatment Period||14
9942137|NCT01359644|11060670|FG003|STARTED|Treatment Period||14
9942138|NCT01359644|11060671|FG004|STARTED|Treatment Period||15
9942139|NCT01359644|11060672|FG005|STARTED|Treatment Period||14
9942140|NCT01359644|11060673|FG006|STARTED|Treatment Period||41
9942141|NCT01359644|11060674|FG007|STARTED|Treatment Period||41
9942142|NCT01359644|11060675|FG008|STARTED|Treatment Period||21
9942143|NCT01359644|11060676|FG009|STARTED|Treatment Period||20
9942144|NCT01359644|11060667|FG000|COMPLETED|Treatment Period||15
9942145|NCT01359644|11060668|FG001|COMPLETED|Treatment Period||15
9942146|NCT01359644|11060669|FG002|COMPLETED|Treatment Period||13
9942147|NCT01359644|11060670|FG003|COMPLETED|Treatment Period||14
9942148|NCT01359644|11060671|FG004|COMPLETED|Treatment Period||15
9942149|NCT01359644|11060672|FG005|COMPLETED|Treatment Period||12
9942150|NCT01359644|11060673|FG006|COMPLETED|Treatment Period||41
9942151|NCT01359644|11060674|FG007|COMPLETED|Treatment Period||41
9942152|NCT01359644|11060675|FG008|COMPLETED|Treatment Period||21
9942153|NCT01359644|11060676|FG009|COMPLETED|Treatment Period||20
9942154|NCT01359644|11060667|FG000|NOT COMPLETED|Treatment Period||0
9942155|NCT01359644|11060668|FG001|NOT COMPLETED|Treatment Period||1
9942156|NCT01359644|11060669|FG002|NOT COMPLETED|Treatment Period||1
9942157|NCT01359644|11060670|FG003|NOT COMPLETED|Treatment Period||0
9942158|NCT01359644|11060671|FG004|NOT COMPLETED|Treatment Period||0
9942159|NCT01359644|11060672|FG005|NOT COMPLETED|Treatment Period||2
9942160|NCT01359644|11060673|FG006|NOT COMPLETED|Treatment Period||0
9942161|NCT01359644|11060674|FG007|NOT COMPLETED|Treatment Period||0
9942162|NCT01359644|11060675|FG008|NOT COMPLETED|Treatment Period||0
9942163|NCT01359644|11060676|FG009|NOT COMPLETED|Treatment Period||0
9942164|NCT01359644|11060667|FG000|STARTED|Follow-up Period||15
9942165|NCT01359644|11060668|FG001|STARTED|Follow-up Period||16
9942166|NCT01359644|11060669|FG002|STARTED|Follow-up Period||14
9942167|NCT01359644|11060670|FG003|STARTED|Follow-up Period||14
9942168|NCT01359644|11060671|FG004|STARTED|Follow-up Period||15
9942169|NCT01359644|11060672|FG005|STARTED|Follow-up Period||13
9942170|NCT01359644|11060673|FG006|STARTED|Follow-up Period||41
9942171|NCT01359644|11060674|FG007|STARTED|Follow-up Period||41
9942172|NCT01359644|11060675|FG008|STARTED|Follow-up Period||21
9942173|NCT01359644|11060676|FG009|STARTED|Follow-up Period||20
9942174|NCT01359644|11060667|FG000|COMPLETED|Follow-up Period||15
9942175|NCT01359644|11060668|FG001|COMPLETED|Follow-up Period||16
9942176|NCT01359644|11060669|FG002|COMPLETED|Follow-up Period||14
9942177|NCT01359644|11060670|FG003|COMPLETED|Follow-up Period||14
9942178|NCT01359644|11060671|FG004|COMPLETED|Follow-up Period||15
9942179|NCT01359644|11060672|FG005|COMPLETED|Follow-up Period||12
9942180|NCT01359644|11060673|FG006|COMPLETED|Follow-up Period||40
9942181|NCT01359644|11060674|FG007|COMPLETED|Follow-up Period||39
9942182|NCT01359644|11060675|FG008|COMPLETED|Follow-up Period||21
9942183|NCT01359644|11060676|FG009|COMPLETED|Follow-up Period||20
9942184|NCT01359644|11060667|FG000|NOT COMPLETED|Follow-up Period||0
9942185|NCT01359644|11060668|FG001|NOT COMPLETED|Follow-up Period||0
9942186|NCT01359644|11060669|FG002|NOT COMPLETED|Follow-up Period||0
9942187|NCT01359644|11060670|FG003|NOT COMPLETED|Follow-up Period||0
9942188|NCT01359644|11060671|FG004|NOT COMPLETED|Follow-up Period||0
9942189|NCT01359644|11060672|FG005|NOT COMPLETED|Follow-up Period||1
9942190|NCT01359644|11060673|FG006|NOT COMPLETED|Follow-up Period||1
9942191|NCT01359644|11060674|FG007|NOT COMPLETED|Follow-up Period||2
9942192|NCT01359644|11060675|FG008|NOT COMPLETED|Follow-up Period||0
9942193|NCT01359644|11060676|FG009|NOT COMPLETED|Follow-up Period||0
9942194|NCT01359735|11060711|FG000|STARTED|Overall Study||4
9942195|NCT01359735|11060712|FG001|STARTED|Overall Study||4
9942196|NCT01359735|11060711|FG000|COMPLETED|Overall Study||4
9942197|NCT01359735|11060712|FG001|COMPLETED|Overall Study||4
9942198|NCT01359735|11060711|FG000|NOT COMPLETED|Overall Study||0
9942199|NCT01359735|11060712|FG001|NOT COMPLETED|Overall Study||0
9942200|NCT01359748|11060722|FG000|STARTED|Overall Study||48
9942201|NCT01359748|11060723|FG001|STARTED|Overall Study||20
9942202|NCT01359748|11060724|FG002|STARTED|Overall Study||10
9942203|NCT01359748|11060725|FG003|STARTED|Overall Study||11
9942204|NCT01359748|11060722|FG000|COMPLETED|Overall Study||48
9942205|NCT01359748|11060723|FG001|COMPLETED|Overall Study||20
9942206|NCT01359748|11060724|FG002|COMPLETED|Overall Study||10
9942207|NCT01359748|11060725|FG003|COMPLETED|Overall Study||11
9942208|NCT01359748|11060722|FG000|NOT COMPLETED|Overall Study||0
9942209|NCT01359748|11060723|FG001|NOT COMPLETED|Overall Study||0
9942210|NCT01359748|11060724|FG002|NOT COMPLETED|Overall Study||0
9942211|NCT01359748|11060725|FG003|NOT COMPLETED|Overall Study||0
9942212|NCT01359904|11060735|FG000|STARTED|Overall Study||15
9942213|NCT01359904|11060736|FG001|STARTED|Overall Study||19
9942214|NCT01359904|11060735|FG000|COMPLETED|Overall Study||14
9942215|NCT01359904|11060736|FG001|COMPLETED|Overall Study||19
9942216|NCT01359904|11060735|FG000|NOT COMPLETED|Overall Study||1
9942217|NCT01359904|11060736|FG001|NOT COMPLETED|Overall Study||0
9942218|NCT01359943|11060745|FG000|STARTED|Double-blind (Weeks 0 - 16)||88
9942219|NCT01359943|11060746|FG001|STARTED|Double-blind (Weeks 0 - 16)||89
9942220|NCT01359943|11060747|FG002|STARTED|Double-blind (Weeks 0 - 16)||44
9942221|NCT01359943|11060745|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86
9942222|NCT01359943|11060746|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85
9942223|NCT01359943|11060747|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44
9942224|NCT01359943|11060745|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
9942225|NCT01359943|11060746|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
9942226|NCT01359943|11060747|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
9942227|NCT01359943|11060745|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
9942228|NCT01359943|11060746|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
9942229|NCT01359943|11060747|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
9942230|NCT01359943|11060745|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
9942231|NCT01359943|11060746|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
9942232|NCT01359943|11060747|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
9942233|NCT01359943|11060745|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
9942234|NCT01359943|11060746|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
9942235|NCT01359943|11060747|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
9942236|NCT01359943|11060745|FG000|STARTED|Follow-up (Weeks 52 - 60)||86
9942237|NCT01359943|11060746|FG001|STARTED|Follow-up (Weeks 52 - 60)||84
9942238|NCT01359943|11060747|FG002|STARTED|Follow-up (Weeks 52 - 60)||44
9942239|NCT01359943|11060745|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78
9942240|NCT01359943|11060746|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69
9942241|NCT01359943|11060747|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36
9942242|NCT01359943|11060745|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
9942243|NCT01359943|11060746|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
9942244|NCT01359943|11060747|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
9942245|NCT01359956|11060761|FG000|STARTED|Overall Study||67
9942246|NCT01359956|11060762|FG001|STARTED|Overall Study||69
9942247|NCT01359956|11060763|FG002|STARTED|Overall Study||71
9942248|NCT01359956|11060764|FG003|STARTED|Overall Study||62
9942249|NCT01359956|11060761|FG000|COMPLETED|Overall Study||6
9942250|NCT01359956|11060762|FG001|COMPLETED|Overall Study||5
9942251|NCT01359956|11060763|FG002|COMPLETED|Overall Study||4
9942252|NCT01359956|11060764|FG003|COMPLETED|Overall Study||4
9942253|NCT01359956|11060761|FG000|NOT COMPLETED|Overall Study||61
9942254|NCT01359956|11060762|FG001|NOT COMPLETED|Overall Study||64
9942255|NCT01359956|11060763|FG002|NOT COMPLETED|Overall Study||67
9942256|NCT01359956|11060764|FG003|NOT COMPLETED|Overall Study||58
9942257|NCT01360021|11060777|FG000|STARTED|Overall Study|Patients randomized|71
9942258|NCT01360021|11060778|FG001|STARTED|Overall Study|Patients randomized|71
9942259|NCT01360021|11060779|FG002|STARTED|Overall Study|Patients randomized|72
9942260|NCT01360021|11060777|FG000|COMPLETED|Overall Study|Patients who completed study|63
9942261|NCT01360021|11060778|FG001|COMPLETED|Overall Study|Patients who completed study|67
9942262|NCT01360021|11060779|FG002|COMPLETED|Overall Study|Patients who completed study|65
9942263|NCT01360021|11060777|FG000|NOT COMPLETED|Overall Study||8
9942264|NCT01360021|11060778|FG001|NOT COMPLETED|Overall Study||4
9942265|NCT01360021|11060779|FG002|NOT COMPLETED|Overall Study||7
9942266|NCT01360229|11060789|FG000|STARTED|Overall Study||47
9942267|NCT01360229|11060790|FG001|STARTED|Overall Study||47
9942268|NCT01360229|11060789|FG000|COMPLETED|Overall Study||44
9942269|NCT01360229|11060790|FG001|COMPLETED|Overall Study||45
9942270|NCT01360229|11060789|FG000|NOT COMPLETED|Overall Study||3
9942271|NCT01360229|11060790|FG001|NOT COMPLETED|Overall Study||2
9942272|NCT01360398|11060796|FG000|STARTED|Overall Study||127
9942273|NCT01360398|11060796|FG000|COMPLETED|Overall Study||105
9942274|NCT01360398|11060796|FG000|NOT COMPLETED|Overall Study||22
9942275|NCT01360450|11060802|FG000|STARTED|Overall Study||6
9942276|NCT01360450|11060803|FG001|STARTED|Overall Study||6
9942277|NCT01360450|11060802|FG000|Completed Treatment|Overall Study||6
9942278|NCT01360450|11060803|FG001|Completed Treatment|Overall Study||6
9942279|NCT01360450|11060802|FG000|COMPLETED|Overall Study||6
9942280|NCT01360450|11060803|FG001|COMPLETED|Overall Study||6
9942281|NCT01360450|11060802|FG000|NOT COMPLETED|Overall Study||0
10011438|NCT01780922|11134204|FG004|STARTED|Washout (7 Days)||2
10011439|NCT01780922|11134205|FG005|STARTED|Washout (7 Days)||2
10011440|NCT01780922|11134200|FG000|COMPLETED|Washout (7 Days)||2
10011441|NCT01780922|11134201|FG001|COMPLETED|Washout (7 Days)||2
10011442|NCT01780922|11134202|FG002|COMPLETED|Washout (7 Days)||2
9942282|NCT01360450|11060803|FG001|NOT COMPLETED|Overall Study||0
9942283|NCT01360554|11060812|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439
9942284|NCT01360554|11060813|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439
9942285|NCT01360554|11060812|FG000|Treated|Overall Study||436
9942286|NCT01360554|11060813|FG001|Treated|Overall Study||436
9942287|NCT01360554|11060812|FG000|COMPLETED|Overall Study||0
9942288|NCT01360554|11060813|FG001|COMPLETED|Overall Study||0
9942289|NCT01360554|11060812|FG000|NOT COMPLETED|Overall Study||439
9942290|NCT01360554|11060813|FG001|NOT COMPLETED|Overall Study||439
9942291|NCT01360632|11060822|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
9942292|NCT01360632|11060823|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
9942293|NCT01360632|11060824|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
10011443|NCT01780922|11134203|FG003|COMPLETED|Washout (7 Days)||2
9942294|NCT01360632|11060825|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
9942295|NCT01360632|11060826|FG004|STARTED|Phase A (8 Weeks)||0
9942296|NCT01360632|11060822|FG000|COMPLETED|Phase A (8 Weeks)||1277
10011444|NCT01780922|11134204|FG004|COMPLETED|Washout (7 Days)||2
9942297|NCT01360632|11060823|FG001|COMPLETED|Phase A (8 Weeks)||0
9942298|NCT01360632|11060824|FG002|COMPLETED|Phase A (8 Weeks)||0
9942299|NCT01360632|11060825|FG003|COMPLETED|Phase A (8 Weeks)||0
9942300|NCT01360632|11060826|FG004|COMPLETED|Phase A (8 Weeks)||0
9942301|NCT01360632|11060822|FG000|NOT COMPLETED|Phase A (8 Weeks)||255
9942302|NCT01360632|11060823|FG001|NOT COMPLETED|Phase A (8 Weeks)||0
9942303|NCT01360632|11060824|FG002|NOT COMPLETED|Phase A (8 Weeks)||0
9942304|NCT01360632|11060825|FG003|NOT COMPLETED|Phase A (8 Weeks)||0
9942305|NCT01360632|11060826|FG004|NOT COMPLETED|Phase A (8 Weeks)||0
9942306|NCT01360632|11060822|FG000|STARTED|Phase B (6 Weeks)||0
9942307|NCT01360632|11060823|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
9942308|NCT01360632|11060824|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
9942309|NCT01360632|11060825|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
9942310|NCT01360632|11060826|FG004|STARTED|Phase B (6 Weeks)||0
9942311|NCT01360632|11060822|FG000|COMPLETED|Phase B (6 Weeks)||0
9942312|NCT01360632|11060823|FG001|COMPLETED|Phase B (6 Weeks)||216
9942313|NCT01360632|11060824|FG002|COMPLETED|Phase B (6 Weeks)||210
9942314|NCT01360632|11060825|FG003|COMPLETED|Phase B (6 Weeks)||208
9942315|NCT01360632|11060826|FG004|COMPLETED|Phase B (6 Weeks)||0
9942316|NCT01360632|11060822|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
9942317|NCT01360632|11060823|FG001|NOT COMPLETED|Phase B (6 Weeks)||10
9942318|NCT01360632|11060824|FG002|NOT COMPLETED|Phase B (6 Weeks)||20
9942319|NCT01360632|11060825|FG003|NOT COMPLETED|Phase B (6 Weeks)||13
9942320|NCT01360632|11060826|FG004|NOT COMPLETED|Phase B (6 Weeks)||0
9942321|NCT01360632|11060822|FG000|STARTED|Phase A+||0
9942322|NCT01360632|11060823|FG001|STARTED|Phase A+||0
9942323|NCT01360632|11060824|FG002|STARTED|Phase A+||0
9942324|NCT01360632|11060825|FG003|STARTED|Phase A+||0
9942325|NCT01360632|11060826|FG004|STARTED|Phase A+||600
9942326|NCT01360632|11060822|FG000|COMPLETED|Phase A+||0
9942327|NCT01360632|11060823|FG001|COMPLETED|Phase A+||0
9942328|NCT01360632|11060824|FG002|COMPLETED|Phase A+||0
9942329|NCT01360632|11060825|FG003|COMPLETED|Phase A+||0
9942330|NCT01360632|11060826|FG004|COMPLETED|Phase A+||575
9942331|NCT01360632|11060822|FG000|NOT COMPLETED|Phase A+||0
9942332|NCT01360632|11060823|FG001|NOT COMPLETED|Phase A+||0
9942333|NCT01360632|11060824|FG002|NOT COMPLETED|Phase A+||0
9942334|NCT01360632|11060825|FG003|NOT COMPLETED|Phase A+||0
9942335|NCT01360632|11060826|FG004|NOT COMPLETED|Phase A+||25
9942336|NCT01360645|11060836|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
9942337|NCT01360645|11060837|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942338|NCT01360645|11060838|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942339|NCT01360645|11060839|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942340|NCT01360645|11060836|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
9942341|NCT01360645|11060837|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942342|NCT01360645|11060838|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942343|NCT01360645|11060839|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942344|NCT01360645|11060836|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
9942345|NCT01360645|11060837|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942346|NCT01360645|11060838|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942347|NCT01360645|11060839|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
9942348|NCT01360645|11060836|FG000|STARTED|Phase B (6 Weeks)||0
9942349|NCT01360645|11060837|FG001|STARTED|Phase B (6 Weeks)||188
9942350|NCT01360645|11060838|FG002|STARTED|Phase B (6 Weeks)||191
9942351|NCT01360645|11060839|FG003|STARTED|Phase B (6 Weeks)||0
9942352|NCT01360645|11060836|FG000|COMPLETED|Phase B (6 Weeks)||0
9942353|NCT01360645|11060837|FG001|COMPLETED|Phase B (6 Weeks)||174
9942354|NCT01360645|11060838|FG002|COMPLETED|Phase B (6 Weeks)||178
9942355|NCT01360645|11060839|FG003|COMPLETED|Phase B (6 Weeks)||0
9942356|NCT01360645|11060836|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
9942357|NCT01360645|11060837|FG001|NOT COMPLETED|Phase B (6 Weeks)||14
9942358|NCT01360645|11060838|FG002|NOT COMPLETED|Phase B (6 Weeks)||13
9942359|NCT01360645|11060839|FG003|NOT COMPLETED|Phase B (6 Weeks)||0
9942360|NCT01360645|11060836|FG000|STARTED|Phase A+||0
9942361|NCT01360645|11060837|FG001|STARTED|Phase A+||0
9942362|NCT01360645|11060838|FG002|STARTED|Phase A+||0
9942363|NCT01360645|11060839|FG003|STARTED|Phase A+||331
9942364|NCT01360645|11060836|FG000|COMPLETED|Phase A+||0
9942365|NCT01360645|11060837|FG001|COMPLETED|Phase A+||0
9942366|NCT01360645|11060838|FG002|COMPLETED|Phase A+||0
9942367|NCT01360645|11060839|FG003|COMPLETED|Phase A+||307
9942368|NCT01360645|11060836|FG000|NOT COMPLETED|Phase A+||0
9942369|NCT01360645|11060837|FG001|NOT COMPLETED|Phase A+||0
9942370|NCT01360645|11060838|FG002|NOT COMPLETED|Phase A+||0
9942371|NCT01360645|11060839|FG003|NOT COMPLETED|Phase A+||24
9942372|NCT01360762|11060845|FG000|STARTED|Main Study Period (12-month Treatment)||74
9942373|NCT01360762|11060845|FG000|COMPLETED|Main Study Period (12-month Treatment)||45
9942374|NCT01360762|11060845|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29
9942375|NCT01360762|11060845|FG000|STARTED|Whole Study Period||74
9942376|NCT01360762|11060845|FG000|COMPLETED|Whole Study Period||38
9942377|NCT01360762|11060845|FG000|NOT COMPLETED|Whole Study Period||36
9942378|NCT01360840|11060852|FG000|STARTED|Overall Study||60
9942379|NCT01360840|11060853|FG001|STARTED|Overall Study||60
9942380|NCT01360840|11060854|FG002|STARTED|Overall Study||60
9942381|NCT01360840|11060852|FG000|COMPLETED|Overall Study||50
9942382|NCT01360840|11060853|FG001|COMPLETED|Overall Study||50
9942383|NCT01360840|11060854|FG002|COMPLETED|Overall Study||51
9942384|NCT01360840|11060852|FG000|NOT COMPLETED|Overall Study||10
9942385|NCT01360840|11060853|FG001|NOT COMPLETED|Overall Study||10
9942386|NCT01360840|11060854|FG002|NOT COMPLETED|Overall Study||9
9942387|NCT01360866|11060868|FG000|STARTED|Overall Study||516
9942388|NCT01360866|11060869|FG001|STARTED|Overall Study||707
9942389|NCT01360866|11060870|FG002|STARTED|Overall Study||1645
9942390|NCT01360866|11060871|FG003|STARTED|Overall Study||76
9942391|NCT01360866|11060868|FG000|COMPLETED|Overall Study||295
9942392|NCT01360866|11060869|FG001|COMPLETED|Overall Study||420
9760632|NCT00382291|10864386|FG000|STARTED|Overall Study||18
9760633|NCT00382291|10864387|FG001|STARTED|Overall Study||17
9760634|NCT00382291|10864388|FG002|STARTED|Overall Study||21
9760635|NCT00382291|10864386|FG000|COMPLETED|Overall Study||14
9760636|NCT00382291|10864387|FG001|COMPLETED|Overall Study||10
9760637|NCT00382291|10864388|FG002|COMPLETED|Overall Study||13
9760638|NCT00382291|10864386|FG000|NOT COMPLETED|Overall Study||4
9760639|NCT00382291|10864387|FG001|NOT COMPLETED|Overall Study||7
9760640|NCT00382291|10864388|FG002|NOT COMPLETED|Overall Study||8
9760641|NCT00382408|10864400|FG000|STARTED|Overall Study||3031
9760642|NCT00382408|10864401|FG001|STARTED|Overall Study||1009
9760643|NCT00382408|10864400|FG000|COMPLETED|Overall Study||2887
9760644|NCT00382408|10864401|FG001|COMPLETED|Overall Study||955
9760645|NCT00382408|10864400|FG000|NOT COMPLETED|Overall Study||144
9760646|NCT00382408|10864401|FG001|NOT COMPLETED|Overall Study||54
9942393|NCT01360866|11060870|FG002|COMPLETED|Overall Study||1126
9942394|NCT01360866|11060871|FG003|COMPLETED|Overall Study||54
9942395|NCT01360866|11060868|FG000|NOT COMPLETED|Overall Study||221
9942396|NCT01360866|11060869|FG001|NOT COMPLETED|Overall Study||287
9942397|NCT01360866|11060870|FG002|NOT COMPLETED|Overall Study||519
9942398|NCT01360866|11060871|FG003|NOT COMPLETED|Overall Study||22
9942399|NCT01360996|11060884|FG000|STARTED|Overall Study||20
9942400|NCT01360996|11060885|FG001|STARTED|Overall Study||21
9942401|NCT01360996|11060886|FG002|STARTED|Overall Study||23
9942402|NCT01360996|11060884|FG000|COMPLETED|Overall Study||14
9942403|NCT01360996|11060885|FG001|COMPLETED|Overall Study||18
9942404|NCT01360996|11060886|FG002|COMPLETED|Overall Study||21
9942405|NCT01360996|11060884|FG000|NOT COMPLETED|Overall Study||6
9942406|NCT01360996|11060885|FG001|NOT COMPLETED|Overall Study||3
9942407|NCT01360996|11060886|FG002|NOT COMPLETED|Overall Study||2
9942408|NCT01361009|11060893|FG000|STARTED|Overall Study||2017
9942409|NCT01361009|11060893|FG000|COMPLETED|Overall Study||1901
9942410|NCT01361009|11060893|FG000|NOT COMPLETED|Overall Study||116
9942411|NCT01361048|11060900|FG000|STARTED|Overall Study||20
9942412|NCT01361048|11060901|FG001|STARTED|Overall Study||10
9942413|NCT01361048|11060902|FG002|STARTED|Overall Study||10
9942414|NCT01361048|11060900|FG000|COMPLETED|Overall Study||20
9942415|NCT01361048|11060901|FG001|COMPLETED|Overall Study||10
9942416|NCT01361048|11060902|FG002|COMPLETED|Overall Study||9
9942417|NCT01361048|11060900|FG000|NOT COMPLETED|Overall Study||0
9942418|NCT01361048|11060901|FG001|NOT COMPLETED|Overall Study||0
9942419|NCT01361048|11060902|FG002|NOT COMPLETED|Overall Study||1
9942420|NCT01361113|11060913|FG000|STARTED|Overall Study||21
9942421|NCT01361113|11060913|FG000|COMPLETED|Overall Study||21
9942422|NCT01361113|11060913|FG000|NOT COMPLETED|Overall Study||0
9942423|NCT01361126|11060921|FG000|STARTED|Overall Study||13
9942424|NCT01361126|11060922|FG001|STARTED|Overall Study||4
9942425|NCT01361126|11060921|FG000|COMPLETED|Overall Study||13
9942426|NCT01361126|11060922|FG001|COMPLETED|Overall Study||2
9942427|NCT01361126|11060921|FG000|NOT COMPLETED|Overall Study||0
9942428|NCT01361126|11060922|FG001|NOT COMPLETED|Overall Study||2
9942429|NCT01361178|11060931|FG000|STARTED|Overall Study||122
9942430|NCT01361178|11060932|FG001|STARTED|Overall Study||11
9942431|NCT01361178|11060931|FG000|COMPLETED|Overall Study||109
9942432|NCT01361178|11060932|FG001|COMPLETED|Overall Study||11
9942433|NCT01361178|11060931|FG000|NOT COMPLETED|Overall Study||13
9942434|NCT01361178|11060932|FG001|NOT COMPLETED|Overall Study||0
9942435|NCT01361217|11060938|FG000|STARTED|Overall Study||10
9942436|NCT01361217|11060938|FG000|COMPLETED|Overall Study||10
9942437|NCT01361217|11060938|FG000|NOT COMPLETED|Overall Study||0
9942438|NCT01361308|11060946|FG000|STARTED|Overall Study||306
9942439|NCT01361308|11060947|FG001|STARTED|Overall Study||308
9942440|NCT01361308|11060946|FG000|COMPLETED|Overall Study||271
9942441|NCT01361308|11060947|FG001|COMPLETED|Overall Study||278
9942442|NCT01361308|11060946|FG000|NOT COMPLETED|Overall Study||35
9942443|NCT01361308|11060947|FG001|NOT COMPLETED|Overall Study||30
9942444|NCT01361464|11060953|FG000|STARTED|Overall Study||21
9942445|NCT01361464|11060953|FG000|COMPLETED|Overall Study||18
9942446|NCT01361464|11060953|FG000|NOT COMPLETED|Overall Study||3
9942447|NCT01361568|11060963|FG000|STARTED|Overall Study||71
9942448|NCT01361568|11060964|FG001|STARTED|Overall Study||71
9942449|NCT01361568|11060965|FG002|STARTED|Overall Study||20
9942450|NCT01361568|11060966|FG003|STARTED|Overall Study||21
9942451|NCT01361568|11060967|FG004|STARTED|Overall Study||7
9942452|NCT01361568|11060968|FG005|STARTED|Overall Study||13
9942453|NCT01361568|11060963|FG000|COMPLETED|Overall Study||69
9942454|NCT01361568|11060964|FG001|COMPLETED|Overall Study||70
9942455|NCT01361568|11060965|FG002|COMPLETED|Overall Study||20
9942456|NCT01361568|11060966|FG003|COMPLETED|Overall Study||21
9942457|NCT01361568|11060967|FG004|COMPLETED|Overall Study||6
9942458|NCT01361568|11060968|FG005|COMPLETED|Overall Study||11
9942459|NCT01361568|11060963|FG000|NOT COMPLETED|Overall Study||2
9942460|NCT01361568|11060964|FG001|NOT COMPLETED|Overall Study||1
9760647|NCT00382590|10864409|FG000|STARTED|Overall Study||4
9942461|NCT01361568|11060965|FG002|NOT COMPLETED|Overall Study||0
9942462|NCT01361568|11060966|FG003|NOT COMPLETED|Overall Study||0
9942463|NCT01361568|11060967|FG004|NOT COMPLETED|Overall Study||1
9942464|NCT01361568|11060968|FG005|NOT COMPLETED|Overall Study||2
9942465|NCT01361594|11060985|FG000|STARTED|Overall Study||152
9942466|NCT01361594|11060986|FG001|STARTED|Overall Study||153
9942467|NCT01361594|11060985|FG000|COMPLETED|Overall Study||151
9942468|NCT01361594|11060986|FG001|COMPLETED|Overall Study||151
9942469|NCT01361594|11060985|FG000|NOT COMPLETED|Overall Study||1
9942470|NCT01361594|11060986|FG001|NOT COMPLETED|Overall Study||2
9942471|NCT01361607|11060994|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
9942472|NCT01361607|11060995|FG001|STARTED|Overall Study||199
9942473|NCT01361607|11060994|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198
9942474|NCT01361607|11060995|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
9942475|NCT01361607|11060994|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
9942476|NCT01361607|11060995|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
9942477|NCT01361607|11060994|FG000|ITT Population|Overall Study||198
9942478|NCT01361607|11060995|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
9942479|NCT01361607|11060994|FG000|COMPLETED|Overall Study||136
9942480|NCT01361607|11060995|FG001|COMPLETED|Overall Study||158
9942481|NCT01361607|11060994|FG000|NOT COMPLETED|Overall Study||64
10207286|NCT03525444|11334114|FG000|Safety Set|Overall Study||201
10207287|NCT03525444|11334115|FG001|Safety Set|Overall Study||202
10207288|NCT03525444|11334114|FG000|COMPLETED|Overall Study||203
9942482|NCT01361607|11060995|FG001|NOT COMPLETED|Overall Study||41
9942483|NCT01361620|11061002|FG000|STARTED|Overall Study||132
9942484|NCT01361620|11061002|FG000|COMPLETED|Overall Study||132
9942485|NCT01361620|11061002|FG000|NOT COMPLETED|Overall Study||0
9942486|NCT01361633|11061008|FG000|STARTED|Overall Study||25
9942487|NCT01361633|11061009|FG001|STARTED|Overall Study||26
9942488|NCT01361633|11061008|FG000|COMPLETED|Overall Study||19
9942489|NCT01361633|11061009|FG001|COMPLETED|Overall Study||23
9942490|NCT01361633|11061008|FG000|NOT COMPLETED|Overall Study||6
9942491|NCT01361633|11061009|FG001|NOT COMPLETED|Overall Study||3
9942492|NCT01361711|11061017|FG000|STARTED|Trial Entry (Registration)||53
9942493|NCT01361711|11061017|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52
9942494|NCT01361711|11061017|FG000|COMPLETED|Trial Entry (Registration)||52
10011445|NCT01780922|11134205|FG005|COMPLETED|Washout (7 Days)||2
10011446|NCT01780922|11134200|FG000|NOT COMPLETED|Washout (7 Days)||0
10011447|NCT01780922|11134201|FG001|NOT COMPLETED|Washout (7 Days)||0
10011448|NCT01780922|11134202|FG002|NOT COMPLETED|Washout (7 Days)||0
10011449|NCT01780922|11134203|FG003|NOT COMPLETED|Washout (7 Days)||0
10011450|NCT01780922|11134204|FG004|NOT COMPLETED|Washout (7 Days)||0
10011451|NCT01780922|11134205|FG005|NOT COMPLETED|Washout (7 Days)||0
10011452|NCT01780922|11134200|FG000|STARTED|Third Intervention (1 Day)||2
10011453|NCT01780922|11134201|FG001|STARTED|Third Intervention (1 Day)||2
10011454|NCT01780922|11134202|FG002|STARTED|Third Intervention (1 Day)||2
10011455|NCT01780922|11134203|FG003|STARTED|Third Intervention (1 Day)||2
10011456|NCT01780922|11134204|FG004|STARTED|Third Intervention (1 Day)||2
9942495|NCT01361711|11061017|FG000|NOT COMPLETED|Trial Entry (Registration)||1
9942496|NCT01361711|11061017|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52
9942497|NCT01361711|11061017|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51
9942498|NCT01361711|11061017|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
9942499|NCT01361711|11061017|FG000|STARTED|Continued Treatment After 9 Weeks||51
9942500|NCT01361711|11061017|FG000|COMPLETED|Continued Treatment After 9 Weeks||44
9942501|NCT01361711|11061017|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7
9942502|NCT01361711|11061017|FG000|STARTED|Continued Treatment After 12 Weeks||44
9942503|NCT01361711|11061017|FG000|COMPLETED|Continued Treatment After 12 Weeks||41
9942504|NCT01361711|11061017|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3
9942505|NCT01361711|11061017|FG000|STARTED|Completed Week 18 of Treatment||41
9942506|NCT01361711|11061017|FG000|COMPLETED|Completed Week 18 of Treatment||30
9942507|NCT01361711|11061017|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11
9942508|NCT01361711|11061017|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
9942509|NCT01361711|11061017|FG000|COMPLETED|10 Year Follow-up||2
9942510|NCT01361711|11061017|FG000|NOT COMPLETED|10 Year Follow-up||50
9942511|NCT01361854|11061021|FG000|STARTED|Day 1||51
9942512|NCT01361854|11061022|FG001|STARTED|Day 1||51
9942513|NCT01361854|11061021|FG000|COMPLETED|Day 1||47
9942514|NCT01361854|11061022|FG001|COMPLETED|Day 1||48
9942515|NCT01361854|11061021|FG000|NOT COMPLETED|Day 1||4
9942516|NCT01361854|11061022|FG001|NOT COMPLETED|Day 1||3
9942517|NCT01361854|11061021|FG000|STARTED|Wash-out, Maximum 2 Weeks||47
9942518|NCT01361854|11061022|FG001|STARTED|Wash-out, Maximum 2 Weeks||48
10011457|NCT01780922|11134205|FG005|STARTED|Third Intervention (1 Day)||2
10207289|NCT03525444|11334115|FG001|COMPLETED|Overall Study||197
9942519|NCT01361854|11061021|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47
9942520|NCT01361854|11061022|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48
9942521|NCT01361854|11061021|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
10011458|NCT01780922|11134200|FG000|COMPLETED|Third Intervention (1 Day)||2
10011459|NCT01780922|11134201|FG001|COMPLETED|Third Intervention (1 Day)||2
10207290|NCT03525444|11334114|FG000|NOT COMPLETED|Overall Study||0
9942522|NCT01361854|11061022|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
9942523|NCT01361854|11061021|FG000|STARTED|Second Intervention||47
9942524|NCT01361854|11061022|FG001|STARTED|Second Intervention||48
9942525|NCT01361854|11061021|FG000|COMPLETED|Second Intervention||47
9942526|NCT01361854|11061022|FG001|COMPLETED|Second Intervention||48
9942527|NCT01361854|11061021|FG000|NOT COMPLETED|Second Intervention||0
9942528|NCT01361854|11061022|FG001|NOT COMPLETED|Second Intervention||0
9942529|NCT01361867|11061028|FG000|STARTED|Overall Study||15
9942530|NCT01361867|11061028|FG000|COMPLETED|Overall Study||15
9942531|NCT01361867|11061028|FG000|NOT COMPLETED|Overall Study||0
9942532|NCT01361919|11061035|FG000|STARTED|Overall Study||100
9942533|NCT01361919|11061036|FG001|STARTED|Overall Study||100
9942534|NCT01361919|11061037|FG002|STARTED|Overall Study||98
9942535|NCT01361919|11061035|FG000|COMPLETED|Overall Study||90
9942536|NCT01361919|11061036|FG001|COMPLETED|Overall Study||88
9942537|NCT01361919|11061037|FG002|COMPLETED|Overall Study||88
9942538|NCT01361919|11061035|FG000|NOT COMPLETED|Overall Study||10
9942539|NCT01361919|11061036|FG001|NOT COMPLETED|Overall Study||12
9942540|NCT01361919|11061037|FG002|NOT COMPLETED|Overall Study||10
9942541|NCT01362049|11061049|FG000|STARTED|Follow-Up at 7 Weeks||26
9942542|NCT01362049|11061050|FG001|STARTED|Follow-Up at 7 Weeks||19
9942543|NCT01362049|11061051|FG002|STARTED|Follow-Up at 7 Weeks||32
9942544|NCT01362049|11061052|FG003|STARTED|Follow-Up at 7 Weeks||25
9942545|NCT01362049|11061049|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
9942546|NCT01362049|11061050|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
9942547|NCT01362049|11061051|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
9942548|NCT01362049|11061052|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
9942549|NCT01362049|11061049|FG000|COMPLETED|Follow-Up at 7 Weeks||23
9942550|NCT01362049|11061050|FG001|COMPLETED|Follow-Up at 7 Weeks||16
9942551|NCT01362049|11061051|FG002|COMPLETED|Follow-Up at 7 Weeks||30
9942552|NCT01362049|11061052|FG003|COMPLETED|Follow-Up at 7 Weeks||24
9942553|NCT01362049|11061049|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3
9942554|NCT01362049|11061050|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3
9942555|NCT01362049|11061051|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2
9942556|NCT01362049|11061052|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1
9942557|NCT01362049|11061049|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23
9942558|NCT01362049|11061050|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16
9942559|NCT01362049|11061051|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30
9942560|NCT01362049|11061052|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24
9942561|NCT01362049|11061049|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
9942562|NCT01362049|11061050|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
9942563|NCT01362049|11061051|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
9942564|NCT01362049|11061052|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
9942565|NCT01362049|11061049|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
9942566|NCT01362049|11061050|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
9942567|NCT01362049|11061051|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
9942568|NCT01362049|11061052|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
9942569|NCT01362062|11061068|FG000|STARTED|Overall Study||48
9942570|NCT01362062|11061069|FG001|STARTED|Overall Study||62
9942571|NCT01362062|11061068|FG000|COMPLETED|Overall Study||22
9942572|NCT01362062|11061069|FG001|COMPLETED|Overall Study||62
9942573|NCT01362062|11061068|FG000|NOT COMPLETED|Overall Study||26
9942574|NCT01362062|11061069|FG001|NOT COMPLETED|Overall Study||0
9942575|NCT01362127|11061076|FG000|STARTED|Overall Study||90
9942576|NCT01362127|11061077|FG001|STARTED|Overall Study||91
9942577|NCT01362127|11061076|FG000|COMPLETED|Overall Study||90
9942578|NCT01362127|11061077|FG001|COMPLETED|Overall Study||91
9942579|NCT01362127|11061076|FG000|NOT COMPLETED|Overall Study||0
9942580|NCT01362127|11061077|FG001|NOT COMPLETED|Overall Study||0
9942581|NCT01362140|11061085|FG000|STARTED|Overall Study||49
9942582|NCT01362140|11061086|FG001|STARTED|Overall Study||98
9942583|NCT01362140|11061085|FG000|Received Treatment|Overall Study||49
9942584|NCT01362140|11061086|FG001|Received Treatment|Overall Study||97
9942585|NCT01362140|11061085|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
9942586|NCT01362140|11061086|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
9942587|NCT01362140|11061085|FG000|NOT COMPLETED|Overall Study||10
9942588|NCT01362140|11061086|FG001|NOT COMPLETED|Overall Study||11
9942589|NCT01362192|11061092|FG000|STARTED|Overall Study||20
9942590|NCT01362192|11061092|FG000|COMPLETED|Overall Study||16
9942591|NCT01362192|11061092|FG000|NOT COMPLETED|Overall Study||4
9942592|NCT01362205|11061098|FG000|STARTED|Overall Study||22
9942593|NCT01362205|11061099|FG001|STARTED|Overall Study||27
9942594|NCT01362205|11061098|FG000|COMPLETED|Overall Study||22
9942595|NCT01362205|11061099|FG001|COMPLETED|Overall Study||27
9942596|NCT01362205|11061098|FG000|NOT COMPLETED|Overall Study||0
9942597|NCT01362205|11061099|FG001|NOT COMPLETED|Overall Study||0
9942598|NCT01362244|11061107|FG000|STARTED|Overall Study||54
9942599|NCT01362244|11061108|FG001|STARTED|Overall Study||51
9942600|NCT01362244|11061107|FG000|COMPLETED|Overall Study||22
9942601|NCT01362244|11061108|FG001|COMPLETED|Overall Study||19
9942602|NCT01362244|11061107|FG000|NOT COMPLETED|Overall Study||32
9942603|NCT01362244|11061108|FG001|NOT COMPLETED|Overall Study||32
9942604|NCT01362270|11061116|FG000|STARTED|Overall Study||7
9942605|NCT01362270|11061117|FG001|STARTED|Overall Study||8
9942606|NCT01362270|11061116|FG000|COMPLETED|Overall Study||5
9942607|NCT01362270|11061117|FG001|COMPLETED|Overall Study||6
9942608|NCT01362270|11061116|FG000|NOT COMPLETED|Overall Study||2
9942609|NCT01362270|11061117|FG001|NOT COMPLETED|Overall Study||2
9942610|NCT01362296|11061125|FG000|STARTED|Randomized Phase (RP)||87
9942611|NCT01362296|11061126|FG001|STARTED|Randomized Phase (RP)||43
9942612|NCT01362296|11061127|FG002|STARTED|Randomized Phase (RP)||0
9942613|NCT01362296|11061128|FG003|STARTED|Randomized Phase (RP)||0
9942614|NCT01362296|11061125|FG000|COMPLETED|Randomized Phase (RP)||0
9942615|NCT01362296|11061126|FG001|COMPLETED|Randomized Phase (RP)||0
9942616|NCT01362296|11061127|FG002|COMPLETED|Randomized Phase (RP)||0
9942617|NCT01362296|11061128|FG003|COMPLETED|Randomized Phase (RP)||0
9942618|NCT01362296|11061125|FG000|NOT COMPLETED|Randomized Phase (RP)||87
9942619|NCT01362296|11061126|FG001|NOT COMPLETED|Randomized Phase (RP)||43
9942620|NCT01362296|11061127|FG002|NOT COMPLETED|Randomized Phase (RP)||0
9942621|NCT01362296|11061128|FG003|NOT COMPLETED|Randomized Phase (RP)||0
9942622|NCT01362296|11061125|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
9942623|NCT01362296|11061126|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
9942624|NCT01362296|11061127|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
9942625|NCT01362296|11061128|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
9942626|NCT01362296|11061125|FG000|COMPLETED|Crossover Phase||0
9942627|NCT01362296|11061126|FG001|COMPLETED|Crossover Phase||0
9942628|NCT01362296|11061127|FG002|COMPLETED|Crossover Phase||0
9942629|NCT01362296|11061128|FG003|COMPLETED|Crossover Phase||0
9942630|NCT01362296|11061125|FG000|NOT COMPLETED|Crossover Phase||0
9942631|NCT01362296|11061126|FG001|NOT COMPLETED|Crossover Phase||0
9942632|NCT01362296|11061127|FG002|NOT COMPLETED|Crossover Phase||23
9942633|NCT01362296|11061128|FG003|NOT COMPLETED|Crossover Phase||2
9942634|NCT01362322|11061140|FG000|STARTED|Overall Study||335
9942635|NCT01362322|11061141|FG001|STARTED|Overall Study||336
9942636|NCT01362322|11061140|FG000|COMPLETED|Overall Study||330
9942637|NCT01362322|11061141|FG001|COMPLETED|Overall Study||329
9942638|NCT01362322|11061140|FG000|NOT COMPLETED|Overall Study||5
9942639|NCT01362322|11061141|FG001|NOT COMPLETED|Overall Study||7
9942640|NCT01362348|11061147|FG000|STARTED|Overall Study||19
9942641|NCT01362348|11061147|FG000|COMPLETED|Overall Study||5
9942642|NCT01362348|11061147|FG000|NOT COMPLETED|Overall Study||14
9942643|NCT01362439|11061151|FG000|STARTED|Overall Study||133
9942644|NCT01362439|11061151|FG000|COMPLETED|Overall Study||118
9942645|NCT01362439|11061151|FG000|NOT COMPLETED|Overall Study||15
9942646|NCT01362491|11061159|FG000|STARTED|Overall Study||91
9942647|NCT01362491|11061160|FG001|STARTED|Overall Study||89
9942648|NCT01362491|11061161|FG002|STARTED|Overall Study||46
9942649|NCT01362491|11061159|FG000|COMPLETED|Overall Study||90
9942650|NCT01362491|11061160|FG001|COMPLETED|Overall Study||89
9942651|NCT01362491|11061161|FG002|COMPLETED|Overall Study||46
9942652|NCT01362491|11061159|FG000|NOT COMPLETED|Overall Study||1
9942653|NCT01362491|11061160|FG001|NOT COMPLETED|Overall Study||0
9942654|NCT01362491|11061161|FG002|NOT COMPLETED|Overall Study||0
9942655|NCT01362517|11061170|FG000|STARTED|Overall Study||131
9942656|NCT01362517|11061170|FG000|COMPLETED|Overall Study||129
9942657|NCT01362517|11061170|FG000|NOT COMPLETED|Overall Study||2
9942658|NCT01362530|11061179|FG000|STARTED|Base Study (Cycle 1)||155
9942659|NCT01362530|11061180|FG001|STARTED|Base Study (Cycle 1)||152
9942660|NCT01362530|11061179|FG000|Received Study Treatment|Base Study (Cycle 1)||152
9942661|NCT01362530|11061180|FG001|Received Study Treatment|Base Study (Cycle 1)||150
9942662|NCT01362530|11061179|FG000|COMPLETED|Base Study (Cycle 1)||150
9942663|NCT01362530|11061180|FG001|COMPLETED|Base Study (Cycle 1)||149
9942664|NCT01362530|11061179|FG000|NOT COMPLETED|Base Study (Cycle 1)||5
9942665|NCT01362530|11061180|FG001|NOT COMPLETED|Base Study (Cycle 1)||3
9942666|NCT01362530|11061179|FG000|STARTED|Optional Extension (Cycles 2-6)||171
9942667|NCT01362530|11061180|FG001|STARTED|Optional Extension (Cycles 2-6)||0
9942668|NCT01362530|11061179|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46
9942669|NCT01362530|11061180|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0
9942670|NCT01362530|11061179|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
9942671|NCT01362530|11061180|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
9942672|NCT01362608|11061189|FG000|STARTED|Overall Study||67
9942673|NCT01362608|11061190|FG001|STARTED|Overall Study||69
9942674|NCT01362608|11061189|FG000|COMPLETED|Overall Study||63
9942675|NCT01362608|11061190|FG001|COMPLETED|Overall Study||61
9942676|NCT01362608|11061189|FG000|NOT COMPLETED|Overall Study||4
9942677|NCT01362608|11061190|FG001|NOT COMPLETED|Overall Study||8
9956752|NCT01448044|11076044|FG001|COMPLETED|Treatment Period||26
9956753|NCT01448044|11076043|FG000|NOT COMPLETED|Treatment Period||23
9956754|NCT01448044|11076044|FG001|NOT COMPLETED|Treatment Period||16
9956755|NCT01448044|11076043|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
9956756|NCT01448044|11076044|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
9956757|NCT01448044|11076043|FG000|COMPLETED|Follow Up Period||65
9956758|NCT01448044|11076044|FG001|COMPLETED|Follow Up Period||26
9956759|NCT01448044|11076043|FG000|NOT COMPLETED|Follow Up Period||12
9956760|NCT01448044|11076044|FG001|NOT COMPLETED|Follow Up Period||14
9956761|NCT01448057|11076052|FG000|STARTED|Overall Study||170
9956762|NCT01448057|11076053|FG001|STARTED|Overall Study||171
9956763|NCT01448057|11076052|FG000|COMPLETED|Overall Study||162
9956764|NCT01448057|11076053|FG001|COMPLETED|Overall Study||167
9942678|NCT01362686|11061199|FG000|STARTED|Overall Study||67
9942679|NCT01362686|11061200|FG001|STARTED|Overall Study||66
9942680|NCT01362686|11061201|FG002|STARTED|Overall Study||63
9942681|NCT01362686|11061199|FG000|COMPLETED|Overall Study||59
10011460|NCT01780922|11134202|FG002|COMPLETED|Third Intervention (1 Day)||2
10011461|NCT01780922|11134203|FG003|COMPLETED|Third Intervention (1 Day)||2
10011462|NCT01780922|11134204|FG004|COMPLETED|Third Intervention (1 Day)||2
10011463|NCT01780922|11134205|FG005|COMPLETED|Third Intervention (1 Day)||2
10011464|NCT01780922|11134200|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10011465|NCT01780922|11134201|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10011466|NCT01780922|11134202|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10011467|NCT01780922|11134203|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10011468|NCT01780922|11134204|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10011469|NCT01780922|11134205|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10011470|NCT01780935|11134215|FG000|STARTED|Overall Study||335
10011471|NCT01780935|11134216|FG001|STARTED|Overall Study||336
10011472|NCT01780935|11134215|FG000|Safety Set|Overall Study||334
10011473|NCT01780935|11134216|FG001|Safety Set|Overall Study||336
10011474|NCT01780935|11134215|FG000|COMPLETED|Overall Study||0
9942682|NCT01362686|11061200|FG001|COMPLETED|Overall Study||54
9942683|NCT01362686|11061201|FG002|COMPLETED|Overall Study||53
9942684|NCT01362686|11061199|FG000|NOT COMPLETED|Overall Study||8
9942685|NCT01362686|11061200|FG001|NOT COMPLETED|Overall Study||12
9942686|NCT01362686|11061201|FG002|NOT COMPLETED|Overall Study||10
9942687|NCT01362790|11061215|FG000|STARTED|Pilot Phase & Phase 2||11
9942688|NCT01362790|11061216|FG001|STARTED|Pilot Phase & Phase 2||8
9942689|NCT01362790|11061217|FG002|STARTED|Pilot Phase & Phase 2||7
9942690|NCT01362790|11061218|FG003|STARTED|Pilot Phase & Phase 2||15
9942691|NCT01362790|11061219|FG004|STARTED|Pilot Phase & Phase 2||0
9942692|NCT01362790|11061220|FG005|STARTED|Pilot Phase & Phase 2||4
9942693|NCT01362790|11061221|FG006|STARTED|Pilot Phase & Phase 2||0
9942694|NCT01362790|11061215|FG000|COMPLETED|Pilot Phase & Phase 2||1
9942695|NCT01362790|11061216|FG001|COMPLETED|Pilot Phase & Phase 2||0
9942696|NCT01362790|11061217|FG002|COMPLETED|Pilot Phase & Phase 2||2
9942697|NCT01362790|11061218|FG003|COMPLETED|Pilot Phase & Phase 2||1
9942698|NCT01362790|11061219|FG004|COMPLETED|Pilot Phase & Phase 2||0
9942699|NCT01362790|11061220|FG005|COMPLETED|Pilot Phase & Phase 2||0
9942700|NCT01362790|11061221|FG006|COMPLETED|Pilot Phase & Phase 2||0
9942701|NCT01362790|11061215|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10
9942702|NCT01362790|11061216|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8
9942703|NCT01362790|11061217|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5
9942704|NCT01362790|11061218|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14
9942705|NCT01362790|11061219|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0
9942706|NCT01362790|11061220|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4
9942707|NCT01362790|11061221|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0
9942708|NCT01362790|11061215|FG000|STARTED|Dose De-escalation of Regimen A||0
9942709|NCT01362790|11061216|FG001|STARTED|Dose De-escalation of Regimen A||0
9942710|NCT01362790|11061217|FG002|STARTED|Dose De-escalation of Regimen A||0
9942711|NCT01362790|11061218|FG003|STARTED|Dose De-escalation of Regimen A||0
9942712|NCT01362790|11061219|FG004|STARTED|Dose De-escalation of Regimen A||8
9942713|NCT01362790|11061220|FG005|STARTED|Dose De-escalation of Regimen A||0
9942714|NCT01362790|11061221|FG006|STARTED|Dose De-escalation of Regimen A||0
9942715|NCT01362790|11061215|FG000|COMPLETED|Dose De-escalation of Regimen A||0
9942716|NCT01362790|11061216|FG001|COMPLETED|Dose De-escalation of Regimen A||0
9942717|NCT01362790|11061217|FG002|COMPLETED|Dose De-escalation of Regimen A||0
9942718|NCT01362790|11061218|FG003|COMPLETED|Dose De-escalation of Regimen A||0
9942719|NCT01362790|11061219|FG004|COMPLETED|Dose De-escalation of Regimen A||2
9942720|NCT01362790|11061220|FG005|COMPLETED|Dose De-escalation of Regimen A||0
9942721|NCT01362790|11061221|FG006|COMPLETED|Dose De-escalation of Regimen A||0
9942722|NCT01362790|11061215|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0
9942723|NCT01362790|11061216|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0
9942724|NCT01362790|11061217|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0
9942725|NCT01362790|11061218|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0
9942726|NCT01362790|11061219|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6
9942727|NCT01362790|11061220|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0
9942728|NCT01362790|11061221|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0
9942729|NCT01362894|11061241|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
9942730|NCT01362894|11061242|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
9942731|NCT01362894|11061241|FG000|COMPLETED|Period One, 1 Week||119
9942732|NCT01362894|11061242|FG001|COMPLETED|Period One, 1 Week||117
9942733|NCT01362894|11061241|FG000|NOT COMPLETED|Period One, 1 Week||0
9942734|NCT01362894|11061242|FG001|NOT COMPLETED|Period One, 1 Week||0
9942735|NCT01362894|11061241|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
9942736|NCT01362894|11061242|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
9942737|NCT01362894|11061241|FG000|COMPLETED|Period Two, 1 Week||118
10011475|NCT01780935|11134216|FG001|COMPLETED|Overall Study||0
10011476|NCT01780935|11134215|FG000|NOT COMPLETED|Overall Study||335
9942738|NCT01362894|11061242|FG001|COMPLETED|Period Two, 1 Week||115
10011477|NCT01780935|11134216|FG001|NOT COMPLETED|Overall Study||336
10011478|NCT01780974|11134224|FG000|STARTED|Overall Study||21
10011479|NCT01780974|11134225|FG001|STARTED|Overall Study||21
10011480|NCT01780974|11134224|FG000|COMPLETED|Overall Study||19
9942739|NCT01362894|11061241|FG000|NOT COMPLETED|Period Two, 1 Week||0
9942740|NCT01362894|11061242|FG001|NOT COMPLETED|Period Two, 1 Week||0
9942741|NCT01362907|11061248|FG000|STARTED|Period 1, One Week||20
9942742|NCT01362907|11061249|FG001|STARTED|Period 1, One Week||20
9942743|NCT01362907|11061248|FG000|COMPLETED|Period 1, One Week||20
9942744|NCT01362907|11061249|FG001|COMPLETED|Period 1, One Week||20
9942745|NCT01362907|11061248|FG000|NOT COMPLETED|Period 1, One Week||0
9942746|NCT01362907|11061249|FG001|NOT COMPLETED|Period 1, One Week||0
9942747|NCT01362907|11061248|FG000|STARTED|Period 2, One Week||20
9942748|NCT01362907|11061249|FG001|STARTED|Period 2, One Week||20
9942749|NCT01362907|11061248|FG000|COMPLETED|Period 2, One Week||20
9942750|NCT01362907|11061249|FG001|COMPLETED|Period 2, One Week||20
9942751|NCT01362907|11061248|FG000|NOT COMPLETED|Period 2, One Week||0
9942752|NCT01362907|11061249|FG001|NOT COMPLETED|Period 2, One Week||0
9942753|NCT01362946|11061255|FG000|STARTED|First Behavior Modification Block||24
9942754|NCT01362946|11061256|FG001|STARTED|First Behavior Modification Block||24
9942755|NCT01362946|11061255|FG000|COMPLETED|First Behavior Modification Block||24
9942756|NCT01362946|11061256|FG001|COMPLETED|First Behavior Modification Block||24
9942757|NCT01362946|11061255|FG000|NOT COMPLETED|First Behavior Modification Block||0
9942758|NCT01362946|11061256|FG001|NOT COMPLETED|First Behavior Modification Block||0
9942759|NCT01362946|11061255|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
9942760|NCT01362946|11061256|FG001|STARTED|Second Behavior Modification Block||24
9942761|NCT01362946|11061255|FG000|COMPLETED|Second Behavior Modification Block||23
9942762|NCT01362946|11061256|FG001|COMPLETED|Second Behavior Modification Block||24
9942763|NCT01362946|11061255|FG000|NOT COMPLETED|Second Behavior Modification Block||0
9942764|NCT01362946|11061256|FG001|NOT COMPLETED|Second Behavior Modification Block||0
9942765|NCT01362959|11061264|FG000|STARTED|Overall Study||21
9942766|NCT01362959|11061265|FG001|STARTED|Overall Study||26
9942767|NCT01362959|11061264|FG000|COMPLETED|Overall Study||21
9942768|NCT01362959|11061265|FG001|COMPLETED|Overall Study||26
9942769|NCT01362959|11061264|FG000|NOT COMPLETED|Overall Study||0
9942770|NCT01362959|11061265|FG001|NOT COMPLETED|Overall Study||0
9942771|NCT01363011|11061273|FG000|STARTED|Main Study||33
9942772|NCT01363011|11061274|FG001|STARTED|Main Study||73
9942773|NCT01363011|11061273|FG000|COMPLETED|Main Study||29
9942774|NCT01363011|11061274|FG001|COMPLETED|Main Study||64
9942775|NCT01363011|11061273|FG000|NOT COMPLETED|Main Study||4
9942776|NCT01363011|11061274|FG001|NOT COMPLETED|Main Study||9
9942777|NCT01363011|11061273|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
9942778|NCT01363011|11061274|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
9942779|NCT01363011|11061273|FG000|COMPLETED|Extension Phase||13
9942780|NCT01363011|11061274|FG001|COMPLETED|Extension Phase||41
9942781|NCT01363011|11061273|FG000|NOT COMPLETED|Extension Phase||5
9942782|NCT01363011|11061274|FG001|NOT COMPLETED|Extension Phase||8
9942783|NCT01363050|11061280|FG000|STARTED|Overall Study||15
9942784|NCT01363050|11061280|FG000|COMPLETED|Overall Study||15
9942785|NCT01363050|11061280|FG000|NOT COMPLETED|Overall Study||0
9942786|NCT01363076|11061288|FG000|STARTED|Overall Study||7
9942787|NCT01363076|11061289|FG001|STARTED|Overall Study||13
9942788|NCT01363076|11061288|FG000|COMPLETED|Overall Study||7
9942789|NCT01363076|11061289|FG001|COMPLETED|Overall Study||12
9942790|NCT01363076|11061288|FG000|NOT COMPLETED|Overall Study||0
9942791|NCT01363076|11061289|FG001|NOT COMPLETED|Overall Study||1
9942792|NCT01363128|11061295|FG000|STARTED|Overall Study||69
9942793|NCT01363128|11061295|FG000|COMPLETED|Overall Study||69
9942794|NCT01363128|11061295|FG000|NOT COMPLETED|Overall Study||0
9942795|NCT01363258|11061301|FG000|STARTED|Overall Study||54
9942796|NCT01363258|11061302|FG001|STARTED|Overall Study||46
9942797|NCT01363258|11061301|FG000|COMPLETED|Overall Study||54
9942798|NCT01363258|11061302|FG001|COMPLETED|Overall Study||46
9942799|NCT01363258|11061301|FG000|NOT COMPLETED|Overall Study||0
9942800|NCT01363258|11061302|FG001|NOT COMPLETED|Overall Study||0
9942801|NCT01363297|11061313|FG000|STARTED|Overall Study||3
9942802|NCT01363297|11061314|FG001|STARTED|Overall Study||12
9942803|NCT01363297|11061315|FG002|STARTED|Overall Study||9
9942804|NCT01363297|11061316|FG003|STARTED|Overall Study||13
9942805|NCT01363297|11061317|FG004|STARTED|Overall Study||35
9942806|NCT01363297|11061313|FG000|COMPLETED|Overall Study||0
9942807|NCT01363297|11061314|FG001|COMPLETED|Overall Study||6
9942808|NCT01363297|11061315|FG002|COMPLETED|Overall Study||3
9942809|NCT01363297|11061316|FG003|COMPLETED|Overall Study||3
9942810|NCT01363297|11061317|FG004|COMPLETED|Overall Study||4
9942811|NCT01363297|11061313|FG000|NOT COMPLETED|Overall Study||3
9942812|NCT01363297|11061314|FG001|NOT COMPLETED|Overall Study||6
9942813|NCT01363297|11061315|FG002|NOT COMPLETED|Overall Study||6
9942814|NCT01363297|11061316|FG003|NOT COMPLETED|Overall Study||10
9942815|NCT01363297|11061317|FG004|NOT COMPLETED|Overall Study||31
9942816|NCT01363349|11061336|FG000|STARTED|Overall Study||133
9942817|NCT01363349|11061337|FG001|STARTED|Overall Study||136
9942818|NCT01363349|11061336|FG000|Randomized|Overall Study||133
9942819|NCT01363349|11061337|FG001|Randomized|Overall Study||136
9942820|NCT01363349|11061336|FG000|COMPLETED|Overall Study||66
9942821|NCT01363349|11061337|FG001|COMPLETED|Overall Study||66
9942822|NCT01363349|11061336|FG000|NOT COMPLETED|Overall Study||67
9942823|NCT01363349|11061337|FG001|NOT COMPLETED|Overall Study||70
9942824|NCT01363388|11061346|FG000|STARTED|Overall Study||23
9942825|NCT01363388|11061347|FG001|STARTED|Overall Study||22
9942826|NCT01363388|11061348|FG002|STARTED|Overall Study||22
9942827|NCT01363388|11061346|FG000|COMPLETED|Overall Study||18
9942828|NCT01363388|11061347|FG001|COMPLETED|Overall Study||19
9942829|NCT01363388|11061348|FG002|COMPLETED|Overall Study||18
9942830|NCT01363388|11061346|FG000|NOT COMPLETED|Overall Study||5
9942831|NCT01363388|11061347|FG001|NOT COMPLETED|Overall Study||3
9942832|NCT01363388|11061348|FG002|NOT COMPLETED|Overall Study||4
9942833|NCT01363440|11061359|FG000|STARTED|Overall Study|randomized|156
9942834|NCT01363440|11061360|FG001|STARTED|Overall Study|randomized|156
10207291|NCT03525444|11334115|FG001|NOT COMPLETED|Overall Study||3
10207292|NCT03525548|11334124|FG000|STARTED|Overall Study||52
9942835|NCT01363440|11061361|FG002|STARTED|Overall Study|randomized|154
9942836|NCT01363440|11061359|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
9942837|NCT01363440|11061360|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
9942838|NCT01363440|11061361|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
9942839|NCT01363440|11061359|FG000|Completed Week 52|Overall Study||145
9942840|NCT01363440|11061360|FG001|Completed Week 52|Overall Study||146
9942841|NCT01363440|11061361|FG002|Completed Week 52|Overall Study||144
9942842|NCT01363440|11061359|FG000|Completed Week 100|Overall Study||133
9942843|NCT01363440|11061360|FG001|Completed Week 100|Overall Study||125
9942844|NCT01363440|11061361|FG002|Completed Week 100|Overall Study||127
9942845|NCT01363440|11061359|FG000|COMPLETED|Overall Study|Completed Week 100|133
9942846|NCT01363440|11061360|FG001|COMPLETED|Overall Study|Completed Week 100|125
9942847|NCT01363440|11061361|FG002|COMPLETED|Overall Study|Completed Week 100|127
9942848|NCT01363440|11061359|FG000|NOT COMPLETED|Overall Study||23
9942849|NCT01363440|11061360|FG001|NOT COMPLETED|Overall Study||31
9942850|NCT01363440|11061361|FG002|NOT COMPLETED|Overall Study||27
9942851|NCT01363479|11061374|FG000|STARTED|Overall Study|number of randomised patients|371
9942852|NCT01363479|11061375|FG001|STARTED|Overall Study|number of randomised patients|372
9942853|NCT01363479|11061374|FG000|COMPLETED|Overall Study||359
9942854|NCT01363479|11061375|FG001|COMPLETED|Overall Study||351
9942855|NCT01363479|11061374|FG000|NOT COMPLETED|Overall Study||12
9942856|NCT01363479|11061375|FG001|NOT COMPLETED|Overall Study||21
9942857|NCT01363492|11061381|FG000|STARTED|Overall Study||14
9942858|NCT01363492|11061381|FG000|COMPLETED|Overall Study||14
9942859|NCT01363492|11061381|FG000|NOT COMPLETED|Overall Study||0
9942860|NCT01363661|11061389|FG000|STARTED|Overall Study||32
9942861|NCT01363661|11061390|FG001|STARTED|Overall Study||32
9942862|NCT01363661|11061389|FG000|COMPLETED|Overall Study||18
9942863|NCT01363661|11061390|FG001|COMPLETED|Overall Study||28
9942864|NCT01363661|11061389|FG000|NOT COMPLETED|Overall Study||14
9942865|NCT01363661|11061390|FG001|NOT COMPLETED|Overall Study||4
9942866|NCT01363700|11061399|FG000|STARTED|Epinastine vs Placebo Period1||43
9942867|NCT01363700|11061400|FG001|STARTED|Epinastine vs Placebo Period1||22
9942868|NCT01363700|11061401|FG002|STARTED|Epinastine vs Placebo Period1||22
9942869|NCT01363700|11061402|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0
9942870|NCT01363700|11061403|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0
9942871|NCT01363700|11061399|FG000|COMPLETED|Epinastine vs Placebo Period1||43
9942872|NCT01363700|11061400|FG001|COMPLETED|Epinastine vs Placebo Period1||21
9942873|NCT01363700|11061401|FG002|COMPLETED|Epinastine vs Placebo Period1||22
9942874|NCT01363700|11061402|FG003|COMPLETED|Epinastine vs Placebo Period1||0
9942875|NCT01363700|11061403|FG004|COMPLETED|Epinastine vs Placebo Period1||0
9942876|NCT01363700|11061399|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0
9942877|NCT01363700|11061400|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1
9942878|NCT01363700|11061401|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0
9942879|NCT01363700|11061402|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0
9942880|NCT01363700|11061403|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0
9942881|NCT01363700|11061399|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
9942882|NCT01363700|11061400|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
9942883|NCT01363700|11061401|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
9942884|NCT01363700|11061402|FG003|STARTED|Epinastine vs Olopatadine Period2||43
9942885|NCT01363700|11061403|FG004|STARTED|Epinastine vs Olopatadine Period2||43
9942886|NCT01363700|11061399|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0
9942887|NCT01363700|11061400|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0
9942888|NCT01363700|11061401|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0
9942889|NCT01363700|11061402|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43
9942890|NCT01363700|11061403|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43
9942891|NCT01363700|11061399|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
9942892|NCT01363700|11061400|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
9942893|NCT01363700|11061401|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
9942894|NCT01363700|11061402|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
9942895|NCT01363700|11061403|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
9942896|NCT01363713|11061414|FG000|STARTED|Overall Study|Assessed for eligibility|130
9942897|NCT01363713|11061414|FG000|ALLOCATED|Overall Study||130
9942898|NCT01363713|11061414|FG000|COMPLETED|Overall Study|Analysed (n=130)|124
9942899|NCT01363713|11061414|FG000|NOT COMPLETED|Overall Study||6
9942900|NCT01363765|11061420|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
9942901|NCT01363765|11061421|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
9956765|NCT01448057|11076052|FG000|NOT COMPLETED|Overall Study||8
9942902|NCT01363765|11061420|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
9942903|NCT01363765|11061421|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
9942904|NCT01363765|11061420|FG000|NOT COMPLETED|Overall Study||5800
9942905|NCT01363765|11061421|FG001|NOT COMPLETED|Overall Study||4731
9942906|NCT01363843|11061429|FG000|STARTED|Overall Study||39
9942907|NCT01363843|11061429|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
9942908|NCT01363843|11061429|FG000|NOT COMPLETED|Overall Study||1
9942909|NCT01363908|11061436|FG000|STARTED|Screening/Enrollment||14
9942910|NCT01363908|11061437|FG001|STARTED|Screening/Enrollment||16
9942911|NCT01363908|11061436|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
9942912|NCT01363908|11061437|FG001|COMPLETED|Screening/Enrollment||16
9942913|NCT01363908|11061436|FG000|NOT COMPLETED|Screening/Enrollment||1
9942914|NCT01363908|11061437|FG001|NOT COMPLETED|Screening/Enrollment||0
9942915|NCT01363908|11061436|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
9942916|NCT01363908|11061437|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
9942917|NCT01363908|11061436|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8
9942918|NCT01363908|11061437|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8
9942919|NCT01363908|11061436|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
9942920|NCT01363908|11061437|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
9942921|NCT01363908|11061436|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
9942922|NCT01363908|11061437|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
9942923|NCT01363908|11061436|FG000|COMPLETED|Chronic Dosing (CD) Phase||3
9942924|NCT01363908|11061437|FG001|COMPLETED|Chronic Dosing (CD) Phase||10
9942925|NCT01363908|11061436|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10
9942926|NCT01363908|11061437|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6
9942927|NCT01363986|11061443|FG000|STARTED|Overall Study||3
9942928|NCT01363986|11061443|FG000|COMPLETED|Overall Study||2
9942929|NCT01363986|11061443|FG000|NOT COMPLETED|Overall Study||1
9942930|NCT01363999|11061447|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24
9942931|NCT01363999|11061447|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
9942932|NCT01363999|11061447|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
9942933|NCT01363999|11061447|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24
9942934|NCT01363999|11061447|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
9942935|NCT01363999|11061447|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
9942936|NCT01363999|11061447|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
9942937|NCT01363999|11061447|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
9942938|NCT01363999|11061447|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
9942939|NCT01363999|11061447|FG000|STARTED|D: RO4607381/ F49 Tablet||24
9942940|NCT01363999|11061447|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24
9942941|NCT01363999|11061447|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
9942942|NCT01364090|11061457|FG000|STARTED|Overall Study||61
9942943|NCT01364090|11061458|FG001|STARTED|Overall Study||26
9942944|NCT01364090|11061459|FG002|STARTED|Overall Study||6
9942945|NCT01364090|11061457|FG000|COMPLETED|Overall Study||58
9942946|NCT01364090|11061458|FG001|COMPLETED|Overall Study||12
9942947|NCT01364090|11061459|FG002|COMPLETED|Overall Study||0
9942948|NCT01364090|11061457|FG000|NOT COMPLETED|Overall Study||3
9942949|NCT01364090|11061458|FG001|NOT COMPLETED|Overall Study||14
9942950|NCT01364090|11061459|FG002|NOT COMPLETED|Overall Study||6
9942951|NCT01364207|11061467|FG000|STARTED|First Visit (~1.5-2 Hours)||54
9942952|NCT01364207|11061468|FG001|STARTED|First Visit (~1.5-2 Hours)||58
9942953|NCT01364207|11061467|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54
9942954|NCT01364207|11061468|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58
9942955|NCT01364207|11061467|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
9942956|NCT01364207|11061468|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
9942957|NCT01364207|11061467|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
9942958|NCT01364207|11061468|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
9942959|NCT01364207|11061467|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
9942960|NCT01364207|11061468|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
9942961|NCT01364207|11061467|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
9942962|NCT01364207|11061468|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
9942963|NCT01364207|11061467|FG000|STARTED|Second Visit (~1.5-2 Hours)||52
9942964|NCT01364207|11061468|FG001|STARTED|Second Visit (~1.5-2 Hours)||54
9942965|NCT01364207|11061467|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52
9942966|NCT01364207|11061468|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54
9942967|NCT01364207|11061467|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
9942968|NCT01364207|11061468|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
9942969|NCT01364233|11061474|FG000|STARTED|Overall Study||10
9942970|NCT01364233|11061474|FG000|COMPLETED|Overall Study||9
9942971|NCT01364233|11061474|FG000|NOT COMPLETED|Overall Study||1
9942972|NCT01364259|11061480|FG000|STARTED|Overall Study||9
9942973|NCT01364259|11061481|FG001|STARTED|Overall Study||8
9942974|NCT01364259|11061480|FG000|COMPLETED|Overall Study||9
9942975|NCT01364259|11061481|FG001|COMPLETED|Overall Study||8
9942976|NCT01364259|11061480|FG000|NOT COMPLETED|Overall Study||0
9942977|NCT01364259|11061481|FG001|NOT COMPLETED|Overall Study||0
9942978|NCT01364298|11061489|FG000|STARTED|Overall Study||176
9942979|NCT01364298|11061490|FG001|STARTED|Overall Study||177
9942980|NCT01364298|11061489|FG000|Treated|Overall Study||174
9942981|NCT01364298|11061490|FG001|Treated|Overall Study||174
9942982|NCT01364298|11061489|FG000|COMPLETED|Overall Study||162
9942983|NCT01364298|11061490|FG001|COMPLETED|Overall Study||154
9942984|NCT01364298|11061489|FG000|NOT COMPLETED|Overall Study||14
9942985|NCT01364298|11061490|FG001|NOT COMPLETED|Overall Study||23
9942986|NCT01364389|11061499|FG000|STARTED|Overall Study||5
9942987|NCT01364389|11061500|FG001|STARTED|Overall Study||6
9942988|NCT01364389|11061501|FG002|STARTED|Overall Study||5
9942989|NCT01364389|11061499|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5
9942990|NCT01364389|11061500|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6
9942991|NCT01364389|11061501|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
9942992|NCT01364389|11061499|FG000|COMPLETED|Overall Study||3
9942993|NCT01364389|11061500|FG001|COMPLETED|Overall Study||5
9942994|NCT01364389|11061501|FG002|COMPLETED|Overall Study||4
9942995|NCT01364389|11061499|FG000|NOT COMPLETED|Overall Study||2
9942996|NCT01364389|11061500|FG001|NOT COMPLETED|Overall Study||1
9942997|NCT01364389|11061501|FG002|NOT COMPLETED|Overall Study||1
9942998|NCT01364428|11061511|FG000|STARTED|Overall Study||186
9942999|NCT01364428|11061512|FG001|STARTED|Overall Study||187
9943000|NCT01364428|11061511|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
9943001|NCT01364428|11061512|FG001|Exposed|Overall Study||187
9943002|NCT01364428|11061511|FG000|COMPLETED|Overall Study||166
9943003|NCT01364428|11061512|FG001|COMPLETED|Overall Study||172
9943004|NCT01364428|11061511|FG000|NOT COMPLETED|Overall Study||20
9943005|NCT01364428|11061512|FG001|NOT COMPLETED|Overall Study||15
9943006|NCT01364467|11061520|FG000|STARTED|Overall Study||10
9943007|NCT01364467|11061521|FG001|STARTED|Overall Study||20
9943008|NCT01364467|11061520|FG000|COMPLETED|Overall Study||9
9943009|NCT01364467|11061521|FG001|COMPLETED|Overall Study||18
9943010|NCT01364467|11061520|FG000|NOT COMPLETED|Overall Study||1
9943011|NCT01364467|11061521|FG001|NOT COMPLETED|Overall Study||2
9943012|NCT01364558|11061527|FG000|STARTED|Dose One||8
9943013|NCT01364558|11061528|FG001|STARTED|Dose One||8
9943014|NCT01364558|11061529|FG002|STARTED|Dose One||8
9943015|NCT01364558|11061527|FG000|COMPLETED|Dose One||8
9943016|NCT01364558|11061528|FG001|COMPLETED|Dose One||8
9943017|NCT01364558|11061529|FG002|COMPLETED|Dose One||8
9943018|NCT01364558|11061527|FG000|NOT COMPLETED|Dose One||0
9943019|NCT01364558|11061528|FG001|NOT COMPLETED|Dose One||0
9943020|NCT01364558|11061529|FG002|NOT COMPLETED|Dose One||0
9943021|NCT01364558|11061527|FG000|STARTED|Dose Two||8
9943022|NCT01364558|11061528|FG001|STARTED|Dose Two||8
9943023|NCT01364558|11061529|FG002|STARTED|Dose Two||8
9943024|NCT01364558|11061527|FG000|COMPLETED|Dose Two||8
9943025|NCT01364558|11061528|FG001|COMPLETED|Dose Two||8
9943026|NCT01364558|11061529|FG002|COMPLETED|Dose Two||8
9943027|NCT01364558|11061527|FG000|NOT COMPLETED|Dose Two||0
9943028|NCT01364558|11061528|FG001|NOT COMPLETED|Dose Two||0
9943029|NCT01364558|11061529|FG002|NOT COMPLETED|Dose Two||0
9943030|NCT01364558|11061527|FG000|STARTED|Dose Three||8
9943031|NCT01364558|11061528|FG001|STARTED|Dose Three||8
9943032|NCT01364558|11061529|FG002|STARTED|Dose Three||8
9943033|NCT01364558|11061527|FG000|COMPLETED|Dose Three||8
9943034|NCT01364558|11061528|FG001|COMPLETED|Dose Three||8
9943035|NCT01364558|11061529|FG002|COMPLETED|Dose Three||8
9943036|NCT01364558|11061527|FG000|NOT COMPLETED|Dose Three||0
9943037|NCT01364558|11061528|FG001|NOT COMPLETED|Dose Three||0
9943038|NCT01364558|11061529|FG002|NOT COMPLETED|Dose Three||0
9943039|NCT01364584|11061539|FG000|STARTED|Overall Study||11
9943040|NCT01364584|11061540|FG001|STARTED|Overall Study||12
9943041|NCT01364584|11061539|FG000|COMPLETED|Overall Study||11
9943042|NCT01364584|11061540|FG001|COMPLETED|Overall Study||12
9943043|NCT01364584|11061539|FG000|NOT COMPLETED|Overall Study||0
9943044|NCT01364584|11061540|FG001|NOT COMPLETED|Overall Study||0
9943045|NCT01364623|11061551|FG000|STARTED|Single Dose||8
9943046|NCT01364623|11061552|FG001|STARTED|Single Dose||8
9943047|NCT01364623|11061553|FG002|STARTED|Single Dose||8
9943048|NCT01364623|11061554|FG003|STARTED|Single Dose||0
9943049|NCT01364623|11061551|FG000|COMPLETED|Single Dose||8
9943050|NCT01364623|11061552|FG001|COMPLETED|Single Dose||8
9943051|NCT01364623|11061553|FG002|COMPLETED|Single Dose||8
9943052|NCT01364623|11061554|FG003|COMPLETED|Single Dose||0
9943053|NCT01364623|11061551|FG000|NOT COMPLETED|Single Dose||0
9943054|NCT01364623|11061552|FG001|NOT COMPLETED|Single Dose||0
9943055|NCT01364623|11061553|FG002|NOT COMPLETED|Single Dose||0
9943056|NCT01364623|11061554|FG003|NOT COMPLETED|Single Dose||0
9943057|NCT01364623|11061551|FG000|STARTED|Multiple Dose||0
9943058|NCT01364623|11061552|FG001|STARTED|Multiple Dose||0
9943059|NCT01364623|11061553|FG002|STARTED|Multiple Dose||0
9943060|NCT01364623|11061554|FG003|STARTED|Multiple Dose||8
9943061|NCT01364623|11061551|FG000|COMPLETED|Multiple Dose||0
9943062|NCT01364623|11061552|FG001|COMPLETED|Multiple Dose||0
9943063|NCT01364623|11061553|FG002|COMPLETED|Multiple Dose||0
9943064|NCT01364623|11061554|FG003|COMPLETED|Multiple Dose||8
9943065|NCT01364623|11061551|FG000|NOT COMPLETED|Multiple Dose||0
9943066|NCT01364623|11061552|FG001|NOT COMPLETED|Multiple Dose||0
9943067|NCT01364623|11061553|FG002|NOT COMPLETED|Multiple Dose||0
9943068|NCT01364623|11061554|FG003|NOT COMPLETED|Multiple Dose||0
9943069|NCT01364649|11061571|FG000|STARTED|Overall Study||225
9943070|NCT01364649|11061572|FG001|STARTED|Overall Study||222
9943071|NCT01364649|11061571|FG000|COMPLETED|Overall Study||169
9943072|NCT01364649|11061572|FG001|COMPLETED|Overall Study||179
9943073|NCT01364649|11061571|FG000|NOT COMPLETED|Overall Study||56
9943074|NCT01364649|11061572|FG001|NOT COMPLETED|Overall Study||43
9943075|NCT01364727|11061578|FG000|STARTED|Overall Study||35
9943076|NCT01364727|11061578|FG000|COMPLETED|Overall Study||33
9943077|NCT01364727|11061578|FG000|NOT COMPLETED|Overall Study||2
9943078|NCT01364740|11061584|FG000|STARTED|Overall Study||10
9943079|NCT01364740|11061584|FG000|COMPLETED|Overall Study||10
9943080|NCT01364740|11061584|FG000|NOT COMPLETED|Overall Study||0
9943081|NCT01364870|11061592|FG000|STARTED|Overall Study||122
9943082|NCT01364870|11061593|FG001|STARTED|Overall Study||123
9943083|NCT01364870|11061594|FG002|STARTED|Overall Study||72
9943084|NCT01364870|11061592|FG000|COMPLETED|Overall Study||100
9943085|NCT01364870|11061593|FG001|COMPLETED|Overall Study||93
9943086|NCT01364870|11061594|FG002|COMPLETED|Overall Study||58
9943087|NCT01364870|11061592|FG000|NOT COMPLETED|Overall Study||22
9943088|NCT01364870|11061593|FG001|NOT COMPLETED|Overall Study||30
9943089|NCT01364870|11061594|FG002|NOT COMPLETED|Overall Study||14
9943090|NCT01364896|11061602|FG000|STARTED|Overall Study||46
9943091|NCT01364896|11061602|FG000|COMPLETED|Overall Study||46
9943092|NCT01364896|11061602|FG000|NOT COMPLETED|Overall Study||0
9943093|NCT01364922|11061609|FG000|STARTED|Open-label (OL) Period||168
9943094|NCT01364922|11061610|FG001|STARTED|Open-label (OL) Period||0
9943095|NCT01364922|11061611|FG002|STARTED|Open-label (OL) Period||0
9943096|NCT01364922|11061609|FG000|COMPLETED|Open-label (OL) Period||146
9943097|NCT01364922|11061610|FG001|COMPLETED|Open-label (OL) Period||0
9943098|NCT01364922|11061611|FG002|COMPLETED|Open-label (OL) Period||0
9943099|NCT01364922|11061609|FG000|NOT COMPLETED|Open-label (OL) Period||22
9943100|NCT01364922|11061610|FG001|NOT COMPLETED|Open-label (OL) Period||0
9943101|NCT01364922|11061611|FG002|NOT COMPLETED|Open-label (OL) Period||0
9943102|NCT01364922|11061609|FG000|STARTED|Double-Blind (DB) Period||0
9943103|NCT01364922|11061610|FG001|STARTED|Double-Blind (DB) Period||99
9943104|NCT01364922|11061611|FG002|STARTED|Double-Blind (DB) Period||47
9943105|NCT01364922|11061609|FG000|COMPLETED|Double-Blind (DB) Period||0
9943106|NCT01364922|11061610|FG001|COMPLETED|Double-Blind (DB) Period||94
9943107|NCT01364922|11061611|FG002|COMPLETED|Double-Blind (DB) Period||42
9943108|NCT01364922|11061609|FG000|NOT COMPLETED|Double-Blind (DB) Period||0
9943109|NCT01364922|11061610|FG001|NOT COMPLETED|Double-Blind (DB) Period||5
9943110|NCT01364922|11061611|FG002|NOT COMPLETED|Double-Blind (DB) Period||5
9943111|NCT01365039|11061620|FG000|STARTED|Overall Study||86
9943112|NCT01365039|11061621|FG001|STARTED|Overall Study||87
9943113|NCT01365039|11061620|FG000|COMPLETED|Overall Study||85
9943114|NCT01365039|11061621|FG001|COMPLETED|Overall Study||87
9943115|NCT01365039|11061620|FG000|NOT COMPLETED|Overall Study||1
9943116|NCT01365039|11061621|FG001|NOT COMPLETED|Overall Study||0
9943117|NCT01365052|11061630|FG000|STARTED|Overall Study||217
9943118|NCT01365052|11061631|FG001|STARTED|Overall Study||109
9943119|NCT01365052|11061630|FG000|COMPLETED|Overall Study||213
9943120|NCT01365052|11061631|FG001|COMPLETED|Overall Study||105
9943121|NCT01365052|11061630|FG000|NOT COMPLETED|Overall Study||4
9943122|NCT01365052|11061631|FG001|NOT COMPLETED|Overall Study||4
9943123|NCT01365091|11061641|FG000|STARTED|Period 1||28
9943124|NCT01365091|11061642|FG001|STARTED|Period 1||28
9943125|NCT01365091|11061643|FG002|STARTED|Period 1||28
9943126|NCT01365091|11061644|FG003|STARTED|Period 1||28
9943127|NCT01365091|11061641|FG000|COMPLETED|Period 1||26
9943128|NCT01365091|11061642|FG001|COMPLETED|Period 1||26
9943129|NCT01365091|11061643|FG002|COMPLETED|Period 1||25
9943130|NCT01365091|11061644|FG003|COMPLETED|Period 1||25
9943131|NCT01365091|11061641|FG000|NOT COMPLETED|Period 1||2
9943132|NCT01365091|11061642|FG001|NOT COMPLETED|Period 1||2
9943133|NCT01365091|11061643|FG002|NOT COMPLETED|Period 1||3
9943134|NCT01365091|11061644|FG003|NOT COMPLETED|Period 1||3
9943135|NCT01365091|11061641|FG000|STARTED|Period 2||26
9943136|NCT01365091|11061642|FG001|STARTED|Period 2||26
9943137|NCT01365091|11061643|FG002|STARTED|Period 2||25
9943138|NCT01365091|11061644|FG003|STARTED|Period 2||25
9943139|NCT01365091|11061641|FG000|COMPLETED|Period 2||25
9943140|NCT01365091|11061642|FG001|COMPLETED|Period 2||26
9943141|NCT01365091|11061643|FG002|COMPLETED|Period 2||24
9943142|NCT01365091|11061644|FG003|COMPLETED|Period 2||25
9943143|NCT01365091|11061641|FG000|NOT COMPLETED|Period 2||1
9943144|NCT01365091|11061642|FG001|NOT COMPLETED|Period 2||0
9943145|NCT01365091|11061643|FG002|NOT COMPLETED|Period 2||1
9943146|NCT01365091|11061644|FG003|NOT COMPLETED|Period 2||0
9943147|NCT01365130|11061668|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
9943148|NCT01365130|11061668|FG000|COMPLETED|Overall Study||13
9943149|NCT01365130|11061668|FG000|NOT COMPLETED|Overall Study||2
9943150|NCT01365273|11061674|FG000|STARTED|Overall Study||22
9943151|NCT01365273|11061675|FG001|STARTED|Overall Study||21
9943152|NCT01365273|11061674|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
9943153|NCT01365273|11061675|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
9943154|NCT01365273|11061674|FG000|COMPLETED|Overall Study||20
9943155|NCT01365273|11061675|FG001|COMPLETED|Overall Study||20
9943156|NCT01365273|11061674|FG000|NOT COMPLETED|Overall Study||2
9943157|NCT01365273|11061675|FG001|NOT COMPLETED|Overall Study||1
9943158|NCT01365455|11061684|FG000|STARTED|Induction Period||245
9943159|NCT01365455|11061685|FG001|STARTED|Induction Period||245
9943160|NCT01365455|11061686|FG002|STARTED|Induction Period||248
9943161|NCT01365455|11061687|FG003|STARTED|Induction Period||0
9943162|NCT01365455|11061688|FG004|STARTED|Induction Period||0
9943163|NCT01365455|11061684|FG000|COMPLETED|Induction Period||230
9943164|NCT01365455|11061685|FG001|COMPLETED|Induction Period||238
9943165|NCT01365455|11061686|FG002|COMPLETED|Induction Period||232
9943166|NCT01365455|11061687|FG003|COMPLETED|Induction Period||0
9943167|NCT01365455|11061688|FG004|COMPLETED|Induction Period||0
9943168|NCT01365455|11061684|FG000|NOT COMPLETED|Induction Period||15
9943169|NCT01365455|11061685|FG001|NOT COMPLETED|Induction Period||7
9943170|NCT01365455|11061686|FG002|NOT COMPLETED|Induction Period||16
9943171|NCT01365455|11061687|FG003|NOT COMPLETED|Induction Period||0
9943172|NCT01365455|11061688|FG004|NOT COMPLETED|Induction Period||0
9943173|NCT01365455|11061684|FG000|STARTED|Maintenance Period||230
9943174|NCT01365455|11061685|FG001|STARTED|Maintenance Period||238
10207293|NCT03525548|11334125|FG001|STARTED|Overall Study||55
10207294|NCT03525548|11334124|FG000|COMPLETED|Overall Study||52
10207295|NCT03525548|11334125|FG001|COMPLETED|Overall Study||55
9943175|NCT01365455|11061686|FG002|STARTED|Maintenance Period||18
10011481|NCT01780974|11134225|FG001|COMPLETED|Overall Study||18
10011482|NCT01780974|11134224|FG000|NOT COMPLETED|Overall Study||2
10011483|NCT01780974|11134225|FG001|NOT COMPLETED|Overall Study||3
9943176|NCT01365455|11061687|FG003|STARTED|Maintenance Period||109
9943177|NCT01365455|11061688|FG004|STARTED|Maintenance Period||105
9943178|NCT01365455|11061684|FG000|COMPLETED|Maintenance Period||201
9943179|NCT01365455|11061685|FG001|COMPLETED|Maintenance Period||215
9943180|NCT01365455|11061686|FG002|COMPLETED|Maintenance Period||15
9943181|NCT01365455|11061687|FG003|COMPLETED|Maintenance Period||100
9943182|NCT01365455|11061688|FG004|COMPLETED|Maintenance Period||92
9943183|NCT01365455|11061684|FG000|NOT COMPLETED|Maintenance Period||29
9943184|NCT01365455|11061685|FG001|NOT COMPLETED|Maintenance Period||23
9943185|NCT01365455|11061686|FG002|NOT COMPLETED|Maintenance Period||3
9943186|NCT01365455|11061687|FG003|NOT COMPLETED|Maintenance Period||9
9943187|NCT01365455|11061688|FG004|NOT COMPLETED|Maintenance Period||13
9943188|NCT01365455|11061684|FG000|STARTED|Follow-up Period||58
9943189|NCT01365455|11061685|FG001|STARTED|Follow-up Period||47
9943190|NCT01365455|11061686|FG002|STARTED|Follow-up Period||18
9943191|NCT01365455|11061687|FG003|STARTED|Follow-up Period||0
9943192|NCT01365455|11061688|FG004|STARTED|Follow-up Period||0
9943193|NCT01365455|11061684|FG000|COMPLETED|Follow-up Period||58
9943194|NCT01365455|11061685|FG001|COMPLETED|Follow-up Period||47
9943195|NCT01365455|11061686|FG002|COMPLETED|Follow-up Period||18
9943196|NCT01365455|11061687|FG003|COMPLETED|Follow-up Period||0
9943197|NCT01365455|11061688|FG004|COMPLETED|Follow-up Period||0
9943198|NCT01365455|11061684|FG000|NOT COMPLETED|Follow-up Period||0
9943199|NCT01365455|11061685|FG001|NOT COMPLETED|Follow-up Period||0
9943200|NCT01365455|11061686|FG002|NOT COMPLETED|Follow-up Period||0
9943201|NCT01365455|11061687|FG003|NOT COMPLETED|Follow-up Period||0
9943202|NCT01365455|11061688|FG004|NOT COMPLETED|Follow-up Period||0
9943203|NCT01365468|11061708|FG000|STARTED|Overall Study||4
9943204|NCT01365468|11061709|FG001|STARTED|Overall Study||5
9943205|NCT01365468|11061708|FG000|COMPLETED|Overall Study||0
9943206|NCT01365468|11061709|FG001|COMPLETED|Overall Study||5
9943207|NCT01365468|11061708|FG000|NOT COMPLETED|Overall Study||4
9943208|NCT01365468|11061709|FG001|NOT COMPLETED|Overall Study||0
9943209|NCT01365481|11061720|FG000|STARTED|Overall Study||23
9943210|NCT01365481|11061721|FG001|STARTED|Overall Study||52
9943211|NCT01365481|11061722|FG002|STARTED|Overall Study||18
9943212|NCT01365481|11061723|FG003|STARTED|Overall Study||57
9943213|NCT01365481|11061720|FG000|COMPLETED|Overall Study||16
9943214|NCT01365481|11061721|FG001|COMPLETED|Overall Study||37
9943215|NCT01365481|11061722|FG002|COMPLETED|Overall Study||14
9943216|NCT01365481|11061723|FG003|COMPLETED|Overall Study||50
9943217|NCT01365481|11061720|FG000|NOT COMPLETED|Overall Study||7
9943218|NCT01365481|11061721|FG001|NOT COMPLETED|Overall Study||15
9943219|NCT01365481|11061722|FG002|NOT COMPLETED|Overall Study||4
9943220|NCT01365481|11061723|FG003|NOT COMPLETED|Overall Study||7
9943221|NCT01365494|11061735|FG000|STARTED|Overall Study||126
9943222|NCT01365494|11061736|FG001|STARTED|Overall Study||124
9943223|NCT01365494|11061735|FG000|COMPLETED|Overall Study||124
9943224|NCT01365494|11061736|FG001|COMPLETED|Overall Study||121
9943225|NCT01365494|11061735|FG000|NOT COMPLETED|Overall Study||2
9943226|NCT01365494|11061736|FG001|NOT COMPLETED|Overall Study||3
10011484|NCT01780987|11134233|FG000|STARTED|Overall Study||40
10011485|NCT01780987|11134234|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
10011486|NCT01780987|11134233|FG000|COMPLETED|Overall Study||37
10011487|NCT01780987|11134234|FG001|COMPLETED|Overall Study||34
9943227|NCT01365507|11061745|FG000|STARTED|Overall Study||136
9943228|NCT01365507|11061746|FG001|STARTED|Overall Study||140
9943229|NCT01365507|11061745|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
9943230|NCT01365507|11061746|FG001|Exposed|Overall Study||140
9943231|NCT01365507|11061745|FG000|COMPLETED|Overall Study||127
9943232|NCT01365507|11061746|FG001|COMPLETED|Overall Study||131
10207296|NCT03525548|11334124|FG000|NOT COMPLETED|Overall Study||0
9943233|NCT01365507|11061745|FG000|NOT COMPLETED|Overall Study||9
9943234|NCT01365507|11061746|FG001|NOT COMPLETED|Overall Study||9
9943235|NCT01365546|11061752|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
9943236|NCT01365546|11061752|FG000|COMPLETED|Overall Study||30
9943237|NCT01365546|11061752|FG000|NOT COMPLETED|Overall Study||11
9943238|NCT01365585|11061760|FG000|STARTED|Overall Study||227
9943239|NCT01365585|11061760|FG000|COMPLETED|Overall Study||227
9943240|NCT01365585|11061760|FG000|NOT COMPLETED|Overall Study||0
9943241|NCT01365611|11061764|FG000|STARTED|Overall Study||36
9943242|NCT01365611|11061764|FG000|COMPLETED|Overall Study||36
9943243|NCT01365611|11061764|FG000|NOT COMPLETED|Overall Study||0
9943244|NCT01365624|11061772|FG000|STARTED|Overall Study||15
9943245|NCT01365624|11061773|FG001|STARTED|Overall Study||15
9943246|NCT01365624|11061772|FG000|COMPLETED|Overall Study||15
9943247|NCT01365624|11061773|FG001|COMPLETED|Overall Study||15
9943248|NCT01365624|11061772|FG000|NOT COMPLETED|Overall Study||0
9943249|NCT01365624|11061773|FG001|NOT COMPLETED|Overall Study||0
9943250|NCT01365650|11061779|FG000|STARTED|Treatment A||24
9943251|NCT01365650|11061779|FG000|COMPLETED|Treatment A||24
9943252|NCT01365650|11061779|FG000|NOT COMPLETED|Treatment A||0
9943253|NCT01365650|11061779|FG000|STARTED|Treatment B||24
9943254|NCT01365650|11061779|FG000|COMPLETED|Treatment B||24
9943255|NCT01365650|11061779|FG000|NOT COMPLETED|Treatment B||0
9943256|NCT01365650|11061779|FG000|STARTED|Treatment C||24
9943257|NCT01365650|11061779|FG000|COMPLETED|Treatment C||24
9943258|NCT01365650|11061779|FG000|NOT COMPLETED|Treatment C||0
9943259|NCT01365793|11061791|FG000|STARTED|Overall Study||344
9943260|NCT01365793|11061792|FG001|STARTED|Overall Study||351
10207297|NCT03525548|11334125|FG001|NOT COMPLETED|Overall Study||0
10207298|NCT03525834|11334131|FG000|STARTED|Overall Study||40
10207299|NCT03525834|11334131|FG000|COMPLETED|Overall Study||39
10207300|NCT03525834|11334131|FG000|NOT COMPLETED|Overall Study||1
10207301|NCT03526055|11334135|FG000|STARTED|Initial Program||5
10207302|NCT03526055|11334136|FG001|STARTED|Initial Program||5
10207303|NCT03526055|11334135|FG000|COMPLETED|Initial Program||5
10207304|NCT03526055|11334136|FG001|COMPLETED|Initial Program||5
10207305|NCT03526055|11334135|FG000|NOT COMPLETED|Initial Program||0
10207306|NCT03526055|11334136|FG001|NOT COMPLETED|Initial Program||0
10207307|NCT03526055|11334135|FG000|STARTED|Second Program||5
10207308|NCT03526055|11334136|FG001|STARTED|Second Program||5
10207309|NCT03526055|11334135|FG000|COMPLETED|Second Program||5
10207310|NCT03526055|11334136|FG001|COMPLETED|Second Program||5
10207311|NCT03526055|11334135|FG000|NOT COMPLETED|Second Program||0
10207312|NCT03526055|11334136|FG001|NOT COMPLETED|Second Program||0
10207313|NCT03526458|11334145|FG000|STARTED|Overall Study||20
10207314|NCT03526458|11334146|FG001|STARTED|Overall Study||20
10207315|NCT03526458|11334145|FG000|COMPLETED|Overall Study||12
10207316|NCT03526458|11334146|FG001|COMPLETED|Overall Study||15
10207317|NCT03526458|11334145|FG000|NOT COMPLETED|Overall Study||8
10207318|NCT03526458|11334146|FG001|NOT COMPLETED|Overall Study||5
10207319|NCT03526861|11334155|FG000|STARTED|Initial Treatment Period||101
10207320|NCT03526861|11334156|FG001|STARTED|Initial Treatment Period||100
10207321|NCT03526861|11334157|FG002|STARTED|Initial Treatment Period||100
10207322|NCT03526861|11334158|FG003|STARTED|Initial Treatment Period||0
10207323|NCT03526861|11334159|FG004|STARTED|Initial Treatment Period||0
10207324|NCT03526861|11334160|FG005|STARTED|Initial Treatment Period||0
10207325|NCT03526861|11334161|FG006|STARTED|Initial Treatment Period||0
10207326|NCT03526861|11334162|FG007|STARTED|Initial Treatment Period||0
10207327|NCT03526861|11334163|FG008|STARTED|Initial Treatment Period||0
10207328|NCT03526861|11334155|FG000|COMPLETED|Initial Treatment Period||94
10207329|NCT03526861|11334156|FG001|COMPLETED|Initial Treatment Period||93
10207330|NCT03526861|11334157|FG002|COMPLETED|Initial Treatment Period||86
10207331|NCT03526861|11334158|FG003|COMPLETED|Initial Treatment Period||0
10207332|NCT03526861|11334159|FG004|COMPLETED|Initial Treatment Period||0
10207333|NCT03526861|11334160|FG005|COMPLETED|Initial Treatment Period||0
10207334|NCT03526861|11334161|FG006|COMPLETED|Initial Treatment Period||0
10207335|NCT03526861|11334162|FG007|COMPLETED|Initial Treatment Period||0
10207336|NCT03526861|11334163|FG008|COMPLETED|Initial Treatment Period||0
10207337|NCT03526861|11334155|FG000|NOT COMPLETED|Initial Treatment Period||7
10207338|NCT03526861|11334156|FG001|NOT COMPLETED|Initial Treatment Period||7
10207339|NCT03526861|11334157|FG002|NOT COMPLETED|Initial Treatment Period||14
10207340|NCT03526861|11334158|FG003|NOT COMPLETED|Initial Treatment Period||0
10207341|NCT03526861|11334159|FG004|NOT COMPLETED|Initial Treatment Period||0
10207342|NCT03526861|11334160|FG005|NOT COMPLETED|Initial Treatment Period||0
10207343|NCT03526861|11334161|FG006|NOT COMPLETED|Initial Treatment Period||0
10207344|NCT03526861|11334162|FG007|NOT COMPLETED|Initial Treatment Period||0
10207345|NCT03526861|11334163|FG008|NOT COMPLETED|Initial Treatment Period||0
10207346|NCT03526861|11334155|FG000|STARTED|Maintenance Treatment Period||0
9943261|NCT01365793|11061793|FG002|STARTED|Overall Study||345
9943262|NCT01365793|11061794|FG003|STARTED|Overall Study||349
9943263|NCT01365793|11061791|FG000|COMPLETED|Overall Study||342
9943264|NCT01365793|11061792|FG001|COMPLETED|Overall Study||344
10207347|NCT03526861|11334156|FG001|STARTED|Maintenance Treatment Period||0
10207348|NCT03526861|11334157|FG002|STARTED|Maintenance Treatment Period||0
10207349|NCT03526861|11334158|FG003|STARTED|Maintenance Treatment Period||13
10207350|NCT03526861|11334159|FG004|STARTED|Maintenance Treatment Period||14
10207351|NCT03526861|11334160|FG005|STARTED|Maintenance Treatment Period||12
10207352|NCT03526861|11334161|FG006|STARTED|Maintenance Treatment Period||14
10207353|NCT03526861|11334162|FG007|STARTED|Maintenance Treatment Period||6
10207354|NCT03526861|11334163|FG008|STARTED|Maintenance Treatment Period||0
10207355|NCT03526861|11334155|FG000|COMPLETED|Maintenance Treatment Period||0
10207356|NCT03526861|11334156|FG001|COMPLETED|Maintenance Treatment Period||0
10207357|NCT03526861|11334157|FG002|COMPLETED|Maintenance Treatment Period||0
10207358|NCT03526861|11334158|FG003|COMPLETED|Maintenance Treatment Period||5
10207359|NCT03526861|11334159|FG004|COMPLETED|Maintenance Treatment Period||8
10207360|NCT03526861|11334160|FG005|COMPLETED|Maintenance Treatment Period||8
9943265|NCT01365793|11061793|FG002|COMPLETED|Overall Study||338
9943266|NCT01365793|11061794|FG003|COMPLETED|Overall Study||347
9943267|NCT01365793|11061791|FG000|NOT COMPLETED|Overall Study||2
9943268|NCT01365793|11061792|FG001|NOT COMPLETED|Overall Study||7
10011488|NCT01780987|11134233|FG000|NOT COMPLETED|Overall Study||3
10011489|NCT01780987|11134234|FG001|NOT COMPLETED|Overall Study||6
10011490|NCT01781078|11134242|FG000|STARTED|Overall Study|Randomized post implantation|229
10011491|NCT01781078|11134243|FG001|STARTED|Overall Study|Randomized post implantation|118
10011492|NCT01781078|11134244|FG002|STARTED|Overall Study||16
10011493|NCT01781078|11134242|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
9943269|NCT01365793|11061793|FG002|NOT COMPLETED|Overall Study||7
9943270|NCT01365793|11061794|FG003|NOT COMPLETED|Overall Study||2
9943271|NCT01365819|11061806|FG000|STARTED|Overall Study||25
9943272|NCT01365819|11061807|FG001|STARTED|Overall Study||27
9943273|NCT01365819|11061806|FG000|COMPLETED|Overall Study||12
9943274|NCT01365819|11061807|FG001|COMPLETED|Overall Study||14
10011494|NCT01781078|11134243|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
10011495|NCT01781078|11134244|FG002|COMPLETED|Overall Study||0
10011496|NCT01781078|11134242|FG000|NOT COMPLETED|Overall Study||12
10011497|NCT01781078|11134243|FG001|NOT COMPLETED|Overall Study||5
10011498|NCT01781078|11134244|FG002|NOT COMPLETED|Overall Study||16
10011499|NCT01781169|11134255|FG000|STARTED|Overall Study||22
9943275|NCT01365819|11061806|FG000|NOT COMPLETED|Overall Study||13
9943276|NCT01365819|11061807|FG001|NOT COMPLETED|Overall Study||13
9943277|NCT01365845|11061813|FG000|STARTED|Induction Phase||18
9943278|NCT01365845|11061814|FG001|STARTED|Induction Phase||0
9943279|NCT01365845|11061815|FG002|STARTED|Induction Phase||0
9943280|NCT01365845|11061813|FG000|COMPLETED|Induction Phase||18
9943281|NCT01365845|11061814|FG001|COMPLETED|Induction Phase||0
9943282|NCT01365845|11061815|FG002|COMPLETED|Induction Phase||0
9943283|NCT01365845|11061813|FG000|NOT COMPLETED|Induction Phase||0
9943284|NCT01365845|11061814|FG001|NOT COMPLETED|Induction Phase||0
9943285|NCT01365845|11061815|FG002|NOT COMPLETED|Induction Phase||0
9943286|NCT01365845|11061813|FG000|STARTED|Treatment Phase||0
9943287|NCT01365845|11061814|FG001|STARTED|Treatment Phase||0
9943288|NCT01365845|11061815|FG002|STARTED|Treatment Phase||18
9943289|NCT01365845|11061813|FG000|COMPLETED|Treatment Phase||0
9943290|NCT01365845|11061814|FG001|COMPLETED|Treatment Phase||0
9943291|NCT01365845|11061815|FG002|COMPLETED|Treatment Phase||18
9943292|NCT01365845|11061813|FG000|NOT COMPLETED|Treatment Phase||0
9943293|NCT01365845|11061814|FG001|NOT COMPLETED|Treatment Phase||0
9943294|NCT01365845|11061815|FG002|NOT COMPLETED|Treatment Phase||0
9943295|NCT01365910|11061820|FG000|STARTED|Overall Study||30
9943296|NCT01365910|11061820|FG000|COMPLETED|Overall Study||0
9943297|NCT01365910|11061820|FG000|NOT COMPLETED|Overall Study||30
9943298|NCT01366196|11061826|FG000|STARTED|Overall Study||43
9943299|NCT01366196|11061827|FG001|STARTED|Overall Study||43
9943300|NCT01366196|11061826|FG000|COMPLETED|Overall Study||43
9943301|NCT01366196|11061827|FG001|COMPLETED|Overall Study||43
9943302|NCT01366196|11061826|FG000|NOT COMPLETED|Overall Study||0
9943303|NCT01366196|11061827|FG001|NOT COMPLETED|Overall Study||0
9943304|NCT01366209|11061835|FG000|STARTED|Overall Study||278
9943305|NCT01366209|11061836|FG001|STARTED|Overall Study||277
9943306|NCT01366209|11061835|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
9943307|NCT01366209|11061836|FG001|COMPLETED|Overall Study||241
9943308|NCT01366209|11061835|FG000|NOT COMPLETED|Overall Study||35
9943309|NCT01366209|11061836|FG001|NOT COMPLETED|Overall Study||36
9943310|NCT01366417|11061842|FG000|STARTED|Overall Study||43
10011500|NCT01781169|11134256|FG001|STARTED|Overall Study||21
10011501|NCT01781169|11134255|FG000|COMPLETED|Overall Study||21
10011502|NCT01781169|11134256|FG001|COMPLETED|Overall Study||21
10011503|NCT01781169|11134255|FG000|NOT COMPLETED|Overall Study||1
9943311|NCT01366417|11061842|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
9943312|NCT01366417|11061842|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
9943313|NCT01366417|11061842|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
9943314|NCT01366417|11061842|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
9943315|NCT01366417|11061842|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
9943316|NCT01366417|11061842|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
9943317|NCT01366417|11061842|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25
9943318|NCT01366417|11061842|FG000|NOT COMPLETED|Overall Study||18
9943319|NCT01366443|11061847|FG000|STARTED|Overall Study||288
9943320|NCT01366443|11061847|FG000|COMPLETED|Overall Study||285
9943321|NCT01366443|11061847|FG000|NOT COMPLETED|Overall Study||3
9943322|NCT01366495|11061856|FG000|STARTED|Testing Study||0
10011504|NCT01781169|11134256|FG001|NOT COMPLETED|Overall Study||0
9943323|NCT01366495|11061857|FG001|STARTED|Testing Study||0
9943324|NCT01366495|11061858|FG002|STARTED|Testing Study||349
9943325|NCT01366495|11061859|FG003|STARTED|Testing Study||348
9943326|NCT01366495|11061856|FG000|COMPLETED|Testing Study||0
9943327|NCT01366495|11061857|FG001|COMPLETED|Testing Study||0
9943328|NCT01366495|11061858|FG002|COMPLETED|Testing Study||349
9943329|NCT01366495|11061859|FG003|COMPLETED|Testing Study||348
9943330|NCT01366495|11061856|FG000|NOT COMPLETED|Testing Study||0
9943331|NCT01366495|11061857|FG001|NOT COMPLETED|Testing Study||0
9943332|NCT01366495|11061858|FG002|NOT COMPLETED|Testing Study||0
9943333|NCT01366495|11061859|FG003|NOT COMPLETED|Testing Study||0
9943334|NCT01366495|11061856|FG000|STARTED|HIV Study||50
9943335|NCT01366495|11061857|FG001|STARTED|HIV Study||50
9943336|NCT01366495|11061858|FG002|STARTED|HIV Study||0
9943337|NCT01366495|11061859|FG003|STARTED|HIV Study||0
9943338|NCT01366495|11061856|FG000|COMPLETED|HIV Study||49
9943339|NCT01366495|11061857|FG001|COMPLETED|HIV Study||50
9943340|NCT01366495|11061858|FG002|COMPLETED|HIV Study||0
9943341|NCT01366495|11061859|FG003|COMPLETED|HIV Study||0
9943342|NCT01366495|11061856|FG000|NOT COMPLETED|HIV Study||1
9943343|NCT01366495|11061857|FG001|NOT COMPLETED|HIV Study||0
9943344|NCT01366495|11061858|FG002|NOT COMPLETED|HIV Study||0
9943345|NCT01366495|11061859|FG003|NOT COMPLETED|HIV Study||0
9943346|NCT01366521|11061873|FG000|STARTED|Overall Study||21
9943347|NCT01366521|11061874|FG001|STARTED|Overall Study||15
9943348|NCT01366521|11061875|FG002|STARTED|Overall Study||23
9943349|NCT01366521|11061876|FG003|STARTED|Overall Study||11
9943350|NCT01366521|11061873|FG000|COMPLETED|Overall Study||20
9943351|NCT01366521|11061874|FG001|COMPLETED|Overall Study||14
9943352|NCT01366521|11061875|FG002|COMPLETED|Overall Study||21
9943353|NCT01366521|11061876|FG003|COMPLETED|Overall Study||11
9943354|NCT01366521|11061873|FG000|NOT COMPLETED|Overall Study||1
9943355|NCT01366521|11061874|FG001|NOT COMPLETED|Overall Study||1
9943356|NCT01366521|11061875|FG002|NOT COMPLETED|Overall Study||2
9943357|NCT01366521|11061876|FG003|NOT COMPLETED|Overall Study||0
9943358|NCT01366534|11061891|FG000|STARTED|Overall Study||28
9943359|NCT01366534|11061892|FG001|STARTED|Overall Study||27
9943360|NCT01366534|11061893|FG002|STARTED|Overall Study||12
9943361|NCT01366534|11061891|FG000|COMPLETED|Overall Study||26
9943362|NCT01366534|11061892|FG001|COMPLETED|Overall Study||25
9943363|NCT01366534|11061893|FG002|COMPLETED|Overall Study||12
9943364|NCT01366534|11061891|FG000|NOT COMPLETED|Overall Study||2
9943365|NCT01366534|11061892|FG001|NOT COMPLETED|Overall Study||2
9943366|NCT01366534|11061893|FG002|NOT COMPLETED|Overall Study||0
9943367|NCT01366638|11061904|FG000|STARTED|Overall Study||24
9943368|NCT01366638|11061905|FG001|STARTED|Overall Study||29
9943369|NCT01366638|11061906|FG002|STARTED|Overall Study||26
9943370|NCT01366638|11061904|FG000|COMPLETED|Overall Study||23
9943371|NCT01366638|11061905|FG001|COMPLETED|Overall Study||29
9943372|NCT01366638|11061906|FG002|COMPLETED|Overall Study||20
9943373|NCT01366638|11061904|FG000|NOT COMPLETED|Overall Study||1
9943374|NCT01366638|11061905|FG001|NOT COMPLETED|Overall Study||0
9943375|NCT01366638|11061906|FG002|NOT COMPLETED|Overall Study||6
9943376|NCT01366846|11061918|FG000|STARTED|Overall Study||235
9943377|NCT01366846|11061919|FG001|STARTED|Overall Study||228
9943378|NCT01366846|11061920|FG002|STARTED|Overall Study||47
9943379|NCT01366846|11061921|FG003|STARTED|Overall Study||46
9943380|NCT01366846|11061918|FG000|COMPLETED|Overall Study||232
9943381|NCT01366846|11061919|FG001|COMPLETED|Overall Study||224
9943382|NCT01366846|11061920|FG002|COMPLETED|Overall Study||46
9943383|NCT01366846|11061921|FG003|COMPLETED|Overall Study||45
9943384|NCT01366846|11061918|FG000|NOT COMPLETED|Overall Study||3
9943385|NCT01366846|11061919|FG001|NOT COMPLETED|Overall Study||4
9943386|NCT01366846|11061920|FG002|NOT COMPLETED|Overall Study||1
9943387|NCT01366846|11061921|FG003|NOT COMPLETED|Overall Study||1
9943388|NCT01366872|11061934|FG000|STARTED|Overall Study||50
9943389|NCT01366872|11061934|FG000|COMPLETED|Overall Study||50
9943390|NCT01366872|11061934|FG000|NOT COMPLETED|Overall Study||0
9943391|NCT01366885|11061938|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
9943392|NCT01366885|11061938|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
9943393|NCT01366885|11061938|FG000|NOT COMPLETED|Overall Study||1
10207361|NCT03526861|11334161|FG006|COMPLETED|Maintenance Treatment Period||8
9943394|NCT01366976|11061944|FG000|STARTED|Overall Study||30
9943395|NCT01366976|11061945|FG001|STARTED|Overall Study||30
9943396|NCT01366976|11061944|FG000|COMPLETED|Overall Study||30
9943397|NCT01366976|11061945|FG001|COMPLETED|Overall Study||30
9943398|NCT01366976|11061944|FG000|NOT COMPLETED|Overall Study||0
9943399|NCT01366976|11061945|FG001|NOT COMPLETED|Overall Study||0
9943400|NCT01367080|11061953|FG000|STARTED|1st Administration||6
9943401|NCT01367080|11061954|FG001|STARTED|1st Administration||6
9943402|NCT01367080|11061953|FG000|COMPLETED|1st Administration||6
9943403|NCT01367080|11061954|FG001|COMPLETED|1st Administration||6
9943404|NCT01367080|11061953|FG000|NOT COMPLETED|1st Administration||0
9943405|NCT01367080|11061954|FG001|NOT COMPLETED|1st Administration||0
9943406|NCT01367080|11061953|FG000|STARTED|2nd Administration||6
9943407|NCT01367080|11061954|FG001|STARTED|2nd Administration||6
9943408|NCT01367080|11061953|FG000|COMPLETED|2nd Administration||6
9943409|NCT01367080|11061954|FG001|COMPLETED|2nd Administration||6
9943410|NCT01367080|11061953|FG000|NOT COMPLETED|2nd Administration||0
9943411|NCT01367080|11061954|FG001|NOT COMPLETED|2nd Administration||0
9943412|NCT01367119|11061964|FG000|STARTED|Overall Study||21
9943413|NCT01367119|11061965|FG001|STARTED|Overall Study||17
9943414|NCT01367119|11061964|FG000|COMPLETED|Overall Study||19
10207362|NCT03526861|11334162|FG007|COMPLETED|Maintenance Treatment Period||4
9943415|NCT01367119|11061965|FG001|COMPLETED|Overall Study||16
9943416|NCT01367119|11061964|FG000|NOT COMPLETED|Overall Study||2
9943417|NCT01367119|11061965|FG001|NOT COMPLETED|Overall Study||1
9943418|NCT01367158|11061982|FG000|STARTED|Overall Study||25
9943419|NCT01367158|11061983|FG001|STARTED|Overall Study||49
9943420|NCT01367158|11061984|FG002|STARTED|Overall Study||24
9943421|NCT01367158|11061985|FG003|STARTED|Overall Study||49
9943422|NCT01367158|11061986|FG004|STARTED|Overall Study||25
9943423|NCT01367158|11061987|FG005|STARTED|Overall Study||48
9943424|NCT01367158|11061988|FG006|STARTED|Overall Study||25
10111639|NCT02497391|11242653|FG000|COMPLETED|Period 2 (14 Days)||12
10111640|NCT02497391|11242654|FG001|COMPLETED|Period 2 (14 Days)||14
10111641|NCT02497391|11242655|FG002|COMPLETED|Period 2 (14 Days)||13
10111642|NCT02497391|11242656|FG003|COMPLETED|Period 2 (14 Days)||13
10111643|NCT02497391|11242657|FG004|COMPLETED|Period 2 (14 Days)||14
10111644|NCT02497391|11242658|FG005|COMPLETED|Period 2 (14 Days)||13
10111645|NCT02497391|11242653|FG000|NOT COMPLETED|Period 2 (14 Days)||4
9943425|NCT01367158|11061989|FG007|STARTED|Overall Study||49
9943426|NCT01367158|11061990|FG008|STARTED|Overall Study||23
9943427|NCT01367158|11061991|FG009|STARTED|Overall Study||50
9943428|NCT01367158|11061992|FG010|STARTED|Overall Study||73
9943429|NCT01367158|11061982|FG000|COMPLETED|Overall Study||25
9943430|NCT01367158|11061983|FG001|COMPLETED|Overall Study||46
9943431|NCT01367158|11061984|FG002|COMPLETED|Overall Study||23
9943432|NCT01367158|11061985|FG003|COMPLETED|Overall Study||48
9943433|NCT01367158|11061986|FG004|COMPLETED|Overall Study||23
9943434|NCT01367158|11061987|FG005|COMPLETED|Overall Study||46
9943435|NCT01367158|11061988|FG006|COMPLETED|Overall Study||25
9943436|NCT01367158|11061989|FG007|COMPLETED|Overall Study||47
9943437|NCT01367158|11061990|FG008|COMPLETED|Overall Study||23
9943438|NCT01367158|11061991|FG009|COMPLETED|Overall Study||50
9943439|NCT01367158|11061992|FG010|COMPLETED|Overall Study||72
9943440|NCT01367158|11061982|FG000|NOT COMPLETED|Overall Study||0
9943441|NCT01367158|11061983|FG001|NOT COMPLETED|Overall Study||3
9943442|NCT01367158|11061984|FG002|NOT COMPLETED|Overall Study||1
9943443|NCT01367158|11061985|FG003|NOT COMPLETED|Overall Study||1
9943444|NCT01367158|11061986|FG004|NOT COMPLETED|Overall Study||2
9943445|NCT01367158|11061987|FG005|NOT COMPLETED|Overall Study||2
9943446|NCT01367158|11061988|FG006|NOT COMPLETED|Overall Study||0
9943447|NCT01367158|11061989|FG007|NOT COMPLETED|Overall Study||2
9943448|NCT01367158|11061990|FG008|NOT COMPLETED|Overall Study||0
9943449|NCT01367158|11061991|FG009|NOT COMPLETED|Overall Study||0
9943450|NCT01367158|11061992|FG010|NOT COMPLETED|Overall Study||1
9943451|NCT01367236|11062029|FG000|STARTED|Overall Study||30
9943452|NCT01367236|11062030|FG001|STARTED|Overall Study||30
9943453|NCT01367236|11062029|FG000|COMPLETED|Overall Study||27
9943454|NCT01367236|11062030|FG001|COMPLETED|Overall Study||29
9943455|NCT01367236|11062029|FG000|NOT COMPLETED|Overall Study||3
9943456|NCT01367236|11062030|FG001|NOT COMPLETED|Overall Study||1
9943457|NCT01367249|11062038|FG000|STARTED|Overall Study||222
9943458|NCT01367249|11062039|FG001|STARTED|Overall Study||218
9943459|NCT01367249|11062038|FG000|COMPLETED|Overall Study||213
9943460|NCT01367249|11062039|FG001|COMPLETED|Overall Study||202
9943461|NCT01367249|11062038|FG000|NOT COMPLETED|Overall Study||9
9943462|NCT01367249|11062039|FG001|NOT COMPLETED|Overall Study||16
9943463|NCT01367262|11062045|FG000|STARTED|Overall Study||6
9943464|NCT01367262|11062045|FG000|COMPLETED|Overall Study||6
9943465|NCT01367262|11062045|FG000|NOT COMPLETED|Overall Study||0
9943466|NCT01367275|11062049|FG000|STARTED|Overall Study||8
9943467|NCT01367275|11062049|FG000|COMPLETED|Overall Study||5
9943468|NCT01367275|11062049|FG000|NOT COMPLETED|Overall Study||3
9943469|NCT01367444|11062060|FG000|STARTED|Overall Study||4
9943470|NCT01367444|11062061|FG001|STARTED|Overall Study||4
9943471|NCT01367444|11062062|FG002|STARTED|Overall Study||4
9943472|NCT01367444|11062063|FG003|STARTED|Overall Study||4
9943473|NCT01367444|11062064|FG004|STARTED|Overall Study||6
9943474|NCT01367444|11062065|FG005|STARTED|Overall Study||4
9943475|NCT01367444|11062066|FG006|STARTED|Overall Study||1
9943476|NCT01367444|11062060|FG000|COMPLETED|Overall Study||4
9943477|NCT01367444|11062061|FG001|COMPLETED|Overall Study||4
9943478|NCT01367444|11062062|FG002|COMPLETED|Overall Study||4
9943479|NCT01367444|11062063|FG003|COMPLETED|Overall Study||4
9943480|NCT01367444|11062064|FG004|COMPLETED|Overall Study||6
9943481|NCT01367444|11062065|FG005|COMPLETED|Overall Study||4
9943482|NCT01367444|11062066|FG006|COMPLETED|Overall Study||1
9943483|NCT01367444|11062060|FG000|NOT COMPLETED|Overall Study||0
9943484|NCT01367444|11062061|FG001|NOT COMPLETED|Overall Study||0
9943485|NCT01367444|11062062|FG002|NOT COMPLETED|Overall Study||0
9943486|NCT01367444|11062063|FG003|NOT COMPLETED|Overall Study||0
9943487|NCT01367444|11062064|FG004|NOT COMPLETED|Overall Study||0
9943488|NCT01367444|11062065|FG005|NOT COMPLETED|Overall Study||0
9943489|NCT01367444|11062066|FG006|NOT COMPLETED|Overall Study||0
9943490|NCT01367457|11062085|FG000|STARTED|Overall Study||193
9943491|NCT01367457|11062086|FG001|STARTED|Overall Study||23
9943492|NCT01367457|11062087|FG002|STARTED|Overall Study||26
9943493|NCT01367457|11062085|FG000|COMPLETED|Overall Study||5
9943494|NCT01367457|11062086|FG001|COMPLETED|Overall Study||23
9943495|NCT01367457|11062087|FG002|COMPLETED|Overall Study||26
9943496|NCT01367457|11062085|FG000|NOT COMPLETED|Overall Study||188
9943497|NCT01367457|11062086|FG001|NOT COMPLETED|Overall Study||0
10111646|NCT02497391|11242654|FG001|NOT COMPLETED|Period 2 (14 Days)||1
9943498|NCT01367457|11062087|FG002|NOT COMPLETED|Overall Study||0
9943499|NCT01367665|11062097|FG000|STARTED|Overall Study||1119
9943500|NCT01367665|11062098|FG001|STARTED|Overall Study||96
9943501|NCT01367665|11062097|FG000|COMPLETED|Overall Study||677
9943502|NCT01367665|11062098|FG001|COMPLETED|Overall Study||41
9943503|NCT01367665|11062097|FG000|NOT COMPLETED|Overall Study||442
9943504|NCT01367665|11062098|FG001|NOT COMPLETED|Overall Study||55
9943505|NCT01367704|11062107|FG000|STARTED|Overall Study||998
9943506|NCT01367704|11062108|FG001|STARTED|Overall Study||1008
9943507|NCT01367704|11062107|FG000|COMPLETED|Overall Study||951
9943508|NCT01367704|11062108|FG001|COMPLETED|Overall Study||847
9943509|NCT01367704|11062107|FG000|NOT COMPLETED|Overall Study||47
9943510|NCT01367704|11062108|FG001|NOT COMPLETED|Overall Study||161
9943511|NCT01367834|11062116|FG000|STARTED|Overall Study||11
9943512|NCT01367834|11062117|FG001|STARTED|Overall Study||6
9943513|NCT01367834|11062116|FG000|COMPLETED|Overall Study||9
9943514|NCT01367834|11062117|FG001|COMPLETED|Overall Study||3
9943515|NCT01367834|11062116|FG000|NOT COMPLETED|Overall Study||2
9943516|NCT01367834|11062117|FG001|NOT COMPLETED|Overall Study||3
9943517|NCT01367847|11062125|FG000|STARTED|Overall Study||10
9943518|NCT01367847|11062126|FG001|STARTED|Overall Study||9
9943519|NCT01367847|11062125|FG000|COMPLETED|Overall Study||8
9943520|NCT01367847|11062126|FG001|COMPLETED|Overall Study||7
9943521|NCT01367847|11062125|FG000|NOT COMPLETED|Overall Study||2
9943522|NCT01367847|11062126|FG001|NOT COMPLETED|Overall Study||2
9943523|NCT01367860|11062135|FG000|STARTED|Overall Study||20
9943524|NCT01367860|11062136|FG001|STARTED|Overall Study||20
9943525|NCT01367860|11062135|FG000|COMPLETED|Overall Study||20
9943526|NCT01367860|11062136|FG001|COMPLETED|Overall Study||20
9943527|NCT01367860|11062135|FG000|NOT COMPLETED|Overall Study||0
9943528|NCT01367860|11062136|FG001|NOT COMPLETED|Overall Study||0
9943529|NCT01367886|11062142|FG000|STARTED|Overall Study||21
9943530|NCT01367886|11062142|FG000|COMPLETED|Overall Study||14
9943531|NCT01367886|11062142|FG000|NOT COMPLETED|Overall Study||7
9943532|NCT01368042|11062147|FG000|STARTED|Overall Study||265
9943533|NCT01368042|11062147|FG000|COMPLETED|Overall Study||235
9943534|NCT01368042|11062147|FG000|NOT COMPLETED|Overall Study||30
9943535|NCT01368081|11062164|FG000|STARTED|Overall Study||136
9943536|NCT01368081|11062165|FG001|STARTED|Overall Study||137
9943537|NCT01368081|11062166|FG002|STARTED|Overall Study||63
9943538|NCT01368081|11062167|FG003|STARTED|Overall Study||68
9943539|NCT01368081|11062168|FG004|STARTED|Overall Study||65
9943540|NCT01368081|11062169|FG005|STARTED|Overall Study||137
9943541|NCT01368081|11062170|FG006|STARTED|Overall Study||136
9943542|NCT01368081|11062171|FG007|STARTED|Overall Study||69
9943543|NCT01368081|11062172|FG008|STARTED|Overall Study||70
9943544|NCT01368081|11062173|FG009|STARTED|Overall Study||68
9943545|NCT01368081|11062174|FG010|STARTED|Overall Study||71
9943546|NCT01368081|11062175|FG011|STARTED|Overall Study||70
9943547|NCT01368081|11062176|FG012|STARTED|Overall Study||70
9943548|NCT01368081|11062164|FG000|COMPLETED|Overall Study||126
9943549|NCT01368081|11062165|FG001|COMPLETED|Overall Study||128
9943550|NCT01368081|11062166|FG002|COMPLETED|Overall Study||59
9943551|NCT01368081|11062167|FG003|COMPLETED|Overall Study||63
9943552|NCT01368081|11062168|FG004|COMPLETED|Overall Study||63
9943553|NCT01368081|11062169|FG005|COMPLETED|Overall Study||127
9943554|NCT01368081|11062170|FG006|COMPLETED|Overall Study||124
9943555|NCT01368081|11062171|FG007|COMPLETED|Overall Study||62
9943556|NCT01368081|11062172|FG008|COMPLETED|Overall Study||62
9943557|NCT01368081|11062173|FG009|COMPLETED|Overall Study||58
9943558|NCT01368081|11062174|FG010|COMPLETED|Overall Study||62
9943559|NCT01368081|11062175|FG011|COMPLETED|Overall Study||67
9943560|NCT01368081|11062176|FG012|COMPLETED|Overall Study||63
9943561|NCT01368081|11062164|FG000|NOT COMPLETED|Overall Study||10
9943562|NCT01368081|11062165|FG001|NOT COMPLETED|Overall Study||9
9943563|NCT01368081|11062166|FG002|NOT COMPLETED|Overall Study||4
9943564|NCT01368081|11062167|FG003|NOT COMPLETED|Overall Study||5
9943565|NCT01368081|11062168|FG004|NOT COMPLETED|Overall Study||2
9943566|NCT01368081|11062169|FG005|NOT COMPLETED|Overall Study||10
9943567|NCT01368081|11062170|FG006|NOT COMPLETED|Overall Study||12
9943568|NCT01368081|11062171|FG007|NOT COMPLETED|Overall Study||7
9943569|NCT01368081|11062172|FG008|NOT COMPLETED|Overall Study||8
9943570|NCT01368081|11062173|FG009|NOT COMPLETED|Overall Study||10
9943571|NCT01368081|11062174|FG010|NOT COMPLETED|Overall Study||9
9943572|NCT01368081|11062175|FG011|NOT COMPLETED|Overall Study||3
9943573|NCT01368081|11062176|FG012|NOT COMPLETED|Overall Study||7
9943574|NCT01368211|11062206|FG000|STARTED|First Platelets Transfusion||8
9943575|NCT01368211|11062207|FG001|STARTED|First Platelets Transfusion||7
9943576|NCT01368211|11062206|FG000|COMPLETED|First Platelets Transfusion||8
9943577|NCT01368211|11062207|FG001|COMPLETED|First Platelets Transfusion||7
9943578|NCT01368211|11062206|FG000|NOT COMPLETED|First Platelets Transfusion||0
9943579|NCT01368211|11062207|FG001|NOT COMPLETED|First Platelets Transfusion||0
9943580|NCT01368211|11062206|FG000|STARTED|Second Platelets Transfusion||8
9943581|NCT01368211|11062207|FG001|STARTED|Second Platelets Transfusion||7
9943582|NCT01368211|11062206|FG000|COMPLETED|Second Platelets Transfusion||7
9943583|NCT01368211|11062207|FG001|COMPLETED|Second Platelets Transfusion||5
9943584|NCT01368211|11062206|FG000|NOT COMPLETED|Second Platelets Transfusion||1
9943585|NCT01368211|11062207|FG001|NOT COMPLETED|Second Platelets Transfusion||2
9943586|NCT01368263|11062216|FG000|STARTED|Overall Study||6
9943587|NCT01368263|11062217|FG001|STARTED|Overall Study||1
9943588|NCT01368263|11062218|FG002|STARTED|Overall Study||1
9943589|NCT01368263|11062216|FG000|COMPLETED|Overall Study||6
9943590|NCT01368263|11062217|FG001|COMPLETED|Overall Study||1
9943591|NCT01368263|11062218|FG002|COMPLETED|Overall Study||1
9943592|NCT01368263|11062216|FG000|NOT COMPLETED|Overall Study||0
9943593|NCT01368263|11062217|FG001|NOT COMPLETED|Overall Study||0
9943594|NCT01368263|11062218|FG002|NOT COMPLETED|Overall Study||0
9943595|NCT01368276|11062228|FG000|STARTED|Overall Study||3
9943596|NCT01368276|11062229|FG001|STARTED|Overall Study||28
9943597|NCT01368276|11062228|FG000|COMPLETED|Overall Study||2
9943598|NCT01368276|11062229|FG001|COMPLETED|Overall Study||18
9943599|NCT01368276|11062228|FG000|NOT COMPLETED|Overall Study||1
9943600|NCT01368276|11062229|FG001|NOT COMPLETED|Overall Study||10
9943601|NCT01368406|11062237|FG000|STARTED|Overall Study||81
9943602|NCT01368406|11062238|FG001|STARTED|Overall Study||79
9943603|NCT01368406|11062237|FG000|COMPLETED|Overall Study||60
9943604|NCT01368406|11062238|FG001|COMPLETED|Overall Study||66
9943605|NCT01368406|11062237|FG000|NOT COMPLETED|Overall Study||21
9943606|NCT01368406|11062238|FG001|NOT COMPLETED|Overall Study||13
9943607|NCT01368432|11062246|FG000|STARTED|Overall Study||6
9943608|NCT01368432|11062247|FG001|STARTED|Overall Study||8
9943609|NCT01368432|11062246|FG000|COMPLETED|Overall Study||6
9943610|NCT01368432|11062247|FG001|COMPLETED|Overall Study||7
9943611|NCT01368432|11062246|FG000|NOT COMPLETED|Overall Study||0
9943612|NCT01368432|11062247|FG001|NOT COMPLETED|Overall Study||1
9943613|NCT01368536|11062270|FG000|STARTED|Overall Study||138
9943614|NCT01368536|11062271|FG001|STARTED|Overall Study||137
9943615|NCT01368536|11062272|FG002|STARTED|Overall Study||142
9943616|NCT01368536|11062270|FG000|Full Analysis Set|Overall Study||138
9943617|NCT01368536|11062271|FG001|Full Analysis Set|Overall Study||137
9943618|NCT01368536|11062272|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
9943619|NCT01368536|11062270|FG000|COMPLETED|Overall Study||87
9943620|NCT01368536|11062271|FG001|COMPLETED|Overall Study||78
9943621|NCT01368536|11062272|FG002|COMPLETED|Overall Study||83
9943622|NCT01368536|11062270|FG000|NOT COMPLETED|Overall Study||51
9943623|NCT01368536|11062271|FG001|NOT COMPLETED|Overall Study||59
9943624|NCT01368536|11062272|FG002|NOT COMPLETED|Overall Study||59
9943625|NCT01368562|11062281|FG000|STARTED|Overall Study||26
9943626|NCT01368562|11062281|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
9943627|NCT01368562|11062281|FG000|COMPLETED|Overall Study||7
9943628|NCT01368562|11062281|FG000|NOT COMPLETED|Overall Study||19
9943629|NCT01368614|11062285|FG000|STARTED|Screening Period||90
9943630|NCT01368614|11062286|FG001|STARTED|Screening Period||0
9943631|NCT01368614|11062287|FG002|STARTED|Screening Period||0
9943632|NCT01368614|11062288|FG003|STARTED|Screening Period||0
9943633|NCT01368614|11062285|FG000|COMPLETED|Screening Period||32
9943634|NCT01368614|11062286|FG001|COMPLETED|Screening Period||0
9943635|NCT01368614|11062287|FG002|COMPLETED|Screening Period||0
9943636|NCT01368614|11062288|FG003|COMPLETED|Screening Period||0
9943637|NCT01368614|11062285|FG000|NOT COMPLETED|Screening Period||58
9943638|NCT01368614|11062286|FG001|NOT COMPLETED|Screening Period||0
9943639|NCT01368614|11062287|FG002|NOT COMPLETED|Screening Period||0
9943640|NCT01368614|11062288|FG003|NOT COMPLETED|Screening Period||0
9943641|NCT01368614|11062285|FG000|STARTED|Study Period||0
9943642|NCT01368614|11062286|FG001|STARTED|Study Period||11
9943643|NCT01368614|11062287|FG002|STARTED|Study Period||10
9943644|NCT01368614|11062288|FG003|STARTED|Study Period||11
9943645|NCT01368614|11062285|FG000|COMPLETED|Study Period||0
9943646|NCT01368614|11062286|FG001|COMPLETED|Study Period||10
9943647|NCT01368614|11062287|FG002|COMPLETED|Study Period||8
9943648|NCT01368614|11062288|FG003|COMPLETED|Study Period||8
9943649|NCT01368614|11062285|FG000|NOT COMPLETED|Study Period||0
9943650|NCT01368614|11062286|FG001|NOT COMPLETED|Study Period||1
9943651|NCT01368614|11062287|FG002|NOT COMPLETED|Study Period||2
9943652|NCT01368614|11062288|FG003|NOT COMPLETED|Study Period||3
9943653|NCT01368653|11062298|FG000|STARTED|Overall Study||47
9943654|NCT01368653|11062299|FG001|STARTED|Overall Study||46
9943655|NCT01368653|11062298|FG000|Completed 4-week Follow-up|Overall Study||44
9943656|NCT01368653|11062299|FG001|Completed 4-week Follow-up|Overall Study||37
9943657|NCT01368653|11062298|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
9943658|NCT01368653|11062299|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
9943659|NCT01368653|11062298|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
9943660|NCT01368653|11062299|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
9943661|NCT01368653|11062298|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
9943662|NCT01368653|11062299|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
9943663|NCT01368653|11062298|FG000|Randomized to Advice Only in Phase 2|Overall Study||10
9943664|NCT01368653|11062299|FG001|Randomized to Advice Only in Phase 2|Overall Study||10
9943665|NCT01368653|11062298|FG000|COMPLETED|Overall Study||41
9943666|NCT01368653|11062299|FG001|COMPLETED|Overall Study||37
9943667|NCT01368653|11062298|FG000|NOT COMPLETED|Overall Study||6
9943668|NCT01368653|11062299|FG001|NOT COMPLETED|Overall Study||9
9943669|NCT01368809|11062314|FG000|STARTED|Overall Study||50
9943670|NCT01368809|11062315|FG001|STARTED|Overall Study||50
9943671|NCT01368809|11062314|FG000|COMPLETED|Overall Study||50
9943672|NCT01368809|11062315|FG001|COMPLETED|Overall Study||50
9943673|NCT01368809|11062314|FG000|NOT COMPLETED|Overall Study||0
9943674|NCT01368809|11062315|FG001|NOT COMPLETED|Overall Study||0
9956766|NCT01448057|11076053|FG001|NOT COMPLETED|Overall Study||4
9956767|NCT01448213|11076061|FG000|STARTED|Overall Study||130
9956768|NCT01448213|11076062|FG001|STARTED|Overall Study||134
9943675|NCT01368835|11062323|FG000|STARTED|Overall Study|103 Subjects Enrolled|103
9943676|NCT01368835|11062323|FG000|COMPLETED|Overall Study||70
9943677|NCT01368835|11062323|FG000|NOT COMPLETED|Overall Study||33
9943678|NCT01368874|11062331|FG000|STARTED|Overall Study||34
9943679|NCT01368874|11062332|FG001|STARTED|Overall Study||5
9943680|NCT01368874|11062333|FG002|STARTED|Overall Study||25
9943681|NCT01368874|11062331|FG000|COMPLETED|Overall Study||31
9943682|NCT01368874|11062332|FG001|COMPLETED|Overall Study||5
9943683|NCT01368874|11062333|FG002|COMPLETED|Overall Study||24
9943684|NCT01368874|11062331|FG000|NOT COMPLETED|Overall Study||3
9943685|NCT01368874|11062332|FG001|NOT COMPLETED|Overall Study||0
9943686|NCT01368874|11062333|FG002|NOT COMPLETED|Overall Study||1
9943687|NCT01368900|11062375|FG000|STARTED|Overall Study||68
9943688|NCT01368900|11062375|FG000|COMPLETED|Overall Study||61
9943689|NCT01368900|11062375|FG000|NOT COMPLETED|Overall Study||7
9943690|NCT01368965|11062381|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
9943691|NCT01368965|11062381|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2
9943692|NCT01368965|11062381|FG000|COMPLETED|Overall Study||40
9943693|NCT01368965|11062381|FG000|NOT COMPLETED|Overall Study||12
9943694|NCT01369030|11062387|FG000|STARTED|Overall Study||594
9943695|NCT01369030|11062387|FG000|COMPLETED|Overall Study||554
9943696|NCT01369030|11062387|FG000|NOT COMPLETED|Overall Study||40
9943697|NCT01369069|11062393|FG000|STARTED|Overall Study||581
9943698|NCT01369069|11062394|FG001|STARTED|Overall Study||570
9943699|NCT01369069|11062393|FG000|COMPLETED|Overall Study||564
9943700|NCT01369069|11062394|FG001|COMPLETED|Overall Study||554
9943701|NCT01369069|11062393|FG000|NOT COMPLETED|Overall Study||17
9943702|NCT01369069|11062394|FG001|NOT COMPLETED|Overall Study||16
9943703|NCT01369108|11062400|FG000|STARTED|Overall Study|120 teeth|60
9943704|NCT01369108|11062400|FG000|COMPLETED|Overall Study||49
9943705|NCT01369108|11062400|FG000|NOT COMPLETED|Overall Study||11
9943706|NCT01369225|11062411|FG000|STARTED|Overall Study||6
9943707|NCT01369225|11062412|FG001|STARTED|Overall Study||3
9943708|NCT01369225|11062413|FG002|STARTED|Overall Study||12
9943709|NCT01369225|11062414|FG003|STARTED|Overall Study||10
9943710|NCT01369225|11062415|FG004|STARTED|Overall Study||12
9943711|NCT01369225|11062416|FG005|STARTED|Overall Study||9
9943712|NCT01369225|11062411|FG000|COMPLETED|Overall Study||4
9943713|NCT01369225|11062412|FG001|COMPLETED|Overall Study||3
9943714|NCT01369225|11062413|FG002|COMPLETED|Overall Study||9
9943715|NCT01369225|11062414|FG003|COMPLETED|Overall Study||8
9943716|NCT01369225|11062415|FG004|COMPLETED|Overall Study||10
9943717|NCT01369225|11062416|FG005|COMPLETED|Overall Study||9
9943718|NCT01369225|11062411|FG000|NOT COMPLETED|Overall Study||2
9943719|NCT01369225|11062412|FG001|NOT COMPLETED|Overall Study||0
9943720|NCT01369225|11062413|FG002|NOT COMPLETED|Overall Study||3
10207363|NCT03526861|11334163|FG008|COMPLETED|Maintenance Treatment Period||0
10207364|NCT03526861|11334155|FG000|NOT COMPLETED|Maintenance Treatment Period||0
10207365|NCT03526861|11334156|FG001|NOT COMPLETED|Maintenance Treatment Period||0
10207366|NCT03526861|11334157|FG002|NOT COMPLETED|Maintenance Treatment Period||0
10207367|NCT03526861|11334158|FG003|NOT COMPLETED|Maintenance Treatment Period||8
10207368|NCT03526861|11334159|FG004|NOT COMPLETED|Maintenance Treatment Period||6
9943721|NCT01369225|11062414|FG003|NOT COMPLETED|Overall Study||2
9943722|NCT01369225|11062415|FG004|NOT COMPLETED|Overall Study||2
9943723|NCT01369225|11062416|FG005|NOT COMPLETED|Overall Study||0
9943724|NCT01369329|11062433|FG000|STARTED|Overall Study||256
9943725|NCT01369329|11062434|FG001|STARTED|Overall Study||254
9943726|NCT01369329|11062435|FG002|STARTED|Overall Study||259
9943727|NCT01369329|11062433|FG000|COMPLETED|Overall Study||244
9943728|NCT01369329|11062434|FG001|COMPLETED|Overall Study||243
9943729|NCT01369329|11062435|FG002|COMPLETED|Overall Study||245
9943730|NCT01369329|11062433|FG000|NOT COMPLETED|Overall Study||12
9943731|NCT01369329|11062434|FG001|NOT COMPLETED|Overall Study||11
9943732|NCT01369329|11062435|FG002|NOT COMPLETED|Overall Study||14
9943733|NCT01369342|11062446|FG000|STARTED|Overall Study||214
9943734|NCT01369342|11062447|FG001|STARTED|Overall Study||213
9943735|NCT01369342|11062448|FG002|STARTED|Overall Study||213
9943736|NCT01369342|11062446|FG000|COMPLETED|Overall Study||201
9943737|NCT01369342|11062447|FG001|COMPLETED|Overall Study||204
9943738|NCT01369342|11062448|FG002|COMPLETED|Overall Study||210
9943739|NCT01369342|11062446|FG000|NOT COMPLETED|Overall Study||13
10011505|NCT01781208|11134262|FG000|STARTED|Overall Study||62
10011506|NCT01781208|11134262|FG000|Overall Study|Overall Study||62
10011507|NCT01781208|11134262|FG000|COMPLETED|Overall Study||62
10011508|NCT01781208|11134262|FG000|NOT COMPLETED|Overall Study||0
10207369|NCT03526861|11334160|FG005|NOT COMPLETED|Maintenance Treatment Period||4
9943740|NCT01369342|11062447|FG001|NOT COMPLETED|Overall Study||9
9943741|NCT01369342|11062448|FG002|NOT COMPLETED|Overall Study||3
9943742|NCT01369355|11062462|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133
9943743|NCT01369355|11062463|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132
9943744|NCT01369355|11062464|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132
9943745|NCT01369355|11062465|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123
10011509|NCT01781234|11134269|FG000|STARTED|Overall Study||27
10011510|NCT01781234|11134270|FG001|STARTED|Overall Study||24
9943746|NCT01369355|11062466|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285
9943747|NCT01369355|11062467|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476
9943748|NCT01369355|11062468|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0
9943749|NCT01369355|11062469|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0
10011511|NCT01781234|11134269|FG000|COMPLETED|Overall Study||18
9943750|NCT01369355|11062470|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0
9943751|NCT01369355|11062462|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102
9943752|NCT01369355|11062463|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103
9943753|NCT01369355|11062464|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101
9943754|NCT01369355|11062465|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93
9943755|NCT01369355|11062466|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131
9943756|NCT01369355|11062467|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204
9943757|NCT01369355|11062468|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0
9943758|NCT01369355|11062469|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0
9943759|NCT01369355|11062470|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0
9943760|NCT01369355|11062462|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
9943761|NCT01369355|11062463|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
9943762|NCT01369355|11062464|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
9943763|NCT01369355|11062465|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
9943764|NCT01369355|11062466|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
9943765|NCT01369355|11062467|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
9943766|NCT01369355|11062468|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
9943767|NCT01369355|11062469|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
9943768|NCT01369355|11062470|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
9943769|NCT01369355|11062462|FG000|STARTED|Long-term Extension (Week 44-272)||0
9943770|NCT01369355|11062463|FG001|STARTED|Long-term Extension (Week 44-272)||0
9943771|NCT01369355|11062464|FG002|STARTED|Long-term Extension (Week 44-272)||0
9943772|NCT01369355|11062465|FG003|STARTED|Long-term Extension (Week 44-272)||0
9943773|NCT01369355|11062466|FG004|STARTED|Long-term Extension (Week 44-272)||0
9943774|NCT01369355|11062467|FG005|STARTED|Long-term Extension (Week 44-272)||0
9943775|NCT01369355|11062468|FG006|STARTED|Long-term Extension (Week 44-272)||151
9943776|NCT01369355|11062469|FG007|STARTED|Long-term Extension (Week 44-272)||213
9943777|NCT01369355|11062470|FG008|STARTED|Long-term Extension (Week 44-272)||354
9943778|NCT01369355|11062462|FG000|COMPLETED|Long-term Extension (Week 44-272)||0
9943779|NCT01369355|11062463|FG001|COMPLETED|Long-term Extension (Week 44-272)||0
9943780|NCT01369355|11062464|FG002|COMPLETED|Long-term Extension (Week 44-272)||0
9943781|NCT01369355|11062465|FG003|COMPLETED|Long-term Extension (Week 44-272)||0
9943782|NCT01369355|11062466|FG004|COMPLETED|Long-term Extension (Week 44-272)||0
9943783|NCT01369355|11062467|FG005|COMPLETED|Long-term Extension (Week 44-272)||0
9943784|NCT01369355|11062468|FG006|COMPLETED|Long-term Extension (Week 44-272)||0
9943785|NCT01369355|11062469|FG007|COMPLETED|Long-term Extension (Week 44-272)||107
9943786|NCT01369355|11062470|FG008|COMPLETED|Long-term Extension (Week 44-272)||183
9943787|NCT01369355|11062462|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0
9943788|NCT01369355|11062463|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0
9943789|NCT01369355|11062464|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0
9943790|NCT01369355|11062465|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0
9943791|NCT01369355|11062466|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0
9943792|NCT01369355|11062467|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0
9943793|NCT01369355|11062468|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151
9943794|NCT01369355|11062469|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106
9943795|NCT01369355|11062470|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171
9943796|NCT01369433|11062489|FG000|STARTED|Overall Study||209
9943797|NCT01369433|11062490|FG001|STARTED|Overall Study||16
9943798|NCT01369433|11062489|FG000|COMPLETED|Overall Study||0
9943799|NCT01369433|11062490|FG001|COMPLETED|Overall Study||0
9943800|NCT01369433|11062489|FG000|NOT COMPLETED|Overall Study||209
9943801|NCT01369433|11062490|FG001|NOT COMPLETED|Overall Study||16
9943802|NCT01369485|11062498|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80
9943803|NCT01369485|11062499|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83
9943804|NCT01369485|11062498|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
9943805|NCT01369485|11062499|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
9943806|NCT01369485|11062498|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
9943807|NCT01369485|11062499|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
10011512|NCT01781234|11134270|FG001|COMPLETED|Overall Study||21
10011513|NCT01781234|11134269|FG000|NOT COMPLETED|Overall Study||9
10011514|NCT01781234|11134270|FG001|NOT COMPLETED|Overall Study||3
10011515|NCT01781286|11134278|FG000|STARTED|Overall Study||7
10011516|NCT01781286|11134279|FG001|STARTED|Overall Study||4
10207370|NCT03526861|11334161|FG006|NOT COMPLETED|Maintenance Treatment Period||6
10207371|NCT03526861|11334162|FG007|NOT COMPLETED|Maintenance Treatment Period||2
10207372|NCT03526861|11334163|FG008|NOT COMPLETED|Maintenance Treatment Period||0
10207373|NCT03526861|11334155|FG000|STARTED|Open-label Treatment Period||0
10207374|NCT03526861|11334156|FG001|STARTED|Open-label Treatment Period||0
10207375|NCT03526861|11334157|FG002|STARTED|Open-label Treatment Period||0
10207376|NCT03526861|11334158|FG003|STARTED|Open-label Treatment Period||0
10207377|NCT03526861|11334159|FG004|STARTED|Open-label Treatment Period||0
9760648|NCT00382590|10864410|FG001|STARTED|Overall Study||6
9760649|NCT00382590|10864409|FG000|COMPLETED|Overall Study||4
9760650|NCT00382590|10864410|FG001|COMPLETED|Overall Study||6
9760651|NCT00382590|10864409|FG000|NOT COMPLETED|Overall Study||0
9760652|NCT00382590|10864410|FG001|NOT COMPLETED|Overall Study||0
9760653|NCT00382720|10864419|FG000|STARTED|Overall Study||79
10207378|NCT03526861|11334160|FG005|STARTED|Open-label Treatment Period||0
10207379|NCT03526861|11334161|FG006|STARTED|Open-label Treatment Period||0
9760654|NCT00382720|10864420|FG001|STARTED|Overall Study||89
9943808|NCT01369485|11062498|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57
9943809|NCT01369485|11062499|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66
9943810|NCT01369485|11062498|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
9943811|NCT01369485|11062499|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
9943812|NCT01369485|11062498|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
9943813|NCT01369485|11062499|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
9943814|NCT01369498|11062517|FG000|STARTED|Overall Study||12
9943815|NCT01369498|11062518|FG001|STARTED|Overall Study||12
9943816|NCT01369498|11062519|FG002|STARTED|Overall Study||15
9943817|NCT01369498|11062520|FG003|STARTED|Overall Study||15
9943818|NCT01369498|11062517|FG000|COMPLETED|Overall Study||0
9943819|NCT01369498|11062518|FG001|COMPLETED|Overall Study||0
9943820|NCT01369498|11062519|FG002|COMPLETED|Overall Study||0
9943821|NCT01369498|11062520|FG003|COMPLETED|Overall Study||0
9943822|NCT01369498|11062517|FG000|NOT COMPLETED|Overall Study||12
9943823|NCT01369498|11062518|FG001|NOT COMPLETED|Overall Study||12
9943824|NCT01369498|11062519|FG002|NOT COMPLETED|Overall Study||15
9943825|NCT01369498|11062520|FG003|NOT COMPLETED|Overall Study||15
9943826|NCT01369511|11062535|FG000|STARTED|Overall Study||98
9943827|NCT01369511|11062536|FG001|STARTED|Overall Study||104
9943828|NCT01369511|11062537|FG002|STARTED|Overall Study||98
9943829|NCT01369511|11062538|FG003|STARTED|Overall Study||100
9943830|NCT01369511|11062535|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98
9943831|NCT01369511|11062536|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
9943832|NCT01369511|11062537|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98
9943833|NCT01369511|11062538|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100
9943834|NCT01369511|11062535|FG000|COMPLETED|Overall Study||85
9943835|NCT01369511|11062536|FG001|COMPLETED|Overall Study||91
9943836|NCT01369511|11062537|FG002|COMPLETED|Overall Study||87
9943837|NCT01369511|11062538|FG003|COMPLETED|Overall Study||89
9943838|NCT01369511|11062535|FG000|NOT COMPLETED|Overall Study||13
9943839|NCT01369511|11062536|FG001|NOT COMPLETED|Overall Study||13
9943840|NCT01369511|11062537|FG002|NOT COMPLETED|Overall Study||11
9943841|NCT01369511|11062538|FG003|NOT COMPLETED|Overall Study||11
9943842|NCT01369615|11062550|FG000|STARTED|Overall Study||9
9943843|NCT01369615|11062551|FG001|STARTED|Overall Study||14
9943844|NCT01369615|11062550|FG000|COMPLETED|Overall Study||9
9943845|NCT01369615|11062551|FG001|COMPLETED|Overall Study||12
9943846|NCT01369615|11062550|FG000|NOT COMPLETED|Overall Study||0
9943847|NCT01369615|11062551|FG001|NOT COMPLETED|Overall Study||2
9943848|NCT01369680|11062561|FG000|STARTED|Overall Study||3
9943849|NCT01369680|11062562|FG001|STARTED|Overall Study||3
9943850|NCT01369680|11062563|FG002|STARTED|Overall Study||3
9943851|NCT01369680|11062564|FG003|STARTED|Overall Study||3
9943852|NCT01369680|11062561|FG000|COMPLETED|Overall Study||3
9943853|NCT01369680|11062562|FG001|COMPLETED|Overall Study||3
9943854|NCT01369680|11062563|FG002|COMPLETED|Overall Study||2
9943855|NCT01369680|11062564|FG003|COMPLETED|Overall Study||1
9943856|NCT01369680|11062561|FG000|NOT COMPLETED|Overall Study||0
9943857|NCT01369680|11062562|FG001|NOT COMPLETED|Overall Study||0
9943858|NCT01369680|11062563|FG002|NOT COMPLETED|Overall Study||1
9943859|NCT01369680|11062564|FG003|NOT COMPLETED|Overall Study||2
9943860|NCT01369706|11062585|FG000|STARTED|Overall Study||388
9943861|NCT01369706|11062585|FG000|COMPLETED|Overall Study||388
9943862|NCT01369706|11062585|FG000|NOT COMPLETED|Overall Study||0
9943863|NCT01369732|11062591|FG000|STARTED|Overall Study||33
9943864|NCT01369732|11062592|FG001|STARTED|Overall Study||33
9943865|NCT01369732|11062591|FG000|COMPLETED|Overall Study||29
9943866|NCT01369732|11062592|FG001|COMPLETED|Overall Study||31
9943867|NCT01369732|11062591|FG000|NOT COMPLETED|Overall Study||4
9943868|NCT01369732|11062592|FG001|NOT COMPLETED|Overall Study||2
9943869|NCT01369745|11062603|FG000|STARTED|Overall Study||32
9943870|NCT01369745|11062604|FG001|STARTED|Overall Study||41
9943871|NCT01369745|11062605|FG002|STARTED|Overall Study||18
9943872|NCT01369745|11062606|FG003|STARTED|Overall Study||84
9943873|NCT01369745|11062607|FG004|STARTED|Overall Study||83
9943874|NCT01369745|11062603|FG000|COMPLETED|Overall Study||25
9943875|NCT01369745|11062604|FG001|COMPLETED|Overall Study||28
9943876|NCT01369745|11062605|FG002|COMPLETED|Overall Study||16
9943877|NCT01369745|11062606|FG003|COMPLETED|Overall Study||64
9943878|NCT01369745|11062607|FG004|COMPLETED|Overall Study||65
9943879|NCT01369745|11062603|FG000|NOT COMPLETED|Overall Study||7
9943880|NCT01369745|11062604|FG001|NOT COMPLETED|Overall Study||13
9943881|NCT01369745|11062605|FG002|NOT COMPLETED|Overall Study||2
9943882|NCT01369745|11062606|FG003|NOT COMPLETED|Overall Study||20
9943883|NCT01369745|11062607|FG004|NOT COMPLETED|Overall Study||18
9943884|NCT01369758|11062619|FG000|STARTED|Overall Study||290
9943885|NCT01369758|11062619|FG000|COMPLETED|Overall Study||290
9943886|NCT01369758|11062619|FG000|NOT COMPLETED|Overall Study||0
9943887|NCT01369784|11062623|FG000|STARTED|Overall Study||158
9943888|NCT01369784|11062623|FG000|COMPLETED|Overall Study||146
9943889|NCT01369784|11062623|FG000|NOT COMPLETED|Overall Study||12
9943890|NCT01369849|11062630|FG000|STARTED|Overall Study||6
9943891|NCT01369849|11062631|FG001|STARTED|Overall Study||4
9943892|NCT01369849|11062632|FG002|STARTED|Overall Study||5
9943893|NCT01369849|11062630|FG000|COMPLETED|Overall Study||6
9943894|NCT01369849|11062631|FG001|COMPLETED|Overall Study||3
9943895|NCT01369849|11062632|FG002|COMPLETED|Overall Study||4
9943896|NCT01369849|11062630|FG000|NOT COMPLETED|Overall Study||0
9943897|NCT01369849|11062631|FG001|NOT COMPLETED|Overall Study||1
9943898|NCT01369849|11062632|FG002|NOT COMPLETED|Overall Study||1
9943899|NCT01369875|11062644|FG000|STARTED|Overall Study||1
9943900|NCT01369875|11062645|FG001|STARTED|Overall Study||1
9943901|NCT01369875|11062644|FG000|COMPLETED|Overall Study||1
9943902|NCT01369875|11062645|FG001|COMPLETED|Overall Study||1
9943903|NCT01369875|11062644|FG000|NOT COMPLETED|Overall Study||0
9943904|NCT01369875|11062645|FG001|NOT COMPLETED|Overall Study||0
9943905|NCT01369888|11062655|FG000|STARTED|Overall Study||1
9943906|NCT01369888|11062656|FG001|STARTED|Overall Study||2
9943907|NCT01369888|11062657|FG002|STARTED|Overall Study||0
9943908|NCT01369888|11062658|FG003|STARTED|Overall Study||0
9943909|NCT01369888|11062655|FG000|COMPLETED|Overall Study||1
9943910|NCT01369888|11062656|FG001|COMPLETED|Overall Study||2
9943911|NCT01369888|11062657|FG002|COMPLETED|Overall Study||0
9943912|NCT01369888|11062658|FG003|COMPLETED|Overall Study||0
9943913|NCT01369888|11062655|FG000|NOT COMPLETED|Overall Study||0
9943914|NCT01369888|11062656|FG001|NOT COMPLETED|Overall Study||0
9943915|NCT01369888|11062657|FG002|NOT COMPLETED|Overall Study||0
9943916|NCT01369888|11062658|FG003|NOT COMPLETED|Overall Study||0
9943917|NCT01370005|11062667|FG000|STARTED|Overall Study||272
9943918|NCT01370005|11062668|FG001|STARTED|Overall Study||276
9943919|NCT01370005|11062669|FG002|STARTED|Overall Study||277
9943920|NCT01370005|11062667|FG000|COMPLETED|Overall Study||256
9943921|NCT01370005|11062668|FG001|COMPLETED|Overall Study||265
9943922|NCT01370005|11062669|FG002|COMPLETED|Overall Study||266
9943923|NCT01370005|11062667|FG000|NOT COMPLETED|Overall Study||16
9943924|NCT01370005|11062668|FG001|NOT COMPLETED|Overall Study||11
9943925|NCT01370005|11062669|FG002|NOT COMPLETED|Overall Study||11
9943926|NCT01370018|11062677|FG000|STARTED|Overall Study||4
9943927|NCT01370018|11062677|FG000|COMPLETED|Overall Study||3
9943928|NCT01370018|11062677|FG000|NOT COMPLETED|Overall Study||1
9943929|NCT01370083|11062683|FG000|STARTED|Overall Study||7
9943930|NCT01370083|11062684|FG001|STARTED|Overall Study||7
9943931|NCT01370083|11062683|FG000|COMPLETED|Overall Study||5
9943932|NCT01370083|11062684|FG001|COMPLETED|Overall Study||6
9943933|NCT01370083|11062683|FG000|NOT COMPLETED|Overall Study||2
9943934|NCT01370083|11062684|FG001|NOT COMPLETED|Overall Study||1
9943935|NCT01370174|11062694|FG000|STARTED|Overall Study||25
9943936|NCT01370174|11062695|FG001|STARTED|Overall Study||26
9943937|NCT01370174|11062696|FG002|STARTED|Overall Study||25
9943938|NCT01370174|11062697|FG003|STARTED|Overall Study||26
9943939|NCT01370174|11062694|FG000|COMPLETED|Overall Study||18
9943940|NCT01370174|11062695|FG001|COMPLETED|Overall Study||15
9943941|NCT01370174|11062696|FG002|COMPLETED|Overall Study||13
9943942|NCT01370174|11062697|FG003|COMPLETED|Overall Study||17
9943943|NCT01370174|11062694|FG000|NOT COMPLETED|Overall Study||7
9943944|NCT01370174|11062695|FG001|NOT COMPLETED|Overall Study||11
9943945|NCT01370174|11062696|FG002|NOT COMPLETED|Overall Study||12
9943946|NCT01370174|11062697|FG003|NOT COMPLETED|Overall Study||9
9943947|NCT01370213|11062710|FG000|STARTED|Overall Study||7
9943948|NCT01370213|11062711|FG001|STARTED|Overall Study||17
9943949|NCT01370213|11062712|FG002|STARTED|Overall Study||1
9943950|NCT01370213|11062710|FG000|COMPLETED|Overall Study||6
9943951|NCT01370213|11062711|FG001|COMPLETED|Overall Study||15
9943952|NCT01370213|11062712|FG002|COMPLETED|Overall Study||1
9943953|NCT01370213|11062710|FG000|NOT COMPLETED|Overall Study||1
9943954|NCT01370213|11062711|FG001|NOT COMPLETED|Overall Study||2
9943955|NCT01370213|11062712|FG002|NOT COMPLETED|Overall Study||0
9943956|NCT01370265|11062719|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6
9943957|NCT01370265|11062720|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6
9943958|NCT01370265|11062719|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
9943959|NCT01370265|11062720|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
9943960|NCT01370265|11062719|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
9943961|NCT01370265|11062720|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
9943962|NCT01370265|11062719|FG000|STARTED|Washout Period (50-minute Period Decay)||6
9943963|NCT01370265|11062720|FG001|STARTED|Washout Period (50-minute Period Decay)||6
9943964|NCT01370265|11062719|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6
9943965|NCT01370265|11062720|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6
9943966|NCT01370265|11062719|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
9943967|NCT01370265|11062720|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
9943968|NCT01370265|11062719|FG000|STARTED|First Intervention||6
9943969|NCT01370265|11062720|FG001|STARTED|First Intervention||6
9943970|NCT01370265|11062719|FG000|COMPLETED|First Intervention||5
9943971|NCT01370265|11062720|FG001|COMPLETED|First Intervention||5
9943972|NCT01370265|11062719|FG000|NOT COMPLETED|First Intervention||1
9943973|NCT01370265|11062720|FG001|NOT COMPLETED|First Intervention||1
9943974|NCT01370265|11062719|FG000|STARTED|Washout Period (50-minute Period Decay)||5
9943975|NCT01370265|11062720|FG001|STARTED|Washout Period (50-minute Period Decay)||5
9943976|NCT01370265|11062719|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5
9943977|NCT01370265|11062720|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5
9943978|NCT01370265|11062719|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
9943979|NCT01370265|11062720|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
9943980|NCT01370265|11062719|FG000|STARTED|Second Intervention||5
9943981|NCT01370265|11062720|FG001|STARTED|Second Intervention||5
9943982|NCT01370265|11062719|FG000|COMPLETED|Second Intervention||5
9943983|NCT01370265|11062720|FG001|COMPLETED|Second Intervention||5
9943984|NCT01370265|11062719|FG000|NOT COMPLETED|Second Intervention||0
9943985|NCT01370265|11062720|FG001|NOT COMPLETED|Second Intervention||0
9943986|NCT01370317|11062729|FG000|STARTED|Overall Study||18
9943987|NCT01370317|11062730|FG001|STARTED|Overall Study||9
9943988|NCT01370317|11062729|FG000|COMPLETED|Overall Study||17
9943989|NCT01370317|11062730|FG001|COMPLETED|Overall Study||8
9943990|NCT01370317|11062729|FG000|NOT COMPLETED|Overall Study||1
9943991|NCT01370317|11062730|FG001|NOT COMPLETED|Overall Study||1
9943992|NCT01370356|11062738|FG000|STARTED|Overall Study||751
9943993|NCT01370356|11062739|FG001|STARTED|Overall Study||742
9943994|NCT01370356|11062738|FG000|COMPLETED|Overall Study||559
9943995|NCT01370356|11062739|FG001|COMPLETED|Overall Study||515
9943996|NCT01370356|11062738|FG000|NOT COMPLETED|Overall Study||192
9943997|NCT01370356|11062739|FG001|NOT COMPLETED|Overall Study||227
9943998|NCT01370369|11062745|FG000|STARTED|Overall Study||20
9943999|NCT01370369|11062745|FG000|COMPLETED|Overall Study||20
9944000|NCT01370369|11062745|FG000|NOT COMPLETED|Overall Study||0
9944001|NCT01370408|11062758|FG000|STARTED|Overall Study||85
9944002|NCT01370408|11062758|FG000|COMPLETED|Overall Study||76
9944003|NCT01370408|11062758|FG000|NOT COMPLETED|Overall Study||9
9944004|NCT01370460|11062764|FG000|STARTED|Overall Study||50
9944005|NCT01370460|11062765|FG001|STARTED|Overall Study||51
9944006|NCT01370460|11062764|FG000|COMPLETED|Overall Study||50
9944007|NCT01370460|11062765|FG001|COMPLETED|Overall Study||51
9944008|NCT01370460|11062764|FG000|NOT COMPLETED|Overall Study||0
9944009|NCT01370460|11062765|FG001|NOT COMPLETED|Overall Study||0
9944010|NCT01370499|11062774|FG000|STARTED|Overall Study||195
9944011|NCT01370499|11062775|FG001|STARTED|Overall Study||93
9944012|NCT01370499|11062774|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188
9944013|NCT01370499|11062775|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
9944014|NCT01370499|11062774|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195
9944015|NCT01370499|11062775|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92
9944016|NCT01370499|11062774|FG000|COMPLETED|Overall Study||84
10207380|NCT03526861|11334162|FG007|STARTED|Open-label Treatment Period||0
10207381|NCT03526861|11334163|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242
10207382|NCT03526861|11334155|FG000|COMPLETED|Open-label Treatment Period||0
10207383|NCT03526861|11334156|FG001|COMPLETED|Open-label Treatment Period||0
10207384|NCT03526861|11334157|FG002|COMPLETED|Open-label Treatment Period||0
10207385|NCT03526861|11334158|FG003|COMPLETED|Open-label Treatment Period||0
10207386|NCT03526861|11334159|FG004|COMPLETED|Open-label Treatment Period||0
10207387|NCT03526861|11334160|FG005|COMPLETED|Open-label Treatment Period||0
10207388|NCT03526861|11334161|FG006|COMPLETED|Open-label Treatment Period||0
10207389|NCT03526861|11334162|FG007|COMPLETED|Open-label Treatment Period||0
10207390|NCT03526861|11334163|FG008|COMPLETED|Open-label Treatment Period||214
10207391|NCT03526861|11334155|FG000|NOT COMPLETED|Open-label Treatment Period||0
10207392|NCT03526861|11334156|FG001|NOT COMPLETED|Open-label Treatment Period||0
9944017|NCT01370499|11062775|FG001|COMPLETED|Overall Study||49
9944018|NCT01370499|11062774|FG000|NOT COMPLETED|Overall Study||111
9944019|NCT01370499|11062775|FG001|NOT COMPLETED|Overall Study||44
9944020|NCT01370525|11062785|FG000|STARTED|Overall Study||171
9944021|NCT01370525|11062786|FG001|STARTED|Overall Study||169
9944022|NCT01370525|11062785|FG000|Patients Who Received Treatment|Overall Study||168
9944023|NCT01370525|11062786|FG001|Patients Who Received Treatment|Overall Study||163
9944024|NCT01370525|11062785|FG000|Patients Who Completed Treatment|Overall Study||163
9944025|NCT01370525|11062786|FG001|Patients Who Completed Treatment|Overall Study||158
9944026|NCT01370525|11062785|FG000|COMPLETED|Overall Study||163
9944027|NCT01370525|11062786|FG001|COMPLETED|Overall Study||158
9944028|NCT01370525|11062785|FG000|NOT COMPLETED|Overall Study||8
9944029|NCT01370525|11062786|FG001|NOT COMPLETED|Overall Study||11
9944030|NCT01370538|11062794|FG000|STARTED|Overall Study||170
9944031|NCT01370538|11062795|FG001|STARTED|Overall Study||171
9944032|NCT01370538|11062794|FG000|Patients Who Received Treatment|Overall Study||165
9944033|NCT01370538|11062795|FG001|Patients Who Received Treatment|Overall Study||161
9944034|NCT01370538|11062794|FG000|Patients Who Completed Treatment|Overall Study||151
9944035|NCT01370538|11062795|FG001|Patients Who Completed Treatment|Overall Study||152
9944036|NCT01370538|11062794|FG000|COMPLETED|Overall Study||151
9944037|NCT01370538|11062795|FG001|COMPLETED|Overall Study||152
9944038|NCT01370538|11062794|FG000|NOT COMPLETED|Overall Study||19
9944039|NCT01370538|11062795|FG001|NOT COMPLETED|Overall Study||19
9944040|NCT01370564|11062801|FG000|STARTED|Overall Study||21
9944041|NCT01370564|11062801|FG000|COMPLETED|Overall Study||21
9944042|NCT01370564|11062801|FG000|NOT COMPLETED|Overall Study||0
9944043|NCT01370616|11062807|FG000|STARTED|Overall Study|Participants randomized|282
9944044|NCT01370616|11062808|FG001|STARTED|Overall Study|Participants randomized|283
9944045|NCT01370616|11062807|FG000|Treated|Overall Study||275
9944046|NCT01370616|11062808|FG001|Treated|Overall Study||275
9944047|NCT01370616|11062807|FG000|COMPLETED|Overall Study||220
9944048|NCT01370616|11062808|FG001|COMPLETED|Overall Study||216
9944049|NCT01370616|11062807|FG000|NOT COMPLETED|Overall Study||62
9944050|NCT01370616|11062808|FG001|NOT COMPLETED|Overall Study||67
9944051|NCT01370629|11062814|FG000|STARTED|Overall Study||2015
9944052|NCT01370629|11062814|FG000|COMPLETED|Overall Study||2009
9944053|NCT01370629|11062814|FG000|NOT COMPLETED|Overall Study||6
9944054|NCT01370642|11062821|FG000|STARTED|Overall Study||98
9944055|NCT01370642|11062822|FG001|STARTED|Overall Study||98
9944056|NCT01370642|11062823|FG002|STARTED|Overall Study||98
9944057|NCT01370642|11062821|FG000|FAS Population|Overall Study||98
9944058|NCT01370642|11062822|FG001|FAS Population|Overall Study||97
9944059|NCT01370642|11062823|FG002|FAS Population|Overall Study||98
9944060|NCT01370642|11062821|FG000|COMPLETED|Overall Study||90
9944061|NCT01370642|11062822|FG001|COMPLETED|Overall Study||92
9944062|NCT01370642|11062823|FG002|COMPLETED|Overall Study||69
9944063|NCT01370642|11062821|FG000|NOT COMPLETED|Overall Study||8
9944064|NCT01370642|11062822|FG001|NOT COMPLETED|Overall Study||6
9944065|NCT01370642|11062823|FG002|NOT COMPLETED|Overall Study||29
9944066|NCT01370655|11062843|FG000|STARTED|Period 1||7
9944067|NCT01370655|11062844|FG001|STARTED|Period 1||7
9944068|NCT01370655|11062845|FG002|STARTED|Period 1||3
9944069|NCT01370655|11062846|FG003|STARTED|Period 1||3
9944070|NCT01370655|11062847|FG004|STARTED|Period 1||3
9944071|NCT01370655|11062848|FG005|STARTED|Period 1||4
9944072|NCT01370655|11062849|FG006|STARTED|Period 1||4
9944073|NCT01370655|11062850|FG007|STARTED|Period 1||4
9944074|NCT01370655|11062851|FG008|STARTED|Period 1||3
9944075|NCT01370655|11062852|FG009|STARTED|Period 1||2
9944076|NCT01370655|11062853|FG010|STARTED|Period 1||3
9944077|NCT01370655|11062854|FG011|STARTED|Period 1||3
9944078|NCT01370655|11062843|FG000|COMPLETED|Period 1||5
9944079|NCT01370655|11062844|FG001|COMPLETED|Period 1||7
9944080|NCT01370655|11062845|FG002|COMPLETED|Period 1||3
9944081|NCT01370655|11062846|FG003|COMPLETED|Period 1||3
9944082|NCT01370655|11062847|FG004|COMPLETED|Period 1||3
9944083|NCT01370655|11062848|FG005|COMPLETED|Period 1||4
9944084|NCT01370655|11062849|FG006|COMPLETED|Period 1||3
9944085|NCT01370655|11062850|FG007|COMPLETED|Period 1||4
9944086|NCT01370655|11062851|FG008|COMPLETED|Period 1||3
9944087|NCT01370655|11062852|FG009|COMPLETED|Period 1||2
9944088|NCT01370655|11062853|FG010|COMPLETED|Period 1||3
9944089|NCT01370655|11062854|FG011|COMPLETED|Period 1||3
9944090|NCT01370655|11062843|FG000|NOT COMPLETED|Period 1||2
9944091|NCT01370655|11062844|FG001|NOT COMPLETED|Period 1||0
9944092|NCT01370655|11062845|FG002|NOT COMPLETED|Period 1||0
9944093|NCT01370655|11062846|FG003|NOT COMPLETED|Period 1||0
9944094|NCT01370655|11062847|FG004|NOT COMPLETED|Period 1||0
9944095|NCT01370655|11062848|FG005|NOT COMPLETED|Period 1||0
9944096|NCT01370655|11062849|FG006|NOT COMPLETED|Period 1||1
9944097|NCT01370655|11062850|FG007|NOT COMPLETED|Period 1||0
9944098|NCT01370655|11062851|FG008|NOT COMPLETED|Period 1||0
9944099|NCT01370655|11062852|FG009|NOT COMPLETED|Period 1||0
9944100|NCT01370655|11062853|FG010|NOT COMPLETED|Period 1||0
9944101|NCT01370655|11062854|FG011|NOT COMPLETED|Period 1||0
9944102|NCT01370655|11062843|FG000|STARTED|Period 2||5
9944103|NCT01370655|11062844|FG001|STARTED|Period 2||7
9944104|NCT01370655|11062845|FG002|STARTED|Period 2||3
9944105|NCT01370655|11062846|FG003|STARTED|Period 2||3
9944106|NCT01370655|11062847|FG004|STARTED|Period 2||3
9944107|NCT01370655|11062848|FG005|STARTED|Period 2||4
9944108|NCT01370655|11062849|FG006|STARTED|Period 2||3
9944109|NCT01370655|11062850|FG007|STARTED|Period 2||4
9944110|NCT01370655|11062851|FG008|STARTED|Period 2||3
9944111|NCT01370655|11062852|FG009|STARTED|Period 2||2
9944112|NCT01370655|11062853|FG010|STARTED|Period 2||3
9944113|NCT01370655|11062854|FG011|STARTED|Period 2||3
9944114|NCT01370655|11062843|FG000|COMPLETED|Period 2||5
9944115|NCT01370655|11062844|FG001|COMPLETED|Period 2||7
9944116|NCT01370655|11062845|FG002|COMPLETED|Period 2||1
9944117|NCT01370655|11062846|FG003|COMPLETED|Period 2||3
9944118|NCT01370655|11062847|FG004|COMPLETED|Period 2||2
9944119|NCT01370655|11062848|FG005|COMPLETED|Period 2||4
9944120|NCT01370655|11062849|FG006|COMPLETED|Period 2||2
9944121|NCT01370655|11062850|FG007|COMPLETED|Period 2||3
9944122|NCT01370655|11062851|FG008|COMPLETED|Period 2||1
9944123|NCT01370655|11062852|FG009|COMPLETED|Period 2||2
9944124|NCT01370655|11062853|FG010|COMPLETED|Period 2||2
9944125|NCT01370655|11062854|FG011|COMPLETED|Period 2||3
9944126|NCT01370655|11062843|FG000|NOT COMPLETED|Period 2||0
9944127|NCT01370655|11062844|FG001|NOT COMPLETED|Period 2||0
9944128|NCT01370655|11062845|FG002|NOT COMPLETED|Period 2||2
9944129|NCT01370655|11062846|FG003|NOT COMPLETED|Period 2||0
9944130|NCT01370655|11062847|FG004|NOT COMPLETED|Period 2||1
9944131|NCT01370655|11062848|FG005|NOT COMPLETED|Period 2||0
9944132|NCT01370655|11062849|FG006|NOT COMPLETED|Period 2||1
9944133|NCT01370655|11062850|FG007|NOT COMPLETED|Period 2||1
9944134|NCT01370655|11062851|FG008|NOT COMPLETED|Period 2||2
9944135|NCT01370655|11062852|FG009|NOT COMPLETED|Period 2||0
9944136|NCT01370655|11062853|FG010|NOT COMPLETED|Period 2||1
9944137|NCT01370655|11062854|FG011|NOT COMPLETED|Period 2||0
9944138|NCT01370694|11062864|FG000|STARTED|Overall Study||7
9944139|NCT01370694|11062864|FG000|COMPLETED|Overall Study||1
9944140|NCT01370694|11062864|FG000|NOT COMPLETED|Overall Study||6
9944141|NCT01370733|11062870|FG000|STARTED|Overall Study||103
9944142|NCT01370733|11062871|FG001|STARTED|Overall Study||99
9944143|NCT01370733|11062870|FG000|COMPLETED|Overall Study||86
9944144|NCT01370733|11062871|FG001|COMPLETED|Overall Study||77
9944145|NCT01370733|11062870|FG000|NOT COMPLETED|Overall Study||17
9944146|NCT01370733|11062871|FG001|NOT COMPLETED|Overall Study||22
9944147|NCT01370837|11062880|FG000|STARTED|Overall Study||12
9944148|NCT01370837|11062881|FG001|STARTED|Overall Study||12
9944149|NCT01370837|11062882|FG002|STARTED|Overall Study||17
9944150|NCT01370837|11062880|FG000|COMPLETED|Overall Study||12
9944151|NCT01370837|11062881|FG001|COMPLETED|Overall Study||12
9944152|NCT01370837|11062882|FG002|COMPLETED|Overall Study||17
9944153|NCT01370837|11062880|FG000|NOT COMPLETED|Overall Study||0
9944154|NCT01370837|11062881|FG001|NOT COMPLETED|Overall Study||0
9944155|NCT01370837|11062882|FG002|NOT COMPLETED|Overall Study||0
9944156|NCT01370863|11062892|FG000|STARTED|Overall Study||34
9944157|NCT01370863|11062893|FG001|STARTED|Overall Study||33
9944158|NCT01370863|11062892|FG000|COMPLETED|Overall Study||32
9944159|NCT01370863|11062893|FG001|COMPLETED|Overall Study||30
9944160|NCT01370863|11062892|FG000|NOT COMPLETED|Overall Study||2
9944161|NCT01370863|11062893|FG001|NOT COMPLETED|Overall Study||3
9944162|NCT01371006|11062901|FG000|STARTED|Overall Study||14
9944163|NCT01371006|11062902|FG001|STARTED|Overall Study||15
9944164|NCT01371006|11062901|FG000|COMPLETED|Overall Study||13
9944165|NCT01371006|11062902|FG001|COMPLETED|Overall Study||15
9944166|NCT01371006|11062901|FG000|NOT COMPLETED|Overall Study||1
9944167|NCT01371006|11062902|FG001|NOT COMPLETED|Overall Study||0
9944168|NCT01371032|11062930|FG000|STARTED|Overall Study||14
9944169|NCT01371032|11062931|FG001|STARTED|Overall Study||14
9944170|NCT01371032|11062930|FG000|COMPLETED|Overall Study||14
9944171|NCT01371032|11062931|FG001|COMPLETED|Overall Study||14
9944172|NCT01371032|11062930|FG000|NOT COMPLETED|Overall Study||0
9944173|NCT01371032|11062931|FG001|NOT COMPLETED|Overall Study||0
9944174|NCT01371110|11062941|FG000|STARTED|Overall Study||1
9944175|NCT01371110|11062942|FG001|STARTED|Overall Study||2
9944176|NCT01371110|11062941|FG000|COMPLETED|Overall Study||1
9944177|NCT01371110|11062942|FG001|COMPLETED|Overall Study||2
9944178|NCT01371110|11062941|FG000|NOT COMPLETED|Overall Study||0
9944179|NCT01371110|11062942|FG001|NOT COMPLETED|Overall Study||0
9944180|NCT01371539|11062948|FG000|STARTED|Period One: One Week||53
9944181|NCT01371539|11062949|FG001|STARTED|Period One: One Week||51
9944182|NCT01371539|11062948|FG000|COMPLETED|Period One: One Week||53
9944183|NCT01371539|11062949|FG001|COMPLETED|Period One: One Week||50
9944184|NCT01371539|11062948|FG000|NOT COMPLETED|Period One: One Week||0
9944185|NCT01371539|11062949|FG001|NOT COMPLETED|Period One: One Week||1
9944186|NCT01371539|11062948|FG000|STARTED|Period Two: One Week||53
9944187|NCT01371539|11062949|FG001|STARTED|Period Two: One Week||50
9944188|NCT01371539|11062948|FG000|COMPLETED|Period Two: One Week||53
9944189|NCT01371539|11062949|FG001|COMPLETED|Period Two: One Week||47
9944190|NCT01371539|11062948|FG000|NOT COMPLETED|Period Two: One Week||0
9944191|NCT01371539|11062949|FG001|NOT COMPLETED|Period Two: One Week||3
9944192|NCT01371552|11062955|FG000|STARTED|Part 1, First 3 Days||19
9944193|NCT01371552|11062956|FG001|STARTED|Part 1, First 3 Days||17
9944194|NCT01371552|11062957|FG002|STARTED|Part 1, First 3 Days||20
9944195|NCT01371552|11062958|FG003|STARTED|Part 1, First 3 Days||20
9944196|NCT01371552|11062959|FG004|STARTED|Part 1, First 3 Days||15
9944197|NCT01371552|11062960|FG005|STARTED|Part 1, First 3 Days||18
9944198|NCT01371552|11062955|FG000|COMPLETED|Part 1, First 3 Days||19
9944199|NCT01371552|11062956|FG001|COMPLETED|Part 1, First 3 Days||17
9944200|NCT01371552|11062957|FG002|COMPLETED|Part 1, First 3 Days||19
9944201|NCT01371552|11062958|FG003|COMPLETED|Part 1, First 3 Days||20
9944202|NCT01371552|11062959|FG004|COMPLETED|Part 1, First 3 Days||15
9944203|NCT01371552|11062960|FG005|COMPLETED|Part 1, First 3 Days||18
9944204|NCT01371552|11062955|FG000|NOT COMPLETED|Part 1, First 3 Days||0
9944205|NCT01371552|11062956|FG001|NOT COMPLETED|Part 1, First 3 Days||0
9944206|NCT01371552|11062957|FG002|NOT COMPLETED|Part 1, First 3 Days||1
9944207|NCT01371552|11062958|FG003|NOT COMPLETED|Part 1, First 3 Days||0
9944208|NCT01371552|11062959|FG004|NOT COMPLETED|Part 1, First 3 Days||0
9944209|NCT01371552|11062960|FG005|NOT COMPLETED|Part 1, First 3 Days||0
9944210|NCT01371552|11062955|FG000|STARTED|Part 1, Second 3 Days||19
9944211|NCT01371552|11062956|FG001|STARTED|Part 1, Second 3 Days||17
9944212|NCT01371552|11062957|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
9944213|NCT01371552|11062958|FG003|STARTED|Part 1, Second 3 Days||20
9944214|NCT01371552|11062959|FG004|STARTED|Part 1, Second 3 Days||15
9944215|NCT01371552|11062960|FG005|STARTED|Part 1, Second 3 Days||18
9944216|NCT01371552|11062955|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
9944217|NCT01371552|11062956|FG001|COMPLETED|Part 1, Second 3 Days||17
9944218|NCT01371552|11062957|FG002|COMPLETED|Part 1, Second 3 Days||18
9944219|NCT01371552|11062958|FG003|COMPLETED|Part 1, Second 3 Days||20
9944220|NCT01371552|11062959|FG004|COMPLETED|Part 1, Second 3 Days||15
9944221|NCT01371552|11062960|FG005|COMPLETED|Part 1, Second 3 Days||18
9944222|NCT01371552|11062955|FG000|NOT COMPLETED|Part 1, Second 3 Days||1
9944223|NCT01371552|11062956|FG001|NOT COMPLETED|Part 1, Second 3 Days||0
9944224|NCT01371552|11062957|FG002|NOT COMPLETED|Part 1, Second 3 Days||0
9944225|NCT01371552|11062958|FG003|NOT COMPLETED|Part 1, Second 3 Days||0
9944226|NCT01371552|11062959|FG004|NOT COMPLETED|Part 1, Second 3 Days||0
9944227|NCT01371552|11062960|FG005|NOT COMPLETED|Part 1, Second 3 Days||0
9944228|NCT01371552|11062955|FG000|STARTED|Part 1, Third 3 Days||19
9944229|NCT01371552|11062956|FG001|STARTED|Part 1, Third 3 Days||17
9944230|NCT01371552|11062957|FG002|STARTED|Part 1, Third 3 Days||18
9944231|NCT01371552|11062958|FG003|STARTED|Part 1, Third 3 Days||20
9944232|NCT01371552|11062959|FG004|STARTED|Part 1, Third 3 Days||15
9944233|NCT01371552|11062960|FG005|STARTED|Part 1, Third 3 Days||18
9944234|NCT01371552|11062955|FG000|COMPLETED|Part 1, Third 3 Days||19
9944235|NCT01371552|11062956|FG001|COMPLETED|Part 1, Third 3 Days||17
9944236|NCT01371552|11062957|FG002|COMPLETED|Part 1, Third 3 Days||18
9944237|NCT01371552|11062958|FG003|COMPLETED|Part 1, Third 3 Days||20
9944238|NCT01371552|11062959|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
10207393|NCT03526861|11334157|FG002|NOT COMPLETED|Open-label Treatment Period||0
10207394|NCT03526861|11334158|FG003|NOT COMPLETED|Open-label Treatment Period||0
10207395|NCT03526861|11334159|FG004|NOT COMPLETED|Open-label Treatment Period||0
10207396|NCT03526861|11334160|FG005|NOT COMPLETED|Open-label Treatment Period||0
10207397|NCT03526861|11334161|FG006|NOT COMPLETED|Open-label Treatment Period||0
10207398|NCT03526861|11334162|FG007|NOT COMPLETED|Open-label Treatment Period||0
10207399|NCT03526861|11334163|FG008|NOT COMPLETED|Open-label Treatment Period||28
10207400|NCT03527160|11334185|FG000|STARTED|Overall Study||134
10207401|NCT03527160|11334185|FG000|COMPLETED|Overall Study||113
10207402|NCT03527160|11334185|FG000|NOT COMPLETED|Overall Study||21
10207403|NCT03527173|11334194|FG000|STARTED|Overall Study||36
10207404|NCT03527173|11334195|FG001|STARTED|Overall Study||35
10207405|NCT03527173|11334194|FG000|COMPLETED|Overall Study||29
10207406|NCT03527173|11334195|FG001|COMPLETED|Overall Study||28
10207407|NCT03527173|11334194|FG000|NOT COMPLETED|Overall Study||7
10207408|NCT03527173|11334195|FG001|NOT COMPLETED|Overall Study||7
10207409|NCT03527550|11334203|FG000|STARTED|Overall Study||24
10207410|NCT03527550|11334204|FG001|STARTED|Overall Study||22
10207411|NCT03527550|11334203|FG000|COMPLETED|Overall Study||15
10207412|NCT03527550|11334204|FG001|COMPLETED|Overall Study||19
10207413|NCT03527550|11334203|FG000|NOT COMPLETED|Overall Study||9
10207414|NCT03527550|11334204|FG001|NOT COMPLETED|Overall Study||3
10207415|NCT03527745|11334238|FG000|STARTED|Overall Study||27
10207416|NCT03527745|11334239|FG001|STARTED|Overall Study||27
10207417|NCT03527745|11334240|FG002|STARTED|Overall Study||30
10207418|NCT03527745|11334241|FG003|STARTED|Overall Study||27
10207419|NCT03527745|11334242|FG004|STARTED|Overall Study||46
10207420|NCT03527745|11334243|FG005|STARTED|Overall Study||45
10207421|NCT03527745|11334244|FG006|STARTED|Overall Study||46
10207422|NCT03527745|11334245|FG007|STARTED|Overall Study||43
10207423|NCT03527745|11334246|FG008|STARTED|Overall Study||10
10207424|NCT03527745|11334247|FG009|STARTED|Overall Study||11
10207425|NCT03527745|11334248|FG010|STARTED|Overall Study||9
10207426|NCT03527745|11334249|FG011|STARTED|Overall Study||12
10207427|NCT03527745|11334250|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
10207428|NCT03527745|11334251|FG013|STARTED|Overall Study||13
10207429|NCT03527745|11334252|FG014|STARTED|Overall Study||13
10207430|NCT03527745|11334253|FG015|STARTED|Overall Study||12
10207431|NCT03527745|11334254|FG016|STARTED|Overall Study||24
10207432|NCT03527745|11334255|FG017|STARTED|Overall Study||27
10207433|NCT03527745|11334256|FG018|STARTED|Overall Study||27
10207434|NCT03527745|11334257|FG019|STARTED|Overall Study||29
10207435|NCT03527745|11334258|FG020|STARTED|Overall Study||26
10207436|NCT03527745|11334259|FG021|STARTED|Overall Study||40
10207437|NCT03527745|11334260|FG022|STARTED|Overall Study||41
10207438|NCT03527745|11334261|FG023|STARTED|Overall Study||38
10207439|NCT03527745|11334262|FG024|STARTED|Overall Study||40
10207440|NCT03527745|11334263|FG025|STARTED|Overall Study||37
10207441|NCT03527745|11334238|FG000|COMPLETED|Overall Study||24
10207442|NCT03527745|11334239|FG001|COMPLETED|Overall Study||21
10207443|NCT03527745|11334240|FG002|COMPLETED|Overall Study||23
10207444|NCT03527745|11334241|FG003|COMPLETED|Overall Study||18
10207445|NCT03527745|11334242|FG004|COMPLETED|Overall Study||46
10207446|NCT03527745|11334243|FG005|COMPLETED|Overall Study||43
10207447|NCT03527745|11334244|FG006|COMPLETED|Overall Study||43
10207448|NCT03527745|11334245|FG007|COMPLETED|Overall Study||41
10207449|NCT03527745|11334246|FG008|COMPLETED|Overall Study||7
10207450|NCT03527745|11334247|FG009|COMPLETED|Overall Study||9
10207451|NCT03527745|11334248|FG010|COMPLETED|Overall Study||8
10207452|NCT03527745|11334249|FG011|COMPLETED|Overall Study||11
10207453|NCT03527745|11334250|FG012|COMPLETED|Overall Study||0
10207454|NCT03527745|11334251|FG013|COMPLETED|Overall Study||13
10207455|NCT03527745|11334252|FG014|COMPLETED|Overall Study||13
10207456|NCT03527745|11334253|FG015|COMPLETED|Overall Study||12
10207457|NCT03527745|11334254|FG016|COMPLETED|Overall Study||23
10207458|NCT03527745|11334255|FG017|COMPLETED|Overall Study||27
10207459|NCT03527745|11334256|FG018|COMPLETED|Overall Study||27
10207460|NCT03527745|11334257|FG019|COMPLETED|Overall Study||28
10207461|NCT03527745|11334258|FG020|COMPLETED|Overall Study||25
10207462|NCT03527745|11334259|FG021|COMPLETED|Overall Study||35
10207463|NCT03527745|11334260|FG022|COMPLETED|Overall Study||35
10207464|NCT03527745|11334261|FG023|COMPLETED|Overall Study||30
10207465|NCT03527745|11334262|FG024|COMPLETED|Overall Study||39
10207466|NCT03527745|11334263|FG025|COMPLETED|Overall Study||34
10207467|NCT03527745|11334238|FG000|NOT COMPLETED|Overall Study||3
10207468|NCT03527745|11334239|FG001|NOT COMPLETED|Overall Study||6
10207469|NCT03527745|11334240|FG002|NOT COMPLETED|Overall Study||7
10207470|NCT03527745|11334241|FG003|NOT COMPLETED|Overall Study||9
10207471|NCT03527745|11334242|FG004|NOT COMPLETED|Overall Study||0
10207472|NCT03527745|11334243|FG005|NOT COMPLETED|Overall Study||2
10207473|NCT03527745|11334244|FG006|NOT COMPLETED|Overall Study||3
10207474|NCT03527745|11334245|FG007|NOT COMPLETED|Overall Study||2
10207475|NCT03527745|11334246|FG008|NOT COMPLETED|Overall Study||3
10207476|NCT03527745|11334247|FG009|NOT COMPLETED|Overall Study||2
10207477|NCT03527745|11334248|FG010|NOT COMPLETED|Overall Study||1
10207478|NCT03527745|11334249|FG011|NOT COMPLETED|Overall Study||1
10207479|NCT03527745|11334250|FG012|NOT COMPLETED|Overall Study||0
10207480|NCT03527745|11334251|FG013|NOT COMPLETED|Overall Study||0
10207481|NCT03527745|11334252|FG014|NOT COMPLETED|Overall Study||0
10207482|NCT03527745|11334253|FG015|NOT COMPLETED|Overall Study||0
10207483|NCT03527745|11334254|FG016|NOT COMPLETED|Overall Study||1
10207484|NCT03527745|11334255|FG017|NOT COMPLETED|Overall Study||0
10207485|NCT03527745|11334256|FG018|NOT COMPLETED|Overall Study||0
10207486|NCT03527745|11334257|FG019|NOT COMPLETED|Overall Study||1
10207487|NCT03527745|11334258|FG020|NOT COMPLETED|Overall Study||1
10207488|NCT03527745|11334259|FG021|NOT COMPLETED|Overall Study||5
10207489|NCT03527745|11334260|FG022|NOT COMPLETED|Overall Study||6
10207490|NCT03527745|11334261|FG023|NOT COMPLETED|Overall Study||8
10207491|NCT03527745|11334262|FG024|NOT COMPLETED|Overall Study||1
10207492|NCT03527745|11334263|FG025|NOT COMPLETED|Overall Study||3
10207493|NCT03527966|11334321|FG000|STARTED|Overall Study||3
10207494|NCT03527966|11334322|FG001|STARTED|Overall Study||0
10207495|NCT03527966|11334321|FG000|COMPLETED|Overall Study||0
10207496|NCT03527966|11334322|FG001|COMPLETED|Overall Study||0
10207497|NCT03527966|11334321|FG000|NOT COMPLETED|Overall Study||3
10207498|NCT03527966|11334322|FG001|NOT COMPLETED|Overall Study||0
10207499|NCT03528174|11334328|FG000|STARTED|Overall Study||10
10207500|NCT03528174|11334328|FG000|COMPLETED|Overall Study||8
9944239|NCT01371552|11062960|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
9944240|NCT01371552|11062955|FG000|NOT COMPLETED|Part 1, Third 3 Days||0
9944241|NCT01371552|11062956|FG001|NOT COMPLETED|Part 1, Third 3 Days||0
9944242|NCT01371552|11062957|FG002|NOT COMPLETED|Part 1, Third 3 Days||0
9944243|NCT01371552|11062958|FG003|NOT COMPLETED|Part 1, Third 3 Days||0
9944244|NCT01371552|11062959|FG004|NOT COMPLETED|Part 1, Third 3 Days||1
9944245|NCT01371552|11062960|FG005|NOT COMPLETED|Part 1, Third 3 Days||1
9944246|NCT01371552|11062955|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
9944247|NCT01371552|11062956|FG001|STARTED|Part 2, One Week||17
9944248|NCT01371552|11062957|FG002|STARTED|Part 2, One Week||18
9944249|NCT01371552|11062958|FG003|STARTED|Part 2, One Week||20
9944250|NCT01371552|11062959|FG004|STARTED|Part 2, One Week||15
9944251|NCT01371552|11062960|FG005|STARTED|Part 2, One Week||18
9944252|NCT01371552|11062955|FG000|COMPLETED|Part 2, One Week||18
9944253|NCT01371552|11062956|FG001|COMPLETED|Part 2, One Week||17
9944254|NCT01371552|11062957|FG002|COMPLETED|Part 2, One Week||18
9944255|NCT01371552|11062958|FG003|COMPLETED|Part 2, One Week||20
9944256|NCT01371552|11062959|FG004|COMPLETED|Part 2, One Week||15
9944257|NCT01371552|11062960|FG005|COMPLETED|Part 2, One Week||18
9944258|NCT01371552|11062955|FG000|NOT COMPLETED|Part 2, One Week||0
9944259|NCT01371552|11062956|FG001|NOT COMPLETED|Part 2, One Week||0
9944260|NCT01371552|11062957|FG002|NOT COMPLETED|Part 2, One Week||0
9944261|NCT01371552|11062958|FG003|NOT COMPLETED|Part 2, One Week||0
9944262|NCT01371552|11062959|FG004|NOT COMPLETED|Part 2, One Week||0
9944263|NCT01371552|11062960|FG005|NOT COMPLETED|Part 2, One Week||0
9944264|NCT01371565|11062969|FG000|STARTED|Overall Study||4
9944265|NCT01371565|11062969|FG000|COMPLETED|Overall Study||1
9944266|NCT01371565|11062969|FG000|NOT COMPLETED|Overall Study||3
9944267|NCT01371643|11062975|FG000|STARTED|Overall Study||15
9944268|NCT01371643|11062976|FG001|STARTED|Overall Study||26
9944269|NCT01371643|11062975|FG000|COMPLETED|Overall Study||12
9944270|NCT01371643|11062976|FG001|COMPLETED|Overall Study||26
9944271|NCT01371643|11062975|FG000|NOT COMPLETED|Overall Study||3
9944272|NCT01371643|11062976|FG001|NOT COMPLETED|Overall Study||0
9944273|NCT01371656|11062984|FG000|STARTED|Overall Study||314
9944274|NCT01371656|11062985|FG001|STARTED|Overall Study||310
9944275|NCT01371656|11062984|FG000|COMPLETED|Overall Study||250
9944276|NCT01371656|11062985|FG001|COMPLETED|Overall Study||296
9944277|NCT01371656|11062984|FG000|NOT COMPLETED|Overall Study||64
9944278|NCT01371656|11062985|FG001|NOT COMPLETED|Overall Study||14
9944279|NCT01371708|11062994|FG000|STARTED|Overall Study||92
9944280|NCT01371708|11062995|FG001|STARTED|Overall Study||93
9944281|NCT01371708|11062996|FG002|STARTED|Overall Study||98
9944282|NCT01371708|11062994|FG000|Received Treatment|Overall Study||91
9944283|NCT01371708|11062995|FG001|Received Treatment|Overall Study||93
9944284|NCT01371708|11062996|FG002|Received Treatment|Overall Study||97
9944285|NCT01371708|11062994|FG000|COMPLETED|Overall Study||66
9944286|NCT01371708|11062995|FG001|COMPLETED|Overall Study||63
9944287|NCT01371708|11062996|FG002|COMPLETED|Overall Study||59
9944288|NCT01371708|11062994|FG000|NOT COMPLETED|Overall Study||26
9944289|NCT01371708|11062995|FG001|NOT COMPLETED|Overall Study||30
9944290|NCT01371708|11062996|FG002|NOT COMPLETED|Overall Study||39
9944291|NCT01371721|11063009|FG000|STARTED|Overall Study||88
9944292|NCT01371721|11063010|FG001|STARTED|Overall Study||89
9944293|NCT01371721|11063011|FG002|STARTED|Overall Study||92
9944294|NCT01371721|11063009|FG000|Treated|Overall Study||87
9944295|NCT01371721|11063010|FG001|Treated|Overall Study||89
9944296|NCT01371721|11063011|FG002|Treated|Overall Study||92
10207501|NCT03528174|11334328|FG000|NOT COMPLETED|Overall Study||2
10207502|NCT03528369|11334335|FG000|STARTED|Overall Study||40
9944297|NCT01371721|11063009|FG000|COMPLETED|Overall Study||59
9944298|NCT01371721|11063010|FG001|COMPLETED|Overall Study||65
9944299|NCT01371721|11063011|FG002|COMPLETED|Overall Study||62
9944300|NCT01371721|11063009|FG000|NOT COMPLETED|Overall Study||29
9944301|NCT01371721|11063010|FG001|NOT COMPLETED|Overall Study||24
9944302|NCT01371721|11063011|FG002|NOT COMPLETED|Overall Study||30
9944303|NCT01371734|11063024|FG000|STARTED|Overall Study||120
10207503|NCT03528369|11334336|FG001|STARTED|Overall Study||42
10207504|NCT03528369|11334337|FG002|STARTED|Overall Study||40
10207505|NCT03528369|11334335|FG000|COMPLETED|Overall Study||37
9944304|NCT01371734|11063025|FG001|STARTED|Overall Study||122
9944305|NCT01371734|11063026|FG002|STARTED|Overall Study||121
9944306|NCT01371734|11063024|FG000|COMPLETED|Overall Study||97
9944307|NCT01371734|11063025|FG001|COMPLETED|Overall Study||103
9944308|NCT01371734|11063026|FG002|COMPLETED|Overall Study||104
9944309|NCT01371734|11063024|FG000|NOT COMPLETED|Overall Study||23
9944310|NCT01371734|11063025|FG001|NOT COMPLETED|Overall Study||19
9944311|NCT01371734|11063026|FG002|NOT COMPLETED|Overall Study||17
9944312|NCT01371747|11063040|FG000|STARTED|Overall Study||74
9944313|NCT01371747|11063041|FG001|STARTED|Overall Study||74
9944314|NCT01371747|11063042|FG002|STARTED|Overall Study||74
9944315|NCT01371747|11063043|FG003|STARTED|Overall Study||26
9944316|NCT01371747|11063044|FG004|STARTED|Overall Study||28
9944317|NCT01371747|11063045|FG005|STARTED|Overall Study||30
9944318|NCT01371747|11063040|FG000|COMPLETED|Overall Study||56
9944319|NCT01371747|11063041|FG001|COMPLETED|Overall Study||51
9944320|NCT01371747|11063042|FG002|COMPLETED|Overall Study||50
9944321|NCT01371747|11063043|FG003|COMPLETED|Overall Study||17
9944322|NCT01371747|11063044|FG004|COMPLETED|Overall Study||21
9944323|NCT01371747|11063045|FG005|COMPLETED|Overall Study||16
9944324|NCT01371747|11063040|FG000|NOT COMPLETED|Overall Study||18
9944325|NCT01371747|11063041|FG001|NOT COMPLETED|Overall Study||23
9944326|NCT01371747|11063042|FG002|NOT COMPLETED|Overall Study||24
9944327|NCT01371747|11063043|FG003|NOT COMPLETED|Overall Study||9
9944328|NCT01371747|11063044|FG004|NOT COMPLETED|Overall Study||7
9944329|NCT01371747|11063045|FG005|NOT COMPLETED|Overall Study||14
10011517|NCT01781286|11134280|FG002|STARTED|Overall Study||9
10011518|NCT01781286|11134281|FG003|STARTED|Overall Study||8
10011519|NCT01781286|11134282|FG004|STARTED|Overall Study||6
10011520|NCT01781286|11134283|FG005|STARTED|Overall Study||3
10011521|NCT01781286|11134278|FG000|Started 1st Intervention|Overall Study||6
10011522|NCT01781286|11134279|FG001|Started 1st Intervention|Overall Study||4
10011523|NCT01781286|11134280|FG002|Started 1st Intervention|Overall Study||9
10011524|NCT01781286|11134281|FG003|Started 1st Intervention|Overall Study||8
10011525|NCT01781286|11134282|FG004|Started 1st Intervention|Overall Study||6
10011526|NCT01781286|11134283|FG005|Started 1st Intervention|Overall Study||2
10011527|NCT01781286|11134278|FG000|Started 2nd Intervention|Overall Study||5
10011528|NCT01781286|11134279|FG001|Started 2nd Intervention|Overall Study||4
10011529|NCT01781286|11134280|FG002|Started 2nd Intervention|Overall Study||9
10011530|NCT01781286|11134281|FG003|Started 2nd Intervention|Overall Study||8
9944330|NCT01371786|11063062|FG000|STARTED|Overall Study||7
9944331|NCT01371786|11063063|FG001|STARTED|Overall Study||7
9944332|NCT01371786|11063062|FG000|COMPLETED|Overall Study||7
9944333|NCT01371786|11063063|FG001|COMPLETED|Overall Study||7
9944334|NCT01371786|11063062|FG000|NOT COMPLETED|Overall Study||0
9944335|NCT01371786|11063063|FG001|NOT COMPLETED|Overall Study||0
9944336|NCT01371825|11063069|FG000|STARTED|Overall Study||9
9944337|NCT01371825|11063069|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
9944338|NCT01371825|11063069|FG000|COMPLETED|Overall Study||5
9944339|NCT01371825|11063069|FG000|NOT COMPLETED|Overall Study||4
9944340|NCT01371838|11063075|FG000|STARTED|Overall Study||381
9944341|NCT01371838|11063076|FG001|STARTED|Overall Study||383
9944342|NCT01371838|11063075|FG000|COMPLETED|Overall Study||332
9944343|NCT01371838|11063076|FG001|COMPLETED|Overall Study||317
9944344|NCT01371838|11063075|FG000|NOT COMPLETED|Overall Study||49
9944345|NCT01371838|11063076|FG001|NOT COMPLETED|Overall Study||66
9944346|NCT01371851|11063084|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
9944347|NCT01371851|11063085|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
9944348|NCT01371851|11063084|FG000|COMPLETED|Overall Study||3
9944349|NCT01371851|11063085|FG001|COMPLETED|Overall Study||2
9944350|NCT01371851|11063084|FG000|NOT COMPLETED|Overall Study||8
9944351|NCT01371851|11063085|FG001|NOT COMPLETED|Overall Study||9
9944352|NCT01371877|11063093|FG000|STARTED|Overall Study||21
9944353|NCT01371877|11063094|FG001|STARTED|Overall Study||21
9944354|NCT01371877|11063093|FG000|COMPLETED|Overall Study||21
9944355|NCT01371877|11063094|FG001|COMPLETED|Overall Study||17
9944356|NCT01371877|11063093|FG000|NOT COMPLETED|Overall Study||0
9944357|NCT01371877|11063094|FG001|NOT COMPLETED|Overall Study||4
9944358|NCT01371994|11063102|FG000|STARTED|Overall Study||320
9944359|NCT01371994|11063103|FG001|STARTED|Overall Study||320
9944360|NCT01371994|11063102|FG000|Received Treatment|Overall Study||310
9944361|NCT01371994|11063103|FG001|Received Treatment|Overall Study||313
9944362|NCT01371994|11063102|FG000|COMPLETED|Overall Study||263
9944363|NCT01371994|11063103|FG001|COMPLETED|Overall Study||278
9944364|NCT01371994|11063102|FG000|NOT COMPLETED|Overall Study||57
9944365|NCT01371994|11063103|FG001|NOT COMPLETED|Overall Study||42
9944366|NCT01372085|11063119|FG000|STARTED|First Intervention (Period 1)||8
9944367|NCT01372085|11063120|FG001|STARTED|First Intervention (Period 1)||2
9944368|NCT01372085|11063121|FG002|STARTED|First Intervention (Period 1)||2
9944369|NCT01372085|11063122|FG003|STARTED|First Intervention (Period 1)||1
10011531|NCT01781286|11134282|FG004|Started 2nd Intervention|Overall Study||6
9944370|NCT01372085|11063123|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
10011532|NCT01781286|11134283|FG005|Started 2nd Intervention|Overall Study||2
10011533|NCT01781286|11134278|FG000|Started 3rd Intervention|Overall Study||5
10011534|NCT01781286|11134279|FG001|Started 3rd Intervention|Overall Study||4
9944371|NCT01372085|11063124|FG005|STARTED|First Intervention (Period 1)||5
9944372|NCT01372085|11063125|FG006|STARTED|First Intervention (Period 1)||3
9944373|NCT01372085|11063126|FG007|STARTED|First Intervention (Period 1)||1
9944374|NCT01372085|11063127|FG008|STARTED|First Intervention (Period 1)||1
10011535|NCT01781286|11134280|FG002|Started 3rd Intervention|Overall Study||7
9944375|NCT01372085|11063128|FG009|STARTED|First Intervention (Period 1)||0
9944376|NCT01372085|11063119|FG000|COMPLETED|First Intervention (Period 1)||8
9944377|NCT01372085|11063120|FG001|COMPLETED|First Intervention (Period 1)||2
9944378|NCT01372085|11063121|FG002|COMPLETED|First Intervention (Period 1)||2
9944379|NCT01372085|11063122|FG003|COMPLETED|First Intervention (Period 1)||1
9944380|NCT01372085|11063123|FG004|COMPLETED|First Intervention (Period 1)||3
9944381|NCT01372085|11063124|FG005|COMPLETED|First Intervention (Period 1)||5
9944382|NCT01372085|11063125|FG006|COMPLETED|First Intervention (Period 1)||3
9944383|NCT01372085|11063126|FG007|COMPLETED|First Intervention (Period 1)||1
9944384|NCT01372085|11063127|FG008|COMPLETED|First Intervention (Period 1)||1
9944385|NCT01372085|11063128|FG009|COMPLETED|First Intervention (Period 1)||0
9944386|NCT01372085|11063119|FG000|NOT COMPLETED|First Intervention (Period 1)||0
9944387|NCT01372085|11063120|FG001|NOT COMPLETED|First Intervention (Period 1)||0
9944388|NCT01372085|11063121|FG002|NOT COMPLETED|First Intervention (Period 1)||0
9944389|NCT01372085|11063122|FG003|NOT COMPLETED|First Intervention (Period 1)||0
9944390|NCT01372085|11063123|FG004|NOT COMPLETED|First Intervention (Period 1)||0
9944391|NCT01372085|11063124|FG005|NOT COMPLETED|First Intervention (Period 1)||0
9944392|NCT01372085|11063125|FG006|NOT COMPLETED|First Intervention (Period 1)||0
9944393|NCT01372085|11063126|FG007|NOT COMPLETED|First Intervention (Period 1)||0
9944394|NCT01372085|11063127|FG008|NOT COMPLETED|First Intervention (Period 1)||0
9944395|NCT01372085|11063128|FG009|NOT COMPLETED|First Intervention (Period 1)||0
9944396|NCT01372085|11063119|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
9944397|NCT01372085|11063120|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
9944398|NCT01372085|11063121|FG002|STARTED|Washout Period 1||2
9944399|NCT01372085|11063122|FG003|STARTED|Washout Period 1||1
9944400|NCT01372085|11063123|FG004|STARTED|Washout Period 1||3
9944401|NCT01372085|11063124|FG005|STARTED|Washout Period 1||5
9944402|NCT01372085|11063125|FG006|STARTED|Washout Period 1||3
9944403|NCT01372085|11063126|FG007|STARTED|Washout Period 1||1
9944404|NCT01372085|11063127|FG008|STARTED|Washout Period 1||1
9944405|NCT01372085|11063128|FG009|STARTED|Washout Period 1||0
9944406|NCT01372085|11063119|FG000|COMPLETED|Washout Period 1||0
9944407|NCT01372085|11063120|FG001|COMPLETED|Washout Period 1||0
9944408|NCT01372085|11063121|FG002|COMPLETED|Washout Period 1||2
9944409|NCT01372085|11063122|FG003|COMPLETED|Washout Period 1||1
9944410|NCT01372085|11063123|FG004|COMPLETED|Washout Period 1||3
9944411|NCT01372085|11063124|FG005|COMPLETED|Washout Period 1||5
9944412|NCT01372085|11063125|FG006|COMPLETED|Washout Period 1||3
9944413|NCT01372085|11063126|FG007|COMPLETED|Washout Period 1||1
9944414|NCT01372085|11063127|FG008|COMPLETED|Washout Period 1||1
9944415|NCT01372085|11063128|FG009|COMPLETED|Washout Period 1||0
9944416|NCT01372085|11063119|FG000|NOT COMPLETED|Washout Period 1||0
9944417|NCT01372085|11063120|FG001|NOT COMPLETED|Washout Period 1||0
9944418|NCT01372085|11063121|FG002|NOT COMPLETED|Washout Period 1||0
9944419|NCT01372085|11063122|FG003|NOT COMPLETED|Washout Period 1||0
9944420|NCT01372085|11063123|FG004|NOT COMPLETED|Washout Period 1||0
9944421|NCT01372085|11063124|FG005|NOT COMPLETED|Washout Period 1||0
9944422|NCT01372085|11063125|FG006|NOT COMPLETED|Washout Period 1||0
9944423|NCT01372085|11063126|FG007|NOT COMPLETED|Washout Period 1||0
9944424|NCT01372085|11063127|FG008|NOT COMPLETED|Washout Period 1||0
9944425|NCT01372085|11063128|FG009|NOT COMPLETED|Washout Period 1||0
9944426|NCT01372085|11063119|FG000|STARTED|Second Intervention (Period 2)||0
9944427|NCT01372085|11063120|FG001|STARTED|Second Intervention (Period 2)||0
9944428|NCT01372085|11063121|FG002|STARTED|Second Intervention (Period 2)||2
9944429|NCT01372085|11063122|FG003|STARTED|Second Intervention (Period 2)||1
9944430|NCT01372085|11063123|FG004|STARTED|Second Intervention (Period 2)||3
9944431|NCT01372085|11063124|FG005|STARTED|Second Intervention (Period 2)||5
9944432|NCT01372085|11063125|FG006|STARTED|Second Intervention (Period 2)||3
9944433|NCT01372085|11063126|FG007|STARTED|Second Intervention (Period 2)||1
9944434|NCT01372085|11063127|FG008|STARTED|Second Intervention (Period 2)||1
9944435|NCT01372085|11063128|FG009|STARTED|Second Intervention (Period 2)||0
9944436|NCT01372085|11063119|FG000|COMPLETED|Second Intervention (Period 2)||0
9944437|NCT01372085|11063120|FG001|COMPLETED|Second Intervention (Period 2)||0
9944438|NCT01372085|11063121|FG002|COMPLETED|Second Intervention (Period 2)||2
9944439|NCT01372085|11063122|FG003|COMPLETED|Second Intervention (Period 2)||1
9944440|NCT01372085|11063123|FG004|COMPLETED|Second Intervention (Period 2)||3
9944441|NCT01372085|11063124|FG005|COMPLETED|Second Intervention (Period 2)||5
9944442|NCT01372085|11063125|FG006|COMPLETED|Second Intervention (Period 2)||3
9944443|NCT01372085|11063126|FG007|COMPLETED|Second Intervention (Period 2)||1
9944444|NCT01372085|11063127|FG008|COMPLETED|Second Intervention (Period 2)||1
9944445|NCT01372085|11063128|FG009|COMPLETED|Second Intervention (Period 2)||0
9944446|NCT01372085|11063119|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
9944447|NCT01372085|11063120|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
9944448|NCT01372085|11063121|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
9944449|NCT01372085|11063122|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
9944450|NCT01372085|11063123|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
9944451|NCT01372085|11063124|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
9944452|NCT01372085|11063125|FG006|NOT COMPLETED|Second Intervention (Period 2)||0
9944453|NCT01372085|11063126|FG007|NOT COMPLETED|Second Intervention (Period 2)||0
9944454|NCT01372085|11063127|FG008|NOT COMPLETED|Second Intervention (Period 2)||0
9944455|NCT01372085|11063128|FG009|NOT COMPLETED|Second Intervention (Period 2)||0
10207506|NCT03528369|11334336|FG001|COMPLETED|Overall Study||41
10207507|NCT03528369|11334337|FG002|COMPLETED|Overall Study||40
10207508|NCT03528369|11334335|FG000|NOT COMPLETED|Overall Study||3
9944456|NCT01372085|11063119|FG000|STARTED|Washout Period 2||0
9944457|NCT01372085|11063120|FG001|STARTED|Washout Period 2||0
9944458|NCT01372085|11063121|FG002|STARTED|Washout Period 2||2
9944459|NCT01372085|11063122|FG003|STARTED|Washout Period 2||1
9944460|NCT01372085|11063123|FG004|STARTED|Washout Period 2||3
9944461|NCT01372085|11063124|FG005|STARTED|Washout Period 2||5
9944462|NCT01372085|11063125|FG006|STARTED|Washout Period 2||3
9944463|NCT01372085|11063126|FG007|STARTED|Washout Period 2||1
9944464|NCT01372085|11063127|FG008|STARTED|Washout Period 2||1
9944465|NCT01372085|11063128|FG009|STARTED|Washout Period 2||0
9944466|NCT01372085|11063119|FG000|COMPLETED|Washout Period 2||0
9944467|NCT01372085|11063120|FG001|COMPLETED|Washout Period 2||0
9944468|NCT01372085|11063121|FG002|COMPLETED|Washout Period 2||2
9944469|NCT01372085|11063122|FG003|COMPLETED|Washout Period 2||1
9944470|NCT01372085|11063123|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
9944471|NCT01372085|11063124|FG005|COMPLETED|Washout Period 2||5
9944472|NCT01372085|11063125|FG006|COMPLETED|Washout Period 2||3
9944473|NCT01372085|11063126|FG007|COMPLETED|Washout Period 2||1
9944474|NCT01372085|11063127|FG008|COMPLETED|Washout Period 2||1
9944475|NCT01372085|11063128|FG009|COMPLETED|Washout Period 2||0
9944476|NCT01372085|11063119|FG000|NOT COMPLETED|Washout Period 2||0
9944477|NCT01372085|11063120|FG001|NOT COMPLETED|Washout Period 2||0
9944478|NCT01372085|11063121|FG002|NOT COMPLETED|Washout Period 2||0
9944479|NCT01372085|11063122|FG003|NOT COMPLETED|Washout Period 2||0
9944480|NCT01372085|11063123|FG004|NOT COMPLETED|Washout Period 2||1
9944481|NCT01372085|11063124|FG005|NOT COMPLETED|Washout Period 2||0
9944482|NCT01372085|11063125|FG006|NOT COMPLETED|Washout Period 2||0
9944483|NCT01372085|11063126|FG007|NOT COMPLETED|Washout Period 2||0
9944484|NCT01372085|11063127|FG008|NOT COMPLETED|Washout Period 2||0
9944485|NCT01372085|11063128|FG009|NOT COMPLETED|Washout Period 2||0
9944486|NCT01372085|11063119|FG000|STARTED|Third Intervention (Period 3)||0
9944487|NCT01372085|11063120|FG001|STARTED|Third Intervention (Period 3)||0
9944488|NCT01372085|11063121|FG002|STARTED|Third Intervention (Period 3)||2
9944489|NCT01372085|11063122|FG003|STARTED|Third Intervention (Period 3)||1
9944490|NCT01372085|11063123|FG004|STARTED|Third Intervention (Period 3)||2
9944491|NCT01372085|11063124|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
9944492|NCT01372085|11063125|FG006|STARTED|Third Intervention (Period 3)||3
9760655|NCT00382720|10864421|FG002|STARTED|Overall Study||86
9760656|NCT00382720|10864419|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10
9760657|NCT00382720|10864420|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11
9944493|NCT01372085|11063126|FG007|STARTED|Third Intervention (Period 3)||1
9944494|NCT01372085|11063127|FG008|STARTED|Third Intervention (Period 3)||1
9944495|NCT01372085|11063128|FG009|STARTED|Third Intervention (Period 3)||0
9944496|NCT01372085|11063119|FG000|COMPLETED|Third Intervention (Period 3)||0
9944497|NCT01372085|11063120|FG001|COMPLETED|Third Intervention (Period 3)||0
9944498|NCT01372085|11063121|FG002|COMPLETED|Third Intervention (Period 3)||2
9944499|NCT01372085|11063122|FG003|COMPLETED|Third Intervention (Period 3)||1
9944500|NCT01372085|11063123|FG004|COMPLETED|Third Intervention (Period 3)||2
9944501|NCT01372085|11063124|FG005|COMPLETED|Third Intervention (Period 3)||7
9944502|NCT01372085|11063125|FG006|COMPLETED|Third Intervention (Period 3)||3
9944503|NCT01372085|11063126|FG007|COMPLETED|Third Intervention (Period 3)||1
9944504|NCT01372085|11063127|FG008|COMPLETED|Third Intervention (Period 3)||1
9944505|NCT01372085|11063128|FG009|COMPLETED|Third Intervention (Period 3)||0
9944506|NCT01372085|11063119|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
10207509|NCT03528369|11334336|FG001|NOT COMPLETED|Overall Study||1
10207510|NCT03528369|11334337|FG002|NOT COMPLETED|Overall Study||0
10207511|NCT03528512|11334347|FG000|STARTED|Overall Study||3
10207512|NCT03528512|11334348|FG001|STARTED|Overall Study||2
10207513|NCT03528512|11334347|FG000|COMPLETED|Overall Study||3
10207514|NCT03528512|11334348|FG001|COMPLETED|Overall Study||2
10207515|NCT03528512|11334347|FG000|NOT COMPLETED|Overall Study||0
10207516|NCT03528512|11334348|FG001|NOT COMPLETED|Overall Study||0
9944507|NCT01372085|11063120|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
9944508|NCT01372085|11063121|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
9944509|NCT01372085|11063122|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
9944510|NCT01372085|11063123|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
9944511|NCT01372085|11063124|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
9944512|NCT01372085|11063125|FG006|NOT COMPLETED|Third Intervention (Period 3)||0
9944513|NCT01372085|11063126|FG007|NOT COMPLETED|Third Intervention (Period 3)||0
9944514|NCT01372085|11063127|FG008|NOT COMPLETED|Third Intervention (Period 3)||0
9944515|NCT01372085|11063128|FG009|NOT COMPLETED|Third Intervention (Period 3)||0
9944516|NCT01372085|11063119|FG000|STARTED|Washout Period 3||0
9944517|NCT01372085|11063120|FG001|STARTED|Washout Period 3||0
9944518|NCT01372085|11063121|FG002|STARTED|Washout Period 3||2
9944519|NCT01372085|11063122|FG003|STARTED|Washout Period 3||1
9944520|NCT01372085|11063123|FG004|STARTED|Washout Period 3||2
10207517|NCT03528551|11334357|FG000|STARTED|Overall Study||25
9944521|NCT01372085|11063124|FG005|STARTED|Washout Period 3||7
9944522|NCT01372085|11063125|FG006|STARTED|Washout Period 3||3
10207518|NCT03528551|11334358|FG001|STARTED|Overall Study||133
10207519|NCT03528551|11334359|FG002|STARTED|Overall Study||2
9944523|NCT01372085|11063126|FG007|STARTED|Washout Period 3||1
9944524|NCT01372085|11063127|FG008|STARTED|Washout Period 3||1
9944525|NCT01372085|11063128|FG009|STARTED|Washout Period 3||0
9944526|NCT01372085|11063119|FG000|COMPLETED|Washout Period 3||0
9944527|NCT01372085|11063120|FG001|COMPLETED|Washout Period 3||0
9944528|NCT01372085|11063121|FG002|COMPLETED|Washout Period 3||2
9944529|NCT01372085|11063122|FG003|COMPLETED|Washout Period 3||1
9944530|NCT01372085|11063123|FG004|COMPLETED|Washout Period 3||2
9944531|NCT01372085|11063124|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
9944532|NCT01372085|11063125|FG006|COMPLETED|Washout Period 3||3
9944533|NCT01372085|11063126|FG007|COMPLETED|Washout Period 3||1
9944534|NCT01372085|11063127|FG008|COMPLETED|Washout Period 3||1
9944535|NCT01372085|11063128|FG009|COMPLETED|Washout Period 3||0
9944536|NCT01372085|11063119|FG000|NOT COMPLETED|Washout Period 3||0
9944537|NCT01372085|11063120|FG001|NOT COMPLETED|Washout Period 3||0
9944538|NCT01372085|11063121|FG002|NOT COMPLETED|Washout Period 3||0
9944539|NCT01372085|11063122|FG003|NOT COMPLETED|Washout Period 3||0
9944540|NCT01372085|11063123|FG004|NOT COMPLETED|Washout Period 3||0
9944541|NCT01372085|11063124|FG005|NOT COMPLETED|Washout Period 3||2
9944542|NCT01372085|11063125|FG006|NOT COMPLETED|Washout Period 3||0
9944543|NCT01372085|11063126|FG007|NOT COMPLETED|Washout Period 3||0
9944544|NCT01372085|11063127|FG008|NOT COMPLETED|Washout Period 3||0
9944545|NCT01372085|11063128|FG009|NOT COMPLETED|Washout Period 3||0
9944546|NCT01372085|11063119|FG000|STARTED|Forth Intervention (Period 4a/4b)||0
9944547|NCT01372085|11063120|FG001|STARTED|Forth Intervention (Period 4a/4b)||0
9944548|NCT01372085|11063121|FG002|STARTED|Forth Intervention (Period 4a/4b)||2
9944549|NCT01372085|11063122|FG003|STARTED|Forth Intervention (Period 4a/4b)||1
9944550|NCT01372085|11063123|FG004|STARTED|Forth Intervention (Period 4a/4b)||2
9944551|NCT01372085|11063124|FG005|STARTED|Forth Intervention (Period 4a/4b)||5
9944552|NCT01372085|11063125|FG006|STARTED|Forth Intervention (Period 4a/4b)||3
9944553|NCT01372085|11063126|FG007|STARTED|Forth Intervention (Period 4a/4b)||1
9944554|NCT01372085|11063127|FG008|STARTED|Forth Intervention (Period 4a/4b)||1
9944555|NCT01372085|11063128|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
9944556|NCT01372085|11063119|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0
9944557|NCT01372085|11063120|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0
9944558|NCT01372085|11063121|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2
9944559|NCT01372085|11063122|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1
9944560|NCT01372085|11063123|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2
9944561|NCT01372085|11063124|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5
9944562|NCT01372085|11063125|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3
9944563|NCT01372085|11063126|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1
9944564|NCT01372085|11063127|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1
9944565|NCT01372085|11063128|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1
9944566|NCT01372085|11063119|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944567|NCT01372085|11063120|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944568|NCT01372085|11063121|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944569|NCT01372085|11063122|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944570|NCT01372085|11063123|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944571|NCT01372085|11063124|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944572|NCT01372085|11063125|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944573|NCT01372085|11063126|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944574|NCT01372085|11063127|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944575|NCT01372085|11063128|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
9944576|NCT01372150|11063155|FG000|STARTED|Overall Study||112
9944577|NCT01372150|11063156|FG001|STARTED|Overall Study||113
9944578|NCT01372150|11063157|FG002|STARTED|Overall Study||115
9944579|NCT01372150|11063155|FG000|Treated|Overall Study||112
9944580|NCT01372150|11063156|FG001|Treated|Overall Study||112
9944581|NCT01372150|11063157|FG002|Treated|Overall Study||115
9944582|NCT01372150|11063155|FG000|COMPLETED|Overall Study||99
9944583|NCT01372150|11063156|FG001|COMPLETED|Overall Study||99
9944584|NCT01372150|11063157|FG002|COMPLETED|Overall Study||99
9944585|NCT01372150|11063155|FG000|NOT COMPLETED|Overall Study||13
9944586|NCT01372150|11063156|FG001|NOT COMPLETED|Overall Study||14
9944587|NCT01372150|11063157|FG002|NOT COMPLETED|Overall Study||16
9944588|NCT01372202|11063168|FG000|STARTED|Overall Study||13
9944589|NCT01372202|11063169|FG001|STARTED|Overall Study||9
9944590|NCT01372202|11063170|FG002|STARTED|Overall Study||9
9944591|NCT01372202|11063168|FG000|COMPLETED|Overall Study||13
9944592|NCT01372202|11063169|FG001|COMPLETED|Overall Study||9
9944593|NCT01372202|11063170|FG002|COMPLETED|Overall Study||9
9944594|NCT01372202|11063168|FG000|NOT COMPLETED|Overall Study||0
9944595|NCT01372202|11063169|FG001|NOT COMPLETED|Overall Study||0
9944596|NCT01372202|11063170|FG002|NOT COMPLETED|Overall Study||0
9944597|NCT01372384|11063183|FG000|STARTED|Overall Study||6
9944598|NCT01372384|11063183|FG000|COMPLETED|Overall Study||3
9944599|NCT01372384|11063183|FG000|NOT COMPLETED|Overall Study||3
9944600|NCT01372410|11063187|FG000|STARTED|Treatment Period 1 (7 Days)||20
9944601|NCT01372410|11063188|FG001|STARTED|Treatment Period 1 (7 Days)||21
9944602|NCT01372410|11063189|FG002|STARTED|Treatment Period 1 (7 Days)||19
9944603|NCT01372410|11063190|FG003|STARTED|Treatment Period 1 (7 Days)||20
9944604|NCT01372410|11063191|FG004|STARTED|Treatment Period 1 (7 Days)||21
9944605|NCT01372410|11063192|FG005|STARTED|Treatment Period 1 (7 Days)||21
9944606|NCT01372410|11063193|FG006|STARTED|Treatment Period 1 (7 Days)||22
9944607|NCT01372410|11063194|FG007|STARTED|Treatment Period 1 (7 Days)||19
9944608|NCT01372410|11063187|FG000|COMPLETED|Treatment Period 1 (7 Days)||19
9944609|NCT01372410|11063188|FG001|COMPLETED|Treatment Period 1 (7 Days)||19
9944610|NCT01372410|11063189|FG002|COMPLETED|Treatment Period 1 (7 Days)||19
9944611|NCT01372410|11063190|FG003|COMPLETED|Treatment Period 1 (7 Days)||20
9944612|NCT01372410|11063191|FG004|COMPLETED|Treatment Period 1 (7 Days)||19
9944613|NCT01372410|11063192|FG005|COMPLETED|Treatment Period 1 (7 Days)||21
9944614|NCT01372410|11063193|FG006|COMPLETED|Treatment Period 1 (7 Days)||20
9944615|NCT01372410|11063194|FG007|COMPLETED|Treatment Period 1 (7 Days)||19
9944616|NCT01372410|11063187|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1
9944617|NCT01372410|11063188|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2
9944618|NCT01372410|11063189|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
9944619|NCT01372410|11063190|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0
9944620|NCT01372410|11063191|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2
9944621|NCT01372410|11063192|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
9944622|NCT01372410|11063193|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2
9944623|NCT01372410|11063194|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0
9944624|NCT01372410|11063187|FG000|STARTED|Washout Period 1 (10-14 Days)||19
9944625|NCT01372410|11063188|FG001|STARTED|Washout Period 1 (10-14 Days)||19
10207520|NCT03528551|11334357|FG000|COMPLETED|Overall Study||23
10207521|NCT03528551|11334358|FG001|COMPLETED|Overall Study||114
10207522|NCT03528551|11334359|FG002|COMPLETED|Overall Study||2
10207523|NCT03528551|11334357|FG000|NOT COMPLETED|Overall Study||2
10207524|NCT03528551|11334358|FG001|NOT COMPLETED|Overall Study||19
10207525|NCT03528551|11334359|FG002|NOT COMPLETED|Overall Study||0
9944626|NCT01372410|11063189|FG002|STARTED|Washout Period 1 (10-14 Days)||19
9944627|NCT01372410|11063190|FG003|STARTED|Washout Period 1 (10-14 Days)||20
9944628|NCT01372410|11063191|FG004|STARTED|Washout Period 1 (10-14 Days)||19
9944629|NCT01372410|11063192|FG005|STARTED|Washout Period 1 (10-14 Days)||21
9944630|NCT01372410|11063193|FG006|STARTED|Washout Period 1 (10-14 Days)||20
9944631|NCT01372410|11063194|FG007|STARTED|Washout Period 1 (10-14 Days)||19
9944632|NCT01372410|11063187|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
9944633|NCT01372410|11063188|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
9944634|NCT01372410|11063189|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
9944635|NCT01372410|11063190|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
9944636|NCT01372410|11063191|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
9944637|NCT01372410|11063192|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
9944638|NCT01372410|11063193|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
9944639|NCT01372410|11063194|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
9944640|NCT01372410|11063187|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
9944641|NCT01372410|11063188|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
9944642|NCT01372410|11063189|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
9944643|NCT01372410|11063190|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
9944644|NCT01372410|11063191|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
9944645|NCT01372410|11063192|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
9944646|NCT01372410|11063193|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
10011536|NCT01781286|11134281|FG003|Started 3rd Intervention|Overall Study||7
10011537|NCT01781286|11134282|FG004|Started 3rd Intervention|Overall Study||6
10011538|NCT01781286|11134283|FG005|Started 3rd Intervention|Overall Study||2
10011539|NCT01781286|11134278|FG000|COMPLETED|Overall Study||5
10011540|NCT01781286|11134279|FG001|COMPLETED|Overall Study||4
10011541|NCT01781286|11134280|FG002|COMPLETED|Overall Study||7
10011542|NCT01781286|11134281|FG003|COMPLETED|Overall Study||7
10011543|NCT01781286|11134282|FG004|COMPLETED|Overall Study||6
10011544|NCT01781286|11134283|FG005|COMPLETED|Overall Study||2
10011545|NCT01781286|11134278|FG000|NOT COMPLETED|Overall Study||2
10011546|NCT01781286|11134279|FG001|NOT COMPLETED|Overall Study||0
10011547|NCT01781286|11134280|FG002|NOT COMPLETED|Overall Study||2
10011548|NCT01781286|11134281|FG003|NOT COMPLETED|Overall Study||1
10207526|NCT03528577|11334368|FG000|STARTED|Sequence 1||128
10207527|NCT03528577|11334368|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
10207528|NCT03528577|11334368|FG000|NOT COMPLETED|Sequence 1||2
9944647|NCT01372410|11063194|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
9944648|NCT01372410|11063187|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
9944649|NCT01372410|11063188|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
9944650|NCT01372410|11063189|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
10011549|NCT01781286|11134282|FG004|NOT COMPLETED|Overall Study||0
10011550|NCT01781286|11134283|FG005|NOT COMPLETED|Overall Study||1
10207529|NCT03528577|11334368|FG000|STARTED|Sequence 2||128
10207530|NCT03528577|11334368|FG000|COMPLETED|Sequence 2||125
10207531|NCT03528577|11334368|FG000|NOT COMPLETED|Sequence 2||3
9944651|NCT01372410|11063190|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
9944652|NCT01372410|11063191|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
9944653|NCT01372410|11063192|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
9944654|NCT01372410|11063193|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
9944655|NCT01372410|11063194|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
9944656|NCT01372410|11063187|FG000|COMPLETED|Treatment Period 2 (7 Days)||19
9944657|NCT01372410|11063188|FG001|COMPLETED|Treatment Period 2 (7 Days)||21
9944658|NCT01372410|11063189|FG002|COMPLETED|Treatment Period 2 (7 Days)||22
9944659|NCT01372410|11063190|FG003|COMPLETED|Treatment Period 2 (7 Days)||17
9944660|NCT01372410|11063191|FG004|COMPLETED|Treatment Period 2 (7 Days)||19
9944661|NCT01372410|11063192|FG005|COMPLETED|Treatment Period 2 (7 Days)||16
9944662|NCT01372410|11063193|FG006|COMPLETED|Treatment Period 2 (7 Days)||21
9944663|NCT01372410|11063194|FG007|COMPLETED|Treatment Period 2 (7 Days)||19
9944664|NCT01372410|11063187|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944665|NCT01372410|11063188|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944666|NCT01372410|11063189|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944667|NCT01372410|11063190|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944668|NCT01372410|11063191|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944669|NCT01372410|11063192|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944670|NCT01372410|11063193|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944671|NCT01372410|11063194|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0
9944672|NCT01372410|11063187|FG000|STARTED|Washout Period 2 (10-14 Days)||19
9944673|NCT01372410|11063188|FG001|STARTED|Washout Period 2 (10-14 Days)||21
9944674|NCT01372410|11063189|FG002|STARTED|Washout Period 2 (10-14 Days)||22
9944675|NCT01372410|11063190|FG003|STARTED|Washout Period 2 (10-14 Days)||17
9944676|NCT01372410|11063191|FG004|STARTED|Washout Period 2 (10-14 Days)||19
9944677|NCT01372410|11063192|FG005|STARTED|Washout Period 2 (10-14 Days)||16
9944678|NCT01372410|11063193|FG006|STARTED|Washout Period 2 (10-14 Days)||21
9944679|NCT01372410|11063194|FG007|STARTED|Washout Period 2 (10-14 Days)||19
9944680|NCT01372410|11063187|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
9944681|NCT01372410|11063188|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
9944682|NCT01372410|11063189|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
9944683|NCT01372410|11063190|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
9944684|NCT01372410|11063191|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
9944685|NCT01372410|11063192|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
9944686|NCT01372410|11063193|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
9944687|NCT01372410|11063194|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
9944688|NCT01372410|11063187|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
9944689|NCT01372410|11063188|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
9944690|NCT01372410|11063189|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
9944691|NCT01372410|11063190|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
9944692|NCT01372410|11063191|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
9944693|NCT01372410|11063192|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
9944694|NCT01372410|11063193|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
9944695|NCT01372410|11063194|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
9944696|NCT01372410|11063187|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
9944697|NCT01372410|11063188|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
9944698|NCT01372410|11063189|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
9944699|NCT01372410|11063190|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
9944700|NCT01372410|11063191|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
9944701|NCT01372410|11063192|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
9944702|NCT01372410|11063193|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
9944703|NCT01372410|11063194|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
9944704|NCT01372410|11063187|FG000|COMPLETED|Treatment Period 3 (7 Days)||21
9944705|NCT01372410|11063188|FG001|COMPLETED|Treatment Period 3 (7 Days)||18
9944706|NCT01372410|11063189|FG002|COMPLETED|Treatment Period 3 (7 Days)||15
9944707|NCT01372410|11063190|FG003|COMPLETED|Treatment Period 3 (7 Days)||22
9944708|NCT01372410|11063191|FG004|COMPLETED|Treatment Period 3 (7 Days)||20
9944709|NCT01372410|11063192|FG005|COMPLETED|Treatment Period 3 (7 Days)||18
9944710|NCT01372410|11063193|FG006|COMPLETED|Treatment Period 3 (7 Days)||15
9944711|NCT01372410|11063194|FG007|COMPLETED|Treatment Period 3 (7 Days)||18
9944712|NCT01372410|11063187|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
9944713|NCT01372410|11063188|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
9944714|NCT01372410|11063189|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1
9944715|NCT01372410|11063190|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
9944716|NCT01372410|11063191|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
9944717|NCT01372410|11063192|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1
9944718|NCT01372410|11063193|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0
9944719|NCT01372410|11063194|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0
9944720|NCT01372462|11063213|FG000|STARTED|NIOV - Room Air||15
9944721|NCT01372462|11063213|FG000|COMPLETED|NIOV - Room Air||15
9944722|NCT01372462|11063213|FG000|NOT COMPLETED|NIOV - Room Air||0
9944723|NCT01372462|11063213|FG000|STARTED|NIOV - Oxygen||15
9944724|NCT01372462|11063213|FG000|COMPLETED|NIOV - Oxygen||15
9944725|NCT01372462|11063213|FG000|NOT COMPLETED|NIOV - Oxygen||0
9944726|NCT01372462|11063213|FG000|STARTED|Oxygen Nasal Cannula||15
9944727|NCT01372462|11063213|FG000|COMPLETED|Oxygen Nasal Cannula||15
9944728|NCT01372462|11063213|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0
9944729|NCT01372462|11063213|FG000|STARTED|No Treatment Control||15
10011551|NCT01781299|11134295|FG000|STARTED|Overall Study||4
10011552|NCT01781299|11134296|FG001|STARTED|Overall Study||5
10011553|NCT01781299|11134295|FG000|COMPLETED|Overall Study||4
10011554|NCT01781299|11134296|FG001|COMPLETED|Overall Study||4
10011555|NCT01781299|11134295|FG000|NOT COMPLETED|Overall Study||0
10011556|NCT01781299|11134296|FG001|NOT COMPLETED|Overall Study||1
10011557|NCT01781403|11134302|FG000|STARTED|Overall Study||2
9944730|NCT01372462|11063213|FG000|COMPLETED|No Treatment Control||15
9944731|NCT01372462|11063213|FG000|NOT COMPLETED|No Treatment Control||0
9944732|NCT01372501|11063223|FG000|STARTED|Overall Study||19
9944733|NCT01372501|11063223|FG000|COMPLETED|Overall Study||14
9944734|NCT01372501|11063223|FG000|NOT COMPLETED|Overall Study||5
9944735|NCT01372605|11063230|FG000|STARTED|Overall Study||149
9944736|NCT01372605|11063231|FG001|STARTED|Overall Study||155
9944737|NCT01372605|11063230|FG000|COMPLETED|Overall Study||137
9944738|NCT01372605|11063231|FG001|COMPLETED|Overall Study||145
9944739|NCT01372605|11063230|FG000|NOT COMPLETED|Overall Study||12
9944740|NCT01372605|11063231|FG001|NOT COMPLETED|Overall Study||10
9944741|NCT01372748|11063239|FG000|STARTED|Overall Study||11045
9944742|NCT01372748|11063240|FG001|STARTED|Overall Study||12642
9944743|NCT01372748|11063239|FG000|COMPLETED|Overall Study|defined as having vital status|11022
9944744|NCT01372748|11063240|FG001|COMPLETED|Overall Study|defined as having vital status|12603
9944745|NCT01372748|11063239|FG000|NOT COMPLETED|Overall Study||23
9944746|NCT01372748|11063240|FG001|NOT COMPLETED|Overall Study||39
9944747|NCT01372774|11063248|FG000|STARTED|Overall Study||96
9944748|NCT01372774|11063249|FG001|STARTED|Overall Study||98
9944749|NCT01372774|11063248|FG000|COMPLETED|Overall Study||92
9944750|NCT01372774|11063249|FG001|COMPLETED|Overall Study||93
9944751|NCT01372774|11063248|FG000|NOT COMPLETED|Overall Study||4
9944752|NCT01372774|11063249|FG001|NOT COMPLETED|Overall Study||5
9944753|NCT01372813|11063257|FG000|STARTED|Overall Study||3
9944754|NCT01372813|11063257|FG000|COMPLETED|Overall Study||3
9944755|NCT01372813|11063257|FG000|NOT COMPLETED|Overall Study||0
9944756|NCT01372878|11063261|FG000|STARTED|Overall Study||884
9944757|NCT01372878|11063261|FG000|COMPLETED|Overall Study||700
9944758|NCT01372878|11063261|FG000|NOT COMPLETED|Overall Study||184
9944759|NCT01372995|11063268|FG000|STARTED|Overall Study||10
9944760|NCT01372995|11063269|FG001|STARTED|Overall Study||10
9944761|NCT01372995|11063270|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
9944762|NCT01372995|11063268|FG000|COMPLETED|Overall Study||10
9944763|NCT01372995|11063269|FG001|COMPLETED|Overall Study||9
9944764|NCT01372995|11063270|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
9944765|NCT01372995|11063268|FG000|NOT COMPLETED|Overall Study||0
9944766|NCT01372995|11063269|FG001|NOT COMPLETED|Overall Study||1
9944767|NCT01372995|11063270|FG002|NOT COMPLETED|Overall Study||1
9944768|NCT01373164|11063283|FG000|STARTED|Overall Study||5
9944769|NCT01373164|11063284|FG001|STARTED|Overall Study||4
9944770|NCT01373164|11063285|FG002|STARTED|Overall Study||5
9944771|NCT01373164|11063286|FG003|STARTED|Overall Study||104
9944772|NCT01373164|11063287|FG004|STARTED|Overall Study||52
9944773|NCT01373164|11063283|FG000|Received at Least One Dose|Overall Study||5
9944774|NCT01373164|11063284|FG001|Received at Least One Dose|Overall Study||4
9944775|NCT01373164|11063285|FG002|Received at Least One Dose|Overall Study||5
9944776|NCT01373164|11063286|FG003|Received at Least One Dose|Overall Study||103
9944777|NCT01373164|11063287|FG004|Received at Least One Dose|Overall Study||52
9944778|NCT01373164|11063283|FG000|COMPLETED|Overall Study||5
9944779|NCT01373164|11063284|FG001|COMPLETED|Overall Study||3
9944780|NCT01373164|11063285|FG002|COMPLETED|Overall Study||4
9944781|NCT01373164|11063286|FG003|COMPLETED|Overall Study||92
9944782|NCT01373164|11063287|FG004|COMPLETED|Overall Study||50
9944783|NCT01373164|11063283|FG000|NOT COMPLETED|Overall Study||0
9944784|NCT01373164|11063284|FG001|NOT COMPLETED|Overall Study||1
9944785|NCT01373164|11063285|FG002|NOT COMPLETED|Overall Study||1
9944786|NCT01373164|11063286|FG003|NOT COMPLETED|Overall Study||12
9944787|NCT01373164|11063287|FG004|NOT COMPLETED|Overall Study||2
9944788|NCT01373229|11063302|FG000|STARTED|Overall Study||15
10011558|NCT01781403|11134303|FG001|STARTED|Overall Study||2
10011559|NCT01781403|11134304|FG002|STARTED|Overall Study||18
10011560|NCT01781403|11134302|FG000|COMPLETED|Overall Study||2
10011561|NCT01781403|11134303|FG001|COMPLETED|Overall Study||2
9944789|NCT01373229|11063302|FG000|COMPLETED|Overall Study||9
9944790|NCT01373229|11063302|FG000|NOT COMPLETED|Overall Study||6
9944791|NCT01373242|11063306|FG000|STARTED|Overall Study||54
9944792|NCT01373242|11063306|FG000|COMPLETED|Overall Study||38
9944793|NCT01373242|11063306|FG000|NOT COMPLETED|Overall Study||16
10011562|NCT01781403|11134304|FG002|COMPLETED|Overall Study||18
10011563|NCT01781403|11134302|FG000|NOT COMPLETED|Overall Study||0
10011564|NCT01781403|11134303|FG001|NOT COMPLETED|Overall Study||0
10011565|NCT01781403|11134304|FG002|NOT COMPLETED|Overall Study||0
10011566|NCT01781429|11134329|FG000|STARTED|Overall Study||1
10011567|NCT01781429|11134330|FG001|STARTED|Overall Study||1
10011568|NCT01781429|11134331|FG002|STARTED|Overall Study||1
10011569|NCT01781429|11134332|FG003|STARTED|Overall Study||1
10011570|NCT01781429|11134333|FG004|STARTED|Overall Study||1
10011571|NCT01781429|11134334|FG005|STARTED|Overall Study||4
10011572|NCT01781429|11134335|FG006|STARTED|Overall Study||7
10011573|NCT01781429|11134336|FG007|STARTED|Overall Study||4
10011574|NCT01781429|11134337|FG008|STARTED|Overall Study||7
10011575|NCT01781429|11134338|FG009|STARTED|Overall Study||24
10011576|NCT01781429|11134339|FG010|STARTED|Overall Study||18
10011577|NCT01781429|11134340|FG011|STARTED|Overall Study||21
10011578|NCT01781429|11134341|FG012|STARTED|Overall Study||22
9944794|NCT01373294|11063314|FG000|STARTED|Overall Study||15
9944795|NCT01373294|11063315|FG001|STARTED|Overall Study||2
9944796|NCT01373294|11063314|FG000|COMPLETED|Overall Study||14
9944797|NCT01373294|11063315|FG001|COMPLETED|Overall Study||2
9944798|NCT01373294|11063314|FG000|NOT COMPLETED|Overall Study||1
9944799|NCT01373294|11063315|FG001|NOT COMPLETED|Overall Study||0
9944800|NCT01373346|11063321|FG000|STARTED|Overall Study||15
9944801|NCT01373346|11063321|FG000|COMPLETED|Overall Study||14
9944802|NCT01373346|11063321|FG000|NOT COMPLETED|Overall Study||1
9944803|NCT01373450|11063330|FG000|STARTED|Crossover Period 1||2
9944804|NCT01373450|11063331|FG001|STARTED|Crossover Period 1||2
9944805|NCT01373450|11063332|FG002|STARTED|Crossover Period 1||2
9944806|NCT01373450|11063333|FG003|STARTED|Crossover Period 1||2
9944807|NCT01373450|11063334|FG004|STARTED|Crossover Period 1||2
9944808|NCT01373450|11063335|FG005|STARTED|Crossover Period 1||2
9944809|NCT01373450|11063330|FG000|COMPLETED|Crossover Period 1||2
9944810|NCT01373450|11063331|FG001|COMPLETED|Crossover Period 1||2
9944811|NCT01373450|11063332|FG002|COMPLETED|Crossover Period 1||2
9944812|NCT01373450|11063333|FG003|COMPLETED|Crossover Period 1||2
9944813|NCT01373450|11063334|FG004|COMPLETED|Crossover Period 1||2
9944814|NCT01373450|11063335|FG005|COMPLETED|Crossover Period 1||2
9944815|NCT01373450|11063330|FG000|NOT COMPLETED|Crossover Period 1||0
9944816|NCT01373450|11063331|FG001|NOT COMPLETED|Crossover Period 1||0
9944817|NCT01373450|11063332|FG002|NOT COMPLETED|Crossover Period 1||0
9944818|NCT01373450|11063333|FG003|NOT COMPLETED|Crossover Period 1||0
9944819|NCT01373450|11063334|FG004|NOT COMPLETED|Crossover Period 1||0
9944820|NCT01373450|11063335|FG005|NOT COMPLETED|Crossover Period 1||0
9944821|NCT01373450|11063330|FG000|STARTED|7 Day Wash-out||2
9944822|NCT01373450|11063331|FG001|STARTED|7 Day Wash-out||2
9944823|NCT01373450|11063332|FG002|STARTED|7 Day Wash-out||2
9944824|NCT01373450|11063333|FG003|STARTED|7 Day Wash-out||2
9944825|NCT01373450|11063334|FG004|STARTED|7 Day Wash-out||2
9944826|NCT01373450|11063335|FG005|STARTED|7 Day Wash-out||2
9944827|NCT01373450|11063330|FG000|COMPLETED|7 Day Wash-out||2
9944828|NCT01373450|11063331|FG001|COMPLETED|7 Day Wash-out||2
9944829|NCT01373450|11063332|FG002|COMPLETED|7 Day Wash-out||2
9944830|NCT01373450|11063333|FG003|COMPLETED|7 Day Wash-out||2
9944831|NCT01373450|11063334|FG004|COMPLETED|7 Day Wash-out||2
9944832|NCT01373450|11063335|FG005|COMPLETED|7 Day Wash-out||2
9944833|NCT01373450|11063330|FG000|NOT COMPLETED|7 Day Wash-out||0
9944834|NCT01373450|11063331|FG001|NOT COMPLETED|7 Day Wash-out||0
9944835|NCT01373450|11063332|FG002|NOT COMPLETED|7 Day Wash-out||0
9944836|NCT01373450|11063333|FG003|NOT COMPLETED|7 Day Wash-out||0
9944837|NCT01373450|11063334|FG004|NOT COMPLETED|7 Day Wash-out||0
9944838|NCT01373450|11063335|FG005|NOT COMPLETED|7 Day Wash-out||0
9944839|NCT01373450|11063330|FG000|STARTED|Crossover Period 2||2
9944840|NCT01373450|11063331|FG001|STARTED|Crossover Period 2||2
9944841|NCT01373450|11063332|FG002|STARTED|Crossover Period 2||2
9944842|NCT01373450|11063333|FG003|STARTED|Crossover Period 2||2
9944843|NCT01373450|11063334|FG004|STARTED|Crossover Period 2||2
9944844|NCT01373450|11063335|FG005|STARTED|Crossover Period 2||2
10011579|NCT01781429|11134342|FG013|STARTED|Overall Study||8
10011580|NCT01781429|11134343|FG014|STARTED|Overall Study||16
10011581|NCT01781429|11134344|FG015|STARTED|Overall Study||0
10011582|NCT01781429|11134329|FG000|COMPLETED|Overall Study||0
10011583|NCT01781429|11134330|FG001|COMPLETED|Overall Study||0
10011584|NCT01781429|11134331|FG002|COMPLETED|Overall Study||0
9944845|NCT01373450|11063330|FG000|COMPLETED|Crossover Period 2||2
9944846|NCT01373450|11063331|FG001|COMPLETED|Crossover Period 2||2
9944847|NCT01373450|11063332|FG002|COMPLETED|Crossover Period 2||2
9944848|NCT01373450|11063333|FG003|COMPLETED|Crossover Period 2||2
9944849|NCT01373450|11063334|FG004|COMPLETED|Crossover Period 2||2
9944850|NCT01373450|11063335|FG005|COMPLETED|Crossover Period 2||2
9944851|NCT01373450|11063330|FG000|NOT COMPLETED|Crossover Period 2||0
9944852|NCT01373450|11063331|FG001|NOT COMPLETED|Crossover Period 2||0
9944853|NCT01373450|11063332|FG002|NOT COMPLETED|Crossover Period 2||0
9944854|NCT01373450|11063333|FG003|NOT COMPLETED|Crossover Period 2||0
9944855|NCT01373450|11063334|FG004|NOT COMPLETED|Crossover Period 2||0
9944856|NCT01373450|11063335|FG005|NOT COMPLETED|Crossover Period 2||0
10011585|NCT01781429|11134332|FG003|COMPLETED|Overall Study||0
10011586|NCT01781429|11134333|FG004|COMPLETED|Overall Study||0
10011587|NCT01781429|11134334|FG005|COMPLETED|Overall Study||0
9944857|NCT01373450|11063330|FG000|STARTED|7 Day Wash-out||2
9944858|NCT01373450|11063331|FG001|STARTED|7 Day Wash-out||2
9944859|NCT01373450|11063332|FG002|STARTED|7 Day Wash-out||2
9944860|NCT01373450|11063333|FG003|STARTED|7 Day Wash-out||2
9944861|NCT01373450|11063334|FG004|STARTED|7 Day Wash-out||2
9944862|NCT01373450|11063335|FG005|STARTED|7 Day Wash-out||2
9944863|NCT01373450|11063330|FG000|COMPLETED|7 Day Wash-out||2
9944864|NCT01373450|11063331|FG001|COMPLETED|7 Day Wash-out||2
9944865|NCT01373450|11063332|FG002|COMPLETED|7 Day Wash-out||2
9944866|NCT01373450|11063333|FG003|COMPLETED|7 Day Wash-out||2
9944867|NCT01373450|11063334|FG004|COMPLETED|7 Day Wash-out||2
9944868|NCT01373450|11063335|FG005|COMPLETED|7 Day Wash-out||2
10011588|NCT01781429|11134335|FG006|COMPLETED|Overall Study||0
10011589|NCT01781429|11134336|FG007|COMPLETED|Overall Study||0
10011590|NCT01781429|11134337|FG008|COMPLETED|Overall Study||0
10011591|NCT01781429|11134338|FG009|COMPLETED|Overall Study||0
9944869|NCT01373450|11063330|FG000|NOT COMPLETED|7 Day Wash-out||0
9944870|NCT01373450|11063331|FG001|NOT COMPLETED|7 Day Wash-out||0
9944871|NCT01373450|11063332|FG002|NOT COMPLETED|7 Day Wash-out||0
9944872|NCT01373450|11063333|FG003|NOT COMPLETED|7 Day Wash-out||0
9944873|NCT01373450|11063334|FG004|NOT COMPLETED|7 Day Wash-out||0
9944874|NCT01373450|11063335|FG005|NOT COMPLETED|7 Day Wash-out||0
9944875|NCT01373450|11063330|FG000|STARTED|Crossover Period 3||2
9944876|NCT01373450|11063331|FG001|STARTED|Crossover Period 3||2
9944877|NCT01373450|11063332|FG002|STARTED|Crossover Period 3||2
9944878|NCT01373450|11063333|FG003|STARTED|Crossover Period 3||2
9944879|NCT01373450|11063334|FG004|STARTED|Crossover Period 3||2
9944880|NCT01373450|11063335|FG005|STARTED|Crossover Period 3||2
9944881|NCT01373450|11063330|FG000|COMPLETED|Crossover Period 3||2
9944882|NCT01373450|11063331|FG001|COMPLETED|Crossover Period 3||2
9944883|NCT01373450|11063332|FG002|COMPLETED|Crossover Period 3||2
9944884|NCT01373450|11063333|FG003|COMPLETED|Crossover Period 3||2
9944885|NCT01373450|11063334|FG004|COMPLETED|Crossover Period 3||2
9944886|NCT01373450|11063335|FG005|COMPLETED|Crossover Period 3||2
9944887|NCT01373450|11063330|FG000|NOT COMPLETED|Crossover Period 3||0
9944888|NCT01373450|11063331|FG001|NOT COMPLETED|Crossover Period 3||0
9944889|NCT01373450|11063332|FG002|NOT COMPLETED|Crossover Period 3||0
9944890|NCT01373450|11063333|FG003|NOT COMPLETED|Crossover Period 3||0
9944891|NCT01373450|11063334|FG004|NOT COMPLETED|Crossover Period 3||0
9944892|NCT01373450|11063335|FG005|NOT COMPLETED|Crossover Period 3||0
9944893|NCT01373450|11063330|FG000|STARTED|7 Day Wash-out||2
9944894|NCT01373450|11063331|FG001|STARTED|7 Day Wash-out||2
9944895|NCT01373450|11063332|FG002|STARTED|7 Day Wash-out||2
9944896|NCT01373450|11063333|FG003|STARTED|7 Day Wash-out||2
9944897|NCT01373450|11063334|FG004|STARTED|7 Day Wash-out||2
9944898|NCT01373450|11063335|FG005|STARTED|7 Day Wash-out||2
9944899|NCT01373450|11063330|FG000|COMPLETED|7 Day Wash-out||2
9944900|NCT01373450|11063331|FG001|COMPLETED|7 Day Wash-out||2
9944901|NCT01373450|11063332|FG002|COMPLETED|7 Day Wash-out||2
9944902|NCT01373450|11063333|FG003|COMPLETED|7 Day Wash-out||2
9944903|NCT01373450|11063334|FG004|COMPLETED|7 Day Wash-out||2
9944904|NCT01373450|11063335|FG005|COMPLETED|7 Day Wash-out||2
9944905|NCT01373450|11063330|FG000|NOT COMPLETED|7 Day Wash-out||0
9944906|NCT01373450|11063331|FG001|NOT COMPLETED|7 Day Wash-out||0
9944907|NCT01373450|11063332|FG002|NOT COMPLETED|7 Day Wash-out||0
9944908|NCT01373450|11063333|FG003|NOT COMPLETED|7 Day Wash-out||0
9944909|NCT01373450|11063334|FG004|NOT COMPLETED|7 Day Wash-out||0
9944910|NCT01373450|11063335|FG005|NOT COMPLETED|7 Day Wash-out||0
9944911|NCT01373450|11063330|FG000|STARTED|Crossover Period 4||2
9944912|NCT01373450|11063331|FG001|STARTED|Crossover Period 4||2
9944913|NCT01373450|11063332|FG002|STARTED|Crossover Period 4||2
9944914|NCT01373450|11063333|FG003|STARTED|Crossover Period 4||2
9944915|NCT01373450|11063334|FG004|STARTED|Crossover Period 4||2
9944916|NCT01373450|11063335|FG005|STARTED|Crossover Period 4||2
9944917|NCT01373450|11063330|FG000|COMPLETED|Crossover Period 4||2
9944918|NCT01373450|11063331|FG001|COMPLETED|Crossover Period 4||2
9944919|NCT01373450|11063332|FG002|COMPLETED|Crossover Period 4||2
9944920|NCT01373450|11063333|FG003|COMPLETED|Crossover Period 4||2
9944921|NCT01373450|11063334|FG004|COMPLETED|Crossover Period 4||2
9944922|NCT01373450|11063335|FG005|COMPLETED|Crossover Period 4||2
10011592|NCT01781429|11134339|FG010|COMPLETED|Overall Study||0
9944923|NCT01373450|11063330|FG000|NOT COMPLETED|Crossover Period 4||0
9944924|NCT01373450|11063331|FG001|NOT COMPLETED|Crossover Period 4||0
9944925|NCT01373450|11063332|FG002|NOT COMPLETED|Crossover Period 4||0
9944926|NCT01373450|11063333|FG003|NOT COMPLETED|Crossover Period 4||0
9944927|NCT01373450|11063334|FG004|NOT COMPLETED|Crossover Period 4||0
9944928|NCT01373450|11063335|FG005|NOT COMPLETED|Crossover Period 4||0
9944929|NCT01373489|11063351|FG000|STARTED|Overall Study||59
9944930|NCT01373489|11063352|FG001|STARTED|Overall Study||54
9944931|NCT01373489|11063351|FG000|COMPLETED|Overall Study||44
9944932|NCT01373489|11063352|FG001|COMPLETED|Overall Study||41
9944933|NCT01373489|11063351|FG000|NOT COMPLETED|Overall Study||15
9944934|NCT01373489|11063352|FG001|NOT COMPLETED|Overall Study||13
9944935|NCT01373580|11063358|FG000|STARTED|Overall Study||373
9944936|NCT01373580|11063358|FG000|COMPLETED|Overall Study||317
9944937|NCT01373580|11063358|FG000|NOT COMPLETED|Overall Study||56
9944938|NCT01373671|11063362|FG000|STARTED|Overall Study||764
9944939|NCT01373671|11063362|FG000|COMPLETED|Overall Study||672
9944940|NCT01373671|11063362|FG000|NOT COMPLETED|Overall Study||92
9944941|NCT01373918|11063369|FG000|STARTED|Overall Study||20
9944942|NCT01373918|11063370|FG001|STARTED|Overall Study||16
9944943|NCT01373918|11063369|FG000|COMPLETED|Overall Study||20
9944944|NCT01373918|11063370|FG001|COMPLETED|Overall Study||15
10011593|NCT01781429|11134340|FG011|COMPLETED|Overall Study||0
10011594|NCT01781429|11134341|FG012|COMPLETED|Overall Study||0
10011595|NCT01781429|11134342|FG013|COMPLETED|Overall Study||0
10011596|NCT01781429|11134343|FG014|COMPLETED|Overall Study||0
10011597|NCT01781429|11134344|FG015|COMPLETED|Overall Study||0
10011598|NCT01781429|11134329|FG000|NOT COMPLETED|Overall Study||1
9944945|NCT01373918|11063369|FG000|NOT COMPLETED|Overall Study||0
9944946|NCT01373918|11063370|FG001|NOT COMPLETED|Overall Study||1
9944947|NCT01373931|11063378|FG000|STARTED|Lead-in Period||10
9944948|NCT01373931|11063379|FG001|STARTED|Lead-in Period||10
9944949|NCT01373931|11063378|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8
9944950|NCT01373931|11063379|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10
9944951|NCT01373931|11063378|FG000|COMPLETED|Lead-in Period||8
9944952|NCT01373931|11063379|FG001|COMPLETED|Lead-in Period||10
9944953|NCT01373931|11063378|FG000|NOT COMPLETED|Lead-in Period||2
9944954|NCT01373931|11063379|FG001|NOT COMPLETED|Lead-in Period||0
9944955|NCT01373931|11063378|FG000|STARTED|Period 1||8
9944956|NCT01373931|11063379|FG001|STARTED|Period 1||10
9944957|NCT01373931|11063378|FG000|COMPLETED|Period 1||6
9944958|NCT01373931|11063379|FG001|COMPLETED|Period 1||8
9944959|NCT01373931|11063378|FG000|NOT COMPLETED|Period 1||2
9944960|NCT01373931|11063379|FG001|NOT COMPLETED|Period 1||2
9944961|NCT01373931|11063378|FG000|STARTED|Period 2||6
9944962|NCT01373931|11063379|FG001|STARTED|Period 2||8
9944963|NCT01373931|11063378|FG000|COMPLETED|Period 2||6
9944964|NCT01373931|11063379|FG001|COMPLETED|Period 2||8
9944965|NCT01373931|11063378|FG000|NOT COMPLETED|Period 2||0
9944966|NCT01373931|11063379|FG001|NOT COMPLETED|Period 2||0
9944967|NCT01374087|11063388|FG000|STARTED|Overall Study||16
9944968|NCT01374087|11063389|FG001|STARTED|Overall Study||15
9944969|NCT01374087|11063388|FG000|COMPLETED|Overall Study||0
9944970|NCT01374087|11063389|FG001|COMPLETED|Overall Study||0
9944971|NCT01374087|11063388|FG000|NOT COMPLETED|Overall Study||16
9944972|NCT01374087|11063389|FG001|NOT COMPLETED|Overall Study||15
9944973|NCT01374178|11063395|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11
9944974|NCT01374178|11063396|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5
9944975|NCT01374178|11063395|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
9944976|NCT01374178|11063396|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
9944977|NCT01374178|11063395|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
9944978|NCT01374178|11063396|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
9944979|NCT01374178|11063395|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
9944980|NCT01374178|11063396|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
9944981|NCT01374178|11063395|FG000|STARTED|Washout Period of at Least 7 Days||11
9944982|NCT01374178|11063396|FG001|STARTED|Washout Period of at Least 7 Days||5
9944983|NCT01374178|11063395|FG000|COMPLETED|Washout Period of at Least 7 Days||10
9944984|NCT01374178|11063396|FG001|COMPLETED|Washout Period of at Least 7 Days||5
9944985|NCT01374178|11063395|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
9944986|NCT01374178|11063396|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
9944987|NCT01374178|11063395|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10
9944988|NCT01374178|11063396|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5
9944989|NCT01374178|11063395|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
9944990|NCT01374178|11063396|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
9944991|NCT01374178|11063395|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
9944992|NCT01374178|11063396|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
9944993|NCT01374217|11063402|FG000|STARTED|Overall Study||13
9944994|NCT01374217|11063402|FG000|COMPLETED|Overall Study||0
9944995|NCT01374217|11063402|FG000|NOT COMPLETED|Overall Study||13
9944996|NCT01374269|11063408|FG000|STARTED|Overall Study||46
9944997|NCT01374269|11063409|FG001|STARTED|Overall Study||44
9944998|NCT01374269|11063408|FG000|COMPLETED|Overall Study||40
9944999|NCT01374269|11063409|FG001|COMPLETED|Overall Study||39
9945000|NCT01374269|11063408|FG000|NOT COMPLETED|Overall Study||6
9945001|NCT01374269|11063409|FG001|NOT COMPLETED|Overall Study||5
9945002|NCT01374425|11063417|FG000|STARTED|Overall Study||188
9945003|NCT01374425|11063418|FG001|STARTED|Overall Study||188
9945004|NCT01374425|11063417|FG000|COMPLETED|Overall Study||0
9945005|NCT01374425|11063418|FG001|COMPLETED|Overall Study||0
9945006|NCT01374425|11063417|FG000|NOT COMPLETED|Overall Study||188
10011599|NCT01781429|11134330|FG001|NOT COMPLETED|Overall Study||1
10011600|NCT01781429|11134331|FG002|NOT COMPLETED|Overall Study||1
9945007|NCT01374425|11063418|FG001|NOT COMPLETED|Overall Study||188
9945008|NCT01374438|11063447|FG000|STARTED|Overall Study||16
9945009|NCT01374438|11063448|FG001|STARTED|Overall Study||13
9945010|NCT01374438|11063447|FG000|COMPLETED|Overall Study||16
9945011|NCT01374438|11063448|FG001|COMPLETED|Overall Study||13
9945012|NCT01374438|11063447|FG000|NOT COMPLETED|Overall Study||0
9945013|NCT01374438|11063448|FG001|NOT COMPLETED|Overall Study||0
10011601|NCT01781429|11134332|FG003|NOT COMPLETED|Overall Study||1
10011602|NCT01781429|11134333|FG004|NOT COMPLETED|Overall Study||1
10011603|NCT01781429|11134334|FG005|NOT COMPLETED|Overall Study||4
9945014|NCT01374451|11063456|FG000|STARTED|Overall Study||79
9945015|NCT01374451|11063457|FG001|STARTED|Overall Study||81
9945016|NCT01374451|11063456|FG000|COMPLETED|Overall Study||78
9945017|NCT01374451|11063457|FG001|COMPLETED|Overall Study||81
9945018|NCT01374451|11063456|FG000|NOT COMPLETED|Overall Study||1
9945019|NCT01374451|11063457|FG001|NOT COMPLETED|Overall Study||0
9945020|NCT01374490|11063463|FG000|STARTED|Overall Study||250
9945021|NCT01374490|11063463|FG000|COMPLETED|Overall Study||190
9945022|NCT01374490|11063463|FG000|NOT COMPLETED|Overall Study||60
9945023|NCT01374568|11063469|FG000|STARTED|Overall Study||2
9945024|NCT01374568|11063470|FG001|STARTED|Overall Study||3
9945025|NCT01374568|11063469|FG000|COMPLETED|Overall Study||2
9945026|NCT01374568|11063470|FG001|COMPLETED|Overall Study||1
9945027|NCT01374568|11063469|FG000|NOT COMPLETED|Overall Study||0
9945028|NCT01374568|11063470|FG001|NOT COMPLETED|Overall Study||2
9945029|NCT01374802|11063476|FG000|STARTED|Overall Study||14
9945030|NCT01374802|11063476|FG000|COMPLETED|Overall Study||14
10207532|NCT03528577|11334368|FG000|STARTED|Sequence 3||128
10207533|NCT03528577|11334368|FG000|COMPLETED|Sequence 3||127
10207534|NCT03528577|11334368|FG000|NOT COMPLETED|Sequence 3||1
10207535|NCT03528577|11334368|FG000|STARTED|Sequence 4||128
10207536|NCT03528577|11334368|FG000|COMPLETED|Sequence 4||125
10207537|NCT03528577|11334368|FG000|NOT COMPLETED|Sequence 4||3
9945031|NCT01374802|11063476|FG000|NOT COMPLETED|Overall Study||0
9956769|NCT01448213|11076061|FG000|COMPLETED|Overall Study||113
9956770|NCT01448213|11076062|FG001|COMPLETED|Overall Study||112
9956771|NCT01448213|11076061|FG000|NOT COMPLETED|Overall Study||17
9956772|NCT01448213|11076062|FG001|NOT COMPLETED|Overall Study||22
9956773|NCT01448356|11076068|FG000|STARTED|Overall Study||10
9956774|NCT01448356|11076068|FG000|COMPLETED|Overall Study|cross-over|10
9956775|NCT01448356|11076068|FG000|NOT COMPLETED|Overall Study||0
9956776|NCT01448421|11076073|FG000|STARTED|Overall Study||37
9956777|NCT01448421|11076073|FG000|COMPLETED|Overall Study||37
9956778|NCT01448421|11076073|FG000|NOT COMPLETED|Overall Study||0
9956779|NCT01448447|11076079|FG000|STARTED|Overall Study||20
9956780|NCT01448447|11076080|FG001|STARTED|Overall Study||0
9956781|NCT01448447|11076079|FG000|COMPLETED|Overall Study||20
9956782|NCT01448447|11076080|FG001|COMPLETED|Overall Study||0
9956783|NCT01448447|11076079|FG000|NOT COMPLETED|Overall Study||0
9956784|NCT01448447|11076080|FG001|NOT COMPLETED|Overall Study||0
9956785|NCT01448486|11076088|FG000|STARTED|Overall Study||3
9956786|NCT01448486|11076089|FG001|STARTED|Overall Study||3
9956787|NCT01448486|11076088|FG000|COMPLETED|Overall Study||3
9956788|NCT01448486|11076089|FG001|COMPLETED|Overall Study||3
9956789|NCT01448486|11076088|FG000|NOT COMPLETED|Overall Study||0
9956790|NCT01448486|11076089|FG001|NOT COMPLETED|Overall Study||0
9956791|NCT01448525|11076097|FG000|STARTED|Overall Study||44
9956792|NCT01448525|11076098|FG001|STARTED|Overall Study||44
9956793|NCT01448525|11076097|FG000|COMPLETED|Overall Study||43
9956794|NCT01448525|11076098|FG001|COMPLETED|Overall Study||42
9956795|NCT01448525|11076097|FG000|NOT COMPLETED|Overall Study||1
9956796|NCT01448525|11076098|FG001|NOT COMPLETED|Overall Study||2
9956797|NCT01448616|11076107|FG000|STARTED|Lead-In (Observational Phase)||73
9956798|NCT01448616|11076108|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
9956799|NCT01448616|11076109|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
9956800|NCT01448616|11076110|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
9956801|NCT01448616|11076107|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
9956802|NCT01448616|11076108|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
9956803|NCT01448616|11076109|FG002|COMPLETED|Lead-In (Observational Phase)||0
9956804|NCT01448616|11076110|FG003|COMPLETED|Lead-In (Observational Phase)||0
9956805|NCT01448616|11076107|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9
9956806|NCT01448616|11076108|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0
9956807|NCT01448616|11076109|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0
9956808|NCT01448616|11076110|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0
9956809|NCT01448616|11076107|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
10207538|NCT03529162|11334377|FG000|STARTED|Overall Study||2
10207539|NCT03529162|11334378|FG001|STARTED|Overall Study||2
10207540|NCT03529162|11334377|FG000|COMPLETED|Overall Study||0
10207541|NCT03529162|11334378|FG001|COMPLETED|Overall Study||0
10207542|NCT03529162|11334377|FG000|NOT COMPLETED|Overall Study||2
10207543|NCT03529162|11334378|FG001|NOT COMPLETED|Overall Study||2
10207544|NCT03529461|11334388|FG000|STARTED|Overall Study||28
10207545|NCT03529461|11334389|FG001|STARTED|Overall Study||28
10207546|NCT03529461|11334388|FG000|COMPLETED|Overall Study||28
9956810|NCT01448616|11076108|FG001|STARTED|Study Drug (Treatment Phase)||24
9956811|NCT01448616|11076109|FG002|STARTED|Study Drug (Treatment Phase)||27
9956812|NCT01448616|11076110|FG003|STARTED|Study Drug (Treatment Phase)||13
9956813|NCT01448616|11076107|FG000|COMPLETED|Study Drug (Treatment Phase)||0
9956814|NCT01448616|11076108|FG001|COMPLETED|Study Drug (Treatment Phase)||22
9956815|NCT01448616|11076109|FG002|COMPLETED|Study Drug (Treatment Phase)||23
9956816|NCT01448616|11076110|FG003|COMPLETED|Study Drug (Treatment Phase)||9
9956817|NCT01448616|11076107|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0
9956818|NCT01448616|11076108|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2
9956819|NCT01448616|11076109|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4
9956820|NCT01448616|11076110|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4
9956821|NCT01448707|11076125|FG000|STARTED|Overall Study||137
9956822|NCT01448707|11076126|FG001|STARTED|Overall Study||136
9945032|NCT01374906|11063484|FG000|STARTED|Overall Study||74
9945033|NCT01374906|11063485|FG001|STARTED|Overall Study||76
9945034|NCT01374906|11063484|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
9945035|NCT01374906|11063485|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
9945036|NCT01374906|11063484|FG000|Completed Core Phase|Overall Study||50
9945037|NCT01374906|11063485|FG001|Completed Core Phase|Overall Study||54
9945038|NCT01374906|11063484|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
9945039|NCT01374906|11063485|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
9945040|NCT01374906|11063484|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40
9945041|NCT01374906|11063485|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41
10011604|NCT01781429|11134335|FG006|NOT COMPLETED|Overall Study||7
10011605|NCT01781429|11134336|FG007|NOT COMPLETED|Overall Study||4
10011606|NCT01781429|11134337|FG008|NOT COMPLETED|Overall Study||7
10011607|NCT01781429|11134338|FG009|NOT COMPLETED|Overall Study||24
9945042|NCT01374906|11063484|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
9945043|NCT01374906|11063485|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
9945044|NCT01374906|11063484|FG000|Completed Extension Phase|Overall Study||24
9945045|NCT01374906|11063485|FG001|Completed Extension Phase|Overall Study||15
9945046|NCT01374906|11063484|FG000|COMPLETED|Overall Study||34
9945047|NCT01374906|11063485|FG001|COMPLETED|Overall Study||28
9945048|NCT01374906|11063484|FG000|NOT COMPLETED|Overall Study||40
9945049|NCT01374906|11063485|FG001|NOT COMPLETED|Overall Study||48
9945050|NCT01374919|11063495|FG000|STARTED|Overall Study||60
9945051|NCT01374919|11063495|FG000|COMPLETED|Overall Study||58
9945052|NCT01374919|11063495|FG000|NOT COMPLETED|Overall Study||2
9945053|NCT01374971|11063499|FG000|STARTED|Overall Study||12
9945054|NCT01374971|11063499|FG000|COMPLETED|Overall Study||11
9945055|NCT01374971|11063499|FG000|NOT COMPLETED|Overall Study||1
9945056|NCT01375010|11063505|FG000|STARTED|Overall Study||43
9945057|NCT01375010|11063506|FG001|STARTED|Overall Study||42
9945058|NCT01375010|11063505|FG000|COMPLETED|Overall Study||31
9945059|NCT01375010|11063506|FG001|COMPLETED|Overall Study||38
9945060|NCT01375010|11063505|FG000|NOT COMPLETED|Overall Study||12
9945061|NCT01375010|11063506|FG001|NOT COMPLETED|Overall Study||4
9945062|NCT01375049|11063512|FG000|STARTED|Overall Study||105
9945063|NCT01375049|11063512|FG000|COMPLETED|Overall Study||55
9945064|NCT01375049|11063512|FG000|NOT COMPLETED|Overall Study||50
9945065|NCT01375075|11063526|FG000|STARTED|Overall Study||27
9945066|NCT01375075|11063527|FG001|STARTED|Overall Study||28
9945067|NCT01375075|11063528|FG002|STARTED|Overall Study||27
9945068|NCT01375075|11063529|FG003|STARTED|Overall Study||28
9945069|NCT01375075|11063530|FG004|STARTED|Overall Study||27
9945070|NCT01375075|11063531|FG005|STARTED|Overall Study||28
9945071|NCT01375075|11063526|FG000|Received at Least One Dose of Study Drug|Overall Study||27
9945072|NCT01375075|11063527|FG001|Received at Least One Dose of Study Drug|Overall Study||28
9945073|NCT01375075|11063528|FG002|Received at Least One Dose of Study Drug|Overall Study||27
9945074|NCT01375075|11063529|FG003|Received at Least One Dose of Study Drug|Overall Study||28
9945075|NCT01375075|11063530|FG004|Received at Least One Dose of Study Drug|Overall Study||27
9945076|NCT01375075|11063531|FG005|Received at Least One Dose of Study Drug|Overall Study||28
9945077|NCT01375075|11063526|FG000|COMPLETED|Overall Study||26
9945078|NCT01375075|11063527|FG001|COMPLETED|Overall Study||27
9945079|NCT01375075|11063528|FG002|COMPLETED|Overall Study||24
9945080|NCT01375075|11063529|FG003|COMPLETED|Overall Study||27
9945081|NCT01375075|11063530|FG004|COMPLETED|Overall Study||27
9945082|NCT01375075|11063531|FG005|COMPLETED|Overall Study||25
9945083|NCT01375075|11063526|FG000|NOT COMPLETED|Overall Study||1
9945084|NCT01375075|11063527|FG001|NOT COMPLETED|Overall Study||1
9945085|NCT01375075|11063528|FG002|NOT COMPLETED|Overall Study||3
9945086|NCT01375075|11063529|FG003|NOT COMPLETED|Overall Study||1
9945087|NCT01375075|11063530|FG004|NOT COMPLETED|Overall Study||0
9945088|NCT01375075|11063531|FG005|NOT COMPLETED|Overall Study||3
9945089|NCT01375127|11063555|FG000|STARTED|Overall Study||1
9945090|NCT01375127|11063556|FG001|STARTED|Overall Study||1
9945091|NCT01375127|11063557|FG002|STARTED|Overall Study||40
9945092|NCT01375127|11063558|FG003|STARTED|Overall Study||33
9945093|NCT01375127|11063559|FG004|STARTED|Overall Study||5
9945094|NCT01375127|11063560|FG005|STARTED|Overall Study||3
9945095|NCT01375127|11063555|FG000|COMPLETED|Overall Study||1
9945096|NCT01375127|11063556|FG001|COMPLETED|Overall Study||1
9945097|NCT01375127|11063557|FG002|COMPLETED|Overall Study||40
9945098|NCT01375127|11063558|FG003|COMPLETED|Overall Study||33
9945099|NCT01375127|11063559|FG004|COMPLETED|Overall Study||5
9945100|NCT01375127|11063560|FG005|COMPLETED|Overall Study||3
9945101|NCT01375127|11063555|FG000|NOT COMPLETED|Overall Study||0
9945102|NCT01375127|11063556|FG001|NOT COMPLETED|Overall Study||0
9945103|NCT01375127|11063557|FG002|NOT COMPLETED|Overall Study||0
9945104|NCT01375127|11063558|FG003|NOT COMPLETED|Overall Study||0
9945105|NCT01375127|11063559|FG004|NOT COMPLETED|Overall Study||0
9945106|NCT01375127|11063560|FG005|NOT COMPLETED|Overall Study||0
9945107|NCT01375140|11063574|FG000|STARTED|Overall Study||31
9945108|NCT01375140|11063574|FG000|COMPLETED|Overall Study||31
9945109|NCT01375140|11063574|FG000|NOT COMPLETED|Overall Study||0
9945110|NCT01375205|11063580|FG000|STARTED|Overall Study||54
9945111|NCT01375205|11063581|FG001|STARTED|Overall Study||46
9945112|NCT01375205|11063580|FG000|COMPLETED|Overall Study||33
9945113|NCT01375205|11063581|FG001|COMPLETED|Overall Study||33
10011608|NCT01781429|11134339|FG010|NOT COMPLETED|Overall Study||18
9945114|NCT01375205|11063580|FG000|NOT COMPLETED|Overall Study||21
9945115|NCT01375205|11063581|FG001|NOT COMPLETED|Overall Study||13
9945116|NCT01375374|11063587|FG000|STARTED|Overall Study||11
9945117|NCT01375374|11063587|FG000|COMPLETED|Overall Study||10
9945118|NCT01375374|11063587|FG000|NOT COMPLETED|Overall Study||1
9945119|NCT01375491|11063594|FG000|STARTED|Overall Study||11
9945120|NCT01375491|11063595|FG001|STARTED|Overall Study||13
9945121|NCT01375491|11063596|FG002|STARTED|Overall Study||15
9945122|NCT01375491|11063594|FG000|COMPLETED|Overall Study||9
9945123|NCT01375491|11063595|FG001|COMPLETED|Overall Study||12
9945124|NCT01375491|11063596|FG002|COMPLETED|Overall Study||15
9945125|NCT01375491|11063594|FG000|NOT COMPLETED|Overall Study||2
9945126|NCT01375491|11063595|FG001|NOT COMPLETED|Overall Study||1
9945127|NCT01375491|11063596|FG002|NOT COMPLETED|Overall Study||0
9945128|NCT01375569|11063603|FG000|STARTED|Overall Study||11
9945129|NCT01375569|11063603|FG000|COMPLETED|Overall Study||11
9945130|NCT01375569|11063603|FG000|NOT COMPLETED|Overall Study||0
9945131|NCT01375608|11063607|FG000|STARTED|Overall Study||10
9945132|NCT01375608|11063607|FG000|COMPLETED|Overall Study||8
9945133|NCT01375608|11063607|FG000|NOT COMPLETED|Overall Study||2
9945134|NCT01375660|11063613|FG000|STARTED|Overall Study||102
9945135|NCT01375660|11063614|FG001|STARTED|Overall Study||103
9945136|NCT01375660|11063613|FG000|COMPLETED|Overall Study||86
9945137|NCT01375660|11063614|FG001|COMPLETED|Overall Study||87
9945138|NCT01375660|11063613|FG000|NOT COMPLETED|Overall Study||16
9945139|NCT01375660|11063614|FG001|NOT COMPLETED|Overall Study||16
9945140|NCT01375673|11063623|FG000|STARTED|Overall Study||7
9945141|NCT01375673|11063624|FG001|STARTED|Overall Study||7
9945142|NCT01375673|11063623|FG000|COMPLETED|Overall Study||7
9945143|NCT01375673|11063624|FG001|COMPLETED|Overall Study||6
9945144|NCT01375673|11063623|FG000|NOT COMPLETED|Overall Study||0
9945145|NCT01375673|11063624|FG001|NOT COMPLETED|Overall Study||1
9945146|NCT01375751|11063633|FG000|STARTED|Overall Study||56
9945147|NCT01375751|11063634|FG001|STARTED|Overall Study||56
9945148|NCT01375751|11063635|FG002|STARTED|Overall Study||56
9945149|NCT01375751|11063633|FG000|Received Treatment|Overall Study||56
9945150|NCT01375751|11063634|FG001|Received Treatment|Overall Study||55
9945151|NCT01375751|11063635|FG002|Received Treatment|Overall Study||56
9945152|NCT01375751|11063633|FG000|COMPLETED|Overall Study||56
9945153|NCT01375751|11063634|FG001|COMPLETED|Overall Study||55
9945154|NCT01375751|11063635|FG002|COMPLETED|Overall Study||56
9945155|NCT01375751|11063633|FG000|NOT COMPLETED|Overall Study||0
9945156|NCT01375751|11063634|FG001|NOT COMPLETED|Overall Study||1
9945157|NCT01375751|11063635|FG002|NOT COMPLETED|Overall Study||0
9945158|NCT01375764|11063648|FG000|STARTED|Overall Study||33
9945159|NCT01375764|11063649|FG001|STARTED|Overall Study||31
9945160|NCT01375764|11063650|FG002|STARTED|Overall Study||32
9945161|NCT01375764|11063651|FG003|STARTED|Overall Study||32
9945162|NCT01375764|11063652|FG004|STARTED|Overall Study||32
9945163|NCT01375764|11063648|FG000|Received Treatment|Overall Study||32
9945164|NCT01375764|11063649|FG001|Received Treatment|Overall Study||30
9945165|NCT01375764|11063650|FG002|Received Treatment|Overall Study||32
9945166|NCT01375764|11063651|FG003|Received Treatment|Overall Study||31
9945167|NCT01375764|11063652|FG004|Received Treatment|Overall Study||32
9945168|NCT01375764|11063648|FG000|COMPLETED|Overall Study||31
9945169|NCT01375764|11063649|FG001|COMPLETED|Overall Study||30
9945170|NCT01375764|11063650|FG002|COMPLETED|Overall Study||32
9945171|NCT01375764|11063651|FG003|COMPLETED|Overall Study||31
10011609|NCT01781429|11134340|FG011|NOT COMPLETED|Overall Study||21
10011610|NCT01781429|11134341|FG012|NOT COMPLETED|Overall Study||22
10011611|NCT01781429|11134342|FG013|NOT COMPLETED|Overall Study||8
10011612|NCT01781429|11134343|FG014|NOT COMPLETED|Overall Study||16
10011613|NCT01781429|11134344|FG015|NOT COMPLETED|Overall Study||0
10011614|NCT01781468|11134380|FG000|STARTED|Overall Study||109
10011615|NCT01781468|11134381|FG001|STARTED|Overall Study||110
10011616|NCT01781468|11134382|FG002|STARTED|Overall Study||109
10011617|NCT01781468|11134380|FG000|COMPLETED|Overall Study||103
10011618|NCT01781468|11134381|FG001|COMPLETED|Overall Study||97
10011619|NCT01781468|11134382|FG002|COMPLETED|Overall Study||97
9945172|NCT01375764|11063652|FG004|COMPLETED|Overall Study||31
9945173|NCT01375764|11063648|FG000|NOT COMPLETED|Overall Study||2
9945174|NCT01375764|11063649|FG001|NOT COMPLETED|Overall Study||1
9945175|NCT01375764|11063650|FG002|NOT COMPLETED|Overall Study||0
9945176|NCT01375764|11063651|FG003|NOT COMPLETED|Overall Study||1
9945177|NCT01375764|11063652|FG004|NOT COMPLETED|Overall Study||1
10011620|NCT01781468|11134380|FG000|NOT COMPLETED|Overall Study||6
9945178|NCT01375777|11063673|FG000|STARTED|Overall Study||46
9945179|NCT01375777|11063674|FG001|STARTED|Overall Study||45
9945180|NCT01375777|11063675|FG002|STARTED|Overall Study||46
9945181|NCT01375777|11063676|FG003|STARTED|Overall Study||45
9945182|NCT01375777|11063677|FG004|STARTED|Overall Study||46
9945183|NCT01375777|11063678|FG005|STARTED|Overall Study||45
9945184|NCT01375777|11063679|FG006|STARTED|Overall Study||46
9945185|NCT01375777|11063680|FG007|STARTED|Overall Study||46
9945186|NCT01375777|11063681|FG008|STARTED|Overall Study||46
9945187|NCT01375777|11063673|FG000|Received Treatment|Overall Study||45
10011621|NCT01781468|11134381|FG001|NOT COMPLETED|Overall Study||13
10011622|NCT01781468|11134382|FG002|NOT COMPLETED|Overall Study||12
9945188|NCT01375777|11063674|FG001|Received Treatment|Overall Study||45
9945189|NCT01375777|11063675|FG002|Received Treatment|Overall Study||45
9945190|NCT01375777|11063676|FG003|Received Treatment|Overall Study||45
9945191|NCT01375777|11063677|FG004|Received Treatment|Overall Study||46
9945192|NCT01375777|11063678|FG005|Received Treatment|Overall Study||45
9945193|NCT01375777|11063679|FG006|Received Treatment|Overall Study||45
9945194|NCT01375777|11063680|FG007|Received Treatment|Overall Study||45
9945195|NCT01375777|11063681|FG008|Received Treatment|Overall Study||45
9945196|NCT01375777|11063673|FG000|COMPLETED|Overall Study||44
9945197|NCT01375777|11063674|FG001|COMPLETED|Overall Study||42
9945198|NCT01375777|11063675|FG002|COMPLETED|Overall Study||45
9945199|NCT01375777|11063676|FG003|COMPLETED|Overall Study||45
9945200|NCT01375777|11063677|FG004|COMPLETED|Overall Study||45
9945201|NCT01375777|11063678|FG005|COMPLETED|Overall Study||44
9945202|NCT01375777|11063679|FG006|COMPLETED|Overall Study||44
9945203|NCT01375777|11063680|FG007|COMPLETED|Overall Study||44
9945204|NCT01375777|11063681|FG008|COMPLETED|Overall Study||44
9945205|NCT01375777|11063673|FG000|NOT COMPLETED|Overall Study||2
9945206|NCT01375777|11063674|FG001|NOT COMPLETED|Overall Study||3
9945207|NCT01375777|11063675|FG002|NOT COMPLETED|Overall Study||1
9945208|NCT01375777|11063676|FG003|NOT COMPLETED|Overall Study||0
9945209|NCT01375777|11063677|FG004|NOT COMPLETED|Overall Study||1
9945210|NCT01375777|11063678|FG005|NOT COMPLETED|Overall Study||1
9945211|NCT01375777|11063679|FG006|NOT COMPLETED|Overall Study||2
9945212|NCT01375777|11063680|FG007|NOT COMPLETED|Overall Study||2
9945213|NCT01375777|11063681|FG008|NOT COMPLETED|Overall Study||2
9945214|NCT01375946|11063701|FG000|STARTED|Overall Study||4
9945215|NCT01375946|11063702|FG001|STARTED|Overall Study||4
9945216|NCT01375946|11063703|FG002|STARTED|Overall Study||4
9945217|NCT01375946|11063704|FG003|STARTED|Overall Study||4
9945218|NCT01375946|11063705|FG004|STARTED|Overall Study||4
9945219|NCT01375946|11063706|FG005|STARTED|Overall Study||4
9945220|NCT01375946|11063701|FG000|COMPLETED|Overall Study||4
9945221|NCT01375946|11063702|FG001|COMPLETED|Overall Study||4
9945222|NCT01375946|11063703|FG002|COMPLETED|Overall Study||4
9945223|NCT01375946|11063704|FG003|COMPLETED|Overall Study||4
9945224|NCT01375946|11063705|FG004|COMPLETED|Overall Study||4
9945225|NCT01375946|11063706|FG005|COMPLETED|Overall Study||4
9945226|NCT01375946|11063701|FG000|NOT COMPLETED|Overall Study||0
9945227|NCT01375946|11063702|FG001|NOT COMPLETED|Overall Study||0
9945228|NCT01375946|11063703|FG002|NOT COMPLETED|Overall Study||0
9945229|NCT01375946|11063704|FG003|NOT COMPLETED|Overall Study||0
9945230|NCT01375946|11063705|FG004|NOT COMPLETED|Overall Study||0
9945231|NCT01375946|11063706|FG005|NOT COMPLETED|Overall Study||0
9945232|NCT01376037|11063712|FG000|STARTED|Overall Study||31
9945233|NCT01376037|11063713|FG001|STARTED|Overall Study||31
9945234|NCT01376037|11063712|FG000|COMPLETED|Overall Study||31
9945235|NCT01376037|11063713|FG001|COMPLETED|Overall Study||29
9945236|NCT01376037|11063712|FG000|NOT COMPLETED|Overall Study||0
9945237|NCT01376037|11063713|FG001|NOT COMPLETED|Overall Study||2
9945238|NCT01376050|11063721|FG000|STARTED|Overall Study||13
9945239|NCT01376050|11063722|FG001|STARTED|Overall Study||11
9945240|NCT01376050|11063721|FG000|COMPLETED|Overall Study||13
9945241|NCT01376050|11063722|FG001|COMPLETED|Overall Study||11
9945242|NCT01376050|11063721|FG000|NOT COMPLETED|Overall Study||0
9945243|NCT01376050|11063722|FG001|NOT COMPLETED|Overall Study||0
9945244|NCT01376089|11063730|FG000|STARTED|Overall Study||151
9945245|NCT01376089|11063731|FG001|STARTED|Overall Study||148
9945246|NCT01376089|11063730|FG000|COMPLETED|Overall Study||148
9945247|NCT01376089|11063731|FG001|COMPLETED|Overall Study||144
9945248|NCT01376089|11063730|FG000|NOT COMPLETED|Overall Study||3
9945249|NCT01376089|11063731|FG001|NOT COMPLETED|Overall Study||4
9945250|NCT01376167|11063744|FG000|STARTED|Overall Study||133
9945251|NCT01376167|11063745|FG001|STARTED|Overall Study||260
9945252|NCT01376167|11063746|FG002|STARTED|Overall Study||129
9945253|NCT01376167|11063744|FG000|COMPLETED|Overall Study||129
9945254|NCT01376167|11063745|FG001|COMPLETED|Overall Study||250
9945255|NCT01376167|11063746|FG002|COMPLETED|Overall Study||123
9945256|NCT01376167|11063744|FG000|NOT COMPLETED|Overall Study||4
9945257|NCT01376167|11063745|FG001|NOT COMPLETED|Overall Study||10
9945258|NCT01376167|11063746|FG002|NOT COMPLETED|Overall Study||6
9945259|NCT01376245|11063761|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744
9945260|NCT01376245|11063762|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0
9945261|NCT01376245|11063763|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0
9945262|NCT01376245|11063764|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0
9945263|NCT01376245|11063765|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0
9945264|NCT01376245|11063761|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
9945265|NCT01376245|11063762|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10207547|NCT03529461|11334389|FG001|COMPLETED|Overall Study||28
10207548|NCT03529461|11334388|FG000|NOT COMPLETED|Overall Study||0
10207549|NCT03529461|11334389|FG001|NOT COMPLETED|Overall Study||0
9945266|NCT01376245|11063763|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
9945267|NCT01376245|11063764|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
9945268|NCT01376245|11063765|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
9945269|NCT01376245|11063761|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
10207550|NCT03530098|11334398|FG000|STARTED|Overall Study||939
9945270|NCT01376245|11063762|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
9945271|NCT01376245|11063763|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
9945272|NCT01376245|11063764|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
9945273|NCT01376245|11063765|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
9945274|NCT01376245|11063761|FG000|STARTED|24-week, Double-blind Treatment Period||0
9945275|NCT01376245|11063762|FG001|STARTED|24-week, Double-blind Treatment Period||162
9945276|NCT01376245|11063763|FG002|STARTED|24-week, Double-blind Treatment Period||160
9945277|NCT01376245|11063764|FG003|STARTED|24-week, Double-blind Treatment Period||161
9945278|NCT01376245|11063765|FG004|STARTED|24-week, Double-blind Treatment Period||160
9945279|NCT01376245|11063761|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
9945280|NCT01376245|11063762|FG001|COMPLETED|24-week, Double-blind Treatment Period||130
9945281|NCT01376245|11063763|FG002|COMPLETED|24-week, Double-blind Treatment Period||135
9945282|NCT01376245|11063764|FG003|COMPLETED|24-week, Double-blind Treatment Period||138
9945283|NCT01376245|11063765|FG004|COMPLETED|24-week, Double-blind Treatment Period||134
9945284|NCT01376245|11063761|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
9945285|NCT01376245|11063762|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32
9945286|NCT01376245|11063763|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25
9945287|NCT01376245|11063764|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23
9945288|NCT01376245|11063765|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26
9945289|NCT01376297|11063777|FG000|STARTED|Overall Study|number of randomised patients|309
9945290|NCT01376297|11063778|FG001|STARTED|Overall Study|number of randomised patients|104
9945291|NCT01376297|11063777|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
9945292|NCT01376297|11063778|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
9945293|NCT01376297|11063777|FG000|NOT COMPLETED|Overall Study||128
9945294|NCT01376297|11063778|FG001|NOT COMPLETED|Overall Study||49
9945295|NCT01376310|11063786|FG000|STARTED|Overall Study||126
10011623|NCT01781481|11134391|FG000|STARTED|Overall Study||148
10011624|NCT01781481|11134391|FG000|COMPLETED|Overall Study||148
10207551|NCT03530098|11334399|FG001|STARTED|Overall Study||964
9945296|NCT01376310|11063787|FG001|STARTED|Overall Study||33
9945297|NCT01376310|11063786|FG000|COMPLETED|Overall Study||90
9945298|NCT01376310|11063787|FG001|COMPLETED|Overall Study||22
9945299|NCT01376310|11063786|FG000|NOT COMPLETED|Overall Study||36
9945300|NCT01376310|11063787|FG001|NOT COMPLETED|Overall Study||11
9945301|NCT01376349|11063796|FG000|STARTED|Raondomized Treatment||147
9945302|NCT01376349|11063797|FG001|STARTED|Raondomized Treatment||149
9945303|NCT01376349|11063798|FG002|STARTED|Raondomized Treatment||147
9945304|NCT01376349|11063796|FG000|COMPLETED|Raondomized Treatment||123
9945305|NCT01376349|11063797|FG001|COMPLETED|Raondomized Treatment||114
9945306|NCT01376349|11063798|FG002|COMPLETED|Raondomized Treatment||118
9945307|NCT01376349|11063796|FG000|NOT COMPLETED|Raondomized Treatment||24
9945308|NCT01376349|11063797|FG001|NOT COMPLETED|Raondomized Treatment||35
9945309|NCT01376349|11063798|FG002|NOT COMPLETED|Raondomized Treatment||29
9945310|NCT01376349|11063796|FG000|STARTED|Optional Continuation Phase||0
9945311|NCT01376349|11063797|FG001|STARTED|Optional Continuation Phase||0
9945312|NCT01376349|11063798|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
10207552|NCT03530098|11334398|FG000|Ground-truth Labeled|Overall Study||741
10207553|NCT03530098|11334399|FG001|Ground-truth Labeled|Overall Study||794
10207554|NCT03530098|11334398|FG000|Primary Analysis Set|Overall Study||739
10207555|NCT03530098|11334399|FG001|Primary Analysis Set|Overall Study||792
10207556|NCT03530098|11334398|FG000|COMPLETED|Overall Study||939
10207557|NCT03530098|11334399|FG001|COMPLETED|Overall Study||964
10207558|NCT03530098|11334398|FG000|NOT COMPLETED|Overall Study||0
10207559|NCT03530098|11334399|FG001|NOT COMPLETED|Overall Study||0
10207560|NCT03530345|11334408|FG000|STARTED|Treatment Period A/Follow-up Period 1||28
10207561|NCT03530345|11334409|FG001|STARTED|Treatment Period A/Follow-up Period 1||29
10207562|NCT03530345|11334408|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
10207563|NCT03530345|11334409|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
10207564|NCT03530345|11334408|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7
10207565|NCT03530345|11334409|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7
10207566|NCT03530345|11334408|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
10207567|NCT03530345|11334409|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
10207568|NCT03530345|11334408|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
10207569|NCT03530345|11334409|FG001|STARTED|Treatment Period B/Follow-up Period 2||7
10207570|NCT03530345|11334408|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
10207571|NCT03530345|11334409|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
10207572|NCT03530345|11334408|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0
10207573|NCT03530345|11334409|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
10207574|NCT03530345|11334408|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
10207575|NCT03530345|11334409|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
10207576|NCT03530631|11334421|FG000|STARTED|Adderall/Truth||4
10207577|NCT03530631|11334421|FG000|COMPLETED|Adderall/Truth||4
10207578|NCT03530631|11334421|FG000|NOT COMPLETED|Adderall/Truth||0
10207579|NCT03530631|11334421|FG000|STARTED|Placebo/Truth||4
10207580|NCT03530631|11334421|FG000|COMPLETED|Placebo/Truth||4
10207581|NCT03530631|11334421|FG000|NOT COMPLETED|Placebo/Truth||0
10207582|NCT03530631|11334421|FG000|STARTED|Adderall/Deception||4
10207583|NCT03530631|11334421|FG000|COMPLETED|Adderall/Deception||4
10207584|NCT03530631|11334421|FG000|NOT COMPLETED|Adderall/Deception||0
10207585|NCT03530631|11334421|FG000|STARTED|Placebo/Deception||4
10207586|NCT03530631|11334421|FG000|COMPLETED|Placebo/Deception||4
10207587|NCT03530631|11334421|FG000|NOT COMPLETED|Placebo/Deception||0
10207588|NCT03530917|11334439|FG000|STARTED|Overall Study||8
10207589|NCT03530917|11334440|FG001|STARTED|Overall Study||8
10207590|NCT03530917|11334441|FG002|STARTED|Overall Study||8
9945313|NCT01376349|11063796|FG000|COMPLETED|Optional Continuation Phase||0
9945314|NCT01376349|11063797|FG001|COMPLETED|Optional Continuation Phase||0
9945315|NCT01376349|11063798|FG002|COMPLETED|Optional Continuation Phase||94
9945316|NCT01376349|11063796|FG000|NOT COMPLETED|Optional Continuation Phase||0
9945317|NCT01376349|11063797|FG001|NOT COMPLETED|Optional Continuation Phase||0
9945318|NCT01376349|11063798|FG002|NOT COMPLETED|Optional Continuation Phase||0
9945319|NCT01376362|11063807|FG000|STARTED|Overall Study||5
9945320|NCT01376362|11063807|FG000|COMPLETED|Overall Study||5
9945321|NCT01376362|11063807|FG000|NOT COMPLETED|Overall Study||0
9945322|NCT01376388|11063811|FG000|STARTED|Overall Study||130
9945323|NCT01376388|11063811|FG000|COMPLETED|Overall Study||112
9945324|NCT01376388|11063811|FG000|NOT COMPLETED|Overall Study||18
9945325|NCT01376557|11063820|FG000|STARTED|Overall Study||59
9945326|NCT01376557|11063821|FG001|STARTED|Overall Study||60
9945327|NCT01376557|11063822|FG002|STARTED|Overall Study||60
9945328|NCT01376557|11063823|FG003|STARTED|Overall Study||60
9945329|NCT01376557|11063824|FG004|STARTED|Overall Study||60
9945330|NCT01376557|11063820|FG000|COMPLETED|Overall Study||51
9945331|NCT01376557|11063821|FG001|COMPLETED|Overall Study||54
9945332|NCT01376557|11063822|FG002|COMPLETED|Overall Study||55
9945333|NCT01376557|11063823|FG003|COMPLETED|Overall Study||54
9945334|NCT01376557|11063824|FG004|COMPLETED|Overall Study||53
9945335|NCT01376557|11063820|FG000|NOT COMPLETED|Overall Study||8
9945336|NCT01376557|11063821|FG001|NOT COMPLETED|Overall Study||6
9945337|NCT01376557|11063822|FG002|NOT COMPLETED|Overall Study||5
9945338|NCT01376557|11063823|FG003|NOT COMPLETED|Overall Study||6
9945339|NCT01376557|11063824|FG004|NOT COMPLETED|Overall Study||7
9945340|NCT01376700|11063836|FG000|STARTED|Overall Study||19
9945341|NCT01376700|11063836|FG000|COMPLETED|Overall Study||3
9945342|NCT01376700|11063836|FG000|NOT COMPLETED|Overall Study||16
9945343|NCT01376804|11063843|FG000|STARTED|Treatment Period||57
9945344|NCT01376804|11063843|FG000|Received Study Drug|Treatment Period||56
9945345|NCT01376804|11063843|FG000|COMPLETED|Treatment Period||49
9945346|NCT01376804|11063843|FG000|NOT COMPLETED|Treatment Period||8
9945347|NCT01376804|11063843|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
9945348|NCT01376804|11063843|FG000|COMPLETED|Follow-up Period||55
9945349|NCT01376804|11063843|FG000|NOT COMPLETED|Follow-up Period||0
9945350|NCT01376908|11063849|FG000|STARTED|Overall Study||27
9945351|NCT01376908|11063850|FG001|STARTED|Overall Study||29
9945352|NCT01376908|11063849|FG000|COMPLETED|Overall Study||25
9945353|NCT01376908|11063850|FG001|COMPLETED|Overall Study||26
9945354|NCT01376908|11063849|FG000|NOT COMPLETED|Overall Study||2
9945355|NCT01376908|11063850|FG001|NOT COMPLETED|Overall Study||3
9945356|NCT01377012|11063866|FG000|STARTED|Core Study||210
9945357|NCT01377012|11063867|FG001|STARTED|Core Study||213
9945358|NCT01377012|11063868|FG002|STARTED|Core Study||214
9945359|NCT01377012|11063866|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0
9945360|NCT01377012|11063867|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0
9945361|NCT01377012|11063868|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
9945362|NCT01377012|11063866|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0
9945363|NCT01377012|11063867|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0
9945364|NCT01377012|11063868|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53
9945365|NCT01377012|11063866|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
9945366|NCT01377012|11063867|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
9945367|NCT01377012|11063868|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
9945368|NCT01377012|11063866|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
9945369|NCT01377012|11063867|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
9945370|NCT01377012|11063868|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
9945371|NCT01377012|11063866|FG000|COMPLETED|Core Study||76
9945372|NCT01377012|11063867|FG001|COMPLETED|Core Study||81
9945373|NCT01377012|11063868|FG002|COMPLETED|Core Study||80
9945374|NCT01377012|11063866|FG000|NOT COMPLETED|Core Study||134
9945375|NCT01377012|11063867|FG001|NOT COMPLETED|Core Study||132
9945376|NCT01377012|11063868|FG002|NOT COMPLETED|Core Study||134
9945377|NCT01377012|11063866|FG000|STARTED|Extension Study, Weeks 104-260||57
9945378|NCT01377012|11063867|FG001|STARTED|Extension Study, Weeks 104-260||71
9945379|NCT01377012|11063868|FG002|STARTED|Extension Study, Weeks 104-260||68
9945380|NCT01377012|11063866|FG000|COMPLETED|Extension Study, Weeks 104-260||0
9945381|NCT01377012|11063867|FG001|COMPLETED|Extension Study, Weeks 104-260||0
9945382|NCT01377012|11063868|FG002|COMPLETED|Extension Study, Weeks 104-260||0
9945383|NCT01377012|11063866|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57
9945384|NCT01377012|11063867|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71
9945385|NCT01377012|11063868|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68
9945386|NCT01377194|11063879|FG000|STARTED|Overall Study||186
9945387|NCT01377194|11063880|FG001|STARTED|Overall Study||188
9945388|NCT01377194|11063881|FG002|STARTED|Overall Study||188
9945389|NCT01377194|11063879|FG000|COMPLETED|Overall Study||154
9945390|NCT01377194|11063880|FG001|COMPLETED|Overall Study||145
9945391|NCT01377194|11063881|FG002|COMPLETED|Overall Study||142
9945392|NCT01377194|11063879|FG000|NOT COMPLETED|Overall Study||32
9945393|NCT01377194|11063880|FG001|NOT COMPLETED|Overall Study||43
9945394|NCT01377194|11063881|FG002|NOT COMPLETED|Overall Study||46
9945395|NCT01377233|11063897|FG000|STARTED|Open-label||46
9945396|NCT01377233|11063898|FG001|STARTED|Open-label||0
9945397|NCT01377233|11063899|FG002|STARTED|Open-label||0
9945398|NCT01377233|11063900|FG003|STARTED|Open-label||0
9945399|NCT01377233|11063901|FG004|STARTED|Open-label||0
9945400|NCT01377233|11063897|FG000|COMPLETED|Open-label||42
9945401|NCT01377233|11063898|FG001|COMPLETED|Open-label||0
9945402|NCT01377233|11063899|FG002|COMPLETED|Open-label||0
9945403|NCT01377233|11063900|FG003|COMPLETED|Open-label||0
9945404|NCT01377233|11063901|FG004|COMPLETED|Open-label||0
9945405|NCT01377233|11063897|FG000|NOT COMPLETED|Open-label||4
9945406|NCT01377233|11063898|FG001|NOT COMPLETED|Open-label||0
9945407|NCT01377233|11063899|FG002|NOT COMPLETED|Open-label||0
9945408|NCT01377233|11063900|FG003|NOT COMPLETED|Open-label||0
9945409|NCT01377233|11063901|FG004|NOT COMPLETED|Open-label||0
9945410|NCT01377233|11063897|FG000|STARTED|Double-blind||0
9945411|NCT01377233|11063898|FG001|STARTED|Double-blind||11
9945412|NCT01377233|11063899|FG002|STARTED|Double-blind||10
9945413|NCT01377233|11063900|FG003|STARTED|Double-blind||11
9945414|NCT01377233|11063901|FG004|STARTED|Double-blind||10
9945415|NCT01377233|11063897|FG000|COMPLETED|Double-blind||0
9945416|NCT01377233|11063898|FG001|COMPLETED|Double-blind||10
9945417|NCT01377233|11063899|FG002|COMPLETED|Double-blind||8
9945418|NCT01377233|11063900|FG003|COMPLETED|Double-blind||7
9945419|NCT01377233|11063901|FG004|COMPLETED|Double-blind||8
9945420|NCT01377233|11063897|FG000|NOT COMPLETED|Double-blind||0
9945421|NCT01377233|11063898|FG001|NOT COMPLETED|Double-blind||1
9945422|NCT01377233|11063899|FG002|NOT COMPLETED|Double-blind||2
9945423|NCT01377233|11063900|FG003|NOT COMPLETED|Double-blind||4
9945424|NCT01377233|11063901|FG004|NOT COMPLETED|Double-blind||2
9945425|NCT01377389|11063917|FG000|STARTED|Overall Study||30
9945426|NCT01377389|11063917|FG000|COMPLETED|Overall Study||27
9945427|NCT01377389|11063917|FG000|NOT COMPLETED|Overall Study||3
9945428|NCT01377402|11063921|FG000|STARTED|Overall Study||982
9945429|NCT01377402|11063921|FG000|COMPLETED|Overall Study||982
9945430|NCT01377402|11063921|FG000|NOT COMPLETED|Overall Study||0
9945431|NCT01377467|11063929|FG000|STARTED|Overall Study||46
9945432|NCT01377467|11063930|FG001|STARTED|Overall Study||44
9945433|NCT01377467|11063929|FG000|COMPLETED|Overall Study||46
9945434|NCT01377467|11063930|FG001|COMPLETED|Overall Study||44
9945435|NCT01377467|11063929|FG000|NOT COMPLETED|Overall Study||0
9945436|NCT01377467|11063930|FG001|NOT COMPLETED|Overall Study||0
9945437|NCT01377480|11063940|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
9945438|NCT01377480|11063941|FG001|STARTED|Overall Study||30
9945439|NCT01377480|11063942|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
9945440|NCT01377480|11063943|FG003|STARTED|Overall Study||30
9945441|NCT01377480|11063940|FG000|COMPLETED|Overall Study||32
9945442|NCT01377480|11063941|FG001|COMPLETED|Overall Study||29
9945443|NCT01377480|11063942|FG002|COMPLETED|Overall Study||18
9945444|NCT01377480|11063943|FG003|COMPLETED|Overall Study||19
9945445|NCT01377480|11063940|FG000|NOT COMPLETED|Overall Study||0
9945446|NCT01377480|11063941|FG001|NOT COMPLETED|Overall Study||1
9945447|NCT01377480|11063942|FG002|NOT COMPLETED|Overall Study||10
9945448|NCT01377480|11063943|FG003|NOT COMPLETED|Overall Study||11
9945449|NCT01377584|11063959|FG000|STARTED|Overall Study||8
9945450|NCT01377584|11063960|FG001|STARTED|Overall Study||8
9945451|NCT01377584|11063961|FG002|STARTED|Overall Study||10
9945452|NCT01377584|11063962|FG003|STARTED|Overall Study||10
9945453|NCT01377584|11063963|FG004|STARTED|Overall Study||12
9945454|NCT01377584|11063964|FG005|STARTED|Overall Study||12
9945455|NCT01377584|11063959|FG000|COMPLETED|Overall Study||5
9945456|NCT01377584|11063960|FG001|COMPLETED|Overall Study||5
9945457|NCT01377584|11063961|FG002|COMPLETED|Overall Study||6
9945458|NCT01377584|11063962|FG003|COMPLETED|Overall Study||6
9945459|NCT01377584|11063963|FG004|COMPLETED|Overall Study||9
9945460|NCT01377584|11063964|FG005|COMPLETED|Overall Study||9
9945461|NCT01377584|11063959|FG000|NOT COMPLETED|Overall Study||3
9945462|NCT01377584|11063960|FG001|NOT COMPLETED|Overall Study||3
9945463|NCT01377584|11063961|FG002|NOT COMPLETED|Overall Study||4
9945464|NCT01377584|11063962|FG003|NOT COMPLETED|Overall Study||4
9945465|NCT01377584|11063963|FG004|NOT COMPLETED|Overall Study||3
9945466|NCT01377584|11063964|FG005|NOT COMPLETED|Overall Study||3
9945467|NCT01377623|11063983|FG000|STARTED|Overall Study||33
9945468|NCT01377623|11063984|FG001|STARTED|Overall Study||33
9945469|NCT01377623|11063983|FG000|COMPLETED|Overall Study||26
9945470|NCT01377623|11063984|FG001|COMPLETED|Overall Study||28
9945471|NCT01377623|11063983|FG000|NOT COMPLETED|Overall Study||7
9945472|NCT01377623|11063984|FG001|NOT COMPLETED|Overall Study||5
9945473|NCT01377636|11063990|FG000|STARTED|Overall Study||20
9945474|NCT01377636|11063990|FG000|COMPLETED|Overall Study||20
9945475|NCT01377636|11063990|FG000|NOT COMPLETED|Overall Study||0
9945476|NCT01377844|11063998|FG000|STARTED|Overall Study||145
9945477|NCT01377844|11063999|FG001|STARTED|Overall Study||143
9945478|NCT01377844|11063998|FG000|Safety Population|Overall Study||145
9945479|NCT01377844|11063999|FG001|Safety Population|Overall Study||141
9945480|NCT01377844|11063998|FG000|COMPLETED|Overall Study||109
9945481|NCT01377844|11063999|FG001|COMPLETED|Overall Study||108
9945482|NCT01377844|11063998|FG000|NOT COMPLETED|Overall Study||36
9945483|NCT01377844|11063999|FG001|NOT COMPLETED|Overall Study||35
9945484|NCT01377922|11064008|FG000|STARTED|Overall Study||22
9945485|NCT01377922|11064009|FG001|STARTED|Overall Study||16
9945486|NCT01377922|11064008|FG000|COMPLETED|Overall Study||21
9945487|NCT01377922|11064009|FG001|COMPLETED|Overall Study||16
9945488|NCT01377922|11064008|FG000|NOT COMPLETED|Overall Study||1
9945489|NCT01377922|11064009|FG001|NOT COMPLETED|Overall Study||0
9945490|NCT01377987|11064015|FG000|STARTED|First Intervention (7 Days)||14
9945491|NCT01377987|11064016|FG001|STARTED|First Intervention (7 Days)||15
9945492|NCT01377987|11064015|FG000|COMPLETED|First Intervention (7 Days)||14
9945493|NCT01377987|11064016|FG001|COMPLETED|First Intervention (7 Days)||15
9945494|NCT01377987|11064015|FG000|NOT COMPLETED|First Intervention (7 Days)||0
9945495|NCT01377987|11064016|FG001|NOT COMPLETED|First Intervention (7 Days)||0
9945496|NCT01377987|11064015|FG000|STARTED|Washout (7 Days)||14
9945497|NCT01377987|11064016|FG001|STARTED|Washout (7 Days)||15
9945498|NCT01377987|11064015|FG000|COMPLETED|Washout (7 Days)||13
9945499|NCT01377987|11064016|FG001|COMPLETED|Washout (7 Days)||14
9945500|NCT01377987|11064015|FG000|NOT COMPLETED|Washout (7 Days)||1
9945501|NCT01377987|11064016|FG001|NOT COMPLETED|Washout (7 Days)||1
9945502|NCT01377987|11064015|FG000|STARTED|Second Intervention (7 Days)||13
9945503|NCT01377987|11064016|FG001|STARTED|Second Intervention (7 Days)||14
9945504|NCT01377987|11064015|FG000|COMPLETED|Second Intervention (7 Days)||13
9945505|NCT01377987|11064016|FG001|COMPLETED|Second Intervention (7 Days)||14
9945506|NCT01377987|11064015|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
9945507|NCT01377987|11064016|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
9945508|NCT01378065|11064022|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
9945509|NCT01378065|11064022|FG000|6 Week|Overall Study||30
9945510|NCT01378065|11064022|FG000|3 Months|Overall Study||30
9945511|NCT01378065|11064022|FG000|6 Months|Overall Study||30
9945512|NCT01378065|11064022|FG000|12 Months|Overall Study||30
9945513|NCT01378065|11064022|FG000|COMPLETED|Overall Study||30
9945514|NCT01378065|11064022|FG000|NOT COMPLETED|Overall Study||0
9945515|NCT01378104|11064028|FG000|STARTED|Overall Study||92
9945516|NCT01378104|11064029|FG001|STARTED|Overall Study||86
9945517|NCT01378104|11064028|FG000|COMPLETED|Overall Study||65
9945518|NCT01378104|11064029|FG001|COMPLETED|Overall Study||60
9945519|NCT01378104|11064028|FG000|NOT COMPLETED|Overall Study||27
9945520|NCT01378104|11064029|FG001|NOT COMPLETED|Overall Study||26
9945521|NCT01378117|11064040|FG000|STARTED|Overall Study||31
9945522|NCT01378117|11064041|FG001|STARTED|Overall Study||30
9945523|NCT01378117|11064042|FG002|STARTED|Overall Study||29
9945524|NCT01378117|11064040|FG000|COMPLETED|Overall Study||27
9945525|NCT01378117|11064041|FG001|COMPLETED|Overall Study||29
9945526|NCT01378117|11064042|FG002|COMPLETED|Overall Study||26
9945527|NCT01378117|11064040|FG000|NOT COMPLETED|Overall Study||4
9945528|NCT01378117|11064041|FG001|NOT COMPLETED|Overall Study||1
9945529|NCT01378117|11064042|FG002|NOT COMPLETED|Overall Study||3
9945530|NCT01378195|11064057|FG000|STARTED|Overall Study||75
10011625|NCT01781481|11134391|FG000|NOT COMPLETED|Overall Study||0
10011626|NCT01781572|11134447|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16
10011627|NCT01781572|11134448|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6
10011628|NCT01781572|11134449|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41
10207591|NCT03530917|11334442|FG003|STARTED|Overall Study||8
10207592|NCT03530917|11334443|FG004|STARTED|Overall Study||8
9945531|NCT01378195|11064058|FG001|STARTED|Overall Study||75
9945532|NCT01378195|11064057|FG000|COMPLETED|Overall Study||46
9945533|NCT01378195|11064058|FG001|COMPLETED|Overall Study||57
9945534|NCT01378195|11064057|FG000|NOT COMPLETED|Overall Study||29
9945535|NCT01378195|11064058|FG001|NOT COMPLETED|Overall Study||18
9945536|NCT01378221|11064066|FG000|STARTED|Overall Study||36
10207593|NCT03530917|11334444|FG005|STARTED|Overall Study||6
10207594|NCT03530917|11334445|FG006|STARTED|Overall Study||8
10207595|NCT03530917|11334446|FG007|STARTED|Overall Study||16
10207596|NCT03530917|11334439|FG000|COMPLETED|Overall Study||8
10207597|NCT03530917|11334440|FG001|COMPLETED|Overall Study||8
10207598|NCT03530917|11334441|FG002|COMPLETED|Overall Study||8
9945537|NCT01378221|11064067|FG001|STARTED|Overall Study||39
9945538|NCT01378221|11064066|FG000|COMPLETED|Overall Study||29
9945539|NCT01378221|11064067|FG001|COMPLETED|Overall Study||30
9945540|NCT01378221|11064066|FG000|NOT COMPLETED|Overall Study||7
9945541|NCT01378221|11064067|FG001|NOT COMPLETED|Overall Study||9
9945542|NCT01378273|11064075|FG000|STARTED|Overall Study||464
9945543|NCT01378273|11064076|FG001|STARTED|Overall Study||477
9945544|NCT01378273|11064075|FG000|COMPLETED|Overall Study||460
9945545|NCT01378273|11064076|FG001|COMPLETED|Overall Study||476
10207599|NCT03530917|11334442|FG003|COMPLETED|Overall Study||8
10207600|NCT03530917|11334443|FG004|COMPLETED|Overall Study||8
10207601|NCT03530917|11334444|FG005|COMPLETED|Overall Study||6
10207602|NCT03530917|11334445|FG006|COMPLETED|Overall Study||8
10207603|NCT03530917|11334446|FG007|COMPLETED|Overall Study||16
10207604|NCT03530917|11334439|FG000|NOT COMPLETED|Overall Study||0
10207605|NCT03530917|11334440|FG001|NOT COMPLETED|Overall Study||0
10207606|NCT03530917|11334441|FG002|NOT COMPLETED|Overall Study||0
10207607|NCT03530917|11334442|FG003|NOT COMPLETED|Overall Study||0
10207608|NCT03530917|11334443|FG004|NOT COMPLETED|Overall Study||0
10207609|NCT03530917|11334444|FG005|NOT COMPLETED|Overall Study||0
10207610|NCT03530917|11334445|FG006|NOT COMPLETED|Overall Study||0
10207611|NCT03530917|11334446|FG007|NOT COMPLETED|Overall Study||0
10207612|NCT03531710|11334476|FG000|STARTED|Overall Study||10
10207613|NCT03531710|11334477|FG001|STARTED|Overall Study||2
9945546|NCT01378273|11064075|FG000|NOT COMPLETED|Overall Study||4
9945547|NCT01378273|11064076|FG001|NOT COMPLETED|Overall Study||1
9945548|NCT01378299|11064086|FG000|STARTED|Overall Study||105
10207614|NCT03531710|11334478|FG002|STARTED|Overall Study||7
9945549|NCT01378299|11064086|FG000|BMI group1|Overall Study||38
9945550|NCT01378299|11064086|FG000|BMI Group 2|Overall Study||40
9945551|NCT01378299|11064086|FG000|BMI Group 3|Overall Study||27
10207615|NCT03531710|11334479|FG003|STARTED|Overall Study||5
10207616|NCT03531710|11334480|FG004|STARTED|Overall Study||8
9945552|NCT01378299|11064086|FG000|COMPLETED|Overall Study||74
9945553|NCT01378299|11064086|FG000|NOT COMPLETED|Overall Study||31
9945554|NCT01378325|11064118|FG000|STARTED|Overall Study||40
9945555|NCT01378325|11064119|FG001|STARTED|Overall Study||40
9945556|NCT01378325|11064118|FG000|COMPLETED|Overall Study||40
9945557|NCT01378325|11064119|FG001|COMPLETED|Overall Study||39
9945558|NCT01378325|11064118|FG000|NOT COMPLETED|Overall Study||0
9945559|NCT01378325|11064119|FG001|NOT COMPLETED|Overall Study||1
9945560|NCT01378377|11064128|FG000|STARTED|Overall Study||4
9945561|NCT01378377|11064129|FG001|STARTED|Overall Study||23
9945562|NCT01378377|11064130|FG002|STARTED|Overall Study||6
9945563|NCT01378377|11064128|FG000|COMPLETED|Overall Study||4
9945564|NCT01378377|11064129|FG001|COMPLETED|Overall Study||23
9945565|NCT01378377|11064130|FG002|COMPLETED|Overall Study||6
9945566|NCT01378377|11064128|FG000|NOT COMPLETED|Overall Study||0
9945567|NCT01378377|11064129|FG001|NOT COMPLETED|Overall Study||0
9945568|NCT01378377|11064130|FG002|NOT COMPLETED|Overall Study||0
9945569|NCT01378416|11064143|FG000|STARTED|Overall Study||16
9945570|NCT01378416|11064143|FG000|COMPLETED|Overall Study||16
9945571|NCT01378416|11064143|FG000|NOT COMPLETED|Overall Study||0
9945572|NCT01378429|11064149|FG000|STARTED|Overall Study||42
9945573|NCT01378429|11064150|FG001|STARTED|Overall Study||47
9945574|NCT01378429|11064149|FG000|COMPLETED|Overall Study||41
9945575|NCT01378429|11064150|FG001|COMPLETED|Overall Study||47
9945576|NCT01378429|11064149|FG000|NOT COMPLETED|Overall Study||1
9945577|NCT01378429|11064150|FG001|NOT COMPLETED|Overall Study||0
9945578|NCT01378520|11064159|FG000|STARTED|First Intervention (Day 2-3)||10
9945579|NCT01378520|11064160|FG001|STARTED|First Intervention (Day 2-3)||10
9945580|NCT01378520|11064159|FG000|COMPLETED|First Intervention (Day 2-3)||10
9945581|NCT01378520|11064160|FG001|COMPLETED|First Intervention (Day 2-3)||10
9945582|NCT01378520|11064159|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0
9945583|NCT01378520|11064160|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0
9945584|NCT01378520|11064159|FG000|STARTED|Second Intervention (Day 4-6)||10
9945585|NCT01378520|11064160|FG001|STARTED|Second Intervention (Day 4-6)||10
9945586|NCT01378520|11064159|FG000|COMPLETED|Second Intervention (Day 4-6)||10
9945587|NCT01378520|11064160|FG001|COMPLETED|Second Intervention (Day 4-6)||10
9945588|NCT01378520|11064159|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0
9945589|NCT01378520|11064160|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0
9945590|NCT01378858|11064168|FG000|STARTED|Overall Study||50
9945591|NCT01378858|11064169|FG001|STARTED|Overall Study||50
9945592|NCT01378858|11064168|FG000|COMPLETED|Overall Study||46
9945593|NCT01378858|11064169|FG001|COMPLETED|Overall Study||46
9945594|NCT01378858|11064168|FG000|NOT COMPLETED|Overall Study||4
9945595|NCT01378858|11064169|FG001|NOT COMPLETED|Overall Study||4
9945596|NCT01378962|11064175|FG000|STARTED|Overall Study||50
9945597|NCT01378962|11064175|FG000|COMPLETED|Overall Study||33
9945598|NCT01378962|11064175|FG000|NOT COMPLETED|Overall Study||17
9945599|NCT01378975|11064181|FG000|STARTED|Overall Study||90
9945600|NCT01378975|11064182|FG001|STARTED|Overall Study||56
9945601|NCT01378975|11064181|FG000|COMPLETED|Overall Study||4
9945602|NCT01378975|11064182|FG001|COMPLETED|Overall Study||6
9945603|NCT01378975|11064181|FG000|NOT COMPLETED|Overall Study||86
9945604|NCT01378975|11064182|FG001|NOT COMPLETED|Overall Study||50
9945605|NCT01378988|11064191|FG000|STARTED|Overall Study||2
9945606|NCT01378988|11064192|FG001|STARTED|Overall Study||3
9945607|NCT01378988|11064191|FG000|COMPLETED|Overall Study||2
9945608|NCT01378988|11064192|FG001|COMPLETED|Overall Study||3
9945609|NCT01378988|11064191|FG000|NOT COMPLETED|Overall Study||0
9945610|NCT01378988|11064192|FG001|NOT COMPLETED|Overall Study||0
9945611|NCT01379183|11064200|FG000|STARTED|Overall Study||19
10207617|NCT03531710|11334481|FG005|STARTED|Overall Study||2
10207618|NCT03531710|11334476|FG000|COMPLETED|Overall Study||8
10207619|NCT03531710|11334477|FG001|COMPLETED|Overall Study||2
10207620|NCT03531710|11334478|FG002|COMPLETED|Overall Study||7
10207621|NCT03531710|11334479|FG003|COMPLETED|Overall Study||5
10207622|NCT03531710|11334480|FG004|COMPLETED|Overall Study||8
10207623|NCT03531710|11334481|FG005|COMPLETED|Overall Study||2
10207624|NCT03531710|11334476|FG000|NOT COMPLETED|Overall Study||2
10207625|NCT03531710|11334477|FG001|NOT COMPLETED|Overall Study||0
10207626|NCT03531710|11334478|FG002|NOT COMPLETED|Overall Study||0
9945612|NCT01379183|11064201|FG001|STARTED|Overall Study||21
9945613|NCT01379183|11064200|FG000|COMPLETED|Overall Study||19
9945614|NCT01379183|11064201|FG001|COMPLETED|Overall Study||21
9945615|NCT01379183|11064200|FG000|NOT COMPLETED|Overall Study||0
9945616|NCT01379183|11064201|FG001|NOT COMPLETED|Overall Study||0
9945617|NCT01379222|11064209|FG000|STARTED|Overall Study||178
9945618|NCT01379222|11064209|FG000|COMPLETED|Overall Study||105
9945619|NCT01379222|11064209|FG000|NOT COMPLETED|Overall Study||73
9945620|NCT01379508|11064217|FG000|STARTED|Treatment to Week 104||99
9945621|NCT01379508|11064218|FG001|STARTED|Treatment to Week 104||22
9945622|NCT01379508|11064219|FG002|STARTED|Treatment to Week 104||109
9945623|NCT01379508|11064220|FG003|STARTED|Treatment to Week 104||11
10207627|NCT03531710|11334479|FG003|NOT COMPLETED|Overall Study||0
10207628|NCT03531710|11334480|FG004|NOT COMPLETED|Overall Study||0
9945624|NCT01379508|11064217|FG000|Completed Wk 24|Treatment to Week 104||93
9945625|NCT01379508|11064218|FG001|Completed Wk 24|Treatment to Week 104||22
9945626|NCT01379508|11064219|FG002|Completed Wk 24|Treatment to Week 104||107
9945627|NCT01379508|11064220|FG003|Completed Wk 24|Treatment to Week 104||11
9945628|NCT01379508|11064217|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
9956823|NCT01448707|11076125|FG000|COMPLETED|Overall Study||119
9945629|NCT01379508|11064218|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
9945630|NCT01379508|11064219|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
9945631|NCT01379508|11064220|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
9945632|NCT01379508|11064217|FG000|COMPLETED|Treatment to Week 104||80
9945633|NCT01379508|11064218|FG001|COMPLETED|Treatment to Week 104||19
9945634|NCT01379508|11064219|FG002|COMPLETED|Treatment to Week 104||96
9945635|NCT01379508|11064220|FG003|COMPLETED|Treatment to Week 104||11
9945636|NCT01379508|11064217|FG000|NOT COMPLETED|Treatment to Week 104||19
9945637|NCT01379508|11064218|FG001|NOT COMPLETED|Treatment to Week 104||3
9945638|NCT01379508|11064219|FG002|NOT COMPLETED|Treatment to Week 104||13
9945639|NCT01379508|11064220|FG003|NOT COMPLETED|Treatment to Week 104||0
9945640|NCT01379508|11064217|FG000|STARTED|Extension Period Weeks 109-156||64
9945641|NCT01379508|11064218|FG001|STARTED|Extension Period Weeks 109-156||17
9945642|NCT01379508|11064219|FG002|STARTED|Extension Period Weeks 109-156||79
9945643|NCT01379508|11064220|FG003|STARTED|Extension Period Weeks 109-156||10
9945644|NCT01379508|11064217|FG000|COMPLETED|Extension Period Weeks 109-156||45
9945645|NCT01379508|11064218|FG001|COMPLETED|Extension Period Weeks 109-156||14
9945646|NCT01379508|11064219|FG002|COMPLETED|Extension Period Weeks 109-156||65
9945647|NCT01379508|11064220|FG003|COMPLETED|Extension Period Weeks 109-156||10
9945648|NCT01379508|11064217|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19
9945649|NCT01379508|11064218|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3
9945650|NCT01379508|11064219|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14
9945651|NCT01379508|11064220|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0
9945652|NCT01379521|11064236|FG000|STARTED|Overall Study -Treatment Period||33
9945653|NCT01379521|11064237|FG001|STARTED|Overall Study -Treatment Period||26
9945654|NCT01379521|11064236|FG000|COMPLETED|Overall Study -Treatment Period||0
9945655|NCT01379521|11064237|FG001|COMPLETED|Overall Study -Treatment Period||0
9945656|NCT01379521|11064236|FG000|NOT COMPLETED|Overall Study -Treatment Period||33
9945657|NCT01379521|11064237|FG001|NOT COMPLETED|Overall Study -Treatment Period||26
9945658|NCT01379521|11064236|FG000|STARTED|Post-Treatment Evaluations||25
9945659|NCT01379521|11064237|FG001|STARTED|Post-Treatment Evaluations||21
9945660|NCT01379521|11064236|FG000|COMPLETED|Post-Treatment Evaluations||0
9945661|NCT01379521|11064237|FG001|COMPLETED|Post-Treatment Evaluations||0
9945662|NCT01379521|11064236|FG000|NOT COMPLETED|Post-Treatment Evaluations||25
9945663|NCT01379521|11064237|FG001|NOT COMPLETED|Post-Treatment Evaluations||21
9945664|NCT01379534|11064245|FG000|STARTED|Treatment Phase||22
9945665|NCT01379534|11064246|FG001|STARTED|Treatment Phase||31
9945666|NCT01379534|11064245|FG000|COMPLETED|Treatment Phase||0
9945667|NCT01379534|11064246|FG001|COMPLETED|Treatment Phase||0
9945668|NCT01379534|11064245|FG000|NOT COMPLETED|Treatment Phase||22
9945669|NCT01379534|11064246|FG001|NOT COMPLETED|Treatment Phase||31
9945670|NCT01379534|11064245|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
9945671|NCT01379534|11064246|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
9945672|NCT01379534|11064245|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
9945673|NCT01379534|11064246|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
9945674|NCT01379534|11064245|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
9945675|NCT01379534|11064246|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
9945676|NCT01379573|11064252|FG000|STARTED|Overall Study||74
9945677|NCT01379573|11064252|FG000|COMPLETED|Overall Study||63
9945678|NCT01379573|11064252|FG000|NOT COMPLETED|Overall Study||11
9945679|NCT01379625|11064258|FG000|STARTED|Overall Study||16
9945680|NCT01379625|11064259|FG001|STARTED|Overall Study||16
10011629|NCT01781572|11134447|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
10011630|NCT01781572|11134448|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
10011631|NCT01781572|11134449|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
10207629|NCT03531710|11334481|FG005|NOT COMPLETED|Overall Study||0
10207630|NCT03531840|11334499|FG000|STARTED|Overall Study||5
10207631|NCT03531840|11334500|FG001|STARTED|Overall Study||6
10207632|NCT03531840|11334501|FG002|STARTED|Overall Study||8
10207633|NCT03531840|11334502|FG003|STARTED|Overall Study||4
10207634|NCT03531840|11334499|FG000|COMPLETED|Overall Study||0
10207635|NCT03531840|11334500|FG001|COMPLETED|Overall Study||1
10207636|NCT03531840|11334501|FG002|COMPLETED|Overall Study||3
10207637|NCT03531840|11334502|FG003|COMPLETED|Overall Study||1
10207638|NCT03531840|11334499|FG000|NOT COMPLETED|Overall Study||5
10207639|NCT03531840|11334500|FG001|NOT COMPLETED|Overall Study||5
10207640|NCT03531840|11334501|FG002|NOT COMPLETED|Overall Study||5
10207641|NCT03531840|11334502|FG003|NOT COMPLETED|Overall Study||3
10207642|NCT03531905|11334520|FG000|STARTED|Overall Study||81
10207643|NCT03531905|11334521|FG001|STARTED|Overall Study||81
10207644|NCT03531905|11334522|FG002|STARTED|Overall Study||80
10207645|NCT03531905|11334520|FG000|COMPLETED|Overall Study||74
9945681|NCT01379625|11064258|FG000|COMPLETED|Overall Study||16
9945682|NCT01379625|11064259|FG001|COMPLETED|Overall Study||16
9945683|NCT01379625|11064258|FG000|NOT COMPLETED|Overall Study||0
9945684|NCT01379625|11064259|FG001|NOT COMPLETED|Overall Study||0
9945685|NCT01379651|11064267|FG000|STARTED|Overall Study||10
9945686|NCT01379651|11064268|FG001|STARTED|Overall Study||10
9945687|NCT01379651|11064267|FG000|COMPLETED|Overall Study||10
9945688|NCT01379651|11064268|FG001|COMPLETED|Overall Study||10
10207646|NCT03531905|11334521|FG001|COMPLETED|Overall Study||76
10207647|NCT03531905|11334522|FG002|COMPLETED|Overall Study||77
10207648|NCT03531905|11334520|FG000|NOT COMPLETED|Overall Study||7
10207649|NCT03531905|11334521|FG001|NOT COMPLETED|Overall Study||5
9945689|NCT01379651|11064267|FG000|NOT COMPLETED|Overall Study||0
9945690|NCT01379651|11064268|FG001|NOT COMPLETED|Overall Study||0
9945691|NCT01379664|11064276|FG000|STARTED|Overall Study||714
9945692|NCT01379664|11064277|FG001|STARTED|Overall Study||870
9945693|NCT01379664|11064276|FG000|COMPLETED|Overall Study||714
9945694|NCT01379664|11064277|FG001|COMPLETED|Overall Study||870
9945695|NCT01379664|11064276|FG000|NOT COMPLETED|Overall Study||0
9945696|NCT01379664|11064277|FG001|NOT COMPLETED|Overall Study||0
9945697|NCT01379703|11064283|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
9945698|NCT01379703|11064284|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
9945699|NCT01379703|11064285|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
9945700|NCT01379703|11064283|FG000|COMPLETED|Study Start Through 9 Months||62
9945701|NCT01379703|11064284|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
9945702|NCT01379703|11064285|FG002|COMPLETED|Study Start Through 9 Months||873
9945703|NCT01379703|11064283|FG000|NOT COMPLETED|Study Start Through 9 Months||4
9945704|NCT01379703|11064284|FG001|NOT COMPLETED|Study Start Through 9 Months||122
9945705|NCT01379703|11064285|FG002|NOT COMPLETED|Study Start Through 9 Months||143
9945706|NCT01379703|11064283|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
9945707|NCT01379703|11064284|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
9945708|NCT01379703|11064285|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
9945709|NCT01379703|11064283|FG000|COMPLETED|9 Months Through 18 Months||0
9945710|NCT01379703|11064284|FG001|COMPLETED|9 Months Through 18 Months||854
9945711|NCT01379703|11064285|FG002|COMPLETED|9 Months Through 18 Months||0
9945712|NCT01379703|11064283|FG000|NOT COMPLETED|9 Months Through 18 Months||0
9945713|NCT01379703|11064284|FG001|NOT COMPLETED|9 Months Through 18 Months||230
9945714|NCT01379703|11064285|FG002|NOT COMPLETED|9 Months Through 18 Months||0
9945715|NCT01379768|11064297|FG000|STARTED|Overall Study||23
9945716|NCT01379768|11064298|FG001|STARTED|Overall Study||22
9945717|NCT01379768|11064299|FG002|STARTED|Overall Study||20
9945718|NCT01379768|11064297|FG000|COMPLETED|Overall Study||20
9945719|NCT01379768|11064298|FG001|COMPLETED|Overall Study||21
9945720|NCT01379768|11064299|FG002|COMPLETED|Overall Study||20
9945721|NCT01379768|11064297|FG000|NOT COMPLETED|Overall Study||3
9945722|NCT01379768|11064298|FG001|NOT COMPLETED|Overall Study||1
9945723|NCT01379768|11064299|FG002|NOT COMPLETED|Overall Study||0
9945724|NCT01379924|11064309|FG000|STARTED|Baseline||72
9945725|NCT01379924|11064310|FG001|STARTED|Baseline||68
9945726|NCT01379924|11064309|FG000|COMPLETED|Baseline||72
9945727|NCT01379924|11064310|FG001|COMPLETED|Baseline||68
9945728|NCT01379924|11064309|FG000|NOT COMPLETED|Baseline||0
9945729|NCT01379924|11064310|FG001|NOT COMPLETED|Baseline||0
9945730|NCT01379924|11064309|FG000|STARTED|12-month Assessment||72
9945731|NCT01379924|11064310|FG001|STARTED|12-month Assessment||68
9945732|NCT01379924|11064309|FG000|COMPLETED|12-month Assessment||62
9945733|NCT01379924|11064310|FG001|COMPLETED|12-month Assessment||55
9945734|NCT01379924|11064309|FG000|NOT COMPLETED|12-month Assessment||10
9945735|NCT01379924|11064310|FG001|NOT COMPLETED|12-month Assessment||13
9945736|NCT01379924|11064309|FG000|STARTED|24-month Assessment||62
9945737|NCT01379924|11064310|FG001|STARTED|24-month Assessment||55
9945738|NCT01379924|11064309|FG000|COMPLETED|24-month Assessment||55
9945739|NCT01379924|11064310|FG001|COMPLETED|24-month Assessment||52
9945740|NCT01379924|11064309|FG000|NOT COMPLETED|24-month Assessment||7
9945741|NCT01379924|11064310|FG001|NOT COMPLETED|24-month Assessment||3
9945742|NCT01379924|11064309|FG000|STARTED|36-month Assessment||55
9945743|NCT01379924|11064310|FG001|STARTED|36-month Assessment||52
9945744|NCT01379924|11064309|FG000|COMPLETED|36-month Assessment||52
9945745|NCT01379924|11064310|FG001|COMPLETED|36-month Assessment||48
9945746|NCT01379924|11064309|FG000|NOT COMPLETED|36-month Assessment||3
9945747|NCT01379924|11064310|FG001|NOT COMPLETED|36-month Assessment||4
9945748|NCT01379937|11064323|FG000|STARTED|Overall Study||156
9945749|NCT01379937|11064324|FG001|STARTED|Overall Study||156
9945750|NCT01379937|11064325|FG002|STARTED|Overall Study||104
9945751|NCT01379937|11064326|FG003|STARTED|Overall Study||104
9945752|NCT01379937|11064323|FG000|COMPLETED|Overall Study||155
9945753|NCT01379937|11064324|FG001|COMPLETED|Overall Study||153
9945754|NCT01379937|11064325|FG002|COMPLETED|Overall Study||102
9945755|NCT01379937|11064326|FG003|COMPLETED|Overall Study||103
9945756|NCT01379937|11064323|FG000|NOT COMPLETED|Overall Study||1
9945757|NCT01379937|11064324|FG001|NOT COMPLETED|Overall Study||3
9945758|NCT01379937|11064325|FG002|NOT COMPLETED|Overall Study||2
9945759|NCT01379937|11064326|FG003|NOT COMPLETED|Overall Study||1
9945760|NCT01379963|11064341|FG000|STARTED|Overall Study||780
9945761|NCT01379963|11064341|FG000|COMPLETED|Overall Study||780
9945762|NCT01379963|11064341|FG000|NOT COMPLETED|Overall Study||0
9945763|NCT01380080|11064347|FG000|STARTED|Overall Study||424
9945764|NCT01380080|11064348|FG001|STARTED|Overall Study||426
9945765|NCT01380080|11064347|FG000|COMPLETED|Overall Study||339
9945766|NCT01380080|11064348|FG001|COMPLETED|Overall Study||343
9945767|NCT01380080|11064347|FG000|NOT COMPLETED|Overall Study||85
9945768|NCT01380080|11064348|FG001|NOT COMPLETED|Overall Study||83
9945769|NCT01380093|11064354|FG000|STARTED|Naloxone Challenge Phase||80
9945770|NCT01380093|11064355|FG001|STARTED|Naloxone Challenge Phase||0
9945771|NCT01380093|11064356|FG002|STARTED|Naloxone Challenge Phase||0
9945772|NCT01380093|11064357|FG003|STARTED|Naloxone Challenge Phase||0
9945773|NCT01380093|11064358|FG004|STARTED|Naloxone Challenge Phase||0
9945774|NCT01380093|11064359|FG005|STARTED|Naloxone Challenge Phase||0
9945775|NCT01380093|11064360|FG006|STARTED|Naloxone Challenge Phase||0
9945776|NCT01380093|11064361|FG007|STARTED|Naloxone Challenge Phase||0
9945777|NCT01380093|11064362|FG008|STARTED|Naloxone Challenge Phase||0
9945778|NCT01380093|11064354|FG000|TREATED|Naloxone Challenge Phase||59
9945779|NCT01380093|11064355|FG001|TREATED|Naloxone Challenge Phase||0
9945780|NCT01380093|11064356|FG002|TREATED|Naloxone Challenge Phase||0
9945781|NCT01380093|11064357|FG003|TREATED|Naloxone Challenge Phase||0
9945782|NCT01380093|11064358|FG004|TREATED|Naloxone Challenge Phase||0
9945783|NCT01380093|11064359|FG005|TREATED|Naloxone Challenge Phase||0
9945784|NCT01380093|11064360|FG006|TREATED|Naloxone Challenge Phase||0
9945785|NCT01380093|11064361|FG007|TREATED|Naloxone Challenge Phase||0
9945786|NCT01380093|11064362|FG008|TREATED|Naloxone Challenge Phase||0
9945787|NCT01380093|11064354|FG000|COMPLETED|Naloxone Challenge Phase||59
9945788|NCT01380093|11064355|FG001|COMPLETED|Naloxone Challenge Phase||0
9945789|NCT01380093|11064356|FG002|COMPLETED|Naloxone Challenge Phase||0
9945790|NCT01380093|11064357|FG003|COMPLETED|Naloxone Challenge Phase||0
9945791|NCT01380093|11064358|FG004|COMPLETED|Naloxone Challenge Phase||0
9945792|NCT01380093|11064359|FG005|COMPLETED|Naloxone Challenge Phase||0
9945793|NCT01380093|11064360|FG006|COMPLETED|Naloxone Challenge Phase||0
9945794|NCT01380093|11064361|FG007|COMPLETED|Naloxone Challenge Phase||0
9945795|NCT01380093|11064362|FG008|COMPLETED|Naloxone Challenge Phase||0
9945796|NCT01380093|11064354|FG000|NOT COMPLETED|Naloxone Challenge Phase||21
9945797|NCT01380093|11064355|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
9945798|NCT01380093|11064356|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
9945799|NCT01380093|11064357|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
9945800|NCT01380093|11064358|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
9945801|NCT01380093|11064359|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
9945802|NCT01380093|11064360|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
9945803|NCT01380093|11064361|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
9945804|NCT01380093|11064362|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
9945805|NCT01380093|11064354|FG000|STARTED|Drug Discrimination Phase: Day 1||0
9945806|NCT01380093|11064355|FG001|STARTED|Drug Discrimination Phase: Day 1||30
9945807|NCT01380093|11064356|FG002|STARTED|Drug Discrimination Phase: Day 1||29
9945808|NCT01380093|11064357|FG003|STARTED|Drug Discrimination Phase: Day 1||0
9945809|NCT01380093|11064358|FG004|STARTED|Drug Discrimination Phase: Day 1||0
9945810|NCT01380093|11064359|FG005|STARTED|Drug Discrimination Phase: Day 1||0
9945811|NCT01380093|11064360|FG006|STARTED|Drug Discrimination Phase: Day 1||0
9945812|NCT01380093|11064361|FG007|STARTED|Drug Discrimination Phase: Day 1||0
9945813|NCT01380093|11064362|FG008|STARTED|Drug Discrimination Phase: Day 1||0
9945814|NCT01380093|11064354|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
9945815|NCT01380093|11064355|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29
9945816|NCT01380093|11064356|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29
9945817|NCT01380093|11064357|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
9945818|NCT01380093|11064358|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
9945819|NCT01380093|11064359|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
9945820|NCT01380093|11064360|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
9945821|NCT01380093|11064361|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
9945822|NCT01380093|11064362|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
9945823|NCT01380093|11064354|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9945824|NCT01380093|11064355|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
9945825|NCT01380093|11064356|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9945826|NCT01380093|11064357|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10011632|NCT01781572|11134447|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
10011633|NCT01781572|11134448|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
10011634|NCT01781572|11134449|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
9945827|NCT01380093|11064358|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9945828|NCT01380093|11064359|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9945829|NCT01380093|11064360|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9945830|NCT01380093|11064361|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9945831|NCT01380093|11064362|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
9945832|NCT01380093|11064354|FG000|STARTED|Drug Discrimination Phase: Day 2||0
9945833|NCT01380093|11064355|FG001|STARTED|Drug Discrimination Phase: Day 2||29
9945834|NCT01380093|11064356|FG002|STARTED|Drug Discrimination Phase: Day 2||29
9945835|NCT01380093|11064357|FG003|STARTED|Drug Discrimination Phase: Day 2||0
9945836|NCT01380093|11064358|FG004|STARTED|Drug Discrimination Phase: Day 2||0
9945837|NCT01380093|11064359|FG005|STARTED|Drug Discrimination Phase: Day 2||0
9945838|NCT01380093|11064360|FG006|STARTED|Drug Discrimination Phase: Day 2||0
9945839|NCT01380093|11064361|FG007|STARTED|Drug Discrimination Phase: Day 2||0
9945840|NCT01380093|11064362|FG008|STARTED|Drug Discrimination Phase: Day 2||0
9945841|NCT01380093|11064354|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
9945842|NCT01380093|11064355|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20
9945843|NCT01380093|11064356|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
9945844|NCT01380093|11064357|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
9945845|NCT01380093|11064358|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
10011635|NCT01781572|11134447|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3
10011636|NCT01781572|11134448|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0
9945846|NCT01380093|11064359|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
9945847|NCT01380093|11064360|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
9945848|NCT01380093|11064361|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
9945849|NCT01380093|11064362|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
9945850|NCT01380093|11064354|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
9945851|NCT01380093|11064355|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
9945852|NCT01380093|11064356|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
9945853|NCT01380093|11064357|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
9945854|NCT01380093|11064358|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
9945855|NCT01380093|11064359|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
9945856|NCT01380093|11064360|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
9945857|NCT01380093|11064361|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
9945858|NCT01380093|11064362|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
9945859|NCT01380093|11064354|FG000|STARTED|Treatment Phase: First Intervention||0
9945860|NCT01380093|11064355|FG001|STARTED|Treatment Phase: First Intervention||0
9945861|NCT01380093|11064356|FG002|STARTED|Treatment Phase: First Intervention||0
9945862|NCT01380093|11064357|FG003|STARTED|Treatment Phase: First Intervention||6
9945863|NCT01380093|11064358|FG004|STARTED|Treatment Phase: First Intervention||6
9945864|NCT01380093|11064359|FG005|STARTED|Treatment Phase: First Intervention||6
9945865|NCT01380093|11064360|FG006|STARTED|Treatment Phase: First Intervention||6
9945866|NCT01380093|11064361|FG007|STARTED|Treatment Phase: First Intervention||6
9945867|NCT01380093|11064362|FG008|STARTED|Treatment Phase: First Intervention||6
9945868|NCT01380093|11064354|FG000|COMPLETED|Treatment Phase: First Intervention||0
9945869|NCT01380093|11064355|FG001|COMPLETED|Treatment Phase: First Intervention||0
9945870|NCT01380093|11064356|FG002|COMPLETED|Treatment Phase: First Intervention||0
9945871|NCT01380093|11064357|FG003|COMPLETED|Treatment Phase: First Intervention||6
9945872|NCT01380093|11064358|FG004|COMPLETED|Treatment Phase: First Intervention||6
9945873|NCT01380093|11064359|FG005|COMPLETED|Treatment Phase: First Intervention||6
9945874|NCT01380093|11064360|FG006|COMPLETED|Treatment Phase: First Intervention||6
9945875|NCT01380093|11064361|FG007|COMPLETED|Treatment Phase: First Intervention||6
9945876|NCT01380093|11064362|FG008|COMPLETED|Treatment Phase: First Intervention||6
9945877|NCT01380093|11064354|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
9945878|NCT01380093|11064355|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
9945879|NCT01380093|11064356|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
10207650|NCT03531905|11334522|FG002|NOT COMPLETED|Overall Study||3
10207651|NCT03532009|11334534|FG000|STARTED|Overall Study||92
10207652|NCT03532009|11334535|FG001|STARTED|Overall Study||90
10207653|NCT03532009|11334534|FG000|Received Treatment|Overall Study||91
10207654|NCT03532009|11334535|FG001|Received Treatment|Overall Study||90
10207655|NCT03532009|11334534|FG000|COMPLETED|Overall Study||90
10207656|NCT03532009|11334535|FG001|COMPLETED|Overall Study||86
10207657|NCT03532009|11334534|FG000|NOT COMPLETED|Overall Study||2
10207658|NCT03532009|11334535|FG001|NOT COMPLETED|Overall Study||4
10207659|NCT03532048|11334543|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
10207660|NCT03532048|11334544|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
10207661|NCT03532048|11334543|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
10207662|NCT03532048|11334544|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
10207663|NCT03532048|11334543|FG000|NOT COMPLETED|Overall Study||19
10207664|NCT03532048|11334544|FG001|NOT COMPLETED|Overall Study||17
10207665|NCT03532308|11334552|FG000|STARTED|Overall Study||10
10207666|NCT03532308|11334553|FG001|STARTED|Overall Study||9
10207667|NCT03532308|11334552|FG000|Completed Assessments|Overall Study||9
10207668|NCT03532308|11334553|FG001|Completed Assessments|Overall Study||7
10207669|NCT03532308|11334552|FG000|COMPLETED|Overall Study||10
10207670|NCT03532308|11334553|FG001|COMPLETED|Overall Study||8
10207671|NCT03532308|11334552|FG000|NOT COMPLETED|Overall Study||0
10207672|NCT03532308|11334553|FG001|NOT COMPLETED|Overall Study||1
10207673|NCT03532776|11334562|FG000|STARTED|Overall Study||201
10207674|NCT03532776|11334563|FG001|STARTED|Overall Study||198
10207675|NCT03532776|11334564|FG002|STARTED|Overall Study||67
10207676|NCT03532776|11334562|FG000|COMPLETED|Overall Study||196
10207677|NCT03532776|11334563|FG001|COMPLETED|Overall Study||194
10207678|NCT03532776|11334564|FG002|COMPLETED|Overall Study||63
10207679|NCT03532776|11334562|FG000|NOT COMPLETED|Overall Study||5
10207680|NCT03532776|11334563|FG001|NOT COMPLETED|Overall Study||4
10207681|NCT03532776|11334564|FG002|NOT COMPLETED|Overall Study||4
10207682|NCT03533036|11334575|FG000|STARTED|Overall Study||15
10207683|NCT03533036|11334576|FG001|STARTED|Overall Study||15
10207684|NCT03533036|11334575|FG000|COMPLETED|Overall Study||15
10207685|NCT03533036|11334576|FG001|COMPLETED|Overall Study||15
10207686|NCT03533036|11334575|FG000|NOT COMPLETED|Overall Study||0
10207687|NCT03533036|11334576|FG001|NOT COMPLETED|Overall Study||0
9945880|NCT01380093|11064357|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
10207688|NCT03533114|11334584|FG000|STARTED|Overall||88
10207689|NCT03533114|11334585|FG001|STARTED|Overall||66
10207690|NCT03533114|11334584|FG000|COMPLETED|Overall||57
10207691|NCT03533114|11334585|FG001|COMPLETED|Overall||38
10207692|NCT03533114|11334584|FG000|NOT COMPLETED|Overall||31
10207693|NCT03533114|11334585|FG001|NOT COMPLETED|Overall||28
10207694|NCT03533114|11334584|FG000|STARTED|Open Label Titration and Optimization||88
10207695|NCT03533114|11334585|FG001|STARTED|Open Label Titration and Optimization||66
9945881|NCT01380093|11064358|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
9945882|NCT01380093|11064359|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
9945883|NCT01380093|11064360|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
9945884|NCT01380093|11064361|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
9945885|NCT01380093|11064362|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
9945886|NCT01380093|11064354|FG000|STARTED|Treatment Phase: Washout Period||0
9945887|NCT01380093|11064355|FG001|STARTED|Treatment Phase: Washout Period||0
9945888|NCT01380093|11064356|FG002|STARTED|Treatment Phase: Washout Period||0
9945889|NCT01380093|11064357|FG003|STARTED|Treatment Phase: Washout Period||6
9945890|NCT01380093|11064358|FG004|STARTED|Treatment Phase: Washout Period||6
9945891|NCT01380093|11064359|FG005|STARTED|Treatment Phase: Washout Period||6
9945892|NCT01380093|11064360|FG006|STARTED|Treatment Phase: Washout Period||6
9945893|NCT01380093|11064361|FG007|STARTED|Treatment Phase: Washout Period||6
9945894|NCT01380093|11064362|FG008|STARTED|Treatment Phase: Washout Period||6
9945895|NCT01380093|11064354|FG000|COMPLETED|Treatment Phase: Washout Period||0
9945896|NCT01380093|11064355|FG001|COMPLETED|Treatment Phase: Washout Period||0
9945897|NCT01380093|11064356|FG002|COMPLETED|Treatment Phase: Washout Period||0
9945898|NCT01380093|11064357|FG003|COMPLETED|Treatment Phase: Washout Period||6
9945899|NCT01380093|11064358|FG004|COMPLETED|Treatment Phase: Washout Period||6
9945900|NCT01380093|11064359|FG005|COMPLETED|Treatment Phase: Washout Period||6
9945901|NCT01380093|11064360|FG006|COMPLETED|Treatment Phase: Washout Period||6
9945902|NCT01380093|11064361|FG007|COMPLETED|Treatment Phase: Washout Period||6
9945903|NCT01380093|11064362|FG008|COMPLETED|Treatment Phase: Washout Period||6
9945904|NCT01380093|11064354|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
9945905|NCT01380093|11064355|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
9945906|NCT01380093|11064356|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
9945907|NCT01380093|11064357|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
9945908|NCT01380093|11064358|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
10207696|NCT03533114|11334584|FG000|COMPLETED|Open Label Titration and Optimization||72
10207697|NCT03533114|11334585|FG001|COMPLETED|Open Label Titration and Optimization||53
10207698|NCT03533114|11334584|FG000|NOT COMPLETED|Open Label Titration and Optimization||16
10207699|NCT03533114|11334585|FG001|NOT COMPLETED|Open Label Titration and Optimization||13
10207700|NCT03533114|11334584|FG000|STARTED|Stable Dose||71
10207701|NCT03533114|11334585|FG001|STARTED|Stable Dose||52
10207702|NCT03533114|11334584|FG000|COMPLETED|Stable Dose||69
10207703|NCT03533114|11334585|FG001|COMPLETED|Stable Dose||50
10207704|NCT03533114|11334584|FG000|NOT COMPLETED|Stable Dose||2
10207705|NCT03533114|11334585|FG001|NOT COMPLETED|Stable Dose||2
10207706|NCT03533114|11334584|FG000|STARTED|Double Blind Randomized-Withdrawal||69
10207707|NCT03533114|11334585|FG001|STARTED|Double Blind Randomized-Withdrawal||47
10207708|NCT03533114|11334584|FG000|JZP-258|Double Blind Randomized-Withdrawal||57
10207709|NCT03533114|11334585|FG001|JZP-258|Double Blind Randomized-Withdrawal||0
10207710|NCT03533114|11334584|FG000|Placebo|Double Blind Randomized-Withdrawal||0
10207711|NCT03533114|11334585|FG001|Placebo|Double Blind Randomized-Withdrawal||59
10207712|NCT03533114|11334584|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67
10207713|NCT03533114|11334585|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46
10207714|NCT03533114|11334584|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2
10207715|NCT03533114|11334585|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1
10207716|NCT03533114|11334584|FG000|STARTED|Open-Label Safety Extension||65
10207717|NCT03533114|11334585|FG001|STARTED|Open-Label Safety Extension||41
10207718|NCT03533114|11334584|FG000|COMPLETED|Open-Label Safety Extension||57
10207719|NCT03533114|11334585|FG001|COMPLETED|Open-Label Safety Extension||38
10207720|NCT03533114|11334584|FG000|NOT COMPLETED|Open-Label Safety Extension||8
10207721|NCT03533114|11334585|FG001|NOT COMPLETED|Open-Label Safety Extension||3
10207722|NCT03533244|11334596|FG000|STARTED|Overall Study||20
10207723|NCT03533244|11334597|FG001|STARTED|Overall Study||22
10207724|NCT03533244|11334598|FG002|STARTED|Overall Study||22
10207725|NCT03533244|11334596|FG000|COMPLETED|Overall Study||18
10207726|NCT03533244|11334597|FG001|COMPLETED|Overall Study||21
10207727|NCT03533244|11334598|FG002|COMPLETED|Overall Study||22
10207728|NCT03533244|11334596|FG000|NOT COMPLETED|Overall Study||2
10207729|NCT03533244|11334597|FG001|NOT COMPLETED|Overall Study||1
10207730|NCT03533244|11334598|FG002|NOT COMPLETED|Overall Study||0
10207731|NCT03533374|11334608|FG000|STARTED|Overall Study||54
10207732|NCT03533374|11334609|FG001|STARTED|Overall Study||46
10207733|NCT03533374|11334608|FG000|COMPLETED|Overall Study||54
10207734|NCT03533374|11334609|FG001|COMPLETED|Overall Study||46
10207735|NCT03533374|11334608|FG000|NOT COMPLETED|Overall Study||0
10207736|NCT03533374|11334609|FG001|NOT COMPLETED|Overall Study||0
10207737|NCT03533608|11334615|FG000|STARTED|Overall Study||39
10207738|NCT03533608|11334615|FG000|COMPLETED|Overall Study||34
10207739|NCT03533608|11334615|FG000|NOT COMPLETED|Overall Study||5
10207740|NCT03533829|11334623|FG000|STARTED|Overall Study||10
10207741|NCT03533829|11334624|FG001|STARTED|Overall Study||10
10207742|NCT03533829|11334625|FG002|STARTED|Overall Study||10
10207743|NCT03533829|11334623|FG000|COMPLETED|Overall Study||10
10207744|NCT03533829|11334624|FG001|COMPLETED|Overall Study||10
9945909|NCT01380093|11064359|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
10207745|NCT03533829|11334625|FG002|COMPLETED|Overall Study||10
10207746|NCT03533829|11334623|FG000|NOT COMPLETED|Overall Study||0
10207747|NCT03533829|11334624|FG001|NOT COMPLETED|Overall Study||0
10207748|NCT03533829|11334625|FG002|NOT COMPLETED|Overall Study||0
10207749|NCT03534427|11334635|FG000|STARTED|Overall Study||20
9945910|NCT01380093|11064360|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
9945911|NCT01380093|11064361|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
9945912|NCT01380093|11064362|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
9945913|NCT01380093|11064354|FG000|STARTED|Treatment Phase: Second Intervention||0
9945914|NCT01380093|11064355|FG001|STARTED|Treatment Phase: Second Intervention||0
9945915|NCT01380093|11064356|FG002|STARTED|Treatment Phase: Second Intervention||0
9945916|NCT01380093|11064357|FG003|STARTED|Treatment Phase: Second Intervention||6
9945917|NCT01380093|11064358|FG004|STARTED|Treatment Phase: Second Intervention||6
9945918|NCT01380093|11064359|FG005|STARTED|Treatment Phase: Second Intervention||6
9945919|NCT01380093|11064360|FG006|STARTED|Treatment Phase: Second Intervention||6
9945920|NCT01380093|11064361|FG007|STARTED|Treatment Phase: Second Intervention||6
9945921|NCT01380093|11064362|FG008|STARTED|Treatment Phase: Second Intervention||6
9945922|NCT01380093|11064354|FG000|COMPLETED|Treatment Phase: Second Intervention||0
9945923|NCT01380093|11064355|FG001|COMPLETED|Treatment Phase: Second Intervention||0
9945924|NCT01380093|11064356|FG002|COMPLETED|Treatment Phase: Second Intervention||0
9945925|NCT01380093|11064357|FG003|COMPLETED|Treatment Phase: Second Intervention||5
9945926|NCT01380093|11064358|FG004|COMPLETED|Treatment Phase: Second Intervention||6
9945927|NCT01380093|11064359|FG005|COMPLETED|Treatment Phase: Second Intervention||6
9945928|NCT01380093|11064360|FG006|COMPLETED|Treatment Phase: Second Intervention||6
10011637|NCT01781572|11134449|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0
10011638|NCT01781572|11134447|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10011639|NCT01781572|11134448|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10011640|NCT01781572|11134449|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10011641|NCT01781572|11134447|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
10011642|NCT01781572|11134448|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10011643|NCT01781572|11134449|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10011644|NCT01781572|11134447|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4
10011645|NCT01781572|11134448|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2
10207750|NCT03534427|11334636|FG001|STARTED|Overall Study||20
9945929|NCT01380093|11064361|FG007|COMPLETED|Treatment Phase: Second Intervention||6
10207751|NCT03534427|11334635|FG000|COMPLETED|Overall Study||20
10207752|NCT03534427|11334636|FG001|COMPLETED|Overall Study||20
9945930|NCT01380093|11064362|FG008|COMPLETED|Treatment Phase: Second Intervention||6
9945931|NCT01380093|11064354|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945932|NCT01380093|11064355|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945933|NCT01380093|11064356|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945934|NCT01380093|11064357|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1
9945935|NCT01380093|11064358|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945936|NCT01380093|11064359|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945937|NCT01380093|11064360|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945938|NCT01380093|11064361|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945939|NCT01380093|11064362|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
9945940|NCT01380093|11064354|FG000|STARTED|Treatment Phase: Washout Period||0
9945941|NCT01380093|11064355|FG001|STARTED|Treatment Phase: Washout Period||0
9945942|NCT01380093|11064356|FG002|STARTED|Treatment Phase: Washout Period||0
9945943|NCT01380093|11064357|FG003|STARTED|Treatment Phase: Washout Period||5
9945944|NCT01380093|11064358|FG004|STARTED|Treatment Phase: Washout Period||6
9945945|NCT01380093|11064359|FG005|STARTED|Treatment Phase: Washout Period||6
9945946|NCT01380093|11064360|FG006|STARTED|Treatment Phase: Washout Period||6
9945947|NCT01380093|11064361|FG007|STARTED|Treatment Phase: Washout Period||6
9945948|NCT01380093|11064362|FG008|STARTED|Treatment Phase: Washout Period||6
9945949|NCT01380093|11064354|FG000|COMPLETED|Treatment Phase: Washout Period||0
9945950|NCT01380093|11064355|FG001|COMPLETED|Treatment Phase: Washout Period||0
9945951|NCT01380093|11064356|FG002|COMPLETED|Treatment Phase: Washout Period||0
9945952|NCT01380093|11064357|FG003|COMPLETED|Treatment Phase: Washout Period||5
9945953|NCT01380093|11064358|FG004|COMPLETED|Treatment Phase: Washout Period||6
9945954|NCT01380093|11064359|FG005|COMPLETED|Treatment Phase: Washout Period||6
9945955|NCT01380093|11064360|FG006|COMPLETED|Treatment Phase: Washout Period||6
9945956|NCT01380093|11064361|FG007|COMPLETED|Treatment Phase: Washout Period||6
9945957|NCT01380093|11064362|FG008|COMPLETED|Treatment Phase: Washout Period||6
9945958|NCT01380093|11064354|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
9945959|NCT01380093|11064355|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
9945960|NCT01380093|11064356|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
9945961|NCT01380093|11064357|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
9945962|NCT01380093|11064358|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
9945963|NCT01380093|11064359|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
9945964|NCT01380093|11064360|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
9945965|NCT01380093|11064361|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
9945966|NCT01380093|11064362|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
9945967|NCT01380093|11064354|FG000|STARTED|Treatment Phase: Third Intervention||0
9945968|NCT01380093|11064355|FG001|STARTED|Treatment Phase: Third Intervention||0
9945969|NCT01380093|11064356|FG002|STARTED|Treatment Phase: Third Intervention||0
9945970|NCT01380093|11064357|FG003|STARTED|Treatment Phase: Third Intervention||5
10011646|NCT01781572|11134449|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0
10011647|NCT01781572|11134447|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
10011648|NCT01781572|11134448|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
10011649|NCT01781572|11134449|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
9945971|NCT01380093|11064358|FG004|STARTED|Treatment Phase: Third Intervention||6
9945972|NCT01380093|11064359|FG005|STARTED|Treatment Phase: Third Intervention||6
9945973|NCT01380093|11064360|FG006|STARTED|Treatment Phase: Third Intervention||6
9945974|NCT01380093|11064361|FG007|STARTED|Treatment Phase: Third Intervention||6
9945975|NCT01380093|11064362|FG008|STARTED|Treatment Phase: Third Intervention||6
9945976|NCT01380093|11064354|FG000|COMPLETED|Treatment Phase: Third Intervention||0
9945977|NCT01380093|11064355|FG001|COMPLETED|Treatment Phase: Third Intervention||0
9945978|NCT01380093|11064356|FG002|COMPLETED|Treatment Phase: Third Intervention||0
9945979|NCT01380093|11064357|FG003|COMPLETED|Treatment Phase: Third Intervention||5
9945980|NCT01380093|11064358|FG004|COMPLETED|Treatment Phase: Third Intervention||6
9945981|NCT01380093|11064359|FG005|COMPLETED|Treatment Phase: Third Intervention||6
9945982|NCT01380093|11064360|FG006|COMPLETED|Treatment Phase: Third Intervention||6
9945983|NCT01380093|11064361|FG007|COMPLETED|Treatment Phase: Third Intervention||6
9945984|NCT01380093|11064362|FG008|COMPLETED|Treatment Phase: Third Intervention||4
9945985|NCT01380093|11064354|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
10011650|NCT01781572|11134447|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
10011651|NCT01781572|11134448|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
10011652|NCT01781572|11134449|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
10207753|NCT03534427|11334635|FG000|NOT COMPLETED|Overall Study||0
10207754|NCT03534427|11334636|FG001|NOT COMPLETED|Overall Study||0
10207755|NCT03534986|11334645|FG000|STARTED|Overall Study||10
9945986|NCT01380093|11064355|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
9945987|NCT01380093|11064356|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
9945988|NCT01380093|11064357|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
9945989|NCT01380093|11064358|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
9945990|NCT01380093|11064359|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
9945991|NCT01380093|11064360|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
9945992|NCT01380093|11064361|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
9945993|NCT01380093|11064362|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2
9945994|NCT01380106|11064378|FG000|STARTED|Overall Study||16
9945995|NCT01380106|11064379|FG001|STARTED|Overall Study||17
9945996|NCT01380106|11064378|FG000|COMPLETED|Overall Study||16
9945997|NCT01380106|11064379|FG001|COMPLETED|Overall Study||17
9945998|NCT01380106|11064378|FG000|NOT COMPLETED|Overall Study||0
9945999|NCT01380106|11064379|FG001|NOT COMPLETED|Overall Study||0
9946000|NCT01380145|11064385|FG000|STARTED|Overall Study||13
9946001|NCT01380145|11064385|FG000|COMPLETED|Overall Study||9
9946002|NCT01380145|11064385|FG000|NOT COMPLETED|Overall Study||4
9946003|NCT01380184|11064391|FG000|STARTED|Part 1 (19 Days)||15
9946004|NCT01380184|11064391|FG000|COMPLETED|Part 1 (19 Days)||14
9946005|NCT01380184|11064391|FG000|NOT COMPLETED|Part 1 (19 Days)||1
9946006|NCT01380184|11064391|FG000|STARTED|Washout Period (≥2 Days)||14
9946007|NCT01380184|11064391|FG000|COMPLETED|Washout Period (≥2 Days)||14
9946008|NCT01380184|11064391|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0
10011653|NCT01781572|11134447|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6
10207756|NCT03534986|11334646|FG001|STARTED|Overall Study||10
10207757|NCT03534986|11334647|FG002|STARTED|Overall Study||12
10207758|NCT03534986|11334645|FG000|COMPLETED|Overall Study||10
10207759|NCT03534986|11334646|FG001|COMPLETED|Overall Study||10
10207760|NCT03534986|11334647|FG002|COMPLETED|Overall Study||10
10207761|NCT03534986|11334645|FG000|NOT COMPLETED|Overall Study||0
10207762|NCT03534986|11334646|FG001|NOT COMPLETED|Overall Study||0
10207763|NCT03534986|11334647|FG002|NOT COMPLETED|Overall Study||2
10207764|NCT03535194|11334660|FG000|STARTED|Induction Period||454
10207765|NCT03535194|11334661|FG001|STARTED|Induction Period||451
10207766|NCT03535194|11334662|FG002|STARTED|Induction Period||112
10207767|NCT03535194|11334663|FG003|STARTED|Induction Period||448
10207768|NCT03535194|11334664|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
10207769|NCT03535194|11334660|FG000|Received at Least One Dose of Study Drug|Induction Period||454
10207770|NCT03535194|11334661|FG001|Received at Least One Dose of Study Drug|Induction Period||450
10207771|NCT03535194|11334662|FG002|Received at Least One Dose of Study Drug|Induction Period||112
10207772|NCT03535194|11334663|FG003|Received at Least One Dose of Study Drug|Induction Period||448
10207773|NCT03535194|11334664|FG004|Received at Least One Dose of Study Drug|Induction Period||19
10207774|NCT03535194|11334660|FG000|COMPLETED|Induction Period||443
10207775|NCT03535194|11334661|FG001|COMPLETED|Induction Period||434
10207776|NCT03535194|11334662|FG002|COMPLETED|Induction Period||104
10207777|NCT03535194|11334663|FG003|COMPLETED|Induction Period||437
10207778|NCT03535194|11334664|FG004|COMPLETED|Induction Period||19
10207779|NCT03535194|11334660|FG000|NOT COMPLETED|Induction Period||11
10207780|NCT03535194|11334661|FG001|NOT COMPLETED|Induction Period||17
10207781|NCT03535194|11334662|FG002|NOT COMPLETED|Induction Period||8
9946009|NCT01380184|11064391|FG000|STARTED|Part 2||14
9946010|NCT01380184|11064391|FG000|COMPLETED|Part 2||0
9946011|NCT01380184|11064391|FG000|NOT COMPLETED|Part 2||14
9946012|NCT01380197|11064397|FG000|STARTED|Overall Study||20
9946013|NCT01380197|11064398|FG001|STARTED|Overall Study||20
9946014|NCT01380197|11064397|FG000|COMPLETED|Overall Study||20
9946015|NCT01380197|11064398|FG001|COMPLETED|Overall Study||20
9946016|NCT01380197|11064397|FG000|NOT COMPLETED|Overall Study||0
9946017|NCT01380197|11064398|FG001|NOT COMPLETED|Overall Study||0
10011654|NCT01781572|11134448|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4
9946018|NCT01380327|11064407|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
9946019|NCT01380327|11064408|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
9946020|NCT01380327|11064409|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
9946021|NCT01380327|11064407|FG000|COMPLETED|Overall Study||27
9946022|NCT01380327|11064408|FG001|COMPLETED|Overall Study||28
9946023|NCT01380327|11064409|FG002|COMPLETED|Overall Study||21
9946024|NCT01380327|11064407|FG000|NOT COMPLETED|Overall Study||3
9946025|NCT01380327|11064408|FG001|NOT COMPLETED|Overall Study||3
9946026|NCT01380327|11064409|FG002|NOT COMPLETED|Overall Study||7
9946027|NCT01380366|11064417|FG000|STARTED|Overall Study||15
9946028|NCT01380366|11064417|FG000|COMPLETED|Overall Study||15
9946029|NCT01380366|11064417|FG000|NOT COMPLETED|Overall Study||0
9946030|NCT01380379|11064422|FG000|STARTED|Overall Study||9
9946031|NCT01380379|11064422|FG000|COMPLETED|Overall Study||8
9946032|NCT01380379|11064422|FG000|NOT COMPLETED|Overall Study||1
9946033|NCT01380535|11064428|FG000|STARTED|Overall Study||29
9946034|NCT01380535|11064429|FG001|STARTED|Overall Study||31
9946035|NCT01380535|11064428|FG000|Baseline Population|Overall Study||29
9946036|NCT01380535|11064429|FG001|Baseline Population|Overall Study||31
9946037|NCT01380535|11064428|FG000|Safety Population|Overall Study||28
9946038|NCT01380535|11064429|FG001|Safety Population|Overall Study||28
9946039|NCT01380535|11064428|FG000|Intent-to-treat Population|Overall Study||29
9946040|NCT01380535|11064429|FG001|Intent-to-treat Population|Overall Study||24
9946041|NCT01380535|11064428|FG000|COMPLETED|Overall Study||22
9946042|NCT01380535|11064429|FG001|COMPLETED|Overall Study||16
9946043|NCT01380535|11064428|FG000|NOT COMPLETED|Overall Study||7
9946044|NCT01380535|11064429|FG001|NOT COMPLETED|Overall Study||15
9946045|NCT01380639|11064437|FG000|STARTED|Overall Study||42
9946046|NCT01380639|11064438|FG001|STARTED|Overall Study||40
9946047|NCT01380639|11064437|FG000|COMPLETED|Overall Study||36
9946048|NCT01380639|11064438|FG001|COMPLETED|Overall Study||36
9946049|NCT01380639|11064437|FG000|NOT COMPLETED|Overall Study||6
9946050|NCT01380639|11064438|FG001|NOT COMPLETED|Overall Study||4
9946051|NCT01380691|11064444|FG000|STARTED|Period 1||7
9946052|NCT01380691|11064445|FG001|STARTED|Period 1||7
9946053|NCT01380691|11064446|FG002|STARTED|Period 1||7
9946054|NCT01380691|11064447|FG003|STARTED|Period 1||7
9946055|NCT01380691|11064444|FG000|COMPLETED|Period 1||7
9946056|NCT01380691|11064445|FG001|COMPLETED|Period 1||7
9946057|NCT01380691|11064446|FG002|COMPLETED|Period 1||7
9946058|NCT01380691|11064447|FG003|COMPLETED|Period 1||7
9946059|NCT01380691|11064444|FG000|NOT COMPLETED|Period 1||0
9946060|NCT01380691|11064445|FG001|NOT COMPLETED|Period 1||0
9946061|NCT01380691|11064446|FG002|NOT COMPLETED|Period 1||0
9946062|NCT01380691|11064447|FG003|NOT COMPLETED|Period 1||0
9946063|NCT01380691|11064444|FG000|STARTED|Washout (7 Days)||7
9946064|NCT01380691|11064445|FG001|STARTED|Washout (7 Days)||7
9946065|NCT01380691|11064446|FG002|STARTED|Washout (7 Days)||7
9946066|NCT01380691|11064447|FG003|STARTED|Washout (7 Days)||7
9946067|NCT01380691|11064444|FG000|COMPLETED|Washout (7 Days)||7
9946068|NCT01380691|11064445|FG001|COMPLETED|Washout (7 Days)||7
9946069|NCT01380691|11064446|FG002|COMPLETED|Washout (7 Days)||6
9946070|NCT01380691|11064447|FG003|COMPLETED|Washout (7 Days)||6
9946071|NCT01380691|11064444|FG000|NOT COMPLETED|Washout (7 Days)||0
9946072|NCT01380691|11064445|FG001|NOT COMPLETED|Washout (7 Days)||0
9946073|NCT01380691|11064446|FG002|NOT COMPLETED|Washout (7 Days)||1
9946074|NCT01380691|11064447|FG003|NOT COMPLETED|Washout (7 Days)||1
9946075|NCT01380691|11064444|FG000|STARTED|Period 2||7
10011655|NCT01781572|11134449|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0
10011656|NCT01781572|11134447|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10011657|NCT01781572|11134448|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10207782|NCT03535194|11334663|FG003|NOT COMPLETED|Induction Period||11
10207783|NCT03535194|11334664|FG004|NOT COMPLETED|Induction Period||0
10207784|NCT03535194|11334660|FG000|STARTED|Maintenance Period||443
10207785|NCT03535194|11334661|FG001|STARTED|Maintenance Period||434
10207786|NCT03535194|11334662|FG002|STARTED|Maintenance Period||104
10207787|NCT03535194|11334663|FG003|STARTED|Maintenance Period||437
10207788|NCT03535194|11334664|FG004|STARTED|Maintenance Period||19
10207789|NCT03535194|11334660|FG000|COMPLETED|Maintenance Period||421
10207790|NCT03535194|11334661|FG001|COMPLETED|Maintenance Period||418
10207791|NCT03535194|11334662|FG002|COMPLETED|Maintenance Period||96
10207792|NCT03535194|11334663|FG003|COMPLETED|Maintenance Period||400
10207793|NCT03535194|11334664|FG004|COMPLETED|Maintenance Period||13
10207794|NCT03535194|11334660|FG000|NOT COMPLETED|Maintenance Period||22
10207795|NCT03535194|11334661|FG001|NOT COMPLETED|Maintenance Period||16
10207796|NCT03535194|11334662|FG002|NOT COMPLETED|Maintenance Period||8
10207797|NCT03535194|11334663|FG003|NOT COMPLETED|Maintenance Period||37
9946076|NCT01380691|11064445|FG001|STARTED|Period 2||7
9946077|NCT01380691|11064446|FG002|STARTED|Period 2||6
9946078|NCT01380691|11064447|FG003|STARTED|Period 2||6
10011658|NCT01781572|11134449|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10207798|NCT03535194|11334664|FG004|NOT COMPLETED|Maintenance Period||6
9946079|NCT01380691|11064444|FG000|COMPLETED|Period 2||7
9946080|NCT01380691|11064445|FG001|COMPLETED|Period 2||7
9946081|NCT01380691|11064446|FG002|COMPLETED|Period 2||6
9946082|NCT01380691|11064447|FG003|COMPLETED|Period 2||6
9946083|NCT01380691|11064444|FG000|NOT COMPLETED|Period 2||0
9946084|NCT01380691|11064445|FG001|NOT COMPLETED|Period 2||0
9946085|NCT01380691|11064446|FG002|NOT COMPLETED|Period 2||0
10011659|NCT01781572|11134447|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
10207799|NCT03535194|11334660|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
10207800|NCT03535194|11334661|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
10207801|NCT03535194|11334662|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
10238805|NCT00476827|11370220|FG001|STARTED|Overall Study||0
10238806|NCT00476827|11370221|FG002|STARTED|Overall Study||1
9946086|NCT01380691|11064447|FG003|NOT COMPLETED|Period 2||0
9946087|NCT01380730|11064466|FG000|STARTED|Overall Study||78
9946088|NCT01380730|11064467|FG001|STARTED|Overall Study||79
9946089|NCT01380730|11064468|FG002|STARTED|Overall Study||79
9946090|NCT01380730|11064469|FG003|STARTED|Overall Study||79
9946091|NCT01380730|11064470|FG004|STARTED|Overall Study||78
9946092|NCT01380730|11064471|FG005|STARTED|Overall Study||79
9946093|NCT01380730|11064472|FG006|STARTED|Overall Study||79
9946094|NCT01380730|11064473|FG007|STARTED|Overall Study||80
9946095|NCT01380730|11064466|FG000|Received Treatment|Overall Study||78
9946096|NCT01380730|11064467|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
9946097|NCT01380730|11064468|FG002|Received Treatment|Overall Study||79
9946098|NCT01380730|11064469|FG003|Received Treatment|Overall Study||79
9946099|NCT01380730|11064470|FG004|Received Treatment|Overall Study||78
9946100|NCT01380730|11064471|FG005|Received Treatment|Overall Study||79
9946101|NCT01380730|11064472|FG006|Received Treatment|Overall Study||79
9946102|NCT01380730|11064473|FG007|Received Treatment|Overall Study||80
9946103|NCT01380730|11064466|FG000|COMPLETED|Overall Study||78
9946104|NCT01380730|11064467|FG001|COMPLETED|Overall Study||79
9946105|NCT01380730|11064468|FG002|COMPLETED|Overall Study||79
9946106|NCT01380730|11064469|FG003|COMPLETED|Overall Study||79
9946107|NCT01380730|11064470|FG004|COMPLETED|Overall Study||77
9946108|NCT01380730|11064471|FG005|COMPLETED|Overall Study||79
9946109|NCT01380730|11064472|FG006|COMPLETED|Overall Study||79
9946110|NCT01380730|11064473|FG007|COMPLETED|Overall Study||80
9946111|NCT01380730|11064466|FG000|NOT COMPLETED|Overall Study||0
9946112|NCT01380730|11064467|FG001|NOT COMPLETED|Overall Study||0
9946113|NCT01380730|11064468|FG002|NOT COMPLETED|Overall Study||0
9946114|NCT01380730|11064469|FG003|NOT COMPLETED|Overall Study||0
9946115|NCT01380730|11064470|FG004|NOT COMPLETED|Overall Study||1
9946116|NCT01380730|11064471|FG005|NOT COMPLETED|Overall Study||0
9946117|NCT01380730|11064472|FG006|NOT COMPLETED|Overall Study||0
9946118|NCT01380730|11064473|FG007|NOT COMPLETED|Overall Study||0
9946119|NCT01380743|11064495|FG000|STARTED|Overall Study||6
9946120|NCT01380743|11064496|FG001|STARTED|Overall Study||6
9946121|NCT01380743|11064497|FG002|STARTED|Overall Study||6
9946122|NCT01380743|11064498|FG003|STARTED|Overall Study||7
9946123|NCT01380743|11064495|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9946124|NCT01380743|11064496|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9946125|NCT01380743|11064497|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9946126|NCT01380743|11064498|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
9946127|NCT01380743|11064495|FG000|COMPLETED|Overall Study||6
9946128|NCT01380743|11064496|FG001|COMPLETED|Overall Study||6
9946129|NCT01380743|11064497|FG002|COMPLETED|Overall Study||6
9946130|NCT01380743|11064498|FG003|COMPLETED|Overall Study||7
9946131|NCT01380743|11064495|FG000|NOT COMPLETED|Overall Study||0
9946132|NCT01380743|11064496|FG001|NOT COMPLETED|Overall Study||0
9946133|NCT01380743|11064497|FG002|NOT COMPLETED|Overall Study||0
9946134|NCT01380743|11064498|FG003|NOT COMPLETED|Overall Study||0
9946135|NCT01380769|11064510|FG000|STARTED|Overall Study||100
9946136|NCT01380769|11064511|FG001|STARTED|Overall Study||57
9946137|NCT01380769|11064510|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
9946138|NCT01380769|11064511|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
9946139|NCT01380769|11064510|FG000|NOT COMPLETED|Overall Study||9
9946140|NCT01380769|11064511|FG001|NOT COMPLETED|Overall Study||14
9946141|NCT01380782|11064519|FG000|STARTED|Overall Study||12
9946142|NCT01380782|11064520|FG001|STARTED|Overall Study||10
9946143|NCT01380782|11064521|FG002|STARTED|Overall Study||11
9946144|NCT01380782|11064522|FG003|STARTED|Overall Study||4
9946145|NCT01380782|11064519|FG000|COMPLETED|Overall Study||0
9946146|NCT01380782|11064520|FG001|COMPLETED|Overall Study||0
9946147|NCT01380782|11064521|FG002|COMPLETED|Overall Study||0
9946148|NCT01380782|11064522|FG003|COMPLETED|Overall Study||0
9946149|NCT01380782|11064519|FG000|NOT COMPLETED|Overall Study||12
9946150|NCT01380782|11064520|FG001|NOT COMPLETED|Overall Study||10
9946151|NCT01380782|11064521|FG002|NOT COMPLETED|Overall Study||11
9946152|NCT01380782|11064522|FG003|NOT COMPLETED|Overall Study||4
9946153|NCT01380834|11064536|FG000|STARTED|Overall Study||42
9946154|NCT01380834|11064537|FG001|STARTED|Overall Study||42
9946155|NCT01380834|11064536|FG000|COMPLETED|Overall Study||41
9946156|NCT01380834|11064537|FG001|COMPLETED|Overall Study||42
9946157|NCT01380834|11064536|FG000|NOT COMPLETED|Overall Study||1
9946158|NCT01380834|11064537|FG001|NOT COMPLETED|Overall Study||0
9946159|NCT01380899|11064546|FG000|STARTED|Overall Study||34
9946160|NCT01380899|11064547|FG001|STARTED|Overall Study||33
9946161|NCT01380899|11064548|FG002|STARTED|Overall Study||20
9946162|NCT01380899|11064546|FG000|COMPLETED|Overall Study||34
9946163|NCT01380899|11064547|FG001|COMPLETED|Overall Study||33
9946164|NCT01380899|11064548|FG002|COMPLETED|Overall Study||20
9946165|NCT01380899|11064546|FG000|NOT COMPLETED|Overall Study||0
9946166|NCT01380899|11064547|FG001|NOT COMPLETED|Overall Study||0
9946167|NCT01380899|11064548|FG002|NOT COMPLETED|Overall Study||0
9946168|NCT01380990|11064558|FG000|STARTED|Overall Study||20
9946169|NCT01380990|11064559|FG001|STARTED|Overall Study||16
9946170|NCT01380990|11064558|FG000|COMPLETED|Overall Study||19
9946171|NCT01380990|11064559|FG001|COMPLETED|Overall Study||15
9946172|NCT01380990|11064558|FG000|NOT COMPLETED|Overall Study||1
9946173|NCT01380990|11064559|FG001|NOT COMPLETED|Overall Study||1
9946174|NCT01381016|11064571|FG000|STARTED|Overall Study||13
9946175|NCT01381016|11064572|FG001|STARTED|Overall Study||17
9946176|NCT01381016|11064571|FG000|COMPLETED|Overall Study||10
9946177|NCT01381016|11064572|FG001|COMPLETED|Overall Study||11
9946178|NCT01381016|11064571|FG000|NOT COMPLETED|Overall Study||3
9946179|NCT01381016|11064572|FG001|NOT COMPLETED|Overall Study||6
9946180|NCT01381068|11064582|FG000|STARTED|Overall Study||25
9946181|NCT01381068|11064583|FG001|STARTED|Overall Study||24
9946182|NCT01381068|11064582|FG000|COMPLETED|Overall Study||24
9946183|NCT01381068|11064583|FG001|COMPLETED|Overall Study||24
9946184|NCT01381068|11064582|FG000|NOT COMPLETED|Overall Study||1
9946185|NCT01381068|11064583|FG001|NOT COMPLETED|Overall Study||0
9946186|NCT01381120|11064591|FG000|STARTED|Overall Study||50
9946187|NCT01381120|11064592|FG001|STARTED|Overall Study||27
9946188|NCT01381120|11064591|FG000|COMPLETED|Overall Study||39
9946189|NCT01381120|11064592|FG001|COMPLETED|Overall Study||18
9946190|NCT01381120|11064591|FG000|NOT COMPLETED|Overall Study||11
10207802|NCT03535194|11334663|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
10207803|NCT03535194|11334664|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
10207804|NCT03535194|11334660|FG000|COMPLETED|Post-Treatment Followup Period||27
10207805|NCT03535194|11334661|FG001|COMPLETED|Post-Treatment Followup Period||21
10207806|NCT03535194|11334662|FG002|COMPLETED|Post-Treatment Followup Period||7
10207807|NCT03535194|11334663|FG003|COMPLETED|Post-Treatment Followup Period||23
10207808|NCT03535194|11334664|FG004|COMPLETED|Post-Treatment Followup Period||8
10207809|NCT03535194|11334660|FG000|NOT COMPLETED|Post-Treatment Followup Period||11
10207810|NCT03535194|11334661|FG001|NOT COMPLETED|Post-Treatment Followup Period||14
10207811|NCT03535194|11334662|FG002|NOT COMPLETED|Post-Treatment Followup Period||11
10207812|NCT03535194|11334663|FG003|NOT COMPLETED|Post-Treatment Followup Period||24
10207813|NCT03535194|11334664|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
10207814|NCT03535571|11334688|FG000|STARTED|Overall Study||20
10207815|NCT03535571|11334688|FG000|COMPLETED|Overall Study||19
10207816|NCT03535571|11334688|FG000|NOT COMPLETED|Overall Study||1
10207817|NCT03535649|11334694|FG000|STARTED|Overall Study||105
10207818|NCT03535649|11334694|FG000|COMPLETED|Overall Study||105
10207819|NCT03535649|11334694|FG000|NOT COMPLETED|Overall Study||0
10207820|NCT03535844|11334700|FG000|STARTED|Overall Study||22
10207821|NCT03535844|11334701|FG001|STARTED|Overall Study||19
10207822|NCT03535844|11334700|FG000|COMPLETED|Overall Study||22
10207823|NCT03535844|11334701|FG001|COMPLETED|Overall Study||18
10207824|NCT03535844|11334700|FG000|NOT COMPLETED|Overall Study||0
10207825|NCT03535844|11334701|FG001|NOT COMPLETED|Overall Study||1
10207826|NCT03535974|11334710|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
10207827|NCT03535974|11334711|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
10207828|NCT03535974|11334712|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
10207829|NCT03535974|11334710|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
10207830|NCT03535974|11334711|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
10207831|NCT03535974|11334712|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
10207832|NCT03535974|11334710|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
10207833|NCT03535974|11334711|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
10207834|NCT03535974|11334712|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
10207835|NCT03535974|11334710|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
10207836|NCT03535974|11334711|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
10207837|NCT03535974|11334712|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
10207838|NCT03535974|11334710|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
10207839|NCT03535974|11334711|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
10207840|NCT03535974|11334712|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
10207841|NCT03535974|11334710|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
9946191|NCT01381120|11064592|FG001|NOT COMPLETED|Overall Study||9
9946192|NCT01381172|11064600|FG000|STARTED|Overall Study||74
9946193|NCT01381172|11064601|FG001|STARTED|Overall Study||86
9946194|NCT01381172|11064600|FG000|COMPLETED|Overall Study||64
9946195|NCT01381172|11064601|FG001|COMPLETED|Overall Study||73
9946196|NCT01381172|11064600|FG000|NOT COMPLETED|Overall Study||10
9946197|NCT01381172|11064601|FG001|NOT COMPLETED|Overall Study||13
9946198|NCT01381406|11064609|FG000|STARTED|Overall Study||2481
10238807|NCT00476827|11370222|FG003|STARTED|Overall Study||0
9946199|NCT01381406|11064610|FG001|STARTED|Overall Study||852
9946200|NCT01381406|11064609|FG000|COMPLETED|Overall Study||2481
9946201|NCT01381406|11064610|FG001|COMPLETED|Overall Study||852
9946202|NCT01381406|11064609|FG000|NOT COMPLETED|Overall Study||0
9946203|NCT01381406|11064610|FG001|NOT COMPLETED|Overall Study||0
9956824|NCT01448707|11076126|FG001|COMPLETED|Overall Study||118
9956825|NCT01448707|11076125|FG000|NOT COMPLETED|Overall Study||18
9956826|NCT01448707|11076126|FG001|NOT COMPLETED|Overall Study||18
9956827|NCT01448824|11076140|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
9956828|NCT01448824|11076141|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
9946204|NCT01381471|11064616|FG000|STARTED|Overall Study||11060
9946205|NCT01381471|11064616|FG000|COMPLETED|Overall Study||11060
9946206|NCT01381471|11064616|FG000|NOT COMPLETED|Overall Study||0
9946207|NCT01381549|11064623|FG000|STARTED|Overall Study||6
9946208|NCT01381549|11064624|FG001|STARTED|Overall Study||8
9946209|NCT01381549|11064625|FG002|STARTED|Overall Study||6
9946210|NCT01381549|11064623|FG000|COMPLETED|Overall Study||6
9946211|NCT01381549|11064624|FG001|COMPLETED|Overall Study||8
9946212|NCT01381549|11064625|FG002|COMPLETED|Overall Study||5
9946213|NCT01381549|11064623|FG000|NOT COMPLETED|Overall Study||0
9946214|NCT01381549|11064624|FG001|NOT COMPLETED|Overall Study||0
9946215|NCT01381549|11064625|FG002|NOT COMPLETED|Overall Study||1
9946216|NCT01381562|11064637|FG000|STARTED|Overall Study||5
9946217|NCT01381562|11064638|FG001|STARTED|Overall Study||4
9946218|NCT01381562|11064639|FG002|STARTED|Overall Study||5
9946219|NCT01381562|11064637|FG000|COMPLETED|Overall Study||5
9946220|NCT01381562|11064638|FG001|COMPLETED|Overall Study||3
9946221|NCT01381562|11064639|FG002|COMPLETED|Overall Study||5
9946222|NCT01381562|11064637|FG000|NOT COMPLETED|Overall Study||0
9946223|NCT01381562|11064638|FG001|NOT COMPLETED|Overall Study||1
9946224|NCT01381562|11064639|FG002|NOT COMPLETED|Overall Study||0
9946225|NCT01381575|11064650|FG000|STARTED|Overall Study||550
9946226|NCT01381575|11064651|FG001|STARTED|Overall Study||482
9946227|NCT01381575|11064652|FG002|STARTED|Overall Study||415
9946228|NCT01381575|11064650|FG000|COMPLETED|Overall Study||524
9946229|NCT01381575|11064651|FG001|COMPLETED|Overall Study||443
9946230|NCT01381575|11064652|FG002|COMPLETED|Overall Study||395
9946231|NCT01381575|11064650|FG000|NOT COMPLETED|Overall Study||26
9946232|NCT01381575|11064651|FG001|NOT COMPLETED|Overall Study||39
9946233|NCT01381575|11064652|FG002|NOT COMPLETED|Overall Study||20
9946234|NCT01381692|11064663|FG000|STARTED|Overall Study||7
9946235|NCT01381692|11064664|FG001|STARTED|Overall Study||2
9946236|NCT01381692|11064665|FG002|STARTED|Overall Study||0
9946237|NCT01381692|11064666|FG003|STARTED|Overall Study||0
9946238|NCT01381692|11064667|FG004|STARTED|Overall Study||0
9946239|NCT01381692|11064668|FG005|STARTED|Overall Study||0
9946240|NCT01381692|11064663|FG000|COMPLETED|Overall Study||6
9946241|NCT01381692|11064664|FG001|COMPLETED|Overall Study||2
9946242|NCT01381692|11064665|FG002|COMPLETED|Overall Study||0
9946243|NCT01381692|11064666|FG003|COMPLETED|Overall Study||0
9946244|NCT01381692|11064667|FG004|COMPLETED|Overall Study||0
9946245|NCT01381692|11064668|FG005|COMPLETED|Overall Study||0
9946246|NCT01381692|11064663|FG000|NOT COMPLETED|Overall Study||1
9946247|NCT01381692|11064664|FG001|NOT COMPLETED|Overall Study||0
9946248|NCT01381692|11064665|FG002|NOT COMPLETED|Overall Study||0
9946249|NCT01381692|11064666|FG003|NOT COMPLETED|Overall Study||0
9946250|NCT01381692|11064667|FG004|NOT COMPLETED|Overall Study||0
9946251|NCT01381692|11064668|FG005|NOT COMPLETED|Overall Study||0
9946252|NCT01381718|11064678|FG000|STARTED|Overall Study||56
9946253|NCT01381718|11064679|FG001|STARTED|Overall Study||56
9946254|NCT01381718|11064678|FG000|COMPLETED|Overall Study||51
10207842|NCT03535974|11334711|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
10207843|NCT03535974|11334712|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
10207844|NCT03536663|11334720|FG000|STARTED|Optiflux||23
10207845|NCT03536663|11334720|FG000|COMPLETED|Optiflux||19
10207846|NCT03536663|11334720|FG000|NOT COMPLETED|Optiflux||4
10207847|NCT03536663|11334720|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
10207848|NCT03536663|11334720|FG000|COMPLETED|Endexo||17
10207849|NCT03536663|11334720|FG000|NOT COMPLETED|Endexo||1
10207850|NCT03536702|11334731|FG000|STARTED|Overall Study||40
10207851|NCT03536702|11334732|FG001|STARTED|Overall Study||20
10207852|NCT03536702|11334731|FG000|COMPLETED|Overall Study||26
10207853|NCT03536702|11334732|FG001|COMPLETED|Overall Study||8
10207854|NCT03536702|11334731|FG000|NOT COMPLETED|Overall Study||14
10207855|NCT03536702|11334732|FG001|NOT COMPLETED|Overall Study||12
10207856|NCT03536819|11334738|FG000|STARTED|Overall Study||20
10207857|NCT03536819|11334738|FG000|COMPLETED|Overall Study||15
10207858|NCT03536819|11334738|FG000|NOT COMPLETED|Overall Study||5
10207859|NCT03536923|11334742|FG000|STARTED|Overall Study||23
10207860|NCT03536923|11334742|FG000|COMPLETED|Overall Study||23
10207861|NCT03536923|11334742|FG000|NOT COMPLETED|Overall Study||0
10207862|NCT03536949|11334748|FG000|STARTED|Overall Study||157
10207863|NCT03536949|11334749|FG001|STARTED|Overall Study||77
10207864|NCT03536949|11334748|FG000|COMPLETED|Overall Study||143
10207865|NCT03536949|11334749|FG001|COMPLETED|Overall Study||75
10207866|NCT03536949|11334748|FG000|NOT COMPLETED|Overall Study||14
9946255|NCT01381718|11064679|FG001|COMPLETED|Overall Study||43
9946256|NCT01381718|11064678|FG000|NOT COMPLETED|Overall Study||5
9946257|NCT01381718|11064679|FG001|NOT COMPLETED|Overall Study||13
9946258|NCT01381861|11064685|FG000|STARTED|Overall Study||23
10207867|NCT03536949|11334749|FG001|NOT COMPLETED|Overall Study||2
9946259|NCT01381861|11064685|FG000|COMPLETED|Overall Study||23
10207868|NCT03537092|11334755|FG000|STARTED|Overall Study||64
10207869|NCT03537092|11334755|FG000|COMPLETED|Overall Study||64
10207870|NCT03537092|11334755|FG000|NOT COMPLETED|Overall Study||0
10207871|NCT03537261|11334761|FG000|STARTED|Overall Study||41
10207872|NCT03537261|11334762|FG001|STARTED|Overall Study||39
10207873|NCT03537261|11334761|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
10207874|NCT03537261|11334762|FG001|Completed Baseline Assessment|Overall Study||28
9946260|NCT01381861|11064685|FG000|NOT COMPLETED|Overall Study||0
9946261|NCT01381874|11064692|FG000|STARTED|Overall Study||102
9946262|NCT01381874|11064693|FG001|STARTED|Overall Study||89
9946263|NCT01381874|11064694|FG002|STARTED|Overall Study||106
9946264|NCT01381874|11064692|FG000|Treated|Overall Study||102
9946265|NCT01381874|11064693|FG001|Treated|Overall Study||87
9946266|NCT01381874|11064694|FG002|Treated|Overall Study||104
9946267|NCT01381874|11064692|FG000|COMPLETED|Overall Study||25
9946268|NCT01381874|11064693|FG001|COMPLETED|Overall Study||26
9946269|NCT01381874|11064694|FG002|COMPLETED|Overall Study||30
9946270|NCT01381874|11064692|FG000|NOT COMPLETED|Overall Study||77
9946271|NCT01381874|11064693|FG001|NOT COMPLETED|Overall Study||63
9946272|NCT01381874|11064694|FG002|NOT COMPLETED|Overall Study||76
9946273|NCT01381900|11064705|FG000|STARTED|Overall Study||226
9946274|NCT01381900|11064706|FG001|STARTED|Overall Study||223
9946275|NCT01381900|11064707|FG002|STARTED|Overall Study||227
9946276|NCT01381900|11064705|FG000|COMPLETED|Overall Study||217
9946277|NCT01381900|11064706|FG001|COMPLETED|Overall Study||214
9946278|NCT01381900|11064707|FG002|COMPLETED|Overall Study||215
9946279|NCT01381900|11064705|FG000|NOT COMPLETED|Overall Study||9
9946280|NCT01381900|11064706|FG001|NOT COMPLETED|Overall Study||9
9946281|NCT01381900|11064707|FG002|NOT COMPLETED|Overall Study||12
9946282|NCT01381926|11064717|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5
9946283|NCT01381926|11064718|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5
9946284|NCT01381926|11064717|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
9946285|NCT01381926|11064718|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
9946286|NCT01381926|11064717|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
9946287|NCT01381926|11064718|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
9946288|NCT01381926|11064717|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3
9946289|NCT01381926|11064718|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4
9946290|NCT01381926|11064717|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
9946291|NCT01381926|11064718|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
9946292|NCT01381926|11064717|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
9946293|NCT01381926|11064718|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
9946294|NCT01381952|11064726|FG000|STARTED|Overall Study||20
9946295|NCT01381952|11064726|FG000|Collected Dose and Image Information|Overall Study||20
9946296|NCT01381952|11064726|FG000|COMPLETED|Overall Study||20
9946297|NCT01381952|11064726|FG000|NOT COMPLETED|Overall Study||0
10207875|NCT03537261|11334761|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
10207876|NCT03537261|11334762|FG001|COMPLETED|Overall Study||27
10207877|NCT03537261|11334761|FG000|NOT COMPLETED|Overall Study||8
10207878|NCT03537261|11334762|FG001|NOT COMPLETED|Overall Study||12
10207879|NCT03537274|11334772|FG000|STARTED|Overall Study||315
10207880|NCT03537274|11334773|FG001|STARTED|Overall Study||298
10207881|NCT03537274|11334774|FG002|STARTED|Overall Study||304
10207882|NCT03537274|11334775|FG003|STARTED|Overall Study||307
10207883|NCT03537274|11334772|FG000|Treated|Overall Study||315
10207884|NCT03537274|11334773|FG001|Treated|Overall Study||297
10207885|NCT03537274|11334774|FG002|Treated|Overall Study||304
10207886|NCT03537274|11334775|FG003|Treated|Overall Study||303
10207887|NCT03537274|11334772|FG000|COMPLETED|Overall Study||255
10207888|NCT03537274|11334773|FG001|COMPLETED|Overall Study||229
10207889|NCT03537274|11334774|FG002|COMPLETED|Overall Study||228
10207890|NCT03537274|11334775|FG003|COMPLETED|Overall Study||231
10207891|NCT03537274|11334772|FG000|NOT COMPLETED|Overall Study||60
10207892|NCT03537274|11334773|FG001|NOT COMPLETED|Overall Study||69
10207893|NCT03537274|11334774|FG002|NOT COMPLETED|Overall Study||76
10207894|NCT03537274|11334775|FG003|NOT COMPLETED|Overall Study||76
10207895|NCT03537404|11334788|FG000|STARTED|First Intervention (A or B or C)||18
10207896|NCT03537404|11334789|FG001|STARTED|First Intervention (A or B or C)||18
10207897|NCT03537404|11334788|FG000|COMPLETED|First Intervention (A or B or C)||18
10207898|NCT03537404|11334789|FG001|COMPLETED|First Intervention (A or B or C)||18
10207899|NCT03537404|11334788|FG000|NOT COMPLETED|First Intervention (A or B or C)||0
10207900|NCT03537404|11334789|FG001|NOT COMPLETED|First Intervention (A or B or C)||0
10207901|NCT03537404|11334788|FG000|STARTED|First Washout Period (8 Days)||18
10207902|NCT03537404|11334789|FG001|STARTED|First Washout Period (8 Days)||18
10207903|NCT03537404|11334788|FG000|COMPLETED|First Washout Period (8 Days)||18
10207904|NCT03537404|11334789|FG001|COMPLETED|First Washout Period (8 Days)||18
10207905|NCT03537404|11334788|FG000|NOT COMPLETED|First Washout Period (8 Days)||0
10207906|NCT03537404|11334789|FG001|NOT COMPLETED|First Washout Period (8 Days)||0
10207907|NCT03537404|11334788|FG000|STARTED|Second Intervention (A or B or C)||18
10207908|NCT03537404|11334789|FG001|STARTED|Second Intervention (A or B or C)||18
10207909|NCT03537404|11334788|FG000|COMPLETED|Second Intervention (A or B or C)||18
9946298|NCT01382108|11064734|FG000|STARTED|Overall Study||20
9946299|NCT01382108|11064735|FG001|STARTED|Overall Study||19
9946300|NCT01382108|11064734|FG000|COMPLETED|Overall Study||20
9946301|NCT01382108|11064735|FG001|COMPLETED|Overall Study||19
9946302|NCT01382108|11064734|FG000|NOT COMPLETED|Overall Study||0
9946303|NCT01382108|11064735|FG001|NOT COMPLETED|Overall Study||0
9946304|NCT01382186|11064744|FG000|STARTED|Overall Study||33
9946305|NCT01382186|11064745|FG001|STARTED|Overall Study||819
9946306|NCT01382186|11064744|FG000|COMPLETED|Overall Study||32
9946307|NCT01382186|11064745|FG001|COMPLETED|Overall Study||819
10207910|NCT03537404|11334789|FG001|COMPLETED|Second Intervention (A or B or C)||18
9946308|NCT01382186|11064744|FG000|NOT COMPLETED|Overall Study||1
9946309|NCT01382186|11064745|FG001|NOT COMPLETED|Overall Study||0
9946310|NCT01382212|11064754|FG000|STARTED|Overall Study||13
9946311|NCT01382212|11064754|FG000|COMPLETED|Overall Study||11
9946312|NCT01382212|11064754|FG000|NOT COMPLETED|Overall Study||2
9946313|NCT01382225|11064760|FG000|STARTED|Overall Study||725
9946314|NCT01382225|11064761|FG001|STARTED|Overall Study||729
9946315|NCT01382225|11064760|FG000|COMPLETED|Overall Study||711
9946316|NCT01382225|11064761|FG001|COMPLETED|Overall Study||722
9946317|NCT01382225|11064760|FG000|NOT COMPLETED|Overall Study||14
9946318|NCT01382225|11064761|FG001|NOT COMPLETED|Overall Study||7
9946319|NCT01382251|11064769|FG000|STARTED|Overall Study||123
9946320|NCT01382251|11064770|FG001|STARTED|Overall Study||123
9946321|NCT01382251|11064769|FG000|COMPLETED|Overall Study||102
9946322|NCT01382251|11064770|FG001|COMPLETED|Overall Study||102
10011660|NCT01781572|11134448|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
10011661|NCT01781572|11134449|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10011662|NCT01781572|11134447|FG000|STARTED|MEK162 30mg LEE011 200mg||0
10011663|NCT01781572|11134448|FG001|STARTED|MEK162 30mg LEE011 200mg||5
10011664|NCT01781572|11134449|FG002|STARTED|MEK162 30mg LEE011 200mg||0
10011665|NCT01781572|11134447|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0
10111647|NCT02497391|11242655|FG002|NOT COMPLETED|Period 2 (14 Days)||3
10207911|NCT03537404|11334788|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0
10207912|NCT03537404|11334789|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0
10207913|NCT03537404|11334788|FG000|STARTED|Second Washout Period (8 Days)||18
10207914|NCT03537404|11334789|FG001|STARTED|Second Washout Period (8 Days)||18
10207915|NCT03537404|11334788|FG000|COMPLETED|Second Washout Period (8 Days)||18
10207916|NCT03537404|11334789|FG001|COMPLETED|Second Washout Period (8 Days)||18
10207917|NCT03537404|11334788|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0
10207918|NCT03537404|11334789|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0
10207919|NCT03537404|11334788|FG000|STARTED|Third Intervention (A or B or C)||18
10207920|NCT03537404|11334789|FG001|STARTED|Third Intervention (A or B or C)||18
10207921|NCT03537404|11334788|FG000|COMPLETED|Third Intervention (A or B or C)||18
10207922|NCT03537404|11334789|FG001|COMPLETED|Third Intervention (A or B or C)||18
10207923|NCT03537404|11334788|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0
10207924|NCT03537404|11334789|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0
10207925|NCT03537651|11334813|FG000|STARTED|Overall Study||130
10207926|NCT03537651|11334813|FG000|113B/116 FAS|Overall Study||64
10207927|NCT03537651|11334813|FG000|113B/116 LCI FAS|Overall Study||30
10207928|NCT03537651|11334813|FG000|115/116 FAS|Overall Study||66
10207929|NCT03537651|11334813|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53
10207930|NCT03537651|11334813|FG000|COMPLETED|Overall Study||69
10207931|NCT03537651|11334813|FG000|NOT COMPLETED|Overall Study||61
10207932|NCT03537664|11334820|FG000|STARTED|Overall Study||20
10207933|NCT03537664|11334821|FG001|STARTED|Overall Study||25
10207934|NCT03537664|11334820|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
10207935|NCT03537664|11334821|FG001|Metabolic Activity of Bacteria|Overall Study||25
10207936|NCT03537664|11334820|FG000|Bacterial Levels|Overall Study||20
10207937|NCT03537664|11334821|FG001|Bacterial Levels|Overall Study||25
10207938|NCT03537664|11334820|FG000|Bacterial Community Diversity|Overall Study||10
10207939|NCT03537664|11334821|FG001|Bacterial Community Diversity|Overall Study||0
10207940|NCT03537664|11334820|FG000|Endodontic Success|Overall Study||20
10207941|NCT03537664|11334821|FG001|Endodontic Success|Overall Study||10
10207942|NCT03537664|11334820|FG000|COMPLETED|Overall Study||20
10207943|NCT03537664|11334821|FG001|COMPLETED|Overall Study||25
10207944|NCT03537664|11334820|FG000|NOT COMPLETED|Overall Study||0
10207945|NCT03537664|11334821|FG001|NOT COMPLETED|Overall Study||0
10011666|NCT01781572|11134448|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0
10011667|NCT01781572|11134449|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0
10011668|NCT01781572|11134447|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
10111648|NCT02497391|11242656|FG003|NOT COMPLETED|Period 2 (14 Days)||3
10111649|NCT02497391|11242657|FG004|NOT COMPLETED|Period 2 (14 Days)||2
10111650|NCT02497391|11242658|FG005|NOT COMPLETED|Period 2 (14 Days)||3
10111651|NCT02497391|11242653|FG000|STARTED|Period 3 (14 Days)||12
10111652|NCT02497391|11242654|FG001|STARTED|Period 3 (14 Days)||14
10111653|NCT02497391|11242655|FG002|STARTED|Period 3 (14 Days)||13
10111654|NCT02497391|11242656|FG003|STARTED|Period 3 (14 Days)||13
10111655|NCT02497391|11242657|FG004|STARTED|Period 3 (14 Days)||14
10111656|NCT02497391|11242658|FG005|STARTED|Period 3 (14 Days)||13
10207946|NCT03538431|11334832|FG000|STARTED|Overall Study||13
9946323|NCT01382251|11064769|FG000|NOT COMPLETED|Overall Study||21
9946324|NCT01382251|11064770|FG001|NOT COMPLETED|Overall Study||21
9946325|NCT01382303|11064777|FG000|STARTED|Overall Study||87
9946326|NCT01382303|11064778|FG001|STARTED|Overall Study||87
9946327|NCT01382303|11064777|FG000|COMPLETED|Overall Study||52
9946328|NCT01382303|11064778|FG001|COMPLETED|Overall Study||70
9946329|NCT01382303|11064777|FG000|NOT COMPLETED|Overall Study||35
9946330|NCT01382303|11064778|FG001|NOT COMPLETED|Overall Study||17
9946331|NCT01382446|11064786|FG000|STARTED|Overall Study||33
9946332|NCT01382446|11064787|FG001|STARTED|Overall Study||33
9946333|NCT01382446|11064786|FG000|COMPLETED|Overall Study||30
9946334|NCT01382446|11064787|FG001|COMPLETED|Overall Study||29
9946335|NCT01382446|11064786|FG000|NOT COMPLETED|Overall Study||3
9946336|NCT01382446|11064787|FG001|NOT COMPLETED|Overall Study||4
9946337|NCT01382602|11064795|FG000|STARTED|Overall Study||93
9946338|NCT01382602|11064796|FG001|STARTED|Overall Study||50
10011669|NCT01781572|11134448|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
10111657|NCT02497391|11242653|FG000|COMPLETED|Period 3 (14 Days)||12
9946339|NCT01382602|11064795|FG000|COMPLETED|Overall Study||93
9946340|NCT01382602|11064796|FG001|COMPLETED|Overall Study||46
9946341|NCT01382602|11064795|FG000|NOT COMPLETED|Overall Study||0
9946342|NCT01382602|11064796|FG001|NOT COMPLETED|Overall Study||4
9946343|NCT01382719|11064806|FG000|STARTED|Overall Study||98
9946344|NCT01382719|11064807|FG001|STARTED|Overall Study||100
9946345|NCT01382719|11064808|FG002|STARTED|Overall Study||100
9946346|NCT01382719|11064809|FG003|STARTED|Overall Study||99
9946347|NCT01382719|11064806|FG000|Subjects Not Dosed|Overall Study||1
9946348|NCT01382719|11064807|FG001|Subjects Not Dosed|Overall Study||0
9946349|NCT01382719|11064808|FG002|Subjects Not Dosed|Overall Study||1
9946350|NCT01382719|11064809|FG003|Subjects Not Dosed|Overall Study||1
9946351|NCT01382719|11064806|FG000|COMPLETED|Overall Study||80
9946352|NCT01382719|11064807|FG001|COMPLETED|Overall Study||81
9946353|NCT01382719|11064808|FG002|COMPLETED|Overall Study||66
9946354|NCT01382719|11064809|FG003|COMPLETED|Overall Study||66
9946355|NCT01382719|11064806|FG000|NOT COMPLETED|Overall Study||18
9946356|NCT01382719|11064807|FG001|NOT COMPLETED|Overall Study||19
9946357|NCT01382719|11064808|FG002|NOT COMPLETED|Overall Study||34
9946358|NCT01382719|11064809|FG003|NOT COMPLETED|Overall Study||33
9946359|NCT01382901|11064821|FG000|STARTED|Overall Study||24
9946360|NCT01382901|11064822|FG001|STARTED|Overall Study||21
9946361|NCT01382901|11064821|FG000|COMPLETED|Overall Study||7
9946362|NCT01382901|11064822|FG001|COMPLETED|Overall Study||7
9946363|NCT01382901|11064821|FG000|NOT COMPLETED|Overall Study||17
9946364|NCT01382901|11064822|FG001|NOT COMPLETED|Overall Study||14
9946365|NCT01382940|11064828|FG000|STARTED|Overall Study||351
9946366|NCT01382940|11064828|FG000|Received Day 1 Infusion|Overall Study||351
9946367|NCT01382940|11064828|FG000|Received Day 15 Infusions|Overall Study||341
9946368|NCT01382940|11064828|FG000|Received Day 168 Infusion|Overall Study||290
9946369|NCT01382940|11064828|FG000|Received Day 182 Infusion|Overall Study||278
9946370|NCT01382940|11064828|FG000|COMPLETED|Overall Study||278
9946371|NCT01382940|11064828|FG000|NOT COMPLETED|Overall Study||73
9946372|NCT01383005|11064834|FG000|STARTED|Overall Study||34
9946373|NCT01383005|11064835|FG001|STARTED|Overall Study||60
9946374|NCT01383005|11064834|FG000|COMPLETED|Overall Study||34
9946375|NCT01383005|11064835|FG001|COMPLETED|Overall Study||60
9946376|NCT01383005|11064834|FG000|NOT COMPLETED|Overall Study||0
9946377|NCT01383005|11064835|FG001|NOT COMPLETED|Overall Study||0
9946378|NCT01383018|11064841|FG000|STARTED|Overall Study||1457
9946379|NCT01383018|11064841|FG000|COMPLETED|Overall Study||1082
9946380|NCT01383018|11064841|FG000|NOT COMPLETED|Overall Study||375
9946381|NCT01383096|11064858|FG000|STARTED|First Intervention (8 Days)||19
9946382|NCT01383096|11064859|FG001|STARTED|First Intervention (8 Days)||17
9946383|NCT01383096|11064860|FG002|STARTED|First Intervention (8 Days)||16
9946384|NCT01383096|11064858|FG000|COMPLETED|First Intervention (8 Days)||19
9946385|NCT01383096|11064859|FG001|COMPLETED|First Intervention (8 Days)||17
9946386|NCT01383096|11064860|FG002|COMPLETED|First Intervention (8 Days)||16
9946387|NCT01383096|11064858|FG000|NOT COMPLETED|First Intervention (8 Days)||0
9946388|NCT01383096|11064859|FG001|NOT COMPLETED|First Intervention (8 Days)||0
9946389|NCT01383096|11064860|FG002|NOT COMPLETED|First Intervention (8 Days)||0
9946390|NCT01383096|11064858|FG000|STARTED|Second Intervention (8 Days)||19
9946391|NCT01383096|11064859|FG001|STARTED|Second Intervention (8 Days)||17
9946392|NCT01383096|11064860|FG002|STARTED|Second Intervention (8 Days)||16
9946393|NCT01383096|11064858|FG000|COMPLETED|Second Intervention (8 Days)||19
9946394|NCT01383096|11064859|FG001|COMPLETED|Second Intervention (8 Days)||16
9946395|NCT01383096|11064860|FG002|COMPLETED|Second Intervention (8 Days)||14
9946396|NCT01383096|11064858|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
9946397|NCT01383096|11064859|FG001|NOT COMPLETED|Second Intervention (8 Days)||1
9946398|NCT01383096|11064860|FG002|NOT COMPLETED|Second Intervention (8 Days)||2
9946399|NCT01383096|11064858|FG000|STARTED|Third Intervention (8 Days)||19
9946400|NCT01383096|11064859|FG001|STARTED|Third Intervention (8 Days)||16
9946401|NCT01383096|11064860|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
9946402|NCT01383096|11064858|FG000|COMPLETED|Third Intervention (8 Days)||15
9946403|NCT01383096|11064859|FG001|COMPLETED|Third Intervention (8 Days)||12
9946404|NCT01383096|11064860|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
9946405|NCT01383096|11064858|FG000|NOT COMPLETED|Third Intervention (8 Days)||4
9946406|NCT01383096|11064859|FG001|NOT COMPLETED|Third Intervention (8 Days)||4
9946407|NCT01383096|11064860|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
9946408|NCT01383096|11064858|FG000|STARTED|Fourth Intervention (8 Days)||15
9946409|NCT01383096|11064859|FG001|STARTED|Fourth Intervention (8 Days)||12
9946410|NCT01383096|11064860|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
9946411|NCT01383096|11064858|FG000|COMPLETED|Fourth Intervention (8 Days)||13
9946412|NCT01383096|11064859|FG001|COMPLETED|Fourth Intervention (8 Days)||12
9946413|NCT01383096|11064860|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
9946414|NCT01383096|11064858|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2
9946415|NCT01383096|11064859|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0
9946416|NCT01383096|11064860|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0
9946417|NCT01383096|11064858|FG000|STARTED|Fifth Intervention (8 Days)||13
9946418|NCT01383096|11064859|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
9946419|NCT01383096|11064860|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
9946420|NCT01383096|11064858|FG000|COMPLETED|Fifth Intervention (8 Days)||11
9946421|NCT01383096|11064859|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
9946422|NCT01383096|11064860|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
9946423|NCT01383096|11064858|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2
9946424|NCT01383096|11064859|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0
9946425|NCT01383096|11064860|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0
9946426|NCT01383161|11064899|FG000|STARTED|Overall Study||25
9946427|NCT01383161|11064900|FG001|STARTED|Overall Study||21
9946428|NCT01383161|11064899|FG000|COMPLETED|Overall Study||20
9946429|NCT01383161|11064900|FG001|COMPLETED|Overall Study||17
9946430|NCT01383161|11064899|FG000|NOT COMPLETED|Overall Study||5
9946431|NCT01383161|11064900|FG001|NOT COMPLETED|Overall Study||4
9946432|NCT01383174|11064908|FG000|STARTED|Baseline Assessment||76
9946433|NCT01383174|11064909|FG001|STARTED|Baseline Assessment||75
9946434|NCT01383174|11064908|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
9946435|NCT01383174|11064909|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
9946436|NCT01383174|11064908|FG000|NOT COMPLETED|Baseline Assessment||0
9946437|NCT01383174|11064909|FG001|NOT COMPLETED|Baseline Assessment||0
9946438|NCT01383174|11064908|FG000|STARTED|3 Month Assessment||76
9946439|NCT01383174|11064909|FG001|STARTED|3 Month Assessment||75
9946440|NCT01383174|11064908|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
9946441|NCT01383174|11064909|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
9946442|NCT01383174|11064908|FG000|NOT COMPLETED|3 Month Assessment||6
9946443|NCT01383174|11064909|FG001|NOT COMPLETED|3 Month Assessment||1
9946444|NCT01383174|11064908|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
9946445|NCT01383174|11064909|FG001|STARTED|6 Month Assessment||74
9946446|NCT01383174|11064908|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
9946447|NCT01383174|11064909|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
9946448|NCT01383174|11064908|FG000|NOT COMPLETED|6 Month Assessment||5
9946449|NCT01383174|11064909|FG001|NOT COMPLETED|6 Month Assessment||1
9946450|NCT01383200|11064917|FG000|STARTED|Overall Study||5
9946451|NCT01383200|11064918|FG001|STARTED|Overall Study||6
9946452|NCT01383200|11064917|FG000|COMPLETED|Overall Study||5
9946453|NCT01383200|11064918|FG001|COMPLETED|Overall Study||6
9946454|NCT01383200|11064917|FG000|NOT COMPLETED|Overall Study||0
9946455|NCT01383200|11064918|FG001|NOT COMPLETED|Overall Study||0
9946456|NCT01383213|11064926|FG000|STARTED|Overall Study||40
9946457|NCT01383213|11064927|FG001|STARTED|Overall Study||41
9946458|NCT01383213|11064926|FG000|COMPLETED|Overall Study||40
9946459|NCT01383213|11064927|FG001|COMPLETED|Overall Study||41
9946460|NCT01383213|11064926|FG000|NOT COMPLETED|Overall Study||0
9946461|NCT01383213|11064927|FG001|NOT COMPLETED|Overall Study||0
9946462|NCT01383317|11064935|FG000|STARTED|Overall Study||29
9946463|NCT01383317|11064936|FG001|STARTED|Overall Study||35
9946464|NCT01383317|11064935|FG000|COMPLETED|Overall Study||26
9946465|NCT01383317|11064936|FG001|COMPLETED|Overall Study||33
9946466|NCT01383317|11064935|FG000|NOT COMPLETED|Overall Study||3
9946467|NCT01383317|11064936|FG001|NOT COMPLETED|Overall Study||2
9946468|NCT01383356|11064942|FG000|STARTED|Period 1|Entered and treated.|29
9946469|NCT01383356|11064943|FG001|STARTED|Period 1|Entered and treated.|29
9946470|NCT01383356|11064942|FG000|COMPLETED|Period 1|Completed period 1.|21
9946471|NCT01383356|11064943|FG001|COMPLETED|Period 1|Completed period 1.|23
9946472|NCT01383356|11064942|FG000|NOT COMPLETED|Period 1||8
9946473|NCT01383356|11064943|FG001|NOT COMPLETED|Period 1||6
9946474|NCT01383356|11064942|FG000|STARTED|Washout Period (at Least 35 Days)||21
9946475|NCT01383356|11064943|FG001|STARTED|Washout Period (at Least 35 Days)||23
9946476|NCT01383356|11064942|FG000|COMPLETED|Washout Period (at Least 35 Days)||21
9946477|NCT01383356|11064943|FG001|COMPLETED|Washout Period (at Least 35 Days)||23
9946478|NCT01383356|11064942|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0
9946479|NCT01383356|11064943|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0
9946480|NCT01383356|11064942|FG000|STARTED|Period 2|Entered and treated.|21
9946481|NCT01383356|11064943|FG001|STARTED|Period 2|Entered and treated.|23
9946482|NCT01383356|11064942|FG000|COMPLETED|Period 2|Completed period 2.|21
9946483|NCT01383356|11064943|FG001|COMPLETED|Period 2|Completed period 2.|23
9946484|NCT01383356|11064942|FG000|NOT COMPLETED|Period 2||0
9946485|NCT01383356|11064943|FG001|NOT COMPLETED|Period 2||0
9946486|NCT01383421|11064949|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
9946487|NCT01383421|11064949|FG000|COMPLETED|Overall Study||679
9946488|NCT01383421|11064949|FG000|NOT COMPLETED|Overall Study||346
9946489|NCT01383486|11064957|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253
9946490|NCT01383486|11064957|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
9946491|NCT01383486|11064957|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
9946492|NCT01383486|11064957|FG000|NOT COMPLETED|Overall Study||18
9946493|NCT01383499|11064962|FG000|STARTED|Period 1 (4 Weeks)||27
10207947|NCT03538431|11334833|FG001|STARTED|Overall Study||13
10207948|NCT03538431|11334832|FG000|COMPLETED|Overall Study||12
10207949|NCT03538431|11334833|FG001|COMPLETED|Overall Study||12
10207950|NCT03538431|11334832|FG000|NOT COMPLETED|Overall Study||1
10207951|NCT03538431|11334833|FG001|NOT COMPLETED|Overall Study||1
10207952|NCT03538678|11334843|FG000|STARTED|Overall Study||20
10207953|NCT03538678|11334844|FG001|STARTED|Overall Study||20
9946494|NCT01383499|11064963|FG001|STARTED|Period 1 (4 Weeks)||24
9946495|NCT01383499|11064964|FG002|STARTED|Period 1 (4 Weeks)||25
9946496|NCT01383499|11064965|FG003|STARTED|Period 1 (4 Weeks)||25
9946497|NCT01383499|11064962|FG000|COMPLETED|Period 1 (4 Weeks)||26
9946498|NCT01383499|11064963|FG001|COMPLETED|Period 1 (4 Weeks)||24
9946499|NCT01383499|11064964|FG002|COMPLETED|Period 1 (4 Weeks)||25
9946500|NCT01383499|11064965|FG003|COMPLETED|Period 1 (4 Weeks)||25
9946501|NCT01383499|11064962|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
9946502|NCT01383499|11064963|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0
9946503|NCT01383499|11064964|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
9946504|NCT01383499|11064965|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
9946505|NCT01383499|11064962|FG000|STARTED|Period 2 (4 Weeks)||26
9946506|NCT01383499|11064963|FG001|STARTED|Period 2 (4 Weeks)||24
9946507|NCT01383499|11064964|FG002|STARTED|Period 2 (4 Weeks)||25
9946508|NCT01383499|11064965|FG003|STARTED|Period 2 (4 Weeks)||25
9946509|NCT01383499|11064962|FG000|COMPLETED|Period 2 (4 Weeks)||26
9946510|NCT01383499|11064963|FG001|COMPLETED|Period 2 (4 Weeks)||24
9946511|NCT01383499|11064964|FG002|COMPLETED|Period 2 (4 Weeks)||25
9946512|NCT01383499|11064965|FG003|COMPLETED|Period 2 (4 Weeks)||25
9946513|NCT01383499|11064962|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
9946514|NCT01383499|11064963|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
9946515|NCT01383499|11064964|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
9946516|NCT01383499|11064965|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
9946517|NCT01383499|11064962|FG000|STARTED|Period 3 (4 Weeks)||26
9946518|NCT01383499|11064963|FG001|STARTED|Period 3 (4 Weeks)||24
9946519|NCT01383499|11064964|FG002|STARTED|Period 3 (4 Weeks)||25
9946520|NCT01383499|11064965|FG003|STARTED|Period 3 (4 Weeks)||25
9946521|NCT01383499|11064962|FG000|COMPLETED|Period 3 (4 Weeks)||26
9946522|NCT01383499|11064963|FG001|COMPLETED|Period 3 (4 Weeks)||24
9946523|NCT01383499|11064964|FG002|COMPLETED|Period 3 (4 Weeks)||25
9946524|NCT01383499|11064965|FG003|COMPLETED|Period 3 (4 Weeks)||25
9946525|NCT01383499|11064962|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
9946526|NCT01383499|11064963|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
9946527|NCT01383499|11064964|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
9946528|NCT01383499|11064965|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
9946529|NCT01383616|11064980|FG000|STARTED|Overall Study||40
9946530|NCT01383616|11064981|FG001|STARTED|Overall Study||44
9946531|NCT01383616|11064980|FG000|COMPLETED|Overall Study||23
9946532|NCT01383616|11064981|FG001|COMPLETED|Overall Study||21
9946533|NCT01383616|11064980|FG000|NOT COMPLETED|Overall Study||17
9946534|NCT01383616|11064981|FG001|NOT COMPLETED|Overall Study||23
9946535|NCT01383707|11064991|FG000|STARTED|Overall Study||77
9946536|NCT01383707|11064991|FG000|COMPLETED|Overall Study||5
9946537|NCT01383707|11064991|FG000|NOT COMPLETED|Overall Study||72
9946538|NCT01383720|11064995|FG000|STARTED|Overall Study||11
9946539|NCT01383720|11064995|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11
9946540|NCT01383720|11064995|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
9946541|NCT01383720|11064995|FG000|NOT COMPLETED|Overall Study||0
9946542|NCT01383759|11065001|FG000|STARTED|Overall Study||19
9946543|NCT01383759|11065002|FG001|STARTED|Overall Study||1
9946544|NCT01383759|11065001|FG000|COMPLETED|Overall Study||19
9946545|NCT01383759|11065002|FG001|COMPLETED|Overall Study||1
9946546|NCT01383759|11065001|FG000|NOT COMPLETED|Overall Study||0
9946547|NCT01383759|11065002|FG001|NOT COMPLETED|Overall Study||0
9946548|NCT01383928|11065011|FG000|STARTED|Overall Study||7
9946549|NCT01383928|11065012|FG001|STARTED|Overall Study||7
9946550|NCT01383928|11065013|FG002|STARTED|Overall Study||50
9946551|NCT01383928|11065011|FG000|COMPLETED|Overall Study||2
9946552|NCT01383928|11065012|FG001|COMPLETED|Overall Study||0
9946553|NCT01383928|11065013|FG002|COMPLETED|Overall Study||10
9946554|NCT01383928|11065011|FG000|NOT COMPLETED|Overall Study||5
9946555|NCT01383928|11065012|FG001|NOT COMPLETED|Overall Study||7
9946556|NCT01383928|11065013|FG002|NOT COMPLETED|Overall Study||40
9946557|NCT01383954|11065023|FG000|STARTED|Overall Study||52
9946558|NCT01383954|11065023|FG000|Safety Population: Received Treatment|Overall Study||48
9946559|NCT01383954|11065023|FG000|COMPLETED|Overall Study||38
9946560|NCT01383954|11065023|FG000|NOT COMPLETED|Overall Study||14
9946561|NCT01383993|11065030|FG000|STARTED|Overall Study||15
9946562|NCT01383993|11065031|FG001|STARTED|Overall Study||4
9946563|NCT01383993|11065032|FG002|STARTED|Overall Study||2
9946564|NCT01383993|11065030|FG000|COMPLETED|Overall Study||12
10207954|NCT03538678|11334843|FG000|COMPLETED|Overall Study||5
10207955|NCT03538678|11334844|FG001|COMPLETED|Overall Study||9
10207956|NCT03538678|11334843|FG000|NOT COMPLETED|Overall Study||15
10207957|NCT03538678|11334844|FG001|NOT COMPLETED|Overall Study||11
10207958|NCT03538743|11334859|FG000|STARTED|Overall Study||25
10207959|NCT03538743|11334860|FG001|STARTED|Overall Study||9
10207960|NCT03538743|11334861|FG002|STARTED|Overall Study||9
9946565|NCT01383993|11065031|FG001|COMPLETED|Overall Study||3
9946566|NCT01383993|11065032|FG002|COMPLETED|Overall Study||1
9946567|NCT01383993|11065030|FG000|NOT COMPLETED|Overall Study||3
9946568|NCT01383993|11065031|FG001|NOT COMPLETED|Overall Study||1
9946569|NCT01383993|11065032|FG002|NOT COMPLETED|Overall Study||1
9946570|NCT01384019|11065043|FG000|STARTED|Overall Study||65
9946571|NCT01384019|11065044|FG001|STARTED|Overall Study||61
9946572|NCT01384019|11065043|FG000|COMPLETED|Overall Study||55
10207961|NCT03538743|11334862|FG003|STARTED|Overall Study||10
10207962|NCT03538743|11334863|FG004|STARTED|Overall Study||9
10207963|NCT03538743|11334864|FG005|STARTED|Overall Study||9
9946573|NCT01384019|11065044|FG001|COMPLETED|Overall Study||55
10207964|NCT03538743|11334865|FG006|STARTED|Overall Study||9
10207965|NCT03538743|11334866|FG007|STARTED|Overall Study||8
10207966|NCT03538743|11334867|FG008|STARTED|Overall Study||10
10207967|NCT03538743|11334859|FG000|Received Treatment|Overall Study||25
9946574|NCT01384019|11065043|FG000|NOT COMPLETED|Overall Study||10
9946575|NCT01384019|11065044|FG001|NOT COMPLETED|Overall Study||6
9946576|NCT01384292|11065053|FG000|STARTED|Part A||5
9946577|NCT01384292|11065054|FG001|STARTED|Part A||5
9946578|NCT01384292|11065055|FG002|STARTED|Part A||4
9946579|NCT01384292|11065053|FG000|COMPLETED|Part A||5
9946580|NCT01384292|11065054|FG001|COMPLETED|Part A||5
9946581|NCT01384292|11065055|FG002|COMPLETED|Part A||4
9946582|NCT01384292|11065053|FG000|NOT COMPLETED|Part A||0
9946583|NCT01384292|11065054|FG001|NOT COMPLETED|Part A||0
9946584|NCT01384292|11065055|FG002|NOT COMPLETED|Part A||0
9946585|NCT01384292|11065053|FG000|STARTED|Part B||3
9946586|NCT01384292|11065054|FG001|STARTED|Part B||6
9946587|NCT01384292|11065055|FG002|STARTED|Part B||0
9946588|NCT01384292|11065053|FG000|COMPLETED|Part B||2
9946589|NCT01384292|11065054|FG001|COMPLETED|Part B||6
9946590|NCT01384292|11065055|FG002|COMPLETED|Part B||0
9946591|NCT01384292|11065053|FG000|NOT COMPLETED|Part B||1
9946592|NCT01384292|11065054|FG001|NOT COMPLETED|Part B||0
9946593|NCT01384292|11065055|FG002|NOT COMPLETED|Part B||0
9946594|NCT01384539|11065067|FG000|STARTED|Overall Study||64
9946595|NCT01384539|11065068|FG001|STARTED|Overall Study||64
9946596|NCT01384539|11065067|FG000|COMPLETED|Overall Study||58
9946597|NCT01384539|11065068|FG001|COMPLETED|Overall Study||57
9946598|NCT01384539|11065067|FG000|NOT COMPLETED|Overall Study||6
9946599|NCT01384539|11065068|FG001|NOT COMPLETED|Overall Study||7
9946600|NCT01384591|11065077|FG000|STARTED|Overall Study||2
9946601|NCT01384591|11065078|FG001|STARTED|Overall Study||2
9946602|NCT01384591|11065079|FG002|STARTED|Overall Study||2
10011670|NCT01781572|11134449|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
10011671|NCT01781572|11134447|FG000|STARTED|MEK162 45mg LEE011 450mg||0
10011672|NCT01781572|11134448|FG001|STARTED|MEK162 45mg LEE011 450mg||9
10011673|NCT01781572|11134449|FG002|STARTED|MEK162 45mg LEE011 450mg||0
10011674|NCT01781572|11134447|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0
10011675|NCT01781572|11134448|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0
9946603|NCT01384591|11065077|FG000|COMPLETED|Overall Study||2
9946604|NCT01384591|11065078|FG001|COMPLETED|Overall Study||2
9946605|NCT01384591|11065079|FG002|COMPLETED|Overall Study||2
9946606|NCT01384591|11065077|FG000|NOT COMPLETED|Overall Study||0
9946607|NCT01384591|11065078|FG001|NOT COMPLETED|Overall Study||0
9946608|NCT01384591|11065079|FG002|NOT COMPLETED|Overall Study||0
9946609|NCT01384734|11065092|FG000|STARTED|Overall Study||50
9946610|NCT01384734|11065093|FG001|STARTED|Overall Study||49
9946611|NCT01384734|11065094|FG002|STARTED|Overall Study||51
9946612|NCT01384734|11065095|FG003|STARTED|Overall Study||50
9946613|NCT01384734|11065096|FG004|STARTED|Overall Study||51
9946614|NCT01384734|11065092|FG000|COMPLETED|Overall Study||33
9946615|NCT01384734|11065093|FG001|COMPLETED|Overall Study||25
9946616|NCT01384734|11065094|FG002|COMPLETED|Overall Study||28
9946617|NCT01384734|11065095|FG003|COMPLETED|Overall Study||22
9946618|NCT01384734|11065096|FG004|COMPLETED|Overall Study||22
9946619|NCT01384734|11065092|FG000|NOT COMPLETED|Overall Study||17
9946620|NCT01384734|11065093|FG001|NOT COMPLETED|Overall Study||24
9946621|NCT01384734|11065094|FG002|NOT COMPLETED|Overall Study||23
9946622|NCT01384734|11065095|FG003|NOT COMPLETED|Overall Study||28
9946623|NCT01384734|11065096|FG004|NOT COMPLETED|Overall Study||29
9946624|NCT01384760|11065107|FG000|STARTED|Overall Study||61
9946625|NCT01384760|11065108|FG001|STARTED|Overall Study||43
10011676|NCT01781572|11134449|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0
10011677|NCT01781572|11134447|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
10011678|NCT01781572|11134448|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
10011679|NCT01781572|11134449|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
10011680|NCT01781572|11134447|FG000|STARTED|MEK162 45mg LEE011 600mg||0
10011681|NCT01781572|11134448|FG001|STARTED|MEK162 45mg LEE011 600mg||6
10011682|NCT01781572|11134449|FG002|STARTED|MEK162 45mg LEE011 600mg||0
10011683|NCT01781572|11134447|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0
10011684|NCT01781572|11134448|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0
10011685|NCT01781572|11134449|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0
10011686|NCT01781572|11134447|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
10011687|NCT01781572|11134448|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
10011688|NCT01781572|11134449|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
9946626|NCT01384760|11065107|FG000|Randomized|Overall Study||61
9946627|NCT01384760|11065108|FG001|Randomized|Overall Study||43
9946628|NCT01384760|11065107|FG000|COMPLETED|Overall Study||45
9946629|NCT01384760|11065108|FG001|COMPLETED|Overall Study||37
9946630|NCT01384760|11065107|FG000|NOT COMPLETED|Overall Study||16
9946631|NCT01384760|11065108|FG001|NOT COMPLETED|Overall Study||6
9946632|NCT01384877|11065116|FG000|STARTED|Treatment 1||17
10011689|NCT01781611|11134480|FG000|STARTED|Overall Study||13
10011690|NCT01781611|11134481|FG001|STARTED|Overall Study||5
10011691|NCT01781611|11134480|FG000|COMPLETED|Overall Study||9
10207968|NCT03538743|11334860|FG001|Received Treatment|Overall Study||9
9946633|NCT01384877|11065117|FG001|STARTED|Treatment 1||15
9946634|NCT01384877|11065116|FG000|COMPLETED|Treatment 1||17
9946635|NCT01384877|11065117|FG001|COMPLETED|Treatment 1||15
9946636|NCT01384877|11065116|FG000|NOT COMPLETED|Treatment 1||0
9946637|NCT01384877|11065117|FG001|NOT COMPLETED|Treatment 1||0
9946638|NCT01384877|11065116|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16
9957079|NCT01449370|11076254|FG019|COMPLETED|Overall Study||0
9946639|NCT01384877|11065117|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13
9946640|NCT01384877|11065116|FG000|COMPLETED|Treatment 2||14
9946641|NCT01384877|11065117|FG001|COMPLETED|Treatment 2||11
9946642|NCT01384877|11065116|FG000|NOT COMPLETED|Treatment 2||2
9946643|NCT01384877|11065117|FG001|NOT COMPLETED|Treatment 2||2
10207969|NCT03538743|11334861|FG002|Received Treatment|Overall Study||9
10207970|NCT03538743|11334862|FG003|Received Treatment|Overall Study||10
10207971|NCT03538743|11334863|FG004|Received Treatment|Overall Study||9
10207972|NCT03538743|11334864|FG005|Received Treatment|Overall Study||9
9946644|NCT01385098|11065123|FG000|STARTED|Overall Study||37
9946645|NCT01385098|11065123|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
9946646|NCT01385098|11065123|FG000|NOT COMPLETED|Overall Study||14
9946647|NCT01385137|11065131|FG000|STARTED|Evaluable at Baseline||131
9946648|NCT01385137|11065132|FG001|STARTED|Evaluable at Baseline||131
9946649|NCT01385137|11065131|FG000|COMPLETED|Evaluable at Baseline||122
9946650|NCT01385137|11065132|FG001|COMPLETED|Evaluable at Baseline||127
9946651|NCT01385137|11065131|FG000|NOT COMPLETED|Evaluable at Baseline||9
9946652|NCT01385137|11065132|FG001|NOT COMPLETED|Evaluable at Baseline||4
9946653|NCT01385137|11065131|FG000|STARTED|Evaluable for Primary Endpoint||131
9946654|NCT01385137|11065132|FG001|STARTED|Evaluable for Primary Endpoint||131
9946655|NCT01385137|11065131|FG000|COMPLETED|Evaluable for Primary Endpoint||102
9946656|NCT01385137|11065132|FG001|COMPLETED|Evaluable for Primary Endpoint||107
9946657|NCT01385137|11065131|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29
9946658|NCT01385137|11065132|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24
9946659|NCT01385189|11065143|FG000|STARTED|Overall Study||12
9946660|NCT01385189|11065144|FG001|STARTED|Overall Study||12
9946661|NCT01385189|11065145|FG002|STARTED|Overall Study||4
9946662|NCT01385189|11065146|FG003|STARTED|Overall Study||4
9946663|NCT01385189|11065147|FG004|STARTED|Overall Study||8
9946664|NCT01385189|11065143|FG000|COMPLETED|Overall Study||11
9946665|NCT01385189|11065144|FG001|COMPLETED|Overall Study||11
9946666|NCT01385189|11065145|FG002|COMPLETED|Overall Study||4
9946667|NCT01385189|11065146|FG003|COMPLETED|Overall Study||3
9946668|NCT01385189|11065147|FG004|COMPLETED|Overall Study||6
9946669|NCT01385189|11065143|FG000|NOT COMPLETED|Overall Study||1
9946670|NCT01385189|11065144|FG001|NOT COMPLETED|Overall Study||1
9946671|NCT01385189|11065145|FG002|NOT COMPLETED|Overall Study||0
9946672|NCT01385189|11065146|FG003|NOT COMPLETED|Overall Study||1
9946673|NCT01385189|11065147|FG004|NOT COMPLETED|Overall Study||2
9946674|NCT01385202|11065166|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
9946675|NCT01385202|11065166|FG000|Study Catheter Inserted|Overall Study||161
9946676|NCT01385202|11065166|FG000|Undergoing Ablation|Overall Study||160
10207973|NCT03538743|11334865|FG006|Received Treatment|Overall Study||9
10207974|NCT03538743|11334866|FG007|Received Treatment|Overall Study||8
10207975|NCT03538743|11334867|FG008|Received Treatment|Overall Study||10
10207976|NCT03538743|11334859|FG000|COMPLETED|Overall Study||25
10207977|NCT03538743|11334860|FG001|COMPLETED|Overall Study||9
10207978|NCT03538743|11334861|FG002|COMPLETED|Overall Study||8
10207979|NCT03538743|11334862|FG003|COMPLETED|Overall Study||8
10207980|NCT03538743|11334863|FG004|COMPLETED|Overall Study||9
10207981|NCT03538743|11334864|FG005|COMPLETED|Overall Study||9
10207982|NCT03538743|11334865|FG006|COMPLETED|Overall Study||9
10207983|NCT03538743|11334866|FG007|COMPLETED|Overall Study||8
10207984|NCT03538743|11334867|FG008|COMPLETED|Overall Study||7
10207985|NCT03538743|11334859|FG000|NOT COMPLETED|Overall Study||0
10207986|NCT03538743|11334860|FG001|NOT COMPLETED|Overall Study||0
10207987|NCT03538743|11334861|FG002|NOT COMPLETED|Overall Study||1
10207988|NCT03538743|11334862|FG003|NOT COMPLETED|Overall Study||2
10207989|NCT03538743|11334863|FG004|NOT COMPLETED|Overall Study||0
10207990|NCT03538743|11334864|FG005|NOT COMPLETED|Overall Study||0
10207991|NCT03538743|11334865|FG006|NOT COMPLETED|Overall Study||0
10207992|NCT03538743|11334866|FG007|NOT COMPLETED|Overall Study||0
10207993|NCT03538743|11334867|FG008|NOT COMPLETED|Overall Study||3
10207994|NCT03538795|11334895|FG000|STARTED|Overall Study||3
10207995|NCT03538795|11334895|FG000|COMPLETED|Overall Study||3
10207996|NCT03538795|11334895|FG000|NOT COMPLETED|Overall Study||0
10207997|NCT03538808|11334903|FG000|STARTED|Overall Study||20
10207998|NCT03538808|11334904|FG001|STARTED|Overall Study||20
10207999|NCT03538808|11334905|FG002|STARTED|Overall Study||20
10208000|NCT03538808|11334906|FG003|STARTED|Overall Study||20
10208001|NCT03538808|11334903|FG000|COMPLETED|Overall Study||18
10208002|NCT03538808|11334904|FG001|COMPLETED|Overall Study||20
10208003|NCT03538808|11334905|FG002|COMPLETED|Overall Study||16
10208004|NCT03538808|11334906|FG003|COMPLETED|Overall Study||18
10208005|NCT03538808|11334903|FG000|NOT COMPLETED|Overall Study||2
10208006|NCT03538808|11334904|FG001|NOT COMPLETED|Overall Study||0
10208007|NCT03538808|11334905|FG002|NOT COMPLETED|Overall Study||4
10208008|NCT03538808|11334906|FG003|NOT COMPLETED|Overall Study||2
9946677|NCT01385202|11065166|FG000|COMPLETED|Overall Study||154
9946678|NCT01385202|11065166|FG000|NOT COMPLETED|Overall Study||18
9946679|NCT01385293|11065172|FG000|STARTED|Overall Study||30
9946680|NCT01385293|11065172|FG000|COMPLETED|Overall Study||30
10208009|NCT03539211|11334918|FG000|STARTED|Overall Study||16
10208010|NCT03539211|11334919|FG001|STARTED|Overall Study||15
10208011|NCT03539211|11334918|FG000|COMPLETED|Overall Study||16
10208012|NCT03539211|11334919|FG001|COMPLETED|Overall Study||15
10208013|NCT03539211|11334918|FG000|NOT COMPLETED|Overall Study||0
10208014|NCT03539211|11334919|FG001|NOT COMPLETED|Overall Study||0
9946681|NCT01385293|11065172|FG000|NOT COMPLETED|Overall Study||0
9946682|NCT01385306|11065176|FG000|STARTED|Overall Study||6
9946683|NCT01385306|11065176|FG000|COMPLETED|Overall Study||6
9946684|NCT01385306|11065176|FG000|NOT COMPLETED|Overall Study||0
9946685|NCT01385371|11065182|FG000|STARTED|Overall Study||752
9946686|NCT01385371|11065183|FG001|STARTED|Overall Study||749
9946687|NCT01385371|11065182|FG000|COMPLETED|Overall Study||603
9946688|NCT01385371|11065183|FG001|COMPLETED|Overall Study||652
10111658|NCT02497391|11242654|FG001|COMPLETED|Period 3 (14 Days)||13
10111659|NCT02497391|11242655|FG002|COMPLETED|Period 3 (14 Days)||12
10111660|NCT02497391|11242656|FG003|COMPLETED|Period 3 (14 Days)||13
10111661|NCT02497391|11242657|FG004|COMPLETED|Period 3 (14 Days)||13
10111662|NCT02497391|11242658|FG005|COMPLETED|Period 3 (14 Days)||13
10111663|NCT02497391|11242653|FG000|NOT COMPLETED|Period 3 (14 Days)||0
9946689|NCT01385371|11065182|FG000|NOT COMPLETED|Overall Study||149
9946690|NCT01385371|11065183|FG001|NOT COMPLETED|Overall Study||97
9946691|NCT01385566|11065195|FG000|STARTED|Overall Study||52
9946692|NCT01385566|11065196|FG001|STARTED|Overall Study||34
9946693|NCT01385566|11065197|FG002|STARTED|Overall Study||34
9946694|NCT01385566|11065198|FG003|STARTED|Overall Study||35
9946695|NCT01385566|11065199|FG004|STARTED|Overall Study||34
9946696|NCT01385566|11065200|FG005|STARTED|Overall Study||34
9946697|NCT01385566|11065195|FG000|COMPLETED|Overall Study||51
9946698|NCT01385566|11065196|FG001|COMPLETED|Overall Study||34
9946699|NCT01385566|11065197|FG002|COMPLETED|Overall Study||34
9946700|NCT01385566|11065198|FG003|COMPLETED|Overall Study||34
9946701|NCT01385566|11065199|FG004|COMPLETED|Overall Study||34
9946702|NCT01385566|11065200|FG005|COMPLETED|Overall Study||34
9946703|NCT01385566|11065195|FG000|NOT COMPLETED|Overall Study||1
9946704|NCT01385566|11065196|FG001|NOT COMPLETED|Overall Study||0
9946705|NCT01385566|11065197|FG002|NOT COMPLETED|Overall Study||0
9946706|NCT01385566|11065198|FG003|NOT COMPLETED|Overall Study||1
9946707|NCT01385566|11065199|FG004|NOT COMPLETED|Overall Study||0
9946708|NCT01385566|11065200|FG005|NOT COMPLETED|Overall Study||0
9946709|NCT01385579|11065218|FG000|STARTED|Overall Study||98
9946710|NCT01385579|11065219|FG001|STARTED|Overall Study||104
9946711|NCT01385579|11065218|FG000|COMPLETED|Overall Study||98
9946712|NCT01385579|11065219|FG001|COMPLETED|Overall Study||104
9946713|NCT01385579|11065218|FG000|NOT COMPLETED|Overall Study||0
10208015|NCT03539432|11334927|FG000|STARTED|Overall Study||2
10208016|NCT03539432|11334928|FG001|STARTED|Overall Study||1
10208017|NCT03539432|11334927|FG000|COMPLETED|Overall Study||2
10208018|NCT03539432|11334928|FG001|COMPLETED|Overall Study||0
10208019|NCT03539432|11334927|FG000|NOT COMPLETED|Overall Study||0
10208020|NCT03539432|11334928|FG001|NOT COMPLETED|Overall Study||1
10208021|NCT03539484|11334941|FG000|STARTED|Overall Study||1
10208022|NCT03539484|11334942|FG001|STARTED|Overall Study||1
10208023|NCT03539484|11334943|FG002|STARTED|Overall Study||1
10208024|NCT03539484|11334944|FG003|STARTED|Overall Study||3
10208025|NCT03539484|11334945|FG004|STARTED|Overall Study||13
10208026|NCT03539484|11334946|FG005|STARTED|Overall Study||5
10208027|NCT03539484|11334947|FG006|STARTED|Overall Study||2
10208028|NCT03539484|11334941|FG000|COMPLETED|Overall Study||0
10208029|NCT03539484|11334942|FG001|COMPLETED|Overall Study||0
10208030|NCT03539484|11334943|FG002|COMPLETED|Overall Study||0
10208031|NCT03539484|11334944|FG003|COMPLETED|Overall Study||0
10208032|NCT03539484|11334945|FG004|COMPLETED|Overall Study||0
10208033|NCT03539484|11334946|FG005|COMPLETED|Overall Study||0
10208034|NCT03539484|11334947|FG006|COMPLETED|Overall Study||0
10208035|NCT03539484|11334941|FG000|NOT COMPLETED|Overall Study||1
10208036|NCT03539484|11334942|FG001|NOT COMPLETED|Overall Study||1
10208037|NCT03539484|11334943|FG002|NOT COMPLETED|Overall Study||1
10208038|NCT03539484|11334944|FG003|NOT COMPLETED|Overall Study||3
10208039|NCT03539484|11334945|FG004|NOT COMPLETED|Overall Study||13
10208040|NCT03539484|11334946|FG005|NOT COMPLETED|Overall Study||5
10208041|NCT03539484|11334947|FG006|NOT COMPLETED|Overall Study||2
10208042|NCT03539549|11334968|FG000|STARTED|Overall Study||123
10208043|NCT03539549|11334968|FG000|COMPLETED|Overall Study||106
10208044|NCT03539549|11334968|FG000|NOT COMPLETED|Overall Study||17
9946714|NCT01385579|11065219|FG001|NOT COMPLETED|Overall Study||0
9946715|NCT01385644|11065227|FG000|STARTED|Overall Study||4
9946716|NCT01385644|11065228|FG001|STARTED|Overall Study||4
9946717|NCT01385644|11065227|FG000|COMPLETED|Overall Study||4
9946718|NCT01385644|11065228|FG001|COMPLETED|Overall Study||4
9946719|NCT01385644|11065227|FG000|NOT COMPLETED|Overall Study||0
9946720|NCT01385644|11065228|FG001|NOT COMPLETED|Overall Study||0
9946721|NCT01385696|11065234|FG000|STARTED|Overall Study||66
9946722|NCT01385696|11065235|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
10111664|NCT02497391|11242654|FG001|NOT COMPLETED|Period 3 (14 Days)||1
10111665|NCT02497391|11242655|FG002|NOT COMPLETED|Period 3 (14 Days)||1
10111666|NCT02497391|11242656|FG003|NOT COMPLETED|Period 3 (14 Days)||0
10111667|NCT02497391|11242657|FG004|NOT COMPLETED|Period 3 (14 Days)||1
10111668|NCT02497391|11242658|FG005|NOT COMPLETED|Period 3 (14 Days)||0
10111669|NCT02497404|11242666|FG000|STARTED|Overall Study||40
10208045|NCT03540030|11334974|FG000|STARTED|Overall Study||48
9946723|NCT01385696|11065234|FG000|COMPLETED|Overall Study||66
9946724|NCT01385696|11065235|FG001|COMPLETED|Overall Study||64
9946725|NCT01385696|11065234|FG000|NOT COMPLETED|Overall Study||0
10208046|NCT03540030|11334975|FG001|STARTED|Overall Study||38
10208047|NCT03540030|11334974|FG000|COMPLETED|Overall Study||30
10208048|NCT03540030|11334975|FG001|COMPLETED|Overall Study||35
10208049|NCT03540030|11334974|FG000|NOT COMPLETED|Overall Study||18
9946726|NCT01385696|11065235|FG001|NOT COMPLETED|Overall Study||0
9946727|NCT01385748|11065245|FG000|STARTED|Overall Study||56
9946728|NCT01385748|11065246|FG001|STARTED|Overall Study||65
9946729|NCT01385748|11065247|FG002|STARTED|Overall Study||62
9946730|NCT01385748|11065245|FG000|COMPLETED|Overall Study||41
9946731|NCT01385748|11065246|FG001|COMPLETED|Overall Study||51
9946732|NCT01385748|11065247|FG002|COMPLETED|Overall Study||49
9946733|NCT01385748|11065245|FG000|NOT COMPLETED|Overall Study||15
9946734|NCT01385748|11065246|FG001|NOT COMPLETED|Overall Study||14
9946735|NCT01385748|11065247|FG002|NOT COMPLETED|Overall Study||13
9946736|NCT01385995|11065261|FG000|STARTED|Period 1, 2 Months||25
9946737|NCT01385995|11065262|FG001|STARTED|Period 1, 2 Months||25
9946738|NCT01385995|11065261|FG000|COMPLETED|Period 1, 2 Months||24
9946739|NCT01385995|11065262|FG001|COMPLETED|Period 1, 2 Months||25
9946740|NCT01385995|11065261|FG000|NOT COMPLETED|Period 1, 2 Months||1
9946741|NCT01385995|11065262|FG001|NOT COMPLETED|Period 1, 2 Months||0
9946742|NCT01385995|11065261|FG000|STARTED|Washout Period, 1 Month||24
9946743|NCT01385995|11065262|FG001|STARTED|Washout Period, 1 Month||25
9946744|NCT01385995|11065261|FG000|COMPLETED|Washout Period, 1 Month||24
9946745|NCT01385995|11065262|FG001|COMPLETED|Washout Period, 1 Month||25
9946746|NCT01385995|11065261|FG000|NOT COMPLETED|Washout Period, 1 Month||0
9946747|NCT01385995|11065262|FG001|NOT COMPLETED|Washout Period, 1 Month||0
9946748|NCT01385995|11065261|FG000|STARTED|Period 2, 2 Months||24
9946749|NCT01385995|11065262|FG001|STARTED|Period 2, 2 Months||25
9946750|NCT01385995|11065261|FG000|COMPLETED|Period 2, 2 Months||24
9946751|NCT01385995|11065262|FG001|COMPLETED|Period 2, 2 Months||25
9946752|NCT01385995|11065261|FG000|NOT COMPLETED|Period 2, 2 Months||0
9946753|NCT01385995|11065262|FG001|NOT COMPLETED|Period 2, 2 Months||0
9946754|NCT01386008|11065270|FG000|STARTED|Overall Study||20
9946755|NCT01386008|11065270|FG000|COMPLETED|Overall Study||0
9946756|NCT01386008|11065270|FG000|NOT COMPLETED|Overall Study||20
9946757|NCT01386528|11065274|FG000|STARTED|Overall Study||13
9946758|NCT01386528|11065274|FG000|COMPLETED|Overall Study||13
9946759|NCT01386528|11065274|FG000|NOT COMPLETED|Overall Study||0
9946760|NCT01386554|11065281|FG000|STARTED|Overall Study||4
9946761|NCT01386554|11065282|FG001|STARTED|Overall Study||35
9946762|NCT01386554|11065283|FG002|STARTED|Overall Study||21
9946763|NCT01386554|11065281|FG000|COMPLETED|Overall Study||1
9946764|NCT01386554|11065282|FG001|COMPLETED|Overall Study||26
9946765|NCT01386554|11065283|FG002|COMPLETED|Overall Study||15
9946766|NCT01386554|11065281|FG000|NOT COMPLETED|Overall Study||3
9946767|NCT01386554|11065282|FG001|NOT COMPLETED|Overall Study||9
9946768|NCT01386554|11065283|FG002|NOT COMPLETED|Overall Study||6
9946769|NCT01386606|11065297|FG000|STARTED|Overall Study||16
9946770|NCT01386606|11065298|FG001|STARTED|Overall Study||14
9946771|NCT01386606|11065299|FG002|STARTED|Overall Study||16
9946772|NCT01386606|11065300|FG003|STARTED|Overall Study||14
9946773|NCT01386606|11065297|FG000|COMPLETED|Overall Study||12
9946774|NCT01386606|11065298|FG001|COMPLETED|Overall Study||10
9946775|NCT01386606|11065299|FG002|COMPLETED|Overall Study||13
9946776|NCT01386606|11065300|FG003|COMPLETED|Overall Study||13
9946777|NCT01386606|11065297|FG000|NOT COMPLETED|Overall Study||4
9946778|NCT01386606|11065298|FG001|NOT COMPLETED|Overall Study||4
9946779|NCT01386606|11065299|FG002|NOT COMPLETED|Overall Study||3
9946780|NCT01386606|11065300|FG003|NOT COMPLETED|Overall Study||1
9946781|NCT01386632|11065316|FG000|STARTED|Overall Study||25
9946782|NCT01386632|11065317|FG001|STARTED|Overall Study||25
9946783|NCT01386632|11065316|FG000|COMPLETED|Overall Study||20
9946784|NCT01386632|11065317|FG001|COMPLETED|Overall Study||21
9946785|NCT01386632|11065316|FG000|NOT COMPLETED|Overall Study||5
9946786|NCT01386632|11065317|FG001|NOT COMPLETED|Overall Study||4
9946787|NCT01386645|11065326|FG000|STARTED|Overall Study||18
9946788|NCT01386645|11065327|FG001|STARTED|Overall Study||19
9946789|NCT01386645|11065328|FG002|STARTED|Overall Study||19
9946790|NCT01386645|11065326|FG000|COMPLETED|Overall Study||18
9946791|NCT01386645|11065327|FG001|COMPLETED|Overall Study||18
9946792|NCT01386645|11065328|FG002|COMPLETED|Overall Study||17
9946793|NCT01386645|11065326|FG000|NOT COMPLETED|Overall Study||0
9946794|NCT01386645|11065327|FG001|NOT COMPLETED|Overall Study||1
9946795|NCT01386645|11065328|FG002|NOT COMPLETED|Overall Study||2
9946796|NCT01386788|11065336|FG000|STARTED|Overall Study||102
9946797|NCT01386788|11065336|FG000|COMPLETED|Overall Study||100
9946798|NCT01386788|11065336|FG000|NOT COMPLETED|Overall Study||2
9946799|NCT01386944|11065340|FG000|STARTED|Overall Study||102
9946800|NCT01386944|11065340|FG000|COMPLETED|Overall Study||46
9946801|NCT01386944|11065340|FG000|NOT COMPLETED|Overall Study||56
9946802|NCT01386970|11065346|FG000|STARTED|Overall Study||20
9946803|NCT01386970|11065347|FG001|STARTED|Overall Study||23
9946804|NCT01386970|11065346|FG000|COMPLETED|Overall Study||16
9946805|NCT01386970|11065347|FG001|COMPLETED|Overall Study||21
9946806|NCT01386970|11065346|FG000|NOT COMPLETED|Overall Study||4
9946807|NCT01386970|11065347|FG001|NOT COMPLETED|Overall Study||2
9946808|NCT01386983|11065357|FG000|STARTED|Overall Study||264
9946809|NCT01386983|11065358|FG001|STARTED|Overall Study||68
9946810|NCT01386983|11065357|FG000|COMPLETED|Overall Study||264
9946811|NCT01386983|11065358|FG001|COMPLETED|Overall Study||68
9946812|NCT01386983|11065357|FG000|NOT COMPLETED|Overall Study||0
9946813|NCT01386983|11065358|FG001|NOT COMPLETED|Overall Study||0
9946814|NCT01387022|11065366|FG000|STARTED|Overall Study||29
9946815|NCT01387022|11065367|FG001|STARTED|Overall Study||30
9946816|NCT01387022|11065366|FG000|COMPLETED|Overall Study||28
9946817|NCT01387022|11065367|FG001|COMPLETED|Overall Study||26
9946818|NCT01387022|11065366|FG000|NOT COMPLETED|Overall Study||1
9946819|NCT01387022|11065367|FG001|NOT COMPLETED|Overall Study||4
9946820|NCT01387074|11065373|FG000|STARTED|Overall Study||108
9946821|NCT01387074|11065373|FG000|COMPLETED|Overall Study||100
9946822|NCT01387074|11065373|FG000|NOT COMPLETED|Overall Study||8
9946823|NCT01387139|11065379|FG000|STARTED|Overall Study||99
9946824|NCT01387139|11065380|FG001|STARTED|Overall Study||84
9946825|NCT01387139|11065379|FG000|COMPLETED|Overall Study||99
9946826|NCT01387139|11065380|FG001|COMPLETED|Overall Study||84
9946827|NCT01387139|11065379|FG000|NOT COMPLETED|Overall Study||0
9946828|NCT01387139|11065380|FG001|NOT COMPLETED|Overall Study||0
9946829|NCT01387178|11065388|FG000|STARTED|Overall Study||11582
9946830|NCT01387178|11065389|FG001|STARTED|Overall Study||10641
9946831|NCT01387178|11065388|FG000|COMPLETED|Overall Study||11582
9946832|NCT01387178|11065389|FG001|COMPLETED|Overall Study||10641
9946833|NCT01387178|11065388|FG000|NOT COMPLETED|Overall Study||0
9946834|NCT01387178|11065389|FG001|NOT COMPLETED|Overall Study||0
9946835|NCT01387230|11065399|FG000|STARTED|Overall Study||68
9946836|NCT01387230|11065400|FG001|STARTED|Overall Study||69
9946837|NCT01387230|11065401|FG002|STARTED|Overall Study||69
9946838|NCT01387230|11065399|FG000|COMPLETED|Overall Study||50
9946839|NCT01387230|11065400|FG001|COMPLETED|Overall Study||62
9946840|NCT01387230|11065401|FG002|COMPLETED|Overall Study||56
9946841|NCT01387230|11065399|FG000|NOT COMPLETED|Overall Study||18
9946842|NCT01387230|11065400|FG001|NOT COMPLETED|Overall Study||7
9946843|NCT01387230|11065401|FG002|NOT COMPLETED|Overall Study||13
9946844|NCT01387269|11065411|FG000|STARTED|Overall Study||323
9946845|NCT01387269|11065412|FG001|STARTED|Overall Study||161
9946846|NCT01387269|11065411|FG000|ITT Population|Overall Study||323
9946847|NCT01387269|11065412|FG001|ITT Population|Overall Study||161
9946848|NCT01387269|11065411|FG000|MITT Population|Overall Study||284
9946849|NCT01387269|11065412|FG001|MITT Population|Overall Study||141
10208050|NCT03540030|11334975|FG001|NOT COMPLETED|Overall Study||3
10208051|NCT03540134|11334981|FG000|STARTED|Overall Study||4
10208052|NCT03540134|11334981|FG000|COMPLETED|Overall Study||4
10208053|NCT03540134|11334981|FG000|NOT COMPLETED|Overall Study||0
10238808|NCT00476827|11370223|FG004|STARTED|Overall Study||2
10238809|NCT00476827|11370224|FG005|STARTED|Overall Study||2
10238810|NCT00476827|11370219|FG000|COMPLETED|Overall Study||3
10238811|NCT00476827|11370220|FG001|COMPLETED|Overall Study||0
10238812|NCT00476827|11370221|FG002|COMPLETED|Overall Study||1
10238813|NCT00476827|11370222|FG003|COMPLETED|Overall Study||0
10238814|NCT00476827|11370223|FG004|COMPLETED|Overall Study||2
10238815|NCT00476827|11370224|FG005|COMPLETED|Overall Study||2
10238816|NCT00476827|11370219|FG000|NOT COMPLETED|Overall Study||0
10238817|NCT00476827|11370220|FG001|NOT COMPLETED|Overall Study||0
10238818|NCT00476827|11370221|FG002|NOT COMPLETED|Overall Study||0
10238819|NCT00476827|11370222|FG003|NOT COMPLETED|Overall Study||0
10238820|NCT00476827|11370223|FG004|NOT COMPLETED|Overall Study||0
10238821|NCT00476827|11370224|FG005|NOT COMPLETED|Overall Study||0
10238822|NCT00475657|11370236|FG000|STARTED|Overall Study||5
10238823|NCT00475657|11370236|FG000|COMPLETED|Overall Study||1
10238824|NCT00475657|11370236|FG000|NOT COMPLETED|Overall Study||4
10238825|NCT00472082|11370240|FG000|STARTED|Overall Study||5
10238826|NCT00472082|11370240|FG000|COMPLETED|Overall Study||0
10238827|NCT00472082|11370240|FG000|NOT COMPLETED|Overall Study||5
10238828|NCT00478062|11370244|FG000|STARTED|Overall Study||1
10238829|NCT00478062|11370244|FG000|COMPLETED|Overall Study||1
10238830|NCT00478062|11370244|FG000|NOT COMPLETED|Overall Study||0
10238831|NCT00470574|11370248|FG000|STARTED|Overall Study||7
10238832|NCT00470574|11370248|FG000|COMPLETED|Overall Study||7
10238833|NCT00470574|11370248|FG000|NOT COMPLETED|Overall Study||0
10238834|NCT00467753|11370254|FG000|STARTED|Overall Study||3
10238835|NCT00467753|11370255|FG001|STARTED|Overall Study||2
10238836|NCT00467753|11370254|FG000|COMPLETED|Overall Study||0
10238837|NCT00467753|11370255|FG001|COMPLETED|Overall Study||0
10238838|NCT00467753|11370254|FG000|NOT COMPLETED|Overall Study||3
10238839|NCT00467753|11370255|FG001|NOT COMPLETED|Overall Study||2
10238840|NCT00456612|11370265|FG000|STARTED|Overall Study||4
10238841|NCT00456612|11370265|FG000|COMPLETED|Overall Study||1
9946850|NCT01387269|11065411|FG000|Safety Population|Overall Study||320
9946851|NCT01387269|11065412|FG001|Safety Population|Overall Study||161
9946852|NCT01387269|11065411|FG000|COMPLETED|Overall Study||231
9946853|NCT01387269|11065412|FG001|COMPLETED|Overall Study||121
9946854|NCT01387269|11065411|FG000|NOT COMPLETED|Overall Study||92
9946855|NCT01387269|11065412|FG001|NOT COMPLETED|Overall Study||40
9946856|NCT01387282|11065420|FG000|STARTED|Overall Study||330
9946857|NCT01387282|11065421|FG001|STARTED|Overall Study||165
9946858|NCT01387282|11065420|FG000|ITT Population|Overall Study||330
9946859|NCT01387282|11065421|FG001|ITT Population|Overall Study||165
9946860|NCT01387282|11065420|FG000|MITT Population|Overall Study||268
9946861|NCT01387282|11065421|FG001|MITT Population|Overall Study||136
9946862|NCT01387282|11065420|FG000|Safety Population|Overall Study||330
9946863|NCT01387282|11065421|FG001|Safety Population|Overall Study||161
9946864|NCT01387282|11065420|FG000|COMPLETED|Overall Study||233
9946865|NCT01387282|11065421|FG001|COMPLETED|Overall Study||118
10238842|NCT00456612|11370265|FG000|NOT COMPLETED|Overall Study||3
10238843|NCT00469612|11370272|FG000|STARTED|Overall Study||2
10238844|NCT00469612|11370273|FG001|STARTED|Overall Study||0
10238845|NCT00469612|11370272|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
10238846|NCT00469612|11370273|FG001|COMPLETED|Overall Study||0
10238847|NCT00469612|11370272|FG000|NOT COMPLETED|Overall Study||2
9946866|NCT01387282|11065420|FG000|NOT COMPLETED|Overall Study||97
9946867|NCT01387282|11065421|FG001|NOT COMPLETED|Overall Study||47
9946868|NCT01387347|11065429|FG000|STARTED|Overall Study||36
9946869|NCT01387347|11065430|FG001|STARTED|Overall Study||36
9946870|NCT01387347|11065429|FG000|COMPLETED|Overall Study||34
9946871|NCT01387347|11065430|FG001|COMPLETED|Overall Study||35
9946872|NCT01387347|11065429|FG000|NOT COMPLETED|Overall Study||2
9946873|NCT01387347|11065430|FG001|NOT COMPLETED|Overall Study||1
9946874|NCT01387464|11065442|FG000|STARTED|Overall Study||30
9946875|NCT01387464|11065443|FG001|STARTED|Overall Study||30
9946876|NCT01387464|11065442|FG000|Safety Population|Overall Study||30
9946877|NCT01387464|11065443|FG001|Safety Population|Overall Study||29
9946878|NCT01387464|11065442|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
9946879|NCT01387464|11065443|FG001|Per-Protocol Population|Overall Study||29
9946880|NCT01387464|11065442|FG000|COMPLETED|Overall Study||29
9946881|NCT01387464|11065443|FG001|COMPLETED|Overall Study||29
9946882|NCT01387464|11065442|FG000|NOT COMPLETED|Overall Study||1
9946883|NCT01387464|11065443|FG001|NOT COMPLETED|Overall Study||1
9946884|NCT01387516|11065453|FG000|STARTED|Overall Study||80
9946885|NCT01387516|11065454|FG001|STARTED|Overall Study||68
9946886|NCT01387516|11065455|FG002|STARTED|Overall Study||79
9946887|NCT01387516|11065456|FG003|STARTED|Overall Study||69
9946888|NCT01387516|11065453|FG000|COMPLETED|Overall Study||75
9946889|NCT01387516|11065454|FG001|COMPLETED|Overall Study||63
9946890|NCT01387516|11065455|FG002|COMPLETED|Overall Study||75
9946891|NCT01387516|11065456|FG003|COMPLETED|Overall Study||65
9946892|NCT01387516|11065453|FG000|NOT COMPLETED|Overall Study||5
9946893|NCT01387516|11065454|FG001|NOT COMPLETED|Overall Study||5
9946894|NCT01387516|11065455|FG002|NOT COMPLETED|Overall Study||4
9946895|NCT01387516|11065456|FG003|NOT COMPLETED|Overall Study||4
9946896|NCT01387542|11065466|FG000|STARTED|Overall Study||40
9946897|NCT01387542|11065466|FG000|Treated|Overall Study||38
9946898|NCT01387542|11065466|FG000|COMPLETED|Overall Study||32
9946899|NCT01387542|11065466|FG000|NOT COMPLETED|Overall Study||8
9946900|NCT01387581|11065473|FG000|STARTED|Overall Study||108
9946901|NCT01387581|11065474|FG001|STARTED|Overall Study||107
9946902|NCT01387581|11065475|FG002|STARTED|Overall Study||12
9946903|NCT01387581|11065473|FG000|COMPLETED|Overall Study||101
9946904|NCT01387581|11065474|FG001|COMPLETED|Overall Study||101
9946905|NCT01387581|11065475|FG002|COMPLETED|Overall Study||9
9946906|NCT01387581|11065473|FG000|NOT COMPLETED|Overall Study||7
9946907|NCT01387581|11065474|FG001|NOT COMPLETED|Overall Study||6
9946908|NCT01387581|11065475|FG002|NOT COMPLETED|Overall Study||3
9946909|NCT01387594|11065485|FG000|STARTED|Overall Study||10
9946910|NCT01387594|11065486|FG001|STARTED|Overall Study||39
9946911|NCT01387594|11065485|FG000|COMPLETED|Overall Study||10
9946912|NCT01387594|11065486|FG001|COMPLETED|Overall Study||36
9946913|NCT01387594|11065485|FG000|NOT COMPLETED|Overall Study||0
9946914|NCT01387594|11065486|FG001|NOT COMPLETED|Overall Study||3
9946915|NCT01387607|11065497|FG000|STARTED|Overall Study||173
9946916|NCT01387607|11065498|FG001|STARTED|Overall Study||170
9946917|NCT01387607|11065497|FG000|Received Treatment|Overall Study||170
9946918|NCT01387607|11065498|FG001|Received Treatment|Overall Study||164
9946919|NCT01387607|11065497|FG000|COMPLETED|Overall Study||122
9946920|NCT01387607|11065498|FG001|COMPLETED|Overall Study||125
9946921|NCT01387607|11065497|FG000|NOT COMPLETED|Overall Study||51
9946922|NCT01387607|11065498|FG001|NOT COMPLETED|Overall Study||45
9946923|NCT01387672|11065510|FG000|STARTED|Overall Study||39
10208054|NCT03540147|11334985|FG000|STARTED|Overall Study||20
10208055|NCT03540147|11334985|FG000|COMPLETED|Overall Study||20
10208056|NCT03540147|11334985|FG000|NOT COMPLETED|Overall Study||0
10208057|NCT03540160|11334997|FG000|STARTED|Overall Study||558
10208058|NCT03540160|11334997|FG000|COMPLETED|Overall Study||179
10208059|NCT03540160|11334997|FG000|NOT COMPLETED|Overall Study||379
10208060|NCT03541044|11335001|FG000|STARTED|Study Period 1: Up to Day 1||23
10208061|NCT03541044|11335002|FG001|STARTED|Study Period 1: Up to Day 1||23
10208062|NCT03541044|11335001|FG000|COMPLETED|Study Period 1: Up to Day 1||23
9946924|NCT01387672|11065511|FG001|STARTED|Overall Study||38
9946925|NCT01387672|11065512|FG002|STARTED|Overall Study||38
9946926|NCT01387672|11065513|FG003|STARTED|Overall Study||39
9946927|NCT01387672|11065514|FG004|STARTED|Overall Study||38
9946928|NCT01387672|11065515|FG005|STARTED|Overall Study||37
9946929|NCT01387672|11065510|FG000|COMPLETED|Overall Study||32
9946930|NCT01387672|11065511|FG001|COMPLETED|Overall Study||31
9946931|NCT01387672|11065512|FG002|COMPLETED|Overall Study||33
9946932|NCT01387672|11065513|FG003|COMPLETED|Overall Study||35
9946933|NCT01387672|11065514|FG004|COMPLETED|Overall Study||34
10208063|NCT03541044|11335002|FG001|COMPLETED|Study Period 1: Up to Day 1||23
10208064|NCT03541044|11335001|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
9946934|NCT01387672|11065515|FG005|COMPLETED|Overall Study||37
9946935|NCT01387672|11065510|FG000|NOT COMPLETED|Overall Study||7
9946936|NCT01387672|11065511|FG001|NOT COMPLETED|Overall Study||7
9946937|NCT01387672|11065512|FG002|NOT COMPLETED|Overall Study||5
9946938|NCT01387672|11065513|FG003|NOT COMPLETED|Overall Study||4
9946939|NCT01387672|11065514|FG004|NOT COMPLETED|Overall Study||4
9946940|NCT01387672|11065515|FG005|NOT COMPLETED|Overall Study||0
9946941|NCT01387737|11065532|FG000|STARTED|Overall Study||584
9946942|NCT01387737|11065533|FG001|STARTED|Overall Study||715
9946943|NCT01387737|11065532|FG000|COMPLETED|Overall Study||532
9946944|NCT01387737|11065533|FG001|COMPLETED|Overall Study||641
9946945|NCT01387737|11065532|FG000|NOT COMPLETED|Overall Study||52
9946946|NCT01387737|11065533|FG001|NOT COMPLETED|Overall Study||74
9946947|NCT01387789|11065539|FG000|STARTED|Overall Study||71
9946948|NCT01387789|11065539|FG000|COMPLETED|Overall Study||63
9946949|NCT01387789|11065539|FG000|NOT COMPLETED|Overall Study||8
9946950|NCT01387815|11065545|FG000|STARTED|Overall Study||302
9946951|NCT01387815|11065546|FG001|STARTED|Overall Study||293
9946952|NCT01387815|11065545|FG000|COMPLETED|Overall Study||162
9946953|NCT01387815|11065546|FG001|COMPLETED|Overall Study||189
9946954|NCT01387815|11065545|FG000|NOT COMPLETED|Overall Study||140
9946955|NCT01387815|11065546|FG001|NOT COMPLETED|Overall Study||104
9946956|NCT01387932|11065554|FG000|STARTED|Randomized and Treated||118
9946957|NCT01387932|11065555|FG001|STARTED|Randomized and Treated||117
9946958|NCT01387932|11065554|FG000|COMPLETED|Randomized and Treated||111
9946959|NCT01387932|11065555|FG001|COMPLETED|Randomized and Treated||113
9946960|NCT01387932|11065554|FG000|NOT COMPLETED|Randomized and Treated||7
9946961|NCT01387932|11065555|FG001|NOT COMPLETED|Randomized and Treated||4
9946962|NCT01387932|11065554|FG000|STARTED|Completion of TACE Cycle||111
9946963|NCT01387932|11065555|FG001|STARTED|Completion of TACE Cycle||113
9946964|NCT01387932|11065554|FG000|COMPLETED|Completion of TACE Cycle||111
9946965|NCT01387932|11065555|FG001|COMPLETED|Completion of TACE Cycle||113
9946966|NCT01387932|11065554|FG000|NOT COMPLETED|Completion of TACE Cycle||0
9946967|NCT01387932|11065555|FG001|NOT COMPLETED|Completion of TACE Cycle||0
9946968|NCT01387932|11065554|FG000|STARTED|Survival Follow-up||111
9946969|NCT01387932|11065555|FG001|STARTED|Survival Follow-up||113
9946970|NCT01387932|11065554|FG000|COMPLETED|Survival Follow-up||27
9946971|NCT01387932|11065555|FG001|COMPLETED|Survival Follow-up||23
9946972|NCT01387932|11065554|FG000|NOT COMPLETED|Survival Follow-up||84
9946973|NCT01387932|11065555|FG001|NOT COMPLETED|Survival Follow-up||90
9946974|NCT01388166|11065563|FG000|STARTED|Overall Study||1253
9946975|NCT01388166|11065563|FG000|COMPLETED|Overall Study||1194
9946976|NCT01388166|11065563|FG000|NOT COMPLETED|Overall Study||59
9946977|NCT01388335|11065567|FG000|STARTED|Period 1||13
9946978|NCT01388335|11065567|FG000|Received at Least 1 Dose of Study Drug|Period 1||13
9946979|NCT01388335|11065567|FG000|COMPLETED|Period 1||12
9946980|NCT01388335|11065567|FG000|NOT COMPLETED|Period 1||1
9946981|NCT01388335|11065567|FG000|STARTED|Period 2||12
9946982|NCT01388335|11065567|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
9946983|NCT01388335|11065567|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
9946984|NCT01388335|11065567|FG000|NOT COMPLETED|Period 2||3
9946985|NCT01388335|11065567|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
9946986|NCT01388335|11065567|FG000|COMPLETED|Safety Extension||0
9946987|NCT01388335|11065567|FG000|NOT COMPLETED|Safety Extension||7
9946988|NCT01388361|11065582|FG000|STARTED|Overall Study||236
9946989|NCT01388361|11065583|FG001|STARTED|Overall Study||88
9946990|NCT01388361|11065584|FG002|STARTED|Overall Study||89
9946991|NCT01388361|11065582|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
9946992|NCT01388361|11065583|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
9946993|NCT01388361|11065584|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
9946994|NCT01388361|11065582|FG000|COMPLETED|Overall Study||224
9946995|NCT01388361|11065583|FG001|COMPLETED|Overall Study||76
9946996|NCT01388361|11065584|FG002|COMPLETED|Overall Study||75
9946997|NCT01388361|11065582|FG000|NOT COMPLETED|Overall Study||12
9946998|NCT01388361|11065583|FG001|NOT COMPLETED|Overall Study||12
9946999|NCT01388361|11065584|FG002|NOT COMPLETED|Overall Study||14
9947000|NCT01388478|11065592|FG000|STARTED|Overall Study||20
9947001|NCT01388478|11065592|FG000|COMPLETED|Overall Study||15
9947002|NCT01388478|11065592|FG000|NOT COMPLETED|Overall Study||5
9947003|NCT01388530|11065596|FG000|STARTED|Overall Study||25
9947004|NCT01388530|11065596|FG000|COMPLETED|Overall Study||20
9947005|NCT01388530|11065596|FG000|NOT COMPLETED|Overall Study||5
9947006|NCT01388543|11065602|FG000|STARTED|Day 7, Primary End Point||15
9947007|NCT01388543|11065603|FG001|STARTED|Day 7, Primary End Point||16
9947008|NCT01388543|11065602|FG000|COMPLETED|Day 7, Primary End Point||15
9947009|NCT01388543|11065603|FG001|COMPLETED|Day 7, Primary End Point||16
9947010|NCT01388543|11065602|FG000|NOT COMPLETED|Day 7, Primary End Point||0
9947011|NCT01388543|11065603|FG001|NOT COMPLETED|Day 7, Primary End Point||0
9947012|NCT01388543|11065602|FG000|STARTED|Day 14||15
9947013|NCT01388543|11065603|FG001|STARTED|Day 14||16
9947014|NCT01388543|11065602|FG000|COMPLETED|Day 14||14
9947015|NCT01388543|11065603|FG001|COMPLETED|Day 14||12
9947016|NCT01388543|11065602|FG000|NOT COMPLETED|Day 14||1
9947017|NCT01388543|11065603|FG001|NOT COMPLETED|Day 14||4
9947018|NCT01388647|11065611|FG000|STARTED|Overall Study||6
9947019|NCT01388647|11065612|FG001|STARTED|Overall Study||6
9947020|NCT01388647|11065611|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
9947021|NCT01388647|11065612|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
9947022|NCT01388647|11065611|FG000|NOT COMPLETED|Overall Study||1
9947023|NCT01388647|11065612|FG001|NOT COMPLETED|Overall Study||2
9947024|NCT01388777|11065619|FG000|STARTED|Overall Study||1
9947025|NCT01388777|11065619|FG000|Cryoablation|Overall Study||1
9947026|NCT01388777|11065619|FG000|COMPLETED|Overall Study||1
9947027|NCT01388777|11065619|FG000|NOT COMPLETED|Overall Study||0
9947028|NCT01388790|11065623|FG000|STARTED|Overall Study||40
9947029|NCT01388790|11065623|FG000|COMPLETED|Overall Study||32
9947030|NCT01388790|11065623|FG000|NOT COMPLETED|Overall Study||8
9947031|NCT01388816|11065631|FG000|STARTED|Overall Study||45
9947032|NCT01388816|11065632|FG001|STARTED|Overall Study||43
9947033|NCT01388816|11065633|FG002|STARTED|Overall Study||44
9947034|NCT01388816|11065634|FG003|STARTED|Overall Study||44
9947035|NCT01388816|11065631|FG000|COMPLETED|Overall Study||43
9947036|NCT01388816|11065632|FG001|COMPLETED|Overall Study||39
9947037|NCT01388816|11065633|FG002|COMPLETED|Overall Study||41
9947038|NCT01388816|11065634|FG003|COMPLETED|Overall Study||44
9947039|NCT01388816|11065631|FG000|NOT COMPLETED|Overall Study||2
9947040|NCT01388816|11065632|FG001|NOT COMPLETED|Overall Study||4
9947041|NCT01388816|11065633|FG002|NOT COMPLETED|Overall Study||3
9947042|NCT01388816|11065634|FG003|NOT COMPLETED|Overall Study||0
9956829|NCT01448824|11076142|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
9956830|NCT01448824|11076143|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
9956831|NCT01448824|11076144|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
9956832|NCT01448824|11076145|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
9956833|NCT01448824|11076146|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
9956834|NCT01448824|11076147|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
9956835|NCT01448824|11076140|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
10208065|NCT03541044|11335002|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
10208066|NCT03541044|11335001|FG000|STARTED|Washout Period: 5 to 7 Days||23
10208067|NCT03541044|11335002|FG001|STARTED|Washout Period: 5 to 7 Days||23
10208068|NCT03541044|11335001|FG000|COMPLETED|Washout Period: 5 to 7 Days||23
10208069|NCT03541044|11335002|FG001|COMPLETED|Washout Period: 5 to 7 Days||23
10208070|NCT03541044|11335001|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10208071|NCT03541044|11335002|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10208072|NCT03541044|11335001|FG000|STARTED|Study Period 2: Up to Day 8||23
10208073|NCT03541044|11335002|FG001|STARTED|Study Period 2: Up to Day 8||23
10208074|NCT03541044|11335001|FG000|COMPLETED|Study Period 2: Up to Day 8||21
10208075|NCT03541044|11335002|FG001|COMPLETED|Study Period 2: Up to Day 8||23
10208076|NCT03541044|11335001|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
10208077|NCT03541044|11335002|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0
10208078|NCT03541356|11335015|FG000|STARTED|Overall Study||8
10208079|NCT03541356|11335016|FG001|STARTED|Overall Study||6
10208080|NCT03541356|11335017|FG002|STARTED|Overall Study||6
10208081|NCT03541356|11335018|FG003|STARTED|Overall Study||6
10208082|NCT03541356|11335019|FG004|STARTED|Overall Study||6
10208083|NCT03541356|11335015|FG000|COMPLETED|Overall Study||8
10208084|NCT03541356|11335016|FG001|COMPLETED|Overall Study||6
10208085|NCT03541356|11335017|FG002|COMPLETED|Overall Study||6
10208086|NCT03541356|11335018|FG003|COMPLETED|Overall Study||6
10208087|NCT03541356|11335019|FG004|COMPLETED|Overall Study||6
10208088|NCT03541356|11335015|FG000|NOT COMPLETED|Overall Study||0
10208089|NCT03541356|11335016|FG001|NOT COMPLETED|Overall Study||0
10208090|NCT03541356|11335017|FG002|NOT COMPLETED|Overall Study||0
10208091|NCT03541356|11335018|FG003|NOT COMPLETED|Overall Study||0
10208092|NCT03541356|11335019|FG004|NOT COMPLETED|Overall Study||0
10208093|NCT03541941|11335039|FG000|STARTED|Overall Study||57
10208094|NCT03541941|11335040|FG001|STARTED|Overall Study||55
10208095|NCT03541941|11335041|FG002|STARTED|Overall Study||52
10208096|NCT03541941|11335039|FG000|COMPLETED|Overall Study||57
10208097|NCT03541941|11335040|FG001|COMPLETED|Overall Study||55
10208098|NCT03541941|11335041|FG002|COMPLETED|Overall Study||52
10208099|NCT03541941|11335039|FG000|NOT COMPLETED|Overall Study||0
10208100|NCT03541941|11335040|FG001|NOT COMPLETED|Overall Study||0
10208101|NCT03541941|11335041|FG002|NOT COMPLETED|Overall Study||0
10208102|NCT03541980|11335051|FG000|STARTED|Overall Study||35
10208103|NCT03541980|11335052|FG001|STARTED|Overall Study||36
10208104|NCT03541980|11335051|FG000|COMPLETED|Overall Study||35
10208105|NCT03541980|11335052|FG001|COMPLETED|Overall Study||36
10208106|NCT03541980|11335051|FG000|NOT COMPLETED|Overall Study||0
10208107|NCT03541980|11335052|FG001|NOT COMPLETED|Overall Study||0
10208108|NCT03542019|11335067|FG000|STARTED|Overall Study||20
10208109|NCT03542019|11335068|FG001|STARTED|Overall Study||20
10208110|NCT03542019|11335069|FG002|STARTED|Overall Study||20
10208111|NCT03542019|11335067|FG000|COMPLETED|Overall Study||19
10208112|NCT03542019|11335068|FG001|COMPLETED|Overall Study||17
10208113|NCT03542019|11335069|FG002|COMPLETED|Overall Study||19
10208114|NCT03542019|11335067|FG000|NOT COMPLETED|Overall Study||1
10208115|NCT03542019|11335068|FG001|NOT COMPLETED|Overall Study||3
10208116|NCT03542019|11335069|FG002|NOT COMPLETED|Overall Study||1
10208117|NCT03542305|11335081|FG000|STARTED|Overall Study||8
10208118|NCT03542305|11335082|FG001|STARTED|Overall Study||8
10208119|NCT03542305|11335083|FG002|STARTED|Overall Study||8
10208120|NCT03542305|11335084|FG003|STARTED|Overall Study||5
10208121|NCT03542305|11335081|FG000|COMPLETED|Overall Study||8
10208122|NCT03542305|11335082|FG001|COMPLETED|Overall Study||8
10208123|NCT03542305|11335083|FG002|COMPLETED|Overall Study||8
10208124|NCT03542305|11335084|FG003|COMPLETED|Overall Study||5
10208125|NCT03542305|11335081|FG000|NOT COMPLETED|Overall Study||0
10208126|NCT03542305|11335082|FG001|NOT COMPLETED|Overall Study||0
10208127|NCT03542305|11335083|FG002|NOT COMPLETED|Overall Study||0
10208128|NCT03542305|11335084|FG003|NOT COMPLETED|Overall Study||0
10208129|NCT03542474|11335094|FG000|STARTED|Overall Study||8
10208130|NCT03542474|11335094|FG000|COMPLETED|Overall Study||8
10208131|NCT03542474|11335094|FG000|NOT COMPLETED|Overall Study||0
10208132|NCT03543085|11335098|FG000|STARTED|Overall Study||10
10208133|NCT03543085|11335098|FG000|COMPLETED|Overall Study||10
10208134|NCT03543085|11335098|FG000|NOT COMPLETED|Overall Study||0
10208135|NCT03543137|11335102|FG000|STARTED|Study Period 1: Up to Day 1||18
10208136|NCT03543137|11335103|FG001|STARTED|Study Period 1: Up to Day 1||19
9947043|NCT01388907|11065649|FG000|STARTED|Overall Study||33
9947044|NCT01388907|11065650|FG001|STARTED|Overall Study||28
9947045|NCT01388907|11065649|FG000|COMPLETED|Overall Study||31
9947046|NCT01388907|11065650|FG001|COMPLETED|Overall Study||28
9947047|NCT01388907|11065649|FG000|NOT COMPLETED|Overall Study||2
9947048|NCT01388907|11065650|FG001|NOT COMPLETED|Overall Study||0
9947049|NCT01388946|11065660|FG000|STARTED|Overall Study||55
9947050|NCT01388946|11065661|FG001|STARTED|Overall Study||55
9947051|NCT01388946|11065660|FG000|COMPLETED|Overall Study||49
9947052|NCT01388946|11065661|FG001|COMPLETED|Overall Study||52
9947053|NCT01388946|11065660|FG000|NOT COMPLETED|Overall Study||6
9947054|NCT01388946|11065661|FG001|NOT COMPLETED|Overall Study||3
9947055|NCT01388985|11065669|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
9947056|NCT01388985|11065670|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
9947057|NCT01388985|11065669|FG000|Primary Vaccination Period|Overall Study||231
9947058|NCT01388985|11065670|FG001|Primary Vaccination Period|Overall Study||238
9947059|NCT01388985|11065669|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
9947060|NCT01388985|11065670|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
9947061|NCT01388985|11065669|FG000|NOT COMPLETED|Overall Study||49
9947062|NCT01388985|11065670|FG001|NOT COMPLETED|Overall Study||38
9947063|NCT01389076|11065676|FG000|STARTED|Overall Study||22
9947064|NCT01389076|11065676|FG000|COMPLETED|Overall Study||22
9947065|NCT01389076|11065676|FG000|NOT COMPLETED|Overall Study||0
9947066|NCT01389102|11065686|FG000|STARTED|Overall Study||75
9947067|NCT01389102|11065687|FG001|STARTED|Overall Study||76
9947068|NCT01389102|11065688|FG002|STARTED|Overall Study||77
9947069|NCT01389102|11065689|FG003|STARTED|Overall Study||76
9947070|NCT01389102|11065690|FG004|STARTED|Overall Study||74
9947071|NCT01389102|11065691|FG005|STARTED|Overall Study||76
9947072|NCT01389102|11065686|FG000|COMPLETED|Overall Study||57
9947073|NCT01389102|11065687|FG001|COMPLETED|Overall Study||64
9947074|NCT01389102|11065688|FG002|COMPLETED|Overall Study||58
9947075|NCT01389102|11065689|FG003|COMPLETED|Overall Study||69
9947076|NCT01389102|11065690|FG004|COMPLETED|Overall Study||61
9947077|NCT01389102|11065691|FG005|COMPLETED|Overall Study||68
9947078|NCT01389102|11065686|FG000|NOT COMPLETED|Overall Study||18
9947079|NCT01389102|11065687|FG001|NOT COMPLETED|Overall Study||12
9947080|NCT01389102|11065688|FG002|NOT COMPLETED|Overall Study||19
9947081|NCT01389102|11065689|FG003|NOT COMPLETED|Overall Study||7
9947082|NCT01389102|11065690|FG004|NOT COMPLETED|Overall Study||13
9947083|NCT01389102|11065691|FG005|NOT COMPLETED|Overall Study||8
9947084|NCT01389128|11065713|FG000|STARTED|Overall Study||40
9947085|NCT01389128|11065714|FG001|STARTED|Overall Study||40
9947086|NCT01389128|11065713|FG000|COMPLETED|Overall Study||35
9947087|NCT01389128|11065714|FG001|COMPLETED|Overall Study||34
9947088|NCT01389128|11065713|FG000|NOT COMPLETED|Overall Study||5
9947089|NCT01389128|11065714|FG001|NOT COMPLETED|Overall Study||6
9947090|NCT01389232|11065724|FG000|STARTED|Overall Study||100
9947091|NCT01389232|11065724|FG000|COMPLETED|Overall Study||81
9947092|NCT01389232|11065724|FG000|NOT COMPLETED|Overall Study||19
9947093|NCT01389245|11065738|FG000|STARTED|Overall Study||42
9947094|NCT01389245|11065738|FG000|COMPLETED|Overall Study||27
9947095|NCT01389245|11065738|FG000|NOT COMPLETED|Overall Study||15
9947096|NCT01389258|11065742|FG000|STARTED|Overall Study||45
9947097|NCT01389258|11065742|FG000|COMPLETED|Overall Study||40
9947098|NCT01389258|11065742|FG000|NOT COMPLETED|Overall Study||5
9947099|NCT01389284|11065749|FG000|STARTED|Overall Study||120
9947100|NCT01389284|11065750|FG001|STARTED|Overall Study||120
9947101|NCT01389284|11065751|FG002|STARTED|Overall Study||60
9947102|NCT01389284|11065749|FG000|COMPLETED|Overall Study||120
9947103|NCT01389284|11065750|FG001|COMPLETED|Overall Study||120
9947104|NCT01389284|11065751|FG002|COMPLETED|Overall Study||60
9947105|NCT01389284|11065749|FG000|NOT COMPLETED|Overall Study||0
9947106|NCT01389284|11065750|FG001|NOT COMPLETED|Overall Study||0
9947107|NCT01389284|11065751|FG002|NOT COMPLETED|Overall Study||0
9947108|NCT01389323|11065759|FG000|STARTED|Treatment Period (up to 48 Weeks)||246
9947109|NCT01389323|11065759|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151
9947110|NCT01389323|11065759|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
9947111|NCT01389323|11065759|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
9947112|NCT01389323|11065759|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184
9947113|NCT01389323|11065759|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
9947114|NCT01389596|11065773|FG000|STARTED|Overall Study||104
9947115|NCT01389596|11065774|FG001|STARTED|Overall Study||97
9947116|NCT01389596|11065775|FG002|STARTED|Overall Study||94
9947117|NCT01389596|11065773|FG000|COMPLETED|Overall Study||94
9947118|NCT01389596|11065774|FG001|COMPLETED|Overall Study||81
9947119|NCT01389596|11065775|FG002|COMPLETED|Overall Study||84
9947120|NCT01389596|11065773|FG000|NOT COMPLETED|Overall Study||10
9947121|NCT01389596|11065774|FG001|NOT COMPLETED|Overall Study||16
9947122|NCT01389596|11065775|FG002|NOT COMPLETED|Overall Study||10
9947123|NCT01389752|11065783|FG000|STARTED|Study Period 1||11
9947124|NCT01389752|11065784|FG001|STARTED|Study Period 1||11
9947125|NCT01389752|11065783|FG000|COMPLETED|Study Period 1||11
9947126|NCT01389752|11065784|FG001|COMPLETED|Study Period 1||9
9947127|NCT01389752|11065783|FG000|NOT COMPLETED|Study Period 1||0
9947128|NCT01389752|11065784|FG001|NOT COMPLETED|Study Period 1||2
9947129|NCT01389752|11065783|FG000|STARTED|Study Period 2||11
9947130|NCT01389752|11065784|FG001|STARTED|Study Period 2||9
9947131|NCT01389752|11065783|FG000|COMPLETED|Study Period 2||10
9947132|NCT01389752|11065784|FG001|COMPLETED|Study Period 2||9
9947133|NCT01389752|11065783|FG000|NOT COMPLETED|Study Period 2||1
9947134|NCT01389752|11065784|FG001|NOT COMPLETED|Study Period 2||0
9947135|NCT01389765|11065791|FG000|STARTED|First Intervention (Day 1)||12
9947136|NCT01389765|11065792|FG001|STARTED|First Intervention (Day 1)||12
9947137|NCT01389765|11065791|FG000|COMPLETED|First Intervention (Day 1)||12
9947138|NCT01389765|11065792|FG001|COMPLETED|First Intervention (Day 1)||12
9947139|NCT01389765|11065791|FG000|NOT COMPLETED|First Intervention (Day 1)||0
9947140|NCT01389765|11065792|FG001|NOT COMPLETED|First Intervention (Day 1)||0
9947141|NCT01389765|11065791|FG000|STARTED|Washout Period (7 Days)||12
9947142|NCT01389765|11065792|FG001|STARTED|Washout Period (7 Days)||12
9947143|NCT01389765|11065791|FG000|COMPLETED|Washout Period (7 Days)||12
9947144|NCT01389765|11065792|FG001|COMPLETED|Washout Period (7 Days)||12
9947145|NCT01389765|11065791|FG000|NOT COMPLETED|Washout Period (7 Days)||0
9947146|NCT01389765|11065792|FG001|NOT COMPLETED|Washout Period (7 Days)||0
9947147|NCT01389765|11065791|FG000|STARTED|Second Intervention (Day 1)||12
9947148|NCT01389765|11065792|FG001|STARTED|Second Intervention (Day 1)||12
9947149|NCT01389765|11065791|FG000|COMPLETED|Second Intervention (Day 1)||12
9947150|NCT01389765|11065792|FG001|COMPLETED|Second Intervention (Day 1)||12
9947151|NCT01389765|11065791|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
10208137|NCT03543137|11335102|FG000|COMPLETED|Study Period 1: Up to Day 1||18
10208138|NCT03543137|11335103|FG001|COMPLETED|Study Period 1: Up to Day 1||19
10208139|NCT03543137|11335102|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
9947152|NCT01389765|11065792|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
9947153|NCT01389856|11065800|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
9947154|NCT01389856|11065801|FG001|STARTED|Overall Study|Randomized and treated.|8
9947155|NCT01389856|11065800|FG000|COMPLETED|Overall Study||13
9947156|NCT01389856|11065801|FG001|COMPLETED|Overall Study||8
9947157|NCT01389856|11065800|FG000|NOT COMPLETED|Overall Study||0
9947158|NCT01389856|11065801|FG001|NOT COMPLETED|Overall Study||0
9947159|NCT01389882|11065809|FG000|STARTED|Overall Study||13
9947160|NCT01389882|11065810|FG001|STARTED|Overall Study||11
9947161|NCT01389882|11065809|FG000|COMPLETED|Overall Study||12
9947162|NCT01389882|11065810|FG001|COMPLETED|Overall Study||7
9947163|NCT01389882|11065809|FG000|NOT COMPLETED|Overall Study||1
9947164|NCT01389882|11065810|FG001|NOT COMPLETED|Overall Study||4
9947165|NCT01389973|11065816|FG000|STARTED|Overall Study||20
9947166|NCT01389973|11065816|FG000|COMPLETED|Overall Study||0
9947167|NCT01389973|11065816|FG000|NOT COMPLETED|Overall Study||20
10208140|NCT03543137|11335103|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
10208141|NCT03543137|11335102|FG000|STARTED|Washout Period: 5 to 7 Days||18
10208142|NCT03543137|11335103|FG001|STARTED|Washout Period: 5 to 7 Days||19
10208143|NCT03543137|11335102|FG000|COMPLETED|Washout Period: 5 to 7 Days||18
10208144|NCT03543137|11335103|FG001|COMPLETED|Washout Period: 5 to 7 Days||19
10208145|NCT03543137|11335102|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10208146|NCT03543137|11335103|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10208147|NCT03543137|11335102|FG000|STARTED|Study Period 2: Up to Day 8||18
10208148|NCT03543137|11335103|FG001|STARTED|Study Period 2: Up to Day 8||19
10208149|NCT03543137|11335102|FG000|Treated|Study Period 2: Up to Day 8||16
10208150|NCT03543137|11335103|FG001|Treated|Study Period 2: Up to Day 8||18
10208151|NCT03543137|11335102|FG000|COMPLETED|Study Period 2: Up to Day 8||16
10208152|NCT03543137|11335103|FG001|COMPLETED|Study Period 2: Up to Day 8||18
10208153|NCT03543137|11335102|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
10208154|NCT03543137|11335103|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1
10208155|NCT03543176|11335113|FG000|STARTED|Overall Study||392
10208156|NCT03543176|11335114|FG001|STARTED|Overall Study||397
10208157|NCT03543176|11335113|FG000|COMPLETED|Overall Study||392
10208158|NCT03543176|11335114|FG001|COMPLETED|Overall Study||397
10208159|NCT03543176|11335113|FG000|NOT COMPLETED|Overall Study||0
10208160|NCT03543176|11335114|FG001|NOT COMPLETED|Overall Study||0
10208161|NCT03543878|11335122|FG000|STARTED|Overall Study||5
10208162|NCT03543878|11335123|FG001|STARTED|Overall Study||5
10208163|NCT03543878|11335122|FG000|COMPLETED|Overall Study||5
10208164|NCT03543878|11335123|FG001|COMPLETED|Overall Study||5
10208165|NCT03543878|11335122|FG000|NOT COMPLETED|Overall Study||0
10208166|NCT03543878|11335123|FG001|NOT COMPLETED|Overall Study||0
10208167|NCT03544216|11335132|FG000|STARTED|Overall Study||42
10208168|NCT03544216|11335133|FG001|STARTED|Overall Study||42
10208169|NCT03544216|11335132|FG000|COMPLETED|Overall Study||42
10208170|NCT03544216|11335133|FG001|COMPLETED|Overall Study||42
10208171|NCT03544216|11335132|FG000|NOT COMPLETED|Overall Study||0
10208172|NCT03544216|11335133|FG001|NOT COMPLETED|Overall Study||0
10208173|NCT03544307|11335142|FG000|STARTED|Overall Study||10
10208174|NCT03544307|11335143|FG001|STARTED|Overall Study||10
10208175|NCT03544307|11335142|FG000|COMPLETED|Overall Study||10
10208176|NCT03544307|11335143|FG001|COMPLETED|Overall Study||10
10208177|NCT03544307|11335142|FG000|NOT COMPLETED|Overall Study||0
10208178|NCT03544307|11335143|FG001|NOT COMPLETED|Overall Study||0
9947168|NCT01390038|11065820|FG000|STARTED|Overall Study||157
10208179|NCT03544333|11335151|FG000|STARTED|Overall Study||3
9947169|NCT01390038|11065820|FG000|COMPLETED|Overall Study||149
9947170|NCT01390038|11065820|FG000|NOT COMPLETED|Overall Study||8
9947171|NCT01390064|11065826|FG000|STARTED|Overall Study||3
9947172|NCT01390064|11065827|FG001|STARTED|Overall Study||3
9947173|NCT01390064|11065826|FG000|COMPLETED|Overall Study||3
9947174|NCT01390064|11065827|FG001|COMPLETED|Overall Study||3
9947175|NCT01390064|11065826|FG000|NOT COMPLETED|Overall Study||0
9947176|NCT01390064|11065827|FG001|NOT COMPLETED|Overall Study||0
9947177|NCT01390077|11065833|FG000|STARTED|Overall Study||8
9947178|NCT01390077|11065833|FG000|Treatment|Overall Study||7
9947179|NCT01390077|11065833|FG000|COMPLETED|Overall Study||7
9947180|NCT01390077|11065833|FG000|NOT COMPLETED|Overall Study||1
9947181|NCT01390220|11065842|FG000|STARTED|Test Dose Phase||292
9947182|NCT01390220|11065843|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
9947183|NCT01390220|11065844|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
9947184|NCT01390220|11065842|FG000|COMPLETED|Test Dose Phase||201
9947185|NCT01390220|11065843|FG001|COMPLETED|Test Dose Phase||0
9947186|NCT01390220|11065844|FG002|COMPLETED|Test Dose Phase||0
9947187|NCT01390220|11065842|FG000|NOT COMPLETED|Test Dose Phase||91
9947188|NCT01390220|11065843|FG001|NOT COMPLETED|Test Dose Phase||0
9947189|NCT01390220|11065844|FG002|NOT COMPLETED|Test Dose Phase||0
9947190|NCT01390220|11065842|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0
9947191|NCT01390220|11065843|FG001|STARTED|Comparative Phase||134
9947192|NCT01390220|11065844|FG002|STARTED|Comparative Phase||67
9947193|NCT01390220|11065842|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0
9947194|NCT01390220|11065843|FG001|COMPLETED|Comparative Phase||133
9947195|NCT01390220|11065844|FG002|COMPLETED|Comparative Phase||67
9947196|NCT01390220|11065842|FG000|NOT COMPLETED|Comparative Phase||0
9947197|NCT01390220|11065843|FG001|NOT COMPLETED|Comparative Phase||1
9947198|NCT01390220|11065844|FG002|NOT COMPLETED|Comparative Phase||0
9947199|NCT01390233|11065856|FG000|STARTED|Overall Study||35
9947200|NCT01390233|11065857|FG001|STARTED|Overall Study||31
9947201|NCT01390233|11065858|FG002|STARTED|Overall Study||36
9947202|NCT01390233|11065856|FG000|COMPLETED|Overall Study||30
9947203|NCT01390233|11065857|FG001|COMPLETED|Overall Study||29
9947204|NCT01390233|11065858|FG002|COMPLETED|Overall Study||30
9947205|NCT01390233|11065856|FG000|NOT COMPLETED|Overall Study||5
9947206|NCT01390233|11065857|FG001|NOT COMPLETED|Overall Study||2
9947207|NCT01390233|11065858|FG002|NOT COMPLETED|Overall Study||6
10011692|NCT01781611|11134481|FG001|COMPLETED|Overall Study||5
10011693|NCT01781611|11134480|FG000|NOT COMPLETED|Overall Study||4
10011694|NCT01781611|11134481|FG001|NOT COMPLETED|Overall Study||0
10208180|NCT03544333|11335152|FG001|STARTED|Overall Study||2
10208181|NCT03544333|11335151|FG000|COMPLETED|Overall Study||2
10208182|NCT03544333|11335152|FG001|COMPLETED|Overall Study||2
10208183|NCT03544333|11335151|FG000|NOT COMPLETED|Overall Study||1
10208184|NCT03544333|11335152|FG001|NOT COMPLETED|Overall Study||0
10208185|NCT03544879|11335160|FG000|STARTED|Overall Study||22
10208186|NCT03544879|11335161|FG001|STARTED|Overall Study||24
10208187|NCT03544879|11335160|FG000|Completed Follow-up Physical Assessment|Overall Study||20
10208188|NCT03544879|11335161|FG001|Completed Follow-up Physical Assessment|Overall Study||21
10208189|NCT03544879|11335160|FG000|COMPLETED|Overall Study||22
10208190|NCT03544879|11335161|FG001|COMPLETED|Overall Study||23
10208191|NCT03544879|11335160|FG000|NOT COMPLETED|Overall Study||0
10208192|NCT03544879|11335161|FG001|NOT COMPLETED|Overall Study||1
10208193|NCT03545165|11335169|FG000|STARTED|Overall Study||6
10208194|NCT03545165|11335169|FG000|COMPLETED|Overall Study||6
10208195|NCT03545165|11335169|FG000|NOT COMPLETED|Overall Study||0
10208196|NCT03545412|11335173|FG000|STARTED|Overall Study||25
10208197|NCT03545412|11335173|FG000|COMPLETED|Overall Study||25
10208198|NCT03545412|11335173|FG000|NOT COMPLETED|Overall Study||0
10208199|NCT03545503|11335179|FG000|STARTED|Overall Study||208
10208200|NCT03545503|11335180|FG001|STARTED|Overall Study||220
10208201|NCT03545503|11335179|FG000|COMPLETED|Overall Study||194
10208202|NCT03545503|11335180|FG001|COMPLETED|Overall Study||204
10208203|NCT03545503|11335179|FG000|NOT COMPLETED|Overall Study||14
10208204|NCT03545503|11335180|FG001|NOT COMPLETED|Overall Study||16
10208205|NCT03545893|11335188|FG000|STARTED|Overall Study||35
10208206|NCT03545893|11335189|FG001|STARTED|Overall Study||35
10208207|NCT03545893|11335188|FG000|COMPLETED|Overall Study||35
10208208|NCT03545893|11335189|FG001|COMPLETED|Overall Study||35
10208209|NCT03545893|11335188|FG000|NOT COMPLETED|Overall Study||0
10208210|NCT03545893|11335189|FG001|NOT COMPLETED|Overall Study||0
9947208|NCT01390246|11065868|FG000|STARTED|Overall Study||30
9947209|NCT01390246|11065869|FG001|STARTED|Overall Study||35
9947210|NCT01390246|11065868|FG000|Visit 2: Quit Day|Overall Study||24
9947211|NCT01390246|11065869|FG001|Visit 2: Quit Day|Overall Study||24
9947212|NCT01390246|11065868|FG000|Visit 6: End of Treatment|Overall Study||15
9947213|NCT01390246|11065869|FG001|Visit 6: End of Treatment|Overall Study||15
9947214|NCT01390246|11065868|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10
9947215|NCT01390246|11065869|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10
9947216|NCT01390246|11065868|FG000|COMPLETED|Overall Study||10
9947217|NCT01390246|11065869|FG001|COMPLETED|Overall Study||10
9947218|NCT01390246|11065868|FG000|NOT COMPLETED|Overall Study||20
10208211|NCT03545984|11335197|FG000|STARTED|Overall Study||24
10208212|NCT03545984|11335198|FG001|STARTED|Overall Study||24
10208213|NCT03545984|11335197|FG000|COMPLETED|Overall Study||13
9947219|NCT01390246|11065869|FG001|NOT COMPLETED|Overall Study||25
9947220|NCT01390259|11065875|FG000|STARTED|Overall Study||5
10208214|NCT03545984|11335198|FG001|COMPLETED|Overall Study||15
10208215|NCT03545984|11335197|FG000|NOT COMPLETED|Overall Study||11
10208216|NCT03545984|11335198|FG001|NOT COMPLETED|Overall Study||9
10208217|NCT03546270|11335206|FG000|STARTED|Overall Study||52
10208218|NCT03546270|11335207|FG001|STARTED|Overall Study||48
10208219|NCT03546270|11335206|FG000|COMPLETED|Overall Study||52
10011695|NCT01781806|11134489|FG000|STARTED|Overall Study||297
10011696|NCT01781806|11134490|FG001|STARTED|Overall Study||4
10011697|NCT01781806|11134489|FG000|Week 0|Overall Study||297
10011698|NCT01781806|11134490|FG001|Week 0|Overall Study||4
10011699|NCT01781806|11134489|FG000|Week 4|Overall Study||284
10011700|NCT01781806|11134490|FG001|Week 4|Overall Study||4
10011701|NCT01781806|11134489|FG000|Week 8|Overall Study||278
10011702|NCT01781806|11134490|FG001|Week 8|Overall Study||4
10011703|NCT01781806|11134489|FG000|Week 12|Overall Study||272
10011704|NCT01781806|11134490|FG001|Week 12|Overall Study||2
10011705|NCT01781806|11134489|FG000|Week 24|Overall Study||260
10208220|NCT03546270|11335207|FG001|COMPLETED|Overall Study||48
10208221|NCT03546270|11335206|FG000|NOT COMPLETED|Overall Study||0
9947221|NCT01390259|11065876|FG001|STARTED|Overall Study||6
9947222|NCT01390259|11065875|FG000|COMPLETED|Overall Study||5
9947223|NCT01390259|11065876|FG001|COMPLETED|Overall Study||6
9947224|NCT01390259|11065875|FG000|NOT COMPLETED|Overall Study||0
9947225|NCT01390259|11065876|FG001|NOT COMPLETED|Overall Study||0
9947226|NCT01390272|11065883|FG000|STARTED|Overall Study||192
9947227|NCT01390272|11065884|FG001|STARTED|Overall Study||193
9947228|NCT01390272|11065883|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
9947229|NCT01390272|11065884|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
9947230|NCT01390272|11065883|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
9947231|NCT01390272|11065884|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
9947232|NCT01390272|11065883|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
9947233|NCT01390272|11065884|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
9947234|NCT01390272|11065883|FG000|COMPLETED|Overall Study||175
9947235|NCT01390272|11065884|FG001|COMPLETED|Overall Study||178
9947236|NCT01390272|11065883|FG000|NOT COMPLETED|Overall Study||17
9947237|NCT01390272|11065884|FG001|NOT COMPLETED|Overall Study||15
9947238|NCT01390298|11065890|FG000|STARTED|Overall Study||55
9947239|NCT01390298|11065890|FG000|COMPLETED|Overall Study||31
9947240|NCT01390298|11065890|FG000|NOT COMPLETED|Overall Study||24
9947241|NCT01390389|11065896|FG000|STARTED|Overall Study||10
9947242|NCT01390389|11065897|FG001|STARTED|Overall Study||9
9947243|NCT01390389|11065896|FG000|COMPLETED|Overall Study||6
9947244|NCT01390389|11065897|FG001|COMPLETED|Overall Study||8
9947245|NCT01390389|11065896|FG000|NOT COMPLETED|Overall Study||4
9947246|NCT01390389|11065897|FG001|NOT COMPLETED|Overall Study||1
10208222|NCT03546270|11335207|FG001|NOT COMPLETED|Overall Study||0
10208223|NCT03546491|11335213|FG000|STARTED|Overall Study||32
10208224|NCT03546491|11335213|FG000|Recieved Test Product 1|Overall Study||32
10208225|NCT03546491|11335213|FG000|Received Test Product 2|Overall Study||32
10208226|NCT03546491|11335213|FG000|COMPLETED|Overall Study||30
10208227|NCT03546491|11335213|FG000|NOT COMPLETED|Overall Study||2
10208228|NCT03546621|11335227|FG000|STARTED|Overall Study||28
10208229|NCT03546621|11335228|FG001|STARTED|Overall Study||32
10208230|NCT03546621|11335229|FG002|STARTED|Overall Study||30
10208231|NCT03546621|11335230|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
10208232|NCT03546621|11335227|FG000|COMPLETED|Overall Study||28
10208233|NCT03546621|11335228|FG001|COMPLETED|Overall Study||29
10208234|NCT03546621|11335229|FG002|COMPLETED|Overall Study||28
10208235|NCT03546621|11335230|FG003|COMPLETED|Overall Study||25
10208236|NCT03546621|11335227|FG000|NOT COMPLETED|Overall Study||0
10208237|NCT03546621|11335228|FG001|NOT COMPLETED|Overall Study||3
10208238|NCT03546621|11335229|FG002|NOT COMPLETED|Overall Study||2
10208239|NCT03546621|11335230|FG003|NOT COMPLETED|Overall Study||3
10208240|NCT03546647|11335240|FG000|STARTED|Overall Study||18
10208241|NCT03546647|11335241|FG001|STARTED|Overall Study|34|17
10208242|NCT03546647|11335240|FG000|COMPLETED|Overall Study||17
10208243|NCT03546647|11335241|FG001|COMPLETED|Overall Study||17
10208244|NCT03546647|11335240|FG000|NOT COMPLETED|Overall Study||1
10208245|NCT03546647|11335241|FG001|NOT COMPLETED|Overall Study||0
10208246|NCT03546816|11335249|FG000|STARTED|Overall Study||142
10208247|NCT03546816|11335250|FG001|STARTED|Overall Study||143
10208248|NCT03546816|11335249|FG000|COMPLETED|Overall Study||121
10208249|NCT03546816|11335250|FG001|COMPLETED|Overall Study||124
10208250|NCT03546816|11335249|FG000|NOT COMPLETED|Overall Study||21
10208251|NCT03546816|11335250|FG001|NOT COMPLETED|Overall Study||19
10208252|NCT03546842|11335258|FG000|STARTED|Overall Study||201
10208253|NCT03546842|11335258|FG000|Vaccination 1|Overall Study||200
10208254|NCT03546842|11335258|FG000|Vaccination 2|Overall Study||200
10208255|NCT03546842|11335258|FG000|Vaccination 3|Overall Study||198
10208256|NCT03546842|11335258|FG000|COMPLETED|Overall Study||198
10208257|NCT03546842|11335258|FG000|NOT COMPLETED|Overall Study||3
10011706|NCT01781806|11134490|FG001|Week 24|Overall Study||1
10011707|NCT01781806|11134489|FG000|Week 36|Overall Study||247
10208258|NCT03547154|11335264|FG000|STARTED|Overall Study||173
10208259|NCT03547154|11335265|FG001|STARTED|Overall Study||171
10208260|NCT03547154|11335264|FG000|COMPLETED|Overall Study||50
10208261|NCT03547154|11335265|FG001|COMPLETED|Overall Study||55
10208262|NCT03547154|11335264|FG000|NOT COMPLETED|Overall Study||123
10208263|NCT03547154|11335265|FG001|NOT COMPLETED|Overall Study||116
10208264|NCT03547167|11335273|FG000|STARTED|Overall Study||1135
10208265|NCT03547167|11335274|FG001|STARTED|Overall Study||380
10238848|NCT00469612|11370273|FG001|NOT COMPLETED|Overall Study||0
9947247|NCT01390402|11065907|FG000|STARTED|Overall Study||6
9947248|NCT01390402|11065907|FG000|COMPLETED|Overall Study||1
9947249|NCT01390402|11065907|FG000|NOT COMPLETED|Overall Study||5
9947250|NCT01390428|11065917|FG000|STARTED|Overall Study||8
9947251|NCT01390428|11065918|FG001|STARTED|Overall Study||8
9947252|NCT01390428|11065919|FG002|STARTED|Overall Study||9
9947253|NCT01390428|11065920|FG003|STARTED|Overall Study||9
9947254|NCT01390428|11065921|FG004|STARTED|Overall Study||8
9947255|NCT01390428|11065922|FG005|STARTED|Overall Study||8
9947256|NCT01390428|11065917|FG000|COMPLETED|Overall Study||8
9947257|NCT01390428|11065918|FG001|COMPLETED|Overall Study||8
9947258|NCT01390428|11065919|FG002|COMPLETED|Overall Study||8
9947259|NCT01390428|11065920|FG003|COMPLETED|Overall Study||9
9947260|NCT01390428|11065921|FG004|COMPLETED|Overall Study||7
9947261|NCT01390428|11065922|FG005|COMPLETED|Overall Study||8
9947262|NCT01390428|11065917|FG000|NOT COMPLETED|Overall Study||0
9947263|NCT01390428|11065918|FG001|NOT COMPLETED|Overall Study||0
10208266|NCT03547167|11335273|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
10208267|NCT03547167|11335274|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
10208268|NCT03547167|11335273|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
10208269|NCT03547167|11335274|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
10208270|NCT03547167|11335273|FG000|COMPLETED|Overall Study||1038
10208271|NCT03547167|11335274|FG001|COMPLETED|Overall Study||350
10208272|NCT03547167|11335273|FG000|NOT COMPLETED|Overall Study||97
10208273|NCT03547167|11335274|FG001|NOT COMPLETED|Overall Study||30
10208274|NCT03547531|11335286|FG000|STARTED|Overall Study||62
10208275|NCT03547531|11335287|FG001|STARTED|Overall Study||62
10208276|NCT03547531|11335286|FG000|COMPLETED|Overall Study||60
10208277|NCT03547531|11335287|FG001|COMPLETED|Overall Study||58
10208278|NCT03547531|11335286|FG000|NOT COMPLETED|Overall Study||2
10208279|NCT03547531|11335287|FG001|NOT COMPLETED|Overall Study||4
10208280|NCT03547583|11335296|FG000|STARTED|Overall Study||263
10208281|NCT03547583|11335297|FG001|STARTED|Overall Study||264
10208282|NCT03547583|11335298|FG002|STARTED|Overall Study||262
10208283|NCT03547583|11335296|FG000|Treated|Overall Study||262
10208284|NCT03547583|11335297|FG001|Treated|Overall Study||264
10208285|NCT03547583|11335298|FG002|Treated|Overall Study||262
10208286|NCT03547583|11335296|FG000|COMPLETED|Overall Study||218
10208287|NCT03547583|11335297|FG001|COMPLETED|Overall Study||224
10208288|NCT03547583|11335298|FG002|COMPLETED|Overall Study||230
10208289|NCT03547583|11335296|FG000|NOT COMPLETED|Overall Study||45
10208290|NCT03547583|11335297|FG001|NOT COMPLETED|Overall Study||40
10208291|NCT03547583|11335298|FG002|NOT COMPLETED|Overall Study||32
10208292|NCT03547635|11335312|FG000|STARTED|Overall Study||41
10208293|NCT03547635|11335313|FG001|STARTED|Overall Study||38
10208294|NCT03547635|11335314|FG002|STARTED|Overall Study||37
10208295|NCT03547635|11335312|FG000|COMPLETED|Overall Study||33
10208296|NCT03547635|11335313|FG001|COMPLETED|Overall Study||31
10208297|NCT03547635|11335314|FG002|COMPLETED|Overall Study||29
10208298|NCT03547635|11335312|FG000|NOT COMPLETED|Overall Study||8
10208299|NCT03547635|11335313|FG001|NOT COMPLETED|Overall Study||7
10208300|NCT03547635|11335314|FG002|NOT COMPLETED|Overall Study||8
10208301|NCT03547687|11335322|FG000|STARTED|Overall Study||9
10208302|NCT03547687|11335322|FG000|COMPLETED|Overall Study||7
10208303|NCT03547687|11335322|FG000|NOT COMPLETED|Overall Study||2
10208304|NCT03548337|11335328|FG000|STARTED|Infant Series||151
10208305|NCT03548337|11335329|FG001|STARTED|Infant Series||150
10208306|NCT03548337|11335328|FG000|Vaccination 1|Infant Series||150
10208307|NCT03548337|11335329|FG001|Vaccination 1|Infant Series||150
10208308|NCT03548337|11335328|FG000|Vaccination 2|Infant Series||144
10208309|NCT03548337|11335329|FG001|Vaccination 2|Infant Series||144
10208310|NCT03548337|11335328|FG000|Vaccination 3|Infant Series||144
10208311|NCT03548337|11335329|FG001|Vaccination 3|Infant Series||141
10208312|NCT03548337|11335328|FG000|COMPLETED|Infant Series||139
10208313|NCT03548337|11335329|FG001|COMPLETED|Infant Series||139
10208314|NCT03548337|11335328|FG000|NOT COMPLETED|Infant Series||12
10208315|NCT03548337|11335329|FG001|NOT COMPLETED|Infant Series||11
10208316|NCT03548337|11335328|FG000|STARTED|Toddler Dose||139
10208317|NCT03548337|11335329|FG001|STARTED|Toddler Dose||139
10208318|NCT03548337|11335328|FG000|Vaccination 4|Toddler Dose||139
10208319|NCT03548337|11335329|FG001|Vaccination 4|Toddler Dose||139
10208320|NCT03548337|11335328|FG000|COMPLETED|Toddler Dose||138
9947264|NCT01390428|11065919|FG002|NOT COMPLETED|Overall Study||1
9947265|NCT01390428|11065920|FG003|NOT COMPLETED|Overall Study||0
9947266|NCT01390428|11065921|FG004|NOT COMPLETED|Overall Study||1
9947267|NCT01390428|11065922|FG005|NOT COMPLETED|Overall Study||0
10208321|NCT03548337|11335329|FG001|COMPLETED|Toddler Dose||138
10208322|NCT03548337|11335328|FG000|NOT COMPLETED|Toddler Dose||1
10208323|NCT03548337|11335329|FG001|NOT COMPLETED|Toddler Dose||1
10208324|NCT03548935|11335343|FG000|STARTED|Overall Study||1306
10208325|NCT03548935|11335344|FG001|STARTED|Overall Study||655
10208326|NCT03548935|11335343|FG000|Full Analysis Set (FAS)|Overall Study||1306
9947268|NCT01390441|11065941|FG000|STARTED|Treatment Period||23
10208327|NCT03548935|11335344|FG001|Full Analysis Set (FAS)|Overall Study||655
10208328|NCT03548935|11335343|FG000|Safety Analysis Set (SAS)|Overall Study||1306
10208329|NCT03548935|11335344|FG001|Safety Analysis Set (SAS)|Overall Study||655
10208330|NCT03548935|11335343|FG000|COMPLETED|Overall Study||1240
10208331|NCT03548935|11335344|FG001|COMPLETED|Overall Study||609
10208332|NCT03548935|11335343|FG000|NOT COMPLETED|Overall Study||66
9947269|NCT01390441|11065942|FG001|STARTED|Treatment Period||22
9947270|NCT01390441|11065943|FG002|STARTED|Treatment Period||18
9947271|NCT01390441|11065944|FG003|STARTED|Treatment Period||19
9947272|NCT01390441|11065945|FG004|STARTED|Treatment Period||18
9947273|NCT01390441|11065941|FG000|COMPLETED|Treatment Period||22
9947274|NCT01390441|11065942|FG001|COMPLETED|Treatment Period||21
9947275|NCT01390441|11065943|FG002|COMPLETED|Treatment Period||8
9947276|NCT01390441|11065944|FG003|COMPLETED|Treatment Period||6
9947277|NCT01390441|11065945|FG004|COMPLETED|Treatment Period||7
9947278|NCT01390441|11065941|FG000|NOT COMPLETED|Treatment Period||1
9947279|NCT01390441|11065942|FG001|NOT COMPLETED|Treatment Period||1
9947280|NCT01390441|11065943|FG002|NOT COMPLETED|Treatment Period||10
9947281|NCT01390441|11065944|FG003|NOT COMPLETED|Treatment Period||13
9947282|NCT01390441|11065945|FG004|NOT COMPLETED|Treatment Period||11
9947283|NCT01390441|11065941|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
9947284|NCT01390441|11065942|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
9947285|NCT01390441|11065943|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
9947286|NCT01390441|11065944|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
9947287|NCT01390441|11065945|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
9947288|NCT01390441|11065941|FG000|COMPLETED|Extension Period||12
9947289|NCT01390441|11065942|FG001|COMPLETED|Extension Period||12
9947290|NCT01390441|11065943|FG002|COMPLETED|Extension Period||1
9947291|NCT01390441|11065944|FG003|COMPLETED|Extension Period||0
9947292|NCT01390441|11065945|FG004|COMPLETED|Extension Period||3
9947293|NCT01390441|11065941|FG000|NOT COMPLETED|Extension Period||3
9947294|NCT01390441|11065942|FG001|NOT COMPLETED|Extension Period||1
9947295|NCT01390441|11065943|FG002|NOT COMPLETED|Extension Period||0
9947296|NCT01390441|11065944|FG003|NOT COMPLETED|Extension Period||1
9947297|NCT01390441|11065945|FG004|NOT COMPLETED|Extension Period||0
9947298|NCT01390584|11065985|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
9947299|NCT01390584|11065986|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
9947300|NCT01390584|11065987|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
9947301|NCT01390584|11065985|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
9947302|NCT01390584|11065986|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
9947303|NCT01390584|11065987|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
9947304|NCT01390584|11065985|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
9947305|NCT01390584|11065986|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
9947306|NCT01390584|11065987|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
9947307|NCT01390584|11065985|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
9947308|NCT01390584|11065986|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
9947309|NCT01390584|11065987|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
10208333|NCT03548935|11335344|FG001|NOT COMPLETED|Overall Study||46
10208334|NCT03549117|11335352|FG000|STARTED|Overall Study||70
10208335|NCT03549117|11335353|FG001|STARTED|Overall Study||70
10208336|NCT03549117|11335352|FG000|COMPLETED|Overall Study||69
10208337|NCT03549117|11335353|FG001|COMPLETED|Overall Study||70
10208338|NCT03549117|11335352|FG000|NOT COMPLETED|Overall Study||1
10208339|NCT03549117|11335353|FG001|NOT COMPLETED|Overall Study||0
10208340|NCT03549130|11335361|FG000|STARTED|Overall Study||64
10208341|NCT03549130|11335362|FG001|STARTED|Overall Study||66
10208342|NCT03549130|11335361|FG000|COMPLETED|Overall Study||64
10208343|NCT03549130|11335362|FG001|COMPLETED|Overall Study||64
10208344|NCT03549130|11335361|FG000|NOT COMPLETED|Overall Study||0
10208345|NCT03549130|11335362|FG001|NOT COMPLETED|Overall Study||2
10208346|NCT03549234|11335372|FG000|STARTED|Overall Study||50
10208347|NCT03549234|11335373|FG001|STARTED|Overall Study||50
10208348|NCT03549234|11335372|FG000|COMPLETED|Overall Study||50
10208349|NCT03549234|11335373|FG001|COMPLETED|Overall Study||50
10208350|NCT03549234|11335372|FG000|NOT COMPLETED|Overall Study||0
10208351|NCT03549234|11335373|FG001|NOT COMPLETED|Overall Study||0
10208352|NCT03549338|11335382|FG000|STARTED|Overall Study||1
10208353|NCT03549338|11335383|FG001|STARTED|Overall Study||1
10208354|NCT03549338|11335384|FG002|STARTED|Overall Study||0
10208355|NCT03549338|11335382|FG000|COMPLETED|Overall Study||0
10208356|NCT03549338|11335383|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
10208357|NCT03549338|11335384|FG002|COMPLETED|Overall Study||0
10208358|NCT03549338|11335382|FG000|NOT COMPLETED|Overall Study||1
10208359|NCT03549338|11335383|FG001|NOT COMPLETED|Overall Study||1
10208360|NCT03549338|11335384|FG002|NOT COMPLETED|Overall Study||0
10208361|NCT03549429|11335392|FG000|STARTED|Overall Study||81
10208362|NCT03549429|11335393|FG001|STARTED|Overall Study||78
10208363|NCT03549429|11335392|FG000|COMPLETED|Overall Study||76
10208364|NCT03549429|11335393|FG001|COMPLETED|Overall Study||75
10208365|NCT03549429|11335392|FG000|NOT COMPLETED|Overall Study||5
10208366|NCT03549429|11335393|FG001|NOT COMPLETED|Overall Study||3
10208367|NCT03549598|11335401|FG000|STARTED|Overall Study||15
10208368|NCT03549598|11335401|FG000|COMPLETED|Overall Study||15
10208369|NCT03549598|11335401|FG000|NOT COMPLETED|Overall Study||0
10208370|NCT03550066|11335409|FG000|STARTED|Overall Study||49
10208371|NCT03550066|11335410|FG001|STARTED|Overall Study||41
10208372|NCT03550066|11335409|FG000|COMPLETED|Overall Study||49
10208373|NCT03550066|11335410|FG001|COMPLETED|Overall Study||41
10208374|NCT03550066|11335409|FG000|NOT COMPLETED|Overall Study||0
10208375|NCT03550066|11335410|FG001|NOT COMPLETED|Overall Study||0
10208376|NCT03550209|11335420|FG000|STARTED|Overall Study||12
9947310|NCT01390584|11065985|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
9947311|NCT01390584|11065986|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
9947312|NCT01390584|11065987|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
9947313|NCT01390584|11065985|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
9947314|NCT01390584|11065986|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
9947315|NCT01390584|11065987|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
9947316|NCT01390649|11065996|FG000|STARTED|Overall Study|Subjects treated with Privigen|57
9947317|NCT01390649|11065996|FG000|COMPLETED|Overall Study||56
9947318|NCT01390649|11065996|FG000|NOT COMPLETED|Overall Study||1
9947319|NCT01390779|11066000|FG000|STARTED|Overall Study||33
9947320|NCT01390779|11066000|FG000|COMPLETED|Overall Study||32
9947321|NCT01390779|11066000|FG000|NOT COMPLETED|Overall Study||1
9947322|NCT01390818|11066019|FG000|STARTED|Overall Study||3
9947323|NCT01390818|11066020|FG001|STARTED|Overall Study||3
9947324|NCT01390818|11066021|FG002|STARTED|Overall Study||3
9947325|NCT01390818|11066022|FG003|STARTED|Overall Study||4
9947326|NCT01390818|11066023|FG004|STARTED|Overall Study||4
9947327|NCT01390818|11066024|FG005|STARTED|Overall Study||3
9947328|NCT01390818|11066025|FG006|STARTED|Overall Study||19
9947329|NCT01390818|11066026|FG007|STARTED|Overall Study||14
9947330|NCT01390818|11066027|FG008|STARTED|Overall Study||3
9947331|NCT01390818|11066028|FG009|STARTED|Overall Study||3
10208377|NCT03550209|11335421|FG001|STARTED|Overall Study||12
10208378|NCT03550209|11335422|FG002|STARTED|Overall Study||13
10208379|NCT03550209|11335423|FG003|STARTED|Overall Study||35
10208380|NCT03550209|11335420|FG000|COMPLETED|Overall Study||11
10208381|NCT03550209|11335421|FG001|COMPLETED|Overall Study||9
10208382|NCT03550209|11335422|FG002|COMPLETED|Overall Study||11
10208383|NCT03550209|11335423|FG003|COMPLETED|Overall Study||31
10208384|NCT03550209|11335420|FG000|NOT COMPLETED|Overall Study||1
10208385|NCT03550209|11335421|FG001|NOT COMPLETED|Overall Study||3
10208386|NCT03550209|11335422|FG002|NOT COMPLETED|Overall Study||2
10208387|NCT03550209|11335423|FG003|NOT COMPLETED|Overall Study||4
10208388|NCT03550313|11335436|FG000|STARTED|Overall Study||192
10208389|NCT03550313|11335437|FG001|STARTED|Overall Study||187
10208390|NCT03550313|11335438|FG002|STARTED|Overall Study||186
10208391|NCT03550313|11335436|FG000|Vaccinated for Dose 1|Overall Study||171
10208392|NCT03550313|11335437|FG001|Vaccinated for Dose 1|Overall Study||147
10208393|NCT03550313|11335438|FG002|Vaccinated for Dose 1|Overall Study||166
10208394|NCT03550313|11335436|FG000|Vaccinated for Dose 2|Overall Study||159
10208395|NCT03550313|11335437|FG001|Vaccinated for Dose 2|Overall Study||135
10208396|NCT03550313|11335438|FG002|Vaccinated for Dose 2|Overall Study||153
10208397|NCT03550313|11335436|FG000|Vaccinated for Dose 3|Overall Study||151
10208398|NCT03550313|11335437|FG001|Vaccinated for Dose 3|Overall Study||127
10208399|NCT03550313|11335438|FG002|Vaccinated for Dose 3|Overall Study||146
10208400|NCT03550313|11335436|FG000|COMPLETED|Overall Study||95
10208401|NCT03550313|11335437|FG001|COMPLETED|Overall Study||77
10208402|NCT03550313|11335438|FG002|COMPLETED|Overall Study||72
10208403|NCT03550313|11335436|FG000|NOT COMPLETED|Overall Study||97
10208404|NCT03550313|11335437|FG001|NOT COMPLETED|Overall Study||110
10208405|NCT03550313|11335438|FG002|NOT COMPLETED|Overall Study||114
10208406|NCT03550378|11335449|FG000|STARTED|Overall Study||20
10208407|NCT03550378|11335450|FG001|STARTED|Overall Study||21
10208408|NCT03550378|11335449|FG000|COMPLETED|Overall Study||20
10208409|NCT03550378|11335450|FG001|COMPLETED|Overall Study||20
10208410|NCT03550378|11335449|FG000|NOT COMPLETED|Overall Study||0
10208411|NCT03550378|11335450|FG001|NOT COMPLETED|Overall Study||1
10208412|NCT03550989|11335461|FG000|STARTED|Overall Study||190
10208413|NCT03550989|11335462|FG001|STARTED|Overall Study||74
10208414|NCT03550989|11335463|FG002|STARTED|Overall Study||77
10208415|NCT03550989|11335464|FG003|STARTED|Overall Study||60
10208416|NCT03550989|11335461|FG000|COMPLETED|Overall Study||188
10208417|NCT03550989|11335462|FG001|COMPLETED|Overall Study||73
10208418|NCT03550989|11335463|FG002|COMPLETED|Overall Study||76
10208419|NCT03550989|11335464|FG003|COMPLETED|Overall Study||60
10208420|NCT03550989|11335461|FG000|NOT COMPLETED|Overall Study||2
10208421|NCT03550989|11335462|FG001|NOT COMPLETED|Overall Study||1
10208422|NCT03550989|11335463|FG002|NOT COMPLETED|Overall Study||1
10208423|NCT03550989|11335464|FG003|NOT COMPLETED|Overall Study||0
10208424|NCT03551730|11335482|FG000|STARTED|Overall Study||9
10208425|NCT03551730|11335483|FG001|STARTED|Overall Study||6
10208426|NCT03551730|11335484|FG002|STARTED|Overall Study||6
9947332|NCT01390818|11066029|FG010|STARTED|Overall Study||4
9947333|NCT01390818|11066030|FG011|STARTED|Overall Study||26
9947334|NCT01390818|11066031|FG012|STARTED|Overall Study||24
10208427|NCT03551730|11335485|FG003|STARTED|Overall Study||6
10208428|NCT03551730|11335482|FG000|COMPLETED|Overall Study||8
10208429|NCT03551730|11335483|FG001|COMPLETED|Overall Study||6
10208430|NCT03551730|11335484|FG002|COMPLETED|Overall Study||6
10208431|NCT03551730|11335485|FG003|COMPLETED|Overall Study||6
10208432|NCT03551730|11335482|FG000|NOT COMPLETED|Overall Study||1
10208433|NCT03551730|11335483|FG001|NOT COMPLETED|Overall Study||0
10208434|NCT03551730|11335484|FG002|NOT COMPLETED|Overall Study||0
10208435|NCT03551730|11335485|FG003|NOT COMPLETED|Overall Study||0
10208436|NCT03551743|11335499|FG000|STARTED|Overall Study||10
10208437|NCT03551743|11335500|FG001|STARTED|Overall Study||6
10208438|NCT03551743|11335501|FG002|STARTED|Overall Study||6
9947335|NCT01390818|11066032|FG013|STARTED|Overall Study||18
10208439|NCT03551743|11335502|FG003|STARTED|Overall Study||6
10208440|NCT03551743|11335499|FG000|COMPLETED|Overall Study||8
10208441|NCT03551743|11335500|FG001|COMPLETED|Overall Study||6
9947336|NCT01390818|11066033|FG014|STARTED|Overall Study||15
9947337|NCT01390818|11066019|FG000|COMPLETED|Overall Study||3
9947338|NCT01390818|11066020|FG001|COMPLETED|Overall Study||3
10011708|NCT01781806|11134490|FG001|Week 36|Overall Study||1
10011709|NCT01781806|11134489|FG000|Week 48|Overall Study||222
10208442|NCT03551743|11335501|FG002|COMPLETED|Overall Study||6
9947339|NCT01390818|11066021|FG002|COMPLETED|Overall Study||3
9947340|NCT01390818|11066022|FG003|COMPLETED|Overall Study||4
9947341|NCT01390818|11066023|FG004|COMPLETED|Overall Study||4
9947342|NCT01390818|11066024|FG005|COMPLETED|Overall Study||3
9947343|NCT01390818|11066025|FG006|COMPLETED|Overall Study||19
9947344|NCT01390818|11066026|FG007|COMPLETED|Overall Study||14
9947345|NCT01390818|11066027|FG008|COMPLETED|Overall Study||3
9947346|NCT01390818|11066028|FG009|COMPLETED|Overall Study||3
9947347|NCT01390818|11066029|FG010|COMPLETED|Overall Study||4
9947348|NCT01390818|11066030|FG011|COMPLETED|Overall Study||26
9947349|NCT01390818|11066031|FG012|COMPLETED|Overall Study||24
9947350|NCT01390818|11066032|FG013|COMPLETED|Overall Study||18
9947351|NCT01390818|11066033|FG014|COMPLETED|Overall Study||15
9947352|NCT01390818|11066019|FG000|NOT COMPLETED|Overall Study||0
9947353|NCT01390818|11066020|FG001|NOT COMPLETED|Overall Study||0
9947354|NCT01390818|11066021|FG002|NOT COMPLETED|Overall Study||0
9947355|NCT01390818|11066022|FG003|NOT COMPLETED|Overall Study||0
9947356|NCT01390818|11066023|FG004|NOT COMPLETED|Overall Study||0
9947357|NCT01390818|11066024|FG005|NOT COMPLETED|Overall Study||0
9947358|NCT01390818|11066025|FG006|NOT COMPLETED|Overall Study||0
9947359|NCT01390818|11066026|FG007|NOT COMPLETED|Overall Study||0
9947360|NCT01390818|11066027|FG008|NOT COMPLETED|Overall Study||0
9947361|NCT01390818|11066028|FG009|NOT COMPLETED|Overall Study||0
10011710|NCT01781806|11134490|FG001|Week 48|Overall Study||1
10208443|NCT03551743|11335502|FG003|COMPLETED|Overall Study||6
10208444|NCT03551743|11335499|FG000|NOT COMPLETED|Overall Study||2
10208445|NCT03551743|11335500|FG001|NOT COMPLETED|Overall Study||0
10208446|NCT03551743|11335501|FG002|NOT COMPLETED|Overall Study||0
10208447|NCT03551743|11335502|FG003|NOT COMPLETED|Overall Study||0
10208448|NCT03551821|11335512|FG000|STARTED|Overall Study||1
10208449|NCT03551821|11335512|FG000|COMPLETED|Overall Study||1
10208450|NCT03551821|11335512|FG000|NOT COMPLETED|Overall Study||0
10208451|NCT03552198|11335520|FG000|STARTED|Overall Study||83
10208452|NCT03552198|11335521|FG001|STARTED|Overall Study||84
10208453|NCT03552198|11335522|FG002|STARTED|Overall Study||24
10208454|NCT03552198|11335523|FG003|STARTED|Overall Study||34
10208455|NCT03552198|11335520|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34
10208456|NCT03552198|11335521|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29
10208457|NCT03552198|11335522|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7
10208458|NCT03552198|11335523|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12
10208459|NCT03552198|11335520|FG000|COMPLETED|Overall Study||34
10208460|NCT03552198|11335521|FG001|COMPLETED|Overall Study||29
10208461|NCT03552198|11335522|FG002|COMPLETED|Overall Study||7
10208462|NCT03552198|11335523|FG003|COMPLETED|Overall Study||12
10208463|NCT03552198|11335520|FG000|NOT COMPLETED|Overall Study||49
10208464|NCT03552198|11335521|FG001|NOT COMPLETED|Overall Study||55
10208465|NCT03552198|11335522|FG002|NOT COMPLETED|Overall Study||17
10208466|NCT03552198|11335523|FG003|NOT COMPLETED|Overall Study||22
10208467|NCT03552289|11335535|FG000|STARTED|Overall Study||102
10208468|NCT03552289|11335536|FG001|STARTED|Overall Study||109
10208469|NCT03552289|11335535|FG000|COMPLETED|Overall Study||101
10208470|NCT03552289|11335536|FG001|COMPLETED|Overall Study||106
10208471|NCT03552289|11335535|FG000|NOT COMPLETED|Overall Study||1
10208472|NCT03552289|11335536|FG001|NOT COMPLETED|Overall Study||3
10208473|NCT03552523|11335542|FG000|STARTED|Overall Study||5
10208474|NCT03552523|11335543|FG001|STARTED|Overall Study||2
10208475|NCT03552523|11335542|FG000|COMPLETED|Overall Study||4
10208476|NCT03552523|11335543|FG001|COMPLETED|Overall Study||1
10208477|NCT03552523|11335542|FG000|NOT COMPLETED|Overall Study||1
10208478|NCT03552523|11335543|FG001|NOT COMPLETED|Overall Study||1
10208479|NCT03552536|11335552|FG000|STARTED|Overall Study||5
10208480|NCT03552536|11335553|FG001|STARTED|Overall Study||0
10208481|NCT03552536|11335554|FG002|STARTED|Overall Study||0
10208482|NCT03552536|11335552|FG000|COMPLETED|Overall Study||5
10208483|NCT03552536|11335553|FG001|COMPLETED|Overall Study||0
10208484|NCT03552536|11335554|FG002|COMPLETED|Overall Study||0
10208485|NCT03552536|11335552|FG000|NOT COMPLETED|Overall Study||0
10208486|NCT03552536|11335553|FG001|NOT COMPLETED|Overall Study||0
10208487|NCT03552536|11335554|FG002|NOT COMPLETED|Overall Study||0
10208488|NCT03552549|11335562|FG000|STARTED|Overall Study||63
9947362|NCT01390818|11066029|FG010|NOT COMPLETED|Overall Study||0
9947363|NCT01390818|11066030|FG011|NOT COMPLETED|Overall Study||0
9947364|NCT01390818|11066031|FG012|NOT COMPLETED|Overall Study||0
9947365|NCT01390818|11066032|FG013|NOT COMPLETED|Overall Study||0
9947366|NCT01390818|11066033|FG014|NOT COMPLETED|Overall Study||0
9947367|NCT01390844|11066137|FG000|STARTED|Treatment Phase||133
10208489|NCT03552549|11335563|FG001|STARTED|Overall Study||63
10208490|NCT03552549|11335562|FG000|Treated|Overall Study||62
10208491|NCT03552549|11335563|FG001|Treated|Overall Study||62
10208492|NCT03552549|11335562|FG000|COMPLETED|Overall Study||10
10208493|NCT03552549|11335563|FG001|COMPLETED|Overall Study||11
10208494|NCT03552549|11335562|FG000|NOT COMPLETED|Overall Study||53
10208495|NCT03552549|11335563|FG001|NOT COMPLETED|Overall Study||52
9947368|NCT01390844|11066138|FG001|STARTED|Treatment Phase||65
10011711|NCT01781806|11134489|FG000|COMPLETED|Overall Study||218
10208496|NCT03552757|11335572|FG000|STARTED|Overall Study||403
9947369|NCT01390844|11066139|FG002|STARTED|Treatment Phase||57
9947370|NCT01390844|11066140|FG003|STARTED|Treatment Phase||27
9947371|NCT01390844|11066137|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133
9947372|NCT01390844|11066138|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65
9947373|NCT01390844|11066139|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47
9947374|NCT01390844|11066140|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24
9947375|NCT01390844|11066137|FG000|COMPLETED|Treatment Phase||93
9947376|NCT01390844|11066138|FG001|COMPLETED|Treatment Phase||37
9947377|NCT01390844|11066139|FG002|COMPLETED|Treatment Phase||26
9947378|NCT01390844|11066140|FG003|COMPLETED|Treatment Phase||8
9947379|NCT01390844|11066137|FG000|NOT COMPLETED|Treatment Phase||40
9947380|NCT01390844|11066138|FG001|NOT COMPLETED|Treatment Phase||28
9947381|NCT01390844|11066139|FG002|NOT COMPLETED|Treatment Phase||31
9947382|NCT01390844|11066140|FG003|NOT COMPLETED|Treatment Phase||19
9947383|NCT01390844|11066137|FG000|STARTED|Follow-Up Phase||93
10111670|NCT02497404|11242666|FG000|COMPLETED|Overall Study||39
10111671|NCT02497404|11242666|FG000|NOT COMPLETED|Overall Study||1
10111672|NCT02497469|11242672|FG000|STARTED|Overall Study||386
9947384|NCT01390844|11066138|FG001|STARTED|Follow-Up Phase||37
9947385|NCT01390844|11066139|FG002|STARTED|Follow-Up Phase||26
9947386|NCT01390844|11066140|FG003|STARTED|Follow-Up Phase||8
9947387|NCT01390844|11066137|FG000|COMPLETED|Follow-Up Phase||92
9947388|NCT01390844|11066138|FG001|COMPLETED|Follow-Up Phase||36
9947389|NCT01390844|11066139|FG002|COMPLETED|Follow-Up Phase||25
9947390|NCT01390844|11066140|FG003|COMPLETED|Follow-Up Phase||8
9947391|NCT01390844|11066137|FG000|NOT COMPLETED|Follow-Up Phase||1
9947392|NCT01390844|11066138|FG001|NOT COMPLETED|Follow-Up Phase||1
9947393|NCT01390844|11066139|FG002|NOT COMPLETED|Follow-Up Phase||1
9947394|NCT01390844|11066140|FG003|NOT COMPLETED|Follow-Up Phase||0
9947395|NCT01390857|11066150|FG000|STARTED|Overall Study||379
9947396|NCT01390857|11066150|FG000|COMPLETED|Overall Study||369
9947397|NCT01390857|11066150|FG000|NOT COMPLETED|Overall Study||10
10208497|NCT03552757|11335573|FG001|STARTED|Overall Study||404
10208498|NCT03552757|11335574|FG002|STARTED|Overall Study||403
10208499|NCT03552757|11335572|FG000|Exposed|Overall Study||402
10208500|NCT03552757|11335573|FG001|Exposed|Overall Study||403
10208501|NCT03552757|11335574|FG002|Exposed|Overall Study||402
10208502|NCT03552757|11335572|FG000|Full Analysis Set (FAS)|Overall Study||403
10208503|NCT03552757|11335573|FG001|Full Analysis Set (FAS)|Overall Study||404
10208504|NCT03552757|11335574|FG002|Full Analysis Set (FAS)|Overall Study||403
10208505|NCT03552757|11335572|FG000|Safety Analysis Set (SAS)|Overall Study||402
10208506|NCT03552757|11335573|FG001|Safety Analysis Set (SAS)|Overall Study||403
10208507|NCT03552757|11335574|FG002|Safety Analysis Set (SAS)|Overall Study||402
10208508|NCT03552757|11335572|FG000|COMPLETED|Overall Study||390
10208509|NCT03552757|11335573|FG001|COMPLETED|Overall Study||391
10208510|NCT03552757|11335574|FG002|COMPLETED|Overall Study||383
10208511|NCT03552757|11335572|FG000|NOT COMPLETED|Overall Study||13
10208512|NCT03552757|11335573|FG001|NOT COMPLETED|Overall Study||13
10208513|NCT03552757|11335574|FG002|NOT COMPLETED|Overall Study||20
10208514|NCT03553758|11335585|FG000|STARTED|Overall Study||16
10208515|NCT03553758|11335585|FG000|Completed Screening Visit|Overall Study||16
10208516|NCT03553758|11335585|FG000|COMPLETED|Overall Study||15
10208517|NCT03553758|11335585|FG000|NOT COMPLETED|Overall Study||1
10208518|NCT03553823|11335593|FG000|STARTED|Overall Study||20
10208519|NCT03553823|11335594|FG001|STARTED|Overall Study||20
10208520|NCT03553823|11335593|FG000|COMPLETED|Overall Study||20
10208521|NCT03553823|11335594|FG001|COMPLETED|Overall Study||19
10208522|NCT03553823|11335593|FG000|NOT COMPLETED|Overall Study||0
10208523|NCT03553823|11335594|FG001|NOT COMPLETED|Overall Study||1
9947398|NCT01390870|11066154|FG000|STARTED|Overall Study||400
9947399|NCT01390870|11066154|FG000|COMPLETED|Overall Study||400
9947400|NCT01390870|11066154|FG000|NOT COMPLETED|Overall Study||0
9947401|NCT01390909|11066164|FG000|STARTED|Overall Study||3454
9947402|NCT01390909|11066165|FG001|STARTED|Overall Study||3552
9947403|NCT01390909|11066166|FG002|STARTED|Overall Study||3552
9947404|NCT01390909|11066167|FG003|STARTED|Overall Study||602
10111673|NCT02497469|11242673|FG001|STARTED|Overall Study||385
10111674|NCT02497469|11242672|FG000|Safety Analysis Set|Overall Study||386
10111675|NCT02497469|11242673|FG001|Safety Analysis Set|Overall Study||383
10111676|NCT02497469|11242672|FG000|COMPLETED|Overall Study||217
10111677|NCT02497469|11242673|FG001|COMPLETED|Overall Study||270
10111678|NCT02497469|11242672|FG000|NOT COMPLETED|Overall Study||169
10111679|NCT02497469|11242673|FG001|NOT COMPLETED|Overall Study||115
10111680|NCT02497755|11242681|FG000|STARTED|Overall Study||18
10111681|NCT02497755|11242682|FG001|STARTED|Overall Study||1
10111682|NCT02497755|11242681|FG000|COMPLETED|Overall Study||17
10111683|NCT02497755|11242682|FG001|COMPLETED|Overall Study||1
9947405|NCT01390909|11066168|FG004|STARTED|Overall Study||613
9947406|NCT01390909|11066169|FG005|STARTED|Overall Study||613
9947407|NCT01390909|11066164|FG000|Participants in Subgroup|Overall Study||0
10111684|NCT02497755|11242681|FG000|NOT COMPLETED|Overall Study||1
10208524|NCT03553940|11335602|FG000|STARTED|Overall Study||22
10208525|NCT03553940|11335603|FG001|STARTED|Overall Study||21
10208526|NCT03553940|11335602|FG000|COMPLETED|Overall Study||22
10208527|NCT03553940|11335603|FG001|COMPLETED|Overall Study||21
10208528|NCT03553940|11335602|FG000|NOT COMPLETED|Overall Study||0
9947408|NCT01390909|11066165|FG001|Participants in Subgroup|Overall Study||3454
9947409|NCT01390909|11066166|FG002|Participants in Subgroup|Overall Study||0
10208529|NCT03553940|11335603|FG001|NOT COMPLETED|Overall Study||0
10208530|NCT03554005|11335615|FG000|STARTED|Overall Study||1
9947410|NCT01390909|11066167|FG003|Participants in Subgroup|Overall Study||0
9947411|NCT01390909|11066168|FG004|Participants in Subgroup|Overall Study||602
9947412|NCT01390909|11066169|FG005|Participants in Subgroup|Overall Study||0
9947413|NCT01390909|11066164|FG000|COMPLETED|Overall Study||3454
9947414|NCT01390909|11066165|FG001|COMPLETED|Overall Study||3552
10208531|NCT03554005|11335616|FG001|STARTED|Overall Study||2
10208532|NCT03554005|11335617|FG002|STARTED|Overall Study||2
10208533|NCT03554005|11335618|FG003|STARTED|Overall Study||2
10208534|NCT03554005|11335619|FG004|STARTED|Overall Study||11
10208535|NCT03554005|11335620|FG005|STARTED|Overall Study||11
10208536|NCT03554005|11335615|FG000|COMPLETED|Overall Study||0
10208537|NCT03554005|11335616|FG001|COMPLETED|Overall Study||1
10208538|NCT03554005|11335617|FG002|COMPLETED|Overall Study||1
10208539|NCT03554005|11335618|FG003|COMPLETED|Overall Study||1
10208540|NCT03554005|11335619|FG004|COMPLETED|Overall Study||5
10208541|NCT03554005|11335620|FG005|COMPLETED|Overall Study||0
10208542|NCT03554005|11335615|FG000|NOT COMPLETED|Overall Study||1
10208543|NCT03554005|11335616|FG001|NOT COMPLETED|Overall Study||1
10208544|NCT03554005|11335617|FG002|NOT COMPLETED|Overall Study||1
10208545|NCT03554005|11335618|FG003|NOT COMPLETED|Overall Study||1
10208546|NCT03554005|11335619|FG004|NOT COMPLETED|Overall Study||6
10208547|NCT03554005|11335620|FG005|NOT COMPLETED|Overall Study||11
10208548|NCT03554018|11335636|FG000|STARTED|Overall Study||60
10208549|NCT03554018|11335637|FG001|STARTED|Overall Study||60
10208550|NCT03554018|11335636|FG000|COMPLETED|Overall Study||57
10208551|NCT03554018|11335637|FG001|COMPLETED|Overall Study||53
10208552|NCT03554018|11335636|FG000|NOT COMPLETED|Overall Study||3
10208553|NCT03554018|11335637|FG001|NOT COMPLETED|Overall Study||7
10208554|NCT03554486|11335645|FG000|STARTED|Run-in Period (2 Weeks)||24
10208555|NCT03554486|11335646|FG001|STARTED|Run-in Period (2 Weeks)||0
10208556|NCT03554486|11335647|FG002|STARTED|Run-in Period (2 Weeks)||0
10208557|NCT03554486|11335645|FG000|COMPLETED|Run-in Period (2 Weeks)||21
10208558|NCT03554486|11335646|FG001|COMPLETED|Run-in Period (2 Weeks)||0
10208559|NCT03554486|11335647|FG002|COMPLETED|Run-in Period (2 Weeks)||0
10208560|NCT03554486|11335645|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3
10208561|NCT03554486|11335646|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
10208562|NCT03554486|11335647|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
10208563|NCT03554486|11335645|FG000|STARTED|Treatment Period 1 (2 Weeks)||0
10208564|NCT03554486|11335646|FG001|STARTED|Treatment Period 1 (2 Weeks)||11
10208565|NCT03554486|11335647|FG002|STARTED|Treatment Period 1 (2 Weeks)||10
10208566|NCT03554486|11335645|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0
10208567|NCT03554486|11335646|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10
10208568|NCT03554486|11335647|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9
10208569|NCT03554486|11335645|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10208570|NCT03554486|11335646|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
10208571|NCT03554486|11335647|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
10208572|NCT03554486|11335645|FG000|STARTED|Treatment Period 2 (2 Weeks)||0
10208573|NCT03554486|11335646|FG001|STARTED|Treatment Period 2 (2 Weeks)||10
10208574|NCT03554486|11335647|FG002|STARTED|Treatment Period 2 (2 Weeks)||9
10208575|NCT03554486|11335645|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0
10208576|NCT03554486|11335646|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10
10208577|NCT03554486|11335647|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9
10208578|NCT03554486|11335645|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10208579|NCT03554486|11335646|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10208580|NCT03554486|11335647|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10208581|NCT03554629|11335654|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
10208582|NCT03554629|11335654|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
10208583|NCT03554629|11335654|FG000|NOT COMPLETED|Overall Study||6
10208584|NCT03554746|11335684|FG000|STARTED|Overall Study||24
10208585|NCT03554746|11335685|FG001|STARTED|Overall Study||24
10208586|NCT03554746|11335684|FG000|COMPLETED|Overall Study||24
10208587|NCT03554746|11335685|FG001|COMPLETED|Overall Study||24
10208588|NCT03554746|11335684|FG000|NOT COMPLETED|Overall Study||0
10208589|NCT03554746|11335685|FG001|NOT COMPLETED|Overall Study||0
10208590|NCT03554772|11335695|FG000|STARTED|Overall Study||30
10208591|NCT03554772|11335696|FG001|STARTED|Overall Study||30
10208592|NCT03554772|11335697|FG002|STARTED|Overall Study||29
10208593|NCT03554772|11335698|FG003|STARTED|Overall Study||31
10208594|NCT03554772|11335695|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
10208595|NCT03554772|11335696|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
9947415|NCT01390909|11066166|FG002|COMPLETED|Overall Study||3552
9947416|NCT01390909|11066167|FG003|COMPLETED|Overall Study||602
9947417|NCT01390909|11066168|FG004|COMPLETED|Overall Study||613
9947418|NCT01390909|11066169|FG005|COMPLETED|Overall Study||613
10208596|NCT03554772|11335697|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
9947419|NCT01390909|11066164|FG000|NOT COMPLETED|Overall Study||0
10208597|NCT03554772|11335698|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
10208598|NCT03554772|11335695|FG000|COMPLETED|Overall Study||30
10208599|NCT03554772|11335696|FG001|COMPLETED|Overall Study||30
10208600|NCT03554772|11335697|FG002|COMPLETED|Overall Study||29
10208601|NCT03554772|11335698|FG003|COMPLETED|Overall Study||29
10208602|NCT03554772|11335695|FG000|NOT COMPLETED|Overall Study||0
10208603|NCT03554772|11335696|FG001|NOT COMPLETED|Overall Study||0
10208604|NCT03554772|11335697|FG002|NOT COMPLETED|Overall Study||0
9947420|NCT01390909|11066165|FG001|NOT COMPLETED|Overall Study||0
9947421|NCT01390909|11066166|FG002|NOT COMPLETED|Overall Study||0
9947422|NCT01390909|11066167|FG003|NOT COMPLETED|Overall Study||0
9947423|NCT01390909|11066168|FG004|NOT COMPLETED|Overall Study||0
9947424|NCT01390909|11066169|FG005|NOT COMPLETED|Overall Study||0
9947425|NCT01390948|11066190|FG000|STARTED|Overall Study||59
10208605|NCT03554772|11335698|FG003|NOT COMPLETED|Overall Study||2
10208606|NCT03554954|11335708|FG000|STARTED|Overall Study||108
10208607|NCT03554954|11335708|FG000|COMPLETED|Overall Study||108
10208608|NCT03554954|11335708|FG000|NOT COMPLETED|Overall Study||0
10208609|NCT03555266|11335718|FG000|STARTED|Overall Study||32
10208610|NCT03555266|11335719|FG001|STARTED|Overall Study||31
10208611|NCT03555266|11335718|FG000|COMPLETED|Overall Study||26
10208612|NCT03555266|11335719|FG001|COMPLETED|Overall Study||27
10208613|NCT03555266|11335718|FG000|NOT COMPLETED|Overall Study||6
10208614|NCT03555266|11335719|FG001|NOT COMPLETED|Overall Study||4
10208615|NCT03555305|11335725|FG000|STARTED|Period 1||29
10208616|NCT03555305|11335726|FG001|STARTED|Period 1||29
10208617|NCT03555305|11335725|FG000|Received at Least 1 Dose of Study Drug|Period 1||29
10208618|NCT03555305|11335726|FG001|Received at Least 1 Dose of Study Drug|Period 1||29
10208619|NCT03555305|11335725|FG000|COMPLETED|Period 1||29
10208620|NCT03555305|11335726|FG001|COMPLETED|Period 1||27
10208621|NCT03555305|11335725|FG000|NOT COMPLETED|Period 1||0
10208622|NCT03555305|11335726|FG001|NOT COMPLETED|Period 1||2
10208623|NCT03555305|11335725|FG000|STARTED|Period 2||29
10208624|NCT03555305|11335726|FG001|STARTED|Period 2||27
10208625|NCT03555305|11335725|FG000|COMPLETED|Period 2||29
10208626|NCT03555305|11335726|FG001|COMPLETED|Period 2||27
10208627|NCT03555305|11335725|FG000|NOT COMPLETED|Period 2||0
10208628|NCT03555305|11335726|FG001|NOT COMPLETED|Period 2||0
10208629|NCT03555435|11335735|FG000|STARTED|Overall Study||28
10208630|NCT03555435|11335736|FG001|STARTED|Overall Study||27
10208631|NCT03555435|11335737|FG002|STARTED|Overall Study||26
10208632|NCT03555435|11335735|FG000|COMPLETED|Overall Study||11
10208633|NCT03555435|11335736|FG001|COMPLETED|Overall Study||8
10208634|NCT03555435|11335737|FG002|COMPLETED|Overall Study||18
10208635|NCT03555435|11335735|FG000|NOT COMPLETED|Overall Study||17
10208636|NCT03555435|11335736|FG001|NOT COMPLETED|Overall Study||19
10208637|NCT03555435|11335737|FG002|NOT COMPLETED|Overall Study||8
10208638|NCT03555565|11335745|FG000|STARTED|Overall Study||1026
10208639|NCT03555565|11335745|FG000|COMPLETED|Overall Study||1011
10208640|NCT03555565|11335745|FG000|NOT COMPLETED|Overall Study||15
10208641|NCT03555890|11335753|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12
10208642|NCT03555890|11335754|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12
10208643|NCT03555890|11335755|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0
10208644|NCT03555890|11335756|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0
10208645|NCT03555890|11335753|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
10208646|NCT03555890|11335754|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
10208647|NCT03555890|11335755|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10208648|NCT03555890|11335756|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10208649|NCT03555890|11335753|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10208650|NCT03555890|11335754|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10208651|NCT03555890|11335755|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10208652|NCT03555890|11335756|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10208653|NCT03555890|11335753|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12
10208654|NCT03555890|11335754|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12
10208655|NCT03555890|11335755|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0
10208656|NCT03555890|11335756|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0
10208657|NCT03555890|11335753|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
10208658|NCT03555890|11335754|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
10208659|NCT03555890|11335755|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10208660|NCT03555890|11335756|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10208661|NCT03555890|11335753|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10208662|NCT03555890|11335754|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10208663|NCT03555890|11335755|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10208664|NCT03555890|11335756|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10208665|NCT03555890|11335753|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12
10208666|NCT03555890|11335754|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12
10208667|NCT03555890|11335755|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0
10208668|NCT03555890|11335756|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0
10208669|NCT03555890|11335753|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
10208670|NCT03555890|11335754|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
10208671|NCT03555890|11335755|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
9947426|NCT01390948|11066191|FG001|STARTED|Overall Study||62
10208672|NCT03555890|11335756|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10208673|NCT03555890|11335753|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10208674|NCT03555890|11335754|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10208675|NCT03555890|11335755|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10208676|NCT03555890|11335756|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10208677|NCT03555890|11335753|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0
10208678|NCT03555890|11335754|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0
9947427|NCT01390948|11066192|FG002|STARTED|Overall Study||3
10208679|NCT03555890|11335755|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24
10208680|NCT03555890|11335756|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24
9947428|NCT01390948|11066190|FG000|Treated|Overall Study||56
9947429|NCT01390948|11066191|FG001|Treated|Overall Study||60
9947430|NCT01390948|11066192|FG002|Treated|Overall Study||3
9947431|NCT01390948|11066190|FG000|COMPLETED|Overall Study||44
9947432|NCT01390948|11066191|FG001|COMPLETED|Overall Study||44
9947433|NCT01390948|11066192|FG002|COMPLETED|Overall Study||2
9947434|NCT01390948|11066190|FG000|NOT COMPLETED|Overall Study||15
10208681|NCT03555890|11335753|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10208682|NCT03555890|11335754|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10208683|NCT03555890|11335755|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
10208684|NCT03555890|11335756|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
10208685|NCT03555890|11335753|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10208686|NCT03555890|11335754|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10208687|NCT03555890|11335755|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10208688|NCT03555890|11335756|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10208689|NCT03555890|11335753|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0
10208690|NCT03555890|11335754|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0
10208691|NCT03555890|11335755|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24
10208692|NCT03555890|11335756|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24
10208693|NCT03555890|11335753|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10208694|NCT03555890|11335754|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10208695|NCT03555890|11335755|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
10208696|NCT03555890|11335756|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
10208697|NCT03555890|11335753|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10208698|NCT03555890|11335754|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10208699|NCT03555890|11335755|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10208700|NCT03555890|11335756|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
10208701|NCT03555890|11335753|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0
10208702|NCT03555890|11335754|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0
10208703|NCT03555890|11335755|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24
10208704|NCT03555890|11335756|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23
10208705|NCT03555890|11335753|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10208706|NCT03555890|11335754|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10208707|NCT03555890|11335755|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
10208708|NCT03555890|11335756|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
10208709|NCT03555890|11335753|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10208710|NCT03555890|11335754|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10208711|NCT03555890|11335755|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10208712|NCT03555890|11335756|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10208713|NCT03556579|11335766|FG000|STARTED|Visit 1||16
10208714|NCT03556579|11335767|FG001|STARTED|Visit 1||14
10208715|NCT03556579|11335768|FG002|STARTED|Visit 1||14
10208716|NCT03556579|11335769|FG003|STARTED|Visit 1||16
10208717|NCT03556579|11335766|FG000|COMPLETED|Visit 1||16
10208718|NCT03556579|11335767|FG001|COMPLETED|Visit 1||14
10208719|NCT03556579|11335768|FG002|COMPLETED|Visit 1||14
10208720|NCT03556579|11335769|FG003|COMPLETED|Visit 1||16
10208721|NCT03556579|11335766|FG000|NOT COMPLETED|Visit 1||0
10208722|NCT03556579|11335767|FG001|NOT COMPLETED|Visit 1||0
10208723|NCT03556579|11335768|FG002|NOT COMPLETED|Visit 1||0
10208724|NCT03556579|11335769|FG003|NOT COMPLETED|Visit 1||0
10208725|NCT03556579|11335766|FG000|STARTED|Visit 2||16
10208726|NCT03556579|11335767|FG001|STARTED|Visit 2||14
10208727|NCT03556579|11335768|FG002|STARTED|Visit 2||14
10208728|NCT03556579|11335769|FG003|STARTED|Visit 2||16
10208729|NCT03556579|11335766|FG000|COMPLETED|Visit 2||16
10208730|NCT03556579|11335767|FG001|COMPLETED|Visit 2||14
10208731|NCT03556579|11335768|FG002|COMPLETED|Visit 2||14
10208732|NCT03556579|11335769|FG003|COMPLETED|Visit 2||16
10208733|NCT03556579|11335766|FG000|NOT COMPLETED|Visit 2||0
10208734|NCT03556579|11335767|FG001|NOT COMPLETED|Visit 2||0
10208735|NCT03556579|11335768|FG002|NOT COMPLETED|Visit 2||0
10208736|NCT03556579|11335769|FG003|NOT COMPLETED|Visit 2||0
10208737|NCT03556761|11335781|FG000|STARTED|Overall Study||192
10208738|NCT03556761|11335782|FG001|STARTED|Overall Study||192
10208739|NCT03556761|11335781|FG000|COMPLETED|Overall Study||168
10208740|NCT03556761|11335782|FG001|COMPLETED|Overall Study||163
10208741|NCT03556761|11335781|FG000|NOT COMPLETED|Overall Study||24
10208742|NCT03556761|11335782|FG001|NOT COMPLETED|Overall Study||29
10208743|NCT03556891|11335788|FG000|STARTED|Overall Study||133
9947435|NCT01390948|11066191|FG001|NOT COMPLETED|Overall Study||18
9947436|NCT01390948|11066192|FG002|NOT COMPLETED|Overall Study||1
10208744|NCT03556891|11335788|FG000|COMPLETED|Overall Study||120
10208745|NCT03556891|11335788|FG000|NOT COMPLETED|Overall Study||13
10208746|NCT03557034|11335794|FG000|STARTED|Overall Study||49
10208747|NCT03557034|11335795|FG001|STARTED|Overall Study||51
10208748|NCT03557034|11335794|FG000|Randomization|Overall Study||49
10208749|NCT03557034|11335795|FG001|Randomization|Overall Study||51
10208750|NCT03557034|11335794|FG000|COMPLETED|Overall Study||48
10208751|NCT03557034|11335795|FG001|COMPLETED|Overall Study||51
10208752|NCT03557034|11335794|FG000|NOT COMPLETED|Overall Study||1
10208753|NCT03557034|11335795|FG001|NOT COMPLETED|Overall Study||0
10208754|NCT03557086|11335803|FG000|STARTED|Overall Study||26
10208755|NCT03557086|11335804|FG001|STARTED|Overall Study||24
10208756|NCT03557086|11335803|FG000|COMPLETED|Overall Study||26
9947437|NCT01391000|11066201|FG000|STARTED|Overall Study||35
9947438|NCT01391000|11066202|FG001|STARTED|Overall Study||35
9947439|NCT01391000|11066201|FG000|COMPLETED|Overall Study||33
9947440|NCT01391000|11066202|FG001|COMPLETED|Overall Study||35
9947441|NCT01391000|11066201|FG000|NOT COMPLETED|Overall Study||2
9947442|NCT01391000|11066202|FG001|NOT COMPLETED|Overall Study||0
9947443|NCT01391013|11066210|FG000|STARTED|Overall Study||15
9947444|NCT01391013|11066211|FG001|STARTED|Overall Study||15
9947445|NCT01391013|11066210|FG000|COMPLETED|Overall Study||15
9947446|NCT01391013|11066211|FG001|COMPLETED|Overall Study||15
9947447|NCT01391013|11066210|FG000|NOT COMPLETED|Overall Study||0
9947448|NCT01391013|11066211|FG001|NOT COMPLETED|Overall Study||0
9947449|NCT01391130|11066219|FG000|STARTED|Overall Study||73
9947450|NCT01391130|11066220|FG001|STARTED|Overall Study||37
9947451|NCT01391130|11066219|FG000|Received At Least One Dose of Study Drug|Overall Study||72
9947452|NCT01391130|11066220|FG001|Received At Least One Dose of Study Drug|Overall Study||36
9947453|NCT01391130|11066219|FG000|COMPLETED|Overall Study||67
9947454|NCT01391130|11066220|FG001|COMPLETED|Overall Study||31
9947455|NCT01391130|11066219|FG000|NOT COMPLETED|Overall Study||6
9947456|NCT01391130|11066220|FG001|NOT COMPLETED|Overall Study||6
9947457|NCT01391273|11066228|FG000|STARTED|Overall Study||88
10208757|NCT03557086|11335804|FG001|COMPLETED|Overall Study||24
10208758|NCT03557086|11335803|FG000|NOT COMPLETED|Overall Study||0
10208759|NCT03557086|11335804|FG001|NOT COMPLETED|Overall Study||0
10208760|NCT03557125|11335814|FG000|STARTED|Overall Study||22
10208761|NCT03557125|11335815|FG001|STARTED|Overall Study||24
10208762|NCT03557125|11335814|FG000|COMPLETED|Overall Study||22
10208763|NCT03557125|11335815|FG001|COMPLETED|Overall Study||24
10208764|NCT03557125|11335814|FG000|NOT COMPLETED|Overall Study||0
10208765|NCT03557125|11335815|FG001|NOT COMPLETED|Overall Study||0
10208766|NCT03557333|11335821|FG000|STARTED|Overall Study||354
10208767|NCT03557333|11335821|FG000|COMPLETED|Overall Study||262
10208768|NCT03557333|11335821|FG000|NOT COMPLETED|Overall Study||92
10208769|NCT03557372|11335827|FG000|STARTED|Overall Study||14
10208770|NCT03557372|11335827|FG000|COMPLETED|Overall Study||14
10208771|NCT03557372|11335827|FG000|NOT COMPLETED|Overall Study||0
10208772|NCT03557476|11335833|FG000|STARTED|Overall Study||13
10208773|NCT03557476|11335834|FG001|STARTED|Overall Study||13
10208774|NCT03557476|11335833|FG000|COMPLETED|Overall Study||13
10208775|NCT03557476|11335834|FG001|COMPLETED|Overall Study||13
10208776|NCT03557476|11335833|FG000|NOT COMPLETED|Overall Study||0
10208777|NCT03557476|11335834|FG001|NOT COMPLETED|Overall Study||0
10208778|NCT03557658|11335842|FG000|STARTED|Overall Study||8
10208779|NCT03557658|11335843|FG001|STARTED|Overall Study||8
10208780|NCT03557658|11335842|FG000|COMPLETED|Overall Study||8
10208781|NCT03557658|11335843|FG001|COMPLETED|Overall Study||8
10208782|NCT03557658|11335842|FG000|NOT COMPLETED|Overall Study||0
10208783|NCT03557658|11335843|FG001|NOT COMPLETED|Overall Study||0
10208784|NCT03557775|11335852|FG000|STARTED|Overall Study||5
10208785|NCT03557775|11335853|FG001|STARTED|Overall Study||7
10208786|NCT03557775|11335854|FG002|STARTED|Overall Study||8
10208787|NCT03557775|11335852|FG000|COMPLETED|Overall Study||4
10208788|NCT03557775|11335853|FG001|COMPLETED|Overall Study||4
10208789|NCT03557775|11335854|FG002|COMPLETED|Overall Study||4
10208790|NCT03557775|11335852|FG000|NOT COMPLETED|Overall Study||1
10208791|NCT03557775|11335853|FG001|NOT COMPLETED|Overall Study||3
10208792|NCT03557775|11335854|FG002|NOT COMPLETED|Overall Study||4
10208793|NCT03557801|11335865|FG000|STARTED|Overall Study||34
10208794|NCT03557801|11335866|FG001|STARTED|Overall Study||33
10208795|NCT03557801|11335867|FG002|STARTED|Overall Study||33
10208796|NCT03557801|11335865|FG000|COMPLETED|Overall Study||32
10208797|NCT03557801|11335866|FG001|COMPLETED|Overall Study||32
10208798|NCT03557801|11335867|FG002|COMPLETED|Overall Study||30
10208799|NCT03557801|11335865|FG000|NOT COMPLETED|Overall Study||2
10208800|NCT03557801|11335866|FG001|NOT COMPLETED|Overall Study||1
10208801|NCT03557801|11335867|FG002|NOT COMPLETED|Overall Study||3
10208802|NCT03558061|11335875|FG000|STARTED|Overall Study||30
10208803|NCT03558061|11335875|FG000|COMPLETED|Overall Study||29
10208804|NCT03558061|11335875|FG000|NOT COMPLETED|Overall Study||1
10208805|NCT03558074|11335879|FG000|STARTED|Overall Study||26
10208806|NCT03558074|11335879|FG000|COMPLETED|Overall Study||24
10208807|NCT03558074|11335879|FG000|NOT COMPLETED|Overall Study||2
10208808|NCT03558230|11335886|FG000|STARTED|Overall Study||7
10208809|NCT03558230|11335887|FG001|STARTED|Overall Study||6
10208810|NCT03558230|11335886|FG000|COMPLETED|Overall Study||7
10208811|NCT03558230|11335887|FG001|COMPLETED|Overall Study||6
9947458|NCT01391273|11066229|FG001|STARTED|Overall Study||85
10208812|NCT03558230|11335886|FG000|NOT COMPLETED|Overall Study||0
10208813|NCT03558230|11335887|FG001|NOT COMPLETED|Overall Study||0
9947459|NCT01391273|11066228|FG000|COMPLETED|Overall Study||84
9947460|NCT01391273|11066229|FG001|COMPLETED|Overall Study||83
10208814|NCT03558516|11335895|FG000|STARTED|Overall Study||40
10208815|NCT03558516|11335896|FG001|STARTED|Overall Study||40
10208816|NCT03558516|11335895|FG000|COMPLETED|Overall Study||38
10208817|NCT03558516|11335896|FG001|COMPLETED|Overall Study||38
10208818|NCT03558516|11335895|FG000|NOT COMPLETED|Overall Study||2
10208819|NCT03558516|11335896|FG001|NOT COMPLETED|Overall Study||2
10208820|NCT03558555|11335904|FG000|STARTED|Overall Study||58
10208821|NCT03558555|11335905|FG001|STARTED|Overall Study||45
10208822|NCT03558555|11335904|FG000|COMPLETED|Overall Study||56
10208823|NCT03558555|11335905|FG001|COMPLETED|Overall Study||44
10208824|NCT03558555|11335904|FG000|NOT COMPLETED|Overall Study||2
10208825|NCT03558555|11335905|FG001|NOT COMPLETED|Overall Study||1
10208826|NCT03558672|11335911|FG000|STARTED|Overall Study||18
10208827|NCT03558672|11335911|FG000|COMPLETED|Overall Study||8
9947461|NCT01391273|11066228|FG000|NOT COMPLETED|Overall Study||4
9947462|NCT01391273|11066229|FG001|NOT COMPLETED|Overall Study||2
9947463|NCT01391286|11066237|FG000|STARTED|Overall Study||18
9947464|NCT01391286|11066238|FG001|STARTED|Overall Study||18
9947465|NCT01391286|11066237|FG000|COMPLETED|Overall Study||18
9947466|NCT01391286|11066238|FG001|COMPLETED|Overall Study||18
9947467|NCT01391286|11066237|FG000|NOT COMPLETED|Overall Study||0
9947468|NCT01391286|11066238|FG001|NOT COMPLETED|Overall Study||0
9947469|NCT01391299|11066247|FG000|STARTED|Overall Study||57
9947470|NCT01391299|11066248|FG001|STARTED|Overall Study||60
9947471|NCT01391299|11066249|FG002|STARTED|Overall Study||58
9947472|NCT01391299|11066247|FG000|COMPLETED|Overall Study||57
9947473|NCT01391299|11066248|FG001|COMPLETED|Overall Study||59
9947474|NCT01391299|11066249|FG002|COMPLETED|Overall Study||56
9947475|NCT01391299|11066247|FG000|NOT COMPLETED|Overall Study||0
9947476|NCT01391299|11066248|FG001|NOT COMPLETED|Overall Study||1
9947477|NCT01391299|11066249|FG002|NOT COMPLETED|Overall Study||2
9947478|NCT01391312|11066259|FG000|STARTED|Overall Study||20
9947479|NCT01391312|11066260|FG001|STARTED|Overall Study||20
9947480|NCT01391312|11066259|FG000|COMPLETED|Overall Study||18
9947481|NCT01391312|11066260|FG001|COMPLETED|Overall Study||19
9947482|NCT01391312|11066259|FG000|NOT COMPLETED|Overall Study||2
9947483|NCT01391312|11066260|FG001|NOT COMPLETED|Overall Study||1
9947484|NCT01391325|11066266|FG000|STARTED|Overall Study||1732
9947485|NCT01391325|11066266|FG000|COMPLETED|Overall Study||1238
9947486|NCT01391325|11066266|FG000|NOT COMPLETED|Overall Study||494
9947487|NCT01391364|11066272|FG000|STARTED|Overall Study||222
9947488|NCT01391364|11066273|FG001|STARTED|Overall Study||216
9947489|NCT01391364|11066272|FG000|COMPLETED|Overall Study||217
9947490|NCT01391364|11066273|FG001|COMPLETED|Overall Study||214
9947491|NCT01391364|11066272|FG000|NOT COMPLETED|Overall Study||5
9947492|NCT01391364|11066273|FG001|NOT COMPLETED|Overall Study||2
9947493|NCT01391468|11066281|FG000|STARTED|Overall Study||24
9947494|NCT01391468|11066282|FG001|STARTED|Overall Study||23
9947495|NCT01391468|11066281|FG000|COMPLETED|Overall Study||18
9947496|NCT01391468|11066282|FG001|COMPLETED|Overall Study||21
9947497|NCT01391468|11066281|FG000|NOT COMPLETED|Overall Study||6
9947498|NCT01391468|11066282|FG001|NOT COMPLETED|Overall Study||2
9947499|NCT01391507|11066297|FG000|STARTED|Overall Study||10
9947500|NCT01391507|11066298|FG001|STARTED|Overall Study||8
9947501|NCT01391507|11066299|FG002|STARTED|Overall Study||6
9947502|NCT01391507|11066300|FG003|STARTED|Overall Study||12
9947503|NCT01391507|11066297|FG000|COMPLETED|Overall Study||6
9947504|NCT01391507|11066298|FG001|COMPLETED|Overall Study||4
9947505|NCT01391507|11066299|FG002|COMPLETED|Overall Study||2
9947506|NCT01391507|11066300|FG003|COMPLETED|Overall Study||5
9947507|NCT01391507|11066297|FG000|NOT COMPLETED|Overall Study||4
9947508|NCT01391507|11066298|FG001|NOT COMPLETED|Overall Study||4
9947509|NCT01391507|11066299|FG002|NOT COMPLETED|Overall Study||4
9947510|NCT01391507|11066300|FG003|NOT COMPLETED|Overall Study||7
9947511|NCT01391546|11066312|FG000|STARTED|Overall Study||177
9947512|NCT01391546|11066313|FG001|STARTED|Overall Study||177
9947513|NCT01391546|11066312|FG000|Vaccinated|Overall Study||176
9947514|NCT01391546|11066313|FG001|Vaccinated|Overall Study||177
9947515|NCT01391546|11066312|FG000|COMPLETED|Overall Study||176
9947516|NCT01391546|11066313|FG001|COMPLETED|Overall Study||177
9947517|NCT01391546|11066312|FG000|NOT COMPLETED|Overall Study||1
9947518|NCT01391546|11066313|FG001|NOT COMPLETED|Overall Study||0
9947519|NCT01391559|11066320|FG000|STARTED|First Intervention||10
9947520|NCT01391559|11066321|FG001|STARTED|First Intervention||10
9947521|NCT01391559|11066320|FG000|COMPLETED|First Intervention||10
9947522|NCT01391559|11066321|FG001|COMPLETED|First Intervention||10
9947523|NCT01391559|11066320|FG000|NOT COMPLETED|First Intervention||0
9947524|NCT01391559|11066321|FG001|NOT COMPLETED|First Intervention||0
9947525|NCT01391559|11066320|FG000|STARTED|Second Intervention||10
9947526|NCT01391559|11066321|FG001|STARTED|Second Intervention||10
9947527|NCT01391559|11066320|FG000|COMPLETED|Second Intervention||10
9947528|NCT01391559|11066321|FG001|COMPLETED|Second Intervention||10
9947529|NCT01391559|11066320|FG000|NOT COMPLETED|Second Intervention||0
9947530|NCT01391559|11066321|FG001|NOT COMPLETED|Second Intervention||0
9947531|NCT01391611|11066327|FG000|STARTED|Overall Study||25
9947532|NCT01391611|11066327|FG000|COMPLETED|Overall Study||3
9947533|NCT01391611|11066327|FG000|NOT COMPLETED|Overall Study||22
9947534|NCT01391663|11066335|FG000|STARTED|Overall Study||12
9947535|NCT01391663|11066336|FG001|STARTED|Overall Study||12
9947536|NCT01391663|11066337|FG002|STARTED|Overall Study||12
9947537|NCT01391663|11066338|FG003|STARTED|Overall Study||12
9947538|NCT01391663|11066335|FG000|COMPLETED|Overall Study||12
9947539|NCT01391663|11066336|FG001|COMPLETED|Overall Study||12
9947540|NCT01391663|11066337|FG002|COMPLETED|Overall Study||11
9947541|NCT01391663|11066338|FG003|COMPLETED|Overall Study||12
9947542|NCT01391663|11066335|FG000|NOT COMPLETED|Overall Study||0
9947543|NCT01391663|11066336|FG001|NOT COMPLETED|Overall Study||0
9947544|NCT01391663|11066337|FG002|NOT COMPLETED|Overall Study||1
9947545|NCT01391663|11066338|FG003|NOT COMPLETED|Overall Study||0
9947546|NCT01391793|11066350|FG000|STARTED|Overall Study||271
9947547|NCT01391793|11066351|FG001|STARTED|Overall Study||275
9947548|NCT01391793|11066350|FG000|Had a Positive Urine Culture|Overall Study||197
9947549|NCT01391793|11066351|FG001|Had a Positive Urine Culture|Overall Study||188
9947550|NCT01391793|11066350|FG000|COMPLETED|Overall Study||124
9947551|NCT01391793|11066351|FG001|COMPLETED|Overall Study||131
9947552|NCT01391793|11066350|FG000|NOT COMPLETED|Overall Study||147
9947553|NCT01391793|11066351|FG001|NOT COMPLETED|Overall Study||144
9947554|NCT01391819|11066357|FG000|STARTED|Overall Study||2116
9947555|NCT01391819|11066357|FG000|COMPLETED|Overall Study||1714
9947556|NCT01391819|11066357|FG000|NOT COMPLETED|Overall Study||402
9947557|NCT01391832|11066366|FG000|STARTED|Overall Study||49
9947558|NCT01391832|11066367|FG001|STARTED|Overall Study||54
9947559|NCT01391832|11066366|FG000|1 Month Follow-Up|Overall Study||30
9947560|NCT01391832|11066367|FG001|1 Month Follow-Up|Overall Study||31
9947561|NCT01391832|11066366|FG000|3 Month Follow-Up|Overall Study||28
9947562|NCT01391832|11066367|FG001|3 Month Follow-Up|Overall Study||29
9947563|NCT01391832|11066366|FG000|COMPLETED|Overall Study||28
9947564|NCT01391832|11066367|FG001|COMPLETED|Overall Study||31
9947565|NCT01391832|11066366|FG000|NOT COMPLETED|Overall Study||21
9947566|NCT01391832|11066367|FG001|NOT COMPLETED|Overall Study||23
9947567|NCT01391858|11066375|FG000|STARTED|Overall Study||25
9947568|NCT01391858|11066376|FG001|STARTED|Overall Study||24
9947569|NCT01391858|11066375|FG000|COMPLETED|Overall Study||23
9947570|NCT01391858|11066376|FG001|COMPLETED|Overall Study||24
9947571|NCT01391858|11066375|FG000|NOT COMPLETED|Overall Study||2
9947572|NCT01391858|11066376|FG001|NOT COMPLETED|Overall Study||0
9947573|NCT01392053|11066384|FG000|STARTED|Overall Study||23
9947574|NCT01392053|11066385|FG001|STARTED|Overall Study||23
9947575|NCT01392053|11066384|FG000|COMPLETED|Overall Study||23
9947576|NCT01392053|11066385|FG001|COMPLETED|Overall Study||23
9947577|NCT01392053|11066384|FG000|NOT COMPLETED|Overall Study||0
10011712|NCT01781806|11134490|FG001|COMPLETED|Overall Study||1
10011713|NCT01781806|11134489|FG000|NOT COMPLETED|Overall Study||79
10011714|NCT01781806|11134490|FG001|NOT COMPLETED|Overall Study||3
9947578|NCT01392053|11066385|FG001|NOT COMPLETED|Overall Study||0
9947579|NCT01392183|11066393|FG000|STARTED|First Drug Administration||35
9947580|NCT01392183|11066394|FG001|STARTED|First Drug Administration||34
9947581|NCT01392183|11066393|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29
9947582|NCT01392183|11066394|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31
9947583|NCT01392183|11066393|FG000|COMPLETED|First Drug Administration||21
9947584|NCT01392183|11066394|FG001|COMPLETED|First Drug Administration||15
9947585|NCT01392183|11066393|FG000|NOT COMPLETED|First Drug Administration||14
9947586|NCT01392183|11066394|FG001|NOT COMPLETED|First Drug Administration||19
9947587|NCT01392183|11066393|FG000|STARTED|Second Drug Administration||21
9947588|NCT01392183|11066394|FG001|STARTED|Second Drug Administration||15
9947589|NCT01392183|11066393|FG000|Treatment Ended: Progression|Second Drug Administration||18
9947590|NCT01392183|11066394|FG001|Treatment Ended: Progression|Second Drug Administration||11
9947591|NCT01392183|11066393|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1
9947592|NCT01392183|11066394|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2
9947593|NCT01392183|11066393|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2
9947594|NCT01392183|11066394|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1
9947595|NCT01392183|11066393|FG000|Treatment Ended: Death|Second Drug Administration||0
9947596|NCT01392183|11066394|FG001|Treatment Ended: Death|Second Drug Administration||1
9947597|NCT01392183|11066393|FG000|COMPLETED|Second Drug Administration||21
9947598|NCT01392183|11066394|FG001|COMPLETED|Second Drug Administration||15
9947599|NCT01392183|11066393|FG000|NOT COMPLETED|Second Drug Administration||0
9947600|NCT01392183|11066394|FG001|NOT COMPLETED|Second Drug Administration||0
9947601|NCT01392300|11066404|FG000|STARTED|Main Period (MP)||210
9947602|NCT01392300|11066405|FG001|STARTED|Main Period (MP)||107
9947603|NCT01392300|11066406|FG002|STARTED|Main Period (MP)||0
9947604|NCT01392300|11066404|FG000|COMPLETED|Main Period (MP)||199
9947605|NCT01392300|11066405|FG001|COMPLETED|Main Period (MP)||100
9947606|NCT01392300|11066406|FG002|COMPLETED|Main Period (MP)||0
9947607|NCT01392300|11066404|FG000|NOT COMPLETED|Main Period (MP)||11
9947608|NCT01392300|11066405|FG001|NOT COMPLETED|Main Period (MP)||7
9947609|NCT01392300|11066406|FG002|NOT COMPLETED|Main Period (MP)||0
9947610|NCT01392300|11066404|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
9947611|NCT01392300|11066405|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
9947612|NCT01392300|11066406|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
9947613|NCT01392300|11066404|FG000|COMPLETED|Open Label Extension (OLEX) Period||0
9947614|NCT01392300|11066405|FG001|COMPLETED|Open Label Extension (OLEX) Period||0
9947615|NCT01392300|11066406|FG002|COMPLETED|Open Label Extension (OLEX) Period||248
9947616|NCT01392300|11066404|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0
9947617|NCT01392300|11066405|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0
9947618|NCT01392300|11066406|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51
10011715|NCT01781832|11134497|FG000|STARTED|Overall Study||26
9947619|NCT01392326|11066416|FG000|STARTED|Overall Study||202
9947620|NCT01392326|11066417|FG001|STARTED|Overall Study||202
9947621|NCT01392326|11066418|FG002|STARTED|Overall Study||202
9947622|NCT01392326|11066416|FG000|COMPLETED|Overall Study||155
9947623|NCT01392326|11066417|FG001|COMPLETED|Overall Study||167
9947624|NCT01392326|11066418|FG002|COMPLETED|Overall Study||154
9947625|NCT01392326|11066416|FG000|NOT COMPLETED|Overall Study||47
9947626|NCT01392326|11066417|FG001|NOT COMPLETED|Overall Study||35
9947627|NCT01392326|11066418|FG002|NOT COMPLETED|Overall Study||48
9947628|NCT01392378|11066431|FG000|STARTED|Infant Series||173
9947629|NCT01392378|11066432|FG001|STARTED|Infant Series||176
10011716|NCT01781832|11134497|FG000|COMPLETED|Overall Study||25
9947630|NCT01392378|11066433|FG002|STARTED|Infant Series||172
9947631|NCT01392378|11066434|FG003|STARTED|Infant Series||177
9947632|NCT01392378|11066435|FG004|STARTED|Infant Series||210
9947633|NCT01392378|11066431|FG000|Vaccinated Dose 1|Infant Series||173
9947634|NCT01392378|11066432|FG001|Vaccinated Dose 1|Infant Series||176
9947635|NCT01392378|11066433|FG002|Vaccinated Dose 1|Infant Series||172
9947636|NCT01392378|11066434|FG003|Vaccinated Dose 1|Infant Series||177
9947637|NCT01392378|11066435|FG004|Vaccinated Dose 1|Infant Series||210
9947638|NCT01392378|11066431|FG000|Vaccinated Dose 2|Infant Series||171
9947639|NCT01392378|11066432|FG001|Vaccinated Dose 2|Infant Series||174
9947640|NCT01392378|11066433|FG002|Vaccinated Dose 2|Infant Series||172
9947641|NCT01392378|11066434|FG003|Vaccinated Dose 2|Infant Series||177
9947642|NCT01392378|11066435|FG004|Vaccinated Dose 2|Infant Series||210
9947643|NCT01392378|11066431|FG000|Vaccinated Dose 3|Infant Series||170
9947644|NCT01392378|11066432|FG001|Vaccinated Dose 3|Infant Series||174
9947645|NCT01392378|11066433|FG002|Vaccinated Dose 3|Infant Series||172
9947646|NCT01392378|11066434|FG003|Vaccinated Dose 3|Infant Series||176
9947647|NCT01392378|11066435|FG004|Vaccinated Dose 3|Infant Series||210
9947648|NCT01392378|11066431|FG000|COMPLETED|Infant Series||169
9947649|NCT01392378|11066432|FG001|COMPLETED|Infant Series||174
9947650|NCT01392378|11066433|FG002|COMPLETED|Infant Series||172
9947651|NCT01392378|11066434|FG003|COMPLETED|Infant Series||175
9947652|NCT01392378|11066435|FG004|COMPLETED|Infant Series||210
9947653|NCT01392378|11066431|FG000|NOT COMPLETED|Infant Series||4
9947654|NCT01392378|11066432|FG001|NOT COMPLETED|Infant Series||2
9947655|NCT01392378|11066433|FG002|NOT COMPLETED|Infant Series||0
9947656|NCT01392378|11066434|FG003|NOT COMPLETED|Infant Series||2
9947657|NCT01392378|11066435|FG004|NOT COMPLETED|Infant Series||0
9947658|NCT01392378|11066431|FG000|STARTED|After Infant Series||169
9947659|NCT01392378|11066432|FG001|STARTED|After Infant Series||174
9947660|NCT01392378|11066433|FG002|STARTED|After Infant Series||172
9947661|NCT01392378|11066434|FG003|STARTED|After Infant Series||175
9947662|NCT01392378|11066435|FG004|STARTED|After Infant Series||210
9947663|NCT01392378|11066431|FG000|COMPLETED|After Infant Series||169
9947664|NCT01392378|11066432|FG001|COMPLETED|After Infant Series||173
9947665|NCT01392378|11066433|FG002|COMPLETED|After Infant Series||170
9947666|NCT01392378|11066434|FG003|COMPLETED|After Infant Series||175
9947667|NCT01392378|11066435|FG004|COMPLETED|After Infant Series||209
9947668|NCT01392378|11066431|FG000|NOT COMPLETED|After Infant Series||0
9947669|NCT01392378|11066432|FG001|NOT COMPLETED|After Infant Series||1
9947670|NCT01392378|11066433|FG002|NOT COMPLETED|After Infant Series||2
9947671|NCT01392378|11066434|FG003|NOT COMPLETED|After Infant Series||0
9947672|NCT01392378|11066435|FG004|NOT COMPLETED|After Infant Series||1
9947673|NCT01392378|11066431|FG000|STARTED|Toddler Dose||169
9947674|NCT01392378|11066432|FG001|STARTED|Toddler Dose||173
9947675|NCT01392378|11066433|FG002|STARTED|Toddler Dose||170
9947676|NCT01392378|11066434|FG003|STARTED|Toddler Dose||175
9947677|NCT01392378|11066435|FG004|STARTED|Toddler Dose||209
9947678|NCT01392378|11066431|FG000|COMPLETED|Toddler Dose||169
9947679|NCT01392378|11066432|FG001|COMPLETED|Toddler Dose||172
9947680|NCT01392378|11066433|FG002|COMPLETED|Toddler Dose||170
9947681|NCT01392378|11066434|FG003|COMPLETED|Toddler Dose||173
9947682|NCT01392378|11066435|FG004|COMPLETED|Toddler Dose||208
9947683|NCT01392378|11066431|FG000|NOT COMPLETED|Toddler Dose||0
9947684|NCT01392378|11066432|FG001|NOT COMPLETED|Toddler Dose||1
9947685|NCT01392378|11066433|FG002|NOT COMPLETED|Toddler Dose||0
9947686|NCT01392378|11066434|FG003|NOT COMPLETED|Toddler Dose||2
9947687|NCT01392378|11066435|FG004|NOT COMPLETED|Toddler Dose||1
9947688|NCT01392443|11066457|FG000|STARTED|Overall Study||120
9947689|NCT01392443|11066457|FG000|COMPLETED|Overall Study||52
9947690|NCT01392443|11066457|FG000|NOT COMPLETED|Overall Study||68
9947691|NCT01392469|11066461|FG000|STARTED|Overall Study||21
9947692|NCT01392469|11066461|FG000|COMPLETED|Overall Study||17
9947693|NCT01392469|11066461|FG000|NOT COMPLETED|Overall Study||4
9947694|NCT01392495|11066476|FG000|STARTED|Overall Study||17
9947695|NCT01392495|11066476|FG000|Received 200 mg|Overall Study||4
9947696|NCT01392495|11066476|FG000|Received 400 mg|Overall Study||13
9947697|NCT01392495|11066476|FG000|COMPLETED|Overall Study||1
9947698|NCT01392495|11066476|FG000|NOT COMPLETED|Overall Study||16
9947699|NCT01392547|11066482|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
9947700|NCT01392547|11066482|FG000|COMPLETED|Overall Study||64
9947701|NCT01392547|11066482|FG000|NOT COMPLETED|Overall Study||8
9947702|NCT01392560|11066488|FG000|STARTED|Overall Study||52
9947703|NCT01392560|11066488|FG000|COMPLETED|Overall Study||40
9947704|NCT01392560|11066488|FG000|NOT COMPLETED|Overall Study||12
9947705|NCT01392573|11066496|FG000|STARTED|Overall Study||207
9947706|NCT01392573|11066497|FG001|STARTED|Overall Study||206
9947707|NCT01392573|11066496|FG000|Exposed|Overall Study||207
9947708|NCT01392573|11066497|FG001|Exposed|Overall Study||206
9947709|NCT01392573|11066496|FG000|COMPLETED|Overall Study||175
9947710|NCT01392573|11066497|FG001|COMPLETED|Overall Study||171
9947711|NCT01392573|11066496|FG000|NOT COMPLETED|Overall Study||32
9947712|NCT01392573|11066497|FG001|NOT COMPLETED|Overall Study||35
9947713|NCT01392625|11066505|FG000|STARTED|Overall Study||18
9947714|NCT01392625|11066506|FG001|STARTED|Overall Study||19
9947715|NCT01392625|11066505|FG000|COMPLETED|Overall Study||16
9947716|NCT01392625|11066506|FG001|COMPLETED|Overall Study||18
9947717|NCT01392625|11066505|FG000|NOT COMPLETED|Overall Study||2
9947718|NCT01392625|11066506|FG001|NOT COMPLETED|Overall Study||1
9947719|NCT01392677|11066514|FG000|STARTED|Overall Study||109
9947720|NCT01392677|11066515|FG001|STARTED|Overall Study||109
9947721|NCT01392677|11066514|FG000|COMPLETED|Overall Study||101
9947722|NCT01392677|11066515|FG001|COMPLETED|Overall Study||101
9947723|NCT01392677|11066514|FG000|NOT COMPLETED|Overall Study||8
9947724|NCT01392677|11066515|FG001|NOT COMPLETED|Overall Study||8
9947725|NCT01392703|11066521|FG000|STARTED|Day 1||26
9947726|NCT01392703|11066522|FG001|STARTED|Day 1||26
9947727|NCT01392703|11066523|FG002|STARTED|Day 1||26
9947728|NCT01392703|11066521|FG000|COMPLETED|Day 1||26
9947729|NCT01392703|11066522|FG001|COMPLETED|Day 1||26
9947730|NCT01392703|11066523|FG002|COMPLETED|Day 1||26
9947731|NCT01392703|11066521|FG000|NOT COMPLETED|Day 1||0
9947732|NCT01392703|11066522|FG001|NOT COMPLETED|Day 1||0
9947733|NCT01392703|11066523|FG002|NOT COMPLETED|Day 1||0
9947734|NCT01392703|11066521|FG000|STARTED|Day 5||26
9947735|NCT01392703|11066522|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
9947736|NCT01392703|11066523|FG002|STARTED|Day 5||26
9947737|NCT01392703|11066521|FG000|COMPLETED|Day 5||26
9947738|NCT01392703|11066522|FG001|COMPLETED|Day 5||25
9947739|NCT01392703|11066523|FG002|COMPLETED|Day 5||26
9947740|NCT01392703|11066521|FG000|NOT COMPLETED|Day 5||0
9947741|NCT01392703|11066522|FG001|NOT COMPLETED|Day 5||0
9947742|NCT01392703|11066523|FG002|NOT COMPLETED|Day 5||0
9947743|NCT01392703|11066521|FG000|STARTED|Day 9||26
9947744|NCT01392703|11066522|FG001|STARTED|Day 9||26
9947745|NCT01392703|11066523|FG002|STARTED|Day 9||25
9947746|NCT01392703|11066521|FG000|COMPLETED|Day 9||26
9947747|NCT01392703|11066522|FG001|COMPLETED|Day 9||26
9947748|NCT01392703|11066523|FG002|COMPLETED|Day 9||25
9947749|NCT01392703|11066521|FG000|NOT COMPLETED|Day 9||0
9947750|NCT01392703|11066522|FG001|NOT COMPLETED|Day 9||0
9947751|NCT01392703|11066523|FG002|NOT COMPLETED|Day 9||0
9947752|NCT01392742|11066533|FG000|STARTED|Overall Study||443
9947753|NCT01392742|11066533|FG000|COMPLETED|Overall Study||242
9947754|NCT01392742|11066533|FG000|NOT COMPLETED|Overall Study||201
9947755|NCT01392859|11066537|FG000|STARTED|Overall Study||15
9947756|NCT01392859|11066538|FG001|STARTED|Overall Study||13
9947757|NCT01392859|11066539|FG002|STARTED|Overall Study||183
9947758|NCT01392859|11066537|FG000|Wash Out 3-7 Days|Overall Study||15
9947759|NCT01392859|11066538|FG001|Wash Out 3-7 Days|Overall Study||13
9947760|NCT01392859|11066539|FG002|Wash Out 3-7 Days|Overall Study||0
9947761|NCT01392859|11066537|FG000|COMPLETED|Overall Study||13
9947762|NCT01392859|11066538|FG001|COMPLETED|Overall Study||13
9947763|NCT01392859|11066539|FG002|COMPLETED|Overall Study||183
9947764|NCT01392859|11066537|FG000|NOT COMPLETED|Overall Study||2
9947765|NCT01392859|11066538|FG001|NOT COMPLETED|Overall Study||0
9947766|NCT01392859|11066539|FG002|NOT COMPLETED|Overall Study||0
9947767|NCT01392963|11066547|FG000|STARTED|Week 0 (First Intervention)||11
9947768|NCT01392963|11066548|FG001|STARTED|Week 0 (First Intervention)||19
9947769|NCT01392963|11066547|FG000|COMPLETED|Week 0 (First Intervention)||11
9947770|NCT01392963|11066548|FG001|COMPLETED|Week 0 (First Intervention)||17
9947771|NCT01392963|11066547|FG000|NOT COMPLETED|Week 0 (First Intervention)||0
9947772|NCT01392963|11066548|FG001|NOT COMPLETED|Week 0 (First Intervention)||2
9947773|NCT01392963|11066547|FG000|STARTED|Week 12 (Second Intervention)||11
9947774|NCT01392963|11066548|FG001|STARTED|Week 12 (Second Intervention)||17
9947775|NCT01392963|11066547|FG000|COMPLETED|Week 12 (Second Intervention)||11
9947776|NCT01392963|11066548|FG001|COMPLETED|Week 12 (Second Intervention)||17
9947777|NCT01392963|11066547|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0
9947778|NCT01392963|11066548|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0
9947779|NCT01392963|11066547|FG000|STARTED|Week 24 Follow-up||11
9947780|NCT01392963|11066548|FG001|STARTED|Week 24 Follow-up||17
9947781|NCT01392963|11066547|FG000|COMPLETED|Week 24 Follow-up||9
9947782|NCT01392963|11066548|FG001|COMPLETED|Week 24 Follow-up||17
9947783|NCT01392963|11066547|FG000|NOT COMPLETED|Week 24 Follow-up||2
9947784|NCT01392963|11066548|FG001|NOT COMPLETED|Week 24 Follow-up||0
9947785|NCT01392989|11066556|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44
9947786|NCT01392989|11066556|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44
9947787|NCT01392989|11066556|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
9947788|NCT01392989|11066556|FG000|STARTED|CIK Cell Infusion||31
9947789|NCT01392989|11066556|FG000|COMPLETED|CIK Cell Infusion||31
9947790|NCT01392989|11066556|FG000|NOT COMPLETED|CIK Cell Infusion||0
9947791|NCT01393106|11066561|FG000|STARTED|Overall Study||25
9947792|NCT01393106|11066561|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
9947793|NCT01393106|11066561|FG000|NOT COMPLETED|Overall Study||5
9947794|NCT01393132|11066567|FG000|STARTED|Overall Study||6
9947795|NCT01393132|11066568|FG001|STARTED|Overall Study||3
9947796|NCT01393132|11066567|FG000|COMPLETED|Overall Study||6
9947797|NCT01393132|11066568|FG001|COMPLETED|Overall Study||3
9947798|NCT01393132|11066567|FG000|NOT COMPLETED|Overall Study||0
9947799|NCT01393132|11066568|FG001|NOT COMPLETED|Overall Study||0
9947800|NCT01393158|11066578|FG000|STARTED|Overall Study||6
9947801|NCT01393158|11066579|FG001|STARTED|Overall Study||10
9947802|NCT01393158|11066578|FG000|COMPLETED|Overall Study||5
9947803|NCT01393158|11066579|FG001|COMPLETED|Overall Study||10
9947804|NCT01393158|11066578|FG000|NOT COMPLETED|Overall Study||1
9947805|NCT01393158|11066579|FG001|NOT COMPLETED|Overall Study||0
9947806|NCT01393301|11066593|FG000|STARTED|Overall Study||26
9947807|NCT01393301|11066594|FG001|STARTED|Overall Study||27
9947808|NCT01393301|11066593|FG000|COMPLETED|Overall Study||17
9947809|NCT01393301|11066594|FG001|COMPLETED|Overall Study||24
9947810|NCT01393301|11066593|FG000|NOT COMPLETED|Overall Study||9
9947811|NCT01393301|11066594|FG001|NOT COMPLETED|Overall Study||3
9947812|NCT01393392|11066602|FG000|STARTED|Overall Study||44
9947813|NCT01393392|11066603|FG001|STARTED|Overall Study||43
9947814|NCT01393392|11066602|FG000|COMPLETED|Overall Study||33
9947815|NCT01393392|11066603|FG001|COMPLETED|Overall Study||24
9947816|NCT01393392|11066602|FG000|NOT COMPLETED|Overall Study||11
9947817|NCT01393392|11066603|FG001|NOT COMPLETED|Overall Study||19
9947818|NCT01393405|11066609|FG000|STARTED|Induction Period (week1-16)||179
9947819|NCT01393405|11066610|FG001|STARTED|Induction Period (week1-16)||0
9947820|NCT01393405|11066611|FG002|STARTED|Induction Period (week1-16)||0
9947821|NCT01393405|11066609|FG000|COMPLETED|Induction Period (week1-16)||84
9947822|NCT01393405|11066610|FG001|COMPLETED|Induction Period (week1-16)||0
9947823|NCT01393405|11066611|FG002|COMPLETED|Induction Period (week1-16)||0
9947824|NCT01393405|11066609|FG000|NOT COMPLETED|Induction Period (week1-16)||95
9947825|NCT01393405|11066610|FG001|NOT COMPLETED|Induction Period (week1-16)||0
9947826|NCT01393405|11066611|FG002|NOT COMPLETED|Induction Period (week1-16)||0
9947827|NCT01393405|11066609|FG000|STARTED|Maintenance Period Week||0
9947828|NCT01393405|11066610|FG001|STARTED|Maintenance Period Week||44
9947829|NCT01393405|11066611|FG002|STARTED|Maintenance Period Week||40
9947830|NCT01393405|11066609|FG000|COMPLETED|Maintenance Period Week||0
9947831|NCT01393405|11066610|FG001|COMPLETED|Maintenance Period Week||15
9947832|NCT01393405|11066611|FG002|COMPLETED|Maintenance Period Week||16
9947833|NCT01393405|11066609|FG000|NOT COMPLETED|Maintenance Period Week||0
9947834|NCT01393405|11066610|FG001|NOT COMPLETED|Maintenance Period Week||29
9947835|NCT01393405|11066611|FG002|NOT COMPLETED|Maintenance Period Week||24
9947836|NCT01393444|11066621|FG000|STARTED|Overall Study||6
9947837|NCT01393444|11066621|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
9947838|NCT01393444|11066621|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
9947839|NCT01393444|11066621|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
9947840|NCT01393444|11066621|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
9947841|NCT01393444|11066621|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
9947842|NCT01393444|11066621|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
9947843|NCT01393444|11066621|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
9947844|NCT01393444|11066621|FG000|NOT COMPLETED|Overall Study||3
9947845|NCT01393457|11066629|FG000|STARTED|Overall Study||26
9947846|NCT01393457|11066630|FG001|STARTED|Overall Study||26
9947847|NCT01393457|11066631|FG002|STARTED|Overall Study||31
9947848|NCT01393457|11066632|FG003|STARTED|Overall Study||27
9947849|NCT01393457|11066629|FG000|COMPLETED|Overall Study||14
9947850|NCT01393457|11066630|FG001|COMPLETED|Overall Study||14
9947851|NCT01393457|11066631|FG002|COMPLETED|Overall Study||16
9947852|NCT01393457|11066632|FG003|COMPLETED|Overall Study||15
9947853|NCT01393457|11066629|FG000|NOT COMPLETED|Overall Study||12
9947854|NCT01393457|11066630|FG001|NOT COMPLETED|Overall Study||12
10208828|NCT03558672|11335911|FG000|NOT COMPLETED|Overall Study||10
10208829|NCT03558997|11335919|FG000|STARTED|Overall Study||25
10208830|NCT03558997|11335920|FG001|STARTED|Overall Study||26
10208831|NCT03558997|11335921|FG002|STARTED|Overall Study||26
10208832|NCT03558997|11335922|FG003|STARTED|Overall Study||26
10208833|NCT03558997|11335919|FG000|COMPLETED|Overall Study||24
10208834|NCT03558997|11335920|FG001|COMPLETED|Overall Study||24
10208835|NCT03558997|11335921|FG002|COMPLETED|Overall Study||18
10208836|NCT03558997|11335922|FG003|COMPLETED|Overall Study||24
10208837|NCT03558997|11335919|FG000|NOT COMPLETED|Overall Study||1
10208838|NCT03558997|11335920|FG001|NOT COMPLETED|Overall Study||2
10208839|NCT03558997|11335921|FG002|NOT COMPLETED|Overall Study||8
10208840|NCT03558997|11335922|FG003|NOT COMPLETED|Overall Study||2
10208841|NCT03559062|11335938|FG000|STARTED|Overall Study||10
10208842|NCT03559062|11335939|FG001|STARTED|Overall Study||54
10208843|NCT03559062|11335940|FG002|STARTED|Overall Study||3
10208844|NCT03559062|11335938|FG000|COMPLETED|Overall Study||10
10208845|NCT03559062|11335939|FG001|COMPLETED|Overall Study||53
10208846|NCT03559062|11335940|FG002|COMPLETED|Overall Study||3
10208847|NCT03559062|11335938|FG000|NOT COMPLETED|Overall Study||0
10208848|NCT03559062|11335939|FG001|NOT COMPLETED|Overall Study||1
10208849|NCT03559062|11335940|FG002|NOT COMPLETED|Overall Study||0
10208850|NCT03559179|11335952|FG000|STARTED|Overall Study||8
10208851|NCT03559179|11335953|FG001|STARTED|Overall Study||24
10208852|NCT03559179|11335954|FG002|STARTED|Overall Study||23
10208853|NCT03559179|11335952|FG000|COMPLETED|Overall Study||8
10208854|NCT03559179|11335953|FG001|COMPLETED|Overall Study||23
10208855|NCT03559179|11335954|FG002|COMPLETED|Overall Study||23
10208856|NCT03559179|11335952|FG000|NOT COMPLETED|Overall Study||0
10208857|NCT03559179|11335953|FG001|NOT COMPLETED|Overall Study||1
9947855|NCT01393457|11066631|FG002|NOT COMPLETED|Overall Study||15
9947856|NCT01393457|11066632|FG003|NOT COMPLETED|Overall Study||12
9947857|NCT01393600|11066642|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9
9947858|NCT01393600|11066643|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8
9947859|NCT01393600|11066644|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10
9947860|NCT01393600|11066645|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10
10208858|NCT03559179|11335954|FG002|NOT COMPLETED|Overall Study||0
10208859|NCT03559205|11335973|FG000|STARTED|Overall Study||177
10208860|NCT03559205|11335974|FG001|STARTED|Overall Study||144
9947861|NCT01393600|11066642|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
9947862|NCT01393600|11066643|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
9947863|NCT01393600|11066644|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
9947864|NCT01393600|11066645|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
9947865|NCT01393600|11066642|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
9947866|NCT01393600|11066643|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
9947867|NCT01393600|11066644|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
9947868|NCT01393600|11066645|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
9947869|NCT01393600|11066642|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9
9947870|NCT01393600|11066643|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7
9947871|NCT01393600|11066644|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9
9947872|NCT01393600|11066645|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9
9947873|NCT01393600|11066642|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
9947874|NCT01393600|11066643|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
9947875|NCT01393600|11066644|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
9947876|NCT01393600|11066645|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
9947877|NCT01393600|11066642|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
9947878|NCT01393600|11066643|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
9947879|NCT01393600|11066644|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
9947880|NCT01393600|11066645|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
9947881|NCT01393600|11066642|FG000|STARTED|Follow-up Period (Day 29 to 35)||9
9947882|NCT01393600|11066643|FG001|STARTED|Follow-up Period (Day 29 to 35)||7
9947883|NCT01393600|11066644|FG002|STARTED|Follow-up Period (Day 29 to 35)||7
9947884|NCT01393600|11066645|FG003|STARTED|Follow-up Period (Day 29 to 35)||8
9947885|NCT01393600|11066642|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9
9947886|NCT01393600|11066643|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7
9947887|NCT01393600|11066644|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6
9947888|NCT01393600|11066645|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8
9947889|NCT01393600|11066642|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
9947890|NCT01393600|11066643|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
9947891|NCT01393600|11066644|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
9947892|NCT01393600|11066645|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
9947893|NCT01393613|11066661|FG000|STARTED|Overall Study||120
9947894|NCT01393613|11066662|FG001|STARTED|Overall Study||186
9947895|NCT01393613|11066663|FG002|STARTED|Overall Study||184
9947896|NCT01393613|11066664|FG003|STARTED|Overall Study||184
9947897|NCT01393613|11066661|FG000|COMPLETED|Overall Study||81
9947898|NCT01393613|11066662|FG001|COMPLETED|Overall Study||129
9947899|NCT01393613|11066663|FG002|COMPLETED|Overall Study||130
9947900|NCT01393613|11066664|FG003|COMPLETED|Overall Study||118
9947901|NCT01393613|11066661|FG000|NOT COMPLETED|Overall Study||39
9947902|NCT01393613|11066662|FG001|NOT COMPLETED|Overall Study||57
9947903|NCT01393613|11066663|FG002|NOT COMPLETED|Overall Study||54
9947904|NCT01393613|11066664|FG003|NOT COMPLETED|Overall Study||66
9947905|NCT01393626|11066680|FG000|STARTED|Overall Study||91
9947906|NCT01393626|11066681|FG001|STARTED|Overall Study||86
9947907|NCT01393626|11066682|FG002|STARTED|Overall Study||86
9947908|NCT01393626|11066683|FG003|STARTED|Overall Study||16
9947909|NCT01393626|11066680|FG000|COMPLETED|Overall Study||73
9947910|NCT01393626|11066681|FG001|COMPLETED|Overall Study||74
9947911|NCT01393626|11066682|FG002|COMPLETED|Overall Study||74
9947912|NCT01393626|11066683|FG003|COMPLETED|Overall Study||15
9947913|NCT01393626|11066680|FG000|NOT COMPLETED|Overall Study||18
9947914|NCT01393626|11066681|FG001|NOT COMPLETED|Overall Study||12
9947915|NCT01393626|11066682|FG002|NOT COMPLETED|Overall Study||12
9947916|NCT01393626|11066683|FG003|NOT COMPLETED|Overall Study||1
9947917|NCT01393704|11066702|FG000|STARTED|Overall Study||76
9947918|NCT01393704|11066703|FG001|STARTED|Overall Study||76
9947919|NCT01393704|11066702|FG000|COMPLETED|Overall Study||76
9947920|NCT01393704|11066703|FG001|COMPLETED|Overall Study||76
9947921|NCT01393704|11066702|FG000|NOT COMPLETED|Overall Study||0
9947922|NCT01393704|11066703|FG001|NOT COMPLETED|Overall Study||0
9947923|NCT01393717|11066709|FG000|STARTED|Overall Study||37
9947924|NCT01393717|11066710|FG001|STARTED|Overall Study||20
9947925|NCT01393717|11066709|FG000|COMPLETED|Overall Study||37
9947926|NCT01393717|11066710|FG001|COMPLETED|Overall Study||20
9947927|NCT01393717|11066709|FG000|NOT COMPLETED|Overall Study||0
9947928|NCT01393717|11066710|FG001|NOT COMPLETED|Overall Study||0
9947929|NCT01393730|11066720|FG000|STARTED|Overall Study||40
9947930|NCT01393730|11066720|FG000|Treated|Overall Study||38
9947931|NCT01393730|11066720|FG000|Evaluable AR Amplification|Overall Study||21
9947932|NCT01393730|11066720|FG000|Evaluable AR Mutation|Overall Study||14
9947933|NCT01393730|11066720|FG000|COMPLETED|Overall Study||34
9947934|NCT01393730|11066720|FG000|NOT COMPLETED|Overall Study||6
9947935|NCT01393743|11066726|FG000|STARTED|Core Study|Treated|82
9947936|NCT01393743|11066727|FG001|STARTED|Core Study|Treated|81
9947937|NCT01393743|11066728|FG002|STARTED|Core Study||0
9947938|NCT01393743|11066726|FG000|COMPLETED|Core Study||72
9947939|NCT01393743|11066727|FG001|COMPLETED|Core Study||68
9947940|NCT01393743|11066728|FG002|COMPLETED|Core Study||0
9947941|NCT01393743|11066726|FG000|NOT COMPLETED|Core Study||10
9947942|NCT01393743|11066727|FG001|NOT COMPLETED|Core Study||13
9947943|NCT01393743|11066728|FG002|NOT COMPLETED|Core Study||0
9947944|NCT01393743|11066726|FG000|STARTED|Extension Phase||0
9947945|NCT01393743|11066727|FG001|STARTED|Extension Phase||0
9947946|NCT01393743|11066728|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
10011717|NCT01781832|11134497|FG000|NOT COMPLETED|Overall Study||1
10011718|NCT01781962|11134501|FG000|STARTED|Overall Study||206
10011719|NCT01781962|11134501|FG000|COMPLETED|Overall Study||201
10011720|NCT01781962|11134501|FG000|NOT COMPLETED|Overall Study||5
10011721|NCT01781975|11134507|FG000|STARTED|Overall Study||45
10011722|NCT01781975|11134508|FG001|STARTED|Overall Study||22
10011723|NCT01781975|11134507|FG000|Treatment Period|Overall Study||44
10011724|NCT01781975|11134508|FG001|Treatment Period|Overall Study||22
10011725|NCT01781975|11134507|FG000|Follow-Up Period|Overall Study||43
9947947|NCT01393743|11066726|FG000|COMPLETED|Extension Phase||0
9947948|NCT01393743|11066727|FG001|COMPLETED|Extension Phase||0
9947949|NCT01393743|11066728|FG002|COMPLETED|Extension Phase||78
9947950|NCT01393743|11066726|FG000|NOT COMPLETED|Extension Phase||0
9947951|NCT01393743|11066727|FG001|NOT COMPLETED|Extension Phase||0
9947952|NCT01393743|11066728|FG002|NOT COMPLETED|Extension Phase||60
9947953|NCT01393821|11066741|FG000|STARTED|Overall Study||14
9947954|NCT01393821|11066742|FG001|STARTED|Overall Study||13
9947955|NCT01393821|11066741|FG000|COMPLETED|Overall Study||9
10208861|NCT03559205|11335973|FG000|Baseline Data|Overall Study||141
10208862|NCT03559205|11335974|FG001|Baseline Data|Overall Study||132
10208863|NCT03559205|11335973|FG000|COMPLETED|Overall Study||65
10208864|NCT03559205|11335974|FG001|COMPLETED|Overall Study||57
10208865|NCT03559205|11335973|FG000|NOT COMPLETED|Overall Study||112
10208866|NCT03559205|11335974|FG001|NOT COMPLETED|Overall Study||87
10208867|NCT03559218|11335982|FG000|STARTED|Overall Study||12
9947956|NCT01393821|11066742|FG001|COMPLETED|Overall Study||10
9947957|NCT01393821|11066741|FG000|NOT COMPLETED|Overall Study||5
9947958|NCT01393821|11066742|FG001|NOT COMPLETED|Overall Study||3
9947959|NCT01393899|11066751|FG000|STARTED|Overall Study||59
9947960|NCT01393899|11066752|FG001|STARTED|Overall Study||60
9947961|NCT01393899|11066753|FG002|STARTED|Overall Study||61
9947962|NCT01393899|11066751|FG000|COMPLETED|Overall Study||27
9947963|NCT01393899|11066752|FG001|COMPLETED|Overall Study||32
9947964|NCT01393899|11066753|FG002|COMPLETED|Overall Study||38
9947965|NCT01393899|11066751|FG000|NOT COMPLETED|Overall Study||32
9760658|NCT00382720|10864421|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0
9760659|NCT00382720|10864419|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78
9760660|NCT00382720|10864420|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88
9760661|NCT00382720|10864421|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82
9760662|NCT00382720|10864419|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
9760663|NCT00382720|10864420|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
9947966|NCT01393899|11066752|FG001|NOT COMPLETED|Overall Study||28
9947967|NCT01393899|11066753|FG002|NOT COMPLETED|Overall Study||23
9947968|NCT01393964|11066766|FG000|STARTED|Overall Study||8
9947969|NCT01393964|11066767|FG001|STARTED|Overall Study||9
9947970|NCT01393964|11066768|FG002|STARTED|Overall Study||9
9947971|NCT01393964|11066766|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0
9947972|NCT01393964|11066767|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0
9947973|NCT01393964|11066768|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0
9947974|NCT01393964|11066766|FG000|NOT COMPLETED|Overall Study||8
9947975|NCT01393964|11066767|FG001|NOT COMPLETED|Overall Study||9
9947976|NCT01393964|11066768|FG002|NOT COMPLETED|Overall Study||9
9947977|NCT01393990|11066800|FG000|STARTED|Overall Study||4
9947978|NCT01393990|11066801|FG001|STARTED|Overall Study||3
9947979|NCT01393990|11066802|FG002|STARTED|Overall Study||3
9947980|NCT01393990|11066803|FG003|STARTED|Overall Study||3
9947981|NCT01393990|11066804|FG004|STARTED|Overall Study||5
9947982|NCT01393990|11066805|FG005|STARTED|Overall Study||3
9947983|NCT01393990|11066806|FG006|STARTED|Overall Study||3
9947984|NCT01393990|11066807|FG007|STARTED|Overall Study||7
9947985|NCT01393990|11066808|FG008|STARTED|Overall Study||6
9947986|NCT01393990|11066809|FG009|STARTED|Overall Study||3
9947987|NCT01393990|11066810|FG010|STARTED|Overall Study||3
9947988|NCT01393990|11066811|FG011|STARTED|Overall Study||3
9947989|NCT01393990|11066812|FG012|STARTED|Overall Study||3
9947990|NCT01393990|11066813|FG013|STARTED|Overall Study||5
9947991|NCT01393990|11066814|FG014|STARTED|Overall Study||18
10011726|NCT01781975|11134508|FG001|Follow-Up Period|Overall Study||21
10011727|NCT01781975|11134507|FG000|COMPLETED|Overall Study||43
10011728|NCT01781975|11134508|FG001|COMPLETED|Overall Study||21
9947992|NCT01393990|11066815|FG015|STARTED|Overall Study||8
9947993|NCT01393990|11066816|FG016|STARTED|Overall Study||3
9947994|NCT01393990|11066817|FG017|STARTED|Overall Study||6
9947995|NCT01393990|11066800|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
9947996|NCT01393990|11066801|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9947997|NCT01393990|11066802|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9947998|NCT01393990|11066803|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10011729|NCT01781975|11134507|FG000|NOT COMPLETED|Overall Study||2
10208868|NCT03559218|11335983|FG001|STARTED|Overall Study||13
9947999|NCT01393990|11066804|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5
9948000|NCT01393990|11066805|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
9948001|NCT01393990|11066806|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
9948002|NCT01393990|11066807|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7
9948003|NCT01393990|11066808|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
10208869|NCT03559218|11335982|FG000|COMPLETED|Overall Study||11
10208870|NCT03559218|11335983|FG001|COMPLETED|Overall Study||13
9948004|NCT01393990|11066809|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3
9948005|NCT01393990|11066810|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
9948006|NCT01393990|11066811|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3
9948007|NCT01393990|11066812|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3
9948008|NCT01393990|11066813|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5
9948009|NCT01393990|11066814|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18
9948010|NCT01393990|11066815|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8
9948011|NCT01393990|11066816|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3
9948012|NCT01393990|11066817|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6
9948013|NCT01393990|11066800|FG000|COMPLETED|Overall Study||3
9948014|NCT01393990|11066801|FG001|COMPLETED|Overall Study||3
9948015|NCT01393990|11066802|FG002|COMPLETED|Overall Study||3
9948016|NCT01393990|11066803|FG003|COMPLETED|Overall Study||2
9948017|NCT01393990|11066804|FG004|COMPLETED|Overall Study||3
9948018|NCT01393990|11066805|FG005|COMPLETED|Overall Study||2
9948019|NCT01393990|11066806|FG006|COMPLETED|Overall Study||2
9948020|NCT01393990|11066807|FG007|COMPLETED|Overall Study||6
9948021|NCT01393990|11066808|FG008|COMPLETED|Overall Study||3
9948022|NCT01393990|11066809|FG009|COMPLETED|Overall Study||2
9948023|NCT01393990|11066810|FG010|COMPLETED|Overall Study||3
9948024|NCT01393990|11066811|FG011|COMPLETED|Overall Study||3
9948025|NCT01393990|11066812|FG012|COMPLETED|Overall Study||3
9948026|NCT01393990|11066813|FG013|COMPLETED|Overall Study||3
9948027|NCT01393990|11066814|FG014|COMPLETED|Overall Study||9
9948028|NCT01393990|11066815|FG015|COMPLETED|Overall Study||5
9948029|NCT01393990|11066816|FG016|COMPLETED|Overall Study||3
9948030|NCT01393990|11066817|FG017|COMPLETED|Overall Study||6
9948031|NCT01393990|11066800|FG000|NOT COMPLETED|Overall Study||1
9948032|NCT01393990|11066801|FG001|NOT COMPLETED|Overall Study||0
9948033|NCT01393990|11066802|FG002|NOT COMPLETED|Overall Study||0
9948034|NCT01393990|11066803|FG003|NOT COMPLETED|Overall Study||1
9948035|NCT01393990|11066804|FG004|NOT COMPLETED|Overall Study||2
9948036|NCT01393990|11066805|FG005|NOT COMPLETED|Overall Study||1
9948037|NCT01393990|11066806|FG006|NOT COMPLETED|Overall Study||1
9948038|NCT01393990|11066807|FG007|NOT COMPLETED|Overall Study||1
9948039|NCT01393990|11066808|FG008|NOT COMPLETED|Overall Study||3
9948040|NCT01393990|11066809|FG009|NOT COMPLETED|Overall Study||1
9948041|NCT01393990|11066810|FG010|NOT COMPLETED|Overall Study||0
9948042|NCT01393990|11066811|FG011|NOT COMPLETED|Overall Study||0
9948043|NCT01393990|11066812|FG012|NOT COMPLETED|Overall Study||0
9948044|NCT01393990|11066813|FG013|NOT COMPLETED|Overall Study||2
9948045|NCT01393990|11066814|FG014|NOT COMPLETED|Overall Study||9
9948046|NCT01393990|11066815|FG015|NOT COMPLETED|Overall Study||3
9948047|NCT01393990|11066816|FG016|NOT COMPLETED|Overall Study||0
9948048|NCT01393990|11066817|FG017|NOT COMPLETED|Overall Study||0
9948049|NCT01394003|11066874|FG000|STARTED|Overall Study||3
9948050|NCT01394003|11066875|FG001|STARTED|Overall Study||8
9948051|NCT01394003|11066876|FG002|STARTED|Overall Study||3
9948052|NCT01394003|11066877|FG003|STARTED|Overall Study||6
9948053|NCT01394003|11066878|FG004|STARTED|Overall Study||3
9948054|NCT01394003|11066879|FG005|STARTED|Overall Study||3
9948055|NCT01394003|11066880|FG006|STARTED|Overall Study||6
9948056|NCT01394003|11066881|FG007|STARTED|Overall Study||2
9948057|NCT01394003|11066874|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9948058|NCT01394003|11066875|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
9948059|NCT01394003|11066876|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9948060|NCT01394003|11066877|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9948061|NCT01394003|11066878|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
9948062|NCT01394003|11066879|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
9948063|NCT01394003|11066880|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
9948064|NCT01394003|11066881|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2
9948065|NCT01394003|11066874|FG000|COMPLETED|Overall Study||3
9948066|NCT01394003|11066875|FG001|COMPLETED|Overall Study||8
9948067|NCT01394003|11066876|FG002|COMPLETED|Overall Study||3
9948068|NCT01394003|11066877|FG003|COMPLETED|Overall Study||6
9948069|NCT01394003|11066878|FG004|COMPLETED|Overall Study||3
9948070|NCT01394003|11066879|FG005|COMPLETED|Overall Study||3
9948071|NCT01394003|11066880|FG006|COMPLETED|Overall Study||6
9948072|NCT01394003|11066881|FG007|COMPLETED|Overall Study||2
9948073|NCT01394003|11066874|FG000|NOT COMPLETED|Overall Study||0
9948074|NCT01394003|11066875|FG001|NOT COMPLETED|Overall Study||0
9948075|NCT01394003|11066876|FG002|NOT COMPLETED|Overall Study||0
9948076|NCT01394003|11066877|FG003|NOT COMPLETED|Overall Study||0
9948077|NCT01394003|11066878|FG004|NOT COMPLETED|Overall Study||0
9948078|NCT01394003|11066879|FG005|NOT COMPLETED|Overall Study||0
9948079|NCT01394003|11066880|FG006|NOT COMPLETED|Overall Study||0
9948080|NCT01394003|11066881|FG007|NOT COMPLETED|Overall Study||0
9948081|NCT01394081|11066907|FG000|STARTED|Overall Study||101
9948082|NCT01394081|11066908|FG001|STARTED|Overall Study||102
9948083|NCT01394081|11066907|FG000|COMPLETED|Overall Study||101
9948084|NCT01394081|11066908|FG001|COMPLETED|Overall Study||102
9948085|NCT01394081|11066907|FG000|NOT COMPLETED|Overall Study||0
9948086|NCT01394081|11066908|FG001|NOT COMPLETED|Overall Study||0
9948087|NCT01394159|11066918|FG000|STARTED|Overall Study||28
9948088|NCT01394159|11066919|FG001|STARTED|Overall Study||28
9948089|NCT01394159|11066918|FG000|COMPLETED|Overall Study||28
9948090|NCT01394159|11066919|FG001|COMPLETED|Overall Study||28
9948091|NCT01394159|11066918|FG000|NOT COMPLETED|Overall Study||0
9948092|NCT01394159|11066919|FG001|NOT COMPLETED|Overall Study||0
9948093|NCT01394185|11066925|FG000|STARTED|Overall Study||8
9948094|NCT01394185|11066926|FG001|STARTED|Overall Study||2
9948095|NCT01394185|11066927|FG002|STARTED|Overall Study||2
9948096|NCT01394185|11066928|FG003|STARTED|Overall Study||4
9948097|NCT01394185|11066929|FG004|STARTED|Overall Study||6
9948098|NCT01394185|11066930|FG005|STARTED|Overall Study||3
9948099|NCT01394185|11066925|FG000|COMPLETED|Overall Study||2
9948100|NCT01394185|11066926|FG001|COMPLETED|Overall Study||2
9948101|NCT01394185|11066927|FG002|COMPLETED|Overall Study||2
9948102|NCT01394185|11066928|FG003|COMPLETED|Overall Study||3
9948103|NCT01394185|11066929|FG004|COMPLETED|Overall Study||2
9948104|NCT01394185|11066930|FG005|COMPLETED|Overall Study||2
9948105|NCT01394185|11066925|FG000|NOT COMPLETED|Overall Study||6
9948106|NCT01394185|11066926|FG001|NOT COMPLETED|Overall Study||0
9948107|NCT01394185|11066927|FG002|NOT COMPLETED|Overall Study||0
9948108|NCT01394185|11066928|FG003|NOT COMPLETED|Overall Study||1
9948109|NCT01394185|11066929|FG004|NOT COMPLETED|Overall Study||4
9948110|NCT01394185|11066930|FG005|NOT COMPLETED|Overall Study||1
9948111|NCT01394250|11066940|FG000|STARTED|Randomization and IV Placement Attempt||134
9948112|NCT01394250|11066941|FG001|STARTED|Randomization and IV Placement Attempt||134
9948113|NCT01394250|11066940|FG000|COMPLETED|Randomization and IV Placement Attempt||120
9948114|NCT01394250|11066941|FG001|COMPLETED|Randomization and IV Placement Attempt||121
9948115|NCT01394250|11066940|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14
9948116|NCT01394250|11066941|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13
9948117|NCT01394250|11066940|FG000|STARTED|Successful IV Placement & Follow-Up||120
9948118|NCT01394250|11066941|FG001|STARTED|Successful IV Placement & Follow-Up||121
9948119|NCT01394250|11066940|FG000|COMPLETED|Successful IV Placement & Follow-Up||114
9948120|NCT01394250|11066941|FG001|COMPLETED|Successful IV Placement & Follow-Up||110
9948121|NCT01394250|11066940|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6
9948122|NCT01394250|11066941|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11
9956836|NCT01448824|11076141|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
9956837|NCT01448824|11076142|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
9956838|NCT01448824|11076143|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
9956839|NCT01448824|11076144|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
9956840|NCT01448824|11076145|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
9956841|NCT01448824|11076146|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
9956842|NCT01448824|11076147|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
9956843|NCT01448824|11076140|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
9956844|NCT01448824|11076141|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
9956845|NCT01448824|11076142|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
9956846|NCT01448824|11076143|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
9956847|NCT01448824|11076144|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
9956848|NCT01448824|11076145|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
9956849|NCT01448824|11076146|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
9956850|NCT01448824|11076147|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
9956851|NCT01448824|11076140|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
9956852|NCT01448824|11076141|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
9956853|NCT01448824|11076142|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
9956854|NCT01448824|11076143|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
9956855|NCT01448824|11076144|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
9956856|NCT01448824|11076145|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
9956857|NCT01448824|11076146|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
9956858|NCT01448824|11076147|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
9956859|NCT01448824|11076140|FG000|STARTED|Part 1: Washout Period||12
9956860|NCT01448824|11076141|FG001|STARTED|Part 1: Washout Period||4
9956861|NCT01448824|11076142|FG002|STARTED|Part 1: Washout Period||4
9956862|NCT01448824|11076143|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
9956863|NCT01448824|11076144|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
9956864|NCT01448824|11076145|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
9956865|NCT01448824|11076146|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
9956866|NCT01448824|11076147|FG007|STARTED|Part 1: Washout Period||0
9956867|NCT01448824|11076140|FG000|COMPLETED|Part 1: Washout Period||11
9956868|NCT01448824|11076141|FG001|COMPLETED|Part 1: Washout Period||4
9956869|NCT01448824|11076142|FG002|COMPLETED|Part 1: Washout Period||4
9956870|NCT01448824|11076143|FG003|COMPLETED|Part 1: Washout Period||0
9956871|NCT01448824|11076144|FG004|COMPLETED|Part 1: Washout Period||0
9956872|NCT01448824|11076145|FG005|COMPLETED|Part 1: Washout Period||0
9956873|NCT01448824|11076146|FG006|COMPLETED|Part 1: Washout Period||0
9956874|NCT01448824|11076147|FG007|COMPLETED|Part 1: Washout Period||0
9956875|NCT01448824|11076140|FG000|NOT COMPLETED|Part 1: Washout Period||1
9956876|NCT01448824|11076141|FG001|NOT COMPLETED|Part 1: Washout Period||0
9956877|NCT01448824|11076142|FG002|NOT COMPLETED|Part 1: Washout Period||0
9956878|NCT01448824|11076143|FG003|NOT COMPLETED|Part 1: Washout Period||0
9948123|NCT01394276|11066947|FG000|STARTED|Overall Study||322
9948124|NCT01394276|11066947|FG000|COMPLETED|Overall Study||260
9948125|NCT01394276|11066947|FG000|NOT COMPLETED|Overall Study||62
9948126|NCT01394510|11066956|FG000|STARTED|Overall Study||13
9948127|NCT01394510|11066956|FG000|COMPLETED|Overall Study||13
9948128|NCT01394510|11066956|FG000|NOT COMPLETED|Overall Study||0
9948129|NCT01394523|11066963|FG000|STARTED|Overall Study||13
9948130|NCT01394523|11066964|FG001|STARTED|Overall Study||13
9948131|NCT01394523|11066965|FG002|STARTED|Overall Study||13
9948132|NCT01394523|11066963|FG000|COMPLETED|Overall Study||12
9948133|NCT01394523|11066964|FG001|COMPLETED|Overall Study||13
9948134|NCT01394523|11066965|FG002|COMPLETED|Overall Study||13
9948135|NCT01394523|11066963|FG000|NOT COMPLETED|Overall Study||1
9948136|NCT01394523|11066964|FG001|NOT COMPLETED|Overall Study||0
9948137|NCT01394523|11066965|FG002|NOT COMPLETED|Overall Study||0
9948138|NCT01394614|11066975|FG000|STARTED|Overall Study||8
9948139|NCT01394614|11066976|FG001|STARTED|Overall Study||16
9948140|NCT01394614|11066975|FG000|COMPLETED|Overall Study||8
9948141|NCT01394614|11066976|FG001|COMPLETED|Overall Study||16
9948142|NCT01394614|11066975|FG000|NOT COMPLETED|Overall Study||0
9948143|NCT01394614|11066976|FG001|NOT COMPLETED|Overall Study||0
9948144|NCT01394627|11066982|FG000|STARTED|First Intervention (1 Day)||8
9948145|NCT01394627|11066983|FG001|STARTED|First Intervention (1 Day)||13
9948146|NCT01394627|11066982|FG000|COMPLETED|First Intervention (1 Day)||8
9948147|NCT01394627|11066983|FG001|COMPLETED|First Intervention (1 Day)||12
9948148|NCT01394627|11066982|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9948149|NCT01394627|11066983|FG001|NOT COMPLETED|First Intervention (1 Day)||1
9948150|NCT01394627|11066982|FG000|STARTED|Washout (1-3 Months)||8
9948151|NCT01394627|11066983|FG001|STARTED|Washout (1-3 Months)||12
9948152|NCT01394627|11066982|FG000|COMPLETED|Washout (1-3 Months)||7
9948153|NCT01394627|11066983|FG001|COMPLETED|Washout (1-3 Months)||12
9948154|NCT01394627|11066982|FG000|NOT COMPLETED|Washout (1-3 Months)||1
9948155|NCT01394627|11066983|FG001|NOT COMPLETED|Washout (1-3 Months)||0
9948156|NCT01394627|11066982|FG000|STARTED|Second Intervention (1 Day)||7
9948157|NCT01394627|11066983|FG001|STARTED|Second Intervention (1 Day)||12
9948158|NCT01394627|11066982|FG000|COMPLETED|Second Intervention (1 Day)||7
9948159|NCT01394627|11066983|FG001|COMPLETED|Second Intervention (1 Day)||12
9948160|NCT01394627|11066982|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9948161|NCT01394627|11066983|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9948162|NCT01394692|11066991|FG000|STARTED|Overall Study||29
9948163|NCT01394692|11066992|FG001|STARTED|Overall Study||29
9760664|NCT00382720|10864421|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
9760665|NCT00382720|10864419|FG000|COMPLETED|Overall Study||0
9760666|NCT00382720|10864420|FG001|COMPLETED|Overall Study||0
9760667|NCT00382720|10864421|FG002|COMPLETED|Overall Study||0
9760668|NCT00382720|10864419|FG000|NOT COMPLETED|Overall Study||79
9760669|NCT00382720|10864420|FG001|NOT COMPLETED|Overall Study||89
9760670|NCT00382720|10864421|FG002|NOT COMPLETED|Overall Study||86
9760671|NCT00382733|10864429|FG000|STARTED|Overall Study||3
9760672|NCT00382733|10864430|FG001|STARTED|Overall Study||4
9760673|NCT00382733|10864431|FG002|STARTED|Overall Study||3
9760674|NCT00382733|10864432|FG003|STARTED|Overall Study||14
9760675|NCT00382733|10864433|FG004|STARTED|Overall Study||2
9760676|NCT00382733|10864429|FG000|COMPLETED|Overall Study||3
9760677|NCT00382733|10864430|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
9760678|NCT00382733|10864431|FG002|COMPLETED|Overall Study||3
9760679|NCT00382733|10864432|FG003|COMPLETED|Overall Study||14
9760680|NCT00382733|10864433|FG004|COMPLETED|Overall Study||2
9760681|NCT00382733|10864429|FG000|NOT COMPLETED|Overall Study||0
9760682|NCT00382733|10864430|FG001|NOT COMPLETED|Overall Study||1
9760683|NCT00382733|10864431|FG002|NOT COMPLETED|Overall Study||0
9760684|NCT00382733|10864432|FG003|NOT COMPLETED|Overall Study||0
9760685|NCT00382733|10864433|FG004|NOT COMPLETED|Overall Study||0
9760686|NCT00382785|10864448|FG000|STARTED|Overall Study||25
9760687|NCT00382785|10864449|FG001|STARTED|Overall Study||26
9760688|NCT00382785|10864448|FG000|COMPLETED|Overall Study||25
9760689|NCT00382785|10864449|FG001|COMPLETED|Overall Study||26
9760690|NCT00382785|10864448|FG000|NOT COMPLETED|Overall Study||0
9760691|NCT00382785|10864449|FG001|NOT COMPLETED|Overall Study||0
9760692|NCT00382824|10864457|FG000|STARTED|Overall Study||32
9760693|NCT00382824|10864458|FG001|STARTED|Overall Study||29
9948164|NCT01394692|11066991|FG000|COMPLETED|Overall Study||29
9948165|NCT01394692|11066992|FG001|COMPLETED|Overall Study||29
10208871|NCT03559218|11335982|FG000|NOT COMPLETED|Overall Study||1
10208872|NCT03559218|11335983|FG001|NOT COMPLETED|Overall Study||0
10208873|NCT03559257|11335991|FG000|STARTED|Double Blind Treatment Period||230
10208874|NCT03559257|11335992|FG001|STARTED|Double Blind Treatment Period||233
9948166|NCT01394692|11066991|FG000|NOT COMPLETED|Overall Study||0
9948167|NCT01394692|11066992|FG001|NOT COMPLETED|Overall Study||0
9948168|NCT01394705|11067000|FG000|STARTED|Overall Study||21
9948169|NCT01394705|11067001|FG001|STARTED|Overall Study||21
9948170|NCT01394705|11067000|FG000|COMPLETED|Overall Study||19
10208875|NCT03559257|11335991|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
9760694|NCT00382824|10864457|FG000|COMPLETED|Overall Study||20
9760695|NCT00382824|10864458|FG001|COMPLETED|Overall Study||16
9948171|NCT01394705|11067001|FG001|COMPLETED|Overall Study||19
9948172|NCT01394705|11067000|FG000|NOT COMPLETED|Overall Study||2
9948173|NCT01394705|11067001|FG001|NOT COMPLETED|Overall Study||2
9948174|NCT01394718|11067010|FG000|STARTED|Overall Study||30
9948175|NCT01394718|11067011|FG001|STARTED|Overall Study||30
9948176|NCT01394718|11067010|FG000|COMPLETED|Overall Study||28
9948177|NCT01394718|11067011|FG001|COMPLETED|Overall Study||29
9948178|NCT01394718|11067010|FG000|NOT COMPLETED|Overall Study||2
9948179|NCT01394718|11067011|FG001|NOT COMPLETED|Overall Study||1
9948180|NCT01394939|11067021|FG000|STARTED|Overall Study||4
9948181|NCT01394939|11067022|FG001|STARTED|Overall Study||25
9948182|NCT01394939|11067023|FG002|STARTED|Overall Study||4
9948183|NCT01394939|11067024|FG003|STARTED|Overall Study||17
9948184|NCT01394939|11067021|FG000|COMPLETED|Overall Study||3
9948185|NCT01394939|11067022|FG001|COMPLETED|Overall Study||15
9948186|NCT01394939|11067023|FG002|COMPLETED|Overall Study||4
9948187|NCT01394939|11067024|FG003|COMPLETED|Overall Study||10
9948188|NCT01394939|11067021|FG000|NOT COMPLETED|Overall Study||1
9948189|NCT01394939|11067022|FG001|NOT COMPLETED|Overall Study||10
9948190|NCT01394939|11067023|FG002|NOT COMPLETED|Overall Study||0
9948191|NCT01394939|11067024|FG003|NOT COMPLETED|Overall Study||7
9948192|NCT01394952|11067036|FG000|STARTED|Overall Study||4952
9948193|NCT01394952|11067037|FG001|STARTED|Overall Study||4949
9948194|NCT01394952|11067036|FG000|Received at Least One Dose of Study Drug|Overall Study||4949
9948195|NCT01394952|11067037|FG001|Received at Least One Dose of Study Drug|Overall Study||4943
9948196|NCT01394952|11067036|FG000|COMPLETED|Overall Study||4935
9948197|NCT01394952|11067037|FG001|COMPLETED|Overall Study||4932
9948198|NCT01394952|11067036|FG000|NOT COMPLETED|Overall Study||17
9948199|NCT01394952|11067037|FG001|NOT COMPLETED|Overall Study||17
9948200|NCT01394978|11067046|FG000|STARTED|Overall Study||168
9948201|NCT01394978|11067047|FG001|STARTED|Overall Study||276
9948202|NCT01394978|11067046|FG000|COMPLETED|Overall Study||147
9948203|NCT01394978|11067047|FG001|COMPLETED|Overall Study||245
9948204|NCT01394978|11067046|FG000|NOT COMPLETED|Overall Study||21
10011730|NCT01781975|11134508|FG001|NOT COMPLETED|Overall Study||1
10011731|NCT01782131|11134516|FG000|STARTED|Overall Study||293
9948205|NCT01394978|11067047|FG001|NOT COMPLETED|Overall Study||31
9948206|NCT01394991|11067056|FG000|STARTED|Overall Study||242
9948207|NCT01394991|11067057|FG001|STARTED|Overall Study||262
9948208|NCT01394991|11067056|FG000|COMPLETED|Overall Study||183
9948209|NCT01394991|11067057|FG001|COMPLETED|Overall Study||190
9948210|NCT01394991|11067056|FG000|NOT COMPLETED|Overall Study||59
9948211|NCT01394991|11067057|FG001|NOT COMPLETED|Overall Study||72
9948212|NCT01395017|11067065|FG000|STARTED|Overall Study||100
9948213|NCT01395017|11067066|FG001|STARTED|Overall Study||102
9948214|NCT01395017|11067065|FG000|Treated|Overall Study||98
9948215|NCT01395017|11067066|FG001|Treated|Overall Study||101
9948216|NCT01395017|11067065|FG000|COMPLETED|Overall Study||0
9948217|NCT01395017|11067066|FG001|COMPLETED|Overall Study||0
9948218|NCT01395017|11067065|FG000|NOT COMPLETED|Overall Study||100
9948219|NCT01395017|11067066|FG001|NOT COMPLETED|Overall Study||102
9948220|NCT01395030|11067073|FG000|STARTED|Overall Study||64
9948221|NCT01395030|11067073|FG000|Complete FCH PET/CT|Overall Study||57
9948222|NCT01395030|11067073|FG000|Adequate Tissue for Analysis|Overall Study||50
9948223|NCT01395030|11067073|FG000|COMPLETED|Overall Study||57
9948224|NCT01395030|11067073|FG000|NOT COMPLETED|Overall Study||7
9948225|NCT01395043|11067079|FG000|STARTED|Overall Study||15
9948226|NCT01395043|11067079|FG000|COMPLETED|Overall Study||15
9948227|NCT01395043|11067079|FG000|NOT COMPLETED|Overall Study||0
9948228|NCT01395277|11067086|FG000|STARTED|Overall Study||15
9948229|NCT01395277|11067087|FG001|STARTED|Overall Study||15
9948230|NCT01395277|11067086|FG000|COMPLETED|Overall Study||15
9948231|NCT01395277|11067087|FG001|COMPLETED|Overall Study||15
9948232|NCT01395277|11067086|FG000|NOT COMPLETED|Overall Study||0
9948233|NCT01395277|11067087|FG001|NOT COMPLETED|Overall Study||0
9948234|NCT01395316|11067095|FG000|STARTED|Overall Study||8
9948235|NCT01395316|11067095|FG000|COMPLETED|Overall Study||5
9948236|NCT01395316|11067095|FG000|NOT COMPLETED|Overall Study||3
9948237|NCT01395329|11067102|FG000|STARTED|Overall Study||14
9948238|NCT01395329|11067103|FG001|STARTED|Overall Study||14
9948239|NCT01395329|11067104|FG002|STARTED|Overall Study||14
9948240|NCT01395329|11067102|FG000|COMPLETED|Overall Study||14
9948241|NCT01395329|11067103|FG001|COMPLETED|Overall Study||14
9948242|NCT01395329|11067104|FG002|COMPLETED|Overall Study||14
9948243|NCT01395329|11067102|FG000|NOT COMPLETED|Overall Study||0
9948244|NCT01395329|11067103|FG001|NOT COMPLETED|Overall Study||0
9948245|NCT01395329|11067104|FG002|NOT COMPLETED|Overall Study||0
9948246|NCT01395368|11067115|FG000|STARTED|Overall Study||108
9948247|NCT01395368|11067115|FG000|COMPLETED|Overall Study||92
9948248|NCT01395368|11067115|FG000|NOT COMPLETED|Overall Study||16
9948249|NCT01395394|11067122|FG000|STARTED|Baseline Study Visit||4
9948250|NCT01395394|11067123|FG001|STARTED|Baseline Study Visit||3
9948251|NCT01395394|11067124|FG002|STARTED|Baseline Study Visit||5
9948252|NCT01395394|11067122|FG000|COMPLETED|Baseline Study Visit||3
9948253|NCT01395394|11067123|FG001|COMPLETED|Baseline Study Visit||3
9948254|NCT01395394|11067124|FG002|COMPLETED|Baseline Study Visit||5
9948255|NCT01395394|11067122|FG000|NOT COMPLETED|Baseline Study Visit||1
9948256|NCT01395394|11067123|FG001|NOT COMPLETED|Baseline Study Visit||0
10011732|NCT01782131|11134517|FG001|STARTED|Overall Study||292
9948257|NCT01395394|11067124|FG002|NOT COMPLETED|Baseline Study Visit||0
9948258|NCT01395394|11067122|FG000|STARTED|Study Visit 2 (Non-responders Only)||3
9948259|NCT01395394|11067123|FG001|STARTED|Study Visit 2 (Non-responders Only)||0
9948260|NCT01395394|11067124|FG002|STARTED|Study Visit 2 (Non-responders Only)||0
10011733|NCT01782131|11134516|FG000|Treated|Overall Study||288
9948261|NCT01395394|11067122|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3
9948262|NCT01395394|11067123|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0
9948263|NCT01395394|11067124|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0
9948264|NCT01395394|11067122|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
9948265|NCT01395394|11067123|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
9948266|NCT01395394|11067124|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
9948267|NCT01395524|11067135|FG000|STARTED|Overall Study||97
9948268|NCT01395524|11067136|FG001|STARTED|Overall Study||99
9948269|NCT01395524|11067137|FG002|STARTED|Overall Study||106
9948270|NCT01395524|11067135|FG000|COMPLETED|Overall Study||79
9948271|NCT01395524|11067136|FG001|COMPLETED|Overall Study||83
9948272|NCT01395524|11067137|FG002|COMPLETED|Overall Study||89
9948273|NCT01395524|11067135|FG000|NOT COMPLETED|Overall Study||18
9948274|NCT01395524|11067136|FG001|NOT COMPLETED|Overall Study||16
9948275|NCT01395524|11067137|FG002|NOT COMPLETED|Overall Study||17
9948276|NCT01395537|11067145|FG000|STARTED|Phase I||13
9948277|NCT01395537|11067145|FG000|COMPLETED|Phase I||13
9948278|NCT01395537|11067145|FG000|NOT COMPLETED|Phase I||0
9948279|NCT01395537|11067145|FG000|STARTED|Phase II||1
9948280|NCT01395537|11067145|FG000|COMPLETED|Phase II||1
9948281|NCT01395537|11067145|FG000|NOT COMPLETED|Phase II||0
9948282|NCT01395758|11067151|FG000|STARTED|Open-label Treatment Period||51
9948283|NCT01395758|11067152|FG001|STARTED|Open-label Treatment Period||45
9948284|NCT01395758|11067153|FG002|STARTED|Open-label Treatment Period||0
9948285|NCT01395758|11067151|FG000|COMPLETED|Open-label Treatment Period||47
9948286|NCT01395758|11067152|FG001|COMPLETED|Open-label Treatment Period||45
9948287|NCT01395758|11067153|FG002|COMPLETED|Open-label Treatment Period||0
9948288|NCT01395758|11067151|FG000|NOT COMPLETED|Open-label Treatment Period||4
9948289|NCT01395758|11067152|FG001|NOT COMPLETED|Open-label Treatment Period||0
9948290|NCT01395758|11067153|FG002|NOT COMPLETED|Open-label Treatment Period||0
9948291|NCT01395758|11067151|FG000|STARTED|Crossover Period||0
10208876|NCT03559257|11335992|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
10208877|NCT03559257|11335991|FG000|COMPLETED|Double Blind Treatment Period||226
10208878|NCT03559257|11335992|FG001|COMPLETED|Double Blind Treatment Period||225
10208879|NCT03559257|11335991|FG000|NOT COMPLETED|Double Blind Treatment Period||4
10208880|NCT03559257|11335992|FG001|NOT COMPLETED|Double Blind Treatment Period||8
10208881|NCT03559257|11335991|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
10208882|NCT03559257|11335992|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
9948292|NCT01395758|11067152|FG001|STARTED|Crossover Period||0
9948293|NCT01395758|11067153|FG002|STARTED|Crossover Period||26
9948294|NCT01395758|11067151|FG000|COMPLETED|Crossover Period||0
9948295|NCT01395758|11067152|FG001|COMPLETED|Crossover Period||0
9948296|NCT01395758|11067153|FG002|COMPLETED|Crossover Period||26
9948297|NCT01395758|11067151|FG000|NOT COMPLETED|Crossover Period||0
9948298|NCT01395758|11067152|FG001|NOT COMPLETED|Crossover Period||0
9948299|NCT01395758|11067153|FG002|NOT COMPLETED|Crossover Period||0
9948300|NCT01395784|11067160|FG000|STARTED|Overall Study||32
9948301|NCT01395784|11067160|FG000|COMPLETED|Overall Study||17
9948302|NCT01395784|11067160|FG000|NOT COMPLETED|Overall Study||15
9948303|NCT01395797|11067170|FG000|STARTED|Overall Study||19
9948304|NCT01395797|11067171|FG001|STARTED|Overall Study||4
9948305|NCT01395797|11067172|FG002|STARTED|Overall Study||18
9948306|NCT01395797|11067173|FG003|STARTED|Overall Study||15
9948307|NCT01395797|11067174|FG004|STARTED|Overall Study||9
9948308|NCT01395797|11067175|FG005|STARTED|Overall Study||17
9948309|NCT01395797|11067170|FG000|COMPLETED|Overall Study||16
9948310|NCT01395797|11067171|FG001|COMPLETED|Overall Study||3
9948311|NCT01395797|11067172|FG002|COMPLETED|Overall Study||14
9948312|NCT01395797|11067173|FG003|COMPLETED|Overall Study||13
9948313|NCT01395797|11067174|FG004|COMPLETED|Overall Study||7
9948314|NCT01395797|11067175|FG005|COMPLETED|Overall Study||14
9948315|NCT01395797|11067170|FG000|NOT COMPLETED|Overall Study||3
9948316|NCT01395797|11067171|FG001|NOT COMPLETED|Overall Study||1
9948317|NCT01395797|11067172|FG002|NOT COMPLETED|Overall Study||4
9948318|NCT01395797|11067173|FG003|NOT COMPLETED|Overall Study||2
9948319|NCT01395797|11067174|FG004|NOT COMPLETED|Overall Study||2
9948320|NCT01395797|11067175|FG005|NOT COMPLETED|Overall Study||3
9948321|NCT01395810|11067199|FG000|STARTED|Overall Study||18
9948322|NCT01395810|11067200|FG001|STARTED|Overall Study||48
9948323|NCT01395810|11067201|FG002|STARTED|Overall Study||0
9948324|NCT01395810|11067202|FG003|STARTED|Overall Study||5
9948325|NCT01395810|11067199|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
9948326|NCT01395810|11067200|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
9948327|NCT01395810|11067201|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
9948328|NCT01395810|11067202|FG003|After Switching the Arms|Overall Study||5
9948329|NCT01395810|11067199|FG000|COMPLETED|Overall Study||16
9948330|NCT01395810|11067200|FG001|COMPLETED|Overall Study||44
9948331|NCT01395810|11067201|FG002|COMPLETED|Overall Study||0
9948332|NCT01395810|11067202|FG003|COMPLETED|Overall Study||5
9948333|NCT01395810|11067199|FG000|NOT COMPLETED|Overall Study||2
9948334|NCT01395810|11067200|FG001|NOT COMPLETED|Overall Study||4
9948335|NCT01395810|11067201|FG002|NOT COMPLETED|Overall Study||0
9948336|NCT01395810|11067202|FG003|NOT COMPLETED|Overall Study||0
9948337|NCT01395823|11067215|FG000|STARTED|Overall Study||137
9948338|NCT01395823|11067216|FG001|STARTED|Overall Study||139
9948339|NCT01395823|11067215|FG000|COMPLETED|Overall Study||122
10208883|NCT03559257|11335991|FG000|COMPLETED|Open-label Treatment Period||215
10208884|NCT03559257|11335992|FG001|COMPLETED|Open-label Treatment Period||217
10208885|NCT03559257|11335991|FG000|NOT COMPLETED|Open-label Treatment Period||10
10208886|NCT03559257|11335992|FG001|NOT COMPLETED|Open-label Treatment Period||7
10208887|NCT03559517|11336004|FG000|STARTED|Overall Study||8
9948340|NCT01395823|11067216|FG001|COMPLETED|Overall Study||130
9948341|NCT01395823|11067215|FG000|NOT COMPLETED|Overall Study||15
9948342|NCT01395823|11067216|FG001|NOT COMPLETED|Overall Study||9
9948343|NCT01395888|11067224|FG000|STARTED|2-week Run-in Period||279
9948344|NCT01395888|11067225|FG001|STARTED|2-week Run-in Period||0
9948345|NCT01395888|11067226|FG002|STARTED|2-week Run-in Period||0
9948346|NCT01395888|11067224|FG000|COMPLETED|2-week Run-in Period||257
9948347|NCT01395888|11067225|FG001|COMPLETED|2-week Run-in Period||0
9948348|NCT01395888|11067226|FG002|COMPLETED|2-week Run-in Period||0
9948349|NCT01395888|11067224|FG000|NOT COMPLETED|2-week Run-in Period||22
9948350|NCT01395888|11067225|FG001|NOT COMPLETED|2-week Run-in Period||0
9948351|NCT01395888|11067226|FG002|NOT COMPLETED|2-week Run-in Period||0
9948352|NCT01395888|11067224|FG000|STARTED|Treatment Period (TP)||0
9948353|NCT01395888|11067225|FG001|STARTED|Treatment Period (TP)||127
9948354|NCT01395888|11067226|FG002|STARTED|Treatment Period (TP)||130
9948355|NCT01395888|11067224|FG000|Completed the Treatment Period|Treatment Period (TP)||0
9948356|NCT01395888|11067225|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
9948357|NCT01395888|11067226|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
9948358|NCT01395888|11067224|FG000|COMPLETED|Treatment Period (TP)||0
9948359|NCT01395888|11067225|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
9948360|NCT01395888|11067226|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
9948361|NCT01395888|11067224|FG000|NOT COMPLETED|Treatment Period (TP)||0
9948362|NCT01395888|11067225|FG001|NOT COMPLETED|Treatment Period (TP)||15
9948363|NCT01395888|11067226|FG002|NOT COMPLETED|Treatment Period (TP)||17
9948364|NCT01395901|11067234|FG000|STARTED|Overall Study|Randomized Population|336
9948365|NCT01395901|11067235|FG001|STARTED|Overall Study|Randomized Population|334
9948366|NCT01395901|11067234|FG000|COMPLETED|Overall Study|Treated patients completing the study|326
9948367|NCT01395901|11067235|FG001|COMPLETED|Overall Study|Treated patients completing the study|329
9948368|NCT01395901|11067234|FG000|NOT COMPLETED|Overall Study||10
9948369|NCT01395901|11067235|FG001|NOT COMPLETED|Overall Study||5
9948370|NCT01395914|11067243|FG000|STARTED|Overall Study||345
9948371|NCT01395914|11067244|FG001|STARTED|Overall Study||168
9948372|NCT01395914|11067243|FG000|ITT Population|Overall Study||345
9948373|NCT01395914|11067244|FG001|ITT Population|Overall Study||168
9948374|NCT01395914|11067243|FG000|Safety Population|Overall Study||343
9948375|NCT01395914|11067244|FG001|Safety Population|Overall Study||167
9948376|NCT01395914|11067243|FG000|COMPLETED|Overall Study||273
9948377|NCT01395914|11067244|FG001|COMPLETED|Overall Study||131
9948378|NCT01395914|11067243|FG000|NOT COMPLETED|Overall Study||72
9948379|NCT01395914|11067244|FG001|NOT COMPLETED|Overall Study||37
9948380|NCT01395966|11067253|FG000|STARTED|Overall Study||109
9948381|NCT01395966|11067254|FG001|STARTED|Overall Study||110
9948382|NCT01395966|11067255|FG002|STARTED|Overall Study||112
9948383|NCT01395966|11067253|FG000|COMPLETED|Overall Study||99
9948384|NCT01395966|11067254|FG001|COMPLETED|Overall Study||91
9948385|NCT01395966|11067255|FG002|COMPLETED|Overall Study||104
9948386|NCT01395966|11067253|FG000|NOT COMPLETED|Overall Study||10
9948387|NCT01395966|11067254|FG001|NOT COMPLETED|Overall Study||19
9948388|NCT01395966|11067255|FG002|NOT COMPLETED|Overall Study||8
9948389|NCT01396005|11067265|FG000|STARTED|Overall Study||10
9948390|NCT01396005|11067266|FG001|STARTED|Overall Study||11
9948391|NCT01396005|11067265|FG000|COMPLETED|Overall Study||10
9948392|NCT01396005|11067266|FG001|COMPLETED|Overall Study||9
9948393|NCT01396005|11067265|FG000|NOT COMPLETED|Overall Study||0
9948394|NCT01396005|11067266|FG001|NOT COMPLETED|Overall Study||2
9948395|NCT01396044|11067276|FG000|STARTED|Overall Study||125
9948396|NCT01396044|11067277|FG001|STARTED|Overall Study||171
9948397|NCT01396044|11067276|FG000|COMPLETED|Overall Study||125
9948398|NCT01396044|11067277|FG001|COMPLETED|Overall Study||171
9948399|NCT01396044|11067276|FG000|NOT COMPLETED|Overall Study||0
9948400|NCT01396044|11067277|FG001|NOT COMPLETED|Overall Study||0
9948401|NCT01396057|11067285|FG000|STARTED|Overall Study||126
9948402|NCT01396057|11067286|FG001|STARTED|Overall Study||118
9948403|NCT01396057|11067285|FG000|COMPLETED|Overall Study||115
9948404|NCT01396057|11067286|FG001|COMPLETED|Overall Study||100
9948405|NCT01396057|11067285|FG000|NOT COMPLETED|Overall Study||11
9948406|NCT01396057|11067286|FG001|NOT COMPLETED|Overall Study||18
9948407|NCT01396070|11067292|FG000|STARTED|Overall Study||36
9948408|NCT01396070|11067292|FG000|COMPLETED|Overall Study||17
9948409|NCT01396070|11067292|FG000|NOT COMPLETED|Overall Study||19
9948410|NCT01396083|11067299|FG000|STARTED|Overall Study||124
9948411|NCT01396083|11067300|FG001|STARTED|Overall Study||119
9948412|NCT01396083|11067299|FG000|COMPLETED|Overall Study||113
9948413|NCT01396083|11067300|FG001|COMPLETED|Overall Study||72
9948414|NCT01396083|11067299|FG000|NOT COMPLETED|Overall Study||11
9948415|NCT01396083|11067300|FG001|NOT COMPLETED|Overall Study||47
10208888|NCT03559517|11336005|FG001|STARTED|Overall Study||9
9948416|NCT01396148|11067306|FG000|STARTED|Overall Study||6
9948417|NCT01396148|11067306|FG000|COMPLETED|Overall Study||5
9948418|NCT01396148|11067306|FG000|NOT COMPLETED|Overall Study||1
9948419|NCT01396161|11067319|FG000|STARTED|Overall Study||12
9948420|NCT01396161|11067320|FG001|STARTED|Overall Study||5
9948421|NCT01396161|11067321|FG002|STARTED|Overall Study||9
9948422|NCT01396161|11067322|FG003|STARTED|Overall Study||9
9948423|NCT01396161|11067323|FG004|STARTED|Overall Study||9
9948424|NCT01396161|11067324|FG005|STARTED|Overall Study||9
9948425|NCT01396161|11067325|FG006|STARTED|Overall Study||11
9948426|NCT01396161|11067319|FG000|COMPLETED|Overall Study||12
9948427|NCT01396161|11067320|FG001|COMPLETED|Overall Study||5
9948428|NCT01396161|11067321|FG002|COMPLETED|Overall Study||9
9948429|NCT01396161|11067322|FG003|COMPLETED|Overall Study||9
9948430|NCT01396161|11067323|FG004|COMPLETED|Overall Study||8
9948431|NCT01396161|11067324|FG005|COMPLETED|Overall Study||9
9948432|NCT01396161|11067325|FG006|COMPLETED|Overall Study||10
9948433|NCT01396161|11067319|FG000|NOT COMPLETED|Overall Study||0
9948434|NCT01396161|11067320|FG001|NOT COMPLETED|Overall Study||0
9948435|NCT01396161|11067321|FG002|NOT COMPLETED|Overall Study||0
9948436|NCT01396161|11067322|FG003|NOT COMPLETED|Overall Study||0
9948437|NCT01396161|11067323|FG004|NOT COMPLETED|Overall Study||1
9948438|NCT01396161|11067324|FG005|NOT COMPLETED|Overall Study||0
9948439|NCT01396161|11067325|FG006|NOT COMPLETED|Overall Study||1
9948440|NCT01396187|11067351|FG000|STARTED|Overall Study||8
9948441|NCT01396187|11067352|FG001|STARTED|Overall Study||12
9948442|NCT01396187|11067353|FG002|STARTED|Overall Study||10
9948443|NCT01396187|11067354|FG003|STARTED|Overall Study||10
9948444|NCT01396187|11067355|FG004|STARTED|Overall Study||10
9948445|NCT01396187|11067351|FG000|COMPLETED|Overall Study||7
9948446|NCT01396187|11067352|FG001|COMPLETED|Overall Study||9
9948447|NCT01396187|11067353|FG002|COMPLETED|Overall Study||9
9948448|NCT01396187|11067354|FG003|COMPLETED|Overall Study||10
9948449|NCT01396187|11067355|FG004|COMPLETED|Overall Study||9
9948450|NCT01396187|11067351|FG000|NOT COMPLETED|Overall Study||1
9948451|NCT01396187|11067352|FG001|NOT COMPLETED|Overall Study||3
9948452|NCT01396187|11067353|FG002|NOT COMPLETED|Overall Study||1
9948453|NCT01396187|11067354|FG003|NOT COMPLETED|Overall Study||0
9948454|NCT01396187|11067355|FG004|NOT COMPLETED|Overall Study||1
9948455|NCT01396226|11067373|FG000|STARTED|Overall Study||12
9948456|NCT01396226|11067374|FG001|STARTED|Overall Study||6
9948457|NCT01396226|11067373|FG000|Patients Who Received Treatment|Overall Study||12
9948458|NCT01396226|11067374|FG001|Patients Who Received Treatment|Overall Study||6
9948459|NCT01396226|11067373|FG000|Patients Who Completed Treatment|Overall Study||12
9948460|NCT01396226|11067374|FG001|Patients Who Completed Treatment|Overall Study||6
9948461|NCT01396226|11067373|FG000|COMPLETED|Overall Study||12
9948462|NCT01396226|11067374|FG001|COMPLETED|Overall Study||6
9948463|NCT01396226|11067373|FG000|NOT COMPLETED|Overall Study||0
9948464|NCT01396226|11067374|FG001|NOT COMPLETED|Overall Study||0
9948465|NCT01396239|11067383|FG000|STARTED|Overall Study||4
9948466|NCT01396239|11067384|FG001|STARTED|Overall Study||2
9948467|NCT01396239|11067385|FG002|STARTED|Overall Study||4
9948468|NCT01396239|11067386|FG003|STARTED|Overall Study||2
9948469|NCT01396239|11067383|FG000|COMPLETED|Overall Study||4
9948470|NCT01396239|11067384|FG001|COMPLETED|Overall Study||2
9948471|NCT01396239|11067385|FG002|COMPLETED|Overall Study||4
9948472|NCT01396239|11067386|FG003|COMPLETED|Overall Study||2
9948473|NCT01396239|11067383|FG000|NOT COMPLETED|Overall Study||0
9948474|NCT01396239|11067384|FG001|NOT COMPLETED|Overall Study||0
9948475|NCT01396239|11067385|FG002|NOT COMPLETED|Overall Study||0
9948476|NCT01396239|11067386|FG003|NOT COMPLETED|Overall Study||0
9948477|NCT01396265|11067403|FG000|STARTED|Afatinib||22
9948478|NCT01396265|11067403|FG000|COMPLETED|Afatinib||22
9948479|NCT01396265|11067403|FG000|NOT COMPLETED|Afatinib||0
9948480|NCT01396265|11067403|FG000|STARTED|Washout||22
9948481|NCT01396265|11067403|FG000|COMPLETED|Washout||22
9948482|NCT01396265|11067403|FG000|NOT COMPLETED|Washout||0
9948483|NCT01396265|11067403|FG000|STARTED|Rifa+Afatinib||22
9948484|NCT01396265|11067403|FG000|COMPLETED|Rifa+Afatinib||21
9948485|NCT01396265|11067403|FG000|NOT COMPLETED|Rifa+Afatinib||1
9948486|NCT01396317|11067411|FG000|STARTED|Overall Study||10
9948487|NCT01396317|11067412|FG001|STARTED|Overall Study||10
9948488|NCT01396317|11067411|FG000|COMPLETED|Overall Study||9
9948489|NCT01396317|11067412|FG001|COMPLETED|Overall Study||10
9948490|NCT01396317|11067411|FG000|NOT COMPLETED|Overall Study||1
9948491|NCT01396317|11067412|FG001|NOT COMPLETED|Overall Study||0
9948492|NCT01396382|11067420|FG000|STARTED|Overall Study||97
9948493|NCT01396382|11067420|FG000|COMPLETED|Overall Study||97
9948494|NCT01396382|11067420|FG000|NOT COMPLETED|Overall Study||0
9948495|NCT01396395|11067427|FG000|STARTED|Overall Study||200
9948496|NCT01396395|11067428|FG001|STARTED|Overall Study||202
9948497|NCT01396395|11067427|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
9948498|NCT01396395|11067428|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
9948499|NCT01396395|11067427|FG000|COMPLETED|Overall Study||160
9948500|NCT01396395|11067428|FG001|COMPLETED|Overall Study||175
9948501|NCT01396395|11067427|FG000|NOT COMPLETED|Overall Study||40
9948502|NCT01396395|11067428|FG001|NOT COMPLETED|Overall Study||27
9948503|NCT01396421|11067440|FG000|STARTED|Overall Study||180
9948504|NCT01396421|11067441|FG001|STARTED|Overall Study||182
9948505|NCT01396421|11067442|FG002|STARTED|Overall Study||90
9948506|NCT01396421|11067443|FG003|STARTED|Overall Study||184
10011734|NCT01782131|11134517|FG001|Treated|Overall Study||287
10011735|NCT01782131|11134516|FG000|COMPLETED|Overall Study||184
10011736|NCT01782131|11134517|FG001|COMPLETED|Overall Study||177
10011737|NCT01782131|11134516|FG000|NOT COMPLETED|Overall Study||109
9948507|NCT01396421|11067440|FG000|COMPLETED|Overall Study||121
9948508|NCT01396421|11067441|FG001|COMPLETED|Overall Study||124
9948509|NCT01396421|11067442|FG002|COMPLETED|Overall Study||56
9948510|NCT01396421|11067443|FG003|COMPLETED|Overall Study||109
9948511|NCT01396421|11067440|FG000|NOT COMPLETED|Overall Study||59
9948512|NCT01396421|11067441|FG001|NOT COMPLETED|Overall Study||58
9948513|NCT01396421|11067442|FG002|NOT COMPLETED|Overall Study||34
9948514|NCT01396421|11067443|FG003|NOT COMPLETED|Overall Study||75
9948515|NCT01396434|11067470|FG000|STARTED|Overall Study||2817
9948516|NCT01396434|11067471|FG001|STARTED|Overall Study||175
9948517|NCT01396434|11067472|FG002|STARTED|Overall Study||14
9948518|NCT01396434|11067470|FG000|COMPLETED|Overall Study||2806
9948519|NCT01396434|11067471|FG001|COMPLETED|Overall Study||175
9948520|NCT01396434|11067472|FG002|COMPLETED|Overall Study||14
9948521|NCT01396434|11067470|FG000|NOT COMPLETED|Overall Study||11
9948522|NCT01396434|11067471|FG001|NOT COMPLETED|Overall Study||0
9948523|NCT01396434|11067472|FG002|NOT COMPLETED|Overall Study||0
9948524|NCT01396447|11067484|FG000|STARTED|Overall Study||148
9948525|NCT01396447|11067485|FG001|STARTED|Overall Study||143
9948526|NCT01396447|11067486|FG002|STARTED|Overall Study||147
9948527|NCT01396447|11067487|FG003|STARTED|Overall Study||146
9948528|NCT01396447|11067484|FG000|Received Treatment|Overall Study||145
9948529|NCT01396447|11067485|FG001|Received Treatment|Overall Study||141
9948530|NCT01396447|11067486|FG002|Received Treatment|Overall Study||146
9948531|NCT01396447|11067487|FG003|Received Treatment|Overall Study||146
9948532|NCT01396447|11067484|FG000|COMPLETED|Overall Study||105
9948533|NCT01396447|11067485|FG001|COMPLETED|Overall Study||103
9948534|NCT01396447|11067486|FG002|COMPLETED|Overall Study||117
9948535|NCT01396447|11067487|FG003|COMPLETED|Overall Study||94
9948536|NCT01396447|11067484|FG000|NOT COMPLETED|Overall Study||43
9948537|NCT01396447|11067485|FG001|NOT COMPLETED|Overall Study||40
9948538|NCT01396447|11067486|FG002|NOT COMPLETED|Overall Study||30
9948539|NCT01396447|11067487|FG003|NOT COMPLETED|Overall Study||52
9948540|NCT01396486|11067500|FG000|STARTED|Overall Study||20
9948541|NCT01396486|11067501|FG001|STARTED|Overall Study||19
9948542|NCT01396486|11067502|FG002|STARTED|Overall Study||22
9948543|NCT01396486|11067500|FG000|Exposed|Overall Study||19
9948544|NCT01396486|11067501|FG001|Exposed|Overall Study||16
9948545|NCT01396486|11067502|FG002|Exposed|Overall Study||17
9948546|NCT01396486|11067500|FG000|COMPLETED|Overall Study||10
9948547|NCT01396486|11067501|FG001|COMPLETED|Overall Study||7
9948548|NCT01396486|11067502|FG002|COMPLETED|Overall Study||10
9948549|NCT01396486|11067500|FG000|NOT COMPLETED|Overall Study||10
9948550|NCT01396486|11067501|FG001|NOT COMPLETED|Overall Study||12
9948551|NCT01396486|11067502|FG002|NOT COMPLETED|Overall Study||12
9948552|NCT01396512|11067512|FG000|STARTED|Overall Study||137
9948553|NCT01396512|11067513|FG001|STARTED|Overall Study||137
9948554|NCT01396512|11067512|FG000|COMPLETED|Overall Study||137
9948555|NCT01396512|11067513|FG001|COMPLETED|Overall Study||136
9948556|NCT01396512|11067512|FG000|NOT COMPLETED|Overall Study||0
9948557|NCT01396512|11067513|FG001|NOT COMPLETED|Overall Study||1
9948558|NCT01396525|11067519|FG000|STARTED|Overall Study||153
9948559|NCT01396525|11067519|FG000|COMPLETED|Overall Study||127
9948560|NCT01396525|11067519|FG000|NOT COMPLETED|Overall Study||26
9948561|NCT01396551|11067527|FG000|STARTED|Overall Study||69
9948562|NCT01396551|11067527|FG000|COMPLETED|Overall Study||69
9948563|NCT01396551|11067527|FG000|NOT COMPLETED|Overall Study||0
9948564|NCT01396837|11067531|FG000|STARTED|Overall Study||20
9948565|NCT01396837|11067531|FG000|COMPLETED|Overall Study||16
9948566|NCT01396837|11067531|FG000|NOT COMPLETED|Overall Study||4
9948567|NCT01397071|11067535|FG000|STARTED|Consumption of Beef Patty Alone||11
9948568|NCT01397071|11067535|FG000|COMPLETED|Consumption of Beef Patty Alone||11
9948569|NCT01397071|11067535|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0
9948570|NCT01397071|11067535|FG000|STARTED|Consumption of Beef Patty With Avocado||11
9948571|NCT01397071|11067535|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11
9948572|NCT01397071|11067535|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
9948573|NCT01397084|11067543|FG000|STARTED|Overall Study||108
9948574|NCT01397084|11067543|FG000|COMPLETED|Overall Study||100
9948575|NCT01397084|11067543|FG000|NOT COMPLETED|Overall Study||8
9948576|NCT01397253|11067549|FG000|STARTED|Overall Study||443
9948577|NCT01397253|11067550|FG001|STARTED|Overall Study||392
9948578|NCT01397253|11067549|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
9948579|NCT01397253|11067550|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
9948580|NCT01397253|11067549|FG000|NOT COMPLETED|Overall Study||126
9948581|NCT01397253|11067550|FG001|NOT COMPLETED|Overall Study||149
9948582|NCT01397409|11067566|FG000|STARTED|Stage 1||9
9948583|NCT01397409|11067567|FG001|STARTED|Stage 1||6
9948584|NCT01397409|11067568|FG002|STARTED|Stage 1||6
9948585|NCT01397409|11067569|FG003|STARTED|Stage 1||3
9948586|NCT01397409|11067570|FG004|STARTED|Stage 1||0
9948587|NCT01397409|11067571|FG005|STARTED|Stage 1||0
9948588|NCT01397409|11067572|FG006|STARTED|Stage 1||0
9948589|NCT01397409|11067573|FG007|STARTED|Stage 1||0
9948590|NCT01397409|11067574|FG008|STARTED|Stage 1||0
9948591|NCT01397409|11067575|FG009|STARTED|Stage 1||0
9948592|NCT01397409|11067566|FG000|COMPLETED|Stage 1||9
10011738|NCT01782131|11134517|FG001|NOT COMPLETED|Overall Study||115
9948593|NCT01397409|11067567|FG001|COMPLETED|Stage 1||6
9948594|NCT01397409|11067568|FG002|COMPLETED|Stage 1||6
9948595|NCT01397409|11067569|FG003|COMPLETED|Stage 1||3
9948596|NCT01397409|11067570|FG004|COMPLETED|Stage 1||0
9948597|NCT01397409|11067571|FG005|COMPLETED|Stage 1||0
9948598|NCT01397409|11067572|FG006|COMPLETED|Stage 1||0
9948599|NCT01397409|11067573|FG007|COMPLETED|Stage 1||0
9948600|NCT01397409|11067574|FG008|COMPLETED|Stage 1||0
9948601|NCT01397409|11067575|FG009|COMPLETED|Stage 1||0
9948602|NCT01397409|11067566|FG000|NOT COMPLETED|Stage 1||0
9948603|NCT01397409|11067567|FG001|NOT COMPLETED|Stage 1||0
9948604|NCT01397409|11067568|FG002|NOT COMPLETED|Stage 1||0
9948605|NCT01397409|11067569|FG003|NOT COMPLETED|Stage 1||0
9948606|NCT01397409|11067570|FG004|NOT COMPLETED|Stage 1||0
9948607|NCT01397409|11067571|FG005|NOT COMPLETED|Stage 1||0
9948608|NCT01397409|11067572|FG006|NOT COMPLETED|Stage 1||0
9948609|NCT01397409|11067573|FG007|NOT COMPLETED|Stage 1||0
9948610|NCT01397409|11067574|FG008|NOT COMPLETED|Stage 1||0
9948611|NCT01397409|11067575|FG009|NOT COMPLETED|Stage 1||0
9948612|NCT01397409|11067566|FG000|STARTED|Stage 2||0
9948613|NCT01397409|11067567|FG001|STARTED|Stage 2||0
9948614|NCT01397409|11067568|FG002|STARTED|Stage 2||0
9948615|NCT01397409|11067569|FG003|STARTED|Stage 2||0
9948616|NCT01397409|11067570|FG004|STARTED|Stage 2||67
9948617|NCT01397409|11067571|FG005|STARTED|Stage 2||58
9948618|NCT01397409|11067572|FG006|STARTED|Stage 2||58
9948619|NCT01397409|11067573|FG007|STARTED|Stage 2||0
9948620|NCT01397409|11067574|FG008|STARTED|Stage 2||0
9948621|NCT01397409|11067575|FG009|STARTED|Stage 2||0
9948622|NCT01397409|11067566|FG000|COMPLETED|Stage 2||0
9948623|NCT01397409|11067567|FG001|COMPLETED|Stage 2||0
9948624|NCT01397409|11067568|FG002|COMPLETED|Stage 2||0
9948625|NCT01397409|11067569|FG003|COMPLETED|Stage 2||0
9948626|NCT01397409|11067570|FG004|COMPLETED|Stage 2||59
9948627|NCT01397409|11067571|FG005|COMPLETED|Stage 2||54
9948628|NCT01397409|11067572|FG006|COMPLETED|Stage 2||58
9948629|NCT01397409|11067573|FG007|COMPLETED|Stage 2||0
9948630|NCT01397409|11067574|FG008|COMPLETED|Stage 2||0
9948631|NCT01397409|11067575|FG009|COMPLETED|Stage 2||0
9948632|NCT01397409|11067566|FG000|NOT COMPLETED|Stage 2||0
9948633|NCT01397409|11067567|FG001|NOT COMPLETED|Stage 2||0
9948634|NCT01397409|11067568|FG002|NOT COMPLETED|Stage 2||0
9948635|NCT01397409|11067569|FG003|NOT COMPLETED|Stage 2||0
9948636|NCT01397409|11067570|FG004|NOT COMPLETED|Stage 2||8
9948637|NCT01397409|11067571|FG005|NOT COMPLETED|Stage 2||4
9948638|NCT01397409|11067572|FG006|NOT COMPLETED|Stage 2||0
9948639|NCT01397409|11067573|FG007|NOT COMPLETED|Stage 2||0
9948640|NCT01397409|11067574|FG008|NOT COMPLETED|Stage 2||0
9948641|NCT01397409|11067575|FG009|NOT COMPLETED|Stage 2||0
9948642|NCT01397409|11067566|FG000|STARTED|Stage 3||0
9948643|NCT01397409|11067567|FG001|STARTED|Stage 3||0
9948644|NCT01397409|11067568|FG002|STARTED|Stage 3||0
9948645|NCT01397409|11067569|FG003|STARTED|Stage 3||0
10011739|NCT01782209|11134523|FG000|STARTED|Overall Study||335
10011740|NCT01782209|11134523|FG000|COMPLETED|Overall Study||225
10011741|NCT01782209|11134523|FG000|NOT COMPLETED|Overall Study||110
10011742|NCT01782222|11134530|FG000|STARTED|Overall Study||40
10011743|NCT01782222|11134531|FG001|STARTED|Overall Study||41
10011744|NCT01782222|11134532|FG002|STARTED|Overall Study||41
9948646|NCT01397409|11067570|FG004|STARTED|Stage 3||0
9948647|NCT01397409|11067571|FG005|STARTED|Stage 3||0
9948648|NCT01397409|11067572|FG006|STARTED|Stage 3||0
9948649|NCT01397409|11067573|FG007|STARTED|Stage 3||23
9948650|NCT01397409|11067574|FG008|STARTED|Stage 3||25
9948651|NCT01397409|11067575|FG009|STARTED|Stage 3||16
9948652|NCT01397409|11067566|FG000|COMPLETED|Stage 3||0
9948653|NCT01397409|11067567|FG001|COMPLETED|Stage 3||0
9948654|NCT01397409|11067568|FG002|COMPLETED|Stage 3||0
9948655|NCT01397409|11067569|FG003|COMPLETED|Stage 3||0
9948656|NCT01397409|11067570|FG004|COMPLETED|Stage 3||0
9948657|NCT01397409|11067571|FG005|COMPLETED|Stage 3||0
9948658|NCT01397409|11067572|FG006|COMPLETED|Stage 3||0
9948659|NCT01397409|11067573|FG007|COMPLETED|Stage 3||21
9948660|NCT01397409|11067574|FG008|COMPLETED|Stage 3||25
9948661|NCT01397409|11067575|FG009|COMPLETED|Stage 3||16
9948662|NCT01397409|11067566|FG000|NOT COMPLETED|Stage 3||0
9948663|NCT01397409|11067567|FG001|NOT COMPLETED|Stage 3||0
9948664|NCT01397409|11067568|FG002|NOT COMPLETED|Stage 3||0
9948665|NCT01397409|11067569|FG003|NOT COMPLETED|Stage 3||0
9948666|NCT01397409|11067570|FG004|NOT COMPLETED|Stage 3||0
9948667|NCT01397409|11067571|FG005|NOT COMPLETED|Stage 3||0
9948668|NCT01397409|11067572|FG006|NOT COMPLETED|Stage 3||0
9948669|NCT01397409|11067573|FG007|NOT COMPLETED|Stage 3||2
9948670|NCT01397409|11067574|FG008|NOT COMPLETED|Stage 3||0
9948671|NCT01397409|11067575|FG009|NOT COMPLETED|Stage 3||0
9948672|NCT01397422|11067602|FG000|STARTED|Overall Study||22
9948673|NCT01397422|11067603|FG001|STARTED|Overall Study||20
9948674|NCT01397422|11067604|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
9948675|NCT01397422|11067605|FG003|STARTED|Overall Study||20
9948676|NCT01397422|11067602|FG000|COMPLETED|Overall Study||20
9948677|NCT01397422|11067603|FG001|COMPLETED|Overall Study||17
9948678|NCT01397422|11067604|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
9948679|NCT01397422|11067605|FG003|COMPLETED|Overall Study||12
9948680|NCT01397422|11067602|FG000|NOT COMPLETED|Overall Study||2
9948681|NCT01397422|11067603|FG001|NOT COMPLETED|Overall Study||3
9948682|NCT01397422|11067604|FG002|NOT COMPLETED|Overall Study||3
9948683|NCT01397422|11067605|FG003|NOT COMPLETED|Overall Study||8
10011745|NCT01782222|11134530|FG000|COMPLETED|Overall Study||32
10011746|NCT01782222|11134531|FG001|COMPLETED|Overall Study||30
9948684|NCT01397448|11067620|FG000|STARTED|Overall Study||156
9948685|NCT01397448|11067621|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
9948686|NCT01397448|11067622|FG002|STARTED|Overall Study||158
9948687|NCT01397448|11067620|FG000|COMPLETED|Overall Study||138
9948688|NCT01397448|11067621|FG001|COMPLETED|Overall Study||142
9948689|NCT01397448|11067622|FG002|COMPLETED|Overall Study||140
9948690|NCT01397448|11067620|FG000|NOT COMPLETED|Overall Study||18
9948691|NCT01397448|11067621|FG001|NOT COMPLETED|Overall Study||15
9948692|NCT01397448|11067622|FG002|NOT COMPLETED|Overall Study||18
10011747|NCT01782222|11134532|FG002|COMPLETED|Overall Study||37
10208889|NCT03559517|11336006|FG002|STARTED|Overall Study||12
10208890|NCT03559517|11336004|FG000|COMPLETED|Overall Study||7
9948693|NCT01397461|11067633|FG000|STARTED|Overall Study||155
9948694|NCT01397461|11067634|FG001|STARTED|Overall Study||156
9948695|NCT01397461|11067635|FG002|STARTED|Overall Study||154
9948696|NCT01397461|11067633|FG000|COMPLETED|Overall Study||153
9948697|NCT01397461|11067634|FG001|COMPLETED|Overall Study||150
9948698|NCT01397461|11067635|FG002|COMPLETED|Overall Study||152
9948699|NCT01397461|11067633|FG000|NOT COMPLETED|Overall Study||2
9948700|NCT01397461|11067634|FG001|NOT COMPLETED|Overall Study||6
9948701|NCT01397461|11067635|FG002|NOT COMPLETED|Overall Study||2
9948702|NCT01397591|11067643|FG000|STARTED|Overall Study||2
9948703|NCT01397591|11067643|FG000|COMPLETED|Overall Study||2
9948704|NCT01397591|11067643|FG000|NOT COMPLETED|Overall Study||0
9948705|NCT01397617|11067651|FG000|STARTED|Overall Study||64
9948706|NCT01397617|11067652|FG001|STARTED|Overall Study||53
9948707|NCT01397617|11067653|FG002|STARTED|Overall Study||60
9948708|NCT01397617|11067651|FG000|COMPLETED|Overall Study||33
9948709|NCT01397617|11067652|FG001|COMPLETED|Overall Study||30
9948710|NCT01397617|11067653|FG002|COMPLETED|Overall Study||31
9948711|NCT01397617|11067651|FG000|NOT COMPLETED|Overall Study||31
9948712|NCT01397617|11067652|FG001|NOT COMPLETED|Overall Study||23
9948713|NCT01397617|11067653|FG002|NOT COMPLETED|Overall Study||29
9948714|NCT01397656|11067666|FG000|STARTED|Overall Study||33
9948715|NCT01397656|11067667|FG001|STARTED|Overall Study||30
9948716|NCT01397656|11067666|FG000|COMPLETED|Overall Study||33
9948717|NCT01397656|11067667|FG001|COMPLETED|Overall Study||30
9948718|NCT01397656|11067666|FG000|NOT COMPLETED|Overall Study||0
9948719|NCT01397656|11067667|FG001|NOT COMPLETED|Overall Study||0
9948720|NCT01397747|11067675|FG000|STARTED|Overall Study||11016
9948721|NCT01397747|11067675|FG000|COMPLETED|Overall Study||9989
9948722|NCT01397747|11067675|FG000|NOT COMPLETED|Overall Study||1027
9948723|NCT01397786|11067683|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
9948724|NCT01397786|11067684|FG001|STARTED|Phase A||0
9948725|NCT01397786|11067685|FG002|STARTED|Phase A||227
9948726|NCT01397786|11067683|FG000|COMPLETED|Phase A||12
9948727|NCT01397786|11067684|FG001|COMPLETED|Phase A||0
9948728|NCT01397786|11067685|FG002|COMPLETED|Phase A||199
9948729|NCT01397786|11067683|FG000|NOT COMPLETED|Phase A||0
9948730|NCT01397786|11067684|FG001|NOT COMPLETED|Phase A||0
9948731|NCT01397786|11067685|FG002|NOT COMPLETED|Phase A||28
9948732|NCT01397786|11067683|FG000|STARTED|Phase B||611
9948733|NCT01397786|11067684|FG001|STARTED|Phase B||204
9948734|NCT01397786|11067685|FG002|STARTED|Phase B||229
9948735|NCT01397786|11067683|FG000|COMPLETED|Phase B||308
9948736|NCT01397786|11067684|FG001|COMPLETED|Phase B||109
9948737|NCT01397786|11067685|FG002|COMPLETED|Phase B||91
9948738|NCT01397786|11067683|FG000|NOT COMPLETED|Phase B||303
9948739|NCT01397786|11067684|FG001|NOT COMPLETED|Phase B||95
10208891|NCT03559517|11336005|FG001|COMPLETED|Overall Study||9
10208892|NCT03559517|11336006|FG002|COMPLETED|Overall Study||12
10208893|NCT03559517|11336004|FG000|NOT COMPLETED|Overall Study||1
10208894|NCT03559517|11336005|FG001|NOT COMPLETED|Overall Study||0
9948740|NCT01397786|11067685|FG002|NOT COMPLETED|Phase B||138
9948741|NCT01397825|11067701|FG000|STARTED|Overall Study||13
9948742|NCT01397825|11067702|FG001|STARTED|Overall Study||4
9948743|NCT01397825|11067703|FG002|STARTED|Overall Study||25
9948744|NCT01397825|11067704|FG003|STARTED|Overall Study||3
9948745|NCT01397825|11067705|FG004|STARTED|Overall Study||0
9948746|NCT01397825|11067701|FG000|COMPLETED|Overall Study||0
9948747|NCT01397825|11067702|FG001|COMPLETED|Overall Study||0
10208895|NCT03559517|11336006|FG002|NOT COMPLETED|Overall Study||0
9948748|NCT01397825|11067703|FG002|COMPLETED|Overall Study||0
9948749|NCT01397825|11067704|FG003|COMPLETED|Overall Study||0
9948750|NCT01397825|11067705|FG004|COMPLETED|Overall Study||0
9948751|NCT01397825|11067701|FG000|NOT COMPLETED|Overall Study||13
9948752|NCT01397825|11067702|FG001|NOT COMPLETED|Overall Study||4
9948753|NCT01397825|11067703|FG002|NOT COMPLETED|Overall Study||25
9948754|NCT01397825|11067704|FG003|NOT COMPLETED|Overall Study||3
9948755|NCT01397825|11067705|FG004|NOT COMPLETED|Overall Study||0
9948756|NCT01397851|11067721|FG000|STARTED|Overall Study||41634
9948757|NCT01397851|11067722|FG001|STARTED|Overall Study||39963
9948758|NCT01397851|11067721|FG000|COMPLETED|Overall Study||41555
9948759|NCT01397851|11067722|FG001|COMPLETED|Overall Study||39917
10208896|NCT03559530|11336014|FG000|STARTED|Overall Study||197
9948760|NCT01397851|11067721|FG000|NOT COMPLETED|Overall Study||79
9948761|NCT01397851|11067722|FG001|NOT COMPLETED|Overall Study||46
9948762|NCT01397890|11067730|FG000|STARTED|Overall Study||287
9948763|NCT01397890|11067731|FG001|STARTED|Overall Study||291
9948764|NCT01397890|11067730|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
9948765|NCT01397890|11067731|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
9948766|NCT01397890|11067730|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
9948767|NCT01397890|11067731|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
9948768|NCT01397890|11067730|FG000|COMPLETED|Overall Study||264
9948769|NCT01397890|11067731|FG001|COMPLETED|Overall Study||260
9948770|NCT01397890|11067730|FG000|NOT COMPLETED|Overall Study||23
9948771|NCT01397890|11067731|FG001|NOT COMPLETED|Overall Study||31
9948772|NCT01398059|11067737|FG000|STARTED|Overall Study||4
9948773|NCT01398059|11067738|FG001|STARTED|Overall Study||3
9948774|NCT01398059|11067739|FG002|STARTED|Overall Study||4
9948775|NCT01398059|11067740|FG003|STARTED|Overall Study||2
9948776|NCT01398059|11067741|FG004|STARTED|Overall Study||4
9948777|NCT01398059|11067742|FG005|STARTED|Overall Study||2
9948778|NCT01398059|11067737|FG000|COMPLETED|Overall Study||4
9948779|NCT01398059|11067738|FG001|COMPLETED|Overall Study||3
9948780|NCT01398059|11067739|FG002|COMPLETED|Overall Study||4
9948781|NCT01398059|11067740|FG003|COMPLETED|Overall Study||2
9948782|NCT01398059|11067741|FG004|COMPLETED|Overall Study||4
9948783|NCT01398059|11067742|FG005|COMPLETED|Overall Study||2
9948784|NCT01398059|11067737|FG000|NOT COMPLETED|Overall Study||0
9948785|NCT01398059|11067738|FG001|NOT COMPLETED|Overall Study||0
9948786|NCT01398059|11067739|FG002|NOT COMPLETED|Overall Study||0
9948787|NCT01398059|11067740|FG003|NOT COMPLETED|Overall Study||0
9948788|NCT01398059|11067741|FG004|NOT COMPLETED|Overall Study||0
9948789|NCT01398059|11067742|FG005|NOT COMPLETED|Overall Study||0
9948790|NCT01398176|11067752|FG000|STARTED|Overall Study||26
9948791|NCT01398176|11067753|FG001|STARTED|Overall Study||25
9948792|NCT01398176|11067752|FG000|COMPLETED|Overall Study||23
9948793|NCT01398176|11067753|FG001|COMPLETED|Overall Study||19
9948794|NCT01398176|11067752|FG000|NOT COMPLETED|Overall Study||3
9948795|NCT01398176|11067753|FG001|NOT COMPLETED|Overall Study||6
9948796|NCT01398280|11067761|FG000|STARTED|Overall Study||11
9948797|NCT01398280|11067762|FG001|STARTED|Overall Study||4
9948798|NCT01398280|11067761|FG000|COMPLETED|Overall Study||7
9948799|NCT01398280|11067762|FG001|COMPLETED|Overall Study||4
9948800|NCT01398280|11067761|FG000|NOT COMPLETED|Overall Study||4
9948801|NCT01398280|11067762|FG001|NOT COMPLETED|Overall Study||0
9948802|NCT01398358|11067771|FG000|STARTED|Overall Study||218
9948803|NCT01398358|11067772|FG001|STARTED|Overall Study||224
9948804|NCT01398358|11067773|FG002|STARTED|Overall Study||255
9948805|NCT01398358|11067771|FG000|COMPLETED|Overall Study||203
10011748|NCT01782222|11134530|FG000|NOT COMPLETED|Overall Study||8
10011749|NCT01782222|11134531|FG001|NOT COMPLETED|Overall Study||11
10011750|NCT01782222|11134532|FG002|NOT COMPLETED|Overall Study||4
10011751|NCT01782313|11134540|FG000|STARTED|Reached First Response/Completed 2 Cycle||58
10011752|NCT01782313|11134540|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52
10208897|NCT03559530|11336015|FG001|STARTED|Overall Study||65
9948806|NCT01398358|11067772|FG001|COMPLETED|Overall Study||201
9948807|NCT01398358|11067773|FG002|COMPLETED|Overall Study||234
10208898|NCT03559530|11336014|FG000|COMPLETED|Overall Study||106
10208899|NCT03559530|11336015|FG001|COMPLETED|Overall Study||65
10208900|NCT03559530|11336014|FG000|NOT COMPLETED|Overall Study||91
10208901|NCT03559530|11336015|FG001|NOT COMPLETED|Overall Study||0
10208902|NCT03559829|11336020|FG000|STARTED|Overall Study||20
9948808|NCT01398358|11067771|FG000|NOT COMPLETED|Overall Study||15
9948809|NCT01398358|11067772|FG001|NOT COMPLETED|Overall Study||23
9948810|NCT01398358|11067773|FG002|NOT COMPLETED|Overall Study||21
9948811|NCT01398410|11067783|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
9948812|NCT01398410|11067784|FG001|STARTED|Overall Study||204
9948813|NCT01398410|11067783|FG000|COMPLETED|Overall Study||143
9948814|NCT01398410|11067784|FG001|COMPLETED|Overall Study||148
9948815|NCT01398410|11067783|FG000|NOT COMPLETED|Overall Study||58
9948816|NCT01398410|11067784|FG001|NOT COMPLETED|Overall Study||56
9948817|NCT01398475|11067790|FG000|STARTED|Overall Study||4
9948818|NCT01398475|11067791|FG001|STARTED|Overall Study||3
9948819|NCT01398475|11067792|FG002|STARTED|Overall Study||4
9948820|NCT01398475|11067793|FG003|STARTED|Overall Study||4
9948821|NCT01398475|11067790|FG000|Received First Intervention|Overall Study||4
9948822|NCT01398475|11067791|FG001|Received First Intervention|Overall Study||3
9948823|NCT01398475|11067792|FG002|Received First Intervention|Overall Study||4
9948824|NCT01398475|11067793|FG003|Received First Intervention|Overall Study||4
9948825|NCT01398475|11067790|FG000|Received Second Intervention|Overall Study||4
10011753|NCT01782313|11134540|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
10208903|NCT03559829|11336020|FG000|COMPLETED|Overall Study||20
9948826|NCT01398475|11067791|FG001|Received Second Intervention|Overall Study||3
9948827|NCT01398475|11067792|FG002|Received Second Intervention|Overall Study||4
9948828|NCT01398475|11067793|FG003|Received Second Intervention|Overall Study||4
9948829|NCT01398475|11067790|FG000|Received Third Intervention|Overall Study||4
9948830|NCT01398475|11067791|FG001|Received Third Intervention|Overall Study||3
9948831|NCT01398475|11067792|FG002|Received Third Intervention|Overall Study||4
9948832|NCT01398475|11067793|FG003|Received Third Intervention|Overall Study||4
9948833|NCT01398475|11067790|FG000|Received Fourth Intervention|Overall Study||4
9948834|NCT01398475|11067791|FG001|Received Fourth Intervention|Overall Study||3
9948835|NCT01398475|11067792|FG002|Received Fourth Intervention|Overall Study||4
9948836|NCT01398475|11067793|FG003|Received Fourth Intervention|Overall Study||4
9948837|NCT01398475|11067790|FG000|COMPLETED|Overall Study||4
10208904|NCT03559829|11336020|FG000|NOT COMPLETED|Overall Study||0
9948838|NCT01398475|11067791|FG001|COMPLETED|Overall Study||3
9948839|NCT01398475|11067792|FG002|COMPLETED|Overall Study||4
9948840|NCT01398475|11067793|FG003|COMPLETED|Overall Study||4
9948841|NCT01398475|11067790|FG000|NOT COMPLETED|Overall Study||0
9948842|NCT01398475|11067791|FG001|NOT COMPLETED|Overall Study||0
9948843|NCT01398475|11067792|FG002|NOT COMPLETED|Overall Study||0
9948844|NCT01398475|11067793|FG003|NOT COMPLETED|Overall Study||0
9948845|NCT01398514|11067805|FG000|STARTED|Overall Study||26
9948846|NCT01398514|11067806|FG001|STARTED|Overall Study||26
9948847|NCT01398514|11067805|FG000|COMPLETED|Overall Study||18
9948848|NCT01398514|11067806|FG001|COMPLETED|Overall Study||20
9948849|NCT01398514|11067805|FG000|NOT COMPLETED|Overall Study||8
9948850|NCT01398514|11067806|FG001|NOT COMPLETED|Overall Study||6
9948851|NCT01398566|11067814|FG000|STARTED|Overall Study|20 enrolled|20
9948852|NCT01398566|11067814|FG000|COMPLETED|Overall Study||20
9948853|NCT01398566|11067814|FG000|NOT COMPLETED|Overall Study||0
9948854|NCT01398787|11067818|FG000|STARTED|Overall Study||198
9948855|NCT01398787|11067818|FG000|COMPLETED|Overall Study||197
9948856|NCT01398787|11067818|FG000|NOT COMPLETED|Overall Study||1
9948857|NCT01398943|11067826|FG000|STARTED|First Intervention (1 Day)||15
9948858|NCT01398943|11067827|FG001|STARTED|First Intervention (1 Day)||15
9948859|NCT01398943|11067828|FG002|STARTED|First Intervention (1 Day)||15
9948860|NCT01398943|11067829|FG003|STARTED|First Intervention (1 Day)||15
9948861|NCT01398943|11067826|FG000|COMPLETED|First Intervention (1 Day)||15
9948862|NCT01398943|11067827|FG001|COMPLETED|First Intervention (1 Day)||15
9948863|NCT01398943|11067828|FG002|COMPLETED|First Intervention (1 Day)||15
9948864|NCT01398943|11067829|FG003|COMPLETED|First Intervention (1 Day)||15
9948865|NCT01398943|11067826|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9948866|NCT01398943|11067827|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9948867|NCT01398943|11067828|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9948868|NCT01398943|11067829|FG003|NOT COMPLETED|First Intervention (1 Day)||0
9948869|NCT01398943|11067826|FG000|STARTED|Washout (2-7 Days)||15
9948870|NCT01398943|11067827|FG001|STARTED|Washout (2-7 Days)||15
9948871|NCT01398943|11067828|FG002|STARTED|Washout (2-7 Days)||15
9948872|NCT01398943|11067829|FG003|STARTED|Washout (2-7 Days)||15
9948873|NCT01398943|11067826|FG000|COMPLETED|Washout (2-7 Days)||15
9948874|NCT01398943|11067827|FG001|COMPLETED|Washout (2-7 Days)||15
9948875|NCT01398943|11067828|FG002|COMPLETED|Washout (2-7 Days)||15
9948876|NCT01398943|11067829|FG003|COMPLETED|Washout (2-7 Days)||15
9948877|NCT01398943|11067826|FG000|NOT COMPLETED|Washout (2-7 Days)||0
9948878|NCT01398943|11067827|FG001|NOT COMPLETED|Washout (2-7 Days)||0
9948879|NCT01398943|11067828|FG002|NOT COMPLETED|Washout (2-7 Days)||0
9948880|NCT01398943|11067829|FG003|NOT COMPLETED|Washout (2-7 Days)||0
9948881|NCT01398943|11067826|FG000|STARTED|Second Intervention (1 Day)||15
9948882|NCT01398943|11067827|FG001|STARTED|Second Intervention (1 Day)||15
9948883|NCT01398943|11067828|FG002|STARTED|Second Intervention (1 Day)||15
9948884|NCT01398943|11067829|FG003|STARTED|Second Intervention (1 Day)||15
9948885|NCT01398943|11067826|FG000|COMPLETED|Second Intervention (1 Day)||15
9948886|NCT01398943|11067827|FG001|COMPLETED|Second Intervention (1 Day)||15
9948887|NCT01398943|11067828|FG002|COMPLETED|Second Intervention (1 Day)||15
9948888|NCT01398943|11067829|FG003|COMPLETED|Second Intervention (1 Day)||15
9948889|NCT01398943|11067826|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9948890|NCT01398943|11067827|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9948891|NCT01398943|11067828|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
9948892|NCT01398943|11067829|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9948893|NCT01398956|11067837|FG000|STARTED|Overall Study||44
9948894|NCT01398956|11067837|FG000|COMPLETED|Overall Study||34
9948895|NCT01398956|11067837|FG000|NOT COMPLETED|Overall Study||10
9948896|NCT01398982|11067844|FG000|STARTED|Overall Study||44
9948897|NCT01398982|11067845|FG001|STARTED|Overall Study||49
9948898|NCT01398982|11067844|FG000|COMPLETED|Overall Study||38
9948899|NCT01398982|11067845|FG001|COMPLETED|Overall Study||47
9948900|NCT01398982|11067844|FG000|NOT COMPLETED|Overall Study||6
9948901|NCT01398982|11067845|FG001|NOT COMPLETED|Overall Study||2
9948902|NCT01399008|11067854|FG000|STARTED|Overall Study||35
9948903|NCT01399008|11067855|FG001|STARTED|Overall Study||32
9948904|NCT01399008|11067856|FG002|STARTED|Overall Study||33
9948905|NCT01399008|11067854|FG000|COMPLETED|Overall Study||32
9948906|NCT01399008|11067855|FG001|COMPLETED|Overall Study||27
9948907|NCT01399008|11067856|FG002|COMPLETED|Overall Study||31
10208905|NCT03559933|11336024|FG000|STARTED|Overall Study||12
10208906|NCT03559933|11336024|FG000|COMPLETED|Overall Study||12
10208907|NCT03559933|11336024|FG000|NOT COMPLETED|Overall Study||0
9948908|NCT01399008|11067854|FG000|NOT COMPLETED|Overall Study||3
9948909|NCT01399008|11067855|FG001|NOT COMPLETED|Overall Study||5
9948910|NCT01399008|11067856|FG002|NOT COMPLETED|Overall Study||2
9948911|NCT01399047|11067866|FG000|STARTED|Overall Study||10
9948912|NCT01399047|11067867|FG001|STARTED|Overall Study||9
9948913|NCT01399047|11067866|FG000|COMPLETED|Overall Study||10
9948914|NCT01399047|11067867|FG001|COMPLETED|Overall Study||8
9948915|NCT01399047|11067866|FG000|NOT COMPLETED|Overall Study||0
9948916|NCT01399047|11067867|FG001|NOT COMPLETED|Overall Study||1
9948917|NCT01399099|11067875|FG000|STARTED|Overall Study||67
9948918|NCT01399099|11067875|FG000|6 Months|Overall Study||47
9948919|NCT01399099|11067875|FG000|COMPLETED|Overall Study||36
9948920|NCT01399099|11067875|FG000|NOT COMPLETED|Overall Study||31
9948921|NCT01399125|11067882|FG000|STARTED|Overall Study||248
10208908|NCT03560102|11336029|FG000|STARTED|Overall Study||1
10208909|NCT03560102|11336029|FG000|COMPLETED|Overall Study||1
9948922|NCT01399125|11067883|FG001|STARTED|Overall Study||253
9948923|NCT01399125|11067882|FG000|Per Protocol (PP) Population|Overall Study||192
9948924|NCT01399125|11067883|FG001|Per Protocol (PP) Population|Overall Study||188
9948925|NCT01399125|11067882|FG000|COMPLETED|Overall Study||197
9948926|NCT01399125|11067883|FG001|COMPLETED|Overall Study||193
9948927|NCT01399125|11067882|FG000|NOT COMPLETED|Overall Study||51
9948928|NCT01399125|11067883|FG001|NOT COMPLETED|Overall Study||60
9948929|NCT01399190|11067889|FG000|STARTED|Overall Study||68
9948930|NCT01399190|11067889|FG000|Included in Final Analysis|Overall Study||63
9948931|NCT01399190|11067889|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60
9948932|NCT01399190|11067889|FG000|COMPLETED|Overall Study||48
9948933|NCT01399190|11067889|FG000|NOT COMPLETED|Overall Study||20
9948934|NCT01399229|11067893|FG000|STARTED|Overall Study||20
9948935|NCT01399229|11067894|FG001|STARTED|Overall Study||5
9948936|NCT01399229|11067895|FG002|STARTED|Overall Study||5
9948937|NCT01399229|11067893|FG000|COMPLETED|Overall Study||20
9948938|NCT01399229|11067894|FG001|COMPLETED|Overall Study||5
9948939|NCT01399229|11067895|FG002|COMPLETED|Overall Study||5
9948940|NCT01399229|11067893|FG000|NOT COMPLETED|Overall Study||0
9948941|NCT01399229|11067894|FG001|NOT COMPLETED|Overall Study||0
9948942|NCT01399229|11067895|FG002|NOT COMPLETED|Overall Study||0
9948943|NCT01399268|11067901|FG000|STARTED|Overall Study||15
9948944|NCT01399268|11067902|FG001|STARTED|Overall Study||15
9948945|NCT01399268|11067901|FG000|COMPLETED|Overall Study||15
9948946|NCT01399268|11067902|FG001|COMPLETED|Overall Study||15
9948947|NCT01399268|11067901|FG000|NOT COMPLETED|Overall Study||0
9948948|NCT01399268|11067902|FG001|NOT COMPLETED|Overall Study||0
9948949|NCT01399593|11067910|FG000|STARTED|Overall Study||51
9948950|NCT01399593|11067911|FG001|STARTED|Overall Study||51
9948951|NCT01399593|11067910|FG000|COMPLETED|Overall Study||48
9948952|NCT01399593|11067911|FG001|COMPLETED|Overall Study||49
9948953|NCT01399593|11067910|FG000|NOT COMPLETED|Overall Study||3
9948954|NCT01399593|11067911|FG001|NOT COMPLETED|Overall Study||2
9948955|NCT01399619|11067919|FG000|STARTED|Overall Study||123
9948956|NCT01399619|11067920|FG001|STARTED|Overall Study||84
9948957|NCT01399619|11067921|FG002|STARTED|Overall Study||86
9948958|NCT01399619|11067922|FG003|STARTED|Overall Study||17
9948959|NCT01399619|11067919|FG000|COMPLETED|Overall Study||98
9948960|NCT01399619|11067920|FG001|COMPLETED|Overall Study||84
9948961|NCT01399619|11067921|FG002|COMPLETED|Overall Study||74
9948962|NCT01399619|11067922|FG003|COMPLETED|Overall Study||0
9948963|NCT01399619|11067919|FG000|NOT COMPLETED|Overall Study||25
9948964|NCT01399619|11067920|FG001|NOT COMPLETED|Overall Study||0
9948965|NCT01399619|11067921|FG002|NOT COMPLETED|Overall Study||12
9948966|NCT01399619|11067922|FG003|NOT COMPLETED|Overall Study||17
9948967|NCT01399697|11067940|FG000|STARTED|Overall Study||96
9948968|NCT01399697|11067941|FG001|STARTED|Overall Study||83
9948969|NCT01399697|11067942|FG002|STARTED|Overall Study||82
9948970|NCT01399697|11067940|FG000|COMPLETED|Overall Study||55
9948971|NCT01399697|11067941|FG001|COMPLETED|Overall Study||80
10011754|NCT01782313|11134540|FG000|STARTED|Treated Cycle 3||52
9948972|NCT01399697|11067942|FG002|COMPLETED|Overall Study||78
9948973|NCT01399697|11067940|FG000|NOT COMPLETED|Overall Study||41
9948974|NCT01399697|11067941|FG001|NOT COMPLETED|Overall Study||3
9948975|NCT01399697|11067942|FG002|NOT COMPLETED|Overall Study||4
9948976|NCT01399723|11067955|FG000|STARTED|Overall Study||263
9948977|NCT01399723|11067956|FG001|STARTED|Overall Study||264
9948978|NCT01399723|11067955|FG000|COMPLETED|Overall Study||263
9948979|NCT01399723|11067956|FG001|COMPLETED|Overall Study||263
9948980|NCT01399723|11067955|FG000|NOT COMPLETED|Overall Study||0
9948981|NCT01399723|11067956|FG001|NOT COMPLETED|Overall Study||1
9948982|NCT01399736|11067965|FG000|STARTED|Overall Study||295
9948983|NCT01399736|11067966|FG001|STARTED|Overall Study||590
9948984|NCT01399736|11067965|FG000|COMPLETED|Overall Study||291
9948985|NCT01399736|11067966|FG001|COMPLETED|Overall Study||586
9948986|NCT01399736|11067965|FG000|NOT COMPLETED|Overall Study||4
9948987|NCT01399736|11067966|FG001|NOT COMPLETED|Overall Study||4
9948988|NCT01399788|11067980|FG000|STARTED|First Intervention Period||18
9948989|NCT01399788|11067981|FG001|STARTED|First Intervention Period||18
9948990|NCT01399788|11067980|FG000|COMPLETED|First Intervention Period||17
9948991|NCT01399788|11067981|FG001|COMPLETED|First Intervention Period||18
9948992|NCT01399788|11067980|FG000|NOT COMPLETED|First Intervention Period||1
9948993|NCT01399788|11067981|FG001|NOT COMPLETED|First Intervention Period||0
9948994|NCT01399788|11067980|FG000|STARTED|Washout Period (at Least 1 Week)||17
9948995|NCT01399788|11067981|FG001|STARTED|Washout Period (at Least 1 Week)||18
9948996|NCT01399788|11067980|FG000|COMPLETED|Washout Period (at Least 1 Week)||17
9948997|NCT01399788|11067981|FG001|COMPLETED|Washout Period (at Least 1 Week)||18
9948998|NCT01399788|11067980|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0
9948999|NCT01399788|11067981|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0
9949000|NCT01399788|11067980|FG000|STARTED|Second Intervention Period||17
9949001|NCT01399788|11067981|FG001|STARTED|Second Intervention Period||18
9949002|NCT01399788|11067980|FG000|COMPLETED|Second Intervention Period||17
9949003|NCT01399788|11067981|FG001|COMPLETED|Second Intervention Period||18
9949004|NCT01399788|11067980|FG000|NOT COMPLETED|Second Intervention Period||0
9949005|NCT01399788|11067981|FG001|NOT COMPLETED|Second Intervention Period||0
9949006|NCT01399827|11067989|FG000|STARTED|Overall Study||1
9949007|NCT01399827|11067990|FG001|STARTED|Overall Study||1
9949008|NCT01399827|11067989|FG000|COMPLETED|Overall Study||1
9949009|NCT01399827|11067990|FG001|COMPLETED|Overall Study||1
10011755|NCT01782313|11134540|FG000|COMPLETED|Treated Cycle 3||31
9949010|NCT01399827|11067989|FG000|NOT COMPLETED|Overall Study||0
9949011|NCT01399827|11067990|FG001|NOT COMPLETED|Overall Study||0
9949012|NCT01399866|11067998|FG000|STARTED|Overall Study||32
9949013|NCT01399866|11067999|FG001|STARTED|Overall Study||30
9949014|NCT01399866|11067998|FG000|COMPLETED|Overall Study||28
9949015|NCT01399866|11067999|FG001|COMPLETED|Overall Study||28
9949016|NCT01399866|11067998|FG000|NOT COMPLETED|Overall Study||4
9949017|NCT01399866|11067999|FG001|NOT COMPLETED|Overall Study||2
9949018|NCT01399905|11068007|FG000|STARTED|Overall Study||7
9949019|NCT01399905|11068008|FG001|STARTED|Overall Study||7
9949020|NCT01399905|11068007|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
9949021|NCT01399905|11068008|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
9949022|NCT01399905|11068007|FG000|NOT COMPLETED|Overall Study||1
9949023|NCT01399905|11068008|FG001|NOT COMPLETED|Overall Study||1
9949024|NCT01400113|11068021|FG000|STARTED|Overall Study||60
9949025|NCT01400113|11068022|FG001|STARTED|Overall Study||60
9949026|NCT01400113|11068021|FG000|COMPLETED|Overall Study||59
9949027|NCT01400113|11068022|FG001|COMPLETED|Overall Study||59
9949028|NCT01400113|11068021|FG000|NOT COMPLETED|Overall Study||1
9949029|NCT01400113|11068022|FG001|NOT COMPLETED|Overall Study||1
9949030|NCT01400139|11068028|FG000|STARTED|HYD Core Study||922
9949031|NCT01400139|11068028|FG000|COMPLETED|HYD Core Study||410
9949032|NCT01400139|11068028|FG000|NOT COMPLETED|HYD Core Study||512
10111685|NCT02497755|11242682|FG001|NOT COMPLETED|Overall Study||0
10111686|NCT02497781|11242691|FG000|STARTED|Overall Study||68
10111687|NCT02497781|11242692|FG001|STARTED|Overall Study||29
10111688|NCT02497781|11242691|FG000|Treated|Overall Study||67
10111689|NCT02497781|11242692|FG001|Treated|Overall Study||28
10111690|NCT02497781|11242691|FG000|COMPLETED|Overall Study||64
10111691|NCT02497781|11242692|FG001|COMPLETED|Overall Study||26
10111692|NCT02497781|11242691|FG000|NOT COMPLETED|Overall Study||4
10111693|NCT02497781|11242692|FG001|NOT COMPLETED|Overall Study||3
10111694|NCT02497937|11242698|FG000|STARTED|Period 1 (Up to 7 Days)||6
10111695|NCT02497937|11242699|FG001|STARTED|Period 1 (Up to 7 Days)||5
9949033|NCT01400139|11068028|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
9760696|NCT00382824|10864457|FG000|NOT COMPLETED|Overall Study||12
9760697|NCT00382824|10864458|FG001|NOT COMPLETED|Overall Study||13
9760698|NCT00382863|10864466|FG000|STARTED|Overall Study||96
9760699|NCT00382863|10864467|FG001|STARTED|Overall Study||114
9760700|NCT00382863|10864466|FG000|COMPLETED|Overall Study||81
9760701|NCT00382863|10864467|FG001|COMPLETED|Overall Study||78
9949034|NCT01400139|11068028|FG000|COMPLETED|HYD Extension Period||83
9949035|NCT01400139|11068028|FG000|NOT COMPLETED|HYD Extension Period||23
9949036|NCT01400243|11068036|FG000|STARTED|Overall Study||64
9949037|NCT01400243|11068037|FG001|STARTED|Overall Study||63
9949038|NCT01400243|11068036|FG000|COMPLETED|Overall Study||56
9949039|NCT01400243|11068037|FG001|COMPLETED|Overall Study||52
9949040|NCT01400243|11068036|FG000|NOT COMPLETED|Overall Study||8
9949041|NCT01400243|11068037|FG001|NOT COMPLETED|Overall Study||11
9949042|NCT01400412|11068047|FG000|STARTED|Overall Study||130
9949043|NCT01400412|11068048|FG001|STARTED|Overall Study||132
9949044|NCT01400412|11068047|FG000|COMPLETED|Overall Study||120
9949045|NCT01400412|11068048|FG001|COMPLETED|Overall Study||115
9949046|NCT01400412|11068047|FG000|NOT COMPLETED|Overall Study||10
9949047|NCT01400412|11068048|FG001|NOT COMPLETED|Overall Study||17
9956879|NCT01448824|11076144|FG004|NOT COMPLETED|Part 1: Washout Period||0
9956880|NCT01448824|11076145|FG005|NOT COMPLETED|Part 1: Washout Period||0
9956881|NCT01448824|11076146|FG006|NOT COMPLETED|Part 1: Washout Period||0
9956882|NCT01448824|11076147|FG007|NOT COMPLETED|Part 1: Washout Period||0
9956883|NCT01448824|11076140|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
9956884|NCT01448824|11076141|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
9956885|NCT01448824|11076142|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
9956886|NCT01448824|11076143|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
9956887|NCT01448824|11076144|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
9956888|NCT01448824|11076145|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
9956889|NCT01448824|11076146|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
9956890|NCT01448824|11076147|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
9956891|NCT01448824|11076140|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
9956892|NCT01448824|11076141|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
9956893|NCT01448824|11076142|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
9956894|NCT01448824|11076143|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
9956895|NCT01448824|11076144|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
9956896|NCT01448824|11076145|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
9956897|NCT01448824|11076146|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
9956898|NCT01448824|11076147|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
9956899|NCT01448824|11076140|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
9956900|NCT01448824|11076141|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
9956901|NCT01448824|11076142|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
9957080|NCT01449370|11076255|FG020|COMPLETED|Overall Study||0
9949048|NCT01400425|11068056|FG000|STARTED|Overall Study||239
9949049|NCT01400425|11068056|FG000|COMPLETED|Overall Study||229
9949050|NCT01400425|11068056|FG000|NOT COMPLETED|Overall Study||10
9949051|NCT01400451|11068065|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6
9949052|NCT01400451|11068066|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4
9949053|NCT01400451|11068067|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2
9949054|NCT01400451|11068065|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
9949055|NCT01400451|11068066|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
9949056|NCT01400451|11068067|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
9949057|NCT01400451|11068065|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
9949058|NCT01400451|11068066|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
9949059|NCT01400451|11068067|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
9949060|NCT01400451|11068065|FG000|STARTED|Combination Treatment (or Intended)||6
9949061|NCT01400451|11068066|FG001|STARTED|Combination Treatment (or Intended)||4
9949062|NCT01400451|11068067|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
9949063|NCT01400451|11068065|FG000|COMPLETED|Combination Treatment (or Intended)||0
9949064|NCT01400451|11068066|FG001|COMPLETED|Combination Treatment (or Intended)||0
9949065|NCT01400451|11068067|FG002|COMPLETED|Combination Treatment (or Intended)||0
9949066|NCT01400451|11068065|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6
9949067|NCT01400451|11068066|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4
9949068|NCT01400451|11068067|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2
9949069|NCT01400477|11068082|FG000|STARTED|Overall Study||40
9949070|NCT01400477|11068083|FG001|STARTED|Overall Study||40
9949071|NCT01400477|11068082|FG000|COMPLETED|Overall Study||38
9949072|NCT01400477|11068083|FG001|COMPLETED|Overall Study||40
9949073|NCT01400477|11068082|FG000|NOT COMPLETED|Overall Study||2
9949074|NCT01400477|11068083|FG001|NOT COMPLETED|Overall Study||0
9949075|NCT01400503|11068089|FG000|STARTED|Overall Study||60
9949076|NCT01400503|11068089|FG000|COMPLETED|Overall Study||0
9949077|NCT01400503|11068089|FG000|NOT COMPLETED|Overall Study||60
9949078|NCT01400516|11068095|FG000|STARTED|Primary Trial||12
9949079|NCT01400516|11068096|FG001|STARTED|Primary Trial||14
10111696|NCT02497937|11242698|FG000|COMPLETED|Period 1 (Up to 7 Days)||6
10111697|NCT02497937|11242699|FG001|COMPLETED|Period 1 (Up to 7 Days)||5
10111698|NCT02497937|11242698|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0
10111699|NCT02497937|11242699|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0
10111700|NCT02497937|11242698|FG000|STARTED|Washout Period (Up to 14 Days)||6
10111701|NCT02497937|11242699|FG001|STARTED|Washout Period (Up to 14 Days)||5
10111702|NCT02497937|11242698|FG000|COMPLETED|Washout Period (Up to 14 Days)||6
10111703|NCT02497937|11242699|FG001|COMPLETED|Washout Period (Up to 14 Days)||5
10111704|NCT02497937|11242698|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10111705|NCT02497937|11242699|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10111706|NCT02497937|11242698|FG000|STARTED|Period 2 (Up to 7 Days)||6
10111707|NCT02497937|11242699|FG001|STARTED|Period 2 (Up to 7 Days)||5
10111708|NCT02497937|11242698|FG000|COMPLETED|Period 2 (Up to 7 Days)||6
10111709|NCT02497937|11242699|FG001|COMPLETED|Period 2 (Up to 7 Days)||5
9949080|NCT01400516|11068095|FG000|COMPLETED|Primary Trial||12
9949081|NCT01400516|11068096|FG001|COMPLETED|Primary Trial||12
9949082|NCT01400516|11068095|FG000|NOT COMPLETED|Primary Trial||0
9949083|NCT01400516|11068096|FG001|NOT COMPLETED|Primary Trial||2
9949084|NCT01400516|11068095|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
9949085|NCT01400516|11068096|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
9949086|NCT01400516|11068095|FG000|COMPLETED|Extension Trial||6
9949087|NCT01400516|11068096|FG001|COMPLETED|Extension Trial||7
9949088|NCT01400516|11068095|FG000|NOT COMPLETED|Extension Trial||0
9949089|NCT01400516|11068096|FG001|NOT COMPLETED|Extension Trial||0
9949090|NCT01400698|11068106|FG000|STARTED|Overall Study||23
9949091|NCT01400698|11068107|FG001|STARTED|Overall Study||23
9949092|NCT01400698|11068108|FG002|STARTED|Overall Study||2
9949093|NCT01400698|11068109|FG003|STARTED|Overall Study||14
9949094|NCT01400698|11068110|FG004|STARTED|Overall Study||14
9949095|NCT01400698|11068111|FG005|STARTED|Overall Study||15
9949096|NCT01400698|11068106|FG000|COMPLETED|Overall Study||8
9949097|NCT01400698|11068107|FG001|COMPLETED|Overall Study||12
9949098|NCT01400698|11068108|FG002|COMPLETED|Overall Study||0
9949099|NCT01400698|11068109|FG003|COMPLETED|Overall Study||6
9949100|NCT01400698|11068110|FG004|COMPLETED|Overall Study||7
9949101|NCT01400698|11068111|FG005|COMPLETED|Overall Study||9
9949102|NCT01400698|11068106|FG000|NOT COMPLETED|Overall Study||15
9949103|NCT01400698|11068107|FG001|NOT COMPLETED|Overall Study||11
10111710|NCT02497937|11242698|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0
10111711|NCT02497937|11242699|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0
9949104|NCT01400698|11068108|FG002|NOT COMPLETED|Overall Study||2
9949105|NCT01400698|11068109|FG003|NOT COMPLETED|Overall Study||8
9949106|NCT01400698|11068110|FG004|NOT COMPLETED|Overall Study||7
9949107|NCT01400698|11068111|FG005|NOT COMPLETED|Overall Study||6
9949108|NCT01400815|11068123|FG000|STARTED|Overall Study||118
9949109|NCT01400815|11068124|FG001|STARTED|Overall Study||116
9949110|NCT01400815|11068123|FG000|COMPLETED|Overall Study||80
9949111|NCT01400815|11068124|FG001|COMPLETED|Overall Study||95
9949112|NCT01400815|11068123|FG000|NOT COMPLETED|Overall Study||38
9949113|NCT01400815|11068124|FG001|NOT COMPLETED|Overall Study||21
9956902|NCT01448824|11076143|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10111712|NCT02497976|11242708|FG000|STARTED|Overall Study||28
9949114|NCT01400841|11068130|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
9949115|NCT01400841|11068130|FG000|COMPLETED|Initial Study Phase (6 Months)||15
9949116|NCT01400841|11068130|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1
9949117|NCT01400841|11068130|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
9949118|NCT01400841|11068130|FG000|COMPLETED|Extended Study Phase (2 Years)||11
9949119|NCT01400841|11068130|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2
9949120|NCT01400880|11068134|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
9949121|NCT01400880|11068134|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
9949122|NCT01400880|11068134|FG000|NOT COMPLETED|Overall Study||2
9949123|NCT01400893|11068140|FG000|STARTED|Overall Study||69
9949124|NCT01400893|11068141|FG001|STARTED|Overall Study||65
9949125|NCT01400893|11068140|FG000|COMPLETED|Overall Study||42
9949126|NCT01400893|11068141|FG001|COMPLETED|Overall Study||38
9949127|NCT01400893|11068140|FG000|NOT COMPLETED|Overall Study||27
9949128|NCT01400893|11068141|FG001|NOT COMPLETED|Overall Study||27
9949129|NCT01400906|11068149|FG000|STARTED|Treatment Period 1||6
9949130|NCT01400906|11068150|FG001|STARTED|Treatment Period 1||6
9949131|NCT01400906|11068151|FG002|STARTED|Treatment Period 1||6
9949132|NCT01400906|11068152|FG003|STARTED|Treatment Period 1||6
9949133|NCT01400906|11068153|FG004|STARTED|Treatment Period 1||6
9949134|NCT01400906|11068154|FG005|STARTED|Treatment Period 1||5
9949135|NCT01400906|11068149|FG000|COMPLETED|Treatment Period 1||6
9949136|NCT01400906|11068150|FG001|COMPLETED|Treatment Period 1||6
9949137|NCT01400906|11068151|FG002|COMPLETED|Treatment Period 1||6
9949138|NCT01400906|11068152|FG003|COMPLETED|Treatment Period 1||6
9949139|NCT01400906|11068153|FG004|COMPLETED|Treatment Period 1||6
9949140|NCT01400906|11068154|FG005|COMPLETED|Treatment Period 1||5
9949141|NCT01400906|11068149|FG000|NOT COMPLETED|Treatment Period 1||0
9949142|NCT01400906|11068150|FG001|NOT COMPLETED|Treatment Period 1||0
9949143|NCT01400906|11068151|FG002|NOT COMPLETED|Treatment Period 1||0
9949144|NCT01400906|11068152|FG003|NOT COMPLETED|Treatment Period 1||0
9949145|NCT01400906|11068153|FG004|NOT COMPLETED|Treatment Period 1||0
9949146|NCT01400906|11068154|FG005|NOT COMPLETED|Treatment Period 1||0
9949147|NCT01400906|11068149|FG000|STARTED|Washout Period 1||6
9949148|NCT01400906|11068150|FG001|STARTED|Washout Period 1||6
9949149|NCT01400906|11068151|FG002|STARTED|Washout Period 1||6
9949150|NCT01400906|11068152|FG003|STARTED|Washout Period 1||6
9949151|NCT01400906|11068153|FG004|STARTED|Washout Period 1||6
9949152|NCT01400906|11068154|FG005|STARTED|Washout Period 1||5
9949153|NCT01400906|11068149|FG000|COMPLETED|Washout Period 1||6
9949154|NCT01400906|11068150|FG001|COMPLETED|Washout Period 1||6
9949155|NCT01400906|11068151|FG002|COMPLETED|Washout Period 1||6
9949156|NCT01400906|11068152|FG003|COMPLETED|Washout Period 1||6
9949157|NCT01400906|11068153|FG004|COMPLETED|Washout Period 1||6
9949158|NCT01400906|11068154|FG005|COMPLETED|Washout Period 1||5
9949159|NCT01400906|11068149|FG000|NOT COMPLETED|Washout Period 1||0
9949160|NCT01400906|11068150|FG001|NOT COMPLETED|Washout Period 1||0
9949161|NCT01400906|11068151|FG002|NOT COMPLETED|Washout Period 1||0
9949162|NCT01400906|11068152|FG003|NOT COMPLETED|Washout Period 1||0
9949163|NCT01400906|11068153|FG004|NOT COMPLETED|Washout Period 1||0
9949164|NCT01400906|11068154|FG005|NOT COMPLETED|Washout Period 1||0
9949165|NCT01400906|11068149|FG000|STARTED|Treatment Period 2||6
9949166|NCT01400906|11068150|FG001|STARTED|Treatment Period 2||6
9949167|NCT01400906|11068151|FG002|STARTED|Treatment Period 2||6
9949168|NCT01400906|11068152|FG003|STARTED|Treatment Period 2||6
9949169|NCT01400906|11068153|FG004|STARTED|Treatment Period 2||6
9949170|NCT01400906|11068154|FG005|STARTED|Treatment Period 2||5
9949171|NCT01400906|11068149|FG000|COMPLETED|Treatment Period 2||6
9949172|NCT01400906|11068150|FG001|COMPLETED|Treatment Period 2||6
9949173|NCT01400906|11068151|FG002|COMPLETED|Treatment Period 2||6
9949174|NCT01400906|11068152|FG003|COMPLETED|Treatment Period 2||6
9949175|NCT01400906|11068153|FG004|COMPLETED|Treatment Period 2||6
9949176|NCT01400906|11068154|FG005|COMPLETED|Treatment Period 2||5
9949177|NCT01400906|11068149|FG000|NOT COMPLETED|Treatment Period 2||0
9949178|NCT01400906|11068150|FG001|NOT COMPLETED|Treatment Period 2||0
9949179|NCT01400906|11068151|FG002|NOT COMPLETED|Treatment Period 2||0
9949180|NCT01400906|11068152|FG003|NOT COMPLETED|Treatment Period 2||0
9949181|NCT01400906|11068153|FG004|NOT COMPLETED|Treatment Period 2||0
9949182|NCT01400906|11068154|FG005|NOT COMPLETED|Treatment Period 2||0
9949183|NCT01400906|11068149|FG000|STARTED|Washout Period 2||6
9949184|NCT01400906|11068150|FG001|STARTED|Washout Period 2||6
9949185|NCT01400906|11068151|FG002|STARTED|Washout Period 2||6
9949186|NCT01400906|11068152|FG003|STARTED|Washout Period 2||6
9949187|NCT01400906|11068153|FG004|STARTED|Washout Period 2||6
9949188|NCT01400906|11068154|FG005|STARTED|Washout Period 2||5
9949189|NCT01400906|11068149|FG000|COMPLETED|Washout Period 2||6
9949190|NCT01400906|11068150|FG001|COMPLETED|Washout Period 2||6
9949191|NCT01400906|11068151|FG002|COMPLETED|Washout Period 2||6
9949192|NCT01400906|11068152|FG003|COMPLETED|Washout Period 2||6
9949193|NCT01400906|11068153|FG004|COMPLETED|Washout Period 2||6
9949194|NCT01400906|11068154|FG005|COMPLETED|Washout Period 2||5
9949195|NCT01400906|11068149|FG000|NOT COMPLETED|Washout Period 2||0
9949196|NCT01400906|11068150|FG001|NOT COMPLETED|Washout Period 2||0
9949197|NCT01400906|11068151|FG002|NOT COMPLETED|Washout Period 2||0
9949198|NCT01400906|11068152|FG003|NOT COMPLETED|Washout Period 2||0
9949199|NCT01400906|11068153|FG004|NOT COMPLETED|Washout Period 2||0
9949200|NCT01400906|11068154|FG005|NOT COMPLETED|Washout Period 2||0
9949201|NCT01400906|11068149|FG000|STARTED|Treatment Period 3||6
9949202|NCT01400906|11068150|FG001|STARTED|Treatment Period 3||6
9949203|NCT01400906|11068151|FG002|STARTED|Treatment Period 3||6
9949204|NCT01400906|11068152|FG003|STARTED|Treatment Period 3||6
9949205|NCT01400906|11068153|FG004|STARTED|Treatment Period 3||6
9949206|NCT01400906|11068154|FG005|STARTED|Treatment Period 3||5
9949207|NCT01400906|11068149|FG000|COMPLETED|Treatment Period 3||6
9949208|NCT01400906|11068150|FG001|COMPLETED|Treatment Period 3||6
9949209|NCT01400906|11068151|FG002|COMPLETED|Treatment Period 3||6
9949210|NCT01400906|11068152|FG003|COMPLETED|Treatment Period 3||6
9949211|NCT01400906|11068153|FG004|COMPLETED|Treatment Period 3||6
9949212|NCT01400906|11068154|FG005|COMPLETED|Treatment Period 3||5
9949213|NCT01400906|11068149|FG000|NOT COMPLETED|Treatment Period 3||0
9949214|NCT01400906|11068150|FG001|NOT COMPLETED|Treatment Period 3||0
9949215|NCT01400906|11068151|FG002|NOT COMPLETED|Treatment Period 3||0
9949216|NCT01400906|11068152|FG003|NOT COMPLETED|Treatment Period 3||0
9949217|NCT01400906|11068153|FG004|NOT COMPLETED|Treatment Period 3||0
9949218|NCT01400906|11068154|FG005|NOT COMPLETED|Treatment Period 3||0
9949219|NCT01400919|11068162|FG000|STARTED|Overall Study||75
9949220|NCT01400919|11068162|FG000|COMPLETED|Overall Study||67
9949221|NCT01400919|11068162|FG000|NOT COMPLETED|Overall Study||8
9949222|NCT01400932|11068168|FG000|STARTED|Overall Study||178
9949223|NCT01400932|11068169|FG001|STARTED|Overall Study||182
9949224|NCT01400932|11068168|FG000|COMPLETED|Overall Study||164
9949225|NCT01400932|11068169|FG001|COMPLETED|Overall Study||167
9949226|NCT01400932|11068168|FG000|NOT COMPLETED|Overall Study||14
9949227|NCT01400932|11068169|FG001|NOT COMPLETED|Overall Study||15
9949228|NCT01400958|11068177|FG000|STARTED|Overall Study||3
9949229|NCT01400958|11068178|FG001|STARTED|Overall Study||3
9949230|NCT01400958|11068177|FG000|COMPLETED|Overall Study||2
9949231|NCT01400958|11068178|FG001|COMPLETED|Overall Study||1
9949232|NCT01400958|11068177|FG000|NOT COMPLETED|Overall Study||1
9949233|NCT01400958|11068178|FG001|NOT COMPLETED|Overall Study||2
9949234|NCT01400971|11068184|FG000|STARTED|Overall Study||4299
9949235|NCT01400971|11068184|FG000|Complete Treatment Data|Overall Study||2528
9949236|NCT01400971|11068184|FG000|COMPLETED|Overall Study||3382
9949237|NCT01400971|11068184|FG000|NOT COMPLETED|Overall Study||917
9949238|NCT01401010|11068190|FG000|STARTED|Overall Study||6
9949239|NCT01401010|11068191|FG001|STARTED|Overall Study||6
9949240|NCT01401010|11068190|FG000|COMPLETED|Overall Study||5
9949241|NCT01401010|11068191|FG001|COMPLETED|Overall Study||6
9949242|NCT01401010|11068190|FG000|NOT COMPLETED|Overall Study||1
9949243|NCT01401010|11068191|FG001|NOT COMPLETED|Overall Study||0
9949244|NCT01401023|11068202|FG000|STARTED|Overall Study||10
9949245|NCT01401023|11068202|FG000|COMPLETED|Overall Study||10
9949246|NCT01401023|11068202|FG000|NOT COMPLETED|Overall Study||0
9949247|NCT01401062|11068210|FG000|STARTED|Overall Study||11
9949248|NCT01401062|11068211|FG001|STARTED|Overall Study||12
9949249|NCT01401062|11068210|FG000|COMPLETED|Overall Study||0
9949250|NCT01401062|11068211|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
9949251|NCT01401062|11068210|FG000|NOT COMPLETED|Overall Study||11
9949252|NCT01401062|11068211|FG001|NOT COMPLETED|Overall Study||8
9949253|NCT01401101|11068219|FG000|STARTED|Overall Study||206
9949254|NCT01401101|11068220|FG001|STARTED|Overall Study||198
9949255|NCT01401101|11068219|FG000|COMPLETED|Overall Study||184
9949256|NCT01401101|11068220|FG001|COMPLETED|Overall Study||171
9949257|NCT01401101|11068219|FG000|NOT COMPLETED|Overall Study||22
9949258|NCT01401101|11068220|FG001|NOT COMPLETED|Overall Study||27
9949259|NCT01401153|11068228|FG000|STARTED|First Test Day||66
9949260|NCT01401153|11068229|FG001|STARTED|First Test Day||55
9949261|NCT01401153|11068228|FG000|COMPLETED|First Test Day||65
9949262|NCT01401153|11068229|FG001|COMPLETED|First Test Day||45
9949263|NCT01401153|11068228|FG000|NOT COMPLETED|First Test Day||1
9949264|NCT01401153|11068229|FG001|NOT COMPLETED|First Test Day||10
9949265|NCT01401153|11068228|FG000|STARTED|Second Test Day||45
9949266|NCT01401153|11068229|FG001|STARTED|Second Test Day||65
9949267|NCT01401153|11068228|FG000|COMPLETED|Second Test Day||45
9949268|NCT01401153|11068229|FG001|COMPLETED|Second Test Day||60
9949269|NCT01401153|11068228|FG000|NOT COMPLETED|Second Test Day||0
9949270|NCT01401153|11068229|FG001|NOT COMPLETED|Second Test Day||5
9949271|NCT01401166|11068238|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
9949272|NCT01401166|11068239|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
9949273|NCT01401166|11068240|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
9949274|NCT01401166|11068241|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
9949275|NCT01401166|11068238|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
9949276|NCT01401166|11068239|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
9949277|NCT01401166|11068240|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
9949278|NCT01401166|11068241|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
9949279|NCT01401166|11068238|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
9949280|NCT01401166|11068239|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
9949281|NCT01401166|11068240|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
9949282|NCT01401166|11068241|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
9949283|NCT01401166|11068238|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
9949284|NCT01401166|11068239|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
9949285|NCT01401166|11068240|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
9949286|NCT01401166|11068241|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
9949287|NCT01401166|11068238|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
9949288|NCT01401166|11068239|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
9949289|NCT01401166|11068240|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
9949290|NCT01401166|11068241|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
9949291|NCT01401166|11068238|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
9949292|NCT01401166|11068239|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
9949293|NCT01401166|11068240|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
9949294|NCT01401166|11068241|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
9949295|NCT01401166|11068238|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113
9949296|NCT01401166|11068239|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116
9949297|NCT01401166|11068240|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107
9949298|NCT01401166|11068241|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105
9949299|NCT01401166|11068238|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
9949300|NCT01401166|11068239|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
10208910|NCT03560102|11336029|FG000|NOT COMPLETED|Overall Study||0
10238849|NCT00461812|11370279|FG000|STARTED|Overall Study||10
9949301|NCT01401166|11068240|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
9949302|NCT01401166|11068241|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
9949303|NCT01401166|11068238|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
9949304|NCT01401166|11068239|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
9949305|NCT01401166|11068240|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
9949306|NCT01401166|11068241|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
9949307|NCT01401166|11068238|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
9949308|NCT01401166|11068239|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
9949309|NCT01401166|11068240|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
9949310|NCT01401166|11068241|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
9949311|NCT01401166|11068238|FG000|COMPLETED|Safety Follow-Up Period||99
9949312|NCT01401166|11068239|FG001|COMPLETED|Safety Follow-Up Period||106
9949313|NCT01401166|11068240|FG002|COMPLETED|Safety Follow-Up Period||104
9949314|NCT01401166|11068241|FG003|COMPLETED|Safety Follow-Up Period||100
9949315|NCT01401166|11068238|FG000|NOT COMPLETED|Safety Follow-Up Period||25
9949316|NCT01401166|11068239|FG001|NOT COMPLETED|Safety Follow-Up Period||18
9949317|NCT01401166|11068240|FG002|NOT COMPLETED|Safety Follow-Up Period||17
9949318|NCT01401166|11068241|FG003|NOT COMPLETED|Safety Follow-Up Period||19
9949319|NCT01401257|11068262|FG000|STARTED|Overall Study||21
9949320|NCT01401257|11068263|FG001|STARTED|Overall Study||21
9949321|NCT01401257|11068264|FG002|STARTED|Overall Study||19
9949322|NCT01401257|11068265|FG003|STARTED|Overall Study||19
9949323|NCT01401257|11068262|FG000|COMPLETED|Overall Study||21
9949324|NCT01401257|11068263|FG001|COMPLETED|Overall Study||19
9949325|NCT01401257|11068264|FG002|COMPLETED|Overall Study||16
9949326|NCT01401257|11068265|FG003|COMPLETED|Overall Study||17
9949327|NCT01401257|11068262|FG000|NOT COMPLETED|Overall Study||0
9949328|NCT01401257|11068263|FG001|NOT COMPLETED|Overall Study||2
9949329|NCT01401257|11068264|FG002|NOT COMPLETED|Overall Study||3
9949330|NCT01401257|11068265|FG003|NOT COMPLETED|Overall Study||2
9949331|NCT01401283|11068277|FG000|STARTED|Overall Study||89
9949332|NCT01401283|11068278|FG001|STARTED|Overall Study||91
9949333|NCT01401283|11068277|FG000|COMPLETED|Overall Study||79
9949334|NCT01401283|11068278|FG001|COMPLETED|Overall Study||81
9949335|NCT01401283|11068277|FG000|NOT COMPLETED|Overall Study||10
9949336|NCT01401283|11068278|FG001|NOT COMPLETED|Overall Study||10
9949337|NCT01401322|11068284|FG000|STARTED|Overall Study||5
9949338|NCT01401322|11068284|FG000|COMPLETED|Overall Study||3
9949339|NCT01401322|11068284|FG000|NOT COMPLETED|Overall Study||2
9949340|NCT01401361|11068288|FG000|STARTED|Overall Study||150
9949341|NCT01401361|11068288|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
9949342|NCT01401361|11068288|FG000|NOT COMPLETED|Overall Study||28
9949343|NCT01401452|11068292|FG000|STARTED|Overall Study||246
9949344|NCT01401452|11068292|FG000|Visit 1 (Baseline)|Overall Study||246
9949345|NCT01401452|11068292|FG000|Visit 2 (1 Month)|Overall Study||225
9949346|NCT01401452|11068292|FG000|Visit 3 (3 Months)|Overall Study||217
9949347|NCT01401452|11068292|FG000|Visit 4 (6 Months)|Overall Study||172
9949348|NCT01401452|11068292|FG000|Visit 5 (9 Months)|Overall Study||175
9949349|NCT01401452|11068292|FG000|COMPLETED|Overall Study||174
9949350|NCT01401452|11068292|FG000|NOT COMPLETED|Overall Study||72
9949351|NCT01401465|11068298|FG000|STARTED|Treatment Period 1||165
9949352|NCT01401465|11068299|FG001|STARTED|Treatment Period 1||162
9949353|NCT01401465|11068298|FG000|COMPLETED|Treatment Period 1||150
9949354|NCT01401465|11068299|FG001|COMPLETED|Treatment Period 1||146
9949355|NCT01401465|11068298|FG000|NOT COMPLETED|Treatment Period 1||15
9949356|NCT01401465|11068299|FG001|NOT COMPLETED|Treatment Period 1||16
9949357|NCT01401465|11068298|FG000|STARTED|Washout||150
10238850|NCT00461812|11370279|FG000|COMPLETED|Overall Study||0
10238851|NCT00461812|11370279|FG000|NOT COMPLETED|Overall Study||10
9949358|NCT01401465|11068299|FG001|STARTED|Washout||146
9949359|NCT01401465|11068298|FG000|COMPLETED|Washout||150
9949360|NCT01401465|11068299|FG001|COMPLETED|Washout||146
9949361|NCT01401465|11068298|FG000|NOT COMPLETED|Washout||0
9949362|NCT01401465|11068299|FG001|NOT COMPLETED|Washout||0
9949363|NCT01401465|11068298|FG000|STARTED|Treatment Period 2||150
9949364|NCT01401465|11068299|FG001|STARTED|Treatment Period 2||146
9949365|NCT01401465|11068298|FG000|COMPLETED|Treatment Period 2||150
9949366|NCT01401465|11068299|FG001|COMPLETED|Treatment Period 2||144
9949367|NCT01401465|11068298|FG000|NOT COMPLETED|Treatment Period 2||0
9949368|NCT01401465|11068299|FG001|NOT COMPLETED|Treatment Period 2||2
9949369|NCT01401478|11068308|FG000|STARTED|Overall Study||86
9949370|NCT01401478|11068308|FG000|COMPLETED|Overall Study||55
9949371|NCT01401478|11068308|FG000|NOT COMPLETED|Overall Study||31
9949372|NCT01401517|11068315|FG000|STARTED|Overall Study||18
9949373|NCT01401517|11068316|FG001|STARTED|Overall Study||19
9949374|NCT01401517|11068317|FG002|STARTED|Overall Study||18
9949375|NCT01401517|11068315|FG000|COMPLETED|Overall Study||15
9949376|NCT01401517|11068316|FG001|COMPLETED|Overall Study||17
9949377|NCT01401517|11068317|FG002|COMPLETED|Overall Study||15
9949378|NCT01401517|11068315|FG000|NOT COMPLETED|Overall Study||3
9949379|NCT01401517|11068316|FG001|NOT COMPLETED|Overall Study||2
9949380|NCT01401517|11068317|FG002|NOT COMPLETED|Overall Study||3
9949381|NCT01401530|11068328|FG000|STARTED|Overall Study||3
9949382|NCT01401530|11068329|FG001|STARTED|Overall Study||7
9949383|NCT01401530|11068330|FG002|STARTED|Overall Study||3
9949384|NCT01401530|11068328|FG000|COMPLETED|Overall Study||0
9949385|NCT01401530|11068329|FG001|COMPLETED|Overall Study||1
9949386|NCT01401530|11068330|FG002|COMPLETED|Overall Study||0
9949387|NCT01401530|11068328|FG000|NOT COMPLETED|Overall Study||3
9949388|NCT01401530|11068329|FG001|NOT COMPLETED|Overall Study||6
9949389|NCT01401530|11068330|FG002|NOT COMPLETED|Overall Study||3
9949390|NCT01401543|11068340|FG000|STARTED|First Intervention||6
9949391|NCT01401543|11068341|FG001|STARTED|First Intervention||6
9949392|NCT01401543|11068342|FG002|STARTED|First Intervention||6
9949393|NCT01401543|11068343|FG003|STARTED|First Intervention||6
9949394|NCT01401543|11068340|FG000|COMPLETED|First Intervention||6
9949395|NCT01401543|11068341|FG001|COMPLETED|First Intervention||6
9949396|NCT01401543|11068342|FG002|COMPLETED|First Intervention||6
9949397|NCT01401543|11068343|FG003|COMPLETED|First Intervention||6
9949398|NCT01401543|11068340|FG000|NOT COMPLETED|First Intervention||0
9949399|NCT01401543|11068341|FG001|NOT COMPLETED|First Intervention||0
9949400|NCT01401543|11068342|FG002|NOT COMPLETED|First Intervention||0
9949401|NCT01401543|11068343|FG003|NOT COMPLETED|First Intervention||0
9949402|NCT01401543|11068340|FG000|STARTED|First Washout Period of 1 Week||6
9949403|NCT01401543|11068341|FG001|STARTED|First Washout Period of 1 Week||6
9949404|NCT01401543|11068342|FG002|STARTED|First Washout Period of 1 Week||6
9949405|NCT01401543|11068343|FG003|STARTED|First Washout Period of 1 Week||6
9949406|NCT01401543|11068340|FG000|COMPLETED|First Washout Period of 1 Week||6
9949407|NCT01401543|11068341|FG001|COMPLETED|First Washout Period of 1 Week||6
9949408|NCT01401543|11068342|FG002|COMPLETED|First Washout Period of 1 Week||6
9949409|NCT01401543|11068343|FG003|COMPLETED|First Washout Period of 1 Week||6
9949410|NCT01401543|11068340|FG000|NOT COMPLETED|First Washout Period of 1 Week||0
9949411|NCT01401543|11068341|FG001|NOT COMPLETED|First Washout Period of 1 Week||0
9949412|NCT01401543|11068342|FG002|NOT COMPLETED|First Washout Period of 1 Week||0
9949413|NCT01401543|11068343|FG003|NOT COMPLETED|First Washout Period of 1 Week||0
9949414|NCT01401543|11068340|FG000|STARTED|Second Intervention||6
9949415|NCT01401543|11068341|FG001|STARTED|Second Intervention||6
9949416|NCT01401543|11068342|FG002|STARTED|Second Intervention||6
9949417|NCT01401543|11068343|FG003|STARTED|Second Intervention||6
9949418|NCT01401543|11068340|FG000|COMPLETED|Second Intervention||6
9949419|NCT01401543|11068341|FG001|COMPLETED|Second Intervention||6
9949420|NCT01401543|11068342|FG002|COMPLETED|Second Intervention||6
9949421|NCT01401543|11068343|FG003|COMPLETED|Second Intervention||6
9949422|NCT01401543|11068340|FG000|NOT COMPLETED|Second Intervention||0
9949423|NCT01401543|11068341|FG001|NOT COMPLETED|Second Intervention||0
9949424|NCT01401543|11068342|FG002|NOT COMPLETED|Second Intervention||0
9949425|NCT01401543|11068343|FG003|NOT COMPLETED|Second Intervention||0
9949426|NCT01401543|11068340|FG000|STARTED|Second Washout Period of 1 Week||6
9949427|NCT01401543|11068341|FG001|STARTED|Second Washout Period of 1 Week||6
9949428|NCT01401543|11068342|FG002|STARTED|Second Washout Period of 1 Week||6
9949429|NCT01401543|11068343|FG003|STARTED|Second Washout Period of 1 Week||6
9949430|NCT01401543|11068340|FG000|COMPLETED|Second Washout Period of 1 Week||6
9949431|NCT01401543|11068341|FG001|COMPLETED|Second Washout Period of 1 Week||6
9949432|NCT01401543|11068342|FG002|COMPLETED|Second Washout Period of 1 Week||6
9949433|NCT01401543|11068343|FG003|COMPLETED|Second Washout Period of 1 Week||6
9949434|NCT01401543|11068340|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0
9949435|NCT01401543|11068341|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0
9949436|NCT01401543|11068342|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0
9949437|NCT01401543|11068343|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0
9949438|NCT01401543|11068340|FG000|STARTED|Third Intervention||6
9949439|NCT01401543|11068341|FG001|STARTED|Third Intervention||6
9949440|NCT01401543|11068342|FG002|STARTED|Third Intervention||6
9949441|NCT01401543|11068343|FG003|STARTED|Third Intervention||6
9949442|NCT01401543|11068340|FG000|COMPLETED|Third Intervention||6
9949443|NCT01401543|11068341|FG001|COMPLETED|Third Intervention||6
9949444|NCT01401543|11068342|FG002|COMPLETED|Third Intervention||6
9949445|NCT01401543|11068343|FG003|COMPLETED|Third Intervention||6
9949446|NCT01401543|11068340|FG000|NOT COMPLETED|Third Intervention||0
9949447|NCT01401543|11068341|FG001|NOT COMPLETED|Third Intervention||0
9949448|NCT01401543|11068342|FG002|NOT COMPLETED|Third Intervention||0
9949449|NCT01401543|11068343|FG003|NOT COMPLETED|Third Intervention||0
9949450|NCT01401543|11068340|FG000|STARTED|Third Washout Period of 1 Week||6
9949451|NCT01401543|11068341|FG001|STARTED|Third Washout Period of 1 Week||6
9949452|NCT01401543|11068342|FG002|STARTED|Third Washout Period of 1 Week||6
9949453|NCT01401543|11068343|FG003|STARTED|Third Washout Period of 1 Week||6
9949454|NCT01401543|11068340|FG000|COMPLETED|Third Washout Period of 1 Week||6
9949455|NCT01401543|11068341|FG001|COMPLETED|Third Washout Period of 1 Week||6
9949456|NCT01401543|11068342|FG002|COMPLETED|Third Washout Period of 1 Week||6
9949457|NCT01401543|11068343|FG003|COMPLETED|Third Washout Period of 1 Week||6
9949458|NCT01401543|11068340|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0
9949459|NCT01401543|11068341|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0
9949460|NCT01401543|11068342|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0
9949461|NCT01401543|11068343|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0
9949462|NCT01401543|11068340|FG000|STARTED|Fourth Intervention||6
9949463|NCT01401543|11068341|FG001|STARTED|Fourth Intervention||6
9949464|NCT01401543|11068342|FG002|STARTED|Fourth Intervention||6
9949465|NCT01401543|11068343|FG003|STARTED|Fourth Intervention||6
9949466|NCT01401543|11068340|FG000|COMPLETED|Fourth Intervention||6
9949467|NCT01401543|11068341|FG001|COMPLETED|Fourth Intervention||6
9949468|NCT01401543|11068342|FG002|COMPLETED|Fourth Intervention||6
9949469|NCT01401543|11068343|FG003|COMPLETED|Fourth Intervention||6
10011756|NCT01782313|11134540|FG000|NOT COMPLETED|Treated Cycle 3||21
10011757|NCT01782313|11134540|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31
10011758|NCT01782313|11134540|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
10011759|NCT01782313|11134540|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
10011760|NCT01782313|11134540|FG000|STARTED|Continued Treatment After 16 Weeks||25
10011761|NCT01782313|11134540|FG000|COMPLETED|Continued Treatment After 16 Weeks||18
9949470|NCT01401543|11068340|FG000|NOT COMPLETED|Fourth Intervention||0
9949471|NCT01401543|11068341|FG001|NOT COMPLETED|Fourth Intervention||0
9949472|NCT01401543|11068342|FG002|NOT COMPLETED|Fourth Intervention||0
9949473|NCT01401543|11068343|FG003|NOT COMPLETED|Fourth Intervention||0
9949474|NCT01401582|11068359|FG000|STARTED|Overall Study||226
9949475|NCT01401582|11068360|FG001|STARTED|Overall Study||408
9949476|NCT01401582|11068359|FG000|Baseline Completed|Overall Study||168
9949477|NCT01401582|11068360|FG001|Baseline Completed|Overall Study||348
9949478|NCT01401582|11068359|FG000|COMPLETED|Overall Study||116
9949479|NCT01401582|11068360|FG001|COMPLETED|Overall Study||291
9949480|NCT01401582|11068359|FG000|NOT COMPLETED|Overall Study||110
9949481|NCT01401582|11068360|FG001|NOT COMPLETED|Overall Study||117
9949482|NCT01401595|11068371|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
9949483|NCT01401595|11068372|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
9949484|NCT01401595|11068371|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
9949485|NCT01401595|11068372|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
9949486|NCT01401595|11068371|FG000|NOT COMPLETED|Recruitment and Screening||43
9949487|NCT01401595|11068372|FG001|NOT COMPLETED|Recruitment and Screening||2
9949488|NCT01401595|11068371|FG000|STARTED|Imaging and Treatment (for NE Arm)||32
9949489|NCT01401595|11068372|FG001|STARTED|Imaging and Treatment (for NE Arm)||10
9949490|NCT01401595|11068371|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18
9949491|NCT01401595|11068372|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10
9949492|NCT01401595|11068371|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
9949493|NCT01401595|11068372|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
9949494|NCT01401647|11068382|FG000|STARTED|Overall Study||972
9949495|NCT01401647|11068383|FG001|STARTED|Overall Study||993
9949496|NCT01401647|11068384|FG002|STARTED|Overall Study||1059
9949497|NCT01401647|11068382|FG000|COMPLETED|Overall Study||968
9949498|NCT01401647|11068383|FG001|COMPLETED|Overall Study||985
9949499|NCT01401647|11068384|FG002|COMPLETED|Overall Study||1056
9949500|NCT01401647|11068382|FG000|NOT COMPLETED|Overall Study||4
9949501|NCT01401647|11068383|FG001|NOT COMPLETED|Overall Study||8
9949502|NCT01401647|11068384|FG002|NOT COMPLETED|Overall Study||3
9949503|NCT01401699|11068392|FG000|STARTED|Overall Study||109
9949504|NCT01401699|11068392|FG000|COMPLETED|Overall Study||109
9949505|NCT01401699|11068392|FG000|NOT COMPLETED|Overall Study||0
9949506|NCT01401842|11068398|FG000|STARTED|Overall Study||298
9949507|NCT01401842|11068399|FG001|STARTED|Overall Study||284
9949508|NCT01401842|11068398|FG000|COMPLETED|Overall Study||230
9949509|NCT01401842|11068399|FG001|COMPLETED|Overall Study||217
9949510|NCT01401842|11068398|FG000|NOT COMPLETED|Overall Study||68
9949511|NCT01401842|11068399|FG001|NOT COMPLETED|Overall Study||67
10011762|NCT01782313|11134540|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7
10011763|NCT01782313|11134540|FG000|STARTED|Survival Follow up||58
10011764|NCT01782313|11134540|FG000|COMPLETED|Survival Follow up||57
10011765|NCT01782313|11134540|FG000|NOT COMPLETED|Survival Follow up||1
10011766|NCT01782326|11134546|FG000|STARTED|Planned Treatment Epoch||1680
10011767|NCT01782326|11134547|FG001|STARTED|Planned Treatment Epoch||1682
9949512|NCT01401907|11068407|FG000|STARTED|Overall Study||175
9949513|NCT01401907|11068408|FG001|STARTED|Overall Study||175
9949514|NCT01401907|11068407|FG000|12 Week Outcomes|Overall Study||148
9949515|NCT01401907|11068408|FG001|12 Week Outcomes|Overall Study||153
9949516|NCT01401907|11068407|FG000|COMPLETED|Overall Study||118
9949517|NCT01401907|11068408|FG001|COMPLETED|Overall Study||124
9949518|NCT01401907|11068407|FG000|NOT COMPLETED|Overall Study||57
9949519|NCT01401907|11068408|FG001|NOT COMPLETED|Overall Study||51
9949520|NCT01401959|11068419|FG000|STARTED|Enrolled||54
9949521|NCT01401959|11068420|FG001|STARTED|Enrolled||42
9949522|NCT01401959|11068421|FG002|STARTED|Enrolled||31
9949523|NCT01401959|11068419|FG000|COMPLETED|Enrolled||53
9949524|NCT01401959|11068420|FG001|COMPLETED|Enrolled||42
9949525|NCT01401959|11068421|FG002|COMPLETED|Enrolled||31
9949526|NCT01401959|11068419|FG000|NOT COMPLETED|Enrolled||1
9949527|NCT01401959|11068420|FG001|NOT COMPLETED|Enrolled||0
9949528|NCT01401959|11068421|FG002|NOT COMPLETED|Enrolled||0
9949529|NCT01401959|11068419|FG000|STARTED|Treated||53
9949530|NCT01401959|11068420|FG001|STARTED|Treated||42
9949531|NCT01401959|11068421|FG002|STARTED|Treated||31
9949532|NCT01401959|11068419|FG000|COMPLETED|Treated||46
9949533|NCT01401959|11068420|FG001|COMPLETED|Treated||34
9949534|NCT01401959|11068421|FG002|COMPLETED|Treated||26
9949535|NCT01401959|11068419|FG000|NOT COMPLETED|Treated||7
9949536|NCT01401959|11068420|FG001|NOT COMPLETED|Treated||8
9949537|NCT01401959|11068421|FG002|NOT COMPLETED|Treated||5
9949538|NCT01402011|11068434|FG000|STARTED|Delayed Treatment Period||29
9949539|NCT01402011|11068435|FG001|STARTED|Delayed Treatment Period||23
9949540|NCT01402011|11068436|FG002|STARTED|Delayed Treatment Period||26
9949541|NCT01402011|11068434|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
9949542|NCT01402011|11068435|FG001|COMPLETED|Delayed Treatment Period||23
9949543|NCT01402011|11068436|FG002|COMPLETED|Delayed Treatment Period||26
9949544|NCT01402011|11068434|FG000|NOT COMPLETED|Delayed Treatment Period||1
9949545|NCT01402011|11068435|FG001|NOT COMPLETED|Delayed Treatment Period||0
9949546|NCT01402011|11068436|FG002|NOT COMPLETED|Delayed Treatment Period||0
9949547|NCT01402011|11068434|FG000|STARTED|Active Treatment Period||28
9949548|NCT01402011|11068435|FG001|STARTED|Active Treatment Period||23
9949549|NCT01402011|11068436|FG002|STARTED|Active Treatment Period||26
9949550|NCT01402011|11068434|FG000|COMPLETED|Active Treatment Period||27
9949551|NCT01402011|11068435|FG001|COMPLETED|Active Treatment Period||20
9949552|NCT01402011|11068436|FG002|COMPLETED|Active Treatment Period||26
9949553|NCT01402011|11068434|FG000|NOT COMPLETED|Active Treatment Period||1
9949554|NCT01402011|11068435|FG001|NOT COMPLETED|Active Treatment Period||3
9949555|NCT01402011|11068436|FG002|NOT COMPLETED|Active Treatment Period||0
9949556|NCT01402011|11068434|FG000|STARTED|Nine Month Follow-up||27
9949557|NCT01402011|11068435|FG001|STARTED|Nine Month Follow-up||20
9949558|NCT01402011|11068436|FG002|STARTED|Nine Month Follow-up||26
9949559|NCT01402011|11068434|FG000|COMPLETED|Nine Month Follow-up||27
9949560|NCT01402011|11068435|FG001|COMPLETED|Nine Month Follow-up||19
9949561|NCT01402011|11068436|FG002|COMPLETED|Nine Month Follow-up||26
9949562|NCT01402011|11068434|FG000|NOT COMPLETED|Nine Month Follow-up||0
9949563|NCT01402011|11068435|FG001|NOT COMPLETED|Nine Month Follow-up||1
9949564|NCT01402011|11068436|FG002|NOT COMPLETED|Nine Month Follow-up||0
9949565|NCT01402050|11068449|FG000|STARTED|Overall Study||185
9949566|NCT01402050|11068450|FG001|STARTED|Overall Study||191
9949567|NCT01402050|11068449|FG000|COMPLETED|Overall Study||185
9949568|NCT01402050|11068450|FG001|COMPLETED|Overall Study||191
9949569|NCT01402050|11068449|FG000|NOT COMPLETED|Overall Study||0
9949570|NCT01402050|11068450|FG001|NOT COMPLETED|Overall Study||0
9949571|NCT01402063|11068458|FG000|STARTED|Overall Study||42
9949572|NCT01402063|11068459|FG001|STARTED|Overall Study||21
9949573|NCT01402063|11068458|FG000|COMPLETED|Overall Study||39
9949574|NCT01402063|11068459|FG001|COMPLETED|Overall Study||18
9949575|NCT01402063|11068458|FG000|NOT COMPLETED|Overall Study||3
9949576|NCT01402063|11068459|FG001|NOT COMPLETED|Overall Study||3
9949577|NCT01402102|11068467|FG000|STARTED|Overall Study||30
9949578|NCT01402102|11068468|FG001|STARTED|Overall Study||30
9949579|NCT01402102|11068467|FG000|COMPLETED|Overall Study||28
9949580|NCT01402102|11068468|FG001|COMPLETED|Overall Study||27
9949581|NCT01402102|11068467|FG000|NOT COMPLETED|Overall Study||2
9949582|NCT01402102|11068468|FG001|NOT COMPLETED|Overall Study||3
9949583|NCT01402115|11068478|FG000|STARTED|Overall Study||30
9949584|NCT01402115|11068479|FG001|STARTED|Overall Study||30
9949585|NCT01402115|11068478|FG000|COMPLETED|Overall Study||29
9949586|NCT01402115|11068479|FG001|COMPLETED|Overall Study||29
9949587|NCT01402115|11068478|FG000|NOT COMPLETED|Overall Study||1
10011768|NCT01782326|11134546|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
10011769|NCT01782326|11134547|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
10011770|NCT01782326|11134546|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
9949588|NCT01402115|11068479|FG001|NOT COMPLETED|Overall Study||1
9949589|NCT01402128|11068487|FG000|STARTED|Overall Study||40
9949590|NCT01402128|11068488|FG001|STARTED|Overall Study||40
9949591|NCT01402128|11068487|FG000|COMPLETED|Overall Study||39
9949592|NCT01402128|11068488|FG001|COMPLETED|Overall Study||40
9949593|NCT01402128|11068487|FG000|NOT COMPLETED|Overall Study||1
9949594|NCT01402128|11068488|FG001|NOT COMPLETED|Overall Study||0
9949595|NCT01402141|11068496|FG000|STARTED|Overall Study||30
9949596|NCT01402141|11068497|FG001|STARTED|Overall Study||30
9949597|NCT01402141|11068496|FG000|COMPLETED|Overall Study||29
9949598|NCT01402141|11068497|FG001|COMPLETED|Overall Study||28
9949599|NCT01402141|11068496|FG000|NOT COMPLETED|Overall Study||1
9949600|NCT01402141|11068497|FG001|NOT COMPLETED|Overall Study||2
9949601|NCT01402284|11068504|FG000|STARTED|Overall Study||45
9949602|NCT01402284|11068504|FG000|COMPLETED|Overall Study||31
9949603|NCT01402284|11068504|FG000|NOT COMPLETED|Overall Study||14
9949604|NCT01402375|11068514|FG000|STARTED|Overall Study||120
9949605|NCT01402375|11068515|FG001|STARTED|Overall Study||120
9949606|NCT01402375|11068516|FG002|STARTED|Overall Study||120
9949607|NCT01402375|11068517|FG003|STARTED|Overall Study||120
9949608|NCT01402375|11068518|FG004|STARTED|Overall Study||120
9949609|NCT01402375|11068519|FG005|STARTED|Overall Study||120
9949610|NCT01402375|11068514|FG000|COMPLETED|Overall Study||120
9949611|NCT01402375|11068515|FG001|COMPLETED|Overall Study||120
9949612|NCT01402375|11068516|FG002|COMPLETED|Overall Study||120
9949613|NCT01402375|11068517|FG003|COMPLETED|Overall Study||120
9949614|NCT01402375|11068518|FG004|COMPLETED|Overall Study||120
9949615|NCT01402375|11068519|FG005|COMPLETED|Overall Study||120
9949616|NCT01402375|11068514|FG000|NOT COMPLETED|Overall Study||0
9949617|NCT01402375|11068515|FG001|NOT COMPLETED|Overall Study||0
9949618|NCT01402375|11068516|FG002|NOT COMPLETED|Overall Study||0
9949619|NCT01402375|11068517|FG003|NOT COMPLETED|Overall Study||0
9949620|NCT01402375|11068518|FG004|NOT COMPLETED|Overall Study||0
9949621|NCT01402375|11068519|FG005|NOT COMPLETED|Overall Study||0
9949622|NCT01402427|11068535|FG000|STARTED|Overall Study||297
9949623|NCT01402427|11068536|FG001|STARTED|Overall Study||294
9949624|NCT01402427|11068535|FG000|COMPLETED|Overall Study||297
9949625|NCT01402427|11068536|FG001|COMPLETED|Overall Study||294
10011771|NCT01782326|11134547|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
10011772|NCT01782326|11134546|FG000|Serial Spirometry Set|Planned Treatment Epoch||280
10011773|NCT01782326|11134547|FG001|Serial Spirometry Set|Planned Treatment Epoch||279
9949626|NCT01402427|11068535|FG000|NOT COMPLETED|Overall Study||0
9949627|NCT01402427|11068536|FG001|NOT COMPLETED|Overall Study||0
9949628|NCT01402492|11068545|FG000|STARTED|Overall Study||100
9949629|NCT01402492|11068546|FG001|STARTED|Overall Study||100
9949630|NCT01402492|11068547|FG002|STARTED|Overall Study||102
9949631|NCT01402492|11068545|FG000|COMPLETED|Overall Study||79
9949632|NCT01402492|11068546|FG001|COMPLETED|Overall Study||83
9949633|NCT01402492|11068547|FG002|COMPLETED|Overall Study||86
9949634|NCT01402492|11068545|FG000|NOT COMPLETED|Overall Study||21
9949635|NCT01402492|11068546|FG001|NOT COMPLETED|Overall Study||17
9949636|NCT01402492|11068547|FG002|NOT COMPLETED|Overall Study||16
9949637|NCT01402544|11068555|FG000|STARTED|Overall Study||12
9949638|NCT01402544|11068555|FG000|COMPLETED|Overall Study||6
9949639|NCT01402544|11068555|FG000|NOT COMPLETED|Overall Study||6
9949640|NCT01402570|11068559|FG000|STARTED|Overall Study||20
9949641|NCT01402570|11068559|FG000|COMPLETED|Overall Study||19
9949642|NCT01402570|11068559|FG000|NOT COMPLETED|Overall Study||1
9949643|NCT01402700|11068564|FG000|STARTED|Overall Study||75
9949644|NCT01402700|11068564|FG000|COMPLETED|Overall Study||68
9949645|NCT01402700|11068564|FG000|NOT COMPLETED|Overall Study||7
9949646|NCT01402817|11068568|FG000|STARTED|Overall Study||19
9949647|NCT01402817|11068568|FG000|COMPLETED|Overall Study||8
9949648|NCT01402817|11068568|FG000|NOT COMPLETED|Overall Study||11
9949649|NCT01402869|11068576|FG000|STARTED|Overall Study||30
9949650|NCT01402869|11068577|FG001|STARTED|Overall Study||30
9949651|NCT01402869|11068578|FG002|STARTED|Overall Study||31
9949652|NCT01402869|11068576|FG000|COMPLETED|Overall Study||30
9949653|NCT01402869|11068577|FG001|COMPLETED|Overall Study||30
9949654|NCT01402869|11068578|FG002|COMPLETED|Overall Study||30
9949655|NCT01402869|11068576|FG000|NOT COMPLETED|Overall Study||0
9949656|NCT01402869|11068577|FG001|NOT COMPLETED|Overall Study||0
9949657|NCT01402869|11068578|FG002|NOT COMPLETED|Overall Study||1
9949658|NCT01402947|11068588|FG000|STARTED|First Intervention||15
9949659|NCT01402947|11068589|FG001|STARTED|First Intervention||15
9949660|NCT01402947|11068588|FG000|COMPLETED|First Intervention||15
9949661|NCT01402947|11068589|FG001|COMPLETED|First Intervention||14
9949662|NCT01402947|11068588|FG000|NOT COMPLETED|First Intervention||0
9949663|NCT01402947|11068589|FG001|NOT COMPLETED|First Intervention||1
9949664|NCT01402947|11068588|FG000|STARTED|Second Intervention||15
9949665|NCT01402947|11068589|FG001|STARTED|Second Intervention||14
9949666|NCT01402947|11068588|FG000|COMPLETED|Second Intervention||15
9949667|NCT01402947|11068589|FG001|COMPLETED|Second Intervention||14
9949668|NCT01402947|11068588|FG000|NOT COMPLETED|Second Intervention||0
9949669|NCT01402947|11068589|FG001|NOT COMPLETED|Second Intervention||0
9949670|NCT01402986|11068599|FG000|STARTED|Overall Study||76
9949671|NCT01402986|11068600|FG001|STARTED|Overall Study||150
9949672|NCT01402986|11068601|FG002|STARTED|Overall Study||75
9949673|NCT01402986|11068602|FG003|STARTED|Overall Study||151
9949674|NCT01402986|11068599|FG000|COMPLETED|Overall Study||67
9949675|NCT01402986|11068600|FG001|COMPLETED|Overall Study||135
9949676|NCT01402986|11068601|FG002|COMPLETED|Overall Study||67
9949677|NCT01402986|11068602|FG003|COMPLETED|Overall Study||129
9949678|NCT01402986|11068599|FG000|NOT COMPLETED|Overall Study||9
9949679|NCT01402986|11068600|FG001|NOT COMPLETED|Overall Study||15
9949680|NCT01402986|11068601|FG002|NOT COMPLETED|Overall Study||8
9949681|NCT01402986|11068602|FG003|NOT COMPLETED|Overall Study||22
9949682|NCT01403051|11068614|FG000|STARTED|Overall Study||81
9949683|NCT01403051|11068615|FG001|STARTED|Overall Study||86
9949684|NCT01403051|11068614|FG000|Initiated Study Treatment|Overall Study||81
9949685|NCT01403051|11068615|FG001|Initiated Study Treatment|Overall Study||86
9949686|NCT01403051|11068614|FG000|COMPLETED|Overall Study||71
9949687|NCT01403051|11068615|FG001|COMPLETED|Overall Study||80
10011774|NCT01782326|11134546|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678
9949688|NCT01403051|11068614|FG000|NOT COMPLETED|Overall Study||10
9949689|NCT01403051|11068615|FG001|NOT COMPLETED|Overall Study||6
9949690|NCT01403064|11068626|FG000|STARTED|Overall Study||24
9949691|NCT01403064|11068627|FG001|STARTED|Overall Study||7
9949692|NCT01403064|11068628|FG002|STARTED|Overall Study||23
9949693|NCT01403064|11068629|FG003|STARTED|Overall Study||22
9949694|NCT01403064|11068626|FG000|COMPLETED|Overall Study||23
9949695|NCT01403064|11068627|FG001|COMPLETED|Overall Study||7
9949696|NCT01403064|11068628|FG002|COMPLETED|Overall Study||19
9949697|NCT01403064|11068629|FG003|COMPLETED|Overall Study||19
9949698|NCT01403064|11068626|FG000|NOT COMPLETED|Overall Study||1
9949699|NCT01403064|11068627|FG001|NOT COMPLETED|Overall Study||0
9949700|NCT01403064|11068628|FG002|NOT COMPLETED|Overall Study||4
9949701|NCT01403064|11068629|FG003|NOT COMPLETED|Overall Study||3
9949702|NCT01403090|11068644|FG000|STARTED|Overall Study||8
9949703|NCT01403090|11068644|FG000|COMPLETED|Overall Study||8
9949704|NCT01403090|11068644|FG000|NOT COMPLETED|Overall Study||0
9949705|NCT01403116|11068650|FG000|STARTED|Overall Study||161
9949706|NCT01403116|11068651|FG001|STARTED|Overall Study||160
9949707|NCT01403116|11068650|FG000|Randomized|Overall Study||162
9949708|NCT01403116|11068651|FG001|Randomized|Overall Study||163
9949709|NCT01403116|11068650|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1
9949710|NCT01403116|11068651|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3
9949711|NCT01403116|11068650|FG000|COMPLETED|Overall Study||129
9949712|NCT01403116|11068651|FG001|COMPLETED|Overall Study||133
9949713|NCT01403116|11068650|FG000|NOT COMPLETED|Overall Study||32
9949714|NCT01403116|11068651|FG001|NOT COMPLETED|Overall Study||27
9949715|NCT01403246|11068657|FG000|STARTED|Overall Study||9
9949716|NCT01403246|11068657|FG000|COMPLETED|Overall Study||9
9949717|NCT01403246|11068657|FG000|NOT COMPLETED|Overall Study||0
9949718|NCT01403376|11068664|FG000|STARTED|Overall Study||41
9949719|NCT01403376|11068665|FG001|STARTED|Overall Study||41
9949720|NCT01403376|11068666|FG002|STARTED|Overall Study||46
9949721|NCT01403376|11068664|FG000|COMPLETED|Overall Study||41
9949722|NCT01403376|11068665|FG001|COMPLETED|Overall Study||41
9949723|NCT01403376|11068666|FG002|COMPLETED|Overall Study||46
9949724|NCT01403376|11068664|FG000|NOT COMPLETED|Overall Study||0
9949725|NCT01403376|11068665|FG001|NOT COMPLETED|Overall Study||0
9949726|NCT01403376|11068666|FG002|NOT COMPLETED|Overall Study||0
9949727|NCT01403441|11068674|FG000|STARTED|Overall Study||3
9949728|NCT01403441|11068674|FG000|COMPLETED|Overall Study||3
9949729|NCT01403441|11068674|FG000|NOT COMPLETED|Overall Study||0
9949730|NCT01403584|11068680|FG000|STARTED|First Intervention (1 Night)||11
9949731|NCT01403584|11068681|FG001|STARTED|First Intervention (1 Night)||10
9949732|NCT01403584|11068680|FG000|COMPLETED|First Intervention (1 Night)||11
9949733|NCT01403584|11068681|FG001|COMPLETED|First Intervention (1 Night)||10
9949734|NCT01403584|11068680|FG000|NOT COMPLETED|First Intervention (1 Night)||0
9949735|NCT01403584|11068681|FG001|NOT COMPLETED|First Intervention (1 Night)||0
9949736|NCT01403584|11068680|FG000|STARTED|Second Intervention(1 Night)||10
9949737|NCT01403584|11068681|FG001|STARTED|Second Intervention(1 Night)||11
9949738|NCT01403584|11068680|FG000|COMPLETED|Second Intervention(1 Night)||10
9949739|NCT01403584|11068681|FG001|COMPLETED|Second Intervention(1 Night)||11
9949740|NCT01403584|11068680|FG000|NOT COMPLETED|Second Intervention(1 Night)||0
9949741|NCT01403584|11068681|FG001|NOT COMPLETED|Second Intervention(1 Night)||0
9949742|NCT01403610|11068691|FG000|STARTED|Overall Study||5
9949743|NCT01403610|11068692|FG001|STARTED|Overall Study||6
9949744|NCT01403610|11068693|FG002|STARTED|Overall Study||4
9949745|NCT01403610|11068694|FG003|STARTED|Overall Study||13
9949746|NCT01403610|11068691|FG000|COMPLETED|Overall Study||3
9949747|NCT01403610|11068692|FG001|COMPLETED|Overall Study||3
9949748|NCT01403610|11068693|FG002|COMPLETED|Overall Study||4
9949749|NCT01403610|11068694|FG003|COMPLETED|Overall Study||13
9949750|NCT01403610|11068691|FG000|NOT COMPLETED|Overall Study||2
10011775|NCT01782326|11134547|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680
10011776|NCT01782326|11134546|FG000|Urine Cortisol Set|Planned Treatment Epoch||266
10011777|NCT01782326|11134547|FG001|Urine Cortisol Set|Planned Treatment Epoch||269
10011778|NCT01782326|11134546|FG000|COMPLETED|Planned Treatment Epoch||1478
9949751|NCT01403610|11068692|FG001|NOT COMPLETED|Overall Study||3
9949752|NCT01403610|11068693|FG002|NOT COMPLETED|Overall Study||0
9949753|NCT01403610|11068694|FG003|NOT COMPLETED|Overall Study||0
9949754|NCT01403805|11068706|FG000|STARTED|Overall Study||94
9949755|NCT01403805|11068707|FG001|STARTED|Overall Study||105
9949756|NCT01403805|11068706|FG000|Pneumonia Diagnosis|Overall Study||21
9949757|NCT01403805|11068707|FG001|Pneumonia Diagnosis|Overall Study||2
9949758|NCT01403805|11068706|FG000|COMPLETED|Overall Study||94
9949759|NCT01403805|11068707|FG001|COMPLETED|Overall Study||98
9949760|NCT01403805|11068706|FG000|NOT COMPLETED|Overall Study||0
9949761|NCT01403805|11068707|FG001|NOT COMPLETED|Overall Study||7
9949762|NCT01403987|11068720|FG000|STARTED|Overall Study||34
9949763|NCT01403987|11068721|FG001|STARTED|Overall Study||34
9949764|NCT01403987|11068722|FG002|STARTED|Overall Study||68
9949765|NCT01403987|11068720|FG000|COMPLETED|Overall Study||16
9949766|NCT01403987|11068721|FG001|COMPLETED|Overall Study||17
9949767|NCT01403987|11068722|FG002|COMPLETED|Overall Study||50
9949768|NCT01403987|11068720|FG000|NOT COMPLETED|Overall Study||18
9949769|NCT01403987|11068721|FG001|NOT COMPLETED|Overall Study||17
9949770|NCT01403987|11068722|FG002|NOT COMPLETED|Overall Study||18
9949771|NCT01404039|11068739|FG000|STARTED|Overall Study||5
9949772|NCT01404039|11068740|FG001|STARTED|Overall Study||5
9949773|NCT01404039|11068741|FG002|STARTED|Overall Study||5
9949774|NCT01404039|11068742|FG003|STARTED|Overall Study||10
9949775|NCT01404039|11068743|FG004|STARTED|Overall Study||10
9949776|NCT01404039|11068744|FG005|STARTED|Overall Study||10
9949777|NCT01404039|11068745|FG006|STARTED|Overall Study||10
9949778|NCT01404039|11068746|FG007|STARTED|Overall Study||15
9949779|NCT01404039|11068747|FG008|STARTED|Overall Study||15
9949780|NCT01404039|11068748|FG009|STARTED|Overall Study||15
9949781|NCT01404039|11068749|FG010|STARTED|Overall Study||15
9949782|NCT01404039|11068750|FG011|STARTED|Overall Study||0
9949783|NCT01404039|11068751|FG012|STARTED|Overall Study||0
9949784|NCT01404039|11068739|FG000|COMPLETED|Overall Study||4
9949785|NCT01404039|11068740|FG001|COMPLETED|Overall Study||5
9949786|NCT01404039|11068741|FG002|COMPLETED|Overall Study||5
9949787|NCT01404039|11068742|FG003|COMPLETED|Overall Study||10
9949788|NCT01404039|11068743|FG004|COMPLETED|Overall Study||10
9949789|NCT01404039|11068744|FG005|COMPLETED|Overall Study||10
9949790|NCT01404039|11068745|FG006|COMPLETED|Overall Study||10
9949791|NCT01404039|11068746|FG007|COMPLETED|Overall Study||15
9949792|NCT01404039|11068747|FG008|COMPLETED|Overall Study||15
9949793|NCT01404039|11068748|FG009|COMPLETED|Overall Study||14
9949794|NCT01404039|11068749|FG010|COMPLETED|Overall Study||14
9949795|NCT01404039|11068750|FG011|COMPLETED|Overall Study||0
9949796|NCT01404039|11068751|FG012|COMPLETED|Overall Study||0
9949797|NCT01404039|11068739|FG000|NOT COMPLETED|Overall Study||1
9949798|NCT01404039|11068740|FG001|NOT COMPLETED|Overall Study||0
9949799|NCT01404039|11068741|FG002|NOT COMPLETED|Overall Study||0
9949800|NCT01404039|11068742|FG003|NOT COMPLETED|Overall Study||0
9949801|NCT01404039|11068743|FG004|NOT COMPLETED|Overall Study||0
9949802|NCT01404039|11068744|FG005|NOT COMPLETED|Overall Study||0
9949803|NCT01404039|11068745|FG006|NOT COMPLETED|Overall Study||0
9949804|NCT01404039|11068746|FG007|NOT COMPLETED|Overall Study||0
9949805|NCT01404039|11068747|FG008|NOT COMPLETED|Overall Study||0
9949806|NCT01404039|11068748|FG009|NOT COMPLETED|Overall Study||1
9949807|NCT01404039|11068749|FG010|NOT COMPLETED|Overall Study||1
9949808|NCT01404039|11068750|FG011|NOT COMPLETED|Overall Study||0
9949809|NCT01404039|11068751|FG012|NOT COMPLETED|Overall Study||0
9949810|NCT01404078|11068777|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
9949811|NCT01404078|11068778|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
9949812|NCT01404078|11068777|FG000|COMPLETED|Overall Study||243
9949813|NCT01404078|11068778|FG001|COMPLETED|Overall Study||237
9949814|NCT01404078|11068777|FG000|NOT COMPLETED|Overall Study||18
9949815|NCT01404078|11068778|FG001|NOT COMPLETED|Overall Study||20
9949816|NCT01404208|11068786|FG000|STARTED|Overall Study||70
9949817|NCT01404208|11068787|FG001|STARTED|Overall Study||72
9949818|NCT01404208|11068786|FG000|COMPLETED|Overall Study||67
9949819|NCT01404208|11068787|FG001|COMPLETED|Overall Study||72
9949820|NCT01404208|11068786|FG000|NOT COMPLETED|Overall Study||3
9949821|NCT01404208|11068787|FG001|NOT COMPLETED|Overall Study||0
9949822|NCT01404234|11068793|FG000|STARTED|Overall Study||61
9949823|NCT01404234|11068793|FG000|COMPLETED|Overall Study||59
9949824|NCT01404234|11068793|FG000|NOT COMPLETED|Overall Study||2
9949825|NCT01404260|11068799|FG000|STARTED|Overall Study||109
9949826|NCT01404260|11068800|FG001|STARTED|Overall Study||110
9949827|NCT01404260|11068799|FG000|COMPLETED|Overall Study||106
9949828|NCT01404260|11068800|FG001|COMPLETED|Overall Study||101
9949829|NCT01404260|11068799|FG000|NOT COMPLETED|Overall Study||3
9949830|NCT01404260|11068800|FG001|NOT COMPLETED|Overall Study||9
9949831|NCT01404325|11068808|FG000|STARTED|Overall Study||67
10208911|NCT03560128|11336035|FG000|STARTED|Overall Study||306
10208912|NCT03560128|11336036|FG001|STARTED|Overall Study||306
10208913|NCT03560128|11336035|FG000|COMPLETED|Overall Study||294
10208914|NCT03560128|11336036|FG001|COMPLETED|Overall Study||298
10208915|NCT03560128|11336035|FG000|NOT COMPLETED|Overall Study||12
10208916|NCT03560128|11336036|FG001|NOT COMPLETED|Overall Study||8
10208917|NCT03560141|11336044|FG000|STARTED|Overall Study||6
10208918|NCT03560141|11336045|FG001|STARTED|Overall Study||5
10208919|NCT03560141|11336044|FG000|COMPLETED|Overall Study||6
10208920|NCT03560141|11336045|FG001|COMPLETED|Overall Study||5
10208921|NCT03560141|11336044|FG000|NOT COMPLETED|Overall Study||0
10208922|NCT03560141|11336045|FG001|NOT COMPLETED|Overall Study||0
10208923|NCT03560245|11336055|FG000|STARTED|Overall Study||53
10208924|NCT03560245|11336056|FG001|STARTED|Overall Study||55
10208925|NCT03560245|11336055|FG000|COMPLETED|Overall Study||48
10208926|NCT03560245|11336056|FG001|COMPLETED|Overall Study||48
10208927|NCT03560245|11336055|FG000|NOT COMPLETED|Overall Study||5
10208928|NCT03560245|11336056|FG001|NOT COMPLETED|Overall Study||7
10208929|NCT03560518|11336067|FG000|STARTED|Double Blind Treatment Period||147
10208930|NCT03560518|11336068|FG001|STARTED|Double Blind Treatment Period||145
10208931|NCT03560518|11336069|FG002|STARTED|Double Blind Treatment Period||147
9949832|NCT01404325|11068809|FG001|STARTED|Overall Study||63
9949833|NCT01404325|11068808|FG000|COMPLETED|Overall Study||63
9949834|NCT01404325|11068809|FG001|COMPLETED|Overall Study||61
9949835|NCT01404325|11068808|FG000|NOT COMPLETED|Overall Study||4
10208932|NCT03560518|11336067|FG000|COMPLETED|Double Blind Treatment Period||122
9949836|NCT01404325|11068809|FG001|NOT COMPLETED|Overall Study||2
9949837|NCT01404429|11068817|FG000|STARTED|Overall Study||47
9949838|NCT01404429|11068818|FG001|STARTED|Overall Study||53
9949839|NCT01404429|11068817|FG000|COMPLETED|Overall Study||38
9949840|NCT01404429|11068818|FG001|COMPLETED|Overall Study||46
9949841|NCT01404429|11068817|FG000|NOT COMPLETED|Overall Study||9
9949842|NCT01404429|11068818|FG001|NOT COMPLETED|Overall Study||7
10208933|NCT03560518|11336068|FG001|COMPLETED|Double Blind Treatment Period||116
10208934|NCT03560518|11336069|FG002|COMPLETED|Double Blind Treatment Period||124
9949843|NCT01404559|11068828|FG000|STARTED|Overall Study||5
9949844|NCT01404559|11068829|FG001|STARTED|Overall Study||5
9949845|NCT01404559|11068830|FG002|STARTED|Overall Study||4
9949846|NCT01404559|11068831|FG003|STARTED|Overall Study||14
9949847|NCT01404559|11068828|FG000|COMPLETED|Overall Study||5
9949848|NCT01404559|11068829|FG001|COMPLETED|Overall Study||5
9949849|NCT01404559|11068830|FG002|COMPLETED|Overall Study||4
9949850|NCT01404559|11068831|FG003|COMPLETED|Overall Study||14
9949851|NCT01404559|11068828|FG000|NOT COMPLETED|Overall Study||0
9949852|NCT01404559|11068829|FG001|NOT COMPLETED|Overall Study||0
9949853|NCT01404559|11068830|FG002|NOT COMPLETED|Overall Study||0
9949854|NCT01404559|11068831|FG003|NOT COMPLETED|Overall Study||0
9949855|NCT01404572|11068838|FG000|STARTED|Overall Study||4
9949856|NCT01404572|11068839|FG001|STARTED|Overall Study||4
9949857|NCT01404572|11068840|FG002|STARTED|Overall Study||4
9949858|NCT01404572|11068838|FG000|COMPLETED|Overall Study||4
9949859|NCT01404572|11068839|FG001|COMPLETED|Overall Study||4
9949860|NCT01404572|11068840|FG002|COMPLETED|Overall Study||4
9949861|NCT01404572|11068838|FG000|NOT COMPLETED|Overall Study||0
9949862|NCT01404572|11068839|FG001|NOT COMPLETED|Overall Study||0
9949863|NCT01404572|11068840|FG002|NOT COMPLETED|Overall Study||0
9949864|NCT01404611|11068854|FG000|STARTED|Overall Study||112
9949865|NCT01404611|11068855|FG001|STARTED|Overall Study||108
9949866|NCT01404611|11068856|FG002|STARTED|Overall Study||111
9949867|NCT01404611|11068854|FG000|COMPLETED|Overall Study||104
9949868|NCT01404611|11068855|FG001|COMPLETED|Overall Study||89
9949869|NCT01404611|11068856|FG002|COMPLETED|Overall Study||106
9949870|NCT01404611|11068854|FG000|NOT COMPLETED|Overall Study||8
9949871|NCT01404611|11068855|FG001|NOT COMPLETED|Overall Study||19
9949872|NCT01404611|11068856|FG002|NOT COMPLETED|Overall Study||5
9949873|NCT01404650|11068864|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
9949874|NCT01404650|11068864|FG000|COMPLETED|Overall Study||25
9949875|NCT01404650|11068864|FG000|NOT COMPLETED|Overall Study||0
9949876|NCT01404832|11068868|FG000|STARTED|Overall Study||21
9949877|NCT01404832|11068868|FG000|COMPLETED|Overall Study||21
9949878|NCT01404832|11068868|FG000|NOT COMPLETED|Overall Study||0
9949879|NCT01404923|11068874|FG000|STARTED|Overall Study||222
9949880|NCT01404923|11068875|FG001|STARTED|Overall Study||214
9949881|NCT01404923|11068874|FG000|COMPLETED|Overall Study||199
9949882|NCT01404923|11068875|FG001|COMPLETED|Overall Study||197
9949883|NCT01404923|11068874|FG000|NOT COMPLETED|Overall Study||23
9949884|NCT01404923|11068875|FG001|NOT COMPLETED|Overall Study||17
9949885|NCT01404936|11068881|FG000|STARTED|Overall Study||30
9949886|NCT01404936|11068881|FG000|COMPLETED|Overall Study||30
9949887|NCT01404936|11068881|FG000|NOT COMPLETED|Overall Study||0
9949888|NCT01404949|11068885|FG000|STARTED|Overall Study||17
10208935|NCT03560518|11336067|FG000|NOT COMPLETED|Double Blind Treatment Period||25
10208936|NCT03560518|11336068|FG001|NOT COMPLETED|Double Blind Treatment Period||29
10208937|NCT03560518|11336069|FG002|NOT COMPLETED|Double Blind Treatment Period||23
10208938|NCT03560518|11336067|FG000|STARTED|Safety Follow-Up Period||10
10208939|NCT03560518|11336068|FG001|STARTED|Safety Follow-Up Period||17
10208940|NCT03560518|11336069|FG002|STARTED|Safety Follow-Up Period||22
10208941|NCT03560518|11336067|FG000|COMPLETED|Safety Follow-Up Period||10
10208942|NCT03560518|11336068|FG001|COMPLETED|Safety Follow-Up Period||17
10208943|NCT03560518|11336069|FG002|COMPLETED|Safety Follow-Up Period||22
10208944|NCT03560518|11336067|FG000|NOT COMPLETED|Safety Follow-Up Period||0
10208945|NCT03560518|11336068|FG001|NOT COMPLETED|Safety Follow-Up Period||0
10208946|NCT03560518|11336069|FG002|NOT COMPLETED|Safety Follow-Up Period||0
10208947|NCT03560739|11336081|FG000|STARTED|Overall Study||128
10208948|NCT03560739|11336082|FG001|STARTED|Overall Study||130
10208949|NCT03560739|11336083|FG002|STARTED|Overall Study||13
10208950|NCT03560739|11336084|FG003|STARTED|Overall Study||13
10208951|NCT03560739|11336081|FG000|COMPLETED|Overall Study||128
10208952|NCT03560739|11336082|FG001|COMPLETED|Overall Study||129
10208953|NCT03560739|11336083|FG002|COMPLETED|Overall Study||13
10208954|NCT03560739|11336084|FG003|COMPLETED|Overall Study||13
10208955|NCT03560739|11336081|FG000|NOT COMPLETED|Overall Study||0
10208956|NCT03560739|11336082|FG001|NOT COMPLETED|Overall Study||1
10208957|NCT03560739|11336083|FG002|NOT COMPLETED|Overall Study||0
10208958|NCT03560739|11336084|FG003|NOT COMPLETED|Overall Study||0
10208959|NCT03560869|11336094|FG000|STARTED|Overall Study||14
10208960|NCT03560869|11336095|FG001|STARTED|Overall Study||21
10208961|NCT03560869|11336094|FG000|COMPLETED|Overall Study||7
10208962|NCT03560869|11336095|FG001|COMPLETED|Overall Study||12
9949889|NCT01404949|11068885|FG000|COMPLETED|Overall Study||16
9949890|NCT01404949|11068885|FG000|NOT COMPLETED|Overall Study||1
9949891|NCT01404988|11068892|FG000|STARTED|Overall Study||33
9949892|NCT01404988|11068893|FG001|STARTED|Overall Study||33
9949893|NCT01404988|11068894|FG002|STARTED|Overall Study||33
10208963|NCT03560869|11336094|FG000|NOT COMPLETED|Overall Study||7
10208964|NCT03560869|11336095|FG001|NOT COMPLETED|Overall Study||9
10208965|NCT03560986|11336103|FG000|STARTED|Treatment Period A/Follow-up Period 1||48
10238852|NCT00459121|11370284|FG000|STARTED|Overall Study||2
9949894|NCT01404988|11068892|FG000|COMPLETED|Overall Study||27
9949895|NCT01404988|11068893|FG001|COMPLETED|Overall Study||29
9949896|NCT01404988|11068894|FG002|COMPLETED|Overall Study||30
9949897|NCT01404988|11068892|FG000|NOT COMPLETED|Overall Study||6
9949898|NCT01404988|11068893|FG001|NOT COMPLETED|Overall Study||4
9949899|NCT01404988|11068894|FG002|NOT COMPLETED|Overall Study||3
9949900|NCT01405027|11068907|FG000|STARTED|Overall Study||84
9949901|NCT01405027|11068908|FG001|STARTED|Overall Study||113
9949902|NCT01405027|11068907|FG000|COMPLETED|Overall Study||52
9949903|NCT01405027|11068908|FG001|COMPLETED|Overall Study||62
9949904|NCT01405027|11068907|FG000|NOT COMPLETED|Overall Study||32
9949905|NCT01405027|11068908|FG001|NOT COMPLETED|Overall Study||51
9949906|NCT01405053|11068918|FG000|STARTED|Overall Study||25
9949907|NCT01405053|11068919|FG001|STARTED|Overall Study||12
9949908|NCT01405053|11068918|FG000|COMPLETED|Overall Study||15
9949909|NCT01405053|11068919|FG001|COMPLETED|Overall Study||4
9949910|NCT01405053|11068918|FG000|NOT COMPLETED|Overall Study||10
9949911|NCT01405053|11068919|FG001|NOT COMPLETED|Overall Study||8
9949912|NCT01405196|11068929|FG000|STARTED|Overall Study||45
9949913|NCT01405196|11068930|FG001|STARTED|Overall Study||47
9949914|NCT01405196|11068931|FG002|STARTED|Overall Study||46
9949915|NCT01405196|11068932|FG003|STARTED|Overall Study||45
9949916|NCT01405196|11068929|FG000|COMPLETED|Overall Study||34
9949917|NCT01405196|11068930|FG001|COMPLETED|Overall Study||35
9949918|NCT01405196|11068931|FG002|COMPLETED|Overall Study||23
9949919|NCT01405196|11068932|FG003|COMPLETED|Overall Study||36
9949920|NCT01405196|11068929|FG000|NOT COMPLETED|Overall Study||11
9949921|NCT01405196|11068930|FG001|NOT COMPLETED|Overall Study||12
9949922|NCT01405196|11068931|FG002|NOT COMPLETED|Overall Study||23
9949923|NCT01405196|11068932|FG003|NOT COMPLETED|Overall Study||9
9949924|NCT01405313|11068943|FG000|STARTED|Overall Study||21
9949925|NCT01405313|11068943|FG000|COMPLETED|Overall Study||21
9949926|NCT01405313|11068943|FG000|NOT COMPLETED|Overall Study||0
9949927|NCT01405456|11068953|FG000|STARTED|Overall Study||25
9949928|NCT01405456|11068954|FG001|STARTED|Overall Study||21
9949929|NCT01405456|11068953|FG000|COMPLETED|Overall Study||22
9949930|NCT01405456|11068954|FG001|COMPLETED|Overall Study||20
9949931|NCT01405456|11068953|FG000|NOT COMPLETED|Overall Study||3
9949932|NCT01405456|11068954|FG001|NOT COMPLETED|Overall Study||1
9949933|NCT01405469|11068960|FG000|STARTED|Overall Study||16
9949934|NCT01405469|11068960|FG000|COMPLETED|Overall Study||16
9949935|NCT01405469|11068960|FG000|NOT COMPLETED|Overall Study||0
9949936|NCT01405508|11068969|FG000|STARTED|Overall Study||26
9949937|NCT01405508|11068970|FG001|STARTED|Overall Study||26
9949938|NCT01405508|11068971|FG002|STARTED|Overall Study||27
9949939|NCT01405508|11068972|FG003|STARTED|Overall Study||26
9949940|NCT01405508|11068969|FG000|COMPLETED|Overall Study||25
9949941|NCT01405508|11068970|FG001|COMPLETED|Overall Study||25
9949942|NCT01405508|11068971|FG002|COMPLETED|Overall Study||27
9949943|NCT01405508|11068972|FG003|COMPLETED|Overall Study||26
9949944|NCT01405508|11068969|FG000|NOT COMPLETED|Overall Study||1
9949945|NCT01405508|11068970|FG001|NOT COMPLETED|Overall Study||1
9949946|NCT01405508|11068971|FG002|NOT COMPLETED|Overall Study||0
9949947|NCT01405508|11068972|FG003|NOT COMPLETED|Overall Study||0
9949948|NCT01405560|11068982|FG000|STARTED|Overall Study||42
9949949|NCT01405560|11068982|FG000|COMPLETED|Overall Study||41
9949950|NCT01405560|11068982|FG000|NOT COMPLETED|Overall Study||1
9949951|NCT01405742|11068986|FG000|STARTED|Overall Study||2
9949952|NCT01405742|11068987|FG001|STARTED|Overall Study||2
9949953|NCT01405742|11068986|FG000|COMPLETED|Overall Study||1
9949954|NCT01405742|11068987|FG001|COMPLETED|Overall Study||2
9949955|NCT01405742|11068986|FG000|NOT COMPLETED|Overall Study||1
9949956|NCT01405742|11068987|FG001|NOT COMPLETED|Overall Study||0
9949957|NCT01405768|11068995|FG000|STARTED|Overall Study||28
9949958|NCT01405768|11068996|FG001|STARTED|Overall Study||28
9949959|NCT01405768|11068995|FG000|COMPLETED|Overall Study||24
9949960|NCT01405768|11068996|FG001|COMPLETED|Overall Study||28
9949961|NCT01405768|11068995|FG000|NOT COMPLETED|Overall Study||4
9949962|NCT01405768|11068996|FG001|NOT COMPLETED|Overall Study||0
9949963|NCT01405794|11069002|FG000|STARTED|First Dose Placebo (14 Days)||12
9949964|NCT01405794|11069002|FG000|COMPLETED|First Dose Placebo (14 Days)||12
9949965|NCT01405794|11069002|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0
9949966|NCT01405794|11069002|FG000|STARTED|72 hr Washout||12
9949967|NCT01405794|11069002|FG000|COMPLETED|72 hr Washout||12
9949968|NCT01405794|11069002|FG000|NOT COMPLETED|72 hr Washout||0
9949969|NCT01405794|11069002|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
9949970|NCT01405794|11069002|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
9949971|NCT01405794|11069002|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
9949972|NCT01405820|11069014|FG000|STARTED|Randomized Treatment Period||54
9949973|NCT01405820|11069015|FG001|STARTED|Randomized Treatment Period||45
9949974|NCT01405820|11069016|FG002|STARTED|Randomized Treatment Period||52
9949975|NCT01405820|11069017|FG003|STARTED|Randomized Treatment Period||54
9949976|NCT01405820|11069018|FG004|STARTED|Randomized Treatment Period||47
9949977|NCT01405820|11069019|FG005|STARTED|Randomized Treatment Period||38
9949978|NCT01405820|11069014|FG000|Safety Population|Randomized Treatment Period||54
9949979|NCT01405820|11069015|FG001|Safety Population|Randomized Treatment Period||45
9949980|NCT01405820|11069016|FG002|Safety Population|Randomized Treatment Period||52
9949981|NCT01405820|11069017|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
9949982|NCT01405820|11069018|FG004|Safety Population|Randomized Treatment Period||47
9949983|NCT01405820|11069019|FG005|Safety Population|Randomized Treatment Period||38
9949984|NCT01405820|11069014|FG000|COMPLETED|Randomized Treatment Period||43
9949985|NCT01405820|11069015|FG001|COMPLETED|Randomized Treatment Period||35
9949986|NCT01405820|11069016|FG002|COMPLETED|Randomized Treatment Period||9
9949987|NCT01405820|11069017|FG003|COMPLETED|Randomized Treatment Period||3
9949988|NCT01405820|11069018|FG004|COMPLETED|Randomized Treatment Period||2
9949989|NCT01405820|11069019|FG005|COMPLETED|Randomized Treatment Period||1
9949990|NCT01405820|11069014|FG000|NOT COMPLETED|Randomized Treatment Period||11
9949991|NCT01405820|11069015|FG001|NOT COMPLETED|Randomized Treatment Period||10
9949992|NCT01405820|11069016|FG002|NOT COMPLETED|Randomized Treatment Period||43
9949993|NCT01405820|11069017|FG003|NOT COMPLETED|Randomized Treatment Period||51
9949994|NCT01405820|11069018|FG004|NOT COMPLETED|Randomized Treatment Period||45
9949995|NCT01405820|11069019|FG005|NOT COMPLETED|Randomized Treatment Period||37
9949996|NCT01405820|11069014|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
9949997|NCT01405820|11069015|FG001|STARTED|Open-Label Treatment Period||35
9949998|NCT01405820|11069016|FG002|STARTED|Open-Label Treatment Period||42
9949999|NCT01405820|11069017|FG003|STARTED|Open-Label Treatment Period||42
9950000|NCT01405820|11069018|FG004|STARTED|Open-Label Treatment Period||42
9950001|NCT01405820|11069019|FG005|STARTED|Open-Label Treatment Period||32
9950002|NCT01405820|11069014|FG000|COMPLETED|Open-Label Treatment Period||40
9950003|NCT01405820|11069015|FG001|COMPLETED|Open-Label Treatment Period||33
9950004|NCT01405820|11069016|FG002|COMPLETED|Open-Label Treatment Period||39
9950005|NCT01405820|11069017|FG003|COMPLETED|Open-Label Treatment Period||37
9950006|NCT01405820|11069018|FG004|COMPLETED|Open-Label Treatment Period||40
9950007|NCT01405820|11069019|FG005|COMPLETED|Open-Label Treatment Period||30
9950008|NCT01405820|11069014|FG000|NOT COMPLETED|Open-Label Treatment Period||4
9950009|NCT01405820|11069015|FG001|NOT COMPLETED|Open-Label Treatment Period||2
9950010|NCT01405820|11069016|FG002|NOT COMPLETED|Open-Label Treatment Period||3
9950011|NCT01405820|11069017|FG003|NOT COMPLETED|Open-Label Treatment Period||5
9950012|NCT01405820|11069018|FG004|NOT COMPLETED|Open-Label Treatment Period||2
9950013|NCT01405820|11069019|FG005|NOT COMPLETED|Open-Label Treatment Period||2
9950014|NCT01405898|11069041|FG000|STARTED|Overall Study||34
9950015|NCT01405898|11069042|FG001|STARTED|Overall Study||34
9950016|NCT01405898|11069041|FG000|COMPLETED|Overall Study||32
9950017|NCT01405898|11069042|FG001|COMPLETED|Overall Study||32
9950018|NCT01405898|11069041|FG000|NOT COMPLETED|Overall Study||2
9950019|NCT01405898|11069042|FG001|NOT COMPLETED|Overall Study||2
9950020|NCT01405911|11069051|FG000|STARTED|Overall Study||83
9950021|NCT01405911|11069052|FG001|STARTED|Overall Study||82
9950022|NCT01405911|11069053|FG002|STARTED|Overall Study||77
9950023|NCT01405911|11069051|FG000|Treated|Overall Study||82
9950024|NCT01405911|11069052|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
9950025|NCT01405911|11069053|FG002|Treated|Overall Study||77
9950026|NCT01405911|11069051|FG000|COMPLETED|Overall Study||79
9950027|NCT01405911|11069052|FG001|COMPLETED|Overall Study||79
9950028|NCT01405911|11069053|FG002|COMPLETED|Overall Study||76
9950029|NCT01405911|11069051|FG000|NOT COMPLETED|Overall Study||4
9950030|NCT01405911|11069052|FG001|NOT COMPLETED|Overall Study||3
9950031|NCT01405911|11069053|FG002|NOT COMPLETED|Overall Study||1
9950032|NCT01405924|11069061|FG000|STARTED|Overall Study||111
9950033|NCT01405924|11069061|FG000|COMPLETED|Overall Study||101
9950034|NCT01405924|11069061|FG000|NOT COMPLETED|Overall Study||10
9950035|NCT01405937|11069069|FG000|STARTED|Overall Study||25
9950036|NCT01405937|11069070|FG001|STARTED|Overall Study||26
9950037|NCT01405937|11069069|FG000|COMPLETED|Overall Study||25
9950038|NCT01405937|11069070|FG001|COMPLETED|Overall Study||26
9950039|NCT01405937|11069069|FG000|NOT COMPLETED|Overall Study||0
9950040|NCT01405937|11069070|FG001|NOT COMPLETED|Overall Study||0
9950041|NCT01405950|11069078|FG000|STARTED|Overall Study||8
9950042|NCT01405950|11069079|FG001|STARTED|Overall Study||2
10011779|NCT01782326|11134547|FG001|COMPLETED|Planned Treatment Epoch||1474
10011780|NCT01782326|11134546|FG000|NOT COMPLETED|Planned Treatment Epoch||202
10011781|NCT01782326|11134547|FG001|NOT COMPLETED|Planned Treatment Epoch||208
10011782|NCT01782326|11134546|FG000|STARTED|Double-blind Treatment||1678
10011783|NCT01782326|11134547|FG001|STARTED|Double-blind Treatment||1680
10011784|NCT01782326|11134546|FG000|COMPLETED|Double-blind Treatment||1400
9950043|NCT01405950|11069080|FG002|STARTED|Overall Study||0
9950044|NCT01405950|11069081|FG003|STARTED|Overall Study||0
9950045|NCT01405950|11069078|FG000|COMPLETED|Overall Study||7
9950046|NCT01405950|11069079|FG001|COMPLETED|Overall Study||2
9950047|NCT01405950|11069080|FG002|COMPLETED|Overall Study||0
9950048|NCT01405950|11069081|FG003|COMPLETED|Overall Study||0
9950049|NCT01405950|11069078|FG000|NOT COMPLETED|Overall Study||1
9950050|NCT01405950|11069079|FG001|NOT COMPLETED|Overall Study||0
9950051|NCT01405950|11069080|FG002|NOT COMPLETED|Overall Study||0
9950052|NCT01405950|11069081|FG003|NOT COMPLETED|Overall Study||0
9956903|NCT01448824|11076144|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956904|NCT01448824|11076145|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956905|NCT01448824|11076146|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956906|NCT01448824|11076147|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956907|NCT01448824|11076140|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956908|NCT01448824|11076141|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956909|NCT01448824|11076142|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956910|NCT01448824|11076143|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956911|NCT01448824|11076144|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956912|NCT01448824|11076145|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956913|NCT01448824|11076146|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956914|NCT01448824|11076147|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
9956915|NCT01448824|11076140|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10011785|NCT01782326|11134547|FG001|COMPLETED|Double-blind Treatment||1360
9950053|NCT01406015|11069091|FG000|STARTED|Overall Study||19
9950054|NCT01406015|11069092|FG001|STARTED|Overall Study||19
9950055|NCT01406015|11069091|FG000|COMPLETED|Overall Study||16
9950056|NCT01406015|11069092|FG001|COMPLETED|Overall Study||16
9950057|NCT01406015|11069091|FG000|NOT COMPLETED|Overall Study||3
9950058|NCT01406015|11069092|FG001|NOT COMPLETED|Overall Study||3
9950059|NCT01406223|11069102|FG000|STARTED|Overall Study||18
9950060|NCT01406223|11069103|FG001|STARTED|Overall Study||19
9950061|NCT01406223|11069104|FG002|STARTED|Overall Study||20
9950062|NCT01406223|11069105|FG003|STARTED|Overall Study||19
9950063|NCT01406223|11069102|FG000|COMPLETED|Overall Study||6
9950064|NCT01406223|11069103|FG001|COMPLETED|Overall Study||7
9950065|NCT01406223|11069104|FG002|COMPLETED|Overall Study||2
9950066|NCT01406223|11069105|FG003|COMPLETED|Overall Study||3
9950067|NCT01406223|11069102|FG000|NOT COMPLETED|Overall Study||12
9950068|NCT01406223|11069103|FG001|NOT COMPLETED|Overall Study||12
9950069|NCT01406223|11069104|FG002|NOT COMPLETED|Overall Study||18
9950070|NCT01406223|11069105|FG003|NOT COMPLETED|Overall Study||16
9950071|NCT01406444|11069118|FG000|STARTED|Overall Study||33
9950072|NCT01406444|11069119|FG001|STARTED|Overall Study||33
9950073|NCT01406444|11069120|FG002|STARTED|Overall Study||16
9950074|NCT01406444|11069118|FG000|COMPLETED|Overall Study||23
9950075|NCT01406444|11069119|FG001|COMPLETED|Overall Study||24
9950076|NCT01406444|11069120|FG002|COMPLETED|Overall Study||14
9950077|NCT01406444|11069118|FG000|NOT COMPLETED|Overall Study||10
9950078|NCT01406444|11069119|FG001|NOT COMPLETED|Overall Study||9
9950079|NCT01406444|11069120|FG002|NOT COMPLETED|Overall Study||2
9950080|NCT01406574|11069128|FG000|STARTED|Overall Study||7
9950081|NCT01406574|11069129|FG001|STARTED|Overall Study||4
9950082|NCT01406574|11069130|FG002|STARTED|Overall Study||7
9950083|NCT01406574|11069131|FG003|STARTED|Overall Study||5
9950084|NCT01406574|11069128|FG000|COMPLETED|Overall Study||6
9950085|NCT01406574|11069129|FG001|COMPLETED|Overall Study||3
9950086|NCT01406574|11069130|FG002|COMPLETED|Overall Study||6
9950087|NCT01406574|11069131|FG003|COMPLETED|Overall Study||1
9950088|NCT01406574|11069128|FG000|NOT COMPLETED|Overall Study||1
9950089|NCT01406574|11069129|FG001|NOT COMPLETED|Overall Study||1
9950090|NCT01406574|11069130|FG002|NOT COMPLETED|Overall Study||1
9950091|NCT01406574|11069131|FG003|NOT COMPLETED|Overall Study||4
9950092|NCT01406652|11069144|FG000|STARTED|Overall Study||109
9950093|NCT01406652|11069145|FG001|STARTED|Overall Study||115
9950094|NCT01406652|11069144|FG000|COMPLETED|Overall Study||89
9950095|NCT01406652|11069145|FG001|COMPLETED|Overall Study||95
9950096|NCT01406652|11069144|FG000|NOT COMPLETED|Overall Study||20
9950097|NCT01406652|11069145|FG001|NOT COMPLETED|Overall Study||20
9950098|NCT01406717|11069155|FG000|STARTED|Overall Study||180
9950099|NCT01406717|11069156|FG001|STARTED|Overall Study||180
9950100|NCT01406717|11069155|FG000|COMPLETED|Overall Study||137
9950101|NCT01406717|11069156|FG001|COMPLETED|Overall Study||149
9950102|NCT01406717|11069155|FG000|NOT COMPLETED|Overall Study||43
9950103|NCT01406717|11069156|FG001|NOT COMPLETED|Overall Study||31
9950104|NCT01406795|11069172|FG000|STARTED|Overall Study||1
10011786|NCT01782326|11134546|FG000|NOT COMPLETED|Double-blind Treatment||278
10011787|NCT01782326|11134547|FG001|NOT COMPLETED|Double-blind Treatment||320
10208966|NCT03560986|11336104|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
9950105|NCT01406795|11069172|FG000|COMPLETED|Overall Study||0
9950106|NCT01406795|11069172|FG000|NOT COMPLETED|Overall Study||1
9950107|NCT01406873|11069178|FG000|STARTED|Overall Study||21
9950108|NCT01406873|11069179|FG001|STARTED|Overall Study||21
9950109|NCT01406873|11069178|FG000|COMPLETED|Overall Study||20
9950110|NCT01406873|11069179|FG001|COMPLETED|Overall Study||20
9950111|NCT01406873|11069178|FG000|NOT COMPLETED|Overall Study||1
9950112|NCT01406873|11069179|FG001|NOT COMPLETED|Overall Study||1
9950113|NCT01406938|11069197|FG000|STARTED|Induction Period||482
9950114|NCT01406938|11069198|FG001|STARTED|Induction Period||484
9950115|NCT01406938|11069199|FG002|STARTED|Induction Period||0
9950116|NCT01406938|11069200|FG003|STARTED|Induction Period||0
9950117|NCT01406938|11069201|FG004|STARTED|Induction Period||0
9950118|NCT01406938|11069202|FG005|STARTED|Induction Period||0
9950119|NCT01406938|11069197|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482
10011788|NCT01782378|11134555|FG000|STARTED|First Series||32
10208967|NCT03560986|11336103|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
10208968|NCT03560986|11336104|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
10208969|NCT03560986|11336103|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12
10208970|NCT03560986|11336104|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13
10208971|NCT03560986|11336103|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
10208972|NCT03560986|11336104|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
10238853|NCT00459121|11370284|FG000|COMPLETED|Overall Study||2
9950120|NCT01406938|11069198|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483
9950121|NCT01406938|11069199|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0
9950122|NCT01406938|11069200|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0
9950123|NCT01406938|11069201|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0
9950124|NCT01406938|11069202|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0
9950125|NCT01406938|11069197|FG000|COMPLETED|Induction Period||464
9950126|NCT01406938|11069198|FG001|COMPLETED|Induction Period||464
9950127|NCT01406938|11069199|FG002|COMPLETED|Induction Period||0
9950128|NCT01406938|11069200|FG003|COMPLETED|Induction Period||0
9950129|NCT01406938|11069201|FG004|COMPLETED|Induction Period||0
9950130|NCT01406938|11069202|FG005|COMPLETED|Induction Period||0
9950131|NCT01406938|11069197|FG000|NOT COMPLETED|Induction Period||18
9950132|NCT01406938|11069198|FG001|NOT COMPLETED|Induction Period||20
9950133|NCT01406938|11069199|FG002|NOT COMPLETED|Induction Period||0
9950134|NCT01406938|11069200|FG003|NOT COMPLETED|Induction Period||0
9950135|NCT01406938|11069201|FG004|NOT COMPLETED|Induction Period||0
9950136|NCT01406938|11069202|FG005|NOT COMPLETED|Induction Period||0
9950137|NCT01406938|11069197|FG000|STARTED|Maintenance Period||0
9950138|NCT01406938|11069198|FG001|STARTED|Maintenance Period||0
9950139|NCT01406938|11069199|FG002|STARTED|Maintenance Period||203
9950140|NCT01406938|11069200|FG003|STARTED|Maintenance Period||217
9950141|NCT01406938|11069201|FG004|STARTED|Maintenance Period||206
9950142|NCT01406938|11069202|FG005|STARTED|Maintenance Period||217
9950143|NCT01406938|11069197|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
9950144|NCT01406938|11069198|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
9950145|NCT01406938|11069199|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
9950146|NCT01406938|11069200|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
9950147|NCT01406938|11069201|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
9950148|NCT01406938|11069202|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
9950149|NCT01406938|11069197|FG000|COMPLETED|Maintenance Period||0
9950150|NCT01406938|11069198|FG001|COMPLETED|Maintenance Period||0
9950151|NCT01406938|11069199|FG002|COMPLETED|Maintenance Period||186
10011789|NCT01782378|11134556|FG001|STARTED|First Series||31
10011790|NCT01782378|11134555|FG000|COMPLETED|First Series||25
10011791|NCT01782378|11134556|FG001|COMPLETED|First Series||23
9950152|NCT01406938|11069200|FG003|COMPLETED|Maintenance Period||199
9950153|NCT01406938|11069201|FG004|COMPLETED|Maintenance Period||181
9950154|NCT01406938|11069202|FG005|COMPLETED|Maintenance Period||201
9950155|NCT01406938|11069197|FG000|NOT COMPLETED|Maintenance Period||0
9950156|NCT01406938|11069198|FG001|NOT COMPLETED|Maintenance Period||0
9950157|NCT01406938|11069199|FG002|NOT COMPLETED|Maintenance Period||17
9950158|NCT01406938|11069200|FG003|NOT COMPLETED|Maintenance Period||18
9950159|NCT01406938|11069201|FG004|NOT COMPLETED|Maintenance Period||25
9950160|NCT01406938|11069202|FG005|NOT COMPLETED|Maintenance Period||16
9950161|NCT01406938|11069197|FG000|STARTED|Follow up||26
9950162|NCT01406938|11069198|FG001|STARTED|Follow up||23
9950163|NCT01406938|11069199|FG002|STARTED|Follow up||40
9950164|NCT01406938|11069200|FG003|STARTED|Follow up||39
9950165|NCT01406938|11069201|FG004|STARTED|Follow up||40
9950166|NCT01406938|11069202|FG005|STARTED|Follow up||35
9950167|NCT01406938|11069197|FG000|COMPLETED|Follow up||18
9950168|NCT01406938|11069198|FG001|COMPLETED|Follow up||18
9950169|NCT01406938|11069199|FG002|COMPLETED|Follow up||32
9950170|NCT01406938|11069200|FG003|COMPLETED|Follow up||36
9950171|NCT01406938|11069201|FG004|COMPLETED|Follow up||31
9950172|NCT01406938|11069202|FG005|COMPLETED|Follow up||32
9950173|NCT01406938|11069197|FG000|NOT COMPLETED|Follow up||8
9950174|NCT01406938|11069198|FG001|NOT COMPLETED|Follow up||5
9950175|NCT01406938|11069199|FG002|NOT COMPLETED|Follow up||8
9950176|NCT01406938|11069200|FG003|NOT COMPLETED|Follow up||3
9950177|NCT01406938|11069201|FG004|NOT COMPLETED|Follow up||9
9950178|NCT01406938|11069202|FG005|NOT COMPLETED|Follow up||3
9950179|NCT01406990|11069222|FG000|STARTED|Overall Study||15
9950180|NCT01406990|11069222|FG000|COMPLETED|Overall Study||15
9950181|NCT01406990|11069222|FG000|NOT COMPLETED|Overall Study||0
9950182|NCT01407068|11069226|FG000|STARTED|Overall Study||60
9950183|NCT01407068|11069226|FG000|COMPLETED|Overall Study||60
9950184|NCT01407068|11069226|FG000|NOT COMPLETED|Overall Study||0
9950185|NCT01407094|11069235|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
9950186|NCT01407094|11069236|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
9950187|NCT01407094|11069237|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
10011792|NCT01782378|11134555|FG000|NOT COMPLETED|First Series||7
9950188|NCT01407094|11069235|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
9950189|NCT01407094|11069236|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
9950190|NCT01407094|11069237|FG002|COMPLETED|Stage 1||0
9950191|NCT01407094|11069235|FG000|NOT COMPLETED|Stage 1||34
9950192|NCT01407094|11069236|FG001|NOT COMPLETED|Stage 1||27
9950193|NCT01407094|11069237|FG002|NOT COMPLETED|Stage 1||0
9950194|NCT01407094|11069235|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
9950195|NCT01407094|11069236|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
9950196|NCT01407094|11069237|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
9950197|NCT01407094|11069235|FG000|COMPLETED|Stage 2||113
9950198|NCT01407094|11069236|FG001|COMPLETED|Stage 2||35
9950199|NCT01407094|11069237|FG002|COMPLETED|Stage 2||38
9950200|NCT01407094|11069235|FG000|NOT COMPLETED|Stage 2||21
9950201|NCT01407094|11069236|FG001|NOT COMPLETED|Stage 2||11
9950202|NCT01407094|11069237|FG002|NOT COMPLETED|Stage 2||15
9950203|NCT01407107|11069248|FG000|STARTED|Overall Study||7
10011793|NCT01782378|11134556|FG001|NOT COMPLETED|First Series||8
10011794|NCT01782378|11134555|FG000|STARTED|Second Series||31
9950204|NCT01407107|11069249|FG001|STARTED|Overall Study||3
9950205|NCT01407107|11069250|FG002|STARTED|Overall Study||3
9950206|NCT01407107|11069248|FG000|COMPLETED|Overall Study||7
9950207|NCT01407107|11069249|FG001|COMPLETED|Overall Study||3
9950208|NCT01407107|11069250|FG002|COMPLETED|Overall Study||3
10011795|NCT01782378|11134556|FG001|STARTED|Second Series||32
9950209|NCT01407107|11069248|FG000|NOT COMPLETED|Overall Study||0
9950210|NCT01407107|11069249|FG001|NOT COMPLETED|Overall Study||0
9950211|NCT01407107|11069250|FG002|NOT COMPLETED|Overall Study||0
9950212|NCT01407276|11069266|FG000|STARTED|Overall Study||6
9950213|NCT01407276|11069267|FG001|STARTED|Overall Study||6
9950214|NCT01407276|11069268|FG002|STARTED|Overall Study||6
9950215|NCT01407276|11069269|FG003|STARTED|Overall Study||6
9950216|NCT01407276|11069270|FG004|STARTED|Overall Study||6
9950217|NCT01407276|11069271|FG005|STARTED|Overall Study||6
9950218|NCT01407276|11069272|FG006|STARTED|Overall Study||6
9950219|NCT01407276|11069273|FG007|STARTED|Overall Study||7
9950220|NCT01407276|11069266|FG000|COMPLETED|Overall Study||6
9950221|NCT01407276|11069267|FG001|COMPLETED|Overall Study||6
9950222|NCT01407276|11069268|FG002|COMPLETED|Overall Study||6
9950223|NCT01407276|11069269|FG003|COMPLETED|Overall Study||6
9950224|NCT01407276|11069270|FG004|COMPLETED|Overall Study||6
9950225|NCT01407276|11069271|FG005|COMPLETED|Overall Study||6
9950226|NCT01407276|11069272|FG006|COMPLETED|Overall Study||6
9950227|NCT01407276|11069273|FG007|COMPLETED|Overall Study||6
9950228|NCT01407276|11069266|FG000|NOT COMPLETED|Overall Study||0
9950229|NCT01407276|11069267|FG001|NOT COMPLETED|Overall Study||0
9950230|NCT01407276|11069268|FG002|NOT COMPLETED|Overall Study||0
9950231|NCT01407276|11069269|FG003|NOT COMPLETED|Overall Study||0
9950232|NCT01407276|11069270|FG004|NOT COMPLETED|Overall Study||0
10208973|NCT03560986|11336103|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
10208974|NCT03560986|11336104|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
10208975|NCT03560986|11336103|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
10208976|NCT03560986|11336104|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
10208977|NCT03560986|11336103|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1
10208978|NCT03560986|11336104|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
10208979|NCT03560986|11336103|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
10208980|NCT03560986|11336104|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
10208981|NCT03561090|11336118|FG000|STARTED|Overall Study||247
10208982|NCT03561090|11336119|FG001|STARTED|Overall Study||248
10208983|NCT03561090|11336118|FG000|Randomized and Treated|Overall Study||246
10208984|NCT03561090|11336119|FG001|Randomized and Treated|Overall Study||247
10208985|NCT03561090|11336118|FG000|COMPLETED|Overall Study||207
10208986|NCT03561090|11336119|FG001|COMPLETED|Overall Study||212
10208987|NCT03561090|11336118|FG000|NOT COMPLETED|Overall Study||40
10208988|NCT03561090|11336119|FG001|NOT COMPLETED|Overall Study||36
10208989|NCT03561883|11336129|FG000|STARTED|Overall Study||305
10208990|NCT03561883|11336130|FG001|STARTED|Overall Study||304
10208991|NCT03561883|11336129|FG000|COMPLETED|Overall Study||259
10208992|NCT03561883|11336130|FG001|COMPLETED|Overall Study||261
10208993|NCT03561883|11336129|FG000|NOT COMPLETED|Overall Study||46
10208994|NCT03561883|11336130|FG001|NOT COMPLETED|Overall Study||43
10208995|NCT03562117|11336139|FG000|STARTED|Part 1, Up to 3 Days||8
10208996|NCT03562117|11336140|FG001|STARTED|Part 1, Up to 3 Days||8
10208997|NCT03562117|11336141|FG002|STARTED|Part 1, Up to 3 Days||0
10208998|NCT03562117|11336139|FG000|COMPLETED|Part 1, Up to 3 Days||7
10208999|NCT03562117|11336140|FG001|COMPLETED|Part 1, Up to 3 Days||8
10209000|NCT03562117|11336141|FG002|COMPLETED|Part 1, Up to 3 Days||0
10209001|NCT03562117|11336139|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1
10209002|NCT03562117|11336140|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0
10209003|NCT03562117|11336141|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0
10209004|NCT03562117|11336139|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
10209005|NCT03562117|11336140|FG001|STARTED|Part 2, Up to 3 Days||0
10209006|NCT03562117|11336141|FG002|STARTED|Part 2, Up to 3 Days||8
10209007|NCT03562117|11336139|FG000|COMPLETED|Part 2, Up to 3 Days||8
10209008|NCT03562117|11336140|FG001|COMPLETED|Part 2, Up to 3 Days||0
10209009|NCT03562117|11336141|FG002|COMPLETED|Part 2, Up to 3 Days||8
10209010|NCT03562117|11336139|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0
10209011|NCT03562117|11336140|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0
10209012|NCT03562117|11336141|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0
10209013|NCT03562377|11336151|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107
10209014|NCT03562377|11336152|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108
10209015|NCT03562377|11336151|FG000|Safety Analysis Set|Treatment Period||107
10209016|NCT03562377|11336152|FG001|Safety Analysis Set|Treatment Period||107
10209017|NCT03562377|11336151|FG000|Per Protocol Anaysis Set|Treatment Period||88
10209018|NCT03562377|11336152|FG001|Per Protocol Anaysis Set|Treatment Period||78
10209019|NCT03562377|11336151|FG000|Full Analysis Set|Treatment Period||106
10209020|NCT03562377|11336152|FG001|Full Analysis Set|Treatment Period||108
9950233|NCT01407276|11069271|FG005|NOT COMPLETED|Overall Study||0
9950234|NCT01407276|11069272|FG006|NOT COMPLETED|Overall Study||0
9950235|NCT01407276|11069273|FG007|NOT COMPLETED|Overall Study||1
9950236|NCT01407354|11069298|FG000|STARTED|First Intervention||20
9950237|NCT01407354|11069299|FG001|STARTED|First Intervention||17
9950238|NCT01407354|11069298|FG000|COMPLETED|First Intervention||18
9950239|NCT01407354|11069299|FG001|COMPLETED|First Intervention||15
9950240|NCT01407354|11069298|FG000|NOT COMPLETED|First Intervention||2
9950241|NCT01407354|11069299|FG001|NOT COMPLETED|First Intervention||2
9950242|NCT01407354|11069298|FG000|STARTED|Second Intervention||18
9950243|NCT01407354|11069299|FG001|STARTED|Second Intervention||15
9950244|NCT01407354|11069298|FG000|COMPLETED|Second Intervention||18
9950245|NCT01407354|11069299|FG001|COMPLETED|Second Intervention||13
9950246|NCT01407354|11069298|FG000|NOT COMPLETED|Second Intervention||0
9950247|NCT01407354|11069299|FG001|NOT COMPLETED|Second Intervention||2
9950248|NCT01407367|11069308|FG000|STARTED|Overall Study||108
9950249|NCT01407367|11069309|FG001|STARTED|Overall Study||242
9950250|NCT01407367|11069308|FG000|COMPLETED|Overall Study||68
9950251|NCT01407367|11069309|FG001|COMPLETED|Overall Study||164
9950252|NCT01407367|11069308|FG000|NOT COMPLETED|Overall Study||40
9950253|NCT01407367|11069309|FG001|NOT COMPLETED|Overall Study||78
9950254|NCT01407523|11069318|FG000|STARTED|Overall Study||16
9950255|NCT01407523|11069318|FG000|COMPLETED|Overall Study||16
9950256|NCT01407523|11069318|FG000|NOT COMPLETED|Overall Study||0
9950257|NCT01407575|11069324|FG000|STARTED|Overall Study||7
9950258|NCT01407575|11069325|FG001|STARTED|Overall Study||6
9950259|NCT01407575|11069324|FG000|COMPLETED|Overall Study||5
9950260|NCT01407575|11069325|FG001|COMPLETED|Overall Study||5
9950261|NCT01407575|11069324|FG000|NOT COMPLETED|Overall Study||2
9950262|NCT01407575|11069325|FG001|NOT COMPLETED|Overall Study||1
9950263|NCT01407926|11069333|FG000|STARTED|Overall Study||142
9950264|NCT01407926|11069333|FG000|COMPLETED|Overall Study||87
9950265|NCT01407926|11069333|FG000|NOT COMPLETED|Overall Study||55
9950266|NCT01407952|11069340|FG000|STARTED|Overall Study||297
9950267|NCT01407952|11069341|FG001|STARTED|Overall Study||303
9950268|NCT01407952|11069340|FG000|COMPLETED|Overall Study||251
9950269|NCT01407952|11069341|FG001|COMPLETED|Overall Study||266
9950270|NCT01407952|11069340|FG000|NOT COMPLETED|Overall Study||46
9950271|NCT01407952|11069341|FG001|NOT COMPLETED|Overall Study||37
9950272|NCT01408030|11069351|FG000|STARTED|Treatment Phase (on Drug)||29
9950273|NCT01408030|11069352|FG001|STARTED|Treatment Phase (on Drug)||31
9950274|NCT01408030|11069353|FG002|STARTED|Treatment Phase (on Drug)||33
9950275|NCT01408030|11069354|FG003|STARTED|Treatment Phase (on Drug)||28
9950276|NCT01408030|11069351|FG000|COMPLETED|Treatment Phase (on Drug)||26
9950277|NCT01408030|11069352|FG001|COMPLETED|Treatment Phase (on Drug)||24
9950278|NCT01408030|11069353|FG002|COMPLETED|Treatment Phase (on Drug)||32
9950279|NCT01408030|11069354|FG003|COMPLETED|Treatment Phase (on Drug)||25
9950280|NCT01408030|11069351|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3
9950281|NCT01408030|11069352|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7
9950282|NCT01408030|11069353|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1
9950283|NCT01408030|11069354|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3
9950284|NCT01408030|11069351|FG000|STARTED|Observation Phase (Off Drug)||26
9950285|NCT01408030|11069352|FG001|STARTED|Observation Phase (Off Drug)||24
9950286|NCT01408030|11069353|FG002|STARTED|Observation Phase (Off Drug)||32
9950287|NCT01408030|11069354|FG003|STARTED|Observation Phase (Off Drug)||25
9950288|NCT01408030|11069351|FG000|COMPLETED|Observation Phase (Off Drug)||22
9950289|NCT01408030|11069352|FG001|COMPLETED|Observation Phase (Off Drug)||18
9950290|NCT01408030|11069353|FG002|COMPLETED|Observation Phase (Off Drug)||26
9950291|NCT01408030|11069354|FG003|COMPLETED|Observation Phase (Off Drug)||21
9950292|NCT01408030|11069351|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4
9950293|NCT01408030|11069352|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6
9950294|NCT01408030|11069353|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6
9950295|NCT01408030|11069354|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4
9950296|NCT01408043|11069364|FG000|STARTED|Overall Study||25
9950297|NCT01408043|11069364|FG000|COMPLETED|Overall Study||24
9950298|NCT01408043|11069364|FG000|NOT COMPLETED|Overall Study||1
9950299|NCT01408147|11069370|FG000|STARTED|Overall Study|174 participants|174
9950300|NCT01408147|11069371|FG001|STARTED|Overall Study|197 participants|197
9950301|NCT01408147|11069370|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
9950302|NCT01408147|11069371|FG001|COMPLETED|Overall Study||196
9950303|NCT01408147|11069370|FG000|NOT COMPLETED|Overall Study||0
9950304|NCT01408147|11069371|FG001|NOT COMPLETED|Overall Study||1
9950305|NCT01408277|11069379|FG000|STARTED|Overall Study||28
9950306|NCT01408277|11069380|FG001|STARTED|Overall Study||27
9950307|NCT01408277|11069379|FG000|COMPLETED|Overall Study||20
9950308|NCT01408277|11069380|FG001|COMPLETED|Overall Study||23
9950309|NCT01408277|11069379|FG000|NOT COMPLETED|Overall Study||8
9950310|NCT01408277|11069380|FG001|NOT COMPLETED|Overall Study||4
9950311|NCT01408303|11069389|FG000|STARTED|Overall Study||215
9950312|NCT01408303|11069390|FG001|STARTED|Overall Study||216
9950313|NCT01408303|11069391|FG002|STARTED|Overall Study||216
9950314|NCT01408303|11069389|FG000|COMPLETED|Overall Study||209
9950315|NCT01408303|11069390|FG001|COMPLETED|Overall Study||204
9950316|NCT01408303|11069391|FG002|COMPLETED|Overall Study||210
9950317|NCT01408303|11069389|FG000|NOT COMPLETED|Overall Study||6
9950318|NCT01408303|11069390|FG001|NOT COMPLETED|Overall Study||12
9950319|NCT01408303|11069391|FG002|NOT COMPLETED|Overall Study||6
9950320|NCT01408329|11069401|FG000|STARTED|Overall Study||13
9950321|NCT01408329|11069402|FG001|STARTED|Overall Study||15
9950322|NCT01408329|11069401|FG000|COMPLETED|Overall Study||10
9950323|NCT01408329|11069402|FG001|COMPLETED|Overall Study||11
9950324|NCT01408329|11069401|FG000|NOT COMPLETED|Overall Study||3
9950325|NCT01408329|11069402|FG001|NOT COMPLETED|Overall Study||4
9950326|NCT01408459|11069410|FG000|STARTED|Overall Study||22
9950327|NCT01408459|11069411|FG001|STARTED|Overall Study||15
9950328|NCT01408459|11069410|FG000|COMPLETED|Overall Study||21
9950329|NCT01408459|11069411|FG001|COMPLETED|Overall Study||14
9950330|NCT01408459|11069410|FG000|NOT COMPLETED|Overall Study||1
9950331|NCT01408459|11069411|FG001|NOT COMPLETED|Overall Study||1
9950332|NCT01408485|11069418|FG000|STARTED|Overall Study||200
9950333|NCT01408485|11069418|FG000|COMPLETED|Overall Study||179
9950334|NCT01408485|11069418|FG000|NOT COMPLETED|Overall Study||21
9950335|NCT01408537|11069422|FG000|STARTED|Overall Study||152
9950336|NCT01408537|11069422|FG000|COMPLETED|Overall Study||144
9950337|NCT01408537|11069422|FG000|NOT COMPLETED|Overall Study||8
9950338|NCT01408563|11069437|FG000|STARTED|Overall Study||33
9950339|NCT01408563|11069437|FG000|Received Transplant|Overall Study||31
9950340|NCT01408563|11069437|FG000|COMPLETED|Overall Study||31
9950341|NCT01408563|11069437|FG000|NOT COMPLETED|Overall Study||2
9950342|NCT01408576|11069444|FG000|STARTED|Overall Study||244
9950343|NCT01408576|11069445|FG001|STARTED|Overall Study||498
10011796|NCT01782378|11134555|FG000|COMPLETED|Second Series||5
10011797|NCT01782378|11134556|FG001|COMPLETED|Second Series||0
10011798|NCT01782378|11134555|FG000|NOT COMPLETED|Second Series||26
9950344|NCT01408576|11069446|FG002|STARTED|Overall Study||508
9950345|NCT01408576|11069444|FG000|COMPLETED|Overall Study||56
9950346|NCT01408576|11069445|FG001|COMPLETED|Overall Study||0
9950347|NCT01408576|11069446|FG002|COMPLETED|Overall Study||0
9950348|NCT01408576|11069444|FG000|NOT COMPLETED|Overall Study||188
9950349|NCT01408576|11069445|FG001|NOT COMPLETED|Overall Study||498
9950350|NCT01408576|11069446|FG002|NOT COMPLETED|Overall Study||508
9950351|NCT01408628|11069466|FG000|STARTED|Consented||51
9950352|NCT01408628|11069466|FG000|COMPLETED|Consented||39
9950353|NCT01408628|11069466|FG000|NOT COMPLETED|Consented||12
9950354|NCT01408628|11069466|FG000|STARTED|Started Classes/Intervention||39
9950355|NCT01408628|11069466|FG000|COMPLETED|Started Classes/Intervention||39
9950356|NCT01408628|11069466|FG000|NOT COMPLETED|Started Classes/Intervention||0
9950357|NCT01408628|11069466|FG000|STARTED|Completed 6 Month Follow-Up||39
9950358|NCT01408628|11069466|FG000|COMPLETED|Completed 6 Month Follow-Up||25
9950359|NCT01408628|11069466|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14
9950360|NCT01408706|11069473|FG000|STARTED|Overall Study||30
9950361|NCT01408706|11069474|FG001|STARTED|Overall Study||30
9950362|NCT01408706|11069473|FG000|COMPLETED|Overall Study||29
9950363|NCT01408706|11069474|FG001|COMPLETED|Overall Study||30
9950364|NCT01408706|11069473|FG000|NOT COMPLETED|Overall Study||1
9950365|NCT01408706|11069474|FG001|NOT COMPLETED|Overall Study||0
9950366|NCT01408719|11069502|FG000|STARTED|First Intervention (35 Days)||2
9950367|NCT01408719|11069503|FG001|STARTED|First Intervention (35 Days)||3
9950368|NCT01408719|11069504|FG002|STARTED|First Intervention (35 Days)||2
9950369|NCT01408719|11069505|FG003|STARTED|First Intervention (35 Days)||2
9950370|NCT01408719|11069506|FG004|STARTED|First Intervention (35 Days)||4
9950371|NCT01408719|11069507|FG005|STARTED|First Intervention (35 Days)||3
9950372|NCT01408719|11069508|FG006|STARTED|First Intervention (35 Days)||2
9950373|NCT01408719|11069509|FG007|STARTED|First Intervention (35 Days)||3
9950374|NCT01408719|11069510|FG008|STARTED|First Intervention (35 Days)||2
9950375|NCT01408719|11069511|FG009|STARTED|First Intervention (35 Days)||1
9950376|NCT01408719|11069512|FG010|STARTED|First Intervention (35 Days)||2
9950377|NCT01408719|11069513|FG011|STARTED|First Intervention (35 Days)||2
9950378|NCT01408719|11069514|FG012|STARTED|First Intervention (35 Days)||2
9950379|NCT01408719|11069515|FG013|STARTED|First Intervention (35 Days)||5
9950380|NCT01408719|11069516|FG014|STARTED|First Intervention (35 Days)||1
9950381|NCT01408719|11069517|FG015|STARTED|First Intervention (35 Days)||2
9950382|NCT01408719|11069518|FG016|STARTED|First Intervention (35 Days)||3
9950383|NCT01408719|11069519|FG017|STARTED|First Intervention (35 Days)||2
9950384|NCT01408719|11069520|FG018|STARTED|First Intervention (35 Days)||1
9950385|NCT01408719|11069521|FG019|STARTED|First Intervention (35 Days)||1
9950386|NCT01408719|11069502|FG000|COMPLETED|First Intervention (35 Days)||2
9950387|NCT01408719|11069503|FG001|COMPLETED|First Intervention (35 Days)||3
9950388|NCT01408719|11069504|FG002|COMPLETED|First Intervention (35 Days)||1
9950389|NCT01408719|11069505|FG003|COMPLETED|First Intervention (35 Days)||2
9950390|NCT01408719|11069506|FG004|COMPLETED|First Intervention (35 Days)||3
9950391|NCT01408719|11069507|FG005|COMPLETED|First Intervention (35 Days)||3
9950392|NCT01408719|11069508|FG006|COMPLETED|First Intervention (35 Days)||2
9950393|NCT01408719|11069509|FG007|COMPLETED|First Intervention (35 Days)||3
9950394|NCT01408719|11069510|FG008|COMPLETED|First Intervention (35 Days)||1
9950395|NCT01408719|11069511|FG009|COMPLETED|First Intervention (35 Days)||1
9950396|NCT01408719|11069512|FG010|COMPLETED|First Intervention (35 Days)||2
9950397|NCT01408719|11069513|FG011|COMPLETED|First Intervention (35 Days)||2
9950398|NCT01408719|11069514|FG012|COMPLETED|First Intervention (35 Days)||2
9950399|NCT01408719|11069515|FG013|COMPLETED|First Intervention (35 Days)||4
10011799|NCT01782378|11134556|FG001|NOT COMPLETED|Second Series||32
10011800|NCT01782469|11134562|FG000|STARTED|Overall Study||16
10011801|NCT01782469|11134562|FG000|COMPLETED|Overall Study||15
10011802|NCT01782469|11134562|FG000|NOT COMPLETED|Overall Study||1
10011803|NCT01782482|11134568|FG000|STARTED|Overall Study||281
9950400|NCT01408719|11069516|FG014|COMPLETED|First Intervention (35 Days)||1
9950401|NCT01408719|11069517|FG015|COMPLETED|First Intervention (35 Days)||2
9950402|NCT01408719|11069518|FG016|COMPLETED|First Intervention (35 Days)||2
9950403|NCT01408719|11069519|FG017|COMPLETED|First Intervention (35 Days)||2
9950404|NCT01408719|11069520|FG018|COMPLETED|First Intervention (35 Days)||0
9950405|NCT01408719|11069521|FG019|COMPLETED|First Intervention (35 Days)||1
9950406|NCT01408719|11069502|FG000|NOT COMPLETED|First Intervention (35 Days)||0
9950407|NCT01408719|11069503|FG001|NOT COMPLETED|First Intervention (35 Days)||0
9950408|NCT01408719|11069504|FG002|NOT COMPLETED|First Intervention (35 Days)||1
9950409|NCT01408719|11069505|FG003|NOT COMPLETED|First Intervention (35 Days)||0
9950410|NCT01408719|11069506|FG004|NOT COMPLETED|First Intervention (35 Days)||1
9950411|NCT01408719|11069507|FG005|NOT COMPLETED|First Intervention (35 Days)||0
9950412|NCT01408719|11069508|FG006|NOT COMPLETED|First Intervention (35 Days)||0
9950413|NCT01408719|11069509|FG007|NOT COMPLETED|First Intervention (35 Days)||0
9950414|NCT01408719|11069510|FG008|NOT COMPLETED|First Intervention (35 Days)||1
9950415|NCT01408719|11069511|FG009|NOT COMPLETED|First Intervention (35 Days)||0
9950416|NCT01408719|11069512|FG010|NOT COMPLETED|First Intervention (35 Days)||0
9950417|NCT01408719|11069513|FG011|NOT COMPLETED|First Intervention (35 Days)||0
9950418|NCT01408719|11069514|FG012|NOT COMPLETED|First Intervention (35 Days)||0
9950419|NCT01408719|11069515|FG013|NOT COMPLETED|First Intervention (35 Days)||1
9950420|NCT01408719|11069516|FG014|NOT COMPLETED|First Intervention (35 Days)||0
9950421|NCT01408719|11069517|FG015|NOT COMPLETED|First Intervention (35 Days)||0
9950422|NCT01408719|11069518|FG016|NOT COMPLETED|First Intervention (35 Days)||1
9950423|NCT01408719|11069519|FG017|NOT COMPLETED|First Intervention (35 Days)||0
9950424|NCT01408719|11069520|FG018|NOT COMPLETED|First Intervention (35 Days)||1
9950425|NCT01408719|11069521|FG019|NOT COMPLETED|First Intervention (35 Days)||0
9950426|NCT01408719|11069502|FG000|STARTED|Washout Period (28 Days)||2
9950427|NCT01408719|11069503|FG001|STARTED|Washout Period (28 Days)||3
9950428|NCT01408719|11069504|FG002|STARTED|Washout Period (28 Days)||1
9950429|NCT01408719|11069505|FG003|STARTED|Washout Period (28 Days)||2
9950430|NCT01408719|11069506|FG004|STARTED|Washout Period (28 Days)||3
9950431|NCT01408719|11069507|FG005|STARTED|Washout Period (28 Days)||3
9950432|NCT01408719|11069508|FG006|STARTED|Washout Period (28 Days)||2
9950433|NCT01408719|11069509|FG007|STARTED|Washout Period (28 Days)||3
9950434|NCT01408719|11069510|FG008|STARTED|Washout Period (28 Days)||1
9950435|NCT01408719|11069511|FG009|STARTED|Washout Period (28 Days)||1
9950436|NCT01408719|11069512|FG010|STARTED|Washout Period (28 Days)||2
9950437|NCT01408719|11069513|FG011|STARTED|Washout Period (28 Days)||2
9950438|NCT01408719|11069514|FG012|STARTED|Washout Period (28 Days)||2
9950439|NCT01408719|11069515|FG013|STARTED|Washout Period (28 Days)||4
9950440|NCT01408719|11069516|FG014|STARTED|Washout Period (28 Days)||1
9950441|NCT01408719|11069517|FG015|STARTED|Washout Period (28 Days)||2
9950442|NCT01408719|11069518|FG016|STARTED|Washout Period (28 Days)||2
9950443|NCT01408719|11069519|FG017|STARTED|Washout Period (28 Days)||2
9950444|NCT01408719|11069520|FG018|STARTED|Washout Period (28 Days)||0
9950445|NCT01408719|11069521|FG019|STARTED|Washout Period (28 Days)||1
9950446|NCT01408719|11069502|FG000|COMPLETED|Washout Period (28 Days)||2
9950447|NCT01408719|11069503|FG001|COMPLETED|Washout Period (28 Days)||3
9950448|NCT01408719|11069504|FG002|COMPLETED|Washout Period (28 Days)||1
9950449|NCT01408719|11069505|FG003|COMPLETED|Washout Period (28 Days)||2
9950450|NCT01408719|11069506|FG004|COMPLETED|Washout Period (28 Days)||3
9950451|NCT01408719|11069507|FG005|COMPLETED|Washout Period (28 Days)||3
9950452|NCT01408719|11069508|FG006|COMPLETED|Washout Period (28 Days)||2
10011804|NCT01782482|11134569|FG001|STARTED|Overall Study||280
10011805|NCT01782482|11134568|FG000|COMPLETED|Overall Study||271
10011806|NCT01782482|11134569|FG001|COMPLETED|Overall Study||270
10011807|NCT01782482|11134568|FG000|NOT COMPLETED|Overall Study||10
9950453|NCT01408719|11069509|FG007|COMPLETED|Washout Period (28 Days)||3
9950454|NCT01408719|11069510|FG008|COMPLETED|Washout Period (28 Days)||1
9950455|NCT01408719|11069511|FG009|COMPLETED|Washout Period (28 Days)||1
9950456|NCT01408719|11069512|FG010|COMPLETED|Washout Period (28 Days)||2
9950457|NCT01408719|11069513|FG011|COMPLETED|Washout Period (28 Days)||2
9950458|NCT01408719|11069514|FG012|COMPLETED|Washout Period (28 Days)||2
9950459|NCT01408719|11069515|FG013|COMPLETED|Washout Period (28 Days)||4
9950460|NCT01408719|11069516|FG014|COMPLETED|Washout Period (28 Days)||1
9950461|NCT01408719|11069517|FG015|COMPLETED|Washout Period (28 Days)||2
9950462|NCT01408719|11069518|FG016|COMPLETED|Washout Period (28 Days)||2
9950463|NCT01408719|11069519|FG017|COMPLETED|Washout Period (28 Days)||2
9950464|NCT01408719|11069520|FG018|COMPLETED|Washout Period (28 Days)||0
9950465|NCT01408719|11069521|FG019|COMPLETED|Washout Period (28 Days)||1
9950466|NCT01408719|11069502|FG000|NOT COMPLETED|Washout Period (28 Days)||0
9950467|NCT01408719|11069503|FG001|NOT COMPLETED|Washout Period (28 Days)||0
9950468|NCT01408719|11069504|FG002|NOT COMPLETED|Washout Period (28 Days)||0
9950469|NCT01408719|11069505|FG003|NOT COMPLETED|Washout Period (28 Days)||0
9950470|NCT01408719|11069506|FG004|NOT COMPLETED|Washout Period (28 Days)||0
9950471|NCT01408719|11069507|FG005|NOT COMPLETED|Washout Period (28 Days)||0
9950472|NCT01408719|11069508|FG006|NOT COMPLETED|Washout Period (28 Days)||0
9950473|NCT01408719|11069509|FG007|NOT COMPLETED|Washout Period (28 Days)||0
9950474|NCT01408719|11069510|FG008|NOT COMPLETED|Washout Period (28 Days)||0
9950475|NCT01408719|11069511|FG009|NOT COMPLETED|Washout Period (28 Days)||0
9950476|NCT01408719|11069512|FG010|NOT COMPLETED|Washout Period (28 Days)||0
9950477|NCT01408719|11069513|FG011|NOT COMPLETED|Washout Period (28 Days)||0
9950478|NCT01408719|11069514|FG012|NOT COMPLETED|Washout Period (28 Days)||0
10011808|NCT01782482|11134569|FG001|NOT COMPLETED|Overall Study||10
9950479|NCT01408719|11069515|FG013|NOT COMPLETED|Washout Period (28 Days)||0
9950480|NCT01408719|11069516|FG014|NOT COMPLETED|Washout Period (28 Days)||0
9950481|NCT01408719|11069517|FG015|NOT COMPLETED|Washout Period (28 Days)||0
9950482|NCT01408719|11069518|FG016|NOT COMPLETED|Washout Period (28 Days)||0
9950483|NCT01408719|11069519|FG017|NOT COMPLETED|Washout Period (28 Days)||0
9950484|NCT01408719|11069520|FG018|NOT COMPLETED|Washout Period (28 Days)||0
9950485|NCT01408719|11069521|FG019|NOT COMPLETED|Washout Period (28 Days)||0
9950486|NCT01408719|11069502|FG000|STARTED|Second Intervention (35 Days)||2
9950487|NCT01408719|11069503|FG001|STARTED|Second Intervention (35 Days)||3
9950488|NCT01408719|11069504|FG002|STARTED|Second Intervention (35 Days)||1
9950489|NCT01408719|11069505|FG003|STARTED|Second Intervention (35 Days)||2
9950490|NCT01408719|11069506|FG004|STARTED|Second Intervention (35 Days)||3
9950491|NCT01408719|11069507|FG005|STARTED|Second Intervention (35 Days)||3
9950492|NCT01408719|11069508|FG006|STARTED|Second Intervention (35 Days)||2
9950493|NCT01408719|11069509|FG007|STARTED|Second Intervention (35 Days)||3
10011809|NCT01782495|11134586|FG000|STARTED|Overall Study||34
10011810|NCT01782495|11134587|FG001|STARTED|Overall Study||27
9760702|NCT00382863|10864466|FG000|NOT COMPLETED|Overall Study||15
9760703|NCT00382863|10864467|FG001|NOT COMPLETED|Overall Study||36
9760704|NCT00382928|10864475|FG000|STARTED|Overall Study||97
9760705|NCT00382928|10864476|FG001|STARTED|Overall Study||95
9760706|NCT00382928|10864475|FG000|COMPLETED|Overall Study||97
9760707|NCT00382928|10864476|FG001|COMPLETED|Overall Study||95
9760708|NCT00382928|10864475|FG000|NOT COMPLETED|Overall Study||0
9760709|NCT00382928|10864476|FG001|NOT COMPLETED|Overall Study||0
9760710|NCT00382967|10864489|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
9760711|NCT00382967|10864490|FG001|STARTED|Overall Study||138
9760712|NCT00382967|10864489|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
9760713|NCT00382967|10864490|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
9950494|NCT01408719|11069510|FG008|STARTED|Second Intervention (35 Days)||1
9950495|NCT01408719|11069511|FG009|STARTED|Second Intervention (35 Days)||1
9950496|NCT01408719|11069512|FG010|STARTED|Second Intervention (35 Days)||2
9950497|NCT01408719|11069513|FG011|STARTED|Second Intervention (35 Days)||2
9950498|NCT01408719|11069514|FG012|STARTED|Second Intervention (35 Days)||2
9950499|NCT01408719|11069515|FG013|STARTED|Second Intervention (35 Days)||4
9950500|NCT01408719|11069516|FG014|STARTED|Second Intervention (35 Days)||1
9950501|NCT01408719|11069517|FG015|STARTED|Second Intervention (35 Days)||2
9950502|NCT01408719|11069518|FG016|STARTED|Second Intervention (35 Days)||2
9950503|NCT01408719|11069519|FG017|STARTED|Second Intervention (35 Days)||2
9950504|NCT01408719|11069520|FG018|STARTED|Second Intervention (35 Days)||0
9950505|NCT01408719|11069521|FG019|STARTED|Second Intervention (35 Days)||1
9950506|NCT01408719|11069502|FG000|COMPLETED|Second Intervention (35 Days)||2
9950507|NCT01408719|11069503|FG001|COMPLETED|Second Intervention (35 Days)||3
9950508|NCT01408719|11069504|FG002|COMPLETED|Second Intervention (35 Days)||1
9950509|NCT01408719|11069505|FG003|COMPLETED|Second Intervention (35 Days)||2
9950510|NCT01408719|11069506|FG004|COMPLETED|Second Intervention (35 Days)||3
9950511|NCT01408719|11069507|FG005|COMPLETED|Second Intervention (35 Days)||3
9950512|NCT01408719|11069508|FG006|COMPLETED|Second Intervention (35 Days)||2
9950513|NCT01408719|11069509|FG007|COMPLETED|Second Intervention (35 Days)||3
9950514|NCT01408719|11069510|FG008|COMPLETED|Second Intervention (35 Days)||1
9950515|NCT01408719|11069511|FG009|COMPLETED|Second Intervention (35 Days)||1
9950516|NCT01408719|11069512|FG010|COMPLETED|Second Intervention (35 Days)||2
9950517|NCT01408719|11069513|FG011|COMPLETED|Second Intervention (35 Days)||2
9950518|NCT01408719|11069514|FG012|COMPLETED|Second Intervention (35 Days)||2
9950519|NCT01408719|11069515|FG013|COMPLETED|Second Intervention (35 Days)||3
9950520|NCT01408719|11069516|FG014|COMPLETED|Second Intervention (35 Days)||1
9950521|NCT01408719|11069517|FG015|COMPLETED|Second Intervention (35 Days)||2
9950522|NCT01408719|11069518|FG016|COMPLETED|Second Intervention (35 Days)||2
9950523|NCT01408719|11069519|FG017|COMPLETED|Second Intervention (35 Days)||2
9950524|NCT01408719|11069520|FG018|COMPLETED|Second Intervention (35 Days)||0
9950525|NCT01408719|11069521|FG019|COMPLETED|Second Intervention (35 Days)||1
9950526|NCT01408719|11069502|FG000|NOT COMPLETED|Second Intervention (35 Days)||0
9950527|NCT01408719|11069503|FG001|NOT COMPLETED|Second Intervention (35 Days)||0
9950528|NCT01408719|11069504|FG002|NOT COMPLETED|Second Intervention (35 Days)||0
9950529|NCT01408719|11069505|FG003|NOT COMPLETED|Second Intervention (35 Days)||0
9950530|NCT01408719|11069506|FG004|NOT COMPLETED|Second Intervention (35 Days)||0
9950531|NCT01408719|11069507|FG005|NOT COMPLETED|Second Intervention (35 Days)||0
9950532|NCT01408719|11069508|FG006|NOT COMPLETED|Second Intervention (35 Days)||0
9950533|NCT01408719|11069509|FG007|NOT COMPLETED|Second Intervention (35 Days)||0
9950534|NCT01408719|11069510|FG008|NOT COMPLETED|Second Intervention (35 Days)||0
9950535|NCT01408719|11069511|FG009|NOT COMPLETED|Second Intervention (35 Days)||0
9950536|NCT01408719|11069512|FG010|NOT COMPLETED|Second Intervention (35 Days)||0
9950537|NCT01408719|11069513|FG011|NOT COMPLETED|Second Intervention (35 Days)||0
9950538|NCT01408719|11069514|FG012|NOT COMPLETED|Second Intervention (35 Days)||0
9950539|NCT01408719|11069515|FG013|NOT COMPLETED|Second Intervention (35 Days)||1
9950540|NCT01408719|11069516|FG014|NOT COMPLETED|Second Intervention (35 Days)||0
9760714|NCT00382967|10864489|FG000|NOT COMPLETED|Overall Study||1
9760715|NCT00382967|10864490|FG001|NOT COMPLETED|Overall Study||1
9760716|NCT00382993|10864496|FG000|STARTED|Migraine Attack 1 (Period 1)||84
9950541|NCT01408719|11069517|FG015|NOT COMPLETED|Second Intervention (35 Days)||0
9950542|NCT01408719|11069518|FG016|NOT COMPLETED|Second Intervention (35 Days)||0
9950543|NCT01408719|11069519|FG017|NOT COMPLETED|Second Intervention (35 Days)||0
9950544|NCT01408719|11069520|FG018|NOT COMPLETED|Second Intervention (35 Days)||0
9950545|NCT01408719|11069521|FG019|NOT COMPLETED|Second Intervention (35 Days)||0
9950546|NCT01408719|11069502|FG000|STARTED|Washout Period (28 Days)||2
9950547|NCT01408719|11069503|FG001|STARTED|Washout Period (28 Days)||3
9950548|NCT01408719|11069504|FG002|STARTED|Washout Period (28 Days)||1
9950549|NCT01408719|11069505|FG003|STARTED|Washout Period (28 Days)||2
9950550|NCT01408719|11069506|FG004|STARTED|Washout Period (28 Days)||3
9950551|NCT01408719|11069507|FG005|STARTED|Washout Period (28 Days)||3
9950552|NCT01408719|11069508|FG006|STARTED|Washout Period (28 Days)||2
9950553|NCT01408719|11069509|FG007|STARTED|Washout Period (28 Days)||3
9950554|NCT01408719|11069510|FG008|STARTED|Washout Period (28 Days)||1
9950555|NCT01408719|11069511|FG009|STARTED|Washout Period (28 Days)||1
9950556|NCT01408719|11069512|FG010|STARTED|Washout Period (28 Days)||2
9950557|NCT01408719|11069513|FG011|STARTED|Washout Period (28 Days)||2
9950558|NCT01408719|11069514|FG012|STARTED|Washout Period (28 Days)||2
9950559|NCT01408719|11069515|FG013|STARTED|Washout Period (28 Days)||3
9950560|NCT01408719|11069516|FG014|STARTED|Washout Period (28 Days)||1
9950561|NCT01408719|11069517|FG015|STARTED|Washout Period (28 Days)||1
9950562|NCT01408719|11069518|FG016|STARTED|Washout Period (28 Days)||2
9950563|NCT01408719|11069519|FG017|STARTED|Washout Period (28 Days)||2
9950564|NCT01408719|11069520|FG018|STARTED|Washout Period (28 Days)||0
9950565|NCT01408719|11069521|FG019|STARTED|Washout Period (28 Days)||1
9950566|NCT01408719|11069502|FG000|COMPLETED|Washout Period (28 Days)||2
9950567|NCT01408719|11069503|FG001|COMPLETED|Washout Period (28 Days)||3
9950568|NCT01408719|11069504|FG002|COMPLETED|Washout Period (28 Days)||1
9950569|NCT01408719|11069505|FG003|COMPLETED|Washout Period (28 Days)||2
9950570|NCT01408719|11069506|FG004|COMPLETED|Washout Period (28 Days)||3
9950571|NCT01408719|11069507|FG005|COMPLETED|Washout Period (28 Days)||3
9950572|NCT01408719|11069508|FG006|COMPLETED|Washout Period (28 Days)||2
9950573|NCT01408719|11069509|FG007|COMPLETED|Washout Period (28 Days)||3
9950574|NCT01408719|11069510|FG008|COMPLETED|Washout Period (28 Days)||1
9950575|NCT01408719|11069511|FG009|COMPLETED|Washout Period (28 Days)||1
9950576|NCT01408719|11069512|FG010|COMPLETED|Washout Period (28 Days)||2
9950577|NCT01408719|11069513|FG011|COMPLETED|Washout Period (28 Days)||2
9950578|NCT01408719|11069514|FG012|COMPLETED|Washout Period (28 Days)||2
9950579|NCT01408719|11069515|FG013|COMPLETED|Washout Period (28 Days)||3
9950580|NCT01408719|11069516|FG014|COMPLETED|Washout Period (28 Days)||1
9950581|NCT01408719|11069517|FG015|COMPLETED|Washout Period (28 Days)||1
9950582|NCT01408719|11069518|FG016|COMPLETED|Washout Period (28 Days)||2
9950583|NCT01408719|11069519|FG017|COMPLETED|Washout Period (28 Days)||2
9950584|NCT01408719|11069520|FG018|COMPLETED|Washout Period (28 Days)||0
9950585|NCT01408719|11069521|FG019|COMPLETED|Washout Period (28 Days)||1
9950586|NCT01408719|11069502|FG000|NOT COMPLETED|Washout Period (28 Days)||0
9950587|NCT01408719|11069503|FG001|NOT COMPLETED|Washout Period (28 Days)||0
9950588|NCT01408719|11069504|FG002|NOT COMPLETED|Washout Period (28 Days)||0
9950589|NCT01408719|11069505|FG003|NOT COMPLETED|Washout Period (28 Days)||0
9950590|NCT01408719|11069506|FG004|NOT COMPLETED|Washout Period (28 Days)||0
9950591|NCT01408719|11069507|FG005|NOT COMPLETED|Washout Period (28 Days)||0
9950592|NCT01408719|11069508|FG006|NOT COMPLETED|Washout Period (28 Days)||0
9950593|NCT01408719|11069509|FG007|NOT COMPLETED|Washout Period (28 Days)||0
9950594|NCT01408719|11069510|FG008|NOT COMPLETED|Washout Period (28 Days)||0
9950595|NCT01408719|11069511|FG009|NOT COMPLETED|Washout Period (28 Days)||0
9950596|NCT01408719|11069512|FG010|NOT COMPLETED|Washout Period (28 Days)||0
9950597|NCT01408719|11069513|FG011|NOT COMPLETED|Washout Period (28 Days)||0
9950598|NCT01408719|11069514|FG012|NOT COMPLETED|Washout Period (28 Days)||0
9950599|NCT01408719|11069515|FG013|NOT COMPLETED|Washout Period (28 Days)||0
9950600|NCT01408719|11069516|FG014|NOT COMPLETED|Washout Period (28 Days)||0
9950601|NCT01408719|11069517|FG015|NOT COMPLETED|Washout Period (28 Days)||0
9950602|NCT01408719|11069518|FG016|NOT COMPLETED|Washout Period (28 Days)||0
9950603|NCT01408719|11069519|FG017|NOT COMPLETED|Washout Period (28 Days)||0
9950604|NCT01408719|11069520|FG018|NOT COMPLETED|Washout Period (28 Days)||0
9950605|NCT01408719|11069521|FG019|NOT COMPLETED|Washout Period (28 Days)||0
9950606|NCT01408719|11069502|FG000|STARTED|Third Intervention (35 Days)||2
9950607|NCT01408719|11069503|FG001|STARTED|Third Intervention (35 Days)||3
9950608|NCT01408719|11069504|FG002|STARTED|Third Intervention (35 Days)||1
9950609|NCT01408719|11069505|FG003|STARTED|Third Intervention (35 Days)||2
9950610|NCT01408719|11069506|FG004|STARTED|Third Intervention (35 Days)||3
9950611|NCT01408719|11069507|FG005|STARTED|Third Intervention (35 Days)||3
9950612|NCT01408719|11069508|FG006|STARTED|Third Intervention (35 Days)||2
9950613|NCT01408719|11069509|FG007|STARTED|Third Intervention (35 Days)||3
9950614|NCT01408719|11069510|FG008|STARTED|Third Intervention (35 Days)||1
9950615|NCT01408719|11069511|FG009|STARTED|Third Intervention (35 Days)||1
9950616|NCT01408719|11069512|FG010|STARTED|Third Intervention (35 Days)||2
9950617|NCT01408719|11069513|FG011|STARTED|Third Intervention (35 Days)||2
9950618|NCT01408719|11069514|FG012|STARTED|Third Intervention (35 Days)||2
9950619|NCT01408719|11069515|FG013|STARTED|Third Intervention (35 Days)||3
9950620|NCT01408719|11069516|FG014|STARTED|Third Intervention (35 Days)||1
9950621|NCT01408719|11069517|FG015|STARTED|Third Intervention (35 Days)||1
9950622|NCT01408719|11069518|FG016|STARTED|Third Intervention (35 Days)||2
9950623|NCT01408719|11069519|FG017|STARTED|Third Intervention (35 Days)||2
9950624|NCT01408719|11069520|FG018|STARTED|Third Intervention (35 Days)||0
9950625|NCT01408719|11069521|FG019|STARTED|Third Intervention (35 Days)||1
9950626|NCT01408719|11069502|FG000|COMPLETED|Third Intervention (35 Days)||2
9950627|NCT01408719|11069503|FG001|COMPLETED|Third Intervention (35 Days)||3
9950628|NCT01408719|11069504|FG002|COMPLETED|Third Intervention (35 Days)||1
9950629|NCT01408719|11069505|FG003|COMPLETED|Third Intervention (35 Days)||2
9950630|NCT01408719|11069506|FG004|COMPLETED|Third Intervention (35 Days)||3
9950631|NCT01408719|11069507|FG005|COMPLETED|Third Intervention (35 Days)||3
9950632|NCT01408719|11069508|FG006|COMPLETED|Third Intervention (35 Days)||2
9950633|NCT01408719|11069509|FG007|COMPLETED|Third Intervention (35 Days)||2
9950634|NCT01408719|11069510|FG008|COMPLETED|Third Intervention (35 Days)||1
9950635|NCT01408719|11069511|FG009|COMPLETED|Third Intervention (35 Days)||1
9950636|NCT01408719|11069512|FG010|COMPLETED|Third Intervention (35 Days)||2
9950637|NCT01408719|11069513|FG011|COMPLETED|Third Intervention (35 Days)||2
9950638|NCT01408719|11069514|FG012|COMPLETED|Third Intervention (35 Days)||2
9950639|NCT01408719|11069515|FG013|COMPLETED|Third Intervention (35 Days)||3
9950640|NCT01408719|11069516|FG014|COMPLETED|Third Intervention (35 Days)||1
9950641|NCT01408719|11069517|FG015|COMPLETED|Third Intervention (35 Days)||1
9950642|NCT01408719|11069518|FG016|COMPLETED|Third Intervention (35 Days)||2
9950643|NCT01408719|11069519|FG017|COMPLETED|Third Intervention (35 Days)||2
9950644|NCT01408719|11069520|FG018|COMPLETED|Third Intervention (35 Days)||0
9950645|NCT01408719|11069521|FG019|COMPLETED|Third Intervention (35 Days)||1
10209021|NCT03562377|11336151|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
10209022|NCT03562377|11336152|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
10209023|NCT03562377|11336151|FG000|NOT COMPLETED|Treatment Period||7
10209024|NCT03562377|11336152|FG001|NOT COMPLETED|Treatment Period||19
10209025|NCT03562377|11336151|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
10209026|NCT03562377|11336152|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
10209027|NCT03562377|11336151|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
10209028|NCT03562377|11336152|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
10209029|NCT03562377|11336151|FG000|NOT COMPLETED|Safety Follow-up Period||59
10209030|NCT03562377|11336152|FG001|NOT COMPLETED|Safety Follow-up Period||57
10209031|NCT03562481|11336160|FG000|STARTED|First Intervention||12
10209032|NCT03562481|11336161|FG001|STARTED|First Intervention||14
9950646|NCT01408719|11069502|FG000|NOT COMPLETED|Third Intervention (35 Days)||0
9950647|NCT01408719|11069503|FG001|NOT COMPLETED|Third Intervention (35 Days)||0
9950648|NCT01408719|11069504|FG002|NOT COMPLETED|Third Intervention (35 Days)||0
9950649|NCT01408719|11069505|FG003|NOT COMPLETED|Third Intervention (35 Days)||0
9950650|NCT01408719|11069506|FG004|NOT COMPLETED|Third Intervention (35 Days)||0
9950651|NCT01408719|11069507|FG005|NOT COMPLETED|Third Intervention (35 Days)||0
9950652|NCT01408719|11069508|FG006|NOT COMPLETED|Third Intervention (35 Days)||0
9950653|NCT01408719|11069509|FG007|NOT COMPLETED|Third Intervention (35 Days)||1
9950654|NCT01408719|11069510|FG008|NOT COMPLETED|Third Intervention (35 Days)||0
9950655|NCT01408719|11069511|FG009|NOT COMPLETED|Third Intervention (35 Days)||0
9950656|NCT01408719|11069512|FG010|NOT COMPLETED|Third Intervention (35 Days)||0
9950657|NCT01408719|11069513|FG011|NOT COMPLETED|Third Intervention (35 Days)||0
9950658|NCT01408719|11069514|FG012|NOT COMPLETED|Third Intervention (35 Days)||0
9950659|NCT01408719|11069515|FG013|NOT COMPLETED|Third Intervention (35 Days)||0
9950660|NCT01408719|11069516|FG014|NOT COMPLETED|Third Intervention (35 Days)||0
9950661|NCT01408719|11069517|FG015|NOT COMPLETED|Third Intervention (35 Days)||0
9950662|NCT01408719|11069518|FG016|NOT COMPLETED|Third Intervention (35 Days)||0
9950663|NCT01408719|11069519|FG017|NOT COMPLETED|Third Intervention (35 Days)||0
9950664|NCT01408719|11069520|FG018|NOT COMPLETED|Third Intervention (35 Days)||0
9950665|NCT01408719|11069521|FG019|NOT COMPLETED|Third Intervention (35 Days)||0
9950666|NCT01408719|11069502|FG000|STARTED|Washout Period (28 Days)||2
9950667|NCT01408719|11069503|FG001|STARTED|Washout Period (28 Days)||3
9950668|NCT01408719|11069504|FG002|STARTED|Washout Period (28 Days)||1
9950669|NCT01408719|11069505|FG003|STARTED|Washout Period (28 Days)||2
9950670|NCT01408719|11069506|FG004|STARTED|Washout Period (28 Days)||3
9950671|NCT01408719|11069507|FG005|STARTED|Washout Period (28 Days)||3
9950672|NCT01408719|11069508|FG006|STARTED|Washout Period (28 Days)||2
9950673|NCT01408719|11069509|FG007|STARTED|Washout Period (28 Days)||2
9950674|NCT01408719|11069510|FG008|STARTED|Washout Period (28 Days)||1
9760717|NCT00382993|10864497|FG001|STARTED|Migraine Attack 1 (Period 1)||85
9760718|NCT00382993|10864496|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
9760719|NCT00382993|10864497|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67
9760720|NCT00382993|10864496|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
10209033|NCT03562481|11336160|FG000|COMPLETED|First Intervention||11
10209034|NCT03562481|11336161|FG001|COMPLETED|First Intervention||14
10209035|NCT03562481|11336160|FG000|NOT COMPLETED|First Intervention||1
10209036|NCT03562481|11336161|FG001|NOT COMPLETED|First Intervention||0
10209037|NCT03562481|11336160|FG000|STARTED|Washout||11
10209038|NCT03562481|11336161|FG001|STARTED|Washout||14
10209039|NCT03562481|11336160|FG000|COMPLETED|Washout||11
9950675|NCT01408719|11069511|FG009|STARTED|Washout Period (28 Days)||1
9950676|NCT01408719|11069512|FG010|STARTED|Washout Period (28 Days)||2
9950677|NCT01408719|11069513|FG011|STARTED|Washout Period (28 Days)||2
9950678|NCT01408719|11069514|FG012|STARTED|Washout Period (28 Days)||1
9950679|NCT01408719|11069515|FG013|STARTED|Washout Period (28 Days)||3
9950680|NCT01408719|11069516|FG014|STARTED|Washout Period (28 Days)||1
9950681|NCT01408719|11069517|FG015|STARTED|Washout Period (28 Days)||1
9950682|NCT01408719|11069518|FG016|STARTED|Washout Period (28 Days)||2
9950683|NCT01408719|11069519|FG017|STARTED|Washout Period (28 Days)||2
9950684|NCT01408719|11069520|FG018|STARTED|Washout Period (28 Days)||0
9950685|NCT01408719|11069521|FG019|STARTED|Washout Period (28 Days)||1
9950686|NCT01408719|11069502|FG000|COMPLETED|Washout Period (28 Days)||2
9950687|NCT01408719|11069503|FG001|COMPLETED|Washout Period (28 Days)||3
9950688|NCT01408719|11069504|FG002|COMPLETED|Washout Period (28 Days)||1
9950689|NCT01408719|11069505|FG003|COMPLETED|Washout Period (28 Days)||2
9950690|NCT01408719|11069506|FG004|COMPLETED|Washout Period (28 Days)||3
9950691|NCT01408719|11069507|FG005|COMPLETED|Washout Period (28 Days)||3
9950692|NCT01408719|11069508|FG006|COMPLETED|Washout Period (28 Days)||2
9950693|NCT01408719|11069509|FG007|COMPLETED|Washout Period (28 Days)||2
9950694|NCT01408719|11069510|FG008|COMPLETED|Washout Period (28 Days)||1
9950695|NCT01408719|11069511|FG009|COMPLETED|Washout Period (28 Days)||1
9950696|NCT01408719|11069512|FG010|COMPLETED|Washout Period (28 Days)||2
9950697|NCT01408719|11069513|FG011|COMPLETED|Washout Period (28 Days)||2
9950698|NCT01408719|11069514|FG012|COMPLETED|Washout Period (28 Days)||1
9950699|NCT01408719|11069515|FG013|COMPLETED|Washout Period (28 Days)||3
9950700|NCT01408719|11069516|FG014|COMPLETED|Washout Period (28 Days)||1
9950701|NCT01408719|11069517|FG015|COMPLETED|Washout Period (28 Days)||1
9950702|NCT01408719|11069518|FG016|COMPLETED|Washout Period (28 Days)||2
9950703|NCT01408719|11069519|FG017|COMPLETED|Washout Period (28 Days)||2
9950704|NCT01408719|11069520|FG018|COMPLETED|Washout Period (28 Days)||0
9950705|NCT01408719|11069521|FG019|COMPLETED|Washout Period (28 Days)||1
9950706|NCT01408719|11069502|FG000|NOT COMPLETED|Washout Period (28 Days)||0
9950707|NCT01408719|11069503|FG001|NOT COMPLETED|Washout Period (28 Days)||0
9950708|NCT01408719|11069504|FG002|NOT COMPLETED|Washout Period (28 Days)||0
9950709|NCT01408719|11069505|FG003|NOT COMPLETED|Washout Period (28 Days)||0
9950710|NCT01408719|11069506|FG004|NOT COMPLETED|Washout Period (28 Days)||0
9950711|NCT01408719|11069507|FG005|NOT COMPLETED|Washout Period (28 Days)||0
9950712|NCT01408719|11069508|FG006|NOT COMPLETED|Washout Period (28 Days)||0
9950713|NCT01408719|11069509|FG007|NOT COMPLETED|Washout Period (28 Days)||0
9950714|NCT01408719|11069510|FG008|NOT COMPLETED|Washout Period (28 Days)||0
9950715|NCT01408719|11069511|FG009|NOT COMPLETED|Washout Period (28 Days)||0
9760721|NCT00382993|10864497|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
9760722|NCT00382993|10864496|FG000|STARTED|Migraine Attack 2 (Period 2)||70
9950716|NCT01408719|11069512|FG010|NOT COMPLETED|Washout Period (28 Days)||0
9950717|NCT01408719|11069513|FG011|NOT COMPLETED|Washout Period (28 Days)||0
9950718|NCT01408719|11069514|FG012|NOT COMPLETED|Washout Period (28 Days)||0
9950719|NCT01408719|11069515|FG013|NOT COMPLETED|Washout Period (28 Days)||0
9950720|NCT01408719|11069516|FG014|NOT COMPLETED|Washout Period (28 Days)||0
9950721|NCT01408719|11069517|FG015|NOT COMPLETED|Washout Period (28 Days)||0
9950722|NCT01408719|11069518|FG016|NOT COMPLETED|Washout Period (28 Days)||0
9950723|NCT01408719|11069519|FG017|NOT COMPLETED|Washout Period (28 Days)||0
9950724|NCT01408719|11069520|FG018|NOT COMPLETED|Washout Period (28 Days)||0
9950725|NCT01408719|11069521|FG019|NOT COMPLETED|Washout Period (28 Days)||0
9950726|NCT01408719|11069502|FG000|STARTED|Fourth Intervention (35 Days)||2
9950727|NCT01408719|11069503|FG001|STARTED|Fourth Intervention (35 Days)||3
9950728|NCT01408719|11069504|FG002|STARTED|Fourth Intervention (35 Days)||1
9950729|NCT01408719|11069505|FG003|STARTED|Fourth Intervention (35 Days)||2
9950730|NCT01408719|11069506|FG004|STARTED|Fourth Intervention (35 Days)||3
9950731|NCT01408719|11069507|FG005|STARTED|Fourth Intervention (35 Days)||3
9950732|NCT01408719|11069508|FG006|STARTED|Fourth Intervention (35 Days)||2
9950733|NCT01408719|11069509|FG007|STARTED|Fourth Intervention (35 Days)||2
9950734|NCT01408719|11069510|FG008|STARTED|Fourth Intervention (35 Days)||1
9950735|NCT01408719|11069511|FG009|STARTED|Fourth Intervention (35 Days)||1
9950736|NCT01408719|11069512|FG010|STARTED|Fourth Intervention (35 Days)||2
9950737|NCT01408719|11069513|FG011|STARTED|Fourth Intervention (35 Days)||2
9950738|NCT01408719|11069514|FG012|STARTED|Fourth Intervention (35 Days)||1
9950739|NCT01408719|11069515|FG013|STARTED|Fourth Intervention (35 Days)||3
9950740|NCT01408719|11069516|FG014|STARTED|Fourth Intervention (35 Days)||1
9950741|NCT01408719|11069517|FG015|STARTED|Fourth Intervention (35 Days)||1
9950742|NCT01408719|11069518|FG016|STARTED|Fourth Intervention (35 Days)||2
9950743|NCT01408719|11069519|FG017|STARTED|Fourth Intervention (35 Days)||2
9950744|NCT01408719|11069520|FG018|STARTED|Fourth Intervention (35 Days)||0
9950745|NCT01408719|11069521|FG019|STARTED|Fourth Intervention (35 Days)||1
9950746|NCT01408719|11069502|FG000|COMPLETED|Fourth Intervention (35 Days)||2
9950747|NCT01408719|11069503|FG001|COMPLETED|Fourth Intervention (35 Days)||3
9950748|NCT01408719|11069504|FG002|COMPLETED|Fourth Intervention (35 Days)||1
9950749|NCT01408719|11069505|FG003|COMPLETED|Fourth Intervention (35 Days)||2
9760723|NCT00382993|10864497|FG001|STARTED|Migraine Attack 2 (Period 2)||67
9760724|NCT00382993|10864496|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68
9760725|NCT00382993|10864497|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63
9829292|NCT00759148|10939889|FG000|STARTED|Overall Study||593
9950750|NCT01408719|11069506|FG004|COMPLETED|Fourth Intervention (35 Days)||3
9950751|NCT01408719|11069507|FG005|COMPLETED|Fourth Intervention (35 Days)||3
9950752|NCT01408719|11069508|FG006|COMPLETED|Fourth Intervention (35 Days)||2
9950753|NCT01408719|11069509|FG007|COMPLETED|Fourth Intervention (35 Days)||2
9950754|NCT01408719|11069510|FG008|COMPLETED|Fourth Intervention (35 Days)||1
9950755|NCT01408719|11069511|FG009|COMPLETED|Fourth Intervention (35 Days)||1
9950756|NCT01408719|11069512|FG010|COMPLETED|Fourth Intervention (35 Days)||2
9950757|NCT01408719|11069513|FG011|COMPLETED|Fourth Intervention (35 Days)||2
9950758|NCT01408719|11069514|FG012|COMPLETED|Fourth Intervention (35 Days)||1
9950759|NCT01408719|11069515|FG013|COMPLETED|Fourth Intervention (35 Days)||3
9950760|NCT01408719|11069516|FG014|COMPLETED|Fourth Intervention (35 Days)||1
9950761|NCT01408719|11069517|FG015|COMPLETED|Fourth Intervention (35 Days)||1
9950762|NCT01408719|11069518|FG016|COMPLETED|Fourth Intervention (35 Days)||2
9950763|NCT01408719|11069519|FG017|COMPLETED|Fourth Intervention (35 Days)||2
9950764|NCT01408719|11069520|FG018|COMPLETED|Fourth Intervention (35 Days)||0
9950765|NCT01408719|11069521|FG019|COMPLETED|Fourth Intervention (35 Days)||1
9950766|NCT01408719|11069502|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950767|NCT01408719|11069503|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950768|NCT01408719|11069504|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950769|NCT01408719|11069505|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950770|NCT01408719|11069506|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950771|NCT01408719|11069507|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950772|NCT01408719|11069508|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950773|NCT01408719|11069509|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950774|NCT01408719|11069510|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950775|NCT01408719|11069511|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950776|NCT01408719|11069512|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950777|NCT01408719|11069513|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950778|NCT01408719|11069514|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950779|NCT01408719|11069515|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950780|NCT01408719|11069516|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950781|NCT01408719|11069517|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950782|NCT01408719|11069518|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950783|NCT01408719|11069519|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950784|NCT01408719|11069520|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950785|NCT01408719|11069521|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0
9950786|NCT01408732|11069531|FG000|STARTED|Overall Study||9
9950787|NCT01408732|11069532|FG001|STARTED|Overall Study||9
9950788|NCT01408732|11069531|FG000|COMPLETED|Overall Study||7
9950789|NCT01408732|11069532|FG001|COMPLETED|Overall Study||7
9950790|NCT01408732|11069531|FG000|NOT COMPLETED|Overall Study||2
9950791|NCT01408732|11069532|FG001|NOT COMPLETED|Overall Study||2
9950792|NCT01408862|11069538|FG000|STARTED|Overall Study||20
9950793|NCT01408862|11069538|FG000|COMPLETED|Overall Study||20
9950794|NCT01408862|11069538|FG000|NOT COMPLETED|Overall Study||0
9950795|NCT01408888|11069543|FG000|STARTED|First Intervention||18
9950796|NCT01408888|11069544|FG001|STARTED|First Intervention||11
9950797|NCT01408888|11069543|FG000|Received at Least 1 Dose of Drug|First Intervention||18
9950798|NCT01408888|11069544|FG001|Received at Least 1 Dose of Drug|First Intervention||11
9950799|NCT01408888|11069543|FG000|COMPLETED|First Intervention||18
9950800|NCT01408888|11069544|FG001|COMPLETED|First Intervention||8
9950801|NCT01408888|11069543|FG000|NOT COMPLETED|First Intervention||0
9950802|NCT01408888|11069544|FG001|NOT COMPLETED|First Intervention||3
9950803|NCT01408888|11069543|FG000|STARTED|Washout of at Least 21 Days||18
9950804|NCT01408888|11069544|FG001|STARTED|Washout of at Least 21 Days||8
9950805|NCT01408888|11069543|FG000|COMPLETED|Washout of at Least 21 Days||18
9950806|NCT01408888|11069544|FG001|COMPLETED|Washout of at Least 21 Days||8
9950807|NCT01408888|11069543|FG000|NOT COMPLETED|Washout of at Least 21 Days||0
9950808|NCT01408888|11069544|FG001|NOT COMPLETED|Washout of at Least 21 Days||0
9950809|NCT01408888|11069543|FG000|STARTED|Second Intervention||18
9950810|NCT01408888|11069544|FG001|STARTED|Second Intervention||8
9950811|NCT01408888|11069543|FG000|COMPLETED|Second Intervention||16
9950812|NCT01408888|11069544|FG001|COMPLETED|Second Intervention||8
9950813|NCT01408888|11069543|FG000|NOT COMPLETED|Second Intervention||2
9950814|NCT01408888|11069544|FG001|NOT COMPLETED|Second Intervention||0
9950815|NCT01408901|11069564|FG000|STARTED|6-Week Follow-Up||53
9950816|NCT01408901|11069565|FG001|STARTED|6-Week Follow-Up||53
9950817|NCT01408901|11069566|FG002|STARTED|6-Week Follow-Up||53
9950818|NCT01408901|11069567|FG003|STARTED|6-Week Follow-Up||51
9950819|NCT01408901|11069564|FG000|COMPLETED|6-Week Follow-Up||50
9950820|NCT01408901|11069565|FG001|COMPLETED|6-Week Follow-Up||51
9950821|NCT01408901|11069566|FG002|COMPLETED|6-Week Follow-Up||50
9950822|NCT01408901|11069567|FG003|COMPLETED|6-Week Follow-Up||47
9950823|NCT01408901|11069564|FG000|NOT COMPLETED|6-Week Follow-Up||3
9950824|NCT01408901|11069565|FG001|NOT COMPLETED|6-Week Follow-Up||2
9950825|NCT01408901|11069566|FG002|NOT COMPLETED|6-Week Follow-Up||3
9950826|NCT01408901|11069567|FG003|NOT COMPLETED|6-Week Follow-Up||4
9950827|NCT01408901|11069564|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50
9950828|NCT01408901|11069565|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52
9950829|NCT01408901|11069566|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50
9950830|NCT01408901|11069567|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49
9950831|NCT01408901|11069564|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
9950832|NCT01408901|11069565|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
9950833|NCT01408901|11069566|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
9950834|NCT01408901|11069567|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
9950835|NCT01408901|11069564|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
9950836|NCT01408901|11069565|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
9950837|NCT01408901|11069566|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
9950838|NCT01408901|11069567|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
9950839|NCT01408901|11069564|FG000|STARTED|26-Week Follow-Up||49
9950840|NCT01408901|11069565|FG001|STARTED|26-Week Follow-Up||52
9950841|NCT01408901|11069566|FG002|STARTED|26-Week Follow-Up||50
9950842|NCT01408901|11069567|FG003|STARTED|26-Week Follow-Up||47
9950843|NCT01408901|11069564|FG000|COMPLETED|26-Week Follow-Up||48
9950844|NCT01408901|11069565|FG001|COMPLETED|26-Week Follow-Up||50
9950845|NCT01408901|11069566|FG002|COMPLETED|26-Week Follow-Up||50
9950846|NCT01408901|11069567|FG003|COMPLETED|26-Week Follow-Up||46
9950847|NCT01408901|11069564|FG000|NOT COMPLETED|26-Week Follow-Up||1
9950848|NCT01408901|11069565|FG001|NOT COMPLETED|26-Week Follow-Up||2
9950849|NCT01408901|11069566|FG002|NOT COMPLETED|26-Week Follow-Up||0
9950850|NCT01408901|11069567|FG003|NOT COMPLETED|26-Week Follow-Up||1
9950851|NCT01408914|11069582|FG000|STARTED|Overall Study||60
9950852|NCT01408914|11069583|FG001|STARTED|Overall Study||60
9950853|NCT01408914|11069584|FG002|STARTED|Overall Study||60
9950854|NCT01408914|11069582|FG000|COMPLETED|Overall Study||48
9950855|NCT01408914|11069583|FG001|COMPLETED|Overall Study||48
9950856|NCT01408914|11069584|FG002|COMPLETED|Overall Study||47
9950857|NCT01408914|11069582|FG000|NOT COMPLETED|Overall Study||12
9950858|NCT01408914|11069583|FG001|NOT COMPLETED|Overall Study||12
9950859|NCT01408914|11069584|FG002|NOT COMPLETED|Overall Study||13
9950860|NCT01408992|11069592|FG000|STARTED|Overall Study||558
9950861|NCT01408992|11069592|FG000|COMPLETED|Overall Study||558
9950862|NCT01408992|11069592|FG000|NOT COMPLETED|Overall Study||0
9950863|NCT01409096|11069606|FG000|STARTED|Overall Study||40
9950864|NCT01409096|11069607|FG001|STARTED|Overall Study||40
9950865|NCT01409096|11069606|FG000|COMPLETED|Overall Study||38
9950866|NCT01409096|11069607|FG001|COMPLETED|Overall Study||35
9950867|NCT01409096|11069606|FG000|NOT COMPLETED|Overall Study||2
9950868|NCT01409096|11069607|FG001|NOT COMPLETED|Overall Study||5
9950869|NCT01409213|11069613|FG000|STARTED|Overall Study||1523
9950870|NCT01409213|11069613|FG000|COMPLETED|Overall Study||1523
9950871|NCT01409213|11069613|FG000|NOT COMPLETED|Overall Study||0
9950872|NCT01409239|11069619|FG000|STARTED|Overall Study||16
9950873|NCT01409239|11069620|FG001|STARTED|Overall Study||17
9950874|NCT01409239|11069619|FG000|COMPLETED|Overall Study||16
9950875|NCT01409239|11069620|FG001|COMPLETED|Overall Study||17
9950876|NCT01409239|11069619|FG000|NOT COMPLETED|Overall Study||0
9950877|NCT01409239|11069620|FG001|NOT COMPLETED|Overall Study||0
9950878|NCT01409291|11069628|FG000|STARTED|Overall Study||36
9950879|NCT01409291|11069629|FG001|STARTED|Overall Study||28
9950880|NCT01409291|11069628|FG000|COMPLETED|Overall Study||29
9950881|NCT01409291|11069629|FG001|COMPLETED|Overall Study||19
9950882|NCT01409291|11069628|FG000|NOT COMPLETED|Overall Study||7
9950883|NCT01409291|11069629|FG001|NOT COMPLETED|Overall Study||9
9950884|NCT01409382|11069637|FG000|STARTED|Overall Study||240
9950885|NCT01409382|11069638|FG001|STARTED|Overall Study||240
9950886|NCT01409382|11069637|FG000|COMPLETED|Overall Study||159
9950887|NCT01409382|11069638|FG001|COMPLETED|Overall Study||160
9950888|NCT01409382|11069637|FG000|NOT COMPLETED|Overall Study||81
9950889|NCT01409382|11069638|FG001|NOT COMPLETED|Overall Study||80
9950890|NCT01409434|11069648|FG000|STARTED|Overall Study||44
9950891|NCT01409434|11069648|FG000|COMPLETED|Overall Study||40
9950892|NCT01409434|11069648|FG000|NOT COMPLETED|Overall Study||4
9950893|NCT01409564|11069654|FG000|STARTED|Overall Study||23
9950894|NCT01409564|11069655|FG001|STARTED|Overall Study||23
9950895|NCT01409564|11069654|FG000|COMPLETED|Overall Study||18
9950896|NCT01409564|11069655|FG001|COMPLETED|Overall Study||18
9950897|NCT01409564|11069654|FG000|NOT COMPLETED|Overall Study||5
9950898|NCT01409564|11069655|FG001|NOT COMPLETED|Overall Study||5
9950899|NCT01409707|11069668|FG000|STARTED|Overall Study||41
9950900|NCT01409707|11069669|FG001|STARTED|Overall Study||45
9950901|NCT01409707|11069670|FG002|STARTED|Overall Study||40
9950902|NCT01409707|11069668|FG000|COMPLETED|Overall Study||36
9950903|NCT01409707|11069669|FG001|COMPLETED|Overall Study||28
9950904|NCT01409707|11069670|FG002|COMPLETED|Overall Study||24
9950905|NCT01409707|11069668|FG000|NOT COMPLETED|Overall Study||5
9950906|NCT01409707|11069669|FG001|NOT COMPLETED|Overall Study||17
9950907|NCT01409707|11069670|FG002|NOT COMPLETED|Overall Study||16
9950908|NCT01409811|11069677|FG000|STARTED|Overall Study||9
9950909|NCT01409811|11069677|FG000|COMPLETED|Overall Study||8
9950910|NCT01409811|11069677|FG000|NOT COMPLETED|Overall Study||1
9950911|NCT01409837|11069683|FG000|STARTED|Overall Study||17
9950912|NCT01409837|11069684|FG001|STARTED|Overall Study||16
9950913|NCT01409837|11069683|FG000|6th Week|Overall Study||17
9950914|NCT01409837|11069684|FG001|6th Week|Overall Study||16
9950915|NCT01409837|11069683|FG000|12th Week|Overall Study|Moved away to another location|16
9950916|NCT01409837|11069684|FG001|12th Week|Overall Study||16
9950917|NCT01409837|11069683|FG000|24th Week|Overall Study||16
9950918|NCT01409837|11069684|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
9950919|NCT01409837|11069683|FG000|48th Week|Overall Study|Lost to follow-up|15
9950920|NCT01409837|11069684|FG001|48th Week|Overall Study||15
9950921|NCT01409837|11069683|FG000|96th Week|Overall Study||15
9950922|NCT01409837|11069684|FG001|96th Week|Overall Study||15
9950923|NCT01409837|11069683|FG000|102nd Week|Overall Study||15
9950924|NCT01409837|11069684|FG001|102nd Week|Overall Study|Married another wife|14
9950925|NCT01409837|11069683|FG000|114th Week|Overall Study||15
9950926|NCT01409837|11069684|FG001|114th Week|Overall Study||14
9950927|NCT01409837|11069683|FG000|138th Week|Overall Study||15
9950928|NCT01409837|11069684|FG001|138th Week|Overall Study||14
9950929|NCT01409837|11069683|FG000|186th Week|Overall Study|Moved away to another location|14
9950930|NCT01409837|11069684|FG001|186th Week|Overall Study||14
9950931|NCT01409837|11069683|FG000|282nd Week|Overall Study||14
9950932|NCT01409837|11069684|FG001|282nd Week|Overall Study||14
9950933|NCT01409837|11069683|FG000|COMPLETED|Overall Study||14
9950934|NCT01409837|11069684|FG001|COMPLETED|Overall Study||14
9950935|NCT01409837|11069683|FG000|NOT COMPLETED|Overall Study||3
9950936|NCT01409837|11069684|FG001|NOT COMPLETED|Overall Study||2
9950937|NCT01409915|11069694|FG000|STARTED|Overall Study||21
9950938|NCT01409915|11069695|FG001|STARTED|Overall Study||23
9950939|NCT01409915|11069694|FG000|COMPLETED|Overall Study||20
9950940|NCT01409915|11069695|FG001|COMPLETED|Overall Study||20
9950941|NCT01409915|11069694|FG000|NOT COMPLETED|Overall Study||1
9950942|NCT01409915|11069695|FG001|NOT COMPLETED|Overall Study||3
9950943|NCT01409928|11069701|FG000|STARTED|Overall Study||16
9950944|NCT01409928|11069701|FG000|COMPLETED|Overall Study||4
9950945|NCT01409928|11069701|FG000|NOT COMPLETED|Overall Study||12
9950946|NCT01409993|11069707|FG000|STARTED|Overall Study||25
9950947|NCT01409993|11069708|FG001|STARTED|Overall Study||26
9950948|NCT01409993|11069709|FG002|STARTED|Overall Study||14
9950949|NCT01409993|11069710|FG003|STARTED|Overall Study||13
9950950|NCT01409993|11069707|FG000|COMPLETED|Overall Study||21
9950951|NCT01409993|11069708|FG001|COMPLETED|Overall Study||21
9950952|NCT01409993|11069709|FG002|COMPLETED|Overall Study||11
9950953|NCT01409993|11069710|FG003|COMPLETED|Overall Study||8
9950954|NCT01409993|11069707|FG000|NOT COMPLETED|Overall Study||4
9950955|NCT01409993|11069708|FG001|NOT COMPLETED|Overall Study||5
9950956|NCT01409993|11069709|FG002|NOT COMPLETED|Overall Study||3
9950957|NCT01409993|11069710|FG003|NOT COMPLETED|Overall Study||5
9950958|NCT01410058|11069726|FG000|STARTED|Washout Day 0||13
9950959|NCT01410058|11069727|FG001|STARTED|Washout Day 0||6
9950960|NCT01410058|11069726|FG000|COMPLETED|Washout Day 0||13
9950961|NCT01410058|11069727|FG001|COMPLETED|Washout Day 0||6
9950962|NCT01410058|11069726|FG000|NOT COMPLETED|Washout Day 0||0
9950963|NCT01410058|11069727|FG001|NOT COMPLETED|Washout Day 0||0
9950964|NCT01410058|11069726|FG000|STARTED|Baseline Day 22||13
9950965|NCT01410058|11069727|FG001|STARTED|Baseline Day 22||6
9950966|NCT01410058|11069726|FG000|COMPLETED|Baseline Day 22||13
9950967|NCT01410058|11069727|FG001|COMPLETED|Baseline Day 22||6
9950968|NCT01410058|11069726|FG000|NOT COMPLETED|Baseline Day 22||0
9950969|NCT01410058|11069727|FG001|NOT COMPLETED|Baseline Day 22||0
9950970|NCT01410058|11069726|FG000|STARTED|Day 35||13
9950971|NCT01410058|11069727|FG001|STARTED|Day 35||6
9950972|NCT01410058|11069726|FG000|COMPLETED|Day 35||13
9950973|NCT01410058|11069727|FG001|COMPLETED|Day 35||6
9950974|NCT01410058|11069726|FG000|NOT COMPLETED|Day 35||0
9950975|NCT01410058|11069727|FG001|NOT COMPLETED|Day 35||0
9950976|NCT01410084|11069737|FG000|STARTED|Overall Study||38
9950977|NCT01410084|11069738|FG001|STARTED|Overall Study||30
9950978|NCT01410084|11069737|FG000|COMPLETED|Overall Study||37
9950979|NCT01410084|11069738|FG001|COMPLETED|Overall Study||27
9950980|NCT01410084|11069737|FG000|NOT COMPLETED|Overall Study||1
9950981|NCT01410084|11069738|FG001|NOT COMPLETED|Overall Study||3
9950982|NCT01410097|11069746|FG000|STARTED|Overall Study||556
9950983|NCT01410097|11069747|FG001|STARTED|Overall Study||533
9950984|NCT01410097|11069746|FG000|COMPLETED|Overall Study||551
9950985|NCT01410097|11069747|FG001|COMPLETED|Overall Study||530
9950986|NCT01410097|11069746|FG000|NOT COMPLETED|Overall Study||5
9950987|NCT01410097|11069747|FG001|NOT COMPLETED|Overall Study||3
9950988|NCT01410110|11069755|FG000|STARTED|Overall Study||24
9950989|NCT01410110|11069756|FG001|STARTED|Overall Study||24
9950990|NCT01410110|11069755|FG000|Randomization|Overall Study||24
9950991|NCT01410110|11069756|FG001|Randomization|Overall Study||24
9950992|NCT01410110|11069755|FG000|3 Months (End of Intervention)|Overall Study||20
9950993|NCT01410110|11069756|FG001|3 Months (End of Intervention)|Overall Study||22
9950994|NCT01410110|11069755|FG000|6 Month Follow-up|Overall Study||20
9950995|NCT01410110|11069756|FG001|6 Month Follow-up|Overall Study||22
9950996|NCT01410110|11069755|FG000|COMPLETED|Overall Study||20
9950997|NCT01410110|11069756|FG001|COMPLETED|Overall Study||22
9950998|NCT01410110|11069755|FG000|NOT COMPLETED|Overall Study||4
9950999|NCT01410110|11069756|FG001|NOT COMPLETED|Overall Study||2
9951000|NCT01410227|11069762|FG000|STARTED|Overall Study||8
9951001|NCT01410227|11069763|FG001|STARTED|Overall Study||8
9951002|NCT01410227|11069764|FG002|STARTED|Overall Study||15
9951003|NCT01410227|11069765|FG003|STARTED|Overall Study||6
9951004|NCT01410227|11069762|FG000|COMPLETED|Overall Study||4
9951005|NCT01410227|11069763|FG001|COMPLETED|Overall Study||8
9951006|NCT01410227|11069764|FG002|COMPLETED|Overall Study||13
9951007|NCT01410227|11069765|FG003|COMPLETED|Overall Study||5
9951008|NCT01410227|11069762|FG000|NOT COMPLETED|Overall Study||4
9951009|NCT01410227|11069763|FG001|NOT COMPLETED|Overall Study||0
9951010|NCT01410227|11069764|FG002|NOT COMPLETED|Overall Study||2
9951011|NCT01410227|11069765|FG003|NOT COMPLETED|Overall Study||1
9951012|NCT01410240|11069778|FG000|STARTED|Overall Study||53
9951013|NCT01410240|11069779|FG001|STARTED|Overall Study||53
9951014|NCT01410240|11069780|FG002|STARTED|Overall Study||12
9951015|NCT01410240|11069778|FG000|COMPLETED|Overall Study||52
9951016|NCT01410240|11069779|FG001|COMPLETED|Overall Study||52
9951017|NCT01410240|11069780|FG002|COMPLETED|Overall Study||10
9951018|NCT01410240|11069778|FG000|NOT COMPLETED|Overall Study||1
9951019|NCT01410240|11069779|FG001|NOT COMPLETED|Overall Study||1
9951020|NCT01410240|11069780|FG002|NOT COMPLETED|Overall Study||2
9951021|NCT01410344|11069789|FG000|STARTED|Overall Study||20
9951022|NCT01410344|11069789|FG000|COMPLETED|Overall Study||17
9951023|NCT01410344|11069789|FG000|NOT COMPLETED|Overall Study||3
9951024|NCT01410357|11069797|FG000|STARTED|Overall Study||100
9951025|NCT01410357|11069798|FG001|STARTED|Overall Study||100
9951026|NCT01410357|11069797|FG000|COMPLETED|Overall Study||74
9951027|NCT01410357|11069798|FG001|COMPLETED|Overall Study||76
9951028|NCT01410357|11069797|FG000|NOT COMPLETED|Overall Study||26
9951029|NCT01410357|11069798|FG001|NOT COMPLETED|Overall Study||24
9951030|NCT01410409|11069808|FG000|STARTED|Overall Study||50
9951031|NCT01410409|11069809|FG001|STARTED|Overall Study||50
9951032|NCT01410409|11069808|FG000|COMPLETED|Overall Study||49
9951033|NCT01410409|11069809|FG001|COMPLETED|Overall Study||46
9951034|NCT01410409|11069808|FG000|NOT COMPLETED|Overall Study||1
9951035|NCT01410409|11069809|FG001|NOT COMPLETED|Overall Study||4
9951036|NCT01410448|11069817|FG000|STARTED|Overall Study||193
9951037|NCT01410448|11069818|FG001|STARTED|Overall Study||190
9951038|NCT01410448|11069817|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193
9951039|NCT01410448|11069818|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190
9951040|NCT01410448|11069817|FG000|Modified ITT Analysis Set|Overall Study||161
9951041|NCT01410448|11069818|FG001|Modified ITT Analysis Set|Overall Study||149
9951042|NCT01410448|11069817|FG000|COMPLETED|Overall Study||181
9951043|NCT01410448|11069818|FG001|COMPLETED|Overall Study||155
9951044|NCT01410448|11069817|FG000|NOT COMPLETED|Overall Study||12
9951045|NCT01410448|11069818|FG001|NOT COMPLETED|Overall Study||35
9951046|NCT01410474|11069826|FG000|STARTED|Overall Study||173
9951047|NCT01410474|11069827|FG001|STARTED|Overall Study||168
9951048|NCT01410474|11069826|FG000|COMPLETED|Overall Study||173
9951049|NCT01410474|11069827|FG001|COMPLETED|Overall Study||167
9951050|NCT01410474|11069826|FG000|NOT COMPLETED|Overall Study||0
9951051|NCT01410474|11069827|FG001|NOT COMPLETED|Overall Study||1
9951052|NCT01410552|11069840|FG000|STARTED|Overall Study||1013
9951053|NCT01410552|11069840|FG000|COMPLETED|Overall Study||877
9951054|NCT01410552|11069840|FG000|NOT COMPLETED|Overall Study||136
9951055|NCT01410565|11069846|FG000|STARTED|Open Label Phase Apaziquone||0
9951056|NCT01410565|11069847|FG001|STARTED|Open Label Phase Apaziquone||0
9951057|NCT01410565|11069848|FG002|STARTED|Open Label Phase Apaziquone||66
9951058|NCT01410565|11069846|FG000|COMPLETED|Open Label Phase Apaziquone||0
9951059|NCT01410565|11069847|FG001|COMPLETED|Open Label Phase Apaziquone||0
9951060|NCT01410565|11069848|FG002|COMPLETED|Open Label Phase Apaziquone||58
9951061|NCT01410565|11069846|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0
9951062|NCT01410565|11069847|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0
9951063|NCT01410565|11069848|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8
9951064|NCT01410565|11069846|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
9951065|NCT01410565|11069847|FG001|STARTED|Double Blind Phase||15
9951066|NCT01410565|11069848|FG002|STARTED|Double Blind Phase||0
9951067|NCT01410565|11069846|FG000|COMPLETED|Double Blind Phase||0
9951068|NCT01410565|11069847|FG001|COMPLETED|Double Blind Phase||0
9951069|NCT01410565|11069848|FG002|COMPLETED|Double Blind Phase||0
9951070|NCT01410565|11069846|FG000|NOT COMPLETED|Double Blind Phase||13
9951071|NCT01410565|11069847|FG001|NOT COMPLETED|Double Blind Phase||15
9951072|NCT01410565|11069848|FG002|NOT COMPLETED|Double Blind Phase||0
9951073|NCT01410604|11069856|FG000|STARTED|Overall Study||15
10209040|NCT03562481|11336161|FG001|COMPLETED|Washout||14
10209041|NCT03562481|11336160|FG000|NOT COMPLETED|Washout||0
10209042|NCT03562481|11336161|FG001|NOT COMPLETED|Washout||0
10209043|NCT03562481|11336160|FG000|STARTED|Second Intervention||11
10209044|NCT03562481|11336161|FG001|STARTED|Second Intervention||14
10209045|NCT03562481|11336160|FG000|COMPLETED|Second Intervention||11
10209046|NCT03562481|11336161|FG001|COMPLETED|Second Intervention||14
10209047|NCT03562481|11336160|FG000|NOT COMPLETED|Second Intervention||0
10209048|NCT03562481|11336161|FG001|NOT COMPLETED|Second Intervention||0
10209049|NCT03562559|11336171|FG000|STARTED|Overall Study||40
10209050|NCT03562559|11336171|FG000|COMPLETED|Overall Study||40
10209051|NCT03562559|11336171|FG000|NOT COMPLETED|Overall Study||0
10209052|NCT03562663|11336177|FG000|STARTED|Overall Study||41
10209053|NCT03562663|11336178|FG001|STARTED|Overall Study||41
10209054|NCT03562663|11336177|FG000|COMPLETED|Overall Study||34
10209055|NCT03562663|11336178|FG001|COMPLETED|Overall Study||35
9951074|NCT01410604|11069857|FG001|STARTED|Overall Study||16
9951075|NCT01410604|11069856|FG000|COMPLETED|Overall Study||12
9951076|NCT01410604|11069857|FG001|COMPLETED|Overall Study||14
9951077|NCT01410604|11069856|FG000|NOT COMPLETED|Overall Study||3
9951078|NCT01410604|11069857|FG001|NOT COMPLETED|Overall Study||2
9951079|NCT01410773|11069863|FG000|STARTED|Overall Study||110
9951080|NCT01410773|11069863|FG000|COMPLETED|Overall Study||110
9951081|NCT01410773|11069863|FG000|NOT COMPLETED|Overall Study||0
9951082|NCT01410812|11069870|FG000|STARTED|Overall Study||75
9951083|NCT01410812|11069871|FG001|STARTED|Overall Study||75
9951084|NCT01410812|11069872|FG002|STARTED|Overall Study||76
9951085|NCT01410812|11069870|FG000|COMPLETED|Overall Study||75
9951086|NCT01410812|11069871|FG001|COMPLETED|Overall Study||75
10209056|NCT03562663|11336177|FG000|NOT COMPLETED|Overall Study||7
9951087|NCT01410812|11069872|FG002|COMPLETED|Overall Study||76
9951088|NCT01410812|11069870|FG000|NOT COMPLETED|Overall Study||0
9951089|NCT01410812|11069871|FG001|NOT COMPLETED|Overall Study||0
9951090|NCT01410812|11069872|FG002|NOT COMPLETED|Overall Study||0
9951091|NCT01411085|11069880|FG000|STARTED|Overall Study||10
9951092|NCT01411085|11069880|FG000|COMPLETED|Overall Study||7
9951093|NCT01411085|11069880|FG000|NOT COMPLETED|Overall Study||3
9951094|NCT01411137|11069884|FG000|STARTED|Part 1: Dose Conversion||43
9951095|NCT01411137|11069884|FG000|COMPLETED|Part 1: Dose Conversion||33
9951096|NCT01411137|11069884|FG000|NOT COMPLETED|Part 1: Dose Conversion||10
9951097|NCT01411137|11069884|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
9951098|NCT01411137|11069884|FG000|COMPLETED|Part 2: Open-Label Extension||25
9951099|NCT01411137|11069884|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7
9951100|NCT01411137|11069884|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
9951101|NCT01411137|11069884|FG000|COMPLETED|Part 3: Open-Label Extension||12
9951102|NCT01411137|11069884|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0
9951103|NCT01411215|11069901|FG000|STARTED|Overall Study||69
9951104|NCT01411215|11069902|FG001|STARTED|Overall Study||91
9951105|NCT01411215|11069901|FG000|Treated|Overall Study||69
9951106|NCT01411215|11069902|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
9951107|NCT01411215|11069901|FG000|COMPLETED|Overall Study||3
9951108|NCT01411215|11069902|FG001|COMPLETED|Overall Study||7
9951109|NCT01411215|11069901|FG000|NOT COMPLETED|Overall Study||66
9951110|NCT01411215|11069902|FG001|NOT COMPLETED|Overall Study||84
9951111|NCT01411228|11069911|FG000|STARTED|Overall Study||5
9951112|NCT01411228|11069912|FG001|STARTED|Overall Study||5
9951113|NCT01411228|11069913|FG002|STARTED|Overall Study||5
9951114|NCT01411228|11069911|FG000|COMPLETED|Overall Study||4
9951115|NCT01411228|11069912|FG001|COMPLETED|Overall Study||5
9951116|NCT01411228|11069913|FG002|COMPLETED|Overall Study||4
9951117|NCT01411228|11069911|FG000|NOT COMPLETED|Overall Study||1
9951118|NCT01411228|11069912|FG001|NOT COMPLETED|Overall Study||0
9951119|NCT01411228|11069913|FG002|NOT COMPLETED|Overall Study||1
9951120|NCT01411319|11069921|FG000|STARTED|Overall Study||25
9951121|NCT01411319|11069921|FG000|COMPLETED|Overall Study||24
9951122|NCT01411319|11069921|FG000|NOT COMPLETED|Overall Study||1
9951123|NCT01411488|11069927|FG000|STARTED|Overall Study||41
9951124|NCT01411488|11069928|FG001|STARTED|Overall Study||38
9951125|NCT01411488|11069927|FG000|COMPLETED|Overall Study||41
9951126|NCT01411488|11069928|FG001|COMPLETED|Overall Study||38
9951127|NCT01411488|11069927|FG000|NOT COMPLETED|Overall Study||0
9951128|NCT01411488|11069928|FG001|NOT COMPLETED|Overall Study||0
9951129|NCT01411501|11069938|FG000|STARTED|Overall Study||168
9951130|NCT01411501|11069939|FG001|STARTED|Overall Study||172
9951131|NCT01411501|11069940|FG002|STARTED|Overall Study||165
9951132|NCT01411501|11069941|FG003|STARTED|Overall Study||170
9951133|NCT01411501|11069938|FG000|COMPLETED|Overall Study||158
10209057|NCT03562663|11336178|FG001|NOT COMPLETED|Overall Study||6
10209058|NCT03562988|11336184|FG000|STARTED|Overall Study||17
10209059|NCT03562988|11336185|FG001|STARTED|Overall Study||18
10209060|NCT03562988|11336184|FG000|COMPLETED|Overall Study||15
10209061|NCT03562988|11336185|FG001|COMPLETED|Overall Study||15
10209062|NCT03562988|11336184|FG000|NOT COMPLETED|Overall Study||2
10209063|NCT03562988|11336185|FG001|NOT COMPLETED|Overall Study||3
10209064|NCT03563027|11336198|FG000|STARTED|Overall Study||60
10209065|NCT03563027|11336199|FG001|STARTED|Overall Study||60
10209066|NCT03563027|11336200|FG002|STARTED|Overall Study||60
10209067|NCT03563027|11336198|FG000|COMPLETED|Overall Study||60
10209068|NCT03563027|11336199|FG001|COMPLETED|Overall Study||60
10209069|NCT03563027|11336200|FG002|COMPLETED|Overall Study||58
10209070|NCT03563027|11336198|FG000|NOT COMPLETED|Overall Study||0
10209071|NCT03563027|11336199|FG001|NOT COMPLETED|Overall Study||0
10209072|NCT03563027|11336200|FG002|NOT COMPLETED|Overall Study||2
10209073|NCT03563183|11336208|FG000|STARTED|Overall Study||26976
10209074|NCT03563183|11336208|FG000|COMPLETED|Overall Study||26976
10209075|NCT03563183|11336208|FG000|NOT COMPLETED|Overall Study||0
10209076|NCT03563209|11336227|FG000|STARTED|Overall Study||60
9951134|NCT01411501|11069939|FG001|COMPLETED|Overall Study||166
9951135|NCT01411501|11069940|FG002|COMPLETED|Overall Study||159
9951136|NCT01411501|11069941|FG003|COMPLETED|Overall Study||163
9951137|NCT01411501|11069938|FG000|NOT COMPLETED|Overall Study||10
9951138|NCT01411501|11069939|FG001|NOT COMPLETED|Overall Study||6
9951139|NCT01411501|11069940|FG002|NOT COMPLETED|Overall Study||6
9951140|NCT01411501|11069941|FG003|NOT COMPLETED|Overall Study||7
9951141|NCT01411527|11069953|FG000|STARTED|Overall Study||1864
9951142|NCT01411527|11069954|FG001|STARTED|Overall Study||93
9951143|NCT01411527|11069953|FG000|COMPLETED|Overall Study||1864
9951144|NCT01411527|11069954|FG001|COMPLETED|Overall Study||93
9951145|NCT01411527|11069953|FG000|NOT COMPLETED|Overall Study||0
9951146|NCT01411527|11069954|FG001|NOT COMPLETED|Overall Study||0
9951147|NCT01411592|11069961|FG000|STARTED|Overall Study||14
9951148|NCT01411592|11069962|FG001|STARTED|Overall Study||16
9951149|NCT01411592|11069961|FG000|5-Year Time Frame|Overall Study||14
9951150|NCT01411592|11069962|FG001|5-Year Time Frame|Overall Study||16
9951151|NCT01411592|11069961|FG000|COMPLETED|Overall Study||14
9951152|NCT01411592|11069962|FG001|COMPLETED|Overall Study||16
9951153|NCT01411592|11069961|FG000|NOT COMPLETED|Overall Study||0
9951154|NCT01411592|11069962|FG001|NOT COMPLETED|Overall Study||0
10209077|NCT03563209|11336227|FG000|COMPLETED|Overall Study||60
9951155|NCT01411696|11069968|FG000|STARTED|Overall Study||289
9951156|NCT01411696|11069968|FG000|COMPLETED|Overall Study||289
9951157|NCT01411696|11069968|FG000|NOT COMPLETED|Overall Study||0
9951158|NCT01411774|11069974|FG000|STARTED|Overall Study||72
9951159|NCT01411774|11069975|FG001|STARTED|Overall Study||70
9951160|NCT01411774|11069974|FG000|COMPLETED|Overall Study||72
9951161|NCT01411774|11069975|FG001|COMPLETED|Overall Study||67
9951162|NCT01411774|11069974|FG000|NOT COMPLETED|Overall Study||0
9951163|NCT01411774|11069975|FG001|NOT COMPLETED|Overall Study||3
9951164|NCT01411839|11069983|FG000|STARTED|Overall Study||20
9951165|NCT01411839|11069984|FG001|STARTED|Overall Study||20
9951166|NCT01411839|11069983|FG000|COMPLETED|Overall Study||16
9951167|NCT01411839|11069984|FG001|COMPLETED|Overall Study||17
9951168|NCT01411839|11069983|FG000|NOT COMPLETED|Overall Study||4
9951169|NCT01411839|11069984|FG001|NOT COMPLETED|Overall Study||3
9951170|NCT01411852|11069992|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
9951171|NCT01411852|11069993|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
9951172|NCT01411852|11069992|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
9951173|NCT01411852|11069993|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
9951174|NCT01411852|11069992|FG000|NOT COMPLETED|Prehospital Intervention Phase||12
9951175|NCT01411852|11069993|FG001|NOT COMPLETED|Prehospital Intervention Phase||7
9951176|NCT01411852|11069992|FG000|STARTED|Hospital Intervention Phase||83
9951177|NCT01411852|11069993|FG001|STARTED|Hospital Intervention Phase||89
9951178|NCT01411852|11069992|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
9951179|NCT01411852|11069993|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
9951180|NCT01411852|11069992|FG000|NOT COMPLETED|Hospital Intervention Phase||24
9951181|NCT01411852|11069993|FG001|NOT COMPLETED|Hospital Intervention Phase||18
9951182|NCT01411891|11070003|FG000|STARTED|Overall Study||50
9951183|NCT01411891|11070004|FG001|STARTED|Overall Study||50
9951184|NCT01411891|11070003|FG000|COMPLETED|Overall Study||47
9951185|NCT01411891|11070004|FG001|COMPLETED|Overall Study||48
9951186|NCT01411891|11070003|FG000|NOT COMPLETED|Overall Study||3
9951187|NCT01411891|11070004|FG001|NOT COMPLETED|Overall Study||2
9951188|NCT01411917|11070012|FG000|STARTED|Overall Study||32
9951189|NCT01411917|11070013|FG001|STARTED|Overall Study||37
9951190|NCT01411917|11070012|FG000|COMPLETED|Overall Study||32
9951191|NCT01411917|11070013|FG001|COMPLETED|Overall Study||36
9951192|NCT01411917|11070012|FG000|NOT COMPLETED|Overall Study||0
9951193|NCT01411917|11070013|FG001|NOT COMPLETED|Overall Study||1
9951194|NCT01411995|11070021|FG000|STARTED|Overall Study||100
9951195|NCT01411995|11070022|FG001|STARTED|Overall Study||100
9951196|NCT01411995|11070021|FG000|COMPLETED|Overall Study||100
9951197|NCT01411995|11070022|FG001|COMPLETED|Overall Study||99
9951198|NCT01411995|11070021|FG000|NOT COMPLETED|Overall Study||0
9951199|NCT01411995|11070022|FG001|NOT COMPLETED|Overall Study||1
9951200|NCT01412021|11070028|FG000|STARTED|Overall Study||375
9951201|NCT01412021|11070028|FG000|Case Report Forms Locked|Overall Study||368
9951202|NCT01412021|11070028|FG000|COMPLETED|Overall Study||356
9951203|NCT01412021|11070028|FG000|NOT COMPLETED|Overall Study||19
9951204|NCT01412060|11070032|FG000|STARTED|Open-label Run-in Period (RIP)||765
9951205|NCT01412060|11070033|FG001|STARTED|Open-label Run-in Period (RIP)||0
9951206|NCT01412060|11070034|FG002|STARTED|Open-label Run-in Period (RIP)||0
9951207|NCT01412060|11070032|FG000|COMPLETED|Open-label Run-in Period (RIP)||418
9951208|NCT01412060|11070033|FG001|COMPLETED|Open-label Run-in Period (RIP)||0
9951209|NCT01412060|11070034|FG002|COMPLETED|Open-label Run-in Period (RIP)||0
9951210|NCT01412060|11070032|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347
9951211|NCT01412060|11070033|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0
9951212|NCT01412060|11070034|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0
9951213|NCT01412060|11070032|FG000|STARTED|Period Between RIP and SP||418
9951214|NCT01412060|11070033|FG001|STARTED|Period Between RIP and SP||0
9951215|NCT01412060|11070034|FG002|STARTED|Period Between RIP and SP||0
9951216|NCT01412060|11070032|FG000|COMPLETED|Period Between RIP and SP||364
9951217|NCT01412060|11070033|FG001|COMPLETED|Period Between RIP and SP||0
9951218|NCT01412060|11070034|FG002|COMPLETED|Period Between RIP and SP||0
9951219|NCT01412060|11070032|FG000|NOT COMPLETED|Period Between RIP and SP||54
9951220|NCT01412060|11070033|FG001|NOT COMPLETED|Period Between RIP and SP||0
9951221|NCT01412060|11070034|FG002|NOT COMPLETED|Period Between RIP and SP||0
9951222|NCT01412060|11070032|FG000|STARTED|Open-label Stabilization Period (SP)||364
9951223|NCT01412060|11070033|FG001|STARTED|Open-label Stabilization Period (SP)||0
9951224|NCT01412060|11070034|FG002|STARTED|Open-label Stabilization Period (SP)||0
9951225|NCT01412060|11070032|FG000|COMPLETED|Open-label Stabilization Period (SP)||264
9951226|NCT01412060|11070033|FG001|COMPLETED|Open-label Stabilization Period (SP)||0
9951227|NCT01412060|11070034|FG002|COMPLETED|Open-label Stabilization Period (SP)||0
9951228|NCT01412060|11070032|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100
9951229|NCT01412060|11070033|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0
9951230|NCT01412060|11070034|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0
9951231|NCT01412060|11070032|FG000|STARTED|Period Between SP and DBP||264
9951232|NCT01412060|11070033|FG001|STARTED|Period Between SP and DBP||0
9951233|NCT01412060|11070034|FG002|STARTED|Period Between SP and DBP||0
9951234|NCT01412060|11070032|FG000|COMPLETED|Period Between SP and DBP||200
9951235|NCT01412060|11070033|FG001|COMPLETED|Period Between SP and DBP||0
9951236|NCT01412060|11070034|FG002|COMPLETED|Period Between SP and DBP||0
9951237|NCT01412060|11070032|FG000|NOT COMPLETED|Period Between SP and DBP||64
9951238|NCT01412060|11070033|FG001|NOT COMPLETED|Period Between SP and DBP||0
9951239|NCT01412060|11070034|FG002|NOT COMPLETED|Period Between SP and DBP||0
9951240|NCT01412060|11070032|FG000|STARTED|Double-blind Treatment Phase (DBP)||0
9951241|NCT01412060|11070033|FG001|STARTED|Double-blind Treatment Phase (DBP)||99
9951242|NCT01412060|11070034|FG002|STARTED|Double-blind Treatment Phase (DBP)||101
9951243|NCT01412060|11070032|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0
9951244|NCT01412060|11070033|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16
9951245|NCT01412060|11070034|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18
9951246|NCT01412060|11070032|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
9951247|NCT01412060|11070033|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
9951248|NCT01412060|11070034|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
9951249|NCT01412086|11070044|FG000|STARTED|Overall Study||112
9951250|NCT01412086|11070044|FG000|COMPLETED|Overall Study||112
9951251|NCT01412086|11070044|FG000|NOT COMPLETED|Overall Study||0
9951252|NCT01412151|11070048|FG000|STARTED|Week 0 - 306 - Treatment Period||10
9951253|NCT01412151|11070048|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5
9951254|NCT01412151|11070048|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
9951255|NCT01412151|11070048|FG000|STARTED|Week 306 - 310 - Washout Period||5
9951256|NCT01412151|11070048|FG000|COMPLETED|Week 306 - 310 - Washout Period||3
9951257|NCT01412151|11070048|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2
9951258|NCT01412164|11070054|FG000|STARTED|Overall Study||730
9951259|NCT01412164|11070054|FG000|COMPLETED|Overall Study||683
9951260|NCT01412164|11070054|FG000|NOT COMPLETED|Overall Study||47
9951261|NCT01412229|11070058|FG000|STARTED|Overall Study||39
9951262|NCT01412229|11070058|FG000|COMPLETED|Overall Study||38
9951263|NCT01412229|11070058|FG000|NOT COMPLETED|Overall Study||1
9951264|NCT01412281|11070067|FG000|STARTED|Overall Study||110
9951265|NCT01412281|11070068|FG001|STARTED|Overall Study||110
9951266|NCT01412281|11070069|FG002|STARTED|Overall Study||110
9951267|NCT01412281|11070070|FG003|STARTED|Overall Study||110
9951268|NCT01412281|11070067|FG000|COMPLETED|Overall Study||110
9951269|NCT01412281|11070068|FG001|COMPLETED|Overall Study||110
9951270|NCT01412281|11070069|FG002|COMPLETED|Overall Study||110
9951271|NCT01412281|11070070|FG003|COMPLETED|Overall Study||110
9951272|NCT01412281|11070067|FG000|NOT COMPLETED|Overall Study||0
9951273|NCT01412281|11070068|FG001|NOT COMPLETED|Overall Study||0
9951274|NCT01412281|11070069|FG002|NOT COMPLETED|Overall Study||0
9951275|NCT01412281|11070070|FG003|NOT COMPLETED|Overall Study||0
9951276|NCT01412372|11070082|FG000|STARTED|Overall Study||30
9951277|NCT01412372|11070083|FG001|STARTED|Overall Study||31
9951278|NCT01412372|11070082|FG000|COMPLETED|Overall Study||26
9951279|NCT01412372|11070083|FG001|COMPLETED|Overall Study||28
9951280|NCT01412372|11070082|FG000|NOT COMPLETED|Overall Study||4
9951281|NCT01412372|11070083|FG001|NOT COMPLETED|Overall Study||3
9951282|NCT01412424|11070089|FG000|STARTED|Core Treatment Period||155
9951283|NCT01412424|11070089|FG000|COMPLETED|Core Treatment Period||102
9951284|NCT01412424|11070089|FG000|NOT COMPLETED|Core Treatment Period||53
9951285|NCT01412424|11070089|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
9951286|NCT01412424|11070089|FG000|COMPLETED|Extension Treatment Period||82
9951287|NCT01412424|11070089|FG000|NOT COMPLETED|Extension Treatment Period||6
9951288|NCT01412541|11070101|FG000|STARTED|Overall Study||372
9951289|NCT01412541|11070102|FG001|STARTED|Overall Study||160
9951290|NCT01412541|11070101|FG000|COMPLETED|Overall Study||246
9951291|NCT01412541|11070102|FG001|COMPLETED|Overall Study||117
9951292|NCT01412541|11070101|FG000|NOT COMPLETED|Overall Study||126
9951293|NCT01412541|11070102|FG001|NOT COMPLETED|Overall Study||43
9951294|NCT01412554|11070111|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
9951295|NCT01412554|11070111|FG000|COMPLETED|Overall Study||103
9951296|NCT01412554|11070111|FG000|NOT COMPLETED|Overall Study||0
9951297|NCT01412710|11070117|FG000|STARTED|Overall Study||50
9951298|NCT01412710|11070118|FG001|STARTED|Overall Study||27
9951299|NCT01412710|11070117|FG000|COMPLETED|Overall Study||46
9951300|NCT01412710|11070118|FG001|COMPLETED|Overall Study||22
9951301|NCT01412710|11070117|FG000|NOT COMPLETED|Overall Study||4
9951302|NCT01412710|11070118|FG001|NOT COMPLETED|Overall Study||5
9951303|NCT01412801|11070130|FG000|STARTED|Overall Study||91
9951304|NCT01412801|11070131|FG001|STARTED|Overall Study||89
9951305|NCT01412801|11070132|FG002|STARTED|Overall Study||90
9951306|NCT01412801|11070133|FG003|STARTED|Overall Study||91
9951307|NCT01412801|11070134|FG004|STARTED|Overall Study||88
9951308|NCT01412801|11070135|FG005|STARTED|Overall Study||87
9951309|NCT01412801|11070130|FG000|COMPLETED|Overall Study||87
9951310|NCT01412801|11070131|FG001|COMPLETED|Overall Study||84
9951311|NCT01412801|11070132|FG002|COMPLETED|Overall Study||83
9951312|NCT01412801|11070133|FG003|COMPLETED|Overall Study||87
9951313|NCT01412801|11070134|FG004|COMPLETED|Overall Study||85
9951314|NCT01412801|11070135|FG005|COMPLETED|Overall Study||84
9951315|NCT01412801|11070130|FG000|NOT COMPLETED|Overall Study||4
9951316|NCT01412801|11070131|FG001|NOT COMPLETED|Overall Study||5
9951317|NCT01412801|11070132|FG002|NOT COMPLETED|Overall Study||7
9951318|NCT01412801|11070133|FG003|NOT COMPLETED|Overall Study||4
9951319|NCT01412801|11070134|FG004|NOT COMPLETED|Overall Study||3
9951320|NCT01412801|11070135|FG005|NOT COMPLETED|Overall Study||3
9951321|NCT01412866|11070160|FG000|STARTED|Overall Study||58
9951322|NCT01412866|11070161|FG001|STARTED|Overall Study||66
9951323|NCT01412866|11070160|FG000|COMPLETED|Overall Study||57
9951324|NCT01412866|11070161|FG001|COMPLETED|Overall Study||64
9951325|NCT01412866|11070160|FG000|NOT COMPLETED|Overall Study||1
9951326|NCT01412866|11070161|FG001|NOT COMPLETED|Overall Study||2
9951327|NCT01412879|11070169|FG000|STARTED|Initial Registration (Induction Therapy)||18
9951328|NCT01412879|11070170|FG001|STARTED|Initial Registration (Induction Therapy)||35
9951329|NCT01412879|11070171|FG002|STARTED|Initial Registration (Induction Therapy)||0
9951330|NCT01412879|11070169|FG000|Treatment Started|Initial Registration (Induction Therapy)||17
9951331|NCT01412879|11070170|FG001|Treatment Started|Initial Registration (Induction Therapy)||35
9951332|NCT01412879|11070171|FG002|Treatment Started|Initial Registration (Induction Therapy)||0
9951333|NCT01412879|11070169|FG000|COMPLETED|Initial Registration (Induction Therapy)||5
9951334|NCT01412879|11070170|FG001|COMPLETED|Initial Registration (Induction Therapy)||27
9951335|NCT01412879|11070171|FG002|COMPLETED|Initial Registration (Induction Therapy)||0
9951336|NCT01412879|11070169|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13
9951337|NCT01412879|11070170|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8
9951338|NCT01412879|11070171|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0
9951339|NCT01412879|11070169|FG000|STARTED|Consolidation Therapy||0
9951340|NCT01412879|11070170|FG001|STARTED|Consolidation Therapy||0
9951341|NCT01412879|11070171|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
9951342|NCT01412879|11070169|FG000|COMPLETED|Consolidation Therapy||0
9951343|NCT01412879|11070170|FG001|COMPLETED|Consolidation Therapy||0
9951344|NCT01412879|11070171|FG002|COMPLETED|Consolidation Therapy||26
9951345|NCT01412879|11070169|FG000|NOT COMPLETED|Consolidation Therapy||0
9951346|NCT01412879|11070170|FG001|NOT COMPLETED|Consolidation Therapy||0
9951347|NCT01412879|11070171|FG002|NOT COMPLETED|Consolidation Therapy||0
9956916|NCT01448824|11076141|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0
9956917|NCT01448824|11076142|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0
9956918|NCT01448824|11076143|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0
9956919|NCT01448824|11076144|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0
9956920|NCT01448824|11076145|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0
9956921|NCT01448824|11076146|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0
9956922|NCT01448824|11076147|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12
9956923|NCT01448824|11076140|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
9956924|NCT01448824|11076141|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
9956925|NCT01448824|11076142|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
9956926|NCT01448824|11076143|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
9956927|NCT01448824|11076144|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
9956928|NCT01448824|11076145|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
9956929|NCT01448824|11076146|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
9956930|NCT01448824|11076147|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
9956931|NCT01448824|11076140|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956932|NCT01448824|11076141|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956933|NCT01448824|11076142|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956934|NCT01448824|11076143|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956935|NCT01448824|11076144|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956936|NCT01448824|11076145|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956937|NCT01448824|11076146|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956938|NCT01448824|11076147|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
9956939|NCT01448824|11076140|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956940|NCT01448824|11076141|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956941|NCT01448824|11076142|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956942|NCT01448824|11076143|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956943|NCT01448824|11076144|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956944|NCT01448824|11076145|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956945|NCT01448824|11076146|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
9956946|NCT01448824|11076147|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
9956947|NCT01448824|11076140|FG000|STARTED|Part 2: Washout Period||0
9956948|NCT01448824|11076141|FG001|STARTED|Part 2: Washout Period||0
9956949|NCT01448824|11076142|FG002|STARTED|Part 2: Washout Period||0
9956950|NCT01448824|11076143|FG003|STARTED|Part 2: Washout Period||0
10209078|NCT03563209|11336227|FG000|NOT COMPLETED|Overall Study||0
10209079|NCT03563313|11336235|FG000|STARTED|Overall Study||112
10209080|NCT03563313|11336236|FG001|STARTED|Overall Study||56
10209081|NCT03563313|11336235|FG000|COMPLETED|Overall Study||112
10209082|NCT03563313|11336236|FG001|COMPLETED|Overall Study||56
10209083|NCT03563313|11336235|FG000|NOT COMPLETED|Overall Study||0
10209084|NCT03563313|11336236|FG001|NOT COMPLETED|Overall Study||0
10209085|NCT03564444|11336250|FG000|STARTED|Overall Study||60
10209086|NCT03564444|11336251|FG001|STARTED|Overall Study||240
10209087|NCT03564444|11336250|FG000|COMPLETED|Overall Study||60
10209088|NCT03564444|11336251|FG001|COMPLETED|Overall Study||240
10209089|NCT03564444|11336250|FG000|NOT COMPLETED|Overall Study||0
9951348|NCT01412918|11070183|FG000|STARTED|Overall Study||20
9951349|NCT01412918|11070184|FG001|STARTED|Overall Study||1
9951350|NCT01412918|11070183|FG000|COMPLETED|Overall Study||20
9951351|NCT01412918|11070184|FG001|COMPLETED|Overall Study||1
9951352|NCT01412918|11070183|FG000|NOT COMPLETED|Overall Study||0
9951353|NCT01412918|11070184|FG001|NOT COMPLETED|Overall Study||0
9951354|NCT01412944|11070193|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
9951355|NCT01412944|11070194|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
9951356|NCT01412944|11070195|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
9951357|NCT01412944|11070196|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
10111713|NCT02497976|11242709|FG001|STARTED|Overall Study||14
10111714|NCT02497976|11242708|FG000|COMPLETED|Overall Study||26
10111715|NCT02497976|11242709|FG001|COMPLETED|Overall Study||13
10111716|NCT02497976|11242708|FG000|NOT COMPLETED|Overall Study||2
10111717|NCT02497976|11242709|FG001|NOT COMPLETED|Overall Study||1
10111718|NCT02498067|11242715|FG000|STARTED|Overall Study||104
10111719|NCT02498067|11242715|FG000|COMPLETED|Overall Study||71
10111720|NCT02498067|11242715|FG000|NOT COMPLETED|Overall Study||33
10111721|NCT02498236|11242729|FG000|STARTED|Overall Study||6
10111722|NCT02498236|11242730|FG001|STARTED|Overall Study||6
10111723|NCT02498236|11242731|FG002|STARTED|Overall Study||6
10111724|NCT02498236|11242732|FG003|STARTED|Overall Study||6
10111725|NCT02498236|11242733|FG004|STARTED|Overall Study||7
10209090|NCT03564444|11336251|FG001|NOT COMPLETED|Overall Study||0
10209091|NCT03564886|11336259|FG000|STARTED|Overall Study||24
9951358|NCT01412944|11070197|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
9951359|NCT01412944|11070198|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
9951360|NCT01412944|11070193|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
9951361|NCT01412944|11070194|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
9951362|NCT01412944|11070195|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
9951363|NCT01412944|11070196|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
9951364|NCT01412944|11070197|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
9951365|NCT01412944|11070198|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
9951366|NCT01412944|11070193|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
9951367|NCT01412944|11070194|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
9951368|NCT01412944|11070195|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
9951369|NCT01412944|11070196|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
9951370|NCT01412944|11070197|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
9951371|NCT01412944|11070198|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
9951372|NCT01412944|11070193|FG000|STARTED|IV: Per CAIN457A2307||21
9951373|NCT01412944|11070194|FG001|STARTED|IV: Per CAIN457A2307||22
9951374|NCT01412944|11070195|FG002|STARTED|IV: Per CAIN457A2307||0
9951375|NCT01412944|11070196|FG003|STARTED|IV: Per CAIN457A2307||0
9951376|NCT01412944|11070197|FG004|STARTED|IV: Per CAIN457A2307||0
10209092|NCT03564886|11336260|FG001|STARTED|Overall Study||24
10209093|NCT03564886|11336259|FG000|COMPLETED|Overall Study||23
10209094|NCT03564886|11336260|FG001|COMPLETED|Overall Study||23
10209095|NCT03564886|11336259|FG000|NOT COMPLETED|Overall Study||1
10209096|NCT03564886|11336260|FG001|NOT COMPLETED|Overall Study||1
10209097|NCT03565068|11336275|FG000|STARTED|Overall Study||12
10209098|NCT03565068|11336276|FG001|STARTED|Overall Study||4
10209099|NCT03565068|11336277|FG002|STARTED|Overall Study||12
10209100|NCT03565068|11336278|FG003|STARTED|Overall Study||4
10209101|NCT03565068|11336279|FG004|STARTED|Overall Study||12
10209102|NCT03565068|11336280|FG005|STARTED|Overall Study||1
10209103|NCT03565068|11336281|FG006|STARTED|Overall Study||4
10209104|NCT03565068|11336282|FG007|STARTED|Overall Study||17
10209105|NCT03565068|11336283|FG008|STARTED|Overall Study||9
10209106|NCT03565068|11336275|FG000|COMPLETED|Overall Study||12
10209107|NCT03565068|11336276|FG001|COMPLETED|Overall Study||4
10209108|NCT03565068|11336277|FG002|COMPLETED|Overall Study||11
10209109|NCT03565068|11336278|FG003|COMPLETED|Overall Study||4
10209110|NCT03565068|11336279|FG004|COMPLETED|Overall Study||8
10209111|NCT03565068|11336280|FG005|COMPLETED|Overall Study||0
10209112|NCT03565068|11336281|FG006|COMPLETED|Overall Study||3
10209113|NCT03565068|11336282|FG007|COMPLETED|Overall Study||9
10209114|NCT03565068|11336283|FG008|COMPLETED|Overall Study||8
10209115|NCT03565068|11336275|FG000|NOT COMPLETED|Overall Study||0
10209116|NCT03565068|11336276|FG001|NOT COMPLETED|Overall Study||0
10209117|NCT03565068|11336277|FG002|NOT COMPLETED|Overall Study||1
10209118|NCT03565068|11336278|FG003|NOT COMPLETED|Overall Study||0
10209119|NCT03565068|11336279|FG004|NOT COMPLETED|Overall Study||4
10209120|NCT03565068|11336280|FG005|NOT COMPLETED|Overall Study||1
9951377|NCT01412944|11070198|FG005|STARTED|IV: Per CAIN457A2307||0
10209121|NCT03565068|11336281|FG006|NOT COMPLETED|Overall Study||1
10209122|NCT03565068|11336282|FG007|NOT COMPLETED|Overall Study||8
10209123|NCT03565068|11336283|FG008|NOT COMPLETED|Overall Study||1
10209124|NCT03565211|11336340|FG000|STARTED|Overall Study||254
10209125|NCT03565211|11336340|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
10209126|NCT03565211|11336340|FG000|COMPLETED|Overall Study||206
10209127|NCT03565211|11336340|FG000|NOT COMPLETED|Overall Study||48
10209128|NCT03565315|11336348|FG000|STARTED|Overall Study||3
10209129|NCT03565315|11336349|FG001|STARTED|Overall Study||3
10209130|NCT03565315|11336350|FG002|STARTED|Overall Study||1
10111726|NCT02498236|11242734|FG005|STARTED|Overall Study||6
10209131|NCT03565315|11336351|FG003|STARTED|Overall Study||2
9951378|NCT01412944|11070193|FG000|COMPLETED|IV: Per CAIN457A2307||20
9951379|NCT01412944|11070194|FG001|COMPLETED|IV: Per CAIN457A2307||20
9951380|NCT01412944|11070195|FG002|COMPLETED|IV: Per CAIN457A2307||0
9951381|NCT01412944|11070196|FG003|COMPLETED|IV: Per CAIN457A2307||0
9951382|NCT01412944|11070197|FG004|COMPLETED|IV: Per CAIN457A2307||0
9951383|NCT01412944|11070198|FG005|COMPLETED|IV: Per CAIN457A2307||0
9951384|NCT01412944|11070193|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1
9951385|NCT01412944|11070194|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2
9951386|NCT01412944|11070195|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0
9951387|NCT01412944|11070196|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0
10209132|NCT03565315|11336348|FG000|Product Administration Completed|Overall Study||3
10209133|NCT03565315|11336349|FG001|Product Administration Completed|Overall Study||0
10209134|NCT03565315|11336350|FG002|Product Administration Completed|Overall Study||1
10209135|NCT03565315|11336351|FG003|Product Administration Completed|Overall Study||0
10209136|NCT03565315|11336348|FG000|Discontinued Product Administrations|Overall Study||0
10209137|NCT03565315|11336349|FG001|Discontinued Product Administrations|Overall Study||3
10011811|NCT01782495|11134588|FG002|STARTED|Overall Study||13
10011812|NCT01782495|11134589|FG003|STARTED|Overall Study||4
10011813|NCT01782495|11134590|FG004|STARTED|Overall Study||2
10209138|NCT03565315|11336350|FG002|Discontinued Product Administrations|Overall Study||0
10209139|NCT03565315|11336351|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
10209140|NCT03565315|11336348|FG000|COMPLETED|Overall Study||3
9951388|NCT01412944|11070197|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0
9951389|NCT01412944|11070198|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0
9951390|NCT01412944|11070193|FG000|STARTED|Entire: IV + Maintenance||0
9951391|NCT01412944|11070194|FG001|STARTED|Entire: IV + Maintenance||0
9951392|NCT01412944|11070195|FG002|STARTED|Entire: IV + Maintenance||15
9951393|NCT01412944|11070196|FG003|STARTED|Entire: IV + Maintenance||6
9951394|NCT01412944|11070197|FG004|STARTED|Entire: IV + Maintenance||14
9951395|NCT01412944|11070198|FG005|STARTED|Entire: IV + Maintenance||8
9951396|NCT01412944|11070193|FG000|COMPLETED|Entire: IV + Maintenance||0
9951397|NCT01412944|11070194|FG001|COMPLETED|Entire: IV + Maintenance||0
9951398|NCT01412944|11070195|FG002|COMPLETED|Entire: IV + Maintenance||14
9951399|NCT01412944|11070196|FG003|COMPLETED|Entire: IV + Maintenance||5
9951400|NCT01412944|11070197|FG004|COMPLETED|Entire: IV + Maintenance||11
9951401|NCT01412944|11070198|FG005|COMPLETED|Entire: IV + Maintenance||6
9951402|NCT01412944|11070193|FG000|NOT COMPLETED|Entire: IV + Maintenance||0
9951403|NCT01412944|11070194|FG001|NOT COMPLETED|Entire: IV + Maintenance||0
9951404|NCT01412944|11070195|FG002|NOT COMPLETED|Entire: IV + Maintenance||1
9951405|NCT01412944|11070196|FG003|NOT COMPLETED|Entire: IV + Maintenance||1
9951406|NCT01412944|11070197|FG004|NOT COMPLETED|Entire: IV + Maintenance||3
9951407|NCT01412944|11070198|FG005|NOT COMPLETED|Entire: IV + Maintenance||2
9951408|NCT01412944|11070193|FG000|STARTED|Entire: IV + Maintenance||21
9951409|NCT01412944|11070194|FG001|STARTED|Entire: IV + Maintenance||22
9951410|NCT01412944|11070195|FG002|STARTED|Entire: IV + Maintenance||0
9951411|NCT01412944|11070196|FG003|STARTED|Entire: IV + Maintenance||0
9951412|NCT01412944|11070197|FG004|STARTED|Entire: IV + Maintenance||0
9951413|NCT01412944|11070198|FG005|STARTED|Entire: IV + Maintenance||0
9951414|NCT01412944|11070193|FG000|COMPLETED|Entire: IV + Maintenance||19
9951415|NCT01412944|11070194|FG001|COMPLETED|Entire: IV + Maintenance||17
9951416|NCT01412944|11070195|FG002|COMPLETED|Entire: IV + Maintenance||0
9951417|NCT01412944|11070196|FG003|COMPLETED|Entire: IV + Maintenance||0
10209141|NCT03565315|11336349|FG001|COMPLETED|Overall Study||3
10209142|NCT03565315|11336350|FG002|COMPLETED|Overall Study||1
10209143|NCT03565315|11336351|FG003|COMPLETED|Overall Study||1
10209144|NCT03565315|11336348|FG000|NOT COMPLETED|Overall Study||0
10209145|NCT03565315|11336349|FG001|NOT COMPLETED|Overall Study||0
10209146|NCT03565315|11336350|FG002|NOT COMPLETED|Overall Study||0
10209147|NCT03565315|11336351|FG003|NOT COMPLETED|Overall Study||1
10209148|NCT03565666|11336374|FG000|STARTED|Overall Study||12
10209149|NCT03565666|11336375|FG001|STARTED|Overall Study||12
10209150|NCT03565666|11336376|FG002|STARTED|Overall Study||12
10209151|NCT03565666|11336374|FG000|COMPLETED|Overall Study||12
10209152|NCT03565666|11336375|FG001|COMPLETED|Overall Study||12
10209153|NCT03565666|11336376|FG002|COMPLETED|Overall Study||11
10209154|NCT03565666|11336374|FG000|NOT COMPLETED|Overall Study||0
10209155|NCT03565666|11336375|FG001|NOT COMPLETED|Overall Study||0
10209156|NCT03565666|11336376|FG002|NOT COMPLETED|Overall Study||1
10209157|NCT03565679|11336387|FG000|STARTED|Overall Study||10
10209158|NCT03565679|11336387|FG000|COMPLETED|Overall Study||10
10209159|NCT03565679|11336387|FG000|NOT COMPLETED|Overall Study||0
10209160|NCT03565874|11336394|FG000|STARTED|Overall Study||6
10209161|NCT03565874|11336394|FG000|COMPLETED|Overall Study||4
10209162|NCT03565874|11336394|FG000|NOT COMPLETED|Overall Study||2
10209163|NCT03565887|11336400|FG000|STARTED|Overall Study||109
10209164|NCT03565887|11336401|FG001|STARTED|Overall Study||55
10209165|NCT03565887|11336400|FG000|COMPLETED|Overall Study||108
10209166|NCT03565887|11336401|FG001|COMPLETED|Overall Study||53
10209167|NCT03565887|11336400|FG000|NOT COMPLETED|Overall Study||1
10209168|NCT03565887|11336401|FG001|NOT COMPLETED|Overall Study||2
10209169|NCT03566238|11336410|FG000|STARTED|Overall Study||23
9951418|NCT01412944|11070197|FG004|COMPLETED|Entire: IV + Maintenance||0
9951419|NCT01412944|11070198|FG005|COMPLETED|Entire: IV + Maintenance||0
9951420|NCT01412944|11070193|FG000|NOT COMPLETED|Entire: IV + Maintenance||2
10011814|NCT01782495|11134591|FG005|STARTED|Overall Study||22
9951421|NCT01412944|11070194|FG001|NOT COMPLETED|Entire: IV + Maintenance||5
9951422|NCT01412944|11070195|FG002|NOT COMPLETED|Entire: IV + Maintenance||0
9951423|NCT01412944|11070196|FG003|NOT COMPLETED|Entire: IV + Maintenance||0
9951424|NCT01412944|11070197|FG004|NOT COMPLETED|Entire: IV + Maintenance||0
9951425|NCT01412944|11070198|FG005|NOT COMPLETED|Entire: IV + Maintenance||0
9951426|NCT01412944|11070193|FG000|STARTED|Follow-up||0
9951427|NCT01412944|11070194|FG001|STARTED|Follow-up||0
9951428|NCT01412944|11070195|FG002|STARTED|Follow-up||2
9951429|NCT01412944|11070196|FG003|STARTED|Follow-up||1
9951430|NCT01412944|11070197|FG004|STARTED|Follow-up||2
9951431|NCT01412944|11070198|FG005|STARTED|Follow-up||0
9951432|NCT01412944|11070193|FG000|COMPLETED|Follow-up||0
9951433|NCT01412944|11070194|FG001|COMPLETED|Follow-up||0
9951434|NCT01412944|11070195|FG002|COMPLETED|Follow-up||2
9951435|NCT01412944|11070196|FG003|COMPLETED|Follow-up||1
9951436|NCT01412944|11070197|FG004|COMPLETED|Follow-up||2
9951437|NCT01412944|11070198|FG005|COMPLETED|Follow-up||0
9951438|NCT01412944|11070193|FG000|NOT COMPLETED|Follow-up||0
9951439|NCT01412944|11070194|FG001|NOT COMPLETED|Follow-up||0
9951440|NCT01412944|11070195|FG002|NOT COMPLETED|Follow-up||0
9951441|NCT01412944|11070196|FG003|NOT COMPLETED|Follow-up||0
9951442|NCT01412944|11070197|FG004|NOT COMPLETED|Follow-up||0
9951443|NCT01412944|11070198|FG005|NOT COMPLETED|Follow-up||0
9951444|NCT01412957|11070216|FG000|STARTED|Overall Study||189
9951445|NCT01412957|11070217|FG001|STARTED|Overall Study||188
9951446|NCT01412957|11070216|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
9951447|NCT01412957|11070217|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
9951448|NCT01412957|11070216|FG000|NOT COMPLETED|Overall Study||149
9951449|NCT01412957|11070217|FG001|NOT COMPLETED|Overall Study||157
9951450|NCT01412983|11070223|FG000|STARTED|1st Period||50
9951451|NCT01412983|11070224|FG001|STARTED|1st Period||50
9951452|NCT01412983|11070223|FG000|COMPLETED|1st Period||50
9951453|NCT01412983|11070224|FG001|COMPLETED|1st Period||46
9951454|NCT01412983|11070223|FG000|NOT COMPLETED|1st Period||0
9951455|NCT01412983|11070224|FG001|NOT COMPLETED|1st Period||4
9951456|NCT01412983|11070223|FG000|STARTED|2nd Period||50
9951457|NCT01412983|11070224|FG001|STARTED|2nd Period||46
10209170|NCT03566238|11336411|FG001|STARTED|Overall Study||19
10209171|NCT03566238|11336412|FG002|STARTED|Overall Study||20
10209172|NCT03566238|11336410|FG000|Received Treatment|Overall Study||23
10209173|NCT03566238|11336411|FG001|Received Treatment|Overall Study||19
10209174|NCT03566238|11336412|FG002|Received Treatment|Overall Study||20
10209175|NCT03566238|11336410|FG000|COMPLETED|Overall Study||18
10209176|NCT03566238|11336411|FG001|COMPLETED|Overall Study||16
10209177|NCT03566238|11336412|FG002|COMPLETED|Overall Study||15
10209178|NCT03566238|11336410|FG000|NOT COMPLETED|Overall Study||5
10209179|NCT03566238|11336411|FG001|NOT COMPLETED|Overall Study||3
10209180|NCT03566238|11336412|FG002|NOT COMPLETED|Overall Study||5
10209181|NCT03566485|11336422|FG000|STARTED|Overall Study||5
10209182|NCT03566485|11336423|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
10209183|NCT03566485|11336422|FG000|COMPLETED|Overall Study||0
10209184|NCT03566485|11336423|FG001|COMPLETED|Overall Study||0
10209185|NCT03566485|11336422|FG000|NOT COMPLETED|Overall Study||5
10209186|NCT03566485|11336423|FG001|NOT COMPLETED|Overall Study||7
10209187|NCT03566550|11336431|FG000|STARTED|Overall Study||12
10209188|NCT03566550|11336432|FG001|STARTED|Overall Study||13
10209189|NCT03566550|11336431|FG000|COMPLETED|Overall Study||12
10209190|NCT03566550|11336432|FG001|COMPLETED|Overall Study||12
10209191|NCT03566550|11336431|FG000|NOT COMPLETED|Overall Study||0
10209192|NCT03566550|11336432|FG001|NOT COMPLETED|Overall Study||1
10209193|NCT03566680|11336438|FG000|STARTED|Overall Study||46
10209194|NCT03566680|11336438|FG000|COMPLETED|Overall Study||29
10209195|NCT03566680|11336438|FG000|NOT COMPLETED|Overall Study||17
10209196|NCT03566810|11336446|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19
10209197|NCT03566810|11336447|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19
10209198|NCT03566810|11336448|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8
10209199|NCT03566810|11336449|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8
10209200|NCT03566810|11336446|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19
10209201|NCT03566810|11336447|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18
10209202|NCT03566810|11336448|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8
10209203|NCT03566810|11336449|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8
10209204|NCT03566810|11336446|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
10209205|NCT03566810|11336447|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
10209206|NCT03566810|11336448|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
9951458|NCT01412983|11070223|FG000|COMPLETED|2nd Period||50
9951459|NCT01412983|11070224|FG001|COMPLETED|2nd Period||46
9951460|NCT01412983|11070223|FG000|NOT COMPLETED|2nd Period||0
9951461|NCT01412983|11070224|FG001|NOT COMPLETED|2nd Period||0
9951462|NCT01413087|11070233|FG000|STARTED|Overall Study||6
9951463|NCT01413087|11070234|FG001|STARTED|Overall Study||6
9951464|NCT01413087|11070233|FG000|COMPLETED|Overall Study||6
9951465|NCT01413087|11070234|FG001|COMPLETED|Overall Study||6
9951466|NCT01413087|11070233|FG000|NOT COMPLETED|Overall Study||0
9951467|NCT01413087|11070234|FG001|NOT COMPLETED|Overall Study||0
9951468|NCT01413178|11070242|FG000|STARTED|Overall Study||105
9951469|NCT01413178|11070243|FG001|STARTED|Overall Study||100
9951470|NCT01413178|11070242|FG000|COMPLETED|Overall Study||104
9951471|NCT01413178|11070243|FG001|COMPLETED|Overall Study||98
9951472|NCT01413178|11070242|FG000|NOT COMPLETED|Overall Study||1
9951473|NCT01413178|11070243|FG001|NOT COMPLETED|Overall Study||2
9951474|NCT01413191|11070249|FG000|STARTED|Overall Study||18
9951475|NCT01413191|11070249|FG000|COMPLETED|Overall Study||7
9951476|NCT01413191|11070249|FG000|NOT COMPLETED|Overall Study||11
9951477|NCT01413204|11070256|FG000|STARTED|Overall Study||90
9951478|NCT01413204|11070257|FG001|STARTED|Overall Study||89
9951479|NCT01413204|11070258|FG002|STARTED|Overall Study||93
9951480|NCT01413204|11070256|FG000|COMPLETED|Overall Study||84
9951481|NCT01413204|11070257|FG001|COMPLETED|Overall Study||83
9951482|NCT01413204|11070258|FG002|COMPLETED|Overall Study||74
9951483|NCT01413204|11070256|FG000|NOT COMPLETED|Overall Study||6
9951484|NCT01413204|11070257|FG001|NOT COMPLETED|Overall Study||6
9951485|NCT01413204|11070258|FG002|NOT COMPLETED|Overall Study||19
9951486|NCT01413360|11070266|FG000|STARTED|Overall Study||10
9951487|NCT01413360|11070266|FG000|COMPLETED|Overall Study||7
9951488|NCT01413360|11070266|FG000|NOT COMPLETED|Overall Study||3
9951489|NCT01413503|11070270|FG000|STARTED|Overall Study||50
9951490|NCT01413503|11070270|FG000|COMPLETED|Overall Study||49
9951491|NCT01413503|11070270|FG000|NOT COMPLETED|Overall Study||1
9951492|NCT01413516|11070276|FG000|STARTED|Overall Study||8
9951493|NCT01413516|11070277|FG001|STARTED|Overall Study||9
9951494|NCT01413516|11070276|FG000|COMPLETED|Overall Study||8
9951495|NCT01413516|11070277|FG001|COMPLETED|Overall Study||9
9951496|NCT01413516|11070276|FG000|NOT COMPLETED|Overall Study||0
9951497|NCT01413516|11070277|FG001|NOT COMPLETED|Overall Study||0
9951498|NCT01413542|11070285|FG000|STARTED|Overall Study||6
9951499|NCT01413542|11070286|FG001|STARTED|Overall Study||6
9951500|NCT01413542|11070287|FG002|STARTED|Overall Study||9
9951501|NCT01413542|11070288|FG003|STARTED|Overall Study||8
9951502|NCT01413542|11070285|FG000|COMPLETED|Overall Study||5
9951503|NCT01413542|11070286|FG001|COMPLETED|Overall Study||6
9951504|NCT01413542|11070287|FG002|COMPLETED|Overall Study||6
9951505|NCT01413542|11070288|FG003|COMPLETED|Overall Study||7
9951506|NCT01413542|11070285|FG000|NOT COMPLETED|Overall Study||1
9951507|NCT01413542|11070286|FG001|NOT COMPLETED|Overall Study||0
9951508|NCT01413542|11070287|FG002|NOT COMPLETED|Overall Study||3
9951509|NCT01413542|11070288|FG003|NOT COMPLETED|Overall Study||1
9951510|NCT01413750|11070304|FG000|STARTED|Overall Study||6
9951511|NCT01413750|11070305|FG001|STARTED|Overall Study||6
9951512|NCT01413750|11070306|FG002|STARTED|Overall Study||4
9951513|NCT01413750|11070307|FG003|STARTED|Overall Study||7
9951514|NCT01413750|11070304|FG000|COMPLETED|Overall Study||6
9951515|NCT01413750|11070305|FG001|COMPLETED|Overall Study||6
9951516|NCT01413750|11070306|FG002|COMPLETED|Overall Study||4
9951517|NCT01413750|11070307|FG003|COMPLETED|Overall Study||7
9951518|NCT01413750|11070304|FG000|NOT COMPLETED|Overall Study||0
9951519|NCT01413750|11070305|FG001|NOT COMPLETED|Overall Study||0
9951520|NCT01413750|11070306|FG002|NOT COMPLETED|Overall Study||0
9951521|NCT01413750|11070307|FG003|NOT COMPLETED|Overall Study||0
9951522|NCT01413958|11070320|FG000|STARTED|Overall Study||288
9951523|NCT01413958|11070321|FG001|STARTED|Overall Study||287
9951524|NCT01413958|11070320|FG000|COMPLETED|Overall Study||288
9951525|NCT01413958|11070321|FG001|COMPLETED|Overall Study||286
9951526|NCT01413958|11070320|FG000|NOT COMPLETED|Overall Study||0
9951527|NCT01413958|11070321|FG001|NOT COMPLETED|Overall Study||1
9951528|NCT01414010|11070332|FG000|STARTED|Overall Study||8
9951529|NCT01414010|11070333|FG001|STARTED|Overall Study||8
9951530|NCT01414010|11070334|FG002|STARTED|Overall Study||8
9951531|NCT01414010|11070335|FG003|STARTED|Overall Study||8
9951532|NCT01414010|11070332|FG000|COMPLETED|Overall Study||6
9951533|NCT01414010|11070333|FG001|COMPLETED|Overall Study||8
10011815|NCT01782495|11134592|FG006|STARTED|Overall Study||12
10011816|NCT01782495|11134593|FG007|STARTED|Overall Study||9
10011817|NCT01782495|11134594|FG008|STARTED|Overall Study||3
10209207|NCT03566810|11336449|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
10209208|NCT03566810|11336446|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10209209|NCT03566810|11336447|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
10209210|NCT03566810|11336448|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10209211|NCT03566810|11336449|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10209212|NCT03566810|11336446|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19
10209213|NCT03566810|11336447|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18
10209214|NCT03566810|11336448|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8
10209215|NCT03566810|11336449|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8
10209216|NCT03566810|11336446|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
10209217|NCT03566810|11336447|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
9951534|NCT01414010|11070334|FG002|COMPLETED|Overall Study||8
9951535|NCT01414010|11070335|FG003|COMPLETED|Overall Study||8
9951536|NCT01414010|11070332|FG000|NOT COMPLETED|Overall Study||2
9951537|NCT01414010|11070333|FG001|NOT COMPLETED|Overall Study||0
9951538|NCT01414010|11070334|FG002|NOT COMPLETED|Overall Study||0
9951539|NCT01414010|11070335|FG003|NOT COMPLETED|Overall Study||0
9951540|NCT01414036|11070353|FG000|STARTED|Received Allocated Intervention||23
9951541|NCT01414036|11070354|FG001|STARTED|Received Allocated Intervention||24
9951542|NCT01414036|11070353|FG000|COMPLETED|Received Allocated Intervention||23
9951543|NCT01414036|11070354|FG001|COMPLETED|Received Allocated Intervention||11
9951544|NCT01414036|11070353|FG000|NOT COMPLETED|Received Allocated Intervention||0
9951545|NCT01414036|11070354|FG001|NOT COMPLETED|Received Allocated Intervention||13
9951546|NCT01414036|11070353|FG000|STARTED|Completed 3 Month Survey||23
9951547|NCT01414036|11070354|FG001|STARTED|Completed 3 Month Survey||24
9951548|NCT01414036|11070353|FG000|COMPLETED|Completed 3 Month Survey||14
9951549|NCT01414036|11070354|FG001|COMPLETED|Completed 3 Month Survey||19
9951550|NCT01414036|11070353|FG000|NOT COMPLETED|Completed 3 Month Survey||9
9951551|NCT01414036|11070354|FG001|NOT COMPLETED|Completed 3 Month Survey||5
9951552|NCT01414075|11070364|FG000|STARTED|Overall Study||24
9951553|NCT01414075|11070365|FG001|STARTED|Overall Study||12
9951554|NCT01414075|11070366|FG002|STARTED|Overall Study||12
9951555|NCT01414075|11070367|FG003|STARTED|Overall Study||12
9951556|NCT01414075|11070364|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
9951557|NCT01414075|11070365|FG001|Efficacy Evaluable (EE) Population|Overall Study||12
9951558|NCT01414075|11070366|FG002|Efficacy Evaluable (EE) Population|Overall Study||10
9951559|NCT01414075|11070367|FG003|Efficacy Evaluable (EE) Population|Overall Study||10
9951560|NCT01414075|11070364|FG000|COMPLETED|Overall Study||21
9951561|NCT01414075|11070365|FG001|COMPLETED|Overall Study||12
9951562|NCT01414075|11070366|FG002|COMPLETED|Overall Study||10
9951563|NCT01414075|11070367|FG003|COMPLETED|Overall Study||10
9951564|NCT01414075|11070364|FG000|NOT COMPLETED|Overall Study||3
9951565|NCT01414075|11070365|FG001|NOT COMPLETED|Overall Study||0
9951566|NCT01414075|11070366|FG002|NOT COMPLETED|Overall Study||2
9951567|NCT01414075|11070367|FG003|NOT COMPLETED|Overall Study||2
9951568|NCT01414114|11070377|FG000|STARTED|Overall Study||37
9951569|NCT01414114|11070377|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32
9951570|NCT01414114|11070377|FG000|NOT COMPLETED|Overall Study||5
9951571|NCT01414153|11070387|FG000|STARTED|Overall Study||38
9951572|NCT01414153|11070388|FG001|STARTED|Overall Study||40
9951573|NCT01414153|11070389|FG002|STARTED|Overall Study||39
9951574|NCT01414153|11070390|FG003|STARTED|Overall Study||41
9951575|NCT01414153|11070387|FG000|COMPLETED|Overall Study||30
9951576|NCT01414153|11070388|FG001|COMPLETED|Overall Study||38
9951577|NCT01414153|11070389|FG002|COMPLETED|Overall Study||35
9951578|NCT01414153|11070390|FG003|COMPLETED|Overall Study||37
9951579|NCT01414153|11070387|FG000|NOT COMPLETED|Overall Study||8
9951580|NCT01414153|11070388|FG001|NOT COMPLETED|Overall Study||2
9951581|NCT01414153|11070389|FG002|NOT COMPLETED|Overall Study||4
9951582|NCT01414153|11070390|FG003|NOT COMPLETED|Overall Study||4
9951583|NCT01414205|11070402|FG000|STARTED|Overall Study||41
9951584|NCT01414205|11070403|FG001|STARTED|Overall Study||39
9951585|NCT01414205|11070402|FG000|Received Study Drug|Overall Study||40
9951586|NCT01414205|11070403|FG001|Received Study Drug|Overall Study||38
9951587|NCT01414205|11070402|FG000|COMPLETED|Overall Study||34
9951588|NCT01414205|11070403|FG001|COMPLETED|Overall Study||32
9951589|NCT01414205|11070402|FG000|NOT COMPLETED|Overall Study||7
9951590|NCT01414205|11070403|FG001|NOT COMPLETED|Overall Study||7
9951591|NCT01414244|11070411|FG000|STARTED|Overall Study||54
9951592|NCT01414244|11070412|FG001|STARTED|Overall Study||52
9951593|NCT01414244|11070411|FG000|COMPLETED|Overall Study||54
9951594|NCT01414244|11070412|FG001|COMPLETED|Overall Study||52
9951595|NCT01414244|11070411|FG000|NOT COMPLETED|Overall Study||0
9951596|NCT01414244|11070412|FG001|NOT COMPLETED|Overall Study||0
9951597|NCT01414257|11070418|FG000|STARTED|Overall Study||2860
9951598|NCT01414257|11070418|FG000|COMPLETED|Overall Study||2838
9951599|NCT01414257|11070418|FG000|NOT COMPLETED|Overall Study||22
9951600|NCT01414413|11070424|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
9951601|NCT01414413|11070425|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
9951602|NCT01414413|11070424|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
9951603|NCT01414413|11070425|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
9951604|NCT01414413|11070424|FG000|NOT COMPLETED|Overall Study||0
9951605|NCT01414413|11070425|FG001|NOT COMPLETED|Overall Study||0
9951606|NCT01414426|11070433|FG000|STARTED|Overall Study||10
9951607|NCT01414426|11070434|FG001|STARTED|Overall Study||10
9951608|NCT01414426|11070433|FG000|COMPLETED|Overall Study||9
9951609|NCT01414426|11070434|FG001|COMPLETED|Overall Study||8
9951610|NCT01414426|11070433|FG000|NOT COMPLETED|Overall Study||1
9951611|NCT01414426|11070434|FG001|NOT COMPLETED|Overall Study||2
9951612|NCT01414634|11070440|FG000|STARTED|Overall Study||1
9951613|NCT01414634|11070441|FG001|STARTED|Overall Study||1
9951614|NCT01414634|11070442|FG002|STARTED|Overall Study||1
9951615|NCT01414634|11070443|FG003|STARTED|Overall Study||1
9951616|NCT01414634|11070444|FG004|STARTED|Overall Study||1
9951617|NCT01414634|11070445|FG005|STARTED|Overall Study||2
9951618|NCT01414634|11070446|FG006|STARTED|Overall Study||1
9951619|NCT01414634|11070447|FG007|STARTED|Overall Study||1
9951620|NCT01414634|11070440|FG000|COMPLETED|Overall Study||1
9951621|NCT01414634|11070441|FG001|COMPLETED|Overall Study||1
9951622|NCT01414634|11070442|FG002|COMPLETED|Overall Study||1
9951623|NCT01414634|11070443|FG003|COMPLETED|Overall Study||1
9951624|NCT01414634|11070444|FG004|COMPLETED|Overall Study||1
9951625|NCT01414634|11070445|FG005|COMPLETED|Overall Study||2
9951626|NCT01414634|11070446|FG006|COMPLETED|Overall Study||1
9951627|NCT01414634|11070447|FG007|COMPLETED|Overall Study||1
9951628|NCT01414634|11070440|FG000|NOT COMPLETED|Overall Study||0
9951629|NCT01414634|11070441|FG001|NOT COMPLETED|Overall Study||0
9951630|NCT01414634|11070442|FG002|NOT COMPLETED|Overall Study||0
9951631|NCT01414634|11070443|FG003|NOT COMPLETED|Overall Study||0
9951632|NCT01414634|11070444|FG004|NOT COMPLETED|Overall Study||0
9951633|NCT01414634|11070445|FG005|NOT COMPLETED|Overall Study||0
9951634|NCT01414634|11070446|FG006|NOT COMPLETED|Overall Study||0
9951635|NCT01414634|11070447|FG007|NOT COMPLETED|Overall Study||0
9951636|NCT01414738|11070458|FG000|STARTED|Overall Study||49
9951637|NCT01414738|11070458|FG000|Follow-up (3 Months)|Overall Study||18
9951638|NCT01414738|11070458|FG000|Follow-up (6 Months)|Overall Study||8
9951639|NCT01414738|11070458|FG000|Follow-up (9 Months)|Overall Study||5
9951640|NCT01414738|11070458|FG000|COMPLETED|Overall Study||5
9951641|NCT01414738|11070458|FG000|NOT COMPLETED|Overall Study||44
9951642|NCT01414855|11070462|FG000|STARTED|Overall Study||100
9951643|NCT01414855|11070462|FG000|COMPLETED|Overall Study||71
9951644|NCT01414855|11070462|FG000|NOT COMPLETED|Overall Study||29
9951645|NCT01415232|11070466|FG000|STARTED|Overall Study||160
9951646|NCT01415232|11070466|FG000|COMPLETED|Overall Study||160
9951647|NCT01415232|11070466|FG000|NOT COMPLETED|Overall Study||0
9951648|NCT01415349|11070470|FG000|STARTED|Treatment Period 1||21
9951649|NCT01415349|11070471|FG001|STARTED|Treatment Period 1||21
9951650|NCT01415349|11070470|FG000|COMPLETED|Treatment Period 1||21
10011818|NCT01782495|11134595|FG009|STARTED|Overall Study||2
10011819|NCT01782495|11134596|FG010|STARTED|Overall Study||1
10011820|NCT01782495|11134586|FG000|COMPLETED|Overall Study||34
10011821|NCT01782495|11134587|FG001|COMPLETED|Overall Study||26
10011822|NCT01782495|11134588|FG002|COMPLETED|Overall Study||13
10209218|NCT03566810|11336448|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
10209219|NCT03566810|11336449|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
10209220|NCT03566810|11336446|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10209221|NCT03566810|11336447|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10209222|NCT03566810|11336448|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10209223|NCT03566810|11336449|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10209224|NCT03566823|11336462|FG000|STARTED|Overall Study||6
10209225|NCT03566823|11336463|FG001|STARTED|Overall Study||15
10209226|NCT03566823|11336464|FG002|STARTED|Overall Study||13
10209227|NCT03566823|11336462|FG000|COMPLETED|Overall Study||4
10209228|NCT03566823|11336463|FG001|COMPLETED|Overall Study||12
10209229|NCT03566823|11336464|FG002|COMPLETED|Overall Study||11
10209230|NCT03566823|11336462|FG000|NOT COMPLETED|Overall Study||2
10209231|NCT03566823|11336463|FG001|NOT COMPLETED|Overall Study||3
10209232|NCT03566823|11336464|FG002|NOT COMPLETED|Overall Study||2
10209233|NCT03566979|11336476|FG000|STARTED|Overall Study||58
10209234|NCT03566979|11336477|FG001|STARTED|Overall Study||152
10209235|NCT03566979|11336478|FG002|STARTED|Overall Study||142
10209236|NCT03566979|11336479|FG003|STARTED|Overall Study||149
10209237|NCT03566979|11336476|FG000|COMPLETED|Overall Study||53
10209238|NCT03566979|11336477|FG001|COMPLETED|Overall Study||145
10209239|NCT03566979|11336478|FG002|COMPLETED|Overall Study||132
10209240|NCT03566979|11336479|FG003|COMPLETED|Overall Study||143
10209241|NCT03566979|11336476|FG000|NOT COMPLETED|Overall Study||5
10209242|NCT03566979|11336477|FG001|NOT COMPLETED|Overall Study||7
10209243|NCT03566979|11336478|FG002|NOT COMPLETED|Overall Study||10
10209244|NCT03566979|11336479|FG003|NOT COMPLETED|Overall Study||6
10209245|NCT03567005|11336489|FG000|STARTED|Period 1, First 7 Days of Wear||29
10209246|NCT03567005|11336490|FG001|STARTED|Period 1, First 7 Days of Wear||31
10209247|NCT03567005|11336489|FG000|COMPLETED|Period 1, First 7 Days of Wear||29
10209248|NCT03567005|11336490|FG001|COMPLETED|Period 1, First 7 Days of Wear||31
10209249|NCT03567005|11336489|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10209250|NCT03567005|11336490|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10209251|NCT03567005|11336489|FG000|STARTED|Period 2, Second 7 Days of Wear||29
10209252|NCT03567005|11336490|FG001|STARTED|Period 2, Second 7 Days of Wear||31
10209253|NCT03567005|11336489|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29
10209254|NCT03567005|11336490|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31
10209255|NCT03567005|11336489|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10209256|NCT03567005|11336490|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10209257|NCT03567252|11336498|FG000|STARTED|Overall Study||48
10209258|NCT03567252|11336499|FG001|STARTED|Overall Study||19
10209259|NCT03567252|11336498|FG000|COMPLETED|Overall Study||48
10209260|NCT03567252|11336499|FG001|COMPLETED|Overall Study||19
10209261|NCT03567252|11336498|FG000|NOT COMPLETED|Overall Study||0
10209262|NCT03567252|11336499|FG001|NOT COMPLETED|Overall Study||0
10209263|NCT03567291|11336505|FG000|STARTED|Period I||228
10209264|NCT03567291|11336506|FG001|STARTED|Period I||0
10209265|NCT03567291|11336507|FG002|STARTED|Period I||0
10209266|NCT03567291|11336508|FG003|STARTED|Period I||0
10209267|NCT03567291|11336505|FG000|Safety Set|Period I||227
10209268|NCT03567291|11336506|FG001|Safety Set|Period I||0
10209269|NCT03567291|11336507|FG002|Safety Set|Period I||0
10209270|NCT03567291|11336508|FG003|Safety Set|Period I||0
10209271|NCT03567291|11336505|FG000|Intent to Treat Set|Period I||228
10209272|NCT03567291|11336506|FG001|Intent to Treat Set|Period I||0
10209273|NCT03567291|11336507|FG002|Intent to Treat Set|Period I||0
10209274|NCT03567291|11336508|FG003|Intent to Treat Set|Period I||0
10209275|NCT03567291|11336505|FG000|COMPLETED|Period I||137
10209276|NCT03567291|11336506|FG001|COMPLETED|Period I||0
10209277|NCT03567291|11336507|FG002|COMPLETED|Period I||0
10209278|NCT03567291|11336508|FG003|COMPLETED|Period I||0
10209279|NCT03567291|11336505|FG000|NOT COMPLETED|Period I||91
9951651|NCT01415349|11070471|FG001|COMPLETED|Treatment Period 1||19
9951652|NCT01415349|11070470|FG000|NOT COMPLETED|Treatment Period 1||0
9951653|NCT01415349|11070471|FG001|NOT COMPLETED|Treatment Period 1||2
9951654|NCT01415349|11070470|FG000|STARTED|Treatment Period 2||21
9951655|NCT01415349|11070471|FG001|STARTED|Treatment Period 2||19
9951656|NCT01415349|11070470|FG000|COMPLETED|Treatment Period 2||21
10011823|NCT01782495|11134589|FG003|COMPLETED|Overall Study||4
10011824|NCT01782495|11134590|FG004|COMPLETED|Overall Study||2
10209280|NCT03567291|11336506|FG001|NOT COMPLETED|Period I||0
10209281|NCT03567291|11336507|FG002|NOT COMPLETED|Period I||0
10209282|NCT03567291|11336508|FG003|NOT COMPLETED|Period I||0
9951657|NCT01415349|11070471|FG001|COMPLETED|Treatment Period 2||19
9951658|NCT01415349|11070470|FG000|NOT COMPLETED|Treatment Period 2||0
9951659|NCT01415349|11070471|FG001|NOT COMPLETED|Treatment Period 2||0
9951660|NCT01415401|11070477|FG000|STARTED|Overall Study||54
9951661|NCT01415401|11070477|FG000|COMPLETED|Overall Study||47
9951662|NCT01415401|11070477|FG000|NOT COMPLETED|Overall Study||7
9951663|NCT01415427|11070485|FG000|STARTED|Overall Study||29
9951664|NCT01415427|11070486|FG001|STARTED|Overall Study||29
9951665|NCT01415427|11070487|FG002|STARTED|Overall Study||59
9951666|NCT01415427|11070488|FG003|STARTED|Overall Study||56
9951667|NCT01415427|11070485|FG000|COMPLETED|Overall Study||0
9951668|NCT01415427|11070486|FG001|COMPLETED|Overall Study||0
9951669|NCT01415427|11070487|FG002|COMPLETED|Overall Study||1
9951670|NCT01415427|11070488|FG003|COMPLETED|Overall Study||0
9951671|NCT01415427|11070485|FG000|NOT COMPLETED|Overall Study||29
9951672|NCT01415427|11070486|FG001|NOT COMPLETED|Overall Study||29
9951673|NCT01415427|11070487|FG002|NOT COMPLETED|Overall Study||58
9951674|NCT01415427|11070488|FG003|NOT COMPLETED|Overall Study||56
9951675|NCT01415440|11070503|FG000|STARTED|Overall Study||41
9951676|NCT01415440|11070504|FG001|STARTED|Overall Study||29
9951677|NCT01415440|11070505|FG002|STARTED|Overall Study||29
9951678|NCT01415440|11070503|FG000|COMPLETED|Overall Study||37
9951679|NCT01415440|11070504|FG001|COMPLETED|Overall Study||28
10209283|NCT03567291|11336505|FG000|STARTED|Period II||0
10209284|NCT03567291|11336506|FG001|STARTED|Period II||91
10209285|NCT03567291|11336507|FG002|STARTED|Period II||46
10209286|NCT03567291|11336508|FG003|STARTED|Period II||0
10209287|NCT03567291|11336505|FG000|COMPLETED|Period II||0
10209288|NCT03567291|11336506|FG001|COMPLETED|Period II||88
10209289|NCT03567291|11336507|FG002|COMPLETED|Period II||45
10209290|NCT03567291|11336508|FG003|COMPLETED|Period II||0
10209291|NCT03567291|11336505|FG000|NOT COMPLETED|Period II||0
10209292|NCT03567291|11336506|FG001|NOT COMPLETED|Period II||3
10209293|NCT03567291|11336507|FG002|NOT COMPLETED|Period II||1
10209294|NCT03567291|11336508|FG003|NOT COMPLETED|Period II||0
10209295|NCT03567291|11336505|FG000|STARTED|Period III||0
10209296|NCT03567291|11336506|FG001|STARTED|Period III||0
10209297|NCT03567291|11336507|FG002|STARTED|Period III||0
10209298|NCT03567291|11336508|FG003|STARTED|Period III||133
10209299|NCT03567291|11336505|FG000|COMPLETED|Period III||0
10209300|NCT03567291|11336506|FG001|COMPLETED|Period III||0
10209301|NCT03567291|11336507|FG002|COMPLETED|Period III||0
10209302|NCT03567291|11336508|FG003|COMPLETED|Period III||48
10209303|NCT03567291|11336505|FG000|NOT COMPLETED|Period III||0
10209304|NCT03567291|11336506|FG001|NOT COMPLETED|Period III||0
10209305|NCT03567291|11336507|FG002|NOT COMPLETED|Period III||0
10209306|NCT03567291|11336508|FG003|NOT COMPLETED|Period III||85
10209307|NCT03567382|11336516|FG000|STARTED|Overall Study||10
10209308|NCT03567382|11336517|FG001|STARTED|Overall Study||81
10209309|NCT03567382|11336518|FG002|STARTED|Overall Study||9
10209310|NCT03567382|11336519|FG003|STARTED|Overall Study||79
10209311|NCT03567382|11336516|FG000|Received Tenofovir|Overall Study||9
10209312|NCT03567382|11336517|FG001|Received Tenofovir|Overall Study||0
10209313|NCT03567382|11336518|FG002|Received Tenofovir|Overall Study||0
10209314|NCT03567382|11336519|FG003|Received Tenofovir|Overall Study||0
10209315|NCT03567382|11336516|FG000|COMPLETED|Overall Study||7
10209316|NCT03567382|11336517|FG001|COMPLETED|Overall Study||46
10209317|NCT03567382|11336518|FG002|COMPLETED|Overall Study||7
10209318|NCT03567382|11336519|FG003|COMPLETED|Overall Study||46
10209319|NCT03567382|11336516|FG000|NOT COMPLETED|Overall Study||3
10209320|NCT03567382|11336517|FG001|NOT COMPLETED|Overall Study||35
10209321|NCT03567382|11336518|FG002|NOT COMPLETED|Overall Study||2
10209322|NCT03567382|11336519|FG003|NOT COMPLETED|Overall Study||33
10209323|NCT03567616|11336532|FG000|STARTED|Overall Study||8
10209324|NCT03567616|11336532|FG000|COMPLETED|Overall Study||0
10209325|NCT03567616|11336532|FG000|NOT COMPLETED|Overall Study||8
10209326|NCT03567980|11336539|FG000|STARTED|Overall Study||30
10209327|NCT03567980|11336539|FG000|COMPLETED|Overall Study||29
10209328|NCT03567980|11336539|FG000|NOT COMPLETED|Overall Study||1
10209329|NCT03568500|11336546|FG000|STARTED|Overall Study||18
10209330|NCT03568500|11336547|FG001|STARTED|Overall Study||20
10209331|NCT03568500|11336548|FG002|STARTED|Overall Study||6
10209332|NCT03568500|11336546|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18
10209333|NCT03568500|11336547|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19
10209334|NCT03568500|11336548|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6
10209335|NCT03568500|11336546|FG000|COMPLETED|Overall Study||8
10209336|NCT03568500|11336547|FG001|COMPLETED|Overall Study||14
10209337|NCT03568500|11336548|FG002|COMPLETED|Overall Study||2
10209338|NCT03568500|11336546|FG000|NOT COMPLETED|Overall Study||10
9951680|NCT01415440|11070505|FG002|COMPLETED|Overall Study||27
9951681|NCT01415440|11070503|FG000|NOT COMPLETED|Overall Study||4
9951682|NCT01415440|11070504|FG001|NOT COMPLETED|Overall Study||1
9951683|NCT01415440|11070505|FG002|NOT COMPLETED|Overall Study||2
9951684|NCT01415453|11070512|FG000|STARTED|Overall Study||1
9951685|NCT01415453|11070512|FG000|Imaging Study|Overall Study||1
9951686|NCT01415453|11070512|FG000|COMPLETED|Overall Study||1
10209339|NCT03568500|11336547|FG001|NOT COMPLETED|Overall Study||6
10209340|NCT03568500|11336548|FG002|NOT COMPLETED|Overall Study||4
10209341|NCT03568539|11336563|FG000|STARTED|Overall Study||3
10209342|NCT03568539|11336564|FG001|STARTED|Overall Study||36
10209343|NCT03568539|11336563|FG000|COMPLETED|Overall Study||3
10209344|NCT03568539|11336564|FG001|COMPLETED|Overall Study||36
9951687|NCT01415453|11070512|FG000|NOT COMPLETED|Overall Study||0
9951688|NCT01415518|11070518|FG000|STARTED|Overall Study||292
9951689|NCT01415518|11070519|FG001|STARTED|Overall Study||292
9951690|NCT01415518|11070518|FG000|Patients Who Received Study Treatment|Overall Study||290
9951691|NCT01415518|11070519|FG001|Patients Who Received Study Treatment|Overall Study||292
9951692|NCT01415518|11070518|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
9951693|NCT01415518|11070519|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
9951694|NCT01415518|11070518|FG000|COMPLETED|Overall Study||276
9951695|NCT01415518|11070519|FG001|COMPLETED|Overall Study||261
9951696|NCT01415518|11070518|FG000|NOT COMPLETED|Overall Study||16
9951697|NCT01415518|11070519|FG001|NOT COMPLETED|Overall Study||31
9951698|NCT01415531|11070527|FG000|STARTED|Overall Study||214
9951699|NCT01415531|11070528|FG001|STARTED|Overall Study||427
9951700|NCT01415531|11070527|FG000|COMPLETED|Overall Study||189
9951701|NCT01415531|11070528|FG001|COMPLETED|Overall Study||390
9951702|NCT01415531|11070527|FG000|NOT COMPLETED|Overall Study||25
9951703|NCT01415531|11070528|FG001|NOT COMPLETED|Overall Study||37
9951704|NCT01415583|11070536|FG000|STARTED|Overall Study||157
9951705|NCT01415583|11070537|FG001|STARTED|Overall Study||157
9951706|NCT01415583|11070536|FG000|COMPLETED|Overall Study||157
9951707|NCT01415583|11070537|FG001|COMPLETED|Overall Study||157
9951708|NCT01415583|11070536|FG000|NOT COMPLETED|Overall Study||0
9951709|NCT01415583|11070537|FG001|NOT COMPLETED|Overall Study||0
9951710|NCT01415908|11070545|FG000|STARTED|Overall Study||11
9951711|NCT01415908|11070546|FG001|STARTED|Overall Study||4
9951712|NCT01415908|11070545|FG000|COMPLETED|Overall Study||10
9951713|NCT01415908|11070546|FG001|COMPLETED|Overall Study||4
9951714|NCT01415908|11070545|FG000|NOT COMPLETED|Overall Study||1
9951715|NCT01415908|11070546|FG001|NOT COMPLETED|Overall Study||0
10209345|NCT03568539|11336563|FG000|NOT COMPLETED|Overall Study||0
10209346|NCT03568539|11336564|FG001|NOT COMPLETED|Overall Study||0
10209347|NCT03568942|11336571|FG000|STARTED|Overall Study||22
10209348|NCT03568942|11336571|FG000|COMPLETED|Overall Study||20
10209349|NCT03568942|11336571|FG000|NOT COMPLETED|Overall Study||2
10209350|NCT03569020|11336577|FG000|STARTED|Period 1||22
10209351|NCT03569020|11336578|FG001|STARTED|Period 1||21
10209352|NCT03569020|11336577|FG000|COMPLETED|Period 1||22
10209353|NCT03569020|11336578|FG001|COMPLETED|Period 1||21
10209354|NCT03569020|11336577|FG000|NOT COMPLETED|Period 1||0
10209355|NCT03569020|11336578|FG001|NOT COMPLETED|Period 1||0
10209356|NCT03569020|11336577|FG000|STARTED|Period 2||22
10209357|NCT03569020|11336578|FG001|STARTED|Period 2||21
10209358|NCT03569020|11336577|FG000|COMPLETED|Period 2||22
10209359|NCT03569020|11336578|FG001|COMPLETED|Period 2||21
10209360|NCT03569020|11336577|FG000|NOT COMPLETED|Period 2||0
10209361|NCT03569020|11336578|FG001|NOT COMPLETED|Period 2||0
10209362|NCT03569033|11336590|FG000|STARTED|Overall Study||23
10209363|NCT03569033|11336591|FG001|STARTED|Overall Study||23
10209364|NCT03569033|11336590|FG000|COMPLETED|Overall Study||23
10209365|NCT03569033|11336591|FG001|COMPLETED|Overall Study||23
10209366|NCT03569033|11336590|FG000|NOT COMPLETED|Overall Study||0
10209367|NCT03569033|11336591|FG001|NOT COMPLETED|Overall Study||0
10209368|NCT03569098|11336600|FG000|STARTED|Double-Blind Treatment Cycle 1||63
10209369|NCT03569098|11336601|FG001|STARTED|Double-Blind Treatment Cycle 1||63
10209370|NCT03569098|11336602|FG002|STARTED|Double-Blind Treatment Cycle 1||60
10209371|NCT03569098|11336600|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61
10209372|NCT03569098|11336601|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63
10209373|NCT03569098|11336602|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56
10209374|NCT03569098|11336600|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55
10209375|NCT03569098|11336601|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53
10209376|NCT03569098|11336602|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49
10209377|NCT03569098|11336600|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
10209378|NCT03569098|11336601|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
10209379|NCT03569098|11336602|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
10209380|NCT03569098|11336600|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
10209381|NCT03569098|11336601|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
10209382|NCT03569098|11336602|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
10209383|NCT03569098|11336600|FG000|COMPLETED|Open-Label Treatment Cycle 2||0
10209384|NCT03569098|11336601|FG001|COMPLETED|Open-Label Treatment Cycle 2||111
10209385|NCT03569098|11336602|FG002|COMPLETED|Open-Label Treatment Cycle 2||0
10209386|NCT03569098|11336600|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0
10209387|NCT03569098|11336601|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35
10209388|NCT03569098|11336602|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0
10209389|NCT03569098|11336600|FG000|STARTED|Open-Label Treatment Cycle 3||0
9951716|NCT01415921|11070554|FG000|STARTED|Overall Study||16
9951717|NCT01415921|11070555|FG001|STARTED|Overall Study||17
9951718|NCT01415921|11070554|FG000|COMPLETED|Overall Study||13
9951719|NCT01415921|11070555|FG001|COMPLETED|Overall Study||14
9951720|NCT01415921|11070554|FG000|NOT COMPLETED|Overall Study||3
9951721|NCT01415921|11070555|FG001|NOT COMPLETED|Overall Study||3
9951722|NCT01415934|11070563|FG000|STARTED|Overall Study||192
9951723|NCT01415934|11070564|FG001|STARTED|Overall Study||189
9951724|NCT01415934|11070563|FG000|COMPLETED|Overall Study||189
9951725|NCT01415934|11070564|FG001|COMPLETED|Overall Study||182
9951726|NCT01415934|11070563|FG000|NOT COMPLETED|Overall Study||3
9951727|NCT01415934|11070564|FG001|NOT COMPLETED|Overall Study||7
9951728|NCT01415960|11070570|FG000|STARTED|Overall Study||163
9951729|NCT01415960|11070570|FG000|ITT|Overall Study||161
9951730|NCT01415960|11070570|FG000|PK Subgroup|Overall Study||30
9951731|NCT01415960|11070570|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
9951732|NCT01415960|11070570|FG000|NOT COMPLETED|Overall Study||12
9951733|NCT01416025|11070576|FG000|STARTED|Overall Study||14
9951734|NCT01416025|11070577|FG001|STARTED|Overall Study||15
9951735|NCT01416025|11070576|FG000|COMPLETED|Overall Study||14
9951736|NCT01416025|11070577|FG001|COMPLETED|Overall Study||15
9951737|NCT01416025|11070576|FG000|NOT COMPLETED|Overall Study||0
9951738|NCT01416025|11070577|FG001|NOT COMPLETED|Overall Study||0
9951739|NCT01416129|11070585|FG000|STARTED|Control Condition: Ischial Containment||5
9951740|NCT01416129|11070586|FG001|STARTED|Control Condition: Ischial Containment||5
9951741|NCT01416129|11070585|FG000|COMPLETED|Control Condition: Ischial Containment||5
10209390|NCT03569098|11336601|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
10209391|NCT03569098|11336602|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
10209392|NCT03569098|11336600|FG000|COMPLETED|Open-Label Treatment Cycle 3||0
10209393|NCT03569098|11336601|FG001|COMPLETED|Open-Label Treatment Cycle 3||7
10209394|NCT03569098|11336602|FG002|COMPLETED|Open-Label Treatment Cycle 3||50
10209395|NCT03569098|11336600|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0
10209396|NCT03569098|11336601|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1
10209397|NCT03569098|11336602|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6
10209398|NCT03569202|11336615|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
10209399|NCT03569202|11336616|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
10209400|NCT03569202|11336615|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
10209401|NCT03569202|11336616|FG001|COMPLETED|Part 1||0
10209402|NCT03569202|11336615|FG000|NOT COMPLETED|Part 1||0
10209403|NCT03569202|11336616|FG001|NOT COMPLETED|Part 1||0
10209404|NCT03569202|11336615|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
10209405|NCT03569202|11336616|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
10209406|NCT03569202|11336615|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
10209407|NCT03569202|11336616|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
10209408|NCT03569202|11336615|FG000|NOT COMPLETED|Part 2||0
10209409|NCT03569202|11336616|FG001|NOT COMPLETED|Part 2||0
10209410|NCT03569202|11336615|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
10209411|NCT03569202|11336616|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
10209412|NCT03569202|11336615|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
10209413|NCT03569202|11336616|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
10209414|NCT03569202|11336615|FG000|NOT COMPLETED|Part 3||2
10209415|NCT03569202|11336616|FG001|NOT COMPLETED|Part 3||1
10209416|NCT03569371|11336622|FG000|STARTED|Overall Study||10
10209417|NCT03569371|11336622|FG000|COMPLETED|Overall Study||7
10209418|NCT03569371|11336622|FG000|NOT COMPLETED|Overall Study||3
10209419|NCT03569397|11336628|FG000|STARTED|Overall Study||29
10209420|NCT03569397|11336629|FG001|STARTED|Overall Study||28
10209421|NCT03569397|11336628|FG000|COMPLETED|Overall Study||29
10209422|NCT03569397|11336629|FG001|COMPLETED|Overall Study||28
10209423|NCT03569397|11336628|FG000|NOT COMPLETED|Overall Study||0
10209424|NCT03569397|11336629|FG001|NOT COMPLETED|Overall Study||0
10209425|NCT03569618|11336636|FG000|STARTED|Overall Study||23
10209426|NCT03569618|11336637|FG001|STARTED|Overall Study||21
10209427|NCT03569618|11336636|FG000|COMPLETED|Overall Study||20
10209428|NCT03569618|11336637|FG001|COMPLETED|Overall Study||20
10209429|NCT03569618|11336636|FG000|NOT COMPLETED|Overall Study||3
10209430|NCT03569618|11336637|FG001|NOT COMPLETED|Overall Study||1
10209431|NCT03569748|11336646|FG000|STARTED|Overall Study||110
10209432|NCT03569748|11336647|FG001|STARTED|Overall Study||110
10209433|NCT03569748|11336646|FG000|COMPLETED|Overall Study||110
10209434|NCT03569748|11336647|FG001|COMPLETED|Overall Study||101
10209435|NCT03569748|11336646|FG000|NOT COMPLETED|Overall Study||0
10209436|NCT03569748|11336647|FG001|NOT COMPLETED|Overall Study||9
10209437|NCT03570047|11336664|FG000|STARTED|Overall Study||15902
10209438|NCT03570047|11336665|FG001|STARTED|Overall Study||22336
10209439|NCT03570047|11336666|FG002|STARTED|Overall Study||6925
10209440|NCT03570047|11336667|FG003|STARTED|Overall Study||16564
10209441|NCT03570047|11336668|FG004|STARTED|Overall Study||12262
10209442|NCT03570047|11336664|FG000|COMPLETED|Overall Study||15902
9951742|NCT01416129|11070586|FG001|COMPLETED|Control Condition: Ischial Containment||5
9951743|NCT01416129|11070585|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0
9951744|NCT01416129|11070586|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0
9951745|NCT01416129|11070585|FG000|STARTED|Experimental Condition: Brimless||5
9951746|NCT01416129|11070586|FG001|STARTED|Experimental Condition: Brimless||5
9951747|NCT01416129|11070585|FG000|COMPLETED|Experimental Condition: Brimless||5
9951748|NCT01416129|11070586|FG001|COMPLETED|Experimental Condition: Brimless||5
9951749|NCT01416129|11070585|FG000|NOT COMPLETED|Experimental Condition: Brimless||0
9951750|NCT01416129|11070586|FG001|NOT COMPLETED|Experimental Condition: Brimless||0
9951751|NCT01416142|11070592|FG000|STARTED|Cross Over at Movie Intermission||32
9951752|NCT01416142|11070593|FG001|STARTED|Cross Over at Movie Intermission||31
9951753|NCT01416142|11070594|FG002|STARTED|Cross Over at Movie Intermission||0
9951754|NCT01416142|11070592|FG000|COMPLETED|Cross Over at Movie Intermission||32
9951755|NCT01416142|11070593|FG001|COMPLETED|Cross Over at Movie Intermission||31
10011825|NCT01782495|11134591|FG005|COMPLETED|Overall Study||22
10011826|NCT01782495|11134592|FG006|COMPLETED|Overall Study||12
10011827|NCT01782495|11134593|FG007|COMPLETED|Overall Study||6
10011828|NCT01782495|11134594|FG008|COMPLETED|Overall Study||3
10011829|NCT01782495|11134595|FG009|COMPLETED|Overall Study||2
10011830|NCT01782495|11134596|FG010|COMPLETED|Overall Study||1
10209443|NCT03570047|11336665|FG001|COMPLETED|Overall Study||22336
10209444|NCT03570047|11336666|FG002|COMPLETED|Overall Study||6925
10209445|NCT03570047|11336667|FG003|COMPLETED|Overall Study||16564
10209446|NCT03570047|11336668|FG004|COMPLETED|Overall Study||12262
10209447|NCT03570047|11336664|FG000|NOT COMPLETED|Overall Study||0
10209448|NCT03570047|11336665|FG001|NOT COMPLETED|Overall Study||0
10209449|NCT03570047|11336666|FG002|NOT COMPLETED|Overall Study||0
10209450|NCT03570047|11336667|FG003|NOT COMPLETED|Overall Study||0
10209451|NCT03570047|11336668|FG004|NOT COMPLETED|Overall Study||0
10209452|NCT03570255|11336680|FG000|STARTED|Overall Study||28
10209453|NCT03570255|11336680|FG000|COMPLETED|Overall Study||28
10209454|NCT03570255|11336680|FG000|NOT COMPLETED|Overall Study||0
10209455|NCT03570476|11336684|FG000|STARTED|Overall Study||2
10209456|NCT03570476|11336684|FG000|COMPLETED|Overall Study||2
10209457|NCT03570476|11336684|FG000|NOT COMPLETED|Overall Study||0
10209458|NCT03570554|11336693|FG000|STARTED|Overall Study||10
10209459|NCT03570554|11336694|FG001|STARTED|Overall Study||10
10209460|NCT03570554|11336695|FG002|STARTED|Overall Study||11
10209461|NCT03570554|11336696|FG003|STARTED|Overall Study||10
10209462|NCT03570554|11336693|FG000|COMPLETED|Overall Study||10
10209463|NCT03570554|11336694|FG001|COMPLETED|Overall Study||10
10209464|NCT03570554|11336695|FG002|COMPLETED|Overall Study||10
10209465|NCT03570554|11336696|FG003|COMPLETED|Overall Study||9
10209466|NCT03570554|11336693|FG000|NOT COMPLETED|Overall Study||0
10209467|NCT03570554|11336694|FG001|NOT COMPLETED|Overall Study||0
10209468|NCT03570554|11336695|FG002|NOT COMPLETED|Overall Study||1
10209469|NCT03570554|11336696|FG003|NOT COMPLETED|Overall Study||1
10209470|NCT03570658|11336710|FG000|STARTED|Single Ascending Dose (SAD)||6
10209471|NCT03570658|11336711|FG001|STARTED|Single Ascending Dose (SAD)||2
10209472|NCT03570658|11336712|FG002|STARTED|Single Ascending Dose (SAD)||10
10209473|NCT03570658|11336713|FG003|STARTED|Single Ascending Dose (SAD)||10
10209474|NCT03570658|11336710|FG000|COMPLETED|Single Ascending Dose (SAD)||6
10209475|NCT03570658|11336711|FG001|COMPLETED|Single Ascending Dose (SAD)||2
10209476|NCT03570658|11336712|FG002|COMPLETED|Single Ascending Dose (SAD)||10
10209477|NCT03570658|11336713|FG003|COMPLETED|Single Ascending Dose (SAD)||10
10209478|NCT03570658|11336710|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
10209479|NCT03570658|11336711|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
10209480|NCT03570658|11336712|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
10209481|NCT03570658|11336713|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
10209482|NCT03570658|11336710|FG000|STARTED|Multiple Ascending Dose (MAD)||4
10209483|NCT03570658|11336711|FG001|STARTED|Multiple Ascending Dose (MAD)||0
10209484|NCT03570658|11336712|FG002|STARTED|Multiple Ascending Dose (MAD)||10
10209485|NCT03570658|11336713|FG003|STARTED|Multiple Ascending Dose (MAD)||10
10209486|NCT03570658|11336710|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4
10209487|NCT03570658|11336711|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
10209488|NCT03570658|11336712|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10
10209489|NCT03570658|11336713|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10
9760726|NCT00382993|10864496|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
9760727|NCT00382993|10864497|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
9760728|NCT00383019|10864505|FG000|STARTED|Overall Study||144
9760729|NCT00383019|10864506|FG001|STARTED|Overall Study||145
9760730|NCT00383019|10864505|FG000|COMPLETED|Overall Study||139
9760731|NCT00383019|10864506|FG001|COMPLETED|Overall Study||143
9760732|NCT00383019|10864505|FG000|NOT COMPLETED|Overall Study||5
9760733|NCT00383019|10864506|FG001|NOT COMPLETED|Overall Study||2
9760734|NCT00383071|10864516|FG000|STARTED|Overall Study||25
9760735|NCT00383071|10864517|FG001|STARTED|Overall Study||25
9760736|NCT00383071|10864518|FG002|STARTED|Overall Study||51
9760737|NCT00383071|10864519|FG003|STARTED|Overall Study||25
9951756|NCT01416142|11070594|FG002|COMPLETED|Cross Over at Movie Intermission||0
9951757|NCT01416142|11070592|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0
9951758|NCT01416142|11070593|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0
10011831|NCT01782495|11134586|FG000|NOT COMPLETED|Overall Study||0
10011832|NCT01782495|11134587|FG001|NOT COMPLETED|Overall Study||1
10011833|NCT01782495|11134588|FG002|NOT COMPLETED|Overall Study||0
10209490|NCT03570658|11336710|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10209491|NCT03570658|11336711|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10209492|NCT03570658|11336712|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10209493|NCT03570658|11336713|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10209494|NCT03571256|11336740|FG000|STARTED|Overall Study||52
10209495|NCT03571256|11336741|FG001|STARTED|Overall Study||54
10209496|NCT03571256|11336742|FG002|STARTED|Overall Study||52
9951759|NCT01416142|11070594|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0
9951760|NCT01416142|11070592|FG000|STARTED|PureVision2 HD||0
9951761|NCT01416142|11070593|FG001|STARTED|PureVision2 HD||0
9951762|NCT01416142|11070594|FG002|STARTED|PureVision2 HD||63
9951763|NCT01416142|11070592|FG000|COMPLETED|PureVision2 HD||0
9951764|NCT01416142|11070593|FG001|COMPLETED|PureVision2 HD||0
9951765|NCT01416142|11070594|FG002|COMPLETED|PureVision2 HD||62
9951766|NCT01416142|11070592|FG000|NOT COMPLETED|PureVision2 HD||0
9951767|NCT01416142|11070593|FG001|NOT COMPLETED|PureVision2 HD||0
9951768|NCT01416142|11070594|FG002|NOT COMPLETED|PureVision2 HD||1
9951769|NCT01416155|11070602|FG000|STARTED|Overall Study||97
9951770|NCT01416155|11070602|FG000|COMPLETED|Overall Study||39
9951771|NCT01416155|11070602|FG000|NOT COMPLETED|Overall Study||58
9951772|NCT01416181|11070608|FG000|STARTED|Part 1||449
9951773|NCT01416181|11070609|FG001|STARTED|Part 1||440
9951774|NCT01416181|11070608|FG000|Withdrew Prior to Dosing|Part 1||0
9951775|NCT01416181|11070609|FG001|Withdrew Prior to Dosing|Part 1||1
9951776|NCT01416181|11070608|FG000|COMPLETED|Part 1|Completed Study through Week 108|312
9951777|NCT01416181|11070609|FG001|COMPLETED|Part 1|Completed Study through Week 108|326
9951778|NCT01416181|11070608|FG000|NOT COMPLETED|Part 1||137
9951779|NCT01416181|11070609|FG001|NOT COMPLETED|Part 1||114
9951780|NCT01416181|11070608|FG000|STARTED|Part 2||274
9951781|NCT01416181|11070609|FG001|STARTED|Part 2||292
9951782|NCT01416181|11070608|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
9951783|NCT01416181|11070609|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
9951784|NCT01416181|11070608|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
9951785|NCT01416181|11070609|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
9951786|NCT01416181|11070608|FG000|Completed Treatment for > 96 Weeks|Part 2||1
9951787|NCT01416181|11070609|FG001|Completed Treatment for > 96 Weeks|Part 2||0
9951788|NCT01416181|11070608|FG000|COMPLETED|Part 2||3
9951789|NCT01416181|11070609|FG001|COMPLETED|Part 2||6
9951790|NCT01416181|11070608|FG000|NOT COMPLETED|Part 2||271
9951791|NCT01416181|11070609|FG001|NOT COMPLETED|Part 2||286
9951792|NCT01416194|11070618|FG000|STARTED|Overall Study||1111
9951793|NCT01416194|11070619|FG001|STARTED|Overall Study||2720
9951794|NCT01416194|11070620|FG002|STARTED|Overall Study||6666
9951795|NCT01416194|11070618|FG000|COMPLETED|Overall Study||1111
9951796|NCT01416194|11070619|FG001|COMPLETED|Overall Study||2720
9951797|NCT01416194|11070620|FG002|COMPLETED|Overall Study||6666
9951798|NCT01416194|11070618|FG000|NOT COMPLETED|Overall Study||0
9951799|NCT01416194|11070619|FG001|NOT COMPLETED|Overall Study||0
9951800|NCT01416194|11070620|FG002|NOT COMPLETED|Overall Study||0
9951801|NCT01416389|11070632|FG000|STARTED|Overall Study||26
9951802|NCT01416389|11070633|FG001|STARTED|Overall Study||13
9951803|NCT01416389|11070632|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
9951804|NCT01416389|11070633|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
9951805|NCT01416389|11070632|FG000|COMPLETED|Overall Study||23
9951806|NCT01416389|11070633|FG001|COMPLETED|Overall Study||13
9951807|NCT01416389|11070632|FG000|NOT COMPLETED|Overall Study||3
9951808|NCT01416389|11070633|FG001|NOT COMPLETED|Overall Study||0
10209497|NCT03571256|11336740|FG000|Safety Analysis Set|Overall Study||52
10209498|NCT03571256|11336741|FG001|Safety Analysis Set|Overall Study||54
10209499|NCT03571256|11336742|FG002|Safety Analysis Set|Overall Study||51
10209500|NCT03571256|11336740|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49
10209501|NCT03571256|11336741|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53
10209502|NCT03571256|11336742|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51
10209503|NCT03571256|11336740|FG000|COMPLETED|Overall Study||46
10209504|NCT03571256|11336741|FG001|COMPLETED|Overall Study||51
10209505|NCT03571256|11336742|FG002|COMPLETED|Overall Study||48
10209506|NCT03571256|11336740|FG000|NOT COMPLETED|Overall Study||6
10209507|NCT03571256|11336741|FG001|NOT COMPLETED|Overall Study||3
10209508|NCT03571256|11336742|FG002|NOT COMPLETED|Overall Study||4
10209509|NCT03571516|11336754|FG000|STARTED|Overall Study||5
10209510|NCT03571516|11336755|FG001|STARTED|Overall Study||5
10209511|NCT03571516|11336754|FG000|COMPLETED|Overall Study||4
9951809|NCT01416441|11070641|FG000|STARTED|Overall Study||170
9951810|NCT01416441|11070641|FG000|COMPLETED|Overall Study||89
9951811|NCT01416441|11070641|FG000|NOT COMPLETED|Overall Study||81
9951812|NCT01416571|11070645|FG000|STARTED|Overall Study||78
9951813|NCT01416571|11070645|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
9951814|NCT01416571|11070645|FG000|NOT COMPLETED|Overall Study||2
9951815|NCT01416584|11070652|FG000|STARTED|Overall Study||30
9951816|NCT01416584|11070653|FG001|STARTED|Overall Study||35
9951817|NCT01416584|11070654|FG002|STARTED|Overall Study||33
9951818|NCT01416584|11070652|FG000|COMPLETED|Overall Study||27
9951819|NCT01416584|11070653|FG001|COMPLETED|Overall Study||33
9951820|NCT01416584|11070654|FG002|COMPLETED|Overall Study||32
9951821|NCT01416584|11070652|FG000|NOT COMPLETED|Overall Study||3
9951822|NCT01416584|11070653|FG001|NOT COMPLETED|Overall Study||2
9951823|NCT01416584|11070654|FG002|NOT COMPLETED|Overall Study||1
9951824|NCT01416610|11070668|FG000|STARTED|Overall Study||88
9951825|NCT01416610|11070668|FG000|Intention to Treat|Overall Study||88
9951826|NCT01416610|11070668|FG000|Safety Population|Overall Study||86
10209512|NCT03571516|11336755|FG001|COMPLETED|Overall Study||4
10209513|NCT03571516|11336754|FG000|NOT COMPLETED|Overall Study||1
10209514|NCT03571516|11336755|FG001|NOT COMPLETED|Overall Study||1
10209515|NCT03571555|11336763|FG000|STARTED|Overall Study||252
10209516|NCT03571555|11336764|FG001|STARTED|Overall Study||263
9951827|NCT01416610|11070668|FG000|Per Protocol|Overall Study||83
9951828|NCT01416610|11070668|FG000|Completed Treatment|Overall Study||47
9951829|NCT01416610|11070668|FG000|Completed Follow-up|Overall Study||45
9951830|NCT01416610|11070668|FG000|COMPLETED|Overall Study||45
9951831|NCT01416610|11070668|FG000|NOT COMPLETED|Overall Study||43
9951832|NCT01416805|11070678|FG000|STARTED|Overall Study||49
9951833|NCT01416805|11070679|FG001|STARTED|Overall Study||51
9951834|NCT01416805|11070678|FG000|COMPLETED|Overall Study||45
9951835|NCT01416805|11070679|FG001|COMPLETED|Overall Study||47
9951836|NCT01416805|11070678|FG000|NOT COMPLETED|Overall Study||4
9951837|NCT01416805|11070679|FG001|NOT COMPLETED|Overall Study||4
9951838|NCT01416987|11070685|FG000|STARTED|Overall Study||600
9951839|NCT01416987|11070685|FG000|COMPLETED|Overall Study||600
9951840|NCT01416987|11070685|FG000|NOT COMPLETED|Overall Study||0
9951841|NCT01417000|11070691|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
9951842|NCT01417000|11070692|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
9951843|NCT01417000|11070691|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
9951844|NCT01417000|11070692|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
9951845|NCT01417000|11070691|FG000|NOT COMPLETED|Overall Study||61
9951846|NCT01417000|11070692|FG001|NOT COMPLETED|Overall Study||29
9951847|NCT01417026|11070700|FG000|STARTED|Overall Study||16
9951848|NCT01417026|11070701|FG001|STARTED|Overall Study||13
9951849|NCT01417026|11070700|FG000|COMPLETED|Overall Study||14
9951850|NCT01417026|11070701|FG001|COMPLETED|Overall Study||13
9951851|NCT01417026|11070700|FG000|NOT COMPLETED|Overall Study||2
9951852|NCT01417026|11070701|FG001|NOT COMPLETED|Overall Study||0
9951853|NCT01417078|11070707|FG000|STARTED|Overall Study||31
9951854|NCT01417078|11070707|FG000|COMPLETED|Overall Study||30
9951855|NCT01417078|11070707|FG000|NOT COMPLETED|Overall Study||1
9951856|NCT01417104|11070715|FG000|STARTED|Overall Study||34
9951857|NCT01417104|11070716|FG001|STARTED|Overall Study||37
9951858|NCT01417104|11070715|FG000|COMPLETED|Overall Study||28
9951859|NCT01417104|11070716|FG001|COMPLETED|Overall Study||35
9951860|NCT01417104|11070715|FG000|NOT COMPLETED|Overall Study||6
9951861|NCT01417104|11070716|FG001|NOT COMPLETED|Overall Study||2
9951862|NCT01417156|11070722|FG000|STARTED|Overall Study||20
9951863|NCT01417156|11070722|FG000|COMPLETED|Overall Study||6
9951864|NCT01417156|11070722|FG000|NOT COMPLETED|Overall Study||14
9951865|NCT01417195|11070728|FG000|STARTED|Overall Study||60
9951866|NCT01417195|11070729|FG001|STARTED|Overall Study||62
9951867|NCT01417195|11070728|FG000|COMPLETED|Overall Study||57
9951868|NCT01417195|11070729|FG001|COMPLETED|Overall Study||61
10011834|NCT01782495|11134589|FG003|NOT COMPLETED|Overall Study||0
10011835|NCT01782495|11134590|FG004|NOT COMPLETED|Overall Study||0
10011836|NCT01782495|11134591|FG005|NOT COMPLETED|Overall Study||0
10011837|NCT01782495|11134592|FG006|NOT COMPLETED|Overall Study||0
10011838|NCT01782495|11134593|FG007|NOT COMPLETED|Overall Study||3
10011839|NCT01782495|11134594|FG008|NOT COMPLETED|Overall Study||0
10011840|NCT01782495|11134595|FG009|NOT COMPLETED|Overall Study||0
10011841|NCT01782495|11134596|FG010|NOT COMPLETED|Overall Study||0
10209517|NCT03571555|11336763|FG000|COMPLETED|Overall Study||177
10209518|NCT03571555|11336764|FG001|COMPLETED|Overall Study||195
10209519|NCT03571555|11336763|FG000|NOT COMPLETED|Overall Study||75
10209520|NCT03571555|11336764|FG001|NOT COMPLETED|Overall Study||68
10209521|NCT03571607|11336772|FG000|STARTED|Overall Study||53
10209522|NCT03571607|11336773|FG001|STARTED|Overall Study||153
10209523|NCT03571607|11336772|FG000|Vaccinated|Overall Study||53
10209524|NCT03571607|11336773|FG001|Vaccinated|Overall Study||153
10209525|NCT03571607|11336772|FG000|COMPLETED|Overall Study||53
10209526|NCT03571607|11336773|FG001|COMPLETED|Overall Study||153
10209527|NCT03571607|11336772|FG000|NOT COMPLETED|Overall Study||0
10209528|NCT03571607|11336773|FG001|NOT COMPLETED|Overall Study||0
10209529|NCT03571672|11336781|FG000|STARTED|Overall Study||153
10209530|NCT03571672|11336781|FG000|COMPLETED|Overall Study||148
10209531|NCT03571672|11336781|FG000|NOT COMPLETED|Overall Study||5
10209532|NCT03571724|11336791|FG000|STARTED|Week -1 (Prior to Switching)||0
10209533|NCT03571724|11336792|FG001|STARTED|Week -1 (Prior to Switching)||0
10209534|NCT03571724|11336793|FG002|STARTED|Week -1 (Prior to Switching)||72
10209535|NCT03571724|11336794|FG003|STARTED|Week -1 (Prior to Switching)||70
10209536|NCT03571724|11336791|FG000|Topography|Week -1 (Prior to Switching)||0
10209537|NCT03571724|11336792|FG001|Topography|Week -1 (Prior to Switching)||0
10209538|NCT03571724|11336793|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
10209539|NCT03571724|11336794|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
10209540|NCT03571724|11336791|FG000|PK Nicotine|Week -1 (Prior to Switching)||0
9951869|NCT01417195|11070728|FG000|NOT COMPLETED|Overall Study||3
9951870|NCT01417195|11070729|FG001|NOT COMPLETED|Overall Study||1
9951871|NCT01417234|11070736|FG000|STARTED|Overall Study||30
9951872|NCT01417234|11070736|FG000|COMPLETED|Overall Study||27
9951873|NCT01417234|11070736|FG000|NOT COMPLETED|Overall Study||3
10209541|NCT03571724|11336792|FG001|PK Nicotine|Week -1 (Prior to Switching)||0
9951874|NCT01417455|11070748|FG000|STARTED|Overall Study||16
9951875|NCT01417455|11070749|FG001|STARTED|Overall Study||16
9951876|NCT01417455|11070750|FG002|STARTED|Overall Study||17
9951877|NCT01417455|11070751|FG003|STARTED|Overall Study||17
10011842|NCT01782664|11134626|FG000|STARTED|Overall Study||14
9951878|NCT01417455|11070752|FG004|STARTED|Overall Study||30
9951879|NCT01417455|11070753|FG005|STARTED|Overall Study||13
9951880|NCT01417455|11070754|FG006|STARTED|Overall Study||13
9951881|NCT01417455|11070755|FG007|STARTED|Overall Study||25
9951882|NCT01417455|11070748|FG000|COMPLETED|Overall Study||16
9951883|NCT01417455|11070749|FG001|COMPLETED|Overall Study||16
9951884|NCT01417455|11070750|FG002|COMPLETED|Overall Study||17
9951885|NCT01417455|11070751|FG003|COMPLETED|Overall Study||17
9951886|NCT01417455|11070752|FG004|COMPLETED|Overall Study||30
9951887|NCT01417455|11070753|FG005|COMPLETED|Overall Study||13
9951888|NCT01417455|11070754|FG006|COMPLETED|Overall Study||13
9951889|NCT01417455|11070755|FG007|COMPLETED|Overall Study||25
9951890|NCT01417455|11070748|FG000|NOT COMPLETED|Overall Study||0
9951891|NCT01417455|11070749|FG001|NOT COMPLETED|Overall Study||0
9951892|NCT01417455|11070750|FG002|NOT COMPLETED|Overall Study||0
9951893|NCT01417455|11070751|FG003|NOT COMPLETED|Overall Study||0
9951894|NCT01417455|11070752|FG004|NOT COMPLETED|Overall Study||0
9951895|NCT01417455|11070753|FG005|NOT COMPLETED|Overall Study||0
9951896|NCT01417455|11070754|FG006|NOT COMPLETED|Overall Study||0
9951897|NCT01417455|11070755|FG007|NOT COMPLETED|Overall Study||0
9951898|NCT01417481|11070775|FG000|STARTED|First Intervention (8 Weeks)||8
9951899|NCT01417481|11070776|FG001|STARTED|First Intervention (8 Weeks)||7
9951900|NCT01417481|11070775|FG000|COMPLETED|First Intervention (8 Weeks)||8
9951901|NCT01417481|11070776|FG001|COMPLETED|First Intervention (8 Weeks)||5
9951902|NCT01417481|11070775|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
9951903|NCT01417481|11070776|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2
9951904|NCT01417481|11070775|FG000|STARTED|Washout (2 Weeks)||8
9951905|NCT01417481|11070776|FG001|STARTED|Washout (2 Weeks)||5
9951906|NCT01417481|11070775|FG000|COMPLETED|Washout (2 Weeks)||8
9951907|NCT01417481|11070776|FG001|COMPLETED|Washout (2 Weeks)||5
9951908|NCT01417481|11070775|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10209542|NCT03571724|11336793|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
10209543|NCT03571724|11336794|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
10209544|NCT03571724|11336791|FG000|COMPLETED|Week -1 (Prior to Switching)||0
10209545|NCT03571724|11336792|FG001|COMPLETED|Week -1 (Prior to Switching)||0
10209546|NCT03571724|11336793|FG002|COMPLETED|Week -1 (Prior to Switching)||72
10209547|NCT03571724|11336794|FG003|COMPLETED|Week -1 (Prior to Switching)||70
10209548|NCT03571724|11336791|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0
10209549|NCT03571724|11336792|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0
10209550|NCT03571724|11336793|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0
10209551|NCT03571724|11336794|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0
10209552|NCT03571724|11336791|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
10209553|NCT03571724|11336792|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
10209554|NCT03571724|11336793|FG002|STARTED|Week 1-6||22
10209555|NCT03571724|11336794|FG003|STARTED|Week 1-6||20
10209556|NCT03571724|11336791|FG000|COMPLETED|Week 1-6||43
10209557|NCT03571724|11336792|FG001|COMPLETED|Week 1-6||42
10209558|NCT03571724|11336793|FG002|COMPLETED|Week 1-6||19
10209559|NCT03571724|11336794|FG003|COMPLETED|Week 1-6||20
10209560|NCT03571724|11336791|FG000|NOT COMPLETED|Week 1-6||7
10209561|NCT03571724|11336792|FG001|NOT COMPLETED|Week 1-6||8
10209562|NCT03571724|11336793|FG002|NOT COMPLETED|Week 1-6||3
10209563|NCT03571724|11336794|FG003|NOT COMPLETED|Week 1-6||0
10209564|NCT03572062|11336825|FG000|STARTED|Overall Study||32
10209565|NCT03572062|11336826|FG001|STARTED|Overall Study||32
10209566|NCT03572062|11336827|FG002|STARTED|Overall Study||32
10209567|NCT03572062|11336828|FG003|STARTED|Overall Study||31
10209568|NCT03572062|11336829|FG004|STARTED|Overall Study||32
10209569|NCT03572062|11336830|FG005|STARTED|Overall Study||32
10209570|NCT03572062|11336831|FG006|STARTED|Overall Study||32
10209571|NCT03572062|11336832|FG007|STARTED|Overall Study||31
10209572|NCT03572062|11336833|FG008|STARTED|Overall Study||32
10209573|NCT03572062|11336834|FG009|STARTED|Overall Study||31
10209574|NCT03572062|11336825|FG000|Treated|Overall Study||32
10209575|NCT03572062|11336826|FG001|Treated|Overall Study||32
10209576|NCT03572062|11336827|FG002|Treated|Overall Study||32
10209577|NCT03572062|11336828|FG003|Treated|Overall Study||31
10209578|NCT03572062|11336829|FG004|Treated|Overall Study||31
10209579|NCT03572062|11336830|FG005|Treated|Overall Study||30
10209580|NCT03572062|11336831|FG006|Treated|Overall Study||32
10209581|NCT03572062|11336832|FG007|Treated|Overall Study||30
10209582|NCT03572062|11336833|FG008|Treated|Overall Study||32
10209583|NCT03572062|11336834|FG009|Treated|Overall Study||31
9951909|NCT01417481|11070776|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9951910|NCT01417481|11070775|FG000|STARTED|Second Period (8 Weeks)||8
10209584|NCT03572062|11336825|FG000|COMPLETED|Overall Study||32
10209585|NCT03572062|11336826|FG001|COMPLETED|Overall Study||32
10209586|NCT03572062|11336827|FG002|COMPLETED|Overall Study||32
10209587|NCT03572062|11336828|FG003|COMPLETED|Overall Study||31
10209588|NCT03572062|11336829|FG004|COMPLETED|Overall Study||31
9951911|NCT01417481|11070776|FG001|STARTED|Second Period (8 Weeks)||5
9951912|NCT01417481|11070775|FG000|COMPLETED|Second Period (8 Weeks)||8
9951913|NCT01417481|11070776|FG001|COMPLETED|Second Period (8 Weeks)||5
9951914|NCT01417481|11070775|FG000|NOT COMPLETED|Second Period (8 Weeks)||0
9951915|NCT01417481|11070776|FG001|NOT COMPLETED|Second Period (8 Weeks)||0
9951916|NCT01417741|11070784|FG000|STARTED|Overall Study||75
10209589|NCT03572062|11336830|FG005|COMPLETED|Overall Study||28
10209590|NCT03572062|11336831|FG006|COMPLETED|Overall Study||31
9951917|NCT01417741|11070785|FG001|STARTED|Overall Study||86
9951918|NCT01417741|11070784|FG000|COMPLETED|Overall Study||75
9951919|NCT01417741|11070785|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
9951920|NCT01417741|11070784|FG000|NOT COMPLETED|Overall Study||0
9951921|NCT01417741|11070785|FG001|NOT COMPLETED|Overall Study||0
9951922|NCT01417780|11070794|FG000|STARTED|Overall Study||15
9951923|NCT01417780|11070795|FG001|STARTED|Overall Study||17
9951924|NCT01417780|11070796|FG002|STARTED|Overall Study||11
9951925|NCT01417780|11070794|FG000|COMPLETED|Overall Study||14
9951926|NCT01417780|11070795|FG001|COMPLETED|Overall Study||14
9951927|NCT01417780|11070796|FG002|COMPLETED|Overall Study||9
9951928|NCT01417780|11070794|FG000|NOT COMPLETED|Overall Study||1
9951929|NCT01417780|11070795|FG001|NOT COMPLETED|Overall Study||3
9951930|NCT01417780|11070796|FG002|NOT COMPLETED|Overall Study||2
9951931|NCT01417936|11070804|FG000|STARTED|Overall Study||26
9951932|NCT01417936|11070804|FG000|COMPLETED|Overall Study||26
9951933|NCT01417936|11070804|FG000|NOT COMPLETED|Overall Study||0
9951934|NCT01418001|11070808|FG000|STARTED|Overall Study||5
9951935|NCT01418001|11070808|FG000|COMPLETED|Overall Study||5
9951936|NCT01418001|11070808|FG000|NOT COMPLETED|Overall Study||0
9951937|NCT01418209|11070816|FG000|STARTED|Overall Study||97
9951938|NCT01418209|11070817|FG001|STARTED|Overall Study||96
9951939|NCT01418209|11070818|FG002|STARTED|Overall Study||146
9951940|NCT01418209|11070816|FG000|COMPLETED|Overall Study||95
9951941|NCT01418209|11070817|FG001|COMPLETED|Overall Study||93
9951942|NCT01418209|11070818|FG002|COMPLETED|Overall Study||142
10209591|NCT03572062|11336832|FG007|COMPLETED|Overall Study||30
10209592|NCT03572062|11336833|FG008|COMPLETED|Overall Study||0
10209593|NCT03572062|11336834|FG009|COMPLETED|Overall Study||0
10209594|NCT03572062|11336825|FG000|NOT COMPLETED|Overall Study||0
10209595|NCT03572062|11336826|FG001|NOT COMPLETED|Overall Study||0
10209596|NCT03572062|11336827|FG002|NOT COMPLETED|Overall Study||0
10209597|NCT03572062|11336828|FG003|NOT COMPLETED|Overall Study||0
10209598|NCT03572062|11336829|FG004|NOT COMPLETED|Overall Study||1
10209599|NCT03572062|11336830|FG005|NOT COMPLETED|Overall Study||4
10209600|NCT03572062|11336831|FG006|NOT COMPLETED|Overall Study||1
10209601|NCT03572062|11336832|FG007|NOT COMPLETED|Overall Study||1
10209602|NCT03572062|11336833|FG008|NOT COMPLETED|Overall Study||32
10209603|NCT03572062|11336834|FG009|NOT COMPLETED|Overall Study||31
10209604|NCT03572218|11336856|FG000|STARTED|Overall Study||36
10209605|NCT03572218|11336857|FG001|STARTED|Overall Study||36
10209606|NCT03572218|11336856|FG000|Week 12|Overall Study||30
10209607|NCT03572218|11336857|FG001|Week 12|Overall Study||31
10209608|NCT03572218|11336856|FG000|Week 26|Overall Study||30
10209609|NCT03572218|11336857|FG001|Week 26|Overall Study||31
10209610|NCT03572218|11336856|FG000|COMPLETED|Overall Study||30
10209611|NCT03572218|11336857|FG001|COMPLETED|Overall Study||31
10209612|NCT03572218|11336856|FG000|NOT COMPLETED|Overall Study||6
10209613|NCT03572218|11336857|FG001|NOT COMPLETED|Overall Study||5
10209614|NCT03572478|11336863|FG000|STARTED|Overall Study||12
10209615|NCT03572478|11336863|FG000|COMPLETED|Overall Study||12
10209616|NCT03572478|11336863|FG000|NOT COMPLETED|Overall Study||0
10209617|NCT03572972|11336872|FG000|STARTED|Overall Study||10548
10209618|NCT03572972|11336873|FG001|STARTED|Overall Study||11414
10209619|NCT03572972|11336874|FG002|STARTED|Overall Study||17779
10209620|NCT03572972|11336875|FG003|STARTED|Overall Study||8648
10209621|NCT03572972|11336876|FG004|STARTED|Overall Study||16295
10209622|NCT03572972|11336872|FG000|COMPLETED|Overall Study||10548
10209623|NCT03572972|11336873|FG001|COMPLETED|Overall Study||11414
10209624|NCT03572972|11336874|FG002|COMPLETED|Overall Study||17779
10209625|NCT03572972|11336875|FG003|COMPLETED|Overall Study||8648
10209626|NCT03572972|11336876|FG004|COMPLETED|Overall Study||16295
10209627|NCT03572972|11336872|FG000|NOT COMPLETED|Overall Study||0
10209628|NCT03572972|11336873|FG001|NOT COMPLETED|Overall Study||0
10209629|NCT03572972|11336874|FG002|NOT COMPLETED|Overall Study||0
10209630|NCT03572972|11336875|FG003|NOT COMPLETED|Overall Study||0
10209631|NCT03572972|11336876|FG004|NOT COMPLETED|Overall Study||0
10209632|NCT03573206|11336896|FG000|STARTED|Overall Study||168
10209633|NCT03573206|11336896|FG000|COMPLETED|Overall Study||168
10209634|NCT03573206|11336896|FG000|NOT COMPLETED|Overall Study||0
10209635|NCT03573323|11336902|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520
9951943|NCT01418209|11070816|FG000|NOT COMPLETED|Overall Study||2
9951944|NCT01418209|11070817|FG001|NOT COMPLETED|Overall Study||3
9951945|NCT01418209|11070818|FG002|NOT COMPLETED|Overall Study||4
10209636|NCT03573323|11336903|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507
10209637|NCT03573323|11336902|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
10209638|NCT03573323|11336903|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
10209639|NCT03573323|11336902|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
10209640|NCT03573323|11336903|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
10209641|NCT03573323|11336902|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
9951946|NCT01418339|11070828|FG000|STARTED|Overall Study||90
9951947|NCT01418339|11070829|FG001|STARTED|Overall Study||45
9951948|NCT01418339|11070828|FG000|COMPLETED|Overall Study||78
9951949|NCT01418339|11070829|FG001|COMPLETED|Overall Study||35
9951950|NCT01418339|11070828|FG000|NOT COMPLETED|Overall Study||12
10209642|NCT03573323|11336903|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
10209643|NCT03573323|11336902|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
10209644|NCT03573323|11336903|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
9951951|NCT01418339|11070829|FG001|NOT COMPLETED|Overall Study||10
9951952|NCT01418352|11070839|FG000|STARTED|Overall Study||20
9951953|NCT01418352|11070840|FG001|STARTED|Overall Study||21
9951954|NCT01418352|11070841|FG002|STARTED|Overall Study||21
9951955|NCT01418352|11070842|FG003|STARTED|Overall Study||21
9951956|NCT01418352|11070839|FG000|COMPLETED|Overall Study||17
9951957|NCT01418352|11070840|FG001|COMPLETED|Overall Study||17
9951958|NCT01418352|11070841|FG002|COMPLETED|Overall Study||16
9951959|NCT01418352|11070842|FG003|COMPLETED|Overall Study||18
9951960|NCT01418352|11070839|FG000|NOT COMPLETED|Overall Study||3
9951961|NCT01418352|11070840|FG001|NOT COMPLETED|Overall Study||4
9951962|NCT01418352|11070841|FG002|NOT COMPLETED|Overall Study||5
9951963|NCT01418352|11070842|FG003|NOT COMPLETED|Overall Study||3
9951964|NCT01418365|11070854|FG000|STARTED|First Intervention||15
9951965|NCT01418365|11070855|FG001|STARTED|First Intervention||15
9951966|NCT01418365|11070854|FG000|COMPLETED|First Intervention||14
9951967|NCT01418365|11070855|FG001|COMPLETED|First Intervention||14
9951968|NCT01418365|11070854|FG000|NOT COMPLETED|First Intervention||1
10011843|NCT01782664|11134627|FG001|STARTED|Overall Study||15
10011844|NCT01782664|11134628|FG002|STARTED|Overall Study||16
10011845|NCT01782664|11134629|FG003|STARTED|Overall Study||14
10011846|NCT01782664|11134630|FG004|STARTED|Overall Study||6
10209645|NCT03573323|11336902|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
10209646|NCT03573323|11336903|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
10209647|NCT03573323|11336902|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
10209648|NCT03573323|11336903|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
10209649|NCT03573505|11336915|FG000|STARTED|Overall Study||52
10209650|NCT03573505|11336916|FG001|STARTED|Overall Study||54
10209651|NCT03573505|11336915|FG000|COMPLETED|Overall Study||0
10209652|NCT03573505|11336916|FG001|COMPLETED|Overall Study||0
10209653|NCT03573505|11336915|FG000|NOT COMPLETED|Overall Study||52
10209654|NCT03573505|11336916|FG001|NOT COMPLETED|Overall Study||54
10209655|NCT03573804|11336923|FG000|STARTED|Overall Study||72
10209656|NCT03573804|11336923|FG000|COMPLETED|Overall Study||62
10209657|NCT03573804|11336923|FG000|NOT COMPLETED|Overall Study||10
10209658|NCT03573830|11336935|FG000|STARTED|Overall Study||364
10209659|NCT03573830|11336936|FG001|STARTED|Overall Study||367
10209660|NCT03573830|11336935|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
10209661|NCT03573830|11336936|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
10209662|NCT03573830|11336935|FG000|COMPLETED|Overall Study||360
10209663|NCT03573830|11336936|FG001|COMPLETED|Overall Study||360
10209664|NCT03573830|11336935|FG000|NOT COMPLETED|Overall Study||4
10209665|NCT03573830|11336936|FG001|NOT COMPLETED|Overall Study||7
10209666|NCT03573908|11336943|FG000|STARTED|Treatment Period||308
10209667|NCT03573908|11336944|FG001|STARTED|Treatment Period||306
10209668|NCT03573908|11336945|FG002|STARTED|Treatment Period||0
10209669|NCT03573908|11336946|FG003|STARTED|Treatment Period||0
10209670|NCT03573908|11336947|FG004|STARTED|Treatment Period||0
10209671|NCT03573908|11336943|FG000|COMPLETED|Treatment Period||284
10209672|NCT03573908|11336944|FG001|COMPLETED|Treatment Period||280
10209673|NCT03573908|11336945|FG002|COMPLETED|Treatment Period||0
10209674|NCT03573908|11336946|FG003|COMPLETED|Treatment Period||0
10209675|NCT03573908|11336947|FG004|COMPLETED|Treatment Period||0
10209676|NCT03573908|11336943|FG000|NOT COMPLETED|Treatment Period||24
10209677|NCT03573908|11336944|FG001|NOT COMPLETED|Treatment Period||26
10209678|NCT03573908|11336945|FG002|NOT COMPLETED|Treatment Period||0
10209679|NCT03573908|11336946|FG003|NOT COMPLETED|Treatment Period||0
10209680|NCT03573908|11336947|FG004|NOT COMPLETED|Treatment Period||0
10209681|NCT03573908|11336943|FG000|STARTED|Randomized Withdrawal Period||0
9951969|NCT01418365|11070855|FG001|NOT COMPLETED|First Intervention||1
9951970|NCT01418365|11070854|FG000|STARTED|Second Intervention||14
9951971|NCT01418365|11070855|FG001|STARTED|Second Intervention||14
9951972|NCT01418365|11070854|FG000|COMPLETED|Second Intervention||14
10011847|NCT01782664|11134631|FG005|STARTED|Overall Study||2
10011848|NCT01782664|11134626|FG000|COMPLETED|Overall Study||8
10011849|NCT01782664|11134627|FG001|COMPLETED|Overall Study||10
10209682|NCT03573908|11336944|FG001|STARTED|Randomized Withdrawal Period||0
10209683|NCT03573908|11336945|FG002|STARTED|Randomized Withdrawal Period||280
10209684|NCT03573908|11336946|FG003|STARTED|Randomized Withdrawal Period||138
10209685|NCT03573908|11336947|FG004|STARTED|Randomized Withdrawal Period||139
10209686|NCT03573908|11336943|FG000|COMPLETED|Randomized Withdrawal Period||0
10209687|NCT03573908|11336944|FG001|COMPLETED|Randomized Withdrawal Period||0
10209688|NCT03573908|11336945|FG002|COMPLETED|Randomized Withdrawal Period||272
10209689|NCT03573908|11336946|FG003|COMPLETED|Randomized Withdrawal Period||136
10209690|NCT03573908|11336947|FG004|COMPLETED|Randomized Withdrawal Period||137
10209691|NCT03573908|11336943|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
10209692|NCT03573908|11336944|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
9951973|NCT01418365|11070855|FG001|COMPLETED|Second Intervention||13
9951974|NCT01418365|11070854|FG000|NOT COMPLETED|Second Intervention||0
9951975|NCT01418365|11070855|FG001|NOT COMPLETED|Second Intervention||1
9951976|NCT01418378|11070863|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
9951977|NCT01418378|11070864|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
9951978|NCT01418378|11070863|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
9951979|NCT01418378|11070864|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
9951980|NCT01418378|11070863|FG000|COMPLETED|Overall Study||89
9951981|NCT01418378|11070864|FG001|COMPLETED|Overall Study||83
9951982|NCT01418378|11070863|FG000|NOT COMPLETED|Overall Study||1
9951983|NCT01418378|11070864|FG001|NOT COMPLETED|Overall Study||5
9951984|NCT01418482|11070870|FG000|STARTED|Overall Study||15
9951985|NCT01418482|11070870|FG000|COMPLETED|Overall Study||15
9951986|NCT01418482|11070870|FG000|NOT COMPLETED|Overall Study||0
9951987|NCT01418703|11070876|FG000|STARTED|Overall Study||13
9951988|NCT01418703|11070877|FG001|STARTED|Overall Study||13
9951989|NCT01418703|11070878|FG002|STARTED|Overall Study||6
9951990|NCT01418703|11070879|FG003|STARTED|Overall Study||6
10011850|NCT01782664|11134628|FG002|COMPLETED|Overall Study||12
10011851|NCT01782664|11134629|FG003|COMPLETED|Overall Study||9
10209693|NCT03573908|11336945|FG002|NOT COMPLETED|Randomized Withdrawal Period||8
10209694|NCT03573908|11336946|FG003|NOT COMPLETED|Randomized Withdrawal Period||2
10209695|NCT03573908|11336947|FG004|NOT COMPLETED|Randomized Withdrawal Period||2
10209696|NCT03574181|11336956|FG000|STARTED|Overall Study||9
10209697|NCT03574181|11336956|FG000|COMPLETED|Overall Study||0
10209698|NCT03574181|11336956|FG000|NOT COMPLETED|Overall Study||9
10209699|NCT03574441|11336963|FG000|STARTED|Overall Study||31
10209700|NCT03574441|11336964|FG001|STARTED|Overall Study||30
10209701|NCT03574441|11336965|FG002|STARTED|Overall Study||30
10209702|NCT03574441|11336963|FG000|COMPLETED|Overall Study||31
10209703|NCT03574441|11336964|FG001|COMPLETED|Overall Study||30
10209704|NCT03574441|11336965|FG002|COMPLETED|Overall Study||30
10209705|NCT03574441|11336963|FG000|NOT COMPLETED|Overall Study||0
10209706|NCT03574441|11336964|FG001|NOT COMPLETED|Overall Study||0
10209707|NCT03574441|11336965|FG002|NOT COMPLETED|Overall Study||0
10209708|NCT03574753|11336973|FG000|STARTED|Overall Study||23
10209709|NCT03574753|11336973|FG000|COMPLETED|Overall Study||0
10209710|NCT03574753|11336973|FG000|NOT COMPLETED|Overall Study||23
10209711|NCT03574818|11336978|FG000|STARTED|Overall Study||1
10209712|NCT03574818|11336978|FG000|COMPLETED|Overall Study||1
10209713|NCT03574818|11336978|FG000|NOT COMPLETED|Overall Study||0
10209714|NCT03575702|11336984|FG000|STARTED|Overall Study||149
10209715|NCT03575702|11336985|FG001|STARTED|Overall Study||150
10209716|NCT03575702|11336984|FG000|COMPLETED|Overall Study||143
10209717|NCT03575702|11336985|FG001|COMPLETED|Overall Study||146
10209718|NCT03575702|11336984|FG000|NOT COMPLETED|Overall Study||6
10209719|NCT03575702|11336985|FG001|NOT COMPLETED|Overall Study||4
10209720|NCT03575754|11336993|FG000|STARTED|Overall Study||25
10209721|NCT03575754|11336994|FG001|STARTED|Overall Study||25
10209722|NCT03575754|11336993|FG000|COMPLETED|Overall Study||25
10209723|NCT03575754|11336994|FG001|COMPLETED|Overall Study||25
10209724|NCT03575754|11336993|FG000|NOT COMPLETED|Overall Study||0
10209725|NCT03575754|11336994|FG001|NOT COMPLETED|Overall Study||0
10209726|NCT03575806|11337002|FG000|STARTED|Overall Study||25
10209727|NCT03575806|11337003|FG001|STARTED|Overall Study||27
10209728|NCT03575806|11337002|FG000|COMPLETED|Overall Study||25
10209729|NCT03575806|11337003|FG001|COMPLETED|Overall Study||23
10209730|NCT03575806|11337002|FG000|NOT COMPLETED|Overall Study||0
10209731|NCT03575806|11337003|FG001|NOT COMPLETED|Overall Study||4
10209732|NCT03575871|11337012|FG000|STARTED|Overall Study||158
10209733|NCT03575871|11337013|FG001|STARTED|Overall Study||155
10209734|NCT03575871|11337014|FG002|STARTED|Overall Study||78
10209735|NCT03575871|11337012|FG000|COMPLETED|Overall Study||137
10209736|NCT03575871|11337013|FG001|COMPLETED|Overall Study||141
10209737|NCT03575871|11337014|FG002|COMPLETED|Overall Study||52
10209738|NCT03575871|11337012|FG000|NOT COMPLETED|Overall Study||21
10209739|NCT03575871|11337013|FG001|NOT COMPLETED|Overall Study||14
10209740|NCT03575871|11337014|FG002|NOT COMPLETED|Overall Study||26
10209741|NCT03575962|11337022|FG000|STARTED|Treatment Period 1 (4 Days)||7
10209742|NCT03575962|11337023|FG001|STARTED|Treatment Period 1 (4 Days)||7
9951991|NCT01418703|11070876|FG000|COMPLETED|Overall Study||13
10011852|NCT01782664|11134630|FG004|COMPLETED|Overall Study||6
10209743|NCT03575962|11337022|FG000|COMPLETED|Treatment Period 1 (4 Days)||7
10209744|NCT03575962|11337023|FG001|COMPLETED|Treatment Period 1 (4 Days)||7
10209745|NCT03575962|11337022|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10209746|NCT03575962|11337023|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10209747|NCT03575962|11337022|FG000|STARTED|Washout Period (7 Days)||7
10209748|NCT03575962|11337023|FG001|STARTED|Washout Period (7 Days)||7
10209749|NCT03575962|11337022|FG000|COMPLETED|Washout Period (7 Days)||7
10209750|NCT03575962|11337023|FG001|COMPLETED|Washout Period (7 Days)||7
10209751|NCT03575962|11337022|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10209752|NCT03575962|11337023|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10209753|NCT03575962|11337022|FG000|STARTED|Treatment Period 2 (4 Days)||7
10209754|NCT03575962|11337023|FG001|STARTED|Treatment Period 2 (4 Days)||7
10209755|NCT03575962|11337022|FG000|COMPLETED|Treatment Period 2 (4 Days)||7
10209756|NCT03575962|11337023|FG001|COMPLETED|Treatment Period 2 (4 Days)||7
9951992|NCT01418703|11070877|FG001|COMPLETED|Overall Study||13
9951993|NCT01418703|11070878|FG002|COMPLETED|Overall Study||6
9951994|NCT01418703|11070879|FG003|COMPLETED|Overall Study||6
9951995|NCT01418703|11070876|FG000|NOT COMPLETED|Overall Study||0
9951996|NCT01418703|11070877|FG001|NOT COMPLETED|Overall Study||0
9951997|NCT01418703|11070878|FG002|NOT COMPLETED|Overall Study||0
9951998|NCT01418703|11070879|FG003|NOT COMPLETED|Overall Study||0
9951999|NCT01418937|11070886|FG000|STARTED|Overall Study||164
9952000|NCT01418937|11070886|FG000|COMPLETED|Overall Study||156
9952001|NCT01418937|11070886|FG000|NOT COMPLETED|Overall Study||8
9952002|NCT01419015|11070890|FG000|STARTED|Overall Study||17
9952003|NCT01419015|11070890|FG000|COMPLETED|Overall Study||15
9952004|NCT01419015|11070890|FG000|NOT COMPLETED|Overall Study||2
9952005|NCT01419028|11070894|FG000|STARTED|Overall Study||48
9952006|NCT01419028|11070894|FG000|COMPLETED|Overall Study||48
9952007|NCT01419028|11070894|FG000|NOT COMPLETED|Overall Study||0
9952008|NCT01419171|11070898|FG000|STARTED|Overall Study||328
9952009|NCT01419171|11070898|FG000|COMPLETED|Overall Study||328
9952010|NCT01419171|11070898|FG000|NOT COMPLETED|Overall Study||0
9952011|NCT01419184|11070904|FG000|STARTED|Overall Study||128
9952012|NCT01419184|11070905|FG001|STARTED|Overall Study||121
9952013|NCT01419184|11070904|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
9952014|NCT01419184|11070905|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106
9952015|NCT01419184|11070904|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
10011853|NCT01782664|11134631|FG005|COMPLETED|Overall Study||2
10011854|NCT01782664|11134626|FG000|NOT COMPLETED|Overall Study||6
10011855|NCT01782664|11134627|FG001|NOT COMPLETED|Overall Study||5
10011856|NCT01782664|11134628|FG002|NOT COMPLETED|Overall Study||4
10011857|NCT01782664|11134629|FG003|NOT COMPLETED|Overall Study||5
10011858|NCT01782664|11134630|FG004|NOT COMPLETED|Overall Study||0
10011859|NCT01782664|11134631|FG005|NOT COMPLETED|Overall Study||0
10011860|NCT01782690|11134645|FG000|STARTED|Overall Study||338
10011861|NCT01782690|11134645|FG000|COMPLETED|Overall Study||39
10209757|NCT03575962|11337022|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10209758|NCT03575962|11337023|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10209759|NCT03575975|11337032|FG000|STARTED|Overall Study||4
10209760|NCT03575975|11337033|FG001|STARTED|Overall Study||5
10209761|NCT03575975|11337034|FG002|STARTED|Overall Study||0
10209762|NCT03575975|11337032|FG000|COMPLETED|Overall Study||3
10209763|NCT03575975|11337033|FG001|COMPLETED|Overall Study||5
10209764|NCT03575975|11337034|FG002|COMPLETED|Overall Study||0
10209765|NCT03575975|11337032|FG000|NOT COMPLETED|Overall Study||1
10209766|NCT03575975|11337033|FG001|NOT COMPLETED|Overall Study||0
10209767|NCT03575975|11337034|FG002|NOT COMPLETED|Overall Study||0
10209768|NCT03576066|11337042|FG000|STARTED|Overall Study||45
10209769|NCT03576066|11337043|FG001|STARTED|Overall Study||28
10209770|NCT03576066|11337042|FG000|COMPLETED|Overall Study||45
10209771|NCT03576066|11337043|FG001|COMPLETED|Overall Study||27
10209772|NCT03576066|11337042|FG000|NOT COMPLETED|Overall Study||0
10209773|NCT03576066|11337043|FG001|NOT COMPLETED|Overall Study||1
10209774|NCT03576118|11337055|FG000|STARTED|Overall Study||37
10209775|NCT03576118|11337056|FG001|STARTED|Overall Study||37
10209776|NCT03576118|11337055|FG000|COMPLETED|Overall Study||34
10209777|NCT03576118|11337056|FG001|COMPLETED|Overall Study||33
10209778|NCT03576118|11337055|FG000|NOT COMPLETED|Overall Study||3
10209779|NCT03576118|11337056|FG001|NOT COMPLETED|Overall Study||4
10209780|NCT03576183|11337064|FG000|STARTED|Overall Study||17
10209781|NCT03576183|11337065|FG001|STARTED|Overall Study||17
10209782|NCT03576183|11337064|FG000|COMPLETED|Overall Study||15
10209783|NCT03576183|11337065|FG001|COMPLETED|Overall Study||16
10209784|NCT03576183|11337064|FG000|NOT COMPLETED|Overall Study||2
10209785|NCT03576183|11337065|FG001|NOT COMPLETED|Overall Study||1
10209786|NCT03576768|11337075|FG000|STARTED|Overall Study||13
10209787|NCT03576768|11337076|FG001|STARTED|Overall Study||12
10209788|NCT03576768|11337077|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
10209789|NCT03576768|11337078|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
10209790|NCT03576768|11337075|FG000|COMPLETED|Overall Study||10
10209791|NCT03576768|11337076|FG001|COMPLETED|Overall Study||9
9952016|NCT01419184|11070905|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
9952017|NCT01419184|11070904|FG000|NOT COMPLETED|Overall Study||10
9952018|NCT01419184|11070905|FG001|NOT COMPLETED|Overall Study||15
9952019|NCT01419197|11070913|FG000|STARTED|Overall Study||404
9952020|NCT01419197|11070914|FG001|STARTED|Overall Study||198
10011862|NCT01782690|11134645|FG000|NOT COMPLETED|Overall Study||299
10011863|NCT01782742|11134651|FG000|STARTED|Double-blind Treatment Phase||16
10011864|NCT01782742|11134652|FG001|STARTED|Double-blind Treatment Phase||4
10011865|NCT01782742|11134651|FG000|COMPLETED|Double-blind Treatment Phase||15
10209792|NCT03576768|11337077|FG002|COMPLETED|Overall Study||0
10209793|NCT03576768|11337078|FG003|COMPLETED|Overall Study||0
10209794|NCT03576768|11337075|FG000|NOT COMPLETED|Overall Study||3
10209795|NCT03576768|11337076|FG001|NOT COMPLETED|Overall Study||3
10209796|NCT03576768|11337077|FG002|NOT COMPLETED|Overall Study||0
10209797|NCT03576768|11337078|FG003|NOT COMPLETED|Overall Study||0
10209798|NCT03577171|11337090|FG000|STARTED|Overall Study||13
10209799|NCT03577171|11337091|FG001|STARTED|Overall Study||12
10209800|NCT03577171|11337090|FG000|COMPLETED|Overall Study||13
10209801|NCT03577171|11337091|FG001|COMPLETED|Overall Study||12
10011866|NCT01782742|11134652|FG001|COMPLETED|Double-blind Treatment Phase||4
10011867|NCT01782742|11134651|FG000|NOT COMPLETED|Double-blind Treatment Phase||1
10011868|NCT01782742|11134652|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
10011869|NCT01782742|11134651|FG000|STARTED|Open Label Phase||19
10011870|NCT01782742|11134652|FG001|STARTED|Open Label Phase||0
10011871|NCT01782742|11134651|FG000|COMPLETED|Open Label Phase||19
10011872|NCT01782742|11134652|FG001|COMPLETED|Open Label Phase||0
10209802|NCT03577171|11337090|FG000|NOT COMPLETED|Overall Study||0
10209803|NCT03577171|11337091|FG001|NOT COMPLETED|Overall Study||0
10209804|NCT03577275|11337097|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32
10209805|NCT03577275|11337097|FG000|Placebo|Overall Study||32
10209806|NCT03577275|11337097|FG000|Moxifloxacin 400mg|Overall Study||32
10209807|NCT03577275|11337097|FG000|NST-4016 600mg|Overall Study||32
10209808|NCT03577275|11337097|FG000|NST-4016 2000mg|Overall Study||32
10209809|NCT03577275|11337097|FG000|COMPLETED|Overall Study||32
10209810|NCT03577275|11337097|FG000|NOT COMPLETED|Overall Study||0
10209811|NCT03577730|11337113|FG000|STARTED|Overall Study||34
10209812|NCT03577730|11337114|FG001|STARTED|Overall Study||31
10209813|NCT03577730|11337113|FG000|Received Treatment|Overall Study||33
10209814|NCT03577730|11337114|FG001|Received Treatment|Overall Study||31
10209815|NCT03577730|11337113|FG000|COMPLETED|Overall Study||30
10209816|NCT03577730|11337114|FG001|COMPLETED|Overall Study||30
10209817|NCT03577730|11337113|FG000|NOT COMPLETED|Overall Study||4
10209818|NCT03577730|11337114|FG001|NOT COMPLETED|Overall Study||1
10209819|NCT03578146|11337126|FG000|STARTED|Overall Study||16
10209820|NCT03578146|11337127|FG001|STARTED|Overall Study||6
10209821|NCT03578146|11337128|FG002|STARTED|Overall Study||6
10209822|NCT03578146|11337129|FG003|STARTED|Overall Study||6
10209823|NCT03578146|11337130|FG004|STARTED|Overall Study||6
10209824|NCT03578146|11337131|FG005|STARTED|Overall Study||8
10209825|NCT03578146|11337126|FG000|COMPLETED|Overall Study||15
10209826|NCT03578146|11337127|FG001|COMPLETED|Overall Study||5
10209827|NCT03578146|11337128|FG002|COMPLETED|Overall Study||5
10209828|NCT03578146|11337129|FG003|COMPLETED|Overall Study||6
10209829|NCT03578146|11337130|FG004|COMPLETED|Overall Study||6
10209830|NCT03578146|11337131|FG005|COMPLETED|Overall Study||5
10209831|NCT03578146|11337126|FG000|NOT COMPLETED|Overall Study||1
10209832|NCT03578146|11337127|FG001|NOT COMPLETED|Overall Study||1
10209833|NCT03578146|11337128|FG002|NOT COMPLETED|Overall Study||1
10209834|NCT03578146|11337129|FG003|NOT COMPLETED|Overall Study||0
10209835|NCT03578146|11337130|FG004|NOT COMPLETED|Overall Study||0
10209836|NCT03578146|11337131|FG005|NOT COMPLETED|Overall Study||3
10209837|NCT03578549|11337145|FG000|STARTED|Overall Study||30
10209838|NCT03578549|11337145|FG000|COMPLETED|Overall Study||29
10209839|NCT03578549|11337145|FG000|NOT COMPLETED|Overall Study||1
10209840|NCT03578926|11337149|FG000|STARTED|First Intervention||21
10209841|NCT03578926|11337150|FG001|STARTED|First Intervention||23
10209842|NCT03578926|11337149|FG000|COMPLETED|First Intervention||21
10209843|NCT03578926|11337150|FG001|COMPLETED|First Intervention||23
10209844|NCT03578926|11337149|FG000|NOT COMPLETED|First Intervention||0
10209845|NCT03578926|11337150|FG001|NOT COMPLETED|First Intervention||0
10209846|NCT03578926|11337149|FG000|STARTED|Second Intervention||23
10209847|NCT03578926|11337150|FG001|STARTED|Second Intervention||21
10209848|NCT03578926|11337149|FG000|COMPLETED|Second Intervention||23
10209849|NCT03578926|11337150|FG001|COMPLETED|Second Intervention||21
10209850|NCT03578926|11337149|FG000|NOT COMPLETED|Second Intervention||0
10209851|NCT03578926|11337150|FG001|NOT COMPLETED|Second Intervention||0
10209852|NCT03579290|11337158|FG000|STARTED|Overall Study||40
10011873|NCT01782742|11134651|FG000|NOT COMPLETED|Open Label Phase||0
10011874|NCT01782742|11134652|FG001|NOT COMPLETED|Open Label Phase||0
10011875|NCT01782833|11134660|FG000|STARTED|Overall Study||3635
10011876|NCT01782833|11134660|FG000|COMPLETED|Overall Study||3365
10011877|NCT01782833|11134660|FG000|NOT COMPLETED|Overall Study||270
10011878|NCT01782859|11134666|FG000|STARTED|Overall Study||20
10011879|NCT01782859|11134667|FG001|STARTED|Overall Study||20
10209853|NCT03579290|11337158|FG000|COMPLETED|Overall Study||31
10209854|NCT03579290|11337158|FG000|NOT COMPLETED|Overall Study||9
10209855|NCT03579433|11337162|FG000|STARTED|Overall Study||104
10209856|NCT03579433|11337162|FG000|ORA With VerifEye+|Overall Study||96
10209857|NCT03579433|11337162|FG000|Barrett Calculator|Overall Study||102
10209858|NCT03579433|11337162|FG000|COMPLETED|Overall Study||98
10209859|NCT03579433|11337162|FG000|NOT COMPLETED|Overall Study||6
10209860|NCT03579719|11337170|FG000|STARTED|Overall Study||15
10209861|NCT03579719|11337170|FG000|COMPLETED|Overall Study||14
10209862|NCT03579719|11337170|FG000|NOT COMPLETED|Overall Study||1
10209863|NCT03579940|11337185|FG000|STARTED|Period 1||3
10209864|NCT03579940|11337186|FG001|STARTED|Period 1||2
10209865|NCT03579940|11337187|FG002|STARTED|Period 1||2
10209866|NCT03579940|11337188|FG003|STARTED|Period 1||2
10209867|NCT03579940|11337189|FG004|STARTED|Period 1||2
10209868|NCT03579940|11337190|FG005|STARTED|Period 1||2
10209869|NCT03579940|11337191|FG006|STARTED|Period 1||3
10209870|NCT03579940|11337192|FG007|STARTED|Period 1||3
10209871|NCT03579940|11337193|FG008|STARTED|Period 1||3
10209872|NCT03579940|11337194|FG009|STARTED|Period 1||2
10209873|NCT03579940|11337195|FG010|STARTED|Period 1||3
10209874|NCT03579940|11337185|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10209875|NCT03579940|11337186|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
10209876|NCT03579940|11337187|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
10209877|NCT03579940|11337188|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
10209878|NCT03579940|11337189|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
10011880|NCT01782859|11134666|FG000|COMPLETED|Overall Study||14
10011881|NCT01782859|11134667|FG001|COMPLETED|Overall Study||13
10011882|NCT01782859|11134666|FG000|NOT COMPLETED|Overall Study||6
10011883|NCT01782859|11134667|FG001|NOT COMPLETED|Overall Study||7
10011884|NCT01782872|11134678|FG000|STARTED|Overall Study||20
10011885|NCT01782872|11134679|FG001|STARTED|Overall Study||20
10011886|NCT01782872|11134680|FG002|STARTED|Overall Study||20
10011887|NCT01782872|11134681|FG003|STARTED|Overall Study||20
10011888|NCT01782872|11134678|FG000|COMPLETED|Overall Study||20
10011889|NCT01782872|11134679|FG001|COMPLETED|Overall Study||19
10011890|NCT01782872|11134680|FG002|COMPLETED|Overall Study||20
10011891|NCT01782872|11134681|FG003|COMPLETED|Overall Study||19
10011892|NCT01782872|11134678|FG000|NOT COMPLETED|Overall Study||0
10011893|NCT01782872|11134679|FG001|NOT COMPLETED|Overall Study||1
10011894|NCT01782872|11134680|FG002|NOT COMPLETED|Overall Study||0
10011895|NCT01782872|11134681|FG003|NOT COMPLETED|Overall Study||1
10011896|NCT01782885|11134693|FG000|STARTED|Overall Study||36
10011897|NCT01782885|11134694|FG001|STARTED|Overall Study||39
10011898|NCT01782885|11134693|FG000|COMPLETED|Overall Study||32
10011899|NCT01782885|11134694|FG001|COMPLETED|Overall Study||33
10209879|NCT03579940|11337190|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
10209880|NCT03579940|11337191|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
10209881|NCT03579940|11337192|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
10209882|NCT03579940|11337193|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
10209883|NCT03579940|11337194|FG009|Received at Least 1 Dose of Study Drug|Period 1||2
9952021|NCT01419197|11070913|FG000|Switched to Trastuzumab Emtansine|Overall Study||0
9952022|NCT01419197|11070914|FG001|Switched to Trastuzumab Emtansine|Overall Study||94
9952023|NCT01419197|11070913|FG000|COMPLETED|Overall Study||0
9952024|NCT01419197|11070914|FG001|COMPLETED|Overall Study||0
9952025|NCT01419197|11070913|FG000|NOT COMPLETED|Overall Study||404
9952026|NCT01419197|11070914|FG001|NOT COMPLETED|Overall Study||198
9952027|NCT01419236|11070923|FG000|STARTED|Overall Study||36
9952028|NCT01419236|11070924|FG001|STARTED|Overall Study||40
9952029|NCT01419236|11070923|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35
9952030|NCT01419236|11070924|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
9952031|NCT01419236|11070923|FG000|COMPLETED|Overall Study||31
9952032|NCT01419236|11070924|FG001|COMPLETED|Overall Study||35
9952033|NCT01419236|11070923|FG000|NOT COMPLETED|Overall Study||5
9952034|NCT01419236|11070924|FG001|NOT COMPLETED|Overall Study||5
9952035|NCT01419249|11070932|FG000|STARTED|Overall Study||318
9952036|NCT01419249|11070933|FG001|STARTED|Overall Study||140
9952037|NCT01419249|11070932|FG000|COMPLETED|Overall Study||318
9952038|NCT01419249|11070933|FG001|COMPLETED|Overall Study||140
9952039|NCT01419249|11070932|FG000|NOT COMPLETED|Overall Study||0
9952040|NCT01419249|11070933|FG001|NOT COMPLETED|Overall Study||0
10209884|NCT03579940|11337195|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
10209885|NCT03579940|11337185|FG000|COMPLETED|Period 1||3
10209886|NCT03579940|11337186|FG001|COMPLETED|Period 1||2
10209887|NCT03579940|11337187|FG002|COMPLETED|Period 1||2
10209888|NCT03579940|11337188|FG003|COMPLETED|Period 1||2
10209889|NCT03579940|11337189|FG004|COMPLETED|Period 1||2
10209890|NCT03579940|11337190|FG005|COMPLETED|Period 1||2
10209891|NCT03579940|11337191|FG006|COMPLETED|Period 1||3
10209892|NCT03579940|11337192|FG007|COMPLETED|Period 1||3
10209893|NCT03579940|11337193|FG008|COMPLETED|Period 1||3
10209894|NCT03579940|11337194|FG009|COMPLETED|Period 1||2
10209895|NCT03579940|11337195|FG010|COMPLETED|Period 1||3
10209896|NCT03579940|11337185|FG000|NOT COMPLETED|Period 1||0
10209897|NCT03579940|11337186|FG001|NOT COMPLETED|Period 1||0
10209898|NCT03579940|11337187|FG002|NOT COMPLETED|Period 1||0
9952041|NCT01419275|11070940|FG000|STARTED|Overall Study||126
9952042|NCT01419275|11070940|FG000|COMPLETED|Overall Study||126
9952043|NCT01419275|11070940|FG000|NOT COMPLETED|Overall Study||0
9952044|NCT01419314|11070946|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
9952045|NCT01419314|11070947|FG001|STARTED|Start of Study|No comfort issues reported.|22
9952046|NCT01419314|11070946|FG000|COMPLETED|Start of Study||23
9952047|NCT01419314|11070947|FG001|COMPLETED|Start of Study||22
9952048|NCT01419314|11070946|FG000|NOT COMPLETED|Start of Study||0
9952049|NCT01419314|11070947|FG001|NOT COMPLETED|Start of Study||0
9952050|NCT01419314|11070946|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
9952051|NCT01419314|11070947|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
9952052|NCT01419314|11070946|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17
10011900|NCT01782885|11134693|FG000|NOT COMPLETED|Overall Study||4
10011901|NCT01782885|11134694|FG001|NOT COMPLETED|Overall Study||6
10011902|NCT01782898|11134702|FG000|STARTED|Overall Study||35
10011903|NCT01782898|11134703|FG001|STARTED|Overall Study||35
10011904|NCT01782898|11134702|FG000|COMPLETED|Overall Study||29
10011905|NCT01782898|11134703|FG001|COMPLETED|Overall Study||29
10011906|NCT01782898|11134702|FG000|NOT COMPLETED|Overall Study||6
10209899|NCT03579940|11337188|FG003|NOT COMPLETED|Period 1||0
10209900|NCT03579940|11337189|FG004|NOT COMPLETED|Period 1||0
10209901|NCT03579940|11337190|FG005|NOT COMPLETED|Period 1||0
10209902|NCT03579940|11337191|FG006|NOT COMPLETED|Period 1||0
10209903|NCT03579940|11337192|FG007|NOT COMPLETED|Period 1||0
10209904|NCT03579940|11337193|FG008|NOT COMPLETED|Period 1||0
10209905|NCT03579940|11337194|FG009|NOT COMPLETED|Period 1||0
10209906|NCT03579940|11337195|FG010|NOT COMPLETED|Period 1||0
10209907|NCT03579940|11337185|FG000|STARTED|Period 2||3
9952053|NCT01419314|11070947|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21
9952054|NCT01419314|11070946|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
9952055|NCT01419314|11070947|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
9952056|NCT01419314|11070946|FG000|STARTED|Follow-up at Week 6 of the Trial||17
10011907|NCT01782898|11134703|FG001|NOT COMPLETED|Overall Study||6
10011908|NCT01782963|11134709|FG000|STARTED|Overall Study||50
10209908|NCT03579940|11337186|FG001|STARTED|Period 2||2
10209909|NCT03579940|11337187|FG002|STARTED|Period 2||2
10209910|NCT03579940|11337188|FG003|STARTED|Period 2||2
10209911|NCT03579940|11337189|FG004|STARTED|Period 2||2
10209912|NCT03579940|11337190|FG005|STARTED|Period 2||2
10209913|NCT03579940|11337191|FG006|STARTED|Period 2||3
10209914|NCT03579940|11337192|FG007|STARTED|Period 2||3
10209915|NCT03579940|11337193|FG008|STARTED|Period 2||3
10209916|NCT03579940|11337194|FG009|STARTED|Period 2||2
10209917|NCT03579940|11337195|FG010|STARTED|Period 2||3
10209918|NCT03579940|11337185|FG000|COMPLETED|Period 2||3
10209919|NCT03579940|11337186|FG001|COMPLETED|Period 2||2
10209920|NCT03579940|11337187|FG002|COMPLETED|Period 2||1
10209921|NCT03579940|11337188|FG003|COMPLETED|Period 2||2
10209922|NCT03579940|11337189|FG004|COMPLETED|Period 2||2
10209923|NCT03579940|11337190|FG005|COMPLETED|Period 2||2
10209924|NCT03579940|11337191|FG006|COMPLETED|Period 2||3
10209925|NCT03579940|11337192|FG007|COMPLETED|Period 2||3
10209926|NCT03579940|11337193|FG008|COMPLETED|Period 2||3
10209927|NCT03579940|11337194|FG009|COMPLETED|Period 2||2
10209928|NCT03579940|11337195|FG010|COMPLETED|Period 2||3
10209929|NCT03579940|11337185|FG000|NOT COMPLETED|Period 2||0
10209930|NCT03579940|11337186|FG001|NOT COMPLETED|Period 2||0
10209931|NCT03579940|11337187|FG002|NOT COMPLETED|Period 2||1
10209932|NCT03579940|11337188|FG003|NOT COMPLETED|Period 2||0
10209933|NCT03579940|11337189|FG004|NOT COMPLETED|Period 2||0
10209934|NCT03579940|11337190|FG005|NOT COMPLETED|Period 2||0
10209935|NCT03579940|11337191|FG006|NOT COMPLETED|Period 2||0
10209936|NCT03579940|11337192|FG007|NOT COMPLETED|Period 2||0
10209937|NCT03579940|11337193|FG008|NOT COMPLETED|Period 2||0
10209938|NCT03579940|11337194|FG009|NOT COMPLETED|Period 2||0
10209939|NCT03579940|11337195|FG010|NOT COMPLETED|Period 2||0
10209940|NCT03579940|11337185|FG000|STARTED|Period 3||3
10209941|NCT03579940|11337186|FG001|STARTED|Period 3||2
10209942|NCT03579940|11337187|FG002|STARTED|Period 3||1
10209943|NCT03579940|11337188|FG003|STARTED|Period 3||2
10209944|NCT03579940|11337189|FG004|STARTED|Period 3||2
10209945|NCT03579940|11337190|FG005|STARTED|Period 3||2
10209946|NCT03579940|11337191|FG006|STARTED|Period 3||3
10209947|NCT03579940|11337192|FG007|STARTED|Period 3||3
10209948|NCT03579940|11337193|FG008|STARTED|Period 3||3
10209949|NCT03579940|11337194|FG009|STARTED|Period 3||2
10209950|NCT03579940|11337195|FG010|STARTED|Period 3||3
10209951|NCT03579940|11337185|FG000|COMPLETED|Period 3||3
10209952|NCT03579940|11337186|FG001|COMPLETED|Period 3||2
10209953|NCT03579940|11337187|FG002|COMPLETED|Period 3||1
10209954|NCT03579940|11337188|FG003|COMPLETED|Period 3||2
10209955|NCT03579940|11337189|FG004|COMPLETED|Period 3||2
10209956|NCT03579940|11337190|FG005|COMPLETED|Period 3||2
10209957|NCT03579940|11337191|FG006|COMPLETED|Period 3||3
10209958|NCT03579940|11337192|FG007|COMPLETED|Period 3||3
10209959|NCT03579940|11337193|FG008|COMPLETED|Period 3||3
10209960|NCT03579940|11337194|FG009|COMPLETED|Period 3||2
10209961|NCT03579940|11337195|FG010|COMPLETED|Period 3||3
10209962|NCT03579940|11337185|FG000|NOT COMPLETED|Period 3||0
10209963|NCT03579940|11337186|FG001|NOT COMPLETED|Period 3||0
10209964|NCT03579940|11337187|FG002|NOT COMPLETED|Period 3||0
10209965|NCT03579940|11337188|FG003|NOT COMPLETED|Period 3||0
10209966|NCT03579940|11337189|FG004|NOT COMPLETED|Period 3||0
10209967|NCT03579940|11337190|FG005|NOT COMPLETED|Period 3||0
10209968|NCT03579940|11337191|FG006|NOT COMPLETED|Period 3||0
9952057|NCT01419314|11070947|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
9952058|NCT01419314|11070946|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
9952059|NCT01419314|11070947|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19
9952060|NCT01419314|11070946|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
10011909|NCT01782963|11134709|FG000|COMPLETED|Overall Study||50
10209969|NCT03579940|11337192|FG007|NOT COMPLETED|Period 3||0
10209970|NCT03579940|11337193|FG008|NOT COMPLETED|Period 3||0
10209971|NCT03579940|11337194|FG009|NOT COMPLETED|Period 3||0
10209972|NCT03579940|11337195|FG010|NOT COMPLETED|Period 3||0
10209973|NCT03580343|11337227|FG000|STARTED|Overall Study||5
10209974|NCT03580343|11337227|FG000|COMPLETED|Overall Study||4
10209975|NCT03580343|11337227|FG000|NOT COMPLETED|Overall Study||1
10209976|NCT03581084|11337231|FG000|STARTED|Overall Study||1
10209977|NCT03581084|11337231|FG000|COMPLETED|Overall Study||1
10209978|NCT03581084|11337231|FG000|NOT COMPLETED|Overall Study||0
10209979|NCT03581097|11337237|FG000|STARTED|Overall Study||46
10209980|NCT03581097|11337238|FG001|STARTED|Overall Study||47
10209981|NCT03581097|11337237|FG000|COMPLETED|Overall Study||46
10209982|NCT03581097|11337238|FG001|COMPLETED|Overall Study||47
10209983|NCT03581097|11337237|FG000|NOT COMPLETED|Overall Study||0
10209984|NCT03581097|11337238|FG001|NOT COMPLETED|Overall Study||0
10238854|NCT00459121|11370284|FG000|NOT COMPLETED|Overall Study||0
10238855|NCT00461682|11370289|FG000|STARTED|Overall Study||1
10238856|NCT00461682|11370289|FG000|COMPLETED|Overall Study||0
10238857|NCT00461682|11370289|FG000|NOT COMPLETED|Overall Study||1
10238858|NCT00462904|11370295|FG000|STARTED|Overall Study||4
10238859|NCT00462904|11370295|FG000|COMPLETED|Overall Study||3
9956951|NCT01448824|11076144|FG004|STARTED|Part 2: Washout Period||0
10209985|NCT03581474|11337246|FG000|STARTED|Overall Study||12
10209986|NCT03581474|11337246|FG000|COMPLETED|Overall Study||12
10209987|NCT03581474|11337246|FG000|NOT COMPLETED|Overall Study||0
10209988|NCT03581825|11337250|FG000|STARTED|Period 1||31
10209989|NCT03581825|11337251|FG001|STARTED|Period 1||31
10209990|NCT03581825|11337250|FG000|COMPLETED|Period 1||30
10209991|NCT03581825|11337251|FG001|COMPLETED|Period 1||31
10209992|NCT03581825|11337250|FG000|NOT COMPLETED|Period 1||1
10209993|NCT03581825|11337251|FG001|NOT COMPLETED|Period 1||0
10209994|NCT03581825|11337250|FG000|STARTED|Period 2||30
10209995|NCT03581825|11337251|FG001|STARTED|Period 2||31
10209996|NCT03581825|11337250|FG000|COMPLETED|Period 2||30
10209997|NCT03581825|11337251|FG001|COMPLETED|Period 2||30
10209998|NCT03581825|11337250|FG000|NOT COMPLETED|Period 2||0
10209999|NCT03581825|11337251|FG001|NOT COMPLETED|Period 2||1
10210000|NCT03582215|11337265|FG000|STARTED|Overall Study||6
10210001|NCT03582215|11337266|FG001|STARTED|Overall Study||6
10210002|NCT03582215|11337267|FG002|STARTED|Overall Study||6
10210003|NCT03582215|11337268|FG003|STARTED|Overall Study||6
10210004|NCT03582215|11337269|FG004|STARTED|Overall Study||12
10210005|NCT03582215|11337270|FG005|STARTED|Overall Study||12
10210006|NCT03582215|11337271|FG006|STARTED|Overall Study||12
10210007|NCT03582215|11337272|FG007|STARTED|Overall Study||12
10210008|NCT03582215|11337265|FG000|COMPLETED|Overall Study||5
10210009|NCT03582215|11337266|FG001|COMPLETED|Overall Study||6
10210010|NCT03582215|11337267|FG002|COMPLETED|Overall Study||6
10210011|NCT03582215|11337268|FG003|COMPLETED|Overall Study||6
10210012|NCT03582215|11337269|FG004|COMPLETED|Overall Study||12
10210013|NCT03582215|11337270|FG005|COMPLETED|Overall Study||12
10210014|NCT03582215|11337271|FG006|COMPLETED|Overall Study||10
10210015|NCT03582215|11337272|FG007|COMPLETED|Overall Study||10
10210016|NCT03582215|11337265|FG000|NOT COMPLETED|Overall Study||1
10210017|NCT03582215|11337266|FG001|NOT COMPLETED|Overall Study||0
10210018|NCT03582215|11337267|FG002|NOT COMPLETED|Overall Study||0
10210019|NCT03582215|11337268|FG003|NOT COMPLETED|Overall Study||0
10210020|NCT03582215|11337269|FG004|NOT COMPLETED|Overall Study||0
10210021|NCT03582215|11337270|FG005|NOT COMPLETED|Overall Study||0
10210022|NCT03582215|11337271|FG006|NOT COMPLETED|Overall Study||2
10210023|NCT03582215|11337272|FG007|NOT COMPLETED|Overall Study||2
10210024|NCT03582553|11337307|FG000|STARTED|Intervention 1/Visit 1||3
10210025|NCT03582553|11337308|FG001|STARTED|Intervention 1/Visit 1||3
10210026|NCT03582553|11337309|FG002|STARTED|Intervention 1/Visit 1||3
10210027|NCT03582553|11337310|FG003|STARTED|Intervention 1/Visit 1||3
10210028|NCT03582553|11337311|FG004|STARTED|Intervention 1/Visit 1||3
10210029|NCT03582553|11337312|FG005|STARTED|Intervention 1/Visit 1||3
10210030|NCT03582553|11337307|FG000|COMPLETED|Intervention 1/Visit 1||3
10210031|NCT03582553|11337308|FG001|COMPLETED|Intervention 1/Visit 1||3
10210032|NCT03582553|11337309|FG002|COMPLETED|Intervention 1/Visit 1||3
10210033|NCT03582553|11337310|FG003|COMPLETED|Intervention 1/Visit 1||3
10210034|NCT03582553|11337311|FG004|COMPLETED|Intervention 1/Visit 1||3
10210035|NCT03582553|11337312|FG005|COMPLETED|Intervention 1/Visit 1||3
10210036|NCT03582553|11337307|FG000|NOT COMPLETED|Intervention 1/Visit 1||0
10210037|NCT03582553|11337308|FG001|NOT COMPLETED|Intervention 1/Visit 1||0
10210038|NCT03582553|11337309|FG002|NOT COMPLETED|Intervention 1/Visit 1||0
10210039|NCT03582553|11337310|FG003|NOT COMPLETED|Intervention 1/Visit 1||0
10210040|NCT03582553|11337311|FG004|NOT COMPLETED|Intervention 1/Visit 1||0
10210041|NCT03582553|11337312|FG005|NOT COMPLETED|Intervention 1/Visit 1||0
10210042|NCT03582553|11337307|FG000|STARTED|Washout Period ( At Least 1 Week)||3
10210043|NCT03582553|11337308|FG001|STARTED|Washout Period ( At Least 1 Week)||3
10210044|NCT03582553|11337309|FG002|STARTED|Washout Period ( At Least 1 Week)||3
10210045|NCT03582553|11337310|FG003|STARTED|Washout Period ( At Least 1 Week)||3
10210046|NCT03582553|11337311|FG004|STARTED|Washout Period ( At Least 1 Week)||3
10210047|NCT03582553|11337312|FG005|STARTED|Washout Period ( At Least 1 Week)||3
10210048|NCT03582553|11337307|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3
10210049|NCT03582553|11337308|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3
10210050|NCT03582553|11337309|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3
10210051|NCT03582553|11337310|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3
10210052|NCT03582553|11337311|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3
10210053|NCT03582553|11337312|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3
10210054|NCT03582553|11337307|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10210055|NCT03582553|11337308|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10210056|NCT03582553|11337309|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10210057|NCT03582553|11337310|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10210058|NCT03582553|11337311|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10210059|NCT03582553|11337312|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10210060|NCT03582553|11337307|FG000|STARTED|Intervention 2/Visit 2||3
10210061|NCT03582553|11337308|FG001|STARTED|Intervention 2/Visit 2||3
10210062|NCT03582553|11337309|FG002|STARTED|Intervention 2/Visit 2||3
10210063|NCT03582553|11337310|FG003|STARTED|Intervention 2/Visit 2||3
10210064|NCT03582553|11337311|FG004|STARTED|Intervention 2/Visit 2||3
10210065|NCT03582553|11337312|FG005|STARTED|Intervention 2/Visit 2||3
10210066|NCT03582553|11337307|FG000|COMPLETED|Intervention 2/Visit 2||3
10210067|NCT03582553|11337308|FG001|COMPLETED|Intervention 2/Visit 2||3
10210068|NCT03582553|11337309|FG002|COMPLETED|Intervention 2/Visit 2||3
10210069|NCT03582553|11337310|FG003|COMPLETED|Intervention 2/Visit 2||3
10210070|NCT03582553|11337311|FG004|COMPLETED|Intervention 2/Visit 2||3
10210071|NCT03582553|11337312|FG005|COMPLETED|Intervention 2/Visit 2||3
9952061|NCT01419314|11070947|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
9952062|NCT01419535|11070959|FG000|STARTED|Overall Study||9
9952063|NCT01419535|11070960|FG001|STARTED|Overall Study||10
9952064|NCT01419535|11070959|FG000|COMPLETED|Overall Study||8
10210072|NCT03582553|11337307|FG000|NOT COMPLETED|Intervention 2/Visit 2||0
10210073|NCT03582553|11337308|FG001|NOT COMPLETED|Intervention 2/Visit 2||0
10210074|NCT03582553|11337309|FG002|NOT COMPLETED|Intervention 2/Visit 2||0
10210075|NCT03582553|11337310|FG003|NOT COMPLETED|Intervention 2/Visit 2||0
10210076|NCT03582553|11337311|FG004|NOT COMPLETED|Intervention 2/Visit 2||0
10210077|NCT03582553|11337312|FG005|NOT COMPLETED|Intervention 2/Visit 2||0
10210078|NCT03582553|11337307|FG000|STARTED|Washout Period (At Least 1 Week)||3
10210079|NCT03582553|11337308|FG001|STARTED|Washout Period (At Least 1 Week)||3
10210080|NCT03582553|11337309|FG002|STARTED|Washout Period (At Least 1 Week)||3
10210081|NCT03582553|11337310|FG003|STARTED|Washout Period (At Least 1 Week)||3
10210082|NCT03582553|11337311|FG004|STARTED|Washout Period (At Least 1 Week)||3
10210083|NCT03582553|11337312|FG005|STARTED|Washout Period (At Least 1 Week)||3
10210084|NCT03582553|11337307|FG000|COMPLETED|Washout Period (At Least 1 Week)||3
10210085|NCT03582553|11337308|FG001|COMPLETED|Washout Period (At Least 1 Week)||3
10210086|NCT03582553|11337309|FG002|COMPLETED|Washout Period (At Least 1 Week)||3
10210087|NCT03582553|11337310|FG003|COMPLETED|Washout Period (At Least 1 Week)||3
10210088|NCT03582553|11337311|FG004|COMPLETED|Washout Period (At Least 1 Week)||3
10210089|NCT03582553|11337312|FG005|COMPLETED|Washout Period (At Least 1 Week)||3
10210090|NCT03582553|11337307|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10210091|NCT03582553|11337308|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10210092|NCT03582553|11337309|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10210093|NCT03582553|11337310|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10210094|NCT03582553|11337311|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10210095|NCT03582553|11337312|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10210096|NCT03582553|11337307|FG000|STARTED|Intervention 3/Visit 3||3
10210097|NCT03582553|11337308|FG001|STARTED|Intervention 3/Visit 3||3
10210098|NCT03582553|11337309|FG002|STARTED|Intervention 3/Visit 3||3
10210099|NCT03582553|11337310|FG003|STARTED|Intervention 3/Visit 3||3
10210100|NCT03582553|11337311|FG004|STARTED|Intervention 3/Visit 3||3
10210101|NCT03582553|11337312|FG005|STARTED|Intervention 3/Visit 3||3
10210102|NCT03582553|11337307|FG000|COMPLETED|Intervention 3/Visit 3||3
10210103|NCT03582553|11337308|FG001|COMPLETED|Intervention 3/Visit 3||3
10210104|NCT03582553|11337309|FG002|COMPLETED|Intervention 3/Visit 3||3
10210105|NCT03582553|11337310|FG003|COMPLETED|Intervention 3/Visit 3||3
10210106|NCT03582553|11337311|FG004|COMPLETED|Intervention 3/Visit 3||3
10210107|NCT03582553|11337312|FG005|COMPLETED|Intervention 3/Visit 3||3
10210108|NCT03582553|11337307|FG000|NOT COMPLETED|Intervention 3/Visit 3||0
10210109|NCT03582553|11337308|FG001|NOT COMPLETED|Intervention 3/Visit 3||0
10210110|NCT03582553|11337309|FG002|NOT COMPLETED|Intervention 3/Visit 3||0
10210111|NCT03582553|11337310|FG003|NOT COMPLETED|Intervention 3/Visit 3||0
10210112|NCT03582553|11337311|FG004|NOT COMPLETED|Intervention 3/Visit 3||0
10210113|NCT03582553|11337312|FG005|NOT COMPLETED|Intervention 3/Visit 3||0
10210114|NCT03582813|11337332|FG000|STARTED|Overall Study||114
10210115|NCT03582813|11337333|FG001|STARTED|Overall Study||102
10210116|NCT03582813|11337332|FG000|COMPLETED|Overall Study||95
10210117|NCT03582813|11337333|FG001|COMPLETED|Overall Study||81
10210118|NCT03582813|11337332|FG000|NOT COMPLETED|Overall Study||19
10210119|NCT03582813|11337333|FG001|NOT COMPLETED|Overall Study||21
10210120|NCT03582826|11337341|FG000|STARTED|Overall Study||119
10210121|NCT03582826|11337342|FG001|STARTED|Overall Study||6
10210122|NCT03582826|11337341|FG000|COMPLETED|Overall Study||78
10210123|NCT03582826|11337342|FG001|COMPLETED|Overall Study||6
10210124|NCT03582826|11337341|FG000|NOT COMPLETED|Overall Study||41
10210125|NCT03582826|11337342|FG001|NOT COMPLETED|Overall Study||0
10210126|NCT03582943|11337359|FG000|STARTED|Allocated to Groups||42
10210127|NCT03582943|11337360|FG001|STARTED|Allocated to Groups||40
10210128|NCT03582943|11337359|FG000|COMPLETED|Allocated to Groups||41
10210129|NCT03582943|11337360|FG001|COMPLETED|Allocated to Groups||39
10210130|NCT03582943|11337359|FG000|NOT COMPLETED|Allocated to Groups||1
10210131|NCT03582943|11337360|FG001|NOT COMPLETED|Allocated to Groups||1
10210132|NCT03582943|11337359|FG000|STARTED|Intervention and Follow up||41
10210133|NCT03582943|11337360|FG001|STARTED|Intervention and Follow up||39
10210134|NCT03582943|11337359|FG000|COMPLETED|Intervention and Follow up||37
10210135|NCT03582943|11337360|FG001|COMPLETED|Intervention and Follow up||37
10210136|NCT03582943|11337359|FG000|NOT COMPLETED|Intervention and Follow up||4
10210137|NCT03582943|11337360|FG001|NOT COMPLETED|Intervention and Follow up||2
10210138|NCT03582943|11337359|FG000|STARTED|Analyzed||37
10210139|NCT03582943|11337360|FG001|STARTED|Analyzed||37
10210140|NCT03582943|11337359|FG000|COMPLETED|Analyzed||33
9952065|NCT01419535|11070960|FG001|COMPLETED|Overall Study||8
9952066|NCT01419535|11070959|FG000|NOT COMPLETED|Overall Study||1
9952067|NCT01419535|11070960|FG001|NOT COMPLETED|Overall Study||2
10210141|NCT03582943|11337360|FG001|COMPLETED|Analyzed||36
10210142|NCT03582943|11337359|FG000|NOT COMPLETED|Analyzed||4
10210143|NCT03582943|11337360|FG001|NOT COMPLETED|Analyzed||1
10210144|NCT03583372|11337370|FG000|STARTED|Overall Study||92
10210145|NCT03583372|11337371|FG001|STARTED|Overall Study||182
10210146|NCT03583372|11337372|FG002|STARTED|Overall Study||91
10210147|NCT03583372|11337373|FG003|STARTED|Overall Study||141
10210148|NCT03583372|11337370|FG000|COMPLETED|Overall Study||79
10210149|NCT03583372|11337371|FG001|COMPLETED|Overall Study||156
10210150|NCT03583372|11337372|FG002|COMPLETED|Overall Study||72
9952068|NCT01419626|11070969|FG000|STARTED|Overall Study||46
9952069|NCT01419626|11070970|FG001|STARTED|Overall Study||47
10210151|NCT03583372|11337373|FG003|COMPLETED|Overall Study||123
10210152|NCT03583372|11337370|FG000|NOT COMPLETED|Overall Study||13
10210153|NCT03583372|11337371|FG001|NOT COMPLETED|Overall Study||26
10210154|NCT03583372|11337372|FG002|NOT COMPLETED|Overall Study||19
10210155|NCT03583372|11337373|FG003|NOT COMPLETED|Overall Study||18
10210156|NCT03583385|11337383|FG000|STARTED|Treatment Period 1||24
10210157|NCT03583385|11337384|FG001|STARTED|Treatment Period 1||24
10210158|NCT03583385|11337383|FG000|COMPLETED|Treatment Period 1||23
10210159|NCT03583385|11337384|FG001|COMPLETED|Treatment Period 1||23
10210160|NCT03583385|11337383|FG000|NOT COMPLETED|Treatment Period 1||1
10210161|NCT03583385|11337384|FG001|NOT COMPLETED|Treatment Period 1||1
10210162|NCT03583385|11337383|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
10210163|NCT03583385|11337384|FG001|STARTED|Treatment Period 2||23
10210164|NCT03583385|11337383|FG000|COMPLETED|Treatment Period 2||21
10210165|NCT03583385|11337384|FG001|COMPLETED|Treatment Period 2||23
10210166|NCT03583385|11337383|FG000|NOT COMPLETED|Treatment Period 2||1
10210167|NCT03583385|11337384|FG001|NOT COMPLETED|Treatment Period 2||0
10210168|NCT03583450|11337392|FG000|STARTED|Overall Study||34
10210169|NCT03583450|11337393|FG001|STARTED|Overall Study||37
10210170|NCT03583450|11337392|FG000|COMPLETED|Overall Study||33
10210171|NCT03583450|11337393|FG001|COMPLETED|Overall Study||37
10210172|NCT03583450|11337392|FG000|NOT COMPLETED|Overall Study||1
10210173|NCT03583450|11337393|FG001|NOT COMPLETED|Overall Study||0
10210174|NCT03583606|11337404|FG000|STARTED|Overall Study||22
10210175|NCT03583606|11337405|FG001|STARTED|Overall Study||20
10210176|NCT03583606|11337406|FG002|STARTED|Overall Study||19
10210177|NCT03583606|11337404|FG000|COMPLETED|Overall Study||21
10210178|NCT03583606|11337405|FG001|COMPLETED|Overall Study||19
10210179|NCT03583606|11337406|FG002|COMPLETED|Overall Study||19
10210180|NCT03583606|11337404|FG000|NOT COMPLETED|Overall Study||1
10210181|NCT03583606|11337405|FG001|NOT COMPLETED|Overall Study||1
10210182|NCT03583606|11337406|FG002|NOT COMPLETED|Overall Study||0
10210189|NCT03584100|11337424|FG000|STARTED|Overall Study||12
10210190|NCT03584100|11337424|FG000|COMPLETED|Overall Study||12
10210191|NCT03584100|11337424|FG000|NOT COMPLETED|Overall Study||0
10210192|NCT03585244|11337431|FG000|STARTED|Overall Study||180
10210193|NCT03585244|11337431|FG000|COMPLETED|Overall Study||165
10210194|NCT03585244|11337431|FG000|NOT COMPLETED|Overall Study||15
10210195|NCT03585296|11337435|FG000|STARTED|Overall Study||22
10210196|NCT03585296|11337435|FG000|COMPLETED|Overall Study||17
10210197|NCT03585296|11337435|FG000|NOT COMPLETED|Overall Study||5
10210198|NCT03585504|11337441|FG000|STARTED|Overall Study||41
10210199|NCT03585504|11337442|FG001|STARTED|Overall Study||40
10210200|NCT03585504|11337441|FG000|COMPLETED|Overall Study||15
10210201|NCT03585504|11337442|FG001|COMPLETED|Overall Study||11
10210202|NCT03585504|11337441|FG000|NOT COMPLETED|Overall Study||26
10210203|NCT03585504|11337442|FG001|NOT COMPLETED|Overall Study||29
10210204|NCT03585543|11337448|FG000|STARTED|Overall Study||30
10210205|NCT03585543|11337448|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25
10210206|NCT03585543|11337448|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22
10210207|NCT03585543|11337448|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15
10210208|NCT03585543|11337448|FG000|COMPLETED|Overall Study||15
10210209|NCT03585543|11337448|FG000|NOT COMPLETED|Overall Study||15
10210210|NCT03585712|11337453|FG000|STARTED|Treatment Period 1||52
10210211|NCT03585712|11337454|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
10210212|NCT03585712|11337455|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
10210213|NCT03585712|11337453|FG000|COMPLETED|Treatment Period 1||51
10210214|NCT03585712|11337454|FG001|COMPLETED|Treatment Period 1||0
10210215|NCT03585712|11337455|FG002|COMPLETED|Treatment Period 1||0
10210216|NCT03585712|11337453|FG000|NOT COMPLETED|Treatment Period 1||1
10210217|NCT03585712|11337454|FG001|NOT COMPLETED|Treatment Period 1||0
10210218|NCT03585712|11337455|FG002|NOT COMPLETED|Treatment Period 1||0
10210219|NCT03585712|11337453|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
9952070|NCT01419626|11070971|FG002|STARTED|Overall Study||47
10210220|NCT03585712|11337454|FG001|STARTED|Treatment Periods 2 and 3||26
10210221|NCT03585712|11337455|FG002|STARTED|Treatment Periods 2 and 3||25
10210222|NCT03585712|11337453|FG000|COMPLETED|Treatment Periods 2 and 3||0
10210223|NCT03585712|11337454|FG001|COMPLETED|Treatment Periods 2 and 3||23
10210224|NCT03585712|11337455|FG002|COMPLETED|Treatment Periods 2 and 3||22
10210225|NCT03585712|11337453|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0
10210226|NCT03585712|11337454|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3
10210227|NCT03585712|11337455|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3
10210228|NCT03585790|11337474|FG000|STARTED|First Intervention (1 Week)||23
10210229|NCT03585790|11337475|FG001|STARTED|First Intervention (1 Week)||22
10210230|NCT03585790|11337474|FG000|COMPLETED|First Intervention (1 Week)||23
9952071|NCT01419626|11070969|FG000|COMPLETED|Overall Study||42
9952072|NCT01419626|11070970|FG001|COMPLETED|Overall Study||44
9952073|NCT01419626|11070971|FG002|COMPLETED|Overall Study||44
10210231|NCT03585790|11337475|FG001|COMPLETED|First Intervention (1 Week)||22
10210232|NCT03585790|11337474|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10210233|NCT03585790|11337475|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10210234|NCT03585790|11337474|FG000|STARTED|Second Intervention (1 Week)||23
10210235|NCT03585790|11337475|FG001|STARTED|Second Intervention (1 Week)||22
10210236|NCT03585790|11337474|FG000|COMPLETED|Second Intervention (1 Week)||23
10210237|NCT03585790|11337475|FG001|COMPLETED|Second Intervention (1 Week)||22
10210238|NCT03585790|11337474|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10210239|NCT03585790|11337475|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10210240|NCT03585959|11337482|FG000|STARTED|Overall Study||50
10210241|NCT03585959|11337482|FG000|COMPLETED|Overall Study||47
10210242|NCT03585959|11337482|FG000|NOT COMPLETED|Overall Study||3
10210243|NCT03586167|11337490|FG000|STARTED|Overall Study||58
10210244|NCT03586167|11337491|FG001|STARTED|Overall Study||28
10210245|NCT03586167|11337490|FG000|COMPLETED|Overall Study||57
10210246|NCT03586167|11337491|FG001|COMPLETED|Overall Study||28
10210247|NCT03586167|11337490|FG000|NOT COMPLETED|Overall Study||1
10210248|NCT03586167|11337491|FG001|NOT COMPLETED|Overall Study||0
10210249|NCT03586544|11337499|FG000|STARTED|First Intervention||6
10210250|NCT03586544|11337500|FG001|STARTED|First Intervention||12
10210251|NCT03586544|11337499|FG000|COMPLETED|First Intervention||6
10210252|NCT03586544|11337500|FG001|COMPLETED|First Intervention||11
10210253|NCT03586544|11337499|FG000|NOT COMPLETED|First Intervention||0
10210254|NCT03586544|11337500|FG001|NOT COMPLETED|First Intervention||1
10210255|NCT03586544|11337499|FG000|STARTED|Second Intervention||6
10210256|NCT03586544|11337500|FG001|STARTED|Second Intervention||11
10210257|NCT03586544|11337499|FG000|COMPLETED|Second Intervention||6
10210258|NCT03586544|11337500|FG001|COMPLETED|Second Intervention||10
10210259|NCT03586544|11337499|FG000|NOT COMPLETED|Second Intervention||0
10210260|NCT03586544|11337500|FG001|NOT COMPLETED|Second Intervention||1
10210261|NCT03586583|11337506|FG000|STARTED|Overall Study||600
10210262|NCT03586583|11337506|FG000|COMPLETED|Overall Study||600
10210263|NCT03586583|11337506|FG000|NOT COMPLETED|Overall Study||0
10210264|NCT03586648|11337511|FG000|STARTED|Period 1||36
10210265|NCT03586648|11337512|FG001|STARTED|Period 1||34
10210266|NCT03586648|11337511|FG000|COMPLETED|Period 1||32
10210267|NCT03586648|11337512|FG001|COMPLETED|Period 1||30
10210268|NCT03586648|11337511|FG000|NOT COMPLETED|Period 1||4
10210269|NCT03586648|11337512|FG001|NOT COMPLETED|Period 1||4
10210270|NCT03586648|11337511|FG000|STARTED|Period 2||32
10210271|NCT03586648|11337512|FG001|STARTED|Period 2||30
10210272|NCT03586648|11337511|FG000|COMPLETED|Period 2||31
10210273|NCT03586648|11337512|FG001|COMPLETED|Period 2||30
10210274|NCT03586648|11337511|FG000|NOT COMPLETED|Period 2||1
10210275|NCT03586648|11337512|FG001|NOT COMPLETED|Period 2||0
10210276|NCT03586726|11337518|FG000|STARTED|Overall Study||16
10210277|NCT03586726|11337518|FG000|COMPLETED|Overall Study||15
10011910|NCT01782963|11134709|FG000|NOT COMPLETED|Overall Study||0
10011911|NCT01783054|11134717|FG000|STARTED|Overall Study||2
10011912|NCT01783054|11134717|FG000|COMPLETED|Overall Study||2
10210278|NCT03586726|11337518|FG000|NOT COMPLETED|Overall Study||1
10210279|NCT03586830|11337526|FG000|STARTED|Overall Study||50
10210280|NCT03586830|11337527|FG001|STARTED|Overall Study||48
10210281|NCT03586830|11337528|FG002|STARTED|Overall Study||49
10210282|NCT03586830|11337529|FG003|STARTED|Overall Study||49
10210283|NCT03586830|11337526|FG000|Treated|Overall Study||49
10210284|NCT03586830|11337527|FG001|Treated|Overall Study||48
10210285|NCT03586830|11337528|FG002|Treated|Overall Study||49
10210286|NCT03586830|11337529|FG003|Treated|Overall Study||49
10210287|NCT03586830|11337526|FG000|COMPLETED|Overall Study||48
10210288|NCT03586830|11337527|FG001|COMPLETED|Overall Study||42
10210289|NCT03586830|11337528|FG002|COMPLETED|Overall Study||41
10210290|NCT03586830|11337529|FG003|COMPLETED|Overall Study||44
10210291|NCT03586830|11337526|FG000|NOT COMPLETED|Overall Study||2
10210292|NCT03586830|11337527|FG001|NOT COMPLETED|Overall Study||6
10210293|NCT03586830|11337528|FG002|NOT COMPLETED|Overall Study||8
10210294|NCT03586830|11337529|FG003|NOT COMPLETED|Overall Study||5
10210295|NCT03587207|11337544|FG000|STARTED|Overall Study||100
10210296|NCT03587207|11337545|FG001|STARTED|Overall Study||104
10210297|NCT03587207|11337546|FG002|STARTED|Overall Study||100
10210298|NCT03587207|11337547|FG003|STARTED|Overall Study||94
10210299|NCT03587207|11337548|FG004|STARTED|Overall Study||102
10210300|NCT03587207|11337544|FG000|COMPLETED|Overall Study||100
10210301|NCT03587207|11337545|FG001|COMPLETED|Overall Study||104
10210302|NCT03587207|11337546|FG002|COMPLETED|Overall Study||100
10210303|NCT03587207|11337547|FG003|COMPLETED|Overall Study||94
10210304|NCT03587207|11337548|FG004|COMPLETED|Overall Study||102
10210305|NCT03587207|11337544|FG000|NOT COMPLETED|Overall Study||0
10210306|NCT03587207|11337545|FG001|NOT COMPLETED|Overall Study||0
10210307|NCT03587207|11337546|FG002|NOT COMPLETED|Overall Study||0
10210308|NCT03587207|11337547|FG003|NOT COMPLETED|Overall Study||0
10011913|NCT01783054|11134717|FG000|NOT COMPLETED|Overall Study||0
10210309|NCT03587207|11337548|FG004|NOT COMPLETED|Overall Study||0
10210310|NCT03587428|11337560|FG000|STARTED|Period 1||3
10210311|NCT03587428|11337561|FG001|STARTED|Period 1||2
10210312|NCT03587428|11337562|FG002|STARTED|Period 1||3
10210313|NCT03587428|11337563|FG003|STARTED|Period 1||3
10210314|NCT03587428|11337564|FG004|STARTED|Period 1||2
10210315|NCT03587428|11337565|FG005|STARTED|Period 1||2
10011914|NCT01783080|11134721|FG000|STARTED|Overall Study||16
10210316|NCT03587428|11337560|FG000|COMPLETED|Period 1||3
10210317|NCT03587428|11337561|FG001|COMPLETED|Period 1||2
10210318|NCT03587428|11337562|FG002|COMPLETED|Period 1||3
10210319|NCT03587428|11337563|FG003|COMPLETED|Period 1||3
10210320|NCT03587428|11337564|FG004|COMPLETED|Period 1||2
10210321|NCT03587428|11337565|FG005|COMPLETED|Period 1||2
10210322|NCT03587428|11337560|FG000|NOT COMPLETED|Period 1||0
10210323|NCT03587428|11337561|FG001|NOT COMPLETED|Period 1||0
10210324|NCT03587428|11337562|FG002|NOT COMPLETED|Period 1||0
10210325|NCT03587428|11337563|FG003|NOT COMPLETED|Period 1||0
10210326|NCT03587428|11337564|FG004|NOT COMPLETED|Period 1||0
10210327|NCT03587428|11337565|FG005|NOT COMPLETED|Period 1||0
10210328|NCT03587428|11337560|FG000|STARTED|Period 2||3
10210329|NCT03587428|11337561|FG001|STARTED|Period 2||2
10210330|NCT03587428|11337562|FG002|STARTED|Period 2||3
10210331|NCT03587428|11337563|FG003|STARTED|Period 2||3
10210332|NCT03587428|11337564|FG004|STARTED|Period 2||2
10210333|NCT03587428|11337565|FG005|STARTED|Period 2||2
10210334|NCT03587428|11337560|FG000|COMPLETED|Period 2||3
10210335|NCT03587428|11337561|FG001|COMPLETED|Period 2||2
10210336|NCT03587428|11337562|FG002|COMPLETED|Period 2||3
10210337|NCT03587428|11337563|FG003|COMPLETED|Period 2||3
10210338|NCT03587428|11337564|FG004|COMPLETED|Period 2||2
10210339|NCT03587428|11337565|FG005|COMPLETED|Period 2||2
10210340|NCT03587428|11337560|FG000|NOT COMPLETED|Period 2||0
10210341|NCT03587428|11337561|FG001|NOT COMPLETED|Period 2||0
10210342|NCT03587428|11337562|FG002|NOT COMPLETED|Period 2||0
10210343|NCT03587428|11337563|FG003|NOT COMPLETED|Period 2||0
10210344|NCT03587428|11337564|FG004|NOT COMPLETED|Period 2||0
10210345|NCT03587428|11337565|FG005|NOT COMPLETED|Period 2||0
10210346|NCT03587428|11337560|FG000|STARTED|Period 3||3
10210347|NCT03587428|11337561|FG001|STARTED|Period 3||2
10210348|NCT03587428|11337562|FG002|STARTED|Period 3||3
10210349|NCT03587428|11337563|FG003|STARTED|Period 3||3
10210350|NCT03587428|11337564|FG004|STARTED|Period 3||2
10210351|NCT03587428|11337565|FG005|STARTED|Period 3||2
10210352|NCT03587428|11337560|FG000|COMPLETED|Period 3||3
10210353|NCT03587428|11337561|FG001|COMPLETED|Period 3||2
10210354|NCT03587428|11337562|FG002|COMPLETED|Period 3||3
10210355|NCT03587428|11337563|FG003|COMPLETED|Period 3||3
10210356|NCT03587428|11337564|FG004|COMPLETED|Period 3||2
10210357|NCT03587428|11337565|FG005|COMPLETED|Period 3||2
10210358|NCT03587428|11337560|FG000|NOT COMPLETED|Period 3||0
10210359|NCT03587428|11337561|FG001|NOT COMPLETED|Period 3||0
10210360|NCT03587428|11337562|FG002|NOT COMPLETED|Period 3||0
10210361|NCT03587428|11337563|FG003|NOT COMPLETED|Period 3||0
10210362|NCT03587428|11337564|FG004|NOT COMPLETED|Period 3||0
10210363|NCT03587428|11337565|FG005|NOT COMPLETED|Period 3||0
10210364|NCT03587974|11337575|FG000|STARTED|Overall Study||30
10210365|NCT03587974|11337576|FG001|STARTED|Overall Study||30
10210366|NCT03587974|11337575|FG000|COMPLETED|Overall Study||25
10210367|NCT03587974|11337576|FG001|COMPLETED|Overall Study||26
10210368|NCT03587974|11337575|FG000|NOT COMPLETED|Overall Study||5
10210369|NCT03587974|11337576|FG001|NOT COMPLETED|Overall Study||4
10210370|NCT03588572|11337584|FG000|STARTED|Visitation 1||22
10210371|NCT03588572|11337585|FG001|STARTED|Visitation 1||21
10210372|NCT03588572|11337584|FG000|COMPLETED|Visitation 1||21
10210373|NCT03588572|11337585|FG001|COMPLETED|Visitation 1||20
10210374|NCT03588572|11337584|FG000|NOT COMPLETED|Visitation 1||1
10210375|NCT03588572|11337585|FG001|NOT COMPLETED|Visitation 1||1
10210376|NCT03588572|11337584|FG000|STARTED|Visitation 2||21
10210377|NCT03588572|11337585|FG001|STARTED|Visitation 2||20
10210378|NCT03588572|11337584|FG000|COMPLETED|Visitation 2||19
10210379|NCT03588572|11337585|FG001|COMPLETED|Visitation 2||18
10210380|NCT03588572|11337584|FG000|NOT COMPLETED|Visitation 2||2
10210381|NCT03588572|11337585|FG001|NOT COMPLETED|Visitation 2||2
10210382|NCT03588572|11337584|FG000|STARTED|Visitation 3||19
10210383|NCT03588572|11337585|FG001|STARTED|Visitation 3||18
10210384|NCT03588572|11337584|FG000|COMPLETED|Visitation 3||16
10210385|NCT03588572|11337585|FG001|COMPLETED|Visitation 3||16
10210386|NCT03588572|11337584|FG000|NOT COMPLETED|Visitation 3||3
10210387|NCT03588572|11337585|FG001|NOT COMPLETED|Visitation 3||2
10210388|NCT03588741|11337591|FG000|STARTED|Overall Study||1
10210389|NCT03588741|11337591|FG000|COMPLETED|Overall Study||0
10210390|NCT03588741|11337591|FG000|NOT COMPLETED|Overall Study||1
10210391|NCT03588806|11337595|FG000|STARTED|Overall Study||11
10210392|NCT03588806|11337595|FG000|COMPLETED|Overall Study||11
10210393|NCT03588806|11337595|FG000|NOT COMPLETED|Overall Study||0
10210394|NCT03588910|11337601|FG000|STARTED|Overall Study||60
10210395|NCT03588910|11337602|FG001|STARTED|Overall Study||60
10210396|NCT03588910|11337601|FG000|Post Op Day 1 Survey|Overall Study||52
10210397|NCT03588910|11337602|FG001|Post Op Day 1 Survey|Overall Study||47
10210398|NCT03588910|11337601|FG000|COMPLETED|Overall Study||47
10210399|NCT03588910|11337602|FG001|COMPLETED|Overall Study||45
10210400|NCT03588910|11337601|FG000|NOT COMPLETED|Overall Study||13
10210401|NCT03588910|11337602|FG001|NOT COMPLETED|Overall Study||15
10210402|NCT03589807|11337614|FG000|STARTED|Overall Study||27
10210403|NCT03589807|11337615|FG001|STARTED|Overall Study||30
10210404|NCT03589807|11337616|FG002|STARTED|Overall Study||33
10210405|NCT03589807|11337617|FG003|STARTED|Overall Study||32
10210406|NCT03589807|11337618|FG004|STARTED|Overall Study||28
10210407|NCT03589807|11337619|FG005|STARTED|Overall Study||30
10210408|NCT03589807|11337614|FG000|COMPLETED|Overall Study||27
10210409|NCT03589807|11337615|FG001|COMPLETED|Overall Study||23
10210410|NCT03589807|11337616|FG002|COMPLETED|Overall Study||31
10210411|NCT03589807|11337617|FG003|COMPLETED|Overall Study||28
10210412|NCT03589807|11337618|FG004|COMPLETED|Overall Study||26
10210413|NCT03589807|11337619|FG005|COMPLETED|Overall Study||29
10210414|NCT03589807|11337614|FG000|NOT COMPLETED|Overall Study||0
10210415|NCT03589807|11337615|FG001|NOT COMPLETED|Overall Study||7
10210416|NCT03589807|11337616|FG002|NOT COMPLETED|Overall Study||2
10210417|NCT03589807|11337617|FG003|NOT COMPLETED|Overall Study||4
10210418|NCT03589807|11337618|FG004|NOT COMPLETED|Overall Study||2
10210419|NCT03589807|11337619|FG005|NOT COMPLETED|Overall Study||1
10210420|NCT03589885|11337639|FG000|STARTED|Treatment Period 1-Randomized Set||41
10210421|NCT03589885|11337640|FG001|STARTED|Treatment Period 1-Randomized Set||41
10210422|NCT03589885|11337641|FG002|STARTED|Treatment Period 1-Randomized Set||40
10210423|NCT03589885|11337642|FG003|STARTED|Treatment Period 1-Randomized Set||0
10210424|NCT03589885|11337643|FG004|STARTED|Treatment Period 1-Randomized Set||0
10210425|NCT03589885|11337639|FG000|COMPLETED|Treatment Period 1-Randomized Set||41
10210426|NCT03589885|11337640|FG001|COMPLETED|Treatment Period 1-Randomized Set||39
10210427|NCT03589885|11337641|FG002|COMPLETED|Treatment Period 1-Randomized Set||37
10210428|NCT03589885|11337642|FG003|COMPLETED|Treatment Period 1-Randomized Set||0
10210429|NCT03589885|11337643|FG004|COMPLETED|Treatment Period 1-Randomized Set||0
10210430|NCT03589885|11337639|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0
10210431|NCT03589885|11337640|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2
10210432|NCT03589885|11337641|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3
10210433|NCT03589885|11337642|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0
10210434|NCT03589885|11337643|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0
10210435|NCT03589885|11337639|FG000|STARTED|Treatment Period 2-Randomized Set||41
10210436|NCT03589885|11337640|FG001|STARTED|Treatment Period 2-Randomized Set||39
10210437|NCT03589885|11337641|FG002|STARTED|Treatment Period 2-Randomized Set||4
10210438|NCT03589885|11337642|FG003|STARTED|Treatment Period 2-Randomized Set||16
10210439|NCT03589885|11337643|FG004|STARTED|Treatment Period 2-Randomized Set||17
10210440|NCT03589885|11337639|FG000|COMPLETED|Treatment Period 2-Randomized Set||40
10210441|NCT03589885|11337640|FG001|COMPLETED|Treatment Period 2-Randomized Set||34
10210442|NCT03589885|11337641|FG002|COMPLETED|Treatment Period 2-Randomized Set||3
10210443|NCT03589885|11337642|FG003|COMPLETED|Treatment Period 2-Randomized Set||16
10210444|NCT03589885|11337643|FG004|COMPLETED|Treatment Period 2-Randomized Set||16
10210445|NCT03589885|11337639|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1
10210446|NCT03589885|11337640|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5
10210447|NCT03589885|11337641|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1
10210448|NCT03589885|11337642|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0
10210449|NCT03589885|11337643|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1
10210450|NCT03590613|11337661|FG000|STARTED|Period 1, 4 Days||3
10210451|NCT03590613|11337662|FG001|STARTED|Period 1, 4 Days||3
10210452|NCT03590613|11337663|FG002|STARTED|Period 1, 4 Days||3
10210453|NCT03590613|11337664|FG003|STARTED|Period 1, 4 Days||3
10210454|NCT03590613|11337661|FG000|COMPLETED|Period 1, 4 Days||3
10210455|NCT03590613|11337662|FG001|COMPLETED|Period 1, 4 Days||3
10210456|NCT03590613|11337663|FG002|COMPLETED|Period 1, 4 Days||3
10210457|NCT03590613|11337664|FG003|COMPLETED|Period 1, 4 Days||3
10210458|NCT03590613|11337661|FG000|NOT COMPLETED|Period 1, 4 Days||0
10210459|NCT03590613|11337662|FG001|NOT COMPLETED|Period 1, 4 Days||0
10210460|NCT03590613|11337663|FG002|NOT COMPLETED|Period 1, 4 Days||0
10210461|NCT03590613|11337664|FG003|NOT COMPLETED|Period 1, 4 Days||0
10210462|NCT03590613|11337661|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3
10210463|NCT03590613|11337662|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3
10210464|NCT03590613|11337663|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3
10210465|NCT03590613|11337664|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3
10210466|NCT03590613|11337661|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10210467|NCT03590613|11337662|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10210468|NCT03590613|11337663|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10210469|NCT03590613|11337664|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10210470|NCT03590613|11337661|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10210471|NCT03590613|11337662|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10210472|NCT03590613|11337663|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10210473|NCT03590613|11337664|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10210474|NCT03590613|11337661|FG000|STARTED|Period 2, 4 Days||3
10210475|NCT03590613|11337662|FG001|STARTED|Period 2, 4 Days||3
10210476|NCT03590613|11337663|FG002|STARTED|Period 2, 4 Days||3
10210477|NCT03590613|11337664|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
10210478|NCT03590613|11337661|FG000|COMPLETED|Period 2, 4 Days||3
10210479|NCT03590613|11337662|FG001|COMPLETED|Period 2, 4 Days||3
10210480|NCT03590613|11337663|FG002|COMPLETED|Period 2, 4 Days||3
10210481|NCT03590613|11337664|FG003|COMPLETED|Period 2, 4 Days||3
10210482|NCT03590613|11337661|FG000|NOT COMPLETED|Period 2, 4 Days||0
10210483|NCT03590613|11337662|FG001|NOT COMPLETED|Period 2, 4 Days||0
10210484|NCT03590613|11337663|FG002|NOT COMPLETED|Period 2, 4 Days||0
10210485|NCT03590613|11337664|FG003|NOT COMPLETED|Period 2, 4 Days||1
10210486|NCT03590613|11337661|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3
10210487|NCT03590613|11337662|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3
10210488|NCT03590613|11337663|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3
10210489|NCT03590613|11337664|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3
10210490|NCT03590613|11337661|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10210491|NCT03590613|11337662|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10210492|NCT03590613|11337663|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10210493|NCT03590613|11337664|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10210494|NCT03590613|11337661|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
9952074|NCT01419626|11070969|FG000|NOT COMPLETED|Overall Study||4
9952075|NCT01419626|11070970|FG001|NOT COMPLETED|Overall Study||3
9952076|NCT01419626|11070971|FG002|NOT COMPLETED|Overall Study||3
9952077|NCT01419639|11070979|FG000|STARTED|Overall Study||10
9952078|NCT01419639|11070979|FG000|COMPLETED|Overall Study||9
9952079|NCT01419639|11070979|FG000|NOT COMPLETED|Overall Study||1
9952080|NCT01419665|11070985|FG000|STARTED|Combination Treatment||312
10210495|NCT03590613|11337662|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
10210496|NCT03590613|11337663|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
10210497|NCT03590613|11337664|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
10210498|NCT03590613|11337661|FG000|STARTED|Period 3, 4 Days||3
10210499|NCT03590613|11337662|FG001|STARTED|Period 3, 4 Days||3
10210500|NCT03590613|11337663|FG002|STARTED|Period 3, 4 Days||3
10210501|NCT03590613|11337664|FG003|STARTED|Period 3, 4 Days||3
10210502|NCT03590613|11337661|FG000|COMPLETED|Period 3, 4 Days||3
10210503|NCT03590613|11337662|FG001|COMPLETED|Period 3, 4 Days||3
10210504|NCT03590613|11337663|FG002|COMPLETED|Period 3, 4 Days||3
10210505|NCT03590613|11337664|FG003|COMPLETED|Period 3, 4 Days||3
10210506|NCT03590613|11337661|FG000|NOT COMPLETED|Period 3, 4 Days||0
10210507|NCT03590613|11337662|FG001|NOT COMPLETED|Period 3, 4 Days||0
10210508|NCT03590613|11337663|FG002|NOT COMPLETED|Period 3, 4 Days||0
10210509|NCT03590613|11337664|FG003|NOT COMPLETED|Period 3, 4 Days||0
10210510|NCT03590613|11337661|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3
10210511|NCT03590613|11337662|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3
10210512|NCT03590613|11337663|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3
10210513|NCT03590613|11337664|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3
10210514|NCT03590613|11337661|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10210515|NCT03590613|11337662|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10210516|NCT03590613|11337663|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10210517|NCT03590613|11337664|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10210518|NCT03590613|11337661|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10210519|NCT03590613|11337662|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10210520|NCT03590613|11337663|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10210521|NCT03590613|11337664|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10210522|NCT03590613|11337661|FG000|STARTED|Period 4, 4 Days||3
10210523|NCT03590613|11337662|FG001|STARTED|Period 4, 4 Days||3
10210524|NCT03590613|11337663|FG002|STARTED|Period 4, 4 Days||3
10210525|NCT03590613|11337664|FG003|STARTED|Period 4, 4 Days||3
10210526|NCT03590613|11337661|FG000|COMPLETED|Period 4, 4 Days||3
10210527|NCT03590613|11337662|FG001|COMPLETED|Period 4, 4 Days||3
10210528|NCT03590613|11337663|FG002|COMPLETED|Period 4, 4 Days||3
10210529|NCT03590613|11337664|FG003|COMPLETED|Period 4, 4 Days||3
10210530|NCT03590613|11337661|FG000|NOT COMPLETED|Period 4, 4 Days||0
10210531|NCT03590613|11337662|FG001|NOT COMPLETED|Period 4, 4 Days||0
10210532|NCT03590613|11337663|FG002|NOT COMPLETED|Period 4, 4 Days||0
10210533|NCT03590613|11337664|FG003|NOT COMPLETED|Period 4, 4 Days||0
10210534|NCT03591068|11337677|FG000|STARTED|Overall Study||11
10210535|NCT03591068|11337677|FG000|COMPLETED|Overall Study||9
10210536|NCT03591068|11337677|FG000|NOT COMPLETED|Overall Study||2
10210537|NCT03591146|11337688|FG000|STARTED|TLC590 190mg and Naropin 150mg||12
10210538|NCT03591146|11337689|FG001|STARTED|TLC590 190mg and Naropin 150mg||0
10210539|NCT03591146|11337690|FG002|STARTED|TLC590 190mg and Naropin 150mg||0
10210540|NCT03591146|11337691|FG003|STARTED|TLC590 190mg and Naropin 150mg||0
10210541|NCT03591146|11337692|FG004|STARTED|TLC590 190mg and Naropin 150mg||4
10210542|NCT03591146|11337688|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12
10210543|NCT03591146|11337689|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0
10210544|NCT03591146|11337690|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0
10210545|NCT03591146|11337691|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0
10210546|NCT03591146|11337692|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3
10210547|NCT03591146|11337688|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10210548|NCT03591146|11337689|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10210549|NCT03591146|11337690|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10210550|NCT03591146|11337691|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10210551|NCT03591146|11337692|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
10210552|NCT03591146|11337688|FG000|STARTED|TLC590 380mg and Naropin 150mg||0
10210553|NCT03591146|11337689|FG001|STARTED|TLC590 380mg and Naropin 150mg||12
10210554|NCT03591146|11337690|FG002|STARTED|TLC590 380mg and Naropin 150mg||0
10210555|NCT03591146|11337691|FG003|STARTED|TLC590 380mg and Naropin 150mg||0
10210556|NCT03591146|11337692|FG004|STARTED|TLC590 380mg and Naropin 150mg||5
10210557|NCT03591146|11337688|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0
10210558|NCT03591146|11337689|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11
10210559|NCT03591146|11337690|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0
10210560|NCT03591146|11337691|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0
10210561|NCT03591146|11337692|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4
10210562|NCT03591146|11337688|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
9952081|NCT01419665|11070986|FG001|STARTED|Combination Treatment||315
9952082|NCT01419665|11070985|FG000|COMPLETED|Combination Treatment||274
10210563|NCT03591146|11337689|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
10210564|NCT03591146|11337690|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
10210565|NCT03591146|11337691|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
10210566|NCT03591146|11337692|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
10210567|NCT03591146|11337688|FG000|STARTED|TLC590 570mg and Naropin 150mg||0
10210568|NCT03591146|11337689|FG001|STARTED|TLC590 570mg and Naropin 150mg||0
10210569|NCT03591146|11337690|FG002|STARTED|TLC590 570mg and Naropin 150mg||12
10210570|NCT03591146|11337691|FG003|STARTED|TLC590 570mg and Naropin 150mg||0
10210571|NCT03591146|11337692|FG004|STARTED|TLC590 570mg and Naropin 150mg||4
10210572|NCT03591146|11337688|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0
10210573|NCT03591146|11337689|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0
10210574|NCT03591146|11337690|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11
10210575|NCT03591146|11337691|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0
10210576|NCT03591146|11337692|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3
10210577|NCT03591146|11337688|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
10210578|NCT03591146|11337689|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
10210579|NCT03591146|11337690|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
10210580|NCT03591146|11337691|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
10210581|NCT03591146|11337692|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
10210582|NCT03591146|11337688|FG000|STARTED|TLC590 475mg and Naropin 150mg||0
10210583|NCT03591146|11337689|FG001|STARTED|TLC590 475mg and Naropin 150mg||0
10210584|NCT03591146|11337690|FG002|STARTED|TLC590 475mg and Naropin 150mg||0
10210585|NCT03591146|11337691|FG003|STARTED|TLC590 475mg and Naropin 150mg||12
10210586|NCT03591146|11337692|FG004|STARTED|TLC590 475mg and Naropin 150mg||4
10210587|NCT03591146|11337688|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0
10210588|NCT03591146|11337689|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0
10210589|NCT03591146|11337690|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0
10210590|NCT03591146|11337691|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12
10210591|NCT03591146|11337692|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4
10210592|NCT03591146|11337688|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10210593|NCT03591146|11337689|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10210594|NCT03591146|11337690|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10210595|NCT03591146|11337691|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10210596|NCT03591146|11337692|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10011915|NCT01783080|11134721|FG000|COMPLETED|Overall Study||16
10011916|NCT01783080|11134721|FG000|NOT COMPLETED|Overall Study||0
10011917|NCT01783236|11134727|FG000|STARTED|Overall Study||8
10210597|NCT03591406|11337706|FG000|STARTED|Overall Study||188
10210598|NCT03591406|11337707|FG001|STARTED|Overall Study||183
10210599|NCT03591406|11337706|FG000|COMPLETED|Overall Study||181
10210600|NCT03591406|11337707|FG001|COMPLETED|Overall Study||174
10210601|NCT03591406|11337706|FG000|NOT COMPLETED|Overall Study||7
10210602|NCT03591406|11337707|FG001|NOT COMPLETED|Overall Study||9
10011918|NCT01783236|11134728|FG001|STARTED|Overall Study||8
10011919|NCT01783236|11134727|FG000|COMPLETED|Overall Study||6
10011920|NCT01783236|11134728|FG001|COMPLETED|Overall Study||8
10011921|NCT01783236|11134727|FG000|NOT COMPLETED|Overall Study||2
10011922|NCT01783236|11134728|FG001|NOT COMPLETED|Overall Study||0
10011923|NCT01783418|11134736|FG000|STARTED|Overall Study||8
10011924|NCT01783418|11134737|FG001|STARTED|Overall Study||6
10011925|NCT01783418|11134736|FG000|COMPLETED|Overall Study||7
10011926|NCT01783418|11134737|FG001|COMPLETED|Overall Study||6
10011927|NCT01783418|11134736|FG000|NOT COMPLETED|Overall Study||1
10011928|NCT01783418|11134737|FG001|NOT COMPLETED|Overall Study||0
10011929|NCT01783444|11134746|FG000|STARTED|Treatment Phase||104
10210603|NCT03592121|11337715|FG000|STARTED|Overall Study||3
10210604|NCT03592121|11337716|FG001|STARTED|Overall Study||0
10210605|NCT03592121|11337715|FG000|COMPLETED|Overall Study||3
10210606|NCT03592121|11337716|FG001|COMPLETED|Overall Study||0
10210607|NCT03592121|11337715|FG000|NOT COMPLETED|Overall Study||0
10210608|NCT03592121|11337716|FG001|NOT COMPLETED|Overall Study||0
10210609|NCT03592745|11337724|FG000|STARTED|Overall Study||18
10210610|NCT03592745|11337725|FG001|STARTED|Overall Study||18
10210611|NCT03592745|11337724|FG000|COMPLETED|Overall Study||15
10210612|NCT03592745|11337725|FG001|COMPLETED|Overall Study||15
10210613|NCT03592745|11337724|FG000|NOT COMPLETED|Overall Study||3
10210614|NCT03592745|11337725|FG001|NOT COMPLETED|Overall Study||3
10210615|NCT03593200|11337731|FG000|STARTED|Overall Study||4
10210616|NCT03593200|11337731|FG000|COMPLETED|Overall Study||4
10210617|NCT03593200|11337731|FG000|NOT COMPLETED|Overall Study||0
10210618|NCT03593538|11337738|FG000|STARTED|Overall Study||26
10011930|NCT01783444|11134747|FG001|STARTED|Treatment Phase||103
10011931|NCT01783444|11134748|FG002|STARTED|Treatment Phase||102
10011932|NCT01783444|11134746|FG000|Safety Set|Treatment Phase||104
10011933|NCT01783444|11134747|FG001|Safety Set|Treatment Phase||103
10011934|NCT01783444|11134748|FG002|Safety Set|Treatment Phase||102
10011935|NCT01783444|11134746|FG000|COMPLETED|Treatment Phase||0
10011936|NCT01783444|11134747|FG001|COMPLETED|Treatment Phase||0
10011937|NCT01783444|11134748|FG002|COMPLETED|Treatment Phase||0
10210619|NCT03593538|11337739|FG001|STARTED|Overall Study||21
10210620|NCT03593538|11337740|FG002|STARTED|Overall Study||22
10210621|NCT03593538|11337738|FG000|COMPLETED|Overall Study||15
10210622|NCT03593538|11337739|FG001|COMPLETED|Overall Study||15
10210623|NCT03593538|11337740|FG002|COMPLETED|Overall Study||11
10210624|NCT03593538|11337738|FG000|NOT COMPLETED|Overall Study||11
10210625|NCT03593538|11337739|FG001|NOT COMPLETED|Overall Study||6
10210626|NCT03593538|11337740|FG002|NOT COMPLETED|Overall Study||11
10210627|NCT03593681|11337748|FG000|STARTED|Overall Study||150
10210628|NCT03593681|11337748|FG000|COMPLETED|Overall Study||115
10210629|NCT03593681|11337748|FG000|NOT COMPLETED|Overall Study||35
10210630|NCT03593876|11337769|FG000|STARTED|Overall Study||16
10210631|NCT03593876|11337769|FG000|COMPLETED|Overall Study||13
10210632|NCT03593876|11337769|FG000|NOT COMPLETED|Overall Study||3
10210633|NCT03593902|11337773|FG000|STARTED|Overall Study||9
10210634|NCT03593902|11337773|FG000|COMPLETED|Overall Study||9
10210635|NCT03593902|11337773|FG000|NOT COMPLETED|Overall Study||0
10210636|NCT03594045|11337779|FG000|STARTED|Overall Study||0
10210637|NCT03594045|11337780|FG001|STARTED|Overall Study||5
10210638|NCT03594045|11337779|FG000|COMPLETED|Overall Study||0
10210639|NCT03594045|11337780|FG001|COMPLETED|Overall Study||5
10210640|NCT03594045|11337779|FG000|NOT COMPLETED|Overall Study||0
10210641|NCT03594045|11337780|FG001|NOT COMPLETED|Overall Study||0
10210642|NCT03594071|11337786|FG000|STARTED|Overall Study||294
10210643|NCT03594071|11337786|FG000|COMPLETED|Overall Study||289
10210644|NCT03594071|11337786|FG000|NOT COMPLETED|Overall Study||5
10210645|NCT03594227|11337794|FG000|STARTED|Overall Study||23
10210646|NCT03594227|11337795|FG001|STARTED|Overall Study||23
10210647|NCT03594227|11337796|FG002|STARTED|Overall Study||22
10210648|NCT03594227|11337797|FG003|STARTED|Overall Study||19
10210649|NCT03594227|11337794|FG000|COMPLETED|Overall Study||18
10210650|NCT03594227|11337795|FG001|COMPLETED|Overall Study||19
10210651|NCT03594227|11337796|FG002|COMPLETED|Overall Study||19
10210652|NCT03594227|11337797|FG003|COMPLETED|Overall Study||14
10210653|NCT03594227|11337794|FG000|NOT COMPLETED|Overall Study||5
10210654|NCT03594227|11337795|FG001|NOT COMPLETED|Overall Study||4
10210655|NCT03594227|11337796|FG002|NOT COMPLETED|Overall Study||3
10210656|NCT03594227|11337797|FG003|NOT COMPLETED|Overall Study||5
10210657|NCT03594500|11337820|FG000|STARTED|Overall Study||66
10210658|NCT03594500|11337821|FG001|STARTED|Overall Study||67
10210659|NCT03594500|11337820|FG000|COMPLETED|Overall Study||60
10210660|NCT03594500|11337821|FG001|COMPLETED|Overall Study||63
10210661|NCT03594500|11337820|FG000|NOT COMPLETED|Overall Study||6
10210662|NCT03594500|11337821|FG001|NOT COMPLETED|Overall Study||4
10210663|NCT03595215|11337830|FG000|STARTED|Overall Study||18
10210664|NCT03595215|11337830|FG000|COMPLETED|Overall Study||10
10210665|NCT03595215|11337830|FG000|NOT COMPLETED|Overall Study||8
10210666|NCT03595280|11337837|FG000|STARTED|Overall Study||119
10210667|NCT03595280|11337838|FG001|STARTED|Overall Study||117
10210668|NCT03595280|11337839|FG002|STARTED|Overall Study||113
10210669|NCT03595280|11337837|FG000|COMPLETED|Overall Study||113
10210670|NCT03595280|11337838|FG001|COMPLETED|Overall Study||108
10210671|NCT03595280|11337839|FG002|COMPLETED|Overall Study||98
10210672|NCT03595280|11337837|FG000|NOT COMPLETED|Overall Study||6
10210673|NCT03595280|11337838|FG001|NOT COMPLETED|Overall Study||9
10210674|NCT03595280|11337839|FG002|NOT COMPLETED|Overall Study||15
10210675|NCT03595449|11337849|FG000|STARTED|Overall Study||118
10210676|NCT03595449|11337850|FG001|STARTED|Overall Study||115
10210677|NCT03595449|11337849|FG000|COMPLETED|Overall Study||118
10210678|NCT03595449|11337850|FG001|COMPLETED|Overall Study||115
10210679|NCT03595449|11337849|FG000|NOT COMPLETED|Overall Study||0
10210680|NCT03595449|11337850|FG001|NOT COMPLETED|Overall Study||0
10210681|NCT03595579|11337858|FG000|STARTED|Overall Study||48
10210682|NCT03595579|11337859|FG001|STARTED|Overall Study||49
10210683|NCT03595579|11337858|FG000|mITT Population|Overall Study||43
10210684|NCT03595579|11337859|FG001|mITT Population|Overall Study||37
10210685|NCT03595579|11337858|FG000|Safety Population|Overall Study||48
10210686|NCT03595579|11337859|FG001|Safety Population|Overall Study||48
10210687|NCT03595579|11337858|FG000|COMPLETED|Overall Study||38
10210688|NCT03595579|11337859|FG001|COMPLETED|Overall Study||35
10210689|NCT03595579|11337858|FG000|NOT COMPLETED|Overall Study||10
10210690|NCT03595579|11337859|FG001|NOT COMPLETED|Overall Study||14
10210691|NCT03595618|11337869|FG000|STARTED|Overall Study||234
10210692|NCT03595618|11337870|FG001|STARTED|Overall Study||231
10210693|NCT03595618|11337871|FG002|STARTED|Overall Study||233
10210694|NCT03595618|11337872|FG003|STARTED|Overall Study||234
10210695|NCT03595618|11337869|FG000|Treated|Overall Study||234
10210696|NCT03595618|11337870|FG001|Treated|Overall Study||231
10210697|NCT03595618|11337871|FG002|Treated|Overall Study||232
10210698|NCT03595618|11337872|FG003|Treated|Overall Study||234
10210699|NCT03595618|11337869|FG000|COMPLETED|Overall Study||191
10210700|NCT03595618|11337870|FG001|COMPLETED|Overall Study||191
10210701|NCT03595618|11337871|FG002|COMPLETED|Overall Study||177
10210702|NCT03595618|11337872|FG003|COMPLETED|Overall Study||200
10210703|NCT03595618|11337869|FG000|NOT COMPLETED|Overall Study||43
10210704|NCT03595618|11337870|FG001|NOT COMPLETED|Overall Study||40
10210705|NCT03595618|11337871|FG002|NOT COMPLETED|Overall Study||56
10210706|NCT03595618|11337872|FG003|NOT COMPLETED|Overall Study||34
10210707|NCT03595904|11337884|FG000|STARTED|Overall Study||39
10210708|NCT03595904|11337885|FG001|STARTED|Overall Study||39
10210709|NCT03595904|11337884|FG000|COMPLETED|Overall Study||29
10210710|NCT03595904|11337885|FG001|COMPLETED|Overall Study||34
10210711|NCT03595904|11337884|FG000|NOT COMPLETED|Overall Study||10
10210712|NCT03595904|11337885|FG001|NOT COMPLETED|Overall Study||5
10210713|NCT03596151|11337891|FG000|STARTED|Overall Study||295
10210714|NCT03596151|11337891|FG000|COMPLETED|Overall Study||294
10210715|NCT03596151|11337891|FG000|NOT COMPLETED|Overall Study||1
10210716|NCT03596177|11337897|FG000|STARTED|Single Blind Period||9
10210717|NCT03596177|11337898|FG001|STARTED|Single Blind Period||19
10210718|NCT03596177|11337897|FG000|COMPLETED|Single Blind Period||7
10210719|NCT03596177|11337898|FG001|COMPLETED|Single Blind Period||18
10210720|NCT03596177|11337897|FG000|NOT COMPLETED|Single Blind Period||2
10210721|NCT03596177|11337898|FG001|NOT COMPLETED|Single Blind Period||1
10210722|NCT03596177|11337897|FG000|STARTED|Double Blind Period||7
10210723|NCT03596177|11337898|FG001|STARTED|Double Blind Period||18
10210724|NCT03596177|11337897|FG000|COMPLETED|Double Blind Period||7
10210725|NCT03596177|11337898|FG001|COMPLETED|Double Blind Period||12
10210726|NCT03596177|11337897|FG000|NOT COMPLETED|Double Blind Period||0
10210727|NCT03596177|11337898|FG001|NOT COMPLETED|Double Blind Period||6
10210728|NCT03596723|11337906|FG000|STARTED|Overall Study||1
10210729|NCT03596723|11337907|FG001|STARTED|Overall Study||1
10210730|NCT03596723|11337906|FG000|COMPLETED|Overall Study||1
10210731|NCT03596723|11337907|FG001|COMPLETED|Overall Study||1
10210732|NCT03596723|11337906|FG000|NOT COMPLETED|Overall Study||0
10210733|NCT03596723|11337907|FG001|NOT COMPLETED|Overall Study||0
10210734|NCT03597009|11337913|FG000|STARTED|Overall Study||1
10210735|NCT03597009|11337913|FG000|COMPLETED|Overall Study||1
10210736|NCT03597009|11337913|FG000|NOT COMPLETED|Overall Study||0
10210737|NCT03597022|11337920|FG000|STARTED|Overall Study||8
10210738|NCT03597022|11337921|FG001|STARTED|Overall Study||8
10210739|NCT03597022|11337922|FG002|STARTED|Overall Study||8
10210740|NCT03597022|11337920|FG000|COMPLETED|Overall Study||0
10210741|NCT03597022|11337921|FG001|COMPLETED|Overall Study||0
10210742|NCT03597022|11337922|FG002|COMPLETED|Overall Study||0
10210743|NCT03597022|11337920|FG000|NOT COMPLETED|Overall Study||8
10210744|NCT03597022|11337921|FG001|NOT COMPLETED|Overall Study||8
10210745|NCT03597022|11337922|FG002|NOT COMPLETED|Overall Study||8
10210746|NCT03597061|11337932|FG000|STARTED|Overall Study||17
10210747|NCT03597061|11337933|FG001|STARTED|Overall Study||17
10210748|NCT03597061|11337932|FG000|COMPLETED|Overall Study||16
10210749|NCT03597061|11337933|FG001|COMPLETED|Overall Study||16
10210750|NCT03597061|11337932|FG000|NOT COMPLETED|Overall Study||1
10210751|NCT03597061|11337933|FG001|NOT COMPLETED|Overall Study||1
10210752|NCT03597139|11337941|FG000|STARTED|Overall Study||51
10210753|NCT03597139|11337942|FG001|STARTED|Overall Study||49
10210754|NCT03597139|11337941|FG000|COMPLETED|Overall Study||47
10210755|NCT03597139|11337942|FG001|COMPLETED|Overall Study||49
10210756|NCT03597139|11337941|FG000|NOT COMPLETED|Overall Study||4
10210757|NCT03597139|11337942|FG001|NOT COMPLETED|Overall Study||0
10210758|NCT03597178|11337948|FG000|STARTED|Overall Study||14
10210759|NCT03597178|11337948|FG000|COMPLETED|Overall Study||14
10210760|NCT03597178|11337948|FG000|NOT COMPLETED|Overall Study||0
10210761|NCT03597347|11337955|FG000|STARTED|Overall Study||7
10210762|NCT03597347|11337956|FG001|STARTED|Overall Study||3
10210763|NCT03597347|11337957|FG002|STARTED|Overall Study||4
10210764|NCT03597347|11337955|FG000|COMPLETED|Overall Study||0
10210765|NCT03597347|11337956|FG001|COMPLETED|Overall Study||0
10210766|NCT03597347|11337957|FG002|COMPLETED|Overall Study||0
10210767|NCT03597347|11337955|FG000|NOT COMPLETED|Overall Study||7
10210768|NCT03597347|11337956|FG001|NOT COMPLETED|Overall Study||3
10210769|NCT03597347|11337957|FG002|NOT COMPLETED|Overall Study||4
10210770|NCT03597529|11337967|FG000|STARTED|Overall Study||42
10210771|NCT03597529|11337968|FG001|STARTED|Overall Study||42
10210772|NCT03597529|11337967|FG000|Follow-up|Overall Study||22
10210773|NCT03597529|11337968|FG001|Follow-up|Overall Study||24
10210774|NCT03597529|11337967|FG000|COMPLETED|Overall Study||22
10210775|NCT03597529|11337968|FG001|COMPLETED|Overall Study||24
10210776|NCT03597529|11337967|FG000|NOT COMPLETED|Overall Study||20
10210777|NCT03597529|11337968|FG001|NOT COMPLETED|Overall Study||18
10210778|NCT03597789|11337974|FG000|STARTED|Overall Study||45
10210779|NCT03597789|11337974|FG000|COMPLETED|Overall Study||10
10210780|NCT03597789|11337974|FG000|NOT COMPLETED|Overall Study||35
10210781|NCT03598647|11337980|FG000|STARTED|Exercisers vs. Non-exercisers||30
10210782|NCT03598647|11337981|FG001|STARTED|Exercisers vs. Non-exercisers||30
10210783|NCT03598647|11337982|FG002|STARTED|Exercisers vs. Non-exercisers||0
10210784|NCT03598647|11337983|FG003|STARTED|Exercisers vs. Non-exercisers||0
10210785|NCT03598647|11337980|FG000|COMPLETED|Exercisers vs. Non-exercisers||29
10210786|NCT03598647|11337981|FG001|COMPLETED|Exercisers vs. Non-exercisers||30
10210787|NCT03598647|11337982|FG002|COMPLETED|Exercisers vs. Non-exercisers||0
10210788|NCT03598647|11337983|FG003|COMPLETED|Exercisers vs. Non-exercisers||0
10210789|NCT03598647|11337980|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1
10210790|NCT03598647|11337981|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0
10210791|NCT03598647|11337982|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0
10210792|NCT03598647|11337983|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0
10210793|NCT03598647|11337980|FG000|STARTED|Interventions for Non-exercisers||0
10210794|NCT03598647|11337981|FG001|STARTED|Interventions for Non-exercisers||0
10210795|NCT03598647|11337982|FG002|STARTED|Interventions for Non-exercisers||14
10210796|NCT03598647|11337983|FG003|STARTED|Interventions for Non-exercisers||16
10210797|NCT03598647|11337980|FG000|COMPLETED|Interventions for Non-exercisers||0
10210798|NCT03598647|11337981|FG001|COMPLETED|Interventions for Non-exercisers||0
10210799|NCT03598647|11337982|FG002|COMPLETED|Interventions for Non-exercisers||14
10011938|NCT01783444|11134746|FG000|NOT COMPLETED|Treatment Phase||104
10011939|NCT01783444|11134747|FG001|NOT COMPLETED|Treatment Phase||103
10011940|NCT01783444|11134748|FG002|NOT COMPLETED|Treatment Phase||102
10011941|NCT01783444|11134746|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
10210800|NCT03598647|11337983|FG003|COMPLETED|Interventions for Non-exercisers||16
10210801|NCT03598647|11337980|FG000|NOT COMPLETED|Interventions for Non-exercisers||0
10210802|NCT03598647|11337981|FG001|NOT COMPLETED|Interventions for Non-exercisers||0
10210803|NCT03598647|11337982|FG002|NOT COMPLETED|Interventions for Non-exercisers||0
10210804|NCT03598647|11337983|FG003|NOT COMPLETED|Interventions for Non-exercisers||0
10210805|NCT03599089|11337997|FG000|STARTED|Overall Study||36
10210806|NCT03599089|11337998|FG001|STARTED|Overall Study||36
10210807|NCT03599089|11337999|FG002|STARTED|Overall Study||38
10210808|NCT03599089|11338000|FG003|STARTED|Overall Study||37
10210809|NCT03599089|11337997|FG000|COMPLETED|Overall Study||33
10210810|NCT03599089|11337998|FG001|COMPLETED|Overall Study||35
10210811|NCT03599089|11337999|FG002|COMPLETED|Overall Study||37
10210812|NCT03599089|11338000|FG003|COMPLETED|Overall Study||35
10210813|NCT03599089|11337997|FG000|NOT COMPLETED|Overall Study||3
10210814|NCT03599089|11337998|FG001|NOT COMPLETED|Overall Study||1
10210815|NCT03599089|11337999|FG002|NOT COMPLETED|Overall Study||1
10210816|NCT03599089|11338000|FG003|NOT COMPLETED|Overall Study||2
10210817|NCT03599193|11338012|FG000|STARTED|Overall Study||34
10210818|NCT03599193|11338013|FG001|STARTED|Overall Study||24
10210819|NCT03599193|11338012|FG000|COMPLETED|Overall Study||32
10210820|NCT03599193|11338013|FG001|COMPLETED|Overall Study||21
10210821|NCT03599193|11338012|FG000|NOT COMPLETED|Overall Study||2
10210822|NCT03599193|11338013|FG001|NOT COMPLETED|Overall Study||3
10210823|NCT03599271|11338022|FG000|STARTED|Overall Study||70
10210824|NCT03599271|11338023|FG001|STARTED|Overall Study||5
10210825|NCT03599271|11338022|FG000|Drug-Coated Device|Overall Study||70
10210826|NCT03599271|11338023|FG001|Drug-Coated Device|Overall Study||5
10210827|NCT03599271|11338022|FG000|Control Device|Overall Study||70
10210828|NCT03599271|11338023|FG001|Control Device|Overall Study||0
10210829|NCT03599271|11338022|FG000|COMPLETED|Overall Study||70
10210830|NCT03599271|11338023|FG001|COMPLETED|Overall Study||5
10210831|NCT03599271|11338022|FG000|NOT COMPLETED|Overall Study||0
10210832|NCT03599271|11338023|FG001|NOT COMPLETED|Overall Study||0
10210833|NCT03599349|11338031|FG000|STARTED|Overall Study||20
10210834|NCT03599349|11338031|FG000|Treated|Overall Study||20
10210835|NCT03599349|11338031|FG000|COMPLETED|Overall Study||19
10210836|NCT03599349|11338031|FG000|NOT COMPLETED|Overall Study||1
10210837|NCT03599362|11338035|FG000|STARTED|Overall Study||7
10210838|NCT03599362|11338035|FG000|COMPLETED|Overall Study||4
10210839|NCT03599362|11338035|FG000|NOT COMPLETED|Overall Study||3
10210840|NCT03599687|11338041|FG000|STARTED|Overall Study||82
10210841|NCT03599687|11338042|FG001|STARTED|Overall Study||82
10210842|NCT03599687|11338041|FG000|COMPLETED|Overall Study||82
10210843|NCT03599687|11338042|FG001|COMPLETED|Overall Study||82
10210844|NCT03599687|11338041|FG000|NOT COMPLETED|Overall Study||0
10210845|NCT03599687|11338042|FG001|NOT COMPLETED|Overall Study||0
10210846|NCT03599986|11338048|FG000|STARTED|Overall Study||398
10210847|NCT03599986|11338048|FG000|COMPLETED|Overall Study||366
10210848|NCT03599986|11338048|FG000|NOT COMPLETED|Overall Study||32
10210849|NCT03600194|11338053|FG000|STARTED|Screening||38
10210850|NCT03600194|11338054|FG001|STARTED|Screening||0
10210851|NCT03600194|11338055|FG002|STARTED|Screening||0
10210852|NCT03600194|11338053|FG000|COMPLETED|Screening||11
10210853|NCT03600194|11338054|FG001|COMPLETED|Screening||0
10210854|NCT03600194|11338055|FG002|COMPLETED|Screening||0
10210855|NCT03600194|11338053|FG000|NOT COMPLETED|Screening||27
10210856|NCT03600194|11338054|FG001|NOT COMPLETED|Screening||0
10210857|NCT03600194|11338055|FG002|NOT COMPLETED|Screening||0
10210858|NCT03600194|11338053|FG000|STARTED|In Lab Phase||0
10210859|NCT03600194|11338054|FG001|STARTED|In Lab Phase||5
10210860|NCT03600194|11338055|FG002|STARTED|In Lab Phase||6
10210861|NCT03600194|11338053|FG000|COMPLETED|In Lab Phase||0
10210862|NCT03600194|11338054|FG001|COMPLETED|In Lab Phase||5
10210863|NCT03600194|11338055|FG002|COMPLETED|In Lab Phase||6
10210864|NCT03600194|11338053|FG000|NOT COMPLETED|In Lab Phase||0
10210865|NCT03600194|11338054|FG001|NOT COMPLETED|In Lab Phase||0
10210866|NCT03600194|11338055|FG002|NOT COMPLETED|In Lab Phase||0
10210867|NCT03600376|11338068|FG000|STARTED|Overall Study||9
10210868|NCT03600376|11338069|FG001|STARTED|Overall Study||8
10210869|NCT03600376|11338068|FG000|COMPLETED|Overall Study||7
10210870|NCT03600376|11338069|FG001|COMPLETED|Overall Study||2
10210871|NCT03600376|11338068|FG000|NOT COMPLETED|Overall Study||2
10210872|NCT03600376|11338069|FG001|NOT COMPLETED|Overall Study||6
10210873|NCT03600428|11338077|FG000|STARTED|Overall Study||79
10210874|NCT03600428|11338078|FG001|STARTED|Overall Study||73
10210875|NCT03600428|11338077|FG000|15-day Follow-up|Overall Study||76
10210876|NCT03600428|11338078|FG001|15-day Follow-up|Overall Study||70
10210877|NCT03600428|11338077|FG000|43-day Follow-up|Overall Study||74
10210878|NCT03600428|11338078|FG001|43-day Follow-up|Overall Study||68
10210879|NCT03600428|11338077|FG000|COMPLETED|Overall Study||74
10210880|NCT03600428|11338078|FG001|COMPLETED|Overall Study||68
10210881|NCT03600428|11338077|FG000|NOT COMPLETED|Overall Study||5
10210882|NCT03600428|11338078|FG001|NOT COMPLETED|Overall Study||5
10210883|NCT03601052|11338084|FG000|STARTED|Overall Study||14
10210884|NCT03601052|11338084|FG000|COMPLETED|Overall Study||12
10210885|NCT03601052|11338084|FG000|NOT COMPLETED|Overall Study||2
10210886|NCT03601715|11338096|FG000|STARTED|First Intervention||7
10210887|NCT03601715|11338097|FG001|STARTED|First Intervention||7
10210888|NCT03601715|11338098|FG002|STARTED|First Intervention||6
10210889|NCT03601715|11338096|FG000|COMPLETED|First Intervention||7
10210890|NCT03601715|11338097|FG001|COMPLETED|First Intervention||7
10210891|NCT03601715|11338098|FG002|COMPLETED|First Intervention||6
10210892|NCT03601715|11338096|FG000|NOT COMPLETED|First Intervention||0
10210893|NCT03601715|11338097|FG001|NOT COMPLETED|First Intervention||0
10210894|NCT03601715|11338098|FG002|NOT COMPLETED|First Intervention||0
10210895|NCT03601715|11338096|FG000|STARTED|Washout 1 (at Least 24 Hours)||7
10210896|NCT03601715|11338097|FG001|STARTED|Washout 1 (at Least 24 Hours)||7
10210897|NCT03601715|11338098|FG002|STARTED|Washout 1 (at Least 24 Hours)||6
10210898|NCT03601715|11338096|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7
10210899|NCT03601715|11338097|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7
10210900|NCT03601715|11338098|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6
10210901|NCT03601715|11338096|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
10210902|NCT03601715|11338097|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
10210903|NCT03601715|11338098|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
10210904|NCT03601715|11338096|FG000|STARTED|Second Intervention||7
10210905|NCT03601715|11338097|FG001|STARTED|Second Intervention||7
10210906|NCT03601715|11338098|FG002|STARTED|Second Intervention||6
10210907|NCT03601715|11338096|FG000|COMPLETED|Second Intervention||6
10210908|NCT03601715|11338097|FG001|COMPLETED|Second Intervention||6
10210909|NCT03601715|11338098|FG002|COMPLETED|Second Intervention||6
10210910|NCT03601715|11338096|FG000|NOT COMPLETED|Second Intervention||1
10210911|NCT03601715|11338097|FG001|NOT COMPLETED|Second Intervention||1
10210912|NCT03601715|11338098|FG002|NOT COMPLETED|Second Intervention||0
10210913|NCT03601715|11338096|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6
10210914|NCT03601715|11338097|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6
10210915|NCT03601715|11338098|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6
10210916|NCT03601715|11338096|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
10210917|NCT03601715|11338097|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
10210918|NCT03601715|11338098|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
10210919|NCT03601715|11338096|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
10210920|NCT03601715|11338097|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
10210921|NCT03601715|11338098|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
10210922|NCT03601715|11338096|FG000|STARTED|Third Intervention||6
10210923|NCT03601715|11338097|FG001|STARTED|Third Intervention||6
10210924|NCT03601715|11338098|FG002|STARTED|Third Intervention||6
10210925|NCT03601715|11338096|FG000|COMPLETED|Third Intervention||6
10210926|NCT03601715|11338097|FG001|COMPLETED|Third Intervention||6
10210927|NCT03601715|11338098|FG002|COMPLETED|Third Intervention||6
10210928|NCT03601715|11338096|FG000|NOT COMPLETED|Third Intervention||0
10210929|NCT03601715|11338097|FG001|NOT COMPLETED|Third Intervention||0
10210930|NCT03601715|11338098|FG002|NOT COMPLETED|Third Intervention||0
10210931|NCT03602053|11338109|FG000|STARTED|Overall Study||150
10210932|NCT03602053|11338110|FG001|STARTED|Overall Study||150
10210933|NCT03602053|11338111|FG002|STARTED|Overall Study||150
10210934|NCT03602053|11338109|FG000|COMPLETED|Overall Study||131
10210935|NCT03602053|11338110|FG001|COMPLETED|Overall Study||132
10210936|NCT03602053|11338111|FG002|COMPLETED|Overall Study||139
10210937|NCT03602053|11338109|FG000|NOT COMPLETED|Overall Study||19
10210938|NCT03602053|11338110|FG001|NOT COMPLETED|Overall Study||18
10210939|NCT03602053|11338111|FG002|NOT COMPLETED|Overall Study||11
10210940|NCT03602339|11338123|FG000|STARTED|Overall Study||157
10210941|NCT03602339|11338123|FG000|Completed Period 1 (Gadoterate)|Overall Study||155
10210942|NCT03602339|11338123|FG000|Started Period 2 (Gadobutrol)|Overall Study||142
10210943|NCT03602339|11338123|FG000|COMPLETED|Overall Study||142
10210944|NCT03602339|11338123|FG000|NOT COMPLETED|Overall Study||15
10210945|NCT03602482|11338132|FG000|STARTED|Overall Study||50
10210946|NCT03602482|11338133|FG001|STARTED|Overall Study||50
10210947|NCT03602482|11338134|FG002|STARTED|Overall Study||20
10210948|NCT03602482|11338135|FG003|STARTED|Overall Study||19
10210949|NCT03602482|11338132|FG000|COMPLETED|Overall Study||44
10210950|NCT03602482|11338133|FG001|COMPLETED|Overall Study||43
10210951|NCT03602482|11338134|FG002|COMPLETED|Overall Study||20
10210952|NCT03602482|11338135|FG003|COMPLETED|Overall Study||19
10210953|NCT03602482|11338132|FG000|NOT COMPLETED|Overall Study||6
10210954|NCT03602482|11338133|FG001|NOT COMPLETED|Overall Study||7
10210955|NCT03602482|11338134|FG002|NOT COMPLETED|Overall Study||0
10210956|NCT03602482|11338135|FG003|NOT COMPLETED|Overall Study||0
10210957|NCT03603028|11338148|FG000|STARTED|Overall Study||13
10210958|NCT03603028|11338148|FG000|COMPLETED|Overall Study||12
10210959|NCT03603028|11338148|FG000|NOT COMPLETED|Overall Study||1
10210960|NCT03603106|11338163|FG000|STARTED|Overall Study||6
10210961|NCT03603106|11338164|FG001|STARTED|Overall Study||6
10210962|NCT03603106|11338165|FG002|STARTED|Overall Study||6
10210963|NCT03603106|11338166|FG003|STARTED|Overall Study||6
10210964|NCT03603106|11338167|FG004|STARTED|Overall Study||6
10210965|NCT03603106|11338168|FG005|STARTED|Overall Study||6
10210966|NCT03603106|11338169|FG006|STARTED|Overall Study||18
10210967|NCT03603106|11338170|FG007|STARTED|Overall Study||3
10210968|NCT03603106|11338171|FG008|STARTED|Overall Study||3
10210969|NCT03603106|11338172|FG009|STARTED|Overall Study||3
10210970|NCT03603106|11338173|FG010|STARTED|Overall Study||3
10210971|NCT03603106|11338163|FG000|COMPLETED|Overall Study||6
10210972|NCT03603106|11338164|FG001|COMPLETED|Overall Study||6
10210973|NCT03603106|11338165|FG002|COMPLETED|Overall Study||6
10210974|NCT03603106|11338166|FG003|COMPLETED|Overall Study||6
10210975|NCT03603106|11338167|FG004|COMPLETED|Overall Study||6
10210976|NCT03603106|11338168|FG005|COMPLETED|Overall Study||6
10210977|NCT03603106|11338169|FG006|COMPLETED|Overall Study||18
10210978|NCT03603106|11338170|FG007|COMPLETED|Overall Study||3
10210979|NCT03603106|11338171|FG008|COMPLETED|Overall Study||3
10210980|NCT03603106|11338172|FG009|COMPLETED|Overall Study||3
10210981|NCT03603106|11338173|FG010|COMPLETED|Overall Study||3
10210982|NCT03603106|11338163|FG000|NOT COMPLETED|Overall Study||0
10210983|NCT03603106|11338164|FG001|NOT COMPLETED|Overall Study||0
10210984|NCT03603106|11338165|FG002|NOT COMPLETED|Overall Study||0
10210985|NCT03603106|11338166|FG003|NOT COMPLETED|Overall Study||0
10210986|NCT03603106|11338167|FG004|NOT COMPLETED|Overall Study||0
10210987|NCT03603106|11338168|FG005|NOT COMPLETED|Overall Study||0
10210988|NCT03603106|11338169|FG006|NOT COMPLETED|Overall Study||0
10210989|NCT03603106|11338170|FG007|NOT COMPLETED|Overall Study||0
10210990|NCT03603106|11338171|FG008|NOT COMPLETED|Overall Study||0
10210991|NCT03603106|11338172|FG009|NOT COMPLETED|Overall Study||0
10210992|NCT03603106|11338173|FG010|NOT COMPLETED|Overall Study||0
10210993|NCT03603652|11338206|FG000|STARTED|Overall Study||10
10210994|NCT03603652|11338206|FG000|COMPLETED|Overall Study||8
10210995|NCT03603652|11338206|FG000|NOT COMPLETED|Overall Study||2
10210996|NCT03604263|11338210|FG000|STARTED|Overall Study||17
10210997|NCT03604263|11338210|FG000|COMPLETED|Overall Study||15
10210998|NCT03604263|11338210|FG000|NOT COMPLETED|Overall Study||2
10210999|NCT03604341|11338216|FG000|STARTED|Overall Study||35
10211000|NCT03604341|11338217|FG001|STARTED|Overall Study||35
10211001|NCT03604341|11338216|FG000|COMPLETED|Overall Study||33
10211002|NCT03604341|11338217|FG001|COMPLETED|Overall Study||33
10211003|NCT03604341|11338216|FG000|NOT COMPLETED|Overall Study||2
10211004|NCT03604341|11338217|FG001|NOT COMPLETED|Overall Study||2
10211005|NCT03604497|11338223|FG000|STARTED|Overall Study||437
10211006|NCT03604497|11338223|FG000|COMPLETED|Overall Study||385
10211007|NCT03604497|11338223|FG000|NOT COMPLETED|Overall Study||52
10211008|NCT03604523|11338233|FG000|STARTED|Overall Study||5
10211009|NCT03604523|11338234|FG001|STARTED|Overall Study||5
10211010|NCT03604523|11338233|FG000|COMPLETED|Overall Study||4
10211011|NCT03604523|11338234|FG001|COMPLETED|Overall Study||5
10211012|NCT03604523|11338233|FG000|NOT COMPLETED|Overall Study||1
10211013|NCT03604523|11338234|FG001|NOT COMPLETED|Overall Study||0
10211014|NCT03604705|11338240|FG000|STARTED|Overall Study||21
10211015|NCT03604705|11338240|FG000|COMPLETED|Overall Study||20
10211016|NCT03604705|11338240|FG000|NOT COMPLETED|Overall Study||1
10211017|NCT03605212|11338257|FG000|STARTED|Baseline Period||3
10211018|NCT03605212|11338258|FG001|STARTED|Baseline Period||0
10211019|NCT03605212|11338259|FG002|STARTED|Baseline Period||3
10211020|NCT03605212|11338260|FG003|STARTED|Baseline Period||0
10211021|NCT03605212|11338261|FG004|STARTED|Baseline Period||24
10211022|NCT03605212|11338257|FG000|COMPLETED|Baseline Period||3
10211023|NCT03605212|11338258|FG001|COMPLETED|Baseline Period||0
10211024|NCT03605212|11338259|FG002|COMPLETED|Baseline Period||3
10211025|NCT03605212|11338260|FG003|COMPLETED|Baseline Period||0
10211026|NCT03605212|11338261|FG004|COMPLETED|Baseline Period||24
10211027|NCT03605212|11338257|FG000|NOT COMPLETED|Baseline Period||0
10211028|NCT03605212|11338258|FG001|NOT COMPLETED|Baseline Period||0
10211029|NCT03605212|11338259|FG002|NOT COMPLETED|Baseline Period||0
10211030|NCT03605212|11338260|FG003|NOT COMPLETED|Baseline Period||0
10211031|NCT03605212|11338261|FG004|NOT COMPLETED|Baseline Period||0
10211032|NCT03605212|11338257|FG000|STARTED|Treatment Period||3
10211033|NCT03605212|11338258|FG001|STARTED|Treatment Period||0
10211034|NCT03605212|11338259|FG002|STARTED|Treatment Period||3
10211035|NCT03605212|11338260|FG003|STARTED|Treatment Period||0
10211036|NCT03605212|11338261|FG004|STARTED|Treatment Period||24
10211037|NCT03605212|11338257|FG000|COMPLETED|Treatment Period||2
10211038|NCT03605212|11338258|FG001|COMPLETED|Treatment Period||0
10211039|NCT03605212|11338259|FG002|COMPLETED|Treatment Period||3
10211040|NCT03605212|11338260|FG003|COMPLETED|Treatment Period||0
10211041|NCT03605212|11338261|FG004|COMPLETED|Treatment Period||23
10211042|NCT03605212|11338257|FG000|NOT COMPLETED|Treatment Period||1
10211043|NCT03605212|11338258|FG001|NOT COMPLETED|Treatment Period||0
10211044|NCT03605212|11338259|FG002|NOT COMPLETED|Treatment Period||0
10211045|NCT03605212|11338260|FG003|NOT COMPLETED|Treatment Period||0
10211046|NCT03605212|11338261|FG004|NOT COMPLETED|Treatment Period||1
10211047|NCT03605693|11338276|FG000|STARTED|Overall Study||5
10211048|NCT03605693|11338277|FG001|STARTED|Overall Study||5
10211049|NCT03605693|11338276|FG000|COMPLETED|Overall Study||0
10211050|NCT03605693|11338277|FG001|COMPLETED|Overall Study||5
10211051|NCT03605693|11338276|FG000|NOT COMPLETED|Overall Study||5
10211052|NCT03605693|11338277|FG001|NOT COMPLETED|Overall Study||0
10211053|NCT03605745|11338283|FG000|STARTED|Overall Study||47
10211054|NCT03605745|11338283|FG000|2 Weeks|Overall Study||47
10211055|NCT03605745|11338283|FG000|6 Weeks|Overall Study||47
10211056|NCT03605745|11338283|FG000|3 Months|Overall Study||47
10211057|NCT03605745|11338283|FG000|6 Months|Overall Study||47
10211058|NCT03605745|11338283|FG000|12 Months|Overall Study||40
10211059|NCT03605745|11338283|FG000|24 Months|Overall Study||1
10211060|NCT03605745|11338283|FG000|COMPLETED|Overall Study||0
10211061|NCT03605745|11338283|FG000|NOT COMPLETED|Overall Study||47
10211062|NCT03605836|11338291|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590
10211063|NCT03605836|11338292|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0
10211064|NCT03605836|11338293|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0
10211065|NCT03605836|11338294|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0
10211066|NCT03605836|11338291|FG000|Treated|OL Placebo Run-in Period [1 Week]||579
10211067|NCT03605836|11338292|FG001|Treated|OL Placebo Run-in Period [1 Week]||0
10211068|NCT03605836|11338293|FG002|Treated|OL Placebo Run-in Period [1 Week]||0
10211069|NCT03605836|11338294|FG003|Treated|OL Placebo Run-in Period [1 Week]||0
10211070|NCT03605836|11338291|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440
10211071|NCT03605836|11338292|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0
10211072|NCT03605836|11338293|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0
10211073|NCT03605836|11338294|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0
10211074|NCT03605836|11338291|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150
10211075|NCT03605836|11338292|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
10211076|NCT03605836|11338293|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
10211077|NCT03605836|11338294|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
10211078|NCT03605836|11338291|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0
10211079|NCT03605836|11338292|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147
10211080|NCT03605836|11338293|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147
10211081|NCT03605836|11338294|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146
10211082|NCT03605836|11338291|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0
10211083|NCT03605836|11338292|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145
10211084|NCT03605836|11338293|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143
10211085|NCT03605836|11338294|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142
10211086|NCT03605836|11338291|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0
10211087|NCT03605836|11338292|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111
10211088|NCT03605836|11338293|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102
10211089|NCT03605836|11338294|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123
10211090|NCT03605836|11338291|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0
10211091|NCT03605836|11338292|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36
10211092|NCT03605836|11338293|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45
10211093|NCT03605836|11338294|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23
10211094|NCT03605914|11338305|FG000|STARTED|Overall Study||57
10211095|NCT03605914|11338306|FG001|STARTED|Overall Study||43
10211096|NCT03605914|11338305|FG000|Completed Day 1 Assessment|Overall Study||31
10211097|NCT03605914|11338306|FG001|Completed Day 1 Assessment|Overall Study||26
10211098|NCT03605914|11338305|FG000|Completed Day 2 Assessment|Overall Study||32
10211099|NCT03605914|11338306|FG001|Completed Day 2 Assessment|Overall Study||27
10211100|NCT03605914|11338305|FG000|Completed Day 3 Assessment|Overall Study||31
10211101|NCT03605914|11338306|FG001|Completed Day 3 Assessment|Overall Study||28
10211102|NCT03605914|11338305|FG000|Completed Day 5 Assessment|Overall Study||30
10211103|NCT03605914|11338306|FG001|Completed Day 5 Assessment|Overall Study||24
10211104|NCT03605914|11338305|FG000|COMPLETED|Overall Study||30
10211105|NCT03605914|11338306|FG001|COMPLETED|Overall Study||24
10211106|NCT03605914|11338305|FG000|NOT COMPLETED|Overall Study||27
10211107|NCT03605914|11338306|FG001|NOT COMPLETED|Overall Study||19
10211108|NCT03606187|11338314|FG000|STARTED|Overall Study||67
10211109|NCT03606187|11338315|FG001|STARTED|Overall Study||61
10211110|NCT03606187|11338314|FG000|COMPLETED|Overall Study||67
10211111|NCT03606187|11338315|FG001|COMPLETED|Overall Study||61
10211112|NCT03606187|11338314|FG000|NOT COMPLETED|Overall Study||0
10211113|NCT03606187|11338315|FG001|NOT COMPLETED|Overall Study||0
10211114|NCT03606343|11338321|FG000|STARTED|Overall Study||21
10211115|NCT03606343|11338321|FG000|COMPLETED|Overall Study||21
10211116|NCT03606343|11338321|FG000|NOT COMPLETED|Overall Study||0
10211117|NCT03606460|11338327|FG000|STARTED|Overall Study||95
10211118|NCT03606460|11338328|FG001|STARTED|Overall Study||46
10211119|NCT03606460|11338327|FG000|COMPLETED|Overall Study||94
10211120|NCT03606460|11338328|FG001|COMPLETED|Overall Study||38
10211121|NCT03606460|11338327|FG000|NOT COMPLETED|Overall Study||1
10211122|NCT03606460|11338328|FG001|NOT COMPLETED|Overall Study||8
10211123|NCT03607539|11338337|FG000|STARTED|Overall Study||266
10211124|NCT03607539|11338338|FG001|STARTED|Overall Study||131
10211125|NCT03607539|11338337|FG000|COMPLETED|Overall Study||0
10211126|NCT03607539|11338338|FG001|COMPLETED|Overall Study||0
10211127|NCT03607539|11338337|FG000|NOT COMPLETED|Overall Study||266
10211128|NCT03607539|11338338|FG001|NOT COMPLETED|Overall Study||131
10238860|NCT00462904|11370295|FG000|NOT COMPLETED|Overall Study||1
10238861|NCT00450333|11370303|FG000|STARTED|Overall Study||98
10238862|NCT00450333|11370304|FG001|STARTED|Overall Study||107
10238863|NCT00450333|11370305|FG002|STARTED|Overall Study||100
10238864|NCT00450333|11370306|FG003|STARTED|Overall Study||102
10238865|NCT00450333|11370303|FG000|COMPLETED|Overall Study||44
10238866|NCT00450333|11370304|FG001|COMPLETED|Overall Study||44
10238867|NCT00450333|11370305|FG002|COMPLETED|Overall Study||75
10238868|NCT00450333|11370306|FG003|COMPLETED|Overall Study||74
10238869|NCT00450333|11370303|FG000|NOT COMPLETED|Overall Study||54
10238870|NCT00450333|11370304|FG001|NOT COMPLETED|Overall Study||63
10238871|NCT00450333|11370305|FG002|NOT COMPLETED|Overall Study||25
10238872|NCT00450333|11370306|FG003|NOT COMPLETED|Overall Study||28
10238873|NCT00455143|11370316|FG000|STARTED|Overall Study||27
10238874|NCT00455143|11370316|FG000|COMPLETED|Overall Study||21
10238875|NCT00455143|11370316|FG000|NOT COMPLETED|Overall Study||6
10238876|NCT00456989|11370321|FG000|STARTED|Overall Study||39
10238877|NCT00456989|11370321|FG000|COMPLETED|Overall Study||39
10238878|NCT00456989|11370321|FG000|NOT COMPLETED|Overall Study||0
10238879|NCT00448682|11370326|FG000|STARTED|Overall Study||25
10238880|NCT00448682|11370326|FG000|COMPLETED|Overall Study||25
10238881|NCT00448682|11370326|FG000|NOT COMPLETED|Overall Study||0
10238882|NCT00454571|11370332|FG000|STARTED|Overall Study||18
10238883|NCT00454571|11370333|FG001|STARTED|Overall Study||19
10238884|NCT00454571|11370332|FG000|COMPLETED|Overall Study||5
10238885|NCT00454571|11370333|FG001|COMPLETED|Overall Study||13
10238886|NCT00454571|11370332|FG000|NOT COMPLETED|Overall Study||13
10238887|NCT00454571|11370333|FG001|NOT COMPLETED|Overall Study||6
10238888|NCT00452361|11370341|FG000|STARTED|Overall Study||21
10238889|NCT00452361|11370342|FG001|STARTED|Overall Study||10
10238890|NCT00452361|11370341|FG000|COMPLETED|Overall Study||0
10238891|NCT00452361|11370342|FG001|COMPLETED|Overall Study||0
10238892|NCT00452361|11370341|FG000|NOT COMPLETED|Overall Study||21
10238893|NCT00452361|11370342|FG001|NOT COMPLETED|Overall Study||10
10238894|NCT00443040|11370351|FG000|STARTED|Overall Study||14
10238895|NCT00443040|11370352|FG001|STARTED|Overall Study||11
10238896|NCT00443040|11370353|FG002|STARTED|Overall Study||10
10211129|NCT03607682|11338344|FG000|STARTED|Overall Study||2
10211130|NCT03607682|11338344|FG000|COMPLETED|Overall Study||0
10211131|NCT03607682|11338344|FG000|NOT COMPLETED|Overall Study||2
10211132|NCT03607695|11338348|FG000|STARTED|2 Week||19
10211133|NCT03607695|11338348|FG000|COMPLETED|2 Week||19
10211134|NCT03607695|11338348|FG000|NOT COMPLETED|2 Week||0
10211135|NCT03607695|11338348|FG000|STARTED|10 Week||19
10211136|NCT03607695|11338348|FG000|COMPLETED|10 Week||18
10211137|NCT03607695|11338348|FG000|NOT COMPLETED|10 Week||1
10211138|NCT03607695|11338348|FG000|STARTED|16 Week||18
10211139|NCT03607695|11338348|FG000|COMPLETED|16 Week||16
10211140|NCT03607695|11338348|FG000|NOT COMPLETED|16 Week||2
10211141|NCT03608488|11338356|FG000|STARTED|Overall Study||22
10211142|NCT03608488|11338357|FG001|STARTED|Overall Study||21
10211143|NCT03608488|11338358|FG002|STARTED|Overall Study||22
10211144|NCT03608488|11338359|FG003|STARTED|Overall Study||45
10211145|NCT03608488|11338356|FG000|COMPLETED|Overall Study||21
10211146|NCT03608488|11338357|FG001|COMPLETED|Overall Study||18
10211147|NCT03608488|11338358|FG002|COMPLETED|Overall Study||20
10211148|NCT03608488|11338359|FG003|COMPLETED|Overall Study||40
10211149|NCT03608488|11338356|FG000|NOT COMPLETED|Overall Study||1
10211150|NCT03608488|11338357|FG001|NOT COMPLETED|Overall Study||3
10211151|NCT03608488|11338358|FG002|NOT COMPLETED|Overall Study||2
10211152|NCT03608488|11338359|FG003|NOT COMPLETED|Overall Study||5
10211153|NCT03608774|11338371|FG000|STARTED|Overall Study||89
10211154|NCT03608774|11338372|FG001|STARTED|Overall Study||88
10211155|NCT03608774|11338371|FG000|COMPLETED|Overall Study||82
10211156|NCT03608774|11338372|FG001|COMPLETED|Overall Study||81
10211157|NCT03608774|11338371|FG000|NOT COMPLETED|Overall Study||7
10211158|NCT03608774|11338372|FG001|NOT COMPLETED|Overall Study||7
10211159|NCT03608839|11338381|FG000|STARTED|Overall Study||9
10211160|NCT03608839|11338382|FG001|STARTED|Overall Study||9
10211161|NCT03608839|11338383|FG002|STARTED|Overall Study||9
10211162|NCT03608839|11338381|FG000|COMPLETED|Overall Study||9
10211163|NCT03608839|11338382|FG001|COMPLETED|Overall Study||9
10211164|NCT03608839|11338383|FG002|COMPLETED|Overall Study||9
10211165|NCT03608839|11338381|FG000|NOT COMPLETED|Overall Study||0
10211166|NCT03608839|11338382|FG001|NOT COMPLETED|Overall Study||0
10211167|NCT03608839|11338383|FG002|NOT COMPLETED|Overall Study||0
10211168|NCT03609619|11338393|FG000|STARTED|Overall Study||54
10211169|NCT03609619|11338394|FG001|STARTED|Overall Study||55
10211170|NCT03609619|11338393|FG000|COMPLETED|Overall Study||44
10211171|NCT03609619|11338394|FG001|COMPLETED|Overall Study||49
10211172|NCT03609619|11338393|FG000|NOT COMPLETED|Overall Study||10
10211173|NCT03609619|11338394|FG001|NOT COMPLETED|Overall Study||6
10211174|NCT03609658|11338402|FG000|STARTED|Overall Study||379
10211175|NCT03609658|11338403|FG001|STARTED|Overall Study||380
10211176|NCT03609658|11338402|FG000|COMPLETED|Overall Study||379
10211177|NCT03609658|11338403|FG001|COMPLETED|Overall Study||380
10211178|NCT03609658|11338402|FG000|NOT COMPLETED|Overall Study||0
10211179|NCT03609658|11338403|FG001|NOT COMPLETED|Overall Study||0
10211180|NCT03610048|11338409|FG000|STARTED|Overall Study||175
10211181|NCT03610048|11338409|FG000|Completed Treatment|Overall Study||15
10211182|NCT03610048|11338409|FG000|COMPLETED|Overall Study||14
10211183|NCT03610048|11338409|FG000|NOT COMPLETED|Overall Study||161
10211184|NCT03610165|11338415|FG000|STARTED|Overall Study||108
10211185|NCT03610165|11338416|FG001|STARTED|Overall Study||106
10211186|NCT03610165|11338415|FG000|COMPLETED|Overall Study||108
10211187|NCT03610165|11338416|FG001|COMPLETED|Overall Study||105
10211188|NCT03610165|11338415|FG000|NOT COMPLETED|Overall Study||0
10211189|NCT03610165|11338416|FG001|NOT COMPLETED|Overall Study||1
10211190|NCT03610269|11338422|FG000|STARTED|Overall Study||143
10211191|NCT03610269|11338422|FG000|COMPLETED|Overall Study||127
10211192|NCT03610269|11338422|FG000|NOT COMPLETED|Overall Study||16
10211193|NCT03610399|11338429|FG000|STARTED|Overall Study||63
10211194|NCT03610399|11338430|FG001|STARTED|Overall Study||96
10211195|NCT03610399|11338431|FG002|STARTED|Overall Study||95
10211196|NCT03610399|11338429|FG000|COMPLETED|Overall Study||53
10211197|NCT03610399|11338430|FG001|COMPLETED|Overall Study||78
10211198|NCT03610399|11338431|FG002|COMPLETED|Overall Study||79
10211199|NCT03610399|11338429|FG000|NOT COMPLETED|Overall Study||10
10211200|NCT03610399|11338430|FG001|NOT COMPLETED|Overall Study||18
10211201|NCT03610399|11338431|FG002|NOT COMPLETED|Overall Study||16
10211202|NCT03610464|11338439|FG000|STARTED|Overall Study||5
10211203|NCT03610464|11338439|FG000|COMPLETED|Overall Study||5
10211204|NCT03610464|11338439|FG000|NOT COMPLETED|Overall Study||0
10211205|NCT03610581|11338446|FG000|STARTED|Overall Study||5
10211206|NCT03610581|11338447|FG001|STARTED|Overall Study||4
10211207|NCT03610581|11338446|FG000|Vaccinated|Overall Study||4
10211208|NCT03610581|11338447|FG001|Vaccinated|Overall Study||4
10211209|NCT03610581|11338446|FG000|COMPLETED|Overall Study||2
10211210|NCT03610581|11338447|FG001|COMPLETED|Overall Study||3
10211211|NCT03610581|11338446|FG000|NOT COMPLETED|Overall Study||3
10211212|NCT03610581|11338447|FG001|NOT COMPLETED|Overall Study||1
10211213|NCT03610633|11338455|FG000|STARTED|Overall Study||5
10211214|NCT03610633|11338456|FG001|STARTED|Overall Study||6
10211215|NCT03610633|11338455|FG000|COMPLETED|Overall Study||5
10211216|NCT03610633|11338456|FG001|COMPLETED|Overall Study||5
10211217|NCT03610633|11338455|FG000|NOT COMPLETED|Overall Study||0
10211218|NCT03610633|11338456|FG001|NOT COMPLETED|Overall Study||1
10211219|NCT03611062|11338464|FG000|STARTED|Overall Study||14
10211220|NCT03611062|11338465|FG001|STARTED|Overall Study||13
10211221|NCT03611062|11338464|FG000|COMPLETED|Overall Study||13
10211222|NCT03611062|11338465|FG001|COMPLETED|Overall Study||12
10211223|NCT03611062|11338464|FG000|NOT COMPLETED|Overall Study||1
10211224|NCT03611062|11338465|FG001|NOT COMPLETED|Overall Study||1
10211225|NCT03611582|11338473|FG000|STARTED|Overall Study||407
10211226|NCT03611582|11338474|FG001|STARTED|Overall Study||204
10211227|NCT03611582|11338473|FG000|Full Analysis Set (FAS)|Overall Study||407
10211228|NCT03611582|11338474|FG001|Full Analysis Set (FAS)|Overall Study||204
10211229|NCT03611582|11338473|FG000|Safety Analysis Set (SAS)|Overall Study||407
10211230|NCT03611582|11338474|FG001|Safety Analysis Set (SAS)|Overall Study||204
10211231|NCT03611582|11338473|FG000|COMPLETED|Overall Study||339
10211232|NCT03611582|11338474|FG001|COMPLETED|Overall Study||166
10211233|NCT03611582|11338473|FG000|NOT COMPLETED|Overall Study||68
10211234|NCT03611582|11338474|FG001|NOT COMPLETED|Overall Study||38
10211235|NCT03611777|11338482|FG000|STARTED|Overall Study||432
10211236|NCT03611777|11338483|FG001|STARTED|Overall Study||469
10211237|NCT03611777|11338482|FG000|COMPLETED|Overall Study||432
10211238|NCT03611777|11338483|FG001|COMPLETED|Overall Study||469
10211239|NCT03611777|11338482|FG000|NOT COMPLETED|Overall Study||0
10211240|NCT03611777|11338483|FG001|NOT COMPLETED|Overall Study||0
10211241|NCT03611829|11338494|FG000|STARTED|Overall Study||43
10211242|NCT03611829|11338495|FG001|STARTED|Overall Study||44
10211243|NCT03611829|11338494|FG000|COMPLETED|Overall Study||21
10211244|NCT03611829|11338495|FG001|COMPLETED|Overall Study||19
10211245|NCT03611829|11338494|FG000|NOT COMPLETED|Overall Study||22
10211246|NCT03611829|11338495|FG001|NOT COMPLETED|Overall Study||25
10211247|NCT03613129|11338506|FG000|STARTED|Pre-treatment Assessment||3
10211248|NCT03613129|11338507|FG001|STARTED|Pre-treatment Assessment||3
10211249|NCT03613129|11338508|FG002|STARTED|Pre-treatment Assessment||7
10211250|NCT03613129|11338509|FG003|STARTED|Pre-treatment Assessment||2
10211251|NCT03613129|11338510|FG004|STARTED|Pre-treatment Assessment||2
10211252|NCT03613129|11338506|FG000|COMPLETED|Pre-treatment Assessment||0
10211253|NCT03613129|11338507|FG001|COMPLETED|Pre-treatment Assessment||3
10211254|NCT03613129|11338508|FG002|COMPLETED|Pre-treatment Assessment||7
10211255|NCT03613129|11338509|FG003|COMPLETED|Pre-treatment Assessment||2
10211256|NCT03613129|11338510|FG004|COMPLETED|Pre-treatment Assessment||2
10211257|NCT03613129|11338506|FG000|NOT COMPLETED|Pre-treatment Assessment||3
10211258|NCT03613129|11338507|FG001|NOT COMPLETED|Pre-treatment Assessment||0
10211259|NCT03613129|11338508|FG002|NOT COMPLETED|Pre-treatment Assessment||0
10211260|NCT03613129|11338509|FG003|NOT COMPLETED|Pre-treatment Assessment||0
10211261|NCT03613129|11338510|FG004|NOT COMPLETED|Pre-treatment Assessment||0
10211262|NCT03613129|11338506|FG000|STARTED|Treatment||0
10211263|NCT03613129|11338507|FG001|STARTED|Treatment||3
10211264|NCT03613129|11338508|FG002|STARTED|Treatment||7
10211265|NCT03613129|11338509|FG003|STARTED|Treatment||2
10211266|NCT03613129|11338510|FG004|STARTED|Treatment||2
10211267|NCT03613129|11338506|FG000|COMPLETED|Treatment||0
10211268|NCT03613129|11338507|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
10211269|NCT03613129|11338508|FG002|COMPLETED|Treatment||7
10211270|NCT03613129|11338509|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
10211271|NCT03613129|11338510|FG004|COMPLETED|Treatment||2
10211272|NCT03613129|11338506|FG000|NOT COMPLETED|Treatment||0
10211273|NCT03613129|11338507|FG001|NOT COMPLETED|Treatment||0
10211274|NCT03613129|11338508|FG002|NOT COMPLETED|Treatment||0
10211275|NCT03613129|11338509|FG003|NOT COMPLETED|Treatment||0
10211276|NCT03613129|11338510|FG004|NOT COMPLETED|Treatment||0
10211277|NCT03613129|11338506|FG000|STARTED|Post-treatment Assessment||0
10211278|NCT03613129|11338507|FG001|STARTED|Post-treatment Assessment||3
10211279|NCT03613129|11338508|FG002|STARTED|Post-treatment Assessment||7
10211280|NCT03613129|11338509|FG003|STARTED|Post-treatment Assessment||2
10211281|NCT03613129|11338510|FG004|STARTED|Post-treatment Assessment||2
10211282|NCT03613129|11338506|FG000|COMPLETED|Post-treatment Assessment||0
10211283|NCT03613129|11338507|FG001|COMPLETED|Post-treatment Assessment||3
10211284|NCT03613129|11338508|FG002|COMPLETED|Post-treatment Assessment||7
10211285|NCT03613129|11338509|FG003|COMPLETED|Post-treatment Assessment||2
10211286|NCT03613129|11338510|FG004|COMPLETED|Post-treatment Assessment||2
10211287|NCT03613129|11338506|FG000|NOT COMPLETED|Post-treatment Assessment||0
10211288|NCT03613129|11338507|FG001|NOT COMPLETED|Post-treatment Assessment||0
10211289|NCT03613129|11338508|FG002|NOT COMPLETED|Post-treatment Assessment||0
10211290|NCT03613129|11338509|FG003|NOT COMPLETED|Post-treatment Assessment||0
10211291|NCT03613129|11338510|FG004|NOT COMPLETED|Post-treatment Assessment||0
10211292|NCT03613454|11338524|FG000|STARTED|Overall Study||24
10211293|NCT03613454|11338525|FG001|STARTED|Overall Study||24
10211294|NCT03613454|11338524|FG000|COMPLETED|Overall Study||23
10211295|NCT03613454|11338525|FG001|COMPLETED|Overall Study||23
10211296|NCT03613454|11338524|FG000|NOT COMPLETED|Overall Study||1
10211297|NCT03613454|11338525|FG001|NOT COMPLETED|Overall Study||1
10211298|NCT03613493|11338535|FG000|STARTED|Overall Study||10
10211299|NCT03613493|11338536|FG001|STARTED|Overall Study||75
10211300|NCT03613493|11338537|FG002|STARTED|Overall Study||0
10211301|NCT03613493|11338538|FG003|STARTED|Overall Study||90
10211302|NCT03613493|11338535|FG000|Enrollment Criteria Met|Overall Study||10
10211303|NCT03613493|11338536|FG001|Enrollment Criteria Met|Overall Study||74
10211304|NCT03613493|11338537|FG002|Enrollment Criteria Met|Overall Study||0
10211305|NCT03613493|11338538|FG003|Enrollment Criteria Met|Overall Study||89
10211306|NCT03613493|11338535|FG000|COMPLETED|Overall Study||10
10211307|NCT03613493|11338536|FG001|COMPLETED|Overall Study||73
10211308|NCT03613493|11338537|FG002|COMPLETED|Overall Study||0
10211309|NCT03613493|11338538|FG003|COMPLETED|Overall Study||83
10211310|NCT03613493|11338535|FG000|NOT COMPLETED|Overall Study||0
10211311|NCT03613493|11338536|FG001|NOT COMPLETED|Overall Study||2
10211312|NCT03613493|11338537|FG002|NOT COMPLETED|Overall Study||0
10211313|NCT03613493|11338538|FG003|NOT COMPLETED|Overall Study||7
10211314|NCT03613649|11338559|FG000|STARTED|First Treatment||6
10211315|NCT03613649|11338560|FG001|STARTED|First Treatment||6
10211316|NCT03613649|11338561|FG002|STARTED|First Treatment||6
10211317|NCT03613649|11338562|FG003|STARTED|First Treatment||6
10211318|NCT03613649|11338563|FG004|STARTED|First Treatment||6
10211319|NCT03613649|11338564|FG005|STARTED|First Treatment||6
10211320|NCT03613649|11338565|FG006|STARTED|First Treatment||6
10211321|NCT03613649|11338566|FG007|STARTED|First Treatment||6
10211322|NCT03613649|11338567|FG008|STARTED|First Treatment||6
10211323|NCT03613649|11338568|FG009|STARTED|First Treatment||6
10211324|NCT03613649|11338569|FG010|STARTED|First Treatment||6
10211325|NCT03613649|11338570|FG011|STARTED|First Treatment||6
10211326|NCT03613649|11338559|FG000|Received Treatment|First Treatment||6
10211327|NCT03613649|11338560|FG001|Received Treatment|First Treatment||6
10211328|NCT03613649|11338561|FG002|Received Treatment|First Treatment||6
10211329|NCT03613649|11338562|FG003|Received Treatment|First Treatment||6
10211330|NCT03613649|11338563|FG004|Received Treatment|First Treatment||6
10211331|NCT03613649|11338564|FG005|Received Treatment|First Treatment||6
10211332|NCT03613649|11338565|FG006|Received Treatment|First Treatment||6
10211333|NCT03613649|11338566|FG007|Received Treatment|First Treatment||6
10211334|NCT03613649|11338567|FG008|Received Treatment|First Treatment||6
10211335|NCT03613649|11338568|FG009|Received Treatment|First Treatment||6
10211336|NCT03613649|11338569|FG010|Received Treatment|First Treatment||6
10211337|NCT03613649|11338570|FG011|Received Treatment|First Treatment||6
10211338|NCT03613649|11338559|FG000|COMPLETED|First Treatment||6
10211339|NCT03613649|11338560|FG001|COMPLETED|First Treatment||6
10211340|NCT03613649|11338561|FG002|COMPLETED|First Treatment||6
10211341|NCT03613649|11338562|FG003|COMPLETED|First Treatment||6
10211342|NCT03613649|11338563|FG004|COMPLETED|First Treatment||6
10211343|NCT03613649|11338564|FG005|COMPLETED|First Treatment||6
10211344|NCT03613649|11338565|FG006|COMPLETED|First Treatment||6
10211345|NCT03613649|11338566|FG007|COMPLETED|First Treatment||6
10211346|NCT03613649|11338567|FG008|COMPLETED|First Treatment||6
10211347|NCT03613649|11338568|FG009|COMPLETED|First Treatment||6
10211348|NCT03613649|11338569|FG010|COMPLETED|First Treatment||6
10211349|NCT03613649|11338570|FG011|COMPLETED|First Treatment||6
10211350|NCT03613649|11338559|FG000|NOT COMPLETED|First Treatment||0
10211351|NCT03613649|11338560|FG001|NOT COMPLETED|First Treatment||0
10211352|NCT03613649|11338561|FG002|NOT COMPLETED|First Treatment||0
10211353|NCT03613649|11338562|FG003|NOT COMPLETED|First Treatment||0
10211354|NCT03613649|11338563|FG004|NOT COMPLETED|First Treatment||0
10211355|NCT03613649|11338564|FG005|NOT COMPLETED|First Treatment||0
10211356|NCT03613649|11338565|FG006|NOT COMPLETED|First Treatment||0
10211357|NCT03613649|11338566|FG007|NOT COMPLETED|First Treatment||0
10211358|NCT03613649|11338567|FG008|NOT COMPLETED|First Treatment||0
10211359|NCT03613649|11338568|FG009|NOT COMPLETED|First Treatment||0
10211360|NCT03613649|11338569|FG010|NOT COMPLETED|First Treatment||0
10211361|NCT03613649|11338570|FG011|NOT COMPLETED|First Treatment||0
10211362|NCT03613649|11338559|FG000|STARTED|Second Treatment||6
10211363|NCT03613649|11338560|FG001|STARTED|Second Treatment||6
10211364|NCT03613649|11338561|FG002|STARTED|Second Treatment||6
10211365|NCT03613649|11338562|FG003|STARTED|Second Treatment||6
10211366|NCT03613649|11338563|FG004|STARTED|Second Treatment||6
10211367|NCT03613649|11338564|FG005|STARTED|Second Treatment||6
10211368|NCT03613649|11338565|FG006|STARTED|Second Treatment||6
10211369|NCT03613649|11338566|FG007|STARTED|Second Treatment||6
10211370|NCT03613649|11338567|FG008|STARTED|Second Treatment||6
10211371|NCT03613649|11338568|FG009|STARTED|Second Treatment||6
10211372|NCT03613649|11338569|FG010|STARTED|Second Treatment||6
10211373|NCT03613649|11338570|FG011|STARTED|Second Treatment||6
10211374|NCT03613649|11338559|FG000|Received Treatment|Second Treatment||6
10211375|NCT03613649|11338560|FG001|Received Treatment|Second Treatment||6
10211376|NCT03613649|11338561|FG002|Received Treatment|Second Treatment||6
10211377|NCT03613649|11338562|FG003|Received Treatment|Second Treatment||6
10211378|NCT03613649|11338563|FG004|Received Treatment|Second Treatment||6
10211379|NCT03613649|11338564|FG005|Received Treatment|Second Treatment||6
10211380|NCT03613649|11338565|FG006|Received Treatment|Second Treatment||6
10211381|NCT03613649|11338566|FG007|Received Treatment|Second Treatment||6
10211382|NCT03613649|11338567|FG008|Received Treatment|Second Treatment||6
10211383|NCT03613649|11338568|FG009|Received Treatment|Second Treatment||6
10211384|NCT03613649|11338569|FG010|Received Treatment|Second Treatment||6
10211385|NCT03613649|11338570|FG011|Received Treatment|Second Treatment||6
10211386|NCT03613649|11338559|FG000|COMPLETED|Second Treatment||6
10211387|NCT03613649|11338560|FG001|COMPLETED|Second Treatment||6
10211388|NCT03613649|11338561|FG002|COMPLETED|Second Treatment||5
10211389|NCT03613649|11338562|FG003|COMPLETED|Second Treatment||6
10211390|NCT03613649|11338563|FG004|COMPLETED|Second Treatment||5
10211391|NCT03613649|11338564|FG005|COMPLETED|Second Treatment||6
10211392|NCT03613649|11338565|FG006|COMPLETED|Second Treatment||6
10211393|NCT03613649|11338566|FG007|COMPLETED|Second Treatment||6
10211394|NCT03613649|11338567|FG008|COMPLETED|Second Treatment||6
10211395|NCT03613649|11338568|FG009|COMPLETED|Second Treatment||6
10211396|NCT03613649|11338569|FG010|COMPLETED|Second Treatment||6
10211397|NCT03613649|11338570|FG011|COMPLETED|Second Treatment||6
10211398|NCT03613649|11338559|FG000|NOT COMPLETED|Second Treatment||0
10211399|NCT03613649|11338560|FG001|NOT COMPLETED|Second Treatment||0
10211400|NCT03613649|11338561|FG002|NOT COMPLETED|Second Treatment||1
10211401|NCT03613649|11338562|FG003|NOT COMPLETED|Second Treatment||0
10211402|NCT03613649|11338563|FG004|NOT COMPLETED|Second Treatment||1
10211403|NCT03613649|11338564|FG005|NOT COMPLETED|Second Treatment||0
10211404|NCT03613649|11338565|FG006|NOT COMPLETED|Second Treatment||0
10211405|NCT03613649|11338566|FG007|NOT COMPLETED|Second Treatment||0
10211406|NCT03613649|11338567|FG008|NOT COMPLETED|Second Treatment||0
10211407|NCT03613649|11338568|FG009|NOT COMPLETED|Second Treatment||0
10211408|NCT03613649|11338569|FG010|NOT COMPLETED|Second Treatment||0
10211409|NCT03613649|11338570|FG011|NOT COMPLETED|Second Treatment||0
10211410|NCT03613649|11338559|FG000|STARTED|Third Treatment||6
10211411|NCT03613649|11338560|FG001|STARTED|Third Treatment||6
10211412|NCT03613649|11338561|FG002|STARTED|Third Treatment||5
10211413|NCT03613649|11338562|FG003|STARTED|Third Treatment||6
10211414|NCT03613649|11338563|FG004|STARTED|Third Treatment||5
10211415|NCT03613649|11338564|FG005|STARTED|Third Treatment||6
10211416|NCT03613649|11338565|FG006|STARTED|Third Treatment||6
10211417|NCT03613649|11338566|FG007|STARTED|Third Treatment||6
10211418|NCT03613649|11338567|FG008|STARTED|Third Treatment||6
10211419|NCT03613649|11338568|FG009|STARTED|Third Treatment||6
10211420|NCT03613649|11338569|FG010|STARTED|Third Treatment||6
10211421|NCT03613649|11338570|FG011|STARTED|Third Treatment||6
10211422|NCT03613649|11338559|FG000|Received Treatment|Third Treatment||6
10211423|NCT03613649|11338560|FG001|Received Treatment|Third Treatment||6
10211424|NCT03613649|11338561|FG002|Received Treatment|Third Treatment||5
10211425|NCT03613649|11338562|FG003|Received Treatment|Third Treatment||6
10211426|NCT03613649|11338563|FG004|Received Treatment|Third Treatment||5
10211427|NCT03613649|11338564|FG005|Received Treatment|Third Treatment||6
10211428|NCT03613649|11338565|FG006|Received Treatment|Third Treatment||5
10211429|NCT03613649|11338566|FG007|Received Treatment|Third Treatment||6
10211430|NCT03613649|11338567|FG008|Received Treatment|Third Treatment||6
10211431|NCT03613649|11338568|FG009|Received Treatment|Third Treatment||6
10211432|NCT03613649|11338569|FG010|Received Treatment|Third Treatment||6
10211433|NCT03613649|11338570|FG011|Received Treatment|Third Treatment||6
10211434|NCT03613649|11338559|FG000|COMPLETED|Third Treatment||6
10211435|NCT03613649|11338560|FG001|COMPLETED|Third Treatment||6
10211436|NCT03613649|11338561|FG002|COMPLETED|Third Treatment||5
10211437|NCT03613649|11338562|FG003|COMPLETED|Third Treatment||6
10211438|NCT03613649|11338563|FG004|COMPLETED|Third Treatment||4
10211439|NCT03613649|11338564|FG005|COMPLETED|Third Treatment||6
10211440|NCT03613649|11338565|FG006|COMPLETED|Third Treatment||5
10211441|NCT03613649|11338566|FG007|COMPLETED|Third Treatment||6
10211442|NCT03613649|11338567|FG008|COMPLETED|Third Treatment||6
10211443|NCT03613649|11338568|FG009|COMPLETED|Third Treatment||6
10211444|NCT03613649|11338569|FG010|COMPLETED|Third Treatment||6
10211445|NCT03613649|11338570|FG011|COMPLETED|Third Treatment||4
10211446|NCT03613649|11338559|FG000|NOT COMPLETED|Third Treatment||0
10211447|NCT03613649|11338560|FG001|NOT COMPLETED|Third Treatment||0
10211448|NCT03613649|11338561|FG002|NOT COMPLETED|Third Treatment||0
10211449|NCT03613649|11338562|FG003|NOT COMPLETED|Third Treatment||0
10211450|NCT03613649|11338563|FG004|NOT COMPLETED|Third Treatment||1
10211451|NCT03613649|11338564|FG005|NOT COMPLETED|Third Treatment||0
10211452|NCT03613649|11338565|FG006|NOT COMPLETED|Third Treatment||1
10211453|NCT03613649|11338566|FG007|NOT COMPLETED|Third Treatment||0
10211454|NCT03613649|11338567|FG008|NOT COMPLETED|Third Treatment||0
10211455|NCT03613649|11338568|FG009|NOT COMPLETED|Third Treatment||0
10211456|NCT03613649|11338569|FG010|NOT COMPLETED|Third Treatment||0
10211457|NCT03613649|11338570|FG011|NOT COMPLETED|Third Treatment||2
10211458|NCT03613649|11338559|FG000|STARTED|Fourth Treatment||6
10211459|NCT03613649|11338560|FG001|STARTED|Fourth Treatment||6
10211460|NCT03613649|11338561|FG002|STARTED|Fourth Treatment||5
10211461|NCT03613649|11338562|FG003|STARTED|Fourth Treatment||6
10211462|NCT03613649|11338563|FG004|STARTED|Fourth Treatment||4
10211463|NCT03613649|11338564|FG005|STARTED|Fourth Treatment||6
10211464|NCT03613649|11338565|FG006|STARTED|Fourth Treatment||5
10211465|NCT03613649|11338566|FG007|STARTED|Fourth Treatment||6
10211466|NCT03613649|11338567|FG008|STARTED|Fourth Treatment||6
9760738|NCT00383071|10864516|FG000|COMPLETED|Overall Study||25
10211467|NCT03613649|11338568|FG009|STARTED|Fourth Treatment||6
10211468|NCT03613649|11338569|FG010|STARTED|Fourth Treatment||6
10211469|NCT03613649|11338570|FG011|STARTED|Fourth Treatment||4
10211470|NCT03613649|11338559|FG000|Received Treatment|Fourth Treatment||5
10211471|NCT03613649|11338560|FG001|Received Treatment|Fourth Treatment||6
10211472|NCT03613649|11338561|FG002|Received Treatment|Fourth Treatment||5
10211473|NCT03613649|11338562|FG003|Received Treatment|Fourth Treatment||6
10211474|NCT03613649|11338563|FG004|Received Treatment|Fourth Treatment||4
10211475|NCT03613649|11338564|FG005|Received Treatment|Fourth Treatment||6
10211476|NCT03613649|11338565|FG006|Received Treatment|Fourth Treatment||4
10211477|NCT03613649|11338566|FG007|Received Treatment|Fourth Treatment||6
10211478|NCT03613649|11338567|FG008|Received Treatment|Fourth Treatment||6
10211479|NCT03613649|11338568|FG009|Received Treatment|Fourth Treatment||6
9760739|NCT00383071|10864517|FG001|COMPLETED|Overall Study||21
10211480|NCT03613649|11338569|FG010|Received Treatment|Fourth Treatment||6
10211481|NCT03613649|11338570|FG011|Received Treatment|Fourth Treatment||4
10211482|NCT03613649|11338559|FG000|COMPLETED|Fourth Treatment||5
10211483|NCT03613649|11338560|FG001|COMPLETED|Fourth Treatment||6
10211484|NCT03613649|11338561|FG002|COMPLETED|Fourth Treatment||5
10211485|NCT03613649|11338562|FG003|COMPLETED|Fourth Treatment||6
10211486|NCT03613649|11338563|FG004|COMPLETED|Fourth Treatment||3
10211487|NCT03613649|11338564|FG005|COMPLETED|Fourth Treatment||6
10211488|NCT03613649|11338565|FG006|COMPLETED|Fourth Treatment||4
10211489|NCT03613649|11338566|FG007|COMPLETED|Fourth Treatment||6
10211490|NCT03613649|11338567|FG008|COMPLETED|Fourth Treatment||6
10211491|NCT03613649|11338568|FG009|COMPLETED|Fourth Treatment||6
10211492|NCT03613649|11338569|FG010|COMPLETED|Fourth Treatment||6
10211493|NCT03613649|11338570|FG011|COMPLETED|Fourth Treatment||4
10211494|NCT03613649|11338559|FG000|NOT COMPLETED|Fourth Treatment||1
10211495|NCT03613649|11338560|FG001|NOT COMPLETED|Fourth Treatment||0
10211496|NCT03613649|11338561|FG002|NOT COMPLETED|Fourth Treatment||0
10211497|NCT03613649|11338562|FG003|NOT COMPLETED|Fourth Treatment||0
10211498|NCT03613649|11338563|FG004|NOT COMPLETED|Fourth Treatment||1
10211499|NCT03613649|11338564|FG005|NOT COMPLETED|Fourth Treatment||0
10211500|NCT03613649|11338565|FG006|NOT COMPLETED|Fourth Treatment||1
10211501|NCT03613649|11338566|FG007|NOT COMPLETED|Fourth Treatment||0
10211502|NCT03613649|11338567|FG008|NOT COMPLETED|Fourth Treatment||0
10211503|NCT03613649|11338568|FG009|NOT COMPLETED|Fourth Treatment||0
10211504|NCT03613649|11338569|FG010|NOT COMPLETED|Fourth Treatment||0
10211505|NCT03613649|11338570|FG011|NOT COMPLETED|Fourth Treatment||0
10211506|NCT03613818|11338590|FG000|STARTED|Overall Study||174
10211507|NCT03613818|11338591|FG001|STARTED|Overall Study||137
10211508|NCT03613818|11338590|FG000|COMPLETED|Overall Study||137
10211509|NCT03613818|11338591|FG001|COMPLETED|Overall Study||110
10211510|NCT03613818|11338590|FG000|NOT COMPLETED|Overall Study||37
10211511|NCT03613818|11338591|FG001|NOT COMPLETED|Overall Study||27
10211512|NCT03614078|11338600|FG000|STARTED|Overall Study||31
10211513|NCT03614078|11338601|FG001|STARTED|Overall Study||30
10211514|NCT03614078|11338602|FG002|STARTED|Overall Study||31
10211515|NCT03614078|11338600|FG000|COMPLETED|Overall Study||28
10211516|NCT03614078|11338601|FG001|COMPLETED|Overall Study||23
10211517|NCT03614078|11338602|FG002|COMPLETED|Overall Study||26
10211518|NCT03614078|11338600|FG000|NOT COMPLETED|Overall Study||3
10211519|NCT03614078|11338601|FG001|NOT COMPLETED|Overall Study||7
10211520|NCT03614078|11338602|FG002|NOT COMPLETED|Overall Study||5
10211521|NCT03614130|11338612|FG000|STARTED|Overall Study||10
10211522|NCT03614130|11338613|FG001|STARTED|Overall Study||12
10211523|NCT03614130|11338612|FG000|COMPLETED|Overall Study||10
10211524|NCT03614130|11338613|FG001|COMPLETED|Overall Study||12
10211525|NCT03614130|11338612|FG000|NOT COMPLETED|Overall Study||0
10211526|NCT03614130|11338613|FG001|NOT COMPLETED|Overall Study||0
10211527|NCT03614156|11338624|FG000|STARTED|Open-Label Treatment Period||363
10211528|NCT03614156|11338625|FG001|STARTED|Open-Label Treatment Period||0
10211529|NCT03614156|11338626|FG002|STARTED|Open-Label Treatment Period||0
10211530|NCT03614156|11338627|FG003|STARTED|Open-Label Treatment Period||0
10211531|NCT03614156|11338624|FG000|COMPLETED|Open-Label Treatment Period||209
10211532|NCT03614156|11338625|FG001|COMPLETED|Open-Label Treatment Period||0
10211533|NCT03614156|11338626|FG002|COMPLETED|Open-Label Treatment Period||0
10211534|NCT03614156|11338627|FG003|COMPLETED|Open-Label Treatment Period||0
10211535|NCT03614156|11338624|FG000|NOT COMPLETED|Open-Label Treatment Period||154
10211536|NCT03614156|11338625|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10211537|NCT03614156|11338626|FG002|NOT COMPLETED|Open-Label Treatment Period||0
10211538|NCT03614156|11338627|FG003|NOT COMPLETED|Open-Label Treatment Period||0
10211539|NCT03614156|11338624|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0
10211540|NCT03614156|11338625|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40
10211541|NCT03614156|11338626|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42
10211542|NCT03614156|11338627|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55
10211543|NCT03614156|11338624|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0
10211544|NCT03614156|11338625|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10
10211545|NCT03614156|11338626|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11
10211546|NCT03614156|11338627|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10
10211547|NCT03614156|11338624|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
10211548|NCT03614156|11338625|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
10211549|NCT03614156|11338626|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
10211550|NCT03614156|11338627|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
10211551|NCT03614156|11338624|FG000|STARTED|Safety Follow-Up Period||165
10211552|NCT03614156|11338625|FG001|STARTED|Safety Follow-Up Period||26
10211553|NCT03614156|11338626|FG002|STARTED|Safety Follow-Up Period||30
10211554|NCT03614156|11338627|FG003|STARTED|Safety Follow-Up Period||35
10011942|NCT01783444|11134747|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
10019024|NCT01827046|11142103|FG000|STARTED|Overall Study||250
10211555|NCT03614156|11338624|FG000|COMPLETED|Safety Follow-Up Period||162
10211556|NCT03614156|11338625|FG001|COMPLETED|Safety Follow-Up Period||26
10211557|NCT03614156|11338626|FG002|COMPLETED|Safety Follow-Up Period||29
10211558|NCT03614156|11338627|FG003|COMPLETED|Safety Follow-Up Period||34
10211559|NCT03614156|11338624|FG000|NOT COMPLETED|Safety Follow-Up Period||3
10211560|NCT03614156|11338625|FG001|NOT COMPLETED|Safety Follow-Up Period||0
10211561|NCT03614156|11338626|FG002|NOT COMPLETED|Safety Follow-Up Period||1
10211562|NCT03614156|11338627|FG003|NOT COMPLETED|Safety Follow-Up Period||1
10211563|NCT03614416|11338636|FG000|STARTED|Overall Study||13
10211564|NCT03614416|11338636|FG000|COMPLETED|Overall Study||13
10211565|NCT03614416|11338636|FG000|NOT COMPLETED|Overall Study||0
10211566|NCT03614975|11338644|FG000|STARTED|Overall Study||85
10211567|NCT03614975|11338645|FG001|STARTED|Overall Study||81
10211568|NCT03614975|11338644|FG000|COMPLETED|Overall Study||75
10211569|NCT03614975|11338645|FG001|COMPLETED|Overall Study||73
10211570|NCT03614975|11338644|FG000|NOT COMPLETED|Overall Study||10
10211571|NCT03614975|11338645|FG001|NOT COMPLETED|Overall Study||8
10211572|NCT03615001|11338651|FG000|STARTED|Overall Study||20
10211573|NCT03615001|11338651|FG000|COMPLETED|Overall Study||20
10211574|NCT03615001|11338651|FG000|NOT COMPLETED|Overall Study||0
10211575|NCT03615079|11338655|FG000|STARTED|Overall Study||28
10211576|NCT03615079|11338655|FG000|COMPLETED|Overall Study||11
10211577|NCT03615079|11338655|FG000|NOT COMPLETED|Overall Study||17
10211578|NCT03615183|11338664|FG000|STARTED|Overall Study||6
10211579|NCT03615183|11338665|FG001|STARTED|Overall Study||6
10211580|NCT03615183|11338666|FG002|STARTED|Overall Study||5
10211581|NCT03615183|11338667|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
10211582|NCT03615183|11338668|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
10211583|NCT03615183|11338664|FG000|COMPLETED|Overall Study||6
10211584|NCT03615183|11338665|FG001|COMPLETED|Overall Study||6
10211585|NCT03615183|11338666|FG002|COMPLETED|Overall Study||5
10211586|NCT03615183|11338667|FG003|COMPLETED|Overall Study||0
10211587|NCT03615183|11338668|FG004|COMPLETED|Overall Study||0
10211588|NCT03615183|11338664|FG000|NOT COMPLETED|Overall Study||0
10211589|NCT03615183|11338665|FG001|NOT COMPLETED|Overall Study||0
10211590|NCT03615183|11338666|FG002|NOT COMPLETED|Overall Study||0
10211591|NCT03615183|11338667|FG003|NOT COMPLETED|Overall Study||0
10211592|NCT03615183|11338668|FG004|NOT COMPLETED|Overall Study||0
10111727|NCT02498236|11242735|FG006|STARTED|Overall Study||7
10111728|NCT02498236|11242736|FG007|STARTED|Overall Study||7
10111729|NCT02498236|11242729|FG000|Randomized|Overall Study||6
10111730|NCT02498236|11242730|FG001|Randomized|Overall Study||6
10111731|NCT02498236|11242731|FG002|Randomized|Overall Study||6
10111732|NCT02498236|11242732|FG003|Randomized|Overall Study||6
10111733|NCT02498236|11242733|FG004|Randomized|Overall Study||7
10111734|NCT02498236|11242734|FG005|Randomized|Overall Study||6
10111735|NCT02498236|11242735|FG006|Randomized|Overall Study||7
10111736|NCT02498236|11242736|FG007|Randomized|Overall Study||7
10111737|NCT02498236|11242729|FG000|COMPLETED|Overall Study||5
10111738|NCT02498236|11242730|FG001|COMPLETED|Overall Study||6
10111739|NCT02498236|11242731|FG002|COMPLETED|Overall Study||6
10111740|NCT02498236|11242732|FG003|COMPLETED|Overall Study||6
10111741|NCT02498236|11242733|FG004|COMPLETED|Overall Study||6
10111742|NCT02498236|11242734|FG005|COMPLETED|Overall Study||6
10111743|NCT02498236|11242735|FG006|COMPLETED|Overall Study||6
10111744|NCT02498236|11242736|FG007|COMPLETED|Overall Study||6
10111745|NCT02498236|11242729|FG000|NOT COMPLETED|Overall Study||1
10111746|NCT02498236|11242730|FG001|NOT COMPLETED|Overall Study||0
10111747|NCT02498236|11242731|FG002|NOT COMPLETED|Overall Study||0
10111748|NCT02498236|11242732|FG003|NOT COMPLETED|Overall Study||0
10111749|NCT02498236|11242733|FG004|NOT COMPLETED|Overall Study||1
10111750|NCT02498236|11242734|FG005|NOT COMPLETED|Overall Study||0
10111751|NCT02498236|11242735|FG006|NOT COMPLETED|Overall Study||1
10111752|NCT02498236|11242736|FG007|NOT COMPLETED|Overall Study||1
10111753|NCT02498418|11242760|FG000|STARTED|Overall Study||247
10111754|NCT02498418|11242761|FG001|STARTED|Overall Study||248
10111755|NCT02498418|11242762|FG002|STARTED|Overall Study||244
10111756|NCT02498418|11242760|FG000|Safety Population|Overall Study||246
10111757|NCT02498418|11242761|FG001|Safety Population|Overall Study||247
10111758|NCT02498418|11242762|FG002|Safety Population|Overall Study||244
10111759|NCT02498418|11242760|FG000|Modified Intent-to-treat Population|Overall Study||183
10111760|NCT02498418|11242761|FG001|Modified Intent-to-treat Population|Overall Study||186
10111761|NCT02498418|11242762|FG002|Modified Intent-to-treat Population|Overall Study||180
10111762|NCT02498418|11242760|FG000|Per-protocol Analysis Set|Overall Study||182
10111763|NCT02498418|11242761|FG001|Per-protocol Analysis Set|Overall Study||181
10111764|NCT02498418|11242762|FG002|Per-protocol Analysis Set|Overall Study||176
10111765|NCT02498418|11242760|FG000|COMPLETED|Overall Study||245
10111766|NCT02498418|11242761|FG001|COMPLETED|Overall Study||246
10111767|NCT02498418|11242762|FG002|COMPLETED|Overall Study||238
10111768|NCT02498418|11242760|FG000|NOT COMPLETED|Overall Study||2
10111769|NCT02498418|11242761|FG001|NOT COMPLETED|Overall Study||2
10111770|NCT02498418|11242762|FG002|NOT COMPLETED|Overall Study||6
10111771|NCT02498483|11242772|FG000|STARTED|Overall Study||6
10111772|NCT02498483|11242773|FG001|STARTED|Overall Study||5
10111773|NCT02498483|11242772|FG000|COMPLETED|Overall Study||6
10111774|NCT02498483|11242773|FG001|COMPLETED|Overall Study||5
10111775|NCT02498483|11242772|FG000|NOT COMPLETED|Overall Study||0
10111776|NCT02498483|11242773|FG001|NOT COMPLETED|Overall Study||0
10111777|NCT02498522|11242781|FG000|STARTED|Overall Study||85
10111778|NCT02498522|11242782|FG001|STARTED|Overall Study||85
10111779|NCT02498522|11242781|FG000|COMPLETED|Overall Study||83
10111780|NCT02498522|11242782|FG001|COMPLETED|Overall Study||83
10111781|NCT02498522|11242781|FG000|NOT COMPLETED|Overall Study||2
10111782|NCT02498522|11242782|FG001|NOT COMPLETED|Overall Study||2
10111783|NCT02498652|11242790|FG000|STARTED|Overall Study||20
10111784|NCT02498652|11242791|FG001|STARTED|Overall Study||21
10111785|NCT02498652|11242790|FG000|COMPLETED|Overall Study||20
10111786|NCT02498652|11242791|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
10111787|NCT02498652|11242790|FG000|NOT COMPLETED|Overall Study||0
10211593|NCT03615404|11338676|FG000|STARTED|Overall Study||11
10211594|NCT03615404|11338676|FG000|COMPLETED|Overall Study||9
10211595|NCT03615404|11338676|FG000|NOT COMPLETED|Overall Study||2
10211596|NCT03615482|11338682|FG000|STARTED|Overall Study||600
10211597|NCT03615482|11338683|FG001|STARTED|Overall Study||600
10211598|NCT03615482|11338682|FG000|Vaccinated|Overall Study||599
10211599|NCT03615482|11338683|FG001|Vaccinated|Overall Study||598
10211600|NCT03615482|11338682|FG000|COMPLETED|Overall Study||583
10211601|NCT03615482|11338683|FG001|COMPLETED|Overall Study||583
10211602|NCT03615482|11338682|FG000|NOT COMPLETED|Overall Study||17
10211603|NCT03615482|11338683|FG001|NOT COMPLETED|Overall Study||17
10211604|NCT03615534|11338693|FG000|STARTED|Overall Study||14
10211605|NCT03615534|11338694|FG001|STARTED|Overall Study||15
10211606|NCT03615534|11338695|FG002|STARTED|Overall Study||14
10211607|NCT03615534|11338696|FG003|STARTED|Overall Study||14
10211608|NCT03615534|11338693|FG000|COMPLETED|Overall Study||12
10211609|NCT03615534|11338694|FG001|COMPLETED|Overall Study||15
10211610|NCT03615534|11338695|FG002|COMPLETED|Overall Study||14
10211611|NCT03615534|11338696|FG003|COMPLETED|Overall Study||13
10211612|NCT03615534|11338693|FG000|NOT COMPLETED|Overall Study||2
10211613|NCT03615534|11338694|FG001|NOT COMPLETED|Overall Study||0
10211614|NCT03615534|11338695|FG002|NOT COMPLETED|Overall Study||0
10211615|NCT03615534|11338696|FG003|NOT COMPLETED|Overall Study||1
10211616|NCT03615807|11338708|FG000|STARTED|Overall Study||91
10211617|NCT03615807|11338709|FG001|STARTED|Overall Study||91
10211618|NCT03615807|11338708|FG000|COMPLETED|Overall Study||79
10211619|NCT03615807|11338709|FG001|COMPLETED|Overall Study||80
10011943|NCT01783444|11134748|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
10011944|NCT01783444|11134746|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10011945|NCT01783444|11134747|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10011946|NCT01783444|11134748|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10011947|NCT01783444|11134746|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
10011948|NCT01783444|11134747|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
10011949|NCT01783444|11134748|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
10211620|NCT03615807|11338708|FG000|NOT COMPLETED|Overall Study||12
10211621|NCT03615807|11338709|FG001|NOT COMPLETED|Overall Study||11
10211622|NCT03615911|11338717|FG000|STARTED|Overall Study||14
10211623|NCT03615911|11338718|FG001|STARTED|Overall Study||12
10211624|NCT03615911|11338717|FG000|Received Late Booster Immunization|Overall Study||3
10211625|NCT03615911|11338718|FG001|Received Late Booster Immunization|Overall Study||7
10211626|NCT03615911|11338717|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
10211627|NCT03615911|11338718|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
10211628|NCT03615911|11338717|FG000|NOT COMPLETED|Overall Study||2
10211629|NCT03615911|11338718|FG001|NOT COMPLETED|Overall Study||1
10211630|NCT03615924|11338728|FG000|STARTED|Overall Study||101
10211631|NCT03615924|11338729|FG001|STARTED|Overall Study||92
10211632|NCT03615924|11338728|FG000|Received Treatment|Overall Study||101
10211633|NCT03615924|11338729|FG001|Received Treatment|Overall Study||92
10211634|NCT03615924|11338728|FG000|COMPLETED|Overall Study||0
10211635|NCT03615924|11338729|FG001|COMPLETED|Overall Study||0
10211636|NCT03615924|11338728|FG000|NOT COMPLETED|Overall Study||101
10211637|NCT03615924|11338729|FG001|NOT COMPLETED|Overall Study||92
10211638|NCT03616106|11338737|FG000|STARTED|Overall Study||56
10211639|NCT03616106|11338738|FG001|STARTED|Overall Study||3
10211640|NCT03616106|11338737|FG000|COMPLETED|Overall Study||42
10211641|NCT03616106|11338738|FG001|COMPLETED|Overall Study||2
10211642|NCT03616106|11338737|FG000|NOT COMPLETED|Overall Study||14
10211643|NCT03616106|11338738|FG001|NOT COMPLETED|Overall Study||1
10211644|NCT03616171|11338745|FG000|STARTED|Overall Study||4
10211645|NCT03616171|11338746|FG001|STARTED|Overall Study||2
10211646|NCT03616171|11338745|FG000|COMPLETED|Overall Study||4
10211647|NCT03616171|11338746|FG001|COMPLETED|Overall Study||2
10211648|NCT03616171|11338745|FG000|NOT COMPLETED|Overall Study||0
10211649|NCT03616171|11338746|FG001|NOT COMPLETED|Overall Study||0
10211650|NCT03616600|11338755|FG000|STARTED|Overall Study||16
10211651|NCT03616600|11338756|FG001|STARTED|Overall Study||15
10211652|NCT03616600|11338755|FG000|COMPLETED|Overall Study||15
10211653|NCT03616600|11338756|FG001|COMPLETED|Overall Study||15
10211654|NCT03616600|11338755|FG000|NOT COMPLETED|Overall Study||1
10211655|NCT03616600|11338756|FG001|NOT COMPLETED|Overall Study||0
10211656|NCT03616899|11338765|FG000|STARTED|Overall Study||447
10211657|NCT03616899|11338766|FG001|STARTED|Overall Study||454
10211658|NCT03616899|11338765|FG000|COMPLETED|Overall Study||437
10211659|NCT03616899|11338766|FG001|COMPLETED|Overall Study||453
10211660|NCT03616899|11338765|FG000|NOT COMPLETED|Overall Study||10
10211661|NCT03616899|11338766|FG001|NOT COMPLETED|Overall Study||1
10211662|NCT03616977|11338772|FG000|STARTED|Period 1||34
10211663|NCT03616977|11338773|FG001|STARTED|Period 1||35
10211664|NCT03616977|11338772|FG000|Received at Least One Dose of Study Drug|Period 1||34
10211665|NCT03616977|11338773|FG001|Received at Least One Dose of Study Drug|Period 1||34
10211666|NCT03616977|11338772|FG000|COMPLETED|Period 1||34
10211667|NCT03616977|11338773|FG001|COMPLETED|Period 1||34
10211668|NCT03616977|11338772|FG000|NOT COMPLETED|Period 1||0
10211669|NCT03616977|11338773|FG001|NOT COMPLETED|Period 1||1
10211670|NCT03616977|11338772|FG000|STARTED|Period 2||34
10211671|NCT03616977|11338773|FG001|STARTED|Period 2||34
10211672|NCT03616977|11338772|FG000|COMPLETED|Period 2||34
10211673|NCT03616977|11338773|FG001|COMPLETED|Period 2||34
10211674|NCT03616977|11338772|FG000|NOT COMPLETED|Period 2||0
10211675|NCT03616977|11338773|FG001|NOT COMPLETED|Period 2||0
10211676|NCT03616977|11338772|FG000|STARTED|Period 3||34
10211677|NCT03616977|11338773|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
10211678|NCT03616977|11338772|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
10211679|NCT03616977|11338773|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
10211680|NCT03616977|11338772|FG000|COMPLETED|Period 3||33
10211681|NCT03616977|11338773|FG001|COMPLETED|Period 3||32
10211682|NCT03616977|11338772|FG000|NOT COMPLETED|Period 3||1
10211683|NCT03616977|11338773|FG001|NOT COMPLETED|Period 3||1
10211684|NCT03616977|11338772|FG000|STARTED|Period 4||33
10211685|NCT03616977|11338773|FG001|STARTED|Period 4||32
10211686|NCT03616977|11338772|FG000|COMPLETED|Period 4||33
10211687|NCT03616977|11338773|FG001|COMPLETED|Period 4||32
10211688|NCT03616977|11338772|FG000|NOT COMPLETED|Period 4||0
10211689|NCT03616977|11338773|FG001|NOT COMPLETED|Period 4||0
10211690|NCT03617419|11338780|FG000|STARTED|Part 1||2
10211691|NCT03617419|11338780|FG000|COMPLETED|Part 1||2
10211692|NCT03617419|11338780|FG000|NOT COMPLETED|Part 1||0
10211693|NCT03617419|11338780|FG000|STARTED|Part 2||14
10211694|NCT03617419|11338780|FG000|COMPLETED|Part 2||14
10211695|NCT03617419|11338780|FG000|NOT COMPLETED|Part 2||0
10211696|NCT03617588|11338786|FG000|STARTED|Overall Study||20
10211697|NCT03617588|11338787|FG001|STARTED|Overall Study||29
10211698|NCT03617588|11338786|FG000|COMPLETED|Overall Study||19
10211699|NCT03617588|11338787|FG001|COMPLETED|Overall Study||29
10211700|NCT03617588|11338786|FG000|NOT COMPLETED|Overall Study||1
10211701|NCT03617588|11338787|FG001|NOT COMPLETED|Overall Study||0
10211702|NCT03617770|11338799|FG000|STARTED|Overall Study|9|9
10211703|NCT03617770|11338800|FG001|STARTED|Overall Study|5|5
10211704|NCT03617770|11338799|FG000|COMPLETED|Overall Study|8|8
10211705|NCT03617770|11338800|FG001|COMPLETED|Overall Study||5
10211706|NCT03617770|11338799|FG000|NOT COMPLETED|Overall Study||1
10211707|NCT03617770|11338800|FG001|NOT COMPLETED|Overall Study||0
10211708|NCT03617861|11338808|FG000|STARTED|First Intervention (1 Day)||5
10211709|NCT03617861|11338809|FG001|STARTED|First Intervention (1 Day)||5
10211710|NCT03617861|11338810|FG002|STARTED|First Intervention (1 Day)||5
10211711|NCT03617861|11338811|FG003|STARTED|First Intervention (1 Day)||5
10211712|NCT03617861|11338808|FG000|COMPLETED|First Intervention (1 Day)||5
10211713|NCT03617861|11338809|FG001|COMPLETED|First Intervention (1 Day)||5
10211714|NCT03617861|11338810|FG002|COMPLETED|First Intervention (1 Day)||5
10211715|NCT03617861|11338811|FG003|COMPLETED|First Intervention (1 Day)||5
10211716|NCT03617861|11338808|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10211717|NCT03617861|11338809|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10211718|NCT03617861|11338810|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10211719|NCT03617861|11338811|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10211720|NCT03617861|11338808|FG000|STARTED|Washout (1 to 4 Weeks)||5
10211721|NCT03617861|11338809|FG001|STARTED|Washout (1 to 4 Weeks)||5
10211722|NCT03617861|11338810|FG002|STARTED|Washout (1 to 4 Weeks)||5
10211723|NCT03617861|11338811|FG003|STARTED|Washout (1 to 4 Weeks)||5
10211724|NCT03617861|11338808|FG000|COMPLETED|Washout (1 to 4 Weeks)||5
10211725|NCT03617861|11338809|FG001|COMPLETED|Washout (1 to 4 Weeks)||5
10211726|NCT03617861|11338810|FG002|COMPLETED|Washout (1 to 4 Weeks)||5
10211727|NCT03617861|11338811|FG003|COMPLETED|Washout (1 to 4 Weeks)||5
10211728|NCT03617861|11338808|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10211729|NCT03617861|11338809|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10211730|NCT03617861|11338810|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10211731|NCT03617861|11338811|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10211732|NCT03617861|11338808|FG000|STARTED|Second Intervention (1 Day)||5
10211733|NCT03617861|11338809|FG001|STARTED|Second Intervention (1 Day)||5
10211734|NCT03617861|11338810|FG002|STARTED|Second Intervention (1 Day)||5
10211735|NCT03617861|11338811|FG003|STARTED|Second Intervention (1 Day)||5
10211736|NCT03617861|11338808|FG000|COMPLETED|Second Intervention (1 Day)||5
10211737|NCT03617861|11338809|FG001|COMPLETED|Second Intervention (1 Day)||5
10211738|NCT03617861|11338810|FG002|COMPLETED|Second Intervention (1 Day)||4
10211739|NCT03617861|11338811|FG003|COMPLETED|Second Intervention (1 Day)||5
10211740|NCT03617861|11338808|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10211741|NCT03617861|11338809|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10211742|NCT03617861|11338810|FG002|NOT COMPLETED|Second Intervention (1 Day)||1
10211743|NCT03617861|11338811|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10211744|NCT03617913|11338821|FG000|STARTED|Overall Study||2
10211745|NCT03617913|11338821|FG000|COMPLETED|Overall Study||2
10211746|NCT03617913|11338821|FG000|NOT COMPLETED|Overall Study||0
10211747|NCT03618017|11338827|FG000|STARTED|Overall Study||33
10211748|NCT03618017|11338828|FG001|STARTED|Overall Study||33
10211749|NCT03618017|11338827|FG000|COMPLETED|Overall Study||26
10211750|NCT03618017|11338828|FG001|COMPLETED|Overall Study||28
10211751|NCT03618017|11338827|FG000|NOT COMPLETED|Overall Study||7
10211752|NCT03618017|11338828|FG001|NOT COMPLETED|Overall Study||5
10211753|NCT03618030|11338838|FG000|STARTED|Overall Study||15
10211754|NCT03618030|11338839|FG001|STARTED|Overall Study||14
10211755|NCT03618030|11338840|FG002|STARTED|Overall Study||21
10211756|NCT03618030|11338841|FG003|STARTED|Overall Study||39
10211757|NCT03618030|11338842|FG004|STARTED|Overall Study||36
10211758|NCT03618030|11338843|FG005|STARTED|Overall Study||27
10011950|NCT01783470|11134757|FG000|STARTED|Overall Study||6
10011951|NCT01783470|11134758|FG001|STARTED|Overall Study|Single-dose|6
10011952|NCT01783470|11134757|FG000|COMPLETED|Overall Study||6
10011953|NCT01783470|11134758|FG001|COMPLETED|Overall Study||6
10011954|NCT01783470|11134757|FG000|NOT COMPLETED|Overall Study||0
10011955|NCT01783470|11134758|FG001|NOT COMPLETED|Overall Study||0
10011956|NCT01783483|11134767|FG000|STARTED|Overall Study||120
10011957|NCT01783483|11134768|FG001|STARTED|Overall Study||116
10011958|NCT01783483|11134767|FG000|COMPLETED|Overall Study||100
10011959|NCT01783483|11134768|FG001|COMPLETED|Overall Study||101
10011960|NCT01783483|11134767|FG000|NOT COMPLETED|Overall Study||20
10011961|NCT01783483|11134768|FG001|NOT COMPLETED|Overall Study||15
10011962|NCT01783496|11134780|FG000|STARTED|Overall Study||10
10011963|NCT01783496|11134781|FG001|STARTED|Overall Study||10
10011964|NCT01783496|11134782|FG002|STARTED|Overall Study||10
10211759|NCT03618030|11338844|FG006|STARTED|Overall Study||18
10211760|NCT03618030|11338845|FG007|STARTED|Overall Study||118
10211761|NCT03618030|11338838|FG000|COMPLETED|Overall Study||3
10211762|NCT03618030|11338839|FG001|COMPLETED|Overall Study||3
10211763|NCT03618030|11338840|FG002|COMPLETED|Overall Study||13
10211764|NCT03618030|11338841|FG003|COMPLETED|Overall Study||30
10211765|NCT03618030|11338842|FG004|COMPLETED|Overall Study||29
10211766|NCT03618030|11338843|FG005|COMPLETED|Overall Study||21
10211767|NCT03618030|11338844|FG006|COMPLETED|Overall Study||14
10211768|NCT03618030|11338845|FG007|COMPLETED|Overall Study||108
10211769|NCT03618030|11338838|FG000|NOT COMPLETED|Overall Study||12
10211770|NCT03618030|11338839|FG001|NOT COMPLETED|Overall Study||11
10011965|NCT01783496|11134783|FG003|STARTED|Overall Study||10
10011966|NCT01783496|11134784|FG004|STARTED|Overall Study||5
10011967|NCT01783496|11134785|FG005|STARTED|Overall Study||5
10011968|NCT01783496|11134780|FG000|COMPLETED|Overall Study||9
10211771|NCT03618030|11338840|FG002|NOT COMPLETED|Overall Study||8
10211772|NCT03618030|11338841|FG003|NOT COMPLETED|Overall Study||9
10211773|NCT03618030|11338842|FG004|NOT COMPLETED|Overall Study||7
10211774|NCT03618030|11338843|FG005|NOT COMPLETED|Overall Study||6
10211775|NCT03618030|11338844|FG006|NOT COMPLETED|Overall Study||4
10211776|NCT03618030|11338845|FG007|NOT COMPLETED|Overall Study||10
10011969|NCT01783496|11134781|FG001|COMPLETED|Overall Study||10
10211777|NCT03618147|11338858|FG000|STARTED|Overall Study||314
10211778|NCT03618147|11338858|FG000|COMPLETED|Overall Study||314
10211779|NCT03618147|11338858|FG000|NOT COMPLETED|Overall Study||0
10211780|NCT03618628|11338863|FG000|STARTED|Overall Study||3
10211781|NCT03618628|11338863|FG000|COMPLETED|Overall Study||1
10211782|NCT03618628|11338863|FG000|NOT COMPLETED|Overall Study||2
10211783|NCT03618823|11338869|FG000|STARTED|Overall Study||132
10211784|NCT03618823|11338870|FG001|STARTED|Overall Study||136
10211785|NCT03618823|11338869|FG000|COMPLETED|Overall Study||69
10211786|NCT03618823|11338870|FG001|COMPLETED|Overall Study||75
10211787|NCT03618823|11338869|FG000|NOT COMPLETED|Overall Study||63
10211788|NCT03618823|11338870|FG001|NOT COMPLETED|Overall Study||61
10211789|NCT03619135|11338881|FG000|STARTED|Overall Study||50
10211790|NCT03619135|11338882|FG001|STARTED|Overall Study||50
10211791|NCT03619135|11338881|FG000|COMPLETED|Overall Study||50
10211792|NCT03619135|11338882|FG001|COMPLETED|Overall Study||50
10211793|NCT03619135|11338881|FG000|NOT COMPLETED|Overall Study||0
10211794|NCT03619135|11338882|FG001|NOT COMPLETED|Overall Study||0
10211795|NCT03619590|11338888|FG000|STARTED|Overall Study||103
10211796|NCT03619590|11338888|FG000|COMPLETED|Overall Study||103
10211797|NCT03619590|11338888|FG000|NOT COMPLETED|Overall Study||0
10211798|NCT03619811|11338892|FG000|STARTED|Overall Study||43
10211799|NCT03619811|11338892|FG000|COMPLETED|Overall Study||31
10211800|NCT03619811|11338892|FG000|NOT COMPLETED|Overall Study||12
10211801|NCT03619837|11338896|FG000|STARTED|Screening||122
10211802|NCT03619837|11338896|FG000|COMPLETED|Screening||24
10211803|NCT03619837|11338896|FG000|NOT COMPLETED|Screening||98
10211804|NCT03619837|11338896|FG000|STARTED|Main Study||24
10211805|NCT03619837|11338896|FG000|COMPLETED|Main Study||24
10211806|NCT03619837|11338896|FG000|NOT COMPLETED|Main Study||0
10211807|NCT03619889|11338902|FG000|STARTED|Overall Study||37
10211808|NCT03619889|11338903|FG001|STARTED|Overall Study||37
10211809|NCT03619889|11338902|FG000|COMPLETED|Overall Study||35
10211810|NCT03619889|11338903|FG001|COMPLETED|Overall Study||37
10211811|NCT03619889|11338902|FG000|NOT COMPLETED|Overall Study||2
10211812|NCT03619889|11338903|FG001|NOT COMPLETED|Overall Study||0
10211813|NCT03620162|11338914|FG000|STARTED|Overall Study||179
10211814|NCT03620162|11338915|FG001|STARTED|Overall Study||181
10211815|NCT03620162|11338916|FG002|STARTED|Overall Study||180
10211816|NCT03620162|11338917|FG003|STARTED|Overall Study||180
10211817|NCT03620162|11338918|FG004|STARTED|Overall Study||180
10211818|NCT03620162|11338914|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
10211819|NCT03620162|11338915|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
10211820|NCT03620162|11338916|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
10211821|NCT03620162|11338917|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
10211822|NCT03620162|11338918|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
10211823|NCT03620162|11338914|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
10211824|NCT03620162|11338915|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
10211825|NCT03620162|11338916|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
10211826|NCT03620162|11338917|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
10211827|NCT03620162|11338918|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
10211828|NCT03620162|11338914|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
10211829|NCT03620162|11338915|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
10211830|NCT03620162|11338916|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
10211831|NCT03620162|11338917|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
10211832|NCT03620162|11338918|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
10211833|NCT03620162|11338914|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
10211834|NCT03620162|11338915|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
10211835|NCT03620162|11338916|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
10211836|NCT03620162|11338917|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
10211837|NCT03620162|11338918|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
10211838|NCT03620162|11338914|FG000|COMPLETED|Overall Study||164
10211839|NCT03620162|11338915|FG001|COMPLETED|Overall Study||167
10211840|NCT03620162|11338916|FG002|COMPLETED|Overall Study||147
10211841|NCT03620162|11338917|FG003|COMPLETED|Overall Study||160
10211842|NCT03620162|11338918|FG004|COMPLETED|Overall Study||167
10211843|NCT03620162|11338914|FG000|NOT COMPLETED|Overall Study||15
10211844|NCT03620162|11338915|FG001|NOT COMPLETED|Overall Study||14
10211845|NCT03620162|11338916|FG002|NOT COMPLETED|Overall Study||33
10011970|NCT01783496|11134782|FG002|COMPLETED|Overall Study||10
10011971|NCT01783496|11134783|FG003|COMPLETED|Overall Study||8
10011972|NCT01783496|11134784|FG004|COMPLETED|Overall Study||5
10011973|NCT01783496|11134785|FG005|COMPLETED|Overall Study||4
10011974|NCT01783496|11134780|FG000|NOT COMPLETED|Overall Study||1
10011975|NCT01783496|11134781|FG001|NOT COMPLETED|Overall Study||0
10011976|NCT01783496|11134782|FG002|NOT COMPLETED|Overall Study||0
10011977|NCT01783496|11134783|FG003|NOT COMPLETED|Overall Study||2
10011978|NCT01783496|11134784|FG004|NOT COMPLETED|Overall Study||0
10011979|NCT01783496|11134785|FG005|NOT COMPLETED|Overall Study||1
10011980|NCT01783522|11134801|FG000|STARTED|Overall Study||4
10211846|NCT03620162|11338917|FG003|NOT COMPLETED|Overall Study||20
10211847|NCT03620162|11338918|FG004|NOT COMPLETED|Overall Study||13
10211848|NCT03620383|11338934|FG000|STARTED|Overall Study||30
10211849|NCT03620383|11338935|FG001|STARTED|Overall Study||15
10211850|NCT03620383|11338934|FG000|COMPLETED|Overall Study||30
10211851|NCT03620383|11338935|FG001|COMPLETED|Overall Study||15
10211852|NCT03620383|11338934|FG000|NOT COMPLETED|Overall Study||0
10211853|NCT03620383|11338935|FG001|NOT COMPLETED|Overall Study||0
10211854|NCT03620708|11338944|FG000|STARTED|Overall Study||19
10211855|NCT03620708|11338945|FG001|STARTED|Overall Study||19
10211856|NCT03620708|11338946|FG002|STARTED|Overall Study||20
10211857|NCT03620708|11338944|FG000|COMPLETED|Overall Study||18
10211858|NCT03620708|11338945|FG001|COMPLETED|Overall Study||18
10211859|NCT03620708|11338946|FG002|COMPLETED|Overall Study||17
10211860|NCT03620708|11338944|FG000|NOT COMPLETED|Overall Study||1
10211861|NCT03620708|11338945|FG001|NOT COMPLETED|Overall Study||1
10211862|NCT03620708|11338946|FG002|NOT COMPLETED|Overall Study||3
10211863|NCT03620890|11338956|FG000|STARTED|Overall Study||57
10211864|NCT03620890|11338957|FG001|STARTED|Overall Study||51
10211865|NCT03620890|11338956|FG000|First Trimester Miscarriage|Overall Study||2
10211866|NCT03620890|11338957|FG001|First Trimester Miscarriage|Overall Study||1
10211867|NCT03620890|11338956|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
10211868|NCT03620890|11338957|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
10211869|NCT03620890|11338956|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
10211870|NCT03620890|11338957|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
10211871|NCT03620890|11338956|FG000|COMPLETED|Overall Study||53
10211872|NCT03620890|11338957|FG001|COMPLETED|Overall Study||50
10211873|NCT03620890|11338956|FG000|NOT COMPLETED|Overall Study||4
10211874|NCT03620890|11338957|FG001|NOT COMPLETED|Overall Study||1
10211875|NCT03621085|11338963|FG000|STARTED|Enrollment||22
10211876|NCT03621085|11338964|FG001|STARTED|Enrollment||21
10211877|NCT03621085|11338963|FG000|COMPLETED|Enrollment||16
10211878|NCT03621085|11338964|FG001|COMPLETED|Enrollment||14
10211879|NCT03621085|11338963|FG000|NOT COMPLETED|Enrollment||6
10211880|NCT03621085|11338964|FG001|NOT COMPLETED|Enrollment||7
10211881|NCT03621085|11338963|FG000|STARTED|First Visit||16
10211882|NCT03621085|11338964|FG001|STARTED|First Visit||14
10211883|NCT03621085|11338963|FG000|COMPLETED|First Visit||16
10211884|NCT03621085|11338964|FG001|COMPLETED|First Visit||14
10211885|NCT03621085|11338963|FG000|NOT COMPLETED|First Visit||0
10211886|NCT03621085|11338964|FG001|NOT COMPLETED|First Visit||0
10211887|NCT03621085|11338963|FG000|STARTED|Washout (at Least 48 Hours)||16
10211888|NCT03621085|11338964|FG001|STARTED|Washout (at Least 48 Hours)||14
10211889|NCT03621085|11338963|FG000|COMPLETED|Washout (at Least 48 Hours)||16
10211890|NCT03621085|11338964|FG001|COMPLETED|Washout (at Least 48 Hours)||14
10211891|NCT03621085|11338963|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
10211892|NCT03621085|11338964|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
10211893|NCT03621085|11338963|FG000|STARTED|Second Visit||16
10211894|NCT03621085|11338964|FG001|STARTED|Second Visit||14
10211895|NCT03621085|11338963|FG000|COMPLETED|Second Visit||16
10211896|NCT03621085|11338964|FG001|COMPLETED|Second Visit||14
10211897|NCT03621085|11338963|FG000|NOT COMPLETED|Second Visit||0
10211898|NCT03621085|11338964|FG001|NOT COMPLETED|Second Visit||0
10211899|NCT03621189|11338972|FG000|STARTED|Overall Study||40
10211900|NCT03621189|11338973|FG001|STARTED|Overall Study||40
10211901|NCT03621189|11338972|FG000|COMPLETED|Overall Study||40
10211902|NCT03621189|11338973|FG001|COMPLETED|Overall Study||35
10211903|NCT03621189|11338972|FG000|NOT COMPLETED|Overall Study||0
10211904|NCT03621189|11338973|FG001|NOT COMPLETED|Overall Study||5
10211905|NCT03621202|11338980|FG000|STARTED|Overall Study||66
10211906|NCT03621202|11338980|FG000|COMPLETED|Overall Study||60
10211907|NCT03621202|11338980|FG000|NOT COMPLETED|Overall Study||6
10211908|NCT03621787|11338984|FG000|STARTED|Overall Study||9
10211909|NCT03621787|11338984|FG000|COMPLETED|Overall Study||9
10211910|NCT03621787|11338984|FG000|NOT COMPLETED|Overall Study||0
10211911|NCT03621878|11338991|FG000|STARTED|Overall Study||17
10211912|NCT03621878|11338992|FG001|STARTED|Overall Study||17
10211913|NCT03621878|11338993|FG002|STARTED|Overall Study||17
10211914|NCT03621878|11338991|FG000|COMPLETED|Overall Study||17
10211915|NCT03621878|11338992|FG001|COMPLETED|Overall Study||17
10211916|NCT03621878|11338993|FG002|COMPLETED|Overall Study||17
10211917|NCT03621878|11338991|FG000|NOT COMPLETED|Overall Study||0
10211918|NCT03621878|11338992|FG001|NOT COMPLETED|Overall Study||0
10211919|NCT03621878|11338993|FG002|NOT COMPLETED|Overall Study||0
10211920|NCT03622112|11339008|FG000|STARTED|Overall Study||110
10211921|NCT03622112|11339009|FG001|STARTED|Overall Study||112
10211922|NCT03622112|11339010|FG002|STARTED|Overall Study||111
10211923|NCT03622112|11339011|FG003|STARTED|Overall Study||113
10211924|NCT03622112|11339012|FG004|STARTED|Overall Study||134
10211925|NCT03622112|11339013|FG005|STARTED|Overall Study||113
10211926|NCT03622112|11339014|FG006|STARTED|Overall Study||112
10211927|NCT03622112|11339008|FG000|COMPLETED|Overall Study||85
10211928|NCT03622112|11339009|FG001|COMPLETED|Overall Study||92
10211929|NCT03622112|11339010|FG002|COMPLETED|Overall Study||95
10211930|NCT03622112|11339011|FG003|COMPLETED|Overall Study||91
10211931|NCT03622112|11339012|FG004|COMPLETED|Overall Study||124
10211932|NCT03622112|11339013|FG005|COMPLETED|Overall Study||71
10211933|NCT03622112|11339014|FG006|COMPLETED|Overall Study||103
10211934|NCT03622112|11339008|FG000|NOT COMPLETED|Overall Study||25
10211935|NCT03622112|11339009|FG001|NOT COMPLETED|Overall Study||20
10211936|NCT03622112|11339010|FG002|NOT COMPLETED|Overall Study||16
10211937|NCT03622112|11339011|FG003|NOT COMPLETED|Overall Study||22
10211938|NCT03622112|11339012|FG004|NOT COMPLETED|Overall Study||10
10211939|NCT03622112|11339013|FG005|NOT COMPLETED|Overall Study||42
10211940|NCT03622112|11339014|FG006|NOT COMPLETED|Overall Study||9
10211941|NCT03622619|11339032|FG000|STARTED|Overall Study||23
10211942|NCT03622619|11339033|FG001|STARTED|Overall Study||23
10211943|NCT03622619|11339032|FG000|COMPLETED|Overall Study||21
10211944|NCT03622619|11339033|FG001|COMPLETED|Overall Study||21
10211945|NCT03622619|11339032|FG000|NOT COMPLETED|Overall Study||2
10211946|NCT03622619|11339033|FG001|NOT COMPLETED|Overall Study||2
10211947|NCT03623035|11339039|FG000|STARTED|Overall Study||10
10211948|NCT03623035|11339039|FG000|COMPLETED|Overall Study||10
10211949|NCT03623035|11339039|FG000|NOT COMPLETED|Overall Study||0
10211950|NCT03623334|11339046|FG000|STARTED|Overall Study||15
10211951|NCT03623334|11339047|FG001|STARTED|Overall Study||21
10211952|NCT03623334|11339048|FG002|STARTED|Overall Study||19
10211953|NCT03623334|11339046|FG000|COMPLETED|Overall Study||15
10211954|NCT03623334|11339047|FG001|COMPLETED|Overall Study||21
10211955|NCT03623334|11339048|FG002|COMPLETED|Overall Study||19
10211956|NCT03623334|11339046|FG000|NOT COMPLETED|Overall Study||0
10211957|NCT03623334|11339047|FG001|NOT COMPLETED|Overall Study||0
10211958|NCT03623334|11339048|FG002|NOT COMPLETED|Overall Study||0
10211959|NCT03623698|11339056|FG000|STARTED|Overall Study||24
10011981|NCT01783522|11134802|FG001|STARTED|Overall Study||5
10011982|NCT01783522|11134801|FG000|COMPLETED|Overall Study||4
10011983|NCT01783522|11134802|FG001|COMPLETED|Overall Study||5
10011984|NCT01783522|11134801|FG000|NOT COMPLETED|Overall Study||0
10011985|NCT01783522|11134802|FG001|NOT COMPLETED|Overall Study||0
10011986|NCT01783548|11134810|FG000|STARTED|Overall Study|Randomized|362
10211960|NCT03623698|11339056|FG000|COMPLETED|Overall Study||24
10211961|NCT03623698|11339056|FG000|NOT COMPLETED|Overall Study||0
10211962|NCT03624192|11339067|FG000|STARTED|Overall Study||3
10211963|NCT03624192|11339068|FG001|STARTED|Overall Study||3
10211964|NCT03624192|11339067|FG000|COMPLETED|Overall Study||2
10211965|NCT03624192|11339068|FG001|COMPLETED|Overall Study||2
10211966|NCT03624192|11339067|FG000|NOT COMPLETED|Overall Study||1
10211967|NCT03624192|11339068|FG001|NOT COMPLETED|Overall Study||1
10211968|NCT03624504|11339076|FG000|STARTED|Overall Study||82
10211969|NCT03624504|11339076|FG000|COMPLETED|Overall Study||81
10211970|NCT03624504|11339076|FG000|NOT COMPLETED|Overall Study||1
10211971|NCT03624920|11339086|FG000|STARTED|Overall Study||14
10211972|NCT03624920|11339087|FG001|STARTED|Overall Study||14
10211973|NCT03624920|11339088|FG002|STARTED|Overall Study||13
10211974|NCT03624920|11339089|FG003|STARTED|Overall Study||13
10211975|NCT03624920|11339090|FG004|STARTED|Overall Study||11
10211976|NCT03624920|11339091|FG005|STARTED|Overall Study||12
10211977|NCT03624920|11339086|FG000|COMPLETED|Overall Study||13
10211978|NCT03624920|11339087|FG001|COMPLETED|Overall Study||12
10211979|NCT03624920|11339088|FG002|COMPLETED|Overall Study||12
10211980|NCT03624920|11339089|FG003|COMPLETED|Overall Study||12
10211981|NCT03624920|11339090|FG004|COMPLETED|Overall Study||7
10211982|NCT03624920|11339091|FG005|COMPLETED|Overall Study||11
10211983|NCT03624920|11339086|FG000|NOT COMPLETED|Overall Study||1
10211984|NCT03624920|11339087|FG001|NOT COMPLETED|Overall Study||2
10211985|NCT03624920|11339088|FG002|NOT COMPLETED|Overall Study||1
10211986|NCT03624920|11339089|FG003|NOT COMPLETED|Overall Study||1
10211987|NCT03624920|11339090|FG004|NOT COMPLETED|Overall Study||4
10211988|NCT03624920|11339091|FG005|NOT COMPLETED|Overall Study||1
10211989|NCT03624946|11339101|FG000|STARTED|Overall Study||19
10211990|NCT03624946|11339102|FG001|STARTED|Overall Study||11
10211991|NCT03624946|11339101|FG000|COMPLETED|Overall Study||19
10211992|NCT03624946|11339102|FG001|COMPLETED|Overall Study||10
10011987|NCT01783548|11134811|FG001|STARTED|Overall Study|Randomized|185
10211993|NCT03624946|11339101|FG000|NOT COMPLETED|Overall Study||0
10211994|NCT03624946|11339102|FG001|NOT COMPLETED|Overall Study||1
10211995|NCT03624972|11339115|FG000|STARTED|Overall Study||71
10211996|NCT03624972|11339116|FG001|STARTED|Overall Study||73
10211997|NCT03624972|11339117|FG002|STARTED|Overall Study||9
10211998|NCT03624972|11339115|FG000|COMPLETED|Overall Study||69
10211999|NCT03624972|11339116|FG001|COMPLETED|Overall Study||71
10212000|NCT03624972|11339117|FG002|COMPLETED|Overall Study||9
10212001|NCT03624972|11339115|FG000|NOT COMPLETED|Overall Study||2
10212002|NCT03624972|11339116|FG001|NOT COMPLETED|Overall Study||2
10212003|NCT03624972|11339117|FG002|NOT COMPLETED|Overall Study||0
10212004|NCT03626415|11339129|FG000|STARTED|Overall Study||8
10212005|NCT03626415|11339130|FG001|STARTED|Overall Study||8
10212006|NCT03626415|11339131|FG002|STARTED|Overall Study||8
10011988|NCT01783548|11134810|FG000|Full Analysis Set (FAS)|Overall Study||358
10011989|NCT01783548|11134811|FG001|Full Analysis Set (FAS)|Overall Study||184
10011990|NCT01783548|11134810|FG000|COMPLETED|Overall Study||328
10212007|NCT03626415|11339129|FG000|COMPLETED|Overall Study||8
10212008|NCT03626415|11339130|FG001|COMPLETED|Overall Study||8
10212009|NCT03626415|11339131|FG002|COMPLETED|Overall Study||8
10212010|NCT03626415|11339129|FG000|NOT COMPLETED|Overall Study||0
10212011|NCT03626415|11339130|FG001|NOT COMPLETED|Overall Study||0
10212012|NCT03626415|11339131|FG002|NOT COMPLETED|Overall Study||0
10212013|NCT03626623|11339141|FG000|STARTED|Overall Study||5
10212014|NCT03626623|11339142|FG001|STARTED|Overall Study||10
10212015|NCT03626623|11339141|FG000|COMPLETED|Overall Study||0
10212016|NCT03626623|11339142|FG001|COMPLETED|Overall Study||0
10212017|NCT03626623|11339141|FG000|NOT COMPLETED|Overall Study||5
10212018|NCT03626623|11339142|FG001|NOT COMPLETED|Overall Study||10
10212019|NCT03626714|11339148|FG000|STARTED|Overall Study||8
10212020|NCT03626714|11339148|FG000|COMPLETED|Overall Study||8
10212021|NCT03626714|11339148|FG000|NOT COMPLETED|Overall Study||0
10212022|NCT03627065|11339152|FG000|STARTED|Overall Study||10
10212023|NCT03627065|11339152|FG000|COMPLETED|Overall Study||7
10212024|NCT03627065|11339152|FG000|NOT COMPLETED|Overall Study||3
10212025|NCT03627195|11339162|FG000|STARTED|Overall Study||6
10212026|NCT03627195|11339163|FG001|STARTED|Overall Study||6
10212027|NCT03627195|11339164|FG002|STARTED|Overall Study||6
10212028|NCT03627195|11339165|FG003|STARTED|Overall Study||6
10212029|NCT03627195|11339166|FG004|STARTED|Overall Study||6
10212030|NCT03627195|11339167|FG005|STARTED|Overall Study||10
10212031|NCT03627195|11339162|FG000|COMPLETED|Overall Study||5
10212032|NCT03627195|11339163|FG001|COMPLETED|Overall Study||6
10212033|NCT03627195|11339164|FG002|COMPLETED|Overall Study||6
10212034|NCT03627195|11339165|FG003|COMPLETED|Overall Study||6
10212035|NCT03627195|11339166|FG004|COMPLETED|Overall Study||6
10212036|NCT03627195|11339167|FG005|COMPLETED|Overall Study||10
10212037|NCT03627195|11339162|FG000|NOT COMPLETED|Overall Study||1
10212038|NCT03627195|11339163|FG001|NOT COMPLETED|Overall Study||0
10212039|NCT03627195|11339164|FG002|NOT COMPLETED|Overall Study||0
10212040|NCT03627195|11339165|FG003|NOT COMPLETED|Overall Study||0
10212041|NCT03627195|11339166|FG004|NOT COMPLETED|Overall Study||0
10212042|NCT03627195|11339167|FG005|NOT COMPLETED|Overall Study||0
10212043|NCT03627299|11339181|FG000|STARTED|Overall Study||10
10212044|NCT03627299|11339181|FG000|COMPLETED|Overall Study||10
10212045|NCT03627299|11339181|FG000|NOT COMPLETED|Overall Study||0
10212046|NCT03627416|11339187|FG000|STARTED|Overall Study||8
10212047|NCT03627416|11339188|FG001|STARTED|Overall Study||7
10212048|NCT03627416|11339187|FG000|COMPLETED|Overall Study||8
10212049|NCT03627416|11339188|FG001|COMPLETED|Overall Study||6
10212050|NCT03627416|11339187|FG000|NOT COMPLETED|Overall Study||0
10212051|NCT03627416|11339188|FG001|NOT COMPLETED|Overall Study||1
10212052|NCT03627494|11339206|FG000|STARTED|Part A Period 1 (4 Days)||3
10212053|NCT03627494|11339207|FG001|STARTED|Part A Period 1 (4 Days)||3
10212054|NCT03627494|11339208|FG002|STARTED|Part A Period 1 (4 Days)||3
10212055|NCT03627494|11339209|FG003|STARTED|Part A Period 1 (4 Days)||3
10212056|NCT03627494|11339210|FG004|STARTED|Part A Period 1 (4 Days)||3
10212057|NCT03627494|11339211|FG005|STARTED|Part A Period 1 (4 Days)||3
10212058|NCT03627494|11339212|FG006|STARTED|Part A Period 1 (4 Days)||0
10212059|NCT03627494|11339213|FG007|STARTED|Part A Period 1 (4 Days)||0
10212060|NCT03627494|11339214|FG008|STARTED|Part A Period 1 (4 Days)||0
10212061|NCT03627494|11339215|FG009|STARTED|Part A Period 1 (4 Days)||0
10212062|NCT03627494|11339216|FG010|STARTED|Part A Period 1 (4 Days)||0
10212063|NCT03627494|11339217|FG011|STARTED|Part A Period 1 (4 Days)||0
10212064|NCT03627494|11339206|FG000|COMPLETED|Part A Period 1 (4 Days)||3
10212065|NCT03627494|11339207|FG001|COMPLETED|Part A Period 1 (4 Days)||3
10212066|NCT03627494|11339208|FG002|COMPLETED|Part A Period 1 (4 Days)||3
10212067|NCT03627494|11339209|FG003|COMPLETED|Part A Period 1 (4 Days)||3
10212068|NCT03627494|11339210|FG004|COMPLETED|Part A Period 1 (4 Days)||3
10212069|NCT03627494|11339211|FG005|COMPLETED|Part A Period 1 (4 Days)||3
10212070|NCT03627494|11339212|FG006|COMPLETED|Part A Period 1 (4 Days)||0
10212071|NCT03627494|11339213|FG007|COMPLETED|Part A Period 1 (4 Days)||0
10212072|NCT03627494|11339214|FG008|COMPLETED|Part A Period 1 (4 Days)||0
10212073|NCT03627494|11339215|FG009|COMPLETED|Part A Period 1 (4 Days)||0
10212074|NCT03627494|11339216|FG010|COMPLETED|Part A Period 1 (4 Days)||0
10212075|NCT03627494|11339217|FG011|COMPLETED|Part A Period 1 (4 Days)||0
10212076|NCT03627494|11339206|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212077|NCT03627494|11339207|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212078|NCT03627494|11339208|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212079|NCT03627494|11339209|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212080|NCT03627494|11339210|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212081|NCT03627494|11339211|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212082|NCT03627494|11339212|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212083|NCT03627494|11339213|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212084|NCT03627494|11339214|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212085|NCT03627494|11339215|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212086|NCT03627494|11339216|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212087|NCT03627494|11339217|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0
10212088|NCT03627494|11339206|FG000|STARTED|Part A Washout 1 (7 Days)||3
10212089|NCT03627494|11339207|FG001|STARTED|Part A Washout 1 (7 Days)||3
10212090|NCT03627494|11339208|FG002|STARTED|Part A Washout 1 (7 Days)||3
10212091|NCT03627494|11339209|FG003|STARTED|Part A Washout 1 (7 Days)||3
10212092|NCT03627494|11339210|FG004|STARTED|Part A Washout 1 (7 Days)||3
10212093|NCT03627494|11339211|FG005|STARTED|Part A Washout 1 (7 Days)||3
10212094|NCT03627494|11339212|FG006|STARTED|Part A Washout 1 (7 Days)||0
10212095|NCT03627494|11339213|FG007|STARTED|Part A Washout 1 (7 Days)||0
10212096|NCT03627494|11339214|FG008|STARTED|Part A Washout 1 (7 Days)||0
10212097|NCT03627494|11339215|FG009|STARTED|Part A Washout 1 (7 Days)||0
10212098|NCT03627494|11339216|FG010|STARTED|Part A Washout 1 (7 Days)||0
10212099|NCT03627494|11339217|FG011|STARTED|Part A Washout 1 (7 Days)||0
10212100|NCT03627494|11339206|FG000|COMPLETED|Part A Washout 1 (7 Days)||3
10212101|NCT03627494|11339207|FG001|COMPLETED|Part A Washout 1 (7 Days)||3
10212102|NCT03627494|11339208|FG002|COMPLETED|Part A Washout 1 (7 Days)||3
10212103|NCT03627494|11339209|FG003|COMPLETED|Part A Washout 1 (7 Days)||3
10212104|NCT03627494|11339210|FG004|COMPLETED|Part A Washout 1 (7 Days)||3
10212105|NCT03627494|11339211|FG005|COMPLETED|Part A Washout 1 (7 Days)||3
10212106|NCT03627494|11339212|FG006|COMPLETED|Part A Washout 1 (7 Days)||0
10212107|NCT03627494|11339213|FG007|COMPLETED|Part A Washout 1 (7 Days)||0
10212108|NCT03627494|11339214|FG008|COMPLETED|Part A Washout 1 (7 Days)||0
10212109|NCT03627494|11339215|FG009|COMPLETED|Part A Washout 1 (7 Days)||0
10212110|NCT03627494|11339216|FG010|COMPLETED|Part A Washout 1 (7 Days)||0
10212111|NCT03627494|11339217|FG011|COMPLETED|Part A Washout 1 (7 Days)||0
10212112|NCT03627494|11339206|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212113|NCT03627494|11339207|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212114|NCT03627494|11339208|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212115|NCT03627494|11339209|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212116|NCT03627494|11339210|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212117|NCT03627494|11339211|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212118|NCT03627494|11339212|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212119|NCT03627494|11339213|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212120|NCT03627494|11339214|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212121|NCT03627494|11339215|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212122|NCT03627494|11339216|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212123|NCT03627494|11339217|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10212124|NCT03627494|11339206|FG000|STARTED|Part A Period 2 (4 Days)||3
10212125|NCT03627494|11339207|FG001|STARTED|Part A Period 2 (4 Days)||3
10212126|NCT03627494|11339208|FG002|STARTED|Part A Period 2 (4 Days)||3
10212127|NCT03627494|11339209|FG003|STARTED|Part A Period 2 (4 Days)||3
10212128|NCT03627494|11339210|FG004|STARTED|Part A Period 2 (4 Days)||3
10212129|NCT03627494|11339211|FG005|STARTED|Part A Period 2 (4 Days)||3
10212130|NCT03627494|11339212|FG006|STARTED|Part A Period 2 (4 Days)||0
10212131|NCT03627494|11339213|FG007|STARTED|Part A Period 2 (4 Days)||0
10212132|NCT03627494|11339214|FG008|STARTED|Part A Period 2 (4 Days)||0
10212133|NCT03627494|11339215|FG009|STARTED|Part A Period 2 (4 Days)||0
10212134|NCT03627494|11339216|FG010|STARTED|Part A Period 2 (4 Days)||0
10212135|NCT03627494|11339217|FG011|STARTED|Part A Period 2 (4 Days)||0
10212136|NCT03627494|11339206|FG000|COMPLETED|Part A Period 2 (4 Days)||3
10212137|NCT03627494|11339207|FG001|COMPLETED|Part A Period 2 (4 Days)||3
10212138|NCT03627494|11339208|FG002|COMPLETED|Part A Period 2 (4 Days)||3
10212139|NCT03627494|11339209|FG003|COMPLETED|Part A Period 2 (4 Days)||3
10212140|NCT03627494|11339210|FG004|COMPLETED|Part A Period 2 (4 Days)||3
10212141|NCT03627494|11339211|FG005|COMPLETED|Part A Period 2 (4 Days)||3
10212142|NCT03627494|11339212|FG006|COMPLETED|Part A Period 2 (4 Days)||0
10212143|NCT03627494|11339213|FG007|COMPLETED|Part A Period 2 (4 Days)||0
10212144|NCT03627494|11339214|FG008|COMPLETED|Part A Period 2 (4 Days)||0
10212145|NCT03627494|11339215|FG009|COMPLETED|Part A Period 2 (4 Days)||0
10212146|NCT03627494|11339216|FG010|COMPLETED|Part A Period 2 (4 Days)||0
10212147|NCT03627494|11339217|FG011|COMPLETED|Part A Period 2 (4 Days)||0
10212148|NCT03627494|11339206|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212149|NCT03627494|11339207|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212150|NCT03627494|11339208|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212151|NCT03627494|11339209|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212152|NCT03627494|11339210|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212153|NCT03627494|11339211|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212154|NCT03627494|11339212|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212155|NCT03627494|11339213|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212156|NCT03627494|11339214|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212157|NCT03627494|11339215|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212158|NCT03627494|11339216|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212159|NCT03627494|11339217|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0
10212160|NCT03627494|11339206|FG000|STARTED|Part A Washout 2 (7 Days)||3
10212161|NCT03627494|11339207|FG001|STARTED|Part A Washout 2 (7 Days)||3
10212162|NCT03627494|11339208|FG002|STARTED|Part A Washout 2 (7 Days)||3
9760740|NCT00383071|10864518|FG002|COMPLETED|Overall Study||44
9760741|NCT00383071|10864519|FG003|COMPLETED|Overall Study||22
9760742|NCT00383071|10864516|FG000|NOT COMPLETED|Overall Study||0
9760743|NCT00383071|10864517|FG001|NOT COMPLETED|Overall Study||4
9760744|NCT00383071|10864518|FG002|NOT COMPLETED|Overall Study||7
9760745|NCT00383071|10864519|FG003|NOT COMPLETED|Overall Study||3
10212163|NCT03627494|11339209|FG003|STARTED|Part A Washout 2 (7 Days)||3
10212164|NCT03627494|11339210|FG004|STARTED|Part A Washout 2 (7 Days)||3
10212165|NCT03627494|11339211|FG005|STARTED|Part A Washout 2 (7 Days)||3
10212166|NCT03627494|11339212|FG006|STARTED|Part A Washout 2 (7 Days)||0
10212167|NCT03627494|11339213|FG007|STARTED|Part A Washout 2 (7 Days)||0
10212168|NCT03627494|11339214|FG008|STARTED|Part A Washout 2 (7 Days)||0
10212169|NCT03627494|11339215|FG009|STARTED|Part A Washout 2 (7 Days)||0
10212170|NCT03627494|11339216|FG010|STARTED|Part A Washout 2 (7 Days)||0
10212171|NCT03627494|11339217|FG011|STARTED|Part A Washout 2 (7 Days)||0
10212172|NCT03627494|11339206|FG000|COMPLETED|Part A Washout 2 (7 Days)||2
10212173|NCT03627494|11339207|FG001|COMPLETED|Part A Washout 2 (7 Days)||3
10212174|NCT03627494|11339208|FG002|COMPLETED|Part A Washout 2 (7 Days)||2
10212175|NCT03627494|11339209|FG003|COMPLETED|Part A Washout 2 (7 Days)||3
10212176|NCT03627494|11339210|FG004|COMPLETED|Part A Washout 2 (7 Days)||3
10212177|NCT03627494|11339211|FG005|COMPLETED|Part A Washout 2 (7 Days)||3
10011991|NCT01783548|11134811|FG001|COMPLETED|Overall Study||167
10011992|NCT01783548|11134810|FG000|NOT COMPLETED|Overall Study||34
10011993|NCT01783548|11134811|FG001|NOT COMPLETED|Overall Study||18
10011994|NCT01783561|11134819|FG000|STARTED|Overall Study||11
10011995|NCT01783561|11134820|FG001|STARTED|Overall Study||10
10212178|NCT03627494|11339212|FG006|COMPLETED|Part A Washout 2 (7 Days)||0
10212179|NCT03627494|11339213|FG007|COMPLETED|Part A Washout 2 (7 Days)||0
10212180|NCT03627494|11339214|FG008|COMPLETED|Part A Washout 2 (7 Days)||0
10212181|NCT03627494|11339215|FG009|COMPLETED|Part A Washout 2 (7 Days)||0
10011996|NCT01783561|11134819|FG000|COMPLETED|Overall Study||11
10011997|NCT01783561|11134820|FG001|COMPLETED|Overall Study||10
10212182|NCT03627494|11339216|FG010|COMPLETED|Part A Washout 2 (7 Days)||0
10212183|NCT03627494|11339217|FG011|COMPLETED|Part A Washout 2 (7 Days)||0
10212184|NCT03627494|11339206|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1
10212185|NCT03627494|11339207|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212186|NCT03627494|11339208|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1
10011998|NCT01783561|11134819|FG000|NOT COMPLETED|Overall Study||0
10212187|NCT03627494|11339209|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212188|NCT03627494|11339210|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212189|NCT03627494|11339211|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212190|NCT03627494|11339212|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212191|NCT03627494|11339213|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212192|NCT03627494|11339214|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212193|NCT03627494|11339215|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212194|NCT03627494|11339216|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212195|NCT03627494|11339217|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10212196|NCT03627494|11339206|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2
10212197|NCT03627494|11339207|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10212198|NCT03627494|11339208|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2
10212199|NCT03627494|11339209|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10212200|NCT03627494|11339210|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10212201|NCT03627494|11339211|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10212202|NCT03627494|11339212|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10212203|NCT03627494|11339213|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10212204|NCT03627494|11339214|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10212205|NCT03627494|11339215|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10212206|NCT03627494|11339216|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10212207|NCT03627494|11339217|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10212208|NCT03627494|11339206|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
10212209|NCT03627494|11339207|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10212210|NCT03627494|11339208|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
10212211|NCT03627494|11339209|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10212212|NCT03627494|11339210|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10212213|NCT03627494|11339211|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10212214|NCT03627494|11339212|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212215|NCT03627494|11339213|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212216|NCT03627494|11339214|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212217|NCT03627494|11339215|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212218|NCT03627494|11339216|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212219|NCT03627494|11339217|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212220|NCT03627494|11339206|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212221|NCT03627494|11339207|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212222|NCT03627494|11339208|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212223|NCT03627494|11339209|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212224|NCT03627494|11339210|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212225|NCT03627494|11339211|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212226|NCT03627494|11339212|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212227|NCT03627494|11339213|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212228|NCT03627494|11339214|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212229|NCT03627494|11339215|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212230|NCT03627494|11339216|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212231|NCT03627494|11339217|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10212232|NCT03627494|11339206|FG000|STARTED|Part B (Maximum of 34 Days)||0
10212233|NCT03627494|11339207|FG001|STARTED|Part B (Maximum of 34 Days)||0
10212234|NCT03627494|11339208|FG002|STARTED|Part B (Maximum of 34 Days)||0
10212235|NCT03627494|11339209|FG003|STARTED|Part B (Maximum of 34 Days)||0
10212236|NCT03627494|11339210|FG004|STARTED|Part B (Maximum of 34 Days)||0
10212237|NCT03627494|11339211|FG005|STARTED|Part B (Maximum of 34 Days)||0
10212238|NCT03627494|11339212|FG006|STARTED|Part B (Maximum of 34 Days)||9
10212239|NCT03627494|11339213|FG007|STARTED|Part B (Maximum of 34 Days)||9
10212240|NCT03627494|11339214|FG008|STARTED|Part B (Maximum of 34 Days)||9
10212241|NCT03627494|11339215|FG009|STARTED|Part B (Maximum of 34 Days)||9
10212242|NCT03627494|11339216|FG010|STARTED|Part B (Maximum of 34 Days)||0
10212243|NCT03627494|11339217|FG011|STARTED|Part B (Maximum of 34 Days)||0
10212244|NCT03627494|11339206|FG000|COMPLETED|Part B (Maximum of 34 Days)||0
10212245|NCT03627494|11339207|FG001|COMPLETED|Part B (Maximum of 34 Days)||0
10212246|NCT03627494|11339208|FG002|COMPLETED|Part B (Maximum of 34 Days)||0
10212247|NCT03627494|11339209|FG003|COMPLETED|Part B (Maximum of 34 Days)||0
10212248|NCT03627494|11339210|FG004|COMPLETED|Part B (Maximum of 34 Days)||0
10212249|NCT03627494|11339211|FG005|COMPLETED|Part B (Maximum of 34 Days)||0
10212250|NCT03627494|11339212|FG006|COMPLETED|Part B (Maximum of 34 Days)||9
10212251|NCT03627494|11339213|FG007|COMPLETED|Part B (Maximum of 34 Days)||9
10212252|NCT03627494|11339214|FG008|COMPLETED|Part B (Maximum of 34 Days)||7
10212253|NCT03627494|11339215|FG009|COMPLETED|Part B (Maximum of 34 Days)||9
10212254|NCT03627494|11339216|FG010|COMPLETED|Part B (Maximum of 34 Days)||0
10212255|NCT03627494|11339217|FG011|COMPLETED|Part B (Maximum of 34 Days)||0
10212256|NCT03627494|11339206|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212257|NCT03627494|11339207|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212258|NCT03627494|11339208|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212259|NCT03627494|11339209|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212260|NCT03627494|11339210|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212261|NCT03627494|11339211|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212262|NCT03627494|11339212|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212263|NCT03627494|11339213|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212264|NCT03627494|11339214|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2
10212265|NCT03627494|11339215|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212266|NCT03627494|11339216|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212267|NCT03627494|11339217|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10212268|NCT03627494|11339206|FG000|STARTED|Part C Period 1 (4 Days)||0
10212269|NCT03627494|11339207|FG001|STARTED|Part C Period 1 (4 Days)||0
10212270|NCT03627494|11339208|FG002|STARTED|Part C Period 1 (4 Days)||0
10212271|NCT03627494|11339209|FG003|STARTED|Part C Period 1 (4 Days)||0
10212272|NCT03627494|11339210|FG004|STARTED|Part C Period 1 (4 Days)||0
10212273|NCT03627494|11339211|FG005|STARTED|Part C Period 1 (4 Days)||0
10212274|NCT03627494|11339212|FG006|STARTED|Part C Period 1 (4 Days)||0
10212275|NCT03627494|11339213|FG007|STARTED|Part C Period 1 (4 Days)||0
10212276|NCT03627494|11339214|FG008|STARTED|Part C Period 1 (4 Days)||0
10212277|NCT03627494|11339215|FG009|STARTED|Part C Period 1 (4 Days)||0
10212278|NCT03627494|11339216|FG010|STARTED|Part C Period 1 (4 Days)||6
10212279|NCT03627494|11339217|FG011|STARTED|Part C Period 1 (4 Days)||6
10212280|NCT03627494|11339206|FG000|COMPLETED|Part C Period 1 (4 Days)||0
10212281|NCT03627494|11339207|FG001|COMPLETED|Part C Period 1 (4 Days)||0
10212282|NCT03627494|11339208|FG002|COMPLETED|Part C Period 1 (4 Days)||0
10212283|NCT03627494|11339209|FG003|COMPLETED|Part C Period 1 (4 Days)||0
10212284|NCT03627494|11339210|FG004|COMPLETED|Part C Period 1 (4 Days)||0
10212285|NCT03627494|11339211|FG005|COMPLETED|Part C Period 1 (4 Days)||0
10212286|NCT03627494|11339212|FG006|COMPLETED|Part C Period 1 (4 Days)||0
10212287|NCT03627494|11339213|FG007|COMPLETED|Part C Period 1 (4 Days)||0
10212288|NCT03627494|11339214|FG008|COMPLETED|Part C Period 1 (4 Days)||0
10212289|NCT03627494|11339215|FG009|COMPLETED|Part C Period 1 (4 Days)||0
10212290|NCT03627494|11339216|FG010|COMPLETED|Part C Period 1 (4 Days)||6
10212291|NCT03627494|11339217|FG011|COMPLETED|Part C Period 1 (4 Days)||6
10212292|NCT03627494|11339206|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212293|NCT03627494|11339207|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212294|NCT03627494|11339208|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212295|NCT03627494|11339209|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212296|NCT03627494|11339210|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212297|NCT03627494|11339211|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212298|NCT03627494|11339212|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212299|NCT03627494|11339213|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212300|NCT03627494|11339214|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212301|NCT03627494|11339215|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212302|NCT03627494|11339216|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212303|NCT03627494|11339217|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0
10212304|NCT03627494|11339206|FG000|STARTED|Part C Washout 1 (7 Days)||0
10212305|NCT03627494|11339207|FG001|STARTED|Part C Washout 1 (7 Days)||0
10212306|NCT03627494|11339208|FG002|STARTED|Part C Washout 1 (7 Days)||0
10212307|NCT03627494|11339209|FG003|STARTED|Part C Washout 1 (7 Days)||0
10212308|NCT03627494|11339210|FG004|STARTED|Part C Washout 1 (7 Days)||0
10212309|NCT03627494|11339211|FG005|STARTED|Part C Washout 1 (7 Days)||0
10212310|NCT03627494|11339212|FG006|STARTED|Part C Washout 1 (7 Days)||0
10212311|NCT03627494|11339213|FG007|STARTED|Part C Washout 1 (7 Days)||0
10212312|NCT03627494|11339214|FG008|STARTED|Part C Washout 1 (7 Days)||0
10212313|NCT03627494|11339215|FG009|STARTED|Part C Washout 1 (7 Days)||0
10212314|NCT03627494|11339216|FG010|STARTED|Part C Washout 1 (7 Days)||6
10212315|NCT03627494|11339217|FG011|STARTED|Part C Washout 1 (7 Days)||6
10212316|NCT03627494|11339206|FG000|COMPLETED|Part C Washout 1 (7 Days)||0
10212317|NCT03627494|11339207|FG001|COMPLETED|Part C Washout 1 (7 Days)||0
10212318|NCT03627494|11339208|FG002|COMPLETED|Part C Washout 1 (7 Days)||0
10212319|NCT03627494|11339209|FG003|COMPLETED|Part C Washout 1 (7 Days)||0
10212320|NCT03627494|11339210|FG004|COMPLETED|Part C Washout 1 (7 Days)||0
10212321|NCT03627494|11339211|FG005|COMPLETED|Part C Washout 1 (7 Days)||0
10212322|NCT03627494|11339212|FG006|COMPLETED|Part C Washout 1 (7 Days)||0
10212323|NCT03627494|11339213|FG007|COMPLETED|Part C Washout 1 (7 Days)||0
10212324|NCT03627494|11339214|FG008|COMPLETED|Part C Washout 1 (7 Days)||0
10212325|NCT03627494|11339215|FG009|COMPLETED|Part C Washout 1 (7 Days)||0
10212326|NCT03627494|11339216|FG010|COMPLETED|Part C Washout 1 (7 Days)||5
10212327|NCT03627494|11339217|FG011|COMPLETED|Part C Washout 1 (7 Days)||5
10212328|NCT03627494|11339206|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212329|NCT03627494|11339207|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212330|NCT03627494|11339208|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212331|NCT03627494|11339209|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212332|NCT03627494|11339210|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212333|NCT03627494|11339211|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212334|NCT03627494|11339212|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212335|NCT03627494|11339213|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212336|NCT03627494|11339214|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212337|NCT03627494|11339215|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10212338|NCT03627494|11339216|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1
10212339|NCT03627494|11339217|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1
10212340|NCT03627494|11339206|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212341|NCT03627494|11339207|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212342|NCT03627494|11339208|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212343|NCT03627494|11339209|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212344|NCT03627494|11339210|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212345|NCT03627494|11339211|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212346|NCT03627494|11339212|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212347|NCT03627494|11339213|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212348|NCT03627494|11339214|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212349|NCT03627494|11339215|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10212350|NCT03627494|11339216|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5
10212351|NCT03627494|11339217|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5
10212352|NCT03627494|11339206|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212353|NCT03627494|11339207|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212354|NCT03627494|11339208|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212355|NCT03627494|11339209|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212356|NCT03627494|11339210|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212357|NCT03627494|11339211|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212358|NCT03627494|11339212|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212359|NCT03627494|11339213|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212360|NCT03627494|11339214|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212361|NCT03627494|11339215|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212362|NCT03627494|11339216|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
10212363|NCT03627494|11339217|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
10212364|NCT03627494|11339206|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212365|NCT03627494|11339207|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212366|NCT03627494|11339208|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212367|NCT03627494|11339209|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212368|NCT03627494|11339210|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212369|NCT03627494|11339211|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212370|NCT03627494|11339212|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212371|NCT03627494|11339213|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212372|NCT03627494|11339214|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212373|NCT03627494|11339215|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212374|NCT03627494|11339216|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212375|NCT03627494|11339217|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10212376|NCT03627767|11339259|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235
10212377|NCT03627767|11339260|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10212378|NCT03627767|11339261|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10212379|NCT03627767|11339262|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10212380|NCT03627767|11339263|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10212381|NCT03627767|11339259|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233
10212382|NCT03627767|11339260|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10212383|NCT03627767|11339261|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10212384|NCT03627767|11339262|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10212385|NCT03627767|11339263|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10212386|NCT03627767|11339259|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798
9760746|NCT00383084|10864531|FG000|STARTED|Overall Study||46
9760747|NCT00383084|10864532|FG001|STARTED|Overall Study||38
9760748|NCT00383084|10864531|FG000|COMPLETED|Overall Study||34
9760749|NCT00383084|10864532|FG001|COMPLETED|Overall Study||28
9760750|NCT00383084|10864531|FG000|NOT COMPLETED|Overall Study||12
9760751|NCT00383084|10864532|FG001|NOT COMPLETED|Overall Study||10
9760752|NCT00383110|10864540|FG000|STARTED|Overall Study||150
10212387|NCT03627767|11339260|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212388|NCT03627767|11339261|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212389|NCT03627767|11339262|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212390|NCT03627767|11339263|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212391|NCT03627767|11339259|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437
10212392|NCT03627767|11339260|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212393|NCT03627767|11339261|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212394|NCT03627767|11339262|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212395|NCT03627767|11339263|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10212396|NCT03627767|11339259|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0
10212397|NCT03627767|11339260|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267
10212398|NCT03627767|11339261|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265
10212399|NCT03627767|11339262|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266
10212400|NCT03627767|11339263|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0
10212401|NCT03627767|11339259|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10212402|NCT03627767|11339260|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208
10212403|NCT03627767|11339261|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109
10212404|NCT03627767|11339262|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44
10212405|NCT03627767|11339263|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
9760753|NCT00383110|10864541|FG001|STARTED|Overall Study||150
10212406|NCT03627767|11339259|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10212407|NCT03627767|11339260|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201
10212408|NCT03627767|11339261|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99
10212409|NCT03627767|11339262|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41
10212410|NCT03627767|11339263|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10212411|NCT03627767|11339259|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10212412|NCT03627767|11339260|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43
10212413|NCT03627767|11339261|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134
10212414|NCT03627767|11339262|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187
10212415|NCT03627767|11339263|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10212416|NCT03627767|11339259|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10212417|NCT03627767|11339260|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251
10212418|NCT03627767|11339261|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243
10212419|NCT03627767|11339262|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231
10212420|NCT03627767|11339263|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10212421|NCT03627767|11339259|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10212422|NCT03627767|11339260|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16
10212423|NCT03627767|11339261|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22
10212424|NCT03627767|11339262|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35
10212425|NCT03627767|11339263|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10212426|NCT03627767|11339259|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0
10212427|NCT03627767|11339260|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
10212428|NCT03627767|11339261|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
10212429|NCT03627767|11339262|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
10212430|NCT03627767|11339263|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361
10212431|NCT03627767|11339259|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10212432|NCT03627767|11339260|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10212433|NCT03627767|11339261|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10212434|NCT03627767|11339262|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10212435|NCT03627767|11339263|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351
10212436|NCT03627767|11339259|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212437|NCT03627767|11339260|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212438|NCT03627767|11339261|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212439|NCT03627767|11339262|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212440|NCT03627767|11339263|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341
10212441|NCT03627767|11339259|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212442|NCT03627767|11339260|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212443|NCT03627767|11339261|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212444|NCT03627767|11339262|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10212445|NCT03627767|11339263|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20
10212446|NCT03627832|11339276|FG000|STARTED|Overall Study||28
10212447|NCT03627832|11339277|FG001|STARTED|Overall Study||28
10212448|NCT03627832|11339276|FG000|COMPLETED|Overall Study||18
10212449|NCT03627832|11339277|FG001|COMPLETED|Overall Study||27
10212450|NCT03627832|11339276|FG000|NOT COMPLETED|Overall Study||10
10212451|NCT03627832|11339277|FG001|NOT COMPLETED|Overall Study||1
10011999|NCT01783561|11134820|FG001|NOT COMPLETED|Overall Study||0
10012000|NCT01783574|11134828|FG000|STARTED|Overall Study||51
10012001|NCT01783574|11134829|FG001|STARTED|Overall Study||50
10012002|NCT01783574|11134828|FG000|COMPLETED|Overall Study||46
10012003|NCT01783574|11134829|FG001|COMPLETED|Overall Study||41
10012004|NCT01783574|11134828|FG000|NOT COMPLETED|Overall Study||5
10012005|NCT01783574|11134829|FG001|NOT COMPLETED|Overall Study||9
10012006|NCT01783639|11134835|FG000|STARTED|Overall Study||120
10012007|NCT01783639|11134835|FG000|COMPLETED|Overall Study||120
10012008|NCT01783639|11134835|FG000|NOT COMPLETED|Overall Study||0
10012009|NCT01783678|11134845|FG000|STARTED|Overall Study||19
10012010|NCT01783678|11134846|FG001|STARTED|Overall Study||112
10012011|NCT01783678|11134847|FG002|STARTED|Overall Study||6
10012012|NCT01783678|11134848|FG003|STARTED|Overall Study||58
10012013|NCT01783678|11134849|FG004|STARTED|Overall Study||49
10012014|NCT01783678|11134850|FG005|STARTED|Overall Study||31
10012015|NCT01783678|11134845|FG000|COMPLETED|Overall Study||17
10012016|NCT01783678|11134846|FG001|COMPLETED|Overall Study||94
10012017|NCT01783678|11134847|FG002|COMPLETED|Overall Study||5
10012018|NCT01783678|11134848|FG003|COMPLETED|Overall Study||50
10012019|NCT01783678|11134849|FG004|COMPLETED|Overall Study||42
10012020|NCT01783678|11134850|FG005|COMPLETED|Overall Study||26
10012021|NCT01783678|11134845|FG000|NOT COMPLETED|Overall Study||2
10012022|NCT01783678|11134846|FG001|NOT COMPLETED|Overall Study||18
10012023|NCT01783678|11134847|FG002|NOT COMPLETED|Overall Study||1
10012024|NCT01783678|11134848|FG003|NOT COMPLETED|Overall Study||8
10012025|NCT01783678|11134849|FG004|NOT COMPLETED|Overall Study||7
10212452|NCT03628417|11339283|FG000|STARTED|Overall Study||7
10212453|NCT03628417|11339284|FG001|STARTED|Overall Study||7
10212454|NCT03628417|11339283|FG000|Day 0|Overall Study||7
10212455|NCT03628417|11339284|FG001|Day 0|Overall Study||7
10212456|NCT03628417|11339283|FG000|Day 7|Overall Study||7
10212457|NCT03628417|11339284|FG001|Day 7|Overall Study||7
10212458|NCT03628417|11339283|FG000|Day 15|Overall Study||7
10212459|NCT03628417|11339284|FG001|Day 15|Overall Study||7
10212460|NCT03628417|11339283|FG000|Day 30|Overall Study||7
10212461|NCT03628417|11339284|FG001|Day 30|Overall Study||7
10212462|NCT03628417|11339283|FG000|Day 60|Overall Study||7
10212463|NCT03628417|11339284|FG001|Day 60|Overall Study||7
10212464|NCT03628417|11339283|FG000|Day 90|Overall Study||7
10212465|NCT03628417|11339284|FG001|Day 90|Overall Study||7
10212466|NCT03628417|11339283|FG000|Day 180|Overall Study||7
10212467|NCT03628417|11339284|FG001|Day 180|Overall Study||7
10212468|NCT03628417|11339283|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
10212469|NCT03628417|11339284|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
10212470|NCT03628417|11339283|FG000|NOT COMPLETED|Overall Study||1
10212471|NCT03628417|11339284|FG001|NOT COMPLETED|Overall Study||1
10212472|NCT03628456|11339294|FG000|STARTED|Overall Study||10
10212473|NCT03628456|11339294|FG000|COMPLETED|Overall Study||10
10212474|NCT03628456|11339294|FG000|NOT COMPLETED|Overall Study||0
10212475|NCT03628508|11339302|FG000|STARTED|Overall Study||40
10212476|NCT03628508|11339302|FG000|COMPLETED|Overall Study||39
10212477|NCT03628508|11339302|FG000|NOT COMPLETED|Overall Study||1
10212478|NCT03628599|11339308|FG000|STARTED|Overall Study||18
10212479|NCT03628599|11339309|FG001|STARTED|Overall Study||19
10212480|NCT03628599|11339308|FG000|COMPLETED|Overall Study||18
10212481|NCT03628599|11339309|FG001|COMPLETED|Overall Study||18
10212482|NCT03628599|11339308|FG000|NOT COMPLETED|Overall Study||0
10212483|NCT03628599|11339309|FG001|NOT COMPLETED|Overall Study||1
10212484|NCT03628885|11339322|FG000|STARTED|Overall Study||306
10212485|NCT03628885|11339323|FG001|STARTED|Overall Study||299
10212486|NCT03628885|11339324|FG002|STARTED|Overall Study||303
10212487|NCT03628885|11339322|FG000|COMPLETED|Overall Study||267
10212488|NCT03628885|11339323|FG001|COMPLETED|Overall Study||252
10212489|NCT03628885|11339324|FG002|COMPLETED|Overall Study||243
10212490|NCT03628885|11339322|FG000|NOT COMPLETED|Overall Study||39
10212491|NCT03628885|11339323|FG001|NOT COMPLETED|Overall Study||47
10212492|NCT03628885|11339324|FG002|NOT COMPLETED|Overall Study||60
10212493|NCT03628898|11339332|FG000|STARTED|Overall Study||27
10212494|NCT03628898|11339332|FG000|COMPLETED|Overall Study||26
10212495|NCT03628898|11339332|FG000|NOT COMPLETED|Overall Study||1
10212496|NCT03628924|11339339|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62
10212497|NCT03628924|11339340|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59
10212498|NCT03628924|11339341|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60
10212499|NCT03628924|11339342|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10212500|NCT03628924|11339343|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10212501|NCT03628924|11339344|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10212502|NCT03628924|11339345|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10212503|NCT03628924|11339339|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
10212504|NCT03628924|11339340|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
10212505|NCT03628924|11339341|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
10212506|NCT03628924|11339342|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212507|NCT03628924|11339343|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212508|NCT03628924|11339344|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212509|NCT03628924|11339345|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212510|NCT03628924|11339339|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
10212511|NCT03628924|11339340|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
10212512|NCT03628924|11339341|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
10212513|NCT03628924|11339342|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212514|NCT03628924|11339343|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212515|NCT03628924|11339344|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212516|NCT03628924|11339345|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10212517|NCT03628924|11339339|FG000|STARTED|Active Treatment Period (Week 16-48)||0
10212518|NCT03628924|11339340|FG001|STARTED|Active Treatment Period (Week 16-48)||0
10212519|NCT03628924|11339341|FG002|STARTED|Active Treatment Period (Week 16-48)||0
10212520|NCT03628924|11339342|FG003|STARTED|Active Treatment Period (Week 16-48)||28
10212521|NCT03628924|11339343|FG004|STARTED|Active Treatment Period (Week 16-48)||28
10212522|NCT03628924|11339344|FG005|STARTED|Active Treatment Period (Week 16-48)||56
10212523|NCT03628924|11339345|FG006|STARTED|Active Treatment Period (Week 16-48)||57
10212524|NCT03628924|11339339|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0
10212525|NCT03628924|11339340|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0
10212526|NCT03628924|11339341|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0
10212527|NCT03628924|11339342|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20
10212528|NCT03628924|11339343|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24
10212529|NCT03628924|11339344|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43
10212530|NCT03628924|11339345|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46
10212531|NCT03628924|11339339|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
10212532|NCT03628924|11339340|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
10212533|NCT03628924|11339341|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
10212534|NCT03628924|11339342|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
10212535|NCT03628924|11339343|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
10212536|NCT03628924|11339344|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
10212537|NCT03628924|11339345|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
10212538|NCT03629028|11339359|FG000|STARTED|Overall Study||141
10212539|NCT03629028|11339360|FG001|STARTED|Overall Study||141
10212540|NCT03629028|11339359|FG000|COMPLETED|Overall Study||109
10212541|NCT03629028|11339360|FG001|COMPLETED|Overall Study||116
10212542|NCT03629028|11339359|FG000|NOT COMPLETED|Overall Study||32
10212543|NCT03629028|11339360|FG001|NOT COMPLETED|Overall Study||25
10212544|NCT03629041|11339376|FG000|STARTED|Visit 1||4
10212545|NCT03629041|11339377|FG001|STARTED|Visit 1||4
10212546|NCT03629041|11339378|FG002|STARTED|Visit 1||4
10212547|NCT03629041|11339379|FG003|STARTED|Visit 1||4
10212548|NCT03629041|11339376|FG000|COMPLETED|Visit 1||4
10212549|NCT03629041|11339377|FG001|COMPLETED|Visit 1||4
10212550|NCT03629041|11339378|FG002|COMPLETED|Visit 1||4
10212551|NCT03629041|11339379|FG003|COMPLETED|Visit 1||4
10212552|NCT03629041|11339376|FG000|NOT COMPLETED|Visit 1||0
10212553|NCT03629041|11339377|FG001|NOT COMPLETED|Visit 1||0
10212554|NCT03629041|11339378|FG002|NOT COMPLETED|Visit 1||0
10212555|NCT03629041|11339379|FG003|NOT COMPLETED|Visit 1||0
10212556|NCT03629041|11339376|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10212557|NCT03629041|11339377|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10212558|NCT03629041|11339378|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10212559|NCT03629041|11339379|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10212560|NCT03629041|11339376|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10212561|NCT03629041|11339377|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
10212562|NCT03629041|11339378|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10212563|NCT03629041|11339379|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10212564|NCT03629041|11339376|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
10212565|NCT03629041|11339377|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
10212566|NCT03629041|11339378|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
10212567|NCT03629041|11339379|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
10212568|NCT03629054|11339399|FG000|STARTED|Period 1 (4 Days)|Started this period|15
10212569|NCT03629054|11339400|FG001|STARTED|Period 1 (4 Days)|Started this period|15
10212570|NCT03629054|11339399|FG000|COMPLETED|Period 1 (4 Days)||15
10212571|NCT03629054|11339400|FG001|COMPLETED|Period 1 (4 Days)||15
10212572|NCT03629054|11339399|FG000|NOT COMPLETED|Period 1 (4 Days)||0
10212573|NCT03629054|11339400|FG001|NOT COMPLETED|Period 1 (4 Days)||0
10212574|NCT03629054|11339399|FG000|STARTED|Wasout Period (35 Days)|Started this period|15
10212575|NCT03629054|11339400|FG001|STARTED|Wasout Period (35 Days)|Started this period|15
10212576|NCT03629054|11339399|FG000|COMPLETED|Wasout Period (35 Days)||15
10212577|NCT03629054|11339400|FG001|COMPLETED|Wasout Period (35 Days)||15
10212578|NCT03629054|11339399|FG000|NOT COMPLETED|Wasout Period (35 Days)||0
10212579|NCT03629054|11339400|FG001|NOT COMPLETED|Wasout Period (35 Days)||0
10212580|NCT03629054|11339399|FG000|STARTED|Period 2 (4 Days)|Started this period|15
10212581|NCT03629054|11339400|FG001|STARTED|Period 2 (4 Days)|Started this period|15
10212582|NCT03629054|11339399|FG000|Treated|Period 2 (4 Days)||15
10212583|NCT03629054|11339400|FG001|Treated|Period 2 (4 Days)||14
10212584|NCT03629054|11339399|FG000|COMPLETED|Period 2 (4 Days)||15
10212585|NCT03629054|11339400|FG001|COMPLETED|Period 2 (4 Days)||14
10212586|NCT03629054|11339399|FG000|NOT COMPLETED|Period 2 (4 Days)||0
10212587|NCT03629054|11339400|FG001|NOT COMPLETED|Period 2 (4 Days)||1
10212588|NCT03629184|11339408|FG000|STARTED|Overall Study||115
10212589|NCT03629184|11339409|FG001|STARTED|Overall Study||58
10212590|NCT03629184|11339408|FG000|COMPLETED|Overall Study||112
10212591|NCT03629184|11339409|FG001|COMPLETED|Overall Study||57
10212592|NCT03629184|11339408|FG000|NOT COMPLETED|Overall Study||3
10212593|NCT03629184|11339409|FG001|NOT COMPLETED|Overall Study||1
10212594|NCT03629249|11339418|FG000|STARTED|Overall Study||201
10212595|NCT03629249|11339419|FG001|STARTED|Overall Study||201
10212596|NCT03629249|11339420|FG002|STARTED|Overall Study||202
10212597|NCT03629249|11339418|FG000|Full Analysis Set (FAS)|Overall Study||201
10212598|NCT03629249|11339419|FG001|Full Analysis Set (FAS)|Overall Study||200
10212599|NCT03629249|11339420|FG002|Full Analysis Set (FAS)|Overall Study||201
10212600|NCT03629249|11339418|FG000|Safety Set (SAF)|Overall Study||201
10212601|NCT03629249|11339419|FG001|Safety Set (SAF)|Overall Study||200
10212602|NCT03629249|11339420|FG002|Safety Set (SAF)|Overall Study||201
10212603|NCT03629249|11339418|FG000|COMPLETED|Overall Study||0
10212604|NCT03629249|11339419|FG001|COMPLETED|Overall Study||0
10212605|NCT03629249|11339420|FG002|COMPLETED|Overall Study||0
10212606|NCT03629249|11339418|FG000|NOT COMPLETED|Overall Study||201
10212607|NCT03629249|11339419|FG001|NOT COMPLETED|Overall Study||201
10212608|NCT03629249|11339420|FG002|NOT COMPLETED|Overall Study||202
10212609|NCT03629535|11339428|FG000|STARTED|Overall Study||8
10212610|NCT03629535|11339428|FG000|COMPLETED|Overall Study||8
10212611|NCT03629535|11339428|FG000|NOT COMPLETED|Overall Study||0
10212612|NCT03629886|11339434|FG000|STARTED|Overall Study||1671
10212613|NCT03629886|11339435|FG001|STARTED|Overall Study||1866
10212614|NCT03629886|11339434|FG000|COMPLETED|Overall Study||1671
10212615|NCT03629886|11339435|FG001|COMPLETED|Overall Study||1686
10212616|NCT03629886|11339434|FG000|NOT COMPLETED|Overall Study||0
10212617|NCT03629886|11339435|FG001|NOT COMPLETED|Overall Study||180
10238897|NCT00443040|11370351|FG000|COMPLETED|Overall Study||10
10212618|NCT03629925|11339444|FG000|STARTED|Overall Study||179
10212619|NCT03629925|11339445|FG001|STARTED|Overall Study||178
10212620|NCT03629925|11339444|FG000|COMPLETED|Overall Study||0
10212621|NCT03629925|11339445|FG001|COMPLETED|Overall Study||0
10212622|NCT03629925|11339444|FG000|NOT COMPLETED|Overall Study||179
10212623|NCT03629925|11339445|FG001|NOT COMPLETED|Overall Study||178
10212624|NCT03630016|11339451|FG000|STARTED|Overall Study||11
10212625|NCT03630016|11339451|FG000|COMPLETED|Overall Study||10
10212626|NCT03630016|11339451|FG000|NOT COMPLETED|Overall Study||1
10212627|NCT03630185|11339457|FG000|STARTED|Overall Study||4
10212628|NCT03630185|11339458|FG001|STARTED|Overall Study||4
10212629|NCT03630185|11339457|FG000|30 Day Follow up|Overall Study||1
10212630|NCT03630185|11339458|FG001|30 Day Follow up|Overall Study||1
10212631|NCT03630185|11339457|FG000|90 Day Follow up|Overall Study||0
10212632|NCT03630185|11339458|FG001|90 Day Follow up|Overall Study||1
10212633|NCT03630185|11339457|FG000|6 Month Follow up|Overall Study||0
10212634|NCT03630185|11339458|FG001|6 Month Follow up|Overall Study||0
10212635|NCT03630185|11339457|FG000|COMPLETED|Overall Study||0
10212636|NCT03630185|11339458|FG001|COMPLETED|Overall Study||0
10212637|NCT03630185|11339457|FG000|NOT COMPLETED|Overall Study||4
10212638|NCT03630185|11339458|FG001|NOT COMPLETED|Overall Study||4
10212639|NCT03630198|11339466|FG000|STARTED|Overall Study||13
10212640|NCT03630198|11339467|FG001|STARTED|Overall Study||18
10212641|NCT03630198|11339466|FG000|COMPLETED|Overall Study||13
10212642|NCT03630198|11339467|FG001|COMPLETED|Overall Study||18
10212643|NCT03630198|11339466|FG000|NOT COMPLETED|Overall Study||0
10212644|NCT03630198|11339467|FG001|NOT COMPLETED|Overall Study||0
10212645|NCT03630302|11339473|FG000|STARTED|Surgery||10
10212646|NCT03630302|11339473|FG000|COMPLETED|Surgery||9
10212647|NCT03630302|11339473|FG000|NOT COMPLETED|Surgery||1
10212648|NCT03630302|11339473|FG000|STARTED|3 Month Visit||9
10212649|NCT03630302|11339473|FG000|COMPLETED|3 Month Visit||7
10212650|NCT03630302|11339473|FG000|NOT COMPLETED|3 Month Visit||2
10212651|NCT03630302|11339473|FG000|STARTED|Data Post Analyses||7
10212652|NCT03630302|11339473|FG000|COMPLETED|Data Post Analyses||5
10212653|NCT03630302|11339473|FG000|NOT COMPLETED|Data Post Analyses||2
10212654|NCT03630679|11339479|FG000|STARTED|Overall Study||20
10212655|NCT03630679|11339480|FG001|STARTED|Overall Study||25
10212656|NCT03630679|11339479|FG000|COMPLETED|Overall Study||13
10212657|NCT03630679|11339480|FG001|COMPLETED|Overall Study||13
10212658|NCT03630679|11339479|FG000|NOT COMPLETED|Overall Study||7
10212659|NCT03630679|11339480|FG001|NOT COMPLETED|Overall Study||12
10212660|NCT03631355|11339488|FG000|STARTED|Overall Study||55
10212661|NCT03631355|11339489|FG001|STARTED|Overall Study||55
10212662|NCT03631355|11339488|FG000|COMPLETED|Overall Study||54
10212663|NCT03631355|11339489|FG001|COMPLETED|Overall Study||53
10212664|NCT03631355|11339488|FG000|NOT COMPLETED|Overall Study||1
10212665|NCT03631355|11339489|FG001|NOT COMPLETED|Overall Study||2
10212666|NCT03631433|11339497|FG000|STARTED|Overall Study||49
10212667|NCT03631433|11339498|FG001|STARTED|Overall Study||53
10212668|NCT03631433|11339497|FG000|COMPLETED|Overall Study||49
10212669|NCT03631433|11339498|FG001|COMPLETED|Overall Study||53
10212670|NCT03631433|11339497|FG000|NOT COMPLETED|Overall Study||0
10212671|NCT03631433|11339498|FG001|NOT COMPLETED|Overall Study||0
10212672|NCT03631732|11339506|FG000|STARTED|Randomized Phase Up to Week 24||331
10212673|NCT03631732|11339507|FG001|STARTED|Randomized Phase Up to Week 24||165
10212674|NCT03631732|11339506|FG000|COMPLETED|Randomized Phase Up to Week 24||324
10212675|NCT03631732|11339507|FG001|COMPLETED|Randomized Phase Up to Week 24||163
10212676|NCT03631732|11339506|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7
10212677|NCT03631732|11339507|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2
10212678|NCT03631732|11339506|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319
10212679|NCT03631732|11339507|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163
10212680|NCT03631732|11339506|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303
10212681|NCT03631732|11339507|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158
10212682|NCT03631732|11339506|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16
10212683|NCT03631732|11339507|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5
10212684|NCT03631927|11339517|FG000|STARTED|Overall Study||5094
9952083|NCT01419665|11070986|FG001|COMPLETED|Combination Treatment||274
9952084|NCT01419665|11070985|FG000|NOT COMPLETED|Combination Treatment||38
10212685|NCT03631927|11339517|FG000|COMPLETED|Overall Study||4669
10212686|NCT03631927|11339517|FG000|NOT COMPLETED|Overall Study||425
10212687|NCT03632083|11339521|FG000|STARTED|First Intervention||5
10212688|NCT03632083|11339522|FG001|STARTED|First Intervention||5
10212689|NCT03632083|11339523|FG002|STARTED|First Intervention||7
10212690|NCT03632083|11339524|FG003|STARTED|First Intervention||7
10212691|NCT03632083|11339525|FG004|STARTED|First Intervention||9
10212692|NCT03632083|11339526|FG005|STARTED|First Intervention||9
10212693|NCT03632083|11339527|FG006|STARTED|First Intervention||7
10212694|NCT03632083|11339528|FG007|STARTED|First Intervention||7
10212695|NCT03632083|11339521|FG000|COMPLETED|First Intervention||5
10212696|NCT03632083|11339522|FG001|COMPLETED|First Intervention||5
10212697|NCT03632083|11339523|FG002|COMPLETED|First Intervention||7
10212698|NCT03632083|11339524|FG003|COMPLETED|First Intervention||7
10212699|NCT03632083|11339525|FG004|COMPLETED|First Intervention||9
10212700|NCT03632083|11339526|FG005|COMPLETED|First Intervention||9
10212701|NCT03632083|11339527|FG006|COMPLETED|First Intervention||7
10212702|NCT03632083|11339528|FG007|COMPLETED|First Intervention||7
10212703|NCT03632083|11339521|FG000|NOT COMPLETED|First Intervention||0
10212704|NCT03632083|11339522|FG001|NOT COMPLETED|First Intervention||0
10212705|NCT03632083|11339523|FG002|NOT COMPLETED|First Intervention||0
10212706|NCT03632083|11339524|FG003|NOT COMPLETED|First Intervention||0
10212707|NCT03632083|11339525|FG004|NOT COMPLETED|First Intervention||0
10212708|NCT03632083|11339526|FG005|NOT COMPLETED|First Intervention||0
10212709|NCT03632083|11339527|FG006|NOT COMPLETED|First Intervention||0
10212710|NCT03632083|11339528|FG007|NOT COMPLETED|First Intervention||0
10212711|NCT03632083|11339521|FG000|STARTED|Second Intervention||5
10212712|NCT03632083|11339522|FG001|STARTED|Second Intervention||5
10212713|NCT03632083|11339523|FG002|STARTED|Second Intervention||7
10212714|NCT03632083|11339524|FG003|STARTED|Second Intervention||7
10212715|NCT03632083|11339525|FG004|STARTED|Second Intervention||9
10212716|NCT03632083|11339526|FG005|STARTED|Second Intervention||9
10212717|NCT03632083|11339527|FG006|STARTED|Second Intervention||7
10012026|NCT01783678|11134850|FG005|NOT COMPLETED|Overall Study||5
10012027|NCT01783730|11134865|FG000|STARTED|Overall Study||163
10012028|NCT01783730|11134865|FG000|COMPLETED|Overall Study||157
10012029|NCT01783730|11134865|FG000|NOT COMPLETED|Overall Study||6
10012030|NCT01783743|11134871|FG000|STARTED|Screening of Subjects by CTA During MDA||13509
10012031|NCT01783743|11134872|FG001|STARTED|Screening of Subjects by CTA During MDA||13964
10212718|NCT03632083|11339528|FG007|STARTED|Second Intervention||7
10212719|NCT03632083|11339521|FG000|COMPLETED|Second Intervention||5
10212720|NCT03632083|11339522|FG001|COMPLETED|Second Intervention||5
10212721|NCT03632083|11339523|FG002|COMPLETED|Second Intervention||7
10212722|NCT03632083|11339524|FG003|COMPLETED|Second Intervention||7
10212723|NCT03632083|11339525|FG004|COMPLETED|Second Intervention||9
10212724|NCT03632083|11339526|FG005|COMPLETED|Second Intervention||9
10212725|NCT03632083|11339527|FG006|COMPLETED|Second Intervention||7
10212726|NCT03632083|11339528|FG007|COMPLETED|Second Intervention||5
10212727|NCT03632083|11339521|FG000|NOT COMPLETED|Second Intervention||0
10212728|NCT03632083|11339522|FG001|NOT COMPLETED|Second Intervention||0
10212729|NCT03632083|11339523|FG002|NOT COMPLETED|Second Intervention||0
10212730|NCT03632083|11339524|FG003|NOT COMPLETED|Second Intervention||0
10212731|NCT03632083|11339525|FG004|NOT COMPLETED|Second Intervention||0
10212732|NCT03632083|11339526|FG005|NOT COMPLETED|Second Intervention||0
10212733|NCT03632083|11339527|FG006|NOT COMPLETED|Second Intervention||0
10212734|NCT03632083|11339528|FG007|NOT COMPLETED|Second Intervention||2
10212735|NCT03632109|11339540|FG000|STARTED|Overall Study||13
10012032|NCT01783743|11134871|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082
10012033|NCT01783743|11134872|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525
10012034|NCT01783743|11134871|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
10012035|NCT01783743|11134872|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
9760754|NCT00383110|10864540|FG000|COMPLETED|Overall Study||150
9760755|NCT00383110|10864541|FG001|COMPLETED|Overall Study||150
9760756|NCT00383110|10864540|FG000|NOT COMPLETED|Overall Study||0
9760757|NCT00383110|10864541|FG001|NOT COMPLETED|Overall Study||0
9760758|NCT00383123|10864550|FG000|STARTED|Overall Study||2115
9760759|NCT00383123|10864551|FG001|STARTED|Overall Study||1210
9760760|NCT00383123|10864550|FG000|COMPLETED|Overall Study||2004
9760761|NCT00383123|10864551|FG001|COMPLETED|Overall Study||1124
9760762|NCT00383123|10864550|FG000|NOT COMPLETED|Overall Study||111
9760763|NCT00383123|10864551|FG001|NOT COMPLETED|Overall Study||86
9760764|NCT00383149|10864557|FG000|STARTED|Overall Study||54
9760765|NCT00383149|10864557|FG000|COMPLETED|Overall Study||0
9760766|NCT00383149|10864557|FG000|NOT COMPLETED|Overall Study||54
10212736|NCT03632109|11339540|FG000|COMPLETED|Overall Study||13
10212737|NCT03632109|11339540|FG000|NOT COMPLETED|Overall Study||0
10212738|NCT03632954|11339546|FG000|STARTED|Overall Study||37
10212739|NCT03632954|11339546|FG000|COMPLETED|Overall Study||3
10212740|NCT03632954|11339546|FG000|NOT COMPLETED|Overall Study||34
10212741|NCT03633084|11339553|FG000|STARTED|Overall Study||3
10212742|NCT03633084|11339554|FG001|STARTED|Overall Study||3
10212743|NCT03633084|11339555|FG002|STARTED|Overall Study||3
10212744|NCT03633084|11339553|FG000|COMPLETED|Overall Study||3
10212745|NCT03633084|11339554|FG001|COMPLETED|Overall Study||3
10212746|NCT03633084|11339555|FG002|COMPLETED|Overall Study||3
10212747|NCT03633084|11339553|FG000|NOT COMPLETED|Overall Study||0
10212748|NCT03633084|11339554|FG001|NOT COMPLETED|Overall Study||0
10212749|NCT03633084|11339555|FG002|NOT COMPLETED|Overall Study||0
10212750|NCT03633331|11339564|FG000|STARTED|Overall Study||93
10212751|NCT03633331|11339564|FG000|COMPLETED|Overall Study||92
10212752|NCT03633331|11339564|FG000|NOT COMPLETED|Overall Study||1
10212753|NCT03633344|11339570|FG000|STARTED|Overall Study||120
10212754|NCT03633344|11339571|FG001|STARTED|Overall Study||24
10212755|NCT03633344|11339570|FG000|COMPLETED|Overall Study||120
10212756|NCT03633344|11339571|FG001|COMPLETED|Overall Study||24
10212757|NCT03633344|11339570|FG000|NOT COMPLETED|Overall Study||0
10212758|NCT03633344|11339571|FG001|NOT COMPLETED|Overall Study||0
10212759|NCT03633448|11339581|FG000|STARTED|Period 1 (1 Day)||12
10212760|NCT03633448|11339582|FG001|STARTED|Period 1 (1 Day)||12
10212761|NCT03633448|11339581|FG000|COMPLETED|Period 1 (1 Day)||12
10212762|NCT03633448|11339582|FG001|COMPLETED|Period 1 (1 Day)||12
10212763|NCT03633448|11339581|FG000|NOT COMPLETED|Period 1 (1 Day)||0
10212764|NCT03633448|11339582|FG001|NOT COMPLETED|Period 1 (1 Day)||0
10212765|NCT03633448|11339581|FG000|STARTED|Washout (7 Days)||12
10212766|NCT03633448|11339582|FG001|STARTED|Washout (7 Days)||12
10212767|NCT03633448|11339581|FG000|COMPLETED|Washout (7 Days)||12
10212768|NCT03633448|11339582|FG001|COMPLETED|Washout (7 Days)||12
10212769|NCT03633448|11339581|FG000|NOT COMPLETED|Washout (7 Days)||0
10212770|NCT03633448|11339582|FG001|NOT COMPLETED|Washout (7 Days)||0
10212771|NCT03633448|11339581|FG000|STARTED|Period 2 (1 Day)||12
10212772|NCT03633448|11339582|FG001|STARTED|Period 2 (1 Day)||12
10212773|NCT03633448|11339581|FG000|COMPLETED|Period 2 (1 Day)||12
10212774|NCT03633448|11339582|FG001|COMPLETED|Period 2 (1 Day)||12
10212775|NCT03633448|11339581|FG000|NOT COMPLETED|Period 2 (1 Day)||0
10212776|NCT03633448|11339582|FG001|NOT COMPLETED|Period 2 (1 Day)||0
10212777|NCT03633487|11339592|FG000|STARTED|Overall Study||24
10212778|NCT03633487|11339592|FG000|COMPLETED|Overall Study||24
10212779|NCT03633487|11339592|FG000|NOT COMPLETED|Overall Study||0
10212780|NCT03633526|11339596|FG000|STARTED|Overall Study||16
10212781|NCT03633526|11339596|FG000|COMPLETED|Overall Study||16
10212782|NCT03633526|11339596|FG000|NOT COMPLETED|Overall Study||0
10212783|NCT03633825|11339602|FG000|STARTED|Enrollment||19838
10212784|NCT03633825|11339603|FG001|STARTED|Enrollment||19612
10212785|NCT03633825|11339602|FG000|COMPLETED|Enrollment||805
10212786|NCT03633825|11339603|FG001|COMPLETED|Enrollment||775
10212787|NCT03633825|11339602|FG000|NOT COMPLETED|Enrollment||19033
10212788|NCT03633825|11339603|FG001|NOT COMPLETED|Enrollment||18837
10212789|NCT03633825|11339602|FG000|STARTED|Allocation||805
10212790|NCT03633825|11339603|FG001|STARTED|Allocation||775
10212791|NCT03633825|11339602|FG000|COMPLETED|Allocation||805
10212792|NCT03633825|11339603|FG001|COMPLETED|Allocation||775
10212793|NCT03633825|11339602|FG000|NOT COMPLETED|Allocation||0
10212794|NCT03633825|11339603|FG001|NOT COMPLETED|Allocation||0
10212795|NCT03633825|11339602|FG000|STARTED|Follow up||805
10212796|NCT03633825|11339603|FG001|STARTED|Follow up||775
10212797|NCT03633825|11339602|FG000|COMPLETED|Follow up||327
10212798|NCT03633825|11339603|FG001|COMPLETED|Follow up||325
10212799|NCT03633825|11339602|FG000|NOT COMPLETED|Follow up||478
10212800|NCT03633825|11339603|FG001|NOT COMPLETED|Follow up||450
10212801|NCT03633825|11339602|FG000|STARTED|Analysis||327
10212802|NCT03633825|11339603|FG001|STARTED|Analysis||325
10212803|NCT03633825|11339602|FG000|COMPLETED|Analysis||327
10212804|NCT03633825|11339603|FG001|COMPLETED|Analysis||325
10212805|NCT03633825|11339602|FG000|NOT COMPLETED|Analysis||0
10212806|NCT03633825|11339603|FG001|NOT COMPLETED|Analysis||0
9760767|NCT00383162|10864563|FG000|STARTED|Migraine Attack 1 (Period 1)||87
9760768|NCT00383162|10864564|FG001|STARTED|Migraine Attack 1 (Period 1)||86
10212807|NCT03633903|11339611|FG000|STARTED|Overall Study||22
10212808|NCT03633903|11339612|FG001|STARTED|Overall Study||18
10212809|NCT03633903|11339611|FG000|Intent to Treat|Overall Study||0
10212810|NCT03633903|11339612|FG001|Intent to Treat|Overall Study||18
10212811|NCT03633903|11339611|FG000|COMPLETED|Overall Study||16
10212812|NCT03633903|11339612|FG001|COMPLETED|Overall Study||11
10212813|NCT03633903|11339611|FG000|NOT COMPLETED|Overall Study||6
10212814|NCT03633903|11339612|FG001|NOT COMPLETED|Overall Study||7
10212815|NCT03633929|11339618|FG000|STARTED|Overall Study||19
10212816|NCT03633929|11339618|FG000|COMPLETED|Overall Study||15
10212817|NCT03633929|11339618|FG000|NOT COMPLETED|Overall Study||4
10212818|NCT03634085|11339624|FG000|STARTED|Overall Study||8
10212819|NCT03634085|11339625|FG001|STARTED|Overall Study||8
10212820|NCT03634085|11339624|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
10212821|NCT03634085|11339625|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
10212822|NCT03634085|11339624|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
10212823|NCT03634085|11339625|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
10212824|NCT03634085|11339624|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
10212825|NCT03634085|11339625|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
10212826|NCT03634085|11339624|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
10212827|NCT03634085|11339625|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0
10212828|NCT03634085|11339624|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
10212829|NCT03634085|11339625|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
10212830|NCT03634085|11339624|FG000|NOT COMPLETED|Overall Study||1
10212831|NCT03634085|11339625|FG001|NOT COMPLETED|Overall Study||2
10212832|NCT03634306|11339641|FG000|STARTED|Overall Study||15
10212833|NCT03634306|11339642|FG001|STARTED|Overall Study||15
10212834|NCT03634306|11339643|FG002|STARTED|Overall Study||5
10212835|NCT03634306|11339641|FG000|COMPLETED|Overall Study||15
10212836|NCT03634306|11339642|FG001|COMPLETED|Overall Study||15
10212837|NCT03634306|11339643|FG002|COMPLETED|Overall Study||5
10212838|NCT03634306|11339641|FG000|NOT COMPLETED|Overall Study||0
10212839|NCT03634306|11339642|FG001|NOT COMPLETED|Overall Study||0
10212840|NCT03634306|11339643|FG002|NOT COMPLETED|Overall Study||0
10212841|NCT03634579|11339651|FG000|STARTED|Overall Study||9
10212842|NCT03634579|11339651|FG000|COMPLETED|Overall Study||0
10212843|NCT03634579|11339651|FG000|NOT COMPLETED|Overall Study||9
10212844|NCT03634800|11339655|FG000|STARTED|Overall Study||6
10212845|NCT03634800|11339655|FG000|COMPLETED|Overall Study||0
10212846|NCT03634800|11339655|FG000|NOT COMPLETED|Overall Study||6
10212847|NCT03634813|11339661|FG000|STARTED|Overall Study||49
10212848|NCT03634813|11339662|FG001|STARTED|Overall Study||51
10212849|NCT03634813|11339661|FG000|COMPLETED|Overall Study||49
10212850|NCT03634813|11339662|FG001|COMPLETED|Overall Study||51
10212851|NCT03634813|11339661|FG000|NOT COMPLETED|Overall Study||0
10212852|NCT03634813|11339662|FG001|NOT COMPLETED|Overall Study||0
10212853|NCT03635086|11339674|FG000|STARTED|Overall Study||12
10212854|NCT03635086|11339675|FG001|STARTED|Overall Study||12
10212855|NCT03635086|11339676|FG002|STARTED|Overall Study||12
10212856|NCT03635086|11339677|FG003|STARTED|Overall Study||12
10212857|NCT03635086|11339678|FG004|STARTED|Overall Study||12
10212858|NCT03635086|11339674|FG000|COMPLETED|Overall Study||11
10212859|NCT03635086|11339675|FG001|COMPLETED|Overall Study||11
10212860|NCT03635086|11339676|FG002|COMPLETED|Overall Study||11
10212861|NCT03635086|11339677|FG003|COMPLETED|Overall Study||12
10212862|NCT03635086|11339678|FG004|COMPLETED|Overall Study||12
10212863|NCT03635086|11339674|FG000|NOT COMPLETED|Overall Study||1
10212864|NCT03635086|11339675|FG001|NOT COMPLETED|Overall Study||1
10212865|NCT03635086|11339676|FG002|NOT COMPLETED|Overall Study||1
10212866|NCT03635086|11339677|FG003|NOT COMPLETED|Overall Study||0
10012036|NCT01783743|11134871|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509
10012037|NCT01783743|11134872|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964
10212867|NCT03635086|11339678|FG004|NOT COMPLETED|Overall Study||0
10212868|NCT03635320|11339693|FG000|STARTED|Overall Study||94
10212869|NCT03635320|11339694|FG001|STARTED|Overall Study||94
10212870|NCT03635320|11339693|FG000|FAS|Overall Study|1 subject was not implanted the device|93
10212871|NCT03635320|11339694|FG001|FAS|Overall Study|2 subjects were not implant the device|92
10212872|NCT03635320|11339693|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
10212873|NCT03635320|11339694|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
10212874|NCT03635320|11339693|FG000|COMPLETED|Overall Study||82
10212875|NCT03635320|11339694|FG001|COMPLETED|Overall Study||86
10212876|NCT03635320|11339693|FG000|NOT COMPLETED|Overall Study||12
10212877|NCT03635320|11339694|FG001|NOT COMPLETED|Overall Study||8
10212878|NCT03635775|11339704|FG000|STARTED|Overall Study||5
10212879|NCT03635775|11339705|FG001|STARTED|Overall Study||0
10212880|NCT03635775|11339706|FG002|STARTED|Overall Study||5
10212881|NCT03635775|11339707|FG003|STARTED|Overall Study||10
10212882|NCT03635775|11339704|FG000|COMPLETED|Overall Study||5
10212883|NCT03635775|11339705|FG001|COMPLETED|Overall Study||0
10212884|NCT03635775|11339706|FG002|COMPLETED|Overall Study||5
10212885|NCT03635775|11339707|FG003|COMPLETED|Overall Study||9
10212886|NCT03635775|11339704|FG000|NOT COMPLETED|Overall Study||0
10212887|NCT03635775|11339705|FG001|NOT COMPLETED|Overall Study||0
10212888|NCT03635775|11339706|FG002|NOT COMPLETED|Overall Study||0
10212889|NCT03635775|11339707|FG003|NOT COMPLETED|Overall Study||1
10212890|NCT03635957|11339717|FG000|STARTED|Run-In Period||15
10212891|NCT03635957|11339717|FG000|COMPLETED|Run-In Period||14
10212892|NCT03635957|11339717|FG000|NOT COMPLETED|Run-In Period||1
10212893|NCT03635957|11339717|FG000|STARTED|Pegloticase + IMM Period||14
10212894|NCT03635957|11339717|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
10212895|NCT03635957|11339717|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
10212896|NCT03635957|11339717|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
10212897|NCT03635957|11339717|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7
10212898|NCT03635957|11339717|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6
10212899|NCT03635957|11339717|FG000|COMPLETED|Pegloticase + IMM Period||11
10212900|NCT03635957|11339717|FG000|NOT COMPLETED|Pegloticase + IMM Period||3
10212901|NCT03636061|11339726|FG000|STARTED|Overall Study||47
10212902|NCT03636061|11339727|FG001|STARTED|Overall Study||48
10212903|NCT03636061|11339728|FG002|STARTED|Overall Study||44
10212904|NCT03636061|11339729|FG003|STARTED|Overall Study||43
10212905|NCT03636061|11339726|FG000|COMPLETED|Overall Study||47
10212906|NCT03636061|11339727|FG001|COMPLETED|Overall Study||46
10212907|NCT03636061|11339728|FG002|COMPLETED|Overall Study||40
10212908|NCT03636061|11339729|FG003|COMPLETED|Overall Study||43
10212909|NCT03636061|11339726|FG000|NOT COMPLETED|Overall Study||0
10212910|NCT03636061|11339727|FG001|NOT COMPLETED|Overall Study||2
10212911|NCT03636061|11339728|FG002|NOT COMPLETED|Overall Study||4
10212912|NCT03636061|11339729|FG003|NOT COMPLETED|Overall Study||0
10212913|NCT03636386|11339744|FG000|STARTED|Overall Study||24
10212914|NCT03636386|11339745|FG001|STARTED|Overall Study||24
10212915|NCT03636386|11339744|FG000|COMPLETED|Overall Study||24
10212916|NCT03636386|11339745|FG001|COMPLETED|Overall Study||24
10212917|NCT03636386|11339744|FG000|NOT COMPLETED|Overall Study||0
10212918|NCT03636386|11339745|FG001|NOT COMPLETED|Overall Study||0
10212919|NCT03636893|11339753|FG000|STARTED|Overall Study||40
10212920|NCT03636893|11339754|FG001|STARTED|Overall Study||34
10212921|NCT03636893|11339753|FG000|COMPLETED|Overall Study||31
10212922|NCT03636893|11339754|FG001|COMPLETED|Overall Study||24
10212923|NCT03636893|11339753|FG000|NOT COMPLETED|Overall Study||9
10212924|NCT03636893|11339754|FG001|NOT COMPLETED|Overall Study||10
10212925|NCT03637296|11339762|FG000|STARTED|Overall Study||10
10212926|NCT03637296|11339763|FG001|STARTED|Overall Study||5
10212927|NCT03637296|11339762|FG000|COMPLETED|Overall Study||10
10212928|NCT03637296|11339763|FG001|COMPLETED|Overall Study||5
10212929|NCT03637296|11339762|FG000|NOT COMPLETED|Overall Study||0
10212930|NCT03637296|11339763|FG001|NOT COMPLETED|Overall Study||0
10212931|NCT03637348|11339769|FG000|STARTED|Overall Study||45
10212932|NCT03637348|11339769|FG000|COMPLETED|Overall Study||45
10212933|NCT03637348|11339769|FG000|NOT COMPLETED|Overall Study||0
10212934|NCT03637517|11339777|FG000|STARTED|Overall Study||14
10212935|NCT03637517|11339778|FG001|STARTED|Overall Study||14
10212936|NCT03637517|11339779|FG002|STARTED|Overall Study||14
10212937|NCT03637517|11339777|FG000|COMPLETED|Overall Study||14
10212938|NCT03637517|11339778|FG001|COMPLETED|Overall Study||14
10212939|NCT03637517|11339779|FG002|COMPLETED|Overall Study||14
10212940|NCT03637517|11339777|FG000|NOT COMPLETED|Overall Study||0
10212941|NCT03637517|11339778|FG001|NOT COMPLETED|Overall Study||0
10212942|NCT03637517|11339779|FG002|NOT COMPLETED|Overall Study||0
10212943|NCT03637699|11339789|FG000|STARTED|Overall Study||15
10212944|NCT03637699|11339790|FG001|STARTED|Overall Study||15
10212945|NCT03637699|11339789|FG000|COMPLETED|Overall Study||14
10212946|NCT03637699|11339790|FG001|COMPLETED|Overall Study||14
10212947|NCT03637699|11339789|FG000|NOT COMPLETED|Overall Study||1
10212948|NCT03637699|11339790|FG001|NOT COMPLETED|Overall Study||1
10212949|NCT03637842|11339799|FG000|STARTED|Overall Study||2
10212950|NCT03637842|11339800|FG001|STARTED|Overall Study||2
10212951|NCT03637842|11339799|FG000|COMPLETED|Overall Study||2
10212952|NCT03637842|11339800|FG001|COMPLETED|Overall Study||2
10212953|NCT03637842|11339799|FG000|NOT COMPLETED|Overall Study||0
10212954|NCT03637842|11339800|FG001|NOT COMPLETED|Overall Study||0
10212955|NCT03638323|11339808|FG000|STARTED|Overall Study||38
10212956|NCT03638323|11339808|FG000|COMPLETED|Overall Study||37
10212957|NCT03638323|11339808|FG000|NOT COMPLETED|Overall Study||1
10212958|NCT03638622|11339815|FG000|STARTED|Overall Study||30
10212959|NCT03638622|11339815|FG000|COMPLETED|Overall Study||29
10212960|NCT03638622|11339815|FG000|NOT COMPLETED|Overall Study||1
10212961|NCT03638635|11339821|FG000|STARTED|Initial Hospitalization||39
10212962|NCT03638635|11339822|FG001|STARTED|Initial Hospitalization||24
10212963|NCT03638635|11339821|FG000|COMPLETED|Initial Hospitalization||39
10212964|NCT03638635|11339822|FG001|COMPLETED|Initial Hospitalization||22
10212965|NCT03638635|11339821|FG000|NOT COMPLETED|Initial Hospitalization||0
10212966|NCT03638635|11339822|FG001|NOT COMPLETED|Initial Hospitalization||2
10212967|NCT03638635|11339821|FG000|STARTED|Follow-Up (30 Days After Discharge)||39
10212968|NCT03638635|11339822|FG001|STARTED|Follow-Up (30 Days After Discharge)||22
10212969|NCT03638635|11339821|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0
10212970|NCT03638635|11339822|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0
10212971|NCT03638635|11339821|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
10212972|NCT03638635|11339822|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
10212973|NCT03638908|11339828|FG000|STARTED|Overall Study||8
10212974|NCT03638908|11339828|FG000|COMPLETED|Overall Study||7
10212975|NCT03638908|11339828|FG000|NOT COMPLETED|Overall Study||1
10212976|NCT03639675|11339836|FG000|STARTED|Overall Study||16
10212977|NCT03639675|11339836|FG000|Received Treatment|Overall Study||16
10212978|NCT03639675|11339836|FG000|COMPLETED|Overall Study||15
10212979|NCT03639675|11339836|FG000|NOT COMPLETED|Overall Study||1
10212980|NCT03639766|11339840|FG000|STARTED|Overall Study||3
10212981|NCT03639766|11339840|FG000|COMPLETED|Overall Study||3
10212982|NCT03639766|11339840|FG000|NOT COMPLETED|Overall Study||0
10212983|NCT03639779|11339846|FG000|STARTED|Overall Study||5
10212984|NCT03639779|11339846|FG000|Baseline|Overall Study||5
10212985|NCT03639779|11339846|FG000|Month 1|Overall Study||5
10212986|NCT03639779|11339846|FG000|Month 2|Overall Study||4
10212987|NCT03639779|11339846|FG000|Month 3|Overall Study||4
10212988|NCT03639779|11339846|FG000|COMPLETED|Overall Study||4
10212989|NCT03639779|11339846|FG000|NOT COMPLETED|Overall Study||1
10212990|NCT03639857|11339852|FG000|STARTED|Overall Study||1
10212991|NCT03639857|11339853|FG001|STARTED|Overall Study||3
10212992|NCT03639857|11339854|FG002|STARTED|Overall Study||3
10212993|NCT03639857|11339852|FG000|COMPLETED|Overall Study||1
10212994|NCT03639857|11339853|FG001|COMPLETED|Overall Study||3
10212995|NCT03639857|11339854|FG002|COMPLETED|Overall Study||3
10212996|NCT03639857|11339852|FG000|NOT COMPLETED|Overall Study||0
10212997|NCT03639857|11339853|FG001|NOT COMPLETED|Overall Study||0
10212998|NCT03639857|11339854|FG002|NOT COMPLETED|Overall Study||0
10212999|NCT03639987|11339864|FG000|STARTED|Overall Study||26
10213000|NCT03639987|11339865|FG001|STARTED|Overall Study||26
10213001|NCT03639987|11339864|FG000|COMPLETED|Overall Study||0
10213002|NCT03639987|11339865|FG001|COMPLETED|Overall Study||0
10213003|NCT03639987|11339864|FG000|NOT COMPLETED|Overall Study||26
10213004|NCT03639987|11339865|FG001|NOT COMPLETED|Overall Study||26
10213005|NCT03640052|11339871|FG000|STARTED|Overall Study||2
10213006|NCT03640052|11339872|FG001|STARTED|Overall Study||1
10213007|NCT03640052|11339873|FG002|STARTED|Overall Study||1
10213008|NCT03640052|11339874|FG003|STARTED|Overall Study||1
10213009|NCT03640052|11339875|FG004|STARTED|Overall Study||1
10213010|NCT03640052|11339871|FG000|COMPLETED|Overall Study||2
10213011|NCT03640052|11339872|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
10213012|NCT03640052|11339873|FG002|COMPLETED|Overall Study||1
10213013|NCT03640052|11339874|FG003|COMPLETED|Overall Study||1
10213014|NCT03640052|11339875|FG004|COMPLETED|Overall Study||1
10213015|NCT03640052|11339871|FG000|NOT COMPLETED|Overall Study||0
10213016|NCT03640052|11339872|FG001|NOT COMPLETED|Overall Study||1
10213017|NCT03640052|11339873|FG002|NOT COMPLETED|Overall Study||0
10213018|NCT03640052|11339874|FG003|NOT COMPLETED|Overall Study||0
10213019|NCT03640052|11339875|FG004|NOT COMPLETED|Overall Study||0
10213020|NCT03640507|11339890|FG000|STARTED|Overall Study||10
10213021|NCT03640507|11339891|FG001|STARTED|Overall Study||9
10213022|NCT03640507|11339892|FG002|STARTED|Overall Study||11
10213023|NCT03640507|11339890|FG000|COMPLETED|Overall Study||10
10213024|NCT03640507|11339891|FG001|COMPLETED|Overall Study||9
10213025|NCT03640507|11339892|FG002|COMPLETED|Overall Study||10
10213026|NCT03640507|11339890|FG000|NOT COMPLETED|Overall Study||0
10213027|NCT03640507|11339891|FG001|NOT COMPLETED|Overall Study||0
10213028|NCT03640507|11339892|FG002|NOT COMPLETED|Overall Study||1
10213029|NCT03640559|11339902|FG000|STARTED|Overall Study||25
10213030|NCT03640559|11339903|FG001|STARTED|Overall Study||25
10213031|NCT03640559|11339902|FG000|COMPLETED|Overall Study||23
10213032|NCT03640559|11339903|FG001|COMPLETED|Overall Study||24
10213033|NCT03640559|11339902|FG000|NOT COMPLETED|Overall Study||2
10213034|NCT03640559|11339903|FG001|NOT COMPLETED|Overall Study||1
10213035|NCT03640832|11339911|FG000|STARTED|Overall Study||44
10213036|NCT03640832|11339912|FG001|STARTED|Overall Study||46
10213037|NCT03640832|11339911|FG000|COMPLETED|Overall Study||44
10213038|NCT03640832|11339912|FG001|COMPLETED|Overall Study||46
10213039|NCT03640832|11339911|FG000|NOT COMPLETED|Overall Study||0
10213040|NCT03640832|11339912|FG001|NOT COMPLETED|Overall Study||0
10213041|NCT03641508|11339920|FG000|STARTED|First Injection||37
10213042|NCT03641508|11339921|FG001|STARTED|First Injection||32
10213043|NCT03641508|11339920|FG000|COMPLETED|First Injection||35
10213044|NCT03641508|11339921|FG001|COMPLETED|First Injection||32
10213045|NCT03641508|11339920|FG000|NOT COMPLETED|First Injection||2
10213046|NCT03641508|11339921|FG001|NOT COMPLETED|First Injection||0
10213047|NCT03641508|11339920|FG000|STARTED|Follow-up/Second Injection||2
10213048|NCT03641508|11339921|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
10213049|NCT03641508|11339920|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
10213050|NCT03641508|11339921|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
10213051|NCT03641508|11339920|FG000|NOT COMPLETED|Follow-up/Second Injection||0
10213052|NCT03641508|11339921|FG001|NOT COMPLETED|Follow-up/Second Injection||0
10213053|NCT03641716|11339927|FG000|STARTED|Overall Study||20
10213054|NCT03641716|11339927|FG000|COMPLETED|Overall Study||15
10213055|NCT03641716|11339927|FG000|NOT COMPLETED|Overall Study||5
10213056|NCT03642262|11339931|FG000|STARTED|Period 1||12
10213057|NCT03642262|11339932|FG001|STARTED|Period 1||18
10213058|NCT03642262|11339931|FG000|COMPLETED|Period 1||11
10213059|NCT03642262|11339932|FG001|COMPLETED|Period 1||16
10213060|NCT03642262|11339931|FG000|NOT COMPLETED|Period 1||1
10213061|NCT03642262|11339932|FG001|NOT COMPLETED|Period 1||2
10213062|NCT03642262|11339931|FG000|STARTED|Washout: 7 Days||11
10213063|NCT03642262|11339932|FG001|STARTED|Washout: 7 Days||16
10213064|NCT03642262|11339931|FG000|COMPLETED|Washout: 7 Days||11
10213065|NCT03642262|11339932|FG001|COMPLETED|Washout: 7 Days||16
10213066|NCT03642262|11339931|FG000|NOT COMPLETED|Washout: 7 Days||0
10213067|NCT03642262|11339932|FG001|NOT COMPLETED|Washout: 7 Days||0
10213068|NCT03642262|11339931|FG000|STARTED|Period 2||11
10213069|NCT03642262|11339932|FG001|STARTED|Period 2||16
10213070|NCT03642262|11339931|FG000|COMPLETED|Period 2||11
10213071|NCT03642262|11339932|FG001|COMPLETED|Period 2||16
10213072|NCT03642262|11339931|FG000|NOT COMPLETED|Period 2||0
10213073|NCT03642262|11339932|FG001|NOT COMPLETED|Period 2||0
10213074|NCT03642457|11339941|FG000|STARTED|Overall Study||35
10213075|NCT03642457|11339942|FG001|STARTED|Overall Study||30
10213076|NCT03642457|11339941|FG000|COMPLETED|Overall Study||35
10213077|NCT03642457|11339942|FG001|COMPLETED|Overall Study||30
10213078|NCT03642457|11339941|FG000|NOT COMPLETED|Overall Study||0
10213079|NCT03642457|11339942|FG001|NOT COMPLETED|Overall Study||0
10213080|NCT03642717|11339948|FG000|STARTED|Overall Study||658
10213081|NCT03642717|11339948|FG000|COMPLETED|Overall Study||620
10213082|NCT03642717|11339948|FG000|NOT COMPLETED|Overall Study||38
10213083|NCT03642873|11339953|FG000|STARTED|First Intervention (1 Day)||4
10213084|NCT03642873|11339954|FG001|STARTED|First Intervention (1 Day)||4
10213085|NCT03642873|11339955|FG002|STARTED|First Intervention (1 Day)||4
10012038|NCT01783743|11134871|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
10012039|NCT01783743|11134872|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
10012040|NCT01783743|11134871|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
10213086|NCT03642873|11339956|FG003|STARTED|First Intervention (1 Day)||4
10213087|NCT03642873|11339957|FG004|STARTED|First Intervention (1 Day)||4
10213088|NCT03642873|11339958|FG005|STARTED|First Intervention (1 Day)||4
10213089|NCT03642873|11339953|FG000|COMPLETED|First Intervention (1 Day)||4
10213090|NCT03642873|11339954|FG001|COMPLETED|First Intervention (1 Day)||4
10213091|NCT03642873|11339955|FG002|COMPLETED|First Intervention (1 Day)||4
10213092|NCT03642873|11339956|FG003|COMPLETED|First Intervention (1 Day)||4
10213093|NCT03642873|11339957|FG004|COMPLETED|First Intervention (1 Day)||4
10213094|NCT03642873|11339958|FG005|COMPLETED|First Intervention (1 Day)||4
10213095|NCT03642873|11339953|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10213096|NCT03642873|11339954|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10213097|NCT03642873|11339955|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10213098|NCT03642873|11339956|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10213099|NCT03642873|11339957|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10213100|NCT03642873|11339958|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10213101|NCT03642873|11339953|FG000|STARTED|Washout (7 Days)||4
10213102|NCT03642873|11339954|FG001|STARTED|Washout (7 Days)||4
10213103|NCT03642873|11339955|FG002|STARTED|Washout (7 Days)||4
10213104|NCT03642873|11339956|FG003|STARTED|Washout (7 Days)||4
10213105|NCT03642873|11339957|FG004|STARTED|Washout (7 Days)||4
10213106|NCT03642873|11339958|FG005|STARTED|Washout (7 Days)||4
10213107|NCT03642873|11339953|FG000|COMPLETED|Washout (7 Days)||4
10213108|NCT03642873|11339954|FG001|COMPLETED|Washout (7 Days)||4
10213109|NCT03642873|11339955|FG002|COMPLETED|Washout (7 Days)||4
10213110|NCT03642873|11339956|FG003|COMPLETED|Washout (7 Days)||4
10213111|NCT03642873|11339957|FG004|COMPLETED|Washout (7 Days)||4
10213112|NCT03642873|11339958|FG005|COMPLETED|Washout (7 Days)||4
10213113|NCT03642873|11339953|FG000|NOT COMPLETED|Washout (7 Days)||0
10213114|NCT03642873|11339954|FG001|NOT COMPLETED|Washout (7 Days)||0
10213115|NCT03642873|11339955|FG002|NOT COMPLETED|Washout (7 Days)||0
10213116|NCT03642873|11339956|FG003|NOT COMPLETED|Washout (7 Days)||0
10213117|NCT03642873|11339957|FG004|NOT COMPLETED|Washout (7 Days)||0
10213118|NCT03642873|11339958|FG005|NOT COMPLETED|Washout (7 Days)||0
10213119|NCT03642873|11339953|FG000|STARTED|Second Intervention (1 Day)||4
10213120|NCT03642873|11339954|FG001|STARTED|Second Intervention (1 Day)||4
10213121|NCT03642873|11339955|FG002|STARTED|Second Intervention (1 Day)||4
10213122|NCT03642873|11339956|FG003|STARTED|Second Intervention (1 Day)||4
10213123|NCT03642873|11339957|FG004|STARTED|Second Intervention (1 Day)||4
10213124|NCT03642873|11339958|FG005|STARTED|Second Intervention (1 Day)||4
10213125|NCT03642873|11339953|FG000|COMPLETED|Second Intervention (1 Day)||4
10213126|NCT03642873|11339954|FG001|COMPLETED|Second Intervention (1 Day)||4
10213127|NCT03642873|11339955|FG002|COMPLETED|Second Intervention (1 Day)||4
10213128|NCT03642873|11339956|FG003|COMPLETED|Second Intervention (1 Day)||4
10213129|NCT03642873|11339957|FG004|COMPLETED|Second Intervention (1 Day)||4
10213130|NCT03642873|11339958|FG005|COMPLETED|Second Intervention (1 Day)||4
10213131|NCT03642873|11339953|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10213132|NCT03642873|11339954|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10213133|NCT03642873|11339955|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10019025|NCT01827046|11142104|FG001|STARTED|Overall Study||249
10213134|NCT03642873|11339956|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10213135|NCT03642873|11339957|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10213136|NCT03642873|11339958|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10213137|NCT03642873|11339953|FG000|STARTED|Washout (7 Days)||4
10213138|NCT03642873|11339954|FG001|STARTED|Washout (7 Days)||4
10213139|NCT03642873|11339955|FG002|STARTED|Washout (7 Days)||4
10213140|NCT03642873|11339956|FG003|STARTED|Washout (7 Days)||4
10213141|NCT03642873|11339957|FG004|STARTED|Washout (7 Days)||4
10213142|NCT03642873|11339958|FG005|STARTED|Washout (7 Days)||4
10213143|NCT03642873|11339953|FG000|COMPLETED|Washout (7 Days)||4
10213144|NCT03642873|11339954|FG001|COMPLETED|Washout (7 Days)||4
10213145|NCT03642873|11339955|FG002|COMPLETED|Washout (7 Days)||4
10213146|NCT03642873|11339956|FG003|COMPLETED|Washout (7 Days)||4
10213147|NCT03642873|11339957|FG004|COMPLETED|Washout (7 Days)||4
10213148|NCT03642873|11339958|FG005|COMPLETED|Washout (7 Days)||4
10213149|NCT03642873|11339953|FG000|NOT COMPLETED|Washout (7 Days)||0
10213150|NCT03642873|11339954|FG001|NOT COMPLETED|Washout (7 Days)||0
10213151|NCT03642873|11339955|FG002|NOT COMPLETED|Washout (7 Days)||0
10213152|NCT03642873|11339956|FG003|NOT COMPLETED|Washout (7 Days)||0
10213153|NCT03642873|11339957|FG004|NOT COMPLETED|Washout (7 Days)||0
10213154|NCT03642873|11339958|FG005|NOT COMPLETED|Washout (7 Days)||0
10213155|NCT03642873|11339953|FG000|STARTED|Third Intervention (1 Day)||4
10213156|NCT03642873|11339954|FG001|STARTED|Third Intervention (1 Day)||4
10213157|NCT03642873|11339955|FG002|STARTED|Third Intervention (1 Day)||4
10213158|NCT03642873|11339956|FG003|STARTED|Third Intervention (1 Day)||4
10213159|NCT03642873|11339957|FG004|STARTED|Third Intervention (1 Day)||4
10213160|NCT03642873|11339958|FG005|STARTED|Third Intervention (1 Day)||4
10213161|NCT03642873|11339953|FG000|COMPLETED|Third Intervention (1 Day)||4
10213162|NCT03642873|11339954|FG001|COMPLETED|Third Intervention (1 Day)||4
10213163|NCT03642873|11339955|FG002|COMPLETED|Third Intervention (1 Day)||4
10213164|NCT03642873|11339956|FG003|COMPLETED|Third Intervention (1 Day)||4
10213165|NCT03642873|11339957|FG004|COMPLETED|Third Intervention (1 Day)||3
10213166|NCT03642873|11339958|FG005|COMPLETED|Third Intervention (1 Day)||4
10213167|NCT03642873|11339953|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10213168|NCT03642873|11339954|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10213169|NCT03642873|11339955|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10213170|NCT03642873|11339956|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10213171|NCT03642873|11339957|FG004|NOT COMPLETED|Third Intervention (1 Day)||1
10213172|NCT03642873|11339958|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10213173|NCT03643432|11339972|FG000|STARTED|Overall Study||27
10213174|NCT03643432|11339973|FG001|STARTED|Overall Study||21
10213175|NCT03643432|11339972|FG000|COMPLETED|Overall Study||26
10213176|NCT03643432|11339973|FG001|COMPLETED|Overall Study||21
10213177|NCT03643432|11339972|FG000|NOT COMPLETED|Overall Study||1
10213178|NCT03643432|11339973|FG001|NOT COMPLETED|Overall Study||0
10213179|NCT03643575|11339979|FG000|STARTED|Period 1||5
10213180|NCT03643575|11339980|FG001|STARTED|Period 1||5
10213181|NCT03643575|11339981|FG002|STARTED|Period 1||5
10213182|NCT03643575|11339982|FG003|STARTED|Period 1||5
10213183|NCT03643575|11339983|FG004|STARTED|Period 1||5
10213184|NCT03643575|11339984|FG005|STARTED|Period 1||5
10213185|NCT03643575|11339979|FG000|COMPLETED|Period 1||5
10213186|NCT03643575|11339980|FG001|COMPLETED|Period 1||5
10213187|NCT03643575|11339981|FG002|COMPLETED|Period 1||5
10213188|NCT03643575|11339982|FG003|COMPLETED|Period 1||5
10213189|NCT03643575|11339983|FG004|COMPLETED|Period 1||5
10213190|NCT03643575|11339984|FG005|COMPLETED|Period 1||5
10213191|NCT03643575|11339979|FG000|NOT COMPLETED|Period 1||0
10213192|NCT03643575|11339980|FG001|NOT COMPLETED|Period 1||0
10213193|NCT03643575|11339981|FG002|NOT COMPLETED|Period 1||0
10213194|NCT03643575|11339982|FG003|NOT COMPLETED|Period 1||0
10213195|NCT03643575|11339983|FG004|NOT COMPLETED|Period 1||0
10213196|NCT03643575|11339984|FG005|NOT COMPLETED|Period 1||0
10213197|NCT03643575|11339979|FG000|STARTED|Washout: 7 Days||5
10213198|NCT03643575|11339980|FG001|STARTED|Washout: 7 Days||5
10213199|NCT03643575|11339981|FG002|STARTED|Washout: 7 Days||5
10213200|NCT03643575|11339982|FG003|STARTED|Washout: 7 Days||5
10213201|NCT03643575|11339983|FG004|STARTED|Washout: 7 Days||5
10213202|NCT03643575|11339984|FG005|STARTED|Washout: 7 Days||5
10213203|NCT03643575|11339979|FG000|COMPLETED|Washout: 7 Days||4
10213204|NCT03643575|11339980|FG001|COMPLETED|Washout: 7 Days||5
10213205|NCT03643575|11339981|FG002|COMPLETED|Washout: 7 Days||5
10213206|NCT03643575|11339982|FG003|COMPLETED|Washout: 7 Days||4
10213207|NCT03643575|11339983|FG004|COMPLETED|Washout: 7 Days||5
10213208|NCT03643575|11339984|FG005|COMPLETED|Washout: 7 Days||5
10213209|NCT03643575|11339979|FG000|NOT COMPLETED|Washout: 7 Days||1
10213210|NCT03643575|11339980|FG001|NOT COMPLETED|Washout: 7 Days||0
10213211|NCT03643575|11339981|FG002|NOT COMPLETED|Washout: 7 Days||0
10213212|NCT03643575|11339982|FG003|NOT COMPLETED|Washout: 7 Days||1
10213213|NCT03643575|11339983|FG004|NOT COMPLETED|Washout: 7 Days||0
10213214|NCT03643575|11339984|FG005|NOT COMPLETED|Washout: 7 Days||0
10213215|NCT03643575|11339979|FG000|STARTED|Period 2||4
10213216|NCT03643575|11339980|FG001|STARTED|Period 2||5
10213217|NCT03643575|11339981|FG002|STARTED|Period 2||5
10213218|NCT03643575|11339982|FG003|STARTED|Period 2||4
10213219|NCT03643575|11339983|FG004|STARTED|Period 2||5
10213220|NCT03643575|11339984|FG005|STARTED|Period 2||5
10213221|NCT03643575|11339979|FG000|COMPLETED|Period 2||4
10213222|NCT03643575|11339980|FG001|COMPLETED|Period 2||5
10213223|NCT03643575|11339981|FG002|COMPLETED|Period 2||5
10213224|NCT03643575|11339982|FG003|COMPLETED|Period 2||4
10213225|NCT03643575|11339983|FG004|COMPLETED|Period 2||5
10213226|NCT03643575|11339984|FG005|COMPLETED|Period 2||5
10213227|NCT03643575|11339979|FG000|NOT COMPLETED|Period 2||0
10213228|NCT03643575|11339980|FG001|NOT COMPLETED|Period 2||0
10213229|NCT03643575|11339981|FG002|NOT COMPLETED|Period 2||0
10213230|NCT03643575|11339982|FG003|NOT COMPLETED|Period 2||0
10213231|NCT03643575|11339983|FG004|NOT COMPLETED|Period 2||0
10213232|NCT03643575|11339984|FG005|NOT COMPLETED|Period 2||0
10213233|NCT03643575|11339979|FG000|STARTED|Washout: 7 Days||4
10213234|NCT03643575|11339980|FG001|STARTED|Washout: 7 Days||5
10213235|NCT03643575|11339981|FG002|STARTED|Washout: 7 Days||5
10213236|NCT03643575|11339982|FG003|STARTED|Washout: 7 Days||4
10213237|NCT03643575|11339983|FG004|STARTED|Washout: 7 Days||5
10213238|NCT03643575|11339984|FG005|STARTED|Washout: 7 Days||5
10213239|NCT03643575|11339979|FG000|COMPLETED|Washout: 7 Days||4
10213240|NCT03643575|11339980|FG001|COMPLETED|Washout: 7 Days||4
10213241|NCT03643575|11339981|FG002|COMPLETED|Washout: 7 Days||5
10213242|NCT03643575|11339982|FG003|COMPLETED|Washout: 7 Days||4
10213243|NCT03643575|11339983|FG004|COMPLETED|Washout: 7 Days||5
10213244|NCT03643575|11339984|FG005|COMPLETED|Washout: 7 Days||5
10213245|NCT03643575|11339979|FG000|NOT COMPLETED|Washout: 7 Days||0
10213246|NCT03643575|11339980|FG001|NOT COMPLETED|Washout: 7 Days||1
10213247|NCT03643575|11339981|FG002|NOT COMPLETED|Washout: 7 Days||0
10213248|NCT03643575|11339982|FG003|NOT COMPLETED|Washout: 7 Days||0
10213249|NCT03643575|11339983|FG004|NOT COMPLETED|Washout: 7 Days||0
10213250|NCT03643575|11339984|FG005|NOT COMPLETED|Washout: 7 Days||0
10213251|NCT03643575|11339979|FG000|STARTED|Period 3||4
10213252|NCT03643575|11339980|FG001|STARTED|Period 3||4
10213253|NCT03643575|11339981|FG002|STARTED|Period 3||5
10213254|NCT03643575|11339982|FG003|STARTED|Period 3||4
10213255|NCT03643575|11339983|FG004|STARTED|Period 3||5
10213256|NCT03643575|11339984|FG005|STARTED|Period 3||5
10213257|NCT03643575|11339979|FG000|COMPLETED|Period 3||4
10213258|NCT03643575|11339980|FG001|COMPLETED|Period 3||4
10213259|NCT03643575|11339981|FG002|COMPLETED|Period 3||5
10213260|NCT03643575|11339982|FG003|COMPLETED|Period 3||4
10213261|NCT03643575|11339983|FG004|COMPLETED|Period 3||5
10213262|NCT03643575|11339984|FG005|COMPLETED|Period 3||5
10213263|NCT03643575|11339979|FG000|NOT COMPLETED|Period 3||0
10213264|NCT03643575|11339980|FG001|NOT COMPLETED|Period 3||0
10213265|NCT03643575|11339981|FG002|NOT COMPLETED|Period 3||0
10213266|NCT03643575|11339982|FG003|NOT COMPLETED|Period 3||0
10213267|NCT03643575|11339983|FG004|NOT COMPLETED|Period 3||0
10213268|NCT03643575|11339984|FG005|NOT COMPLETED|Period 3||0
10213269|NCT03643692|11339992|FG000|STARTED|Overall Study||12
10213270|NCT03643692|11339992|FG000|COMPLETED|Overall Study||12
10213271|NCT03643692|11339992|FG000|NOT COMPLETED|Overall Study||0
10213272|NCT03643952|11339996|FG000|STARTED|Overall Study||18
10213273|NCT03643952|11339996|FG000|COMPLETED|Overall Study||17
10213274|NCT03643952|11339996|FG000|NOT COMPLETED|Overall Study||1
10213275|NCT03644095|11340008|FG000|STARTED|Period 1||15
10213276|NCT03644095|11340009|FG001|STARTED|Period 1||15
10213277|NCT03644095|11340008|FG000|COMPLETED|Period 1||15
10213278|NCT03644095|11340009|FG001|COMPLETED|Period 1||15
10213279|NCT03644095|11340008|FG000|NOT COMPLETED|Period 1||0
10213280|NCT03644095|11340009|FG001|NOT COMPLETED|Period 1||0
10213281|NCT03644095|11340008|FG000|STARTED|Washout (7 Days)||15
10213282|NCT03644095|11340009|FG001|STARTED|Washout (7 Days)||15
10213283|NCT03644095|11340008|FG000|COMPLETED|Washout (7 Days)||15
10213284|NCT03644095|11340009|FG001|COMPLETED|Washout (7 Days)||15
10213285|NCT03644095|11340008|FG000|NOT COMPLETED|Washout (7 Days)||0
10213286|NCT03644095|11340009|FG001|NOT COMPLETED|Washout (7 Days)||0
10213287|NCT03644095|11340008|FG000|STARTED|Period 2||15
10213288|NCT03644095|11340009|FG001|STARTED|Period 2||15
10213289|NCT03644095|11340008|FG000|COMPLETED|Period 2||15
10213290|NCT03644095|11340009|FG001|COMPLETED|Period 2||15
10213291|NCT03644095|11340008|FG000|NOT COMPLETED|Period 2||0
10213292|NCT03644095|11340009|FG001|NOT COMPLETED|Period 2||0
10213293|NCT03644108|11340015|FG000|STARTED|Overall Study||30
10213294|NCT03644108|11340015|FG000|COMPLETED|Overall Study||30
10213295|NCT03644108|11340015|FG000|NOT COMPLETED|Overall Study||0
10213296|NCT03644173|11340019|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37
10213297|NCT03644173|11340019|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16
10213298|NCT03644173|11340019|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21
10213299|NCT03644173|11340019|FG000|STARTED|Participants at the 1-month Follow up||16
10213300|NCT03644173|11340019|FG000|COMPLETED|Participants at the 1-month Follow up||12
10213301|NCT03644173|11340019|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4
10213302|NCT03644173|11340019|FG000|STARTED|Participants at the 3-month Follow up||12
10213303|NCT03644173|11340019|FG000|COMPLETED|Participants at the 3-month Follow up||10
10213304|NCT03644173|11340019|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2
10213305|NCT03644212|11340026|FG000|STARTED|Overall Study||63
10213306|NCT03644212|11340027|FG001|STARTED|Overall Study||16
10213307|NCT03644212|11340026|FG000|COMPLETED|Overall Study||63
10213308|NCT03644212|11340027|FG001|COMPLETED|Overall Study||16
10213309|NCT03644212|11340026|FG000|NOT COMPLETED|Overall Study||0
10213310|NCT03644212|11340027|FG001|NOT COMPLETED|Overall Study||0
10213311|NCT03645421|11340037|FG000|STARTED|Overall Study||16
10213312|NCT03645421|11340038|FG001|STARTED|Overall Study||15
10213313|NCT03645421|11340039|FG002|STARTED|Overall Study||15
10213314|NCT03645421|11340040|FG003|STARTED|Overall Study||15
10213315|NCT03645421|11340037|FG000|Received Investigational Product (IP)|Overall Study||16
10213316|NCT03645421|11340038|FG001|Received Investigational Product (IP)|Overall Study||15
10213317|NCT03645421|11340039|FG002|Received Investigational Product (IP)|Overall Study||15
10213318|NCT03645421|11340040|FG003|Received Investigational Product (IP)|Overall Study||15
10213319|NCT03645421|11340037|FG000|COMPLETED|Overall Study||16
10213320|NCT03645421|11340038|FG001|COMPLETED|Overall Study||15
10213321|NCT03645421|11340039|FG002|COMPLETED|Overall Study||10
10213322|NCT03645421|11340040|FG003|COMPLETED|Overall Study||11
10213323|NCT03645421|11340037|FG000|NOT COMPLETED|Overall Study||0
10213324|NCT03645421|11340038|FG001|NOT COMPLETED|Overall Study||0
10213325|NCT03645421|11340039|FG002|NOT COMPLETED|Overall Study||5
10213326|NCT03645421|11340040|FG003|NOT COMPLETED|Overall Study||4
10213327|NCT03645434|11340053|FG000|STARTED|Period 1||12
10213328|NCT03645434|11340054|FG001|STARTED|Period 1||13
10213329|NCT03645434|11340055|FG002|STARTED|Period 1||13
10213330|NCT03645434|11340056|FG003|STARTED|Period 1||11
10213331|NCT03645434|11340057|FG004|STARTED|Period 1||12
10213332|NCT03645434|11340058|FG005|STARTED|Period 1||12
10213333|NCT03645434|11340053|FG000|COMPLETED|Period 1||12
10213334|NCT03645434|11340054|FG001|COMPLETED|Period 1||13
10213335|NCT03645434|11340055|FG002|COMPLETED|Period 1||13
10213336|NCT03645434|11340056|FG003|COMPLETED|Period 1||10
10213337|NCT03645434|11340057|FG004|COMPLETED|Period 1||11
10213338|NCT03645434|11340058|FG005|COMPLETED|Period 1||12
10213339|NCT03645434|11340053|FG000|NOT COMPLETED|Period 1||0
10213340|NCT03645434|11340054|FG001|NOT COMPLETED|Period 1||0
10213341|NCT03645434|11340055|FG002|NOT COMPLETED|Period 1||0
10213342|NCT03645434|11340056|FG003|NOT COMPLETED|Period 1||1
10213343|NCT03645434|11340057|FG004|NOT COMPLETED|Period 1||1
10213344|NCT03645434|11340058|FG005|NOT COMPLETED|Period 1||0
10213345|NCT03645434|11340053|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
10213346|NCT03645434|11340054|FG001|STARTED|Period 2||13
10213347|NCT03645434|11340055|FG002|STARTED|Period 2||13
10213348|NCT03645434|11340056|FG003|STARTED|Period 2||10
10213349|NCT03645434|11340057|FG004|STARTED|Period 2||11
10213350|NCT03645434|11340058|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
10213351|NCT03645434|11340053|FG000|COMPLETED|Period 2||10
10213352|NCT03645434|11340054|FG001|COMPLETED|Period 2||13
10213353|NCT03645434|11340055|FG002|COMPLETED|Period 2||13
10213354|NCT03645434|11340056|FG003|COMPLETED|Period 2||10
10213355|NCT03645434|11340057|FG004|COMPLETED|Period 2||11
10213356|NCT03645434|11340058|FG005|COMPLETED|Period 2||11
10012041|NCT01783743|11134872|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
10213357|NCT03645434|11340053|FG000|NOT COMPLETED|Period 2||0
10213358|NCT03645434|11340054|FG001|NOT COMPLETED|Period 2||0
10213359|NCT03645434|11340055|FG002|NOT COMPLETED|Period 2||0
10213360|NCT03645434|11340056|FG003|NOT COMPLETED|Period 2||0
10213361|NCT03645434|11340057|FG004|NOT COMPLETED|Period 2||0
10213362|NCT03645434|11340058|FG005|NOT COMPLETED|Period 2||0
10213363|NCT03645434|11340053|FG000|STARTED|Period 3||10
10213364|NCT03645434|11340054|FG001|STARTED|Period 3||13
10213365|NCT03645434|11340055|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
10213366|NCT03645434|11340056|FG003|STARTED|Period 3||10
10111788|NCT02498652|11242791|FG001|NOT COMPLETED|Overall Study||1
10111789|NCT02498678|11242817|FG000|STARTED|Overall Study||25
10111790|NCT02498678|11242818|FG001|STARTED|Overall Study||25
10111791|NCT02498678|11242817|FG000|COMPLETED|Overall Study||25
10111792|NCT02498678|11242818|FG001|COMPLETED|Overall Study||23
10111793|NCT02498678|11242817|FG000|NOT COMPLETED|Overall Study||0
10213367|NCT03645434|11340057|FG004|STARTED|Period 3||11
10213368|NCT03645434|11340058|FG005|STARTED|Period 3||11
10213369|NCT03645434|11340053|FG000|COMPLETED|Period 3||10
10213370|NCT03645434|11340054|FG001|COMPLETED|Period 3||13
10213371|NCT03645434|11340055|FG002|COMPLETED|Period 3||11
10213372|NCT03645434|11340056|FG003|COMPLETED|Period 3||10
10213373|NCT03645434|11340057|FG004|COMPLETED|Period 3||11
10213374|NCT03645434|11340058|FG005|COMPLETED|Period 3||11
10213375|NCT03645434|11340053|FG000|NOT COMPLETED|Period 3||0
10213376|NCT03645434|11340054|FG001|NOT COMPLETED|Period 3||0
10213377|NCT03645434|11340055|FG002|NOT COMPLETED|Period 3||0
10012042|NCT01783743|11134871|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
10012043|NCT01783743|11134872|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
10012044|NCT01783743|11134871|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613
10012045|NCT01783743|11134872|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044
10012046|NCT01783743|11134871|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
10012047|NCT01783743|11134872|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
10012048|NCT01783821|11134880|FG000|STARTED|Overall Study||30
10012049|NCT01783821|11134881|FG001|STARTED|Overall Study||31
10111794|NCT02498678|11242818|FG001|NOT COMPLETED|Overall Study||2
10111795|NCT02498769|11242826|FG000|STARTED|Overall Study||63
10111796|NCT02498769|11242827|FG001|STARTED|Overall Study||67
10111797|NCT02498769|11242826|FG000|COMPLETED|Overall Study||63
10111798|NCT02498769|11242827|FG001|COMPLETED|Overall Study||67
10111799|NCT02498769|11242826|FG000|NOT COMPLETED|Overall Study||0
10111800|NCT02498769|11242827|FG001|NOT COMPLETED|Overall Study||0
10111801|NCT02498821|11242835|FG000|STARTED|Overall Study||63
10111802|NCT02498821|11242836|FG001|STARTED|Overall Study||65
10111803|NCT02498821|11242835|FG000|COMPLETED|Overall Study||60
10111804|NCT02498821|11242836|FG001|COMPLETED|Overall Study||60
10111805|NCT02498821|11242835|FG000|NOT COMPLETED|Overall Study||3
10111806|NCT02498821|11242836|FG001|NOT COMPLETED|Overall Study||5
10111807|NCT02498834|11242844|FG000|STARTED|Overall Study||185
10111808|NCT02498834|11242845|FG001|STARTED|Overall Study||174
10111809|NCT02498834|11242844|FG000|COMPLETED|Overall Study||175
10111810|NCT02498834|11242845|FG001|COMPLETED|Overall Study||164
10111811|NCT02498834|11242844|FG000|NOT COMPLETED|Overall Study||10
10111812|NCT02498834|11242845|FG001|NOT COMPLETED|Overall Study||10
10111813|NCT02499029|11242853|FG000|STARTED|Overall Study||18
10111814|NCT02499029|11242854|FG001|STARTED|Overall Study||17
10111815|NCT02499029|11242853|FG000|COMPLETED|Overall Study||13
10111816|NCT02499029|11242854|FG001|COMPLETED|Overall Study||14
10111817|NCT02499029|11242853|FG000|NOT COMPLETED|Overall Study||5
10111818|NCT02499029|11242854|FG001|NOT COMPLETED|Overall Study||3
10111819|NCT02499081|11242860|FG000|STARTED|Overall Study||20
10213378|NCT03645434|11340056|FG003|NOT COMPLETED|Period 3||0
10213379|NCT03645434|11340057|FG004|NOT COMPLETED|Period 3||0
10213380|NCT03645434|11340058|FG005|NOT COMPLETED|Period 3||0
10213381|NCT03645785|11340066|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
10213382|NCT03645785|11340066|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
10213383|NCT03645785|11340066|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
10213384|NCT03645785|11340066|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
10213385|NCT03645785|11340066|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
10213386|NCT03645785|11340066|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
10213387|NCT03645811|11340085|FG000|STARTED|Overall Study||32
10213388|NCT03645811|11340086|FG001|STARTED|Overall Study||32
10213389|NCT03645811|11340087|FG002|STARTED|Overall Study||32
10213390|NCT03645811|11340085|FG000|COMPLETED|Overall Study||30
10213391|NCT03645811|11340086|FG001|COMPLETED|Overall Study||30
10213392|NCT03645811|11340087|FG002|COMPLETED|Overall Study||30
10213393|NCT03645811|11340085|FG000|NOT COMPLETED|Overall Study||2
10213394|NCT03645811|11340086|FG001|NOT COMPLETED|Overall Study||2
10213395|NCT03645811|11340087|FG002|NOT COMPLETED|Overall Study||2
10213396|NCT03645954|11340097|FG000|STARTED|Overall Study||40
10213397|NCT03645954|11340098|FG001|STARTED|Overall Study||40
10213398|NCT03645954|11340097|FG000|COMPLETED|Overall Study||37
10213399|NCT03645954|11340098|FG001|COMPLETED|Overall Study||40
10213400|NCT03645954|11340097|FG000|NOT COMPLETED|Overall Study||3
10213401|NCT03645954|11340098|FG001|NOT COMPLETED|Overall Study||0
10213402|NCT03646305|11340108|FG000|STARTED|Overall Study||32
10213403|NCT03646305|11340109|FG001|STARTED|Overall Study||35
10213404|NCT03646305|11340110|FG002|STARTED|Overall Study||33
10213405|NCT03646305|11340111|FG003|STARTED|Overall Study||33
10213406|NCT03646305|11340108|FG000|Received Treatment|Overall Study||31
10213407|NCT03646305|11340109|FG001|Received Treatment|Overall Study||35
10213408|NCT03646305|11340110|FG002|Received Treatment|Overall Study||32
10213409|NCT03646305|11340111|FG003|Received Treatment|Overall Study||32
10213410|NCT03646305|11340108|FG000|No Treatment Recieved|Overall Study||1
10213411|NCT03646305|11340109|FG001|No Treatment Recieved|Overall Study||0
10213412|NCT03646305|11340110|FG002|No Treatment Recieved|Overall Study||1
10213413|NCT03646305|11340111|FG003|No Treatment Recieved|Overall Study||1
10213414|NCT03646305|11340108|FG000|COMPLETED|Overall Study||27
10213415|NCT03646305|11340109|FG001|COMPLETED|Overall Study||33
10213416|NCT03646305|11340110|FG002|COMPLETED|Overall Study||31
10213417|NCT03646305|11340111|FG003|COMPLETED|Overall Study||31
10213418|NCT03646305|11340108|FG000|NOT COMPLETED|Overall Study||5
10213419|NCT03646305|11340109|FG001|NOT COMPLETED|Overall Study||2
10213420|NCT03646305|11340110|FG002|NOT COMPLETED|Overall Study||2
10213421|NCT03646305|11340111|FG003|NOT COMPLETED|Overall Study||2
10213422|NCT03646656|11340127|FG000|STARTED|Overall Study||12
10213423|NCT03646656|11340128|FG001|STARTED|Overall Study||3
10213424|NCT03646656|11340127|FG000|Attended 1st Group Session|Overall Study||10
10213425|NCT03646656|11340128|FG001|Attended 1st Group Session|Overall Study||3
10213426|NCT03646656|11340127|FG000|COMPLETED|Overall Study||9
10213427|NCT03646656|11340128|FG001|COMPLETED|Overall Study||3
10213428|NCT03646656|11340127|FG000|NOT COMPLETED|Overall Study||3
10213429|NCT03646656|11340128|FG001|NOT COMPLETED|Overall Study||0
10213430|NCT03647033|11340140|FG000|STARTED|Overall Study||16
10213431|NCT03647033|11340141|FG001|STARTED|Overall Study||16
10213432|NCT03647033|11340140|FG000|COMPLETED|Overall Study||16
10213433|NCT03647033|11340141|FG001|COMPLETED|Overall Study||16
10213434|NCT03647033|11340140|FG000|NOT COMPLETED|Overall Study||0
10213435|NCT03647033|11340141|FG001|NOT COMPLETED|Overall Study||0
10213436|NCT03647046|11340147|FG000|STARTED|Overall Study||12
10213437|NCT03647046|11340147|FG000|COMPLETED|Overall Study||8
10213438|NCT03647046|11340147|FG000|NOT COMPLETED|Overall Study||4
10213439|NCT03647267|11340153|FG000|STARTED|Overall Study||24
10213440|NCT03647267|11340154|FG001|STARTED|Overall Study||22
10213441|NCT03647267|11340153|FG000|COMPLETED|Overall Study||23
10213442|NCT03647267|11340154|FG001|COMPLETED|Overall Study||22
10213443|NCT03647267|11340153|FG000|NOT COMPLETED|Overall Study||1
10213444|NCT03647267|11340154|FG001|NOT COMPLETED|Overall Study||0
10213445|NCT03647475|11340162|FG000|STARTED|Overall Study||752
10213446|NCT03647475|11340162|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
10213447|NCT03647475|11340162|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
10213448|NCT03647475|11340162|FG000|COMPLETED|Overall Study||75
10213449|NCT03647475|11340162|FG000|NOT COMPLETED|Overall Study||677
10213450|NCT03647709|11340166|FG000|STARTED|Overall Study||400
10213451|NCT03647709|11340166|FG000|COMPLETED|Overall Study||386
10213452|NCT03647709|11340166|FG000|NOT COMPLETED|Overall Study||14
10213453|NCT03648853|11340172|FG000|STARTED|Overall Study||12
10213454|NCT03648853|11340172|FG000|COMPLETED|Overall Study||12
10213455|NCT03648853|11340172|FG000|NOT COMPLETED|Overall Study||0
10213456|NCT03648879|11340176|FG000|STARTED|Overall Study||37
10213457|NCT03648879|11340176|FG000|COMPLETED|Overall Study||36
10213458|NCT03648879|11340176|FG000|NOT COMPLETED|Overall Study||1
10213459|NCT03649412|11340182|FG000|STARTED|Part A, Period 1 (4 Days)||16
10213460|NCT03649412|11340183|FG001|STARTED|Part A, Period 1 (4 Days)||0
10213461|NCT03649412|11340182|FG000|COMPLETED|Part A, Period 1 (4 Days)||16
10213462|NCT03649412|11340183|FG001|COMPLETED|Part A, Period 1 (4 Days)||0
10213463|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0
10213464|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0
10213465|NCT03649412|11340182|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16
10213466|NCT03649412|11340183|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0
10213467|NCT03649412|11340182|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15
10213468|NCT03649412|11340183|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0
10213469|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
10213470|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
10213471|NCT03649412|11340182|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
10213472|NCT03649412|11340183|FG001|STARTED|Part A, Period 2 (3 Days)||0
10213473|NCT03649412|11340182|FG000|COMPLETED|Part A, Period 2 (3 Days)||16
10213474|NCT03649412|11340183|FG001|COMPLETED|Part A, Period 2 (3 Days)||0
10213475|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0
10213476|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0
10213477|NCT03649412|11340182|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16
10213478|NCT03649412|11340183|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0
10213479|NCT03649412|11340182|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16
10213480|NCT03649412|11340183|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0
10213481|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
10213482|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
10213483|NCT03649412|11340182|FG000|STARTED|Part A, Period 3 (4 Days)||16
10213484|NCT03649412|11340183|FG001|STARTED|Part A, Period 3 (4 Days)||0
10213485|NCT03649412|11340182|FG000|COMPLETED|Part A, Period 3 (4 Days)||16
10213486|NCT03649412|11340183|FG001|COMPLETED|Part A, Period 3 (4 Days)||0
10213487|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0
10213488|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0
10213489|NCT03649412|11340182|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16
10213490|NCT03649412|11340183|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0
10213491|NCT03649412|11340182|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16
10213492|NCT03649412|11340183|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0
10213493|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
10213494|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
10213495|NCT03649412|11340182|FG000|STARTED|Part A, Period 4 (4 Days)||16
10213496|NCT03649412|11340183|FG001|STARTED|Part A, Period 4 (4 Days)||0
10213497|NCT03649412|11340182|FG000|COMPLETED|Part A, Period 4 (4 Days)||16
10213498|NCT03649412|11340183|FG001|COMPLETED|Part A, Period 4 (4 Days)||0
10213499|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0
10213500|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0
10213501|NCT03649412|11340182|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16
10213502|NCT03649412|11340183|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0
10213503|NCT03649412|11340182|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14
10213504|NCT03649412|11340183|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0
10213505|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
10213506|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
10213507|NCT03649412|11340182|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
10213508|NCT03649412|11340183|FG001|STARTED|Part A, Period 5 (4 Days)||0
10213509|NCT03649412|11340182|FG000|COMPLETED|Part A, Period 5 (4 Days)||12
10213510|NCT03649412|11340183|FG001|COMPLETED|Part A, Period 5 (4 Days)||0
10213511|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0
10213512|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0
10213513|NCT03649412|11340182|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12
10213514|NCT03649412|11340183|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0
10213515|NCT03649412|11340182|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11
10213516|NCT03649412|11340183|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0
10213517|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
10213518|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
10213519|NCT03649412|11340182|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
10213520|NCT03649412|11340183|FG001|STARTED|Part A, Period 6 (4 Days)||0
10213521|NCT03649412|11340182|FG000|COMPLETED|Part A, Period 6 (4 Days)||12
10213522|NCT03649412|11340183|FG001|COMPLETED|Part A, Period 6 (4 Days)||0
10213523|NCT03649412|11340182|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0
10213524|NCT03649412|11340183|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0
10213525|NCT03649412|11340182|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
10213526|NCT03649412|11340183|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
10012050|NCT01783821|11134880|FG000|COMPLETED|Overall Study||29
10012051|NCT01783821|11134881|FG001|COMPLETED|Overall Study||30
10012052|NCT01783821|11134880|FG000|NOT COMPLETED|Overall Study||1
10012053|NCT01783821|11134881|FG001|NOT COMPLETED|Overall Study||1
10012054|NCT01783847|11134890|FG000|STARTED|Overall Study||85
10213527|NCT03649412|11340182|FG000|COMPLETED|Part B, Period 1 (4 Days)||0
10213528|NCT03649412|11340183|FG001|COMPLETED|Part B, Period 1 (4 Days)||16
10213529|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0
10213530|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0
10213531|NCT03649412|11340182|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0
10012055|NCT01783847|11134891|FG001|STARTED|Overall Study||16
10012056|NCT01783847|11134892|FG002|STARTED|Overall Study||16
10012057|NCT01783847|11134890|FG000|COMPLETED|Overall Study||69
10213532|NCT03649412|11340183|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16
10213533|NCT03649412|11340182|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0
10213534|NCT03649412|11340183|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15
10213535|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
10213536|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
10213537|NCT03649412|11340182|FG000|STARTED|Part B, Period 2 (4 Days)||0
10213538|NCT03649412|11340183|FG001|STARTED|Part B, Period 2 (4 Days)||15
10213539|NCT03649412|11340182|FG000|COMPLETED|Part B, Period 2 (4 Days)||0
10213540|NCT03649412|11340183|FG001|COMPLETED|Part B, Period 2 (4 Days)||15
10213541|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0
10213542|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0
10213543|NCT03649412|11340182|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0
10213544|NCT03649412|11340183|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15
10213545|NCT03649412|11340182|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0
10213546|NCT03649412|11340183|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15
10213547|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
10213548|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
10213549|NCT03649412|11340182|FG000|STARTED|Part B, Period 3 (4 Days)||0
10213550|NCT03649412|11340183|FG001|STARTED|Part B, Period 3 (4 Days)||15
10213551|NCT03649412|11340182|FG000|COMPLETED|Part B, Period 3 (4 Days)||0
10213552|NCT03649412|11340183|FG001|COMPLETED|Part B, Period 3 (4 Days)||15
10213553|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0
10213554|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0
10213555|NCT03649412|11340182|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0
10213556|NCT03649412|11340183|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15
10213557|NCT03649412|11340182|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0
10213558|NCT03649412|11340183|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15
10213559|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
10213560|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
10213561|NCT03649412|11340182|FG000|STARTED|Part B, Period 4 (4 Days)||0
10213562|NCT03649412|11340183|FG001|STARTED|Part B, Period 4 (4 Days)||15
10213563|NCT03649412|11340182|FG000|COMPLETED|Part B, Period 4 (4 Days)||0
10213564|NCT03649412|11340183|FG001|COMPLETED|Part B, Period 4 (4 Days)||15
10213565|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0
10213566|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0
10213567|NCT03649412|11340182|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0
10213568|NCT03649412|11340183|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15
10213569|NCT03649412|11340182|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0
10213570|NCT03649412|11340183|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15
10213571|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
10213572|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
10213573|NCT03649412|11340182|FG000|STARTED|Part B, Period 5 (4 Days)||0
10213574|NCT03649412|11340183|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
10213575|NCT03649412|11340182|FG000|COMPLETED|Part B, Period 5 (4 Days)||0
10213576|NCT03649412|11340183|FG001|COMPLETED|Part B, Period 5 (4 Days)||14
10213577|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0
10213578|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0
10213579|NCT03649412|11340182|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0
10213580|NCT03649412|11340183|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14
10213581|NCT03649412|11340182|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0
10213582|NCT03649412|11340183|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13
10213583|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
10213584|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
10213585|NCT03649412|11340182|FG000|STARTED|Part B, Period 6 (4days)||0
10213586|NCT03649412|11340183|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
10213587|NCT03649412|11340182|FG000|COMPLETED|Part B, Period 6 (4days)||0
10213588|NCT03649412|11340183|FG001|COMPLETED|Part B, Period 6 (4days)||14
10213589|NCT03649412|11340182|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0
10213590|NCT03649412|11340183|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0
10213591|NCT03649477|11340229|FG000|STARTED|Overall Study||44
10213592|NCT03649477|11340230|FG001|STARTED|Overall Study||43
10213593|NCT03649477|11340231|FG002|STARTED|Overall Study||43
10213594|NCT03649477|11340229|FG000|COMPLETED|Overall Study||42
10213595|NCT03649477|11340230|FG001|COMPLETED|Overall Study||43
10213596|NCT03649477|11340231|FG002|COMPLETED|Overall Study||43
10213597|NCT03649477|11340229|FG000|NOT COMPLETED|Overall Study||2
10213598|NCT03649477|11340230|FG001|NOT COMPLETED|Overall Study||0
10213599|NCT03649477|11340231|FG002|NOT COMPLETED|Overall Study||0
10213600|NCT03649646|11340239|FG000|STARTED|Overall Study||4542
10213601|NCT03649646|11340239|FG000|COMPLETED|Overall Study||4075
10213602|NCT03649646|11340239|FG000|NOT COMPLETED|Overall Study||467
10213603|NCT03649750|11340243|FG000|STARTED|Period 1||12
10213604|NCT03649750|11340244|FG001|STARTED|Period 1||24
10213605|NCT03649750|11340243|FG000|COMPLETED|Period 1||12
10213606|NCT03649750|11340244|FG001|COMPLETED|Period 1||24
10213607|NCT03649750|11340243|FG000|NOT COMPLETED|Period 1||0
10213608|NCT03649750|11340244|FG001|NOT COMPLETED|Period 1||0
10213609|NCT03649750|11340243|FG000|STARTED|Washout: 7 Days||12
10213610|NCT03649750|11340244|FG001|STARTED|Washout: 7 Days||24
10213611|NCT03649750|11340243|FG000|COMPLETED|Washout: 7 Days||12
10213612|NCT03649750|11340244|FG001|COMPLETED|Washout: 7 Days||24
10213613|NCT03649750|11340243|FG000|NOT COMPLETED|Washout: 7 Days||0
10213614|NCT03649750|11340244|FG001|NOT COMPLETED|Washout: 7 Days||0
10213615|NCT03649750|11340243|FG000|STARTED|Period 2||12
10213616|NCT03649750|11340244|FG001|STARTED|Period 2||24
10213617|NCT03649750|11340243|FG000|COMPLETED|Period 2||12
10213618|NCT03649750|11340244|FG001|COMPLETED|Period 2||24
10213619|NCT03649750|11340243|FG000|NOT COMPLETED|Period 2||0
10213620|NCT03649750|11340244|FG001|NOT COMPLETED|Period 2||0
10213621|NCT03649815|11340251|FG000|STARTED|Overall Study||38
10213622|NCT03649815|11340251|FG000|COMPLETED|Overall Study||38
10213623|NCT03649815|11340251|FG000|NOT COMPLETED|Overall Study||0
10213624|NCT03649867|11340255|FG000|STARTED|Overall Study||13
10012058|NCT01783847|11134891|FG001|COMPLETED|Overall Study||15
10012059|NCT01783847|11134892|FG002|COMPLETED|Overall Study||16
10012060|NCT01783847|11134890|FG000|NOT COMPLETED|Overall Study||16
10012061|NCT01783847|11134891|FG001|NOT COMPLETED|Overall Study||1
10012062|NCT01783847|11134892|FG002|NOT COMPLETED|Overall Study||0
10012063|NCT01783860|11134905|FG000|STARTED|Overall Study||50
10012064|NCT01783860|11134906|FG001|STARTED|Overall Study||50
10012065|NCT01783860|11134905|FG000|COMPLETED|Overall Study||50
10012066|NCT01783860|11134906|FG001|COMPLETED|Overall Study||50
10012067|NCT01783860|11134905|FG000|NOT COMPLETED|Overall Study||0
10012068|NCT01783860|11134906|FG001|NOT COMPLETED|Overall Study||0
10012069|NCT01783886|11134915|FG000|STARTED|Overall Study||127
10012070|NCT01783886|11134916|FG001|STARTED|Overall Study||127
10012071|NCT01783886|11134917|FG002|STARTED|Overall Study||127
10213625|NCT03649867|11340255|FG000|COMPLETED|Overall Study||13
10213626|NCT03649867|11340255|FG000|NOT COMPLETED|Overall Study||0
10213627|NCT03649932|11340262|FG000|STARTED|Overall Study||14
10213628|NCT03649932|11340263|FG001|STARTED|Overall Study||14
10213629|NCT03649932|11340264|FG002|STARTED|Overall Study||14
10213630|NCT03649932|11340262|FG000|COMPLETED|Overall Study||14
10213631|NCT03649932|11340263|FG001|COMPLETED|Overall Study||13
10213632|NCT03649932|11340264|FG002|COMPLETED|Overall Study||13
10213633|NCT03649932|11340262|FG000|NOT COMPLETED|Overall Study||0
10213634|NCT03649932|11340263|FG001|NOT COMPLETED|Overall Study||1
10213635|NCT03649932|11340264|FG002|NOT COMPLETED|Overall Study||1
10213636|NCT03650192|11340272|FG000|STARTED|Overall Study||40
10213637|NCT03650192|11340272|FG000|COMPLETED|Overall Study||40
10213638|NCT03650192|11340272|FG000|NOT COMPLETED|Overall Study||0
10213639|NCT03650387|11340276|FG000|STARTED|Overall Study||207
10213640|NCT03650387|11340276|FG000|COMPLETED|Overall Study||173
10213641|NCT03650387|11340276|FG000|NOT COMPLETED|Overall Study||34
10213642|NCT03650400|11340291|FG000|STARTED|Overall Study||6
10213643|NCT03650400|11340292|FG001|STARTED|Overall Study||5
10213644|NCT03650400|11340291|FG000|COMPLETED|Overall Study||6
10213645|NCT03650400|11340292|FG001|COMPLETED|Overall Study||0
10213646|NCT03650400|11340291|FG000|NOT COMPLETED|Overall Study||0
10213647|NCT03650400|11340292|FG001|NOT COMPLETED|Overall Study||5
10213648|NCT03650452|11340300|FG000|STARTED|Overall Study||70
10213649|NCT03650452|11340301|FG001|STARTED|Overall Study||71
10213650|NCT03650452|11340300|FG000|COMPLETED|Overall Study||60
10213651|NCT03650452|11340301|FG001|COMPLETED|Overall Study||66
10213652|NCT03650452|11340300|FG000|NOT COMPLETED|Overall Study||10
10213653|NCT03650452|11340301|FG001|NOT COMPLETED|Overall Study||5
10213654|NCT03650842|11340307|FG000|STARTED|Overall Study||25
10213655|NCT03650842|11340307|FG000|COMPLETED|Overall Study||25
10213656|NCT03650842|11340307|FG000|NOT COMPLETED|Overall Study||0
10213657|NCT03651479|11340313|FG000|STARTED|Overall Study||20
10213658|NCT03651479|11340314|FG001|STARTED|Overall Study||20
10213659|NCT03651479|11340313|FG000|COMPLETED|Overall Study||20
10213660|NCT03651479|11340314|FG001|COMPLETED|Overall Study||20
10213661|NCT03651479|11340313|FG000|NOT COMPLETED|Overall Study||0
10213662|NCT03651479|11340314|FG001|NOT COMPLETED|Overall Study||0
10213663|NCT03651856|11340320|FG000|STARTED|Overall Study||10
10213664|NCT03651856|11340320|FG000|COMPLETED|Overall Study||10
10213665|NCT03651856|11340320|FG000|NOT COMPLETED|Overall Study||0
10213666|NCT03652610|11340326|FG000|STARTED|Overall Study||490
10213667|NCT03652610|11340327|FG001|STARTED|Overall Study||489
10213668|NCT03652610|11340326|FG000|COMPLETED|Overall Study||486
10213669|NCT03652610|11340327|FG001|COMPLETED|Overall Study||484
10012072|NCT01783886|11134915|FG000|Participants Received Treatment|Overall Study||127
10012073|NCT01783886|11134916|FG001|Participants Received Treatment|Overall Study||127
10012074|NCT01783886|11134917|FG002|Participants Received Treatment|Overall Study||124
10213670|NCT03652610|11340326|FG000|NOT COMPLETED|Overall Study||4
10213671|NCT03652610|11340327|FG001|NOT COMPLETED|Overall Study||5
10213672|NCT03652662|11340335|FG000|STARTED|Overall Study||18
10213673|NCT03652662|11340336|FG001|STARTED|Overall Study||16
10213674|NCT03652662|11340335|FG000|COMPLETED|Overall Study||15
10213675|NCT03652662|11340336|FG001|COMPLETED|Overall Study||15
10213676|NCT03652662|11340335|FG000|NOT COMPLETED|Overall Study||3
10213677|NCT03652662|11340336|FG001|NOT COMPLETED|Overall Study||1
10213678|NCT03652675|11340344|FG000|STARTED|Overall Study||16
10213679|NCT03652675|11340345|FG001|STARTED|Overall Study||15
10213680|NCT03652675|11340344|FG000|COMPLETED|Overall Study||12
10213681|NCT03652675|11340345|FG001|COMPLETED|Overall Study||11
10012075|NCT01783886|11134915|FG000|COMPLETED|Overall Study||122
10012076|NCT01783886|11134916|FG001|COMPLETED|Overall Study||116
10012077|NCT01783886|11134917|FG002|COMPLETED|Overall Study||117
10213682|NCT03652675|11340344|FG000|NOT COMPLETED|Overall Study||4
10213683|NCT03652675|11340345|FG001|NOT COMPLETED|Overall Study||4
10213684|NCT03652818|11340356|FG000|STARTED|Overall Study||24
10213685|NCT03652818|11340357|FG001|STARTED|Overall Study||23
10213686|NCT03652818|11340358|FG002|STARTED|Overall Study||22
10213687|NCT03652818|11340359|FG003|STARTED|Overall Study||23
10213688|NCT03652818|11340360|FG004|STARTED|Overall Study||23
10213689|NCT03652818|11340356|FG000|COMPLETED|Overall Study||22
10213690|NCT03652818|11340357|FG001|COMPLETED|Overall Study||22
10213691|NCT03652818|11340358|FG002|COMPLETED|Overall Study||20
10213692|NCT03652818|11340359|FG003|COMPLETED|Overall Study||22
10213693|NCT03652818|11340360|FG004|COMPLETED|Overall Study||22
10213694|NCT03652818|11340356|FG000|NOT COMPLETED|Overall Study||2
10213695|NCT03652818|11340357|FG001|NOT COMPLETED|Overall Study||1
10213696|NCT03652818|11340358|FG002|NOT COMPLETED|Overall Study||2
10213697|NCT03652818|11340359|FG003|NOT COMPLETED|Overall Study||1
10213698|NCT03652818|11340360|FG004|NOT COMPLETED|Overall Study||1
10213699|NCT03653208|11340381|FG000|STARTED|Overall Study||3
10213700|NCT03653208|11340382|FG001|STARTED|Overall Study||3
10213701|NCT03653208|11340383|FG002|STARTED|Overall Study||6
10213702|NCT03653208|11340384|FG003|STARTED|Overall Study||6
10213703|NCT03653208|11340385|FG004|STARTED|Overall Study||6
10213704|NCT03653208|11340386|FG005|STARTED|Overall Study||6
10213705|NCT03653208|11340387|FG006|STARTED|Overall Study||6
10213706|NCT03653208|11340388|FG007|STARTED|Overall Study||6
10213707|NCT03653208|11340389|FG008|STARTED|Overall Study||14
10213708|NCT03653208|11340381|FG000|COMPLETED|Overall Study||3
10213709|NCT03653208|11340382|FG001|COMPLETED|Overall Study||3
10213710|NCT03653208|11340383|FG002|COMPLETED|Overall Study||6
10213711|NCT03653208|11340384|FG003|COMPLETED|Overall Study||6
10213712|NCT03653208|11340385|FG004|COMPLETED|Overall Study||5
10213713|NCT03653208|11340386|FG005|COMPLETED|Overall Study||6
10213714|NCT03653208|11340387|FG006|COMPLETED|Overall Study||6
10213715|NCT03653208|11340388|FG007|COMPLETED|Overall Study||5
10213716|NCT03653208|11340389|FG008|COMPLETED|Overall Study||13
10213717|NCT03653208|11340381|FG000|NOT COMPLETED|Overall Study||0
10213718|NCT03653208|11340382|FG001|NOT COMPLETED|Overall Study||0
10213719|NCT03653208|11340383|FG002|NOT COMPLETED|Overall Study||0
10213720|NCT03653208|11340384|FG003|NOT COMPLETED|Overall Study||0
10213721|NCT03653208|11340385|FG004|NOT COMPLETED|Overall Study||1
10213722|NCT03653208|11340386|FG005|NOT COMPLETED|Overall Study||0
10012078|NCT01783886|11134915|FG000|NOT COMPLETED|Overall Study||5
10012079|NCT01783886|11134916|FG001|NOT COMPLETED|Overall Study||11
10012080|NCT01783886|11134917|FG002|NOT COMPLETED|Overall Study||10
10213723|NCT03653208|11340387|FG006|NOT COMPLETED|Overall Study||0
10213724|NCT03653208|11340388|FG007|NOT COMPLETED|Overall Study||1
10213725|NCT03653208|11340389|FG008|NOT COMPLETED|Overall Study||1
10213726|NCT03653351|11340411|FG000|STARTED|Overall Study||14
10213727|NCT03653351|11340412|FG001|STARTED|Overall Study||12
10213728|NCT03653351|11340411|FG000|COMPLETED|Overall Study||13
10213729|NCT03653351|11340412|FG001|COMPLETED|Overall Study||10
10213730|NCT03653351|11340411|FG000|NOT COMPLETED|Overall Study||1
10213731|NCT03653351|11340412|FG001|NOT COMPLETED|Overall Study||2
10238898|NCT00443040|11370352|FG001|COMPLETED|Overall Study||11
10238899|NCT00443040|11370353|FG002|COMPLETED|Overall Study||9
10238900|NCT00443040|11370351|FG000|NOT COMPLETED|Overall Study||4
10238901|NCT00443040|11370352|FG001|NOT COMPLETED|Overall Study||0
10238902|NCT00443040|11370353|FG002|NOT COMPLETED|Overall Study||1
10238903|NCT00447421|11370361|FG000|STARTED|Overall Study||9
10238904|NCT00447421|11370361|FG000|COMPLETED|Overall Study||3
10238905|NCT00447421|11370361|FG000|NOT COMPLETED|Overall Study||6
10238906|NCT00441272|11370367|FG000|STARTED|Overall Study||25
10238907|NCT00441272|11370368|FG001|STARTED|Overall Study||25
10238908|NCT00441272|11370367|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
10238909|NCT00441272|11370368|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
10238910|NCT00441272|11370367|FG000|NOT COMPLETED|Overall Study||25
10238911|NCT00441272|11370368|FG001|NOT COMPLETED|Overall Study||25
10238912|NCT00437398|11370374|FG000|STARTED|Overall Study||2
10238913|NCT00437398|11370374|FG000|COMPLETED|Overall Study||2
10238914|NCT00437398|11370374|FG000|NOT COMPLETED|Overall Study||0
10238915|NCT00440271|11370380|FG000|STARTED|Overall Study||15
10238916|NCT00440271|11370381|FG001|STARTED|Overall Study||18
10238917|NCT00440271|11370380|FG000|COMPLETED|Overall Study||3
10238918|NCT00440271|11370381|FG001|COMPLETED|Overall Study||3
10238919|NCT00440271|11370380|FG000|NOT COMPLETED|Overall Study||12
10238920|NCT00440271|11370381|FG001|NOT COMPLETED|Overall Study||15
10238921|NCT00442260|11370387|FG000|STARTED|Overall Study||2
10238922|NCT00442260|11370387|FG000|COMPLETED|Overall Study||2
10238923|NCT00442260|11370387|FG000|NOT COMPLETED|Overall Study||0
10238924|NCT00429026|11370391|FG000|STARTED|Overall Study||40
10238925|NCT00429026|11370391|FG000|COMPLETED|Overall Study||0
10238926|NCT00429026|11370391|FG000|NOT COMPLETED|Overall Study||40
10239827|NCT03998189|11371566|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0
10239828|NCT03998189|11371565|FG000|NOT COMPLETED|Overall Study||0
10239829|NCT03998189|11371566|FG001|NOT COMPLETED|Overall Study||1
10239830|NCT02212574|11371572|FG000|STARTED|Overall Study||6
10239831|NCT02212574|11371572|FG000|COMPLETED|Overall Study||6
10012081|NCT01783912|11134928|FG000|STARTED|Overall Study||118
10239832|NCT02212574|11371572|FG000|NOT COMPLETED|Overall Study||0
10239833|NCT04422210|11371585|FG000|STARTED|Overall Study||0
10239834|NCT04422210|11371586|FG001|STARTED|Overall Study||0
10239835|NCT04422210|11371587|FG002|STARTED|Overall Study||0
10239836|NCT04422210|11371588|FG003|STARTED|Overall Study||0
10239837|NCT04422210|11371589|FG004|STARTED|Overall Study||0
10239838|NCT04422210|11371590|FG005|STARTED|Overall Study||0
10213732|NCT03653416|11340420|FG000|STARTED|Overall Study||52
10213733|NCT03653416|11340421|FG001|STARTED|Overall Study||47
10213734|NCT03653416|11340420|FG000|COMPLETED|Overall Study||46
10213735|NCT03653416|11340421|FG001|COMPLETED|Overall Study||46
10213736|NCT03653416|11340420|FG000|NOT COMPLETED|Overall Study||6
10213737|NCT03653416|11340421|FG001|NOT COMPLETED|Overall Study||1
10213738|NCT03653429|11340429|FG000|STARTED|Overall Study||49
10213739|NCT03653429|11340430|FG001|STARTED|Overall Study||51
10213740|NCT03653429|11340429|FG000|COMPLETED|Overall Study||45
10012082|NCT01783912|11134929|FG001|STARTED|Overall Study||104
10012083|NCT01783912|11134930|FG002|STARTED|Overall Study||48
10012084|NCT01783912|11134928|FG000|COMPLETED|Overall Study||88
10012085|NCT01783912|11134929|FG001|COMPLETED|Overall Study||58
10213741|NCT03653429|11340430|FG001|COMPLETED|Overall Study||41
10213742|NCT03653429|11340429|FG000|NOT COMPLETED|Overall Study||4
10213743|NCT03653429|11340430|FG001|NOT COMPLETED|Overall Study||10
10213744|NCT03654326|11340438|FG000|STARTED|Overall Study||94
10213745|NCT03654326|11340439|FG001|STARTED|Overall Study||93
10213746|NCT03654326|11340438|FG000|COMPLETED|Overall Study||88
10213747|NCT03654326|11340439|FG001|COMPLETED|Overall Study||87
10213748|NCT03654326|11340438|FG000|NOT COMPLETED|Overall Study||6
10213749|NCT03654326|11340439|FG001|NOT COMPLETED|Overall Study||6
10213750|NCT03654417|11340447|FG000|STARTED|Overall Study||19
10213751|NCT03654417|11340448|FG001|STARTED|Overall Study||18
10213752|NCT03654417|11340447|FG000|COMPLETED|Overall Study||19
10213753|NCT03654417|11340448|FG001|COMPLETED|Overall Study||18
10213754|NCT03654417|11340447|FG000|NOT COMPLETED|Overall Study||0
10213755|NCT03654417|11340448|FG001|NOT COMPLETED|Overall Study||0
10213756|NCT03654560|11340456|FG000|STARTED|Overall Study||118
10213757|NCT03654560|11340457|FG001|STARTED|Overall Study||118
10213758|NCT03654560|11340456|FG000|COMPLETED|Overall Study||114
10213759|NCT03654560|11340457|FG001|COMPLETED|Overall Study||117
10213760|NCT03654560|11340456|FG000|NOT COMPLETED|Overall Study||4
10213761|NCT03654560|11340457|FG001|NOT COMPLETED|Overall Study||1
10213762|NCT03655080|11340463|FG000|STARTED|Overall Study||2
10213763|NCT03655080|11340463|FG000|COMPLETED|Overall Study||2
10213764|NCT03655080|11340463|FG000|NOT COMPLETED|Overall Study||0
10213765|NCT03655106|11340469|FG000|STARTED|Overall Study||135
10213766|NCT03655106|11340470|FG001|STARTED|Overall Study||135
10213767|NCT03655106|11340469|FG000|COMPLETED|Overall Study||126
10213768|NCT03655106|11340470|FG001|COMPLETED|Overall Study||131
10213769|NCT03655106|11340469|FG000|NOT COMPLETED|Overall Study||9
10213770|NCT03655106|11340470|FG001|NOT COMPLETED|Overall Study||4
10213771|NCT03655301|11340476|FG000|STARTED|Overall Study||13
10213772|NCT03655301|11340476|FG000|COMPLETED|Overall Study||13
10213773|NCT03655301|11340476|FG000|NOT COMPLETED|Overall Study||0
10213774|NCT03655405|11340482|FG000|STARTED|Overall Study||32
10213775|NCT03655405|11340483|FG001|STARTED|Overall Study||30
10213776|NCT03655405|11340482|FG000|COMPLETED|Overall Study||27
10213777|NCT03655405|11340483|FG001|COMPLETED|Overall Study||25
10213778|NCT03655405|11340482|FG000|NOT COMPLETED|Overall Study||5
10213779|NCT03655405|11340483|FG001|NOT COMPLETED|Overall Study||5
10213780|NCT03655444|11340491|FG000|STARTED|Overall Study||3
10213781|NCT03655444|11340492|FG001|STARTED|Overall Study||3
10213782|NCT03655444|11340491|FG000|COMPLETED|Overall Study||3
10213783|NCT03655444|11340492|FG001|COMPLETED|Overall Study||3
10213784|NCT03655444|11340491|FG000|NOT COMPLETED|Overall Study||0
10213785|NCT03655444|11340492|FG001|NOT COMPLETED|Overall Study||0
10213786|NCT03655951|11340500|FG000|STARTED|Overall Study||358
10213787|NCT03655951|11340501|FG001|STARTED|Overall Study||372
10213788|NCT03655951|11340500|FG000|Completed Pretest|Overall Study||344
10213789|NCT03655951|11340501|FG001|Completed Pretest|Overall Study||366
10213790|NCT03655951|11340500|FG000|COMPLETED|Overall Study||319
10213791|NCT03655951|11340501|FG001|COMPLETED|Overall Study||351
10213792|NCT03655951|11340500|FG000|NOT COMPLETED|Overall Study||39
10213793|NCT03655951|11340501|FG001|NOT COMPLETED|Overall Study||21
10213794|NCT03656939|11340507|FG000|STARTED|Overall Study||21240
10213795|NCT03656939|11340507|FG000|Main Study Cohort|Overall Study||21240
10213796|NCT03656939|11340507|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
10213797|NCT03656939|11340507|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
10213798|NCT03656939|11340507|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
10213799|NCT03656939|11340507|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
10213800|NCT03656939|11340507|FG000|Prospective Study Cohort|Overall Study||2300
10213801|NCT03656939|11340507|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
10213802|NCT03656939|11340507|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
10213803|NCT03656939|11340507|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
10213804|NCT03656939|11340507|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
10213805|NCT03656939|11340507|FG000|COMPLETED|Overall Study||21240
10213806|NCT03656939|11340507|FG000|NOT COMPLETED|Overall Study||0
10213807|NCT03657095|11340515|FG000|STARTED|Overall Study||59
10213808|NCT03657095|11340516|FG001|STARTED|Overall Study||53
10213809|NCT03657095|11340515|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59
10213810|NCT03657095|11340516|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53
10213811|NCT03657095|11340515|FG000|COMPLETED|Overall Study||0
10213812|NCT03657095|11340516|FG001|COMPLETED|Overall Study||0
10213813|NCT03657095|11340515|FG000|NOT COMPLETED|Overall Study||59
10213814|NCT03657095|11340516|FG001|NOT COMPLETED|Overall Study||53
10213815|NCT03657134|11340522|FG000|STARTED|Overall Study||20
10012086|NCT01783912|11134930|FG002|COMPLETED|Overall Study||25
10213816|NCT03657134|11340522|FG000|COMPLETED|Overall Study||20
10213817|NCT03657134|11340522|FG000|NOT COMPLETED|Overall Study||0
10213818|NCT03657264|11340531|FG000|STARTED|Overall Study||12
10213819|NCT03657264|11340532|FG001|STARTED|Overall Study||12
10213820|NCT03657264|11340533|FG002|STARTED|Overall Study||12
10213821|NCT03657264|11340534|FG003|STARTED|Overall Study||12
10213822|NCT03657264|11340531|FG000|COMPLETED|Overall Study||12
10213823|NCT03657264|11340532|FG001|COMPLETED|Overall Study||12
10213824|NCT03657264|11340533|FG002|COMPLETED|Overall Study||12
10213825|NCT03657264|11340534|FG003|COMPLETED|Overall Study||12
10213826|NCT03657264|11340531|FG000|NOT COMPLETED|Overall Study||0
10213827|NCT03657264|11340532|FG001|NOT COMPLETED|Overall Study||0
10213828|NCT03657264|11340533|FG002|NOT COMPLETED|Overall Study||0
10213829|NCT03657264|11340534|FG003|NOT COMPLETED|Overall Study||0
10213830|NCT03657277|11340545|FG000|STARTED|Overall Study||46
10213831|NCT03657277|11340545|FG000|COMPLETED|Overall Study||35
10213832|NCT03657277|11340545|FG000|NOT COMPLETED|Overall Study||11
10213833|NCT03657407|11340551|FG000|STARTED|Overall Study||29
10213834|NCT03657407|11340552|FG001|STARTED|Overall Study||27
10213835|NCT03657407|11340551|FG000|COMPLETED|Overall Study||29
10213836|NCT03657407|11340552|FG001|COMPLETED|Overall Study||27
10213837|NCT03657407|11340551|FG000|NOT COMPLETED|Overall Study||0
10213838|NCT03657407|11340552|FG001|NOT COMPLETED|Overall Study||0
10213839|NCT03658811|11340558|FG000|STARTED|Overall Study||19
10213840|NCT03658811|11340558|FG000|COMPLETED|Overall Study||16
10213841|NCT03658811|11340558|FG000|NOT COMPLETED|Overall Study||3
10213842|NCT03658876|11340564|FG000|STARTED|Overall Study||88
10213843|NCT03658876|11340565|FG001|STARTED|Overall Study||96
10213844|NCT03658876|11340564|FG000|COMPLETED|Overall Study||76
10213845|NCT03658876|11340565|FG001|COMPLETED|Overall Study||84
10213846|NCT03658876|11340564|FG000|NOT COMPLETED|Overall Study||12
10213847|NCT03658876|11340565|FG001|NOT COMPLETED|Overall Study||12
10213848|NCT03658889|11340573|FG000|STARTED|Overall Study|Enrolled population|308
10213849|NCT03658889|11340574|FG001|STARTED|Overall Study||69
10213850|NCT03658889|11340573|FG000|COMPLETED|Overall Study|Analysis population|306
10213851|NCT03658889|11340574|FG001|COMPLETED|Overall Study||69
10213852|NCT03658889|11340573|FG000|NOT COMPLETED|Overall Study||2
10213853|NCT03658889|11340574|FG001|NOT COMPLETED|Overall Study||0
10213854|NCT03660787|11340583|FG000|STARTED|Overall Study||26
10213855|NCT03660787|11340584|FG001|STARTED|Overall Study||26
10213856|NCT03660787|11340585|FG002|STARTED|Overall Study||26
10213857|NCT03660787|11340586|FG003|STARTED|Overall Study||26
10213858|NCT03660787|11340583|FG000|COMPLETED|Overall Study||25
10213859|NCT03660787|11340584|FG001|COMPLETED|Overall Study||25
10213860|NCT03660787|11340585|FG002|COMPLETED|Overall Study||25
10213861|NCT03660787|11340586|FG003|COMPLETED|Overall Study||26
10213862|NCT03660787|11340583|FG000|NOT COMPLETED|Overall Study||1
10213863|NCT03660787|11340584|FG001|NOT COMPLETED|Overall Study||1
10213864|NCT03660787|11340585|FG002|NOT COMPLETED|Overall Study||1
10213865|NCT03660787|11340586|FG003|NOT COMPLETED|Overall Study||0
10213866|NCT03661346|11340598|FG000|STARTED|Overall Study|Esmolol administration|13
10213867|NCT03661346|11340599|FG001|STARTED|Overall Study||15
10213868|NCT03661346|11340598|FG000|COMPLETED|Overall Study||13
10213869|NCT03661346|11340599|FG001|COMPLETED|Overall Study||15
10213870|NCT03661346|11340598|FG000|NOT COMPLETED|Overall Study||0
10213871|NCT03661346|11340599|FG001|NOT COMPLETED|Overall Study||0
10213872|NCT03661541|11340608|FG000|STARTED|Overall Study||12
10213873|NCT03661541|11340609|FG001|STARTED|Overall Study||12
10213874|NCT03661541|11340610|FG002|STARTED|Overall Study||12
10213875|NCT03661541|11340608|FG000|COMPLETED|Overall Study||10
10213876|NCT03661541|11340609|FG001|COMPLETED|Overall Study||10
10213877|NCT03661541|11340610|FG002|COMPLETED|Overall Study||10
10213878|NCT03661541|11340608|FG000|NOT COMPLETED|Overall Study||2
10213879|NCT03661541|11340609|FG001|NOT COMPLETED|Overall Study||2
10213880|NCT03661541|11340610|FG002|NOT COMPLETED|Overall Study||2
10213881|NCT03661697|11340624|FG000|STARTED|Overall Study||7
10213882|NCT03661697|11340625|FG001|STARTED|Overall Study||7
10213883|NCT03661697|11340624|FG000|COMPLETED|Overall Study||7
10213884|NCT03661697|11340625|FG001|COMPLETED|Overall Study||7
10213885|NCT03661697|11340624|FG000|NOT COMPLETED|Overall Study||0
10213886|NCT03661697|11340625|FG001|NOT COMPLETED|Overall Study||0
10213887|NCT03661762|11340631|FG000|STARTED|Overall Study||18
10213888|NCT03661762|11340631|FG000|COMPLETED|Overall Study||10
10213889|NCT03661762|11340631|FG000|NOT COMPLETED|Overall Study||8
10213890|NCT03661814|11340638|FG000|STARTED|Overall Study||2
10213891|NCT03661814|11340639|FG001|STARTED|Overall Study||5
10213892|NCT03661814|11340638|FG000|COMPLETED|Overall Study||2
10213893|NCT03661814|11340639|FG001|COMPLETED|Overall Study||5
10213894|NCT03661814|11340638|FG000|NOT COMPLETED|Overall Study||0
10213895|NCT03661814|11340639|FG001|NOT COMPLETED|Overall Study||0
10213896|NCT03661983|11340645|FG000|STARTED|Open Label Stabilization Phase||36
10213897|NCT03661983|11340646|FG001|STARTED|Open Label Stabilization Phase||0
10213898|NCT03661983|11340647|FG002|STARTED|Open Label Stabilization Phase||0
10213899|NCT03661983|11340648|FG003|STARTED|Open Label Stabilization Phase||0
10213900|NCT03661983|11340645|FG000|COMPLETED|Open Label Stabilization Phase||25
10213901|NCT03661983|11340646|FG001|COMPLETED|Open Label Stabilization Phase||0
10213902|NCT03661983|11340647|FG002|COMPLETED|Open Label Stabilization Phase||0
10213903|NCT03661983|11340648|FG003|COMPLETED|Open Label Stabilization Phase||0
10213904|NCT03661983|11340645|FG000|NOT COMPLETED|Open Label Stabilization Phase||11
10213905|NCT03661983|11340646|FG001|NOT COMPLETED|Open Label Stabilization Phase||0
10213906|NCT03661983|11340647|FG002|NOT COMPLETED|Open Label Stabilization Phase||0
10213907|NCT03661983|11340648|FG003|NOT COMPLETED|Open Label Stabilization Phase||0
10213908|NCT03661983|11340645|FG000|STARTED|Double-blind Randomized Phase||0
10213909|NCT03661983|11340646|FG001|STARTED|Double-blind Randomized Phase||9
10213910|NCT03661983|11340647|FG002|STARTED|Double-blind Randomized Phase||8
10213911|NCT03661983|11340648|FG003|STARTED|Double-blind Randomized Phase||8
10213912|NCT03661983|11340645|FG000|COMPLETED|Double-blind Randomized Phase||0
10213913|NCT03661983|11340646|FG001|COMPLETED|Double-blind Randomized Phase||7
10012087|NCT01783912|11134928|FG000|NOT COMPLETED|Overall Study||30
10012088|NCT01783912|11134929|FG001|NOT COMPLETED|Overall Study||46
10012089|NCT01783912|11134930|FG002|NOT COMPLETED|Overall Study||23
10012090|NCT01783938|11134940|FG000|STARTED|Overall Study||68
10012091|NCT01783938|11134941|FG001|STARTED|Overall Study||70
10012092|NCT01783938|11134940|FG000|COMPLETED|Overall Study||11
10012093|NCT01783938|11134941|FG001|COMPLETED|Overall Study||9
10012094|NCT01783938|11134940|FG000|NOT COMPLETED|Overall Study||57
10012095|NCT01783938|11134941|FG001|NOT COMPLETED|Overall Study||61
10012096|NCT01783990|11134949|FG000|STARTED|Overall Study||130
10012097|NCT01783990|11134950|FG001|STARTED|Overall Study||20
10012098|NCT01783990|11134949|FG000|COMPLETED|Overall Study||125
10012099|NCT01783990|11134950|FG001|COMPLETED|Overall Study||18
10012100|NCT01783990|11134949|FG000|NOT COMPLETED|Overall Study||5
10012101|NCT01783990|11134950|FG001|NOT COMPLETED|Overall Study||2
10213914|NCT03661983|11340647|FG002|COMPLETED|Double-blind Randomized Phase||7
10213915|NCT03661983|11340648|FG003|COMPLETED|Double-blind Randomized Phase||0
10213916|NCT03661983|11340645|FG000|NOT COMPLETED|Double-blind Randomized Phase||0
10213917|NCT03661983|11340646|FG001|NOT COMPLETED|Double-blind Randomized Phase||2
10213918|NCT03661983|11340647|FG002|NOT COMPLETED|Double-blind Randomized Phase||1
10213919|NCT03661983|11340648|FG003|NOT COMPLETED|Double-blind Randomized Phase||8
10213920|NCT03662074|11340657|FG000|STARTED|Overall Study||14
10213921|NCT03662074|11340657|FG000|COMPLETED|Overall Study||14
10213922|NCT03662074|11340657|FG000|NOT COMPLETED|Overall Study||0
10213923|NCT03662139|11340663|FG000|STARTED|Overall Study||16
10213924|NCT03662139|11340664|FG001|STARTED|Overall Study||16
10213925|NCT03662139|11340663|FG000|COMPLETED|Overall Study||16
10213926|NCT03662139|11340664|FG001|COMPLETED|Overall Study||16
10213927|NCT03662139|11340663|FG000|NOT COMPLETED|Overall Study||0
10213928|NCT03662139|11340664|FG001|NOT COMPLETED|Overall Study||0
10213929|NCT03662282|11340672|FG000|STARTED|Overall Study||2
10213930|NCT03662282|11340672|FG000|COMPLETED|Overall Study||2
10213931|NCT03662282|11340672|FG000|NOT COMPLETED|Overall Study||0
10213932|NCT03662334|11340678|FG000|STARTED|Part 1: Treatment Period 1||0
10213933|NCT03662334|11340679|FG001|STARTED|Part 1: Treatment Period 1||0
10213934|NCT03662334|11340678|FG000|COMPLETED|Part 1: Treatment Period 1||0
10213935|NCT03662334|11340679|FG001|COMPLETED|Part 1: Treatment Period 1||0
10213936|NCT03662334|11340678|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0
10213937|NCT03662334|11340679|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0
10213938|NCT03662334|11340678|FG000|STARTED|Part 1: Treatment Period 2||0
10213939|NCT03662334|11340679|FG001|STARTED|Part 1: Treatment Period 2||0
10213940|NCT03662334|11340678|FG000|COMPLETED|Part 1: Treatment Period 2||0
10213941|NCT03662334|11340679|FG001|COMPLETED|Part 1: Treatment Period 2||0
10213942|NCT03662334|11340678|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0
10213943|NCT03662334|11340679|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0
10213944|NCT03662334|11340678|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
10213945|NCT03662334|11340679|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
10213946|NCT03662334|11340678|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
10213947|NCT03662334|11340679|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
10213948|NCT03662334|11340678|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
10213949|NCT03662334|11340679|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
10213950|NCT03662334|11340678|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7
10213951|NCT03662334|11340679|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7
10213952|NCT03662334|11340678|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
10213953|NCT03662334|11340679|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
10213954|NCT03662334|11340678|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
10213955|NCT03662334|11340679|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
10213956|NCT03662334|11340678|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
10213957|NCT03662334|11340679|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
10213958|NCT03662334|11340678|FG000|COMPLETED|Part 3: Treatment Period 1||0
10213959|NCT03662334|11340679|FG001|COMPLETED|Part 3: Treatment Period 1||0
10213960|NCT03662334|11340678|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0
10213961|NCT03662334|11340679|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0
10213962|NCT03662334|11340678|FG000|STARTED|Part 3: Treatment Period 2||0
10012102|NCT01784029|11134961|FG000|STARTED|Overall Study||61
10012103|NCT01784029|11134962|FG001|STARTED|Overall Study||59
10213963|NCT03662334|11340679|FG001|STARTED|Part 3: Treatment Period 2||0
10213964|NCT03662334|11340678|FG000|COMPLETED|Part 3: Treatment Period 2||0
10213965|NCT03662334|11340679|FG001|COMPLETED|Part 3: Treatment Period 2||0
10012104|NCT01784029|11134963|FG002|STARTED|Overall Study||63
10012105|NCT01784029|11134961|FG000|COMPLETED|Overall Study||42
10012106|NCT01784029|11134962|FG001|COMPLETED|Overall Study||39
10012107|NCT01784029|11134963|FG002|COMPLETED|Overall Study||41
10213966|NCT03662334|11340678|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0
10213967|NCT03662334|11340679|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0
10213968|NCT03662360|11340687|FG000|STARTED|Overall Study||16
10213969|NCT03662360|11340688|FG001|STARTED|Overall Study||16
10213970|NCT03662360|11340687|FG000|COMPLETED|Overall Study||16
10213971|NCT03662360|11340688|FG001|COMPLETED|Overall Study||14
10213972|NCT03662360|11340687|FG000|NOT COMPLETED|Overall Study||0
10213973|NCT03662360|11340688|FG001|NOT COMPLETED|Overall Study||2
10213974|NCT03662750|11340695|FG000|STARTED|Overall Study||3
10213975|NCT03662750|11340695|FG000|COMPLETED|Overall Study||2
10213976|NCT03662750|11340695|FG000|NOT COMPLETED|Overall Study||1
10213977|NCT03662789|11340701|FG000|STARTED|Overall Study|Baseline|52
10213978|NCT03662789|11340702|FG001|STARTED|Overall Study|Baseline|50
10213979|NCT03662789|11340701|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47
10213980|NCT03662789|11340702|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43
10213981|NCT03662789|11340701|FG000|NOT COMPLETED|Overall Study||5
10213982|NCT03662789|11340702|FG001|NOT COMPLETED|Overall Study||7
10213983|NCT03662997|11340712|FG000|STARTED|Overall Study||11
10213984|NCT03662997|11340713|FG001|STARTED|Overall Study||10
10213985|NCT03662997|11340714|FG002|STARTED|Overall Study||11
10213986|NCT03662997|11340715|FG003|STARTED|Overall Study||8
10213987|NCT03662997|11340712|FG000|COMPLETED|Overall Study||11
10213988|NCT03662997|11340713|FG001|COMPLETED|Overall Study||8
10213989|NCT03662997|11340714|FG002|COMPLETED|Overall Study||11
10213990|NCT03662997|11340715|FG003|COMPLETED|Overall Study||8
10213991|NCT03662997|11340712|FG000|NOT COMPLETED|Overall Study||0
10213992|NCT03662997|11340713|FG001|NOT COMPLETED|Overall Study||2
10213993|NCT03662997|11340714|FG002|NOT COMPLETED|Overall Study||0
10213994|NCT03662997|11340715|FG003|NOT COMPLETED|Overall Study||0
10213995|NCT03663101|11340731|FG000|STARTED|Overall Study||4
10213996|NCT03663101|11340732|FG001|STARTED|Overall Study||3
10213997|NCT03663101|11340733|FG002|STARTED|Overall Study||5
10213998|NCT03663101|11340734|FG003|STARTED|Overall Study||4
10213999|NCT03663101|11340731|FG000|COMPLETED|Overall Study||4
10214000|NCT03663101|11340732|FG001|COMPLETED|Overall Study||3
10214001|NCT03663101|11340733|FG002|COMPLETED|Overall Study||5
10214002|NCT03663101|11340734|FG003|COMPLETED|Overall Study||4
10214003|NCT03663101|11340731|FG000|NOT COMPLETED|Overall Study||0
10214004|NCT03663101|11340732|FG001|NOT COMPLETED|Overall Study||0
10214005|NCT03663101|11340733|FG002|NOT COMPLETED|Overall Study||0
10214006|NCT03663101|11340734|FG003|NOT COMPLETED|Overall Study||0
10214007|NCT03663179|11340746|FG000|STARTED|Overall Study||18
10214008|NCT03663179|11340747|FG001|STARTED|Overall Study||14
10214009|NCT03663179|11340746|FG000|COMPLETED|Overall Study||14
10214010|NCT03663179|11340747|FG001|COMPLETED|Overall Study||13
10214011|NCT03663179|11340746|FG000|NOT COMPLETED|Overall Study||4
10214012|NCT03663179|11340747|FG001|NOT COMPLETED|Overall Study||1
10214013|NCT03663231|11340755|FG000|STARTED|First Intervention||16
10214014|NCT03663231|11340756|FG001|STARTED|First Intervention||13
10214015|NCT03663231|11340755|FG000|COMPLETED|First Intervention||14
10214016|NCT03663231|11340756|FG001|COMPLETED|First Intervention||12
10214017|NCT03663231|11340755|FG000|NOT COMPLETED|First Intervention||2
10214018|NCT03663231|11340756|FG001|NOT COMPLETED|First Intervention||1
10214019|NCT03663231|11340755|FG000|STARTED|Washout||14
10214020|NCT03663231|11340756|FG001|STARTED|Washout||12
10214021|NCT03663231|11340755|FG000|COMPLETED|Washout||14
10214022|NCT03663231|11340756|FG001|COMPLETED|Washout||12
10214023|NCT03663231|11340755|FG000|NOT COMPLETED|Washout||0
10214024|NCT03663231|11340756|FG001|NOT COMPLETED|Washout||0
10214025|NCT03663231|11340755|FG000|STARTED|Second Intervention||14
10214026|NCT03663231|11340756|FG001|STARTED|Second Intervention||12
10214027|NCT03663231|11340755|FG000|COMPLETED|Second Intervention||14
10214028|NCT03663231|11340756|FG001|COMPLETED|Second Intervention||12
10214029|NCT03663231|11340755|FG000|NOT COMPLETED|Second Intervention||0
10214030|NCT03663231|11340756|FG001|NOT COMPLETED|Second Intervention||0
10214031|NCT03663283|11340764|FG000|STARTED|Overall Study||52
10214032|NCT03663283|11340765|FG001|STARTED|Overall Study||52
10214033|NCT03663283|11340764|FG000|COMPLETED|Overall Study||52
10214034|NCT03663283|11340765|FG001|COMPLETED|Overall Study||52
10214035|NCT03663283|11340764|FG000|NOT COMPLETED|Overall Study||0
10214036|NCT03663283|11340765|FG001|NOT COMPLETED|Overall Study||0
10214037|NCT03663569|11340771|FG000|STARTED|Overall Study||4819
10214038|NCT03663569|11340771|FG000|COMPLETED|Overall Study||4756
10214039|NCT03663569|11340771|FG000|NOT COMPLETED|Overall Study||63
10214040|NCT03663582|11340775|FG000|STARTED|Overall Study||7
10214041|NCT03663582|11340775|FG000|COMPLETED|Overall Study||6
10214042|NCT03663582|11340775|FG000|NOT COMPLETED|Overall Study||1
10214043|NCT03663816|11340779|FG000|STARTED|Overall Study||15
10214044|NCT03663816|11340779|FG000|COMPLETED|Overall Study||15
10214045|NCT03663816|11340779|FG000|NOT COMPLETED|Overall Study||0
10214046|NCT03664193|11340783|FG000|STARTED|Overall Study||30
10214047|NCT03664193|11340783|FG000|COMPLETED|Overall Study||30
10214048|NCT03664193|11340783|FG000|NOT COMPLETED|Overall Study||0
10214049|NCT03664544|11340789|FG000|STARTED|Overall Study||6
10214050|NCT03664544|11340790|FG001|STARTED|Overall Study||6
10214051|NCT03664544|11340789|FG000|COMPLETED|Overall Study||6
10214052|NCT03664544|11340790|FG001|COMPLETED|Overall Study||6
10214053|NCT03664544|11340789|FG000|NOT COMPLETED|Overall Study||0
10214054|NCT03664544|11340790|FG001|NOT COMPLETED|Overall Study||0
10214055|NCT03665155|11340799|FG000|STARTED|Overall Study||3
10214056|NCT03665155|11340800|FG001|STARTED|Overall Study||7
10214057|NCT03665155|11340801|FG002|STARTED|Overall Study||1
10214058|NCT03665155|11340799|FG000|COMPLETED|Overall Study||3
10214059|NCT03665155|11340800|FG001|COMPLETED|Overall Study||7
10214060|NCT03665155|11340801|FG002|COMPLETED|Overall Study||1
10214061|NCT03665155|11340799|FG000|NOT COMPLETED|Overall Study||0
10214062|NCT03665155|11340800|FG001|NOT COMPLETED|Overall Study||0
10214063|NCT03665155|11340801|FG002|NOT COMPLETED|Overall Study||0
10214064|NCT03666026|11340811|FG000|STARTED|Overall Study||41070
10214065|NCT03666026|11340812|FG001|STARTED|Overall Study||41055
10214066|NCT03666026|11340813|FG002|STARTED|Overall Study||41046
10214067|NCT03666026|11340814|FG003|STARTED|Overall Study||41034
10214068|NCT03666026|11340811|FG000|COMPLETED|Overall Study||41070
10214069|NCT03666026|11340812|FG001|COMPLETED|Overall Study||41055
10214070|NCT03666026|11340813|FG002|COMPLETED|Overall Study||41046
10214071|NCT03666026|11340814|FG003|COMPLETED|Overall Study||41034
10214072|NCT03666026|11340811|FG000|NOT COMPLETED|Overall Study||0
10214073|NCT03666026|11340812|FG001|NOT COMPLETED|Overall Study||0
10214074|NCT03666026|11340813|FG002|NOT COMPLETED|Overall Study||0
10214075|NCT03666026|11340814|FG003|NOT COMPLETED|Overall Study||0
10214076|NCT03666663|11340828|FG000|STARTED|Overall Study||3
10214077|NCT03666663|11340829|FG001|STARTED|Overall Study||1
10214078|NCT03666663|11340830|FG002|STARTED|Overall Study||3
10214079|NCT03666663|11340831|FG003|STARTED|Overall Study||3
10214080|NCT03666663|11340828|FG000|COMPLETED|Overall Study||3
10214081|NCT03666663|11340829|FG001|COMPLETED|Overall Study||1
10214082|NCT03666663|11340830|FG002|COMPLETED|Overall Study||1
10214083|NCT03666663|11340831|FG003|COMPLETED|Overall Study||1
10214084|NCT03666663|11340828|FG000|NOT COMPLETED|Overall Study||0
10214085|NCT03666663|11340829|FG001|NOT COMPLETED|Overall Study||0
10214086|NCT03666663|11340830|FG002|NOT COMPLETED|Overall Study||2
10214087|NCT03666663|11340831|FG003|NOT COMPLETED|Overall Study||2
10214088|NCT03666858|11340841|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
10214089|NCT03666858|11340842|FG001|STARTED|Cohort 1||0
10214090|NCT03666858|11340841|FG000|COMPLETED|Cohort 1||215
10214091|NCT03666858|11340842|FG001|COMPLETED|Cohort 1||0
10214092|NCT03666858|11340841|FG000|NOT COMPLETED|Cohort 1||1
10214093|NCT03666858|11340842|FG001|NOT COMPLETED|Cohort 1||0
10214094|NCT03666858|11340841|FG000|STARTED|Cohort 2||0
10214095|NCT03666858|11340842|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
10214096|NCT03666858|11340841|FG000|COMPLETED|Cohort 2||0
10214097|NCT03666858|11340842|FG001|COMPLETED|Cohort 2||137
10214098|NCT03666858|11340841|FG000|NOT COMPLETED|Cohort 2||0
10214099|NCT03666858|11340842|FG001|NOT COMPLETED|Cohort 2||1
10214100|NCT03667053|11340851|FG000|STARTED|Overall Study||21
10214101|NCT03667053|11340852|FG001|STARTED|Overall Study||11
10214102|NCT03667053|11340853|FG002|STARTED|Overall Study||10
10214103|NCT03667053|11340851|FG000|Randomized and Treated|Overall Study||20
10214104|NCT03667053|11340852|FG001|Randomized and Treated|Overall Study||11
10214105|NCT03667053|11340853|FG002|Randomized and Treated|Overall Study||10
10214106|NCT03667053|11340851|FG000|COMPLETED|Overall Study||20
10214107|NCT03667053|11340852|FG001|COMPLETED|Overall Study||11
10214108|NCT03667053|11340853|FG002|COMPLETED|Overall Study||10
10214109|NCT03667053|11340851|FG000|NOT COMPLETED|Overall Study||1
10214110|NCT03667053|11340852|FG001|NOT COMPLETED|Overall Study||0
10214111|NCT03667053|11340853|FG002|NOT COMPLETED|Overall Study||0
10214112|NCT03667547|11340868|FG000|STARTED|Overall Study||12
10214113|NCT03667547|11340868|FG000|COMPLETED|Overall Study||12
10214114|NCT03667547|11340868|FG000|NOT COMPLETED|Overall Study||0
10214115|NCT03668600|11340872|FG000|STARTED|Overall Study||230
10214116|NCT03668600|11340872|FG000|COMPLETED|Overall Study||0
10214117|NCT03668600|11340872|FG000|NOT COMPLETED|Overall Study||230
10214118|NCT03668613|11340878|FG000|STARTED|Overall Study||42
10214119|NCT03668613|11340879|FG001|STARTED|Overall Study||42
10214120|NCT03668613|11340878|FG000|COMPLETED|Overall Study||42
10214121|NCT03668613|11340879|FG001|COMPLETED|Overall Study||39
10214122|NCT03668613|11340878|FG000|NOT COMPLETED|Overall Study||0
10214123|NCT03668613|11340879|FG001|NOT COMPLETED|Overall Study||3
10214124|NCT03669081|11340888|FG000|STARTED|Overall Study||34
10214125|NCT03669081|11340889|FG001|STARTED|Overall Study||30
10214126|NCT03669081|11340888|FG000|COMPLETED|Overall Study||33
10214127|NCT03669081|11340889|FG001|COMPLETED|Overall Study||29
10214128|NCT03669081|11340888|FG000|NOT COMPLETED|Overall Study||1
10214129|NCT03669081|11340889|FG001|NOT COMPLETED|Overall Study||1
10214130|NCT03669354|11340899|FG000|STARTED|Overall Study||73
10214131|NCT03669354|11340900|FG001|STARTED|Overall Study||22
10214132|NCT03669354|11340901|FG002|STARTED|Overall Study||47
10214133|NCT03669354|11340902|FG003|STARTED|Overall Study||53
10214134|NCT03669354|11340899|FG000|COMPLETED|Overall Study||73
10214135|NCT03669354|11340900|FG001|COMPLETED|Overall Study||22
10214136|NCT03669354|11340901|FG002|COMPLETED|Overall Study||47
10214137|NCT03669354|11340902|FG003|COMPLETED|Overall Study||53
10214138|NCT03669354|11340899|FG000|NOT COMPLETED|Overall Study||0
10214139|NCT03669354|11340900|FG001|NOT COMPLETED|Overall Study||0
10214140|NCT03669354|11340901|FG002|NOT COMPLETED|Overall Study||0
10214141|NCT03669354|11340902|FG003|NOT COMPLETED|Overall Study||0
10214142|NCT03669549|11340913|FG000|STARTED|Overall Study||15
10214143|NCT03669549|11340913|FG000|COMPLETED|Overall Study||9
10214144|NCT03669549|11340913|FG000|NOT COMPLETED|Overall Study||6
10214145|NCT03669861|11340921|FG000|STARTED|Overall Study||10
10214146|NCT03669861|11340921|FG000|COMPLETED|Overall Study||3
10214147|NCT03669861|11340921|FG000|NOT COMPLETED|Overall Study||7
10214148|NCT03670017|11340925|FG000|STARTED|Overall Study||68
10214149|NCT03670017|11340925|FG000|COMPLETED|Overall Study||50
10214150|NCT03670017|11340925|FG000|NOT COMPLETED|Overall Study||18
10214151|NCT03670030|11340929|FG000|STARTED|Overall Study||5
10214152|NCT03670030|11340929|FG000|COMPLETED|Overall Study||5
10214153|NCT03670030|11340929|FG000|NOT COMPLETED|Overall Study||0
10214154|NCT03670160|11340935|FG000|STARTED|Overall Study||11
10214155|NCT03670160|11340936|FG001|STARTED|Overall Study||14
10214156|NCT03670160|11340935|FG000|COMPLETED|Overall Study||11
10214157|NCT03670160|11340936|FG001|COMPLETED|Overall Study||14
10214158|NCT03670160|11340935|FG000|NOT COMPLETED|Overall Study||0
10214159|NCT03670160|11340936|FG001|NOT COMPLETED|Overall Study||0
10214160|NCT03670264|11340945|FG000|STARTED|Overall Study||5
10214161|NCT03670264|11340946|FG001|STARTED|Overall Study||5
10214162|NCT03670264|11340947|FG002|STARTED|Overall Study||5
10214163|NCT03670264|11340945|FG000|COMPLETED|Overall Study||5
10214164|NCT03670264|11340946|FG001|COMPLETED|Overall Study||5
10214165|NCT03670264|11340947|FG002|COMPLETED|Overall Study||5
10214166|NCT03670264|11340945|FG000|NOT COMPLETED|Overall Study||0
10214167|NCT03670264|11340946|FG001|NOT COMPLETED|Overall Study||0
10214168|NCT03670264|11340947|FG002|NOT COMPLETED|Overall Study||0
10214169|NCT03670537|11340955|FG000|STARTED|Overall Study||102
10214170|NCT03670537|11340955|FG000|COMPLETED|Overall Study||101
10214171|NCT03670537|11340955|FG000|NOT COMPLETED|Overall Study||1
10214172|NCT03670641|11340959|FG000|STARTED|Overall Study||10
10214173|NCT03670641|11340959|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7
10214174|NCT03670641|11340959|FG000|NOT COMPLETED|Overall Study||3
10214175|NCT03670810|11340969|FG000|STARTED|Overall Study||485
10214176|NCT03670810|11340970|FG001|STARTED|Overall Study||486
10214177|NCT03670810|11340971|FG002|STARTED|Overall Study||249
10214178|NCT03670810|11340972|FG003|STARTED|Overall Study||251
10214179|NCT03670810|11340969|FG000|Treated at Least One Migraine Attack|Overall Study||485
10214180|NCT03670810|11340970|FG001|Treated at Least One Migraine Attack|Overall Study||486
10214181|NCT03670810|11340971|FG002|Treated at Least One Migraine Attack|Overall Study||249
10214182|NCT03670810|11340972|FG003|Treated at Least One Migraine Attack|Overall Study||251
10214183|NCT03670810|11340969|FG000|COMPLETED|Overall Study||381
10214184|NCT03670810|11340970|FG001|COMPLETED|Overall Study||369
10214185|NCT03670810|11340971|FG002|COMPLETED|Overall Study||208
10214186|NCT03670810|11340972|FG003|COMPLETED|Overall Study||213
10214187|NCT03670810|11340969|FG000|NOT COMPLETED|Overall Study||104
10214188|NCT03670810|11340970|FG001|NOT COMPLETED|Overall Study||117
10214189|NCT03670810|11340971|FG002|NOT COMPLETED|Overall Study||41
10214190|NCT03670810|11340972|FG003|NOT COMPLETED|Overall Study||38
10214191|NCT03672006|11340984|FG000|STARTED|Overall Study||10
10214192|NCT03672006|11340985|FG001|STARTED|Overall Study||10
10214193|NCT03672006|11340984|FG000|COMPLETED|Overall Study||10
10214194|NCT03672006|11340985|FG001|COMPLETED|Overall Study||9
10214195|NCT03672006|11340984|FG000|NOT COMPLETED|Overall Study||0
10214196|NCT03672006|11340985|FG001|NOT COMPLETED|Overall Study||1
10214197|NCT03672032|11340995|FG000|STARTED|Overall Study||67
10214198|NCT03672032|11340996|FG001|STARTED|Overall Study||67
10214199|NCT03672032|11340995|FG000|COMPLETED|Overall Study||67
10214200|NCT03672032|11340996|FG001|COMPLETED|Overall Study||67
10214201|NCT03672032|11340995|FG000|NOT COMPLETED|Overall Study||0
10214202|NCT03672032|11340996|FG001|NOT COMPLETED|Overall Study||0
10214203|NCT03672097|11341002|FG000|STARTED|Period 1||204
10214204|NCT03672097|11341002|FG000|COMPLETED|Period 1||200
10214205|NCT03672097|11341002|FG000|NOT COMPLETED|Period 1||4
10214206|NCT03672097|11341002|FG000|STARTED|Period 2||200
10214207|NCT03672097|11341002|FG000|COMPLETED|Period 2||196
10214208|NCT03672097|11341002|FG000|NOT COMPLETED|Period 2||4
10214209|NCT03672370|11341006|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
10214210|NCT03672370|11341006|FG000|COMPLETED|Overall Study||42
10214211|NCT03672370|11341006|FG000|NOT COMPLETED|Overall Study||47
10214212|NCT03672396|11341010|FG000|STARTED|Overall Study||22
10214213|NCT03672396|11341010|FG000|COMPLETED|Overall Study||16
10214214|NCT03672396|11341010|FG000|NOT COMPLETED|Overall Study||6
10214215|NCT03673670|11341020|FG000|STARTED|Treatment Period 1 (3 Days)||14
10214216|NCT03673670|11341021|FG001|STARTED|Treatment Period 1 (3 Days)||14
10214217|NCT03673670|11341022|FG002|STARTED|Treatment Period 1 (3 Days)||13
10214218|NCT03673670|11341023|FG003|STARTED|Treatment Period 1 (3 Days)||12
10214219|NCT03673670|11341024|FG004|STARTED|Treatment Period 1 (3 Days)||13
10214220|NCT03673670|11341025|FG005|STARTED|Treatment Period 1 (3 Days)||13
10214221|NCT03673670|11341020|FG000|COMPLETED|Treatment Period 1 (3 Days)||13
10214222|NCT03673670|11341021|FG001|COMPLETED|Treatment Period 1 (3 Days)||14
10214223|NCT03673670|11341022|FG002|COMPLETED|Treatment Period 1 (3 Days)||12
10214224|NCT03673670|11341023|FG003|COMPLETED|Treatment Period 1 (3 Days)||12
10214225|NCT03673670|11341024|FG004|COMPLETED|Treatment Period 1 (3 Days)||13
10214226|NCT03673670|11341025|FG005|COMPLETED|Treatment Period 1 (3 Days)||11
10214227|NCT03673670|11341020|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1
10214228|NCT03673670|11341021|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10214229|NCT03673670|11341022|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1
10214230|NCT03673670|11341023|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10214231|NCT03673670|11341024|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10214232|NCT03673670|11341025|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2
10214233|NCT03673670|11341020|FG000|STARTED|Washout Period 1 (7-14 Days)||13
10214234|NCT03673670|11341021|FG001|STARTED|Washout Period 1 (7-14 Days)||14
10214235|NCT03673670|11341022|FG002|STARTED|Washout Period 1 (7-14 Days)||12
10214236|NCT03673670|11341023|FG003|STARTED|Washout Period 1 (7-14 Days)||12
10214237|NCT03673670|11341024|FG004|STARTED|Washout Period 1 (7-14 Days)||13
10214238|NCT03673670|11341025|FG005|STARTED|Washout Period 1 (7-14 Days)||11
10214239|NCT03673670|11341020|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13
10214240|NCT03673670|11341021|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14
10214241|NCT03673670|11341022|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12
10214242|NCT03673670|11341023|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12
10214243|NCT03673670|11341024|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13
10214244|NCT03673670|11341025|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11
10214245|NCT03673670|11341020|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10214246|NCT03673670|11341021|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10214247|NCT03673670|11341022|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10214248|NCT03673670|11341023|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10214249|NCT03673670|11341024|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10214250|NCT03673670|11341025|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10214251|NCT03673670|11341020|FG000|STARTED|Treatment Period 2 (3 Days)||13
10214252|NCT03673670|11341021|FG001|STARTED|Treatment Period 2 (3 Days)||14
10214253|NCT03673670|11341022|FG002|STARTED|Treatment Period 2 (3 Days)||12
10214254|NCT03673670|11341023|FG003|STARTED|Treatment Period 2 (3 Days)||12
10214255|NCT03673670|11341024|FG004|STARTED|Treatment Period 2 (3 Days)||13
10214256|NCT03673670|11341025|FG005|STARTED|Treatment Period 2 (3 Days)||11
10214257|NCT03673670|11341020|FG000|COMPLETED|Treatment Period 2 (3 Days)||13
10214258|NCT03673670|11341021|FG001|COMPLETED|Treatment Period 2 (3 Days)||14
10214259|NCT03673670|11341022|FG002|COMPLETED|Treatment Period 2 (3 Days)||11
10214260|NCT03673670|11341023|FG003|COMPLETED|Treatment Period 2 (3 Days)||12
10214261|NCT03673670|11341024|FG004|COMPLETED|Treatment Period 2 (3 Days)||12
10214262|NCT03673670|11341025|FG005|COMPLETED|Treatment Period 2 (3 Days)||11
10214263|NCT03673670|11341020|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10214264|NCT03673670|11341021|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10214265|NCT03673670|11341022|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1
10214266|NCT03673670|11341023|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10214267|NCT03673670|11341024|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1
9760769|NCT00383162|10864563|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
9760770|NCT00383162|10864564|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
9760771|NCT00383162|10864563|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
9760772|NCT00383162|10864564|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
9760773|NCT00383162|10864563|FG000|STARTED|Migraine Attack 2 (Period 2)||67
9760774|NCT00383162|10864564|FG001|STARTED|Migraine Attack 2 (Period 2)||73
9760775|NCT00383162|10864563|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65
9760776|NCT00383162|10864564|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66
9760777|NCT00383162|10864563|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
10214268|NCT03673670|11341025|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10214269|NCT03673670|11341020|FG000|STARTED|Washout Period 2 (7-14 Days)||13
10214270|NCT03673670|11341021|FG001|STARTED|Washout Period 2 (7-14 Days)||14
10214271|NCT03673670|11341022|FG002|STARTED|Washout Period 2 (7-14 Days)||11
10214272|NCT03673670|11341023|FG003|STARTED|Washout Period 2 (7-14 Days)||12
10214273|NCT03673670|11341024|FG004|STARTED|Washout Period 2 (7-14 Days)||12
10214274|NCT03673670|11341025|FG005|STARTED|Washout Period 2 (7-14 Days)||11
10214275|NCT03673670|11341020|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13
10214276|NCT03673670|11341021|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14
10214277|NCT03673670|11341022|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11
10214278|NCT03673670|11341023|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12
10214279|NCT03673670|11341024|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11
10214280|NCT03673670|11341025|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11
10214281|NCT03673670|11341020|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10214282|NCT03673670|11341021|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10214283|NCT03673670|11341022|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10214284|NCT03673670|11341023|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10214285|NCT03673670|11341024|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
10214286|NCT03673670|11341025|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10214287|NCT03673670|11341020|FG000|STARTED|Treatment Period 3 (3 Days)||13
10214288|NCT03673670|11341021|FG001|STARTED|Treatment Period 3 (3 Days)||14
10214289|NCT03673670|11341022|FG002|STARTED|Treatment Period 3 (3 Days)||11
10214290|NCT03673670|11341023|FG003|STARTED|Treatment Period 3 (3 Days)||12
10214291|NCT03673670|11341024|FG004|STARTED|Treatment Period 3 (3 Days)||11
10214292|NCT03673670|11341025|FG005|STARTED|Treatment Period 3 (3 Days)||11
10214293|NCT03673670|11341020|FG000|COMPLETED|Treatment Period 3 (3 Days)||13
10214294|NCT03673670|11341021|FG001|COMPLETED|Treatment Period 3 (3 Days)||14
10214295|NCT03673670|11341022|FG002|COMPLETED|Treatment Period 3 (3 Days)||11
10214296|NCT03673670|11341023|FG003|COMPLETED|Treatment Period 3 (3 Days)||12
10214297|NCT03673670|11341024|FG004|COMPLETED|Treatment Period 3 (3 Days)||10
10214298|NCT03673670|11341025|FG005|COMPLETED|Treatment Period 3 (3 Days)||11
10214299|NCT03673670|11341020|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10214300|NCT03673670|11341021|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10214301|NCT03673670|11341022|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10214302|NCT03673670|11341023|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10214303|NCT03673670|11341024|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1
10214304|NCT03673670|11341025|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10214305|NCT03674177|11341046|FG000|STARTED|Overall Study||124
10214306|NCT03674177|11341047|FG001|STARTED|Overall Study||126
10214307|NCT03674177|11341048|FG002|STARTED|Overall Study||126
10214308|NCT03674177|11341049|FG003|STARTED|Overall Study||126
10214309|NCT03674177|11341046|FG000|COMPLETED|Overall Study||122
10214310|NCT03674177|11341047|FG001|COMPLETED|Overall Study||125
10214311|NCT03674177|11341048|FG002|COMPLETED|Overall Study||126
10214312|NCT03674177|11341049|FG003|COMPLETED|Overall Study||124
10214313|NCT03674177|11341046|FG000|NOT COMPLETED|Overall Study||2
10214314|NCT03674177|11341047|FG001|NOT COMPLETED|Overall Study||1
10214315|NCT03674177|11341048|FG002|NOT COMPLETED|Overall Study||0
10214316|NCT03674177|11341049|FG003|NOT COMPLETED|Overall Study||2
10214317|NCT03674281|11341062|FG000|STARTED|Overall Study||18
10214318|NCT03674281|11341063|FG001|STARTED|Overall Study||16
10214319|NCT03674281|11341064|FG002|STARTED|Overall Study||16
10214320|NCT03674281|11341062|FG000|COMPLETED|Overall Study||15
10214321|NCT03674281|11341063|FG001|COMPLETED|Overall Study||13
10214322|NCT03674281|11341064|FG002|COMPLETED|Overall Study||13
10214323|NCT03674281|11341062|FG000|NOT COMPLETED|Overall Study||3
10214324|NCT03674281|11341063|FG001|NOT COMPLETED|Overall Study||3
10214325|NCT03674281|11341064|FG002|NOT COMPLETED|Overall Study||3
10214326|NCT03674970|11341083|FG000|STARTED|Overall Study||15
10214327|NCT03674970|11341084|FG001|STARTED|Overall Study||15
10214328|NCT03674970|11341085|FG002|STARTED|Overall Study||15
10214329|NCT03674970|11341083|FG000|COMPLETED|Overall Study||12
10214330|NCT03674970|11341084|FG001|COMPLETED|Overall Study||8
10214331|NCT03674970|11341085|FG002|COMPLETED|Overall Study||12
10214332|NCT03674970|11341083|FG000|NOT COMPLETED|Overall Study||3
10214333|NCT03674970|11341084|FG001|NOT COMPLETED|Overall Study||7
10214334|NCT03674970|11341085|FG002|NOT COMPLETED|Overall Study||3
10214335|NCT03675451|11341093|FG000|STARTED|Overall Study||20
10214336|NCT03675451|11341093|FG000|COMPLETED|Overall Study||20
10214337|NCT03675451|11341093|FG000|NOT COMPLETED|Overall Study||0
10214338|NCT03675581|11341104|FG000|STARTED|Period 1: Microgynon Alone||17
10214339|NCT03675581|11341104|FG000|COMPLETED|Period 1: Microgynon Alone||17
10214340|NCT03675581|11341104|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0
10214341|NCT03675581|11341104|FG000|STARTED|Period 2: Microgynon + Nintedanib||17
10214342|NCT03675581|11341104|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17
10214343|NCT03675581|11341104|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
10214344|NCT03675685|11341112|FG000|STARTED|Overall Study||12
10214345|NCT03675685|11341112|FG000|COMPLETED|Overall Study||12
10214346|NCT03675685|11341112|FG000|NOT COMPLETED|Overall Study||0
10214347|NCT03675776|11341123|FG000|STARTED|Double Blind Treatment Period||15
10214348|NCT03675776|11341124|FG001|STARTED|Double Blind Treatment Period||17
10214349|NCT03675776|11341125|FG002|STARTED|Double Blind Treatment Period||18
10214350|NCT03675776|11341123|FG000|COMPLETED|Double Blind Treatment Period||9
10214351|NCT03675776|11341124|FG001|COMPLETED|Double Blind Treatment Period||11
10214352|NCT03675776|11341125|FG002|COMPLETED|Double Blind Treatment Period||10
10214353|NCT03675776|11341123|FG000|NOT COMPLETED|Double Blind Treatment Period||6
10214354|NCT03675776|11341124|FG001|NOT COMPLETED|Double Blind Treatment Period||6
10214355|NCT03675776|11341125|FG002|NOT COMPLETED|Double Blind Treatment Period||8
10214356|NCT03675776|11341123|FG000|STARTED|Safety Follow-up Period||6
10214357|NCT03675776|11341124|FG001|STARTED|Safety Follow-up Period||8
10214358|NCT03675776|11341125|FG002|STARTED|Safety Follow-up Period||7
10214359|NCT03675776|11341123|FG000|COMPLETED|Safety Follow-up Period||6
10214360|NCT03675776|11341124|FG001|COMPLETED|Safety Follow-up Period||8
10214361|NCT03675776|11341125|FG002|COMPLETED|Safety Follow-up Period||7
10214362|NCT03675776|11341123|FG000|NOT COMPLETED|Safety Follow-up Period||0
10214363|NCT03675776|11341124|FG001|NOT COMPLETED|Safety Follow-up Period||0
10214364|NCT03675776|11341125|FG002|NOT COMPLETED|Safety Follow-up Period||0
10214365|NCT03676270|11341133|FG000|STARTED|Overall Study||6915
10214366|NCT03676270|11341133|FG000|COMPLETED|Overall Study||6915
10111820|NCT02499081|11242860|FG000|COMPLETED|Overall Study||1
10111821|NCT02499081|11242860|FG000|NOT COMPLETED|Overall Study||19
10111822|NCT02499120|11242866|FG000|STARTED|Overall Study||65
10111823|NCT02499120|11242867|FG001|STARTED|Overall Study||60
10111824|NCT02499120|11242866|FG000|Received Treatment|Overall Study||64
10111825|NCT02499120|11242867|FG001|Received Treatment|Overall Study||60
10111826|NCT02499120|11242866|FG000|COMPLETED|Overall Study||0
10111827|NCT02499120|11242867|FG001|COMPLETED|Overall Study||0
10111828|NCT02499120|11242866|FG000|NOT COMPLETED|Overall Study||65
10111829|NCT02499120|11242867|FG001|NOT COMPLETED|Overall Study||60
10111830|NCT02499146|11242873|FG000|STARTED|Overall Study||26
10111831|NCT02499146|11242873|FG000|COMPLETED|Overall Study||0
10111832|NCT02499146|11242873|FG000|NOT COMPLETED|Overall Study||26
10214367|NCT03676270|11341133|FG000|NOT COMPLETED|Overall Study||0
10214368|NCT03676634|11341137|FG000|STARTED|Overall Study||32
10214369|NCT03676634|11341137|FG000|Screening|Overall Study||32
10214370|NCT03676634|11341137|FG000|Participants Received rBV A/B Injection|Overall Study||32
10214371|NCT03676634|11341137|FG000|Participants Included in the Plasma-donating Population|Overall Study||32
10214372|NCT03676634|11341137|FG000|Participants Completed Follow up|Overall Study||32
10214373|NCT03676634|11341137|FG000|COMPLETED|Overall Study||29
10214374|NCT03676634|11341137|FG000|NOT COMPLETED|Overall Study||3
10214375|NCT03676725|11341147|FG000|STARTED|Overall Study||23
10214376|NCT03676725|11341148|FG001|STARTED|Overall Study||14
10214377|NCT03676725|11341149|FG002|STARTED|Overall Study||22
10214378|NCT03676725|11341150|FG003|STARTED|Overall Study||5
10214379|NCT03676725|11341151|FG004|STARTED|Overall Study||15
10214380|NCT03676725|11341152|FG005|STARTED|Overall Study||11
10111833|NCT02499159|11242879|FG000|STARTED|Randomization||50
10111834|NCT02499159|11242880|FG001|STARTED|Randomization||50
10111835|NCT02499159|11242879|FG000|COMPLETED|Randomization||49
10111836|NCT02499159|11242880|FG001|COMPLETED|Randomization||49
10111837|NCT02499159|11242879|FG000|NOT COMPLETED|Randomization||1
10111838|NCT02499159|11242880|FG001|NOT COMPLETED|Randomization||1
10111839|NCT02499159|11242879|FG000|STARTED|30-Day Follow-Up Phone Call||49
10111840|NCT02499159|11242880|FG001|STARTED|30-Day Follow-Up Phone Call||49
10111841|NCT02499159|11242879|FG000|COMPLETED|30-Day Follow-Up Phone Call||42
10111842|NCT02499159|11242880|FG001|COMPLETED|30-Day Follow-Up Phone Call||47
10111843|NCT02499159|11242879|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7
10111844|NCT02499159|11242880|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2
10111845|NCT02499172|11242890|FG000|STARTED|Overall Study||900
10111846|NCT02499172|11242891|FG001|STARTED|Overall Study||899
10111847|NCT02499172|11242892|FG002|STARTED|Overall Study||523
10111848|NCT02499172|11242893|FG003|STARTED|Overall Study||436
10214381|NCT03676725|11341147|FG000|COMPLETED|Overall Study||23
10214382|NCT03676725|11341148|FG001|COMPLETED|Overall Study||14
10214383|NCT03676725|11341149|FG002|COMPLETED|Overall Study||22
10214384|NCT03676725|11341150|FG003|COMPLETED|Overall Study||5
10214385|NCT03676725|11341151|FG004|COMPLETED|Overall Study||15
10214386|NCT03676725|11341152|FG005|COMPLETED|Overall Study||11
10214387|NCT03676725|11341147|FG000|NOT COMPLETED|Overall Study||0
10214388|NCT03676725|11341148|FG001|NOT COMPLETED|Overall Study||0
10111849|NCT02499172|11242890|FG000|COMPLETED|Overall Study||835
10111850|NCT02499172|11242891|FG001|COMPLETED|Overall Study||835
10111851|NCT02499172|11242892|FG002|COMPLETED|Overall Study||0
10111852|NCT02499172|11242893|FG003|COMPLETED|Overall Study||0
10214389|NCT03676725|11341149|FG002|NOT COMPLETED|Overall Study||0
10214390|NCT03676725|11341150|FG003|NOT COMPLETED|Overall Study||0
10214391|NCT03676725|11341151|FG004|NOT COMPLETED|Overall Study||0
10214392|NCT03676725|11341152|FG005|NOT COMPLETED|Overall Study||0
10214393|NCT03676803|11341163|FG000|STARTED|Overall Study||15
10214394|NCT03676803|11341164|FG001|STARTED|Overall Study||16
10214395|NCT03676803|11341163|FG000|COMPLETED|Overall Study||15
10214396|NCT03676803|11341164|FG001|COMPLETED|Overall Study||16
10214397|NCT03676803|11341163|FG000|NOT COMPLETED|Overall Study||0
10214398|NCT03676803|11341164|FG001|NOT COMPLETED|Overall Study||0
10214399|NCT03676972|11341172|FG000|STARTED|Overall Study||60
10214400|NCT03676972|11341172|FG000|COMPLETED|Overall Study||58
10214401|NCT03676972|11341172|FG000|NOT COMPLETED|Overall Study||2
10214402|NCT03677089|11341176|FG000|STARTED|Overall Study||148
10214403|NCT03677089|11341176|FG000|Baseline/Pre-Intervention|Overall Study||137
10214404|NCT03677089|11341176|FG000|Mid-Intervention|Overall Study||120
10214405|NCT03677089|11341176|FG000|Post-Intervention|Overall Study||117
10214406|NCT03677089|11341176|FG000|Follow-Up|Overall Study||114
10214407|NCT03677089|11341176|FG000|COMPLETED|Overall Study||114
10214408|NCT03677089|11341176|FG000|NOT COMPLETED|Overall Study||34
10214409|NCT03677245|11341184|FG000|STARTED|Overall Study||8
10214410|NCT03677245|11341184|FG000|COMPLETED|Overall Study||8
10214411|NCT03677245|11341184|FG000|NOT COMPLETED|Overall Study||0
10214412|NCT03677375|11341189|FG000|STARTED|Overall Study||93
10214413|NCT03677375|11341189|FG000|COMPLETED|Overall Study||81
10214414|NCT03677375|11341189|FG000|NOT COMPLETED|Overall Study||12
10214415|NCT03677401|11341195|FG000|STARTED|Overall Study||148
10214416|NCT03677401|11341196|FG001|STARTED|Overall Study||147
10214417|NCT03677401|11341195|FG000|COMPLETED|Overall Study||138
10214418|NCT03677401|11341196|FG001|COMPLETED|Overall Study||129
10214419|NCT03677401|11341195|FG000|NOT COMPLETED|Overall Study||10
10214420|NCT03677401|11341196|FG001|NOT COMPLETED|Overall Study||18
10214421|NCT03677869|11341202|FG000|STARTED|Overall Study||35
10214422|NCT03677869|11341202|FG000|COMPLETED|Overall Study||34
10214423|NCT03677869|11341202|FG000|NOT COMPLETED|Overall Study||1
10214424|NCT03678103|11341206|FG000|STARTED|Overall Study||30
10214425|NCT03678103|11341206|FG000|COMPLETED|Overall Study||26
10214426|NCT03678103|11341206|FG000|NOT COMPLETED|Overall Study||4
10214427|NCT03678285|11341210|FG000|STARTED|Overall Study||42
10214428|NCT03678285|11341210|FG000|Started Workout|Overall Study||40
10214429|NCT03678285|11341210|FG000|COMPLETED|Overall Study||38
10214430|NCT03678285|11341210|FG000|NOT COMPLETED|Overall Study||4
10214431|NCT03678311|11341214|FG000|STARTED|Overall Study||9
10214432|NCT03678311|11341214|FG000|COMPLETED|Overall Study||9
10214433|NCT03678311|11341214|FG000|NOT COMPLETED|Overall Study||0
10214434|NCT03678870|11341220|FG000|STARTED|Overall Study||97
10214435|NCT03678870|11341221|FG001|STARTED|Overall Study||99
10214436|NCT03678870|11341220|FG000|COMPLETED|Overall Study||84
10214437|NCT03678870|11341221|FG001|COMPLETED|Overall Study||91
10214438|NCT03678870|11341220|FG000|NOT COMPLETED|Overall Study||13
10012108|NCT01784029|11134961|FG000|NOT COMPLETED|Overall Study||19
10012109|NCT01784029|11134962|FG001|NOT COMPLETED|Overall Study||20
10012110|NCT01784029|11134963|FG002|NOT COMPLETED|Overall Study||22
10012111|NCT01784055|11134971|FG000|STARTED|Overall Study||126
10012112|NCT01784055|11134971|FG000|COMPLETED|Overall Study||100
10012113|NCT01784055|11134971|FG000|NOT COMPLETED|Overall Study||26
10214439|NCT03678870|11341221|FG001|NOT COMPLETED|Overall Study||8
10214440|NCT03679494|11341229|FG000|STARTED|Overall Study||67
10214441|NCT03679494|11341230|FG001|STARTED|Overall Study||63
10214442|NCT03679494|11341229|FG000|COMPLETED|Overall Study||67
10214443|NCT03679494|11341230|FG001|COMPLETED|Overall Study||63
10214444|NCT03679494|11341229|FG000|NOT COMPLETED|Overall Study||0
10214445|NCT03679494|11341230|FG001|NOT COMPLETED|Overall Study||0
10214446|NCT03679741|11341236|FG000|STARTED|Period 1||59
10214447|NCT03679741|11341237|FG001|STARTED|Period 1||61
10214448|NCT03679741|11341236|FG000|COMPLETED|Period 1||57
10214449|NCT03679741|11341237|FG001|COMPLETED|Period 1||58
10214450|NCT03679741|11341236|FG000|NOT COMPLETED|Period 1||2
10214451|NCT03679741|11341237|FG001|NOT COMPLETED|Period 1||3
10214452|NCT03679741|11341236|FG000|STARTED|Period 2||57
10214453|NCT03679741|11341237|FG001|STARTED|Period 2||58
10214454|NCT03679741|11341236|FG000|COMPLETED|Period 2||54
10214455|NCT03679741|11341237|FG001|COMPLETED|Period 2||56
10214456|NCT03679741|11341236|FG000|NOT COMPLETED|Period 2||3
10214457|NCT03679741|11341237|FG001|NOT COMPLETED|Period 2||2
10214458|NCT03679741|11341236|FG000|STARTED|Period 3||54
10214459|NCT03679741|11341237|FG001|STARTED|Period 3||56
10214460|NCT03679741|11341236|FG000|COMPLETED|Period 3||54
10214461|NCT03679741|11341237|FG001|COMPLETED|Period 3||56
10214462|NCT03679741|11341236|FG000|NOT COMPLETED|Period 3||0
10214463|NCT03679741|11341237|FG001|NOT COMPLETED|Period 3||0
10214464|NCT03679975|11341243|FG000|STARTED|Overall Study||9
10214465|NCT03679975|11341243|FG000|COMPLETED|Overall Study||9
10214466|NCT03679975|11341243|FG000|NOT COMPLETED|Overall Study||0
10214467|NCT03680105|11341256|FG000|STARTED|Overall Study||8
10214468|NCT03680105|11341257|FG001|STARTED|Overall Study||8
10012114|NCT01784068|11134975|FG000|STARTED|NTCS Phase||215
10214469|NCT03680105|11341258|FG002|STARTED|Overall Study||8
10214470|NCT03680105|11341259|FG003|STARTED|Overall Study||8
10214471|NCT03680105|11341260|FG004|STARTED|Overall Study||8
10214472|NCT03680105|11341261|FG005|STARTED|Overall Study||12
10214473|NCT03680105|11341262|FG006|STARTED|Overall Study||8
10214474|NCT03680105|11341263|FG007|STARTED|Overall Study||8
10214475|NCT03680105|11341264|FG008|STARTED|Overall Study||8
10214476|NCT03680105|11341256|FG000|COMPLETED|Overall Study||8
10214477|NCT03680105|11341257|FG001|COMPLETED|Overall Study||8
10214478|NCT03680105|11341258|FG002|COMPLETED|Overall Study||8
10214479|NCT03680105|11341259|FG003|COMPLETED|Overall Study||8
10214480|NCT03680105|11341260|FG004|COMPLETED|Overall Study||8
10214481|NCT03680105|11341261|FG005|COMPLETED|Overall Study||12
10214482|NCT03680105|11341262|FG006|COMPLETED|Overall Study||8
10214483|NCT03680105|11341263|FG007|COMPLETED|Overall Study||8
10214484|NCT03680105|11341264|FG008|COMPLETED|Overall Study||8
10214485|NCT03680105|11341256|FG000|NOT COMPLETED|Overall Study||0
10214486|NCT03680105|11341257|FG001|NOT COMPLETED|Overall Study||0
10214487|NCT03680105|11341258|FG002|NOT COMPLETED|Overall Study||0
10214488|NCT03680105|11341259|FG003|NOT COMPLETED|Overall Study||0
10214489|NCT03680105|11341260|FG004|NOT COMPLETED|Overall Study||0
10214490|NCT03680105|11341261|FG005|NOT COMPLETED|Overall Study||0
10214491|NCT03680105|11341262|FG006|NOT COMPLETED|Overall Study||0
10214492|NCT03680105|11341263|FG007|NOT COMPLETED|Overall Study||0
10214493|NCT03680105|11341264|FG008|NOT COMPLETED|Overall Study||0
10214494|NCT03680521|11341290|FG000|STARTED|Overall Study||7
10214495|NCT03680521|11341291|FG001|STARTED|Overall Study||13
10214496|NCT03680521|11341290|FG000|COMPLETED|Overall Study||0
10214497|NCT03680521|11341291|FG001|COMPLETED|Overall Study||2
10214498|NCT03680521|11341290|FG000|NOT COMPLETED|Overall Study||7
10214499|NCT03680521|11341291|FG001|NOT COMPLETED|Overall Study||11
10214500|NCT03680742|11341300|FG000|STARTED|Overall Study||34
10214501|NCT03680742|11341300|FG000|COMPLETED|Overall Study||32
10214502|NCT03680742|11341300|FG000|NOT COMPLETED|Overall Study||2
10214503|NCT03681093|11341307|FG000|STARTED|Overall Study||32
10214504|NCT03681093|11341308|FG001|STARTED|Overall Study||34
10214505|NCT03681093|11341309|FG002|STARTED|Overall Study||32
10214506|NCT03681093|11341307|FG000|Full Analysis Set (FAS)|Overall Study||31
10214507|NCT03681093|11341308|FG001|Full Analysis Set (FAS)|Overall Study||32
10214508|NCT03681093|11341309|FG002|Full Analysis Set (FAS)|Overall Study||28
10214509|NCT03681093|11341307|FG000|Safety Analysis Set (SAF)|Overall Study||32
10214510|NCT03681093|11341308|FG001|Safety Analysis Set (SAF)|Overall Study||34
10214511|NCT03681093|11341309|FG002|Safety Analysis Set (SAF)|Overall Study||32
10214512|NCT03681093|11341307|FG000|COMPLETED|Overall Study||32
10214513|NCT03681093|11341308|FG001|COMPLETED|Overall Study||32
10214514|NCT03681093|11341309|FG002|COMPLETED|Overall Study||31
10214515|NCT03681093|11341307|FG000|NOT COMPLETED|Overall Study||0
10214516|NCT03681093|11341308|FG001|NOT COMPLETED|Overall Study||2
10214517|NCT03681093|11341309|FG002|NOT COMPLETED|Overall Study||1
10214518|NCT03681119|11341319|FG000|STARTED|Overall Study||72
10214519|NCT03681119|11341320|FG001|STARTED|Overall Study||11
10214520|NCT03681119|11341319|FG000|COMPLETED|Overall Study||66
10214521|NCT03681119|11341320|FG001|COMPLETED|Overall Study||11
10214522|NCT03681119|11341319|FG000|NOT COMPLETED|Overall Study||6
10214523|NCT03681119|11341320|FG001|NOT COMPLETED|Overall Study||0
10214524|NCT03681353|11341324|FG000|STARTED|Overall Study||25
10214525|NCT03681353|11341324|FG000|COMPLETED|Overall Study||18
10214526|NCT03681353|11341324|FG000|NOT COMPLETED|Overall Study||7
10214527|NCT03681405|11341330|FG000|STARTED|Overall Study||14
10214528|NCT03681405|11341331|FG001|STARTED|Overall Study||17
10214529|NCT03681405|11341330|FG000|COMPLETED|Overall Study||13
10214530|NCT03681405|11341331|FG001|COMPLETED|Overall Study||17
10214531|NCT03681405|11341330|FG000|NOT COMPLETED|Overall Study||1
10214532|NCT03681405|11341331|FG001|NOT COMPLETED|Overall Study||0
10238927|NCT00428207|11370395|FG000|STARTED|Overall Study||2
10238928|NCT00428207|11370396|FG001|STARTED|Overall Study||2
10238929|NCT00428207|11370395|FG000|COMPLETED|Overall Study||2
10238930|NCT00428207|11370396|FG001|COMPLETED|Overall Study||2
10238931|NCT00428207|11370395|FG000|NOT COMPLETED|Overall Study||0
10238932|NCT00428207|11370396|FG001|NOT COMPLETED|Overall Study||0
10238933|NCT00439569|11370402|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7
10238934|NCT00439569|11370402|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
10238935|NCT00439569|11370402|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
10238936|NCT00439569|11370402|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
10238937|NCT00439569|11370402|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
10238938|NCT00439569|11370402|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
10238939|NCT00422669|11370409|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
10238940|NCT00422669|11370410|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
10238941|NCT00422669|11370411|FG002|STARTED|Overall Study||7
10238942|NCT00422669|11370409|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
10238943|NCT00422669|11370410|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
10238944|NCT00422669|11370411|FG002|COMPLETED|Overall Study||0
10238945|NCT00422669|11370409|FG000|NOT COMPLETED|Overall Study||98
10238946|NCT00422669|11370410|FG001|NOT COMPLETED|Overall Study||100
10238947|NCT00422669|11370411|FG002|NOT COMPLETED|Overall Study||7
10238948|NCT00432445|11370417|FG000|STARTED|Overall Study||2
10238949|NCT00432445|11370417|FG000|COMPLETED|Overall Study||2
10238950|NCT00432445|11370417|FG000|NOT COMPLETED|Overall Study||0
10238951|NCT00434590|11370423|FG000|STARTED|Overall Study||5
10238952|NCT00434590|11370424|FG001|STARTED|Overall Study||5
10238953|NCT00434590|11370423|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
10238954|NCT00434590|11370424|FG001|COMPLETED|Overall Study||0
10214533|NCT03681808|11341341|FG000|STARTED|Overall Study||123
10214534|NCT03681808|11341342|FG001|STARTED|Overall Study||119
10214535|NCT03681808|11341341|FG000|COMPLETED|Overall Study||109
10214536|NCT03681808|11341342|FG001|COMPLETED|Overall Study||102
10214537|NCT03681808|11341341|FG000|NOT COMPLETED|Overall Study||14
10214538|NCT03681808|11341342|FG001|NOT COMPLETED|Overall Study||17
10214539|NCT03681886|11341348|FG000|STARTED|Overall Study||78
10214540|NCT03681886|11341348|FG000|Successful Implantation|Overall Study||76
10214541|NCT03681886|11341348|FG000|Failed Implantation|Overall Study||2
10214542|NCT03681886|11341348|FG000|Underwent Optic Exchange|Overall Study||4
10214543|NCT03681886|11341348|FG000|COMPLETED|Overall Study||76
10214544|NCT03681886|11341348|FG000|NOT COMPLETED|Overall Study||2
10214545|NCT03681951|11341377|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
10214546|NCT03681951|11341378|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
10214547|NCT03681951|11341379|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
10214548|NCT03681951|11341380|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
10214549|NCT03681951|11341381|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
10214550|NCT03681951|11341382|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
10214551|NCT03681951|11341383|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
10214552|NCT03681951|11341384|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
10214553|NCT03681951|11341377|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214554|NCT03681951|11341378|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214555|NCT03681951|11341379|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214556|NCT03681951|11341380|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214557|NCT03681951|11341381|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214558|NCT03681951|11341382|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214559|NCT03681951|11341383|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214560|NCT03681951|11341384|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214561|NCT03681951|11341377|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
10214562|NCT03681951|11341378|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214563|NCT03681951|11341379|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214564|NCT03681951|11341380|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214565|NCT03681951|11341381|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214566|NCT03681951|11341382|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214567|NCT03681951|11341383|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214568|NCT03681951|11341384|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10214569|NCT03681951|11341377|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214570|NCT03681951|11341378|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214571|NCT03681951|11341379|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214572|NCT03681951|11341380|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214573|NCT03681951|11341381|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214574|NCT03681951|11341382|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214575|NCT03681951|11341383|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214576|NCT03681951|11341384|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10214577|NCT03681951|11341377|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214578|NCT03681951|11341378|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214579|NCT03681951|11341379|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214580|NCT03681951|11341380|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214581|NCT03681951|11341381|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214582|NCT03681951|11341382|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214583|NCT03681951|11341383|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214584|NCT03681951|11341384|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214585|NCT03681951|11341377|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214586|NCT03681951|11341378|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214587|NCT03681951|11341379|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214588|NCT03681951|11341380|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214589|NCT03681951|11341381|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214590|NCT03681951|11341382|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214591|NCT03681951|11341383|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214592|NCT03681951|11341384|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10214593|NCT03681951|11341377|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214594|NCT03681951|11341378|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214595|NCT03681951|11341379|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214596|NCT03681951|11341380|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214597|NCT03681951|11341381|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214598|NCT03681951|11341382|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214599|NCT03681951|11341383|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214600|NCT03681951|11341384|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214601|NCT03681951|11341377|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214602|NCT03681951|11341378|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214603|NCT03681951|11341379|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214604|NCT03681951|11341380|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214605|NCT03681951|11341381|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214606|NCT03681951|11341382|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214607|NCT03681951|11341383|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214608|NCT03681951|11341384|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214609|NCT03681951|11341377|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214610|NCT03681951|11341378|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214611|NCT03681951|11341379|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214612|NCT03681951|11341380|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214613|NCT03681951|11341381|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214614|NCT03681951|11341382|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214615|NCT03681951|11341383|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214616|NCT03681951|11341384|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10214617|NCT03681951|11341377|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214618|NCT03681951|11341378|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214619|NCT03681951|11341379|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214620|NCT03681951|11341380|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214621|NCT03681951|11341381|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214622|NCT03681951|11341382|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214623|NCT03681951|11341383|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214624|NCT03681951|11341384|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214625|NCT03681951|11341377|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214626|NCT03681951|11341378|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214627|NCT03681951|11341379|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214628|NCT03681951|11341380|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214629|NCT03681951|11341381|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214630|NCT03681951|11341382|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214631|NCT03681951|11341383|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214632|NCT03681951|11341384|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214633|NCT03681951|11341377|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214634|NCT03681951|11341378|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214635|NCT03681951|11341379|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214636|NCT03681951|11341380|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214637|NCT03681951|11341381|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214638|NCT03681951|11341382|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214639|NCT03681951|11341383|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214640|NCT03681951|11341384|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10214641|NCT03682107|11341412|FG000|STARTED|Overall Study||10
10214642|NCT03682107|11341413|FG001|STARTED|Overall Study||10
10214643|NCT03682107|11341414|FG002|STARTED|Overall Study||10
10214644|NCT03682107|11341415|FG003|STARTED|Overall Study||10
10214645|NCT03682107|11341416|FG004|STARTED|Overall Study||8
10214646|NCT03682107|11341412|FG000|COMPLETED|Overall Study||10
10214647|NCT03682107|11341413|FG001|COMPLETED|Overall Study||9
10214648|NCT03682107|11341414|FG002|COMPLETED|Overall Study||10
10214649|NCT03682107|11341415|FG003|COMPLETED|Overall Study||10
10214650|NCT03682107|11341416|FG004|COMPLETED|Overall Study||8
10214651|NCT03682107|11341412|FG000|NOT COMPLETED|Overall Study||0
10214652|NCT03682107|11341413|FG001|NOT COMPLETED|Overall Study||1
10214653|NCT03682107|11341414|FG002|NOT COMPLETED|Overall Study||0
10214654|NCT03682107|11341415|FG003|NOT COMPLETED|Overall Study||0
10214655|NCT03682107|11341416|FG004|NOT COMPLETED|Overall Study||0
10214656|NCT03682120|11341432|FG000|STARTED|Overall Study||105
10214657|NCT03682120|11341433|FG001|STARTED|Overall Study||105
10214658|NCT03682120|11341434|FG002|STARTED|Overall Study||105
10214659|NCT03682120|11341435|FG003|STARTED|Overall Study||57
10214660|NCT03682120|11341432|FG000|COMPLETED|Overall Study||92
10214661|NCT03682120|11341433|FG001|COMPLETED|Overall Study||97
10214662|NCT03682120|11341434|FG002|COMPLETED|Overall Study||97
10214663|NCT03682120|11341435|FG003|COMPLETED|Overall Study||55
10214664|NCT03682120|11341432|FG000|NOT COMPLETED|Overall Study||13
10214665|NCT03682120|11341433|FG001|NOT COMPLETED|Overall Study||8
10214666|NCT03682120|11341434|FG002|NOT COMPLETED|Overall Study||8
10214667|NCT03682120|11341435|FG003|NOT COMPLETED|Overall Study||2
10214668|NCT03682302|11341451|FG000|STARTED|Overall Study||31
10214669|NCT03682302|11341452|FG001|STARTED|Overall Study||30
10214670|NCT03682302|11341453|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
10214671|NCT03682302|11341454|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
10214672|NCT03682302|11341451|FG000|COMPLETED|Overall Study||30
10214673|NCT03682302|11341452|FG001|COMPLETED|Overall Study||28
10214674|NCT03682302|11341453|FG002|COMPLETED|Overall Study||5
10214675|NCT03682302|11341454|FG003|COMPLETED|Overall Study||28
10214676|NCT03682302|11341451|FG000|NOT COMPLETED|Overall Study||1
10214677|NCT03682302|11341452|FG001|NOT COMPLETED|Overall Study||2
10214678|NCT03682302|11341453|FG002|NOT COMPLETED|Overall Study||1
10214679|NCT03682302|11341454|FG003|NOT COMPLETED|Overall Study||2
10214680|NCT03682705|11341470|FG000|STARTED|Overall Study||19
10214681|NCT03682705|11341471|FG001|STARTED|Overall Study||62
10214682|NCT03682705|11341472|FG002|STARTED|Overall Study||41
10214683|NCT03682705|11341473|FG003|STARTED|Overall Study||39
10214684|NCT03682705|11341474|FG004|STARTED|Overall Study||41
10214685|NCT03682705|11341475|FG005|STARTED|Overall Study||40
10214686|NCT03682705|11341470|FG000|COMPLETED|Overall Study||17
10214687|NCT03682705|11341471|FG001|COMPLETED|Overall Study||58
10214688|NCT03682705|11341472|FG002|COMPLETED|Overall Study||38
10214689|NCT03682705|11341473|FG003|COMPLETED|Overall Study||34
10214690|NCT03682705|11341474|FG004|COMPLETED|Overall Study||35
10214691|NCT03682705|11341475|FG005|COMPLETED|Overall Study||38
10214692|NCT03682705|11341470|FG000|NOT COMPLETED|Overall Study||2
10214693|NCT03682705|11341471|FG001|NOT COMPLETED|Overall Study||4
10214694|NCT03682705|11341472|FG002|NOT COMPLETED|Overall Study||3
10214695|NCT03682705|11341473|FG003|NOT COMPLETED|Overall Study||5
10214696|NCT03682705|11341474|FG004|NOT COMPLETED|Overall Study||6
10214697|NCT03682705|11341475|FG005|NOT COMPLETED|Overall Study||2
10214698|NCT03682809|11341491|FG000|STARTED|Overall Study||22
10214699|NCT03682809|11341492|FG001|STARTED|Overall Study||24
10214700|NCT03682809|11341491|FG000|COMPLETED|Overall Study||22
10214701|NCT03682809|11341492|FG001|COMPLETED|Overall Study||24
10214702|NCT03682809|11341491|FG000|NOT COMPLETED|Overall Study||0
10214703|NCT03682809|11341492|FG001|NOT COMPLETED|Overall Study||0
10214704|NCT03682965|11341500|FG000|STARTED|Overall Study||11
10214705|NCT03682965|11341501|FG001|STARTED|Overall Study||10
10214706|NCT03682965|11341500|FG000|COMPLETED|Overall Study||11
10214707|NCT03682965|11341501|FG001|COMPLETED|Overall Study||10
10214708|NCT03682965|11341500|FG000|NOT COMPLETED|Overall Study||0
10214709|NCT03682965|11341501|FG001|NOT COMPLETED|Overall Study||0
10214710|NCT03683576|11341511|FG000|STARTED|Overall Study||120
10214711|NCT03683576|11341512|FG001|STARTED|Overall Study||120
10214712|NCT03683576|11341513|FG002|STARTED|Overall Study||118
10214713|NCT03683576|11341514|FG003|STARTED|Overall Study||122
10214714|NCT03683576|11341511|FG000|COMPLETED|Overall Study||114
10214715|NCT03683576|11341512|FG001|COMPLETED|Overall Study||116
10214716|NCT03683576|11341513|FG002|COMPLETED|Overall Study||106
10214717|NCT03683576|11341514|FG003|COMPLETED|Overall Study||114
10214718|NCT03683576|11341511|FG000|NOT COMPLETED|Overall Study||6
10214719|NCT03683576|11341512|FG001|NOT COMPLETED|Overall Study||4
10214720|NCT03683576|11341513|FG002|NOT COMPLETED|Overall Study||12
10214721|NCT03683576|11341514|FG003|NOT COMPLETED|Overall Study||8
10214722|NCT03683719|11341529|FG000|STARTED|Overall Study||52
10214723|NCT03683719|11341530|FG001|STARTED|Overall Study||51
10214724|NCT03683719|11341531|FG002|STARTED|Overall Study||52
10214725|NCT03683719|11341532|FG003|STARTED|Overall Study||53
10214726|NCT03683719|11341533|FG004|STARTED|Overall Study||50
10214727|NCT03683719|11341529|FG000|COMPLETED|Overall Study||40
10214728|NCT03683719|11341530|FG001|COMPLETED|Overall Study||38
10214729|NCT03683719|11341531|FG002|COMPLETED|Overall Study||44
10214730|NCT03683719|11341532|FG003|COMPLETED|Overall Study||46
10214731|NCT03683719|11341533|FG004|COMPLETED|Overall Study||36
10214732|NCT03683719|11341529|FG000|NOT COMPLETED|Overall Study||12
10214733|NCT03683719|11341530|FG001|NOT COMPLETED|Overall Study||13
10214734|NCT03683719|11341531|FG002|NOT COMPLETED|Overall Study||8
10214735|NCT03683719|11341532|FG003|NOT COMPLETED|Overall Study||7
10214736|NCT03683719|11341533|FG004|NOT COMPLETED|Overall Study||14
10214737|NCT03683758|11341547|FG000|STARTED|Overall Study||11
10214738|NCT03683758|11341548|FG001|STARTED|Overall Study||10
10214739|NCT03683758|11341547|FG000|COMPLETED|Overall Study||8
10214740|NCT03683758|11341548|FG001|COMPLETED|Overall Study||7
10214741|NCT03683758|11341547|FG000|NOT COMPLETED|Overall Study||3
10214742|NCT03683758|11341548|FG001|NOT COMPLETED|Overall Study||3
10214743|NCT03683901|11341554|FG000|STARTED|Overall Study||10
10214744|NCT03683901|11341554|FG000|COMPLETED|Overall Study||10
10214745|NCT03683901|11341554|FG000|NOT COMPLETED|Overall Study||0
10214746|NCT03684044|11341562|FG000|STARTED|Overall Study||239
10214747|NCT03684044|11341563|FG001|STARTED|Overall Study||124
10214748|NCT03684044|11341562|FG000|COMPLETED|Overall Study||217
10214749|NCT03684044|11341563|FG001|COMPLETED|Overall Study||104
10214750|NCT03684044|11341562|FG000|NOT COMPLETED|Overall Study||22
10214751|NCT03684044|11341563|FG001|NOT COMPLETED|Overall Study||20
10214752|NCT03684265|11341571|FG000|STARTED|Treatment Period 1||13
10214753|NCT03684265|11341572|FG001|STARTED|Treatment Period 1||13
10214754|NCT03684265|11341571|FG000|COMPLETED|Treatment Period 1||13
10214755|NCT03684265|11341572|FG001|COMPLETED|Treatment Period 1||13
10214756|NCT03684265|11341571|FG000|NOT COMPLETED|Treatment Period 1||0
10214757|NCT03684265|11341572|FG001|NOT COMPLETED|Treatment Period 1||0
10214758|NCT03684265|11341571|FG000|STARTED|Washout Period of 1 Week||13
10214759|NCT03684265|11341572|FG001|STARTED|Washout Period of 1 Week||13
10214760|NCT03684265|11341571|FG000|COMPLETED|Washout Period of 1 Week||13
10214761|NCT03684265|11341572|FG001|COMPLETED|Washout Period of 1 Week||13
10214762|NCT03684265|11341571|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10214763|NCT03684265|11341572|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10214764|NCT03684265|11341571|FG000|STARTED|Treatment Period 2||13
10214765|NCT03684265|11341572|FG001|STARTED|Treatment Period 2||13
10214766|NCT03684265|11341571|FG000|COMPLETED|Treatment Period 2||13
10214767|NCT03684265|11341572|FG001|COMPLETED|Treatment Period 2||13
10214768|NCT03684265|11341571|FG000|NOT COMPLETED|Treatment Period 2||0
10214769|NCT03684265|11341572|FG001|NOT COMPLETED|Treatment Period 2||0
10214770|NCT03684642|11341581|FG000|STARTED|Overall Study||303
10214771|NCT03684642|11341582|FG001|STARTED|Overall Study||302
10214772|NCT03684642|11341583|FG002|STARTED|Overall Study||303
10214773|NCT03684642|11341581|FG000|Treated|Overall Study||303
10214774|NCT03684642|11341582|FG001|Treated|Overall Study||302
10214775|NCT03684642|11341583|FG002|Treated|Overall Study||302
10214776|NCT03684642|11341581|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313
10214777|NCT03684642|11341582|FG001|Safety Population|Overall Study||292
10214778|NCT03684642|11341583|FG002|Safety Population|Overall Study||302
10214779|NCT03684642|11341581|FG000|COMPLETED|Overall Study||200
10214780|NCT03684642|11341582|FG001|COMPLETED|Overall Study||169
10214781|NCT03684642|11341583|FG002|COMPLETED|Overall Study||197
10214782|NCT03684642|11341581|FG000|NOT COMPLETED|Overall Study||103
10214783|NCT03684642|11341582|FG001|NOT COMPLETED|Overall Study||133
10214784|NCT03684642|11341583|FG002|NOT COMPLETED|Overall Study||106
10214785|NCT03684928|11341591|FG000|STARTED|First Intervention||23
10214786|NCT03684928|11341592|FG001|STARTED|First Intervention||22
10214787|NCT03684928|11341591|FG000|COMPLETED|First Intervention||23
10214788|NCT03684928|11341592|FG001|COMPLETED|First Intervention||19
10214789|NCT03684928|11341591|FG000|NOT COMPLETED|First Intervention||0
10214790|NCT03684928|11341592|FG001|NOT COMPLETED|First Intervention||3
10214791|NCT03684928|11341591|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
10214792|NCT03684928|11341592|FG001|STARTED|Second Intervention||19
10214793|NCT03684928|11341591|FG000|COMPLETED|Second Intervention||20
10214794|NCT03684928|11341592|FG001|COMPLETED|Second Intervention||19
10214795|NCT03684928|11341591|FG000|NOT COMPLETED|Second Intervention||1
10214796|NCT03684928|11341592|FG001|NOT COMPLETED|Second Intervention||0
10214797|NCT03685344|11341602|FG000|STARTED|Overall Study||3
10214798|NCT03685344|11341603|FG001|STARTED|Overall Study||3
10214799|NCT03685344|11341604|FG002|STARTED|Overall Study||7
10214800|NCT03685344|11341605|FG003|STARTED|Overall Study||0
10214801|NCT03685344|11341602|FG000|Received Treatment|Overall Study||3
10214802|NCT03685344|11341603|FG001|Received Treatment|Overall Study||3
10214803|NCT03685344|11341604|FG002|Received Treatment|Overall Study||7
10214804|NCT03685344|11341605|FG003|Received Treatment|Overall Study||0
10214805|NCT03685344|11341602|FG000|COMPLETED|Overall Study||0
10214806|NCT03685344|11341603|FG001|COMPLETED|Overall Study||0
10214807|NCT03685344|11341604|FG002|COMPLETED|Overall Study||0
10214808|NCT03685344|11341605|FG003|COMPLETED|Overall Study||0
10214809|NCT03685344|11341602|FG000|NOT COMPLETED|Overall Study||3
10214810|NCT03685344|11341603|FG001|NOT COMPLETED|Overall Study||3
10214811|NCT03685344|11341604|FG002|NOT COMPLETED|Overall Study||7
10214812|NCT03685344|11341605|FG003|NOT COMPLETED|Overall Study||0
10214813|NCT03685396|11341617|FG000|STARTED|Overall Study||21
10214814|NCT03685396|11341618|FG001|STARTED|Overall Study||21
10214815|NCT03685396|11341617|FG000|COMPLETED|Overall Study||21
10214816|NCT03685396|11341618|FG001|COMPLETED|Overall Study||21
10214817|NCT03685396|11341617|FG000|NOT COMPLETED|Overall Study||0
10214818|NCT03685396|11341618|FG001|NOT COMPLETED|Overall Study||0
10214819|NCT03685643|11341626|FG000|STARTED|Overall Study||290
10214820|NCT03685643|11341627|FG001|STARTED|Overall Study||288
10214821|NCT03685643|11341626|FG000|COMPLETED|Overall Study||276
10214822|NCT03685643|11341627|FG001|COMPLETED|Overall Study||266
10214823|NCT03685643|11341626|FG000|NOT COMPLETED|Overall Study||14
10012115|NCT01784068|11134976|FG001|STARTED|NTCS Phase||0
10012116|NCT01784068|11134975|FG000|NTRI Phase|NTCS Phase||86
10012117|NCT01784068|11134976|FG001|NTRI Phase|NTCS Phase||0
10214824|NCT03685643|11341627|FG001|NOT COMPLETED|Overall Study||22
10214825|NCT03685968|11341636|FG000|STARTED|Overall Study||75
10214826|NCT03685968|11341637|FG001|STARTED|Overall Study||75
10214827|NCT03685968|11341638|FG002|STARTED|Overall Study||75
10214828|NCT03685968|11341636|FG000|COMPLETED|Overall Study||75
10214829|NCT03685968|11341637|FG001|COMPLETED|Overall Study||75
10214830|NCT03685968|11341638|FG002|COMPLETED|Overall Study||75
10214831|NCT03685968|11341636|FG000|NOT COMPLETED|Overall Study||0
10214832|NCT03685968|11341637|FG001|NOT COMPLETED|Overall Study||0
10214833|NCT03685968|11341638|FG002|NOT COMPLETED|Overall Study||0
10214834|NCT03686033|11341646|FG000|STARTED|Treatment Period 1 (1 Day)||1
10214835|NCT03686033|11341647|FG001|STARTED|Treatment Period 1 (1 Day)||1
10214836|NCT03686033|11341648|FG002|STARTED|Treatment Period 1 (1 Day)||1
10214837|NCT03686033|11341649|FG003|STARTED|Treatment Period 1 (1 Day)||1
10214838|NCT03686033|11341650|FG004|STARTED|Treatment Period 1 (1 Day)||1
10214839|NCT03686033|11341651|FG005|STARTED|Treatment Period 1 (1 Day)||0
10214840|NCT03686033|11341646|FG000|COMPLETED|Treatment Period 1 (1 Day)||1
10214841|NCT03686033|11341647|FG001|COMPLETED|Treatment Period 1 (1 Day)||1
10214842|NCT03686033|11341648|FG002|COMPLETED|Treatment Period 1 (1 Day)||1
10214843|NCT03686033|11341649|FG003|COMPLETED|Treatment Period 1 (1 Day)||1
10214844|NCT03686033|11341650|FG004|COMPLETED|Treatment Period 1 (1 Day)||1
10214845|NCT03686033|11341651|FG005|COMPLETED|Treatment Period 1 (1 Day)||0
10214846|NCT03686033|11341646|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10214847|NCT03686033|11341647|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10214848|NCT03686033|11341648|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10214849|NCT03686033|11341649|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10214850|NCT03686033|11341650|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10214851|NCT03686033|11341651|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10214852|NCT03686033|11341646|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
10214853|NCT03686033|11341647|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
10012118|NCT01784068|11134975|FG000|NTCT Phase|NTCS Phase||13
10214854|NCT03686033|11341648|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
10214855|NCT03686033|11341649|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
10214856|NCT03686033|11341650|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1
10214857|NCT03686033|11341651|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
10214858|NCT03686033|11341646|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214859|NCT03686033|11341647|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214860|NCT03686033|11341648|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214861|NCT03686033|11341649|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214862|NCT03686033|11341650|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214863|NCT03686033|11341651|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214864|NCT03686033|11341646|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214865|NCT03686033|11341647|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214866|NCT03686033|11341648|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214867|NCT03686033|11341649|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214868|NCT03686033|11341650|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214869|NCT03686033|11341651|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214870|NCT03686033|11341646|FG000|STARTED|Treatment Period 2 (1 Day)||1
10214871|NCT03686033|11341647|FG001|STARTED|Treatment Period 2 (1 Day)||1
10214872|NCT03686033|11341648|FG002|STARTED|Treatment Period 2 (1 Day)||1
10214873|NCT03686033|11341649|FG003|STARTED|Treatment Period 2 (1 Day)||1
10214874|NCT03686033|11341650|FG004|STARTED|Treatment Period 2 (1 Day)||1
10214875|NCT03686033|11341651|FG005|STARTED|Treatment Period 2 (1 Day)||0
10214876|NCT03686033|11341646|FG000|COMPLETED|Treatment Period 2 (1 Day)||1
10214877|NCT03686033|11341647|FG001|COMPLETED|Treatment Period 2 (1 Day)||1
10214878|NCT03686033|11341648|FG002|COMPLETED|Treatment Period 2 (1 Day)||1
10214879|NCT03686033|11341649|FG003|COMPLETED|Treatment Period 2 (1 Day)||1
10214880|NCT03686033|11341650|FG004|COMPLETED|Treatment Period 2 (1 Day)||0
10214881|NCT03686033|11341651|FG005|COMPLETED|Treatment Period 2 (1 Day)||0
10214882|NCT03686033|11341646|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10214883|NCT03686033|11341647|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10214884|NCT03686033|11341648|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10214885|NCT03686033|11341649|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10214886|NCT03686033|11341650|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1
10214887|NCT03686033|11341651|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10214888|NCT03686033|11341646|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
10214889|NCT03686033|11341647|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
10214890|NCT03686033|11341648|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
10214891|NCT03686033|11341649|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
10214892|NCT03686033|11341650|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
10214893|NCT03686033|11341651|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
10214894|NCT03686033|11341646|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214895|NCT03686033|11341647|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214896|NCT03686033|11341648|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214897|NCT03686033|11341649|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214898|NCT03686033|11341650|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214899|NCT03686033|11341651|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214900|NCT03686033|11341646|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214901|NCT03686033|11341647|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214902|NCT03686033|11341648|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214903|NCT03686033|11341649|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214904|NCT03686033|11341650|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214905|NCT03686033|11341651|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214906|NCT03686033|11341646|FG000|STARTED|Treatment Period 3 (1 Day)||1
10214907|NCT03686033|11341647|FG001|STARTED|Treatment Period 3 (1 Day)||1
10214908|NCT03686033|11341648|FG002|STARTED|Treatment Period 3 (1 Day)||1
10214909|NCT03686033|11341649|FG003|STARTED|Treatment Period 3 (1 Day)||1
10214910|NCT03686033|11341650|FG004|STARTED|Treatment Period 3 (1 Day)||0
10214911|NCT03686033|11341651|FG005|STARTED|Treatment Period 3 (1 Day)||0
10214912|NCT03686033|11341646|FG000|COMPLETED|Treatment Period 3 (1 Day)||1
10214913|NCT03686033|11341647|FG001|COMPLETED|Treatment Period 3 (1 Day)||1
10214914|NCT03686033|11341648|FG002|COMPLETED|Treatment Period 3 (1 Day)||1
10214915|NCT03686033|11341649|FG003|COMPLETED|Treatment Period 3 (1 Day)||1
10214916|NCT03686033|11341650|FG004|COMPLETED|Treatment Period 3 (1 Day)||0
10214917|NCT03686033|11341651|FG005|COMPLETED|Treatment Period 3 (1 Day)||0
10214918|NCT03686033|11341646|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10214919|NCT03686033|11341647|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10214920|NCT03686033|11341648|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10214921|NCT03686033|11341649|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10214922|NCT03686033|11341650|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10214923|NCT03686033|11341651|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10214924|NCT03686033|11341646|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
10214925|NCT03686033|11341647|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
10214926|NCT03686033|11341648|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
10214927|NCT03686033|11341649|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
10214928|NCT03686033|11341650|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
10214929|NCT03686033|11341651|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
10214930|NCT03686033|11341646|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214931|NCT03686033|11341647|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214932|NCT03686033|11341648|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214933|NCT03686033|11341649|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10214934|NCT03686033|11341650|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214935|NCT03686033|11341651|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214936|NCT03686033|11341646|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214937|NCT03686033|11341647|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214938|NCT03686033|11341648|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214939|NCT03686033|11341649|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214940|NCT03686033|11341650|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214941|NCT03686033|11341651|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10214942|NCT03686033|11341646|FG000|STARTED|Treatment Period 4 (1 Day)||1
10214943|NCT03686033|11341647|FG001|STARTED|Treatment Period 4 (1 Day)||1
10214944|NCT03686033|11341648|FG002|STARTED|Treatment Period 4 (1 Day)||1
10214945|NCT03686033|11341649|FG003|STARTED|Treatment Period 4 (1 Day)||1
10214946|NCT03686033|11341650|FG004|STARTED|Treatment Period 4 (1 Day)||0
10214947|NCT03686033|11341651|FG005|STARTED|Treatment Period 4 (1 Day)||0
10214948|NCT03686033|11341646|FG000|COMPLETED|Treatment Period 4 (1 Day)||1
10214949|NCT03686033|11341647|FG001|COMPLETED|Treatment Period 4 (1 Day)||1
10214950|NCT03686033|11341648|FG002|COMPLETED|Treatment Period 4 (1 Day)||1
10214951|NCT03686033|11341649|FG003|COMPLETED|Treatment Period 4 (1 Day)||1
10214952|NCT03686033|11341650|FG004|COMPLETED|Treatment Period 4 (1 Day)||0
10214953|NCT03686033|11341651|FG005|COMPLETED|Treatment Period 4 (1 Day)||0
10214954|NCT03686033|11341646|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10214955|NCT03686033|11341647|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10214956|NCT03686033|11341648|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10214957|NCT03686033|11341649|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10214958|NCT03686033|11341650|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10214959|NCT03686033|11341651|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10214960|NCT03686176|11341668|FG000|STARTED|Overall Study||19
10214961|NCT03686176|11341669|FG001|STARTED|Overall Study||25
10214962|NCT03686176|11341670|FG002|STARTED|Overall Study||20
10214963|NCT03686176|11341668|FG000|COMPLETED|Overall Study||17
10214964|NCT03686176|11341669|FG001|COMPLETED|Overall Study||25
10214965|NCT03686176|11341670|FG002|COMPLETED|Overall Study||20
10214966|NCT03686176|11341668|FG000|NOT COMPLETED|Overall Study||2
10214967|NCT03686176|11341669|FG001|NOT COMPLETED|Overall Study||0
10214968|NCT03686176|11341670|FG002|NOT COMPLETED|Overall Study||0
10214969|NCT03687125|11341680|FG000|STARTED|Overall Study||3
10214970|NCT03687125|11341681|FG001|STARTED|Overall Study||3
10214971|NCT03687125|11341680|FG000|COMPLETED|Overall Study||0
10214972|NCT03687125|11341681|FG001|COMPLETED|Overall Study||2
10214973|NCT03687125|11341680|FG000|NOT COMPLETED|Overall Study||3
10214974|NCT03687125|11341681|FG001|NOT COMPLETED|Overall Study||1
10214975|NCT03687372|11341691|FG000|STARTED|Overall Study||254
10214976|NCT03687372|11341692|FG001|STARTED|Overall Study||249
10214977|NCT03687372|11341691|FG000|COMPLETED|Overall Study||237
10214978|NCT03687372|11341692|FG001|COMPLETED|Overall Study||210
10214979|NCT03687372|11341691|FG000|NOT COMPLETED|Overall Study||17
10214980|NCT03687372|11341692|FG001|NOT COMPLETED|Overall Study||39
10214981|NCT03687450|11341702|FG000|STARTED|Overall Study||38
10214982|NCT03687450|11341703|FG001|STARTED|Overall Study||18
10214983|NCT03687450|11341702|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
10214984|NCT03687450|11341703|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
10214985|NCT03687450|11341702|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26
10214986|NCT03687450|11341703|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
10214987|NCT03687450|11341702|FG000|COMPLETED|Overall Study||26
10214988|NCT03687450|11341703|FG001|COMPLETED|Overall Study||16
10214989|NCT03687450|11341702|FG000|NOT COMPLETED|Overall Study||12
10214990|NCT03687450|11341703|FG001|NOT COMPLETED|Overall Study||2
10214991|NCT03687684|11341718|FG000|STARTED|Overall Study||4
10214992|NCT03687684|11341719|FG001|STARTED|Overall Study||2
10214993|NCT03687684|11341720|FG002|STARTED|Overall Study||2
10214994|NCT03687684|11341721|FG003|STARTED|Overall Study||6
10214995|NCT03687684|11341722|FG004|STARTED|Overall Study||6
10214996|NCT03687684|11341723|FG005|STARTED|Overall Study||6
10214997|NCT03687684|11341724|FG006|STARTED|Overall Study||6
10214998|NCT03687684|11341725|FG007|STARTED|Overall Study||2
10214999|NCT03687684|11341726|FG008|STARTED|Overall Study||6
10215000|NCT03687684|11341718|FG000|COMPLETED|Overall Study||4
10215001|NCT03687684|11341719|FG001|COMPLETED|Overall Study||2
10215002|NCT03687684|11341720|FG002|COMPLETED|Overall Study||2
10215003|NCT03687684|11341721|FG003|COMPLETED|Overall Study||6
10215004|NCT03687684|11341722|FG004|COMPLETED|Overall Study||6
10215005|NCT03687684|11341723|FG005|COMPLETED|Overall Study||6
10215006|NCT03687684|11341724|FG006|COMPLETED|Overall Study||6
10215007|NCT03687684|11341725|FG007|COMPLETED|Overall Study||2
10215008|NCT03687684|11341726|FG008|COMPLETED|Overall Study||6
10215009|NCT03687684|11341718|FG000|NOT COMPLETED|Overall Study||0
10215010|NCT03687684|11341719|FG001|NOT COMPLETED|Overall Study||0
10215011|NCT03687684|11341720|FG002|NOT COMPLETED|Overall Study||0
10215012|NCT03687684|11341721|FG003|NOT COMPLETED|Overall Study||0
10215013|NCT03687684|11341722|FG004|NOT COMPLETED|Overall Study||0
10215014|NCT03687684|11341723|FG005|NOT COMPLETED|Overall Study||0
10215015|NCT03687684|11341724|FG006|NOT COMPLETED|Overall Study||0
10215016|NCT03687684|11341725|FG007|NOT COMPLETED|Overall Study||0
10215017|NCT03687684|11341726|FG008|NOT COMPLETED|Overall Study||0
10215018|NCT03687736|11341756|FG000|STARTED|Overall Study||120
10215019|NCT03687736|11341756|FG000|COMPLETED|Overall Study||110
10215020|NCT03687736|11341756|FG000|NOT COMPLETED|Overall Study||10
10215021|NCT03687827|11341762|FG000|STARTED|Treatment Period 1||249
10215022|NCT03687827|11341763|FG001|STARTED|Treatment Period 1||249
10215023|NCT03687827|11341762|FG000|Full Analysis Set (FAS)|Treatment Period 1||249
10215024|NCT03687827|11341763|FG001|Full Analysis Set (FAS)|Treatment Period 1||249
10215025|NCT03687827|11341762|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249
10215026|NCT03687827|11341763|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249
10215027|NCT03687827|11341762|FG000|Per Protocol Set|Treatment Period 1||219
10215028|NCT03687827|11341763|FG001|Per Protocol Set|Treatment Period 1||229
10215029|NCT03687827|11341762|FG000|COMPLETED|Treatment Period 1||235
10215030|NCT03687827|11341763|FG001|COMPLETED|Treatment Period 1||241
10215031|NCT03687827|11341762|FG000|NOT COMPLETED|Treatment Period 1||14
10215032|NCT03687827|11341763|FG001|NOT COMPLETED|Treatment Period 1||8
10215033|NCT03687827|11341762|FG000|STARTED|Treatment Period 2||235
10215034|NCT03687827|11341763|FG001|STARTED|Treatment Period 2||241
10215035|NCT03687827|11341762|FG000|COMPLETED|Treatment Period 2||230
10215036|NCT03687827|11341763|FG001|COMPLETED|Treatment Period 2||238
10215037|NCT03687827|11341762|FG000|NOT COMPLETED|Treatment Period 2||5
10215038|NCT03687827|11341763|FG001|NOT COMPLETED|Treatment Period 2||3
10215039|NCT03687970|11341771|FG000|STARTED|Overall Study||22
10215040|NCT03687970|11341772|FG001|STARTED|Overall Study||20
10215041|NCT03687970|11341771|FG000|COMPLETED|Overall Study||20
10215042|NCT03687970|11341772|FG001|COMPLETED|Overall Study||20
10215043|NCT03687970|11341771|FG000|NOT COMPLETED|Overall Study||2
10215044|NCT03687970|11341772|FG001|NOT COMPLETED|Overall Study||0
10215045|NCT03688282|11341780|FG000|STARTED|Sham Treatment for 30 Minutes||18
10215046|NCT03688282|11341780|FG000|COMPLETED|Sham Treatment for 30 Minutes||17
10215047|NCT03688282|11341780|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1
10215048|NCT03688282|11341780|FG000|STARTED|Washout (7 Days)||17
10215049|NCT03688282|11341780|FG000|COMPLETED|Washout (7 Days)||17
10215050|NCT03688282|11341780|FG000|NOT COMPLETED|Washout (7 Days)||0
10215051|NCT03688282|11341780|FG000|STARTED|Active Treatment for 30 Minutes||17
10215052|NCT03688282|11341780|FG000|COMPLETED|Active Treatment for 30 Minutes||17
10215053|NCT03688282|11341780|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0
10215054|NCT03688542|11341788|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
10215055|NCT03688542|11341789|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
10215056|NCT03688542|11341788|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|
10215057|NCT03688542|11341789|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|
10215058|NCT03688542|11341788|FG000|NOT COMPLETED|Overall Study||
10215059|NCT03688542|11341789|FG001|NOT COMPLETED|Overall Study||
10215060|NCT03688620|11341798|FG000|STARTED|Overall Study||329
10215061|NCT03688620|11341799|FG001|STARTED|Overall Study||278
10215062|NCT03688620|11341800|FG002|STARTED|Overall Study||453
10215063|NCT03688620|11341798|FG000|COMPLETED|Overall Study||313
10215064|NCT03688620|11341799|FG001|COMPLETED|Overall Study||277
10215065|NCT03688620|11341800|FG002|COMPLETED|Overall Study||445
10215066|NCT03688620|11341798|FG000|NOT COMPLETED|Overall Study||16
10215067|NCT03688620|11341799|FG001|NOT COMPLETED|Overall Study||1
10215068|NCT03688620|11341800|FG002|NOT COMPLETED|Overall Study||8
10215069|NCT03688685|11341810|FG000|STARTED|Overall Study||25
10215070|NCT03688685|11341810|FG000|COMPLETED|Overall Study||21
10215071|NCT03688685|11341810|FG000|NOT COMPLETED|Overall Study||4
10215072|NCT03688711|11341816|FG000|STARTED|Overall Study||34
10215073|NCT03688711|11341817|FG001|STARTED|Overall Study||11
10215074|NCT03688711|11341816|FG000|COMPLETED|Overall Study||34
10215075|NCT03688711|11341817|FG001|COMPLETED|Overall Study||10
10215076|NCT03688711|11341816|FG000|NOT COMPLETED|Overall Study||0
10215077|NCT03688711|11341817|FG001|NOT COMPLETED|Overall Study||1
10215078|NCT03688880|11341825|FG000|STARTED|Overall Study||29
10215079|NCT03688880|11341826|FG001|STARTED|Overall Study||60
10215080|NCT03688880|11341825|FG000|COMPLETED|Overall Study||15
10215081|NCT03688880|11341826|FG001|COMPLETED|Overall Study||29
10215082|NCT03688880|11341825|FG000|NOT COMPLETED|Overall Study||14
10215083|NCT03688880|11341826|FG001|NOT COMPLETED|Overall Study||31
10215084|NCT03689452|11341834|FG000|STARTED|Overall Study||15
10215085|NCT03689452|11341835|FG001|STARTED|Overall Study||15
10215086|NCT03689452|11341834|FG000|COMPLETED|Overall Study||14
10215087|NCT03689452|11341835|FG001|COMPLETED|Overall Study||14
10215088|NCT03689452|11341834|FG000|NOT COMPLETED|Overall Study||1
10215089|NCT03689452|11341835|FG001|NOT COMPLETED|Overall Study||1
10215090|NCT03689504|11341843|FG000|STARTED|Overall Study||70
10215091|NCT03689504|11341844|FG001|STARTED|Overall Study||70
10215092|NCT03689504|11341843|FG000|COMPLETED|Overall Study||65
10215093|NCT03689504|11341844|FG001|COMPLETED|Overall Study||70
10215094|NCT03689504|11341843|FG000|NOT COMPLETED|Overall Study||5
10215095|NCT03689504|11341844|FG001|NOT COMPLETED|Overall Study||0
10215096|NCT03690375|11341852|FG000|STARTED|Overall Study||10
10215097|NCT03690375|11341853|FG001|STARTED|Overall Study||10
10215098|NCT03690375|11341852|FG000|COMPLETED|Overall Study||10
10215099|NCT03690375|11341853|FG001|COMPLETED|Overall Study||10
10215100|NCT03690375|11341852|FG000|NOT COMPLETED|Overall Study||0
10215101|NCT03690375|11341853|FG001|NOT COMPLETED|Overall Study||0
10215102|NCT03691779|11341862|FG000|STARTED|Part A (15 Days)||16
10215103|NCT03691779|11341863|FG001|STARTED|Part A (15 Days)||0
10215104|NCT03691779|11341862|FG000|COMPLETED|Part A (15 Days)||16
10215105|NCT03691779|11341863|FG001|COMPLETED|Part A (15 Days)||0
10215106|NCT03691779|11341862|FG000|NOT COMPLETED|Part A (15 Days)||0
10215107|NCT03691779|11341863|FG001|NOT COMPLETED|Part A (15 Days)||0
10215108|NCT03691779|11341862|FG000|STARTED|Part B (24 Weeks)||0
10215109|NCT03691779|11341863|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66
10215110|NCT03691779|11341862|FG000|COMPLETED|Part B (24 Weeks)||0
10215111|NCT03691779|11341863|FG001|COMPLETED|Part B (24 Weeks)||64
10215112|NCT03691779|11341862|FG000|NOT COMPLETED|Part B (24 Weeks)||0
10012119|NCT01784068|11134976|FG001|NTCT Phase|NTCS Phase||0
10012120|NCT01784068|11134975|FG000|TFR-2 Phase|NTCS Phase||8
10012121|NCT01784068|11134976|FG001|TFR-2 Phase|NTCS Phase||0
10215113|NCT03691779|11341863|FG001|NOT COMPLETED|Part B (24 Weeks)||2
10215114|NCT03691831|11341872|FG000|STARTED|Overall Study||251
10215115|NCT03691831|11341873|FG001|STARTED|Overall Study||251
10215116|NCT03691831|11341872|FG000|COMPLETED|Overall Study||224
10215117|NCT03691831|11341873|FG001|COMPLETED|Overall Study||220
10215118|NCT03691831|11341872|FG000|NOT COMPLETED|Overall Study||27
10215119|NCT03691831|11341873|FG001|NOT COMPLETED|Overall Study||31
10215120|NCT03691844|11341883|FG000|STARTED|Overall Study||121
10215121|NCT03691844|11341884|FG001|STARTED|Overall Study||121
10215122|NCT03691844|11341885|FG002|STARTED|Overall Study||121
10215123|NCT03691844|11341886|FG003|STARTED|Overall Study||81
10215124|NCT03691844|11341883|FG000|COMPLETED|Overall Study||114
10215125|NCT03691844|11341884|FG001|COMPLETED|Overall Study||109
10215126|NCT03691844|11341885|FG002|COMPLETED|Overall Study||108
10215127|NCT03691844|11341886|FG003|COMPLETED|Overall Study||70
10215128|NCT03691844|11341883|FG000|NOT COMPLETED|Overall Study||7
10215129|NCT03691844|11341884|FG001|NOT COMPLETED|Overall Study||12
10215130|NCT03691844|11341885|FG002|NOT COMPLETED|Overall Study||13
10215131|NCT03691844|11341886|FG003|NOT COMPLETED|Overall Study||11
10215132|NCT03691948|11341900|FG000|STARTED|Overall Study||27
10215133|NCT03691948|11341901|FG001|STARTED|Overall Study||33
10215134|NCT03691948|11341900|FG000|COMPLETED|Overall Study||26
10215135|NCT03691948|11341901|FG001|COMPLETED|Overall Study||30
10215136|NCT03691948|11341900|FG000|NOT COMPLETED|Overall Study||1
10215137|NCT03691948|11341901|FG001|NOT COMPLETED|Overall Study||3
10215138|NCT03692676|11341912|FG000|STARTED|Overall Study||10365
10215139|NCT03692676|11341913|FG001|STARTED|Overall Study||51142
10215140|NCT03692676|11341914|FG002|STARTED|Overall Study||49479
10215141|NCT03692676|11341915|FG003|STARTED|Overall Study||5147
10215142|NCT03692676|11341912|FG000|COMPLETED|Overall Study||940
10215143|NCT03692676|11341913|FG001|COMPLETED|Overall Study||3704
10215144|NCT03692676|11341914|FG002|COMPLETED|Overall Study||11135
10215145|NCT03692676|11341915|FG003|COMPLETED|Overall Study||1561
10215146|NCT03692676|11341912|FG000|NOT COMPLETED|Overall Study||9425
10215147|NCT03692676|11341913|FG001|NOT COMPLETED|Overall Study||47438
10215148|NCT03692676|11341914|FG002|NOT COMPLETED|Overall Study||38344
10215149|NCT03692676|11341915|FG003|NOT COMPLETED|Overall Study||3586
10215150|NCT03693625|11341927|FG000|STARTED|Overall Study||23
10215151|NCT03693625|11341928|FG001|STARTED|Overall Study||8
10215152|NCT03693625|11341927|FG000|COMPLETED|Overall Study||0
10215153|NCT03693625|11341928|FG001|COMPLETED|Overall Study||0
10215154|NCT03693625|11341927|FG000|NOT COMPLETED|Overall Study||23
10215155|NCT03693625|11341928|FG001|NOT COMPLETED|Overall Study||8
10215156|NCT03693742|11341936|FG000|STARTED|Overall Study||7
10215157|NCT03693742|11341937|FG001|STARTED|Overall Study||3
10215158|NCT03693742|11341936|FG000|COMPLETED|Overall Study||7
10215159|NCT03693742|11341937|FG001|COMPLETED|Overall Study||3
10215160|NCT03693742|11341936|FG000|NOT COMPLETED|Overall Study||0
10215161|NCT03693742|11341937|FG001|NOT COMPLETED|Overall Study||0
10215162|NCT03693937|11341945|FG000|STARTED|Overall Study||776
10215163|NCT03693937|11341945|FG000|COMPLETED|Overall Study||776
10215164|NCT03693937|11341945|FG000|NOT COMPLETED|Overall Study||0
10012122|NCT01784068|11134975|FG000|NTCT-P Phase|NTCS Phase||2
10215165|NCT03693950|11341951|FG000|STARTED|Overall Study||29
10215166|NCT03693950|11341952|FG001|STARTED|Overall Study||28
10215167|NCT03693950|11341951|FG000|COMPLETED|Overall Study||28
10215168|NCT03693950|11341952|FG001|COMPLETED|Overall Study||28
10215169|NCT03693950|11341951|FG000|NOT COMPLETED|Overall Study||1
10215170|NCT03693950|11341952|FG001|NOT COMPLETED|Overall Study||0
10215171|NCT03693989|11341960|FG000|STARTED|Overall Study||88
10215172|NCT03693989|11341961|FG001|STARTED|Overall Study||90
10215173|NCT03693989|11341960|FG000|COMPLETED|Overall Study||85
10215174|NCT03693989|11341961|FG001|COMPLETED|Overall Study||86
10215175|NCT03693989|11341960|FG000|NOT COMPLETED|Overall Study||3
10215176|NCT03693989|11341961|FG001|NOT COMPLETED|Overall Study||4
10215177|NCT03694197|11341967|FG000|STARTED|Overall Study||1385
10215178|NCT03694197|11341967|FG000|COMPLETED|Overall Study||0
10215179|NCT03694197|11341967|FG000|NOT COMPLETED|Overall Study||1385
10215180|NCT03694210|11341971|FG000|STARTED|Overall Study||37
10215181|NCT03694210|11341971|FG000|COMPLETED|Overall Study||29
10215182|NCT03694210|11341971|FG000|NOT COMPLETED|Overall Study||8
10215183|NCT03694548|11341979|FG000|STARTED|Part A Survey||18
10215184|NCT03694548|11341980|FG001|STARTED|Part A Survey||17
10215185|NCT03694548|11341981|FG002|STARTED|Part A Survey||0
10215186|NCT03694548|11341979|FG000|COMPLETED|Part A Survey||15
10215187|NCT03694548|11341980|FG001|COMPLETED|Part A Survey||14
10215188|NCT03694548|11341981|FG002|COMPLETED|Part A Survey||0
10012123|NCT01784068|11134976|FG001|NTCT-P Phase|NTCS Phase||0
10012124|NCT01784068|11134975|FG000|NTRI-2|NTCS Phase||0
10012125|NCT01784068|11134976|FG001|NTRI-2|NTCS Phase||0
10215189|NCT03694548|11341979|FG000|NOT COMPLETED|Part A Survey||3
10215190|NCT03694548|11341980|FG001|NOT COMPLETED|Part A Survey||3
10215191|NCT03694548|11341981|FG002|NOT COMPLETED|Part A Survey||0
10215192|NCT03694548|11341979|FG000|STARTED|Part B Yoga Program||0
10215193|NCT03694548|11341980|FG001|STARTED|Part B Yoga Program||0
10215194|NCT03694548|11341981|FG002|STARTED|Part B Yoga Program||12
10215195|NCT03694548|11341979|FG000|COMPLETED|Part B Yoga Program||0
10215196|NCT03694548|11341980|FG001|COMPLETED|Part B Yoga Program||0
10215197|NCT03694548|11341981|FG002|COMPLETED|Part B Yoga Program||1
10215198|NCT03694548|11341979|FG000|NOT COMPLETED|Part B Yoga Program||0
10215199|NCT03694548|11341980|FG001|NOT COMPLETED|Part B Yoga Program||0
10215200|NCT03694548|11341981|FG002|NOT COMPLETED|Part B Yoga Program||11
10215201|NCT03694613|11341991|FG000|STARTED|Overall Study||65
10215202|NCT03694613|11341991|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
10215203|NCT03694613|11341991|FG000|NOT COMPLETED|Overall Study||0
10215204|NCT03694925|11342007|FG000|STARTED|Overall Study||30
10215205|NCT03694925|11342008|FG001|STARTED|Overall Study||73
10215206|NCT03694925|11342009|FG002|STARTED|Overall Study||53
10215207|NCT03694925|11342007|FG000|COMPLETED|Overall Study||30
10215208|NCT03694925|11342008|FG001|COMPLETED|Overall Study||70
10215209|NCT03694925|11342009|FG002|COMPLETED|Overall Study||53
10215210|NCT03694925|11342007|FG000|NOT COMPLETED|Overall Study||0
10215211|NCT03694925|11342008|FG001|NOT COMPLETED|Overall Study||3
10215212|NCT03694925|11342009|FG002|NOT COMPLETED|Overall Study||0
10215213|NCT03695094|11342021|FG000|STARTED|Overall Study||16
10215214|NCT03695094|11342022|FG001|STARTED|Overall Study||15
10215215|NCT03695094|11342021|FG000|COMPLETED|Overall Study||14
10215216|NCT03695094|11342022|FG001|COMPLETED|Overall Study||14
10215217|NCT03695094|11342021|FG000|NOT COMPLETED|Overall Study||2
10215218|NCT03695094|11342022|FG001|NOT COMPLETED|Overall Study||1
10215219|NCT03695367|11342032|FG000|STARTED|Overall Study||33
10215220|NCT03695367|11342033|FG001|STARTED|Overall Study||30
10215221|NCT03695367|11342032|FG000|COMPLETED|Overall Study||32
10215222|NCT03695367|11342033|FG001|COMPLETED|Overall Study||26
10215223|NCT03695367|11342032|FG000|NOT COMPLETED|Overall Study||1
10215224|NCT03695367|11342033|FG001|NOT COMPLETED|Overall Study||4
10215225|NCT03695393|11342041|FG000|STARTED|Overall Study||67
10215226|NCT03695393|11342042|FG001|STARTED|Overall Study||33
10215227|NCT03695393|11342041|FG000|1-month|Overall Study||66
10215228|NCT03695393|11342042|FG001|1-month|Overall Study||32
10215229|NCT03695393|11342041|FG000|6-month|Overall Study||64
10215230|NCT03695393|11342042|FG001|6-month|Overall Study||31
10215231|NCT03695393|11342041|FG000|COMPLETED|Overall Study||64
10215232|NCT03695393|11342042|FG001|COMPLETED|Overall Study||31
10215233|NCT03695393|11342041|FG000|NOT COMPLETED|Overall Study||3
10215234|NCT03695393|11342042|FG001|NOT COMPLETED|Overall Study||2
10215235|NCT03695913|11342048|FG000|STARTED|Overall Study||15
10215236|NCT03695913|11342048|FG000|COMPLETED|Overall Study||15
10215237|NCT03695913|11342048|FG000|NOT COMPLETED|Overall Study||0
10215238|NCT03696108|11342054|FG000|STARTED|Overall Study||84
10215239|NCT03696108|11342055|FG001|STARTED|Overall Study||85
10215240|NCT03696108|11342054|FG000|COMPLETED|Overall Study||80
10215241|NCT03696108|11342055|FG001|COMPLETED|Overall Study||79
10215242|NCT03696108|11342054|FG000|NOT COMPLETED|Overall Study||4
10215243|NCT03696108|11342055|FG001|NOT COMPLETED|Overall Study||6
10215244|NCT03696342|11342063|FG000|STARTED|Overall Study||23
10215245|NCT03696342|11342064|FG001|STARTED|Overall Study||23
10215246|NCT03696342|11342063|FG000|COMPLETED|Overall Study||22
10215247|NCT03696342|11342064|FG001|COMPLETED|Overall Study||23
10215248|NCT03696342|11342063|FG000|NOT COMPLETED|Overall Study||1
10215249|NCT03696342|11342064|FG001|NOT COMPLETED|Overall Study||0
10215250|NCT03696576|11342072|FG000|STARTED|Overall Study||13
10215251|NCT03696576|11342073|FG001|STARTED|Overall Study||11
10215252|NCT03696576|11342072|FG000|COMPLETED|Overall Study||10
10215253|NCT03696576|11342073|FG001|COMPLETED|Overall Study||6
10215254|NCT03696576|11342072|FG000|NOT COMPLETED|Overall Study||3
10215255|NCT03696576|11342073|FG001|NOT COMPLETED|Overall Study||5
10215256|NCT03696589|11342079|FG000|STARTED|Overall Study||13
10215257|NCT03696589|11342079|FG000|COMPLETED|Overall Study||12
10215258|NCT03696589|11342079|FG000|NOT COMPLETED|Overall Study||1
10215259|NCT03696758|11342092|FG000|STARTED|First Intervention||3
10215260|NCT03696758|11342093|FG001|STARTED|First Intervention||6
10215261|NCT03696758|11342092|FG000|COMPLETED|First Intervention||3
10215262|NCT03696758|11342093|FG001|COMPLETED|First Intervention||6
10215263|NCT03696758|11342092|FG000|NOT COMPLETED|First Intervention||0
10215264|NCT03696758|11342093|FG001|NOT COMPLETED|First Intervention||0
10215265|NCT03696758|11342092|FG000|STARTED|Wash Out>12 Hours||3
10215266|NCT03696758|11342093|FG001|STARTED|Wash Out>12 Hours||6
10215267|NCT03696758|11342092|FG000|COMPLETED|Wash Out>12 Hours||3
10215268|NCT03696758|11342093|FG001|COMPLETED|Wash Out>12 Hours||6
10215269|NCT03696758|11342092|FG000|NOT COMPLETED|Wash Out>12 Hours||0
10215270|NCT03696758|11342093|FG001|NOT COMPLETED|Wash Out>12 Hours||0
10215271|NCT03696758|11342092|FG000|STARTED|Second Intervention||3
10215272|NCT03696758|11342093|FG001|STARTED|Second Intervention||6
10215273|NCT03696758|11342092|FG000|COMPLETED|Second Intervention||3
10215274|NCT03696758|11342093|FG001|COMPLETED|Second Intervention||6
10215275|NCT03696758|11342092|FG000|NOT COMPLETED|Second Intervention||0
10215276|NCT03696758|11342093|FG001|NOT COMPLETED|Second Intervention||0
10215277|NCT03697083|11342102|FG000|STARTED|Overall Study||262
10215278|NCT03697083|11342103|FG001|STARTED|Overall Study||260
10215279|NCT03697083|11342104|FG002|STARTED|Overall Study||255
10215280|NCT03697083|11342102|FG000|COMPLETED|Overall Study||262
10215281|NCT03697083|11342103|FG001|COMPLETED|Overall Study||250
10215282|NCT03697083|11342104|FG002|COMPLETED|Overall Study||255
10215283|NCT03697083|11342102|FG000|NOT COMPLETED|Overall Study||0
10215284|NCT03697083|11342103|FG001|NOT COMPLETED|Overall Study||10
10215285|NCT03697083|11342104|FG002|NOT COMPLETED|Overall Study||0
10215286|NCT03697122|11342112|FG000|STARTED|Overall Study||14
10215287|NCT03697122|11342112|FG000|COMPLETED|Overall Study||14
10215288|NCT03697122|11342112|FG000|NOT COMPLETED|Overall Study||0
10215289|NCT03697252|11342118|FG000|STARTED|Overall Study||90
10215290|NCT03697252|11342119|FG001|STARTED|Overall Study||92
10215291|NCT03697252|11342118|FG000|COMPLETED|Overall Study||72
10215292|NCT03697252|11342119|FG001|COMPLETED|Overall Study||73
10215293|NCT03697252|11342118|FG000|NOT COMPLETED|Overall Study||18
10215294|NCT03697252|11342119|FG001|NOT COMPLETED|Overall Study||19
10215295|NCT03697460|11342125|FG000|STARTED|Overall Study||12
10215296|NCT03697460|11342125|FG000|COMPLETED|Overall Study||9
10215297|NCT03697460|11342125|FG000|NOT COMPLETED|Overall Study||3
10215298|NCT03697993|11342131|FG000|STARTED|Overall Study||32
10215299|NCT03697993|11342132|FG001|STARTED|Overall Study||30
10215300|NCT03697993|11342131|FG000|Initiated Treatment|Overall Study||30
10215301|NCT03697993|11342132|FG001|Initiated Treatment|Overall Study||28
10215302|NCT03697993|11342131|FG000|Switched Treatment|Overall Study||0
10215303|NCT03697993|11342132|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
10215304|NCT03697993|11342131|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
10215305|NCT03697993|11342132|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
10215306|NCT03697993|11342131|FG000|COMPLETED|Overall Study||22
10215307|NCT03697993|11342132|FG001|COMPLETED|Overall Study||25
10215308|NCT03697993|11342131|FG000|NOT COMPLETED|Overall Study||10
10215309|NCT03697993|11342132|FG001|NOT COMPLETED|Overall Study||5
10215310|NCT03698331|11342141|FG000|STARTED|Overall Study||44
10215311|NCT03698331|11342142|FG001|STARTED|Overall Study||45
10215312|NCT03698331|11342141|FG000|Entered Withdrawal Period|Overall Study||42
10215313|NCT03698331|11342142|FG001|Entered Withdrawal Period|Overall Study||39
10215314|NCT03698331|11342141|FG000|COMPLETED|Overall Study||40
10215315|NCT03698331|11342142|FG001|COMPLETED|Overall Study||39
10215316|NCT03698331|11342141|FG000|NOT COMPLETED|Overall Study||4
10215317|NCT03698331|11342142|FG001|NOT COMPLETED|Overall Study||6
10215318|NCT03698591|11342150|FG000|STARTED|Overall Study||20
10215319|NCT03698591|11342151|FG001|STARTED|Overall Study||20
10215320|NCT03698591|11342150|FG000|COMPLETED|Overall Study||15
10215321|NCT03698591|11342151|FG001|COMPLETED|Overall Study||15
10215322|NCT03698591|11342150|FG000|NOT COMPLETED|Overall Study||5
10215323|NCT03698591|11342151|FG001|NOT COMPLETED|Overall Study||5
10215324|NCT03699124|11342160|FG000|STARTED|Overall Study||377
10215325|NCT03699124|11342161|FG001|STARTED|Overall Study||375
10215326|NCT03699124|11342162|FG002|STARTED|Overall Study||377
10215327|NCT03699124|11342160|FG000|COMPLETED|Overall Study||332
10215328|NCT03699124|11342161|FG001|COMPLETED|Overall Study||335
10215329|NCT03699124|11342162|FG002|COMPLETED|Overall Study||337
10215330|NCT03699124|11342160|FG000|NOT COMPLETED|Overall Study||45
10215331|NCT03699124|11342161|FG001|NOT COMPLETED|Overall Study||40
10215332|NCT03699124|11342162|FG002|NOT COMPLETED|Overall Study||40
10215333|NCT03700320|11342172|FG000|STARTED|Overall Study||198
10215334|NCT03700320|11342173|FG001|STARTED|Overall Study||546
10215335|NCT03700320|11342172|FG000|Safety Population; Received Treatment|Overall Study||196
10215336|NCT03700320|11342173|FG001|Safety Population; Received Treatment|Overall Study||543
10215337|NCT03700320|11342172|FG000|Entered Safety Follow-up|Overall Study||159
10215338|NCT03700320|11342173|FG001|Entered Safety Follow-up|Overall Study||472
10215339|NCT03700320|11342172|FG000|COMPLETED|Overall Study||136
10215340|NCT03700320|11342173|FG001|COMPLETED|Overall Study||373
10215341|NCT03700320|11342172|FG000|NOT COMPLETED|Overall Study||62
10012126|NCT01784068|11134975|FG000|COMPLETED|NTCS Phase||0
10012127|NCT01784068|11134976|FG001|COMPLETED|NTCS Phase||0
10215342|NCT03700320|11342173|FG001|NOT COMPLETED|Overall Study||173
10215343|NCT03700372|11342179|FG000|STARTED|Overall Study||7
10215344|NCT03700372|11342179|FG000|COMPLETED|Overall Study||7
10215345|NCT03700372|11342179|FG000|NOT COMPLETED|Overall Study||0
10215346|NCT03700385|11342183|FG000|STARTED|Overall Study||40
10215347|NCT03700385|11342183|FG000|COMPLETED|Overall Study||39
10215348|NCT03700385|11342183|FG000|NOT COMPLETED|Overall Study||1
10215349|NCT03700671|11342189|FG000|STARTED|Overall Study||21
10215350|NCT03700671|11342190|FG001|STARTED|Overall Study||21
10215351|NCT03700671|11342189|FG000|COMPLETED|Overall Study||20
10215352|NCT03700671|11342190|FG001|COMPLETED|Overall Study||19
10215353|NCT03700671|11342189|FG000|NOT COMPLETED|Overall Study||1
10215354|NCT03700671|11342190|FG001|NOT COMPLETED|Overall Study||2
10215355|NCT03700736|11342200|FG000|STARTED|Overall Study||30
10215356|NCT03700736|11342201|FG001|STARTED|Overall Study||32
10215357|NCT03700736|11342200|FG000|COMPLETED|Overall Study||27
10215358|NCT03700736|11342201|FG001|COMPLETED|Overall Study||25
10215359|NCT03700736|11342200|FG000|NOT COMPLETED|Overall Study||3
10215360|NCT03700736|11342201|FG001|NOT COMPLETED|Overall Study||7
10215361|NCT03700892|11342212|FG000|STARTED|Baseline||15
10215362|NCT03700892|11342213|FG001|STARTED|Baseline||0
10215363|NCT03700892|11342214|FG002|STARTED|Baseline||4
10215364|NCT03700892|11342212|FG000|COMPLETED|Baseline||15
10215365|NCT03700892|11342213|FG001|COMPLETED|Baseline||0
10215366|NCT03700892|11342214|FG002|COMPLETED|Baseline||4
10215367|NCT03700892|11342212|FG000|NOT COMPLETED|Baseline||0
10215368|NCT03700892|11342213|FG001|NOT COMPLETED|Baseline||0
10215369|NCT03700892|11342214|FG002|NOT COMPLETED|Baseline||0
10215370|NCT03700892|11342212|FG000|STARTED|First Intervention (Single 1-Day Visit)||1
10215371|NCT03700892|11342213|FG001|STARTED|First Intervention (Single 1-Day Visit)||4
10215372|NCT03700892|11342214|FG002|STARTED|First Intervention (Single 1-Day Visit)||0
10215373|NCT03700892|11342212|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1
10215374|NCT03700892|11342213|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4
10215375|NCT03700892|11342214|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0
10215376|NCT03700892|11342212|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10215377|NCT03700892|11342213|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10215378|NCT03700892|11342214|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10215379|NCT03700892|11342212|FG000|STARTED|Washout (2-3 Weeks)||1
10215380|NCT03700892|11342213|FG001|STARTED|Washout (2-3 Weeks)||4
10215381|NCT03700892|11342214|FG002|STARTED|Washout (2-3 Weeks)||0
10215382|NCT03700892|11342212|FG000|COMPLETED|Washout (2-3 Weeks)||1
10215383|NCT03700892|11342213|FG001|COMPLETED|Washout (2-3 Weeks)||4
10215384|NCT03700892|11342214|FG002|COMPLETED|Washout (2-3 Weeks)||0
10215385|NCT03700892|11342212|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0
10215386|NCT03700892|11342213|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0
10215387|NCT03700892|11342214|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0
10215388|NCT03700892|11342212|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1
10215389|NCT03700892|11342213|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4
10215390|NCT03700892|11342214|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0
10215391|NCT03700892|11342212|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1
10215392|NCT03700892|11342213|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3
10215393|NCT03700892|11342214|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0
10215394|NCT03700892|11342212|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1
10215395|NCT03700892|11342213|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
10215396|NCT03700892|11342214|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0
10215397|NCT03700892|11342212|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10215398|NCT03700892|11342213|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
10215399|NCT03700892|11342214|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10215400|NCT03701061|11342225|FG000|STARTED|Overall Study||9
10215401|NCT03701061|11342226|FG001|STARTED|Overall Study||3
10215402|NCT03701061|11342225|FG000|COMPLETED|Overall Study||9
10215403|NCT03701061|11342226|FG001|COMPLETED|Overall Study||3
10215404|NCT03701061|11342225|FG000|NOT COMPLETED|Overall Study||0
10012128|NCT01784068|11134975|FG000|NOT COMPLETED|NTCS Phase||215
10215405|NCT03701061|11342226|FG001|NOT COMPLETED|Overall Study||0
10215406|NCT03701074|11342234|FG000|STARTED|Overall Study||1
10215407|NCT03701074|11342235|FG001|STARTED|Overall Study||0
10215408|NCT03701074|11342234|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
10215409|NCT03701074|11342235|FG001|COMPLETED|Overall Study||0
10215410|NCT03701074|11342234|FG000|NOT COMPLETED|Overall Study||1
10215411|NCT03701074|11342235|FG001|NOT COMPLETED|Overall Study||0
10215412|NCT03702010|11342243|FG000|STARTED|First Stimulation (5 Days)||13
10215413|NCT03702010|11342244|FG001|STARTED|First Stimulation (5 Days)||14
10215414|NCT03702010|11342243|FG000|COMPLETED|First Stimulation (5 Days)||13
10215415|NCT03702010|11342244|FG001|COMPLETED|First Stimulation (5 Days)||14
10215416|NCT03702010|11342243|FG000|NOT COMPLETED|First Stimulation (5 Days)||0
10215417|NCT03702010|11342244|FG001|NOT COMPLETED|First Stimulation (5 Days)||0
10215418|NCT03702010|11342243|FG000|STARTED|Washout + Second Stimulation (2+5days)||13
10215419|NCT03702010|11342244|FG001|STARTED|Washout + Second Stimulation (2+5days)||14
10012129|NCT01784068|11134976|FG001|NOT COMPLETED|NTCS Phase||0
10012130|NCT01784068|11134975|FG000|STARTED|TFR Phase||0
10215420|NCT03702010|11342243|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13
10215421|NCT03702010|11342244|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14
10215422|NCT03702010|11342243|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
10215423|NCT03702010|11342244|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
10215424|NCT03702010|11342243|FG000|STARTED|Follow-up (30days)||13
10215425|NCT03702010|11342244|FG001|STARTED|Follow-up (30days)||14
10215426|NCT03702010|11342243|FG000|COMPLETED|Follow-up (30days)||11
10215427|NCT03702010|11342244|FG001|COMPLETED|Follow-up (30days)||12
10215428|NCT03702010|11342243|FG000|NOT COMPLETED|Follow-up (30days)||2
10215429|NCT03702010|11342244|FG001|NOT COMPLETED|Follow-up (30days)||2
10215430|NCT03702166|11342256|FG000|STARTED|Overall Study||10
10215431|NCT03702166|11342256|FG000|COMPLETED|Overall Study||8
10215432|NCT03702166|11342256|FG000|NOT COMPLETED|Overall Study||2
10215433|NCT03702608|11342261|FG000|STARTED|Overall Study||50
10215434|NCT03702608|11342261|FG000|COMPLETED|Overall Study||50
10215435|NCT03702608|11342261|FG000|NOT COMPLETED|Overall Study||0
10215436|NCT03703336|11342267|FG000|STARTED|Overall Study||552
10215437|NCT03703336|11342268|FG001|STARTED|Overall Study||273
10215438|NCT03703336|11342267|FG000|Received Dose 1|Overall Study||552
10215439|NCT03703336|11342268|FG001|Received Dose 1|Overall Study||273
10215440|NCT03703336|11342267|FG000|Received Dose 2|Overall Study||518
10215441|NCT03703336|11342268|FG001|Received Dose 2|Overall Study||263
10215442|NCT03703336|11342267|FG000|Safety Population|Overall Study||551
10215443|NCT03703336|11342268|FG001|Safety Population|Overall Study||274
10215444|NCT03703336|11342267|FG000|COMPLETED|Overall Study||514
10215445|NCT03703336|11342268|FG001|COMPLETED|Overall Study||259
10215446|NCT03703336|11342267|FG000|NOT COMPLETED|Overall Study||38
10215447|NCT03703336|11342268|FG001|NOT COMPLETED|Overall Study||14
10215448|NCT03703817|11342276|FG000|STARTED|Overall Study||288
10215449|NCT03703817|11342277|FG001|STARTED|Overall Study||133
10215450|NCT03703817|11342276|FG000|COMPLETED|Overall Study||281
10215451|NCT03703817|11342277|FG001|COMPLETED|Overall Study||129
10215452|NCT03703817|11342276|FG000|NOT COMPLETED|Overall Study||7
10215453|NCT03703817|11342277|FG001|NOT COMPLETED|Overall Study||4
10215454|NCT03704194|11342285|FG000|STARTED|Overall Study||8
10215455|NCT03704194|11342286|FG001|STARTED|Overall Study||9
10215456|NCT03704194|11342285|FG000|COMPLETED|Overall Study||8
10215457|NCT03704194|11342286|FG001|COMPLETED|Overall Study||8
10215458|NCT03704194|11342285|FG000|NOT COMPLETED|Overall Study||0
10215459|NCT03704194|11342286|FG001|NOT COMPLETED|Overall Study||1
10012131|NCT01784068|11134976|FG001|STARTED|TFR Phase||190
10012132|NCT01784068|11134975|FG000|COMPLETED|TFR Phase||0
10012133|NCT01784068|11134976|FG001|COMPLETED|TFR Phase||97
10012134|NCT01784068|11134975|FG000|NOT COMPLETED|TFR Phase||0
10012135|NCT01784068|11134976|FG001|NOT COMPLETED|TFR Phase||93
10215460|NCT03704376|11342296|FG000|STARTED|Overall Study||42
10215461|NCT03704376|11342297|FG001|STARTED|Overall Study||44
10215462|NCT03704376|11342296|FG000|COMPLETED|Overall Study||38
10215463|NCT03704376|11342297|FG001|COMPLETED|Overall Study||40
10215464|NCT03704376|11342296|FG000|NOT COMPLETED|Overall Study||4
10215465|NCT03704376|11342297|FG001|NOT COMPLETED|Overall Study||4
10215466|NCT03704467|11342303|FG000|STARTED|Overall Study||3
10215467|NCT03704467|11342303|FG000|COMPLETED|Overall Study||3
10215468|NCT03704467|11342303|FG000|NOT COMPLETED|Overall Study||0
10215469|NCT03705273|11342309|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
10215470|NCT03705273|11342310|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
10215471|NCT03705273|11342309|FG000|COMPLETED|Overall Study||20
10215472|NCT03705273|11342310|FG001|COMPLETED|Overall Study||20
10215473|NCT03705273|11342309|FG000|NOT COMPLETED|Overall Study||0
10215474|NCT03705273|11342310|FG001|NOT COMPLETED|Overall Study||0
10215475|NCT03705481|11342316|FG000|STARTED|Overall Study||5
10215476|NCT03705481|11342316|FG000|COMPLETED|Overall Study||5
10215477|NCT03705481|11342316|FG000|NOT COMPLETED|Overall Study||0
10215478|NCT03705494|11342325|FG000|STARTED|Overall Study||10
10215479|NCT03705494|11342326|FG001|STARTED|Overall Study||10
10215480|NCT03705494|11342325|FG000|COMPLETED|Overall Study||3
10215481|NCT03705494|11342326|FG001|COMPLETED|Overall Study||7
10215482|NCT03705494|11342325|FG000|NOT COMPLETED|Overall Study||7
10215483|NCT03705494|11342326|FG001|NOT COMPLETED|Overall Study||3
10215484|NCT03705793|11342334|FG000|STARTED|Overall Study||27
10215485|NCT03705793|11342335|FG001|STARTED|Overall Study||26
10215486|NCT03705793|11342334|FG000|COMPLETED|Overall Study||22
10215487|NCT03705793|11342335|FG001|COMPLETED|Overall Study||21
10215488|NCT03705793|11342334|FG000|NOT COMPLETED|Overall Study||5
10215489|NCT03705793|11342335|FG001|NOT COMPLETED|Overall Study||5
10215490|NCT03706040|11342344|FG000|STARTED|Period A (Week 0 to Week 16)||34
10215491|NCT03706040|11342345|FG001|STARTED|Period A (Week 0 to Week 16)||69
10215492|NCT03706040|11342346|FG002|STARTED|Period A (Week 0 to Week 16)||69
10215493|NCT03706040|11342347|FG003|STARTED|Period A (Week 0 to Week 16)||0
10215494|NCT03706040|11342348|FG004|STARTED|Period A (Week 0 to Week 16)||0
10215495|NCT03706040|11342349|FG005|STARTED|Period A (Week 0 to Week 16)||0
10215496|NCT03706040|11342350|FG006|STARTED|Period A (Week 0 to Week 16)||0
10012136|NCT01784211|11134989|FG000|STARTED|Part A (Days 1-15)||38
10012137|NCT01784211|11134990|FG001|STARTED|Part A (Days 1-15)||38
10012138|NCT01784211|11134991|FG002|STARTED|Part A (Days 1-15)||0
10012139|NCT01784211|11134992|FG003|STARTED|Part A (Days 1-15)||0
10012140|NCT01784211|11134993|FG004|STARTED|Part A (Days 1-15)||0
10012141|NCT01784211|11134994|FG005|STARTED|Part A (Days 1-15)||0
10215497|NCT03706040|11342344|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34
10215498|NCT03706040|11342345|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69
10215499|NCT03706040|11342346|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69
10215500|NCT03706040|11342347|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0
10215501|NCT03706040|11342348|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0
10215502|NCT03706040|11342349|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0
10215503|NCT03706040|11342350|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0
10215504|NCT03706040|11342344|FG000|COMPLETED|Period A (Week 0 to Week 16)||25
10215505|NCT03706040|11342345|FG001|COMPLETED|Period A (Week 0 to Week 16)||61
10215506|NCT03706040|11342346|FG002|COMPLETED|Period A (Week 0 to Week 16)||58
10215507|NCT03706040|11342347|FG003|COMPLETED|Period A (Week 0 to Week 16)||0
10215508|NCT03706040|11342348|FG004|COMPLETED|Period A (Week 0 to Week 16)||0
10215509|NCT03706040|11342349|FG005|COMPLETED|Period A (Week 0 to Week 16)||0
10215510|NCT03706040|11342350|FG006|COMPLETED|Period A (Week 0 to Week 16)||0
10215511|NCT03706040|11342344|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9
10215512|NCT03706040|11342345|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8
10215513|NCT03706040|11342346|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11
10215514|NCT03706040|11342347|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10215515|NCT03706040|11342348|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10215516|NCT03706040|11342349|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10215517|NCT03706040|11342350|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10215518|NCT03706040|11342344|FG000|STARTED|Period B (Week 16 to Week 52)||0
10215519|NCT03706040|11342345|FG001|STARTED|Period B (Week 16 to Week 52)||0
10215520|NCT03706040|11342346|FG002|STARTED|Period B (Week 16 to Week 52)||0
10215521|NCT03706040|11342347|FG003|STARTED|Period B (Week 16 to Week 52)||13
10215522|NCT03706040|11342348|FG004|STARTED|Period B (Week 16 to Week 52)||12
10215523|NCT03706040|11342349|FG005|STARTED|Period B (Week 16 to Week 52)||61
10215524|NCT03706040|11342350|FG006|STARTED|Period B (Week 16 to Week 52)||58
10215525|NCT03706040|11342344|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0
10215526|NCT03706040|11342345|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0
10215527|NCT03706040|11342346|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0
10215528|NCT03706040|11342347|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13
10215529|NCT03706040|11342348|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11
10215530|NCT03706040|11342349|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61
10215531|NCT03706040|11342350|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57
10215532|NCT03706040|11342344|FG000|COMPLETED|Period B (Week 16 to Week 52)||0
10215533|NCT03706040|11342345|FG001|COMPLETED|Period B (Week 16 to Week 52)||0
10215534|NCT03706040|11342346|FG002|COMPLETED|Period B (Week 16 to Week 52)||0
10215535|NCT03706040|11342347|FG003|COMPLETED|Period B (Week 16 to Week 52)||5
10215536|NCT03706040|11342348|FG004|COMPLETED|Period B (Week 16 to Week 52)||3
10215537|NCT03706040|11342349|FG005|COMPLETED|Period B (Week 16 to Week 52)||33
10215538|NCT03706040|11342350|FG006|COMPLETED|Period B (Week 16 to Week 52)||30
10215539|NCT03706040|11342344|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0
10215540|NCT03706040|11342345|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0
10215541|NCT03706040|11342346|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0
10215542|NCT03706040|11342347|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8
10215543|NCT03706040|11342348|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9
10215544|NCT03706040|11342349|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28
10215545|NCT03706040|11342350|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28
10215546|NCT03706313|11342368|FG000|STARTED|Overall Study||20
10215547|NCT03706313|11342369|FG001|STARTED|Overall Study||20
10215548|NCT03706313|11342368|FG000|COMPLETED|Overall Study||20
10215549|NCT03706313|11342369|FG001|COMPLETED|Overall Study||20
10215550|NCT03706313|11342368|FG000|NOT COMPLETED|Overall Study||0
10215551|NCT03706313|11342369|FG001|NOT COMPLETED|Overall Study||0
10215552|NCT03706456|11342375|FG000|STARTED|Overall Study||22
10215553|NCT03706456|11342375|FG000|Started|Overall Study||22
10215554|NCT03706456|11342375|FG000|Completed|Overall Study||0
10215555|NCT03706456|11342375|FG000|COMPLETED|Overall Study||0
10215556|NCT03706456|11342375|FG000|NOT COMPLETED|Overall Study||22
10215557|NCT03706469|11342383|FG000|STARTED|Overall Study||4
10215558|NCT03706469|11342384|FG001|STARTED|Overall Study||4
10215559|NCT03706469|11342385|FG002|STARTED|Overall Study||4
10215560|NCT03706469|11342386|FG003|STARTED|Overall Study||4
10215561|NCT03706469|11342383|FG000|COMPLETED|Overall Study||4
10215562|NCT03706469|11342384|FG001|COMPLETED|Overall Study||4
10215563|NCT03706469|11342385|FG002|COMPLETED|Overall Study||4
10215564|NCT03706469|11342386|FG003|COMPLETED|Overall Study||4
10215565|NCT03706469|11342383|FG000|NOT COMPLETED|Overall Study||0
10215566|NCT03706469|11342384|FG001|NOT COMPLETED|Overall Study||0
10215567|NCT03706469|11342385|FG002|NOT COMPLETED|Overall Study||0
10215568|NCT03706469|11342386|FG003|NOT COMPLETED|Overall Study||0
10215569|NCT03707041|11342403|FG000|STARTED|Overall Study||6
10215570|NCT03707041|11342404|FG001|STARTED|Overall Study||2
10215571|NCT03707041|11342405|FG002|STARTED|Overall Study||9
10215572|NCT03707041|11342406|FG003|STARTED|Overall Study||3
10215573|NCT03707041|11342407|FG004|STARTED|Overall Study||9
10215574|NCT03707041|11342408|FG005|STARTED|Overall Study||3
10215575|NCT03707041|11342403|FG000|COMPLETED|Overall Study||6
10215576|NCT03707041|11342404|FG001|COMPLETED|Overall Study||2
10215577|NCT03707041|11342405|FG002|COMPLETED|Overall Study||9
10215578|NCT03707041|11342406|FG003|COMPLETED|Overall Study||3
10215579|NCT03707041|11342407|FG004|COMPLETED|Overall Study||9
10215580|NCT03707041|11342408|FG005|COMPLETED|Overall Study||3
10215581|NCT03707041|11342403|FG000|NOT COMPLETED|Overall Study||0
10215582|NCT03707041|11342404|FG001|NOT COMPLETED|Overall Study||0
10215583|NCT03707041|11342405|FG002|NOT COMPLETED|Overall Study||0
10215584|NCT03707041|11342406|FG003|NOT COMPLETED|Overall Study||0
10215585|NCT03707041|11342407|FG004|NOT COMPLETED|Overall Study||0
10215586|NCT03707041|11342408|FG005|NOT COMPLETED|Overall Study||0
10215587|NCT03707522|11342427|FG000|STARTED|Overall Study||31
10215588|NCT03707522|11342428|FG001|STARTED|Overall Study||36
10215589|NCT03707522|11342429|FG002|STARTED|Overall Study||52
10215590|NCT03707522|11342430|FG003|STARTED|Overall Study||43
10215591|NCT03707522|11342427|FG000|COMPLETED|Overall Study||7
10215592|NCT03707522|11342428|FG001|COMPLETED|Overall Study||9
10215593|NCT03707522|11342429|FG002|COMPLETED|Overall Study||11
10215594|NCT03707522|11342430|FG003|COMPLETED|Overall Study||7
10215595|NCT03707522|11342427|FG000|NOT COMPLETED|Overall Study||24
10215596|NCT03707522|11342428|FG001|NOT COMPLETED|Overall Study||27
10215597|NCT03707522|11342429|FG002|NOT COMPLETED|Overall Study||41
10215598|NCT03707522|11342430|FG003|NOT COMPLETED|Overall Study||36
10215599|NCT03707587|11342442|FG000|STARTED|Overall Study||7
10215600|NCT03707587|11342443|FG001|STARTED|Overall Study||2
10215601|NCT03707587|11342442|FG000|COMPLETED|Overall Study||7
10215602|NCT03707587|11342443|FG001|COMPLETED|Overall Study||1
10215603|NCT03707587|11342442|FG000|NOT COMPLETED|Overall Study||0
10215604|NCT03707587|11342443|FG001|NOT COMPLETED|Overall Study||1
10215605|NCT03707821|11342451|FG000|STARTED|Overall Study||125
10215606|NCT03707821|11342452|FG001|STARTED|Overall Study||126
10215607|NCT03707821|11342451|FG000|COMPLETED|Overall Study||123
10215608|NCT03707821|11342452|FG001|COMPLETED|Overall Study||125
10215609|NCT03707821|11342451|FG000|NOT COMPLETED|Overall Study||2
10215610|NCT03707821|11342452|FG001|NOT COMPLETED|Overall Study||1
10215611|NCT03707912|11342460|FG000|STARTED|Overall Study||104
10215612|NCT03707912|11342461|FG001|STARTED|Overall Study||100
10215613|NCT03707912|11342460|FG000|COMPLETED|Overall Study||103
10215614|NCT03707912|11342461|FG001|COMPLETED|Overall Study||100
10215615|NCT03707912|11342460|FG000|NOT COMPLETED|Overall Study||1
10215616|NCT03707912|11342461|FG001|NOT COMPLETED|Overall Study||0
10238955|NCT00434590|11370423|FG000|NOT COMPLETED|Overall Study||5
10238956|NCT00434590|11370424|FG001|NOT COMPLETED|Overall Study||5
10238957|NCT00424645|11370432|FG000|STARTED|Overall Study||3
10238958|NCT00424645|11370433|FG001|STARTED|Overall Study||0
10238959|NCT00424645|11370432|FG000|COMPLETED|Overall Study||2
10238960|NCT00424645|11370433|FG001|COMPLETED|Overall Study||0
10238961|NCT00424645|11370432|FG000|NOT COMPLETED|Overall Study||1
10238962|NCT00424645|11370433|FG001|NOT COMPLETED|Overall Study||0
10238963|NCT00430027|11370439|FG000|STARTED|Overall Study||8
10238964|NCT00430027|11370439|FG000|COMPLETED|Overall Study||0
10238965|NCT00430027|11370439|FG000|NOT COMPLETED|Overall Study||8
10238966|NCT00429858|11370443|FG000|STARTED|Overall Study||21
10238967|NCT00429858|11370443|FG000|COMPLETED|Overall Study||19
10238968|NCT00429858|11370443|FG000|NOT COMPLETED|Overall Study||2
10238969|NCT00425438|11370450|FG000|STARTED|Overall Study||25
10238970|NCT00425438|11370451|FG001|STARTED|Overall Study||27
10238971|NCT00425438|11370450|FG000|COMPLETED|Overall Study||0
10238972|NCT00425438|11370451|FG001|COMPLETED|Overall Study||0
10238973|NCT00425438|11370450|FG000|NOT COMPLETED|Overall Study||25
10238974|NCT00425438|11370451|FG001|NOT COMPLETED|Overall Study||27
10238975|NCT00421954|11370457|FG000|STARTED|Overall Study||0
10238976|NCT00421954|11370457|FG000|COMPLETED|Overall Study||0
10238977|NCT00421954|11370457|FG000|NOT COMPLETED|Overall Study||0
10238978|NCT00422942|11370461|FG000|STARTED|Overall Study||3
10238979|NCT00422942|11370461|FG000|COMPLETED|Overall Study||0
10238980|NCT00422942|11370461|FG000|NOT COMPLETED|Overall Study||3
10238981|NCT00409344|11370467|FG000|STARTED|Overall Study|No participants enrolled|0
10238982|NCT00409344|11370468|FG001|STARTED|Overall Study|No participants enrolled|0
10238983|NCT00409344|11370467|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0
10238984|NCT00409344|11370468|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0
10238985|NCT00409344|11370467|FG000|NOT COMPLETED|Overall Study||0
10238986|NCT00409344|11370468|FG001|NOT COMPLETED|Overall Study||0
10238987|NCT00414453|11370474|FG000|STARTED|Overall Study||19
10238988|NCT00414453|11370474|FG000|COMPLETED|Overall Study||3
10238989|NCT00414453|11370474|FG000|NOT COMPLETED|Overall Study||16
10238990|NCT00417248|11370484|FG000|STARTED|Overall Study||8
10238991|NCT00417248|11370484|FG000|COMPLETED|Overall Study||0
10238992|NCT00417248|11370484|FG000|NOT COMPLETED|Overall Study||8
10238993|NCT00418145|11370489|FG000|STARTED|Overall Study||16
10238994|NCT00418145|11370489|FG000|COMPLETED|Overall Study||10
10238995|NCT00418145|11370489|FG000|NOT COMPLETED|Overall Study||6
10238996|NCT00409331|11370495|FG000|STARTED|Overall Study||1
10238997|NCT00409331|11370495|FG000|COMPLETED|Overall Study||0
10238998|NCT00409331|11370495|FG000|NOT COMPLETED|Overall Study||1
10238999|NCT00392860|11370501|FG000|STARTED|Overall Study||3
10239000|NCT00392860|11370502|FG001|STARTED|Overall Study||0
10239001|NCT00392860|11370503|FG002|STARTED|Overall Study||1
10239002|NCT00392860|11370501|FG000|COMPLETED|Overall Study||3
10239003|NCT00392860|11370502|FG001|COMPLETED|Overall Study||0
10239004|NCT00392860|11370503|FG002|COMPLETED|Overall Study||1
10239005|NCT00392860|11370501|FG000|NOT COMPLETED|Overall Study||0
10239006|NCT00392860|11370502|FG001|NOT COMPLETED|Overall Study||0
10239007|NCT00392860|11370503|FG002|NOT COMPLETED|Overall Study||0
10239008|NCT00391430|11370512|FG000|STARTED|Overall Study||8
10239009|NCT00391430|11370513|FG001|STARTED|Overall Study||0
10215617|NCT03708211|11342469|FG000|STARTED|Overall Study||12
10215618|NCT03708211|11342470|FG001|STARTED|Overall Study||8
10215619|NCT03708211|11342469|FG000|COMPLETED|Overall Study||0
10215620|NCT03708211|11342470|FG001|COMPLETED|Overall Study||0
10215621|NCT03708211|11342469|FG000|NOT COMPLETED|Overall Study||12
10215622|NCT03708211|11342470|FG001|NOT COMPLETED|Overall Study||8
10215623|NCT03708367|11342480|FG000|STARTED|Overall Study||59
10215624|NCT03708367|11342481|FG001|STARTED|Overall Study||58
10215625|NCT03708367|11342480|FG000|COMPLETED|Overall Study||58
10215626|NCT03708367|11342481|FG001|COMPLETED|Overall Study||57
10215627|NCT03708367|11342480|FG000|NOT COMPLETED|Overall Study||1
10215628|NCT03708367|11342481|FG001|NOT COMPLETED|Overall Study||1
10215629|NCT03708393|11342488|FG000|STARTED|Overall Study||155
10215630|NCT03708393|11342488|FG000|COMPLETED|Overall Study||155
10215631|NCT03708393|11342488|FG000|NOT COMPLETED|Overall Study||0
10215632|NCT03708562|11342497|FG000|STARTED|Overall Study||24
10215633|NCT03708562|11342497|FG000|COMPLETED|Overall Study||12
10215634|NCT03708562|11342497|FG000|NOT COMPLETED|Overall Study||12
10215635|NCT03708744|11342501|FG000|STARTED|Overall Study||7
10215636|NCT03708744|11342502|FG001|STARTED|Overall Study||6
10215637|NCT03708744|11342503|FG002|STARTED|Overall Study||5
10215638|NCT03708744|11342504|FG003|STARTED|Overall Study||6
10215639|NCT03708744|11342501|FG000|COMPLETED|Overall Study||7
10215640|NCT03708744|11342502|FG001|COMPLETED|Overall Study||6
10215641|NCT03708744|11342503|FG002|COMPLETED|Overall Study||4
10215642|NCT03708744|11342504|FG003|COMPLETED|Overall Study||6
10215643|NCT03708744|11342501|FG000|NOT COMPLETED|Overall Study||0
10215644|NCT03708744|11342502|FG001|NOT COMPLETED|Overall Study||0
10215645|NCT03708744|11342503|FG002|NOT COMPLETED|Overall Study||1
10215646|NCT03708744|11342504|FG003|NOT COMPLETED|Overall Study||0
10215647|NCT03708770|11342514|FG000|STARTED|Overall Study||32
10215648|NCT03708770|11342514|FG000|COMPLETED|Overall Study||22
10215649|NCT03708770|11342514|FG000|NOT COMPLETED|Overall Study||10
10215650|NCT03709602|11342521|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
10215651|NCT03709602|11342522|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
10215652|NCT03709602|11342523|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
10215653|NCT03709602|11342521|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
10215654|NCT03709602|11342522|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
10215655|NCT03709602|11342523|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
10215656|NCT03709602|11342521|FG000|NOT COMPLETED|Overall Study||0
10215657|NCT03709602|11342522|FG001|NOT COMPLETED|Overall Study||0
10215658|NCT03709602|11342523|FG002|NOT COMPLETED|Overall Study||0
10215659|NCT03709654|11342531|FG000|STARTED|Overall Study||23
10215660|NCT03709654|11342532|FG001|STARTED|Overall Study||13
10215661|NCT03709654|11342531|FG000|COMPLETED|Overall Study||20
10215662|NCT03709654|11342532|FG001|COMPLETED|Overall Study||11
10215663|NCT03709654|11342531|FG000|NOT COMPLETED|Overall Study||3
10215664|NCT03709654|11342532|FG001|NOT COMPLETED|Overall Study||2
10215665|NCT03709810|11342538|FG000|STARTED|Treatment Period 1 (Visit 2)||24
10215666|NCT03709810|11342539|FG001|STARTED|Treatment Period 1 (Visit 2)||24
10215667|NCT03709810|11342538|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24
10215668|NCT03709810|11342539|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24
10215669|NCT03709810|11342538|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
10215670|NCT03709810|11342539|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
10215671|NCT03709810|11342538|FG000|STARTED|Treatment Period 2 (Visit 3)||24
10215672|NCT03709810|11342539|FG001|STARTED|Treatment Period 2 (Visit 3)||24
10215673|NCT03709810|11342538|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24
10215674|NCT03709810|11342539|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24
10215675|NCT03709810|11342538|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
10215676|NCT03709810|11342539|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
10215677|NCT03709823|11342551|FG000|STARTED|Overall Study||51
10215678|NCT03709823|11342552|FG001|STARTED|Overall Study||50
10215679|NCT03709823|11342553|FG002|STARTED|Overall Study||25
10215680|NCT03709823|11342554|FG003|STARTED|Overall Study||52
10215681|NCT03709823|11342555|FG004|STARTED|Overall Study||50
10215682|NCT03709823|11342556|FG005|STARTED|Overall Study||26
10215683|NCT03709823|11342551|FG000|COMPLETED|Overall Study||48
10215684|NCT03709823|11342552|FG001|COMPLETED|Overall Study||45
10215685|NCT03709823|11342553|FG002|COMPLETED|Overall Study||22
10215686|NCT03709823|11342554|FG003|COMPLETED|Overall Study||50
10215687|NCT03709823|11342555|FG004|COMPLETED|Overall Study||49
10215688|NCT03709823|11342556|FG005|COMPLETED|Overall Study||26
10215689|NCT03709823|11342551|FG000|NOT COMPLETED|Overall Study||3
10215690|NCT03709823|11342552|FG001|NOT COMPLETED|Overall Study||5
10215691|NCT03709823|11342553|FG002|NOT COMPLETED|Overall Study||3
10215692|NCT03709823|11342554|FG003|NOT COMPLETED|Overall Study||2
10215693|NCT03709823|11342555|FG004|NOT COMPLETED|Overall Study||1
10215694|NCT03709823|11342556|FG005|NOT COMPLETED|Overall Study||0
10215695|NCT03710083|11342573|FG000|STARTED|Overall Study||66
10215696|NCT03710083|11342573|FG000|COMPLETED|Overall Study||63
10215697|NCT03710083|11342573|FG000|NOT COMPLETED|Overall Study||3
10215698|NCT03710161|11342579|FG000|STARTED|Overall Study||3
10215699|NCT03710161|11342580|FG001|STARTED|Overall Study||2
10215700|NCT03710161|11342579|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
10215701|NCT03710161|11342580|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
10215702|NCT03710161|11342579|FG000|NOT COMPLETED|Overall Study||3
10215703|NCT03710161|11342580|FG001|NOT COMPLETED|Overall Study||2
10215704|NCT03710187|11342588|FG000|STARTED|Overall Study||41
10215705|NCT03710187|11342589|FG001|STARTED|Overall Study||43
10215706|NCT03710187|11342588|FG000|COMPLETED|Overall Study||41
10215707|NCT03710187|11342589|FG001|COMPLETED|Overall Study||43
10215708|NCT03710187|11342588|FG000|NOT COMPLETED|Overall Study||0
10215709|NCT03710187|11342589|FG001|NOT COMPLETED|Overall Study||0
10215710|NCT03710577|11342597|FG000|STARTED|First Intervention||8
10215711|NCT03710577|11342598|FG001|STARTED|First Intervention||4
10215712|NCT03710577|11342597|FG000|COMPLETED|First Intervention||8
10012142|NCT01784211|11134989|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
10012143|NCT01784211|11134990|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
10215713|NCT03710577|11342598|FG001|COMPLETED|First Intervention||4
10215714|NCT03710577|11342597|FG000|NOT COMPLETED|First Intervention||0
10215715|NCT03710577|11342598|FG001|NOT COMPLETED|First Intervention||0
10215716|NCT03710577|11342597|FG000|STARTED|Time Between Sessions (2-5 Days)||8
10215717|NCT03710577|11342598|FG001|STARTED|Time Between Sessions (2-5 Days)||4
10215718|NCT03710577|11342597|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8
10215719|NCT03710577|11342598|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4
10215720|NCT03710577|11342597|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
10215721|NCT03710577|11342598|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
10215722|NCT03710577|11342597|FG000|STARTED|Second Intervention||8
10215723|NCT03710577|11342598|FG001|STARTED|Second Intervention||4
10215724|NCT03710577|11342597|FG000|COMPLETED|Second Intervention||8
10215725|NCT03710577|11342598|FG001|COMPLETED|Second Intervention||4
10215726|NCT03710577|11342597|FG000|NOT COMPLETED|Second Intervention||0
10215727|NCT03710577|11342598|FG001|NOT COMPLETED|Second Intervention||0
10215728|NCT03710590|11342606|FG000|STARTED|Overall Study||22
10215729|NCT03710590|11342607|FG001|STARTED|Overall Study||23
10215730|NCT03710590|11342606|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
10215731|NCT03710590|11342607|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
10215732|NCT03710590|11342606|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
10215733|NCT03710590|11342607|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
10215734|NCT03710590|11342606|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
10215735|NCT03710590|11342607|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
10215736|NCT03710590|11342606|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
10215737|NCT03710590|11342607|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
10215738|NCT03710590|11342606|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
10215739|NCT03710590|11342607|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
10215740|NCT03710590|11342606|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
10215741|NCT03710590|11342607|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
10215742|NCT03710590|11342606|FG000|COMPLETED|Overall Study||12
10215743|NCT03710590|11342607|FG001|COMPLETED|Overall Study||15
10215744|NCT03710590|11342606|FG000|NOT COMPLETED|Overall Study||10
10215745|NCT03710590|11342607|FG001|NOT COMPLETED|Overall Study||8
10215746|NCT03710889|11342613|FG000|STARTED|Overall Study||23
10215747|NCT03710889|11342613|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
10215748|NCT03710889|11342613|FG000|Bone-Biopsy Population|Overall Study||19
10215749|NCT03710889|11342613|FG000|COMPLETED|Overall Study||20
10215750|NCT03710889|11342613|FG000|NOT COMPLETED|Overall Study||3
10215751|NCT03711396|11342617|FG000|STARTED|Overall Study||13
10215752|NCT03711396|11342618|FG001|STARTED|Overall Study||13
10215753|NCT03711396|11342617|FG000|COMPLETED|Overall Study||13
10215754|NCT03711396|11342618|FG001|COMPLETED|Overall Study||13
10215755|NCT03711396|11342617|FG000|NOT COMPLETED|Overall Study||0
10215756|NCT03711396|11342618|FG001|NOT COMPLETED|Overall Study||0
10215757|NCT03711578|11342625|FG000|STARTED|Overall Study||20
10215758|NCT03711578|11342625|FG000|COMPLETED|Overall Study||20
10215759|NCT03711578|11342625|FG000|NOT COMPLETED|Overall Study||0
10215760|NCT03712189|11342631|FG000|STARTED|Overall Study||15
10215761|NCT03712189|11342632|FG001|STARTED|Overall Study||15
10215762|NCT03712189|11342631|FG000|COMPLETED|Overall Study||15
10215763|NCT03712189|11342632|FG001|COMPLETED|Overall Study||15
10215764|NCT03712189|11342631|FG000|NOT COMPLETED|Overall Study||0
10215765|NCT03712189|11342632|FG001|NOT COMPLETED|Overall Study||0
10215766|NCT03712280|11342642|FG000|STARTED|Overall Study||12
10215767|NCT03712280|11342643|FG001|STARTED|Overall Study||12
10215768|NCT03712280|11342644|FG002|STARTED|Overall Study||13
10215769|NCT03712280|11342645|FG003|STARTED|Overall Study||13
10215770|NCT03712280|11342642|FG000|Safety Population|Overall Study||12
10215771|NCT03712280|11342643|FG001|Safety Population|Overall Study||11
10215772|NCT03712280|11342644|FG002|Safety Population|Overall Study||13
10215773|NCT03712280|11342645|FG003|Safety Population|Overall Study||12
10215774|NCT03712280|11342642|FG000|Modified Intent to Treat Population|Overall Study||12
10215775|NCT03712280|11342643|FG001|Modified Intent to Treat Population|Overall Study||11
10215776|NCT03712280|11342644|FG002|Modified Intent to Treat Population|Overall Study||13
10215777|NCT03712280|11342645|FG003|Modified Intent to Treat Population|Overall Study||12
10215778|NCT03712280|11342642|FG000|Completed 5 Day Treatment|Overall Study||11
10215779|NCT03712280|11342643|FG001|Completed 5 Day Treatment|Overall Study||11
10215780|NCT03712280|11342644|FG002|Completed 5 Day Treatment|Overall Study||12
10215781|NCT03712280|11342645|FG003|Completed 5 Day Treatment|Overall Study||12
10012144|NCT01784211|11134991|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10215782|NCT03712280|11342642|FG000|COMPLETED|Overall Study||11
10215783|NCT03712280|11342643|FG001|COMPLETED|Overall Study||11
10215784|NCT03712280|11342644|FG002|COMPLETED|Overall Study||12
10215785|NCT03712280|11342645|FG003|COMPLETED|Overall Study||12
10215786|NCT03712280|11342642|FG000|NOT COMPLETED|Overall Study||1
10215787|NCT03712280|11342643|FG001|NOT COMPLETED|Overall Study||1
10215788|NCT03712280|11342644|FG002|NOT COMPLETED|Overall Study||1
10215789|NCT03712280|11342645|FG003|NOT COMPLETED|Overall Study||1
10215790|NCT03712449|11342657|FG000|STARTED|Overall Study||13
10215791|NCT03712449|11342658|FG001|STARTED|Overall Study||46
10215792|NCT03712449|11342657|FG000|Full Analysis Population|Overall Study||13
10215793|NCT03712449|11342658|FG001|Full Analysis Population|Overall Study||45
10215794|NCT03712449|11342657|FG000|COMPLETED|Overall Study||13
10215795|NCT03712449|11342658|FG001|COMPLETED|Overall Study||45
10215796|NCT03712449|11342657|FG000|NOT COMPLETED|Overall Study||0
10215797|NCT03712449|11342658|FG001|NOT COMPLETED|Overall Study||1
10215798|NCT03712852|11342667|FG000|STARTED|Overall Study||20
10215799|NCT03712852|11342668|FG001|STARTED|Overall Study||20
10215800|NCT03712852|11342669|FG002|STARTED|Overall Study||20
10215801|NCT03712852|11342667|FG000|COMPLETED|Overall Study||20
10215802|NCT03712852|11342668|FG001|COMPLETED|Overall Study||20
10215803|NCT03712852|11342669|FG002|COMPLETED|Overall Study||20
10215804|NCT03712852|11342667|FG000|NOT COMPLETED|Overall Study||0
10215805|NCT03712852|11342668|FG001|NOT COMPLETED|Overall Study||0
10215806|NCT03712852|11342669|FG002|NOT COMPLETED|Overall Study||0
10215807|NCT03712917|11342680|FG000|STARTED|Overall Study||40
10215808|NCT03712917|11342681|FG001|STARTED|Overall Study||40
10215809|NCT03712917|11342682|FG002|STARTED|Overall Study||40
10215810|NCT03712917|11342680|FG000|COMPLETED|Overall Study||31
10215811|NCT03712917|11342681|FG001|COMPLETED|Overall Study||32
10215812|NCT03712917|11342682|FG002|COMPLETED|Overall Study||31
10215813|NCT03712917|11342680|FG000|NOT COMPLETED|Overall Study||9
10215814|NCT03712917|11342681|FG001|NOT COMPLETED|Overall Study||8
10215815|NCT03712917|11342682|FG002|NOT COMPLETED|Overall Study||9
10215816|NCT03712930|11342690|FG000|STARTED|Overall Study||13
10215817|NCT03712930|11342690|FG000|COMPLETED|Overall Study||0
10215818|NCT03712930|11342690|FG000|NOT COMPLETED|Overall Study||13
10215819|NCT03713398|11342696|FG000|STARTED|Overall Study||50
10215820|NCT03713398|11342697|FG001|STARTED|Overall Study||50
10215821|NCT03713398|11342696|FG000|COMPLETED|Overall Study||24
10215822|NCT03713398|11342697|FG001|COMPLETED|Overall Study||23
10215823|NCT03713398|11342696|FG000|NOT COMPLETED|Overall Study||26
10215824|NCT03713398|11342697|FG001|NOT COMPLETED|Overall Study||27
10215825|NCT03714022|11342705|FG000|STARTED|Overall Study||70
10215826|NCT03714022|11342706|FG001|STARTED|Overall Study||70
10215827|NCT03714022|11342705|FG000|COMPLETED|Overall Study||66
10215828|NCT03714022|11342706|FG001|COMPLETED|Overall Study||67
10215829|NCT03714022|11342705|FG000|NOT COMPLETED|Overall Study||4
10215830|NCT03714022|11342706|FG001|NOT COMPLETED|Overall Study||3
10215831|NCT03714256|11342714|FG000|STARTED|Overall Study||14
10215832|NCT03714256|11342715|FG001|STARTED|Overall Study||19
10215833|NCT03714256|11342714|FG000|COMPLETED|Overall Study||14
10215834|NCT03714256|11342715|FG001|COMPLETED|Overall Study||19
10215835|NCT03714256|11342714|FG000|NOT COMPLETED|Overall Study||0
10215836|NCT03714256|11342715|FG001|NOT COMPLETED|Overall Study||0
10215837|NCT03714659|11342721|FG000|STARTED|Overall Study||20
10215838|NCT03714659|11342721|FG000|COMPLETED|Overall Study||19
10215839|NCT03714659|11342721|FG000|NOT COMPLETED|Overall Study||1
10215840|NCT03714672|11342729|FG000|STARTED|Overall Study||209
10215841|NCT03714672|11342730|FG001|STARTED|Overall Study||206
10215842|NCT03714672|11342731|FG002|STARTED|Overall Study||206
10215843|NCT03714672|11342732|FG003|STARTED|Overall Study||208
10215844|NCT03714672|11342729|FG000|Safety Set|Overall Study||208
10215845|NCT03714672|11342730|FG001|Safety Set|Overall Study||205
10215846|NCT03714672|11342731|FG002|Safety Set|Overall Study||206
10215847|NCT03714672|11342732|FG003|Safety Set|Overall Study||207
10215848|NCT03714672|11342729|FG000|COMPLETED|Overall Study||207
10215849|NCT03714672|11342730|FG001|COMPLETED|Overall Study||202
10012145|NCT01784211|11134992|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10012146|NCT01784211|11134993|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10215850|NCT03714672|11342731|FG002|COMPLETED|Overall Study||202
10215851|NCT03714672|11342732|FG003|COMPLETED|Overall Study||207
10215852|NCT03714672|11342729|FG000|NOT COMPLETED|Overall Study||2
10215853|NCT03714672|11342730|FG001|NOT COMPLETED|Overall Study||4
10215854|NCT03714672|11342731|FG002|NOT COMPLETED|Overall Study||4
10215855|NCT03714672|11342732|FG003|NOT COMPLETED|Overall Study||1
10215856|NCT03714919|11342743|FG000|STARTED|Overall Study||10
10215857|NCT03714919|11342743|FG000|COMPLETED|Overall Study||10
10215858|NCT03714919|11342743|FG000|NOT COMPLETED|Overall Study||0
10215859|NCT03715426|11342749|FG000|STARTED|Overall Study||133
10215860|NCT03715426|11342750|FG001|STARTED|Overall Study||117
10215861|NCT03715426|11342749|FG000|1-Month Follow-Up Survey|Overall Study||113
10215862|NCT03715426|11342750|FG001|1-Month Follow-Up Survey|Overall Study||97
10215863|NCT03715426|11342749|FG000|4-Month Follow-Up Survey|Overall Study||112
10215864|NCT03715426|11342750|FG001|4-Month Follow-Up Survey|Overall Study||92
10215865|NCT03715426|11342749|FG000|COMPLETED|Overall Study||112
10215866|NCT03715426|11342750|FG001|COMPLETED|Overall Study||92
10215867|NCT03715426|11342749|FG000|NOT COMPLETED|Overall Study||21
10215868|NCT03715426|11342750|FG001|NOT COMPLETED|Overall Study||25
10215869|NCT03715452|11342756|FG000|STARTED|Overall Study||114
10215870|NCT03715452|11342756|FG000|COMPLETED|Overall Study||114
10215871|NCT03715452|11342756|FG000|NOT COMPLETED|Overall Study||0
10215872|NCT03715530|11342763|FG000|STARTED|Overall Study||33
10215873|NCT03715530|11342764|FG001|STARTED|Overall Study||42
10215874|NCT03715530|11342765|FG002|STARTED|Overall Study||87
10215875|NCT03715530|11342763|FG000|COMPLETED|Overall Study||30
10215876|NCT03715530|11342764|FG001|COMPLETED|Overall Study||41
10215877|NCT03715530|11342765|FG002|COMPLETED|Overall Study||85
10215878|NCT03715530|11342763|FG000|NOT COMPLETED|Overall Study||3
10215879|NCT03715530|11342764|FG001|NOT COMPLETED|Overall Study||1
10215880|NCT03715530|11342765|FG002|NOT COMPLETED|Overall Study||2
10215881|NCT03715803|11342775|FG000|STARTED|Overall Study||91
10215882|NCT03715803|11342776|FG001|STARTED|Overall Study||126
10215883|NCT03715803|11342775|FG000|COMPLETED|Overall Study||91
10215884|NCT03715803|11342776|FG001|COMPLETED|Overall Study||126
10215885|NCT03715803|11342775|FG000|NOT COMPLETED|Overall Study||0
10215886|NCT03715803|11342776|FG001|NOT COMPLETED|Overall Study||0
10215887|NCT03716024|11342784|FG000|STARTED|Overall Study||118
10215888|NCT03716024|11342785|FG001|STARTED|Overall Study||116
10215889|NCT03716024|11342784|FG000|COMPLETED|Overall Study||107
10012147|NCT01784211|11134994|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10012148|NCT01784211|11134989|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
10012149|NCT01784211|11134990|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
10012150|NCT01784211|11134991|FG002|Entered Part B|Part A (Days 1-15)||0
10012151|NCT01784211|11134992|FG003|Entered Part B|Part A (Days 1-15)||0
10012152|NCT01784211|11134993|FG004|Entered Part B|Part A (Days 1-15)||0
10012153|NCT01784211|11134994|FG005|Entered Part B|Part A (Days 1-15)||0
10012154|NCT01784211|11134989|FG000|COMPLETED|Part A (Days 1-15)||35
10012155|NCT01784211|11134990|FG001|COMPLETED|Part A (Days 1-15)||36
10012156|NCT01784211|11134991|FG002|COMPLETED|Part A (Days 1-15)||0
10012157|NCT01784211|11134992|FG003|COMPLETED|Part A (Days 1-15)||0
10012158|NCT01784211|11134993|FG004|COMPLETED|Part A (Days 1-15)||0
10012159|NCT01784211|11134994|FG005|COMPLETED|Part A (Days 1-15)||0
10012160|NCT01784211|11134989|FG000|NOT COMPLETED|Part A (Days 1-15)||3
10012161|NCT01784211|11134990|FG001|NOT COMPLETED|Part A (Days 1-15)||2
10012162|NCT01784211|11134991|FG002|NOT COMPLETED|Part A (Days 1-15)||0
10012163|NCT01784211|11134992|FG003|NOT COMPLETED|Part A (Days 1-15)||0
10012164|NCT01784211|11134993|FG004|NOT COMPLETED|Part A (Days 1-15)||0
10012165|NCT01784211|11134994|FG005|NOT COMPLETED|Part A (Days 1-15)||0
10012166|NCT01784211|11134989|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
10012167|NCT01784211|11134990|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
10111853|NCT02499172|11242890|FG000|NOT COMPLETED|Overall Study||65
10111854|NCT02499172|11242891|FG001|NOT COMPLETED|Overall Study||64
10012168|NCT01784211|11134991|FG002|STARTED|Part B (Days 16-21)||10
10012169|NCT01784211|11134992|FG003|STARTED|Part B (Days 16-21)||9
10012170|NCT01784211|11134993|FG004|STARTED|Part B (Days 16-21)||11
10111855|NCT02499172|11242892|FG002|NOT COMPLETED|Overall Study||523
10111856|NCT02499172|11242893|FG003|NOT COMPLETED|Overall Study||436
10111857|NCT02499263|11242903|FG000|STARTED|Overall Study||146
10111858|NCT02499263|11242903|FG000|COMPLETED|Overall Study||84
10111859|NCT02499263|11242903|FG000|NOT COMPLETED|Overall Study||62
10111860|NCT02499380|11242907|FG000|STARTED|Overall Study||20
10111861|NCT02499380|11242907|FG000|COMPLETED|Overall Study||17
10111862|NCT02499380|11242907|FG000|NOT COMPLETED|Overall Study||3
10111863|NCT02499406|11242911|FG000|STARTED|Overall Study||17
10111864|NCT02499406|11242911|FG000|COMPLETED|Overall Study||13
10111865|NCT02499406|11242911|FG000|NOT COMPLETED|Overall Study||4
10111866|NCT02499497|11242919|FG000|STARTED|Overall Study||36
10111867|NCT02499497|11242920|FG001|STARTED|Overall Study||28
10111868|NCT02499497|11242921|FG002|STARTED|Overall Study||36
10111869|NCT02499497|11242922|FG003|STARTED|Overall Study||14
10111870|NCT02499497|11242919|FG000|COMPLETED|Overall Study||32
10111871|NCT02499497|11242920|FG001|COMPLETED|Overall Study||22
10111872|NCT02499497|11242921|FG002|COMPLETED|Overall Study||35
10111873|NCT02499497|11242922|FG003|COMPLETED|Overall Study||13
10111874|NCT02499497|11242919|FG000|NOT COMPLETED|Overall Study||4
10111875|NCT02499497|11242920|FG001|NOT COMPLETED|Overall Study||6
10111876|NCT02499497|11242921|FG002|NOT COMPLETED|Overall Study||1
10111877|NCT02499497|11242922|FG003|NOT COMPLETED|Overall Study||1
10111878|NCT02499575|11242934|FG000|STARTED|Overall Study||1
10111879|NCT02499575|11242935|FG001|STARTED|Overall Study||1
10111880|NCT02499575|11242934|FG000|COMPLETED|Overall Study||1
10111881|NCT02499575|11242935|FG001|COMPLETED|Overall Study||0
10111882|NCT02499575|11242934|FG000|NOT COMPLETED|Overall Study||0
10111883|NCT02499575|11242935|FG001|NOT COMPLETED|Overall Study||1
10111884|NCT02499692|11242941|FG000|STARTED|Overall Study||103
10111885|NCT02499692|11242941|FG000|COMPLETED|Overall Study||103
10111886|NCT02499692|11242941|FG000|NOT COMPLETED|Overall Study||0
10111887|NCT02499770|11242947|FG000|STARTED|Overall Study||19
10111888|NCT02499770|11242948|FG001|STARTED|Overall Study||77
10111889|NCT02499770|11242947|FG000|COMPLETED|Overall Study||0
10111890|NCT02499770|11242948|FG001|COMPLETED|Overall Study||0
10111891|NCT02499770|11242947|FG000|NOT COMPLETED|Overall Study||19
10111892|NCT02499770|11242948|FG001|NOT COMPLETED|Overall Study||77
10111893|NCT02499783|11242962|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
10111894|NCT02499783|11242963|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
10111895|NCT02499783|11242964|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
10012171|NCT01784211|11134994|FG005|STARTED|Part B (Days 16-21)||10
10012172|NCT01784211|11134989|FG000|COMPLETED|Part B (Days 16-21)||0
10012173|NCT01784211|11134990|FG001|COMPLETED|Part B (Days 16-21)||0
10012174|NCT01784211|11134991|FG002|COMPLETED|Part B (Days 16-21)||10
10012175|NCT01784211|11134992|FG003|COMPLETED|Part B (Days 16-21)||9
10012176|NCT01784211|11134993|FG004|COMPLETED|Part B (Days 16-21)||11
10012177|NCT01784211|11134994|FG005|COMPLETED|Part B (Days 16-21)||10
10012178|NCT01784211|11134989|FG000|NOT COMPLETED|Part B (Days 16-21)||0
10012179|NCT01784211|11134990|FG001|NOT COMPLETED|Part B (Days 16-21)||0
10012180|NCT01784211|11134991|FG002|NOT COMPLETED|Part B (Days 16-21)||0
10012181|NCT01784211|11134992|FG003|NOT COMPLETED|Part B (Days 16-21)||0
10012182|NCT01784211|11134993|FG004|NOT COMPLETED|Part B (Days 16-21)||0
10012183|NCT01784211|11134994|FG005|NOT COMPLETED|Part B (Days 16-21)||0
10012184|NCT01784419|11135006|FG000|STARTED|Overall Study||10
10012185|NCT01784419|11135006|FG000|COMPLETED|Overall Study||7
10012186|NCT01784419|11135006|FG000|NOT COMPLETED|Overall Study||3
10012187|NCT01784523|11135012|FG000|STARTED|Overall Study||7
10012188|NCT01784523|11135013|FG001|STARTED|Overall Study||4
10012189|NCT01784523|11135012|FG000|COMPLETED|Overall Study||0
10012190|NCT01784523|11135013|FG001|COMPLETED|Overall Study||0
10012191|NCT01784523|11135012|FG000|NOT COMPLETED|Overall Study||7
10012192|NCT01784523|11135013|FG001|NOT COMPLETED|Overall Study||4
10012193|NCT01784588|11135021|FG000|STARTED|Overall Study||141
10012194|NCT01784588|11135022|FG001|STARTED|Overall Study||140
10012195|NCT01784588|11135021|FG000|COMPLETED|Overall Study||104
10012196|NCT01784588|11135022|FG001|COMPLETED|Overall Study||108
10012197|NCT01784588|11135021|FG000|NOT COMPLETED|Overall Study||37
10012198|NCT01784588|11135022|FG001|NOT COMPLETED|Overall Study||32
10012199|NCT01784614|11135028|FG000|STARTED|Period 1||3
10012200|NCT01784614|11135029|FG001|STARTED|Period 1||3
10012201|NCT01784614|11135030|FG002|STARTED|Period 1||3
10012202|NCT01784614|11135031|FG003|STARTED|Period 1||3
10012203|NCT01784614|11135032|FG004|STARTED|Period 1||3
10012204|NCT01784614|11135033|FG005|STARTED|Period 1||3
10012205|NCT01784614|11135034|FG006|STARTED|Period 1||3
10012206|NCT01784614|11135035|FG007|STARTED|Period 1||3
10012207|NCT01784614|11135028|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10012208|NCT01784614|11135029|FG001|Received at Least 1 Dose of Study Drug|Period 1||3
10012209|NCT01784614|11135030|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
10012210|NCT01784614|11135031|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
10012211|NCT01784614|11135032|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
10012212|NCT01784614|11135033|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
10012213|NCT01784614|11135034|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
10012214|NCT01784614|11135035|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
10012215|NCT01784614|11135028|FG000|COMPLETED|Period 1||3
10012216|NCT01784614|11135029|FG001|COMPLETED|Period 1||3
10012217|NCT01784614|11135030|FG002|COMPLETED|Period 1||3
10012218|NCT01784614|11135031|FG003|COMPLETED|Period 1||3
10012219|NCT01784614|11135032|FG004|COMPLETED|Period 1||3
10012220|NCT01784614|11135033|FG005|COMPLETED|Period 1||3
10012221|NCT01784614|11135034|FG006|COMPLETED|Period 1||3
10012222|NCT01784614|11135035|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
10012223|NCT01784614|11135028|FG000|NOT COMPLETED|Period 1||0
10012224|NCT01784614|11135029|FG001|NOT COMPLETED|Period 1||0
10012225|NCT01784614|11135030|FG002|NOT COMPLETED|Period 1||0
10012226|NCT01784614|11135031|FG003|NOT COMPLETED|Period 1||0
10012227|NCT01784614|11135032|FG004|NOT COMPLETED|Period 1||0
10012228|NCT01784614|11135033|FG005|NOT COMPLETED|Period 1||0
10012229|NCT01784614|11135034|FG006|NOT COMPLETED|Period 1||0
10012230|NCT01784614|11135035|FG007|NOT COMPLETED|Period 1||0
10012231|NCT01784614|11135028|FG000|STARTED|Period 2||3
10012232|NCT01784614|11135029|FG001|STARTED|Period 2||3
10012233|NCT01784614|11135030|FG002|STARTED|Period 2||3
10012234|NCT01784614|11135031|FG003|STARTED|Period 2||3
10012235|NCT01784614|11135032|FG004|STARTED|Period 2||3
10012236|NCT01784614|11135033|FG005|STARTED|Period 2||3
10012237|NCT01784614|11135034|FG006|STARTED|Period 2||3
10012238|NCT01784614|11135035|FG007|STARTED|Period 2||2
10012239|NCT01784614|11135028|FG000|COMPLETED|Period 2||3
10012240|NCT01784614|11135029|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
10012241|NCT01784614|11135030|FG002|COMPLETED|Period 2||3
10012242|NCT01784614|11135031|FG003|COMPLETED|Period 2||3
10012243|NCT01784614|11135032|FG004|COMPLETED|Period 2||3
10012244|NCT01784614|11135033|FG005|COMPLETED|Period 2||3
10012245|NCT01784614|11135034|FG006|COMPLETED|Period 2||3
10012246|NCT01784614|11135035|FG007|COMPLETED|Period 2||2
10012247|NCT01784614|11135028|FG000|NOT COMPLETED|Period 2||0
10012248|NCT01784614|11135029|FG001|NOT COMPLETED|Period 2||0
10012249|NCT01784614|11135030|FG002|NOT COMPLETED|Period 2||0
10012250|NCT01784614|11135031|FG003|NOT COMPLETED|Period 2||0
10012251|NCT01784614|11135032|FG004|NOT COMPLETED|Period 2||0
10012252|NCT01784614|11135033|FG005|NOT COMPLETED|Period 2||0
10012253|NCT01784614|11135034|FG006|NOT COMPLETED|Period 2||0
10012254|NCT01784614|11135035|FG007|NOT COMPLETED|Period 2||0
10012255|NCT01784614|11135028|FG000|STARTED|Period 3||3
10012256|NCT01784614|11135029|FG001|STARTED|Period 3||2
10012257|NCT01784614|11135030|FG002|STARTED|Period 3||3
10012258|NCT01784614|11135031|FG003|STARTED|Period 3||3
10012259|NCT01784614|11135032|FG004|STARTED|Period 3||3
10012260|NCT01784614|11135033|FG005|STARTED|Period 3||3
10012261|NCT01784614|11135034|FG006|STARTED|Period 3||3
10012262|NCT01784614|11135035|FG007|STARTED|Period 3||2
10012263|NCT01784614|11135028|FG000|COMPLETED|Period 3||3
10012264|NCT01784614|11135029|FG001|COMPLETED|Period 3||2
10012265|NCT01784614|11135030|FG002|COMPLETED|Period 3||3
10012266|NCT01784614|11135031|FG003|COMPLETED|Period 3||3
10012267|NCT01784614|11135032|FG004|COMPLETED|Period 3||3
10012268|NCT01784614|11135033|FG005|COMPLETED|Period 3||3
10012269|NCT01784614|11135034|FG006|COMPLETED|Period 3||3
10012270|NCT01784614|11135035|FG007|COMPLETED|Period 3||2
10012271|NCT01784614|11135028|FG000|NOT COMPLETED|Period 3||0
10012272|NCT01784614|11135029|FG001|NOT COMPLETED|Period 3||0
10012273|NCT01784614|11135030|FG002|NOT COMPLETED|Period 3||0
10012274|NCT01784614|11135031|FG003|NOT COMPLETED|Period 3||0
10012275|NCT01784614|11135032|FG004|NOT COMPLETED|Period 3||0
10012276|NCT01784614|11135033|FG005|NOT COMPLETED|Period 3||0
10012277|NCT01784614|11135034|FG006|NOT COMPLETED|Period 3||0
10012278|NCT01784614|11135035|FG007|NOT COMPLETED|Period 3||0
10012279|NCT01784614|11135028|FG000|STARTED|Period 4||3
10012280|NCT01784614|11135029|FG001|STARTED|Period 4||2
10012281|NCT01784614|11135030|FG002|STARTED|Period 4||3
10012282|NCT01784614|11135031|FG003|STARTED|Period 4||3
10012283|NCT01784614|11135032|FG004|STARTED|Period 4||3
10012284|NCT01784614|11135033|FG005|STARTED|Period 4||3
10012285|NCT01784614|11135034|FG006|STARTED|Period 4||3
10012286|NCT01784614|11135035|FG007|STARTED|Period 4||2
10012287|NCT01784614|11135028|FG000|COMPLETED|Period 4||3
10012288|NCT01784614|11135029|FG001|COMPLETED|Period 4||2
10012289|NCT01784614|11135030|FG002|COMPLETED|Period 4||3
10215890|NCT03716024|11342785|FG001|COMPLETED|Overall Study||98
10215891|NCT03716024|11342784|FG000|NOT COMPLETED|Overall Study||11
10215892|NCT03716024|11342785|FG001|NOT COMPLETED|Overall Study||18
10215893|NCT03716050|11342799|FG000|STARTED|Overall Study||2
10215894|NCT03716050|11342800|FG001|STARTED|Overall Study||4
10215895|NCT03716050|11342801|FG002|STARTED|Overall Study||1
10215896|NCT03716050|11342802|FG003|STARTED|Overall Study||3
10215897|NCT03716050|11342803|FG004|STARTED|Overall Study||1
10215898|NCT03716050|11342804|FG005|STARTED|Overall Study||0
10215899|NCT03716050|11342805|FG006|STARTED|Overall Study||4
10215900|NCT03716050|11342806|FG007|STARTED|Overall Study||2
10215901|NCT03716050|11342799|FG000|COMPLETED|Overall Study||2
10215902|NCT03716050|11342800|FG001|COMPLETED|Overall Study||4
10215903|NCT03716050|11342801|FG002|COMPLETED|Overall Study||0
10215904|NCT03716050|11342802|FG003|COMPLETED|Overall Study||1
10215905|NCT03716050|11342803|FG004|COMPLETED|Overall Study||1
10215906|NCT03716050|11342804|FG005|COMPLETED|Overall Study||0
10215907|NCT03716050|11342805|FG006|COMPLETED|Overall Study||4
10215908|NCT03716050|11342806|FG007|COMPLETED|Overall Study||0
10215909|NCT03716050|11342799|FG000|NOT COMPLETED|Overall Study||0
10215910|NCT03716050|11342800|FG001|NOT COMPLETED|Overall Study||0
10215911|NCT03716050|11342801|FG002|NOT COMPLETED|Overall Study||1
10215912|NCT03716050|11342802|FG003|NOT COMPLETED|Overall Study||2
10215913|NCT03716050|11342803|FG004|NOT COMPLETED|Overall Study||0
10215914|NCT03716050|11342804|FG005|NOT COMPLETED|Overall Study||0
10215915|NCT03716050|11342805|FG006|NOT COMPLETED|Overall Study||0
10215916|NCT03716050|11342806|FG007|NOT COMPLETED|Overall Study||2
10215917|NCT03716076|11342825|FG000|STARTED|Overall Study||25
10215918|NCT03716076|11342826|FG001|STARTED|Overall Study||25
10215919|NCT03716076|11342825|FG000|COMPLETED|Overall Study||22
10215920|NCT03716076|11342826|FG001|COMPLETED|Overall Study||19
10215921|NCT03716076|11342825|FG000|NOT COMPLETED|Overall Study||3
10215922|NCT03716076|11342826|FG001|NOT COMPLETED|Overall Study||6
10215923|NCT03717012|11342834|FG000|STARTED|Overall Study||9
10215924|NCT03717012|11342835|FG001|STARTED|Overall Study||10
10215925|NCT03717012|11342834|FG000|COMPLETED|Overall Study||8
10215926|NCT03717012|11342835|FG001|COMPLETED|Overall Study||4
10215927|NCT03717012|11342834|FG000|NOT COMPLETED|Overall Study||1
10012290|NCT01784614|11135031|FG003|COMPLETED|Period 4||3
10012291|NCT01784614|11135032|FG004|COMPLETED|Period 4||3
10012292|NCT01784614|11135033|FG005|COMPLETED|Period 4||3
10012293|NCT01784614|11135034|FG006|COMPLETED|Period 4||3
10012294|NCT01784614|11135035|FG007|COMPLETED|Period 4||2
10012295|NCT01784614|11135028|FG000|NOT COMPLETED|Period 4||0
10012296|NCT01784614|11135029|FG001|NOT COMPLETED|Period 4||0
10012297|NCT01784614|11135030|FG002|NOT COMPLETED|Period 4||0
10215928|NCT03717012|11342835|FG001|NOT COMPLETED|Overall Study||6
10215929|NCT03717051|11342843|FG000|STARTED|Overall Study||352
10215930|NCT03717051|11342844|FG001|STARTED|Overall Study||482
10215931|NCT03717051|11342843|FG000|COMPLETED|Overall Study||352
10215932|NCT03717051|11342844|FG001|COMPLETED|Overall Study||482
10215933|NCT03717051|11342843|FG000|NOT COMPLETED|Overall Study||0
10215934|NCT03717051|11342844|FG001|NOT COMPLETED|Overall Study||0
10215935|NCT03717064|11342850|FG000|STARTED|Period 1||18
10215936|NCT03717064|11342850|FG000|COMPLETED|Period 1||18
10215937|NCT03717064|11342850|FG000|NOT COMPLETED|Period 1||0
10012298|NCT01784614|11135031|FG003|NOT COMPLETED|Period 4||0
10012299|NCT01784614|11135032|FG004|NOT COMPLETED|Period 4||0
10012300|NCT01784614|11135033|FG005|NOT COMPLETED|Period 4||0
10012301|NCT01784614|11135034|FG006|NOT COMPLETED|Period 4||0
10012302|NCT01784614|11135035|FG007|NOT COMPLETED|Period 4||0
10012303|NCT01784666|11135058|FG000|STARTED|Overall Study||1
10012304|NCT01784666|11135059|FG001|STARTED|Overall Study||0
10215938|NCT03717064|11342850|FG000|STARTED|Period 2||18
10215939|NCT03717064|11342850|FG000|COMPLETED|Period 2||17
10215940|NCT03717064|11342850|FG000|NOT COMPLETED|Period 2||1
10215941|NCT03717506|11342857|FG000|STARTED|Overall Study||496
10215942|NCT03717506|11342858|FG001|STARTED|Overall Study||491
10215943|NCT03717506|11342859|FG002|STARTED|Overall Study||249
10215944|NCT03717506|11342857|FG000|COMPLETED|Overall Study||447
10012305|NCT01784666|11135060|FG002|STARTED|Overall Study||1
10012306|NCT01784666|11135058|FG000|COMPLETED|Overall Study||1
10215945|NCT03717506|11342858|FG001|COMPLETED|Overall Study||441
10215946|NCT03717506|11342859|FG002|COMPLETED|Overall Study||222
10215947|NCT03717506|11342857|FG000|NOT COMPLETED|Overall Study||49
10215948|NCT03717506|11342858|FG001|NOT COMPLETED|Overall Study||50
10215949|NCT03717506|11342859|FG002|NOT COMPLETED|Overall Study||27
10215950|NCT03718871|11342869|FG000|STARTED|Overall Study||250
10215951|NCT03718871|11342870|FG001|STARTED|Overall Study||250
10215952|NCT03718871|11342869|FG000|COMPLETED|Overall Study||250
10215953|NCT03718871|11342870|FG001|COMPLETED|Overall Study||250
10215954|NCT03718871|11342869|FG000|NOT COMPLETED|Overall Study||0
10215955|NCT03718871|11342870|FG001|NOT COMPLETED|Overall Study||0
10215956|NCT03719300|11342877|FG000|STARTED|Overall Study||32
10215957|NCT03719300|11342877|FG000|COMPLETED|Overall Study||32
10215958|NCT03719300|11342877|FG000|NOT COMPLETED|Overall Study||0
10215959|NCT03719378|11342883|FG000|STARTED|Overall Study||75
10215960|NCT03719378|11342884|FG001|STARTED|Overall Study||75
10215961|NCT03719378|11342883|FG000|COMPLETED|Overall Study||65
10215962|NCT03719378|11342884|FG001|COMPLETED|Overall Study||65
10215963|NCT03719378|11342883|FG000|NOT COMPLETED|Overall Study||10
10215964|NCT03719378|11342884|FG001|NOT COMPLETED|Overall Study||10
10215965|NCT03719586|11342894|FG000|STARTED|Overall Study||177
10215966|NCT03719586|11342895|FG001|STARTED|Overall Study||176
10215967|NCT03719586|11342896|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158
10215968|NCT03719586|11342897|FG003|STARTED|Overall Study||169
10215969|NCT03719586|11342894|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
10215970|NCT03719586|11342895|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
10215971|NCT03719586|11342896|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154
10215972|NCT03719586|11342897|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
10215973|NCT03719586|11342894|FG000|NOT COMPLETED|Overall Study||8
10215974|NCT03719586|11342895|FG001|NOT COMPLETED|Overall Study||7
10215975|NCT03719586|11342896|FG002|NOT COMPLETED|Overall Study||4
10215976|NCT03719586|11342897|FG003|NOT COMPLETED|Overall Study||0
10215977|NCT03719612|11342907|FG000|STARTED|Overall Study||160
10215978|NCT03719612|11342907|FG000|COMPLETED|Overall Study||148
10215979|NCT03719612|11342907|FG000|NOT COMPLETED|Overall Study||12
10215980|NCT03719677|11342913|FG000|STARTED|Overall Study||7
10215981|NCT03719677|11342913|FG000|COMPLETED|Overall Study||7
10215982|NCT03719677|11342913|FG000|NOT COMPLETED|Overall Study||0
10215983|NCT03719885|11342917|FG000|STARTED|Overall Study||55
10215984|NCT03719885|11342917|FG000|COMPLETED|Overall Study||35
10215985|NCT03719885|11342917|FG000|NOT COMPLETED|Overall Study||20
10215986|NCT03720119|11342923|FG000|STARTED|Overall Study||78
10215987|NCT03720119|11342923|FG000|COMPLETED|Overall Study||69
10215988|NCT03720119|11342923|FG000|NOT COMPLETED|Overall Study||9
10215989|NCT03720470|11342931|FG000|STARTED|Treatment Period: First Part 16 Weeks||131
10215990|NCT03720470|11342932|FG001|STARTED|Treatment Period: First Part 16 Weeks||0
10215991|NCT03720470|11342933|FG002|STARTED|Treatment Period: First Part 16 Weeks||0
10215992|NCT03720470|11342934|FG003|STARTED|Treatment Period: First Part 16 Weeks||238
10215993|NCT03720470|11342935|FG004|STARTED|Treatment Period: First Part 16 Weeks||226
10215994|NCT03720470|11342936|FG005|STARTED|Treatment Period: First Part 16 Weeks||243
10215995|NCT03720470|11342931|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
10215996|NCT03720470|11342932|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
10215997|NCT03720470|11342933|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
10215998|NCT03720470|11342934|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
10215999|NCT03720470|11342935|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
10216000|NCT03720470|11342936|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
10216001|NCT03720470|11342931|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
10216002|NCT03720470|11342932|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
10216003|NCT03720470|11342933|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
10216004|NCT03720470|11342934|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
10216005|NCT03720470|11342935|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
10216006|NCT03720470|11342936|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
10216007|NCT03720470|11342931|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117
10216008|NCT03720470|11342932|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0
10216009|NCT03720470|11342933|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0
10216010|NCT03720470|11342934|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217
10216011|NCT03720470|11342935|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208
10216012|NCT03720470|11342936|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223
10216013|NCT03720470|11342931|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
10216014|NCT03720470|11342932|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
10012307|NCT01784666|11135059|FG001|COMPLETED|Overall Study||0
10216015|NCT03720470|11342933|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
10216016|NCT03720470|11342934|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
10216017|NCT03720470|11342935|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
10012308|NCT01784666|11135060|FG002|COMPLETED|Overall Study||1
10216018|NCT03720470|11342936|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
10216019|NCT03720470|11342931|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
10216020|NCT03720470|11342932|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
10216021|NCT03720470|11342933|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
10216022|NCT03720470|11342934|FG003|STARTED|Treatment Period: Final 4 Weeks||217
10216023|NCT03720470|11342935|FG004|STARTED|Treatment Period: Final 4 Weeks||208
10216024|NCT03720470|11342936|FG005|STARTED|Treatment Period: Final 4 Weeks||223
10216025|NCT03720470|11342931|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
10216026|NCT03720470|11342932|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
10216027|NCT03720470|11342933|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
10216028|NCT03720470|11342934|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
10216029|NCT03720470|11342935|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
10216030|NCT03720470|11342936|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
10216031|NCT03720470|11342931|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0
10216032|NCT03720470|11342932|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60
10216033|NCT03720470|11342933|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57
10216034|NCT03720470|11342934|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217
10216035|NCT03720470|11342935|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208
10216036|NCT03720470|11342936|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223
10216037|NCT03720470|11342931|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0
10216038|NCT03720470|11342932|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58
10216039|NCT03720470|11342933|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55
10216040|NCT03720470|11342934|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210
10216041|NCT03720470|11342935|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204
10216042|NCT03720470|11342936|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218
10216043|NCT03720470|11342931|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
10216044|NCT03720470|11342932|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
10216045|NCT03720470|11342933|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
10216046|NCT03720470|11342934|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
10216047|NCT03720470|11342935|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
10216048|NCT03720470|11342936|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
10216049|NCT03720652|11342958|FG000|STARTED|Overall Study||12
10216050|NCT03720652|11342959|FG001|STARTED|Overall Study||27
10216051|NCT03720652|11342958|FG000|Baseline Interview|Overall Study||12
10216052|NCT03720652|11342959|FG001|Baseline Interview|Overall Study||22
10216053|NCT03720652|11342958|FG000|Start Intervention|Overall Study||11
10216054|NCT03720652|11342959|FG001|Start Intervention|Overall Study||21
10216055|NCT03720652|11342958|FG000|Complete Intervention|Overall Study||10
10216056|NCT03720652|11342959|FG001|Complete Intervention|Overall Study||20
10216057|NCT03720652|11342958|FG000|3-Month Follow Up Interview|Overall Study||10
10216058|NCT03720652|11342959|FG001|3-Month Follow Up Interview|Overall Study||19
10216059|NCT03720652|11342958|FG000|6-Month Follow Up Interview|Overall Study||10
10216060|NCT03720652|11342959|FG001|6-Month Follow Up Interview|Overall Study||16
10216061|NCT03720652|11342958|FG000|COMPLETED|Overall Study||10
10216062|NCT03720652|11342959|FG001|COMPLETED|Overall Study||16
10216063|NCT03720652|11342958|FG000|NOT COMPLETED|Overall Study||2
10216064|NCT03720652|11342959|FG001|NOT COMPLETED|Overall Study||11
10216065|NCT03720847|11342967|FG000|STARTED|Condition 1||15
10216066|NCT03720847|11342968|FG001|STARTED|Condition 1||15
10216067|NCT03720847|11342967|FG000|COMPLETED|Condition 1||15
10216068|NCT03720847|11342968|FG001|COMPLETED|Condition 1||15
10216069|NCT03720847|11342967|FG000|NOT COMPLETED|Condition 1||0
10216070|NCT03720847|11342968|FG001|NOT COMPLETED|Condition 1||0
10216071|NCT03720847|11342967|FG000|STARTED|Washout||15
10216072|NCT03720847|11342968|FG001|STARTED|Washout||15
10216073|NCT03720847|11342967|FG000|COMPLETED|Washout||14
10216074|NCT03720847|11342968|FG001|COMPLETED|Washout||13
10012309|NCT01784666|11135058|FG000|NOT COMPLETED|Overall Study||0
10012310|NCT01784666|11135059|FG001|NOT COMPLETED|Overall Study||0
10012311|NCT01784666|11135060|FG002|NOT COMPLETED|Overall Study||0
10012312|NCT01784770|11135068|FG000|STARTED|Overall Study||21
10012313|NCT01784770|11135068|FG000|COMPLETED|Overall Study||21
10012314|NCT01784770|11135068|FG000|NOT COMPLETED|Overall Study||0
10012315|NCT01784796|11135074|FG000|STARTED|Overall Study|These are participants who provided informed consent|87
10012316|NCT01784796|11135075|FG001|STARTED|Overall Study|These are participants who provided informed consent|77
10012317|NCT01784796|11135074|FG000|Baseline Data Collected|Overall Study||75
10012318|NCT01784796|11135075|FG001|Baseline Data Collected|Overall Study||61
10012319|NCT01784796|11135074|FG000|4 Week Data Collection|Overall Study||48
10012320|NCT01784796|11135075|FG001|4 Week Data Collection|Overall Study||41
10216075|NCT03720847|11342967|FG000|NOT COMPLETED|Washout||1
10216076|NCT03720847|11342968|FG001|NOT COMPLETED|Washout||2
10216077|NCT03720847|11342967|FG000|STARTED|Condition 2||14
10216078|NCT03720847|11342968|FG001|STARTED|Condition 2||13
10216079|NCT03720847|11342967|FG000|COMPLETED|Condition 2||14
10216080|NCT03720847|11342968|FG001|COMPLETED|Condition 2||13
10216081|NCT03720847|11342967|FG000|NOT COMPLETED|Condition 2||0
10216082|NCT03720847|11342968|FG001|NOT COMPLETED|Condition 2||0
10216083|NCT03720938|11342977|FG000|STARTED|Overall Study||242
10216084|NCT03720938|11342978|FG001|STARTED|Overall Study||676
10216085|NCT03720938|11342977|FG000|COMPLETED|Overall Study||53
10216086|NCT03720938|11342978|FG001|COMPLETED|Overall Study||53
10216087|NCT03720938|11342977|FG000|NOT COMPLETED|Overall Study||189
10216088|NCT03720938|11342978|FG001|NOT COMPLETED|Overall Study||623
10216089|NCT03721172|11342997|FG000|STARTED|Placebo-controlled Phase||298
10216090|NCT03721172|11342998|FG001|STARTED|Placebo-controlled Phase||297
10216091|NCT03721172|11342999|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10216092|NCT03721172|11342997|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
10216093|NCT03721172|11342998|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
10216094|NCT03721172|11342999|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10216095|NCT03721172|11342997|FG000|COMPLETED|Placebo-controlled Phase||246
10216096|NCT03721172|11342998|FG001|COMPLETED|Placebo-controlled Phase||258
10216097|NCT03721172|11342999|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10216098|NCT03721172|11342997|FG000|NOT COMPLETED|Placebo-controlled Phase||52
10216099|NCT03721172|11342998|FG001|NOT COMPLETED|Placebo-controlled Phase||39
10216100|NCT03721172|11342999|FG002|NOT COMPLETED|Placebo-controlled Phase||0
10216101|NCT03721172|11342997|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10216102|NCT03721172|11342998|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10216103|NCT03721172|11342999|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
10216104|NCT03721172|11342997|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10216105|NCT03721172|11342998|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10216106|NCT03721172|11342999|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503
10216107|NCT03721172|11342997|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10216108|NCT03721172|11342998|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10216109|NCT03721172|11342999|FG002|COMPLETED|Apremilast Extension Phase||437
10216110|NCT03721172|11342997|FG000|NOT COMPLETED|Apremilast Extension Phase||0
10216111|NCT03721172|11342998|FG001|NOT COMPLETED|Apremilast Extension Phase||0
10216112|NCT03721172|11342999|FG002|NOT COMPLETED|Apremilast Extension Phase||66
10216113|NCT03721549|11343009|FG000|STARTED|Overall Study||8
10216114|NCT03721549|11343010|FG001|STARTED|Overall Study||8
10216115|NCT03721549|11343009|FG000|COMPLETED|Overall Study||7
10216116|NCT03721549|11343010|FG001|COMPLETED|Overall Study||8
10216117|NCT03721549|11343009|FG000|NOT COMPLETED|Overall Study||1
10216118|NCT03721549|11343010|FG001|NOT COMPLETED|Overall Study||0
10216119|NCT03722030|11343018|FG000|STARTED|Overall Study||20
10216120|NCT03722030|11343019|FG001|STARTED|Overall Study||20
10216121|NCT03722030|11343018|FG000|COMPLETED|Overall Study||19
10216122|NCT03722030|11343019|FG001|COMPLETED|Overall Study||20
10216123|NCT03722030|11343018|FG000|NOT COMPLETED|Overall Study||1
10216124|NCT03722030|11343019|FG001|NOT COMPLETED|Overall Study||0
10216125|NCT03722238|11343028|FG000|STARTED|Overall Study||608
10216126|NCT03722238|11343029|FG001|STARTED|Overall Study||5
10216127|NCT03722238|11343028|FG000|Safety Set|Overall Study||198
10216128|NCT03722238|11343029|FG001|Safety Set|Overall Study||5
10216129|NCT03722238|11343028|FG000|Actual Drug Users|Overall Study||179
10216130|NCT03722238|11343029|FG001|Actual Drug Users|Overall Study||5
10216131|NCT03722238|11343028|FG000|COMPLETED|Overall Study||143
10216132|NCT03722238|11343029|FG001|COMPLETED|Overall Study||4
10216133|NCT03722238|11343028|FG000|NOT COMPLETED|Overall Study||465
10216134|NCT03722238|11343029|FG001|NOT COMPLETED|Overall Study||1
10216135|NCT03722264|11343035|FG000|STARTED|Overall Study||12
10216136|NCT03722264|11343035|FG000|COMPLETED|Overall Study||9
10216137|NCT03722264|11343035|FG000|NOT COMPLETED|Overall Study||3
10216138|NCT03722446|11343043|FG000|STARTED|Overall Study||135
10216139|NCT03722446|11343044|FG001|STARTED|Overall Study||122
10216140|NCT03722446|11343043|FG000|COMPLETED|Overall Study||120
10216141|NCT03722446|11343044|FG001|COMPLETED|Overall Study||120
10216142|NCT03722446|11343043|FG000|NOT COMPLETED|Overall Study||15
10012321|NCT01784796|11135074|FG000|8 wk Data Collection|Overall Study||50
10012322|NCT01784796|11135075|FG001|8 wk Data Collection|Overall Study||46
10012323|NCT01784796|11135074|FG000|COMPLETED|Overall Study||39
10012324|NCT01784796|11135075|FG001|COMPLETED|Overall Study||34
10012325|NCT01784796|11135074|FG000|NOT COMPLETED|Overall Study||48
10012326|NCT01784796|11135075|FG001|NOT COMPLETED|Overall Study||43
10012327|NCT01784861|11135088|FG000|STARTED|Overall Study||3
10012328|NCT01784861|11135089|FG001|STARTED|Overall Study||3
10012329|NCT01784861|11135090|FG002|STARTED|Overall Study||4
10012330|NCT01784861|11135091|FG003|STARTED|Overall Study||8
10012331|NCT01784861|11135092|FG004|STARTED|Overall Study||3
10012332|NCT01784861|11135093|FG005|STARTED|Overall Study||2
10216143|NCT03722446|11343044|FG001|NOT COMPLETED|Overall Study||2
10216144|NCT03722524|11343050|FG000|STARTED|Overall Study||1247
10216145|NCT03722524|11343050|FG000|COMPLETED|Overall Study||1148
10216146|NCT03722524|11343050|FG000|NOT COMPLETED|Overall Study||99
10216147|NCT03722576|11343054|FG000|STARTED|Overall Study||18
10216148|NCT03722576|11343054|FG000|COMPLETED|Overall Study||11
10216149|NCT03722576|11343054|FG000|NOT COMPLETED|Overall Study||7
10216150|NCT03722784|11343060|FG000|STARTED|Overall Study||58
10216151|NCT03722784|11343061|FG001|STARTED|Overall Study||30
10216152|NCT03722784|11343060|FG000|COMPLETED|Overall Study||56
10216153|NCT03722784|11343061|FG001|COMPLETED|Overall Study||28
10012333|NCT01784861|11135088|FG000|COMPLETED|Overall Study||3
10012334|NCT01784861|11135089|FG001|COMPLETED|Overall Study||3
10216154|NCT03722784|11343060|FG000|NOT COMPLETED|Overall Study||2
10216155|NCT03722784|11343061|FG001|NOT COMPLETED|Overall Study||2
10216156|NCT03723915|11343068|FG000|STARTED|Screening||17
10216157|NCT03723915|11343068|FG000|COMPLETED|Screening||15
10216158|NCT03723915|11343068|FG000|NOT COMPLETED|Screening||2
10216159|NCT03723915|11343068|FG000|STARTED|On Treatment||15
10216160|NCT03723915|11343068|FG000|Registered on Study|On Treatment||15
10216161|NCT03723915|11343068|FG000|Received First Dose of Study Drugs|On Treatment||13
10216162|NCT03723915|11343068|FG000|COMPLETED|On Treatment||13
10216163|NCT03723915|11343068|FG000|NOT COMPLETED|On Treatment||2
10216164|NCT03723915|11343068|FG000|STARTED|Survival Follow-up||13
10216165|NCT03723915|11343068|FG000|COMPLETED|Survival Follow-up||13
10216166|NCT03723915|11343068|FG000|NOT COMPLETED|Survival Follow-up||0
10216167|NCT03724812|11343072|FG000|STARTED|Overall Study||46
10216168|NCT03724812|11343072|FG000|Discharge|Overall Study||46
10216169|NCT03724812|11343072|FG000|30 Day Follow-Up|Overall Study||45
10216170|NCT03724812|11343072|FG000|6 Month Follow-Up|Overall Study||42
10216171|NCT03724812|11343072|FG000|12-Month Follow-Up|Overall Study||42
10012335|NCT01784861|11135090|FG002|COMPLETED|Overall Study||3
10012336|NCT01784861|11135091|FG003|COMPLETED|Overall Study||3
10012337|NCT01784861|11135092|FG004|COMPLETED|Overall Study||2
10216172|NCT03724812|11343072|FG000|COMPLETED|Overall Study||42
10216173|NCT03724812|11343072|FG000|NOT COMPLETED|Overall Study||4
10216174|NCT03725982|11343079|FG000|STARTED|First Intervention||20
10216175|NCT03725982|11343080|FG001|STARTED|First Intervention||19
10216176|NCT03725982|11343079|FG000|COMPLETED|First Intervention||19
10216177|NCT03725982|11343080|FG001|COMPLETED|First Intervention||17
10216178|NCT03725982|11343079|FG000|NOT COMPLETED|First Intervention||1
10216179|NCT03725982|11343080|FG001|NOT COMPLETED|First Intervention||2
10216180|NCT03725982|11343079|FG000|STARTED|Second Intervention||19
10216181|NCT03725982|11343080|FG001|STARTED|Second Intervention||17
10216182|NCT03725982|11343079|FG000|COMPLETED|Second Intervention||19
10216183|NCT03725982|11343080|FG001|COMPLETED|Second Intervention||17
10216184|NCT03725982|11343079|FG000|NOT COMPLETED|Second Intervention||0
10216185|NCT03725982|11343080|FG001|NOT COMPLETED|Second Intervention||0
10216186|NCT03727841|11343094|FG000|STARTED|Overall Study||3
10216187|NCT03727841|11343095|FG001|STARTED|Overall Study||1
10216188|NCT03727841|11343094|FG000|COMPLETED|Overall Study||1
10216189|NCT03727841|11343095|FG001|COMPLETED|Overall Study||0
10216190|NCT03727841|11343094|FG000|NOT COMPLETED|Overall Study||2
10216191|NCT03727841|11343095|FG001|NOT COMPLETED|Overall Study||1
10012338|NCT01784861|11135093|FG005|COMPLETED|Overall Study||1
10012339|NCT01784861|11135088|FG000|NOT COMPLETED|Overall Study||0
10012340|NCT01784861|11135089|FG001|NOT COMPLETED|Overall Study||0
10012341|NCT01784861|11135090|FG002|NOT COMPLETED|Overall Study||1
10012342|NCT01784861|11135091|FG003|NOT COMPLETED|Overall Study||5
10012343|NCT01784861|11135092|FG004|NOT COMPLETED|Overall Study||1
10012344|NCT01784861|11135093|FG005|NOT COMPLETED|Overall Study||1
10012345|NCT01784926|11135111|FG000|STARTED|Overall Study||54
10012346|NCT01784926|11135112|FG001|STARTED|Overall Study||50
10012347|NCT01784926|11135111|FG000|COMPLETED|Overall Study||43
10216192|NCT03736967|11343105|FG000|STARTED|Overall Study||51
10216193|NCT03736967|11343106|FG001|STARTED|Overall Study||52
10216194|NCT03736967|11343107|FG002|STARTED|Overall Study||51
10216195|NCT03736967|11343108|FG003|STARTED|Overall Study||52
10216196|NCT03736967|11343105|FG000|Treated|Overall Study||50
10216197|NCT03736967|11343106|FG001|Treated|Overall Study||52
10216198|NCT03736967|11343107|FG002|Treated|Overall Study||51
10216199|NCT03736967|11343108|FG003|Treated|Overall Study||52
10216200|NCT03736967|11343105|FG000|COMPLETED|Overall Study||20
10216201|NCT03736967|11343106|FG001|COMPLETED|Overall Study||24
10216202|NCT03736967|11343107|FG002|COMPLETED|Overall Study||27
10216203|NCT03736967|11343108|FG003|COMPLETED|Overall Study||22
10216204|NCT03736967|11343105|FG000|NOT COMPLETED|Overall Study||31
10216205|NCT03736967|11343106|FG001|NOT COMPLETED|Overall Study||28
10216206|NCT03736967|11343107|FG002|NOT COMPLETED|Overall Study||24
10216207|NCT03736967|11343108|FG003|NOT COMPLETED|Overall Study||30
10216208|NCT03739840|11343125|FG000|STARTED|Treatment Period: Wk0-16||56
10216209|NCT03739840|11343126|FG001|STARTED|Treatment Period: Wk0-16||60
10216210|NCT03739840|11343127|FG002|STARTED|Treatment Period: Wk0-16||57
10216211|NCT03739840|11343128|FG003|STARTED|Treatment Period: Wk0-16||59
10111896|NCT02499783|11242962|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
10111897|NCT02499783|11242963|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
10111898|NCT02499783|11242964|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
10111899|NCT02499783|11242962|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
10111900|NCT02499783|11242963|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
10111901|NCT02499783|11242964|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
10111902|NCT02499783|11242962|FG000|STARTED|DB Period: Weeks 0-8||102
10111903|NCT02499783|11242963|FG001|STARTED|DB Period: Weeks 0-8||103
10111904|NCT02499783|11242964|FG002|STARTED|DB Period: Weeks 0-8||0
10111905|NCT02499783|11242962|FG000|COMPLETED|DB Period: Weeks 0-8||92
10111906|NCT02499783|11242963|FG001|COMPLETED|DB Period: Weeks 0-8||96
10216212|NCT03739840|11343125|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
10216213|NCT03739840|11343126|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58
10216214|NCT03739840|11343127|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51
10216215|NCT03739840|11343128|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
10012348|NCT01784926|11135112|FG001|COMPLETED|Overall Study||42
10012349|NCT01784926|11135111|FG000|NOT COMPLETED|Overall Study||11
10216216|NCT03739840|11343125|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46
10216217|NCT03739840|11343126|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44
10216218|NCT03739840|11343127|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44
10216219|NCT03739840|11343128|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36
10216220|NCT03739840|11343125|FG000|COMPLETED|Treatment Period: Wk0-16||46
10216221|NCT03739840|11343126|FG001|COMPLETED|Treatment Period: Wk0-16||44
10216222|NCT03739840|11343127|FG002|COMPLETED|Treatment Period: Wk0-16||44
10216223|NCT03739840|11343128|FG003|COMPLETED|Treatment Period: Wk0-16||36
10216224|NCT03739840|11343125|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10
10216225|NCT03739840|11343126|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16
10216226|NCT03739840|11343127|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13
10216227|NCT03739840|11343128|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23
10012350|NCT01784926|11135112|FG001|NOT COMPLETED|Overall Study||8
10012351|NCT01784965|11135120|FG000|STARTED|Overall Study||33
10012352|NCT01784965|11135121|FG001|STARTED|Overall Study||35
10012353|NCT01784965|11135120|FG000|COMPLETED|Overall Study||27
10216228|NCT03739840|11343125|FG000|STARTED|Post-Treatment Period: Wk16-23||46
10216229|NCT03739840|11343126|FG001|STARTED|Post-Treatment Period: Wk16-23||44
10216230|NCT03739840|11343127|FG002|STARTED|Post-Treatment Period: Wk16-23||44
10216231|NCT03739840|11343128|FG003|STARTED|Post-Treatment Period: Wk16-23||36
10216232|NCT03739840|11343125|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33
10216233|NCT03739840|11343126|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31
10216234|NCT03739840|11343127|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29
10216235|NCT03739840|11343128|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28
10216236|NCT03739840|11343125|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33
10216237|NCT03739840|11343126|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31
10216238|NCT03739840|11343127|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29
10216239|NCT03739840|11343128|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28
10216240|NCT03739840|11343125|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19
10216241|NCT03739840|11343126|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
10216242|NCT03739840|11343127|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21
10216243|NCT03739840|11343128|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13
10216244|NCT03739840|11343125|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15
10216245|NCT03739840|11343126|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16
10216246|NCT03739840|11343127|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
10216247|NCT03739840|11343128|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12
10216248|NCT03739840|11343125|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27
10216249|NCT03739840|11343126|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26
10216250|NCT03739840|11343127|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
10216251|NCT03739840|11343128|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
10216252|NCT03739840|11343125|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42
10216253|NCT03739840|11343126|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42
10216254|NCT03739840|11343127|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41
10216255|NCT03739840|11343128|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35
10216256|NCT03739840|11343125|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4
10216257|NCT03739840|11343126|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2
10216258|NCT03739840|11343127|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3
10216259|NCT03739840|11343128|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
10216260|NCT03739983|11343150|FG000|STARTED|Overall Study||2
10216261|NCT03739983|11343150|FG000|COMPLETED|Overall Study||2
10216262|NCT03739983|11343150|FG000|NOT COMPLETED|Overall Study||0
10216263|NCT03746002|11343156|FG000|STARTED|Overall Study||1
10216264|NCT03746002|11343157|FG001|STARTED|Overall Study||2
10216265|NCT03746002|11343156|FG000|COMPLETED|Overall Study||1
10216266|NCT03746002|11343157|FG001|COMPLETED|Overall Study||2
10216267|NCT03746002|11343156|FG000|NOT COMPLETED|Overall Study||0
10216268|NCT03746002|11343157|FG001|NOT COMPLETED|Overall Study||0
10216269|NCT03748771|11343163|FG000|STARTED|Overall Study||20
10216270|NCT03748771|11343163|FG000|COMPLETED|Overall Study||20
10216271|NCT03748771|11343163|FG000|NOT COMPLETED|Overall Study||0
10216272|NCT03752177|11343171|FG000|STARTED|Overall Study||3
10216273|NCT03752177|11343172|FG001|STARTED|Overall Study||3
10216274|NCT03752177|11343173|FG002|STARTED|Overall Study||3
10216275|NCT03752177|11343174|FG003|STARTED|Overall Study||3
10216276|NCT03752177|11343171|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10216277|NCT03752177|11343172|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10216278|NCT03752177|11343173|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10216279|NCT03752177|11343174|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10216280|NCT03752177|11343171|FG000|COMPLETED|Overall Study||3
10216281|NCT03752177|11343172|FG001|COMPLETED|Overall Study||3
10216282|NCT03752177|11343173|FG002|COMPLETED|Overall Study||3
10216283|NCT03752177|11343174|FG003|COMPLETED|Overall Study||3
10216284|NCT03752177|11343171|FG000|NOT COMPLETED|Overall Study||0
10216285|NCT03752177|11343172|FG001|NOT COMPLETED|Overall Study||0
10216286|NCT03752177|11343173|FG002|NOT COMPLETED|Overall Study||0
10216287|NCT03752177|11343174|FG003|NOT COMPLETED|Overall Study||0
10216288|NCT03753763|11343187|FG000|STARTED|Overall Study||32
10216289|NCT03753763|11343188|FG001|STARTED|Overall Study||17
10216290|NCT03753763|11343187|FG000|COMPLETED|Overall Study||26
10216291|NCT03753763|11343188|FG001|COMPLETED|Overall Study||16
10216292|NCT03753763|11343187|FG000|NOT COMPLETED|Overall Study||6
10216293|NCT03753763|11343188|FG001|NOT COMPLETED|Overall Study||1
10216294|NCT03756571|11343196|FG000|STARTED|Overall Study||10
10216295|NCT03756571|11343197|FG001|STARTED|Overall Study||11
10216296|NCT03756571|11343196|FG000|COMPLETED|Overall Study||9
10216297|NCT03756571|11343197|FG001|COMPLETED|Overall Study||10
10216298|NCT03756571|11343196|FG000|NOT COMPLETED|Overall Study||1
10216299|NCT03756571|11343197|FG001|NOT COMPLETED|Overall Study||1
10216300|NCT03761537|11343205|FG000|STARTED|Overall Study||140
10216301|NCT03761537|11343206|FG001|STARTED|Overall Study||137
10216302|NCT03761537|11343205|FG000|COMPLETED|Overall Study||125
10216303|NCT03761537|11343206|FG001|COMPLETED|Overall Study||120
10216304|NCT03761537|11343205|FG000|NOT COMPLETED|Overall Study||15
10216305|NCT03761537|11343206|FG001|NOT COMPLETED|Overall Study||17
10216306|NCT03763877|11343224|FG000|STARTED|Overall Study||31
10216307|NCT03763877|11343225|FG001|STARTED|Overall Study||30
10216308|NCT03763877|11343226|FG002|STARTED|Overall Study||31
10216309|NCT03763877|11343227|FG003|STARTED|Overall Study||29
10216310|NCT03763877|11343224|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31
10216311|NCT03763877|11343225|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
10216312|NCT03763877|11343226|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
10216313|NCT03763877|11343227|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29
10216314|NCT03763877|11343224|FG000|Completed the Double-blind Period|Overall Study||27
10216315|NCT03763877|11343225|FG001|Completed the Double-blind Period|Overall Study||26
10216316|NCT03763877|11343226|FG002|Completed the Double-blind Period|Overall Study||25
10216317|NCT03763877|11343227|FG003|Completed the Double-blind Period|Overall Study||24
10216318|NCT03763877|11343224|FG000|COMPLETED|Overall Study||26
10216319|NCT03763877|11343225|FG001|COMPLETED|Overall Study||26
10216320|NCT03763877|11343226|FG002|COMPLETED|Overall Study||24
10216321|NCT03763877|11343227|FG003|COMPLETED|Overall Study||24
10216322|NCT03763877|11343224|FG000|NOT COMPLETED|Overall Study||5
10216323|NCT03763877|11343225|FG001|NOT COMPLETED|Overall Study||4
10216324|NCT03763877|11343226|FG002|NOT COMPLETED|Overall Study||7
10216325|NCT03763877|11343227|FG003|NOT COMPLETED|Overall Study||5
10216326|NCT03764007|11343241|FG000|STARTED|Overall Study||98
10216327|NCT03764007|11343241|FG000|Imaging Completed|Overall Study||98
10216328|NCT03764007|11343241|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77
10216329|NCT03764007|11343241|FG000|COMPLETED|Overall Study||77
10216330|NCT03764007|11343241|FG000|NOT COMPLETED|Overall Study||21
10216331|NCT03772587|11343250|FG000|STARTED|Overall Study||14
10216332|NCT03772587|11343251|FG001|STARTED|Overall Study||14
10216333|NCT03772587|11343252|FG002|STARTED|Overall Study||13
10216334|NCT03772587|11343253|FG003|STARTED|Overall Study||13
10216335|NCT03772587|11343254|FG004|STARTED|Overall Study||14
10216336|NCT03772587|11343250|FG000|COMPLETED|Overall Study||13
10216337|NCT03772587|11343251|FG001|COMPLETED|Overall Study||14
10216338|NCT03772587|11343252|FG002|COMPLETED|Overall Study||12
10216339|NCT03772587|11343253|FG003|COMPLETED|Overall Study||12
10216340|NCT03772587|11343254|FG004|COMPLETED|Overall Study||14
10216341|NCT03772587|11343250|FG000|NOT COMPLETED|Overall Study||1
10216342|NCT03772587|11343251|FG001|NOT COMPLETED|Overall Study||0
10216343|NCT03772587|11343252|FG002|NOT COMPLETED|Overall Study||1
10216344|NCT03772587|11343253|FG003|NOT COMPLETED|Overall Study||1
10216345|NCT03772587|11343254|FG004|NOT COMPLETED|Overall Study||0
10216346|NCT03789292|11343278|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324
10216347|NCT03789292|11343279|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324
10216348|NCT03789292|11343280|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0
10216349|NCT03789292|11343278|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303
10216350|NCT03789292|11343279|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305
10216351|NCT03789292|11343280|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0
10216352|NCT03789292|11343278|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21
10216353|NCT03789292|11343279|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19
10216354|NCT03789292|11343280|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0
10216355|NCT03789292|11343278|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303
10239010|NCT00391430|11370514|FG002|STARTED|Overall Study||31
10239011|NCT00391430|11370512|FG000|COMPLETED|Overall Study||5
10216356|NCT03789292|11343279|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153
10216357|NCT03789292|11343280|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152
10216358|NCT03789292|11343278|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287
10216359|NCT03789292|11343279|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147
10216360|NCT03789292|11343280|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143
10216361|NCT03789292|11343278|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16
10216362|NCT03789292|11343279|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6
10216363|NCT03789292|11343280|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9
10216364|NCT03799289|11343296|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
10216365|NCT03799289|11343297|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
10216366|NCT03799289|11343296|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24
10216367|NCT03799289|11343297|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27
10216368|NCT03799289|11343296|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6
10216369|NCT03799289|11343297|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3
10216370|NCT03799289|11343296|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24
10216371|NCT03799289|11343297|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27
10216372|NCT03799289|11343296|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24
10216373|NCT03799289|11343297|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27
10216374|NCT03799289|11343296|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
10216375|NCT03799289|11343297|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
10216376|NCT03801408|11343303|FG000|STARTED|Overall Study||145
10216377|NCT03801408|11343303|FG000|COMPLETED|Overall Study||145
10216378|NCT03801408|11343303|FG000|NOT COMPLETED|Overall Study||0
10216379|NCT03805438|11343307|FG000|STARTED|Overall Study||47
10216380|NCT03805438|11343307|FG000|COMPLETED|Overall Study||45
10216381|NCT03805438|11343307|FG000|NOT COMPLETED|Overall Study||2
10216382|NCT03808948|11343311|FG000|STARTED|Overall Study||50
10216383|NCT03808948|11343311|FG000|COMPLETED|Overall Study||50
10216384|NCT03808948|11343311|FG000|NOT COMPLETED|Overall Study||0
10216385|NCT03810053|11343315|FG000|STARTED|Overall Study||290
10216386|NCT03810053|11343315|FG000|COMPLETED|Overall Study||290
10216387|NCT03810053|11343315|FG000|NOT COMPLETED|Overall Study||0
10216388|NCT03817528|11343319|FG000|STARTED|Overall Study||4
10216389|NCT03817528|11343319|FG000|COMPLETED|Overall Study||1
10216390|NCT03817528|11343319|FG000|NOT COMPLETED|Overall Study||3
10216391|NCT03817580|11343326|FG000|STARTED|Overall Study||57
10216392|NCT03817580|11343327|FG001|STARTED|Overall Study||56
10216393|NCT03817580|11343328|FG002|STARTED|Overall Study||57
10216394|NCT03817580|11343326|FG000|COMPLETED|Overall Study||57
10216395|NCT03817580|11343327|FG001|COMPLETED|Overall Study||56
10216396|NCT03817580|11343328|FG002|COMPLETED|Overall Study||57
10216397|NCT03817580|11343326|FG000|NOT COMPLETED|Overall Study||0
10216398|NCT03817580|11343327|FG001|NOT COMPLETED|Overall Study||0
10216399|NCT03817580|11343328|FG002|NOT COMPLETED|Overall Study||0
10216400|NCT03828422|11343338|FG000|STARTED|Overall Study||40
10216401|NCT03828422|11343339|FG001|STARTED|Overall Study||42
10216402|NCT03828422|11343338|FG000|COMPLETED|Overall Study||36
10216403|NCT03828422|11343339|FG001|COMPLETED|Overall Study||38
10216404|NCT03828422|11343338|FG000|NOT COMPLETED|Overall Study||4
10216405|NCT03828422|11343339|FG001|NOT COMPLETED|Overall Study||4
10216406|NCT03829228|11343346|FG000|STARTED|Overall Study||30
10216407|NCT03829228|11343346|FG000|COMPLETED|Overall Study||29
10216408|NCT03829228|11343346|FG000|NOT COMPLETED|Overall Study||1
10216409|NCT03829618|11343353|FG000|STARTED|Overall Study||15
10216410|NCT03829618|11343354|FG001|STARTED|Overall Study||7
10216411|NCT03829618|11343355|FG002|STARTED|Overall Study||7
9760778|NCT00383162|10864564|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
9760779|NCT00383188|10864575|FG000|STARTED|Overall Study||69
10216412|NCT03829618|11343353|FG000|COMPLETED|Overall Study||15
10216413|NCT03829618|11343354|FG001|COMPLETED|Overall Study||7
10216414|NCT03829618|11343355|FG002|COMPLETED|Overall Study||7
10216415|NCT03829618|11343353|FG000|NOT COMPLETED|Overall Study||0
10216416|NCT03829618|11343354|FG001|NOT COMPLETED|Overall Study||0
10216417|NCT03829618|11343355|FG002|NOT COMPLETED|Overall Study||0
10216418|NCT03830333|11343365|FG000|STARTED|Overall Study||134
10216419|NCT03830333|11343366|FG001|STARTED|Overall Study||134
10216420|NCT03830333|11343365|FG000|Clinically Evaluable Population|Overall Study||105
10216421|NCT03830333|11343366|FG001|Clinically Evaluable Population|Overall Study||116
10216422|NCT03830333|11343365|FG000|COMPLETED|Overall Study||126
10216423|NCT03830333|11343366|FG001|COMPLETED|Overall Study||130
10216424|NCT03830333|11343365|FG000|NOT COMPLETED|Overall Study||8
10216425|NCT03830333|11343366|FG001|NOT COMPLETED|Overall Study||4
10216426|NCT03831880|11343374|FG000|STARTED|Period 1 (12 Weeks)||43
10216427|NCT03831880|11343375|FG001|STARTED|Period 1 (12 Weeks)||44
10216428|NCT03831880|11343374|FG000|COMPLETED|Period 1 (12 Weeks)||43
10216429|NCT03831880|11343375|FG001|COMPLETED|Period 1 (12 Weeks)||43
10216430|NCT03831880|11343374|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
10216431|NCT03831880|11343375|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1
10216432|NCT03831880|11343374|FG000|STARTED|Period 2 (12 Weeks)||43
10216433|NCT03831880|11343375|FG001|STARTED|Period 2 (12 Weeks)||43
10216434|NCT03831880|11343374|FG000|COMPLETED|Period 2 (12 Weeks)||43
9760780|NCT00383188|10864576|FG001|STARTED|Overall Study||74
10216435|NCT03831880|11343375|FG001|COMPLETED|Period 2 (12 Weeks)||42
10216436|NCT03831880|11343374|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
10216437|NCT03831880|11343375|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1
10216438|NCT03831880|11343374|FG000|STARTED|Follow-up (5 Weeks)||43
10216439|NCT03831880|11343375|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43
10216440|NCT03831880|11343374|FG000|COMPLETED|Follow-up (5 Weeks)||43
10216441|NCT03831880|11343375|FG001|COMPLETED|Follow-up (5 Weeks)||43
10216442|NCT03831880|11343374|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0
10216443|NCT03831880|11343375|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0
10216444|NCT03831945|11343385|FG000|STARTED|Overall Study||10
10216445|NCT03831945|11343386|FG001|STARTED|Overall Study||10
10216446|NCT03831945|11343385|FG000|COMPLETED|Overall Study||3
10216447|NCT03831945|11343386|FG001|COMPLETED|Overall Study||4
10216448|NCT03831945|11343385|FG000|NOT COMPLETED|Overall Study||7
10216449|NCT03831945|11343386|FG001|NOT COMPLETED|Overall Study||6
10216450|NCT03835728|11343394|FG000|STARTED|Overall Study||2
10216451|NCT03835728|11343395|FG001|STARTED|Overall Study||1
10216452|NCT03835728|11343394|FG000|COMPLETED|Overall Study||2
10216453|NCT03835728|11343395|FG001|COMPLETED|Overall Study||1
10216454|NCT03835728|11343394|FG000|NOT COMPLETED|Overall Study||0
10216455|NCT03835728|11343395|FG001|NOT COMPLETED|Overall Study||0
10216456|NCT03840174|11343405|FG000|STARTED|Overall Study||6
10216457|NCT03840174|11343406|FG001|STARTED|Overall Study||6
10216458|NCT03840174|11343407|FG002|STARTED|Overall Study||3
10216459|NCT03840174|11343408|FG003|STARTED|Overall Study||3
10216460|NCT03840174|11343405|FG000|Vaccination 1|Overall Study||6
10216461|NCT03840174|11343406|FG001|Vaccination 1|Overall Study||6
10216462|NCT03840174|11343407|FG002|Vaccination 1|Overall Study||3
10216463|NCT03840174|11343408|FG003|Vaccination 1|Overall Study||3
10216464|NCT03840174|11343405|FG000|Vaccination 2|Overall Study||5
10216465|NCT03840174|11343406|FG001|Vaccination 2|Overall Study||6
10216466|NCT03840174|11343407|FG002|Vaccination 2|Overall Study||3
10216467|NCT03840174|11343408|FG003|Vaccination 2|Overall Study||3
10216468|NCT03840174|11343405|FG000|Vaccination 3|Overall Study||5
10216469|NCT03840174|11343406|FG001|Vaccination 3|Overall Study||6
10216470|NCT03840174|11343407|FG002|Vaccination 3|Overall Study||3
10216471|NCT03840174|11343408|FG003|Vaccination 3|Overall Study||3
10216472|NCT03840174|11343405|FG000|COMPLETED|Overall Study||5
10216473|NCT03840174|11343406|FG001|COMPLETED|Overall Study||6
10216474|NCT03840174|11343407|FG002|COMPLETED|Overall Study||3
10216475|NCT03840174|11343408|FG003|COMPLETED|Overall Study||3
10216476|NCT03840174|11343405|FG000|NOT COMPLETED|Overall Study||1
10216477|NCT03840174|11343406|FG001|NOT COMPLETED|Overall Study||0
10216478|NCT03840174|11343407|FG002|NOT COMPLETED|Overall Study||0
10216479|NCT03840174|11343408|FG003|NOT COMPLETED|Overall Study||0
10216480|NCT03848910|11343419|FG000|STARTED|Overall Study||11
10216481|NCT03848910|11343419|FG000|COMPLETED|Overall Study||11
10216482|NCT03848910|11343419|FG000|NOT COMPLETED|Overall Study||0
10216483|NCT03852524|11343426|FG000|STARTED|Overall Study||41
10216484|NCT03852524|11343427|FG001|STARTED|Overall Study||41
10216485|NCT03852524|11343426|FG000|COMPLETED|Overall Study||41
10216486|NCT03852524|11343427|FG001|COMPLETED|Overall Study||41
10216487|NCT03852524|11343426|FG000|NOT COMPLETED|Overall Study||0
10216488|NCT03852524|11343427|FG001|NOT COMPLETED|Overall Study||0
10216489|NCT03857841|11343437|FG000|STARTED|Overall Study||2
10012354|NCT01784965|11135121|FG001|COMPLETED|Overall Study||24
10012355|NCT01784965|11135120|FG000|NOT COMPLETED|Overall Study||6
10012356|NCT01784965|11135121|FG001|NOT COMPLETED|Overall Study||11
10216490|NCT03857841|11343438|FG001|STARTED|Overall Study||0
10216491|NCT03857841|11343439|FG002|STARTED|Overall Study||0
10216492|NCT03857841|11343440|FG003|STARTED|Overall Study||1
10216493|NCT03857841|11343437|FG000|COMPLETED|Overall Study||0
10216494|NCT03857841|11343438|FG001|COMPLETED|Overall Study||0
10216495|NCT03857841|11343439|FG002|COMPLETED|Overall Study||0
10216496|NCT03857841|11343440|FG003|COMPLETED|Overall Study||1
10216497|NCT03857841|11343437|FG000|NOT COMPLETED|Overall Study||2
10216498|NCT03857841|11343438|FG001|NOT COMPLETED|Overall Study||0
10216499|NCT03857841|11343439|FG002|NOT COMPLETED|Overall Study||0
10216500|NCT03857841|11343440|FG003|NOT COMPLETED|Overall Study||0
10216501|NCT03861780|11343453|FG000|STARTED|Overall Study||51
10216502|NCT03861780|11343454|FG001|STARTED|Overall Study||50
10216503|NCT03861780|11343455|FG002|STARTED|Overall Study||51
10216504|NCT03861780|11343453|FG000|COMPLETED|Overall Study||51
10216505|NCT03861780|11343454|FG001|COMPLETED|Overall Study||50
10216506|NCT03861780|11343455|FG002|COMPLETED|Overall Study||51
10216507|NCT03861780|11343453|FG000|NOT COMPLETED|Overall Study||0
10216508|NCT03861780|11343454|FG001|NOT COMPLETED|Overall Study||0
10216509|NCT03861780|11343455|FG002|NOT COMPLETED|Overall Study||0
10216510|NCT03862625|11343465|FG000|STARTED|Overall Study||15
10216511|NCT03862625|11343466|FG001|STARTED|Overall Study||15
10216512|NCT03862625|11343465|FG000|COMPLETED|Overall Study||15
10216513|NCT03862625|11343466|FG001|COMPLETED|Overall Study||14
10216514|NCT03862625|11343465|FG000|NOT COMPLETED|Overall Study||0
10216515|NCT03862625|11343466|FG001|NOT COMPLETED|Overall Study||1
10216516|NCT03862755|11343472|FG000|STARTED|Overall Study||581
10216517|NCT03862755|11343472|FG000|COMPLETED|Overall Study||581
10216518|NCT03862755|11343472|FG000|NOT COMPLETED|Overall Study||0
10239012|NCT00391430|11370513|FG001|COMPLETED|Overall Study||0
10239013|NCT00391430|11370514|FG002|COMPLETED|Overall Study||19
10239014|NCT00391430|11370512|FG000|NOT COMPLETED|Overall Study||3
10239015|NCT00391430|11370513|FG001|NOT COMPLETED|Overall Study||0
10216519|NCT03869541|11343479|FG000|STARTED|Overall Study||40
10216520|NCT03869541|11343480|FG001|STARTED|Overall Study||50
10216521|NCT03869541|11343481|FG002|STARTED|Overall Study||10
10216522|NCT03869541|11343479|FG000|COMPLETED|Overall Study||40
10216523|NCT03869541|11343480|FG001|COMPLETED|Overall Study||50
10216524|NCT03869541|11343481|FG002|COMPLETED|Overall Study||10
10216525|NCT03869541|11343479|FG000|NOT COMPLETED|Overall Study||0
10216526|NCT03869541|11343480|FG001|NOT COMPLETED|Overall Study||0
10216527|NCT03869541|11343481|FG002|NOT COMPLETED|Overall Study||0
10216528|NCT03877224|11343494|FG000|STARTED|Overall Study||253
10216529|NCT03877224|11343495|FG001|STARTED|Overall Study||251
10216530|NCT03877224|11343494|FG000|Treated|Overall Study||252
10216531|NCT03877224|11343495|FG001|Treated|Overall Study||249
10216532|NCT03877224|11343494|FG000|COMPLETED|Overall Study||248
10216533|NCT03877224|11343495|FG001|COMPLETED|Overall Study||243
10216534|NCT03877224|11343494|FG000|NOT COMPLETED|Overall Study||5
10216535|NCT03877224|11343495|FG001|NOT COMPLETED|Overall Study||8
10216536|NCT03883607|11343503|FG000|STARTED|Overall Study||5
10216537|NCT03883607|11343504|FG001|STARTED|Overall Study||5
10216538|NCT03883607|11343503|FG000|COMPLETED|Overall Study||5
10216539|NCT03883607|11343504|FG001|COMPLETED|Overall Study||5
10216540|NCT03883607|11343503|FG000|NOT COMPLETED|Overall Study||0
10216541|NCT03883607|11343504|FG001|NOT COMPLETED|Overall Study||0
10216542|NCT03885596|11343514|FG000|STARTED|Overall Study||9
10216543|NCT03885596|11343515|FG001|STARTED|Overall Study||9
10216544|NCT03885596|11343516|FG002|STARTED|Overall Study||9
10216545|NCT03885596|11343517|FG003|STARTED|Overall Study||9
10216546|NCT03885596|11343514|FG000|COMPLETED|Overall Study||7
10216547|NCT03885596|11343515|FG001|COMPLETED|Overall Study||8
10216548|NCT03885596|11343516|FG002|COMPLETED|Overall Study||9
10216549|NCT03885596|11343517|FG003|COMPLETED|Overall Study||9
10216550|NCT03885596|11343514|FG000|NOT COMPLETED|Overall Study||2
10216551|NCT03885596|11343515|FG001|NOT COMPLETED|Overall Study||1
10216552|NCT03885596|11343516|FG002|NOT COMPLETED|Overall Study||0
10216553|NCT03885596|11343517|FG003|NOT COMPLETED|Overall Study||0
10216554|NCT03885661|11343532|FG000|STARTED|Overall Study||12
10216555|NCT03885661|11343533|FG001|STARTED|Overall Study||8
10216556|NCT03885661|11343532|FG000|Baseline|Overall Study||12
10216557|NCT03885661|11343533|FG001|Baseline|Overall Study||8
10216558|NCT03885661|11343532|FG000|Treatment Visit (12 Week)|Overall Study||11
10216559|NCT03885661|11343533|FG001|Treatment Visit (12 Week)|Overall Study||7
10216560|NCT03885661|11343532|FG000|COMPLETED|Overall Study||11
10216561|NCT03885661|11343533|FG001|COMPLETED|Overall Study||7
10216562|NCT03885661|11343532|FG000|NOT COMPLETED|Overall Study||1
10216563|NCT03885661|11343533|FG001|NOT COMPLETED|Overall Study||1
10216564|NCT03886493|11343539|FG000|STARTED|Overall Study||7
10216565|NCT03886493|11343539|FG000|COMPLETED|Overall Study||6
10216566|NCT03886493|11343539|FG000|NOT COMPLETED|Overall Study||1
10216567|NCT03888235|11343546|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21
10216568|NCT03888235|11343547|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21
10216569|NCT03888235|11343548|FG002|STARTED|Overall Study||20
10216570|NCT03888235|11343546|FG000|COMPLETED|Overall Study||20
10216571|NCT03888235|11343547|FG001|COMPLETED|Overall Study||20
10216572|NCT03888235|11343548|FG002|COMPLETED|Overall Study||20
10216573|NCT03888235|11343546|FG000|NOT COMPLETED|Overall Study||1
10216574|NCT03888235|11343547|FG001|NOT COMPLETED|Overall Study||1
10216575|NCT03888235|11343548|FG002|NOT COMPLETED|Overall Study||0
10216576|NCT03889158|11343581|FG000|STARTED|Overall Study||20
10216577|NCT03889158|11343582|FG001|STARTED|Overall Study||15
10216578|NCT03889158|11343581|FG000|COMPLETED|Overall Study||16
10216579|NCT03889158|11343582|FG001|COMPLETED|Overall Study||9
10216580|NCT03889158|11343581|FG000|NOT COMPLETED|Overall Study||4
10216581|NCT03889158|11343582|FG001|NOT COMPLETED|Overall Study||6
10216582|NCT03890419|11343592|FG000|STARTED|Overall Study||34
10216583|NCT03890419|11343593|FG001|STARTED|Overall Study||30
10216584|NCT03890419|11343594|FG002|STARTED|Overall Study||30
10216585|NCT03890419|11343592|FG000|COMPLETED|Overall Study||27
10216586|NCT03890419|11343593|FG001|COMPLETED|Overall Study||27
10216587|NCT03890419|11343594|FG002|COMPLETED|Overall Study||25
10216588|NCT03890419|11343592|FG000|NOT COMPLETED|Overall Study||7
10216589|NCT03890419|11343593|FG001|NOT COMPLETED|Overall Study||3
10216590|NCT03890419|11343594|FG002|NOT COMPLETED|Overall Study||5
10216627|NCT03900416|11343620|FG000|STARTED|Baseline||72
10216628|NCT03900416|11343621|FG001|STARTED|Baseline||80
10216629|NCT03900416|11343620|FG000|COMPLETED|Baseline||72
10216630|NCT03900416|11343621|FG001|COMPLETED|Baseline||80
10216631|NCT03900416|11343620|FG000|NOT COMPLETED|Baseline||0
10216632|NCT03900416|11343621|FG001|NOT COMPLETED|Baseline||0
10216633|NCT03900416|11343620|FG000|STARTED|Post||72
10216634|NCT03900416|11343621|FG001|STARTED|Post||80
10216635|NCT03900416|11343620|FG000|COMPLETED|Post||72
10216636|NCT03900416|11343621|FG001|COMPLETED|Post||80
10216637|NCT03900416|11343620|FG000|NOT COMPLETED|Post||0
10216638|NCT03900416|11343621|FG001|NOT COMPLETED|Post||0
10216639|NCT03900416|11343620|FG000|STARTED|Six Week Follow-up||72
10216640|NCT03900416|11343621|FG001|STARTED|Six Week Follow-up||80
10216641|NCT03900416|11343620|FG000|COMPLETED|Six Week Follow-up||70
10216642|NCT03900416|11343621|FG001|COMPLETED|Six Week Follow-up||80
10216643|NCT03900416|11343620|FG000|NOT COMPLETED|Six Week Follow-up||2
10216644|NCT03900416|11343621|FG001|NOT COMPLETED|Six Week Follow-up||0
10216645|NCT03900416|11343620|FG000|STARTED|Twelve Week Follow-up||70
10216646|NCT03900416|11343621|FG001|STARTED|Twelve Week Follow-up||80
10216647|NCT03900416|11343620|FG000|COMPLETED|Twelve Week Follow-up||69
10216648|NCT03900416|11343621|FG001|COMPLETED|Twelve Week Follow-up||76
10216649|NCT03900416|11343620|FG000|NOT COMPLETED|Twelve Week Follow-up||1
10012357|NCT01785069|11135133|FG000|STARTED|Overall Study||107
10012358|NCT01785069|11135134|FG001|STARTED|Overall Study||76
10012359|NCT01785069|11135135|FG002|STARTED|Overall Study||104
10216650|NCT03900416|11343621|FG001|NOT COMPLETED|Twelve Week Follow-up||4
10216651|NCT03900416|11343620|FG000|STARTED|Six Month Follow-up||69
10216652|NCT03900416|11343621|FG001|STARTED|Six Month Follow-up||76
10216653|NCT03900416|11343620|FG000|COMPLETED|Six Month Follow-up||64
10216654|NCT03900416|11343621|FG001|COMPLETED|Six Month Follow-up||72
10216655|NCT03900416|11343620|FG000|NOT COMPLETED|Six Month Follow-up||5
10216656|NCT03900416|11343621|FG001|NOT COMPLETED|Six Month Follow-up||4
10216657|NCT03905863|11343629|FG000|STARTED|Overall Study||64
10216658|NCT03905863|11343630|FG001|STARTED|Overall Study||81
10216659|NCT03905863|11343629|FG000|COMPLETED|Overall Study||59
10216660|NCT03905863|11343630|FG001|COMPLETED|Overall Study||69
10216661|NCT03905863|11343629|FG000|NOT COMPLETED|Overall Study||5
10216662|NCT03905863|11343630|FG001|NOT COMPLETED|Overall Study||12
10216663|NCT03907033|11343638|FG000|STARTED|Overall Study||14
10216664|NCT03907033|11343639|FG001|STARTED|Overall Study||14
10216665|NCT03907033|11343638|FG000|COMPLETED|Overall Study||14
10216666|NCT03907033|11343639|FG001|COMPLETED|Overall Study||14
10216667|NCT03907033|11343638|FG000|NOT COMPLETED|Overall Study||0
10216668|NCT03907033|11343639|FG001|NOT COMPLETED|Overall Study||0
10216669|NCT03909971|11343647|FG000|STARTED|Overall Study||67
10216670|NCT03909971|11343648|FG001|STARTED|Overall Study||42
10216671|NCT03909971|11343647|FG000|COMPLETED|Overall Study||57
10216672|NCT03909971|11343648|FG001|COMPLETED|Overall Study||20
10216673|NCT03909971|11343647|FG000|NOT COMPLETED|Overall Study||10
10216674|NCT03909971|11343648|FG001|NOT COMPLETED|Overall Study||22
10216675|NCT03920215|11343659|FG000|STARTED|Overall Study||26
10216676|NCT03920215|11343660|FG001|STARTED|Overall Study||29
10216677|NCT03920215|11343661|FG002|STARTED|Overall Study||23
10216678|NCT03920215|11343662|FG003|STARTED|Overall Study||23
10012360|NCT01785069|11135136|FG003|STARTED|Overall Study||68
10012361|NCT01785069|11135133|FG000|COMPLETED|Overall Study||95
10012362|NCT01785069|11135134|FG001|COMPLETED|Overall Study||64
10012363|NCT01785069|11135135|FG002|COMPLETED|Overall Study||91
10216679|NCT03920215|11343659|FG000|COMPLETED|Overall Study||25
10216680|NCT03920215|11343660|FG001|COMPLETED|Overall Study||27
10216681|NCT03920215|11343661|FG002|COMPLETED|Overall Study||23
10216682|NCT03920215|11343662|FG003|COMPLETED|Overall Study||22
10216683|NCT03920215|11343659|FG000|NOT COMPLETED|Overall Study||1
10216684|NCT03920215|11343660|FG001|NOT COMPLETED|Overall Study||2
10216685|NCT03920215|11343661|FG002|NOT COMPLETED|Overall Study||0
10216686|NCT03920215|11343662|FG003|NOT COMPLETED|Overall Study||1
10216687|NCT03921151|11343674|FG000|STARTED|Overall Study||46
10216688|NCT03921151|11343675|FG001|STARTED|Overall Study||44
10216689|NCT03921151|11343674|FG000|COMPLETED|Overall Study||35
10216690|NCT03921151|11343675|FG001|COMPLETED|Overall Study||28
10216691|NCT03921151|11343674|FG000|NOT COMPLETED|Overall Study||11
10216692|NCT03921151|11343675|FG001|NOT COMPLETED|Overall Study||16
10012364|NCT01785069|11135136|FG003|COMPLETED|Overall Study||54
10012365|NCT01785069|11135133|FG000|NOT COMPLETED|Overall Study||12
10216693|NCT03926039|11343683|FG000|STARTED|Overall Study||35
10012366|NCT01785069|11135134|FG001|NOT COMPLETED|Overall Study||12
10216694|NCT03926039|11343684|FG001|STARTED|Overall Study||35
10216695|NCT03926039|11343683|FG000|COMPLETED|Overall Study||35
10216696|NCT03926039|11343684|FG001|COMPLETED|Overall Study||34
10216697|NCT03926039|11343683|FG000|NOT COMPLETED|Overall Study||0
10216698|NCT03926039|11343684|FG001|NOT COMPLETED|Overall Study||1
10216699|NCT03927911|11343696|FG000|STARTED|Overall Study||0
10216700|NCT03927911|11343697|FG001|STARTED|Overall Study||17
10216701|NCT03927911|11343698|FG002|STARTED|Overall Study||0
10216702|NCT03927911|11343699|FG003|STARTED|Overall Study||3
10216703|NCT03927911|11343700|FG004|STARTED|Overall Study||13
10216704|NCT03927911|11343701|FG005|STARTED|Overall Study||32
10216705|NCT03927911|11343696|FG000|COMPLETED|Overall Study||0
10216706|NCT03927911|11343697|FG001|COMPLETED|Overall Study||15
10216707|NCT03927911|11343698|FG002|COMPLETED|Overall Study||0
10216708|NCT03927911|11343699|FG003|COMPLETED|Overall Study||1
10216709|NCT03927911|11343700|FG004|COMPLETED|Overall Study||13
10216710|NCT03927911|11343701|FG005|COMPLETED|Overall Study||25
10216711|NCT03927911|11343696|FG000|NOT COMPLETED|Overall Study||0
10216712|NCT03927911|11343697|FG001|NOT COMPLETED|Overall Study||2
10216713|NCT03927911|11343698|FG002|NOT COMPLETED|Overall Study||0
10216714|NCT03927911|11343699|FG003|NOT COMPLETED|Overall Study||2
10216715|NCT03927911|11343700|FG004|NOT COMPLETED|Overall Study||0
10216716|NCT03927911|11343701|FG005|NOT COMPLETED|Overall Study||7
10216717|NCT03937570|11343717|FG000|STARTED|Overall Study||13
10216718|NCT03937570|11343718|FG001|STARTED|Overall Study||14
10216719|NCT03937570|11343717|FG000|COMPLETED|Overall Study||13
10216720|NCT03937570|11343718|FG001|COMPLETED|Overall Study||14
10216721|NCT03937570|11343717|FG000|NOT COMPLETED|Overall Study||0
10216722|NCT03937570|11343718|FG001|NOT COMPLETED|Overall Study||0
10216723|NCT03938857|11343728|FG000|STARTED|Overall Study||6
10216724|NCT03938857|11343729|FG001|STARTED|Overall Study||12
10216725|NCT03938857|11343730|FG002|STARTED|Overall Study||12
10216726|NCT03938857|11343731|FG003|STARTED|Overall Study||0
10216727|NCT03938857|11343728|FG000|COMPLETED|Overall Study||5
10216728|NCT03938857|11343729|FG001|COMPLETED|Overall Study||12
10216729|NCT03938857|11343730|FG002|COMPLETED|Overall Study||12
10216730|NCT03938857|11343731|FG003|COMPLETED|Overall Study||0
10216731|NCT03938857|11343728|FG000|NOT COMPLETED|Overall Study||1
10216732|NCT03938857|11343729|FG001|NOT COMPLETED|Overall Study||0
10216733|NCT03938857|11343730|FG002|NOT COMPLETED|Overall Study||0
10216734|NCT03938857|11343731|FG003|NOT COMPLETED|Overall Study||0
10216735|NCT03941912|11343741|FG000|STARTED|Overall Study||44
10216736|NCT03941912|11343741|FG000|COMPLETED|Overall Study||44
10216737|NCT03941912|11343741|FG000|NOT COMPLETED|Overall Study||0
10216738|NCT03945981|11343745|FG000|STARTED|Overall Study||131
10216739|NCT03945981|11343745|FG000|COMPLETED|Overall Study||108
10216740|NCT03945981|11343745|FG000|NOT COMPLETED|Overall Study||23
10216741|NCT03950167|11343751|FG000|STARTED|Overall Study||25
10216742|NCT03950167|11343752|FG001|STARTED|Overall Study||25
10216743|NCT03950167|11343751|FG000|COMPLETED|Overall Study||24
10216744|NCT03950167|11343752|FG001|COMPLETED|Overall Study||22
10216745|NCT03950167|11343751|FG000|NOT COMPLETED|Overall Study||1
10216746|NCT03950167|11343752|FG001|NOT COMPLETED|Overall Study||3
10216747|NCT03954834|11343762|FG000|STARTED|Overall Study||121
10216748|NCT03954834|11343763|FG001|STARTED|Overall Study||121
10216749|NCT03954834|11343764|FG002|STARTED|Overall Study||121
10216750|NCT03954834|11343765|FG003|STARTED|Overall Study||115
10216751|NCT03954834|11343762|FG000|Received at Least One Dose of Study Drug|Overall Study||121
10216752|NCT03954834|11343763|FG001|Received at Least One Dose of Study Drug|Overall Study||121
10216753|NCT03954834|11343764|FG002|Received at Least One Dose of Study Drug|Overall Study||121
10216754|NCT03954834|11343765|FG003|Received at Least One Dose of Study Drug|Overall Study||115
10216755|NCT03954834|11343762|FG000|COMPLETED|Overall Study||114
10216756|NCT03954834|11343763|FG001|COMPLETED|Overall Study||112
10216757|NCT03954834|11343764|FG002|COMPLETED|Overall Study||103
10216758|NCT03954834|11343765|FG003|COMPLETED|Overall Study||99
10216759|NCT03954834|11343762|FG000|NOT COMPLETED|Overall Study||7
10216760|NCT03954834|11343763|FG001|NOT COMPLETED|Overall Study||9
10216761|NCT03954834|11343764|FG002|NOT COMPLETED|Overall Study||18
10216762|NCT03954834|11343765|FG003|NOT COMPLETED|Overall Study||16
10216763|NCT03958071|11343778|FG000|STARTED|Overall Study||347
10216764|NCT03958071|11343779|FG001|STARTED|Overall Study||423
10216765|NCT03958071|11343780|FG002|STARTED|Overall Study||12494
10216766|NCT03958071|11343778|FG000|COMPLETED|Overall Study||347
10216767|NCT03958071|11343779|FG001|COMPLETED|Overall Study||423
10216768|NCT03958071|11343780|FG002|COMPLETED|Overall Study||12494
10216769|NCT03958071|11343778|FG000|NOT COMPLETED|Overall Study||0
10216770|NCT03958071|11343779|FG001|NOT COMPLETED|Overall Study||0
10216771|NCT03958071|11343780|FG002|NOT COMPLETED|Overall Study||0
10216772|NCT03961529|11343792|FG000|STARTED|Overall Study||166
10216773|NCT03961529|11343793|FG001|STARTED|Overall Study||144
10216774|NCT03961529|11343794|FG002|STARTED|Overall Study||56
10216775|NCT03961529|11343792|FG000|COMPLETED|Overall Study||124
10216776|NCT03961529|11343793|FG001|COMPLETED|Overall Study||127
10216777|NCT03961529|11343794|FG002|COMPLETED|Overall Study||51
10216778|NCT03961529|11343792|FG000|NOT COMPLETED|Overall Study||42
10216779|NCT03961529|11343793|FG001|NOT COMPLETED|Overall Study||17
10216780|NCT03961529|11343794|FG002|NOT COMPLETED|Overall Study||5
10216781|NCT03968159|11343804|FG000|STARTED|Overall Study||148
10216782|NCT03968159|11343805|FG001|STARTED|Overall Study||150
10216783|NCT03968159|11343804|FG000|COMPLETED|Overall Study||135
10216784|NCT03968159|11343805|FG001|COMPLETED|Overall Study||135
10216785|NCT03968159|11343804|FG000|NOT COMPLETED|Overall Study||13
10216786|NCT03968159|11343805|FG001|NOT COMPLETED|Overall Study||15
10216787|NCT03968965|11343813|FG000|STARTED|Overall Study||32
10216788|NCT03968965|11343814|FG001|STARTED|Overall Study||32
10216789|NCT03968965|11343813|FG000|COMPLETED|Overall Study||32
10216790|NCT03968965|11343814|FG001|COMPLETED|Overall Study||30
10216791|NCT03968965|11343813|FG000|NOT COMPLETED|Overall Study||0
10216792|NCT03968965|11343814|FG001|NOT COMPLETED|Overall Study||2
10216793|NCT03970824|11343823|FG000|STARTED|Overall Study||103
10216794|NCT03970824|11343824|FG001|STARTED|Overall Study||103
10216795|NCT03970824|11343825|FG002|STARTED|Overall Study||106
10216796|NCT03970824|11343823|FG000|COMPLETED|Overall Study||101
10216797|NCT03970824|11343824|FG001|COMPLETED|Overall Study||100
10216798|NCT03970824|11343825|FG002|COMPLETED|Overall Study||102
10216799|NCT03970824|11343823|FG000|NOT COMPLETED|Overall Study||2
10216800|NCT03970824|11343824|FG001|NOT COMPLETED|Overall Study||3
10216801|NCT03970824|11343825|FG002|NOT COMPLETED|Overall Study||4
10216802|NCT03978403|11343837|FG000|STARTED|Overall Study||6
10216803|NCT03978403|11343838|FG001|STARTED|Overall Study||6
10216804|NCT03978403|11343839|FG002|STARTED|Overall Study||6
10216805|NCT03978403|11343840|FG003|STARTED|Overall Study||6
10216806|NCT03978403|11343837|FG000|COMPLETED|Overall Study||6
10216807|NCT03978403|11343838|FG001|COMPLETED|Overall Study||6
10216808|NCT03978403|11343839|FG002|COMPLETED|Overall Study||6
10216809|NCT03978403|11343840|FG003|COMPLETED|Overall Study||6
10216810|NCT03978403|11343837|FG000|NOT COMPLETED|Overall Study||0
10216811|NCT03978403|11343838|FG001|NOT COMPLETED|Overall Study||0
10216812|NCT03978403|11343839|FG002|NOT COMPLETED|Overall Study||0
10216813|NCT03978403|11343840|FG003|NOT COMPLETED|Overall Study||0
10216814|NCT03979807|11343853|FG000|STARTED|Overall Study||3876
10216815|NCT03979807|11343854|FG001|STARTED|Overall Study||7420
10216816|NCT03979807|11343853|FG000|COMPLETED|Overall Study||3876
10216817|NCT03979807|11343854|FG001|COMPLETED|Overall Study||7420
10216818|NCT03979807|11343853|FG000|NOT COMPLETED|Overall Study||0
10216819|NCT03979807|11343854|FG001|NOT COMPLETED|Overall Study||0
10216820|NCT03980470|11343860|FG000|STARTED|Overall Study||50
10216821|NCT03980470|11343860|FG000|COMPLETED|Overall Study||50
10216822|NCT03980470|11343860|FG000|NOT COMPLETED|Overall Study||0
10216823|NCT03982069|11343871|FG000|STARTED|Overall Study||108
10216824|NCT03982069|11343872|FG001|STARTED|Overall Study||110
10216825|NCT03982069|11343873|FG002|STARTED|Overall Study||127
10216826|NCT03982069|11343874|FG003|STARTED|Overall Study||120
10216827|NCT03982069|11343871|FG000|COMPLETED|Overall Study||98
10216828|NCT03982069|11343872|FG001|COMPLETED|Overall Study||100
10216829|NCT03982069|11343873|FG002|COMPLETED|Overall Study||118
10216830|NCT03982069|11343874|FG003|COMPLETED|Overall Study||112
10216831|NCT03982069|11343871|FG000|NOT COMPLETED|Overall Study||10
10216832|NCT03982069|11343872|FG001|NOT COMPLETED|Overall Study||10
10216833|NCT03982069|11343873|FG002|NOT COMPLETED|Overall Study||9
10216834|NCT03982069|11343874|FG003|NOT COMPLETED|Overall Study||8
10216835|NCT03984812|11343893|FG000|STARTED|Part 1 (Up to Day 28)||6
10216836|NCT03984812|11343894|FG001|STARTED|Part 1 (Up to Day 28)||6
10216837|NCT03984812|11343895|FG002|STARTED|Part 1 (Up to Day 28)||6
10216838|NCT03984812|11343896|FG003|STARTED|Part 1 (Up to Day 28)||6
10216839|NCT03984812|11343897|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
10012367|NCT01785069|11135135|FG002|NOT COMPLETED|Overall Study||13
10012368|NCT01785069|11135136|FG003|NOT COMPLETED|Overall Study||14
10012369|NCT01785095|11135146|FG000|STARTED|Overall Study||27
10012370|NCT01785095|11135146|FG000|COMPLETED|Overall Study||24
10012371|NCT01785095|11135146|FG000|NOT COMPLETED|Overall Study||3
10012372|NCT01785134|11135155|FG000|STARTED|Overall Study||41
10012373|NCT01785134|11135156|FG001|STARTED|Overall Study||40
10012374|NCT01785134|11135155|FG000|COMPLETED|Overall Study||29
10012375|NCT01785134|11135156|FG001|COMPLETED|Overall Study||33
10012376|NCT01785134|11135155|FG000|NOT COMPLETED|Overall Study||12
10012377|NCT01785134|11135156|FG001|NOT COMPLETED|Overall Study||7
10012378|NCT01785160|11135162|FG000|STARTED|Treatment Period 1: Raltegravir||25
10012379|NCT01785160|11135162|FG000|COMPLETED|Treatment Period 1: Raltegravir||24
10012380|NCT01785160|11135162|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1
10012381|NCT01785160|11135162|FG000|STARTED|Washout Period of at Least 7 Days||24
10012382|NCT01785160|11135162|FG000|COMPLETED|Washout Period of at Least 7 Days||23
10012383|NCT01785160|11135162|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
10012384|NCT01785160|11135162|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23
10012385|NCT01785160|11135162|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
10216840|NCT03984812|11343898|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
10216841|NCT03984812|11343899|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
10216842|NCT03984812|11343900|FG007|STARTED|Part 1 (Up to Day 28)||0
10216843|NCT03984812|11343901|FG008|STARTED|Part 1 (Up to Day 28)||0
10216844|NCT03984812|11343902|FG009|STARTED|Part 1 (Up to Day 28)||0
10012386|NCT01785160|11135162|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
10216845|NCT03984812|11343903|FG010|STARTED|Part 1 (Up to Day 28)||0
10216846|NCT03984812|11343893|FG000|COMPLETED|Part 1 (Up to Day 28)||6
10216847|NCT03984812|11343894|FG001|COMPLETED|Part 1 (Up to Day 28)||6
10012387|NCT01785186|11135173|FG000|STARTED|Overall Study||59
10216848|NCT03984812|11343895|FG002|COMPLETED|Part 1 (Up to Day 28)||5
10216849|NCT03984812|11343896|FG003|COMPLETED|Part 1 (Up to Day 28)||6
10216850|NCT03984812|11343897|FG004|COMPLETED|Part 1 (Up to Day 28)||0
10216851|NCT03984812|11343898|FG005|COMPLETED|Part 1 (Up to Day 28)||0
10216852|NCT03984812|11343899|FG006|COMPLETED|Part 1 (Up to Day 28)||0
10216853|NCT03984812|11343900|FG007|COMPLETED|Part 1 (Up to Day 28)||0
10216854|NCT03984812|11343901|FG008|COMPLETED|Part 1 (Up to Day 28)||0
10216855|NCT03984812|11343902|FG009|COMPLETED|Part 1 (Up to Day 28)||0
10216856|NCT03984812|11343903|FG010|COMPLETED|Part 1 (Up to Day 28)||0
10216857|NCT03984812|11343893|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216858|NCT03984812|11343894|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216859|NCT03984812|11343895|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1
10216860|NCT03984812|11343896|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216861|NCT03984812|11343897|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216862|NCT03984812|11343898|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216863|NCT03984812|11343899|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216864|NCT03984812|11343900|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216865|NCT03984812|11343901|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216866|NCT03984812|11343902|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216867|NCT03984812|11343903|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0
10216868|NCT03984812|11343893|FG000|STARTED|Part 2 (Up to Day 49)||0
10216869|NCT03984812|11343894|FG001|STARTED|Part 2 (Up to Day 49)||0
10216870|NCT03984812|11343895|FG002|STARTED|Part 2 (Up to Day 49)||0
10216871|NCT03984812|11343896|FG003|STARTED|Part 2 (Up to Day 49)||0
10216872|NCT03984812|11343897|FG004|STARTED|Part 2 (Up to Day 49)||0
10216873|NCT03984812|11343898|FG005|STARTED|Part 2 (Up to Day 49)||0
10216874|NCT03984812|11343899|FG006|STARTED|Part 2 (Up to Day 49)||0
10216875|NCT03984812|11343900|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10216876|NCT03984812|11343901|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10216877|NCT03984812|11343902|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10216878|NCT03984812|11343903|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10216879|NCT03984812|11343893|FG000|COMPLETED|Part 2 (Up to Day 49)||0
10216880|NCT03984812|11343894|FG001|COMPLETED|Part 2 (Up to Day 49)||0
10216881|NCT03984812|11343895|FG002|COMPLETED|Part 2 (Up to Day 49)||0
10216882|NCT03984812|11343896|FG003|COMPLETED|Part 2 (Up to Day 49)||0
10216883|NCT03984812|11343897|FG004|COMPLETED|Part 2 (Up to Day 49)||0
10216884|NCT03984812|11343898|FG005|COMPLETED|Part 2 (Up to Day 49)||0
10216885|NCT03984812|11343899|FG006|COMPLETED|Part 2 (Up to Day 49)||0
10216886|NCT03984812|11343900|FG007|COMPLETED|Part 2 (Up to Day 49)||0
10216887|NCT03984812|11343901|FG008|COMPLETED|Part 2 (Up to Day 49)||0
10216888|NCT03984812|11343902|FG009|COMPLETED|Part 2 (Up to Day 49)||0
10216889|NCT03984812|11343903|FG010|COMPLETED|Part 2 (Up to Day 49)||0
10216890|NCT03984812|11343893|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216891|NCT03984812|11343894|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216892|NCT03984812|11343895|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216893|NCT03984812|11343896|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216894|NCT03984812|11343897|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216895|NCT03984812|11343898|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216896|NCT03984812|11343899|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216897|NCT03984812|11343900|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216898|NCT03984812|11343901|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216899|NCT03984812|11343902|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216900|NCT03984812|11343903|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0
10216901|NCT03985813|11343932|FG000|STARTED|Overall Study||27
10216902|NCT03985813|11343933|FG001|STARTED|Overall Study||26
10216903|NCT03985813|11343932|FG000|COMPLETED|Overall Study||27
10216904|NCT03985813|11343933|FG001|COMPLETED|Overall Study||26
10216905|NCT03985813|11343932|FG000|NOT COMPLETED|Overall Study||0
10216906|NCT03985813|11343933|FG001|NOT COMPLETED|Overall Study||0
10216907|NCT03998163|11343939|FG000|STARTED|Overall Study||222
10216908|NCT03998163|11343939|FG000|COMPLETED|Overall Study||197
10216909|NCT03998163|11343939|FG000|NOT COMPLETED|Overall Study||25
10216910|NCT04000373|11343943|FG000|STARTED|Overall Study||5
10216911|NCT04000373|11343943|FG000|COMPLETED|Overall Study||5
10216912|NCT04000373|11343943|FG000|NOT COMPLETED|Overall Study||0
10216913|NCT04001517|11343950|FG000|STARTED|Overall Study||20
10216914|NCT04001517|11343951|FG001|STARTED|Overall Study||26
10216915|NCT04001517|11343952|FG002|STARTED|Overall Study||27
10216916|NCT04001517|11343953|FG003|STARTED|Overall Study||18
10216917|NCT04001517|11343950|FG000|COMPLETED|Overall Study||20
10216918|NCT04001517|11343951|FG001|COMPLETED|Overall Study||20
10216919|NCT04001517|11343952|FG002|COMPLETED|Overall Study||26
10216920|NCT04001517|11343953|FG003|COMPLETED|Overall Study||15
10216921|NCT04001517|11343950|FG000|NOT COMPLETED|Overall Study||0
10216922|NCT04001517|11343951|FG001|NOT COMPLETED|Overall Study||6
10216923|NCT04001517|11343952|FG002|NOT COMPLETED|Overall Study||1
10216924|NCT04001517|11343953|FG003|NOT COMPLETED|Overall Study||3
10216925|NCT04006171|11343966|FG000|STARTED|Overall Study||48
10216926|NCT04006171|11343967|FG001|STARTED|Overall Study||42
10216927|NCT04006171|11343966|FG000|COMPLETED|Overall Study||36
10216928|NCT04006171|11343967|FG001|COMPLETED|Overall Study||30
10216929|NCT04006171|11343966|FG000|NOT COMPLETED|Overall Study||12
10216930|NCT04006171|11343967|FG001|NOT COMPLETED|Overall Study||12
10216931|NCT04011436|11343976|FG000|STARTED|Overall Study||20
10216932|NCT04011436|11343977|FG001|STARTED|Overall Study||20
10216933|NCT04011436|11343976|FG000|COMPLETED|Overall Study||19
10216934|NCT04011436|11343977|FG001|COMPLETED|Overall Study||19
10216935|NCT04011436|11343976|FG000|NOT COMPLETED|Overall Study||1
10216936|NCT04011436|11343977|FG001|NOT COMPLETED|Overall Study||1
10216937|NCT04011592|11343985|FG000|STARTED|Overall Study||1
10216938|NCT04011592|11343986|FG001|STARTED|Overall Study||0
10216939|NCT04011592|11343985|FG000|COMPLETED|Overall Study||1
10216940|NCT04011592|11343986|FG001|COMPLETED|Overall Study||0
10216941|NCT04011592|11343985|FG000|NOT COMPLETED|Overall Study||0
10216942|NCT04011592|11343986|FG001|NOT COMPLETED|Overall Study||0
10216943|NCT04013529|11343994|FG000|STARTED|Overall Study||20
10216944|NCT04013529|11343995|FG001|STARTED|Overall Study||20
10216945|NCT04013529|11343994|FG000|COMPLETED|Overall Study||19
10216946|NCT04013529|11343995|FG001|COMPLETED|Overall Study||19
10216947|NCT04013529|11343994|FG000|NOT COMPLETED|Overall Study||1
10216948|NCT04013529|11343995|FG001|NOT COMPLETED|Overall Study||1
10216949|NCT04016324|11344001|FG000|STARTED|Overall Study||110
10216950|NCT04016324|11344001|FG000|COMPLETED|Overall Study||107
10216951|NCT04016324|11344001|FG000|NOT COMPLETED|Overall Study||3
10216952|NCT04017910|11344006|FG000|STARTED|Overall Study||17
10216953|NCT04017910|11344006|FG000|COMPLETED|Overall Study||17
10216954|NCT04017910|11344006|FG000|NOT COMPLETED|Overall Study||0
10216955|NCT04018066|11344010|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34
10216956|NCT04018066|11344010|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30
10216957|NCT04018066|11344010|FG000|NOT COMPLETED|Overall Study||4
10216958|NCT04018794|11344015|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
10216959|NCT04018794|11344015|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
10216960|NCT04018794|11344015|FG000|NOT COMPLETED|Overall Study||0
10216961|NCT04032327|11344021|FG000|STARTED|Overall Study||60
10216962|NCT04032327|11344022|FG001|STARTED|Overall Study||60
10216963|NCT04032327|11344021|FG000|COMPLETED|Overall Study||60
10216964|NCT04032327|11344022|FG001|COMPLETED|Overall Study||60
10216965|NCT04032327|11344021|FG000|NOT COMPLETED|Overall Study||0
10216966|NCT04032327|11344022|FG001|NOT COMPLETED|Overall Study||0
10216967|NCT04033640|11344030|FG000|STARTED|Overall Study||1736
10216968|NCT04033640|11344031|FG001|STARTED|Overall Study||18
10216969|NCT04033640|11344030|FG000|COMPLETED|Overall Study||1736
10216970|NCT04033640|11344031|FG001|COMPLETED|Overall Study||18
10216971|NCT04033640|11344030|FG000|NOT COMPLETED|Overall Study||0
10216972|NCT04033640|11344031|FG001|NOT COMPLETED|Overall Study||0
10216973|NCT04036292|11344040|FG000|STARTED|Overall Study||260
10216974|NCT04036292|11344041|FG001|STARTED|Overall Study||246
10216975|NCT04036292|11344042|FG002|STARTED|Overall Study||252
10216976|NCT04036292|11344040|FG000|COMPLETED|Overall Study||239
10216977|NCT04036292|11344041|FG001|COMPLETED|Overall Study||212
10216978|NCT04036292|11344042|FG002|COMPLETED|Overall Study||228
10216979|NCT04036292|11344040|FG000|NOT COMPLETED|Overall Study||21
10216980|NCT04036292|11344041|FG001|NOT COMPLETED|Overall Study||34
10216981|NCT04036292|11344042|FG002|NOT COMPLETED|Overall Study||24
10216982|NCT04041440|11344055|FG000|STARTED|Overall Study||12
10216983|NCT04041440|11344056|FG001|STARTED|Overall Study||22
10216984|NCT04041440|11344055|FG000|COMPLETED|Overall Study||12
10216985|NCT04041440|11344056|FG001|COMPLETED|Overall Study||20
10216986|NCT04041440|11344055|FG000|NOT COMPLETED|Overall Study||0
10216987|NCT04041440|11344056|FG001|NOT COMPLETED|Overall Study||2
10216988|NCT04041570|11344065|FG000|STARTED|Overall Study||20
10216989|NCT04041570|11344066|FG001|STARTED|Overall Study||20
10216990|NCT04041570|11344065|FG000|COMPLETED|Overall Study||20
10216991|NCT04041570|11344066|FG001|COMPLETED|Overall Study||18
10012388|NCT01785186|11135174|FG001|STARTED|Overall Study||63
10012389|NCT01785186|11135175|FG002|STARTED|Overall Study||57
10012390|NCT01785186|11135176|FG003|STARTED|Overall Study||63
10012391|NCT01785186|11135177|FG004|STARTED|Overall Study||123
10012392|NCT01785186|11135173|FG000|COMPLETED|Overall Study||53
10216992|NCT04041570|11344065|FG000|NOT COMPLETED|Overall Study||0
10216993|NCT04041570|11344066|FG001|NOT COMPLETED|Overall Study||2
10216994|NCT04043143|11344075|FG000|STARTED|Overall Study||29
10216995|NCT04043143|11344076|FG001|STARTED|Overall Study||27
10216996|NCT04043143|11344075|FG000|COMPLETED|Overall Study||23
10216997|NCT04043143|11344076|FG001|COMPLETED|Overall Study||22
10216998|NCT04043143|11344075|FG000|NOT COMPLETED|Overall Study||6
10216999|NCT04043143|11344076|FG001|NOT COMPLETED|Overall Study||5
10217000|NCT04049123|11344082|FG000|STARTED|Period 1||5
10217001|NCT04049123|11344083|FG001|STARTED|Period 1||5
10217002|NCT04049123|11344084|FG002|STARTED|Period 1||5
10217003|NCT04049123|11344082|FG000|Received at Least One Dose of Study Drug|Period 1||5
10217004|NCT04049123|11344083|FG001|Received at Least One Dose of Study Drug|Period 1||5
10217005|NCT04049123|11344084|FG002|Received at Least One Dose of Study Drug|Period 1||5
10217006|NCT04049123|11344082|FG000|COMPLETED|Period 1||5
10217007|NCT04049123|11344083|FG001|COMPLETED|Period 1||5
10217008|NCT04049123|11344084|FG002|COMPLETED|Period 1||5
10217009|NCT04049123|11344082|FG000|NOT COMPLETED|Period 1||0
10217010|NCT04049123|11344083|FG001|NOT COMPLETED|Period 1||0
10217011|NCT04049123|11344084|FG002|NOT COMPLETED|Period 1||0
10217012|NCT04049123|11344082|FG000|STARTED|Period 2||5
10217013|NCT04049123|11344083|FG001|STARTED|Period 2||5
10217014|NCT04049123|11344084|FG002|STARTED|Period 2||5
10217015|NCT04049123|11344082|FG000|COMPLETED|Period 2||5
10217016|NCT04049123|11344083|FG001|COMPLETED|Period 2||5
10217017|NCT04049123|11344084|FG002|COMPLETED|Period 2||5
10012393|NCT01785186|11135174|FG001|COMPLETED|Overall Study||57
10012394|NCT01785186|11135175|FG002|COMPLETED|Overall Study||52
10217018|NCT04049123|11344082|FG000|NOT COMPLETED|Period 2||0
10217019|NCT04049123|11344083|FG001|NOT COMPLETED|Period 2||0
10217020|NCT04049123|11344084|FG002|NOT COMPLETED|Period 2||0
10217021|NCT04049123|11344082|FG000|STARTED|Period 3||5
10217022|NCT04049123|11344083|FG001|STARTED|Period 3||5
10217023|NCT04049123|11344084|FG002|STARTED|Period 3||5
10217024|NCT04049123|11344082|FG000|COMPLETED|Period 3||5
10217025|NCT04049123|11344083|FG001|COMPLETED|Period 3||5
10217026|NCT04049123|11344084|FG002|COMPLETED|Period 3||5
10217027|NCT04049123|11344082|FG000|NOT COMPLETED|Period 3||0
10217028|NCT04049123|11344083|FG001|NOT COMPLETED|Period 3||0
10217029|NCT04049123|11344084|FG002|NOT COMPLETED|Period 3||0
10217030|NCT04051463|11344094|FG000|STARTED|Overall Study||15
10217031|NCT04051463|11344095|FG001|STARTED|Overall Study||14
10217032|NCT04051463|11344094|FG000|COMPLETED|Overall Study||13
10217033|NCT04051463|11344095|FG001|COMPLETED|Overall Study||13
10217034|NCT04051463|11344094|FG000|NOT COMPLETED|Overall Study||2
10217035|NCT04051463|11344095|FG001|NOT COMPLETED|Overall Study||1
10217036|NCT04052204|11344101|FG000|STARTED|Overall Study||3
10217037|NCT04052204|11344102|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0
10217038|NCT04052204|11344103|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0
10217039|NCT04052204|11344101|FG000|COMPLETED|Overall Study||0
10217040|NCT04052204|11344102|FG001|COMPLETED|Overall Study||0
10217041|NCT04052204|11344103|FG002|COMPLETED|Overall Study||0
10217042|NCT04052204|11344101|FG000|NOT COMPLETED|Overall Study||3
10217043|NCT04052204|11344102|FG001|NOT COMPLETED|Overall Study||0
10217044|NCT04052204|11344103|FG002|NOT COMPLETED|Overall Study||0
10217045|NCT04054661|11344107|FG000|STARTED|Overall Study||229
10217046|NCT04054661|11344107|FG000|Enrolled in Repeatability Sub-study|Overall Study||15
10217047|NCT04054661|11344107|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3
10217048|NCT04054661|11344107|FG000|COMPLETED|Overall Study||229
10217049|NCT04054661|11344107|FG000|NOT COMPLETED|Overall Study||0
10217050|NCT04067011|11344123|FG000|STARTED|Overall Study||70
10217051|NCT04067011|11344124|FG001|STARTED|Overall Study||71
10217052|NCT04067011|11344125|FG002|STARTED|Overall Study||69
10217053|NCT04067011|11344123|FG000|COMPLETED|Overall Study||51
10217054|NCT04067011|11344124|FG001|COMPLETED|Overall Study||58
10217055|NCT04067011|11344125|FG002|COMPLETED|Overall Study||61
10217056|NCT04067011|11344123|FG000|NOT COMPLETED|Overall Study||19
10217057|NCT04067011|11344124|FG001|NOT COMPLETED|Overall Study||13
10217058|NCT04067011|11344125|FG002|NOT COMPLETED|Overall Study||8
10217059|NCT04072159|11344137|FG000|STARTED|Overall Study||16
10217060|NCT04072159|11344138|FG001|STARTED|Overall Study||17
10217061|NCT04072159|11344137|FG000|COMPLETED|Overall Study||8
10217062|NCT04072159|11344138|FG001|COMPLETED|Overall Study||11
10217063|NCT04072159|11344137|FG000|NOT COMPLETED|Overall Study||8
10217064|NCT04072159|11344138|FG001|NOT COMPLETED|Overall Study||6
10217065|NCT04085341|11344148|FG000|STARTED|Overall Study||10
10217066|NCT04085341|11344149|FG001|STARTED|Overall Study||11
10217067|NCT04085341|11344148|FG000|COMPLETED|Overall Study||10
10217068|NCT04085341|11344149|FG001|COMPLETED|Overall Study||11
10217069|NCT04085341|11344148|FG000|NOT COMPLETED|Overall Study||0
10217070|NCT04085341|11344149|FG001|NOT COMPLETED|Overall Study||0
10217071|NCT04094870|11344157|FG000|STARTED|Overall Study||40
10217072|NCT04094870|11344158|FG001|STARTED|Overall Study||40
10217073|NCT04094870|11344157|FG000|COMPLETED|Overall Study||39
10217074|NCT04094870|11344158|FG001|COMPLETED|Overall Study||39
10217075|NCT04094870|11344157|FG000|NOT COMPLETED|Overall Study||1
10217076|NCT04094870|11344158|FG001|NOT COMPLETED|Overall Study||1
10217077|NCT04096482|11344171|FG000|STARTED|Overall Study||6
10217078|NCT04096482|11344171|FG000|COMPLETED|Overall Study||6
10217079|NCT04096482|11344171|FG000|NOT COMPLETED|Overall Study||0
10217080|NCT04098172|11344177|FG000|STARTED|Overall Study||39
10012395|NCT01785186|11135176|FG003|COMPLETED|Overall Study||58
10012396|NCT01785186|11135177|FG004|COMPLETED|Overall Study||117
10012397|NCT01785186|11135173|FG000|NOT COMPLETED|Overall Study||6
10012398|NCT01785186|11135174|FG001|NOT COMPLETED|Overall Study||6
10012399|NCT01785186|11135175|FG002|NOT COMPLETED|Overall Study||5
10012400|NCT01785186|11135176|FG003|NOT COMPLETED|Overall Study||5
10012401|NCT01785186|11135177|FG004|NOT COMPLETED|Overall Study||6
10012402|NCT01785459|11135193|FG000|STARTED|Overall Study||11
10012403|NCT01785459|11135194|FG001|STARTED|Overall Study||12
10012404|NCT01785459|11135193|FG000|COMPLETED|Overall Study||11
10012405|NCT01785459|11135194|FG001|COMPLETED|Overall Study||12
10012406|NCT01785459|11135193|FG000|NOT COMPLETED|Overall Study||0
10217081|NCT04098172|11344177|FG000|COMPLETED|Overall Study||39
10217082|NCT04098172|11344177|FG000|NOT COMPLETED|Overall Study||0
10217083|NCT04103515|11344184|FG000|STARTED|Overall Study||25
10217084|NCT04103515|11344185|FG001|STARTED|Overall Study||25
10217085|NCT04103515|11344184|FG000|COMPLETED|Overall Study||25
10217086|NCT04103515|11344185|FG001|COMPLETED|Overall Study||25
10217087|NCT04103515|11344184|FG000|NOT COMPLETED|Overall Study||0
10012407|NCT01785459|11135194|FG001|NOT COMPLETED|Overall Study||0
10019026|NCT01827046|11142103|FG000|COMPLETED|Overall Study||249
10217088|NCT04103515|11344185|FG001|NOT COMPLETED|Overall Study||0
10217089|NCT04111276|11344191|FG000|STARTED|Overall Study||23
10217090|NCT04111276|11344191|FG000|COMPLETED|Overall Study||20
10217091|NCT04111276|11344191|FG000|NOT COMPLETED|Overall Study||3
10217092|NCT04123405|11344199|FG000|STARTED|Overall Study||235
10019027|NCT01827046|11142104|FG001|COMPLETED|Overall Study||240
10019028|NCT01827046|11142103|FG000|NOT COMPLETED|Overall Study||1
10019029|NCT01827046|11142104|FG001|NOT COMPLETED|Overall Study||9
10012408|NCT01785472|11135203|FG000|STARTED|Overall Study||479
10012409|NCT01785472|11135204|FG001|STARTED|Overall Study||473
10012410|NCT01785472|11135205|FG002|STARTED|Overall Study||486
10012411|NCT01785472|11135203|FG000|Full Analysis Set (FAS)|Overall Study||479
10012412|NCT01785472|11135204|FG001|Full Analysis Set (FAS)|Overall Study||472
10012413|NCT01785472|11135205|FG002|Full Analysis Set (FAS)|Overall Study||484
10012414|NCT01785472|11135203|FG000|Safety Set (SAF)|Overall Study||478
10012415|NCT01785472|11135204|FG001|Safety Set (SAF)|Overall Study||472
10012416|NCT01785472|11135205|FG002|Safety Set (SAF)|Overall Study||484
10012417|NCT01785472|11135203|FG000|COMPLETED|Overall Study||455
10012418|NCT01785472|11135204|FG001|COMPLETED|Overall Study||454
10012419|NCT01785472|11135205|FG002|COMPLETED|Overall Study||464
10012420|NCT01785472|11135203|FG000|NOT COMPLETED|Overall Study||24
10012421|NCT01785472|11135204|FG001|NOT COMPLETED|Overall Study||19
10012422|NCT01785472|11135205|FG002|NOT COMPLETED|Overall Study||22
10012423|NCT01785524|11135217|FG000|STARTED|Overall Study||7
10012424|NCT01785524|11135218|FG001|STARTED|Overall Study||4
10012425|NCT01785524|11135217|FG000|COMPLETED|Overall Study||5
10217093|NCT04123405|11344200|FG001|STARTED|Overall Study||238
10217094|NCT04123405|11344201|FG002|STARTED|Overall Study||238
10217095|NCT04123405|11344202|FG003|STARTED|Overall Study||233
10217096|NCT04123405|11344199|FG000|Full Analysis Set|Overall Study||235
10217097|NCT04123405|11344200|FG001|Full Analysis Set|Overall Study||236
10217098|NCT04123405|11344201|FG002|Full Analysis Set|Overall Study||238
10217099|NCT04123405|11344202|FG003|Full Analysis Set|Overall Study||230
10217100|NCT04123405|11344199|FG000|Per-protocol Set|Overall Study||213
10012426|NCT01785524|11135218|FG001|COMPLETED|Overall Study||2
10012427|NCT01785524|11135217|FG000|NOT COMPLETED|Overall Study||2
10012428|NCT01785524|11135218|FG001|NOT COMPLETED|Overall Study||2
10012429|NCT01785602|11135226|FG000|STARTED|Overall Study||76
10012430|NCT01785602|11135227|FG001|STARTED|Overall Study||27
10217101|NCT04123405|11344200|FG001|Per-protocol Set|Overall Study||215
10217102|NCT04123405|11344201|FG002|Per-protocol Set|Overall Study||212
10217103|NCT04123405|11344202|FG003|Per-protocol Set|Overall Study||207
10217104|NCT04123405|11344199|FG000|Safety Set|Overall Study||235
10217105|NCT04123405|11344200|FG001|Safety Set|Overall Study||238
10217106|NCT04123405|11344201|FG002|Safety Set|Overall Study||238
10217107|NCT04123405|11344202|FG003|Safety Set|Overall Study||233
10217108|NCT04123405|11344199|FG000|COMPLETED|Overall Study||231
10217109|NCT04123405|11344200|FG001|COMPLETED|Overall Study||231
10217110|NCT04123405|11344201|FG002|COMPLETED|Overall Study||235
10217111|NCT04123405|11344202|FG003|COMPLETED|Overall Study||225
10217112|NCT04123405|11344199|FG000|NOT COMPLETED|Overall Study||4
10217113|NCT04123405|11344200|FG001|NOT COMPLETED|Overall Study||7
10217114|NCT04123405|11344201|FG002|NOT COMPLETED|Overall Study||3
10217115|NCT04123405|11344202|FG003|NOT COMPLETED|Overall Study||8
10217116|NCT04128527|11344212|FG000|STARTED|Overall Study||16
10217117|NCT04128527|11344212|FG000|COMPLETED|Overall Study||16
10217118|NCT04128527|11344212|FG000|NOT COMPLETED|Overall Study||0
10217119|NCT04132973|11344216|FG000|STARTED|Overall Study||34
10217120|NCT04132973|11344216|FG000|Completed Intervention|Overall Study||11
10217121|NCT04132973|11344216|FG000|COMPLETED|Overall Study||8
10217122|NCT04132973|11344216|FG000|NOT COMPLETED|Overall Study||26
10217123|NCT04133415|11344220|FG000|STARTED|Overall Study||20
10217124|NCT04133415|11344220|FG000|COMPLETED|Overall Study||20
10217125|NCT04133415|11344220|FG000|NOT COMPLETED|Overall Study||0
10217126|NCT04138758|11344226|FG000|STARTED|Overall Study||2600
10217127|NCT04138758|11344227|FG001|STARTED|Overall Study||40353
10217128|NCT04138758|11344226|FG000|COMPLETED|Overall Study||2600
10217129|NCT04138758|11344227|FG001|COMPLETED|Overall Study||40353
10217130|NCT04138758|11344226|FG000|NOT COMPLETED|Overall Study||0
10217131|NCT04138758|11344227|FG001|NOT COMPLETED|Overall Study||0
10217132|NCT04147715|11344245|FG000|STARTED|Overall Study||12
10217133|NCT04147715|11344246|FG001|STARTED|Overall Study||6
10217134|NCT04147715|11344247|FG002|STARTED|Overall Study||6
10217135|NCT04147715|11344248|FG003|STARTED|Overall Study||8
10217136|NCT04147715|11344249|FG004|STARTED|Overall Study||6
10217137|NCT04147715|11344250|FG005|STARTED|Overall Study||6
10217138|NCT04147715|11344251|FG006|STARTED|Overall Study||6
10217139|NCT04147715|11344252|FG007|STARTED|Overall Study||4
10217140|NCT04147715|11344253|FG008|STARTED|Overall Study||8
10217141|NCT04147715|11344254|FG009|STARTED|Overall Study||8
10217142|NCT04147715|11344255|FG010|STARTED|Overall Study||14
10217143|NCT04147715|11344256|FG011|STARTED|Overall Study||14
10217144|NCT04147715|11344245|FG000|COMPLETED|Overall Study||12
10217145|NCT04147715|11344246|FG001|COMPLETED|Overall Study||6
10217146|NCT04147715|11344247|FG002|COMPLETED|Overall Study||6
10217147|NCT04147715|11344248|FG003|COMPLETED|Overall Study||8
10217148|NCT04147715|11344249|FG004|COMPLETED|Overall Study||6
10217149|NCT04147715|11344250|FG005|COMPLETED|Overall Study||6
10217150|NCT04147715|11344251|FG006|COMPLETED|Overall Study||6
10217151|NCT04147715|11344252|FG007|COMPLETED|Overall Study||2
10217152|NCT04147715|11344253|FG008|COMPLETED|Overall Study||7
10217153|NCT04147715|11344254|FG009|COMPLETED|Overall Study||8
10217154|NCT04147715|11344255|FG010|COMPLETED|Overall Study||14
10217155|NCT04147715|11344256|FG011|COMPLETED|Overall Study||14
10217156|NCT04147715|11344245|FG000|NOT COMPLETED|Overall Study||0
10217157|NCT04147715|11344246|FG001|NOT COMPLETED|Overall Study||0
10217158|NCT04147715|11344247|FG002|NOT COMPLETED|Overall Study||0
10217159|NCT04147715|11344248|FG003|NOT COMPLETED|Overall Study||0
10217160|NCT04147715|11344249|FG004|NOT COMPLETED|Overall Study||0
10217161|NCT04147715|11344250|FG005|NOT COMPLETED|Overall Study||0
10217162|NCT04147715|11344251|FG006|NOT COMPLETED|Overall Study||0
10217163|NCT04147715|11344252|FG007|NOT COMPLETED|Overall Study||2
10217164|NCT04147715|11344253|FG008|NOT COMPLETED|Overall Study||1
10217165|NCT04147715|11344254|FG009|NOT COMPLETED|Overall Study||0
10217166|NCT04147715|11344255|FG010|NOT COMPLETED|Overall Study||0
10217167|NCT04147715|11344256|FG011|NOT COMPLETED|Overall Study||0
10217168|NCT04154605|11344330|FG000|STARTED|Overall Study||68
10217169|NCT04154605|11344331|FG001|STARTED|Overall Study||65
10217170|NCT04154605|11344330|FG000|COMPLETED|Overall Study||65
10217171|NCT04154605|11344331|FG001|COMPLETED|Overall Study||63
10217172|NCT04154605|11344330|FG000|NOT COMPLETED|Overall Study||3
10217173|NCT04154605|11344331|FG001|NOT COMPLETED|Overall Study||2
10217174|NCT04160091|11344341|FG000|STARTED|Overall Study||7
10217175|NCT04160091|11344342|FG001|STARTED|Overall Study||3
10217176|NCT04160091|11344343|FG002|STARTED|Overall Study||5
10217177|NCT04160091|11344344|FG003|STARTED|Overall Study||4
10217178|NCT04160091|11344341|FG000|COMPLETED|Overall Study||0
10217179|NCT04160091|11344342|FG001|COMPLETED|Overall Study||0
10217180|NCT04160091|11344343|FG002|COMPLETED|Overall Study||0
10217181|NCT04160091|11344344|FG003|COMPLETED|Overall Study||0
10217182|NCT04160091|11344341|FG000|NOT COMPLETED|Overall Study||7
10217183|NCT04160091|11344342|FG001|NOT COMPLETED|Overall Study||3
10217184|NCT04160091|11344343|FG002|NOT COMPLETED|Overall Study||5
10217185|NCT04160091|11344344|FG003|NOT COMPLETED|Overall Study||4
10217186|NCT04160260|11344354|FG000|STARTED|Overall Study||18
10217187|NCT04160260|11344354|FG000|COMPLETED|Overall Study||18
10217188|NCT04160260|11344354|FG000|NOT COMPLETED|Overall Study||0
10217189|NCT04164758|11344361|FG000|STARTED|Overall Study||4
10217190|NCT04164758|11344362|FG001|STARTED|Overall Study||4
10217191|NCT04164758|11344363|FG002|STARTED|Overall Study||3
10217192|NCT04164758|11344361|FG000|COMPLETED|Overall Study||3
10217193|NCT04164758|11344362|FG001|COMPLETED|Overall Study||3
10217194|NCT04164758|11344363|FG002|COMPLETED|Overall Study||3
10217195|NCT04164758|11344361|FG000|NOT COMPLETED|Overall Study||1
10217196|NCT04164758|11344362|FG001|NOT COMPLETED|Overall Study||1
10217197|NCT04164758|11344363|FG002|NOT COMPLETED|Overall Study||0
10217198|NCT04165031|11344377|FG000|STARTED|Overall Study||2
10217199|NCT04165031|11344378|FG001|STARTED|Overall Study||1
10217200|NCT04165031|11344379|FG002|STARTED|Overall Study||2
10217201|NCT04165031|11344380|FG003|STARTED|Overall Study||0
10217202|NCT04165031|11344381|FG004|STARTED|Overall Study||0
10217203|NCT04165031|11344382|FG005|STARTED|Overall Study||0
10217204|NCT04165031|11344377|FG000|Received at Least One Dose of Study Drug|Overall Study||2
10217205|NCT04165031|11344378|FG001|Received at Least One Dose of Study Drug|Overall Study||1
10217206|NCT04165031|11344379|FG002|Received at Least One Dose of Study Drug|Overall Study||2
10217207|NCT04165031|11344380|FG003|Received at Least One Dose of Study Drug|Overall Study||0
10217208|NCT04165031|11344381|FG004|Received at Least One Dose of Study Drug|Overall Study||0
10217209|NCT04165031|11344382|FG005|Received at Least One Dose of Study Drug|Overall Study||0
10217210|NCT04165031|11344377|FG000|COMPLETED|Overall Study||1
10217211|NCT04165031|11344378|FG001|COMPLETED|Overall Study||0
10217212|NCT04165031|11344379|FG002|COMPLETED|Overall Study||1
10217213|NCT04165031|11344380|FG003|COMPLETED|Overall Study||0
10217214|NCT04165031|11344381|FG004|COMPLETED|Overall Study||0
10217215|NCT04165031|11344382|FG005|COMPLETED|Overall Study||0
10217216|NCT04165031|11344377|FG000|NOT COMPLETED|Overall Study||1
10217217|NCT04165031|11344378|FG001|NOT COMPLETED|Overall Study||1
10217218|NCT04165031|11344379|FG002|NOT COMPLETED|Overall Study||1
10217219|NCT04165031|11344380|FG003|NOT COMPLETED|Overall Study||0
10217220|NCT04165031|11344381|FG004|NOT COMPLETED|Overall Study||0
10217221|NCT04165031|11344382|FG005|NOT COMPLETED|Overall Study||0
10217222|NCT04166032|11344397|FG000|STARTED|Overall Study||15
10217223|NCT04166032|11344397|FG000|COMPLETED|Overall Study||14
10217224|NCT04166032|11344397|FG000|NOT COMPLETED|Overall Study||1
10217225|NCT04171414|11344401|FG000|STARTED|Overall Study||62
10217226|NCT04171414|11344401|FG000|COMPLETED|Overall Study||60
10217227|NCT04171414|11344401|FG000|NOT COMPLETED|Overall Study||2
10217228|NCT04175808|11344405|FG000|STARTED|Part A||70
10217229|NCT04175808|11344406|FG001|STARTED|Part A||0
10217230|NCT04175808|11344407|FG002|STARTED|Part A||0
10217231|NCT04175808|11344408|FG003|STARTED|Part A||0
10217232|NCT04175808|11344409|FG004|STARTED|Part A||0
10217233|NCT04175808|11344410|FG005|STARTED|Part A||0
10217234|NCT04175808|11344411|FG006|STARTED|Part A||0
10217235|NCT04175808|11344405|FG000|COMPLETED|Part A||68
10217236|NCT04175808|11344406|FG001|COMPLETED|Part A||0
10217237|NCT04175808|11344407|FG002|COMPLETED|Part A||0
10217238|NCT04175808|11344408|FG003|COMPLETED|Part A||0
9952085|NCT01419665|11070986|FG001|NOT COMPLETED|Combination Treatment||41
9952086|NCT01419665|11070985|FG000|STARTED|Maintenance Treatment and/or Follow up||254
9952087|NCT01419665|11070986|FG001|STARTED|Maintenance Treatment and/or Follow up||252
9952088|NCT01419665|11070985|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132
10217239|NCT04175808|11344409|FG004|COMPLETED|Part A||0
10217240|NCT04175808|11344410|FG005|COMPLETED|Part A||0
10217241|NCT04175808|11344411|FG006|COMPLETED|Part A||0
10217242|NCT04175808|11344405|FG000|NOT COMPLETED|Part A||2
10217243|NCT04175808|11344406|FG001|NOT COMPLETED|Part A||0
10217244|NCT04175808|11344407|FG002|NOT COMPLETED|Part A||0
10217245|NCT04175808|11344408|FG003|NOT COMPLETED|Part A||0
10217246|NCT04175808|11344409|FG004|NOT COMPLETED|Part A||0
10217247|NCT04175808|11344410|FG005|NOT COMPLETED|Part A||0
10217248|NCT04175808|11344411|FG006|NOT COMPLETED|Part A||0
10217249|NCT04175808|11344405|FG000|STARTED|Part B||0
10217250|NCT04175808|11344406|FG001|STARTED|Part B||10
10217251|NCT04175808|11344407|FG002|STARTED|Part B||10
10217252|NCT04175808|11344408|FG003|STARTED|Part B||10
10217253|NCT04175808|11344409|FG004|STARTED|Part B||10
10217254|NCT04175808|11344410|FG005|STARTED|Part B||10
10217255|NCT04175808|11344411|FG006|STARTED|Part B||10
10217256|NCT04175808|11344405|FG000|COMPLETED|Part B||0
10217257|NCT04175808|11344406|FG001|COMPLETED|Part B||10
10217258|NCT04175808|11344407|FG002|COMPLETED|Part B||10
10217259|NCT04175808|11344408|FG003|COMPLETED|Part B||10
10217260|NCT04175808|11344409|FG004|COMPLETED|Part B||10
10217261|NCT04175808|11344410|FG005|COMPLETED|Part B||10
10217262|NCT04175808|11344411|FG006|COMPLETED|Part B||10
10217263|NCT04175808|11344405|FG000|NOT COMPLETED|Part B||0
10217264|NCT04175808|11344406|FG001|NOT COMPLETED|Part B||0
10217265|NCT04175808|11344407|FG002|NOT COMPLETED|Part B||0
10217266|NCT04175808|11344408|FG003|NOT COMPLETED|Part B||0
10217267|NCT04175808|11344409|FG004|NOT COMPLETED|Part B||0
10217268|NCT04175808|11344410|FG005|NOT COMPLETED|Part B||0
10217269|NCT04175808|11344411|FG006|NOT COMPLETED|Part B||0
10217270|NCT04178720|11344429|FG000|STARTED|Overall Study||40
10217271|NCT04178720|11344430|FG001|STARTED|Overall Study||78
10217272|NCT04178720|11344429|FG000|COMPLETED|Overall Study||38
10217273|NCT04178720|11344430|FG001|COMPLETED|Overall Study||77
10217274|NCT04178720|11344429|FG000|NOT COMPLETED|Overall Study||2
10217275|NCT04178720|11344430|FG001|NOT COMPLETED|Overall Study||1
10217276|NCT04184297|11344441|FG000|STARTED|Overall Study||2864
9952089|NCT01419665|11070986|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150
9952090|NCT01419665|11070985|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
10217277|NCT04184297|11344442|FG001|STARTED|Overall Study||24326
10217278|NCT04184297|11344441|FG000|COMPLETED|Overall Study||2864
10217279|NCT04184297|11344442|FG001|COMPLETED|Overall Study||24326
10217280|NCT04184297|11344441|FG000|NOT COMPLETED|Overall Study||0
10217281|NCT04184297|11344442|FG001|NOT COMPLETED|Overall Study||0
10217282|NCT04189848|11344448|FG000|STARTED|Treatment Period 1 (Day 1)||26
10217283|NCT04189848|11344449|FG001|STARTED|Treatment Period 1 (Day 1)||26
10217284|NCT04189848|11344450|FG002|STARTED|Treatment Period 1 (Day 1)||25
10217285|NCT04189848|11344451|FG003|STARTED|Treatment Period 1 (Day 1)||27
10217286|NCT04189848|11344448|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
10217287|NCT04189848|11344449|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
10217288|NCT04189848|11344450|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
10217289|NCT04189848|11344451|FG003|COMPLETED|Treatment Period 1 (Day 1)||27
10217290|NCT04189848|11344448|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10217291|NCT04189848|11344449|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10217292|NCT04189848|11344450|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10217293|NCT04189848|11344451|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10217294|NCT04189848|11344448|FG000|STARTED|Treatment Period 2 (Day 1)||26
10217295|NCT04189848|11344449|FG001|STARTED|Treatment Period 2 (Day 1)||26
10217296|NCT04189848|11344450|FG002|STARTED|Treatment Period 2 (Day 1)||25
10217297|NCT04189848|11344451|FG003|STARTED|Treatment Period 2 (Day 1)||27
10217298|NCT04189848|11344448|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
10217299|NCT04189848|11344449|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
10217300|NCT04189848|11344450|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
10217301|NCT04189848|11344451|FG003|COMPLETED|Treatment Period 2 (Day 1)||27
10217302|NCT04189848|11344448|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10217303|NCT04189848|11344449|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10217304|NCT04189848|11344450|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10217305|NCT04189848|11344451|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10217306|NCT04210232|11344456|FG000|STARTED|Overall Study||54
10217307|NCT04210232|11344456|FG000|COMPLETED|Overall Study||54
10217308|NCT04210232|11344456|FG000|NOT COMPLETED|Overall Study||0
10217309|NCT04211909|11344462|FG000|STARTED|Overall Study||54
10217310|NCT04211909|11344463|FG001|STARTED|Overall Study||33
10217311|NCT04211909|11344462|FG000|COMPLETED|Overall Study||54
10217312|NCT04211909|11344463|FG001|COMPLETED|Overall Study||33
10217313|NCT04211909|11344462|FG000|NOT COMPLETED|Overall Study||0
10217314|NCT04211909|11344463|FG001|NOT COMPLETED|Overall Study||0
10217315|NCT04218110|11344473|FG000|STARTED|Overall Study||82
10217316|NCT04218110|11344474|FG001|STARTED|Overall Study||81
10217317|NCT04218110|11344475|FG002|STARTED|Overall Study||83
10217318|NCT04218110|11344476|FG003|STARTED|Overall Study||83
10217319|NCT04218110|11344473|FG000|Received Treatment|Overall Study||82
10217320|NCT04218110|11344474|FG001|Received Treatment|Overall Study||81
10217321|NCT04218110|11344475|FG002|Received Treatment|Overall Study||83
10217322|NCT04218110|11344476|FG003|Received Treatment|Overall Study||82
10217323|NCT04218110|11344473|FG000|COMPLETED|Overall Study||82
10217324|NCT04218110|11344474|FG001|COMPLETED|Overall Study||81
10217325|NCT04218110|11344475|FG002|COMPLETED|Overall Study||83
10217326|NCT04218110|11344476|FG003|COMPLETED|Overall Study||82
10217327|NCT04218110|11344473|FG000|NOT COMPLETED|Overall Study||0
10217328|NCT04218110|11344474|FG001|NOT COMPLETED|Overall Study||0
10217329|NCT04218110|11344475|FG002|NOT COMPLETED|Overall Study||0
10217330|NCT04218110|11344476|FG003|NOT COMPLETED|Overall Study||1
10217331|NCT04222725|11344490|FG000|STARTED|Overall Study||8
10217332|NCT04222725|11344491|FG001|STARTED|Overall Study||10
10217333|NCT04222725|11344492|FG002|STARTED|Overall Study||9
10217334|NCT04222725|11344493|FG003|STARTED|Overall Study||10
10217335|NCT04222725|11344490|FG000|COMPLETED|Overall Study||8
10217336|NCT04222725|11344491|FG001|COMPLETED|Overall Study||9
10217337|NCT04222725|11344492|FG002|COMPLETED|Overall Study||9
10217338|NCT04222725|11344493|FG003|COMPLETED|Overall Study||10
10217339|NCT04222725|11344490|FG000|NOT COMPLETED|Overall Study||0
10217340|NCT04222725|11344491|FG001|NOT COMPLETED|Overall Study||1
10217341|NCT04222725|11344492|FG002|NOT COMPLETED|Overall Study||0
10217342|NCT04222725|11344493|FG003|NOT COMPLETED|Overall Study||0
10217343|NCT04223843|11344507|FG000|STARTED|Overall Study||55
10217344|NCT04223843|11344508|FG001|STARTED|Overall Study||55
10217345|NCT04223843|11344509|FG002|STARTED|Overall Study||51
10217346|NCT04223843|11344510|FG003|STARTED|Overall Study||52
10217347|NCT04223843|11344507|FG000|COMPLETED|Overall Study||55
10217348|NCT04223843|11344508|FG001|COMPLETED|Overall Study||55
10217349|NCT04223843|11344509|FG002|COMPLETED|Overall Study||51
10217350|NCT04223843|11344510|FG003|COMPLETED|Overall Study||52
10217351|NCT04223843|11344507|FG000|NOT COMPLETED|Overall Study||0
10217352|NCT04223843|11344508|FG001|NOT COMPLETED|Overall Study||0
10217353|NCT04223843|11344509|FG002|NOT COMPLETED|Overall Study||0
10217354|NCT04223843|11344510|FG003|NOT COMPLETED|Overall Study||0
10217355|NCT04229303|11344527|FG000|STARTED|Overall Study||6
10217356|NCT04229303|11344528|FG001|STARTED|Overall Study||6
10217357|NCT04229303|11344529|FG002|STARTED|Overall Study||6
10217358|NCT04229303|11344530|FG003|STARTED|Overall Study||6
10217359|NCT04229303|11344531|FG004|STARTED|Overall Study||6
10217360|NCT04229303|11344532|FG005|STARTED|Overall Study||6
10217361|NCT04229303|11344533|FG006|STARTED|Overall Study||6
10217362|NCT04229303|11344534|FG007|STARTED|Overall Study||8
10217363|NCT04229303|11344535|FG008|STARTED|Overall Study||8
10217364|NCT04229303|11344527|FG000|COMPLETED|Overall Study||6
10217365|NCT04229303|11344528|FG001|COMPLETED|Overall Study||6
10217366|NCT04229303|11344529|FG002|COMPLETED|Overall Study||6
10217367|NCT04229303|11344530|FG003|COMPLETED|Overall Study||6
10217368|NCT04229303|11344531|FG004|COMPLETED|Overall Study||6
10217369|NCT04229303|11344532|FG005|COMPLETED|Overall Study||6
10217370|NCT04229303|11344533|FG006|COMPLETED|Overall Study||6
10217371|NCT04229303|11344534|FG007|COMPLETED|Overall Study||8
10217372|NCT04229303|11344535|FG008|COMPLETED|Overall Study||8
10217373|NCT04229303|11344527|FG000|NOT COMPLETED|Overall Study||0
10217374|NCT04229303|11344528|FG001|NOT COMPLETED|Overall Study||0
10217375|NCT04229303|11344529|FG002|NOT COMPLETED|Overall Study||0
10217376|NCT04229303|11344530|FG003|NOT COMPLETED|Overall Study||0
10217377|NCT04229303|11344531|FG004|NOT COMPLETED|Overall Study||0
10217378|NCT04229303|11344532|FG005|NOT COMPLETED|Overall Study||0
10217379|NCT04229303|11344533|FG006|NOT COMPLETED|Overall Study||0
10217380|NCT04229303|11344534|FG007|NOT COMPLETED|Overall Study||0
10217381|NCT04229303|11344535|FG008|NOT COMPLETED|Overall Study||0
10217382|NCT04243421|11344563|FG000|STARTED|Overall Study||30
10217383|NCT04243421|11344563|FG000|COMPLETED|Overall Study||30
10217384|NCT04243421|11344563|FG000|NOT COMPLETED|Overall Study||0
10217385|NCT04256603|11344570|FG000|STARTED|Overall Study||21
10217386|NCT04256603|11344571|FG001|STARTED|Overall Study||6
10217387|NCT04256603|11344570|FG000|COMPLETED|Overall Study||21
10217388|NCT04256603|11344571|FG001|COMPLETED|Overall Study||6
10217389|NCT04256603|11344570|FG000|NOT COMPLETED|Overall Study||0
10217390|NCT04256603|11344571|FG001|NOT COMPLETED|Overall Study||0
10217391|NCT04258995|11344579|FG000|STARTED|Overall Study||76
10217392|NCT04258995|11344580|FG001|STARTED|Overall Study||75
10217393|NCT04258995|11344579|FG000|Vaccinated|Overall Study||76
10217394|NCT04258995|11344580|FG001|Vaccinated|Overall Study||75
10217395|NCT04258995|11344579|FG000|COMPLETED|Overall Study||75
10217396|NCT04258995|11344580|FG001|COMPLETED|Overall Study||74
10217397|NCT04258995|11344579|FG000|NOT COMPLETED|Overall Study||1
10217398|NCT04258995|11344580|FG001|NOT COMPLETED|Overall Study||1
10217399|NCT04280445|11344586|FG000|STARTED|Overall Study||3
10217400|NCT04280445|11344586|FG000|COMPLETED|Overall Study||3
10217401|NCT04280445|11344586|FG000|NOT COMPLETED|Overall Study||0
10217402|NCT04285489|11344590|FG000|STARTED|Overall Study||130
10217403|NCT04285489|11344590|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130
10217404|NCT04285489|11344590|FG000|NOT COMPLETED|Overall Study||0
10217405|NCT04290494|11344597|FG000|STARTED|Overall Study||10968
10217406|NCT04290494|11344598|FG001|STARTED|Overall Study||17823
10217407|NCT04290494|11344599|FG002|STARTED|Overall Study||13397
10217408|NCT04290494|11344597|FG000|COMPLETED|Overall Study||10968
10217409|NCT04290494|11344598|FG001|COMPLETED|Overall Study||17823
10217410|NCT04290494|11344599|FG002|COMPLETED|Overall Study||13397
10217411|NCT04290494|11344597|FG000|NOT COMPLETED|Overall Study||0
10217412|NCT04290494|11344598|FG001|NOT COMPLETED|Overall Study||0
10217413|NCT04290494|11344599|FG002|NOT COMPLETED|Overall Study||0
10217414|NCT04303156|11344609|FG000|STARTED|Overall Study||6
10217415|NCT04303156|11344610|FG001|STARTED|Overall Study||6
9760781|NCT00383188|10864577|FG002|STARTED|Overall Study||44
9760782|NCT00383188|10864578|FG003|STARTED|Overall Study||40
9760783|NCT00383188|10864579|FG004|STARTED|Overall Study||75
9760784|NCT00383188|10864575|FG000|COMPLETED|Overall Study||52
9760785|NCT00383188|10864576|FG001|COMPLETED|Overall Study||63
9760786|NCT00383188|10864577|FG002|COMPLETED|Overall Study||31
9760787|NCT00383188|10864578|FG003|COMPLETED|Overall Study||28
9760788|NCT00383188|10864579|FG004|COMPLETED|Overall Study||52
9760789|NCT00383188|10864575|FG000|NOT COMPLETED|Overall Study||17
9760790|NCT00383188|10864576|FG001|NOT COMPLETED|Overall Study||11
9760791|NCT00383188|10864577|FG002|NOT COMPLETED|Overall Study||13
9760792|NCT00383188|10864578|FG003|NOT COMPLETED|Overall Study||12
9760793|NCT00383188|10864579|FG004|NOT COMPLETED|Overall Study||23
9760794|NCT00383266|10864593|FG000|STARTED|Overall Study||9
9760795|NCT00383266|10864593|FG000|COMPLETED|Overall Study||9
9760796|NCT00383266|10864593|FG000|NOT COMPLETED|Overall Study||0
9760797|NCT00383292|10864600|FG000|STARTED|Overall Study||68
9760798|NCT00383292|10864601|FG001|STARTED|Overall Study||32
9760799|NCT00383292|10864602|FG002|STARTED|Overall Study||30
9760800|NCT00383292|10864600|FG000|Received at Least One Dose of Study Drug|Overall Study||68
9760801|NCT00383292|10864601|FG001|Received at Least One Dose of Study Drug|Overall Study||32
9760802|NCT00383292|10864602|FG002|Received at Least One Dose of Study Drug|Overall Study||30
9760803|NCT00383292|10864600|FG000|COMPLETED|Overall Study||53
9760804|NCT00383292|10864601|FG001|COMPLETED|Overall Study||26
9760805|NCT00383292|10864602|FG002|COMPLETED|Overall Study||22
9760806|NCT00383292|10864600|FG000|NOT COMPLETED|Overall Study||15
9760807|NCT00383292|10864601|FG001|NOT COMPLETED|Overall Study||6
9760808|NCT00383292|10864602|FG002|NOT COMPLETED|Overall Study||8
9760809|NCT00383331|10864613|FG000|STARTED|Overall Study||10
9760810|NCT00383331|10864614|FG001|STARTED|Overall Study||9
9760811|NCT00383331|10864613|FG000|COMPLETED|Overall Study||10
9760812|NCT00383331|10864614|FG001|COMPLETED|Overall Study||8
9760813|NCT00383331|10864613|FG000|NOT COMPLETED|Overall Study||0
9760814|NCT00383331|10864614|FG001|NOT COMPLETED|Overall Study||1
9760815|NCT00383448|10864620|FG000|STARTED|Overall Study||38
9760816|NCT00383448|10864620|FG000|COMPLETED|Overall Study||38
9760817|NCT00383448|10864620|FG000|NOT COMPLETED|Overall Study||0
9760818|NCT00383500|10864628|FG000|STARTED|Overall Study||27
9760819|NCT00383500|10864629|FG001|STARTED|Overall Study||24
9760820|NCT00383500|10864630|FG002|STARTED|Overall Study||24
9760821|NCT00383500|10864628|FG000|COMPLETED|Overall Study||19
9760822|NCT00383500|10864629|FG001|COMPLETED|Overall Study||21
9760823|NCT00383500|10864630|FG002|COMPLETED|Overall Study||22
9760824|NCT00383500|10864628|FG000|NOT COMPLETED|Overall Study||8
9760825|NCT00383500|10864629|FG001|NOT COMPLETED|Overall Study||3
9760826|NCT00383500|10864630|FG002|NOT COMPLETED|Overall Study||2
9760827|NCT00383565|10864639|FG000|STARTED|Overall Study||9
9760828|NCT00383565|10864639|FG000|COMPLETED|Overall Study||9
9760829|NCT00383565|10864639|FG000|NOT COMPLETED|Overall Study||0
9760830|NCT00383643|10864646|FG000|STARTED|Overall Study||18
9760831|NCT00383643|10864647|FG001|STARTED|Overall Study||16
9760832|NCT00383643|10864648|FG002|STARTED|Overall Study||14
9760833|NCT00383643|10864646|FG000|COMPLETED|Overall Study||17
9760834|NCT00383643|10864647|FG001|COMPLETED|Overall Study||15
9760835|NCT00383643|10864648|FG002|COMPLETED|Overall Study||13
9760836|NCT00383643|10864646|FG000|NOT COMPLETED|Overall Study||1
9760837|NCT00383643|10864647|FG001|NOT COMPLETED|Overall Study||1
9760838|NCT00383643|10864648|FG002|NOT COMPLETED|Overall Study||1
9760839|NCT00383747|10864658|FG000|STARTED|Visit 1||14
9760840|NCT00383747|10864659|FG001|STARTED|Visit 1||14
9760841|NCT00383747|10864660|FG002|STARTED|Visit 1||16
9760842|NCT00383747|10864661|FG003|STARTED|Visit 1||16
9760843|NCT00383747|10864658|FG000|COMPLETED|Visit 1||14
9760844|NCT00383747|10864659|FG001|COMPLETED|Visit 1||14
9760845|NCT00383747|10864660|FG002|COMPLETED|Visit 1||16
9760846|NCT00383747|10864661|FG003|COMPLETED|Visit 1||16
9760847|NCT00383747|10864658|FG000|NOT COMPLETED|Visit 1||0
9760848|NCT00383747|10864659|FG001|NOT COMPLETED|Visit 1||0
10217416|NCT04303156|11344609|FG000|COMPLETED|Overall Study||6
10217417|NCT04303156|11344610|FG001|COMPLETED|Overall Study||6
10217418|NCT04303156|11344609|FG000|NOT COMPLETED|Overall Study||0
10217419|NCT04303156|11344610|FG001|NOT COMPLETED|Overall Study||0
10217420|NCT04317040|11344619|FG000|STARTED|Overall Study||116
10217421|NCT04317040|11344620|FG001|STARTED|Overall Study||118
10217422|NCT04317040|11344619|FG000|Treated|Overall Study||114
10217423|NCT04317040|11344620|FG001|Treated|Overall Study||115
10217424|NCT04317040|11344619|FG000|COMPLETED|Overall Study||98
10217425|NCT04317040|11344620|FG001|COMPLETED|Overall Study||98
10217426|NCT04317040|11344619|FG000|NOT COMPLETED|Overall Study||18
10217427|NCT04317040|11344620|FG001|NOT COMPLETED|Overall Study||20
10217428|NCT04317313|11344628|FG000|STARTED|Overall Study||100
10217429|NCT04317313|11344629|FG001|STARTED|Overall Study||52
10217430|NCT04317313|11344628|FG000|COMPLETED|Overall Study||100
10217431|NCT04317313|11344629|FG001|COMPLETED|Overall Study||52
10217432|NCT04317313|11344628|FG000|NOT COMPLETED|Overall Study||0
10217433|NCT04317313|11344629|FG001|NOT COMPLETED|Overall Study||0
10217434|NCT04319159|11344637|FG000|STARTED|Overall Study||48
10217435|NCT04319159|11344637|FG000|COMPLETED|Overall Study||32
10217436|NCT04319159|11344637|FG000|NOT COMPLETED|Overall Study||16
10217437|NCT04321239|11344645|FG000|STARTED|Overall Study||25
10217438|NCT04321239|11344646|FG001|STARTED|Overall Study||26
10217439|NCT04321239|11344645|FG000|COMPLETED|Overall Study||22
10217440|NCT04321239|11344646|FG001|COMPLETED|Overall Study||24
10217441|NCT04321239|11344645|FG000|NOT COMPLETED|Overall Study||3
10217442|NCT04321239|11344646|FG001|NOT COMPLETED|Overall Study||2
10217443|NCT04323852|11344654|FG000|STARTED|Overall Study||35
10217444|NCT04323852|11344655|FG001|STARTED|Overall Study||35
10217445|NCT04323852|11344654|FG000|COMPLETED|Overall Study||35
10217446|NCT04323852|11344655|FG001|COMPLETED|Overall Study||35
10217447|NCT04323852|11344654|FG000|NOT COMPLETED|Overall Study||0
10217448|NCT04323852|11344655|FG001|NOT COMPLETED|Overall Study||0
10217449|NCT04327843|11344661|FG000|STARTED|Baseline Assessment||19
10217450|NCT04327843|11344661|FG000|COMPLETED|Baseline Assessment||19
10217451|NCT04327843|11344661|FG000|NOT COMPLETED|Baseline Assessment||0
10217452|NCT04327843|11344661|FG000|STARTED|Week 13 Assessment||19
10217453|NCT04327843|11344661|FG000|COMPLETED|Week 13 Assessment||19
10217454|NCT04327843|11344661|FG000|NOT COMPLETED|Week 13 Assessment||0
10217455|NCT04327843|11344661|FG000|STARTED|Week 25 Assessment||19
10217456|NCT04327843|11344661|FG000|COMPLETED|Week 25 Assessment||18
10217457|NCT04327843|11344661|FG000|NOT COMPLETED|Week 25 Assessment||1
10239016|NCT00391430|11370514|FG002|NOT COMPLETED|Overall Study||12
10239017|NCT00399841|11370522|FG000|STARTED|Overall Study||13
10239018|NCT00399841|11370523|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239019|NCT00399841|11370524|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239020|NCT00399841|11370522|FG000|Permanent Implant|Overall Study||6
10239021|NCT00399841|11370523|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239022|NCT00399841|11370524|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239023|NCT00399841|11370522|FG000|12-week|Overall Study||2
10239024|NCT00399841|11370523|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239025|NCT00399841|11370524|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239026|NCT00399841|11370522|FG000|COMPLETED|Overall Study||1
10239027|NCT00399841|11370523|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239028|NCT00399841|11370524|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10239029|NCT00399841|11370522|FG000|NOT COMPLETED|Overall Study||12
10239030|NCT00399841|11370523|FG001|NOT COMPLETED|Overall Study||0
10239031|NCT00399841|11370524|FG002|NOT COMPLETED|Overall Study||0
10239032|NCT00387673|11370529|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10239033|NCT00387673|11370530|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10239034|NCT00387673|11370531|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10239035|NCT00387673|11370529|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10239036|NCT00387673|11370530|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10239037|NCT00387673|11370531|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
9760849|NCT00383747|10864660|FG002|NOT COMPLETED|Visit 1||0
9760850|NCT00383747|10864661|FG003|NOT COMPLETED|Visit 1||0
9760851|NCT00383747|10864658|FG000|STARTED|Visit 2||14
9760852|NCT00383747|10864659|FG001|STARTED|Visit 2||14
10217458|NCT04331899|11344667|FG000|STARTED|Trial Period (28 Days)||60
10217459|NCT04331899|11344668|FG001|STARTED|Trial Period (28 Days)||60
10217460|NCT04331899|11344667|FG000|COMPLETED|Trial Period (28 Days)||58
10217461|NCT04331899|11344668|FG001|COMPLETED|Trial Period (28 Days)||58
10217462|NCT04331899|11344667|FG000|NOT COMPLETED|Trial Period (28 Days)||2
10217463|NCT04331899|11344668|FG001|NOT COMPLETED|Trial Period (28 Days)||2
10217464|NCT04331899|11344667|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42
10217465|NCT04331899|11344668|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43
10217466|NCT04331899|11344667|FG000|COMPLETED|Follow-up Period (10 Months)||42
10217467|NCT04331899|11344668|FG001|COMPLETED|Follow-up Period (10 Months)||43
10217468|NCT04331899|11344667|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0
10217469|NCT04331899|11344668|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0
10217470|NCT04334148|11344676|FG000|STARTED|Overall Study||683
10217471|NCT04334148|11344677|FG001|STARTED|Overall Study||677
10217472|NCT04334148|11344676|FG000|COMPLETED|Overall Study||683
10217473|NCT04334148|11344677|FG001|COMPLETED|Overall Study||676
10217474|NCT04334148|11344676|FG000|NOT COMPLETED|Overall Study||0
10217475|NCT04334148|11344677|FG001|NOT COMPLETED|Overall Study||1
10217476|NCT04343287|11344685|FG000|STARTED|Overall Study||108
10217477|NCT04343287|11344686|FG001|STARTED|Overall Study||112
10217478|NCT04343287|11344685|FG000|COMPLETED|Overall Study||108
10217479|NCT04343287|11344686|FG001|COMPLETED|Overall Study||111
10217480|NCT04343287|11344685|FG000|NOT COMPLETED|Overall Study||0
10217481|NCT04343287|11344686|FG001|NOT COMPLETED|Overall Study||1
10217482|NCT04347954|11344697|FG000|STARTED|Overall Study||15
10217483|NCT04347954|11344698|FG001|STARTED|Overall Study||15
10217484|NCT04347954|11344699|FG002|STARTED|Overall Study||17
10217485|NCT04347954|11344697|FG000|Received Allocated Intervention|Overall Study||12
10217486|NCT04347954|11344698|FG001|Received Allocated Intervention|Overall Study||15
10217487|NCT04347954|11344699|FG002|Received Allocated Intervention|Overall Study||14
10217488|NCT04347954|11344697|FG000|Negative PCR Swab at Baseline|Overall Study||1
10217489|NCT04347954|11344698|FG001|Negative PCR Swab at Baseline|Overall Study||3
10217490|NCT04347954|11344699|FG002|Negative PCR Swab at Baseline|Overall Study||1
10217491|NCT04347954|11344697|FG000|COMPLETED|Overall Study||12
10217492|NCT04347954|11344698|FG001|COMPLETED|Overall Study||14
10217493|NCT04347954|11344699|FG002|COMPLETED|Overall Study||14
10217494|NCT04347954|11344697|FG000|NOT COMPLETED|Overall Study||3
10217495|NCT04347954|11344698|FG001|NOT COMPLETED|Overall Study||1
10217496|NCT04347954|11344699|FG002|NOT COMPLETED|Overall Study||3
10217497|NCT04349098|11344709|FG000|STARTED|Overall Study||103
10217498|NCT04349098|11344710|FG001|STARTED|Overall Study||87
10217499|NCT04349098|11344709|FG000|Treated|Overall Study||102
10217500|NCT04349098|11344710|FG001|Treated|Overall Study||86
10217501|NCT04349098|11344709|FG000|COMPLETED|Overall Study||65
10217502|NCT04349098|11344710|FG001|COMPLETED|Overall Study||61
10217503|NCT04349098|11344709|FG000|NOT COMPLETED|Overall Study||38
10012431|NCT01785602|11135226|FG000|COMPLETED|Overall Study||63
10012432|NCT01785602|11135227|FG001|COMPLETED|Overall Study||18
10012433|NCT01785602|11135226|FG000|NOT COMPLETED|Overall Study||13
10012434|NCT01785602|11135227|FG001|NOT COMPLETED|Overall Study||9
10012435|NCT01785615|11135236|FG000|STARTED|Dietary Phase||0
10012436|NCT01785615|11135237|FG001|STARTED|Dietary Phase||0
10012437|NCT01785615|11135238|FG002|STARTED|Dietary Phase||35
10217504|NCT04349098|11344710|FG001|NOT COMPLETED|Overall Study||26
10217505|NCT04353037|11344720|FG000|STARTED|Overall Study||6
10217506|NCT04353037|11344721|FG001|STARTED|Overall Study||3
10217507|NCT04353037|11344722|FG002|STARTED|Overall Study||13
10217508|NCT04353037|11344723|FG003|STARTED|Overall Study||17
10217509|NCT04353037|11344720|FG000|COMPLETED|Overall Study||6
10217510|NCT04353037|11344721|FG001|COMPLETED|Overall Study||0
10217511|NCT04353037|11344722|FG002|COMPLETED|Overall Study||6
10217512|NCT04353037|11344723|FG003|COMPLETED|Overall Study||7
10217513|NCT04353037|11344720|FG000|NOT COMPLETED|Overall Study||0
10217514|NCT04353037|11344721|FG001|NOT COMPLETED|Overall Study||3
10217515|NCT04353037|11344722|FG002|NOT COMPLETED|Overall Study||7
10217516|NCT04353037|11344723|FG003|NOT COMPLETED|Overall Study||10
10217517|NCT04355117|11344735|FG000|STARTED|Overall Study||71
10217518|NCT04355117|11344735|FG000|COMPLETED|Overall Study||71
10217519|NCT04355117|11344735|FG000|NOT COMPLETED|Overall Study||0
10217520|NCT04355767|11344743|FG000|STARTED|Overall Study||257
10217521|NCT04355767|11344744|FG001|STARTED|Overall Study||254
10217522|NCT04355767|11344743|FG000|Intention-to-treat Population|Overall Study||257
10217523|NCT04355767|11344744|FG001|Intention-to-treat Population|Overall Study||254
10217524|NCT04355767|11344743|FG000|Had Data for 15-day Outcome|Overall Study||257
10217525|NCT04355767|11344744|FG001|Had Data for 15-day Outcome|Overall Study||254
10217526|NCT04355767|11344743|FG000|COMPLETED|Overall Study||250
10217527|NCT04355767|11344744|FG001|COMPLETED|Overall Study||251
10217528|NCT04355767|11344743|FG000|NOT COMPLETED|Overall Study||7
10012438|NCT01785615|11135239|FG003|STARTED|Dietary Phase||140
10217529|NCT04355767|11344744|FG001|NOT COMPLETED|Overall Study||3
10217530|NCT04356573|11344752|FG000|STARTED|Overall Study||7
10217531|NCT04356573|11344753|FG001|STARTED|Overall Study||6
10012439|NCT01785615|11135236|FG000|COMPLETED|Dietary Phase||0
10012440|NCT01785615|11135237|FG001|COMPLETED|Dietary Phase||0
10217532|NCT04356573|11344752|FG000|COMPLETED|Overall Study||6
10217533|NCT04356573|11344753|FG001|COMPLETED|Overall Study||6
10217534|NCT04356573|11344752|FG000|NOT COMPLETED|Overall Study||1
10217535|NCT04356573|11344753|FG001|NOT COMPLETED|Overall Study||0
10217536|NCT04357379|11344759|FG000|STARTED|Overall Study||10
10217537|NCT04357379|11344759|FG000|COMPLETED|Overall Study||10
10217538|NCT04357379|11344759|FG000|NOT COMPLETED|Overall Study||0
10217539|NCT04358068|11344765|FG000|STARTED|Overall Study||9
10217540|NCT04358068|11344766|FG001|STARTED|Overall Study||11
10217541|NCT04358068|11344765|FG000|COMPLETED|Overall Study||7
10217542|NCT04358068|11344766|FG001|COMPLETED|Overall Study||9
10217543|NCT04358068|11344765|FG000|NOT COMPLETED|Overall Study||2
10217544|NCT04358068|11344766|FG001|NOT COMPLETED|Overall Study||2
10217545|NCT04366349|11344778|FG000|STARTED|Overall Study||13
10217546|NCT04366349|11344779|FG001|STARTED|Overall Study||18
10217547|NCT04366349|11344780|FG002|STARTED|Overall Study||18
10217548|NCT04366349|11344781|FG003|STARTED|Overall Study||4
10217549|NCT04366349|11344782|FG004|STARTED|Overall Study||6
10217550|NCT04366349|11344783|FG005|STARTED|Overall Study||6
10217551|NCT04366349|11344778|FG000|COMPLETED|Overall Study||12
10217552|NCT04366349|11344779|FG001|COMPLETED|Overall Study||18
10217553|NCT04366349|11344780|FG002|COMPLETED|Overall Study||18
10217554|NCT04366349|11344781|FG003|COMPLETED|Overall Study||4
10217555|NCT04366349|11344782|FG004|COMPLETED|Overall Study||6
10217556|NCT04366349|11344783|FG005|COMPLETED|Overall Study||6
10217557|NCT04366349|11344778|FG000|NOT COMPLETED|Overall Study||1
10217558|NCT04366349|11344779|FG001|NOT COMPLETED|Overall Study||0
10217559|NCT04366349|11344780|FG002|NOT COMPLETED|Overall Study||0
10217560|NCT04366349|11344781|FG003|NOT COMPLETED|Overall Study||0
10217561|NCT04366349|11344782|FG004|NOT COMPLETED|Overall Study||0
10217562|NCT04366349|11344783|FG005|NOT COMPLETED|Overall Study||0
10217563|NCT04369885|11344801|FG000|STARTED|Overall Study||12
10217564|NCT04369885|11344801|FG000|COMPLETED|Overall Study||10
10217565|NCT04369885|11344801|FG000|NOT COMPLETED|Overall Study||2
10217566|NCT04373421|11344808|FG000|STARTED|Overall Study||30
10217567|NCT04373421|11344809|FG001|STARTED|Overall Study||30
10217568|NCT04373421|11344810|FG002|STARTED|Overall Study||30
10217569|NCT04373421|11344808|FG000|COMPLETED|Overall Study||26
10217570|NCT04373421|11344809|FG001|COMPLETED|Overall Study||26
10217571|NCT04373421|11344810|FG002|COMPLETED|Overall Study||29
10217572|NCT04373421|11344808|FG000|NOT COMPLETED|Overall Study||4
10217573|NCT04373421|11344809|FG001|NOT COMPLETED|Overall Study||4
10217574|NCT04373421|11344810|FG002|NOT COMPLETED|Overall Study||1
10217575|NCT04381728|11344821|FG000|STARTED|Overall Study||23
10217576|NCT04381728|11344821|FG000|COMPLETED|Overall Study||23
10217577|NCT04381728|11344821|FG000|NOT COMPLETED|Overall Study||0
10217578|NCT04388826|11344827|FG000|STARTED|Overall Study||19
10217579|NCT04388826|11344828|FG001|STARTED|Overall Study||20
10217580|NCT04388826|11344827|FG000|COMPLETED|Overall Study||15
10217581|NCT04388826|11344828|FG001|COMPLETED|Overall Study||18
10217582|NCT04388826|11344827|FG000|NOT COMPLETED|Overall Study||4
10217583|NCT04388826|11344828|FG001|NOT COMPLETED|Overall Study||2
10217584|NCT04394845|11344834|FG000|STARTED|Overall Study||6
10217585|NCT04394845|11344834|FG000|COMPLETED|Overall Study||6
10217586|NCT04394845|11344834|FG000|NOT COMPLETED|Overall Study||0
10217587|NCT04398732|11344840|FG000|STARTED|Overall Study||486
10217588|NCT04398732|11344840|FG000|COMPLETED|Overall Study||436
10217589|NCT04398732|11344840|FG000|NOT COMPLETED|Overall Study||50
10217590|NCT04401293|11344848|FG000|STARTED|Overall Study||130
10217591|NCT04401293|11344849|FG001|STARTED|Overall Study||127
10217592|NCT04401293|11344848|FG000|COMPLETED|Overall Study||129
10217593|NCT04401293|11344849|FG001|COMPLETED|Overall Study||124
10217594|NCT04401293|11344848|FG000|NOT COMPLETED|Overall Study||1
10217595|NCT04401293|11344849|FG001|NOT COMPLETED|Overall Study||3
10217596|NCT04411628|11344859|FG000|STARTED|Overall Study||7
10217597|NCT04411628|11344860|FG001|STARTED|Overall Study||6
10217598|NCT04411628|11344861|FG002|STARTED|Overall Study||7
10217599|NCT04411628|11344862|FG003|STARTED|Overall Study||6
10217600|NCT04411628|11344859|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10217601|NCT04411628|11344860|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10217602|NCT04411628|11344861|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10217603|NCT04411628|11344862|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10217604|NCT04411628|11344859|FG000|COMPLETED|Overall Study||6
10217605|NCT04411628|11344860|FG001|COMPLETED|Overall Study||4
10217606|NCT04411628|11344861|FG002|COMPLETED|Overall Study||5
10217607|NCT04411628|11344862|FG003|COMPLETED|Overall Study||6
10217608|NCT04411628|11344859|FG000|NOT COMPLETED|Overall Study||1
10217609|NCT04411628|11344860|FG001|NOT COMPLETED|Overall Study||2
10217610|NCT04411628|11344861|FG002|NOT COMPLETED|Overall Study||2
10217611|NCT04411628|11344862|FG003|NOT COMPLETED|Overall Study||0
10217612|NCT04418947|11344880|FG000|STARTED|Overall Study||1108
10217613|NCT04418947|11344881|FG001|STARTED|Overall Study||1351
10217614|NCT04418947|11344882|FG002|STARTED|Overall Study||1351
10217615|NCT04418947|11344883|FG003|STARTED|Overall Study||3655
10217616|NCT04418947|11344884|FG004|STARTED|Overall Study||3655
10217617|NCT04418947|11344880|FG000|COMPLETED|Overall Study||1108
10217618|NCT04418947|11344881|FG001|COMPLETED|Overall Study||1351
10217619|NCT04418947|11344882|FG002|COMPLETED|Overall Study||1351
10217620|NCT04418947|11344883|FG003|COMPLETED|Overall Study||3655
10217621|NCT04418947|11344884|FG004|COMPLETED|Overall Study||3655
10217622|NCT04418947|11344880|FG000|NOT COMPLETED|Overall Study||0
10217623|NCT04418947|11344881|FG001|NOT COMPLETED|Overall Study||0
10217624|NCT04418947|11344882|FG002|NOT COMPLETED|Overall Study||0
10217625|NCT04418947|11344883|FG003|NOT COMPLETED|Overall Study||0
10217626|NCT04418947|11344884|FG004|NOT COMPLETED|Overall Study||0
10217627|NCT04420273|11344898|FG000|STARTED|Overall Study||501
10217628|NCT04420273|11344899|FG001|STARTED|Overall Study||499
10217629|NCT04420273|11344898|FG000|COMPLETED|Overall Study||390
10217630|NCT04420273|11344899|FG001|COMPLETED|Overall Study||414
10217631|NCT04420273|11344898|FG000|NOT COMPLETED|Overall Study||111
10217632|NCT04420273|11344899|FG001|NOT COMPLETED|Overall Study||85
10217633|NCT04420572|11344907|FG000|STARTED|Overall Study||33
10217634|NCT04420572|11344908|FG001|STARTED|Overall Study||30
10217635|NCT04420572|11344907|FG000|COMPLETED|Overall Study||33
10217636|NCT04420572|11344908|FG001|COMPLETED|Overall Study||30
10217637|NCT04420572|11344907|FG000|NOT COMPLETED|Overall Study||0
10217638|NCT04420572|11344908|FG001|NOT COMPLETED|Overall Study||0
10217639|NCT04428411|11344914|FG000|STARTED|Overall Study||486
10217640|NCT04428411|11344914|FG000|Participants With Difficult to Treat Sites|Overall Study||397
10217641|NCT04428411|11344914|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89
10217642|NCT04428411|11344914|FG000|Participants Adherent to Treatment|Overall Study||417
10217643|NCT04428411|11344914|FG000|Participants Not Adherent to Treatment|Overall Study||69
10217644|NCT04428411|11344914|FG000|COMPLETED|Overall Study||372
10217645|NCT04428411|11344914|FG000|NOT COMPLETED|Overall Study||114
10217646|NCT04435184|11344923|FG000|STARTED|Overall Study||25
10217647|NCT04435184|11344924|FG001|STARTED|Overall Study||25
10217648|NCT04435184|11344923|FG000|COMPLETED|Overall Study||22
10217649|NCT04435184|11344924|FG001|COMPLETED|Overall Study||20
10217650|NCT04435184|11344923|FG000|NOT COMPLETED|Overall Study||3
10217651|NCT04435184|11344924|FG001|NOT COMPLETED|Overall Study||5
10217652|NCT04476784|11344932|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31
10217653|NCT04476784|11344933|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35
10217654|NCT04476784|11344932|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30
10217655|NCT04476784|11344933|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35
10217656|NCT04476784|11344932|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1
10217657|NCT04476784|11344933|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0
10217658|NCT04476784|11344932|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30
10217659|NCT04476784|11344933|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35
10217660|NCT04476784|11344932|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30
10217661|NCT04476784|11344933|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35
10217662|NCT04476784|11344932|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
10217663|NCT04476784|11344933|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
10217664|NCT04484207|11344945|FG000|STARTED|Overall Study||86
10217665|NCT04484207|11344946|FG001|STARTED|Overall Study||44
10217666|NCT04484207|11344947|FG002|STARTED|Overall Study||42
10217667|NCT04484207|11344945|FG000|14-Day Follow-Up|Overall Study||69
10217668|NCT04484207|11344946|FG001|14-Day Follow-Up|Overall Study||40
10217669|NCT04484207|11344947|FG002|14-Day Follow-Up|Overall Study||33
10217670|NCT04484207|11344945|FG000|30-Day Follow-Up|Overall Study||65
10217671|NCT04484207|11344946|FG001|30-Day Follow-Up|Overall Study||34
10217672|NCT04484207|11344947|FG002|30-Day Follow-Up|Overall Study||31
10217673|NCT04484207|11344945|FG000|COMPLETED|Overall Study||65
10217674|NCT04484207|11344946|FG001|COMPLETED|Overall Study||34
10217675|NCT04484207|11344947|FG002|COMPLETED|Overall Study||31
10217676|NCT04484207|11344945|FG000|NOT COMPLETED|Overall Study||21
10217677|NCT04484207|11344946|FG001|NOT COMPLETED|Overall Study||10
10217678|NCT04484207|11344947|FG002|NOT COMPLETED|Overall Study||11
10217679|NCT04485455|11344958|FG000|STARTED|Overall Study||5
10217680|NCT04485455|11344958|FG000|COMPLETED|Overall Study||5
10217681|NCT04485455|11344958|FG000|NOT COMPLETED|Overall Study||0
10217682|NCT04495283|11344965|FG000|STARTED|Overall Study||35
10217683|NCT04495283|11344966|FG001|STARTED|Overall Study||35
10217684|NCT04495283|11344967|FG002|STARTED|Overall Study||17
10217685|NCT04495283|11344965|FG000|COMPLETED|Overall Study||34
10217686|NCT04495283|11344966|FG001|COMPLETED|Overall Study||34
10217687|NCT04495283|11344967|FG002|COMPLETED|Overall Study||14
10217688|NCT04495283|11344965|FG000|NOT COMPLETED|Overall Study||1
10217689|NCT04495283|11344966|FG001|NOT COMPLETED|Overall Study||1
10217690|NCT04495283|11344967|FG002|NOT COMPLETED|Overall Study||3
10217691|NCT04497948|11344978|FG000|STARTED|Overall Study||9
10217692|NCT04497948|11344978|FG000|COMPLETED|Overall Study||7
10217693|NCT04497948|11344978|FG000|NOT COMPLETED|Overall Study||2
10217694|NCT04501640|11344990|FG000|STARTED|Period 1 (5 Days)||6
10217695|NCT04501640|11344991|FG001|STARTED|Period 1 (5 Days)||6
10217696|NCT04501640|11344992|FG002|STARTED|Period 1 (5 Days)||6
10217697|NCT04501640|11344993|FG003|STARTED|Period 1 (5 Days)||6
10217698|NCT04501640|11344990|FG000|COMPLETED|Period 1 (5 Days)||6
10217699|NCT04501640|11344991|FG001|COMPLETED|Period 1 (5 Days)||6
10217700|NCT04501640|11344992|FG002|COMPLETED|Period 1 (5 Days)||6
10217701|NCT04501640|11344993|FG003|COMPLETED|Period 1 (5 Days)||6
10217702|NCT04501640|11344990|FG000|NOT COMPLETED|Period 1 (5 Days)||0
10217703|NCT04501640|11344991|FG001|NOT COMPLETED|Period 1 (5 Days)||0
10217704|NCT04501640|11344992|FG002|NOT COMPLETED|Period 1 (5 Days)||0
10217705|NCT04501640|11344993|FG003|NOT COMPLETED|Period 1 (5 Days)||0
10217706|NCT04501640|11344990|FG000|STARTED|Washout Period (10 Days)||6
10217707|NCT04501640|11344991|FG001|STARTED|Washout Period (10 Days)||6
10217708|NCT04501640|11344992|FG002|STARTED|Washout Period (10 Days)||6
10217709|NCT04501640|11344993|FG003|STARTED|Washout Period (10 Days)||6
10217710|NCT04501640|11344990|FG000|COMPLETED|Washout Period (10 Days)||6
10217711|NCT04501640|11344991|FG001|COMPLETED|Washout Period (10 Days)||6
10217712|NCT04501640|11344992|FG002|COMPLETED|Washout Period (10 Days)||6
10217713|NCT04501640|11344993|FG003|COMPLETED|Washout Period (10 Days)||6
10217714|NCT04501640|11344990|FG000|NOT COMPLETED|Washout Period (10 Days)||0
10217715|NCT04501640|11344991|FG001|NOT COMPLETED|Washout Period (10 Days)||0
10217716|NCT04501640|11344992|FG002|NOT COMPLETED|Washout Period (10 Days)||0
10217717|NCT04501640|11344993|FG003|NOT COMPLETED|Washout Period (10 Days)||0
10217718|NCT04501640|11344990|FG000|STARTED|Period 2 (5 Days)||6
10217719|NCT04501640|11344991|FG001|STARTED|Period 2 (5 Days)||6
10217720|NCT04501640|11344992|FG002|STARTED|Period 2 (5 Days)||6
10217721|NCT04501640|11344993|FG003|STARTED|Period 2 (5 Days)||6
10217722|NCT04501640|11344990|FG000|COMPLETED|Period 2 (5 Days)||6
10217723|NCT04501640|11344991|FG001|COMPLETED|Period 2 (5 Days)||6
10217724|NCT04501640|11344992|FG002|COMPLETED|Period 2 (5 Days)||6
10217725|NCT04501640|11344993|FG003|COMPLETED|Period 2 (5 Days)||6
10217726|NCT04501640|11344990|FG000|NOT COMPLETED|Period 2 (5 Days)||0
10217727|NCT04501640|11344991|FG001|NOT COMPLETED|Period 2 (5 Days)||0
10217728|NCT04501640|11344992|FG002|NOT COMPLETED|Period 2 (5 Days)||0
10217729|NCT04501640|11344993|FG003|NOT COMPLETED|Period 2 (5 Days)||0
10217730|NCT04501952|11345005|FG000|STARTED|Overall Study||292
10217731|NCT04501952|11345006|FG001|STARTED|Overall Study||292
10217732|NCT04501952|11345005|FG000|COMPLETED|Overall Study||266
10217733|NCT04501952|11345006|FG001|COMPLETED|Overall Study||272
10217734|NCT04501952|11345005|FG000|NOT COMPLETED|Overall Study||26
10217735|NCT04501952|11345006|FG001|NOT COMPLETED|Overall Study||20
10217736|NCT04504032|11345015|FG000|STARTED|Overall Study||246
10217737|NCT04504032|11345016|FG001|STARTED|Overall Study||251
10217738|NCT04504032|11345015|FG000|COMPLETED|Overall Study||210
10217739|NCT04504032|11345016|FG001|COMPLETED|Overall Study||223
10217740|NCT04504032|11345015|FG000|NOT COMPLETED|Overall Study||36
10217741|NCT04504032|11345016|FG001|NOT COMPLETED|Overall Study||28
10217742|NCT04507763|11345022|FG000|STARTED|Overall Study||763
10217743|NCT04507763|11345022|FG000|COMPLETED|Overall Study||562
10217744|NCT04507763|11345022|FG000|NOT COMPLETED|Overall Study||201
10217745|NCT04507867|11345031|FG000|STARTED|Overall Study||40
10217746|NCT04507867|11345032|FG001|STARTED|Overall Study||40
10217747|NCT04507867|11345031|FG000|COMPLETED|Overall Study||33
10217748|NCT04507867|11345032|FG001|COMPLETED|Overall Study||39
10217749|NCT04507867|11345031|FG000|NOT COMPLETED|Overall Study||7
10217750|NCT04507867|11345032|FG001|NOT COMPLETED|Overall Study||1
10217751|NCT04525079|11345059|FG000|STARTED|Overall Study||6
10217752|NCT04525079|11345060|FG001|STARTED|Overall Study||6
10217753|NCT04525079|11345061|FG002|STARTED|Overall Study||6
10217754|NCT04525079|11345062|FG003|STARTED|Overall Study||6
10217755|NCT04525079|11345063|FG004|STARTED|Overall Study||8
10217756|NCT04525079|11345059|FG000|COMPLETED|Overall Study||6
10217757|NCT04525079|11345060|FG001|COMPLETED|Overall Study||6
10217758|NCT04525079|11345061|FG002|COMPLETED|Overall Study||6
10217759|NCT04525079|11345062|FG003|COMPLETED|Overall Study||6
10217760|NCT04525079|11345063|FG004|COMPLETED|Overall Study||8
10217761|NCT04525079|11345059|FG000|NOT COMPLETED|Overall Study||0
10217762|NCT04525079|11345060|FG001|NOT COMPLETED|Overall Study||0
10217763|NCT04525079|11345061|FG002|NOT COMPLETED|Overall Study||0
10217764|NCT04525079|11345062|FG003|NOT COMPLETED|Overall Study||0
10217765|NCT04525079|11345063|FG004|NOT COMPLETED|Overall Study||0
10217766|NCT04527978|11345077|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
10217767|NCT04527978|11345078|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
10217768|NCT04527978|11345077|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26
10217769|NCT04527978|11345078|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
10217770|NCT04527978|11345077|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
10217771|NCT04527978|11345078|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10217772|NCT04527978|11345077|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26
10217773|NCT04527978|11345078|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
10217774|NCT04527978|11345077|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
10217775|NCT04527978|11345078|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
10217776|NCT04527978|11345077|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10217777|NCT04527978|11345078|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10217778|NCT04528017|11345089|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
10217779|NCT04528017|11345090|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
10217780|NCT04528017|11345089|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27
10217781|NCT04528017|11345090|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
10217782|NCT04528017|11345089|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10217783|NCT04528017|11345090|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10217784|NCT04528017|11345089|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27
10217785|NCT04528017|11345090|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
10217786|NCT04528017|11345089|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27
10217787|NCT04528017|11345090|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
10217788|NCT04528017|11345089|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10217789|NCT04528017|11345090|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10217790|NCT04529109|11345099|FG000|STARTED|Period 1||27
10217791|NCT04529109|11345100|FG001|STARTED|Period 1||29
10217792|NCT04529109|11345099|FG000|COMPLETED|Period 1||27
10217793|NCT04529109|11345100|FG001|COMPLETED|Period 1||28
10217794|NCT04529109|11345099|FG000|NOT COMPLETED|Period 1||0
10217795|NCT04529109|11345100|FG001|NOT COMPLETED|Period 1||1
10217796|NCT04529109|11345099|FG000|STARTED|Period 2||27
10217797|NCT04529109|11345100|FG001|STARTED|Period 2||28
10217798|NCT04529109|11345099|FG000|COMPLETED|Period 2||27
10217799|NCT04529109|11345100|FG001|COMPLETED|Period 2||28
10217800|NCT04529109|11345099|FG000|NOT COMPLETED|Period 2||0
10217801|NCT04529109|11345100|FG001|NOT COMPLETED|Period 2||0
10217802|NCT04536571|11345106|FG000|STARTED|First Intervention||11
10217803|NCT04536571|11345107|FG001|STARTED|First Intervention||16
10217804|NCT04536571|11345106|FG000|COMPLETED|First Intervention||11
10217805|NCT04536571|11345107|FG001|COMPLETED|First Intervention||16
10217806|NCT04536571|11345106|FG000|NOT COMPLETED|First Intervention||0
10217807|NCT04536571|11345107|FG001|NOT COMPLETED|First Intervention||0
10217808|NCT04536571|11345106|FG000|STARTED|Second Intervention||11
10217809|NCT04536571|11345107|FG001|STARTED|Second Intervention||16
10217810|NCT04536571|11345106|FG000|COMPLETED|Second Intervention||11
10217811|NCT04536571|11345107|FG001|COMPLETED|Second Intervention||16
10217812|NCT04536571|11345106|FG000|NOT COMPLETED|Second Intervention||0
10217813|NCT04536571|11345107|FG001|NOT COMPLETED|Second Intervention||0
10217814|NCT04544787|11345124|FG000|STARTED|Overall Study||50
10217815|NCT04544787|11345125|FG001|STARTED|Overall Study||50
10217816|NCT04544787|11345126|FG002|STARTED|Overall Study||50
10217817|NCT04544787|11345127|FG003|STARTED|Overall Study||50
10217818|NCT04544787|11345128|FG004|STARTED|Overall Study||17
10217819|NCT04544787|11345129|FG005|STARTED|Overall Study||16
10217820|NCT04544787|11345130|FG006|STARTED|Overall Study||17
10217821|NCT04544787|11345124|FG000|Received First Dose of Vaccine|Overall Study||50
10217822|NCT04544787|11345125|FG001|Received First Dose of Vaccine|Overall Study||50
10217823|NCT04544787|11345126|FG002|Received First Dose of Vaccine|Overall Study||50
10217824|NCT04544787|11345127|FG003|Received First Dose of Vaccine|Overall Study||50
10217825|NCT04544787|11345128|FG004|Received First Dose of Vaccine|Overall Study||17
10217826|NCT04544787|11345129|FG005|Received First Dose of Vaccine|Overall Study||16
10217827|NCT04544787|11345130|FG006|Received First Dose of Vaccine|Overall Study||17
10217828|NCT04544787|11345124|FG000|Received Second Dose of Vaccine|Overall Study||0
10217829|NCT04544787|11345125|FG001|Received Second Dose of Vaccine|Overall Study||49
10217830|NCT04544787|11345126|FG002|Received Second Dose of Vaccine|Overall Study||0
10217831|NCT04544787|11345127|FG003|Received Second Dose of Vaccine|Overall Study||49
10217832|NCT04544787|11345128|FG004|Received Second Dose of Vaccine|Overall Study||17
10217833|NCT04544787|11345129|FG005|Received Second Dose of Vaccine|Overall Study||15
10217834|NCT04544787|11345130|FG006|Received Second Dose of Vaccine|Overall Study||16
10217835|NCT04544787|11345124|FG000|COMPLETED|Overall Study||50
10217836|NCT04544787|11345125|FG001|COMPLETED|Overall Study||50
10217837|NCT04544787|11345126|FG002|COMPLETED|Overall Study||50
10217838|NCT04544787|11345127|FG003|COMPLETED|Overall Study||50
10217839|NCT04544787|11345128|FG004|COMPLETED|Overall Study||17
10217840|NCT04544787|11345129|FG005|COMPLETED|Overall Study||16
10217841|NCT04544787|11345130|FG006|COMPLETED|Overall Study||17
10217842|NCT04544787|11345124|FG000|NOT COMPLETED|Overall Study||0
10217843|NCT04544787|11345125|FG001|NOT COMPLETED|Overall Study||0
10217844|NCT04544787|11345126|FG002|NOT COMPLETED|Overall Study||0
10217845|NCT04544787|11345127|FG003|NOT COMPLETED|Overall Study||0
10217846|NCT04544787|11345128|FG004|NOT COMPLETED|Overall Study||0
10217847|NCT04544787|11345129|FG005|NOT COMPLETED|Overall Study||0
10217848|NCT04544787|11345130|FG006|NOT COMPLETED|Overall Study||0
10217849|NCT04555031|11345169|FG000|STARTED|Overall Study||10
10217850|NCT04555031|11345169|FG000|COMPLETED|Overall Study||10
10217851|NCT04555031|11345169|FG000|NOT COMPLETED|Overall Study||0
10217852|NCT04559282|11345176|FG000|STARTED|Intervention 1 (Day 0)||8
10217853|NCT04559282|11345177|FG001|STARTED|Intervention 1 (Day 0)||8
10217854|NCT04559282|11345176|FG000|COMPLETED|Intervention 1 (Day 0)||8
10217855|NCT04559282|11345177|FG001|COMPLETED|Intervention 1 (Day 0)||8
10217856|NCT04559282|11345176|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0
10217857|NCT04559282|11345177|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0
10217858|NCT04559282|11345176|FG000|STARTED|Intervention 2 (Day 7)||8
10217859|NCT04559282|11345177|FG001|STARTED|Intervention 2 (Day 7)||8
10217860|NCT04559282|11345176|FG000|COMPLETED|Intervention 2 (Day 7)||8
10217861|NCT04559282|11345177|FG001|COMPLETED|Intervention 2 (Day 7)||8
10217862|NCT04559282|11345176|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0
10217863|NCT04559282|11345177|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0
10217864|NCT04559282|11345176|FG000|STARTED|Intervention 3 (Day 14)||8
10217865|NCT04559282|11345177|FG001|STARTED|Intervention 3 (Day 14)||8
10217866|NCT04559282|11345176|FG000|COMPLETED|Intervention 3 (Day 14)||8
10217867|NCT04559282|11345177|FG001|COMPLETED|Intervention 3 (Day 14)||8
10217868|NCT04559282|11345176|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0
10217869|NCT04559282|11345177|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0
10217870|NCT04574297|11345190|FG000|STARTED|Overall Study||180
10217871|NCT04574297|11345191|FG001|STARTED|Overall Study||263
10217872|NCT04574297|11345192|FG002|STARTED|Overall Study||230
10217873|NCT04574297|11345193|FG003|STARTED|Overall Study||125
10217874|NCT04574297|11345190|FG000|COMPLETED|Overall Study||180
10217875|NCT04574297|11345191|FG001|COMPLETED|Overall Study||263
10217876|NCT04574297|11345192|FG002|COMPLETED|Overall Study||230
10217877|NCT04574297|11345193|FG003|COMPLETED|Overall Study||125
10217878|NCT04574297|11345190|FG000|NOT COMPLETED|Overall Study||0
10217879|NCT04574297|11345191|FG001|NOT COMPLETED|Overall Study||0
10217880|NCT04574297|11345192|FG002|NOT COMPLETED|Overall Study||0
10217881|NCT04574297|11345193|FG003|NOT COMPLETED|Overall Study||0
10217882|NCT04580290|11345205|FG000|STARTED|Overall Study||88
10217883|NCT04580290|11345206|FG001|STARTED|Overall Study||32
10217884|NCT04580290|11345205|FG000|COMPLETED|Overall Study||88
10217885|NCT04580290|11345206|FG001|COMPLETED|Overall Study||32
10217886|NCT04580290|11345205|FG000|NOT COMPLETED|Overall Study||0
10217887|NCT04580290|11345206|FG001|NOT COMPLETED|Overall Study||0
10217888|NCT04601103|11345215|FG000|STARTED|Overall Study||18
10217889|NCT04601103|11345216|FG001|STARTED|Overall Study||18
10217890|NCT04601103|11345217|FG002|STARTED|Overall Study||17
10217891|NCT04601103|11345215|FG000|COMPLETED|Overall Study||0
10217892|NCT04601103|11345216|FG001|COMPLETED|Overall Study||0
10217893|NCT04601103|11345217|FG002|COMPLETED|Overall Study||0
10217894|NCT04601103|11345215|FG000|NOT COMPLETED|Overall Study||18
10217895|NCT04601103|11345216|FG001|NOT COMPLETED|Overall Study||18
10217896|NCT04601103|11345217|FG002|NOT COMPLETED|Overall Study||17
10217897|NCT04617574|11345227|FG000|STARTED|Overall Study||30
10217898|NCT04617574|11345228|FG001|STARTED|Overall Study||30
10217899|NCT04617574|11345227|FG000|COMPLETED|Overall Study||30
10217900|NCT04617574|11345228|FG001|COMPLETED|Overall Study||30
10217901|NCT04617574|11345227|FG000|NOT COMPLETED|Overall Study||0
10217902|NCT04617574|11345228|FG001|NOT COMPLETED|Overall Study||0
10217903|NCT04658797|11345236|FG000|STARTED|Overall Study||15
10217904|NCT04658797|11345237|FG001|STARTED|Overall Study||15
10217905|NCT04658797|11345236|FG000|COMPLETED|Overall Study||15
10217906|NCT04658797|11345237|FG001|COMPLETED|Overall Study||15
10217907|NCT04658797|11345236|FG000|NOT COMPLETED|Overall Study||0
10217908|NCT04658797|11345237|FG001|NOT COMPLETED|Overall Study||0
10217909|NCT04664855|11345245|FG000|STARTED|Overall Study||23
10217910|NCT04664855|11345246|FG001|STARTED|Overall Study||24
10111907|NCT02499783|11242964|FG002|COMPLETED|DB Period: Weeks 0-8||0
10111908|NCT02499783|11242962|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10
10111909|NCT02499783|11242963|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7
10217911|NCT04664855|11345245|FG000|COMPLETED|Overall Study||23
10217912|NCT04664855|11345246|FG001|COMPLETED|Overall Study||22
10217913|NCT04664855|11345245|FG000|NOT COMPLETED|Overall Study||0
10217914|NCT04664855|11345246|FG001|NOT COMPLETED|Overall Study||2
10217915|NCT04701658|11345252|FG000|STARTED|Overall Study||109
10217916|NCT04701658|11345252|FG000|Received Single Dose of Bamlanivimab|Overall Study||109
10217917|NCT04701658|11345252|FG000|COMPLETED|Overall Study||103
10217918|NCT04701658|11345252|FG000|NOT COMPLETED|Overall Study||6
10239038|NCT00387673|11370529|FG000|NOT COMPLETED|Overall Study||0
10239039|NCT00387673|11370530|FG001|NOT COMPLETED|Overall Study||0
10239040|NCT00387673|11370531|FG002|NOT COMPLETED|Overall Study||0
10239041|NCT00386724|11370537|FG000|STARTED|Overall Study||8
10239042|NCT00386724|11370537|FG000|3 Months Post-activation|Overall Study||4
10239043|NCT00386724|11370537|FG000|COMPLETED|Overall Study||3
10239044|NCT00386724|11370537|FG000|NOT COMPLETED|Overall Study||5
10239045|NCT00387244|11370541|FG000|STARTED|Overall Study||7
10239046|NCT00387244|11370541|FG000|End of Trial|Overall Study||0
10239047|NCT00387244|11370541|FG000|COMPLETED|Overall Study||0
10239048|NCT00387244|11370541|FG000|NOT COMPLETED|Overall Study||7
10239049|NCT00384293|11370547|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937
10239050|NCT00384293|11370548|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0
10239051|NCT00384293|11370549|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0
10239052|NCT00384293|11370547|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
10239053|NCT00384293|11370548|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
10111910|NCT02499783|11242964|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0
10111911|NCT02499783|11242962|FG000|STARTED|Open Label Period: Weeks 8 to 26||0
10111912|NCT02499783|11242963|FG001|STARTED|Open Label Period: Weeks 8 to 26||0
10111913|NCT02499783|11242964|FG002|STARTED|Open Label Period: Weeks 8 to 26||188
10111914|NCT02499783|11242962|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0
10111915|NCT02499783|11242963|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0
10111916|NCT02499783|11242964|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159
10111917|NCT02499783|11242962|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
10111918|NCT02499783|11242963|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
10113431|NCT02509117|11244197|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0
10239054|NCT00384293|11370549|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
10239055|NCT00384293|11370547|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
10239056|NCT00384293|11370548|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
10217919|NCT04706416|11345258|FG000|STARTED|Overall Study||50
10217920|NCT04706416|11345259|FG001|STARTED|Overall Study||100
10217921|NCT04706416|11345258|FG000|COMPLETED|Overall Study||48
10217922|NCT04706416|11345259|FG001|COMPLETED|Overall Study||100
10217923|NCT04706416|11345258|FG000|NOT COMPLETED|Overall Study||2
10217924|NCT04706416|11345259|FG001|NOT COMPLETED|Overall Study||0
10217925|NCT04709484|11345270|FG000|STARTED|Overall Study||34
10217926|NCT04709484|11345271|FG001|STARTED|Overall Study||32
10217927|NCT04709484|11345270|FG000|COMPLETED|Overall Study||34
10217928|NCT04709484|11345271|FG001|COMPLETED|Overall Study||32
10217929|NCT04709484|11345270|FG000|NOT COMPLETED|Overall Study||0
10217930|NCT04709484|11345271|FG001|NOT COMPLETED|Overall Study||0
10217931|NCT04727749|11345279|FG000|STARTED|Overall Study||107
10217932|NCT04727749|11345280|FG001|STARTED|Overall Study||104
10217933|NCT04727749|11345279|FG000|COMPLETED|Overall Study||97
10217934|NCT04727749|11345280|FG001|COMPLETED|Overall Study||101
10217935|NCT04727749|11345279|FG000|NOT COMPLETED|Overall Study||10
10217936|NCT04727749|11345280|FG001|NOT COMPLETED|Overall Study||3
10217937|NCT04777214|11345290|FG000|STARTED|Initial Randomization||5
10217938|NCT04777214|11345291|FG001|STARTED|Initial Randomization||5
10217939|NCT04777214|11345290|FG000|COMPLETED|Initial Randomization||5
10217940|NCT04777214|11345291|FG001|COMPLETED|Initial Randomization||5
10217941|NCT04777214|11345290|FG000|NOT COMPLETED|Initial Randomization||0
10217942|NCT04777214|11345291|FG001|NOT COMPLETED|Initial Randomization||0
10217943|NCT04777214|11345290|FG000|STARTED|Sham Crossover to Active TMS Arm||0
10217944|NCT04777214|11345291|FG001|STARTED|Sham Crossover to Active TMS Arm||5
10217945|NCT04777214|11345290|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0
10217946|NCT04777214|11345291|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5
10217947|NCT04777214|11345290|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
10217948|NCT04777214|11345291|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
10217949|NCT04854707|11345302|FG000|STARTED|Overall Study||2625
10217950|NCT04854707|11345303|FG001|STARTED|Overall Study||2183
10217951|NCT04854707|11345304|FG002|STARTED|Overall Study||676
10217952|NCT04854707|11345302|FG000|COMPLETED|Overall Study||2547
10217953|NCT04854707|11345303|FG001|COMPLETED|Overall Study||2124
10217954|NCT04854707|11345304|FG002|COMPLETED|Overall Study||646
10217955|NCT04854707|11345302|FG000|NOT COMPLETED|Overall Study||78
10217956|NCT04854707|11345303|FG001|NOT COMPLETED|Overall Study||59
10217957|NCT04854707|11345304|FG002|NOT COMPLETED|Overall Study||30
10217958|NCT04898166|11345318|FG000|STARTED|Overall Study||220
10217959|NCT04898166|11345319|FG001|STARTED|Overall Study||80
10217960|NCT04898166|11345318|FG000|COMPLETED|Overall Study||220
10217961|NCT04898166|11345319|FG001|COMPLETED|Overall Study||80
10217962|NCT04898166|11345318|FG000|NOT COMPLETED|Overall Study||0
10217963|NCT04898166|11345319|FG001|NOT COMPLETED|Overall Study||0
10217964|NCT04926233|11345339|FG000|STARTED|Overall Study||1280486
10217965|NCT04926233|11345340|FG001|STARTED|Overall Study||90660
10217966|NCT04926233|11345339|FG000|COMPLETED|Overall Study||1280486
10217967|NCT04926233|11345340|FG001|COMPLETED|Overall Study||90660
10217968|NCT04926233|11345339|FG000|NOT COMPLETED|Overall Study||0
10217969|NCT04926233|11345340|FG001|NOT COMPLETED|Overall Study||0
10217970|NCT04943159|11345392|FG000|STARTED|Overall Study||3
10217971|NCT04943159|11345392|FG000|COMPLETED|Overall Study||3
10217972|NCT04943159|11345392|FG000|NOT COMPLETED|Overall Study||0
10217973|NCT04947436|11345399|FG000|STARTED|Overall Study||7
10217974|NCT04947436|11345400|FG001|STARTED|Overall Study||10
10217975|NCT04947436|11345401|FG002|STARTED|Overall Study||11
10217976|NCT04947436|11345399|FG000|COMPLETED|Overall Study||3
10217977|NCT04947436|11345400|FG001|COMPLETED|Overall Study||2
10217978|NCT04947436|11345401|FG002|COMPLETED|Overall Study||5
10217979|NCT04947436|11345399|FG000|NOT COMPLETED|Overall Study||4
10217980|NCT04947436|11345400|FG001|NOT COMPLETED|Overall Study||8
10217981|NCT04947436|11345401|FG002|NOT COMPLETED|Overall Study||6
10217982|NCT05002972|11345409|FG000|STARTED|Overall Study||63
10217983|NCT05002972|11345409|FG000|COMPLETED|Overall Study||61
10217984|NCT05002972|11345409|FG000|NOT COMPLETED|Overall Study||2
10217985|NCT05002985|11345413|FG000|STARTED|Overall Study||49
10217986|NCT05002985|11345413|FG000|COMPLETED|Overall Study||48
10217987|NCT05002985|11345413|FG000|NOT COMPLETED|Overall Study||1
10217988|NCT04512482|11345419|FG000|STARTED|First Intervention (1 Day)||24
10217989|NCT04512482|11345420|FG001|STARTED|First Intervention (1 Day)||21
10217990|NCT04512482|11345419|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24
10217991|NCT04512482|11345420|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21
10217992|NCT04512482|11345419|FG000|Baseline Photographs|First Intervention (1 Day)||24
10217993|NCT04512482|11345420|FG001|Baseline Photographs|First Intervention (1 Day)||21
10217994|NCT04512482|11345419|FG000|Received Rinse Intervention|First Intervention (1 Day)||24
10217995|NCT04512482|11345420|FG001|Received Rinse Intervention|First Intervention (1 Day)||21
10217996|NCT04512482|11345419|FG000|Post-rinse Photographs|First Intervention (1 Day)||24
10217997|NCT04512482|11345420|FG001|Post-rinse Photographs|First Intervention (1 Day)||21
10217998|NCT04512482|11345419|FG000|Toothbrush Utilization|First Intervention (1 Day)||24
10217999|NCT04512482|11345420|FG001|Toothbrush Utilization|First Intervention (1 Day)||21
10218000|NCT04512482|11345419|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24
10218001|NCT04512482|11345420|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21
10218002|NCT04512482|11345419|FG000|Waterpik Utilization|First Intervention (1 Day)||24
10218003|NCT04512482|11345420|FG001|Waterpik Utilization|First Intervention (1 Day)||21
10218004|NCT04512482|11345419|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24
10218005|NCT04512482|11345420|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21
10218006|NCT04512482|11345419|FG000|COMPLETED|First Intervention (1 Day)||24
10218007|NCT04512482|11345420|FG001|COMPLETED|First Intervention (1 Day)||21
10218008|NCT04512482|11345419|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10218009|NCT04512482|11345420|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10218010|NCT04512482|11345419|FG000|STARTED|Washout (1 Week)||24
10218011|NCT04512482|11345420|FG001|STARTED|Washout (1 Week)||21
10218012|NCT04512482|11345419|FG000|COMPLETED|Washout (1 Week)||24
10218013|NCT04512482|11345420|FG001|COMPLETED|Washout (1 Week)||21
10218014|NCT04512482|11345419|FG000|NOT COMPLETED|Washout (1 Week)||0
10218015|NCT04512482|11345420|FG001|NOT COMPLETED|Washout (1 Week)||0
10218016|NCT04512482|11345419|FG000|STARTED|Second Intervention (1 Day)||24
10218017|NCT04512482|11345420|FG001|STARTED|Second Intervention (1 Day)||21
10218018|NCT04512482|11345419|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22
10218019|NCT04512482|11345420|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20
10218020|NCT04512482|11345419|FG000|Baseline Photographs|Second Intervention (1 Day)||22
10218021|NCT04512482|11345420|FG001|Baseline Photographs|Second Intervention (1 Day)||20
10218022|NCT04512482|11345419|FG000|Received Intervention|Second Intervention (1 Day)||22
10218023|NCT04512482|11345420|FG001|Received Intervention|Second Intervention (1 Day)||20
10218024|NCT04512482|11345419|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22
10218025|NCT04512482|11345420|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20
10218026|NCT04512482|11345419|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22
10218027|NCT04512482|11345420|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20
10218028|NCT04512482|11345419|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22
10218029|NCT04512482|11345420|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20
10218030|NCT04512482|11345419|FG000|Waterpik Utilization|Second Intervention (1 Day)||22
10218031|NCT04512482|11345420|FG001|Waterpik Utilization|Second Intervention (1 Day)||20
10218032|NCT04512482|11345419|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22
10218033|NCT04512482|11345420|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20
10218034|NCT04512482|11345419|FG000|COMPLETED|Second Intervention (1 Day)||22
10218035|NCT04512482|11345420|FG001|COMPLETED|Second Intervention (1 Day)||20
10218036|NCT04512482|11345419|FG000|NOT COMPLETED|Second Intervention (1 Day)||2
10218037|NCT04512482|11345420|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
10218038|NCT04499599|11345429|FG000|STARTED|Overall Study||35
10218039|NCT04499599|11345430|FG001|STARTED|Overall Study||35
10218040|NCT04499599|11345431|FG002|STARTED|Overall Study||35
10218041|NCT04499599|11345429|FG000|COMPLETED|Overall Study||35
10218042|NCT04499599|11345430|FG001|COMPLETED|Overall Study||35
10218043|NCT04499599|11345431|FG002|COMPLETED|Overall Study||35
10218044|NCT04499599|11345429|FG000|NOT COMPLETED|Overall Study||0
10218045|NCT04499599|11345430|FG001|NOT COMPLETED|Overall Study||0
10218046|NCT04499599|11345431|FG002|NOT COMPLETED|Overall Study||0
10218047|NCT04525157|11345439|FG000|STARTED|Overall Study||18
10218048|NCT04525157|11345439|FG000|COMPLETED|Overall Study||15
10218049|NCT04525157|11345439|FG000|NOT COMPLETED|Overall Study||3
10218050|NCT04523831|11345445|FG000|STARTED|Overall Study||200
10218051|NCT04523831|11345446|FG001|STARTED|Overall Study||200
10218052|NCT04523831|11345445|FG000|COMPLETED|Overall Study||183
10218053|NCT04523831|11345446|FG001|COMPLETED|Overall Study||180
10218054|NCT04523831|11345445|FG000|NOT COMPLETED|Overall Study||17
10218055|NCT04523831|11345446|FG001|NOT COMPLETED|Overall Study||20
10218056|NCT04521777|11345455|FG000|STARTED|Overall Study||24
10218057|NCT04521777|11345455|FG000|COMPLETED|Overall Study||20
10218058|NCT04521777|11345455|FG000|NOT COMPLETED|Overall Study||4
10218059|NCT04512703|11345461|FG000|STARTED|Within 7 Days From Start of Device Wear||6
10218060|NCT04512703|11345462|FG001|STARTED|Within 7 Days From Start of Device Wear||45
10218061|NCT04512703|11345461|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6
10218062|NCT04512703|11345462|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45
10218063|NCT04512703|11345461|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6
10218064|NCT04512703|11345462|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45
10218065|NCT04512703|11345461|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6
10218066|NCT04512703|11345462|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45
10218067|NCT04512703|11345461|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
10218068|NCT04512703|11345462|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
10218069|NCT04512703|11345461|FG000|STARTED|Between 7th and 90th Day of Device Wear||6
10218070|NCT04512703|11345462|FG001|STARTED|Between 7th and 90th Day of Device Wear||45
10218071|NCT04512703|11345461|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
10218072|NCT04512703|11345462|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
10218073|NCT04512703|11345461|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
10218074|NCT04512703|11345462|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
10218075|NCT04512703|11345461|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6
10218076|NCT04512703|11345462|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45
10218077|NCT04512703|11345461|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
10218078|NCT04512703|11345462|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
10218079|NCT04511520|11345474|FG000|STARTED|Overall Study||24
10218080|NCT04511520|11345475|FG001|STARTED|Overall Study||24
10218081|NCT04511520|11345476|FG002|STARTED|Overall Study||24
10218082|NCT04511520|11345474|FG000|COMPLETED|Overall Study||24
10218083|NCT04511520|11345475|FG001|COMPLETED|Overall Study||24
10218084|NCT04511520|11345476|FG002|COMPLETED|Overall Study||24
10218085|NCT04511520|11345474|FG000|NOT COMPLETED|Overall Study||0
10012441|NCT01785615|11135238|FG002|COMPLETED|Dietary Phase||35
10218086|NCT04511520|11345475|FG001|NOT COMPLETED|Overall Study||0
10218087|NCT04511520|11345476|FG002|NOT COMPLETED|Overall Study||0
10218088|NCT04507776|11345485|FG000|STARTED|Overall Study||763
10218089|NCT04507776|11345485|FG000|COMPLETED|Overall Study||562
10218090|NCT04507776|11345485|FG000|NOT COMPLETED|Overall Study||201
10218091|NCT04502979|11345496|FG000|STARTED|Overall Study||37
10218092|NCT04502979|11345497|FG001|STARTED|Overall Study||34
10218093|NCT04502979|11345496|FG000|COMPLETED|Overall Study||34
10218094|NCT04502979|11345497|FG001|COMPLETED|Overall Study||30
10218095|NCT04502979|11345496|FG000|NOT COMPLETED|Overall Study||3
10218096|NCT04502979|11345497|FG001|NOT COMPLETED|Overall Study||4
10218097|NCT04502056|11345505|FG000|STARTED|Overall Study||2046
10218098|NCT04502056|11345506|FG001|STARTED|Overall Study||2044
10218099|NCT04502056|11345507|FG002|STARTED|Overall Study||2045
10218100|NCT04502056|11345508|FG003|STARTED|Overall Study||2046
10218101|NCT04502056|11345509|FG004|STARTED|Overall Study||2044
10218102|NCT04502056|11345510|FG005|STARTED|Overall Study||2052
10218103|NCT04502056|11345511|FG006|STARTED|Overall Study||2046
10218104|NCT04502056|11345512|FG007|STARTED|Overall Study||2043
10218105|NCT04502056|11345513|FG008|STARTED|Overall Study||1026
10218106|NCT04502056|11345514|FG009|STARTED|Overall Study||1025
10218107|NCT04502056|11345515|FG010|STARTED|Overall Study||1023
10218108|NCT04502056|11345516|FG011|STARTED|Overall Study||1020
10218109|NCT04502056|11345505|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
10218110|NCT04502056|11345506|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
10218111|NCT04502056|11345507|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
10218112|NCT04502056|11345508|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
10218113|NCT04502056|11345509|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
10218114|NCT04502056|11345510|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
10218115|NCT04502056|11345511|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
10218116|NCT04502056|11345512|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
10218117|NCT04502056|11345513|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
10218118|NCT04502056|11345514|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
10218119|NCT04502056|11345515|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
10218120|NCT04502056|11345516|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
10218121|NCT04502056|11345505|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
10218122|NCT04502056|11345506|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
10218123|NCT04502056|11345507|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
10218124|NCT04502056|11345508|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
10218125|NCT04502056|11345509|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
10218126|NCT04502056|11345510|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
10218127|NCT04502056|11345511|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
10218128|NCT04502056|11345512|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
10218129|NCT04502056|11345513|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
10218130|NCT04502056|11345514|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
10218131|NCT04502056|11345515|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
10218132|NCT04502056|11345516|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
10218133|NCT04502056|11345505|FG000|Completed the Follow-up Survey|Overall Study||608
10218134|NCT04502056|11345506|FG001|Completed the Follow-up Survey|Overall Study||607
10218135|NCT04502056|11345507|FG002|Completed the Follow-up Survey|Overall Study||591
10218136|NCT04502056|11345508|FG003|Completed the Follow-up Survey|Overall Study||601
10218137|NCT04502056|11345509|FG004|Completed the Follow-up Survey|Overall Study||631
10218138|NCT04502056|11345510|FG005|Completed the Follow-up Survey|Overall Study||598
10218139|NCT04502056|11345511|FG006|Completed the Follow-up Survey|Overall Study||607
10218140|NCT04502056|11345512|FG007|Completed the Follow-up Survey|Overall Study||607
10218141|NCT04502056|11345513|FG008|Completed the Follow-up Survey|Overall Study||301
10218142|NCT04502056|11345514|FG009|Completed the Follow-up Survey|Overall Study||313
10218143|NCT04502056|11345515|FG010|Completed the Follow-up Survey|Overall Study||291
10218144|NCT04502056|11345516|FG011|Completed the Follow-up Survey|Overall Study||316
10218145|NCT04502056|11345505|FG000|COMPLETED|Overall Study||604
10218146|NCT04502056|11345506|FG001|COMPLETED|Overall Study||602
10218147|NCT04502056|11345507|FG002|COMPLETED|Overall Study||586
9760853|NCT00383747|10864660|FG002|STARTED|Visit 2||16
9760854|NCT00383747|10864661|FG003|STARTED|Visit 2||16
10218148|NCT04502056|11345508|FG003|COMPLETED|Overall Study||597
10218149|NCT04502056|11345509|FG004|COMPLETED|Overall Study||626
10218150|NCT04502056|11345510|FG005|COMPLETED|Overall Study||596
10218151|NCT04502056|11345511|FG006|COMPLETED|Overall Study||605
9760855|NCT00383747|10864658|FG000|COMPLETED|Visit 2||14
10218152|NCT04502056|11345512|FG007|COMPLETED|Overall Study||603
10218153|NCT04502056|11345513|FG008|COMPLETED|Overall Study||298
10218154|NCT04502056|11345514|FG009|COMPLETED|Overall Study||311
10218155|NCT04502056|11345515|FG010|COMPLETED|Overall Study||288
10218156|NCT04502056|11345516|FG011|COMPLETED|Overall Study||614
10218157|NCT04502056|11345505|FG000|NOT COMPLETED|Overall Study||1442
10218158|NCT04502056|11345506|FG001|NOT COMPLETED|Overall Study||1442
10218159|NCT04502056|11345507|FG002|NOT COMPLETED|Overall Study||1459
10218160|NCT04502056|11345508|FG003|NOT COMPLETED|Overall Study||1449
10218161|NCT04502056|11345509|FG004|NOT COMPLETED|Overall Study||1418
10218162|NCT04502056|11345510|FG005|NOT COMPLETED|Overall Study||1456
10218163|NCT04502056|11345511|FG006|NOT COMPLETED|Overall Study||1441
10218164|NCT04502056|11345512|FG007|NOT COMPLETED|Overall Study||1440
10218165|NCT04502056|11345513|FG008|NOT COMPLETED|Overall Study||728
10218166|NCT04502056|11345514|FG009|NOT COMPLETED|Overall Study||714
10218167|NCT04502056|11345515|FG010|NOT COMPLETED|Overall Study||735
10218168|NCT04502056|11345516|FG011|NOT COMPLETED|Overall Study||406
10218169|NCT04498403|11345540|FG000|STARTED|Overall Study||30
10218170|NCT04498403|11345541|FG001|STARTED|Overall Study||10
10218171|NCT04498403|11345540|FG000|Completed Follow up|Overall Study||30
10218172|NCT04498403|11345541|FG001|Completed Follow up|Overall Study||10
10218173|NCT04498403|11345540|FG000|COMPLETED|Overall Study||0
10218174|NCT04498403|11345541|FG001|COMPLETED|Overall Study||0
10218175|NCT04498403|11345540|FG000|NOT COMPLETED|Overall Study||30
10218176|NCT04498403|11345541|FG001|NOT COMPLETED|Overall Study||10
10012442|NCT01785615|11135239|FG003|COMPLETED|Dietary Phase||116
10012443|NCT01785615|11135236|FG000|NOT COMPLETED|Dietary Phase||0
10012444|NCT01785615|11135237|FG001|NOT COMPLETED|Dietary Phase||0
10012445|NCT01785615|11135238|FG002|NOT COMPLETED|Dietary Phase||0
10012446|NCT01785615|11135239|FG003|NOT COMPLETED|Dietary Phase||24
10218177|NCT04495374|11345549|FG000|STARTED|Overall Study||30
10218178|NCT04495374|11345550|FG001|STARTED|Overall Study||28
10218179|NCT04495374|11345549|FG000|COMPLETED|Overall Study||28
10218180|NCT04495374|11345550|FG001|COMPLETED|Overall Study||27
10218181|NCT04495374|11345549|FG000|NOT COMPLETED|Overall Study||2
10218182|NCT04495374|11345550|FG001|NOT COMPLETED|Overall Study||1
10218183|NCT04495712|11345558|FG000|STARTED|Overall Study||44
10218184|NCT04495712|11345559|FG001|STARTED|Overall Study||46
10218185|NCT04495712|11345558|FG000|COMPLETED|Overall Study||44
10218186|NCT04495712|11345559|FG001|COMPLETED|Overall Study||46
10218187|NCT04495712|11345558|FG000|NOT COMPLETED|Overall Study||0
10218188|NCT04495712|11345559|FG001|NOT COMPLETED|Overall Study||0
10218189|NCT04492397|11345565|FG000|STARTED|First Intervention||17
10218190|NCT04492397|11345566|FG001|STARTED|First Intervention||18
10218191|NCT04492397|11345565|FG000|COMPLETED|First Intervention||17
10218192|NCT04492397|11345566|FG001|COMPLETED|First Intervention||18
10218193|NCT04492397|11345565|FG000|NOT COMPLETED|First Intervention||0
10218194|NCT04492397|11345566|FG001|NOT COMPLETED|First Intervention||0
10218195|NCT04492397|11345565|FG000|STARTED|Second Intervention||17
10218196|NCT04492397|11345566|FG001|STARTED|Second Intervention||18
10218197|NCT04492397|11345565|FG000|COMPLETED|Second Intervention||17
10218198|NCT04492397|11345566|FG001|COMPLETED|Second Intervention||18
10218199|NCT04492397|11345565|FG000|NOT COMPLETED|Second Intervention||0
10218200|NCT04492397|11345566|FG001|NOT COMPLETED|Second Intervention||0
10218201|NCT04491994|11345574|FG000|STARTED|Overall Study||180
10218202|NCT04491994|11345575|FG001|STARTED|Overall Study||360
10218203|NCT04491994|11345574|FG000|COMPLETED|Overall Study||151
10218204|NCT04491994|11345575|FG001|COMPLETED|Overall Study||349
10218205|NCT04491994|11345574|FG000|NOT COMPLETED|Overall Study||29
10218206|NCT04491994|11345575|FG001|NOT COMPLETED|Overall Study||11
10218207|NCT04491240|11345584|FG000|STARTED|Overall Study||10
10218208|NCT04491240|11345585|FG001|STARTED|Overall Study||10
10218209|NCT04491240|11345586|FG002|STARTED|Overall Study||10
10218210|NCT04491240|11345584|FG000|COMPLETED|Overall Study||10
10218211|NCT04491240|11345585|FG001|COMPLETED|Overall Study||10
10218212|NCT04491240|11345586|FG002|COMPLETED|Overall Study||10
10218213|NCT04491240|11345584|FG000|NOT COMPLETED|Overall Study||0
10218214|NCT04491240|11345585|FG001|NOT COMPLETED|Overall Study||0
10218215|NCT04491240|11345586|FG002|NOT COMPLETED|Overall Study||0
10218216|NCT04490863|11345594|FG000|STARTED|Overall Study||26
10218217|NCT04490863|11345594|FG000|COMPLETED|Overall Study||26
10218218|NCT04490863|11345594|FG000|NOT COMPLETED|Overall Study||0
10218219|NCT04490499|11345598|FG000|STARTED|Overall Study||207
10218220|NCT04490499|11345598|FG000|Vaccinated|Overall Study||205
10218221|NCT04490499|11345598|FG000|COMPLETED|Overall Study||205
10218222|NCT04490499|11345598|FG000|NOT COMPLETED|Overall Study||2
10218223|NCT04490239|11345602|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6
10218224|NCT04490239|11345602|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6
10218225|NCT04490239|11345602|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
10012447|NCT01785615|11135236|FG000|STARTED|Atorvastatin Phase||44
10012448|NCT01785615|11135237|FG001|STARTED|Atorvastatin Phase||44
10012449|NCT01785615|11135238|FG002|STARTED|Atorvastatin Phase||0
10218226|NCT04490239|11345602|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6
10218227|NCT04490239|11345602|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6
10218228|NCT04490239|11345602|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
10218229|NCT04490239|11345602|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6
10218230|NCT04490239|11345602|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
10218231|NCT04490239|11345602|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
10218232|NCT04486235|11345608|FG000|STARTED|Overall Study||32
10218233|NCT04486235|11345609|FG001|STARTED|Overall Study||30
10218234|NCT04486235|11345608|FG000|Analysis|Overall Study||30
10218235|NCT04486235|11345609|FG001|Analysis|Overall Study||30
10218236|NCT04486235|11345608|FG000|COMPLETED|Overall Study||30
10218237|NCT04486235|11345609|FG001|COMPLETED|Overall Study||30
10218238|NCT04486235|11345608|FG000|NOT COMPLETED|Overall Study||2
10218239|NCT04486235|11345609|FG001|NOT COMPLETED|Overall Study||0
10218240|NCT04483011|11345618|FG000|STARTED|Intervention Period 1 (8 Days)||9
10218241|NCT04483011|11345619|FG001|STARTED|Intervention Period 1 (8 Days)||9
10218242|NCT04483011|11345618|FG000|COMPLETED|Intervention Period 1 (8 Days)||9
10218243|NCT04483011|11345619|FG001|COMPLETED|Intervention Period 1 (8 Days)||9
10218244|NCT04483011|11345618|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0
10218245|NCT04483011|11345619|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0
10218246|NCT04483011|11345618|FG000|STARTED|Washout (7 Days)||9
10218247|NCT04483011|11345619|FG001|STARTED|Washout (7 Days)||9
10218248|NCT04483011|11345618|FG000|COMPLETED|Washout (7 Days)||9
10218249|NCT04483011|11345619|FG001|COMPLETED|Washout (7 Days)||8
10218250|NCT04483011|11345618|FG000|NOT COMPLETED|Washout (7 Days)||0
10218251|NCT04483011|11345619|FG001|NOT COMPLETED|Washout (7 Days)||1
10218252|NCT04483011|11345618|FG000|STARTED|Intervention Period 2 (8 Days)||9
10218253|NCT04483011|11345619|FG001|STARTED|Intervention Period 2 (8 Days)||8
10218254|NCT04483011|11345618|FG000|COMPLETED|Intervention Period 2 (8 Days)||9
10218255|NCT04483011|11345619|FG001|COMPLETED|Intervention Period 2 (8 Days)||8
10218256|NCT04483011|11345618|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0
10218257|NCT04483011|11345619|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0
10218258|NCT04475588|11345629|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
10218259|NCT04475588|11345630|FG001|STARTED|Overall Study||10
10218260|NCT04475588|11345629|FG000|COMPLETED|Overall Study||20
10218261|NCT04475588|11345630|FG001|COMPLETED|Overall Study||10
10218262|NCT04475588|11345629|FG000|NOT COMPLETED|Overall Study||2
10218263|NCT04475588|11345630|FG001|NOT COMPLETED|Overall Study||0
10218264|NCT04474496|11345637|FG000|STARTED|Overall Study||120
10218265|NCT04474496|11345637|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
10218266|NCT04474496|11345637|FG000|NOT COMPLETED|Overall Study||0
10218267|NCT04448210|11345643|FG000|STARTED|Overall Study||22
10218268|NCT04448210|11345644|FG001|STARTED|Overall Study||20
10218269|NCT04448210|11345643|FG000|COMPLETED|Overall Study||22
10218270|NCT04448210|11345644|FG001|COMPLETED|Overall Study||20
10218271|NCT04448210|11345643|FG000|NOT COMPLETED|Overall Study||0
10218272|NCT04448210|11345644|FG001|NOT COMPLETED|Overall Study||0
10218273|NCT04474405|11345656|FG000|STARTED|Overall Study||4
10218274|NCT04474405|11345657|FG001|STARTED|Overall Study||3
10218275|NCT04474405|11345658|FG002|STARTED|Overall Study||5
10218276|NCT04474405|11345659|FG003|STARTED|Overall Study||4
10218277|NCT04474405|11345660|FG004|STARTED|Overall Study||13
10218278|NCT04474405|11345661|FG005|STARTED|Overall Study||7
10218279|NCT04474405|11345656|FG000|Flortaucipir PET Scan|Overall Study||4
10218280|NCT04474405|11345657|FG001|Flortaucipir PET Scan|Overall Study||3
10218281|NCT04474405|11345658|FG002|Flortaucipir PET Scan|Overall Study||4
10218282|NCT04474405|11345659|FG003|Flortaucipir PET Scan|Overall Study||4
10218283|NCT04474405|11345660|FG004|Flortaucipir PET Scan|Overall Study||9
10218284|NCT04474405|11345661|FG005|Flortaucipir PET Scan|Overall Study||0
10218285|NCT04474405|11345656|FG000|Florbetapir PET Scan|Overall Study||4
10218286|NCT04474405|11345657|FG001|Florbetapir PET Scan|Overall Study||3
10218287|NCT04474405|11345658|FG002|Florbetapir PET Scan|Overall Study||0
10218288|NCT04474405|11345659|FG003|Florbetapir PET Scan|Overall Study||4
10218289|NCT04474405|11345660|FG004|Florbetapir PET Scan|Overall Study||0
10218290|NCT04474405|11345661|FG005|Florbetapir PET Scan|Overall Study||4
10218291|NCT04474405|11345656|FG000|COMPLETED|Overall Study||4
10218292|NCT04474405|11345657|FG001|COMPLETED|Overall Study||3
10218293|NCT04474405|11345658|FG002|COMPLETED|Overall Study||4
10218294|NCT04474405|11345659|FG003|COMPLETED|Overall Study||4
10218295|NCT04474405|11345660|FG004|COMPLETED|Overall Study||9
10218296|NCT04474405|11345661|FG005|COMPLETED|Overall Study||7
10218297|NCT04474405|11345656|FG000|NOT COMPLETED|Overall Study||0
10218298|NCT04474405|11345657|FG001|NOT COMPLETED|Overall Study||0
10218299|NCT04474405|11345658|FG002|NOT COMPLETED|Overall Study||1
10218300|NCT04474405|11345659|FG003|NOT COMPLETED|Overall Study||0
10218301|NCT04474405|11345660|FG004|NOT COMPLETED|Overall Study||4
10218302|NCT04474405|11345661|FG005|NOT COMPLETED|Overall Study||0
10218303|NCT04470375|11345675|FG000|STARTED|Overall Study||20
10218304|NCT04470375|11345675|FG000|COMPLETED|Overall Study||20
10218305|NCT04470375|11345675|FG000|NOT COMPLETED|Overall Study||0
10218306|NCT04468347|11345683|FG000|STARTED|Overall Study||6
10218307|NCT04468347|11345684|FG001|STARTED|Overall Study||11
10218308|NCT04468347|11345685|FG002|STARTED|Overall Study||47
10218309|NCT04468347|11345686|FG003|STARTED|Overall Study||25
10218310|NCT04468347|11345683|FG000|Baseline Flortacuipir PET Scan|Overall Study||5
10218311|NCT04468347|11345684|FG001|Baseline Flortacuipir PET Scan|Overall Study||11
10218312|NCT04468347|11345685|FG002|Baseline Flortacuipir PET Scan|Overall Study||45
10218313|NCT04468347|11345686|FG003|Baseline Flortacuipir PET Scan|Overall Study||25
10218314|NCT04468347|11345683|FG000|COMPLETED|Overall Study||4
10218315|NCT04468347|11345684|FG001|COMPLETED|Overall Study||10
10218316|NCT04468347|11345685|FG002|COMPLETED|Overall Study||41
10218317|NCT04468347|11345686|FG003|COMPLETED|Overall Study||21
10218318|NCT04468347|11345683|FG000|NOT COMPLETED|Overall Study||2
10218319|NCT04468347|11345684|FG001|NOT COMPLETED|Overall Study||1
10218320|NCT04468347|11345685|FG002|NOT COMPLETED|Overall Study||6
10218321|NCT04468347|11345686|FG003|NOT COMPLETED|Overall Study||4
10218322|NCT04467424|11345702|FG000|STARTED|Overall Study||100
10218323|NCT04467424|11345703|FG001|STARTED|Overall Study||100
10218324|NCT04467424|11345702|FG000|COMPLETED|Overall Study||100
10218325|NCT04467424|11345703|FG001|COMPLETED|Overall Study||100
10218326|NCT04467424|11345702|FG000|NOT COMPLETED|Overall Study||0
10218327|NCT04467424|11345703|FG001|NOT COMPLETED|Overall Study||0
10218328|NCT04465422|11345711|FG000|STARTED|Overall Study||17
10218329|NCT04465422|11345712|FG001|STARTED|Overall Study||16
10218330|NCT04465422|11345711|FG000|COMPLETED|Overall Study||17
10218331|NCT04465422|11345712|FG001|COMPLETED|Overall Study||14
10218332|NCT04465422|11345711|FG000|NOT COMPLETED|Overall Study||0
10218333|NCT04465422|11345712|FG001|NOT COMPLETED|Overall Study||2
10218334|NCT04463004|11345722|FG000|STARTED|Overall Study||1
10218335|NCT04463004|11345723|FG001|STARTED|Overall Study||1
10218336|NCT04463004|11345722|FG000|COMPLETED|Overall Study||1
10218337|NCT04463004|11345723|FG001|COMPLETED|Overall Study||1
10218338|NCT04463004|11345722|FG000|NOT COMPLETED|Overall Study||0
10218339|NCT04463004|11345723|FG001|NOT COMPLETED|Overall Study||0
10218340|NCT04448561|11345731|FG000|STARTED|Overall Study||16
10218341|NCT04448561|11345732|FG001|STARTED|Overall Study||8
10218342|NCT04448561|11345731|FG000|COMPLETED|Overall Study||15
10218343|NCT04448561|11345732|FG001|COMPLETED|Overall Study||8
10218344|NCT04448561|11345731|FG000|NOT COMPLETED|Overall Study||1
10218345|NCT04448561|11345732|FG001|NOT COMPLETED|Overall Study||0
10218346|NCT04462731|11345748|FG000|STARTED|Overall Study||97
10218347|NCT04462731|11345749|FG001|STARTED|Overall Study||97
10218348|NCT04462731|11345748|FG000|COMPLETED|Overall Study||41
10218349|NCT04462731|11345749|FG001|COMPLETED|Overall Study||51
10218350|NCT04462731|11345748|FG000|NOT COMPLETED|Overall Study||56
10218351|NCT04462731|11345749|FG001|NOT COMPLETED|Overall Study||46
10218352|NCT04459585|11345755|FG000|STARTED|Period 1 (Day 1 to Day 5)||20
10218353|NCT04459585|11345755|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20
10218354|NCT04459585|11345755|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
10218355|NCT04459585|11345755|FG000|STARTED|Period 2 (Day 5 to Day 12)||20
10218356|NCT04459585|11345755|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20
10218357|NCT04459585|11345755|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
10218358|NCT04458818|11345762|FG000|STARTED|Overall Study|May 01 2020|39
10218359|NCT04458818|11345762|FG000|COMPLETED|Overall Study|Jan 30 2021|39
10218360|NCT04458818|11345762|FG000|NOT COMPLETED|Overall Study||0
10218361|NCT04456634|11345768|FG000|STARTED|Overall Study||6
10218362|NCT04456634|11345769|FG001|STARTED|Overall Study||2
10218363|NCT04456634|11345768|FG000|COMPLETED|Overall Study||5
10218364|NCT04456634|11345769|FG001|COMPLETED|Overall Study||2
10218365|NCT04456634|11345768|FG000|NOT COMPLETED|Overall Study||1
10218366|NCT04456634|11345769|FG001|NOT COMPLETED|Overall Study||0
10218367|NCT04454138|11345777|FG000|STARTED|Overall Study||65
10218368|NCT04454138|11345778|FG001|STARTED|Overall Study||77
10218369|NCT04454138|11345777|FG000|COMPLETED|Overall Study||65
10218370|NCT04454138|11345778|FG001|COMPLETED|Overall Study||77
10218371|NCT04454138|11345777|FG000|NOT COMPLETED|Overall Study||0
10218372|NCT04454138|11345778|FG001|NOT COMPLETED|Overall Study||0
10218373|NCT04452435|11345786|FG000|STARTED|Screening||51
10218374|NCT04452435|11345787|FG001|STARTED|Screening||55
10218375|NCT04452435|11345786|FG000|COMPLETED|Screening||51
10218376|NCT04452435|11345787|FG001|COMPLETED|Screening||55
10218377|NCT04452435|11345786|FG000|NOT COMPLETED|Screening||0
10218378|NCT04452435|11345787|FG001|NOT COMPLETED|Screening||0
10218379|NCT04452435|11345786|FG000|STARTED|Treatment Period||51
10218380|NCT04452435|11345787|FG001|STARTED|Treatment Period||55
10218381|NCT04452435|11345786|FG000|COMPLETED|Treatment Period||45
10218382|NCT04452435|11345787|FG001|COMPLETED|Treatment Period||43
10218383|NCT04452435|11345786|FG000|NOT COMPLETED|Treatment Period||6
10218384|NCT04452435|11345787|FG001|NOT COMPLETED|Treatment Period||12
10218385|NCT04452435|11345786|FG000|STARTED|Follow-up||45
10218386|NCT04452435|11345787|FG001|STARTED|Follow-up||43
10218387|NCT04452435|11345786|FG000|COMPLETED|Follow-up||45
10218388|NCT04452435|11345787|FG001|COMPLETED|Follow-up||42
10218389|NCT04452435|11345786|FG000|NOT COMPLETED|Follow-up||0
10218390|NCT04452435|11345787|FG001|NOT COMPLETED|Follow-up||1
10218391|NCT04451707|11345794|FG000|STARTED|Overall Study||67
10218392|NCT04451707|11345794|FG000|COMPLETED|Overall Study||67
10218393|NCT04451707|11345794|FG000|NOT COMPLETED|Overall Study||0
10218394|NCT04449263|11345798|FG000|STARTED|First Intervention||29
10218395|NCT04449263|11345799|FG001|STARTED|First Intervention||30
10218396|NCT04449263|11345798|FG000|COMPLETED|First Intervention||29
10218397|NCT04449263|11345799|FG001|COMPLETED|First Intervention||30
10218398|NCT04449263|11345798|FG000|NOT COMPLETED|First Intervention||0
10218399|NCT04449263|11345799|FG001|NOT COMPLETED|First Intervention||0
10218400|NCT04449263|11345798|FG000|STARTED|Second Intervention||29
10218401|NCT04449263|11345799|FG001|STARTED|Second Intervention||30
10218402|NCT04449263|11345798|FG000|COMPLETED|Second Intervention||29
10218403|NCT04449263|11345799|FG001|COMPLETED|Second Intervention||30
10218404|NCT04449263|11345798|FG000|NOT COMPLETED|Second Intervention||0
10218405|NCT04449263|11345799|FG001|NOT COMPLETED|Second Intervention||0
10218406|NCT04449263|11345798|FG000|STARTED|Third Intervention||29
10218407|NCT04449263|11345799|FG001|STARTED|Third Intervention||30
10218408|NCT04449263|11345798|FG000|COMPLETED|Third Intervention||29
10218409|NCT04449263|11345799|FG001|COMPLETED|Third Intervention||30
10218410|NCT04449263|11345798|FG000|NOT COMPLETED|Third Intervention||0
10218411|NCT04449263|11345799|FG001|NOT COMPLETED|Third Intervention||0
10239057|NCT00384293|11370549|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
10239058|NCT00384293|11370547|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
10239059|NCT00384293|11370548|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10239060|NCT00384293|11370549|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10239061|NCT00384293|11370547|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
10239062|NCT00384293|11370548|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10239063|NCT00384293|11370549|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10239064|NCT00384293|11370547|FG000|STARTED|Post-randomization Period||0
10239065|NCT00384293|11370548|FG001|STARTED|Post-randomization Period||214
10239066|NCT00384293|11370549|FG002|STARTED|Post-randomization Period||219
10239067|NCT00384293|11370547|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
10239068|NCT00384293|11370548|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
10239069|NCT00384293|11370549|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
10239070|NCT00384293|11370547|FG000|COMPLETED|Post-randomization Period||0
10239071|NCT00384293|11370548|FG001|COMPLETED|Post-randomization Period||0
10239072|NCT00384293|11370549|FG002|COMPLETED|Post-randomization Period||0
10239073|NCT00384293|11370547|FG000|NOT COMPLETED|Post-randomization Period||0
10239074|NCT00384293|11370548|FG001|NOT COMPLETED|Post-randomization Period||214
10239075|NCT00384293|11370549|FG002|NOT COMPLETED|Post-randomization Period||219
10239076|NCT00383630|11370557|FG000|STARTED|Overall Study||1
10239077|NCT00383630|11370557|FG000|COMPLETED|Overall Study||1
10239078|NCT00383630|11370557|FG000|NOT COMPLETED|Overall Study||0
10239079|NCT00374543|11370563|FG000|STARTED|Overall Study||2
10239080|NCT00374543|11370564|FG001|STARTED|Overall Study||1
10239081|NCT00374543|11370563|FG000|COMPLETED|Overall Study||2
10239082|NCT00374543|11370564|FG001|COMPLETED|Overall Study||1
10239083|NCT00374543|11370563|FG000|NOT COMPLETED|Overall Study||0
10239084|NCT00374543|11370564|FG001|NOT COMPLETED|Overall Study||0
10239085|NCT00377455|11370570|FG000|STARTED|Overall Study||5
10239086|NCT00377455|11370570|FG000|COMPLETED|Overall Study||4
10239087|NCT00377455|11370570|FG000|NOT COMPLETED|Overall Study||1
10239088|NCT00371462|11370576|FG000|STARTED|Overall Study||35
10239089|NCT00371462|11370577|FG001|STARTED|Overall Study||35
10239090|NCT00371462|11370576|FG000|COMPLETED|Overall Study||27
10239091|NCT00371462|11370577|FG001|COMPLETED|Overall Study||27
10239092|NCT00371462|11370576|FG000|NOT COMPLETED|Overall Study||8
10239093|NCT00371462|11370577|FG001|NOT COMPLETED|Overall Study||8
10239094|NCT00369265|11370585|FG000|STARTED|Overall Study||4
10239095|NCT00369265|11370586|FG001|STARTED|Overall Study||7
10239096|NCT00369265|11370585|FG000|COMPLETED|Overall Study||0
10239097|NCT00369265|11370586|FG001|COMPLETED|Overall Study||0
10239098|NCT00369265|11370585|FG000|NOT COMPLETED|Overall Study||4
10239099|NCT00369265|11370586|FG001|NOT COMPLETED|Overall Study||7
10239100|NCT00370695|11370592|FG000|STARTED|Overall Study||15
10239101|NCT00370695|11370592|FG000|12 Weeks Post-activation|Overall Study||2
10239102|NCT00370695|11370592|FG000|COMPLETED|Overall Study||0
10239103|NCT00370695|11370592|FG000|NOT COMPLETED|Overall Study||15
10239104|NCT00364689|11370599|FG000|STARTED|Overall Study||13
10239105|NCT00364689|11370599|FG000|COMPLETED|Overall Study||12
10239106|NCT00364689|11370599|FG000|NOT COMPLETED|Overall Study||1
10012450|NCT01785615|11135239|FG003|STARTED|Atorvastatin Phase||0
10239107|NCT00352118|11370605|FG000|STARTED|Overall Study||4
10239108|NCT00352118|11370605|FG000|COMPLETED|Overall Study||0
10239109|NCT00352118|11370605|FG000|NOT COMPLETED|Overall Study||4
10239110|NCT00368654|11370613|FG000|STARTED|Overall Study||3
10239111|NCT00368654|11370614|FG001|STARTED|Overall Study||3
10239112|NCT00368654|11370615|FG002|STARTED|Overall Study||3
10239113|NCT00368654|11370616|FG003|STARTED|Overall Study||3
10239114|NCT00368654|11370613|FG000|COMPLETED|Overall Study||0
10239115|NCT00368654|11370614|FG001|COMPLETED|Overall Study||0
10239116|NCT00368654|11370615|FG002|COMPLETED|Overall Study||0
10239117|NCT00368654|11370616|FG003|COMPLETED|Overall Study||0
9952091|NCT01419665|11070986|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
9952092|NCT01419665|11070985|FG000|STARTED|Open Label Phase||44
9952093|NCT01419665|11070986|FG001|STARTED|Open Label Phase||39
9952094|NCT01419665|11070985|FG000|COMPLETED|Open Label Phase||43
9952095|NCT01419665|11070986|FG001|COMPLETED|Open Label Phase||38
9952096|NCT01419665|11070985|FG000|NOT COMPLETED|Open Label Phase||1
9952097|NCT01419665|11070986|FG001|NOT COMPLETED|Open Label Phase||1
10012451|NCT01785615|11135236|FG000|COMPLETED|Atorvastatin Phase||44
10012452|NCT01785615|11135237|FG001|COMPLETED|Atorvastatin Phase||44
10239118|NCT00368654|11370613|FG000|NOT COMPLETED|Overall Study||3
10239119|NCT00368654|11370614|FG001|NOT COMPLETED|Overall Study||3
10239120|NCT00368654|11370615|FG002|NOT COMPLETED|Overall Study||3
10239121|NCT00368654|11370616|FG003|NOT COMPLETED|Overall Study||3
10239122|NCT00356421|11370628|FG000|STARTED|Overall Study||38
10239123|NCT00356421|11370629|FG001|STARTED|Overall Study||20
10239124|NCT00356421|11370628|FG000|COMPLETED|Overall Study||6
10239125|NCT00356421|11370629|FG001|COMPLETED|Overall Study||3
10239126|NCT00356421|11370628|FG000|NOT COMPLETED|Overall Study||32
10239127|NCT00356421|11370629|FG001|NOT COMPLETED|Overall Study||17
10239128|NCT00350623|11370638|FG000|STARTED|Overall Study||71
9952098|NCT01419717|11070994|FG000|STARTED|Overall Study||129
9952099|NCT01419717|11070994|FG000|Received Denosumab|Overall Study||128
9952100|NCT01419717|11070994|FG000|COMPLETED|Overall Study||4
10218412|NCT04450381|11345807|FG000|STARTED|Overall Study||131
10218413|NCT04450381|11345807|FG000|COMPLETED|Overall Study||125
10218414|NCT04450381|11345807|FG000|NOT COMPLETED|Overall Study||6
10218415|NCT04449341|11345813|FG000|STARTED|Overall Study||31
10218416|NCT04449341|11345814|FG001|STARTED|Overall Study||28
10218417|NCT04449341|11345813|FG000|COMPLETED|Overall Study||30
10218418|NCT04449341|11345814|FG001|COMPLETED|Overall Study||28
10218419|NCT04449341|11345813|FG000|NOT COMPLETED|Overall Study||1
10218420|NCT04449341|11345814|FG001|NOT COMPLETED|Overall Study||0
10218421|NCT04441255|11345822|FG000|STARTED|Period 1 (1 Day)||7
10218422|NCT04441255|11345823|FG001|STARTED|Period 1 (1 Day)||7
10218423|NCT04441255|11345822|FG000|COMPLETED|Period 1 (1 Day)||7
10218424|NCT04441255|11345823|FG001|COMPLETED|Period 1 (1 Day)||7
10218425|NCT04441255|11345822|FG000|NOT COMPLETED|Period 1 (1 Day)||0
10218426|NCT04441255|11345823|FG001|NOT COMPLETED|Period 1 (1 Day)||0
10218427|NCT04441255|11345822|FG000|STARTED|Washout Period (10 Days)||7
10218428|NCT04441255|11345823|FG001|STARTED|Washout Period (10 Days)||7
10218429|NCT04441255|11345822|FG000|COMPLETED|Washout Period (10 Days)||7
10218430|NCT04441255|11345823|FG001|COMPLETED|Washout Period (10 Days)||7
10218431|NCT04441255|11345822|FG000|NOT COMPLETED|Washout Period (10 Days)||0
10218432|NCT04441255|11345823|FG001|NOT COMPLETED|Washout Period (10 Days)||0
10218433|NCT04441255|11345822|FG000|STARTED|Period 2 (1 Day)||7
10218434|NCT04441255|11345823|FG001|STARTED|Period 2 (1 Day)||7
10218435|NCT04441255|11345822|FG000|COMPLETED|Period 2 (1 Day)||7
10218436|NCT04441255|11345823|FG001|COMPLETED|Period 2 (1 Day)||7
10218437|NCT04441255|11345822|FG000|NOT COMPLETED|Period 2 (1 Day)||0
10218438|NCT04441255|11345823|FG001|NOT COMPLETED|Period 2 (1 Day)||0
10218439|NCT04439214|11345829|FG000|STARTED|Overall Study||47
10218440|NCT04439214|11345829|FG000|Eligible|Overall Study||42
10218441|NCT04439214|11345829|FG000|Treated|Overall Study||47
10218442|NCT04439214|11345829|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
10218443|NCT04439214|11345829|FG000|Eligible and Treated|Overall Study||42
10218444|NCT04439214|11345829|FG000|COMPLETED|Overall Study||0
10218445|NCT04439214|11345829|FG000|NOT COMPLETED|Overall Study||47
10218446|NCT04439240|11345833|FG000|STARTED|Overall Study||52
10218447|NCT04439240|11345833|FG000|Started Protocol Therapy|Overall Study||50
10218448|NCT04439240|11345833|FG000|Eligible|Overall Study||49
10218449|NCT04439240|11345833|FG000|Eligible and Started Protocol Therapy|Overall Study||48
10218450|NCT04439240|11345833|FG000|Reported Adverse Events Data|Overall Study||49
10218451|NCT04439240|11345833|FG000|COMPLETED|Overall Study||0
10218452|NCT04439240|11345833|FG000|NOT COMPLETED|Overall Study||52
10218453|NCT04438785|11345839|FG000|STARTED|Overall Study||20
10218454|NCT04438785|11345840|FG001|STARTED|Overall Study||20
10218455|NCT04438785|11345839|FG000|COMPLETED|Overall Study||18
10218456|NCT04438785|11345840|FG001|COMPLETED|Overall Study||10
10012453|NCT01785615|11135238|FG002|COMPLETED|Atorvastatin Phase||0
10012454|NCT01785615|11135239|FG003|COMPLETED|Atorvastatin Phase||0
10012455|NCT01785615|11135236|FG000|NOT COMPLETED|Atorvastatin Phase||0
10012456|NCT01785615|11135237|FG001|NOT COMPLETED|Atorvastatin Phase||0
10012457|NCT01785615|11135238|FG002|NOT COMPLETED|Atorvastatin Phase||0
10218457|NCT04438785|11345839|FG000|NOT COMPLETED|Overall Study||2
10218458|NCT04438785|11345840|FG001|NOT COMPLETED|Overall Study||10
10218459|NCT04431908|11345848|FG000|STARTED|Overall Study||1042
10218460|NCT04431908|11345849|FG001|STARTED|Overall Study||278
10218461|NCT04431908|11345848|FG000|COMPLETED|Overall Study||1042
10218462|NCT04431908|11345849|FG001|COMPLETED|Overall Study||278
10218463|NCT04431908|11345848|FG000|NOT COMPLETED|Overall Study||0
10218464|NCT04431908|11345849|FG001|NOT COMPLETED|Overall Study||0
10218465|NCT04413929|11345856|FG000|STARTED|Overall Study||8411
10218466|NCT04413929|11345856|FG000|COMPLETED|Overall Study||8411
10218467|NCT04413929|11345856|FG000|NOT COMPLETED|Overall Study||0
10218468|NCT04430634|11345869|FG000|STARTED|Overall Study||5
10218469|NCT04430634|11345870|FG001|STARTED|Overall Study||5
10218470|NCT04430634|11345871|FG002|STARTED|Overall Study||5
10218471|NCT04430634|11345872|FG003|STARTED|Overall Study||5
10218472|NCT04430634|11345873|FG004|STARTED|Overall Study||5
10012458|NCT01785615|11135239|FG003|NOT COMPLETED|Atorvastatin Phase||0
10012459|NCT01785628|11135253|FG000|STARTED|Overall Study||15
10218473|NCT04430634|11345874|FG005|STARTED|Overall Study||5
10218474|NCT04430634|11345875|FG006|STARTED|Overall Study||5
10218475|NCT04430634|11345876|FG007|STARTED|Overall Study||5
10218476|NCT04430634|11345869|FG000|COMPLETED|Overall Study||5
10218477|NCT04430634|11345870|FG001|COMPLETED|Overall Study||5
10218478|NCT04430634|11345871|FG002|COMPLETED|Overall Study||5
10218479|NCT04430634|11345872|FG003|COMPLETED|Overall Study||4
10218480|NCT04430634|11345873|FG004|COMPLETED|Overall Study||5
10218481|NCT04430634|11345874|FG005|COMPLETED|Overall Study||5
10218482|NCT04430634|11345875|FG006|COMPLETED|Overall Study||4
10218483|NCT04430634|11345876|FG007|COMPLETED|Overall Study||5
10218484|NCT04430634|11345869|FG000|NOT COMPLETED|Overall Study||0
10218485|NCT04430634|11345870|FG001|NOT COMPLETED|Overall Study||0
10218486|NCT04430634|11345871|FG002|NOT COMPLETED|Overall Study||0
10218487|NCT04430634|11345872|FG003|NOT COMPLETED|Overall Study||1
10218488|NCT04430634|11345873|FG004|NOT COMPLETED|Overall Study||0
10218489|NCT04430634|11345874|FG005|NOT COMPLETED|Overall Study||0
10218490|NCT04430634|11345875|FG006|NOT COMPLETED|Overall Study||1
10218491|NCT04430634|11345876|FG007|NOT COMPLETED|Overall Study||0
10218492|NCT04429932|11345903|FG000|STARTED|Overall Study||4
10218493|NCT04429932|11345904|FG001|STARTED|Overall Study||5
10218494|NCT04429932|11345905|FG002|STARTED|Overall Study||5
10218495|NCT04429932|11345906|FG003|STARTED|Overall Study||5
10218496|NCT04429932|11345907|FG004|STARTED|Overall Study||5
10218497|NCT04429932|11345908|FG005|STARTED|Overall Study||5
10111919|NCT02499783|11242964|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
10111920|NCT02499952|11242974|FG000|STARTED|Overall Study||12
10111921|NCT02499952|11242974|FG000|COMPLETED|Overall Study||2
10111922|NCT02499952|11242974|FG000|NOT COMPLETED|Overall Study||10
10111923|NCT02500043|11242980|FG000|STARTED|Overall Study||337
10111924|NCT02500043|11242981|FG001|STARTED|Overall Study||170
10111925|NCT02500043|11242980|FG000|As-Treated (AT) Population|Overall Study||335
10111926|NCT02500043|11242981|FG001|As-Treated (AT) Population|Overall Study||168
10111927|NCT02500043|11242980|FG000|COMPLETED|Overall Study||0
10111928|NCT02500043|11242981|FG001|COMPLETED|Overall Study||0
10111929|NCT02500043|11242980|FG000|NOT COMPLETED|Overall Study||337
10111930|NCT02500043|11242981|FG001|NOT COMPLETED|Overall Study||170
10111931|NCT02500056|11242989|FG000|STARTED|Overall Study||70
10111932|NCT02500056|11242990|FG001|STARTED|Overall Study||73
10111933|NCT02500056|11242989|FG000|COMPLETED|Overall Study||63
10111934|NCT02500056|11242990|FG001|COMPLETED|Overall Study||65
10111935|NCT02500056|11242989|FG000|NOT COMPLETED|Overall Study||7
10218498|NCT04429932|11345909|FG006|STARTED|Overall Study||5
10218499|NCT04429932|11345910|FG007|STARTED|Overall Study||5
10218500|NCT04429932|11345903|FG000|COMPLETED|Overall Study||3
10218501|NCT04429932|11345904|FG001|COMPLETED|Overall Study||5
10218502|NCT04429932|11345905|FG002|COMPLETED|Overall Study||5
10218503|NCT04429932|11345906|FG003|COMPLETED|Overall Study||2
10218504|NCT04429932|11345907|FG004|COMPLETED|Overall Study||5
10218505|NCT04429932|11345908|FG005|COMPLETED|Overall Study||5
10218506|NCT04429932|11345909|FG006|COMPLETED|Overall Study||5
10218507|NCT04429932|11345910|FG007|COMPLETED|Overall Study||5
10218508|NCT04429932|11345903|FG000|NOT COMPLETED|Overall Study||1
10218509|NCT04429932|11345904|FG001|NOT COMPLETED|Overall Study||0
10218510|NCT04429932|11345905|FG002|NOT COMPLETED|Overall Study||0
10218511|NCT04429932|11345906|FG003|NOT COMPLETED|Overall Study||3
10218512|NCT04429932|11345907|FG004|NOT COMPLETED|Overall Study||0
10218513|NCT04429932|11345908|FG005|NOT COMPLETED|Overall Study||0
10218514|NCT04429932|11345909|FG006|NOT COMPLETED|Overall Study||0
10218515|NCT04429932|11345910|FG007|NOT COMPLETED|Overall Study||0
10218516|NCT04428502|11345929|FG000|STARTED|Overall Study||127
10218517|NCT04428502|11345929|FG000|COMPLETED|Overall Study||113
10218518|NCT04428502|11345929|FG000|NOT COMPLETED|Overall Study||14
10218519|NCT04428424|11345934|FG000|STARTED|Overall Study||1493
10218520|NCT04428424|11345934|FG000|COMPLETED|Overall Study||1246
10218521|NCT04428424|11345934|FG000|NOT COMPLETED|Overall Study||247
10218522|NCT04428359|11345940|FG000|STARTED|Overall Study||33
10218523|NCT04428359|11345941|FG001|STARTED|Overall Study||33
10218524|NCT04428359|11345940|FG000|COMPLETED|Overall Study||31
10218525|NCT04428359|11345941|FG001|COMPLETED|Overall Study||30
10218526|NCT04428359|11345940|FG000|NOT COMPLETED|Overall Study||2
10218527|NCT04428359|11345941|FG001|NOT COMPLETED|Overall Study||3
10218528|NCT04410159|11345951|FG000|STARTED|Overall Study||5
10218529|NCT04410159|11345952|FG001|STARTED|Overall Study||5
10218530|NCT04410159|11345953|FG002|STARTED|Overall Study||5
10218531|NCT04410159|11345954|FG003|STARTED|Overall Study||5
10218532|NCT04410159|11345951|FG000|COMPLETED|Overall Study||5
10218533|NCT04410159|11345952|FG001|COMPLETED|Overall Study||5
10218534|NCT04410159|11345953|FG002|COMPLETED|Overall Study||5
10218535|NCT04410159|11345954|FG003|COMPLETED|Overall Study||5
10218536|NCT04410159|11345951|FG000|NOT COMPLETED|Overall Study||0
10218537|NCT04410159|11345952|FG001|NOT COMPLETED|Overall Study||0
10218538|NCT04410159|11345953|FG002|NOT COMPLETED|Overall Study||0
10218539|NCT04410159|11345954|FG003|NOT COMPLETED|Overall Study||0
10218540|NCT04425850|11345966|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
10218541|NCT04425850|11345967|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
10218542|NCT04425850|11345966|FG000|COMPLETED|Overall Study||131
10218543|NCT04425850|11345967|FG001|COMPLETED|Overall Study||98
10218544|NCT04425850|11345966|FG000|NOT COMPLETED|Overall Study||0
10218545|NCT04425850|11345967|FG001|NOT COMPLETED|Overall Study||0
10218546|NCT04425863|11345978|FG000|STARTED|Overall Study||135
10218547|NCT04425863|11345979|FG001|STARTED|Overall Study||12
10218548|NCT04425863|11345980|FG002|STARTED|Overall Study||20
10218549|NCT04425863|11345978|FG000|COMPLETED|Overall Study||135
10218550|NCT04425863|11345979|FG001|COMPLETED|Overall Study||12
10218551|NCT04425863|11345980|FG002|COMPLETED|Overall Study||19
10218552|NCT04425863|11345978|FG000|NOT COMPLETED|Overall Study||0
10218553|NCT04425863|11345979|FG001|NOT COMPLETED|Overall Study||0
10218554|NCT04425863|11345980|FG002|NOT COMPLETED|Overall Study||1
10218555|NCT04425746|11346002|FG000|STARTED|Overall Study||9
10218556|NCT04425746|11346003|FG001|STARTED|Overall Study||7
10218557|NCT04425746|11346002|FG000|COMPLETED|Overall Study||9
10218558|NCT04425746|11346003|FG001|COMPLETED|Overall Study||6
10218559|NCT04425746|11346002|FG000|NOT COMPLETED|Overall Study||0
10218560|NCT04425746|11346003|FG001|NOT COMPLETED|Overall Study||1
10218561|NCT04422561|11346013|FG000|STARTED|Overall Study||228
10218562|NCT04422561|11346014|FG001|STARTED|Overall Study||112
10218563|NCT04422561|11346013|FG000|COMPLETED|Overall Study||203
10218564|NCT04422561|11346014|FG001|COMPLETED|Overall Study||101
10218565|NCT04422561|11346013|FG000|NOT COMPLETED|Overall Study||25
10218566|NCT04422561|11346014|FG001|NOT COMPLETED|Overall Study||11
10218567|NCT04421404|11346022|FG000|STARTED|Overall Study||16
10218568|NCT04421404|11346023|FG001|STARTED|Overall Study||18
10218569|NCT04421404|11346022|FG000|COMPLETED|Overall Study||16
10218570|NCT04421404|11346023|FG001|COMPLETED|Overall Study||18
10218571|NCT04421404|11346022|FG000|NOT COMPLETED|Overall Study||0
10218572|NCT04421404|11346023|FG001|NOT COMPLETED|Overall Study||0
10218573|NCT04419311|11346031|FG000|STARTED|Overall Study||33
10218574|NCT04419311|11346032|FG001|STARTED|Overall Study||33
10218575|NCT04419311|11346031|FG000|COMPLETED|Overall Study||32
10218576|NCT04419311|11346032|FG001|COMPLETED|Overall Study||33
10218577|NCT04419311|11346031|FG000|NOT COMPLETED|Overall Study||1
10218578|NCT04419311|11346032|FG001|NOT COMPLETED|Overall Study||0
10218579|NCT04415489|11346042|FG000|STARTED|Overall Study||50
10218580|NCT04415489|11346043|FG001|STARTED|Overall Study||50
10218581|NCT04415489|11346042|FG000|COMPLETED|Overall Study||50
10218582|NCT04415489|11346043|FG001|COMPLETED|Overall Study||50
10218583|NCT04415489|11346042|FG000|NOT COMPLETED|Overall Study||0
10218584|NCT04415489|11346043|FG001|NOT COMPLETED|Overall Study||0
10218585|NCT04411667|11346052|FG000|STARTED|Overall Study||17
10218586|NCT04411667|11346053|FG001|STARTED|Overall Study||17
10218587|NCT04411667|11346052|FG000|COMPLETED|Overall Study||16
10218588|NCT04411667|11346053|FG001|COMPLETED|Overall Study||17
10218589|NCT04411667|11346052|FG000|NOT COMPLETED|Overall Study||1
10218590|NCT04411667|11346053|FG001|NOT COMPLETED|Overall Study||0
10218591|NCT04409886|11346059|FG000|STARTED|Overall Study||1
10218592|NCT04409886|11346059|FG000|COMPLETED|Overall Study||1
10218593|NCT04409886|11346059|FG000|NOT COMPLETED|Overall Study||0
10218594|NCT04407507|11346065|FG000|STARTED|Overall Study||33
10218595|NCT04407507|11346066|FG001|STARTED|Overall Study||33
10218596|NCT04407507|11346065|FG000|COMPLETED|Overall Study||33
10218597|NCT04407507|11346066|FG001|COMPLETED|Overall Study||32
10218598|NCT04407507|11346065|FG000|NOT COMPLETED|Overall Study||0
10218599|NCT04407507|11346066|FG001|NOT COMPLETED|Overall Study||1
10218600|NCT04406194|11346074|FG000|STARTED|Period 1||15
10218601|NCT04406194|11346075|FG001|STARTED|Period 1||15
10218602|NCT04406194|11346074|FG000|COMPLETED|Period 1||15
10218603|NCT04406194|11346075|FG001|COMPLETED|Period 1||14
10218604|NCT04406194|11346074|FG000|NOT COMPLETED|Period 1||0
10218605|NCT04406194|11346075|FG001|NOT COMPLETED|Period 1||1
10218606|NCT04406194|11346074|FG000|STARTED|Period 2||15
10218607|NCT04406194|11346075|FG001|STARTED|Period 2||14
10218608|NCT04406194|11346074|FG000|COMPLETED|Period 2||15
10218609|NCT04406194|11346075|FG001|COMPLETED|Period 2||14
10218610|NCT04406194|11346074|FG000|NOT COMPLETED|Period 2||0
10218611|NCT04406194|11346075|FG001|NOT COMPLETED|Period 2||0
10218612|NCT04404907|11346086|FG000|STARTED|Overall Study||442
10218613|NCT04404907|11346087|FG001|STARTED|Overall Study||95
10218614|NCT04404907|11346086|FG000|Occasional Tan|Overall Study||0
10218615|NCT04404907|11346087|FG001|Occasional Tan|Overall Study||88
10218616|NCT04404907|11346086|FG000|Frequent Tan|Overall Study||0
10218617|NCT04404907|11346087|FG001|Frequent Tan|Overall Study||7
10218618|NCT04404907|11346086|FG000|COMPLETED|Overall Study||442
10218619|NCT04404907|11346087|FG001|COMPLETED|Overall Study||95
10218620|NCT04404907|11346086|FG000|NOT COMPLETED|Overall Study||0
10218621|NCT04404907|11346087|FG001|NOT COMPLETED|Overall Study||0
10218622|NCT04404010|11346095|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10
10218623|NCT04404010|11346096|FG001|STARTED|Overall Study||9
10218624|NCT04404010|11346095|FG000|COMPLETED|Overall Study||9
10218625|NCT04404010|11346096|FG001|COMPLETED|Overall Study||9
10218626|NCT04404010|11346095|FG000|NOT COMPLETED|Overall Study||1
10218627|NCT04404010|11346096|FG001|NOT COMPLETED|Overall Study||0
10218628|NCT04403399|11346106|FG000|STARTED|Period 1||18
10218629|NCT04403399|11346107|FG001|STARTED|Period 1||16
10218630|NCT04403399|11346106|FG000|COMPLETED|Period 1||18
10218631|NCT04403399|11346107|FG001|COMPLETED|Period 1||16
10218632|NCT04403399|11346106|FG000|NOT COMPLETED|Period 1||0
10218633|NCT04403399|11346107|FG001|NOT COMPLETED|Period 1||0
10218634|NCT04403399|11346106|FG000|STARTED|Period 2||18
10218635|NCT04403399|11346107|FG001|STARTED|Period 2||16
10218636|NCT04403399|11346106|FG000|COMPLETED|Period 2||18
10218637|NCT04403399|11346107|FG001|COMPLETED|Period 2||15
10218638|NCT04403399|11346106|FG000|NOT COMPLETED|Period 2||0
10218639|NCT04403399|11346107|FG001|NOT COMPLETED|Period 2||1
10218640|NCT04402970|11346115|FG000|STARTED|Overall Study||10
10218641|NCT04402970|11346116|FG001|STARTED|Overall Study||20
10218642|NCT04402970|11346115|FG000|COMPLETED|Overall Study||10
10218643|NCT04402970|11346116|FG001|COMPLETED|Overall Study||20
10218644|NCT04402970|11346115|FG000|NOT COMPLETED|Overall Study||0
10218645|NCT04402970|11346116|FG001|NOT COMPLETED|Overall Study||0
10218646|NCT04403113|11346124|FG000|STARTED|Overall Study||20
10218647|NCT04403113|11346125|FG001|STARTED|Overall Study||20
10218648|NCT04403113|11346124|FG000|COMPLETED|Overall Study||20
10218649|NCT04403113|11346125|FG001|COMPLETED|Overall Study||20
10218650|NCT04403113|11346124|FG000|NOT COMPLETED|Overall Study||0
10218651|NCT04403113|11346125|FG001|NOT COMPLETED|Overall Study||0
10218652|NCT04401202|11346137|FG000|STARTED|Overall Study||92
10218653|NCT04401202|11346138|FG001|STARTED|Overall Study||91
10218654|NCT04401202|11346137|FG000|COMPLETED|Overall Study||86
10218655|NCT04401202|11346138|FG001|COMPLETED|Overall Study||87
10218656|NCT04401202|11346137|FG000|NOT COMPLETED|Overall Study||6
10218657|NCT04401202|11346138|FG001|NOT COMPLETED|Overall Study||4
10218658|NCT04400682|11346147|FG000|STARTED|Period 1||15
10218659|NCT04400682|11346148|FG001|STARTED|Period 1||15
10218660|NCT04400682|11346147|FG000|COMPLETED|Period 1||14
10218661|NCT04400682|11346148|FG001|COMPLETED|Period 1||11
10218662|NCT04400682|11346147|FG000|NOT COMPLETED|Period 1||1
10218663|NCT04400682|11346148|FG001|NOT COMPLETED|Period 1||4
10218664|NCT04400682|11346147|FG000|STARTED|Period 2||14
10218665|NCT04400682|11346148|FG001|STARTED|Period 2||11
10218666|NCT04400682|11346147|FG000|COMPLETED|Period 2||14
10218667|NCT04400682|11346148|FG001|COMPLETED|Period 2||11
10218668|NCT04400682|11346147|FG000|NOT COMPLETED|Period 2||0
10218669|NCT04400682|11346148|FG001|NOT COMPLETED|Period 2||0
10218670|NCT04399161|11346157|FG000|STARTED|Overall Study||20
10218671|NCT04399161|11346158|FG001|STARTED|Overall Study||20
10218672|NCT04399161|11346159|FG002|STARTED|Overall Study||20
10218673|NCT04399161|11346157|FG000|COMPLETED|Overall Study||18
10218674|NCT04399161|11346158|FG001|COMPLETED|Overall Study||18
10218675|NCT04399161|11346159|FG002|COMPLETED|Overall Study||18
10218676|NCT04399161|11346157|FG000|NOT COMPLETED|Overall Study||2
10218677|NCT04399161|11346158|FG001|NOT COMPLETED|Overall Study||2
10218678|NCT04399161|11346159|FG002|NOT COMPLETED|Overall Study||2
10218679|NCT04399980|11346169|FG000|STARTED|Overall Study||21
10218680|NCT04399980|11346170|FG001|STARTED|Overall Study||19
10218681|NCT04399980|11346169|FG000|COMPLETED|Overall Study||21
10218682|NCT04399980|11346170|FG001|COMPLETED|Overall Study||19
10218683|NCT04399980|11346169|FG000|NOT COMPLETED|Overall Study||0
10218684|NCT04399980|11346170|FG001|NOT COMPLETED|Overall Study||0
10218685|NCT04399122|11346178|FG000|STARTED|Overall Study||100
10218686|NCT04399122|11346179|FG001|STARTED|Overall Study||100
10218687|NCT04399122|11346178|FG000|COMPLETED|Overall Study||97
10218688|NCT04399122|11346179|FG001|COMPLETED|Overall Study||100
10218689|NCT04399122|11346178|FG000|NOT COMPLETED|Overall Study||3
10218690|NCT04399122|11346179|FG001|NOT COMPLETED|Overall Study||0
10218691|NCT04397445|11346185|FG000|STARTED|Overall Study||5
10218692|NCT04397445|11346186|FG001|STARTED|Overall Study||5
10218693|NCT04397445|11346187|FG002|STARTED|Overall Study||4
10218694|NCT04397445|11346188|FG003|STARTED|Overall Study||4
10218695|NCT04397445|11346185|FG000|COMPLETED|Overall Study||4
10218696|NCT04397445|11346186|FG001|COMPLETED|Overall Study||5
10218697|NCT04397445|11346187|FG002|COMPLETED|Overall Study||4
10218698|NCT04397445|11346188|FG003|COMPLETED|Overall Study||4
10218699|NCT04397445|11346185|FG000|NOT COMPLETED|Overall Study||1
10218700|NCT04397445|11346186|FG001|NOT COMPLETED|Overall Study||0
10218701|NCT04397445|11346187|FG002|NOT COMPLETED|Overall Study||0
10218702|NCT04397445|11346188|FG003|NOT COMPLETED|Overall Study||0
10218703|NCT04397094|11346205|FG000|STARTED|Overall Study||30
10218704|NCT04397094|11346206|FG001|STARTED|Overall Study||30
10218705|NCT04397094|11346205|FG000|COMPLETED|Overall Study||30
10218706|NCT04397094|11346206|FG001|COMPLETED|Overall Study||30
10218707|NCT04397094|11346205|FG000|NOT COMPLETED|Overall Study||0
10218708|NCT04397094|11346206|FG001|NOT COMPLETED|Overall Study||0
10218709|NCT04396639|11346214|FG000|STARTED|Overall Study||50
10218710|NCT04396639|11346214|FG000|Completed Follow up|Overall Study||48
10218711|NCT04396639|11346214|FG000|COMPLETED|Overall Study||48
10218712|NCT04396639|11346214|FG000|NOT COMPLETED|Overall Study||2
10218713|NCT04396665|11346220|FG000|STARTED|Overall Study||134
10218714|NCT04396665|11346221|FG001|STARTED|Overall Study||90
10218715|NCT04396665|11346220|FG000|COMPLETED|Overall Study||99
10218716|NCT04396665|11346221|FG001|COMPLETED|Overall Study||83
10218717|NCT04396665|11346220|FG000|NOT COMPLETED|Overall Study||35
10218718|NCT04396665|11346221|FG001|NOT COMPLETED|Overall Study||7
10218719|NCT04393493|11346233|FG000|STARTED|Follow up||40
10218720|NCT04393493|11346234|FG001|STARTED|Follow up||40
10218721|NCT04393493|11346233|FG000|COMPLETED|Follow up||40
10218722|NCT04393493|11346234|FG001|COMPLETED|Follow up||40
10218723|NCT04393493|11346233|FG000|NOT COMPLETED|Follow up||0
10218724|NCT04393493|11346234|FG001|NOT COMPLETED|Follow up||0
10218725|NCT04393493|11346233|FG000|STARTED|First 4 Days of Intervention||40
10218726|NCT04393493|11346234|FG001|STARTED|First 4 Days of Intervention||40
10218727|NCT04393493|11346233|FG000|COMPLETED|First 4 Days of Intervention||35
10218728|NCT04393493|11346234|FG001|COMPLETED|First 4 Days of Intervention||33
10218729|NCT04393493|11346233|FG000|NOT COMPLETED|First 4 Days of Intervention||5
10218730|NCT04393493|11346234|FG001|NOT COMPLETED|First 4 Days of Intervention||7
10218731|NCT04392362|11346244|FG000|STARTED|Overall Study||23
10218732|NCT04392362|11346245|FG001|STARTED|Overall Study||7
10218733|NCT04392362|11346244|FG000|COMPLETED|Overall Study||23
10218734|NCT04392362|11346245|FG001|COMPLETED|Overall Study||7
10218735|NCT04392362|11346244|FG000|NOT COMPLETED|Overall Study||0
10218736|NCT04392362|11346245|FG001|NOT COMPLETED|Overall Study||0
10218737|NCT04392141|11346253|FG000|STARTED|Overall Study||60
10218738|NCT04392141|11346254|FG001|STARTED|Overall Study||60
10218739|NCT04392141|11346253|FG000|COMPLETED|Overall Study||60
10218740|NCT04392141|11346254|FG001|COMPLETED|Overall Study||60
10218741|NCT04392141|11346253|FG000|NOT COMPLETED|Overall Study||0
10218742|NCT04392141|11346254|FG001|NOT COMPLETED|Overall Study||0
10218743|NCT04392219|11346278|FG000|STARTED|Overall Study||16
10218744|NCT04392219|11346279|FG001|STARTED|Overall Study||6
10218745|NCT04392219|11346280|FG002|STARTED|Overall Study||6
10218746|NCT04392219|11346281|FG003|STARTED|Overall Study||6
10218747|NCT04392219|11346282|FG004|STARTED|Overall Study||6
10218748|NCT04392219|11346283|FG005|STARTED|Overall Study||6
10218749|NCT04392219|11346284|FG006|STARTED|Overall Study||6
10218750|NCT04392219|11346285|FG007|STARTED|Overall Study||6
10218751|NCT04392219|11346286|FG008|STARTED|Overall Study||6
10218752|NCT04392219|11346287|FG009|STARTED|Overall Study||10
10218753|NCT04392219|11346288|FG010|STARTED|Overall Study||14
10218754|NCT04392219|11346289|FG011|STARTED|Overall Study||6
10218755|NCT04392219|11346290|FG012|STARTED|Overall Study||6
10218756|NCT04392219|11346291|FG013|STARTED|Overall Study||6
10218757|NCT04392219|11346292|FG014|STARTED|Overall Study||6
10218758|NCT04392219|11346293|FG015|STARTED|Overall Study||6
10218759|NCT04392219|11346294|FG016|STARTED|Overall Study||6
10218760|NCT04392219|11346295|FG017|STARTED|Overall Study||6
10218761|NCT04392219|11346278|FG000|COMPLETED|Overall Study||16
10218762|NCT04392219|11346279|FG001|COMPLETED|Overall Study||6
10218763|NCT04392219|11346280|FG002|COMPLETED|Overall Study||6
10218764|NCT04392219|11346281|FG003|COMPLETED|Overall Study||6
10218765|NCT04392219|11346282|FG004|COMPLETED|Overall Study||6
10218766|NCT04392219|11346283|FG005|COMPLETED|Overall Study||6
10218767|NCT04392219|11346284|FG006|COMPLETED|Overall Study||6
10218768|NCT04392219|11346285|FG007|COMPLETED|Overall Study||6
10218769|NCT04392219|11346286|FG008|COMPLETED|Overall Study||6
10218770|NCT04392219|11346287|FG009|COMPLETED|Overall Study||10
10218771|NCT04392219|11346288|FG010|COMPLETED|Overall Study||14
10218772|NCT04392219|11346289|FG011|COMPLETED|Overall Study||6
10218773|NCT04392219|11346290|FG012|COMPLETED|Overall Study||6
10218774|NCT04392219|11346291|FG013|COMPLETED|Overall Study||6
10218775|NCT04392219|11346292|FG014|COMPLETED|Overall Study||6
10218776|NCT04392219|11346293|FG015|COMPLETED|Overall Study||6
10218777|NCT04392219|11346294|FG016|COMPLETED|Overall Study||6
10218778|NCT04392219|11346295|FG017|COMPLETED|Overall Study||6
10218779|NCT04392219|11346278|FG000|NOT COMPLETED|Overall Study||0
10218780|NCT04392219|11346279|FG001|NOT COMPLETED|Overall Study||0
10218781|NCT04392219|11346280|FG002|NOT COMPLETED|Overall Study||0
10218782|NCT04392219|11346281|FG003|NOT COMPLETED|Overall Study||0
10218783|NCT04392219|11346282|FG004|NOT COMPLETED|Overall Study||0
10218784|NCT04392219|11346283|FG005|NOT COMPLETED|Overall Study||0
10218785|NCT04392219|11346284|FG006|NOT COMPLETED|Overall Study||0
10218786|NCT04392219|11346285|FG007|NOT COMPLETED|Overall Study||0
10218787|NCT04392219|11346286|FG008|NOT COMPLETED|Overall Study||0
10218788|NCT04392219|11346287|FG009|NOT COMPLETED|Overall Study||0
10218789|NCT04392219|11346288|FG010|NOT COMPLETED|Overall Study||0
10218790|NCT04392219|11346289|FG011|NOT COMPLETED|Overall Study||0
10218791|NCT04392219|11346290|FG012|NOT COMPLETED|Overall Study||0
10218792|NCT04392219|11346291|FG013|NOT COMPLETED|Overall Study||0
10218793|NCT04392219|11346292|FG014|NOT COMPLETED|Overall Study||0
10218794|NCT04392219|11346293|FG015|NOT COMPLETED|Overall Study||0
10218795|NCT04392219|11346294|FG016|NOT COMPLETED|Overall Study||0
10218796|NCT04392219|11346295|FG017|NOT COMPLETED|Overall Study||0
10218797|NCT04391842|11346333|FG000|STARTED|Overall Study||34
10218798|NCT04391842|11346333|FG000|COMPLETED|Overall Study||32
10218799|NCT04391842|11346333|FG000|NOT COMPLETED|Overall Study||2
10218800|NCT04390022|11346339|FG000|STARTED|Overall Study||12
10218801|NCT04390022|11346340|FG001|STARTED|Overall Study||12
10218802|NCT04390022|11346339|FG000|COMPLETED|Overall Study||12
10218803|NCT04390022|11346340|FG001|COMPLETED|Overall Study||12
10218804|NCT04390022|11346339|FG000|NOT COMPLETED|Overall Study||0
10218805|NCT04390022|11346340|FG001|NOT COMPLETED|Overall Study||0
10218806|NCT04386902|11346346|FG000|STARTED|Overall Study||60
10218807|NCT04386902|11346346|FG000|COMPLETED|Overall Study||50
10218808|NCT04386902|11346346|FG000|NOT COMPLETED|Overall Study||10
10218809|NCT04385238|11346352|FG000|STARTED|Overall Study||5712
10218810|NCT04385238|11346353|FG001|STARTED|Overall Study||1182
10218811|NCT04385238|11346352|FG000|COMPLETED|Overall Study||5712
10218812|NCT04385238|11346353|FG001|COMPLETED|Overall Study||1182
10218813|NCT04385238|11346352|FG000|NOT COMPLETED|Overall Study||0
10218814|NCT04385238|11346353|FG001|NOT COMPLETED|Overall Study||0
10218815|NCT04384523|11346365|FG000|STARTED|Overall Study||10
10218816|NCT04384523|11346366|FG001|STARTED|Overall Study||6
10218817|NCT04384523|11346367|FG002|STARTED|Overall Study||6
10218818|NCT04384523|11346368|FG003|STARTED|Overall Study||6
10218819|NCT04384523|11346369|FG004|STARTED|Overall Study||7
10218820|NCT04384523|11346370|FG005|STARTED|Overall Study||6
10218821|NCT04384523|11346365|FG000|COMPLETED|Overall Study||9
10218822|NCT04384523|11346366|FG001|COMPLETED|Overall Study||5
10218823|NCT04384523|11346367|FG002|COMPLETED|Overall Study||6
10218824|NCT04384523|11346368|FG003|COMPLETED|Overall Study||6
10218825|NCT04384523|11346369|FG004|COMPLETED|Overall Study||7
10218826|NCT04384523|11346370|FG005|COMPLETED|Overall Study||5
10218827|NCT04384523|11346365|FG000|NOT COMPLETED|Overall Study||1
10218828|NCT04384523|11346366|FG001|NOT COMPLETED|Overall Study||1
10218829|NCT04384523|11346367|FG002|NOT COMPLETED|Overall Study||0
10218830|NCT04384523|11346368|FG003|NOT COMPLETED|Overall Study||0
10218831|NCT04384523|11346369|FG004|NOT COMPLETED|Overall Study||0
10218832|NCT04384523|11346370|FG005|NOT COMPLETED|Overall Study||1
10218833|NCT04383665|11346390|FG000|STARTED|Overall Study||2
10218834|NCT04383665|11346391|FG001|STARTED|Overall Study||2
10218835|NCT04383665|11346392|FG002|STARTED|Overall Study||2
10218836|NCT04383665|11346393|FG003|STARTED|Overall Study||2
10218837|NCT04383665|11346394|FG004|STARTED|Overall Study||2
10218838|NCT04383665|11346395|FG005|STARTED|Overall Study||2
10218839|NCT04383665|11346390|FG000|COMPLETED|Overall Study||2
10218840|NCT04383665|11346391|FG001|COMPLETED|Overall Study||2
10218841|NCT04383665|11346392|FG002|COMPLETED|Overall Study||2
10218842|NCT04383665|11346393|FG003|COMPLETED|Overall Study||2
10218843|NCT04383665|11346394|FG004|COMPLETED|Overall Study||2
10218844|NCT04383665|11346395|FG005|COMPLETED|Overall Study||2
10218845|NCT04383665|11346390|FG000|NOT COMPLETED|Overall Study||0
10218846|NCT04383665|11346391|FG001|NOT COMPLETED|Overall Study||0
10218847|NCT04383665|11346392|FG002|NOT COMPLETED|Overall Study||0
10218848|NCT04383665|11346393|FG003|NOT COMPLETED|Overall Study||0
10218849|NCT04383665|11346394|FG004|NOT COMPLETED|Overall Study||0
10218850|NCT04383665|11346395|FG005|NOT COMPLETED|Overall Study||0
10218851|NCT04383132|11346405|FG000|STARTED|Overall Study||173
10218852|NCT04383132|11346406|FG001|STARTED|Overall Study||173
10218853|NCT04383132|11346405|FG000|COMPLETED|Overall Study||173
10218854|NCT04383132|11346406|FG001|COMPLETED|Overall Study||173
10218855|NCT04383132|11346405|FG000|NOT COMPLETED|Overall Study||0
10218856|NCT04383132|11346406|FG001|NOT COMPLETED|Overall Study||0
10218857|NCT04382066|11346415|FG000|STARTED|Overall Study||15
10218858|NCT04382066|11346416|FG001|STARTED|Overall Study||15
10218859|NCT04382066|11346417|FG002|STARTED|Overall Study||15
10218860|NCT04382066|11346415|FG000|Completed 3-day Treatment|Overall Study||14
10218861|NCT04382066|11346416|FG001|Completed 3-day Treatment|Overall Study||15
10218862|NCT04382066|11346417|FG002|Completed 3-day Treatment|Overall Study||15
10218863|NCT04382066|11346415|FG000|COMPLETED|Overall Study||13
10218864|NCT04382066|11346416|FG001|COMPLETED|Overall Study||15
10218865|NCT04382066|11346417|FG002|COMPLETED|Overall Study||14
10218866|NCT04382066|11346415|FG000|NOT COMPLETED|Overall Study||2
10218867|NCT04382066|11346416|FG001|NOT COMPLETED|Overall Study||0
10218868|NCT04382066|11346417|FG002|NOT COMPLETED|Overall Study||1
10218869|NCT04381481|11346439|FG000|STARTED|Overall Study||200
10218870|NCT04381481|11346440|FG001|STARTED|Overall Study||205
10218871|NCT04381481|11346441|FG002|STARTED|Overall Study||199
10218872|NCT04381481|11346442|FG003|STARTED|Overall Study||197
10218873|NCT04381481|11346443|FG004|STARTED|Overall Study||199
10218874|NCT04381481|11346444|FG005|STARTED|Overall Study||195
10218875|NCT04381481|11346445|FG006|STARTED|Overall Study||194
10218876|NCT04381481|11346446|FG007|STARTED|Overall Study||193
10218877|NCT04381481|11346447|FG008|STARTED|Overall Study||214
10218878|NCT04381481|11346448|FG009|STARTED|Overall Study||198
10218879|NCT04381481|11346449|FG010|STARTED|Overall Study||192
10218880|NCT04381481|11346450|FG011|STARTED|Overall Study||188
10218881|NCT04381481|11346439|FG000|COMPLETED|Overall Study||185
10218882|NCT04381481|11346440|FG001|COMPLETED|Overall Study||190
10218883|NCT04381481|11346441|FG002|COMPLETED|Overall Study||190
10218884|NCT04381481|11346442|FG003|COMPLETED|Overall Study||183
10218885|NCT04381481|11346443|FG004|COMPLETED|Overall Study||191
10218886|NCT04381481|11346444|FG005|COMPLETED|Overall Study||180
10218887|NCT04381481|11346445|FG006|COMPLETED|Overall Study||184
10218888|NCT04381481|11346446|FG007|COMPLETED|Overall Study||177
10218889|NCT04381481|11346447|FG008|COMPLETED|Overall Study||195
10218890|NCT04381481|11346448|FG009|COMPLETED|Overall Study||188
10218891|NCT04381481|11346449|FG010|COMPLETED|Overall Study||183
10218892|NCT04381481|11346450|FG011|COMPLETED|Overall Study||173
10218893|NCT04381481|11346439|FG000|NOT COMPLETED|Overall Study||15
10218894|NCT04381481|11346440|FG001|NOT COMPLETED|Overall Study||15
10218895|NCT04381481|11346441|FG002|NOT COMPLETED|Overall Study||9
10218896|NCT04381481|11346442|FG003|NOT COMPLETED|Overall Study||14
10218897|NCT04381481|11346443|FG004|NOT COMPLETED|Overall Study||8
10218898|NCT04381481|11346444|FG005|NOT COMPLETED|Overall Study||15
10218899|NCT04381481|11346445|FG006|NOT COMPLETED|Overall Study||10
10218900|NCT04381481|11346446|FG007|NOT COMPLETED|Overall Study||16
10218901|NCT04381481|11346447|FG008|NOT COMPLETED|Overall Study||19
10218902|NCT04381481|11346448|FG009|NOT COMPLETED|Overall Study||10
10218903|NCT04381481|11346449|FG010|NOT COMPLETED|Overall Study||9
10218904|NCT04381481|11346450|FG011|NOT COMPLETED|Overall Study||15
10218905|NCT04380688|11346478|FG000|STARTED|Overall Study||31
10218906|NCT04380688|11346479|FG001|STARTED|Overall Study||31
10218907|NCT04380688|11346478|FG000|COMPLETED|Overall Study||24
10218908|NCT04380688|11346479|FG001|COMPLETED|Overall Study||22
10218909|NCT04380688|11346478|FG000|NOT COMPLETED|Overall Study||7
10218910|NCT04380688|11346479|FG001|NOT COMPLETED|Overall Study||9
10218911|NCT04376060|11346485|FG000|STARTED|Overall Study||15
10218912|NCT04376060|11346485|FG000|COMPLETED|Overall Study||14
10218913|NCT04376060|11346485|FG000|NOT COMPLETED|Overall Study||1
10218914|NCT04374500|11346489|FG000|STARTED|Overall Study||10
10218915|NCT04374500|11346490|FG001|STARTED|Overall Study||10
10218916|NCT04374500|11346491|FG002|STARTED|Overall Study||83
10218917|NCT04374500|11346489|FG000|COMPLETED|Overall Study||10
10218918|NCT04374500|11346490|FG001|COMPLETED|Overall Study||10
10218919|NCT04374500|11346491|FG002|COMPLETED|Overall Study||83
10218920|NCT04374500|11346489|FG000|NOT COMPLETED|Overall Study||0
10218921|NCT04374500|11346490|FG001|NOT COMPLETED|Overall Study||0
10218922|NCT04374500|11346491|FG002|NOT COMPLETED|Overall Study||0
10218923|NCT04372186|11346504|FG000|STARTED|Overall Study||249
10218924|NCT04372186|11346505|FG001|STARTED|Overall Study||128
10218925|NCT04372186|11346504|FG000|COMPLETED|Overall Study||225
10218926|NCT04372186|11346505|FG001|COMPLETED|Overall Study||115
10218927|NCT04372186|11346504|FG000|NOT COMPLETED|Overall Study||24
10218928|NCT04372186|11346505|FG001|NOT COMPLETED|Overall Study||13
10218929|NCT04371419|11346513|FG000|STARTED|Overall Study||784
10218930|NCT04371419|11346514|FG001|STARTED|Overall Study||791
10218931|NCT04371419|11346515|FG002|STARTED|Overall Study||780
10218932|NCT04371419|11346516|FG003|STARTED|Overall Study||778
10218933|NCT04371419|11346517|FG004|STARTED|Overall Study||777
10218934|NCT04371419|11346518|FG005|STARTED|Overall Study||788
10218935|NCT04371419|11346519|FG006|STARTED|Overall Study||783
10218936|NCT04371419|11346520|FG007|STARTED|Overall Study||788
10218937|NCT04371419|11346521|FG008|STARTED|Overall Study||779
10218938|NCT04371419|11346522|FG009|STARTED|Overall Study||780
10218939|NCT04371419|11346523|FG010|STARTED|Overall Study||782
10218940|NCT04371419|11346524|FG011|STARTED|Overall Study||790
10218941|NCT04371419|11346525|FG012|STARTED|Overall Study||779
10218942|NCT04371419|11346526|FG013|STARTED|Overall Study||786
10218943|NCT04371419|11346527|FG014|STARTED|Overall Study||781
10218944|NCT04371419|11346528|FG015|STARTED|Overall Study||781
10218945|NCT04371419|11346529|FG016|STARTED|Overall Study||1617
10218946|NCT04371419|11346513|FG000|Completed the Knowledge Questions|Overall Study||663
10218947|NCT04371419|11346514|FG001|Completed the Knowledge Questions|Overall Study||669
10218948|NCT04371419|11346515|FG002|Completed the Knowledge Questions|Overall Study||673
10218949|NCT04371419|11346516|FG003|Completed the Knowledge Questions|Overall Study||664
10218950|NCT04371419|11346517|FG004|Completed the Knowledge Questions|Overall Study||666
10218951|NCT04371419|11346518|FG005|Completed the Knowledge Questions|Overall Study||683
10218952|NCT04371419|11346519|FG006|Completed the Knowledge Questions|Overall Study||664
10218953|NCT04371419|11346520|FG007|Completed the Knowledge Questions|Overall Study||679
10218954|NCT04371419|11346521|FG008|Completed the Knowledge Questions|Overall Study||670
10218955|NCT04371419|11346522|FG009|Completed the Knowledge Questions|Overall Study||655
10218956|NCT04371419|11346523|FG010|Completed the Knowledge Questions|Overall Study||656
10218957|NCT04371419|11346524|FG011|Completed the Knowledge Questions|Overall Study||692
10218958|NCT04371419|11346525|FG012|Completed the Knowledge Questions|Overall Study||664
10218959|NCT04371419|11346526|FG013|Completed the Knowledge Questions|Overall Study||687
10218960|NCT04371419|11346527|FG014|Completed the Knowledge Questions|Overall Study||652
10218961|NCT04371419|11346528|FG015|Completed the Knowledge Questions|Overall Study||652
10218962|NCT04371419|11346529|FG016|Completed the Knowledge Questions|Overall Study||1526
10218963|NCT04371419|11346513|FG000|COMPLETED|Overall Study||641
10218964|NCT04371419|11346514|FG001|COMPLETED|Overall Study||636
10218965|NCT04371419|11346515|FG002|COMPLETED|Overall Study||639
10218966|NCT04371419|11346516|FG003|COMPLETED|Overall Study||631
10218967|NCT04371419|11346517|FG004|COMPLETED|Overall Study||644
10218968|NCT04371419|11346518|FG005|COMPLETED|Overall Study||654
10218969|NCT04371419|11346519|FG006|COMPLETED|Overall Study||639
10218970|NCT04371419|11346520|FG007|COMPLETED|Overall Study||658
10218971|NCT04371419|11346521|FG008|COMPLETED|Overall Study||649
10218972|NCT04371419|11346522|FG009|COMPLETED|Overall Study||621
10218973|NCT04371419|11346523|FG010|COMPLETED|Overall Study||626
10218974|NCT04371419|11346524|FG011|COMPLETED|Overall Study||662
10218975|NCT04371419|11346525|FG012|COMPLETED|Overall Study||633
10218976|NCT04371419|11346526|FG013|COMPLETED|Overall Study||660
10218977|NCT04371419|11346527|FG014|COMPLETED|Overall Study||626
10218978|NCT04371419|11346528|FG015|COMPLETED|Overall Study||625
10218979|NCT04371419|11346529|FG016|COMPLETED|Overall Study||1450
10218980|NCT04371419|11346513|FG000|NOT COMPLETED|Overall Study||143
10218981|NCT04371419|11346514|FG001|NOT COMPLETED|Overall Study||155
10218982|NCT04371419|11346515|FG002|NOT COMPLETED|Overall Study||141
10218983|NCT04371419|11346516|FG003|NOT COMPLETED|Overall Study||147
10218984|NCT04371419|11346517|FG004|NOT COMPLETED|Overall Study||133
10218985|NCT04371419|11346518|FG005|NOT COMPLETED|Overall Study||134
10218986|NCT04371419|11346519|FG006|NOT COMPLETED|Overall Study||144
10218987|NCT04371419|11346520|FG007|NOT COMPLETED|Overall Study||130
10218988|NCT04371419|11346521|FG008|NOT COMPLETED|Overall Study||130
10218989|NCT04371419|11346522|FG009|NOT COMPLETED|Overall Study||159
10218990|NCT04371419|11346523|FG010|NOT COMPLETED|Overall Study||156
10218991|NCT04371419|11346524|FG011|NOT COMPLETED|Overall Study||128
10218992|NCT04371419|11346525|FG012|NOT COMPLETED|Overall Study||146
10218993|NCT04371419|11346526|FG013|NOT COMPLETED|Overall Study||126
10218994|NCT04371419|11346527|FG014|NOT COMPLETED|Overall Study||155
10218995|NCT04371419|11346528|FG015|NOT COMPLETED|Overall Study||156
10218996|NCT04371419|11346529|FG016|NOT COMPLETED|Overall Study||167
10218997|NCT04370834|11346560|FG000|STARTED|Overall Study||1
10218998|NCT04370834|11346560|FG000|COMPLETED|Overall Study||1
10218999|NCT04370834|11346560|FG000|NOT COMPLETED|Overall Study||0
10219000|NCT04370548|11346572|FG000|STARTED|Overall Study||204
10219001|NCT04370548|11346573|FG001|STARTED|Overall Study||103
10219002|NCT04370548|11346572|FG000|COMPLETED|Overall Study||190
10219003|NCT04370548|11346573|FG001|COMPLETED|Overall Study||100
10219004|NCT04370548|11346572|FG000|NOT COMPLETED|Overall Study||14
10219005|NCT04370548|11346573|FG001|NOT COMPLETED|Overall Study||3
10219006|NCT04370028|11346579|FG000|STARTED|Overall Study||2583
10219007|NCT04370028|11346579|FG000|COMPLETED|Overall Study||1876
10219008|NCT04370028|11346579|FG000|NOT COMPLETED|Overall Study||707
10219009|NCT04363736|11346592|FG000|STARTED|Overall Study||49
10219010|NCT04363736|11346593|FG001|STARTED|Overall Study||48
10219011|NCT04363736|11346592|FG000|COMPLETED|Overall Study||30
10219012|NCT04363736|11346593|FG001|COMPLETED|Overall Study||35
10219013|NCT04363736|11346592|FG000|NOT COMPLETED|Overall Study||19
10219014|NCT04363736|11346593|FG001|NOT COMPLETED|Overall Study||13
10219015|NCT04366583|11346601|FG000|STARTED|Overall Study||82
10219016|NCT04366583|11346602|FG001|STARTED|Overall Study||84
10219017|NCT04366583|11346601|FG000|COMPLETED|Overall Study||82
10219018|NCT04366583|11346602|FG001|COMPLETED|Overall Study||84
10219019|NCT04366583|11346601|FG000|NOT COMPLETED|Overall Study||0
10219020|NCT04366583|11346602|FG001|NOT COMPLETED|Overall Study||0
10219021|NCT04365699|11346611|FG000|STARTED|Overall Study||10
10219022|NCT04365699|11346612|FG001|STARTED|Overall Study||16
10219023|NCT04365699|11346613|FG002|STARTED|Overall Study||55
10219024|NCT04365699|11346611|FG000|COMPLETED|Overall Study||8
10219025|NCT04365699|11346612|FG001|COMPLETED|Overall Study||11
10219026|NCT04365699|11346613|FG002|COMPLETED|Overall Study||40
10219027|NCT04365699|11346611|FG000|NOT COMPLETED|Overall Study||2
10219028|NCT04365699|11346612|FG001|NOT COMPLETED|Overall Study||5
10219029|NCT04365699|11346613|FG002|NOT COMPLETED|Overall Study||15
10219030|NCT04365153|11346624|FG000|STARTED|Overall Study||15
10219031|NCT04365153|11346625|FG001|STARTED|Overall Study||14
10219032|NCT04365153|11346626|FG002|STARTED|Overall Study||16
10219033|NCT04365153|11346624|FG000|COMPLETED|Overall Study||15
10219034|NCT04365153|11346625|FG001|COMPLETED|Overall Study||14
10219035|NCT04365153|11346626|FG002|COMPLETED|Overall Study||16
10219036|NCT04365153|11346624|FG000|NOT COMPLETED|Overall Study||0
10219037|NCT04365153|11346625|FG001|NOT COMPLETED|Overall Study||0
10219038|NCT04365153|11346626|FG002|NOT COMPLETED|Overall Study||0
10219039|NCT04363879|11346637|FG000|STARTED|Overall Study||78
10219040|NCT04363879|11346638|FG001|STARTED|Overall Study||92
10219041|NCT04363879|11346637|FG000|COMPLETED|Overall Study||78
10219042|NCT04363879|11346638|FG001|COMPLETED|Overall Study||92
10219043|NCT04363879|11346637|FG000|NOT COMPLETED|Overall Study||0
10219044|NCT04363879|11346638|FG001|NOT COMPLETED|Overall Study||0
10219045|NCT04362137|11346646|FG000|STARTED|Overall Study||287
10219046|NCT04362137|11346647|FG001|STARTED|Overall Study||145
10219047|NCT04362137|11346646|FG000|Safety Set|Overall Study||281
10219048|NCT04362137|11346647|FG001|Safety Set|Overall Study||143
10219049|NCT04362137|11346646|FG000|COMPLETED|Overall Study||269
10219050|NCT04362137|11346647|FG001|COMPLETED|Overall Study||139
10219051|NCT04362137|11346646|FG000|NOT COMPLETED|Overall Study||18
10219052|NCT04362137|11346647|FG001|NOT COMPLETED|Overall Study||6
10219053|NCT04359771|11346655|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
10219054|NCT04359771|11346656|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
10219055|NCT04359771|11346655|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
10219056|NCT04359771|11346656|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
10219057|NCT04359771|11346655|FG000|NOT COMPLETED|Overall Study||2
10219058|NCT04359771|11346656|FG001|NOT COMPLETED|Overall Study||2
10219059|NCT04358991|11346662|FG000|STARTED|Overall Study||20
10219060|NCT04358991|11346662|FG000|COMPLETED|Overall Study||20
10219061|NCT04358991|11346662|FG000|NOT COMPLETED|Overall Study||0
10219062|NCT04358081|11346669|FG000|STARTED|Treatment Phase of Study||7
10219063|NCT04358081|11346670|FG001|STARTED|Treatment Phase of Study||7
10219064|NCT04358081|11346671|FG002|STARTED|Treatment Phase of Study||5
10219065|NCT04358081|11346669|FG000|COMPLETED|Treatment Phase of Study||3
10219066|NCT04358081|11346670|FG001|COMPLETED|Treatment Phase of Study||6
10219067|NCT04358081|11346671|FG002|COMPLETED|Treatment Phase of Study||2
10219068|NCT04358081|11346669|FG000|NOT COMPLETED|Treatment Phase of Study||4
10219069|NCT04358081|11346670|FG001|NOT COMPLETED|Treatment Phase of Study||1
10219070|NCT04358081|11346671|FG002|NOT COMPLETED|Treatment Phase of Study||3
10219071|NCT04358081|11346669|FG000|STARTED|Study Completion Phase||7
10219072|NCT04358081|11346670|FG001|STARTED|Study Completion Phase||7
10219073|NCT04358081|11346671|FG002|STARTED|Study Completion Phase||5
10219074|NCT04358081|11346669|FG000|COMPLETED|Study Completion Phase||6
10219075|NCT04358081|11346670|FG001|COMPLETED|Study Completion Phase||7
10219076|NCT04358081|11346671|FG002|COMPLETED|Study Completion Phase||3
10219077|NCT04358081|11346669|FG000|NOT COMPLETED|Study Completion Phase||1
10219078|NCT04358081|11346670|FG001|NOT COMPLETED|Study Completion Phase||0
10219079|NCT04358081|11346671|FG002|NOT COMPLETED|Study Completion Phase||2
10219080|NCT04356937|11346683|FG000|STARTED|Randomization (Safety Population)||161
10219081|NCT04356937|11346684|FG001|STARTED|Randomization (Safety Population)||82
10219082|NCT04356937|11346683|FG000|COMPLETED|Randomization (Safety Population)||161
10219083|NCT04356937|11346684|FG001|COMPLETED|Randomization (Safety Population)||82
10219084|NCT04356937|11346683|FG000|NOT COMPLETED|Randomization (Safety Population)||0
10219085|NCT04356937|11346684|FG001|NOT COMPLETED|Randomization (Safety Population)||0
10219086|NCT04356937|11346683|FG000|STARTED|Treatment (mITT Population)||161
10219087|NCT04356937|11346684|FG001|STARTED|Treatment (mITT Population)||82
10219088|NCT04356937|11346683|FG000|COMPLETED|Treatment (mITT Population)||161
10219089|NCT04356937|11346684|FG001|COMPLETED|Treatment (mITT Population)||81
10219090|NCT04356937|11346683|FG000|NOT COMPLETED|Treatment (mITT Population)||0
10219091|NCT04356937|11346684|FG001|NOT COMPLETED|Treatment (mITT Population)||1
10219092|NCT04355663|11346693|FG000|STARTED|Overall Study||42
10219093|NCT04355663|11346694|FG001|STARTED|Overall Study||29
10219094|NCT04355663|11346695|FG002|STARTED|Overall Study||21
10219095|NCT04355663|11346693|FG000|COMPLETED|Overall Study||40
10219096|NCT04355663|11346694|FG001|COMPLETED|Overall Study||14
10219097|NCT04355663|11346695|FG002|COMPLETED|Overall Study||17
10219098|NCT04355663|11346693|FG000|NOT COMPLETED|Overall Study||2
10219099|NCT04355663|11346694|FG001|NOT COMPLETED|Overall Study||15
10219100|NCT04355663|11346695|FG002|NOT COMPLETED|Overall Study||4
10219101|NCT04354870|11346705|FG000|STARTED|Overall Study||83
10219102|NCT04354870|11346706|FG001|STARTED|Overall Study||47
10219103|NCT04354870|11346705|FG000|COMPLETED|Overall Study||35
10219104|NCT04354870|11346706|FG001|COMPLETED|Overall Study||14
10219105|NCT04354870|11346705|FG000|NOT COMPLETED|Overall Study||48
10219106|NCT04354870|11346706|FG001|NOT COMPLETED|Overall Study||33
10219107|NCT04350307|11346714|FG000|STARTED|Overall Study||84
10219108|NCT04350307|11346715|FG001|STARTED|Overall Study||78
10219109|NCT04350307|11346714|FG000|COMPLETED|Overall Study||84
10219110|NCT04350307|11346715|FG001|COMPLETED|Overall Study||78
10219111|NCT04350307|11346714|FG000|NOT COMPLETED|Overall Study||0
10219112|NCT04350307|11346715|FG001|NOT COMPLETED|Overall Study||0
10219113|NCT04352660|11346723|FG000|STARTED|Overall Study||50
10219114|NCT04352660|11346724|FG001|STARTED|Overall Study||50
10219115|NCT04352660|11346723|FG000|COMPLETED|Overall Study||36
10219116|NCT04352660|11346724|FG001|COMPLETED|Overall Study||40
10219117|NCT04352660|11346723|FG000|NOT COMPLETED|Overall Study||14
10219118|NCT04352660|11346724|FG001|NOT COMPLETED|Overall Study||10
10219119|NCT04350788|11346732|FG000|STARTED|Overall Study||62
10219120|NCT04350788|11346733|FG001|STARTED|Overall Study||62
10219121|NCT04350788|11346732|FG000|COMPLETED|Overall Study||50
10219122|NCT04350788|11346733|FG001|COMPLETED|Overall Study||56
10219123|NCT04350788|11346732|FG000|NOT COMPLETED|Overall Study||12
10219124|NCT04350788|11346733|FG001|NOT COMPLETED|Overall Study||6
10219125|NCT04349917|11346746|FG000|STARTED|First Intervention (2-4 Hours)||19
10219126|NCT04349917|11346747|FG001|STARTED|First Intervention (2-4 Hours)||18
10219127|NCT04349917|11346746|FG000|Received Intervention|First Intervention (2-4 Hours)||19
10219128|NCT04349917|11346747|FG001|Received Intervention|First Intervention (2-4 Hours)||17
10219129|NCT04349917|11346746|FG000|COMPLETED|First Intervention (2-4 Hours)||19
10219130|NCT04349917|11346747|FG001|COMPLETED|First Intervention (2-4 Hours)||16
10219131|NCT04349917|11346746|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0
10219132|NCT04349917|11346747|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2
10219133|NCT04349917|11346746|FG000|STARTED|Washout Period (4-20 Days)||19
10219134|NCT04349917|11346747|FG001|STARTED|Washout Period (4-20 Days)||16
10219135|NCT04349917|11346746|FG000|COMPLETED|Washout Period (4-20 Days)||19
10219136|NCT04349917|11346747|FG001|COMPLETED|Washout Period (4-20 Days)||16
10219137|NCT04349917|11346746|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0
10219138|NCT04349917|11346747|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0
10219139|NCT04349917|11346746|FG000|STARTED|Second Intervention (2-4 Hours)||19
10219140|NCT04349917|11346747|FG001|STARTED|Second Intervention (2-4 Hours)||16
10219141|NCT04349917|11346746|FG000|Received Intervention|Second Intervention (2-4 Hours)||19
10239129|NCT00350623|11370639|FG001|STARTED|Overall Study||71
10219142|NCT04349917|11346747|FG001|Received Intervention|Second Intervention (2-4 Hours)||16
10219143|NCT04349917|11346746|FG000|COMPLETED|Second Intervention (2-4 Hours)||19
10219144|NCT04349917|11346747|FG001|COMPLETED|Second Intervention (2-4 Hours)||16
10219145|NCT04349917|11346746|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0
10219146|NCT04349917|11346747|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0
10219147|NCT04348851|11346758|FG000|STARTED|Post-Test 1||13
10219148|NCT04348851|11346759|FG001|STARTED|Post-Test 1||13
10219149|NCT04348851|11346760|FG002|STARTED|Post-Test 1||13
10219150|NCT04348851|11346761|FG003|STARTED|Post-Test 1||14
10219151|NCT04348851|11346758|FG000|COMPLETED|Post-Test 1||13
10219152|NCT04348851|11346759|FG001|COMPLETED|Post-Test 1||11
10219153|NCT04348851|11346760|FG002|COMPLETED|Post-Test 1||13
10219154|NCT04348851|11346761|FG003|COMPLETED|Post-Test 1||14
10219155|NCT04348851|11346758|FG000|NOT COMPLETED|Post-Test 1||0
10219156|NCT04348851|11346759|FG001|NOT COMPLETED|Post-Test 1||2
10219157|NCT04348851|11346760|FG002|NOT COMPLETED|Post-Test 1||0
10219158|NCT04348851|11346761|FG003|NOT COMPLETED|Post-Test 1||0
10012460|NCT01785628|11135254|FG001|STARTED|Overall Study||15
10012461|NCT01785628|11135253|FG000|COMPLETED|Overall Study||13
10012462|NCT01785628|11135254|FG001|COMPLETED|Overall Study||12
10012463|NCT01785628|11135253|FG000|NOT COMPLETED|Overall Study||2
10012464|NCT01785628|11135254|FG001|NOT COMPLETED|Overall Study||3
10012465|NCT01785680|11135262|FG000|STARTED|Overall Study||1100
10219159|NCT04348851|11346758|FG000|STARTED|Post-Test 2||13
10219160|NCT04348851|11346759|FG001|STARTED|Post-Test 2||11
10219161|NCT04348851|11346760|FG002|STARTED|Post-Test 2||13
10219162|NCT04348851|11346761|FG003|STARTED|Post-Test 2||14
10219163|NCT04348851|11346758|FG000|COMPLETED|Post-Test 2||13
10012466|NCT01785680|11135263|FG001|STARTED|Overall Study||857
10012467|NCT01785680|11135262|FG000|COMPLETED|Overall Study||1100
10012468|NCT01785680|11135263|FG001|COMPLETED|Overall Study||857
10012469|NCT01785680|11135262|FG000|NOT COMPLETED|Overall Study||0
10012470|NCT01785680|11135263|FG001|NOT COMPLETED|Overall Study||0
10012471|NCT01785810|11135269|FG000|STARTED|Overall Study||37
10219164|NCT04348851|11346759|FG001|COMPLETED|Post-Test 2||10
10219165|NCT04348851|11346760|FG002|COMPLETED|Post-Test 2||13
10219166|NCT04348851|11346761|FG003|COMPLETED|Post-Test 2||13
10219167|NCT04348851|11346758|FG000|NOT COMPLETED|Post-Test 2||0
10219168|NCT04348851|11346759|FG001|NOT COMPLETED|Post-Test 2||1
10219169|NCT04348851|11346760|FG002|NOT COMPLETED|Post-Test 2||0
10219170|NCT04348851|11346761|FG003|NOT COMPLETED|Post-Test 2||1
10012472|NCT01785810|11135269|FG000|COMPLETED|Overall Study||29
10012473|NCT01785810|11135269|FG000|NOT COMPLETED|Overall Study||8
10219171|NCT04348357|11346773|FG000|STARTED|Overall Study||25
10219172|NCT04348357|11346774|FG001|STARTED|Overall Study||28
10219173|NCT04348357|11346773|FG000|COMPLETED|Overall Study||25
10219174|NCT04348357|11346774|FG001|COMPLETED|Overall Study||16
10219175|NCT04348357|11346773|FG000|NOT COMPLETED|Overall Study||0
10219176|NCT04348357|11346774|FG001|NOT COMPLETED|Overall Study||12
10219177|NCT04346199|11346782|FG000|STARTED|Overall Study||89
10219178|NCT04346199|11346783|FG001|STARTED|Overall Study||88
10219179|NCT04346199|11346782|FG000|COMPLETED|Overall Study||74
10219180|NCT04346199|11346783|FG001|COMPLETED|Overall Study||77
10219181|NCT04346199|11346782|FG000|NOT COMPLETED|Overall Study||15
10219182|NCT04346199|11346783|FG001|NOT COMPLETED|Overall Study||11
10219183|NCT04345653|11346789|FG000|STARTED|Overall Study||48
10219184|NCT04345653|11346789|FG000|COMPLETED|Overall Study||46
10219185|NCT04345653|11346789|FG000|NOT COMPLETED|Overall Study||2
10219186|NCT04343261|11346794|FG000|STARTED|Overall Study||48
10219187|NCT04343261|11346794|FG000|COMPLETED|Overall Study||40
10219188|NCT04343261|11346794|FG000|NOT COMPLETED|Overall Study||8
10219189|NCT04343222|11346801|FG000|STARTED|Overall Study||16
10219190|NCT04343222|11346802|FG001|STARTED|Overall Study||15
10219191|NCT04343222|11346803|FG002|STARTED|Overall Study||15
10219192|NCT04343222|11346801|FG000|COMPLETED|Overall Study||16
10219193|NCT04343222|11346802|FG001|COMPLETED|Overall Study||15
10219194|NCT04343222|11346803|FG002|COMPLETED|Overall Study||15
10219195|NCT04343222|11346801|FG000|NOT COMPLETED|Overall Study||0
10219196|NCT04343222|11346802|FG001|NOT COMPLETED|Overall Study||0
10219197|NCT04343222|11346803|FG002|NOT COMPLETED|Overall Study||0
10219198|NCT04343092|11346811|FG000|STARTED|Overall Study||16
10219199|NCT04343092|11346811|FG000|COMPLETED|Overall Study||16
10219200|NCT04343092|11346811|FG000|NOT COMPLETED|Overall Study||0
10219201|NCT04342663|11346817|FG000|STARTED|Overall Study||80
10219202|NCT04342663|11346818|FG001|STARTED|Overall Study||72
10219203|NCT04342663|11346817|FG000|COMPLETED|Overall Study||62
10219204|NCT04342663|11346818|FG001|COMPLETED|Overall Study||53
10219205|NCT04342663|11346817|FG000|NOT COMPLETED|Overall Study||18
10219206|NCT04342663|11346818|FG001|NOT COMPLETED|Overall Study||19
10219207|NCT04342897|11346826|FG000|STARTED|Overall Study||47
10012474|NCT01785849|11135275|FG000|STARTED|Overall Study||254
10012475|NCT01785849|11135276|FG001|STARTED|Overall Study||254
10219208|NCT04342897|11346827|FG001|STARTED|Overall Study||48
10219209|NCT04342897|11346826|FG000|Received at Least One Dose of Study Drug|Overall Study||47
10219210|NCT04342897|11346827|FG001|Received at Least One Dose of Study Drug|Overall Study||48
10012476|NCT01785849|11135275|FG000|Received Treatment|Overall Study||254
10012477|NCT01785849|11135276|FG001|Received Treatment|Overall Study||251
10219211|NCT04342897|11346826|FG000|COMPLETED|Overall Study||33
10219212|NCT04342897|11346827|FG001|COMPLETED|Overall Study||36
10219213|NCT04342897|11346826|FG000|NOT COMPLETED|Overall Study||14
10219214|NCT04342897|11346827|FG001|NOT COMPLETED|Overall Study||12
10219215|NCT04342130|11346833|FG000|STARTED|Overall Study||10
10219216|NCT04342130|11346833|FG000|COMPLETED|Overall Study||10
10219217|NCT04342130|11346833|FG000|NOT COMPLETED|Overall Study||0
10219218|NCT04340557|11346839|FG000|STARTED|Overall Study||16
10219219|NCT04340557|11346840|FG001|STARTED|Overall Study||15
10219220|NCT04340557|11346839|FG000|COMPLETED|Overall Study||15
10219221|NCT04340557|11346840|FG001|COMPLETED|Overall Study||13
10219222|NCT04340557|11346839|FG000|NOT COMPLETED|Overall Study||1
10219223|NCT04340557|11346840|FG001|NOT COMPLETED|Overall Study||2
10219224|NCT04339972|11346848|FG000|STARTED|Overall Study||15
10219225|NCT04339972|11346849|FG001|STARTED|Overall Study||14
10219226|NCT04339972|11346848|FG000|COMPLETED|Overall Study||10
10219227|NCT04339972|11346849|FG001|COMPLETED|Overall Study||9
10219228|NCT04339972|11346848|FG000|NOT COMPLETED|Overall Study||5
10219229|NCT04339972|11346849|FG001|NOT COMPLETED|Overall Study||5
10219230|NCT04339296|11346857|FG000|STARTED|Overall Study||24
10219231|NCT04339296|11346858|FG001|STARTED|Overall Study||26
10219232|NCT04339296|11346857|FG000|Completed Baseline|Overall Study||23
10219233|NCT04339296|11346858|FG001|Completed Baseline|Overall Study||25
10219234|NCT04339296|11346857|FG000|Received Allocated Intervention|Overall Study||21
10219235|NCT04339296|11346858|FG001|Received Allocated Intervention|Overall Study||24
10219236|NCT04339296|11346857|FG000|COMPLETED|Overall Study||16
10219237|NCT04339296|11346858|FG001|COMPLETED|Overall Study||17
10219238|NCT04339296|11346857|FG000|NOT COMPLETED|Overall Study||8
10219239|NCT04339296|11346858|FG001|NOT COMPLETED|Overall Study||9
10219240|NCT04338009|11346866|FG000|STARTED|Overall Study||77
10219241|NCT04338009|11346867|FG001|STARTED|Overall Study||75
10219242|NCT04338009|11346866|FG000|COMPLETED|Overall Study||77
10219243|NCT04338009|11346867|FG001|COMPLETED|Overall Study||75
10219244|NCT04338009|11346866|FG000|NOT COMPLETED|Overall Study||0
10219245|NCT04338009|11346867|FG001|NOT COMPLETED|Overall Study||0
10219246|NCT04338074|11346875|FG000|STARTED|Overall Study||3
10219247|NCT04338074|11346876|FG001|STARTED|Overall Study||2
10219248|NCT04338074|11346875|FG000|COMPLETED|Overall Study||3
10219249|NCT04338074|11346876|FG001|COMPLETED|Overall Study||2
10219250|NCT04338074|11346875|FG000|NOT COMPLETED|Overall Study||0
10219251|NCT04338074|11346876|FG001|NOT COMPLETED|Overall Study||0
10219252|NCT04337138|11346882|FG000|STARTED|Overall Study||32
10219253|NCT04337138|11346882|FG000|COMPLETED|Overall Study||32
10219254|NCT04337138|11346882|FG000|NOT COMPLETED|Overall Study||0
10219255|NCT04336475|11346888|FG000|STARTED|Overall Study||30
10219256|NCT04336475|11346889|FG001|STARTED|Overall Study||30
10219257|NCT04336475|11346888|FG000|COMPLETED|Overall Study||28
10219258|NCT04336475|11346889|FG001|COMPLETED|Overall Study||28
10219259|NCT04336475|11346888|FG000|NOT COMPLETED|Overall Study||2
10219260|NCT04336475|11346889|FG001|NOT COMPLETED|Overall Study||2
10219261|NCT04335929|11346895|FG000|STARTED|Overall Study||32
10219262|NCT04335929|11346895|FG000|COMPLETED|Overall Study||22
10219263|NCT04335929|11346895|FG000|NOT COMPLETED|Overall Study||10
10219264|NCT04335812|11346901|FG000|STARTED|Overall Study||63
10219265|NCT04335812|11346902|FG001|STARTED|Overall Study||63
10219266|NCT04335812|11346901|FG000|COMPLETED|Overall Study||28
10219267|NCT04335812|11346902|FG001|COMPLETED|Overall Study||30
10219268|NCT04335812|11346901|FG000|NOT COMPLETED|Overall Study||35
10219269|NCT04335812|11346902|FG001|NOT COMPLETED|Overall Study||33
10219270|NCT04335136|11346910|FG000|STARTED|Overall Study||91
10219271|NCT04335136|11346911|FG001|STARTED|Overall Study||90
10219272|NCT04335136|11346910|FG000|Treated|Overall Study||88
10219273|NCT04335136|11346911|FG001|Treated|Overall Study||90
10219274|NCT04335136|11346910|FG000|COMPLETED|Overall Study||77
10219275|NCT04335136|11346911|FG001|COMPLETED|Overall Study||83
10219276|NCT04335136|11346910|FG000|NOT COMPLETED|Overall Study||14
10219277|NCT04335136|11346911|FG001|NOT COMPLETED|Overall Study||7
10219278|NCT04335552|11346921|FG000|STARTED|Overall Study||2
10219279|NCT04335552|11346922|FG001|STARTED|Overall Study||4
10219280|NCT04335552|11346923|FG002|STARTED|Overall Study||3
10219281|NCT04335552|11346924|FG003|STARTED|Overall Study||2
10219282|NCT04335552|11346921|FG000|COMPLETED|Overall Study||1
10219283|NCT04335552|11346922|FG001|COMPLETED|Overall Study||4
10219284|NCT04335552|11346923|FG002|COMPLETED|Overall Study||3
10219285|NCT04335552|11346924|FG003|COMPLETED|Overall Study||2
10219286|NCT04335552|11346921|FG000|NOT COMPLETED|Overall Study||1
10219287|NCT04335552|11346922|FG001|NOT COMPLETED|Overall Study||0
10219288|NCT04335552|11346923|FG002|NOT COMPLETED|Overall Study||0
10219289|NCT04335552|11346924|FG003|NOT COMPLETED|Overall Study||0
10219290|NCT04334876|11346934|FG000|STARTED|Overall Study||571
10219291|NCT04334876|11346934|FG000|COMPLETED|Overall Study||500
10219292|NCT04334876|11346934|FG000|NOT COMPLETED|Overall Study||71
10219293|NCT04334681|11346940|FG000|STARTED|Overall Study||135
10219294|NCT04334681|11346941|FG001|STARTED|Overall Study||143
10219295|NCT04334681|11346940|FG000|COMPLETED|Overall Study||135
10219296|NCT04334681|11346941|FG001|COMPLETED|Overall Study||143
10219297|NCT04334681|11346940|FG000|NOT COMPLETED|Overall Study||0
10219298|NCT04334681|11346941|FG001|NOT COMPLETED|Overall Study||0
10219299|NCT04333225|11346951|FG000|STARTED|Overall Study||101
10219300|NCT04333225|11346952|FG001|STARTED|Overall Study||120
10219301|NCT04333225|11346951|FG000|COMPLETED|Overall Study||98
10219302|NCT04333225|11346952|FG001|COMPLETED|Overall Study||115
10219303|NCT04333225|11346951|FG000|NOT COMPLETED|Overall Study||3
10219304|NCT04333225|11346952|FG001|NOT COMPLETED|Overall Study||5
10239130|NCT00350623|11370640|FG002|STARTED|Overall Study||68
10239131|NCT00350623|11370638|FG000|COMPLETED|Overall Study||63
10239132|NCT00350623|11370639|FG001|COMPLETED|Overall Study||67
10219305|NCT04333199|11346961|FG000|STARTED|Evaluated Patients||1669
10219306|NCT04333199|11346962|FG001|STARTED|Evaluated Patients||1672
10219307|NCT04333199|11346963|FG002|STARTED|Evaluated Patients||1671
10219308|NCT04333199|11346961|FG000|COMPLETED|Evaluated Patients||1669
10219309|NCT04333199|11346962|FG001|COMPLETED|Evaluated Patients||1671
10219310|NCT04333199|11346963|FG002|COMPLETED|Evaluated Patients||1669
10219311|NCT04333199|11346961|FG000|NOT COMPLETED|Evaluated Patients||0
10219312|NCT04333199|11346962|FG001|NOT COMPLETED|Evaluated Patients||1
10219313|NCT04333199|11346963|FG002|NOT COMPLETED|Evaluated Patients||2
10219314|NCT04333199|11346961|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0
10219315|NCT04333199|11346962|FG001|STARTED|Emailed Patients||1671
10219316|NCT04333199|11346963|FG002|STARTED|Emailed Patients||1669
10219317|NCT04333199|11346961|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
10219318|NCT04333199|11346962|FG001|Valid Email Address|Emailed Patients||1495
10219319|NCT04333199|11346963|FG002|Valid Email Address|Emailed Patients||1441
10219320|NCT04333199|11346961|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
10219321|NCT04333199|11346962|FG001|COMPLETED|Emailed Patients||1399
10219322|NCT04333199|11346963|FG002|COMPLETED|Emailed Patients||1351
10219323|NCT04333199|11346961|FG000|NOT COMPLETED|Emailed Patients||0
10219324|NCT04333199|11346962|FG001|NOT COMPLETED|Emailed Patients||272
10219325|NCT04333199|11346963|FG002|NOT COMPLETED|Emailed Patients||318
10219326|NCT04332991|11346974|FG000|STARTED|Overall Study||242
10219327|NCT04332991|11346975|FG001|STARTED|Overall Study||237
10219328|NCT04332991|11346974|FG000|COMPLETED|Overall Study||242
10219329|NCT04332991|11346975|FG001|COMPLETED|Overall Study||237
10219330|NCT04332991|11346974|FG000|NOT COMPLETED|Overall Study||0
10219331|NCT04332991|11346975|FG001|NOT COMPLETED|Overall Study||0
10219332|NCT04332614|11346987|FG000|STARTED|~1 Week After Study Launch||2350
10219333|NCT04332614|11346988|FG001|STARTED|~1 Week After Study Launch||2350
10219334|NCT04332614|11346989|FG002|STARTED|~1 Week After Study Launch||2350
10219335|NCT04332614|11346990|FG003|STARTED|~1 Week After Study Launch||2350
10219336|NCT04332614|11346991|FG004|STARTED|~1 Week After Study Launch||2350
10219337|NCT04332614|11346992|FG005|STARTED|~1 Week After Study Launch||2349
10219338|NCT04332614|11346987|FG000|Data in EHR|~1 Week After Study Launch||2245
10219339|NCT04332614|11346988|FG001|Data in EHR|~1 Week After Study Launch||2273
10219340|NCT04332614|11346989|FG002|Data in EHR|~1 Week After Study Launch||2251
10219341|NCT04332614|11346990|FG003|Data in EHR|~1 Week After Study Launch||2254
10219342|NCT04332614|11346991|FG004|Data in EHR|~1 Week After Study Launch||2251
10219343|NCT04332614|11346992|FG005|Data in EHR|~1 Week After Study Launch||2249
10219344|NCT04332614|11346987|FG000|COMPLETED|~1 Week After Study Launch||2117
10219345|NCT04332614|11346988|FG001|COMPLETED|~1 Week After Study Launch||2129
10219346|NCT04332614|11346989|FG002|COMPLETED|~1 Week After Study Launch||2124
10219347|NCT04332614|11346990|FG003|COMPLETED|~1 Week After Study Launch||2131
10219348|NCT04332614|11346991|FG004|COMPLETED|~1 Week After Study Launch||2127
10219349|NCT04332614|11346992|FG005|COMPLETED|~1 Week After Study Launch||2115
10219350|NCT04332614|11346987|FG000|NOT COMPLETED|~1 Week After Study Launch||233
10219351|NCT04332614|11346988|FG001|NOT COMPLETED|~1 Week After Study Launch||221
10219352|NCT04332614|11346989|FG002|NOT COMPLETED|~1 Week After Study Launch||226
10219353|NCT04332614|11346990|FG003|NOT COMPLETED|~1 Week After Study Launch||219
10219354|NCT04332614|11346991|FG004|NOT COMPLETED|~1 Week After Study Launch||223
10219355|NCT04332614|11346992|FG005|NOT COMPLETED|~1 Week After Study Launch||234
10219356|NCT04332614|11346987|FG000|STARTED|~1 Month After Study Launch||2117
10219357|NCT04332614|11346988|FG001|STARTED|~1 Month After Study Launch||2129
10219358|NCT04332614|11346989|FG002|STARTED|~1 Month After Study Launch||2124
10219359|NCT04332614|11346990|FG003|STARTED|~1 Month After Study Launch||2131
10219360|NCT04332614|11346991|FG004|STARTED|~1 Month After Study Launch||2127
10219361|NCT04332614|11346992|FG005|STARTED|~1 Month After Study Launch||2115
10219362|NCT04332614|11346987|FG000|COMPLETED|~1 Month After Study Launch||2095
10219363|NCT04332614|11346988|FG001|COMPLETED|~1 Month After Study Launch||2107
10219364|NCT04332614|11346989|FG002|COMPLETED|~1 Month After Study Launch||2094
10219365|NCT04332614|11346990|FG003|COMPLETED|~1 Month After Study Launch||2107
10219366|NCT04332614|11346991|FG004|COMPLETED|~1 Month After Study Launch||2107
10219367|NCT04332614|11346992|FG005|COMPLETED|~1 Month After Study Launch||2096
10219368|NCT04332614|11346987|FG000|NOT COMPLETED|~1 Month After Study Launch||22
10219369|NCT04332614|11346988|FG001|NOT COMPLETED|~1 Month After Study Launch||22
10219370|NCT04332614|11346989|FG002|NOT COMPLETED|~1 Month After Study Launch||30
10219371|NCT04332614|11346990|FG003|NOT COMPLETED|~1 Month After Study Launch||24
10219372|NCT04332614|11346991|FG004|NOT COMPLETED|~1 Month After Study Launch||20
10219373|NCT04332614|11346992|FG005|NOT COMPLETED|~1 Month After Study Launch||19
10219374|NCT04322968|11347011|FG000|STARTED|Overall Study||11
10219375|NCT04322968|11347012|FG001|STARTED|Overall Study||10
10219376|NCT04322968|11347013|FG002|STARTED|Overall Study||10
10219377|NCT04322968|11347014|FG003|STARTED|Overall Study||10
10219378|NCT04322968|11347011|FG000|COMPLETED|Overall Study||10
10219379|NCT04322968|11347012|FG001|COMPLETED|Overall Study||9
10219380|NCT04322968|11347013|FG002|COMPLETED|Overall Study||10
10219381|NCT04322968|11347014|FG003|COMPLETED|Overall Study||10
10219382|NCT04322968|11347011|FG000|NOT COMPLETED|Overall Study||1
10219383|NCT04322968|11347012|FG001|NOT COMPLETED|Overall Study||1
10219384|NCT04322968|11347013|FG002|NOT COMPLETED|Overall Study||0
10219385|NCT04322968|11347014|FG003|NOT COMPLETED|Overall Study||0
10219386|NCT04332081|11347026|FG000|STARTED|Overall Study||20
10219387|NCT04332081|11347027|FG001|STARTED|Overall Study||60
10219388|NCT04332081|11347026|FG000|COMPLETED|Overall Study||20
10219389|NCT04332081|11347027|FG001|COMPLETED|Overall Study||60
10219390|NCT04332081|11347026|FG000|NOT COMPLETED|Overall Study||0
10219391|NCT04332081|11347027|FG001|NOT COMPLETED|Overall Study||0
10219392|NCT04332107|11347035|FG000|STARTED|Day 3||171
10219393|NCT04332107|11347036|FG001|STARTED|Day 3||92
10219394|NCT04332107|11347035|FG000|COMPLETED|Day 3||145
10219395|NCT04332107|11347036|FG001|COMPLETED|Day 3||72
10219396|NCT04332107|11347035|FG000|NOT COMPLETED|Day 3||26
10219397|NCT04332107|11347036|FG001|NOT COMPLETED|Day 3||20
10219398|NCT04332107|11347035|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148
10219399|NCT04332107|11347036|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78
10219400|NCT04332107|11347035|FG000|COMPLETED|Day 14||131
10219401|NCT04332107|11347036|FG001|COMPLETED|Day 14||70
10219402|NCT04332107|11347035|FG000|NOT COMPLETED|Day 14||17
10219403|NCT04332107|11347036|FG001|NOT COMPLETED|Day 14||8
10219404|NCT04332107|11347035|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135
10219405|NCT04332107|11347036|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74
10219406|NCT04332107|11347035|FG000|COMPLETED|Day 21||125
10219407|NCT04332107|11347036|FG001|COMPLETED|Day 21||72
10219408|NCT04332107|11347035|FG000|NOT COMPLETED|Day 21||10
10219409|NCT04332107|11347036|FG001|NOT COMPLETED|Day 21||2
10219410|NCT04323592|11347044|FG000|STARTED|Overall Study||83
10219411|NCT04323592|11347045|FG001|STARTED|Overall Study||90
10219412|NCT04323592|11347044|FG000|COMPLETED|Overall Study||83
10219413|NCT04323592|11347045|FG001|COMPLETED|Overall Study||90
10219414|NCT04323592|11347044|FG000|NOT COMPLETED|Overall Study||0
10219415|NCT04323592|11347045|FG001|NOT COMPLETED|Overall Study||0
10219416|NCT04326842|11347053|FG000|STARTED|Overall Study||40
10219417|NCT04326842|11347054|FG001|STARTED|Overall Study||89
10219418|NCT04326842|11347053|FG000|COMPLETED|Overall Study||31
10219419|NCT04326842|11347054|FG001|COMPLETED|Overall Study||31
10219420|NCT04326842|11347053|FG000|NOT COMPLETED|Overall Study||9
10219421|NCT04326842|11347054|FG001|NOT COMPLETED|Overall Study||58
10219422|NCT04325542|11347060|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743
10219423|NCT04325542|11347060|FG000|COMPLETED|Overall Study||742
10219424|NCT04325542|11347060|FG000|NOT COMPLETED|Overall Study||1
10219425|NCT04329923|11347070|FG000|STARTED|Overall Study||17
10219426|NCT04329923|11347071|FG001|STARTED|Overall Study||17
10219427|NCT04329923|11347072|FG002|STARTED|Overall Study||4
10219428|NCT04329923|11347073|FG003|STARTED|Overall Study||3
10219429|NCT04329923|11347074|FG004|STARTED|Overall Study||66
10219430|NCT04329923|11347075|FG005|STARTED|Overall Study||66
10219431|NCT04329923|11347070|FG000|COMPLETED|Overall Study||16
10219432|NCT04329923|11347071|FG001|COMPLETED|Overall Study||13
10219433|NCT04329923|11347072|FG002|COMPLETED|Overall Study||3
10219434|NCT04329923|11347073|FG003|COMPLETED|Overall Study||2
10219435|NCT04329923|11347074|FG004|COMPLETED|Overall Study||64
10219436|NCT04329923|11347075|FG005|COMPLETED|Overall Study||61
10219437|NCT04329923|11347070|FG000|NOT COMPLETED|Overall Study||1
10219438|NCT04329923|11347071|FG001|NOT COMPLETED|Overall Study||4
10219439|NCT04329923|11347072|FG002|NOT COMPLETED|Overall Study||1
10219440|NCT04329923|11347073|FG003|NOT COMPLETED|Overall Study||1
10219441|NCT04329923|11347074|FG004|NOT COMPLETED|Overall Study||2
10219442|NCT04329923|11347075|FG005|NOT COMPLETED|Overall Study||5
10219443|NCT04328467|11347092|FG000|STARTED|Overall Study||494
10219444|NCT04328467|11347093|FG001|STARTED|Overall Study||495
10219445|NCT04328467|11347094|FG002|STARTED|Overall Study||494
10219446|NCT04328467|11347092|FG000|COMPLETED|Overall Study||490
10219447|NCT04328467|11347093|FG001|COMPLETED|Overall Study||493
10219448|NCT04328467|11347094|FG002|COMPLETED|Overall Study||493
10219449|NCT04328467|11347092|FG000|NOT COMPLETED|Overall Study||4
10219450|NCT04328467|11347093|FG001|NOT COMPLETED|Overall Study||2
10219451|NCT04328467|11347094|FG002|NOT COMPLETED|Overall Study||1
10219452|NCT04322526|11347104|FG000|STARTED|First Intervention (1 Day)||13
10219453|NCT04322526|11347105|FG001|STARTED|First Intervention (1 Day)||12
10219454|NCT04322526|11347104|FG000|COMPLETED|First Intervention (1 Day)||12
10219455|NCT04322526|11347105|FG001|COMPLETED|First Intervention (1 Day)||11
10012478|NCT01785849|11135275|FG000|COMPLETED|Overall Study||193
10012479|NCT01785849|11135276|FG001|COMPLETED|Overall Study||220
10012480|NCT01785849|11135275|FG000|NOT COMPLETED|Overall Study||61
10012481|NCT01785849|11135276|FG001|NOT COMPLETED|Overall Study||34
10012482|NCT01785875|11135282|FG000|STARTED|Overall Study||384
10219456|NCT04322526|11347104|FG000|NOT COMPLETED|First Intervention (1 Day)||1
10219457|NCT04322526|11347105|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10219458|NCT04322526|11347104|FG000|STARTED|Washout (1 Week)||12
10219459|NCT04322526|11347105|FG001|STARTED|Washout (1 Week)||11
10219460|NCT04322526|11347104|FG000|COMPLETED|Washout (1 Week)||11
10219461|NCT04322526|11347105|FG001|COMPLETED|Washout (1 Week)||9
10219462|NCT04322526|11347104|FG000|NOT COMPLETED|Washout (1 Week)||1
10219463|NCT04322526|11347105|FG001|NOT COMPLETED|Washout (1 Week)||2
10219464|NCT04322526|11347104|FG000|STARTED|Second Intervention (1day)||11
10219465|NCT04322526|11347105|FG001|STARTED|Second Intervention (1day)||9
10219466|NCT04322526|11347104|FG000|COMPLETED|Second Intervention (1day)||11
10219467|NCT04322526|11347105|FG001|COMPLETED|Second Intervention (1day)||9
10219468|NCT04322526|11347104|FG000|NOT COMPLETED|Second Intervention (1day)||0
10219469|NCT04322526|11347105|FG001|NOT COMPLETED|Second Intervention (1day)||0
10219470|NCT04322500|11347113|FG000|STARTED|Overall Study||13
10219471|NCT04322500|11347114|FG001|STARTED|Overall Study||13
10219472|NCT04322500|11347113|FG000|COMPLETED|Overall Study||13
10219473|NCT04322500|11347114|FG001|COMPLETED|Overall Study||13
10219474|NCT04322500|11347113|FG000|NOT COMPLETED|Overall Study||0
10219475|NCT04322500|11347114|FG001|NOT COMPLETED|Overall Study||0
10219476|NCT04322682|11347122|FG000|STARTED|Overall Study||2235
10219477|NCT04322682|11347123|FG001|STARTED|Overall Study||2253
10219478|NCT04322682|11347122|FG000|COMPLETED|Overall Study||2192
10219479|NCT04322682|11347123|FG001|COMPLETED|Overall Study||2189
10219480|NCT04322682|11347122|FG000|NOT COMPLETED|Overall Study||43
10219481|NCT04322682|11347123|FG001|NOT COMPLETED|Overall Study||64
10219482|NCT04321980|11347131|FG000|STARTED|Overall Study||4
10219483|NCT04321980|11347132|FG001|STARTED|Overall Study||4
10219484|NCT04321980|11347131|FG000|COMPLETED|Overall Study||4
10219485|NCT04321980|11347132|FG001|COMPLETED|Overall Study||4
10219486|NCT04321980|11347131|FG000|NOT COMPLETED|Overall Study||0
10219487|NCT04321980|11347132|FG001|NOT COMPLETED|Overall Study||0
10219488|NCT04322396|11347140|FG000|STARTED|Overall Study||56
10219489|NCT04322396|11347141|FG001|STARTED|Overall Study||61
10219490|NCT04322396|11347140|FG000|COMPLETED|Overall Study||56
10219491|NCT04322396|11347141|FG001|COMPLETED|Overall Study||61
10219492|NCT04322396|11347140|FG000|NOT COMPLETED|Overall Study||0
10219493|NCT04322396|11347141|FG001|NOT COMPLETED|Overall Study||0
10219494|NCT04320823|11347149|FG000|STARTED|Overall Study||1717
10219495|NCT04320823|11347150|FG001|STARTED|Overall Study||1726
10219496|NCT04320823|11347149|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
10219497|NCT04320823|11347150|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
10219498|NCT04320823|11347149|FG000|NOT COMPLETED|Overall Study||0
10219499|NCT04320823|11347150|FG001|NOT COMPLETED|Overall Study||0
10219500|NCT04320615|11347174|FG000|STARTED|Overall Study||144
10219501|NCT04320615|11347175|FG001|STARTED|Overall Study||294
10219502|NCT04320615|11347174|FG000|COMPLETED|Overall Study||96
10219503|NCT04320615|11347175|FG001|COMPLETED|Overall Study||190
10219504|NCT04320615|11347174|FG000|NOT COMPLETED|Overall Study||48
10219505|NCT04320615|11347175|FG001|NOT COMPLETED|Overall Study||104
10219506|NCT04318535|11347185|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
10219507|NCT04318535|11347186|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
10219508|NCT04318535|11347187|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
10219509|NCT04318535|11347185|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
10219510|NCT04318535|11347186|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
10219511|NCT04318535|11347187|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
10219512|NCT04318535|11347185|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
10219513|NCT04318535|11347186|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
10219514|NCT04318535|11347187|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
10219515|NCT04318535|11347185|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
10219516|NCT04318535|11347186|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
10219517|NCT04318535|11347187|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
10219518|NCT04318535|11347185|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
10219519|NCT04318535|11347186|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
10219520|NCT04318535|11347187|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
10219521|NCT04318535|11347185|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
10219522|NCT04318535|11347186|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
10219523|NCT04318535|11347187|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
10219524|NCT04318535|11347185|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
10219525|NCT04318535|11347186|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
10219526|NCT04318535|11347187|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
10219527|NCT04318535|11347185|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
10219528|NCT04318535|11347186|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
10219529|NCT04318535|11347187|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
10219530|NCT04318535|11347185|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
10219531|NCT04318535|11347186|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
10219532|NCT04318535|11347187|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
10219533|NCT04318535|11347185|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
10219534|NCT04318535|11347186|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
10219535|NCT04318535|11347187|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
10219536|NCT04318535|11347185|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
10219537|NCT04318535|11347186|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
10219538|NCT04318535|11347187|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
10219539|NCT04318535|11347185|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
10219540|NCT04318535|11347186|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
10219541|NCT04318535|11347187|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
10219542|NCT04318535|11347185|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
10219543|NCT04318535|11347186|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
10219544|NCT04318535|11347187|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
10219545|NCT04318535|11347185|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
10219546|NCT04318535|11347186|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
10219547|NCT04318535|11347187|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
10219548|NCT04318535|11347185|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
10239133|NCT00350623|11370640|FG002|COMPLETED|Overall Study||62
10219549|NCT04318535|11347186|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
10219550|NCT04318535|11347187|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
10219551|NCT04316260|11347198|FG000|STARTED|Overall Study||34
10219552|NCT04316260|11347199|FG001|STARTED|Overall Study||17
10219553|NCT04316260|11347198|FG000|COMPLETED|Overall Study||34
10219554|NCT04316260|11347199|FG001|COMPLETED|Overall Study||17
10219555|NCT04316260|11347198|FG000|NOT COMPLETED|Overall Study||0
10219556|NCT04316260|11347199|FG001|NOT COMPLETED|Overall Study||0
10219557|NCT04314037|11347208|FG000|STARTED|Treatment Period 1||18
10219558|NCT04314037|11347209|FG001|STARTED|Treatment Period 1||18
10219559|NCT04314037|11347208|FG000|COMPLETED|Treatment Period 1||18
10219560|NCT04314037|11347209|FG001|COMPLETED|Treatment Period 1||18
10219561|NCT04314037|11347208|FG000|NOT COMPLETED|Treatment Period 1||0
10219562|NCT04314037|11347209|FG001|NOT COMPLETED|Treatment Period 1||0
10219563|NCT04314037|11347208|FG000|STARTED|Treatment Period 2||18
10219564|NCT04314037|11347209|FG001|STARTED|Treatment Period 2||18
10219565|NCT04314037|11347208|FG000|COMPLETED|Treatment Period 2||17
10219566|NCT04314037|11347209|FG001|COMPLETED|Treatment Period 2||18
10219567|NCT04314037|11347208|FG000|NOT COMPLETED|Treatment Period 2||1
10219568|NCT04314037|11347209|FG001|NOT COMPLETED|Treatment Period 2||0
10219569|NCT04314037|11347208|FG000|STARTED|Treatment Period 3||17
10219570|NCT04314037|11347209|FG001|STARTED|Treatment Period 3||18
10219571|NCT04314037|11347208|FG000|COMPLETED|Treatment Period 3||16
10219572|NCT04314037|11347209|FG001|COMPLETED|Treatment Period 3||17
10219573|NCT04314037|11347208|FG000|NOT COMPLETED|Treatment Period 3||1
10219574|NCT04314037|11347209|FG001|NOT COMPLETED|Treatment Period 3||1
10219575|NCT04314037|11347208|FG000|STARTED|Treatment Period 4||16
10219576|NCT04314037|11347209|FG001|STARTED|Treatment Period 4||17
10219577|NCT04314037|11347208|FG000|COMPLETED|Treatment Period 4||16
10219578|NCT04314037|11347209|FG001|COMPLETED|Treatment Period 4||17
10219579|NCT04314037|11347208|FG000|NOT COMPLETED|Treatment Period 4||0
10219580|NCT04314037|11347209|FG001|NOT COMPLETED|Treatment Period 4||0
10219581|NCT04315298|11347240|FG000|STARTED|Overall Study||90
10219582|NCT04315298|11347241|FG001|STARTED|Overall Study||187
10219583|NCT04315298|11347242|FG002|STARTED|Overall Study||180
10219584|NCT04315298|11347243|FG003|STARTED|Overall Study||170
10219585|NCT04315298|11347244|FG004|STARTED|Overall Study||242
10219586|NCT04315298|11347245|FG005|STARTED|Overall Study||338
10219587|NCT04315298|11347246|FG006|STARTED|Overall Study||70
10219588|NCT04315298|11347247|FG007|STARTED|Overall Study||140
10219589|NCT04315298|11347248|FG008|STARTED|Overall Study||137
10219590|NCT04315298|11347249|FG009|STARTED|Overall Study||46
10219591|NCT04315298|11347250|FG010|STARTED|Overall Study||95
10219592|NCT04315298|11347251|FG011|STARTED|Overall Study||92
10219593|NCT04315298|11347252|FG012|STARTED|Overall Study||8
10219594|NCT04315298|11347253|FG013|STARTED|Overall Study||12
10219595|NCT04315298|11347254|FG014|STARTED|Overall Study||15
10219596|NCT04315298|11347255|FG015|STARTED|Overall Study||15
10219597|NCT04315298|11347256|FG016|STARTED|Overall Study||16
10219598|NCT04315298|11347257|FG017|STARTED|Overall Study||6
10219599|NCT04315298|11347258|FG018|STARTED|Overall Study||2
10219600|NCT04315298|11347240|FG000|COMPLETED|Overall Study||61
10219601|NCT04315298|11347241|FG001|COMPLETED|Overall Study||117
10219602|NCT04315298|11347242|FG002|COMPLETED|Overall Study||125
10219603|NCT04315298|11347243|FG003|COMPLETED|Overall Study||101
10219604|NCT04315298|11347244|FG004|COMPLETED|Overall Study||157
10219605|NCT04315298|11347245|FG005|COMPLETED|Overall Study||209
10219606|NCT04315298|11347246|FG006|COMPLETED|Overall Study||52
10219607|NCT04315298|11347247|FG007|COMPLETED|Overall Study||111
10219608|NCT04315298|11347248|FG008|COMPLETED|Overall Study||101
10219609|NCT04315298|11347249|FG009|COMPLETED|Overall Study||29
10219610|NCT04315298|11347250|FG010|COMPLETED|Overall Study||53
10219611|NCT04315298|11347251|FG011|COMPLETED|Overall Study||51
10219612|NCT04315298|11347252|FG012|COMPLETED|Overall Study||5
10219613|NCT04315298|11347253|FG013|COMPLETED|Overall Study||8
10219614|NCT04315298|11347254|FG014|COMPLETED|Overall Study||9
10219615|NCT04315298|11347255|FG015|COMPLETED|Overall Study||9
10219616|NCT04315298|11347256|FG016|COMPLETED|Overall Study||13
10219617|NCT04315298|11347257|FG017|COMPLETED|Overall Study||5
10219618|NCT04315298|11347258|FG018|COMPLETED|Overall Study||2
10219619|NCT04315298|11347240|FG000|NOT COMPLETED|Overall Study||29
10219620|NCT04315298|11347241|FG001|NOT COMPLETED|Overall Study||70
10219621|NCT04315298|11347242|FG002|NOT COMPLETED|Overall Study||55
10219622|NCT04315298|11347243|FG003|NOT COMPLETED|Overall Study||69
10219623|NCT04315298|11347244|FG004|NOT COMPLETED|Overall Study||85
10219624|NCT04315298|11347245|FG005|NOT COMPLETED|Overall Study||129
10219625|NCT04315298|11347246|FG006|NOT COMPLETED|Overall Study||18
10219626|NCT04315298|11347247|FG007|NOT COMPLETED|Overall Study||29
10219627|NCT04315298|11347248|FG008|NOT COMPLETED|Overall Study||36
10219628|NCT04315298|11347249|FG009|NOT COMPLETED|Overall Study||17
10219629|NCT04315298|11347250|FG010|NOT COMPLETED|Overall Study||42
10219630|NCT04315298|11347251|FG011|NOT COMPLETED|Overall Study||41
10219631|NCT04315298|11347252|FG012|NOT COMPLETED|Overall Study||3
10219632|NCT04315298|11347253|FG013|NOT COMPLETED|Overall Study||4
10219633|NCT04315298|11347254|FG014|NOT COMPLETED|Overall Study||6
10219634|NCT04315298|11347255|FG015|NOT COMPLETED|Overall Study||6
10219635|NCT04315298|11347256|FG016|NOT COMPLETED|Overall Study||3
10219636|NCT04315298|11347257|FG017|NOT COMPLETED|Overall Study||1
10219637|NCT04315298|11347258|FG018|NOT COMPLETED|Overall Study||0
10219638|NCT04313647|11347330|FG000|STARTED|Overall Study||3
10219639|NCT04313647|11347331|FG001|STARTED|Overall Study||3
10219640|NCT04313647|11347332|FG002|STARTED|Overall Study||6
10219641|NCT04313647|11347333|FG003|STARTED|Overall Study||6
10219642|NCT04313647|11347334|FG004|STARTED|Overall Study||6
10219643|NCT04313647|11347330|FG000|COMPLETED|Overall Study||3
10219644|NCT04313647|11347331|FG001|COMPLETED|Overall Study||3
10219645|NCT04313647|11347332|FG002|COMPLETED|Overall Study||6
10219646|NCT04313647|11347333|FG003|COMPLETED|Overall Study||6
10219647|NCT04313647|11347334|FG004|COMPLETED|Overall Study||6
10219648|NCT04313647|11347330|FG000|NOT COMPLETED|Overall Study||0
10219649|NCT04313647|11347331|FG001|NOT COMPLETED|Overall Study||0
10219650|NCT04313647|11347332|FG002|NOT COMPLETED|Overall Study||0
10219651|NCT04313647|11347333|FG003|NOT COMPLETED|Overall Study||0
10219652|NCT04313647|11347334|FG004|NOT COMPLETED|Overall Study||0
10219653|NCT04310085|11347353|FG000|STARTED|Overall Study||8
10219654|NCT04310085|11347354|FG001|STARTED|Overall Study||8
10219655|NCT04310085|11347353|FG000|COMPLETED|Overall Study||8
10219656|NCT04310085|11347354|FG001|COMPLETED|Overall Study||8
10219657|NCT04310085|11347353|FG000|NOT COMPLETED|Overall Study||0
10219658|NCT04310085|11347354|FG001|NOT COMPLETED|Overall Study||0
10219659|NCT04309617|11347360|FG000|STARTED|Overall Study||618
10219660|NCT04309617|11347360|FG000|Modified High Risk of Recurrence|Overall Study||136
10219661|NCT04309617|11347360|FG000|COMPLETED|Overall Study||618
10219662|NCT04309617|11347360|FG000|NOT COMPLETED|Overall Study||0
10219663|NCT04308239|11347368|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20
10219664|NCT04308239|11347369|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14
10219665|NCT04308239|11347368|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
10219666|NCT04308239|11347369|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
10219667|NCT04308239|11347368|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
10219668|NCT04308239|11347369|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
10219669|NCT04308239|11347368|FG000|STARTED|Intervention (2 Weeks)||20
10219670|NCT04308239|11347369|FG001|STARTED|Intervention (2 Weeks)||14
10219671|NCT04308239|11347368|FG000|COMPLETED|Intervention (2 Weeks)||20
10219672|NCT04308239|11347369|FG001|COMPLETED|Intervention (2 Weeks)||14
10219673|NCT04308239|11347368|FG000|NOT COMPLETED|Intervention (2 Weeks)||0
10219674|NCT04308239|11347369|FG001|NOT COMPLETED|Intervention (2 Weeks)||0
10219675|NCT04308239|11347368|FG000|STARTED|Post-intervention Evaluation (1 Week)||20
10219676|NCT04308239|11347369|FG001|STARTED|Post-intervention Evaluation (1 Week)||14
10219677|NCT04308239|11347368|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19
10219678|NCT04308239|11347369|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10
10219679|NCT04308239|11347368|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
10219680|NCT04308239|11347369|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
10219681|NCT04308668|11347381|FG000|STARTED|Overall Study||658
10219682|NCT04308668|11347382|FG001|STARTED|Overall Study||654
10219683|NCT04308668|11347381|FG000|COMPLETED|Overall Study||622
10219684|NCT04308668|11347382|FG001|COMPLETED|Overall Study||612
10219685|NCT04308668|11347381|FG000|NOT COMPLETED|Overall Study||36
10219686|NCT04308668|11347382|FG001|NOT COMPLETED|Overall Study||42
10219687|NCT04307940|11347391|FG000|STARTED|Overall Study||90
10219688|NCT04307940|11347392|FG001|STARTED|Overall Study||87
10219689|NCT04307940|11347393|FG002|STARTED|Overall Study||44
10219690|NCT04307940|11347391|FG000|COMPLETED|Overall Study||85
10219691|NCT04307940|11347392|FG001|COMPLETED|Overall Study||84
10219692|NCT04307940|11347393|FG002|COMPLETED|Overall Study||42
10219693|NCT04307940|11347391|FG000|NOT COMPLETED|Overall Study||5
10219694|NCT04307940|11347392|FG001|NOT COMPLETED|Overall Study||3
10219695|NCT04307940|11347393|FG002|NOT COMPLETED|Overall Study||2
10219696|NCT04302545|11347403|FG000|STARTED|Overall Study||107
10219697|NCT04302545|11347404|FG001|STARTED|Overall Study||107
10219698|NCT04302545|11347403|FG000|COMPLETED|Overall Study||104
10219699|NCT04302545|11347404|FG001|COMPLETED|Overall Study||103
10219700|NCT04302545|11347403|FG000|NOT COMPLETED|Overall Study||3
10219701|NCT04302545|11347404|FG001|NOT COMPLETED|Overall Study||4
10219702|NCT04297631|11347421|FG000|STARTED|Overall Study||20
10219703|NCT04297631|11347421|FG000|COMPLETED|Overall Study||20
10219704|NCT04297631|11347421|FG000|NOT COMPLETED|Overall Study||0
10219705|NCT04297241|11347426|FG000|STARTED|Overall Study||20
10219706|NCT04297241|11347426|FG000|COMPLETED|Overall Study||15
10219707|NCT04297241|11347426|FG000|NOT COMPLETED|Overall Study||5
10219708|NCT04296448|11347442|FG000|STARTED|Overall Study||98
10219709|NCT04296448|11347443|FG001|STARTED|Overall Study||99
10219710|NCT04296448|11347442|FG000|COMPLETED|Overall Study||98
10219711|NCT04296448|11347443|FG001|COMPLETED|Overall Study||99
10219712|NCT04296448|11347442|FG000|NOT COMPLETED|Overall Study||0
10219713|NCT04296448|11347443|FG001|NOT COMPLETED|Overall Study||0
10219714|NCT04296227|11347449|FG000|STARTED|Overall Study||85
10219715|NCT04296227|11347449|FG000|COMPLETED|Overall Study||85
10219716|NCT04296227|11347449|FG000|NOT COMPLETED|Overall Study||0
10219717|NCT04295356|11347455|FG000|STARTED|Overall Study||93
10219718|NCT04295356|11347456|FG001|STARTED|Overall Study||87
10219719|NCT04295356|11347455|FG000|COMPLETED|Overall Study||92
10219720|NCT04295356|11347456|FG001|COMPLETED|Overall Study||83
10219721|NCT04295356|11347455|FG000|NOT COMPLETED|Overall Study||1
10219722|NCT04295356|11347456|FG001|NOT COMPLETED|Overall Study||4
10219723|NCT04292639|11347462|FG000|STARTED|Overall Study||20
10219724|NCT04292639|11347462|FG000|COMPLETED|Overall Study||20
10219725|NCT04292639|11347462|FG000|NOT COMPLETED|Overall Study||0
10219726|NCT04292535|11347480|FG000|STARTED|Overall Study||8
10219727|NCT04292535|11347481|FG001|STARTED|Overall Study||8
10219728|NCT04292535|11347482|FG002|STARTED|Overall Study||9
10219729|NCT04292535|11347483|FG003|STARTED|Overall Study||8
10219730|NCT04292535|11347484|FG004|STARTED|Overall Study||8
10219731|NCT04292535|11347485|FG005|STARTED|Overall Study||9
10219732|NCT04292535|11347486|FG006|STARTED|Overall Study||8
10219733|NCT04292535|11347487|FG007|STARTED|Overall Study||10
10219734|NCT04292535|11347488|FG008|STARTED|Overall Study||8
10219735|NCT04292535|11347489|FG009|STARTED|Overall Study||8
10219736|NCT04292535|11347490|FG010|STARTED|Overall Study||7
10219737|NCT04292535|11347491|FG011|STARTED|Overall Study||7
10219738|NCT04292535|11347492|FG012|STARTED|Overall Study||9
10219739|NCT04292535|11347493|FG013|STARTED|Overall Study||9
10219740|NCT04292535|11347480|FG000|COMPLETED|Overall Study||8
10219741|NCT04292535|11347481|FG001|COMPLETED|Overall Study||8
10219742|NCT04292535|11347482|FG002|COMPLETED|Overall Study||9
10219743|NCT04292535|11347483|FG003|COMPLETED|Overall Study||8
10219744|NCT04292535|11347484|FG004|COMPLETED|Overall Study||8
10219745|NCT04292535|11347485|FG005|COMPLETED|Overall Study||9
10219746|NCT04292535|11347486|FG006|COMPLETED|Overall Study||8
10219747|NCT04292535|11347487|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
10219748|NCT04292535|11347488|FG008|COMPLETED|Overall Study||8
10219749|NCT04292535|11347489|FG009|COMPLETED|Overall Study||8
10219750|NCT04292535|11347490|FG010|COMPLETED|Overall Study||7
10219751|NCT04292535|11347491|FG011|COMPLETED|Overall Study||6
10219752|NCT04292535|11347492|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
10219753|NCT04292535|11347493|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
10219754|NCT04292535|11347480|FG000|NOT COMPLETED|Overall Study||0
10219755|NCT04292535|11347481|FG001|NOT COMPLETED|Overall Study||0
10219756|NCT04292535|11347482|FG002|NOT COMPLETED|Overall Study||0
10219757|NCT04292535|11347483|FG003|NOT COMPLETED|Overall Study||0
10219758|NCT04292535|11347484|FG004|NOT COMPLETED|Overall Study||0
10219759|NCT04292535|11347485|FG005|NOT COMPLETED|Overall Study||0
10219760|NCT04292535|11347486|FG006|NOT COMPLETED|Overall Study||0
10219761|NCT04292535|11347487|FG007|NOT COMPLETED|Overall Study||2
10219762|NCT04292535|11347488|FG008|NOT COMPLETED|Overall Study||0
10219763|NCT04292535|11347489|FG009|NOT COMPLETED|Overall Study||0
10219764|NCT04292535|11347490|FG010|NOT COMPLETED|Overall Study||0
10219765|NCT04292535|11347491|FG011|NOT COMPLETED|Overall Study||1
10219766|NCT04292535|11347492|FG012|NOT COMPLETED|Overall Study||1
10219767|NCT04292535|11347493|FG013|NOT COMPLETED|Overall Study||2
10219768|NCT04292171|11347525|FG000|STARTED|Overall Study||109
10219769|NCT04292171|11347526|FG001|STARTED|Overall Study||110
10219770|NCT04292171|11347525|FG000|COMPLETED|Overall Study||107
10219771|NCT04292171|11347526|FG001|COMPLETED|Overall Study||109
10219772|NCT04292171|11347525|FG000|NOT COMPLETED|Overall Study||2
10219773|NCT04292171|11347526|FG001|NOT COMPLETED|Overall Study||1
10219774|NCT04292899|11347536|FG000|STARTED|Overall Study||200
10219775|NCT04292899|11347537|FG001|STARTED|Overall Study||197
10219776|NCT04292899|11347538|FG002|STARTED|Overall Study||844
10219777|NCT04292899|11347539|FG003|STARTED|Overall Study||3597
10219778|NCT04292899|11347536|FG000|COMPLETED|Overall Study||168
10219779|NCT04292899|11347537|FG001|COMPLETED|Overall Study||164
10219780|NCT04292899|11347538|FG002|COMPLETED|Overall Study||621
10219781|NCT04292899|11347539|FG003|COMPLETED|Overall Study||2952
10219782|NCT04292899|11347536|FG000|NOT COMPLETED|Overall Study||32
10219783|NCT04292899|11347537|FG001|NOT COMPLETED|Overall Study||33
10219784|NCT04292899|11347538|FG002|NOT COMPLETED|Overall Study||223
10219785|NCT04292899|11347539|FG003|NOT COMPLETED|Overall Study||645
10219786|NCT04292730|11347551|FG000|STARTED|Overall Study||199
10219787|NCT04292730|11347552|FG001|STARTED|Overall Study||197
10219788|NCT04292730|11347553|FG002|STARTED|Overall Study||200
10219789|NCT04292730|11347554|FG003|STARTED|Overall Study||517
10219790|NCT04292730|11347551|FG000|COMPLETED|Overall Study||179
10219791|NCT04292730|11347552|FG001|COMPLETED|Overall Study||176
10219792|NCT04292730|11347553|FG002|COMPLETED|Overall Study||178
10219793|NCT04292730|11347554|FG003|COMPLETED|Overall Study||437
10219794|NCT04292730|11347551|FG000|NOT COMPLETED|Overall Study||20
10219795|NCT04292730|11347552|FG001|NOT COMPLETED|Overall Study||21
10219796|NCT04292730|11347553|FG002|NOT COMPLETED|Overall Study||22
10219797|NCT04292730|11347554|FG003|NOT COMPLETED|Overall Study||80
10219798|NCT04290676|11347563|FG000|STARTED|Overall Study||527
10219799|NCT04290676|11347563|FG000|COMPLETED|Overall Study||527
10219800|NCT04290676|11347563|FG000|NOT COMPLETED|Overall Study||0
10219801|NCT04290039|11347570|FG000|STARTED|Period 1 (Visit 1; Day 1)||5
10219802|NCT04290039|11347571|FG001|STARTED|Period 1 (Visit 1; Day 1)||5
10219803|NCT04290039|11347572|FG002|STARTED|Period 1 (Visit 1; Day 1)||5
10219804|NCT04290039|11347570|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5
10219805|NCT04290039|11347571|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5
10219806|NCT04290039|11347572|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5
10219807|NCT04290039|11347570|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
10219808|NCT04290039|11347571|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
10219809|NCT04290039|11347572|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
10219810|NCT04290039|11347570|FG000|STARTED|Period 2 (Visit 2; Day 8)||5
10219811|NCT04290039|11347571|FG001|STARTED|Period 2 (Visit 2; Day 8)||5
10219812|NCT04290039|11347572|FG002|STARTED|Period 2 (Visit 2; Day 8)||5
10219813|NCT04290039|11347570|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5
10219814|NCT04290039|11347571|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5
10219815|NCT04290039|11347572|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5
10219816|NCT04290039|11347570|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
10219817|NCT04290039|11347571|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
10219818|NCT04290039|11347572|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
10219819|NCT04290039|11347570|FG000|STARTED|Period 3 (Visit 3; Day 15)||5
10219820|NCT04290039|11347571|FG001|STARTED|Period 3 (Visit 3; Day 15)||4
10219821|NCT04290039|11347572|FG002|STARTED|Period 3 (Visit 3; Day 15)||5
10012483|NCT01785875|11135283|FG001|STARTED|Overall Study||384
10012484|NCT01785875|11135284|FG002|STARTED|Overall Study||123
10012485|NCT01785875|11135282|FG000|Received Etelcalcetide|Overall Study||383
10012486|NCT01785875|11135283|FG001|Received Etelcalcetide|Overall Study||384
10219822|NCT04290039|11347570|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5
10219823|NCT04290039|11347571|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4
10219824|NCT04290039|11347572|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5
10219825|NCT04290039|11347570|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
10219826|NCT04290039|11347571|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
10219827|NCT04290039|11347572|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
10219828|NCT04289623|11347587|FG000|STARTED|Wave 1 Emails||6782
10219829|NCT04289623|11347588|FG001|STARTED|Wave 1 Emails||6764
10219830|NCT04289623|11347589|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
10219831|NCT04289623|11347590|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
10219832|NCT04289623|11347591|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10219833|NCT04289623|11347592|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10219834|NCT04289623|11347587|FG000|COMPLETED|Wave 1 Emails||6514
10219835|NCT04289623|11347588|FG001|COMPLETED|Wave 1 Emails||6507
10219836|NCT04289623|11347589|FG002|COMPLETED|Wave 1 Emails||0
10219837|NCT04289623|11347590|FG003|COMPLETED|Wave 1 Emails||0
9760856|NCT00383747|10864659|FG001|COMPLETED|Visit 2||14
9760857|NCT00383747|10864660|FG002|COMPLETED|Visit 2||16
9760858|NCT00383747|10864661|FG003|COMPLETED|Visit 2||16
9760859|NCT00383747|10864658|FG000|NOT COMPLETED|Visit 2||0
9760860|NCT00383747|10864659|FG001|NOT COMPLETED|Visit 2||0
9760861|NCT00383747|10864660|FG002|NOT COMPLETED|Visit 2||0
10219838|NCT04289623|11347591|FG004|COMPLETED|Wave 1 Emails||0
10219839|NCT04289623|11347592|FG005|COMPLETED|Wave 1 Emails||0
10219840|NCT04289623|11347587|FG000|NOT COMPLETED|Wave 1 Emails||268
9760862|NCT00383747|10864661|FG003|NOT COMPLETED|Visit 2||0
10012487|NCT01785875|11135284|FG002|Received Etelcalcetide|Overall Study||123
10012488|NCT01785875|11135282|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
10219841|NCT04289623|11347588|FG001|NOT COMPLETED|Wave 1 Emails||257
10219842|NCT04289623|11347589|FG002|NOT COMPLETED|Wave 1 Emails||0
10219843|NCT04289623|11347590|FG003|NOT COMPLETED|Wave 1 Emails||0
10219844|NCT04289623|11347591|FG004|NOT COMPLETED|Wave 1 Emails||0
10219845|NCT04289623|11347592|FG005|NOT COMPLETED|Wave 1 Emails||0
10219846|NCT04289623|11347587|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
10219847|NCT04289623|11347588|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
10219848|NCT04289623|11347589|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
10019030|NCT01827163|11142110|FG000|STARTED|Overall Study||20
10219849|NCT04289623|11347590|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
10219850|NCT04289623|11347591|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10219851|NCT04289623|11347592|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10219852|NCT04289623|11347587|FG000|COMPLETED|Wave 2 Emails||0
10219853|NCT04289623|11347588|FG001|COMPLETED|Wave 2 Emails||0
10219854|NCT04289623|11347589|FG002|COMPLETED|Wave 2 Emails||6099
10219855|NCT04289623|11347590|FG003|COMPLETED|Wave 2 Emails||6117
10219856|NCT04289623|11347591|FG004|COMPLETED|Wave 2 Emails||0
10219857|NCT04289623|11347592|FG005|COMPLETED|Wave 2 Emails||0
10219858|NCT04289623|11347587|FG000|NOT COMPLETED|Wave 2 Emails||0
10219859|NCT04289623|11347588|FG001|NOT COMPLETED|Wave 2 Emails||0
10219860|NCT04289623|11347589|FG002|NOT COMPLETED|Wave 2 Emails||0
10219861|NCT04289623|11347590|FG003|NOT COMPLETED|Wave 2 Emails||0
10219862|NCT04289623|11347591|FG004|NOT COMPLETED|Wave 2 Emails||0
10219863|NCT04289623|11347592|FG005|NOT COMPLETED|Wave 2 Emails||0
10219864|NCT04276207|11347606|FG000|STARTED|Period 1||15
10219865|NCT04276207|11347607|FG001|STARTED|Period 1||17
10219866|NCT04276207|11347606|FG000|Received at Least One Dose of Study Drug|Period 1||15
10219867|NCT04276207|11347607|FG001|Received at Least One Dose of Study Drug|Period 1||17
10219868|NCT04276207|11347606|FG000|COMPLETED|Period 1||15
10219869|NCT04276207|11347607|FG001|COMPLETED|Period 1||16
10219870|NCT04276207|11347606|FG000|NOT COMPLETED|Period 1||0
10219871|NCT04276207|11347607|FG001|NOT COMPLETED|Period 1||1
10219872|NCT04276207|11347606|FG000|STARTED|Washout (3- 14 Days)||15
10219873|NCT04276207|11347607|FG001|STARTED|Washout (3- 14 Days)||16
10219874|NCT04276207|11347606|FG000|COMPLETED|Washout (3- 14 Days)||15
10219875|NCT04276207|11347607|FG001|COMPLETED|Washout (3- 14 Days)||16
10219876|NCT04276207|11347606|FG000|NOT COMPLETED|Washout (3- 14 Days)||0
10219877|NCT04276207|11347607|FG001|NOT COMPLETED|Washout (3- 14 Days)||0
10219878|NCT04276207|11347606|FG000|STARTED|Period 2||15
10219879|NCT04276207|11347607|FG001|STARTED|Period 2||16
10219880|NCT04276207|11347606|FG000|COMPLETED|Period 2||15
10219881|NCT04276207|11347607|FG001|COMPLETED|Period 2||16
10219882|NCT04276207|11347606|FG000|NOT COMPLETED|Period 2||0
10219883|NCT04276207|11347607|FG001|NOT COMPLETED|Period 2||0
10219884|NCT04289714|11347616|FG000|STARTED|Overall Study||14
10219885|NCT04289714|11347617|FG001|STARTED|Overall Study||11
10219886|NCT04289714|11347618|FG002|STARTED|Overall Study||10
10219887|NCT04289714|11347616|FG000|COMPLETED|Overall Study||8
10219888|NCT04289714|11347617|FG001|COMPLETED|Overall Study||6
10219889|NCT04289714|11347618|FG002|COMPLETED|Overall Study||4
10219890|NCT04289714|11347616|FG000|NOT COMPLETED|Overall Study||6
10219891|NCT04289714|11347617|FG001|NOT COMPLETED|Overall Study||5
10219892|NCT04289714|11347618|FG002|NOT COMPLETED|Overall Study||6
10219893|NCT04288752|11347628|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
10219894|NCT04288752|11347629|FG001|STARTED|Overall Study||88
10219895|NCT04288752|11347628|FG000|COMPLETED|Overall Study||81
10219896|NCT04288752|11347629|FG001|COMPLETED|Overall Study||85
10219897|NCT04288752|11347628|FG000|NOT COMPLETED|Overall Study||6
10219898|NCT04288752|11347629|FG001|NOT COMPLETED|Overall Study||3
10219899|NCT04287517|11347637|FG000|STARTED|Overall Study||19
10219900|NCT04287517|11347638|FG001|STARTED|Overall Study||19
10219901|NCT04287517|11347637|FG000|COMPLETED|Overall Study||18
10219902|NCT04287517|11347638|FG001|COMPLETED|Overall Study||18
10219903|NCT04287517|11347637|FG000|NOT COMPLETED|Overall Study||1
10219904|NCT04287517|11347638|FG001|NOT COMPLETED|Overall Study||1
10219905|NCT04287036|11347644|FG000|STARTED|Period 1||13
10219906|NCT04287036|11347645|FG001|STARTED|Period 1||12
10219907|NCT04287036|11347644|FG000|COMPLETED|Period 1||13
10219908|NCT04287036|11347645|FG001|COMPLETED|Period 1||12
10219909|NCT04287036|11347644|FG000|NOT COMPLETED|Period 1||0
10219910|NCT04287036|11347645|FG001|NOT COMPLETED|Period 1||0
10219911|NCT04287036|11347644|FG000|STARTED|Period 2||13
10219912|NCT04287036|11347645|FG001|STARTED|Period 2||12
10219913|NCT04287036|11347644|FG000|COMPLETED|Period 2||13
10219914|NCT04287036|11347645|FG001|COMPLETED|Period 2||12
10219915|NCT04287036|11347644|FG000|NOT COMPLETED|Period 2||0
10219916|NCT04287036|11347645|FG001|NOT COMPLETED|Period 2||0
10219917|NCT04286412|11347651|FG000|STARTED|Overall Study||25
10219918|NCT04286412|11347651|FG000|COMPLETED|Overall Study||25
10219919|NCT04286412|11347651|FG000|NOT COMPLETED|Overall Study||0
10219920|NCT04285411|11347655|FG000|STARTED|Overall Study||10
10219921|NCT04285411|11347655|FG000|COMPLETED|Overall Study||10
10219922|NCT04285411|11347655|FG000|NOT COMPLETED|Overall Study||0
10219923|NCT04284930|11347663|FG000|STARTED|Overall Study||8
10219924|NCT04284930|11347664|FG001|STARTED|Overall Study||5
10219925|NCT04284930|11347665|FG002|STARTED|Overall Study||8
10219926|NCT04284930|11347663|FG000|COMPLETED|Overall Study||8
10219927|NCT04284930|11347664|FG001|COMPLETED|Overall Study||5
10219928|NCT04284930|11347665|FG002|COMPLETED|Overall Study||8
10219929|NCT04284930|11347663|FG000|NOT COMPLETED|Overall Study||0
10219930|NCT04284930|11347664|FG001|NOT COMPLETED|Overall Study||0
10219931|NCT04284930|11347665|FG002|NOT COMPLETED|Overall Study||0
10219932|NCT04283773|11347676|FG000|STARTED|Overall Study||22
10219933|NCT04283773|11347677|FG001|STARTED|Overall Study||20
10219934|NCT04283773|11347678|FG002|STARTED|Overall Study||20
10219935|NCT04283773|11347676|FG000|COMPLETED|Overall Study||22
10219936|NCT04283773|11347677|FG001|COMPLETED|Overall Study||20
10219937|NCT04283773|11347678|FG002|COMPLETED|Overall Study||20
10219938|NCT04283773|11347676|FG000|NOT COMPLETED|Overall Study||0
10219939|NCT04283773|11347677|FG001|NOT COMPLETED|Overall Study||0
10219940|NCT04283773|11347678|FG002|NOT COMPLETED|Overall Study||0
10219941|NCT04281901|11347690|FG000|STARTED|Overall Study||12
10219942|NCT04281901|11347691|FG001|STARTED|Overall Study||12
10219943|NCT04281901|11347690|FG000|2. Check-up|Overall Study||11
10219944|NCT04281901|11347691|FG001|2. Check-up|Overall Study||11
10219945|NCT04281901|11347690|FG000|3. Check-up|Overall Study||11
10219946|NCT04281901|11347691|FG001|3. Check-up|Overall Study||11
10219947|NCT04281901|11347690|FG000|COMPLETED|Overall Study||11
10219948|NCT04281901|11347691|FG001|COMPLETED|Overall Study||11
10219949|NCT04281901|11347690|FG000|NOT COMPLETED|Overall Study||1
10219950|NCT04281901|11347691|FG001|NOT COMPLETED|Overall Study||1
10219951|NCT04280653|11347697|FG000|STARTED|Overall Study||15
10219952|NCT04280653|11347697|FG000|COMPLETED|Overall Study||15
10219953|NCT04280653|11347697|FG000|NOT COMPLETED|Overall Study||0
10219954|NCT04277936|11347701|FG000|STARTED|Overall Study||1
10219955|NCT04277936|11347701|FG000|COMPLETED|Overall Study||1
10219956|NCT04277936|11347701|FG000|NOT COMPLETED|Overall Study||0
10219957|NCT04275336|11347708|FG000|STARTED|Overall Study||120
10219958|NCT04275336|11347709|FG001|STARTED|Overall Study||118
10219959|NCT04275336|11347710|FG002|STARTED|Overall Study||116
10219960|NCT04275336|11347708|FG000|COMPLETED|Overall Study||103
10219961|NCT04275336|11347709|FG001|COMPLETED|Overall Study||96
10219962|NCT04275336|11347710|FG002|COMPLETED|Overall Study||100
10219963|NCT04275336|11347708|FG000|NOT COMPLETED|Overall Study||17
10219964|NCT04275336|11347709|FG001|NOT COMPLETED|Overall Study||22
10219965|NCT04275336|11347710|FG002|NOT COMPLETED|Overall Study||16
10219966|NCT04272775|11347723|FG000|STARTED|Overall Study||7
10219967|NCT04272775|11347724|FG001|STARTED|Overall Study||7
10219968|NCT04272775|11347723|FG000|COMPLETED|Overall Study||0
10219969|NCT04272775|11347724|FG001|COMPLETED|Overall Study||0
10219970|NCT04272775|11347723|FG000|NOT COMPLETED|Overall Study||7
10219971|NCT04272775|11347724|FG001|NOT COMPLETED|Overall Study||7
10219972|NCT04271020|11347730|FG000|STARTED|Overall Study||12
10219973|NCT04271020|11347730|FG000|COMPLETED|Overall Study||12
10219974|NCT04271020|11347730|FG000|NOT COMPLETED|Overall Study||0
10012489|NCT01785875|11135283|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
10012490|NCT01785875|11135284|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
10012491|NCT01785875|11135282|FG000|NOT COMPLETED|Overall Study||294
10012492|NCT01785875|11135283|FG001|NOT COMPLETED|Overall Study||289
10012493|NCT01785875|11135284|FG002|NOT COMPLETED|Overall Study||107
10219975|NCT04274075|11347740|FG000|STARTED|Overall Study||3
10219976|NCT04274075|11347741|FG001|STARTED|Overall Study||3
10219977|NCT04274075|11347742|FG002|STARTED|Overall Study||3
10219978|NCT04274075|11347743|FG003|STARTED|Overall Study||3
10219979|NCT04274075|11347744|FG004|STARTED|Overall Study||3
10219980|NCT04274075|11347745|FG005|STARTED|Overall Study||3
10219981|NCT04274075|11347740|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3
10219982|NCT04274075|11347741|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3
10219983|NCT04274075|11347742|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3
10219984|NCT04274075|11347743|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3
10219985|NCT04274075|11347744|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3
10219986|NCT04274075|11347745|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3
10219987|NCT04274075|11347740|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3
10219988|NCT04274075|11347741|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3
10219989|NCT04274075|11347742|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3
10219990|NCT04274075|11347743|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3
10219991|NCT04274075|11347744|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3
10219992|NCT04274075|11347745|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3
10219993|NCT04274075|11347740|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3
10219994|NCT04274075|11347741|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3
10219995|NCT04274075|11347742|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3
10219996|NCT04274075|11347743|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3
10219997|NCT04274075|11347744|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3
10219998|NCT04274075|11347745|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3
10219999|NCT04274075|11347740|FG000|Completed Follow-up Visit|Overall Study||3
10220000|NCT04274075|11347741|FG001|Completed Follow-up Visit|Overall Study||3
10220001|NCT04274075|11347742|FG002|Completed Follow-up Visit|Overall Study||3
10220002|NCT04274075|11347743|FG003|Completed Follow-up Visit|Overall Study||3
10220003|NCT04274075|11347744|FG004|Completed Follow-up Visit|Overall Study||3
10220004|NCT04274075|11347745|FG005|Completed Follow-up Visit|Overall Study||3
10220005|NCT04274075|11347740|FG000|COMPLETED|Overall Study||3
10220006|NCT04274075|11347741|FG001|COMPLETED|Overall Study||3
10220007|NCT04274075|11347742|FG002|COMPLETED|Overall Study||3
10220008|NCT04274075|11347743|FG003|COMPLETED|Overall Study||3
10220009|NCT04274075|11347744|FG004|COMPLETED|Overall Study||3
10220010|NCT04274075|11347745|FG005|COMPLETED|Overall Study||3
10220011|NCT04274075|11347740|FG000|NOT COMPLETED|Overall Study||0
10220012|NCT04274075|11347741|FG001|NOT COMPLETED|Overall Study||0
10220013|NCT04274075|11347742|FG002|NOT COMPLETED|Overall Study||0
10220014|NCT04274075|11347743|FG003|NOT COMPLETED|Overall Study||0
10220015|NCT04274075|11347744|FG004|NOT COMPLETED|Overall Study||0
10220016|NCT04274075|11347745|FG005|NOT COMPLETED|Overall Study||0
10220017|NCT04271605|11347756|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
10220018|NCT04271605|11347756|FG000|COMPLETED|Overall Study||0
10220019|NCT04271605|11347756|FG000|NOT COMPLETED|Overall Study||5
10220020|NCT04271761|11347760|FG000|STARTED|Overall Study||14
10220021|NCT04271761|11347760|FG000|COMPLETED|Overall Study||14
10220022|NCT04271761|11347760|FG000|NOT COMPLETED|Overall Study||0
10220023|NCT04268316|11347767|FG000|STARTED|Overall Study||5
10220024|NCT04268316|11347768|FG001|STARTED|Overall Study||4
10220025|NCT04268316|11347769|FG002|STARTED|Overall Study||4
10220026|NCT04268316|11347767|FG000|COMPLETED|Overall Study||3
10220027|NCT04268316|11347768|FG001|COMPLETED|Overall Study||3
10220028|NCT04268316|11347769|FG002|COMPLETED|Overall Study||4
10220029|NCT04268316|11347767|FG000|NOT COMPLETED|Overall Study||2
10220030|NCT04268316|11347768|FG001|NOT COMPLETED|Overall Study||1
10220031|NCT04268316|11347769|FG002|NOT COMPLETED|Overall Study||0
10220032|NCT04269629|11347777|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
10220033|NCT04269629|11347777|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
10220034|NCT04269629|11347777|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
10220035|NCT04269629|11347777|FG000|NOT COMPLETED|Overall Study||239
10220036|NCT04267575|11347785|FG000|STARTED|Overall Study||20
10220037|NCT04267575|11347785|FG000|COMPLETED|Overall Study||20
10220038|NCT04267575|11347785|FG000|NOT COMPLETED|Overall Study||0
10220039|NCT04267770|11347791|FG000|STARTED|Overall Study||9
10220040|NCT04267770|11347792|FG001|STARTED|Overall Study||8
10220041|NCT04267770|11347791|FG000|COMPLETED|Overall Study||9
10220042|NCT04267770|11347792|FG001|COMPLETED|Overall Study||8
10220043|NCT04267770|11347791|FG000|NOT COMPLETED|Overall Study||0
10220044|NCT04267770|11347792|FG001|NOT COMPLETED|Overall Study||0
10220045|NCT04266925|11347800|FG000|STARTED|1 Referee Game (~1 Hour)||23
10220046|NCT04266925|11347801|FG001|STARTED|1 Referee Game (~1 Hour)||26
10220047|NCT04266925|11347800|FG000|COMPLETED|1 Referee Game (~1 Hour)||23
10220048|NCT04266925|11347801|FG001|COMPLETED|1 Referee Game (~1 Hour)||26
10220049|NCT04266925|11347800|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0
10220050|NCT04266925|11347801|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0
10220051|NCT04266925|11347800|FG000|STARTED|3 Referee Game (~1 Hour)||23
10220052|NCT04266925|11347801|FG001|STARTED|3 Referee Game (~1 Hour)||26
10220053|NCT04266925|11347800|FG000|COMPLETED|3 Referee Game (~1 Hour)||23
10220054|NCT04266925|11347801|FG001|COMPLETED|3 Referee Game (~1 Hour)||26
10220055|NCT04266925|11347800|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0
10220056|NCT04266925|11347801|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0
10220057|NCT04263142|11347812|FG000|STARTED|Part 1 Period 1 (Day 1)||9
10220058|NCT04263142|11347813|FG001|STARTED|Part 1 Period 1 (Day 1)||9
10220059|NCT04263142|11347814|FG002|STARTED|Part 1 Period 1 (Day 1)||0
10220060|NCT04263142|11347815|FG003|STARTED|Part 1 Period 1 (Day 1)||0
10220061|NCT04263142|11347816|FG004|STARTED|Part 1 Period 1 (Day 1)||0
10220062|NCT04263142|11347812|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9
10220063|NCT04263142|11347813|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9
10220064|NCT04263142|11347814|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0
10220065|NCT04263142|11347815|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0
10220066|NCT04263142|11347816|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0
10220067|NCT04263142|11347812|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10220068|NCT04263142|11347813|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10220069|NCT04263142|11347814|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10220070|NCT04263142|11347815|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10220071|NCT04263142|11347816|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10220072|NCT04263142|11347812|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9
10220073|NCT04263142|11347813|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9
10220074|NCT04263142|11347814|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0
10220075|NCT04263142|11347815|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0
10220076|NCT04263142|11347816|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0
10220077|NCT04263142|11347812|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
10220078|NCT04263142|11347813|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
10220079|NCT04263142|11347814|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220080|NCT04263142|11347815|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220081|NCT04263142|11347816|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220082|NCT04263142|11347812|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220083|NCT04263142|11347813|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220084|NCT04263142|11347814|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220085|NCT04263142|11347815|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220086|NCT04263142|11347816|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10220087|NCT04263142|11347812|FG000|STARTED|Part 2 Period 1 (Day 1)||0
10220088|NCT04263142|11347813|FG001|STARTED|Part 2 Period 1 (Day 1)||0
10220089|NCT04263142|11347814|FG002|STARTED|Part 2 Period 1 (Day 1)||7
10220090|NCT04263142|11347815|FG003|STARTED|Part 2 Period 1 (Day 1)||7
10220091|NCT04263142|11347816|FG004|STARTED|Part 2 Period 1 (Day 1)||7
10220092|NCT04263142|11347812|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0
10220093|NCT04263142|11347813|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0
10220094|NCT04263142|11347814|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7
10220095|NCT04263142|11347815|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7
10220096|NCT04263142|11347816|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6
10220097|NCT04263142|11347812|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10220098|NCT04263142|11347813|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10220099|NCT04263142|11347814|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10220100|NCT04263142|11347815|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10220101|NCT04263142|11347816|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
10220102|NCT04263142|11347812|FG000|STARTED|Part 2 Period 2 (Day 1)||0
10220103|NCT04263142|11347813|FG001|STARTED|Part 2 Period 2 (Day 1)||0
10220104|NCT04263142|11347814|FG002|STARTED|Part 2 Period 2 (Day 1)||7
10220105|NCT04263142|11347815|FG003|STARTED|Part 2 Period 2 (Day 1)||7
10220106|NCT04263142|11347816|FG004|STARTED|Part 2 Period 2 (Day 1)||6
10220107|NCT04263142|11347812|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0
10220108|NCT04263142|11347813|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0
10220109|NCT04263142|11347814|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7
10220110|NCT04263142|11347815|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7
10220111|NCT04263142|11347816|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5
10220112|NCT04263142|11347812|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10220113|NCT04263142|11347813|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10220114|NCT04263142|11347814|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10220115|NCT04263142|11347815|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10220116|NCT04263142|11347816|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
10220117|NCT04263142|11347812|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0
10220118|NCT04263142|11347813|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0
10220119|NCT04263142|11347814|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7
10220120|NCT04263142|11347815|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7
10220121|NCT04263142|11347816|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5
10220122|NCT04263142|11347812|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10220123|NCT04263142|11347813|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10220124|NCT04263142|11347814|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
10220125|NCT04263142|11347815|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
10220126|NCT04263142|11347816|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
10220127|NCT04263142|11347812|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10220128|NCT04263142|11347813|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10220129|NCT04263142|11347814|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10220130|NCT04263142|11347815|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10220131|NCT04263142|11347816|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10220132|NCT04256785|11347831|FG000|STARTED|Overall Study||54
10220133|NCT04256785|11347832|FG001|STARTED|Overall Study||56
10220134|NCT04256785|11347831|FG000|COMPLETED|Overall Study||26
10220135|NCT04256785|11347832|FG001|COMPLETED|Overall Study||31
10220136|NCT04256785|11347831|FG000|NOT COMPLETED|Overall Study||28
10220137|NCT04256785|11347832|FG001|NOT COMPLETED|Overall Study||25
10220138|NCT04252092|11347842|FG000|STARTED|Overall Study||15
10220139|NCT04252092|11347843|FG001|STARTED|Overall Study||15
10220140|NCT04252092|11347842|FG000|COMPLETED|Overall Study||15
10220141|NCT04252092|11347843|FG001|COMPLETED|Overall Study||15
10220142|NCT04252092|11347842|FG000|NOT COMPLETED|Overall Study||0
10220143|NCT04252092|11347843|FG001|NOT COMPLETED|Overall Study||0
10220144|NCT04250987|11347849|FG000|STARTED|Overall Study||12
10220145|NCT04250987|11347849|FG000|COMPLETED|Overall Study||12
10220146|NCT04250987|11347849|FG000|NOT COMPLETED|Overall Study||0
10220147|NCT04249336|11347857|FG000|STARTED|Overall Study||35
10220148|NCT04249336|11347858|FG001|STARTED|Overall Study||35
10220149|NCT04249336|11347859|FG002|STARTED|Overall Study||35
10220150|NCT04249336|11347860|FG003|STARTED|Overall Study||35
10220151|NCT04249336|11347857|FG000|Per Protocol Population Day 3|Overall Study||32
10220152|NCT04249336|11347858|FG001|Per Protocol Population Day 3|Overall Study||32
10220153|NCT04249336|11347859|FG002|Per Protocol Population Day 3|Overall Study||32
10220154|NCT04249336|11347860|FG003|Per Protocol Population Day 3|Overall Study||32
10220155|NCT04249336|11347857|FG000|Per Protocol Population Week 4|Overall Study||33
10220156|NCT04249336|11347858|FG001|Per Protocol Population Week 4|Overall Study||35
10220157|NCT04249336|11347859|FG002|Per Protocol Population Week 4|Overall Study||33
10220158|NCT04249336|11347860|FG003|Per Protocol Population Week 4|Overall Study||34
10220159|NCT04249336|11347857|FG000|COMPLETED|Overall Study||32
10220160|NCT04249336|11347858|FG001|COMPLETED|Overall Study||32
10220161|NCT04249336|11347859|FG002|COMPLETED|Overall Study||32
10220162|NCT04249336|11347860|FG003|COMPLETED|Overall Study||32
10220163|NCT04249336|11347857|FG000|NOT COMPLETED|Overall Study||3
10220164|NCT04249336|11347858|FG001|NOT COMPLETED|Overall Study||3
10220165|NCT04249336|11347859|FG002|NOT COMPLETED|Overall Study||3
10220166|NCT04249336|11347860|FG003|NOT COMPLETED|Overall Study||3
10220167|NCT04247581|11347872|FG000|STARTED|Overall Study||241
10220168|NCT04247581|11347873|FG001|STARTED|Overall Study||305
10220169|NCT04247581|11347872|FG000|COMPLETED|Overall Study||241
10220170|NCT04247581|11347873|FG001|COMPLETED|Overall Study||293
10220171|NCT04247581|11347872|FG000|NOT COMPLETED|Overall Study||0
10220172|NCT04247581|11347873|FG001|NOT COMPLETED|Overall Study||12
10220173|NCT04247061|11347879|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
10220174|NCT04247061|11347879|FG000|COMPLETED|Overall Study||4
10220175|NCT04247061|11347879|FG000|NOT COMPLETED|Overall Study||9
10220176|NCT04245202|11347885|FG000|STARTED|Overall Study|After getting consent.|48
10220177|NCT04245202|11347886|FG001|STARTED|Overall Study|After getting consent|39
10220178|NCT04245202|11347885|FG000|COMPLETED|Overall Study||38
10220179|NCT04245202|11347886|FG001|COMPLETED|Overall Study||38
10220180|NCT04245202|11347885|FG000|NOT COMPLETED|Overall Study||10
10220181|NCT04245202|11347886|FG001|NOT COMPLETED|Overall Study||1
10220182|NCT04243369|11347893|FG000|STARTED|Overall Study||30
10220183|NCT04243369|11347893|FG000|COMPLETED|Overall Study||30
10220184|NCT04243369|11347893|FG000|NOT COMPLETED|Overall Study||0
10220185|NCT04241146|11347899|FG000|STARTED|Overall Study||24
10220186|NCT04241146|11347900|FG001|STARTED|Overall Study||28
10220187|NCT04241146|11347899|FG000|COMPLETED|Overall Study||24
10220188|NCT04241146|11347900|FG001|COMPLETED|Overall Study||28
10220189|NCT04241146|11347899|FG000|NOT COMPLETED|Overall Study||0
10220190|NCT04241146|11347900|FG001|NOT COMPLETED|Overall Study||0
10220191|NCT04240678|11347908|FG000|STARTED|Overall Study||4141
10220192|NCT04240678|11347909|FG001|STARTED|Overall Study||4158
10220193|NCT04240678|11347908|FG000|COMPLETED|Overall Study||4141
10220194|NCT04240678|11347909|FG001|COMPLETED|Overall Study||4158
10220195|NCT04240678|11347908|FG000|NOT COMPLETED|Overall Study||0
10220196|NCT04240678|11347909|FG001|NOT COMPLETED|Overall Study||0
10220197|NCT04238650|11347917|FG000|STARTED|Overall Study||24
10220198|NCT04238650|11347918|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
10220199|NCT04238650|11347917|FG000|COMPLETED|Overall Study||24
10220200|NCT04238650|11347918|FG001|COMPLETED|Overall Study||24
10220201|NCT04238650|11347917|FG000|NOT COMPLETED|Overall Study||0
10220202|NCT04238650|11347918|FG001|NOT COMPLETED|Overall Study||1
10220203|NCT04238663|11347927|FG000|STARTED|Overall Study||38
10220204|NCT04238663|11347928|FG001|STARTED|Overall Study||38
10220205|NCT04238663|11347929|FG002|STARTED|Overall Study||38
10220206|NCT04238663|11347927|FG000|COMPLETED|Overall Study||38
10220207|NCT04238663|11347928|FG001|COMPLETED|Overall Study||37
10220208|NCT04238663|11347929|FG002|COMPLETED|Overall Study||38
10220209|NCT04238663|11347927|FG000|NOT COMPLETED|Overall Study||0
10220210|NCT04238663|11347928|FG001|NOT COMPLETED|Overall Study||1
10220211|NCT04238663|11347929|FG002|NOT COMPLETED|Overall Study||0
10220212|NCT04235582|11347940|FG000|STARTED|Overall Study||12
10220213|NCT04235582|11347941|FG001|STARTED|Overall Study||13
10220214|NCT04235582|11347942|FG002|STARTED|Overall Study||11
10220215|NCT04235582|11347940|FG000|COMPLETED|Overall Study||12
10220216|NCT04235582|11347941|FG001|COMPLETED|Overall Study||12
10220217|NCT04235582|11347942|FG002|COMPLETED|Overall Study||8
10220218|NCT04235582|11347940|FG000|NOT COMPLETED|Overall Study||0
10220219|NCT04235582|11347941|FG001|NOT COMPLETED|Overall Study||1
10220220|NCT04235582|11347942|FG002|NOT COMPLETED|Overall Study||3
10220221|NCT04203225|11347952|FG000|STARTED|Overall Study||21
10220222|NCT04203225|11347953|FG001|STARTED|Overall Study||27
10220223|NCT04203225|11347952|FG000|COMPLETED|Overall Study||21
10220224|NCT04203225|11347953|FG001|COMPLETED|Overall Study||27
10220225|NCT04203225|11347952|FG000|NOT COMPLETED|Overall Study||0
10220226|NCT04203225|11347953|FG001|NOT COMPLETED|Overall Study||0
10220227|NCT04234672|11347959|FG000|STARTED|Treatment Period 1 (Day 1)||6
10220228|NCT04234672|11347959|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
10220229|NCT04234672|11347959|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10220230|NCT04234672|11347959|FG000|STARTED|Washout Period (Day 2 to 8)||6
10220231|NCT04234672|11347959|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
10220232|NCT04234672|11347959|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
10220233|NCT04234672|11347959|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
10220234|NCT04234672|11347959|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
10220235|NCT04234672|11347959|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
10220236|NCT04223635|11347972|FG000|STARTED|Overall Study||8
10220237|NCT04223635|11347973|FG001|STARTED|Overall Study||8
10220238|NCT04223635|11347972|FG000|COMPLETED|Overall Study||8
10220239|NCT04223635|11347973|FG001|COMPLETED|Overall Study||8
10220240|NCT04223635|11347972|FG000|NOT COMPLETED|Overall Study||0
10220241|NCT04223635|11347973|FG001|NOT COMPLETED|Overall Study||0
10220242|NCT04214951|11347981|FG000|STARTED|Overall Study||50
10220243|NCT04214951|11347982|FG001|STARTED|Overall Study||50
10220244|NCT04214951|11347981|FG000|COMPLETED|Overall Study||10
10220245|NCT04214951|11347982|FG001|COMPLETED|Overall Study||10
10220246|NCT04214951|11347981|FG000|NOT COMPLETED|Overall Study||40
10220247|NCT04214951|11347982|FG001|NOT COMPLETED|Overall Study||40
10220248|NCT04234425|11347988|FG000|STARTED|Overall Study||18
10220249|NCT04234425|11347988|FG000|Midpoint-Week 4|Overall Study||18
10220250|NCT04234425|11347988|FG000|COMPLETED|Overall Study||18
10220251|NCT04234425|11347988|FG000|NOT COMPLETED|Overall Study||0
10220252|NCT04232137|11347996|FG000|STARTED|Overall Study||254
10220253|NCT04232137|11347997|FG001|STARTED|Overall Study||185
10220254|NCT04232137|11347996|FG000|COMPLETED|Overall Study||254
10220255|NCT04232137|11347997|FG001|COMPLETED|Overall Study||185
10220256|NCT04232137|11347996|FG000|NOT COMPLETED|Overall Study||0
10220257|NCT04232137|11347997|FG001|NOT COMPLETED|Overall Study||0
10220258|NCT04222699|11348003|FG000|STARTED|Overall Study||28
10220259|NCT04222699|11348003|FG000|COMPLETED|Overall Study||26
10220260|NCT04222699|11348003|FG000|NOT COMPLETED|Overall Study||2
10220261|NCT04208698|11348012|FG000|STARTED|Overall Study||2
10220262|NCT04208698|11348013|FG001|STARTED|Overall Study||0
10220263|NCT04208698|11348014|FG002|STARTED|Overall Study||0
10220264|NCT04208698|11348015|FG003|STARTED|Overall Study||0
10220265|NCT04208698|11348016|FG004|STARTED|Overall Study||0
10220266|NCT04208698|11348012|FG000|COMPLETED|Overall Study||0
10220267|NCT04208698|11348013|FG001|COMPLETED|Overall Study||0
10220268|NCT04208698|11348014|FG002|COMPLETED|Overall Study||0
10220269|NCT04208698|11348015|FG003|COMPLETED|Overall Study||0
10220270|NCT04208698|11348016|FG004|COMPLETED|Overall Study||0
10220271|NCT04208698|11348012|FG000|NOT COMPLETED|Overall Study||2
10220272|NCT04208698|11348013|FG001|NOT COMPLETED|Overall Study||0
10220273|NCT04208698|11348014|FG002|NOT COMPLETED|Overall Study||0
10220274|NCT04208698|11348015|FG003|NOT COMPLETED|Overall Study||0
10220275|NCT04208698|11348016|FG004|NOT COMPLETED|Overall Study||0
10220276|NCT04206293|11348026|FG000|STARTED|Overall Study||11
10220277|NCT04206293|11348026|FG000|COMPLETED|Overall Study||10
10220278|NCT04206293|11348026|FG000|NOT COMPLETED|Overall Study||1
10220279|NCT04228302|11348037|FG000|STARTED|Overall Study||6
10220280|NCT04228302|11348038|FG001|STARTED|Overall Study||6
10220281|NCT04228302|11348039|FG002|STARTED|Overall Study||6
10220282|NCT04228302|11348040|FG003|STARTED|Overall Study||6
10220283|NCT04228302|11348041|FG004|STARTED|Overall Study||6
10220284|NCT04228302|11348042|FG005|STARTED|Overall Study||10
10220285|NCT04228302|11348037|FG000|COMPLETED|Overall Study||6
10220286|NCT04228302|11348038|FG001|COMPLETED|Overall Study||6
10220287|NCT04228302|11348039|FG002|COMPLETED|Overall Study||6
10220288|NCT04228302|11348040|FG003|COMPLETED|Overall Study||6
10220289|NCT04228302|11348041|FG004|COMPLETED|Overall Study||5
10220290|NCT04228302|11348042|FG005|COMPLETED|Overall Study||10
10220291|NCT04228302|11348037|FG000|NOT COMPLETED|Overall Study||0
10220292|NCT04228302|11348038|FG001|NOT COMPLETED|Overall Study||0
10220293|NCT04228302|11348039|FG002|NOT COMPLETED|Overall Study||0
10220294|NCT04228302|11348040|FG003|NOT COMPLETED|Overall Study||0
10220295|NCT04228302|11348041|FG004|NOT COMPLETED|Overall Study||1
10220296|NCT04228302|11348042|FG005|NOT COMPLETED|Overall Study||0
10220297|NCT04227119|11348056|FG000|STARTED|Overall Study||11
10220298|NCT04227119|11348056|FG000|COMPLETED|Overall Study||11
10220299|NCT04227119|11348056|FG000|NOT COMPLETED|Overall Study||0
10220300|NCT04224753|11348062|FG000|STARTED|Overall Study||51
10220301|NCT04224753|11348062|FG000|COMPLETED|Overall Study||51
10220302|NCT04224753|11348062|FG000|NOT COMPLETED|Overall Study||0
10220303|NCT04218799|11348066|FG000|STARTED|Overall Study||7
10220304|NCT04218799|11348066|FG000|COMPLETED|Overall Study||7
10220305|NCT04218799|11348066|FG000|NOT COMPLETED|Overall Study||0
10220306|NCT04204057|11348070|FG000|STARTED|Overall Study||21
10220307|NCT04204057|11348070|FG000|COMPLETED|Overall Study||21
10220308|NCT04204057|11348070|FG000|NOT COMPLETED|Overall Study||0
10220309|NCT04195594|11348074|FG000|STARTED|Overall Study||14
10220310|NCT04195594|11348074|FG000|COMPLETED|Overall Study||11
10220311|NCT04195594|11348074|FG000|NOT COMPLETED|Overall Study||3
10220312|NCT04223687|11348080|FG000|STARTED|Overall Study||163
10220313|NCT04223687|11348081|FG001|STARTED|Overall Study||163
10220314|NCT04223687|11348080|FG000|COMPLETED|Overall Study||162
10220315|NCT04223687|11348081|FG001|COMPLETED|Overall Study||163
10220316|NCT04223687|11348080|FG000|NOT COMPLETED|Overall Study||1
10220317|NCT04223687|11348081|FG001|NOT COMPLETED|Overall Study||0
10220318|NCT04223232|11348087|FG000|STARTED|Overall Study||6
10220319|NCT04223232|11348087|FG000|COMPLETED|Overall Study||5
10220320|NCT04223232|11348087|FG000|NOT COMPLETED|Overall Study||1
10220321|NCT04189224|11348091|FG000|STARTED|Period 1||23
10220322|NCT04189224|11348092|FG001|STARTED|Period 1||21
10220323|NCT04189224|11348091|FG000|COMPLETED|Period 1||23
10220324|NCT04189224|11348092|FG001|COMPLETED|Period 1||21
10220325|NCT04189224|11348091|FG000|NOT COMPLETED|Period 1||0
10220326|NCT04189224|11348092|FG001|NOT COMPLETED|Period 1||0
10220327|NCT04189224|11348091|FG000|STARTED|Period 2||23
10220328|NCT04189224|11348092|FG001|STARTED|Period 2||21
10220329|NCT04189224|11348091|FG000|COMPLETED|Period 2||23
10220330|NCT04189224|11348092|FG001|COMPLETED|Period 2||20
10220331|NCT04189224|11348091|FG000|NOT COMPLETED|Period 2||0
10220332|NCT04189224|11348092|FG001|NOT COMPLETED|Period 2||1
10220333|NCT04214600|11348100|FG000|STARTED|Overall Study||50
10220334|NCT04214600|11348101|FG001|STARTED|Overall Study||50
10220335|NCT04214600|11348100|FG000|COMPLETED|Overall Study||41
10220336|NCT04214600|11348101|FG001|COMPLETED|Overall Study||36
10220337|NCT04214600|11348100|FG000|NOT COMPLETED|Overall Study||9
10220338|NCT04214600|11348101|FG001|NOT COMPLETED|Overall Study||14
10220339|NCT04202497|11348108|FG000|STARTED|Baseline Scan (Day-1)||7
10220340|NCT04202497|11348109|FG001|STARTED|Baseline Scan (Day-1)||0
10220341|NCT04202497|11348110|FG002|STARTED|Baseline Scan (Day-1)||0
10220342|NCT04202497|11348111|FG003|STARTED|Baseline Scan (Day-1)||0
10220343|NCT04202497|11348108|FG000|COMPLETED|Baseline Scan (Day-1)||6
10220344|NCT04202497|11348109|FG001|COMPLETED|Baseline Scan (Day-1)||0
10220345|NCT04202497|11348110|FG002|COMPLETED|Baseline Scan (Day-1)||0
10220346|NCT04202497|11348111|FG003|COMPLETED|Baseline Scan (Day-1)||0
10220347|NCT04202497|11348108|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1
10220348|NCT04202497|11348109|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0
10220349|NCT04202497|11348110|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0
10220350|NCT04202497|11348111|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0
10220351|NCT04202497|11348108|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
10220352|NCT04202497|11348109|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
10220353|NCT04202497|11348110|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
10220354|NCT04202497|11348111|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
10220355|NCT04202497|11348108|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10220356|NCT04202497|11348109|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
10220357|NCT04202497|11348110|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
10220358|NCT04202497|11348111|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
10220359|NCT04202497|11348108|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10220360|NCT04202497|11348109|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10220361|NCT04202497|11348110|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10220362|NCT04202497|11348111|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10220363|NCT04214080|11348127|FG000|STARTED|Overall Study||20
10220364|NCT04214080|11348128|FG001|STARTED|Overall Study||20
10220365|NCT04214080|11348127|FG000|COMPLETED|Overall Study||20
10220366|NCT04214080|11348128|FG001|COMPLETED|Overall Study||20
10220367|NCT04214080|11348127|FG000|NOT COMPLETED|Overall Study||0
10220368|NCT04214080|11348128|FG001|NOT COMPLETED|Overall Study||0
10239134|NCT00350623|11370638|FG000|NOT COMPLETED|Overall Study||8
10239135|NCT00350623|11370639|FG001|NOT COMPLETED|Overall Study||4
10239136|NCT00350623|11370640|FG002|NOT COMPLETED|Overall Study||6
10239137|NCT00356187|11370650|FG000|STARTED|Overall Study||0
10239138|NCT00356187|11370651|FG001|STARTED|Overall Study||0
10239139|NCT00356187|11370650|FG000|COMPLETED|Overall Study||0
10239140|NCT00356187|11370651|FG001|COMPLETED|Overall Study||0
10239141|NCT00356187|11370650|FG000|NOT COMPLETED|Overall Study||0
10239142|NCT00356187|11370651|FG001|NOT COMPLETED|Overall Study||0
10239143|NCT00353275|11370661|FG000|STARTED|Overall Study||2
10239144|NCT00353275|11370662|FG001|STARTED|Overall Study||3
10239145|NCT00353275|11370661|FG000|COMPLETED|Overall Study||2
10239146|NCT00353275|11370662|FG001|COMPLETED|Overall Study||3
10239147|NCT00353275|11370661|FG000|NOT COMPLETED|Overall Study||0
10239148|NCT00353275|11370662|FG001|NOT COMPLETED|Overall Study||0
10239149|NCT00350844|11370668|FG000|STARTED|Overall Study||6
10239150|NCT00350844|11370668|FG000|COMPLETED|Overall Study||5
10239151|NCT00350844|11370668|FG000|NOT COMPLETED|Overall Study||1
10239152|NCT00348556|11370672|FG000|STARTED|Overall Study||4
10239153|NCT00348556|11370672|FG000|COMPLETED|Overall Study||3
10239154|NCT00348556|11370672|FG000|NOT COMPLETED|Overall Study||1
10239155|NCT00319839|11370676|FG000|STARTED|Overall Study||7
10239156|NCT00319839|11370676|FG000|COMPLETED|Overall Study||1
10239157|NCT00319839|11370676|FG000|NOT COMPLETED|Overall Study||6
10239158|NCT00344019|11370683|FG000|STARTED|Overall Study||12
10239159|NCT00344019|11370684|FG001|STARTED|Overall Study||11
10239160|NCT00344019|11370685|FG002|STARTED|Overall Study||74
10239161|NCT00344019|11370683|FG000|COMPLETED|Overall Study||12
10239162|NCT00344019|11370684|FG001|COMPLETED|Overall Study||11
10239163|NCT00344019|11370685|FG002|COMPLETED|Overall Study||0
10239164|NCT00344019|11370683|FG000|NOT COMPLETED|Overall Study||0
10239165|NCT00344019|11370684|FG001|NOT COMPLETED|Overall Study||0
10239166|NCT00344019|11370685|FG002|NOT COMPLETED|Overall Study||74
10239167|NCT00338455|11370698|FG000|STARTED|Overall Study||9
10239168|NCT00338455|11370699|FG001|STARTED|Overall Study||7
10239169|NCT00338455|11370698|FG000|Administered Study Drug|Overall Study||8
10239170|NCT00338455|11370699|FG001|Administered Study Drug|Overall Study||7
10239171|NCT00338455|11370698|FG000|COMPLETED|Overall Study||6
10239172|NCT00338455|11370699|FG001|COMPLETED|Overall Study||6
10239173|NCT00338455|11370698|FG000|NOT COMPLETED|Overall Study||3
10239174|NCT00338455|11370699|FG001|NOT COMPLETED|Overall Study||1
10239175|NCT00329108|11370707|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15
10239176|NCT00329108|11370708|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14
10239177|NCT00329108|11370707|FG000|COMPLETED|Overall Study||5
10239178|NCT00329108|11370708|FG001|COMPLETED|Overall Study||2
10239179|NCT00329108|11370707|FG000|NOT COMPLETED|Overall Study||10
10239180|NCT00329108|11370708|FG001|NOT COMPLETED|Overall Study||12
10239181|NCT00325572|11370716|FG000|STARTED|PHASE I||45
10239182|NCT00325572|11370717|FG001|STARTED|PHASE I||44
10239183|NCT00325572|11370716|FG000|COMPLETED|PHASE I||45
10012494|NCT01786109|11135298|FG000|STARTED|Overall Study||24
10012495|NCT01786109|11135299|FG001|STARTED|Overall Study||24
10012496|NCT01786109|11135300|FG002|STARTED|Overall Study||27
10012497|NCT01786109|11135298|FG000|COMPLETED|Overall Study||23
10012498|NCT01786109|11135299|FG001|COMPLETED|Overall Study||24
10012499|NCT01786109|11135300|FG002|COMPLETED|Overall Study||25
10012500|NCT01786109|11135298|FG000|NOT COMPLETED|Overall Study||1
10012501|NCT01786109|11135299|FG001|NOT COMPLETED|Overall Study||0
10239184|NCT00325572|11370717|FG001|COMPLETED|PHASE I||44
10012502|NCT01786109|11135300|FG002|NOT COMPLETED|Overall Study||2
10012503|NCT01786148|11135310|FG000|STARTED|Overall Study||77
10239185|NCT00325572|11370716|FG000|NOT COMPLETED|PHASE I||0
10239186|NCT00325572|11370717|FG001|NOT COMPLETED|PHASE I||0
10239187|NCT00325572|11370716|FG000|STARTED|PHASE ii||0
10239188|NCT00325572|11370717|FG001|STARTED|PHASE ii||0
10239189|NCT00325572|11370716|FG000|COMPLETED|PHASE ii||0
10239190|NCT00325572|11370717|FG001|COMPLETED|PHASE ii||0
10239191|NCT00325572|11370716|FG000|NOT COMPLETED|PHASE ii||0
10220369|NCT04209530|11348138|FG000|STARTED|Overall Study||4
10220370|NCT04209530|11348139|FG001|STARTED|Overall Study||3
10220371|NCT04209530|11348138|FG000|COMPLETED|Overall Study||0
10220372|NCT04209530|11348139|FG001|COMPLETED|Overall Study||0
10220373|NCT04209530|11348138|FG000|NOT COMPLETED|Overall Study||4
10220374|NCT04209530|11348139|FG001|NOT COMPLETED|Overall Study||3
10220375|NCT04209335|11348145|FG000|STARTED|Overall Study||48
10220376|NCT04209335|11348145|FG000|COMPLETED|Overall Study||48
10220377|NCT04209335|11348145|FG000|NOT COMPLETED|Overall Study||0
10220378|NCT04207333|11348152|FG000|STARTED|First Intervention (Single 1-Day Visit)||3
10220379|NCT04207333|11348153|FG001|STARTED|First Intervention (Single 1-Day Visit)||3
10220380|NCT04207333|11348152|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3
10220381|NCT04207333|11348153|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3
10220382|NCT04207333|11348152|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10220383|NCT04207333|11348153|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10220384|NCT04207333|11348152|FG000|STARTED|Washout (2-7 Days)||3
10220385|NCT04207333|11348153|FG001|STARTED|Washout (2-7 Days)||3
10220386|NCT04207333|11348152|FG000|COMPLETED|Washout (2-7 Days)||3
10220387|NCT04207333|11348153|FG001|COMPLETED|Washout (2-7 Days)||3
10220388|NCT04207333|11348152|FG000|NOT COMPLETED|Washout (2-7 Days)||0
10220389|NCT04207333|11348153|FG001|NOT COMPLETED|Washout (2-7 Days)||0
10220390|NCT04207333|11348152|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3
10220391|NCT04207333|11348153|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3
10220392|NCT04207333|11348152|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3
10220393|NCT04207333|11348153|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
10220394|NCT04207333|11348152|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10220395|NCT04207333|11348153|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10220396|NCT04207840|11348159|FG000|STARTED|Treatment Period 1||9
10220397|NCT04207840|11348160|FG001|STARTED|Treatment Period 1||10
10220398|NCT04207840|11348161|FG002|STARTED|Treatment Period 1||9
10220399|NCT04207840|11348159|FG000|COMPLETED|Treatment Period 1||9
10220400|NCT04207840|11348160|FG001|COMPLETED|Treatment Period 1||10
10220401|NCT04207840|11348161|FG002|COMPLETED|Treatment Period 1||9
10220402|NCT04207840|11348159|FG000|NOT COMPLETED|Treatment Period 1||0
10220403|NCT04207840|11348160|FG001|NOT COMPLETED|Treatment Period 1||0
10220404|NCT04207840|11348161|FG002|NOT COMPLETED|Treatment Period 1||0
10220405|NCT04207840|11348159|FG000|STARTED|Washout Period 1 (2-7 Days)||9
10220406|NCT04207840|11348160|FG001|STARTED|Washout Period 1 (2-7 Days)||10
10220407|NCT04207840|11348161|FG002|STARTED|Washout Period 1 (2-7 Days)||9
10220408|NCT04207840|11348159|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9
10220409|NCT04207840|11348160|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10
10220410|NCT04207840|11348161|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8
10220411|NCT04207840|11348159|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
10220412|NCT04207840|11348160|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
10220413|NCT04207840|11348161|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
10220414|NCT04207840|11348159|FG000|STARTED|Treatment Period 2||9
10220415|NCT04207840|11348160|FG001|STARTED|Treatment Period 2||10
10220416|NCT04207840|11348161|FG002|STARTED|Treatment Period 2||8
10220417|NCT04207840|11348159|FG000|COMPLETED|Treatment Period 2||9
10220418|NCT04207840|11348160|FG001|COMPLETED|Treatment Period 2||10
10220419|NCT04207840|11348161|FG002|COMPLETED|Treatment Period 2||8
10220420|NCT04207840|11348159|FG000|NOT COMPLETED|Treatment Period 2||0
10220421|NCT04207840|11348160|FG001|NOT COMPLETED|Treatment Period 2||0
10220422|NCT04207840|11348161|FG002|NOT COMPLETED|Treatment Period 2||0
10220423|NCT04207840|11348159|FG000|STARTED|Washout Period 2 (2-7 Days)||9
10220424|NCT04207840|11348160|FG001|STARTED|Washout Period 2 (2-7 Days)||10
10220425|NCT04207840|11348161|FG002|STARTED|Washout Period 2 (2-7 Days)||8
10220426|NCT04207840|11348159|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9
10220427|NCT04207840|11348160|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10
10220428|NCT04207840|11348161|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7
10220429|NCT04207840|11348159|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
10220430|NCT04207840|11348160|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
10220431|NCT04207840|11348161|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
10220432|NCT04207840|11348159|FG000|STARTED|Treatment Period 3||9
10220433|NCT04207840|11348160|FG001|STARTED|Treatment Period 3||10
10220434|NCT04207840|11348161|FG002|STARTED|Treatment Period 3||7
10220435|NCT04207840|11348159|FG000|COMPLETED|Treatment Period 3||9
10220436|NCT04207840|11348160|FG001|COMPLETED|Treatment Period 3||10
10220437|NCT04207840|11348161|FG002|COMPLETED|Treatment Period 3||7
10220438|NCT04207840|11348159|FG000|NOT COMPLETED|Treatment Period 3||0
10220439|NCT04207840|11348160|FG001|NOT COMPLETED|Treatment Period 3||0
10220440|NCT04207840|11348161|FG002|NOT COMPLETED|Treatment Period 3||0
10220441|NCT04206800|11348171|FG000|STARTED|Overall Study||4
10220442|NCT04206800|11348172|FG001|STARTED|Overall Study||1
10220443|NCT04206800|11348171|FG000|COMPLETED|Overall Study||4
10220444|NCT04206800|11348172|FG001|COMPLETED|Overall Study||1
10220445|NCT04206800|11348171|FG000|NOT COMPLETED|Overall Study||0
10220446|NCT04206800|11348172|FG001|NOT COMPLETED|Overall Study||0
10220447|NCT04205669|11348180|FG000|STARTED|Overall Study||47
10220448|NCT04205669|11348181|FG001|STARTED|Overall Study||57
10220449|NCT04205669|11348180|FG000|COMPLETED|Overall Study||34
10220450|NCT04205669|11348181|FG001|COMPLETED|Overall Study||45
10220451|NCT04205669|11348180|FG000|NOT COMPLETED|Overall Study||13
10220452|NCT04205669|11348181|FG001|NOT COMPLETED|Overall Study||12
10220453|NCT04198948|11348189|FG000|STARTED|First Period||7
10220454|NCT04198948|11348190|FG001|STARTED|First Period||8
10220455|NCT04198948|11348189|FG000|COMPLETED|First Period||7
10220456|NCT04198948|11348190|FG001|COMPLETED|First Period||8
10220457|NCT04198948|11348189|FG000|NOT COMPLETED|First Period||0
10220458|NCT04198948|11348190|FG001|NOT COMPLETED|First Period||0
10220459|NCT04198948|11348189|FG000|STARTED|Wash-out (10 Days)||7
10220460|NCT04198948|11348190|FG001|STARTED|Wash-out (10 Days)||8
10012504|NCT01786148|11135311|FG001|STARTED|Overall Study||72
10012505|NCT01786148|11135310|FG000|COMPLETED|Overall Study||55
10012506|NCT01786148|11135311|FG001|COMPLETED|Overall Study||50
10012507|NCT01786148|11135310|FG000|NOT COMPLETED|Overall Study||22
10012508|NCT01786148|11135311|FG001|NOT COMPLETED|Overall Study||22
10012509|NCT01786161|11135319|FG000|STARTED|Overall Study||22
10220461|NCT04198948|11348189|FG000|COMPLETED|Wash-out (10 Days)||7
10220462|NCT04198948|11348190|FG001|COMPLETED|Wash-out (10 Days)||8
10220463|NCT04198948|11348189|FG000|NOT COMPLETED|Wash-out (10 Days)||0
10220464|NCT04198948|11348190|FG001|NOT COMPLETED|Wash-out (10 Days)||0
10220465|NCT04198948|11348189|FG000|STARTED|Second Period||7
10220466|NCT04198948|11348190|FG001|STARTED|Second Period||8
10220467|NCT04198948|11348189|FG000|COMPLETED|Second Period||7
10220468|NCT04198948|11348190|FG001|COMPLETED|Second Period||7
10220469|NCT04198948|11348189|FG000|NOT COMPLETED|Second Period||0
10220470|NCT04198948|11348190|FG001|NOT COMPLETED|Second Period||1
10220471|NCT04206384|11348196|FG000|STARTED|Overall Study||52
10220472|NCT04206384|11348196|FG000|COMPLETED|Overall Study||42
10220473|NCT04206384|11348196|FG000|NOT COMPLETED|Overall Study||10
10220474|NCT04204200|11348203|FG000|STARTED|Overall Study||22
10220475|NCT04204200|11348204|FG001|STARTED|Overall Study||22
10220476|NCT04204200|11348205|FG002|STARTED|Overall Study||22
10012510|NCT01786161|11135320|FG001|STARTED|Overall Study||22
10012511|NCT01786161|11135319|FG000|COMPLETED|Overall Study||22
10220477|NCT04204200|11348203|FG000|COMPLETED|Overall Study||22
10220478|NCT04204200|11348204|FG001|COMPLETED|Overall Study||22
10220479|NCT04204200|11348205|FG002|COMPLETED|Overall Study||22
10220480|NCT04204200|11348203|FG000|NOT COMPLETED|Overall Study||0
10220481|NCT04204200|11348204|FG001|NOT COMPLETED|Overall Study||0
10220482|NCT04204200|11348205|FG002|NOT COMPLETED|Overall Study||0
10220483|NCT04196907|11348213|FG000|STARTED|Overall Study||20
10220484|NCT04196907|11348213|FG000|COMPLETED|Overall Study||20
10220485|NCT04196907|11348213|FG000|NOT COMPLETED|Overall Study||0
10220486|NCT04195893|11348217|FG000|STARTED|First Intervention||27
10220487|NCT04195893|11348218|FG001|STARTED|First Intervention||29
10220488|NCT04195893|11348217|FG000|COMPLETED|First Intervention||27
10220489|NCT04195893|11348218|FG001|COMPLETED|First Intervention||29
10220490|NCT04195893|11348217|FG000|NOT COMPLETED|First Intervention||0
10220491|NCT04195893|11348218|FG001|NOT COMPLETED|First Intervention||0
10220492|NCT04195893|11348217|FG000|STARTED|Second Intervention||27
10220493|NCT04195893|11348218|FG001|STARTED|Second Intervention||29
10220494|NCT04195893|11348217|FG000|COMPLETED|Second Intervention||26
10220495|NCT04195893|11348218|FG001|COMPLETED|Second Intervention||29
10220496|NCT04195893|11348217|FG000|NOT COMPLETED|Second Intervention||1
10012512|NCT01786161|11135320|FG001|COMPLETED|Overall Study||22
10012513|NCT01786161|11135319|FG000|NOT COMPLETED|Overall Study||0
10012514|NCT01786161|11135320|FG001|NOT COMPLETED|Overall Study||0
10012515|NCT01786174|11135330|FG000|STARTED|Overall Study||18
10012516|NCT01786174|11135331|FG001|STARTED|Overall Study||10
10220497|NCT04195893|11348218|FG001|NOT COMPLETED|Second Intervention||0
10220498|NCT04195880|11348226|FG000|STARTED|Overall Study||3205
10220499|NCT04195880|11348227|FG001|STARTED|Overall Study||3338
10220500|NCT04195880|11348226|FG000|COMPLETED|Overall Study||3205
10220501|NCT04195880|11348227|FG001|COMPLETED|Overall Study||3338
10220502|NCT04195880|11348226|FG000|NOT COMPLETED|Overall Study||0
10220503|NCT04195880|11348227|FG001|NOT COMPLETED|Overall Study||0
10220504|NCT04195581|11348233|FG000|STARTED|Comfilcon A With All in One Light||28
10220505|NCT04195581|11348233|FG000|COMPLETED|Comfilcon A With All in One Light||24
10220506|NCT04195581|11348233|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4
10220507|NCT04195581|11348233|FG000|STARTED|Comfilcon A With Hy-Care||30
10220508|NCT04195581|11348233|FG000|COMPLETED|Comfilcon A With Hy-Care||25
10220509|NCT04195581|11348233|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5
10220510|NCT04195581|11348233|FG000|STARTED|Comfilcon A With Refine One Step||25
10220511|NCT04195581|11348233|FG000|COMPLETED|Comfilcon A With Refine One Step||24
10220512|NCT04195581|11348233|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1
10220513|NCT04195581|11348233|FG000|STARTED|Fanfilcon A With All in One Light||28
10220514|NCT04195581|11348233|FG000|COMPLETED|Fanfilcon A With All in One Light||27
10220515|NCT04195581|11348233|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1
10220516|NCT04195581|11348233|FG000|STARTED|Fanfilcon A With Hy-Care||28
10220517|NCT04195581|11348233|FG000|COMPLETED|Fanfilcon A With Hy-Care||25
10220518|NCT04195581|11348233|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3
10220519|NCT04195581|11348233|FG000|STARTED|Fanfilcon A With Refine One Step||29
10220520|NCT04195581|11348233|FG000|COMPLETED|Fanfilcon A With Refine One Step||27
10220521|NCT04195581|11348233|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2
10220522|NCT04194151|11348257|FG000|STARTED|Overall Study||32
10220523|NCT04194151|11348258|FG001|STARTED|Overall Study||32
10220524|NCT04194151|11348259|FG002|STARTED|Overall Study||32
10220525|NCT04194151|11348260|FG003|STARTED|Overall Study||32
9760863|NCT00383760|10864674|FG000|STARTED|Overall Study||15
9760864|NCT00383760|10864674|FG000|COMPLETED|Overall Study||15
9760865|NCT00383760|10864674|FG000|NOT COMPLETED|Overall Study||0
9760866|NCT00383786|10864681|FG000|STARTED|Overall Study||22
9760867|NCT00383786|10864682|FG001|STARTED|Overall Study||25
9760868|NCT00383786|10864681|FG000|COMPLETED|Overall Study||18
9760869|NCT00383786|10864682|FG001|COMPLETED|Overall Study||13
9760870|NCT00383786|10864681|FG000|NOT COMPLETED|Overall Study||4
9760871|NCT00383786|10864682|FG001|NOT COMPLETED|Overall Study||12
9760872|NCT00383942|10864690|FG000|STARTED|Overall Study||40
9760873|NCT00383942|10864691|FG001|STARTED|Overall Study||40
9760874|NCT00383942|10864690|FG000|COMPLETED|Overall Study||40
9760875|NCT00383942|10864691|FG001|COMPLETED|Overall Study||40
9760876|NCT00383942|10864690|FG000|NOT COMPLETED|Overall Study||0
9760877|NCT00383942|10864691|FG001|NOT COMPLETED|Overall Study||0
9760878|NCT00384033|10864701|FG000|STARTED|Overall Study||164
9760879|NCT00384033|10864702|FG001|STARTED|Overall Study||155
9760880|NCT00384033|10864703|FG002|STARTED|Overall Study||160
9760881|NCT00384033|10864704|FG003|STARTED|Overall Study||159
9760882|NCT00384033|10864701|FG000|Treated|Overall Study||161
10220526|NCT04194151|11348261|FG004|STARTED|Overall Study||32
10220527|NCT04194151|11348262|FG005|STARTED|Overall Study||32
10220528|NCT04194151|11348257|FG000|COMPLETED|Overall Study||31
10220529|NCT04194151|11348258|FG001|COMPLETED|Overall Study||30
9760883|NCT00384033|10864702|FG001|Treated|Overall Study||148
9760884|NCT00384033|10864703|FG002|Treated|Overall Study||150
10012517|NCT01786174|11135330|FG000|Randomized|Overall Study||19
10012518|NCT01786174|11135331|FG001|Randomized|Overall Study||11
10012519|NCT01786174|11135330|FG000|COMPLETED|Overall Study||16
10012520|NCT01786174|11135331|FG001|COMPLETED|Overall Study||10
10220530|NCT04194151|11348259|FG002|COMPLETED|Overall Study||31
10220531|NCT04194151|11348260|FG003|COMPLETED|Overall Study||31
10220532|NCT04194151|11348261|FG004|COMPLETED|Overall Study||32
10220533|NCT04194151|11348262|FG005|COMPLETED|Overall Study||31
10220534|NCT04194151|11348257|FG000|NOT COMPLETED|Overall Study||1
9760885|NCT00384033|10864704|FG003|Treated|Overall Study||157
9760886|NCT00384033|10864701|FG000|COMPLETED|Overall Study||123
10012521|NCT01786174|11135330|FG000|NOT COMPLETED|Overall Study||2
9760887|NCT00384033|10864702|FG001|COMPLETED|Overall Study||120
9760888|NCT00384033|10864703|FG002|COMPLETED|Overall Study||117
10220535|NCT04194151|11348258|FG001|NOT COMPLETED|Overall Study||2
10220536|NCT04194151|11348259|FG002|NOT COMPLETED|Overall Study||1
10220537|NCT04194151|11348260|FG003|NOT COMPLETED|Overall Study||1
10220538|NCT04194151|11348261|FG004|NOT COMPLETED|Overall Study||0
10220539|NCT04194151|11348262|FG005|NOT COMPLETED|Overall Study||1
10220540|NCT04194008|11348276|FG000|STARTED|Baseline (Run-in) Phase||126
10220541|NCT04194008|11348276|FG000|COMPLETED|Baseline (Run-in) Phase||99
10220542|NCT04194008|11348276|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27
10220543|NCT04194008|11348276|FG000|STARTED|Treatment Phase With Nerivio||99
10220544|NCT04194008|11348276|FG000|COMPLETED|Treatment Phase With Nerivio||91
10220545|NCT04194008|11348276|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8
10220546|NCT04191668|11348280|FG000|STARTED|Overall Study||106
10220547|NCT04191668|11348280|FG000|COMPLETED|Overall Study||106
10220548|NCT04191668|11348280|FG000|NOT COMPLETED|Overall Study||0
10220549|NCT04189081|11348287|FG000|STARTED|Overall Study||46
10220550|NCT04189081|11348288|FG001|STARTED|Overall Study||45
10220551|NCT04189081|11348289|FG002|STARTED|Overall Study||46
10220552|NCT04189081|11348287|FG000|COMPLETED|Overall Study||45
10220553|NCT04189081|11348288|FG001|COMPLETED|Overall Study||45
10220554|NCT04189081|11348289|FG002|COMPLETED|Overall Study||45
10220555|NCT04189081|11348287|FG000|NOT COMPLETED|Overall Study||1
10220556|NCT04189081|11348288|FG001|NOT COMPLETED|Overall Study||0
10220557|NCT04189081|11348289|FG002|NOT COMPLETED|Overall Study||1
10220558|NCT04186780|11348299|FG000|STARTED|Overall Study||36
10220559|NCT04186780|11348300|FG001|STARTED|Overall Study||32
10220560|NCT04186780|11348299|FG000|COMPLETED|Overall Study||22
10220561|NCT04186780|11348300|FG001|COMPLETED|Overall Study||25
10220562|NCT04186780|11348299|FG000|NOT COMPLETED|Overall Study||14
10220563|NCT04186780|11348300|FG001|NOT COMPLETED|Overall Study||7
10220564|NCT04186806|11348310|FG000|STARTED|Period 1: 7 Days||20
10220565|NCT04186806|11348311|FG001|STARTED|Period 1: 7 Days||20
10220566|NCT04186806|11348310|FG000|COMPLETED|Period 1: 7 Days||19
10220567|NCT04186806|11348311|FG001|COMPLETED|Period 1: 7 Days||20
10220568|NCT04186806|11348310|FG000|NOT COMPLETED|Period 1: 7 Days||1
10220569|NCT04186806|11348311|FG001|NOT COMPLETED|Period 1: 7 Days||0
10220570|NCT04186806|11348310|FG000|STARTED|Washout Period: at Least 2 Days||19
10220571|NCT04186806|11348311|FG001|STARTED|Washout Period: at Least 2 Days||20
10220572|NCT04186806|11348310|FG000|COMPLETED|Washout Period: at Least 2 Days||19
10220573|NCT04186806|11348311|FG001|COMPLETED|Washout Period: at Least 2 Days||20
10220574|NCT04186806|11348310|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0
10220575|NCT04186806|11348311|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0
10220576|NCT04186806|11348310|FG000|STARTED|Period 2: 7 Days||19
10220577|NCT04186806|11348311|FG001|STARTED|Period 2: 7 Days||20
10220578|NCT04186806|11348310|FG000|COMPLETED|Period 2: 7 Days||19
10220579|NCT04186806|11348311|FG001|COMPLETED|Period 2: 7 Days||20
10220580|NCT04186806|11348310|FG000|NOT COMPLETED|Period 2: 7 Days||0
10220581|NCT04186806|11348311|FG001|NOT COMPLETED|Period 2: 7 Days||0
10220582|NCT04186481|11348318|FG000|STARTED|Overall Study||32
10220583|NCT04186481|11348318|FG000|Completed 6 Month Visit|Overall Study||31
10220584|NCT04186481|11348318|FG000|Completed 12 Month Visit|Overall Study||4
10220585|NCT04186481|11348318|FG000|COMPLETED|Overall Study||32
10220586|NCT04186481|11348318|FG000|NOT COMPLETED|Overall Study||0
10220587|NCT04184999|11348324|FG000|STARTED|Overall Study||40
10220588|NCT04184999|11348325|FG001|STARTED|Overall Study||40
10220589|NCT04184999|11348324|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40
10220590|NCT04184999|11348325|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40
10220591|NCT04184999|11348324|FG000|COMPLETED|Overall Study||40
10220592|NCT04184999|11348325|FG001|COMPLETED|Overall Study||40
10220593|NCT04184999|11348324|FG000|NOT COMPLETED|Overall Study||0
10220594|NCT04184999|11348325|FG001|NOT COMPLETED|Overall Study||0
10220595|NCT04184271|11348331|FG000|STARTED|Overall Study||16
10220596|NCT04184271|11348331|FG000|COMPLETED|Overall Study||16
10220597|NCT04184271|11348331|FG000|NOT COMPLETED|Overall Study||0
10220598|NCT04183231|11348335|FG000|STARTED|Overall Study||16
10220599|NCT04183231|11348335|FG000|COMPLETED|Overall Study||16
10220600|NCT04183231|11348335|FG000|NOT COMPLETED|Overall Study||0
10220601|NCT04182958|11348339|FG000|STARTED|Overall Study||8
10220602|NCT04182958|11348339|FG000|COMPLETED|Overall Study||8
10220603|NCT04182958|11348339|FG000|NOT COMPLETED|Overall Study||0
10220604|NCT04179838|11348345|FG000|STARTED|First Intervention (1 Day)||13
10220605|NCT04179838|11348346|FG001|STARTED|First Intervention (1 Day)||16
10220606|NCT04179838|11348345|FG000|COMPLETED|First Intervention (1 Day)||13
10220607|NCT04179838|11348346|FG001|COMPLETED|First Intervention (1 Day)||13
10220608|NCT04179838|11348345|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10220609|NCT04179838|11348346|FG001|NOT COMPLETED|First Intervention (1 Day)||3
10220610|NCT04179838|11348345|FG000|STARTED|Washout (4 Weeks)||13
10220611|NCT04179838|11348346|FG001|STARTED|Washout (4 Weeks)||13
10220612|NCT04179838|11348345|FG000|COMPLETED|Washout (4 Weeks)||13
10220613|NCT04179838|11348346|FG001|COMPLETED|Washout (4 Weeks)||13
10220614|NCT04179838|11348345|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10220615|NCT04179838|11348346|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10220616|NCT04179838|11348345|FG000|STARTED|Second Intervention (1 Day)||13
10220617|NCT04179838|11348346|FG001|STARTED|Second Intervention (1 Day)||13
10220618|NCT04179838|11348345|FG000|COMPLETED|Second Intervention (1 Day)||13
10220619|NCT04179838|11348346|FG001|COMPLETED|Second Intervention (1 Day)||12
10220620|NCT04179838|11348345|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10220621|NCT04179838|11348346|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
10220622|NCT04179461|11348352|FG000|STARTED|Overall Study||21
10220623|NCT04179461|11348352|FG000|COMPLETED|Overall Study||17
10220624|NCT04179461|11348352|FG000|NOT COMPLETED|Overall Study||4
10220625|NCT04179474|11348358|FG000|STARTED|Treatment Period 1 (First Intervention)||20
10220626|NCT04179474|11348359|FG001|STARTED|Treatment Period 1 (First Intervention)||20
10220627|NCT04179474|11348358|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20
10220628|NCT04179474|11348359|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20
10220629|NCT04179474|11348358|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
10220630|NCT04179474|11348359|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
10220631|NCT04179474|11348358|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
10220632|NCT04179474|11348359|FG001|STARTED|Treatment Period 2 (Second Intervention)||20
10220633|NCT04179474|11348358|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19
10220634|NCT04179474|11348359|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20
10220635|NCT04179474|11348358|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
10220636|NCT04179474|11348359|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
10220637|NCT04179474|11348358|FG000|STARTED|Treatment Period 3 (Third Intervention)||19
10220638|NCT04179474|11348359|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
10220639|NCT04179474|11348358|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19
10220640|NCT04179474|11348359|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19
10220641|NCT04179474|11348358|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
10220642|NCT04179474|11348359|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
10220643|NCT04178590|11348380|FG000|STARTED|Overall Study||32
10220644|NCT04178590|11348380|FG000|COMPLETED|Overall Study||30
10220645|NCT04178590|11348380|FG000|NOT COMPLETED|Overall Study||2
10220646|NCT04177862|11348408|FG000|STARTED|Overall Study||35
10220647|NCT04177862|11348409|FG001|STARTED|Overall Study||40
10220648|NCT04177862|11348408|FG000|COMPLETED|Overall Study||33
10220649|NCT04177862|11348409|FG001|COMPLETED|Overall Study||33
10220650|NCT04177862|11348408|FG000|NOT COMPLETED|Overall Study||2
10220651|NCT04177862|11348409|FG001|NOT COMPLETED|Overall Study||7
10220652|NCT04176406|11348416|FG000|STARTED|Overall Study||0
10220653|NCT04176406|11348417|FG001|STARTED|Overall Study||0
10220654|NCT04176406|11348418|FG002|STARTED|Overall Study||0
10220655|NCT04176406|11348419|FG003|STARTED|Overall Study||0
10220656|NCT04176406|11348416|FG000|COMPLETED|Overall Study||0
10220657|NCT04176406|11348417|FG001|COMPLETED|Overall Study||0
10220658|NCT04176406|11348418|FG002|COMPLETED|Overall Study||0
10220659|NCT04176406|11348419|FG003|COMPLETED|Overall Study||0
10220660|NCT04176406|11348416|FG000|NOT COMPLETED|Overall Study||0
10220661|NCT04176406|11348417|FG001|NOT COMPLETED|Overall Study||0
10220662|NCT04176406|11348418|FG002|NOT COMPLETED|Overall Study||0
10220663|NCT04176406|11348419|FG003|NOT COMPLETED|Overall Study||0
10220664|NCT04175262|11348430|FG000|STARTED|Overall Study||102
10220665|NCT04175262|11348430|FG000|COMPLETED|Overall Study||102
10220666|NCT04175262|11348430|FG000|NOT COMPLETED|Overall Study||0
10220667|NCT04171102|11348437|FG000|STARTED|Overall Study||4
10220668|NCT04171102|11348438|FG001|STARTED|Overall Study||5
10220669|NCT04171102|11348439|FG002|STARTED|Overall Study||6
10220670|NCT04171102|11348437|FG000|COMPLETED|Overall Study||4
10220671|NCT04171102|11348438|FG001|COMPLETED|Overall Study||5
10220672|NCT04171102|11348439|FG002|COMPLETED|Overall Study||6
10012522|NCT01786174|11135331|FG001|NOT COMPLETED|Overall Study||0
10012523|NCT01786187|11135339|FG000|STARTED|Overall Study||40
10012524|NCT01786187|11135340|FG001|STARTED|Overall Study||47
10012525|NCT01786187|11135339|FG000|COMPLETED|Overall Study||35
10220673|NCT04171102|11348437|FG000|NOT COMPLETED|Overall Study||0
10220674|NCT04171102|11348438|FG001|NOT COMPLETED|Overall Study||0
10220675|NCT04171102|11348439|FG002|NOT COMPLETED|Overall Study||0
10220676|NCT04174638|11348449|FG000|STARTED|Overall Study||32
10220677|NCT04174638|11348450|FG001|STARTED|Overall Study||28
10220678|NCT04174638|11348449|FG000|COMPLETED|Overall Study||32
10220679|NCT04174638|11348450|FG001|COMPLETED|Overall Study||28
10220680|NCT04174638|11348449|FG000|NOT COMPLETED|Overall Study||0
10220681|NCT04174638|11348450|FG001|NOT COMPLETED|Overall Study||0
10220682|NCT04174313|11348461|FG000|STARTED|Overall Study||15
10220683|NCT04174313|11348462|FG001|STARTED|Overall Study||50
10220684|NCT04174313|11348461|FG000|COMPLETED|Overall Study||15
10220685|NCT04174313|11348462|FG001|COMPLETED|Overall Study||50
10220686|NCT04174313|11348461|FG000|NOT COMPLETED|Overall Study||0
10220687|NCT04174313|11348462|FG001|NOT COMPLETED|Overall Study||0
10220688|NCT04173429|11348474|FG000|STARTED|Overall Study||32
10220689|NCT04173429|11348475|FG001|STARTED|Overall Study||32
10220690|NCT04173429|11348474|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
10220691|NCT04173429|11348475|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
10220692|NCT04173429|11348474|FG000|COMPLETED|Overall Study||30
10220693|NCT04173429|11348475|FG001|COMPLETED|Overall Study||30
10220694|NCT04173429|11348474|FG000|NOT COMPLETED|Overall Study||2
10220695|NCT04173429|11348475|FG001|NOT COMPLETED|Overall Study||2
10220696|NCT04173741|11348484|FG000|STARTED|Overall Study||23
10220697|NCT04173741|11348485|FG001|STARTED|Overall Study||23
10012526|NCT01786187|11135340|FG001|COMPLETED|Overall Study||37
10220698|NCT04173741|11348484|FG000|COMPLETED|Overall Study||22
10012527|NCT01786187|11135339|FG000|NOT COMPLETED|Overall Study||5
10012528|NCT01786187|11135340|FG001|NOT COMPLETED|Overall Study||10
10220699|NCT04173741|11348485|FG001|COMPLETED|Overall Study||22
10220700|NCT04173741|11348484|FG000|NOT COMPLETED|Overall Study||1
10220701|NCT04173741|11348485|FG001|NOT COMPLETED|Overall Study||1
10220702|NCT04169061|11348491|FG000|STARTED|Overall Study||36
10220703|NCT04169061|11348491|FG000|Safety Population|Overall Study||36
10220704|NCT04169061|11348491|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34
10220705|NCT04169061|11348491|FG000|COMPLETED|Overall Study||31
10220706|NCT04169061|11348491|FG000|NOT COMPLETED|Overall Study||5
10220707|NCT04157738|11348497|FG000|STARTED|Overall Study||12
10220708|NCT04157738|11348498|FG001|STARTED|Overall Study||12
10220709|NCT04157738|11348497|FG000|COMPLETED|Overall Study||11
10220710|NCT04157738|11348498|FG001|COMPLETED|Overall Study||10
10220711|NCT04157738|11348497|FG000|NOT COMPLETED|Overall Study||1
10220712|NCT04157738|11348498|FG001|NOT COMPLETED|Overall Study||2
10220713|NCT04156646|11348506|FG000|STARTED|Treatment Period 1 (6 Days)||8
10220714|NCT04156646|11348507|FG001|STARTED|Treatment Period 1 (6 Days)||8
10220715|NCT04156646|11348506|FG000|COMPLETED|Treatment Period 1 (6 Days)||8
10220716|NCT04156646|11348507|FG001|COMPLETED|Treatment Period 1 (6 Days)||8
10220717|NCT04156646|11348506|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10220718|NCT04156646|11348507|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10220719|NCT04156646|11348506|FG000|STARTED|Wash-out Period (12- to 21-days)||8
10220720|NCT04156646|11348507|FG001|STARTED|Wash-out Period (12- to 21-days)||8
10220721|NCT04156646|11348506|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
10220722|NCT04156646|11348507|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
10220723|NCT04156646|11348506|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10220724|NCT04156646|11348507|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10220725|NCT04156646|11348506|FG000|STARTED|Treatment Period 2 (6 Days)||8
10220726|NCT04156646|11348507|FG001|STARTED|Treatment Period 2 (6 Days)||8
10220727|NCT04156646|11348506|FG000|COMPLETED|Treatment Period 2 (6 Days)||8
10220728|NCT04156646|11348507|FG001|COMPLETED|Treatment Period 2 (6 Days)||8
10220729|NCT04156646|11348506|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10220730|NCT04156646|11348507|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10220731|NCT04156646|11348506|FG000|STARTED|Wash-out Period (12- to 21-days)||8
10220732|NCT04156646|11348507|FG001|STARTED|Wash-out Period (12- to 21-days)||8
10220733|NCT04156646|11348506|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
10220734|NCT04156646|11348507|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
10220735|NCT04156646|11348506|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10220736|NCT04156646|11348507|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10220737|NCT04156646|11348506|FG000|STARTED|Treatment Period 3 (6 Days)||8
10220738|NCT04156646|11348507|FG001|STARTED|Treatment Period 3 (6 Days)||8
10220739|NCT04156646|11348506|FG000|COMPLETED|Treatment Period 3 (6 Days)||8
10220740|NCT04156646|11348507|FG001|COMPLETED|Treatment Period 3 (6 Days)||7
10220741|NCT04156646|11348506|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10220742|NCT04156646|11348507|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1
10220743|NCT04170686|11348518|FG000|STARTED|Screening||74
10220744|NCT04170686|11348519|FG001|STARTED|Screening||72
10220745|NCT04170686|11348518|FG000|COMPLETED|Screening||62
10220746|NCT04170686|11348519|FG001|COMPLETED|Screening||59
10220747|NCT04170686|11348518|FG000|NOT COMPLETED|Screening||12
10220748|NCT04170686|11348519|FG001|NOT COMPLETED|Screening||13
10220749|NCT04170686|11348518|FG000|STARTED|Randomization and Treatment||62
10220750|NCT04170686|11348519|FG001|STARTED|Randomization and Treatment||59
10220751|NCT04170686|11348518|FG000|COMPLETED|Randomization and Treatment||36
10220752|NCT04170686|11348519|FG001|COMPLETED|Randomization and Treatment||44
10220753|NCT04170686|11348518|FG000|NOT COMPLETED|Randomization and Treatment||26
10220754|NCT04170686|11348519|FG001|NOT COMPLETED|Randomization and Treatment||15
10220755|NCT04169113|11348527|FG000|STARTED|Overall Study||52
10220756|NCT04169113|11348528|FG001|STARTED|Overall Study||59
10220757|NCT04169113|11348527|FG000|COMPLETED|Overall Study||47
10220758|NCT04169113|11348528|FG001|COMPLETED|Overall Study||53
10220759|NCT04169113|11348527|FG000|NOT COMPLETED|Overall Study||5
10220760|NCT04169113|11348528|FG001|NOT COMPLETED|Overall Study||6
10220761|NCT04160975|11348540|FG000|STARTED|Overall Study||479
10220762|NCT04160975|11348541|FG001|STARTED|Overall Study||496
10220763|NCT04160975|11348542|FG002|STARTED|Overall Study||478
10220764|NCT04160975|11348543|FG003|STARTED|Overall Study||485
10220765|NCT04160975|11348544|FG004|STARTED|Overall Study||649
10220766|NCT04160975|11348545|FG005|STARTED|Overall Study||658
10220767|NCT04160975|11348540|FG000|COMPLETED|Overall Study||415
10220768|NCT04160975|11348541|FG001|COMPLETED|Overall Study||430
10220769|NCT04160975|11348542|FG002|COMPLETED|Overall Study||417
10220770|NCT04160975|11348543|FG003|COMPLETED|Overall Study||410
10220771|NCT04160975|11348544|FG004|COMPLETED|Overall Study||614
10220772|NCT04160975|11348545|FG005|COMPLETED|Overall Study||607
10220773|NCT04160975|11348540|FG000|NOT COMPLETED|Overall Study||64
10220774|NCT04160975|11348541|FG001|NOT COMPLETED|Overall Study||66
10220775|NCT04160975|11348542|FG002|NOT COMPLETED|Overall Study||61
10220776|NCT04160975|11348543|FG003|NOT COMPLETED|Overall Study||75
10220777|NCT04160975|11348544|FG004|NOT COMPLETED|Overall Study||35
10220778|NCT04160975|11348545|FG005|NOT COMPLETED|Overall Study||51
10220779|NCT04153409|11348560|FG000|STARTED|Overall Study||10
10220780|NCT04153409|11348561|FG001|STARTED|Overall Study||11
10220781|NCT04153409|11348560|FG000|COMPLETED|Overall Study||8
10220782|NCT04153409|11348561|FG001|COMPLETED|Overall Study||9
10220783|NCT04153409|11348560|FG000|NOT COMPLETED|Overall Study||2
10220784|NCT04153409|11348561|FG001|NOT COMPLETED|Overall Study||2
10220785|NCT04167189|11348567|FG000|STARTED|Overall Study||28
10220786|NCT04167189|11348567|FG000|COMPLETED|Overall Study||28
10220787|NCT04167189|11348567|FG000|NOT COMPLETED|Overall Study||0
10220788|NCT04162795|11348571|FG000|STARTED|Overall Study||468
10220789|NCT04162795|11348571|FG000|COMPLETED|Overall Study||442
10220790|NCT04162795|11348571|FG000|NOT COMPLETED|Overall Study||26
10220791|NCT04161807|11348575|FG000|STARTED|Overall Study||42
10220792|NCT04161807|11348575|FG000|COMPLETED|Overall Study||38
10220793|NCT04161807|11348575|FG000|NOT COMPLETED|Overall Study||4
10220794|NCT04161144|11348581|FG000|STARTED|Overall Study||12
10220795|NCT04161144|11348582|FG001|STARTED|Overall Study||10
10220796|NCT04161144|11348581|FG000|COMPLETED|Overall Study||11
10220797|NCT04161144|11348582|FG001|COMPLETED|Overall Study||9
10220798|NCT04161144|11348581|FG000|NOT COMPLETED|Overall Study||1
10220799|NCT04161144|11348582|FG001|NOT COMPLETED|Overall Study||1
10220800|NCT04161079|11348588|FG000|STARTED|Clinical Investigation 2010-040||12
10220801|NCT04161079|11348588|FG000|COMPLETED|Clinical Investigation 2010-040||11
10220802|NCT04161079|11348588|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1
10220803|NCT04161079|11348588|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
10220804|NCT04161079|11348588|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
10220805|NCT04161079|11348588|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
10220806|NCT04158466|11348598|FG000|STARTED|Overall Study||124
10220807|NCT04158466|11348599|FG001|STARTED|Overall Study||127
10220808|NCT04158466|11348598|FG000|COMPLETED|Overall Study||121
10220809|NCT04158466|11348599|FG001|COMPLETED|Overall Study||126
10220810|NCT04158466|11348598|FG000|NOT COMPLETED|Overall Study||3
10220811|NCT04158466|11348599|FG001|NOT COMPLETED|Overall Study||1
10220812|NCT04152083|11348607|FG000|STARTED|Overall Study||241
10220813|NCT04152083|11348608|FG001|STARTED|Overall Study||244
10220814|NCT04152083|11348607|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238
10220815|NCT04152083|11348608|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242
10220816|NCT04152083|11348607|FG000|COMPLETED|Overall Study||235
10220817|NCT04152083|11348608|FG001|COMPLETED|Overall Study||241
10220818|NCT04152083|11348607|FG000|NOT COMPLETED|Overall Study||6
10220819|NCT04152083|11348608|FG001|NOT COMPLETED|Overall Study||3
10220820|NCT04155567|11348614|FG000|STARTED|Overall Study||10
10220821|NCT04155567|11348614|FG000|COMPLETED|Overall Study||10
10220822|NCT04155567|11348614|FG000|NOT COMPLETED|Overall Study||0
10220823|NCT04155047|11348620|FG000|STARTED|Overall Study||11
10220824|NCT04155047|11348621|FG001|STARTED|Overall Study||11
10220825|NCT04155047|11348620|FG000|COMPLETED|Overall Study||9
10220826|NCT04155047|11348621|FG001|COMPLETED|Overall Study||11
10220827|NCT04155047|11348620|FG000|NOT COMPLETED|Overall Study||2
10220828|NCT04155047|11348621|FG001|NOT COMPLETED|Overall Study||0
10220829|NCT04152642|11348627|FG000|STARTED|Overall Study||22
10220830|NCT04152642|11348627|FG000|C (Water/Negative) Control|Overall Study||20
10220831|NCT04152642|11348627|FG000|A (Marketed Rinse)|Overall Study||19
10220832|NCT04152642|11348627|FG000|B (Experimental Rinse)|Overall Study||19
10220833|NCT04152642|11348627|FG000|COMPLETED|Overall Study||15
10220834|NCT04152642|11348627|FG000|NOT COMPLETED|Overall Study||7
10220835|NCT04150861|11348638|FG000|STARTED|Overall Study||8
10220836|NCT04150861|11348639|FG001|STARTED|Overall Study||8
10220837|NCT04150861|11348640|FG002|STARTED|Overall Study||8
10220838|NCT04150861|11348638|FG000|COMPLETED|Overall Study||8
10220839|NCT04150861|11348639|FG001|COMPLETED|Overall Study||8
10220840|NCT04150861|11348640|FG002|COMPLETED|Overall Study||8
10220841|NCT04150861|11348638|FG000|NOT COMPLETED|Overall Study||0
10220842|NCT04150861|11348639|FG001|NOT COMPLETED|Overall Study||0
10220843|NCT04150861|11348640|FG002|NOT COMPLETED|Overall Study||0
10012529|NCT01786239|11135351|FG000|STARTED|Overall Study||25
10012530|NCT01786239|11135352|FG001|STARTED|Overall Study||25
10012531|NCT01786239|11135351|FG000|COMPLETED|Overall Study||14
10012532|NCT01786239|11135352|FG001|COMPLETED|Overall Study||14
10012533|NCT01786239|11135351|FG000|NOT COMPLETED|Overall Study||11
10012534|NCT01786239|11135352|FG001|NOT COMPLETED|Overall Study||11
10012535|NCT01786252|11135360|FG000|STARTED|Overall Study||7
10012536|NCT01786252|11135361|FG001|STARTED|Overall Study||8
10012537|NCT01786252|11135360|FG000|COMPLETED|Overall Study||7
10012538|NCT01786252|11135361|FG001|COMPLETED|Overall Study||8
10012539|NCT01786252|11135360|FG000|NOT COMPLETED|Overall Study||0
10012540|NCT01786252|11135361|FG001|NOT COMPLETED|Overall Study||0
10012541|NCT01786330|11135369|FG000|STARTED|Overall Study||30
10220844|NCT04150250|11348650|FG000|STARTED|Overall Study||23
10220845|NCT04150250|11348651|FG001|STARTED|Overall Study||24
10220846|NCT04150250|11348650|FG000|COMPLETED|Overall Study||23
10220847|NCT04150250|11348651|FG001|COMPLETED|Overall Study||22
10220848|NCT04150250|11348650|FG000|NOT COMPLETED|Overall Study||0
10220849|NCT04150250|11348651|FG001|NOT COMPLETED|Overall Study||2
10220850|NCT04149925|11348659|FG000|STARTED|Overall Study||30
10220851|NCT04149925|11348660|FG001|STARTED|Overall Study||30
10220852|NCT04149925|11348659|FG000|COMPLETED|Overall Study||30
10220853|NCT04149925|11348660|FG001|COMPLETED|Overall Study||30
10220854|NCT04149925|11348659|FG000|NOT COMPLETED|Overall Study||0
10012542|NCT01786330|11135370|FG001|STARTED|Overall Study||30
10012543|NCT01786330|11135369|FG000|COMPLETED|Overall Study||29
10012544|NCT01786330|11135370|FG001|COMPLETED|Overall Study||27
10220855|NCT04149925|11348660|FG001|NOT COMPLETED|Overall Study||0
10012545|NCT01786330|11135369|FG000|NOT COMPLETED|Overall Study||1
10012546|NCT01786330|11135370|FG001|NOT COMPLETED|Overall Study||3
10012547|NCT01786343|11135378|FG000|STARTED|Overall Study||28
10012548|NCT01786343|11135379|FG001|STARTED|Overall Study||46
10220856|NCT04150224|11348672|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10239192|NCT00325572|11370717|FG001|NOT COMPLETED|PHASE ii||0
10220857|NCT04150224|11348673|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10220858|NCT04150224|11348674|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10220859|NCT04150224|11348675|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10220860|NCT04150224|11348676|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10220861|NCT04150224|11348677|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10
10220862|NCT04150224|11348672|FG000|COMPLETED|Overall Study||10
10220863|NCT04150224|11348673|FG001|COMPLETED|Overall Study||10
10220864|NCT04150224|11348674|FG002|COMPLETED|Overall Study||10
10220865|NCT04150224|11348675|FG003|COMPLETED|Overall Study||10
10220866|NCT04150224|11348676|FG004|COMPLETED|Overall Study||10
10220867|NCT04150224|11348677|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10
10220868|NCT04150224|11348672|FG000|NOT COMPLETED|Overall Study||0
10220869|NCT04150224|11348673|FG001|NOT COMPLETED|Overall Study||0
10220870|NCT04150224|11348674|FG002|NOT COMPLETED|Overall Study||0
10220871|NCT04150224|11348675|FG003|NOT COMPLETED|Overall Study||0
10220872|NCT04150224|11348676|FG004|NOT COMPLETED|Overall Study||0
10220873|NCT04150224|11348677|FG005|NOT COMPLETED|Overall Study||0
10220874|NCT04149405|11348704|FG000|STARTED|Overall Study||12
10220875|NCT04149405|11348705|FG001|STARTED|Overall Study||10
10220876|NCT04149405|11348706|FG002|STARTED|Overall Study||11
10220877|NCT04149405|11348707|FG003|STARTED|Overall Study||10
10220878|NCT04149405|11348704|FG000|COMPLETED|Overall Study||12
10220879|NCT04149405|11348705|FG001|COMPLETED|Overall Study||10
10220880|NCT04149405|11348706|FG002|COMPLETED|Overall Study||11
10220881|NCT04149405|11348707|FG003|COMPLETED|Overall Study||10
10220882|NCT04149405|11348704|FG000|NOT COMPLETED|Overall Study||0
10220883|NCT04149405|11348705|FG001|NOT COMPLETED|Overall Study||0
10220884|NCT04149405|11348706|FG002|NOT COMPLETED|Overall Study||0
10220885|NCT04149405|11348707|FG003|NOT COMPLETED|Overall Study||0
10220886|NCT04144088|11348726|FG000|STARTED|Overall Study||20
10220887|NCT04144088|11348727|FG001|STARTED|Overall Study||20
10220888|NCT04144088|11348728|FG002|STARTED|Overall Study||20
10220889|NCT04144088|11348726|FG000|COMPLETED|Overall Study||14
10220890|NCT04144088|11348727|FG001|COMPLETED|Overall Study||15
10220891|NCT04144088|11348728|FG002|COMPLETED|Overall Study||13
10220892|NCT04144088|11348726|FG000|NOT COMPLETED|Overall Study||6
10220893|NCT04144088|11348727|FG001|NOT COMPLETED|Overall Study||5
10220894|NCT04144088|11348728|FG002|NOT COMPLETED|Overall Study||7
10012549|NCT01786343|11135378|FG000|COMPLETED|Overall Study||28
10012550|NCT01786343|11135379|FG001|COMPLETED|Overall Study||46
10012551|NCT01786343|11135378|FG000|NOT COMPLETED|Overall Study||0
10012552|NCT01786343|11135379|FG001|NOT COMPLETED|Overall Study||0
10220895|NCT04149353|11348736|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
10220896|NCT04149353|11348736|FG000|COMPLETED|Overall Study||0
10220897|NCT04149353|11348736|FG000|NOT COMPLETED|Overall Study||1
10220898|NCT04137783|11348744|FG000|STARTED|Overall Study||7
10220899|NCT04137783|11348745|FG001|STARTED|Overall Study||10
10220900|NCT04137783|11348746|FG002|STARTED|Overall Study||22
10220901|NCT04137783|11348744|FG000|COMPLETED|Overall Study||7
10220902|NCT04137783|11348745|FG001|COMPLETED|Overall Study||10
10220903|NCT04137783|11348746|FG002|COMPLETED|Overall Study||22
10220904|NCT04137783|11348744|FG000|NOT COMPLETED|Overall Study||0
10220905|NCT04137783|11348745|FG001|NOT COMPLETED|Overall Study||0
10220906|NCT04137783|11348746|FG002|NOT COMPLETED|Overall Study||0
10220907|NCT04136444|11348756|FG000|STARTED|Overall Study||3
10220908|NCT04136444|11348757|FG001|STARTED|Overall Study||9
10220909|NCT04136444|11348756|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
10220910|NCT04136444|11348757|FG001|COMPLETED|Overall Study||8
10220911|NCT04136444|11348756|FG000|NOT COMPLETED|Overall Study||0
10220912|NCT04136444|11348757|FG001|NOT COMPLETED|Overall Study||1
10220913|NCT04124536|11348774|FG000|STARTED|Overall Study||58
10220914|NCT04124536|11348775|FG001|STARTED|Overall Study||58
10220915|NCT04124536|11348776|FG002|STARTED|Overall Study||105
10220916|NCT04124536|11348777|FG003|STARTED|Overall Study||105
10220917|NCT04124536|11348778|FG004|STARTED|Overall Study||15
10220918|NCT04124536|11348774|FG000|COMPLETED|Overall Study||47
10220919|NCT04124536|11348775|FG001|COMPLETED|Overall Study||53
10220920|NCT04124536|11348776|FG002|COMPLETED|Overall Study||102
10220921|NCT04124536|11348777|FG003|COMPLETED|Overall Study||98
10220922|NCT04124536|11348778|FG004|COMPLETED|Overall Study||15
10220923|NCT04124536|11348774|FG000|NOT COMPLETED|Overall Study||11
10220924|NCT04124536|11348775|FG001|NOT COMPLETED|Overall Study||5
10220925|NCT04124536|11348776|FG002|NOT COMPLETED|Overall Study||3
10220926|NCT04124536|11348777|FG003|NOT COMPLETED|Overall Study||7
10220927|NCT04124536|11348778|FG004|NOT COMPLETED|Overall Study||0
10220928|NCT04147611|11348791|FG000|STARTED|Overall Study||9
10220929|NCT04147611|11348792|FG001|STARTED|Overall Study||13
10220930|NCT04147611|11348791|FG000|COMPLETED|Overall Study||9
10220931|NCT04147611|11348792|FG001|COMPLETED|Overall Study||12
10220932|NCT04147611|11348791|FG000|NOT COMPLETED|Overall Study||0
10220933|NCT04147611|11348792|FG001|NOT COMPLETED|Overall Study||1
10220934|NCT04147442|11348798|FG000|STARTED|Overall Study||20
10220935|NCT04147442|11348798|FG000|COMPLETED|Overall Study||20
10220936|NCT04147442|11348798|FG000|NOT COMPLETED|Overall Study||0
10220937|NCT04147455|11348812|FG000|STARTED|Overall Study||397
10012553|NCT01786512|11135396|FG000|STARTED|Overall Study||11
10220938|NCT04147455|11348813|FG001|STARTED|Overall Study||396
10220939|NCT04147455|11348812|FG000|COMPLETED|Overall Study||375
10220940|NCT04147455|11348813|FG001|COMPLETED|Overall Study||364
10220941|NCT04147455|11348812|FG000|NOT COMPLETED|Overall Study||22
10220942|NCT04147455|11348813|FG001|NOT COMPLETED|Overall Study||32
10220943|NCT04146272|11348823|FG000|STARTED|First Intervention||11
10220944|NCT04146272|11348824|FG001|STARTED|First Intervention||11
10220945|NCT04146272|11348825|FG002|STARTED|First Intervention||6
10220946|NCT04146272|11348826|FG003|STARTED|First Intervention||5
10220947|NCT04146272|11348823|FG000|COMPLETED|First Intervention||11
10220948|NCT04146272|11348824|FG001|COMPLETED|First Intervention||11
10220949|NCT04146272|11348825|FG002|COMPLETED|First Intervention||6
10220950|NCT04146272|11348826|FG003|COMPLETED|First Intervention||5
10220951|NCT04146272|11348823|FG000|NOT COMPLETED|First Intervention||0
10220952|NCT04146272|11348824|FG001|NOT COMPLETED|First Intervention||0
10220953|NCT04146272|11348825|FG002|NOT COMPLETED|First Intervention||0
10220954|NCT04146272|11348826|FG003|NOT COMPLETED|First Intervention||0
10220955|NCT04146272|11348823|FG000|STARTED|Second Intervention||11
10220956|NCT04146272|11348824|FG001|STARTED|Second Intervention||11
10220957|NCT04146272|11348825|FG002|STARTED|Second Intervention||6
10220958|NCT04146272|11348826|FG003|STARTED|Second Intervention||5
10220959|NCT04146272|11348823|FG000|COMPLETED|Second Intervention||11
10220960|NCT04146272|11348824|FG001|COMPLETED|Second Intervention||11
10220961|NCT04146272|11348825|FG002|COMPLETED|Second Intervention||6
10220962|NCT04146272|11348826|FG003|COMPLETED|Second Intervention||5
10220963|NCT04146272|11348823|FG000|NOT COMPLETED|Second Intervention||0
10220964|NCT04146272|11348824|FG001|NOT COMPLETED|Second Intervention||0
10220965|NCT04146272|11348825|FG002|NOT COMPLETED|Second Intervention||0
10220966|NCT04146272|11348826|FG003|NOT COMPLETED|Second Intervention||0
10220967|NCT04143945|11348845|FG000|STARTED|Treatment Period 1 (Day 1)||26
10220968|NCT04143945|11348846|FG001|STARTED|Treatment Period 1 (Day 1)||26
10220969|NCT04143945|11348847|FG002|STARTED|Treatment Period 1 (Day 1)||26
10220970|NCT04143945|11348848|FG003|STARTED|Treatment Period 1 (Day 1)||26
10220971|NCT04143945|11348845|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10220972|NCT04143945|11348846|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10220973|NCT04143945|11348847|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10220974|NCT04143945|11348848|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10220975|NCT04143945|11348845|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10220976|NCT04143945|11348846|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10220977|NCT04143945|11348847|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10220978|NCT04143945|11348848|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10220979|NCT04143945|11348845|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26
10220980|NCT04143945|11348846|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26
10220981|NCT04143945|11348847|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26
10220982|NCT04143945|11348848|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26
10220983|NCT04143945|11348845|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
10220984|NCT04143945|11348846|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
10220985|NCT04143945|11348847|FG002|COMPLETED|Treatment Period 1 (Day 1)||26
10220986|NCT04143945|11348848|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
10220987|NCT04143945|11348845|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10220988|NCT04143945|11348846|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10220989|NCT04143945|11348847|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10220990|NCT04143945|11348848|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10220991|NCT04143945|11348845|FG000|STARTED|Treatment Period 2 (Day 1)||26
10220992|NCT04143945|11348846|FG001|STARTED|Treatment Period 2 (Day 1)||26
10220993|NCT04143945|11348847|FG002|STARTED|Treatment Period 2 (Day 1)||26
10220994|NCT04143945|11348848|FG003|STARTED|Treatment Period 2 (Day 1)||26
10220995|NCT04143945|11348845|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
10220996|NCT04143945|11348846|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
10220997|NCT04143945|11348847|FG002|COMPLETED|Treatment Period 2 (Day 1)||26
10220998|NCT04143945|11348848|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
10220999|NCT04143945|11348845|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10221000|NCT04143945|11348846|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10221001|NCT04143945|11348847|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10221002|NCT04143945|11348848|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10221003|NCT04143373|11348853|FG000|STARTED|Overall Study||20
10221004|NCT04143373|11348854|FG001|STARTED|Overall Study||20
10221005|NCT04143373|11348853|FG000|COMPLETED|Overall Study||20
10221006|NCT04143373|11348854|FG001|COMPLETED|Overall Study||20
10221007|NCT04143373|11348853|FG000|NOT COMPLETED|Overall Study||0
10221008|NCT04143373|11348854|FG001|NOT COMPLETED|Overall Study||0
10221009|NCT04142216|11348861|FG000|STARTED|Overall Study||28
10221010|NCT04142216|11348862|FG001|STARTED|Overall Study||28
10221011|NCT04142216|11348861|FG000|COMPLETED|Overall Study||22
10221012|NCT04142216|11348862|FG001|COMPLETED|Overall Study||22
10221013|NCT04142216|11348861|FG000|NOT COMPLETED|Overall Study||6
10221014|NCT04142216|11348862|FG001|NOT COMPLETED|Overall Study||6
10221015|NCT04141930|11348868|FG000|STARTED|Overall Study||302
10221016|NCT04141930|11348869|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
10221017|NCT04141930|11348868|FG000|COMPLETED|Overall Study||302
10221018|NCT04141930|11348869|FG001|COMPLETED|Overall Study||179
10221019|NCT04141930|11348868|FG000|NOT COMPLETED|Overall Study||0
10221020|NCT04141930|11348869|FG001|NOT COMPLETED|Overall Study||0
10221021|NCT04142450|11348873|FG000|STARTED|Overall Study||50
10221022|NCT04142450|11348873|FG000|Safety Population|Overall Study||49
10221023|NCT04142450|11348873|FG000|COMPLETED|Overall Study||48
10221024|NCT04142450|11348873|FG000|NOT COMPLETED|Overall Study||2
10221025|NCT04140890|11348879|FG000|STARTED|Overall Study||9
10221026|NCT04140890|11348880|FG001|STARTED|Overall Study||12
10221027|NCT04140890|11348879|FG000|COMPLETED|Overall Study||9
10221028|NCT04140890|11348880|FG001|COMPLETED|Overall Study||11
10221029|NCT04140890|11348879|FG000|NOT COMPLETED|Overall Study||0
10221030|NCT04140890|11348880|FG001|NOT COMPLETED|Overall Study||1
10221031|NCT04139018|11348891|FG000|STARTED|Overall Study||14
10221032|NCT04139018|11348892|FG001|STARTED|Overall Study||13
10221033|NCT04139018|11348891|FG000|COMPLETED|Overall Study||11
10221034|NCT04139018|11348892|FG001|COMPLETED|Overall Study||12
10221035|NCT04139018|11348891|FG000|NOT COMPLETED|Overall Study||3
10221036|NCT04139018|11348892|FG001|NOT COMPLETED|Overall Study||1
10221037|NCT04138810|11348900|FG000|STARTED|Overall Study||27
10221038|NCT04138810|11348901|FG001|STARTED|Overall Study||27
10221039|NCT04138810|11348900|FG000|COMPLETED|Overall Study||26
10221040|NCT04138810|11348901|FG001|COMPLETED|Overall Study||26
10221041|NCT04138810|11348900|FG000|NOT COMPLETED|Overall Study||1
10221042|NCT04138810|11348901|FG001|NOT COMPLETED|Overall Study||1
10221043|NCT04131556|11348907|FG000|STARTED|Overall Study||20
10221044|NCT04131556|11348907|FG000|COMPLETED|Overall Study||18
10221045|NCT04131556|11348907|FG000|NOT COMPLETED|Overall Study||2
10221046|NCT04126174|11348914|FG000|STARTED|Overall Study||41
10221047|NCT04126174|11348915|FG001|STARTED|Overall Study||41
10221048|NCT04126174|11348914|FG000|COMPLETED|Overall Study||38
10221049|NCT04126174|11348915|FG001|COMPLETED|Overall Study||38
10221050|NCT04126174|11348914|FG000|NOT COMPLETED|Overall Study||3
10221051|NCT04126174|11348915|FG001|NOT COMPLETED|Overall Study||3
10221052|NCT04134429|11348921|FG000|STARTED|Overall Study||20
10221053|NCT04134429|11348921|FG000|COMPLETED|Overall Study||19
10221054|NCT04134429|11348921|FG000|NOT COMPLETED|Overall Study||1
10221055|NCT04130425|11348925|FG000|STARTED|Overall Study||30
10221056|NCT04130425|11348925|FG000|COMPLETED|Overall Study||30
10221057|NCT04130425|11348925|FG000|NOT COMPLETED|Overall Study||0
10221058|NCT04138498|11348940|FG000|STARTED|Overall Study||11
10221059|NCT04138498|11348941|FG001|STARTED|Overall Study||10
10221060|NCT04138498|11348942|FG002|STARTED|Overall Study||12
10221061|NCT04138498|11348943|FG003|STARTED|Overall Study||12
10221062|NCT04138498|11348940|FG000|COMPLETED|Overall Study||10
10221063|NCT04138498|11348941|FG001|COMPLETED|Overall Study||10
10221064|NCT04138498|11348942|FG002|COMPLETED|Overall Study||10
10221065|NCT04138498|11348943|FG003|COMPLETED|Overall Study||9
10221066|NCT04138498|11348940|FG000|NOT COMPLETED|Overall Study||1
10221067|NCT04138498|11348941|FG001|NOT COMPLETED|Overall Study||0
10221068|NCT04138498|11348942|FG002|NOT COMPLETED|Overall Study||2
10221069|NCT04138498|11348943|FG003|NOT COMPLETED|Overall Study||3
10221070|NCT04138043|11348959|FG000|STARTED|Overall Study||2
10221071|NCT04138043|11348960|FG001|STARTED|Overall Study||7
10221072|NCT04138043|11348959|FG000|COMPLETED|Overall Study||2
10221073|NCT04138043|11348960|FG001|COMPLETED|Overall Study||6
10221074|NCT04138043|11348959|FG000|NOT COMPLETED|Overall Study||0
10221075|NCT04138043|11348960|FG001|NOT COMPLETED|Overall Study||1
10221076|NCT04137627|11348969|FG000|STARTED|Overall Study||25
10221077|NCT04137627|11348970|FG001|STARTED|Overall Study||25
10221078|NCT04137627|11348969|FG000|COMPLETED|Overall Study||13
10221079|NCT04137627|11348970|FG001|COMPLETED|Overall Study||12
10221080|NCT04137627|11348969|FG000|NOT COMPLETED|Overall Study||12
10221081|NCT04137627|11348970|FG001|NOT COMPLETED|Overall Study||13
10221082|NCT04136145|11348978|FG000|STARTED|Overall Study||12
10221083|NCT04136145|11348979|FG001|STARTED|Overall Study||24
10221084|NCT04136145|11348978|FG000|COMPLETED|Overall Study||12
10221085|NCT04136145|11348979|FG001|COMPLETED|Overall Study||24
10221086|NCT04136145|11348978|FG000|NOT COMPLETED|Overall Study||0
10221087|NCT04136145|11348979|FG001|NOT COMPLETED|Overall Study||0
10221088|NCT04132336|11348993|FG000|STARTED|Overall Study||32
10221089|NCT04132336|11348994|FG001|STARTED|Overall Study||32
10221090|NCT04132336|11348995|FG002|STARTED|Overall Study||32
10221091|NCT04132336|11348996|FG003|STARTED|Overall Study||32
10221092|NCT04132336|11348997|FG004|STARTED|Overall Study||32
10221093|NCT04132336|11348998|FG005|STARTED|Overall Study||16
10221094|NCT04132336|11348999|FG006|STARTED|Overall Study||17
10221095|NCT04132336|11348993|FG000|COMPLETED|Overall Study||32
10221096|NCT04132336|11348994|FG001|COMPLETED|Overall Study||31
10221097|NCT04132336|11348995|FG002|COMPLETED|Overall Study||32
10221098|NCT04132336|11348996|FG003|COMPLETED|Overall Study||32
10221099|NCT04132336|11348997|FG004|COMPLETED|Overall Study||32
10221100|NCT04132336|11348998|FG005|COMPLETED|Overall Study||16
10221101|NCT04132336|11348999|FG006|COMPLETED|Overall Study||17
10221102|NCT04132336|11348993|FG000|NOT COMPLETED|Overall Study||0
10221103|NCT04132336|11348994|FG001|NOT COMPLETED|Overall Study||1
10221104|NCT04132336|11348995|FG002|NOT COMPLETED|Overall Study||0
10221105|NCT04132336|11348996|FG003|NOT COMPLETED|Overall Study||0
10221106|NCT04132336|11348997|FG004|NOT COMPLETED|Overall Study||0
10221107|NCT04132336|11348998|FG005|NOT COMPLETED|Overall Study||0
10221108|NCT04132336|11348999|FG006|NOT COMPLETED|Overall Study||0
10221109|NCT04131517|11349017|FG000|STARTED|Overall Study||7
10221110|NCT04131517|11349018|FG001|STARTED|Overall Study||7
10221111|NCT04131517|11349017|FG000|COMPLETED|Overall Study||7
10221112|NCT04131517|11349018|FG001|COMPLETED|Overall Study||7
10221113|NCT04131517|11349017|FG000|NOT COMPLETED|Overall Study||0
10221114|NCT04131517|11349018|FG001|NOT COMPLETED|Overall Study||0
10221115|NCT04128293|11349039|FG000|STARTED|Treatment Period 1 (1 Day)||4
10221116|NCT04128293|11349040|FG001|STARTED|Treatment Period 1 (1 Day)||4
10221117|NCT04128293|11349041|FG002|STARTED|Treatment Period 1 (1 Day)||4
10221118|NCT04128293|11349042|FG003|STARTED|Treatment Period 1 (1 Day)||4
10221119|NCT04128293|11349039|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
10221120|NCT04128293|11349040|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
10221121|NCT04128293|11349041|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
10221122|NCT04128293|11349042|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
10221123|NCT04128293|11349039|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10221124|NCT04128293|11349040|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10221125|NCT04128293|11349041|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10221126|NCT04128293|11349042|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10221127|NCT04128293|11349039|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4
10221128|NCT04128293|11349040|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4
10221129|NCT04128293|11349041|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4
10221130|NCT04128293|11349042|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4
10221131|NCT04128293|11349039|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10221132|NCT04128293|11349040|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10221133|NCT04128293|11349041|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10221134|NCT04128293|11349042|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10221135|NCT04128293|11349039|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10221136|NCT04128293|11349040|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10221137|NCT04128293|11349041|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10221138|NCT04128293|11349042|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10221139|NCT04128293|11349039|FG000|STARTED|Treatment Period 2 (1 Day)||4
10221140|NCT04128293|11349040|FG001|STARTED|Treatment Period 2 (1 Day)||4
10221141|NCT04128293|11349041|FG002|STARTED|Treatment Period 2 (1 Day)||4
10221142|NCT04128293|11349042|FG003|STARTED|Treatment Period 2 (1 Day)||4
10221143|NCT04128293|11349039|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
10221144|NCT04128293|11349040|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
10221145|NCT04128293|11349041|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
10221146|NCT04128293|11349042|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
10221147|NCT04128293|11349039|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10221148|NCT04128293|11349040|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10221149|NCT04128293|11349041|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10221150|NCT04128293|11349042|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10221151|NCT04128293|11349039|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4
10221152|NCT04128293|11349040|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4
10221153|NCT04128293|11349041|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4
10221154|NCT04128293|11349042|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4
10221155|NCT04128293|11349039|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10221156|NCT04128293|11349040|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10221157|NCT04128293|11349041|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10221158|NCT04128293|11349042|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10221159|NCT04128293|11349039|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10221160|NCT04128293|11349040|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10221161|NCT04128293|11349041|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10221162|NCT04128293|11349042|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10221163|NCT04128293|11349039|FG000|STARTED|Treatment Period 3 (1 Day)||0
10221164|NCT04128293|11349040|FG001|STARTED|Treatment Period 3 (1 Day)||0
10221165|NCT04128293|11349041|FG002|STARTED|Treatment Period 3 (1 Day)||0
10221166|NCT04128293|11349042|FG003|STARTED|Treatment Period 3 (1 Day)||0
10221167|NCT04128293|11349039|FG000|COMPLETED|Treatment Period 3 (1 Day)||0
10221168|NCT04128293|11349040|FG001|COMPLETED|Treatment Period 3 (1 Day)||0
10221169|NCT04128293|11349041|FG002|COMPLETED|Treatment Period 3 (1 Day)||0
10221170|NCT04128293|11349042|FG003|COMPLETED|Treatment Period 3 (1 Day)||0
10221171|NCT04128293|11349039|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10221172|NCT04128293|11349040|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10221173|NCT04128293|11349041|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10221174|NCT04128293|11349042|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10221175|NCT04128293|11349039|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0
10221176|NCT04128293|11349040|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0
10221177|NCT04128293|11349041|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0
10221178|NCT04128293|11349042|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0
10221179|NCT04128293|11349039|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221180|NCT04128293|11349040|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221181|NCT04128293|11349041|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221182|NCT04128293|11349042|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221183|NCT04128293|11349039|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221184|NCT04128293|11349040|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221185|NCT04128293|11349041|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221186|NCT04128293|11349042|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10221187|NCT04128293|11349039|FG000|STARTED|Treatment Period 4 (1 Day)||0
10221188|NCT04128293|11349040|FG001|STARTED|Treatment Period 4 (1 Day)||0
10221189|NCT04128293|11349041|FG002|STARTED|Treatment Period 4 (1 Day)||0
10221190|NCT04128293|11349042|FG003|STARTED|Treatment Period 4 (1 Day)||0
10221191|NCT04128293|11349039|FG000|COMPLETED|Treatment Period 4 (1 Day)||0
10221192|NCT04128293|11349040|FG001|COMPLETED|Treatment Period 4 (1 Day)||0
10221193|NCT04128293|11349041|FG002|COMPLETED|Treatment Period 4 (1 Day)||0
10221194|NCT04128293|11349042|FG003|COMPLETED|Treatment Period 4 (1 Day)||0
10221195|NCT04128293|11349039|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10221196|NCT04128293|11349040|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10221197|NCT04128293|11349041|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10221198|NCT04128293|11349042|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10221199|NCT04126343|11349063|FG000|STARTED|Overall Study||9
10221200|NCT04126343|11349064|FG001|STARTED|Overall Study||9
10221201|NCT04126343|11349065|FG002|STARTED|Overall Study||9
10221202|NCT04126343|11349066|FG003|STARTED|Overall Study||9
10221203|NCT04126343|11349067|FG004|STARTED|Overall Study||9
10221204|NCT04126343|11349068|FG005|STARTED|Overall Study||9
10221205|NCT04126343|11349063|FG000|Completed Padsevonil Period|Overall Study||9
10221206|NCT04126343|11349064|FG001|Completed Padsevonil Period|Overall Study||9
10221207|NCT04126343|11349065|FG002|Completed Padsevonil Period|Overall Study||9
10221208|NCT04126343|11349066|FG003|Completed Padsevonil Period|Overall Study||7
10221209|NCT04126343|11349067|FG004|Completed Padsevonil Period|Overall Study||9
10221210|NCT04126343|11349068|FG005|Completed Padsevonil Period|Overall Study||8
10221211|NCT04126343|11349063|FG000|Completed Placebo Period|Overall Study||9
10012554|NCT01786512|11135397|FG001|STARTED|Overall Study||11
10012555|NCT01786512|11135398|FG002|STARTED|Overall Study||14
10012556|NCT01786512|11135399|FG003|STARTED|Overall Study||13
10012557|NCT01786512|11135400|FG004|STARTED|Overall Study||10
10012558|NCT01786512|11135401|FG005|STARTED|Overall Study||11
10012559|NCT01786512|11135402|FG006|STARTED|Overall Study||12
10012560|NCT01786512|11135403|FG007|STARTED|Overall Study||14
10012561|NCT01786512|11135404|FG008|STARTED|Overall Study||149
10012562|NCT01786512|11135405|FG009|STARTED|Overall Study||150
10012563|NCT01786512|11135406|FG010|STARTED|Overall Study||149
10012564|NCT01786512|11135396|FG000|Received Study Treatment|Overall Study||11
10012565|NCT01786512|11135397|FG001|Received Study Treatment|Overall Study||10
10012566|NCT01786512|11135398|FG002|Received Study Treatment|Overall Study||14
10012567|NCT01786512|11135399|FG003|Received Study Treatment|Overall Study||13
10012568|NCT01786512|11135400|FG004|Received Study Treatment|Overall Study||10
10012569|NCT01786512|11135401|FG005|Received Study Treatment|Overall Study||11
10012570|NCT01786512|11135402|FG006|Received Study Treatment|Overall Study||11
10012571|NCT01786512|11135403|FG007|Received Study Treatment|Overall Study||14
10012572|NCT01786512|11135404|FG008|Received Study Treatment|Overall Study||149
10012573|NCT01786512|11135405|FG009|Received Study Treatment|Overall Study||150
10012574|NCT01786512|11135406|FG010|Received Study Treatment|Overall Study||146
10012575|NCT01786512|11135396|FG000|COMPLETED|Overall Study||11
10012576|NCT01786512|11135397|FG001|COMPLETED|Overall Study||10
10012577|NCT01786512|11135398|FG002|COMPLETED|Overall Study||14
10012578|NCT01786512|11135399|FG003|COMPLETED|Overall Study||13
10012579|NCT01786512|11135400|FG004|COMPLETED|Overall Study||10
10012580|NCT01786512|11135401|FG005|COMPLETED|Overall Study||11
10012581|NCT01786512|11135402|FG006|COMPLETED|Overall Study||11
10012582|NCT01786512|11135403|FG007|COMPLETED|Overall Study||14
10012583|NCT01786512|11135404|FG008|COMPLETED|Overall Study||145
10012584|NCT01786512|11135405|FG009|COMPLETED|Overall Study||145
10012585|NCT01786512|11135406|FG010|COMPLETED|Overall Study||137
10221212|NCT04126343|11349064|FG001|Completed Placebo Period|Overall Study||7
10221213|NCT04126343|11349065|FG002|Completed Placebo Period|Overall Study||9
10221214|NCT04126343|11349066|FG003|Completed Placebo Period|Overall Study||9
10221215|NCT04126343|11349067|FG004|Completed Placebo Period|Overall Study||7
10221216|NCT04126343|11349068|FG005|Completed Placebo Period|Overall Study||9
10221217|NCT04126343|11349063|FG000|Completed Moxifloxacin Period|Overall Study||8
10221218|NCT04126343|11349064|FG001|Completed Moxifloxacin Period|Overall Study||9
10221219|NCT04126343|11349065|FG002|Completed Moxifloxacin Period|Overall Study||7
10221220|NCT04126343|11349066|FG003|Completed Moxifloxacin Period|Overall Study||9
10221221|NCT04126343|11349067|FG004|Completed Moxifloxacin Period|Overall Study||9
10221222|NCT04126343|11349068|FG005|Completed Moxifloxacin Period|Overall Study||9
10221223|NCT04126343|11349063|FG000|COMPLETED|Overall Study||6
10221224|NCT04126343|11349064|FG001|COMPLETED|Overall Study||5
10221225|NCT04126343|11349065|FG002|COMPLETED|Overall Study||6
10221226|NCT04126343|11349066|FG003|COMPLETED|Overall Study||5
10221227|NCT04126343|11349067|FG004|COMPLETED|Overall Study||6
10221228|NCT04126343|11349068|FG005|COMPLETED|Overall Study||5
10221229|NCT04126343|11349063|FG000|NOT COMPLETED|Overall Study||3
10221230|NCT04126343|11349064|FG001|NOT COMPLETED|Overall Study||4
10221231|NCT04126343|11349065|FG002|NOT COMPLETED|Overall Study||3
10221232|NCT04126343|11349066|FG003|NOT COMPLETED|Overall Study||4
10012586|NCT01786512|11135396|FG000|NOT COMPLETED|Overall Study||0
10012587|NCT01786512|11135397|FG001|NOT COMPLETED|Overall Study||1
10012588|NCT01786512|11135398|FG002|NOT COMPLETED|Overall Study||0
10012589|NCT01786512|11135399|FG003|NOT COMPLETED|Overall Study||0
10012590|NCT01786512|11135400|FG004|NOT COMPLETED|Overall Study||0
10012591|NCT01786512|11135401|FG005|NOT COMPLETED|Overall Study||0
10012592|NCT01786512|11135402|FG006|NOT COMPLETED|Overall Study||1
10012593|NCT01786512|11135403|FG007|NOT COMPLETED|Overall Study||0
10012594|NCT01786512|11135404|FG008|NOT COMPLETED|Overall Study||4
10221233|NCT04126343|11349067|FG004|NOT COMPLETED|Overall Study||3
10221234|NCT04126343|11349068|FG005|NOT COMPLETED|Overall Study||4
10221235|NCT04126187|11349083|FG000|STARTED|Overall Study||30
10221236|NCT04126187|11349083|FG000|COMPLETED|Overall Study||30
10221237|NCT04126187|11349083|FG000|NOT COMPLETED|Overall Study||0
10221238|NCT04124952|11349087|FG000|STARTED|Overall Study||30
10221239|NCT04124952|11349087|FG000|COMPLETED|Overall Study||29
10012595|NCT01786512|11135405|FG009|NOT COMPLETED|Overall Study||5
10012596|NCT01786512|11135406|FG010|NOT COMPLETED|Overall Study||12
10221240|NCT04124952|11349087|FG000|NOT COMPLETED|Overall Study||1
10221241|NCT04123665|11349093|FG000|STARTED|Overall Study||50
10221242|NCT04123665|11349094|FG001|STARTED|Overall Study||48
10221243|NCT04123665|11349093|FG000|COMPLETED|Overall Study||42
10221244|NCT04123665|11349094|FG001|COMPLETED|Overall Study||48
10221245|NCT04123665|11349093|FG000|NOT COMPLETED|Overall Study||8
10221246|NCT04123665|11349094|FG001|NOT COMPLETED|Overall Study||0
10221247|NCT04122534|11349100|FG000|STARTED|Overall Study||48
10221248|NCT04122534|11349100|FG000|COMPLETED|Overall Study||44
10221249|NCT04122534|11349100|FG000|NOT COMPLETED|Overall Study||4
10221250|NCT04121078|11349106|FG000|STARTED|Study Period 1 (1 Day)||6
10221251|NCT04121078|11349107|FG001|STARTED|Study Period 1 (1 Day)||6
10221252|NCT04121078|11349106|FG000|COMPLETED|Study Period 1 (1 Day)||6
10221253|NCT04121078|11349107|FG001|COMPLETED|Study Period 1 (1 Day)||6
10221254|NCT04121078|11349106|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0
10221255|NCT04121078|11349107|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0
10221256|NCT04121078|11349106|FG000|STARTED|Washout Period (at Least 7 Days)||6
10221257|NCT04121078|11349107|FG001|STARTED|Washout Period (at Least 7 Days)||6
10221258|NCT04121078|11349106|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
10221259|NCT04121078|11349107|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
10221260|NCT04121078|11349106|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10221261|NCT04121078|11349107|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10221262|NCT04121078|11349106|FG000|STARTED|Study Period 2 (1 Day)||6
10221263|NCT04121078|11349107|FG001|STARTED|Study Period 2 (1 Day)||6
10221264|NCT04121078|11349106|FG000|COMPLETED|Study Period 2 (1 Day)||6
10221265|NCT04121078|11349107|FG001|COMPLETED|Study Period 2 (1 Day)||6
10221266|NCT04121078|11349106|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0
10221267|NCT04121078|11349107|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0
10221268|NCT04117607|11349116|FG000|STARTED|Overall Study||3
10221269|NCT04117607|11349117|FG001|STARTED|Overall Study||7
10221270|NCT04117607|11349118|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10012597|NCT01786551|11135438|FG000|STARTED|Overall Study||16
10012598|NCT01786551|11135438|FG000|COMPLETED|Overall Study||14
10012599|NCT01786551|11135438|FG000|NOT COMPLETED|Overall Study||2
10012600|NCT01786564|11135442|FG000|STARTED|Overall Study||120
10012601|NCT01786564|11135442|FG000|COMPLETED|Overall Study||56
10012602|NCT01786564|11135442|FG000|NOT COMPLETED|Overall Study||64
10221271|NCT04117607|11349119|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221272|NCT04117607|11349120|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221273|NCT04117607|11349121|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221274|NCT04117607|11349122|FG006|STARTED|Overall Study||4
10221275|NCT04117607|11349123|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221276|NCT04117607|11349124|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221277|NCT04117607|11349125|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221278|NCT04117607|11349126|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221279|NCT04117607|11349127|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221280|NCT04117607|11349128|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221281|NCT04117607|11349129|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10221282|NCT04117607|11349116|FG000|Received Study Product|Overall Study||3
10221283|NCT04117607|11349117|FG001|Received Study Product|Overall Study||6
10221284|NCT04117607|11349118|FG002|Received Study Product|Overall Study||0
10221285|NCT04117607|11349119|FG003|Received Study Product|Overall Study||0
10221286|NCT04117607|11349120|FG004|Received Study Product|Overall Study||0
10221287|NCT04117607|11349121|FG005|Received Study Product|Overall Study||0
10221288|NCT04117607|11349122|FG006|Received Study Product|Overall Study||3
10221289|NCT04117607|11349123|FG007|Received Study Product|Overall Study||0
10221290|NCT04117607|11349124|FG008|Received Study Product|Overall Study||0
10221291|NCT04117607|11349125|FG009|Received Study Product|Overall Study||0
10221292|NCT04117607|11349126|FG010|Received Study Product|Overall Study||0
10221293|NCT04117607|11349127|FG011|Received Study Product|Overall Study||0
10221294|NCT04117607|11349128|FG012|Received Study Product|Overall Study||0
10221295|NCT04117607|11349129|FG013|Received Study Product|Overall Study||0
10221296|NCT04117607|11349116|FG000|Completed All PK Blood Draws|Overall Study||0
10221297|NCT04117607|11349117|FG001|Completed All PK Blood Draws|Overall Study||6
10221298|NCT04117607|11349118|FG002|Completed All PK Blood Draws|Overall Study||0
10221299|NCT04117607|11349119|FG003|Completed All PK Blood Draws|Overall Study||0
10221300|NCT04117607|11349120|FG004|Completed All PK Blood Draws|Overall Study||0
10221301|NCT04117607|11349121|FG005|Completed All PK Blood Draws|Overall Study||0
10221302|NCT04117607|11349122|FG006|Completed All PK Blood Draws|Overall Study||1
10012603|NCT01786603|11135448|FG000|STARTED|Overall Study||60
10012604|NCT01786603|11135449|FG001|STARTED|Overall Study||20
10012605|NCT01786603|11135448|FG000|COMPLETED|Overall Study||42
10221303|NCT04117607|11349123|FG007|Completed All PK Blood Draws|Overall Study||0
10221304|NCT04117607|11349124|FG008|Completed All PK Blood Draws|Overall Study||0
10221305|NCT04117607|11349125|FG009|Completed All PK Blood Draws|Overall Study||0
10221306|NCT04117607|11349126|FG010|Completed All PK Blood Draws|Overall Study||0
10221307|NCT04117607|11349127|FG011|Completed All PK Blood Draws|Overall Study||0
10221308|NCT04117607|11349128|FG012|Completed All PK Blood Draws|Overall Study||0
10221309|NCT04117607|11349129|FG013|Completed All PK Blood Draws|Overall Study||0
10221310|NCT04117607|11349116|FG000|COMPLETED|Overall Study||3
10221311|NCT04117607|11349117|FG001|COMPLETED|Overall Study||6
10221312|NCT04117607|11349118|FG002|COMPLETED|Overall Study||0
10221313|NCT04117607|11349119|FG003|COMPLETED|Overall Study||0
10221314|NCT04117607|11349120|FG004|COMPLETED|Overall Study||0
10221315|NCT04117607|11349121|FG005|COMPLETED|Overall Study||0
10221316|NCT04117607|11349122|FG006|COMPLETED|Overall Study||3
10221317|NCT04117607|11349123|FG007|COMPLETED|Overall Study||0
10221318|NCT04117607|11349124|FG008|COMPLETED|Overall Study||0
10221319|NCT04117607|11349125|FG009|COMPLETED|Overall Study||0
10221320|NCT04117607|11349126|FG010|COMPLETED|Overall Study||0
10221321|NCT04117607|11349127|FG011|COMPLETED|Overall Study||0
10221322|NCT04117607|11349128|FG012|COMPLETED|Overall Study||0
10221323|NCT04117607|11349129|FG013|COMPLETED|Overall Study||0
10221324|NCT04117607|11349116|FG000|NOT COMPLETED|Overall Study||0
10221325|NCT04117607|11349117|FG001|NOT COMPLETED|Overall Study||1
10221326|NCT04117607|11349118|FG002|NOT COMPLETED|Overall Study||0
10221327|NCT04117607|11349119|FG003|NOT COMPLETED|Overall Study||0
10221328|NCT04117607|11349120|FG004|NOT COMPLETED|Overall Study||0
10221329|NCT04117607|11349121|FG005|NOT COMPLETED|Overall Study||0
10221330|NCT04117607|11349122|FG006|NOT COMPLETED|Overall Study||1
10221331|NCT04117607|11349123|FG007|NOT COMPLETED|Overall Study||0
10221332|NCT04117607|11349124|FG008|NOT COMPLETED|Overall Study||0
10221333|NCT04117607|11349125|FG009|NOT COMPLETED|Overall Study||0
10221334|NCT04117607|11349126|FG010|NOT COMPLETED|Overall Study||0
10221335|NCT04117607|11349127|FG011|NOT COMPLETED|Overall Study||0
10221336|NCT04117607|11349128|FG012|NOT COMPLETED|Overall Study||0
10221337|NCT04117607|11349129|FG013|NOT COMPLETED|Overall Study||0
10221338|NCT04116684|11349147|FG000|STARTED|Overall Study||3
10221339|NCT04116684|11349148|FG001|STARTED|Overall Study||1
10221340|NCT04116684|11349147|FG000|COMPLETED|Overall Study||1
10221341|NCT04116684|11349148|FG001|COMPLETED|Overall Study||1
10221342|NCT04116684|11349147|FG000|NOT COMPLETED|Overall Study||2
10221343|NCT04116684|11349148|FG001|NOT COMPLETED|Overall Study||0
10221344|NCT04096365|11349154|FG000|STARTED|Overall Study||12
10221345|NCT04096365|11349154|FG000|COMPLETED|Overall Study||11
10221346|NCT04096365|11349154|FG000|NOT COMPLETED|Overall Study||1
10221347|NCT04080297|11349160|FG000|STARTED|Overall Study||10
10221348|NCT04080297|11349161|FG001|STARTED|Overall Study||11
10221349|NCT04080297|11349160|FG000|COMPLETED|Overall Study||8
10221350|NCT04080297|11349161|FG001|COMPLETED|Overall Study||8
10221351|NCT04080297|11349160|FG000|NOT COMPLETED|Overall Study||2
10221352|NCT04080297|11349161|FG001|NOT COMPLETED|Overall Study||3
10221353|NCT04115358|11349170|FG000|STARTED|Overall Study||34
10221354|NCT04115358|11349171|FG001|STARTED|Overall Study||33
10221355|NCT04115358|11349172|FG002|STARTED|Overall Study||34
10221356|NCT04115358|11349170|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
10221357|NCT04115358|11349171|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
10221358|NCT04115358|11349172|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
10221359|NCT04115358|11349170|FG000|NOT COMPLETED|Overall Study||0
10221360|NCT04115358|11349171|FG001|NOT COMPLETED|Overall Study||0
10221361|NCT04115358|11349172|FG002|NOT COMPLETED|Overall Study||1
10221362|NCT04114058|11349183|FG000|STARTED|Overall Study||20
10221363|NCT04114058|11349184|FG001|STARTED|Overall Study||17
10221364|NCT04114058|11349183|FG000|COMPLETED|Overall Study||20
10221365|NCT04114058|11349184|FG001|COMPLETED|Overall Study||17
10221366|NCT04114058|11349183|FG000|NOT COMPLETED|Overall Study||0
10221367|NCT04114058|11349184|FG001|NOT COMPLETED|Overall Study||0
10221368|NCT04113785|11349190|FG000|STARTED|Overall Study||21
10221369|NCT04113785|11349190|FG000|COMPLETED|Overall Study||21
10221370|NCT04113785|11349190|FG000|NOT COMPLETED|Overall Study||0
10221371|NCT04113694|11349196|FG000|STARTED|Overall Study||259
10221372|NCT04113694|11349196|FG000|COMPLETED|Overall Study||248
10221373|NCT04113694|11349196|FG000|NOT COMPLETED|Overall Study||11
10239193|NCT00333762|11370723|FG000|STARTED|Overall Study||4
10239194|NCT00333762|11370723|FG000|COMPLETED|Overall Study||0
10239195|NCT00333762|11370723|FG000|NOT COMPLETED|Overall Study||4
10239196|NCT00333229|11370729|FG000|STARTED|Overall Study||6
10239197|NCT00333229|11370730|FG001|STARTED|Overall Study||5
10239198|NCT00333229|11370729|FG000|COMPLETED|Overall Study||6
10239199|NCT00333229|11370730|FG001|COMPLETED|Overall Study||4
10239200|NCT00333229|11370729|FG000|NOT COMPLETED|Overall Study||0
10239201|NCT00333229|11370730|FG001|NOT COMPLETED|Overall Study||1
10239202|NCT00322855|11370736|FG000|STARTED|Overall Study||1
10239203|NCT00322855|11370736|FG000|COMPLETED|Overall Study||1
10239204|NCT00322855|11370736|FG000|NOT COMPLETED|Overall Study||0
10239205|NCT00323635|11370742|FG000|STARTED|Overall Study||10
10239206|NCT00323635|11370743|FG001|STARTED|Overall Study||9
10239207|NCT00323635|11370742|FG000|COMPLETED|Overall Study||10
10239208|NCT00323635|11370743|FG001|COMPLETED|Overall Study||9
10239209|NCT00323635|11370742|FG000|NOT COMPLETED|Overall Study||0
10239210|NCT00323635|11370743|FG001|NOT COMPLETED|Overall Study||0
10239211|NCT00329732|11370753|FG000|STARTED|Overall Study||2
10239212|NCT00329732|11370754|FG001|STARTED|Overall Study||0
10239213|NCT00329732|11370753|FG000|COMPLETED|Overall Study||2
10239214|NCT00329732|11370754|FG001|COMPLETED|Overall Study||0
10239215|NCT00329732|11370753|FG000|NOT COMPLETED|Overall Study||0
10239216|NCT00329732|11370754|FG001|NOT COMPLETED|Overall Study||0
10239217|NCT00320931|11370759|FG000|STARTED|Overall Study||30
10239218|NCT00320931|11370759|FG000|COMPLETED|Overall Study||30
10239219|NCT00320931|11370759|FG000|NOT COMPLETED|Overall Study||0
10239220|NCT00314353|11370765|FG000|STARTED|Protocol Therapy (8 Cycles)||4
10239221|NCT00314353|11370766|FG001|STARTED|Protocol Therapy (8 Cycles)||3
10239222|NCT00314353|11370765|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
10239223|NCT00314353|11370766|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
10239224|NCT00314353|11370765|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
10239225|NCT00314353|11370766|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
10239226|NCT00314353|11370765|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
10239227|NCT00314353|11370766|FG001|STARTED|Follow-up||0
10239228|NCT00314353|11370765|FG000|COMPLETED|Follow-up||3
10239229|NCT00314353|11370766|FG001|COMPLETED|Follow-up||0
10239230|NCT00314353|11370765|FG000|NOT COMPLETED|Follow-up||0
10239231|NCT00314353|11370766|FG001|NOT COMPLETED|Follow-up||0
10239232|NCT00314093|11370772|FG000|STARTED|Overall Study||0
10239233|NCT00314093|11370772|FG000|COMPLETED|Overall Study||0
10239234|NCT00314093|11370772|FG000|NOT COMPLETED|Overall Study||0
10239235|NCT00314327|11370776|FG000|STARTED|Overall Study||1
10239236|NCT00314327|11370776|FG000|COMPLETED|Overall Study||0
10239237|NCT00314327|11370776|FG000|NOT COMPLETED|Overall Study||1
10239238|NCT00308113|11370784|FG000|STARTED|Overall Study||0
10239239|NCT00308113|11370785|FG001|STARTED|Overall Study||0
10239240|NCT00308113|11370786|FG002|STARTED|Overall Study||1
10239241|NCT00308113|11370787|FG003|STARTED|Overall Study||2
10239242|NCT00308113|11370784|FG000|COMPLETED|Overall Study||0
10221374|NCT04112160|11349205|FG000|STARTED|Overall Study||63
10221375|NCT04112160|11349206|FG001|STARTED|Overall Study||62
10221376|NCT04112160|11349205|FG000|COMPLETED|Overall Study||62
10221377|NCT04112160|11349206|FG001|COMPLETED|Overall Study||62
10221378|NCT04112160|11349205|FG000|NOT COMPLETED|Overall Study||1
10221379|NCT04112160|11349206|FG001|NOT COMPLETED|Overall Study||0
10221380|NCT04112069|11349212|FG000|STARTED|Overall Study||10
10221381|NCT04112069|11349213|FG001|STARTED|Overall Study||10
10221382|NCT04112069|11349212|FG000|COMPLETED|Overall Study||10
10221383|NCT04112069|11349213|FG001|COMPLETED|Overall Study||10
10221384|NCT04112069|11349212|FG000|NOT COMPLETED|Overall Study||0
10221385|NCT04112069|11349213|FG001|NOT COMPLETED|Overall Study||0
10221386|NCT04109703|11349221|FG000|STARTED|Overall Study||49
10221387|NCT04109703|11349222|FG001|STARTED|Overall Study||51
10221388|NCT04109703|11349221|FG000|COMPLETED|Overall Study||49
10221389|NCT04109703|11349222|FG001|COMPLETED|Overall Study||51
10221390|NCT04109703|11349221|FG000|NOT COMPLETED|Overall Study||0
10221391|NCT04109703|11349222|FG001|NOT COMPLETED|Overall Study||0
10221392|NCT04109443|11349232|FG000|STARTED|Overall Study||77
10221393|NCT04109443|11349233|FG001|STARTED|Overall Study||77
10221394|NCT04109443|11349232|FG000|COMPLETED|Overall Study||67
10221395|NCT04109443|11349233|FG001|COMPLETED|Overall Study||65
10221396|NCT04109443|11349232|FG000|NOT COMPLETED|Overall Study||10
10221397|NCT04109443|11349233|FG001|NOT COMPLETED|Overall Study||12
10221398|NCT04107493|11349242|FG000|STARTED|First Intervention (1 Hour)||16
10221399|NCT04107493|11349243|FG001|STARTED|First Intervention (1 Hour)||17
10221400|NCT04107493|11349242|FG000|COMPLETED|First Intervention (1 Hour)||16
10221401|NCT04107493|11349243|FG001|COMPLETED|First Intervention (1 Hour)||17
10221402|NCT04107493|11349242|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
10221403|NCT04107493|11349243|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
10221404|NCT04107493|11349242|FG000|STARTED|Washout (One Hour)||16
10221405|NCT04107493|11349243|FG001|STARTED|Washout (One Hour)||17
10221406|NCT04107493|11349242|FG000|COMPLETED|Washout (One Hour)||16
10221407|NCT04107493|11349243|FG001|COMPLETED|Washout (One Hour)||17
10221408|NCT04107493|11349242|FG000|NOT COMPLETED|Washout (One Hour)||0
10221409|NCT04107493|11349243|FG001|NOT COMPLETED|Washout (One Hour)||0
10221410|NCT04107493|11349242|FG000|STARTED|Second Intervention||16
10221411|NCT04107493|11349243|FG001|STARTED|Second Intervention||17
10221412|NCT04107493|11349242|FG000|COMPLETED|Second Intervention||16
10221413|NCT04107493|11349243|FG001|COMPLETED|Second Intervention||17
10221414|NCT04107493|11349242|FG000|NOT COMPLETED|Second Intervention||0
10221415|NCT04107493|11349243|FG001|NOT COMPLETED|Second Intervention||0
10221416|NCT04106817|11349252|FG000|STARTED|Overall Study||12
10221417|NCT04106817|11349253|FG001|STARTED|Overall Study||11
10221418|NCT04106817|11349254|FG002|STARTED|Overall Study||12
10221419|NCT04106817|11349252|FG000|COMPLETED|Overall Study||11
10221420|NCT04106817|11349253|FG001|COMPLETED|Overall Study||11
10221421|NCT04106817|11349254|FG002|COMPLETED|Overall Study||12
10221422|NCT04106817|11349252|FG000|NOT COMPLETED|Overall Study||1
10221423|NCT04106817|11349253|FG001|NOT COMPLETED|Overall Study||0
10221424|NCT04106817|11349254|FG002|NOT COMPLETED|Overall Study||0
10221425|NCT04105972|11349264|FG000|STARTED|Overall Study||88
10221426|NCT04105972|11349265|FG001|STARTED|Overall Study||87
10221427|NCT04105972|11349264|FG000|COMPLETED|Overall Study||86
10221428|NCT04105972|11349265|FG001|COMPLETED|Overall Study||86
10221429|NCT04105972|11349264|FG000|NOT COMPLETED|Overall Study||2
10221430|NCT04105972|11349265|FG001|NOT COMPLETED|Overall Study||1
10221431|NCT04105218|11349273|FG000|STARTED|Overall Study||6
10221432|NCT04105218|11349274|FG001|STARTED|Overall Study||6
10221433|NCT04105218|11349273|FG000|Completed First Condition|Overall Study||0
10221434|NCT04105218|11349274|FG001|Completed First Condition|Overall Study||1
10221435|NCT04105218|11349273|FG000|Completed Second Condition|Overall Study||0
10221436|NCT04105218|11349274|FG001|Completed Second Condition|Overall Study||0
10221437|NCT04105218|11349273|FG000|COMPLETED|Overall Study||0
10221438|NCT04105218|11349274|FG001|COMPLETED|Overall Study||0
10221439|NCT04105218|11349273|FG000|NOT COMPLETED|Overall Study||6
10221440|NCT04105218|11349274|FG001|NOT COMPLETED|Overall Study||6
10221441|NCT04102956|11349282|FG000|STARTED|Overall Study||42
10221442|NCT04102956|11349283|FG001|STARTED|Overall Study||38
10221443|NCT04102956|11349282|FG000|COMPLETED|Overall Study||42
10221444|NCT04102956|11349283|FG001|COMPLETED|Overall Study||38
10221445|NCT04102956|11349282|FG000|NOT COMPLETED|Overall Study||0
10221446|NCT04102956|11349283|FG001|NOT COMPLETED|Overall Study||0
10221447|NCT04102540|11349289|FG000|STARTED|Overall Study||32
10221448|NCT04102540|11349289|FG000|COMPLETED|Overall Study||24
10221449|NCT04102540|11349289|FG000|NOT COMPLETED|Overall Study||8
10221450|NCT04102345|11349295|FG000|STARTED|Overall Study||26
10221451|NCT04102345|11349296|FG001|STARTED|Overall Study||32
10221452|NCT04102345|11349295|FG000|COMPLETED|Overall Study||25
10221453|NCT04102345|11349296|FG001|COMPLETED|Overall Study||32
10221454|NCT04102345|11349295|FG000|NOT COMPLETED|Overall Study||1
10221455|NCT04102345|11349296|FG001|NOT COMPLETED|Overall Study||0
10221456|NCT04092907|11349304|FG000|STARTED|Overall Study||50
10221457|NCT04092907|11349305|FG001|STARTED|Overall Study||50
10221458|NCT04092907|11349304|FG000|COMPLETED|Overall Study||48
10221459|NCT04092907|11349305|FG001|COMPLETED|Overall Study||50
10221460|NCT04092907|11349304|FG000|NOT COMPLETED|Overall Study||2
10221461|NCT04092907|11349305|FG001|NOT COMPLETED|Overall Study||0
10221462|NCT04089982|11349313|FG000|STARTED|Overall Study||6
10221463|NCT04089982|11349314|FG001|STARTED|Overall Study||5
10221464|NCT04089982|11349313|FG000|COMPLETED|Overall Study||6
10221465|NCT04089982|11349314|FG001|COMPLETED|Overall Study||5
10221466|NCT04089982|11349313|FG000|NOT COMPLETED|Overall Study||0
10221467|NCT04089982|11349314|FG001|NOT COMPLETED|Overall Study||0
10221468|NCT04086433|11349322|FG000|STARTED|Overall Study||17
10221469|NCT04086433|11349323|FG001|STARTED|Overall Study||18
10221470|NCT04086433|11349322|FG000|COMPLETED|Overall Study||17
10221471|NCT04086433|11349323|FG001|COMPLETED|Overall Study||18
10221472|NCT04086433|11349322|FG000|NOT COMPLETED|Overall Study||0
10221473|NCT04086433|11349323|FG001|NOT COMPLETED|Overall Study||0
10221474|NCT04086407|11349329|FG000|STARTED|Overall Study||8
10221475|NCT04086407|11349329|FG000|COMPLETED|Overall Study||8
10221476|NCT04086407|11349329|FG000|NOT COMPLETED|Overall Study||0
10221477|NCT04099277|11349336|FG000|STARTED|Overall Study||2
10221478|NCT04099277|11349336|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10221479|NCT04099277|11349336|FG000|COMPLETED|Overall Study||0
10221480|NCT04099277|11349336|FG000|NOT COMPLETED|Overall Study||2
10221481|NCT04098809|11349342|FG000|STARTED|Overall Study||27
10221482|NCT04098809|11349343|FG001|STARTED|Overall Study||25
10221483|NCT04098809|11349342|FG000|COMPLETED|Overall Study||24
10221484|NCT04098809|11349343|FG001|COMPLETED|Overall Study||21
10221485|NCT04098809|11349342|FG000|NOT COMPLETED|Overall Study||3
10221486|NCT04098809|11349343|FG001|NOT COMPLETED|Overall Study||4
10221487|NCT04098575|11349352|FG000|STARTED|Overall Study||505
10221488|NCT04098575|11349353|FG001|STARTED|Overall Study||2961
10221489|NCT04098575|11349354|FG002|STARTED|Overall Study||6105
10221490|NCT04098575|11349352|FG000|COMPLETED|Overall Study||505
10221491|NCT04098575|11349353|FG001|COMPLETED|Overall Study||2961
10221492|NCT04098575|11349354|FG002|COMPLETED|Overall Study||6105
10221493|NCT04098575|11349352|FG000|NOT COMPLETED|Overall Study||0
10221494|NCT04098575|11349353|FG001|NOT COMPLETED|Overall Study||0
10221495|NCT04098575|11349354|FG002|NOT COMPLETED|Overall Study||0
10221496|NCT04098458|11349362|FG000|STARTED|Overall Study||18
10221497|NCT04098458|11349362|FG000|COMPLETED|Overall Study||14
10221498|NCT04098458|11349362|FG000|NOT COMPLETED|Overall Study||4
10221499|NCT04095286|11349367|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4
10221500|NCT04095286|11349368|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5
10221501|NCT04095286|11349369|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5
10221502|NCT04095286|11349370|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5
10221503|NCT04095286|11349371|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5
10221504|NCT04095286|11349372|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5
10221505|NCT04095286|11349367|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
10221506|NCT04095286|11349368|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
10221507|NCT04095286|11349369|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
10221508|NCT04095286|11349370|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
10221509|NCT04095286|11349371|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
10221510|NCT04095286|11349372|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
10221511|NCT04095286|11349367|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
10221512|NCT04095286|11349368|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
10221513|NCT04095286|11349369|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
10221514|NCT04095286|11349370|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
10221515|NCT04095286|11349371|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
10221516|NCT04095286|11349372|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
10221517|NCT04095286|11349367|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3
10221518|NCT04095286|11349368|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4
10221519|NCT04095286|11349369|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4
10221520|NCT04095286|11349370|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5
10221521|NCT04095286|11349371|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5
10221522|NCT04095286|11349372|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5
10221523|NCT04095286|11349367|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
10221524|NCT04095286|11349368|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
10221525|NCT04095286|11349369|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
10221526|NCT04095286|11349370|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
10221527|NCT04095286|11349371|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
10221528|NCT04095286|11349372|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
10221529|NCT04095286|11349367|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10221530|NCT04095286|11349368|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10221531|NCT04095286|11349369|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
10221532|NCT04095286|11349370|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10221533|NCT04095286|11349371|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
10221534|NCT04095286|11349372|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10221535|NCT04095286|11349367|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
10221536|NCT04095286|11349368|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
10221537|NCT04095286|11349369|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
10012606|NCT01786603|11135449|FG001|COMPLETED|Overall Study||8
10012607|NCT01786603|11135448|FG000|NOT COMPLETED|Overall Study||18
10012608|NCT01786603|11135449|FG001|NOT COMPLETED|Overall Study||12
10012609|NCT01786629|11135457|FG000|STARTED|Overall Study||169
10012610|NCT01786629|11135458|FG001|STARTED|Overall Study||169
10221538|NCT04095286|11349370|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
10221539|NCT04095286|11349371|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
10221540|NCT04095286|11349372|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
10012611|NCT01786629|11135457|FG000|COMPLETED|Overall Study||169
10012612|NCT01786629|11135458|FG001|COMPLETED|Overall Study||164
10221541|NCT04095286|11349367|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
10221542|NCT04095286|11349368|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
10221543|NCT04095286|11349369|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
10221544|NCT04095286|11349370|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
10221545|NCT04095286|11349371|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
10221546|NCT04095286|11349372|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
10221547|NCT04095286|11349367|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10221548|NCT04095286|11349368|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10221549|NCT04095286|11349369|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10221550|NCT04095286|11349370|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10221551|NCT04095286|11349371|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10221552|NCT04095286|11349372|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10221553|NCT04094883|11349380|FG000|STARTED|Overall Study||11
10221554|NCT04094883|11349380|FG000|COMPLETED|Overall Study||10
10221555|NCT04094883|11349380|FG000|NOT COMPLETED|Overall Study||1
10221556|NCT04091659|11349386|FG000|STARTED|Overall Study||40
10221557|NCT04091659|11349387|FG001|STARTED|Overall Study||58
10221558|NCT04091659|11349386|FG000|COMPLETED|Overall Study||37
10221559|NCT04091659|11349387|FG001|COMPLETED|Overall Study||57
10221560|NCT04091659|11349386|FG000|NOT COMPLETED|Overall Study||3
10221561|NCT04091659|11349387|FG001|NOT COMPLETED|Overall Study||1
10221562|NCT04091061|11349397|FG000|STARTED|Overall Study||6
10221563|NCT04091061|11349398|FG001|STARTED|Overall Study||6
10221564|NCT04091061|11349399|FG002|STARTED|Overall Study||6
10221565|NCT04091061|11349400|FG003|STARTED|Overall Study||6
10221566|NCT04091061|11349397|FG000|COMPLETED|Overall Study||6
10221567|NCT04091061|11349398|FG001|COMPLETED|Overall Study||6
10221568|NCT04091061|11349399|FG002|COMPLETED|Overall Study||6
10221569|NCT04091061|11349400|FG003|COMPLETED|Overall Study||6
10221570|NCT04091061|11349397|FG000|NOT COMPLETED|Overall Study||0
10221571|NCT04091061|11349398|FG001|NOT COMPLETED|Overall Study||0
10221572|NCT04091061|11349399|FG002|NOT COMPLETED|Overall Study||0
10221573|NCT04091061|11349400|FG003|NOT COMPLETED|Overall Study||0
10221574|NCT04090242|11349412|FG000|STARTED|Overall Study||28
10221575|NCT04090242|11349413|FG001|STARTED|Overall Study||30
10221576|NCT04090242|11349412|FG000|COMPLETED|Overall Study||27
10221577|NCT04090242|11349413|FG001|COMPLETED|Overall Study||30
10221578|NCT04090242|11349412|FG000|NOT COMPLETED|Overall Study||1
10221579|NCT04090242|11349413|FG001|NOT COMPLETED|Overall Study||0
10221580|NCT04089761|11349420|FG000|STARTED|"Run In Phase"||60
10221581|NCT04089761|11349420|FG000|COMPLETED|"Run In Phase"||45
10221582|NCT04089761|11349420|FG000|NOT COMPLETED|"Run In Phase"||15
10221583|NCT04089761|11349420|FG000|STARTED|"Treatment Phase"||45
10221584|NCT04089761|11349420|FG000|COMPLETED|"Treatment Phase"||39
10221585|NCT04089761|11349420|FG000|NOT COMPLETED|"Treatment Phase"||6
10221586|NCT04089761|11349420|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
10221587|NCT04089761|11349420|FG000|COMPLETED|"Follow Up Phase (Optional)"||27
10221588|NCT04089761|11349420|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0
10221589|NCT04079803|11349427|FG000|STARTED|Overall Study||22
10221590|NCT04079803|11349428|FG001|STARTED|Overall Study||21
10221591|NCT04079803|11349429|FG002|STARTED|Overall Study||21
10221592|NCT04079803|11349427|FG000|COMPLETED|Overall Study||22
10221593|NCT04079803|11349428|FG001|COMPLETED|Overall Study||21
10221594|NCT04079803|11349429|FG002|COMPLETED|Overall Study||20
10221595|NCT04079803|11349427|FG000|NOT COMPLETED|Overall Study||0
10221596|NCT04079803|11349428|FG001|NOT COMPLETED|Overall Study||0
10221597|NCT04079803|11349429|FG002|NOT COMPLETED|Overall Study||1
10221598|NCT04086576|11349453|FG000|STARTED|Overall Study||10
10221599|NCT04086576|11349454|FG001|STARTED|Overall Study||10
10221600|NCT04086576|11349453|FG000|COMPLETED|Overall Study||10
10221601|NCT04086576|11349454|FG001|COMPLETED|Overall Study||10
10221602|NCT04086576|11349453|FG000|NOT COMPLETED|Overall Study||0
10221603|NCT04086576|11349454|FG001|NOT COMPLETED|Overall Study||0
10221604|NCT04086641|11349472|FG000|STARTED|Foot 1 (Two Week Utilization)||2
10221605|NCT04086641|11349473|FG001|STARTED|Foot 1 (Two Week Utilization)||3
10221606|NCT04086641|11349472|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1
10221607|NCT04086641|11349473|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1
10221608|NCT04086641|11349472|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
10221609|NCT04086641|11349473|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
10221610|NCT04086641|11349472|FG000|STARTED|Foot 2 (Two Week Utilization)||1
10221611|NCT04086641|11349473|FG001|STARTED|Foot 2 (Two Week Utilization)||1
10221612|NCT04086641|11349472|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1
10221613|NCT04086641|11349473|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1
10221614|NCT04086641|11349472|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
10221615|NCT04086641|11349473|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
10221616|NCT04080882|11349481|FG000|STARTED|Overall Study||20
10221617|NCT04080882|11349482|FG001|STARTED|Overall Study||60
10221618|NCT04080882|11349481|FG000|COMPLETED|Overall Study||18
10221619|NCT04080882|11349482|FG001|COMPLETED|Overall Study||58
10221620|NCT04080882|11349481|FG000|NOT COMPLETED|Overall Study||2
10221621|NCT04080882|11349482|FG001|NOT COMPLETED|Overall Study||2
10221622|NCT04085289|11349491|FG000|STARTED|Overall Study||6
10221623|NCT04085289|11349492|FG001|STARTED|Overall Study||12
10221624|NCT04085289|11349493|FG002|STARTED|Overall Study||12
10221625|NCT04085289|11349491|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10221626|NCT04085289|11349492|FG001|Received at Least One Dose of Study Drug|Overall Study||12
10221627|NCT04085289|11349493|FG002|Received at Least One Dose of Study Drug|Overall Study||12
10221628|NCT04085289|11349491|FG000|COMPLETED|Overall Study||6
10221629|NCT04085289|11349492|FG001|COMPLETED|Overall Study||12
10221630|NCT04085289|11349493|FG002|COMPLETED|Overall Study||11
10221631|NCT04085289|11349491|FG000|NOT COMPLETED|Overall Study||0
10221632|NCT04085289|11349492|FG001|NOT COMPLETED|Overall Study||0
10221633|NCT04085289|11349493|FG002|NOT COMPLETED|Overall Study||1
10221634|NCT04084015|11349500|FG000|STARTED|Overall Study||2
10221635|NCT04084015|11349500|FG000|COMPLETED|Overall Study||2
10221636|NCT04084015|11349500|FG000|NOT COMPLETED|Overall Study||0
10221637|NCT04082663|11349504|FG000|STARTED|Overall Study||20
10221638|NCT04082663|11349504|FG000|COMPLETED|Overall Study||13
10221639|NCT04082663|11349504|FG000|NOT COMPLETED|Overall Study||7
10221640|NCT04084028|11349512|FG000|STARTED|Overall Study||18
10221641|NCT04084028|11349513|FG001|STARTED|Overall Study||16
10012613|NCT01786629|11135457|FG000|NOT COMPLETED|Overall Study||0
10012614|NCT01786629|11135458|FG001|NOT COMPLETED|Overall Study||5
10012615|NCT01786668|11135468|FG000|STARTED|Overall Study||52
10221642|NCT04084028|11349514|FG002|STARTED|Overall Study||9
10221643|NCT04084028|11349515|FG003|STARTED|Overall Study||10
10221644|NCT04084028|11349512|FG000|COMPLETED|Overall Study||18
10221645|NCT04084028|11349513|FG001|COMPLETED|Overall Study||16
10221646|NCT04084028|11349514|FG002|COMPLETED|Overall Study||9
10221647|NCT04084028|11349515|FG003|COMPLETED|Overall Study||10
10221648|NCT04084028|11349512|FG000|NOT COMPLETED|Overall Study||0
10221649|NCT04084028|11349513|FG001|NOT COMPLETED|Overall Study||0
10221650|NCT04084028|11349514|FG002|NOT COMPLETED|Overall Study||0
10221651|NCT04084028|11349515|FG003|NOT COMPLETED|Overall Study||0
10221652|NCT04082819|11349530|FG000|STARTED|Overall Study||37
10221653|NCT04082819|11349531|FG001|STARTED|Overall Study||54
10221654|NCT04082819|11349532|FG002|STARTED|Overall Study||3
10221655|NCT04082819|11349530|FG000|COMPLETED|Overall Study||37
10221656|NCT04082819|11349531|FG001|COMPLETED|Overall Study||54
10221657|NCT04082819|11349532|FG002|COMPLETED|Overall Study||3
10221658|NCT04082819|11349530|FG000|NOT COMPLETED|Overall Study||0
10221659|NCT04082819|11349531|FG001|NOT COMPLETED|Overall Study||0
10221660|NCT04082819|11349532|FG002|NOT COMPLETED|Overall Study||0
10221661|NCT04081961|11349546|FG000|STARTED|Overall Study||9
10221662|NCT04081961|11349547|FG001|STARTED|Overall Study||9
10221663|NCT04081961|11349548|FG002|STARTED|Overall Study||9
10221664|NCT04081961|11349546|FG000|COMPLETED|Overall Study||9
10221665|NCT04081961|11349547|FG001|COMPLETED|Overall Study||9
10221666|NCT04081961|11349548|FG002|COMPLETED|Overall Study||9
10221667|NCT04081961|11349546|FG000|NOT COMPLETED|Overall Study||0
10221668|NCT04081961|11349547|FG001|NOT COMPLETED|Overall Study||0
10221669|NCT04081961|11349548|FG002|NOT COMPLETED|Overall Study||0
10012616|NCT01786668|11135469|FG001|STARTED|Overall Study||52
10012617|NCT01786668|11135470|FG002|STARTED|Overall Study||52
10012618|NCT01786668|11135471|FG003|STARTED|Overall Study||51
10012619|NCT01786668|11135468|FG000|COMPLETED|Overall Study||51
10012620|NCT01786668|11135469|FG001|COMPLETED|Overall Study||51
10012621|NCT01786668|11135470|FG002|COMPLETED|Overall Study||47
10012622|NCT01786668|11135471|FG003|COMPLETED|Overall Study||47
10012623|NCT01786668|11135468|FG000|NOT COMPLETED|Overall Study||1
10221670|NCT04081610|11349558|FG000|STARTED|Overall Study||16
10221671|NCT04081610|11349559|FG001|STARTED|Overall Study||18
10221672|NCT04081610|11349558|FG000|COMPLETED|Overall Study||16
10221673|NCT04081610|11349559|FG001|COMPLETED|Overall Study||18
10221674|NCT04081610|11349558|FG000|NOT COMPLETED|Overall Study||0
10221675|NCT04081610|11349559|FG001|NOT COMPLETED|Overall Study||0
10012624|NCT01786668|11135469|FG001|NOT COMPLETED|Overall Study||1
10012625|NCT01786668|11135470|FG002|NOT COMPLETED|Overall Study||5
10012626|NCT01786668|11135471|FG003|NOT COMPLETED|Overall Study||4
10012627|NCT01786707|11135483|FG000|STARTED|Overall Study||1
10012628|NCT01786707|11135484|FG001|STARTED|Overall Study||1
10012629|NCT01786707|11135483|FG000|COMPLETED|Overall Study||0
10012630|NCT01786707|11135484|FG001|COMPLETED|Overall Study||0
10012631|NCT01786707|11135483|FG000|NOT COMPLETED|Overall Study||1
10012632|NCT01786707|11135484|FG001|NOT COMPLETED|Overall Study||1
10012633|NCT01786876|11135490|FG000|STARTED|Overall Study||6
10012634|NCT01786876|11135490|FG000|COMPLETED|Overall Study||6
10012635|NCT01786876|11135490|FG000|NOT COMPLETED|Overall Study||0
10012636|NCT01786902|11135496|FG000|STARTED|Overall Study||36
10221676|NCT04081324|11349569|FG000|STARTED|Overall Study||6
10221677|NCT04081324|11349570|FG001|STARTED|Overall Study||10
10221678|NCT04081324|11349571|FG002|STARTED|Overall Study||10
10221679|NCT04081324|11349572|FG003|STARTED|Overall Study||10
10221680|NCT04081324|11349569|FG000|Received At Least One Dose of Study Drug|Overall Study||6
10221681|NCT04081324|11349570|FG001|Received At Least One Dose of Study Drug|Overall Study||10
10012637|NCT01786902|11135497|FG001|STARTED|Overall Study||34
10012638|NCT01786902|11135496|FG000|COMPLETED|Overall Study||32
10012639|NCT01786902|11135497|FG001|COMPLETED|Overall Study||31
10012640|NCT01786902|11135496|FG000|NOT COMPLETED|Overall Study||4
10221682|NCT04081324|11349571|FG002|Received At Least One Dose of Study Drug|Overall Study||10
10221683|NCT04081324|11349572|FG003|Received At Least One Dose of Study Drug|Overall Study||10
10221684|NCT04081324|11349569|FG000|COMPLETED|Overall Study||6
10221685|NCT04081324|11349570|FG001|COMPLETED|Overall Study||10
10221686|NCT04081324|11349571|FG002|COMPLETED|Overall Study||10
10221687|NCT04081324|11349572|FG003|COMPLETED|Overall Study||10
10221688|NCT04081324|11349569|FG000|NOT COMPLETED|Overall Study||0
10221689|NCT04081324|11349570|FG001|NOT COMPLETED|Overall Study||0
10221690|NCT04081324|11349571|FG002|NOT COMPLETED|Overall Study||0
10221691|NCT04081324|11349572|FG003|NOT COMPLETED|Overall Study||0
10221692|NCT04079790|11349585|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
10221693|NCT04079790|11349586|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
10221694|NCT04079790|11349587|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
10221695|NCT04079790|11349588|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
10221696|NCT04079790|11349585|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
10221697|NCT04079790|11349586|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
10221698|NCT04079790|11349587|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10221699|NCT04079790|11349588|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10221700|NCT04079790|11349585|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
10221701|NCT04079790|11349586|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10221702|NCT04079790|11349587|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10221703|NCT04079790|11349588|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10221704|NCT04079790|11349585|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
10221705|NCT04079790|11349586|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
10221706|NCT04079790|11349587|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
10221707|NCT04079790|11349588|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
10221708|NCT04079790|11349585|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
10221709|NCT04079790|11349586|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
10221710|NCT04079790|11349587|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10221711|NCT04079790|11349588|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10221712|NCT04079790|11349585|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10221713|NCT04079790|11349586|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10221714|NCT04079790|11349587|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10221715|NCT04079790|11349588|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10221716|NCT04079790|11349585|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
10221717|NCT04079790|11349586|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
10221718|NCT04079790|11349587|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
10221719|NCT04079790|11349588|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
10221720|NCT04079790|11349585|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
10221721|NCT04079790|11349586|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
10221722|NCT04079790|11349587|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10221723|NCT04079790|11349588|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10221724|NCT04079790|11349585|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10221725|NCT04079790|11349586|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10221726|NCT04079790|11349587|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10221727|NCT04079790|11349588|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10221728|NCT04079790|11349585|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
10221729|NCT04079790|11349586|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
10221730|NCT04079790|11349587|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
10221731|NCT04079790|11349588|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
10221732|NCT04079790|11349585|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10221733|NCT04079790|11349586|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10221734|NCT04079790|11349587|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
10221735|NCT04079790|11349588|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
10221736|NCT04079790|11349585|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10221737|NCT04079790|11349586|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10221738|NCT04079790|11349587|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
10221739|NCT04079790|11349588|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10221740|NCT04079790|11349585|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
10221741|NCT04079790|11349586|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
10221742|NCT04079790|11349587|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
10221743|NCT04079790|11349588|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
10221744|NCT04079790|11349585|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10221745|NCT04079790|11349586|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10221746|NCT04079790|11349587|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
10221747|NCT04079790|11349588|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
10221748|NCT04079790|11349585|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10221749|NCT04079790|11349586|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10221750|NCT04079790|11349587|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10221751|NCT04079790|11349588|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10221752|NCT04079127|11349614|FG000|STARTED|Overall Study|hips (in 141 patients)|150
10221753|NCT04079127|11349614|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
10221754|NCT04079127|11349614|FG000|NOT COMPLETED|Overall Study||61
10221755|NCT04076787|11349621|FG000|STARTED|Overall Study||318
10221756|NCT04076787|11349622|FG001|STARTED|Overall Study||1031
10221757|NCT04076787|11349623|FG002|STARTED|Overall Study||420
10221758|NCT04076787|11349621|FG000|COMPLETED|Overall Study||318
10221759|NCT04076787|11349622|FG001|COMPLETED|Overall Study||1031
10221760|NCT04076787|11349623|FG002|COMPLETED|Overall Study||420
10221761|NCT04076787|11349621|FG000|NOT COMPLETED|Overall Study||0
10221762|NCT04076787|11349622|FG001|NOT COMPLETED|Overall Study||0
10221763|NCT04076787|11349623|FG002|NOT COMPLETED|Overall Study||0
10221764|NCT04075812|11349631|FG000|STARTED|Overall Study||2
10221765|NCT04075812|11349631|FG000|COMPLETED|Overall Study||2
10221766|NCT04075812|11349631|FG000|NOT COMPLETED|Overall Study||0
10221767|NCT04075409|11349638|FG000|STARTED|Overall Study||13
10221768|NCT04075409|11349639|FG001|STARTED|Overall Study||13
10221769|NCT04075409|11349640|FG002|STARTED|Overall Study||13
10221770|NCT04075409|11349638|FG000|COMPLETED|Overall Study||13
10221771|NCT04075409|11349639|FG001|COMPLETED|Overall Study||13
10221772|NCT04075409|11349640|FG002|COMPLETED|Overall Study||13
10221773|NCT04075409|11349638|FG000|NOT COMPLETED|Overall Study||0
10221774|NCT04075409|11349639|FG001|NOT COMPLETED|Overall Study||0
10221775|NCT04075409|11349640|FG002|NOT COMPLETED|Overall Study||0
10221776|NCT04074941|11349661|FG000|STARTED|Overall Study||11
10221777|NCT04074941|11349662|FG001|STARTED|Overall Study||9
10221778|NCT04074941|11349661|FG000|COMPLETED|Overall Study||11
10221779|NCT04074941|11349662|FG001|COMPLETED|Overall Study||9
10221780|NCT04074941|11349661|FG000|NOT COMPLETED|Overall Study||0
10221781|NCT04074941|11349662|FG001|NOT COMPLETED|Overall Study||0
10221782|NCT04073823|11349670|FG000|STARTED|Overall Study||1
10221783|NCT04073823|11349671|FG001|STARTED|Overall Study||1
10221784|NCT04073823|11349670|FG000|COMPLETED|Overall Study||1
10012641|NCT01786902|11135497|FG001|NOT COMPLETED|Overall Study||3
10012642|NCT01786954|11135503|FG000|STARTED|Overall Study||34
10012643|NCT01786954|11135504|FG001|STARTED|Overall Study||34
10012644|NCT01786954|11135503|FG000|COMPLETED|Overall Study||34
10012645|NCT01786954|11135504|FG001|COMPLETED|Overall Study||34
10012646|NCT01786954|11135503|FG000|NOT COMPLETED|Overall Study||0
10012647|NCT01786954|11135504|FG001|NOT COMPLETED|Overall Study||0
10012648|NCT01786967|11135514|FG000|STARTED|Overall Study||61
10012649|NCT01786967|11135514|FG000|Extensive Metabolizers|Overall Study||54
10221785|NCT04073823|11349671|FG001|COMPLETED|Overall Study||1
10221786|NCT04073823|11349670|FG000|NOT COMPLETED|Overall Study||0
10221787|NCT04073823|11349671|FG001|NOT COMPLETED|Overall Study||0
10221788|NCT04073407|11349679|FG000|STARTED|Part 1||6
10221789|NCT04073407|11349680|FG001|STARTED|Part 1||3
10012650|NCT01786967|11135514|FG000|Poor Metabolizers|Overall Study||4
10012651|NCT01786967|11135514|FG000|Metabolizer Status Undetermined|Overall Study||3
10221790|NCT04073407|11349679|FG000|COMPLETED|Part 1||1
10221791|NCT04073407|11349680|FG001|COMPLETED|Part 1||2
10221792|NCT04073407|11349679|FG000|NOT COMPLETED|Part 1||5
10221793|NCT04073407|11349680|FG001|NOT COMPLETED|Part 1||1
10221794|NCT04073407|11349679|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0
10221795|NCT04073407|11349680|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1
10221796|NCT04073407|11349679|FG000|COMPLETED|Part 2||0
10221797|NCT04073407|11349680|FG001|COMPLETED|Part 2||0
10221798|NCT04073407|11349679|FG000|NOT COMPLETED|Part 2||0
10221799|NCT04073407|11349680|FG001|NOT COMPLETED|Part 2||1
10221800|NCT04073368|11349690|FG000|STARTED|Overall Study||32
10221801|NCT04073368|11349691|FG001|STARTED|Overall Study||26
10221802|NCT04073368|11349692|FG002|STARTED|Overall Study||29
10221803|NCT04073368|11349693|FG003|STARTED|Overall Study||15
10221804|NCT04073368|11349690|FG000|COMPLETED|Overall Study||20
10221805|NCT04073368|11349691|FG001|COMPLETED|Overall Study||18
10221806|NCT04073368|11349692|FG002|COMPLETED|Overall Study||26
10221807|NCT04073368|11349693|FG003|COMPLETED|Overall Study||13
10221808|NCT04073368|11349690|FG000|NOT COMPLETED|Overall Study||12
10221809|NCT04073368|11349691|FG001|NOT COMPLETED|Overall Study||8
10221810|NCT04073368|11349692|FG002|NOT COMPLETED|Overall Study||3
10221811|NCT04073368|11349693|FG003|NOT COMPLETED|Overall Study||2
10221812|NCT04073186|11349703|FG000|STARTED|First Wearing Cycle||86
10221813|NCT04073186|11349703|FG000|COMPLETED|First Wearing Cycle||80
10221814|NCT04073186|11349703|FG000|NOT COMPLETED|First Wearing Cycle||6
10221815|NCT04073186|11349703|FG000|STARTED|Second Wearing Cycle||80
10221816|NCT04073186|11349703|FG000|COMPLETED|Second Wearing Cycle||79
10221817|NCT04073186|11349703|FG000|NOT COMPLETED|Second Wearing Cycle||1
10221818|NCT04072237|11349708|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11
10012652|NCT01786967|11135514|FG000|COMPLETED|Overall Study||61
10012653|NCT01786967|11135514|FG000|NOT COMPLETED|Overall Study||0
10012654|NCT01786993|11135525|FG000|STARTED|Overall Study||201
10221819|NCT04072237|11349708|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
10221820|NCT04072237|11349708|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
10221821|NCT04072237|11349708|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
10221822|NCT04072237|11349708|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
10221823|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
10221824|NCT04072237|11349708|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
10221825|NCT04072237|11349708|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
10221826|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
10221827|NCT04072237|11349708|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
10221828|NCT04072237|11349708|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
10221829|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
10221830|NCT04072237|11349708|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
10221831|NCT04072237|11349708|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
10221832|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
10221833|NCT04072237|11349708|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
10221834|NCT04072237|11349708|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
10221835|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
10221836|NCT04072237|11349708|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
10221837|NCT04072237|11349708|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
10221838|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
10221839|NCT04072237|11349708|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
10221840|NCT04072237|11349708|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
10221841|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
10221842|NCT04072237|11349708|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
10221843|NCT04072237|11349708|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
10221844|NCT04072237|11349708|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
10221845|NCT04063371|11349738|FG000|STARTED|Overall Study||100
10221846|NCT04063371|11349739|FG001|STARTED|Overall Study||100
10221847|NCT04063371|11349740|FG002|STARTED|Overall Study||100
10221848|NCT04063371|11349738|FG000|COMPLETED|Overall Study||100
10221849|NCT04063371|11349739|FG001|COMPLETED|Overall Study||100
10221850|NCT04063371|11349740|FG002|COMPLETED|Overall Study||100
10221851|NCT04063371|11349738|FG000|NOT COMPLETED|Overall Study||0
10221852|NCT04063371|11349739|FG001|NOT COMPLETED|Overall Study||0
10221853|NCT04063371|11349740|FG002|NOT COMPLETED|Overall Study||0
10221854|NCT04042324|11349750|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12
10221855|NCT04042324|11349751|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0
10221856|NCT04042324|11349752|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0
10221857|NCT04042324|11349750|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12
10221858|NCT04042324|11349751|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0
10221859|NCT04042324|11349752|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0
10221860|NCT04042324|11349750|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
10221861|NCT04042324|11349751|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
10221862|NCT04042324|11349752|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
10221863|NCT04042324|11349750|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0
10221864|NCT04042324|11349751|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12
10221865|NCT04042324|11349752|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0
10221866|NCT04042324|11349750|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0
10221867|NCT04042324|11349751|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12
10221868|NCT04042324|11349752|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0
10221869|NCT04042324|11349750|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
10221870|NCT04042324|11349751|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
10221871|NCT04042324|11349752|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
10221872|NCT04042324|11349750|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0
10221873|NCT04042324|11349751|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0
10221874|NCT04042324|11349752|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12
10221875|NCT04042324|11349750|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10221876|NCT04042324|11349751|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10221877|NCT04042324|11349752|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
10221878|NCT04042324|11349750|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10221879|NCT04042324|11349751|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10221880|NCT04042324|11349752|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10221881|NCT04071392|11349764|FG000|STARTED|Overall Study||12
10221882|NCT04071392|11349765|FG001|STARTED|Overall Study||12
10221883|NCT04071392|11349764|FG000|COMPLETED|Overall Study||10
10221884|NCT04071392|11349765|FG001|COMPLETED|Overall Study||10
10221885|NCT04071392|11349764|FG000|NOT COMPLETED|Overall Study||2
10221886|NCT04071392|11349765|FG001|NOT COMPLETED|Overall Study||2
10221887|NCT04071301|11349771|FG000|STARTED|Overall Study||15
10221888|NCT04071301|11349771|FG000|COMPLETED|Overall Study||8
10221889|NCT04071301|11349771|FG000|NOT COMPLETED|Overall Study||7
10221890|NCT04071158|11349780|FG000|STARTED|Overall Study||143
10221891|NCT04071158|11349781|FG001|STARTED|Overall Study||143
10221892|NCT04071158|11349782|FG002|STARTED|Overall Study||143
10221893|NCT04071158|11349783|FG003|STARTED|Overall Study||143
10221894|NCT04071158|11349784|FG004|STARTED|Overall Study||141
10221895|NCT04071158|11349780|FG000|Treated|Overall Study||141
10221896|NCT04071158|11349781|FG001|Treated|Overall Study||141
10221897|NCT04071158|11349782|FG002|Treated|Overall Study||143
10221898|NCT04071158|11349783|FG003|Treated|Overall Study||143
10221899|NCT04071158|11349784|FG004|Treated|Overall Study||141
10221900|NCT04071158|11349780|FG000|Safety Population|Overall Study||141
10221901|NCT04071158|11349781|FG001|Safety Population|Overall Study||141
10221902|NCT04071158|11349782|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
10221903|NCT04071158|11349783|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
10221904|NCT04071158|11349784|FG004|Safety Population|Overall Study||141
10221905|NCT04071158|11349780|FG000|COMPLETED|Overall Study||140
10221906|NCT04071158|11349781|FG001|COMPLETED|Overall Study||139
10221907|NCT04071158|11349782|FG002|COMPLETED|Overall Study||140
10221908|NCT04071158|11349783|FG003|COMPLETED|Overall Study||140
10221909|NCT04071158|11349784|FG004|COMPLETED|Overall Study||136
10221910|NCT04071158|11349780|FG000|NOT COMPLETED|Overall Study||3
10221911|NCT04071158|11349781|FG001|NOT COMPLETED|Overall Study||4
10221912|NCT04071158|11349782|FG002|NOT COMPLETED|Overall Study||3
10221913|NCT04071158|11349783|FG003|NOT COMPLETED|Overall Study||3
10221914|NCT04071158|11349784|FG004|NOT COMPLETED|Overall Study||5
10221915|NCT04070287|11349807|FG000|STARTED|Overall Study||114
10221916|NCT04070287|11349808|FG001|STARTED|Overall Study||86
10221917|NCT04070287|11349809|FG002|STARTED|Overall Study||81
10221918|NCT04070287|11349810|FG003|STARTED|Overall Study||11
10221919|NCT04070287|11349811|FG004|STARTED|Overall Study||96
10221920|NCT04070287|11349807|FG000|COMPLETED|Overall Study||103
10221921|NCT04070287|11349808|FG001|COMPLETED|Overall Study||44
10221922|NCT04070287|11349809|FG002|COMPLETED|Overall Study||75
10221923|NCT04070287|11349810|FG003|COMPLETED|Overall Study||7
10221924|NCT04070287|11349811|FG004|COMPLETED|Overall Study||95
10221925|NCT04070287|11349807|FG000|NOT COMPLETED|Overall Study||11
10221926|NCT04070287|11349808|FG001|NOT COMPLETED|Overall Study||42
10221927|NCT04070287|11349809|FG002|NOT COMPLETED|Overall Study||6
10221928|NCT04070287|11349810|FG003|NOT COMPLETED|Overall Study||4
10221929|NCT04070287|11349811|FG004|NOT COMPLETED|Overall Study||1
10221930|NCT04069715|11349825|FG000|STARTED|Overall Study||47
10221931|NCT04069715|11349826|FG001|STARTED|Overall Study||48
10221932|NCT04069715|11349825|FG000|COMPLETED|Overall Study||42
10221933|NCT04069715|11349826|FG001|COMPLETED|Overall Study||43
10221934|NCT04069715|11349825|FG000|NOT COMPLETED|Overall Study||5
10221935|NCT04069715|11349826|FG001|NOT COMPLETED|Overall Study||5
10221936|NCT04050722|11349834|FG000|STARTED|Overall Study||65
10221937|NCT04050722|11349835|FG001|STARTED|Overall Study||65
10221938|NCT04050722|11349834|FG000|COMPLETED|Overall Study||64
10221939|NCT04050722|11349835|FG001|COMPLETED|Overall Study||65
10221940|NCT04050722|11349834|FG000|NOT COMPLETED|Overall Study||1
10221941|NCT04050722|11349835|FG001|NOT COMPLETED|Overall Study||0
10221942|NCT04069221|11349843|FG000|STARTED|Overall Study||8
10221943|NCT04069221|11349844|FG001|STARTED|Overall Study||6
10221944|NCT04069221|11349845|FG002|STARTED|Overall Study||6
10221945|NCT04069221|11349846|FG003|STARTED|Overall Study||6
10221946|NCT04069221|11349843|FG000|COMPLETED|Overall Study||8
10221947|NCT04069221|11349844|FG001|COMPLETED|Overall Study||6
10221948|NCT04069221|11349845|FG002|COMPLETED|Overall Study||6
10221949|NCT04069221|11349846|FG003|COMPLETED|Overall Study||6
10221950|NCT04069221|11349843|FG000|NOT COMPLETED|Overall Study||0
10221951|NCT04069221|11349844|FG001|NOT COMPLETED|Overall Study||0
10221952|NCT04069221|11349845|FG002|NOT COMPLETED|Overall Study||0
10221953|NCT04069221|11349846|FG003|NOT COMPLETED|Overall Study||0
10221954|NCT04067141|11349856|FG000|STARTED|First Intervention||35
10221955|NCT04067141|11349857|FG001|STARTED|First Intervention||35
10221956|NCT04067141|11349856|FG000|COMPLETED|First Intervention||35
10221957|NCT04067141|11349857|FG001|COMPLETED|First Intervention||34
10221958|NCT04067141|11349856|FG000|NOT COMPLETED|First Intervention||0
10221959|NCT04067141|11349857|FG001|NOT COMPLETED|First Intervention||1
10221960|NCT04067141|11349856|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
10221961|NCT04067141|11349857|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
10221962|NCT04067141|11349856|FG000|COMPLETED|Second Intervention||34
10221963|NCT04067141|11349857|FG001|COMPLETED|Second Intervention||31
10221964|NCT04067141|11349856|FG000|NOT COMPLETED|Second Intervention||0
10221965|NCT04067141|11349857|FG001|NOT COMPLETED|Second Intervention||2
10221966|NCT04049578|11349863|FG000|STARTED|Overall Study||2
10221967|NCT04049578|11349863|FG000|COMPLETED|Overall Study||1
10221968|NCT04049578|11349863|FG000|NOT COMPLETED|Overall Study||1
10221969|NCT04067401|11349869|FG000|STARTED|Overall Study||748
10221970|NCT04067401|11349870|FG001|STARTED|Overall Study||737
10221971|NCT04067401|11349869|FG000|Baseline Survey Completion|Overall Study||746
10221972|NCT04067401|11349870|FG001|Baseline Survey Completion|Overall Study||735
10221973|NCT04067401|11349869|FG000|1 Month Survey Completion|Overall Study||697
10221974|NCT04067401|11349870|FG001|1 Month Survey Completion|Overall Study||694
10221975|NCT04067401|11349869|FG000|6 Month Survey Completion|Overall Study||629
10221976|NCT04067401|11349870|FG001|6 Month Survey Completion|Overall Study||618
10221977|NCT04067401|11349869|FG000|COMPLETED|Overall Study||740
10221978|NCT04067401|11349870|FG001|COMPLETED|Overall Study||737
10221979|NCT04067401|11349869|FG000|NOT COMPLETED|Overall Study||8
10221980|NCT04067401|11349870|FG001|NOT COMPLETED|Overall Study||0
10221981|NCT04067050|11349878|FG000|STARTED|One Month||32
10221982|NCT04067050|11349879|FG001|STARTED|One Month||29
10221983|NCT04067050|11349878|FG000|COMPLETED|One Month||28
10221984|NCT04067050|11349879|FG001|COMPLETED|One Month||29
10221985|NCT04067050|11349878|FG000|NOT COMPLETED|One Month||4
10221986|NCT04067050|11349879|FG001|NOT COMPLETED|One Month||0
10221987|NCT04067050|11349878|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
10221988|NCT04067050|11349879|FG001|STARTED|Two Month||29
10221989|NCT04067050|11349878|FG000|COMPLETED|Two Month||20
10221990|NCT04067050|11349879|FG001|COMPLETED|Two Month||29
10221991|NCT04067050|11349878|FG000|NOT COMPLETED|Two Month||2
10221992|NCT04067050|11349879|FG001|NOT COMPLETED|Two Month||0
10221993|NCT04066647|11349885|FG000|STARTED|Overall Study||7
10221994|NCT04066647|11349885|FG000|COMPLETED|Overall Study||7
10221995|NCT04066647|11349885|FG000|NOT COMPLETED|Overall Study||0
10221996|NCT04066426|11349893|FG000|STARTED|Overall Study||50
10221997|NCT04066426|11349894|FG001|STARTED|Overall Study||50
10221998|NCT04066426|11349895|FG002|STARTED|Overall Study||50
10221999|NCT04066426|11349896|FG003|STARTED|Overall Study||50
10222000|NCT04066426|11349893|FG000|COMPLETED|Overall Study||40
10222001|NCT04066426|11349894|FG001|COMPLETED|Overall Study||40
10222002|NCT04066426|11349895|FG002|COMPLETED|Overall Study||42
10222003|NCT04066426|11349896|FG003|COMPLETED|Overall Study||47
10222004|NCT04066426|11349893|FG000|NOT COMPLETED|Overall Study||10
10222005|NCT04066426|11349894|FG001|NOT COMPLETED|Overall Study||10
10222006|NCT04066426|11349895|FG002|NOT COMPLETED|Overall Study||8
10222007|NCT04066426|11349896|FG003|NOT COMPLETED|Overall Study||3
10222008|NCT04061694|11349908|FG000|STARTED|Overall Study||21
10222009|NCT04061694|11349909|FG001|STARTED|Overall Study||25
10222010|NCT04061694|11349908|FG000|COMPLETED|Overall Study||19
10222011|NCT04061694|11349909|FG001|COMPLETED|Overall Study||25
10222012|NCT04061694|11349908|FG000|NOT COMPLETED|Overall Study||2
10222013|NCT04061694|11349909|FG001|NOT COMPLETED|Overall Study||0
10222014|NCT04060654|11349915|FG000|STARTED|Overall Study||17
10222015|NCT04060654|11349915|FG000|COMPLETED|Overall Study||11
10222016|NCT04060654|11349915|FG000|NOT COMPLETED|Overall Study||6
10222017|NCT04059250|11349919|FG000|STARTED|Overall Study||25
10222018|NCT04059250|11349920|FG001|STARTED|Overall Study||25
10222019|NCT04059250|11349919|FG000|COMPLETED|Overall Study||25
10222020|NCT04059250|11349920|FG001|COMPLETED|Overall Study||25
10222021|NCT04059250|11349919|FG000|NOT COMPLETED|Overall Study||0
10222022|NCT04059250|11349920|FG001|NOT COMPLETED|Overall Study||0
10222023|NCT04058353|11349928|FG000|STARTED|Overall Study||126
10222024|NCT04058353|11349929|FG001|STARTED|Overall Study||132
10222025|NCT04058353|11349928|FG000|COMPLETED|Overall Study||122
10222026|NCT04058353|11349929|FG001|COMPLETED|Overall Study||131
10222027|NCT04058353|11349928|FG000|NOT COMPLETED|Overall Study||4
10222028|NCT04058353|11349929|FG001|NOT COMPLETED|Overall Study||1
10222029|NCT04057248|11349936|FG000|STARTED|Overall Study||14
10012655|NCT01786993|11135526|FG001|STARTED|Overall Study||180
10012656|NCT01786993|11135525|FG000|Per Protocol Population at 9 Months|Overall Study||189
10012657|NCT01786993|11135526|FG001|Per Protocol Population at 9 Months|Overall Study||170
10012658|NCT01786993|11135525|FG000|COMPLETED|Overall Study||189
10222030|NCT04057248|11349936|FG000|COMPLETED|Overall Study||12
10222031|NCT04057248|11349936|FG000|NOT COMPLETED|Overall Study||2
10222032|NCT04055519|11349940|FG000|STARTED|First Wear Period (30 Days)||16
10222033|NCT04055519|11349941|FG001|STARTED|First Wear Period (30 Days)||20
10222034|NCT04055519|11349940|FG000|COMPLETED|First Wear Period (30 Days)||16
10222035|NCT04055519|11349941|FG001|COMPLETED|First Wear Period (30 Days)||20
10222036|NCT04055519|11349940|FG000|NOT COMPLETED|First Wear Period (30 Days)||0
10222037|NCT04055519|11349941|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
10222038|NCT04055519|11349940|FG000|STARTED|Second Wear Period (30 Days)||16
10222039|NCT04055519|11349941|FG001|STARTED|Second Wear Period (30 Days)||20
10222040|NCT04055519|11349940|FG000|COMPLETED|Second Wear Period (30 Days)||16
10222041|NCT04055519|11349941|FG001|COMPLETED|Second Wear Period (30 Days)||20
10222042|NCT04055519|11349940|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
10222043|NCT04055519|11349941|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
10222044|NCT04055675|11349952|FG000|STARTED|Overall Study||96
10012659|NCT01786993|11135526|FG001|COMPLETED|Overall Study||170
10222045|NCT04055675|11349953|FG001|STARTED|Overall Study||104
10222046|NCT04055675|11349952|FG000|COMPLETED|Overall Study||96
10222047|NCT04055675|11349953|FG001|COMPLETED|Overall Study||104
10222048|NCT04055675|11349952|FG000|NOT COMPLETED|Overall Study||0
10222049|NCT04055675|11349953|FG001|NOT COMPLETED|Overall Study||0
10222050|NCT04054765|11349961|FG000|STARTED|Baseline||155
10222051|NCT04054765|11349962|FG001|STARTED|Baseline||132
10222052|NCT04054765|11349961|FG000|COMPLETED|Baseline||150
10222053|NCT04054765|11349962|FG001|COMPLETED|Baseline||129
10222054|NCT04054765|11349961|FG000|NOT COMPLETED|Baseline||5
10222055|NCT04054765|11349962|FG001|NOT COMPLETED|Baseline||3
10222056|NCT04054765|11349961|FG000|STARTED|Post-Gameplay / 1-week Follow up||150
10222057|NCT04054765|11349962|FG001|STARTED|Post-Gameplay / 1-week Follow up||129
10222058|NCT04054765|11349961|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142
10222059|NCT04054765|11349962|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126
10222060|NCT04054765|11349961|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
10222061|NCT04054765|11349962|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
10222062|NCT04054765|11349961|FG000|STARTED|3-month Follow up||142
10222063|NCT04054765|11349962|FG001|STARTED|3-month Follow up||126
10222064|NCT04054765|11349961|FG000|COMPLETED|3-month Follow up||142
10222065|NCT04054765|11349962|FG001|COMPLETED|3-month Follow up||123
10222066|NCT04054765|11349961|FG000|NOT COMPLETED|3-month Follow up||0
10222067|NCT04054765|11349962|FG001|NOT COMPLETED|3-month Follow up||3
10222068|NCT04054765|11349961|FG000|STARTED|6-month Follow up||142
10222069|NCT04054765|11349962|FG001|STARTED|6-month Follow up||123
10222070|NCT04054765|11349961|FG000|COMPLETED|6-month Follow up||110
10222071|NCT04054765|11349962|FG001|COMPLETED|6-month Follow up||91
10222072|NCT04054765|11349961|FG000|NOT COMPLETED|6-month Follow up||32
10222073|NCT04054765|11349962|FG001|NOT COMPLETED|6-month Follow up||32
10222074|NCT04054011|11349968|FG000|STARTED|Overall Study||15
10222075|NCT04054011|11349968|FG000|COMPLETED|Overall Study||12
10222076|NCT04054011|11349968|FG000|NOT COMPLETED|Overall Study||3
10222077|NCT04059094|11349979|FG000|STARTED|Overall Study||18
10222078|NCT04059094|11349980|FG001|STARTED|Overall Study||6
10222079|NCT04059094|11349981|FG002|STARTED|Overall Study||5
10222080|NCT04059094|11349982|FG003|STARTED|Overall Study||5
10222081|NCT04059094|11349983|FG004|STARTED|Overall Study||18
10222082|NCT04059094|11349979|FG000|COMPLETED|Overall Study||18
10222083|NCT04059094|11349980|FG001|COMPLETED|Overall Study||4
10012660|NCT01786993|11135525|FG000|NOT COMPLETED|Overall Study||12
10012661|NCT01786993|11135526|FG001|NOT COMPLETED|Overall Study||10
10222084|NCT04059094|11349981|FG002|COMPLETED|Overall Study||5
10222085|NCT04059094|11349982|FG003|COMPLETED|Overall Study||5
10222086|NCT04059094|11349983|FG004|COMPLETED|Overall Study||17
10222087|NCT04059094|11349979|FG000|NOT COMPLETED|Overall Study||0
10222088|NCT04059094|11349980|FG001|NOT COMPLETED|Overall Study||2
10222089|NCT04059094|11349981|FG002|NOT COMPLETED|Overall Study||0
10222090|NCT04059094|11349982|FG003|NOT COMPLETED|Overall Study||0
10222091|NCT04059094|11349983|FG004|NOT COMPLETED|Overall Study||1
10222092|NCT04051684|11350001|FG000|STARTED|Overall Study||12
10222093|NCT04051684|11350002|FG001|STARTED|Overall Study||11
10222094|NCT04051684|11350001|FG000|COMPLETED|Overall Study||12
10222095|NCT04051684|11350002|FG001|COMPLETED|Overall Study||11
10222096|NCT04051684|11350001|FG000|NOT COMPLETED|Overall Study||0
10222097|NCT04051684|11350002|FG001|NOT COMPLETED|Overall Study||0
10222098|NCT04046341|11350008|FG000|STARTED|Overall Study||15
10222099|NCT04046341|11350008|FG000|COMPLETED|Overall Study||12
10222100|NCT04046341|11350008|FG000|NOT COMPLETED|Overall Study||3
10222101|NCT04045964|11350014|FG000|STARTED|Overall Study||16
10222102|NCT04045964|11350015|FG001|STARTED|Overall Study||16
10222103|NCT04045964|11350014|FG000|Intervention Visit(s)|Overall Study||15
10222104|NCT04045964|11350015|FG001|Intervention Visit(s)|Overall Study||16
10222105|NCT04045964|11350014|FG000|Follow up Visit 1|Overall Study||15
10222106|NCT04045964|11350015|FG001|Follow up Visit 1|Overall Study||15
10222107|NCT04045964|11350014|FG000|Follow up Visit 2|Overall Study||15
10222108|NCT04045964|11350015|FG001|Follow up Visit 2|Overall Study||15
10222109|NCT04045964|11350014|FG000|COMPLETED|Overall Study||15
10222110|NCT04045964|11350015|FG001|COMPLETED|Overall Study||15
10222111|NCT04045964|11350014|FG000|NOT COMPLETED|Overall Study||1
10012662|NCT01787006|11135535|FG000|STARTED|Overall Study||35
10012663|NCT01787006|11135536|FG001|STARTED|Overall Study||39
10012664|NCT01787006|11135535|FG000|COMPLETED|Overall Study||32
10012665|NCT01787006|11135536|FG001|COMPLETED|Overall Study||36
10012666|NCT01787006|11135535|FG000|NOT COMPLETED|Overall Study||3
10012667|NCT01787006|11135536|FG001|NOT COMPLETED|Overall Study||3
10012668|NCT01787032|11135548|FG000|STARTED|Overall Study||3
10012669|NCT01787032|11135549|FG001|STARTED|Overall Study||3
10012670|NCT01787032|11135550|FG002|STARTED|Overall Study||3
10012671|NCT01787032|11135551|FG003|STARTED|Overall Study||3
10012672|NCT01787032|11135552|FG004|STARTED|Overall Study||4
10012673|NCT01787032|11135553|FG005|STARTED|Overall Study||4
10012674|NCT01787032|11135548|FG000|Received R|Overall Study||3
10012675|NCT01787032|11135549|FG001|Received R|Overall Study||3
10012676|NCT01787032|11135550|FG002|Received R|Overall Study||3
10012677|NCT01787032|11135551|FG003|Received R|Overall Study||3
10012678|NCT01787032|11135552|FG004|Received R|Overall Study||4
10222112|NCT04045964|11350015|FG001|NOT COMPLETED|Overall Study||1
10222113|NCT04043416|11350023|FG000|STARTED|Campaign 1||14
10222114|NCT04043416|11350024|FG001|STARTED|Campaign 1||14
10222115|NCT04043416|11350023|FG000|COMPLETED|Campaign 1||14
10222116|NCT04043416|11350024|FG001|COMPLETED|Campaign 1||14
10222117|NCT04043416|11350023|FG000|NOT COMPLETED|Campaign 1||0
10222118|NCT04043416|11350024|FG001|NOT COMPLETED|Campaign 1||0
10222119|NCT04043416|11350023|FG000|STARTED|Washout||14
10222120|NCT04043416|11350024|FG001|STARTED|Washout||14
10222121|NCT04043416|11350023|FG000|COMPLETED|Washout||14
10222122|NCT04043416|11350024|FG001|COMPLETED|Washout||13
10222123|NCT04043416|11350023|FG000|NOT COMPLETED|Washout||0
10222124|NCT04043416|11350024|FG001|NOT COMPLETED|Washout||1
10222125|NCT04043416|11350023|FG000|STARTED|Campaign 2||14
10222126|NCT04043416|11350024|FG001|STARTED|Campaign 2||13
10222127|NCT04043416|11350023|FG000|COMPLETED|Campaign 2||14
10222128|NCT04043416|11350024|FG001|COMPLETED|Campaign 2||13
10222129|NCT04043416|11350023|FG000|NOT COMPLETED|Campaign 2||0
10222130|NCT04043416|11350024|FG001|NOT COMPLETED|Campaign 2||0
10222131|NCT04057768|11350033|FG000|STARTED|Overall Study||10
10222132|NCT04057768|11350033|FG000|COMPLETED|Overall Study||10
10222133|NCT04057768|11350033|FG000|NOT COMPLETED|Overall Study||0
10222134|NCT04052542|11350049|FG000|STARTED|Overall Study||116
10222135|NCT04052542|11350050|FG001|STARTED|Overall Study||28
10222136|NCT04052542|11350051|FG002|STARTED|Overall Study||146
10222137|NCT04052542|11350052|FG003|STARTED|Overall Study||188
10222138|NCT04052542|11350053|FG004|STARTED|Overall Study||24
10222139|NCT04052542|11350054|FG005|STARTED|Overall Study||183
10222140|NCT04052542|11350055|FG006|STARTED|Overall Study||275
10222141|NCT04052542|11350056|FG007|STARTED|Overall Study||27
10222142|NCT04052542|11350057|FG008|STARTED|Overall Study||276
10222143|NCT04052542|11350058|FG009|STARTED|Overall Study||22
10222144|NCT04052542|11350059|FG010|STARTED|Overall Study||31
10222145|NCT04052542|11350060|FG011|STARTED|Overall Study||12
10222146|NCT04052542|11350049|FG000|COMPLETED|Overall Study||116
10012679|NCT01787032|11135553|FG005|Received R|Overall Study||3
10012680|NCT01787032|11135548|FG000|Received T1|Overall Study||3
10012681|NCT01787032|11135549|FG001|Received T1|Overall Study||3
10222147|NCT04052542|11350050|FG001|COMPLETED|Overall Study||28
10222148|NCT04052542|11350051|FG002|COMPLETED|Overall Study||146
10222149|NCT04052542|11350052|FG003|COMPLETED|Overall Study||188
10222150|NCT04052542|11350053|FG004|COMPLETED|Overall Study||24
10222151|NCT04052542|11350054|FG005|COMPLETED|Overall Study||183
10222152|NCT04052542|11350055|FG006|COMPLETED|Overall Study||275
10012682|NCT01787032|11135550|FG002|Received T1|Overall Study||3
10222153|NCT04052542|11350056|FG007|COMPLETED|Overall Study||27
10012683|NCT01787032|11135551|FG003|Received T1|Overall Study||3
10012684|NCT01787032|11135552|FG004|Received T1|Overall Study||3
10012685|NCT01787032|11135553|FG005|Received T1|Overall Study||4
10012686|NCT01787032|11135548|FG000|Received T2|Overall Study||3
10222154|NCT04052542|11350057|FG008|COMPLETED|Overall Study||276
10222155|NCT04052542|11350058|FG009|COMPLETED|Overall Study||22
10222156|NCT04052542|11350059|FG010|COMPLETED|Overall Study||31
10222157|NCT04052542|11350060|FG011|COMPLETED|Overall Study||12
10222158|NCT04052542|11350049|FG000|NOT COMPLETED|Overall Study||0
10012687|NCT01787032|11135549|FG001|Received T2|Overall Study||3
10012688|NCT01787032|11135550|FG002|Received T2|Overall Study||3
10012689|NCT01787032|11135551|FG003|Received T2|Overall Study||3
10012690|NCT01787032|11135552|FG004|Received T2|Overall Study||4
10012691|NCT01787032|11135553|FG005|Received T2|Overall Study||4
10012692|NCT01787032|11135548|FG000|COMPLETED|Overall Study||3
10012693|NCT01787032|11135549|FG001|COMPLETED|Overall Study||3
10012694|NCT01787032|11135550|FG002|COMPLETED|Overall Study||3
10012695|NCT01787032|11135551|FG003|COMPLETED|Overall Study||3
10012696|NCT01787032|11135552|FG004|COMPLETED|Overall Study||3
10012697|NCT01787032|11135553|FG005|COMPLETED|Overall Study||3
10012698|NCT01787032|11135548|FG000|NOT COMPLETED|Overall Study||0
10012699|NCT01787032|11135549|FG001|NOT COMPLETED|Overall Study||0
10012700|NCT01787032|11135550|FG002|NOT COMPLETED|Overall Study||0
10012701|NCT01787032|11135551|FG003|NOT COMPLETED|Overall Study||0
10012702|NCT01787032|11135552|FG004|NOT COMPLETED|Overall Study||1
10012703|NCT01787032|11135553|FG005|NOT COMPLETED|Overall Study||1
10012704|NCT01787097|11135563|FG000|STARTED|Overall Study|Study started in 2012/2013|8
10012705|NCT01787097|11135564|FG001|STARTED|Overall Study||7
10012706|NCT01787097|11135565|FG002|STARTED|Overall Study||7
10012707|NCT01787097|11135566|FG003|STARTED|Overall Study||9
10012708|NCT01787097|11135563|FG000|COMPLETED|Overall Study|Study completed|7
10222159|NCT04052542|11350050|FG001|NOT COMPLETED|Overall Study||0
10222160|NCT04052542|11350051|FG002|NOT COMPLETED|Overall Study||0
10222161|NCT04052542|11350052|FG003|NOT COMPLETED|Overall Study||0
10222162|NCT04052542|11350053|FG004|NOT COMPLETED|Overall Study||0
10222163|NCT04052542|11350054|FG005|NOT COMPLETED|Overall Study||0
10222164|NCT04052542|11350055|FG006|NOT COMPLETED|Overall Study||0
10222165|NCT04052542|11350056|FG007|NOT COMPLETED|Overall Study||0
10222166|NCT04052542|11350057|FG008|NOT COMPLETED|Overall Study||0
10222167|NCT04052542|11350058|FG009|NOT COMPLETED|Overall Study||0
10222168|NCT04052542|11350059|FG010|NOT COMPLETED|Overall Study||0
10222169|NCT04052542|11350060|FG011|NOT COMPLETED|Overall Study||0
10222170|NCT04054193|11350086|FG000|STARTED|Cycle 1||103
10222171|NCT04054193|11350086|FG000|Treated (≥1 Dose)|Cycle 1||100
10222172|NCT04054193|11350086|FG000|COMPLETED|Cycle 1||98
10222173|NCT04054193|11350086|FG000|NOT COMPLETED|Cycle 1||5
10222174|NCT04054193|11350086|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69
10222175|NCT04054193|11350086|FG000|COMPLETED|Cycles 2-3||48
10222176|NCT04054193|11350086|FG000|NOT COMPLETED|Cycles 2-3||21
10222177|NCT04050618|11350093|FG000|STARTED|First Intervention||58
10222178|NCT04050618|11350094|FG001|STARTED|First Intervention||56
10222179|NCT04050618|11350093|FG000|COMPLETED|First Intervention||56
10222180|NCT04050618|11350094|FG001|COMPLETED|First Intervention||56
10222181|NCT04050618|11350093|FG000|NOT COMPLETED|First Intervention||2
10222182|NCT04050618|11350094|FG001|NOT COMPLETED|First Intervention||0
10222183|NCT04050618|11350093|FG000|STARTED|Second Intervention||56
10222184|NCT04050618|11350094|FG001|STARTED|Second Intervention||56
10222185|NCT04050618|11350093|FG000|COMPLETED|Second Intervention||55
10222186|NCT04050618|11350094|FG001|COMPLETED|Second Intervention||56
10222187|NCT04050618|11350093|FG000|NOT COMPLETED|Second Intervention||1
10222188|NCT04050618|11350094|FG001|NOT COMPLETED|Second Intervention||0
10222189|NCT04053465|11350107|FG000|STARTED|Overall Study||22
10222190|NCT04053465|11350108|FG001|STARTED|Overall Study||12
10222191|NCT04053465|11350107|FG000|COMPLETED|Overall Study||18
10222192|NCT04053465|11350108|FG001|COMPLETED|Overall Study||8
10222193|NCT04053465|11350107|FG000|NOT COMPLETED|Overall Study||4
10222194|NCT04053465|11350108|FG001|NOT COMPLETED|Overall Study||4
10222195|NCT04053270|11350116|FG000|STARTED|Overall Study||49
10222196|NCT04053270|11350117|FG001|STARTED|Overall Study||51
10222197|NCT04053270|11350116|FG000|COMPLETED|Overall Study||47
10222198|NCT04053270|11350117|FG001|COMPLETED|Overall Study||46
10222199|NCT04053270|11350116|FG000|NOT COMPLETED|Overall Study||2
10222200|NCT04053270|11350117|FG001|NOT COMPLETED|Overall Study||5
10222201|NCT04049552|11350127|FG000|STARTED|Overall Study||4
10222202|NCT04049552|11350127|FG000|COMPLETED|Overall Study||3
10222203|NCT04049552|11350127|FG000|NOT COMPLETED|Overall Study||1
10222204|NCT04053023|11350135|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
10222205|NCT04053023|11350136|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
10222206|NCT04053023|11350135|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
10222207|NCT04053023|11350136|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
10222208|NCT04053023|11350135|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
10012709|NCT01787097|11135564|FG001|COMPLETED|Overall Study||7
10012710|NCT01787097|11135565|FG002|COMPLETED|Overall Study||7
10222209|NCT04053023|11350136|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
10222210|NCT04053023|11350135|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
10222211|NCT04053023|11350136|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
10222212|NCT04053023|11350135|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
10222213|NCT04053023|11350136|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
10012711|NCT01787097|11135566|FG003|COMPLETED|Overall Study||9
10222214|NCT04053023|11350135|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
10222215|NCT04053023|11350136|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
10222216|NCT04053023|11350135|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
10222217|NCT04053023|11350136|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
10222218|NCT04053023|11350135|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10222219|NCT04053023|11350136|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10012712|NCT01787097|11135563|FG000|NOT COMPLETED|Overall Study||1
10222220|NCT04053023|11350135|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10222221|NCT04053023|11350136|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10222222|NCT04053023|11350135|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
10222223|NCT04053023|11350136|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
10222224|NCT04053023|11350135|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10222225|NCT04053023|11350136|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10222226|NCT04053023|11350135|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10222227|NCT04053023|11350136|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10222228|NCT04051710|11350149|FG000|STARTED|Overall Study||620
10222229|NCT04051710|11350150|FG001|STARTED|Overall Study||620
10222230|NCT04051710|11350151|FG002|STARTED|Overall Study||310
10222231|NCT04051710|11350149|FG000|COMPLETED|Overall Study||616
10222232|NCT04051710|11350150|FG001|COMPLETED|Overall Study||612
10222233|NCT04051710|11350151|FG002|COMPLETED|Overall Study||306
10222234|NCT04051710|11350149|FG000|NOT COMPLETED|Overall Study||4
10222235|NCT04051710|11350150|FG001|NOT COMPLETED|Overall Study||8
10222236|NCT04051710|11350151|FG002|NOT COMPLETED|Overall Study||4
10222237|NCT04050865|11350161|FG000|STARTED|Overall Study||48
10222238|NCT04050865|11350162|FG001|STARTED|Overall Study||48
10222239|NCT04050865|11350161|FG000|COMPLETED|Overall Study||44
10222240|NCT04050865|11350162|FG001|COMPLETED|Overall Study||43
10222241|NCT04050865|11350161|FG000|NOT COMPLETED|Overall Study||4
10222242|NCT04050865|11350162|FG001|NOT COMPLETED|Overall Study||5
10222243|NCT04050605|11350168|FG000|STARTED|Overall Study||40
10222244|NCT04050605|11350168|FG000|COMPLETED|Overall Study||40
10222245|NCT04050605|11350168|FG000|NOT COMPLETED|Overall Study||0
10222246|NCT04050371|11350180|FG000|STARTED|Overall Study||24
10222247|NCT04050371|11350181|FG001|STARTED|Overall Study||24
10222248|NCT04050371|11350180|FG000|COMPLETED|Overall Study||23
10222249|NCT04050371|11350181|FG001|COMPLETED|Overall Study||24
10222250|NCT04050371|11350180|FG000|NOT COMPLETED|Overall Study||1
10222251|NCT04050371|11350181|FG001|NOT COMPLETED|Overall Study||0
10222252|NCT04048460|11350187|FG000|STARTED|Overall Study||10
10222253|NCT04048460|11350187|FG000|COMPLETED|Overall Study||10
10222254|NCT04048460|11350187|FG000|NOT COMPLETED|Overall Study||0
10222255|NCT04048681|11350191|FG000|STARTED|Overall Study||1
10222256|NCT04048681|11350192|FG001|STARTED|Overall Study||1
10222257|NCT04048681|11350193|FG002|STARTED|Overall Study||1
10222258|NCT04048681|11350194|FG003|STARTED|Overall Study||1
10222259|NCT04048681|11350195|FG004|STARTED|Overall Study||1
10222260|NCT04048681|11350191|FG000|COMPLETED|Overall Study||1
10222261|NCT04048681|11350192|FG001|COMPLETED|Overall Study||1
10222262|NCT04048681|11350193|FG002|COMPLETED|Overall Study||1
10222263|NCT04048681|11350194|FG003|COMPLETED|Overall Study||0
10222264|NCT04048681|11350195|FG004|COMPLETED|Overall Study||1
10222265|NCT04048681|11350191|FG000|NOT COMPLETED|Overall Study||0
10222266|NCT04048681|11350192|FG001|NOT COMPLETED|Overall Study||0
10222267|NCT04048681|11350193|FG002|NOT COMPLETED|Overall Study||0
10222268|NCT04048681|11350194|FG003|NOT COMPLETED|Overall Study||1
10222269|NCT04048681|11350195|FG004|NOT COMPLETED|Overall Study||0
10222270|NCT04046250|11350205|FG000|STARTED|Overall Study||11
10222271|NCT04046250|11350206|FG001|STARTED|Overall Study||11
10222272|NCT04046250|11350205|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
10222273|NCT04046250|11350206|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
10222274|NCT04046250|11350205|FG000|NOT COMPLETED|Overall Study||3
10222275|NCT04046250|11350206|FG001|NOT COMPLETED|Overall Study||4
10222276|NCT04047342|11350214|FG000|STARTED|Overall Study||409
10222277|NCT04047342|11350215|FG001|STARTED|Overall Study||415
10222278|NCT04047342|11350214|FG000|COMPLETED|Overall Study||409
10222279|NCT04047342|11350215|FG001|COMPLETED|Overall Study||415
10222280|NCT04047342|11350214|FG000|NOT COMPLETED|Overall Study||0
10222281|NCT04047342|11350215|FG001|NOT COMPLETED|Overall Study||0
10222282|NCT04044352|11350221|FG000|STARTED|Overall Study||76
10222283|NCT04044352|11350221|FG000|COMPLETED|Overall Study||65
10222284|NCT04044352|11350221|FG000|NOT COMPLETED|Overall Study||11
10222285|NCT04043728|11350229|FG000|STARTED|Overall Study||6
10222286|NCT04043728|11350230|FG001|STARTED|Overall Study||6
10222287|NCT04043728|11350231|FG002|STARTED|Overall Study||6
10222288|NCT04043728|11350229|FG000|COMPLETED|Overall Study||5
10222289|NCT04043728|11350230|FG001|COMPLETED|Overall Study||4
10222290|NCT04043728|11350231|FG002|COMPLETED|Overall Study||6
10222291|NCT04043728|11350229|FG000|NOT COMPLETED|Overall Study||1
10222292|NCT04043728|11350230|FG001|NOT COMPLETED|Overall Study||2
10222293|NCT04043728|11350231|FG002|NOT COMPLETED|Overall Study||0
10222294|NCT04041453|11350243|FG000|STARTED|Overall Study||38
10222295|NCT04041453|11350244|FG001|STARTED|Overall Study||57
10222296|NCT04041453|11350245|FG002|STARTED|Overall Study||23
9760889|NCT00384033|10864704|FG003|COMPLETED|Overall Study||119
9760890|NCT00384033|10864701|FG000|NOT COMPLETED|Overall Study||41
9760891|NCT00384033|10864702|FG001|NOT COMPLETED|Overall Study||35
9760892|NCT00384033|10864703|FG002|NOT COMPLETED|Overall Study||43
9760893|NCT00384033|10864704|FG003|NOT COMPLETED|Overall Study||40
9760894|NCT00384059|10864716|FG000|STARTED|Infant Series||141
9760895|NCT00384059|10864717|FG001|STARTED|Infant Series||145
9760896|NCT00384059|10864716|FG000|Vaccinated Dose 1|Infant Series||139
9760897|NCT00384059|10864717|FG001|Vaccinated Dose 1|Infant Series||139
9760898|NCT00384059|10864716|FG000|Vaccinated Dose 2|Infant Series||136
9760899|NCT00384059|10864717|FG001|Vaccinated Dose 2|Infant Series||135
9760900|NCT00384059|10864716|FG000|COMPLETED|Infant Series||135
9760901|NCT00384059|10864717|FG001|COMPLETED|Infant Series||132
9760902|NCT00384059|10864716|FG000|NOT COMPLETED|Infant Series||6
10222297|NCT04041453|11350246|FG003|STARTED|Overall Study||58
10222298|NCT04041453|11350243|FG000|Safety Population|Overall Study||38
10222299|NCT04041453|11350244|FG001|Safety Population|Overall Study||56
10222300|NCT04041453|11350245|FG002|Safety Population|Overall Study||23
10222301|NCT04041453|11350246|FG003|Safety Population|Overall Study||58
10222302|NCT04041453|11350243|FG000|COMPLETED|Overall Study||24
10222303|NCT04041453|11350244|FG001|COMPLETED|Overall Study||35
10222304|NCT04041453|11350245|FG002|COMPLETED|Overall Study||18
10222305|NCT04041453|11350246|FG003|COMPLETED|Overall Study||40
10222306|NCT04041453|11350243|FG000|NOT COMPLETED|Overall Study||14
10222307|NCT04041453|11350244|FG001|NOT COMPLETED|Overall Study||22
10222308|NCT04041453|11350245|FG002|NOT COMPLETED|Overall Study||5
10222309|NCT04041453|11350246|FG003|NOT COMPLETED|Overall Study||18
10222310|NCT04041414|11350260|FG000|STARTED|Overall Study||27
10222311|NCT04041414|11350261|FG001|STARTED|Overall Study||20
10222312|NCT04041414|11350260|FG000|COMPLETED|Overall Study||26
10222313|NCT04041414|11350261|FG001|COMPLETED|Overall Study||18
10222314|NCT04041414|11350260|FG000|NOT COMPLETED|Overall Study||1
10222315|NCT04041414|11350261|FG001|NOT COMPLETED|Overall Study||2
10222316|NCT04041219|11350270|FG000|STARTED|Overall Study||10
10222317|NCT04041219|11350270|FG000|COMPLETED|Overall Study||10
10222318|NCT04041219|11350270|FG000|NOT COMPLETED|Overall Study||0
10222319|NCT04041700|11350274|FG000|STARTED|Overall Study||29
10222320|NCT04041700|11350274|FG000|COMPLETED|Overall Study||27
10222321|NCT04041700|11350274|FG000|NOT COMPLETED|Overall Study||2
10222322|NCT04040933|11350278|FG000|STARTED|Overall Study||36
10222323|NCT04040933|11350278|FG000|Treated|Overall Study||36
10222324|NCT04040933|11350278|FG000|COMPLETED|Overall Study||33
10222325|NCT04040933|11350278|FG000|NOT COMPLETED|Overall Study||3
10239243|NCT00308113|11370785|FG001|COMPLETED|Overall Study||0
10239244|NCT00308113|11370786|FG002|COMPLETED|Overall Study||1
10239245|NCT00308113|11370787|FG003|COMPLETED|Overall Study||1
10239246|NCT00308113|11370784|FG000|NOT COMPLETED|Overall Study||0
10239247|NCT00308113|11370785|FG001|NOT COMPLETED|Overall Study||0
10239248|NCT00308113|11370786|FG002|NOT COMPLETED|Overall Study||0
10239249|NCT00308113|11370787|FG003|NOT COMPLETED|Overall Study||1
10239250|NCT00305643|11370799|FG000|STARTED|Overall Study||6
10239251|NCT00305643|11370800|FG001|STARTED|Overall Study||5
10239252|NCT00305643|11370799|FG000|COMPLETED|Overall Study||6
10239253|NCT00305643|11370800|FG001|COMPLETED|Overall Study||5
10239254|NCT00305643|11370799|FG000|NOT COMPLETED|Overall Study||0
10239255|NCT00305643|11370800|FG001|NOT COMPLETED|Overall Study||0
10239256|NCT00298740|11370807|FG000|STARTED|Overall Study||12
10239257|NCT00298740|11370807|FG000|COMPLETED|Overall Study||3
10239258|NCT00298740|11370807|FG000|NOT COMPLETED|Overall Study||9
10239259|NCT00301080|11370811|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4
10239260|NCT00301080|11370812|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3
10239261|NCT00301080|11370813|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
10239262|NCT00301080|11370814|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
10239263|NCT00301080|11370815|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
10239264|NCT00301080|11370811|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
10239265|NCT00301080|11370812|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
10239266|NCT00301080|11370813|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
10239267|NCT00301080|11370814|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
10239268|NCT00301080|11370815|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
10239269|NCT00301080|11370811|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
10239270|NCT00301080|11370812|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
10239271|NCT00301080|11370813|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
10239272|NCT00301080|11370814|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
10239273|NCT00301080|11370815|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
10239274|NCT00301080|11370811|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
10239275|NCT00301080|11370812|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
10239276|NCT00301080|11370813|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10239277|NCT00301080|11370814|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10239278|NCT00301080|11370815|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10239279|NCT00301080|11370811|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
10239280|NCT00301080|11370812|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10239281|NCT00301080|11370813|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10239282|NCT00301080|11370814|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10239283|NCT00301080|11370815|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10239284|NCT00301080|11370811|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
10239285|NCT00301080|11370812|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
10239286|NCT00301080|11370813|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0
10239287|NCT00301080|11370814|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0
10239288|NCT00301080|11370815|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0
10239289|NCT00301080|11370811|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10239290|NCT00301080|11370812|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10239291|NCT00301080|11370813|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10239292|NCT00301080|11370814|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10222326|NCT04039867|11350289|FG000|STARTED|Overall Study||17
10222327|NCT04039867|11350289|FG000|COMPLETED|Overall Study||17
10222328|NCT04039867|11350289|FG000|NOT COMPLETED|Overall Study||0
10222329|NCT04039412|11350296|FG000|STARTED|Overall Study||110
10222330|NCT04039412|11350297|FG001|STARTED|Overall Study||110
10222331|NCT04039412|11350298|FG002|STARTED|Overall Study||110
10222332|NCT04039412|11350296|FG000|COMPLETED|Overall Study||109
10222333|NCT04039412|11350297|FG001|COMPLETED|Overall Study||107
10222334|NCT04039412|11350298|FG002|COMPLETED|Overall Study||108
10222335|NCT04039412|11350296|FG000|NOT COMPLETED|Overall Study||1
10222336|NCT04039412|11350297|FG001|NOT COMPLETED|Overall Study||3
10222337|NCT04039412|11350298|FG002|NOT COMPLETED|Overall Study||2
10222338|NCT04035161|11350309|FG000|STARTED|Overall Study||1121
10222339|NCT04035161|11350309|FG000|Treated With Investigational Product|Overall Study||609
10222340|NCT04035161|11350309|FG000|Treated With Reference Standard|Overall Study||419
10222341|NCT04035161|11350309|FG000|Treated With Active Control|Overall Study||609
10222342|NCT04035161|11350309|FG000|Treated With Negative Control|Overall Study||605
10222343|NCT04035161|11350309|FG000|COMPLETED|Overall Study||1121
10222344|NCT04035161|11350309|FG000|NOT COMPLETED|Overall Study||0
10222345|NCT04029519|11350319|FG000|STARTED|Overall Study||84
10222346|NCT04029519|11350319|FG000|COMPLETED|Overall Study||79
10222347|NCT04029519|11350319|FG000|NOT COMPLETED|Overall Study||5
10222348|NCT04039919|11350328|FG000|STARTED|Treatment Period 1||7
10222349|NCT04039919|11350329|FG001|STARTED|Treatment Period 1||6
10222350|NCT04039919|11350330|FG002|STARTED|Treatment Period 1||5
10222351|NCT04039919|11350331|FG003|STARTED|Treatment Period 1||6
10222352|NCT04039919|11350332|FG004|STARTED|Treatment Period 1||16
10222353|NCT04039919|11350328|FG000|COMPLETED|Treatment Period 1||6
10222354|NCT04039919|11350329|FG001|COMPLETED|Treatment Period 1||6
10222355|NCT04039919|11350330|FG002|COMPLETED|Treatment Period 1||5
10222356|NCT04039919|11350331|FG003|COMPLETED|Treatment Period 1||6
10222357|NCT04039919|11350332|FG004|COMPLETED|Treatment Period 1||0
10222358|NCT04039919|11350328|FG000|NOT COMPLETED|Treatment Period 1||1
10222359|NCT04039919|11350329|FG001|NOT COMPLETED|Treatment Period 1||0
10222360|NCT04039919|11350330|FG002|NOT COMPLETED|Treatment Period 1||0
10222361|NCT04039919|11350331|FG003|NOT COMPLETED|Treatment Period 1||0
10222362|NCT04039919|11350332|FG004|NOT COMPLETED|Treatment Period 1||16
10222363|NCT04039919|11350328|FG000|STARTED|Treatment Period 2||6
10222364|NCT04039919|11350329|FG001|STARTED|Treatment Period 2||6
10222365|NCT04039919|11350330|FG002|STARTED|Treatment Period 2||5
10222366|NCT04039919|11350331|FG003|STARTED|Treatment Period 2||6
10222367|NCT04039919|11350332|FG004|STARTED|Treatment Period 2||0
10222368|NCT04039919|11350328|FG000|COMPLETED|Treatment Period 2||6
10222369|NCT04039919|11350329|FG001|COMPLETED|Treatment Period 2||6
10222370|NCT04039919|11350330|FG002|COMPLETED|Treatment Period 2||5
10222371|NCT04039919|11350331|FG003|COMPLETED|Treatment Period 2||6
10222372|NCT04039919|11350332|FG004|COMPLETED|Treatment Period 2||0
10222373|NCT04039919|11350328|FG000|NOT COMPLETED|Treatment Period 2||0
10222374|NCT04039919|11350329|FG001|NOT COMPLETED|Treatment Period 2||0
10222375|NCT04039919|11350330|FG002|NOT COMPLETED|Treatment Period 2||0
10222376|NCT04039919|11350331|FG003|NOT COMPLETED|Treatment Period 2||0
10222377|NCT04039919|11350332|FG004|NOT COMPLETED|Treatment Period 2||0
10222378|NCT04039919|11350328|FG000|STARTED|Treatment Period 3||6
10222379|NCT04039919|11350329|FG001|STARTED|Treatment Period 3||6
10222380|NCT04039919|11350330|FG002|STARTED|Treatment Period 3||5
10222381|NCT04039919|11350331|FG003|STARTED|Treatment Period 3||6
10222382|NCT04039919|11350332|FG004|STARTED|Treatment Period 3||0
10222383|NCT04039919|11350328|FG000|COMPLETED|Treatment Period 3||6
10222384|NCT04039919|11350329|FG001|COMPLETED|Treatment Period 3||6
10222385|NCT04039919|11350330|FG002|COMPLETED|Treatment Period 3||5
10222386|NCT04039919|11350331|FG003|COMPLETED|Treatment Period 3||6
10222387|NCT04039919|11350332|FG004|COMPLETED|Treatment Period 3||0
10222388|NCT04039919|11350328|FG000|NOT COMPLETED|Treatment Period 3||0
10222389|NCT04039919|11350329|FG001|NOT COMPLETED|Treatment Period 3||0
10222390|NCT04039919|11350330|FG002|NOT COMPLETED|Treatment Period 3||0
10222391|NCT04039919|11350331|FG003|NOT COMPLETED|Treatment Period 3||0
10222392|NCT04039919|11350332|FG004|NOT COMPLETED|Treatment Period 3||0
10222393|NCT04039919|11350328|FG000|STARTED|Treatment Period 4||6
10222394|NCT04039919|11350329|FG001|STARTED|Treatment Period 4||6
10222395|NCT04039919|11350330|FG002|STARTED|Treatment Period 4||5
10222396|NCT04039919|11350331|FG003|STARTED|Treatment Period 4||6
10222397|NCT04039919|11350332|FG004|STARTED|Treatment Period 4||0
10222398|NCT04039919|11350328|FG000|COMPLETED|Treatment Period 4||6
10222399|NCT04039919|11350329|FG001|COMPLETED|Treatment Period 4||6
10222400|NCT04039919|11350330|FG002|COMPLETED|Treatment Period 4||5
10222401|NCT04039919|11350331|FG003|COMPLETED|Treatment Period 4||6
10222402|NCT04039919|11350332|FG004|COMPLETED|Treatment Period 4||0
10222403|NCT04039919|11350328|FG000|NOT COMPLETED|Treatment Period 4||0
10222404|NCT04039919|11350329|FG001|NOT COMPLETED|Treatment Period 4||0
10222405|NCT04039919|11350330|FG002|NOT COMPLETED|Treatment Period 4||0
10222406|NCT04039919|11350331|FG003|NOT COMPLETED|Treatment Period 4||0
10222407|NCT04039919|11350332|FG004|NOT COMPLETED|Treatment Period 4||0
10222408|NCT04039919|11350328|FG000|STARTED|Treatment Period 5||6
10222409|NCT04039919|11350329|FG001|STARTED|Treatment Period 5||6
10222410|NCT04039919|11350330|FG002|STARTED|Treatment Period 5||5
10222411|NCT04039919|11350331|FG003|STARTED|Treatment Period 5||6
10222412|NCT04039919|11350332|FG004|STARTED|Treatment Period 5||0
10222413|NCT04039919|11350328|FG000|COMPLETED|Treatment Period 5||5
10222414|NCT04039919|11350329|FG001|COMPLETED|Treatment Period 5||6
10222415|NCT04039919|11350330|FG002|COMPLETED|Treatment Period 5||5
10222416|NCT04039919|11350331|FG003|COMPLETED|Treatment Period 5||6
10222417|NCT04039919|11350332|FG004|COMPLETED|Treatment Period 5||0
10222418|NCT04039919|11350328|FG000|NOT COMPLETED|Treatment Period 5||1
10222419|NCT04039919|11350329|FG001|NOT COMPLETED|Treatment Period 5||0
10222420|NCT04039919|11350330|FG002|NOT COMPLETED|Treatment Period 5||0
10222421|NCT04039919|11350331|FG003|NOT COMPLETED|Treatment Period 5||0
10222422|NCT04039919|11350332|FG004|NOT COMPLETED|Treatment Period 5||0
10222423|NCT04039919|11350328|FG000|STARTED|Treatment Period 6||5
10222424|NCT04039919|11350329|FG001|STARTED|Treatment Period 6||6
10222425|NCT04039919|11350330|FG002|STARTED|Treatment Period 6||5
10222426|NCT04039919|11350331|FG003|STARTED|Treatment Period 6||6
10222427|NCT04039919|11350332|FG004|STARTED|Treatment Period 6||0
10222428|NCT04039919|11350328|FG000|COMPLETED|Treatment Period 6||5
10012713|NCT01787097|11135564|FG001|NOT COMPLETED|Overall Study||0
10012714|NCT01787097|11135565|FG002|NOT COMPLETED|Overall Study||0
10012715|NCT01787097|11135566|FG003|NOT COMPLETED|Overall Study||0
10222429|NCT04039919|11350329|FG001|COMPLETED|Treatment Period 6||6
10222430|NCT04039919|11350330|FG002|COMPLETED|Treatment Period 6||5
10222431|NCT04039919|11350331|FG003|COMPLETED|Treatment Period 6||6
10222432|NCT04039919|11350332|FG004|COMPLETED|Treatment Period 6||0
10222433|NCT04039919|11350328|FG000|NOT COMPLETED|Treatment Period 6||0
10222434|NCT04039919|11350329|FG001|NOT COMPLETED|Treatment Period 6||0
10222435|NCT04039919|11350330|FG002|NOT COMPLETED|Treatment Period 6||0
10222436|NCT04039919|11350331|FG003|NOT COMPLETED|Treatment Period 6||0
10222437|NCT04039919|11350332|FG004|NOT COMPLETED|Treatment Period 6||0
10222438|NCT04037969|11350368|FG000|STARTED|Overall Study||10
10222439|NCT04037969|11350369|FG001|STARTED|Overall Study||10
10222440|NCT04037969|11350368|FG000|COMPLETED|Overall Study||10
10222441|NCT04037969|11350369|FG001|COMPLETED|Overall Study||10
10222442|NCT04037969|11350368|FG000|NOT COMPLETED|Overall Study||0
10222443|NCT04037969|11350369|FG001|NOT COMPLETED|Overall Study||0
10222444|NCT04037865|11350374|FG000|STARTED|Overall Study||8
10222445|NCT04037865|11350374|FG000|COMPLETED|Overall Study||8
10222446|NCT04037865|11350374|FG000|NOT COMPLETED|Overall Study||0
10222447|NCT04037748|11350381|FG000|STARTED|Treatment Period 1||36
10222448|NCT04037748|11350382|FG001|STARTED|Treatment Period 1||36
10222449|NCT04037748|11350381|FG000|COMPLETED|Treatment Period 1||28
10222450|NCT04037748|11350382|FG001|COMPLETED|Treatment Period 1||30
10222451|NCT04037748|11350381|FG000|NOT COMPLETED|Treatment Period 1||8
10222452|NCT04037748|11350382|FG001|NOT COMPLETED|Treatment Period 1||6
10222453|NCT04037748|11350381|FG000|STARTED|Treatment Period 2||28
10222454|NCT04037748|11350382|FG001|STARTED|Treatment Period 2||30
10222455|NCT04037748|11350381|FG000|COMPLETED|Treatment Period 2||26
10222456|NCT04037748|11350382|FG001|COMPLETED|Treatment Period 2||29
10222457|NCT04037748|11350381|FG000|NOT COMPLETED|Treatment Period 2||2
10222458|NCT04037748|11350382|FG001|NOT COMPLETED|Treatment Period 2||1
10222459|NCT04036838|11350388|FG000|STARTED|Overall Study||415
10222460|NCT04036838|11350388|FG000|COMPLETED|Overall Study||324
10222461|NCT04036838|11350388|FG000|NOT COMPLETED|Overall Study||91
10222462|NCT04034121|11350392|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
10222463|NCT04034121|11350392|FG000|COMPLETED|European Cohort||30
10222464|NCT04034121|11350392|FG000|NOT COMPLETED|European Cohort||0
10222465|NCT04034121|11350392|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
10222466|NCT04034121|11350392|FG000|COMPLETED|Brazil Cohort||20
10222467|NCT04034121|11350392|FG000|NOT COMPLETED|Brazil Cohort||0
10222468|NCT04027686|11350399|FG000|STARTED|Overall Study||17
10222469|NCT04027686|11350400|FG001|STARTED|Overall Study||6
10222470|NCT04027686|11350399|FG000|COMPLETED|Overall Study||15
10222471|NCT04027686|11350400|FG001|COMPLETED|Overall Study||5
10222472|NCT04027686|11350399|FG000|NOT COMPLETED|Overall Study||2
10222473|NCT04027686|11350400|FG001|NOT COMPLETED|Overall Study||1
10222474|NCT04022694|11350412|FG000|STARTED|Overall Study||167
10222475|NCT04022694|11350413|FG001|STARTED|Overall Study||145
10222476|NCT04022694|11350414|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
10222477|NCT04022694|11350415|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
10222478|NCT04022694|11350412|FG000|COMPLETED|Overall Study||167
10222479|NCT04022694|11350413|FG001|COMPLETED|Overall Study||145
10222480|NCT04022694|11350414|FG002|COMPLETED|Overall Study||143
10222481|NCT04022694|11350415|FG003|COMPLETED|Overall Study||173
10222482|NCT04022694|11350412|FG000|NOT COMPLETED|Overall Study||0
10222483|NCT04022694|11350413|FG001|NOT COMPLETED|Overall Study||0
10222484|NCT04022694|11350414|FG002|NOT COMPLETED|Overall Study||0
10222485|NCT04022694|11350415|FG003|NOT COMPLETED|Overall Study||0
10012716|NCT01787175|11135588|FG000|STARTED|Overall Study||30
10222486|NCT04036110|11350430|FG000|STARTED|Overall Study||12
10222487|NCT04036110|11350431|FG001|STARTED|Overall Study||12
10222488|NCT04036110|11350432|FG002|STARTED|Overall Study||12
10222489|NCT04036110|11350430|FG000|COMPLETED|Overall Study||5
10222490|NCT04036110|11350431|FG001|COMPLETED|Overall Study||5
10222491|NCT04036110|11350432|FG002|COMPLETED|Overall Study||10
10222492|NCT04036110|11350430|FG000|NOT COMPLETED|Overall Study||7
10222493|NCT04036110|11350431|FG001|NOT COMPLETED|Overall Study||7
10222494|NCT04036110|11350432|FG002|NOT COMPLETED|Overall Study||2
10222495|NCT04035694|11350442|FG000|STARTED|Overall Study||374
10222496|NCT04035694|11350443|FG001|STARTED|Overall Study||216
10012717|NCT01787175|11135589|FG001|STARTED|Overall Study||28
10222497|NCT04035694|11350442|FG000|COMPLETED|Overall Study||374
10222498|NCT04035694|11350443|FG001|COMPLETED|Overall Study||216
10222499|NCT04035694|11350442|FG000|NOT COMPLETED|Overall Study||0
10222500|NCT04035694|11350443|FG001|NOT COMPLETED|Overall Study||0
10222501|NCT04035577|11350449|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
10222502|NCT04035577|11350449|FG000|COMPLETED|Overall Study||19
10222503|NCT04035577|11350449|FG000|NOT COMPLETED|Overall Study||2
10222504|NCT04035564|11350457|FG000|STARTED|Overall Study||27
10222505|NCT04035564|11350458|FG001|STARTED|Overall Study||25
10222506|NCT04035564|11350457|FG000|COMPLETED|Overall Study||23
10222507|NCT04035564|11350458|FG001|COMPLETED|Overall Study||19
10222508|NCT04035564|11350457|FG000|NOT COMPLETED|Overall Study||4
10222509|NCT04035564|11350458|FG001|NOT COMPLETED|Overall Study||6
10222510|NCT04032977|11350466|FG000|STARTED|Overall Study||80
10222511|NCT04032977|11350467|FG001|STARTED|Overall Study||78
10222512|NCT04032977|11350466|FG000|COMPLETED|Overall Study||71
10222513|NCT04032977|11350467|FG001|COMPLETED|Overall Study||70
10222514|NCT04032977|11350466|FG000|NOT COMPLETED|Overall Study||9
10222515|NCT04032977|11350467|FG001|NOT COMPLETED|Overall Study||8
10222516|NCT04032652|11350475|FG000|STARTED|Overall Study||1
10222517|NCT04032652|11350476|FG001|STARTED|Overall Study||1
10222518|NCT04032652|11350475|FG000|COMPLETED|Overall Study||0
10222519|NCT04032652|11350476|FG001|COMPLETED|Overall Study||0
10222520|NCT04032652|11350475|FG000|NOT COMPLETED|Overall Study||1
10222521|NCT04032652|11350476|FG001|NOT COMPLETED|Overall Study||1
10222522|NCT04024501|11350482|FG000|STARTED|Overall Study||25
10222523|NCT04024501|11350482|FG000|COMPLETED|Overall Study||25
10222524|NCT04024501|11350482|FG000|NOT COMPLETED|Overall Study||0
10222525|NCT04032613|11350496|FG000|STARTED|Overall Study||21
10222526|NCT04032613|11350497|FG001|STARTED|Overall Study||25
10222527|NCT04032613|11350496|FG000|COMPLETED|Overall Study||16
10222528|NCT04032613|11350497|FG001|COMPLETED|Overall Study||23
10222529|NCT04032613|11350496|FG000|NOT COMPLETED|Overall Study||5
10222530|NCT04032613|11350497|FG001|NOT COMPLETED|Overall Study||2
10222531|NCT04032171|11350505|FG000|STARTED|Overall Study||1
10222532|NCT04032171|11350506|FG001|STARTED|Overall Study||0
10222533|NCT04032171|11350505|FG000|COMPLETED|Overall Study||0
10222534|NCT04032171|11350506|FG001|COMPLETED|Overall Study||0
10222535|NCT04032171|11350505|FG000|NOT COMPLETED|Overall Study||1
10222536|NCT04032171|11350506|FG001|NOT COMPLETED|Overall Study||0
10222537|NCT04032158|11350514|FG000|STARTED|Overall Study||2
10222538|NCT04032158|11350515|FG001|STARTED|Overall Study||1
10222539|NCT04032158|11350514|FG000|COMPLETED|Overall Study||0
10222540|NCT04032158|11350515|FG001|COMPLETED|Overall Study||0
10222541|NCT04032158|11350514|FG000|NOT COMPLETED|Overall Study||2
10222542|NCT04032158|11350515|FG001|NOT COMPLETED|Overall Study||1
10222543|NCT04031404|11350521|FG000|STARTED|Baseline||10
10222544|NCT04031404|11350522|FG001|STARTED|Baseline||13
10222545|NCT04031404|11350521|FG000|COMPLETED|Baseline||8
10222546|NCT04031404|11350522|FG001|COMPLETED|Baseline||8
10222547|NCT04031404|11350521|FG000|NOT COMPLETED|Baseline||2
10222548|NCT04031404|11350522|FG001|NOT COMPLETED|Baseline||5
10222549|NCT04031404|11350521|FG000|STARTED|Pre-randomization||8
10222550|NCT04031404|11350522|FG001|STARTED|Pre-randomization||8
10222551|NCT04031404|11350521|FG000|COMPLETED|Pre-randomization||6
10222552|NCT04031404|11350522|FG001|COMPLETED|Pre-randomization||5
10222553|NCT04031404|11350521|FG000|NOT COMPLETED|Pre-randomization||2
10222554|NCT04031404|11350522|FG001|NOT COMPLETED|Pre-randomization||3
10222555|NCT04031404|11350521|FG000|STARTED|First Drink Visit||6
10222556|NCT04031404|11350522|FG001|STARTED|First Drink Visit||5
10222557|NCT04031404|11350521|FG000|COMPLETED|First Drink Visit||6
10222558|NCT04031404|11350522|FG001|COMPLETED|First Drink Visit||5
10222559|NCT04031404|11350521|FG000|NOT COMPLETED|First Drink Visit||0
10222560|NCT04031404|11350522|FG001|NOT COMPLETED|First Drink Visit||0
10222561|NCT04031404|11350521|FG000|STARTED|Washout (5 Day Min)||6
10222562|NCT04031404|11350522|FG001|STARTED|Washout (5 Day Min)||5
10222563|NCT04031404|11350521|FG000|COMPLETED|Washout (5 Day Min)||5
10222564|NCT04031404|11350522|FG001|COMPLETED|Washout (5 Day Min)||5
10222565|NCT04031404|11350521|FG000|NOT COMPLETED|Washout (5 Day Min)||1
10222566|NCT04031404|11350522|FG001|NOT COMPLETED|Washout (5 Day Min)||0
10222567|NCT04031404|11350521|FG000|STARTED|Second Drink Visit||5
10222568|NCT04031404|11350522|FG001|STARTED|Second Drink Visit||5
10222569|NCT04031404|11350521|FG000|COMPLETED|Second Drink Visit||5
10222570|NCT04031404|11350522|FG001|COMPLETED|Second Drink Visit||5
10222571|NCT04031404|11350521|FG000|NOT COMPLETED|Second Drink Visit||0
10222572|NCT04031404|11350522|FG001|NOT COMPLETED|Second Drink Visit||0
10222573|NCT04031885|11350538|FG000|STARTED|Overall Study||1
10222574|NCT04031885|11350539|FG001|STARTED|Overall Study||3
10222575|NCT04031885|11350538|FG000|Received Any Quantity of Study Treatment|Overall Study||1
10222576|NCT04031885|11350539|FG001|Received Any Quantity of Study Treatment|Overall Study||1
10222577|NCT04031885|11350538|FG000|COMPLETED|Overall Study||1
10222578|NCT04031885|11350539|FG001|COMPLETED|Overall Study||3
10222579|NCT04031885|11350538|FG000|NOT COMPLETED|Overall Study||0
10222580|NCT04031885|11350539|FG001|NOT COMPLETED|Overall Study||0
10222581|NCT04018924|11350545|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
10222582|NCT04018924|11350545|FG000|Standard Of Care Intervention|Overall Study||90
10222583|NCT04018924|11350545|FG000|EmoLED Intervention|Overall Study||90
10222584|NCT04018924|11350545|FG000|COMPLETED|Overall Study||84
10222585|NCT04018924|11350545|FG000|NOT COMPLETED|Overall Study||6
10222586|NCT04015440|11350551|FG000|STARTED|Overall Study||117
10222587|NCT04015440|11350552|FG001|STARTED|Overall Study||112
10222588|NCT04015440|11350551|FG000|COMPLETED|Overall Study||109
10222589|NCT04015440|11350552|FG001|COMPLETED|Overall Study||108
10222590|NCT04015440|11350551|FG000|NOT COMPLETED|Overall Study||8
10222591|NCT04015440|11350552|FG001|NOT COMPLETED|Overall Study||4
10222592|NCT04030104|11350558|FG000|STARTED|Overall Study||480
10222593|NCT04030104|11350558|FG000|COMPLETED|Overall Study||480
10222594|NCT04030104|11350558|FG000|NOT COMPLETED|Overall Study||0
10222595|NCT04029961|11350567|FG000|STARTED|Overall Study||13
10222596|NCT04029961|11350568|FG001|STARTED|Overall Study||13
10222597|NCT04029961|11350567|FG000|COMPLETED|Overall Study||12
10222598|NCT04029961|11350568|FG001|COMPLETED|Overall Study||12
10222599|NCT04029961|11350567|FG000|NOT COMPLETED|Overall Study||1
10222600|NCT04029961|11350568|FG001|NOT COMPLETED|Overall Study||1
10222601|NCT04025684|11350578|FG000|STARTED|Overall Study||20
10222602|NCT04025684|11350579|FG001|STARTED|Overall Study||19
10222603|NCT04025684|11350580|FG002|STARTED|Overall Study||20
10222604|NCT04025684|11350581|FG003|STARTED|Overall Study||21
10222605|NCT04025684|11350578|FG000|COMPLETED|Overall Study||18
10222606|NCT04025684|11350579|FG001|COMPLETED|Overall Study||15
10222607|NCT04025684|11350580|FG002|COMPLETED|Overall Study||20
10222608|NCT04025684|11350581|FG003|COMPLETED|Overall Study||20
10222609|NCT04025684|11350578|FG000|NOT COMPLETED|Overall Study||2
10222610|NCT04025684|11350579|FG001|NOT COMPLETED|Overall Study||4
10222611|NCT04025684|11350580|FG002|NOT COMPLETED|Overall Study||0
10222612|NCT04025684|11350581|FG003|NOT COMPLETED|Overall Study||1
10222613|NCT04019054|11350593|FG000|STARTED|Overall Study||11
10222614|NCT04019054|11350594|FG001|STARTED|Overall Study||11
10222615|NCT04019054|11350593|FG000|COMPLETED|Overall Study||8
10222616|NCT04019054|11350594|FG001|COMPLETED|Overall Study||9
10222617|NCT04019054|11350593|FG000|NOT COMPLETED|Overall Study||3
10222618|NCT04019054|11350594|FG001|NOT COMPLETED|Overall Study||2
10222619|NCT04029545|11350603|FG000|STARTED|Overall Study||2
10222620|NCT04029545|11350604|FG001|STARTED|Overall Study||1
10222621|NCT04029545|11350605|FG002|STARTED|Overall Study||2
10222622|NCT04029545|11350603|FG000|COMPLETED|Overall Study||2
10222623|NCT04029545|11350604|FG001|COMPLETED|Overall Study||1
10222624|NCT04029545|11350605|FG002|COMPLETED|Overall Study||2
10222625|NCT04029545|11350603|FG000|NOT COMPLETED|Overall Study||0
10222626|NCT04029545|11350604|FG001|NOT COMPLETED|Overall Study||0
10222627|NCT04029545|11350605|FG002|NOT COMPLETED|Overall Study||0
10222628|NCT04029584|11350613|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4
10222629|NCT04029584|11350614|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6
10222630|NCT04029584|11350613|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4
10222631|NCT04029584|11350614|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6
10222632|NCT04029584|11350613|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
10222633|NCT04029584|11350614|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
10222634|NCT04029584|11350613|FG000|STARTED|Uninduced Washout (1 Day)||4
10222635|NCT04029584|11350614|FG001|STARTED|Uninduced Washout (1 Day)||6
10222636|NCT04029584|11350613|FG000|COMPLETED|Uninduced Washout (1 Day)||4
10222637|NCT04029584|11350614|FG001|COMPLETED|Uninduced Washout (1 Day)||6
10222638|NCT04029584|11350613|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0
10222639|NCT04029584|11350614|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0
10222640|NCT04029584|11350613|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4
10222641|NCT04029584|11350614|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6
10222642|NCT04029584|11350613|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4
10222643|NCT04029584|11350614|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6
10222644|NCT04029584|11350613|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
10222645|NCT04029584|11350614|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
10222646|NCT04029584|11350613|FG000|STARTED|Washout Between (>1 Week)||4
10222647|NCT04029584|11350614|FG001|STARTED|Washout Between (>1 Week)||6
10222648|NCT04029584|11350613|FG000|COMPLETED|Washout Between (>1 Week)||4
10222649|NCT04029584|11350614|FG001|COMPLETED|Washout Between (>1 Week)||6
10222650|NCT04029584|11350613|FG000|NOT COMPLETED|Washout Between (>1 Week)||0
10222651|NCT04029584|11350614|FG001|NOT COMPLETED|Washout Between (>1 Week)||0
10222652|NCT04029584|11350613|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2
10222653|NCT04029584|11350614|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8
10222654|NCT04029584|11350613|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2
10222655|NCT04029584|11350614|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8
10222656|NCT04029584|11350613|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
10222657|NCT04029584|11350614|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
10222658|NCT04029584|11350613|FG000|STARTED|Induced Washout (1 Day)||2
10222659|NCT04029584|11350614|FG001|STARTED|Induced Washout (1 Day)||8
10222660|NCT04029584|11350613|FG000|COMPLETED|Induced Washout (1 Day)||2
10222661|NCT04029584|11350614|FG001|COMPLETED|Induced Washout (1 Day)||8
10222662|NCT04029584|11350613|FG000|NOT COMPLETED|Induced Washout (1 Day)||0
10222663|NCT04029584|11350614|FG001|NOT COMPLETED|Induced Washout (1 Day)||0
10222664|NCT04029584|11350613|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2
10222665|NCT04029584|11350614|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8
10222666|NCT04029584|11350613|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2
10222667|NCT04029584|11350614|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8
10222668|NCT04029584|11350613|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
10222669|NCT04029584|11350614|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
10222670|NCT04029311|11350626|FG000|STARTED|Overall Study||15
10222671|NCT04029311|11350627|FG001|STARTED|Overall Study||13
10222672|NCT04029311|11350626|FG000|COMPLETED|Overall Study||12
10222673|NCT04029311|11350627|FG001|COMPLETED|Overall Study||13
10222674|NCT04029311|11350626|FG000|NOT COMPLETED|Overall Study||3
10222675|NCT04029311|11350627|FG001|NOT COMPLETED|Overall Study||0
10222676|NCT04028960|11350635|FG000|STARTED|Overall Study||2
10222677|NCT04028960|11350636|FG001|STARTED|Overall Study||2
10222678|NCT04028960|11350635|FG000|COMPLETED|Overall Study||2
10222679|NCT04028960|11350636|FG001|COMPLETED|Overall Study||2
10222680|NCT04028960|11350635|FG000|NOT COMPLETED|Overall Study||0
10222681|NCT04028960|11350636|FG001|NOT COMPLETED|Overall Study||0
10222682|NCT04026399|11350644|FG000|STARTED|Overall Study||6
10222683|NCT04026399|11350645|FG001|STARTED|Overall Study||6
10222684|NCT04026399|11350644|FG000|COMPLETED|Overall Study||1
10222685|NCT04026399|11350645|FG001|COMPLETED|Overall Study||3
10222686|NCT04026399|11350644|FG000|NOT COMPLETED|Overall Study||5
10222687|NCT04026399|11350645|FG001|NOT COMPLETED|Overall Study||3
10222688|NCT04023578|11350651|FG000|STARTED|Overall Study||15
10222689|NCT04023578|11350651|FG000|COMPLETED|Overall Study||13
10222690|NCT04023578|11350651|FG000|NOT COMPLETED|Overall Study||2
10222691|NCT04023695|11350658|FG000|STARTED|Overall Study||57
10222692|NCT04023695|11350659|FG001|STARTED|Overall Study||53
10222693|NCT04023695|11350658|FG000|COMPLETED|Overall Study||57
10222694|NCT04023695|11350659|FG001|COMPLETED|Overall Study||53
10222695|NCT04023695|11350658|FG000|NOT COMPLETED|Overall Study||0
10222696|NCT04023695|11350659|FG001|NOT COMPLETED|Overall Study||0
10222697|NCT04018664|11350673|FG000|STARTED|Overall Study||14
10222698|NCT04018664|11350674|FG001|STARTED|Overall Study||6
10222699|NCT04018664|11350675|FG002|STARTED|Overall Study||6
10222700|NCT04018664|11350676|FG003|STARTED|Overall Study||6
10222701|NCT04018664|11350677|FG004|STARTED|Overall Study||6
10222702|NCT04018664|11350678|FG005|STARTED|Overall Study||6
10222703|NCT04018664|11350679|FG006|STARTED|Overall Study||6
10222704|NCT04018664|11350680|FG007|STARTED|Overall Study||6
10222705|NCT04018664|11350673|FG000|COMPLETED|Overall Study||14
10222706|NCT04018664|11350674|FG001|COMPLETED|Overall Study||6
10222707|NCT04018664|11350675|FG002|COMPLETED|Overall Study||6
10222708|NCT04018664|11350676|FG003|COMPLETED|Overall Study||6
10222709|NCT04018664|11350677|FG004|COMPLETED|Overall Study||6
10222710|NCT04018664|11350678|FG005|COMPLETED|Overall Study||6
10222711|NCT04018664|11350679|FG006|COMPLETED|Overall Study||6
10222712|NCT04018664|11350680|FG007|COMPLETED|Overall Study||6
10222713|NCT04018664|11350673|FG000|NOT COMPLETED|Overall Study||0
10222714|NCT04018664|11350674|FG001|NOT COMPLETED|Overall Study||0
10222715|NCT04018664|11350675|FG002|NOT COMPLETED|Overall Study||0
10222716|NCT04018664|11350676|FG003|NOT COMPLETED|Overall Study||0
10222717|NCT04018664|11350677|FG004|NOT COMPLETED|Overall Study||0
10222718|NCT04018664|11350678|FG005|NOT COMPLETED|Overall Study||0
10222719|NCT04018664|11350679|FG006|NOT COMPLETED|Overall Study||0
10222720|NCT04018664|11350680|FG007|NOT COMPLETED|Overall Study||0
10222721|NCT04016259|11350700|FG000|STARTED|Overall Study||15
10222722|NCT04016259|11350701|FG001|STARTED|Overall Study||15
10222723|NCT04016259|11350700|FG000|COMPLETED|Overall Study||15
10222724|NCT04016259|11350701|FG001|COMPLETED|Overall Study||15
10222725|NCT04016259|11350700|FG000|NOT COMPLETED|Overall Study||0
10222726|NCT04016259|11350701|FG001|NOT COMPLETED|Overall Study||0
10222727|NCT04016077|11350709|FG000|STARTED|Overall Study||10
10222728|NCT04016077|11350710|FG001|STARTED|Overall Study||8
10222729|NCT04016077|11350709|FG000|COMPLETED|Overall Study||10
10222730|NCT04016077|11350710|FG001|COMPLETED|Overall Study||8
10222731|NCT04016077|11350709|FG000|NOT COMPLETED|Overall Study||0
10222732|NCT04016077|11350710|FG001|NOT COMPLETED|Overall Study||0
10222733|NCT04027803|11350718|FG000|STARTED|Overall Study||39
10222734|NCT04027803|11350719|FG001|STARTED|Overall Study||39
10222735|NCT04027803|11350718|FG000|COMPLETED|Overall Study||39
10222736|NCT04027803|11350719|FG001|COMPLETED|Overall Study||39
10222737|NCT04027803|11350718|FG000|NOT COMPLETED|Overall Study||0
10222738|NCT04027803|11350719|FG001|NOT COMPLETED|Overall Study||0
10222739|NCT04016311|11350727|FG000|STARTED|Overall Study||18
10222740|NCT04016311|11350728|FG001|STARTED|Overall Study||20
10222741|NCT04016311|11350727|FG000|COMPLETED|Overall Study||17
10222742|NCT04016311|11350728|FG001|COMPLETED|Overall Study||20
10222743|NCT04016311|11350727|FG000|NOT COMPLETED|Overall Study||1
10222744|NCT04016311|11350728|FG001|NOT COMPLETED|Overall Study||0
10222745|NCT04027439|11350742|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
10222746|NCT04027439|11350743|FG001|STARTED|Part A (R, PC, PG) Single Dose||6
10222747|NCT04027439|11350744|FG002|STARTED|Part A (R, PC, PG) Single Dose||7
10222748|NCT04027439|11350745|FG003|STARTED|Part A (R, PC, PG) Single Dose||6
10222749|NCT04027439|11350746|FG004|STARTED|Part A (R, PC, PG) Single Dose||6
10222750|NCT04027439|11350747|FG005|STARTED|Part A (R, PC, PG) Single Dose||6
10222751|NCT04027439|11350748|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
10222752|NCT04027439|11350749|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
10222753|NCT04027439|11350750|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
10222754|NCT04027439|11350751|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
10222755|NCT04027439|11350752|FG010|STARTED|Part A (R, PC, PG) Single Dose||0
10222756|NCT04027439|11350753|FG011|STARTED|Part A (R, PC, PG) Single Dose||0
10222757|NCT04027439|11350754|FG012|STARTED|Part A (R, PC, PG) Single Dose||0
10222758|NCT04027439|11350755|FG013|STARTED|Part A (R, PC, PG) Single Dose||0
10222759|NCT04027439|11350756|FG014|STARTED|Part A (R, PC, PG) Single Dose||0
10222760|NCT04027439|11350757|FG015|STARTED|Part A (R, PC, PG) Single Dose||0
10222761|NCT04027439|11350742|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
10222762|NCT04027439|11350743|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6
10222763|NCT04027439|11350744|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7
10222764|NCT04027439|11350745|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6
10222765|NCT04027439|11350746|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6
10222766|NCT04027439|11350747|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6
10222767|NCT04027439|11350748|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222768|NCT04027439|11350749|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222769|NCT04027439|11350750|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222770|NCT04027439|11350751|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222771|NCT04027439|11350752|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222772|NCT04027439|11350753|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222773|NCT04027439|11350754|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222774|NCT04027439|11350755|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222775|NCT04027439|11350756|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222776|NCT04027439|11350757|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0
10222777|NCT04027439|11350742|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222778|NCT04027439|11350743|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222779|NCT04027439|11350744|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222780|NCT04027439|11350745|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222781|NCT04027439|11350746|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222782|NCT04027439|11350747|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222783|NCT04027439|11350748|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222784|NCT04027439|11350749|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222785|NCT04027439|11350750|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222786|NCT04027439|11350751|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222787|NCT04027439|11350752|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222788|NCT04027439|11350753|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222789|NCT04027439|11350754|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222790|NCT04027439|11350755|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222791|NCT04027439|11350756|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222792|NCT04027439|11350757|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10222793|NCT04027439|11350742|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222794|NCT04027439|11350743|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222795|NCT04027439|11350744|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222796|NCT04027439|11350745|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222797|NCT04027439|11350746|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222798|NCT04027439|11350747|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222799|NCT04027439|11350748|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222800|NCT04027439|11350749|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222801|NCT04027439|11350750|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222802|NCT04027439|11350751|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222803|NCT04027439|11350752|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222804|NCT04027439|11350753|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222805|NCT04027439|11350754|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222806|NCT04027439|11350755|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222807|NCT04027439|11350756|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222808|NCT04027439|11350757|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222809|NCT04027439|11350742|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222810|NCT04027439|11350743|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222811|NCT04027439|11350744|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222812|NCT04027439|11350745|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222813|NCT04027439|11350746|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222814|NCT04027439|11350747|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222815|NCT04027439|11350748|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222816|NCT04027439|11350749|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
10222817|NCT04027439|11350750|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222818|NCT04027439|11350751|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222819|NCT04027439|11350752|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222820|NCT04027439|11350753|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222821|NCT04027439|11350754|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222822|NCT04027439|11350755|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222823|NCT04027439|11350756|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10222824|NCT04027439|11350757|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10222825|NCT04027439|11350742|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222826|NCT04027439|11350743|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222827|NCT04027439|11350744|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222828|NCT04027439|11350745|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222829|NCT04027439|11350746|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222830|NCT04027439|11350747|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222831|NCT04027439|11350748|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222832|NCT04027439|11350749|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
10222833|NCT04027439|11350750|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222834|NCT04027439|11350751|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222835|NCT04027439|11350752|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222836|NCT04027439|11350753|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222837|NCT04027439|11350754|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222838|NCT04027439|11350755|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222839|NCT04027439|11350756|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222840|NCT04027439|11350757|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10222841|NCT04027218|11350787|FG000|STARTED|Overall Study||10
10222842|NCT04027218|11350788|FG001|STARTED|Overall Study||11
10222843|NCT04027218|11350789|FG002|STARTED|Overall Study||9
10222844|NCT04027218|11350790|FG003|STARTED|Overall Study||11
10222845|NCT04027218|11350791|FG004|STARTED|Overall Study||10
10222846|NCT04027218|11350792|FG005|STARTED|Overall Study||11
10222847|NCT04027218|11350787|FG000|COMPLETED|Overall Study||10
10222848|NCT04027218|11350788|FG001|COMPLETED|Overall Study||8
10222849|NCT04027218|11350789|FG002|COMPLETED|Overall Study||9
10222850|NCT04027218|11350790|FG003|COMPLETED|Overall Study||11
10222851|NCT04027218|11350791|FG004|COMPLETED|Overall Study||10
10222852|NCT04027218|11350792|FG005|COMPLETED|Overall Study||11
10222853|NCT04027218|11350787|FG000|NOT COMPLETED|Overall Study||0
10222854|NCT04027218|11350788|FG001|NOT COMPLETED|Overall Study||3
10222855|NCT04027218|11350789|FG002|NOT COMPLETED|Overall Study||0
10222856|NCT04027218|11350790|FG003|NOT COMPLETED|Overall Study||0
10222857|NCT04027218|11350791|FG004|NOT COMPLETED|Overall Study||0
10222858|NCT04027218|11350792|FG005|NOT COMPLETED|Overall Study||0
10222859|NCT04026750|11350804|FG000|STARTED|Overall Study||3
10222860|NCT04026750|11350805|FG001|STARTED|Overall Study||2
10222861|NCT04026750|11350804|FG000|COMPLETED|Overall Study||3
10222862|NCT04026750|11350805|FG001|COMPLETED|Overall Study||2
10222863|NCT04026750|11350804|FG000|NOT COMPLETED|Overall Study||0
10222864|NCT04026750|11350805|FG001|NOT COMPLETED|Overall Study||0
10222865|NCT04026308|11350814|FG000|STARTED|Overall Study||14
10222866|NCT04026308|11350815|FG001|STARTED|Overall Study||16
10222867|NCT04026308|11350814|FG000|COMPLETED|Overall Study||14
10222868|NCT04026308|11350815|FG001|COMPLETED|Overall Study||16
10222869|NCT04026308|11350814|FG000|NOT COMPLETED|Overall Study||0
10222870|NCT04026308|11350815|FG001|NOT COMPLETED|Overall Study||0
10222871|NCT04023682|11350821|FG000|STARTED|Overall Study||31
10222872|NCT04023682|11350821|FG000|COMPLETED|Overall Study||25
10222873|NCT04023682|11350821|FG000|NOT COMPLETED|Overall Study||6
10222874|NCT04021771|11350831|FG000|STARTED|Overall Study||55
10222875|NCT04021771|11350832|FG001|STARTED|Overall Study||54
10222876|NCT04021771|11350831|FG000|COMPLETED|Overall Study||55
10222877|NCT04021771|11350832|FG001|COMPLETED|Overall Study||54
10222878|NCT04021771|11350831|FG000|NOT COMPLETED|Overall Study||0
10222879|NCT04021771|11350832|FG001|NOT COMPLETED|Overall Study||0
10222880|NCT04019626|11350843|FG000|STARTED|Overall Study||42
10222881|NCT04019626|11350844|FG001|STARTED|Overall Study||42
10222882|NCT04019626|11350845|FG002|STARTED|Overall Study||45
10222883|NCT04019626|11350846|FG003|STARTED|Overall Study||46
10222884|NCT04019626|11350847|FG004|STARTED|Overall Study||44
10222885|NCT04019626|11350848|FG005|STARTED|Overall Study||21
10222886|NCT04019626|11350843|FG000|COMPLETED|Overall Study||36
10222887|NCT04019626|11350844|FG001|COMPLETED|Overall Study||32
10222888|NCT04019626|11350845|FG002|COMPLETED|Overall Study||37
10222889|NCT04019626|11350846|FG003|COMPLETED|Overall Study||39
10222890|NCT04019626|11350847|FG004|COMPLETED|Overall Study||38
10222891|NCT04019626|11350848|FG005|COMPLETED|Overall Study||20
10222892|NCT04019626|11350843|FG000|NOT COMPLETED|Overall Study||6
10222893|NCT04019626|11350844|FG001|NOT COMPLETED|Overall Study||10
10222894|NCT04019626|11350845|FG002|NOT COMPLETED|Overall Study||8
10222895|NCT04019626|11350846|FG003|NOT COMPLETED|Overall Study||7
10222896|NCT04019626|11350847|FG004|NOT COMPLETED|Overall Study||6
10222897|NCT04019626|11350848|FG005|NOT COMPLETED|Overall Study||1
10222898|NCT04023994|11350868|FG000|STARTED|Overall Study||10
10222899|NCT04023994|11350869|FG001|STARTED|Overall Study||4
10222900|NCT04023994|11350870|FG002|STARTED|Overall Study||4
10222901|NCT04023994|11350871|FG003|STARTED|Overall Study||6
10222902|NCT04023994|11350872|FG004|STARTED|Overall Study||6
10222903|NCT04023994|11350873|FG005|STARTED|Overall Study||6
10222904|NCT04023994|11350868|FG000|COMPLETED|Overall Study||10
10222905|NCT04023994|11350869|FG001|COMPLETED|Overall Study||3
10222906|NCT04023994|11350870|FG002|COMPLETED|Overall Study||2
10222907|NCT04023994|11350871|FG003|COMPLETED|Overall Study||5
10222908|NCT04023994|11350872|FG004|COMPLETED|Overall Study||6
10222909|NCT04023994|11350873|FG005|COMPLETED|Overall Study||6
10222910|NCT04023994|11350868|FG000|NOT COMPLETED|Overall Study||0
10222911|NCT04023994|11350869|FG001|NOT COMPLETED|Overall Study||1
10222912|NCT04023994|11350870|FG002|NOT COMPLETED|Overall Study||2
10222913|NCT04023994|11350871|FG003|NOT COMPLETED|Overall Study||1
10222914|NCT04023994|11350872|FG004|NOT COMPLETED|Overall Study||0
10222915|NCT04023994|11350873|FG005|NOT COMPLETED|Overall Study||0
10222916|NCT04022668|11350895|FG000|STARTED|Overall Study||1000
10222917|NCT04022668|11350896|FG001|STARTED|Overall Study||1000
10222918|NCT04022668|11350897|FG002|STARTED|Overall Study||1000
10222919|NCT04022668|11350895|FG000|COMPLETED|Overall Study||986
10222920|NCT04022668|11350896|FG001|COMPLETED|Overall Study||973
10222921|NCT04022668|11350897|FG002|COMPLETED|Overall Study||1000
10222922|NCT04022668|11350895|FG000|NOT COMPLETED|Overall Study||14
10222923|NCT04022668|11350896|FG001|NOT COMPLETED|Overall Study||27
10222924|NCT04022668|11350897|FG002|NOT COMPLETED|Overall Study||0
10222925|NCT04020822|11350905|FG000|STARTED|Overall Study||19
10222926|NCT04020822|11350905|FG000|COMPLETED|Overall Study||19
10222927|NCT04020822|11350905|FG000|NOT COMPLETED|Overall Study||0
10222928|NCT04019990|11350909|FG000|STARTED|Overall Study||13
10222929|NCT04019990|11350910|FG001|STARTED|Overall Study||15
10222930|NCT04019990|11350909|FG000|COMPLETED|Overall Study||12
10222931|NCT04019990|11350910|FG001|COMPLETED|Overall Study||12
10222932|NCT04019990|11350909|FG000|NOT COMPLETED|Overall Study||1
10222933|NCT04019990|11350910|FG001|NOT COMPLETED|Overall Study||3
10222934|NCT04017611|11350916|FG000|STARTED|Overall Study||13
10222935|NCT04017611|11350916|FG000|COMPLETED|Overall Study||12
10222936|NCT04017611|11350916|FG000|NOT COMPLETED|Overall Study||1
10222937|NCT04015232|11350922|FG000|STARTED|Overall Study||100
10222938|NCT04015232|11350923|FG001|STARTED|Overall Study||100
10222939|NCT04015232|11350922|FG000|COMPLETED|Overall Study||89
10222940|NCT04015232|11350923|FG001|COMPLETED|Overall Study||93
10222941|NCT04015232|11350922|FG000|NOT COMPLETED|Overall Study||11
10222942|NCT04015232|11350923|FG001|NOT COMPLETED|Overall Study||7
10222943|NCT04016623|11350933|FG000|STARTED|Pair 1 Test / Control Dispense||10
10222944|NCT04016623|11350933|FG000|COMPLETED|Pair 1 Test / Control Dispense||10
10222945|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0
10222946|NCT04016623|11350933|FG000|STARTED|Pair 1 Test /Control Follow up||10
10222947|NCT04016623|11350933|FG000|COMPLETED|Pair 1 Test /Control Follow up||10
10222948|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0
10222949|NCT04016623|11350933|FG000|STARTED|Pair 2 Test / Control Dispense||10
10222950|NCT04016623|11350933|FG000|COMPLETED|Pair 2 Test / Control Dispense||10
10222951|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0
10222952|NCT04016623|11350933|FG000|STARTED|Pair 2 Test /Control Follow up||10
10222953|NCT04016623|11350933|FG000|COMPLETED|Pair 2 Test /Control Follow up||10
10222954|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0
10222955|NCT04016623|11350933|FG000|STARTED|Pair 3 Test / Control Dispense||10
10222956|NCT04016623|11350933|FG000|COMPLETED|Pair 3 Test / Control Dispense||10
10222957|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0
10222958|NCT04016623|11350933|FG000|STARTED|Pair 3 Test /Control Follow up||10
10222959|NCT04016623|11350933|FG000|COMPLETED|Pair 3 Test /Control Follow up||10
10222960|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0
10222961|NCT04016623|11350933|FG000|STARTED|Pair 4 Test / Control Dispense||10
10222962|NCT04016623|11350933|FG000|COMPLETED|Pair 4 Test / Control Dispense||10
10222963|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0
10222964|NCT04016623|11350933|FG000|STARTED|Pair 4 Test /Control Follow up||10
10222965|NCT04016623|11350933|FG000|COMPLETED|Pair 4 Test /Control Follow up||10
10222966|NCT04016623|11350933|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0
10222967|NCT04013737|11350955|FG000|STARTED|Overall Study||18
10222968|NCT04013737|11350956|FG001|STARTED|Overall Study||15
10222969|NCT04013737|11350955|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18
10222970|NCT04013737|11350956|FG001|COMPLETED|Overall Study||15
10222971|NCT04013737|11350955|FG000|NOT COMPLETED|Overall Study||0
10222972|NCT04013737|11350956|FG001|NOT COMPLETED|Overall Study||0
10222973|NCT04014062|11350963|FG000|STARTED|Period I: Dosing||71
10222974|NCT04014062|11350964|FG001|STARTED|Period I: Dosing||71
10222975|NCT04014062|11350963|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
10222976|NCT04014062|11350964|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
10222977|NCT04014062|11350963|FG000|NOT COMPLETED|Period I: Dosing||7
10222978|NCT04014062|11350964|FG001|NOT COMPLETED|Period I: Dosing||6
10222979|NCT04014062|11350963|FG000|STARTED|Period II: Crossover Dosing||64
10222980|NCT04014062|11350964|FG001|STARTED|Period II: Crossover Dosing||65
10222981|NCT04014062|11350963|FG000|COMPLETED|Period II: Crossover Dosing||64
10222982|NCT04014062|11350964|FG001|COMPLETED|Period II: Crossover Dosing||65
10222983|NCT04014062|11350963|FG000|NOT COMPLETED|Period II: Crossover Dosing||0
10222984|NCT04014062|11350964|FG001|NOT COMPLETED|Period II: Crossover Dosing||0
10222985|NCT04013789|11350975|FG000|STARTED|First Wear Period (1 Week)||33
10222986|NCT04013789|11350976|FG001|STARTED|First Wear Period (1 Week)||34
10222987|NCT04013789|11350975|FG000|COMPLETED|First Wear Period (1 Week)||33
10222988|NCT04013789|11350976|FG001|COMPLETED|First Wear Period (1 Week)||34
10222989|NCT04013789|11350975|FG000|NOT COMPLETED|First Wear Period (1 Week)||0
10222990|NCT04013789|11350976|FG001|NOT COMPLETED|First Wear Period (1 Week)||0
10222991|NCT04013789|11350975|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
10222992|NCT04013789|11350976|FG001|STARTED|Second Wear Period (1 Week)||34
10222993|NCT04013789|11350975|FG000|COMPLETED|Second Wear Period (1 Week)||32
10222994|NCT04013789|11350976|FG001|COMPLETED|Second Wear Period (1 Week)||34
10222995|NCT04013789|11350975|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0
10222996|NCT04013789|11350976|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0
10222997|NCT04012970|11350986|FG000|STARTED|Intervention Session, 30 Minutes||26
10222998|NCT04012970|11350987|FG001|STARTED|Intervention Session, 30 Minutes||14
10222999|NCT04012970|11350986|FG000|COMPLETED|Intervention Session, 30 Minutes||26
10223000|NCT04012970|11350987|FG001|COMPLETED|Intervention Session, 30 Minutes||14
10223001|NCT04012970|11350986|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0
10223002|NCT04012970|11350987|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0
10223003|NCT04012970|11350986|FG000|STARTED|Control Session, 30 Minutes||26
10223004|NCT04012970|11350987|FG001|STARTED|Control Session, 30 Minutes||14
10223005|NCT04012970|11350986|FG000|COMPLETED|Control Session, 30 Minutes||26
10223006|NCT04012970|11350987|FG001|COMPLETED|Control Session, 30 Minutes||14
10223007|NCT04012970|11350986|FG000|NOT COMPLETED|Control Session, 30 Minutes||0
10223008|NCT04012970|11350987|FG001|NOT COMPLETED|Control Session, 30 Minutes||0
10223009|NCT04013191|11351001|FG000|STARTED|Overall Study||10
10223010|NCT04013191|11351002|FG001|STARTED|Overall Study||18
10223011|NCT04013191|11351001|FG000|Completed Period 1A (Single Dose)|Overall Study||10
10223012|NCT04013191|11351002|FG001|Completed Period 1A (Single Dose)|Overall Study||18
10223013|NCT04013191|11351001|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9
10223014|NCT04013191|11351002|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18
10223015|NCT04013191|11351001|FG000|COMPLETED|Overall Study||9
10223016|NCT04013191|11351002|FG001|COMPLETED|Overall Study||18
10223017|NCT04013191|11351001|FG000|NOT COMPLETED|Overall Study||1
10223018|NCT04013191|11351002|FG001|NOT COMPLETED|Overall Study||0
10223019|NCT04011631|11351012|FG000|STARTED|Overall Study||100
10223020|NCT04011631|11351012|FG000|COMPLETED|Overall Study||100
10223021|NCT04011631|11351012|FG000|NOT COMPLETED|Overall Study||0
10223022|NCT04011735|11351019|FG000|STARTED|Overall Study||133
10223023|NCT04011735|11351020|FG001|STARTED|Overall Study||71
10223024|NCT04011735|11351021|FG002|STARTED|Overall Study||56
10223025|NCT04011735|11351019|FG000|COMPLETED|Overall Study||132
10223026|NCT04011735|11351020|FG001|COMPLETED|Overall Study||70
10223027|NCT04011735|11351021|FG002|COMPLETED|Overall Study||55
10223028|NCT04011735|11351019|FG000|NOT COMPLETED|Overall Study||1
10223029|NCT04011735|11351020|FG001|NOT COMPLETED|Overall Study||1
10223030|NCT04011735|11351021|FG002|NOT COMPLETED|Overall Study||1
10223031|NCT04009577|11351035|FG000|STARTED|Core Study||7
10223032|NCT04009577|11351036|FG001|STARTED|Core Study||3
10223033|NCT04009577|11351037|FG002|STARTED|Core Study||21
10223034|NCT04009577|11351038|FG003|STARTED|Core Study||22
10223035|NCT04009577|11351035|FG000|LEM5|Core Study||7
10223036|NCT04009577|11351036|FG001|LEM5|Core Study||3
10223037|NCT04009577|11351037|FG002|LEM5|Core Study||21
10223038|NCT04009577|11351038|FG003|LEM5|Core Study||5
10223039|NCT04009577|11351035|FG000|LEM10|Core Study||3
10223040|NCT04009577|11351036|FG001|LEM10|Core Study||2
10223041|NCT04009577|11351037|FG002|LEM10|Core Study||10
10223042|NCT04009577|11351038|FG003|LEM10|Core Study||22
10223043|NCT04009577|11351035|FG000|COMPLETED|Core Study||6
10223044|NCT04009577|11351036|FG001|COMPLETED|Core Study||3
10223045|NCT04009577|11351037|FG002|COMPLETED|Core Study||17
10223046|NCT04009577|11351038|FG003|COMPLETED|Core Study||17
10223047|NCT04009577|11351035|FG000|NOT COMPLETED|Core Study||1
10223048|NCT04009577|11351036|FG001|NOT COMPLETED|Core Study||0
10223049|NCT04009577|11351037|FG002|NOT COMPLETED|Core Study||4
10223050|NCT04009577|11351038|FG003|NOT COMPLETED|Core Study||5
10223051|NCT04009577|11351035|FG000|STARTED|Extension Phase||6
10223052|NCT04009577|11351036|FG001|STARTED|Extension Phase||3
10223053|NCT04009577|11351037|FG002|STARTED|Extension Phase||17
10223054|NCT04009577|11351038|FG003|STARTED|Extension Phase||17
10223055|NCT04009577|11351035|FG000|Treated|Extension Phase||6
10223056|NCT04009577|11351036|FG001|Treated|Extension Phase||3
10223057|NCT04009577|11351037|FG002|Treated|Extension Phase||15
10223058|NCT04009577|11351038|FG003|Treated|Extension Phase||17
10223059|NCT04009577|11351035|FG000|LEM5|Extension Phase||6
10223060|NCT04009577|11351036|FG001|LEM5|Extension Phase||3
10223061|NCT04009577|11351037|FG002|LEM5|Extension Phase||15
10223062|NCT04009577|11351038|FG003|LEM5|Extension Phase||8
10223063|NCT04009577|11351035|FG000|LEM10|Extension Phase||5
10223064|NCT04009577|11351036|FG001|LEM10|Extension Phase||3
10223065|NCT04009577|11351037|FG002|LEM10|Extension Phase||12
10223066|NCT04009577|11351038|FG003|LEM10|Extension Phase||17
10223067|NCT04009577|11351035|FG000|COMPLETED|Extension Phase||6
10223068|NCT04009577|11351036|FG001|COMPLETED|Extension Phase||3
10223069|NCT04009577|11351037|FG002|COMPLETED|Extension Phase||13
10223070|NCT04009577|11351038|FG003|COMPLETED|Extension Phase||16
10223071|NCT04009577|11351035|FG000|NOT COMPLETED|Extension Phase||0
10223072|NCT04009577|11351036|FG001|NOT COMPLETED|Extension Phase||0
10223073|NCT04009577|11351037|FG002|NOT COMPLETED|Extension Phase||4
10223074|NCT04009577|11351038|FG003|NOT COMPLETED|Extension Phase||1
10223075|NCT04007159|11351064|FG000|STARTED|Induction Phase||280
10223076|NCT04007159|11351064|FG000|COMPLETED|Induction Phase||258
10223077|NCT04007159|11351064|FG000|NOT COMPLETED|Induction Phase||22
10223078|NCT04007159|11351064|FG000|STARTED|Rest Phase||258
10223079|NCT04007159|11351064|FG000|COMPLETED|Rest Phase||258
10223080|NCT04007159|11351064|FG000|NOT COMPLETED|Rest Phase||0
10223081|NCT04007159|11351064|FG000|STARTED|Challenge Phase||258
10223082|NCT04007159|11351064|FG000|COMPLETED|Challenge Phase||255
10223083|NCT04007159|11351064|FG000|NOT COMPLETED|Challenge Phase||3
10223084|NCT04007107|11351075|FG000|STARTED|Treatment Period 1 (Day 1)||26
10223085|NCT04007107|11351076|FG001|STARTED|Treatment Period 1 (Day 1)||26
10223086|NCT04007107|11351077|FG002|STARTED|Treatment Period 1 (Day 1)||25
10223087|NCT04007107|11351078|FG003|STARTED|Treatment Period 1 (Day 1)||26
10223088|NCT04007107|11351075|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10223089|NCT04007107|11351076|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10223090|NCT04007107|11351077|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
10223091|NCT04007107|11351078|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10223092|NCT04007107|11351075|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10223093|NCT04007107|11351076|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10223094|NCT04007107|11351077|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
10223095|NCT04007107|11351078|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10223096|NCT04007107|11351075|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
10223097|NCT04007107|11351076|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
10223098|NCT04007107|11351077|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
10223099|NCT04007107|11351078|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
10223100|NCT04007107|11351075|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
10223101|NCT04007107|11351076|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
10223102|NCT04007107|11351077|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
10223103|NCT04007107|11351078|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
10223104|NCT04007107|11351075|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10223105|NCT04007107|11351076|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10223106|NCT04007107|11351077|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10223107|NCT04007107|11351078|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10223108|NCT04007107|11351075|FG000|STARTED|Treatment Period 2 (Day 1)||26
10223109|NCT04007107|11351076|FG001|STARTED|Treatment Period 2 (Day 1)||26
10223110|NCT04007107|11351077|FG002|STARTED|Treatment Period 2 (Day 1)||25
10223111|NCT04007107|11351078|FG003|STARTED|Treatment Period 2 (Day 1)||26
10223112|NCT04007107|11351075|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
10223113|NCT04007107|11351076|FG001|COMPLETED|Treatment Period 2 (Day 1)||25
10223114|NCT04007107|11351077|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
10223115|NCT04007107|11351078|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
10223116|NCT04007107|11351075|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10223117|NCT04007107|11351076|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1
10223118|NCT04007107|11351077|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10223119|NCT04007107|11351078|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10223120|NCT04006795|11351083|FG000|STARTED|Induction Phase||37
10223121|NCT04006795|11351083|FG000|COMPLETED|Induction Phase||37
10223122|NCT04006795|11351083|FG000|NOT COMPLETED|Induction Phase||0
10223123|NCT04006795|11351083|FG000|STARTED|Rest Phase||37
10223124|NCT04006795|11351083|FG000|COMPLETED|Rest Phase||37
10223125|NCT04006795|11351083|FG000|NOT COMPLETED|Rest Phase||0
10223126|NCT04006795|11351083|FG000|STARTED|Challenge Phase||37
10223127|NCT04006795|11351083|FG000|COMPLETED|Challenge Phase||37
10223128|NCT04006795|11351083|FG000|NOT COMPLETED|Challenge Phase||0
10012718|NCT01787175|11135588|FG000|COMPLETED|Overall Study||30
10012719|NCT01787175|11135589|FG001|COMPLETED|Overall Study||28
10012720|NCT01787175|11135588|FG000|NOT COMPLETED|Overall Study||0
10012721|NCT01787175|11135589|FG001|NOT COMPLETED|Overall Study||0
10012722|NCT01787188|11135598|FG000|STARTED|Overall Study||139
10012723|NCT01787188|11135599|FG001|STARTED|Overall Study||130
10012724|NCT01787188|11135600|FG002|STARTED|Overall Study||134
10012725|NCT01787188|11135598|FG000|COMPLETED|Overall Study||122
10012726|NCT01787188|11135599|FG001|COMPLETED|Overall Study||112
10012727|NCT01787188|11135600|FG002|COMPLETED|Overall Study||116
10012728|NCT01787188|11135598|FG000|NOT COMPLETED|Overall Study||17
10012729|NCT01787188|11135599|FG001|NOT COMPLETED|Overall Study||18
10012730|NCT01787188|11135600|FG002|NOT COMPLETED|Overall Study||18
10012731|NCT01787240|11135610|FG000|STARTED|Overall Study||15
10012732|NCT01787240|11135611|FG001|STARTED|Overall Study||5
10223129|NCT04005885|11351094|FG000|STARTED|First Intervention||26
10223130|NCT04005885|11351095|FG001|STARTED|First Intervention||29
10223131|NCT04005885|11351094|FG000|COMPLETED|First Intervention||25
10223132|NCT04005885|11351095|FG001|COMPLETED|First Intervention||28
10223133|NCT04005885|11351094|FG000|NOT COMPLETED|First Intervention||1
10223134|NCT04005885|11351095|FG001|NOT COMPLETED|First Intervention||1
10223135|NCT04005885|11351094|FG000|STARTED|Second Intervention||25
10223136|NCT04005885|11351095|FG001|STARTED|Second Intervention||28
10223137|NCT04005885|11351094|FG000|COMPLETED|Second Intervention||25
10223138|NCT04005885|11351095|FG001|COMPLETED|Second Intervention||26
10223139|NCT04005885|11351094|FG000|NOT COMPLETED|Second Intervention||0
10223140|NCT04005885|11351095|FG001|NOT COMPLETED|Second Intervention||2
10223141|NCT04005885|11351094|FG000|STARTED|Third Intervention||25
10012733|NCT01787240|11135610|FG000|COMPLETED|Overall Study||10
10012734|NCT01787240|11135611|FG001|COMPLETED|Overall Study||4
10012735|NCT01787240|11135610|FG000|NOT COMPLETED|Overall Study||5
10012736|NCT01787240|11135611|FG001|NOT COMPLETED|Overall Study||1
10012737|NCT01787279|11135620|FG000|STARTED|Overall Study||59
10012738|NCT01787279|11135620|FG000|COMPLETED|Overall Study||56
10012739|NCT01787279|11135620|FG000|NOT COMPLETED|Overall Study||3
10223142|NCT04005885|11351095|FG001|STARTED|Third Intervention||26
10223143|NCT04005885|11351094|FG000|COMPLETED|Third Intervention||25
10223144|NCT04005885|11351095|FG001|COMPLETED|Third Intervention||26
10223145|NCT04005885|11351094|FG000|NOT COMPLETED|Third Intervention||0
10223146|NCT04005885|11351095|FG001|NOT COMPLETED|Third Intervention||0
10223147|NCT04000815|11351109|FG000|STARTED|Overall Study||29
10223148|NCT04000815|11351110|FG001|STARTED|Overall Study||20
10223149|NCT04000815|11351111|FG002|STARTED|Overall Study||22
10223150|NCT04000815|11351109|FG000|COMPLETED|Overall Study||15
10223151|NCT04000815|11351110|FG001|COMPLETED|Overall Study||15
10223152|NCT04000815|11351111|FG002|COMPLETED|Overall Study||15
10012740|NCT01787292|11135624|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
10012741|NCT01787292|11135625|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
10223153|NCT04000815|11351109|FG000|NOT COMPLETED|Overall Study||14
10223154|NCT04000815|11351110|FG001|NOT COMPLETED|Overall Study||5
10223155|NCT04000815|11351111|FG002|NOT COMPLETED|Overall Study||7
10012742|NCT01787292|11135624|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
10012743|NCT01787292|11135625|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
10012744|NCT01787292|11135624|FG000|NOT COMPLETED|Crossover Exercise Interventions||2
10012745|NCT01787292|11135625|FG001|NOT COMPLETED|Crossover Exercise Interventions||2
10012746|NCT01787292|11135624|FG000|STARTED|Home Based Exercise Program||15
10012747|NCT01787292|11135625|FG001|STARTED|Home Based Exercise Program||14
10012748|NCT01787292|11135624|FG000|COMPLETED|Home Based Exercise Program||12
10012749|NCT01787292|11135625|FG001|COMPLETED|Home Based Exercise Program||13
10012750|NCT01787292|11135624|FG000|NOT COMPLETED|Home Based Exercise Program||3
10012751|NCT01787292|11135625|FG001|NOT COMPLETED|Home Based Exercise Program||1
10012752|NCT01787331|11135636|FG000|STARTED|Overall Study||21
10012753|NCT01787331|11135636|FG000|COMPLETED|Overall Study||19
10223156|NCT03999944|11351119|FG000|STARTED|First Sleep Night||26
10223157|NCT03999944|11351120|FG001|STARTED|First Sleep Night||26
10223158|NCT03999944|11351119|FG000|COMPLETED|First Sleep Night||22
10223159|NCT03999944|11351120|FG001|COMPLETED|First Sleep Night||24
10223160|NCT03999944|11351119|FG000|NOT COMPLETED|First Sleep Night||4
10223161|NCT03999944|11351120|FG001|NOT COMPLETED|First Sleep Night||2
10223162|NCT03999944|11351119|FG000|STARTED|Second Sleep Night||22
10223163|NCT03999944|11351120|FG001|STARTED|Second Sleep Night||24
10223164|NCT03999944|11351119|FG000|COMPLETED|Second Sleep Night||22
10223165|NCT03999944|11351120|FG001|COMPLETED|Second Sleep Night||20
10223166|NCT03999944|11351119|FG000|NOT COMPLETED|Second Sleep Night||0
10223167|NCT03999944|11351120|FG001|NOT COMPLETED|Second Sleep Night||4
10012754|NCT01787331|11135636|FG000|NOT COMPLETED|Overall Study||2
10012755|NCT01787383|11135642|FG000|STARTED|Overall Study||101
10012756|NCT01787383|11135643|FG001|STARTED|Overall Study||98
10012757|NCT01787383|11135642|FG000|COMPLETED|Overall Study||92
10012758|NCT01787383|11135643|FG001|COMPLETED|Overall Study||76
10012759|NCT01787383|11135642|FG000|NOT COMPLETED|Overall Study||9
10012760|NCT01787383|11135643|FG001|NOT COMPLETED|Overall Study||22
10012761|NCT01787461|11135659|FG000|STARTED|Overall Study||96
10012762|NCT01787461|11135660|FG001|STARTED|Overall Study||98
10012763|NCT01787461|11135659|FG000|COMPLETED|Overall Study||82
10012764|NCT01787461|11135660|FG001|COMPLETED|Overall Study||89
10012765|NCT01787461|11135659|FG000|NOT COMPLETED|Overall Study||14
10012766|NCT01787461|11135660|FG001|NOT COMPLETED|Overall Study||9
10012767|NCT01787591|11135668|FG000|STARTED|Period 1 (Cross-over Arm 1)||5
10012768|NCT01787591|11135669|FG001|STARTED|Period 1 (Cross-over Arm 1)||5
10012769|NCT01787591|11135670|FG002|STARTED|Period 1 (Cross-over Arm 1)||5
10223168|NCT03995680|11351129|FG000|STARTED|Overall Study||199
10223169|NCT03995680|11351130|FG001|STARTED|Overall Study||198
10223170|NCT03995680|11351129|FG000|COMPLETED|Overall Study||197
10223171|NCT03995680|11351130|FG001|COMPLETED|Overall Study||196
10223172|NCT03995680|11351129|FG000|NOT COMPLETED|Overall Study||2
10223173|NCT03995680|11351130|FG001|NOT COMPLETED|Overall Study||2
10223174|NCT04006366|11351136|FG000|STARTED|Overall Study||6
10223175|NCT04006366|11351136|FG000|COMPLETED|Overall Study||5
10223176|NCT04006366|11351136|FG000|NOT COMPLETED|Overall Study||1
10223177|NCT04006145|11351142|FG000|STARTED|Overall Study||23
10223178|NCT04006145|11351143|FG001|STARTED|Overall Study||24
10223179|NCT04006145|11351142|FG000|Received Treatment|Overall Study||23
10223180|NCT04006145|11351143|FG001|Received Treatment|Overall Study||24
10223181|NCT04006145|11351142|FG000|COMPLETED|Overall Study||22
10012770|NCT01787591|11135671|FG003|STARTED|Period 1 (Cross-over Arm 1)||6
10012771|NCT01787591|11135668|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5
10012772|NCT01787591|11135669|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5
10012773|NCT01787591|11135670|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5
10012774|NCT01787591|11135671|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5
10012775|NCT01787591|11135668|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
10012776|NCT01787591|11135669|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
10012777|NCT01787591|11135670|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
10223182|NCT04006145|11351143|FG001|COMPLETED|Overall Study||21
10223183|NCT04006145|11351142|FG000|NOT COMPLETED|Overall Study||1
10223184|NCT04006145|11351143|FG001|NOT COMPLETED|Overall Study||3
10223185|NCT04005755|11351149|FG000|STARTED|Overall Study||232
10223186|NCT04005755|11351149|FG000|COMPLETED|Overall Study||215
10012778|NCT01787591|11135671|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
10223187|NCT04005755|11351149|FG000|NOT COMPLETED|Overall Study||17
10223188|NCT04005586|11351153|FG000|STARTED|Overall Study||25
10223189|NCT04005586|11351153|FG000|COMPLETED|Overall Study||25
10223190|NCT04005586|11351153|FG000|NOT COMPLETED|Overall Study||0
10223191|NCT04005404|11351160|FG000|STARTED|Overall Study||43
10223192|NCT04005404|11351161|FG001|STARTED|Overall Study||34
10223193|NCT04005404|11351162|FG002|STARTED|Overall Study||3
10223194|NCT04005404|11351160|FG000|COMPLETED|Overall Study||42
10012779|NCT01787591|11135668|FG000|STARTED|Period 2 (Cross-over Arm 2)||5
10012780|NCT01787591|11135669|FG001|STARTED|Period 2 (Cross-over Arm 2)||5
10012781|NCT01787591|11135670|FG002|STARTED|Period 2 (Cross-over Arm 2)||5
10012782|NCT01787591|11135671|FG003|STARTED|Period 2 (Cross-over Arm 2)||5
10012783|NCT01787591|11135668|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5
10012784|NCT01787591|11135669|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5
10012785|NCT01787591|11135670|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5
10012786|NCT01787591|11135671|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5
10012787|NCT01787591|11135668|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10012788|NCT01787591|11135669|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10012789|NCT01787591|11135670|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10012790|NCT01787591|11135671|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10012791|NCT01787591|11135668|FG000|STARTED|Period 3 (Cross-over Arm 3)||5
10223195|NCT04005404|11351161|FG001|COMPLETED|Overall Study||33
10223196|NCT04005404|11351162|FG002|COMPLETED|Overall Study||3
10223197|NCT04005404|11351160|FG000|NOT COMPLETED|Overall Study||1
10223198|NCT04005404|11351161|FG001|NOT COMPLETED|Overall Study||1
10223199|NCT04005404|11351162|FG002|NOT COMPLETED|Overall Study||0
10223200|NCT03993288|11351172|FG000|STARTED|Overall Study||133
10223201|NCT03993288|11351173|FG001|STARTED|Overall Study||134
10223202|NCT03993288|11351172|FG000|Intention-to-treat (ITT) Population|Overall Study||123
10223203|NCT03993288|11351173|FG001|Intention-to-treat (ITT) Population|Overall Study||129
10223204|NCT03993288|11351172|FG000|Safety Analysis Set|Overall Study||133
10223205|NCT03993288|11351173|FG001|Safety Analysis Set|Overall Study||134
10223206|NCT03993288|11351172|FG000|COMPLETED|Overall Study||123
10223207|NCT03993288|11351173|FG001|COMPLETED|Overall Study||129
10223208|NCT03993288|11351172|FG000|NOT COMPLETED|Overall Study||10
10223209|NCT03993288|11351173|FG001|NOT COMPLETED|Overall Study||5
10223210|NCT03990298|11351179|FG000|STARTED|Overall Study||16
10223211|NCT03990298|11351179|FG000|COMPLETED|Overall Study||16
10223212|NCT03990298|11351179|FG000|NOT COMPLETED|Overall Study||0
10223213|NCT03988647|11351183|FG000|STARTED|Overall Study||1
10223214|NCT03988647|11351183|FG000|COMPLETED|Overall Study||1
10223215|NCT03988647|11351183|FG000|NOT COMPLETED|Overall Study||0
10223216|NCT03979872|11351191|FG000|STARTED|Overall Study||22
10223217|NCT03979872|11351192|FG001|STARTED|Overall Study||23
10223218|NCT03979872|11351193|FG002|STARTED|Overall Study||24
10223219|NCT03979872|11351194|FG003|STARTED|Overall Study||23
10223220|NCT03979872|11351191|FG000|COMPLETED|Overall Study||19
10223221|NCT03979872|11351192|FG001|COMPLETED|Overall Study||15
10223222|NCT03979872|11351193|FG002|COMPLETED|Overall Study||18
10223223|NCT03979872|11351194|FG003|COMPLETED|Overall Study||19
10223224|NCT03979872|11351191|FG000|NOT COMPLETED|Overall Study||3
10223225|NCT03979872|11351192|FG001|NOT COMPLETED|Overall Study||8
10223226|NCT03979872|11351193|FG002|NOT COMPLETED|Overall Study||6
10223227|NCT03979872|11351194|FG003|NOT COMPLETED|Overall Study||4
10223228|NCT03978832|11351204|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
10223229|NCT03978832|11351204|FG000|Stabilization Period|Overall Study||25
10223230|NCT03978832|11351204|FG000|Treatment Period|Overall Study||23
10223231|NCT03978832|11351204|FG000|COMPLETED|Overall Study||15
10223232|NCT03978832|11351204|FG000|NOT COMPLETED|Overall Study||54
10223233|NCT04005391|11351210|FG000|STARTED|Overall Study|10/23/18|108
10223234|NCT04005391|11351211|FG001|STARTED|Overall Study|10/23/18|100
10223235|NCT04005391|11351210|FG000|COMPLETED|Overall Study||101
10223236|NCT04005391|11351211|FG001|COMPLETED|Overall Study||100
10223237|NCT04005391|11351210|FG000|NOT COMPLETED|Overall Study||7
10223238|NCT04005391|11351211|FG001|NOT COMPLETED|Overall Study||0
10223239|NCT04004481|11351221|FG000|STARTED|Overall Study||50
10223240|NCT04004481|11351221|FG000|COMPLETED|Overall Study||47
10223241|NCT04004481|11351221|FG000|NOT COMPLETED|Overall Study||3
10012792|NCT01787591|11135669|FG001|STARTED|Period 3 (Cross-over Arm 3)||5
10223242|NCT04004260|11351245|FG000|STARTED|Overall Study||79
10223243|NCT04004260|11351246|FG001|STARTED|Overall Study||79
10223244|NCT04004260|11351245|FG000|COMPLETED|Overall Study||37
10223245|NCT04004260|11351246|FG001|COMPLETED|Overall Study||47
10223246|NCT04004260|11351245|FG000|NOT COMPLETED|Overall Study||42
10223247|NCT04004260|11351246|FG001|NOT COMPLETED|Overall Study||32
10223248|NCT03997851|11351252|FG000|STARTED|Overall Study||17
10223249|NCT03997851|11351252|FG000|COMPLETED|Overall Study||17
10223250|NCT03997851|11351252|FG000|NOT COMPLETED|Overall Study||0
10223251|NCT03991715|11351262|FG000|STARTED|Overall Study||5
10223252|NCT03991715|11351262|FG000|COMPLETED|Overall Study||5
10223253|NCT03991715|11351262|FG000|NOT COMPLETED|Overall Study||0
10223254|NCT03990415|11351269|FG000|STARTED|Overall Study||19
10223255|NCT03990415|11351270|FG001|STARTED|Overall Study||19
10223256|NCT03990415|11351271|FG002|STARTED|Overall Study||14
10223257|NCT03990415|11351269|FG000|COMPLETED|Overall Study||15
10223258|NCT03990415|11351270|FG001|COMPLETED|Overall Study||17
10223259|NCT03990415|11351271|FG002|COMPLETED|Overall Study||14
10223260|NCT03990415|11351269|FG000|NOT COMPLETED|Overall Study||4
10223261|NCT03990415|11351270|FG001|NOT COMPLETED|Overall Study||2
10223262|NCT03990415|11351271|FG002|NOT COMPLETED|Overall Study||0
10223263|NCT04002960|11351279|FG000|STARTED|Overall Study||23
10223264|NCT04002960|11351279|FG000|COMPLETED|Overall Study||21
10223265|NCT04002960|11351279|FG000|NOT COMPLETED|Overall Study||2
10223266|NCT04002973|11351283|FG000|STARTED|Overall Study||11
10223267|NCT04002973|11351283|FG000|COMPLETED|Overall Study||11
10223268|NCT04002973|11351283|FG000|NOT COMPLETED|Overall Study||0
10223269|NCT04002648|11351289|FG000|STARTED|Overall Study||104
10223270|NCT04002648|11351290|FG001|STARTED|Overall Study||104
10223271|NCT04002648|11351289|FG000|COMPLETED|Overall Study||102
10223272|NCT04002648|11351290|FG001|COMPLETED|Overall Study||104
10223273|NCT04002648|11351289|FG000|NOT COMPLETED|Overall Study||2
10223274|NCT04002648|11351290|FG001|NOT COMPLETED|Overall Study||0
10223275|NCT03993210|11351298|FG000|STARTED|Overall Study||1
10223276|NCT03993210|11351299|FG001|STARTED|Overall Study||0
10223277|NCT03993210|11351298|FG000|COMPLETED|Overall Study||1
10223278|NCT03993210|11351299|FG001|COMPLETED|Overall Study||0
10223279|NCT03993210|11351298|FG000|NOT COMPLETED|Overall Study||0
10223280|NCT03993210|11351299|FG001|NOT COMPLETED|Overall Study||0
10223281|NCT03992014|11351309|FG000|STARTED|Treatment Period 1 (8 Days)||6
10223282|NCT03992014|11351309|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
10223283|NCT03992014|11351309|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10223284|NCT03992014|11351309|FG000|STARTED|Washout Period (7 Days)||6
10223285|NCT03992014|11351309|FG000|COMPLETED|Washout Period (7 Days)||6
10223286|NCT03992014|11351309|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10223287|NCT03992014|11351309|FG000|STARTED|Treatment Period 2 (8 Days)||6
10223288|NCT03992014|11351309|FG000|COMPLETED|Treatment Period 2 (8 Days)||6
10223289|NCT03992014|11351309|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10223290|NCT03990649|11351319|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9
10223291|NCT03990649|11351320|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15
10223292|NCT03990649|11351321|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0
10223293|NCT03990649|11351319|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
10223294|NCT03990649|11351320|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
10223295|NCT03990649|11351321|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
10223296|NCT03990649|11351319|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
10223297|NCT03990649|11351320|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
10223298|NCT03990649|11351321|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
10223299|NCT03990649|11351319|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0
10223300|NCT03990649|11351320|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0
10223301|NCT03990649|11351321|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18
10223302|NCT03990649|11351319|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10223303|NCT03990649|11351320|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10223304|NCT03990649|11351321|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
10223305|NCT03990649|11351319|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10223306|NCT03990649|11351320|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10223307|NCT03990649|11351321|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
10223308|NCT04002791|11351330|FG000|STARTED|Overall Study||127
10223309|NCT04002791|11351331|FG001|STARTED|Overall Study||126
10223310|NCT04002791|11351330|FG000|COMPLETED|Overall Study||127
10223311|NCT04002791|11351331|FG001|COMPLETED|Overall Study||126
10223312|NCT04002791|11351330|FG000|NOT COMPLETED|Overall Study||0
10223313|NCT04002791|11351331|FG001|NOT COMPLETED|Overall Study||0
10223314|NCT04000581|11351339|FG000|STARTED|Overall Study||5
10223315|NCT04000581|11351340|FG001|STARTED|Overall Study||12
10223316|NCT04000581|11351339|FG000|COMPLETED|Overall Study||5
10223317|NCT04000581|11351340|FG001|COMPLETED|Overall Study||11
10223318|NCT04000581|11351339|FG000|NOT COMPLETED|Overall Study||0
10223319|NCT04000581|11351340|FG001|NOT COMPLETED|Overall Study||1
10223320|NCT03996694|11351346|FG000|STARTED|First Intervention (1 Day)||3
10223321|NCT03996694|11351347|FG001|STARTED|First Intervention (1 Day)||3
10223322|NCT03996694|11351348|FG002|STARTED|First Intervention (1 Day)||4
10223323|NCT03996694|11351349|FG003|STARTED|First Intervention (1 Day)||3
10223324|NCT03996694|11351350|FG004|STARTED|First Intervention (1 Day)||3
10223325|NCT03996694|11351351|FG005|STARTED|First Intervention (1 Day)||3
10223326|NCT03996694|11351346|FG000|COMPLETED|First Intervention (1 Day)||3
10223327|NCT03996694|11351347|FG001|COMPLETED|First Intervention (1 Day)||3
10223328|NCT03996694|11351348|FG002|COMPLETED|First Intervention (1 Day)||4
10223329|NCT03996694|11351349|FG003|COMPLETED|First Intervention (1 Day)||3
10223330|NCT03996694|11351350|FG004|COMPLETED|First Intervention (1 Day)||3
10223331|NCT03996694|11351351|FG005|COMPLETED|First Intervention (1 Day)||3
10223332|NCT03996694|11351346|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10223333|NCT03996694|11351347|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10223334|NCT03996694|11351348|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10223335|NCT03996694|11351349|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10223336|NCT03996694|11351350|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10223337|NCT03996694|11351351|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10223338|NCT03996694|11351346|FG000|STARTED|First Washout (7 Days)||3
10223339|NCT03996694|11351347|FG001|STARTED|First Washout (7 Days)||3
10223340|NCT03996694|11351348|FG002|STARTED|First Washout (7 Days)||4
10223341|NCT03996694|11351349|FG003|STARTED|First Washout (7 Days)||3
10223342|NCT03996694|11351350|FG004|STARTED|First Washout (7 Days)||3
10223343|NCT03996694|11351351|FG005|STARTED|First Washout (7 Days)||3
10223344|NCT03996694|11351346|FG000|COMPLETED|First Washout (7 Days)||3
10223345|NCT03996694|11351347|FG001|COMPLETED|First Washout (7 Days)||2
10223346|NCT03996694|11351348|FG002|COMPLETED|First Washout (7 Days)||2
10223347|NCT03996694|11351349|FG003|COMPLETED|First Washout (7 Days)||3
10223348|NCT03996694|11351350|FG004|COMPLETED|First Washout (7 Days)||3
10223349|NCT03996694|11351351|FG005|COMPLETED|First Washout (7 Days)||3
10223350|NCT03996694|11351346|FG000|NOT COMPLETED|First Washout (7 Days)||0
10223351|NCT03996694|11351347|FG001|NOT COMPLETED|First Washout (7 Days)||1
10223352|NCT03996694|11351348|FG002|NOT COMPLETED|First Washout (7 Days)||2
10223353|NCT03996694|11351349|FG003|NOT COMPLETED|First Washout (7 Days)||0
10223354|NCT03996694|11351350|FG004|NOT COMPLETED|First Washout (7 Days)||0
10223355|NCT03996694|11351351|FG005|NOT COMPLETED|First Washout (7 Days)||0
10223356|NCT03996694|11351346|FG000|STARTED|Second Intervention (1 Day)||3
10223357|NCT03996694|11351347|FG001|STARTED|Second Intervention (1 Day)||2
10223358|NCT03996694|11351348|FG002|STARTED|Second Intervention (1 Day)||2
10223359|NCT03996694|11351349|FG003|STARTED|Second Intervention (1 Day)||3
10223360|NCT03996694|11351350|FG004|STARTED|Second Intervention (1 Day)||3
10223361|NCT03996694|11351351|FG005|STARTED|Second Intervention (1 Day)||3
10223362|NCT03996694|11351346|FG000|COMPLETED|Second Intervention (1 Day)||3
10223363|NCT03996694|11351347|FG001|COMPLETED|Second Intervention (1 Day)||2
10223364|NCT03996694|11351348|FG002|COMPLETED|Second Intervention (1 Day)||2
10223365|NCT03996694|11351349|FG003|COMPLETED|Second Intervention (1 Day)||3
10223366|NCT03996694|11351350|FG004|COMPLETED|Second Intervention (1 Day)||3
10223367|NCT03996694|11351351|FG005|COMPLETED|Second Intervention (1 Day)||3
10223368|NCT03996694|11351346|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10223369|NCT03996694|11351347|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10223370|NCT03996694|11351348|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10223371|NCT03996694|11351349|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10223372|NCT03996694|11351350|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10223373|NCT03996694|11351351|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10223374|NCT03996694|11351346|FG000|STARTED|Second Washout (7 Days)||3
10223375|NCT03996694|11351347|FG001|STARTED|Second Washout (7 Days)||2
10223376|NCT03996694|11351348|FG002|STARTED|Second Washout (7 Days)||2
10223377|NCT03996694|11351349|FG003|STARTED|Second Washout (7 Days)||3
10223378|NCT03996694|11351350|FG004|STARTED|Second Washout (7 Days)||3
10223379|NCT03996694|11351351|FG005|STARTED|Second Washout (7 Days)||3
10223380|NCT03996694|11351346|FG000|COMPLETED|Second Washout (7 Days)||3
10223381|NCT03996694|11351347|FG001|COMPLETED|Second Washout (7 Days)||2
10223382|NCT03996694|11351348|FG002|COMPLETED|Second Washout (7 Days)||2
10223383|NCT03996694|11351349|FG003|COMPLETED|Second Washout (7 Days)||3
10223384|NCT03996694|11351350|FG004|COMPLETED|Second Washout (7 Days)||3
10223385|NCT03996694|11351351|FG005|COMPLETED|Second Washout (7 Days)||3
10223386|NCT03996694|11351346|FG000|NOT COMPLETED|Second Washout (7 Days)||0
10223387|NCT03996694|11351347|FG001|NOT COMPLETED|Second Washout (7 Days)||0
10223388|NCT03996694|11351348|FG002|NOT COMPLETED|Second Washout (7 Days)||0
10223389|NCT03996694|11351349|FG003|NOT COMPLETED|Second Washout (7 Days)||0
10223390|NCT03996694|11351350|FG004|NOT COMPLETED|Second Washout (7 Days)||0
10223391|NCT03996694|11351351|FG005|NOT COMPLETED|Second Washout (7 Days)||0
10223392|NCT03996694|11351346|FG000|STARTED|Third Intervention (1 Day)||3
10223393|NCT03996694|11351347|FG001|STARTED|Third Intervention (1 Day)||2
10223394|NCT03996694|11351348|FG002|STARTED|Third Intervention (1 Day)||2
10223395|NCT03996694|11351349|FG003|STARTED|Third Intervention (1 Day)||3
10223396|NCT03996694|11351350|FG004|STARTED|Third Intervention (1 Day)||3
10223397|NCT03996694|11351351|FG005|STARTED|Third Intervention (1 Day)||3
10223398|NCT03996694|11351346|FG000|COMPLETED|Third Intervention (1 Day)||3
10223399|NCT03996694|11351347|FG001|COMPLETED|Third Intervention (1 Day)||2
10223400|NCT03996694|11351348|FG002|COMPLETED|Third Intervention (1 Day)||2
10223401|NCT03996694|11351349|FG003|COMPLETED|Third Intervention (1 Day)||3
10223402|NCT03996694|11351350|FG004|COMPLETED|Third Intervention (1 Day)||3
10223403|NCT03996694|11351351|FG005|COMPLETED|Third Intervention (1 Day)||3
10223404|NCT03996694|11351346|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10223405|NCT03996694|11351347|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10223406|NCT03996694|11351348|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10223407|NCT03996694|11351349|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10223408|NCT03996694|11351350|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10223409|NCT03996694|11351351|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10223410|NCT03996694|11351346|FG000|STARTED|Third Washout (7 Days)||3
10223411|NCT03996694|11351347|FG001|STARTED|Third Washout (7 Days)||2
10223412|NCT03996694|11351348|FG002|STARTED|Third Washout (7 Days)||2
10223413|NCT03996694|11351349|FG003|STARTED|Third Washout (7 Days)||3
10223414|NCT03996694|11351350|FG004|STARTED|Third Washout (7 Days)||3
10223415|NCT03996694|11351351|FG005|STARTED|Third Washout (7 Days)||3
10223416|NCT03996694|11351346|FG000|COMPLETED|Third Washout (7 Days)||3
10012793|NCT01787591|11135670|FG002|STARTED|Period 3 (Cross-over Arm 3)||5
10012794|NCT01787591|11135671|FG003|STARTED|Period 3 (Cross-over Arm 3)||5
10012795|NCT01787591|11135668|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5
10012796|NCT01787591|11135669|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5
10012797|NCT01787591|11135670|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5
10012798|NCT01787591|11135671|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5
10012799|NCT01787591|11135668|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10012800|NCT01787591|11135669|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10223417|NCT03996694|11351347|FG001|COMPLETED|Third Washout (7 Days)||2
10223418|NCT03996694|11351348|FG002|COMPLETED|Third Washout (7 Days)||2
10223419|NCT03996694|11351349|FG003|COMPLETED|Third Washout (7 Days)||3
10223420|NCT03996694|11351350|FG004|COMPLETED|Third Washout (7 Days)||2
10223421|NCT03996694|11351351|FG005|COMPLETED|Third Washout (7 Days)||3
10223422|NCT03996694|11351346|FG000|NOT COMPLETED|Third Washout (7 Days)||0
10223423|NCT03996694|11351347|FG001|NOT COMPLETED|Third Washout (7 Days)||0
10223424|NCT03996694|11351348|FG002|NOT COMPLETED|Third Washout (7 Days)||0
10223425|NCT03996694|11351349|FG003|NOT COMPLETED|Third Washout (7 Days)||0
10223426|NCT03996694|11351350|FG004|NOT COMPLETED|Third Washout (7 Days)||1
10223427|NCT03996694|11351351|FG005|NOT COMPLETED|Third Washout (7 Days)||0
10223428|NCT03996694|11351346|FG000|STARTED|Fourth Intervention (1 Day)||3
10223429|NCT03996694|11351347|FG001|STARTED|Fourth Intervention (1 Day)||2
10223430|NCT03996694|11351348|FG002|STARTED|Fourth Intervention (1 Day)||2
10223431|NCT03996694|11351349|FG003|STARTED|Fourth Intervention (1 Day)||3
10223432|NCT03996694|11351350|FG004|STARTED|Fourth Intervention (1 Day)||2
10223433|NCT03996694|11351351|FG005|STARTED|Fourth Intervention (1 Day)||3
10223434|NCT03996694|11351346|FG000|COMPLETED|Fourth Intervention (1 Day)||3
10223435|NCT03996694|11351347|FG001|COMPLETED|Fourth Intervention (1 Day)||2
10223436|NCT03996694|11351348|FG002|COMPLETED|Fourth Intervention (1 Day)||2
10223437|NCT03996694|11351349|FG003|COMPLETED|Fourth Intervention (1 Day)||3
10223438|NCT03996694|11351350|FG004|COMPLETED|Fourth Intervention (1 Day)||2
10223439|NCT03996694|11351351|FG005|COMPLETED|Fourth Intervention (1 Day)||3
10223440|NCT03996694|11351346|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10223441|NCT03996694|11351347|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10223442|NCT03996694|11351348|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
10223443|NCT03996694|11351349|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
10223444|NCT03996694|11351350|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
10223445|NCT03996694|11351351|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
10223446|NCT03996694|11351346|FG000|STARTED|Fourth Washout (7 Days)||3
10223447|NCT03996694|11351347|FG001|STARTED|Fourth Washout (7 Days)||2
10223448|NCT03996694|11351348|FG002|STARTED|Fourth Washout (7 Days)||2
10223449|NCT03996694|11351349|FG003|STARTED|Fourth Washout (7 Days)||3
10223450|NCT03996694|11351350|FG004|STARTED|Fourth Washout (7 Days)||2
10223451|NCT03996694|11351351|FG005|STARTED|Fourth Washout (7 Days)||3
10223452|NCT03996694|11351346|FG000|COMPLETED|Fourth Washout (7 Days)||3
10223453|NCT03996694|11351347|FG001|COMPLETED|Fourth Washout (7 Days)||2
10223454|NCT03996694|11351348|FG002|COMPLETED|Fourth Washout (7 Days)||2
10223455|NCT03996694|11351349|FG003|COMPLETED|Fourth Washout (7 Days)||3
10223456|NCT03996694|11351350|FG004|COMPLETED|Fourth Washout (7 Days)||2
10223457|NCT03996694|11351351|FG005|COMPLETED|Fourth Washout (7 Days)||3
10223458|NCT03996694|11351346|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0
10223459|NCT03996694|11351347|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0
10223460|NCT03996694|11351348|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0
10223461|NCT03996694|11351349|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0
10223462|NCT03996694|11351350|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0
10223463|NCT03996694|11351351|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0
10223464|NCT03996694|11351346|FG000|STARTED|Fifth Intervention (1 Day)||3
10223465|NCT03996694|11351347|FG001|STARTED|Fifth Intervention (1 Day)||2
10223466|NCT03996694|11351348|FG002|STARTED|Fifth Intervention (1 Day)||2
10223467|NCT03996694|11351349|FG003|STARTED|Fifth Intervention (1 Day)||3
10223468|NCT03996694|11351350|FG004|STARTED|Fifth Intervention (1 Day)||2
10223469|NCT03996694|11351351|FG005|STARTED|Fifth Intervention (1 Day)||3
10223470|NCT03996694|11351346|FG000|COMPLETED|Fifth Intervention (1 Day)||3
10223471|NCT03996694|11351347|FG001|COMPLETED|Fifth Intervention (1 Day)||2
10223472|NCT03996694|11351348|FG002|COMPLETED|Fifth Intervention (1 Day)||2
10223473|NCT03996694|11351349|FG003|COMPLETED|Fifth Intervention (1 Day)||3
10223474|NCT03996694|11351350|FG004|COMPLETED|Fifth Intervention (1 Day)||2
10223475|NCT03996694|11351351|FG005|COMPLETED|Fifth Intervention (1 Day)||3
10223476|NCT03996694|11351346|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0
10223477|NCT03996694|11351347|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0
10223478|NCT03996694|11351348|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0
10223479|NCT03996694|11351349|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0
10223480|NCT03996694|11351350|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0
10223481|NCT03996694|11351351|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0
10223482|NCT03996694|11351346|FG000|STARTED|Fifth Washout (7 Days)||3
10223483|NCT03996694|11351347|FG001|STARTED|Fifth Washout (7 Days)||2
10223484|NCT03996694|11351348|FG002|STARTED|Fifth Washout (7 Days)||2
10223485|NCT03996694|11351349|FG003|STARTED|Fifth Washout (7 Days)||3
10223486|NCT03996694|11351350|FG004|STARTED|Fifth Washout (7 Days)||2
10223487|NCT03996694|11351351|FG005|STARTED|Fifth Washout (7 Days)||3
10223488|NCT03996694|11351346|FG000|COMPLETED|Fifth Washout (7 Days)||3
10223489|NCT03996694|11351347|FG001|COMPLETED|Fifth Washout (7 Days)||2
10223490|NCT03996694|11351348|FG002|COMPLETED|Fifth Washout (7 Days)||2
10223491|NCT03996694|11351349|FG003|COMPLETED|Fifth Washout (7 Days)||3
10223492|NCT03996694|11351350|FG004|COMPLETED|Fifth Washout (7 Days)||2
10223493|NCT03996694|11351351|FG005|COMPLETED|Fifth Washout (7 Days)||3
10012801|NCT01787591|11135670|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10012802|NCT01787591|11135671|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10012803|NCT01787591|11135668|FG000|STARTED|Period 4 (Cross-over Arm 4)||5
10012804|NCT01787591|11135669|FG001|STARTED|Period 4 (Cross-over Arm 4)||5
10012805|NCT01787591|11135670|FG002|STARTED|Period 4 (Cross-over Arm 4)||5
10223494|NCT03996694|11351346|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0
10223495|NCT03996694|11351347|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0
10223496|NCT03996694|11351348|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0
10223497|NCT03996694|11351349|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0
10012806|NCT01787591|11135671|FG003|STARTED|Period 4 (Cross-over Arm 4)||5
10223498|NCT03996694|11351350|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0
10223499|NCT03996694|11351351|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0
10012807|NCT01787591|11135668|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5
10223500|NCT03996694|11351346|FG000|STARTED|Sixth Intervention (1 Day)||3
10223501|NCT03996694|11351347|FG001|STARTED|Sixth Intervention (1 Day)||2
10223502|NCT03996694|11351348|FG002|STARTED|Sixth Intervention (1 Day)||2
10223503|NCT03996694|11351349|FG003|STARTED|Sixth Intervention (1 Day)||3
10223504|NCT03996694|11351350|FG004|STARTED|Sixth Intervention (1 Day)||2
10223505|NCT03996694|11351351|FG005|STARTED|Sixth Intervention (1 Day)||3
10223506|NCT03996694|11351346|FG000|COMPLETED|Sixth Intervention (1 Day)||3
10223507|NCT03996694|11351347|FG001|COMPLETED|Sixth Intervention (1 Day)||2
10223508|NCT03996694|11351348|FG002|COMPLETED|Sixth Intervention (1 Day)||2
10223509|NCT03996694|11351349|FG003|COMPLETED|Sixth Intervention (1 Day)||3
10223510|NCT03996694|11351350|FG004|COMPLETED|Sixth Intervention (1 Day)||2
10223511|NCT03996694|11351351|FG005|COMPLETED|Sixth Intervention (1 Day)||3
10223512|NCT03996694|11351346|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0
10223513|NCT03996694|11351347|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0
10223514|NCT03996694|11351348|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0
10223515|NCT03996694|11351349|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0
10223516|NCT03996694|11351350|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0
10223517|NCT03996694|11351351|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0
10223518|NCT03988907|11351367|FG000|STARTED|Overall Study||8
10223519|NCT03988907|11351368|FG001|STARTED|Overall Study||27
10223520|NCT03988907|11351367|FG000|COMPLETED|Overall Study||8
10223521|NCT03988907|11351368|FG001|COMPLETED|Overall Study||26
10223522|NCT03988907|11351367|FG000|NOT COMPLETED|Overall Study||0
10223523|NCT03988907|11351368|FG001|NOT COMPLETED|Overall Study||1
10223524|NCT03988088|11351382|FG000|STARTED|Single-Dose Pharmacokinetic Study||11
10223525|NCT03988088|11351383|FG001|STARTED|Single-Dose Pharmacokinetic Study||7
10223526|NCT03988088|11351384|FG002|STARTED|Single-Dose Pharmacokinetic Study||0
10223527|NCT03988088|11351385|FG003|STARTED|Single-Dose Pharmacokinetic Study||0
10223528|NCT03988088|11351382|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11
10223529|NCT03988088|11351383|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6
10223530|NCT03988088|11351384|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0
10012808|NCT01787591|11135669|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5
10012809|NCT01787591|11135670|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5
10012810|NCT01787591|11135671|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5
10012811|NCT01787591|11135668|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10223531|NCT03988088|11351385|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0
10223532|NCT03988088|11351382|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
10223533|NCT03988088|11351383|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
10223534|NCT03988088|11351384|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
10223535|NCT03988088|11351385|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
10223536|NCT03988088|11351382|FG000|STARTED|Open-Label Addendum||0
10223537|NCT03988088|11351383|FG001|STARTED|Open-Label Addendum||0
10223538|NCT03988088|11351384|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
10223539|NCT03988088|11351385|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
10223540|NCT03988088|11351382|FG000|COMPLETED|Open-Label Addendum||0
10223541|NCT03988088|11351383|FG001|COMPLETED|Open-Label Addendum||0
10223542|NCT03988088|11351384|FG002|COMPLETED|Open-Label Addendum||1
10223543|NCT03988088|11351385|FG003|COMPLETED|Open-Label Addendum||2
10223544|NCT03988088|11351382|FG000|NOT COMPLETED|Open-Label Addendum||0
10223545|NCT03988088|11351383|FG001|NOT COMPLETED|Open-Label Addendum||0
10223546|NCT03988088|11351384|FG002|NOT COMPLETED|Open-Label Addendum||1
10223547|NCT03988088|11351385|FG003|NOT COMPLETED|Open-Label Addendum||0
10223548|NCT03980522|11351398|FG000|STARTED|Treatment Period||13
10223549|NCT03980522|11351399|FG001|STARTED|Treatment Period||3
10223550|NCT03980522|11351400|FG002|STARTED|Treatment Period||6
10223551|NCT03980522|11351401|FG003|STARTED|Treatment Period||1
10223552|NCT03980522|11351402|FG004|STARTED|Treatment Period||3
10223553|NCT03980522|11351398|FG000|COMPLETED|Treatment Period||12
10223554|NCT03980522|11351399|FG001|COMPLETED|Treatment Period||3
10223555|NCT03980522|11351400|FG002|COMPLETED|Treatment Period||6
10223556|NCT03980522|11351401|FG003|COMPLETED|Treatment Period||1
10223557|NCT03980522|11351402|FG004|COMPLETED|Treatment Period||3
10223558|NCT03980522|11351398|FG000|NOT COMPLETED|Treatment Period||1
10223559|NCT03980522|11351399|FG001|NOT COMPLETED|Treatment Period||0
10223560|NCT03980522|11351400|FG002|NOT COMPLETED|Treatment Period||0
10223561|NCT03980522|11351401|FG003|NOT COMPLETED|Treatment Period||0
10223562|NCT03980522|11351402|FG004|NOT COMPLETED|Treatment Period||0
10223563|NCT03980522|11351398|FG000|STARTED|Extension Period||12
10223564|NCT03980522|11351399|FG001|STARTED|Extension Period||3
10223565|NCT03980522|11351400|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
10223566|NCT03980522|11351401|FG003|STARTED|Extension Period||1
10223567|NCT03980522|11351402|FG004|STARTED|Extension Period||3
10223568|NCT03980522|11351398|FG000|COMPLETED|Extension Period||12
10223569|NCT03980522|11351399|FG001|COMPLETED|Extension Period||3
10223570|NCT03980522|11351400|FG002|COMPLETED|Extension Period||5
10223571|NCT03980522|11351401|FG003|COMPLETED|Extension Period||1
10223572|NCT03980522|11351402|FG004|COMPLETED|Extension Period||3
10223573|NCT03980522|11351398|FG000|NOT COMPLETED|Extension Period||0
10223574|NCT03980522|11351399|FG001|NOT COMPLETED|Extension Period||0
10223575|NCT03980522|11351400|FG002|NOT COMPLETED|Extension Period||0
10223576|NCT03980522|11351401|FG003|NOT COMPLETED|Extension Period||0
10223577|NCT03980522|11351402|FG004|NOT COMPLETED|Extension Period||0
10223578|NCT03999684|11351414|FG000|STARTED|Overall Study||18
10223579|NCT03999684|11351414|FG000|COMPLETED|Overall Study||18
10223580|NCT03999684|11351414|FG000|NOT COMPLETED|Overall Study||0
10239293|NCT00301080|11370815|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10223581|NCT03995784|11351418|FG000|STARTED|Overall Study||6
10223582|NCT03995784|11351418|FG000|COMPLETED|Overall Study||5
10223583|NCT03995784|11351418|FG000|NOT COMPLETED|Overall Study||1
10223584|NCT03993392|11351429|FG000|STARTED|Overall Study||26
10223585|NCT03993392|11351429|FG000|Treated With SUBLOCADE|Overall Study||24
10223586|NCT03993392|11351429|FG000|COMPLETED|Overall Study||20
10223587|NCT03993392|11351429|FG000|NOT COMPLETED|Overall Study||6
10223588|NCT03989427|11351436|FG000|STARTED|First Intervention (2 Weeks)||15
10223589|NCT03989427|11351437|FG001|STARTED|First Intervention (2 Weeks)||15
10223590|NCT03989427|11351436|FG000|COMPLETED|First Intervention (2 Weeks)||15
10223591|NCT03989427|11351437|FG001|COMPLETED|First Intervention (2 Weeks)||15
10223592|NCT03989427|11351436|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10223593|NCT03989427|11351437|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10223594|NCT03989427|11351436|FG000|STARTED|Washout (1 Week)||15
10223595|NCT03989427|11351437|FG001|STARTED|Washout (1 Week)||15
10223596|NCT03989427|11351436|FG000|COMPLETED|Washout (1 Week)||15
10223597|NCT03989427|11351437|FG001|COMPLETED|Washout (1 Week)||15
10223598|NCT03989427|11351436|FG000|NOT COMPLETED|Washout (1 Week)||0
10223599|NCT03989427|11351437|FG001|NOT COMPLETED|Washout (1 Week)||0
10223600|NCT03989427|11351436|FG000|STARTED|Second Intervention (2 Weeks)||15
10223601|NCT03989427|11351437|FG001|STARTED|Second Intervention (2 Weeks)||15
10223602|NCT03989427|11351436|FG000|COMPLETED|Second Intervention (2 Weeks)||15
10223603|NCT03989427|11351437|FG001|COMPLETED|Second Intervention (2 Weeks)||15
10223604|NCT03989427|11351436|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10223605|NCT03989427|11351437|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10223606|NCT03981822|11351452|FG000|STARTED|Overall Study||5
10223607|NCT03981822|11351453|FG001|STARTED|Overall Study||5
10223608|NCT03981822|11351454|FG002|STARTED|Overall Study||5
10223609|NCT03981822|11351455|FG003|STARTED|Overall Study||3
10223610|NCT03981822|11351456|FG004|STARTED|Overall Study||25
10223611|NCT03981822|11351457|FG005|STARTED|Overall Study||23
10223612|NCT03981822|11351458|FG006|STARTED|Overall Study||22
10223613|NCT03981822|11351459|FG007|STARTED|Overall Study||17
10223614|NCT03981822|11351452|FG000|COMPLETED|Overall Study||5
10223615|NCT03981822|11351453|FG001|COMPLETED|Overall Study||3
10223616|NCT03981822|11351454|FG002|COMPLETED|Overall Study||4
10223617|NCT03981822|11351455|FG003|COMPLETED|Overall Study||3
10223618|NCT03981822|11351456|FG004|COMPLETED|Overall Study||17
10223619|NCT03981822|11351457|FG005|COMPLETED|Overall Study||17
10223620|NCT03981822|11351458|FG006|COMPLETED|Overall Study||16
10223621|NCT03981822|11351459|FG007|COMPLETED|Overall Study||12
10223622|NCT03981822|11351452|FG000|NOT COMPLETED|Overall Study||0
10223623|NCT03981822|11351453|FG001|NOT COMPLETED|Overall Study||2
10223624|NCT03981822|11351454|FG002|NOT COMPLETED|Overall Study||1
10223625|NCT03981822|11351455|FG003|NOT COMPLETED|Overall Study||0
10223626|NCT03981822|11351456|FG004|NOT COMPLETED|Overall Study||8
10223627|NCT03981822|11351457|FG005|NOT COMPLETED|Overall Study||6
10223628|NCT03981822|11351458|FG006|NOT COMPLETED|Overall Study||6
10223629|NCT03981822|11351459|FG007|NOT COMPLETED|Overall Study||5
10223630|NCT03992482|11351473|FG000|STARTED|Overall Study||13
10223631|NCT03992482|11351474|FG001|STARTED|Overall Study||14
10223632|NCT03992482|11351473|FG000|COMPLETED|Overall Study||13
10223633|NCT03992482|11351474|FG001|COMPLETED|Overall Study||14
10223634|NCT03992482|11351473|FG000|NOT COMPLETED|Overall Study||0
10223635|NCT03992482|11351474|FG001|NOT COMPLETED|Overall Study||0
10223636|NCT03993119|11351484|FG000|STARTED|Overall Study||192
10223637|NCT03993119|11351485|FG001|STARTED|Overall Study||76
10223638|NCT03993119|11351486|FG002|STARTED|Overall Study||166
10223639|NCT03993119|11351487|FG003|STARTED|Overall Study||66
10223640|NCT03993119|11351484|FG000|COMPLETED|Overall Study||192
10223641|NCT03993119|11351485|FG001|COMPLETED|Overall Study||76
10223642|NCT03993119|11351486|FG002|COMPLETED|Overall Study||166
10223643|NCT03993119|11351487|FG003|COMPLETED|Overall Study||66
10223644|NCT03993119|11351484|FG000|NOT COMPLETED|Overall Study||0
10223645|NCT03993119|11351485|FG001|NOT COMPLETED|Overall Study||0
10223646|NCT03993119|11351486|FG002|NOT COMPLETED|Overall Study||0
10012812|NCT01787591|11135669|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10012813|NCT01787591|11135670|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10012814|NCT01787591|11135671|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10012815|NCT01787604|11135684|FG000|STARTED|Overall Study||32
10012816|NCT01787604|11135685|FG001|STARTED|Overall Study||32
10012817|NCT01787604|11135684|FG000|COMPLETED|Overall Study||28
10012818|NCT01787604|11135685|FG001|COMPLETED|Overall Study||28
10012819|NCT01787604|11135684|FG000|NOT COMPLETED|Overall Study||4
10012820|NCT01787604|11135685|FG001|NOT COMPLETED|Overall Study||4
10012821|NCT01787760|11135694|FG000|STARTED|Overall Study||51
10223647|NCT03993119|11351487|FG003|NOT COMPLETED|Overall Study||0
10223648|NCT03991494|11351512|FG000|STARTED|Overall Study||4
10223649|NCT03991494|11351512|FG000|COMPLETED|Overall Study||0
10223650|NCT03991494|11351512|FG000|NOT COMPLETED|Overall Study||4
10012822|NCT01787760|11135695|FG001|STARTED|Overall Study||50
10012823|NCT01787760|11135696|FG002|STARTED|Overall Study||51
10223651|NCT03989570|11351521|FG000|STARTED|Overall Study||31
10223652|NCT03989570|11351522|FG001|STARTED|Overall Study||31
10223653|NCT03989570|11351523|FG002|STARTED|Overall Study||31
10223654|NCT03989570|11351521|FG000|COMPLETED|Overall Study||31
10223655|NCT03989570|11351522|FG001|COMPLETED|Overall Study||31
10223656|NCT03989570|11351523|FG002|COMPLETED|Overall Study||31
10223657|NCT03989570|11351521|FG000|NOT COMPLETED|Overall Study||0
10223658|NCT03989570|11351522|FG001|NOT COMPLETED|Overall Study||0
10223659|NCT03989570|11351523|FG002|NOT COMPLETED|Overall Study||0
10223660|NCT03988803|11351531|FG000|STARTED|Screening||16
10223661|NCT03988803|11351531|FG000|COMPLETED|Screening||16
10223662|NCT03988803|11351531|FG000|NOT COMPLETED|Screening||0
10223663|NCT03988803|11351531|FG000|STARTED|Period 1||16
10223664|NCT03988803|11351531|FG000|COMPLETED|Period 1||16
10223665|NCT03988803|11351531|FG000|NOT COMPLETED|Period 1||0
10223666|NCT03988803|11351531|FG000|STARTED|Period 2||16
10223667|NCT03988803|11351531|FG000|Treated|Period 2||15
10223668|NCT03988803|11351531|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
10223669|NCT03988803|11351531|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
10223670|NCT03988803|11351531|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
10223671|NCT03988803|11351531|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
10223672|NCT03988803|11351531|FG000|COMPLETED|Period 2||13
10223673|NCT03988803|11351531|FG000|NOT COMPLETED|Period 2||3
10223674|NCT03988803|11351531|FG000|STARTED|Period 3||13
10223675|NCT03988803|11351531|FG000|COMPLETED|Period 3||13
10223676|NCT03988803|11351531|FG000|NOT COMPLETED|Period 3||0
10223677|NCT03987932|11351542|FG000|STARTED|Overall Study||4
10223678|NCT03987932|11351543|FG001|STARTED|Overall Study||3
10223679|NCT03987932|11351544|FG002|STARTED|Overall Study||4
10223680|NCT03987932|11351542|FG000|1 Month|Overall Study||4
10223681|NCT03987932|11351543|FG001|1 Month|Overall Study||2
10223682|NCT03987932|11351544|FG002|1 Month|Overall Study||3
10223683|NCT03987932|11351542|FG000|3 Months|Overall Study||4
10223684|NCT03987932|11351543|FG001|3 Months|Overall Study||2
10223685|NCT03987932|11351544|FG002|3 Months|Overall Study||3
10223686|NCT03987932|11351542|FG000|6 Months|Overall Study||2
10223687|NCT03987932|11351543|FG001|6 Months|Overall Study||2
10223688|NCT03987932|11351544|FG002|6 Months|Overall Study||2
10223689|NCT03987932|11351542|FG000|COMPLETED|Overall Study||2
10223690|NCT03987932|11351543|FG001|COMPLETED|Overall Study||2
10223691|NCT03987932|11351544|FG002|COMPLETED|Overall Study||2
10223692|NCT03987932|11351542|FG000|NOT COMPLETED|Overall Study||2
10223693|NCT03987932|11351543|FG001|NOT COMPLETED|Overall Study||1
10223694|NCT03987932|11351544|FG002|NOT COMPLETED|Overall Study||2
10223695|NCT03987191|11351554|FG000|STARTED|Overall Study||17
10223696|NCT03987191|11351555|FG001|STARTED|Overall Study||15
10223697|NCT03987191|11351554|FG000|Data Collected|Overall Study||17
10223698|NCT03987191|11351555|FG001|Data Collected|Overall Study||13
10223699|NCT03987191|11351554|FG000|COMPLETED|Overall Study||17
10223700|NCT03987191|11351555|FG001|COMPLETED|Overall Study||13
10223701|NCT03987191|11351554|FG000|NOT COMPLETED|Overall Study||0
10223702|NCT03987191|11351555|FG001|NOT COMPLETED|Overall Study||2
10223703|NCT03988842|11351561|FG000|STARTED|Overall Study||4
10223704|NCT03988842|11351561|FG000|COMPLETED|Overall Study||3
10223705|NCT03988842|11351561|FG000|NOT COMPLETED|Overall Study||1
10223706|NCT03981861|11351566|FG000|STARTED|Overall Study||12
10223707|NCT03981861|11351566|FG000|COMPLETED|Overall Study||9
10223708|NCT03981861|11351566|FG000|NOT COMPLETED|Overall Study||3
10223709|NCT03974334|11351570|FG000|STARTED|Overall Study||25
10223710|NCT03974334|11351570|FG000|COMPLETED|Overall Study||24
10223711|NCT03974334|11351570|FG000|NOT COMPLETED|Overall Study||1
10223712|NCT03988426|11351574|FG000|STARTED|Overall Study||25
10223713|NCT03988426|11351574|FG000|COMPLETED|Overall Study||24
10223714|NCT03988426|11351574|FG000|NOT COMPLETED|Overall Study||1
10223715|NCT03988374|11351583|FG000|STARTED|Overall Study||104
10223716|NCT03988374|11351584|FG001|STARTED|Overall Study||107
10223717|NCT03988374|11351585|FG002|STARTED|Overall Study||108
10223718|NCT03988374|11351583|FG000|COMPLETED|Overall Study||103
10223719|NCT03988374|11351584|FG001|COMPLETED|Overall Study||105
10223720|NCT03988374|11351585|FG002|COMPLETED|Overall Study||107
10223721|NCT03988374|11351583|FG000|NOT COMPLETED|Overall Study||1
10223722|NCT03988374|11351584|FG001|NOT COMPLETED|Overall Study||2
10223723|NCT03988374|11351585|FG002|NOT COMPLETED|Overall Study||1
10223724|NCT03987074|11351598|FG000|STARTED|Overall Study||21
10223725|NCT03987074|11351599|FG001|STARTED|Overall Study||22
10223726|NCT03987074|11351600|FG002|STARTED|Overall Study||22
10223727|NCT03987074|11351601|FG003|STARTED|Overall Study||22
10223728|NCT03987074|11351602|FG004|STARTED|Overall Study||21
10223729|NCT03987074|11351598|FG000|COMPLETED|Overall Study||18
10223730|NCT03987074|11351599|FG001|COMPLETED|Overall Study||20
10223731|NCT03987074|11351600|FG002|COMPLETED|Overall Study||21
10223732|NCT03987074|11351601|FG003|COMPLETED|Overall Study||18
10223733|NCT03987074|11351602|FG004|COMPLETED|Overall Study||19
10223734|NCT03987074|11351598|FG000|NOT COMPLETED|Overall Study||3
10223735|NCT03987074|11351599|FG001|NOT COMPLETED|Overall Study||2
10223736|NCT03987074|11351600|FG002|NOT COMPLETED|Overall Study||1
10223737|NCT03987074|11351601|FG003|NOT COMPLETED|Overall Study||4
10223738|NCT03987074|11351602|FG004|NOT COMPLETED|Overall Study||2
10223739|NCT03977935|11351616|FG000|STARTED|Overall Study||40
10223740|NCT03977935|11351617|FG001|STARTED|Overall Study||40
10223741|NCT03977935|11351616|FG000|COMPLETED|Overall Study||40
10223742|NCT03977935|11351617|FG001|COMPLETED|Overall Study||40
10223743|NCT03977935|11351616|FG000|NOT COMPLETED|Overall Study||0
10223744|NCT03977935|11351617|FG001|NOT COMPLETED|Overall Study||0
10223745|NCT03988049|11351625|FG000|STARTED|Overall Study||22
10223746|NCT03988049|11351626|FG001|STARTED|Overall Study||22
10223747|NCT03988049|11351625|FG000|COMPLETED|Overall Study||22
10223748|NCT03988049|11351626|FG001|COMPLETED|Overall Study||22
10223749|NCT03988049|11351625|FG000|NOT COMPLETED|Overall Study||0
10223750|NCT03988049|11351626|FG001|NOT COMPLETED|Overall Study||0
10223751|NCT03979820|11351636|FG000|STARTED|Overall Study||13
10223752|NCT03979820|11351637|FG001|STARTED|Overall Study||14
10223753|NCT03979820|11351638|FG002|STARTED|Overall Study||16
10223754|NCT03979820|11351639|FG003|STARTED|Overall Study||10
10223755|NCT03979820|11351636|FG000|COMPLETED|Overall Study||7
10223756|NCT03979820|11351637|FG001|COMPLETED|Overall Study||14
10223757|NCT03979820|11351638|FG002|COMPLETED|Overall Study||15
10223758|NCT03979820|11351639|FG003|COMPLETED|Overall Study||0
10223759|NCT03979820|11351636|FG000|NOT COMPLETED|Overall Study||6
10223760|NCT03979820|11351637|FG001|NOT COMPLETED|Overall Study||0
10223761|NCT03979820|11351638|FG002|NOT COMPLETED|Overall Study||1
10223762|NCT03979820|11351639|FG003|NOT COMPLETED|Overall Study||10
10223763|NCT03972137|11351653|FG000|STARTED|Overall Study||10
10223764|NCT03972137|11351653|FG000|Enrolled|Overall Study||10
10223765|NCT03972137|11351653|FG000|Treatment Completed|Overall Study||6
10223766|NCT03972137|11351653|FG000|Follow-up Completed|Overall Study||4
10223767|NCT03972137|11351653|FG000|COMPLETED|Overall Study||4
10223768|NCT03972137|11351653|FG000|NOT COMPLETED|Overall Study||6
10223769|NCT03970395|11351671|FG000|STARTED|Overall Study||48
10223770|NCT03970395|11351672|FG001|STARTED|Overall Study||48
10223771|NCT03970395|11351671|FG000|COMPLETED|Overall Study||41
10223772|NCT03970395|11351672|FG001|COMPLETED|Overall Study||36
10223773|NCT03970395|11351671|FG000|NOT COMPLETED|Overall Study||7
10223774|NCT03970395|11351672|FG001|NOT COMPLETED|Overall Study||12
10223775|NCT03987620|11351684|FG000|STARTED|Overall Study||303
10223776|NCT03987620|11351685|FG001|STARTED|Overall Study||152
10223777|NCT03987620|11351684|FG000|Withdrawn Before Treatment|Overall Study||5
10223778|NCT03987620|11351685|FG001|Withdrawn Before Treatment|Overall Study||1
10223779|NCT03987620|11351684|FG000|Withdrawn Before TOC|Overall Study||48
10223780|NCT03987620|11351685|FG001|Withdrawn Before TOC|Overall Study||45
10223781|NCT03987620|11351684|FG000|Completed the TOC Visit|Overall Study||250
10223782|NCT03987620|11351685|FG001|Completed the TOC Visit|Overall Study||106
10223783|NCT03987620|11351684|FG000|Withdrawn At or After the TOC Visit|Overall Study||4
10223784|NCT03987620|11351685|FG001|Withdrawn At or After the TOC Visit|Overall Study||4
10223785|NCT03987620|11351684|FG000|COMPLETED|Overall Study||246
10223786|NCT03987620|11351685|FG001|COMPLETED|Overall Study||102
10223787|NCT03987620|11351684|FG000|NOT COMPLETED|Overall Study||57
10223788|NCT03987620|11351685|FG001|NOT COMPLETED|Overall Study||50
10223789|NCT03983317|11351691|FG000|STARTED|Overall Study||25
10223790|NCT03983317|11351691|FG000|COMPLETED|Overall Study||20
10223791|NCT03983317|11351691|FG000|NOT COMPLETED|Overall Study||5
10223792|NCT03985657|11351695|FG000|STARTED|Intervention 1 (One Night)||20
10223793|NCT03985657|11351696|FG001|STARTED|Intervention 1 (One Night)||11
10223794|NCT03985657|11351695|FG000|COMPLETED|Intervention 1 (One Night)||20
10223795|NCT03985657|11351696|FG001|COMPLETED|Intervention 1 (One Night)||10
10223796|NCT03985657|11351695|FG000|NOT COMPLETED|Intervention 1 (One Night)||0
10223797|NCT03985657|11351696|FG001|NOT COMPLETED|Intervention 1 (One Night)||1
10223798|NCT03985657|11351695|FG000|STARTED|Washout (Up to 1 Week)||20
10223799|NCT03985657|11351696|FG001|STARTED|Washout (Up to 1 Week)||10
10223800|NCT03985657|11351695|FG000|COMPLETED|Washout (Up to 1 Week)||20
10223801|NCT03985657|11351696|FG001|COMPLETED|Washout (Up to 1 Week)||10
10223802|NCT03985657|11351695|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0
10223803|NCT03985657|11351696|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0
10223804|NCT03985657|11351695|FG000|STARTED|Intervention 2 (One Night)||20
10223805|NCT03985657|11351696|FG001|STARTED|Intervention 2 (One Night)||10
10223806|NCT03985657|11351695|FG000|COMPLETED|Intervention 2 (One Night)||20
10223807|NCT03985657|11351696|FG001|COMPLETED|Intervention 2 (One Night)||10
10223808|NCT03985657|11351695|FG000|NOT COMPLETED|Intervention 2 (One Night)||0
10223809|NCT03985657|11351696|FG001|NOT COMPLETED|Intervention 2 (One Night)||0
10223810|NCT03981939|11351705|FG000|STARTED|Overall Study||549
10223811|NCT03981939|11351706|FG001|STARTED|Overall Study||1902
10223812|NCT03981939|11351707|FG002|STARTED|Overall Study||581
10223813|NCT03981939|11351705|FG000|COMPLETED|Overall Study||549
10223814|NCT03981939|11351706|FG001|COMPLETED|Overall Study||1902
10223815|NCT03981939|11351707|FG002|COMPLETED|Overall Study||581
10223816|NCT03981939|11351705|FG000|NOT COMPLETED|Overall Study||0
10223817|NCT03981939|11351706|FG001|NOT COMPLETED|Overall Study||0
10223818|NCT03981939|11351707|FG002|NOT COMPLETED|Overall Study||0
10223819|NCT03973905|11351720|FG000|STARTED|Overall Study||107
10223820|NCT03973905|11351721|FG001|STARTED|Overall Study||183
10223821|NCT03973905|11351720|FG000|COMPLETED|Overall Study||107
10223822|NCT03973905|11351721|FG001|COMPLETED|Overall Study||183
10223823|NCT03973905|11351720|FG000|NOT COMPLETED|Overall Study||0
10223824|NCT03973905|11351721|FG001|NOT COMPLETED|Overall Study||0
10223825|NCT03984838|11351727|FG000|STARTED|Overall Study||16
10223826|NCT03984838|11351727|FG000|COMPLETED|Overall Study||16
10223827|NCT03984838|11351727|FG000|NOT COMPLETED|Overall Study||0
10223828|NCT03983941|11351733|FG000|STARTED|Overall Study||2
10223829|NCT03983941|11351734|FG001|STARTED|Overall Study||5
10223830|NCT03983941|11351733|FG000|COMPLETED|Overall Study||2
10223831|NCT03983941|11351734|FG001|COMPLETED|Overall Study||5
10223832|NCT03983941|11351733|FG000|NOT COMPLETED|Overall Study||0
10223833|NCT03983941|11351734|FG001|NOT COMPLETED|Overall Study||0
10223834|NCT03976752|11351742|FG000|STARTED|Overall Study||4
10223835|NCT03976752|11351743|FG001|STARTED|Overall Study||37
10223836|NCT03976752|11351742|FG000|Started Study Arm A|Overall Study||0
10223837|NCT03976752|11351743|FG001|Started Study Arm A|Overall Study||14
10223838|NCT03976752|11351742|FG000|Completed Study Arm A|Overall Study||0
10223839|NCT03976752|11351743|FG001|Completed Study Arm A|Overall Study||8
10223840|NCT03976752|11351742|FG000|Started Study Arm B|Overall Study||0
10223841|NCT03976752|11351743|FG001|Started Study Arm B|Overall Study||8
10223842|NCT03976752|11351742|FG000|Completed Study Arm B|Overall Study||0
10223843|NCT03976752|11351743|FG001|Completed Study Arm B|Overall Study||8
10223844|NCT03976752|11351742|FG000|Started Study Arm C|Overall Study||0
10223845|NCT03976752|11351743|FG001|Started Study Arm C|Overall Study||11
10223846|NCT03976752|11351742|FG000|Completed Study Arm C|Overall Study||0
10223847|NCT03976752|11351743|FG001|Completed Study Arm C|Overall Study||8
10223848|NCT03976752|11351742|FG000|Started Study Arm D|Overall Study||0
10223849|NCT03976752|11351743|FG001|Started Study Arm D|Overall Study||6
10223850|NCT03976752|11351742|FG000|Completed Study Arm D|Overall Study||0
10223851|NCT03976752|11351743|FG001|Completed Study Arm D|Overall Study||4
10223852|NCT03976752|11351742|FG000|COMPLETED|Overall Study||3
10223853|NCT03976752|11351743|FG001|COMPLETED|Overall Study||28
10223854|NCT03976752|11351742|FG000|NOT COMPLETED|Overall Study||1
10223855|NCT03976752|11351743|FG001|NOT COMPLETED|Overall Study||9
10223856|NCT03984825|11351754|FG000|STARTED|Run-in Period (Day -3 to -1)||23
10223857|NCT03984825|11351754|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23
10223858|NCT03984825|11351754|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
10223859|NCT03984825|11351754|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23
10223860|NCT03984825|11351754|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
10223861|NCT03984825|11351754|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
10223862|NCT03984825|11351754|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21
10223863|NCT03984825|11351754|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
10223864|NCT03984825|11351754|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
10223865|NCT03971721|11351763|FG000|STARTED|Overall Study||3
10223866|NCT03971721|11351763|FG000|COMPLETED|Overall Study||3
10223867|NCT03971721|11351763|FG000|NOT COMPLETED|Overall Study||0
10223868|NCT03982433|11351767|FG000|STARTED|Overall Study||8
10223869|NCT03982433|11351767|FG000|COMPLETED|Overall Study||7
10223870|NCT03982433|11351767|FG000|NOT COMPLETED|Overall Study||1
10223871|NCT03979677|11351771|FG000|STARTED|Overall Study|Participants enrolled|41
10223872|NCT03979677|11351771|FG000|COMPLETED|Overall Study|participants completed|28
10223873|NCT03979677|11351771|FG000|NOT COMPLETED|Overall Study||13
10223874|NCT03976466|11351777|FG000|STARTED|Overall Study||44
10223875|NCT03976466|11351778|FG001|STARTED|Overall Study||43
10223876|NCT03976466|11351777|FG000|COMPLETED|Overall Study||43
10223877|NCT03976466|11351778|FG001|COMPLETED|Overall Study||40
10223878|NCT03976466|11351777|FG000|NOT COMPLETED|Overall Study||1
10223879|NCT03976466|11351778|FG001|NOT COMPLETED|Overall Study||3
10223880|NCT03979638|11351788|FG000|STARTED|Period 1||33
10223881|NCT03979638|11351789|FG001|STARTED|Period 1||35
10223882|NCT03979638|11351788|FG000|COMPLETED|Period 1||26
10223883|NCT03979638|11351789|FG001|COMPLETED|Period 1||28
10223884|NCT03979638|11351788|FG000|NOT COMPLETED|Period 1||7
10223885|NCT03979638|11351789|FG001|NOT COMPLETED|Period 1||7
10223886|NCT03979638|11351788|FG000|STARTED|Period 2||26
10223887|NCT03979638|11351789|FG001|STARTED|Period 2||28
10223888|NCT03979638|11351788|FG000|COMPLETED|Period 2||25
10223889|NCT03979638|11351789|FG001|COMPLETED|Period 2||27
10223890|NCT03979638|11351788|FG000|NOT COMPLETED|Period 2||1
10223891|NCT03979638|11351789|FG001|NOT COMPLETED|Period 2||1
10223892|NCT03979274|11351804|FG000|STARTED|Treatment Period 1||22
10223893|NCT03979274|11351805|FG001|STARTED|Treatment Period 1||22
10223894|NCT03979274|11351804|FG000|COMPLETED|Treatment Period 1||22
10223895|NCT03979274|11351805|FG001|COMPLETED|Treatment Period 1||22
10223896|NCT03979274|11351804|FG000|NOT COMPLETED|Treatment Period 1||0
10223897|NCT03979274|11351805|FG001|NOT COMPLETED|Treatment Period 1||0
10223898|NCT03979274|11351804|FG000|STARTED|Treatment Period 2||22
10223899|NCT03979274|11351805|FG001|STARTED|Treatment Period 2||22
10223900|NCT03979274|11351804|FG000|COMPLETED|Treatment Period 2||22
10223901|NCT03979274|11351805|FG001|COMPLETED|Treatment Period 2||21
10223902|NCT03979274|11351804|FG000|NOT COMPLETED|Treatment Period 2||0
10223903|NCT03979274|11351805|FG001|NOT COMPLETED|Treatment Period 2||1
10223904|NCT03979066|11351813|FG000|STARTED|Overall Study||0
10223905|NCT03979066|11351814|FG001|STARTED|Overall Study||0
10223906|NCT03979066|11351813|FG000|COMPLETED|Overall Study||0
10223907|NCT03979066|11351814|FG001|COMPLETED|Overall Study||0
10223908|NCT03979066|11351813|FG000|NOT COMPLETED|Overall Study||0
10223909|NCT03979066|11351814|FG001|NOT COMPLETED|Overall Study||0
10223910|NCT03977727|11351822|FG000|STARTED|First Treatment||20
10223911|NCT03977727|11351823|FG001|STARTED|First Treatment||20
10223912|NCT03977727|11351822|FG000|Received Treatment|First Treatment||20
10223913|NCT03977727|11351823|FG001|Received Treatment|First Treatment||20
10223914|NCT03977727|11351822|FG000|COMPLETED|First Treatment||20
10223915|NCT03977727|11351823|FG001|COMPLETED|First Treatment||20
10223916|NCT03977727|11351822|FG000|NOT COMPLETED|First Treatment||0
10223917|NCT03977727|11351823|FG001|NOT COMPLETED|First Treatment||0
10223918|NCT03977727|11351822|FG000|STARTED|Second Treatment||20
10223919|NCT03977727|11351823|FG001|STARTED|Second Treatment||20
10223920|NCT03977727|11351822|FG000|COMPLETED|Second Treatment||20
10223921|NCT03977727|11351823|FG001|COMPLETED|Second Treatment||17
10223922|NCT03977727|11351822|FG000|NOT COMPLETED|Second Treatment||0
10223923|NCT03977727|11351823|FG001|NOT COMPLETED|Second Treatment||3
10223924|NCT03977155|11351832|FG000|STARTED|Overall Study||43
10223925|NCT03977155|11351833|FG001|STARTED|Overall Study||48
10223926|NCT03977155|11351834|FG002|STARTED|Overall Study||42
10223927|NCT03977155|11351832|FG000|COMPLETED|Overall Study||38
10223928|NCT03977155|11351833|FG001|COMPLETED|Overall Study||46
10223929|NCT03977155|11351834|FG002|COMPLETED|Overall Study||40
10223930|NCT03977155|11351832|FG000|NOT COMPLETED|Overall Study||5
10223931|NCT03977155|11351833|FG001|NOT COMPLETED|Overall Study||2
10223932|NCT03977155|11351834|FG002|NOT COMPLETED|Overall Study||2
10223933|NCT03974802|11351844|FG000|STARTED|Overall Study||41
10223934|NCT03974802|11351844|FG000|COMPLETED|Overall Study||41
10223935|NCT03974802|11351844|FG000|NOT COMPLETED|Overall Study||0
10223936|NCT03970733|11351856|FG000|STARTED|Overall Study||97
10223937|NCT03970733|11351857|FG001|STARTED|Overall Study||98
10223938|NCT03970733|11351858|FG002|STARTED|Overall Study||51
10223939|NCT03970733|11351856|FG000|COMPLETED|Overall Study||93
10223940|NCT03970733|11351857|FG001|COMPLETED|Overall Study||92
10223941|NCT03970733|11351858|FG002|COMPLETED|Overall Study||49
10223942|NCT03970733|11351856|FG000|NOT COMPLETED|Overall Study||4
10223943|NCT03970733|11351857|FG001|NOT COMPLETED|Overall Study||6
10223944|NCT03970733|11351858|FG002|NOT COMPLETED|Overall Study||2
10223945|NCT03968978|11351868|FG000|STARTED|Overall Study||111
10223946|NCT03968978|11351869|FG001|STARTED|Overall Study||105
10223947|NCT03968978|11351868|FG000|COMPLETED|Overall Study||110
10223948|NCT03968978|11351869|FG001|COMPLETED|Overall Study||105
10223949|NCT03968978|11351868|FG000|NOT COMPLETED|Overall Study||1
10223950|NCT03968978|11351869|FG001|NOT COMPLETED|Overall Study||0
10223951|NCT03968848|11351877|FG000|STARTED|Overall Study||8
10223952|NCT03968848|11351878|FG001|STARTED|Overall Study||8
10223953|NCT03968848|11351877|FG000|COMPLETED|Overall Study||8
10223954|NCT03968848|11351878|FG001|COMPLETED|Overall Study||8
10223955|NCT03968848|11351877|FG000|NOT COMPLETED|Overall Study||0
10223956|NCT03968848|11351878|FG001|NOT COMPLETED|Overall Study||0
10223957|NCT03967444|11351886|FG000|STARTED|Overall Study||19
10223958|NCT03967444|11351887|FG001|STARTED|Overall Study||40
10223959|NCT03967444|11351886|FG000|COMPLETED|Overall Study||18
10223960|NCT03967444|11351887|FG001|COMPLETED|Overall Study||38
10223961|NCT03967444|11351886|FG000|NOT COMPLETED|Overall Study||1
10223962|NCT03967444|11351887|FG001|NOT COMPLETED|Overall Study||2
10223963|NCT03966924|11351893|FG000|STARTED|Overall Study||2
10223964|NCT03966924|11351893|FG000|COMPLETED|Overall Study||2
10223965|NCT03966924|11351893|FG000|NOT COMPLETED|Overall Study||0
10223966|NCT03966911|11351899|FG000|STARTED|Overall Study||169
10223967|NCT03966911|11351900|FG001|STARTED|Overall Study||142
10223968|NCT03966911|11351899|FG000|COMPLETED|Overall Study||160
10223969|NCT03966911|11351900|FG001|COMPLETED|Overall Study||126
10223970|NCT03966911|11351899|FG000|NOT COMPLETED|Overall Study||9
10223971|NCT03966911|11351900|FG001|NOT COMPLETED|Overall Study||16
10223972|NCT03966365|11351910|FG000|STARTED|Overall Study||12
10223973|NCT03966365|11351911|FG001|STARTED|Overall Study||12
10223974|NCT03966365|11351910|FG000|COMPLETED|Overall Study||11
10223975|NCT03966365|11351911|FG001|COMPLETED|Overall Study||12
10223976|NCT03966365|11351910|FG000|NOT COMPLETED|Overall Study||1
10223977|NCT03966365|11351911|FG001|NOT COMPLETED|Overall Study||0
10223978|NCT03965403|11351917|FG000|STARTED|Overall Study||7
10223979|NCT03965403|11351917|FG000|COMPLETED|Overall Study||6
10223980|NCT03965403|11351917|FG000|NOT COMPLETED|Overall Study||1
10223981|NCT03965754|11351925|FG000|STARTED|Overall Study||1422
10223982|NCT03965754|11351926|FG001|STARTED|Overall Study||1425
10223983|NCT03965754|11351927|FG002|STARTED|Overall Study||1425
10223984|NCT03965754|11351928|FG003|STARTED|Overall Study||1425
10223985|NCT03965754|11351925|FG000|COMPLETED|Overall Study||1422
10223986|NCT03965754|11351926|FG001|COMPLETED|Overall Study||1425
10223987|NCT03965754|11351927|FG002|COMPLETED|Overall Study||1425
10223988|NCT03965754|11351928|FG003|COMPLETED|Overall Study||1425
10223989|NCT03965754|11351925|FG000|NOT COMPLETED|Overall Study||0
10223990|NCT03965754|11351926|FG001|NOT COMPLETED|Overall Study||0
10223991|NCT03965754|11351927|FG002|NOT COMPLETED|Overall Study||0
10223992|NCT03965754|11351928|FG003|NOT COMPLETED|Overall Study||0
10223993|NCT03965533|11351945|FG000|STARTED|Part A (112 Days)||2
10223994|NCT03965533|11351946|FG001|STARTED|Part A (112 Days)||6
10223995|NCT03965533|11351947|FG002|STARTED|Part A (112 Days)||2
10223996|NCT03965533|11351948|FG003|STARTED|Part A (112 Days)||6
10223997|NCT03965533|11351949|FG004|STARTED|Part A (112 Days)||0
10223998|NCT03965533|11351950|FG005|STARTED|Part A (112 Days)||0
10223999|NCT03965533|11351951|FG006|STARTED|Part A (112 Days)||0
10224000|NCT03965533|11351945|FG000|COMPLETED|Part A (112 Days)||2
10224001|NCT03965533|11351946|FG001|COMPLETED|Part A (112 Days)||6
10224002|NCT03965533|11351947|FG002|COMPLETED|Part A (112 Days)||2
10224003|NCT03965533|11351948|FG003|COMPLETED|Part A (112 Days)||6
10224004|NCT03965533|11351949|FG004|COMPLETED|Part A (112 Days)||0
10224005|NCT03965533|11351950|FG005|COMPLETED|Part A (112 Days)||0
10224006|NCT03965533|11351951|FG006|COMPLETED|Part A (112 Days)||0
10224007|NCT03965533|11351945|FG000|NOT COMPLETED|Part A (112 Days)||0
10224008|NCT03965533|11351946|FG001|NOT COMPLETED|Part A (112 Days)||0
10224009|NCT03965533|11351947|FG002|NOT COMPLETED|Part A (112 Days)||0
10224010|NCT03965533|11351948|FG003|NOT COMPLETED|Part A (112 Days)||0
10224011|NCT03965533|11351949|FG004|NOT COMPLETED|Part A (112 Days)||0
10224012|NCT03965533|11351950|FG005|NOT COMPLETED|Part A (112 Days)||0
10224013|NCT03965533|11351951|FG006|NOT COMPLETED|Part A (112 Days)||0
10224014|NCT03965533|11351945|FG000|STARTED|Part B (112 Days)||0
10224015|NCT03965533|11351946|FG001|STARTED|Part B (112 Days)||0
10224016|NCT03965533|11351947|FG002|STARTED|Part B (112 Days)||0
10224017|NCT03965533|11351948|FG003|STARTED|Part B (112 Days)||0
10224018|NCT03965533|11351949|FG004|STARTED|Part B (112 Days)||4
10224019|NCT03965533|11351950|FG005|STARTED|Part B (112 Days)||8
10224020|NCT03965533|11351951|FG006|STARTED|Part B (112 Days)||8
10224021|NCT03965533|11351945|FG000|COMPLETED|Part B (112 Days)||0
10224022|NCT03965533|11351946|FG001|COMPLETED|Part B (112 Days)||0
10224023|NCT03965533|11351947|FG002|COMPLETED|Part B (112 Days)||0
10224024|NCT03965533|11351948|FG003|COMPLETED|Part B (112 Days)||0
10224025|NCT03965533|11351949|FG004|COMPLETED|Part B (112 Days)||4
10224026|NCT03965533|11351950|FG005|COMPLETED|Part B (112 Days)||8
10224027|NCT03965533|11351951|FG006|COMPLETED|Part B (112 Days)||8
10224028|NCT03965533|11351945|FG000|NOT COMPLETED|Part B (112 Days)||0
10224029|NCT03965533|11351946|FG001|NOT COMPLETED|Part B (112 Days)||0
10224030|NCT03965533|11351947|FG002|NOT COMPLETED|Part B (112 Days)||0
10224031|NCT03965533|11351948|FG003|NOT COMPLETED|Part B (112 Days)||0
10224032|NCT03965533|11351949|FG004|NOT COMPLETED|Part B (112 Days)||0
10224033|NCT03965533|11351950|FG005|NOT COMPLETED|Part B (112 Days)||0
10224034|NCT03965533|11351951|FG006|NOT COMPLETED|Part B (112 Days)||0
10224035|NCT03965351|11351974|FG000|STARTED|First Intervention (4 Weeks)||3
10224036|NCT03965351|11351975|FG001|STARTED|First Intervention (4 Weeks)||5
10224037|NCT03965351|11351974|FG000|COMPLETED|First Intervention (4 Weeks)||3
10224038|NCT03965351|11351975|FG001|COMPLETED|First Intervention (4 Weeks)||4
10224039|NCT03965351|11351974|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10224040|NCT03965351|11351975|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10224041|NCT03965351|11351974|FG000|STARTED|Wash Out Period (4 Weeks)||3
10224042|NCT03965351|11351975|FG001|STARTED|Wash Out Period (4 Weeks)||4
10224043|NCT03965351|11351974|FG000|COMPLETED|Wash Out Period (4 Weeks)||3
10224044|NCT03965351|11351975|FG001|COMPLETED|Wash Out Period (4 Weeks)||4
10224045|NCT03965351|11351974|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0
10224046|NCT03965351|11351975|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0
10224047|NCT03965351|11351974|FG000|STARTED|Second Intervention (4 Weeks)||3
10224048|NCT03965351|11351975|FG001|STARTED|Second Intervention (4 Weeks)||4
10224049|NCT03965351|11351974|FG000|COMPLETED|Second Intervention (4 Weeks)||3
10224050|NCT03965351|11351975|FG001|COMPLETED|Second Intervention (4 Weeks)||3
10224051|NCT03965351|11351974|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10224052|NCT03965351|11351975|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10224053|NCT03964220|11351983|FG000|STARTED|Overall Study||2619
10224054|NCT03964220|11351984|FG001|STARTED|Overall Study||5238
10224055|NCT03964220|11351983|FG000|COMPLETED|Overall Study||2619
10224056|NCT03964220|11351984|FG001|COMPLETED|Overall Study||5238
10224057|NCT03964220|11351983|FG000|NOT COMPLETED|Overall Study||0
10224058|NCT03964220|11351984|FG001|NOT COMPLETED|Overall Study||0
10224059|NCT03958955|11351990|FG000|STARTED|Overall Study||27
10224060|NCT03958955|11351990|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27
10224061|NCT03958955|11351990|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
10224062|NCT03958955|11351990|FG000|COMPLETED|Overall Study||26
10224063|NCT03958955|11351990|FG000|NOT COMPLETED|Overall Study||1
10224064|NCT03965052|11351998|FG000|STARTED|Overall Study||12
10224065|NCT03965052|11351999|FG001|STARTED|Overall Study||12
10224066|NCT03965052|11351998|FG000|COMPLETED|Overall Study||11
10224067|NCT03965052|11351999|FG001|COMPLETED|Overall Study||12
10224068|NCT03965052|11351998|FG000|NOT COMPLETED|Overall Study||1
10224069|NCT03965052|11351999|FG001|NOT COMPLETED|Overall Study||0
10224070|NCT03965039|11352009|FG000|STARTED|Overall Study||30
10224071|NCT03965039|11352010|FG001|STARTED|Overall Study||30
10224072|NCT03965039|11352011|FG002|STARTED|Overall Study||30
10224073|NCT03965039|11352012|FG003|STARTED|Overall Study||30
10224074|NCT03965039|11352009|FG000|COMPLETED|Overall Study||30
10224075|NCT03965039|11352010|FG001|COMPLETED|Overall Study||29
10224076|NCT03965039|11352011|FG002|COMPLETED|Overall Study||30
10224077|NCT03965039|11352012|FG003|COMPLETED|Overall Study||29
10224078|NCT03965039|11352009|FG000|NOT COMPLETED|Overall Study||0
10224079|NCT03965039|11352010|FG001|NOT COMPLETED|Overall Study||1
10224080|NCT03965039|11352011|FG002|NOT COMPLETED|Overall Study||0
10224081|NCT03965039|11352012|FG003|NOT COMPLETED|Overall Study||1
10224082|NCT03963401|11352028|FG000|STARTED|Initial Period (Day 1 - Week 16)||60
10224083|NCT03963401|11352029|FG001|STARTED|Initial Period (Day 1 - Week 16)||61
10224084|NCT03963401|11352030|FG002|STARTED|Initial Period (Day 1 - Week 16)||16
10224085|NCT03963401|11352031|FG003|STARTED|Initial Period (Day 1 - Week 16)||15
10224086|NCT03963401|11352032|FG004|STARTED|Initial Period (Day 1 - Week 16)||34
10224087|NCT03963401|11352033|FG005|STARTED|Initial Period (Day 1 - Week 16)||33
10224088|NCT03963401|11352028|FG000|Treated|Initial Period (Day 1 - Week 16)||60
10224089|NCT03963401|11352029|FG001|Treated|Initial Period (Day 1 - Week 16)||60
10224090|NCT03963401|11352030|FG002|Treated|Initial Period (Day 1 - Week 16)||16
10224091|NCT03963401|11352031|FG003|Treated|Initial Period (Day 1 - Week 16)||15
10224092|NCT03963401|11352032|FG004|Treated|Initial Period (Day 1 - Week 16)||34
10224093|NCT03963401|11352033|FG005|Treated|Initial Period (Day 1 - Week 16)||33
10224094|NCT03963401|11352028|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57
10224095|NCT03963401|11352029|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57
10224096|NCT03963401|11352030|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14
10224097|NCT03963401|11352031|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13
10224098|NCT03963401|11352032|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31
10224099|NCT03963401|11352033|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31
10224100|NCT03963401|11352028|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
10224101|NCT03963401|11352029|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
10224102|NCT03963401|11352030|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
10224103|NCT03963401|11352031|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
10224104|NCT03963401|11352032|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
10224105|NCT03963401|11352033|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
10224106|NCT03963401|11352028|FG000|STARTED|Extension Period (Week 17 - Week 52)||57
10224107|NCT03963401|11352029|FG001|STARTED|Extension Period (Week 17 - Week 52)||57
10224108|NCT03963401|11352030|FG002|STARTED|Extension Period (Week 17 - Week 52)||14
10224109|NCT03963401|11352031|FG003|STARTED|Extension Period (Week 17 - Week 52)||13
10224110|NCT03963401|11352032|FG004|STARTED|Extension Period (Week 17 - Week 52)||31
10224111|NCT03963401|11352033|FG005|STARTED|Extension Period (Week 17 - Week 52)||31
10224112|NCT03963401|11352028|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43
10224113|NCT03963401|11352029|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52
10224114|NCT03963401|11352030|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10
10224115|NCT03963401|11352031|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12
10224116|NCT03963401|11352032|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25
10224117|NCT03963401|11352033|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26
10224118|NCT03963401|11352028|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
10224119|NCT03963401|11352029|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
10224120|NCT03963401|11352030|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
10224121|NCT03963401|11352031|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
10224122|NCT03963401|11352032|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
10224123|NCT03963401|11352033|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
10224124|NCT03962634|11352053|FG000|STARTED|Overall Study||1
10224125|NCT03962634|11352054|FG001|STARTED|Overall Study||2
10224126|NCT03962634|11352053|FG000|COMPLETED|Overall Study||1
10224127|NCT03962634|11352054|FG001|COMPLETED|Overall Study||2
10224128|NCT03962634|11352053|FG000|NOT COMPLETED|Overall Study||0
10224129|NCT03962634|11352054|FG001|NOT COMPLETED|Overall Study||0
10224130|NCT03962790|11352060|FG000|STARTED|Period 1||48
10224131|NCT03962790|11352061|FG001|STARTED|Period 1||46
10224132|NCT03962790|11352060|FG000|COMPLETED|Period 1||45
10224133|NCT03962790|11352061|FG001|COMPLETED|Period 1||44
10224134|NCT03962790|11352060|FG000|NOT COMPLETED|Period 1||3
10224135|NCT03962790|11352061|FG001|NOT COMPLETED|Period 1||2
10224136|NCT03962790|11352060|FG000|STARTED|Period 2||45
10224137|NCT03962790|11352061|FG001|STARTED|Period 2||44
10224138|NCT03962790|11352060|FG000|COMPLETED|Period 2||45
10224139|NCT03962790|11352061|FG001|COMPLETED|Period 2||44
10224140|NCT03962790|11352060|FG000|NOT COMPLETED|Period 2||0
10224141|NCT03962790|11352061|FG001|NOT COMPLETED|Period 2||0
10224142|NCT03956225|11352069|FG000|STARTED|Overall Study||119
10224143|NCT03956225|11352070|FG001|STARTED|Overall Study||117
10224144|NCT03956225|11352069|FG000|COMPLETED|Overall Study||114
10224145|NCT03956225|11352070|FG001|COMPLETED|Overall Study||113
10224146|NCT03956225|11352069|FG000|NOT COMPLETED|Overall Study||5
10224147|NCT03956225|11352070|FG001|NOT COMPLETED|Overall Study||4
10224148|NCT03951610|11352079|FG000|STARTED|First Intervention||27
10224149|NCT03951610|11352080|FG001|STARTED|First Intervention||25
10224150|NCT03951610|11352079|FG000|COMPLETED|First Intervention||27
10224151|NCT03951610|11352080|FG001|COMPLETED|First Intervention||25
10224152|NCT03951610|11352079|FG000|NOT COMPLETED|First Intervention||0
10224153|NCT03951610|11352080|FG001|NOT COMPLETED|First Intervention||0
10224154|NCT03951610|11352079|FG000|STARTED|Second Intervention||27
10224155|NCT03951610|11352080|FG001|STARTED|Second Intervention||25
10224156|NCT03951610|11352079|FG000|COMPLETED|Second Intervention||27
10224157|NCT03951610|11352080|FG001|COMPLETED|Second Intervention||25
10224158|NCT03951610|11352079|FG000|NOT COMPLETED|Second Intervention||0
10224159|NCT03951610|11352080|FG001|NOT COMPLETED|Second Intervention||0
10224160|NCT03958149|11352088|FG000|STARTED|Overall Study||20
10224161|NCT03958149|11352089|FG001|STARTED|Overall Study||18
10224162|NCT03958149|11352088|FG000|COMPLETED|Overall Study||20
10224163|NCT03958149|11352089|FG001|COMPLETED|Overall Study||17
10224164|NCT03958149|11352088|FG000|NOT COMPLETED|Overall Study||0
10224165|NCT03958149|11352089|FG001|NOT COMPLETED|Overall Study||1
10224166|NCT03953183|11352101|FG000|STARTED|Overall Study||30
10224167|NCT03953183|11352102|FG001|STARTED|Overall Study||30
10224168|NCT03953183|11352101|FG000|COMPLETED|Overall Study||30
10224169|NCT03953183|11352102|FG001|COMPLETED|Overall Study||28
10224170|NCT03953183|11352101|FG000|NOT COMPLETED|Overall Study||0
10224171|NCT03953183|11352102|FG001|NOT COMPLETED|Overall Study||2
10224172|NCT03949335|11352110|FG000|STARTED|Overall Study||135
10224173|NCT03949335|11352111|FG001|STARTED|Overall Study||137
10224174|NCT03949335|11352110|FG000|COMPLETED|Overall Study||132
10224175|NCT03949335|11352111|FG001|COMPLETED|Overall Study||131
10224176|NCT03949335|11352110|FG000|NOT COMPLETED|Overall Study||3
10224177|NCT03949335|11352111|FG001|NOT COMPLETED|Overall Study||6
10224178|NCT03962738|11352123|FG000|STARTED|Overall Study||258
10224179|NCT03962738|11352124|FG001|STARTED|Overall Study||109
10224180|NCT03962738|11352125|FG002|STARTED|Overall Study||261
10224181|NCT03962738|11352126|FG003|STARTED|Overall Study||218
10224182|NCT03962738|11352123|FG000|Received At Least One Dose of Study Drug|Overall Study||214
10224183|NCT03962738|11352124|FG001|Received At Least One Dose of Study Drug|Overall Study||87
10224184|NCT03962738|11352125|FG002|Received At Least One Dose of Study Drug|Overall Study||208
10224185|NCT03962738|11352126|FG003|Received At Least One Dose of Study Drug|Overall Study||182
10224186|NCT03962738|11352123|FG000|COMPLETED|Overall Study||251
10224187|NCT03962738|11352124|FG001|COMPLETED|Overall Study||109
10224188|NCT03962738|11352125|FG002|COMPLETED|Overall Study||259
10224189|NCT03962738|11352126|FG003|COMPLETED|Overall Study||217
10224190|NCT03962738|11352123|FG000|NOT COMPLETED|Overall Study||7
10224191|NCT03962738|11352124|FG001|NOT COMPLETED|Overall Study||0
10224192|NCT03962738|11352125|FG002|NOT COMPLETED|Overall Study||2
10224193|NCT03962738|11352126|FG003|NOT COMPLETED|Overall Study||1
10224194|NCT03962101|11352144|FG000|STARTED|Overall Study||45
10224195|NCT03962101|11352144|FG000|COMPLETED|Overall Study||41
10224196|NCT03962101|11352144|FG000|NOT COMPLETED|Overall Study||4
10224197|NCT03959137|11352149|FG000|STARTED|Overall Study||215
10224198|NCT03959137|11352149|FG000|COMPLETED|Overall Study||209
10224199|NCT03959137|11352149|FG000|NOT COMPLETED|Overall Study||6
10224200|NCT03946124|11352153|FG000|STARTED|Overall Study||74
10224201|NCT03946124|11352153|FG000|COMPLETED|Overall Study||55
10224202|NCT03946124|11352153|FG000|NOT COMPLETED|Overall Study||19
10224203|NCT03961308|11352159|FG000|STARTED|Overall Study||102
10224204|NCT03961308|11352160|FG001|STARTED|Overall Study||102
10224205|NCT03961308|11352159|FG000|COMPLETED|Overall Study||100
10224206|NCT03961308|11352160|FG001|COMPLETED|Overall Study||100
10224207|NCT03961308|11352159|FG000|NOT COMPLETED|Overall Study||2
10224208|NCT03961308|11352160|FG001|NOT COMPLETED|Overall Study||2
10224209|NCT03961295|11352168|FG000|STARTED|Overall Study||12
10224210|NCT03961295|11352169|FG001|STARTED|Overall Study||12
10224211|NCT03961295|11352168|FG000|COMPLETED|Overall Study||12
10224212|NCT03961295|11352169|FG001|COMPLETED|Overall Study||12
10224213|NCT03961295|11352168|FG000|NOT COMPLETED|Overall Study||0
10224214|NCT03961295|11352169|FG001|NOT COMPLETED|Overall Study||0
10224215|NCT03960957|11352177|FG000|STARTED|Overall Study||224
10224216|NCT03960957|11352178|FG001|STARTED|Overall Study||77
10224217|NCT03960957|11352177|FG000|COMPLETED|Overall Study||216
10224218|NCT03960957|11352178|FG001|COMPLETED|Overall Study||71
10224219|NCT03960957|11352177|FG000|NOT COMPLETED|Overall Study||8
10224220|NCT03960957|11352178|FG001|NOT COMPLETED|Overall Study||6
10224221|NCT03956862|11352186|FG000|STARTED|Overall Study||50
10224222|NCT03956862|11352187|FG001|STARTED|Overall Study||47
10224223|NCT03956862|11352186|FG000|COMPLETED|Overall Study||48
10224224|NCT03956862|11352187|FG001|COMPLETED|Overall Study||45
10224225|NCT03956862|11352186|FG000|NOT COMPLETED|Overall Study||2
10224226|NCT03956862|11352187|FG001|NOT COMPLETED|Overall Study||2
10224227|NCT03954444|11352196|FG000|STARTED|Overall Study||379
10224228|NCT03954444|11352197|FG001|STARTED|Overall Study||382
10224229|NCT03954444|11352198|FG002|STARTED|Overall Study||344
10224230|NCT03954444|11352196|FG000|COMPLETED|Overall Study||366
10224231|NCT03954444|11352197|FG001|COMPLETED|Overall Study||366
10224232|NCT03954444|11352198|FG002|COMPLETED|Overall Study||327
10224233|NCT03954444|11352196|FG000|NOT COMPLETED|Overall Study||13
10224234|NCT03954444|11352197|FG001|NOT COMPLETED|Overall Study||16
10224235|NCT03954444|11352198|FG002|NOT COMPLETED|Overall Study||17
10224236|NCT03953820|11352206|FG000|STARTED|Two-Sequence, Two-Way Crossover||15
10224237|NCT03953820|11352207|FG001|STARTED|Two-Sequence, Two-Way Crossover||16
10224238|NCT03953820|11352208|FG002|STARTED|Two-Sequence, Two-Way Crossover||0
10224239|NCT03953820|11352206|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13
10224240|NCT03953820|11352207|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16
10224241|NCT03953820|11352208|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0
10224242|NCT03953820|11352206|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
10224243|NCT03953820|11352207|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
10224244|NCT03953820|11352208|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
10224245|NCT03953820|11352206|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
10224246|NCT03953820|11352207|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
10224247|NCT03953820|11352208|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
10224248|NCT03953820|11352206|FG000|COMPLETED|DBF Following High-Fat Meal||0
10224249|NCT03953820|11352207|FG001|COMPLETED|DBF Following High-Fat Meal||0
10224250|NCT03953820|11352208|FG002|COMPLETED|DBF Following High-Fat Meal||10
10224251|NCT03953820|11352206|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0
10224252|NCT03953820|11352207|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0
10224253|NCT03953820|11352208|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0
10224254|NCT03951766|11352221|FG000|STARTED|Treatment Phase||100
10224255|NCT03951766|11352221|FG000|COMPLETED|Treatment Phase||99
10224256|NCT03951766|11352221|FG000|NOT COMPLETED|Treatment Phase||1
10224257|NCT03951766|11352221|FG000|STARTED|Follow-up Phase||99
10224258|NCT03951766|11352221|FG000|COMPLETED|Follow-up Phase||89
10224259|NCT03951766|11352221|FG000|NOT COMPLETED|Follow-up Phase||10
10224260|NCT03961100|11352231|FG000|STARTED|Part 1||5
10224261|NCT03961100|11352232|FG001|STARTED|Part 1||5
10224262|NCT03961100|11352233|FG002|STARTED|Part 1||5
10224263|NCT03961100|11352234|FG003|STARTED|Part 1||0
10224264|NCT03961100|11352235|FG004|STARTED|Part 1||0
10224265|NCT03961100|11352231|FG000|COMPLETED|Part 1||5
10224266|NCT03961100|11352232|FG001|COMPLETED|Part 1||5
10224267|NCT03961100|11352233|FG002|COMPLETED|Part 1||5
10224268|NCT03961100|11352234|FG003|COMPLETED|Part 1||0
10224269|NCT03961100|11352235|FG004|COMPLETED|Part 1||0
10224270|NCT03961100|11352231|FG000|NOT COMPLETED|Part 1||0
10224271|NCT03961100|11352232|FG001|NOT COMPLETED|Part 1||0
10224272|NCT03961100|11352233|FG002|NOT COMPLETED|Part 1||0
10224273|NCT03961100|11352234|FG003|NOT COMPLETED|Part 1||0
10224274|NCT03961100|11352235|FG004|NOT COMPLETED|Part 1||0
10224275|NCT03961100|11352231|FG000|STARTED|Part 2||0
10224276|NCT03961100|11352232|FG001|STARTED|Part 2||0
10224277|NCT03961100|11352233|FG002|STARTED|Part 2||0
10224278|NCT03961100|11352234|FG003|STARTED|Part 2||8
10224279|NCT03961100|11352235|FG004|STARTED|Part 2||8
10224280|NCT03961100|11352231|FG000|COMPLETED|Part 2||0
10224281|NCT03961100|11352232|FG001|COMPLETED|Part 2||0
10224282|NCT03961100|11352233|FG002|COMPLETED|Part 2||0
10224283|NCT03961100|11352234|FG003|COMPLETED|Part 2||8
10224284|NCT03961100|11352235|FG004|COMPLETED|Part 2||8
10224285|NCT03961100|11352231|FG000|NOT COMPLETED|Part 2||0
10224286|NCT03961100|11352232|FG001|NOT COMPLETED|Part 2||0
10224287|NCT03961100|11352233|FG002|NOT COMPLETED|Part 2||0
10224288|NCT03961100|11352234|FG003|NOT COMPLETED|Part 2||0
10224289|NCT03961100|11352235|FG004|NOT COMPLETED|Part 2||0
10224290|NCT03950856|11352251|FG000|STARTED|Overall Study||702
10224291|NCT03950856|11352252|FG001|STARTED|Overall Study||704
10224292|NCT03950856|11352253|FG002|STARTED|Overall Study||701
10224293|NCT03950856|11352254|FG003|STARTED|Overall Study||233
10224294|NCT03950856|11352251|FG000|Vaccinated|Overall Study||698
10224295|NCT03950856|11352252|FG001|Vaccinated|Overall Study||704
10224296|NCT03950856|11352253|FG002|Vaccinated|Overall Study||700
10224297|NCT03950856|11352254|FG003|Vaccinated|Overall Study||231
10224298|NCT03950856|11352251|FG000|COMPLETED|Overall Study||683
10224299|NCT03950856|11352252|FG001|COMPLETED|Overall Study||689
10224300|NCT03950856|11352253|FG002|COMPLETED|Overall Study||683
10224301|NCT03950856|11352254|FG003|COMPLETED|Overall Study||227
10224302|NCT03950856|11352251|FG000|NOT COMPLETED|Overall Study||19
10224303|NCT03950856|11352252|FG001|NOT COMPLETED|Overall Study||15
10224304|NCT03950856|11352253|FG002|NOT COMPLETED|Overall Study||18
10224305|NCT03950856|11352254|FG003|NOT COMPLETED|Overall Study||6
10224306|NCT03947983|11352268|FG000|STARTED|Overall Study||19
10224307|NCT03947983|11352269|FG001|STARTED|Overall Study||19
10224308|NCT03947983|11352268|FG000|12 Weeks|Overall Study||15
10224309|NCT03947983|11352269|FG001|12 Weeks|Overall Study||17
10224310|NCT03947983|11352268|FG000|COMPLETED|Overall Study||14
10224311|NCT03947983|11352269|FG001|COMPLETED|Overall Study||13
10224312|NCT03947983|11352268|FG000|NOT COMPLETED|Overall Study||5
10224313|NCT03947983|11352269|FG001|NOT COMPLETED|Overall Study||6
10224314|NCT03960658|11352275|FG000|STARTED|Overall Study||12
10224315|NCT03960658|11352275|FG000|COMPLETED|Overall Study||10
10224316|NCT03960658|11352275|FG000|NOT COMPLETED|Overall Study||2
10224317|NCT03959332|11352281|FG000|STARTED|Overall Study||16
10224318|NCT03959332|11352282|FG001|STARTED|Overall Study||16
10224319|NCT03959332|11352281|FG000|COMPLETED|Overall Study||16
10224320|NCT03959332|11352282|FG001|COMPLETED|Overall Study||16
10224321|NCT03959332|11352281|FG000|NOT COMPLETED|Overall Study||0
10224322|NCT03959332|11352282|FG001|NOT COMPLETED|Overall Study||0
10224323|NCT03959189|11352290|FG000|STARTED|Overall Study||7
10224324|NCT03959189|11352291|FG001|STARTED|Overall Study||5
10224325|NCT03959189|11352290|FG000|COMPLETED|Overall Study||7
10224326|NCT03959189|11352291|FG001|COMPLETED|Overall Study||5
10224327|NCT03959189|11352290|FG000|NOT COMPLETED|Overall Study||0
10224328|NCT03959189|11352291|FG001|NOT COMPLETED|Overall Study||0
10224329|NCT03956550|11352307|FG000|STARTED|Overall Study||88
10224330|NCT03956550|11352308|FG001|STARTED|Overall Study||86
10224331|NCT03956550|11352309|FG002|STARTED|Overall Study||85
10224332|NCT03956550|11352307|FG000|COMPLETED|Overall Study||18
10224333|NCT03956550|11352308|FG001|COMPLETED|Overall Study||14
10224334|NCT03956550|11352309|FG002|COMPLETED|Overall Study||15
10224335|NCT03956550|11352307|FG000|NOT COMPLETED|Overall Study||70
10224336|NCT03956550|11352308|FG001|NOT COMPLETED|Overall Study||72
10224337|NCT03956550|11352309|FG002|NOT COMPLETED|Overall Study||70
10224338|NCT03954158|11352321|FG000|STARTED|Overall Study||20
10224339|NCT03954158|11352322|FG001|STARTED|Overall Study||21
10224340|NCT03954158|11352323|FG002|STARTED|Overall Study||20
10224341|NCT03954158|11352324|FG003|STARTED|Overall Study||20
10224342|NCT03954158|11352321|FG000|COMPLETED|Overall Study||20
10224343|NCT03954158|11352322|FG001|COMPLETED|Overall Study||21
10224344|NCT03954158|11352323|FG002|COMPLETED|Overall Study||20
10224345|NCT03954158|11352324|FG003|COMPLETED|Overall Study||20
10224346|NCT03954158|11352321|FG000|NOT COMPLETED|Overall Study||0
10224347|NCT03954158|11352322|FG001|NOT COMPLETED|Overall Study||0
10224348|NCT03954158|11352323|FG002|NOT COMPLETED|Overall Study||0
10224349|NCT03954158|11352324|FG003|NOT COMPLETED|Overall Study||0
10224350|NCT03958656|11352361|FG000|STARTED|Overall Study||3
10224351|NCT03958656|11352362|FG001|STARTED|Overall Study||4
10224352|NCT03958656|11352363|FG002|STARTED|Overall Study||5
10224353|NCT03958656|11352364|FG003|STARTED|Overall Study||1
10012824|NCT01787760|11135694|FG000|COMPLETED|Overall Study||25
10012825|NCT01787760|11135695|FG001|COMPLETED|Overall Study||34
10012826|NCT01787760|11135696|FG002|COMPLETED|Overall Study||46
10012827|NCT01787760|11135694|FG000|NOT COMPLETED|Overall Study||26
10224354|NCT03958656|11352361|FG000|COMPLETED|Overall Study||3
10224355|NCT03958656|11352362|FG001|COMPLETED|Overall Study||3
10224356|NCT03958656|11352363|FG002|COMPLETED|Overall Study||3
10224357|NCT03958656|11352364|FG003|COMPLETED|Overall Study||1
10224358|NCT03958656|11352361|FG000|NOT COMPLETED|Overall Study||0
10224359|NCT03958656|11352362|FG001|NOT COMPLETED|Overall Study||1
10224360|NCT03958656|11352363|FG002|NOT COMPLETED|Overall Study||2
10224361|NCT03958656|11352364|FG003|NOT COMPLETED|Overall Study||0
10224362|NCT03955133|11352374|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19
10224363|NCT03955133|11352374|FG000|COMPLETED|Overall Study|End of study funding|19
10224364|NCT03955133|11352374|FG000|NOT COMPLETED|Overall Study||0
10224365|NCT03954626|11352379|FG000|STARTED|Overall Study||14
10224366|NCT03954626|11352379|FG000|COMPLETED|Overall Study||14
10224367|NCT03954626|11352379|FG000|NOT COMPLETED|Overall Study||0
10224368|NCT03951805|11352387|FG000|STARTED|Overall Study||51
10224369|NCT03951805|11352388|FG001|STARTED|Overall Study||51
10224370|NCT03951805|11352389|FG002|STARTED|Overall Study||52
10224371|NCT03951805|11352390|FG003|STARTED|Overall Study||51
10224372|NCT03951805|11352387|FG000|Full Analysis Set (FAS)|Overall Study||51
10224373|NCT03951805|11352388|FG001|Full Analysis Set (FAS)|Overall Study||51
10224374|NCT03951805|11352389|FG002|Full Analysis Set (FAS)|Overall Study||52
10224375|NCT03951805|11352390|FG003|Full Analysis Set (FAS)|Overall Study||51
10224376|NCT03951805|11352387|FG000|Safety Analysis Set (SAS)|Overall Study||51
10224377|NCT03951805|11352388|FG001|Safety Analysis Set (SAS)|Overall Study||51
10224378|NCT03951805|11352389|FG002|Safety Analysis Set (SAS)|Overall Study||52
10224379|NCT03951805|11352390|FG003|Safety Analysis Set (SAS)|Overall Study||51
10224380|NCT03951805|11352387|FG000|COMPLETED|Overall Study||50
10224381|NCT03951805|11352388|FG001|COMPLETED|Overall Study||51
10224382|NCT03951805|11352389|FG002|COMPLETED|Overall Study||52
10224383|NCT03951805|11352390|FG003|COMPLETED|Overall Study||51
10224384|NCT03951805|11352387|FG000|NOT COMPLETED|Overall Study||1
10224385|NCT03951805|11352388|FG001|NOT COMPLETED|Overall Study||0
10224386|NCT03951805|11352389|FG002|NOT COMPLETED|Overall Study||0
10224387|NCT03951805|11352390|FG003|NOT COMPLETED|Overall Study||0
10224388|NCT03944785|11352403|FG000|STARTED|2 Month Study Completion||2
10224389|NCT03944785|11352404|FG001|STARTED|2 Month Study Completion||34
10224390|NCT03944785|11352405|FG002|STARTED|2 Month Study Completion||128
10224391|NCT03944785|11352403|FG000|COMPLETED|2 Month Study Completion||2
10224392|NCT03944785|11352404|FG001|COMPLETED|2 Month Study Completion||30
10224393|NCT03944785|11352405|FG002|COMPLETED|2 Month Study Completion||123
10224394|NCT03944785|11352403|FG000|NOT COMPLETED|2 Month Study Completion||0
10224395|NCT03944785|11352404|FG001|NOT COMPLETED|2 Month Study Completion||4
10224396|NCT03944785|11352405|FG002|NOT COMPLETED|2 Month Study Completion||5
10224397|NCT03944785|11352403|FG000|STARTED|4 Month Study Optional Extension||1
10224398|NCT03944785|11352404|FG001|STARTED|4 Month Study Optional Extension||10
10224399|NCT03944785|11352405|FG002|STARTED|4 Month Study Optional Extension||64
10224400|NCT03944785|11352403|FG000|COMPLETED|4 Month Study Optional Extension||0
10224401|NCT03944785|11352404|FG001|COMPLETED|4 Month Study Optional Extension||8
10224402|NCT03944785|11352405|FG002|COMPLETED|4 Month Study Optional Extension||41
10224403|NCT03944785|11352403|FG000|NOT COMPLETED|4 Month Study Optional Extension||1
10224404|NCT03944785|11352404|FG001|NOT COMPLETED|4 Month Study Optional Extension||2
10224405|NCT03944785|11352405|FG002|NOT COMPLETED|4 Month Study Optional Extension||23
10224406|NCT03950622|11352415|FG000|STARTED|Overall Study||604
10224407|NCT03950622|11352416|FG001|STARTED|Overall Study||601
10012828|NCT01787760|11135695|FG001|NOT COMPLETED|Overall Study||16
10012829|NCT01787760|11135696|FG002|NOT COMPLETED|Overall Study||5
10012830|NCT01787799|11135705|FG000|STARTED|Overall Study||100
10012831|NCT01787799|11135705|FG000|COMPLETED|Overall Study||100
10224408|NCT03950622|11352415|FG000|Vaccinated|Overall Study||602
10224409|NCT03950622|11352416|FG001|Vaccinated|Overall Study||600
10224410|NCT03950622|11352415|FG000|COMPLETED|Overall Study||596
10224411|NCT03950622|11352416|FG001|COMPLETED|Overall Study||594
10224412|NCT03950622|11352415|FG000|NOT COMPLETED|Overall Study||8
10224413|NCT03950622|11352416|FG001|NOT COMPLETED|Overall Study||7
10224414|NCT03949621|11352424|FG000|STARTED|Overall Study||12
10224415|NCT03949621|11352425|FG001|STARTED|Overall Study||12
10224416|NCT03949621|11352424|FG000|COMPLETED|Overall Study||12
10224417|NCT03949621|11352425|FG001|COMPLETED|Overall Study||12
10224418|NCT03949621|11352424|FG000|NOT COMPLETED|Overall Study||0
10224419|NCT03949621|11352425|FG001|NOT COMPLETED|Overall Study||0
10224420|NCT03949244|11352434|FG000|STARTED|Overall Study||12
10224421|NCT03949244|11352435|FG001|STARTED|Overall Study||21
10224422|NCT03949244|11352436|FG002|STARTED|Overall Study||14
10224423|NCT03949244|11352434|FG000|COMPLETED|Overall Study||12
10224424|NCT03949244|11352435|FG001|COMPLETED|Overall Study||21
10224425|NCT03949244|11352436|FG002|COMPLETED|Overall Study||14
10224426|NCT03949244|11352434|FG000|NOT COMPLETED|Overall Study||0
10224427|NCT03949244|11352435|FG001|NOT COMPLETED|Overall Study||0
10224428|NCT03949244|11352436|FG002|NOT COMPLETED|Overall Study||0
10224429|NCT03948581|11352446|FG000|STARTED|Overall Study||51
10224430|NCT03948581|11352447|FG001|STARTED|Overall Study||51
10224431|NCT03948581|11352446|FG000|COMPLETED|Overall Study||51
10224432|NCT03948581|11352447|FG001|COMPLETED|Overall Study||50
10224433|NCT03948581|11352446|FG000|NOT COMPLETED|Overall Study||0
10224434|NCT03948581|11352447|FG001|NOT COMPLETED|Overall Study||1
10224435|NCT03948386|11352456|FG000|STARTED|Overall Study||52
10224436|NCT03948386|11352457|FG001|STARTED|Overall Study||54
10224437|NCT03948386|11352458|FG002|STARTED|Overall Study||53
10224438|NCT03948386|11352456|FG000|COMPLETED|Overall Study||51
10224439|NCT03948386|11352457|FG001|COMPLETED|Overall Study||53
10224440|NCT03948386|11352458|FG002|COMPLETED|Overall Study||50
10224441|NCT03948386|11352456|FG000|NOT COMPLETED|Overall Study||1
10224442|NCT03948386|11352457|FG001|NOT COMPLETED|Overall Study||1
10224443|NCT03948386|11352458|FG002|NOT COMPLETED|Overall Study||3
10224444|NCT03948334|11352468|FG000|STARTED|Overall Study||60
10224445|NCT03948334|11352469|FG001|STARTED|Overall Study||63
10224446|NCT03948334|11352468|FG000|COMPLETED|Overall Study||0
10224447|NCT03948334|11352469|FG001|COMPLETED|Overall Study||0
10224448|NCT03948334|11352468|FG000|NOT COMPLETED|Overall Study||60
10224449|NCT03948334|11352469|FG001|NOT COMPLETED|Overall Study||63
10224450|NCT03946059|11352485|FG000|STARTED|Overall Study||13
10224451|NCT03946059|11352486|FG001|STARTED|Overall Study||12
10224452|NCT03946059|11352485|FG000|COMPLETED|Overall Study||13
10224453|NCT03946059|11352486|FG001|COMPLETED|Overall Study||11
10224454|NCT03946059|11352485|FG000|NOT COMPLETED|Overall Study||0
10224455|NCT03946059|11352486|FG001|NOT COMPLETED|Overall Study||1
10224456|NCT03944707|11352496|FG000|STARTED|Overall Study||47
10224457|NCT03944707|11352497|FG001|STARTED|Overall Study||29
10224458|NCT03944707|11352496|FG000|PK Analysis Set|Overall Study||33
10224459|NCT03944707|11352497|FG001|PK Analysis Set|Overall Study||0
10224460|NCT03944707|11352496|FG000|PD Analysis Set|Overall Study||47
10224461|NCT03944707|11352497|FG001|PD Analysis Set|Overall Study||29
10224462|NCT03944707|11352496|FG000|COMPLETED|Overall Study||35
10224463|NCT03944707|11352497|FG001|COMPLETED|Overall Study||19
10224464|NCT03944707|11352496|FG000|NOT COMPLETED|Overall Study||12
10224465|NCT03944707|11352497|FG001|NOT COMPLETED|Overall Study||10
10224466|NCT03944668|11352503|FG000|STARTED|Overall Study|Enrolled in Study|17
10224467|NCT03944668|11352503|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
10224468|NCT03944668|11352503|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
10224469|NCT03944668|11352503|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
10224470|NCT03944668|11352503|FG000|NOT COMPLETED|Overall Study||9
10224471|NCT03943160|11352508|FG000|STARTED|Overall Study||50
10224472|NCT03943160|11352508|FG000|COMPLETED|Overall Study||50
10224473|NCT03943160|11352508|FG000|NOT COMPLETED|Overall Study||0
10224474|NCT03943095|11352514|FG000|STARTED|Overall Study||52
10224475|NCT03943095|11352515|FG001|STARTED|Overall Study||52
10224476|NCT03943095|11352514|FG000|COMPLETED|Overall Study||51
10224477|NCT03943095|11352515|FG001|COMPLETED|Overall Study||51
10224478|NCT03943095|11352514|FG000|NOT COMPLETED|Overall Study||1
10224479|NCT03943095|11352515|FG001|NOT COMPLETED|Overall Study||1
10224480|NCT03943290|11352531|FG000|STARTED|Overall Study||7
10224481|NCT03943290|11352532|FG001|STARTED|Overall Study||1
10224482|NCT03943290|11352533|FG002|STARTED|Overall Study||13
10224483|NCT03943290|11352534|FG003|STARTED|Overall Study||6
10224484|NCT03943290|11352535|FG004|STARTED|Overall Study||7
10224485|NCT03943290|11352536|FG005|STARTED|Overall Study||6
10224486|NCT03943290|11352537|FG006|STARTED|Overall Study||6
10224487|NCT03943290|11352538|FG007|STARTED|Overall Study||8
10224488|NCT03943290|11352539|FG008|STARTED|Overall Study||8
10224489|NCT03943290|11352531|FG000|COMPLETED|Overall Study||0
10224490|NCT03943290|11352532|FG001|COMPLETED|Overall Study||0
10224491|NCT03943290|11352533|FG002|COMPLETED|Overall Study||0
10224492|NCT03943290|11352534|FG003|COMPLETED|Overall Study||0
10224493|NCT03943290|11352535|FG004|COMPLETED|Overall Study||0
10224494|NCT03943290|11352536|FG005|COMPLETED|Overall Study||0
10224495|NCT03943290|11352537|FG006|COMPLETED|Overall Study||0
10224496|NCT03943290|11352538|FG007|COMPLETED|Overall Study||0
10224497|NCT03943290|11352539|FG008|COMPLETED|Overall Study||0
10224498|NCT03943290|11352531|FG000|NOT COMPLETED|Overall Study||7
10224499|NCT03943290|11352532|FG001|NOT COMPLETED|Overall Study||1
10224500|NCT03943290|11352533|FG002|NOT COMPLETED|Overall Study||13
10224501|NCT03943290|11352534|FG003|NOT COMPLETED|Overall Study||6
10224502|NCT03943290|11352535|FG004|NOT COMPLETED|Overall Study||7
10224503|NCT03943290|11352536|FG005|NOT COMPLETED|Overall Study||6
10224504|NCT03943290|11352537|FG006|NOT COMPLETED|Overall Study||6
10224505|NCT03943290|11352538|FG007|NOT COMPLETED|Overall Study||8
10224506|NCT03943290|11352539|FG008|NOT COMPLETED|Overall Study||8
10239294|NCT00301080|11370811|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10239295|NCT00301080|11370812|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10239296|NCT00301080|11370813|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10239297|NCT00301080|11370814|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10111936|NCT02500056|11242990|FG001|NOT COMPLETED|Overall Study||8
10111937|NCT02500368|11242996|FG000|STARTED|First Intervention (1 Week)||20
10111938|NCT02500368|11242997|FG001|STARTED|First Intervention (1 Week)||20
10111939|NCT02500368|11242996|FG000|COMPLETED|First Intervention (1 Week)||20
10111940|NCT02500368|11242997|FG001|COMPLETED|First Intervention (1 Week)||20
10111941|NCT02500368|11242996|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10111942|NCT02500368|11242997|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10111943|NCT02500368|11242996|FG000|STARTED|Second Intervention (1 Week)||20
10111944|NCT02500368|11242997|FG001|STARTED|Second Intervention (1 Week)||20
10111945|NCT02500368|11242996|FG000|COMPLETED|Second Intervention (1 Week)||20
10111946|NCT02500368|11242997|FG001|COMPLETED|Second Intervention (1 Week)||20
10111947|NCT02500368|11242996|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10111948|NCT02500368|11242997|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10111949|NCT02500537|11243005|FG000|STARTED|Overall Study||60
10111950|NCT02500537|11243006|FG001|STARTED|Overall Study||40
10111951|NCT02500537|11243005|FG000|COMPLETED|Overall Study||57
10111952|NCT02500537|11243006|FG001|COMPLETED|Overall Study||39
10111953|NCT02500537|11243005|FG000|NOT COMPLETED|Overall Study||3
10111954|NCT02500537|11243006|FG001|NOT COMPLETED|Overall Study||1
10111955|NCT02500550|11243013|FG000|STARTED|Overall Study||15
10111956|NCT02500550|11243013|FG000|COMPLETED|Overall Study||8
10111957|NCT02500550|11243013|FG000|NOT COMPLETED|Overall Study||7
10111958|NCT02500602|11243019|FG000|STARTED|Treatment Phase||74
10111959|NCT02500602|11243020|FG001|STARTED|Treatment Phase||70
10111960|NCT02500602|11243019|FG000|COMPLETED|Treatment Phase||68
10111961|NCT02500602|11243020|FG001|COMPLETED|Treatment Phase||69
10111962|NCT02500602|11243019|FG000|NOT COMPLETED|Treatment Phase||6
10111963|NCT02500602|11243020|FG001|NOT COMPLETED|Treatment Phase||1
10111964|NCT02500602|11243019|FG000|STARTED|Follow Up Phase||68
10111965|NCT02500602|11243020|FG001|STARTED|Follow Up Phase||69
10111966|NCT02500602|11243019|FG000|COMPLETED|Follow Up Phase||53
10111967|NCT02500602|11243020|FG001|COMPLETED|Follow Up Phase||47
10111968|NCT02500602|11243019|FG000|NOT COMPLETED|Follow Up Phase||15
10111969|NCT02500602|11243020|FG001|NOT COMPLETED|Follow Up Phase||22
10111970|NCT02500628|11243030|FG000|STARTED|Overall Study||38
10111971|NCT02500628|11243031|FG001|STARTED|Overall Study||23
10111972|NCT02500628|11243030|FG000|COMPLETED|Overall Study||38
10111973|NCT02500628|11243031|FG001|COMPLETED|Overall Study||23
10111974|NCT02500628|11243030|FG000|NOT COMPLETED|Overall Study||0
10111975|NCT02500628|11243031|FG001|NOT COMPLETED|Overall Study||0
10111976|NCT02500641|11243041|FG000|STARTED|Overall Study||98
10111977|NCT02500641|11243042|FG001|STARTED|Overall Study||98
10111978|NCT02500641|11243041|FG000|COMPLETED|Overall Study||88
10111979|NCT02500641|11243042|FG001|COMPLETED|Overall Study||86
10111980|NCT02500641|11243041|FG000|NOT COMPLETED|Overall Study||10
10111981|NCT02500641|11243042|FG001|NOT COMPLETED|Overall Study||12
10111982|NCT02500706|11243051|FG000|STARTED|Overall Study||342
10111983|NCT02500706|11243052|FG001|STARTED|Overall Study||341
10111984|NCT02500706|11243053|FG002|STARTED|Overall Study||342
10111985|NCT02500706|11243051|FG000|Exposed|Overall Study||342
10111986|NCT02500706|11243052|FG001|Exposed|Overall Study||341
10111987|NCT02500706|11243053|FG002|Exposed|Overall Study||342
10111988|NCT02500706|11243051|FG000|COMPLETED|Overall Study||338
10111989|NCT02500706|11243052|FG001|COMPLETED|Overall Study||334
10111990|NCT02500706|11243053|FG002|COMPLETED|Overall Study||335
10111991|NCT02500706|11243051|FG000|NOT COMPLETED|Overall Study||4
10111992|NCT02500706|11243052|FG001|NOT COMPLETED|Overall Study||7
10111993|NCT02500706|11243053|FG002|NOT COMPLETED|Overall Study||7
10111994|NCT02500719|11243063|FG000|STARTED|Overall Study||14
10111995|NCT02500719|11243064|FG001|STARTED|Overall Study||16
10111996|NCT02500719|11243063|FG000|COMPLETED|Overall Study||11
10111997|NCT02500719|11243064|FG001|COMPLETED|Overall Study||9
10111998|NCT02500719|11243063|FG000|NOT COMPLETED|Overall Study||3
10111999|NCT02500719|11243064|FG001|NOT COMPLETED|Overall Study||7
10112000|NCT02500732|11243072|FG000|STARTED|Overall Study||27
10112001|NCT02500732|11243073|FG001|STARTED|Overall Study||30
10112002|NCT02500732|11243072|FG000|COMPLETED|Overall Study||27
10112003|NCT02500732|11243073|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
10112004|NCT02500732|11243072|FG000|NOT COMPLETED|Overall Study||0
10112005|NCT02500732|11243073|FG001|NOT COMPLETED|Overall Study||1
10112006|NCT02500758|11243081|FG000|STARTED|First Intervention (2 Minutes)||15
10112007|NCT02500758|11243082|FG001|STARTED|First Intervention (2 Minutes)||15
10112008|NCT02500758|11243081|FG000|COMPLETED|First Intervention (2 Minutes)||15
10112009|NCT02500758|11243082|FG001|COMPLETED|First Intervention (2 Minutes)||14
10112010|NCT02500758|11243081|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0
10112011|NCT02500758|11243082|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1
10112012|NCT02500758|11243081|FG000|STARTED|Washout (1 Week)||15
10112013|NCT02500758|11243082|FG001|STARTED|Washout (1 Week)||14
10112014|NCT02500758|11243081|FG000|COMPLETED|Washout (1 Week)||13
10112015|NCT02500758|11243082|FG001|COMPLETED|Washout (1 Week)||12
10112016|NCT02500758|11243081|FG000|NOT COMPLETED|Washout (1 Week)||2
10112017|NCT02500758|11243082|FG001|NOT COMPLETED|Washout (1 Week)||2
10112018|NCT02500758|11243081|FG000|STARTED|Second Intervention (2 Minutes)||13
10112019|NCT02500758|11243082|FG001|STARTED|Second Intervention (2 Minutes)||12
10112020|NCT02500758|11243081|FG000|COMPLETED|Second Intervention (2 Minutes)||10
10112021|NCT02500758|11243082|FG001|COMPLETED|Second Intervention (2 Minutes)||10
10224507|NCT03942042|11352574|FG000|STARTED|Induction Dosing Period (12 Weeks)||7
10224508|NCT03942042|11352575|FG001|STARTED|Induction Dosing Period (12 Weeks)||5
10224509|NCT03942042|11352574|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
10224510|NCT03942042|11352575|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
10224511|NCT03942042|11352574|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
10224512|NCT03942042|11352575|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
10012832|NCT01787799|11135705|FG000|NOT COMPLETED|Overall Study||0
10012833|NCT01787825|11135709|FG000|STARTED|Overall Study||60
10224513|NCT03942042|11352574|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
10224514|NCT03942042|11352575|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
10224515|NCT03942042|11352574|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6
10224516|NCT03942042|11352575|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4
10224517|NCT03942042|11352574|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
10224518|NCT03942042|11352575|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
10224519|NCT03942042|11352574|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
10224520|NCT03942042|11352575|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4
10224521|NCT03942042|11352574|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
10224522|NCT03942042|11352575|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
10224523|NCT03942042|11352574|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
10224524|NCT03942042|11352575|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
10224525|NCT03938337|11352587|FG000|STARTED|Overall Study||1
10224526|NCT03938337|11352588|FG001|STARTED|Overall Study||0
10224527|NCT03938337|11352587|FG000|COMPLETED|Overall Study||1
10224528|NCT03938337|11352588|FG001|COMPLETED|Overall Study||0
10224529|NCT03938337|11352587|FG000|NOT COMPLETED|Overall Study||0
10224530|NCT03938337|11352588|FG001|NOT COMPLETED|Overall Study||0
10224531|NCT03923530|11352594|FG000|STARTED|Overall Study||12
10224532|NCT03923530|11352594|FG000|COMPLETED|Overall Study||8
10224533|NCT03923530|11352594|FG000|NOT COMPLETED|Overall Study||4
10224534|NCT03914417|11352598|FG000|STARTED|Overall Study||21
10224535|NCT03914417|11352598|FG000|COMPLETED|Overall Study||19
10224536|NCT03914417|11352598|FG000|NOT COMPLETED|Overall Study||2
10224537|NCT03913377|11352604|FG000|STARTED|Period 1||21
10224538|NCT03913377|11352605|FG001|STARTED|Period 1||22
10224539|NCT03913377|11352606|FG002|STARTED|Period 1||22
10224540|NCT03913377|11352604|FG000|COMPLETED|Period 1||21
10224541|NCT03913377|11352605|FG001|COMPLETED|Period 1||21
10224542|NCT03913377|11352606|FG002|COMPLETED|Period 1||21
10224543|NCT03913377|11352604|FG000|NOT COMPLETED|Period 1||0
10224544|NCT03913377|11352605|FG001|NOT COMPLETED|Period 1||1
10224545|NCT03913377|11352606|FG002|NOT COMPLETED|Period 1||1
10224546|NCT03913377|11352604|FG000|STARTED|Period 2||0
10224547|NCT03913377|11352605|FG001|STARTED|Period 2||21
10224548|NCT03913377|11352606|FG002|STARTED|Period 2||21
10224549|NCT03913377|11352604|FG000|COMPLETED|Period 2||0
10224550|NCT03913377|11352605|FG001|COMPLETED|Period 2||21
10224551|NCT03913377|11352606|FG002|COMPLETED|Period 2||21
10224552|NCT03913377|11352604|FG000|NOT COMPLETED|Period 2||0
10224553|NCT03913377|11352605|FG001|NOT COMPLETED|Period 2||0
10224554|NCT03913377|11352606|FG002|NOT COMPLETED|Period 2||0
10224555|NCT03937791|11352613|FG000|STARTED|Overall Study||1
10224556|NCT03937791|11352613|FG000|COMPLETED|Overall Study||1
10224557|NCT03937791|11352613|FG000|NOT COMPLETED|Overall Study||0
10224558|NCT03937778|11352617|FG000|STARTED|Overall Study||7
10224559|NCT03937778|11352617|FG000|COMPLETED|Overall Study||5
10224560|NCT03937778|11352617|FG000|NOT COMPLETED|Overall Study||2
10224561|NCT03937479|11352626|FG000|STARTED|Overall Study||83
10224562|NCT03937479|11352627|FG001|STARTED|Overall Study||85
10224563|NCT03937479|11352628|FG002|STARTED|Overall Study||82
10224564|NCT03937479|11352629|FG003|STARTED|Overall Study||82
10224565|NCT03937479|11352630|FG004|STARTED|Overall Study||84
10224566|NCT03937479|11352626|FG000|Received Treatment|Overall Study||83
10224567|NCT03937479|11352627|FG001|Received Treatment|Overall Study||83
10224568|NCT03937479|11352628|FG002|Received Treatment|Overall Study||81
10224569|NCT03937479|11352629|FG003|Received Treatment|Overall Study||82
10224570|NCT03937479|11352630|FG004|Received Treatment|Overall Study||84
10224571|NCT03937479|11352626|FG000|COMPLETED|Overall Study||73
10224572|NCT03937479|11352627|FG001|COMPLETED|Overall Study||70
10224573|NCT03937479|11352628|FG002|COMPLETED|Overall Study||75
10224574|NCT03937479|11352629|FG003|COMPLETED|Overall Study||76
10224575|NCT03937479|11352630|FG004|COMPLETED|Overall Study||79
10224576|NCT03937479|11352626|FG000|NOT COMPLETED|Overall Study||10
10224577|NCT03937479|11352627|FG001|NOT COMPLETED|Overall Study||15
10224578|NCT03937479|11352628|FG002|NOT COMPLETED|Overall Study||7
10224579|NCT03937479|11352629|FG003|NOT COMPLETED|Overall Study||6
10224580|NCT03937479|11352630|FG004|NOT COMPLETED|Overall Study||5
10224581|NCT03936387|11352642|FG000|STARTED|Overall Study||10
10224582|NCT03936387|11352642|FG000|COMPLETED|Overall Study||10
10224583|NCT03936387|11352642|FG000|NOT COMPLETED|Overall Study||0
10224584|NCT03935399|11352648|FG000|STARTED|First Study Day||5
10224585|NCT03935399|11352649|FG001|STARTED|First Study Day||5
10224586|NCT03935399|11352648|FG000|COMPLETED|First Study Day||5
10224587|NCT03935399|11352649|FG001|COMPLETED|First Study Day||5
10224588|NCT03935399|11352648|FG000|NOT COMPLETED|First Study Day||0
10224589|NCT03935399|11352649|FG001|NOT COMPLETED|First Study Day||0
10224590|NCT03935399|11352648|FG000|STARTED|Second Study Day||5
10224591|NCT03935399|11352649|FG001|STARTED|Second Study Day||5
10224592|NCT03935399|11352648|FG000|COMPLETED|Second Study Day||5
10224593|NCT03935399|11352649|FG001|COMPLETED|Second Study Day||5
10224594|NCT03935399|11352648|FG000|NOT COMPLETED|Second Study Day||0
10224595|NCT03935399|11352649|FG001|NOT COMPLETED|Second Study Day||0
10224596|NCT03936608|11352657|FG000|STARTED|Overall Study||2
10224597|NCT03936608|11352658|FG001|STARTED|Overall Study||2
10224598|NCT03936608|11352657|FG000|COMPLETED|Overall Study||0
10224599|NCT03936608|11352658|FG001|COMPLETED|Overall Study||0
10224600|NCT03936608|11352657|FG000|NOT COMPLETED|Overall Study||2
10224601|NCT03936608|11352658|FG001|NOT COMPLETED|Overall Study||2
10224602|NCT03936244|11352666|FG000|STARTED|Overall Study||57
10224603|NCT03936244|11352667|FG001|STARTED|Overall Study||43
10224604|NCT03936244|11352666|FG000|COMPLETED|Overall Study||45
10224605|NCT03936244|11352667|FG001|COMPLETED|Overall Study||39
10224606|NCT03936244|11352666|FG000|NOT COMPLETED|Overall Study||12
10224607|NCT03936244|11352667|FG001|NOT COMPLETED|Overall Study||4
10224608|NCT03935126|11352674|FG000|STARTED|Overall Study||3
10224609|NCT03935126|11352674|FG000|COMPLETED|Overall Study||0
10224610|NCT03935126|11352674|FG000|NOT COMPLETED|Overall Study||3
10224611|NCT03928327|11352680|FG000|STARTED|Period 1||12
10224612|NCT03928327|11352681|FG001|STARTED|Period 1||12
10224613|NCT03928327|11352680|FG000|COMPLETED|Period 1||12
10224614|NCT03928327|11352681|FG001|COMPLETED|Period 1||12
10224615|NCT03928327|11352680|FG000|NOT COMPLETED|Period 1||0
10224616|NCT03928327|11352681|FG001|NOT COMPLETED|Period 1||0
10224617|NCT03928327|11352680|FG000|STARTED|Washout Period||12
10224618|NCT03928327|11352681|FG001|STARTED|Washout Period||12
10224619|NCT03928327|11352680|FG000|COMPLETED|Washout Period||12
10224620|NCT03928327|11352681|FG001|COMPLETED|Washout Period||12
10224621|NCT03928327|11352680|FG000|NOT COMPLETED|Washout Period||0
10224622|NCT03928327|11352681|FG001|NOT COMPLETED|Washout Period||0
10224623|NCT03928327|11352680|FG000|STARTED|Period 2||12
10224624|NCT03928327|11352681|FG001|STARTED|Period 2||12
10224625|NCT03928327|11352680|FG000|COMPLETED|Period 2||12
10224626|NCT03928327|11352681|FG001|COMPLETED|Period 2||12
10224627|NCT03928327|11352680|FG000|NOT COMPLETED|Period 2||0
10224628|NCT03928327|11352681|FG001|NOT COMPLETED|Period 2||0
10224629|NCT03933462|11352693|FG000|STARTED|Overall Study||10
10224630|NCT03933462|11352694|FG001|STARTED|Overall Study||10
10224631|NCT03933462|11352693|FG000|Crossover|Overall Study||8
10224632|NCT03933462|11352694|FG001|Crossover|Overall Study||10
10224633|NCT03933462|11352693|FG000|COMPLETED|Overall Study||8
10224634|NCT03933462|11352694|FG001|COMPLETED|Overall Study||10
10224635|NCT03933462|11352693|FG000|NOT COMPLETED|Overall Study||2
10224636|NCT03933462|11352694|FG001|NOT COMPLETED|Overall Study||0
10224637|NCT03933774|11352702|FG000|STARTED|Overall Study||12
10224638|NCT03933774|11352703|FG001|STARTED|Overall Study||13
10224639|NCT03933774|11352702|FG000|COMPLETED|Overall Study||10
10224640|NCT03933774|11352703|FG001|COMPLETED|Overall Study||11
10224641|NCT03933774|11352702|FG000|NOT COMPLETED|Overall Study||2
10224642|NCT03933774|11352703|FG001|NOT COMPLETED|Overall Study||2
10224643|NCT03931330|11352709|FG000|STARTED|Overall Study||8
10224644|NCT03931330|11352709|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
10224645|NCT03931330|11352709|FG000|COMPLETED|Overall Study||7
10224646|NCT03931330|11352709|FG000|NOT COMPLETED|Overall Study||1
10224647|NCT03918811|11352716|FG000|STARTED|Overall Study||367
10224648|NCT03918811|11352717|FG001|STARTED|Overall Study||358
10224649|NCT03918811|11352716|FG000|COMPLETED|Overall Study||363
10224650|NCT03918811|11352717|FG001|COMPLETED|Overall Study||345
10224651|NCT03918811|11352716|FG000|NOT COMPLETED|Overall Study||4
10224652|NCT03918811|11352717|FG001|NOT COMPLETED|Overall Study||13
10224653|NCT03933618|11352729|FG000|STARTED|Baseline||4
10224654|NCT03933618|11352730|FG001|STARTED|Baseline||4
10224655|NCT03933618|11352731|FG002|STARTED|Baseline||4
10224656|NCT03933618|11352732|FG003|STARTED|Baseline||4
10224657|NCT03933618|11352733|FG004|STARTED|Baseline||4
10224658|NCT03933618|11352734|FG005|STARTED|Baseline||4
10224659|NCT03933618|11352729|FG000|COMPLETED|Baseline||4
10224660|NCT03933618|11352730|FG001|COMPLETED|Baseline||4
10224661|NCT03933618|11352731|FG002|COMPLETED|Baseline||4
10224662|NCT03933618|11352732|FG003|COMPLETED|Baseline||4
10224663|NCT03933618|11352733|FG004|COMPLETED|Baseline||4
10224664|NCT03933618|11352734|FG005|COMPLETED|Baseline||4
10224665|NCT03933618|11352729|FG000|NOT COMPLETED|Baseline||0
10224666|NCT03933618|11352730|FG001|NOT COMPLETED|Baseline||0
10224667|NCT03933618|11352731|FG002|NOT COMPLETED|Baseline||0
10224668|NCT03933618|11352732|FG003|NOT COMPLETED|Baseline||0
10224669|NCT03933618|11352733|FG004|NOT COMPLETED|Baseline||0
10224670|NCT03933618|11352734|FG005|NOT COMPLETED|Baseline||0
10012834|NCT01787825|11135710|FG001|STARTED|Overall Study||61
10012835|NCT01787825|11135709|FG000|COMPLETED|Overall Study||54
10012836|NCT01787825|11135710|FG001|COMPLETED|Overall Study||60
10224671|NCT03933618|11352729|FG000|STARTED|Baseline to Week 8||4
10224672|NCT03933618|11352730|FG001|STARTED|Baseline to Week 8||4
10224673|NCT03933618|11352731|FG002|STARTED|Baseline to Week 8||4
10224674|NCT03933618|11352732|FG003|STARTED|Baseline to Week 8||4
10224675|NCT03933618|11352733|FG004|STARTED|Baseline to Week 8||4
10224676|NCT03933618|11352734|FG005|STARTED|Baseline to Week 8||4
10224677|NCT03933618|11352729|FG000|COMPLETED|Baseline to Week 8||4
10224678|NCT03933618|11352730|FG001|COMPLETED|Baseline to Week 8||4
10224679|NCT03933618|11352731|FG002|COMPLETED|Baseline to Week 8||4
10224680|NCT03933618|11352732|FG003|COMPLETED|Baseline to Week 8||4
10224681|NCT03933618|11352733|FG004|COMPLETED|Baseline to Week 8||4
10224682|NCT03933618|11352734|FG005|COMPLETED|Baseline to Week 8||4
10224683|NCT03933618|11352729|FG000|NOT COMPLETED|Baseline to Week 8||0
10224684|NCT03933618|11352730|FG001|NOT COMPLETED|Baseline to Week 8||0
10224685|NCT03933618|11352731|FG002|NOT COMPLETED|Baseline to Week 8||0
10224686|NCT03933618|11352732|FG003|NOT COMPLETED|Baseline to Week 8||0
10224687|NCT03933618|11352733|FG004|NOT COMPLETED|Baseline to Week 8||0
10224688|NCT03933618|11352734|FG005|NOT COMPLETED|Baseline to Week 8||0
10224689|NCT03933618|11352729|FG000|STARTED|Week 8 to Week 16||4
10224690|NCT03933618|11352730|FG001|STARTED|Week 8 to Week 16||4
10224691|NCT03933618|11352731|FG002|STARTED|Week 8 to Week 16||4
10224692|NCT03933618|11352732|FG003|STARTED|Week 8 to Week 16||4
10224693|NCT03933618|11352733|FG004|STARTED|Week 8 to Week 16||4
10224694|NCT03933618|11352734|FG005|STARTED|Week 8 to Week 16||4
10224695|NCT03933618|11352729|FG000|COMPLETED|Week 8 to Week 16||4
10224696|NCT03933618|11352730|FG001|COMPLETED|Week 8 to Week 16||4
10224697|NCT03933618|11352731|FG002|COMPLETED|Week 8 to Week 16||4
10224698|NCT03933618|11352732|FG003|COMPLETED|Week 8 to Week 16||4
10224699|NCT03933618|11352733|FG004|COMPLETED|Week 8 to Week 16||4
10224700|NCT03933618|11352734|FG005|COMPLETED|Week 8 to Week 16||4
10224701|NCT03933618|11352729|FG000|NOT COMPLETED|Week 8 to Week 16||0
10224702|NCT03933618|11352730|FG001|NOT COMPLETED|Week 8 to Week 16||0
10224703|NCT03933618|11352731|FG002|NOT COMPLETED|Week 8 to Week 16||0
10224704|NCT03933618|11352732|FG003|NOT COMPLETED|Week 8 to Week 16||0
10224705|NCT03933618|11352733|FG004|NOT COMPLETED|Week 8 to Week 16||0
10224706|NCT03933618|11352734|FG005|NOT COMPLETED|Week 8 to Week 16||0
10224707|NCT03933618|11352729|FG000|STARTED|Week 16 to Week 24||4
10224708|NCT03933618|11352730|FG001|STARTED|Week 16 to Week 24||4
10224709|NCT03933618|11352731|FG002|STARTED|Week 16 to Week 24||4
10224710|NCT03933618|11352732|FG003|STARTED|Week 16 to Week 24||4
10224711|NCT03933618|11352733|FG004|STARTED|Week 16 to Week 24||4
10224712|NCT03933618|11352734|FG005|STARTED|Week 16 to Week 24||4
10224713|NCT03933618|11352729|FG000|COMPLETED|Week 16 to Week 24||4
10224714|NCT03933618|11352730|FG001|COMPLETED|Week 16 to Week 24||4
10224715|NCT03933618|11352731|FG002|COMPLETED|Week 16 to Week 24||4
10012837|NCT01787825|11135709|FG000|NOT COMPLETED|Overall Study||6
10012838|NCT01787825|11135710|FG001|NOT COMPLETED|Overall Study||1
10012839|NCT01787838|11135717|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
10012840|NCT01787838|11135717|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
10012841|NCT01787838|11135717|FG000|NOT COMPLETED|Overall Study||1413
10012842|NCT01787916|11135721|FG000|STARTED|First Intervention (24 Weeks)||8
10224716|NCT03933618|11352732|FG003|COMPLETED|Week 16 to Week 24||4
10224717|NCT03933618|11352733|FG004|COMPLETED|Week 16 to Week 24||4
10224718|NCT03933618|11352734|FG005|COMPLETED|Week 16 to Week 24||4
10012843|NCT01787916|11135722|FG001|STARTED|First Intervention (24 Weeks)||7
10012844|NCT01787916|11135721|FG000|COMPLETED|First Intervention (24 Weeks)||8
10012845|NCT01787916|11135722|FG001|COMPLETED|First Intervention (24 Weeks)||7
10224719|NCT03933618|11352729|FG000|NOT COMPLETED|Week 16 to Week 24||0
10224720|NCT03933618|11352730|FG001|NOT COMPLETED|Week 16 to Week 24||0
10224721|NCT03933618|11352731|FG002|NOT COMPLETED|Week 16 to Week 24||0
10224722|NCT03933618|11352732|FG003|NOT COMPLETED|Week 16 to Week 24||0
10224723|NCT03933618|11352733|FG004|NOT COMPLETED|Week 16 to Week 24||0
10224724|NCT03933618|11352734|FG005|NOT COMPLETED|Week 16 to Week 24||0
10224725|NCT03931785|11352752|FG000|STARTED|Overall Study||97
10224726|NCT03931785|11352753|FG001|STARTED|Overall Study||97
10224727|NCT03931785|11352754|FG002|STARTED|Overall Study||97
10224728|NCT03931785|11352755|FG003|STARTED|Overall Study||97
10224729|NCT03931785|11352752|FG000|COMPLETED|Overall Study||92
10224730|NCT03931785|11352753|FG001|COMPLETED|Overall Study||90
10224731|NCT03931785|11352754|FG002|COMPLETED|Overall Study||84
10224732|NCT03931785|11352755|FG003|COMPLETED|Overall Study||86
10224733|NCT03931785|11352752|FG000|NOT COMPLETED|Overall Study||5
10224734|NCT03931785|11352753|FG001|NOT COMPLETED|Overall Study||7
10224735|NCT03931785|11352754|FG002|NOT COMPLETED|Overall Study||13
10224736|NCT03931785|11352755|FG003|NOT COMPLETED|Overall Study||11
10224737|NCT03930641|11352765|FG000|STARTED|Overall Study||34
10224738|NCT03930641|11352765|FG000|COMPLETED|Overall Study||34
10224739|NCT03930641|11352765|FG000|NOT COMPLETED|Overall Study||0
10224740|NCT03927846|11352771|FG000|STARTED|Overall Study||30
10224741|NCT03927846|11352772|FG001|STARTED|Overall Study||30
10224742|NCT03927846|11352771|FG000|COMPLETED|Overall Study||20
10224743|NCT03927846|11352772|FG001|COMPLETED|Overall Study||19
10224744|NCT03927846|11352771|FG000|NOT COMPLETED|Overall Study||10
10224745|NCT03927846|11352772|FG001|NOT COMPLETED|Overall Study||11
10224746|NCT03927105|11352778|FG000|STARTED|Overall Study||4
10224747|NCT03927105|11352778|FG000|Began Treatment|Overall Study||3
10224748|NCT03927105|11352778|FG000|Follow-up|Overall Study||3
10224749|NCT03927105|11352778|FG000|COMPLETED|Overall Study||0
10224750|NCT03927105|11352778|FG000|NOT COMPLETED|Overall Study||4
10224751|NCT03923933|11352784|FG000|STARTED|Overall Study||17
10224752|NCT03923933|11352785|FG001|STARTED|Overall Study||17
10224753|NCT03923933|11352784|FG000|COMPLETED|Overall Study||16
10224754|NCT03923933|11352785|FG001|COMPLETED|Overall Study||16
10224755|NCT03923933|11352784|FG000|NOT COMPLETED|Overall Study||1
10224756|NCT03923933|11352785|FG001|NOT COMPLETED|Overall Study||1
10224757|NCT03909295|11352791|FG000|STARTED|Overall Study||52
9760903|NCT00384059|10864717|FG001|NOT COMPLETED|Infant Series||13
9760904|NCT00384059|10864716|FG000|STARTED|After Infant Series||135
9760905|NCT00384059|10864717|FG001|STARTED|After Infant Series||132
10224758|NCT03909295|11352791|FG000|Safety Set (SAF)|Overall Study||52
10224759|NCT03909295|11352791|FG000|COMPLETED|Overall Study||0
10224760|NCT03909295|11352791|FG000|NOT COMPLETED|Overall Study||52
10224761|NCT03908970|11352797|FG000|STARTED|Overall Study||182
10224762|NCT03908970|11352798|FG001|STARTED|Overall Study||182
10224763|NCT03908970|11352797|FG000|COMPLETED|Overall Study||165
10224764|NCT03908970|11352798|FG001|COMPLETED|Overall Study||135
10224765|NCT03908970|11352797|FG000|NOT COMPLETED|Overall Study||17
10224766|NCT03908970|11352798|FG001|NOT COMPLETED|Overall Study||47
10224767|NCT03897179|11352804|FG000|STARTED|Overall Study||27
10224768|NCT03897179|11352804|FG000|COMPLETED|Overall Study||26
10224769|NCT03897179|11352804|FG000|NOT COMPLETED|Overall Study||1
10224770|NCT03930264|11352810|FG000|STARTED|Overall Study||15
10224771|NCT03930264|11352811|FG001|STARTED|Overall Study||15
10224772|NCT03930264|11352810|FG000|COMPLETED|Overall Study||15
10224773|NCT03930264|11352811|FG001|COMPLETED|Overall Study||14
10224774|NCT03930264|11352810|FG000|NOT COMPLETED|Overall Study||0
10224775|NCT03930264|11352811|FG001|NOT COMPLETED|Overall Study||1
10224776|NCT03929367|11352817|FG000|STARTED|Overall Study||11
10224777|NCT03929367|11352817|FG000|COMPLETED|Overall Study||11
10224778|NCT03929367|11352817|FG000|NOT COMPLETED|Overall Study||0
10224779|NCT03928522|11352826|FG000|STARTED|Overall Study||12
10224780|NCT03928522|11352827|FG001|STARTED|Overall Study||12
10224781|NCT03928522|11352828|FG002|STARTED|Overall Study||12
10224782|NCT03928522|11352829|FG003|STARTED|Overall Study||12
10224783|NCT03928522|11352830|FG004|STARTED|Overall Study||12
10224784|NCT03928522|11352826|FG000|COMPLETED|Overall Study||12
10224785|NCT03928522|11352827|FG001|COMPLETED|Overall Study||12
10224786|NCT03928522|11352828|FG002|COMPLETED|Overall Study||12
10224787|NCT03928522|11352829|FG003|COMPLETED|Overall Study||12
10224788|NCT03928522|11352830|FG004|COMPLETED|Overall Study||12
10224789|NCT03928522|11352826|FG000|NOT COMPLETED|Overall Study||0
10224790|NCT03928522|11352827|FG001|NOT COMPLETED|Overall Study||0
10224791|NCT03928522|11352828|FG002|NOT COMPLETED|Overall Study||0
10224792|NCT03928522|11352829|FG003|NOT COMPLETED|Overall Study||0
10224793|NCT03928522|11352830|FG004|NOT COMPLETED|Overall Study||0
10224794|NCT03910439|11352842|FG000|STARTED|Overall Study||4
10224795|NCT03910439|11352842|FG000|COMPLETED|Overall Study||4
10224796|NCT03910439|11352842|FG000|NOT COMPLETED|Overall Study||0
10224797|NCT03907241|11352853|FG000|STARTED|Overall Study||27
10224798|NCT03907241|11352853|FG000|COMPLETED|Overall Study||23
10224799|NCT03907241|11352853|FG000|NOT COMPLETED|Overall Study||4
10224800|NCT03927950|11352868|FG000|STARTED|Overall Study||135
10224801|NCT03927950|11352868|FG000|COMPLETED|Overall Study||126
10224802|NCT03927950|11352868|FG000|NOT COMPLETED|Overall Study||9
10224803|NCT03927781|11352873|FG000|STARTED|Overall Study||10
10224804|NCT03927781|11352873|FG000|COMPLETED|Overall Study||10
10224805|NCT03927781|11352873|FG000|NOT COMPLETED|Overall Study||0
10224806|NCT03927209|11352879|FG000|STARTED|Overall Study||5
10224807|NCT03927209|11352880|FG001|STARTED|Overall Study||5
10224808|NCT03927209|11352879|FG000|COMPLETED|Overall Study||5
10224809|NCT03927209|11352880|FG001|COMPLETED|Overall Study||5
10224810|NCT03927209|11352879|FG000|NOT COMPLETED|Overall Study||0
10224811|NCT03927209|11352880|FG001|NOT COMPLETED|Overall Study||0
10224812|NCT03920670|11352890|FG000|STARTED|Overall Study||60
10224813|NCT03920670|11352891|FG001|STARTED|Overall Study||60
10224814|NCT03920670|11352890|FG000|COMPLETED|Overall Study||57
10224815|NCT03920670|11352891|FG001|COMPLETED|Overall Study||58
10224816|NCT03920670|11352890|FG000|NOT COMPLETED|Overall Study||3
10224817|NCT03920670|11352891|FG001|NOT COMPLETED|Overall Study||2
10224818|NCT03919422|11352899|FG000|STARTED|Overall Study||40
10224819|NCT03919422|11352900|FG001|STARTED|Overall Study||40
10224820|NCT03919422|11352899|FG000|COMPLETED|Overall Study||40
10224821|NCT03919422|11352900|FG001|COMPLETED|Overall Study||40
10224822|NCT03919422|11352899|FG000|NOT COMPLETED|Overall Study||0
10224823|NCT03919422|11352900|FG001|NOT COMPLETED|Overall Study||0
10224824|NCT03907579|11352906|FG000|STARTED|Overall Study||100
10224825|NCT03907579|11352906|FG000|COMPLETED|Overall Study||100
10224826|NCT03907579|11352906|FG000|NOT COMPLETED|Overall Study||0
10224827|NCT03898063|11352912|FG000|STARTED|Overall Study||74
10224828|NCT03898063|11352913|FG001|STARTED|Overall Study||74
10224829|NCT03898063|11352912|FG000|COMPLETED|Overall Study||64
10224830|NCT03898063|11352913|FG001|COMPLETED|Overall Study||66
10224831|NCT03898063|11352912|FG000|NOT COMPLETED|Overall Study||10
10224832|NCT03898063|11352913|FG001|NOT COMPLETED|Overall Study||8
10224833|NCT03895307|11352923|FG000|STARTED|Overall Study||21
10224834|NCT03895307|11352924|FG001|STARTED|Overall Study||20
10224835|NCT03895307|11352925|FG002|STARTED|Overall Study||22
10224836|NCT03895307|11352926|FG003|STARTED|Overall Study||21
10224837|NCT03895307|11352923|FG000|COMPLETED|Overall Study||19
10224838|NCT03895307|11352924|FG001|COMPLETED|Overall Study||20
10224839|NCT03895307|11352925|FG002|COMPLETED|Overall Study||20
10224840|NCT03895307|11352926|FG003|COMPLETED|Overall Study||21
10224841|NCT03895307|11352923|FG000|NOT COMPLETED|Overall Study||2
10224842|NCT03895307|11352924|FG001|NOT COMPLETED|Overall Study||0
10224843|NCT03895307|11352925|FG002|NOT COMPLETED|Overall Study||2
10224844|NCT03895307|11352926|FG003|NOT COMPLETED|Overall Study||0
10224845|NCT03926208|11352938|FG000|STARTED|Overall Study||119
10224846|NCT03926208|11352939|FG001|STARTED|Overall Study||123
10224847|NCT03926208|11352938|FG000|COMPLETED|Overall Study||119
10224848|NCT03926208|11352939|FG001|COMPLETED|Overall Study||123
10224849|NCT03926208|11352938|FG000|NOT COMPLETED|Overall Study||0
10224850|NCT03926208|11352939|FG001|NOT COMPLETED|Overall Study||0
10224851|NCT03926065|11352945|FG000|STARTED|Study Week 1||11
10224852|NCT03926065|11352946|FG001|STARTED|Study Week 1||9
10224853|NCT03926065|11352947|FG002|STARTED|Study Week 1||14
10224854|NCT03926065|11352948|FG003|STARTED|Study Week 1||18
10224855|NCT03926065|11352949|FG004|STARTED|Study Week 1||15
10224856|NCT03926065|11352945|FG000|COMPLETED|Study Week 1||11
10224857|NCT03926065|11352946|FG001|COMPLETED|Study Week 1||9
10224858|NCT03926065|11352947|FG002|COMPLETED|Study Week 1||14
10224859|NCT03926065|11352948|FG003|COMPLETED|Study Week 1||18
10224860|NCT03926065|11352949|FG004|COMPLETED|Study Week 1||15
10224861|NCT03926065|11352945|FG000|NOT COMPLETED|Study Week 1||0
10224862|NCT03926065|11352946|FG001|NOT COMPLETED|Study Week 1||0
10224863|NCT03926065|11352947|FG002|NOT COMPLETED|Study Week 1||0
10224864|NCT03926065|11352948|FG003|NOT COMPLETED|Study Week 1||0
10224865|NCT03926065|11352949|FG004|NOT COMPLETED|Study Week 1||0
10224866|NCT03926065|11352945|FG000|STARTED|Study Week 2||11
10224867|NCT03926065|11352946|FG001|STARTED|Study Week 2||9
10224868|NCT03926065|11352947|FG002|STARTED|Study Week 2||14
10224869|NCT03926065|11352948|FG003|STARTED|Study Week 2||18
10224870|NCT03926065|11352949|FG004|STARTED|Study Week 2||15
10224871|NCT03926065|11352945|FG000|COMPLETED|Study Week 2||11
10224872|NCT03926065|11352946|FG001|COMPLETED|Study Week 2||9
10224873|NCT03926065|11352947|FG002|COMPLETED|Study Week 2||14
10224874|NCT03926065|11352948|FG003|COMPLETED|Study Week 2||18
10224875|NCT03926065|11352949|FG004|COMPLETED|Study Week 2||15
10224876|NCT03926065|11352945|FG000|NOT COMPLETED|Study Week 2||0
10224877|NCT03926065|11352946|FG001|NOT COMPLETED|Study Week 2||0
10224878|NCT03926065|11352947|FG002|NOT COMPLETED|Study Week 2||0
10224879|NCT03926065|11352948|FG003|NOT COMPLETED|Study Week 2||0
10224880|NCT03926065|11352949|FG004|NOT COMPLETED|Study Week 2||0
10224881|NCT03926065|11352945|FG000|STARTED|Study Week 3||11
10224882|NCT03926065|11352946|FG001|STARTED|Study Week 3||9
10224883|NCT03926065|11352947|FG002|STARTED|Study Week 3||14
10224884|NCT03926065|11352948|FG003|STARTED|Study Week 3||18
10224885|NCT03926065|11352949|FG004|STARTED|Study Week 3||15
10224886|NCT03926065|11352945|FG000|COMPLETED|Study Week 3||11
10224887|NCT03926065|11352946|FG001|COMPLETED|Study Week 3||9
10224888|NCT03926065|11352947|FG002|COMPLETED|Study Week 3||14
10224889|NCT03926065|11352948|FG003|COMPLETED|Study Week 3||18
10224890|NCT03926065|11352949|FG004|COMPLETED|Study Week 3||15
10224891|NCT03926065|11352945|FG000|NOT COMPLETED|Study Week 3||0
10224892|NCT03926065|11352946|FG001|NOT COMPLETED|Study Week 3||0
10224893|NCT03926065|11352947|FG002|NOT COMPLETED|Study Week 3||0
10224894|NCT03926065|11352948|FG003|NOT COMPLETED|Study Week 3||0
10224895|NCT03926065|11352949|FG004|NOT COMPLETED|Study Week 3||0
10224896|NCT03926065|11352945|FG000|STARTED|Study Week 4||11
10224897|NCT03926065|11352946|FG001|STARTED|Study Week 4||9
10224898|NCT03926065|11352947|FG002|STARTED|Study Week 4||14
10224899|NCT03926065|11352948|FG003|STARTED|Study Week 4||18
10224900|NCT03926065|11352949|FG004|STARTED|Study Week 4||15
10224901|NCT03926065|11352945|FG000|COMPLETED|Study Week 4||11
10224902|NCT03926065|11352946|FG001|COMPLETED|Study Week 4||9
10224903|NCT03926065|11352947|FG002|COMPLETED|Study Week 4||14
10224904|NCT03926065|11352948|FG003|COMPLETED|Study Week 4||18
10224905|NCT03926065|11352949|FG004|COMPLETED|Study Week 4||15
10224906|NCT03926065|11352945|FG000|NOT COMPLETED|Study Week 4||0
10224907|NCT03926065|11352946|FG001|NOT COMPLETED|Study Week 4||0
10224908|NCT03926065|11352947|FG002|NOT COMPLETED|Study Week 4||0
10224909|NCT03926065|11352948|FG003|NOT COMPLETED|Study Week 4||0
10224910|NCT03926065|11352949|FG004|NOT COMPLETED|Study Week 4||0
10224911|NCT03909100|11352959|FG000|STARTED|Overall Study||120
10224912|NCT03909100|11352959|FG000|Safety Population|Overall Study||112
10224913|NCT03909100|11352959|FG000|Received Treatment in Session 2|Overall Study||107
10224914|NCT03909100|11352959|FG000|Evaluable Population|Overall Study||106
10224915|NCT03909100|11352959|FG000|COMPLETED|Overall Study||105
10224916|NCT03909100|11352959|FG000|NOT COMPLETED|Overall Study||15
10224917|NCT03905642|11352966|FG000|STARTED|Overall Study||49
10224918|NCT03905642|11352966|FG000|COMPLETED|Overall Study||41
10224919|NCT03905642|11352966|FG000|NOT COMPLETED|Overall Study||8
10224920|NCT03892889|11352970|FG000|STARTED|Overall Study||277
10224921|NCT03892889|11352970|FG000|COMPLETED|Overall Study||73
10224922|NCT03892889|11352970|FG000|NOT COMPLETED|Overall Study||204
10224923|NCT03921723|11352974|FG000|STARTED|Period 1 (4 Days)||22
10224924|NCT03921723|11352974|FG000|COMPLETED|Period 1 (4 Days)||22
10224925|NCT03921723|11352974|FG000|NOT COMPLETED|Period 1 (4 Days)||0
10224926|NCT03921723|11352974|FG000|STARTED|Period 2 (4 Days)||22
10224927|NCT03921723|11352974|FG000|COMPLETED|Period 2 (4 Days)||19
10224928|NCT03921723|11352974|FG000|NOT COMPLETED|Period 2 (4 Days)||3
10224929|NCT03921723|11352974|FG000|STARTED|Period 3 (4 Days)||19
10224930|NCT03921723|11352974|FG000|COMPLETED|Period 3 (4 Days)||18
10224931|NCT03921723|11352974|FG000|NOT COMPLETED|Period 3 (4 Days)||1
10224932|NCT03921190|11352984|FG000|STARTED|Overall Study||56
10224933|NCT03921190|11352985|FG001|STARTED|Overall Study||64
10224934|NCT03921190|11352984|FG000|COMPLETED|Overall Study||56
10224935|NCT03921190|11352985|FG001|COMPLETED|Overall Study||64
10224936|NCT03921190|11352984|FG000|NOT COMPLETED|Overall Study||0
10224937|NCT03921190|11352985|FG001|NOT COMPLETED|Overall Study||0
10224938|NCT03920865|11352996|FG000|STARTED|Overall Study||8
10224939|NCT03920865|11352997|FG001|STARTED|Overall Study||8
10224940|NCT03920865|11352998|FG002|STARTED|Overall Study||10
10224941|NCT03920865|11352996|FG000|COMPLETED|Overall Study||8
10224942|NCT03920865|11352997|FG001|COMPLETED|Overall Study||8
10224943|NCT03920865|11352998|FG002|COMPLETED|Overall Study||10
10224944|NCT03920865|11352996|FG000|NOT COMPLETED|Overall Study||0
10224945|NCT03920865|11352997|FG001|NOT COMPLETED|Overall Study||0
10224946|NCT03920865|11352998|FG002|NOT COMPLETED|Overall Study||0
10224947|NCT03918239|11353018|FG000|STARTED|Overall Study||94
10224948|NCT03918239|11353019|FG001|STARTED|Overall Study||96
10224949|NCT03918239|11353018|FG000|COMPLETED|Overall Study||84
10224950|NCT03918239|11353019|FG001|COMPLETED|Overall Study||89
10224951|NCT03918239|11353018|FG000|NOT COMPLETED|Overall Study||10
10224952|NCT03918239|11353019|FG001|NOT COMPLETED|Overall Study||7
10224953|NCT03917823|11353027|FG000|STARTED|Overall Study||2
10224954|NCT03917823|11353028|FG001|STARTED|Overall Study||2
10224955|NCT03917823|11353027|FG000|COMPLETED|Overall Study||1
10224956|NCT03917823|11353028|FG001|COMPLETED|Overall Study||0
10224957|NCT03917823|11353027|FG000|NOT COMPLETED|Overall Study||1
10224958|NCT03917823|11353028|FG001|NOT COMPLETED|Overall Study||2
10224959|NCT03911752|11353037|FG000|STARTED|Overall Study||8
10224960|NCT03911752|11353038|FG001|STARTED|Overall Study||2
10224961|NCT03911752|11353039|FG002|STARTED|Overall Study||2
10224962|NCT03911752|11353037|FG000|COMPLETED|Overall Study||8
10224963|NCT03911752|11353038|FG001|COMPLETED|Overall Study||2
10224964|NCT03911752|11353039|FG002|COMPLETED|Overall Study||2
10224965|NCT03911752|11353037|FG000|NOT COMPLETED|Overall Study||0
10224966|NCT03911752|11353038|FG001|NOT COMPLETED|Overall Study||0
10224967|NCT03911752|11353039|FG002|NOT COMPLETED|Overall Study||0
10224968|NCT03902613|11353049|FG000|STARTED|Overall Study||1
10224969|NCT03902613|11353049|FG000|COMPLETED|Overall Study||0
10224970|NCT03902613|11353049|FG000|NOT COMPLETED|Overall Study||1
10224971|NCT03902574|11353056|FG000|STARTED|Overall Study||7
10224972|NCT03902574|11353057|FG001|STARTED|Overall Study||7
10224973|NCT03902574|11353058|FG002|STARTED|Overall Study||7
10224974|NCT03902574|11353056|FG000|COMPLETED|Overall Study||7
10224975|NCT03902574|11353057|FG001|COMPLETED|Overall Study||7
10224976|NCT03902574|11353058|FG002|COMPLETED|Overall Study||6
10224977|NCT03902574|11353056|FG000|NOT COMPLETED|Overall Study||0
10224978|NCT03902574|11353057|FG001|NOT COMPLETED|Overall Study||0
10224979|NCT03902574|11353058|FG002|NOT COMPLETED|Overall Study||1
10224980|NCT03914950|11353066|FG000|STARTED|Overall Study||174
10224981|NCT03914950|11353066|FG000|COMPLETED|Overall Study||120
10224982|NCT03914950|11353066|FG000|NOT COMPLETED|Overall Study||54
10224983|NCT03911843|11353078|FG000|STARTED|Overall Study||26
10224984|NCT03911843|11353079|FG001|STARTED|Overall Study||38
10224985|NCT03911843|11353078|FG000|COMPLETED|Overall Study||22
10224986|NCT03911843|11353079|FG001|COMPLETED|Overall Study||37
10224987|NCT03911843|11353078|FG000|NOT COMPLETED|Overall Study||4
10224988|NCT03911843|11353079|FG001|NOT COMPLETED|Overall Study||1
10224989|NCT03896633|11353087|FG000|STARTED|Overall Study||321
10224990|NCT03896633|11353088|FG001|STARTED|Overall Study||316
10224991|NCT03896633|11353087|FG000|COMPLETED|Overall Study||312
10224992|NCT03896633|11353088|FG001|COMPLETED|Overall Study||306
10224993|NCT03896633|11353087|FG000|NOT COMPLETED|Overall Study||9
10224994|NCT03896633|11353088|FG001|NOT COMPLETED|Overall Study||10
10224995|NCT03894813|11353096|FG000|STARTED|Overall Study||63
10224996|NCT03894813|11353097|FG001|STARTED|Overall Study||63
10224997|NCT03894813|11353096|FG000|COMPLETED|Overall Study||52
10224998|NCT03894813|11353097|FG001|COMPLETED|Overall Study||47
10224999|NCT03894813|11353096|FG000|NOT COMPLETED|Overall Study||11
10225000|NCT03894813|11353097|FG001|NOT COMPLETED|Overall Study||16
10225001|NCT03911960|11353105|FG000|STARTED|Overall Study||9
10225002|NCT03911960|11353106|FG001|STARTED|Overall Study||5
10225003|NCT03911960|11353105|FG000|COMPLETED|Overall Study||4
10225004|NCT03911960|11353106|FG001|COMPLETED|Overall Study||2
10225005|NCT03911960|11353105|FG000|NOT COMPLETED|Overall Study||5
10225006|NCT03911960|11353106|FG001|NOT COMPLETED|Overall Study||3
10225007|NCT03907072|11353116|FG000|STARTED|Overall Study||2
10225008|NCT03907072|11353117|FG001|STARTED|Overall Study||2
10225009|NCT03907072|11353118|FG002|STARTED|Overall Study||2
10225010|NCT03907072|11353116|FG000|COMPLETED|Overall Study||0
10225011|NCT03907072|11353117|FG001|COMPLETED|Overall Study||0
10225012|NCT03907072|11353118|FG002|COMPLETED|Overall Study||0
10225013|NCT03907072|11353116|FG000|NOT COMPLETED|Overall Study||2
10225014|NCT03907072|11353117|FG001|NOT COMPLETED|Overall Study||2
10225015|NCT03907072|11353118|FG002|NOT COMPLETED|Overall Study||2
10225016|NCT03906448|11353128|FG000|STARTED|Overall Study||1
10225017|NCT03906448|11353129|FG001|STARTED|Overall Study||0
10225018|NCT03906448|11353128|FG000|COMPLETED|Overall Study||1
10225019|NCT03906448|11353129|FG001|COMPLETED|Overall Study||0
10225020|NCT03906448|11353128|FG000|NOT COMPLETED|Overall Study||0
10225021|NCT03906448|11353129|FG001|NOT COMPLETED|Overall Study||0
10225022|NCT03911401|11353138|FG000|STARTED|Overall Study||83
10225023|NCT03911401|11353139|FG001|STARTED|Overall Study||85
10225024|NCT03911401|11353140|FG002|STARTED|Overall Study||83
10225025|NCT03911401|11353138|FG000|COMPLETED|Overall Study||76
10225026|NCT03911401|11353139|FG001|COMPLETED|Overall Study||76
10225027|NCT03911401|11353140|FG002|COMPLETED|Overall Study||58
10225028|NCT03911401|11353138|FG000|NOT COMPLETED|Overall Study||7
10225029|NCT03911401|11353139|FG001|NOT COMPLETED|Overall Study||9
10225030|NCT03911401|11353140|FG002|NOT COMPLETED|Overall Study||25
10225031|NCT03909763|11353148|FG000|STARTED|Overall Study||55
10225032|NCT03909763|11353148|FG000|COMPLETED|Overall Study||45
10225033|NCT03909763|11353148|FG000|NOT COMPLETED|Overall Study||10
10225034|NCT03909009|11353154|FG000|STARTED|Overall Study||10
10225035|NCT03909009|11353155|FG001|STARTED|Overall Study||10
10225036|NCT03909009|11353154|FG000|COMPLETED|Overall Study||10
10225037|NCT03909009|11353155|FG001|COMPLETED|Overall Study||10
10225038|NCT03909009|11353154|FG000|NOT COMPLETED|Overall Study||0
10225039|NCT03909009|11353155|FG001|NOT COMPLETED|Overall Study||0
10225040|NCT03906968|11353161|FG000|STARTED|Overall Study||40
10225041|NCT03906968|11353161|FG000|COMPLETED|Overall Study||40
10225042|NCT03906968|11353161|FG000|NOT COMPLETED|Overall Study||0
10225043|NCT03904420|11353167|FG000|STARTED|Overall Study||2
10225044|NCT03904420|11353168|FG001|STARTED|Overall Study||2
10225045|NCT03904420|11353167|FG000|COMPLETED|Overall Study||0
10225046|NCT03904420|11353168|FG001|COMPLETED|Overall Study||0
10225047|NCT03904420|11353167|FG000|NOT COMPLETED|Overall Study||2
10225048|NCT03904420|11353168|FG001|NOT COMPLETED|Overall Study||2
10225049|NCT03903822|11353182|FG000|STARTED|Treatment Phase (6 Weeks)||37
10225050|NCT03903822|11353183|FG001|STARTED|Treatment Phase (6 Weeks)||37
10225051|NCT03903822|11353184|FG002|STARTED|Treatment Phase (6 Weeks)||36
10225052|NCT03903822|11353185|FG003|STARTED|Treatment Phase (6 Weeks)||37
10225053|NCT03903822|11353186|FG004|STARTED|Treatment Phase (6 Weeks)||36
10225054|NCT03903822|11353187|FG005|STARTED|Treatment Phase (6 Weeks)||36
10225055|NCT03903822|11353188|FG006|STARTED|Treatment Phase (6 Weeks)||36
10225056|NCT03903822|11353189|FG007|STARTED|Treatment Phase (6 Weeks)||37
10225057|NCT03903822|11353182|FG000|COMPLETED|Treatment Phase (6 Weeks)||28
10225058|NCT03903822|11353183|FG001|COMPLETED|Treatment Phase (6 Weeks)||27
10225059|NCT03903822|11353184|FG002|COMPLETED|Treatment Phase (6 Weeks)||33
10225060|NCT03903822|11353185|FG003|COMPLETED|Treatment Phase (6 Weeks)||32
10225061|NCT03903822|11353186|FG004|COMPLETED|Treatment Phase (6 Weeks)||31
10225062|NCT03903822|11353187|FG005|COMPLETED|Treatment Phase (6 Weeks)||25
10225063|NCT03903822|11353188|FG006|COMPLETED|Treatment Phase (6 Weeks)||31
10225064|NCT03903822|11353189|FG007|COMPLETED|Treatment Phase (6 Weeks)||33
10225065|NCT03903822|11353182|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9
10225066|NCT03903822|11353183|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10
10225067|NCT03903822|11353184|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3
10225068|NCT03903822|11353185|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5
10225069|NCT03903822|11353186|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5
10225070|NCT03903822|11353187|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11
10225071|NCT03903822|11353188|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5
10225072|NCT03903822|11353189|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4
10225073|NCT03903822|11353182|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10225074|NCT03903822|11353183|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10225075|NCT03903822|11353184|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10225076|NCT03903822|11353185|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10225077|NCT03903822|11353186|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10225078|NCT03903822|11353187|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10225079|NCT03903822|11353188|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10012846|NCT01787916|11135721|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0
10012847|NCT01787916|11135722|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0
10012848|NCT01787916|11135721|FG000|STARTED|Washout (4 Weeks)||8
10225080|NCT03903822|11353189|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10225081|NCT03903822|11353182|FG000|COMPLETED|Follow up Phase (4 Weeks)||29
10225082|NCT03903822|11353183|FG001|COMPLETED|Follow up Phase (4 Weeks)||29
10225083|NCT03903822|11353184|FG002|COMPLETED|Follow up Phase (4 Weeks)||32
10225084|NCT03903822|11353185|FG003|COMPLETED|Follow up Phase (4 Weeks)||33
10225085|NCT03903822|11353186|FG004|COMPLETED|Follow up Phase (4 Weeks)||32
10225086|NCT03903822|11353187|FG005|COMPLETED|Follow up Phase (4 Weeks)||28
10225087|NCT03903822|11353188|FG006|COMPLETED|Follow up Phase (4 Weeks)||31
10225088|NCT03903822|11353189|FG007|COMPLETED|Follow up Phase (4 Weeks)||31
10225089|NCT03903822|11353182|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8
10225090|NCT03903822|11353183|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8
10225091|NCT03903822|11353184|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4
10225092|NCT03903822|11353185|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4
10225093|NCT03903822|11353186|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4
10225094|NCT03903822|11353187|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8
10225095|NCT03903822|11353188|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5
10225096|NCT03903822|11353189|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6
10225097|NCT03905096|11353209|FG000|STARTED|Period 1 for Trial Part 1 and 2||18
10225098|NCT03905096|11353210|FG001|STARTED|Period 1 for Trial Part 1 and 2||14
10012849|NCT01787916|11135722|FG001|STARTED|Washout (4 Weeks)||7
10012850|NCT01787916|11135721|FG000|COMPLETED|Washout (4 Weeks)||8
10225099|NCT03905096|11353209|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18
10225100|NCT03905096|11353210|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14
10225101|NCT03905096|11353209|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
10225102|NCT03905096|11353210|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
10225103|NCT03905096|11353209|FG000|STARTED|Period 2 for Trial Part 1 and 2||18
10225104|NCT03905096|11353210|FG001|STARTED|Period 2 for Trial Part 1 and 2||14
10225105|NCT03905096|11353209|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17
10225106|NCT03905096|11353210|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14
10225107|NCT03905096|11353209|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
10225108|NCT03905096|11353210|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
10225109|NCT03899064|11353223|FG000|STARTED|Overall Study||58
10225110|NCT03899064|11353223|FG000|MC2-01 Cream, Irradiation|Overall Study||58
10225111|NCT03899064|11353223|FG000|MC2-01 Cream, No Irradiation|Overall Study||58
10225112|NCT03899064|11353223|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58
10225113|NCT03899064|11353223|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58
10225114|NCT03899064|11353223|FG000|Control, Irradiation|Overall Study||58
10225115|NCT03899064|11353223|FG000|COMPLETED|Overall Study||51
10225116|NCT03899064|11353223|FG000|NOT COMPLETED|Overall Study||7
10225117|NCT03903159|11353227|FG000|STARTED|Overall Study||15
10225118|NCT03903159|11353227|FG000|COMPLETED|Overall Study||10
10225119|NCT03903159|11353227|FG000|NOT COMPLETED|Overall Study||5
10225120|NCT03902392|11353233|FG000|STARTED|Overall Study||25
10225121|NCT03902392|11353234|FG001|STARTED|Overall Study||25
10225122|NCT03902392|11353233|FG000|COMPLETED|Overall Study||18
10225123|NCT03902392|11353234|FG001|COMPLETED|Overall Study||18
10225124|NCT03902392|11353233|FG000|NOT COMPLETED|Overall Study||7
10225125|NCT03902392|11353234|FG001|NOT COMPLETED|Overall Study||7
10225126|NCT03901105|11353240|FG000|STARTED|Overall Study||205
10225127|NCT03901105|11353240|FG000|COMPLETED|Overall Study||205
10225128|NCT03901105|11353240|FG000|NOT COMPLETED|Overall Study||0
10225129|NCT03895853|11353252|FG000|STARTED|Overall Study||0
10225130|NCT03895853|11353253|FG001|STARTED|Overall Study||2
10225131|NCT03895853|11353252|FG000|COMPLETED|Overall Study||0
10225132|NCT03895853|11353253|FG001|COMPLETED|Overall Study||2
10225133|NCT03895853|11353252|FG000|NOT COMPLETED|Overall Study||0
10225134|NCT03895853|11353253|FG001|NOT COMPLETED|Overall Study||0
10225135|NCT03901313|11353259|FG000|STARTED|Overall Study||4
10225136|NCT03901313|11353260|FG001|STARTED|Overall Study||4
10225137|NCT03901313|11353261|FG002|STARTED|Overall Study||4
10225138|NCT03901313|11353262|FG003|STARTED|Overall Study||4
10225139|NCT03901313|11353263|FG004|STARTED|Overall Study||4
10225140|NCT03901313|11353264|FG005|STARTED|Overall Study||4
10225141|NCT03901313|11353259|FG000|COMPLETED|Overall Study||4
10225142|NCT03901313|11353260|FG001|COMPLETED|Overall Study||4
10225143|NCT03901313|11353261|FG002|COMPLETED|Overall Study||4
10225144|NCT03901313|11353262|FG003|COMPLETED|Overall Study||4
10225145|NCT03901313|11353263|FG004|COMPLETED|Overall Study||4
10225146|NCT03901313|11353264|FG005|COMPLETED|Overall Study||4
10225147|NCT03901313|11353259|FG000|NOT COMPLETED|Overall Study||0
10225148|NCT03901313|11353260|FG001|NOT COMPLETED|Overall Study||0
10225149|NCT03901313|11353261|FG002|NOT COMPLETED|Overall Study||0
10225150|NCT03901313|11353262|FG003|NOT COMPLETED|Overall Study||0
10225151|NCT03901313|11353263|FG004|NOT COMPLETED|Overall Study||0
10225152|NCT03901313|11353264|FG005|NOT COMPLETED|Overall Study||0
10225153|NCT03901092|11353272|FG000|STARTED|Overall Study||83
10225154|NCT03901092|11353273|FG001|STARTED|Overall Study||159
10225155|NCT03901092|11353272|FG000|COMPLETED|Overall Study||83
10225156|NCT03901092|11353273|FG001|COMPLETED|Overall Study||159
10225157|NCT03901092|11353272|FG000|NOT COMPLETED|Overall Study||0
10225158|NCT03901092|11353273|FG001|NOT COMPLETED|Overall Study||0
9760906|NCT00384059|10864716|FG000|COMPLETED|After Infant Series||131
9760907|NCT00384059|10864717|FG001|COMPLETED|After Infant Series||122
9760908|NCT00384059|10864716|FG000|NOT COMPLETED|After Infant Series||4
9760909|NCT00384059|10864717|FG001|NOT COMPLETED|After Infant Series||10
9760910|NCT00384059|10864716|FG000|STARTED|Toddler Dose||131
9760911|NCT00384059|10864717|FG001|STARTED|Toddler Dose||122
9760912|NCT00384059|10864716|FG000|COMPLETED|Toddler Dose||130
9760913|NCT00384059|10864717|FG001|COMPLETED|Toddler Dose||120
9760914|NCT00384059|10864716|FG000|NOT COMPLETED|Toddler Dose||1
9760915|NCT00384059|10864717|FG001|NOT COMPLETED|Toddler Dose||2
9760916|NCT00384085|10864747|FG000|STARTED|Overall Study|Randomized|195
9760917|NCT00384085|10864748|FG001|STARTED|Overall Study|Randomized|196
10225159|NCT03900728|11353290|FG000|STARTED|Overall Study||40
10225160|NCT03900728|11353291|FG001|STARTED|Overall Study||57
10225161|NCT03900728|11353292|FG002|STARTED|Overall Study||39
10225162|NCT03900728|11353290|FG000|COMPLETED|Overall Study||40
10225163|NCT03900728|11353291|FG001|COMPLETED|Overall Study||57
10225164|NCT03900728|11353292|FG002|COMPLETED|Overall Study||35
10225165|NCT03900728|11353290|FG000|NOT COMPLETED|Overall Study||0
10225166|NCT03900728|11353291|FG001|NOT COMPLETED|Overall Study||0
10225167|NCT03900728|11353292|FG002|NOT COMPLETED|Overall Study||4
10225168|NCT03900299|11353302|FG000|STARTED|Overall Study||56
10225169|NCT03900299|11353303|FG001|STARTED|Overall Study||58
10225170|NCT03900299|11353302|FG000|COMPLETED|Overall Study||56
10225171|NCT03900299|11353303|FG001|COMPLETED|Overall Study||58
10225172|NCT03900299|11353302|FG000|NOT COMPLETED|Overall Study||0
10225173|NCT03900299|11353303|FG001|NOT COMPLETED|Overall Study||0
10225174|NCT03898349|11353312|FG000|STARTED|Overall Study||125
10225175|NCT03898349|11353313|FG001|STARTED|Overall Study||625
10225176|NCT03898349|11353312|FG000|COMPLETED|Overall Study||15
10225177|NCT03898349|11353313|FG001|COMPLETED|Overall Study||15
10225178|NCT03898349|11353312|FG000|NOT COMPLETED|Overall Study||110
10225179|NCT03898349|11353313|FG001|NOT COMPLETED|Overall Study||610
10225180|NCT03897634|11353319|FG000|STARTED|Overall Study||22
10225181|NCT03897634|11353319|FG000|COMPLETED|Overall Study||22
10225182|NCT03897634|11353319|FG000|NOT COMPLETED|Overall Study||0
10225183|NCT03895372|11353331|FG000|STARTED|Investigational Treatment Period||23
10225184|NCT03895372|11353332|FG001|STARTED|Investigational Treatment Period||22
10225185|NCT03895372|11353333|FG002|STARTED|Investigational Treatment Period||11
10225186|NCT03895372|11353334|FG003|STARTED|Investigational Treatment Period||11
10225187|NCT03895372|11353335|FG004|STARTED|Investigational Treatment Period||12
10225188|NCT03895372|11353336|FG005|STARTED|Investigational Treatment Period||11
10225189|NCT03895372|11353337|FG006|STARTED|Investigational Treatment Period||45
10225190|NCT03895372|11353338|FG007|STARTED|Investigational Treatment Period||43
10225191|NCT03895372|11353331|FG000|COMPLETED|Investigational Treatment Period||19
10225192|NCT03895372|11353332|FG001|COMPLETED|Investigational Treatment Period||19
10225193|NCT03895372|11353333|FG002|COMPLETED|Investigational Treatment Period||10
10225194|NCT03895372|11353334|FG003|COMPLETED|Investigational Treatment Period||9
10225195|NCT03895372|11353335|FG004|COMPLETED|Investigational Treatment Period||12
10225196|NCT03895372|11353336|FG005|COMPLETED|Investigational Treatment Period||9
10225197|NCT03895372|11353337|FG006|COMPLETED|Investigational Treatment Period||37
10225198|NCT03895372|11353338|FG007|COMPLETED|Investigational Treatment Period||38
10225199|NCT03895372|11353331|FG000|NOT COMPLETED|Investigational Treatment Period||4
10225200|NCT03895372|11353332|FG001|NOT COMPLETED|Investigational Treatment Period||3
10225201|NCT03895372|11353333|FG002|NOT COMPLETED|Investigational Treatment Period||1
10225202|NCT03895372|11353334|FG003|NOT COMPLETED|Investigational Treatment Period||2
10225203|NCT03895372|11353335|FG004|NOT COMPLETED|Investigational Treatment Period||0
10225204|NCT03895372|11353336|FG005|NOT COMPLETED|Investigational Treatment Period||2
10225205|NCT03895372|11353337|FG006|NOT COMPLETED|Investigational Treatment Period||8
10225206|NCT03895372|11353338|FG007|NOT COMPLETED|Investigational Treatment Period||5
10225207|NCT03895372|11353331|FG000|STARTED|Extension Treatment Period||19
10225208|NCT03895372|11353332|FG001|STARTED|Extension Treatment Period||19
10225209|NCT03895372|11353333|FG002|STARTED|Extension Treatment Period||10
10225210|NCT03895372|11353334|FG003|STARTED|Extension Treatment Period||9
10225211|NCT03895372|11353335|FG004|STARTED|Extension Treatment Period||12
10225212|NCT03895372|11353336|FG005|STARTED|Extension Treatment Period||9
10225213|NCT03895372|11353337|FG006|STARTED|Extension Treatment Period||37
10225214|NCT03895372|11353338|FG007|STARTED|Extension Treatment Period||38
10225215|NCT03895372|11353331|FG000|COMPLETED|Extension Treatment Period||16
10225216|NCT03895372|11353332|FG001|COMPLETED|Extension Treatment Period||14
10225217|NCT03895372|11353333|FG002|COMPLETED|Extension Treatment Period||10
10225218|NCT03895372|11353334|FG003|COMPLETED|Extension Treatment Period||8
10225219|NCT03895372|11353335|FG004|COMPLETED|Extension Treatment Period||9
10225220|NCT03895372|11353336|FG005|COMPLETED|Extension Treatment Period||8
10225221|NCT03895372|11353337|FG006|COMPLETED|Extension Treatment Period||33
10225222|NCT03895372|11353338|FG007|COMPLETED|Extension Treatment Period||32
10225223|NCT03895372|11353331|FG000|NOT COMPLETED|Extension Treatment Period||3
10225224|NCT03895372|11353332|FG001|NOT COMPLETED|Extension Treatment Period||5
10225225|NCT03895372|11353333|FG002|NOT COMPLETED|Extension Treatment Period||0
10225226|NCT03895372|11353334|FG003|NOT COMPLETED|Extension Treatment Period||1
10225227|NCT03895372|11353335|FG004|NOT COMPLETED|Extension Treatment Period||3
10225228|NCT03895372|11353336|FG005|NOT COMPLETED|Extension Treatment Period||1
10225229|NCT03895372|11353337|FG006|NOT COMPLETED|Extension Treatment Period||4
10225230|NCT03895372|11353338|FG007|NOT COMPLETED|Extension Treatment Period||6
10225231|NCT03896022|11353364|FG000|STARTED|Overall Study||74
10225232|NCT03896022|11353365|FG001|STARTED|Overall Study||51
10225233|NCT03896022|11353366|FG002|STARTED|Overall Study||52
10225234|NCT03896022|11353364|FG000|COMPLETED|Overall Study||70
10225235|NCT03896022|11353365|FG001|COMPLETED|Overall Study||51
10225236|NCT03896022|11353366|FG002|COMPLETED|Overall Study||52
10225237|NCT03896022|11353364|FG000|NOT COMPLETED|Overall Study||4
10225238|NCT03896022|11353365|FG001|NOT COMPLETED|Overall Study||0
10225239|NCT03896022|11353366|FG002|NOT COMPLETED|Overall Study||0
10225240|NCT03891862|11353378|FG000|STARTED|Open-label Period||135
10225241|NCT03891862|11353379|FG001|STARTED|Open-label Period||0
10225242|NCT03891862|11353380|FG002|STARTED|Open-label Period||0
10225243|NCT03891862|11353378|FG000|Safety Analysis Set|Open-label Period||132
10225244|NCT03891862|11353379|FG001|Safety Analysis Set|Open-label Period||0
10225245|NCT03891862|11353380|FG002|Safety Analysis Set|Open-label Period||0
10225246|NCT03891862|11353378|FG000|COMPLETED|Open-label Period||119
10225247|NCT03891862|11353379|FG001|COMPLETED|Open-label Period||0
10225248|NCT03891862|11353380|FG002|COMPLETED|Open-label Period||0
10225249|NCT03891862|11353378|FG000|NOT COMPLETED|Open-label Period||16
10225250|NCT03891862|11353379|FG001|NOT COMPLETED|Open-label Period||0
10225251|NCT03891862|11353380|FG002|NOT COMPLETED|Open-label Period||0
10225252|NCT03891862|11353378|FG000|STARTED|Placebo-controlled Period and Follow-up||0
10225253|NCT03891862|11353379|FG001|STARTED|Placebo-controlled Period and Follow-up||59
10225254|NCT03891862|11353380|FG002|STARTED|Placebo-controlled Period and Follow-up||59
10225255|NCT03891862|11353378|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
10225256|NCT03891862|11353379|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
10225257|NCT03891862|11353380|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
10239839|NCT04422210|11371591|FG006|STARTED|Overall Study||0
10225258|NCT03891862|11353378|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
10225259|NCT03891862|11353379|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
10225260|NCT03891862|11353380|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
10225261|NCT03891862|11353378|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0
10225262|NCT03891862|11353379|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53
10225263|NCT03891862|11353380|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55
10225264|NCT03891862|11353378|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
10225265|NCT03891862|11353379|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
10225266|NCT03891862|11353380|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
10225267|NCT03894449|11353392|FG000|STARTED|Overall Study||15
10225268|NCT03894449|11353393|FG001|STARTED|Overall Study||15
10225269|NCT03894449|11353394|FG002|STARTED|Overall Study||15
10225270|NCT03894449|11353395|FG003|STARTED|Overall Study||15
10225271|NCT03894449|11353396|FG004|STARTED|Overall Study||15
10225272|NCT03894449|11353392|FG000|COMPLETED|Overall Study||15
10225273|NCT03894449|11353393|FG001|COMPLETED|Overall Study||15
10225274|NCT03894449|11353394|FG002|COMPLETED|Overall Study||15
10225275|NCT03894449|11353395|FG003|COMPLETED|Overall Study||15
10225276|NCT03894449|11353396|FG004|COMPLETED|Overall Study||15
10225277|NCT03894449|11353392|FG000|NOT COMPLETED|Overall Study||0
10225278|NCT03894449|11353393|FG001|NOT COMPLETED|Overall Study||0
10225279|NCT03894449|11353394|FG002|NOT COMPLETED|Overall Study||0
10225280|NCT03894449|11353395|FG003|NOT COMPLETED|Overall Study||0
10225281|NCT03894449|11353396|FG004|NOT COMPLETED|Overall Study||0
10225282|NCT03892564|11353408|FG000|STARTED|Overall Study||35
10225283|NCT03892564|11353408|FG000|MC2-01 Cream + Irridiation|Overall Study||35
10225284|NCT03892564|11353408|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35
10225285|NCT03892564|11353408|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35
10225286|NCT03892564|11353408|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35
10225287|NCT03892564|11353408|FG000|Control Site|Overall Study||35
10225288|NCT03892564|11353408|FG000|COMPLETED|Overall Study||33
10225289|NCT03892564|11353408|FG000|NOT COMPLETED|Overall Study||2
10225290|NCT03892707|11353415|FG000|STARTED|Overall Study||250
10225291|NCT03892707|11353416|FG001|STARTED|Overall Study||250
10225292|NCT03892707|11353415|FG000|Started Study Treatment at Baseline|Overall Study||244
10225293|NCT03892707|11353416|FG001|Started Study Treatment at Baseline|Overall Study||250
10225294|NCT03892707|11353415|FG000|COMPLETED|Overall Study||244
10225295|NCT03892707|11353416|FG001|COMPLETED|Overall Study||244
10225296|NCT03892707|11353415|FG000|NOT COMPLETED|Overall Study||6
10225297|NCT03892707|11353416|FG001|NOT COMPLETED|Overall Study||6
10225298|NCT03892460|11353425|FG000|STARTED|Overall Study||30
10225299|NCT03892460|11353426|FG001|STARTED|Overall Study||24
10225300|NCT03892460|11353425|FG000|Randomization|Overall Study||25
10225301|NCT03892460|11353426|FG001|Randomization|Overall Study||20
10225302|NCT03892460|11353425|FG000|COMPLETED|Overall Study||18
10225303|NCT03892460|11353426|FG001|COMPLETED|Overall Study||19
10225304|NCT03892460|11353425|FG000|NOT COMPLETED|Overall Study||12
10225305|NCT03892460|11353426|FG001|NOT COMPLETED|Overall Study||5
10225306|NCT03891641|11353435|FG000|STARTED|Overall Study||10
10225307|NCT03891641|11353436|FG001|STARTED|Overall Study||7
10225308|NCT03891641|11353435|FG000|COMPLETED|Overall Study||8
10225309|NCT03891641|11353436|FG001|COMPLETED|Overall Study||5
10225310|NCT03891641|11353435|FG000|NOT COMPLETED|Overall Study||2
10225311|NCT03891641|11353436|FG001|NOT COMPLETED|Overall Study||2
10225312|NCT03889704|11353442|FG000|STARTED|Overall Study||2
10225313|NCT03889704|11353442|FG000|COMPLETED|Overall Study||1
10225314|NCT03889704|11353442|FG000|NOT COMPLETED|Overall Study||1
10225315|NCT03889444|11353446|FG000|STARTED|Overall Study||141
10225316|NCT03889444|11353446|FG000|COMPLETED|Overall Study||141
10225317|NCT03889444|11353446|FG000|NOT COMPLETED|Overall Study||0
10225318|NCT03888755|11353450|FG000|STARTED|Overall Study||8
10225319|NCT03888755|11353450|FG000|COMPLETED|Overall Study||8
10225320|NCT03888755|11353450|FG000|NOT COMPLETED|Overall Study||0
10225321|NCT03888391|11353456|FG000|STARTED|Overall Study||18
10225322|NCT03888391|11353456|FG000|COMPLETED|Overall Study||3
10225323|NCT03888391|11353456|FG000|NOT COMPLETED|Overall Study||15
10225324|NCT03888482|11353462|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76
10225325|NCT03888482|11353463|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75
10225326|NCT03888482|11353462|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76
10225327|NCT03888482|11353463|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75
10225328|NCT03888482|11353462|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10225329|NCT03888482|11353463|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10225330|NCT03888482|11353462|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
10225331|NCT03888482|11353463|FG001|STARTED|Second Wear (8 -1/+2 Days)||75
10225332|NCT03888482|11353462|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73
10225333|NCT03888482|11353463|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74
10225334|NCT03888482|11353462|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
10225335|NCT03888482|11353463|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
10225336|NCT03888274|11353471|FG000|STARTED|Overall Study||30
10225337|NCT03888274|11353471|FG000|COMPLETED|Overall Study||30
10225338|NCT03888274|11353471|FG000|NOT COMPLETED|Overall Study||0
10225339|NCT03888365|11353477|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20
10225340|NCT03888365|11353478|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23
10225341|NCT03888365|11353477|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
10225342|NCT03888365|11353478|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
10225343|NCT03888365|11353477|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
10225344|NCT03888365|11353478|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
10225345|NCT03888365|11353477|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
10225346|NCT03888365|11353478|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
10225347|NCT03888365|11353477|FG000|STARTED|Rest - At Least 1 h||20
10225348|NCT03888365|11353478|FG001|STARTED|Rest - At Least 1 h||23
10225349|NCT03888365|11353477|FG000|COMPLETED|Rest - At Least 1 h||20
10225350|NCT03888365|11353478|FG001|COMPLETED|Rest - At Least 1 h||23
10225351|NCT03888365|11353477|FG000|NOT COMPLETED|Rest - At Least 1 h||0
10225352|NCT03888365|11353478|FG001|NOT COMPLETED|Rest - At Least 1 h||0
10225353|NCT03888365|11353477|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20
10225354|NCT03888365|11353478|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23
10225355|NCT03888365|11353477|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
10225356|NCT03888365|11353478|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
10225357|NCT03888365|11353477|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
10225358|NCT03888365|11353478|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
10225359|NCT03888469|11353487|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46
10225360|NCT03888469|11353488|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46
10225361|NCT03888469|11353487|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46
10225362|NCT03888469|11353488|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46
10225363|NCT03888469|11353487|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10225364|NCT03888469|11353488|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10225365|NCT03888469|11353487|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46
10225366|NCT03888469|11353488|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46
10225367|NCT03888469|11353487|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
10225368|NCT03888469|11353488|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
10225369|NCT03888469|11353487|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
10225370|NCT03888469|11353488|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
10225371|NCT03887442|11353498|FG000|STARTED|Overall Study||9
10225372|NCT03887442|11353499|FG001|STARTED|Overall Study||8
10225373|NCT03887442|11353498|FG000|COMPLETED|Overall Study||8
10225374|NCT03887442|11353499|FG001|COMPLETED|Overall Study||8
10225375|NCT03887442|11353498|FG000|NOT COMPLETED|Overall Study||1
10225376|NCT03887442|11353499|FG001|NOT COMPLETED|Overall Study||0
10225377|NCT03887286|11353507|FG000|STARTED|Overall Study||47
10225378|NCT03887286|11353507|FG000|COMPLETED|Overall Study||47
10225379|NCT03887286|11353507|FG000|NOT COMPLETED|Overall Study||0
10225380|NCT03881007|11353514|FG000|STARTED|First 3 Months||172
10225381|NCT03881007|11353515|FG001|STARTED|First 3 Months||171
10225382|NCT03881007|11353514|FG000|COMPLETED|First 3 Months||121
10225383|NCT03881007|11353515|FG001|COMPLETED|First 3 Months||119
10225384|NCT03881007|11353514|FG000|NOT COMPLETED|First 3 Months||51
10225385|NCT03881007|11353515|FG001|NOT COMPLETED|First 3 Months||52
10225386|NCT03881007|11353514|FG000|STARTED|Last 3 Months||121
10225387|NCT03881007|11353515|FG001|STARTED|Last 3 Months||119
10225388|NCT03881007|11353514|FG000|COMPLETED|Last 3 Months||77
10225389|NCT03881007|11353515|FG001|COMPLETED|Last 3 Months||74
10225390|NCT03881007|11353514|FG000|NOT COMPLETED|Last 3 Months||44
10225391|NCT03881007|11353515|FG001|NOT COMPLETED|Last 3 Months||45
10225392|NCT03878602|11353523|FG000|STARTED|Overall Study||75
10225393|NCT03878602|11353524|FG001|STARTED|Overall Study||67
10225394|NCT03878602|11353523|FG000|COMPLETED|Overall Study||66
10225395|NCT03878602|11353524|FG001|COMPLETED|Overall Study||66
10225396|NCT03878602|11353523|FG000|NOT COMPLETED|Overall Study||9
10225397|NCT03878602|11353524|FG001|NOT COMPLETED|Overall Study||1
10225398|NCT03875118|11353534|FG000|STARTED|Overall Study||34
10225399|NCT03875118|11353535|FG001|STARTED|Overall Study||34
10225400|NCT03875118|11353534|FG000|COMPLETED|Overall Study||30
10012851|NCT01787916|11135722|FG001|COMPLETED|Washout (4 Weeks)||7
10012852|NCT01787916|11135721|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10012853|NCT01787916|11135722|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10012854|NCT01787916|11135721|FG000|STARTED|Second Intervention (24 Weeks)||8
10225401|NCT03875118|11353535|FG001|COMPLETED|Overall Study||30
10225402|NCT03875118|11353534|FG000|NOT COMPLETED|Overall Study||4
10225403|NCT03875118|11353535|FG001|NOT COMPLETED|Overall Study||4
10225404|NCT03873987|11353543|FG000|STARTED|Overall Study||52
10225405|NCT03873987|11353544|FG001|STARTED|Overall Study||50
10225406|NCT03873987|11353543|FG000|COMPLETED|Overall Study||50
10225407|NCT03873987|11353544|FG001|COMPLETED|Overall Study||49
10225408|NCT03873987|11353543|FG000|NOT COMPLETED|Overall Study||2
10225409|NCT03873987|11353544|FG001|NOT COMPLETED|Overall Study||1
10239298|NCT00301080|11370815|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10239299|NCT00299195|11370826|FG000|STARTED|Overall Study||30
10239300|NCT00299195|11370827|FG001|STARTED|Overall Study||33
10239301|NCT00299195|11370826|FG000|COMPLETED|Overall Study||30
10239302|NCT00299195|11370827|FG001|COMPLETED|Overall Study||33
10239303|NCT00299195|11370826|FG000|NOT COMPLETED|Overall Study||0
10239304|NCT00299195|11370827|FG001|NOT COMPLETED|Overall Study||0
10239305|NCT00290407|11370833|FG000|STARTED|Overall Study||2
10239306|NCT00290407|11370833|FG000|COMPLETED|Overall Study||0
10239307|NCT00290407|11370833|FG000|NOT COMPLETED|Overall Study||2
10239308|NCT00295490|11370841|FG000|STARTED|Overall Study||15
10239309|NCT00295490|11370842|FG001|STARTED|Overall Study||19
10239310|NCT00295490|11370843|FG002|STARTED|Overall Study||16
10239311|NCT00295490|11370844|FG003|STARTED|Overall Study||17
10225410|NCT03870893|11353553|FG000|STARTED|Overall Study||23
10225411|NCT03870893|11353554|FG001|STARTED|Overall Study||24
10225412|NCT03870893|11353553|FG000|COMPLETED|Overall Study||23
10225413|NCT03870893|11353554|FG001|COMPLETED|Overall Study||23
10225414|NCT03870893|11353553|FG000|NOT COMPLETED|Overall Study||0
10225415|NCT03870893|11353554|FG001|NOT COMPLETED|Overall Study||1
10225416|NCT03887299|11353563|FG000|STARTED|Overall Study||77
10225417|NCT03887299|11353564|FG001|STARTED|Overall Study||77
10225418|NCT03887299|11353563|FG000|COMPLETED|Overall Study||77
10225419|NCT03887299|11353564|FG001|COMPLETED|Overall Study||77
10225420|NCT03887299|11353563|FG000|NOT COMPLETED|Overall Study||0
10225421|NCT03887299|11353564|FG001|NOT COMPLETED|Overall Study||0
10225422|NCT03878758|11353570|FG000|STARTED|Overall Study||158
10225423|NCT03878758|11353570|FG000|COMPLETED|Overall Study||154
10225424|NCT03878758|11353570|FG000|NOT COMPLETED|Overall Study||4
10225425|NCT03849300|11353587|FG000|STARTED|Overall Study||42
10225426|NCT03849300|11353588|FG001|STARTED|Overall Study||42
10225427|NCT03849300|11353589|FG002|STARTED|Overall Study||32
10225428|NCT03849300|11353590|FG003|STARTED|Overall Study||31
10225429|NCT03849300|11353587|FG000|COMPLETED|Overall Study||37
10225430|NCT03849300|11353588|FG001|COMPLETED|Overall Study||35
10225431|NCT03849300|11353589|FG002|COMPLETED|Overall Study||28
10225432|NCT03849300|11353590|FG003|COMPLETED|Overall Study||25
10225433|NCT03849300|11353587|FG000|NOT COMPLETED|Overall Study||5
10225434|NCT03849300|11353588|FG001|NOT COMPLETED|Overall Study||7
10225435|NCT03849300|11353589|FG002|NOT COMPLETED|Overall Study||4
10225436|NCT03849300|11353590|FG003|NOT COMPLETED|Overall Study||6
10225437|NCT03887429|11353606|FG000|STARTED|Overall Study||8
10225438|NCT03887429|11353607|FG001|STARTED|Overall Study||9
10225439|NCT03887429|11353608|FG002|STARTED|Overall Study||9
10225440|NCT03887429|11353609|FG003|STARTED|Overall Study||8
10225441|NCT03887429|11353606|FG000|Completed First Intervention (5 Days)|Overall Study||7
10225442|NCT03887429|11353607|FG001|Completed First Intervention (5 Days)|Overall Study||8
10225443|NCT03887429|11353608|FG002|Completed First Intervention (5 Days)|Overall Study||7
10225444|NCT03887429|11353609|FG003|Completed First Intervention (5 Days)|Overall Study||7
10225445|NCT03887429|11353606|FG000|Completed Washout (9 Days)|Overall Study||7
10225446|NCT03887429|11353607|FG001|Completed Washout (9 Days)|Overall Study||8
10225447|NCT03887429|11353608|FG002|Completed Washout (9 Days)|Overall Study||7
10225448|NCT03887429|11353609|FG003|Completed Washout (9 Days)|Overall Study||7
10225449|NCT03887429|11353606|FG000|Completed Second Intervention (5 Days)|Overall Study||7
10225450|NCT03887429|11353607|FG001|Completed Second Intervention (5 Days)|Overall Study||8
10225451|NCT03887429|11353608|FG002|Completed Second Intervention (5 Days)|Overall Study||7
10225452|NCT03887429|11353609|FG003|Completed Second Intervention (5 Days)|Overall Study||7
10225453|NCT03887429|11353606|FG000|COMPLETED|Overall Study||7
10225454|NCT03887429|11353607|FG001|COMPLETED|Overall Study||8
10225455|NCT03887429|11353608|FG002|COMPLETED|Overall Study||7
10225456|NCT03887429|11353609|FG003|COMPLETED|Overall Study||7
10225457|NCT03887429|11353606|FG000|NOT COMPLETED|Overall Study||1
10225458|NCT03887429|11353607|FG001|NOT COMPLETED|Overall Study||1
10225459|NCT03887429|11353608|FG002|NOT COMPLETED|Overall Study||2
10225460|NCT03887429|11353609|FG003|NOT COMPLETED|Overall Study||1
10225461|NCT03886701|11353624|FG000|STARTED|Period 1: Study Days 1-4||11
10225462|NCT03886701|11353624|FG000|COMPLETED|Period 1: Study Days 1-4||11
10225463|NCT03886701|11353624|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0
10225464|NCT03886701|11353624|FG000|STARTED|Period 2: Study Days 7-21||11
10225465|NCT03886701|11353624|FG000|COMPLETED|Period 2: Study Days 7-21||11
10225466|NCT03886701|11353624|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0
10225467|NCT03883113|11353632|FG000|STARTED|Overall Study||87
10225468|NCT03883113|11353633|FG001|STARTED|Overall Study||58
10225469|NCT03883113|11353632|FG000|COMPLETED|Overall Study||71
10225470|NCT03883113|11353633|FG001|COMPLETED|Overall Study||46
10225471|NCT03883113|11353632|FG000|NOT COMPLETED|Overall Study||16
10225472|NCT03883113|11353633|FG001|NOT COMPLETED|Overall Study||12
10225473|NCT03880227|11353655|FG000|STARTED|First Visit||20
10225474|NCT03880227|11353656|FG001|STARTED|First Visit||21
10225475|NCT03880227|11353657|FG002|STARTED|First Visit||22
10225476|NCT03880227|11353658|FG003|STARTED|First Visit||18
10225477|NCT03880227|11353655|FG000|COMPLETED|First Visit||19
10225478|NCT03880227|11353656|FG001|COMPLETED|First Visit||21
10225479|NCT03880227|11353657|FG002|COMPLETED|First Visit||22
10225480|NCT03880227|11353658|FG003|COMPLETED|First Visit||18
10225481|NCT03880227|11353655|FG000|NOT COMPLETED|First Visit||1
10225482|NCT03880227|11353656|FG001|NOT COMPLETED|First Visit||0
10225483|NCT03880227|11353657|FG002|NOT COMPLETED|First Visit||0
10225484|NCT03880227|11353658|FG003|NOT COMPLETED|First Visit||0
10225485|NCT03880227|11353655|FG000|STARTED|1 Week Washout/ Delay||19
10225486|NCT03880227|11353656|FG001|STARTED|1 Week Washout/ Delay||21
10225487|NCT03880227|11353657|FG002|STARTED|1 Week Washout/ Delay||22
10225488|NCT03880227|11353658|FG003|STARTED|1 Week Washout/ Delay||18
10225489|NCT03880227|11353655|FG000|COMPLETED|1 Week Washout/ Delay||19
10225490|NCT03880227|11353656|FG001|COMPLETED|1 Week Washout/ Delay||20
10225491|NCT03880227|11353657|FG002|COMPLETED|1 Week Washout/ Delay||19
10225492|NCT03880227|11353658|FG003|COMPLETED|1 Week Washout/ Delay||18
10225493|NCT03880227|11353655|FG000|NOT COMPLETED|1 Week Washout/ Delay||0
10225494|NCT03880227|11353656|FG001|NOT COMPLETED|1 Week Washout/ Delay||1
10225495|NCT03880227|11353657|FG002|NOT COMPLETED|1 Week Washout/ Delay||3
10225496|NCT03880227|11353658|FG003|NOT COMPLETED|1 Week Washout/ Delay||0
10225497|NCT03880227|11353655|FG000|STARTED|Second Visit||19
10225498|NCT03880227|11353656|FG001|STARTED|Second Visit||20
10225499|NCT03880227|11353657|FG002|STARTED|Second Visit||19
10225500|NCT03880227|11353658|FG003|STARTED|Second Visit||18
10225501|NCT03880227|11353655|FG000|COMPLETED|Second Visit||19
10225502|NCT03880227|11353656|FG001|COMPLETED|Second Visit||20
10225503|NCT03880227|11353657|FG002|COMPLETED|Second Visit||19
10225504|NCT03880227|11353658|FG003|COMPLETED|Second Visit||18
10225505|NCT03880227|11353655|FG000|NOT COMPLETED|Second Visit||0
10225506|NCT03880227|11353656|FG001|NOT COMPLETED|Second Visit||0
10225507|NCT03880227|11353657|FG002|NOT COMPLETED|Second Visit||0
10225508|NCT03880227|11353658|FG003|NOT COMPLETED|Second Visit||0
10225509|NCT03876743|11353672|FG000|STARTED|Overall Study||54
10225510|NCT03876743|11353673|FG001|STARTED|Overall Study||51
10225511|NCT03876743|11353674|FG002|STARTED|Overall Study||46
10225512|NCT03876743|11353675|FG003|STARTED|Overall Study||50
10225513|NCT03876743|11353672|FG000|COMPLETED|Overall Study||48
10225514|NCT03876743|11353673|FG001|COMPLETED|Overall Study||47
10225515|NCT03876743|11353674|FG002|COMPLETED|Overall Study||42
10225516|NCT03876743|11353675|FG003|COMPLETED|Overall Study||43
10225517|NCT03876743|11353672|FG000|NOT COMPLETED|Overall Study||6
10225518|NCT03876743|11353673|FG001|NOT COMPLETED|Overall Study||4
10225519|NCT03876743|11353674|FG002|NOT COMPLETED|Overall Study||4
10225520|NCT03876743|11353675|FG003|NOT COMPLETED|Overall Study||7
10225521|NCT03885934|11353695|FG000|STARTED|Overall Study||64
10225522|NCT03885934|11353696|FG001|STARTED|Overall Study||64
10225523|NCT03885934|11353697|FG002|STARTED|Overall Study||62
10225524|NCT03885934|11353698|FG003|STARTED|Overall Study||64
10225525|NCT03885934|11353699|FG004|STARTED|Overall Study||177
10225526|NCT03885934|11353700|FG005|STARTED|Overall Study||175
10225527|NCT03885934|11353695|FG000|PCV Dose 1|Overall Study||64
10225528|NCT03885934|11353696|FG001|PCV Dose 1|Overall Study||64
10225529|NCT03885934|11353697|FG002|PCV Dose 1|Overall Study||62
10225530|NCT03885934|11353698|FG003|PCV Dose 1|Overall Study||64
10225531|NCT03885934|11353699|FG004|PCV Dose 1|Overall Study||177
10225532|NCT03885934|11353700|FG005|PCV Dose 1|Overall Study||175
10225533|NCT03885934|11353695|FG000|PCV Dose 2|Overall Study||63
10225534|NCT03885934|11353696|FG001|PCV Dose 2|Overall Study||64
10225535|NCT03885934|11353697|FG002|PCV Dose 2|Overall Study||62
10225536|NCT03885934|11353698|FG003|PCV Dose 2|Overall Study||64
10225537|NCT03885934|11353699|FG004|PCV Dose 2|Overall Study||0
10225538|NCT03885934|11353700|FG005|PCV Dose 2|Overall Study||0
10225539|NCT03885934|11353695|FG000|PCV Dose 3|Overall Study||63
10225540|NCT03885934|11353696|FG001|PCV Dose 3|Overall Study||64
10225541|NCT03885934|11353697|FG002|PCV Dose 3|Overall Study||0
10225542|NCT03885934|11353698|FG003|PCV Dose 3|Overall Study||0
10225543|NCT03885934|11353699|FG004|PCV Dose 3|Overall Study||0
10225544|NCT03885934|11353700|FG005|PCV Dose 3|Overall Study||0
10225545|NCT03885934|11353695|FG000|COMPLETED|Overall Study||63
10225546|NCT03885934|11353696|FG001|COMPLETED|Overall Study||64
10225547|NCT03885934|11353697|FG002|COMPLETED|Overall Study||62
10225548|NCT03885934|11353698|FG003|COMPLETED|Overall Study||64
10225549|NCT03885934|11353699|FG004|COMPLETED|Overall Study||177
10225550|NCT03885934|11353700|FG005|COMPLETED|Overall Study||175
10225551|NCT03885934|11353695|FG000|NOT COMPLETED|Overall Study||1
10225552|NCT03885934|11353696|FG001|NOT COMPLETED|Overall Study||0
10225553|NCT03885934|11353697|FG002|NOT COMPLETED|Overall Study||0
10225554|NCT03885934|11353698|FG003|NOT COMPLETED|Overall Study||0
10225555|NCT03885934|11353699|FG004|NOT COMPLETED|Overall Study||0
10012855|NCT01787916|11135722|FG001|STARTED|Second Intervention (24 Weeks)||7
10012856|NCT01787916|11135721|FG000|COMPLETED|Second Intervention (24 Weeks)||8
10012857|NCT01787916|11135722|FG001|COMPLETED|Second Intervention (24 Weeks)||7
10012858|NCT01787916|11135721|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
10012859|NCT01787916|11135722|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
10012860|NCT01788046|11135730|FG000|STARTED|Overall Study||260
10012861|NCT01788046|11135731|FG001|STARTED|Overall Study||255
10012862|NCT01788046|11135730|FG000|Received Treatment|Overall Study||259
10012863|NCT01788046|11135731|FG001|Received Treatment|Overall Study||252
10225556|NCT03885934|11353700|FG005|NOT COMPLETED|Overall Study||0
10225557|NCT03885726|11353714|FG000|STARTED|Overall Study||32
10225558|NCT03885726|11353714|FG000|COMPLETED|Overall Study||28
10225559|NCT03885726|11353714|FG000|NOT COMPLETED|Overall Study||4
10225560|NCT03885154|11353726|FG000|STARTED|Overall Study||12
10225561|NCT03885154|11353727|FG001|STARTED|Overall Study||10
10225562|NCT03885154|11353728|FG002|STARTED|Overall Study||0
10225563|NCT03885154|11353729|FG003|STARTED|Overall Study||2
10225564|NCT03885154|11353726|FG000|COMPLETED|Overall Study||12
10225565|NCT03885154|11353727|FG001|COMPLETED|Overall Study||10
10225566|NCT03885154|11353728|FG002|COMPLETED|Overall Study||0
10225567|NCT03885154|11353729|FG003|COMPLETED|Overall Study||2
10225568|NCT03885154|11353726|FG000|NOT COMPLETED|Overall Study||0
10225569|NCT03885154|11353727|FG001|NOT COMPLETED|Overall Study||0
10225570|NCT03885154|11353728|FG002|NOT COMPLETED|Overall Study||0
10225571|NCT03885154|11353729|FG003|NOT COMPLETED|Overall Study||0
10225572|NCT03883386|11353739|FG000|STARTED|First Assignment||2
10225573|NCT03883386|11353740|FG001|STARTED|First Assignment||1
10225574|NCT03883386|11353739|FG000|Surveys Begun|First Assignment||1
10225575|NCT03883386|11353740|FG001|Surveys Begun|First Assignment||1
10225576|NCT03883386|11353739|FG000|COMPLETED|First Assignment||0
10225577|NCT03883386|11353740|FG001|COMPLETED|First Assignment||0
10225578|NCT03883386|11353739|FG000|NOT COMPLETED|First Assignment||2
10225579|NCT03883386|11353740|FG001|NOT COMPLETED|First Assignment||1
10225580|NCT03883386|11353739|FG000|STARTED|Washout and Second Assignment||0
10225581|NCT03883386|11353740|FG001|STARTED|Washout and Second Assignment||0
10225582|NCT03883386|11353739|FG000|COMPLETED|Washout and Second Assignment||0
10225583|NCT03883386|11353740|FG001|COMPLETED|Washout and Second Assignment||0
10225584|NCT03883386|11353739|FG000|NOT COMPLETED|Washout and Second Assignment||0
10225585|NCT03883386|11353740|FG001|NOT COMPLETED|Washout and Second Assignment||0
10225586|NCT03882528|11353746|FG000|STARTED|Overall Study||12
10225587|NCT03882528|11353746|FG000|COMPLETED|Overall Study||12
10225588|NCT03882528|11353746|FG000|NOT COMPLETED|Overall Study||0
10225589|NCT03882801|11353752|FG000|STARTED|Period 1||12
10225590|NCT03882801|11353753|FG001|STARTED|Period 1||12
10225591|NCT03882801|11353752|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11
10225592|NCT03882801|11353753|FG001|Treated|Period 1||12
10225593|NCT03882801|11353752|FG000|COMPLETED|Period 1||10
10225594|NCT03882801|11353753|FG001|COMPLETED|Period 1||10
10225595|NCT03882801|11353752|FG000|NOT COMPLETED|Period 1||2
10225596|NCT03882801|11353753|FG001|NOT COMPLETED|Period 1||2
10225597|NCT03882801|11353752|FG000|STARTED|Washout Period||10
10225598|NCT03882801|11353753|FG001|STARTED|Washout Period||10
10225599|NCT03882801|11353752|FG000|COMPLETED|Washout Period||10
10225600|NCT03882801|11353753|FG001|COMPLETED|Washout Period||9
10225601|NCT03882801|11353752|FG000|NOT COMPLETED|Washout Period||0
10225602|NCT03882801|11353753|FG001|NOT COMPLETED|Washout Period||1
10225603|NCT03882801|11353752|FG000|STARTED|Period 2||10
10225604|NCT03882801|11353753|FG001|STARTED|Period 2||9
10225605|NCT03882801|11353752|FG000|COMPLETED|Period 2||10
10225606|NCT03882801|11353753|FG001|COMPLETED|Period 2||8
10225607|NCT03882801|11353752|FG000|NOT COMPLETED|Period 2||0
10225608|NCT03882801|11353753|FG001|NOT COMPLETED|Period 2||1
10225609|NCT03882424|11353764|FG000|STARTED|Overall Study||38
10225610|NCT03882424|11353765|FG001|STARTED|Overall Study||38
10225611|NCT03882424|11353766|FG002|STARTED|Overall Study||38
10225612|NCT03882424|11353764|FG000|COMPLETED|Overall Study||34
10225613|NCT03882424|11353765|FG001|COMPLETED|Overall Study||38
10225614|NCT03882424|11353766|FG002|COMPLETED|Overall Study||38
10225615|NCT03882424|11353764|FG000|NOT COMPLETED|Overall Study||4
10225616|NCT03882424|11353765|FG001|NOT COMPLETED|Overall Study||0
10225617|NCT03882424|11353766|FG002|NOT COMPLETED|Overall Study||0
10225618|NCT03881163|11353774|FG000|STARTED|Overall Study||24
10225619|NCT03881163|11353774|FG000|COMPLETED|Overall Study||24
10225620|NCT03881163|11353774|FG000|NOT COMPLETED|Overall Study||0
10225621|NCT03881670|11353782|FG000|STARTED|Overall Study||12
10225622|NCT03881670|11353783|FG001|STARTED|Overall Study||12
10225623|NCT03881670|11353782|FG000|Completed First Intervention|Overall Study||12
10225624|NCT03881670|11353783|FG001|Completed First Intervention|Overall Study||12
10225625|NCT03881670|11353782|FG000|Completed Second Intervetion|Overall Study||12
10225626|NCT03881670|11353783|FG001|Completed Second Intervetion|Overall Study||12
10225627|NCT03881670|11353782|FG000|COMPLETED|Overall Study||12
10225628|NCT03881670|11353783|FG001|COMPLETED|Overall Study||12
10225629|NCT03881670|11353782|FG000|NOT COMPLETED|Overall Study||0
10225630|NCT03881670|11353783|FG001|NOT COMPLETED|Overall Study||0
10225631|NCT03880266|11353799|FG000|STARTED|Overall Study||12
10225632|NCT03880266|11353800|FG001|STARTED|Overall Study||6
10225633|NCT03880266|11353801|FG002|STARTED|Overall Study||12
10225634|NCT03880266|11353802|FG003|STARTED|Overall Study||4
10225635|NCT03880266|11353803|FG004|STARTED|Overall Study||12
10225636|NCT03880266|11353804|FG005|STARTED|Overall Study||6
10225637|NCT03880266|11353805|FG006|STARTED|Overall Study||13
10225638|NCT03880266|11353806|FG007|STARTED|Overall Study||7
10225639|NCT03880266|11353799|FG000|COMPLETED|Overall Study||12
10225640|NCT03880266|11353800|FG001|COMPLETED|Overall Study||5
10225641|NCT03880266|11353801|FG002|COMPLETED|Overall Study||11
10225642|NCT03880266|11353802|FG003|COMPLETED|Overall Study||4
10225643|NCT03880266|11353803|FG004|COMPLETED|Overall Study||12
10225644|NCT03880266|11353804|FG005|COMPLETED|Overall Study||6
10225645|NCT03880266|11353805|FG006|COMPLETED|Overall Study||13
10225646|NCT03880266|11353806|FG007|COMPLETED|Overall Study||7
10225647|NCT03880266|11353799|FG000|NOT COMPLETED|Overall Study||0
10225648|NCT03880266|11353800|FG001|NOT COMPLETED|Overall Study||1
10225649|NCT03880266|11353801|FG002|NOT COMPLETED|Overall Study||1
10225650|NCT03880266|11353802|FG003|NOT COMPLETED|Overall Study||0
10225651|NCT03880266|11353803|FG004|NOT COMPLETED|Overall Study||0
10225652|NCT03880266|11353804|FG005|NOT COMPLETED|Overall Study||0
10225653|NCT03880266|11353805|FG006|NOT COMPLETED|Overall Study||0
10225654|NCT03880266|11353806|FG007|NOT COMPLETED|Overall Study||0
10225655|NCT03856320|11353826|FG000|STARTED|Overall Study||20
10225656|NCT03856320|11353827|FG001|STARTED|Overall Study||22
10225657|NCT03856320|11353826|FG000|COMPLETED|Overall Study||20
10225658|NCT03856320|11353827|FG001|COMPLETED|Overall Study||20
10225659|NCT03856320|11353826|FG000|NOT COMPLETED|Overall Study||0
10225660|NCT03856320|11353827|FG001|NOT COMPLETED|Overall Study||2
10225661|NCT03848871|11353833|FG000|STARTED|Overall Study||20
10225662|NCT03848871|11353833|FG000|COMPLETED|Overall Study||20
10225663|NCT03848871|11353833|FG000|NOT COMPLETED|Overall Study||0
10225664|NCT03880474|11353839|FG000|STARTED|Overall Study||1077
10225665|NCT03880474|11353840|FG001|STARTED|Overall Study||1075
10225666|NCT03880474|11353839|FG000|COMPLETED|Overall Study||1054
10225667|NCT03880474|11353840|FG001|COMPLETED|Overall Study||1055
10225668|NCT03880474|11353839|FG000|NOT COMPLETED|Overall Study||23
10225669|NCT03880474|11353840|FG001|NOT COMPLETED|Overall Study||20
10225670|NCT03878160|11353849|FG000|STARTED|Overall Study||7
10225671|NCT03878160|11353850|FG001|STARTED|Overall Study||9
10225672|NCT03878160|11353851|FG002|STARTED|Overall Study||11
10225673|NCT03878160|11353849|FG000|COMPLETED|Overall Study||5
10225674|NCT03878160|11353850|FG001|COMPLETED|Overall Study||8
10225675|NCT03878160|11353851|FG002|COMPLETED|Overall Study||10
10225676|NCT03878160|11353849|FG000|NOT COMPLETED|Overall Study||2
10225677|NCT03878160|11353850|FG001|NOT COMPLETED|Overall Study||1
10225678|NCT03878160|11353851|FG002|NOT COMPLETED|Overall Study||1
10225679|NCT03864627|11353861|FG000|STARTED|Overall Study||11
10225680|NCT03864627|11353862|FG001|STARTED|Overall Study||22
10225681|NCT03864627|11353861|FG000|COMPLETED|Overall Study||7
10225682|NCT03864627|11353862|FG001|COMPLETED|Overall Study||10
10225683|NCT03864627|11353861|FG000|NOT COMPLETED|Overall Study||4
10225684|NCT03864627|11353862|FG001|NOT COMPLETED|Overall Study||12
10225685|NCT03861000|11353871|FG000|STARTED|Overall Study||2
10225686|NCT03861000|11353872|FG001|STARTED|Overall Study||1
10225687|NCT03861000|11353871|FG000|COMPLETED|Overall Study||2
10225688|NCT03861000|11353872|FG001|COMPLETED|Overall Study||1
10225689|NCT03861000|11353871|FG000|NOT COMPLETED|Overall Study||0
10225690|NCT03861000|11353872|FG001|NOT COMPLETED|Overall Study||0
10225691|NCT03848403|11353877|FG000|STARTED|Period 1 (Day 1)||24
10225692|NCT03848403|11353878|FG001|STARTED|Period 1 (Day 1)||24
10225693|NCT03848403|11353879|FG002|STARTED|Period 1 (Day 1)||22
10225694|NCT03848403|11353877|FG000|Received Intervention|Period 1 (Day 1)||24
10225695|NCT03848403|11353878|FG001|Received Intervention|Period 1 (Day 1)||24
10225696|NCT03848403|11353879|FG002|Received Intervention|Period 1 (Day 1)||22
10225697|NCT03848403|11353877|FG000|COMPLETED|Period 1 (Day 1)||24
10225698|NCT03848403|11353878|FG001|COMPLETED|Period 1 (Day 1)||24
10225699|NCT03848403|11353879|FG002|COMPLETED|Period 1 (Day 1)||22
10225700|NCT03848403|11353877|FG000|NOT COMPLETED|Period 1 (Day 1)||0
10225701|NCT03848403|11353878|FG001|NOT COMPLETED|Period 1 (Day 1)||0
10225702|NCT03848403|11353879|FG002|NOT COMPLETED|Period 1 (Day 1)||0
10225703|NCT03848403|11353877|FG000|STARTED|Period 2 (Day 8)||24
10225704|NCT03848403|11353878|FG001|STARTED|Period 2 (Day 8)||24
10225705|NCT03848403|11353879|FG002|STARTED|Period 2 (Day 8)||22
10225706|NCT03848403|11353877|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
10225707|NCT03848403|11353878|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
10225708|NCT03848403|11353879|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
10225709|NCT03848403|11353877|FG000|COMPLETED|Period 2 (Day 8)||15
10225710|NCT03848403|11353878|FG001|COMPLETED|Period 2 (Day 8)||15
10225711|NCT03848403|11353879|FG002|COMPLETED|Period 2 (Day 8)||15
10225712|NCT03848403|11353877|FG000|NOT COMPLETED|Period 2 (Day 8)||9
10225713|NCT03848403|11353878|FG001|NOT COMPLETED|Period 2 (Day 8)||9
10225714|NCT03848403|11353879|FG002|NOT COMPLETED|Period 2 (Day 8)||7
10225715|NCT03848403|11353877|FG000|STARTED|Period 3 (Day 15)||15
10225716|NCT03848403|11353878|FG001|STARTED|Period 3 (Day 15)||15
10225717|NCT03848403|11353879|FG002|STARTED|Period 3 (Day 15)||15
10225718|NCT03848403|11353877|FG000|COMPLETED|Period 3 (Day 15)||15
10225719|NCT03848403|11353878|FG001|COMPLETED|Period 3 (Day 15)||15
10225720|NCT03848403|11353879|FG002|COMPLETED|Period 3 (Day 15)||15
10225721|NCT03848403|11353877|FG000|NOT COMPLETED|Period 3 (Day 15)||0
10225722|NCT03848403|11353878|FG001|NOT COMPLETED|Period 3 (Day 15)||0
10225723|NCT03848403|11353879|FG002|NOT COMPLETED|Period 3 (Day 15)||0
10225724|NCT03847233|11353887|FG000|STARTED|Index Procedure||31
10225725|NCT03847233|11353887|FG000|COMPLETED|Index Procedure||31
10225726|NCT03847233|11353887|FG000|NOT COMPLETED|Index Procedure||0
10225727|NCT03847233|11353887|FG000|STARTED|6 Month After Index Procedure||31
10225728|NCT03847233|11353887|FG000|COMPLETED|6 Month After Index Procedure||30
10225729|NCT03847233|11353887|FG000|NOT COMPLETED|6 Month After Index Procedure||1
10225730|NCT03879603|11353898|FG000|STARTED|Overall Study||5
10225731|NCT03879603|11353899|FG001|STARTED|Overall Study||5
10225732|NCT03879603|11353900|FG002|STARTED|Overall Study||5
10225733|NCT03879603|11353901|FG003|STARTED|Overall Study||5
10225734|NCT03879603|11353902|FG004|STARTED|Overall Study||5
10225735|NCT03879603|11353903|FG005|STARTED|Overall Study||5
10225736|NCT03879603|11353898|FG000|Received First Product Administration|Overall Study||5
10225737|NCT03879603|11353899|FG001|Received First Product Administration|Overall Study||5
10225738|NCT03879603|11353900|FG002|Received First Product Administration|Overall Study||5
10225739|NCT03879603|11353901|FG003|Received First Product Administration|Overall Study||5
10225740|NCT03879603|11353902|FG004|Received First Product Administration|Overall Study||5
10225741|NCT03879603|11353903|FG005|Received First Product Administration|Overall Study||5
10225742|NCT03879603|11353898|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
10225743|NCT03879603|11353899|FG001|Received All Product Administrations|Overall Study||5
10225744|NCT03879603|11353900|FG002|Received All Product Administrations|Overall Study||5
10225745|NCT03879603|11353901|FG003|Received All Product Administrations|Overall Study||5
10225746|NCT03879603|11353902|FG004|Received All Product Administrations|Overall Study||5
10225747|NCT03879603|11353903|FG005|Received All Product Administrations|Overall Study||5
10225748|NCT03879603|11353898|FG000|COMPLETED|Overall Study||5
10225749|NCT03879603|11353899|FG001|COMPLETED|Overall Study||5
10225750|NCT03879603|11353900|FG002|COMPLETED|Overall Study||5
10225751|NCT03879603|11353901|FG003|COMPLETED|Overall Study||5
10225752|NCT03879603|11353902|FG004|COMPLETED|Overall Study||5
10225753|NCT03879603|11353903|FG005|COMPLETED|Overall Study||5
10225754|NCT03879603|11353898|FG000|NOT COMPLETED|Overall Study||0
10225755|NCT03879603|11353899|FG001|NOT COMPLETED|Overall Study||0
10225756|NCT03879603|11353900|FG002|NOT COMPLETED|Overall Study||0
10225757|NCT03879603|11353901|FG003|NOT COMPLETED|Overall Study||0
10225758|NCT03879603|11353902|FG004|NOT COMPLETED|Overall Study||0
10225759|NCT03879603|11353903|FG005|NOT COMPLETED|Overall Study||0
10225760|NCT03878745|11353919|FG000|STARTED|Overall Study||55
10225761|NCT03878745|11353919|FG000|COMPLETED|Overall Study||55
10225762|NCT03878745|11353919|FG000|NOT COMPLETED|Overall Study||0
10225763|NCT03848221|11353934|FG000|STARTED|Overall Study||25
10225764|NCT03848221|11353935|FG001|STARTED|Overall Study||24
10225765|NCT03848221|11353936|FG002|STARTED|Overall Study||24
10225766|NCT03848221|11353934|FG000|COMPLETED|Overall Study||25
10225767|NCT03848221|11353935|FG001|COMPLETED|Overall Study||24
10225768|NCT03848221|11353936|FG002|COMPLETED|Overall Study||24
10225769|NCT03848221|11353934|FG000|NOT COMPLETED|Overall Study||0
10225770|NCT03848221|11353935|FG001|NOT COMPLETED|Overall Study||0
10225771|NCT03848221|11353936|FG002|NOT COMPLETED|Overall Study||0
10225772|NCT03878108|11353946|FG000|STARTED|Overall Study||11
10225773|NCT03878108|11353947|FG001|STARTED|Overall Study||10
10225774|NCT03878108|11353946|FG000|Completed First Phase|Overall Study||10
10225775|NCT03878108|11353947|FG001|Completed First Phase|Overall Study||10
10225776|NCT03878108|11353946|FG000|COMPLETED|Overall Study||10
10225777|NCT03878108|11353947|FG001|COMPLETED|Overall Study||10
10225778|NCT03878108|11353946|FG000|NOT COMPLETED|Overall Study||1
10225779|NCT03878108|11353947|FG001|NOT COMPLETED|Overall Study||0
10225780|NCT03877432|11353953|FG000|STARTED|Overall Study||10
10225781|NCT03877432|11353953|FG000|COMPLETED|Overall Study||10
10225782|NCT03877432|11353953|FG000|NOT COMPLETED|Overall Study||0
10225783|NCT03877237|11353963|FG000|STARTED|Overall Study||156
10225784|NCT03877237|11353964|FG001|STARTED|Overall Study||157
10225785|NCT03877237|11353963|FG000|Treated|Overall Study||156
10225786|NCT03877237|11353964|FG001|Treated|Overall Study||157
10225787|NCT03877237|11353963|FG000|COMPLETED|Overall Study||151
10225788|NCT03877237|11353964|FG001|COMPLETED|Overall Study||151
10225789|NCT03877237|11353963|FG000|NOT COMPLETED|Overall Study||5
10225790|NCT03877237|11353964|FG001|NOT COMPLETED|Overall Study||6
10225791|NCT03866434|11353970|FG000|STARTED|Overall Study||20
10225792|NCT03866434|11353970|FG000|COMPLETED|Overall Study||20
10225793|NCT03866434|11353970|FG000|NOT COMPLETED|Overall Study||0
10225794|NCT03863210|11353976|FG000|STARTED|Overall Study|March 1st, 2014.|104
10225795|NCT03863210|11353976|FG000|COMPLETED|Overall Study|September 1st, 2014.|102
10225796|NCT03863210|11353976|FG000|NOT COMPLETED|Overall Study||2
10225797|NCT03859323|11353993|FG000|STARTED|Overall Study||5
10225798|NCT03859323|11353994|FG001|STARTED|Overall Study||5
10225799|NCT03859323|11353995|FG002|STARTED|Overall Study||5
10225800|NCT03859323|11353996|FG003|STARTED|Overall Study||5
10225801|NCT03859323|11353997|FG004|STARTED|Overall Study||5
10225802|NCT03859323|11353998|FG005|STARTED|Overall Study||5
10225803|NCT03859323|11353999|FG006|STARTED|Overall Study||12
10225804|NCT03859323|11354000|FG007|STARTED|Overall Study||10
10225805|NCT03859323|11354001|FG008|STARTED|Overall Study||10
10225806|NCT03859323|11354002|FG009|STARTED|Overall Study||10
10225807|NCT03859323|11354003|FG010|STARTED|Overall Study||10
10225808|NCT03859323|11354004|FG011|STARTED|Overall Study||12
10225809|NCT03859323|11354005|FG012|STARTED|Overall Study||10
10225810|NCT03859323|11353993|FG000|COMPLETED|Overall Study||5
10225811|NCT03859323|11353994|FG001|COMPLETED|Overall Study||5
10225812|NCT03859323|11353995|FG002|COMPLETED|Overall Study||4
10225813|NCT03859323|11353996|FG003|COMPLETED|Overall Study||5
10225814|NCT03859323|11353997|FG004|COMPLETED|Overall Study||5
10225815|NCT03859323|11353998|FG005|COMPLETED|Overall Study||4
10225816|NCT03859323|11353999|FG006|COMPLETED|Overall Study||11
10225817|NCT03859323|11354000|FG007|COMPLETED|Overall Study||10
10225818|NCT03859323|11354001|FG008|COMPLETED|Overall Study||10
10225819|NCT03859323|11354002|FG009|COMPLETED|Overall Study||8
10225820|NCT03859323|11354003|FG010|COMPLETED|Overall Study||9
10225821|NCT03859323|11354004|FG011|COMPLETED|Overall Study||10
10225822|NCT03859323|11354005|FG012|COMPLETED|Overall Study||9
10225823|NCT03859323|11353993|FG000|NOT COMPLETED|Overall Study||0
10225824|NCT03859323|11353994|FG001|NOT COMPLETED|Overall Study||0
10225825|NCT03859323|11353995|FG002|NOT COMPLETED|Overall Study||1
10225826|NCT03859323|11353996|FG003|NOT COMPLETED|Overall Study||0
10225827|NCT03859323|11353997|FG004|NOT COMPLETED|Overall Study||0
10225828|NCT03859323|11353998|FG005|NOT COMPLETED|Overall Study||1
10225829|NCT03859323|11353999|FG006|NOT COMPLETED|Overall Study||1
10225830|NCT03859323|11354000|FG007|NOT COMPLETED|Overall Study||0
10225831|NCT03859323|11354001|FG008|NOT COMPLETED|Overall Study||0
10225832|NCT03859323|11354002|FG009|NOT COMPLETED|Overall Study||2
10225833|NCT03859323|11354003|FG010|NOT COMPLETED|Overall Study||1
10225834|NCT03859323|11354004|FG011|NOT COMPLETED|Overall Study||2
10225835|NCT03859323|11354005|FG012|NOT COMPLETED|Overall Study||1
10225836|NCT03867838|11354044|FG000|STARTED|Overall Study||6
10225837|NCT03867838|11354044|FG000|COMPLETED|Overall Study||6
10225838|NCT03867838|11354044|FG000|NOT COMPLETED|Overall Study||0
10225839|NCT03855059|11354050|FG000|STARTED|Overall Study||25
10225840|NCT03855059|11354051|FG001|STARTED|Overall Study||25
10225841|NCT03855059|11354050|FG000|COMPLETED|Overall Study||23
10225842|NCT03855059|11354051|FG001|COMPLETED|Overall Study||25
10225843|NCT03855059|11354050|FG000|NOT COMPLETED|Overall Study||2
10225844|NCT03855059|11354051|FG001|NOT COMPLETED|Overall Study||0
10225845|NCT03852537|11354059|FG000|STARTED|Overall Study||23
10225846|NCT03852537|11354060|FG001|STARTED|Overall Study||21
10225847|NCT03852537|11354059|FG000|COMPLETED|Overall Study||23
10225848|NCT03852537|11354060|FG001|COMPLETED|Overall Study||21
10225849|NCT03852537|11354059|FG000|NOT COMPLETED|Overall Study||0
10225850|NCT03852537|11354060|FG001|NOT COMPLETED|Overall Study||0
10225851|NCT03875859|11354066|FG000|STARTED|Overall Study||4
10225852|NCT03875859|11354066|FG000|COMPLETED|Overall Study||4
10012864|NCT01788046|11135730|FG000|COMPLETED|Overall Study||204
10012865|NCT01788046|11135731|FG001|COMPLETED|Overall Study||218
10012866|NCT01788046|11135730|FG000|NOT COMPLETED|Overall Study||56
10012867|NCT01788046|11135731|FG001|NOT COMPLETED|Overall Study||37
10012868|NCT01788150|11135739|FG000|STARTED|Overall Study||108
10012869|NCT01788150|11135740|FG001|STARTED|Overall Study||51
10012870|NCT01788150|11135739|FG000|COMPLETED|Overall Study||95
10012871|NCT01788150|11135740|FG001|COMPLETED|Overall Study||48
10012872|NCT01788150|11135739|FG000|NOT COMPLETED|Overall Study||13
10012873|NCT01788150|11135740|FG001|NOT COMPLETED|Overall Study||3
10012874|NCT01788163|11135755|FG000|STARTED|Overall Study||1458
10012875|NCT01788163|11135756|FG001|STARTED|Overall Study||271
10012876|NCT01788163|11135757|FG002|STARTED|Overall Study||62
10012877|NCT01788163|11135758|FG003|STARTED|Overall Study||71
10012878|NCT01788163|11135759|FG004|STARTED|Overall Study||94
10012879|NCT01788163|11135760|FG005|STARTED|Overall Study||102
10012880|NCT01788163|11135761|FG006|STARTED|Overall Study||50
10012881|NCT01788163|11135762|FG007|STARTED|Overall Study||302
10012882|NCT01788163|11135763|FG008|STARTED|Overall Study||972
10012883|NCT01788163|11135755|FG000|COMPLETED|Overall Study||1403
10012884|NCT01788163|11135756|FG001|COMPLETED|Overall Study||271
10012885|NCT01788163|11135757|FG002|COMPLETED|Overall Study||62
10012886|NCT01788163|11135758|FG003|COMPLETED|Overall Study||71
10012887|NCT01788163|11135759|FG004|COMPLETED|Overall Study||94
10012888|NCT01788163|11135760|FG005|COMPLETED|Overall Study||95
10012889|NCT01788163|11135761|FG006|COMPLETED|Overall Study||49
10012890|NCT01788163|11135762|FG007|COMPLETED|Overall Study||254
10012891|NCT01788163|11135763|FG008|COMPLETED|Overall Study||956
10012892|NCT01788163|11135755|FG000|NOT COMPLETED|Overall Study||55
10012893|NCT01788163|11135756|FG001|NOT COMPLETED|Overall Study||0
10012894|NCT01788163|11135757|FG002|NOT COMPLETED|Overall Study||0
10012895|NCT01788163|11135758|FG003|NOT COMPLETED|Overall Study||0
10225853|NCT03875859|11354066|FG000|NOT COMPLETED|Overall Study||0
10225854|NCT03875508|11354070|FG000|STARTED|Overall Study||108
10225855|NCT03875508|11354070|FG000|COMPLETED|Overall Study||96
10225856|NCT03875508|11354070|FG000|NOT COMPLETED|Overall Study||12
10225857|NCT03869333|11354078|FG000|STARTED|Overall Study||14
10225858|NCT03869333|11354079|FG001|STARTED|Overall Study||16
10225859|NCT03869333|11354080|FG002|STARTED|Overall Study||16
10225860|NCT03869333|11354081|FG003|STARTED|Overall Study||12
10225861|NCT03869333|11354078|FG000|Received First Dose|Overall Study||14
10225862|NCT03869333|11354079|FG001|Received First Dose|Overall Study||16
10225863|NCT03869333|11354080|FG002|Received First Dose|Overall Study||16
10225864|NCT03869333|11354081|FG003|Received First Dose|Overall Study||12
10225865|NCT03869333|11354078|FG000|Received Second Dose|Overall Study||13
10225866|NCT03869333|11354079|FG001|Received Second Dose|Overall Study||15
10225867|NCT03869333|11354080|FG002|Received Second Dose|Overall Study||16
10225868|NCT03869333|11354081|FG003|Received Second Dose|Overall Study||12
10225869|NCT03869333|11354078|FG000|Received Third Dose|Overall Study||13
10225870|NCT03869333|11354079|FG001|Received Third Dose|Overall Study||15
10225871|NCT03869333|11354080|FG002|Received Third Dose|Overall Study||16
10225872|NCT03869333|11354081|FG003|Received Third Dose|Overall Study||11
10225873|NCT03869333|11354078|FG000|COMPLETED|Overall Study||12
10225874|NCT03869333|11354079|FG001|COMPLETED|Overall Study||15
10225875|NCT03869333|11354080|FG002|COMPLETED|Overall Study||16
10225876|NCT03869333|11354081|FG003|COMPLETED|Overall Study||12
10225877|NCT03869333|11354078|FG000|NOT COMPLETED|Overall Study||2
10225878|NCT03869333|11354079|FG001|NOT COMPLETED|Overall Study||1
10225879|NCT03869333|11354080|FG002|NOT COMPLETED|Overall Study||0
10225880|NCT03869333|11354081|FG003|NOT COMPLETED|Overall Study||0
10225881|NCT03864900|11354093|FG000|STARTED|Overall Study||36
10225882|NCT03864900|11354094|FG001|STARTED|Overall Study||36
10225883|NCT03864900|11354093|FG000|COMPLETED|Overall Study||33
10225884|NCT03864900|11354094|FG001|COMPLETED|Overall Study||30
10225885|NCT03864900|11354093|FG000|NOT COMPLETED|Overall Study||3
10225886|NCT03864900|11354094|FG001|NOT COMPLETED|Overall Study||6
10225887|NCT03863795|11354104|FG000|STARTED|Overall Study||306
10225888|NCT03863795|11354105|FG001|STARTED|Overall Study||269
10225889|NCT03863795|11354106|FG002|STARTED|Overall Study||244
10225890|NCT03863795|11354107|FG003|STARTED|Overall Study||281
10225891|NCT03863795|11354104|FG000|COMPLETED|Overall Study||306
10012896|NCT01788163|11135759|FG004|NOT COMPLETED|Overall Study||0
10012897|NCT01788163|11135760|FG005|NOT COMPLETED|Overall Study||7
10012898|NCT01788163|11135761|FG006|NOT COMPLETED|Overall Study||1
10012899|NCT01788163|11135762|FG007|NOT COMPLETED|Overall Study||48
10225892|NCT03863795|11354105|FG001|COMPLETED|Overall Study||269
10225893|NCT03863795|11354106|FG002|COMPLETED|Overall Study||244
10225894|NCT03863795|11354107|FG003|COMPLETED|Overall Study||281
10225895|NCT03863795|11354104|FG000|NOT COMPLETED|Overall Study||0
10225896|NCT03863795|11354105|FG001|NOT COMPLETED|Overall Study||0
10225897|NCT03863795|11354106|FG002|NOT COMPLETED|Overall Study||0
10225898|NCT03863795|11354107|FG003|NOT COMPLETED|Overall Study||0
10012900|NCT01788163|11135763|FG008|NOT COMPLETED|Overall Study||16
10012901|NCT01788215|11135844|FG000|STARTED|Overall Study||5
10012902|NCT01788215|11135845|FG001|STARTED|Overall Study||5
10012903|NCT01788215|11135844|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5
10012904|NCT01788215|11135845|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5
10012905|NCT01788215|11135844|FG000|COMPLETED|Overall Study||3
10012906|NCT01788215|11135845|FG001|COMPLETED|Overall Study||4
10012907|NCT01788215|11135844|FG000|NOT COMPLETED|Overall Study||2
10012908|NCT01788215|11135845|FG001|NOT COMPLETED|Overall Study||1
10012909|NCT01788228|11135853|FG000|STARTED|Overall Study||49
10012910|NCT01788228|11135854|FG001|STARTED|Overall Study||1
10012911|NCT01788228|11135853|FG000|COMPLETED|Overall Study||48
10012912|NCT01788228|11135854|FG001|COMPLETED|Overall Study||1
10225899|NCT03875482|11354119|FG000|STARTED|Overall Study||105
10225900|NCT03875482|11354120|FG001|STARTED|Overall Study||52
10225901|NCT03875482|11354119|FG000|COMPLETED|Overall Study||92
10225902|NCT03875482|11354120|FG001|COMPLETED|Overall Study||32
10225903|NCT03875482|11354119|FG000|NOT COMPLETED|Overall Study||13
10225904|NCT03875482|11354120|FG001|NOT COMPLETED|Overall Study||20
10225905|NCT03874377|11354126|FG000|STARTED|Overall Study||11
10225906|NCT03874377|11354126|FG000|COMPLETED|Overall Study||8
10225907|NCT03874377|11354126|FG000|NOT COMPLETED|Overall Study||3
10225908|NCT03863496|11354130|FG000|STARTED|Overall Study||71
10225909|NCT03863496|11354130|FG000|COMPLETED|Overall Study||71
10225910|NCT03863496|11354130|FG000|NOT COMPLETED|Overall Study||0
10225911|NCT03874013|11354138|FG000|STARTED|Overall Study||22
10225912|NCT03874013|11354139|FG001|STARTED|Overall Study||22
10225913|NCT03874013|11354138|FG000|COMPLETED|Overall Study||22
10225914|NCT03874013|11354139|FG001|COMPLETED|Overall Study||21
10225915|NCT03874013|11354138|FG000|NOT COMPLETED|Overall Study||0
10225916|NCT03874013|11354139|FG001|NOT COMPLETED|Overall Study||1
10225917|NCT03873116|11354148|FG000|STARTED|Overall Study||6
10225918|NCT03873116|11354149|FG001|STARTED|Overall Study||7
10225919|NCT03873116|11354150|FG002|STARTED|Overall Study||6
10225920|NCT03873116|11354148|FG000|COMPLETED|Overall Study||6
10225921|NCT03873116|11354149|FG001|COMPLETED|Overall Study||7
10225922|NCT03873116|11354150|FG002|COMPLETED|Overall Study||5
10225923|NCT03873116|11354148|FG000|NOT COMPLETED|Overall Study||0
10225924|NCT03873116|11354149|FG001|NOT COMPLETED|Overall Study||0
10225925|NCT03873116|11354150|FG002|NOT COMPLETED|Overall Study||1
10225926|NCT03872843|11354160|FG000|STARTED|Overall Study||12
10225927|NCT03872843|11354161|FG001|STARTED|Overall Study||10
10225928|NCT03872843|11354160|FG000|COMPLETED|Overall Study||7
10225929|NCT03872843|11354161|FG001|COMPLETED|Overall Study||3
10225930|NCT03872843|11354160|FG000|NOT COMPLETED|Overall Study||5
10225931|NCT03872843|11354161|FG001|NOT COMPLETED|Overall Study||7
10225932|NCT03870997|11354173|FG000|STARTED|Overall Study||15702
10225933|NCT03870997|11354174|FG001|STARTED|Overall Study||15702
10225934|NCT03870997|11354175|FG002|STARTED|Overall Study||15756
10225935|NCT03870997|11354176|FG003|STARTED|Overall Study||15757
10225936|NCT03870997|11354177|FG004|STARTED|Overall Study||15702
10225937|NCT03870997|11354178|FG005|STARTED|Overall Study||15702
10225938|NCT03870997|11354173|FG000|COMPLETED|Overall Study||5158
10225939|NCT03870997|11354174|FG001|COMPLETED|Overall Study||5271
10225940|NCT03870997|11354175|FG002|COMPLETED|Overall Study||4778
10225941|NCT03870997|11354176|FG003|COMPLETED|Overall Study||4810
10225942|NCT03870997|11354177|FG004|COMPLETED|Overall Study||5114
10225943|NCT03870997|11354178|FG005|COMPLETED|Overall Study||5171
10225944|NCT03870997|11354173|FG000|NOT COMPLETED|Overall Study||10544
10225945|NCT03870997|11354174|FG001|NOT COMPLETED|Overall Study||10431
10225946|NCT03870997|11354175|FG002|NOT COMPLETED|Overall Study||10978
10225947|NCT03870997|11354176|FG003|NOT COMPLETED|Overall Study||10947
10225948|NCT03870997|11354177|FG004|NOT COMPLETED|Overall Study||10588
10225949|NCT03870997|11354178|FG005|NOT COMPLETED|Overall Study||10531
10225950|NCT03869684|11354190|FG000|STARTED|Overall Study||3
10225951|NCT03869684|11354191|FG001|STARTED|Overall Study||5
10225952|NCT03869684|11354192|FG002|STARTED|Overall Study||5
10225953|NCT03869684|11354190|FG000|COMPLETED|Overall Study||1
10225954|NCT03869684|11354191|FG001|COMPLETED|Overall Study||2
10225955|NCT03869684|11354192|FG002|COMPLETED|Overall Study||2
10225956|NCT03869684|11354190|FG000|NOT COMPLETED|Overall Study||2
10225957|NCT03869684|11354191|FG001|NOT COMPLETED|Overall Study||3
10012913|NCT01788228|11135853|FG000|NOT COMPLETED|Overall Study||1
10012914|NCT01788228|11135854|FG001|NOT COMPLETED|Overall Study||0
10225958|NCT03869684|11354192|FG002|NOT COMPLETED|Overall Study||3
10225959|NCT03861338|11354200|FG000|STARTED|Overall Study||10
10225960|NCT03861338|11354200|FG000|COMPLETED|Overall Study||8
10225961|NCT03861338|11354200|FG000|NOT COMPLETED|Overall Study||2
10225962|NCT03858335|11354206|FG000|STARTED|Overall Study||16
10012915|NCT01788358|11135863|FG000|STARTED|Overall Study||508
10225963|NCT03858335|11354207|FG001|STARTED|Overall Study||16
10225964|NCT03858335|11354206|FG000|COMPLETED|Overall Study||12
10225965|NCT03858335|11354207|FG001|COMPLETED|Overall Study||12
10225966|NCT03858335|11354206|FG000|NOT COMPLETED|Overall Study||4
10225967|NCT03858335|11354207|FG001|NOT COMPLETED|Overall Study||4
10225968|NCT03857243|11354215|FG000|STARTED|Overall Study||1
10225969|NCT03857243|11354216|FG001|STARTED|Overall Study||1
10225970|NCT03857243|11354215|FG000|COMPLETED|Overall Study||1
10225971|NCT03857243|11354216|FG001|COMPLETED|Overall Study||1
10225972|NCT03857243|11354215|FG000|NOT COMPLETED|Overall Study||0
10225973|NCT03857243|11354216|FG001|NOT COMPLETED|Overall Study||0
10225974|NCT03851744|11354224|FG000|STARTED|Overall Study||4
10225975|NCT03851744|11354225|FG001|STARTED|Overall Study||6
10225976|NCT03851744|11354224|FG000|COMPLETED|Overall Study||4
10225977|NCT03851744|11354225|FG001|COMPLETED|Overall Study||4
10225978|NCT03851744|11354224|FG000|NOT COMPLETED|Overall Study||0
10225979|NCT03851744|11354225|FG001|NOT COMPLETED|Overall Study||2
10225980|NCT03849937|11354231|FG000|STARTED|Overall Study||147
10225981|NCT03849937|11354232|FG001|STARTED|Overall Study||72
10225982|NCT03849937|11354231|FG000|COMPLETED|Overall Study||94
10225983|NCT03849937|11354232|FG001|COMPLETED|Overall Study||35
10225984|NCT03849937|11354231|FG000|NOT COMPLETED|Overall Study||53
10225985|NCT03849937|11354232|FG001|NOT COMPLETED|Overall Study||37
10225986|NCT03848416|11354246|FG000|STARTED|Overall Study||33
10225987|NCT03848416|11354247|FG001|STARTED|Overall Study||33
10225988|NCT03848416|11354248|FG002|STARTED|Overall Study||33
10225989|NCT03848416|11354246|FG000|Received at Least One Dose of Study Drug|Overall Study||33
10225990|NCT03848416|11354247|FG001|Received at Least One Dose of Study Drug|Overall Study||33
10225991|NCT03848416|11354248|FG002|Received at Least One Dose of Study Drug|Overall Study||33
10225992|NCT03848416|11354246|FG000|COMPLETED|Overall Study||32
10225993|NCT03848416|11354247|FG001|COMPLETED|Overall Study||33
10225994|NCT03848416|11354248|FG002|COMPLETED|Overall Study||32
10225995|NCT03848416|11354246|FG000|NOT COMPLETED|Overall Study||1
10225996|NCT03848416|11354247|FG001|NOT COMPLETED|Overall Study||0
10225997|NCT03848416|11354248|FG002|NOT COMPLETED|Overall Study||1
10225998|NCT03847987|11354258|FG000|STARTED|Overall Study||16
10225999|NCT03847987|11354259|FG001|STARTED|Overall Study||8
10226000|NCT03847987|11354258|FG000|COMPLETED|Overall Study||13
10226001|NCT03847987|11354259|FG001|COMPLETED|Overall Study||8
10226002|NCT03847987|11354258|FG000|NOT COMPLETED|Overall Study||3
10226003|NCT03847987|11354259|FG001|NOT COMPLETED|Overall Study||0
10226004|NCT03854253|11354278|FG000|STARTED|Overall Study||50
10226005|NCT03854253|11354279|FG001|STARTED|Overall Study||50
10226006|NCT03854253|11354278|FG000|COMPLETED|Overall Study||49
10226007|NCT03854253|11354279|FG001|COMPLETED|Overall Study||50
10226008|NCT03854253|11354278|FG000|NOT COMPLETED|Overall Study||1
10226009|NCT03854253|11354279|FG001|NOT COMPLETED|Overall Study||0
10226010|NCT03870737|11354285|FG000|STARTED|Overall Study||22
10226011|NCT03870737|11354285|FG000|COMPLETED|Overall Study||20
10226012|NCT03870737|11354285|FG000|NOT COMPLETED|Overall Study||2
10226013|NCT03860181|11354293|FG000|STARTED|Overall Study||21
10226014|NCT03860181|11354294|FG001|STARTED|Overall Study||22
10226015|NCT03860181|11354295|FG002|STARTED|Overall Study||25
10226016|NCT03860181|11354296|FG003|STARTED|Overall Study||21
10226017|NCT03860181|11354293|FG000|COMPLETED|Overall Study||21
10226018|NCT03860181|11354294|FG001|COMPLETED|Overall Study||22
10226019|NCT03860181|11354295|FG002|COMPLETED|Overall Study||25
10226020|NCT03860181|11354296|FG003|COMPLETED|Overall Study||21
10226021|NCT03860181|11354293|FG000|NOT COMPLETED|Overall Study||0
10226022|NCT03860181|11354294|FG001|NOT COMPLETED|Overall Study||0
10226023|NCT03860181|11354295|FG002|NOT COMPLETED|Overall Study||0
10226024|NCT03860181|11354296|FG003|NOT COMPLETED|Overall Study||0
10226025|NCT03856944|11354317|FG000|STARTED|Overall Study||29
10226026|NCT03856944|11354317|FG000|COMPLETED|Overall Study||29
10226027|NCT03856944|11354317|FG000|NOT COMPLETED|Overall Study||0
10226028|NCT03853551|11354321|FG000|STARTED|Overall Study||60
10226029|NCT03853551|11354321|FG000|COMPLETED|Overall Study||51
10226030|NCT03853551|11354321|FG000|NOT COMPLETED|Overall Study||9
10226031|NCT03870555|11354328|FG000|STARTED|Period 1 (2 Days)||2
10226032|NCT03870555|11354329|FG001|STARTED|Period 1 (2 Days)||2
10226033|NCT03870555|11354330|FG002|STARTED|Period 1 (2 Days)||2
10226034|NCT03870555|11354328|FG000|COMPLETED|Period 1 (2 Days)||2
10226035|NCT03870555|11354329|FG001|COMPLETED|Period 1 (2 Days)||2
10226036|NCT03870555|11354330|FG002|COMPLETED|Period 1 (2 Days)||2
10226037|NCT03870555|11354328|FG000|NOT COMPLETED|Period 1 (2 Days)||0
10226038|NCT03870555|11354329|FG001|NOT COMPLETED|Period 1 (2 Days)||0
10226039|NCT03870555|11354330|FG002|NOT COMPLETED|Period 1 (2 Days)||0
10226040|NCT03870555|11354328|FG000|STARTED|Washout Period (at Least 16 Days)||2
10226041|NCT03870555|11354329|FG001|STARTED|Washout Period (at Least 16 Days)||2
10226042|NCT03870555|11354330|FG002|STARTED|Washout Period (at Least 16 Days)||2
10226043|NCT03870555|11354328|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
10226044|NCT03870555|11354329|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
10226045|NCT03870555|11354330|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
10226046|NCT03870555|11354328|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10226047|NCT03870555|11354329|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10226048|NCT03870555|11354330|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10226049|NCT03870555|11354328|FG000|STARTED|Period 2 (2 Days)||2
10226050|NCT03870555|11354329|FG001|STARTED|Period 2 (2 Days)||2
10226051|NCT03870555|11354330|FG002|STARTED|Period 2 (2 Days)||2
10226052|NCT03870555|11354328|FG000|COMPLETED|Period 2 (2 Days)||2
10226053|NCT03870555|11354329|FG001|COMPLETED|Period 2 (2 Days)||2
10226054|NCT03870555|11354330|FG002|COMPLETED|Period 2 (2 Days)||2
10226055|NCT03870555|11354328|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10226056|NCT03870555|11354329|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10226057|NCT03870555|11354330|FG002|NOT COMPLETED|Period 2 (2 Days)||0
10226058|NCT03870555|11354328|FG000|STARTED|Washout Period (at Least 16 Days)||2
10226059|NCT03870555|11354329|FG001|STARTED|Washout Period (at Least 16 Days)||2
10226060|NCT03870555|11354330|FG002|STARTED|Washout Period (at Least 16 Days)||2
10226061|NCT03870555|11354328|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
10226062|NCT03870555|11354329|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
10226063|NCT03870555|11354330|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
10226064|NCT03870555|11354328|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10226065|NCT03870555|11354329|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10226066|NCT03870555|11354330|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10226067|NCT03870555|11354328|FG000|STARTED|Period 3 (2 Days)||2
10226068|NCT03870555|11354329|FG001|STARTED|Period 3 (2 Days)||2
10226069|NCT03870555|11354330|FG002|STARTED|Period 3 (2 Days)||2
10226070|NCT03870555|11354328|FG000|COMPLETED|Period 3 (2 Days)||1
10226071|NCT03870555|11354329|FG001|COMPLETED|Period 3 (2 Days)||2
10226072|NCT03870555|11354330|FG002|COMPLETED|Period 3 (2 Days)||2
10226073|NCT03870555|11354328|FG000|NOT COMPLETED|Period 3 (2 Days)||1
10226074|NCT03870555|11354329|FG001|NOT COMPLETED|Period 3 (2 Days)||0
10226075|NCT03870555|11354330|FG002|NOT COMPLETED|Period 3 (2 Days)||0
10226076|NCT03861845|11354344|FG000|STARTED|Overall Study||6
10226077|NCT03861845|11354345|FG001|STARTED|Overall Study||5
10226078|NCT03861845|11354346|FG002|STARTED|Overall Study||4
10226079|NCT03861845|11354344|FG000|COMPLETED|Overall Study||6
10226080|NCT03861845|11354345|FG001|COMPLETED|Overall Study||5
10226081|NCT03861845|11354346|FG002|COMPLETED|Overall Study||4
10226082|NCT03861845|11354344|FG000|NOT COMPLETED|Overall Study||0
10226083|NCT03861845|11354345|FG001|NOT COMPLETED|Overall Study||0
10226084|NCT03861845|11354346|FG002|NOT COMPLETED|Overall Study||0
10226085|NCT03851094|11354356|FG000|STARTED|Overall Study||111
10226086|NCT03851094|11354357|FG001|STARTED|Overall Study||55
10012916|NCT01788358|11135863|FG000|Treated|Overall Study||508
10012917|NCT01788358|11135863|FG000|Completed Week 28|Overall Study||417
10226087|NCT03851094|11354356|FG000|COMPLETED|Overall Study||111
10226088|NCT03851094|11354357|FG001|COMPLETED|Overall Study||51
10226089|NCT03851094|11354356|FG000|NOT COMPLETED|Overall Study||0
10226090|NCT03851094|11354357|FG001|NOT COMPLETED|Overall Study||4
10226091|NCT03869450|11354368|FG000|STARTED|Overall Study||31
10226092|NCT03869450|11354369|FG001|STARTED|Overall Study||25
10226093|NCT03869450|11354370|FG002|STARTED|Overall Study||34
10226094|NCT03869450|11354368|FG000|COMPLETED|Overall Study||30
10226095|NCT03869450|11354369|FG001|COMPLETED|Overall Study||23
10226096|NCT03869450|11354370|FG002|COMPLETED|Overall Study||34
10226097|NCT03869450|11354368|FG000|NOT COMPLETED|Overall Study||1
10226098|NCT03869450|11354369|FG001|NOT COMPLETED|Overall Study||2
10226099|NCT03869450|11354370|FG002|NOT COMPLETED|Overall Study||0
10226100|NCT03868631|11354380|FG000|STARTED|Baseline to Week 6||30
10226101|NCT03868631|11354381|FG001|STARTED|Baseline to Week 6||31
10226102|NCT03868631|11354380|FG000|COMPLETED|Baseline to Week 6||26
10226103|NCT03868631|11354381|FG001|COMPLETED|Baseline to Week 6||27
10226104|NCT03868631|11354380|FG000|NOT COMPLETED|Baseline to Week 6||4
10226105|NCT03868631|11354381|FG001|NOT COMPLETED|Baseline to Week 6||4
10226106|NCT03868631|11354380|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26
10226107|NCT03868631|11354381|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27
10226108|NCT03868631|11354380|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22
10226109|NCT03868631|11354381|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26
10226110|NCT03868631|11354380|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
10226111|NCT03868631|11354381|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
10226112|NCT03865953|11354389|FG000|STARTED|First Intervention (4 Weeks)||25
10226113|NCT03865953|11354390|FG001|STARTED|First Intervention (4 Weeks)||28
10226114|NCT03865953|11354389|FG000|COMPLETED|First Intervention (4 Weeks)||23
10226115|NCT03865953|11354390|FG001|COMPLETED|First Intervention (4 Weeks)||27
10226116|NCT03865953|11354389|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10226117|NCT03865953|11354390|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10226118|NCT03865953|11354389|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23
10226119|NCT03865953|11354390|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27
10226120|NCT03865953|11354389|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23
10226121|NCT03865953|11354390|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27
10226122|NCT03865953|11354389|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
10226123|NCT03865953|11354390|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
10226124|NCT03865953|11354389|FG000|STARTED|Second Intervention (4 Weeks)||23
10226125|NCT03865953|11354390|FG001|STARTED|Second Intervention (4 Weeks)||27
10226126|NCT03865953|11354389|FG000|COMPLETED|Second Intervention (4 Weeks)||23
10226127|NCT03865953|11354390|FG001|COMPLETED|Second Intervention (4 Weeks)||25
10226128|NCT03865953|11354389|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10226129|NCT03865953|11354390|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
10226130|NCT03865381|11354396|FG000|STARTED|Overall Study||60
10226131|NCT03865381|11354396|FG000|COMPLETED|Overall Study||55
10226132|NCT03865381|11354396|FG000|NOT COMPLETED|Overall Study||5
10226133|NCT03865446|11354402|FG000|STARTED|Overall Study||8
10226134|NCT03865446|11354403|FG001|STARTED|Overall Study||8
10226135|NCT03865446|11354402|FG000|COMPLETED|Overall Study||8
10226136|NCT03865446|11354403|FG001|COMPLETED|Overall Study||8
10226137|NCT03865446|11354402|FG000|NOT COMPLETED|Overall Study||0
10226138|NCT03865446|11354403|FG001|NOT COMPLETED|Overall Study||0
10226139|NCT03862027|11354409|FG000|STARTED|Overall Study||1
10226140|NCT03862027|11354409|FG000|COMPLETED|Overall Study||1
10226141|NCT03862027|11354409|FG000|NOT COMPLETED|Overall Study||0
10226142|NCT03859960|11354415|FG000|STARTED|Overall Study||14
10226143|NCT03859960|11354416|FG001|STARTED|Overall Study||19
10226144|NCT03859960|11354415|FG000|COMPLETED|Overall Study||14
10226145|NCT03859960|11354416|FG001|COMPLETED|Overall Study||19
10226146|NCT03859960|11354415|FG000|NOT COMPLETED|Overall Study||0
10226147|NCT03859960|11354416|FG001|NOT COMPLETED|Overall Study||0
10226148|NCT03868059|11354424|FG000|STARTED|Overall Study||138
10226149|NCT03868059|11354424|FG000|COMPLETED|Overall Study||126
10226150|NCT03868059|11354424|FG000|NOT COMPLETED|Overall Study||12
10226151|NCT03868254|11354430|FG000|STARTED|Overall Study||98
10226152|NCT03868254|11354431|FG001|STARTED|Overall Study||76
10226153|NCT03868254|11354430|FG000|COMPLETED|Overall Study||98
10226154|NCT03868254|11354431|FG001|COMPLETED|Overall Study||76
10226155|NCT03868254|11354430|FG000|NOT COMPLETED|Overall Study||0
10226156|NCT03868254|11354431|FG001|NOT COMPLETED|Overall Study||0
10226157|NCT03865407|11354439|FG000|STARTED|Overall Study||10
10226158|NCT03865407|11354440|FG001|STARTED|Overall Study||7
10226159|NCT03865407|11354439|FG000|COMPLETED|Overall Study||7
10226160|NCT03865407|11354440|FG001|COMPLETED|Overall Study||7
10226161|NCT03865407|11354439|FG000|NOT COMPLETED|Overall Study||3
10226162|NCT03865407|11354440|FG001|NOT COMPLETED|Overall Study||0
10226163|NCT03857230|11354448|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12
10226164|NCT03857230|11354449|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12
10226165|NCT03857230|11354448|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12
10226166|NCT03857230|11354449|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12
10226167|NCT03857230|11354448|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
10226168|NCT03857230|11354449|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
10226169|NCT03857230|11354448|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12
10226170|NCT03857230|11354449|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12
10226171|NCT03857230|11354448|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12
10226172|NCT03857230|11354449|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12
10226173|NCT03857230|11354448|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
10226174|NCT03857230|11354449|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
10226175|NCT03865329|11354455|FG000|STARTED|Overall Study||9
10226176|NCT03865329|11354455|FG000|COMPLETED|Overall Study||9
10226177|NCT03865329|11354455|FG000|NOT COMPLETED|Overall Study||0
10226178|NCT03864653|11354459|FG000|STARTED|Overall Study||39
10226179|NCT03864653|11354459|FG000|COMPLETED|Overall Study||38
10226180|NCT03864653|11354459|FG000|NOT COMPLETED|Overall Study||1
10226181|NCT03862482|11354466|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
10226182|NCT03862482|11354467|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
10239312|NCT00295490|11370841|FG000|COMPLETED|Overall Study||14
10239313|NCT00295490|11370842|FG001|COMPLETED|Overall Study||15
10239314|NCT00295490|11370843|FG002|COMPLETED|Overall Study||12
10226183|NCT03862482|11354468|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
10226184|NCT03862482|11354466|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
10226185|NCT03862482|11354467|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
10226186|NCT03862482|11354468|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
10226187|NCT03862482|11354466|FG000|NOT COMPLETED|Overall Study||0
10226188|NCT03862482|11354467|FG001|NOT COMPLETED|Overall Study||0
10226189|NCT03862482|11354468|FG002|NOT COMPLETED|Overall Study||0
10226190|NCT03853213|11354476|FG000|STARTED|Overall Study||11
10226191|NCT03853213|11354477|FG001|STARTED|Overall Study||9
10226192|NCT03853213|11354476|FG000|COMPLETED|Overall Study||10
10226193|NCT03853213|11354477|FG001|COMPLETED|Overall Study||7
10226194|NCT03853213|11354476|FG000|NOT COMPLETED|Overall Study||1
10226195|NCT03853213|11354477|FG001|NOT COMPLETED|Overall Study||2
10226196|NCT03847610|11354483|FG000|STARTED|Overall Study||11
10226197|NCT03847610|11354483|FG000|COMPLETED|Overall Study||10
10226198|NCT03847610|11354483|FG000|NOT COMPLETED|Overall Study||1
10226199|NCT03850093|11354490|FG000|STARTED|Overall Study||22
10226200|NCT03850093|11354491|FG001|STARTED|Overall Study||22
10226201|NCT03850093|11354492|FG002|STARTED|Overall Study||19
10226202|NCT03850093|11354490|FG000|COMPLETED|Overall Study||21
10226203|NCT03850093|11354491|FG001|COMPLETED|Overall Study||22
10226204|NCT03850093|11354492|FG002|COMPLETED|Overall Study||17
10226205|NCT03850093|11354490|FG000|NOT COMPLETED|Overall Study||1
10226206|NCT03850093|11354491|FG001|NOT COMPLETED|Overall Study||0
10226207|NCT03850093|11354492|FG002|NOT COMPLETED|Overall Study||2
10226208|NCT03848208|11354510|FG000|STARTED|Overall Study||18
10226209|NCT03848208|11354511|FG001|STARTED|Overall Study||6
10226210|NCT03848208|11354512|FG002|STARTED|Overall Study||6
10226211|NCT03848208|11354513|FG003|STARTED|Overall Study||6
10226212|NCT03848208|11354514|FG004|STARTED|Overall Study||6
10226213|NCT03848208|11354515|FG005|STARTED|Overall Study||6
10226214|NCT03848208|11354516|FG006|STARTED|Overall Study||6
10226215|NCT03848208|11354517|FG007|STARTED|Overall Study||6
10226216|NCT03848208|11354518|FG008|STARTED|Overall Study||6
10226217|NCT03848208|11354519|FG009|STARTED|Overall Study||6
10226218|NCT03848208|11354510|FG000|COMPLETED|Overall Study||18
10226219|NCT03848208|11354511|FG001|COMPLETED|Overall Study||6
10226220|NCT03848208|11354512|FG002|COMPLETED|Overall Study||6
10226221|NCT03848208|11354513|FG003|COMPLETED|Overall Study||6
10226222|NCT03848208|11354514|FG004|COMPLETED|Overall Study||6
10226223|NCT03848208|11354515|FG005|COMPLETED|Overall Study||6
10226224|NCT03848208|11354516|FG006|COMPLETED|Overall Study||6
10226225|NCT03848208|11354517|FG007|COMPLETED|Overall Study||6
10226226|NCT03848208|11354518|FG008|COMPLETED|Overall Study||6
10226227|NCT03848208|11354519|FG009|COMPLETED|Overall Study||6
10226228|NCT03848208|11354510|FG000|NOT COMPLETED|Overall Study||0
10226229|NCT03848208|11354511|FG001|NOT COMPLETED|Overall Study||0
10226230|NCT03848208|11354512|FG002|NOT COMPLETED|Overall Study||0
10226231|NCT03848208|11354513|FG003|NOT COMPLETED|Overall Study||0
10012918|NCT01788358|11135863|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
10012919|NCT01788358|11135863|FG000|Completed Week 52|Overall Study||193
10012920|NCT01788358|11135863|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
10012921|NCT01788358|11135863|FG000|NOT COMPLETED|Overall Study||98
10226232|NCT03848208|11354514|FG004|NOT COMPLETED|Overall Study||0
10226233|NCT03848208|11354515|FG005|NOT COMPLETED|Overall Study||0
10226234|NCT03848208|11354516|FG006|NOT COMPLETED|Overall Study||0
10226235|NCT03848208|11354517|FG007|NOT COMPLETED|Overall Study||0
10226236|NCT03848208|11354518|FG008|NOT COMPLETED|Overall Study||0
10226237|NCT03848208|11354519|FG009|NOT COMPLETED|Overall Study||0
10226238|NCT03847389|11354553|FG000|STARTED|Overall Study||8
10226239|NCT03847389|11354554|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
10226240|NCT03847389|11354555|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
10226241|NCT03847389|11354553|FG000|COMPLETED|Overall Study||8
10226242|NCT03847389|11354554|FG001|COMPLETED|Overall Study||0
10226243|NCT03847389|11354555|FG002|COMPLETED|Overall Study||0
10226244|NCT03847389|11354553|FG000|NOT COMPLETED|Overall Study||0
10226245|NCT03847389|11354554|FG001|NOT COMPLETED|Overall Study||0
10226246|NCT03847389|11354555|FG002|NOT COMPLETED|Overall Study||0
10226247|NCT03862040|11354566|FG000|STARTED|Overall Study||7
10226248|NCT03862040|11354566|FG000|COMPLETED|Overall Study||7
10226249|NCT03862040|11354566|FG000|NOT COMPLETED|Overall Study||0
10226250|NCT03861936|11354573|FG000|STARTED|Overall Study||48
10226251|NCT03861936|11354574|FG001|STARTED|Overall Study||53
10226252|NCT03861936|11354575|FG002|STARTED|Overall Study||49
10226253|NCT03861936|11354573|FG000|COMPLETED|Overall Study||34
10226254|NCT03861936|11354574|FG001|COMPLETED|Overall Study||43
10226255|NCT03861936|11354575|FG002|COMPLETED|Overall Study||39
10226256|NCT03861936|11354573|FG000|NOT COMPLETED|Overall Study||14
10226257|NCT03861936|11354574|FG001|NOT COMPLETED|Overall Study||10
10226258|NCT03861936|11354575|FG002|NOT COMPLETED|Overall Study||10
10226259|NCT03859739|11354587|FG000|STARTED|Overall Study||5
10226260|NCT03859739|11354588|FG001|STARTED|Overall Study||6
10226261|NCT03859739|11354589|FG002|STARTED|Overall Study||6
10226262|NCT03859739|11354590|FG003|STARTED|Overall Study||4
10226263|NCT03859739|11354587|FG000|COMPLETED|Overall Study||5
10226264|NCT03859739|11354588|FG001|COMPLETED|Overall Study||6
10226265|NCT03859739|11354589|FG002|COMPLETED|Overall Study||6
10226266|NCT03859739|11354590|FG003|COMPLETED|Overall Study||4
10226267|NCT03859739|11354587|FG000|NOT COMPLETED|Overall Study||0
10226268|NCT03859739|11354588|FG001|NOT COMPLETED|Overall Study||0
10226269|NCT03859739|11354589|FG002|NOT COMPLETED|Overall Study||0
10226270|NCT03859739|11354590|FG003|NOT COMPLETED|Overall Study||0
10226271|NCT03857750|11354602|FG000|STARTED|Overall Study||16
10226272|NCT03857750|11354603|FG001|STARTED|Overall Study||16
10226273|NCT03857750|11354602|FG000|COMPLETED|Overall Study||16
10226274|NCT03857750|11354603|FG001|COMPLETED|Overall Study||16
10226275|NCT03857750|11354602|FG000|NOT COMPLETED|Overall Study||0
10226276|NCT03857750|11354603|FG001|NOT COMPLETED|Overall Study||0
10226277|NCT03856255|11354609|FG000|STARTED|Overall Study||23
10226278|NCT03856255|11354609|FG000|COMPLETED|Overall Study||23
10226279|NCT03856255|11354609|FG000|NOT COMPLETED|Overall Study||0
10226280|NCT03850509|11354615|FG000|STARTED|Overall Study||2
10226281|NCT03850509|11354616|FG001|STARTED|Overall Study||1
10226282|NCT03850509|11354615|FG000|COMPLETED|Overall Study||0
10226283|NCT03850509|11354616|FG001|COMPLETED|Overall Study||0
10226284|NCT03850509|11354615|FG000|NOT COMPLETED|Overall Study||2
10226285|NCT03850509|11354616|FG001|NOT COMPLETED|Overall Study||1
10226286|NCT03860753|11354624|FG000|STARTED|Overall Study||4
10226287|NCT03860753|11354625|FG001|STARTED|Overall Study||0
10226288|NCT03860753|11354624|FG000|COMPLETED|Overall Study||4
10226289|NCT03860753|11354625|FG001|COMPLETED|Overall Study||0
10226290|NCT03860753|11354624|FG000|NOT COMPLETED|Overall Study||0
10226291|NCT03860753|11354625|FG001|NOT COMPLETED|Overall Study||0
10226292|NCT03848455|11354634|FG000|STARTED|Overall Study||90
10226293|NCT03848455|11354635|FG001|STARTED|Overall Study||125
10226294|NCT03848455|11354636|FG002|STARTED|Overall Study||23
10226295|NCT03848455|11354634|FG000|COMPLETED|Overall Study||90
10226296|NCT03848455|11354635|FG001|COMPLETED|Overall Study||125
10226297|NCT03848455|11354636|FG002|COMPLETED|Overall Study||23
10226298|NCT03848455|11354634|FG000|NOT COMPLETED|Overall Study||0
10226299|NCT03848455|11354635|FG001|NOT COMPLETED|Overall Study||0
10226300|NCT03848455|11354636|FG002|NOT COMPLETED|Overall Study||0
10226301|NCT03858894|11354647|FG000|STARTED|Overall Study||48
10226302|NCT03858894|11354648|FG001|STARTED|Overall Study||50
10226303|NCT03858894|11354647|FG000|COMPLETED|Overall Study||44
10226304|NCT03858894|11354648|FG001|COMPLETED|Overall Study||50
10226305|NCT03858894|11354647|FG000|NOT COMPLETED|Overall Study||4
10226306|NCT03858894|11354648|FG001|NOT COMPLETED|Overall Study||0
10226307|NCT03856164|11354656|FG000|STARTED|Overall Study||55
10226308|NCT03856164|11354657|FG001|STARTED|Overall Study||55
10226309|NCT03856164|11354656|FG000|COMPLETED|Overall Study||55
10226310|NCT03856164|11354657|FG001|COMPLETED|Overall Study||55
10226311|NCT03856164|11354656|FG000|NOT COMPLETED|Overall Study||0
10226312|NCT03856164|11354657|FG001|NOT COMPLETED|Overall Study||0
10226313|NCT03850275|11354671|FG000|STARTED|Overall Study||5
10226314|NCT03850275|11354672|FG001|STARTED|Overall Study||5
10226315|NCT03850275|11354673|FG002|STARTED|Overall Study||5
10226316|NCT03850275|11354674|FG003|STARTED|Overall Study||5
10226317|NCT03850275|11354675|FG004|STARTED|Overall Study||5
10226318|NCT03850275|11354676|FG005|STARTED|Overall Study||5
10226319|NCT03850275|11354671|FG000|COMPLETED|Overall Study||5
10226320|NCT03850275|11354672|FG001|COMPLETED|Overall Study||5
10226321|NCT03850275|11354673|FG002|COMPLETED|Overall Study||5
10226322|NCT03850275|11354674|FG003|COMPLETED|Overall Study||5
10226323|NCT03850275|11354675|FG004|COMPLETED|Overall Study||5
10226324|NCT03850275|11354676|FG005|COMPLETED|Overall Study||5
10226325|NCT03850275|11354671|FG000|NOT COMPLETED|Overall Study||0
10226326|NCT03850275|11354672|FG001|NOT COMPLETED|Overall Study||0
10226327|NCT03850275|11354673|FG002|NOT COMPLETED|Overall Study||0
10226328|NCT03850275|11354674|FG003|NOT COMPLETED|Overall Study||0
10226329|NCT03850275|11354675|FG004|NOT COMPLETED|Overall Study||0
10226330|NCT03850275|11354676|FG005|NOT COMPLETED|Overall Study||0
10226331|NCT03851016|11354701|FG000|STARTED|First Intervention (3 Weeks)||12
10226332|NCT03851016|11354702|FG001|STARTED|First Intervention (3 Weeks)||12
10226333|NCT03851016|11354701|FG000|COMPLETED|First Intervention (3 Weeks)||11
10226334|NCT03851016|11354702|FG001|COMPLETED|First Intervention (3 Weeks)||10
10226335|NCT03851016|11354701|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
10226336|NCT03851016|11354702|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
10226337|NCT03851016|11354701|FG000|STARTED|Washout (1 Week)||11
10226338|NCT03851016|11354702|FG001|STARTED|Washout (1 Week)||10
10226339|NCT03851016|11354701|FG000|COMPLETED|Washout (1 Week)||11
10226340|NCT03851016|11354702|FG001|COMPLETED|Washout (1 Week)||10
10226341|NCT03851016|11354701|FG000|NOT COMPLETED|Washout (1 Week)||0
10226342|NCT03851016|11354702|FG001|NOT COMPLETED|Washout (1 Week)||0
10226343|NCT03851016|11354701|FG000|STARTED|Second Intervention (3 Weeks)||11
10226344|NCT03851016|11354702|FG001|STARTED|Second Intervention (3 Weeks)||10
10226345|NCT03851016|11354701|FG000|COMPLETED|Second Intervention (3 Weeks)||11
10226346|NCT03851016|11354702|FG001|COMPLETED|Second Intervention (3 Weeks)||10
10226347|NCT03851016|11354701|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10226348|NCT03851016|11354702|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10226349|NCT03850496|11354711|FG000|STARTED|Overall Study||26
10226350|NCT03850496|11354712|FG001|STARTED|Overall Study||25
10226351|NCT03850496|11354713|FG002|STARTED|Overall Study||25
10012922|NCT01788423|11135870|FG000|STARTED|Overall Study||53
10012923|NCT01788423|11135871|FG001|STARTED|Overall Study||55
10012924|NCT01788423|11135872|FG002|STARTED|Overall Study||55
10226352|NCT03850496|11354711|FG000|COMPLETED|Overall Study||25
10226353|NCT03850496|11354712|FG001|COMPLETED|Overall Study||24
10226354|NCT03850496|11354713|FG002|COMPLETED|Overall Study||21
10226355|NCT03850496|11354711|FG000|NOT COMPLETED|Overall Study||1
10226356|NCT03850496|11354712|FG001|NOT COMPLETED|Overall Study||1
10226357|NCT03850496|11354713|FG002|NOT COMPLETED|Overall Study||4
10226358|NCT03848949|11354723|FG000|STARTED|Overall Study||54
10226359|NCT03848949|11354724|FG001|STARTED|Overall Study||53
10226360|NCT03848949|11354723|FG000|COMPLETED|Overall Study||49
10226361|NCT03848949|11354724|FG001|COMPLETED|Overall Study||46
10226362|NCT03848949|11354723|FG000|NOT COMPLETED|Overall Study||5
10226363|NCT03848949|11354724|FG001|NOT COMPLETED|Overall Study||7
10239315|NCT00295490|11370844|FG003|COMPLETED|Overall Study||12
10239316|NCT00295490|11370841|FG000|NOT COMPLETED|Overall Study||1
10239317|NCT00295490|11370842|FG001|NOT COMPLETED|Overall Study||4
10239318|NCT00295490|11370843|FG002|NOT COMPLETED|Overall Study||4
10239319|NCT00295490|11370844|FG003|NOT COMPLETED|Overall Study||5
10239320|NCT00268463|11370856|FG000|STARTED|Overall Study||10
10239321|NCT00268463|11370857|FG001|STARTED|Overall Study||12
10239322|NCT00268463|11370856|FG000|COMPLETED|Overall Study||0
10239323|NCT00268463|11370857|FG001|COMPLETED|Overall Study||0
10239324|NCT00268463|11370856|FG000|NOT COMPLETED|Overall Study||10
10239325|NCT00268463|11370857|FG001|NOT COMPLETED|Overall Study||12
10239326|NCT00271102|11370865|FG000|STARTED|Overall Study||35
10012925|NCT01788423|11135870|FG000|COMPLETED|Overall Study||53
10239327|NCT00271102|11370866|FG001|STARTED|Overall Study||35
10019031|NCT01827163|11142110|FG000|COMPLETED|Overall Study||9
10226364|NCT03849690|11354730|FG000|STARTED|Period 1 (3 Days)||12
10226365|NCT03849690|11354730|FG000|COMPLETED|Period 1 (3 Days)||12
10226366|NCT03849690|11354730|FG000|NOT COMPLETED|Period 1 (3 Days)||0
10226367|NCT03849690|11354730|FG000|STARTED|Washout Period (at Least 4 Days)||12
10226368|NCT03849690|11354730|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
10226369|NCT03849690|11354730|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
10226370|NCT03849690|11354730|FG000|STARTED|Period 2 (6 Days)||12
10226371|NCT03849690|11354730|FG000|COMPLETED|Period 2 (6 Days)||12
10226372|NCT03849690|11354730|FG000|NOT COMPLETED|Period 2 (6 Days)||0
10226373|NCT03845933|11354741|FG000|STARTED|Overall Study||131
10226374|NCT03845933|11354742|FG001|STARTED|Overall Study||131
10226375|NCT03845933|11354741|FG000|COMPLETED|Overall Study||131
10226376|NCT03845933|11354742|FG001|COMPLETED|Overall Study||131
10226377|NCT03845933|11354741|FG000|NOT COMPLETED|Overall Study||0
10226378|NCT03845933|11354742|FG001|NOT COMPLETED|Overall Study||0
10226379|NCT03844945|11354752|FG000|STARTED|Overall Study||55
10226380|NCT03844945|11354753|FG001|STARTED|Overall Study||54
10226381|NCT03844945|11354754|FG002|STARTED|Overall Study||51
10226382|NCT03844945|11354755|FG003|STARTED|Overall Study||55
10226383|NCT03844945|11354752|FG000|COMPLETED|Overall Study||54
10226384|NCT03844945|11354753|FG001|COMPLETED|Overall Study||53
10226385|NCT03844945|11354754|FG002|COMPLETED|Overall Study||46
10226386|NCT03844945|11354755|FG003|COMPLETED|Overall Study||54
10226387|NCT03844945|11354752|FG000|NOT COMPLETED|Overall Study||1
10226388|NCT03844945|11354753|FG001|NOT COMPLETED|Overall Study||1
10226389|NCT03844945|11354754|FG002|NOT COMPLETED|Overall Study||5
10226390|NCT03844945|11354755|FG003|NOT COMPLETED|Overall Study||1
10226391|NCT03844321|11354767|FG000|STARTED|Overall Study||2220
10226392|NCT03844321|11354768|FG001|STARTED|Overall Study||2192
10226393|NCT03844321|11354767|FG000|COMPLETED|Overall Study||579
10226394|NCT03844321|11354768|FG001|COMPLETED|Overall Study||533
10226395|NCT03844321|11354767|FG000|NOT COMPLETED|Overall Study||1641
10226396|NCT03844321|11354768|FG001|NOT COMPLETED|Overall Study||1659
10226397|NCT03843632|11354778|FG000|STARTED|Overall Study||50
10226398|NCT03843632|11354779|FG001|STARTED|Overall Study||30
10226399|NCT03843632|11354780|FG002|STARTED|Overall Study||33
10226400|NCT03843632|11354781|FG003|STARTED|Overall Study||37
10226401|NCT03843632|11354778|FG000|Vaccination 1|Overall Study||50
10226402|NCT03843632|11354779|FG001|Vaccination 1|Overall Study||30
10226403|NCT03843632|11354780|FG002|Vaccination 1|Overall Study||33
10226404|NCT03843632|11354781|FG003|Vaccination 1|Overall Study||37
10226405|NCT03843632|11354778|FG000|Vaccination 2|Overall Study||49
10226406|NCT03843632|11354779|FG001|Vaccination 2|Overall Study||30
10226407|NCT03843632|11354780|FG002|Vaccination 2|Overall Study||0
10226408|NCT03843632|11354781|FG003|Vaccination 2|Overall Study||0
10226409|NCT03843632|11354778|FG000|COMPLETED|Overall Study||49
10226410|NCT03843632|11354779|FG001|COMPLETED|Overall Study||30
10226411|NCT03843632|11354780|FG002|COMPLETED|Overall Study||33
10226412|NCT03843632|11354781|FG003|COMPLETED|Overall Study||37
10226413|NCT03843632|11354778|FG000|NOT COMPLETED|Overall Study||1
10226414|NCT03843632|11354779|FG001|NOT COMPLETED|Overall Study||0
10226415|NCT03843632|11354780|FG002|NOT COMPLETED|Overall Study||0
10226416|NCT03843632|11354781|FG003|NOT COMPLETED|Overall Study||0
10226417|NCT03840811|11354794|FG000|STARTED|Overall Study||9
10226418|NCT03840811|11354795|FG001|STARTED|Overall Study||6
10226419|NCT03840811|11354796|FG002|STARTED|Overall Study||12
10226420|NCT03840811|11354794|FG000|COMPLETED|Overall Study||9
10226421|NCT03840811|11354795|FG001|COMPLETED|Overall Study||6
10226422|NCT03840811|11354796|FG002|COMPLETED|Overall Study||11
10226423|NCT03840811|11354794|FG000|NOT COMPLETED|Overall Study||0
10226424|NCT03840811|11354795|FG001|NOT COMPLETED|Overall Study||0
10226425|NCT03840811|11354796|FG002|NOT COMPLETED|Overall Study||1
10226426|NCT03837028|11354808|FG000|STARTED|Overall Study||35
10226427|NCT03837028|11354809|FG001|STARTED|Overall Study||34
10226428|NCT03837028|11354810|FG002|STARTED|Overall Study||33
10226429|NCT03837028|11354811|FG003|STARTED|Overall Study||25
10226430|NCT03837028|11354808|FG000|COMPLETED|Overall Study||19
10226431|NCT03837028|11354809|FG001|COMPLETED|Overall Study||23
10226432|NCT03837028|11354810|FG002|COMPLETED|Overall Study||20
10226433|NCT03837028|11354811|FG003|COMPLETED|Overall Study||18
10226434|NCT03837028|11354808|FG000|NOT COMPLETED|Overall Study||16
10226435|NCT03837028|11354809|FG001|NOT COMPLETED|Overall Study||11
10226436|NCT03837028|11354810|FG002|NOT COMPLETED|Overall Study||13
10226437|NCT03837028|11354811|FG003|NOT COMPLETED|Overall Study||7
10226438|NCT03825939|11354824|FG000|STARTED|Overall Study||18
10226439|NCT03825939|11354825|FG001|STARTED|Overall Study||20
10226440|NCT03825939|11354826|FG002|STARTED|Overall Study||14
10226441|NCT03825939|11354824|FG000|COMPLETED|Overall Study||18
10226442|NCT03825939|11354825|FG001|COMPLETED|Overall Study||20
10226443|NCT03825939|11354826|FG002|COMPLETED|Overall Study||14
10226444|NCT03825939|11354824|FG000|NOT COMPLETED|Overall Study||0
10226445|NCT03825939|11354825|FG001|NOT COMPLETED|Overall Study||0
10226446|NCT03825939|11354826|FG002|NOT COMPLETED|Overall Study||0
10226447|NCT03817775|11354836|FG000|STARTED|Overall Study||22
10226448|NCT03817775|11354837|FG001|STARTED|Overall Study||54
10226449|NCT03817775|11354836|FG000|COMPLETED|Overall Study||22
10226450|NCT03817775|11354837|FG001|COMPLETED|Overall Study||54
10226451|NCT03817775|11354836|FG000|NOT COMPLETED|Overall Study||0
10226452|NCT03817775|11354837|FG001|NOT COMPLETED|Overall Study||0
10226453|NCT03843372|11354845|FG000|STARTED|Overall Study||14
10226454|NCT03843372|11354846|FG001|STARTED|Overall Study||18
10226455|NCT03843372|11354845|FG000|COMPLETED|Overall Study||12
10226456|NCT03843372|11354846|FG001|COMPLETED|Overall Study||16
10226457|NCT03843372|11354845|FG000|NOT COMPLETED|Overall Study||2
10226458|NCT03843372|11354846|FG001|NOT COMPLETED|Overall Study||2
10226459|NCT03841331|11354854|FG000|STARTED|Overall Study||117
10226460|NCT03841331|11354855|FG001|STARTED|Overall Study||116
10226461|NCT03841331|11354854|FG000|COMPLETED|Overall Study||108
10226462|NCT03841331|11354855|FG001|COMPLETED|Overall Study||106
10226463|NCT03841331|11354854|FG000|NOT COMPLETED|Overall Study||9
10226464|NCT03841331|11354855|FG001|NOT COMPLETED|Overall Study||10
10226465|NCT03840278|11354861|FG000|STARTED|Overall Study||5
10226466|NCT03840278|11354862|FG001|STARTED|Overall Study||5
10226467|NCT03840278|11354861|FG000|COMPLETED|Overall Study||5
10226468|NCT03840278|11354862|FG001|COMPLETED|Overall Study||5
10226469|NCT03840278|11354861|FG000|NOT COMPLETED|Overall Study||0
10226470|NCT03840278|11354862|FG001|NOT COMPLETED|Overall Study||0
10226471|NCT03840135|11354870|FG000|STARTED|Overall Study||86
10226472|NCT03840135|11354871|FG001|STARTED|Overall Study||86
10226473|NCT03840135|11354870|FG000|COMPLETED|Overall Study||79
10226474|NCT03840135|11354871|FG001|COMPLETED|Overall Study||85
10226475|NCT03840135|11354870|FG000|NOT COMPLETED|Overall Study||7
10226476|NCT03840135|11354871|FG001|NOT COMPLETED|Overall Study||1
10226477|NCT03839641|11354883|FG000|STARTED|Overall Study||5
10226478|NCT03839641|11354884|FG001|STARTED|Overall Study||5
10226479|NCT03839641|11354883|FG000|COMPLETED|Overall Study||4
10226480|NCT03839641|11354884|FG001|COMPLETED|Overall Study||4
10226481|NCT03839641|11354883|FG000|NOT COMPLETED|Overall Study||1
10226482|NCT03839641|11354884|FG001|NOT COMPLETED|Overall Study||1
10226483|NCT03839212|11354892|FG000|STARTED|Overall Study||18
10226484|NCT03839212|11354892|FG000|COMPLETED|Overall Study||14
10226485|NCT03839212|11354892|FG000|NOT COMPLETED|Overall Study||4
10226486|NCT03839355|11354898|FG000|STARTED|Overall Study||18
10226487|NCT03839355|11354899|FG001|STARTED|Overall Study||16
10226488|NCT03839355|11354898|FG000|COMPLETED|Overall Study||17
10226489|NCT03839355|11354899|FG001|COMPLETED|Overall Study||16
10226490|NCT03839355|11354898|FG000|NOT COMPLETED|Overall Study||1
10226491|NCT03839355|11354899|FG001|NOT COMPLETED|Overall Study||0
10226492|NCT03838874|11354907|FG000|STARTED|Overall Study||80
10226493|NCT03838874|11354908|FG001|STARTED|Overall Study||74
10226494|NCT03838874|11354907|FG000|COMPLETED|Overall Study||80
10226495|NCT03838874|11354908|FG001|COMPLETED|Overall Study||74
10226496|NCT03838874|11354907|FG000|NOT COMPLETED|Overall Study||0
10226497|NCT03838874|11354908|FG001|NOT COMPLETED|Overall Study||0
10226498|NCT03838731|11354916|FG000|STARTED|Overall Study||27
10226499|NCT03838731|11354917|FG001|STARTED|Overall Study||29
10226500|NCT03838731|11354916|FG000|COMPLETED|Overall Study||26
10226501|NCT03838731|11354917|FG001|COMPLETED|Overall Study||28
10226502|NCT03838731|11354916|FG000|NOT COMPLETED|Overall Study||1
10226503|NCT03838731|11354917|FG001|NOT COMPLETED|Overall Study||1
10226504|NCT03838198|11354925|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
10226505|NCT03838198|11354926|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10226506|NCT03838198|11354927|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
10226507|NCT03838198|11354928|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10226508|NCT03838198|11354925|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10226509|NCT03838198|11354926|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10226510|NCT03838198|11354927|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10226511|NCT03838198|11354928|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10226512|NCT03838198|11354925|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10226513|NCT03838198|11354926|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10226514|NCT03838198|11354927|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10226515|NCT03838198|11354928|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10226516|NCT03838198|11354925|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
10226517|NCT03838198|11354926|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
10226518|NCT03838198|11354927|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
10226519|NCT03838198|11354928|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
10226520|NCT03838198|11354925|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
10226521|NCT03838198|11354926|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0
10226522|NCT03838198|11354927|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
10226523|NCT03838198|11354928|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0
10226524|NCT03838198|11354925|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
10226525|NCT03838198|11354926|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
10226526|NCT03838198|11354927|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
10226527|NCT03838198|11354928|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
10226528|NCT03838198|11354925|FG000|STARTED|1 Month Follow up Period||18
10226529|NCT03838198|11354926|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
10226530|NCT03838198|11354927|FG002|STARTED|1 Month Follow up Period||17
10226531|NCT03838198|11354928|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
10226532|NCT03838198|11354925|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16
10226533|NCT03838198|11354926|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22
10226534|NCT03838198|11354927|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16
10226535|NCT03838198|11354928|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22
10226536|NCT03838198|11354925|FG000|COMPLETED|1 Month Follow up Period||16
10226537|NCT03838198|11354926|FG001|COMPLETED|1 Month Follow up Period||22
10226538|NCT03838198|11354927|FG002|COMPLETED|1 Month Follow up Period||16
10226539|NCT03838198|11354928|FG003|COMPLETED|1 Month Follow up Period||21
10226540|NCT03838198|11354925|FG000|NOT COMPLETED|1 Month Follow up Period||2
10226541|NCT03838198|11354926|FG001|NOT COMPLETED|1 Month Follow up Period||0
10226542|NCT03838198|11354927|FG002|NOT COMPLETED|1 Month Follow up Period||1
10226543|NCT03838198|11354928|FG003|NOT COMPLETED|1 Month Follow up Period||1
10226544|NCT03838198|11354925|FG000|STARTED|3 Month Follow up Period||18
10226545|NCT03838198|11354926|FG001|STARTED|3 Month Follow up Period||22
10226546|NCT03838198|11354927|FG002|STARTED|3 Month Follow up Period||17
10226547|NCT03838198|11354928|FG003|STARTED|3 Month Follow up Period||22
10226548|NCT03838198|11354925|FG000|Adolescent Survey Completed|3 Month Follow up Period||16
10226549|NCT03838198|11354926|FG001|Adolescent Survey Completed|3 Month Follow up Period||21
10226550|NCT03838198|11354927|FG002|Adolescent Survey Completed|3 Month Follow up Period||15
10226551|NCT03838198|11354928|FG003|Adolescent Survey Completed|3 Month Follow up Period||21
10226552|NCT03838198|11354925|FG000|COMPLETED|3 Month Follow up Period||15
10226553|NCT03838198|11354926|FG001|COMPLETED|3 Month Follow up Period||19
10226554|NCT03838198|11354927|FG002|COMPLETED|3 Month Follow up Period||14
10226555|NCT03838198|11354928|FG003|COMPLETED|3 Month Follow up Period||18
10226556|NCT03838198|11354925|FG000|NOT COMPLETED|3 Month Follow up Period||3
10226557|NCT03838198|11354926|FG001|NOT COMPLETED|3 Month Follow up Period||3
10226558|NCT03838198|11354927|FG002|NOT COMPLETED|3 Month Follow up Period||3
10226559|NCT03838198|11354928|FG003|NOT COMPLETED|3 Month Follow up Period||4
10226560|NCT03831451|11354941|FG000|STARTED|Overall Study||74
10226561|NCT03831451|11354942|FG001|STARTED|Overall Study||55
10226562|NCT03831451|11354941|FG000|COMPLETED|Overall Study||74
10226563|NCT03831451|11354942|FG001|COMPLETED|Overall Study||55
10226564|NCT03831451|11354941|FG000|NOT COMPLETED|Overall Study||0
10226565|NCT03831451|11354942|FG001|NOT COMPLETED|Overall Study||0
10226566|NCT03822078|11354954|FG000|STARTED|Overall Study||12
10226567|NCT03822078|11354955|FG001|STARTED|Overall Study||6
10226568|NCT03822078|11354956|FG002|STARTED|Overall Study||6
10226569|NCT03822078|11354957|FG003|STARTED|Overall Study||8
10226570|NCT03822078|11354958|FG004|STARTED|Overall Study||7
10226571|NCT03822078|11354959|FG005|STARTED|Overall Study||6
10226572|NCT03822078|11354954|FG000|Received Study Drug|Overall Study||10
10226573|NCT03822078|11354955|FG001|Received Study Drug|Overall Study||6
10226574|NCT03822078|11354956|FG002|Received Study Drug|Overall Study||6
10226575|NCT03822078|11354957|FG003|Received Study Drug|Overall Study||6
10226576|NCT03822078|11354958|FG004|Received Study Drug|Overall Study||6
10226577|NCT03822078|11354959|FG005|Received Study Drug|Overall Study||6
10226578|NCT03822078|11354954|FG000|COMPLETED|Overall Study||10
10226579|NCT03822078|11354955|FG001|COMPLETED|Overall Study||6
10226580|NCT03822078|11354956|FG002|COMPLETED|Overall Study||6
10226581|NCT03822078|11354957|FG003|COMPLETED|Overall Study||6
10226582|NCT03822078|11354958|FG004|COMPLETED|Overall Study||6
10226583|NCT03822078|11354959|FG005|COMPLETED|Overall Study||6
10226584|NCT03822078|11354954|FG000|NOT COMPLETED|Overall Study||2
10226585|NCT03822078|11354955|FG001|NOT COMPLETED|Overall Study||0
10226586|NCT03822078|11354956|FG002|NOT COMPLETED|Overall Study||0
10226587|NCT03822078|11354957|FG003|NOT COMPLETED|Overall Study||2
10226588|NCT03822078|11354958|FG004|NOT COMPLETED|Overall Study||1
10226589|NCT03822078|11354959|FG005|NOT COMPLETED|Overall Study||0
10226590|NCT03815240|11354979|FG000|STARTED|Intervention no Dressing||2
10226591|NCT03815240|11354980|FG001|STARTED|Intervention no Dressing||1
10226592|NCT03815240|11354981|FG002|STARTED|Intervention no Dressing||1
10226593|NCT03815240|11354982|FG003|STARTED|Intervention no Dressing||2
10226594|NCT03815240|11354983|FG004|STARTED|Intervention no Dressing||1
10226595|NCT03815240|11354984|FG005|STARTED|Intervention no Dressing||2
10226596|NCT03815240|11354985|FG006|STARTED|Intervention no Dressing||1
10226597|NCT03815240|11354986|FG007|STARTED|Intervention no Dressing||1
10226598|NCT03815240|11354987|FG008|STARTED|Intervention no Dressing||1
10226599|NCT03815240|11354979|FG000|COMPLETED|Intervention no Dressing||2
10226600|NCT03815240|11354980|FG001|COMPLETED|Intervention no Dressing||1
10226601|NCT03815240|11354981|FG002|COMPLETED|Intervention no Dressing||1
10226602|NCT03815240|11354982|FG003|COMPLETED|Intervention no Dressing||2
10226603|NCT03815240|11354983|FG004|COMPLETED|Intervention no Dressing||1
10226604|NCT03815240|11354984|FG005|COMPLETED|Intervention no Dressing||2
10226605|NCT03815240|11354985|FG006|COMPLETED|Intervention no Dressing||1
10226606|NCT03815240|11354986|FG007|COMPLETED|Intervention no Dressing||1
10226607|NCT03815240|11354987|FG008|COMPLETED|Intervention no Dressing||1
10226608|NCT03815240|11354979|FG000|NOT COMPLETED|Intervention no Dressing||0
10226609|NCT03815240|11354980|FG001|NOT COMPLETED|Intervention no Dressing||0
10226610|NCT03815240|11354981|FG002|NOT COMPLETED|Intervention no Dressing||0
10226611|NCT03815240|11354982|FG003|NOT COMPLETED|Intervention no Dressing||0
10226612|NCT03815240|11354983|FG004|NOT COMPLETED|Intervention no Dressing||0
10226613|NCT03815240|11354984|FG005|NOT COMPLETED|Intervention no Dressing||0
10226614|NCT03815240|11354985|FG006|NOT COMPLETED|Intervention no Dressing||0
10226615|NCT03815240|11354986|FG007|NOT COMPLETED|Intervention no Dressing||0
10226616|NCT03815240|11354987|FG008|NOT COMPLETED|Intervention no Dressing||0
10226617|NCT03815240|11354979|FG000|STARTED|Intervention Mepilex Dressing||2
10226618|NCT03815240|11354980|FG001|STARTED|Intervention Mepilex Dressing||1
10226619|NCT03815240|11354981|FG002|STARTED|Intervention Mepilex Dressing||1
10226620|NCT03815240|11354982|FG003|STARTED|Intervention Mepilex Dressing||2
10226621|NCT03815240|11354983|FG004|STARTED|Intervention Mepilex Dressing||1
10226622|NCT03815240|11354984|FG005|STARTED|Intervention Mepilex Dressing||2
10226623|NCT03815240|11354985|FG006|STARTED|Intervention Mepilex Dressing||1
10226624|NCT03815240|11354986|FG007|STARTED|Intervention Mepilex Dressing||1
10226625|NCT03815240|11354987|FG008|STARTED|Intervention Mepilex Dressing||1
10226626|NCT03815240|11354979|FG000|COMPLETED|Intervention Mepilex Dressing||2
10226627|NCT03815240|11354980|FG001|COMPLETED|Intervention Mepilex Dressing||1
10226628|NCT03815240|11354981|FG002|COMPLETED|Intervention Mepilex Dressing||1
10226629|NCT03815240|11354982|FG003|COMPLETED|Intervention Mepilex Dressing||2
10226630|NCT03815240|11354983|FG004|COMPLETED|Intervention Mepilex Dressing||1
10226631|NCT03815240|11354984|FG005|COMPLETED|Intervention Mepilex Dressing||2
10226632|NCT03815240|11354985|FG006|COMPLETED|Intervention Mepilex Dressing||1
10226633|NCT03815240|11354986|FG007|COMPLETED|Intervention Mepilex Dressing||1
10226634|NCT03815240|11354987|FG008|COMPLETED|Intervention Mepilex Dressing||1
10226635|NCT03815240|11354979|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0
10226636|NCT03815240|11354980|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0
10226637|NCT03815240|11354981|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0
10226638|NCT03815240|11354982|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0
10226639|NCT03815240|11354983|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0
10226640|NCT03815240|11354984|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0
10226641|NCT03815240|11354985|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0
10226642|NCT03815240|11354986|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0
10226643|NCT03815240|11354987|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0
10226644|NCT03815240|11354979|FG000|STARTED|Intervention Allevyn Dressing||2
10226645|NCT03815240|11354980|FG001|STARTED|Intervention Allevyn Dressing||1
10226646|NCT03815240|11354981|FG002|STARTED|Intervention Allevyn Dressing||1
10226647|NCT03815240|11354982|FG003|STARTED|Intervention Allevyn Dressing||2
10226648|NCT03815240|11354983|FG004|STARTED|Intervention Allevyn Dressing||1
10226649|NCT03815240|11354984|FG005|STARTED|Intervention Allevyn Dressing||2
10226650|NCT03815240|11354985|FG006|STARTED|Intervention Allevyn Dressing||1
10226651|NCT03815240|11354986|FG007|STARTED|Intervention Allevyn Dressing||1
10226652|NCT03815240|11354987|FG008|STARTED|Intervention Allevyn Dressing||1
10226653|NCT03815240|11354979|FG000|COMPLETED|Intervention Allevyn Dressing||2
10226654|NCT03815240|11354980|FG001|COMPLETED|Intervention Allevyn Dressing||1
10226655|NCT03815240|11354981|FG002|COMPLETED|Intervention Allevyn Dressing||1
10226656|NCT03815240|11354982|FG003|COMPLETED|Intervention Allevyn Dressing||2
10226657|NCT03815240|11354983|FG004|COMPLETED|Intervention Allevyn Dressing||1
10226658|NCT03815240|11354984|FG005|COMPLETED|Intervention Allevyn Dressing||2
10226659|NCT03815240|11354985|FG006|COMPLETED|Intervention Allevyn Dressing||1
10226660|NCT03815240|11354986|FG007|COMPLETED|Intervention Allevyn Dressing||1
10226661|NCT03815240|11354987|FG008|COMPLETED|Intervention Allevyn Dressing||1
10226662|NCT03815240|11354979|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0
10226663|NCT03815240|11354980|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0
10226664|NCT03815240|11354981|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0
10226665|NCT03815240|11354982|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0
10226666|NCT03815240|11354983|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0
10226667|NCT03815240|11354984|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0
10226668|NCT03815240|11354985|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0
10226669|NCT03815240|11354986|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0
10226670|NCT03815240|11354987|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0
10226671|NCT03815240|11354979|FG000|STARTED|Intervention Optifoam Dressing||2
10226672|NCT03815240|11354980|FG001|STARTED|Intervention Optifoam Dressing||1
10226673|NCT03815240|11354981|FG002|STARTED|Intervention Optifoam Dressing||1
10226674|NCT03815240|11354982|FG003|STARTED|Intervention Optifoam Dressing||2
10226675|NCT03815240|11354983|FG004|STARTED|Intervention Optifoam Dressing||1
10226676|NCT03815240|11354984|FG005|STARTED|Intervention Optifoam Dressing||2
10226677|NCT03815240|11354985|FG006|STARTED|Intervention Optifoam Dressing||1
10226678|NCT03815240|11354986|FG007|STARTED|Intervention Optifoam Dressing||1
10226679|NCT03815240|11354987|FG008|STARTED|Intervention Optifoam Dressing||1
10226680|NCT03815240|11354979|FG000|COMPLETED|Intervention Optifoam Dressing||2
10226681|NCT03815240|11354980|FG001|COMPLETED|Intervention Optifoam Dressing||1
10226682|NCT03815240|11354981|FG002|COMPLETED|Intervention Optifoam Dressing||1
10226683|NCT03815240|11354982|FG003|COMPLETED|Intervention Optifoam Dressing||2
10226684|NCT03815240|11354983|FG004|COMPLETED|Intervention Optifoam Dressing||1
10226685|NCT03815240|11354984|FG005|COMPLETED|Intervention Optifoam Dressing||2
10226686|NCT03815240|11354985|FG006|COMPLETED|Intervention Optifoam Dressing||1
10226687|NCT03815240|11354986|FG007|COMPLETED|Intervention Optifoam Dressing||1
10226688|NCT03815240|11354987|FG008|COMPLETED|Intervention Optifoam Dressing||1
10226689|NCT03815240|11354979|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0
10226690|NCT03815240|11354980|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0
10226691|NCT03815240|11354981|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0
10226692|NCT03815240|11354982|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0
10226693|NCT03815240|11354983|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0
10226694|NCT03815240|11354984|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0
10226695|NCT03815240|11354985|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0
10226696|NCT03815240|11354986|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0
10226697|NCT03815240|11354987|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0
10226698|NCT03836859|11355005|FG000|STARTED|Overall Study||20
10226699|NCT03836859|11355006|FG001|STARTED|Overall Study||10
10226700|NCT03836859|11355005|FG000|COMPLETED|Overall Study||20
10226701|NCT03836859|11355006|FG001|COMPLETED|Overall Study||10
10226702|NCT03836859|11355005|FG000|NOT COMPLETED|Overall Study||0
10226703|NCT03836859|11355006|FG001|NOT COMPLETED|Overall Study||0
9952101|NCT01419717|11070994|FG000|NOT COMPLETED|Overall Study||125
9952102|NCT01419769|11070998|FG000|STARTED|Overall Study||33
9952103|NCT01419769|11070998|FG000|COMPLETED|Overall Study||29
9952104|NCT01419769|11070998|FG000|NOT COMPLETED|Overall Study||4
9952105|NCT01419795|11071004|FG000|STARTED|Overall Study||3
9952106|NCT01419795|11071005|FG001|STARTED|Overall Study||0
10226704|NCT03835078|11355012|FG000|STARTED|Overall Study||39
10226705|NCT03835078|11355012|FG000|COMPLETED|Overall Study||39
10226706|NCT03835078|11355012|FG000|NOT COMPLETED|Overall Study||0
9952107|NCT01419795|11071004|FG000|COMPLETED|Overall Study||3
9952108|NCT01419795|11071005|FG001|COMPLETED|Overall Study||0
9952109|NCT01419795|11071004|FG000|NOT COMPLETED|Overall Study||0
9952110|NCT01419795|11071005|FG001|NOT COMPLETED|Overall Study||0
9952111|NCT01419977|11071013|FG000|STARTED|Overall Study||16
9952112|NCT01419977|11071014|FG001|STARTED|Overall Study||13
9952113|NCT01419977|11071013|FG000|COMPLETED|Overall Study||16
9952114|NCT01419977|11071014|FG001|COMPLETED|Overall Study||13
9952115|NCT01419977|11071013|FG000|NOT COMPLETED|Overall Study||0
9952116|NCT01419977|11071014|FG001|NOT COMPLETED|Overall Study||0
10012926|NCT01788423|11135871|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
10012927|NCT01788423|11135872|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
10226707|NCT03834025|11355025|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150
10226708|NCT03834025|11355026|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871
10226709|NCT03834025|11355027|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121
10226710|NCT03834025|11355028|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693
10226711|NCT03834025|11355029|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0
10226712|NCT03834025|11355030|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0
10226713|NCT03834025|11355031|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0
10226714|NCT03834025|11355025|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
10226715|NCT03834025|11355026|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
10226716|NCT03834025|11355027|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
10226717|NCT03834025|11355028|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
10226718|NCT03834025|11355029|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0
10226719|NCT03834025|11355030|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0
10226720|NCT03834025|11355031|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0
10226721|NCT03834025|11355025|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
10226722|NCT03834025|11355026|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
10226723|NCT03834025|11355027|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
10226724|NCT03834025|11355028|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
10226725|NCT03834025|11355029|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
10226726|NCT03834025|11355030|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
10226727|NCT03834025|11355031|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
10012928|NCT01788423|11135870|FG000|NOT COMPLETED|Overall Study||0
10226728|NCT03834025|11355025|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36
10226729|NCT03834025|11355026|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36
10226730|NCT03834025|11355027|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44
10226731|NCT03834025|11355028|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44
10226732|NCT03834025|11355029|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0
10226733|NCT03834025|11355030|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0
10226734|NCT03834025|11355031|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0
10226735|NCT03834025|11355025|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
10226736|NCT03834025|11355026|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
10226737|NCT03834025|11355027|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
10226738|NCT03834025|11355028|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
10226739|NCT03834025|11355029|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
10226740|NCT03834025|11355030|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
9952117|NCT01420016|11071022|FG000|STARTED|Primary Analysis||6970
9952118|NCT01420016|11071023|FG001|STARTED|Primary Analysis||6411
10226741|NCT03834025|11355031|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
10226742|NCT03834025|11355025|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0
10226743|NCT03834025|11355026|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0
10226744|NCT03834025|11355027|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0
10226745|NCT03834025|11355028|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0
9952119|NCT01420016|11071024|FG002|STARTED|Primary Analysis||0
9952120|NCT01420016|11071025|FG003|STARTED|Primary Analysis||0
10226746|NCT03834025|11355029|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24
10226747|NCT03834025|11355030|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21
10226748|NCT03834025|11355031|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28
10226749|NCT03834025|11355025|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226750|NCT03834025|11355026|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226751|NCT03834025|11355027|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226752|NCT03834025|11355028|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226753|NCT03834025|11355029|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24
10226754|NCT03834025|11355030|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21
10226755|NCT03834025|11355031|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27
10226756|NCT03834025|11355025|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226757|NCT03834025|11355026|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226758|NCT03834025|11355027|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226759|NCT03834025|11355028|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226760|NCT03834025|11355029|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226761|NCT03834025|11355030|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10226762|NCT03834025|11355031|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
10226763|NCT03836677|11355047|FG000|STARTED|Period 1||13
10226764|NCT03836677|11355048|FG001|STARTED|Period 1||10
10226765|NCT03836677|11355047|FG000|COMPLETED|Period 1||13
10226766|NCT03836677|11355048|FG001|COMPLETED|Period 1||9
10226767|NCT03836677|11355047|FG000|NOT COMPLETED|Period 1||0
10226768|NCT03836677|11355048|FG001|NOT COMPLETED|Period 1||1
10226769|NCT03836677|11355047|FG000|STARTED|Washout||13
10226770|NCT03836677|11355048|FG001|STARTED|Washout||9
10226771|NCT03836677|11355047|FG000|COMPLETED|Washout||13
10226772|NCT03836677|11355048|FG001|COMPLETED|Washout||9
10226773|NCT03836677|11355047|FG000|NOT COMPLETED|Washout||0
10226774|NCT03836677|11355048|FG001|NOT COMPLETED|Washout||0
10226775|NCT03836677|11355047|FG000|STARTED|Period 2||13
10226776|NCT03836677|11355048|FG001|STARTED|Period 2||9
10226777|NCT03836677|11355047|FG000|COMPLETED|Period 2||12
10226778|NCT03836677|11355048|FG001|COMPLETED|Period 2||9
10226779|NCT03836677|11355047|FG000|NOT COMPLETED|Period 2||1
10226780|NCT03836677|11355048|FG001|NOT COMPLETED|Period 2||0
10226781|NCT03836989|11355056|FG000|STARTED|Overall Study||4
10226782|NCT03836989|11355057|FG001|STARTED|Overall Study||0
10226783|NCT03836989|11355056|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
10226784|NCT03836989|11355057|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
10226785|NCT03836989|11355056|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
10226786|NCT03836989|11355057|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
10226787|NCT03836989|11355056|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
10226788|NCT03836989|11355057|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
10226789|NCT03836989|11355056|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
10226790|NCT03836989|11355057|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
10226791|NCT03836989|11355056|FG000|COMPLETED|Overall Study||4
10226792|NCT03836989|11355057|FG001|COMPLETED|Overall Study||0
10226793|NCT03836989|11355056|FG000|NOT COMPLETED|Overall Study||0
10226794|NCT03836989|11355057|FG001|NOT COMPLETED|Overall Study||0
10226795|NCT03827564|11355068|FG000|STARTED|Overall Study||9
10226796|NCT03827564|11355069|FG001|STARTED|Overall Study||5
10226797|NCT03827564|11355068|FG000|COMPLETED|Overall Study||8
10226798|NCT03827564|11355069|FG001|COMPLETED|Overall Study||5
10226799|NCT03827564|11355068|FG000|NOT COMPLETED|Overall Study||1
10226800|NCT03827564|11355069|FG001|NOT COMPLETED|Overall Study||0
10226801|NCT03824236|11355078|FG000|STARTED|Overall Study||25
10226802|NCT03824236|11355079|FG001|STARTED|Overall Study||24
10226803|NCT03824236|11355080|FG002|STARTED|Overall Study||12
10226804|NCT03824236|11355078|FG000|COMPLETED|Overall Study||25
10226805|NCT03824236|11355079|FG001|COMPLETED|Overall Study||24
10226806|NCT03824236|11355080|FG002|COMPLETED|Overall Study||11
10226807|NCT03824236|11355078|FG000|NOT COMPLETED|Overall Study||0
10226808|NCT03824236|11355079|FG001|NOT COMPLETED|Overall Study||0
10226809|NCT03824236|11355080|FG002|NOT COMPLETED|Overall Study||1
10226810|NCT03811951|11355090|FG000|STARTED|First Intervention (1 Day)||2
10226811|NCT03811951|11355091|FG001|STARTED|First Intervention (1 Day)||2
10226812|NCT03811951|11355090|FG000|COMPLETED|First Intervention (1 Day)||2
10226813|NCT03811951|11355091|FG001|COMPLETED|First Intervention (1 Day)||2
10226814|NCT03811951|11355090|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10226815|NCT03811951|11355091|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10226816|NCT03811951|11355090|FG000|STARTED|Washout (1 Week)||2
10226817|NCT03811951|11355091|FG001|STARTED|Washout (1 Week)||2
10226818|NCT03811951|11355090|FG000|COMPLETED|Washout (1 Week)||2
10226819|NCT03811951|11355091|FG001|COMPLETED|Washout (1 Week)||2
10226820|NCT03811951|11355090|FG000|NOT COMPLETED|Washout (1 Week)||0
10226821|NCT03811951|11355091|FG001|NOT COMPLETED|Washout (1 Week)||0
10226822|NCT03811951|11355090|FG000|STARTED|Second Intervention (1 Day)||2
10226823|NCT03811951|11355091|FG001|STARTED|Second Intervention (1 Day)||2
10226824|NCT03811951|11355090|FG000|COMPLETED|Second Intervention (1 Day)||2
10226825|NCT03811951|11355091|FG001|COMPLETED|Second Intervention (1 Day)||2
10226826|NCT03811951|11355090|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10226827|NCT03811951|11355091|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10226828|NCT03810235|11355101|FG000|STARTED|Overall Study||32
10226829|NCT03810235|11355102|FG001|STARTED|Overall Study||31
10226830|NCT03810235|11355101|FG000|Participant Data Analyzed|Overall Study||30
10226831|NCT03810235|11355102|FG001|Participant Data Analyzed|Overall Study||31
10226832|NCT03810235|11355101|FG000|COMPLETED|Overall Study||30
10226833|NCT03810235|11355102|FG001|COMPLETED|Overall Study||31
10226834|NCT03810235|11355101|FG000|NOT COMPLETED|Overall Study||2
10226835|NCT03810235|11355102|FG001|NOT COMPLETED|Overall Study||0
10226836|NCT03806556|11355111|FG000|STARTED|Overall Study||6
10226837|NCT03806556|11355112|FG001|STARTED|Overall Study||5
10226838|NCT03806556|11355111|FG000|COMPLETED|Overall Study||6
10226839|NCT03806556|11355112|FG001|COMPLETED|Overall Study||5
10226840|NCT03806556|11355111|FG000|NOT COMPLETED|Overall Study||0
10226841|NCT03806556|11355112|FG001|NOT COMPLETED|Overall Study||0
10226842|NCT03836664|11355121|FG000|STARTED|Overall Study||14
10226843|NCT03836664|11355122|FG001|STARTED|Overall Study||11
10226844|NCT03836664|11355121|FG000|COMPLETED|Overall Study||11
10226845|NCT03836664|11355122|FG001|COMPLETED|Overall Study||8
10226846|NCT03836664|11355121|FG000|NOT COMPLETED|Overall Study||3
10226847|NCT03836664|11355122|FG001|NOT COMPLETED|Overall Study||3
10226848|NCT03832738|11355135|FG000|STARTED|Overall Study||51
10226849|NCT03832738|11355136|FG001|STARTED|Overall Study||50
10226850|NCT03832738|11355137|FG002|STARTED|Overall Study||51
10226851|NCT03832738|11355135|FG000|COMPLETED|Overall Study||43
10226852|NCT03832738|11355136|FG001|COMPLETED|Overall Study||38
10226853|NCT03832738|11355137|FG002|COMPLETED|Overall Study||32
10226854|NCT03832738|11355135|FG000|NOT COMPLETED|Overall Study||8
10226855|NCT03832738|11355136|FG001|NOT COMPLETED|Overall Study||12
10226856|NCT03832738|11355137|FG002|NOT COMPLETED|Overall Study||19
10226857|NCT03823391|11355147|FG000|STARTED|Period 1: Week 1 to Week 12||17
10226858|NCT03823391|11355148|FG001|STARTED|Period 1: Week 1 to Week 12||31
10226859|NCT03823391|11355147|FG000|COMPLETED|Period 1: Week 1 to Week 12||17
10226860|NCT03823391|11355148|FG001|COMPLETED|Period 1: Week 1 to Week 12||31
10226861|NCT03823391|11355147|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0
10226862|NCT03823391|11355148|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0
10226863|NCT03823391|11355147|FG000|STARTED|Period 2: Weeks 12 to Week 24||17
10226864|NCT03823391|11355148|FG001|STARTED|Period 2: Weeks 12 to Week 24||31
10226865|NCT03823391|11355147|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15
10226866|NCT03823391|11355148|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30
10226867|NCT03823391|11355147|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
10226868|NCT03823391|11355148|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
10226869|NCT03820258|11355156|FG000|STARTED|Overall Study||21
10226870|NCT03820258|11355156|FG000|COMPLETED|Overall Study||21
10226871|NCT03820258|11355156|FG000|NOT COMPLETED|Overall Study||0
10226872|NCT03819491|11355162|FG000|STARTED|Before Randomization||24
10226873|NCT03819491|11355163|FG001|STARTED|Before Randomization||0
10226874|NCT03819491|11355162|FG000|COMPLETED|Before Randomization||24
10226875|NCT03819491|11355163|FG001|COMPLETED|Before Randomization||0
10012929|NCT01788423|11135871|FG001|NOT COMPLETED|Overall Study||4
10012930|NCT01788423|11135872|FG002|NOT COMPLETED|Overall Study||5
10012931|NCT01788566|11135880|FG000|STARTED|Overall Study||61
10012932|NCT01788566|11135880|FG000|COMPLETED|Overall Study||53
10012933|NCT01788566|11135880|FG000|NOT COMPLETED|Overall Study||8
10012934|NCT01788631|11135886|FG000|STARTED|Overall Study||52
10012935|NCT01788631|11135887|FG001|STARTED|Overall Study||44
10012936|NCT01788631|11135886|FG000|Randomized|Overall Study||53
10012937|NCT01788631|11135887|FG001|Randomized|Overall Study||47
10012938|NCT01788631|11135886|FG000|COMPLETED|Overall Study||49
10012939|NCT01788631|11135887|FG001|COMPLETED|Overall Study||43
10012940|NCT01788631|11135886|FG000|NOT COMPLETED|Overall Study||3
10012941|NCT01788631|11135887|FG001|NOT COMPLETED|Overall Study||1
10012942|NCT01788943|11135895|FG000|STARTED|Overall Study|Recruitment for study began.|13
10012943|NCT01788943|11135896|FG001|STARTED|Overall Study||12
10012944|NCT01788943|11135895|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
10012945|NCT01788943|11135896|FG001|COMPLETED|Overall Study||12
10012946|NCT01788943|11135895|FG000|NOT COMPLETED|Overall Study||1
10012947|NCT01788943|11135896|FG001|NOT COMPLETED|Overall Study||0
10012948|NCT01789047|11135904|FG000|STARTED|Overall Study||21
10012949|NCT01789047|11135905|FG001|STARTED|Overall Study||21
10012950|NCT01789047|11135904|FG000|COMPLETED|Overall Study||17
10012951|NCT01789047|11135905|FG001|COMPLETED|Overall Study||17
10226876|NCT03819491|11355162|FG000|NOT COMPLETED|Before Randomization||0
10226877|NCT03819491|11355163|FG001|NOT COMPLETED|Before Randomization||0
10226878|NCT03819491|11355162|FG000|STARTED|After Randomization||12
10226879|NCT03819491|11355163|FG001|STARTED|After Randomization||12
10226880|NCT03819491|11355162|FG000|COMPLETED|After Randomization||12
10226881|NCT03819491|11355163|FG001|COMPLETED|After Randomization||12
10226882|NCT03819491|11355162|FG000|NOT COMPLETED|After Randomization||0
10226883|NCT03819491|11355163|FG001|NOT COMPLETED|After Randomization||0
10226884|NCT03808298|11355170|FG000|STARTED|Overall Study||57
10012952|NCT01789047|11135904|FG000|NOT COMPLETED|Overall Study||4
10012953|NCT01789047|11135905|FG001|NOT COMPLETED|Overall Study||4
10012954|NCT01789138|11135913|FG000|STARTED|Overall Study||254
10012955|NCT01789138|11135914|FG001|STARTED|Overall Study||258
10012956|NCT01789138|11135913|FG000|COMPLETED|Overall Study||213
10012957|NCT01789138|11135914|FG001|COMPLETED|Overall Study||206
10012958|NCT01789138|11135913|FG000|NOT COMPLETED|Overall Study||41
10012959|NCT01789138|11135914|FG001|NOT COMPLETED|Overall Study||52
10226885|NCT03808298|11355170|FG000|COMPLETED|Overall Study||49
10226886|NCT03808298|11355170|FG000|NOT COMPLETED|Overall Study||8
10226887|NCT03836729|11355199|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16
10226888|NCT03836729|11355199|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16
10226889|NCT03836729|11355199|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
10226890|NCT03836729|11355199|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16
10226891|NCT03836729|11355199|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15
10226892|NCT03836729|11355199|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
10226893|NCT03835975|11355212|FG000|STARTED|Overall Study||253
10226894|NCT03835975|11355213|FG001|STARTED|Overall Study||122
10226895|NCT03835975|11355214|FG002|STARTED|Overall Study||248
10226896|NCT03835975|11355215|FG003|STARTED|Overall Study||127
10226897|NCT03835975|11355216|FG004|STARTED|Overall Study||125
10226898|NCT03835975|11355212|FG000|Vaccinated|Overall Study||253
10226899|NCT03835975|11355213|FG001|Vaccinated|Overall Study||122
10226900|NCT03835975|11355214|FG002|Vaccinated|Overall Study||246
10226901|NCT03835975|11355215|FG003|Vaccinated|Overall Study||127
10226902|NCT03835975|11355216|FG004|Vaccinated|Overall Study||125
10226903|NCT03835975|11355212|FG000|Safety Population|Overall Study||253
10226904|NCT03835975|11355213|FG001|Safety Population|Overall Study||122
10226905|NCT03835975|11355214|FG002|Safety Population|Overall Study||246
10226906|NCT03835975|11355215|FG003|Safety Population|Overall Study||127
10226907|NCT03835975|11355216|FG004|Safety Population|Overall Study||125
10226908|NCT03835975|11355212|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
10226909|NCT03835975|11355213|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
10226910|NCT03835975|11355214|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
10226911|NCT03835975|11355215|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
10226912|NCT03835975|11355216|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
10226913|NCT03835975|11355212|FG000|COMPLETED|Overall Study||250
10226914|NCT03835975|11355213|FG001|COMPLETED|Overall Study||119
10226915|NCT03835975|11355214|FG002|COMPLETED|Overall Study||245
10226916|NCT03835975|11355215|FG003|COMPLETED|Overall Study||126
10226917|NCT03835975|11355216|FG004|COMPLETED|Overall Study||125
10226918|NCT03835975|11355212|FG000|NOT COMPLETED|Overall Study||3
10226919|NCT03835975|11355213|FG001|NOT COMPLETED|Overall Study||3
10226920|NCT03835975|11355214|FG002|NOT COMPLETED|Overall Study||3
10226921|NCT03835975|11355215|FG003|NOT COMPLETED|Overall Study||1
10226922|NCT03835975|11355216|FG004|NOT COMPLETED|Overall Study||0
10226923|NCT03821259|11355230|FG000|STARTED|Overall Study||88
10226924|NCT03821259|11355230|FG000|COMPLETED|Overall Study||88
10226925|NCT03821259|11355230|FG000|NOT COMPLETED|Overall Study||0
10226926|NCT03803085|11355236|FG000|STARTED|Overall Study||30
10226927|NCT03803085|11355237|FG001|STARTED|Overall Study||30
10226928|NCT03803085|11355236|FG000|COMPLETED|Overall Study||28
10226929|NCT03803085|11355237|FG001|COMPLETED|Overall Study||28
10012960|NCT01789203|11135922|FG000|STARTED|Overall Study||133
10012961|NCT01789203|11135923|FG001|STARTED|Overall Study||67
10226930|NCT03803085|11355236|FG000|NOT COMPLETED|Overall Study||2
10226931|NCT03803085|11355237|FG001|NOT COMPLETED|Overall Study||2
10226932|NCT03801473|11355246|FG000|STARTED|Overall Study||21
10226933|NCT03801473|11355247|FG001|STARTED|Overall Study||21
10226934|NCT03801473|11355246|FG000|COMPLETED|Overall Study||18
10226935|NCT03801473|11355247|FG001|COMPLETED|Overall Study||19
10226936|NCT03801473|11355246|FG000|NOT COMPLETED|Overall Study||3
10226937|NCT03801473|11355247|FG001|NOT COMPLETED|Overall Study||2
10226938|NCT03834168|11355255|FG000|STARTED|Overall Study||19
10226939|NCT03834168|11355256|FG001|STARTED|Overall Study||23
10226940|NCT03834168|11355255|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
10226941|NCT03834168|11355256|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
10226942|NCT03834168|11355255|FG000|Ineligible Participants|Overall Study||3
10226943|NCT03834168|11355256|FG001|Ineligible Participants|Overall Study||7
10226944|NCT03834168|11355255|FG000|Unable to Complete the Protocol|Overall Study||0
10226945|NCT03834168|11355256|FG001|Unable to Complete the Protocol|Overall Study||1
10226946|NCT03834168|11355255|FG000|Study Dropouts|Overall Study||1
10226947|NCT03834168|11355256|FG001|Study Dropouts|Overall Study||0
10226948|NCT03834168|11355255|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19
10226949|NCT03834168|11355256|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23
10226950|NCT03834168|11355255|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
10226951|NCT03834168|11355256|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
10226952|NCT03834168|11355255|FG000|COMPLETED|Overall Study||18
10226953|NCT03834168|11355256|FG001|COMPLETED|Overall Study||22
10226954|NCT03834168|11355255|FG000|NOT COMPLETED|Overall Study||1
10226955|NCT03834168|11355256|FG001|NOT COMPLETED|Overall Study||1
10226956|NCT03828149|11355264|FG000|STARTED|First Intervention (Single Dose)||9
10226957|NCT03828149|11355265|FG001|STARTED|First Intervention (Single Dose)||8
10226958|NCT03828149|11355264|FG000|COMPLETED|First Intervention (Single Dose)||9
10226959|NCT03828149|11355265|FG001|COMPLETED|First Intervention (Single Dose)||8
10226960|NCT03828149|11355264|FG000|NOT COMPLETED|First Intervention (Single Dose)||0
10226961|NCT03828149|11355265|FG001|NOT COMPLETED|First Intervention (Single Dose)||0
10226962|NCT03828149|11355264|FG000|STARTED|Washout (6 Days)||9
10226963|NCT03828149|11355265|FG001|STARTED|Washout (6 Days)||8
10226964|NCT03828149|11355264|FG000|COMPLETED|Washout (6 Days)||9
10226965|NCT03828149|11355265|FG001|COMPLETED|Washout (6 Days)||8
10226966|NCT03828149|11355264|FG000|NOT COMPLETED|Washout (6 Days)||0
10012962|NCT01789203|11135922|FG000|COMPLETED|Overall Study||124
10012963|NCT01789203|11135923|FG001|COMPLETED|Overall Study||63
10226967|NCT03828149|11355265|FG001|NOT COMPLETED|Washout (6 Days)||0
10226968|NCT03828149|11355264|FG000|STARTED|Second Intervention (Single Dose)||9
10226969|NCT03828149|11355265|FG001|STARTED|Second Intervention (Single Dose)||8
10226970|NCT03828149|11355264|FG000|COMPLETED|Second Intervention (Single Dose)||9
10226971|NCT03828149|11355265|FG001|COMPLETED|Second Intervention (Single Dose)||8
10226972|NCT03828149|11355264|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0
10226973|NCT03828149|11355265|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0
10226974|NCT03835221|11355271|FG000|STARTED|Methafilcon A||43
10226975|NCT03835221|11355271|FG000|COMPLETED|Methafilcon A||42
10226976|NCT03835221|11355271|FG000|NOT COMPLETED|Methafilcon A||1
10226977|NCT03835221|11355271|FG000|STARTED|Fanfilcon A||42
10226978|NCT03835221|11355271|FG000|COMPLETED|Fanfilcon A||42
10226979|NCT03835221|11355271|FG000|NOT COMPLETED|Fanfilcon A||0
10226980|NCT03819634|11355277|FG000|STARTED|Overall Study||24
10226981|NCT03819634|11355277|FG000|COMPLETED|Overall Study||22
10226982|NCT03819634|11355277|FG000|NOT COMPLETED|Overall Study||2
10226983|NCT03812679|11355281|FG000|STARTED|Overall Study||22
10226984|NCT03812679|11355281|FG000|COMPLETED|Overall Study||14
10226985|NCT03812679|11355281|FG000|NOT COMPLETED|Overall Study||8
10226986|NCT03809052|11355296|FG000|STARTED|Overall Study||6
10226987|NCT03809052|11355297|FG001|STARTED|Overall Study||6
10226988|NCT03809052|11355298|FG002|STARTED|Overall Study||6
10226989|NCT03809052|11355299|FG003|STARTED|Overall Study||6
10226990|NCT03809052|11355300|FG004|STARTED|Overall Study||6
10226991|NCT03809052|11355301|FG005|STARTED|Overall Study||6
10226992|NCT03809052|11355302|FG006|STARTED|Overall Study||6
10226993|NCT03809052|11355303|FG007|STARTED|Overall Study||14
10226994|NCT03809052|11355304|FG008|STARTED|Overall Study||8
10226995|NCT03809052|11355305|FG009|STARTED|Overall Study||8
10226996|NCT03809052|11355306|FG010|STARTED|Overall Study||6
10226997|NCT03809052|11355296|FG000|COMPLETED|Overall Study||6
10226998|NCT03809052|11355297|FG001|COMPLETED|Overall Study||6
10226999|NCT03809052|11355298|FG002|COMPLETED|Overall Study||6
10227000|NCT03809052|11355299|FG003|COMPLETED|Overall Study||6
10227001|NCT03809052|11355300|FG004|COMPLETED|Overall Study||6
10227002|NCT03809052|11355301|FG005|COMPLETED|Overall Study||6
10227003|NCT03809052|11355302|FG006|COMPLETED|Overall Study||6
10227004|NCT03809052|11355303|FG007|COMPLETED|Overall Study||14
10227005|NCT03809052|11355304|FG008|COMPLETED|Overall Study||8
10227006|NCT03809052|11355305|FG009|COMPLETED|Overall Study||8
10227007|NCT03809052|11355306|FG010|COMPLETED|Overall Study||6
10227008|NCT03809052|11355296|FG000|NOT COMPLETED|Overall Study||0
10227009|NCT03809052|11355297|FG001|NOT COMPLETED|Overall Study||0
10227010|NCT03809052|11355298|FG002|NOT COMPLETED|Overall Study||0
10227011|NCT03809052|11355299|FG003|NOT COMPLETED|Overall Study||0
10227012|NCT03809052|11355300|FG004|NOT COMPLETED|Overall Study||0
10227013|NCT03809052|11355301|FG005|NOT COMPLETED|Overall Study||0
10227014|NCT03809052|11355302|FG006|NOT COMPLETED|Overall Study||0
10227015|NCT03809052|11355303|FG007|NOT COMPLETED|Overall Study||0
10227016|NCT03809052|11355304|FG008|NOT COMPLETED|Overall Study||0
10227017|NCT03809052|11355305|FG009|NOT COMPLETED|Overall Study||0
10227018|NCT03809052|11355306|FG010|NOT COMPLETED|Overall Study||0
10227019|NCT03801148|11355336|FG000|STARTED|Period 1 (2 Days)||31
10227020|NCT03801148|11355337|FG001|STARTED|Period 1 (2 Days)||31
10227021|NCT03801148|11355338|FG002|STARTED|Period 1 (2 Days)||30
10227022|NCT03801148|11355339|FG003|STARTED|Period 1 (2 Days)||30
10227023|NCT03801148|11355336|FG000|COMPLETED|Period 1 (2 Days)||30
10227024|NCT03801148|11355337|FG001|COMPLETED|Period 1 (2 Days)||30
10227025|NCT03801148|11355338|FG002|COMPLETED|Period 1 (2 Days)||30
10227026|NCT03801148|11355339|FG003|COMPLETED|Period 1 (2 Days)||30
10227027|NCT03801148|11355336|FG000|NOT COMPLETED|Period 1 (2 Days)||1
10227028|NCT03801148|11355337|FG001|NOT COMPLETED|Period 1 (2 Days)||1
10227029|NCT03801148|11355338|FG002|NOT COMPLETED|Period 1 (2 Days)||0
10227030|NCT03801148|11355339|FG003|NOT COMPLETED|Period 1 (2 Days)||0
10227031|NCT03801148|11355336|FG000|STARTED|Washout Period (at Least 5 Days)||30
10227032|NCT03801148|11355337|FG001|STARTED|Washout Period (at Least 5 Days)||30
10227033|NCT03801148|11355338|FG002|STARTED|Washout Period (at Least 5 Days)||30
10227034|NCT03801148|11355339|FG003|STARTED|Washout Period (at Least 5 Days)||30
10227035|NCT03801148|11355336|FG000|COMPLETED|Washout Period (at Least 5 Days)||30
10227036|NCT03801148|11355337|FG001|COMPLETED|Washout Period (at Least 5 Days)||30
10227037|NCT03801148|11355338|FG002|COMPLETED|Washout Period (at Least 5 Days)||29
10227038|NCT03801148|11355339|FG003|COMPLETED|Washout Period (at Least 5 Days)||29
10227039|NCT03801148|11355336|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0
10227040|NCT03801148|11355337|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0
10227041|NCT03801148|11355338|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1
10227042|NCT03801148|11355339|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1
10227043|NCT03801148|11355336|FG000|STARTED|Period 2 (2 Days)||30
10227044|NCT03801148|11355337|FG001|STARTED|Period 2 (2 Days)||30
10227045|NCT03801148|11355338|FG002|STARTED|Period 2 (2 Days)||29
10227046|NCT03801148|11355339|FG003|STARTED|Period 2 (2 Days)||29
10227047|NCT03801148|11355336|FG000|COMPLETED|Period 2 (2 Days)||30
10227048|NCT03801148|11355337|FG001|COMPLETED|Period 2 (2 Days)||30
10227049|NCT03801148|11355338|FG002|COMPLETED|Period 2 (2 Days)||29
10227050|NCT03801148|11355339|FG003|COMPLETED|Period 2 (2 Days)||29
10227051|NCT03801148|11355336|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10227052|NCT03801148|11355337|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10227053|NCT03801148|11355338|FG002|NOT COMPLETED|Period 2 (2 Days)||0
10227054|NCT03801148|11355339|FG003|NOT COMPLETED|Period 2 (2 Days)||0
10227055|NCT03801148|11355336|FG000|STARTED|Follow-Up (12 Days)||30
10227056|NCT03801148|11355337|FG001|STARTED|Follow-Up (12 Days)||30
10227057|NCT03801148|11355338|FG002|STARTED|Follow-Up (12 Days)||29
10227058|NCT03801148|11355339|FG003|STARTED|Follow-Up (12 Days)||29
10227059|NCT03801148|11355336|FG000|COMPLETED|Follow-Up (12 Days)||30
10227060|NCT03801148|11355337|FG001|COMPLETED|Follow-Up (12 Days)||29
10227061|NCT03801148|11355338|FG002|COMPLETED|Follow-Up (12 Days)||28
10227062|NCT03801148|11355339|FG003|COMPLETED|Follow-Up (12 Days)||29
10227063|NCT03801148|11355336|FG000|NOT COMPLETED|Follow-Up (12 Days)||0
10227064|NCT03801148|11355337|FG001|NOT COMPLETED|Follow-Up (12 Days)||1
10227065|NCT03801148|11355338|FG002|NOT COMPLETED|Follow-Up (12 Days)||1
10227066|NCT03801148|11355339|FG003|NOT COMPLETED|Follow-Up (12 Days)||0
10227067|NCT03832907|11355349|FG000|STARTED|Overall Study||101
10227068|NCT03832907|11355349|FG000|COMPLETED|Overall Study||91
10227069|NCT03832907|11355349|FG000|NOT COMPLETED|Overall Study||10
10227070|NCT03832322|11355355|FG000|STARTED|Overall Study||89
10227071|NCT03832322|11355356|FG001|STARTED|Overall Study||87
10227072|NCT03832322|11355355|FG000|COMPLETED|Overall Study||86
10227073|NCT03832322|11355356|FG001|COMPLETED|Overall Study||86
10227074|NCT03832322|11355355|FG000|NOT COMPLETED|Overall Study||3
10227075|NCT03832322|11355356|FG001|NOT COMPLETED|Overall Study||1
10227076|NCT03832387|11355366|FG000|STARTED|Overall Study||38
10227077|NCT03832387|11355367|FG001|STARTED|Overall Study||39
10227078|NCT03832387|11355366|FG000|COMPLETED|Overall Study||33
10227079|NCT03832387|11355367|FG001|COMPLETED|Overall Study||32
10227080|NCT03832387|11355366|FG000|NOT COMPLETED|Overall Study||5
10227081|NCT03832387|11355367|FG001|NOT COMPLETED|Overall Study||7
10227082|NCT03831971|11355373|FG000|STARTED|Overall Study||12
10227083|NCT03831971|11355373|FG000|COMPLETED|Overall Study||12
10227084|NCT03831971|11355373|FG000|NOT COMPLETED|Overall Study||0
10227085|NCT03831854|11355379|FG000|STARTED|Overall Study||23
10227086|NCT03831854|11355380|FG001|STARTED|Overall Study||23
10227087|NCT03831854|11355379|FG000|COMPLETED|Overall Study||23
10227088|NCT03831854|11355380|FG001|COMPLETED|Overall Study||23
10227089|NCT03831854|11355379|FG000|NOT COMPLETED|Overall Study||0
10227090|NCT03831854|11355380|FG001|NOT COMPLETED|Overall Study||0
10227091|NCT03807739|11355390|FG000|STARTED|Overall Study||9
10227092|NCT03807739|11355391|FG001|STARTED|Overall Study||10
10227093|NCT03807739|11355392|FG002|STARTED|Overall Study||9
10227094|NCT03807739|11355393|FG003|STARTED|Overall Study||10
10227095|NCT03807739|11355390|FG000|COMPLETED|Overall Study||7
10227096|NCT03807739|11355391|FG001|COMPLETED|Overall Study||10
10227097|NCT03807739|11355392|FG002|COMPLETED|Overall Study||9
10227098|NCT03807739|11355393|FG003|COMPLETED|Overall Study||10
10227099|NCT03807739|11355390|FG000|NOT COMPLETED|Overall Study||2
10227100|NCT03807739|11355391|FG001|NOT COMPLETED|Overall Study||0
10227101|NCT03807739|11355392|FG002|NOT COMPLETED|Overall Study||0
10227102|NCT03807739|11355393|FG003|NOT COMPLETED|Overall Study||0
10227103|NCT03831282|11355403|FG000|STARTED|Overall Study||12
10227104|NCT03831282|11355403|FG000|COMPLETED|Overall Study||11
10227105|NCT03831282|11355403|FG000|NOT COMPLETED|Overall Study||1
10227106|NCT03824912|11355410|FG000|STARTED|Overall Study||332
10227107|NCT03824912|11355411|FG001|STARTED|Overall Study||335
10227108|NCT03824912|11355412|FG002|STARTED|Overall Study||164
10227109|NCT03824912|11355410|FG000|COMPLETED|Overall Study||192
10227110|NCT03824912|11355411|FG001|COMPLETED|Overall Study||201
10227111|NCT03824912|11355412|FG002|COMPLETED|Overall Study||96
10227112|NCT03824912|11355410|FG000|NOT COMPLETED|Overall Study||140
10227113|NCT03824912|11355411|FG001|NOT COMPLETED|Overall Study||134
10227114|NCT03824912|11355412|FG002|NOT COMPLETED|Overall Study||68
10227115|NCT03822884|11355426|FG000|STARTED|Overall Study||4
10227116|NCT03822884|11355427|FG001|STARTED|Overall Study||4
10227117|NCT03822884|11355428|FG002|STARTED|Overall Study||4
10227118|NCT03822884|11355429|FG003|STARTED|Overall Study||4
10227119|NCT03822884|11355430|FG004|STARTED|Overall Study||4
10227120|NCT03822884|11355431|FG005|STARTED|Overall Study||4
10227121|NCT03822884|11355426|FG000|COMPLETED|Overall Study||4
10227122|NCT03822884|11355427|FG001|COMPLETED|Overall Study||4
10227123|NCT03822884|11355428|FG002|COMPLETED|Overall Study||4
10227124|NCT03822884|11355429|FG003|COMPLETED|Overall Study||4
10227125|NCT03822884|11355430|FG004|COMPLETED|Overall Study||3
10227126|NCT03822884|11355431|FG005|COMPLETED|Overall Study||4
10227127|NCT03822884|11355426|FG000|NOT COMPLETED|Overall Study||0
10227128|NCT03822884|11355427|FG001|NOT COMPLETED|Overall Study||0
10227129|NCT03822884|11355428|FG002|NOT COMPLETED|Overall Study||0
10227130|NCT03822884|11355429|FG003|NOT COMPLETED|Overall Study||0
10227131|NCT03822884|11355430|FG004|NOT COMPLETED|Overall Study||1
10012964|NCT01789203|11135922|FG000|NOT COMPLETED|Overall Study||9
10012965|NCT01789203|11135923|FG001|NOT COMPLETED|Overall Study||4
10012966|NCT01789255|11135931|FG000|STARTED|Overall Study||12
10227132|NCT03822884|11355431|FG005|NOT COMPLETED|Overall Study||0
10227133|NCT03816709|11355439|FG000|STARTED|Overall Study||25
10227134|NCT03816709|11355439|FG000|COMPLETED|Overall Study||25
10227135|NCT03816709|11355439|FG000|NOT COMPLETED|Overall Study||0
10227136|NCT03810014|11355447|FG000|STARTED|Overall Study||215
10227137|NCT03810014|11355448|FG001|STARTED|Overall Study||204
10227138|NCT03810014|11355449|FG002|STARTED|Overall Study||210
10227139|NCT03810014|11355450|FG003|STARTED|Overall Study||213
10227140|NCT03810014|11355447|FG000|COMPLETED|Overall Study||213
10227141|NCT03810014|11355448|FG001|COMPLETED|Overall Study||202
10227142|NCT03810014|11355449|FG002|COMPLETED|Overall Study||210
10227143|NCT03810014|11355450|FG003|COMPLETED|Overall Study||211
10227144|NCT03810014|11355447|FG000|NOT COMPLETED|Overall Study||2
10227145|NCT03810014|11355448|FG001|NOT COMPLETED|Overall Study||2
10227146|NCT03810014|11355449|FG002|NOT COMPLETED|Overall Study||0
10227147|NCT03810014|11355450|FG003|NOT COMPLETED|Overall Study||2
10227148|NCT03806270|11355463|FG000|STARTED|Overall Study||15
10227149|NCT03806270|11355464|FG001|STARTED|Overall Study||15
10227150|NCT03806270|11355465|FG002|STARTED|Overall Study||15
10227151|NCT03806270|11355463|FG000|COMPLETED|Overall Study||15
10227152|NCT03806270|11355464|FG001|COMPLETED|Overall Study||15
10227153|NCT03806270|11355465|FG002|COMPLETED|Overall Study||15
10227154|NCT03806270|11355463|FG000|NOT COMPLETED|Overall Study||0
10227155|NCT03806270|11355464|FG001|NOT COMPLETED|Overall Study||0
10227156|NCT03806270|11355465|FG002|NOT COMPLETED|Overall Study||0
10227157|NCT03830892|11355475|FG000|STARTED|Overall Study||25
10227158|NCT03830892|11355476|FG001|STARTED|Overall Study||23
10227159|NCT03830892|11355475|FG000|15 Watts, 10 mg Nicotine|Overall Study||19
10227160|NCT03830892|11355476|FG001|15 Watts, 10 mg Nicotine|Overall Study||17
10227161|NCT03830892|11355475|FG000|15 Watts, 30 mg Nicotine|Overall Study||19
10227162|NCT03830892|11355476|FG001|15 Watts, 30 mg Nicotine|Overall Study||17
10227163|NCT03830892|11355475|FG000|30 Watts, 10 mg Nicotine|Overall Study||19
10227164|NCT03830892|11355476|FG001|30 Watts, 10 mg Nicotine|Overall Study||17
10227165|NCT03830892|11355475|FG000|30 Watts, 30 mg Nicotine|Overall Study||19
10227166|NCT03830892|11355476|FG001|30 Watts, 30 mg Nicotine|Overall Study||17
10227167|NCT03830892|11355475|FG000|Own Brand|Overall Study||19
10227168|NCT03830892|11355476|FG001|Own Brand|Overall Study||17
10227169|NCT03830892|11355475|FG000|COMPLETED|Overall Study||19
10227170|NCT03830892|11355476|FG001|COMPLETED|Overall Study||17
10227171|NCT03830892|11355475|FG000|NOT COMPLETED|Overall Study||6
10227172|NCT03830892|11355476|FG001|NOT COMPLETED|Overall Study||6
10227173|NCT03830307|11355482|FG000|STARTED|Overall Study||5
10227174|NCT03830307|11355482|FG000|COMPLETED|Overall Study||5
10227175|NCT03830307|11355482|FG000|NOT COMPLETED|Overall Study||0
10227176|NCT03825042|11355488|FG000|STARTED|Overall Study||40
10227177|NCT03825042|11355489|FG001|STARTED|Overall Study||40
10227178|NCT03825042|11355488|FG000|COMPLETED|Overall Study||38
10227179|NCT03825042|11355489|FG001|COMPLETED|Overall Study||40
10227180|NCT03825042|11355488|FG000|NOT COMPLETED|Overall Study||2
10227181|NCT03825042|11355489|FG001|NOT COMPLETED|Overall Study||0
10227182|NCT03823378|11355501|FG000|STARTED|Overall Study||28
10227183|NCT03823378|11355502|FG001|STARTED|Overall Study||16
10227184|NCT03823378|11355503|FG002|STARTED|Overall Study||12
10227185|NCT03823378|11355504|FG003|STARTED|Overall Study||12
10227186|NCT03823378|11355505|FG004|STARTED|Overall Study||20
10227187|NCT03823378|11355506|FG005|STARTED|Overall Study||9
10227188|NCT03823378|11355501|FG000|COMPLETED|Overall Study||7
10227189|NCT03823378|11355502|FG001|COMPLETED|Overall Study||0
10227190|NCT03823378|11355503|FG002|COMPLETED|Overall Study||2
10227191|NCT03823378|11355504|FG003|COMPLETED|Overall Study||2
10227192|NCT03823378|11355505|FG004|COMPLETED|Overall Study||2
10227193|NCT03823378|11355506|FG005|COMPLETED|Overall Study||1
10227194|NCT03823378|11355501|FG000|NOT COMPLETED|Overall Study||21
10227195|NCT03823378|11355502|FG001|NOT COMPLETED|Overall Study||16
10227196|NCT03823378|11355503|FG002|NOT COMPLETED|Overall Study||10
10227197|NCT03823378|11355504|FG003|NOT COMPLETED|Overall Study||10
10227198|NCT03823378|11355505|FG004|NOT COMPLETED|Overall Study||18
10227199|NCT03823378|11355506|FG005|NOT COMPLETED|Overall Study||8
10227200|NCT03831191|11355524|FG000|STARTED|Induction Period (16 Weeks)||33
10227201|NCT03831191|11355525|FG001|STARTED|Induction Period (16 Weeks)||35
10227202|NCT03831191|11355526|FG002|STARTED|Induction Period (16 Weeks)||34
10227203|NCT03831191|11355527|FG003|STARTED|Induction Period (16 Weeks)||34
10227204|NCT03831191|11355528|FG004|STARTED|Induction Period (16 Weeks)||0
10227205|NCT03831191|11355529|FG005|STARTED|Induction Period (16 Weeks)||0
10227206|NCT03831191|11355530|FG006|STARTED|Induction Period (16 Weeks)||0
10227207|NCT03831191|11355531|FG007|STARTED|Induction Period (16 Weeks)||0
10227208|NCT03831191|11355532|FG008|STARTED|Induction Period (16 Weeks)||0
10227209|NCT03831191|11355533|FG009|STARTED|Induction Period (16 Weeks)||0
10227210|NCT03831191|11355534|FG010|STARTED|Induction Period (16 Weeks)||0
10227211|NCT03831191|11355535|FG011|STARTED|Induction Period (16 Weeks)||0
10227212|NCT03831191|11355536|FG012|STARTED|Induction Period (16 Weeks)||0
10227213|NCT03831191|11355537|FG013|STARTED|Induction Period (16 Weeks)||0
10227214|NCT03831191|11355538|FG014|STARTED|Induction Period (16 Weeks)||0
10227215|NCT03831191|11355524|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
10227216|NCT03831191|11355525|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
10227217|NCT03831191|11355526|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
10227218|NCT03831191|11355527|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
10227219|NCT03831191|11355528|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227220|NCT03831191|11355529|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227221|NCT03831191|11355530|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227222|NCT03831191|11355531|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227223|NCT03831191|11355532|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227224|NCT03831191|11355533|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227225|NCT03831191|11355534|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227226|NCT03831191|11355535|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227227|NCT03831191|11355536|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10239328|NCT00271102|11370865|FG000|COMPLETED|Overall Study||30
10227228|NCT03831191|11355537|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227229|NCT03831191|11355538|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10227230|NCT03831191|11355524|FG000|COMPLETED|Induction Period (16 Weeks)||10
10227231|NCT03831191|11355525|FG001|COMPLETED|Induction Period (16 Weeks)||14
10227232|NCT03831191|11355526|FG002|COMPLETED|Induction Period (16 Weeks)||13
10227233|NCT03831191|11355527|FG003|COMPLETED|Induction Period (16 Weeks)||11
10227234|NCT03831191|11355528|FG004|COMPLETED|Induction Period (16 Weeks)||0
10227235|NCT03831191|11355529|FG005|COMPLETED|Induction Period (16 Weeks)||0
10227236|NCT03831191|11355530|FG006|COMPLETED|Induction Period (16 Weeks)||0
10227237|NCT03831191|11355531|FG007|COMPLETED|Induction Period (16 Weeks)||0
10227238|NCT03831191|11355532|FG008|COMPLETED|Induction Period (16 Weeks)||0
10227239|NCT03831191|11355533|FG009|COMPLETED|Induction Period (16 Weeks)||0
10227240|NCT03831191|11355534|FG010|COMPLETED|Induction Period (16 Weeks)||0
10227241|NCT03831191|11355535|FG011|COMPLETED|Induction Period (16 Weeks)||0
10227242|NCT03831191|11355536|FG012|COMPLETED|Induction Period (16 Weeks)||0
10227243|NCT03831191|11355537|FG013|COMPLETED|Induction Period (16 Weeks)||0
10227244|NCT03831191|11355538|FG014|COMPLETED|Induction Period (16 Weeks)||0
10227245|NCT03831191|11355524|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23
10227246|NCT03831191|11355525|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21
10227247|NCT03831191|11355526|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21
10227248|NCT03831191|11355527|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23
10227249|NCT03831191|11355528|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
10227250|NCT03831191|11355529|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
10227251|NCT03831191|11355530|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
10227252|NCT03831191|11355531|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
10227253|NCT03831191|11355532|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
10227254|NCT03831191|11355533|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
10227255|NCT03831191|11355534|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
10227256|NCT03831191|11355535|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0
10227257|NCT03831191|11355536|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0
10227258|NCT03831191|11355537|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0
10227259|NCT03831191|11355538|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0
10227260|NCT03831191|11355524|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10227261|NCT03831191|11355525|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10227262|NCT03831191|11355526|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10227263|NCT03831191|11355527|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10227264|NCT03831191|11355528|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
10227265|NCT03831191|11355529|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
10227266|NCT03831191|11355530|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
10227267|NCT03831191|11355531|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
10227268|NCT03831191|11355532|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
10227269|NCT03831191|11355533|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
10227270|NCT03831191|11355534|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
10227271|NCT03831191|11355535|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
10227272|NCT03831191|11355536|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
10227273|NCT03831191|11355537|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
10227274|NCT03831191|11355538|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
10227275|NCT03831191|11355524|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
10227276|NCT03831191|11355525|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
10227277|NCT03831191|11355526|FG002|COMPLETED|Maintenance Period (36 Weeks)||0
10227278|NCT03831191|11355527|FG003|COMPLETED|Maintenance Period (36 Weeks)||0
10227279|NCT03831191|11355528|FG004|COMPLETED|Maintenance Period (36 Weeks)||0
10227280|NCT03831191|11355529|FG005|COMPLETED|Maintenance Period (36 Weeks)||0
10227281|NCT03831191|11355530|FG006|COMPLETED|Maintenance Period (36 Weeks)||0
10227282|NCT03831191|11355531|FG007|COMPLETED|Maintenance Period (36 Weeks)||0
10227283|NCT03831191|11355532|FG008|COMPLETED|Maintenance Period (36 Weeks)||0
10227284|NCT03831191|11355533|FG009|COMPLETED|Maintenance Period (36 Weeks)||0
10227285|NCT03831191|11355534|FG010|COMPLETED|Maintenance Period (36 Weeks)||0
10227286|NCT03831191|11355535|FG011|COMPLETED|Maintenance Period (36 Weeks)||1
10227287|NCT03831191|11355536|FG012|COMPLETED|Maintenance Period (36 Weeks)||0
10227288|NCT03831191|11355537|FG013|COMPLETED|Maintenance Period (36 Weeks)||0
10227289|NCT03831191|11355538|FG014|COMPLETED|Maintenance Period (36 Weeks)||0
10227290|NCT03831191|11355524|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10227291|NCT03831191|11355525|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10227292|NCT03831191|11355526|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10227293|NCT03831191|11355527|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10227294|NCT03831191|11355528|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10227295|NCT03831191|11355529|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5
10227296|NCT03831191|11355530|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2
10227297|NCT03831191|11355531|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10227298|NCT03831191|11355532|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8
10227299|NCT03831191|11355533|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10227300|NCT03831191|11355534|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10227301|NCT03831191|11355535|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7
10227302|NCT03831191|11355536|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10227303|NCT03831191|11355537|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10227304|NCT03831191|11355538|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9
10227305|NCT03831191|11355524|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227306|NCT03831191|11355525|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227307|NCT03831191|11355526|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227308|NCT03831191|11355527|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227309|NCT03831191|11355528|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227310|NCT03831191|11355529|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227311|NCT03831191|11355530|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227312|NCT03831191|11355531|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227313|NCT03831191|11355532|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227314|NCT03831191|11355533|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227315|NCT03831191|11355534|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227316|NCT03831191|11355535|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
10227317|NCT03831191|11355536|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227318|NCT03831191|11355537|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227319|NCT03831191|11355538|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227320|NCT03831191|11355524|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227321|NCT03831191|11355525|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227322|NCT03831191|11355526|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227323|NCT03831191|11355527|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227324|NCT03831191|11355528|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227325|NCT03831191|11355529|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227326|NCT03831191|11355530|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227327|NCT03831191|11355531|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227328|NCT03831191|11355532|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227329|NCT03831191|11355533|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227330|NCT03831191|11355534|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227331|NCT03831191|11355535|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227332|NCT03831191|11355536|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227333|NCT03831191|11355537|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227334|NCT03831191|11355538|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227335|NCT03831191|11355524|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227336|NCT03831191|11355525|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227337|NCT03831191|11355526|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10239329|NCT00271102|11370866|FG001|COMPLETED|Overall Study||30
9760918|NCT00384085|10864749|FG002|STARTED|Overall Study|Randomized|197
9760919|NCT00384085|10864747|FG000|Intent-To-Treat (ITT)|Overall Study||195
9760920|NCT00384085|10864748|FG001|Intent-To-Treat (ITT)|Overall Study||196
9760921|NCT00384085|10864749|FG002|Intent-To-Treat (ITT)|Overall Study||197
9760922|NCT00384085|10864747|FG000|Treated (Safety Population)|Overall Study||194
9760923|NCT00384085|10864748|FG001|Treated (Safety Population)|Overall Study||194
10227338|NCT03831191|11355527|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227339|NCT03831191|11355528|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227340|NCT03831191|11355529|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227341|NCT03831191|11355530|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227342|NCT03831191|11355531|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227343|NCT03831191|11355532|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227344|NCT03831191|11355533|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227345|NCT03831191|11355534|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227346|NCT03831191|11355535|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227347|NCT03831191|11355536|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227348|NCT03831191|11355537|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227349|NCT03831191|11355538|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10227350|NCT03830281|11355573|FG000|STARTED|Lead-in Period (2 Weeks)||471
10227351|NCT03830281|11355574|FG001|STARTED|Lead-in Period (2 Weeks)||0
10227352|NCT03830281|11355573|FG000|COMPLETED|Lead-in Period (2 Weeks)||432
10227353|NCT03830281|11355574|FG001|COMPLETED|Lead-in Period (2 Weeks)||0
10227354|NCT03830281|11355573|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39
10227355|NCT03830281|11355574|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0
10227356|NCT03830281|11355573|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
10227357|NCT03830281|11355574|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
10227358|NCT03830281|11355573|FG000|COMPLETED|Treatment Period (16 Weeks)||205
10227359|NCT03830281|11355574|FG001|COMPLETED|Treatment Period (16 Weeks)||198
10227360|NCT03830281|11355573|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12
10227361|NCT03830281|11355574|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17
10227362|NCT03828734|11355581|FG000|STARTED|Baseline||32
10227363|NCT03828734|11355582|FG001|STARTED|Baseline||26
10227364|NCT03828734|11355581|FG000|COMPLETED|Baseline||32
10227365|NCT03828734|11355582|FG001|COMPLETED|Baseline||26
10227366|NCT03828734|11355581|FG000|NOT COMPLETED|Baseline||0
10227367|NCT03828734|11355582|FG001|NOT COMPLETED|Baseline||0
10227368|NCT03828734|11355581|FG000|STARTED|Pre-Randomization (1 Week)||32
10227369|NCT03828734|11355582|FG001|STARTED|Pre-Randomization (1 Week)||26
10227370|NCT03828734|11355581|FG000|COMPLETED|Pre-Randomization (1 Week)||29
10227371|NCT03828734|11355582|FG001|COMPLETED|Pre-Randomization (1 Week)||25
10227372|NCT03828734|11355581|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3
10227373|NCT03828734|11355582|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1
10227374|NCT03828734|11355581|FG000|STARTED|First Intervention||29
10227375|NCT03828734|11355582|FG001|STARTED|First Intervention||25
10227376|NCT03828734|11355581|FG000|COMPLETED|First Intervention||25
10227377|NCT03828734|11355582|FG001|COMPLETED|First Intervention||25
10227378|NCT03828734|11355581|FG000|NOT COMPLETED|First Intervention||4
10227379|NCT03828734|11355582|FG001|NOT COMPLETED|First Intervention||0
10227380|NCT03828734|11355581|FG000|STARTED|First Washout (1 Week)||25
10227381|NCT03828734|11355582|FG001|STARTED|First Washout (1 Week)||25
10227382|NCT03828734|11355581|FG000|COMPLETED|First Washout (1 Week)||25
10227383|NCT03828734|11355582|FG001|COMPLETED|First Washout (1 Week)||24
10227384|NCT03828734|11355581|FG000|NOT COMPLETED|First Washout (1 Week)||0
10227385|NCT03828734|11355582|FG001|NOT COMPLETED|First Washout (1 Week)||1
10227386|NCT03828734|11355581|FG000|STARTED|Second Intervention||25
10227387|NCT03828734|11355582|FG001|STARTED|Second Intervention||24
10227388|NCT03828734|11355581|FG000|COMPLETED|Second Intervention||25
10227389|NCT03828734|11355582|FG001|COMPLETED|Second Intervention||24
10227390|NCT03828734|11355581|FG000|NOT COMPLETED|Second Intervention||0
10227391|NCT03828734|11355582|FG001|NOT COMPLETED|Second Intervention||0
10227392|NCT03827395|11355590|FG000|STARTED|Overall Study||20
10227393|NCT03827395|11355591|FG001|STARTED|Overall Study||5
10227394|NCT03827395|11355590|FG000|COMPLETED|Overall Study||17
10227395|NCT03827395|11355591|FG001|COMPLETED|Overall Study||3
10227396|NCT03827395|11355590|FG000|NOT COMPLETED|Overall Study||3
10227397|NCT03827395|11355591|FG001|NOT COMPLETED|Overall Study||2
10227398|NCT03819218|11355597|FG000|STARTED|Overall Study||7
10227399|NCT03819218|11355597|FG000|COMPLETED|Overall Study||6
10227400|NCT03819218|11355597|FG000|NOT COMPLETED|Overall Study||1
10227401|NCT03818815|11355603|FG000|STARTED|Overall Study||56
10227402|NCT03818815|11355604|FG001|STARTED|Overall Study||47
10227403|NCT03818815|11355603|FG000|COMPLETED|Overall Study||48
10227404|NCT03818815|11355604|FG001|COMPLETED|Overall Study||42
10227405|NCT03818815|11355603|FG000|NOT COMPLETED|Overall Study||8
10012967|NCT01789255|11135931|FG000|COMPLETED|Overall Study||12
10012968|NCT01789255|11135931|FG000|NOT COMPLETED|Overall Study||0
10227406|NCT03818815|11355604|FG001|NOT COMPLETED|Overall Study||5
10227407|NCT03828487|11355610|FG000|STARTED|Overall Study||8
10227408|NCT03828487|11355610|FG000|COMPLETED|Overall Study||7
10227409|NCT03828487|11355610|FG000|NOT COMPLETED|Overall Study||1
10227410|NCT03828617|11355618|FG000|STARTED|Overall Study||489
10227411|NCT03828617|11355619|FG001|STARTED|Overall Study||490
10227412|NCT03828617|11355620|FG002|STARTED|Overall Study||486
10012969|NCT01789281|11135937|FG000|STARTED|Overall Study||22
10012970|NCT01789281|11135938|FG001|STARTED|Overall Study||12
10012971|NCT01789281|11135937|FG000|COMPLETED|Overall Study||0
10227413|NCT03828617|11355621|FG003|STARTED|Overall Study||245
10227414|NCT03828617|11355618|FG000|Vaccinated|Overall Study||488
10227415|NCT03828617|11355619|FG001|Vaccinated|Overall Study||489
10227416|NCT03828617|11355620|FG002|Vaccinated|Overall Study||486
10227417|NCT03828617|11355621|FG003|Vaccinated|Overall Study||245
10227418|NCT03828617|11355618|FG000|Safety Population|Overall Study||488
10227419|NCT03828617|11355619|FG001|Safety Population|Overall Study||489
10227420|NCT03828617|11355620|FG002|Safety Population|Overall Study||486
10227421|NCT03828617|11355621|FG003|Safety Population|Overall Study||245
10227422|NCT03828617|11355618|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463
10227423|NCT03828617|11355619|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473
10227424|NCT03828617|11355620|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456
10227425|NCT03828617|11355621|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232
10227426|NCT03828617|11355618|FG000|COMPLETED|Overall Study||465
10227427|NCT03828617|11355619|FG001|COMPLETED|Overall Study||475
10227428|NCT03828617|11355620|FG002|COMPLETED|Overall Study||460
10227429|NCT03828617|11355621|FG003|COMPLETED|Overall Study||235
10227430|NCT03828617|11355618|FG000|NOT COMPLETED|Overall Study||24
10227431|NCT03828617|11355619|FG001|NOT COMPLETED|Overall Study||15
10227432|NCT03828617|11355620|FG002|NOT COMPLETED|Overall Study||26
10227433|NCT03828617|11355621|FG003|NOT COMPLETED|Overall Study||10
10227434|NCT03828539|11355632|FG000|STARTED|Overall Study||389
10227435|NCT03828539|11355633|FG001|STARTED|Overall Study||388
10227436|NCT03828539|11355632|FG000|Full Analysis Set (FAS)|Overall Study||388
10227437|NCT03828539|11355633|FG001|Full Analysis Set (FAS)|Overall Study||388
10227438|NCT03828539|11355632|FG000|Safety Analysis Set (SAF)|Overall Study||388
10227439|NCT03828539|11355633|FG001|Safety Analysis Set (SAF)|Overall Study||388
10227440|NCT03828539|11355632|FG000|COMPLETED|Overall Study||373
10227441|NCT03828539|11355633|FG001|COMPLETED|Overall Study||366
10227442|NCT03828539|11355632|FG000|NOT COMPLETED|Overall Study||16
10227443|NCT03828539|11355633|FG001|NOT COMPLETED|Overall Study||22
10227444|NCT03824704|11355639|FG000|STARTED|Overall Study||1
10227445|NCT03824704|11355639|FG000|COMPLETED|Overall Study||0
10227446|NCT03824704|11355639|FG000|NOT COMPLETED|Overall Study||1
10227447|NCT03823937|11355645|FG000|STARTED|Overall Study||30
10227448|NCT03823937|11355646|FG001|STARTED|Overall Study||20
10227449|NCT03823937|11355645|FG000|COMPLETED|Overall Study||30
10227450|NCT03823937|11355646|FG001|COMPLETED|Overall Study||20
10012972|NCT01789281|11135938|FG001|COMPLETED|Overall Study||2
10012973|NCT01789281|11135937|FG000|NOT COMPLETED|Overall Study||22
10227451|NCT03823937|11355645|FG000|NOT COMPLETED|Overall Study||0
10227452|NCT03823937|11355646|FG001|NOT COMPLETED|Overall Study||0
10227453|NCT03817879|11355654|FG000|STARTED|Overall Study||35
10227454|NCT03817879|11355655|FG001|STARTED|Overall Study||35
10227455|NCT03817879|11355654|FG000|COMPLETED|Overall Study||30
10227456|NCT03817879|11355655|FG001|COMPLETED|Overall Study||22
10227457|NCT03817879|11355654|FG000|NOT COMPLETED|Overall Study||5
10227458|NCT03817879|11355655|FG001|NOT COMPLETED|Overall Study||13
10227459|NCT03811834|11355661|FG000|STARTED|Period 1 ( 7 Days)||7
10227460|NCT03811834|11355661|FG000|COMPLETED|Period 1 ( 7 Days)||6
10227461|NCT03811834|11355661|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1
10227462|NCT03811834|11355661|FG000|STARTED|Washout Period (9 Days)||6
10227463|NCT03811834|11355661|FG000|COMPLETED|Washout Period (9 Days)||6
10227464|NCT03811834|11355661|FG000|NOT COMPLETED|Washout Period (9 Days)||0
10227465|NCT03811834|11355661|FG000|STARTED|Period 2 (10 Days)||6
10227466|NCT03811834|11355661|FG000|COMPLETED|Period 2 (10 Days)||6
10227467|NCT03811834|11355661|FG000|NOT COMPLETED|Period 2 (10 Days)||0
10227468|NCT03806127|11355676|FG000|STARTED|Overall Study||111
10227469|NCT03806127|11355677|FG001|STARTED|Overall Study||111
10227470|NCT03806127|11355676|FG000|COMPLETED|Overall Study||90
10227471|NCT03806127|11355677|FG001|COMPLETED|Overall Study||99
10227472|NCT03806127|11355676|FG000|NOT COMPLETED|Overall Study||21
10227473|NCT03806127|11355677|FG001|NOT COMPLETED|Overall Study||12
10227474|NCT03827473|11355685|FG000|STARTED|Overall Study||1
10227475|NCT03827473|11355686|FG001|STARTED|Overall Study||0
10227476|NCT03827473|11355685|FG000|COMPLETED|Overall Study||0
10227477|NCT03827473|11355686|FG001|COMPLETED|Overall Study||0
10227478|NCT03827473|11355685|FG000|NOT COMPLETED|Overall Study||1
10227479|NCT03827473|11355686|FG001|NOT COMPLETED|Overall Study||0
10227480|NCT03826914|11355694|FG000|STARTED|Overall Study||35
10227481|NCT03826914|11355695|FG001|STARTED|Overall Study||34
10227482|NCT03826914|11355694|FG000|COMPLETED|Overall Study||34
10227483|NCT03826914|11355695|FG001|COMPLETED|Overall Study||33
10227484|NCT03826914|11355694|FG000|NOT COMPLETED|Overall Study||1
10227485|NCT03826914|11355695|FG001|NOT COMPLETED|Overall Study||1
10227486|NCT03812328|11355706|FG000|STARTED|Overall Study||55
10227487|NCT03812328|11355707|FG001|STARTED|Overall Study||63
10227488|NCT03812328|11355708|FG002|STARTED|Overall Study||89
10227489|NCT03812328|11355706|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48
10227490|NCT03812328|11355707|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61
10227491|NCT03812328|11355708|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84
10227492|NCT03812328|11355706|FG000|Safety Population|Overall Study||55
10227493|NCT03812328|11355707|FG001|Safety Population|Overall Study||63
10012974|NCT01789281|11135938|FG001|NOT COMPLETED|Overall Study||10
10227494|NCT03812328|11355708|FG002|Safety Population|Overall Study||88
10227495|NCT03812328|11355706|FG000|COMPLETED|Overall Study||55
10227496|NCT03812328|11355707|FG001|COMPLETED|Overall Study||60
10227497|NCT03812328|11355708|FG002|COMPLETED|Overall Study||88
10227498|NCT03812328|11355706|FG000|NOT COMPLETED|Overall Study||0
10227499|NCT03812328|11355707|FG001|NOT COMPLETED|Overall Study||3
10227500|NCT03812328|11355708|FG002|NOT COMPLETED|Overall Study||1
10227501|NCT03808688|11355718|FG000|STARTED|Overall Study||99
10227502|NCT03808688|11355719|FG001|STARTED|Overall Study||161
10227503|NCT03808688|11355718|FG000|COMPLETED|Overall Study||81
10227504|NCT03808688|11355719|FG001|COMPLETED|Overall Study||138
10227505|NCT03808688|11355718|FG000|NOT COMPLETED|Overall Study||18
10227506|NCT03808688|11355719|FG001|NOT COMPLETED|Overall Study||23
10227507|NCT03811093|11355729|FG000|STARTED|Overall Study||20
10227508|NCT03811093|11355730|FG001|STARTED|Overall Study||19
10227509|NCT03811093|11355729|FG000|COMPLETED|Overall Study||18
10227510|NCT03811093|11355730|FG001|COMPLETED|Overall Study||15
10227511|NCT03811093|11355729|FG000|NOT COMPLETED|Overall Study||2
10227512|NCT03811093|11355730|FG001|NOT COMPLETED|Overall Study||4
10227513|NCT03822182|11355742|FG000|STARTED|Overall Study||26
10227514|NCT03822182|11355743|FG001|STARTED|Overall Study||25
10227515|NCT03822182|11355744|FG002|STARTED|Overall Study||27
10227516|NCT03822182|11355742|FG000|COMPLETED|Overall Study||26
10227517|NCT03822182|11355743|FG001|COMPLETED|Overall Study||24
10227518|NCT03822182|11355744|FG002|COMPLETED|Overall Study||26
10227519|NCT03822182|11355742|FG000|NOT COMPLETED|Overall Study||0
10227520|NCT03822182|11355743|FG001|NOT COMPLETED|Overall Study||1
10227521|NCT03822182|11355744|FG002|NOT COMPLETED|Overall Study||1
10227522|NCT03822416|11355755|FG000|STARTED|Overall Study||19
10227523|NCT03822416|11355756|FG001|STARTED|Overall Study||19
10012975|NCT01789320|11135945|FG000|STARTED|Overall Study||11
10012976|NCT01789320|11135945|FG000|COMPLETED|Overall Study||9
10012977|NCT01789320|11135945|FG000|NOT COMPLETED|Overall Study||2
10012978|NCT01789476|11135951|FG000|STARTED|Overall Study||34
10227524|NCT03822416|11355755|FG000|COMPLETED|Overall Study||18
10227525|NCT03822416|11355756|FG001|COMPLETED|Overall Study||18
10227526|NCT03822416|11355755|FG000|NOT COMPLETED|Overall Study||1
10227527|NCT03822416|11355756|FG001|NOT COMPLETED|Overall Study||1
10227528|NCT03809104|11355762|FG000|STARTED|Overall Study||43
10227529|NCT03809104|11355762|FG000|COMPLETED|Overall Study||40
10227530|NCT03809104|11355762|FG000|NOT COMPLETED|Overall Study||3
10227531|NCT03807089|11355768|FG000|STARTED|Overall Study||101
10227532|NCT03807089|11355769|FG001|STARTED|Overall Study||93
10227533|NCT03807089|11355768|FG000|COMPLETED|Overall Study||101
10227534|NCT03807089|11355769|FG001|COMPLETED|Overall Study||93
10227535|NCT03807089|11355768|FG000|NOT COMPLETED|Overall Study||0
10227536|NCT03807089|11355769|FG001|NOT COMPLETED|Overall Study||0
10227537|NCT03806231|11355777|FG000|STARTED|Overall Study||4
10227538|NCT03806231|11355778|FG001|STARTED|Overall Study||4
10227539|NCT03806231|11355777|FG000|COMPLETED|Overall Study||2
10227540|NCT03806231|11355778|FG001|COMPLETED|Overall Study||4
10227541|NCT03806231|11355777|FG000|NOT COMPLETED|Overall Study||2
10227542|NCT03806231|11355778|FG001|NOT COMPLETED|Overall Study||0
10227543|NCT03804710|11355786|FG000|STARTED|Overall Study||75
10227544|NCT03804710|11355787|FG001|STARTED|Overall Study||74
10227545|NCT03804710|11355786|FG000|COMPLETED|Overall Study||73
10227546|NCT03804710|11355787|FG001|COMPLETED|Overall Study||69
10227547|NCT03804710|11355786|FG000|NOT COMPLETED|Overall Study||2
10227548|NCT03804710|11355787|FG001|NOT COMPLETED|Overall Study||5
10227549|NCT03822377|11355799|FG000|STARTED|Overall Study||65
10227550|NCT03822377|11355800|FG001|STARTED|Overall Study||65
10227551|NCT03822377|11355799|FG000|COMPLETED|Overall Study||65
10227552|NCT03822377|11355800|FG001|COMPLETED|Overall Study||65
10227553|NCT03822377|11355799|FG000|NOT COMPLETED|Overall Study||0
10227554|NCT03822377|11355800|FG001|NOT COMPLETED|Overall Study||0
10227555|NCT03820388|11355811|FG000|STARTED|Overall Study||25
10227556|NCT03820388|11355812|FG001|STARTED|Overall Study||25
10227557|NCT03820388|11355813|FG002|STARTED|Overall Study||25
10227558|NCT03820388|11355811|FG000|COMPLETED|Overall Study||25
10227559|NCT03820388|11355812|FG001|COMPLETED|Overall Study||25
10227560|NCT03820388|11355813|FG002|COMPLETED|Overall Study||25
10227561|NCT03820388|11355811|FG000|NOT COMPLETED|Overall Study||0
10227562|NCT03820388|11355812|FG001|NOT COMPLETED|Overall Study||0
10227563|NCT03820388|11355813|FG002|NOT COMPLETED|Overall Study||0
10227564|NCT03816696|11355821|FG000|STARTED|Period 1 (Up to Day 5)||16
10227565|NCT03816696|11355821|FG000|COMPLETED|Period 1 (Up to Day 5)||16
10227566|NCT03816696|11355821|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0
10227567|NCT03816696|11355821|FG000|STARTED|Wash Out Period (Days 6 to 9)||16
10227568|NCT03816696|11355821|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16
10227569|NCT03816696|11355821|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
10227570|NCT03816696|11355821|FG000|STARTED|Period 2 (Up to Day 7)||16
10227571|NCT03816696|11355821|FG000|COMPLETED|Period 2 (Up to Day 7)||16
10227572|NCT03816696|11355821|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0
10227573|NCT03816696|11355821|FG000|STARTED|Period 3 (Up to Day 11)||16
10227574|NCT03816696|11355821|FG000|COMPLETED|Period 3 (Up to Day 11)||16
10227575|NCT03816696|11355821|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0
10227576|NCT03821064|11355831|FG000|STARTED|Overall Study||11
10227577|NCT03821064|11355831|FG000|COMPLETED|Overall Study||10
10227578|NCT03821064|11355831|FG000|NOT COMPLETED|Overall Study||1
10227579|NCT03820544|11355837|FG000|STARTED|Overall Study||2
10012979|NCT01789476|11135952|FG001|STARTED|Overall Study||17
10012980|NCT01789476|11135951|FG000|COMPLETED|Overall Study||26
10227580|NCT03820544|11355838|FG001|STARTED|Overall Study||2
10227581|NCT03820544|11355837|FG000|COMPLETED|Overall Study||2
10012981|NCT01789476|11135952|FG001|COMPLETED|Overall Study||15
10227582|NCT03820544|11355838|FG001|COMPLETED|Overall Study||2
10227583|NCT03820544|11355837|FG000|NOT COMPLETED|Overall Study||0
10227584|NCT03820544|11355838|FG001|NOT COMPLETED|Overall Study||0
10227585|NCT03820024|11355846|FG000|STARTED|Overall Study||19
10227586|NCT03820024|11355847|FG001|STARTED|Overall Study||20
10227587|NCT03820024|11355846|FG000|COMPLETED|Overall Study||18
10227588|NCT03820024|11355847|FG001|COMPLETED|Overall Study||18
10227589|NCT03820024|11355846|FG000|NOT COMPLETED|Overall Study||1
10227590|NCT03820024|11355847|FG001|NOT COMPLETED|Overall Study||2
10227591|NCT03807544|11355853|FG000|STARTED|Overall Study||17
10227592|NCT03807544|11355853|FG000|COMPLETED|Overall Study||17
10227593|NCT03807544|11355853|FG000|NOT COMPLETED|Overall Study||0
10227594|NCT03809182|11355860|FG000|STARTED|Overall Study||20
10227595|NCT03809182|11355861|FG001|STARTED|Overall Study||20
10227596|NCT03809182|11355860|FG000|COMPLETED|Overall Study||20
10227597|NCT03809182|11355861|FG001|COMPLETED|Overall Study||20
10227598|NCT03809182|11355860|FG000|NOT COMPLETED|Overall Study||0
10227599|NCT03809182|11355861|FG001|NOT COMPLETED|Overall Study||0
10227600|NCT03816761|11355872|FG000|STARTED|First Treatment Period (7 Days)||4
10227601|NCT03816761|11355873|FG001|STARTED|First Treatment Period (7 Days)||4
10227602|NCT03816761|11355874|FG002|STARTED|First Treatment Period (7 Days)||4
10227603|NCT03816761|11355875|FG003|STARTED|First Treatment Period (7 Days)||4
10227604|NCT03816761|11355876|FG004|STARTED|First Treatment Period (7 Days)||4
10227605|NCT03816761|11355877|FG005|STARTED|First Treatment Period (7 Days)||4
10227606|NCT03816761|11355872|FG000|COMPLETED|First Treatment Period (7 Days)||4
10227607|NCT03816761|11355873|FG001|COMPLETED|First Treatment Period (7 Days)||4
10227608|NCT03816761|11355874|FG002|COMPLETED|First Treatment Period (7 Days)||4
10227609|NCT03816761|11355875|FG003|COMPLETED|First Treatment Period (7 Days)||4
10227610|NCT03816761|11355876|FG004|COMPLETED|First Treatment Period (7 Days)||4
10227611|NCT03816761|11355877|FG005|COMPLETED|First Treatment Period (7 Days)||3
10227612|NCT03816761|11355872|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0
10227613|NCT03816761|11355873|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0
10227614|NCT03816761|11355874|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0
10227615|NCT03816761|11355875|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0
10227616|NCT03816761|11355876|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0
10227617|NCT03816761|11355877|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1
10227618|NCT03816761|11355872|FG000|STARTED|Second Treatment Period (7 Days)||4
10227619|NCT03816761|11355873|FG001|STARTED|Second Treatment Period (7 Days)||4
10227620|NCT03816761|11355874|FG002|STARTED|Second Treatment Period (7 Days)||4
10227621|NCT03816761|11355875|FG003|STARTED|Second Treatment Period (7 Days)||4
10227622|NCT03816761|11355876|FG004|STARTED|Second Treatment Period (7 Days)||4
10227623|NCT03816761|11355877|FG005|STARTED|Second Treatment Period (7 Days)||3
10227624|NCT03816761|11355872|FG000|COMPLETED|Second Treatment Period (7 Days)||4
10227625|NCT03816761|11355873|FG001|COMPLETED|Second Treatment Period (7 Days)||4
10227626|NCT03816761|11355874|FG002|COMPLETED|Second Treatment Period (7 Days)||4
10227627|NCT03816761|11355875|FG003|COMPLETED|Second Treatment Period (7 Days)||3
10227628|NCT03816761|11355876|FG004|COMPLETED|Second Treatment Period (7 Days)||4
10227629|NCT03816761|11355877|FG005|COMPLETED|Second Treatment Period (7 Days)||3
10227630|NCT03816761|11355872|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0
10227631|NCT03816761|11355873|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0
10227632|NCT03816761|11355874|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0
10227633|NCT03816761|11355875|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1
10227634|NCT03816761|11355876|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0
10227635|NCT03816761|11355877|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0
10239330|NCT00271102|11370865|FG000|NOT COMPLETED|Overall Study||5
10239331|NCT00271102|11370866|FG001|NOT COMPLETED|Overall Study||5
10239332|NCT00276419|11370874|FG000|STARTED|First Intervention||8
10239333|NCT00276419|11370875|FG001|STARTED|First Intervention||10
10239334|NCT00276419|11370874|FG000|COMPLETED|First Intervention||7
10239335|NCT00276419|11370875|FG001|COMPLETED|First Intervention||8
10239336|NCT00276419|11370874|FG000|NOT COMPLETED|First Intervention||1
10239337|NCT00276419|11370875|FG001|NOT COMPLETED|First Intervention||2
10239338|NCT00276419|11370874|FG000|STARTED|Wash-out Phase||7
10239339|NCT00276419|11370875|FG001|STARTED|Wash-out Phase||8
10239340|NCT00276419|11370874|FG000|COMPLETED|Wash-out Phase||7
10239341|NCT00276419|11370875|FG001|COMPLETED|Wash-out Phase||8
10239342|NCT00276419|11370874|FG000|NOT COMPLETED|Wash-out Phase||0
10239343|NCT00276419|11370875|FG001|NOT COMPLETED|Wash-out Phase||0
10239344|NCT00276419|11370874|FG000|STARTED|Second Intervention||7
10239345|NCT00276419|11370875|FG001|STARTED|Second Intervention||8
10239346|NCT00276419|11370874|FG000|COMPLETED|Second Intervention||7
10239347|NCT00276419|11370875|FG001|COMPLETED|Second Intervention||8
10239348|NCT00276419|11370874|FG000|NOT COMPLETED|Second Intervention||0
10239349|NCT00276419|11370875|FG001|NOT COMPLETED|Second Intervention||0
10239350|NCT00279409|11370883|FG000|STARTED|Overall Study||0
10239351|NCT00279409|11370884|FG001|STARTED|Overall Study||0
10239352|NCT00279409|11370883|FG000|COMPLETED|Overall Study||0
10239353|NCT00279409|11370884|FG001|COMPLETED|Overall Study||0
10239354|NCT00279409|11370883|FG000|NOT COMPLETED|Overall Study||0
10239355|NCT00279409|11370884|FG001|NOT COMPLETED|Overall Study||0
10239356|NCT00281879|11370898|FG000|STARTED|Overall Study||128
10239357|NCT00281879|11370899|FG001|STARTED|Overall Study||36
10239358|NCT00281879|11370900|FG002|STARTED|Overall Study||20
10239359|NCT00281879|11370901|FG003|STARTED|Overall Study||0
10239360|NCT00281879|11370902|FG004|STARTED|Overall Study||6
10239361|NCT00281879|11370903|FG005|STARTED|Overall Study||9
10239362|NCT00281879|11370904|FG006|STARTED|Overall Study||0
10239363|NCT00281879|11370905|FG007|STARTED|Overall Study||1
10239364|NCT00281879|11370898|FG000|COMPLETED|Overall Study||0
10239365|NCT00281879|11370899|FG001|COMPLETED|Overall Study||0
10239366|NCT00281879|11370900|FG002|COMPLETED|Overall Study||0
10239367|NCT00281879|11370901|FG003|COMPLETED|Overall Study||0
10227636|NCT03801044|11355899|FG000|STARTED|Overall Study||21
10227637|NCT03801044|11355899|FG000|COMPLETED|Overall Study||21
10227638|NCT03801044|11355899|FG000|NOT COMPLETED|Overall Study||0
10227639|NCT03805672|11355909|FG000|STARTED|Overall Study||2
10227640|NCT03805672|11355910|FG001|STARTED|Overall Study||2
10227641|NCT03805672|11355909|FG000|COMPLETED|Overall Study||2
10227642|NCT03805672|11355910|FG001|COMPLETED|Overall Study||2
10227643|NCT03805672|11355909|FG000|NOT COMPLETED|Overall Study||0
10227644|NCT03805672|11355910|FG001|NOT COMPLETED|Overall Study||0
10227645|NCT03808493|11355920|FG000|STARTED|Overall Study||12
10227646|NCT03808493|11355921|FG001|STARTED|Overall Study||12
10227647|NCT03808493|11355922|FG002|STARTED|Overall Study||12
10227648|NCT03808493|11355923|FG003|STARTED|Overall Study||12
10227649|NCT03808493|11355920|FG000|COMPLETED|Overall Study||12
10227650|NCT03808493|11355921|FG001|COMPLETED|Overall Study||12
10227651|NCT03808493|11355922|FG002|COMPLETED|Overall Study||12
10227652|NCT03808493|11355923|FG003|COMPLETED|Overall Study||12
10227653|NCT03808493|11355920|FG000|NOT COMPLETED|Overall Study||0
10227654|NCT03808493|11355921|FG001|NOT COMPLETED|Overall Study||0
10227655|NCT03808493|11355922|FG002|NOT COMPLETED|Overall Study||0
10012982|NCT01789476|11135951|FG000|NOT COMPLETED|Overall Study||8
10012983|NCT01789476|11135952|FG001|NOT COMPLETED|Overall Study||2
10012984|NCT01789567|11135958|FG000|STARTED|Overall Study||20
10012985|NCT01789567|11135958|FG000|COMPLETED|Overall Study||14
10012986|NCT01789567|11135958|FG000|NOT COMPLETED|Overall Study||6
10012987|NCT01789606|11135964|FG000|STARTED|Overall Study||251
10012988|NCT01789606|11135965|FG001|STARTED|Overall Study||832
10012989|NCT01789606|11135964|FG000|COMPLETED|Overall Study||228
10012990|NCT01789606|11135965|FG001|COMPLETED|Overall Study||382
10012991|NCT01789606|11135964|FG000|NOT COMPLETED|Overall Study||23
10012992|NCT01789606|11135965|FG001|NOT COMPLETED|Overall Study||450
10012993|NCT01789775|11135972|FG000|STARTED|Overall Study||55
10012994|NCT01789775|11135973|FG001|STARTED|Overall Study||57
10012995|NCT01789775|11135972|FG000|COMPLETED|Overall Study||53
10012996|NCT01789775|11135973|FG001|COMPLETED|Overall Study||50
10012997|NCT01789775|11135972|FG000|NOT COMPLETED|Overall Study||2
10012998|NCT01789775|11135973|FG001|NOT COMPLETED|Overall Study||7
10012999|NCT01789814|11135981|FG000|STARTED|Overall Study||12
10013000|NCT01789814|11135982|FG001|STARTED|Overall Study||12
10013001|NCT01789814|11135981|FG000|COMPLETED|Overall Study||12
10013002|NCT01789814|11135982|FG001|COMPLETED|Overall Study||12
10013003|NCT01789814|11135981|FG000|NOT COMPLETED|Overall Study||0
10013004|NCT01789814|11135982|FG001|NOT COMPLETED|Overall Study||0
10013005|NCT01789840|11135990|FG000|STARTED|Overall Study||52
10013006|NCT01789840|11135991|FG001|STARTED|Overall Study||7
10013007|NCT01789840|11135990|FG000|COMPLETED|Overall Study||52
10013008|NCT01789840|11135991|FG001|COMPLETED|Overall Study||6
10013009|NCT01789840|11135990|FG000|NOT COMPLETED|Overall Study||0
10013010|NCT01789840|11135991|FG001|NOT COMPLETED|Overall Study||1
10013011|NCT01789905|11135999|FG000|STARTED|Overall Study||116
10013012|NCT01789905|11135999|FG000|COMPLETED|Overall Study||116
10013013|NCT01789905|11135999|FG000|NOT COMPLETED|Overall Study||0
10013014|NCT01789970|11136005|FG000|STARTED|Open-label Titration Period||625
10013015|NCT01789970|11136006|FG001|STARTED|Open-label Titration Period||0
10013016|NCT01789970|11136007|FG002|STARTED|Open-label Titration Period||0
10013017|NCT01789970|11136005|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
10013018|NCT01789970|11136006|FG001|Safety Analysis Set|Open-label Titration Period||0
10013019|NCT01789970|11136007|FG002|Safety Analysis Set|Open-label Titration Period||0
10013020|NCT01789970|11136005|FG000|COMPLETED|Open-label Titration Period||371
10013021|NCT01789970|11136006|FG001|COMPLETED|Open-label Titration Period||0
10013022|NCT01789970|11136007|FG002|COMPLETED|Open-label Titration Period||0
10013023|NCT01789970|11136005|FG000|NOT COMPLETED|Open-label Titration Period||254
10013024|NCT01789970|11136006|FG001|NOT COMPLETED|Open-label Titration Period||0
10013025|NCT01789970|11136007|FG002|NOT COMPLETED|Open-label Titration Period||0
10227656|NCT03808493|11355923|FG003|NOT COMPLETED|Overall Study||0
10227657|NCT03815292|11355935|FG000|STARTED|Overall Study||135
10227658|NCT03815292|11355936|FG001|STARTED|Overall Study||140
10227659|NCT03815292|11355935|FG000|COMPLETED|Overall Study||135
10227660|NCT03815292|11355936|FG001|COMPLETED|Overall Study||140
10227661|NCT03815292|11355935|FG000|NOT COMPLETED|Overall Study||0
10227662|NCT03815292|11355936|FG001|NOT COMPLETED|Overall Study||0
10227663|NCT03812510|11355942|FG000|STARTED|Overall Study||426
10227664|NCT03812510|11355942|FG000|COMPLETED|Overall Study||274
10227665|NCT03812510|11355942|FG000|NOT COMPLETED|Overall Study||152
10227666|NCT03802994|11355952|FG000|STARTED|Overall Study||9
10227667|NCT03802994|11355953|FG001|STARTED|Overall Study||12
10227668|NCT03802994|11355954|FG002|STARTED|Overall Study||15
10013026|NCT01789970|11136005|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
10013027|NCT01789970|11136006|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180
10013028|NCT01789970|11136007|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191
10013029|NCT01789970|11136005|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
10013030|NCT01789970|11136006|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
10013031|NCT01789970|11136007|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
10013032|NCT01789970|11136005|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
10227669|NCT03802994|11355955|FG003|STARTED|Overall Study||11
10227670|NCT03802994|11355956|FG004|STARTED|Overall Study||10
10227671|NCT03802994|11355952|FG000|COMPLETED|Overall Study||9
10227672|NCT03802994|11355953|FG001|COMPLETED|Overall Study||10
10227673|NCT03802994|11355954|FG002|COMPLETED|Overall Study||12
10227674|NCT03802994|11355955|FG003|COMPLETED|Overall Study||9
10227675|NCT03802994|11355956|FG004|COMPLETED|Overall Study||8
10227676|NCT03802994|11355952|FG000|NOT COMPLETED|Overall Study||0
10227677|NCT03802994|11355953|FG001|NOT COMPLETED|Overall Study||2
10227678|NCT03802994|11355954|FG002|NOT COMPLETED|Overall Study||3
10227679|NCT03802994|11355955|FG003|NOT COMPLETED|Overall Study||2
10227680|NCT03802994|11355956|FG004|NOT COMPLETED|Overall Study||2
10227681|NCT03810183|11355981|FG000|STARTED|Overall Study||6
10227682|NCT03810183|11355982|FG001|STARTED|Overall Study||3
10227683|NCT03810183|11355981|FG000|COMPLETED|Overall Study||4
10227684|NCT03810183|11355982|FG001|COMPLETED|Overall Study||2
10227685|NCT03810183|11355981|FG000|NOT COMPLETED|Overall Study||2
10227686|NCT03810183|11355982|FG001|NOT COMPLETED|Overall Study||1
10227687|NCT03809910|11355989|FG000|STARTED|Period 1 (Visit 2)||20
10227688|NCT03809910|11355990|FG001|STARTED|Period 1 (Visit 2)||19
10227689|NCT03809910|11355989|FG000|COMPLETED|Period 1 (Visit 2)||20
10227690|NCT03809910|11355990|FG001|COMPLETED|Period 1 (Visit 2)||19
10227691|NCT03809910|11355989|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
10227692|NCT03809910|11355990|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
10227693|NCT03809910|11355989|FG000|STARTED|Washout Period 1 (3 Days)||20
10227694|NCT03809910|11355990|FG001|STARTED|Washout Period 1 (3 Days)||19
10227695|NCT03809910|11355989|FG000|COMPLETED|Washout Period 1 (3 Days)||20
10227696|NCT03809910|11355990|FG001|COMPLETED|Washout Period 1 (3 Days)||19
10227697|NCT03809910|11355989|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
10227698|NCT03809910|11355990|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
10227699|NCT03809910|11355989|FG000|STARTED|Period 2 (Visit 3)||20
10227700|NCT03809910|11355990|FG001|STARTED|Period 2 (Visit 3)||19
10227701|NCT03809910|11355989|FG000|COMPLETED|Period 2 (Visit 3)||20
10227702|NCT03809910|11355990|FG001|COMPLETED|Period 2 (Visit 3)||19
10227703|NCT03809910|11355989|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
10227704|NCT03809910|11355990|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
10227705|NCT03809910|11355989|FG000|STARTED|Washout Period 2 (3 Days)||20
10227706|NCT03809910|11355990|FG001|STARTED|Washout Period 2 (3 Days)||19
10227707|NCT03809910|11355989|FG000|COMPLETED|Washout Period 2 (3 Days)||20
10227708|NCT03809910|11355990|FG001|COMPLETED|Washout Period 2 (3 Days)||19
10227709|NCT03809910|11355989|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
10227710|NCT03809910|11355990|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
10227711|NCT03809910|11355989|FG000|STARTED|Period 3 (Visit 4)||20
10227712|NCT03809910|11355990|FG001|STARTED|Period 3 (Visit 4)||19
10227713|NCT03809910|11355989|FG000|COMPLETED|Period 3 (Visit 4)||20
10227714|NCT03809910|11355990|FG001|COMPLETED|Period 3 (Visit 4)||19
10227715|NCT03809910|11355989|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
10227716|NCT03809910|11355990|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
10227717|NCT03806790|11356002|FG000|STARTED|Overall Study||87
10227718|NCT03806790|11356003|FG001|STARTED|Overall Study||95
10227719|NCT03806790|11356002|FG000|COMPLETED|Overall Study||87
10227720|NCT03806790|11356003|FG001|COMPLETED|Overall Study||95
10227721|NCT03806790|11356002|FG000|NOT COMPLETED|Overall Study||0
10227722|NCT03806790|11356003|FG001|NOT COMPLETED|Overall Study||0
10227723|NCT03807245|11356012|FG000|STARTED|Overall Study||24
10227724|NCT03807245|11356013|FG001|STARTED|Overall Study||24
10227725|NCT03807245|11356014|FG002|STARTED|Overall Study||12
10227726|NCT03807245|11356012|FG000|COMPLETED|Overall Study||23
10227727|NCT03807245|11356013|FG001|COMPLETED|Overall Study||24
10227728|NCT03807245|11356014|FG002|COMPLETED|Overall Study||12
10227729|NCT03807245|11356012|FG000|NOT COMPLETED|Overall Study||1
10227730|NCT03807245|11356013|FG001|NOT COMPLETED|Overall Study||0
10227731|NCT03807245|11356014|FG002|NOT COMPLETED|Overall Study||0
10227732|NCT03805971|11356022|FG000|STARTED|Overall Study||65
10227733|NCT03805971|11356022|FG000|COMPLETED|Overall Study||62
10227734|NCT03805971|11356022|FG000|NOT COMPLETED|Overall Study||3
10227735|NCT03802916|11356029|FG000|STARTED|Overall Study||15
10227736|NCT03802916|11356030|FG001|STARTED|Overall Study||15
10227737|NCT03802916|11356029|FG000|COMPLETED|Overall Study||15
10227738|NCT03802916|11356030|FG001|COMPLETED|Overall Study||13
10227739|NCT03802916|11356029|FG000|NOT COMPLETED|Overall Study||0
10227740|NCT03802916|11356030|FG001|NOT COMPLETED|Overall Study||2
10227741|NCT03809039|11356047|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11
10227742|NCT03809039|11356048|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
10227743|NCT03809039|11356049|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
10227744|NCT03809039|11356050|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6
10227745|NCT03809039|11356051|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
10227746|NCT03809039|11356052|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4
10227747|NCT03809039|11356053|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5
10227748|NCT03809039|11356054|FG007|STARTED|Part 1||0
10227749|NCT03809039|11356055|FG008|STARTED|Part 1||0
10227750|NCT03809039|11356047|FG000|COMPLETED|Part 1||10
10227751|NCT03809039|11356048|FG001|COMPLETED|Part 1||6
10227752|NCT03809039|11356049|FG002|COMPLETED|Part 1||6
10227753|NCT03809039|11356050|FG003|COMPLETED|Part 1||5
10227754|NCT03809039|11356051|FG004|COMPLETED|Part 1||6
10227755|NCT03809039|11356052|FG005|COMPLETED|Part 1||4
10227756|NCT03809039|11356053|FG006|COMPLETED|Part 1||5
10227757|NCT03809039|11356054|FG007|COMPLETED|Part 1||0
10227758|NCT03809039|11356055|FG008|COMPLETED|Part 1||0
10227759|NCT03809039|11356047|FG000|NOT COMPLETED|Part 1||1
10227760|NCT03809039|11356048|FG001|NOT COMPLETED|Part 1||0
10227761|NCT03809039|11356049|FG002|NOT COMPLETED|Part 1||0
10227762|NCT03809039|11356050|FG003|NOT COMPLETED|Part 1||1
10227763|NCT03809039|11356051|FG004|NOT COMPLETED|Part 1||0
10227764|NCT03809039|11356052|FG005|NOT COMPLETED|Part 1||0
10227765|NCT03809039|11356053|FG006|NOT COMPLETED|Part 1||0
10227766|NCT03809039|11356054|FG007|NOT COMPLETED|Part 1||0
10227767|NCT03809039|11356055|FG008|NOT COMPLETED|Part 1||0
10227768|NCT03809039|11356047|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1
10227769|NCT03809039|11356048|FG001|STARTED|Part 2||0
10227770|NCT03809039|11356049|FG002|STARTED|Part 2||0
10227771|NCT03809039|11356050|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5
10227772|NCT03809039|11356051|FG004|STARTED|Part 2||0
10227773|NCT03809039|11356052|FG005|STARTED|Part 2||0
10227774|NCT03809039|11356053|FG006|STARTED|Part 2||0
10227775|NCT03809039|11356054|FG007|STARTED|Part 2||0
10227776|NCT03809039|11356055|FG008|STARTED|Part 2||0
10227777|NCT03809039|11356047|FG000|COMPLETED|Part 2||1
10227778|NCT03809039|11356048|FG001|COMPLETED|Part 2||0
10227779|NCT03809039|11356049|FG002|COMPLETED|Part 2||0
10227780|NCT03809039|11356050|FG003|COMPLETED|Part 2||5
10227781|NCT03809039|11356051|FG004|COMPLETED|Part 2||0
10227782|NCT03809039|11356052|FG005|COMPLETED|Part 2||0
10227783|NCT03809039|11356053|FG006|COMPLETED|Part 2||0
10227784|NCT03809039|11356054|FG007|COMPLETED|Part 2||0
10227785|NCT03809039|11356055|FG008|COMPLETED|Part 2||0
10227786|NCT03809039|11356047|FG000|NOT COMPLETED|Part 2||0
10227787|NCT03809039|11356048|FG001|NOT COMPLETED|Part 2||0
10227788|NCT03809039|11356049|FG002|NOT COMPLETED|Part 2||0
10227789|NCT03809039|11356050|FG003|NOT COMPLETED|Part 2||0
10227790|NCT03809039|11356051|FG004|NOT COMPLETED|Part 2||0
10227791|NCT03809039|11356052|FG005|NOT COMPLETED|Part 2||0
10227792|NCT03809039|11356053|FG006|NOT COMPLETED|Part 2||0
10227793|NCT03809039|11356054|FG007|NOT COMPLETED|Part 2||0
10227794|NCT03809039|11356055|FG008|NOT COMPLETED|Part 2||0
10227795|NCT03809039|11356047|FG000|STARTED|Part 3||0
10227796|NCT03809039|11356048|FG001|STARTED|Part 3||0
10227797|NCT03809039|11356049|FG002|STARTED|Part 3||0
10227798|NCT03809039|11356050|FG003|STARTED|Part 3||0
10227799|NCT03809039|11356051|FG004|STARTED|Part 3||0
10227800|NCT03809039|11356052|FG005|STARTED|Part 3||0
10227801|NCT03809039|11356053|FG006|STARTED|Part 3||0
10227802|NCT03809039|11356054|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2
10227803|NCT03809039|11356055|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6
10227804|NCT03809039|11356047|FG000|COMPLETED|Part 3||0
10227805|NCT03809039|11356048|FG001|COMPLETED|Part 3||0
10227806|NCT03809039|11356049|FG002|COMPLETED|Part 3||0
10227807|NCT03809039|11356050|FG003|COMPLETED|Part 3||0
10227808|NCT03809039|11356051|FG004|COMPLETED|Part 3||0
10227809|NCT03809039|11356052|FG005|COMPLETED|Part 3||0
10227810|NCT03809039|11356053|FG006|COMPLETED|Part 3||0
10227811|NCT03809039|11356054|FG007|COMPLETED|Part 3||0
10227812|NCT03809039|11356055|FG008|COMPLETED|Part 3||0
10227813|NCT03809039|11356047|FG000|NOT COMPLETED|Part 3||0
10227814|NCT03809039|11356048|FG001|NOT COMPLETED|Part 3||0
10227815|NCT03809039|11356049|FG002|NOT COMPLETED|Part 3||0
10227816|NCT03809039|11356050|FG003|NOT COMPLETED|Part 3||0
10227817|NCT03809039|11356051|FG004|NOT COMPLETED|Part 3||0
10227818|NCT03809039|11356052|FG005|NOT COMPLETED|Part 3||0
10227819|NCT03809039|11356053|FG006|NOT COMPLETED|Part 3||0
10227820|NCT03809039|11356054|FG007|NOT COMPLETED|Part 3||2
10227821|NCT03809039|11356055|FG008|NOT COMPLETED|Part 3||6
10227822|NCT03807700|11356090|FG000|STARTED|Overall Study||60
10227823|NCT03807700|11356091|FG001|STARTED|Overall Study||59
10227824|NCT03807700|11356090|FG000|COMPLETED|Overall Study||58
10227825|NCT03807700|11356091|FG001|COMPLETED|Overall Study||58
10227826|NCT03807700|11356090|FG000|NOT COMPLETED|Overall Study||2
10227827|NCT03807700|11356091|FG001|NOT COMPLETED|Overall Study||1
10227828|NCT03804918|11356098|FG000|STARTED|Overall Study||17
10227829|NCT03804918|11356098|FG000|COMPLETED|Overall Study||16
10227830|NCT03804918|11356098|FG000|NOT COMPLETED|Overall Study||1
10227831|NCT03805386|11356104|FG000|STARTED|Overall Study||32
10227832|NCT03805386|11356105|FG001|STARTED|Overall Study||33
10227833|NCT03805386|11356104|FG000|COMPLETED|Overall Study||32
10227834|NCT03805386|11356105|FG001|COMPLETED|Overall Study||33
10227835|NCT03805386|11356104|FG000|NOT COMPLETED|Overall Study||0
10227836|NCT03805386|11356105|FG001|NOT COMPLETED|Overall Study||0
10227837|NCT03803475|11356114|FG000|STARTED|Overall Study||485
10227838|NCT03803475|11356114|FG000|COMPLETED|Overall Study||484
10227839|NCT03803475|11356114|FG000|NOT COMPLETED|Overall Study||1
10227840|NCT03802227|11356120|FG000|STARTED|Overall Study||4
10227841|NCT03802227|11356121|FG001|STARTED|Overall Study||4
10227842|NCT03802227|11356120|FG000|COMPLETED|Overall Study||4
10227843|NCT03802227|11356121|FG001|COMPLETED|Overall Study||4
10227844|NCT03802227|11356120|FG000|NOT COMPLETED|Overall Study||0
10227845|NCT03802227|11356121|FG001|NOT COMPLETED|Overall Study||0
10227846|NCT03802864|11356131|FG000|STARTED|Overall Study||25
10227847|NCT03802864|11356132|FG001|STARTED|Overall Study||25
10227848|NCT03802864|11356131|FG000|COMPLETED|Overall Study||25
10227849|NCT03802864|11356132|FG001|COMPLETED|Overall Study||25
10227850|NCT03802864|11356131|FG000|NOT COMPLETED|Overall Study||0
10227851|NCT03802864|11356132|FG001|NOT COMPLETED|Overall Study||0
10227852|NCT03801265|11356140|FG000|STARTED|Overall Study||23
10227853|NCT03801265|11356141|FG001|STARTED|Overall Study||23
10227854|NCT03801265|11356140|FG000|COMPLETED|Overall Study||23
10227855|NCT03801265|11356141|FG001|COMPLETED|Overall Study||23
10227856|NCT03801265|11356140|FG000|NOT COMPLETED|Overall Study||0
10227857|NCT03801265|11356141|FG001|NOT COMPLETED|Overall Study||0
10227858|NCT03802344|11356150|FG000|STARTED|Overall Study||213
10227859|NCT03802344|11356151|FG001|STARTED|Overall Study||209
10227860|NCT03802344|11356152|FG002|STARTED|Overall Study||68
10227861|NCT03802344|11356150|FG000|COMPLETED|Overall Study||205
10227862|NCT03802344|11356151|FG001|COMPLETED|Overall Study||203
10227863|NCT03802344|11356152|FG002|COMPLETED|Overall Study||55
10227864|NCT03802344|11356150|FG000|NOT COMPLETED|Overall Study||8
10227865|NCT03802344|11356151|FG001|NOT COMPLETED|Overall Study||6
10227866|NCT03802344|11356152|FG002|NOT COMPLETED|Overall Study||13
10227867|NCT03801928|11356167|FG000|STARTED|Overall Study||18
10227868|NCT03801928|11356168|FG001|STARTED|Overall Study||21
10227869|NCT03801928|11356169|FG002|STARTED|Overall Study||9
10227870|NCT03801928|11356170|FG003|STARTED|Overall Study||21
10227871|NCT03801928|11356171|FG004|STARTED|Overall Study||36
10227872|NCT03801928|11356172|FG005|STARTED|Overall Study||10
10227873|NCT03801928|11356167|FG000|COMPLETED|Overall Study||12
10227874|NCT03801928|11356168|FG001|COMPLETED|Overall Study||18
10227875|NCT03801928|11356169|FG002|COMPLETED|Overall Study||4
10227876|NCT03801928|11356170|FG003|COMPLETED|Overall Study||13
10227877|NCT03801928|11356171|FG004|COMPLETED|Overall Study||32
10227878|NCT03801928|11356172|FG005|COMPLETED|Overall Study||5
10227879|NCT03801928|11356167|FG000|NOT COMPLETED|Overall Study||6
10227880|NCT03801928|11356168|FG001|NOT COMPLETED|Overall Study||3
10227881|NCT03801928|11356169|FG002|NOT COMPLETED|Overall Study||5
10227882|NCT03801928|11356170|FG003|NOT COMPLETED|Overall Study||8
10227883|NCT03801928|11356171|FG004|NOT COMPLETED|Overall Study||4
10227884|NCT03801928|11356172|FG005|NOT COMPLETED|Overall Study||5
10227885|NCT03800173|11356194|FG000|STARTED|Overall Study||8
10227886|NCT03800173|11356195|FG001|STARTED|Overall Study||6
10227887|NCT03800173|11356196|FG002|STARTED|Overall Study||6
10227888|NCT03800173|11356197|FG003|STARTED|Overall Study||6
10227889|NCT03800173|11356198|FG004|STARTED|Overall Study||6
10227890|NCT03800173|11356194|FG000|Safety Population|Overall Study||8
10227891|NCT03800173|11356195|FG001|Safety Population|Overall Study||6
10227892|NCT03800173|11356196|FG002|Safety Population|Overall Study||6
10227893|NCT03800173|11356197|FG003|Safety Population|Overall Study||6
10227894|NCT03800173|11356198|FG004|Safety Population|Overall Study||6
10227895|NCT03800173|11356194|FG000|PK Population|Overall Study||0
10227896|NCT03800173|11356195|FG001|PK Population|Overall Study||6
10227897|NCT03800173|11356196|FG002|PK Population|Overall Study||6
10227898|NCT03800173|11356197|FG003|PK Population|Overall Study||6
10227899|NCT03800173|11356198|FG004|PK Population|Overall Study||6
10227900|NCT03800173|11356194|FG000|COMPLETED|Overall Study||8
10227901|NCT03800173|11356195|FG001|COMPLETED|Overall Study||6
10227902|NCT03800173|11356196|FG002|COMPLETED|Overall Study||6
10227903|NCT03800173|11356197|FG003|COMPLETED|Overall Study||6
10227904|NCT03800173|11356198|FG004|COMPLETED|Overall Study||5
10227905|NCT03800173|11356194|FG000|NOT COMPLETED|Overall Study||0
10227906|NCT03800173|11356195|FG001|NOT COMPLETED|Overall Study||0
10227907|NCT03800173|11356196|FG002|NOT COMPLETED|Overall Study||0
10227908|NCT03800173|11356197|FG003|NOT COMPLETED|Overall Study||0
10227909|NCT03800173|11356198|FG004|NOT COMPLETED|Overall Study||1
10227910|NCT03799783|11356214|FG000|STARTED|Overall Study||19
10227911|NCT03799783|11356214|FG000|COMPLETED|Overall Study||19
10227912|NCT03799783|11356214|FG000|NOT COMPLETED|Overall Study||0
10227913|NCT03800030|11356218|FG000|STARTED|Baseline||4
10227914|NCT03800030|11356219|FG001|STARTED|Baseline||4
10227915|NCT03800030|11356220|FG002|STARTED|Baseline||4
10227916|NCT03800030|11356221|FG003|STARTED|Baseline||6
10227917|NCT03800030|11356222|FG004|STARTED|Baseline||4
10227918|NCT03800030|11356223|FG005|STARTED|Baseline||4
10227919|NCT03800030|11356218|FG000|COMPLETED|Baseline||4
10227920|NCT03800030|11356219|FG001|COMPLETED|Baseline||4
10227921|NCT03800030|11356220|FG002|COMPLETED|Baseline||4
10013033|NCT01789970|11136006|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
10013034|NCT01789970|11136007|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
10013035|NCT01789970|11136005|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
10013036|NCT01789970|11136006|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
10227922|NCT03800030|11356221|FG003|COMPLETED|Baseline||6
10227923|NCT03800030|11356222|FG004|COMPLETED|Baseline||4
10227924|NCT03800030|11356223|FG005|COMPLETED|Baseline||4
10227925|NCT03800030|11356218|FG000|NOT COMPLETED|Baseline||0
10227926|NCT03800030|11356219|FG001|NOT COMPLETED|Baseline||0
10227927|NCT03800030|11356220|FG002|NOT COMPLETED|Baseline||0
10227928|NCT03800030|11356221|FG003|NOT COMPLETED|Baseline||0
10227929|NCT03800030|11356222|FG004|NOT COMPLETED|Baseline||0
10227930|NCT03800030|11356223|FG005|NOT COMPLETED|Baseline||0
10227931|NCT03800030|11356218|FG000|STARTED|Pre-Randomization Period (1 Week)||4
10227932|NCT03800030|11356219|FG001|STARTED|Pre-Randomization Period (1 Week)||4
10227933|NCT03800030|11356220|FG002|STARTED|Pre-Randomization Period (1 Week)||4
10227934|NCT03800030|11356221|FG003|STARTED|Pre-Randomization Period (1 Week)||6
10227935|NCT03800030|11356222|FG004|STARTED|Pre-Randomization Period (1 Week)||4
10227936|NCT03800030|11356223|FG005|STARTED|Pre-Randomization Period (1 Week)||4
10227937|NCT03800030|11356218|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4
10227938|NCT03800030|11356219|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4
10227939|NCT03800030|11356220|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4
10227940|NCT03800030|11356221|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6
10227941|NCT03800030|11356222|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4
10227942|NCT03800030|11356223|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4
10227943|NCT03800030|11356218|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10227944|NCT03800030|11356219|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10227945|NCT03800030|11356220|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10227946|NCT03800030|11356221|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10227947|NCT03800030|11356222|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10227948|NCT03800030|11356223|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10227949|NCT03800030|11356218|FG000|STARTED|First Intervention||4
10227950|NCT03800030|11356219|FG001|STARTED|First Intervention||4
10227951|NCT03800030|11356220|FG002|STARTED|First Intervention||4
10227952|NCT03800030|11356221|FG003|STARTED|First Intervention||6
10227953|NCT03800030|11356222|FG004|STARTED|First Intervention||4
10227954|NCT03800030|11356223|FG005|STARTED|First Intervention||4
10227955|NCT03800030|11356218|FG000|COMPLETED|First Intervention||4
10227956|NCT03800030|11356219|FG001|COMPLETED|First Intervention||4
10227957|NCT03800030|11356220|FG002|COMPLETED|First Intervention||4
10227958|NCT03800030|11356221|FG003|COMPLETED|First Intervention||6
10227959|NCT03800030|11356222|FG004|COMPLETED|First Intervention||4
10227960|NCT03800030|11356223|FG005|COMPLETED|First Intervention||4
10227961|NCT03800030|11356218|FG000|NOT COMPLETED|First Intervention||0
10227962|NCT03800030|11356219|FG001|NOT COMPLETED|First Intervention||0
10227963|NCT03800030|11356220|FG002|NOT COMPLETED|First Intervention||0
10227964|NCT03800030|11356221|FG003|NOT COMPLETED|First Intervention||0
10227965|NCT03800030|11356222|FG004|NOT COMPLETED|First Intervention||0
10227966|NCT03800030|11356223|FG005|NOT COMPLETED|First Intervention||0
10227967|NCT03800030|11356218|FG000|STARTED|First Washout (1 Week)||4
10227968|NCT03800030|11356219|FG001|STARTED|First Washout (1 Week)||4
10227969|NCT03800030|11356220|FG002|STARTED|First Washout (1 Week)||4
10227970|NCT03800030|11356221|FG003|STARTED|First Washout (1 Week)||6
10227971|NCT03800030|11356222|FG004|STARTED|First Washout (1 Week)||4
10227972|NCT03800030|11356223|FG005|STARTED|First Washout (1 Week)||4
10227973|NCT03800030|11356218|FG000|COMPLETED|First Washout (1 Week)||4
10227974|NCT03800030|11356219|FG001|COMPLETED|First Washout (1 Week)||4
10227975|NCT03800030|11356220|FG002|COMPLETED|First Washout (1 Week)||4
10227976|NCT03800030|11356221|FG003|COMPLETED|First Washout (1 Week)||6
10227977|NCT03800030|11356222|FG004|COMPLETED|First Washout (1 Week)||4
10227978|NCT03800030|11356223|FG005|COMPLETED|First Washout (1 Week)||4
10227979|NCT03800030|11356218|FG000|NOT COMPLETED|First Washout (1 Week)||0
10227980|NCT03800030|11356219|FG001|NOT COMPLETED|First Washout (1 Week)||0
10227981|NCT03800030|11356220|FG002|NOT COMPLETED|First Washout (1 Week)||0
10227982|NCT03800030|11356221|FG003|NOT COMPLETED|First Washout (1 Week)||0
10227983|NCT03800030|11356222|FG004|NOT COMPLETED|First Washout (1 Week)||0
10227984|NCT03800030|11356223|FG005|NOT COMPLETED|First Washout (1 Week)||0
10227985|NCT03800030|11356218|FG000|STARTED|Second Intervention||4
10227986|NCT03800030|11356219|FG001|STARTED|Second Intervention||4
10227987|NCT03800030|11356220|FG002|STARTED|Second Intervention||4
10227988|NCT03800030|11356221|FG003|STARTED|Second Intervention||6
10227989|NCT03800030|11356222|FG004|STARTED|Second Intervention||4
10227990|NCT03800030|11356223|FG005|STARTED|Second Intervention||4
10227991|NCT03800030|11356218|FG000|COMPLETED|Second Intervention||4
10227992|NCT03800030|11356219|FG001|COMPLETED|Second Intervention||4
10227993|NCT03800030|11356220|FG002|COMPLETED|Second Intervention||4
10227994|NCT03800030|11356221|FG003|COMPLETED|Second Intervention||5
10227995|NCT03800030|11356222|FG004|COMPLETED|Second Intervention||4
10227996|NCT03800030|11356223|FG005|COMPLETED|Second Intervention||4
10227997|NCT03800030|11356218|FG000|NOT COMPLETED|Second Intervention||0
10227998|NCT03800030|11356219|FG001|NOT COMPLETED|Second Intervention||0
10227999|NCT03800030|11356220|FG002|NOT COMPLETED|Second Intervention||0
10228000|NCT03800030|11356221|FG003|NOT COMPLETED|Second Intervention||1
10228001|NCT03800030|11356222|FG004|NOT COMPLETED|Second Intervention||0
10228002|NCT03800030|11356223|FG005|NOT COMPLETED|Second Intervention||0
10228003|NCT03800030|11356218|FG000|STARTED|Second Washout (1 Week)||4
10228004|NCT03800030|11356219|FG001|STARTED|Second Washout (1 Week)||4
10228005|NCT03800030|11356220|FG002|STARTED|Second Washout (1 Week)||4
10228006|NCT03800030|11356221|FG003|STARTED|Second Washout (1 Week)||5
10228007|NCT03800030|11356222|FG004|STARTED|Second Washout (1 Week)||4
10228008|NCT03800030|11356223|FG005|STARTED|Second Washout (1 Week)||4
10228009|NCT03800030|11356218|FG000|COMPLETED|Second Washout (1 Week)||4
10228010|NCT03800030|11356219|FG001|COMPLETED|Second Washout (1 Week)||4
10228011|NCT03800030|11356220|FG002|COMPLETED|Second Washout (1 Week)||4
10228012|NCT03800030|11356221|FG003|COMPLETED|Second Washout (1 Week)||4
10228013|NCT03800030|11356222|FG004|COMPLETED|Second Washout (1 Week)||4
10228014|NCT03800030|11356223|FG005|COMPLETED|Second Washout (1 Week)||4
10228015|NCT03800030|11356218|FG000|NOT COMPLETED|Second Washout (1 Week)||0
10228016|NCT03800030|11356219|FG001|NOT COMPLETED|Second Washout (1 Week)||0
10228017|NCT03800030|11356220|FG002|NOT COMPLETED|Second Washout (1 Week)||0
10228018|NCT03800030|11356221|FG003|NOT COMPLETED|Second Washout (1 Week)||1
10228019|NCT03800030|11356222|FG004|NOT COMPLETED|Second Washout (1 Week)||0
10228020|NCT03800030|11356223|FG005|NOT COMPLETED|Second Washout (1 Week)||0
10228021|NCT03800030|11356218|FG000|STARTED|Third Intervention||4
10228022|NCT03800030|11356219|FG001|STARTED|Third Intervention||4
10228023|NCT03800030|11356220|FG002|STARTED|Third Intervention||4
10228024|NCT03800030|11356221|FG003|STARTED|Third Intervention||4
10228025|NCT03800030|11356222|FG004|STARTED|Third Intervention||4
10228026|NCT03800030|11356223|FG005|STARTED|Third Intervention||4
10228027|NCT03800030|11356218|FG000|COMPLETED|Third Intervention||4
10228028|NCT03800030|11356219|FG001|COMPLETED|Third Intervention||4
10228029|NCT03800030|11356220|FG002|COMPLETED|Third Intervention||4
10228030|NCT03800030|11356221|FG003|COMPLETED|Third Intervention||4
10228031|NCT03800030|11356222|FG004|COMPLETED|Third Intervention||4
10228032|NCT03800030|11356223|FG005|COMPLETED|Third Intervention||4
10228033|NCT03800030|11356218|FG000|NOT COMPLETED|Third Intervention||0
10228034|NCT03800030|11356219|FG001|NOT COMPLETED|Third Intervention||0
10228035|NCT03800030|11356220|FG002|NOT COMPLETED|Third Intervention||0
10228036|NCT03800030|11356221|FG003|NOT COMPLETED|Third Intervention||0
10228037|NCT03800030|11356222|FG004|NOT COMPLETED|Third Intervention||0
10228038|NCT03800030|11356223|FG005|NOT COMPLETED|Third Intervention||0
10228039|NCT03799211|11356233|FG000|STARTED|Overall Study||36
10228040|NCT03799211|11356234|FG001|STARTED|Overall Study||40
10228041|NCT03799211|11356233|FG000|COMPLETED|Overall Study||32
10228042|NCT03799211|11356234|FG001|COMPLETED|Overall Study||27
10228043|NCT03799211|11356233|FG000|NOT COMPLETED|Overall Study||4
10228044|NCT03799211|11356234|FG001|NOT COMPLETED|Overall Study||13
10228045|NCT03798717|11356248|FG000|STARTED|Overall Study||4
10228046|NCT03798717|11356249|FG001|STARTED|Overall Study||3
10228047|NCT03798717|11356250|FG002|STARTED|Overall Study||3
10228048|NCT03798717|11356251|FG003|STARTED|Overall Study||4
10228049|NCT03798717|11356252|FG004|STARTED|Overall Study||3
10228050|NCT03798717|11356253|FG005|STARTED|Overall Study||3
10228051|NCT03798717|11356248|FG000|COMPLETED|Overall Study||2
10228052|NCT03798717|11356249|FG001|COMPLETED|Overall Study||2
10228053|NCT03798717|11356250|FG002|COMPLETED|Overall Study||2
10228054|NCT03798717|11356251|FG003|COMPLETED|Overall Study||2
10228055|NCT03798717|11356252|FG004|COMPLETED|Overall Study||2
10228056|NCT03798717|11356253|FG005|COMPLETED|Overall Study||2
10228057|NCT03798717|11356248|FG000|NOT COMPLETED|Overall Study||2
10228058|NCT03798717|11356249|FG001|NOT COMPLETED|Overall Study||1
10228059|NCT03798717|11356250|FG002|NOT COMPLETED|Overall Study||1
10228060|NCT03798717|11356251|FG003|NOT COMPLETED|Overall Study||2
10228061|NCT03798717|11356252|FG004|NOT COMPLETED|Overall Study||1
10228062|NCT03798717|11356253|FG005|NOT COMPLETED|Overall Study||1
10228063|NCT03798483|11356262|FG000|STARTED|Overall Study||15
10228064|NCT03798483|11356262|FG000|Returned All Follow-up Outcome Data|Overall Study||11
10228065|NCT03798483|11356262|FG000|COMPLETED|Overall Study||13
10228066|NCT03798483|11356262|FG000|NOT COMPLETED|Overall Study||2
10228067|NCT03798366|11356272|FG000|STARTED|Overall Study||21
10228068|NCT03798366|11356273|FG001|STARTED|Overall Study||12
10228069|NCT03798366|11356272|FG000|COMPLETED|Overall Study||21
10228070|NCT03798366|11356273|FG001|COMPLETED|Overall Study||11
10228071|NCT03798366|11356272|FG000|NOT COMPLETED|Overall Study||0
10228072|NCT03798366|11356273|FG001|NOT COMPLETED|Overall Study||1
10228073|NCT03799952|11356281|FG000|STARTED|Overall Study||31
10228074|NCT03799952|11356282|FG001|STARTED|Overall Study||31
10228075|NCT03799952|11356281|FG000|COMPLETED|Overall Study||30
10228076|NCT03799952|11356282|FG001|COMPLETED|Overall Study||29
10228077|NCT03799952|11356281|FG000|NOT COMPLETED|Overall Study||1
10228078|NCT03799952|11356282|FG001|NOT COMPLETED|Overall Study||2
10228079|NCT03797872|11356290|FG000|STARTED|Overall Study||1
10228080|NCT03797872|11356291|FG001|STARTED|Overall Study||0
10228081|NCT03797872|11356290|FG000|COMPLETED|Overall Study||0
10228082|NCT03797872|11356291|FG001|COMPLETED|Overall Study||0
10228083|NCT03797872|11356290|FG000|NOT COMPLETED|Overall Study||1
10228084|NCT03797872|11356291|FG001|NOT COMPLETED|Overall Study||0
10228085|NCT03799614|11356299|FG000|STARTED|Overall Study||15
10228086|NCT03799614|11356300|FG001|STARTED|Overall Study||15
10228087|NCT03799614|11356299|FG000|COMPLETED|Overall Study||15
10228088|NCT03799614|11356300|FG001|COMPLETED|Overall Study||15
10228089|NCT03799614|11356299|FG000|NOT COMPLETED|Overall Study||0
10228090|NCT03799614|11356300|FG001|NOT COMPLETED|Overall Study||0
10228091|NCT03799484|11356309|FG000|STARTED|Overall Study||14
10228092|NCT03799484|11356309|FG000|COMPLETED|Overall Study||14
10228093|NCT03799484|11356309|FG000|NOT COMPLETED|Overall Study||0
10228094|NCT03796728|11356316|FG000|STARTED|Overall Study||60
10228095|NCT03796728|11356316|FG000|COMPLETED|Overall Study||36
10228096|NCT03796728|11356316|FG000|NOT COMPLETED|Overall Study||24
10228097|NCT03797144|11356322|FG000|STARTED|Enrollment||16
10228098|NCT03797144|11356323|FG001|STARTED|Enrollment||11
10228099|NCT03797144|11356322|FG000|COMPLETED|Enrollment||12
10228100|NCT03797144|11356323|FG001|COMPLETED|Enrollment||10
10228101|NCT03797144|11356322|FG000|NOT COMPLETED|Enrollment||4
10228102|NCT03797144|11356323|FG001|NOT COMPLETED|Enrollment||1
10228103|NCT03797144|11356322|FG000|STARTED|Surgery||12
10228104|NCT03797144|11356323|FG001|STARTED|Surgery||10
10228105|NCT03797144|11356322|FG000|COMPLETED|Surgery||11
10228106|NCT03797144|11356323|FG001|COMPLETED|Surgery||10
10228107|NCT03797144|11356322|FG000|NOT COMPLETED|Surgery||1
10228108|NCT03797144|11356323|FG001|NOT COMPLETED|Surgery||0
10228109|NCT03797144|11356322|FG000|STARTED|3 Month||11
10228110|NCT03797144|11356323|FG001|STARTED|3 Month||10
10228111|NCT03797144|11356322|FG000|COMPLETED|3 Month||9
10228112|NCT03797144|11356323|FG001|COMPLETED|3 Month||10
10228113|NCT03797144|11356322|FG000|NOT COMPLETED|3 Month||2
10228114|NCT03797144|11356323|FG001|NOT COMPLETED|3 Month||0
10228115|NCT03797144|11356322|FG000|STARTED|12 Month||9
10228116|NCT03797144|11356323|FG001|STARTED|12 Month||10
10228117|NCT03797144|11356322|FG000|COMPLETED|12 Month||1
10228118|NCT03797144|11356323|FG001|COMPLETED|12 Month||1
10228119|NCT03797144|11356322|FG000|NOT COMPLETED|12 Month||8
10228120|NCT03797144|11356323|FG001|NOT COMPLETED|12 Month||9
10228121|NCT03797144|11356322|FG000|STARTED|24 Month||1
10228122|NCT03797144|11356323|FG001|STARTED|24 Month||1
10228123|NCT03797144|11356322|FG000|COMPLETED|24 Month||0
10228124|NCT03797144|11356323|FG001|COMPLETED|24 Month||0
10228125|NCT03797144|11356322|FG000|NOT COMPLETED|24 Month||1
10228126|NCT03797144|11356323|FG001|NOT COMPLETED|24 Month||1
10228127|NCT03782571|11356330|FG000|STARTED|Period 1||6
10228128|NCT03782571|11356331|FG001|STARTED|Period 1||6
10228129|NCT03782571|11356332|FG002|STARTED|Period 1||6
10228130|NCT03782571|11356333|FG003|STARTED|Period 1||7
10228131|NCT03782571|11356330|FG000|COMPLETED|Period 1||5
10228132|NCT03782571|11356331|FG001|COMPLETED|Period 1||6
10228133|NCT03782571|11356332|FG002|COMPLETED|Period 1||6
10228134|NCT03782571|11356333|FG003|COMPLETED|Period 1||7
10228135|NCT03782571|11356330|FG000|NOT COMPLETED|Period 1||1
10228136|NCT03782571|11356331|FG001|NOT COMPLETED|Period 1||0
10228137|NCT03782571|11356332|FG002|NOT COMPLETED|Period 1||0
10228138|NCT03782571|11356333|FG003|NOT COMPLETED|Period 1||0
10228139|NCT03782571|11356330|FG000|STARTED|Period 2||5
10228140|NCT03782571|11356331|FG001|STARTED|Period 2||6
10228141|NCT03782571|11356332|FG002|STARTED|Period 2||6
10228142|NCT03782571|11356333|FG003|STARTED|Period 2||7
10228143|NCT03782571|11356330|FG000|COMPLETED|Period 2||5
10228144|NCT03782571|11356331|FG001|COMPLETED|Period 2||6
10228145|NCT03782571|11356332|FG002|COMPLETED|Period 2||6
10228146|NCT03782571|11356333|FG003|COMPLETED|Period 2||7
10228147|NCT03782571|11356330|FG000|NOT COMPLETED|Period 2||0
10228148|NCT03782571|11356331|FG001|NOT COMPLETED|Period 2||0
10228149|NCT03782571|11356332|FG002|NOT COMPLETED|Period 2||0
10228150|NCT03782571|11356333|FG003|NOT COMPLETED|Period 2||0
10228151|NCT03782571|11356330|FG000|STARTED|Period 3||5
10228152|NCT03782571|11356331|FG001|STARTED|Period 3||6
10228153|NCT03782571|11356332|FG002|STARTED|Period 3||6
10228154|NCT03782571|11356333|FG003|STARTED|Period 3||7
10228155|NCT03782571|11356330|FG000|COMPLETED|Period 3||3
10228156|NCT03782571|11356331|FG001|COMPLETED|Period 3||6
10228157|NCT03782571|11356332|FG002|COMPLETED|Period 3||6
10228158|NCT03782571|11356333|FG003|COMPLETED|Period 3||7
10228159|NCT03782571|11356330|FG000|NOT COMPLETED|Period 3||2
10228160|NCT03782571|11356331|FG001|NOT COMPLETED|Period 3||0
10228161|NCT03782571|11356332|FG002|NOT COMPLETED|Period 3||0
10228162|NCT03782571|11356333|FG003|NOT COMPLETED|Period 3||0
10228163|NCT03782571|11356330|FG000|STARTED|Period 4||3
10228164|NCT03782571|11356331|FG001|STARTED|Period 4||6
10228165|NCT03782571|11356332|FG002|STARTED|Period 4||6
10228166|NCT03782571|11356333|FG003|STARTED|Period 4||7
10228167|NCT03782571|11356330|FG000|COMPLETED|Period 4||3
10228168|NCT03782571|11356331|FG001|COMPLETED|Period 4||6
10228169|NCT03782571|11356332|FG002|COMPLETED|Period 4||6
10228170|NCT03782571|11356333|FG003|COMPLETED|Period 4||7
10228171|NCT03782571|11356330|FG000|NOT COMPLETED|Period 4||0
10228172|NCT03782571|11356331|FG001|NOT COMPLETED|Period 4||0
10228173|NCT03782571|11356332|FG002|NOT COMPLETED|Period 4||0
10228174|NCT03782571|11356333|FG003|NOT COMPLETED|Period 4||0
10228175|NCT03796260|11356347|FG000|STARTED|Period 1||7
10228176|NCT03796260|11356348|FG001|STARTED|Period 1||7
10228177|NCT03796260|11356347|FG000|COMPLETED|Period 1||7
10228178|NCT03796260|11356348|FG001|COMPLETED|Period 1||7
10228179|NCT03796260|11356347|FG000|NOT COMPLETED|Period 1||0
10228180|NCT03796260|11356348|FG001|NOT COMPLETED|Period 1||0
10228181|NCT03796260|11356347|FG000|STARTED|Period 2||7
10228182|NCT03796260|11356348|FG001|STARTED|Period 2||7
10228183|NCT03796260|11356347|FG000|COMPLETED|Period 2||7
10228184|NCT03796260|11356348|FG001|COMPLETED|Period 2||7
10228185|NCT03796260|11356347|FG000|NOT COMPLETED|Period 2||0
10228186|NCT03796260|11356348|FG001|NOT COMPLETED|Period 2||0
10228187|NCT03796039|11356356|FG000|STARTED|Overall Study||50
10228188|NCT03796039|11356357|FG001|STARTED|Overall Study||47
10228189|NCT03796039|11356356|FG000|COMPLETED|Overall Study||41
10228190|NCT03796039|11356357|FG001|COMPLETED|Overall Study||42
10228191|NCT03796039|11356356|FG000|NOT COMPLETED|Overall Study||9
10228192|NCT03796039|11356357|FG001|NOT COMPLETED|Overall Study||5
10228193|NCT03783780|11356363|FG000|STARTED|Overall Study||21
10228194|NCT03783780|11356363|FG000|COMPLETED|Overall Study||20
10228195|NCT03783780|11356363|FG000|NOT COMPLETED|Overall Study||1
10228196|NCT03780959|11356371|FG000|STARTED|Part 1||69
10228197|NCT03780959|11356372|FG001|STARTED|Part 1||0
10228198|NCT03780959|11356373|FG002|STARTED|Part 1||0
10228199|NCT03780959|11356371|FG000|COMPLETED|Part 1||64
10228200|NCT03780959|11356372|FG001|COMPLETED|Part 1||0
10228201|NCT03780959|11356373|FG002|COMPLETED|Part 1||0
10228202|NCT03780959|11356371|FG000|NOT COMPLETED|Part 1||5
10228203|NCT03780959|11356372|FG001|NOT COMPLETED|Part 1||0
10228204|NCT03780959|11356373|FG002|NOT COMPLETED|Part 1||0
10228205|NCT03780959|11356371|FG000|STARTED|Part 2||0
10228206|NCT03780959|11356372|FG001|STARTED|Part 2||26
10228207|NCT03780959|11356373|FG002|STARTED|Part 2||25
10228208|NCT03780959|11356371|FG000|COMPLETED|Part 2||0
10228209|NCT03780959|11356372|FG001|COMPLETED|Part 2||7
10228210|NCT03780959|11356373|FG002|COMPLETED|Part 2||19
10228211|NCT03780959|11356371|FG000|NOT COMPLETED|Part 2||0
10228212|NCT03780959|11356372|FG001|NOT COMPLETED|Part 2||19
10228213|NCT03780959|11356373|FG002|NOT COMPLETED|Part 2||6
10228214|NCT03796182|11356383|FG000|STARTED|Period 1||6
10228215|NCT03796182|11356384|FG001|STARTED|Period 1||6
10228216|NCT03796182|11356383|FG000|COMPLETED|Period 1||6
10228217|NCT03796182|11356384|FG001|COMPLETED|Period 1||6
10228218|NCT03796182|11356383|FG000|NOT COMPLETED|Period 1||0
10228219|NCT03796182|11356384|FG001|NOT COMPLETED|Period 1||0
10228220|NCT03796182|11356383|FG000|STARTED|Washout Period||6
10228221|NCT03796182|11356384|FG001|STARTED|Washout Period||6
10228222|NCT03796182|11356383|FG000|COMPLETED|Washout Period||6
10228223|NCT03796182|11356384|FG001|COMPLETED|Washout Period||6
10228224|NCT03796182|11356383|FG000|NOT COMPLETED|Washout Period||0
10228225|NCT03796182|11356384|FG001|NOT COMPLETED|Washout Period||0
10228226|NCT03796182|11356383|FG000|STARTED|Period 2||6
10228227|NCT03796182|11356384|FG001|STARTED|Period 2||6
10228228|NCT03796182|11356383|FG000|COMPLETED|Period 2||6
10228229|NCT03796182|11356384|FG001|COMPLETED|Period 2||6
10228230|NCT03796182|11356383|FG000|NOT COMPLETED|Period 2||0
10228231|NCT03796182|11356384|FG001|NOT COMPLETED|Period 2||0
10228232|NCT03796013|11356392|FG000|STARTED|Period 1||14
10228233|NCT03796013|11356393|FG001|STARTED|Period 1||14
10228234|NCT03796013|11356392|FG000|COMPLETED|Period 1||14
10228235|NCT03796013|11356393|FG001|COMPLETED|Period 1||14
10228236|NCT03796013|11356392|FG000|NOT COMPLETED|Period 1||0
10228237|NCT03796013|11356393|FG001|NOT COMPLETED|Period 1||0
10228238|NCT03796013|11356392|FG000|STARTED|Period 2||14
10228239|NCT03796013|11356393|FG001|STARTED|Period 2||14
10228240|NCT03796013|11356392|FG000|COMPLETED|Period 2||14
10228241|NCT03796013|11356393|FG001|COMPLETED|Period 2||14
10228242|NCT03796013|11356392|FG000|NOT COMPLETED|Period 2||0
10228243|NCT03796013|11356393|FG001|NOT COMPLETED|Period 2||0
10228244|NCT03795753|11356401|FG000|STARTED|Overall Study||23
10228245|NCT03795753|11356402|FG001|STARTED|Overall Study||13
10228246|NCT03795753|11356401|FG000|COMPLETED|Overall Study||23
10228247|NCT03795753|11356402|FG001|COMPLETED|Overall Study||13
10228248|NCT03795753|11356401|FG000|NOT COMPLETED|Overall Study||0
10228249|NCT03795753|11356402|FG001|NOT COMPLETED|Overall Study||0
10228250|NCT03792477|11356413|FG000|STARTED|Overall Study||6
10228251|NCT03792477|11356414|FG001|STARTED|Overall Study||6
10228252|NCT03792477|11356415|FG002|STARTED|Overall Study||21
10228253|NCT03792477|11356416|FG003|STARTED|Overall Study||21
10228254|NCT03792477|11356417|FG004|STARTED|Overall Study||20
10228255|NCT03792477|11356413|FG000|COMPLETED|Overall Study||6
10228256|NCT03792477|11356414|FG001|COMPLETED|Overall Study||6
10013037|NCT01789970|11136007|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
10013038|NCT01790048|11136023|FG000|STARTED|Overall Study||1156
10013039|NCT01790048|11136024|FG001|STARTED|Overall Study||1103
10013040|NCT01790048|11136023|FG000|COMPLETED|Overall Study||1144
10013041|NCT01790048|11136024|FG001|COMPLETED|Overall Study||1086
10013042|NCT01790048|11136023|FG000|NOT COMPLETED|Overall Study||12
10013043|NCT01790048|11136024|FG001|NOT COMPLETED|Overall Study||17
10013044|NCT01790113|11136034|FG000|STARTED|Overall Study||79
10228257|NCT03792477|11356415|FG002|COMPLETED|Overall Study||19
10228258|NCT03792477|11356416|FG003|COMPLETED|Overall Study||20
10228259|NCT03792477|11356417|FG004|COMPLETED|Overall Study||19
10228260|NCT03792477|11356413|FG000|NOT COMPLETED|Overall Study||0
10228261|NCT03792477|11356414|FG001|NOT COMPLETED|Overall Study||0
10228262|NCT03792477|11356415|FG002|NOT COMPLETED|Overall Study||2
10228263|NCT03792477|11356416|FG003|NOT COMPLETED|Overall Study||1
10228264|NCT03792477|11356417|FG004|NOT COMPLETED|Overall Study||1
10228265|NCT03783962|11356425|FG000|STARTED|Overall Study||28
10228266|NCT03783962|11356426|FG001|STARTED|Overall Study||28
10228267|NCT03783962|11356425|FG000|COMPLETED|Overall Study||25
10228268|NCT03783962|11356426|FG001|COMPLETED|Overall Study||21
10228269|NCT03783962|11356425|FG000|NOT COMPLETED|Overall Study||3
10228270|NCT03783962|11356426|FG001|NOT COMPLETED|Overall Study||7
10013045|NCT01790113|11136035|FG001|STARTED|Overall Study||224
10228271|NCT03782272|11356434|FG000|STARTED|Overall Study||6
10228272|NCT03782272|11356435|FG001|STARTED|Overall Study||6
10228273|NCT03782272|11356434|FG000|COMPLETED|Overall Study||6
10228274|NCT03782272|11356435|FG001|COMPLETED|Overall Study||6
10228275|NCT03782272|11356434|FG000|NOT COMPLETED|Overall Study||0
10228276|NCT03782272|11356435|FG001|NOT COMPLETED|Overall Study||0
10228277|NCT03779724|11356444|FG000|STARTED|Overall Study||25
10228278|NCT03779724|11356445|FG001|STARTED|Overall Study||25
10228279|NCT03779724|11356444|FG000|COMPLETED|Overall Study||19
10228280|NCT03779724|11356445|FG001|COMPLETED|Overall Study||21
10228281|NCT03779724|11356444|FG000|NOT COMPLETED|Overall Study||6
10228282|NCT03779724|11356445|FG001|NOT COMPLETED|Overall Study||4
10228283|NCT03775915|11356455|FG000|STARTED|Overall Study||12
10228284|NCT03775915|11356456|FG001|STARTED|Overall Study||12
10228285|NCT03775915|11356455|FG000|COMPLETED|Overall Study||12
10228286|NCT03775915|11356456|FG001|COMPLETED|Overall Study||12
10228287|NCT03775915|11356455|FG000|NOT COMPLETED|Overall Study||0
10228288|NCT03775915|11356456|FG001|NOT COMPLETED|Overall Study||0
10228289|NCT03794752|11356462|FG000|STARTED|Overall Study||8
10228290|NCT03794752|11356462|FG000|COMPLETED|Overall Study||8
10228291|NCT03794752|11356462|FG000|NOT COMPLETED|Overall Study||0
10228292|NCT03793751|11356472|FG000|STARTED|Overall Study||60
10228293|NCT03793751|11356473|FG001|STARTED|Overall Study||60
10228294|NCT03793751|11356472|FG000|COMPLETED|Overall Study||60
10228295|NCT03793751|11356473|FG001|COMPLETED|Overall Study||60
10228296|NCT03793751|11356472|FG000|NOT COMPLETED|Overall Study||0
10228297|NCT03793751|11356473|FG001|NOT COMPLETED|Overall Study||0
10228298|NCT03793556|11356481|FG000|STARTED|Overall Study||35
10228299|NCT03793556|11356482|FG001|STARTED|Overall Study||36
10228300|NCT03793556|11356481|FG000|COMPLETED|Overall Study||22
10228301|NCT03793556|11356482|FG001|COMPLETED|Overall Study||34
10228302|NCT03793556|11356481|FG000|NOT COMPLETED|Overall Study||13
10228303|NCT03793556|11356482|FG001|NOT COMPLETED|Overall Study||2
10228304|NCT03785548|11356493|FG000|STARTED|Overall Study||73
10228305|NCT03785548|11356494|FG001|STARTED|Overall Study||74
10228306|NCT03785548|11356493|FG000|COMPLETED|Overall Study||71
10228307|NCT03785548|11356494|FG001|COMPLETED|Overall Study||74
10228308|NCT03785548|11356493|FG000|NOT COMPLETED|Overall Study||2
10228309|NCT03785548|11356494|FG001|NOT COMPLETED|Overall Study||0
10228310|NCT03782701|11356500|FG000|STARTED|Overall Study||43
10228311|NCT03782701|11356500|FG000|Lumify|Overall Study||43
10228312|NCT03782701|11356500|FG000|Saline Solution|Overall Study||43
10228313|NCT03782701|11356500|FG000|COMPLETED|Overall Study||43
10228314|NCT03782701|11356500|FG000|NOT COMPLETED|Overall Study||0
10228315|NCT03773133|11356506|FG000|STARTED|Overall Study||8
10228316|NCT03773133|11356506|FG000|Received the Screening IIP|Overall Study||8
10228317|NCT03773133|11356506|FG000|Received the Therapeutic IRPP|Overall Study||0
10228318|NCT03773133|11356506|FG000|COMPLETED|Overall Study||0
10228319|NCT03773133|11356506|FG000|NOT COMPLETED|Overall Study||8
10228320|NCT03792672|11356511|FG000|STARTED|Treatment Period 1 (1 Day)||4
10228321|NCT03792672|11356512|FG001|STARTED|Treatment Period 1 (1 Day)||4
10228322|NCT03792672|11356513|FG002|STARTED|Treatment Period 1 (1 Day)||4
10228323|NCT03792672|11356514|FG003|STARTED|Treatment Period 1 (1 Day)||4
10228324|NCT03792672|11356515|FG004|STARTED|Treatment Period 1 (1 Day)||4
10228325|NCT03792672|11356516|FG005|STARTED|Treatment Period 1 (1 Day)||4
10228326|NCT03792672|11356511|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
10228327|NCT03792672|11356512|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
10228328|NCT03792672|11356513|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
10228329|NCT03792672|11356514|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
10228330|NCT03792672|11356515|FG004|COMPLETED|Treatment Period 1 (1 Day)||4
10228331|NCT03792672|11356516|FG005|COMPLETED|Treatment Period 1 (1 Day)||4
10228332|NCT03792672|11356511|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10228333|NCT03792672|11356512|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10228334|NCT03792672|11356513|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10228335|NCT03792672|11356514|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10228336|NCT03792672|11356515|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10228337|NCT03792672|11356516|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10228338|NCT03792672|11356511|FG000|STARTED|Washout Period 1 (10 Days)||4
10228339|NCT03792672|11356512|FG001|STARTED|Washout Period 1 (10 Days)||4
10228340|NCT03792672|11356513|FG002|STARTED|Washout Period 1 (10 Days)||4
10228341|NCT03792672|11356514|FG003|STARTED|Washout Period 1 (10 Days)||4
10228342|NCT03792672|11356515|FG004|STARTED|Washout Period 1 (10 Days)||4
10228343|NCT03792672|11356516|FG005|STARTED|Washout Period 1 (10 Days)||4
10228344|NCT03792672|11356511|FG000|COMPLETED|Washout Period 1 (10 Days)||4
10228345|NCT03792672|11356512|FG001|COMPLETED|Washout Period 1 (10 Days)||4
10228346|NCT03792672|11356513|FG002|COMPLETED|Washout Period 1 (10 Days)||4
10228347|NCT03792672|11356514|FG003|COMPLETED|Washout Period 1 (10 Days)||4
10228348|NCT03792672|11356515|FG004|COMPLETED|Washout Period 1 (10 Days)||4
10228349|NCT03792672|11356516|FG005|COMPLETED|Washout Period 1 (10 Days)||4
10228350|NCT03792672|11356511|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0
10228351|NCT03792672|11356512|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0
10228352|NCT03792672|11356513|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0
10228353|NCT03792672|11356514|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0
10228354|NCT03792672|11356515|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0
10228355|NCT03792672|11356516|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0
10228356|NCT03792672|11356511|FG000|STARTED|Treatment Period 2 (1 Day)||4
10228357|NCT03792672|11356512|FG001|STARTED|Treatment Period 2 (1 Day)||4
10228358|NCT03792672|11356513|FG002|STARTED|Treatment Period 2 (1 Day)||4
10228359|NCT03792672|11356514|FG003|STARTED|Treatment Period 2 (1 Day)||4
10228360|NCT03792672|11356515|FG004|STARTED|Treatment Period 2 (1 Day)||4
10228361|NCT03792672|11356516|FG005|STARTED|Treatment Period 2 (1 Day)||4
10228362|NCT03792672|11356511|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
10228363|NCT03792672|11356512|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
10228364|NCT03792672|11356513|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
10228365|NCT03792672|11356514|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
10228366|NCT03792672|11356515|FG004|COMPLETED|Treatment Period 2 (1 Day)||4
10228367|NCT03792672|11356516|FG005|COMPLETED|Treatment Period 2 (1 Day)||4
10228368|NCT03792672|11356511|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10228369|NCT03792672|11356512|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10228370|NCT03792672|11356513|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10228371|NCT03792672|11356514|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10228372|NCT03792672|11356515|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10228373|NCT03792672|11356516|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10228374|NCT03792672|11356511|FG000|STARTED|Washout Period 2 (10 Days)||4
10228375|NCT03792672|11356512|FG001|STARTED|Washout Period 2 (10 Days)||4
10228376|NCT03792672|11356513|FG002|STARTED|Washout Period 2 (10 Days)||4
10228377|NCT03792672|11356514|FG003|STARTED|Washout Period 2 (10 Days)||4
10228378|NCT03792672|11356515|FG004|STARTED|Washout Period 2 (10 Days)||4
10228379|NCT03792672|11356516|FG005|STARTED|Washout Period 2 (10 Days)||4
10228380|NCT03792672|11356511|FG000|COMPLETED|Washout Period 2 (10 Days)||4
10228381|NCT03792672|11356512|FG001|COMPLETED|Washout Period 2 (10 Days)||4
10228382|NCT03792672|11356513|FG002|COMPLETED|Washout Period 2 (10 Days)||4
10228383|NCT03792672|11356514|FG003|COMPLETED|Washout Period 2 (10 Days)||4
10228384|NCT03792672|11356515|FG004|COMPLETED|Washout Period 2 (10 Days)||4
10228385|NCT03792672|11356516|FG005|COMPLETED|Washout Period 2 (10 Days)||4
10228386|NCT03792672|11356511|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0
10013046|NCT01790113|11136034|FG000|COMPLETED|Overall Study||76
10013047|NCT01790113|11136035|FG001|COMPLETED|Overall Study||149
10013048|NCT01790113|11136034|FG000|NOT COMPLETED|Overall Study||3
10228387|NCT03792672|11356512|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0
10228388|NCT03792672|11356513|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0
10228389|NCT03792672|11356514|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0
10228390|NCT03792672|11356515|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0
10228391|NCT03792672|11356516|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0
10228392|NCT03792672|11356511|FG000|STARTED|Treatment Period 3 (1 Day)||4
10228393|NCT03792672|11356512|FG001|STARTED|Treatment Period 3 (1 Day)||4
10228394|NCT03792672|11356513|FG002|STARTED|Treatment Period 3 (1 Day)||4
10228395|NCT03792672|11356514|FG003|STARTED|Treatment Period 3 (1 Day)||4
10228396|NCT03792672|11356515|FG004|STARTED|Treatment Period 3 (1 Day)||4
10228397|NCT03792672|11356516|FG005|STARTED|Treatment Period 3 (1 Day)||4
10228398|NCT03792672|11356511|FG000|COMPLETED|Treatment Period 3 (1 Day)||4
10228399|NCT03792672|11356512|FG001|COMPLETED|Treatment Period 3 (1 Day)||4
10228400|NCT03792672|11356513|FG002|COMPLETED|Treatment Period 3 (1 Day)||4
10228401|NCT03792672|11356514|FG003|COMPLETED|Treatment Period 3 (1 Day)||4
10228402|NCT03792672|11356515|FG004|COMPLETED|Treatment Period 3 (1 Day)||4
10228403|NCT03792672|11356516|FG005|COMPLETED|Treatment Period 3 (1 Day)||4
10228404|NCT03792672|11356511|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10228405|NCT03792672|11356512|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10228406|NCT03792672|11356513|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10228407|NCT03792672|11356514|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10228408|NCT03792672|11356515|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10228409|NCT03792672|11356516|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10228410|NCT03792672|11356511|FG000|STARTED|Washout Period 3 (10 Days)||4
10228411|NCT03792672|11356512|FG001|STARTED|Washout Period 3 (10 Days)||4
10228412|NCT03792672|11356513|FG002|STARTED|Washout Period 3 (10 Days)||4
10228413|NCT03792672|11356514|FG003|STARTED|Washout Period 3 (10 Days)||4
10228414|NCT03792672|11356515|FG004|STARTED|Washout Period 3 (10 Days)||4
10228415|NCT03792672|11356516|FG005|STARTED|Washout Period 3 (10 Days)||4
10228416|NCT03792672|11356511|FG000|COMPLETED|Washout Period 3 (10 Days)||3
10228417|NCT03792672|11356512|FG001|COMPLETED|Washout Period 3 (10 Days)||4
10228418|NCT03792672|11356513|FG002|COMPLETED|Washout Period 3 (10 Days)||3
10228419|NCT03792672|11356514|FG003|COMPLETED|Washout Period 3 (10 Days)||2
10228420|NCT03792672|11356515|FG004|COMPLETED|Washout Period 3 (10 Days)||4
10228421|NCT03792672|11356516|FG005|COMPLETED|Washout Period 3 (10 Days)||4
10228422|NCT03792672|11356511|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1
10228423|NCT03792672|11356512|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0
10228424|NCT03792672|11356513|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1
10228425|NCT03792672|11356514|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2
10228426|NCT03792672|11356515|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0
10228427|NCT03792672|11356516|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0
10228428|NCT03792672|11356511|FG000|STARTED|Treatment Period 4 (2 Days)||3
10228429|NCT03792672|11356512|FG001|STARTED|Treatment Period 4 (2 Days)||4
10228430|NCT03792672|11356513|FG002|STARTED|Treatment Period 4 (2 Days)||3
10228431|NCT03792672|11356514|FG003|STARTED|Treatment Period 4 (2 Days)||2
10228432|NCT03792672|11356515|FG004|STARTED|Treatment Period 4 (2 Days)||4
10228433|NCT03792672|11356516|FG005|STARTED|Treatment Period 4 (2 Days)||4
10228434|NCT03792672|11356511|FG000|COMPLETED|Treatment Period 4 (2 Days)||2
10228435|NCT03792672|11356512|FG001|COMPLETED|Treatment Period 4 (2 Days)||4
10228436|NCT03792672|11356513|FG002|COMPLETED|Treatment Period 4 (2 Days)||3
10228437|NCT03792672|11356514|FG003|COMPLETED|Treatment Period 4 (2 Days)||2
10228438|NCT03792672|11356515|FG004|COMPLETED|Treatment Period 4 (2 Days)||4
10228439|NCT03792672|11356516|FG005|COMPLETED|Treatment Period 4 (2 Days)||4
10228440|NCT03792672|11356511|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1
10228441|NCT03792672|11356512|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10228442|NCT03792672|11356513|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10228443|NCT03792672|11356514|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10228444|NCT03792672|11356515|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10228445|NCT03792672|11356516|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10228446|NCT03786744|11356528|FG000|STARTED|Overall Study||10
10228447|NCT03786744|11356529|FG001|STARTED|Overall Study||10
10228448|NCT03786744|11356528|FG000|COMPLETED|Overall Study||10
10228449|NCT03786744|11356529|FG001|COMPLETED|Overall Study||10
10228450|NCT03786744|11356528|FG000|NOT COMPLETED|Overall Study||0
10228451|NCT03786744|11356529|FG001|NOT COMPLETED|Overall Study||0
10228452|NCT03782181|11356538|FG000|STARTED|Overall Study||20
10228453|NCT03782181|11356539|FG001|STARTED|Overall Study||20
10228454|NCT03782181|11356538|FG000|COMPLETED|Overall Study||20
10228455|NCT03782181|11356539|FG001|COMPLETED|Overall Study||20
10228456|NCT03782181|11356538|FG000|NOT COMPLETED|Overall Study||0
10228457|NCT03782181|11356539|FG001|NOT COMPLETED|Overall Study||0
10228458|NCT03792191|11356548|FG000|STARTED|Overall Study||140
10228459|NCT03792191|11356549|FG001|STARTED|Overall Study||140
10228460|NCT03792191|11356548|FG000|COMPLETED|Overall Study||140
10228461|NCT03792191|11356549|FG001|COMPLETED|Overall Study||140
10228462|NCT03792191|11356548|FG000|NOT COMPLETED|Overall Study||0
10228463|NCT03792191|11356549|FG001|NOT COMPLETED|Overall Study||0
10228464|NCT03791489|11356555|FG000|STARTED|30 Days||30
10228465|NCT03791489|11356555|FG000|COMPLETED|30 Days||30
10228466|NCT03791489|11356555|FG000|NOT COMPLETED|30 Days||0
10228467|NCT03791489|11356555|FG000|STARTED|90 Days (Primary Endpoint)||30
10228468|NCT03791489|11356555|FG000|COMPLETED|90 Days (Primary Endpoint)||30
10228469|NCT03791489|11356555|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0
10228470|NCT03790865|11356562|FG000|STARTED|Overall Study||52
10228471|NCT03790865|11356563|FG001|STARTED|Overall Study||52
10013049|NCT01790113|11136035|FG001|NOT COMPLETED|Overall Study||75
10013050|NCT01790126|11136044|FG000|STARTED|Overall Study||30
10013051|NCT01790126|11136045|FG001|STARTED|Overall Study||29
10013052|NCT01790126|11136046|FG002|STARTED|Overall Study||31
10228472|NCT03790865|11356564|FG002|STARTED|Overall Study||54
10228473|NCT03790865|11356562|FG000|COMPLETED|Overall Study||52
10228474|NCT03790865|11356563|FG001|COMPLETED|Overall Study||50
10228475|NCT03790865|11356564|FG002|COMPLETED|Overall Study||54
10228476|NCT03790865|11356562|FG000|NOT COMPLETED|Overall Study||0
10228477|NCT03790865|11356563|FG001|NOT COMPLETED|Overall Study||2
10228478|NCT03790865|11356564|FG002|NOT COMPLETED|Overall Study||0
10228479|NCT03784300|11356578|FG000|STARTED|Overall Study||6
10228480|NCT03784300|11356579|FG001|STARTED|Overall Study||2
10228481|NCT03784300|11356580|FG002|STARTED|Overall Study||6
10228482|NCT03784300|11356581|FG003|STARTED|Overall Study||2
10228483|NCT03784300|11356582|FG004|STARTED|Overall Study||6
10228484|NCT03784300|11356583|FG005|STARTED|Overall Study||2
10228485|NCT03784300|11356578|FG000|COMPLETED|Overall Study||6
10228486|NCT03784300|11356579|FG001|COMPLETED|Overall Study||2
10228487|NCT03784300|11356580|FG002|COMPLETED|Overall Study||6
10228488|NCT03784300|11356581|FG003|COMPLETED|Overall Study||2
10228489|NCT03784300|11356582|FG004|COMPLETED|Overall Study||6
10228490|NCT03784300|11356583|FG005|COMPLETED|Overall Study||2
10228491|NCT03784300|11356578|FG000|NOT COMPLETED|Overall Study||0
10228492|NCT03784300|11356579|FG001|NOT COMPLETED|Overall Study||0
10228493|NCT03784300|11356580|FG002|NOT COMPLETED|Overall Study||0
10228494|NCT03784300|11356581|FG003|NOT COMPLETED|Overall Study||0
10228495|NCT03784300|11356582|FG004|NOT COMPLETED|Overall Study||0
10228496|NCT03784300|11356583|FG005|NOT COMPLETED|Overall Study||0
10228497|NCT03790878|11356600|FG000|STARTED|Overall Study||26
10228498|NCT03790878|11356601|FG001|STARTED|Overall Study||27
10228499|NCT03790878|11356602|FG002|STARTED|Overall Study||27
10228500|NCT03790878|11356600|FG000|COMPLETED|Overall Study||26
10228501|NCT03790878|11356601|FG001|COMPLETED|Overall Study||27
10228502|NCT03790878|11356602|FG002|COMPLETED|Overall Study||27
10228503|NCT03790878|11356600|FG000|NOT COMPLETED|Overall Study||0
10228504|NCT03790878|11356601|FG001|NOT COMPLETED|Overall Study||0
10228505|NCT03790878|11356602|FG002|NOT COMPLETED|Overall Study||0
10228506|NCT03789474|11356612|FG000|STARTED|Overall Study||30
10228507|NCT03789474|11356613|FG001|STARTED|Overall Study||30
10228508|NCT03789474|11356612|FG000|COMPLETED|Overall Study||30
10228509|NCT03789474|11356613|FG001|COMPLETED|Overall Study||30
10228510|NCT03789474|11356612|FG000|NOT COMPLETED|Overall Study||0
10228511|NCT03789474|11356613|FG001|NOT COMPLETED|Overall Study||0
10228512|NCT03789175|11356619|FG000|STARTED|Week 0 to Week 12 of NR||1
10228513|NCT03789175|11356619|FG000|COMPLETED|Week 0 to Week 12 of NR||1
10228514|NCT03789175|11356619|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0
10228515|NCT03789175|11356619|FG000|STARTED|Week 12 to Week 24 of NR||1
10228516|NCT03789175|11356619|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
10228517|NCT03789175|11356619|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0
10228518|NCT03787615|11356625|FG000|STARTED|Overall Study||31
10228519|NCT03787615|11356625|FG000|COMPLETED|Overall Study||27
10013053|NCT01790126|11136044|FG000|Treated|Overall Study||29
10013054|NCT01790126|11136045|FG001|Treated|Overall Study||29
10228520|NCT03787615|11356625|FG000|NOT COMPLETED|Overall Study||4
10228521|NCT03786718|11356630|FG000|STARTED|Overall Study||67
10228522|NCT03786718|11356630|FG000|COMPLETED|Overall Study||60
10228523|NCT03786718|11356630|FG000|NOT COMPLETED|Overall Study||7
10228524|NCT03784963|11356639|FG000|STARTED|Overall Study||12
10228525|NCT03784963|11356640|FG001|STARTED|Overall Study||10
10228526|NCT03784963|11356641|FG002|STARTED|Overall Study||1
10228527|NCT03784963|11356642|FG003|STARTED|Overall Study||0
10228528|NCT03784963|11356639|FG000|COMPLETED|Overall Study||0
10228529|NCT03784963|11356640|FG001|COMPLETED|Overall Study||0
10228530|NCT03784963|11356641|FG002|COMPLETED|Overall Study||0
10228531|NCT03784963|11356642|FG003|COMPLETED|Overall Study||0
10228532|NCT03784963|11356639|FG000|NOT COMPLETED|Overall Study||12
10228533|NCT03784963|11356640|FG001|NOT COMPLETED|Overall Study||10
10228534|NCT03784963|11356641|FG002|NOT COMPLETED|Overall Study||1
10228535|NCT03784963|11356642|FG003|NOT COMPLETED|Overall Study||0
10228536|NCT03771274|11356652|FG000|STARTED|Overall Study||39
10228537|NCT03771274|11356652|FG000|COMPLETED|Overall Study||39
10228538|NCT03771274|11356652|FG000|NOT COMPLETED|Overall Study||0
10228539|NCT03787472|11356656|FG000|STARTED|Period 1||23
10228540|NCT03787472|11356657|FG001|STARTED|Period 1||22
10228541|NCT03787472|11356656|FG000|COMPLETED|Period 1||23
10228542|NCT03787472|11356657|FG001|COMPLETED|Period 1||22
10228543|NCT03787472|11356656|FG000|NOT COMPLETED|Period 1||0
10228544|NCT03787472|11356657|FG001|NOT COMPLETED|Period 1||0
10228545|NCT03787472|11356656|FG000|STARTED|Period 2||23
10228546|NCT03787472|11356657|FG001|STARTED|Period 2||22
10228547|NCT03787472|11356656|FG000|COMPLETED|Period 2||23
10228548|NCT03787472|11356657|FG001|COMPLETED|Period 2||22
10228549|NCT03787472|11356656|FG000|NOT COMPLETED|Period 2||0
10228550|NCT03787472|11356657|FG001|NOT COMPLETED|Period 2||0
10228551|NCT03787212|11356663|FG000|STARTED|Period 1||2
10228552|NCT03787212|11356664|FG001|STARTED|Period 1||2
10228553|NCT03787212|11356663|FG000|COMPLETED|Period 1||2
10228554|NCT03787212|11356664|FG001|COMPLETED|Period 1||2
10228555|NCT03787212|11356663|FG000|NOT COMPLETED|Period 1||0
10228556|NCT03787212|11356664|FG001|NOT COMPLETED|Period 1||0
10228557|NCT03787212|11356663|FG000|STARTED|Period 1||2
10228558|NCT03787212|11356664|FG001|STARTED|Period 1||2
10228559|NCT03787212|11356663|FG000|COMPLETED|Period 1||0
10228560|NCT03787212|11356664|FG001|COMPLETED|Period 1||0
10228561|NCT03787212|11356663|FG000|NOT COMPLETED|Period 1||2
10228562|NCT03787212|11356664|FG001|NOT COMPLETED|Period 1||2
10228563|NCT03784001|11356673|FG000|STARTED|Overall Study||46
10228564|NCT03784001|11356674|FG001|STARTED|Overall Study||38
10228565|NCT03784001|11356675|FG002|STARTED|Overall Study||41
10228566|NCT03784001|11356673|FG000|COMPLETED|Overall Study||44
10228567|NCT03784001|11356674|FG001|COMPLETED|Overall Study||38
10228568|NCT03784001|11356675|FG002|COMPLETED|Overall Study||40
10228569|NCT03784001|11356673|FG000|NOT COMPLETED|Overall Study||2
10228570|NCT03784001|11356674|FG001|NOT COMPLETED|Overall Study||0
10228571|NCT03784001|11356675|FG002|NOT COMPLETED|Overall Study||1
10228572|NCT03783702|11356685|FG000|STARTED|Overall Study||56
10228573|NCT03783702|11356686|FG001|STARTED|Overall Study||62
10228574|NCT03783702|11356685|FG000|COMPLETED|Overall Study||49
10228575|NCT03783702|11356686|FG001|COMPLETED|Overall Study||51
10228576|NCT03783702|11356685|FG000|NOT COMPLETED|Overall Study||7
10228577|NCT03783702|11356686|FG001|NOT COMPLETED|Overall Study||11
10228578|NCT03781479|11356695|FG000|STARTED|Overall Study||6
10228579|NCT03781479|11356696|FG001|STARTED|Overall Study||6
10228580|NCT03781479|11356697|FG002|STARTED|Overall Study||1
10228581|NCT03781479|11356695|FG000|COMPLETED|Overall Study||6
10228582|NCT03781479|11356696|FG001|COMPLETED|Overall Study||6
10228583|NCT03781479|11356697|FG002|COMPLETED|Overall Study||0
10228584|NCT03781479|11356695|FG000|NOT COMPLETED|Overall Study||0
10228585|NCT03781479|11356696|FG001|NOT COMPLETED|Overall Study||0
10228586|NCT03781479|11356697|FG002|NOT COMPLETED|Overall Study||1
10228587|NCT03781037|11356703|FG000|STARTED|Overall Study||18
10228588|NCT03781037|11356703|FG000|COMPLETED|Overall Study||18
10228589|NCT03781037|11356703|FG000|NOT COMPLETED|Overall Study||0
10228590|NCT03784079|11356715|FG000|STARTED|Part 1: Up to Day 24||6
10228591|NCT03784079|11356716|FG001|STARTED|Part 1: Up to Day 24||6
10228592|NCT03784079|11356717|FG002|STARTED|Part 1: Up to Day 24||2
10228593|NCT03784079|11356718|FG003|STARTED|Part 1: Up to Day 24||0
10228594|NCT03784079|11356719|FG004|STARTED|Part 1: Up to Day 24||0
10228595|NCT03784079|11356720|FG005|STARTED|Part 1: Up to Day 24||0
10228596|NCT03784079|11356721|FG006|STARTED|Part 1: Up to Day 24||0
10228597|NCT03784079|11356715|FG000|COMPLETED|Part 1: Up to Day 24||6
10228598|NCT03784079|11356716|FG001|COMPLETED|Part 1: Up to Day 24||6
10228599|NCT03784079|11356717|FG002|COMPLETED|Part 1: Up to Day 24||2
10228600|NCT03784079|11356718|FG003|COMPLETED|Part 1: Up to Day 24||0
10228601|NCT03784079|11356719|FG004|COMPLETED|Part 1: Up to Day 24||0
10228602|NCT03784079|11356720|FG005|COMPLETED|Part 1: Up to Day 24||0
10228603|NCT03784079|11356721|FG006|COMPLETED|Part 1: Up to Day 24||0
10228604|NCT03784079|11356715|FG000|NOT COMPLETED|Part 1: Up to Day 24||0
10228605|NCT03784079|11356716|FG001|NOT COMPLETED|Part 1: Up to Day 24||0
10228606|NCT03784079|11356717|FG002|NOT COMPLETED|Part 1: Up to Day 24||0
10228607|NCT03784079|11356718|FG003|NOT COMPLETED|Part 1: Up to Day 24||0
10228608|NCT03784079|11356719|FG004|NOT COMPLETED|Part 1: Up to Day 24||0
10228609|NCT03784079|11356720|FG005|NOT COMPLETED|Part 1: Up to Day 24||0
10228610|NCT03784079|11356721|FG006|NOT COMPLETED|Part 1: Up to Day 24||0
10228611|NCT03784079|11356715|FG000|STARTED|Part 2: Up to Day 12||0
10228612|NCT03784079|11356716|FG001|STARTED|Part 2: Up to Day 12||0
10228613|NCT03784079|11356717|FG002|STARTED|Part 2: Up to Day 12||0
10228614|NCT03784079|11356718|FG003|STARTED|Part 2: Up to Day 12||6
10228615|NCT03784079|11356719|FG004|STARTED|Part 2: Up to Day 12||6
10228616|NCT03784079|11356720|FG005|STARTED|Part 2: Up to Day 12||6
10228617|NCT03784079|11356721|FG006|STARTED|Part 2: Up to Day 12||2
10228618|NCT03784079|11356715|FG000|COMPLETED|Part 2: Up to Day 12||0
10228619|NCT03784079|11356716|FG001|COMPLETED|Part 2: Up to Day 12||0
10228620|NCT03784079|11356717|FG002|COMPLETED|Part 2: Up to Day 12||0
10228621|NCT03784079|11356718|FG003|COMPLETED|Part 2: Up to Day 12||6
10228622|NCT03784079|11356719|FG004|COMPLETED|Part 2: Up to Day 12||6
10228623|NCT03784079|11356720|FG005|COMPLETED|Part 2: Up to Day 12||6
10228624|NCT03784079|11356721|FG006|COMPLETED|Part 2: Up to Day 12||2
10228625|NCT03784079|11356715|FG000|NOT COMPLETED|Part 2: Up to Day 12||0
10228626|NCT03784079|11356716|FG001|NOT COMPLETED|Part 2: Up to Day 12||0
10228627|NCT03784079|11356717|FG002|NOT COMPLETED|Part 2: Up to Day 12||0
10228628|NCT03784079|11356718|FG003|NOT COMPLETED|Part 2: Up to Day 12||0
10228629|NCT03784079|11356719|FG004|NOT COMPLETED|Part 2: Up to Day 12||0
10228630|NCT03784079|11356720|FG005|NOT COMPLETED|Part 2: Up to Day 12||0
10228631|NCT03784079|11356721|FG006|NOT COMPLETED|Part 2: Up to Day 12||0
10228632|NCT03783039|11356744|FG000|STARTED|Overall Study||119
10228633|NCT03783039|11356745|FG001|STARTED|Overall Study||115
10228634|NCT03783039|11356744|FG000|COMPLETED|Overall Study||117
10228635|NCT03783039|11356745|FG001|COMPLETED|Overall Study||114
10228636|NCT03783039|11356744|FG000|NOT COMPLETED|Overall Study||2
10228637|NCT03783039|11356745|FG001|NOT COMPLETED|Overall Study||1
10228638|NCT03783130|11356755|FG000|STARTED|Overall Study||3
10228639|NCT03783130|11356756|FG001|STARTED|Overall Study||3
10228640|NCT03783130|11356757|FG002|STARTED|Overall Study||5
10228641|NCT03783130|11356758|FG003|STARTED|Overall Study||5
10228642|NCT03783130|11356755|FG000|Received All Product Administrations|Overall Study||3
10228643|NCT03783130|11356756|FG001|Received All Product Administrations|Overall Study||3
10228644|NCT03783130|11356757|FG002|Received All Product Administrations|Overall Study||5
10228645|NCT03783130|11356758|FG003|Received All Product Administrations|Overall Study||5
10228646|NCT03783130|11356755|FG000|COMPLETED|Overall Study||3
10228647|NCT03783130|11356756|FG001|COMPLETED|Overall Study||3
10228648|NCT03783130|11356757|FG002|COMPLETED|Overall Study||5
10228649|NCT03783130|11356758|FG003|COMPLETED|Overall Study||5
10228650|NCT03783130|11356755|FG000|NOT COMPLETED|Overall Study||0
10228651|NCT03783130|11356756|FG001|NOT COMPLETED|Overall Study||0
10228652|NCT03783130|11356757|FG002|NOT COMPLETED|Overall Study||0
10228653|NCT03783130|11356758|FG003|NOT COMPLETED|Overall Study||0
10228654|NCT03776175|11356773|FG000|STARTED|Treatment Period (42 Days)||14
10228655|NCT03776175|11356774|FG001|STARTED|Treatment Period (42 Days)||29
10228656|NCT03776175|11356775|FG002|STARTED|Treatment Period (42 Days)||28
10228657|NCT03776175|11356776|FG003|STARTED|Treatment Period (42 Days)||28
10228658|NCT03776175|11356773|FG000|Treated|Treatment Period (42 Days)||14
10228659|NCT03776175|11356774|FG001|Treated|Treatment Period (42 Days)||29
10228660|NCT03776175|11356775|FG002|Treated|Treatment Period (42 Days)||28
10228661|NCT03776175|11356776|FG003|Treated|Treatment Period (42 Days)||28
10228662|NCT03776175|11356773|FG000|COMPLETED|Treatment Period (42 Days)||13
10228663|NCT03776175|11356774|FG001|COMPLETED|Treatment Period (42 Days)||22
10228664|NCT03776175|11356775|FG002|COMPLETED|Treatment Period (42 Days)||24
10228665|NCT03776175|11356776|FG003|COMPLETED|Treatment Period (42 Days)||26
10228666|NCT03776175|11356773|FG000|NOT COMPLETED|Treatment Period (42 Days)||1
10228667|NCT03776175|11356774|FG001|NOT COMPLETED|Treatment Period (42 Days)||7
10228668|NCT03776175|11356775|FG002|NOT COMPLETED|Treatment Period (42 Days)||4
10228669|NCT03776175|11356776|FG003|NOT COMPLETED|Treatment Period (42 Days)||2
10228670|NCT03776175|11356773|FG000|STARTED|Follow-Up Period (35 Days)||13
10228671|NCT03776175|11356774|FG001|STARTED|Follow-Up Period (35 Days)||22
10228672|NCT03776175|11356775|FG002|STARTED|Follow-Up Period (35 Days)||24
10228673|NCT03776175|11356776|FG003|STARTED|Follow-Up Period (35 Days)||26
10228674|NCT03776175|11356773|FG000|COMPLETED|Follow-Up Period (35 Days)||13
10228675|NCT03776175|11356774|FG001|COMPLETED|Follow-Up Period (35 Days)||22
10228676|NCT03776175|11356775|FG002|COMPLETED|Follow-Up Period (35 Days)||24
10228677|NCT03776175|11356776|FG003|COMPLETED|Follow-Up Period (35 Days)||24
10228678|NCT03776175|11356773|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0
10228679|NCT03776175|11356774|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0
10228680|NCT03776175|11356775|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0
10228681|NCT03776175|11356776|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2
10228682|NCT03771963|11356786|FG000|STARTED|Overall Study||200
10228683|NCT03771963|11356786|FG000|COMPLETED|Overall Study||168
10228684|NCT03771963|11356786|FG000|NOT COMPLETED|Overall Study||32
10228685|NCT03771352|11356790|FG000|STARTED|Overall Study||55
10228686|NCT03771352|11356790|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
10228687|NCT03771352|11356790|FG000|NOT COMPLETED|Overall Study||4
10228688|NCT03773796|11356794|FG000|STARTED|Overall Study||22
10228689|NCT03773796|11356794|FG000|COMPLETED|Overall Study||19
10228690|NCT03773796|11356794|FG000|NOT COMPLETED|Overall Study||3
10228691|NCT03782233|11356800|FG000|STARTED|Overall Study||50
10228692|NCT03782233|11356801|FG001|STARTED|Overall Study||33
10228693|NCT03782233|11356800|FG000|COMPLETED|Overall Study||46
10228694|NCT03782233|11356801|FG001|COMPLETED|Overall Study||31
10228695|NCT03782233|11356800|FG000|NOT COMPLETED|Overall Study||4
10228696|NCT03782233|11356801|FG001|NOT COMPLETED|Overall Study||2
10228697|NCT03781375|11356811|FG000|STARTED|Double-blind Phase||12
10228698|NCT03781375|11356812|FG001|STARTED|Double-blind Phase||13
10228699|NCT03781375|11356811|FG000|Received Study Drug|Double-blind Phase||12
10228700|NCT03781375|11356812|FG001|Received Study Drug|Double-blind Phase||13
10228701|NCT03781375|11356811|FG000|COMPLETED|Double-blind Phase||5
10228702|NCT03781375|11356812|FG001|COMPLETED|Double-blind Phase||7
10228703|NCT03781375|11356811|FG000|NOT COMPLETED|Double-blind Phase||7
10228704|NCT03781375|11356812|FG001|NOT COMPLETED|Double-blind Phase||6
10228705|NCT03781375|11356811|FG000|STARTED|Open-label Phase||11
10228706|NCT03781375|11356812|FG001|STARTED|Open-label Phase||9
10228707|NCT03781375|11356811|FG000|Received Study Drug|Open-label Phase||10
10228708|NCT03781375|11356812|FG001|Received Study Drug|Open-label Phase||9
10228709|NCT03781375|11356811|FG000|COMPLETED|Open-label Phase||8
10228710|NCT03781375|11356812|FG001|COMPLETED|Open-label Phase||6
10228711|NCT03781375|11356811|FG000|NOT COMPLETED|Open-label Phase||3
10228712|NCT03781375|11356812|FG001|NOT COMPLETED|Open-label Phase||3
10228713|NCT03781336|11356821|FG000|STARTED|Overall Study||45
10228714|NCT03781336|11356822|FG001|STARTED|Overall Study||37
10228715|NCT03781336|11356821|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
10228716|NCT03781336|11356822|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
10228717|NCT03781336|11356821|FG000|NOT COMPLETED|Overall Study||2
10228718|NCT03781336|11356822|FG001|NOT COMPLETED|Overall Study||2
10228719|NCT03780400|11356828|FG000|STARTED|Overall Study||60
10228720|NCT03780400|11356828|FG000|COMPLETED|Overall Study||53
10228721|NCT03780400|11356828|FG000|NOT COMPLETED|Overall Study||7
10228722|NCT03779997|11356834|FG000|STARTED|Overall Study||39
10228723|NCT03779997|11356835|FG001|STARTED|Overall Study||39
10228724|NCT03779997|11356834|FG000|Completed at Least One Visit|Overall Study||39
10228725|NCT03779997|11356835|FG001|Completed at Least One Visit|Overall Study||39
10228726|NCT03779997|11356834|FG000|COMPLETED|Overall Study||39
10228727|NCT03779997|11356835|FG001|COMPLETED|Overall Study||39
10013055|NCT01790126|11136046|FG002|Treated|Overall Study||31
10013056|NCT01790126|11136044|FG000|COMPLETED|Overall Study||0
10013057|NCT01790126|11136045|FG001|COMPLETED|Overall Study||0
10013058|NCT01790126|11136046|FG002|COMPLETED|Overall Study||0
10013059|NCT01790126|11136044|FG000|NOT COMPLETED|Overall Study||30
10013060|NCT01790126|11136045|FG001|NOT COMPLETED|Overall Study||29
10013061|NCT01790126|11136046|FG002|NOT COMPLETED|Overall Study||31
10013062|NCT01790178|11136057|FG000|STARTED|Overall Study||16
10013063|NCT01790178|11136058|FG001|STARTED|Overall Study||24
10013064|NCT01790178|11136057|FG000|COMPLETED|Overall Study||16
10013065|NCT01790178|11136058|FG001|COMPLETED|Overall Study||24
10013066|NCT01790178|11136057|FG000|NOT COMPLETED|Overall Study||0
10013067|NCT01790178|11136058|FG001|NOT COMPLETED|Overall Study||0
10013068|NCT01790243|11136066|FG000|STARTED|Overall Study||1029
10013069|NCT01790243|11136067|FG001|STARTED|Overall Study||160
10013070|NCT01790243|11136066|FG000|COMPLETED|Overall Study||739
10013071|NCT01790243|11136067|FG001|COMPLETED|Overall Study||117
10013072|NCT01790243|11136066|FG000|NOT COMPLETED|Overall Study||290
10228728|NCT03779997|11356834|FG000|NOT COMPLETED|Overall Study||0
10228729|NCT03779997|11356835|FG001|NOT COMPLETED|Overall Study||0
10228730|NCT03779503|11356841|FG000|STARTED|First Intervention||28
10228731|NCT03779503|11356842|FG001|STARTED|First Intervention||27
10228732|NCT03779503|11356841|FG000|COMPLETED|First Intervention||27
10228733|NCT03779503|11356842|FG001|COMPLETED|First Intervention||26
10228734|NCT03779503|11356841|FG000|NOT COMPLETED|First Intervention||1
10228735|NCT03779503|11356842|FG001|NOT COMPLETED|First Intervention||1
10228736|NCT03779503|11356841|FG000|STARTED|Second Intervention||27
10228737|NCT03779503|11356842|FG001|STARTED|Second Intervention||26
10228738|NCT03779503|11356841|FG000|COMPLETED|Second Intervention||27
10228739|NCT03779503|11356842|FG001|COMPLETED|Second Intervention||26
10228740|NCT03779503|11356841|FG000|NOT COMPLETED|Second Intervention||0
10228741|NCT03779503|11356842|FG001|NOT COMPLETED|Second Intervention||0
10228742|NCT03780010|11356850|FG000|STARTED|Overall Study||3
10228743|NCT03780010|11356851|FG001|STARTED|Overall Study||12
10228744|NCT03780010|11356850|FG000|COMPLETED|Overall Study||3
10228745|NCT03780010|11356851|FG001|COMPLETED|Overall Study||12
10228746|NCT03780010|11356850|FG000|NOT COMPLETED|Overall Study||0
10228747|NCT03780010|11356851|FG001|NOT COMPLETED|Overall Study||0
10228748|NCT03778190|11356868|FG000|STARTED|Overall Study||10
10228749|NCT03778190|11356868|FG000|COMPLETED|Overall Study||10
10228750|NCT03778190|11356868|FG000|NOT COMPLETED|Overall Study||0
10228751|NCT03777059|11356876|FG000|STARTED|DB Treatment Period (Up to Week 12)||223
10228752|NCT03777059|11356877|FG001|STARTED|DB Treatment Period (Up to Week 12)||222
10228753|NCT03777059|11356878|FG002|STARTED|DB Treatment Period (Up to Week 12)||230
10228754|NCT03777059|11356879|FG003|STARTED|DB Treatment Period (Up to Week 12)||235
10228755|NCT03777059|11356876|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
10228756|NCT03777059|11356877|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
10228757|NCT03777059|11356878|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
10228758|NCT03777059|11356879|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
10228759|NCT03777059|11356876|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201
10228760|NCT03777059|11356877|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193
10228761|NCT03777059|11356878|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207
10228762|NCT03777059|11356879|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204
10228763|NCT03777059|11356876|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
10013073|NCT01790243|11136067|FG001|NOT COMPLETED|Overall Study||43
10013074|NCT01790295|11136073|FG000|STARTED|Overall Study||21
10013075|NCT01790295|11136073|FG000|COMPLETED|Overall Study||10
10013076|NCT01790295|11136073|FG000|NOT COMPLETED|Overall Study||11
10013077|NCT01790438|11136080|FG000|STARTED|Overall Study||428
10013078|NCT01790438|11136081|FG001|STARTED|Overall Study||213
10228764|NCT03777059|11356877|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
10228765|NCT03777059|11356878|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
10228766|NCT03777059|11356879|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
10228767|NCT03777059|11356876|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46
10228768|NCT03777059|11356877|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54
10228769|NCT03777059|11356878|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38
10228770|NCT03777059|11356879|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45
10228771|NCT03777059|11356876|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
10228772|NCT03777059|11356877|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
10228773|NCT03777059|11356878|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
10228774|NCT03777059|11356879|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
10228775|NCT03777059|11356876|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
10228776|NCT03777059|11356877|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
10228777|NCT03777059|11356878|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
10228778|NCT03777059|11356879|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
10228779|NCT03772522|11356891|FG000|STARTED|Pre-intervention||12
10228780|NCT03772522|11356892|FG001|STARTED|Pre-intervention||15
10228781|NCT03772522|11356891|FG000|COMPLETED|Pre-intervention||9
10228782|NCT03772522|11356892|FG001|COMPLETED|Pre-intervention||11
10228783|NCT03772522|11356891|FG000|NOT COMPLETED|Pre-intervention||3
10228784|NCT03772522|11356892|FG001|NOT COMPLETED|Pre-intervention||4
10228785|NCT03772522|11356891|FG000|STARTED|Intervention||9
10228786|NCT03772522|11356892|FG001|STARTED|Intervention||11
10228787|NCT03772522|11356891|FG000|COMPLETED|Intervention||8
10228788|NCT03772522|11356892|FG001|COMPLETED|Intervention||11
10228789|NCT03772522|11356891|FG000|NOT COMPLETED|Intervention||1
10228790|NCT03772522|11356892|FG001|NOT COMPLETED|Intervention||0
10228791|NCT03772522|11356891|FG000|STARTED|Post-intervention Follow-up||8
10228792|NCT03772522|11356892|FG001|STARTED|Post-intervention Follow-up||11
10228793|NCT03772522|11356891|FG000|COMPLETED|Post-intervention Follow-up||7
10228794|NCT03772522|11356892|FG001|COMPLETED|Post-intervention Follow-up||11
10228795|NCT03772522|11356891|FG000|NOT COMPLETED|Post-intervention Follow-up||1
10228796|NCT03772522|11356892|FG001|NOT COMPLETED|Post-intervention Follow-up||0
10228797|NCT03772327|11356904|FG000|STARTED|Overall Study||30
10228798|NCT03772327|11356905|FG001|STARTED|Overall Study||33
10228799|NCT03772327|11356904|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
10228800|NCT03772327|11356905|FG001|Week 0 Visit|Overall Study||33
10228801|NCT03772327|11356904|FG000|COMPLETED|Overall Study||25
10228802|NCT03772327|11356905|FG001|COMPLETED|Overall Study||26
10228803|NCT03772327|11356904|FG000|NOT COMPLETED|Overall Study||5
10228804|NCT03772327|11356905|FG001|NOT COMPLETED|Overall Study||7
10228805|NCT03777865|11356911|FG000|STARTED|Overall Study||100
10228806|NCT03777865|11356911|FG000|COMPLETED|Overall Study||100
10228807|NCT03777865|11356911|FG000|NOT COMPLETED|Overall Study||0
10228808|NCT03774576|11356915|FG000|STARTED|Period 1||14
10228809|NCT03774576|11356915|FG000|COMPLETED|Period 1||14
10228810|NCT03774576|11356915|FG000|NOT COMPLETED|Period 1||0
10228811|NCT03774576|11356915|FG000|STARTED|Period 2||14
10228812|NCT03774576|11356915|FG000|COMPLETED|Period 2||13
10228813|NCT03774576|11356915|FG000|NOT COMPLETED|Period 2||1
10228814|NCT03776539|11356928|FG000|STARTED|Overall Study||6
10228815|NCT03776539|11356929|FG001|STARTED|Overall Study||6
10228816|NCT03776539|11356930|FG002|STARTED|Overall Study||6
10228817|NCT03776539|11356931|FG003|STARTED|Overall Study||6
10228818|NCT03776539|11356928|FG000|COMPLETED|Overall Study||6
10228819|NCT03776539|11356929|FG001|COMPLETED|Overall Study||6
10228820|NCT03776539|11356930|FG002|COMPLETED|Overall Study||6
10228821|NCT03776539|11356931|FG003|COMPLETED|Overall Study||6
10228822|NCT03776539|11356928|FG000|NOT COMPLETED|Overall Study||0
10228823|NCT03776539|11356929|FG001|NOT COMPLETED|Overall Study||0
10228824|NCT03776539|11356930|FG002|NOT COMPLETED|Overall Study||0
10228825|NCT03776539|11356931|FG003|NOT COMPLETED|Overall Study||0
10228826|NCT03772041|11356943|FG000|STARTED|Overall Study||149
10228827|NCT03772041|11356944|FG001|STARTED|Overall Study||145
10228828|NCT03772041|11356943|FG000|COMPLETED|Overall Study||135
10228829|NCT03772041|11356944|FG001|COMPLETED|Overall Study||135
10228830|NCT03772041|11356943|FG000|NOT COMPLETED|Overall Study||14
10228831|NCT03772041|11356944|FG001|NOT COMPLETED|Overall Study||10
10228832|NCT03775681|11356950|FG000|STARTED|Overall Study||33
10228833|NCT03775681|11356950|FG000|COMPLETED|Overall Study||30
10228834|NCT03775681|11356950|FG000|NOT COMPLETED|Overall Study||3
10228835|NCT03774823|11356956|FG000|STARTED|Overall Study||5
10228836|NCT03774823|11356957|FG001|STARTED|Overall Study||5
10228837|NCT03774823|11356956|FG000|COMPLETED|Overall Study||4
10228838|NCT03774823|11356957|FG001|COMPLETED|Overall Study||4
10228839|NCT03774823|11356956|FG000|NOT COMPLETED|Overall Study||1
10228840|NCT03774823|11356957|FG001|NOT COMPLETED|Overall Study||1
10228841|NCT03774745|11356965|FG000|STARTED|Overall Study||6
10228842|NCT03774745|11356966|FG001|STARTED|Overall Study||6
10228843|NCT03774745|11356965|FG000|Follow-Up 1|Overall Study||5
10228844|NCT03774745|11356966|FG001|Follow-Up 1|Overall Study||6
10228845|NCT03774745|11356965|FG000|Follow-up 2|Overall Study||4
10228846|NCT03774745|11356966|FG001|Follow-up 2|Overall Study||2
10228847|NCT03774745|11356965|FG000|COMPLETED|Overall Study||4
10228848|NCT03774745|11356966|FG001|COMPLETED|Overall Study||2
10228849|NCT03774745|11356965|FG000|NOT COMPLETED|Overall Study||2
10228850|NCT03774745|11356966|FG001|NOT COMPLETED|Overall Study||4
10228851|NCT03774433|11356972|FG000|STARTED|Overall Study||114
10228852|NCT03774433|11356972|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
10228853|NCT03774433|11356972|FG000|NOT COMPLETED|Overall Study||14
10239368|NCT00281879|11370902|FG004|COMPLETED|Overall Study||0
10239369|NCT00281879|11370903|FG005|COMPLETED|Overall Study||0
10239370|NCT00281879|11370904|FG006|COMPLETED|Overall Study||0
10239371|NCT00281879|11370905|FG007|COMPLETED|Overall Study||0
10239372|NCT00281879|11370898|FG000|NOT COMPLETED|Overall Study||128
10239373|NCT00281879|11370899|FG001|NOT COMPLETED|Overall Study||36
10239374|NCT00281879|11370900|FG002|NOT COMPLETED|Overall Study||20
10239375|NCT00281879|11370901|FG003|NOT COMPLETED|Overall Study||0
10239376|NCT00281879|11370902|FG004|NOT COMPLETED|Overall Study||6
10239377|NCT00281879|11370903|FG005|NOT COMPLETED|Overall Study||9
10239378|NCT00281879|11370904|FG006|NOT COMPLETED|Overall Study||0
10239379|NCT00281879|11370905|FG007|NOT COMPLETED|Overall Study||1
10239380|NCT00271947|11370923|FG000|STARTED|Overall Study||1
10239381|NCT00271947|11370923|FG000|COMPLETED|Overall Study||0
10239382|NCT00271947|11370923|FG000|NOT COMPLETED|Overall Study||1
10239383|NCT00271011|11370927|FG000|STARTED|Overall Study||13
10239384|NCT00271011|11370927|FG000|COMPLETED|Overall Study||13
10239385|NCT00271011|11370927|FG000|NOT COMPLETED|Overall Study||0
10239386|NCT00253981|11370933|FG000|STARTED|Overall Study||16
10239387|NCT00253981|11370934|FG001|STARTED|Overall Study||14
10239388|NCT00253981|11370933|FG000|COMPLETED|Overall Study||16
10239389|NCT00253981|11370934|FG001|COMPLETED|Overall Study||14
10239390|NCT00253981|11370933|FG000|NOT COMPLETED|Overall Study||0
10239391|NCT00253981|11370934|FG001|NOT COMPLETED|Overall Study||0
10239392|NCT00252174|11370943|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
10239393|NCT00252174|11370944|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2
10239394|NCT00252174|11370945|FG002|STARTED|Overall Study|No subjects entered Stage 2|0
10239395|NCT00252174|11370943|FG000|COMPLETED|Overall Study||0
10239396|NCT00252174|11370944|FG001|COMPLETED|Overall Study||1
10239397|NCT00252174|11370945|FG002|COMPLETED|Overall Study||0
10239398|NCT00252174|11370943|FG000|NOT COMPLETED|Overall Study||0
10239399|NCT00252174|11370944|FG001|NOT COMPLETED|Overall Study||1
10239400|NCT00252174|11370945|FG002|NOT COMPLETED|Overall Study||0
10239401|NCT00256295|11370953|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
10239402|NCT00256295|11370953|FG000|COMPLETED|Overall Study||3
10239403|NCT00256295|11370953|FG000|NOT COMPLETED|Overall Study||4
10239404|NCT00245128|11370957|FG000|STARTED|Overall Study||10
10239405|NCT00245128|11370957|FG000|COMPLETED|Overall Study||0
10239406|NCT00245128|11370957|FG000|NOT COMPLETED|Overall Study||10
10239407|NCT00268450|11370961|FG000|STARTED|Overall Study||21
10239408|NCT00268450|11370961|FG000|COMPLETED|Overall Study||21
10239409|NCT00268450|11370961|FG000|NOT COMPLETED|Overall Study||0
10239410|NCT00239720|11370967|FG000|STARTED|Overall Study||3
10239411|NCT00239720|11370968|FG001|STARTED|Overall Study||1
10239412|NCT00239720|11370967|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
10239413|NCT00239720|11370968|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0
10239414|NCT00239720|11370967|FG000|NOT COMPLETED|Overall Study||1
10239415|NCT00239720|11370968|FG001|NOT COMPLETED|Overall Study||1
10239416|NCT00250718|11370974|FG000|STARTED|Overall Study||17
10239417|NCT00250718|11370974|FG000|Received Treatment|Overall Study||16
10239418|NCT00250718|11370974|FG000|COMPLETED|Overall Study||14
10239419|NCT00250718|11370974|FG000|NOT COMPLETED|Overall Study||3
10239420|NCT00244010|11370980|FG000|STARTED|Overall Study||2
10239421|NCT00244010|11370981|FG001|STARTED|Overall Study||2
10239422|NCT00244010|11370980|FG000|COMPLETED|Overall Study||2
10239423|NCT00244010|11370981|FG001|COMPLETED|Overall Study||2
10239424|NCT00244010|11370980|FG000|NOT COMPLETED|Overall Study||0
10239425|NCT00244010|11370981|FG001|NOT COMPLETED|Overall Study||0
10239426|NCT00218036|11370992|FG000|STARTED|Overall Study||11
10239427|NCT00218036|11370993|FG001|STARTED|Overall Study||6
10239428|NCT00218036|11370994|FG002|STARTED|Overall Study||13
10239429|NCT00218036|11370995|FG003|STARTED|Overall Study||12
10239430|NCT00218036|11370996|FG004|STARTED|Overall Study||9
10239431|NCT00218036|11370992|FG000|COMPLETED|Overall Study||6
10239432|NCT00218036|11370993|FG001|COMPLETED|Overall Study||3
10239433|NCT00218036|11370994|FG002|COMPLETED|Overall Study||5
10239434|NCT00218036|11370995|FG003|COMPLETED|Overall Study||6
10239435|NCT00218036|11370996|FG004|COMPLETED|Overall Study||3
10239436|NCT00218036|11370992|FG000|NOT COMPLETED|Overall Study||5
10239437|NCT00218036|11370993|FG001|NOT COMPLETED|Overall Study||3
10239438|NCT00218036|11370994|FG002|NOT COMPLETED|Overall Study||8
10239439|NCT00218036|11370995|FG003|NOT COMPLETED|Overall Study||6
10239440|NCT00218036|11370996|FG004|NOT COMPLETED|Overall Study||6
10239441|NCT00240227|11371008|FG000|STARTED|Overall Study||8
10239442|NCT00240227|11371008|FG000|COMPLETED|Overall Study||8
10239443|NCT00240227|11371008|FG000|NOT COMPLETED|Overall Study||0
10239444|NCT00205868|11371015|FG000|STARTED|Overall Study||304
10239445|NCT00205868|11371015|FG000|COMPLETED|Overall Study||304
10239446|NCT00205868|11371015|FG000|NOT COMPLETED|Overall Study||0
10239447|NCT00206375|11371022|FG000|STARTED|Overall Study||6
10239448|NCT00206375|11371023|FG001|STARTED|Overall Study||3
10239449|NCT00206375|11371024|FG002|STARTED|Overall Study||7
10239450|NCT00206375|11371022|FG000|COMPLETED|Overall Study||3
10239451|NCT00206375|11371023|FG001|COMPLETED|Overall Study||1
10239452|NCT00206375|11371024|FG002|COMPLETED|Overall Study||3
10239453|NCT00206375|11371022|FG000|NOT COMPLETED|Overall Study||3
10239454|NCT00206375|11371023|FG001|NOT COMPLETED|Overall Study||2
10228854|NCT03771560|11356976|FG000|STARTED|Overall Study||18
10228855|NCT03771560|11356976|FG000|COMPLETED|Overall Study||12
10228856|NCT03771560|11356976|FG000|NOT COMPLETED|Overall Study||6
10228857|NCT03770091|11356983|FG000|STARTED|Overall Study||15
10228858|NCT03770091|11356984|FG001|STARTED|Overall Study||13
10228859|NCT03770091|11356985|FG002|STARTED|Overall Study||12
10228860|NCT03770091|11356983|FG000|COMPLETED|Overall Study||15
10228861|NCT03770091|11356984|FG001|COMPLETED|Overall Study||13
10228862|NCT03770091|11356985|FG002|COMPLETED|Overall Study||12
10228863|NCT03770091|11356983|FG000|NOT COMPLETED|Overall Study||0
10228864|NCT03770091|11356984|FG001|NOT COMPLETED|Overall Study||0
10228865|NCT03770091|11356985|FG002|NOT COMPLETED|Overall Study||0
10228866|NCT03769896|11356995|FG000|STARTED|Open-label Phase||47
10228867|NCT03769896|11356996|FG001|STARTED|Open-label Phase||0
10228868|NCT03769896|11356995|FG000|COMPLETED|Open-label Phase||38
10228869|NCT03769896|11356996|FG001|COMPLETED|Open-label Phase||0
10228870|NCT03769896|11356995|FG000|NOT COMPLETED|Open-label Phase||9
10228871|NCT03769896|11356996|FG001|NOT COMPLETED|Open-label Phase||0
10228872|NCT03769896|11356995|FG000|STARTED|Double-blind Treatment Phase||19
10228873|NCT03769896|11356996|FG001|STARTED|Double-blind Treatment Phase||19
10228874|NCT03769896|11356995|FG000|COMPLETED|Double-blind Treatment Phase||19
10228875|NCT03769896|11356996|FG001|COMPLETED|Double-blind Treatment Phase||19
10228876|NCT03769896|11356995|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
10228877|NCT03769896|11356996|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
10228878|NCT03769207|11357003|FG000|STARTED|Overall Study||17
10228879|NCT03769207|11357003|FG000|Attended First Study Visit|Overall Study||11
10228880|NCT03769207|11357003|FG000|ECG Patch Shipped|Overall Study||11
10228881|NCT03769207|11357003|FG000|ECG Patch Returned and Readable|Overall Study||9
10228882|NCT03769207|11357003|FG000|Attended Second Study Visit|Overall Study||6
10228883|NCT03769207|11357003|FG000|COMPLETED|Overall Study||6
10228884|NCT03769207|11357003|FG000|NOT COMPLETED|Overall Study||11
10228885|NCT03768856|11357007|FG000|STARTED|Overall Study||5
10228886|NCT03768856|11357007|FG000|COMPLETED|Overall Study||5
10228887|NCT03768856|11357007|FG000|NOT COMPLETED|Overall Study||0
10228888|NCT03768726|11357013|FG000|STARTED|Treatment Phase||10
10228889|NCT03768726|11357014|FG001|STARTED|Treatment Phase||13
10228890|NCT03768726|11357013|FG000|COMPLETED|Treatment Phase||2
10228891|NCT03768726|11357014|FG001|COMPLETED|Treatment Phase||10
10228892|NCT03768726|11357013|FG000|NOT COMPLETED|Treatment Phase||8
10228893|NCT03768726|11357014|FG001|NOT COMPLETED|Treatment Phase||3
10228894|NCT03768726|11357013|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
10228895|NCT03768726|11357014|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
10228896|NCT03768726|11357013|FG000|Received Treatment|Follow-Up||8
10228897|NCT03768726|11357014|FG001|Received Treatment|Follow-Up||12
10228898|NCT03768726|11357013|FG000|COMPLETED|Follow-Up||2
10228899|NCT03768726|11357014|FG001|COMPLETED|Follow-Up||9
10228900|NCT03768726|11357013|FG000|NOT COMPLETED|Follow-Up||6
10228901|NCT03768726|11357014|FG001|NOT COMPLETED|Follow-Up||3
10228902|NCT03768206|11357022|FG000|STARTED|Overall Study||24
10228903|NCT03768206|11357023|FG001|STARTED|Overall Study||21
10228904|NCT03768206|11357022|FG000|COMPLETED|Overall Study||22
10228905|NCT03768206|11357023|FG001|COMPLETED|Overall Study||19
10228906|NCT03768206|11357022|FG000|NOT COMPLETED|Overall Study||2
10228907|NCT03768206|11357023|FG001|NOT COMPLETED|Overall Study||2
10228908|NCT03767894|11357030|FG000|STARTED|Overall Study||12
10228909|NCT03767894|11357030|FG000|COMPLETED|Overall Study||11
10228910|NCT03767894|11357030|FG000|NOT COMPLETED|Overall Study||1
10228911|NCT03767738|11357036|FG000|STARTED|Overall Study||35
10228912|NCT03767738|11357037|FG001|STARTED|Overall Study||30
10228913|NCT03767738|11357036|FG000|COMPLETED|Overall Study||35
10228914|NCT03767738|11357037|FG001|COMPLETED|Overall Study||30
10228915|NCT03767738|11357036|FG000|NOT COMPLETED|Overall Study||0
10228916|NCT03767738|11357037|FG001|NOT COMPLETED|Overall Study||0
10228917|NCT03767153|11357045|FG000|STARTED|Overall Study||14
10228918|NCT03767153|11357046|FG001|STARTED|Overall Study||11
10228919|NCT03767153|11357045|FG000|COMPLETED|Overall Study||14
10228920|NCT03767153|11357046|FG001|COMPLETED|Overall Study||11
10228921|NCT03767153|11357045|FG000|NOT COMPLETED|Overall Study||0
10228922|NCT03767153|11357046|FG001|NOT COMPLETED|Overall Study||0
10228923|NCT03767062|11357054|FG000|STARTED|Overall Study||45
10228924|NCT03767062|11357055|FG001|STARTED|Overall Study||45
10228925|NCT03767062|11357054|FG000|COMPLETED|Overall Study||37
10228926|NCT03767062|11357055|FG001|COMPLETED|Overall Study||41
10228927|NCT03767062|11357054|FG000|NOT COMPLETED|Overall Study||8
10228928|NCT03767062|11357055|FG001|NOT COMPLETED|Overall Study||4
10228929|NCT03766646|11357063|FG000|STARTED|Overall Study||19
10013079|NCT01790438|11136080|FG000|Received at Least One Dose of Study Drug|Overall Study||427
10013080|NCT01790438|11136081|FG001|Received at Least One Dose of Study Drug|Overall Study||212
10013081|NCT01790438|11136080|FG000|COMPLETED|Overall Study||393
10013082|NCT01790438|11136081|FG001|COMPLETED|Overall Study||202
10013083|NCT01790438|11136080|FG000|NOT COMPLETED|Overall Study||35
10228930|NCT03766646|11357064|FG001|STARTED|Overall Study||15
10228931|NCT03766646|11357063|FG000|COMPLETED|Overall Study||18
10228932|NCT03766646|11357064|FG001|COMPLETED|Overall Study||12
10228933|NCT03766646|11357063|FG000|NOT COMPLETED|Overall Study||1
10228934|NCT03766646|11357064|FG001|NOT COMPLETED|Overall Study||3
10228935|NCT03766373|11357072|FG000|STARTED|Overall Study||12
10013084|NCT01790438|11136081|FG001|NOT COMPLETED|Overall Study||11
10228936|NCT03766373|11357073|FG001|STARTED|Overall Study||12
10228937|NCT03766373|11357072|FG000|COMPLETED|Overall Study||12
10228938|NCT03766373|11357073|FG001|COMPLETED|Overall Study||12
10228939|NCT03766373|11357072|FG000|NOT COMPLETED|Overall Study||0
10228940|NCT03766373|11357073|FG001|NOT COMPLETED|Overall Study||0
10228941|NCT03766165|11357081|FG000|STARTED|Overall Study||19
10228942|NCT03766165|11357082|FG001|STARTED|Overall Study||19
10228943|NCT03766165|11357081|FG000|COMPLETED|Overall Study||19
10228944|NCT03766165|11357082|FG001|COMPLETED|Overall Study||19
10228945|NCT03766165|11357081|FG000|NOT COMPLETED|Overall Study||0
10228946|NCT03766165|11357082|FG001|NOT COMPLETED|Overall Study||0
10228947|NCT03765996|11357091|FG000|STARTED|Overall Study||18
10228948|NCT03765996|11357092|FG001|STARTED|Overall Study||18
10228949|NCT03765996|11357091|FG000|COMPLETED|Overall Study||14
10228950|NCT03765996|11357092|FG001|COMPLETED|Overall Study||18
10228951|NCT03765996|11357091|FG000|NOT COMPLETED|Overall Study||4
10228952|NCT03765996|11357092|FG001|NOT COMPLETED|Overall Study||0
10228953|NCT03765762|11357100|FG000|STARTED|Overall Study||18
10228954|NCT03765762|11357101|FG001|STARTED|Overall Study||8
10228955|NCT03765762|11357100|FG000|COMPLETED|Overall Study||18
10228956|NCT03765762|11357101|FG001|COMPLETED|Overall Study||8
10228957|NCT03765762|11357100|FG000|NOT COMPLETED|Overall Study||0
10228958|NCT03765762|11357101|FG001|NOT COMPLETED|Overall Study||0
10228959|NCT03765502|11357110|FG000|STARTED|Simulation 1||20
10228960|NCT03765502|11357111|FG001|STARTED|Simulation 1||13
10228961|NCT03765502|11357112|FG002|STARTED|Simulation 1||33
10228962|NCT03765502|11357113|FG003|STARTED|Simulation 1||16
10228963|NCT03765502|11357114|FG004|STARTED|Simulation 1||17
10228964|NCT03765502|11357110|FG000|COMPLETED|Simulation 1||20
10228965|NCT03765502|11357111|FG001|COMPLETED|Simulation 1||13
10228966|NCT03765502|11357112|FG002|COMPLETED|Simulation 1||33
10228967|NCT03765502|11357113|FG003|COMPLETED|Simulation 1||16
10228968|NCT03765502|11357114|FG004|COMPLETED|Simulation 1||17
10228969|NCT03765502|11357110|FG000|NOT COMPLETED|Simulation 1||0
10228970|NCT03765502|11357111|FG001|NOT COMPLETED|Simulation 1||0
10228971|NCT03765502|11357112|FG002|NOT COMPLETED|Simulation 1||0
10228972|NCT03765502|11357113|FG003|NOT COMPLETED|Simulation 1||0
10228973|NCT03765502|11357114|FG004|NOT COMPLETED|Simulation 1||0
10228974|NCT03765502|11357110|FG000|STARTED|Simulation 2||20
10228975|NCT03765502|11357111|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
10228976|NCT03765502|11357112|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
10228977|NCT03765502|11357113|FG003|STARTED|Simulation 2||16
10228978|NCT03765502|11357114|FG004|STARTED|Simulation 2||17
10228979|NCT03765502|11357110|FG000|COMPLETED|Simulation 2||20
10228980|NCT03765502|11357111|FG001|COMPLETED|Simulation 2||12
10228981|NCT03765502|11357112|FG002|COMPLETED|Simulation 2||32
10228982|NCT03765502|11357113|FG003|COMPLETED|Simulation 2||16
10228983|NCT03765502|11357114|FG004|COMPLETED|Simulation 2||17
10228984|NCT03765502|11357110|FG000|NOT COMPLETED|Simulation 2||0
10228985|NCT03765502|11357111|FG001|NOT COMPLETED|Simulation 2||0
10228986|NCT03765502|11357112|FG002|NOT COMPLETED|Simulation 2||0
10228987|NCT03765502|11357113|FG003|NOT COMPLETED|Simulation 2||0
10228988|NCT03765502|11357114|FG004|NOT COMPLETED|Simulation 2||0
10228989|NCT03765164|11357136|FG000|STARTED|Pre-intervention||78
10228990|NCT03765164|11357137|FG001|STARTED|Pre-intervention||78
10228991|NCT03765164|11357136|FG000|COMPLETED|Pre-intervention||73
10228992|NCT03765164|11357137|FG001|COMPLETED|Pre-intervention||72
10228993|NCT03765164|11357136|FG000|NOT COMPLETED|Pre-intervention||5
10228994|NCT03765164|11357137|FG001|NOT COMPLETED|Pre-intervention||6
10228995|NCT03765164|11357136|FG000|STARTED|Post-intervention||73
10228996|NCT03765164|11357137|FG001|STARTED|Post-intervention||72
10228997|NCT03765164|11357136|FG000|COMPLETED|Post-intervention||0
10228998|NCT03765164|11357137|FG001|COMPLETED|Post-intervention||0
10228999|NCT03765164|11357136|FG000|NOT COMPLETED|Post-intervention||73
10229000|NCT03765164|11357137|FG001|NOT COMPLETED|Post-intervention||72
10229001|NCT03765138|11357143|FG000|STARTED|Overall Study||1
10229002|NCT03765138|11357143|FG000|COMPLETED|Overall Study||0
10229003|NCT03765138|11357143|FG000|NOT COMPLETED|Overall Study||1
10229004|NCT03764449|11357150|FG000|STARTED|Overall Study||8
10229005|NCT03764449|11357151|FG001|STARTED|Overall Study||8
10229006|NCT03764449|11357150|FG000|COMPLETED|Overall Study||8
10229007|NCT03764449|11357151|FG001|COMPLETED|Overall Study||8
10229008|NCT03764449|11357150|FG000|NOT COMPLETED|Overall Study||0
10229009|NCT03764449|11357151|FG001|NOT COMPLETED|Overall Study||0
10229010|NCT03763929|11357166|FG000|STARTED|Overall Study||2
10229011|NCT03763929|11357167|FG001|STARTED|Overall Study||4
10229012|NCT03763929|11357166|FG000|COMPLETED|Overall Study||2
10229013|NCT03763929|11357167|FG001|COMPLETED|Overall Study||4
10229014|NCT03763929|11357166|FG000|NOT COMPLETED|Overall Study||0
10229015|NCT03763929|11357167|FG001|NOT COMPLETED|Overall Study||0
10229016|NCT03763747|11357173|FG000|STARTED|Overall Study||200
10229017|NCT03763747|11357173|FG000|COMPLETED|Overall Study||200
10229018|NCT03763747|11357173|FG000|NOT COMPLETED|Overall Study||0
10229019|NCT03763175|11357180|FG000|STARTED|Overall Study||20
10229020|NCT03763175|11357181|FG001|STARTED|Overall Study||19
10229021|NCT03763175|11357182|FG002|STARTED|Overall Study||20
10229022|NCT03763175|11357180|FG000|COMPLETED|Overall Study||19
10229023|NCT03763175|11357181|FG001|COMPLETED|Overall Study||17
10229024|NCT03763175|11357182|FG002|COMPLETED|Overall Study||19
10229025|NCT03763175|11357180|FG000|NOT COMPLETED|Overall Study||1
10229026|NCT03763175|11357181|FG001|NOT COMPLETED|Overall Study||2
10229027|NCT03763175|11357182|FG002|NOT COMPLETED|Overall Study||1
10229028|NCT03763058|11357190|FG000|STARTED|Overall Study||20
10229029|NCT03763058|11357190|FG000|COMPLETED|Overall Study||18
10229030|NCT03763058|11357190|FG000|NOT COMPLETED|Overall Study||2
10229031|NCT03762993|11357196|FG000|STARTED|Overall Study||21
10229032|NCT03762993|11357197|FG001|STARTED|Overall Study||10
10229033|NCT03762993|11357196|FG000|COMPLETED|Overall Study||21
10229034|NCT03762993|11357197|FG001|COMPLETED|Overall Study||10
10229035|NCT03762993|11357196|FG000|NOT COMPLETED|Overall Study||0
10229036|NCT03762993|11357197|FG001|NOT COMPLETED|Overall Study||0
10229037|NCT03762681|11357211|FG000|STARTED|Part 1||8
10229038|NCT03762681|11357212|FG001|STARTED|Part 1||8
10229039|NCT03762681|11357213|FG002|STARTED|Part 1||8
10229040|NCT03762681|11357214|FG003|STARTED|Part 1||8
10229041|NCT03762681|11357215|FG004|STARTED|Part 1||8
10229042|NCT03762681|11357216|FG005|STARTED|Part 1||0
10229043|NCT03762681|11357217|FG006|STARTED|Part 1||0
10229044|NCT03762681|11357218|FG007|STARTED|Part 1||0
10229045|NCT03762681|11357211|FG000|COMPLETED|Part 1||8
10229046|NCT03762681|11357212|FG001|COMPLETED|Part 1||8
10229047|NCT03762681|11357213|FG002|COMPLETED|Part 1||8
10229048|NCT03762681|11357214|FG003|COMPLETED|Part 1||7
10229049|NCT03762681|11357215|FG004|COMPLETED|Part 1||8
10229050|NCT03762681|11357216|FG005|COMPLETED|Part 1||0
10229051|NCT03762681|11357217|FG006|COMPLETED|Part 1||0
10229052|NCT03762681|11357218|FG007|COMPLETED|Part 1||0
10229053|NCT03762681|11357211|FG000|NOT COMPLETED|Part 1||0
10229054|NCT03762681|11357212|FG001|NOT COMPLETED|Part 1||0
10229055|NCT03762681|11357213|FG002|NOT COMPLETED|Part 1||0
10229056|NCT03762681|11357214|FG003|NOT COMPLETED|Part 1||1
10229057|NCT03762681|11357215|FG004|NOT COMPLETED|Part 1||0
10229058|NCT03762681|11357216|FG005|NOT COMPLETED|Part 1||0
10229059|NCT03762681|11357217|FG006|NOT COMPLETED|Part 1||0
10013085|NCT01790490|11136092|FG000|STARTED|Overall Study||3
10229060|NCT03762681|11357218|FG007|NOT COMPLETED|Part 1||0
10229061|NCT03762681|11357211|FG000|STARTED|Part 2a||0
10229062|NCT03762681|11357212|FG001|STARTED|Part 2a||0
10229063|NCT03762681|11357213|FG002|STARTED|Part 2a||0
10229064|NCT03762681|11357214|FG003|STARTED|Part 2a||0
10229065|NCT03762681|11357215|FG004|STARTED|Part 2a||0
10229066|NCT03762681|11357216|FG005|STARTED|Part 2a||2
10229067|NCT03762681|11357217|FG006|STARTED|Part 2a||8
10229068|NCT03762681|11357218|FG007|STARTED|Part 2a||5
10229069|NCT03762681|11357211|FG000|COMPLETED|Part 2a||0
10229070|NCT03762681|11357212|FG001|COMPLETED|Part 2a||0
10229071|NCT03762681|11357213|FG002|COMPLETED|Part 2a||0
10229072|NCT03762681|11357214|FG003|COMPLETED|Part 2a||0
10229073|NCT03762681|11357215|FG004|COMPLETED|Part 2a||0
10229074|NCT03762681|11357216|FG005|COMPLETED|Part 2a||2
10229075|NCT03762681|11357217|FG006|COMPLETED|Part 2a||8
10229076|NCT03762681|11357218|FG007|COMPLETED|Part 2a||4
10229077|NCT03762681|11357211|FG000|NOT COMPLETED|Part 2a||0
10229078|NCT03762681|11357212|FG001|NOT COMPLETED|Part 2a||0
10229079|NCT03762681|11357213|FG002|NOT COMPLETED|Part 2a||0
10229080|NCT03762681|11357214|FG003|NOT COMPLETED|Part 2a||0
10229081|NCT03762681|11357215|FG004|NOT COMPLETED|Part 2a||0
10229082|NCT03762681|11357216|FG005|NOT COMPLETED|Part 2a||0
10229083|NCT03762681|11357217|FG006|NOT COMPLETED|Part 2a||0
10229084|NCT03762681|11357218|FG007|NOT COMPLETED|Part 2a||1
10229085|NCT03762668|11357247|FG000|STARTED|Period 1, First Week of Wear||30
10229086|NCT03762668|11357248|FG001|STARTED|Period 1, First Week of Wear||30
10229087|NCT03762668|11357247|FG000|COMPLETED|Period 1, First Week of Wear||30
10229088|NCT03762668|11357248|FG001|COMPLETED|Period 1, First Week of Wear||29
10229089|NCT03762668|11357247|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10229090|NCT03762668|11357248|FG001|NOT COMPLETED|Period 1, First Week of Wear||1
10229091|NCT03762668|11357247|FG000|STARTED|Period 2, Second Week of Wear||30
10229092|NCT03762668|11357248|FG001|STARTED|Period 2, Second Week of Wear||29
10229093|NCT03762668|11357247|FG000|COMPLETED|Period 2, Second Week of Wear||30
10229094|NCT03762668|11357248|FG001|COMPLETED|Period 2, Second Week of Wear||29
10229095|NCT03762668|11357247|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
10229096|NCT03762668|11357248|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
10229097|NCT03762616|11357254|FG000|STARTED|Overall Study||120
10229098|NCT03762616|11357254|FG000|COMPLETED|Overall Study||118
10229099|NCT03762616|11357254|FG000|NOT COMPLETED|Overall Study||2
10229100|NCT03762213|11357262|FG000|STARTED|Overall Study||16
10229101|NCT03762213|11357263|FG001|STARTED|Overall Study||14
10229102|NCT03762213|11357262|FG000|COMPLETED|Overall Study||16
10229103|NCT03762213|11357263|FG001|COMPLETED|Overall Study||14
10229104|NCT03762213|11357262|FG000|NOT COMPLETED|Overall Study||0
10229105|NCT03762213|11357263|FG001|NOT COMPLETED|Overall Study||0
10229106|NCT03762200|11357269|FG000|STARTED|Overall Study||103
10229107|NCT03762200|11357269|FG000|COMPLETED|Overall Study||101
10229108|NCT03762200|11357269|FG000|NOT COMPLETED|Overall Study||2
10229109|NCT03761368|11357275|FG000|STARTED|Overall Study||50
10229110|NCT03761368|11357276|FG001|STARTED|Overall Study||51
10229111|NCT03761368|11357275|FG000|COMPLETED|Overall Study||50
10229112|NCT03761368|11357276|FG001|COMPLETED|Overall Study||51
10229113|NCT03761368|11357275|FG000|NOT COMPLETED|Overall Study||0
10229114|NCT03761368|11357276|FG001|NOT COMPLETED|Overall Study||0
10013086|NCT01790490|11136093|FG001|STARTED|Overall Study||3
10229115|NCT03761147|11357284|FG000|STARTED|Overall Study||32
10229116|NCT03761147|11357285|FG001|STARTED|Overall Study||32
10229117|NCT03761147|11357284|FG000|COMPLETED|Overall Study||25
10229118|NCT03761147|11357285|FG001|COMPLETED|Overall Study||28
10229119|NCT03761147|11357284|FG000|NOT COMPLETED|Overall Study||7
10229120|NCT03761147|11357285|FG001|NOT COMPLETED|Overall Study||4
10229121|NCT03760913|11357310|FG000|STARTED|Overall Study||17
10229122|NCT03760913|11357311|FG001|STARTED|Overall Study||3
10229123|NCT03760913|11357312|FG002|STARTED|Overall Study||6
10229124|NCT03760913|11357313|FG003|STARTED|Overall Study||3
10229125|NCT03760913|11357314|FG004|STARTED|Overall Study||6
10229126|NCT03760913|11357315|FG005|STARTED|Overall Study||3
10229127|NCT03760913|11357316|FG006|STARTED|Overall Study||6
10229128|NCT03760913|11357317|FG007|STARTED|Overall Study||3
10229129|NCT03760913|11357318|FG008|STARTED|Overall Study||3
10229130|NCT03760913|11357319|FG009|STARTED|Overall Study||6
10229131|NCT03760913|11357320|FG010|STARTED|Overall Study||6
10229132|NCT03760913|11357321|FG011|STARTED|Overall Study||6
10229133|NCT03760913|11357322|FG012|STARTED|Overall Study||12
10229134|NCT03760913|11357323|FG013|STARTED|Overall Study||6
10229135|NCT03760913|11357324|FG014|STARTED|Overall Study||6
10229136|NCT03760913|11357325|FG015|STARTED|Overall Study||6
10229137|NCT03760913|11357326|FG016|STARTED|Overall Study||6
10229138|NCT03760913|11357327|FG017|STARTED|Overall Study||6
10229139|NCT03760913|11357328|FG018|STARTED|Overall Study||6
10229140|NCT03760913|11357310|FG000|COMPLETED|Overall Study||17
10229141|NCT03760913|11357311|FG001|COMPLETED|Overall Study||3
10229142|NCT03760913|11357312|FG002|COMPLETED|Overall Study||6
10229143|NCT03760913|11357313|FG003|COMPLETED|Overall Study||3
10229144|NCT03760913|11357314|FG004|COMPLETED|Overall Study||6
10229145|NCT03760913|11357315|FG005|COMPLETED|Overall Study||3
10229146|NCT03760913|11357316|FG006|COMPLETED|Overall Study||6
10229147|NCT03760913|11357317|FG007|COMPLETED|Overall Study||3
10229148|NCT03760913|11357318|FG008|COMPLETED|Overall Study||3
10229149|NCT03760913|11357319|FG009|COMPLETED|Overall Study||6
10229150|NCT03760913|11357320|FG010|COMPLETED|Overall Study||6
10229151|NCT03760913|11357321|FG011|COMPLETED|Overall Study||6
10229152|NCT03760913|11357322|FG012|COMPLETED|Overall Study||12
10229153|NCT03760913|11357323|FG013|COMPLETED|Overall Study||6
10229154|NCT03760913|11357324|FG014|COMPLETED|Overall Study||6
10229155|NCT03760913|11357325|FG015|COMPLETED|Overall Study||6
10229156|NCT03760913|11357326|FG016|COMPLETED|Overall Study||6
10229157|NCT03760913|11357327|FG017|COMPLETED|Overall Study||6
10229158|NCT03760913|11357328|FG018|COMPLETED|Overall Study||6
10229159|NCT03760913|11357310|FG000|NOT COMPLETED|Overall Study||0
10229160|NCT03760913|11357311|FG001|NOT COMPLETED|Overall Study||0
10229161|NCT03760913|11357312|FG002|NOT COMPLETED|Overall Study||0
10229162|NCT03760913|11357313|FG003|NOT COMPLETED|Overall Study||0
10229163|NCT03760913|11357314|FG004|NOT COMPLETED|Overall Study||0
10229164|NCT03760913|11357315|FG005|NOT COMPLETED|Overall Study||0
10229165|NCT03760913|11357316|FG006|NOT COMPLETED|Overall Study||0
10229166|NCT03760913|11357317|FG007|NOT COMPLETED|Overall Study||0
10229167|NCT03760913|11357318|FG008|NOT COMPLETED|Overall Study||0
10229168|NCT03760913|11357319|FG009|NOT COMPLETED|Overall Study||0
10229169|NCT03760913|11357320|FG010|NOT COMPLETED|Overall Study||0
10229170|NCT03760913|11357321|FG011|NOT COMPLETED|Overall Study||0
10229171|NCT03760913|11357322|FG012|NOT COMPLETED|Overall Study||0
10229172|NCT03760913|11357323|FG013|NOT COMPLETED|Overall Study||0
10229173|NCT03760913|11357324|FG014|NOT COMPLETED|Overall Study||0
10229174|NCT03760913|11357325|FG015|NOT COMPLETED|Overall Study||0
10229175|NCT03760913|11357326|FG016|NOT COMPLETED|Overall Study||0
10229176|NCT03760913|11357327|FG017|NOT COMPLETED|Overall Study||0
10229177|NCT03760913|11357328|FG018|NOT COMPLETED|Overall Study||0
10229178|NCT03760796|11357381|FG000|STARTED|Overall Study||200
10229179|NCT03760796|11357382|FG001|STARTED|Overall Study||864
10229180|NCT03760796|11357381|FG000|COMPLETED|Overall Study||200
10229181|NCT03760796|11357382|FG001|COMPLETED|Overall Study||864
10229182|NCT03760796|11357381|FG000|NOT COMPLETED|Overall Study||0
10229183|NCT03760796|11357382|FG001|NOT COMPLETED|Overall Study||0
10229184|NCT03760640|11357390|FG000|STARTED|Period 1||20
10229185|NCT03760640|11357391|FG001|STARTED|Period 1||22
10229186|NCT03760640|11357390|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
10229187|NCT03760640|11357391|FG001|Received at Least 1 Dose of Study Drug|Period 1||22
10229188|NCT03760640|11357390|FG000|COMPLETED|Period 1||20
10229189|NCT03760640|11357391|FG001|COMPLETED|Period 1||22
10229190|NCT03760640|11357390|FG000|NOT COMPLETED|Period 1||0
10229191|NCT03760640|11357391|FG001|NOT COMPLETED|Period 1||0
10229192|NCT03760640|11357390|FG000|STARTED|Period 2||20
10229193|NCT03760640|11357391|FG001|STARTED|Period 2||22
10229194|NCT03760640|11357390|FG000|COMPLETED|Period 2||20
10229195|NCT03760640|11357391|FG001|COMPLETED|Period 2||22
10229196|NCT03760640|11357390|FG000|NOT COMPLETED|Period 2||0
10229197|NCT03760640|11357391|FG001|NOT COMPLETED|Period 2||0
10229198|NCT03760510|11357399|FG000|STARTED|Overall Study||250
10229199|NCT03760510|11357400|FG001|STARTED|Overall Study||250
10229200|NCT03760510|11357399|FG000|COMPLETED|Overall Study||145
10229201|NCT03760510|11357400|FG001|COMPLETED|Overall Study||153
10229202|NCT03760510|11357399|FG000|NOT COMPLETED|Overall Study||105
10229203|NCT03760510|11357400|FG001|NOT COMPLETED|Overall Study||97
10229204|NCT03760250|11357406|FG000|STARTED|Overall Study||6
10229205|NCT03760250|11357406|FG000|COMPLETED|Overall Study||4
10229206|NCT03760250|11357406|FG000|NOT COMPLETED|Overall Study||2
10229207|NCT03759600|11357410|FG000|STARTED|Overall Study||20
10229208|NCT03759600|11357410|FG000|COMPLETED|Overall Study||0
10229209|NCT03759600|11357410|FG000|NOT COMPLETED|Overall Study||20
10229210|NCT03759340|11357414|FG000|STARTED|Overall Study||56
10229211|NCT03759340|11357414|FG000|COMPLETED|Overall Study||0
10229212|NCT03759340|11357414|FG000|NOT COMPLETED|Overall Study||56
10229213|NCT03758716|11357418|FG000|STARTED|Overall Study||12
10229214|NCT03758716|11357418|FG000|COMPLETED|Overall Study||12
10229215|NCT03758716|11357418|FG000|NOT COMPLETED|Overall Study||0
10229216|NCT03758365|11357422|FG000|STARTED|Overall Study||36
10229217|NCT03758365|11357422|FG000|MC2-01 Cream|Overall Study||36
10229218|NCT03758365|11357422|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36
10229219|NCT03758365|11357422|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
10229220|NCT03758365|11357422|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
10229221|NCT03758365|11357422|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
10229222|NCT03758365|11357422|FG000|Desonide 0.05% Cream|Overall Study||36
10229223|NCT03758365|11357422|FG000|Vehicle Cream|Overall Study||36
10229224|NCT03758365|11357422|FG000|COMPLETED|Overall Study||36
10229225|NCT03758365|11357422|FG000|NOT COMPLETED|Overall Study||0
10229226|NCT03758157|11357433|FG000|STARTED|Overall Study||110
10229227|NCT03758157|11357433|FG000|COMPLETED|Overall Study||110
10229228|NCT03758157|11357433|FG000|NOT COMPLETED|Overall Study||0
10229229|NCT03757988|11357437|FG000|STARTED|Overall Study||17
10229230|NCT03757988|11357437|FG000|COMPLETED|Overall Study||16
10229231|NCT03757988|11357437|FG000|NOT COMPLETED|Overall Study||1
10229232|NCT03757312|11357444|FG000|STARTED|Overall Study||5
10229233|NCT03757312|11357445|FG001|STARTED|Overall Study||9
10229234|NCT03757312|11357444|FG000|COMPLETED|Overall Study||5
10229235|NCT03757312|11357445|FG001|COMPLETED|Overall Study||9
10229236|NCT03757312|11357444|FG000|NOT COMPLETED|Overall Study||0
10229237|NCT03757312|11357445|FG001|NOT COMPLETED|Overall Study||0
10229238|NCT03757234|11357458|FG000|STARTED|Overall Study||75
10229239|NCT03757234|11357459|FG001|STARTED|Overall Study||18
10229240|NCT03757234|11357460|FG002|STARTED|Overall Study||17
10229241|NCT03757234|11357461|FG003|STARTED|Overall Study||17
10229242|NCT03757234|11357462|FG004|STARTED|Overall Study||74
10229243|NCT03757234|11357458|FG000|Completed PTE Visit|Overall Study||72
10229244|NCT03757234|11357459|FG001|Completed PTE Visit|Overall Study||16
10229245|NCT03757234|11357460|FG002|Completed PTE Visit|Overall Study||17
10229246|NCT03757234|11357461|FG003|Completed PTE Visit|Overall Study||16
10229247|NCT03757234|11357462|FG004|Completed PTE Visit|Overall Study||71
10229248|NCT03757234|11357458|FG000|COMPLETED|Overall Study||72
10229249|NCT03757234|11357459|FG001|COMPLETED|Overall Study||16
10229250|NCT03757234|11357460|FG002|COMPLETED|Overall Study||17
9952121|NCT01420016|11071022|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
9952122|NCT01420016|11071023|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
9952123|NCT01420016|11071024|FG002|COMPLETED|Primary Analysis||0
9952124|NCT01420016|11071025|FG003|COMPLETED|Primary Analysis||0
9952125|NCT01420016|11071022|FG000|NOT COMPLETED|Primary Analysis||2927
9952126|NCT01420016|11071023|FG001|NOT COMPLETED|Primary Analysis||2540
9952127|NCT01420016|11071024|FG002|NOT COMPLETED|Primary Analysis||0
9952128|NCT01420016|11071025|FG003|NOT COMPLETED|Primary Analysis||0
9952129|NCT01420016|11071022|FG000|STARTED|Safety Analysis||0
10229251|NCT03757234|11357461|FG003|COMPLETED|Overall Study||16
10229252|NCT03757234|11357462|FG004|COMPLETED|Overall Study||70
10229253|NCT03757234|11357458|FG000|NOT COMPLETED|Overall Study||3
10229254|NCT03757234|11357459|FG001|NOT COMPLETED|Overall Study||2
10229255|NCT03757234|11357460|FG002|NOT COMPLETED|Overall Study||0
10229256|NCT03757234|11357461|FG003|NOT COMPLETED|Overall Study||1
10229257|NCT03757234|11357462|FG004|NOT COMPLETED|Overall Study||4
10229258|NCT03757039|11357478|FG000|STARTED|Overall Study||32
10229259|NCT03757039|11357479|FG001|STARTED|Overall Study||9
10229260|NCT03757039|11357478|FG000|AOHG MF|Overall Study||11
10229261|NCT03757039|11357479|FG001|AOHG MF|Overall Study||0
10229262|NCT03757039|11357478|FG000|DT1 MF|Overall Study||11
10229263|NCT03757039|11357479|FG001|DT1 MF|Overall Study||0
10229264|NCT03757039|11357478|FG000|DACP MF|Overall Study||10
10229265|NCT03757039|11357479|FG001|DACP MF|Overall Study||0
10229266|NCT03757039|11357478|FG000|COMPLETED|Overall Study||32
10229267|NCT03757039|11357479|FG001|COMPLETED|Overall Study||9
10229268|NCT03757039|11357478|FG000|NOT COMPLETED|Overall Study||0
10229269|NCT03757039|11357479|FG001|NOT COMPLETED|Overall Study||0
10229270|NCT03756883|11357490|FG000|STARTED|Overall Study||485
10229271|NCT03756883|11357491|FG001|STARTED|Overall Study||413
10229272|NCT03756883|11357492|FG002|STARTED|Overall Study||101
10229273|NCT03756883|11357490|FG000|COMPLETED|Overall Study||472
10229274|NCT03756883|11357491|FG001|COMPLETED|Overall Study||402
10229275|NCT03756883|11357492|FG002|COMPLETED|Overall Study||94
10229276|NCT03756883|11357490|FG000|NOT COMPLETED|Overall Study||13
10229277|NCT03756883|11357491|FG001|NOT COMPLETED|Overall Study||11
10229278|NCT03756883|11357492|FG002|NOT COMPLETED|Overall Study||7
10229279|NCT03756506|11357502|FG000|STARTED|Overall Study||7
10229280|NCT03756506|11357503|FG001|STARTED|Overall Study||6
10229281|NCT03756506|11357502|FG000|COMPLETED|Overall Study||6
10229282|NCT03756506|11357503|FG001|COMPLETED|Overall Study||6
10229283|NCT03756506|11357502|FG000|NOT COMPLETED|Overall Study||1
10229284|NCT03756506|11357503|FG001|NOT COMPLETED|Overall Study||0
10229285|NCT03756285|11357511|FG000|STARTED|Overall Study||27
10229286|NCT03756285|11357512|FG001|STARTED|Overall Study||14
10229287|NCT03756285|11357511|FG000|COMPLETED|Overall Study||24
10229288|NCT03756285|11357512|FG001|COMPLETED|Overall Study||9
10229289|NCT03756285|11357511|FG000|NOT COMPLETED|Overall Study||3
10229290|NCT03756285|11357512|FG001|NOT COMPLETED|Overall Study||5
10229291|NCT03756129|11357525|FG000|STARTED|Overall Study||11
10229292|NCT03756129|11357526|FG001|STARTED|Overall Study||10
10229293|NCT03756129|11357527|FG002|STARTED|Overall Study||10
10229294|NCT03756129|11357528|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
10239455|NCT00206375|11371024|FG002|NOT COMPLETED|Overall Study||4
10229295|NCT03756129|11357529|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
10229296|NCT03756129|11357530|FG005|STARTED|Overall Study||20
10229297|NCT03756129|11357525|FG000|COMPLETED|Overall Study||8
10229298|NCT03756129|11357526|FG001|COMPLETED|Overall Study||8
10229299|NCT03756129|11357527|FG002|COMPLETED|Overall Study||7
10229300|NCT03756129|11357528|FG003|COMPLETED|Overall Study||6
10229301|NCT03756129|11357529|FG004|COMPLETED|Overall Study||9
10229302|NCT03756129|11357530|FG005|COMPLETED|Overall Study||15
10229303|NCT03756129|11357525|FG000|NOT COMPLETED|Overall Study||3
10229304|NCT03756129|11357526|FG001|NOT COMPLETED|Overall Study||2
10229305|NCT03756129|11357527|FG002|NOT COMPLETED|Overall Study||3
10229306|NCT03756129|11357528|FG003|NOT COMPLETED|Overall Study||3
10229307|NCT03756129|11357529|FG004|NOT COMPLETED|Overall Study||1
10229308|NCT03756129|11357530|FG005|NOT COMPLETED|Overall Study||5
10229309|NCT03756038|11357554|FG000|STARTED|Overall Study||1
10229310|NCT03756038|11357555|FG001|STARTED|Overall Study||0
10229311|NCT03756038|11357554|FG000|COMPLETED|Overall Study||1
10229312|NCT03756038|11357555|FG001|COMPLETED|Overall Study||0
10229313|NCT03756038|11357554|FG000|NOT COMPLETED|Overall Study||0
10229314|NCT03756038|11357555|FG001|NOT COMPLETED|Overall Study||0
10229315|NCT03756012|11357561|FG000|STARTED|Overall Study||15
10229316|NCT03756012|11357561|FG000|COMPLETED|Overall Study||15
10229317|NCT03756012|11357561|FG000|NOT COMPLETED|Overall Study||0
10229318|NCT03755882|11357566|FG000|STARTED|Period 1||23
10229319|NCT03755882|11357567|FG001|STARTED|Period 1||22
10229320|NCT03755882|11357566|FG000|COMPLETED|Period 1||19
10229321|NCT03755882|11357567|FG001|COMPLETED|Period 1||22
10229322|NCT03755882|11357566|FG000|NOT COMPLETED|Period 1||4
10229323|NCT03755882|11357567|FG001|NOT COMPLETED|Period 1||0
10229324|NCT03755882|11357566|FG000|STARTED|Period 2||19
10229325|NCT03755882|11357567|FG001|STARTED|Period 2||22
10229326|NCT03755882|11357566|FG000|COMPLETED|Period 2||19
10229327|NCT03755882|11357567|FG001|COMPLETED|Period 2||22
10229328|NCT03755882|11357566|FG000|NOT COMPLETED|Period 2||0
10229329|NCT03755882|11357567|FG001|NOT COMPLETED|Period 2||0
10229330|NCT03755661|11357575|FG000|STARTED|Overall Study||12
10229331|NCT03755661|11357576|FG001|STARTED|Overall Study||12
10229332|NCT03755661|11357575|FG000|COMPLETED|Overall Study||11
10229333|NCT03755661|11357576|FG001|COMPLETED|Overall Study||12
10229334|NCT03755661|11357575|FG000|NOT COMPLETED|Overall Study||1
10229335|NCT03755661|11357576|FG001|NOT COMPLETED|Overall Study||0
10229336|NCT03754582|11357582|FG000|STARTED|Pretreatment Phase||21
10229337|NCT03754582|11357583|FG001|STARTED|Pretreatment Phase||0
10229338|NCT03754582|11357584|FG002|STARTED|Pretreatment Phase||0
10229339|NCT03754582|11357582|FG000|COMPLETED|Pretreatment Phase||21
10229340|NCT03754582|11357583|FG001|COMPLETED|Pretreatment Phase||0
10229341|NCT03754582|11357584|FG002|COMPLETED|Pretreatment Phase||0
10229342|NCT03754582|11357582|FG000|NOT COMPLETED|Pretreatment Phase||0
10229343|NCT03754582|11357583|FG001|NOT COMPLETED|Pretreatment Phase||0
10229344|NCT03754582|11357584|FG002|NOT COMPLETED|Pretreatment Phase||0
9760924|NCT00384085|10864749|FG002|Treated (Safety Population)|Overall Study||194
9760925|NCT00384085|10864747|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
9760926|NCT00384085|10864748|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
9760927|NCT00384085|10864749|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
9760928|NCT00384085|10864747|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156
9760929|NCT00384085|10864748|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150
9760930|NCT00384085|10864749|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141
9760931|NCT00384085|10864747|FG000|NOT COMPLETED|Overall Study||39
9760932|NCT00384085|10864748|FG001|NOT COMPLETED|Overall Study||46
9760933|NCT00384085|10864749|FG002|NOT COMPLETED|Overall Study||56
9760934|NCT00384176|10864762|FG000|STARTED|Overall Study||709
9760935|NCT00384176|10864763|FG001|STARTED|Overall Study||713
9760936|NCT00384176|10864764|FG002|STARTED|Overall Study||192
9760937|NCT00384176|10864762|FG000|COMPLETED|Overall Study||397
9760938|NCT00384176|10864763|FG001|COMPLETED|Overall Study||394
9760939|NCT00384176|10864764|FG002|COMPLETED|Overall Study||60
9760940|NCT00384176|10864762|FG000|NOT COMPLETED|Overall Study||312
9760941|NCT00384176|10864763|FG001|NOT COMPLETED|Overall Study||319
9760942|NCT00384176|10864764|FG002|NOT COMPLETED|Overall Study||132
9760943|NCT00384189|10864776|FG000|STARTED|Overall Study||305
9760944|NCT00384189|10864777|FG001|STARTED|Overall Study||312
9760945|NCT00384189|10864778|FG002|STARTED|Overall Study||313
9760946|NCT00384189|10864779|FG003|STARTED|Overall Study||150
9760947|NCT00384189|10864776|FG000|Randomized, Not Treated|Overall Study||1
9760948|NCT00384189|10864777|FG001|Randomized, Not Treated|Overall Study||0
9760949|NCT00384189|10864778|FG002|Randomized, Not Treated|Overall Study||2
9760950|NCT00384189|10864779|FG003|Randomized, Not Treated|Overall Study||4
9760951|NCT00384189|10864776|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
9760952|NCT00384189|10864777|FG001|Actual Treatment Received|Overall Study||312
9760953|NCT00384189|10864778|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
9760954|NCT00384189|10864779|FG003|Actual Treatment Received|Overall Study||146
9760955|NCT00384189|10864776|FG000|COMPLETED|Overall Study||255
9760956|NCT00384189|10864777|FG001|COMPLETED|Overall Study||255
9760957|NCT00384189|10864778|FG002|COMPLETED|Overall Study||255
9760958|NCT00384189|10864779|FG003|COMPLETED|Overall Study||110
9760959|NCT00384189|10864776|FG000|NOT COMPLETED|Overall Study||50
9760960|NCT00384189|10864777|FG001|NOT COMPLETED|Overall Study||57
9760961|NCT00384189|10864778|FG002|NOT COMPLETED|Overall Study||58
9760962|NCT00384189|10864779|FG003|NOT COMPLETED|Overall Study||40
9760963|NCT00384241|10864791|FG000|STARTED|Overall Study||500
9760964|NCT00384241|10864792|FG001|STARTED|Overall Study||599
9760965|NCT00384241|10864791|FG000|COMPLETED|Overall Study||500
9760966|NCT00384241|10864792|FG001|COMPLETED|Overall Study||599
9760967|NCT00384241|10864791|FG000|NOT COMPLETED|Overall Study||0
9760968|NCT00384241|10864792|FG001|NOT COMPLETED|Overall Study||0
9760969|NCT00384332|10864799|FG000|STARTED|Overall Study||13
9760970|NCT00384332|10864800|FG001|STARTED|Overall Study||10
9760971|NCT00384332|10864799|FG000|COMPLETED|Overall Study||9
9760972|NCT00384332|10864800|FG001|COMPLETED|Overall Study||10
9760973|NCT00384332|10864799|FG000|NOT COMPLETED|Overall Study||4
9760974|NCT00384332|10864800|FG001|NOT COMPLETED|Overall Study||0
9760975|NCT00384397|10864811|FG000|STARTED|Overall Study||407
9760976|NCT00384397|10864812|FG001|STARTED|Overall Study||293
9760977|NCT00384397|10864813|FG002|STARTED|Overall Study||418
9760978|NCT00384397|10864811|FG000|COMPLETED|Overall Study||375
9760979|NCT00384397|10864812|FG001|COMPLETED|Overall Study||247
9760980|NCT00384397|10864813|FG002|COMPLETED|Overall Study||385
9760981|NCT00384397|10864811|FG000|NOT COMPLETED|Overall Study||32
9760982|NCT00384397|10864812|FG001|NOT COMPLETED|Overall Study||46
9760983|NCT00384397|10864813|FG002|NOT COMPLETED|Overall Study||33
9760984|NCT00384449|10864821|FG000|STARTED|Overall Study||1
9760985|NCT00384449|10864821|FG000|COMPLETED|Overall Study||1
9760986|NCT00384449|10864821|FG000|NOT COMPLETED|Overall Study||0
9760987|NCT00384670|10864825|FG000|STARTED|Overall Study||7
9760988|NCT00384670|10864825|FG000|COMPLETED|Overall Study||7
9760989|NCT00384670|10864825|FG000|NOT COMPLETED|Overall Study||0
9760990|NCT00384748|10864831|FG000|STARTED|Overall Study||25
9760991|NCT00384748|10864832|FG001|STARTED|Overall Study||23
9760992|NCT00384748|10864831|FG000|COMPLETED|Overall Study||25
9760993|NCT00384748|10864832|FG001|COMPLETED|Overall Study||23
9760994|NCT00384748|10864831|FG000|NOT COMPLETED|Overall Study||0
9760995|NCT00384748|10864832|FG001|NOT COMPLETED|Overall Study||0
9760996|NCT00384774|10864845|FG000|STARTED|Overall Study||42
9760997|NCT00384774|10864846|FG001|STARTED|Overall Study||4
9760998|NCT00384774|10864847|FG002|STARTED|Overall Study||12
9760999|NCT00384774|10864848|FG003|STARTED|Overall Study||24
9761000|NCT00384774|10864849|FG004|STARTED|Overall Study||28
9761001|NCT00384774|10864850|FG005|STARTED|Overall Study||16
9761002|NCT00384774|10864851|FG006|STARTED|Overall Study||4
9761003|NCT00384774|10864845|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
9761004|NCT00384774|10864846|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
9761005|NCT00384774|10864847|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
9761006|NCT00384774|10864848|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24
9761007|NCT00384774|10864849|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28
9761008|NCT00384774|10864850|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16
9761009|NCT00384774|10864851|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
9761010|NCT00384774|10864845|FG000|COMPLETED|Overall Study||42
9761011|NCT00384774|10864846|FG001|COMPLETED|Overall Study||4
9761012|NCT00384774|10864847|FG002|COMPLETED|Overall Study||12
9761013|NCT00384774|10864848|FG003|COMPLETED|Overall Study||24
9761014|NCT00384774|10864849|FG004|COMPLETED|Overall Study||28
9761015|NCT00384774|10864850|FG005|COMPLETED|Overall Study||16
9761016|NCT00384774|10864851|FG006|COMPLETED|Overall Study||4
9761017|NCT00384774|10864845|FG000|NOT COMPLETED|Overall Study||0
9761018|NCT00384774|10864846|FG001|NOT COMPLETED|Overall Study||0
9761019|NCT00384774|10864847|FG002|NOT COMPLETED|Overall Study||0
9761020|NCT00384774|10864848|FG003|NOT COMPLETED|Overall Study||0
9761021|NCT00384774|10864849|FG004|NOT COMPLETED|Overall Study||0
9761022|NCT00384774|10864850|FG005|NOT COMPLETED|Overall Study||0
9761023|NCT00384774|10864851|FG006|NOT COMPLETED|Overall Study||0
9761024|NCT00384813|10864869|FG000|STARTED|Overall Study||23
9761025|NCT00384813|10864870|FG001|STARTED|Overall Study||20
9761026|NCT00384813|10864869|FG000|COMPLETED|Overall Study||21
9761027|NCT00384813|10864870|FG001|COMPLETED|Overall Study||20
10229345|NCT03754582|11357582|FG000|STARTED|Treatment Phase||0
10229346|NCT03754582|11357583|FG001|STARTED|Treatment Phase||21
10229347|NCT03754582|11357584|FG002|STARTED|Treatment Phase||0
10229348|NCT03754582|11357582|FG000|COMPLETED|Treatment Phase||0
10229349|NCT03754582|11357583|FG001|COMPLETED|Treatment Phase||20
10229350|NCT03754582|11357584|FG002|COMPLETED|Treatment Phase||0
10229351|NCT03754582|11357582|FG000|NOT COMPLETED|Treatment Phase||0
10229352|NCT03754582|11357583|FG001|NOT COMPLETED|Treatment Phase||1
10229353|NCT03754582|11357584|FG002|NOT COMPLETED|Treatment Phase||0
10229354|NCT03754582|11357582|FG000|STARTED|Follow-up Phase||0
10229355|NCT03754582|11357583|FG001|STARTED|Follow-up Phase||0
10229356|NCT03754582|11357584|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
10229357|NCT03754582|11357582|FG000|COMPLETED|Follow-up Phase||0
10229358|NCT03754582|11357583|FG001|COMPLETED|Follow-up Phase||0
10229359|NCT03754582|11357584|FG002|COMPLETED|Follow-up Phase||20
10229360|NCT03754582|11357582|FG000|NOT COMPLETED|Follow-up Phase||0
10229361|NCT03754582|11357583|FG001|NOT COMPLETED|Follow-up Phase||0
10229362|NCT03754582|11357584|FG002|NOT COMPLETED|Follow-up Phase||1
10229363|NCT03754556|11357600|FG000|STARTED|Overall Study||326658
10229364|NCT03754556|11357600|FG000|COMPLETED|Overall Study||326658
10229365|NCT03754556|11357600|FG000|NOT COMPLETED|Overall Study||0
10229366|NCT03753113|11357606|FG000|STARTED|Overall Study||12
10229367|NCT03753113|11357607|FG001|STARTED|Overall Study||12
10229368|NCT03753113|11357606|FG000|COMPLETED|Overall Study||12
10229369|NCT03753113|11357607|FG001|COMPLETED|Overall Study||12
10229370|NCT03753113|11357606|FG000|NOT COMPLETED|Overall Study||0
10229371|NCT03753113|11357607|FG001|NOT COMPLETED|Overall Study||0
10229372|NCT03752567|11357613|FG000|STARTED|Overall Study||40
10229373|NCT03752567|11357613|FG000|COMPLETED|Overall Study||40
10229374|NCT03752567|11357613|FG000|NOT COMPLETED|Overall Study||0
10229375|NCT03752528|11357617|FG000|STARTED|Part A||53
10229376|NCT03752528|11357617|FG000|COMPLETED|Part A||51
10229377|NCT03752528|11357617|FG000|NOT COMPLETED|Part A||2
10229378|NCT03752528|11357617|FG000|STARTED|Part B||24
10229379|NCT03752528|11357617|FG000|COMPLETED|Part B||20
10229380|NCT03752528|11357617|FG000|NOT COMPLETED|Part B||4
9761028|NCT00384813|10864869|FG000|NOT COMPLETED|Overall Study||2
9761029|NCT00384813|10864870|FG001|NOT COMPLETED|Overall Study||0
9761030|NCT00384839|10864876|FG000|STARTED|Overall Study||36
9761031|NCT00384839|10864876|FG000|COMPLETED|Overall Study||28
9761032|NCT00384839|10864876|FG000|NOT COMPLETED|Overall Study||8
9761033|NCT00384865|10864884|FG000|STARTED|Overall Study||16
9761034|NCT00384865|10864885|FG001|STARTED|Overall Study||16
9761035|NCT00384865|10864886|FG002|STARTED|Overall Study||16
10229381|NCT03752151|11357624|FG000|STARTED|Overall Study||77
10229382|NCT03752151|11357624|FG000|COMPLETED|Overall Study||75
10229383|NCT03752151|11357624|FG000|NOT COMPLETED|Overall Study||2
10229384|NCT03751657|11357631|FG000|STARTED|Overall Study||125
10229385|NCT03751657|11357632|FG001|STARTED|Overall Study||122
10229386|NCT03751657|11357631|FG000|COMPLETED|Overall Study||122
10229387|NCT03751657|11357632|FG001|COMPLETED|Overall Study||119
10229388|NCT03751657|11357631|FG000|NOT COMPLETED|Overall Study||3
10229389|NCT03751657|11357632|FG001|NOT COMPLETED|Overall Study||3
10229390|NCT03751280|11357640|FG000|STARTED|Overall Study||56
10229391|NCT03751280|11357641|FG001|STARTED|Overall Study||56
10229392|NCT03751280|11357640|FG000|Full Analysis Set (FAS)|Overall Study||54
10229393|NCT03751280|11357641|FG001|Full Analysis Set (FAS)|Overall Study||55
10229394|NCT03751280|11357640|FG000|Safety Set (SAF)|Overall Study||55
10229395|NCT03751280|11357641|FG001|Safety Set (SAF)|Overall Study||55
10229396|NCT03751280|11357640|FG000|COMPLETED|Overall Study||48
10229397|NCT03751280|11357641|FG001|COMPLETED|Overall Study||44
10229398|NCT03751280|11357640|FG000|NOT COMPLETED|Overall Study||8
10229399|NCT03751280|11357641|FG001|NOT COMPLETED|Overall Study||12
10229400|NCT03751020|11357651|FG000|STARTED|Overall Study||36
10229401|NCT03751020|11357652|FG001|STARTED|Overall Study||36
10229402|NCT03751020|11357653|FG002|STARTED|Overall Study||36
10229403|NCT03751020|11357651|FG000|Post Intervention|Overall Study||33
10229404|NCT03751020|11357652|FG001|Post Intervention|Overall Study||33
10229405|NCT03751020|11357653|FG002|Post Intervention|Overall Study||30
10229406|NCT03751020|11357651|FG000|3 Month Follow Up|Overall Study||27
10229407|NCT03751020|11357652|FG001|3 Month Follow Up|Overall Study||32
10229408|NCT03751020|11357653|FG002|3 Month Follow Up|Overall Study||26
10229409|NCT03751020|11357651|FG000|COMPLETED|Overall Study||27
10229410|NCT03751020|11357652|FG001|COMPLETED|Overall Study||32
10229411|NCT03751020|11357653|FG002|COMPLETED|Overall Study||26
10229412|NCT03751020|11357651|FG000|NOT COMPLETED|Overall Study||9
10229413|NCT03751020|11357652|FG001|NOT COMPLETED|Overall Study||4
10229414|NCT03751020|11357653|FG002|NOT COMPLETED|Overall Study||10
10229415|NCT03750955|11357663|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
10229416|NCT03750955|11357664|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
10229417|NCT03750955|11357663|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13
10229418|NCT03750955|11357664|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13
10229419|NCT03750955|11357663|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
10229420|NCT03750955|11357664|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
10229421|NCT03750955|11357663|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13
10229422|NCT03750955|11357664|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13
10229423|NCT03750955|11357663|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
10229424|NCT03750955|11357664|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
10229425|NCT03750955|11357663|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
10229426|NCT03750955|11357664|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
10229427|NCT03750955|11357663|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
10229428|NCT03750955|11357664|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
10229429|NCT03750955|11357663|FG000|COMPLETED|Resolution Phase of 2 Weeks||13
10229430|NCT03750955|11357664|FG001|COMPLETED|Resolution Phase of 2 Weeks||13
10229431|NCT03750955|11357663|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0
10229432|NCT03750955|11357664|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0
10229433|NCT03750695|11357672|FG000|STARTED|Overall Study||8
10229434|NCT03750695|11357673|FG001|STARTED|Overall Study||8
10229435|NCT03750695|11357672|FG000|COMPLETED|Overall Study||8
10229436|NCT03750695|11357673|FG001|COMPLETED|Overall Study||7
10229437|NCT03750695|11357672|FG000|NOT COMPLETED|Overall Study||0
10229438|NCT03750695|11357673|FG001|NOT COMPLETED|Overall Study||1
10229439|NCT03748992|11357684|FG000|STARTED|Overall Study||10
10229440|NCT03748992|11357684|FG000|COMPLETED|Overall Study||10
10229441|NCT03748992|11357684|FG000|NOT COMPLETED|Overall Study||0
10229442|NCT03748979|11357699|FG000|STARTED|Overall Study||6
10229443|NCT03748979|11357700|FG001|STARTED|Overall Study||6
10229444|NCT03748979|11357701|FG002|STARTED|Overall Study||6
10229445|NCT03748979|11357702|FG003|STARTED|Overall Study||6
10229446|NCT03748979|11357703|FG004|STARTED|Overall Study||4
10229447|NCT03748979|11357704|FG005|STARTED|Overall Study||4
10229448|NCT03748979|11357705|FG006|STARTED|Overall Study||5
10229449|NCT03748979|11357706|FG007|STARTED|Overall Study||5
10229450|NCT03748979|11357707|FG008|STARTED|Overall Study||4
10229451|NCT03748979|11357708|FG009|STARTED|Overall Study||5
10229452|NCT03748979|11357709|FG010|STARTED|Overall Study||6
10229453|NCT03748979|11357699|FG000|COMPLETED|Overall Study||6
10229454|NCT03748979|11357700|FG001|COMPLETED|Overall Study||6
10229455|NCT03748979|11357701|FG002|COMPLETED|Overall Study||6
10229456|NCT03748979|11357702|FG003|COMPLETED|Overall Study||6
10229457|NCT03748979|11357703|FG004|COMPLETED|Overall Study||4
10229458|NCT03748979|11357704|FG005|COMPLETED|Overall Study||4
10229459|NCT03748979|11357705|FG006|COMPLETED|Overall Study||5
10229460|NCT03748979|11357706|FG007|COMPLETED|Overall Study||5
10229461|NCT03748979|11357707|FG008|COMPLETED|Overall Study||4
10229462|NCT03748979|11357708|FG009|COMPLETED|Overall Study||5
10229463|NCT03748979|11357709|FG010|COMPLETED|Overall Study||6
10229464|NCT03748979|11357699|FG000|NOT COMPLETED|Overall Study||0
10229465|NCT03748979|11357700|FG001|NOT COMPLETED|Overall Study||0
10229466|NCT03748979|11357701|FG002|NOT COMPLETED|Overall Study||0
10229467|NCT03748979|11357702|FG003|NOT COMPLETED|Overall Study||0
10229468|NCT03748979|11357703|FG004|NOT COMPLETED|Overall Study||0
10229469|NCT03748979|11357704|FG005|NOT COMPLETED|Overall Study||0
10229470|NCT03748979|11357705|FG006|NOT COMPLETED|Overall Study||0
10229471|NCT03748979|11357706|FG007|NOT COMPLETED|Overall Study||0
10229472|NCT03748979|11357707|FG008|NOT COMPLETED|Overall Study||0
10229473|NCT03748979|11357708|FG009|NOT COMPLETED|Overall Study||0
10229474|NCT03748979|11357709|FG010|NOT COMPLETED|Overall Study||0
10229475|NCT03748758|11357749|FG000|STARTED|Overall Study||12
10229476|NCT03748758|11357750|FG001|STARTED|Overall Study||12
10229477|NCT03748758|11357751|FG002|STARTED|Overall Study||6
10229478|NCT03748758|11357749|FG000|COMPLETED|Overall Study||12
10229479|NCT03748758|11357750|FG001|COMPLETED|Overall Study||12
10229480|NCT03748758|11357751|FG002|COMPLETED|Overall Study||5
10229481|NCT03748758|11357749|FG000|NOT COMPLETED|Overall Study||0
10229482|NCT03748758|11357750|FG001|NOT COMPLETED|Overall Study||0
10229483|NCT03748758|11357751|FG002|NOT COMPLETED|Overall Study||1
10229484|NCT03748706|11357781|FG000|STARTED|Overall Study||13
10229485|NCT03748706|11357781|FG000|COMPLETED|Overall Study||12
10229486|NCT03748706|11357781|FG000|NOT COMPLETED|Overall Study||1
10229487|NCT03748264|11357788|FG000|STARTED|Overall Study||21
10229488|NCT03748264|11357789|FG001|STARTED|Overall Study||21
10229489|NCT03748264|11357790|FG002|STARTED|Overall Study||20
10229490|NCT03748264|11357788|FG000|COMPLETED|Overall Study||21
10229491|NCT03748264|11357789|FG001|COMPLETED|Overall Study||21
10229492|NCT03748264|11357790|FG002|COMPLETED|Overall Study||20
10229493|NCT03748264|11357788|FG000|NOT COMPLETED|Overall Study||0
10229494|NCT03748264|11357789|FG001|NOT COMPLETED|Overall Study||0
10229495|NCT03748264|11357790|FG002|NOT COMPLETED|Overall Study||0
10229496|NCT03747497|11357800|FG000|STARTED|Overall Study||131
10229497|NCT03747497|11357801|FG001|STARTED|Overall Study||65
10229498|NCT03747497|11357800|FG000|COMPLETED|Overall Study||106
10229499|NCT03747497|11357801|FG001|COMPLETED|Overall Study||55
10229500|NCT03747497|11357800|FG000|NOT COMPLETED|Overall Study||25
10229501|NCT03747497|11357801|FG001|NOT COMPLETED|Overall Study||10
10229502|NCT03746405|11357809|FG000|STARTED|Overall Study||10
10229503|NCT03746405|11357810|FG001|STARTED|Overall Study||8
10229504|NCT03746405|11357809|FG000|COMPLETED|Overall Study||7
10229505|NCT03746405|11357810|FG001|COMPLETED|Overall Study||6
10229506|NCT03746405|11357809|FG000|NOT COMPLETED|Overall Study||3
10229507|NCT03746405|11357810|FG001|NOT COMPLETED|Overall Study||2
10229508|NCT03745937|11357820|FG000|STARTED|Overall Study||2
10229509|NCT03745937|11357821|FG001|STARTED|Overall Study||6
10229510|NCT03745937|11357822|FG002|STARTED|Overall Study||3
10229511|NCT03745937|11357823|FG003|STARTED|Overall Study||9
10229512|NCT03745937|11357820|FG000|COMPLETED|Overall Study||2
10229513|NCT03745937|11357821|FG001|COMPLETED|Overall Study||5
10229514|NCT03745937|11357822|FG002|COMPLETED|Overall Study||3
10229515|NCT03745937|11357823|FG003|COMPLETED|Overall Study||7
10229516|NCT03745937|11357820|FG000|NOT COMPLETED|Overall Study||0
10229517|NCT03745937|11357821|FG001|NOT COMPLETED|Overall Study||1
10229518|NCT03745937|11357822|FG002|NOT COMPLETED|Overall Study||0
10229519|NCT03745937|11357823|FG003|NOT COMPLETED|Overall Study||2
10229520|NCT03745222|11357837|FG000|STARTED|Overall Study||0
10229521|NCT03745222|11357838|FG001|STARTED|Overall Study||1
10229522|NCT03745222|11357839|FG002|STARTED|Overall Study||0
10229523|NCT03745222|11357837|FG000|COMPLETED|Overall Study||0
10229524|NCT03745222|11357838|FG001|COMPLETED|Overall Study||0
10229525|NCT03745222|11357839|FG002|COMPLETED|Overall Study||0
10229526|NCT03745222|11357837|FG000|NOT COMPLETED|Overall Study||0
10229527|NCT03745222|11357838|FG001|NOT COMPLETED|Overall Study||1
10229528|NCT03745222|11357839|FG002|NOT COMPLETED|Overall Study||0
10229529|NCT03745092|11357849|FG000|STARTED|Overall Study||26
10229530|NCT03745092|11357850|FG001|STARTED|Overall Study||23
10229531|NCT03745092|11357849|FG000|COMPLETED|Overall Study||26
10229532|NCT03745092|11357850|FG001|COMPLETED|Overall Study||23
10229533|NCT03745092|11357849|FG000|NOT COMPLETED|Overall Study||0
10229534|NCT03745092|11357850|FG001|NOT COMPLETED|Overall Study||0
10229535|NCT03744780|11357856|FG000|STARTED|Overall Study||32
10229536|NCT03744780|11357856|FG000|COMPLETED|Overall Study||32
10229537|NCT03744780|11357856|FG000|NOT COMPLETED|Overall Study||0
10229538|NCT03743311|11357863|FG000|STARTED|Overall Study||311
10229539|NCT03743311|11357864|FG001|STARTED|Overall Study||298
10229540|NCT03743311|11357865|FG002|STARTED|Overall Study||423
10229541|NCT03743311|11357863|FG000|COMPLETED|Overall Study||311
10229542|NCT03743311|11357864|FG001|COMPLETED|Overall Study||298
10229543|NCT03743311|11357865|FG002|COMPLETED|Overall Study||423
10229544|NCT03743311|11357863|FG000|NOT COMPLETED|Overall Study||0
10229545|NCT03743311|11357864|FG001|NOT COMPLETED|Overall Study||0
10229546|NCT03743311|11357865|FG002|NOT COMPLETED|Overall Study||0
10229547|NCT03743038|11357874|FG000|STARTED|Overall Study||12
10229548|NCT03743038|11357874|FG000|Test Article A|Overall Study||12
10229549|NCT03743038|11357874|FG000|Test Article B|Overall Study||12
10229550|NCT03743038|11357874|FG000|COMPLETED|Overall Study||11
10229551|NCT03743038|11357874|FG000|NOT COMPLETED|Overall Study||1
10229552|NCT03742973|11357882|FG000|STARTED|Overall Study||0
10229553|NCT03742973|11357883|FG001|STARTED|Overall Study||0
10229554|NCT03742973|11357882|FG000|COMPLETED|Overall Study||0
10229555|NCT03742973|11357883|FG001|COMPLETED|Overall Study||0
10229556|NCT03742973|11357882|FG000|NOT COMPLETED|Overall Study||0
10229557|NCT03742973|11357883|FG001|NOT COMPLETED|Overall Study||0
10229558|NCT03742440|11357889|FG000|STARTED|Overall Study||40
10229559|NCT03742440|11357889|FG000|COMPLETED|Overall Study||40
10229560|NCT03742440|11357889|FG000|NOT COMPLETED|Overall Study||0
10229561|NCT03742427|11357893|FG000|STARTED|Overall Study||50
10229562|NCT03742427|11357893|FG000|COMPLETED|Overall Study||50
10229563|NCT03742427|11357893|FG000|NOT COMPLETED|Overall Study||0
10229564|NCT03742271|11357897|FG000|STARTED|Overall Study||127
10229565|NCT03742271|11357897|FG000|COMPLETED|Overall Study||115
10229566|NCT03742271|11357897|FG000|NOT COMPLETED|Overall Study||12
10229567|NCT03742154|11357903|FG000|STARTED|Overall Study||50
10229568|NCT03742154|11357904|FG001|STARTED|Overall Study||49
10229569|NCT03742154|11357903|FG000|COMPLETED|Overall Study||50
10229570|NCT03742154|11357904|FG001|COMPLETED|Overall Study||49
10229571|NCT03742154|11357903|FG000|NOT COMPLETED|Overall Study||0
10229572|NCT03742154|11357904|FG001|NOT COMPLETED|Overall Study||0
10229573|NCT03741725|11357913|FG000|STARTED|Overall Study||101
10229574|NCT03741725|11357914|FG001|STARTED|Overall Study||100
10229575|NCT03741725|11357915|FG002|STARTED|Overall Study||100
10229576|NCT03741725|11357913|FG000|COMPLETED|Overall Study||101
10229577|NCT03741725|11357914|FG001|COMPLETED|Overall Study||100
10229578|NCT03741725|11357915|FG002|COMPLETED|Overall Study||100
10229579|NCT03741725|11357913|FG000|NOT COMPLETED|Overall Study||0
10229580|NCT03741725|11357914|FG001|NOT COMPLETED|Overall Study||0
10229581|NCT03741725|11357915|FG002|NOT COMPLETED|Overall Study||0
10229582|NCT03741088|11357926|FG000|STARTED|Overall Study||8
10229583|NCT03741088|11357926|FG000|COMPLETED|Overall Study||5
10229584|NCT03741088|11357926|FG000|NOT COMPLETED|Overall Study||3
10229585|NCT03741062|11357932|FG000|STARTED|Overall Study||5
10229586|NCT03741062|11357933|FG001|STARTED|Overall Study||6
10229587|NCT03741062|11357932|FG000|COMPLETED|Overall Study||4
10229588|NCT03741062|11357933|FG001|COMPLETED|Overall Study||6
10229589|NCT03741062|11357932|FG000|NOT COMPLETED|Overall Study||1
10229590|NCT03741062|11357933|FG001|NOT COMPLETED|Overall Study||0
10229591|NCT03740659|11357942|FG000|STARTED|Overall Study||42
10229592|NCT03740659|11357943|FG001|STARTED|Overall Study||42
10229593|NCT03740659|11357944|FG002|STARTED|Overall Study||41
10229594|NCT03740659|11357942|FG000|COMPLETED|Overall Study||42
10229595|NCT03740659|11357943|FG001|COMPLETED|Overall Study||42
10229596|NCT03740659|11357944|FG002|COMPLETED|Overall Study||41
10229597|NCT03740659|11357942|FG000|NOT COMPLETED|Overall Study||0
10229598|NCT03740659|11357943|FG001|NOT COMPLETED|Overall Study||0
10229599|NCT03740659|11357944|FG002|NOT COMPLETED|Overall Study||0
10229600|NCT03740152|11357952|FG000|STARTED|Overall Study||10
10229601|NCT03740152|11357952|FG000|COMPLETED|Overall Study||10
10229602|NCT03740152|11357952|FG000|NOT COMPLETED|Overall Study||0
10229603|NCT03739866|11357964|FG000|STARTED|Overall Study||6
10229604|NCT03739866|11357965|FG001|STARTED|Overall Study||6
10229605|NCT03739866|11357966|FG002|STARTED|Overall Study||7
10229606|NCT03739866|11357967|FG003|STARTED|Overall Study||6
10229607|NCT03739866|11357968|FG004|STARTED|Overall Study||6
10229608|NCT03739866|11357969|FG005|STARTED|Overall Study||10
10229609|NCT03739866|11357970|FG006|STARTED|Overall Study||7
10229610|NCT03739866|11357971|FG007|STARTED|Overall Study||5
10229611|NCT03739866|11357964|FG000|COMPLETED|Overall Study||6
10229612|NCT03739866|11357965|FG001|COMPLETED|Overall Study||6
10229613|NCT03739866|11357966|FG002|COMPLETED|Overall Study||6
10229614|NCT03739866|11357967|FG003|COMPLETED|Overall Study||5
10229615|NCT03739866|11357968|FG004|COMPLETED|Overall Study||5
10229616|NCT03739866|11357969|FG005|COMPLETED|Overall Study||10
10229617|NCT03739866|11357970|FG006|COMPLETED|Overall Study||7
10229618|NCT03739866|11357971|FG007|COMPLETED|Overall Study||5
10229619|NCT03739866|11357964|FG000|NOT COMPLETED|Overall Study||0
10229620|NCT03739866|11357965|FG001|NOT COMPLETED|Overall Study||0
10229621|NCT03739866|11357966|FG002|NOT COMPLETED|Overall Study||1
10229622|NCT03739866|11357967|FG003|NOT COMPLETED|Overall Study||1
10229623|NCT03739866|11357968|FG004|NOT COMPLETED|Overall Study||1
10229624|NCT03739866|11357969|FG005|NOT COMPLETED|Overall Study||0
10229625|NCT03739866|11357970|FG006|NOT COMPLETED|Overall Study||0
10229626|NCT03739866|11357971|FG007|NOT COMPLETED|Overall Study||0
10229627|NCT03739684|11357993|FG000|STARTED|Overall Study||208
10229628|NCT03739684|11357993|FG000|COMPLETED|Overall Study||195
10229629|NCT03739684|11357993|FG000|NOT COMPLETED|Overall Study||13
10229630|NCT03739528|11357999|FG000|STARTED|Overall Study||403
10229631|NCT03739528|11358000|FG001|STARTED|Overall Study||405
10229632|NCT03739528|11357999|FG000|Received at Least One Treatment|Overall Study||395
10229633|NCT03739528|11358000|FG001|Received at Least One Treatment|Overall Study||393
10229634|NCT03739528|11357999|FG000|COMPLETED|Overall Study||388
10013087|NCT01790490|11136094|FG002|STARTED|Overall Study||2
10013088|NCT01790490|11136092|FG000|COMPLETED|Overall Study||3
10013089|NCT01790490|11136093|FG001|COMPLETED|Overall Study||3
10013090|NCT01790490|11136094|FG002|COMPLETED|Overall Study||2
10013091|NCT01790490|11136092|FG000|NOT COMPLETED|Overall Study||0
10013092|NCT01790490|11136093|FG001|NOT COMPLETED|Overall Study||0
10013093|NCT01790490|11136094|FG002|NOT COMPLETED|Overall Study||0
10229635|NCT03739528|11358000|FG001|COMPLETED|Overall Study||388
10229636|NCT03739528|11357999|FG000|NOT COMPLETED|Overall Study||15
10229637|NCT03739528|11358000|FG001|NOT COMPLETED|Overall Study||17
10229638|NCT03739242|11358011|FG000|STARTED|Overall Study||44
10229639|NCT03739242|11358012|FG001|STARTED|Overall Study||44
10229640|NCT03739242|11358011|FG000|COMPLETED|Overall Study||43
10229641|NCT03739242|11358012|FG001|COMPLETED|Overall Study||42
10229642|NCT03739242|11358011|FG000|NOT COMPLETED|Overall Study||1
10229643|NCT03739242|11358012|FG001|NOT COMPLETED|Overall Study||2
10229644|NCT03738865|11358020|FG000|STARTED|Overall Study||66
10229645|NCT03738865|11358021|FG001|STARTED|Overall Study||66
10229646|NCT03738865|11358020|FG000|COMPLETED|Overall Study||61
10229647|NCT03738865|11358021|FG001|COMPLETED|Overall Study||62
10229648|NCT03738865|11358020|FG000|NOT COMPLETED|Overall Study||5
10229649|NCT03738865|11358021|FG001|NOT COMPLETED|Overall Study||4
10229650|NCT03738826|11358029|FG000|STARTED|Overall Study||130
10229651|NCT03738826|11358030|FG001|STARTED|Overall Study||5
10229652|NCT03738826|11358029|FG000|COMPLETED|Overall Study||130
10229653|NCT03738826|11358030|FG001|COMPLETED|Overall Study||5
10229654|NCT03738826|11358029|FG000|NOT COMPLETED|Overall Study||0
10229655|NCT03738826|11358030|FG001|NOT COMPLETED|Overall Study||0
10229656|NCT03738475|11358038|FG000|STARTED|Overall Study||16
10229657|NCT03738475|11358039|FG001|STARTED|Overall Study||18
10229658|NCT03738475|11358038|FG000|COMPLETED|Overall Study||15
10229659|NCT03738475|11358039|FG001|COMPLETED|Overall Study||18
10229660|NCT03738475|11358038|FG000|NOT COMPLETED|Overall Study||1
10229661|NCT03738475|11358039|FG001|NOT COMPLETED|Overall Study||0
10229662|NCT03738241|11358055|FG000|STARTED|Overall Study||38
10229663|NCT03738241|11358056|FG001|STARTED|Overall Study||40
10229664|NCT03738241|11358057|FG002|STARTED|Overall Study||24
10229665|NCT03738241|11358058|FG003|STARTED|Overall Study||18
10229666|NCT03738241|11358059|FG004|STARTED|Overall Study||40
10229667|NCT03738241|11358060|FG005|STARTED|Overall Study||44
10229668|NCT03738241|11358061|FG006|STARTED|Overall Study||20
10229669|NCT03738241|11358062|FG007|STARTED|Overall Study||16
10229670|NCT03738241|11358063|FG008|STARTED|Overall Study||29
10229671|NCT03738241|11358064|FG009|STARTED|Overall Study||35
10229672|NCT03738241|11358055|FG000|COMPLETED|Overall Study||37
10229673|NCT03738241|11358056|FG001|COMPLETED|Overall Study||40
10229674|NCT03738241|11358057|FG002|COMPLETED|Overall Study||24
10229675|NCT03738241|11358058|FG003|COMPLETED|Overall Study||18
10229676|NCT03738241|11358059|FG004|COMPLETED|Overall Study||40
10229677|NCT03738241|11358060|FG005|COMPLETED|Overall Study||44
10229678|NCT03738241|11358061|FG006|COMPLETED|Overall Study||20
10229679|NCT03738241|11358062|FG007|COMPLETED|Overall Study||16
10229680|NCT03738241|11358063|FG008|COMPLETED|Overall Study||28
10229681|NCT03738241|11358064|FG009|COMPLETED|Overall Study||34
10229682|NCT03738241|11358055|FG000|NOT COMPLETED|Overall Study||1
10229683|NCT03738241|11358056|FG001|NOT COMPLETED|Overall Study||0
10229684|NCT03738241|11358057|FG002|NOT COMPLETED|Overall Study||0
10229685|NCT03738241|11358058|FG003|NOT COMPLETED|Overall Study||0
10229686|NCT03738241|11358059|FG004|NOT COMPLETED|Overall Study||0
10229687|NCT03738241|11358060|FG005|NOT COMPLETED|Overall Study||0
10229688|NCT03738241|11358061|FG006|NOT COMPLETED|Overall Study||0
10229689|NCT03738241|11358062|FG007|NOT COMPLETED|Overall Study||0
10229690|NCT03738241|11358063|FG008|NOT COMPLETED|Overall Study||1
10229691|NCT03738241|11358064|FG009|NOT COMPLETED|Overall Study||1
10229692|NCT03738163|11358086|FG000|STARTED|Overall Study||121
10229693|NCT03738163|11358086|FG000|COMPLETED|Overall Study||114
10229694|NCT03738163|11358086|FG000|NOT COMPLETED|Overall Study||7
10229695|NCT03738020|11358090|FG000|STARTED|Overall Study||58
10229696|NCT03738020|11358090|FG000|COMPLETED|Overall Study||57
10229697|NCT03738020|11358090|FG000|NOT COMPLETED|Overall Study||1
10229698|NCT03736928|11358102|FG000|STARTED|Overall Study||80
10229699|NCT03736928|11358103|FG001|STARTED|Overall Study||80
10229700|NCT03736928|11358104|FG002|STARTED|Overall Study||80
10229701|NCT03736928|11358105|FG003|STARTED|Overall Study||81
10229702|NCT03736928|11358106|FG004|STARTED|Overall Study||78
10229703|NCT03736928|11358102|FG000|COMPLETED|Overall Study||73
10229704|NCT03736928|11358103|FG001|COMPLETED|Overall Study||78
10229705|NCT03736928|11358104|FG002|COMPLETED|Overall Study||75
10229706|NCT03736928|11358105|FG003|COMPLETED|Overall Study||76
10229707|NCT03736928|11358106|FG004|COMPLETED|Overall Study||67
10229708|NCT03736928|11358102|FG000|NOT COMPLETED|Overall Study||7
10229709|NCT03736928|11358103|FG001|NOT COMPLETED|Overall Study||2
10229710|NCT03736928|11358104|FG002|NOT COMPLETED|Overall Study||5
10229711|NCT03736928|11358105|FG003|NOT COMPLETED|Overall Study||5
10229712|NCT03736928|11358106|FG004|NOT COMPLETED|Overall Study||11
10229713|NCT03736785|11358121|FG000|STARTED|Overall Study||135
10229714|NCT03736785|11358122|FG001|STARTED|Overall Study||132
10229715|NCT03736785|11358123|FG002|STARTED|Overall Study||132
10229716|NCT03736785|11358121|FG000|COMPLETED|Overall Study||118
10229717|NCT03736785|11358122|FG001|COMPLETED|Overall Study||115
10229718|NCT03736785|11358123|FG002|COMPLETED|Overall Study||118
10229719|NCT03736785|11358121|FG000|NOT COMPLETED|Overall Study||17
10229720|NCT03736785|11358122|FG001|NOT COMPLETED|Overall Study||17
10229721|NCT03736785|11358123|FG002|NOT COMPLETED|Overall Study||14
10239456|NCT00229931|11371034|FG000|STARTED|Overall Study||6
10239457|NCT00229931|11371035|FG001|STARTED|Overall Study||5
10239458|NCT00229931|11371034|FG000|COMPLETED|Overall Study||2
10239459|NCT00229931|11371035|FG001|COMPLETED|Overall Study||3
10239460|NCT00229931|11371034|FG000|NOT COMPLETED|Overall Study||4
10239461|NCT00229931|11371035|FG001|NOT COMPLETED|Overall Study||2
10239462|NCT00209131|11371043|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
10239463|NCT00209131|11371044|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
10239464|NCT00209131|11371043|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
10239465|NCT00209131|11371044|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
10239466|NCT00209131|11371043|FG000|NOT COMPLETED|Overall Study||15
10239467|NCT00209131|11371044|FG001|NOT COMPLETED|Overall Study||11
10239468|NCT00233090|11371052|FG000|STARTED|Overall Study||12
10239469|NCT00233090|11371053|FG001|STARTED|Overall Study||9
10239470|NCT00233090|11371052|FG000|COMPLETED|Overall Study||12
10229722|NCT03736031|11358134|FG000|STARTED|Overall Study||56
10229723|NCT03736031|11358135|FG001|STARTED|Overall Study||46
10229724|NCT03736031|11358134|FG000|COMPLETED|Overall Study||24
10229725|NCT03736031|11358135|FG001|COMPLETED|Overall Study||40
10229726|NCT03736031|11358134|FG000|NOT COMPLETED|Overall Study||32
10229727|NCT03736031|11358135|FG001|NOT COMPLETED|Overall Study||6
10229728|NCT03735862|11358141|FG000|STARTED|Overall Study||73
10229729|NCT03735862|11358141|FG000|COMPLETED|Overall Study||73
10229730|NCT03735862|11358141|FG000|NOT COMPLETED|Overall Study||0
10229731|NCT03734991|11358147|FG000|STARTED|Overall Study||249
10229732|NCT03734991|11358148|FG001|STARTED|Overall Study||127
10229733|NCT03734991|11358147|FG000|Withdrawn Before Treatment|Overall Study||2
10229734|NCT03734991|11358148|FG001|Withdrawn Before Treatment|Overall Study||3
10229735|NCT03734991|11358147|FG000|Withdrawn Before TOC|Overall Study||59
10229736|NCT03734991|11358148|FG001|Withdrawn Before TOC|Overall Study||41
10229737|NCT03734991|11358147|FG000|Completed the TOC Visit|Overall Study||188
10229738|NCT03734991|11358148|FG001|Completed the TOC Visit|Overall Study||83
10229739|NCT03734991|11358147|FG000|Withdrawn At or After the TOC Visit|Overall Study||5
10229740|NCT03734991|11358148|FG001|Withdrawn At or After the TOC Visit|Overall Study||3
10229741|NCT03734991|11358147|FG000|COMPLETED|Overall Study||183
10229742|NCT03734991|11358148|FG001|COMPLETED|Overall Study||80
10229743|NCT03734991|11358147|FG000|NOT COMPLETED|Overall Study||66
10229744|NCT03734991|11358148|FG001|NOT COMPLETED|Overall Study||47
10229745|NCT03734822|11358154|FG000|STARTED|Overall Study||47
10229746|NCT03734822|11358154|FG000|COMPLETED|Overall Study||47
10229747|NCT03734822|11358154|FG000|NOT COMPLETED|Overall Study||0
10229748|NCT03734601|11358158|FG000|STARTED|Overall Study||22
10229749|NCT03734601|11358158|FG000|COMPLETED|Overall Study||22
10229750|NCT03734601|11358158|FG000|NOT COMPLETED|Overall Study||0
10229751|NCT03733899|11358162|FG000|STARTED|Period 1||3
10229752|NCT03733899|11358163|FG001|STARTED|Period 1||3
10229753|NCT03733899|11358164|FG002|STARTED|Period 1||3
10229754|NCT03733899|11358165|FG003|STARTED|Period 1||4
10229755|NCT03733899|11358166|FG004|STARTED|Period 1||4
10229756|NCT03733899|11358167|FG005|STARTED|Period 1||3
10229757|NCT03733899|11358162|FG000|COMPLETED|Period 1||3
10229758|NCT03733899|11358163|FG001|COMPLETED|Period 1||3
10229759|NCT03733899|11358164|FG002|COMPLETED|Period 1||3
10229760|NCT03733899|11358165|FG003|COMPLETED|Period 1||4
10229761|NCT03733899|11358166|FG004|COMPLETED|Period 1||4
10229762|NCT03733899|11358167|FG005|COMPLETED|Period 1||2
10229763|NCT03733899|11358162|FG000|NOT COMPLETED|Period 1||0
10229764|NCT03733899|11358163|FG001|NOT COMPLETED|Period 1||0
10229765|NCT03733899|11358164|FG002|NOT COMPLETED|Period 1||0
10229766|NCT03733899|11358165|FG003|NOT COMPLETED|Period 1||0
10229767|NCT03733899|11358166|FG004|NOT COMPLETED|Period 1||0
10229768|NCT03733899|11358167|FG005|NOT COMPLETED|Period 1||1
10229769|NCT03733899|11358162|FG000|STARTED|Period 2||3
10229770|NCT03733899|11358163|FG001|STARTED|Period 2||3
10229771|NCT03733899|11358164|FG002|STARTED|Period 2||3
10229772|NCT03733899|11358165|FG003|STARTED|Period 2||4
10229773|NCT03733899|11358166|FG004|STARTED|Period 2||4
10229774|NCT03733899|11358167|FG005|STARTED|Period 2||2
10229775|NCT03733899|11358162|FG000|COMPLETED|Period 2||3
10229776|NCT03733899|11358163|FG001|COMPLETED|Period 2||2
10229777|NCT03733899|11358164|FG002|COMPLETED|Period 2||3
10229778|NCT03733899|11358165|FG003|COMPLETED|Period 2||4
10229779|NCT03733899|11358166|FG004|COMPLETED|Period 2||4
10229780|NCT03733899|11358167|FG005|COMPLETED|Period 2||2
10229781|NCT03733899|11358162|FG000|NOT COMPLETED|Period 2||0
10229782|NCT03733899|11358163|FG001|NOT COMPLETED|Period 2||1
10229783|NCT03733899|11358164|FG002|NOT COMPLETED|Period 2||0
10229784|NCT03733899|11358165|FG003|NOT COMPLETED|Period 2||0
10229785|NCT03733899|11358166|FG004|NOT COMPLETED|Period 2||0
10229786|NCT03733899|11358167|FG005|NOT COMPLETED|Period 2||0
10229787|NCT03733899|11358162|FG000|STARTED|Period 3||3
10229788|NCT03733899|11358163|FG001|STARTED|Period 3||2
10229789|NCT03733899|11358164|FG002|STARTED|Period 3||3
10229790|NCT03733899|11358165|FG003|STARTED|Period 3||4
10229791|NCT03733899|11358166|FG004|STARTED|Period 3||4
10229792|NCT03733899|11358167|FG005|STARTED|Period 3||2
10229793|NCT03733899|11358162|FG000|COMPLETED|Period 3||2
10229794|NCT03733899|11358163|FG001|COMPLETED|Period 3||2
10229795|NCT03733899|11358164|FG002|COMPLETED|Period 3||3
10229796|NCT03733899|11358165|FG003|COMPLETED|Period 3||4
10229797|NCT03733899|11358166|FG004|COMPLETED|Period 3||4
10229798|NCT03733899|11358167|FG005|COMPLETED|Period 3||2
10229799|NCT03733899|11358162|FG000|NOT COMPLETED|Period 3||1
10229800|NCT03733899|11358163|FG001|NOT COMPLETED|Period 3||0
10229801|NCT03733899|11358164|FG002|NOT COMPLETED|Period 3||0
10229802|NCT03733899|11358165|FG003|NOT COMPLETED|Period 3||0
10229803|NCT03733899|11358166|FG004|NOT COMPLETED|Period 3||0
10229804|NCT03733899|11358167|FG005|NOT COMPLETED|Period 3||0
10229805|NCT03733483|11358180|FG000|STARTED|Overall Study||12
10229806|NCT03733483|11358180|FG000|COMPLETED|Overall Study||12
10229807|NCT03733483|11358180|FG000|NOT COMPLETED|Overall Study||0
10229808|NCT03733470|11358186|FG000|STARTED|Overall Study||8
10229809|NCT03733470|11358187|FG001|STARTED|Overall Study||11
10229810|NCT03733470|11358186|FG000|COMPLETED|Overall Study||7
10229811|NCT03733470|11358187|FG001|COMPLETED|Overall Study||10
10229812|NCT03733470|11358186|FG000|NOT COMPLETED|Overall Study||1
10229813|NCT03733470|11358187|FG001|NOT COMPLETED|Overall Study||1
10229814|NCT03733301|11358196|FG000|STARTED|Overall Study||109
10229815|NCT03733301|11358197|FG001|STARTED|Overall Study||109
10229816|NCT03733301|11358198|FG002|STARTED|Overall Study||111
10229817|NCT03733301|11358196|FG000|Received One Dose of Study Drug|Overall Study||108
10013094|NCT01790503|11136116|FG000|STARTED|Overall Study||3
10229818|NCT03733301|11358197|FG001|Received One Dose of Study Drug|Overall Study||109
10229819|NCT03733301|11358198|FG002|Received One Dose of Study Drug|Overall Study||111
10229820|NCT03733301|11358196|FG000|COMPLETED|Overall Study||102
10229821|NCT03733301|11358197|FG001|COMPLETED|Overall Study||100
10229822|NCT03733301|11358198|FG002|COMPLETED|Overall Study||107
10229823|NCT03733301|11358196|FG000|NOT COMPLETED|Overall Study||7
10229824|NCT03733301|11358197|FG001|NOT COMPLETED|Overall Study||9
10229825|NCT03733301|11358198|FG002|NOT COMPLETED|Overall Study||4
10229826|NCT03732638|11358209|FG000|STARTED|Overall Study||370
10229827|NCT03732638|11358210|FG001|STARTED|Overall Study||371
10229828|NCT03732638|11358209|FG000|COMPLETED|Overall Study||316
10229829|NCT03732638|11358210|FG001|COMPLETED|Overall Study||310
10229830|NCT03732638|11358209|FG000|NOT COMPLETED|Overall Study||54
10229831|NCT03732638|11358210|FG001|NOT COMPLETED|Overall Study||61
10229832|NCT03732248|11358219|FG000|STARTED|Overall Study||11
10229833|NCT03732248|11358220|FG001|STARTED|Overall Study||10
10229834|NCT03732248|11358219|FG000|COMPLETED|Overall Study||10
10229835|NCT03732248|11358220|FG001|COMPLETED|Overall Study||10
10229836|NCT03732248|11358219|FG000|NOT COMPLETED|Overall Study||1
10229837|NCT03732248|11358220|FG001|NOT COMPLETED|Overall Study||0
10229838|NCT03731182|11358228|FG000|STARTED|Overall Study||70
10229839|NCT03731182|11358229|FG001|STARTED|Overall Study||34
10229840|NCT03731182|11358228|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
10229841|NCT03731182|11358229|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
10229842|NCT03731182|11358228|FG000|COMPLETED|Overall Study||65
10229843|NCT03731182|11358229|FG001|COMPLETED|Overall Study||34
10229844|NCT03731182|11358228|FG000|NOT COMPLETED|Overall Study||5
10229845|NCT03731182|11358229|FG001|NOT COMPLETED|Overall Study||0
10229846|NCT03730961|11358238|FG000|STARTED|Overall Study||12
10229847|NCT03730961|11358239|FG001|STARTED|Overall Study||11
10229848|NCT03730961|11358238|FG000|Period 1 Completion|Overall Study||12
10229849|NCT03730961|11358239|FG001|Period 1 Completion|Overall Study||11
10229850|NCT03730961|11358238|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
10229851|NCT03730961|11358239|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
10229852|NCT03730961|11358238|FG000|COMPLETED|Overall Study||12
10229853|NCT03730961|11358239|FG001|COMPLETED|Overall Study||10
10229854|NCT03730961|11358238|FG000|NOT COMPLETED|Overall Study||0
10229855|NCT03730961|11358239|FG001|NOT COMPLETED|Overall Study||1
10229856|NCT03730116|11358245|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
10229857|NCT03730116|11358245|FG000|FVFP|Inclusion||1909
10229858|NCT03730116|11358245|FG000|COMPLETED|Inclusion||1909
10229859|NCT03730116|11358245|FG000|NOT COMPLETED|Inclusion||0
10229860|NCT03730116|11358245|FG000|STARTED|1 Month After Inclusion||1909
10229861|NCT03730116|11358245|FG000|1 Month After Inclusion|1 Month After Inclusion||1909
10229862|NCT03730116|11358245|FG000|COMPLETED|1 Month After Inclusion||1909
10229863|NCT03730116|11358245|FG000|NOT COMPLETED|1 Month After Inclusion||0
10229864|NCT03730116|11358245|FG000|STARTED|3 Month After Inclusion||1909
10229865|NCT03730116|11358245|FG000|3 Month After Inclusion|3 Month After Inclusion||1909
10229866|NCT03730116|11358245|FG000|COMPLETED|3 Month After Inclusion||1892
10229867|NCT03730116|11358245|FG000|NOT COMPLETED|3 Month After Inclusion||17
10229868|NCT03730103|11358255|FG000|STARTED|Overall Study||61
10229869|NCT03730103|11358256|FG001|STARTED|Overall Study||52
10229870|NCT03730103|11358255|FG000|COMPLETED|Overall Study||61
10229871|NCT03730103|11358256|FG001|COMPLETED|Overall Study||47
10229872|NCT03730103|11358255|FG000|NOT COMPLETED|Overall Study||0
10229873|NCT03730103|11358256|FG001|NOT COMPLETED|Overall Study||5
10229874|NCT03729960|11358262|FG000|STARTED|Overall Study||20
10229875|NCT03729960|11358262|FG000|COMPLETED|Overall Study||20
10229876|NCT03729960|11358262|FG000|NOT COMPLETED|Overall Study||0
10229877|NCT03729024|11358267|FG000|STARTED|Overall Study||21
10229878|NCT03729024|11358267|FG000|COMPLETED|Overall Study||21
10229879|NCT03729024|11358267|FG000|NOT COMPLETED|Overall Study||0
10229880|NCT03728790|11358273|FG000|STARTED|Overall Study||112
10229881|NCT03728790|11358274|FG001|STARTED|Overall Study||101
10229882|NCT03728790|11358273|FG000|COMPLETED|Overall Study||112
10229883|NCT03728790|11358274|FG001|COMPLETED|Overall Study||101
10229884|NCT03728790|11358273|FG000|NOT COMPLETED|Overall Study||0
10229885|NCT03728790|11358274|FG001|NOT COMPLETED|Overall Study||0
10229886|NCT03728348|11358280|FG000|STARTED|Overall Study||983
10229887|NCT03728348|11358280|FG000|Did Not Complete Study Procedures|Overall Study||107
10229888|NCT03728348|11358280|FG000|Multi-target DNA Test Excluded|Overall Study||15
10229889|NCT03728348|11358280|FG000|Colonoscopy Excluded|Overall Study||19
10229890|NCT03728348|11358280|FG000|COMPLETED|Overall Study||842
10229891|NCT03728348|11358280|FG000|NOT COMPLETED|Overall Study||141
10229892|NCT03728140|11358286|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
10229893|NCT03728140|11358287|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175
10229894|NCT03728140|11358286|FG000|COMPLETED|Overall Study||150
10229895|NCT03728140|11358287|FG001|COMPLETED|Overall Study||168
10229896|NCT03728140|11358286|FG000|NOT COMPLETED|Overall Study||10
10229897|NCT03728140|11358287|FG001|NOT COMPLETED|Overall Study||7
10229898|NCT03727854|11358295|FG000|STARTED|Overall Study||20
10229899|NCT03727854|11358296|FG001|STARTED|Overall Study||20
10229900|NCT03727854|11358295|FG000|COMPLETED|Overall Study||20
10229901|NCT03727854|11358296|FG001|COMPLETED|Overall Study||20
10013095|NCT01790503|11136117|FG001|STARTED|Overall Study||1
10229902|NCT03727854|11358295|FG000|NOT COMPLETED|Overall Study||0
10229903|NCT03727854|11358296|FG001|NOT COMPLETED|Overall Study||0
10229904|NCT03727425|11358302|FG000|STARTED|Overall Study||55
10229905|NCT03727425|11358302|FG000|COMPLETED|Overall Study||55
10229906|NCT03727425|11358302|FG000|NOT COMPLETED|Overall Study||0
10229907|NCT03727347|11358306|FG000|STARTED|Overall Study||50
10229908|NCT03727347|11358306|FG000|2-week Evaluation|Overall Study||50
10229909|NCT03727347|11358306|FG000|4-week Evaluation|Overall Study||50
10229910|NCT03727347|11358306|FG000|12-week Primary Endpoint Evaluation|Overall Study||50
10229911|NCT03727347|11358306|FG000|26-week Evaluation|Overall Study||48
10229912|NCT03727347|11358306|FG000|52-week Evaluation|Overall Study||47
10229913|NCT03727347|11358306|FG000|COMPLETED|Overall Study||47
10229914|NCT03727347|11358306|FG000|NOT COMPLETED|Overall Study||3
10229915|NCT03726996|11358319|FG000|STARTED|Overall Study||4
10229916|NCT03726996|11358319|FG000|COMPLETED|Overall Study||0
10229917|NCT03726996|11358319|FG000|NOT COMPLETED|Overall Study||4
10229918|NCT03726164|11358325|FG000|STARTED|Overall Study||310
10229919|NCT03726164|11358326|FG001|STARTED|Overall Study||316
10229920|NCT03726164|11358325|FG000|COMPLETED|Overall Study||99
10229921|NCT03726164|11358326|FG001|COMPLETED|Overall Study||119
10229922|NCT03726164|11358325|FG000|NOT COMPLETED|Overall Study||211
10229923|NCT03726164|11358326|FG001|NOT COMPLETED|Overall Study||197
10229924|NCT03725852|11358334|FG000|STARTED|Overall Study||45
10229925|NCT03725852|11358335|FG001|STARTED|Overall Study||23
10229926|NCT03725852|11358334|FG000|COMPLETED|Overall Study||41
10229927|NCT03725852|11358335|FG001|COMPLETED|Overall Study||23
10229928|NCT03725852|11358334|FG000|NOT COMPLETED|Overall Study||4
10229929|NCT03725852|11358335|FG001|NOT COMPLETED|Overall Study||0
10229930|NCT03725722|11358346|FG000|STARTED|Overall Study||49
10229931|NCT03725722|11358347|FG001|STARTED|Overall Study||50
10229932|NCT03725722|11358348|FG002|STARTED|Overall Study||50
10229933|NCT03725722|11358349|FG003|STARTED|Overall Study||52
10229934|NCT03725722|11358350|FG004|STARTED|Overall Study||50
10229935|NCT03725722|11358346|FG000|COMPLETED|Overall Study||38
10229936|NCT03725722|11358347|FG001|COMPLETED|Overall Study||44
10229937|NCT03725722|11358348|FG002|COMPLETED|Overall Study||44
10229938|NCT03725722|11358349|FG003|COMPLETED|Overall Study||46
10229939|NCT03725722|11358350|FG004|COMPLETED|Overall Study||36
10229940|NCT03725722|11358346|FG000|NOT COMPLETED|Overall Study||11
10229941|NCT03725722|11358347|FG001|NOT COMPLETED|Overall Study||6
10229942|NCT03725722|11358348|FG002|NOT COMPLETED|Overall Study||6
10229943|NCT03725722|11358349|FG003|NOT COMPLETED|Overall Study||6
10229944|NCT03725722|11358350|FG004|NOT COMPLETED|Overall Study||14
10229945|NCT03725098|11358364|FG000|STARTED|Overall Study||53
10229946|NCT03725098|11358365|FG001|STARTED|Overall Study||52
10229947|NCT03725098|11358364|FG000|COMPLETED|Overall Study||53
10229948|NCT03725098|11358365|FG001|COMPLETED|Overall Study||52
10229949|NCT03725098|11358364|FG000|NOT COMPLETED|Overall Study||0
10229950|NCT03725098|11358365|FG001|NOT COMPLETED|Overall Study||0
10229951|NCT03725085|11358371|FG000|STARTED|Overall Study||552
10229952|NCT03725085|11358371|FG000|COMPLETED|Overall Study||550
10229953|NCT03725085|11358371|FG000|NOT COMPLETED|Overall Study||2
10229954|NCT03725033|11358378|FG000|STARTED|Overall Study||105
10229955|NCT03725033|11358379|FG001|STARTED|Overall Study||97
10229956|NCT03725033|11358378|FG000|COMPLETED|Overall Study||105
10229957|NCT03725033|11358379|FG001|COMPLETED|Overall Study||97
10229958|NCT03725033|11358378|FG000|NOT COMPLETED|Overall Study||0
10229959|NCT03725033|11358379|FG001|NOT COMPLETED|Overall Study||0
10229960|NCT03724981|11358387|FG000|STARTED|First Device||156
10229961|NCT03724981|11358388|FG001|STARTED|First Device||156
10229962|NCT03724981|11358387|FG000|COMPLETED|First Device||155
10229963|NCT03724981|11358388|FG001|COMPLETED|First Device||155
10229964|NCT03724981|11358387|FG000|NOT COMPLETED|First Device||1
10229965|NCT03724981|11358388|FG001|NOT COMPLETED|First Device||1
10229966|NCT03724981|11358387|FG000|STARTED|Second Device||155
10229967|NCT03724981|11358388|FG001|STARTED|Second Device||155
10229968|NCT03724981|11358387|FG000|COMPLETED|Second Device||155
10229969|NCT03724981|11358388|FG001|COMPLETED|Second Device||155
10229970|NCT03724981|11358387|FG000|NOT COMPLETED|Second Device||0
10229971|NCT03724981|11358388|FG001|NOT COMPLETED|Second Device||0
10229972|NCT03724968|11358398|FG000|STARTED|Overall Study||0
10229973|NCT03724968|11358399|FG001|STARTED|Overall Study||2
10229974|NCT03724968|11358398|FG000|COMPLETED|Overall Study||0
10229975|NCT03724968|11358399|FG001|COMPLETED|Overall Study||0
10229976|NCT03724968|11358398|FG000|NOT COMPLETED|Overall Study||0
10229977|NCT03724968|11358399|FG001|NOT COMPLETED|Overall Study||2
10229978|NCT03724877|11358407|FG000|STARTED|Overall Study||6921
10229979|NCT03724877|11358408|FG001|STARTED|Overall Study||1932
10229980|NCT03724877|11358407|FG000|COMPLETED|Overall Study||6921
10229981|NCT03724877|11358408|FG001|COMPLETED|Overall Study||1932
10229982|NCT03724877|11358407|FG000|NOT COMPLETED|Overall Study||0
10229983|NCT03724877|11358408|FG001|NOT COMPLETED|Overall Study||0
10229984|NCT03724253|11358419|FG000|STARTED|Overall Study||5
10229985|NCT03724253|11358420|FG001|STARTED|Overall Study||5
10229986|NCT03724253|11358421|FG002|STARTED|Overall Study||5
10229987|NCT03724253|11358422|FG003|STARTED|Overall Study||3
10229988|NCT03724253|11358423|FG004|STARTED|Overall Study||1
10229989|NCT03724253|11358419|FG000|COMPLETED|Overall Study||5
10229990|NCT03724253|11358420|FG001|COMPLETED|Overall Study||5
10229991|NCT03724253|11358421|FG002|COMPLETED|Overall Study||5
10229992|NCT03724253|11358422|FG003|COMPLETED|Overall Study||3
10229993|NCT03724253|11358423|FG004|COMPLETED|Overall Study||1
10229994|NCT03724253|11358419|FG000|NOT COMPLETED|Overall Study||0
10229995|NCT03724253|11358420|FG001|NOT COMPLETED|Overall Study||0
10229996|NCT03724253|11358421|FG002|NOT COMPLETED|Overall Study||0
10229997|NCT03724253|11358422|FG003|NOT COMPLETED|Overall Study||0
10229998|NCT03724253|11358423|FG004|NOT COMPLETED|Overall Study||0
10229999|NCT03723980|11358437|FG000|STARTED|Overall Study||40
10230000|NCT03723980|11358438|FG001|STARTED|Overall Study||40
10230001|NCT03723980|11358437|FG000|COMPLETED|Overall Study||33
10230002|NCT03723980|11358438|FG001|COMPLETED|Overall Study||35
10230003|NCT03723980|11358437|FG000|NOT COMPLETED|Overall Study||7
10230004|NCT03723980|11358438|FG001|NOT COMPLETED|Overall Study||5
10230005|NCT03723603|11358450|FG000|STARTED|Overall Study||8
10230006|NCT03723603|11358450|FG000|COMPLETED|Overall Study||5
10230007|NCT03723603|11358450|FG000|NOT COMPLETED|Overall Study||3
10230008|NCT03723447|11358456|FG000|STARTED|Overall Study||50
10230009|NCT03723447|11358457|FG001|STARTED|Overall Study||51
10230010|NCT03723447|11358456|FG000|COMPLETED|Overall Study||50
10230011|NCT03723447|11358457|FG001|COMPLETED|Overall Study||51
10230012|NCT03723447|11358456|FG000|NOT COMPLETED|Overall Study||0
10230013|NCT03723447|11358457|FG001|NOT COMPLETED|Overall Study||0
10230014|NCT03723070|11358463|FG000|STARTED|Overall Study||88
10230015|NCT03723070|11358463|FG000|COMPLETED|Overall Study||79
10230016|NCT03723070|11358463|FG000|NOT COMPLETED|Overall Study||9
10230017|NCT03720210|11358467|FG000|STARTED|Overall Study||1
9761036|NCT00384865|10864887|FG003|STARTED|Overall Study||16
9761037|NCT00384865|10864884|FG000|Completed Six Month Assessment|Overall Study||11
9761038|NCT00384865|10864885|FG001|Completed Six Month Assessment|Overall Study||12
9761039|NCT00384865|10864886|FG002|Completed Six Month Assessment|Overall Study||15
9761040|NCT00384865|10864887|FG003|Completed Six Month Assessment|Overall Study||11
9761041|NCT00384865|10864884|FG000|COMPLETED|Overall Study||16
9761042|NCT00384865|10864885|FG001|COMPLETED|Overall Study||16
9761043|NCT00384865|10864886|FG002|COMPLETED|Overall Study||16
9761044|NCT00384865|10864887|FG003|COMPLETED|Overall Study||16
9761045|NCT00384865|10864884|FG000|NOT COMPLETED|Overall Study||0
9761046|NCT00384865|10864885|FG001|NOT COMPLETED|Overall Study||0
9761047|NCT00384865|10864886|FG002|NOT COMPLETED|Overall Study||0
9761048|NCT00384865|10864887|FG003|NOT COMPLETED|Overall Study||0
9761049|NCT00384930|10864902|FG000|STARTED|Overall Study||212
9761050|NCT00384930|10864903|FG001|STARTED|Overall Study||209
9761051|NCT00384930|10864904|FG002|STARTED|Overall Study||212
9761052|NCT00384930|10864905|FG003|STARTED|Overall Study||216
9761053|NCT00384930|10864906|FG004|STARTED|Overall Study||209
9761054|NCT00384930|10864902|FG000|Received Double-Blind Study Drug|Overall Study||211
9761055|NCT00384930|10864903|FG001|Received Double-Blind Study Drug|Overall Study||208
9761056|NCT00384930|10864904|FG002|Received Double-Blind Study Drug|Overall Study||212
9761057|NCT00384930|10864905|FG003|Received Double-Blind Study Drug|Overall Study||216
9761058|NCT00384930|10864906|FG004|Received Double-Blind Study Drug|Overall Study||209
9761059|NCT00384930|10864902|FG000|COMPLETED|Overall Study||185
9761060|NCT00384930|10864903|FG001|COMPLETED|Overall Study||182
9761061|NCT00384930|10864904|FG002|COMPLETED|Overall Study||182
9761062|NCT00384930|10864905|FG003|COMPLETED|Overall Study||175
9761063|NCT00384930|10864906|FG004|COMPLETED|Overall Study||162
9761064|NCT00384930|10864902|FG000|NOT COMPLETED|Overall Study||27
10230018|NCT03720210|11358467|FG000|COMPLETED|Overall Study||0
10230019|NCT03720210|11358467|FG000|NOT COMPLETED|Overall Study||1
10230020|NCT03718455|11358471|FG000|STARTED|Overall Study||1
10230021|NCT03718455|11358471|FG000|COMPLETED|Overall Study||1
10230022|NCT03718455|11358471|FG000|NOT COMPLETED|Overall Study||0
10230023|NCT03718143|11358475|FG000|STARTED|Overall Study||3
10230024|NCT03718143|11358476|FG001|STARTED|Overall Study||2
10230025|NCT03718143|11358477|FG002|STARTED|Overall Study||1
10230026|NCT03718143|11358475|FG000|COMPLETED|Overall Study||0
10230027|NCT03718143|11358476|FG001|COMPLETED|Overall Study||0
10230028|NCT03718143|11358477|FG002|COMPLETED|Overall Study||0
10230029|NCT03718143|11358475|FG000|NOT COMPLETED|Overall Study||3
10230030|NCT03718143|11358476|FG001|NOT COMPLETED|Overall Study||2
10230031|NCT03718143|11358477|FG002|NOT COMPLETED|Overall Study||1
10230032|NCT03709576|11358485|FG000|STARTED|Overall Study||3
10230033|NCT03709576|11358485|FG000|COMPLETED|Overall Study||2
10230034|NCT03709576|11358485|FG000|NOT COMPLETED|Overall Study||1
10230035|NCT03704636|11358490|FG000|STARTED|Overall Study||23
10230036|NCT03704636|11358490|FG000|COMPLETED|Overall Study||20
10230037|NCT03704636|11358490|FG000|NOT COMPLETED|Overall Study||3
10230038|NCT03703791|11358496|FG000|STARTED|Overall Study||0
10230039|NCT03703791|11358497|FG001|STARTED|Overall Study||1
10230040|NCT03703791|11358496|FG000|COMPLETED|Overall Study||0
10230041|NCT03703791|11358497|FG001|COMPLETED|Overall Study||0
10230042|NCT03703791|11358496|FG000|NOT COMPLETED|Overall Study||0
10230043|NCT03703791|11358497|FG001|NOT COMPLETED|Overall Study||1
10230044|NCT03701295|11358503|FG000|STARTED|Overall Study||1
10230045|NCT03701295|11358503|FG000|COMPLETED|Overall Study||1
10230046|NCT03701295|11358503|FG000|NOT COMPLETED|Overall Study||0
9761065|NCT00384930|10864903|FG001|NOT COMPLETED|Overall Study||27
10230047|NCT03697551|11358507|FG000|STARTED|Overall Study||4
10230048|NCT03697551|11358507|FG000|COMPLETED|Overall Study||4
10230049|NCT03697551|11358507|FG000|NOT COMPLETED|Overall Study||0
10230050|NCT03694821|11358514|FG000|STARTED|Overall Study||4
10230051|NCT03694821|11358515|FG001|STARTED|Overall Study||8
10230052|NCT03694821|11358516|FG002|STARTED|Overall Study||6
10230053|NCT03694821|11358514|FG000|COMPLETED|Overall Study||0
9761066|NCT00384930|10864904|FG002|NOT COMPLETED|Overall Study||30
10230054|NCT03694821|11358515|FG001|COMPLETED|Overall Study||0
10230055|NCT03694821|11358516|FG002|COMPLETED|Overall Study||2
10230056|NCT03694821|11358514|FG000|NOT COMPLETED|Overall Study||4
10230057|NCT03694821|11358515|FG001|NOT COMPLETED|Overall Study||8
10230058|NCT03694821|11358516|FG002|NOT COMPLETED|Overall Study||4
10230059|NCT03686969|11358526|FG000|STARTED|Overall Study||1
10230060|NCT03686969|11358527|FG001|STARTED|Overall Study||0
10230061|NCT03686969|11358526|FG000|COMPLETED|Overall Study||0
10230062|NCT03686969|11358527|FG001|COMPLETED|Overall Study||0
10230063|NCT03686969|11358526|FG000|NOT COMPLETED|Overall Study||1
10230064|NCT03686969|11358527|FG001|NOT COMPLETED|Overall Study||0
10230065|NCT03682367|11358535|FG000|STARTED|Overall Study||4
10230066|NCT03682367|11358536|FG001|STARTED|Overall Study||4
10230067|NCT03682367|11358535|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
10230068|NCT03682367|11358536|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
10230069|NCT03682367|11358535|FG000|NOT COMPLETED|Overall Study||2
10230070|NCT03682367|11358536|FG001|NOT COMPLETED|Overall Study||4
10230071|NCT03680911|11358544|FG000|STARTED|Visit 1 (Baseline)||3
10230072|NCT03680911|11358545|FG001|STARTED|Visit 1 (Baseline)||4
10230073|NCT03680911|11358544|FG000|COMPLETED|Visit 1 (Baseline)||3
10230074|NCT03680911|11358545|FG001|COMPLETED|Visit 1 (Baseline)||4
10230075|NCT03680911|11358544|FG000|NOT COMPLETED|Visit 1 (Baseline)||0
10230076|NCT03680911|11358545|FG001|NOT COMPLETED|Visit 1 (Baseline)||0
10230077|NCT03680911|11358544|FG000|STARTED|At Home Treatment||3
10230078|NCT03680911|11358545|FG001|STARTED|At Home Treatment||4
10230079|NCT03680911|11358544|FG000|COMPLETED|At Home Treatment||0
10230080|NCT03680911|11358545|FG001|COMPLETED|At Home Treatment||1
10230081|NCT03680911|11358544|FG000|NOT COMPLETED|At Home Treatment||3
10230082|NCT03680911|11358545|FG001|NOT COMPLETED|At Home Treatment||3
10230083|NCT03680911|11358544|FG000|STARTED|Visit 2 (1 Month Follow up)||0
10230084|NCT03680911|11358545|FG001|STARTED|Visit 2 (1 Month Follow up)||1
10230085|NCT03680911|11358544|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0
10230086|NCT03680911|11358545|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1
10230087|NCT03680911|11358544|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
10230088|NCT03680911|11358545|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
10230089|NCT03680911|11358544|FG000|STARTED|Visit 3 (4 Month Follow up)||0
10230090|NCT03680911|11358545|FG001|STARTED|Visit 3 (4 Month Follow up)||1
10230091|NCT03680911|11358544|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0
10230092|NCT03680911|11358545|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0
10230093|NCT03680911|11358544|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
10230094|NCT03680911|11358545|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
10230095|NCT03656692|11358551|FG000|STARTED|Overall Study||5
10230096|NCT03656692|11358551|FG000|COMPLETED|Overall Study||2
10230097|NCT03656692|11358551|FG000|NOT COMPLETED|Overall Study||3
10230098|NCT03648983|11358555|FG000|STARTED|Overall Study||95
10230099|NCT03648983|11358555|FG000|COMPLETED|Overall Study||0
10230100|NCT03648983|11358555|FG000|NOT COMPLETED|Overall Study||95
10230101|NCT03643159|11358562|FG000|STARTED|Overall Study||2
10230102|NCT03643159|11358562|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2
10230103|NCT03643159|11358562|FG000|COMPLETED|Overall Study||0
10230104|NCT03643159|11358562|FG000|NOT COMPLETED|Overall Study||2
10230105|NCT03632655|11358569|FG000|STARTED|Overall Study||22
10230106|NCT03632655|11358570|FG001|STARTED|Overall Study||16
10230107|NCT03632655|11358569|FG000|COMPLETED|Overall Study||0
10230108|NCT03632655|11358570|FG001|COMPLETED|Overall Study||0
10230109|NCT03632655|11358569|FG000|NOT COMPLETED|Overall Study||22
10230110|NCT03632655|11358570|FG001|NOT COMPLETED|Overall Study||16
10230111|NCT03630120|11358580|FG000|STARTED|Overall Study||2
10230112|NCT03630120|11358581|FG001|STARTED|Overall Study||2
10230113|NCT03630120|11358582|FG002|STARTED|Overall Study||1
10230114|NCT03630120|11358583|FG003|STARTED|Overall Study||1
10230115|NCT03630120|11358580|FG000|COMPLETED|Overall Study||2
10230116|NCT03630120|11358581|FG001|COMPLETED|Overall Study||1
10230117|NCT03630120|11358582|FG002|COMPLETED|Overall Study||0
10230118|NCT03630120|11358583|FG003|COMPLETED|Overall Study||0
10230119|NCT03630120|11358580|FG000|NOT COMPLETED|Overall Study||0
10230120|NCT03630120|11358581|FG001|NOT COMPLETED|Overall Study||1
10230121|NCT03630120|11358582|FG002|NOT COMPLETED|Overall Study||1
10230122|NCT03630120|11358583|FG003|NOT COMPLETED|Overall Study||1
10230123|NCT03621657|11358596|FG000|STARTED|Overall Study||0
10230124|NCT03621657|11358597|FG001|STARTED|Overall Study||0
10230125|NCT03621657|11358598|FG002|STARTED|Overall Study||1
10230126|NCT03621657|11358596|FG000|COMPLETED|Overall Study||0
10230127|NCT03621657|11358597|FG001|COMPLETED|Overall Study||0
10230128|NCT03621657|11358598|FG002|COMPLETED|Overall Study||1
10230129|NCT03621657|11358596|FG000|NOT COMPLETED|Overall Study||0
10230130|NCT03621657|11358597|FG001|NOT COMPLETED|Overall Study||0
10230131|NCT03621657|11358598|FG002|NOT COMPLETED|Overall Study||0
10230132|NCT03615144|11358610|FG000|STARTED|Overall Study||1
10230133|NCT03615144|11358611|FG001|STARTED|Overall Study||0
10230134|NCT03615144|11358610|FG000|COMPLETED|Overall Study||0
10230135|NCT03615144|11358611|FG001|COMPLETED|Overall Study||0
10230136|NCT03615144|11358610|FG000|NOT COMPLETED|Overall Study||1
10230137|NCT03615144|11358611|FG001|NOT COMPLETED|Overall Study||0
10230138|NCT03605303|11358617|FG000|STARTED|Period 1||2
10230139|NCT03605303|11358618|FG001|STARTED|Period 1||1
10230140|NCT03605303|11358617|FG000|COMPLETED|Period 1||0
10230141|NCT03605303|11358618|FG001|COMPLETED|Period 1||0
10230142|NCT03605303|11358617|FG000|NOT COMPLETED|Period 1||2
10230143|NCT03605303|11358618|FG001|NOT COMPLETED|Period 1||1
10230144|NCT03605303|11358617|FG000|STARTED|Period 2||0
10230145|NCT03605303|11358618|FG001|STARTED|Period 2||0
10230146|NCT03605303|11358617|FG000|COMPLETED|Period 2||0
10230147|NCT03605303|11358618|FG001|COMPLETED|Period 2||0
10230148|NCT03605303|11358617|FG000|NOT COMPLETED|Period 2||0
10230149|NCT03605303|11358618|FG001|NOT COMPLETED|Period 2||0
10230150|NCT03600740|11358624|FG000|STARTED|Overall Study||1
10230151|NCT03600740|11358624|FG000|COMPLETED|Overall Study||0
10230152|NCT03600740|11358624|FG000|NOT COMPLETED|Overall Study||1
10230153|NCT03598140|11358630|FG000|STARTED|Overall Study||10
10230154|NCT03598140|11358631|FG001|STARTED|Overall Study||11
10230155|NCT03598140|11358630|FG000|COMPLETED|Overall Study||9
10230156|NCT03598140|11358631|FG001|COMPLETED|Overall Study||11
10230157|NCT03598140|11358630|FG000|NOT COMPLETED|Overall Study||1
10230158|NCT03598140|11358631|FG001|NOT COMPLETED|Overall Study||0
10230159|NCT03598036|11358639|FG000|STARTED|Overall Study||5
10230160|NCT03598036|11358640|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0
10230161|NCT03598036|11358639|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5
10230162|NCT03598036|11358640|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0
10230163|NCT03598036|11358639|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5
10230164|NCT03598036|11358640|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0
10230165|NCT03598036|11358639|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5
10230166|NCT03598036|11358640|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0
10230167|NCT03598036|11358639|FG000|COMPLETED|Overall Study||4
10230168|NCT03598036|11358640|FG001|COMPLETED|Overall Study||0
10230169|NCT03598036|11358639|FG000|NOT COMPLETED|Overall Study||1
10230170|NCT03598036|11358640|FG001|NOT COMPLETED|Overall Study||0
10230171|NCT03591458|11358650|FG000|STARTED|Overall Study||1
10230172|NCT03591458|11358651|FG001|STARTED|Overall Study||1
10230173|NCT03591458|11358650|FG000|COMPLETED|Overall Study||1
10230174|NCT03591458|11358651|FG001|COMPLETED|Overall Study||1
10230175|NCT03591458|11358650|FG000|NOT COMPLETED|Overall Study||0
10230176|NCT03591458|11358651|FG001|NOT COMPLETED|Overall Study||0
10230177|NCT03590743|11358659|FG000|STARTED|Overall Study||2
10230178|NCT03590743|11358660|FG001|STARTED|Overall Study||3
10230179|NCT03590743|11358659|FG000|COMPLETED|Overall Study||2
10230180|NCT03590743|11358660|FG001|COMPLETED|Overall Study||2
10230181|NCT03590743|11358659|FG000|NOT COMPLETED|Overall Study||0
10230182|NCT03590743|11358660|FG001|NOT COMPLETED|Overall Study||1
10230183|NCT03580382|11358668|FG000|STARTED|Overall Study||0
10230184|NCT03580382|11358669|FG001|STARTED|Overall Study||3
10230185|NCT03580382|11358668|FG000|COMPLETED|Overall Study||0
10230186|NCT03580382|11358669|FG001|COMPLETED|Overall Study||0
10230187|NCT03580382|11358668|FG000|NOT COMPLETED|Overall Study||0
10230188|NCT03580382|11358669|FG001|NOT COMPLETED|Overall Study||3
10230189|NCT03571646|11358676|FG000|STARTED|Overall Study||3
10230190|NCT03571646|11358677|FG001|STARTED|Overall Study||3
10230191|NCT03571646|11358676|FG000|COMPLETED|Overall Study||1
10230192|NCT03571646|11358677|FG001|COMPLETED|Overall Study||2
10230193|NCT03571646|11358676|FG000|NOT COMPLETED|Overall Study||2
10230194|NCT03571646|11358677|FG001|NOT COMPLETED|Overall Study||1
10230195|NCT03565328|11358683|FG000|STARTED|Overall Study||1
10230196|NCT03565328|11358683|FG000|COMPLETED|Overall Study||1
10230197|NCT03565328|11358683|FG000|NOT COMPLETED|Overall Study||0
10230198|NCT03544242|11358690|FG000|STARTED|Overall Study||1
10230199|NCT03544242|11358691|FG001|STARTED|Overall Study||1
10230200|NCT03544242|11358692|FG002|STARTED|Overall Study||2
10230201|NCT03544242|11358690|FG000|COMPLETED|Overall Study||1
10230202|NCT03544242|11358691|FG001|COMPLETED|Overall Study||1
10230203|NCT03544242|11358692|FG002|COMPLETED|Overall Study||2
10230204|NCT03544242|11358690|FG000|NOT COMPLETED|Overall Study||0
10230205|NCT03544242|11358691|FG001|NOT COMPLETED|Overall Study||0
10230206|NCT03544242|11358692|FG002|NOT COMPLETED|Overall Study||0
10230207|NCT03543358|11358700|FG000|STARTED|Overall Study||3
10230208|NCT03543358|11358701|FG001|STARTED|Overall Study||0
10230209|NCT03543358|11358700|FG000|Received Treatment or Retreatment|Overall Study||0
10230210|NCT03543358|11358701|FG001|Received Treatment or Retreatment|Overall Study||0
10230211|NCT03543358|11358700|FG000|COMPLETED|Overall Study||0
10230212|NCT03543358|11358701|FG001|COMPLETED|Overall Study||0
10230213|NCT03543358|11358700|FG000|NOT COMPLETED|Overall Study||3
10230214|NCT03543358|11358701|FG001|NOT COMPLETED|Overall Study||0
10230215|NCT03538015|11358708|FG000|STARTED|Overall Study||0
10230216|NCT03538015|11358709|FG001|STARTED|Overall Study||0
10230217|NCT03538015|11358710|FG002|STARTED|Overall Study||1
10230218|NCT03538015|11358708|FG000|COMPLETED|Overall Study||0
10230219|NCT03538015|11358709|FG001|COMPLETED|Overall Study||0
10230220|NCT03538015|11358710|FG002|COMPLETED|Overall Study||0
10230221|NCT03538015|11358708|FG000|NOT COMPLETED|Overall Study||0
10230222|NCT03538015|11358709|FG001|NOT COMPLETED|Overall Study||0
10230223|NCT03538015|11358710|FG002|NOT COMPLETED|Overall Study||1
10230224|NCT03534362|11358720|FG000|STARTED|Overall Study||0
10230225|NCT03534362|11358721|FG001|STARTED|Overall Study||1
10230226|NCT03534362|11358720|FG000|COMPLETED|Overall Study||0
10230227|NCT03534362|11358721|FG001|COMPLETED|Overall Study||1
10230228|NCT03534362|11358720|FG000|NOT COMPLETED|Overall Study||0
10230229|NCT03534362|11358721|FG001|NOT COMPLETED|Overall Study||0
10230230|NCT03509207|11358729|FG000|STARTED|Overall Study||3
10230231|NCT03509207|11358729|FG000|COMPLETED|Overall Study||1
10230232|NCT03509207|11358729|FG000|NOT COMPLETED|Overall Study||2
10230233|NCT03505372|11358733|FG000|STARTED|Overall Study||5
10230234|NCT03505372|11358733|FG000|COMPLETED|Overall Study||5
10230235|NCT03505372|11358733|FG000|NOT COMPLETED|Overall Study||0
10230236|NCT03500406|11358739|FG000|STARTED|Overall Study||4
10230237|NCT03500406|11358740|FG001|STARTED|Overall Study||20
10230238|NCT03500406|11358739|FG000|COMPLETED|Overall Study||4
10230239|NCT03500406|11358740|FG001|COMPLETED|Overall Study||20
10230240|NCT03500406|11358739|FG000|NOT COMPLETED|Overall Study||0
10230241|NCT03500406|11358740|FG001|NOT COMPLETED|Overall Study||0
10230242|NCT03500341|11358746|FG000|STARTED|Overall Study||16
10230243|NCT03500341|11358746|FG000|COMPLETED|Overall Study||14
10230244|NCT03500341|11358746|FG000|NOT COMPLETED|Overall Study||2
10230245|NCT03500159|11358752|FG000|STARTED|Overall Study||2
10230246|NCT03500159|11358753|FG001|STARTED|Overall Study||1
10230247|NCT03500159|11358752|FG000|COMPLETED|Overall Study||0
10230248|NCT03500159|11358753|FG001|COMPLETED|Overall Study||0
10230249|NCT03500159|11358752|FG000|NOT COMPLETED|Overall Study||2
10230250|NCT03500159|11358753|FG001|NOT COMPLETED|Overall Study||1
10230251|NCT03490916|11358761|FG000|STARTED|Overall Study||0
10230252|NCT03490916|11358762|FG001|STARTED|Overall Study||0
10230253|NCT03490916|11358761|FG000|COMPLETED|Overall Study||0
10230254|NCT03490916|11358762|FG001|COMPLETED|Overall Study||0
10230255|NCT03490916|11358761|FG000|NOT COMPLETED|Overall Study||0
10230256|NCT03490916|11358762|FG001|NOT COMPLETED|Overall Study||0
10230257|NCT03483051|11358770|FG000|STARTED|First Treatment, Pre Crossover||2
10013096|NCT01790503|11136118|FG002|STARTED|Overall Study||1
10013097|NCT01790503|11136119|FG003|STARTED|Overall Study||2
10013098|NCT01790503|11136120|FG004|STARTED|Overall Study||5
10230258|NCT03483051|11358771|FG001|STARTED|First Treatment, Pre Crossover||1
10230259|NCT03483051|11358770|FG000|COMPLETED|First Treatment, Pre Crossover||2
10013099|NCT01790503|11136121|FG005|STARTED|Overall Study||5
10230260|NCT03483051|11358771|FG001|COMPLETED|First Treatment, Pre Crossover||1
10230261|NCT03483051|11358770|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0
10230262|NCT03483051|11358771|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0
10230263|NCT03483051|11358770|FG000|STARTED|Second Treatment, After Crossover||2
10230264|NCT03483051|11358771|FG001|STARTED|Second Treatment, After Crossover||1
10230265|NCT03483051|11358770|FG000|COMPLETED|Second Treatment, After Crossover||2
10230266|NCT03483051|11358771|FG001|COMPLETED|Second Treatment, After Crossover||1
10230267|NCT03483051|11358770|FG000|NOT COMPLETED|Second Treatment, After Crossover||0
10230268|NCT03483051|11358771|FG001|NOT COMPLETED|Second Treatment, After Crossover||0
10230269|NCT03477903|11358779|FG000|STARTED|Overall Study||1
10230270|NCT03477903|11358779|FG000|COMPLETED|Overall Study||0
10230271|NCT03477903|11358779|FG000|NOT COMPLETED|Overall Study||1
10230272|NCT03469258|11358783|FG000|STARTED|Overall Study||4
10230273|NCT03469258|11358783|FG000|COMPLETED|Overall Study||0
10230274|NCT03469258|11358783|FG000|NOT COMPLETED|Overall Study||4
10230275|NCT03466658|11358787|FG000|STARTED|Overall Study||17
10230276|NCT03466658|11358787|FG000|COMPLETED|Overall Study||14
10230277|NCT03466658|11358787|FG000|NOT COMPLETED|Overall Study||3
10230278|NCT03465891|11358795|FG000|STARTED|Overall Study||1
10230279|NCT03465891|11358796|FG001|STARTED|Overall Study||1
10230280|NCT03465891|11358795|FG000|COMPLETED|Overall Study||0
10230281|NCT03465891|11358796|FG001|COMPLETED|Overall Study||0
10230282|NCT03465891|11358795|FG000|NOT COMPLETED|Overall Study||1
10230283|NCT03465891|11358796|FG001|NOT COMPLETED|Overall Study||1
10230284|NCT03465735|11358804|FG000|STARTED|Overall Study||8
10230285|NCT03465735|11358805|FG001|STARTED|Overall Study||7
10230286|NCT03465735|11358804|FG000|COMPLETED|Overall Study||7
10230287|NCT03465735|11358805|FG001|COMPLETED|Overall Study||5
10230288|NCT03465735|11358804|FG000|NOT COMPLETED|Overall Study||1
10230289|NCT03465735|11358805|FG001|NOT COMPLETED|Overall Study||2
10230290|NCT03461705|11358811|FG000|STARTED|Overall Study||5
10230291|NCT03461705|11358811|FG000|COMPLETED|Overall Study||5
10230292|NCT03461705|11358811|FG000|NOT COMPLETED|Overall Study||0
10230293|NCT03457818|11358817|FG000|STARTED|Overall Study||4
10230294|NCT03457818|11358818|FG001|STARTED|Overall Study||4
10230295|NCT03457818|11358817|FG000|COMPLETED|Overall Study|Study terminated|0
10230296|NCT03457818|11358818|FG001|COMPLETED|Overall Study|study terminated|0
10230297|NCT03457818|11358817|FG000|NOT COMPLETED|Overall Study||4
10230298|NCT03457818|11358818|FG001|NOT COMPLETED|Overall Study||4
10230299|NCT03455556|11358824|FG000|STARTED|Overall Study||1
10230300|NCT03455556|11358824|FG000|COMPLETED|Overall Study||1
10230301|NCT03455556|11358824|FG000|NOT COMPLETED|Overall Study||0
10230302|NCT03447639|11358830|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
10230303|NCT03447639|11358831|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
10230304|NCT03447639|11358830|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
10230305|NCT03447639|11358831|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
10230306|NCT03447639|11358830|FG000|NOT COMPLETED|Overall Study||0
10230307|NCT03447639|11358831|FG001|NOT COMPLETED|Overall Study||2
10230308|NCT03429712|11358837|FG000|STARTED|Overall Study||19
10230309|NCT03429712|11358837|FG000|COMPLETED|Overall Study||10
10230310|NCT03429712|11358837|FG000|NOT COMPLETED|Overall Study||9
10230311|NCT03426137|11358844|FG000|STARTED|Overall Study||0
10230312|NCT03426137|11358845|FG001|STARTED|Overall Study||0
10230313|NCT03426137|11358846|FG002|STARTED|Overall Study||0
10230314|NCT03426137|11358844|FG000|COMPLETED|Overall Study||0
10230315|NCT03426137|11358845|FG001|COMPLETED|Overall Study||0
10230316|NCT03426137|11358846|FG002|COMPLETED|Overall Study||0
10230317|NCT03426137|11358844|FG000|NOT COMPLETED|Overall Study||0
10230318|NCT03426137|11358845|FG001|NOT COMPLETED|Overall Study||0
10230319|NCT03426137|11358846|FG002|NOT COMPLETED|Overall Study||0
10230320|NCT03425799|11358856|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0
10230321|NCT03425799|11358857|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0
10230322|NCT03425799|11358856|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0
10230323|NCT03425799|11358857|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0
10230324|NCT03425799|11358856|FG000|NOT COMPLETED|Overall Study||0
10230325|NCT03425799|11358857|FG001|NOT COMPLETED|Overall Study||0
10230326|NCT03423654|11358865|FG000|STARTED|Overall Study||3
10230327|NCT03423654|11358866|FG001|STARTED|Overall Study||3
10230328|NCT03423654|11358865|FG000|COMPLETED|Overall Study||3
10230329|NCT03423654|11358866|FG001|COMPLETED|Overall Study||3
10230330|NCT03423654|11358865|FG000|NOT COMPLETED|Overall Study||0
10230331|NCT03423654|11358866|FG001|NOT COMPLETED|Overall Study||0
10230332|NCT03387059|11358874|FG000|STARTED|Overall Study||5
10230333|NCT03387059|11358875|FG001|STARTED|Overall Study||4
10230334|NCT03387059|11358874|FG000|COMPLETED|Overall Study||0
10230335|NCT03387059|11358875|FG001|COMPLETED|Overall Study||0
10230336|NCT03387059|11358874|FG000|NOT COMPLETED|Overall Study||5
10230337|NCT03387059|11358875|FG001|NOT COMPLETED|Overall Study||4
10230338|NCT03382925|11358883|FG000|STARTED|Overall Study||10
10230339|NCT03382925|11358884|FG001|STARTED|Overall Study||6
10230340|NCT03382925|11358883|FG000|COMPLETED|Overall Study||10
10230341|NCT03382925|11358884|FG001|COMPLETED|Overall Study||6
10230342|NCT03382925|11358883|FG000|NOT COMPLETED|Overall Study||0
10230343|NCT03382925|11358884|FG001|NOT COMPLETED|Overall Study||0
10230344|NCT03379233|11358892|FG000|STARTED|Overall Study||1
10230345|NCT03379233|11358893|FG001|STARTED|Overall Study||6
10230346|NCT03379233|11358892|FG000|COMPLETED|Overall Study||0
10230347|NCT03379233|11358893|FG001|COMPLETED|Overall Study||0
10230348|NCT03379233|11358892|FG000|NOT COMPLETED|Overall Study||1
10230349|NCT03379233|11358893|FG001|NOT COMPLETED|Overall Study||6
10230350|NCT03370536|11358899|FG000|STARTED|Overall Study||1
10230351|NCT03370536|11358899|FG000|COMPLETED|Overall Study||0
10230352|NCT03370536|11358899|FG000|NOT COMPLETED|Overall Study||1
10230353|NCT03363633|11358903|FG000|STARTED|Overall Study||12
10230354|NCT03363633|11358903|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
10230355|NCT03363633|11358903|FG000|NOT COMPLETED|Overall Study||12
10230356|NCT03361228|11358909|FG000|STARTED|Overall Study||4
10230357|NCT03361228|11358910|FG001|STARTED|Overall Study||1
10230358|NCT03361228|11358909|FG000|COMPLETED|Overall Study||0
10230359|NCT03361228|11358910|FG001|COMPLETED|Overall Study||0
10230360|NCT03361228|11358909|FG000|NOT COMPLETED|Overall Study||4
10230361|NCT03361228|11358910|FG001|NOT COMPLETED|Overall Study||1
10230362|NCT03360903|11358918|FG000|STARTED|First Intervention||4
10230363|NCT03360903|11358919|FG001|STARTED|First Intervention||4
10230364|NCT03360903|11358918|FG000|COMPLETED|First Intervention||4
10230365|NCT03360903|11358919|FG001|COMPLETED|First Intervention||4
10230366|NCT03360903|11358918|FG000|NOT COMPLETED|First Intervention||0
10230367|NCT03360903|11358919|FG001|NOT COMPLETED|First Intervention||0
10230368|NCT03360903|11358918|FG000|STARTED|Washout (2 Weeks)||4
10230369|NCT03360903|11358919|FG001|STARTED|Washout (2 Weeks)||4
10230370|NCT03360903|11358918|FG000|COMPLETED|Washout (2 Weeks)||4
10230371|NCT03360903|11358919|FG001|COMPLETED|Washout (2 Weeks)||4
10230372|NCT03360903|11358918|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10230373|NCT03360903|11358919|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10230374|NCT03360903|11358918|FG000|STARTED|Second Intervention||4
10230375|NCT03360903|11358919|FG001|STARTED|Second Intervention||4
10230376|NCT03360903|11358918|FG000|COMPLETED|Second Intervention||4
10230377|NCT03360903|11358919|FG001|COMPLETED|Second Intervention||4
10230378|NCT03360903|11358918|FG000|NOT COMPLETED|Second Intervention||0
10230379|NCT03360903|11358919|FG001|NOT COMPLETED|Second Intervention||0
10230380|NCT03359174|11358925|FG000|STARTED|Overall Study||2
10230381|NCT03359174|11358925|FG000|COMPLETED|Overall Study||1
10230382|NCT03359174|11358925|FG000|NOT COMPLETED|Overall Study||1
10230383|NCT03352882|11358929|FG000|STARTED|Overall Study||1
10230384|NCT03352882|11358929|FG000|COMPLETED|Overall Study||1
10230385|NCT03352882|11358929|FG000|NOT COMPLETED|Overall Study||0
10230386|NCT03348904|11358936|FG000|STARTED|Overall Study||0
10230387|NCT03348904|11358937|FG001|STARTED|Overall Study||2
10230388|NCT03348904|11358938|FG002|STARTED|Overall Study||0
10230389|NCT03348904|11358936|FG000|COMPLETED|Overall Study||0
10013100|NCT01790503|11136122|FG006|STARTED|Overall Study||1
10013101|NCT01790503|11136123|FG007|STARTED|Overall Study||1
10013102|NCT01790503|11136124|FG008|STARTED|Overall Study||3
10013103|NCT01790503|11136125|FG009|STARTED|Overall Study||27
10013104|NCT01790503|11136126|FG010|STARTED|Overall Study||16
10013105|NCT01790503|11136116|FG000|COMPLETED|Overall Study||0
10013106|NCT01790503|11136117|FG001|COMPLETED|Overall Study||0
10013107|NCT01790503|11136118|FG002|COMPLETED|Overall Study||0
10013108|NCT01790503|11136119|FG003|COMPLETED|Overall Study||0
10013109|NCT01790503|11136120|FG004|COMPLETED|Overall Study||0
10013110|NCT01790503|11136121|FG005|COMPLETED|Overall Study||0
10013111|NCT01790503|11136122|FG006|COMPLETED|Overall Study||0
10013112|NCT01790503|11136123|FG007|COMPLETED|Overall Study||0
10013113|NCT01790503|11136124|FG008|COMPLETED|Overall Study||0
10013114|NCT01790503|11136125|FG009|COMPLETED|Overall Study||1
10013115|NCT01790503|11136126|FG010|COMPLETED|Overall Study||0
10013116|NCT01790503|11136116|FG000|NOT COMPLETED|Overall Study||3
10013117|NCT01790503|11136117|FG001|NOT COMPLETED|Overall Study||1
10230390|NCT03348904|11358937|FG001|COMPLETED|Overall Study||1
10230391|NCT03348904|11358938|FG002|COMPLETED|Overall Study||0
10230392|NCT03348904|11358936|FG000|NOT COMPLETED|Overall Study||0
10230393|NCT03348904|11358937|FG001|NOT COMPLETED|Overall Study||1
10230394|NCT03348904|11358938|FG002|NOT COMPLETED|Overall Study||0
10239471|NCT00233090|11371053|FG001|COMPLETED|Overall Study||9
10239472|NCT00233090|11371052|FG000|NOT COMPLETED|Overall Study||0
10239473|NCT00233090|11371053|FG001|NOT COMPLETED|Overall Study||0
10239474|NCT00214149|11371059|FG000|STARTED|Overall Study||127
10239475|NCT00214149|11371059|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
10239476|NCT00214149|11371059|FG000|NOT COMPLETED|Overall Study||127
10239477|NCT00205049|11371065|FG000|STARTED|Overall Study||0
10239478|NCT00205049|11371066|FG001|STARTED|Overall Study||0
10239479|NCT00205049|11371065|FG000|COMPLETED|Overall Study||0
10239480|NCT00205049|11371066|FG001|COMPLETED|Overall Study||0
10239481|NCT00205049|11371065|FG000|NOT COMPLETED|Overall Study||0
10239482|NCT00205049|11371066|FG001|NOT COMPLETED|Overall Study||0
10239483|NCT00209027|11371074|FG000|STARTED|Overall Study||10
10239484|NCT00209027|11371075|FG001|STARTED|Overall Study||10
10239485|NCT00209027|11371074|FG000|COMPLETED|Overall Study||0
10239486|NCT00209027|11371075|FG001|COMPLETED|Overall Study||10
10239487|NCT00209027|11371074|FG000|NOT COMPLETED|Overall Study||10
10239488|NCT00209027|11371075|FG001|NOT COMPLETED|Overall Study||0
10239489|NCT00182637|11371081|FG000|STARTED|Overall Study|active/on treatment date|5
10239490|NCT00182637|11371081|FG000|COMPLETED|Overall Study|off study date|2
10239491|NCT00182637|11371081|FG000|NOT COMPLETED|Overall Study||3
10239492|NCT00176488|11371086|FG000|STARTED|Overall Study||31
10013118|NCT01790503|11136118|FG002|NOT COMPLETED|Overall Study||1
10013119|NCT01790503|11136119|FG003|NOT COMPLETED|Overall Study||2
10013120|NCT01790503|11136120|FG004|NOT COMPLETED|Overall Study||5
10013121|NCT01790503|11136121|FG005|NOT COMPLETED|Overall Study||5
10239493|NCT00176488|11371086|FG000|COMPLETED|Overall Study||30
10239494|NCT00176488|11371086|FG000|NOT COMPLETED|Overall Study||1
10239495|NCT00179127|11371092|FG000|STARTED|Overall Study||0
10239496|NCT00179127|11371093|FG001|STARTED|Overall Study||0
10239497|NCT00179127|11371092|FG000|COMPLETED|Overall Study||0
10239498|NCT00179127|11371093|FG001|COMPLETED|Overall Study||0
10239499|NCT00179127|11371092|FG000|NOT COMPLETED|Overall Study||0
10239500|NCT00179127|11371093|FG001|NOT COMPLETED|Overall Study||0
10239501|NCT00183963|11371103|FG000|STARTED|Overall Study||1
10239502|NCT00183963|11371104|FG001|STARTED|Overall Study||1
10239503|NCT00183963|11371105|FG002|STARTED|Overall Study||1
10239504|NCT00183963|11371106|FG003|STARTED|Overall Study||1
10230395|NCT03345901|11358946|FG000|STARTED|Overall Study||18
10230396|NCT03345901|11358946|FG000|COMPLETED|Overall Study||0
10230397|NCT03345901|11358946|FG000|NOT COMPLETED|Overall Study||18
10230398|NCT03344562|11358953|FG000|STARTED|Overall Study||10
10230399|NCT03344562|11358954|FG001|STARTED|Overall Study||9
10230400|NCT03344562|11358953|FG000|COMPLETED|Overall Study||8
10230401|NCT03344562|11358954|FG001|COMPLETED|Overall Study||9
10230402|NCT03344562|11358953|FG000|NOT COMPLETED|Overall Study||2
10230403|NCT03344562|11358954|FG001|NOT COMPLETED|Overall Study||0
10230404|NCT03342638|11358962|FG000|STARTED|Overall Study||34
10230405|NCT03342638|11358963|FG001|STARTED|Overall Study||32
10230406|NCT03342638|11358962|FG000|COMPLETED|Overall Study||33
10230407|NCT03342638|11358963|FG001|COMPLETED|Overall Study||31
10230408|NCT03342638|11358962|FG000|NOT COMPLETED|Overall Study||1
10230409|NCT03342638|11358963|FG001|NOT COMPLETED|Overall Study||1
10230410|NCT03342157|11358971|FG000|STARTED|Overall Study||1
10230411|NCT03342157|11358972|FG001|STARTED|Overall Study||1
10230412|NCT03342157|11358971|FG000|COMPLETED|Overall Study||1
10230413|NCT03342157|11358972|FG001|COMPLETED|Overall Study||1
10230414|NCT03342157|11358971|FG000|NOT COMPLETED|Overall Study||0
10013122|NCT01790503|11136122|FG006|NOT COMPLETED|Overall Study||1
10013123|NCT01790503|11136123|FG007|NOT COMPLETED|Overall Study||1
10013124|NCT01790503|11136124|FG008|NOT COMPLETED|Overall Study||3
10013125|NCT01790503|11136125|FG009|NOT COMPLETED|Overall Study||26
10013126|NCT01790503|11136126|FG010|NOT COMPLETED|Overall Study||16
10013127|NCT01790516|11136165|FG000|STARTED|Overall Study||1
10013128|NCT01790516|11136166|FG001|STARTED|Overall Study||1
10013129|NCT01790516|11136165|FG000|COMPLETED|Overall Study||0
10013130|NCT01790516|11136166|FG001|COMPLETED|Overall Study||1
10230415|NCT03342157|11358972|FG001|NOT COMPLETED|Overall Study||0
10230416|NCT03339401|11358980|FG000|STARTED|Overall Study||20
10230417|NCT03339401|11358981|FG001|STARTED|Overall Study||9
10230418|NCT03339401|11358980|FG000|COMPLETED|Overall Study||11
10230419|NCT03339401|11358981|FG001|COMPLETED|Overall Study||5
10230420|NCT03339401|11358980|FG000|NOT COMPLETED|Overall Study||9
10230421|NCT03339401|11358981|FG001|NOT COMPLETED|Overall Study||4
10230422|NCT03339245|11358989|FG000|STARTED|Overall Study||6
10230423|NCT03339245|11358990|FG001|STARTED|Overall Study||7
10230424|NCT03339245|11358989|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4
10230425|NCT03339245|11358990|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
10230426|NCT03339245|11358989|FG000|NOT COMPLETED|Overall Study||2
10230427|NCT03339245|11358990|FG001|NOT COMPLETED|Overall Study||1
10230428|NCT03333746|11358996|FG000|STARTED|Overall Study||1
10230429|NCT03333746|11358996|FG000|COMPLETED|Overall Study||0
10230430|NCT03333746|11358996|FG000|NOT COMPLETED|Overall Study||1
10230431|NCT03329404|11359002|FG000|STARTED|Overall Study||4
10230432|NCT03329404|11359003|FG001|STARTED|Overall Study||5
10230433|NCT03329404|11359002|FG000|COMPLETED|Overall Study||3
10230434|NCT03329404|11359003|FG001|COMPLETED|Overall Study||1
10230435|NCT03329404|11359002|FG000|NOT COMPLETED|Overall Study||1
10230436|NCT03329404|11359003|FG001|NOT COMPLETED|Overall Study||4
10230437|NCT03326869|11359011|FG000|STARTED|Overall Study||1
10230438|NCT03326869|11359012|FG001|STARTED|Overall Study||1
10230439|NCT03326869|11359011|FG000|COMPLETED|Overall Study||0
10230440|NCT03326869|11359012|FG001|COMPLETED|Overall Study||0
10230441|NCT03326869|11359011|FG000|NOT COMPLETED|Overall Study||1
10230442|NCT03326869|11359012|FG001|NOT COMPLETED|Overall Study||1
10230443|NCT03325114|11359018|FG000|STARTED|Overall Study||1
10230444|NCT03325114|11359018|FG000|COMPLETED|Overall Study||0
10230445|NCT03325114|11359018|FG000|NOT COMPLETED|Overall Study||1
10230446|NCT03319407|11359022|FG000|STARTED|Overall Study||21
10230447|NCT03319407|11359022|FG000|COMPLETED|Overall Study||0
10230448|NCT03319407|11359022|FG000|NOT COMPLETED|Overall Study||21
10230449|NCT03316105|11359028|FG000|STARTED|Overall Study||9
10230450|NCT03316105|11359029|FG001|STARTED|Overall Study||7
10230451|NCT03316105|11359028|FG000|COMPLETED|Overall Study||9
10230452|NCT03316105|11359029|FG001|COMPLETED|Overall Study||7
10230453|NCT03316105|11359028|FG000|NOT COMPLETED|Overall Study||0
10230454|NCT03316105|11359029|FG001|NOT COMPLETED|Overall Study||0
10230455|NCT03305055|11359037|FG000|STARTED|Overall Study||2
10230456|NCT03305055|11359038|FG001|STARTED|Overall Study||2
10230457|NCT03305055|11359037|FG000|COMPLETED|Overall Study||1
10230458|NCT03305055|11359038|FG001|COMPLETED|Overall Study||0
10230459|NCT03305055|11359037|FG000|NOT COMPLETED|Overall Study||1
10230460|NCT03305055|11359038|FG001|NOT COMPLETED|Overall Study||2
10013131|NCT01790516|11136165|FG000|NOT COMPLETED|Overall Study||1
10230461|NCT03303469|11359044|FG000|STARTED|Overall Study||3
10230462|NCT03303469|11359044|FG000|COMPLETED|Overall Study||1
10230463|NCT03303469|11359044|FG000|NOT COMPLETED|Overall Study||2
10230464|NCT03302247|11359048|FG000|STARTED|Overall Study||3
10230465|NCT03302247|11359048|FG000|COMPLETED|Overall Study||0
10230466|NCT03302247|11359048|FG000|NOT COMPLETED|Overall Study||3
10230467|NCT03300024|11359054|FG000|STARTED|Overall Study||4
10230468|NCT03300024|11359055|FG001|STARTED|Overall Study||6
10013132|NCT01790516|11136166|FG001|NOT COMPLETED|Overall Study||0
10013133|NCT01790568|11136172|FG000|STARTED|Overall Study||12
10230469|NCT03300024|11359054|FG000|COMPLETED|Overall Study||0
10230470|NCT03300024|11359055|FG001|COMPLETED|Overall Study||0
10230471|NCT03300024|11359054|FG000|NOT COMPLETED|Overall Study||4
10230472|NCT03300024|11359055|FG001|NOT COMPLETED|Overall Study||6
10230473|NCT03283709|11359065|FG000|STARTED|Overall Study||0
10230474|NCT03283709|11359066|FG001|STARTED|Overall Study||1
10230475|NCT03283709|11359065|FG000|COMPLETED|Overall Study||0
10230476|NCT03283709|11359066|FG001|COMPLETED|Overall Study||0
10230477|NCT03283709|11359065|FG000|NOT COMPLETED|Overall Study||0
10230478|NCT03283709|11359066|FG001|NOT COMPLETED|Overall Study||1
10230479|NCT03277183|11359074|FG000|STARTED|Overall Study||3
10230480|NCT03277183|11359075|FG001|STARTED|Overall Study||2
10230481|NCT03277183|11359074|FG000|COMPLETED|Overall Study||0
10230482|NCT03277183|11359075|FG001|COMPLETED|Overall Study||0
10230483|NCT03277183|11359074|FG000|NOT COMPLETED|Overall Study||3
10230484|NCT03277183|11359075|FG001|NOT COMPLETED|Overall Study||2
10230485|NCT03269968|11359083|FG000|STARTED|Overall Study||0
10230486|NCT03269968|11359084|FG001|STARTED|Overall Study||0
10230487|NCT03269968|11359083|FG000|COMPLETED|Overall Study||0
10230488|NCT03269968|11359084|FG001|COMPLETED|Overall Study||0
10230489|NCT03269968|11359083|FG000|NOT COMPLETED|Overall Study||0
10230490|NCT03269968|11359084|FG001|NOT COMPLETED|Overall Study||0
10230491|NCT03248141|11359092|FG000|STARTED|Overall Study||11
10230492|NCT03248141|11359093|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
10230493|NCT03248141|11359092|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
10230494|NCT03248141|11359093|FG001|COMPLETED|Overall Study||0
10230495|NCT03248141|11359092|FG000|NOT COMPLETED|Overall Study||0
10230496|NCT03248141|11359093|FG001|NOT COMPLETED|Overall Study||0
10230497|NCT03263806|11359101|FG000|STARTED|Overall Study||6
10230498|NCT03263806|11359102|FG001|STARTED|Overall Study||7
10230499|NCT03263806|11359101|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
10230500|NCT03263806|11359102|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
10230501|NCT03263806|11359101|FG000|NOT COMPLETED|Overall Study||6
10230502|NCT03263806|11359102|FG001|NOT COMPLETED|Overall Study||7
10230503|NCT03261531|11359108|FG000|STARTED|Overall Study||7
10230504|NCT03261531|11359108|FG000|COMPLETED|Overall Study||3
10230505|NCT03261531|11359108|FG000|NOT COMPLETED|Overall Study||4
10230506|NCT03219372|11359114|FG000|STARTED|Overall Study||1
10230507|NCT03219372|11359115|FG001|STARTED|Overall Study||0
10230508|NCT03219372|11359114|FG000|COMPLETED|Overall Study||0
10230509|NCT03219372|11359115|FG001|COMPLETED|Overall Study||0
10230510|NCT03219372|11359114|FG000|NOT COMPLETED|Overall Study||1
10230511|NCT03219372|11359115|FG001|NOT COMPLETED|Overall Study||0
10230512|NCT03217175|11359121|FG000|STARTED|Overall Study||4
10230513|NCT03217175|11359122|FG001|STARTED|Overall Study||1
10230514|NCT03217175|11359121|FG000|COMPLETED|Overall Study||0
10230515|NCT03217175|11359122|FG001|COMPLETED|Overall Study||0
10230516|NCT03217175|11359121|FG000|NOT COMPLETED|Overall Study||4
10230517|NCT03217175|11359122|FG001|NOT COMPLETED|Overall Study||1
10230518|NCT03231397|11359132|FG000|STARTED|Overall Study||0
10230519|NCT03231397|11359133|FG001|STARTED|Overall Study||1
10230520|NCT03231397|11359134|FG002|STARTED|Overall Study||1
10230521|NCT03231397|11359135|FG003|STARTED|Overall Study||0
10230522|NCT03231397|11359132|FG000|COMPLETED|Overall Study||0
10230523|NCT03231397|11359133|FG001|COMPLETED|Overall Study||1
10230524|NCT03231397|11359134|FG002|COMPLETED|Overall Study||1
10230525|NCT03231397|11359135|FG003|COMPLETED|Overall Study||0
10230526|NCT03231397|11359132|FG000|NOT COMPLETED|Overall Study||0
10230527|NCT03231397|11359133|FG001|NOT COMPLETED|Overall Study||0
10230528|NCT03231397|11359134|FG002|NOT COMPLETED|Overall Study||0
9952130|NCT01420016|11071023|FG001|STARTED|Safety Analysis||0
9952131|NCT01420016|11071024|FG002|STARTED|Safety Analysis||6392
9952132|NCT01420016|11071025|FG003|STARTED|Safety Analysis||5159
9952133|NCT01420016|11071022|FG000|COMPLETED|Safety Analysis||0
9952134|NCT01420016|11071023|FG001|COMPLETED|Safety Analysis||0
9952135|NCT01420016|11071024|FG002|COMPLETED|Safety Analysis||6392
9952136|NCT01420016|11071025|FG003|COMPLETED|Safety Analysis||5159
9952137|NCT01420016|11071022|FG000|NOT COMPLETED|Safety Analysis||0
9952138|NCT01420016|11071023|FG001|NOT COMPLETED|Safety Analysis||0
9952139|NCT01420016|11071024|FG002|NOT COMPLETED|Safety Analysis||0
9952140|NCT01420016|11071025|FG003|NOT COMPLETED|Safety Analysis||0
9952141|NCT01420068|11071033|FG000|STARTED|Overall Study||51
9952142|NCT01420068|11071034|FG001|STARTED|Overall Study||55
9952143|NCT01420068|11071033|FG000|COMPLETED|Overall Study||49
9952144|NCT01420068|11071034|FG001|COMPLETED|Overall Study||50
9952145|NCT01420068|11071033|FG000|NOT COMPLETED|Overall Study||2
9952146|NCT01420068|11071034|FG001|NOT COMPLETED|Overall Study||5
9952147|NCT01420081|11071049|FG000|STARTED|Overall Study||3
10230529|NCT03231397|11359135|FG003|NOT COMPLETED|Overall Study||0
10230530|NCT03232892|11359145|FG000|STARTED|Overall Study||1
10230531|NCT03232892|11359145|FG000|COMPLETED|Overall Study||1
9952148|NCT01420081|11071050|FG001|STARTED|Overall Study||1
9952149|NCT01420081|11071051|FG002|STARTED|Overall Study||11
9952150|NCT01420081|11071052|FG003|STARTED|Overall Study||3
9952151|NCT01420081|11071053|FG004|STARTED|Overall Study||20
9952152|NCT01420081|11071054|FG005|STARTED|Overall Study||20
10230532|NCT03232892|11359145|FG000|NOT COMPLETED|Overall Study||0
10230533|NCT03223662|11359149|FG000|STARTED|Overall Study||2
10230534|NCT03223662|11359149|FG000|COMPLETED|Overall Study||0
10230535|NCT03223662|11359149|FG000|NOT COMPLETED|Overall Study||2
10230536|NCT03212144|11359155|FG000|STARTED|First Sequence (4 Weeks)||2
10013134|NCT01790568|11136173|FG001|STARTED|Overall Study||26
10013135|NCT01790568|11136172|FG000|COMPLETED|Overall Study||12
10013136|NCT01790568|11136173|FG001|COMPLETED|Overall Study||25
10013137|NCT01790568|11136172|FG000|NOT COMPLETED|Overall Study||0
10013138|NCT01790568|11136173|FG001|NOT COMPLETED|Overall Study||1
10013139|NCT01790581|11136179|FG000|STARTED|Overall Study||12
10013140|NCT01790581|11136180|FG001|STARTED|Overall Study||12
10013141|NCT01790581|11136179|FG000|COMPLETED|Overall Study||12
10013142|NCT01790581|11136180|FG001|COMPLETED|Overall Study||12
10013143|NCT01790581|11136179|FG000|NOT COMPLETED|Overall Study||0
10013144|NCT01790581|11136180|FG001|NOT COMPLETED|Overall Study||0
10013145|NCT01790594|11136188|FG000|STARTED|Overall Study||22
10013146|NCT01790594|11136189|FG001|STARTED|Overall Study||21
10013147|NCT01790594|11136190|FG002|STARTED|Overall Study||3
10230537|NCT03212144|11359156|FG001|STARTED|First Sequence (4 Weeks)||1
10230538|NCT03212144|11359155|FG000|COMPLETED|First Sequence (4 Weeks)||1
10230539|NCT03212144|11359156|FG001|COMPLETED|First Sequence (4 Weeks)||1
10230540|NCT03212144|11359155|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1
10230541|NCT03212144|11359156|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0
10230542|NCT03212144|11359155|FG000|STARTED|Washout (4 Weeks)||1
10230543|NCT03212144|11359156|FG001|STARTED|Washout (4 Weeks)||1
10230544|NCT03212144|11359155|FG000|COMPLETED|Washout (4 Weeks)||1
10230545|NCT03212144|11359156|FG001|COMPLETED|Washout (4 Weeks)||1
10230546|NCT03212144|11359155|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9952153|NCT01420081|11071055|FG006|STARTED|Overall Study||3
9952154|NCT01420081|11071056|FG007|STARTED|Overall Study||3
9952155|NCT01420081|11071057|FG008|STARTED|Overall Study||3
9952156|NCT01420081|11071049|FG000|COMPLETED|Overall Study||0
9952157|NCT01420081|11071050|FG001|COMPLETED|Overall Study||0
9952158|NCT01420081|11071051|FG002|COMPLETED|Overall Study||0
9952159|NCT01420081|11071052|FG003|COMPLETED|Overall Study||0
9952160|NCT01420081|11071053|FG004|COMPLETED|Overall Study||0
9952161|NCT01420081|11071054|FG005|COMPLETED|Overall Study||0
9952162|NCT01420081|11071055|FG006|COMPLETED|Overall Study||0
9952163|NCT01420081|11071056|FG007|COMPLETED|Overall Study||0
10013148|NCT01790594|11136188|FG000|COMPLETED|Overall Study||17
10230547|NCT03212144|11359156|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10230548|NCT03212144|11359155|FG000|STARTED|Second Sequence (4 Weeks)||1
10230549|NCT03212144|11359156|FG001|STARTED|Second Sequence (4 Weeks)||1
10230550|NCT03212144|11359155|FG000|COMPLETED|Second Sequence (4 Weeks)||0
10230551|NCT03212144|11359156|FG001|COMPLETED|Second Sequence (4 Weeks)||0
10230552|NCT03212144|11359155|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1
10230553|NCT03212144|11359156|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1
10230554|NCT03218163|11359162|FG000|STARTED|Overall Study||0
10230555|NCT03218163|11359162|FG000|COMPLETED|Overall Study||0
10230556|NCT03218163|11359162|FG000|NOT COMPLETED|Overall Study||0
10230557|NCT03172520|11359166|FG000|STARTED|Overall Study||10
10230558|NCT03172520|11359166|FG000|COMPLETED|Overall Study||0
10230559|NCT03172520|11359166|FG000|NOT COMPLETED|Overall Study||10
10230560|NCT03204539|11359172|FG000|STARTED|Overall Study||0
10230561|NCT03204539|11359173|FG001|STARTED|Overall Study||1
10230562|NCT03204539|11359172|FG000|COMPLETED|Overall Study||0
10230563|NCT03204539|11359173|FG001|COMPLETED|Overall Study||0
10230564|NCT03204539|11359172|FG000|NOT COMPLETED|Overall Study||0
10230565|NCT03204539|11359173|FG001|NOT COMPLETED|Overall Study||1
10230566|NCT03206216|11359181|FG000|STARTED|Overall Study||0
10230567|NCT03206216|11359182|FG001|STARTED|Overall Study||1
10230568|NCT03206216|11359181|FG000|COMPLETED|Overall Study||0
10230569|NCT03206216|11359182|FG001|COMPLETED|Overall Study||0
10230570|NCT03206216|11359181|FG000|NOT COMPLETED|Overall Study||0
10230571|NCT03206216|11359182|FG001|NOT COMPLETED|Overall Study||1
10230572|NCT03195660|11359188|FG000|STARTED|Overall Study||2
10230573|NCT03195660|11359188|FG000|COMPLETED|Overall Study||0
10230574|NCT03195660|11359188|FG000|NOT COMPLETED|Overall Study||2
10230575|NCT03195465|11359192|FG000|STARTED|Overall Study||0
10230576|NCT03195465|11359192|FG000|COMPLETED|Overall Study||0
10230577|NCT03195465|11359192|FG000|NOT COMPLETED|Overall Study||0
10230578|NCT03166618|11359198|FG000|STARTED|Overall Study||0
10230579|NCT03166618|11359199|FG001|STARTED|Overall Study||1
10230580|NCT03166618|11359198|FG000|COMPLETED|Overall Study||0
10230581|NCT03166618|11359199|FG001|COMPLETED|Overall Study||0
10230582|NCT03166618|11359198|FG000|NOT COMPLETED|Overall Study||0
10230583|NCT03166618|11359199|FG001|NOT COMPLETED|Overall Study||1
10013149|NCT01790594|11136189|FG001|COMPLETED|Overall Study||18
10013150|NCT01790594|11136190|FG002|COMPLETED|Overall Study||0
10013151|NCT01790594|11136188|FG000|NOT COMPLETED|Overall Study||5
10013152|NCT01790594|11136189|FG001|NOT COMPLETED|Overall Study||3
10013153|NCT01790594|11136190|FG002|NOT COMPLETED|Overall Study||3
10013154|NCT01790633|11136199|FG000|STARTED|Overall Study||163
9952164|NCT01420081|11071057|FG008|COMPLETED|Overall Study||0
10013155|NCT01790633|11136200|FG001|STARTED|Overall Study||164
10013156|NCT01790633|11136199|FG000|COMPLETED|Overall Study||115
10013157|NCT01790633|11136200|FG001|COMPLETED|Overall Study||159
10013158|NCT01790633|11136199|FG000|NOT COMPLETED|Overall Study||48
10230584|NCT03169530|11359207|FG000|STARTED|Overall Study||15
10230585|NCT03169530|11359208|FG001|STARTED|Overall Study||17
10230586|NCT03169530|11359207|FG000|COMPLETED|Overall Study||0
10230587|NCT03169530|11359208|FG001|COMPLETED|Overall Study||0
10230588|NCT03169530|11359207|FG000|NOT COMPLETED|Overall Study||15
9952165|NCT01420081|11071049|FG000|NOT COMPLETED|Overall Study||3
10013159|NCT01790633|11136200|FG001|NOT COMPLETED|Overall Study||5
10013160|NCT01790659|11136209|FG000|STARTED|Overall Study||201
10230589|NCT03169530|11359208|FG001|NOT COMPLETED|Overall Study||17
10230590|NCT03189433|11359216|FG000|STARTED|Overall Study||2
10230591|NCT03189433|11359217|FG001|STARTED|Overall Study||0
10230592|NCT03189433|11359216|FG000|COMPLETED|Overall Study||0
10230593|NCT03189433|11359217|FG001|COMPLETED|Overall Study||0
10230594|NCT03189433|11359216|FG000|NOT COMPLETED|Overall Study||2
10230595|NCT03189433|11359217|FG001|NOT COMPLETED|Overall Study||0
10230596|NCT03151226|11359223|FG000|STARTED|Overall Study||3
10230597|NCT03151226|11359223|FG000|COMPLETED|Overall Study||0
10230598|NCT03151226|11359223|FG000|NOT COMPLETED|Overall Study||3
10230599|NCT03165747|11359229|FG000|STARTED|Overall Study||0
10230600|NCT03165747|11359230|FG001|STARTED|Overall Study||0
10230601|NCT03165747|11359229|FG000|COMPLETED|Overall Study||0
10230602|NCT03165747|11359230|FG001|COMPLETED|Overall Study||0
10230603|NCT03165747|11359229|FG000|NOT COMPLETED|Overall Study||0
10230604|NCT03165747|11359230|FG001|NOT COMPLETED|Overall Study||0
10230605|NCT03168906|11359238|FG000|STARTED|Overall Study||6
10230606|NCT03168906|11359239|FG001|STARTED|Overall Study||6
10230607|NCT03168906|11359238|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
10230608|NCT03168906|11359239|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
10230609|NCT03168906|11359238|FG000|NOT COMPLETED|Overall Study||6
10230610|NCT03168906|11359239|FG001|NOT COMPLETED|Overall Study||6
10230611|NCT03178201|11359246|FG000|STARTED|Overall Study||5
10230612|NCT03178201|11359246|FG000|COMPLETED|Overall Study||0
10230613|NCT03178201|11359246|FG000|NOT COMPLETED|Overall Study||5
10230614|NCT03172026|11359252|FG000|STARTED|Overall Study||2
10230615|NCT03172026|11359253|FG001|STARTED|Overall Study||0
10230616|NCT03172026|11359252|FG000|8 Week Assessment|Overall Study||0
10230617|NCT03172026|11359253|FG001|8 Week Assessment|Overall Study||0
10230618|NCT03172026|11359252|FG000|6 Month Assessment|Overall Study||0
10230619|NCT03172026|11359253|FG001|6 Month Assessment|Overall Study||0
10230620|NCT03172026|11359252|FG000|COMPLETED|Overall Study||0
10230621|NCT03172026|11359253|FG001|COMPLETED|Overall Study||0
10230622|NCT03172026|11359252|FG000|NOT COMPLETED|Overall Study||2
10230623|NCT03172026|11359253|FG001|NOT COMPLETED|Overall Study||0
10230624|NCT03152526|11359262|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0
10230625|NCT03152526|11359263|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1
10230626|NCT03152526|11359262|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
10230627|NCT03152526|11359263|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
10230628|NCT03152526|11359262|FG000|NOT COMPLETED|Overall Study||0
10230629|NCT03152526|11359263|FG001|NOT COMPLETED|Overall Study||1
10230630|NCT03161964|11359271|FG000|STARTED|Overall Study||1
10230631|NCT03161964|11359272|FG001|STARTED|Overall Study||1
10230632|NCT03161964|11359271|FG000|COMPLETED|Overall Study||1
10230633|NCT03161964|11359272|FG001|COMPLETED|Overall Study||0
10230634|NCT03161964|11359271|FG000|NOT COMPLETED|Overall Study||0
10230635|NCT03161964|11359272|FG001|NOT COMPLETED|Overall Study||1
10230636|NCT03150160|11359280|FG000|STARTED|Overall Study||0
10230637|NCT03150160|11359281|FG001|STARTED|Overall Study||1
10230638|NCT03150160|11359280|FG000|COMPLETED|Overall Study||0
10230639|NCT03150160|11359281|FG001|COMPLETED|Overall Study||1
10230640|NCT03150160|11359280|FG000|NOT COMPLETED|Overall Study||0
10230641|NCT03150160|11359281|FG001|NOT COMPLETED|Overall Study||0
10230642|NCT03137225|11359289|FG000|STARTED|First 4 Hour Measurement Period||1
10230643|NCT03137225|11359290|FG001|STARTED|First 4 Hour Measurement Period||0
10230644|NCT03137225|11359289|FG000|COMPLETED|First 4 Hour Measurement Period||1
10230645|NCT03137225|11359290|FG001|COMPLETED|First 4 Hour Measurement Period||0
10230646|NCT03137225|11359289|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0
10230647|NCT03137225|11359290|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0
10230648|NCT03137225|11359289|FG000|STARTED|Second 4 Hour Measurement Period||1
10230649|NCT03137225|11359290|FG001|STARTED|Second 4 Hour Measurement Period||0
10230650|NCT03137225|11359289|FG000|COMPLETED|Second 4 Hour Measurement Period||1
10230651|NCT03137225|11359290|FG001|COMPLETED|Second 4 Hour Measurement Period||0
10230652|NCT03137225|11359289|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0
10230653|NCT03137225|11359290|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0
10230654|NCT03123393|11359298|FG000|STARTED|Overall Study||24
10230655|NCT03123393|11359299|FG001|STARTED|Overall Study||25
10230656|NCT03123393|11359298|FG000|COMPLETED|Overall Study||3
10230657|NCT03123393|11359299|FG001|COMPLETED|Overall Study||2
10013161|NCT01790659|11136210|FG001|STARTED|Overall Study||198
10013162|NCT01790659|11136209|FG000|COMPLETED|Overall Study||195
10013163|NCT01790659|11136210|FG001|COMPLETED|Overall Study||192
10013164|NCT01790659|11136209|FG000|NOT COMPLETED|Overall Study||6
10013165|NCT01790659|11136210|FG001|NOT COMPLETED|Overall Study||6
10230658|NCT03123393|11359298|FG000|NOT COMPLETED|Overall Study||21
10230659|NCT03123393|11359299|FG001|NOT COMPLETED|Overall Study||23
10230660|NCT03123328|11359305|FG000|STARTED|Overall Study||380
10230661|NCT03123328|11359305|FG000|COMPLETED|Overall Study||351
10230662|NCT03123328|11359305|FG000|NOT COMPLETED|Overall Study||29
10230663|NCT03119662|11359311|FG000|STARTED|Overall Study||2
10230664|NCT03119662|11359312|FG001|STARTED|Overall Study||2
10013166|NCT01790685|11136218|FG000|STARTED|Overall Study||23
10013167|NCT01790685|11136219|FG001|STARTED|Overall Study||17
10013168|NCT01790685|11136218|FG000|COMPLETED|Overall Study||23
10230665|NCT03119662|11359311|FG000|COMPLETED|Overall Study||2
10230666|NCT03119662|11359312|FG001|COMPLETED|Overall Study||1
10230667|NCT03119662|11359311|FG000|NOT COMPLETED|Overall Study||0
10230668|NCT03119662|11359312|FG001|NOT COMPLETED|Overall Study||1
10230669|NCT03109418|11359320|FG000|STARTED|Overall Study||2
10230670|NCT03109418|11359321|FG001|STARTED|Overall Study||4
10230671|NCT03109418|11359320|FG000|COMPLETED|Overall Study||2
10230672|NCT03109418|11359321|FG001|COMPLETED|Overall Study||3
10230673|NCT03109418|11359320|FG000|NOT COMPLETED|Overall Study||0
10230674|NCT03109418|11359321|FG001|NOT COMPLETED|Overall Study||1
10230675|NCT03120676|11359327|FG000|STARTED|Overall Study||3
10230676|NCT03120676|11359327|FG000|COMPLETED|Overall Study||2
10230677|NCT03120676|11359327|FG000|NOT COMPLETED|Overall Study||1
10230678|NCT03109873|11359333|FG000|STARTED|Overall Study||5
10230679|NCT03109873|11359334|FG001|STARTED|Overall Study||4
10230680|NCT03109873|11359333|FG000|COMPLETED|Overall Study||5
10230681|NCT03109873|11359334|FG001|COMPLETED|Overall Study||4
10230682|NCT03109873|11359333|FG000|NOT COMPLETED|Overall Study||0
10230683|NCT03109873|11359334|FG001|NOT COMPLETED|Overall Study||0
10230684|NCT03100617|11359340|FG000|STARTED|Overall Study||6
10230685|NCT03100617|11359340|FG000|COMPLETED|Overall Study||6
10230686|NCT03100617|11359340|FG000|NOT COMPLETED|Overall Study||0
10230687|NCT03115853|11359344|FG000|STARTED|Overall Study||31
10230688|NCT03115853|11359344|FG000|COMPLETED|Overall Study||31
10230689|NCT03115853|11359344|FG000|NOT COMPLETED|Overall Study||0
10230690|NCT03113071|11359352|FG000|STARTED|Overall Study||1
10230691|NCT03113071|11359353|FG001|STARTED|Overall Study||0
10230692|NCT03113071|11359352|FG000|COMPLETED|Overall Study||0
10230693|NCT03113071|11359353|FG001|COMPLETED|Overall Study||0
10230694|NCT03113071|11359352|FG000|NOT COMPLETED|Overall Study||1
10230695|NCT03113071|11359353|FG001|NOT COMPLETED|Overall Study||0
10230696|NCT03110900|11359361|FG000|STARTED|Overall Study||1
10230697|NCT03110900|11359362|FG001|STARTED|Overall Study||1
10230698|NCT03110900|11359361|FG000|COMPLETED|Overall Study||0
10230699|NCT03110900|11359362|FG001|COMPLETED|Overall Study||0
10230700|NCT03110900|11359361|FG000|NOT COMPLETED|Overall Study||1
10230701|NCT03110900|11359362|FG001|NOT COMPLETED|Overall Study||1
10230702|NCT03078868|11359368|FG000|STARTED|Overall Study||3
10230703|NCT03078868|11359368|FG000|COMPLETED|Overall Study||0
10230704|NCT03078868|11359368|FG000|NOT COMPLETED|Overall Study||3
10230705|NCT03078270|11359374|FG000|STARTED|Overall Study||4
10230706|NCT03078270|11359375|FG001|STARTED|Overall Study||0
10230707|NCT03078270|11359374|FG000|COMPLETED|Overall Study||0
10230708|NCT03078270|11359375|FG001|COMPLETED|Overall Study||0
10230709|NCT03078270|11359374|FG000|NOT COMPLETED|Overall Study||4
10230710|NCT03078270|11359375|FG001|NOT COMPLETED|Overall Study||0
10230711|NCT03065933|11359381|FG000|STARTED|Overall Study||5
10230712|NCT03065933|11359381|FG000|COMPLETED|Overall Study||0
10230713|NCT03065933|11359381|FG000|NOT COMPLETED|Overall Study||5
10230714|NCT03070002|11359385|FG000|STARTED|3 Cycles of Treatment||1
10230715|NCT03070002|11359385|FG000|COMPLETED|3 Cycles of Treatment||1
10230716|NCT03070002|11359385|FG000|NOT COMPLETED|3 Cycles of Treatment||0
10230717|NCT03070002|11359385|FG000|STARTED|Follow up for 2 Years||1
10230718|NCT03070002|11359385|FG000|COMPLETED|Follow up for 2 Years||0
10230719|NCT03070002|11359385|FG000|NOT COMPLETED|Follow up for 2 Years||1
10230720|NCT03058705|11359389|FG000|STARTED|Overall Study||10
10230721|NCT03058705|11359389|FG000|COMPLETED|Overall Study||6
10230722|NCT03058705|11359389|FG000|NOT COMPLETED|Overall Study||4
10230723|NCT03061279|11359395|FG000|STARTED|Overall Study||0
10230724|NCT03061279|11359396|FG001|STARTED|Overall Study||1
10230725|NCT03061279|11359395|FG000|COMPLETED|Overall Study||0
10230726|NCT03061279|11359396|FG001|COMPLETED|Overall Study||0
10230727|NCT03061279|11359395|FG000|NOT COMPLETED|Overall Study||0
10230728|NCT03061279|11359396|FG001|NOT COMPLETED|Overall Study||1
10230729|NCT03040323|11359404|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
10230730|NCT03040323|11359405|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
10230731|NCT03040323|11359404|FG000|COMPLETED|Overall Study||0
10230732|NCT03040323|11359405|FG001|COMPLETED|Overall Study||0
10230733|NCT03040323|11359404|FG000|NOT COMPLETED|Overall Study||0
10230734|NCT03040323|11359405|FG001|NOT COMPLETED|Overall Study||0
10230735|NCT03053518|11359411|FG000|STARTED|Overall Study||22
10230736|NCT03053518|11359411|FG000|COMPLETED|Overall Study||12
10230737|NCT03053518|11359411|FG000|NOT COMPLETED|Overall Study||10
10230738|NCT03050398|11359415|FG000|STARTED|Overall Study||8
10230739|NCT03050398|11359415|FG000|COMPLETED|Overall Study||0
10230740|NCT03050398|11359415|FG000|NOT COMPLETED|Overall Study||8
10230741|NCT03042780|11359419|FG000|STARTED|Overall Study||2
10230742|NCT03042780|11359419|FG000|COMPLETED|Overall Study||2
10230743|NCT03042780|11359419|FG000|NOT COMPLETED|Overall Study||0
10230744|NCT03053960|11359423|FG000|STARTED|Overall Study||8
10230745|NCT03053960|11359423|FG000|COMPLETED|Overall Study||8
10230746|NCT03053960|11359423|FG000|NOT COMPLETED|Overall Study||0
10230747|NCT03036735|11359427|FG000|STARTED|Overall Study||10
10230748|NCT03036735|11359427|FG000|COMPLETED|Overall Study||0
10230749|NCT03036735|11359427|FG000|NOT COMPLETED|Overall Study||10
10230750|NCT03029832|11359433|FG000|STARTED|Overall Study||4
10230751|NCT03029832|11359434|FG001|STARTED|Overall Study||1
10230752|NCT03029832|11359433|FG000|COMPLETED|Overall Study||0
10230753|NCT03029832|11359434|FG001|COMPLETED|Overall Study||0
10230754|NCT03029832|11359433|FG000|NOT COMPLETED|Overall Study||4
10230755|NCT03029832|11359434|FG001|NOT COMPLETED|Overall Study||1
10230756|NCT03020446|11359440|FG000|STARTED|Overall Study||3
10230757|NCT03020446|11359440|FG000|COMPLETED|Overall Study||0
10230758|NCT03020446|11359440|FG000|NOT COMPLETED|Overall Study||3
10230759|NCT03031340|11359446|FG000|STARTED|Overall Study||2
10230760|NCT03031340|11359447|FG001|STARTED|Overall Study||1
10230761|NCT03031340|11359446|FG000|COMPLETED|Overall Study||0
10230762|NCT03031340|11359447|FG001|COMPLETED|Overall Study||0
10230763|NCT03031340|11359446|FG000|NOT COMPLETED|Overall Study||2
10230764|NCT03031340|11359447|FG001|NOT COMPLETED|Overall Study||1
10230765|NCT03017040|11359453|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
10230766|NCT03017040|11359454|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
10230767|NCT03017040|11359453|FG000|COMPLETED|Overall Study||0
10230768|NCT03017040|11359454|FG001|COMPLETED|Overall Study||0
10230769|NCT03017040|11359453|FG000|NOT COMPLETED|Overall Study||1
10230770|NCT03017040|11359454|FG001|NOT COMPLETED|Overall Study||1
10230771|NCT03007719|11359462|FG000|STARTED|Overall Study||0
10230772|NCT03007719|11359463|FG001|STARTED|Overall Study||4
10230773|NCT03007719|11359462|FG000|COMPLETED|Overall Study||0
10230774|NCT03007719|11359463|FG001|COMPLETED|Overall Study||4
10230775|NCT03007719|11359462|FG000|NOT COMPLETED|Overall Study||0
10230776|NCT03007719|11359463|FG001|NOT COMPLETED|Overall Study||0
10230777|NCT03010423|11359469|FG000|STARTED|Overall Study||8
10230778|NCT03010423|11359469|FG000|COMPLETED|Overall Study||0
10230779|NCT03010423|11359469|FG000|NOT COMPLETED|Overall Study||8
10230780|NCT02985801|11359475|FG000|STARTED|Overall Study||8
10230781|NCT02985801|11359476|FG001|STARTED|Overall Study||8
10230782|NCT02985801|11359475|FG000|COMPLETED|Overall Study||8
10230783|NCT02985801|11359476|FG001|COMPLETED|Overall Study||8
10230784|NCT02985801|11359475|FG000|NOT COMPLETED|Overall Study||0
10230785|NCT02985801|11359476|FG001|NOT COMPLETED|Overall Study||0
10230786|NCT02991430|11359485|FG000|STARTED|Treatment Period 1||14
10230787|NCT02991430|11359486|FG001|STARTED|Treatment Period 1||15
10230788|NCT02991430|11359487|FG002|STARTED|Treatment Period 1||16
10230789|NCT02991430|11359485|FG000|COMPLETED|Treatment Period 1||13
10230790|NCT02991430|11359486|FG001|COMPLETED|Treatment Period 1||11
10230791|NCT02991430|11359487|FG002|COMPLETED|Treatment Period 1||14
10230792|NCT02991430|11359485|FG000|NOT COMPLETED|Treatment Period 1||1
10230793|NCT02991430|11359486|FG001|NOT COMPLETED|Treatment Period 1||4
10230794|NCT02991430|11359487|FG002|NOT COMPLETED|Treatment Period 1||2
10230795|NCT02991430|11359485|FG000|STARTED|Treatment Period 2||13
10230796|NCT02991430|11359486|FG001|STARTED|Treatment Period 2||11
10230797|NCT02991430|11359487|FG002|STARTED|Treatment Period 2||14
10230798|NCT02991430|11359485|FG000|COMPLETED|Treatment Period 2||7
10013169|NCT01790685|11136219|FG001|COMPLETED|Overall Study||17
10013170|NCT01790685|11136218|FG000|NOT COMPLETED|Overall Study||0
10013171|NCT01790685|11136219|FG001|NOT COMPLETED|Overall Study||0
10013172|NCT01790750|11136225|FG000|STARTED|Overall Study||50
10013173|NCT01790750|11136225|FG000|COMPLETED|Overall Study||50
10230799|NCT02991430|11359486|FG001|COMPLETED|Treatment Period 2||8
10230800|NCT02991430|11359487|FG002|COMPLETED|Treatment Period 2||10
10230801|NCT02991430|11359485|FG000|NOT COMPLETED|Treatment Period 2||6
10230802|NCT02991430|11359486|FG001|NOT COMPLETED|Treatment Period 2||3
10230803|NCT02991430|11359487|FG002|NOT COMPLETED|Treatment Period 2||4
10230804|NCT02991430|11359485|FG000|STARTED|Post-treatment Observation Period||7
10230805|NCT02991430|11359486|FG001|STARTED|Post-treatment Observation Period||8
10230806|NCT02991430|11359487|FG002|STARTED|Post-treatment Observation Period||10
10230807|NCT02991430|11359485|FG000|COMPLETED|Post-treatment Observation Period||4
10230808|NCT02991430|11359486|FG001|COMPLETED|Post-treatment Observation Period||2
10230809|NCT02991430|11359487|FG002|COMPLETED|Post-treatment Observation Period||5
10230810|NCT02991430|11359485|FG000|NOT COMPLETED|Post-treatment Observation Period||3
10230811|NCT02991430|11359486|FG001|NOT COMPLETED|Post-treatment Observation Period||6
10230812|NCT02991430|11359487|FG002|NOT COMPLETED|Post-treatment Observation Period||5
10230813|NCT02995967|11359497|FG000|STARTED|Overall Study||1
10230814|NCT02995967|11359498|FG001|STARTED|Overall Study||2
10230815|NCT02995967|11359497|FG000|COMPLETED|Overall Study||1
10230816|NCT02995967|11359498|FG001|COMPLETED|Overall Study||2
10230817|NCT02995967|11359497|FG000|NOT COMPLETED|Overall Study||0
10230818|NCT02995967|11359498|FG001|NOT COMPLETED|Overall Study||0
10230819|NCT02994251|11359505|FG000|STARTED|Overall Study||0
10230820|NCT02994251|11359505|FG000|COMPLETED|Overall Study||0
10230821|NCT02994251|11359505|FG000|NOT COMPLETED|Overall Study||0
10230822|NCT02978885|11359511|FG000|STARTED|Overall Study||0
10230823|NCT02978885|11359512|FG001|STARTED|Overall Study||1
10230824|NCT02978885|11359511|FG000|COMPLETED|Overall Study||0
10230825|NCT02978885|11359512|FG001|COMPLETED|Overall Study||1
10013174|NCT01790750|11136225|FG000|NOT COMPLETED|Overall Study||0
10230826|NCT02978885|11359511|FG000|NOT COMPLETED|Overall Study||0
10230827|NCT02978885|11359512|FG001|NOT COMPLETED|Overall Study||0
10230828|NCT02978833|11359520|FG000|STARTED|Overall Study||1
10230829|NCT02978833|11359521|FG001|STARTED|Overall Study||1
10230830|NCT02978833|11359520|FG000|COMPLETED|Overall Study||0
10230831|NCT02978833|11359521|FG001|COMPLETED|Overall Study||0
10230832|NCT02978833|11359520|FG000|NOT COMPLETED|Overall Study||1
10230833|NCT02978833|11359521|FG001|NOT COMPLETED|Overall Study||1
10013175|NCT01790828|11136230|FG000|STARTED|Overall Study||42
10013176|NCT01790828|11136230|FG000|COMPLETED|Overall Study||8
10013177|NCT01790828|11136230|FG000|NOT COMPLETED|Overall Study||34
10013178|NCT01790932|11136234|FG000|STARTED|Overall Study||50
10230834|NCT02971839|11359533|FG000|STARTED|Overall Study||2
10230835|NCT02971839|11359534|FG001|STARTED|Overall Study||2
10230836|NCT02971839|11359535|FG002|STARTED|Overall Study||2
10230837|NCT02971839|11359536|FG003|STARTED|Overall Study||2
10230838|NCT02971839|11359537|FG004|STARTED|Overall Study||3
10230839|NCT02971839|11359533|FG000|COMPLETED|Overall Study||2
10230840|NCT02971839|11359534|FG001|COMPLETED|Overall Study||2
10230841|NCT02971839|11359535|FG002|COMPLETED|Overall Study||2
10230842|NCT02971839|11359536|FG003|COMPLETED|Overall Study||2
10230843|NCT02971839|11359537|FG004|COMPLETED|Overall Study||3
10230844|NCT02971839|11359533|FG000|NOT COMPLETED|Overall Study||0
10230845|NCT02971839|11359534|FG001|NOT COMPLETED|Overall Study||0
10230846|NCT02971839|11359535|FG002|NOT COMPLETED|Overall Study||0
10230847|NCT02971839|11359536|FG003|NOT COMPLETED|Overall Study||0
10230848|NCT02971839|11359537|FG004|NOT COMPLETED|Overall Study||0
10230849|NCT02985840|11359551|FG000|STARTED|Overall Study||64
10230850|NCT02985840|11359552|FG001|STARTED|Overall Study||63
10230851|NCT02985840|11359551|FG000|COMPLETED|Overall Study||64
10230852|NCT02985840|11359552|FG001|COMPLETED|Overall Study||63
10230853|NCT02985840|11359551|FG000|NOT COMPLETED|Overall Study||0
10230854|NCT02985840|11359552|FG001|NOT COMPLETED|Overall Study||0
10230855|NCT02966223|11359558|FG000|STARTED|Overall Study||20
10230856|NCT02966223|11359558|FG000|COMPLETED|Overall Study||5
9952166|NCT01420081|11071050|FG001|NOT COMPLETED|Overall Study||1
9952167|NCT01420081|11071051|FG002|NOT COMPLETED|Overall Study||11
9952168|NCT01420081|11071052|FG003|NOT COMPLETED|Overall Study||3
9952169|NCT01420081|11071053|FG004|NOT COMPLETED|Overall Study||20
9952170|NCT01420081|11071054|FG005|NOT COMPLETED|Overall Study||20
9952171|NCT01420081|11071055|FG006|NOT COMPLETED|Overall Study||3
9952172|NCT01420081|11071056|FG007|NOT COMPLETED|Overall Study||3
9952173|NCT01420081|11071057|FG008|NOT COMPLETED|Overall Study||3
9952174|NCT01420146|11071073|FG000|STARTED|Overall Study||20
9952175|NCT01420146|11071073|FG000|COMPLETED|Overall Study||20
9952176|NCT01420146|11071073|FG000|NOT COMPLETED|Overall Study||0
9952177|NCT01420289|11071079|FG000|STARTED|Overall Study||18
10230857|NCT02966223|11359558|FG000|NOT COMPLETED|Overall Study||15
10230858|NCT02965846|11359565|FG000|STARTED|Overall Study||5
10230859|NCT02965846|11359566|FG001|STARTED|Overall Study||5
10230860|NCT02965846|11359567|FG002|STARTED|Overall Study||33
10230861|NCT02965846|11359565|FG000|COMPLETED|Overall Study||0
9952178|NCT01420289|11071080|FG001|STARTED|Overall Study||16
9952179|NCT01420289|11071079|FG000|COMPLETED|Overall Study||18
9952180|NCT01420289|11071080|FG001|COMPLETED|Overall Study||16
9952181|NCT01420289|11071079|FG000|NOT COMPLETED|Overall Study||0
9952182|NCT01420289|11071080|FG001|NOT COMPLETED|Overall Study||0
9952183|NCT01420536|11071088|FG000|STARTED|Period 1 (30 Days)||22
9952184|NCT01420536|11071089|FG001|STARTED|Period 1 (30 Days)||22
10112022|NCT02500758|11243081|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3
10112023|NCT02500758|11243082|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2
10112024|NCT02500836|11243092|FG000|STARTED|Overall Study||259
10112025|NCT02500836|11243093|FG001|STARTED|Overall Study||259
10112026|NCT02500836|11243094|FG002|STARTED|Overall Study||128
10112027|NCT02500836|11243092|FG000|COMPLETED|Overall Study||256
10112028|NCT02500836|11243093|FG001|COMPLETED|Overall Study||254
10112029|NCT02500836|11243094|FG002|COMPLETED|Overall Study||127
10112030|NCT02500836|11243092|FG000|NOT COMPLETED|Overall Study||3
10112031|NCT02500836|11243093|FG001|NOT COMPLETED|Overall Study||5
10112032|NCT02500836|11243094|FG002|NOT COMPLETED|Overall Study||1
10112033|NCT02500979|11243104|FG000|STARTED|Period 1||16
10112034|NCT02500979|11243105|FG001|STARTED|Period 1||17
10112035|NCT02500979|11243104|FG000|COMPLETED|Period 1||12
10112036|NCT02500979|11243105|FG001|COMPLETED|Period 1||16
10112037|NCT02500979|11243104|FG000|NOT COMPLETED|Period 1||4
10112038|NCT02500979|11243105|FG001|NOT COMPLETED|Period 1||1
10112039|NCT02500979|11243104|FG000|STARTED|Period 2||12
10112040|NCT02500979|11243105|FG001|STARTED|Period 2||16
10112041|NCT02500979|11243104|FG000|COMPLETED|Period 2||11
10112042|NCT02500979|11243105|FG001|COMPLETED|Period 2||16
10112043|NCT02500979|11243104|FG000|NOT COMPLETED|Period 2||1
10112044|NCT02500979|11243105|FG001|NOT COMPLETED|Period 2||0
10113432|NCT02509117|11244198|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0
10113433|NCT02509117|11244199|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0
10113434|NCT02509117|11244190|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10113435|NCT02509117|11244191|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10113436|NCT02509117|11244192|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10113437|NCT02509117|11244193|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10230862|NCT02965846|11359566|FG001|COMPLETED|Overall Study||0
10230863|NCT02965846|11359567|FG002|COMPLETED|Overall Study||0
10230864|NCT02965846|11359565|FG000|NOT COMPLETED|Overall Study||5
10230865|NCT02965846|11359566|FG001|NOT COMPLETED|Overall Study||5
10230866|NCT02965846|11359567|FG002|NOT COMPLETED|Overall Study||33
10230867|NCT02974803|11359573|FG000|STARTED|Overall Study||6
10230868|NCT02974803|11359573|FG000|COMPLETED|Overall Study||6
9952185|NCT01420536|11071088|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
9952186|NCT01420536|11071089|FG001|COMPLETED|Period 1 (30 Days)||22
9952187|NCT01420536|11071088|FG000|NOT COMPLETED|Period 1 (30 Days)||3
9952188|NCT01420536|11071089|FG001|NOT COMPLETED|Period 1 (30 Days)||0
9952189|NCT01420536|11071088|FG000|STARTED|Period 2 (30 Days)||19
10230869|NCT02974803|11359573|FG000|NOT COMPLETED|Overall Study||0
10230870|NCT02974686|11359579|FG000|STARTED|Overall Study||0
10230871|NCT02974686|11359580|FG001|STARTED|Overall Study||0
10230872|NCT02974686|11359579|FG000|COMPLETED|Overall Study||0
10230873|NCT02974686|11359580|FG001|COMPLETED|Overall Study||0
10230874|NCT02974686|11359579|FG000|NOT COMPLETED|Overall Study||0
10230875|NCT02974686|11359580|FG001|NOT COMPLETED|Overall Study||0
10230876|NCT02956005|11359588|FG000|STARTED|Overall Study||18
9952190|NCT01420536|11071089|FG001|STARTED|Period 2 (30 Days)||22
9952191|NCT01420536|11071088|FG000|COMPLETED|Period 2 (30 Days)||19
9952192|NCT01420536|11071089|FG001|COMPLETED|Period 2 (30 Days)||22
10230877|NCT02956005|11359588|FG000|COMPLETED|Overall Study||2
10230878|NCT02956005|11359588|FG000|NOT COMPLETED|Overall Study||16
10230879|NCT02966184|11359594|FG000|STARTED|Overall Study||0
10230880|NCT02966184|11359595|FG001|STARTED|Overall Study||8
10230881|NCT02966184|11359594|FG000|COMPLETED|Overall Study||0
10230882|NCT02966184|11359595|FG001|COMPLETED|Overall Study||0
10230883|NCT02966184|11359594|FG000|NOT COMPLETED|Overall Study||0
10230884|NCT02966184|11359595|FG001|NOT COMPLETED|Overall Study||8
10230885|NCT02940223|11359603|FG000|STARTED|Overall Study||2
10230886|NCT02940223|11359604|FG001|STARTED|Overall Study||0
10230887|NCT02940223|11359603|FG000|COMPLETED|Overall Study||0
10230888|NCT02940223|11359604|FG001|COMPLETED|Overall Study||0
10230889|NCT02940223|11359603|FG000|NOT COMPLETED|Overall Study||2
10230890|NCT02940223|11359604|FG001|NOT COMPLETED|Overall Study||0
10230891|NCT02954159|11359612|FG000|STARTED|Overall Study||2
10230892|NCT02954159|11359613|FG001|STARTED|Overall Study||2
10230893|NCT02954159|11359612|FG000|COMPLETED|Overall Study||1
10230894|NCT02954159|11359613|FG001|COMPLETED|Overall Study||1
10230895|NCT02954159|11359612|FG000|NOT COMPLETED|Overall Study||1
10230896|NCT02954159|11359613|FG001|NOT COMPLETED|Overall Study||1
10230897|NCT02954952|11359622|FG000|STARTED|Overall Study||36
10230898|NCT02954952|11359623|FG001|STARTED|Overall Study||5
10230899|NCT02954952|11359624|FG002|STARTED|Overall Study||3
10230900|NCT02954952|11359622|FG000|COMPLETED|Overall Study||35
10230901|NCT02954952|11359623|FG001|COMPLETED|Overall Study||4
10230902|NCT02954952|11359624|FG002|COMPLETED|Overall Study||3
10230903|NCT02954952|11359622|FG000|NOT COMPLETED|Overall Study||1
10230904|NCT02954952|11359623|FG001|NOT COMPLETED|Overall Study||1
10230905|NCT02954952|11359624|FG002|NOT COMPLETED|Overall Study||0
10230906|NCT02950896|11359632|FG000|STARTED|Overall Study||4
10230907|NCT02950896|11359632|FG000|COMPLETED|Overall Study||4
10230908|NCT02950896|11359632|FG000|NOT COMPLETED|Overall Study||0
10230909|NCT02947022|11359636|FG000|STARTED|Overall Study||1
10230910|NCT02947022|11359636|FG000|COMPLETED|Overall Study||0
10230911|NCT02947022|11359636|FG000|NOT COMPLETED|Overall Study||1
10230912|NCT02936999|11359643|FG000|STARTED|Overall Study||8
9952193|NCT01420536|11071088|FG000|NOT COMPLETED|Period 2 (30 Days)||0
9952194|NCT01420536|11071089|FG001|NOT COMPLETED|Period 2 (30 Days)||0
9952195|NCT01420549|11071099|FG000|STARTED|Overall Study||66
9952196|NCT01420549|11071100|FG001|STARTED|Overall Study||63
9952197|NCT01420549|11071099|FG000|COMPLETED|Overall Study||59
9952198|NCT01420549|11071100|FG001|COMPLETED|Overall Study||58
10013179|NCT01790932|11136234|FG000|COMPLETED|Overall Study||0
10013180|NCT01790932|11136234|FG000|NOT COMPLETED|Overall Study||50
10013181|NCT01790984|11136240|FG000|STARTED|First Dietary Intervention (12 Weeks)||6
10013182|NCT01790984|11136241|FG001|STARTED|First Dietary Intervention (12 Weeks)||8
10013183|NCT01790984|11136242|FG002|STARTED|First Dietary Intervention (12 Weeks)||6
10013184|NCT01790984|11136243|FG003|STARTED|First Dietary Intervention (12 Weeks)||7
10013185|NCT01790984|11136240|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5
10013186|NCT01790984|11136241|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7
10013187|NCT01790984|11136242|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6
10013188|NCT01790984|11136243|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7
10013189|NCT01790984|11136240|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
10013190|NCT01790984|11136241|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
10013191|NCT01790984|11136242|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
10013192|NCT01790984|11136243|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
10013193|NCT01790984|11136240|FG000|STARTED|Wash-out (4 Weeks)||5
10013194|NCT01790984|11136241|FG001|STARTED|Wash-out (4 Weeks)||7
10013195|NCT01790984|11136242|FG002|STARTED|Wash-out (4 Weeks)||6
10013196|NCT01790984|11136243|FG003|STARTED|Wash-out (4 Weeks)||7
10013197|NCT01790984|11136240|FG000|COMPLETED|Wash-out (4 Weeks)||5
10013198|NCT01790984|11136241|FG001|COMPLETED|Wash-out (4 Weeks)||7
10013199|NCT01790984|11136242|FG002|COMPLETED|Wash-out (4 Weeks)||6
10230913|NCT02936999|11359643|FG000|COMPLETED|Overall Study||8
10230914|NCT02936999|11359643|FG000|NOT COMPLETED|Overall Study||0
10230915|NCT02950480|11359651|FG000|STARTED|Overall Study||2
10230916|NCT02950480|11359652|FG001|STARTED|Overall Study||2
10230917|NCT02950480|11359651|FG000|COMPLETED|Overall Study||1
10230918|NCT02950480|11359652|FG001|COMPLETED|Overall Study||2
10230919|NCT02950480|11359651|FG000|NOT COMPLETED|Overall Study||1
10230920|NCT02950480|11359652|FG001|NOT COMPLETED|Overall Study||0
10230921|NCT02949947|11359660|FG000|STARTED|Overall Study||1
10230922|NCT02949947|11359661|FG001|STARTED|Overall Study||2
10230923|NCT02949947|11359660|FG000|COMPLETED|Overall Study||0
10230924|NCT02949947|11359661|FG001|COMPLETED|Overall Study||1
10230925|NCT02949947|11359660|FG000|NOT COMPLETED|Overall Study||1
10230926|NCT02949947|11359661|FG001|NOT COMPLETED|Overall Study||1
10230927|NCT02947100|11359667|FG000|STARTED|Overall Study||4
9952199|NCT01420549|11071099|FG000|NOT COMPLETED|Overall Study||7
9952200|NCT01420549|11071100|FG001|NOT COMPLETED|Overall Study||5
10230928|NCT02947100|11359667|FG000|COMPLETED|Overall Study||0
10230929|NCT02947100|11359667|FG000|NOT COMPLETED|Overall Study||4
10230930|NCT02936206|11359673|FG000|STARTED|Overall Study||0
10230931|NCT02936206|11359674|FG001|STARTED|Overall Study||2
10230932|NCT02936206|11359673|FG000|COMPLETED|Overall Study||0
10230933|NCT02936206|11359674|FG001|COMPLETED|Overall Study||2
10230934|NCT02936206|11359673|FG000|NOT COMPLETED|Overall Study||0
10230935|NCT02936206|11359674|FG001|NOT COMPLETED|Overall Study||0
10230936|NCT02934932|11359680|FG000|STARTED|Overall Study||9
10230937|NCT02934932|11359680|FG000|COMPLETED|Overall Study||6
10230938|NCT02934932|11359680|FG000|NOT COMPLETED|Overall Study||3
10230939|NCT02908516|11359688|FG000|STARTED|Overall Study||3
10230940|NCT02908516|11359689|FG001|STARTED|Overall Study||3
10230941|NCT02908516|11359688|FG000|COMPLETED|Overall Study||0
10230942|NCT02908516|11359689|FG001|COMPLETED|Overall Study||0
10230943|NCT02908516|11359688|FG000|NOT COMPLETED|Overall Study||3
10230944|NCT02908516|11359689|FG001|NOT COMPLETED|Overall Study||3
10239505|NCT00183963|11371103|FG000|COMPLETED|Overall Study||0
10239506|NCT00183963|11371104|FG001|COMPLETED|Overall Study||0
10239507|NCT00183963|11371105|FG002|COMPLETED|Overall Study||0
10239508|NCT00183963|11371106|FG003|COMPLETED|Overall Study||0
10239509|NCT00183963|11371103|FG000|NOT COMPLETED|Overall Study||1
10239510|NCT00183963|11371104|FG001|NOT COMPLETED|Overall Study||1
10239511|NCT00183963|11371105|FG002|NOT COMPLETED|Overall Study||1
10239512|NCT00183963|11371106|FG003|NOT COMPLETED|Overall Study||1
10239513|NCT00178477|11371119|FG000|STARTED|Overall Study||10
10239514|NCT00178477|11371119|FG000|COMPLETED|Overall Study||5
10239515|NCT00178477|11371119|FG000|NOT COMPLETED|Overall Study||5
10239516|NCT00162773|11371123|FG000|STARTED|Overall Study||29
10239517|NCT00162773|11371123|FG000|COMPLETED|Overall Study||7
10239518|NCT00162773|11371123|FG000|NOT COMPLETED|Overall Study||22
10239519|NCT00176631|11371127|FG000|STARTED|Overall Study||10
10239520|NCT00176631|11371127|FG000|COMPLETED|Overall Study||10
10239521|NCT00176631|11371127|FG000|NOT COMPLETED|Overall Study||0
10239522|NCT00176501|11371131|FG000|STARTED|Overall Study||3
10239523|NCT00176501|11371131|FG000|COMPLETED|Overall Study||3
10239524|NCT00176501|11371131|FG000|NOT COMPLETED|Overall Study||0
10239525|NCT00177970|11371137|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
10239526|NCT00177970|11371138|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
10239527|NCT00177970|11371137|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
10239528|NCT00177970|11371138|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
10239529|NCT00177970|11371137|FG000|NOT COMPLETED|Overall Study||0
10239530|NCT00177970|11371138|FG001|NOT COMPLETED|Overall Study||0
10239531|NCT00177866|11371146|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
10239532|NCT00177866|11371147|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
10239533|NCT00177866|11371146|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
10239534|NCT00177866|11371147|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
10239535|NCT00177866|11371146|FG000|NOT COMPLETED|Overall Study||0
10239536|NCT00177866|11371147|FG001|NOT COMPLETED|Overall Study||0
10239537|NCT00147238|11371153|FG000|STARTED|Overall Study||10
10239538|NCT00147238|11371153|FG000|COMPLETED|Overall Study||2
10239539|NCT00147238|11371153|FG000|NOT COMPLETED|Overall Study||8
10239540|NCT00165503|11371157|FG000|STARTED|Overall Study||16
10239541|NCT00165503|11371157|FG000|COMPLETED|Overall Study||0
10239542|NCT00165503|11371157|FG000|NOT COMPLETED|Overall Study||16
10239543|NCT00160563|11371164|FG000|STARTED|Overall Study||59
10239544|NCT00160563|11371165|FG001|STARTED|Overall Study||47
10239545|NCT00160563|11371166|FG002|STARTED|Overall Study||101
10239546|NCT00160563|11371164|FG000|COMPLETED|Overall Study||8
10239547|NCT00160563|11371165|FG001|COMPLETED|Overall Study||2
10239548|NCT00160563|11371166|FG002|COMPLETED|Overall Study||11
10239549|NCT00160563|11371164|FG000|NOT COMPLETED|Overall Study||51
10239550|NCT00160563|11371165|FG001|NOT COMPLETED|Overall Study||45
10239551|NCT00160563|11371166|FG002|NOT COMPLETED|Overall Study||90
10239552|NCT00142519|11371177|FG000|STARTED|Overall Study||25
10239553|NCT00142519|11371178|FG001|STARTED|Overall Study||25
10239554|NCT00142519|11371177|FG000|COMPLETED|Overall Study||7
10239555|NCT00142519|11371178|FG001|COMPLETED|Overall Study||9
10239556|NCT00142519|11371177|FG000|NOT COMPLETED|Overall Study||18
10239557|NCT00142519|11371178|FG001|NOT COMPLETED|Overall Study||16
10239558|NCT00145704|11371186|FG000|STARTED|Overall Study||3
10239559|NCT00145704|11371187|FG001|STARTED|Overall Study||3
10239560|NCT00145704|11371186|FG000|COMPLETED|Overall Study||0
10239561|NCT00145704|11371187|FG001|COMPLETED|Overall Study||0
10239562|NCT00145704|11371186|FG000|NOT COMPLETED|Overall Study||3
10239563|NCT00145704|11371187|FG001|NOT COMPLETED|Overall Study||3
10239564|NCT00138073|11371193|FG000|STARTED|Overall Study||55
10239565|NCT00138073|11371193|FG000|Pre-intervention Testing|Overall Study||55
10239566|NCT00138073|11371193|FG000|COMPLETED|Overall Study||0
10239567|NCT00138073|11371193|FG000|NOT COMPLETED|Overall Study||55
10239840|NCT04422210|11371592|FG007|STARTED|Overall Study||0
10239841|NCT04422210|11371585|FG000|COMPLETED|Overall Study||0
10239842|NCT04422210|11371586|FG001|COMPLETED|Overall Study||0
10239843|NCT04422210|11371587|FG002|COMPLETED|Overall Study||0
10239844|NCT04422210|11371588|FG003|COMPLETED|Overall Study||0
10239845|NCT04422210|11371589|FG004|COMPLETED|Overall Study||0
10239846|NCT04422210|11371590|FG005|COMPLETED|Overall Study||0
10239847|NCT04422210|11371591|FG006|COMPLETED|Overall Study||0
10230945|NCT02923830|11359697|FG000|STARTED|Overall Study||13
10230946|NCT02923830|11359698|FG001|STARTED|Overall Study||15
10230947|NCT02923830|11359697|FG000|COMPLETED|Overall Study|Study terminated|0
10230948|NCT02923830|11359698|FG001|COMPLETED|Overall Study|Study terminated|0
10230949|NCT02923830|11359697|FG000|NOT COMPLETED|Overall Study||13
10230950|NCT02923830|11359698|FG001|NOT COMPLETED|Overall Study||15
10230951|NCT02920450|11359704|FG000|STARTED|Overall Study||3
10230952|NCT02920450|11359705|FG001|STARTED|Overall Study||0
10230953|NCT02920450|11359706|FG002|STARTED|Overall Study||0
10230954|NCT02920450|11359707|FG003|STARTED|Overall Study||0
10230955|NCT02920450|11359704|FG000|COMPLETED|Overall Study||1
10230956|NCT02920450|11359705|FG001|COMPLETED|Overall Study||0
10230957|NCT02920450|11359706|FG002|COMPLETED|Overall Study||0
10230958|NCT02920450|11359707|FG003|COMPLETED|Overall Study||0
10230959|NCT02920450|11359704|FG000|NOT COMPLETED|Overall Study||2
10230960|NCT02920450|11359705|FG001|NOT COMPLETED|Overall Study||0
10230961|NCT02920450|11359706|FG002|NOT COMPLETED|Overall Study||0
10230962|NCT02920450|11359707|FG003|NOT COMPLETED|Overall Study||0
10230963|NCT02920177|11359716|FG000|STARTED|Overall Study||2
10230964|NCT02920177|11359717|FG001|STARTED|Overall Study||2
9952201|NCT01420627|11071106|FG000|STARTED|Adagen Lead-in Period||7
9952202|NCT01420627|11071106|FG000|COMPLETED|Adagen Lead-in Period||7
9952203|NCT01420627|11071106|FG000|NOT COMPLETED|Adagen Lead-in Period||0
9952204|NCT01420627|11071106|FG000|STARTED|EZN-2279 Treatment Period||7
9952205|NCT01420627|11071106|FG000|COMPLETED|EZN-2279 Treatment Period||6
9952206|NCT01420627|11071106|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1
9952207|NCT01420627|11071106|FG000|STARTED|EZN-2279 Maintenance Period||6
9952208|NCT01420627|11071106|FG000|COMPLETED|EZN-2279 Maintenance Period||6
9952209|NCT01420627|11071106|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0
9952210|NCT01420653|11071118|FG000|STARTED|Overall Study||110
9952211|NCT01420653|11071119|FG001|STARTED|Overall Study||111
10230965|NCT02920177|11359716|FG000|COMPLETED|Overall Study||0
10230966|NCT02920177|11359717|FG001|COMPLETED|Overall Study||0
10230967|NCT02920177|11359716|FG000|NOT COMPLETED|Overall Study||2
10230968|NCT02920177|11359717|FG001|NOT COMPLETED|Overall Study||2
10230969|NCT02926638|11359725|FG000|STARTED|Overall Study||4
10230970|NCT02926638|11359726|FG001|STARTED|Overall Study||5
10230971|NCT02926638|11359725|FG000|Eligible|Overall Study||3
10230972|NCT02926638|11359726|FG001|Eligible|Overall Study||5
10230973|NCT02926638|11359725|FG000|COMPLETED|Overall Study||0
10230974|NCT02926638|11359726|FG001|COMPLETED|Overall Study||0
10230975|NCT02926638|11359725|FG000|NOT COMPLETED|Overall Study||4
10230976|NCT02926638|11359726|FG001|NOT COMPLETED|Overall Study||5
10230977|NCT02920242|11359735|FG000|STARTED|Overall Study||13
10230978|NCT02920242|11359736|FG001|STARTED|Overall Study||11
10230979|NCT02920242|11359737|FG002|STARTED|Overall Study||4
10230980|NCT02920242|11359735|FG000|Safety Set|Overall Study||12
10230981|NCT02920242|11359736|FG001|Safety Set|Overall Study||11
10230982|NCT02920242|11359737|FG002|Safety Set|Overall Study||4
10230983|NCT02920242|11359735|FG000|COMPLETED|Overall Study||11
10230984|NCT02920242|11359736|FG001|COMPLETED|Overall Study||11
10230985|NCT02920242|11359737|FG002|COMPLETED|Overall Study||3
10230986|NCT02920242|11359735|FG000|NOT COMPLETED|Overall Study||2
10230987|NCT02920242|11359736|FG001|NOT COMPLETED|Overall Study||0
10230988|NCT02920242|11359737|FG002|NOT COMPLETED|Overall Study||1
10230989|NCT02900781|11359747|FG000|STARTED|Overall Study||4
10230990|NCT02900781|11359748|FG001|STARTED|Overall Study||5
10230991|NCT02900781|11359747|FG000|COMPLETED|Overall Study||0
10230992|NCT02900781|11359748|FG001|COMPLETED|Overall Study||0
10230993|NCT02900781|11359747|FG000|NOT COMPLETED|Overall Study||4
10230994|NCT02900781|11359748|FG001|NOT COMPLETED|Overall Study||5
10230995|NCT02892500|11359756|FG000|STARTED|Overall Study||0
10230996|NCT02892500|11359757|FG001|STARTED|Overall Study||0
10230997|NCT02892500|11359756|FG000|COMPLETED|Overall Study||0
10230998|NCT02892500|11359757|FG001|COMPLETED|Overall Study||0
10230999|NCT02892500|11359756|FG000|NOT COMPLETED|Overall Study||0
10231000|NCT02892500|11359757|FG001|NOT COMPLETED|Overall Study||0
9952212|NCT01420653|11071120|FG002|STARTED|Overall Study||112
10231001|NCT02904356|11359763|FG000|STARTED|Overall Study||2
10231002|NCT02904356|11359763|FG000|COMPLETED|Overall Study||2
10231003|NCT02904356|11359763|FG000|NOT COMPLETED|Overall Study||0
10231004|NCT02899728|11359769|FG000|STARTED|Overall Study|0|5
10231005|NCT02899728|11359770|FG001|STARTED|Overall Study||3
10231006|NCT02899728|11359769|FG000|COMPLETED|Overall Study||4
10231007|NCT02899728|11359770|FG001|COMPLETED|Overall Study||2
10231008|NCT02899728|11359769|FG000|NOT COMPLETED|Overall Study||1
10231009|NCT02899728|11359770|FG001|NOT COMPLETED|Overall Study||1
10231010|NCT02875067|11359776|FG000|STARTED|Overall Study||6
10231011|NCT02875067|11359776|FG000|COMPLETED|Overall Study||0
10231012|NCT02875067|11359776|FG000|NOT COMPLETED|Overall Study||6
10231013|NCT02877732|11359782|FG000|STARTED|Overall Study||6
10231014|NCT02877732|11359783|FG001|STARTED|Overall Study||6
10231015|NCT02877732|11359782|FG000|COMPLETED|Overall Study||0
10231016|NCT02877732|11359783|FG001|COMPLETED|Overall Study||0
10231017|NCT02877732|11359782|FG000|NOT COMPLETED|Overall Study||6
10231018|NCT02877732|11359783|FG001|NOT COMPLETED|Overall Study||6
10231019|NCT02860169|11359791|FG000|STARTED|Part A||46
10231020|NCT02860169|11359791|FG000|Healthy Participants|Part A||46
10231021|NCT02860169|11359791|FG000|Participants With Cold and Flu|Part A||0
10231022|NCT02860169|11359791|FG000|COMPLETED|Part A||35
10231023|NCT02860169|11359791|FG000|NOT COMPLETED|Part A||11
10231024|NCT02860169|11359791|FG000|STARTED|Part B||20
10231025|NCT02860169|11359791|FG000|Healthy Participants|Part B||10
10231026|NCT02860169|11359791|FG000|Participants With Cold and Flu|Part B||10
9952213|NCT01420653|11071121|FG003|STARTED|Overall Study||75
9952214|NCT01420653|11071118|FG000|COMPLETED|Overall Study||107
9952215|NCT01420653|11071119|FG001|COMPLETED|Overall Study||108
9952216|NCT01420653|11071120|FG002|COMPLETED|Overall Study||108
10231027|NCT02860169|11359791|FG000|COMPLETED|Part B||9
10231028|NCT02860169|11359791|FG000|NOT COMPLETED|Part B||11
10231029|NCT02860169|11359791|FG000|STARTED|Part C||48
9952217|NCT01420653|11071121|FG003|COMPLETED|Overall Study||68
9952218|NCT01420653|11071118|FG000|NOT COMPLETED|Overall Study||3
9952219|NCT01420653|11071119|FG001|NOT COMPLETED|Overall Study||3
9952220|NCT01420653|11071120|FG002|NOT COMPLETED|Overall Study||4
9952221|NCT01420653|11071121|FG003|NOT COMPLETED|Overall Study||7
9956952|NCT01448824|11076145|FG005|STARTED|Part 2: Washout Period||0
9956953|NCT01448824|11076146|FG006|STARTED|Part 2: Washout Period||0
9956954|NCT01448824|11076147|FG007|STARTED|Part 2: Washout Period||11
10231030|NCT02860169|11359791|FG000|Healthy Participants|Part C||6
10231031|NCT02860169|11359791|FG000|Participants With Cold and Flu|Part C||42
10231032|NCT02860169|11359791|FG000|COMPLETED|Part C||47
10231033|NCT02860169|11359791|FG000|NOT COMPLETED|Part C||1
10231034|NCT02865395|11359800|FG000|STARTED|Overall Study||6
10231035|NCT02865395|11359801|FG001|STARTED|Overall Study||10
9956955|NCT01448824|11076140|FG000|COMPLETED|Part 2: Washout Period||0
9956956|NCT01448824|11076141|FG001|COMPLETED|Part 2: Washout Period||0
9956957|NCT01448824|11076142|FG002|COMPLETED|Part 2: Washout Period||0
9956958|NCT01448824|11076143|FG003|COMPLETED|Part 2: Washout Period||0
9956959|NCT01448824|11076144|FG004|COMPLETED|Part 2: Washout Period||0
9956960|NCT01448824|11076145|FG005|COMPLETED|Part 2: Washout Period||0
9956961|NCT01448824|11076146|FG006|COMPLETED|Part 2: Washout Period||0
9956962|NCT01448824|11076147|FG007|COMPLETED|Part 2: Washout Period||11
9956963|NCT01448824|11076140|FG000|NOT COMPLETED|Part 2: Washout Period||0
9956964|NCT01448824|11076141|FG001|NOT COMPLETED|Part 2: Washout Period||0
9956965|NCT01448824|11076142|FG002|NOT COMPLETED|Part 2: Washout Period||0
9956966|NCT01448824|11076143|FG003|NOT COMPLETED|Part 2: Washout Period||0
9956967|NCT01448824|11076144|FG004|NOT COMPLETED|Part 2: Washout Period||0
9956968|NCT01448824|11076145|FG005|NOT COMPLETED|Part 2: Washout Period||0
9956969|NCT01448824|11076146|FG006|NOT COMPLETED|Part 2: Washout Period||0
9956970|NCT01448824|11076147|FG007|NOT COMPLETED|Part 2: Washout Period||0
9956971|NCT01448824|11076140|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0
9956972|NCT01448824|11076141|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0
9956973|NCT01448824|11076142|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0
9956974|NCT01448824|11076143|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0
9956975|NCT01448824|11076144|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10013200|NCT01790984|11136243|FG003|COMPLETED|Wash-out (4 Weeks)||7
10013201|NCT01790984|11136240|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
10231036|NCT02865395|11359802|FG002|STARTED|Overall Study||7
10231037|NCT02865395|11359800|FG000|COMPLETED|Overall Study|Data Not Collected|0
10231038|NCT02865395|11359801|FG001|COMPLETED|Overall Study|Data Not Collected|0
10231039|NCT02865395|11359802|FG002|COMPLETED|Overall Study|Data Not Collected|0
10231040|NCT02865395|11359800|FG000|NOT COMPLETED|Overall Study||6
10231041|NCT02865395|11359801|FG001|NOT COMPLETED|Overall Study||10
10231042|NCT02865395|11359802|FG002|NOT COMPLETED|Overall Study||7
10231043|NCT02868892|11359810|FG000|STARTED|Overall Study||6
10231044|NCT02868892|11359810|FG000|COMPLETED|Overall Study||0
10231045|NCT02868892|11359810|FG000|NOT COMPLETED|Overall Study||6
10231046|NCT02865083|11359816|FG000|STARTED|Overall Study||3
10231047|NCT02865083|11359817|FG001|STARTED|Overall Study||1
10231048|NCT02865083|11359816|FG000|COMPLETED|Overall Study||0
10231049|NCT02865083|11359817|FG001|COMPLETED|Overall Study||0
10231050|NCT02865083|11359816|FG000|NOT COMPLETED|Overall Study||3
10231051|NCT02865083|11359817|FG001|NOT COMPLETED|Overall Study||1
10231052|NCT02865122|11359826|FG000|STARTED|Overall Study||1
10231053|NCT02865122|11359827|FG001|STARTED|Overall Study||1
10231054|NCT02865122|11359828|FG002|STARTED|Overall Study||0
10231055|NCT02865122|11359826|FG000|COMPLETED|Overall Study||0
10231056|NCT02865122|11359827|FG001|COMPLETED|Overall Study||1
9956976|NCT01448824|11076145|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0
9956977|NCT01448824|11076146|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10231057|NCT02865122|11359828|FG002|COMPLETED|Overall Study||0
10231058|NCT02865122|11359826|FG000|NOT COMPLETED|Overall Study||1
10231059|NCT02865122|11359827|FG001|NOT COMPLETED|Overall Study||0
10231060|NCT02865122|11359828|FG002|NOT COMPLETED|Overall Study||0
10231061|NCT02865915|11359838|FG000|STARTED|Overall Study||25
10231062|NCT02865915|11359839|FG001|STARTED|Overall Study||30
10231063|NCT02865915|11359838|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
10231064|NCT02865915|11359839|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
10231065|NCT02865915|11359838|FG000|NOT COMPLETED|Overall Study||25
10231066|NCT02865915|11359839|FG001|NOT COMPLETED|Overall Study||30
10231067|NCT02855411|11359845|FG000|STARTED|Overall Study||35
10231068|NCT02855411|11359845|FG000|Assigned to Study Treatment|Overall Study||0
10231069|NCT02855411|11359845|FG000|COMPLETED|Overall Study||0
10231070|NCT02855411|11359845|FG000|NOT COMPLETED|Overall Study||35
10231071|NCT02828124|11359853|FG000|STARTED|Overall Study||1
10231072|NCT02828124|11359854|FG001|STARTED|Overall Study||2
10231073|NCT02828124|11359855|FG002|STARTED|Overall Study||1
10231074|NCT02828124|11359856|FG003|STARTED|Overall Study||6
10231075|NCT02828124|11359853|FG000|COMPLETED|Overall Study||0
10231076|NCT02828124|11359854|FG001|COMPLETED|Overall Study||0
10231077|NCT02828124|11359855|FG002|COMPLETED|Overall Study||0
10231078|NCT02828124|11359856|FG003|COMPLETED|Overall Study||0
10231079|NCT02828124|11359853|FG000|NOT COMPLETED|Overall Study||1
10231080|NCT02828124|11359854|FG001|NOT COMPLETED|Overall Study||2
10231081|NCT02828124|11359855|FG002|NOT COMPLETED|Overall Study||1
10231082|NCT02828124|11359856|FG003|NOT COMPLETED|Overall Study||6
10231083|NCT02826551|11359868|FG000|STARTED|Overall Study||11
10231084|NCT02826551|11359869|FG001|STARTED|Overall Study||12
10231085|NCT02826551|11359868|FG000|COMPLETED|Overall Study||11
10231086|NCT02826551|11359869|FG001|COMPLETED|Overall Study||12
10231087|NCT02826551|11359868|FG000|NOT COMPLETED|Overall Study||0
10231088|NCT02826551|11359869|FG001|NOT COMPLETED|Overall Study||0
10231089|NCT02825043|11359875|FG000|STARTED|Overall Study||6
10231090|NCT02825043|11359875|FG000|COMPLETED|Overall Study||2
10231091|NCT02825043|11359875|FG000|NOT COMPLETED|Overall Study||4
10231092|NCT02819804|11359879|FG000|STARTED|Complete Cycle 1 (28 Days)||1
10231093|NCT02819804|11359879|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0
10231094|NCT02819804|11359879|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
10231095|NCT02819804|11359879|FG000|STARTED|Start Cycle 2 and Beyond||0
10231096|NCT02819804|11359879|FG000|COMPLETED|Start Cycle 2 and Beyond||0
10231097|NCT02819804|11359879|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0
10231098|NCT02819804|11359879|FG000|STARTED|Follow-up for 1 Year||1
10231099|NCT02819804|11359879|FG000|COMPLETED|Follow-up for 1 Year||1
10231100|NCT02819804|11359879|FG000|NOT COMPLETED|Follow-up for 1 Year||0
10231101|NCT02809118|11359886|FG000|STARTED|Overall Study||18
10231102|NCT02809118|11359887|FG001|STARTED|Overall Study||19
10231103|NCT02809118|11359888|FG002|STARTED|Overall Study||19
10231104|NCT02809118|11359886|FG000|COMPLETED|Overall Study||18
10231105|NCT02809118|11359887|FG001|COMPLETED|Overall Study||18
10231106|NCT02809118|11359888|FG002|COMPLETED|Overall Study||18
10231107|NCT02809118|11359886|FG000|NOT COMPLETED|Overall Study||0
10231108|NCT02809118|11359887|FG001|NOT COMPLETED|Overall Study||1
10231109|NCT02809118|11359888|FG002|NOT COMPLETED|Overall Study||1
10231110|NCT02818946|11359896|FG000|STARTED|Overall Study||30
10231111|NCT02818946|11359896|FG000|COMPLETED|Overall Study||30
10231112|NCT02818946|11359896|FG000|NOT COMPLETED|Overall Study||0
10231113|NCT02819908|11359902|FG000|STARTED|Overall Study||12
10231114|NCT02819908|11359903|FG001|STARTED|Overall Study||13
10231115|NCT02819908|11359902|FG000|COMPLETED|Overall Study||12
10231116|NCT02819908|11359903|FG001|COMPLETED|Overall Study||13
10231117|NCT02819908|11359902|FG000|NOT COMPLETED|Overall Study||0
10231118|NCT02819908|11359903|FG001|NOT COMPLETED|Overall Study||0
10231119|NCT02808390|11359914|FG000|STARTED|Overall Study||4
10231120|NCT02808390|11359915|FG001|STARTED|Overall Study||8
10231121|NCT02808390|11359916|FG002|STARTED|Overall Study||7
10231122|NCT02808390|11359914|FG000|COMPLETED|Overall Study||2
10231123|NCT02808390|11359915|FG001|COMPLETED|Overall Study||2
10231124|NCT02808390|11359916|FG002|COMPLETED|Overall Study||4
10231125|NCT02808390|11359914|FG000|NOT COMPLETED|Overall Study||2
10231126|NCT02808390|11359915|FG001|NOT COMPLETED|Overall Study||6
10231127|NCT02808390|11359916|FG002|NOT COMPLETED|Overall Study||3
10231128|NCT02806960|11359924|FG000|STARTED|Period 1||3
10231129|NCT02806960|11359925|FG001|STARTED|Period 1||3
10231130|NCT02806960|11359926|FG002|STARTED|Period 1||3
9952222|NCT01420679|11071133|FG000|STARTED|Overall Study||14
9952223|NCT01420679|11071134|FG001|STARTED|Overall Study||7
9952224|NCT01420679|11071133|FG000|COMPLETED|Overall Study||0
9952225|NCT01420679|11071134|FG001|COMPLETED|Overall Study||0
9952226|NCT01420679|11071133|FG000|NOT COMPLETED|Overall Study||14
9952227|NCT01420679|11071134|FG001|NOT COMPLETED|Overall Study||7
10231131|NCT02806960|11359927|FG003|STARTED|Period 1||3
10231132|NCT02806960|11359924|FG000|COMPLETED|Period 1||0
10231133|NCT02806960|11359925|FG001|COMPLETED|Period 1||0
10231134|NCT02806960|11359926|FG002|COMPLETED|Period 1||0
10231135|NCT02806960|11359927|FG003|COMPLETED|Period 1||0
10231136|NCT02806960|11359924|FG000|NOT COMPLETED|Period 1||3
10231137|NCT02806960|11359925|FG001|NOT COMPLETED|Period 1||3
10231138|NCT02806960|11359926|FG002|NOT COMPLETED|Period 1||3
10231139|NCT02806960|11359927|FG003|NOT COMPLETED|Period 1||3
10231140|NCT02806960|11359924|FG000|STARTED|Period 2||0
10231141|NCT02806960|11359925|FG001|STARTED|Period 2||0
10231142|NCT02806960|11359926|FG002|STARTED|Period 2||0
10231143|NCT02806960|11359927|FG003|STARTED|Period 2||0
10231144|NCT02806960|11359924|FG000|COMPLETED|Period 2||0
10231145|NCT02806960|11359925|FG001|COMPLETED|Period 2||0
10231146|NCT02806960|11359926|FG002|COMPLETED|Period 2||0
10231147|NCT02806960|11359927|FG003|COMPLETED|Period 2||0
10231148|NCT02806960|11359924|FG000|NOT COMPLETED|Period 2||0
10231149|NCT02806960|11359925|FG001|NOT COMPLETED|Period 2||0
10231150|NCT02806960|11359926|FG002|NOT COMPLETED|Period 2||0
10231151|NCT02806960|11359927|FG003|NOT COMPLETED|Period 2||0
10231152|NCT02806960|11359924|FG000|STARTED|Period 3||0
10231153|NCT02806960|11359925|FG001|STARTED|Period 3||0
10231154|NCT02806960|11359926|FG002|STARTED|Period 3||0
10231155|NCT02806960|11359927|FG003|STARTED|Period 3||0
10231156|NCT02806960|11359924|FG000|COMPLETED|Period 3||0
10231157|NCT02806960|11359925|FG001|COMPLETED|Period 3||0
10231158|NCT02806960|11359926|FG002|COMPLETED|Period 3||0
10231159|NCT02806960|11359927|FG003|COMPLETED|Period 3||0
10231160|NCT02806960|11359924|FG000|NOT COMPLETED|Period 3||0
10231161|NCT02806960|11359925|FG001|NOT COMPLETED|Period 3||0
10231162|NCT02806960|11359926|FG002|NOT COMPLETED|Period 3||0
10231163|NCT02806960|11359927|FG003|NOT COMPLETED|Period 3||0
10231164|NCT02806960|11359924|FG000|STARTED|Period 4||0
10231165|NCT02806960|11359925|FG001|STARTED|Period 4||0
10231166|NCT02806960|11359926|FG002|STARTED|Period 4||0
10231167|NCT02806960|11359927|FG003|STARTED|Period 4||0
10231168|NCT02806960|11359924|FG000|COMPLETED|Period 4||0
9952228|NCT01420848|11071143|FG000|STARTED|Overall Study||24
9952229|NCT01420848|11071144|FG001|STARTED|Overall Study||25
9952230|NCT01420848|11071145|FG002|STARTED|Overall Study||22
9952231|NCT01420848|11071143|FG000|COMPLETED|Overall Study||24
9952232|NCT01420848|11071144|FG001|COMPLETED|Overall Study||25
9952233|NCT01420848|11071145|FG002|COMPLETED|Overall Study||22
9952234|NCT01420848|11071143|FG000|NOT COMPLETED|Overall Study||0
9952235|NCT01420848|11071144|FG001|NOT COMPLETED|Overall Study||0
9952236|NCT01420848|11071145|FG002|NOT COMPLETED|Overall Study||0
9952237|NCT01421017|11071156|FG000|STARTED|Overall Study||12
9952238|NCT01421017|11071157|FG001|STARTED|Overall Study||12
9952239|NCT01421017|11071158|FG002|STARTED|Overall Study||7
10231169|NCT02806960|11359925|FG001|COMPLETED|Period 4||0
10231170|NCT02806960|11359926|FG002|COMPLETED|Period 4||0
10231171|NCT02806960|11359927|FG003|COMPLETED|Period 4||0
10231172|NCT02806960|11359924|FG000|NOT COMPLETED|Period 4||0
10231173|NCT02806960|11359925|FG001|NOT COMPLETED|Period 4||0
10231174|NCT02806960|11359926|FG002|NOT COMPLETED|Period 4||0
10231175|NCT02806960|11359927|FG003|NOT COMPLETED|Period 4||0
10231176|NCT02815397|11359937|FG000|STARTED|Overall Study||2
10231177|NCT02815397|11359937|FG000|COMPLETED|Overall Study||0
10231178|NCT02815397|11359937|FG000|NOT COMPLETED|Overall Study||2
10231179|NCT02802592|11359941|FG000|STARTED|Overall Study||4
10231180|NCT02802592|11359941|FG000|COMPLETED|Overall Study||0
10231181|NCT02802592|11359941|FG000|NOT COMPLETED|Overall Study||4
10231182|NCT02774148|11359948|FG000|STARTED|Overall Study||0
10231183|NCT02774148|11359949|FG001|STARTED|Overall Study||0
10231184|NCT02774148|11359948|FG000|COMPLETED|Overall Study||0
10231185|NCT02774148|11359949|FG001|COMPLETED|Overall Study||0
10231186|NCT02774148|11359948|FG000|NOT COMPLETED|Overall Study||0
10231187|NCT02774148|11359949|FG001|NOT COMPLETED|Overall Study||0
10231188|NCT02773576|11359957|FG000|STARTED|Overall Study||0
10231189|NCT02773576|11359958|FG001|STARTED|Overall Study||0
10231190|NCT02773576|11359957|FG000|COMPLETED|Overall Study||0
10231191|NCT02773576|11359958|FG001|COMPLETED|Overall Study||0
10231192|NCT02773576|11359957|FG000|NOT COMPLETED|Overall Study||0
10231193|NCT02773576|11359958|FG001|NOT COMPLETED|Overall Study||0
10231194|NCT02730793|11359966|FG000|STARTED|Overall Study||2
10231195|NCT02730793|11359967|FG001|STARTED|Overall Study||3
10231196|NCT02730793|11359966|FG000|COMPLETED|Overall Study||2
10231197|NCT02730793|11359967|FG001|COMPLETED|Overall Study||1
10231198|NCT02730793|11359966|FG000|NOT COMPLETED|Overall Study||0
10231199|NCT02730793|11359967|FG001|NOT COMPLETED|Overall Study||2
10231200|NCT02744352|11359975|FG000|STARTED|Overall Study||4
10231201|NCT02744352|11359976|FG001|STARTED|Overall Study||4
10231202|NCT02744352|11359975|FG000|COMPLETED|Overall Study||4
10231203|NCT02744352|11359976|FG001|COMPLETED|Overall Study||4
10231204|NCT02744352|11359975|FG000|NOT COMPLETED|Overall Study||0
10231205|NCT02744352|11359976|FG001|NOT COMPLETED|Overall Study||0
10231206|NCT02760602|11359984|FG000|STARTED|Overall Study||13
10231207|NCT02760602|11359985|FG001|STARTED|Overall Study||13
10231208|NCT02760602|11359984|FG000|COMPLETED|Overall Study||0
10231209|NCT02760602|11359985|FG001|COMPLETED|Overall Study||0
10231210|NCT02760602|11359984|FG000|NOT COMPLETED|Overall Study||13
10231211|NCT02760602|11359985|FG001|NOT COMPLETED|Overall Study||13
10231212|NCT02757521|11359993|FG000|STARTED|Overall Study||1
10231213|NCT02757521|11359994|FG001|STARTED|Overall Study||0
10231214|NCT02757521|11359993|FG000|COMPLETED|Overall Study||0
10231215|NCT02757521|11359994|FG001|COMPLETED|Overall Study||0
10231216|NCT02757521|11359993|FG000|NOT COMPLETED|Overall Study||1
10231217|NCT02757521|11359994|FG001|NOT COMPLETED|Overall Study||0
10231218|NCT02758132|11360002|FG000|STARTED|Overall Study||0
9952240|NCT01421017|11071156|FG000|COMPLETED|Overall Study||10
9952241|NCT01421017|11071157|FG001|COMPLETED|Overall Study||6
9952242|NCT01421017|11071158|FG002|COMPLETED|Overall Study||4
9952243|NCT01421017|11071156|FG000|NOT COMPLETED|Overall Study||2
10231219|NCT02758132|11360003|FG001|STARTED|Overall Study||1
10231220|NCT02758132|11360002|FG000|COMPLETED|Overall Study||0
10231221|NCT02758132|11360003|FG001|COMPLETED|Overall Study||0
10231222|NCT02758132|11360002|FG000|NOT COMPLETED|Overall Study||0
10231223|NCT02758132|11360003|FG001|NOT COMPLETED|Overall Study||1
10231224|NCT02757547|11360009|FG000|STARTED|Overall Study||2
10231225|NCT02757547|11360009|FG000|COMPLETED|Overall Study||2
10231226|NCT02757547|11360009|FG000|NOT COMPLETED|Overall Study||0
10231227|NCT02757053|11360016|FG000|STARTED|Overall Study||3
10231228|NCT02757053|11360017|FG001|STARTED|Overall Study||5
9952244|NCT01421017|11071157|FG001|NOT COMPLETED|Overall Study||6
10231229|NCT02757053|11360016|FG000|COMPLETED|Overall Study||0
10231230|NCT02757053|11360017|FG001|COMPLETED|Overall Study||0
10231231|NCT02757053|11360016|FG000|NOT COMPLETED|Overall Study||3
10231232|NCT02757053|11360017|FG001|NOT COMPLETED|Overall Study||5
10231233|NCT02734940|11360025|FG000|STARTED|Overall Study||0
10231234|NCT02734940|11360026|FG001|STARTED|Overall Study||0
10231235|NCT02734940|11360025|FG000|COMPLETED|Overall Study||0
10231236|NCT02734940|11360026|FG001|COMPLETED|Overall Study||0
10231237|NCT02734940|11360025|FG000|NOT COMPLETED|Overall Study||0
10231238|NCT02734940|11360026|FG001|NOT COMPLETED|Overall Study||0
10231239|NCT02749617|11360032|FG000|STARTED|Overall Study||2
10231240|NCT02749617|11360032|FG000|COMPLETED|Overall Study||2
10231241|NCT02749617|11360032|FG000|NOT COMPLETED|Overall Study||0
10231242|NCT02749227|11360036|FG000|STARTED|Overall Study||4
10231243|NCT02749227|11360036|FG000|COMPLETED|Overall Study||4
10231244|NCT02749227|11360036|FG000|NOT COMPLETED|Overall Study||0
10231245|NCT02745210|11360042|FG000|STARTED|Overall Study||0
10231246|NCT02745210|11360043|FG001|STARTED|Overall Study||9
10231247|NCT02745210|11360042|FG000|COMPLETED|Overall Study||0
10231248|NCT02745210|11360043|FG001|COMPLETED|Overall Study||9
10231249|NCT02745210|11360042|FG000|NOT COMPLETED|Overall Study||0
10231250|NCT02745210|11360043|FG001|NOT COMPLETED|Overall Study||0
10231251|NCT02725671|11360047|FG000|STARTED|Overall Study||2
10231252|NCT02725671|11360047|FG000|COMPLETED|Overall Study||1
10231253|NCT02725671|11360047|FG000|NOT COMPLETED|Overall Study||1
10231254|NCT02746263|11360055|FG000|STARTED|Overall Study||0
10231255|NCT02746263|11360056|FG001|STARTED|Overall Study||1
10231256|NCT02746263|11360055|FG000|Per Protocol Analysis Set|Overall Study||0
10231257|NCT02746263|11360056|FG001|Per Protocol Analysis Set|Overall Study||0
10231258|NCT02746263|11360055|FG000|COMPLETED|Overall Study||0
10231259|NCT02746263|11360056|FG001|COMPLETED|Overall Study||1
10231260|NCT02746263|11360055|FG000|NOT COMPLETED|Overall Study||0
10231261|NCT02746263|11360056|FG001|NOT COMPLETED|Overall Study||0
10231262|NCT02721277|11360062|FG000|STARTED|Overall Study||2
10231263|NCT02721277|11360062|FG000|COMPLETED|Overall Study||2
10231264|NCT02721277|11360062|FG000|NOT COMPLETED|Overall Study||0
10231265|NCT02732327|11360068|FG000|STARTED|Overall Study||0
10231266|NCT02732327|11360069|FG001|STARTED|Overall Study||2
10231267|NCT02732327|11360068|FG000|COMPLETED|Overall Study||0
10231268|NCT02732327|11360069|FG001|COMPLETED|Overall Study||1
10231269|NCT02732327|11360068|FG000|NOT COMPLETED|Overall Study||0
10231270|NCT02732327|11360069|FG001|NOT COMPLETED|Overall Study||1
10231271|NCT02726399|11360075|FG000|STARTED|Overall Study||7
10231272|NCT02726399|11360075|FG000|COMPLETED|Overall Study||0
10231273|NCT02726399|11360075|FG000|NOT COMPLETED|Overall Study||7
10231274|NCT02720510|11360081|FG000|STARTED|Overall Study||3
10231275|NCT02720510|11360082|FG001|STARTED|Overall Study||3
10231276|NCT02720510|11360081|FG000|COMPLETED|Overall Study||0
10231277|NCT02720510|11360082|FG001|COMPLETED|Overall Study||0
10231278|NCT02720510|11360081|FG000|NOT COMPLETED|Overall Study||3
10231279|NCT02720510|11360082|FG001|NOT COMPLETED|Overall Study||3
10231280|NCT02715765|11360091|FG000|STARTED|Overall Study||3
10231281|NCT02715765|11360092|FG001|STARTED|Overall Study||0
10231282|NCT02715765|11360093|FG002|STARTED|Overall Study||0
10231283|NCT02715765|11360091|FG000|COMPLETED|Overall Study||0
10231284|NCT02715765|11360092|FG001|COMPLETED|Overall Study||0
10231285|NCT02715765|11360093|FG002|COMPLETED|Overall Study||0
10231286|NCT02715765|11360091|FG000|NOT COMPLETED|Overall Study||3
10231287|NCT02715765|11360092|FG001|NOT COMPLETED|Overall Study||0
10231288|NCT02715765|11360093|FG002|NOT COMPLETED|Overall Study||0
10231289|NCT02717949|11360103|FG000|STARTED|Overall Study||0
10231290|NCT02717949|11360104|FG001|STARTED|Overall Study||0
10231291|NCT02717949|11360103|FG000|COMPLETED|Overall Study||0
10231292|NCT02717949|11360104|FG001|COMPLETED|Overall Study||0
10231293|NCT02717949|11360103|FG000|NOT COMPLETED|Overall Study||0
10231294|NCT02717949|11360104|FG001|NOT COMPLETED|Overall Study||0
10231295|NCT02717130|11360112|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
10231296|NCT02717130|11360112|FG000|COMPLETED|Overall Study||1
10231297|NCT02717130|11360112|FG000|NOT COMPLETED|Overall Study||7
10231298|NCT02685202|11360116|FG000|STARTED|Overall Study||9
10231299|NCT02685202|11360116|FG000|COMPLETED|Overall Study||0
10231300|NCT02685202|11360116|FG000|NOT COMPLETED|Overall Study||9
10231301|NCT02709083|11360120|FG000|STARTED|Overall Study||7
10231302|NCT02709083|11360120|FG000|COMPLETED|Overall Study||0
10231303|NCT02709083|11360120|FG000|NOT COMPLETED|Overall Study||7
10231304|NCT02693171|11360124|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
10231305|NCT02693171|11360124|FG000|COMPLETED|Overall Study||3
10231306|NCT02693171|11360124|FG000|NOT COMPLETED|Overall Study||9
10231307|NCT02696226|11360132|FG000|STARTED|Overall Study||1
10231308|NCT02696226|11360133|FG001|STARTED|Overall Study||0
10231309|NCT02696226|11360134|FG002|STARTED|Overall Study||2
10231310|NCT02696226|11360135|FG003|STARTED|Overall Study||0
10231311|NCT02696226|11360132|FG000|COMPLETED|Overall Study||0
10231312|NCT02696226|11360133|FG001|COMPLETED|Overall Study||0
10231313|NCT02696226|11360134|FG002|COMPLETED|Overall Study||0
10231314|NCT02696226|11360135|FG003|COMPLETED|Overall Study||0
10231315|NCT02696226|11360132|FG000|NOT COMPLETED|Overall Study||1
10231316|NCT02696226|11360133|FG001|NOT COMPLETED|Overall Study||0
10231317|NCT02696226|11360134|FG002|NOT COMPLETED|Overall Study||2
10231318|NCT02696226|11360135|FG003|NOT COMPLETED|Overall Study||0
10231319|NCT02693743|11360147|FG000|STARTED|Overall Study||1
10231320|NCT02693743|11360148|FG001|STARTED|Overall Study||0
10231321|NCT02693743|11360147|FG000|COMPLETED|Overall Study||0
10231322|NCT02693743|11360148|FG001|COMPLETED|Overall Study||0
10231323|NCT02693743|11360147|FG000|NOT COMPLETED|Overall Study||1
10231324|NCT02693743|11360148|FG001|NOT COMPLETED|Overall Study||0
10231325|NCT02706691|11360154|FG000|STARTED|Overall Study||1
10231326|NCT02706691|11360154|FG000|COMPLETED|Overall Study||0
10231327|NCT02706691|11360154|FG000|NOT COMPLETED|Overall Study||1
10231328|NCT02708849|11360161|FG000|STARTED|Overall Study||2
10231329|NCT02708849|11360162|FG001|STARTED|Overall Study||1
10231330|NCT02708849|11360161|FG000|COMPLETED|Overall Study||1
10231331|NCT02708849|11360162|FG001|COMPLETED|Overall Study||1
10231332|NCT02708849|11360161|FG000|NOT COMPLETED|Overall Study||1
10231333|NCT02708849|11360162|FG001|NOT COMPLETED|Overall Study||0
10231334|NCT02693717|11360168|FG000|STARTED|Overall Study||7
10231335|NCT02693717|11360168|FG000|COMPLETED|Overall Study||7
10231336|NCT02693717|11360168|FG000|NOT COMPLETED|Overall Study||0
10231337|NCT02694757|11360172|FG000|STARTED|Overall Study||3
10231338|NCT02694757|11360172|FG000|COMPLETED|Overall Study||0
10231339|NCT02694757|11360172|FG000|NOT COMPLETED|Overall Study||3
10231340|NCT02693002|11360178|FG000|STARTED|Overall Study||2
10231341|NCT02693002|11360179|FG001|STARTED|Overall Study||2
10231342|NCT02693002|11360178|FG000|COMPLETED|Overall Study||1
10231343|NCT02693002|11360179|FG001|COMPLETED|Overall Study||2
10231344|NCT02693002|11360178|FG000|NOT COMPLETED|Overall Study||1
10231345|NCT02693002|11360179|FG001|NOT COMPLETED|Overall Study||0
10231346|NCT02689518|11360185|FG000|STARTED|Overall Study||49
10231347|NCT02689518|11360185|FG000|COMPLETED|Overall Study||46
10231348|NCT02689518|11360185|FG000|NOT COMPLETED|Overall Study||3
10231349|NCT02687165|11360189|FG000|STARTED|Overall Study||0
10231350|NCT02687165|11360190|FG001|STARTED|Overall Study||0
10231351|NCT02687165|11360189|FG000|COMPLETED|Overall Study||0
10231352|NCT02687165|11360190|FG001|COMPLETED|Overall Study||0
10231353|NCT02687165|11360189|FG000|NOT COMPLETED|Overall Study||0
10231354|NCT02687165|11360190|FG001|NOT COMPLETED|Overall Study||0
10231355|NCT02679560|11360198|FG000|STARTED|Overall Study||1
10231356|NCT02679560|11360199|FG001|STARTED|Overall Study||2
10231357|NCT02679560|11360198|FG000|COMPLETED|Overall Study||1
10231358|NCT02679560|11360199|FG001|COMPLETED|Overall Study||2
10231359|NCT02679560|11360198|FG000|NOT COMPLETED|Overall Study||0
10231360|NCT02679560|11360199|FG001|NOT COMPLETED|Overall Study||0
10231361|NCT02679066|11360207|FG000|STARTED|Overall Study||100
10231362|NCT02679066|11360208|FG001|STARTED|Overall Study||100
10231363|NCT02679066|11360207|FG000|COMPLETED|Overall Study||100
10231364|NCT02679066|11360208|FG001|COMPLETED|Overall Study||100
10231365|NCT02679066|11360207|FG000|NOT COMPLETED|Overall Study||0
10231366|NCT02679066|11360208|FG001|NOT COMPLETED|Overall Study||0
10231367|NCT02673684|11360216|FG000|STARTED|Overall Study||9
10231368|NCT02673684|11360217|FG001|STARTED|Overall Study||8
10231369|NCT02673684|11360216|FG000|COMPLETED|Overall Study||0
10231370|NCT02673684|11360217|FG001|COMPLETED|Overall Study||0
10231371|NCT02673684|11360216|FG000|NOT COMPLETED|Overall Study||9
10231372|NCT02673684|11360217|FG001|NOT COMPLETED|Overall Study||8
10231373|NCT02674204|11360227|FG000|STARTED|Overall Study||1
10231374|NCT02674204|11360228|FG001|STARTED|Overall Study||1
10231375|NCT02674204|11360227|FG000|COMPLETED|Overall Study||0
10231376|NCT02674204|11360228|FG001|COMPLETED|Overall Study||1
10231377|NCT02674204|11360227|FG000|NOT COMPLETED|Overall Study||1
10231378|NCT02674204|11360228|FG001|NOT COMPLETED|Overall Study||0
10231379|NCT02665221|11360236|FG000|STARTED|Overall Study||15
10231380|NCT02665221|11360237|FG001|STARTED|Overall Study||15
10231381|NCT02665221|11360236|FG000|COMPLETED|Overall Study||0
10231382|NCT02665221|11360237|FG001|COMPLETED|Overall Study||0
10231383|NCT02665221|11360236|FG000|NOT COMPLETED|Overall Study||15
10231384|NCT02665221|11360237|FG001|NOT COMPLETED|Overall Study||15
10231385|NCT02672033|11360243|FG000|STARTED|Overall Study||2
10231386|NCT02672033|11360243|FG000|COMPLETED|Overall Study||2
10231387|NCT02672033|11360243|FG000|NOT COMPLETED|Overall Study||0
10231388|NCT02671461|11360250|FG000|STARTED|Treatment||3
10231389|NCT02671461|11360251|FG001|STARTED|Treatment||5
10231390|NCT02671461|11360252|FG002|STARTED|Treatment||7
10231391|NCT02671461|11360250|FG000|COMPLETED|Treatment||1
10231392|NCT02671461|11360251|FG001|COMPLETED|Treatment||2
10231393|NCT02671461|11360252|FG002|COMPLETED|Treatment||2
10231394|NCT02671461|11360250|FG000|NOT COMPLETED|Treatment||2
10231395|NCT02671461|11360251|FG001|NOT COMPLETED|Treatment||3
10231396|NCT02671461|11360252|FG002|NOT COMPLETED|Treatment||5
10231397|NCT02671461|11360250|FG000|STARTED|Follow-up||2
10231398|NCT02671461|11360251|FG001|STARTED|Follow-up||5
10231399|NCT02671461|11360252|FG002|STARTED|Follow-up||7
10231400|NCT02671461|11360250|FG000|COMPLETED|Follow-up||1
10231401|NCT02671461|11360251|FG001|COMPLETED|Follow-up||4
10231402|NCT02671461|11360252|FG002|COMPLETED|Follow-up||6
10231403|NCT02671461|11360250|FG000|NOT COMPLETED|Follow-up||1
10231404|NCT02671461|11360251|FG001|NOT COMPLETED|Follow-up||1
10231405|NCT02671461|11360252|FG002|NOT COMPLETED|Follow-up||1
10231406|NCT02671136|11360262|FG000|STARTED|Overall Study||3
10231407|NCT02671136|11360263|FG001|STARTED|Overall Study||0
10231408|NCT02671136|11360262|FG000|COMPLETED|Overall Study||3
10231409|NCT02671136|11360263|FG001|COMPLETED|Overall Study||0
10231410|NCT02671136|11360262|FG000|NOT COMPLETED|Overall Study||0
10231411|NCT02671136|11360263|FG001|NOT COMPLETED|Overall Study||0
10231412|NCT02663752|11360269|FG000|STARTED|Overall Study||1
10231413|NCT02663752|11360269|FG000|COMPLETED|Overall Study||1
10231414|NCT02663752|11360269|FG000|NOT COMPLETED|Overall Study||0
10231415|NCT02658357|11360275|FG000|STARTED|Overall Study||0
10231416|NCT02658357|11360276|FG001|STARTED|Overall Study||0
10231417|NCT02658357|11360275|FG000|COMPLETED|Overall Study||0
10231418|NCT02658357|11360276|FG001|COMPLETED|Overall Study||0
10231419|NCT02658357|11360275|FG000|NOT COMPLETED|Overall Study||0
10231420|NCT02658357|11360276|FG001|NOT COMPLETED|Overall Study||0
10231421|NCT02665988|11360284|FG000|STARTED|Overall Study||2
10231422|NCT02665988|11360285|FG001|STARTED|Overall Study||2
10231423|NCT02665988|11360284|FG000|COMPLETED|Overall Study||2
10231424|NCT02665988|11360285|FG001|COMPLETED|Overall Study||2
10231425|NCT02665988|11360284|FG000|NOT COMPLETED|Overall Study||0
10231426|NCT02665988|11360285|FG001|NOT COMPLETED|Overall Study||0
10231427|NCT02660528|11360291|FG000|STARTED|Overall Study||0
10231428|NCT02660528|11360291|FG000|COMPLETED|Overall Study||0
10231429|NCT02660528|11360291|FG000|NOT COMPLETED|Overall Study||0
10231430|NCT02658877|11360297|FG000|STARTED|Overall Study||3
10231431|NCT02658877|11360298|FG001|STARTED|Overall Study||0
10231432|NCT02658877|11360297|FG000|COMPLETED|Overall Study||3
10231433|NCT02658877|11360298|FG001|COMPLETED|Overall Study||0
10231434|NCT02658877|11360297|FG000|NOT COMPLETED|Overall Study||0
10231435|NCT02658877|11360298|FG001|NOT COMPLETED|Overall Study||0
10231436|NCT02654782|11360306|FG000|STARTED|Overall Study||5
10231437|NCT02654782|11360307|FG001|STARTED|Overall Study||5
10231438|NCT02654782|11360306|FG000|COMPLETED|Overall Study||5
10231439|NCT02654782|11360307|FG001|COMPLETED|Overall Study||5
10231440|NCT02654782|11360306|FG000|NOT COMPLETED|Overall Study||0
10231441|NCT02654782|11360307|FG001|NOT COMPLETED|Overall Study||0
10231442|NCT02656199|11360313|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
10231443|NCT02656199|11360313|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
10231444|NCT02656199|11360313|FG000|NOT COMPLETED|Overall Study||0
10231445|NCT02654639|11360317|FG000|STARTED|Overall Study||4
10231446|NCT02654639|11360317|FG000|COMPLETED|Overall Study||4
10231447|NCT02654639|11360317|FG000|NOT COMPLETED|Overall Study||0
10231448|NCT02653495|11360323|FG000|STARTED|Overall Study||15
10231449|NCT02653495|11360324|FG001|STARTED|Overall Study||2
10231450|NCT02653495|11360323|FG000|COMPLETED|Overall Study||3
10231451|NCT02653495|11360324|FG001|COMPLETED|Overall Study||2
10231452|NCT02653495|11360323|FG000|NOT COMPLETED|Overall Study||12
10231453|NCT02653495|11360324|FG001|NOT COMPLETED|Overall Study||0
10013202|NCT01790984|11136241|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
10013203|NCT01790984|11136242|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0
10013204|NCT01790984|11136243|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0
10013205|NCT01790984|11136240|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5
10013206|NCT01790984|11136241|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7
10013207|NCT01790984|11136242|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6
10013208|NCT01790984|11136243|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7
10013209|NCT01790984|11136240|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5
10013210|NCT01790984|11136241|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7
10013211|NCT01790984|11136242|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6
10013212|NCT01790984|11136243|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7
10013213|NCT01790984|11136240|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10231454|NCT02640573|11360330|FG000|STARTED|Overall Study||1
9761067|NCT00384930|10864905|FG003|NOT COMPLETED|Overall Study||41
9761068|NCT00384930|10864906|FG004|NOT COMPLETED|Overall Study||47
9761069|NCT00384956|10864921|FG000|STARTED|Overall Study||25
9761070|NCT00384956|10864921|FG000|COMPLETED|Overall Study||22
9761071|NCT00384956|10864921|FG000|NOT COMPLETED|Overall Study||3
9761072|NCT00385008|10864927|FG000|STARTED|Overall Study||10
9761073|NCT00385008|10864928|FG001|STARTED|Overall Study||10
9761074|NCT00385008|10864927|FG000|In Absence of Migraine|Overall Study||10
9761075|NCT00385008|10864928|FG001|In Absence of Migraine|Overall Study||10
9761076|NCT00385008|10864927|FG000|In Presence of Migraine|Overall Study||5
9761077|NCT00385008|10864928|FG001|In Presence of Migraine|Overall Study||5
9761078|NCT00385008|10864927|FG000|COMPLETED|Overall Study||10
9761079|NCT00385008|10864928|FG001|COMPLETED|Overall Study||10
9761080|NCT00385008|10864927|FG000|NOT COMPLETED|Overall Study||0
9761081|NCT00385008|10864928|FG001|NOT COMPLETED|Overall Study||0
9761082|NCT00385138|10864937|FG000|STARTED|Overall Study||2695
9761083|NCT00385138|10864938|FG001|STARTED|Overall Study||2669
9761084|NCT00385138|10864937|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
9761085|NCT00385138|10864938|FG001|Intent-to-treat (ITT)|Overall Study||2669
9829293|NCT00759148|10939890|FG001|STARTED|Overall Study||586
10231455|NCT02640573|11360330|FG000|COMPLETED|Overall Study||0
10231456|NCT02640573|11360330|FG000|NOT COMPLETED|Overall Study||1
10231457|NCT02639390|11360336|FG000|STARTED|Overall Study||0
10231458|NCT02639390|11360337|FG001|STARTED|Overall Study||5
10231459|NCT02639390|11360336|FG000|COMPLETED|Overall Study||0
10231460|NCT02639390|11360337|FG001|COMPLETED|Overall Study||3
10231461|NCT02639390|11360336|FG000|NOT COMPLETED|Overall Study||0
10231462|NCT02639390|11360337|FG001|NOT COMPLETED|Overall Study||2
10013214|NCT01790984|11136241|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10231463|NCT02634606|11360343|FG000|STARTED|Overall Study||13
10231464|NCT02634606|11360343|FG000|COMPLETED|Overall Study||0
10231465|NCT02634606|11360343|FG000|NOT COMPLETED|Overall Study||13
10013215|NCT01790984|11136242|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10231466|NCT02634827|11360351|FG000|STARTED|Overall Study||1
10231467|NCT02634827|11360351|FG000|COMPLETED|Overall Study||1
10231468|NCT02634827|11360351|FG000|NOT COMPLETED|Overall Study||0
10231469|NCT02636283|11360357|FG000|STARTED|Overall Study||3
10231470|NCT02636283|11360358|FG001|STARTED|Overall Study||3
10231471|NCT02636283|11360357|FG000|COMPLETED|Overall Study||1
10231472|NCT02636283|11360358|FG001|COMPLETED|Overall Study||0
10231473|NCT02636283|11360357|FG000|NOT COMPLETED|Overall Study||2
10231474|NCT02636283|11360358|FG001|NOT COMPLETED|Overall Study||3
10231475|NCT02638129|11360366|FG000|STARTED|Overall Study||28
10231476|NCT02638129|11360367|FG001|STARTED|Overall Study||30
10231477|NCT02638129|11360366|FG000|COMPLETED|Overall Study||0
10231478|NCT02638129|11360367|FG001|COMPLETED|Overall Study||0
10231479|NCT02638129|11360366|FG000|NOT COMPLETED|Overall Study||28
10231480|NCT02638129|11360367|FG001|NOT COMPLETED|Overall Study||30
10231481|NCT02615990|11360375|FG000|STARTED|Overall Study||1
10231482|NCT02615990|11360376|FG001|STARTED|Overall Study||1
10231483|NCT02615990|11360375|FG000|COMPLETED|Overall Study||0
10231484|NCT02615990|11360376|FG001|COMPLETED|Overall Study||0
10231485|NCT02615990|11360375|FG000|NOT COMPLETED|Overall Study||1
10231486|NCT02615990|11360376|FG001|NOT COMPLETED|Overall Study||1
10231487|NCT02640677|11360382|FG000|STARTED|Overall Study||2
10231488|NCT02640677|11360382|FG000|COMPLETED|Overall Study||0
10231489|NCT02640677|11360382|FG000|NOT COMPLETED|Overall Study||2
10231490|NCT02633540|11360386|FG000|STARTED|Overall Study||2
10231491|NCT02633540|11360386|FG000|COMPLETED|Overall Study||2
10231492|NCT02633540|11360386|FG000|NOT COMPLETED|Overall Study||0
10231493|NCT02623959|11360392|FG000|STARTED|Overall Study||0
10231494|NCT02623959|11360393|FG001|STARTED|Overall Study||1
10231495|NCT02623959|11360392|FG000|COMPLETED|Overall Study||0
10231496|NCT02623959|11360393|FG001|COMPLETED|Overall Study|due to progression|0
10231497|NCT02623959|11360392|FG000|NOT COMPLETED|Overall Study||0
10231498|NCT02623959|11360393|FG001|NOT COMPLETED|Overall Study||1
10231499|NCT02631148|11360403|FG000|STARTED|Overall Study||12
10231500|NCT02631148|11360404|FG001|STARTED|Overall Study||0
10231501|NCT02631148|11360403|FG000|COMPLETED|Overall Study||2
10231502|NCT02631148|11360404|FG001|COMPLETED|Overall Study||0
10231503|NCT02631148|11360403|FG000|NOT COMPLETED|Overall Study||10
10231504|NCT02631148|11360404|FG001|NOT COMPLETED|Overall Study||0
10231505|NCT02630472|11360412|FG000|STARTED|Overall Study||10
10231506|NCT02630472|11360413|FG001|STARTED|Overall Study||0
10231507|NCT02630472|11360412|FG000|COMPLETED|Overall Study||0
10231508|NCT02630472|11360413|FG001|COMPLETED|Overall Study||0
10231509|NCT02630472|11360412|FG000|NOT COMPLETED|Overall Study||10
10231510|NCT02630472|11360413|FG001|NOT COMPLETED|Overall Study||0
10231511|NCT02626520|11360422|FG000|STARTED|Overall Study||1
10231512|NCT02626520|11360423|FG001|STARTED|Overall Study||10
10231513|NCT02626520|11360422|FG000|COMPLETED|Overall Study||0
10231514|NCT02626520|11360423|FG001|COMPLETED|Overall Study||0
10231515|NCT02626520|11360422|FG000|NOT COMPLETED|Overall Study||1
10231516|NCT02626520|11360423|FG001|NOT COMPLETED|Overall Study||10
10231517|NCT02614898|11360431|FG000|STARTED|Overall Study||15
10231518|NCT02614898|11360432|FG001|STARTED|Overall Study||52
10231519|NCT02614898|11360431|FG000|Safety Population|Overall Study||15
10231520|NCT02614898|11360432|FG001|Safety Population|Overall Study||52
10231521|NCT02614898|11360431|FG000|COMPLETED|Overall Study||0
10231522|NCT02614898|11360432|FG001|COMPLETED|Overall Study||1
10231523|NCT02614898|11360431|FG000|NOT COMPLETED|Overall Study||15
10231524|NCT02614898|11360432|FG001|NOT COMPLETED|Overall Study||51
10231525|NCT02622828|11360439|FG000|STARTED|Overall Study||4
10231526|NCT02622828|11360439|FG000|COMPLETED|Overall Study||1
10231527|NCT02622828|11360439|FG000|NOT COMPLETED|Overall Study||3
10231528|NCT02624739|11360445|FG000|STARTED|Overall Study||0
10231529|NCT02624739|11360446|FG001|STARTED|Overall Study||0
10231530|NCT02624739|11360445|FG000|COMPLETED|Overall Study||0
10231531|NCT02624739|11360446|FG001|COMPLETED|Overall Study||0
10231532|NCT02624739|11360445|FG000|NOT COMPLETED|Overall Study||0
10231533|NCT02624739|11360446|FG001|NOT COMPLETED|Overall Study||0
10231534|NCT02608905|11360454|FG000|STARTED|Overall Study||7
10231535|NCT02608905|11360455|FG001|STARTED|Overall Study||10
10231536|NCT02608905|11360454|FG000|COMPLETED|Overall Study||5
10231537|NCT02608905|11360455|FG001|COMPLETED|Overall Study||10
10231538|NCT02608905|11360454|FG000|NOT COMPLETED|Overall Study||2
10231539|NCT02608905|11360455|FG001|NOT COMPLETED|Overall Study||0
10231540|NCT02619812|11360465|FG000|STARTED|Overall Study||0
10013216|NCT01790984|11136243|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10013217|NCT01791127|11136266|FG000|STARTED|Overall Study||1758
10231541|NCT02619812|11360466|FG001|STARTED|Overall Study||0
10231542|NCT02619812|11360467|FG002|STARTED|Overall Study||1
10231543|NCT02619812|11360468|FG003|STARTED|Overall Study||2
10231544|NCT02619812|11360465|FG000|COMPLETED|Overall Study||0
10231545|NCT02619812|11360466|FG001|COMPLETED|Overall Study||0
10231546|NCT02619812|11360467|FG002|COMPLETED|Overall Study||0
10231547|NCT02619812|11360468|FG003|COMPLETED|Overall Study||0
10231548|NCT02619812|11360465|FG000|NOT COMPLETED|Overall Study||0
10231549|NCT02619812|11360466|FG001|NOT COMPLETED|Overall Study||0
10231550|NCT02619812|11360467|FG002|NOT COMPLETED|Overall Study||1
10231551|NCT02619812|11360468|FG003|NOT COMPLETED|Overall Study||2
10231552|NCT02612285|11360478|FG000|STARTED|Overall Study||1
10231553|NCT02612285|11360478|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
10231554|NCT02612285|11360478|FG000|NOT COMPLETED|Overall Study||1
10231555|NCT02614586|11360482|FG000|STARTED|Overall Study||11
10231556|NCT02614586|11360482|FG000|COMPLETED|Overall Study||11
10231557|NCT02614586|11360482|FG000|NOT COMPLETED|Overall Study||0
10239568|NCT00113386|11371199|FG000|STARTED|Overall Study||10
10239569|NCT00113386|11371200|FG001|STARTED|Overall Study||9
10239570|NCT00113386|11371199|FG000|COMPLETED|Overall Study||3
10231558|NCT02606279|11360488|FG000|STARTED|Overall Study||0
10231559|NCT02606279|11360489|FG001|STARTED|Overall Study||1
10231560|NCT02606279|11360488|FG000|COMPLETED|Overall Study||0
10231561|NCT02606279|11360489|FG001|COMPLETED|Overall Study||0
10231562|NCT02606279|11360488|FG000|NOT COMPLETED|Overall Study||0
10231563|NCT02606279|11360489|FG001|NOT COMPLETED|Overall Study||1
10231564|NCT02605824|11360497|FG000|STARTED|Overall Study||1
10231565|NCT02605824|11360498|FG001|STARTED|Overall Study||0
10231566|NCT02605824|11360497|FG000|COMPLETED|Overall Study||0
10231567|NCT02605824|11360498|FG001|COMPLETED|Overall Study||0
10231568|NCT02605824|11360497|FG000|NOT COMPLETED|Overall Study||1
10231569|NCT02605824|11360498|FG001|NOT COMPLETED|Overall Study||0
10231570|NCT02598622|11360506|FG000|STARTED|Overall Study||8
10231571|NCT02598622|11360507|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
10231572|NCT02598622|11360506|FG000|COMPLETED|Overall Study||2
10231573|NCT02598622|11360507|FG001|COMPLETED|Overall Study||0
10231574|NCT02598622|11360506|FG000|NOT COMPLETED|Overall Study||6
10231575|NCT02598622|11360507|FG001|NOT COMPLETED|Overall Study||0
10231576|NCT02589145|11360516|FG000|STARTED|Overall Study||4
10231577|NCT02589145|11360517|FG001|STARTED|Overall Study||2
10231578|NCT02589145|11360518|FG002|STARTED|Overall Study||2
10231579|NCT02589145|11360516|FG000|COMPLETED|Overall Study||4
10231580|NCT02589145|11360517|FG001|COMPLETED|Overall Study||2
10231581|NCT02589145|11360518|FG002|COMPLETED|Overall Study||2
10231582|NCT02589145|11360516|FG000|NOT COMPLETED|Overall Study||0
10231583|NCT02589145|11360517|FG001|NOT COMPLETED|Overall Study||0
10231584|NCT02589145|11360518|FG002|NOT COMPLETED|Overall Study||0
10231585|NCT02582749|11360528|FG000|STARTED|Overall Study||5
10231586|NCT02582749|11360529|FG001|STARTED|Overall Study||11
10231587|NCT02582749|11360528|FG000|COMPLETED|Overall Study||0
10231588|NCT02582749|11360529|FG001|COMPLETED|Overall Study||0
10231589|NCT02582749|11360528|FG000|NOT COMPLETED|Overall Study||5
10231590|NCT02582749|11360529|FG001|NOT COMPLETED|Overall Study||11
10231591|NCT02590068|11360537|FG000|STARTED|Overall Study||0
10231592|NCT02590068|11360538|FG001|STARTED|Overall Study||14
10231593|NCT02590068|11360537|FG000|COMPLETED|Overall Study||0
10231594|NCT02590068|11360538|FG001|COMPLETED|Overall Study||14
10231595|NCT02590068|11360537|FG000|NOT COMPLETED|Overall Study||0
10231596|NCT02590068|11360538|FG001|NOT COMPLETED|Overall Study||0
10231597|NCT02593682|11360546|FG000|STARTED|Overall Study||0
10231598|NCT02593682|11360547|FG001|STARTED|Overall Study||0
10231599|NCT02593682|11360546|FG000|COMPLETED|Overall Study||0
10231600|NCT02593682|11360547|FG001|COMPLETED|Overall Study||0
10231601|NCT02593682|11360546|FG000|NOT COMPLETED|Overall Study||0
10231602|NCT02593682|11360547|FG001|NOT COMPLETED|Overall Study||0
10231603|NCT02587650|11360553|FG000|STARTED|Overall Study||0
10231604|NCT02587650|11360554|FG001|STARTED|Overall Study||0
10231605|NCT02587650|11360555|FG002|STARTED|Overall Study||1
10231606|NCT02587650|11360556|FG003|STARTED|Overall Study||0
10231607|NCT02587650|11360553|FG000|COMPLETED|Overall Study||0
10231608|NCT02587650|11360554|FG001|COMPLETED|Overall Study||0
10231609|NCT02587650|11360555|FG002|COMPLETED|Overall Study||1
10231610|NCT02587650|11360556|FG003|COMPLETED|Overall Study||0
10231611|NCT02587650|11360553|FG000|NOT COMPLETED|Overall Study||0
10231612|NCT02587650|11360554|FG001|NOT COMPLETED|Overall Study||0
10231613|NCT02587650|11360555|FG002|NOT COMPLETED|Overall Study||0
10231614|NCT02587650|11360556|FG003|NOT COMPLETED|Overall Study||0
10231615|NCT02569957|11360562|FG000|STARTED|Overall Study||0
10231616|NCT02569957|11360563|FG001|STARTED|Overall Study||1
10231617|NCT02569957|11360562|FG000|COMPLETED|Overall Study||0
10231618|NCT02569957|11360563|FG001|COMPLETED|Overall Study||0
10231619|NCT02569957|11360562|FG000|NOT COMPLETED|Overall Study||0
10231620|NCT02569957|11360563|FG001|NOT COMPLETED|Overall Study||1
10231621|NCT02568007|11360572|FG000|STARTED|Overall Study||2
10231622|NCT02568007|11360573|FG001|STARTED|Overall Study||2
10231623|NCT02568007|11360574|FG002|STARTED|Overall Study||0
10231624|NCT02568007|11360572|FG000|COMPLETED|Overall Study||2
10231625|NCT02568007|11360573|FG001|COMPLETED|Overall Study||2
10231626|NCT02568007|11360574|FG002|COMPLETED|Overall Study||0
10231627|NCT02568007|11360572|FG000|NOT COMPLETED|Overall Study||0
10231628|NCT02568007|11360573|FG001|NOT COMPLETED|Overall Study||0
10231629|NCT02568007|11360574|FG002|NOT COMPLETED|Overall Study||0
10231630|NCT02575365|11360582|FG000|STARTED|Overall Study||4
10231631|NCT02575365|11360582|FG000|COMPLETED|Overall Study||0
10231632|NCT02575365|11360582|FG000|NOT COMPLETED|Overall Study||4
10231633|NCT02549755|11360586|FG000|STARTED|Overall Study||1
10231634|NCT02549755|11360586|FG000|COMPLETED|Overall Study||0
10231635|NCT02549755|11360586|FG000|NOT COMPLETED|Overall Study||1
10231636|NCT02547129|11360592|FG000|STARTED|Overall Study||2
10231637|NCT02547129|11360593|FG001|STARTED|Overall Study||2
10231638|NCT02547129|11360592|FG000|COMPLETED|Overall Study||1
10231639|NCT02547129|11360593|FG001|COMPLETED|Overall Study||2
10231640|NCT02547129|11360592|FG000|NOT COMPLETED|Overall Study||1
10231641|NCT02547129|11360593|FG001|NOT COMPLETED|Overall Study||0
10231642|NCT02528097|11360601|FG000|STARTED|Overall Study||1
10231643|NCT02528097|11360602|FG001|STARTED|Overall Study||1
10231644|NCT02528097|11360601|FG000|COMPLETED|Overall Study||1
10231645|NCT02528097|11360602|FG001|COMPLETED|Overall Study||1
10231646|NCT02528097|11360601|FG000|NOT COMPLETED|Overall Study||0
10231647|NCT02528097|11360602|FG001|NOT COMPLETED|Overall Study||0
10231648|NCT02549716|11360610|FG000|STARTED|Overall Study||1
10231649|NCT02549716|11360611|FG001|STARTED|Overall Study||2
10231650|NCT02549716|11360610|FG000|COMPLETED|Overall Study||1
10231651|NCT02549716|11360611|FG001|COMPLETED|Overall Study||2
10231652|NCT02549716|11360610|FG000|NOT COMPLETED|Overall Study||0
10231653|NCT02549716|11360611|FG001|NOT COMPLETED|Overall Study||0
10231654|NCT02540434|11360619|FG000|STARTED|Overall Study||1
10231655|NCT02540434|11360620|FG001|STARTED|Overall Study||1
10231656|NCT02540434|11360619|FG000|COMPLETED|Overall Study||1
10231657|NCT02540434|11360620|FG001|COMPLETED|Overall Study||1
10231658|NCT02540434|11360619|FG000|NOT COMPLETED|Overall Study||0
10231659|NCT02540434|11360620|FG001|NOT COMPLETED|Overall Study||0
10231660|NCT02531308|11360628|FG000|STARTED|Overall Study||5
10231661|NCT02531308|11360628|FG000|COMPLETED|Overall Study||2
10231662|NCT02531308|11360628|FG000|NOT COMPLETED|Overall Study||3
10231663|NCT02533531|11360632|FG000|STARTED|Overall Study||1
10231664|NCT02533531|11360632|FG000|COMPLETED|Overall Study||0
10231665|NCT02533531|11360632|FG000|NOT COMPLETED|Overall Study||1
10231666|NCT02534038|11360638|FG000|STARTED|Period 1 (6 Weeks)||1
10231667|NCT02534038|11360639|FG001|STARTED|Period 1 (6 Weeks)||0
10231668|NCT02534038|11360638|FG000|COMPLETED|Period 1 (6 Weeks)||1
10231669|NCT02534038|11360639|FG001|COMPLETED|Period 1 (6 Weeks)||0
10231670|NCT02534038|11360638|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
10231671|NCT02534038|11360639|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
10231672|NCT02534038|11360638|FG000|STARTED|Period 2 (6 Weeks)||1
10231673|NCT02534038|11360639|FG001|STARTED|Period 2 (6 Weeks)||0
10231674|NCT02534038|11360638|FG000|COMPLETED|Period 2 (6 Weeks)||1
10231675|NCT02534038|11360639|FG001|COMPLETED|Period 2 (6 Weeks)||0
10231676|NCT02534038|11360638|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
10231677|NCT02534038|11360639|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
10231678|NCT02520726|11360648|FG000|STARTED|Overall Study||3
10231679|NCT02520726|11360649|FG001|STARTED|Overall Study||2
10231680|NCT02520726|11360648|FG000|COMPLETED|Overall Study||0
10231681|NCT02520726|11360649|FG001|COMPLETED|Overall Study||0
10231682|NCT02520726|11360648|FG000|NOT COMPLETED|Overall Study||3
10231683|NCT02520726|11360649|FG001|NOT COMPLETED|Overall Study||2
10231684|NCT02520297|11360655|FG000|STARTED|Overall Study||1
10231685|NCT02520297|11360655|FG000|COMPLETED|Overall Study||1
10231686|NCT02520297|11360655|FG000|NOT COMPLETED|Overall Study||0
10231687|NCT02519712|11360659|FG000|STARTED|Overall Study||4
10231688|NCT02519712|11360659|FG000|COMPLETED|Overall Study||0
10231689|NCT02519712|11360659|FG000|NOT COMPLETED|Overall Study||4
10231690|NCT02518750|11360663|FG000|STARTED|Overall Study||3
10231691|NCT02518750|11360663|FG000|COMPLETED|Overall Study||1
10231692|NCT02518750|11360663|FG000|NOT COMPLETED|Overall Study||2
10231693|NCT02516228|11360667|FG000|STARTED|Overall Study||6
10231694|NCT02516228|11360667|FG000|COMPLETED|Overall Study||3
10231695|NCT02516228|11360667|FG000|NOT COMPLETED|Overall Study||3
10231696|NCT02515851|11360673|FG000|STARTED|Overall Study||15
10231697|NCT02515851|11360674|FG001|STARTED|Overall Study||15
10231698|NCT02515851|11360673|FG000|COMPLETED|Overall Study||15
10231699|NCT02515851|11360674|FG001|COMPLETED|Overall Study||15
10231700|NCT02515851|11360673|FG000|NOT COMPLETED|Overall Study||0
10231701|NCT02515851|11360674|FG001|NOT COMPLETED|Overall Study||0
10231702|NCT02506985|11360682|FG000|STARTED|Overall Study||4
10231703|NCT02506985|11360683|FG001|STARTED|Overall Study||6
10231704|NCT02506985|11360682|FG000|COMPLETED|Overall Study||4
10231705|NCT02506985|11360683|FG001|COMPLETED|Overall Study||6
10231706|NCT02506985|11360682|FG000|NOT COMPLETED|Overall Study||0
10231707|NCT02506985|11360683|FG001|NOT COMPLETED|Overall Study||0
10231708|NCT02514252|11360689|FG000|STARTED|Overall Study||6
10231709|NCT02514252|11360689|FG000|COMPLETED|Overall Study||6
10231710|NCT02514252|11360689|FG000|NOT COMPLETED|Overall Study||0
10231711|NCT02501759|11360693|FG000|STARTED|Overall Study||2
10231712|NCT02501759|11360693|FG000|COMPLETED|Overall Study||1
10231713|NCT02501759|11360693|FG000|NOT COMPLETED|Overall Study||1
10231714|NCT02487277|11360699|FG000|STARTED|Overall Study||3
10231715|NCT02487277|11360700|FG001|STARTED|Overall Study||0
10231716|NCT02487277|11360699|FG000|COMPLETED|Overall Study||3
10231717|NCT02487277|11360700|FG001|COMPLETED|Overall Study||0
10231718|NCT02487277|11360699|FG000|NOT COMPLETED|Overall Study||0
10231719|NCT02487277|11360700|FG001|NOT COMPLETED|Overall Study||0
10231720|NCT02506101|11360707|FG000|STARTED|Overall Study||2
10231721|NCT02506101|11360708|FG001|STARTED|Overall Study||0
10231722|NCT02506101|11360707|FG000|COMPLETED|Overall Study||0
10231723|NCT02506101|11360708|FG001|COMPLETED|Overall Study||0
10231724|NCT02506101|11360707|FG000|NOT COMPLETED|Overall Study||2
10231725|NCT02506101|11360708|FG001|NOT COMPLETED|Overall Study||0
10231726|NCT02499887|11360716|FG000|STARTED|Overall Study||3
10231727|NCT02499887|11360717|FG001|STARTED|Overall Study||3
10231728|NCT02499887|11360716|FG000|COMPLETED|Overall Study||3
10231729|NCT02499887|11360717|FG001|COMPLETED|Overall Study||3
10231730|NCT02499887|11360716|FG000|NOT COMPLETED|Overall Study||0
10231731|NCT02499887|11360717|FG001|NOT COMPLETED|Overall Study||0
10231732|NCT02504099|11360723|FG000|STARTED|Overall Study||3
10231733|NCT02504099|11360723|FG000|COMPLETED|Overall Study||3
10231734|NCT02504099|11360723|FG000|NOT COMPLETED|Overall Study||0
10231735|NCT02500901|11360727|FG000|STARTED|Overall Study||2
10231736|NCT02500901|11360727|FG000|COMPLETED|Overall Study||0
10231737|NCT02500901|11360727|FG000|NOT COMPLETED|Overall Study||2
10231738|NCT02483533|11360733|FG000|STARTED|Overall Study||50
10231739|NCT02483533|11360734|FG001|STARTED|Overall Study||50
10231740|NCT02483533|11360733|FG000|COMPLETED|Overall Study||0
10231741|NCT02483533|11360734|FG001|COMPLETED|Overall Study||0
10231742|NCT02483533|11360733|FG000|NOT COMPLETED|Overall Study||50
10231743|NCT02483533|11360734|FG001|NOT COMPLETED|Overall Study||50
10231744|NCT02496039|11360740|FG000|STARTED|Overall Study||5
10231745|NCT02496039|11360740|FG000|COMPLETED|Overall Study||1
10231746|NCT02496039|11360740|FG000|NOT COMPLETED|Overall Study||4
10231747|NCT02492295|11360744|FG000|STARTED|Overall Study||0
10231748|NCT02492295|11360744|FG000|COMPLETED|Overall Study||0
10231749|NCT02492295|11360744|FG000|NOT COMPLETED|Overall Study||0
10231750|NCT02494206|11360749|FG000|STARTED|Overall Study||9
10231751|NCT02494206|11360749|FG000|COMPLETED|Overall Study||7
10231752|NCT02494206|11360749|FG000|NOT COMPLETED|Overall Study||2
10231753|NCT02473445|11360753|FG000|STARTED|Overall Study||22
10013218|NCT01791127|11136266|FG000|COMPLETED|Overall Study||286
10013219|NCT01791127|11136266|FG000|NOT COMPLETED|Overall Study||1472
10013220|NCT01791153|11136287|FG000|STARTED|Part 1: Blinded Period||100
10013221|NCT01791153|11136288|FG001|STARTED|Part 1: Blinded Period||49
10013222|NCT01791153|11136289|FG002|STARTED|Part 1: Blinded Period||50
10013223|NCT01791153|11136290|FG003|STARTED|Part 1: Blinded Period||51
10013224|NCT01791153|11136291|FG004|STARTED|Part 1: Blinded Period||0
10231754|NCT02473445|11360753|FG000|COMPLETED|Overall Study||0
10231755|NCT02473445|11360753|FG000|NOT COMPLETED|Overall Study||22
10231756|NCT02491411|11360757|FG000|STARTED|Overall Study||4
10231757|NCT02491411|11360757|FG000|COMPLETED|Overall Study||0
10231758|NCT02491411|11360757|FG000|NOT COMPLETED|Overall Study||4
10231759|NCT02476994|11360763|FG000|STARTED|Overall Study||1
10231760|NCT02476994|11360764|FG001|STARTED|Overall Study||0
10231761|NCT02476994|11360763|FG000|COMPLETED|Overall Study||0
10231762|NCT02476994|11360764|FG001|COMPLETED|Overall Study||0
10231763|NCT02476994|11360763|FG000|NOT COMPLETED|Overall Study||1
10231764|NCT02476994|11360764|FG001|NOT COMPLETED|Overall Study||0
10231765|NCT02473523|11360770|FG000|STARTED|Overall Study||2
10231766|NCT02473523|11360770|FG000|COMPLETED|Overall Study||0
10231767|NCT02473523|11360770|FG000|NOT COMPLETED|Overall Study||2
10231768|NCT02468583|11360776|FG000|STARTED|Overall Study||3
10231769|NCT02468583|11360777|FG001|STARTED|Overall Study||3
10231770|NCT02468583|11360776|FG000|COMPLETED|Overall Study||3
10231771|NCT02468583|11360777|FG001|COMPLETED|Overall Study||3
10231772|NCT02468583|11360776|FG000|NOT COMPLETED|Overall Study||0
10231773|NCT02468583|11360777|FG001|NOT COMPLETED|Overall Study||0
10231774|NCT02450591|11360783|FG000|STARTED|Overall Study||4
10231775|NCT02450591|11360783|FG000|COMPLETED|Overall Study||4
10231776|NCT02450591|11360783|FG000|NOT COMPLETED|Overall Study||0
10231777|NCT02472639|11360789|FG000|STARTED|Overall Study||4
10231778|NCT02472639|11360790|FG001|STARTED|Overall Study||3
10231779|NCT02472639|11360789|FG000|COMPLETED|Overall Study||0
10231780|NCT02472639|11360790|FG001|COMPLETED|Overall Study||0
10231781|NCT02472639|11360789|FG000|NOT COMPLETED|Overall Study||4
10231782|NCT02472639|11360790|FG001|NOT COMPLETED|Overall Study||3
10231783|NCT02469415|11360796|FG000|STARTED|Overall Study||3
10231784|NCT02469415|11360796|FG000|COMPLETED|Overall Study||0
10231785|NCT02469415|11360796|FG000|NOT COMPLETED|Overall Study||3
10231786|NCT02461550|11360800|FG000|STARTED|Overall Study||2
10231787|NCT02461550|11360800|FG000|COMPLETED|Overall Study||2
10231788|NCT02461550|11360800|FG000|NOT COMPLETED|Overall Study||0
10231789|NCT02461355|11360804|FG000|STARTED|Overall Study||2
10231790|NCT02461355|11360804|FG000|COMPLETED|Overall Study||2
10231791|NCT02461355|11360804|FG000|NOT COMPLETED|Overall Study||0
10231792|NCT02452359|11360808|FG000|STARTED|Overall Study||54
10231793|NCT02452359|11360808|FG000|COMPLETED|Overall Study||33
10231794|NCT02452359|11360808|FG000|NOT COMPLETED|Overall Study||21
10231795|NCT02434146|11360812|FG000|STARTED|Overall Study||3
10231796|NCT02434146|11360812|FG000|COMPLETED|Overall Study||3
10231797|NCT02434146|11360812|FG000|NOT COMPLETED|Overall Study||0
10231798|NCT02452398|11360816|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
10231799|NCT02452398|11360816|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
10231800|NCT02452398|11360816|FG000|NOT COMPLETED|Overall Study||41
10231801|NCT02447887|11360820|FG000|STARTED|Overall Study||3
10231802|NCT02447887|11360820|FG000|COMPLETED|Overall Study||0
10231803|NCT02447887|11360820|FG000|NOT COMPLETED|Overall Study||3
10231804|NCT02431494|11360827|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
10231805|NCT02431494|11360828|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
10231806|NCT02431494|11360829|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
10231807|NCT02431494|11360827|FG000|COMPLETED|Overall Study||0
10231808|NCT02431494|11360828|FG001|COMPLETED|Overall Study||0
10231809|NCT02431494|11360829|FG002|COMPLETED|Overall Study||0
10231810|NCT02431494|11360827|FG000|NOT COMPLETED|Overall Study||0
10231811|NCT02431494|11360828|FG001|NOT COMPLETED|Overall Study||0
10231812|NCT02431494|11360829|FG002|NOT COMPLETED|Overall Study||0
10231813|NCT02439970|11360841|FG000|STARTED|Overall Study||2
10231814|NCT02439970|11360842|FG001|STARTED|Overall Study||3
10231815|NCT02439970|11360841|FG000|COMPLETED|Overall Study||0
10231816|NCT02439970|11360842|FG001|COMPLETED|Overall Study||0
10231817|NCT02439970|11360841|FG000|NOT COMPLETED|Overall Study||2
10231818|NCT02439970|11360842|FG001|NOT COMPLETED|Overall Study||3
10013225|NCT01791153|11136292|FG005|STARTED|Part 1: Blinded Period||0
10231819|NCT02439957|11360850|FG000|STARTED|Overall Study||3
10231820|NCT02439957|11360851|FG001|STARTED|Overall Study||3
10013226|NCT01791153|11136293|FG006|STARTED|Part 1: Blinded Period||0
10013227|NCT01791153|11136294|FG007|STARTED|Part 1: Blinded Period||0
10231821|NCT02439957|11360850|FG000|Blinded Treatment Period|Overall Study||1
10231822|NCT02439957|11360851|FG001|Blinded Treatment Period|Overall Study||2
10231823|NCT02439957|11360850|FG000|COMPLETED|Overall Study||0
10231824|NCT02439957|11360851|FG001|COMPLETED|Overall Study||0
10231825|NCT02439957|11360850|FG000|NOT COMPLETED|Overall Study||3
10231826|NCT02439957|11360851|FG001|NOT COMPLETED|Overall Study||3
10231827|NCT02441036|11360862|FG000|STARTED|Overall Study||3
10231828|NCT02441036|11360863|FG001|STARTED|Overall Study||5
10231829|NCT02441036|11360864|FG002|STARTED|Overall Study||3
10231830|NCT02441036|11360865|FG003|STARTED|Overall Study||4
10231831|NCT02441036|11360866|FG004|STARTED|Overall Study||1
10231832|NCT02441036|11360862|FG000|Treated|Overall Study||3
10231833|NCT02441036|11360863|FG001|Treated|Overall Study||5
10231834|NCT02441036|11360864|FG002|Treated|Overall Study||3
10231835|NCT02441036|11360865|FG003|Treated|Overall Study||4
10231836|NCT02441036|11360866|FG004|Treated|Overall Study||1
10231837|NCT02441036|11360862|FG000|Tissue Resected|Overall Study||3
10231838|NCT02441036|11360863|FG001|Tissue Resected|Overall Study||4
10231839|NCT02441036|11360864|FG002|Tissue Resected|Overall Study||3
10231840|NCT02441036|11360865|FG003|Tissue Resected|Overall Study||3
10231841|NCT02441036|11360866|FG004|Tissue Resected|Overall Study||1
10231842|NCT02441036|11360862|FG000|COMPLETED|Overall Study||3
10231843|NCT02441036|11360863|FG001|COMPLETED|Overall Study||4
10231844|NCT02441036|11360864|FG002|COMPLETED|Overall Study||3
10231845|NCT02441036|11360865|FG003|COMPLETED|Overall Study||3
10231846|NCT02441036|11360866|FG004|COMPLETED|Overall Study||1
10231847|NCT02441036|11360862|FG000|NOT COMPLETED|Overall Study||0
10231848|NCT02441036|11360863|FG001|NOT COMPLETED|Overall Study||1
10231849|NCT02441036|11360864|FG002|NOT COMPLETED|Overall Study||0
10231850|NCT02441036|11360865|FG003|NOT COMPLETED|Overall Study||1
10231851|NCT02441036|11360866|FG004|NOT COMPLETED|Overall Study||0
10231852|NCT02436265|11360881|FG000|STARTED|Overall Study||3
10231853|NCT02436265|11360882|FG001|STARTED|Overall Study||4
10231854|NCT02436265|11360881|FG000|COMPLETED|Overall Study||3
10231855|NCT02436265|11360882|FG001|COMPLETED|Overall Study||4
10231856|NCT02436265|11360881|FG000|NOT COMPLETED|Overall Study||0
10231857|NCT02436265|11360882|FG001|NOT COMPLETED|Overall Study||0
10231858|NCT02429583|11360890|FG000|STARTED|Overall Study||1
10231859|NCT02429583|11360891|FG001|STARTED|Overall Study||23
10231860|NCT02429583|11360890|FG000|COMPLETED|Overall Study||1
10231861|NCT02429583|11360891|FG001|COMPLETED|Overall Study||3
10231862|NCT02429583|11360890|FG000|NOT COMPLETED|Overall Study||0
10231863|NCT02429583|11360891|FG001|NOT COMPLETED|Overall Study||20
10231864|NCT02417870|11360897|FG000|STARTED|Overall Study||2
10231865|NCT02417870|11360897|FG000|COMPLETED|Overall Study||0
10231866|NCT02417870|11360897|FG000|NOT COMPLETED|Overall Study||2
10231867|NCT02430532|11360903|FG000|STARTED|Overall Study||30
10231868|NCT02430532|11360904|FG001|STARTED|Overall Study||28
10231869|NCT02430532|11360903|FG000|COMPLETED|Overall Study||0
10231870|NCT02430532|11360904|FG001|COMPLETED|Overall Study||0
10231871|NCT02430532|11360903|FG000|NOT COMPLETED|Overall Study||30
10231872|NCT02430532|11360904|FG001|NOT COMPLETED|Overall Study||28
10231873|NCT02428231|11360914|FG000|STARTED|Overall Study||30
10231874|NCT02428231|11360915|FG001|STARTED|Overall Study||32
10231875|NCT02428231|11360914|FG000|COMPLETED|Overall Study||17
10231876|NCT02428231|11360915|FG001|COMPLETED|Overall Study||15
10231877|NCT02428231|11360914|FG000|NOT COMPLETED|Overall Study||13
10231878|NCT02428231|11360915|FG001|NOT COMPLETED|Overall Study||17
10231879|NCT02424565|11360921|FG000|STARTED|Period 1 (D0)||8
10231880|NCT02424565|11360922|FG001|STARTED|Period 1 (D0)||7
10231881|NCT02424565|11360921|FG000|COMPLETED|Period 1 (D0)||8
10231882|NCT02424565|11360922|FG001|COMPLETED|Period 1 (D0)||6
10231883|NCT02424565|11360921|FG000|NOT COMPLETED|Period 1 (D0)||0
10231884|NCT02424565|11360922|FG001|NOT COMPLETED|Period 1 (D0)||1
10231885|NCT02424565|11360921|FG000|STARTED|Washout Period||8
10231886|NCT02424565|11360922|FG001|STARTED|Washout Period||6
10231887|NCT02424565|11360921|FG000|COMPLETED|Washout Period||8
10231888|NCT02424565|11360922|FG001|COMPLETED|Washout Period||6
10231889|NCT02424565|11360921|FG000|NOT COMPLETED|Washout Period||0
10231890|NCT02424565|11360922|FG001|NOT COMPLETED|Washout Period||0
10231891|NCT02424565|11360921|FG000|STARTED|Period 2 (D3)||8
10231892|NCT02424565|11360922|FG001|STARTED|Period 2 (D3)||6
10231893|NCT02424565|11360921|FG000|COMPLETED|Period 2 (D3)||8
10231894|NCT02424565|11360922|FG001|COMPLETED|Period 2 (D3)||6
10231895|NCT02424565|11360921|FG000|NOT COMPLETED|Period 2 (D3)||0
10231896|NCT02424565|11360922|FG001|NOT COMPLETED|Period 2 (D3)||0
10231897|NCT02413047|11360928|FG000|STARTED|Overall Study||3
10231898|NCT02413047|11360928|FG000|Participants on Infliximab|Overall Study||2
10231899|NCT02413047|11360928|FG000|Participants on Adalimumab|Overall Study||1
10231900|NCT02413047|11360928|FG000|COMPLETED|Overall Study||3
10231901|NCT02413047|11360928|FG000|NOT COMPLETED|Overall Study||0
10231902|NCT02414698|11360934|FG000|STARTED|Overall Study||3
10231903|NCT02414698|11360935|FG001|STARTED|Overall Study||1
10231904|NCT02414698|11360934|FG000|COMPLETED|Overall Study||3
10231905|NCT02414698|11360935|FG001|COMPLETED|Overall Study||1
10231906|NCT02414698|11360934|FG000|NOT COMPLETED|Overall Study||0
10231907|NCT02414698|11360935|FG001|NOT COMPLETED|Overall Study||0
10231908|NCT02422303|11360943|FG000|STARTED|Overall Study||6
10231909|NCT02422303|11360944|FG001|STARTED|Overall Study||6
10231910|NCT02422303|11360943|FG000|COMPLETED|Overall Study||5
10231911|NCT02422303|11360944|FG001|COMPLETED|Overall Study||5
10231912|NCT02422303|11360943|FG000|NOT COMPLETED|Overall Study||1
10231913|NCT02422303|11360944|FG001|NOT COMPLETED|Overall Study||1
10231914|NCT02415166|11360954|FG000|STARTED|Overall Study||6
10231915|NCT02415166|11360955|FG001|STARTED|Overall Study||0
10231916|NCT02415166|11360956|FG002|STARTED|Overall Study||0
10231917|NCT02415166|11360957|FG003|STARTED|Overall Study||0
10231918|NCT02415166|11360954|FG000|COMPLETED|Overall Study||6
10231919|NCT02415166|11360955|FG001|COMPLETED|Overall Study||0
10231920|NCT02415166|11360956|FG002|COMPLETED|Overall Study||0
10231921|NCT02415166|11360957|FG003|COMPLETED|Overall Study||0
10231922|NCT02415166|11360954|FG000|NOT COMPLETED|Overall Study||0
10231923|NCT02415166|11360955|FG001|NOT COMPLETED|Overall Study||0
10231924|NCT02415166|11360956|FG002|NOT COMPLETED|Overall Study||0
10231925|NCT02415166|11360957|FG003|NOT COMPLETED|Overall Study||0
10231926|NCT02414152|11360967|FG000|STARTED|Overall Study||2
10231927|NCT02414152|11360967|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
10231928|NCT02414152|11360967|FG000|NOT COMPLETED|Overall Study||2
10231929|NCT02410551|11360971|FG000|STARTED|Overall Study||4
10231930|NCT02410551|11360971|FG000|COMPLETED|Overall Study||0
10231931|NCT02410551|11360971|FG000|NOT COMPLETED|Overall Study||4
10231932|NCT02411643|11360976|FG000|STARTED|Overall Study||2
10231933|NCT02411643|11360976|FG000|COMPLETED|Overall Study||2
10231934|NCT02411643|11360976|FG000|NOT COMPLETED|Overall Study||0
10231935|NCT02410954|11360982|FG000|STARTED|Overall Study||14
10231936|NCT02410954|11360983|FG001|STARTED|Overall Study||0
10231937|NCT02410954|11360982|FG000|COMPLETED|Overall Study||0
10231938|NCT02410954|11360983|FG001|COMPLETED|Overall Study||0
10231939|NCT02410954|11360982|FG000|NOT COMPLETED|Overall Study||14
10231940|NCT02410954|11360983|FG001|NOT COMPLETED|Overall Study||0
10231941|NCT02410577|11360989|FG000|STARTED|Overall Study||2
10231942|NCT02410577|11360989|FG000|COMPLETED|Overall Study||2
10231943|NCT02410577|11360989|FG000|NOT COMPLETED|Overall Study||0
10231944|NCT02409355|11360995|FG000|STARTED|Overall Study||4
10231945|NCT02409355|11360996|FG001|STARTED|Overall Study||4
10231946|NCT02409355|11360995|FG000|COMPLETED|Overall Study||0
10231947|NCT02409355|11360996|FG001|COMPLETED|Overall Study||0
10231948|NCT02409355|11360995|FG000|NOT COMPLETED|Overall Study||4
10231949|NCT02409355|11360996|FG001|NOT COMPLETED|Overall Study||4
10231950|NCT02403154|11361006|FG000|STARTED|Overall Study||2
10231951|NCT02403154|11361007|FG001|STARTED|Overall Study||0
10231952|NCT02403154|11361008|FG002|STARTED|Overall Study||1
10231953|NCT02403154|11361009|FG003|STARTED|Overall Study||1
10231954|NCT02403154|11361006|FG000|COMPLETED|Overall Study||0
10231955|NCT02403154|11361007|FG001|COMPLETED|Overall Study||0
10231956|NCT02403154|11361008|FG002|COMPLETED|Overall Study||0
10231957|NCT02403154|11361009|FG003|COMPLETED|Overall Study||0
10231958|NCT02403154|11361006|FG000|NOT COMPLETED|Overall Study||2
10231959|NCT02403154|11361007|FG001|NOT COMPLETED|Overall Study||0
10231960|NCT02403154|11361008|FG002|NOT COMPLETED|Overall Study||1
10231961|NCT02403154|11361009|FG003|NOT COMPLETED|Overall Study||1
10231962|NCT02404545|11361021|FG000|STARTED|Overall Study||6
10231963|NCT02404545|11361022|FG001|STARTED|Overall Study||6
10231964|NCT02404545|11361021|FG000|COMPLETED|Overall Study||0
10231965|NCT02404545|11361022|FG001|COMPLETED|Overall Study||0
10231966|NCT02404545|11361021|FG000|NOT COMPLETED|Overall Study||6
10231967|NCT02404545|11361022|FG001|NOT COMPLETED|Overall Study||6
10013228|NCT01791153|11136287|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
10013229|NCT01791153|11136288|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
10231968|NCT02392377|11361031|FG000|STARTED|Overall Study||0
10231969|NCT02392377|11361032|FG001|STARTED|Overall Study||1
10231970|NCT02392377|11361031|FG000|COMPLETED|Overall Study||0
10231971|NCT02392377|11361032|FG001|COMPLETED|Overall Study||0
10231972|NCT02392377|11361031|FG000|NOT COMPLETED|Overall Study||0
10231973|NCT02392377|11361032|FG001|NOT COMPLETED|Overall Study||1
10231974|NCT02399111|11361044|FG000|STARTED|Overall Study||4
10231975|NCT02399111|11361045|FG001|STARTED|Overall Study||1
10231976|NCT02399111|11361046|FG002|STARTED|Overall Study||4
10231977|NCT02399111|11361047|FG003|STARTED|Overall Study||0
10231978|NCT02399111|11361044|FG000|COMPLETED|Overall Study||4
10231979|NCT02399111|11361045|FG001|COMPLETED|Overall Study||1
10231980|NCT02399111|11361046|FG002|COMPLETED|Overall Study||4
10231981|NCT02399111|11361047|FG003|COMPLETED|Overall Study||0
10231982|NCT02399111|11361044|FG000|NOT COMPLETED|Overall Study||0
10231983|NCT02399111|11361045|FG001|NOT COMPLETED|Overall Study||0
10231984|NCT02399111|11361046|FG002|NOT COMPLETED|Overall Study||0
10231985|NCT02399111|11361047|FG003|NOT COMPLETED|Overall Study||0
10231986|NCT02402036|11361059|FG000|STARTED|Overall Study||10
10231987|NCT02402036|11361059|FG000|COMPLETED|Overall Study||10
10231988|NCT02402036|11361059|FG000|NOT COMPLETED|Overall Study||0
10231989|NCT02394665|11361066|FG000|STARTED|Overall Study||1
10231990|NCT02394665|11361067|FG001|STARTED|Overall Study||0
10231991|NCT02394665|11361068|FG002|STARTED|Overall Study||0
10231992|NCT02394665|11361066|FG000|COMPLETED|Overall Study||0
10231993|NCT02394665|11361067|FG001|COMPLETED|Overall Study||0
10231994|NCT02394665|11361068|FG002|COMPLETED|Overall Study||0
10231995|NCT02394665|11361066|FG000|NOT COMPLETED|Overall Study||1
10231996|NCT02394665|11361067|FG001|NOT COMPLETED|Overall Study||0
10013230|NCT01791153|11136289|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
10013231|NCT01791153|11136290|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
10013232|NCT01791153|11136291|FG004|COMPLETED|Part 1: Blinded Period||0
10231997|NCT02394665|11361068|FG002|NOT COMPLETED|Overall Study||0
10231998|NCT02389712|11361078|FG000|STARTED|Overall Study||1
10231999|NCT02389712|11361079|FG001|STARTED|Overall Study||1
10232000|NCT02389712|11361078|FG000|COMPLETED|Overall Study||1
10232001|NCT02389712|11361079|FG001|COMPLETED|Overall Study||1
10232002|NCT02389712|11361078|FG000|NOT COMPLETED|Overall Study||0
10232003|NCT02389712|11361079|FG001|NOT COMPLETED|Overall Study||0
10232004|NCT02390362|11361087|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
10232005|NCT02390362|11361088|FG001|STARTED|Overall Study||2
10232006|NCT02390362|11361087|FG000|COMPLETED|Overall Study||1
10232007|NCT02390362|11361088|FG001|COMPLETED|Overall Study||1
10232008|NCT02390362|11361087|FG000|NOT COMPLETED|Overall Study||0
10232009|NCT02390362|11361088|FG001|NOT COMPLETED|Overall Study||1
10232010|NCT02388776|11361094|FG000|STARTED|Overall Study||2
10232011|NCT02388776|11361094|FG000|COMPLETED|Overall Study||0
10232012|NCT02388776|11361094|FG000|NOT COMPLETED|Overall Study||2
10232013|NCT02383433|11361099|FG000|STARTED|Overall Study||2
10232014|NCT02383433|11361099|FG000|COMPLETED|Overall Study||0
10232015|NCT02383433|11361099|FG000|NOT COMPLETED|Overall Study||2
10232016|NCT02382588|11361105|FG000|STARTED|Overall Study||4
10232017|NCT02382588|11361106|FG001|STARTED|Overall Study||4
10232018|NCT02382588|11361105|FG000|COMPLETED|Overall Study||4
10232019|NCT02382588|11361106|FG001|COMPLETED|Overall Study||4
10232020|NCT02382588|11361105|FG000|NOT COMPLETED|Overall Study||0
10232021|NCT02382588|11361106|FG001|NOT COMPLETED|Overall Study||0
10232022|NCT02381626|11361115|FG000|STARTED|Overall Study||17
10232023|NCT02381626|11361116|FG001|STARTED|Overall Study||16
10232024|NCT02381626|11361117|FG002|STARTED|Overall Study||6
10232025|NCT02381626|11361115|FG000|COMPLETED|Overall Study||17
10232026|NCT02381626|11361116|FG001|COMPLETED|Overall Study||16
10232027|NCT02381626|11361117|FG002|COMPLETED|Overall Study||6
10232028|NCT02381626|11361115|FG000|NOT COMPLETED|Overall Study||0
10232029|NCT02381626|11361116|FG001|NOT COMPLETED|Overall Study||0
10232030|NCT02381626|11361117|FG002|NOT COMPLETED|Overall Study||0
10232031|NCT02379390|11361127|FG000|STARTED|Overall Study||4
10232032|NCT02379390|11361128|FG001|STARTED|Overall Study||4
10232033|NCT02379390|11361127|FG000|COMPLETED|Overall Study||2
10232034|NCT02379390|11361128|FG001|COMPLETED|Overall Study||2
10232035|NCT02379390|11361127|FG000|NOT COMPLETED|Overall Study||2
10232036|NCT02379390|11361128|FG001|NOT COMPLETED|Overall Study||2
10232037|NCT02373865|11361139|FG000|STARTED|Overall Study||2
10232038|NCT02373865|11361140|FG001|STARTED|Overall Study||2
10232039|NCT02373865|11361139|FG000|COMPLETED|Overall Study||2
10232040|NCT02373865|11361140|FG001|COMPLETED|Overall Study||2
10232041|NCT02373865|11361139|FG000|NOT COMPLETED|Overall Study||0
10232042|NCT02373865|11361140|FG001|NOT COMPLETED|Overall Study||0
10232043|NCT02365688|11361146|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
10232044|NCT02365688|11361146|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
10232045|NCT02365688|11361146|FG000|NOT COMPLETED|Overall Study||0
10232046|NCT02361580|11361152|FG000|STARTED|Overall Study||6
10232047|NCT02361580|11361153|FG001|STARTED|Overall Study||3
10232048|NCT02361580|11361152|FG000|COMPLETED|Overall Study||0
10232049|NCT02361580|11361153|FG001|COMPLETED|Overall Study||0
10232050|NCT02361580|11361152|FG000|NOT COMPLETED|Overall Study||6
10232051|NCT02361580|11361153|FG001|NOT COMPLETED|Overall Study||3
10232052|NCT02369744|11361161|FG000|STARTED|Overall Study||0
10232053|NCT02369744|11361162|FG001|STARTED|Overall Study||0
10232054|NCT02369744|11361161|FG000|COMPLETED|Overall Study||0
10232055|NCT02369744|11361162|FG001|COMPLETED|Overall Study||0
10232056|NCT02369744|11361161|FG000|NOT COMPLETED|Overall Study||0
10232057|NCT02369744|11361162|FG001|NOT COMPLETED|Overall Study||0
10013233|NCT01791153|11136292|FG005|COMPLETED|Part 1: Blinded Period||0
10232058|NCT02379585|11361170|FG000|STARTED|Overall Study||3
10232059|NCT02379585|11361171|FG001|STARTED|Overall Study||5
10232060|NCT02379585|11361170|FG000|COMPLETED|Overall Study||0
10232061|NCT02379585|11361171|FG001|COMPLETED|Overall Study||0
10232062|NCT02379585|11361170|FG000|NOT COMPLETED|Overall Study||3
10232063|NCT02379585|11361171|FG001|NOT COMPLETED|Overall Study||5
10232064|NCT02370888|11361184|FG000|STARTED|Overall Study||9
10232065|NCT02370888|11361184|FG000|Proceed to Treatment|Overall Study||3
10232066|NCT02370888|11361184|FG000|COMPLETED|Overall Study||1
10232067|NCT02370888|11361184|FG000|NOT COMPLETED|Overall Study||8
10232068|NCT02367170|11361194|FG000|STARTED|Overall Study||1
10232069|NCT02367170|11361195|FG001|STARTED|Overall Study||0
10232070|NCT02367170|11361194|FG000|COMPLETED|Overall Study||1
10232071|NCT02367170|11361195|FG001|COMPLETED|Overall Study||0
10232072|NCT02367170|11361194|FG000|NOT COMPLETED|Overall Study||0
10232073|NCT02367170|11361195|FG001|NOT COMPLETED|Overall Study||0
10232074|NCT02376933|11361201|FG000|STARTED|Overall Study||10
10232075|NCT02376933|11361201|FG000|COMPLETED|Overall Study||8
10232076|NCT02376933|11361201|FG000|NOT COMPLETED|Overall Study||2
10232077|NCT02365233|11361208|FG000|STARTED|Overall Study||1
10232078|NCT02365233|11361209|FG001|STARTED|Overall Study||2
10232079|NCT02365233|11361210|FG002|STARTED|Overall Study||2
10232080|NCT02365233|11361208|FG000|COMPLETED|Overall Study||0
10232081|NCT02365233|11361209|FG001|COMPLETED|Overall Study||0
10232082|NCT02365233|11361210|FG002|COMPLETED|Overall Study||0
10232083|NCT02365233|11361208|FG000|NOT COMPLETED|Overall Study||1
10232084|NCT02365233|11361209|FG001|NOT COMPLETED|Overall Study||2
10232085|NCT02365233|11361210|FG002|NOT COMPLETED|Overall Study||2
10232086|NCT02347943|11361221|FG000|STARTED|Overall Study||140
10232087|NCT02347943|11361222|FG001|STARTED|Overall Study||67
10232088|NCT02347943|11361223|FG002|STARTED|Overall Study||45
10232089|NCT02347943|11361221|FG000|COMPLETED|Overall Study||0
10232090|NCT02347943|11361222|FG001|COMPLETED|Overall Study||0
10232091|NCT02347943|11361223|FG002|COMPLETED|Overall Study||0
10232092|NCT02347943|11361221|FG000|NOT COMPLETED|Overall Study||140
10232093|NCT02347943|11361222|FG001|NOT COMPLETED|Overall Study||67
10232094|NCT02347943|11361223|FG002|NOT COMPLETED|Overall Study||45
10232095|NCT02365207|11361231|FG000|STARTED|Overall Study||6
10232096|NCT02365207|11361231|FG000|COMPLETED|Overall Study||4
10232097|NCT02365207|11361231|FG000|NOT COMPLETED|Overall Study||2
10232098|NCT02360111|11361235|FG000|STARTED|Overall Study||3
10232099|NCT02360111|11361235|FG000|COMPLETED|Overall Study||1
10232100|NCT02360111|11361235|FG000|NOT COMPLETED|Overall Study||2
10232101|NCT02353468|11361239|FG000|STARTED|Overall Study||3
10232102|NCT02353468|11361239|FG000|COMPLETED|Overall Study||0
10232103|NCT02353468|11361239|FG000|NOT COMPLETED|Overall Study||3
10232104|NCT02360059|11361245|FG000|STARTED|Overall Study||1
10232105|NCT02360059|11361246|FG001|STARTED|Overall Study||0
10232106|NCT02360059|11361245|FG000|COMPLETED|Overall Study||1
10232107|NCT02360059|11361246|FG001|COMPLETED|Overall Study||0
10232108|NCT02360059|11361245|FG000|NOT COMPLETED|Overall Study||0
10232109|NCT02360059|11361246|FG001|NOT COMPLETED|Overall Study||0
10232110|NCT02350777|11361254|FG000|STARTED|Overall Study||2
10013234|NCT01791153|11136293|FG006|COMPLETED|Part 1: Blinded Period||0
10013235|NCT01791153|11136294|FG007|COMPLETED|Part 1: Blinded Period||0
10013236|NCT01791153|11136287|FG000|NOT COMPLETED|Part 1: Blinded Period||15
10013237|NCT01791153|11136288|FG001|NOT COMPLETED|Part 1: Blinded Period||8
10013238|NCT01791153|11136289|FG002|NOT COMPLETED|Part 1: Blinded Period||6
10013239|NCT01791153|11136290|FG003|NOT COMPLETED|Part 1: Blinded Period||5
10013240|NCT01791153|11136291|FG004|NOT COMPLETED|Part 1: Blinded Period||0
10013241|NCT01791153|11136292|FG005|NOT COMPLETED|Part 1: Blinded Period||0
10013242|NCT01791153|11136293|FG006|NOT COMPLETED|Part 1: Blinded Period||0
10013243|NCT01791153|11136294|FG007|NOT COMPLETED|Part 1: Blinded Period||0
10013244|NCT01791153|11136287|FG000|STARTED|Part 2: Open-label Period||0
10013245|NCT01791153|11136288|FG001|STARTED|Part 2: Open-label Period||0
10013246|NCT01791153|11136289|FG002|STARTED|Part 2: Open-label Period||0
10013247|NCT01791153|11136290|FG003|STARTED|Part 2: Open-label Period||0
10013248|NCT01791153|11136291|FG004|STARTED|Part 2: Open-label Period||40
10013249|NCT01791153|11136292|FG005|STARTED|Part 2: Open-label Period||58
10013250|NCT01791153|11136293|FG006|STARTED|Part 2: Open-label Period||50
10013251|NCT01791153|11136294|FG007|STARTED|Part 2: Open-label Period||67
10013252|NCT01791153|11136287|FG000|COMPLETED|Part 2: Open-label Period||0
10013253|NCT01791153|11136288|FG001|COMPLETED|Part 2: Open-label Period||0
10013254|NCT01791153|11136289|FG002|COMPLETED|Part 2: Open-label Period||0
10013255|NCT01791153|11136290|FG003|COMPLETED|Part 2: Open-label Period||0
10013256|NCT01791153|11136291|FG004|COMPLETED|Part 2: Open-label Period||38
10013257|NCT01791153|11136292|FG005|COMPLETED|Part 2: Open-label Period||54
10013258|NCT01791153|11136293|FG006|COMPLETED|Part 2: Open-label Period||44
10013259|NCT01791153|11136294|FG007|COMPLETED|Part 2: Open-label Period||61
10013260|NCT01791153|11136287|FG000|NOT COMPLETED|Part 2: Open-label Period||0
10013261|NCT01791153|11136288|FG001|NOT COMPLETED|Part 2: Open-label Period||0
10013262|NCT01791153|11136289|FG002|NOT COMPLETED|Part 2: Open-label Period||0
10013263|NCT01791153|11136290|FG003|NOT COMPLETED|Part 2: Open-label Period||0
10013264|NCT01791153|11136291|FG004|NOT COMPLETED|Part 2: Open-label Period||2
10013265|NCT01791153|11136292|FG005|NOT COMPLETED|Part 2: Open-label Period||4
10013266|NCT01791153|11136293|FG006|NOT COMPLETED|Part 2: Open-label Period||6
10013267|NCT01791153|11136294|FG007|NOT COMPLETED|Part 2: Open-label Period||6
10013268|NCT01791205|11136311|FG000|STARTED|Phase I||152
10013269|NCT01791205|11136312|FG001|STARTED|Phase I||152
10232111|NCT02350777|11361255|FG001|STARTED|Overall Study||2
10232112|NCT02350777|11361254|FG000|COMPLETED|Overall Study||2
10232113|NCT02350777|11361255|FG001|COMPLETED|Overall Study||2
10232114|NCT02350777|11361254|FG000|NOT COMPLETED|Overall Study||0
10232115|NCT02350777|11361255|FG001|NOT COMPLETED|Overall Study||0
10232116|NCT02345460|11361261|FG000|STARTED|Overall Study||1
10013270|NCT01791205|11136311|FG000|COMPLETED|Phase I||152
10013271|NCT01791205|11136312|FG001|COMPLETED|Phase I||152
10013272|NCT01791205|11136311|FG000|NOT COMPLETED|Phase I||0
10013273|NCT01791205|11136312|FG001|NOT COMPLETED|Phase I||0
10232117|NCT02345460|11361261|FG000|COMPLETED|Overall Study||1
10232118|NCT02345460|11361261|FG000|NOT COMPLETED|Overall Study||0
10239571|NCT00113386|11371200|FG001|COMPLETED|Overall Study||5
10013274|NCT01791205|11136311|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
10013275|NCT01791205|11136312|FG001|STARTED|Phase II||0
10013276|NCT01791205|11136311|FG000|COMPLETED|Phase II||92
10013277|NCT01791205|11136312|FG001|COMPLETED|Phase II||0
10013278|NCT01791205|11136311|FG000|NOT COMPLETED|Phase II||12
10013279|NCT01791205|11136312|FG001|NOT COMPLETED|Phase II||0
10232119|NCT02346877|11361267|FG000|STARTED|Overall Study||19
10232120|NCT02346877|11361268|FG001|STARTED|Overall Study||0
10232121|NCT02346877|11361267|FG000|COMPLETED|Overall Study||0
10232122|NCT02346877|11361268|FG001|COMPLETED|Overall Study||0
10232123|NCT02346877|11361267|FG000|NOT COMPLETED|Overall Study||19
10232124|NCT02346877|11361268|FG001|NOT COMPLETED|Overall Study||0
10232125|NCT02351063|11361274|FG000|STARTED|Overall Study||1
10232126|NCT02351063|11361274|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1
10232127|NCT02351063|11361274|FG000|NOT COMPLETED|Overall Study||0
10232128|NCT02345772|11361278|FG000|STARTED|Overall Study||4
10232129|NCT02345772|11361278|FG000|COMPLETED|Overall Study||0
10232130|NCT02345772|11361278|FG000|NOT COMPLETED|Overall Study||4
10232131|NCT02340728|11361284|FG000|STARTED|Overall Study||13
10232132|NCT02340728|11361285|FG001|STARTED|Overall Study||11
10232133|NCT02340728|11361284|FG000|COMPLETED|Overall Study||13
10232134|NCT02340728|11361285|FG001|COMPLETED|Overall Study||11
10232135|NCT02340728|11361284|FG000|NOT COMPLETED|Overall Study||0
10232136|NCT02340728|11361285|FG001|NOT COMPLETED|Overall Study||0
10232137|NCT02353572|11361291|FG000|STARTED|Overall Study||3
10232138|NCT02353572|11361291|FG000|COMPLETED|Overall Study||0
10232139|NCT02353572|11361291|FG000|NOT COMPLETED|Overall Study||3
10232140|NCT02345369|11361297|FG000|STARTED|Overall Study||0
10232141|NCT02345369|11361298|FG001|STARTED|Overall Study||0
10232142|NCT02345369|11361297|FG000|COMPLETED|Overall Study||0
10232143|NCT02345369|11361298|FG001|COMPLETED|Overall Study||0
10232144|NCT02345369|11361297|FG000|NOT COMPLETED|Overall Study||0
10232145|NCT02345369|11361298|FG001|NOT COMPLETED|Overall Study||0
10232146|NCT02343263|11361307|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5
10232147|NCT02343263|11361308|FG001|STARTED|Overall Study||3
10232148|NCT02343263|11361309|FG002|STARTED|Overall Study||1
10232149|NCT02343263|11361307|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0
10232150|NCT02343263|11361308|FG001|COMPLETED|Overall Study||0
10232151|NCT02343263|11361309|FG002|COMPLETED|Overall Study||0
10232152|NCT02343263|11361307|FG000|NOT COMPLETED|Overall Study||5
10232153|NCT02343263|11361308|FG001|NOT COMPLETED|Overall Study||3
10232154|NCT02343263|11361309|FG002|NOT COMPLETED|Overall Study||1
10013280|NCT01791244|11136320|FG000|STARTED|Overall Study||46
10013281|NCT01791244|11136321|FG001|STARTED|Overall Study||47
10013282|NCT01791244|11136320|FG000|Intent to Treat (ITT)|Overall Study||38
10013283|NCT01791244|11136321|FG001|Intent to Treat (ITT)|Overall Study||39
10232155|NCT02343159|11361324|FG000|STARTED|Overall Study||27
10232156|NCT02343159|11361325|FG001|STARTED|Overall Study||27
10232157|NCT02343159|11361326|FG002|STARTED|Overall Study||30
10232158|NCT02343159|11361324|FG000|COMPLETED|Overall Study||1
10232159|NCT02343159|11361325|FG001|COMPLETED|Overall Study||1
10232160|NCT02343159|11361326|FG002|COMPLETED|Overall Study||0
10232161|NCT02343159|11361324|FG000|NOT COMPLETED|Overall Study||26
10232162|NCT02343159|11361325|FG001|NOT COMPLETED|Overall Study||26
10232163|NCT02343159|11361326|FG002|NOT COMPLETED|Overall Study||30
10232164|NCT02341495|11361335|FG000|STARTED|Overall Study||4
10232165|NCT02341495|11361335|FG000|COMPLETED|Overall Study||4
10232166|NCT02341495|11361335|FG000|NOT COMPLETED|Overall Study||0
10112045|NCT02501135|11243111|FG000|STARTED|Overall Study||281
10112046|NCT02501135|11243111|FG000|COMPLETED|Overall Study||281
10112047|NCT02501135|11243111|FG000|NOT COMPLETED|Overall Study||0
10112048|NCT02501161|11243123|FG000|STARTED|Overall Study||506
10112049|NCT02501161|11243124|FG001|STARTED|Overall Study||506
9829294|NCT00759148|10939889|FG000|COMPLETED|Overall Study||579
9829295|NCT00759148|10939890|FG001|COMPLETED|Overall Study||554
10013284|NCT01791244|11136320|FG000|COMPLETED|Overall Study||31
10013285|NCT01791244|11136321|FG001|COMPLETED|Overall Study||29
10013286|NCT01791244|11136320|FG000|NOT COMPLETED|Overall Study||15
10013287|NCT01791244|11136321|FG001|NOT COMPLETED|Overall Study||18
10013288|NCT01791413|11136331|FG000|STARTED|Overall Study||20
10013289|NCT01791413|11136332|FG001|STARTED|Overall Study||20
10013290|NCT01791413|11136331|FG000|COMPLETED|Overall Study||15
10013291|NCT01791413|11136332|FG001|COMPLETED|Overall Study||19
10013292|NCT01791413|11136331|FG000|NOT COMPLETED|Overall Study||5
10013293|NCT01791413|11136332|FG001|NOT COMPLETED|Overall Study||1
10013294|NCT01791465|11136339|FG000|STARTED|Overall Study||6
10013295|NCT01791465|11136339|FG000|COMPLETED|Overall Study||6
10013296|NCT01791465|11136339|FG000|NOT COMPLETED|Overall Study||0
10013297|NCT01791491|11136344|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
10013298|NCT01791491|11136344|FG000|COMPLETED|Overall Study||9
10013299|NCT01791491|11136344|FG000|NOT COMPLETED|Overall Study||0
9761086|NCT00385138|10864937|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
9761087|NCT00385138|10864938|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
9761088|NCT00385138|10864937|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
9761089|NCT00385138|10864938|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
9952245|NCT01421017|11071158|FG002|NOT COMPLETED|Overall Study||3
9952246|NCT01421134|11071168|FG000|STARTED|Overall Study||109
9761090|NCT00385138|10864937|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
9761091|NCT00385138|10864938|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
9761092|NCT00385138|10864937|FG000|NOT COMPLETED|Overall Study||30
9761093|NCT00385138|10864938|FG001|NOT COMPLETED|Overall Study||28
9761094|NCT00385203|10864946|FG000|STARTED|Overall Study||26
9761095|NCT00385203|10864947|FG001|STARTED|Overall Study||10
9761096|NCT00385203|10864946|FG000|COMPLETED|Overall Study||0
9761097|NCT00385203|10864947|FG001|COMPLETED|Overall Study||3
9761098|NCT00385203|10864946|FG000|NOT COMPLETED|Overall Study||26
9761099|NCT00385203|10864947|FG001|NOT COMPLETED|Overall Study||7
9761100|NCT00385216|10864954|FG000|STARTED|First Intervention||11
9761101|NCT00385216|10864955|FG001|STARTED|First Intervention||9
9761102|NCT00385216|10864954|FG000|COMPLETED|First Intervention||11
9761103|NCT00385216|10864955|FG001|COMPLETED|First Intervention||9
9761104|NCT00385216|10864954|FG000|NOT COMPLETED|First Intervention||0
9761105|NCT00385216|10864955|FG001|NOT COMPLETED|First Intervention||0
9761106|NCT00385216|10864954|FG000|STARTED|Second Intervention||11
9761107|NCT00385216|10864955|FG001|STARTED|Second Intervention||9
9761108|NCT00385216|10864954|FG000|COMPLETED|Second Intervention||11
9761109|NCT00385216|10864955|FG001|COMPLETED|Second Intervention||9
9761110|NCT00385216|10864954|FG000|NOT COMPLETED|Second Intervention||0
9761111|NCT00385216|10864955|FG001|NOT COMPLETED|Second Intervention||0
9761112|NCT00385255|10864963|FG000|STARTED|Overall Study||860
9761113|NCT00385255|10864964|FG001|STARTED|Overall Study||858
9761114|NCT00385255|10864963|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
9761115|NCT00385255|10864964|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
9761116|NCT00385255|10864963|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748
9761117|NCT00385255|10864964|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749
9761118|NCT00385255|10864963|FG000|COMPLETED|Overall Study||839
9761119|NCT00385255|10864964|FG001|COMPLETED|Overall Study||785
9761120|NCT00385255|10864963|FG000|NOT COMPLETED|Overall Study||21
9761121|NCT00385255|10864964|FG001|NOT COMPLETED|Overall Study||73
9761122|NCT00385268|10864976|FG000|STARTED|Overall Study||34
9761123|NCT00385268|10864977|FG001|STARTED|Overall Study||26
9761124|NCT00385268|10864976|FG000|COMPLETED|Overall Study||18
9761125|NCT00385268|10864977|FG001|COMPLETED|Overall Study||18
9761126|NCT00385268|10864976|FG000|NOT COMPLETED|Overall Study||16
9761127|NCT00385268|10864977|FG001|NOT COMPLETED|Overall Study||8
9761128|NCT00385541|10864985|FG000|STARTED|Overall Study||25
9761129|NCT00385541|10864986|FG001|STARTED|Overall Study||25
9761130|NCT00385541|10864985|FG000|COMPLETED|Overall Study||25
9761131|NCT00385541|10864986|FG001|COMPLETED|Overall Study||24
9761132|NCT00385541|10864985|FG000|NOT COMPLETED|Overall Study||0
9761133|NCT00385541|10864986|FG001|NOT COMPLETED|Overall Study||1
9761134|NCT00385580|10864994|FG000|STARTED|Overall Study|Number of participants treated.|48
9761135|NCT00385580|10864995|FG001|STARTED|Overall Study|Number of participants treated.|47
9761136|NCT00385580|10864994|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
9761137|NCT00385580|10864995|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
9761138|NCT00385580|10864994|FG000|NOT COMPLETED|Overall Study||0
9761139|NCT00385580|10864995|FG001|NOT COMPLETED|Overall Study||0
9761140|NCT00385593|10865013|FG000|STARTED|Overall Study||328
9761141|NCT00385593|10865014|FG001|STARTED|Overall Study||326
9761142|NCT00385593|10865013|FG000|COMPLETED|Overall Study||270
9761143|NCT00385593|10865014|FG001|COMPLETED|Overall Study||289
9761144|NCT00385593|10865013|FG000|NOT COMPLETED|Overall Study||58
9761145|NCT00385593|10865014|FG001|NOT COMPLETED|Overall Study||37
9761146|NCT00385671|10865023|FG000|STARTED|Overall Study||134
9761147|NCT00385671|10865024|FG001|STARTED|Overall Study||138
9761148|NCT00385671|10865025|FG002|STARTED|Overall Study||135
9761149|NCT00385671|10865023|FG000|COMPLETED|Overall Study||96
9761150|NCT00385671|10865024|FG001|COMPLETED|Overall Study||87
9761151|NCT00385671|10865025|FG002|COMPLETED|Overall Study||99
9761152|NCT00385671|10865023|FG000|NOT COMPLETED|Overall Study||38
9761153|NCT00385671|10865024|FG001|NOT COMPLETED|Overall Study||51
9761154|NCT00385671|10865025|FG002|NOT COMPLETED|Overall Study||36
9952247|NCT01421134|11071169|FG001|STARTED|Overall Study||102
9761155|NCT00385684|10865035|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6
9761156|NCT00385684|10865036|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5
9761157|NCT00385684|10865035|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5
9761158|NCT00385684|10865036|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5
9761159|NCT00385684|10865035|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
9761160|NCT00385684|10865036|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
10013300|NCT01791517|11136351|FG000|STARTED|Phase I: Period 1||19
10013301|NCT01791517|11136352|FG001|STARTED|Phase I: Period 1||20
10013302|NCT01791517|11136353|FG002|STARTED|Phase I: Period 1||20
10013303|NCT01791517|11136354|FG003|STARTED|Phase I: Period 1||19
10013304|NCT01791517|11136355|FG004|STARTED|Phase I: Period 1||20
10013305|NCT01791517|11136356|FG005|STARTED|Phase I: Period 1||20
10013306|NCT01791517|11136357|FG006|STARTED|Phase I: Period 1||20
10013307|NCT01791517|11136358|FG007|STARTED|Phase I: Period 1||20
10013308|NCT01791517|11136359|FG008|STARTED|Phase I: Period 1||20
10013309|NCT01791517|11136360|FG009|STARTED|Phase I: Period 1||20
10013310|NCT01791517|11136361|FG010|STARTED|Phase I: Period 1||18
10013311|NCT01791517|11136362|FG011|STARTED|Phase I: Period 1||20
10112050|NCT02501161|11243123|FG000|Exposed|Overall Study||506
10112051|NCT02501161|11243124|FG001|Exposed|Overall Study||504
10112052|NCT02501161|11243123|FG000|COMPLETED|Overall Study||484
10112053|NCT02501161|11243124|FG001|COMPLETED|Overall Study||481
10112054|NCT02501161|11243123|FG000|NOT COMPLETED|Overall Study||22
10112055|NCT02501161|11243124|FG001|NOT COMPLETED|Overall Study||25
10112056|NCT02501265|11243134|FG000|STARTED|Overall Study||63
10112057|NCT02501265|11243135|FG001|STARTED|Overall Study||30
10232167|NCT02336425|11361343|FG000|STARTED|Overall Study||2
10232168|NCT02336425|11361344|FG001|STARTED|Overall Study||2
10232169|NCT02336425|11361345|FG002|STARTED|Overall Study||3
10232170|NCT02336425|11361346|FG003|STARTED|Overall Study||3
10232171|NCT02336425|11361343|FG000|COMPLETED|Overall Study||0
10232172|NCT02336425|11361344|FG001|COMPLETED|Overall Study||0
10232173|NCT02336425|11361345|FG002|COMPLETED|Overall Study||0
10232174|NCT02336425|11361346|FG003|COMPLETED|Overall Study||0
10232175|NCT02336425|11361343|FG000|NOT COMPLETED|Overall Study||2
10232176|NCT02336425|11361344|FG001|NOT COMPLETED|Overall Study||2
10232177|NCT02336425|11361345|FG002|NOT COMPLETED|Overall Study||3
10232178|NCT02336425|11361346|FG003|NOT COMPLETED|Overall Study||3
10232179|NCT02336763|11361356|FG000|STARTED|Overall Study||2
10232180|NCT02336763|11361356|FG000|COMPLETED|Overall Study||2
10232181|NCT02336763|11361356|FG000|NOT COMPLETED|Overall Study||0
10232182|NCT02320825|11361362|FG000|STARTED|Overall Study||8
10013312|NCT01791517|11136351|FG000|COMPLETED|Phase I: Period 1||18
10013313|NCT01791517|11136352|FG001|COMPLETED|Phase I: Period 1||18
10013314|NCT01791517|11136353|FG002|COMPLETED|Phase I: Period 1||18
10013315|NCT01791517|11136354|FG003|COMPLETED|Phase I: Period 1||17
10013316|NCT01791517|11136355|FG004|COMPLETED|Phase I: Period 1||19
10013317|NCT01791517|11136356|FG005|COMPLETED|Phase I: Period 1||19
10013318|NCT01791517|11136357|FG006|COMPLETED|Phase I: Period 1||19
10013319|NCT01791517|11136358|FG007|COMPLETED|Phase I: Period 1||20
10013320|NCT01791517|11136359|FG008|COMPLETED|Phase I: Period 1||19
10013321|NCT01791517|11136360|FG009|COMPLETED|Phase I: Period 1||19
10013322|NCT01791517|11136361|FG010|COMPLETED|Phase I: Period 1||18
10013323|NCT01791517|11136362|FG011|COMPLETED|Phase I: Period 1||19
10013324|NCT01791517|11136351|FG000|NOT COMPLETED|Phase I: Period 1||1
10013325|NCT01791517|11136352|FG001|NOT COMPLETED|Phase I: Period 1||2
10013326|NCT01791517|11136353|FG002|NOT COMPLETED|Phase I: Period 1||2
10013327|NCT01791517|11136354|FG003|NOT COMPLETED|Phase I: Period 1||2
10013328|NCT01791517|11136355|FG004|NOT COMPLETED|Phase I: Period 1||1
10013329|NCT01791517|11136356|FG005|NOT COMPLETED|Phase I: Period 1||1
10013330|NCT01791517|11136357|FG006|NOT COMPLETED|Phase I: Period 1||1
10013331|NCT01791517|11136358|FG007|NOT COMPLETED|Phase I: Period 1||0
10013332|NCT01791517|11136359|FG008|NOT COMPLETED|Phase I: Period 1||1
10013333|NCT01791517|11136360|FG009|NOT COMPLETED|Phase I: Period 1||1
10013334|NCT01791517|11136361|FG010|NOT COMPLETED|Phase I: Period 1||0
10013335|NCT01791517|11136362|FG011|NOT COMPLETED|Phase I: Period 1||1
10013336|NCT01791517|11136351|FG000|STARTED|Phase I: Period 2||18
10013337|NCT01791517|11136352|FG001|STARTED|Phase I: Period 2||18
10013338|NCT01791517|11136353|FG002|STARTED|Phase I: Period 2||18
10013339|NCT01791517|11136354|FG003|STARTED|Phase I: Period 2||17
10013340|NCT01791517|11136355|FG004|STARTED|Phase I: Period 2||19
10013341|NCT01791517|11136356|FG005|STARTED|Phase I: Period 2||19
10013342|NCT01791517|11136357|FG006|STARTED|Phase I: Period 2||19
10013343|NCT01791517|11136358|FG007|STARTED|Phase I: Period 2||20
9761161|NCT00385684|10865035|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5
9761162|NCT00385684|10865036|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5
9761163|NCT00385684|10865035|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5
9761164|NCT00385684|10865036|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3
9761165|NCT00385684|10865035|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
9761166|NCT00385684|10865036|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
9761167|NCT00385684|10865035|FG000|STARTED|PHASE B||5
9761168|NCT00385684|10865036|FG001|STARTED|PHASE B||3
9761169|NCT00385684|10865035|FG000|COMPLETED|PHASE B||5
9761170|NCT00385684|10865036|FG001|COMPLETED|PHASE B||3
9761171|NCT00385684|10865035|FG000|NOT COMPLETED|PHASE B||0
9761172|NCT00385684|10865036|FG001|NOT COMPLETED|PHASE B||0
9761173|NCT00385723|10865045|FG000|STARTED|Overall Study||46
9761174|NCT00385723|10865046|FG001|STARTED|Overall Study||46
9761175|NCT00385723|10865047|FG002|STARTED|Overall Study||46
9761176|NCT00385723|10865045|FG000|COMPLETED|Overall Study||44
9761177|NCT00385723|10865046|FG001|COMPLETED|Overall Study||45
9761178|NCT00385723|10865047|FG002|COMPLETED|Overall Study||44
9761179|NCT00385723|10865045|FG000|NOT COMPLETED|Overall Study||2
9761180|NCT00385723|10865046|FG001|NOT COMPLETED|Overall Study||1
9761181|NCT00385723|10865047|FG002|NOT COMPLETED|Overall Study||2
9761182|NCT00385736|10865058|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
9761183|NCT00385736|10865059|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
9761184|NCT00385736|10865060|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
9761185|NCT00385736|10865058|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
9761186|NCT00385736|10865059|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
9761187|NCT00385736|10865060|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
9761188|NCT00385736|10865058|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9
9761189|NCT00385736|10865059|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12
9761190|NCT00385736|10865060|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9
9761191|NCT00385736|10865058|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
9761192|NCT00385736|10865059|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
9761193|NCT00385736|10865060|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
9761194|NCT00385736|10865058|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153
9761195|NCT00385736|10865059|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86
9761196|NCT00385736|10865060|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143
9761197|NCT00385736|10865058|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
9761198|NCT00385736|10865059|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
9761199|NCT00385736|10865060|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
9761200|NCT00385736|10865058|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
9761201|NCT00385736|10865059|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
9761202|NCT00385736|10865060|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
9761203|NCT00385736|10865058|FG000|COMPLETED|Safety Analysis Set||153
9761204|NCT00385736|10865059|FG001|COMPLETED|Safety Analysis Set||86
9761205|NCT00385736|10865060|FG002|COMPLETED|Safety Analysis Set||143
9761206|NCT00385736|10865058|FG000|NOT COMPLETED|Safety Analysis Set||70
9761207|NCT00385736|10865059|FG001|NOT COMPLETED|Safety Analysis Set||44
9761208|NCT00385736|10865060|FG002|NOT COMPLETED|Safety Analysis Set||80
9761209|NCT00385762|10865071|FG000|STARTED|Overall Study||35
9761210|NCT00385762|10865071|FG000|COMPLETED|Overall Study||33
9761211|NCT00385762|10865071|FG000|NOT COMPLETED|Overall Study||2
9761212|NCT00385788|10865077|FG000|STARTED|Overall Study||12
10232183|NCT02320825|11361363|FG001|STARTED|Overall Study||8
10232184|NCT02320825|11361362|FG000|COMPLETED|Overall Study||8
10232185|NCT02320825|11361363|FG001|COMPLETED|Overall Study||8
10232186|NCT02320825|11361362|FG000|NOT COMPLETED|Overall Study||0
10232187|NCT02320825|11361363|FG001|NOT COMPLETED|Overall Study||0
10232188|NCT02319005|11361371|FG000|STARTED|Overall Study||140
10232189|NCT02319005|11361372|FG001|STARTED|Overall Study||66
10232190|NCT02319005|11361371|FG000|COMPLETED|Overall Study||92
10232191|NCT02319005|11361372|FG001|COMPLETED|Overall Study||51
10232192|NCT02319005|11361371|FG000|NOT COMPLETED|Overall Study||48
10232193|NCT02319005|11361372|FG001|NOT COMPLETED|Overall Study||15
10232194|NCT02318901|11361381|FG000|STARTED|Overall Study||5
10232195|NCT02318901|11361382|FG001|STARTED|Overall Study||1
10232196|NCT02318901|11361383|FG002|STARTED|Overall Study||10
10232197|NCT02318901|11361381|FG000|COMPLETED|Overall Study||0
10232198|NCT02318901|11361382|FG001|COMPLETED|Overall Study||0
10232199|NCT02318901|11361383|FG002|COMPLETED|Overall Study||0
10232200|NCT02318901|11361381|FG000|NOT COMPLETED|Overall Study||5
10232201|NCT02318901|11361382|FG001|NOT COMPLETED|Overall Study||1
10232202|NCT02318901|11361383|FG002|NOT COMPLETED|Overall Study||10
10232203|NCT02317276|11361391|FG000|STARTED|Overall Study||11
10232204|NCT02317276|11361391|FG000|COMPLETED|Overall Study||5
10232205|NCT02317276|11361391|FG000|NOT COMPLETED|Overall Study||6
10232206|NCT02307188|11361395|FG000|STARTED|Overall Study||5
10232207|NCT02307188|11361395|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
10232208|NCT02307188|11361395|FG000|NOT COMPLETED|Overall Study||4
10232209|NCT02308475|11361399|FG000|STARTED|Overall Study||2
10232210|NCT02308475|11361399|FG000|COMPLETED|Overall Study||2
10232211|NCT02308475|11361399|FG000|NOT COMPLETED|Overall Study||0
10232212|NCT02308735|11361407|FG000|STARTED|Overall Study||2
10232213|NCT02308735|11361408|FG001|STARTED|Overall Study||0
10013344|NCT01791517|11136359|FG008|STARTED|Phase I: Period 2||19
10013345|NCT01791517|11136360|FG009|STARTED|Phase I: Period 2||19
10013346|NCT01791517|11136361|FG010|STARTED|Phase I: Period 2||18
10013347|NCT01791517|11136362|FG011|STARTED|Phase I: Period 2||19
10013348|NCT01791517|11136351|FG000|COMPLETED|Phase I: Period 2||17
10013349|NCT01791517|11136352|FG001|COMPLETED|Phase I: Period 2||15
10013350|NCT01791517|11136353|FG002|COMPLETED|Phase I: Period 2||16
10013351|NCT01791517|11136354|FG003|COMPLETED|Phase I: Period 2||16
10013352|NCT01791517|11136355|FG004|COMPLETED|Phase I: Period 2||19
10013353|NCT01791517|11136356|FG005|COMPLETED|Phase I: Period 2||18
10013354|NCT01791517|11136357|FG006|COMPLETED|Phase I: Period 2||19
10013355|NCT01791517|11136358|FG007|COMPLETED|Phase I: Period 2||20
10013356|NCT01791517|11136359|FG008|COMPLETED|Phase I: Period 2||19
10013357|NCT01791517|11136360|FG009|COMPLETED|Phase I: Period 2||18
10013358|NCT01791517|11136361|FG010|COMPLETED|Phase I: Period 2||16
10013359|NCT01791517|11136362|FG011|COMPLETED|Phase I: Period 2||19
10013360|NCT01791517|11136351|FG000|NOT COMPLETED|Phase I: Period 2||1
10013361|NCT01791517|11136352|FG001|NOT COMPLETED|Phase I: Period 2||3
10013362|NCT01791517|11136353|FG002|NOT COMPLETED|Phase I: Period 2||2
10013363|NCT01791517|11136354|FG003|NOT COMPLETED|Phase I: Period 2||1
10013364|NCT01791517|11136355|FG004|NOT COMPLETED|Phase I: Period 2||0
10013365|NCT01791517|11136356|FG005|NOT COMPLETED|Phase I: Period 2||1
10013366|NCT01791517|11136357|FG006|NOT COMPLETED|Phase I: Period 2||0
10013367|NCT01791517|11136358|FG007|NOT COMPLETED|Phase I: Period 2||0
10013368|NCT01791517|11136359|FG008|NOT COMPLETED|Phase I: Period 2||0
10013369|NCT01791517|11136360|FG009|NOT COMPLETED|Phase I: Period 2||1
10013370|NCT01791517|11136361|FG010|NOT COMPLETED|Phase I: Period 2||2
10013371|NCT01791517|11136362|FG011|NOT COMPLETED|Phase I: Period 2||0
10013372|NCT01791517|11136351|FG000|STARTED|Phase I: Period 3||17
10013373|NCT01791517|11136352|FG001|STARTED|Phase I: Period 3||15
10013374|NCT01791517|11136353|FG002|STARTED|Phase I: Period 3||16
10013375|NCT01791517|11136354|FG003|STARTED|Phase I: Period 3||16
10013376|NCT01791517|11136355|FG004|STARTED|Phase I: Period 3||19
10013377|NCT01791517|11136356|FG005|STARTED|Phase I: Period 3||18
10013378|NCT01791517|11136357|FG006|STARTED|Phase I: Period 3||19
10013379|NCT01791517|11136358|FG007|STARTED|Phase I: Period 3||20
10013380|NCT01791517|11136359|FG008|STARTED|Phase I: Period 3||19
10013381|NCT01791517|11136360|FG009|STARTED|Phase I: Period 3||18
9952248|NCT01421134|11071168|FG000|COMPLETED|Overall Study||102
9952249|NCT01421134|11071169|FG001|COMPLETED|Overall Study||87
9952250|NCT01421134|11071168|FG000|NOT COMPLETED|Overall Study||7
9952251|NCT01421134|11071169|FG001|NOT COMPLETED|Overall Study||15
9952252|NCT01421147|11071177|FG000|STARTED|Treatment Period||269
9952253|NCT01421147|11071178|FG001|STARTED|Treatment Period||267
10013382|NCT01791517|11136361|FG010|STARTED|Phase I: Period 3||16
9952254|NCT01421147|11071177|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268
9952255|NCT01421147|11071178|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267
10013383|NCT01791517|11136362|FG011|STARTED|Phase I: Period 3||19
10013384|NCT01791517|11136351|FG000|COMPLETED|Phase I: Period 3||17
10013385|NCT01791517|11136352|FG001|COMPLETED|Phase I: Period 3||14
10013386|NCT01791517|11136353|FG002|COMPLETED|Phase I: Period 3||16
10013387|NCT01791517|11136354|FG003|COMPLETED|Phase I: Period 3||15
10013388|NCT01791517|11136355|FG004|COMPLETED|Phase I: Period 3||18
10013389|NCT01791517|11136356|FG005|COMPLETED|Phase I: Period 3||18
10013390|NCT01791517|11136357|FG006|COMPLETED|Phase I: Period 3||19
10013391|NCT01791517|11136358|FG007|COMPLETED|Phase I: Period 3||20
9761213|NCT00385788|10865078|FG001|STARTED|Overall Study||40
9761214|NCT00385788|10865077|FG000|COMPLETED|Overall Study||12
9761215|NCT00385788|10865078|FG001|COMPLETED|Overall Study||40
9761216|NCT00385788|10865077|FG000|NOT COMPLETED|Overall Study||0
9761217|NCT00385788|10865078|FG001|NOT COMPLETED|Overall Study||0
9761218|NCT00385801|10865086|FG000|STARTED|Overall Study||15
9761219|NCT00385801|10865087|FG001|STARTED|Overall Study||16
9761220|NCT00385801|10865086|FG000|COMPLETED|Overall Study||6
9761221|NCT00385801|10865087|FG001|COMPLETED|Overall Study||8
9761222|NCT00385801|10865086|FG000|NOT COMPLETED|Overall Study||9
9761223|NCT00385801|10865087|FG001|NOT COMPLETED|Overall Study||8
9761224|NCT00385827|10865097|FG000|STARTED|Part 1||9
9761225|NCT00385827|10865098|FG001|STARTED|Part 1||0
9761226|NCT00385827|10865099|FG002|STARTED|Part 1||0
9761227|NCT00385827|10865097|FG000|Treated|Part 1||9
9761228|NCT00385827|10865098|FG001|Treated|Part 1||0
9761229|NCT00385827|10865099|FG002|Treated|Part 1||0
9761230|NCT00385827|10865097|FG000|COMPLETED|Part 1||0
9761231|NCT00385827|10865098|FG001|COMPLETED|Part 1||0
9761232|NCT00385827|10865099|FG002|COMPLETED|Part 1||0
9761233|NCT00385827|10865097|FG000|NOT COMPLETED|Part 1||9
9761234|NCT00385827|10865098|FG001|NOT COMPLETED|Part 1||0
9761235|NCT00385827|10865099|FG002|NOT COMPLETED|Part 1||0
9761236|NCT00385827|10865097|FG000|STARTED|Part 2||0
9761237|NCT00385827|10865098|FG001|STARTED|Part 2||49
9761238|NCT00385827|10865099|FG002|STARTED|Part 2||48
9761239|NCT00385827|10865097|FG000|Treated|Part 2||0
9761240|NCT00385827|10865098|FG001|Treated|Part 2||47
9761241|NCT00385827|10865099|FG002|Treated|Part 2||46
9761242|NCT00385827|10865097|FG000|COMPLETED|Part 2||0
9761243|NCT00385827|10865098|FG001|COMPLETED|Part 2||16
10013392|NCT01791517|11136359|FG008|COMPLETED|Phase I: Period 3||19
10013393|NCT01791517|11136360|FG009|COMPLETED|Phase I: Period 3||18
10013394|NCT01791517|11136361|FG010|COMPLETED|Phase I: Period 3||16
10013395|NCT01791517|11136362|FG011|COMPLETED|Phase I: Period 3||18
10013396|NCT01791517|11136351|FG000|NOT COMPLETED|Phase I: Period 3||0
9761244|NCT00385827|10865099|FG002|COMPLETED|Part 2||0
9761245|NCT00385827|10865097|FG000|NOT COMPLETED|Part 2||0
9761246|NCT00385827|10865098|FG001|NOT COMPLETED|Part 2||33
9761247|NCT00385827|10865099|FG002|NOT COMPLETED|Part 2||48
9761248|NCT00385840|10865111|FG000|STARTED|Overall Study||133
9761249|NCT00385840|10865112|FG001|STARTED|Overall Study||545
9761250|NCT00385840|10865111|FG000|COMPLETED|Overall Study||129
9761251|NCT00385840|10865112|FG001|COMPLETED|Overall Study||531
9761252|NCT00385840|10865111|FG000|NOT COMPLETED|Overall Study||4
9761253|NCT00385840|10865112|FG001|NOT COMPLETED|Overall Study||14
9761254|NCT00385918|10865120|FG000|STARTED|Feasibility & Baseline Measurement Phase||0
9761255|NCT00385918|10865121|FG001|STARTED|Feasibility & Baseline Measurement Phase||0
9761256|NCT00385918|10865122|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
9761257|NCT00385918|10865120|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0
9761258|NCT00385918|10865121|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0
9761259|NCT00385918|10865122|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
9761260|NCT00385918|10865120|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
10013397|NCT01791517|11136352|FG001|NOT COMPLETED|Phase I: Period 3||1
10013398|NCT01791517|11136353|FG002|NOT COMPLETED|Phase I: Period 3||0
10013399|NCT01791517|11136354|FG003|NOT COMPLETED|Phase I: Period 3||1
10013400|NCT01791517|11136355|FG004|NOT COMPLETED|Phase I: Period 3||1
10013401|NCT01791517|11136356|FG005|NOT COMPLETED|Phase I: Period 3||0
10013402|NCT01791517|11136357|FG006|NOT COMPLETED|Phase I: Period 3||0
9761261|NCT00385918|10865121|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
9761262|NCT00385918|10865122|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
9761263|NCT00385918|10865120|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0
9761264|NCT00385918|10865121|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0
9761265|NCT00385918|10865122|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21
9761266|NCT00385918|10865120|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
10013403|NCT01791517|11136358|FG007|NOT COMPLETED|Phase I: Period 3||0
9761267|NCT00385918|10865121|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
9761268|NCT00385918|10865122|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
9829296|NCT00759148|10939889|FG000|NOT COMPLETED|Overall Study||14
10013404|NCT01791517|11136359|FG008|NOT COMPLETED|Phase I: Period 3||0
10013405|NCT01791517|11136360|FG009|NOT COMPLETED|Phase I: Period 3||0
10013406|NCT01791517|11136361|FG010|NOT COMPLETED|Phase I: Period 3||0
10013407|NCT01791517|11136362|FG011|NOT COMPLETED|Phase I: Period 3||1
10013408|NCT01791517|11136351|FG000|STARTED|Phase I: Period 4||17
10013409|NCT01791517|11136352|FG001|STARTED|Phase I: Period 4||14
10013410|NCT01791517|11136353|FG002|STARTED|Phase I: Period 4||16
10013411|NCT01791517|11136354|FG003|STARTED|Phase I: Period 4||15
10013412|NCT01791517|11136355|FG004|STARTED|Phase I: Period 4||18
10013413|NCT01791517|11136356|FG005|STARTED|Phase I: Period 4||18
10013414|NCT01791517|11136357|FG006|STARTED|Phase I: Period 4||19
10013415|NCT01791517|11136358|FG007|STARTED|Phase I: Period 4||20
10013416|NCT01791517|11136359|FG008|STARTED|Phase I: Period 4||19
10013417|NCT01791517|11136360|FG009|STARTED|Phase I: Period 4||18
10013418|NCT01791517|11136361|FG010|STARTED|Phase I: Period 4||16
10013419|NCT01791517|11136362|FG011|STARTED|Phase I: Period 4||18
10013420|NCT01791517|11136351|FG000|COMPLETED|Phase I: Period 4||17
10013421|NCT01791517|11136352|FG001|COMPLETED|Phase I: Period 4||14
10013422|NCT01791517|11136353|FG002|COMPLETED|Phase I: Period 4||16
10013423|NCT01791517|11136354|FG003|COMPLETED|Phase I: Period 4||15
10013424|NCT01791517|11136355|FG004|COMPLETED|Phase I: Period 4||18
10013425|NCT01791517|11136356|FG005|COMPLETED|Phase I: Period 4||18
10013426|NCT01791517|11136357|FG006|COMPLETED|Phase I: Period 4||19
10013427|NCT01791517|11136358|FG007|COMPLETED|Phase I: Period 4||20
10013428|NCT01791517|11136359|FG008|COMPLETED|Phase I: Period 4||19
10013429|NCT01791517|11136360|FG009|COMPLETED|Phase I: Period 4||18
10013430|NCT01791517|11136361|FG010|COMPLETED|Phase I: Period 4||16
10013431|NCT01791517|11136362|FG011|COMPLETED|Phase I: Period 4||18
10013432|NCT01791517|11136351|FG000|NOT COMPLETED|Phase I: Period 4||0
10013433|NCT01791517|11136352|FG001|NOT COMPLETED|Phase I: Period 4||0
10013434|NCT01791517|11136353|FG002|NOT COMPLETED|Phase I: Period 4||0
10013435|NCT01791517|11136354|FG003|NOT COMPLETED|Phase I: Period 4||0
10013436|NCT01791517|11136355|FG004|NOT COMPLETED|Phase I: Period 4||0
10013437|NCT01791517|11136356|FG005|NOT COMPLETED|Phase I: Period 4||0
10013438|NCT01791517|11136357|FG006|NOT COMPLETED|Phase I: Period 4||0
10013439|NCT01791517|11136358|FG007|NOT COMPLETED|Phase I: Period 4||0
10013440|NCT01791517|11136359|FG008|NOT COMPLETED|Phase I: Period 4||0
10013441|NCT01791517|11136360|FG009|NOT COMPLETED|Phase I: Period 4||0
10013442|NCT01791517|11136361|FG010|NOT COMPLETED|Phase I: Period 4||0
10013443|NCT01791517|11136362|FG011|NOT COMPLETED|Phase I: Period 4||0
10013444|NCT01791517|11136351|FG000|STARTED|Phase II||17
10013445|NCT01791517|11136352|FG001|STARTED|Phase II||14
10013446|NCT01791517|11136353|FG002|STARTED|Phase II||16
10013447|NCT01791517|11136354|FG003|STARTED|Phase II||15
10013448|NCT01791517|11136355|FG004|STARTED|Phase II||18
10013449|NCT01791517|11136356|FG005|STARTED|Phase II||18
10013450|NCT01791517|11136357|FG006|STARTED|Phase II||19
10013451|NCT01791517|11136358|FG007|STARTED|Phase II||20
10013452|NCT01791517|11136359|FG008|STARTED|Phase II||19
10013453|NCT01791517|11136360|FG009|STARTED|Phase II||18
10013454|NCT01791517|11136361|FG010|STARTED|Phase II||16
10013455|NCT01791517|11136362|FG011|STARTED|Phase II||18
10013456|NCT01791517|11136351|FG000|COMPLETED|Phase II||15
10013457|NCT01791517|11136352|FG001|COMPLETED|Phase II||14
10013458|NCT01791517|11136353|FG002|COMPLETED|Phase II||15
10013459|NCT01791517|11136354|FG003|COMPLETED|Phase II||15
10013460|NCT01791517|11136355|FG004|COMPLETED|Phase II||16
10013461|NCT01791517|11136356|FG005|COMPLETED|Phase II||14
10013462|NCT01791517|11136357|FG006|COMPLETED|Phase II||17
10013463|NCT01791517|11136358|FG007|COMPLETED|Phase II||17
10013464|NCT01791517|11136359|FG008|COMPLETED|Phase II||17
10013465|NCT01791517|11136360|FG009|COMPLETED|Phase II||15
10013466|NCT01791517|11136361|FG010|COMPLETED|Phase II||15
10013467|NCT01791517|11136362|FG011|COMPLETED|Phase II||17
10013468|NCT01791517|11136351|FG000|NOT COMPLETED|Phase II||2
10013469|NCT01791517|11136352|FG001|NOT COMPLETED|Phase II||0
10013470|NCT01791517|11136353|FG002|NOT COMPLETED|Phase II||1
10013471|NCT01791517|11136354|FG003|NOT COMPLETED|Phase II||0
10013472|NCT01791517|11136355|FG004|NOT COMPLETED|Phase II||2
10013473|NCT01791517|11136356|FG005|NOT COMPLETED|Phase II||4
10013474|NCT01791517|11136357|FG006|NOT COMPLETED|Phase II||2
10013475|NCT01791517|11136358|FG007|NOT COMPLETED|Phase II||3
10013476|NCT01791517|11136359|FG008|NOT COMPLETED|Phase II||2
10013477|NCT01791517|11136360|FG009|NOT COMPLETED|Phase II||3
10013478|NCT01791517|11136361|FG010|NOT COMPLETED|Phase II||1
10013479|NCT01791517|11136362|FG011|NOT COMPLETED|Phase II||1
10019032|NCT01827163|11142110|FG000|NOT COMPLETED|Overall Study||11
10019167|NCT01828255|11142326|FG000|COMPLETED|Overall Study||20
10019168|NCT01828255|11142327|FG001|COMPLETED|Overall Study||20
10019169|NCT01828255|11142326|FG000|NOT COMPLETED|Overall Study||0
10019170|NCT01828255|11142327|FG001|NOT COMPLETED|Overall Study||0
10019171|NCT01828281|11142337|FG000|STARTED|Overall Study||45
10019172|NCT01828281|11142338|FG001|STARTED|Overall Study||45
10019173|NCT01828281|11142337|FG000|COMPLETED|Overall Study||44
10019174|NCT01828281|11142338|FG001|COMPLETED|Overall Study||45
10019175|NCT01828281|11142337|FG000|NOT COMPLETED|Overall Study||1
10019176|NCT01828281|11142338|FG001|NOT COMPLETED|Overall Study||0
10019177|NCT01828476|11142347|FG000|STARTED|Overall Study||13
10019178|NCT01828476|11142348|FG001|STARTED|Overall Study||0
10019179|NCT01828476|11142347|FG000|COMPLETED|Overall Study||13
10019180|NCT01828476|11142348|FG001|COMPLETED|Overall Study||0
10019181|NCT01828476|11142347|FG000|NOT COMPLETED|Overall Study||0
10019182|NCT01828476|11142348|FG001|NOT COMPLETED|Overall Study||0
10019183|NCT01828515|11142356|FG000|STARTED|First Intervention (19 Days)||13
10019184|NCT01828515|11142357|FG001|STARTED|First Intervention (19 Days)||11
10019185|NCT01828515|11142356|FG000|COMPLETED|First Intervention (19 Days)||11
10019186|NCT01828515|11142357|FG001|COMPLETED|First Intervention (19 Days)||9
10019187|NCT01828515|11142356|FG000|NOT COMPLETED|First Intervention (19 Days)||2
10019188|NCT01828515|11142357|FG001|NOT COMPLETED|First Intervention (19 Days)||2
10013480|NCT01791725|11136383|FG000|STARTED|Overall Study||12
10013481|NCT01791725|11136384|FG001|STARTED|Overall Study||5
10013482|NCT01791725|11136385|FG002|STARTED|Overall Study||6
10013483|NCT01791725|11136383|FG000|COMPLETED|Overall Study||12
10013484|NCT01791725|11136384|FG001|COMPLETED|Overall Study||4
10013485|NCT01791725|11136385|FG002|COMPLETED|Overall Study||6
10013486|NCT01791725|11136383|FG000|NOT COMPLETED|Overall Study||0
10013487|NCT01791725|11136384|FG001|NOT COMPLETED|Overall Study||1
10013488|NCT01791725|11136385|FG002|NOT COMPLETED|Overall Study||0
10013489|NCT01791803|11136397|FG000|STARTED|Overall Study||41
10013490|NCT01791803|11136398|FG001|STARTED|Overall Study||41
10013491|NCT01791803|11136399|FG002|STARTED|Overall Study||40
10013492|NCT01791803|11136400|FG003|STARTED|Overall Study||42
10013493|NCT01791803|11136397|FG000|COMPLETED|Overall Study||41
10013494|NCT01791803|11136398|FG001|COMPLETED|Overall Study||39
10232214|NCT02308735|11361409|FG002|STARTED|Overall Study||0
10232215|NCT02308735|11361410|FG003|STARTED|Overall Study||2
10232216|NCT02308735|11361407|FG000|COMPLETED|Overall Study||0
10232217|NCT02308735|11361408|FG001|COMPLETED|Overall Study||0
10232218|NCT02308735|11361409|FG002|COMPLETED|Overall Study||0
10232219|NCT02308735|11361410|FG003|COMPLETED|Overall Study||0
10232220|NCT02308735|11361407|FG000|NOT COMPLETED|Overall Study||2
10232221|NCT02308735|11361408|FG001|NOT COMPLETED|Overall Study||0
10232222|NCT02308735|11361409|FG002|NOT COMPLETED|Overall Study||0
10013495|NCT01791803|11136399|FG002|COMPLETED|Overall Study||38
10013496|NCT01791803|11136400|FG003|COMPLETED|Overall Study||37
9761269|NCT00385918|10865120|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
9829297|NCT00759148|10939890|FG001|NOT COMPLETED|Overall Study||32
10013497|NCT01791803|11136397|FG000|NOT COMPLETED|Overall Study||0
10013498|NCT01791803|11136398|FG001|NOT COMPLETED|Overall Study||2
10013499|NCT01791803|11136399|FG002|NOT COMPLETED|Overall Study||2
10013500|NCT01791803|11136400|FG003|NOT COMPLETED|Overall Study||5
10013501|NCT01791894|11136413|FG000|STARTED|Overall Study||5
10013502|NCT01791894|11136413|FG000|COMPLETED|Overall Study||4
10013503|NCT01791894|11136413|FG000|NOT COMPLETED|Overall Study||1
10013504|NCT01791972|11136420|FG000|STARTED|Overall Study||19
10013505|NCT01791972|11136421|FG001|STARTED|Overall Study||19
10013506|NCT01791972|11136420|FG000|COMPLETED|Overall Study||19
10013507|NCT01791972|11136421|FG001|COMPLETED|Overall Study||19
10232223|NCT02308735|11361410|FG003|NOT COMPLETED|Overall Study||2
10232224|NCT02299206|11361420|FG000|STARTED|Overall Study||4
9952256|NCT01421147|11071177|FG000|COMPLETED|Treatment Period||253
9952257|NCT01421147|11071178|FG001|COMPLETED|Treatment Period||256
9952258|NCT01421147|11071177|FG000|NOT COMPLETED|Treatment Period||16
9952259|NCT01421147|11071178|FG001|NOT COMPLETED|Treatment Period||11
9952260|NCT01421147|11071177|FG000|STARTED|Extension Period||253
9952261|NCT01421147|11071178|FG001|STARTED|Extension Period||256
9952262|NCT01421147|11071177|FG000|COMPLETED|Extension Period||245
9952263|NCT01421147|11071178|FG001|COMPLETED|Extension Period||245
9952264|NCT01421147|11071177|FG000|NOT COMPLETED|Extension Period||8
9952265|NCT01421147|11071178|FG001|NOT COMPLETED|Extension Period||11
9952266|NCT01421186|11071189|FG000|STARTED|Overall Study||31
9952267|NCT01421186|11071190|FG001|STARTED|Overall Study||4
9952268|NCT01421186|11071191|FG002|STARTED|Overall Study||18
10232225|NCT02299206|11361420|FG000|COMPLETED|Overall Study||2
10232226|NCT02299206|11361420|FG000|NOT COMPLETED|Overall Study||2
10232227|NCT02302859|11361426|FG000|STARTED|Overall Study||2
10232228|NCT02302859|11361427|FG001|STARTED|Overall Study||6
10232229|NCT02302859|11361426|FG000|COMPLETED|Overall Study||1
10232230|NCT02302859|11361427|FG001|COMPLETED|Overall Study||4
10232231|NCT02302859|11361426|FG000|NOT COMPLETED|Overall Study||1
10232232|NCT02302859|11361427|FG001|NOT COMPLETED|Overall Study||2
10232233|NCT02299934|11361433|FG000|STARTED|Overall Study||13
10232234|NCT02299934|11361433|FG000|COMPLETED|Overall Study||0
10232235|NCT02299934|11361433|FG000|NOT COMPLETED|Overall Study||13
10013508|NCT01791972|11136420|FG000|NOT COMPLETED|Overall Study||0
10013509|NCT01791972|11136421|FG001|NOT COMPLETED|Overall Study||0
10013510|NCT01792024|11136427|FG000|STARTED|Overall Study||27
10013511|NCT01792024|11136427|FG000|COMPLETED|Overall Study||27
10013512|NCT01792024|11136427|FG000|NOT COMPLETED|Overall Study||0
10013513|NCT01792115|11136434|FG000|STARTED|Overall Study||7
10013514|NCT01792115|11136435|FG001|STARTED|Overall Study||7
10013515|NCT01792115|11136436|FG002|STARTED|Overall Study||8
10013516|NCT01792115|11136434|FG000|COMPLETED|Overall Study||7
10013517|NCT01792115|11136435|FG001|COMPLETED|Overall Study||6
10013518|NCT01792115|11136436|FG002|COMPLETED|Overall Study||8
10013519|NCT01792115|11136434|FG000|NOT COMPLETED|Overall Study||0
10013520|NCT01792115|11136435|FG001|NOT COMPLETED|Overall Study||1
10013521|NCT01792115|11136436|FG002|NOT COMPLETED|Overall Study||0
10013522|NCT01792284|11136444|FG000|STARTED|Lead-in Period||212
10013523|NCT01792284|11136445|FG001|STARTED|Lead-in Period||0
10013524|NCT01792284|11136446|FG002|STARTED|Lead-in Period||0
10013525|NCT01792284|11136444|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
10013526|NCT01792284|11136445|FG001|COMPLETED|Lead-in Period||0
10013527|NCT01792284|11136446|FG002|COMPLETED|Lead-in Period||0
10013528|NCT01792284|11136444|FG000|NOT COMPLETED|Lead-in Period||30
10013529|NCT01792284|11136445|FG001|NOT COMPLETED|Lead-in Period||0
10013530|NCT01792284|11136446|FG002|NOT COMPLETED|Lead-in Period||0
10013531|NCT01792284|11136444|FG000|STARTED|Randomization Period 1||0
10013532|NCT01792284|11136445|FG001|STARTED|Randomization Period 1||92
10013533|NCT01792284|11136446|FG002|STARTED|Randomization Period 1||90
10013534|NCT01792284|11136444|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
10013535|NCT01792284|11136445|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
10013536|NCT01792284|11136446|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
10013537|NCT01792284|11136444|FG000|COMPLETED|Randomization Period 1||0
10013538|NCT01792284|11136445|FG001|COMPLETED|Randomization Period 1||90
10013539|NCT01792284|11136446|FG002|COMPLETED|Randomization Period 1||85
10013540|NCT01792284|11136444|FG000|NOT COMPLETED|Randomization Period 1||0
10013541|NCT01792284|11136445|FG001|NOT COMPLETED|Randomization Period 1||2
10013542|NCT01792284|11136446|FG002|NOT COMPLETED|Randomization Period 1||5
10013543|NCT01792284|11136444|FG000|STARTED|Randomization Period 2||0
10013544|NCT01792284|11136445|FG001|STARTED|Randomization Period 2||90
10013545|NCT01792284|11136446|FG002|STARTED|Randomization Period 2||85
10013546|NCT01792284|11136444|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
10013547|NCT01792284|11136445|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
10013548|NCT01792284|11136446|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
10013549|NCT01792284|11136444|FG000|COMPLETED|Randomization Period 2||0
10013550|NCT01792284|11136445|FG001|COMPLETED|Randomization Period 2||87
10013551|NCT01792284|11136446|FG002|COMPLETED|Randomization Period 2||85
10013552|NCT01792284|11136444|FG000|NOT COMPLETED|Randomization Period 2||0
10013553|NCT01792284|11136445|FG001|NOT COMPLETED|Randomization Period 2||3
10013554|NCT01792284|11136446|FG002|NOT COMPLETED|Randomization Period 2||0
10013555|NCT01792518|11136456|FG000|STARTED|Overall Study||178
10013556|NCT01792518|11136457|FG001|STARTED|Overall Study||182
10013557|NCT01792518|11136456|FG000|COMPLETED|Overall Study||170
10013558|NCT01792518|11136457|FG001|COMPLETED|Overall Study||175
10013559|NCT01792518|11136456|FG000|NOT COMPLETED|Overall Study||8
10013560|NCT01792518|11136457|FG001|NOT COMPLETED|Overall Study||7
10013561|NCT01792635|11136466|FG000|STARTED|Part A||6
10013562|NCT01792635|11136467|FG001|STARTED|Part A||0
10013563|NCT01792635|11136468|FG002|STARTED|Part A||0
10013564|NCT01792635|11136466|FG000|COMPLETED|Part A||6
10013565|NCT01792635|11136467|FG001|COMPLETED|Part A||0
10013566|NCT01792635|11136468|FG002|COMPLETED|Part A||0
10013567|NCT01792635|11136466|FG000|NOT COMPLETED|Part A||0
10013568|NCT01792635|11136467|FG001|NOT COMPLETED|Part A||0
10013569|NCT01792635|11136468|FG002|NOT COMPLETED|Part A||0
10013570|NCT01792635|11136466|FG000|STARTED|Part B||0
10013571|NCT01792635|11136467|FG001|STARTED|Part B||6
10013572|NCT01792635|11136468|FG002|STARTED|Part B||7
10013573|NCT01792635|11136466|FG000|COMPLETED|Part B||0
10013574|NCT01792635|11136467|FG001|COMPLETED|Part B||2
10013575|NCT01792635|11136468|FG002|COMPLETED|Part B||3
10013576|NCT01792635|11136466|FG000|NOT COMPLETED|Part B||0
10013577|NCT01792635|11136467|FG001|NOT COMPLETED|Part B||4
10013578|NCT01792635|11136468|FG002|NOT COMPLETED|Part B||4
10019033|NCT01827254|11142114|FG000|STARTED|Overall Study||61
10019034|NCT01827254|11142114|FG000|Evaluable Population|Overall Study||52
10019035|NCT01827254|11142114|FG000|COMPLETED|Overall Study||2
10019036|NCT01827254|11142114|FG000|NOT COMPLETED|Overall Study||59
10019037|NCT01827267|11142124|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
10019038|NCT01827267|11142125|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
10019039|NCT01827267|11142124|FG000|Received Study Drug|Overall Study||17
10019040|NCT01827267|11142125|FG001|Received Study Drug|Overall Study||43
10019041|NCT01827267|11142124|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
10019042|NCT01827267|11142125|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
10019043|NCT01827267|11142124|FG000|COMPLETED|Overall Study||13
10019044|NCT01827267|11142125|FG001|COMPLETED|Overall Study||32
10019045|NCT01827267|11142124|FG000|NOT COMPLETED|Overall Study||5
10019046|NCT01827267|11142125|FG001|NOT COMPLETED|Overall Study||12
10019047|NCT01827306|11142134|FG000|STARTED|Overall Study||21
10019048|NCT01827306|11142135|FG001|STARTED|Overall Study||13
10019049|NCT01827306|11142134|FG000|COMPLETED|Overall Study||10
10019050|NCT01827306|11142135|FG001|COMPLETED|Overall Study||8
10019051|NCT01827306|11142134|FG000|NOT COMPLETED|Overall Study||11
10019052|NCT01827306|11142135|FG001|NOT COMPLETED|Overall Study||5
10019053|NCT01827319|11142141|FG000|STARTED|Overall Study||203
10019054|NCT01827319|11142141|FG000|COMPLETED|Overall Study||200
10019055|NCT01827319|11142141|FG000|NOT COMPLETED|Overall Study||3
10019056|NCT01827332|11142147|FG000|STARTED|Overall Study||8
10019057|NCT01827332|11142148|FG001|STARTED|Overall Study||8
10019058|NCT01827332|11142147|FG000|COMPLETED|Overall Study||6
10019059|NCT01827332|11142148|FG001|COMPLETED|Overall Study||7
10019060|NCT01827332|11142147|FG000|NOT COMPLETED|Overall Study||2
10019061|NCT01827332|11142148|FG001|NOT COMPLETED|Overall Study||1
10019062|NCT01827358|11142156|FG000|STARTED|Overall Study||80
10019063|NCT01827358|11142157|FG001|STARTED|Overall Study||75
10019064|NCT01827358|11142156|FG000|COMPLETED|Overall Study||45
10019065|NCT01827358|11142157|FG001|COMPLETED|Overall Study||44
10019066|NCT01827358|11142156|FG000|NOT COMPLETED|Overall Study||35
10019067|NCT01827358|11142157|FG001|NOT COMPLETED|Overall Study||31
10019068|NCT01827371|11142167|FG000|STARTED|Overall Study||115
10019069|NCT01827371|11142168|FG001|STARTED|Overall Study||96
10019070|NCT01827371|11142169|FG002|STARTED|Overall Study||104
10019071|NCT01827371|11142170|FG003|STARTED|Overall Study||120
10019072|NCT01827371|11142167|FG000|COMPLETED|Overall Study||102
10019073|NCT01827371|11142168|FG001|COMPLETED|Overall Study||89
10019074|NCT01827371|11142169|FG002|COMPLETED|Overall Study||93
10019075|NCT01827371|11142170|FG003|COMPLETED|Overall Study||97
10019076|NCT01827371|11142167|FG000|NOT COMPLETED|Overall Study||13
10019077|NCT01827371|11142168|FG001|NOT COMPLETED|Overall Study||7
10019078|NCT01827371|11142169|FG002|NOT COMPLETED|Overall Study||11
10019079|NCT01827371|11142170|FG003|NOT COMPLETED|Overall Study||23
10019080|NCT01827462|11142183|FG000|STARTED|Overall Study||59
10019081|NCT01827462|11142184|FG001|STARTED|Overall Study||37
10019082|NCT01827462|11142185|FG002|STARTED|Overall Study||40
10019083|NCT01827462|11142183|FG000|COMPLETED|Overall Study||18
10019084|NCT01827462|11142184|FG001|COMPLETED|Overall Study||19
10019085|NCT01827462|11142185|FG002|COMPLETED|Overall Study||12
10019086|NCT01827462|11142183|FG000|NOT COMPLETED|Overall Study||41
10019087|NCT01827462|11142184|FG001|NOT COMPLETED|Overall Study||18
10019088|NCT01827462|11142185|FG002|NOT COMPLETED|Overall Study||28
10019089|NCT01827475|11142199|FG000|STARTED|Overall Study||30
10019090|NCT01827475|11142200|FG001|STARTED|Overall Study||30
10019091|NCT01827475|11142201|FG002|STARTED|Overall Study||30
10019092|NCT01827475|11142199|FG000|COMPLETED|Overall Study||30
10019093|NCT01827475|11142200|FG001|COMPLETED|Overall Study||30
10019094|NCT01827475|11142201|FG002|COMPLETED|Overall Study||30
10019095|NCT01827475|11142199|FG000|NOT COMPLETED|Overall Study||0
10019096|NCT01827475|11142200|FG001|NOT COMPLETED|Overall Study||0
10013579|NCT01792817|11136479|FG000|STARTED|Phase 1 Double Blind Period||77
10013580|NCT01792817|11136480|FG001|STARTED|Phase 1 Double Blind Period||73
10013581|NCT01792817|11136481|FG002|STARTED|Phase 1 Double Blind Period||0
10013582|NCT01792817|11136479|FG000|COMPLETED|Phase 1 Double Blind Period||58
10013583|NCT01792817|11136480|FG001|COMPLETED|Phase 1 Double Blind Period||42
10013584|NCT01792817|11136481|FG002|COMPLETED|Phase 1 Double Blind Period||0
10013585|NCT01792817|11136479|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19
10013586|NCT01792817|11136480|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31
10013587|NCT01792817|11136481|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0
10013588|NCT01792817|11136479|FG000|STARTED|Phase 2 Open Label||0
10013589|NCT01792817|11136480|FG001|STARTED|Phase 2 Open Label||0
10013590|NCT01792817|11136481|FG002|STARTED|Phase 2 Open Label||100
10013591|NCT01792817|11136479|FG000|COMPLETED|Phase 2 Open Label||0
10013592|NCT01792817|11136480|FG001|COMPLETED|Phase 2 Open Label||0
10013593|NCT01792817|11136481|FG002|COMPLETED|Phase 2 Open Label||74
10013594|NCT01792817|11136479|FG000|NOT COMPLETED|Phase 2 Open Label||0
10013595|NCT01792817|11136480|FG001|NOT COMPLETED|Phase 2 Open Label||0
10013596|NCT01792817|11136481|FG002|NOT COMPLETED|Phase 2 Open Label||26
10013597|NCT01792830|11136499|FG000|STARTED|Overall Study||84
10013598|NCT01792830|11136500|FG001|STARTED|Overall Study||3
10013599|NCT01792830|11136501|FG002|STARTED|Overall Study||4
10013600|NCT01792830|11136502|FG003|STARTED|Overall Study||21
10013601|NCT01792830|11136503|FG004|STARTED|Overall Study||2
10013602|NCT01792830|11136504|FG005|STARTED|Overall Study||4
10013603|NCT01792830|11136505|FG006|STARTED|Overall Study||14
10013604|NCT01792830|11136506|FG007|STARTED|Overall Study||7
10013605|NCT01792830|11136507|FG008|STARTED|Overall Study||20
10013606|NCT01792830|11136508|FG009|STARTED|Overall Study||4
10013607|NCT01792830|11136509|FG010|STARTED|Overall Study||12
10013608|NCT01792830|11136499|FG000|COMPLETED|Overall Study||59
10013609|NCT01792830|11136500|FG001|COMPLETED|Overall Study||3
10013610|NCT01792830|11136501|FG002|COMPLETED|Overall Study||4
10013611|NCT01792830|11136502|FG003|COMPLETED|Overall Study||18
10013612|NCT01792830|11136503|FG004|COMPLETED|Overall Study||1
10013613|NCT01792830|11136504|FG005|COMPLETED|Overall Study||3
10013614|NCT01792830|11136505|FG006|COMPLETED|Overall Study||12
10013615|NCT01792830|11136506|FG007|COMPLETED|Overall Study||6
10013616|NCT01792830|11136507|FG008|COMPLETED|Overall Study||11
10013617|NCT01792830|11136508|FG009|COMPLETED|Overall Study||4
10013618|NCT01792830|11136509|FG010|COMPLETED|Overall Study||9
10013619|NCT01792830|11136499|FG000|NOT COMPLETED|Overall Study||25
10013620|NCT01792830|11136500|FG001|NOT COMPLETED|Overall Study||0
10013621|NCT01792830|11136501|FG002|NOT COMPLETED|Overall Study||0
10013622|NCT01792830|11136502|FG003|NOT COMPLETED|Overall Study||3
10013623|NCT01792830|11136503|FG004|NOT COMPLETED|Overall Study||1
10013624|NCT01792830|11136504|FG005|NOT COMPLETED|Overall Study||1
10013625|NCT01792830|11136505|FG006|NOT COMPLETED|Overall Study||2
10013626|NCT01792830|11136506|FG007|NOT COMPLETED|Overall Study||1
10013627|NCT01792830|11136507|FG008|NOT COMPLETED|Overall Study||9
10013628|NCT01792830|11136508|FG009|NOT COMPLETED|Overall Study||0
10013629|NCT01792830|11136509|FG010|NOT COMPLETED|Overall Study||3
10013630|NCT01792986|11136539|FG000|STARTED|Overall Study||12
10013631|NCT01792986|11136539|FG000|COMPLETED|Overall Study||12
10013632|NCT01792986|11136539|FG000|NOT COMPLETED|Overall Study||0
10013633|NCT01793051|11136545|FG000|STARTED|Overall Study||43
10013634|NCT01793051|11136546|FG001|STARTED|Overall Study||44
10013635|NCT01793051|11136545|FG000|COMPLETED|Overall Study||33
10013636|NCT01793051|11136546|FG001|COMPLETED|Overall Study||36
10013637|NCT01793051|11136545|FG000|NOT COMPLETED|Overall Study||10
10013638|NCT01793051|11136546|FG001|NOT COMPLETED|Overall Study||8
10013639|NCT01793142|11136552|FG000|STARTED|Overall Study||3430
10013640|NCT01793142|11136552|FG000|Treated|Overall Study||3423
10013641|NCT01793142|11136552|FG000|COMPLETED|Overall Study||3423
10013642|NCT01793142|11136552|FG000|NOT COMPLETED|Overall Study||7
10013643|NCT01793285|11136556|FG000|STARTED|Overall Study||85
10013644|NCT01793285|11136556|FG000|COMPLETED|Overall Study||85
10013645|NCT01793285|11136556|FG000|NOT COMPLETED|Overall Study||0
10013646|NCT01793688|11136560|FG000|STARTED|Overall Study||982
10013647|NCT01793688|11136560|FG000|COMPLETED|Overall Study||980
10013648|NCT01793688|11136560|FG000|NOT COMPLETED|Overall Study||2
10013649|NCT01793792|11136564|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
10013650|NCT01793792|11136564|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
10013651|NCT01793792|11136564|FG000|COMPLETED|Overall Study||141
10013652|NCT01793792|11136564|FG000|NOT COMPLETED|Overall Study||12
10013653|NCT01793883|11136571|FG000|STARTED|Overall Study||213
10013654|NCT01793883|11136572|FG001|STARTED|Overall Study||214
10013655|NCT01793883|11136573|FG002|STARTED|Overall Study||212
10013656|NCT01793883|11136571|FG000|COMPLETED|Overall Study||201
10013657|NCT01793883|11136572|FG001|COMPLETED|Overall Study||204
10013658|NCT01793883|11136573|FG002|COMPLETED|Overall Study||204
10013659|NCT01793883|11136571|FG000|NOT COMPLETED|Overall Study||12
10013660|NCT01793883|11136572|FG001|NOT COMPLETED|Overall Study||10
10013661|NCT01793883|11136573|FG002|NOT COMPLETED|Overall Study||8
10013662|NCT01793909|11136583|FG000|STARTED|Overall Study||30
10013663|NCT01793909|11136584|FG001|STARTED|Overall Study||25
10013664|NCT01793909|11136583|FG000|COMPLETED|Overall Study||20
10013665|NCT01793909|11136584|FG001|COMPLETED|Overall Study||20
10013666|NCT01793909|11136583|FG000|NOT COMPLETED|Overall Study||10
10013667|NCT01793909|11136584|FG001|NOT COMPLETED|Overall Study||5
10013668|NCT01793935|11136592|FG000|STARTED|Overall Study||34
10013669|NCT01793935|11136593|FG001|STARTED|Overall Study||34
10013670|NCT01793935|11136592|FG000|COMPLETED|Overall Study||28
10013671|NCT01793935|11136593|FG001|COMPLETED|Overall Study||31
10013672|NCT01793935|11136592|FG000|NOT COMPLETED|Overall Study||6
10013673|NCT01793935|11136593|FG001|NOT COMPLETED|Overall Study||3
10013674|NCT01794000|11136601|FG000|STARTED|Double-Blind Phase (DBP)||171
10013675|NCT01794000|11136602|FG001|STARTED|Double-Blind Phase (DBP)||170
10013676|NCT01794000|11136601|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
10013677|NCT01794000|11136602|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
10013678|NCT01794000|11136601|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
10013679|NCT01794000|11136602|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
10013680|NCT01794000|11136601|FG000|COMPLETED|Double-Blind Phase (DBP)||2
10013681|NCT01794000|11136602|FG001|COMPLETED|Double-Blind Phase (DBP)||4
10013682|NCT01794000|11136601|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169
10013683|NCT01794000|11136602|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166
10013684|NCT01794000|11136601|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
10013685|NCT01794000|11136602|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
10013686|NCT01794000|11136601|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
10013687|NCT01794000|11136602|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
10013688|NCT01794000|11136601|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
10013689|NCT01794000|11136602|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10013690|NCT01794039|11136611|FG000|STARTED|Overall Study||5
10013691|NCT01794039|11136612|FG001|STARTED|Overall Study||4
10013692|NCT01794039|11136611|FG000|COMPLETED|Overall Study||5
10013693|NCT01794039|11136612|FG001|COMPLETED|Overall Study||4
10013694|NCT01794039|11136611|FG000|NOT COMPLETED|Overall Study||0
10013695|NCT01794039|11136612|FG001|NOT COMPLETED|Overall Study||0
10013696|NCT01794117|11136624|FG000|STARTED|Overall Study||1
10013697|NCT01794117|11136625|FG001|STARTED|Overall Study||3
10013698|NCT01794117|11136626|FG002|STARTED|Overall Study||2
10013699|NCT01794117|11136627|FG003|STARTED|Overall Study||12
10013700|NCT01794117|11136624|FG000|COMPLETED|Overall Study||0
10013701|NCT01794117|11136625|FG001|COMPLETED|Overall Study||0
10013702|NCT01794117|11136626|FG002|COMPLETED|Overall Study||2
10013703|NCT01794117|11136627|FG003|COMPLETED|Overall Study||12
10013704|NCT01794117|11136624|FG000|NOT COMPLETED|Overall Study||1
10013705|NCT01794117|11136625|FG001|NOT COMPLETED|Overall Study||3
10013706|NCT01794117|11136626|FG002|NOT COMPLETED|Overall Study||0
10013707|NCT01794117|11136627|FG003|NOT COMPLETED|Overall Study||0
10013708|NCT01794299|11136638|FG000|STARTED|Overall Study||31
10013709|NCT01794299|11136638|FG000|COMPLETED|Overall Study||9
10013710|NCT01794299|11136638|FG000|NOT COMPLETED|Overall Study||22
10013711|NCT01794312|11136644|FG000|STARTED|Overall Study||74
10013712|NCT01794312|11136645|FG001|STARTED|Overall Study||78
10013713|NCT01794312|11136644|FG000|COMPLETED|Overall Study||68
10013714|NCT01794312|11136645|FG001|COMPLETED|Overall Study||67
10013715|NCT01794312|11136644|FG000|NOT COMPLETED|Overall Study||6
10013716|NCT01794312|11136645|FG001|NOT COMPLETED|Overall Study||11
10013717|NCT01794455|11136653|FG000|STARTED|Overall Study||0
10013718|NCT01794455|11136654|FG001|STARTED|Overall Study||1
10013719|NCT01794455|11136653|FG000|COMPLETED|Overall Study||0
10013720|NCT01794455|11136654|FG001|COMPLETED|Overall Study||1
9761270|NCT00385918|10865121|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
9761271|NCT00385918|10865122|FG002|STARTED|Intervention Phase After Randomization||0
9761272|NCT00385918|10865120|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
9761273|NCT00385918|10865121|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
9761274|NCT00385918|10865122|FG002|COMPLETED|Intervention Phase After Randomization||0
9761275|NCT00385918|10865120|FG000|NOT COMPLETED|Intervention Phase After Randomization||3
9761276|NCT00385918|10865121|FG001|NOT COMPLETED|Intervention Phase After Randomization||0
9761277|NCT00385918|10865122|FG002|NOT COMPLETED|Intervention Phase After Randomization||0
9761278|NCT00385944|10865131|FG000|STARTED|Loading Dose||0
9761279|NCT00385944|10865132|FG001|STARTED|Loading Dose||0
9761280|NCT00385944|10865133|FG002|STARTED|Loading Dose||56
9761281|NCT00385944|10865131|FG000|COMPLETED|Loading Dose||0
9761282|NCT00385944|10865132|FG001|COMPLETED|Loading Dose||0
9761283|NCT00385944|10865133|FG002|COMPLETED|Loading Dose||56
9761284|NCT00385944|10865131|FG000|NOT COMPLETED|Loading Dose||0
9761285|NCT00385944|10865132|FG001|NOT COMPLETED|Loading Dose||0
9761286|NCT00385944|10865133|FG002|NOT COMPLETED|Loading Dose||0
9761287|NCT00385944|10865131|FG000|STARTED|1st Maintenance Dose Period||29
9761288|NCT00385944|10865132|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
9761289|NCT00385944|10865133|FG002|STARTED|1st Maintenance Dose Period||0
9761290|NCT00385944|10865131|FG000|COMPLETED|1st Maintenance Dose Period||25
9761291|NCT00385944|10865132|FG001|COMPLETED|1st Maintenance Dose Period||24
9761292|NCT00385944|10865133|FG002|COMPLETED|1st Maintenance Dose Period||0
9761293|NCT00385944|10865131|FG000|NOT COMPLETED|1st Maintenance Dose Period||4
9761294|NCT00385944|10865132|FG001|NOT COMPLETED|1st Maintenance Dose Period||1
9761295|NCT00385944|10865133|FG002|NOT COMPLETED|1st Maintenance Dose Period||0
10112058|NCT02501265|11243136|FG002|STARTED|Overall Study||64
10112059|NCT02501265|11243137|FG003|STARTED|Overall Study||31
10112060|NCT02501265|11243134|FG000|COMPLETED|Overall Study||46
10112061|NCT02501265|11243135|FG001|COMPLETED|Overall Study||21
10112062|NCT02501265|11243136|FG002|COMPLETED|Overall Study||46
10112063|NCT02501265|11243137|FG003|COMPLETED|Overall Study||23
10112064|NCT02501265|11243134|FG000|NOT COMPLETED|Overall Study||17
10112065|NCT02501265|11243135|FG001|NOT COMPLETED|Overall Study||9
10112066|NCT02501265|11243136|FG002|NOT COMPLETED|Overall Study||18
10112067|NCT02501265|11243137|FG003|NOT COMPLETED|Overall Study||8
10112068|NCT02501473|11243154|FG000|STARTED|Overall Study||3
9829298|NCT00759161|10939896|FG000|STARTED|Overall Study||35
10112069|NCT02501473|11243155|FG001|STARTED|Overall Study||3
10112070|NCT02501473|11243156|FG002|STARTED|Overall Study||13
9761296|NCT00385944|10865131|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
9761297|NCT00385944|10865132|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
9761298|NCT00385944|10865133|FG002|STARTED|2nd Maintenance Dose Period||0
9761299|NCT00385944|10865131|FG000|COMPLETED|2nd Maintenance Dose Period||22
9761300|NCT00385944|10865132|FG001|COMPLETED|2nd Maintenance Dose Period||19
9761301|NCT00385944|10865133|FG002|COMPLETED|2nd Maintenance Dose Period||0
9761302|NCT00385944|10865131|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2
9761303|NCT00385944|10865132|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3
9761304|NCT00385944|10865133|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0
9761305|NCT00385996|10865148|FG000|STARTED|Overall Study||22
9761306|NCT00385996|10865148|FG000|COMPLETED|Overall Study||22
9761307|NCT00385996|10865148|FG000|NOT COMPLETED|Overall Study||0
9761308|NCT00386009|10865155|FG000|STARTED|Overall Study||101
9761309|NCT00386009|10865156|FG001|STARTED|Overall Study||99
9761310|NCT00386009|10865155|FG000|COMPLETED|Overall Study||92
9761311|NCT00386009|10865156|FG001|COMPLETED|Overall Study||89
9761312|NCT00386009|10865155|FG000|NOT COMPLETED|Overall Study||9
9761313|NCT00386009|10865156|FG001|NOT COMPLETED|Overall Study||10
9761314|NCT00386022|10865164|FG000|STARTED|Baseline||10
9761315|NCT00386022|10865165|FG001|STARTED|Baseline||9
9761316|NCT00386022|10865164|FG000|All Doses of GnRH|Baseline||10
9761317|NCT00386022|10865165|FG001|All Doses of GnRH|Baseline||9
9761318|NCT00386022|10865164|FG000|COMPLETED|Baseline||10
9761319|NCT00386022|10865165|FG001|COMPLETED|Baseline||9
9761320|NCT00386022|10865164|FG000|NOT COMPLETED|Baseline||0
9761321|NCT00386022|10865165|FG001|NOT COMPLETED|Baseline||0
9761322|NCT00386022|10865164|FG000|STARTED|Plus Estrogen||10
9761323|NCT00386022|10865165|FG001|STARTED|Plus Estrogen||9
9761324|NCT00386022|10865164|FG000|Estrogen Patch|Plus Estrogen||8
9761325|NCT00386022|10865165|FG001|Estrogen Patch|Plus Estrogen||9
9761326|NCT00386022|10865164|FG000|All Doses GnRH|Plus Estrogen||8
9761327|NCT00386022|10865165|FG001|All Doses GnRH|Plus Estrogen||8
9761328|NCT00386022|10865164|FG000|COMPLETED|Plus Estrogen||8
9761329|NCT00386022|10865165|FG001|COMPLETED|Plus Estrogen||8
9761330|NCT00386022|10865164|FG000|NOT COMPLETED|Plus Estrogen||2
9761331|NCT00386022|10865165|FG001|NOT COMPLETED|Plus Estrogen||1
9761332|NCT00386100|10865175|FG000|STARTED|Overall Study||340
9761333|NCT00386100|10865176|FG001|STARTED|Overall Study||348
9761334|NCT00386100|10865175|FG000|COMPLETED|Overall Study||186
9761335|NCT00386100|10865176|FG001|COMPLETED|Overall Study||217
9761336|NCT00386100|10865175|FG000|NOT COMPLETED|Overall Study||154
9761337|NCT00386100|10865176|FG001|NOT COMPLETED|Overall Study||131
9761338|NCT00386152|10865185|FG000|STARTED|Overall Study|number of subjects treated|75
9761339|NCT00386152|10865186|FG001|STARTED|Overall Study|number of subjects treated|77
9761340|NCT00386152|10865187|FG002|STARTED|Overall Study|number of subjects treated|75
9761341|NCT00386152|10865185|FG000|COMPLETED|Overall Study||31
9761342|NCT00386152|10865186|FG001|COMPLETED|Overall Study||37
9761343|NCT00386152|10865187|FG002|COMPLETED|Overall Study||42
9761344|NCT00386152|10865185|FG000|NOT COMPLETED|Overall Study||44
9761345|NCT00386152|10865186|FG001|NOT COMPLETED|Overall Study||40
9761346|NCT00386152|10865187|FG002|NOT COMPLETED|Overall Study||33
9761347|NCT00386243|10865197|FG000|STARTED|Overall Study||121
9761348|NCT00386243|10865198|FG001|STARTED|Overall Study||121
9761349|NCT00386243|10865197|FG000|COMPLETED|Overall Study||114
9761350|NCT00386243|10865198|FG001|COMPLETED|Overall Study||108
9761351|NCT00386243|10865197|FG000|NOT COMPLETED|Overall Study||7
9761352|NCT00386243|10865198|FG001|NOT COMPLETED|Overall Study||13
9761353|NCT00386256|10865208|FG000|STARTED|Overall Study||16
9761354|NCT00386256|10865209|FG001|STARTED|Overall Study||15
9761355|NCT00386256|10865210|FG002|STARTED|Overall Study||4
9761356|NCT00386256|10865211|FG003|STARTED|Overall Study||3
9761357|NCT00386256|10865208|FG000|COMPLETED|Overall Study||16
9761358|NCT00386256|10865209|FG001|COMPLETED|Overall Study||15
9761359|NCT00386256|10865210|FG002|COMPLETED|Overall Study||4
9761360|NCT00386256|10865211|FG003|COMPLETED|Overall Study||3
9761361|NCT00386256|10865208|FG000|NOT COMPLETED|Overall Study||0
9761362|NCT00386256|10865209|FG001|NOT COMPLETED|Overall Study||0
9761363|NCT00386256|10865210|FG002|NOT COMPLETED|Overall Study||0
9761364|NCT00386256|10865211|FG003|NOT COMPLETED|Overall Study||0
9761365|NCT00386308|10865223|FG000|STARTED|Overall Study||123
9761366|NCT00386308|10865224|FG001|STARTED|Overall Study||73
9761367|NCT00386308|10865223|FG000|Intent to Treat Population|Overall Study||117
9761368|NCT00386308|10865224|FG001|Intent to Treat Population|Overall Study||72
9761369|NCT00386308|10865223|FG000|Modified Intent to Treat Population|Overall Study||115
9761370|NCT00386308|10865224|FG001|Modified Intent to Treat Population|Overall Study||72
9761371|NCT00386308|10865223|FG000|COMPLETED|Overall Study||94
9761372|NCT00386308|10865224|FG001|COMPLETED|Overall Study||54
9761373|NCT00386308|10865223|FG000|NOT COMPLETED|Overall Study||29
9761374|NCT00386308|10865224|FG001|NOT COMPLETED|Overall Study||19
9761375|NCT00386334|10865232|FG000|STARTED|Double Blind Period||194
9761376|NCT00386334|10865233|FG001|STARTED|Double Blind Period||194
9761377|NCT00386334|10865232|FG000|COMPLETED|Double Blind Period||148
9761378|NCT00386334|10865233|FG001|COMPLETED|Double Blind Period||147
9761379|NCT00386334|10865232|FG000|NOT COMPLETED|Double Blind Period||46
9761380|NCT00386334|10865233|FG001|NOT COMPLETED|Double Blind Period||47
9761381|NCT00386334|10865232|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
9829299|NCT00759161|10939896|FG000|COMPLETED|Overall Study||35
9761382|NCT00386334|10865233|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
9761383|NCT00386334|10865232|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
9761384|NCT00386334|10865233|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
9761385|NCT00386334|10865232|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
9761386|NCT00386334|10865233|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
9761387|NCT00386360|10865241|FG000|STARTED|Overall Study||49
9761388|NCT00386360|10865242|FG001|STARTED|Overall Study||112
9761389|NCT00386360|10865241|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
9761390|NCT00386360|10865242|FG001|Intent to Treat Population (ITT)|Overall Study||110
9761391|NCT00386360|10865241|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
9761392|NCT00386360|10865242|FG001|Primary Efficacy|Overall Study||77
9761393|NCT00386360|10865241|FG000|COMPLETED|Overall Study||40
9761394|NCT00386360|10865242|FG001|COMPLETED|Overall Study||95
9761395|NCT00386360|10865241|FG000|NOT COMPLETED|Overall Study||9
9761396|NCT00386360|10865242|FG001|NOT COMPLETED|Overall Study||17
9761397|NCT00386425|10865251|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
9761398|NCT00386425|10865252|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
9761399|NCT00386425|10865253|FG002|STARTED|Overall Study||53
9761400|NCT00386425|10865251|FG000|Received Study Drug|Overall Study||227
9761401|NCT00386425|10865252|FG001|Received Study Drug|Overall Study||206
9761402|NCT00386425|10865253|FG002|Received Study Drug|Overall Study||53
9761403|NCT00386425|10865251|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
9761404|NCT00386425|10865252|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
9761405|NCT00386425|10865253|FG002|COMPLETED|Overall Study||53
9761406|NCT00386425|10865251|FG000|NOT COMPLETED|Overall Study||3
9761407|NCT00386425|10865252|FG001|NOT COMPLETED|Overall Study||1
9761408|NCT00386425|10865253|FG002|NOT COMPLETED|Overall Study||0
9761409|NCT00386477|10865267|FG000|STARTED|Overall Study||155
9761410|NCT00386477|10865268|FG001|STARTED|Overall Study||145
9761411|NCT00386477|10865267|FG000|COMPLETED|Overall Study||155
9761412|NCT00386477|10865268|FG001|COMPLETED|Overall Study||145
9761413|NCT00386477|10865267|FG000|NOT COMPLETED|Overall Study||0
9761414|NCT00386477|10865268|FG001|NOT COMPLETED|Overall Study||0
9761415|NCT00386607|10865274|FG000|STARTED|Core||601
9761416|NCT00386607|10865275|FG001|STARTED|Core||0
9761417|NCT00386607|10865274|FG000|COMPLETED|Core||486
9761418|NCT00386607|10865275|FG001|COMPLETED|Core||0
9761419|NCT00386607|10865274|FG000|NOT COMPLETED|Core||115
9761420|NCT00386607|10865275|FG001|NOT COMPLETED|Core||0
9761421|NCT00386607|10865274|FG000|STARTED|Extension||0
9761422|NCT00386607|10865275|FG001|STARTED|Extension||162
9761423|NCT00386607|10865274|FG000|COMPLETED|Extension||0
9761424|NCT00386607|10865275|FG001|COMPLETED|Extension||145
9761425|NCT00386607|10865274|FG000|NOT COMPLETED|Extension||0
9761426|NCT00386607|10865275|FG001|NOT COMPLETED|Extension||17
9761427|NCT00386776|10865287|FG000|STARTED|Overall Study||40
9761428|NCT00386776|10865287|FG000|COMPLETED|Overall Study||32
9761429|NCT00386776|10865287|FG000|NOT COMPLETED|Overall Study||8
9761430|NCT00386880|10865293|FG000|STARTED|Overall Study||30
9761431|NCT00386880|10865294|FG001|STARTED|Overall Study||8
9761432|NCT00386880|10865293|FG000|COMPLETED|Overall Study||30
9761433|NCT00386880|10865294|FG001|COMPLETED|Overall Study||8
9761434|NCT00386880|10865293|FG000|NOT COMPLETED|Overall Study||0
9761435|NCT00386880|10865294|FG001|NOT COMPLETED|Overall Study||0
9761436|NCT00387010|10865299|FG000|STARTED|Dose Titration Period||218
9761437|NCT00387010|10865299|FG000|COMPLETED|Dose Titration Period||180
9761438|NCT00387010|10865299|FG000|NOT COMPLETED|Dose Titration Period||38
9761439|NCT00387010|10865299|FG000|STARTED|Treatment Period||180
9761440|NCT00387010|10865299|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
9761441|NCT00387010|10865299|FG000|COMPLETED|Treatment Period||169
9761442|NCT00387010|10865299|FG000|NOT COMPLETED|Treatment Period||11
9761443|NCT00387023|10865303|FG000|STARTED|Overall Study||12
9761444|NCT00387023|10865303|FG000|COMPLETED|Overall Study||12
9761445|NCT00387023|10865303|FG000|NOT COMPLETED|Overall Study||0
9761446|NCT00387036|10865307|FG000|STARTED|2-Week First Intervention||6
9761447|NCT00387036|10865308|FG001|STARTED|2-Week First Intervention||6
9761448|NCT00387036|10865307|FG000|COMPLETED|2-Week First Intervention||6
9761449|NCT00387036|10865308|FG001|COMPLETED|2-Week First Intervention||6
9761450|NCT00387036|10865307|FG000|NOT COMPLETED|2-Week First Intervention||0
9761451|NCT00387036|10865308|FG001|NOT COMPLETED|2-Week First Intervention||0
9761452|NCT00387036|10865307|FG000|STARTED|2-Week Placebo Washout||6
9761453|NCT00387036|10865308|FG001|STARTED|2-Week Placebo Washout||6
9761454|NCT00387036|10865307|FG000|COMPLETED|2-Week Placebo Washout||6
9761455|NCT00387036|10865308|FG001|COMPLETED|2-Week Placebo Washout||6
9761456|NCT00387036|10865307|FG000|NOT COMPLETED|2-Week Placebo Washout||0
9761457|NCT00387036|10865308|FG001|NOT COMPLETED|2-Week Placebo Washout||0
9761458|NCT00387036|10865307|FG000|STARTED|2-Week Crossover Second Intervention||6
9761459|NCT00387036|10865308|FG001|STARTED|2-Week Crossover Second Intervention||6
9761460|NCT00387036|10865307|FG000|COMPLETED|2-Week Crossover Second Intervention||6
9761461|NCT00387036|10865308|FG001|COMPLETED|2-Week Crossover Second Intervention||6
9761462|NCT00387036|10865307|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0
9829300|NCT00759161|10939896|FG000|NOT COMPLETED|Overall Study||0
9761463|NCT00387036|10865308|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0
9761464|NCT00387088|10865316|FG000|STARTED|Overall Study||1989
9761465|NCT00387088|10865317|FG001|STARTED|Overall Study||2002
9761466|NCT00387088|10865316|FG000|COMPLETED|Overall Study||1671
9761467|NCT00387088|10865317|FG001|COMPLETED|Overall Study||1629
9761468|NCT00387088|10865316|FG000|NOT COMPLETED|Overall Study||318
9761469|NCT00387088|10865317|FG001|NOT COMPLETED|Overall Study||373
9761470|NCT00387127|10865325|FG000|STARTED|Overall Study||33
9761471|NCT00387127|10865326|FG001|STARTED|Overall Study||34
9761472|NCT00387127|10865325|FG000|COMPLETED|Overall Study||0
9761473|NCT00387127|10865326|FG001|COMPLETED|Overall Study||0
9761474|NCT00387127|10865325|FG000|NOT COMPLETED|Overall Study||33
9761475|NCT00387127|10865326|FG001|NOT COMPLETED|Overall Study||34
9761476|NCT00387153|10865334|FG000|STARTED|Overall Study||8
9761477|NCT00387153|10865334|FG000|COMPLETED|Overall Study||0
9761478|NCT00387153|10865334|FG000|NOT COMPLETED|Overall Study||8
9761479|NCT00387335|10865340|FG000|STARTED|Overall Study||15
9761480|NCT00387335|10865341|FG001|STARTED|Overall Study||7
9761481|NCT00387335|10865340|FG000|COMPLETED|Overall Study||15
9761482|NCT00387335|10865341|FG001|COMPLETED|Overall Study||7
9761483|NCT00387335|10865340|FG000|NOT COMPLETED|Overall Study||0
9761484|NCT00387335|10865341|FG001|NOT COMPLETED|Overall Study||0
9761485|NCT00387348|10865350|FG000|STARTED|Overall Study||8
9761486|NCT00387348|10865351|FG001|STARTED|Overall Study||5
9761487|NCT00387348|10865352|FG002|STARTED|Overall Study||11
9761488|NCT00387348|10865350|FG000|COMPLETED|Overall Study||5
9761489|NCT00387348|10865351|FG001|COMPLETED|Overall Study||2
9761490|NCT00387348|10865352|FG002|COMPLETED|Overall Study||7
9761491|NCT00387348|10865350|FG000|NOT COMPLETED|Overall Study||3
9761492|NCT00387348|10865351|FG001|NOT COMPLETED|Overall Study||3
9761493|NCT00387348|10865352|FG002|NOT COMPLETED|Overall Study||4
9761494|NCT00387426|10865365|FG000|STARTED|Overall Study||14
9761495|NCT00387426|10865365|FG000|COMPLETED|Overall Study||0
9761496|NCT00387426|10865365|FG000|NOT COMPLETED|Overall Study||14
9761497|NCT00387465|10865372|FG000|STARTED|Overall Study||3
9761498|NCT00387465|10865373|FG001|STARTED|Overall Study||7
9761499|NCT00387465|10865374|FG002|STARTED|Overall Study||35
9761500|NCT00387465|10865372|FG000|COMPLETED|Overall Study||3
9761501|NCT00387465|10865373|FG001|COMPLETED|Overall Study||6
9761502|NCT00387465|10865374|FG002|COMPLETED|Overall Study||35
9761503|NCT00387465|10865372|FG000|NOT COMPLETED|Overall Study||0
9761504|NCT00387465|10865373|FG001|NOT COMPLETED|Overall Study||1
9761505|NCT00387465|10865374|FG002|NOT COMPLETED|Overall Study||0
9761506|NCT00387621|10865385|FG000|STARTED|First Intervention||29
9761507|NCT00387621|10865386|FG001|STARTED|First Intervention||29
9761508|NCT00387621|10865385|FG000|COMPLETED|First Intervention||29
9761509|NCT00387621|10865386|FG001|COMPLETED|First Intervention||29
9761510|NCT00387621|10865385|FG000|NOT COMPLETED|First Intervention||0
9761511|NCT00387621|10865386|FG001|NOT COMPLETED|First Intervention||0
9761512|NCT00387621|10865385|FG000|STARTED|Washout Period of 2 Weeks||29
9761513|NCT00387621|10865386|FG001|STARTED|Washout Period of 2 Weeks||29
9761514|NCT00387621|10865385|FG000|COMPLETED|Washout Period of 2 Weeks||29
9761515|NCT00387621|10865386|FG001|COMPLETED|Washout Period of 2 Weeks||29
9761516|NCT00387621|10865385|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9761517|NCT00387621|10865386|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9761518|NCT00387621|10865385|FG000|STARTED|Second Intervention||29
9761519|NCT00387621|10865386|FG001|STARTED|Second Intervention||29
9761520|NCT00387621|10865385|FG000|COMPLETED|Second Intervention||29
9761521|NCT00387621|10865386|FG001|COMPLETED|Second Intervention||29
9761522|NCT00387621|10865385|FG000|NOT COMPLETED|Second Intervention||0
9761523|NCT00387621|10865386|FG001|NOT COMPLETED|Second Intervention||0
9761524|NCT00387647|10865398|FG000|STARTED|Overall Study||24
9761525|NCT00387647|10865398|FG000|COMPLETED|Overall Study||6
9761526|NCT00387647|10865398|FG000|NOT COMPLETED|Overall Study||18
9761527|NCT00387660|10865404|FG000|STARTED|Overall Study||40
9761528|NCT00387660|10865405|FG001|STARTED|Overall Study||40
9761529|NCT00387660|10865404|FG000|COMPLETED|Overall Study||40
9761530|NCT00387660|10865405|FG001|COMPLETED|Overall Study||40
9761531|NCT00387660|10865404|FG000|NOT COMPLETED|Overall Study||0
9761532|NCT00387660|10865405|FG001|NOT COMPLETED|Overall Study||0
9761533|NCT00387712|10865413|FG000|STARTED|Overall Study||47
9761534|NCT00387712|10865414|FG001|STARTED|Overall Study||52
9761535|NCT00387712|10865413|FG000|COMPLETED|Overall Study||18
9761536|NCT00387712|10865414|FG001|COMPLETED|Overall Study||16
10013721|NCT01794455|11136653|FG000|NOT COMPLETED|Overall Study||0
10013722|NCT01794455|11136654|FG001|NOT COMPLETED|Overall Study||0
10013723|NCT01794689|11136664|FG000|STARTED|Intervention 1 (2 Nights)||25
10013724|NCT01794689|11136665|FG001|STARTED|Intervention 1 (2 Nights)||29
9761537|NCT00387712|10865413|FG000|NOT COMPLETED|Overall Study||29
9761538|NCT00387712|10865414|FG001|NOT COMPLETED|Overall Study||36
9761539|NCT00387725|10865424|FG000|STARTED|Overall Study||21
10013725|NCT01794689|11136666|FG002|STARTED|Intervention 1 (2 Nights)||24
9761540|NCT00387725|10865425|FG001|STARTED|Overall Study||16
9761541|NCT00387725|10865426|FG002|STARTED|Overall Study||45
9761542|NCT00387725|10865427|FG003|STARTED|Overall Study||45
9761543|NCT00387725|10865424|FG000|COMPLETED|Overall Study||20
9761544|NCT00387725|10865425|FG001|COMPLETED|Overall Study||15
9761545|NCT00387725|10865426|FG002|COMPLETED|Overall Study||43
9761546|NCT00387725|10865427|FG003|COMPLETED|Overall Study||43
9761547|NCT00387725|10865424|FG000|NOT COMPLETED|Overall Study||1
9761548|NCT00387725|10865425|FG001|NOT COMPLETED|Overall Study||1
9761549|NCT00387725|10865426|FG002|NOT COMPLETED|Overall Study||2
9761550|NCT00387725|10865427|FG003|NOT COMPLETED|Overall Study||2
9761551|NCT00387751|10865437|FG000|STARTED|Overall Study||14
9761552|NCT00387751|10865437|FG000|COMPLETED|Overall Study||14
9761553|NCT00387751|10865437|FG000|NOT COMPLETED|Overall Study||0
9761554|NCT00387764|10865443|FG000|STARTED|Overall Study||80
9761555|NCT00387764|10865443|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
9761556|NCT00387764|10865443|FG000|NOT COMPLETED|Overall Study||31
9761557|NCT00387790|10865447|FG000|STARTED|Overall Study||64
9761558|NCT00387790|10865447|FG000|COMPLETED|Overall Study||50
9761559|NCT00387790|10865447|FG000|NOT COMPLETED|Overall Study||14
9829301|NCT00759174|10939905|FG000|STARTED|Overall Study||76
9829302|NCT00759174|10939906|FG001|STARTED|Overall Study||597
9829303|NCT00759174|10939905|FG000|COMPLETED|Overall Study||76
9829304|NCT00759174|10939906|FG001|COMPLETED|Overall Study||595
9829305|NCT00759174|10939905|FG000|NOT COMPLETED|Overall Study||0
9829306|NCT00759174|10939906|FG001|NOT COMPLETED|Overall Study||2
9829307|NCT00759187|10939916|FG000|STARTED|Overall Study||8
9829308|NCT00759187|10939917|FG001|STARTED|Overall Study||8
9829309|NCT00759187|10939918|FG002|STARTED|Overall Study||9
9829310|NCT00759187|10939916|FG000|COMPLETED|Overall Study||8
9829311|NCT00759187|10939917|FG001|COMPLETED|Overall Study||8
9829312|NCT00759187|10939918|FG002|COMPLETED|Overall Study||9
9829313|NCT00759187|10939916|FG000|NOT COMPLETED|Overall Study||0
9829314|NCT00759187|10939917|FG001|NOT COMPLETED|Overall Study||0
9829315|NCT00759187|10939918|FG002|NOT COMPLETED|Overall Study||0
9829316|NCT00759330|10939930|FG000|STARTED|Overall Study||20
9829317|NCT00759330|10939931|FG001|STARTED|Overall Study||42
9829318|NCT00759330|10939932|FG002|STARTED|Overall Study||22
9829319|NCT00759330|10939933|FG003|STARTED|Overall Study||43
9829320|NCT00759330|10939930|FG000|COMPLETED|Overall Study||19
9829321|NCT00759330|10939931|FG001|COMPLETED|Overall Study||41
9829322|NCT00759330|10939932|FG002|COMPLETED|Overall Study||22
9829323|NCT00759330|10939933|FG003|COMPLETED|Overall Study||41
9829324|NCT00759330|10939930|FG000|NOT COMPLETED|Overall Study||1
9829325|NCT00759330|10939931|FG001|NOT COMPLETED|Overall Study||1
9829326|NCT00759330|10939932|FG002|NOT COMPLETED|Overall Study||0
9829327|NCT00759330|10939933|FG003|NOT COMPLETED|Overall Study||2
9829328|NCT00759356|10939946|FG000|STARTED|Overall Study||18
9829329|NCT00759356|10939947|FG001|STARTED|Overall Study||18
9829330|NCT00759356|10939946|FG000|COMPLETED|Overall Study||17
9829331|NCT00759356|10939947|FG001|COMPLETED|Overall Study||15
9829332|NCT00759356|10939946|FG000|NOT COMPLETED|Overall Study||1
9829333|NCT00759356|10939947|FG001|NOT COMPLETED|Overall Study||3
9829334|NCT00759395|10939955|FG000|STARTED|Overall Study||13
9829335|NCT00759395|10939956|FG001|STARTED|Overall Study||9
9829336|NCT00759395|10939955|FG000|COMPLETED|Overall Study||11
9829337|NCT00759395|10939956|FG001|COMPLETED|Overall Study||7
9829338|NCT00759395|10939955|FG000|NOT COMPLETED|Overall Study||2
9829339|NCT00759395|10939956|FG001|NOT COMPLETED|Overall Study||2
9829340|NCT00759408|10939962|FG000|STARTED|Overall Study||38
9829341|NCT00759408|10939962|FG000|COMPLETED|Overall Study||19
9829342|NCT00759408|10939962|FG000|NOT COMPLETED|Overall Study||19
9829343|NCT00759473|10939971|FG000|STARTED|Overall Study||10
9829344|NCT00759473|10939972|FG001|STARTED|Overall Study||10
9829345|NCT00759473|10939973|FG002|STARTED|Overall Study||12
9829346|NCT00759473|10939974|FG003|STARTED|Overall Study||23
9829347|NCT00759473|10939975|FG004|STARTED|Overall Study||24
9829348|NCT00759473|10939971|FG000|COMPLETED|Overall Study||10
9829349|NCT00759473|10939972|FG001|COMPLETED|Overall Study||10
9829350|NCT00759473|10939973|FG002|COMPLETED|Overall Study||12
9829351|NCT00759473|10939974|FG003|COMPLETED|Overall Study||23
9829352|NCT00759473|10939975|FG004|COMPLETED|Overall Study||24
9829353|NCT00759473|10939971|FG000|NOT COMPLETED|Overall Study||0
9829354|NCT00759473|10939972|FG001|NOT COMPLETED|Overall Study||0
9829355|NCT00759473|10939973|FG002|NOT COMPLETED|Overall Study||0
9829356|NCT00759473|10939974|FG003|NOT COMPLETED|Overall Study||0
9829357|NCT00759473|10939975|FG004|NOT COMPLETED|Overall Study||0
9829358|NCT00759525|10939987|FG000|STARTED|First Intervention (14 Days)||7
9829359|NCT00759525|10939988|FG001|STARTED|First Intervention (14 Days)||8
9829360|NCT00759525|10939987|FG000|COMPLETED|First Intervention (14 Days)||7
9829361|NCT00759525|10939988|FG001|COMPLETED|First Intervention (14 Days)||8
10232236|NCT02297230|11361441|FG000|STARTED|Overall Study||11
10232237|NCT02297230|11361442|FG001|STARTED|Overall Study||11
10232238|NCT02297230|11361443|FG002|STARTED|Overall Study||11
10232239|NCT02297230|11361444|FG003|STARTED|Overall Study||11
10232240|NCT02297230|11361441|FG000|COMPLETED|Overall Study||11
10232241|NCT02297230|11361442|FG001|COMPLETED|Overall Study||11
9829362|NCT00759525|10939987|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10232242|NCT02297230|11361443|FG002|COMPLETED|Overall Study||11
9829363|NCT00759525|10939988|FG001|NOT COMPLETED|First Intervention (14 Days)||0
9829364|NCT00759525|10939987|FG000|STARTED|Washout (14 Days)||7
9829365|NCT00759525|10939988|FG001|STARTED|Washout (14 Days)||8
9829366|NCT00759525|10939987|FG000|COMPLETED|Washout (14 Days)||7
9829367|NCT00759525|10939988|FG001|COMPLETED|Washout (14 Days)||8
9829368|NCT00759525|10939987|FG000|NOT COMPLETED|Washout (14 Days)||0
9829369|NCT00759525|10939988|FG001|NOT COMPLETED|Washout (14 Days)||0
9829370|NCT00759525|10939987|FG000|STARTED|Second Intervention (14 Days)||7
9829371|NCT00759525|10939988|FG001|STARTED|Second Intervention (14 Days)||8
9829372|NCT00759525|10939987|FG000|COMPLETED|Second Intervention (14 Days)||7
10232243|NCT02297230|11361444|FG003|COMPLETED|Overall Study||11
10232244|NCT02297230|11361441|FG000|NOT COMPLETED|Overall Study||0
9761560|NCT00387829|10865453|FG000|STARTED|Safety Population||178
9761561|NCT00387829|10865454|FG001|STARTED|Safety Population||169
9761562|NCT00387829|10865453|FG000|COMPLETED|Safety Population||139
9761563|NCT00387829|10865454|FG001|COMPLETED|Safety Population||136
9761564|NCT00387829|10865453|FG000|NOT COMPLETED|Safety Population||39
9761565|NCT00387829|10865454|FG001|NOT COMPLETED|Safety Population||33
9761566|NCT00387829|10865453|FG000|STARTED|Intent-to-treat Population||177
9761567|NCT00387829|10865454|FG001|STARTED|Intent-to-treat Population||166
9761568|NCT00387829|10865453|FG000|COMPLETED|Intent-to-treat Population||139
9761569|NCT00387829|10865454|FG001|COMPLETED|Intent-to-treat Population||136
9761570|NCT00387829|10865453|FG000|NOT COMPLETED|Intent-to-treat Population||38
9761571|NCT00387829|10865454|FG001|NOT COMPLETED|Intent-to-treat Population||30
9761572|NCT00387881|10865462|FG000|STARTED|Overall Study||334
9761573|NCT00387881|10865463|FG001|STARTED|Overall Study||345
9761574|NCT00387881|10865462|FG000|COMPLETED|Overall Study||245
9761575|NCT00387881|10865463|FG001|COMPLETED|Overall Study||243
9761576|NCT00387881|10865462|FG000|NOT COMPLETED|Overall Study||89
9761577|NCT00387881|10865463|FG001|NOT COMPLETED|Overall Study||102
9761578|NCT00387894|10865469|FG000|STARTED|Overall Study||6
9761579|NCT00387894|10865469|FG000|COMPLETED|Overall Study||5
9761580|NCT00387894|10865469|FG000|NOT COMPLETED|Overall Study||1
9761581|NCT00387959|10865473|FG000|STARTED|Overall Study||17
9761582|NCT00387959|10865473|FG000|COMPLETED|Overall Study||16
9761583|NCT00387959|10865473|FG000|NOT COMPLETED|Overall Study||1
9761584|NCT00388037|10865477|FG000|STARTED|Overall Study||31
9761585|NCT00388037|10865477|FG000|COMPLETED|Overall Study||30
9761586|NCT00388037|10865477|FG000|NOT COMPLETED|Overall Study||1
9761587|NCT00388154|10865481|FG000|STARTED|Overall Study||21
9761588|NCT00388154|10865481|FG000|COMPLETED|Overall Study||20
9761589|NCT00388154|10865481|FG000|NOT COMPLETED|Overall Study||1
9761590|NCT00388297|10865489|FG000|STARTED|Overall Study||339
9761591|NCT00388297|10865490|FG001|STARTED|Overall Study||338
9761592|NCT00388297|10865491|FG002|STARTED|Overall Study||265
9761593|NCT00388297|10865492|FG003|STARTED|Overall Study||261
9761594|NCT00388297|10865489|FG000|COMPLETED|Overall Study||323
9761595|NCT00388297|10865490|FG001|COMPLETED|Overall Study||326
9761596|NCT00388297|10865491|FG002|COMPLETED|Overall Study||254
9761597|NCT00388297|10865492|FG003|COMPLETED|Overall Study||253
9761598|NCT00388297|10865489|FG000|NOT COMPLETED|Overall Study||16
9761599|NCT00388297|10865490|FG001|NOT COMPLETED|Overall Study||12
9761600|NCT00388297|10865491|FG002|NOT COMPLETED|Overall Study||11
9761601|NCT00388297|10865492|FG003|NOT COMPLETED|Overall Study||8
9761602|NCT00388349|10865502|FG000|STARTED|Phase I Dose Escalation||3
9761603|NCT00388349|10865503|FG001|STARTED|Phase I Dose Escalation||4
9761604|NCT00388349|10865502|FG000|COMPLETED|Phase I Dose Escalation||3
9761605|NCT00388349|10865503|FG001|COMPLETED|Phase I Dose Escalation||1
9761606|NCT00388349|10865502|FG000|NOT COMPLETED|Phase I Dose Escalation||0
9761607|NCT00388349|10865503|FG001|NOT COMPLETED|Phase I Dose Escalation||3
9761608|NCT00388349|10865502|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
9761609|NCT00388349|10865503|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
9761610|NCT00388349|10865502|FG000|COMPLETED|Phase 2 Dose Expansion||139
9761611|NCT00388349|10865503|FG001|COMPLETED|Phase 2 Dose Expansion||0
9761612|NCT00388349|10865502|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0
9761613|NCT00388349|10865503|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0
9761614|NCT00388362|10865511|FG000|STARTED|Enrolled||36
9761615|NCT00388362|10865511|FG000|COMPLETED|Enrolled||23
9761616|NCT00388362|10865511|FG000|NOT COMPLETED|Enrolled||13
9761617|NCT00388362|10865511|FG000|STARTED|Remained on Study Median of 514 Days||23
9761618|NCT00388362|10865511|FG000|COMPLETED|Remained on Study Median of 514 Days||21
9761619|NCT00388362|10865511|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2
9761620|NCT00388414|10865517|FG000|STARTED|First Intervention (8 Weeks)||7
9761621|NCT00388414|10865518|FG001|STARTED|First Intervention (8 Weeks)||7
9761622|NCT00388414|10865517|FG000|COMPLETED|First Intervention (8 Weeks)||7
9761623|NCT00388414|10865518|FG001|COMPLETED|First Intervention (8 Weeks)||7
9761624|NCT00388414|10865517|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
9761625|NCT00388414|10865518|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
9761626|NCT00388414|10865517|FG000|STARTED|Washout (1 Week)||7
9761627|NCT00388414|10865518|FG001|STARTED|Washout (1 Week)||7
9761628|NCT00388414|10865517|FG000|COMPLETED|Washout (1 Week)||7
9761629|NCT00388414|10865518|FG001|COMPLETED|Washout (1 Week)||7
9761630|NCT00388414|10865517|FG000|NOT COMPLETED|Washout (1 Week)||0
9761631|NCT00388414|10865518|FG001|NOT COMPLETED|Washout (1 Week)||0
9761632|NCT00388414|10865517|FG000|STARTED|Second Intervention (8 Weeks)||7
9761633|NCT00388414|10865518|FG001|STARTED|Second Intervention (8 Weeks)||7
9761634|NCT00388414|10865517|FG000|COMPLETED|Second Intervention (8 Weeks)||7
9761635|NCT00388414|10865518|FG001|COMPLETED|Second Intervention (8 Weeks)||7
9761636|NCT00388414|10865517|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
9761637|NCT00388414|10865518|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
9761638|NCT00388453|10865529|FG000|STARTED|Overall Study||20
9761639|NCT00388453|10865530|FG001|STARTED|Overall Study||17
9761640|NCT00388453|10865531|FG002|STARTED|Overall Study||10
9761641|NCT00388453|10865529|FG000|COMPLETED|Overall Study||20
9761642|NCT00388453|10865530|FG001|COMPLETED|Overall Study||17
9761643|NCT00388453|10865531|FG002|COMPLETED|Overall Study||10
9761644|NCT00388453|10865529|FG000|NOT COMPLETED|Overall Study||0
9761645|NCT00388453|10865530|FG001|NOT COMPLETED|Overall Study||0
9761646|NCT00388453|10865531|FG002|NOT COMPLETED|Overall Study||0
9761647|NCT00388505|10865541|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
9761648|NCT00388505|10865542|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
9761649|NCT00388505|10865541|FG000|COMPLETED|Overall Study||225
9761650|NCT00388505|10865542|FG001|COMPLETED|Overall Study||171
9761651|NCT00388505|10865541|FG000|NOT COMPLETED|Overall Study||83
9761652|NCT00388505|10865542|FG001|NOT COMPLETED|Overall Study||38
9761653|NCT00388583|10865550|FG000|STARTED|Overall Study||407
9761654|NCT00388583|10865551|FG001|STARTED|Overall Study||410
9761655|NCT00388583|10865550|FG000|COMPLETED|Overall Study||401
9761656|NCT00388583|10865551|FG001|COMPLETED|Overall Study||406
9761657|NCT00388583|10865550|FG000|NOT COMPLETED|Overall Study||6
9761658|NCT00388583|10865551|FG001|NOT COMPLETED|Overall Study||4
9761659|NCT00388674|10865559|FG000|STARTED|Initial Treatment||6216
9761660|NCT00388674|10865560|FG001|STARTED|Initial Treatment||6162
9761661|NCT00388674|10865559|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
9761662|NCT00388674|10865560|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
9761663|NCT00388674|10865559|FG000|NOT COMPLETED|Initial Treatment||1828
9761664|NCT00388674|10865560|FG001|NOT COMPLETED|Initial Treatment||2586
9761665|NCT00388674|10865559|FG000|STARTED|End of Study||6216
9761666|NCT00388674|10865560|FG001|STARTED|End of Study||6162
9761667|NCT00388674|10865559|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
9761668|NCT00388674|10865560|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
9761669|NCT00388674|10865559|FG000|NOT COMPLETED|End of Study||1734
9761670|NCT00388674|10865560|FG001|NOT COMPLETED|End of Study||2169
9761671|NCT00388726|10865568|FG000|STARTED|Overall Study||508
9761672|NCT00388726|10865569|FG001|STARTED|Overall Study||254
9761673|NCT00388726|10865568|FG000|COMPLETED|Overall Study||24
9761674|NCT00388726|10865569|FG001|COMPLETED|Overall Study||10
9761675|NCT00388726|10865568|FG000|NOT COMPLETED|Overall Study||484
9761676|NCT00388726|10865569|FG001|NOT COMPLETED|Overall Study||244
9761677|NCT00388804|10865577|FG000|STARTED|Overall Study||17
9761678|NCT00388804|10865578|FG001|STARTED|Overall Study||21
9761679|NCT00388804|10865577|FG000|COMPLETED|Overall Study||17
9761680|NCT00388804|10865578|FG001|COMPLETED|Overall Study||21
9761681|NCT00388804|10865577|FG000|NOT COMPLETED|Overall Study||0
9761682|NCT00388804|10865578|FG001|NOT COMPLETED|Overall Study||0
9761683|NCT00388947|10865584|FG000|STARTED|Overall Study||1590
9761684|NCT00388947|10865584|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
9761685|NCT00388947|10865584|FG000|NOT COMPLETED|Overall Study||47
9761686|NCT00388973|10865590|FG000|STARTED|Overall Study|Randomized|166
9761687|NCT00388973|10865591|FG001|STARTED|Overall Study|Randomized|172
9761688|NCT00388973|10865590|FG000|Completed Study|Overall Study||110
9761689|NCT00388973|10865591|FG001|Completed Study|Overall Study||114
9761690|NCT00388973|10865590|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
9761691|NCT00388973|10865591|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
9761692|NCT00388973|10865590|FG000|NOT COMPLETED|Overall Study||56
9761693|NCT00388973|10865591|FG001|NOT COMPLETED|Overall Study||58
9761694|NCT00389064|10865599|FG000|STARTED|Overall Study||223
9761695|NCT00389064|10865600|FG001|STARTED|Overall Study||227
9761696|NCT00389064|10865599|FG000|COMPLETED|Overall Study||178
9761697|NCT00389064|10865600|FG001|COMPLETED|Overall Study||168
9761698|NCT00389064|10865599|FG000|NOT COMPLETED|Overall Study||45
9761699|NCT00389064|10865600|FG001|NOT COMPLETED|Overall Study||59
9761700|NCT00389168|10865608|FG000|STARTED|Overall Study||56
9761701|NCT00389168|10865609|FG001|STARTED|Overall Study||58
9761702|NCT00389168|10865608|FG000|COMPLETED|Overall Study||47
9761703|NCT00389168|10865609|FG001|COMPLETED|Overall Study||53
9761704|NCT00389168|10865608|FG000|NOT COMPLETED|Overall Study||9
9761705|NCT00389168|10865609|FG001|NOT COMPLETED|Overall Study||5
9761706|NCT00389207|10865618|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
9761707|NCT00389207|10865619|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
9761708|NCT00389207|10865620|FG002|STARTED|Overall Study||193
9761709|NCT00389207|10865618|FG000|COMPLETED|Overall Study||125
9761710|NCT00389207|10865619|FG001|COMPLETED|Overall Study||116
9761711|NCT00389207|10865620|FG002|COMPLETED|Overall Study||152
9761712|NCT00389207|10865618|FG000|NOT COMPLETED|Overall Study||63
9761713|NCT00389207|10865619|FG001|NOT COMPLETED|Overall Study||72
9761714|NCT00389207|10865620|FG002|NOT COMPLETED|Overall Study||41
9761715|NCT00389324|10865633|FG000|STARTED|Run-In Phase||21
10013726|NCT01794689|11136667|FG003|STARTED|Intervention 1 (2 Nights)||22
10013727|NCT01794689|11136664|FG000|COMPLETED|Intervention 1 (2 Nights)||20
10013728|NCT01794689|11136665|FG001|COMPLETED|Intervention 1 (2 Nights)||27
10013729|NCT01794689|11136666|FG002|COMPLETED|Intervention 1 (2 Nights)||21
10013730|NCT01794689|11136667|FG003|COMPLETED|Intervention 1 (2 Nights)||18
10013731|NCT01794689|11136664|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5
10013732|NCT01794689|11136665|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2
9761716|NCT00389324|10865633|FG000|COMPLETED|Run-In Phase||18
9761717|NCT00389324|10865633|FG000|NOT COMPLETED|Run-In Phase||3
9761718|NCT00389324|10865633|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
9761719|NCT00389324|10865633|FG000|COMPLETED|Intravenous Phase||32
9761720|NCT00389324|10865633|FG000|NOT COMPLETED|Intravenous Phase||0
9761721|NCT00389324|10865633|FG000|STARTED|Subcutaneous Phase||32
9761722|NCT00389324|10865633|FG000|COMPLETED|Subcutaneous Phase||25
9761723|NCT00389324|10865633|FG000|NOT COMPLETED|Subcutaneous Phase||7
9761724|NCT00389441|10865640|FG000|STARTED|Overall Study||52
9761725|NCT00389441|10865640|FG000|COMPLETED|Overall Study||0
9761726|NCT00389441|10865640|FG000|NOT COMPLETED|Overall Study||52
9761727|NCT00389467|10865648|FG000|STARTED|Overall Study||34
9761728|NCT00389467|10865649|FG001|STARTED|Overall Study||34
9761729|NCT00389467|10865650|FG002|STARTED|Overall Study||30
9761730|NCT00389467|10865651|FG003|STARTED|Overall Study||20
9761731|NCT00389467|10865648|FG000|COMPLETED|Overall Study||34
9761732|NCT00389467|10865649|FG001|COMPLETED|Overall Study||34
9761733|NCT00389467|10865650|FG002|COMPLETED|Overall Study||30
9761734|NCT00389467|10865651|FG003|COMPLETED|Overall Study||20
9761735|NCT00389467|10865648|FG000|NOT COMPLETED|Overall Study||0
9761736|NCT00389467|10865649|FG001|NOT COMPLETED|Overall Study||0
9761737|NCT00389467|10865650|FG002|NOT COMPLETED|Overall Study||0
9761738|NCT00389467|10865651|FG003|NOT COMPLETED|Overall Study||0
9761739|NCT00389493|10865665|FG000|STARTED|Overall Study||40
9761740|NCT00389493|10865666|FG001|STARTED|Overall Study||40
9761741|NCT00389493|10865667|FG002|STARTED|Overall Study||20
9761742|NCT00389493|10865665|FG000|COMPLETED|Overall Study||37
9761743|NCT00389493|10865666|FG001|COMPLETED|Overall Study||32
9761744|NCT00389493|10865667|FG002|COMPLETED|Overall Study||17
9761745|NCT00389493|10865665|FG000|NOT COMPLETED|Overall Study||3
9761746|NCT00389493|10865666|FG001|NOT COMPLETED|Overall Study||8
9761747|NCT00389493|10865667|FG002|NOT COMPLETED|Overall Study||3
9761748|NCT00389519|10865682|FG000|STARTED|Placebo Run-In||422
9761749|NCT00389519|10865683|FG001|STARTED|Placebo Run-In||0
9761750|NCT00389519|10865684|FG002|STARTED|Placebo Run-In||0
9761751|NCT00389519|10865685|FG003|STARTED|Placebo Run-In||0
9761752|NCT00389519|10865682|FG000|COMPLETED|Placebo Run-In||244
9761753|NCT00389519|10865683|FG001|COMPLETED|Placebo Run-In||0
9761754|NCT00389519|10865684|FG002|COMPLETED|Placebo Run-In||0
9761755|NCT00389519|10865685|FG003|COMPLETED|Placebo Run-In||0
9761756|NCT00389519|10865682|FG000|NOT COMPLETED|Placebo Run-In||178
9761757|NCT00389519|10865683|FG001|NOT COMPLETED|Placebo Run-In||0
9761758|NCT00389519|10865684|FG002|NOT COMPLETED|Placebo Run-In||0
9761759|NCT00389519|10865685|FG003|NOT COMPLETED|Placebo Run-In||0
9761760|NCT00389519|10865682|FG000|STARTED|Randomized||83
9761761|NCT00389519|10865683|FG001|STARTED|Randomized||41
9761762|NCT00389519|10865684|FG002|STARTED|Randomized||40
9761763|NCT00389519|10865685|FG003|STARTED|Randomized||80
9761764|NCT00389519|10865682|FG000|COMPLETED|Randomized||81
9761765|NCT00389519|10865683|FG001|COMPLETED|Randomized||41
9761766|NCT00389519|10865684|FG002|COMPLETED|Randomized||40
9761767|NCT00389519|10865685|FG003|COMPLETED|Randomized||80
9761768|NCT00389519|10865682|FG000|NOT COMPLETED|Randomized||2
9761769|NCT00389519|10865683|FG001|NOT COMPLETED|Randomized||0
9761770|NCT00389519|10865684|FG002|NOT COMPLETED|Randomized||0
9761771|NCT00389519|10865685|FG003|NOT COMPLETED|Randomized||0
9761772|NCT00389519|10865682|FG000|STARTED|Treated||81
9761773|NCT00389519|10865683|FG001|STARTED|Treated||41
9761774|NCT00389519|10865684|FG002|STARTED|Treated||40
9761775|NCT00389519|10865685|FG003|STARTED|Treated||80
9761776|NCT00389519|10865682|FG000|COMPLETED|Treated||79
9761777|NCT00389519|10865683|FG001|COMPLETED|Treated||40
9761778|NCT00389519|10865684|FG002|COMPLETED|Treated||40
9761779|NCT00389519|10865685|FG003|COMPLETED|Treated||76
9761780|NCT00389519|10865682|FG000|NOT COMPLETED|Treated||2
9761781|NCT00389519|10865683|FG001|NOT COMPLETED|Treated||1
9761782|NCT00389519|10865684|FG002|NOT COMPLETED|Treated||0
9761783|NCT00389519|10865685|FG003|NOT COMPLETED|Treated||4
9761784|NCT00389532|10865697|FG000|STARTED|Overall Study||60
9761785|NCT00389532|10865698|FG001|STARTED|Overall Study||56
9761786|NCT00389532|10865697|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
9761787|NCT00389532|10865698|FG001|COMPLETED|Overall Study||56
9761788|NCT00389532|10865697|FG000|NOT COMPLETED|Overall Study||0
9761789|NCT00389532|10865698|FG001|NOT COMPLETED|Overall Study||0
10232245|NCT02297230|11361442|FG001|NOT COMPLETED|Overall Study||0
10232246|NCT02297230|11361443|FG002|NOT COMPLETED|Overall Study||0
10232247|NCT02297230|11361444|FG003|NOT COMPLETED|Overall Study||0
9761790|NCT00389597|10865708|FG000|STARTED|Overall Study||164
9761791|NCT00389597|10865709|FG001|STARTED|Overall Study||81
9761792|NCT00389597|10865710|FG002|STARTED|Overall Study||225
9761793|NCT00389597|10865711|FG003|STARTED|Overall Study||105
9761794|NCT00389597|10865708|FG000|24 mo|Overall Study||156
9761795|NCT00389597|10865709|FG001|24 mo|Overall Study||75
9761796|NCT00389597|10865710|FG002|24 mo|Overall Study||221
9761797|NCT00389597|10865711|FG003|24 mo|Overall Study||99
9761798|NCT00389597|10865708|FG000|COMPLETED|Overall Study||156
9761799|NCT00389597|10865709|FG001|COMPLETED|Overall Study||75
9761800|NCT00389597|10865710|FG002|COMPLETED|Overall Study||221
9761801|NCT00389597|10865711|FG003|COMPLETED|Overall Study||99
9761802|NCT00389597|10865708|FG000|NOT COMPLETED|Overall Study||8
9761803|NCT00389597|10865709|FG001|NOT COMPLETED|Overall Study||6
9761804|NCT00389597|10865710|FG002|NOT COMPLETED|Overall Study||4
9761805|NCT00389597|10865711|FG003|NOT COMPLETED|Overall Study||6
9761806|NCT00389805|10865723|FG000|STARTED|Phase I||15
9761807|NCT00389805|10865724|FG001|STARTED|Phase I||12
9761808|NCT00389805|10865723|FG000|COMPLETED|Phase I||15
9761809|NCT00389805|10865724|FG001|COMPLETED|Phase I||12
9761810|NCT00389805|10865723|FG000|NOT COMPLETED|Phase I||0
9761811|NCT00389805|10865724|FG001|NOT COMPLETED|Phase I||0
10232248|NCT02294981|11361460|FG000|STARTED|Overall Study||4
9761812|NCT00389805|10865723|FG000|STARTED|Phase II|The Phase II study was not conducted.|0
9761813|NCT00389805|10865724|FG001|STARTED|Phase II|The Phase II study was not conducted.|0
9761814|NCT00389805|10865723|FG000|COMPLETED|Phase II||0
9761815|NCT00389805|10865724|FG001|COMPLETED|Phase II||0
9761816|NCT00389805|10865723|FG000|NOT COMPLETED|Phase II||0
9761817|NCT00389805|10865724|FG001|NOT COMPLETED|Phase II||0
9761818|NCT00389818|10865730|FG000|STARTED|Overall Study||43
9761819|NCT00389818|10865730|FG000|COMPLETED|Overall Study||40
9761820|NCT00389818|10865730|FG000|NOT COMPLETED|Overall Study||3
9761821|NCT00389831|10865736|FG000|STARTED|Overall Study||10
9761822|NCT00389831|10865737|FG001|STARTED|Overall Study||34
9761823|NCT00389831|10865736|FG000|COMPLETED|Overall Study||10
9761824|NCT00389831|10865737|FG001|COMPLETED|Overall Study||27
9761825|NCT00389831|10865736|FG000|NOT COMPLETED|Overall Study||0
9761826|NCT00389831|10865737|FG001|NOT COMPLETED|Overall Study||7
9761827|NCT00389857|10865757|FG000|STARTED|Overall Study||14
9761828|NCT00389857|10865758|FG001|STARTED|Overall Study||17
9761829|NCT00389857|10865757|FG000|COMPLETED|Overall Study||14
9761830|NCT00389857|10865758|FG001|COMPLETED|Overall Study||17
9761831|NCT00389857|10865757|FG000|NOT COMPLETED|Overall Study||0
9761832|NCT00389857|10865758|FG001|NOT COMPLETED|Overall Study||0
9761833|NCT00389974|10865764|FG000|STARTED|Overall Study||19
9761834|NCT00389974|10865764|FG000|COMPLETED|Overall Study||19
9761835|NCT00389974|10865764|FG000|NOT COMPLETED|Overall Study||0
9761836|NCT00390013|10865771|FG000|STARTED|Phase 1||0
9761837|NCT00390013|10865772|FG001|STARTED|Phase 1||0
9761838|NCT00390013|10865773|FG002|STARTED|Phase 1||2
9761839|NCT00390013|10865774|FG003|STARTED|Phase 1||2
9761840|NCT00390013|10865771|FG000|COMPLETED|Phase 1||0
9761841|NCT00390013|10865772|FG001|COMPLETED|Phase 1||0
9761842|NCT00390013|10865773|FG002|COMPLETED|Phase 1||2
9761843|NCT00390013|10865774|FG003|COMPLETED|Phase 1||1
9761844|NCT00390013|10865771|FG000|NOT COMPLETED|Phase 1||0
9761845|NCT00390013|10865772|FG001|NOT COMPLETED|Phase 1||0
9761846|NCT00390013|10865773|FG002|NOT COMPLETED|Phase 1||0
9761847|NCT00390013|10865774|FG003|NOT COMPLETED|Phase 1||1
9761848|NCT00390013|10865771|FG000|STARTED|Phase 2 First Treatment||3
9761849|NCT00390013|10865772|FG001|STARTED|Phase 2 First Treatment||2
9761850|NCT00390013|10865773|FG002|STARTED|Phase 2 First Treatment||0
9761851|NCT00390013|10865774|FG003|STARTED|Phase 2 First Treatment||0
9761852|NCT00390013|10865771|FG000|COMPLETED|Phase 2 First Treatment||2
9761853|NCT00390013|10865772|FG001|COMPLETED|Phase 2 First Treatment||1
9761854|NCT00390013|10865773|FG002|COMPLETED|Phase 2 First Treatment||0
9761855|NCT00390013|10865774|FG003|COMPLETED|Phase 2 First Treatment||0
9761856|NCT00390013|10865771|FG000|NOT COMPLETED|Phase 2 First Treatment||1
9761857|NCT00390013|10865772|FG001|NOT COMPLETED|Phase 2 First Treatment||1
9761858|NCT00390013|10865773|FG002|NOT COMPLETED|Phase 2 First Treatment||0
9761859|NCT00390013|10865774|FG003|NOT COMPLETED|Phase 2 First Treatment||0
9761860|NCT00390013|10865771|FG000|STARTED|Phase 2 Second Treatment||2
9761861|NCT00390013|10865772|FG001|STARTED|Phase 2 Second Treatment||1
9761862|NCT00390013|10865773|FG002|STARTED|Phase 2 Second Treatment||0
9761863|NCT00390013|10865774|FG003|STARTED|Phase 2 Second Treatment||0
9761864|NCT00390013|10865771|FG000|COMPLETED|Phase 2 Second Treatment||2
9761865|NCT00390013|10865772|FG001|COMPLETED|Phase 2 Second Treatment||1
9761866|NCT00390013|10865773|FG002|COMPLETED|Phase 2 Second Treatment||0
9761867|NCT00390013|10865774|FG003|COMPLETED|Phase 2 Second Treatment||0
9761868|NCT00390013|10865771|FG000|NOT COMPLETED|Phase 2 Second Treatment||0
9761869|NCT00390013|10865772|FG001|NOT COMPLETED|Phase 2 Second Treatment||0
9761870|NCT00390013|10865773|FG002|NOT COMPLETED|Phase 2 Second Treatment||0
9761871|NCT00390013|10865774|FG003|NOT COMPLETED|Phase 2 Second Treatment||0
9761872|NCT00390182|10865780|FG000|STARTED|Overall Study||38
9761873|NCT00390182|10865780|FG000|COMPLETED|Overall Study||33
9761874|NCT00390182|10865780|FG000|NOT COMPLETED|Overall Study||5
9761875|NCT00390221|10865787|FG000|STARTED|Overall Study||204
9761876|NCT00390221|10865788|FG001|STARTED|Overall Study||208
9761877|NCT00390221|10865789|FG002|STARTED|Overall Study||209
9761878|NCT00390221|10865787|FG000|COMPLETED|Overall Study||186
9761879|NCT00390221|10865788|FG001|COMPLETED|Overall Study||188
9761880|NCT00390221|10865789|FG002|COMPLETED|Overall Study||194
9761881|NCT00390221|10865787|FG000|NOT COMPLETED|Overall Study||18
9761882|NCT00390221|10865788|FG001|NOT COMPLETED|Overall Study||20
10013733|NCT01794689|11136666|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3
10013734|NCT01794689|11136667|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4
9761883|NCT00390221|10865789|FG002|NOT COMPLETED|Overall Study||15
9761884|NCT00390234|10865798|FG000|STARTED|Overall Study||63
9761885|NCT00390234|10865798|FG000|COMPLETED|Overall Study||63
9761886|NCT00390234|10865798|FG000|NOT COMPLETED|Overall Study||0
9761887|NCT00390299|10865808|FG000|STARTED|Overall Study||4
9761888|NCT00390299|10865809|FG001|STARTED|Overall Study||3
9761889|NCT00390299|10865810|FG002|STARTED|Overall Study||3
9761890|NCT00390299|10865811|FG003|STARTED|Overall Study||3
9761891|NCT00390299|10865812|FG004|STARTED|Overall Study||10
9761892|NCT00390299|10865808|FG000|COMPLETED|Overall Study||3
9761893|NCT00390299|10865809|FG001|COMPLETED|Overall Study||3
9761894|NCT00390299|10865810|FG002|COMPLETED|Overall Study||3
9761895|NCT00390299|10865811|FG003|COMPLETED|Overall Study||3
9761896|NCT00390299|10865812|FG004|COMPLETED|Overall Study||10
9761897|NCT00390299|10865808|FG000|NOT COMPLETED|Overall Study||1
9761898|NCT00390299|10865809|FG001|NOT COMPLETED|Overall Study||0
9761899|NCT00390299|10865810|FG002|NOT COMPLETED|Overall Study||0
9761900|NCT00390299|10865811|FG003|NOT COMPLETED|Overall Study||0
9761901|NCT00390299|10865812|FG004|NOT COMPLETED|Overall Study||0
9761902|NCT00390364|10865826|FG000|STARTED|Overall Study||1
9761903|NCT00390364|10865826|FG000|COMPLETED|Overall Study||1
9761904|NCT00390364|10865826|FG000|NOT COMPLETED|Overall Study||0
9761905|NCT00390416|10865830|FG000|STARTED|Overall Study||48
9761906|NCT00390416|10865830|FG000|COMPLETED|Overall Study||44
9761907|NCT00390416|10865830|FG000|NOT COMPLETED|Overall Study||4
9761908|NCT00390429|10865837|FG000|STARTED|Overall Study||5
9761909|NCT00390429|10865838|FG001|STARTED|Overall Study||12
9761910|NCT00390429|10865839|FG002|STARTED|Overall Study||25
9761911|NCT00390429|10865840|FG003|STARTED|Overall Study||39
9761912|NCT00390429|10865837|FG000|COMPLETED|Overall Study||5
9761913|NCT00390429|10865838|FG001|COMPLETED|Overall Study||12
9761914|NCT00390429|10865839|FG002|COMPLETED|Overall Study||25
9761915|NCT00390429|10865840|FG003|COMPLETED|Overall Study||39
9761916|NCT00390429|10865837|FG000|NOT COMPLETED|Overall Study||0
9761917|NCT00390429|10865838|FG001|NOT COMPLETED|Overall Study||0
9761918|NCT00390429|10865839|FG002|NOT COMPLETED|Overall Study||0
9761919|NCT00390429|10865840|FG003|NOT COMPLETED|Overall Study||0
9761920|NCT00390455|10865853|FG000|STARTED|Overall Study||148
9761921|NCT00390455|10865854|FG001|STARTED|Overall Study||147
9761922|NCT00390455|10865853|FG000|COMPLETED|Overall Study||116
9761923|NCT00390455|10865854|FG001|COMPLETED|Overall Study||124
9761924|NCT00390455|10865853|FG000|NOT COMPLETED|Overall Study||32
9761925|NCT00390455|10865854|FG001|NOT COMPLETED|Overall Study||23
9761926|NCT00390468|10865860|FG000|STARTED|Overall Study||18
9761927|NCT00390468|10865860|FG000|COMPLETED|Overall Study||15
9761928|NCT00390468|10865860|FG000|NOT COMPLETED|Overall Study||3
9761929|NCT00390546|10865866|FG000|STARTED|Overall Study||33
9761930|NCT00390546|10865867|FG001|STARTED|Overall Study||39
9761931|NCT00390546|10865866|FG000|COMPLETED|Overall Study||27
9761932|NCT00390546|10865867|FG001|COMPLETED|Overall Study||34
9761933|NCT00390546|10865866|FG000|NOT COMPLETED|Overall Study||6
9761934|NCT00390546|10865867|FG001|NOT COMPLETED|Overall Study||5
9761935|NCT00390559|10865874|FG000|STARTED|Overall Study||124
9761936|NCT00390559|10865874|FG000|Received PlaceboP/Active C|Overall Study||93
9761937|NCT00390559|10865874|FG000|ActiveP/ActiveC|Overall Study||87
9761938|NCT00390559|10865874|FG000|PlaceboP/PlaceboC|Overall Study||93
9761939|NCT00390559|10865874|FG000|ActiveP/PlaceboC|Overall Study||90
9761940|NCT00390559|10865874|FG000|COMPLETED|Overall Study||80
9761941|NCT00390559|10865874|FG000|NOT COMPLETED|Overall Study||44
9761942|NCT00390572|10865886|FG000|STARTED|Overall Study||68
9761943|NCT00390572|10865887|FG001|STARTED|Overall Study||69
9761944|NCT00390572|10865886|FG000|COMPLETED|Overall Study||60
9761945|NCT00390572|10865887|FG001|COMPLETED|Overall Study||64
9761946|NCT00390572|10865886|FG000|NOT COMPLETED|Overall Study||8
9761947|NCT00390572|10865887|FG001|NOT COMPLETED|Overall Study||5
9761948|NCT00390611|10865895|FG000|STARTED|6 Cycles of Study Treatment||43
9761949|NCT00390611|10865896|FG001|STARTED|6 Cycles of Study Treatment||42
9761950|NCT00390611|10865895|FG000|COMPLETED|6 Cycles of Study Treatment||34
9761951|NCT00390611|10865896|FG001|COMPLETED|6 Cycles of Study Treatment||37
9761952|NCT00390611|10865895|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9
9761953|NCT00390611|10865896|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5
9761954|NCT00390611|10865895|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
9761955|NCT00390611|10865896|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
9761956|NCT00390611|10865895|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13
9761957|NCT00390611|10865896|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0
9761958|NCT00390611|10865895|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
9761959|NCT00390611|10865896|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
9761960|NCT00390689|10865907|FG000|STARTED|Overall Study||48
9761961|NCT00390689|10865908|FG001|STARTED|Overall Study||53
9761962|NCT00390689|10865909|FG002|STARTED|Overall Study||53
9761963|NCT00390689|10865907|FG000|COMPLETED|Overall Study||43
9761964|NCT00390689|10865908|FG001|COMPLETED|Overall Study||48
9761965|NCT00390689|10865909|FG002|COMPLETED|Overall Study||50
9761966|NCT00390689|10865907|FG000|NOT COMPLETED|Overall Study||5
9761967|NCT00390689|10865908|FG001|NOT COMPLETED|Overall Study||5
9761968|NCT00390689|10865909|FG002|NOT COMPLETED|Overall Study||3
9761969|NCT00390780|10865928|FG000|STARTED|Overall Study||291
9761970|NCT00390780|10865929|FG001|STARTED|Overall Study||287
9761971|NCT00390780|10865928|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
9761972|NCT00390780|10865929|FG001|Treatment|Overall Study||287
9761973|NCT00390780|10865928|FG000|COMPLETED|Overall Study||268
9761974|NCT00390780|10865929|FG001|COMPLETED|Overall Study||260
9761975|NCT00390780|10865928|FG000|NOT COMPLETED|Overall Study||23
9761976|NCT00390780|10865929|FG001|NOT COMPLETED|Overall Study||27
9761977|NCT00390806|10865937|FG000|STARTED|Overall Study||236
9761978|NCT00390806|10865938|FG001|STARTED|Overall Study||236
9761979|NCT00390806|10865937|FG000|Ongoing|Overall Study||4
9761980|NCT00390806|10865938|FG001|Ongoing|Overall Study||2
9761981|NCT00390806|10865937|FG000|COMPLETED|Overall Study||206
9761982|NCT00390806|10865938|FG001|COMPLETED|Overall Study||204
9761983|NCT00390806|10865937|FG000|NOT COMPLETED|Overall Study||30
9761984|NCT00390806|10865938|FG001|NOT COMPLETED|Overall Study||32
9761985|NCT00390858|10865946|FG000|STARTED|Overall Study|20 participants started the Core Study|20
9761986|NCT00390858|10865947|FG001|STARTED|Overall Study|20 Participants started the Core Study|20
9761987|NCT00390858|10865946|FG000|Completed Core & Entered Extension Study|Overall Study||19
9761988|NCT00390858|10865947|FG001|Completed Core & Entered Extension Study|Overall Study||20
9761989|NCT00390858|10865946|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
9761990|NCT00390858|10865947|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
9761991|NCT00390858|10865946|FG000|NOT COMPLETED|Overall Study||9
9761992|NCT00390858|10865947|FG001|NOT COMPLETED|Overall Study||7
9761993|NCT00390884|10865955|FG000|STARTED|Overall Study||116
9761994|NCT00390884|10865956|FG001|STARTED|Overall Study||57
9761995|NCT00390884|10865955|FG000|COMPLETED|Overall Study||114
9761996|NCT00390884|10865956|FG001|COMPLETED|Overall Study||55
9761997|NCT00390884|10865955|FG000|NOT COMPLETED|Overall Study||2
9761998|NCT00390884|10865956|FG001|NOT COMPLETED|Overall Study||2
9761999|NCT00390910|10865965|FG000|STARTED|Overall Study||50
9762000|NCT00390910|10865966|FG001|STARTED|Overall Study||87
9762001|NCT00390910|10865967|FG002|STARTED|Overall Study||149
9762002|NCT00390910|10865965|FG000|COMPLETED|Overall Study||48
9762003|NCT00390910|10865966|FG001|COMPLETED|Overall Study||83
9762004|NCT00390910|10865967|FG002|COMPLETED|Overall Study||139
9762005|NCT00390910|10865965|FG000|NOT COMPLETED|Overall Study||2
9762006|NCT00390910|10865966|FG001|NOT COMPLETED|Overall Study||4
9762007|NCT00390910|10865967|FG002|NOT COMPLETED|Overall Study||10
9762008|NCT00390949|10865979|FG000|STARTED|Overall Study||4662
9762009|NCT00390949|10865980|FG001|STARTED|Overall Study||4792
9762010|NCT00390949|10865979|FG000|COMPLETED|Overall Study||2564
9762011|NCT00390949|10865980|FG001|COMPLETED|Overall Study||2664
9762012|NCT00390949|10865979|FG000|NOT COMPLETED|Overall Study||2098
9762013|NCT00390949|10865980|FG001|NOT COMPLETED|Overall Study||2128
9762014|NCT00391027|10865988|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
9762015|NCT00391027|10865989|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
9762016|NCT00391027|10865988|FG000|COMPLETED|Overall Study||110
9762017|NCT00391027|10865989|FG001|COMPLETED|Overall Study||110
9762018|NCT00391027|10865988|FG000|NOT COMPLETED|Overall Study||25
9762019|NCT00391027|10865989|FG001|NOT COMPLETED|Overall Study||12
9762020|NCT00391053|10865999|FG000|STARTED|Overall Study||857
9762021|NCT00391053|10866000|FG001|STARTED|Overall Study||848
9762022|NCT00391053|10866001|FG002|STARTED|Overall Study||870
9762023|NCT00391053|10866002|FG003|STARTED|Overall Study||1262
9762024|NCT00391053|10865999|FG000|COMPLETED|Overall Study||848
9762025|NCT00391053|10866000|FG001|COMPLETED|Overall Study||847
9762026|NCT00391053|10866001|FG002|COMPLETED|Overall Study||868
9762027|NCT00391053|10866002|FG003|COMPLETED|Overall Study||1252
9762028|NCT00391053|10865999|FG000|NOT COMPLETED|Overall Study||9
9762029|NCT00391053|10866000|FG001|NOT COMPLETED|Overall Study||1
9762030|NCT00391053|10866001|FG002|NOT COMPLETED|Overall Study||2
9762031|NCT00391053|10866002|FG003|NOT COMPLETED|Overall Study||10
9762032|NCT00391079|10866014|FG000|STARTED|Overall Study||167
9762033|NCT00391079|10866015|FG001|STARTED|Overall Study||172
9762034|NCT00391079|10866014|FG000|COMPLETED|Overall Study||141
10232249|NCT02294981|11361460|FG000|COMPLETED|Overall Study||3
10232250|NCT02294981|11361460|FG000|NOT COMPLETED|Overall Study||1
9762035|NCT00391079|10866015|FG001|COMPLETED|Overall Study||156
9762036|NCT00391079|10866014|FG000|NOT COMPLETED|Overall Study||26
9762037|NCT00391079|10866015|FG001|NOT COMPLETED|Overall Study||16
9762038|NCT00391092|10866023|FG000|STARTED|Overall Study||208
9762039|NCT00391092|10866024|FG001|STARTED|Overall Study||216
9762040|NCT00391092|10866023|FG000|Received Treatment|Overall Study||206
9762041|NCT00391092|10866024|FG001|Received Treatment|Overall Study||215
9762042|NCT00391092|10866023|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
9762043|NCT00391092|10866024|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
9762044|NCT00391092|10866023|FG000|NOT COMPLETED|Overall Study||208
9762045|NCT00391092|10866024|FG001|NOT COMPLETED|Overall Study||216
9762046|NCT00391118|10866033|FG000|STARTED|Overall Study||11
9762047|NCT00391118|10866034|FG001|STARTED|Overall Study||69
9762048|NCT00391118|10866035|FG002|STARTED|Overall Study||73
9762049|NCT00391118|10866033|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
9762050|NCT00391118|10866034|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
9762051|NCT00391118|10866035|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
9762052|NCT00391118|10866033|FG000|COMPLETED|Overall Study||0
9762053|NCT00391118|10866034|FG001|COMPLETED|Overall Study||14
9762054|NCT00391118|10866035|FG002|COMPLETED|Overall Study||15
9762055|NCT00391118|10866033|FG000|NOT COMPLETED|Overall Study||11
9762056|NCT00391118|10866034|FG001|NOT COMPLETED|Overall Study||55
9762057|NCT00391118|10866035|FG002|NOT COMPLETED|Overall Study||58
9762058|NCT00391222|10866049|FG000|STARTED|Period II (Open-label Risperidone LAI)||0
9762059|NCT00391222|10866050|FG001|STARTED|Period II (Open-label Risperidone LAI)||0
9762060|NCT00391222|10866051|FG002|STARTED|Period II (Open-label Risperidone LAI)||0
9762061|NCT00391222|10866052|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
9762062|NCT00391222|10866049|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0
9762063|NCT00391222|10866050|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0
9762064|NCT00391222|10866051|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0
9762065|NCT00391222|10866052|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398
9762066|NCT00391222|10866049|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10232251|NCT02284906|11361467|FG000|STARTED|Overall Study||3
9762067|NCT00391222|10866050|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10232252|NCT02284906|11361468|FG001|STARTED|Overall Study||18
9762068|NCT00391222|10866051|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
9762069|NCT00391222|10866052|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
9762070|NCT00391222|10866049|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
9762071|NCT00391222|10866050|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
9762072|NCT00391222|10866051|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
9762073|NCT00391222|10866052|FG003|STARTED|Period III (Double-Blind Treatment)||0
9762074|NCT00391222|10866049|FG000|COMPLETED|Period III (Double-Blind Treatment)||104
9762075|NCT00391222|10866050|FG001|COMPLETED|Period III (Double-Blind Treatment)||113
9762076|NCT00391222|10866051|FG002|COMPLETED|Period III (Double-Blind Treatment)||108
9762077|NCT00391222|10866052|FG003|COMPLETED|Period III (Double-Blind Treatment)||0
9762078|NCT00391222|10866049|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28
9762079|NCT00391222|10866050|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22
9762080|NCT00391222|10866051|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23
9762081|NCT00391222|10866052|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0
9762082|NCT00391274|10866064|FG000|STARTED|Overall Study||107
9762083|NCT00391274|10866065|FG001|STARTED|Overall Study||104
9762084|NCT00391274|10866064|FG000|Received at Least One Dose of Study Drug|Overall Study||106
9762085|NCT00391274|10866065|FG001|Received at Least One Dose of Study Drug|Overall Study||102
9762086|NCT00391274|10866064|FG000|COMPLETED|Overall Study||46
9762087|NCT00391274|10866065|FG001|COMPLETED|Overall Study||47
9762088|NCT00391274|10866064|FG000|NOT COMPLETED|Overall Study||61
9762089|NCT00391274|10866065|FG001|NOT COMPLETED|Overall Study||57
9762090|NCT00391391|10866075|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98
9762091|NCT00391391|10866076|FG001|STARTED|Overall Study||97
9762092|NCT00391391|10866077|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161
9762093|NCT00391391|10866078|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164
9762094|NCT00391391|10866075|FG000|COMPLETED|Overall Study||89
9762095|NCT00391391|10866076|FG001|COMPLETED|Overall Study||87
9762096|NCT00391391|10866077|FG002|COMPLETED|Overall Study||138
9762097|NCT00391391|10866078|FG003|COMPLETED|Overall Study||145
9762098|NCT00391391|10866075|FG000|NOT COMPLETED|Overall Study||9
9762099|NCT00391391|10866076|FG001|NOT COMPLETED|Overall Study||10
9762100|NCT00391391|10866077|FG002|NOT COMPLETED|Overall Study||23
9762101|NCT00391391|10866078|FG003|NOT COMPLETED|Overall Study||19
9762102|NCT00391443|10866090|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
9762103|NCT00391443|10866091|FG001|STARTED|Overall Study||407
9762104|NCT00391443|10866090|FG000|COMPLETED|Overall Study||209
9762105|NCT00391443|10866091|FG001|COMPLETED|Overall Study||407
9762106|NCT00391443|10866090|FG000|NOT COMPLETED|Overall Study||0
9762107|NCT00391443|10866091|FG001|NOT COMPLETED|Overall Study||0
9762108|NCT00391469|10866101|FG000|STARTED|Overall Study||688
9762109|NCT00391469|10866102|FG001|STARTED|Overall Study||671
9762110|NCT00391469|10866101|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
9762111|NCT00391469|10866102|FG001|COMPLETED|Overall Study||671
9762112|NCT00391469|10866101|FG000|NOT COMPLETED|Overall Study||0
9762113|NCT00391469|10866102|FG001|NOT COMPLETED|Overall Study||0
9762114|NCT00391586|10866110|FG000|STARTED|Overall Study||45
9762115|NCT00391586|10866110|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
9762116|NCT00391586|10866110|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
9762117|NCT00391586|10866110|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
9762118|NCT00391586|10866110|FG000|NOT COMPLETED|Overall Study||24
9762119|NCT00391599|10866116|FG000|STARTED|Overall Study||65
9762120|NCT00391599|10866117|FG001|STARTED|Overall Study||65
9762121|NCT00391599|10866116|FG000|COMPLETED|Overall Study||65
9762122|NCT00391599|10866117|FG001|COMPLETED|Overall Study||65
9762123|NCT00391599|10866116|FG000|NOT COMPLETED|Overall Study||0
9762124|NCT00391599|10866117|FG001|NOT COMPLETED|Overall Study||0
9762125|NCT00391625|10866125|FG000|STARTED|Baseline||10
9762126|NCT00391625|10866125|FG000|COMPLETED|Baseline||10
9762127|NCT00391625|10866125|FG000|NOT COMPLETED|Baseline||0
9762128|NCT00391625|10866125|FG000|STARTED|Month 14||10
9762129|NCT00391625|10866125|FG000|COMPLETED|Month 14||9
9762130|NCT00391625|10866125|FG000|NOT COMPLETED|Month 14||1
9762131|NCT00391625|10866125|FG000|STARTED|Month 50||9
9762132|NCT00391625|10866125|FG000|COMPLETED|Month 50||8
9762133|NCT00391625|10866125|FG000|NOT COMPLETED|Month 50||1
9762134|NCT00391625|10866125|FG000|STARTED|Month 84||8
9762135|NCT00391625|10866125|FG000|COMPLETED|Month 84||8
9762136|NCT00391625|10866125|FG000|NOT COMPLETED|Month 84||0
9762137|NCT00391716|10866155|FG000|STARTED|Overall Study||54
9762138|NCT00391716|10866156|FG001|STARTED|Overall Study||47
9762139|NCT00391716|10866157|FG002|STARTED|Overall Study||49
9762140|NCT00391716|10866155|FG000|COMPLETED|Overall Study||27
9762141|NCT00391716|10866156|FG001|COMPLETED|Overall Study||28
9762142|NCT00391716|10866157|FG002|COMPLETED|Overall Study||30
9762143|NCT00391716|10866155|FG000|NOT COMPLETED|Overall Study||27
9762144|NCT00391716|10866156|FG001|NOT COMPLETED|Overall Study||19
9762145|NCT00391716|10866157|FG002|NOT COMPLETED|Overall Study||19
9762146|NCT00391768|10866172|FG000|STARTED|Overall Study||12
9762147|NCT00391768|10866173|FG001|STARTED|Overall Study||3
9762148|NCT00391768|10866174|FG002|STARTED|Overall Study||7
9762149|NCT00391768|10866175|FG003|STARTED|Overall Study||8
9762150|NCT00391768|10866176|FG004|STARTED|Overall Study||24
9762151|NCT00391768|10866177|FG005|STARTED|Overall Study||10
9762152|NCT00391768|10866178|FG006|STARTED|Overall Study||23
9762153|NCT00391768|10866172|FG000|COMPLETED|Overall Study||12
9762154|NCT00391768|10866173|FG001|COMPLETED|Overall Study||3
9762155|NCT00391768|10866174|FG002|COMPLETED|Overall Study||6
9762156|NCT00391768|10866175|FG003|COMPLETED|Overall Study||7
9762157|NCT00391768|10866176|FG004|COMPLETED|Overall Study||22
9762158|NCT00391768|10866177|FG005|COMPLETED|Overall Study||7
9762159|NCT00391768|10866178|FG006|COMPLETED|Overall Study||19
9762160|NCT00391768|10866172|FG000|NOT COMPLETED|Overall Study||0
9762161|NCT00391768|10866173|FG001|NOT COMPLETED|Overall Study||0
9762162|NCT00391768|10866174|FG002|NOT COMPLETED|Overall Study||1
9762163|NCT00391768|10866175|FG003|NOT COMPLETED|Overall Study||1
9762164|NCT00391768|10866176|FG004|NOT COMPLETED|Overall Study||2
9762165|NCT00391768|10866177|FG005|NOT COMPLETED|Overall Study||3
9762166|NCT00391768|10866178|FG006|NOT COMPLETED|Overall Study||4
9762167|NCT00391807|10866212|FG000|STARTED|Overall Study||1683
9762168|NCT00391807|10866212|FG000|COMPLETED|Overall Study||968
9762169|NCT00391807|10866212|FG000|NOT COMPLETED|Overall Study||715
9762170|NCT00391846|10866218|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
9762171|NCT00391846|10866219|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
9762172|NCT00391846|10866218|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
9762173|NCT00391846|10866219|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
9762174|NCT00391846|10866218|FG000|NOT COMPLETED|Overall Study||8
9762175|NCT00391846|10866219|FG001|NOT COMPLETED|Overall Study||7
9762176|NCT00391872|10866227|FG000|STARTED|Overall Study||9333
9762177|NCT00391872|10866228|FG001|STARTED|Overall Study||9291
9762178|NCT00391872|10866227|FG000|COMPLETED|Overall Study||9026
9762179|NCT00391872|10866228|FG001|COMPLETED|Overall Study||9036
9762180|NCT00391872|10866227|FG000|NOT COMPLETED|Overall Study||307
9762181|NCT00391872|10866228|FG001|NOT COMPLETED|Overall Study||255
9762182|NCT00391898|10866236|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
9762183|NCT00391898|10866237|FG001|STARTED|Overall Study||49
9762184|NCT00391898|10866236|FG000|COMPLETED|Overall Study||35
9762185|NCT00391898|10866237|FG001|COMPLETED|Overall Study||39
9762186|NCT00391898|10866236|FG000|NOT COMPLETED|Overall Study||11
9762187|NCT00391898|10866237|FG001|NOT COMPLETED|Overall Study||10
9762188|NCT00391976|10866246|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
9762189|NCT00391976|10866247|FG001|STARTED|Overall Study||43
9762190|NCT00391976|10866248|FG002|STARTED|Overall Study||35
9762191|NCT00391976|10866246|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
9762192|NCT00391976|10866247|FG001|Randomized|Overall Study||43
9762193|NCT00391976|10866248|FG002|Randomized|Overall Study||0
10013735|NCT01794689|11136664|FG000|STARTED|Washout (2 Weeks)||20
10013736|NCT01794689|11136665|FG001|STARTED|Washout (2 Weeks)||27
10013737|NCT01794689|11136666|FG002|STARTED|Washout (2 Weeks)||21
9762194|NCT00391976|10866246|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
9762195|NCT00391976|10866247|FG001|Safety Population|Overall Study||43
9762196|NCT00391976|10866248|FG002|Safety Population|Overall Study||35
9762197|NCT00391976|10866246|FG000|COMPLETED|Overall Study||18
9762198|NCT00391976|10866247|FG001|COMPLETED|Overall Study||18
9762199|NCT00391976|10866248|FG002|COMPLETED|Overall Study||0
9762200|NCT00391976|10866246|FG000|NOT COMPLETED|Overall Study||27
9762201|NCT00391976|10866247|FG001|NOT COMPLETED|Overall Study||25
9762202|NCT00391976|10866248|FG002|NOT COMPLETED|Overall Study||35
9762203|NCT00391989|10866258|FG000|STARTED|Overall Study||55
9762204|NCT00391989|10866258|FG000|COMPLETED|Overall Study||53
9762205|NCT00391989|10866258|FG000|NOT COMPLETED|Overall Study||2
9762206|NCT00392015|10866268|FG000|STARTED|Overall Study||6
9762207|NCT00392015|10866269|FG001|STARTED|Overall Study||6
9762208|NCT00392015|10866270|FG002|STARTED|Overall Study||20
9762209|NCT00392015|10866271|FG003|STARTED|Overall Study||6
9762210|NCT00392015|10866272|FG004|STARTED|Overall Study||15
9762211|NCT00392015|10866273|FG005|STARTED|Overall Study||6
9762212|NCT00392015|10866268|FG000|COMPLETED|Overall Study||4
9762213|NCT00392015|10866269|FG001|COMPLETED|Overall Study||6
9762214|NCT00392015|10866270|FG002|COMPLETED|Overall Study||16
9762215|NCT00392015|10866271|FG003|COMPLETED|Overall Study||5
9762216|NCT00392015|10866272|FG004|COMPLETED|Overall Study||12
9762217|NCT00392015|10866273|FG005|COMPLETED|Overall Study||6
9762218|NCT00392015|10866268|FG000|NOT COMPLETED|Overall Study||2
9762219|NCT00392015|10866269|FG001|NOT COMPLETED|Overall Study||0
9762220|NCT00392015|10866270|FG002|NOT COMPLETED|Overall Study||4
9762221|NCT00392015|10866271|FG003|NOT COMPLETED|Overall Study||1
9762222|NCT00392015|10866272|FG004|NOT COMPLETED|Overall Study||3
9762223|NCT00392015|10866273|FG005|NOT COMPLETED|Overall Study||0
9762224|NCT00392041|10866294|FG000|STARTED|First 4 Weeks||19
9762225|NCT00392041|10866295|FG001|STARTED|First 4 Weeks||17
9762226|NCT00392041|10866294|FG000|COMPLETED|First 4 Weeks||11
9762227|NCT00392041|10866295|FG001|COMPLETED|First 4 Weeks||14
9762228|NCT00392041|10866294|FG000|NOT COMPLETED|First 4 Weeks||8
9762229|NCT00392041|10866295|FG001|NOT COMPLETED|First 4 Weeks||3
9762230|NCT00392041|10866294|FG000|STARTED|Weeks 5 - 12||11
9762231|NCT00392041|10866295|FG001|STARTED|Weeks 5 - 12||14
9762232|NCT00392041|10866294|FG000|COMPLETED|Weeks 5 - 12||7
9762233|NCT00392041|10866295|FG001|COMPLETED|Weeks 5 - 12||9
9762234|NCT00392041|10866294|FG000|NOT COMPLETED|Weeks 5 - 12||4
9762235|NCT00392041|10866295|FG001|NOT COMPLETED|Weeks 5 - 12||5
9762236|NCT00392054|10866303|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66
9762237|NCT00392054|10866304|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61
9762238|NCT00392054|10866303|FG000|Received Allocated Intervention|Overall Study||65
9762239|NCT00392054|10866304|FG001|Received Allocated Intervention|Overall Study||60
9762240|NCT00392054|10866303|FG000|COMPLETED|Overall Study||66
9762241|NCT00392054|10866304|FG001|COMPLETED|Overall Study||61
9762242|NCT00392054|10866303|FG000|NOT COMPLETED|Overall Study||0
9762243|NCT00392054|10866304|FG001|NOT COMPLETED|Overall Study||0
9762244|NCT00392171|10866314|FG000|STARTED|Overall Study||120
9762245|NCT00392171|10866314|FG000|COMPLETED|Overall Study||15
9762246|NCT00392171|10866314|FG000|NOT COMPLETED|Overall Study||105
9762247|NCT00392197|10866320|FG000|STARTED|Overall Study||48
9762248|NCT00392197|10866321|FG001|STARTED|Overall Study||63
9762249|NCT00392197|10866320|FG000|COMPLETED|Overall Study||27
9762250|NCT00392197|10866321|FG001|COMPLETED|Overall Study||33
9762251|NCT00392197|10866320|FG000|NOT COMPLETED|Overall Study||21
9762252|NCT00392197|10866321|FG001|NOT COMPLETED|Overall Study||30
9762253|NCT00392210|10866329|FG000|STARTED|First Voiding Trial||36
9762254|NCT00392210|10866330|FG001|STARTED|First Voiding Trial||33
9762255|NCT00392210|10866329|FG000|COMPLETED|First Voiding Trial||34
9762256|NCT00392210|10866330|FG001|COMPLETED|First Voiding Trial||31
9762257|NCT00392210|10866329|FG000|NOT COMPLETED|First Voiding Trial||2
9762258|NCT00392210|10866330|FG001|NOT COMPLETED|First Voiding Trial||2
9762259|NCT00392210|10866329|FG000|STARTED|Second Voiding Trial||34
9762260|NCT00392210|10866330|FG001|STARTED|Second Voiding Trial||31
9762261|NCT00392210|10866329|FG000|COMPLETED|Second Voiding Trial||34
9762262|NCT00392210|10866330|FG001|COMPLETED|Second Voiding Trial||31
9762263|NCT00392210|10866329|FG000|NOT COMPLETED|Second Voiding Trial||0
9762264|NCT00392210|10866330|FG001|NOT COMPLETED|Second Voiding Trial||0
9762265|NCT00392223|10866338|FG000|STARTED|Overall Study||58
9762266|NCT00392223|10866339|FG001|STARTED|Overall Study||60
9762267|NCT00392223|10866338|FG000|COMPLETED|Overall Study||49
9762268|NCT00392223|10866339|FG001|COMPLETED|Overall Study||47
9762269|NCT00392223|10866338|FG000|NOT COMPLETED|Overall Study||9
9762270|NCT00392223|10866339|FG001|NOT COMPLETED|Overall Study||13
9762271|NCT00392236|10866347|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
9762272|NCT00392236|10866348|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
9762273|NCT00392236|10866347|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
9762274|NCT00392236|10866348|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
9762275|NCT00392236|10866347|FG000|NOT COMPLETED|Overall Study||12
9762276|NCT00392236|10866348|FG001|NOT COMPLETED|Overall Study||6
9762277|NCT00392288|10866357|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
9762278|NCT00392288|10866358|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
9762279|NCT00392288|10866359|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
9762280|NCT00392288|10866357|FG000|Treatment Period|Overall Study||172
9762281|NCT00392288|10866358|FG001|Treatment Period|Overall Study||174
9762282|NCT00392288|10866359|FG002|Treatment Period|Overall Study||175
9762283|NCT00392288|10866357|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143
9762284|NCT00392288|10866358|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155
9762285|NCT00392288|10866359|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159
9762286|NCT00392288|10866357|FG000|NOT COMPLETED|Overall Study||32
9762287|NCT00392288|10866358|FG001|NOT COMPLETED|Overall Study||22
9762288|NCT00392288|10866359|FG002|NOT COMPLETED|Overall Study||17
9762289|NCT00392379|10866369|FG000|STARTED|Overall Study|Medication period|136
9762290|NCT00392379|10866370|FG001|STARTED|Overall Study|Medication period|134
9762291|NCT00392379|10866369|FG000|COMPLETED|Overall Study|Medication period|114
9762292|NCT00392379|10866370|FG001|COMPLETED|Overall Study|Medication period|96
9762293|NCT00392379|10866369|FG000|NOT COMPLETED|Overall Study||22
9762294|NCT00392379|10866370|FG001|NOT COMPLETED|Overall Study||38
9762295|NCT00392392|10866376|FG000|STARTED|Overall Study||29
9762296|NCT00392392|10866376|FG000|COMPLETED|Overall Study||9
9762297|NCT00392392|10866376|FG000|NOT COMPLETED|Overall Study||20
9762298|NCT00392444|10866380|FG000|STARTED|Overall Study||39
9762299|NCT00392444|10866380|FG000|COMPLETED|Overall Study||39
9762300|NCT00392444|10866380|FG000|NOT COMPLETED|Overall Study||0
9762301|NCT00392496|10866384|FG000|STARTED|Overall Study||19
9762302|NCT00392496|10866384|FG000|COMPLETED|Overall Study||19
9762303|NCT00392496|10866384|FG000|NOT COMPLETED|Overall Study||0
9762304|NCT00392665|10866390|FG000|STARTED|Overall Study||18
9762305|NCT00392665|10866391|FG001|STARTED|Overall Study||18
9762306|NCT00392665|10866390|FG000|COMPLETED|Overall Study||1
9762307|NCT00392665|10866391|FG001|COMPLETED|Overall Study||3
9762308|NCT00392665|10866390|FG000|NOT COMPLETED|Overall Study||17
9762309|NCT00392665|10866391|FG001|NOT COMPLETED|Overall Study||15
9762310|NCT00392678|10866401|FG000|STARTED|Overall Study||27
9762311|NCT00392678|10866402|FG001|STARTED|Overall Study||27
9762312|NCT00392678|10866403|FG002|STARTED|Overall Study||27
9762313|NCT00392678|10866404|FG003|STARTED|Overall Study||27
9762314|NCT00392678|10866401|FG000|COMPLETED|Overall Study||27
9762315|NCT00392678|10866402|FG001|COMPLETED|Overall Study||26
9762316|NCT00392678|10866403|FG002|COMPLETED|Overall Study||25
9762317|NCT00392678|10866404|FG003|COMPLETED|Overall Study||26
9762318|NCT00392678|10866401|FG000|NOT COMPLETED|Overall Study||0
9762319|NCT00392678|10866402|FG001|NOT COMPLETED|Overall Study||1
9762320|NCT00392678|10866403|FG002|NOT COMPLETED|Overall Study||2
9762321|NCT00392678|10866404|FG003|NOT COMPLETED|Overall Study||1
9762322|NCT00392704|10866423|FG000|STARTED|Neoadjuvant Chemotherapy||60
9762323|NCT00392704|10866423|FG000|COMPLETED|Neoadjuvant Chemotherapy||54
9762324|NCT00392704|10866423|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6
9762325|NCT00392704|10866423|FG000|STARTED|Combined Modality Therapy||54
9762326|NCT00392704|10866423|FG000|COMPLETED|Combined Modality Therapy||49
9762327|NCT00392704|10866423|FG000|NOT COMPLETED|Combined Modality Therapy||5
9762328|NCT00392769|10866427|FG000|STARTED|Overall Study||33
9762329|NCT00392769|10866427|FG000|COMPLETED|Overall Study||23
9762330|NCT00392769|10866427|FG000|NOT COMPLETED|Overall Study||10
9762331|NCT00392782|10866431|FG000|STARTED|Overall Study||24
9762332|NCT00392782|10866431|FG000|COMPLETED|Overall Study||24
9762333|NCT00392782|10866431|FG000|NOT COMPLETED|Overall Study||0
9762334|NCT00392808|10866439|FG000|STARTED|Overall Study||87
9762335|NCT00392808|10866440|FG001|STARTED|Overall Study||89
9762336|NCT00392808|10866441|FG002|STARTED|Overall Study||109
9762337|NCT00392808|10866442|FG003|STARTED|Overall Study||104
9762338|NCT00392808|10866439|FG000|COMPLETED|Overall Study||81
9762339|NCT00392808|10866440|FG001|COMPLETED|Overall Study||86
9762340|NCT00392808|10866441|FG002|COMPLETED|Overall Study||107
9762341|NCT00392808|10866442|FG003|COMPLETED|Overall Study||100
9762342|NCT00392808|10866439|FG000|NOT COMPLETED|Overall Study||6
9762343|NCT00392808|10866440|FG001|NOT COMPLETED|Overall Study||3
9762344|NCT00392808|10866441|FG002|NOT COMPLETED|Overall Study||2
9762345|NCT00392808|10866442|FG003|NOT COMPLETED|Overall Study||4
9762346|NCT00392834|10866454|FG000|STARTED|Overall Study||2
9762347|NCT00392834|10866455|FG001|STARTED|Overall Study||32
9762348|NCT00392834|10866454|FG000|COMPLETED|Overall Study||2
9762349|NCT00392834|10866455|FG001|COMPLETED|Overall Study||32
9762350|NCT00392834|10866454|FG000|NOT COMPLETED|Overall Study||0
9762351|NCT00392834|10866455|FG001|NOT COMPLETED|Overall Study||0
9762352|NCT00392925|10866465|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177
9762353|NCT00392925|10866466|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0
9762354|NCT00392925|10866467|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0
9762355|NCT00392925|10866468|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0
9762356|NCT00392925|10866465|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
9762357|NCT00392925|10866466|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
9762358|NCT00392925|10866467|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
9762359|NCT00392925|10866468|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
9762360|NCT00392925|10866465|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
9762361|NCT00392925|10866466|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
9762362|NCT00392925|10866467|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
9762363|NCT00392925|10866468|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
9762364|NCT00392925|10866465|FG000|STARTED|Randomization to Treatment Group Period||0
9762365|NCT00392925|10866466|FG001|STARTED|Randomization to Treatment Group Period||27
9762366|NCT00392925|10866467|FG002|STARTED|Randomization to Treatment Group Period||56
9762367|NCT00392925|10866468|FG003|STARTED|Randomization to Treatment Group Period||56
9762368|NCT00392925|10866465|FG000|COMPLETED|Randomization to Treatment Group Period||0
9762369|NCT00392925|10866466|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
9762370|NCT00392925|10866467|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
9762371|NCT00392925|10866468|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
9762372|NCT00392925|10866465|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0
9762373|NCT00392925|10866466|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8
9762374|NCT00392925|10866467|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19
9762375|NCT00392925|10866468|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18
9762376|NCT00392951|10866484|FG000|STARTED|Overall Study||30
9762377|NCT00392951|10866484|FG000|COMPLETED|Overall Study||30
9762378|NCT00392951|10866484|FG000|NOT COMPLETED|Overall Study||0
9762379|NCT00392990|10866490|FG000|STARTED|Treatment on Study||20
9762380|NCT00392990|10866491|FG001|STARTED|Treatment on Study||5
9762381|NCT00392990|10866490|FG000|COMPLETED|Treatment on Study||17
9762382|NCT00392990|10866491|FG001|COMPLETED|Treatment on Study||4
9762383|NCT00392990|10866490|FG000|NOT COMPLETED|Treatment on Study||3
9762384|NCT00392990|10866491|FG001|NOT COMPLETED|Treatment on Study||1
9762385|NCT00392990|10866490|FG000|STARTED|Follow up for 2 Years||20
9762386|NCT00392990|10866491|FG001|STARTED|Follow up for 2 Years||5
9762387|NCT00392990|10866490|FG000|COMPLETED|Follow up for 2 Years||16
9762388|NCT00392990|10866491|FG001|COMPLETED|Follow up for 2 Years||5
9762389|NCT00392990|10866490|FG000|NOT COMPLETED|Follow up for 2 Years||4
9762390|NCT00392990|10866491|FG001|NOT COMPLETED|Follow up for 2 Years||0
9762391|NCT00393029|10866499|FG000|STARTED|Overall Study||2
9762392|NCT00393029|10866500|FG001|STARTED|Overall Study||10
9762393|NCT00393029|10866499|FG000|COMPLETED|Overall Study||2
9762394|NCT00393029|10866500|FG001|COMPLETED|Overall Study||9
9762395|NCT00393029|10866499|FG000|NOT COMPLETED|Overall Study||0
9762396|NCT00393029|10866500|FG001|NOT COMPLETED|Overall Study||1
9762397|NCT00393042|10866507|FG000|STARTED|First Intervention||31
9762398|NCT00393042|10866508|FG001|STARTED|First Intervention||33
9762399|NCT00393042|10866507|FG000|Completed the Placebo Dosage|First Intervention||27
9762400|NCT00393042|10866508|FG001|Completed the Placebo Dosage|First Intervention||29
9762401|NCT00393042|10866507|FG000|Completed 10mg Dosage|First Intervention||29
9762402|NCT00393042|10866508|FG001|Completed 10mg Dosage|First Intervention||29
9762403|NCT00393042|10866507|FG000|Completed 20 mg Dosage|First Intervention||26
9762404|NCT00393042|10866508|FG001|Completed 20 mg Dosage|First Intervention||28
9762405|NCT00393042|10866507|FG000|Completed 25/30mg Dosage|First Intervention||27
9762406|NCT00393042|10866508|FG001|Completed 25/30mg Dosage|First Intervention||27
9762407|NCT00393042|10866507|FG000|COMPLETED|First Intervention||26
9762408|NCT00393042|10866508|FG001|COMPLETED|First Intervention||27
9762409|NCT00393042|10866507|FG000|NOT COMPLETED|First Intervention||5
9762410|NCT00393042|10866508|FG001|NOT COMPLETED|First Intervention||6
9762411|NCT00393042|10866507|FG000|STARTED|Second Intervetion||26
9762412|NCT00393042|10866508|FG001|STARTED|Second Intervetion||27
9762413|NCT00393042|10866507|FG000|Completed Placebo Dosage|Second Intervetion||25
9762414|NCT00393042|10866508|FG001|Completed Placebo Dosage|Second Intervetion||21
9762415|NCT00393042|10866507|FG000|Completed 10 mg Dosage|Second Intervetion||26
9762416|NCT00393042|10866508|FG001|Completed 10 mg Dosage|Second Intervetion||24
9762417|NCT00393042|10866507|FG000|Completed the 20mg Dosage|Second Intervetion||24
9762418|NCT00393042|10866508|FG001|Completed the 20mg Dosage|Second Intervetion||21
9762419|NCT00393042|10866507|FG000|Completed 25/30 mg Dosage|Second Intervetion||24
9762420|NCT00393042|10866508|FG001|Completed 25/30 mg Dosage|Second Intervetion||20
9762421|NCT00393042|10866507|FG000|COMPLETED|Second Intervetion||24
9762422|NCT00393042|10866508|FG001|COMPLETED|Second Intervetion||19
9762423|NCT00393042|10866507|FG000|NOT COMPLETED|Second Intervetion||2
9762424|NCT00393042|10866508|FG001|NOT COMPLETED|Second Intervetion||8
9829373|NCT00759525|10939988|FG001|COMPLETED|Second Intervention (14 Days)||8
9829374|NCT00759525|10939987|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
9829375|NCT00759525|10939988|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
9829376|NCT00759564|10939999|FG000|STARTED|First Intervention Period (4 Days)||8
9829377|NCT00759564|10940000|FG001|STARTED|First Intervention Period (4 Days)||8
9829378|NCT00759564|10940001|FG002|STARTED|First Intervention Period (4 Days)||8
9829379|NCT00759564|10940002|FG003|STARTED|First Intervention Period (4 Days)||1
9829380|NCT00759564|10940003|FG004|STARTED|First Intervention Period (4 Days)||4
9829381|NCT00759564|10939999|FG000|COMPLETED|First Intervention Period (4 Days)||8
9829382|NCT00759564|10940000|FG001|COMPLETED|First Intervention Period (4 Days)||8
9829383|NCT00759564|10940001|FG002|COMPLETED|First Intervention Period (4 Days)||8
9829384|NCT00759564|10940002|FG003|COMPLETED|First Intervention Period (4 Days)||1
9829385|NCT00759564|10940003|FG004|COMPLETED|First Intervention Period (4 Days)||4
9829386|NCT00759564|10939999|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0
9829387|NCT00759564|10940000|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0
9829388|NCT00759564|10940001|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0
9829389|NCT00759564|10940002|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0
9829390|NCT00759564|10940003|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0
9829391|NCT00759564|10939999|FG000|STARTED|Washout Period (at Least 14 Days)||8
9829392|NCT00759564|10940000|FG001|STARTED|Washout Period (at Least 14 Days)||8
9829393|NCT00759564|10940001|FG002|STARTED|Washout Period (at Least 14 Days)||8
9829394|NCT00759564|10940002|FG003|STARTED|Washout Period (at Least 14 Days)||1
9829395|NCT00759564|10940003|FG004|STARTED|Washout Period (at Least 14 Days)||4
9829396|NCT00759564|10939999|FG000|COMPLETED|Washout Period (at Least 14 Days)||8
9829397|NCT00759564|10940000|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
9829398|NCT00759564|10940001|FG002|COMPLETED|Washout Period (at Least 14 Days)||8
9829399|NCT00759564|10940002|FG003|COMPLETED|Washout Period (at Least 14 Days)||1
9829400|NCT00759564|10940003|FG004|COMPLETED|Washout Period (at Least 14 Days)||3
9829401|NCT00759564|10939999|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9829402|NCT00759564|10940000|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9829403|NCT00759564|10940001|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9829404|NCT00759564|10940002|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9829405|NCT00759564|10940003|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1
9829406|NCT00759564|10939999|FG000|STARTED|Second Intervention Period (4 Days)||8
9829407|NCT00759564|10940000|FG001|STARTED|Second Intervention Period (4 Days)||8
9829408|NCT00759564|10940001|FG002|STARTED|Second Intervention Period (4 Days)||8
9829409|NCT00759564|10940002|FG003|STARTED|Second Intervention Period (4 Days)||1
9829410|NCT00759564|10940003|FG004|STARTED|Second Intervention Period (4 Days)||3
9829411|NCT00759564|10939999|FG000|COMPLETED|Second Intervention Period (4 Days)||8
9829412|NCT00759564|10940000|FG001|COMPLETED|Second Intervention Period (4 Days)||8
9829413|NCT00759564|10940001|FG002|COMPLETED|Second Intervention Period (4 Days)||8
9829414|NCT00759564|10940002|FG003|COMPLETED|Second Intervention Period (4 Days)||1
9829415|NCT00759564|10940003|FG004|COMPLETED|Second Intervention Period (4 Days)||3
9829416|NCT00759564|10939999|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0
9829417|NCT00759564|10940000|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0
9829418|NCT00759564|10940001|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0
9829419|NCT00759564|10940002|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0
9829420|NCT00759564|10940003|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0
9829421|NCT00759603|10940035|FG000|STARTED|Overall Study||59
9829422|NCT00759603|10940035|FG000|COMPLETED|Overall Study||59
9829423|NCT00759603|10940035|FG000|NOT COMPLETED|Overall Study||0
9829424|NCT00759642|10940039|FG000|STARTED|Overall Study||33
9762425|NCT00393094|10866562|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31
9762426|NCT00393094|10866562|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
9762427|NCT00393094|10866562|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
9762428|NCT00393094|10866562|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30
9762429|NCT00393094|10866562|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29
9762430|NCT00393094|10866562|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
9762431|NCT00393367|10866570|FG000|STARTED|Overall Study||91
9762432|NCT00393367|10866571|FG001|STARTED|Overall Study||88
9762433|NCT00393367|10866570|FG000|COMPLETED|Overall Study||89
9762434|NCT00393367|10866571|FG001|COMPLETED|Overall Study||81
9762435|NCT00393367|10866570|FG000|NOT COMPLETED|Overall Study||2
9762436|NCT00393367|10866571|FG001|NOT COMPLETED|Overall Study||7
9762437|NCT00393380|10866579|FG000|STARTED|Overall Study||13
9762438|NCT00393380|10866579|FG000|COMPLETED|Overall Study||13
9762439|NCT00393380|10866579|FG000|NOT COMPLETED|Overall Study||0
9762440|NCT00393458|10866587|FG000|STARTED|Overall Study||437
9762441|NCT00393458|10866588|FG001|STARTED|Overall Study||428
9762442|NCT00393458|10866589|FG002|STARTED|Overall Study||435
9762443|NCT00393458|10866590|FG003|STARTED|Overall Study||432
9762444|NCT00393458|10866587|FG000|Exposed to Study Medication or Placebo|Overall Study||437
9762445|NCT00393458|10866588|FG001|Exposed to Study Medication or Placebo|Overall Study||425
9762446|NCT00393458|10866589|FG002|Exposed to Study Medication or Placebo|Overall Study||434
9762447|NCT00393458|10866590|FG003|Exposed to Study Medication or Placebo|Overall Study||432
9762448|NCT00393458|10866587|FG000|COMPLETED|Overall Study||338
9762449|NCT00393458|10866588|FG001|COMPLETED|Overall Study||326
9762450|NCT00393458|10866589|FG002|COMPLETED|Overall Study||323
9762451|NCT00393458|10866590|FG003|COMPLETED|Overall Study||295
9762452|NCT00393458|10866587|FG000|NOT COMPLETED|Overall Study||99
9762453|NCT00393458|10866588|FG001|NOT COMPLETED|Overall Study||102
9762454|NCT00393458|10866589|FG002|NOT COMPLETED|Overall Study||112
9762455|NCT00393458|10866590|FG003|NOT COMPLETED|Overall Study||137
9762456|NCT00393484|10866602|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
9762457|NCT00393484|10866603|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
9762458|NCT00393484|10866602|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
9762459|NCT00393484|10866603|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
9762460|NCT00393484|10866602|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
9762461|NCT00393484|10866603|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
9762462|NCT00393484|10866602|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
9762463|NCT00393484|10866603|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
9762464|NCT00393484|10866602|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48
9762465|NCT00393484|10866603|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44
9762466|NCT00393484|10866602|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
9762467|NCT00393484|10866603|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
9762468|NCT00393484|10866602|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
9762469|NCT00393484|10866603|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
9762470|NCT00393484|10866602|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40
9762471|NCT00393484|10866603|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21
9762472|NCT00393484|10866602|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
9762473|NCT00393484|10866603|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
9762474|NCT00393510|10866613|FG000|STARTED|Overall Study||40
10013738|NCT01794689|11136667|FG003|STARTED|Washout (2 Weeks)||18
10013739|NCT01794689|11136664|FG000|COMPLETED|Washout (2 Weeks)||20
10013740|NCT01794689|11136665|FG001|COMPLETED|Washout (2 Weeks)||27
10013741|NCT01794689|11136666|FG002|COMPLETED|Washout (2 Weeks)||21
10013742|NCT01794689|11136667|FG003|COMPLETED|Washout (2 Weeks)||18
10013743|NCT01794689|11136664|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10013744|NCT01794689|11136665|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9762475|NCT00393510|10866614|FG001|STARTED|Overall Study||40
9762476|NCT00393510|10866613|FG000|COMPLETED|Overall Study||37
9762477|NCT00393510|10866614|FG001|COMPLETED|Overall Study||31
9762478|NCT00393510|10866613|FG000|NOT COMPLETED|Overall Study||3
9762479|NCT00393510|10866614|FG001|NOT COMPLETED|Overall Study||9
9762480|NCT00393523|10866625|FG000|STARTED|Overall Study||376
9762481|NCT00393523|10866626|FG001|STARTED|Overall Study||375
9762482|NCT00393523|10866627|FG002|STARTED|Overall Study||353
9762483|NCT00393523|10866628|FG003|STARTED|Overall Study||354
9762484|NCT00393523|10866629|FG004|STARTED|Overall Study||20
9762485|NCT00393523|10866625|FG000|Vaccination Visit 1|Overall Study||374
9762486|NCT00393523|10866626|FG001|Vaccination Visit 1|Overall Study||375
9762487|NCT00393523|10866627|FG002|Vaccination Visit 1|Overall Study||349
9762488|NCT00393523|10866628|FG003|Vaccination Visit 1|Overall Study||352
9762489|NCT00393523|10866629|FG004|Vaccination Visit 1|Overall Study||20
9762490|NCT00393523|10866625|FG000|COMPLETED|Overall Study||364
9762491|NCT00393523|10866626|FG001|COMPLETED|Overall Study||366
9762492|NCT00393523|10866627|FG002|COMPLETED|Overall Study||349
9762493|NCT00393523|10866628|FG003|COMPLETED|Overall Study||348
9762494|NCT00393523|10866629|FG004|COMPLETED|Overall Study||19
9762495|NCT00393523|10866625|FG000|NOT COMPLETED|Overall Study||12
9762496|NCT00393523|10866626|FG001|NOT COMPLETED|Overall Study||9
10013745|NCT01794689|11136666|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10013746|NCT01794689|11136667|FG003|NOT COMPLETED|Washout (2 Weeks)||0
9762497|NCT00393523|10866627|FG002|NOT COMPLETED|Overall Study||4
9762498|NCT00393523|10866628|FG003|NOT COMPLETED|Overall Study||6
9762499|NCT00393523|10866629|FG004|NOT COMPLETED|Overall Study||1
9762500|NCT00393705|10866642|FG000|STARTED|Overall Study||151
9762501|NCT00393705|10866643|FG001|STARTED|Overall Study||151
9762502|NCT00393705|10866642|FG000|Received at Least One Dose of Study Drug|Overall Study||139
9762503|NCT00393705|10866643|FG001|Received at Least One Dose of Study Drug|Overall Study||139
9762504|NCT00393705|10866642|FG000|COMPLETED|Overall Study||128
9762505|NCT00393705|10866643|FG001|COMPLETED|Overall Study||128
9762506|NCT00393705|10866642|FG000|NOT COMPLETED|Overall Study||23
9762507|NCT00393705|10866643|FG001|NOT COMPLETED|Overall Study||23
9762508|NCT00393718|10866651|FG000|STARTED|Overall Study||268
9762509|NCT00393718|10866652|FG001|STARTED|Overall Study||132
9762510|NCT00393718|10866651|FG000|COMPLETED|Overall Study||225
9762511|NCT00393718|10866652|FG001|COMPLETED|Overall Study||110
9762512|NCT00393718|10866651|FG000|NOT COMPLETED|Overall Study||43
9762513|NCT00393718|10866652|FG001|NOT COMPLETED|Overall Study||22
9762514|NCT00393796|10866660|FG000|STARTED|Double Blind Period||26
9762515|NCT00393796|10866661|FG001|STARTED|Double Blind Period||28
9762516|NCT00393796|10866660|FG000|COMPLETED|Double Blind Period||26
9762517|NCT00393796|10866661|FG001|COMPLETED|Double Blind Period||28
9762518|NCT00393796|10866660|FG000|NOT COMPLETED|Double Blind Period||0
10013747|NCT01794689|11136664|FG000|STARTED|Intervention 2 (2 Nights)||20
10013748|NCT01794689|11136665|FG001|STARTED|Intervention 2 (2 Nights)||27
10013749|NCT01794689|11136666|FG002|STARTED|Intervention 2 (2 Nights)||21
10013750|NCT01794689|11136667|FG003|STARTED|Intervention 2 (2 Nights)||18
10013751|NCT01794689|11136664|FG000|COMPLETED|Intervention 2 (2 Nights)||20
10013752|NCT01794689|11136665|FG001|COMPLETED|Intervention 2 (2 Nights)||27
9762519|NCT00393796|10866661|FG001|NOT COMPLETED|Double Blind Period||0
9762520|NCT00393796|10866660|FG000|STARTED|Open Label Period - Placebo to SUTENT||0
9762521|NCT00393796|10866661|FG001|STARTED|Open Label Period - Placebo to SUTENT||16
9762522|NCT00393796|10866660|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0
9762523|NCT00393796|10866661|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16
9762524|NCT00393796|10866660|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
9762525|NCT00393796|10866661|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
9762526|NCT00393848|10866671|FG000|STARTED|Overall Study||16
9762527|NCT00393848|10866672|FG001|STARTED|Overall Study||9
9762528|NCT00393848|10866673|FG002|STARTED|Overall Study||6
9762529|NCT00393848|10866674|FG003|STARTED|Overall Study||9
9762530|NCT00393848|10866671|FG000|COMPLETED|Overall Study||16
9762531|NCT00393848|10866672|FG001|COMPLETED|Overall Study||9
9762532|NCT00393848|10866673|FG002|COMPLETED|Overall Study||4
9762533|NCT00393848|10866674|FG003|COMPLETED|Overall Study||8
9762534|NCT00393848|10866671|FG000|NOT COMPLETED|Overall Study||0
9762535|NCT00393848|10866672|FG001|NOT COMPLETED|Overall Study||0
9762536|NCT00393848|10866673|FG002|NOT COMPLETED|Overall Study||2
9762537|NCT00393848|10866674|FG003|NOT COMPLETED|Overall Study||1
9762538|NCT00393861|10866685|FG000|STARTED|Overall Study||29
9762539|NCT00393861|10866685|FG000|COMPLETED|Overall Study||3
9762540|NCT00393861|10866685|FG000|NOT COMPLETED|Overall Study||26
9762541|NCT00393874|10866692|FG000|STARTED|Overall Study||18
9762542|NCT00393874|10866693|FG001|STARTED|Overall Study||17
9762543|NCT00393874|10866694|FG002|STARTED|Overall Study||15
9762544|NCT00393874|10866692|FG000|COMPLETED|Overall Study||15
9762545|NCT00393874|10866693|FG001|COMPLETED|Overall Study||13
9762546|NCT00393874|10866694|FG002|COMPLETED|Overall Study||13
9762547|NCT00393874|10866692|FG000|NOT COMPLETED|Overall Study||3
9762548|NCT00393874|10866693|FG001|NOT COMPLETED|Overall Study||4
9762549|NCT00393874|10866694|FG002|NOT COMPLETED|Overall Study||2
9762550|NCT00393887|10866707|FG000|STARTED|Overall Study||50
9762551|NCT00393887|10866708|FG001|STARTED|Overall Study||50
9762552|NCT00393887|10866707|FG000|1 Year|Overall Study||45
9762553|NCT00393887|10866708|FG001|1 Year|Overall Study||50
9762554|NCT00393887|10866707|FG000|COMPLETED|Overall Study||34
9762555|NCT00393887|10866708|FG001|COMPLETED|Overall Study||41
9762556|NCT00393887|10866707|FG000|NOT COMPLETED|Overall Study||16
9762557|NCT00393887|10866708|FG001|NOT COMPLETED|Overall Study||9
9762558|NCT00393913|10866714|FG000|STARTED|Initial Assessment||144
9762559|NCT00393913|10866714|FG000|COMPLETED|Initial Assessment||107
9762560|NCT00393913|10866714|FG000|NOT COMPLETED|Initial Assessment||37
9762561|NCT00393913|10866714|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100
9762562|NCT00393913|10866714|FG000|COMPLETED|CPAP||93
9762563|NCT00393913|10866714|FG000|NOT COMPLETED|CPAP||7
9762564|NCT00393913|10866714|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
9762565|NCT00393913|10866714|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
9762566|NCT00393913|10866714|FG000|COMPLETED|CPAP Withdrawal||42
9762567|NCT00393913|10866714|FG000|NOT COMPLETED|CPAP Withdrawal||0
9762568|NCT00393939|10866721|FG000|STARTED|Overall Study||296
9762569|NCT00393939|10866722|FG001|STARTED|Overall Study||297
9762570|NCT00393939|10866721|FG000|Treated|Overall Study||295
9762571|NCT00393939|10866722|FG001|Treated|Overall Study||293
9762572|NCT00393939|10866721|FG000|COMPLETED|Overall Study||0
9762573|NCT00393939|10866722|FG001|COMPLETED|Overall Study||0
9762574|NCT00393939|10866721|FG000|NOT COMPLETED|Overall Study||296
9762575|NCT00393939|10866722|FG001|NOT COMPLETED|Overall Study||297
9762576|NCT00393978|10866730|FG000|STARTED|Overall Study||37
9762577|NCT00393978|10866731|FG001|STARTED|Overall Study||38
9762578|NCT00393978|10866730|FG000|COMPLETED|Overall Study||21
9762579|NCT00393978|10866731|FG001|COMPLETED|Overall Study||18
9762580|NCT00393978|10866730|FG000|NOT COMPLETED|Overall Study||16
9762581|NCT00393978|10866731|FG001|NOT COMPLETED|Overall Study||20
9762582|NCT00394082|10866737|FG000|STARTED|Overall Study||50
9762583|NCT00394082|10866737|FG000|At Least One Response Assessment|Overall Study||43
9762584|NCT00394082|10866737|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24
9762585|NCT00394082|10866737|FG000|NOT COMPLETED|Overall Study||26
9762586|NCT00394095|10866743|FG000|STARTED|Overall Study||17
9762587|NCT00394095|10866744|FG001|STARTED|Overall Study||14
9762588|NCT00394095|10866743|FG000|Screened|Overall Study||17
9762589|NCT00394095|10866744|FG001|Screened|Overall Study||14
9762590|NCT00394095|10866743|FG000|COMPLETED|Overall Study||16
9762591|NCT00394095|10866744|FG001|COMPLETED|Overall Study||14
9762592|NCT00394095|10866743|FG000|NOT COMPLETED|Overall Study||1
9762593|NCT00394095|10866744|FG001|NOT COMPLETED|Overall Study||0
9762594|NCT00394212|10866753|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
9762595|NCT00394212|10866754|FG001|STARTED|Overall Study||27
9762596|NCT00394212|10866753|FG000|6 Week Follow-up|Overall Study||45
9762597|NCT00394212|10866754|FG001|6 Week Follow-up|Overall Study||26
9762598|NCT00394212|10866753|FG000|3 Month Follow-up|Overall Study||45
9762599|NCT00394212|10866754|FG001|3 Month Follow-up|Overall Study||26
9762600|NCT00394212|10866753|FG000|6 Month Follow-up|Overall Study||43
9762601|NCT00394212|10866754|FG001|6 Month Follow-up|Overall Study||26
9762602|NCT00394212|10866753|FG000|COMPLETED|Overall Study||43
9762603|NCT00394212|10866754|FG001|COMPLETED|Overall Study||26
9762604|NCT00394212|10866753|FG000|NOT COMPLETED|Overall Study||7
9762605|NCT00394212|10866754|FG001|NOT COMPLETED|Overall Study||1
9762606|NCT00394251|10866762|FG000|STARTED|Overall Study||98
9762607|NCT00394251|10866763|FG001|STARTED|Overall Study||99
9762608|NCT00394251|10866762|FG000|At Least One Dose of Taxane|Overall Study||93
9762609|NCT00394251|10866763|FG001|At Least One Dose of Taxane|Overall Study||93
9762610|NCT00394251|10866762|FG000|COMPLETED|Overall Study||61
9762611|NCT00394251|10866763|FG001|COMPLETED|Overall Study||61
9762612|NCT00394251|10866762|FG000|NOT COMPLETED|Overall Study||37
9762613|NCT00394251|10866763|FG001|NOT COMPLETED|Overall Study||38
9762614|NCT00394277|10866777|FG000|STARTED|Overall Study||195
9762615|NCT00394277|10866778|FG001|STARTED|Overall Study||196
9762616|NCT00394277|10866779|FG002|STARTED|Overall Study||393
9762617|NCT00394277|10866780|FG003|STARTED|Overall Study||391
9762618|NCT00394277|10866777|FG000|COMPLETED|Overall Study||137
9762619|NCT00394277|10866778|FG001|COMPLETED|Overall Study||136
9762620|NCT00394277|10866779|FG002|COMPLETED|Overall Study||273
9762621|NCT00394277|10866780|FG003|COMPLETED|Overall Study||266
9762622|NCT00394277|10866777|FG000|NOT COMPLETED|Overall Study||58
9762623|NCT00394277|10866778|FG001|NOT COMPLETED|Overall Study||60
9762624|NCT00394277|10866779|FG002|NOT COMPLETED|Overall Study||120
9762625|NCT00394277|10866780|FG003|NOT COMPLETED|Overall Study||125
9762626|NCT00394329|10866794|FG000|STARTED|Overall Study||71
9762627|NCT00394329|10866795|FG001|STARTED|Overall Study||72
9762628|NCT00394329|10866796|FG002|STARTED|Overall Study||71
9762629|NCT00394329|10866797|FG003|STARTED|Overall Study||74
9762630|NCT00394329|10866794|FG000|COMPLETED|Overall Study||63
9762631|NCT00394329|10866795|FG001|COMPLETED|Overall Study||63
9762632|NCT00394329|10866796|FG002|COMPLETED|Overall Study||58
9762633|NCT00394329|10866797|FG003|COMPLETED|Overall Study||50
9762634|NCT00394329|10866794|FG000|NOT COMPLETED|Overall Study||8
9762635|NCT00394329|10866795|FG001|NOT COMPLETED|Overall Study||9
9762636|NCT00394329|10866796|FG002|NOT COMPLETED|Overall Study||13
9762637|NCT00394329|10866797|FG003|NOT COMPLETED|Overall Study||24
9762638|NCT00394433|10866813|FG000|STARTED|Overall Study||38
9762639|NCT00394433|10866813|FG000|Evaluable and Treated|Overall Study||35
9762640|NCT00394433|10866813|FG000|COMPLETED|Overall Study||35
9762641|NCT00394433|10866813|FG000|NOT COMPLETED|Overall Study||3
9762642|NCT00394472|10866819|FG000|STARTED|Overall Study||122
9762643|NCT00394472|10866820|FG001|STARTED|Overall Study||122
9762644|NCT00394472|10866819|FG000|COMPLETED|Overall Study||113
9762645|NCT00394472|10866820|FG001|COMPLETED|Overall Study||111
9762646|NCT00394472|10866819|FG000|NOT COMPLETED|Overall Study||9
9762647|NCT00394472|10866820|FG001|NOT COMPLETED|Overall Study||11
9762648|NCT00394524|10866828|FG000|STARTED|Overall Study||80
9762649|NCT00394524|10866829|FG001|STARTED|Overall Study||80
9762650|NCT00394524|10866828|FG000|COMPLETED|Overall Study||77
9762651|NCT00394524|10866829|FG001|COMPLETED|Overall Study||76
9762652|NCT00394524|10866828|FG000|NOT COMPLETED|Overall Study||3
9762653|NCT00394524|10866829|FG001|NOT COMPLETED|Overall Study||4
9762654|NCT00394589|10866840|FG000|STARTED|Overall Study||14
9762655|NCT00394589|10866841|FG001|STARTED|Overall Study||11
9762656|NCT00394589|10866842|FG002|STARTED|Overall Study||18
9762657|NCT00394589|10866840|FG000|COMPLETED|Overall Study||6
9762658|NCT00394589|10866841|FG001|COMPLETED|Overall Study||8
9762659|NCT00394589|10866842|FG002|COMPLETED|Overall Study||11
9762660|NCT00394589|10866840|FG000|NOT COMPLETED|Overall Study||8
9762661|NCT00394589|10866841|FG001|NOT COMPLETED|Overall Study||3
9762662|NCT00394589|10866842|FG002|NOT COMPLETED|Overall Study||7
9762663|NCT00394654|10866852|FG000|STARTED|Overall Study||15
9762664|NCT00394654|10866853|FG001|STARTED|Overall Study||15
9762665|NCT00394654|10866852|FG000|COMPLETED|Overall Study||13
9762666|NCT00394654|10866853|FG001|COMPLETED|Overall Study||15
9762667|NCT00394654|10866852|FG000|NOT COMPLETED|Overall Study||2
9762668|NCT00394654|10866853|FG001|NOT COMPLETED|Overall Study||0
9762669|NCT00394706|10866867|FG000|STARTED|Overall Study||1819
9762670|NCT00394706|10866868|FG001|STARTED|Overall Study||1862
9762671|NCT00394706|10866869|FG002|STARTED|Overall Study||1624
9762672|NCT00394706|10866870|FG003|STARTED|Overall Study||1633
9762673|NCT00394706|10866871|FG004|STARTED|Overall Study||1636
9762674|NCT00394706|10866872|FG005|STARTED|Overall Study||1384
9762675|NCT00394706|10866873|FG006|STARTED|Overall Study||929
9762676|NCT00394706|10866874|FG007|STARTED|Overall Study||851
9762677|NCT00394706|10866867|FG000|COMPLETED|Overall Study||1815
9762678|NCT00394706|10866868|FG001|COMPLETED|Overall Study||1860
9762679|NCT00394706|10866869|FG002|COMPLETED|Overall Study||1615
9762680|NCT00394706|10866870|FG003|COMPLETED|Overall Study||1632
9762681|NCT00394706|10866871|FG004|COMPLETED|Overall Study||1634
9762682|NCT00394706|10866872|FG005|COMPLETED|Overall Study||1377
9762683|NCT00394706|10866873|FG006|COMPLETED|Overall Study||926
9762684|NCT00394706|10866874|FG007|COMPLETED|Overall Study||851
9762685|NCT00394706|10866867|FG000|NOT COMPLETED|Overall Study||4
9762686|NCT00394706|10866868|FG001|NOT COMPLETED|Overall Study||2
9762687|NCT00394706|10866869|FG002|NOT COMPLETED|Overall Study||9
9762688|NCT00394706|10866870|FG003|NOT COMPLETED|Overall Study||1
9762689|NCT00394706|10866871|FG004|NOT COMPLETED|Overall Study||2
9762690|NCT00394706|10866872|FG005|NOT COMPLETED|Overall Study||7
9762691|NCT00394706|10866873|FG006|NOT COMPLETED|Overall Study||3
9762692|NCT00394706|10866874|FG007|NOT COMPLETED|Overall Study||0
9762693|NCT00394771|10866892|FG000|STARTED|Overall Study|Safety population of treated participants|140
9762694|NCT00394771|10866893|FG001|STARTED|Overall Study|Safety population of treated participants|136
9762695|NCT00394771|10866894|FG002|STARTED|Overall Study|Safety population of treated participants|143
9762696|NCT00394771|10866895|FG003|STARTED|Overall Study|Safety population of treated participants|148
9762697|NCT00394771|10866892|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
9762698|NCT00394771|10866893|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
9762699|NCT00394771|10866894|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
9762700|NCT00394771|10866895|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
9762701|NCT00394771|10866892|FG000|COMPLETED|Overall Study||99
9762702|NCT00394771|10866893|FG001|COMPLETED|Overall Study||102
9762703|NCT00394771|10866894|FG002|COMPLETED|Overall Study||96
9762704|NCT00394771|10866895|FG003|COMPLETED|Overall Study||109
9762705|NCT00394771|10866892|FG000|NOT COMPLETED|Overall Study||41
9762706|NCT00394771|10866893|FG001|NOT COMPLETED|Overall Study||34
9762707|NCT00394771|10866894|FG002|NOT COMPLETED|Overall Study||47
9762708|NCT00394771|10866895|FG003|NOT COMPLETED|Overall Study||39
9762709|NCT00394836|10866907|FG000|STARTED|Teatment or Follow-up Phase||30
9762710|NCT00394836|10866908|FG001|STARTED|Teatment or Follow-up Phase||86
9762711|NCT00394836|10866907|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
9762712|NCT00394836|10866908|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
9762713|NCT00394836|10866907|FG000|COMPLETED|Teatment or Follow-up Phase||2
9762714|NCT00394836|10866908|FG001|COMPLETED|Teatment or Follow-up Phase||8
9762715|NCT00394836|10866907|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28
9762716|NCT00394836|10866908|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78
9762717|NCT00394836|10866907|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
9762718|NCT00394836|10866908|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
9762719|NCT00394836|10866907|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
9762720|NCT00394836|10866908|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
9762721|NCT00394836|10866907|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
9762722|NCT00394836|10866908|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
9762723|NCT00394888|10866919|FG000|STARTED|Overall Study||108
9762724|NCT00394888|10866920|FG001|STARTED|Overall Study||48
9762725|NCT00394888|10866921|FG002|STARTED|Overall Study||201
9762726|NCT00394888|10866919|FG000|COMPLETED|Overall Study||108
9762727|NCT00394888|10866920|FG001|COMPLETED|Overall Study||48
9762728|NCT00394888|10866921|FG002|COMPLETED|Overall Study||201
9762729|NCT00394888|10866919|FG000|NOT COMPLETED|Overall Study||0
9762730|NCT00394888|10866920|FG001|NOT COMPLETED|Overall Study||0
9762731|NCT00394888|10866921|FG002|NOT COMPLETED|Overall Study||0
9762732|NCT00394901|10866931|FG000|STARTED|Baseline Phase|Subjects randomized|98
9762733|NCT00394901|10866932|FG001|STARTED|Baseline Phase|Subjects randomized|87
9762734|NCT00394901|10866933|FG002|STARTED|Baseline Phase|Subjects randomized|90
9762735|NCT00394901|10866934|FG003|STARTED|Baseline Phase|Subjects randomized|97
9762736|NCT00394901|10866931|FG000|COMPLETED|Baseline Phase||98
9762737|NCT00394901|10866932|FG001|COMPLETED|Baseline Phase||87
9762738|NCT00394901|10866933|FG002|COMPLETED|Baseline Phase||89
9762739|NCT00394901|10866934|FG003|COMPLETED|Baseline Phase||97
9762740|NCT00394901|10866931|FG000|NOT COMPLETED|Baseline Phase||0
9762741|NCT00394901|10866932|FG001|NOT COMPLETED|Baseline Phase||0
9762742|NCT00394901|10866933|FG002|NOT COMPLETED|Baseline Phase||1
9762743|NCT00394901|10866934|FG003|NOT COMPLETED|Baseline Phase||0
9762744|NCT00394901|10866931|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
9762745|NCT00394901|10866932|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
9762746|NCT00394901|10866933|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
9762747|NCT00394901|10866934|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
9762748|NCT00394901|10866931|FG000|COMPLETED|Double-blind Phase||83
9762749|NCT00394901|10866932|FG001|COMPLETED|Double-blind Phase||73
9762750|NCT00394901|10866933|FG002|COMPLETED|Double-blind Phase||71
9762751|NCT00394901|10866934|FG003|COMPLETED|Double-blind Phase||70
9762752|NCT00394901|10866931|FG000|NOT COMPLETED|Double-blind Phase||15
9762753|NCT00394901|10866932|FG001|NOT COMPLETED|Double-blind Phase||14
9762754|NCT00394901|10866933|FG002|NOT COMPLETED|Double-blind Phase||18
9762755|NCT00394901|10866934|FG003|NOT COMPLETED|Double-blind Phase||27
9762756|NCT00394914|10866949|FG000|STARTED|Screening Period||311
9762757|NCT00394914|10866950|FG001|STARTED|Screening Period||0
9762758|NCT00394914|10866951|FG002|STARTED|Screening Period||0
9762759|NCT00394914|10866949|FG000|COMPLETED|Screening Period||311
9762760|NCT00394914|10866950|FG001|COMPLETED|Screening Period||0
9762761|NCT00394914|10866951|FG002|COMPLETED|Screening Period||0
9762762|NCT00394914|10866949|FG000|NOT COMPLETED|Screening Period||0
9762763|NCT00394914|10866950|FG001|NOT COMPLETED|Screening Period||0
9762764|NCT00394914|10866951|FG002|NOT COMPLETED|Screening Period||0
9762765|NCT00394914|10866949|FG000|STARTED|Pre-exposure Period||311
9762766|NCT00394914|10866950|FG001|STARTED|Pre-exposure Period||0
9762767|NCT00394914|10866951|FG002|STARTED|Pre-exposure Period||0
9762768|NCT00394914|10866949|FG000|COMPLETED|Pre-exposure Period||311
9762769|NCT00394914|10866950|FG001|COMPLETED|Pre-exposure Period||0
9762770|NCT00394914|10866951|FG002|COMPLETED|Pre-exposure Period||0
9762771|NCT00394914|10866949|FG000|NOT COMPLETED|Pre-exposure Period||0
9762772|NCT00394914|10866950|FG001|NOT COMPLETED|Pre-exposure Period||0
9762773|NCT00394914|10866951|FG002|NOT COMPLETED|Pre-exposure Period||0
9762774|NCT00394914|10866949|FG000|STARTED|Treatment Period||0
9762775|NCT00394914|10866950|FG001|STARTED|Treatment Period||154
9762776|NCT00394914|10866951|FG002|STARTED|Treatment Period||157
9762777|NCT00394914|10866949|FG000|COMPLETED|Treatment Period||0
9762778|NCT00394914|10866950|FG001|COMPLETED|Treatment Period||144
9762779|NCT00394914|10866951|FG002|COMPLETED|Treatment Period||151
9762780|NCT00394914|10866949|FG000|NOT COMPLETED|Treatment Period||0
9762781|NCT00394914|10866950|FG001|NOT COMPLETED|Treatment Period||10
9762782|NCT00394914|10866951|FG002|NOT COMPLETED|Treatment Period||6
9762783|NCT00394953|10866959|FG000|STARTED|First Treatment Period||245
10013753|NCT01794689|11136666|FG002|COMPLETED|Intervention 2 (2 Nights)||21
10013754|NCT01794689|11136667|FG003|COMPLETED|Intervention 2 (2 Nights)||18
10013755|NCT01794689|11136664|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0
10013756|NCT01794689|11136665|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0
10013757|NCT01794689|11136666|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0
10013758|NCT01794689|11136667|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0
10013759|NCT01794702|11136686|FG000|STARTED|Overall Study||18
9762784|NCT00394953|10866960|FG001|STARTED|First Treatment Period||244
9762785|NCT00394953|10866959|FG000|COMPLETED|First Treatment Period||216
9762786|NCT00394953|10866960|FG001|COMPLETED|First Treatment Period||222
9762787|NCT00394953|10866959|FG000|NOT COMPLETED|First Treatment Period||29
9762788|NCT00394953|10866960|FG001|NOT COMPLETED|First Treatment Period||22
9762789|NCT00394953|10866959|FG000|STARTED|Second Treatment Period||216
9762790|NCT00394953|10866960|FG001|STARTED|Second Treatment Period||222
10013760|NCT01794702|11136687|FG001|STARTED|Overall Study||0
10013761|NCT01794702|11136688|FG002|STARTED|Overall Study||47
10013762|NCT01794702|11136686|FG000|COMPLETED|Overall Study||18
10013763|NCT01794702|11136687|FG001|COMPLETED|Overall Study||0
10013764|NCT01794702|11136688|FG002|COMPLETED|Overall Study||47
10013765|NCT01794702|11136686|FG000|NOT COMPLETED|Overall Study||0
10013766|NCT01794702|11136687|FG001|NOT COMPLETED|Overall Study||0
10013767|NCT01794702|11136688|FG002|NOT COMPLETED|Overall Study||0
10112071|NCT02501473|11243157|FG003|STARTED|Overall Study||14
10112072|NCT02501473|11243158|FG004|STARTED|Overall Study||4
10112073|NCT02501473|11243159|FG005|STARTED|Overall Study||14
10112074|NCT02501473|11243160|FG006|STARTED|Overall Study||1
10112075|NCT02501473|11243161|FG007|STARTED|Overall Study||0
10112076|NCT02501473|11243154|FG000|Treated|Overall Study||3
10112077|NCT02501473|11243155|FG001|Treated|Overall Study||3
10112078|NCT02501473|11243156|FG002|Treated|Overall Study||13
10112079|NCT02501473|11243157|FG003|Treated|Overall Study||13
10112080|NCT02501473|11243158|FG004|Treated|Overall Study||4
10112081|NCT02501473|11243159|FG005|Treated|Overall Study||14
10112082|NCT02501473|11243160|FG006|Treated|Overall Study||1
10112083|NCT02501473|11243161|FG007|Treated|Overall Study||0
10112084|NCT02501473|11243154|FG000|COMPLETED|Overall Study||0
10112085|NCT02501473|11243155|FG001|COMPLETED|Overall Study||0
10112086|NCT02501473|11243156|FG002|COMPLETED|Overall Study||0
9762791|NCT00394953|10866959|FG000|COMPLETED|Second Treatment Period||187
9762792|NCT00394953|10866960|FG001|COMPLETED|Second Treatment Period||148
9762793|NCT00394953|10866959|FG000|NOT COMPLETED|Second Treatment Period||29
9762794|NCT00394953|10866960|FG001|NOT COMPLETED|Second Treatment Period||74
9762795|NCT00395018|10866966|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
10013768|NCT01794741|11136698|FG000|STARTED|Overall Study||304
10013769|NCT01794741|11136699|FG001|STARTED|Overall Study||101
10013770|NCT01794741|11136698|FG000|COMPLETED|Overall Study||285
10013771|NCT01794741|11136699|FG001|COMPLETED|Overall Study||92
10013772|NCT01794741|11136698|FG000|NOT COMPLETED|Overall Study||19
10112087|NCT02501473|11243157|FG003|COMPLETED|Overall Study||0
10112088|NCT02501473|11243158|FG004|COMPLETED|Overall Study||0
10112089|NCT02501473|11243159|FG005|COMPLETED|Overall Study||0
10112090|NCT02501473|11243160|FG006|COMPLETED|Overall Study||0
10112091|NCT02501473|11243161|FG007|COMPLETED|Overall Study||0
9762796|NCT00395018|10866966|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
10112092|NCT02501473|11243154|FG000|NOT COMPLETED|Overall Study||3
9762797|NCT00395018|10866966|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
9762798|NCT00395018|10866966|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
9762799|NCT00395018|10866966|FG000|NOT COMPLETED|On-Treatment||10
9762800|NCT00395018|10866966|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
9762801|NCT00395018|10866966|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
9762802|NCT00395018|10866966|FG000|NOT COMPLETED|Off-Treatment Follow-up||4
9762803|NCT00395044|10866972|FG000|STARTED|Overall Study||25
9762804|NCT00395044|10866973|FG001|STARTED|Overall Study||25
9762805|NCT00395044|10866972|FG000|COMPLETED|Overall Study||7
9762806|NCT00395044|10866973|FG001|COMPLETED|Overall Study||11
9762807|NCT00395044|10866972|FG000|NOT COMPLETED|Overall Study||18
9762808|NCT00395044|10866973|FG001|NOT COMPLETED|Overall Study||14
9762809|NCT00395057|10866983|FG000|STARTED|Overall Study||34
9762810|NCT00395057|10866984|FG001|STARTED|Overall Study||35
9762811|NCT00395057|10866985|FG002|STARTED|Overall Study||35
9762812|NCT00395057|10866986|FG003|STARTED|Overall Study||34
9762813|NCT00395057|10866983|FG000|COMPLETED|Overall Study||2
9762814|NCT00395057|10866984|FG001|COMPLETED|Overall Study||1
9762815|NCT00395057|10866985|FG002|COMPLETED|Overall Study||2
9762816|NCT00395057|10866986|FG003|COMPLETED|Overall Study||1
9762817|NCT00395057|10866983|FG000|NOT COMPLETED|Overall Study||32
9762818|NCT00395057|10866984|FG001|NOT COMPLETED|Overall Study||34
9762819|NCT00395057|10866985|FG002|NOT COMPLETED|Overall Study||33
9762820|NCT00395057|10866986|FG003|NOT COMPLETED|Overall Study||33
9762821|NCT00395083|10866998|FG000|STARTED|Overall Study||217
9762822|NCT00395083|10866999|FG001|STARTED|Overall Study||209
9762823|NCT00395083|10866998|FG000|COMPLETED|Overall Study||207
9762824|NCT00395083|10866999|FG001|COMPLETED|Overall Study||201
9762825|NCT00395083|10866998|FG000|NOT COMPLETED|Overall Study||10
9762826|NCT00395083|10866999|FG001|NOT COMPLETED|Overall Study||8
9762827|NCT00395135|10867007|FG000|STARTED|Year 1||1595
9762828|NCT00395135|10867008|FG001|STARTED|Year 1||1587
9762829|NCT00395135|10867009|FG002|STARTED|Year 1||0
9762830|NCT00395135|10867010|FG003|STARTED|Year 1||0
9762831|NCT00395135|10867011|FG004|STARTED|Year 1||0
9762832|NCT00395135|10867007|FG000|COMPLETED|Year 1||883
9762833|NCT00395135|10867008|FG001|COMPLETED|Year 1||716
9762834|NCT00395135|10867009|FG002|COMPLETED|Year 1||0
9762835|NCT00395135|10867010|FG003|COMPLETED|Year 1||0
9762836|NCT00395135|10867011|FG004|COMPLETED|Year 1||0
9762837|NCT00395135|10867007|FG000|NOT COMPLETED|Year 1||712
9762838|NCT00395135|10867008|FG001|NOT COMPLETED|Year 1||871
9762839|NCT00395135|10867009|FG002|NOT COMPLETED|Year 1||0
9762840|NCT00395135|10867010|FG003|NOT COMPLETED|Year 1||0
9762841|NCT00395135|10867011|FG004|NOT COMPLETED|Year 1||0
9762842|NCT00395135|10867007|FG000|STARTED|Year 2||0
9762843|NCT00395135|10867008|FG001|STARTED|Year 2||0
9762844|NCT00395135|10867009|FG002|STARTED|Year 2||573
9762845|NCT00395135|10867010|FG003|STARTED|Year 2||283
9762846|NCT00395135|10867011|FG004|STARTED|Year 2||697
9762847|NCT00395135|10867007|FG000|COMPLETED|Year 2||0
9762848|NCT00395135|10867008|FG001|COMPLETED|Year 2||0
9762849|NCT00395135|10867009|FG002|COMPLETED|Year 2||426
9762850|NCT00395135|10867010|FG003|COMPLETED|Year 2||195
9762851|NCT00395135|10867011|FG004|COMPLETED|Year 2||507
9762852|NCT00395135|10867007|FG000|NOT COMPLETED|Year 2||0
9762853|NCT00395135|10867008|FG001|NOT COMPLETED|Year 2||0
9762854|NCT00395135|10867009|FG002|NOT COMPLETED|Year 2||147
9762855|NCT00395135|10867010|FG003|NOT COMPLETED|Year 2||88
9762856|NCT00395135|10867011|FG004|NOT COMPLETED|Year 2||190
9762857|NCT00395161|10867027|FG000|STARTED|Overall Study||149
9762858|NCT00395161|10867028|FG001|STARTED|Overall Study||144
9762859|NCT00395161|10867027|FG000|COMPLETED|Overall Study||149
9762860|NCT00395161|10867028|FG001|COMPLETED|Overall Study||144
9762861|NCT00395161|10867027|FG000|NOT COMPLETED|Overall Study||0
9762862|NCT00395161|10867028|FG001|NOT COMPLETED|Overall Study||0
9762863|NCT00395226|10867038|FG000|STARTED|Overall Study||26
9762864|NCT00395226|10867039|FG001|STARTED|Overall Study||27
9762865|NCT00395226|10867038|FG000|COMPLETED|Overall Study||22
9762866|NCT00395226|10867039|FG001|COMPLETED|Overall Study||22
9762867|NCT00395226|10867038|FG000|NOT COMPLETED|Overall Study||4
9762868|NCT00395226|10867039|FG001|NOT COMPLETED|Overall Study||5
9762869|NCT00395291|10867045|FG000|STARTED|First Intervention||17
9762870|NCT00395291|10867046|FG001|STARTED|First Intervention||9
9762871|NCT00395291|10867045|FG000|COMPLETED|First Intervention||15
9762872|NCT00395291|10867046|FG001|COMPLETED|First Intervention||9
9762873|NCT00395291|10867045|FG000|NOT COMPLETED|First Intervention||2
9762874|NCT00395291|10867046|FG001|NOT COMPLETED|First Intervention||0
9762875|NCT00395291|10867045|FG000|STARTED|Washout Period for 30 Days||15
9762876|NCT00395291|10867046|FG001|STARTED|Washout Period for 30 Days||9
9762877|NCT00395291|10867045|FG000|COMPLETED|Washout Period for 30 Days||13
9762878|NCT00395291|10867046|FG001|COMPLETED|Washout Period for 30 Days||9
9762879|NCT00395291|10867045|FG000|NOT COMPLETED|Washout Period for 30 Days||2
9762880|NCT00395291|10867046|FG001|NOT COMPLETED|Washout Period for 30 Days||0
9762881|NCT00395291|10867045|FG000|STARTED|Second Intervention||13
9762882|NCT00395291|10867046|FG001|STARTED|Second Intervention||9
9762883|NCT00395291|10867045|FG000|COMPLETED|Second Intervention||13
9762884|NCT00395291|10867046|FG001|COMPLETED|Second Intervention||9
9762885|NCT00395291|10867045|FG000|NOT COMPLETED|Second Intervention||0
9762886|NCT00395291|10867046|FG001|NOT COMPLETED|Second Intervention||0
9762887|NCT00395304|10867052|FG000|STARTED|Treatment Period 1||31
9762888|NCT00395304|10867053|FG001|STARTED|Treatment Period 1||30
9762889|NCT00395304|10867054|FG002|STARTED|Treatment Period 1||30
9762890|NCT00395304|10867055|FG003|STARTED|Treatment Period 1||31
9762891|NCT00395304|10867056|FG004|STARTED|Treatment Period 1||28
9762892|NCT00395304|10867057|FG005|STARTED|Treatment Period 1||32
9762893|NCT00395304|10867052|FG000|COMPLETED|Treatment Period 1||30
9762894|NCT00395304|10867053|FG001|COMPLETED|Treatment Period 1||26
9762895|NCT00395304|10867054|FG002|COMPLETED|Treatment Period 1||30
9762896|NCT00395304|10867055|FG003|COMPLETED|Treatment Period 1||28
9762897|NCT00395304|10867056|FG004|COMPLETED|Treatment Period 1||27
9762898|NCT00395304|10867057|FG005|COMPLETED|Treatment Period 1||30
9762899|NCT00395304|10867052|FG000|NOT COMPLETED|Treatment Period 1||1
9762900|NCT00395304|10867053|FG001|NOT COMPLETED|Treatment Period 1||4
9762901|NCT00395304|10867054|FG002|NOT COMPLETED|Treatment Period 1||0
9762902|NCT00395304|10867055|FG003|NOT COMPLETED|Treatment Period 1||3
9762903|NCT00395304|10867056|FG004|NOT COMPLETED|Treatment Period 1||1
9762904|NCT00395304|10867057|FG005|NOT COMPLETED|Treatment Period 1||2
9762905|NCT00395304|10867052|FG000|STARTED|Treatment Period 2||30
9762906|NCT00395304|10867053|FG001|STARTED|Treatment Period 2||26
9762907|NCT00395304|10867054|FG002|STARTED|Treatment Period 2||30
9762908|NCT00395304|10867055|FG003|STARTED|Treatment Period 2||28
9762909|NCT00395304|10867056|FG004|STARTED|Treatment Period 2||27
9762910|NCT00395304|10867057|FG005|STARTED|Treatment Period 2||30
9762911|NCT00395304|10867052|FG000|COMPLETED|Treatment Period 2||30
9762912|NCT00395304|10867053|FG001|COMPLETED|Treatment Period 2||22
9762913|NCT00395304|10867054|FG002|COMPLETED|Treatment Period 2||29
9762914|NCT00395304|10867055|FG003|COMPLETED|Treatment Period 2||27
9762915|NCT00395304|10867056|FG004|COMPLETED|Treatment Period 2||27
9762916|NCT00395304|10867057|FG005|COMPLETED|Treatment Period 2||28
9762917|NCT00395304|10867052|FG000|NOT COMPLETED|Treatment Period 2||0
9762918|NCT00395304|10867053|FG001|NOT COMPLETED|Treatment Period 2||4
9762919|NCT00395304|10867054|FG002|NOT COMPLETED|Treatment Period 2||1
9762920|NCT00395304|10867055|FG003|NOT COMPLETED|Treatment Period 2||1
9762921|NCT00395304|10867056|FG004|NOT COMPLETED|Treatment Period 2||0
9762922|NCT00395304|10867057|FG005|NOT COMPLETED|Treatment Period 2||2
9762923|NCT00395304|10867052|FG000|STARTED|Treatment Period 3||30
9762924|NCT00395304|10867053|FG001|STARTED|Treatment Period 3||22
9762925|NCT00395304|10867054|FG002|STARTED|Treatment Period 3||29
9762926|NCT00395304|10867055|FG003|STARTED|Treatment Period 3||27
9762927|NCT00395304|10867056|FG004|STARTED|Treatment Period 3||27
9762928|NCT00395304|10867057|FG005|STARTED|Treatment Period 3||28
9762929|NCT00395304|10867052|FG000|COMPLETED|Treatment Period 3||29
9762930|NCT00395304|10867053|FG001|COMPLETED|Treatment Period 3||20
9762931|NCT00395304|10867054|FG002|COMPLETED|Treatment Period 3||29
9762932|NCT00395304|10867055|FG003|COMPLETED|Treatment Period 3||25
9762933|NCT00395304|10867056|FG004|COMPLETED|Treatment Period 3||27
9762934|NCT00395304|10867057|FG005|COMPLETED|Treatment Period 3||27
9762935|NCT00395304|10867052|FG000|NOT COMPLETED|Treatment Period 3||1
9762936|NCT00395304|10867053|FG001|NOT COMPLETED|Treatment Period 3||2
9762937|NCT00395304|10867054|FG002|NOT COMPLETED|Treatment Period 3||0
9762938|NCT00395304|10867055|FG003|NOT COMPLETED|Treatment Period 3||2
9762939|NCT00395304|10867056|FG004|NOT COMPLETED|Treatment Period 3||0
9762940|NCT00395304|10867057|FG005|NOT COMPLETED|Treatment Period 3||1
9762941|NCT00395343|10867066|FG000|STARTED|Overall Study||322
9762942|NCT00395343|10867067|FG001|STARTED|Overall Study||319
9762943|NCT00395343|10867066|FG000|COMPLETED|Overall Study||281
9762944|NCT00395343|10867067|FG001|COMPLETED|Overall Study||283
9762945|NCT00395343|10867066|FG000|NOT COMPLETED|Overall Study||41
9762946|NCT00395343|10867067|FG001|NOT COMPLETED|Overall Study||36
9762947|NCT00395447|10867075|FG000|STARTED|Overall Study||1031
9762948|NCT00395447|10867076|FG001|STARTED|Overall Study||713
9762949|NCT00395447|10867075|FG000|COMPLETED|Overall Study||910
9762950|NCT00395447|10867076|FG001|COMPLETED|Overall Study||602
9762951|NCT00395447|10867075|FG000|NOT COMPLETED|Overall Study||121
9762952|NCT00395447|10867076|FG001|NOT COMPLETED|Overall Study||111
9762953|NCT00395460|10867084|FG000|STARTED|Overall Study||72
9762954|NCT00395460|10867085|FG001|STARTED|Overall Study||75
9762955|NCT00395460|10867084|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
9762956|NCT00395460|10867085|FG001|Received Treatment|Overall Study||75
9762957|NCT00395460|10867084|FG000|COMPLETED|Overall Study||71
9762958|NCT00395460|10867085|FG001|COMPLETED|Overall Study||75
9762959|NCT00395460|10867084|FG000|NOT COMPLETED|Overall Study||1
9762960|NCT00395460|10867085|FG001|NOT COMPLETED|Overall Study||0
9762961|NCT00395486|10867093|FG000|STARTED|Overall Study|Randomized subjects|132
9762962|NCT00395486|10867094|FG001|STARTED|Overall Study|Randomized subjects|126
9762963|NCT00395486|10867093|FG000|COMPLETED|Overall Study|Completed subjects|126
9762964|NCT00395486|10867094|FG001|COMPLETED|Overall Study|Completed subjects|121
9762965|NCT00395486|10867093|FG000|NOT COMPLETED|Overall Study||6
9762966|NCT00395486|10867094|FG001|NOT COMPLETED|Overall Study||5
9762967|NCT00395512|10867104|FG000|STARTED|Overall Study||164
9762968|NCT00395512|10867105|FG001|STARTED|Overall Study||163
9762969|NCT00395512|10867106|FG002|STARTED|Overall Study||164
9762970|NCT00395512|10867107|FG003|STARTED|Overall Study||164
9762971|NCT00395512|10867104|FG000|Safety Set|Overall Study||164
9762972|NCT00395512|10867105|FG001|Safety Set|Overall Study||163
9762973|NCT00395512|10867106|FG002|Safety Set|Overall Study||164
9762974|NCT00395512|10867107|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
9762975|NCT00395512|10867104|FG000|COMPLETED|Overall Study||126
9762976|NCT00395512|10867105|FG001|COMPLETED|Overall Study||126
9762977|NCT00395512|10867106|FG002|COMPLETED|Overall Study||136
9762978|NCT00395512|10867107|FG003|COMPLETED|Overall Study||126
9762979|NCT00395512|10867104|FG000|NOT COMPLETED|Overall Study||38
9762980|NCT00395512|10867105|FG001|NOT COMPLETED|Overall Study||37
9762981|NCT00395512|10867106|FG002|NOT COMPLETED|Overall Study||28
9762982|NCT00395512|10867107|FG003|NOT COMPLETED|Overall Study||38
9762983|NCT00395538|10867120|FG000|STARTED|Overall Study||8
9762984|NCT00395538|10867121|FG001|STARTED|Overall Study||15
9762985|NCT00395538|10867122|FG002|STARTED|Overall Study||23
9762986|NCT00395538|10867120|FG000|Signed Consent to the New Protocol|Overall Study||7
9762987|NCT00395538|10867121|FG001|Signed Consent to the New Protocol|Overall Study||5
9762988|NCT00395538|10867122|FG002|Signed Consent to the New Protocol|Overall Study||23
9762989|NCT00395538|10867120|FG000|Received HPTH on New Protocol|Overall Study||7
9762990|NCT00395538|10867121|FG001|Received HPTH on New Protocol|Overall Study||5
9762991|NCT00395538|10867122|FG002|Received HPTH on New Protocol|Overall Study||19
9762992|NCT00395538|10867120|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0
9762993|NCT00395538|10867121|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1
9762994|NCT00395538|10867122|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5
9762995|NCT00395538|10867120|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0
9762996|NCT00395538|10867121|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2
9762997|NCT00395538|10867122|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6
9762998|NCT00395538|10867120|FG000|Randomized to Bone Biospy Year 4|Overall Study||0
9762999|NCT00395538|10867121|FG001|Randomized to Bone Biospy Year 4|Overall Study||2
9763000|NCT00395538|10867122|FG002|Randomized to Bone Biospy Year 4|Overall Study||8
9763001|NCT00395538|10867120|FG000|Completed Bone Biopsy Year 1|Overall Study||0
9763002|NCT00395538|10867121|FG001|Completed Bone Biopsy Year 1|Overall Study||1
9763003|NCT00395538|10867122|FG002|Completed Bone Biopsy Year 1|Overall Study||4
9763004|NCT00395538|10867120|FG000|Completed Bone Biopsy Year 2|Overall Study||0
9763005|NCT00395538|10867121|FG001|Completed Bone Biopsy Year 2|Overall Study||2
9763006|NCT00395538|10867122|FG002|Completed Bone Biopsy Year 2|Overall Study||3
9763007|NCT00395538|10867120|FG000|Completed Bone Biopsy Year 4|Overall Study||0
9763008|NCT00395538|10867121|FG001|Completed Bone Biopsy Year 4|Overall Study||1
9763009|NCT00395538|10867122|FG002|Completed Bone Biopsy Year 4|Overall Study||1
9763010|NCT00395538|10867120|FG000|COMPLETED|Overall Study||5
9763011|NCT00395538|10867121|FG001|COMPLETED|Overall Study||2
9763012|NCT00395538|10867122|FG002|COMPLETED|Overall Study||0
9763013|NCT00395538|10867120|FG000|NOT COMPLETED|Overall Study||3
9763014|NCT00395538|10867121|FG001|NOT COMPLETED|Overall Study||13
9763015|NCT00395538|10867122|FG002|NOT COMPLETED|Overall Study||23
9763016|NCT00395629|10867133|FG000|STARTED|Core Study||11
9763017|NCT00395629|10867134|FG001|STARTED|Core Study||15
9763018|NCT00395629|10867135|FG002|STARTED|Core Study||23
9763019|NCT00395629|10867133|FG000|COMPLETED|Core Study||10
9763020|NCT00395629|10867134|FG001|COMPLETED|Core Study||11
9763021|NCT00395629|10867135|FG002|COMPLETED|Core Study||16
9763022|NCT00395629|10867133|FG000|NOT COMPLETED|Core Study||1
9763023|NCT00395629|10867134|FG001|NOT COMPLETED|Core Study||4
9763024|NCT00395629|10867135|FG002|NOT COMPLETED|Core Study||7
9763025|NCT00395629|10867133|FG000|STARTED|Extension Study||9
9763026|NCT00395629|10867134|FG001|STARTED|Extension Study||6
9763027|NCT00395629|10867135|FG002|STARTED|Extension Study||11
9763028|NCT00395629|10867133|FG000|COMPLETED|Extension Study||9
9763029|NCT00395629|10867134|FG001|COMPLETED|Extension Study||6
9763030|NCT00395629|10867135|FG002|COMPLETED|Extension Study||8
9763031|NCT00395629|10867133|FG000|NOT COMPLETED|Extension Study||0
9763032|NCT00395629|10867134|FG001|NOT COMPLETED|Extension Study||0
9763033|NCT00395629|10867135|FG002|NOT COMPLETED|Extension Study||3
9763034|NCT00395642|10867146|FG000|STARTED|Overall Study||66
9763035|NCT00395642|10867146|FG000|COMPLETED|Overall Study||53
9763036|NCT00395642|10867146|FG000|NOT COMPLETED|Overall Study||13
9763037|NCT00395694|10867152|FG000|STARTED|Escalation Phase + Maintenance Phase||51
9763038|NCT00395694|10867153|FG001|STARTED|Escalation Phase + Maintenance Phase||51
9763039|NCT00395694|10867152|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50
9763040|NCT00395694|10867153|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49
9763041|NCT00395694|10867152|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
9763042|NCT00395694|10867153|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
9763043|NCT00395694|10867152|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
9763044|NCT00395694|10867153|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
9763045|NCT00395694|10867152|FG000|COMPLETED|Continuation Phase||34
9763046|NCT00395694|10867153|FG001|COMPLETED|Continuation Phase||35
9763047|NCT00395694|10867152|FG000|NOT COMPLETED|Continuation Phase||15
9763048|NCT00395694|10867153|FG001|NOT COMPLETED|Continuation Phase||13
9763049|NCT00395733|10867164|FG000|STARTED|Period 1||41
9763050|NCT00395733|10867165|FG001|STARTED|Period 1||42
9763051|NCT00395733|10867164|FG000|COMPLETED|Period 1||41
9763052|NCT00395733|10867165|FG001|COMPLETED|Period 1||42
9763053|NCT00395733|10867164|FG000|NOT COMPLETED|Period 1||0
9763054|NCT00395733|10867165|FG001|NOT COMPLETED|Period 1||0
9763055|NCT00395733|10867164|FG000|STARTED|Period 2||41
9763056|NCT00395733|10867165|FG001|STARTED|Period 2||42
9763057|NCT00395733|10867164|FG000|COMPLETED|Period 2||39
9763058|NCT00395733|10867165|FG001|COMPLETED|Period 2||37
9763059|NCT00395733|10867164|FG000|NOT COMPLETED|Period 2||2
9763060|NCT00395733|10867165|FG001|NOT COMPLETED|Period 2||5
9763061|NCT00395746|10867174|FG000|STARTED|Overall Study|Exposed to study drug|88
9763062|NCT00395746|10867175|FG001|STARTED|Overall Study|Exposed to study drug|88
9763063|NCT00395746|10867176|FG002|STARTED|Overall Study|Exposed to study drug|88
9763064|NCT00395746|10867174|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78
9763065|NCT00395746|10867175|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84
9763066|NCT00395746|10867176|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66
9763067|NCT00395746|10867174|FG000|NOT COMPLETED|Overall Study||10
9763068|NCT00395746|10867175|FG001|NOT COMPLETED|Overall Study||4
9763069|NCT00395746|10867176|FG002|NOT COMPLETED|Overall Study||22
9763070|NCT00395850|10867188|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
9763071|NCT00395850|10867189|FG001|STARTED|Pre-randomization Baseline/Induction||0
9763072|NCT00395850|10867190|FG002|STARTED|Pre-randomization Baseline/Induction||0
9763073|NCT00395850|10867191|FG003|STARTED|Pre-randomization Baseline/Induction||0
9763074|NCT00395850|10867188|FG000|COMPLETED|Pre-randomization Baseline/Induction||107
9763075|NCT00395850|10867189|FG001|COMPLETED|Pre-randomization Baseline/Induction||0
9763076|NCT00395850|10867190|FG002|COMPLETED|Pre-randomization Baseline/Induction||0
9763077|NCT00395850|10867191|FG003|COMPLETED|Pre-randomization Baseline/Induction||0
9763078|NCT00395850|10867188|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11
9763079|NCT00395850|10867189|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0
9763080|NCT00395850|10867190|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0
9763081|NCT00395850|10867191|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0
9763082|NCT00395850|10867188|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27
9763083|NCT00395850|10867189|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25
9763084|NCT00395850|10867190|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30
9763085|NCT00395850|10867191|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25
9763086|NCT00395850|10867188|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
9763087|NCT00395850|10867189|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
9763088|NCT00395850|10867190|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
9763089|NCT00395850|10867191|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
9763090|NCT00395850|10867188|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
9763091|NCT00395850|10867189|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
9763092|NCT00395850|10867190|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
9763093|NCT00395850|10867191|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
9763094|NCT00395850|10867188|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
9763095|NCT00395850|10867189|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
9763096|NCT00395850|10867190|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
9763097|NCT00395850|10867191|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
9763098|NCT00395850|10867188|FG000|COMPLETED|Disulfiram/Placebo Treatment||11
9763099|NCT00395850|10867189|FG001|COMPLETED|Disulfiram/Placebo Treatment||9
9763100|NCT00395850|10867190|FG002|COMPLETED|Disulfiram/Placebo Treatment||5
9763101|NCT00395850|10867191|FG003|COMPLETED|Disulfiram/Placebo Treatment||8
9763102|NCT00395850|10867188|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9
9763103|NCT00395850|10867189|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14
9763104|NCT00395850|10867190|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19
9763105|NCT00395850|10867191|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13
9763106|NCT00395863|10867203|FG000|STARTED|Overall Study||23
9763107|NCT00395863|10867204|FG001|STARTED|Overall Study||23
9763108|NCT00395863|10867203|FG000|COMPLETED|Overall Study||21
9763109|NCT00395863|10867204|FG001|COMPLETED|Overall Study||20
9763110|NCT00395863|10867203|FG000|NOT COMPLETED|Overall Study||2
9763111|NCT00395863|10867204|FG001|NOT COMPLETED|Overall Study||3
9763112|NCT00395876|10867215|FG000|STARTED|Overall Study||50
9763113|NCT00395876|10867216|FG001|STARTED|Overall Study||50
9763114|NCT00395876|10867215|FG000|COMPLETED|Overall Study||47
9763115|NCT00395876|10867216|FG001|COMPLETED|Overall Study||50
9763116|NCT00395876|10867215|FG000|NOT COMPLETED|Overall Study||3
9763117|NCT00395876|10867216|FG001|NOT COMPLETED|Overall Study||0
9763118|NCT00395967|10867222|FG000|STARTED|Treatment Period||5
9763119|NCT00395967|10867222|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
9763120|NCT00395967|10867222|FG000|NOT COMPLETED|Treatment Period||1
9763121|NCT00395967|10867222|FG000|STARTED|Follow-up Period|Participants who had transplants.|5
9763122|NCT00395967|10867222|FG000|COMPLETED|Follow-up Period||3
9763123|NCT00395967|10867222|FG000|NOT COMPLETED|Follow-up Period||2
9763124|NCT00395993|10867228|FG000|STARTED|Overall Study||246
9763125|NCT00395993|10867229|FG001|STARTED|Overall Study||231
9763126|NCT00395993|10867228|FG000|COMPLETED|Overall Study||211
9763127|NCT00395993|10867229|FG001|COMPLETED|Overall Study||212
9763128|NCT00395993|10867228|FG000|NOT COMPLETED|Overall Study||35
9763129|NCT00395993|10867229|FG001|NOT COMPLETED|Overall Study||19
9763130|NCT00396006|10867235|FG000|STARTED|Overall Study||13
9763131|NCT00396006|10867235|FG000|COMPLETED|Overall Study||13
9763132|NCT00396006|10867235|FG000|NOT COMPLETED|Overall Study||0
9763133|NCT00396019|10867243|FG000|STARTED|Overall Study||27
9763134|NCT00396019|10867244|FG001|STARTED|Overall Study||29
9763135|NCT00396019|10867245|FG002|STARTED|Overall Study||30
9763136|NCT00396019|10867243|FG000|COMPLETED|Overall Study||27
9763137|NCT00396019|10867244|FG001|COMPLETED|Overall Study||26
9763138|NCT00396019|10867245|FG002|COMPLETED|Overall Study||29
9763139|NCT00396019|10867243|FG000|NOT COMPLETED|Overall Study||0
9763140|NCT00396019|10867244|FG001|NOT COMPLETED|Overall Study||3
9763141|NCT00396019|10867245|FG002|NOT COMPLETED|Overall Study||1
9763142|NCT00396032|10867256|FG000|STARTED|Overall Study||74
9763143|NCT00396032|10867257|FG001|STARTED|Overall Study||76
9763144|NCT00396032|10867256|FG000|COMPLETED|Overall Study||70
9763145|NCT00396032|10867257|FG001|COMPLETED|Overall Study||71
9763146|NCT00396032|10867256|FG000|NOT COMPLETED|Overall Study||4
9763147|NCT00396032|10867257|FG001|NOT COMPLETED|Overall Study||5
9763148|NCT00396084|10867269|FG000|STARTED|Overall Study||10
9763149|NCT00396084|10867270|FG001|STARTED|Overall Study||10
9763150|NCT00396084|10867271|FG002|STARTED|Overall Study||10
9763151|NCT00396084|10867272|FG003|STARTED|Overall Study||10
9763152|NCT00396084|10867273|FG004|STARTED|Overall Study||10
9763153|NCT00396084|10867274|FG005|STARTED|Overall Study||20
9763154|NCT00396084|10867269|FG000|COMPLETED|Overall Study||10
9763155|NCT00396084|10867270|FG001|COMPLETED|Overall Study||10
9763156|NCT00396084|10867271|FG002|COMPLETED|Overall Study||10
9763157|NCT00396084|10867272|FG003|COMPLETED|Overall Study||9
9763158|NCT00396084|10867273|FG004|COMPLETED|Overall Study||9
9763159|NCT00396084|10867274|FG005|COMPLETED|Overall Study||18
9763160|NCT00396084|10867269|FG000|NOT COMPLETED|Overall Study||0
9763161|NCT00396084|10867270|FG001|NOT COMPLETED|Overall Study||0
9763162|NCT00396084|10867271|FG002|NOT COMPLETED|Overall Study||0
9763163|NCT00396084|10867272|FG003|NOT COMPLETED|Overall Study||1
9763164|NCT00396084|10867273|FG004|NOT COMPLETED|Overall Study||1
9763165|NCT00396084|10867274|FG005|NOT COMPLETED|Overall Study||2
9763166|NCT00396097|10867294|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
9763167|NCT00396097|10867295|FG001|STARTED|Overall Study||202
9763168|NCT00396097|10867294|FG000|COMPLETED|Overall Study||88
9763169|NCT00396097|10867295|FG001|COMPLETED|Overall Study||156
9763170|NCT00396097|10867294|FG000|NOT COMPLETED|Overall Study||26
9763171|NCT00396097|10867295|FG001|NOT COMPLETED|Overall Study||46
9763172|NCT00396136|10867305|FG000|STARTED|Overall Study||221
9763173|NCT00396136|10867305|FG000|COMPLETED|Overall Study||96
9763174|NCT00396136|10867305|FG000|NOT COMPLETED|Overall Study||125
9763175|NCT00396162|10867311|FG000|STARTED|Overall Study||39
9763176|NCT00396162|10867312|FG001|STARTED|Overall Study||38
9763177|NCT00396162|10867311|FG000|COMPLETED|Overall Study||37
9763178|NCT00396162|10867312|FG001|COMPLETED|Overall Study||35
9763179|NCT00396162|10867311|FG000|NOT COMPLETED|Overall Study||2
9763180|NCT00396162|10867312|FG001|NOT COMPLETED|Overall Study||3
9763181|NCT00396201|10867322|FG000|STARTED|Treatment Period||22
9763182|NCT00396201|10867322|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
9763183|NCT00396201|10867322|FG000|NOT COMPLETED|Treatment Period||0
9763184|NCT00396201|10867322|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
9763185|NCT00396201|10867322|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
9763186|NCT00396201|10867322|FG000|NOT COMPLETED|Follow-up Period||0
9763187|NCT00396253|10867327|FG000|STARTED|Overall Study||223
9763188|NCT00396253|10867327|FG000|COMPLETED|Overall Study||210
9763189|NCT00396253|10867327|FG000|NOT COMPLETED|Overall Study||13
9763190|NCT00396266|10867333|FG000|STARTED|Overall Study||8
9763191|NCT00396266|10867334|FG001|STARTED|Overall Study||14
9763192|NCT00396266|10867333|FG000|COMPLETED|Overall Study||8
9763193|NCT00396266|10867334|FG001|COMPLETED|Overall Study||14
9763194|NCT00396266|10867333|FG000|NOT COMPLETED|Overall Study||0
9763195|NCT00396266|10867334|FG001|NOT COMPLETED|Overall Study||0
9763196|NCT00396279|10867344|FG000|STARTED|Overall Study||37
9763197|NCT00396279|10867344|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7
9763198|NCT00396279|10867344|FG000|NOT COMPLETED|Overall Study||30
9763199|NCT00396292|10867350|FG000|STARTED|Overall Study||174
9763200|NCT00396292|10867351|FG001|STARTED|Overall Study||178
9763201|NCT00396292|10867350|FG000|COMPLETED|Overall Study||165
9763202|NCT00396292|10867351|FG001|COMPLETED|Overall Study||162
9763203|NCT00396292|10867350|FG000|NOT COMPLETED|Overall Study||9
9763204|NCT00396292|10867351|FG001|NOT COMPLETED|Overall Study||16
9763205|NCT00396318|10867357|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246
9763206|NCT00396318|10867357|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
9763207|NCT00396318|10867357|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
9763208|NCT00396318|10867357|FG000|STARTED|48- to 96-Hour Follow-Up Period||246
9763209|NCT00396318|10867357|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241
9763210|NCT00396318|10867357|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
9763211|NCT00396318|10867357|FG000|STARTED|7-Day Post-Treatment Contact||241
9763212|NCT00396318|10867357|FG000|COMPLETED|7-Day Post-Treatment Contact||240
9763213|NCT00396318|10867357|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1
9763214|NCT00396331|10867365|FG000|STARTED|Overall Study||100
9763215|NCT00396331|10867365|FG000|Number of Participants Treated|Overall Study||100
9763216|NCT00396331|10867365|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
9763217|NCT00396331|10867365|FG000|COMPLETED|Overall Study||68
9763218|NCT00396331|10867365|FG000|NOT COMPLETED|Overall Study||32
9763219|NCT00396383|10867377|FG000|STARTED|Overall Study||9
9763220|NCT00396383|10867377|FG000|COMPLETED|Overall Study||6
9763221|NCT00396383|10867377|FG000|NOT COMPLETED|Overall Study||3
9763222|NCT00396409|10867383|FG000|STARTED|Period 1 - 2007||65
9763223|NCT00396409|10867384|FG001|STARTED|Period 1 - 2007||63
9763224|NCT00396409|10867383|FG000|COMPLETED|Period 1 - 2007||62
9763225|NCT00396409|10867384|FG001|COMPLETED|Period 1 - 2007||57
9763226|NCT00396409|10867383|FG000|NOT COMPLETED|Period 1 - 2007||3
9763227|NCT00396409|10867384|FG001|NOT COMPLETED|Period 1 - 2007||6
9763228|NCT00396409|10867383|FG000|STARTED|Between Period 1 and Period 2||62
9763229|NCT00396409|10867384|FG001|STARTED|Between Period 1 and Period 2||57
9763230|NCT00396409|10867383|FG000|COMPLETED|Between Period 1 and Period 2||59
9763231|NCT00396409|10867384|FG001|COMPLETED|Between Period 1 and Period 2||55
9763232|NCT00396409|10867383|FG000|NOT COMPLETED|Between Period 1 and Period 2||3
9763233|NCT00396409|10867384|FG001|NOT COMPLETED|Between Period 1 and Period 2||2
9763234|NCT00396409|10867383|FG000|STARTED|Period 2 - 2008||59
9763235|NCT00396409|10867384|FG001|STARTED|Period 2 - 2008||55
9763236|NCT00396409|10867383|FG000|COMPLETED|Period 2 - 2008||52
9763237|NCT00396409|10867384|FG001|COMPLETED|Period 2 - 2008||53
9763238|NCT00396409|10867383|FG000|NOT COMPLETED|Period 2 - 2008||7
9763239|NCT00396409|10867384|FG001|NOT COMPLETED|Period 2 - 2008||2
9763240|NCT00396565|10867395|FG000|STARTED|Overall Study||136
9763241|NCT00396565|10867396|FG001|STARTED|Overall Study||138
9763242|NCT00396565|10867397|FG002|STARTED|Overall Study||47
9763243|NCT00396565|10867395|FG000|COMPLETED|Overall Study||88
9763244|NCT00396565|10867396|FG001|COMPLETED|Overall Study||47
9763245|NCT00396565|10867397|FG002|COMPLETED|Overall Study||30
9763246|NCT00396565|10867395|FG000|NOT COMPLETED|Overall Study||48
9763247|NCT00396565|10867396|FG001|NOT COMPLETED|Overall Study||91
9763248|NCT00396565|10867397|FG002|NOT COMPLETED|Overall Study||17
9763249|NCT00396591|10867405|FG000|STARTED|Overall Study||16
9763250|NCT00396591|10867405|FG000|COMPLETED|Overall Study||0
9763251|NCT00396591|10867405|FG000|NOT COMPLETED|Overall Study||16
9763252|NCT00396630|10867411|FG000|STARTED|Overall Study||100
9763253|NCT00396630|10867412|FG001|STARTED|Overall Study||100
9763254|NCT00396630|10867411|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
9763255|NCT00396630|10867412|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
9763256|NCT00396630|10867411|FG000|NOT COMPLETED|Overall Study||5
9763257|NCT00396630|10867412|FG001|NOT COMPLETED|Overall Study||5
9763258|NCT00396656|10867419|FG000|STARTED|First Treatment Period||15
9763259|NCT00396656|10867420|FG001|STARTED|First Treatment Period||15
9763260|NCT00396656|10867419|FG000|COMPLETED|First Treatment Period||15
9763261|NCT00396656|10867420|FG001|COMPLETED|First Treatment Period||13
9763262|NCT00396656|10867419|FG000|NOT COMPLETED|First Treatment Period||0
9763263|NCT00396656|10867420|FG001|NOT COMPLETED|First Treatment Period||2
9763264|NCT00396656|10867419|FG000|STARTED|Second Treatment Period||15
9763265|NCT00396656|10867420|FG001|STARTED|Second Treatment Period||13
9763266|NCT00396656|10867419|FG000|COMPLETED|Second Treatment Period||15
9763267|NCT00396656|10867420|FG001|COMPLETED|Second Treatment Period||12
9763268|NCT00396656|10867419|FG000|NOT COMPLETED|Second Treatment Period||0
9763269|NCT00396656|10867420|FG001|NOT COMPLETED|Second Treatment Period||1
9763270|NCT00396812|10867426|FG000|STARTED|Overall Study||4
9763271|NCT00396812|10867426|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
9763272|NCT00396812|10867426|FG000|NOT COMPLETED|Overall Study||1
9763273|NCT00396877|10867432|FG000|STARTED|Overall Study|Randomized|439
9763274|NCT00396877|10867433|FG001|STARTED|Overall Study|Randomized|467
9763275|NCT00396877|10867432|FG000|Treated|Overall Study||436
9763276|NCT00396877|10867433|FG001|Treated|Overall Study||464
9763277|NCT00396877|10867432|FG000|Completed Treatment|Overall Study||356
9763278|NCT00396877|10867433|FG001|Completed Treatment|Overall Study||352
9763279|NCT00396877|10867432|FG000|COMPLETED|Overall Study|Completed follow-up|433
9763280|NCT00396877|10867433|FG001|COMPLETED|Overall Study|Completed follow-up|459
10013773|NCT01794741|11136699|FG001|NOT COMPLETED|Overall Study||9
10013774|NCT01794780|11136713|FG000|STARTED|Overall Study||32
10013775|NCT01794780|11136714|FG001|STARTED|Overall Study||276
9763281|NCT00396877|10867432|FG000|NOT COMPLETED|Overall Study||6
9763282|NCT00396877|10867433|FG001|NOT COMPLETED|Overall Study||8
9763283|NCT00396981|10867441|FG000|STARTED|Overall Study||311
9763284|NCT00396981|10867442|FG001|STARTED|Overall Study||315
9763285|NCT00396981|10867441|FG000|COMPLETED|Overall Study||296
9763286|NCT00396981|10867442|FG001|COMPLETED|Overall Study||306
9763287|NCT00396981|10867441|FG000|NOT COMPLETED|Overall Study||15
9763288|NCT00396981|10867442|FG001|NOT COMPLETED|Overall Study||9
9763289|NCT00397020|10867450|FG000|STARTED|Overall Study||14
9763290|NCT00397020|10867451|FG001|STARTED|Overall Study||16
9763291|NCT00397020|10867450|FG000|COMPLETED|Overall Study||13
9763292|NCT00397020|10867451|FG001|COMPLETED|Overall Study||15
10013776|NCT01794780|11136715|FG002|STARTED|Overall Study||813
10013777|NCT01794780|11136716|FG003|STARTED|Overall Study||283
9763293|NCT00397020|10867450|FG000|NOT COMPLETED|Overall Study||1
9763294|NCT00397020|10867451|FG001|NOT COMPLETED|Overall Study||1
9763295|NCT00397033|10867460|FG000|STARTED|Overall Study||107
9763296|NCT00397033|10867461|FG001|STARTED|Overall Study||109
9763297|NCT00397033|10867462|FG002|STARTED|Overall Study||100
9763298|NCT00397033|10867460|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107
9763299|NCT00397033|10867461|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108
9763300|NCT00397033|10867462|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98
9763301|NCT00397033|10867460|FG000|ITT Population|Overall Study||107
9763302|NCT00397033|10867461|FG001|ITT Population|Overall Study||105
9763303|NCT00397033|10867462|FG002|ITT Population|Overall Study||98
9763304|NCT00397033|10867460|FG000|COMPLETED|Overall Study||63
9763305|NCT00397033|10867461|FG001|COMPLETED|Overall Study||72
10013778|NCT01794780|11136717|FG004|STARTED|Overall Study||9
9763306|NCT00397033|10867462|FG002|COMPLETED|Overall Study||77
9763307|NCT00397033|10867460|FG000|NOT COMPLETED|Overall Study||44
9763308|NCT00397033|10867461|FG001|NOT COMPLETED|Overall Study||37
9763309|NCT00397033|10867462|FG002|NOT COMPLETED|Overall Study||23
9763310|NCT00397046|10867474|FG000|STARTED|Overall Study||3
9763311|NCT00397046|10867475|FG001|STARTED|Overall Study||3
9763312|NCT00397046|10867476|FG002|STARTED|Overall Study||10
9763313|NCT00397046|10867477|FG003|STARTED|Overall Study||5
9763314|NCT00397046|10867474|FG000|COMPLETED|Overall Study||0
9763315|NCT00397046|10867475|FG001|COMPLETED|Overall Study||0
9763316|NCT00397046|10867476|FG002|COMPLETED|Overall Study||0
9763317|NCT00397046|10867477|FG003|COMPLETED|Overall Study||0
9763318|NCT00397046|10867474|FG000|NOT COMPLETED|Overall Study||3
9763319|NCT00397046|10867475|FG001|NOT COMPLETED|Overall Study||3
9763320|NCT00397046|10867476|FG002|NOT COMPLETED|Overall Study||10
9763321|NCT00397046|10867477|FG003|NOT COMPLETED|Overall Study||5
9763322|NCT00397150|10867490|FG000|STARTED|Overall Study||1323
9763323|NCT00397150|10867491|FG001|STARTED|Overall Study||1256
9763324|NCT00397150|10867490|FG000|COMPLETED|Overall Study||1188
9763325|NCT00397150|10867491|FG001|COMPLETED|Overall Study||1111
9763326|NCT00397150|10867490|FG000|NOT COMPLETED|Overall Study||135
9763327|NCT00397150|10867491|FG001|NOT COMPLETED|Overall Study||145
9763328|NCT00397189|10867499|FG000|STARTED|3 Weeks Period||394
9763329|NCT00397189|10867500|FG001|STARTED|3 Weeks Period||395
9763330|NCT00397189|10867499|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
9763331|NCT00397189|10867500|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
9763332|NCT00397189|10867499|FG000|NOT COMPLETED|3 Weeks Period||21
9763333|NCT00397189|10867500|FG001|NOT COMPLETED|3 Weeks Period||22
9763334|NCT00397189|10867499|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
9763335|NCT00397189|10867500|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
9763336|NCT00397189|10867499|FG000|COMPLETED|Extension Period||421
9763337|NCT00397189|10867500|FG001|COMPLETED|Extension Period||134
9763338|NCT00397189|10867499|FG000|NOT COMPLETED|Extension Period||113
9763339|NCT00397189|10867500|FG001|NOT COMPLETED|Extension Period||43
9763340|NCT00397215|10867512|FG000|STARTED|Month 0 (Day 0)||165
9763341|NCT00397215|10867513|FG001|STARTED|Month 0 (Day 0)||61
9763342|NCT00397215|10867514|FG002|STARTED|Month 0 (Day 0)||159
9763343|NCT00397215|10867515|FG003|STARTED|Month 0 (Day 0)||52
9763344|NCT00397215|10867512|FG000|COMPLETED|Month 0 (Day 0)||158
9763345|NCT00397215|10867513|FG001|COMPLETED|Month 0 (Day 0)||56
9763346|NCT00397215|10867514|FG002|COMPLETED|Month 0 (Day 0)||153
9763347|NCT00397215|10867515|FG003|COMPLETED|Month 0 (Day 0)||48
9763348|NCT00397215|10867512|FG000|NOT COMPLETED|Month 0 (Day 0)||7
9763349|NCT00397215|10867513|FG001|NOT COMPLETED|Month 0 (Day 0)||5
9763350|NCT00397215|10867514|FG002|NOT COMPLETED|Month 0 (Day 0)||6
9763351|NCT00397215|10867515|FG003|NOT COMPLETED|Month 0 (Day 0)||4
9763352|NCT00397215|10867512|FG000|STARTED|Month 6 (Day 180)||164
9763353|NCT00397215|10867513|FG001|STARTED|Month 6 (Day 180)||58
9763354|NCT00397215|10867514|FG002|STARTED|Month 6 (Day 180)||158
9763355|NCT00397215|10867515|FG003|STARTED|Month 6 (Day 180)||51
9763356|NCT00397215|10867512|FG000|COMPLETED|Month 6 (Day 180)||162
9763357|NCT00397215|10867513|FG001|COMPLETED|Month 6 (Day 180)||55
9763358|NCT00397215|10867514|FG002|COMPLETED|Month 6 (Day 180)||153
9763359|NCT00397215|10867515|FG003|COMPLETED|Month 6 (Day 180)||51
9763360|NCT00397215|10867512|FG000|NOT COMPLETED|Month 6 (Day 180)||2
9763361|NCT00397215|10867513|FG001|NOT COMPLETED|Month 6 (Day 180)||3
9763362|NCT00397215|10867514|FG002|NOT COMPLETED|Month 6 (Day 180)||5
9763363|NCT00397215|10867515|FG003|NOT COMPLETED|Month 6 (Day 180)||0
9763364|NCT00397215|10867512|FG000|STARTED|Month 12 (Day 360)||130
9763365|NCT00397215|10867513|FG001|STARTED|Month 12 (Day 360)||48
9763366|NCT00397215|10867514|FG002|STARTED|Month 12 (Day 360)||125
9763367|NCT00397215|10867515|FG003|STARTED|Month 12 (Day 360)||42
9763368|NCT00397215|10867512|FG000|COMPLETED|Month 12 (Day 360)||130
9763369|NCT00397215|10867513|FG001|COMPLETED|Month 12 (Day 360)||48
9763370|NCT00397215|10867514|FG002|COMPLETED|Month 12 (Day 360)||125
9763371|NCT00397215|10867515|FG003|COMPLETED|Month 12 (Day 360)||42
9763372|NCT00397215|10867512|FG000|NOT COMPLETED|Month 12 (Day 360)||0
9763373|NCT00397215|10867513|FG001|NOT COMPLETED|Month 12 (Day 360)||0
9763374|NCT00397215|10867514|FG002|NOT COMPLETED|Month 12 (Day 360)||0
9763375|NCT00397215|10867515|FG003|NOT COMPLETED|Month 12 (Day 360)||0
9763376|NCT00397215|10867512|FG000|STARTED|Month 24 (Day 720)||122
9763377|NCT00397215|10867513|FG001|STARTED|Month 24 (Day 720)||45
9763378|NCT00397215|10867514|FG002|STARTED|Month 24 (Day 720)||117
9763379|NCT00397215|10867515|FG003|STARTED|Month 24 (Day 720)||36
9763380|NCT00397215|10867512|FG000|COMPLETED|Month 24 (Day 720)||122
9763381|NCT00397215|10867513|FG001|COMPLETED|Month 24 (Day 720)||45
9763382|NCT00397215|10867514|FG002|COMPLETED|Month 24 (Day 720)||117
9763383|NCT00397215|10867515|FG003|COMPLETED|Month 24 (Day 720)||36
9763384|NCT00397215|10867512|FG000|NOT COMPLETED|Month 24 (Day 720)||0
9763385|NCT00397215|10867513|FG001|NOT COMPLETED|Month 24 (Day 720)||0
9763386|NCT00397215|10867514|FG002|NOT COMPLETED|Month 24 (Day 720)||0
9763387|NCT00397215|10867515|FG003|NOT COMPLETED|Month 24 (Day 720)||0
9763388|NCT00397462|10867531|FG000|STARTED|Overall Study||16
9763389|NCT00397462|10867532|FG001|STARTED|Overall Study||13
9763390|NCT00397462|10867533|FG002|STARTED|Overall Study||15
9763391|NCT00397462|10867531|FG000|COMPLETED|Overall Study||16
9763392|NCT00397462|10867532|FG001|COMPLETED|Overall Study||13
9763393|NCT00397462|10867533|FG002|COMPLETED|Overall Study||15
9763394|NCT00397462|10867531|FG000|NOT COMPLETED|Overall Study||0
9763395|NCT00397462|10867532|FG001|NOT COMPLETED|Overall Study||0
9763396|NCT00397462|10867533|FG002|NOT COMPLETED|Overall Study||0
9763397|NCT00397488|10867541|FG000|STARTED|Overall Study||78
9763398|NCT00397488|10867541|FG000|COMPLETED|Overall Study||71
9763399|NCT00397488|10867541|FG000|NOT COMPLETED|Overall Study||7
9763400|NCT00397514|10867545|FG000|STARTED|Overall Study||34
9763401|NCT00397514|10867545|FG000|COMPLETED|Overall Study||25
9763402|NCT00397514|10867545|FG000|NOT COMPLETED|Overall Study||9
9763403|NCT00397540|10867557|FG000|STARTED|Overall Study||60
9763404|NCT00397540|10867558|FG001|STARTED|Overall Study||85
9763405|NCT00397540|10867557|FG000|COMPLETED|Overall Study||59
9763406|NCT00397540|10867558|FG001|COMPLETED|Overall Study||85
9763407|NCT00397540|10867557|FG000|NOT COMPLETED|Overall Study||1
9763408|NCT00397540|10867558|FG001|NOT COMPLETED|Overall Study||0
9763409|NCT00397579|10867565|FG000|STARTED|Overall Study||11
9763410|NCT00397579|10867565|FG000|COMPLETED|Overall Study||11
9763411|NCT00397579|10867565|FG000|NOT COMPLETED|Overall Study||0
9763412|NCT00397631|10867571|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261
9763413|NCT00397631|10867572|FG001|STARTED|Overall Study||259
9763414|NCT00397631|10867571|FG000|COMPLETED|Overall Study||231
9763415|NCT00397631|10867572|FG001|COMPLETED|Overall Study||215
9763416|NCT00397631|10867571|FG000|NOT COMPLETED|Overall Study||30
9763417|NCT00397631|10867572|FG001|NOT COMPLETED|Overall Study||44
9763418|NCT00397813|10867584|FG000|STARTED|Overall Study||36
9763419|NCT00397813|10867585|FG001|STARTED|Overall Study||0
9763420|NCT00397813|10867586|FG002|STARTED|Overall Study||0
9763421|NCT00397813|10867587|FG003|STARTED|Overall Study||12
9763422|NCT00397813|10867588|FG004|STARTED|Overall Study||5
9763423|NCT00397813|10867589|FG005|STARTED|Overall Study||24
9763424|NCT00397813|10867584|FG000|COMPLETED|Overall Study||36
9763425|NCT00397813|10867585|FG001|COMPLETED|Overall Study||0
9763426|NCT00397813|10867586|FG002|COMPLETED|Overall Study||0
9763427|NCT00397813|10867587|FG003|COMPLETED|Overall Study||12
9763428|NCT00397813|10867588|FG004|COMPLETED|Overall Study||5
9763429|NCT00397813|10867589|FG005|COMPLETED|Overall Study||24
9763430|NCT00397813|10867584|FG000|NOT COMPLETED|Overall Study||0
9763431|NCT00397813|10867585|FG001|NOT COMPLETED|Overall Study||0
9763432|NCT00397813|10867586|FG002|NOT COMPLETED|Overall Study||0
9763433|NCT00397813|10867587|FG003|NOT COMPLETED|Overall Study||0
9763434|NCT00397813|10867588|FG004|NOT COMPLETED|Overall Study||0
9763435|NCT00397813|10867589|FG005|NOT COMPLETED|Overall Study||0
9763436|NCT00397839|10867605|FG000|STARTED|Overall Study||48
9763437|NCT00397839|10867606|FG001|STARTED|Overall Study||87
9763438|NCT00397839|10867605|FG000|COMPLETED|Overall Study||41
9763439|NCT00397839|10867606|FG001|COMPLETED|Overall Study||69
9763440|NCT00397839|10867605|FG000|NOT COMPLETED|Overall Study||7
9763441|NCT00397839|10867606|FG001|NOT COMPLETED|Overall Study||18
9763442|NCT00397878|10867612|FG000|STARTED|Overall Study||10
9763443|NCT00397878|10867612|FG000|COMPLETED|Overall Study||10
9763444|NCT00397878|10867612|FG000|NOT COMPLETED|Overall Study||0
9763445|NCT00397891|10867621|FG000|STARTED|Overall Study||6
9763446|NCT00397891|10867622|FG001|STARTED|Overall Study||6
9763447|NCT00397891|10867623|FG002|STARTED|Overall Study||6
9763448|NCT00397891|10867624|FG003|STARTED|Overall Study||6
9763449|NCT00397891|10867625|FG004|STARTED|Overall Study||8
9763450|NCT00397891|10867621|FG000|COMPLETED|Overall Study||5
9763451|NCT00397891|10867622|FG001|COMPLETED|Overall Study||6
9763452|NCT00397891|10867623|FG002|COMPLETED|Overall Study||6
9763453|NCT00397891|10867624|FG003|COMPLETED|Overall Study||6
9763454|NCT00397891|10867625|FG004|COMPLETED|Overall Study||7
9763455|NCT00397891|10867621|FG000|NOT COMPLETED|Overall Study||1
9763456|NCT00397891|10867622|FG001|NOT COMPLETED|Overall Study||0
9763457|NCT00397891|10867623|FG002|NOT COMPLETED|Overall Study||0
9763458|NCT00397891|10867624|FG003|NOT COMPLETED|Overall Study||0
9763459|NCT00397891|10867625|FG004|NOT COMPLETED|Overall Study||1
9763460|NCT00397904|10867637|FG000|STARTED|Overall Study||16
9763461|NCT00397904|10867637|FG000|COMPLETED|Overall Study||16
9763462|NCT00397904|10867637|FG000|NOT COMPLETED|Overall Study||0
9829425|NCT00759642|10940039|FG000|COMPLETED|Overall Study||33
9829426|NCT00759642|10940039|FG000|NOT COMPLETED|Overall Study||0
9829427|NCT00759668|10940045|FG000|STARTED|Overall Study||17
9829428|NCT00759668|10940046|FG001|STARTED|Overall Study||18
9829429|NCT00759668|10940045|FG000|COMPLETED|Overall Study||16
9829430|NCT00759668|10940046|FG001|COMPLETED|Overall Study||15
9829431|NCT00759668|10940045|FG000|NOT COMPLETED|Overall Study||1
9829432|NCT00759668|10940046|FG001|NOT COMPLETED|Overall Study||3
9829433|NCT00759681|10940054|FG000|STARTED|Overall Study||107
9829434|NCT00759681|10940055|FG001|STARTED|Overall Study||110
9829435|NCT00759681|10940054|FG000|COMPLETED|Overall Study||97
9829436|NCT00759681|10940055|FG001|COMPLETED|Overall Study||100
9829437|NCT00759681|10940054|FG000|NOT COMPLETED|Overall Study||10
9829438|NCT00759681|10940055|FG001|NOT COMPLETED|Overall Study||10
9829439|NCT00759707|10940062|FG000|STARTED|Overall Study||19
9829440|NCT00759707|10940062|FG000|COMPLETED|Overall Study||19
9829441|NCT00759707|10940062|FG000|NOT COMPLETED|Overall Study||0
9829442|NCT00759759|10940068|FG000|STARTED|Overall Study||18
9829443|NCT00759759|10940069|FG001|STARTED|Overall Study||18
9829444|NCT00759759|10940068|FG000|COMPLETED|Overall Study||14
9829445|NCT00759759|10940069|FG001|COMPLETED|Overall Study||17
9829446|NCT00759759|10940068|FG000|NOT COMPLETED|Overall Study||4
9829447|NCT00759759|10940069|FG001|NOT COMPLETED|Overall Study||1
9763463|NCT00397930|10867643|FG000|STARTED|Overall Study||206
9763464|NCT00397930|10867644|FG001|STARTED|Overall Study||204
9763465|NCT00397930|10867643|FG000|COMPLETED|Overall Study||168
9763466|NCT00397930|10867644|FG001|COMPLETED|Overall Study||153
9763467|NCT00397930|10867643|FG000|NOT COMPLETED|Overall Study||38
9763468|NCT00397930|10867644|FG001|NOT COMPLETED|Overall Study||51
9763469|NCT00397943|10867655|FG000|STARTED|Overall Study||40
9763470|NCT00397943|10867656|FG001|STARTED|Overall Study||40
9763471|NCT00397943|10867657|FG002|STARTED|Overall Study||10
9763472|NCT00397943|10867658|FG003|STARTED|Overall Study||10
9763473|NCT00397943|10867659|FG004|STARTED|Overall Study||10
9763474|NCT00397943|10867655|FG000|COMPLETED|Overall Study||28
10232253|NCT02284906|11361469|FG002|STARTED|Overall Study||19
10232254|NCT02284906|11361467|FG000|COMPLETED|Overall Study||0
10232255|NCT02284906|11361468|FG001|COMPLETED|Overall Study||0
9763475|NCT00397943|10867656|FG001|COMPLETED|Overall Study||31
9763476|NCT00397943|10867657|FG002|COMPLETED|Overall Study||10
9763477|NCT00397943|10867658|FG003|COMPLETED|Overall Study||10
9763478|NCT00397943|10867659|FG004|COMPLETED|Overall Study||10
9763479|NCT00397943|10867655|FG000|NOT COMPLETED|Overall Study||12
9763480|NCT00397943|10867656|FG001|NOT COMPLETED|Overall Study||9
9763481|NCT00397943|10867657|FG002|NOT COMPLETED|Overall Study||0
9763482|NCT00397943|10867658|FG003|NOT COMPLETED|Overall Study||0
9763483|NCT00397943|10867659|FG004|NOT COMPLETED|Overall Study||0
9763484|NCT00397982|10867671|FG000|STARTED|Overall Study||17
9763485|NCT00397982|10867671|FG000|COMPLETED|Overall Study||13
9763486|NCT00397982|10867671|FG000|NOT COMPLETED|Overall Study||4
9763487|NCT00398047|10867676|FG000|STARTED|Overall Study||3
9763488|NCT00398047|10867676|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0
9763489|NCT00398047|10867676|FG000|NOT COMPLETED|Overall Study||3
9763490|NCT00398073|10867683|FG000|STARTED|Overall Study||18
9763491|NCT00398073|10867684|FG001|STARTED|Overall Study||17
9763492|NCT00398073|10867683|FG000|COMPLETED|Overall Study||17
9763493|NCT00398073|10867684|FG001|COMPLETED|Overall Study||17
9763494|NCT00398073|10867683|FG000|NOT COMPLETED|Overall Study||1
9763495|NCT00398073|10867684|FG001|NOT COMPLETED|Overall Study||0
9763496|NCT00398086|10867693|FG000|STARTED|Overall Study||20
9763497|NCT00398086|10867694|FG001|STARTED|Overall Study||44
9763498|NCT00398086|10867695|FG002|STARTED|Overall Study||3
9763499|NCT00398086|10867693|FG000|Phase 1, Dose Escalation Population|Overall Study||20
9763500|NCT00398086|10867694|FG001|Phase 1, Dose Escalation Population|Overall Study||7
9763501|NCT00398086|10867695|FG002|Phase 1, Dose Escalation Population|Overall Study||3
9763502|NCT00398086|10867693|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
9763503|NCT00398086|10867694|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
9763504|NCT00398086|10867695|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
9763505|NCT00398086|10867693|FG000|NOT COMPLETED|Overall Study||9
9763506|NCT00398086|10867694|FG001|NOT COMPLETED|Overall Study||23
9763507|NCT00398086|10867695|FG002|NOT COMPLETED|Overall Study||2
9763508|NCT00398112|10867703|FG000|STARTED|Overall Study||18
9763509|NCT00398112|10867703|FG000|COMPLETED|Overall Study||0
9763510|NCT00398112|10867703|FG000|NOT COMPLETED|Overall Study||18
9763511|NCT00398138|10867707|FG000|STARTED|Overall Study||12
9763512|NCT00398138|10867707|FG000|COMPLETED|Overall Study||10
9763513|NCT00398138|10867707|FG000|NOT COMPLETED|Overall Study||2
9763514|NCT00398216|10867716|FG000|STARTED|Overall Study||192
9763515|NCT00398216|10867717|FG001|STARTED|Overall Study||170
9763516|NCT00398216|10867718|FG002|STARTED|Overall Study||185
9763517|NCT00398216|10867719|FG003|STARTED|Overall Study||177
9763518|NCT00398216|10867720|FG004|STARTED|Overall Study||172
9763519|NCT00398216|10867716|FG000|COMPLETED|Overall Study||181
9763520|NCT00398216|10867717|FG001|COMPLETED|Overall Study||151
9763521|NCT00398216|10867718|FG002|COMPLETED|Overall Study||164
9763522|NCT00398216|10867719|FG003|COMPLETED|Overall Study||155
9763523|NCT00398216|10867720|FG004|COMPLETED|Overall Study||157
9763524|NCT00398216|10867716|FG000|NOT COMPLETED|Overall Study||11
9763525|NCT00398216|10867717|FG001|NOT COMPLETED|Overall Study||19
9763526|NCT00398216|10867718|FG002|NOT COMPLETED|Overall Study||21
9763527|NCT00398216|10867719|FG003|NOT COMPLETED|Overall Study||22
9763528|NCT00398216|10867720|FG004|NOT COMPLETED|Overall Study||15
9763529|NCT00398320|10867732|FG000|STARTED|Overall Study||40
9763530|NCT00398320|10867732|FG000|COMPLETED|Overall Study||34
9763531|NCT00398320|10867732|FG000|NOT COMPLETED|Overall Study||6
9763532|NCT00398398|10867736|FG000|STARTED|Overall Study||44
9763533|NCT00398398|10867736|FG000|COMPLETED|Overall Study||44
9763534|NCT00398398|10867736|FG000|NOT COMPLETED|Overall Study||0
9763535|NCT00398411|10867742|FG000|STARTED|Overall Study||34
9763536|NCT00398411|10867743|FG001|STARTED|Overall Study||32
10232256|NCT02284906|11361469|FG002|COMPLETED|Overall Study||0
9763537|NCT00398411|10867742|FG000|COMPLETED|Overall Study||34
9763538|NCT00398411|10867743|FG001|COMPLETED|Overall Study||31
9763539|NCT00398411|10867742|FG000|NOT COMPLETED|Overall Study||0
9763540|NCT00398411|10867743|FG001|NOT COMPLETED|Overall Study||1
9763541|NCT00398476|10867749|FG000|STARTED|Treatment Period 1||63
9763542|NCT00398476|10867750|FG001|STARTED|Treatment Period 1||64
9763543|NCT00398476|10867749|FG000|COMPLETED|Treatment Period 1||63
9763544|NCT00398476|10867750|FG001|COMPLETED|Treatment Period 1||64
9763545|NCT00398476|10867749|FG000|NOT COMPLETED|Treatment Period 1||0
9763546|NCT00398476|10867750|FG001|NOT COMPLETED|Treatment Period 1||0
10232257|NCT02284906|11361467|FG000|NOT COMPLETED|Overall Study||3
9763547|NCT00398476|10867749|FG000|STARTED|Washout Period (20 Minutes)||63
9763548|NCT00398476|10867750|FG001|STARTED|Washout Period (20 Minutes)||64
9763549|NCT00398476|10867749|FG000|COMPLETED|Washout Period (20 Minutes)||63
9763550|NCT00398476|10867750|FG001|COMPLETED|Washout Period (20 Minutes)||64
9763551|NCT00398476|10867749|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0
9763552|NCT00398476|10867750|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0
9763553|NCT00398476|10867749|FG000|STARTED|Treatment Period 2||63
9763554|NCT00398476|10867750|FG001|STARTED|Treatment Period 2||64
9763555|NCT00398476|10867749|FG000|COMPLETED|Treatment Period 2||63
9763556|NCT00398476|10867750|FG001|COMPLETED|Treatment Period 2||64
9763557|NCT00398476|10867749|FG000|NOT COMPLETED|Treatment Period 2||0
9763558|NCT00398476|10867750|FG001|NOT COMPLETED|Treatment Period 2||0
9763559|NCT00398567|10867761|FG000|STARTED|Overall Study||4
9763560|NCT00398567|10867762|FG001|STARTED|Overall Study||4
9763561|NCT00398567|10867763|FG002|STARTED|Overall Study||37
9763562|NCT00398567|10867761|FG000|COMPLETED|Overall Study||0
9763563|NCT00398567|10867762|FG001|COMPLETED|Overall Study||0
9763564|NCT00398567|10867763|FG002|COMPLETED|Overall Study||3
9763565|NCT00398567|10867761|FG000|NOT COMPLETED|Overall Study||4
9763566|NCT00398567|10867762|FG001|NOT COMPLETED|Overall Study||4
9763567|NCT00398567|10867763|FG002|NOT COMPLETED|Overall Study||34
9763568|NCT00398632|10867769|FG000|STARTED|Overall Study||6
9763569|NCT00398632|10867769|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
9763570|NCT00398632|10867769|FG000|NOT COMPLETED|Overall Study||2
9763571|NCT00398866|10867777|FG000|STARTED|Overall Study||66
9763572|NCT00398866|10867778|FG001|STARTED|Overall Study||68
9763573|NCT00398866|10867779|FG002|STARTED|Overall Study||66
9763574|NCT00398866|10867777|FG000|COMPLETED|Overall Study||52
9763575|NCT00398866|10867778|FG001|COMPLETED|Overall Study||60
9763576|NCT00398866|10867779|FG002|COMPLETED|Overall Study||58
9763577|NCT00398866|10867777|FG000|NOT COMPLETED|Overall Study||14
9763578|NCT00398866|10867778|FG001|NOT COMPLETED|Overall Study||8
9763579|NCT00398866|10867779|FG002|NOT COMPLETED|Overall Study||8
9763580|NCT00398918|10867788|FG000|STARTED|Overall Study||10
9763581|NCT00398918|10867788|FG000|COMPLETED|Overall Study||10
9763582|NCT00398918|10867788|FG000|NOT COMPLETED|Overall Study||0
9763583|NCT00398983|10867794|FG000|STARTED|Overall Study||20
9763584|NCT00398983|10867795|FG001|STARTED|Overall Study||25
9763585|NCT00398983|10867794|FG000|COMPLETED|Overall Study||20
9763586|NCT00398983|10867795|FG001|COMPLETED|Overall Study||25
9763587|NCT00398983|10867794|FG000|NOT COMPLETED|Overall Study||0
9763588|NCT00398983|10867795|FG001|NOT COMPLETED|Overall Study||0
9763589|NCT00399035|10867804|FG000|STARTED|Overall Study||502
9763590|NCT00399035|10867805|FG001|STARTED|Overall Study||216
9763591|NCT00399035|10867806|FG002|STARTED|Overall Study||358
9763592|NCT00399035|10867804|FG000|COMPLETED|Overall Study||189
9763593|NCT00399035|10867805|FG001|COMPLETED|Overall Study||58
9763594|NCT00399035|10867806|FG002|COMPLETED|Overall Study||106
9763595|NCT00399035|10867804|FG000|NOT COMPLETED|Overall Study||313
9763596|NCT00399035|10867805|FG001|NOT COMPLETED|Overall Study||158
9763597|NCT00399035|10867806|FG002|NOT COMPLETED|Overall Study||252
9763598|NCT00399308|10867816|FG000|STARTED|Overall Study||13
9763599|NCT00399308|10867817|FG001|STARTED|Overall Study||15
9763600|NCT00399308|10867818|FG002|STARTED|Overall Study||12
9763601|NCT00399308|10867816|FG000|COMPLETED|Overall Study||13
9763602|NCT00399308|10867817|FG001|COMPLETED|Overall Study||15
9763603|NCT00399308|10867818|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
9763604|NCT00399308|10867816|FG000|NOT COMPLETED|Overall Study||0
9763605|NCT00399308|10867817|FG001|NOT COMPLETED|Overall Study||0
9763606|NCT00399308|10867818|FG002|NOT COMPLETED|Overall Study||1
9763607|NCT00399360|10867830|FG000|STARTED|Overall Study||11
9763608|NCT00399360|10867831|FG001|STARTED|Overall Study||11
9763609|NCT00399360|10867832|FG002|STARTED|Overall Study||13
9763610|NCT00399360|10867833|FG003|STARTED|Overall Study||15
9763611|NCT00399360|10867830|FG000|COMPLETED|Overall Study||9
9763612|NCT00399360|10867831|FG001|COMPLETED|Overall Study||8
9763613|NCT00399360|10867832|FG002|COMPLETED|Overall Study||10
9763614|NCT00399360|10867833|FG003|COMPLETED|Overall Study||9
9763615|NCT00399360|10867830|FG000|NOT COMPLETED|Overall Study||2
9763616|NCT00399360|10867831|FG001|NOT COMPLETED|Overall Study||3
9763617|NCT00399360|10867832|FG002|NOT COMPLETED|Overall Study||3
10013779|NCT01794780|11136718|FG005|STARTED|Overall Study||632
10013780|NCT01794780|11136719|FG006|STARTED|Overall Study||154
10013781|NCT01794780|11136720|FG007|STARTED|Overall Study||30
10013782|NCT01794780|11136713|FG000|COMPLETED|Overall Study||15
10013783|NCT01794780|11136714|FG001|COMPLETED|Overall Study||180
9763618|NCT00399360|10867833|FG003|NOT COMPLETED|Overall Study||6
9763619|NCT00399490|10867848|FG000|STARTED|Overall Study||281
9763620|NCT00399490|10867848|FG000|COMPLETED|Overall Study||183
9763621|NCT00399490|10867848|FG000|NOT COMPLETED|Overall Study||98
9763622|NCT00399516|10867854|FG000|STARTED|Overall Study||21
9763623|NCT00399516|10867854|FG000|COMPLETED|Overall Study||19
9763624|NCT00399516|10867854|FG000|NOT COMPLETED|Overall Study||2
9763625|NCT00399529|10867858|FG000|STARTED|Overall Study||22
9763626|NCT00399529|10867858|FG000|COMPLETED|Overall Study||20
9763627|NCT00399529|10867858|FG000|NOT COMPLETED|Overall Study||2
9763628|NCT00399542|10867865|FG000|STARTED|Overall Study||387
9763629|NCT00399542|10867866|FG001|STARTED|Overall Study||194
10013784|NCT01794780|11136715|FG002|COMPLETED|Overall Study||571
9763630|NCT00399542|10867865|FG000|COMPLETED|Overall Study||303
10013785|NCT01794780|11136716|FG003|COMPLETED|Overall Study||200
9763631|NCT00399542|10867866|FG001|COMPLETED|Overall Study||151
9763632|NCT00399542|10867865|FG000|NOT COMPLETED|Overall Study||84
9763633|NCT00399542|10867866|FG001|NOT COMPLETED|Overall Study||43
9763634|NCT00399568|10867874|FG000|STARTED|Overall Study||166
9763635|NCT00399568|10867875|FG001|STARTED|Overall Study||165
9763636|NCT00399568|10867874|FG000|COMPLETED|Overall Study||154
9763637|NCT00399568|10867875|FG001|COMPLETED|Overall Study||156
9763638|NCT00399568|10867874|FG000|NOT COMPLETED|Overall Study||12
9763639|NCT00399568|10867875|FG001|NOT COMPLETED|Overall Study||9
9763640|NCT00399763|10867885|FG000|STARTED|Overall Study||35
9763641|NCT00399763|10867886|FG001|STARTED|Overall Study||35
9763642|NCT00399763|10867885|FG000|COMPLETED|Overall Study||33
9763643|NCT00399763|10867886|FG001|COMPLETED|Overall Study||32
9763644|NCT00399763|10867885|FG000|NOT COMPLETED|Overall Study||2
9763645|NCT00399763|10867886|FG001|NOT COMPLETED|Overall Study||3
9763646|NCT00399802|10867894|FG000|STARTED|Overall Study||14
9763647|NCT00399802|10867895|FG001|STARTED|Overall Study||29
9763648|NCT00399802|10867894|FG000|COMPLETED|Overall Study||14
9763649|NCT00399802|10867895|FG001|COMPLETED|Overall Study||26
9763650|NCT00399802|10867894|FG000|NOT COMPLETED|Overall Study||0
9763651|NCT00399802|10867895|FG001|NOT COMPLETED|Overall Study||3
9763652|NCT00399880|10867903|FG000|STARTED|Overall Study||65
9763653|NCT00399880|10867904|FG001|STARTED|Overall Study||65
9763654|NCT00399880|10867903|FG000|COMPLETED|Overall Study||65
9763655|NCT00399880|10867904|FG001|COMPLETED|Overall Study||65
9763656|NCT00399880|10867903|FG000|NOT COMPLETED|Overall Study||0
9763657|NCT00399880|10867904|FG001|NOT COMPLETED|Overall Study||0
9763658|NCT00399893|10867912|FG000|STARTED|Overall Study||2
9763659|NCT00399893|10867913|FG001|STARTED|Overall Study||3
9763660|NCT00399893|10867912|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
9763661|NCT00399893|10867913|FG001|COMPLETED|Overall Study||3
9763662|NCT00399893|10867912|FG000|NOT COMPLETED|Overall Study||1
9763663|NCT00399893|10867913|FG001|NOT COMPLETED|Overall Study||0
9763664|NCT00400153|10867922|FG000|STARTED|Overall Study||486
9763665|NCT00400153|10867923|FG001|STARTED|Overall Study||491
9763666|NCT00400153|10867924|FG002|STARTED|Overall Study||483
9763667|NCT00400153|10867922|FG000|COMPLETED|Overall Study||438
9763668|NCT00400153|10867923|FG001|COMPLETED|Overall Study||436
9763669|NCT00400153|10867924|FG002|COMPLETED|Overall Study||422
10013786|NCT01794780|11136717|FG004|COMPLETED|Overall Study||6
10013787|NCT01794780|11136718|FG005|COMPLETED|Overall Study||452
10013788|NCT01794780|11136719|FG006|COMPLETED|Overall Study||112
10013789|NCT01794780|11136720|FG007|COMPLETED|Overall Study||21
10013790|NCT01794780|11136713|FG000|NOT COMPLETED|Overall Study||17
10013791|NCT01794780|11136714|FG001|NOT COMPLETED|Overall Study||96
10013792|NCT01794780|11136715|FG002|NOT COMPLETED|Overall Study||242
10013793|NCT01794780|11136716|FG003|NOT COMPLETED|Overall Study||83
10013794|NCT01794780|11136717|FG004|NOT COMPLETED|Overall Study||3
10013795|NCT01794780|11136718|FG005|NOT COMPLETED|Overall Study||180
10013796|NCT01794780|11136719|FG006|NOT COMPLETED|Overall Study||42
10013797|NCT01794780|11136720|FG007|NOT COMPLETED|Overall Study||9
10013798|NCT01794806|11136747|FG000|STARTED|Overall Study||31
10013799|NCT01794806|11136748|FG001|STARTED|Overall Study||28
10013800|NCT01794806|11136747|FG000|1 Week|Overall Study||28
10013801|NCT01794806|11136748|FG001|1 Week|Overall Study||28
10013802|NCT01794806|11136747|FG000|4 Weeks|Overall Study||26
10013803|NCT01794806|11136748|FG001|4 Weeks|Overall Study||27
10013804|NCT01794806|11136747|FG000|COMPLETED|Overall Study||26
10013805|NCT01794806|11136748|FG001|COMPLETED|Overall Study||27
10013806|NCT01794806|11136747|FG000|NOT COMPLETED|Overall Study||5
10013807|NCT01794806|11136748|FG001|NOT COMPLETED|Overall Study||1
10013808|NCT01794845|11136754|FG000|STARTED|Overall Study||5
10013809|NCT01794845|11136754|FG000|COMPLETED|Overall Study||4
10013810|NCT01794845|11136754|FG000|NOT COMPLETED|Overall Study||1
10013811|NCT01794923|11136761|FG000|STARTED|Overall Study||83
10013812|NCT01794923|11136762|FG001|STARTED|Overall Study||60
10013813|NCT01794923|11136763|FG002|STARTED|Overall Study||62
10013814|NCT01794923|11136761|FG000|COMPLETED|Overall Study||83
10013815|NCT01794923|11136762|FG001|COMPLETED|Overall Study||60
10013816|NCT01794923|11136763|FG002|COMPLETED|Overall Study||61
10013817|NCT01794923|11136761|FG000|NOT COMPLETED|Overall Study||0
10013818|NCT01794923|11136762|FG001|NOT COMPLETED|Overall Study||0
10013819|NCT01794923|11136763|FG002|NOT COMPLETED|Overall Study||1
10013820|NCT01794949|11136773|FG000|STARTED|Overall Study||7
10013821|NCT01794949|11136774|FG001|STARTED|Overall Study||1
10013822|NCT01794949|11136773|FG000|6 Month Follow-up|Overall Study||6
10013823|NCT01794949|11136774|FG001|6 Month Follow-up|Overall Study||1
10013824|NCT01794949|11136773|FG000|COMPLETED|Overall Study||6
10013825|NCT01794949|11136774|FG001|COMPLETED|Overall Study||1
10013826|NCT01794949|11136773|FG000|NOT COMPLETED|Overall Study||1
10013827|NCT01794949|11136774|FG001|NOT COMPLETED|Overall Study||0
10013828|NCT01795079|11136782|FG000|STARTED|Overall Study||16
9763670|NCT00400153|10867922|FG000|NOT COMPLETED|Overall Study||48
9763671|NCT00400153|10867923|FG001|NOT COMPLETED|Overall Study||55
9763672|NCT00400153|10867924|FG002|NOT COMPLETED|Overall Study||61
9763673|NCT00400179|10867939|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527
9763674|NCT00400179|10867940|FG001|STARTED|Overall Study||526
9763675|NCT00400179|10867939|FG000|COMPLETED|Overall Study|Received Treatment|521
9763676|NCT00400179|10867940|FG001|COMPLETED|Overall Study||508
10013829|NCT01795079|11136783|FG001|STARTED|Overall Study||15
10013830|NCT01795079|11136782|FG000|COMPLETED|Overall Study||13
10013831|NCT01795079|11136783|FG001|COMPLETED|Overall Study||12
10013832|NCT01795079|11136782|FG000|NOT COMPLETED|Overall Study||3
10013833|NCT01795079|11136783|FG001|NOT COMPLETED|Overall Study||3
10013834|NCT01795105|11136789|FG000|STARTED|Overall Study||692
10013835|NCT01795105|11136789|FG000|COMPLETED|Overall Study||648
10013836|NCT01795105|11136789|FG000|NOT COMPLETED|Overall Study||44
10013837|NCT01795495|11136797|FG000|STARTED|Overall Study||20
10013838|NCT01795495|11136798|FG001|STARTED|Overall Study||22
9763677|NCT00400179|10867939|FG000|NOT COMPLETED|Overall Study||6
9763678|NCT00400179|10867940|FG001|NOT COMPLETED|Overall Study||18
9763679|NCT00400205|10867946|FG000|STARTED|Overall Study||14
9763680|NCT00400205|10867946|FG000|COMPLETED|Overall Study||9
9763681|NCT00400205|10867946|FG000|NOT COMPLETED|Overall Study||5
9763682|NCT00400400|10867953|FG000|STARTED|Overall Study||200
9763683|NCT00400400|10867954|FG001|STARTED|Overall Study||200
9763684|NCT00400400|10867953|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
9763685|NCT00400400|10867954|FG001|Intent-to-Treat Population|Overall Study||197
9763686|NCT00400400|10867953|FG000|COMPLETED|Overall Study||186
9763687|NCT00400400|10867954|FG001|COMPLETED|Overall Study||185
9763688|NCT00400400|10867953|FG000|NOT COMPLETED|Overall Study||14
9763689|NCT00400400|10867954|FG001|NOT COMPLETED|Overall Study||15
9763690|NCT00400439|10867962|FG000|STARTED|Overall Study||52
9763691|NCT00400439|10867963|FG001|STARTED|Overall Study||25
9763692|NCT00400439|10867962|FG000|COMPLETED|Overall Study||47
9763693|NCT00400439|10867963|FG001|COMPLETED|Overall Study||23
9763694|NCT00400439|10867962|FG000|NOT COMPLETED|Overall Study||5
9763695|NCT00400439|10867963|FG001|NOT COMPLETED|Overall Study||2
9763696|NCT00400517|10867969|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
9763697|NCT00400517|10867969|FG000|COMPLETED|Overall Study||26
9763698|NCT00400517|10867969|FG000|NOT COMPLETED|Overall Study||2
9763699|NCT00400569|10867973|FG000|STARTED|Overall Study||48
9763700|NCT00400569|10867973|FG000|COMPLETED|Overall Study||47
9763701|NCT00400569|10867973|FG000|NOT COMPLETED|Overall Study||1
9763702|NCT00400634|10867982|FG000|STARTED|Overall Study||38
9763703|NCT00400634|10867983|FG001|STARTED|Overall Study||20
9763704|NCT00400634|10867982|FG000|COMPLETED|Overall Study||34
9763705|NCT00400634|10867983|FG001|COMPLETED|Overall Study||19
9763706|NCT00400634|10867982|FG000|NOT COMPLETED|Overall Study||4
9763707|NCT00400634|10867983|FG001|NOT COMPLETED|Overall Study||1
9763708|NCT00400686|10867989|FG000|STARTED|Overall Study||31
9763709|NCT00400686|10867989|FG000|COMPLETED|Overall Study||31
9763710|NCT00400686|10867989|FG000|NOT COMPLETED|Overall Study||0
9763711|NCT00400712|10867995|FG000|STARTED|Overall Study||52
9763712|NCT00400712|10867996|FG001|STARTED|Overall Study||51
9763713|NCT00400712|10867995|FG000|COMPLETED|Overall Study||35
9763714|NCT00400712|10867996|FG001|COMPLETED|Overall Study||35
9763715|NCT00400712|10867995|FG000|NOT COMPLETED|Overall Study||17
9763716|NCT00400712|10867996|FG001|NOT COMPLETED|Overall Study||16
9763717|NCT00400764|10868009|FG000|STARTED|Phase Ib||6
9763718|NCT00400764|10868010|FG001|STARTED|Phase Ib||6
9763719|NCT00400764|10868011|FG002|STARTED|Phase Ib||0
9763720|NCT00400764|10868012|FG003|STARTED|Phase Ib||0
9763721|NCT00400764|10868013|FG004|STARTED|Phase Ib||0
9763722|NCT00400764|10868009|FG000|Treated|Phase Ib||6
9763723|NCT00400764|10868010|FG001|Treated|Phase Ib||6
9763724|NCT00400764|10868011|FG002|Treated|Phase Ib||0
9763725|NCT00400764|10868012|FG003|Treated|Phase Ib||0
9763726|NCT00400764|10868013|FG004|Treated|Phase Ib||0
9763727|NCT00400764|10868009|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
9763728|NCT00400764|10868010|FG001|COMPLETED|Phase Ib||2
9763729|NCT00400764|10868011|FG002|COMPLETED|Phase Ib||0
9763730|NCT00400764|10868012|FG003|COMPLETED|Phase Ib||0
9763731|NCT00400764|10868013|FG004|COMPLETED|Phase Ib||0
9763732|NCT00400764|10868009|FG000|NOT COMPLETED|Phase Ib||6
9763733|NCT00400764|10868010|FG001|NOT COMPLETED|Phase Ib||4
9763734|NCT00400764|10868011|FG002|NOT COMPLETED|Phase Ib||0
9763735|NCT00400764|10868012|FG003|NOT COMPLETED|Phase Ib||0
9763736|NCT00400764|10868013|FG004|NOT COMPLETED|Phase Ib||0
9763737|NCT00400764|10868009|FG000|STARTED|Phase II||0
9763738|NCT00400764|10868010|FG001|STARTED|Phase II||0
9763739|NCT00400764|10868011|FG002|STARTED|Phase II||23
9763740|NCT00400764|10868012|FG003|STARTED|Phase II||26
9763741|NCT00400764|10868013|FG004|STARTED|Phase II||11
9763742|NCT00400764|10868009|FG000|Treated|Phase II||0
9763743|NCT00400764|10868010|FG001|Treated|Phase II||0
9763744|NCT00400764|10868011|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
9763745|NCT00400764|10868012|FG003|Treated|Phase II||26
9763746|NCT00400764|10868013|FG004|Treated|Phase II||11
9763747|NCT00400764|10868009|FG000|COMPLETED|Phase II||0
9763748|NCT00400764|10868010|FG001|COMPLETED|Phase II||0
9763749|NCT00400764|10868011|FG002|COMPLETED|Phase II||0
10013839|NCT01795495|11136799|FG002|STARTED|Overall Study||21
10013840|NCT01795495|11136797|FG000|COMPLETED|Overall Study||19
9763750|NCT00400764|10868012|FG003|COMPLETED|Phase II||0
9763751|NCT00400764|10868013|FG004|COMPLETED|Phase II||0
9763752|NCT00400764|10868009|FG000|NOT COMPLETED|Phase II||0
9763753|NCT00400764|10868010|FG001|NOT COMPLETED|Phase II||0
9763754|NCT00400764|10868011|FG002|NOT COMPLETED|Phase II||23
9763755|NCT00400764|10868012|FG003|NOT COMPLETED|Phase II||26
9763756|NCT00400764|10868013|FG004|NOT COMPLETED|Phase II||11
10013841|NCT01795495|11136798|FG001|COMPLETED|Overall Study||22
9763757|NCT00400803|10868030|FG000|STARTED|Overall Study||35
9763758|NCT00400803|10868030|FG000|COMPLETED|Overall Study||35
9763759|NCT00400803|10868030|FG000|NOT COMPLETED|Overall Study||0
9763760|NCT00400829|10868038|FG000|STARTED|Overall Study||66
9763761|NCT00400829|10868038|FG000|COMPLETED|Overall Study||66
9763762|NCT00400829|10868038|FG000|NOT COMPLETED|Overall Study||0
9763763|NCT00400881|10868044|FG000|STARTED|Overall Study||62
9763764|NCT00400881|10868045|FG001|STARTED|Overall Study||60
9763765|NCT00400881|10868044|FG000|COMPLETED|Overall Study||62
9763766|NCT00400881|10868045|FG001|COMPLETED|Overall Study||60
9763767|NCT00400881|10868044|FG000|NOT COMPLETED|Overall Study||0
9763768|NCT00400881|10868045|FG001|NOT COMPLETED|Overall Study||0
9763769|NCT00400985|10868052|FG000|STARTED|Overall Study||501
9763770|NCT00400985|10868052|FG000|COMPLETED|Overall Study||449
9763771|NCT00400985|10868052|FG000|NOT COMPLETED|Overall Study||52
9763772|NCT00401102|10868056|FG000|STARTED|Overall Study||12
9763773|NCT00401102|10868056|FG000|COMPLETED|Overall Study||5
9763774|NCT00401102|10868056|FG000|NOT COMPLETED|Overall Study||7
9763775|NCT00401193|10868063|FG000|STARTED|Overall Study||118
9763776|NCT00401193|10868064|FG001|STARTED|Overall Study||117
9763777|NCT00401193|10868065|FG002|STARTED|Overall Study||69
9763778|NCT00401193|10868063|FG000|Intent to Treat Population|Overall Study||115
9763779|NCT00401193|10868064|FG001|Intent to Treat Population|Overall Study||115
9763780|NCT00401193|10868065|FG002|Intent to Treat Population|Overall Study||67
9763781|NCT00401193|10868063|FG000|Modified Intent to Treat Population|Overall Study||112
9763782|NCT00401193|10868064|FG001|Modified Intent to Treat Population|Overall Study||115
9763783|NCT00401193|10868065|FG002|Modified Intent to Treat Population|Overall Study||67
9763784|NCT00401193|10868063|FG000|COMPLETED|Overall Study||103
9763785|NCT00401193|10868064|FG001|COMPLETED|Overall Study||106
9763786|NCT00401193|10868065|FG002|COMPLETED|Overall Study||63
9763787|NCT00401193|10868063|FG000|NOT COMPLETED|Overall Study||15
9763788|NCT00401193|10868064|FG001|NOT COMPLETED|Overall Study||11
9763789|NCT00401193|10868065|FG002|NOT COMPLETED|Overall Study||6
9763790|NCT00401245|10868078|FG000|STARTED|Double Blind Titration Phase||126
9763791|NCT00401245|10868079|FG001|STARTED|Double Blind Titration Phase||121
9763792|NCT00401245|10868080|FG002|STARTED|Double Blind Titration Phase||124
9763793|NCT00401245|10868081|FG003|STARTED|Double Blind Titration Phase||122
9763794|NCT00401245|10868082|FG004|STARTED|Double Blind Titration Phase||0
9763795|NCT00401245|10868083|FG005|STARTED|Double Blind Titration Phase||0
9763796|NCT00401245|10868084|FG006|STARTED|Double Blind Titration Phase||0
9763797|NCT00401245|10868085|FG007|STARTED|Double Blind Titration Phase||0
9763798|NCT00401245|10868078|FG000|COMPLETED|Double Blind Titration Phase||122
9763799|NCT00401245|10868079|FG001|COMPLETED|Double Blind Titration Phase||118
9763800|NCT00401245|10868080|FG002|COMPLETED|Double Blind Titration Phase||118
9763801|NCT00401245|10868081|FG003|COMPLETED|Double Blind Titration Phase||107
9763802|NCT00401245|10868082|FG004|COMPLETED|Double Blind Titration Phase||0
9763803|NCT00401245|10868083|FG005|COMPLETED|Double Blind Titration Phase||0
9763804|NCT00401245|10868084|FG006|COMPLETED|Double Blind Titration Phase||0
9763805|NCT00401245|10868085|FG007|COMPLETED|Double Blind Titration Phase||0
9763806|NCT00401245|10868078|FG000|NOT COMPLETED|Double Blind Titration Phase||4
9763807|NCT00401245|10868079|FG001|NOT COMPLETED|Double Blind Titration Phase||3
9763808|NCT00401245|10868080|FG002|NOT COMPLETED|Double Blind Titration Phase||6
9763809|NCT00401245|10868081|FG003|NOT COMPLETED|Double Blind Titration Phase||15
9763810|NCT00401245|10868082|FG004|NOT COMPLETED|Double Blind Titration Phase||0
9763811|NCT00401245|10868083|FG005|NOT COMPLETED|Double Blind Titration Phase||0
9763812|NCT00401245|10868084|FG006|NOT COMPLETED|Double Blind Titration Phase||0
9763813|NCT00401245|10868085|FG007|NOT COMPLETED|Double Blind Titration Phase||0
9763814|NCT00401245|10868078|FG000|STARTED|Between Titration and Open Label Phase||122
9763815|NCT00401245|10868079|FG001|STARTED|Between Titration and Open Label Phase||118
9763816|NCT00401245|10868080|FG002|STARTED|Between Titration and Open Label Phase||118
9763817|NCT00401245|10868081|FG003|STARTED|Between Titration and Open Label Phase||107
9763818|NCT00401245|10868082|FG004|STARTED|Between Titration and Open Label Phase||0
9763819|NCT00401245|10868083|FG005|STARTED|Between Titration and Open Label Phase||0
9763820|NCT00401245|10868084|FG006|STARTED|Between Titration and Open Label Phase||0
9763821|NCT00401245|10868085|FG007|STARTED|Between Titration and Open Label Phase||0
9763822|NCT00401245|10868078|FG000|COMPLETED|Between Titration and Open Label Phase||122
9763823|NCT00401245|10868079|FG001|COMPLETED|Between Titration and Open Label Phase||116
9763824|NCT00401245|10868080|FG002|COMPLETED|Between Titration and Open Label Phase||118
9763825|NCT00401245|10868081|FG003|COMPLETED|Between Titration and Open Label Phase||105
9763826|NCT00401245|10868082|FG004|COMPLETED|Between Titration and Open Label Phase||0
9763827|NCT00401245|10868083|FG005|COMPLETED|Between Titration and Open Label Phase||0
9763828|NCT00401245|10868084|FG006|COMPLETED|Between Titration and Open Label Phase||0
9763829|NCT00401245|10868085|FG007|COMPLETED|Between Titration and Open Label Phase||0
9763830|NCT00401245|10868078|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0
9763831|NCT00401245|10868079|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2
9763832|NCT00401245|10868080|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0
9763833|NCT00401245|10868081|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2
9763834|NCT00401245|10868082|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0
9763835|NCT00401245|10868083|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0
9763836|NCT00401245|10868084|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0
9763837|NCT00401245|10868085|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0
9763838|NCT00401245|10868078|FG000|STARTED|Open Label Phase||122
9763839|NCT00401245|10868079|FG001|STARTED|Open Label Phase||116
9763840|NCT00401245|10868080|FG002|STARTED|Open Label Phase||118
9763841|NCT00401245|10868081|FG003|STARTED|Open Label Phase||105
9763842|NCT00401245|10868082|FG004|STARTED|Open Label Phase||0
9763843|NCT00401245|10868083|FG005|STARTED|Open Label Phase||0
9763844|NCT00401245|10868084|FG006|STARTED|Open Label Phase||0
9763845|NCT00401245|10868085|FG007|STARTED|Open Label Phase||0
9763846|NCT00401245|10868078|FG000|COMPLETED|Open Label Phase||101
9763847|NCT00401245|10868079|FG001|COMPLETED|Open Label Phase||81
9763848|NCT00401245|10868080|FG002|COMPLETED|Open Label Phase||95
9763849|NCT00401245|10868081|FG003|COMPLETED|Open Label Phase||84
9763850|NCT00401245|10868082|FG004|COMPLETED|Open Label Phase||0
9763851|NCT00401245|10868083|FG005|COMPLETED|Open Label Phase||0
9763852|NCT00401245|10868084|FG006|COMPLETED|Open Label Phase||0
9763853|NCT00401245|10868085|FG007|COMPLETED|Open Label Phase||0
9763854|NCT00401245|10868078|FG000|NOT COMPLETED|Open Label Phase||21
9763855|NCT00401245|10868079|FG001|NOT COMPLETED|Open Label Phase||35
9763856|NCT00401245|10868080|FG002|NOT COMPLETED|Open Label Phase||23
9763857|NCT00401245|10868081|FG003|NOT COMPLETED|Open Label Phase||21
9763858|NCT00401245|10868082|FG004|NOT COMPLETED|Open Label Phase||0
9763859|NCT00401245|10868083|FG005|NOT COMPLETED|Open Label Phase||0
9763860|NCT00401245|10868084|FG006|NOT COMPLETED|Open Label Phase||0
9763861|NCT00401245|10868085|FG007|NOT COMPLETED|Open Label Phase||0
9763862|NCT00401245|10868078|FG000|STARTED|Double Blind Tapering Phase||0
9763863|NCT00401245|10868079|FG001|STARTED|Double Blind Tapering Phase||0
9763864|NCT00401245|10868080|FG002|STARTED|Double Blind Tapering Phase||0
9763865|NCT00401245|10868081|FG003|STARTED|Double Blind Tapering Phase||0
9763866|NCT00401245|10868082|FG004|STARTED|Double Blind Tapering Phase||101
9763867|NCT00401245|10868083|FG005|STARTED|Double Blind Tapering Phase||94
9763868|NCT00401245|10868084|FG006|STARTED|Double Blind Tapering Phase||87
9763869|NCT00401245|10868085|FG007|STARTED|Double Blind Tapering Phase||102
9763870|NCT00401245|10868078|FG000|COMPLETED|Double Blind Tapering Phase||0
9763871|NCT00401245|10868079|FG001|COMPLETED|Double Blind Tapering Phase||0
9763872|NCT00401245|10868080|FG002|COMPLETED|Double Blind Tapering Phase||0
9763873|NCT00401245|10868081|FG003|COMPLETED|Double Blind Tapering Phase||0
9763874|NCT00401245|10868082|FG004|COMPLETED|Double Blind Tapering Phase||97
9763875|NCT00401245|10868083|FG005|COMPLETED|Double Blind Tapering Phase||90
9763876|NCT00401245|10868084|FG006|COMPLETED|Double Blind Tapering Phase||80
9763877|NCT00401245|10868085|FG007|COMPLETED|Double Blind Tapering Phase||95
9763878|NCT00401245|10868078|FG000|NOT COMPLETED|Double Blind Tapering Phase||0
9763879|NCT00401245|10868079|FG001|NOT COMPLETED|Double Blind Tapering Phase||0
9763880|NCT00401245|10868080|FG002|NOT COMPLETED|Double Blind Tapering Phase||0
9763881|NCT00401245|10868081|FG003|NOT COMPLETED|Double Blind Tapering Phase||0
9763882|NCT00401245|10868082|FG004|NOT COMPLETED|Double Blind Tapering Phase||4
9763883|NCT00401245|10868083|FG005|NOT COMPLETED|Double Blind Tapering Phase||4
9763884|NCT00401245|10868084|FG006|NOT COMPLETED|Double Blind Tapering Phase||7
9763885|NCT00401245|10868085|FG007|NOT COMPLETED|Double Blind Tapering Phase||7
9763886|NCT00401258|10868105|FG000|STARTED|Overall Study||15
9763887|NCT00401258|10868105|FG000|COMPLETED|Overall Study||8
9763888|NCT00401258|10868105|FG000|NOT COMPLETED|Overall Study||7
9763889|NCT00401375|10868112|FG000|STARTED|Overall Study||174
9763890|NCT00401375|10868113|FG001|STARTED|Overall Study||176
9763891|NCT00401375|10868114|FG002|STARTED|Overall Study||174
9763892|NCT00401375|10868112|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171
9763893|NCT00401375|10868113|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173
9763894|NCT00401375|10868114|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171
9763895|NCT00401375|10868112|FG000|COMPLETED|Overall Study||152
9763896|NCT00401375|10868113|FG001|COMPLETED|Overall Study||151
9763897|NCT00401375|10868114|FG002|COMPLETED|Overall Study||149
9763898|NCT00401375|10868112|FG000|NOT COMPLETED|Overall Study||22
9763899|NCT00401375|10868113|FG001|NOT COMPLETED|Overall Study||25
9763900|NCT00401375|10868114|FG002|NOT COMPLETED|Overall Study||25
9763901|NCT00401401|10868126|FG000|STARTED|Overall Study||6
9763902|NCT00401401|10868127|FG001|STARTED|Overall Study||6
9763903|NCT00401401|10868128|FG002|STARTED|Overall Study||6
9763904|NCT00401401|10868129|FG003|STARTED|Overall Study||12
9763905|NCT00401401|10868126|FG000|COMPLETED|Overall Study||6
9763906|NCT00401401|10868127|FG001|COMPLETED|Overall Study||6
9763907|NCT00401401|10868128|FG002|COMPLETED|Overall Study||5
9763908|NCT00401401|10868129|FG003|COMPLETED|Overall Study||9
9763909|NCT00401401|10868126|FG000|NOT COMPLETED|Overall Study||0
9763910|NCT00401401|10868127|FG001|NOT COMPLETED|Overall Study||0
9763911|NCT00401401|10868128|FG002|NOT COMPLETED|Overall Study||1
9763912|NCT00401401|10868129|FG003|NOT COMPLETED|Overall Study||3
9763913|NCT00401414|10868146|FG000|STARTED|Overall Study||118
9763914|NCT00401414|10868147|FG001|STARTED|Overall Study||147
9763915|NCT00401414|10868148|FG002|STARTED|Overall Study||79
9763916|NCT00401414|10868146|FG000|COMPLETED|Overall Study||118
9763917|NCT00401414|10868147|FG001|COMPLETED|Overall Study||147
9763918|NCT00401414|10868148|FG002|COMPLETED|Overall Study||79
9763919|NCT00401414|10868146|FG000|NOT COMPLETED|Overall Study||0
9763920|NCT00401414|10868147|FG001|NOT COMPLETED|Overall Study||0
9763921|NCT00401414|10868148|FG002|NOT COMPLETED|Overall Study||0
9763922|NCT00401518|10868161|FG000|STARTED|Overall Study||46
9763923|NCT00401518|10868162|FG001|STARTED|Overall Study||227
9763924|NCT00401518|10868163|FG002|STARTED|Overall Study||117
9763925|NCT00401518|10868161|FG000|COMPLETED|Overall Study||40
9763926|NCT00401518|10868162|FG001|COMPLETED|Overall Study||190
9763927|NCT00401518|10868163|FG002|COMPLETED|Overall Study||94
9763928|NCT00401518|10868161|FG000|NOT COMPLETED|Overall Study||6
9763929|NCT00401518|10868162|FG001|NOT COMPLETED|Overall Study||37
9763930|NCT00401518|10868163|FG002|NOT COMPLETED|Overall Study||23
9763931|NCT00401531|10868173|FG000|STARTED|Overall Study||206
9763932|NCT00401531|10868174|FG001|STARTED|Overall Study||206
9763933|NCT00401531|10868173|FG000|COMPLETED|Overall Study||197
9763934|NCT00401531|10868174|FG001|COMPLETED|Overall Study||196
9763935|NCT00401531|10868173|FG000|NOT COMPLETED|Overall Study||9
9763936|NCT00401531|10868174|FG001|NOT COMPLETED|Overall Study||10
9763937|NCT00401544|10868184|FG000|STARTED|Overall Study|Randomized and treated|56
9763938|NCT00401544|10868185|FG001|STARTED|Overall Study|Randomized and treated|62
9763939|NCT00401544|10868186|FG002|STARTED|Overall Study|Randomized and treated|60
9763940|NCT00401544|10868187|FG003|STARTED|Overall Study|Randomized and treated|60
9763941|NCT00401544|10868184|FG000|COMPLETED|Overall Study||38
9763942|NCT00401544|10868185|FG001|COMPLETED|Overall Study||44
9763943|NCT00401544|10868186|FG002|COMPLETED|Overall Study||48
9763944|NCT00401544|10868187|FG003|COMPLETED|Overall Study||44
9763945|NCT00401544|10868184|FG000|NOT COMPLETED|Overall Study||18
9763946|NCT00401544|10868185|FG001|NOT COMPLETED|Overall Study||18
9763947|NCT00401544|10868186|FG002|NOT COMPLETED|Overall Study||12
9763948|NCT00401544|10868187|FG003|NOT COMPLETED|Overall Study||16
9763949|NCT00401622|10868204|FG000|STARTED|Overall Study||160
9763950|NCT00401622|10868205|FG001|STARTED|Overall Study||160
9763951|NCT00401622|10868204|FG000|COMPLETED|Overall Study||126
9763952|NCT00401622|10868205|FG001|COMPLETED|Overall Study||117
9763953|NCT00401622|10868204|FG000|NOT COMPLETED|Overall Study||34
9763954|NCT00401622|10868205|FG001|NOT COMPLETED|Overall Study||43
9763955|NCT00401726|10868213|FG000|STARTED|Overall Study||269
9763956|NCT00401726|10868214|FG001|STARTED|Overall Study||268
9763957|NCT00401726|10868213|FG000|COMPLETED|Overall Study||172
9763958|NCT00401726|10868214|FG001|COMPLETED|Overall Study||156
9763959|NCT00401726|10868213|FG000|NOT COMPLETED|Overall Study||97
9763960|NCT00401726|10868214|FG001|NOT COMPLETED|Overall Study||112
9763961|NCT00401752|10868222|FG000|STARTED|Overall Study||107
9763962|NCT00401752|10868223|FG001|STARTED|Overall Study||112
9763963|NCT00401752|10868222|FG000|Number of Patients Received Treatment|Overall Study||107
9763964|NCT00401752|10868223|FG001|Number of Patients Received Treatment|Overall Study||111
9763965|NCT00401752|10868222|FG000|Patients Included in ITT Population|Overall Study||106
9763966|NCT00401752|10868223|FG001|Patients Included in ITT Population|Overall Study||111
9763967|NCT00401752|10868222|FG000|Patients Included in Safety Population|Overall Study||107
9763968|NCT00401752|10868223|FG001|Patients Included in Safety Population|Overall Study||110
9763969|NCT00401752|10868222|FG000|Patients Included in Per-Protocol Popula|Overall Study||100
9763970|NCT00401752|10868223|FG001|Patients Included in Per-Protocol Popula|Overall Study||99
9763971|NCT00401752|10868222|FG000|COMPLETED|Overall Study||97
9763972|NCT00401752|10868223|FG001|COMPLETED|Overall Study||94
9763973|NCT00401752|10868222|FG000|NOT COMPLETED|Overall Study||10
9763974|NCT00401752|10868223|FG001|NOT COMPLETED|Overall Study||18
9763975|NCT00401778|10868232|FG000|STARTED|Overall Study||10
9763976|NCT00401778|10868233|FG001|STARTED|Overall Study||12
9763977|NCT00401778|10868234|FG002|STARTED|Overall Study||11
9763978|NCT00401778|10868232|FG000|COMPLETED|Overall Study||9
9763979|NCT00401778|10868233|FG001|COMPLETED|Overall Study||11
9763980|NCT00401778|10868234|FG002|COMPLETED|Overall Study||10
9763981|NCT00401778|10868232|FG000|NOT COMPLETED|Overall Study||1
9763982|NCT00401778|10868233|FG001|NOT COMPLETED|Overall Study||1
9763983|NCT00401778|10868234|FG002|NOT COMPLETED|Overall Study||1
9763984|NCT00401817|10868242|FG000|STARTED|Overall Study||11
9763985|NCT00401817|10868242|FG000|COMPLETED|Overall Study||11
9763986|NCT00401817|10868242|FG000|NOT COMPLETED|Overall Study||0
9763987|NCT00401830|10868249|FG000|STARTED|Overall Study||81
9763988|NCT00401830|10868250|FG001|STARTED|Overall Study||78
9763989|NCT00401830|10868249|FG000|COMPLETED|Overall Study||50
9763990|NCT00401830|10868250|FG001|COMPLETED|Overall Study||46
9763991|NCT00401830|10868249|FG000|NOT COMPLETED|Overall Study||31
9763992|NCT00401830|10868250|FG001|NOT COMPLETED|Overall Study||32
9763993|NCT00401843|10868259|FG000|STARTED|Overall Study||21
9763994|NCT00401843|10868260|FG001|STARTED|Overall Study||144
9763995|NCT00401843|10868261|FG002|STARTED|Overall Study||142
9763996|NCT00401843|10868259|FG000|Treated|Overall Study||21
9763997|NCT00401843|10868260|FG001|Treated|Overall Study||142
9763998|NCT00401843|10868261|FG002|Treated|Overall Study||139
9763999|NCT00401843|10868259|FG000|COMPLETED|Overall Study||0
9764000|NCT00401843|10868260|FG001|COMPLETED|Overall Study||0
9764001|NCT00401843|10868261|FG002|COMPLETED|Overall Study||0
9764002|NCT00401843|10868259|FG000|NOT COMPLETED|Overall Study||21
9764003|NCT00401843|10868260|FG001|NOT COMPLETED|Overall Study||144
9764004|NCT00401843|10868261|FG002|NOT COMPLETED|Overall Study||142
9764005|NCT00401882|10868273|FG000|STARTED|Overall Study||2
9764006|NCT00401882|10868274|FG001|STARTED|Overall Study||5
9764007|NCT00401882|10868273|FG000|COMPLETED|Overall Study||2
9764008|NCT00401882|10868274|FG001|COMPLETED|Overall Study||5
9764009|NCT00401882|10868273|FG000|NOT COMPLETED|Overall Study||0
9764010|NCT00401882|10868274|FG001|NOT COMPLETED|Overall Study||0
9764011|NCT00401960|10868288|FG000|STARTED|Overall Study||5
9764012|NCT00401960|10868289|FG001|STARTED|Overall Study||1
9764013|NCT00401960|10868288|FG000|COMPLETED|Overall Study||0
9764014|NCT00401960|10868289|FG001|COMPLETED|Overall Study||1
9764015|NCT00401960|10868288|FG000|NOT COMPLETED|Overall Study||5
9764016|NCT00401960|10868289|FG001|NOT COMPLETED|Overall Study||0
9764017|NCT00401973|10868300|FG000|STARTED|Overall Study||50
9764018|NCT00401973|10868301|FG001|STARTED|Overall Study||76
9764019|NCT00401973|10868302|FG002|STARTED|Overall Study||73
9764020|NCT00401973|10868300|FG000|COMPLETED|Overall Study||39
9764021|NCT00401973|10868301|FG001|COMPLETED|Overall Study||50
9764022|NCT00401973|10868302|FG002|COMPLETED|Overall Study||50
9764023|NCT00401973|10868300|FG000|NOT COMPLETED|Overall Study||11
9764024|NCT00401973|10868301|FG001|NOT COMPLETED|Overall Study||26
9764025|NCT00401973|10868302|FG002|NOT COMPLETED|Overall Study||23
9764026|NCT00401986|10868312|FG000|STARTED|Overall Study||14
9764027|NCT00401986|10868312|FG000|COMPLETED|Overall Study||12
9764028|NCT00401986|10868312|FG000|NOT COMPLETED|Overall Study||2
9764029|NCT00402025|10868324|FG000|STARTED|Overall Study||3
9764030|NCT00402025|10868325|FG001|STARTED|Overall Study||4
9764031|NCT00402025|10868326|FG002|STARTED|Overall Study||10
9764032|NCT00402025|10868324|FG000|COMPLETED|Overall Study||1
9764033|NCT00402025|10868325|FG001|COMPLETED|Overall Study||1
9764034|NCT00402025|10868326|FG002|COMPLETED|Overall Study||0
9764035|NCT00402025|10868324|FG000|NOT COMPLETED|Overall Study||2
9764036|NCT00402025|10868325|FG001|NOT COMPLETED|Overall Study||3
9764037|NCT00402025|10868326|FG002|NOT COMPLETED|Overall Study||10
9764038|NCT00402051|10868336|FG000|STARTED|Overall Study||66
9764039|NCT00402051|10868337|FG001|STARTED|Overall Study||67
9764040|NCT00402051|10868336|FG000|Received Treatment|Overall Study||65
9764041|NCT00402051|10868337|FG001|Received Treatment|Overall Study||65
9764042|NCT00402051|10868336|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
9764043|NCT00402051|10868337|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
9764044|NCT00402051|10868336|FG000|NOT COMPLETED|Overall Study||38
9764045|NCT00402051|10868337|FG001|NOT COMPLETED|Overall Study||35
9764046|NCT00402103|10868345|FG000|STARTED|Overall Study||470
9764047|NCT00402103|10868346|FG001|STARTED|Overall Study||86
9764048|NCT00402103|10868345|FG000|COMPLETED|Overall Study||379
9764049|NCT00402103|10868346|FG001|COMPLETED|Overall Study||73
9764050|NCT00402103|10868345|FG000|NOT COMPLETED|Overall Study||91
9764051|NCT00402103|10868346|FG001|NOT COMPLETED|Overall Study||13
9764052|NCT00402116|10868359|FG000|STARTED|Overall Study||6
9764053|NCT00402116|10868360|FG001|STARTED|Overall Study||6
9764054|NCT00402116|10868361|FG002|STARTED|Overall Study||60
9764055|NCT00402116|10868359|FG000|COMPLETED|Overall Study||3
9764056|NCT00402116|10868360|FG001|COMPLETED|Overall Study||0
9764057|NCT00402116|10868361|FG002|COMPLETED|Overall Study||5
9764058|NCT00402116|10868359|FG000|NOT COMPLETED|Overall Study||3
9764059|NCT00402116|10868360|FG001|NOT COMPLETED|Overall Study||6
9764060|NCT00402116|10868361|FG002|NOT COMPLETED|Overall Study||55
9764061|NCT00402168|10868391|FG000|STARTED|Randomized||84
9764062|NCT00402168|10868392|FG001|STARTED|Randomized||89
9764063|NCT00402168|10868391|FG000|COMPLETED|Randomized||83
9764064|NCT00402168|10868392|FG001|COMPLETED|Randomized||88
9764065|NCT00402168|10868391|FG000|NOT COMPLETED|Randomized||1
9764066|NCT00402168|10868392|FG001|NOT COMPLETED|Randomized||1
9764067|NCT00402168|10868391|FG000|STARTED|Treatment (up to 12 Months)||83
9764068|NCT00402168|10868392|FG001|STARTED|Treatment (up to 12 Months)||88
9764069|NCT00402168|10868391|FG000|COMPLETED|Treatment (up to 12 Months)||81
9764070|NCT00402168|10868392|FG001|COMPLETED|Treatment (up to 12 Months)||86
9764071|NCT00402168|10868391|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2
9764072|NCT00402168|10868392|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2
9764073|NCT00402168|10868391|FG000|STARTED|Long Term (LT)||81
9764074|NCT00402168|10868392|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
9764075|NCT00402168|10868391|FG000|COMPLETED|Long Term (LT)||70
9764076|NCT00402168|10868392|FG001|COMPLETED|Long Term (LT)||64
9764077|NCT00402168|10868391|FG000|NOT COMPLETED|Long Term (LT)||11
9764078|NCT00402168|10868392|FG001|NOT COMPLETED|Long Term (LT)||17
9764079|NCT00402168|10868391|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
9764080|NCT00402168|10868392|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
9764081|NCT00402168|10868391|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32
9764082|NCT00402168|10868392|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0
9764083|NCT00402168|10868391|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
9764084|NCT00402168|10868392|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
9764085|NCT00402194|10868408|FG000|STARTED|Overall Study||9
9764086|NCT00402194|10868409|FG001|STARTED|Overall Study||8
9764087|NCT00402194|10868408|FG000|COMPLETED|Overall Study||9
9764088|NCT00402194|10868409|FG001|COMPLETED|Overall Study||8
9764089|NCT00402194|10868408|FG000|NOT COMPLETED|Overall Study||0
9764090|NCT00402194|10868409|FG001|NOT COMPLETED|Overall Study||0
9764091|NCT00402233|10868419|FG000|STARTED|Overall Study||77
9764092|NCT00402233|10868420|FG001|STARTED|Overall Study||80
9764093|NCT00402233|10868421|FG002|STARTED|Overall Study||81
9764094|NCT00402233|10868422|FG003|STARTED|Overall Study||73
9764095|NCT00402233|10868419|FG000|COMPLETED|Overall Study||72
9764096|NCT00402233|10868420|FG001|COMPLETED|Overall Study||70
9764097|NCT00402233|10868421|FG002|COMPLETED|Overall Study||70
9764098|NCT00402233|10868422|FG003|COMPLETED|Overall Study||62
9764099|NCT00402233|10868419|FG000|NOT COMPLETED|Overall Study||5
9764100|NCT00402233|10868420|FG001|NOT COMPLETED|Overall Study||10
9764101|NCT00402233|10868421|FG002|NOT COMPLETED|Overall Study||11
9764102|NCT00402233|10868422|FG003|NOT COMPLETED|Overall Study||11
9764103|NCT00402246|10868434|FG000|STARTED|Overall Study||1014
9764104|NCT00402246|10868435|FG001|STARTED|Overall Study||983
9764105|NCT00402246|10868434|FG000|COMPLETED|Overall Study||794
9764106|NCT00402246|10868435|FG001|COMPLETED|Overall Study||749
9764107|NCT00402246|10868434|FG000|NOT COMPLETED|Overall Study||220
9764108|NCT00402246|10868435|FG001|NOT COMPLETED|Overall Study||234
9764109|NCT00402285|10868446|FG000|STARTED|Overall Study||29
9764110|NCT00402285|10868447|FG001|STARTED|Overall Study||27
9764111|NCT00402285|10868448|FG002|STARTED|Overall Study||28
9764112|NCT00402285|10868446|FG000|COMPLETED|Overall Study||22
9764113|NCT00402285|10868447|FG001|COMPLETED|Overall Study||21
9764114|NCT00402285|10868448|FG002|COMPLETED|Overall Study||26
9764115|NCT00402285|10868446|FG000|NOT COMPLETED|Overall Study||7
9764116|NCT00402285|10868447|FG001|NOT COMPLETED|Overall Study||6
9764117|NCT00402285|10868448|FG002|NOT COMPLETED|Overall Study||2
9764118|NCT00402298|10868456|FG000|STARTED|Overall Study||3
9764119|NCT00402298|10868457|FG001|STARTED|Overall Study||2
9764120|NCT00402298|10868456|FG000|COMPLETED|Overall Study||2
9764121|NCT00402298|10868457|FG001|COMPLETED|Overall Study||2
9764122|NCT00402298|10868456|FG000|NOT COMPLETED|Overall Study||1
9764123|NCT00402298|10868457|FG001|NOT COMPLETED|Overall Study||0
9764124|NCT00402324|10868465|FG000|STARTED|Overall Study||101
9764125|NCT00402324|10868466|FG001|STARTED|Overall Study||101
9764126|NCT00402324|10868465|FG000|COMPLETED|Overall Study||58
9764127|NCT00402324|10868466|FG001|COMPLETED|Overall Study||60
9764128|NCT00402324|10868465|FG000|NOT COMPLETED|Overall Study||43
9764129|NCT00402324|10868466|FG001|NOT COMPLETED|Overall Study||41
9764130|NCT00402337|10868477|FG000|STARTED|Overall Study||59
9764131|NCT00402337|10868478|FG001|STARTED|Overall Study||57
9764132|NCT00402337|10868479|FG002|STARTED|Overall Study||62
9764133|NCT00402337|10868480|FG003|STARTED|Overall Study||63
9764134|NCT00402337|10868481|FG004|STARTED|Overall Study||69
9764135|NCT00402337|10868477|FG000|COMPLETED|Overall Study||54
9764136|NCT00402337|10868478|FG001|COMPLETED|Overall Study||51
9764137|NCT00402337|10868479|FG002|COMPLETED|Overall Study||58
9764138|NCT00402337|10868480|FG003|COMPLETED|Overall Study||51
9764139|NCT00402337|10868481|FG004|COMPLETED|Overall Study||61
9764140|NCT00402337|10868477|FG000|NOT COMPLETED|Overall Study||5
9764141|NCT00402337|10868478|FG001|NOT COMPLETED|Overall Study||6
9764142|NCT00402337|10868479|FG002|NOT COMPLETED|Overall Study||4
9764143|NCT00402337|10868480|FG003|NOT COMPLETED|Overall Study||12
9764144|NCT00402337|10868481|FG004|NOT COMPLETED|Overall Study||8
9764145|NCT00402363|10868497|FG000|STARTED|Overall Study||266
9764146|NCT00402363|10868498|FG001|STARTED|Overall Study||276
9764147|NCT00402363|10868499|FG002|STARTED|Overall Study||66
9764148|NCT00402363|10868500|FG003|STARTED|Overall Study||55
9764149|NCT00402363|10868497|FG000|COMPLETED|Overall Study||233
9764150|NCT00402363|10868498|FG001|COMPLETED|Overall Study||246
9764151|NCT00402363|10868499|FG002|COMPLETED|Overall Study||60
9764152|NCT00402363|10868500|FG003|COMPLETED|Overall Study||45
9764153|NCT00402363|10868497|FG000|NOT COMPLETED|Overall Study||33
9764154|NCT00402363|10868498|FG001|NOT COMPLETED|Overall Study||30
9764155|NCT00402363|10868499|FG002|NOT COMPLETED|Overall Study||6
9764156|NCT00402363|10868500|FG003|NOT COMPLETED|Overall Study||10
9764157|NCT00402597|10868521|FG000|STARTED|Overall Study||1153
9764158|NCT00402597|10868522|FG001|STARTED|Overall Study||307
9764159|NCT00402597|10868523|FG002|STARTED|Overall Study||1046
9764160|NCT00402597|10868524|FG003|STARTED|Overall Study||353
9764161|NCT00402597|10868525|FG004|STARTED|Overall Study||603
9764162|NCT00402597|10868521|FG000|COMPLETED|Overall Study||962
9764163|NCT00402597|10868522|FG001|COMPLETED|Overall Study||261
9764164|NCT00402597|10868523|FG002|COMPLETED|Overall Study||834
9764165|NCT00402597|10868524|FG003|COMPLETED|Overall Study||279
9764166|NCT00402597|10868525|FG004|COMPLETED|Overall Study||479
9764167|NCT00402597|10868521|FG000|NOT COMPLETED|Overall Study||191
9764168|NCT00402597|10868522|FG001|NOT COMPLETED|Overall Study||46
9764169|NCT00402597|10868523|FG002|NOT COMPLETED|Overall Study||212
9764170|NCT00402597|10868524|FG003|NOT COMPLETED|Overall Study||74
9764171|NCT00402597|10868525|FG004|NOT COMPLETED|Overall Study||124
9764172|NCT00402649|10868537|FG000|STARTED|Overall Study||35
9764173|NCT00402649|10868537|FG000|COMPLETED|Overall Study||33
9764174|NCT00402649|10868537|FG000|NOT COMPLETED|Overall Study||2
9764175|NCT00402688|10868544|FG000|STARTED|Overall Study||81
9764176|NCT00402688|10868545|FG001|STARTED|Overall Study||81
9764177|NCT00402688|10868546|FG002|STARTED|Overall Study||80
9764178|NCT00402688|10868544|FG000|COMPLETED|Overall Study||60
9764179|NCT00402688|10868545|FG001|COMPLETED|Overall Study||65
9764180|NCT00402688|10868546|FG002|COMPLETED|Overall Study||65
9764181|NCT00402688|10868544|FG000|NOT COMPLETED|Overall Study||21
9764182|NCT00402688|10868545|FG001|NOT COMPLETED|Overall Study||16
9764183|NCT00402688|10868546|FG002|NOT COMPLETED|Overall Study||15
9764184|NCT00402714|10868556|FG000|STARTED|Overall Study||3
9764185|NCT00402714|10868557|FG001|STARTED|Overall Study||11
9764186|NCT00402714|10868556|FG000|COMPLETED|Overall Study||3
9764187|NCT00402714|10868557|FG001|COMPLETED|Overall Study||11
9764188|NCT00402714|10868556|FG000|NOT COMPLETED|Overall Study||0
9764189|NCT00402714|10868557|FG001|NOT COMPLETED|Overall Study||0
9764190|NCT00402727|10868567|FG000|STARTED|Overall Study||432
9764191|NCT00402727|10868568|FG001|STARTED|Overall Study||381
9764192|NCT00402727|10868567|FG000|Achieving End Of Treatment (EOT)|Overall Study||408
9764193|NCT00402727|10868568|FG001|Achieving End Of Treatment (EOT)|Overall Study||355
9764194|NCT00402727|10868567|FG000|Achieving Test Of Cure (TOC)|Overall Study||390
9764195|NCT00402727|10868568|FG001|Achieving Test Of Cure (TOC)|Overall Study||347
9764196|NCT00402727|10868567|FG000|COMPLETED|Overall Study||390
9764197|NCT00402727|10868568|FG001|COMPLETED|Overall Study||347
9764198|NCT00402727|10868567|FG000|NOT COMPLETED|Overall Study||42
9764199|NCT00402727|10868568|FG001|NOT COMPLETED|Overall Study||34
9764200|NCT00402740|10868574|FG000|STARTED|Overall Study||322
9764201|NCT00402740|10868574|FG000|COMPLETED|Overall Study||242
9764202|NCT00402740|10868574|FG000|NOT COMPLETED|Overall Study||80
9764203|NCT00402779|10868584|FG000|STARTED|Overall Study||152
10013842|NCT01795495|11136799|FG002|COMPLETED|Overall Study||19
10013843|NCT01795495|11136797|FG000|NOT COMPLETED|Overall Study||1
10013844|NCT01795495|11136798|FG001|NOT COMPLETED|Overall Study||0
10013845|NCT01795495|11136799|FG002|NOT COMPLETED|Overall Study||2
10013846|NCT01795534|11136807|FG000|STARTED|First Intervention (First Shot)||5
9764204|NCT00402779|10868585|FG001|STARTED|Overall Study||151
9764205|NCT00402779|10868584|FG000|COMPLETED|Overall Study||75
9764206|NCT00402779|10868585|FG001|COMPLETED|Overall Study||75
9764207|NCT00402779|10868584|FG000|NOT COMPLETED|Overall Study||77
9764208|NCT00402779|10868585|FG001|NOT COMPLETED|Overall Study||76
9764209|NCT00402831|10868593|FG000|STARTED|Overall Study||202
9764210|NCT00402831|10868594|FG001|STARTED|Overall Study||203
9764211|NCT00402831|10868593|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202
9764212|NCT00402831|10868594|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203
9764213|NCT00402831|10868593|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202
9764214|NCT00402831|10868594|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203
9764215|NCT00402831|10868593|FG000|COMPLETED|Overall Study||201
9764216|NCT00402831|10868594|FG001|COMPLETED|Overall Study||200
9764217|NCT00402831|10868593|FG000|NOT COMPLETED|Overall Study||1
9764218|NCT00402831|10868594|FG001|NOT COMPLETED|Overall Study||3
9764219|NCT00402896|10868602|FG000|STARTED|Overall Study||20
9764220|NCT00402896|10868602|FG000|COMPLETED|Overall Study||20
9764221|NCT00402896|10868602|FG000|NOT COMPLETED|Overall Study||0
9764222|NCT00402987|10868610|FG000|STARTED|Overall Study||90
9764223|NCT00402987|10868611|FG001|STARTED|Overall Study||45
9764224|NCT00402987|10868612|FG002|STARTED|Overall Study||45
9764225|NCT00402987|10868613|FG003|STARTED|Overall Study||89
9764226|NCT00402987|10868610|FG000|COMPLETED|Overall Study||90
9764227|NCT00402987|10868611|FG001|COMPLETED|Overall Study||45
9764228|NCT00402987|10868612|FG002|COMPLETED|Overall Study||44
9764229|NCT00402987|10868613|FG003|COMPLETED|Overall Study||89
9764230|NCT00402987|10868610|FG000|NOT COMPLETED|Overall Study||0
9764231|NCT00402987|10868611|FG001|NOT COMPLETED|Overall Study||0
9764232|NCT00402987|10868612|FG002|NOT COMPLETED|Overall Study||1
9764233|NCT00402987|10868613|FG003|NOT COMPLETED|Overall Study||0
9764234|NCT00403117|10868637|FG000|STARTED|Overall Study||49
9764235|NCT00403117|10868637|FG000|COMPLETED|Overall Study||29
9764236|NCT00403117|10868637|FG000|NOT COMPLETED|Overall Study||20
9764237|NCT00403130|10868668|FG000|STARTED|2 Years From Start of Treatment||31
9764238|NCT00403130|10868668|FG000|COMPLETED|2 Years From Start of Treatment||26
9764239|NCT00403130|10868668|FG000|NOT COMPLETED|2 Years From Start of Treatment||5
9764240|NCT00403130|10868668|FG000|STARTED|Survival Follow-up up to 6 Years||26
9764241|NCT00403130|10868668|FG000|COMPLETED|Survival Follow-up up to 6 Years||16
9764242|NCT00403130|10868668|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10
9764243|NCT00403234|10868676|FG000|STARTED|Overall Study||2
10013847|NCT01795534|11136808|FG001|STARTED|First Intervention (First Shot)||5
9764244|NCT00403234|10868677|FG001|STARTED|Overall Study||3
9764245|NCT00403234|10868678|FG002|STARTED|Overall Study||3
9764246|NCT00403234|10868679|FG003|STARTED|Overall Study||2
9764247|NCT00403234|10868676|FG000|COMPLETED|Overall Study||1
9764248|NCT00403234|10868677|FG001|COMPLETED|Overall Study||2
9764249|NCT00403234|10868678|FG002|COMPLETED|Overall Study||2
9764250|NCT00403234|10868679|FG003|COMPLETED|Overall Study||2
9764251|NCT00403234|10868676|FG000|NOT COMPLETED|Overall Study||1
9764252|NCT00403234|10868677|FG001|NOT COMPLETED|Overall Study||1
9764253|NCT00403234|10868678|FG002|NOT COMPLETED|Overall Study||1
9764254|NCT00403234|10868679|FG003|NOT COMPLETED|Overall Study||0
9764255|NCT00403260|10868691|FG000|STARTED|Overall Study|Patients randomized and treated.|848
9764256|NCT00403260|10868692|FG001|STARTED|Overall Study|Patients randomized and treated.|423
9764257|NCT00403260|10868691|FG000|COMPLETED|Overall Study||723
9764258|NCT00403260|10868692|FG001|COMPLETED|Overall Study||357
9764259|NCT00403260|10868691|FG000|NOT COMPLETED|Overall Study||125
9764260|NCT00403260|10868692|FG001|NOT COMPLETED|Overall Study||66
9764261|NCT00403273|10868700|FG000|STARTED|Overall Study||25
9764262|NCT00403273|10868701|FG001|STARTED|Overall Study||29
9764263|NCT00403273|10868700|FG000|COMPLETED|Overall Study||22
9764264|NCT00403273|10868701|FG001|COMPLETED|Overall Study||25
9764265|NCT00403273|10868700|FG000|NOT COMPLETED|Overall Study||3
9764266|NCT00403273|10868701|FG001|NOT COMPLETED|Overall Study||4
9764267|NCT00403390|10868711|FG000|STARTED|Overall Study||16
9764268|NCT00403390|10868712|FG001|STARTED|Overall Study||18
10013848|NCT01795534|11136807|FG000|COMPLETED|First Intervention (First Shot)||5
9764269|NCT00403390|10868711|FG000|COMPLETED|Overall Study||13
9764270|NCT00403390|10868712|FG001|COMPLETED|Overall Study||18
9764271|NCT00403390|10868711|FG000|NOT COMPLETED|Overall Study||3
9764272|NCT00403390|10868712|FG001|NOT COMPLETED|Overall Study||0
9764273|NCT00403403|10868720|FG000|STARTED|Overall Study||50
9764274|NCT00403403|10868721|FG001|STARTED|Overall Study||52
9764275|NCT00403403|10868720|FG000|Safety-Evaluable Patients|Overall Study||47
9764276|NCT00403403|10868721|FG001|Safety-Evaluable Patients|Overall Study||51
9764277|NCT00403403|10868720|FG000|COMPLETED|Overall Study||50
9764278|NCT00403403|10868721|FG001|COMPLETED|Overall Study||52
9764279|NCT00403403|10868720|FG000|NOT COMPLETED|Overall Study||0
9764280|NCT00403403|10868721|FG001|NOT COMPLETED|Overall Study||0
9764281|NCT00403455|10868727|FG000|STARTED|Overall Study||38
9764282|NCT00403455|10868727|FG000|COMPLETED|Overall Study||37
9764283|NCT00403455|10868727|FG000|NOT COMPLETED|Overall Study||1
9764284|NCT00403481|10868731|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
9764285|NCT00403481|10868731|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
9764286|NCT00403481|10868731|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
9764287|NCT00403481|10868731|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
9764288|NCT00403481|10868731|FG000|COMPLETED|Olm 40 mg||177
9764289|NCT00403481|10868731|FG000|NOT COMPLETED|Olm 40 mg||5
9764290|NCT00403481|10868731|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
9764291|NCT00403481|10868731|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
9764292|NCT00403481|10868731|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
9764293|NCT00403481|10868731|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
9764294|NCT00403481|10868731|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
9764295|NCT00403481|10868731|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
9764296|NCT00403494|10868740|FG000|STARTED|Overall Study||96
9764297|NCT00403494|10868741|FG001|STARTED|Overall Study||94
9764298|NCT00403494|10868740|FG000|Intent to Treat|Overall Study||87
9764299|NCT00403494|10868741|FG001|Intent to Treat|Overall Study||83
9764300|NCT00403494|10868740|FG000|Per-protocol|Overall Study||69
9764301|NCT00403494|10868741|FG001|Per-protocol|Overall Study||69
9764302|NCT00403494|10868740|FG000|Safety Population|Overall Study||97
9764303|NCT00403494|10868741|FG001|Safety Population|Overall Study||91
9764304|NCT00403494|10868740|FG000|COMPLETED|Overall Study||81
9764305|NCT00403494|10868741|FG001|COMPLETED|Overall Study||80
9764306|NCT00403494|10868740|FG000|NOT COMPLETED|Overall Study||15
9764307|NCT00403494|10868741|FG001|NOT COMPLETED|Overall Study||14
9764308|NCT00403546|10868751|FG000|STARTED|Signed Informed Consent/Open-Label||131
9764309|NCT00403546|10868752|FG001|STARTED|Signed Informed Consent/Open-Label||0
9764310|NCT00403546|10868753|FG002|STARTED|Signed Informed Consent/Open-Label||0
9764311|NCT00403546|10868751|FG000|COMPLETED|Signed Informed Consent/Open-Label||103
9764312|NCT00403546|10868752|FG001|COMPLETED|Signed Informed Consent/Open-Label||0
9764313|NCT00403546|10868753|FG002|COMPLETED|Signed Informed Consent/Open-Label||0
9764314|NCT00403546|10868751|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28
9764315|NCT00403546|10868752|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0
9764316|NCT00403546|10868753|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0
9764317|NCT00403546|10868751|FG000|STARTED|Screening Phase||103
9764318|NCT00403546|10868752|FG001|STARTED|Screening Phase||0
9764319|NCT00403546|10868753|FG002|STARTED|Screening Phase||0
9764320|NCT00403546|10868751|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
9764321|NCT00403546|10868752|FG001|COMPLETED|Screening Phase||0
9764322|NCT00403546|10868753|FG002|COMPLETED|Screening Phase||0
9764323|NCT00403546|10868751|FG000|NOT COMPLETED|Screening Phase||28
9764324|NCT00403546|10868752|FG001|NOT COMPLETED|Screening Phase||0
9764325|NCT00403546|10868753|FG002|NOT COMPLETED|Screening Phase||0
9764326|NCT00403546|10868751|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
9764327|NCT00403546|10868752|FG001|STARTED|Randomized Trial||38
9764328|NCT00403546|10868753|FG002|STARTED|Randomized Trial||37
9764329|NCT00403546|10868751|FG000|COMPLETED|Randomized Trial||0
9764330|NCT00403546|10868752|FG001|COMPLETED|Randomized Trial||21
9764331|NCT00403546|10868753|FG002|COMPLETED|Randomized Trial||21
9764332|NCT00403546|10868751|FG000|NOT COMPLETED|Randomized Trial||0
9764333|NCT00403546|10868752|FG001|NOT COMPLETED|Randomized Trial||17
9764334|NCT00403546|10868753|FG002|NOT COMPLETED|Randomized Trial||16
9829448|NCT00759772|10940077|FG000|STARTED|Overall Study||12
9829449|NCT00759772|10940078|FG001|STARTED|Overall Study||11
9829450|NCT00759772|10940077|FG000|COMPLETED|Overall Study||12
9829451|NCT00759772|10940078|FG001|COMPLETED|Overall Study||11
9829452|NCT00759772|10940077|FG000|NOT COMPLETED|Overall Study||0
9829453|NCT00759772|10940078|FG001|NOT COMPLETED|Overall Study||0
9829454|NCT00759785|10940086|FG000|STARTED|Overall Study||26
9829455|NCT00759785|10940087|FG001|STARTED|Overall Study||22
9829456|NCT00759785|10940086|FG000|Treated|Overall Study||25
9829457|NCT00759785|10940087|FG001|Treated|Overall Study||20
9829458|NCT00759785|10940086|FG000|COMPLETED|Overall Study||14
9829459|NCT00759785|10940087|FG001|COMPLETED|Overall Study||17
9829460|NCT00759785|10940086|FG000|NOT COMPLETED|Overall Study||12
9829461|NCT00759785|10940087|FG001|NOT COMPLETED|Overall Study||5
9829462|NCT00759798|10940093|FG000|STARTED|Overall Study||289
9829463|NCT00759798|10940093|FG000|COMPLETED|Overall Study||289
9829464|NCT00759798|10940093|FG000|NOT COMPLETED|Overall Study||0
9829465|NCT00759811|10940099|FG000|STARTED|Overall Study||25
9829466|NCT00759811|10940100|FG001|STARTED|Overall Study||25
9829467|NCT00759811|10940099|FG000|COMPLETED|Overall Study||23
9829468|NCT00759811|10940100|FG001|COMPLETED|Overall Study||24
9829469|NCT00759811|10940099|FG000|NOT COMPLETED|Overall Study||2
9829470|NCT00759811|10940100|FG001|NOT COMPLETED|Overall Study||1
9829471|NCT00759863|10940108|FG000|STARTED|Overall Study||144
9829472|NCT00759863|10940109|FG001|STARTED|Overall Study||98
9829473|NCT00759863|10940108|FG000|COMPLETED|Overall Study||124
9829474|NCT00759863|10940109|FG001|COMPLETED|Overall Study||80
9829475|NCT00759863|10940108|FG000|NOT COMPLETED|Overall Study||20
9829476|NCT00759863|10940109|FG001|NOT COMPLETED|Overall Study||18
9764335|NCT00403585|10868762|FG000|STARTED|Initial Treatment Phase||104
9764336|NCT00403585|10868762|FG000|COMPLETED|Initial Treatment Phase||102
9764337|NCT00403585|10868762|FG000|NOT COMPLETED|Initial Treatment Phase||2
9764338|NCT00403585|10868762|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
9764339|NCT00403585|10868762|FG000|COMPLETED|Open-Label Phase; Extension Study||74
9764340|NCT00403585|10868762|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6
9764341|NCT00403754|10868766|FG000|STARTED|Core Treatment Period 1||11
9764342|NCT00403754|10868767|FG001|STARTED|Core Treatment Period 1||10
9764343|NCT00403754|10868768|FG002|STARTED|Core Treatment Period 1||9
9764344|NCT00403754|10868769|FG003|STARTED|Core Treatment Period 1||11
9764345|NCT00403754|10868766|FG000|COMPLETED|Core Treatment Period 1||11
9764346|NCT00403754|10868767|FG001|COMPLETED|Core Treatment Period 1||9
9764347|NCT00403754|10868768|FG002|COMPLETED|Core Treatment Period 1||9
9764348|NCT00403754|10868769|FG003|COMPLETED|Core Treatment Period 1||11
9764349|NCT00403754|10868766|FG000|NOT COMPLETED|Core Treatment Period 1||0
9764350|NCT00403754|10868767|FG001|NOT COMPLETED|Core Treatment Period 1||1
9764351|NCT00403754|10868768|FG002|NOT COMPLETED|Core Treatment Period 1||0
9764352|NCT00403754|10868769|FG003|NOT COMPLETED|Core Treatment Period 1||0
9764353|NCT00403754|10868766|FG000|STARTED|Core Treatment Period 2||11
10013849|NCT01795534|11136808|FG001|COMPLETED|First Intervention (First Shot)||5
9764354|NCT00403754|10868767|FG001|STARTED|Core Treatment Period 2||9
9764355|NCT00403754|10868768|FG002|STARTED|Core Treatment Period 2||9
9764356|NCT00403754|10868769|FG003|STARTED|Core Treatment Period 2||11
9764357|NCT00403754|10868766|FG000|COMPLETED|Core Treatment Period 2||11
9764358|NCT00403754|10868767|FG001|COMPLETED|Core Treatment Period 2||9
9764359|NCT00403754|10868768|FG002|COMPLETED|Core Treatment Period 2||8
9764360|NCT00403754|10868769|FG003|COMPLETED|Core Treatment Period 2||11
9764361|NCT00403754|10868766|FG000|NOT COMPLETED|Core Treatment Period 2||0
9764362|NCT00403754|10868767|FG001|NOT COMPLETED|Core Treatment Period 2||0
9764363|NCT00403754|10868768|FG002|NOT COMPLETED|Core Treatment Period 2||1
9764364|NCT00403754|10868769|FG003|NOT COMPLETED|Core Treatment Period 2||0
9764365|NCT00403754|10868766|FG000|STARTED|Core Treatment Period 3||11
9764366|NCT00403754|10868767|FG001|STARTED|Core Treatment Period 3||9
9764367|NCT00403754|10868768|FG002|STARTED|Core Treatment Period 3||8
9764368|NCT00403754|10868769|FG003|STARTED|Core Treatment Period 3||11
9764369|NCT00403754|10868766|FG000|COMPLETED|Core Treatment Period 3||11
9764370|NCT00403754|10868767|FG001|COMPLETED|Core Treatment Period 3||9
9764371|NCT00403754|10868768|FG002|COMPLETED|Core Treatment Period 3||8
9764372|NCT00403754|10868769|FG003|COMPLETED|Core Treatment Period 3||11
9764373|NCT00403754|10868766|FG000|NOT COMPLETED|Core Treatment Period 3||0
9764374|NCT00403754|10868767|FG001|NOT COMPLETED|Core Treatment Period 3||0
9764375|NCT00403754|10868768|FG002|NOT COMPLETED|Core Treatment Period 3||0
9764376|NCT00403754|10868769|FG003|NOT COMPLETED|Core Treatment Period 3||0
9764377|NCT00403754|10868766|FG000|STARTED|Core Treatment Period 4||11
9764378|NCT00403754|10868767|FG001|STARTED|Core Treatment Period 4||9
9764379|NCT00403754|10868768|FG002|STARTED|Core Treatment Period 4||8
9764380|NCT00403754|10868769|FG003|STARTED|Core Treatment Period 4||11
9764381|NCT00403754|10868766|FG000|COMPLETED|Core Treatment Period 4||11
9764382|NCT00403754|10868767|FG001|COMPLETED|Core Treatment Period 4||9
9764383|NCT00403754|10868768|FG002|COMPLETED|Core Treatment Period 4||8
9764384|NCT00403754|10868769|FG003|COMPLETED|Core Treatment Period 4||11
9764385|NCT00403754|10868766|FG000|NOT COMPLETED|Core Treatment Period 4||0
9764386|NCT00403754|10868767|FG001|NOT COMPLETED|Core Treatment Period 4||0
9764387|NCT00403754|10868768|FG002|NOT COMPLETED|Core Treatment Period 4||0
9764388|NCT00403754|10868769|FG003|NOT COMPLETED|Core Treatment Period 4||0
9764389|NCT00403754|10868766|FG000|STARTED|Open Label: Salmeterol||11
9764390|NCT00403754|10868767|FG001|STARTED|Open Label: Salmeterol||9
9764391|NCT00403754|10868768|FG002|STARTED|Open Label: Salmeterol||8
9764392|NCT00403754|10868769|FG003|STARTED|Open Label: Salmeterol||11
9764393|NCT00403754|10868766|FG000|COMPLETED|Open Label: Salmeterol||11
9764394|NCT00403754|10868767|FG001|COMPLETED|Open Label: Salmeterol||9
9764395|NCT00403754|10868768|FG002|COMPLETED|Open Label: Salmeterol||8
9764396|NCT00403754|10868769|FG003|COMPLETED|Open Label: Salmeterol||11
9764397|NCT00403754|10868766|FG000|NOT COMPLETED|Open Label: Salmeterol||0
9764398|NCT00403754|10868767|FG001|NOT COMPLETED|Open Label: Salmeterol||0
9764399|NCT00403754|10868768|FG002|NOT COMPLETED|Open Label: Salmeterol||0
9764400|NCT00403754|10868769|FG003|NOT COMPLETED|Open Label: Salmeterol||0
9764401|NCT00403767|10868783|FG000|STARTED|Overall Study||7111
9764402|NCT00403767|10868784|FG001|STARTED|Overall Study||7125
9764403|NCT00403767|10868783|FG000|COMPLETED|Overall Study||4591
9764404|NCT00403767|10868784|FG001|COMPLETED|Overall Study||4657
9764405|NCT00403767|10868783|FG000|NOT COMPLETED|Overall Study||2520
9764406|NCT00403767|10868784|FG001|NOT COMPLETED|Overall Study||2468
9764407|NCT00403845|10868790|FG000|STARTED|Treatment Period 1||12
9764408|NCT00403845|10868791|FG001|STARTED|Treatment Period 1||13
9764409|NCT00403845|10868792|FG002|STARTED|Treatment Period 1||11
9764410|NCT00403845|10868793|FG003|STARTED|Treatment Period 1||14
9764411|NCT00403845|10868790|FG000|COMPLETED|Treatment Period 1||11
9764412|NCT00403845|10868791|FG001|COMPLETED|Treatment Period 1||13
9764413|NCT00403845|10868792|FG002|COMPLETED|Treatment Period 1||11
9764414|NCT00403845|10868793|FG003|COMPLETED|Treatment Period 1||13
9764415|NCT00403845|10868790|FG000|NOT COMPLETED|Treatment Period 1||1
9764416|NCT00403845|10868791|FG001|NOT COMPLETED|Treatment Period 1||0
9764417|NCT00403845|10868792|FG002|NOT COMPLETED|Treatment Period 1||0
9764418|NCT00403845|10868793|FG003|NOT COMPLETED|Treatment Period 1||1
9764419|NCT00403845|10868790|FG000|STARTED|Treatment Period 2||11
9764420|NCT00403845|10868791|FG001|STARTED|Treatment Period 2||13
9764421|NCT00403845|10868792|FG002|STARTED|Treatment Period 2||11
9764422|NCT00403845|10868793|FG003|STARTED|Treatment Period 2||13
9764423|NCT00403845|10868790|FG000|COMPLETED|Treatment Period 2||10
9764424|NCT00403845|10868791|FG001|COMPLETED|Treatment Period 2||13
9764425|NCT00403845|10868792|FG002|COMPLETED|Treatment Period 2||11
9764426|NCT00403845|10868793|FG003|COMPLETED|Treatment Period 2||13
9764427|NCT00403845|10868790|FG000|NOT COMPLETED|Treatment Period 2||1
9764428|NCT00403845|10868791|FG001|NOT COMPLETED|Treatment Period 2||0
9764429|NCT00403845|10868792|FG002|NOT COMPLETED|Treatment Period 2||0
9764430|NCT00403845|10868793|FG003|NOT COMPLETED|Treatment Period 2||0
9764431|NCT00403845|10868790|FG000|STARTED|Treatment Period 3||10
9764432|NCT00403845|10868791|FG001|STARTED|Treatment Period 3||13
9764433|NCT00403845|10868792|FG002|STARTED|Treatment Period 3||11
9764434|NCT00403845|10868793|FG003|STARTED|Treatment Period 3||13
9764435|NCT00403845|10868790|FG000|COMPLETED|Treatment Period 3||10
9764436|NCT00403845|10868791|FG001|COMPLETED|Treatment Period 3||13
9764437|NCT00403845|10868792|FG002|COMPLETED|Treatment Period 3||11
9764438|NCT00403845|10868793|FG003|COMPLETED|Treatment Period 3||11
9764439|NCT00403845|10868790|FG000|NOT COMPLETED|Treatment Period 3||0
9764440|NCT00403845|10868791|FG001|NOT COMPLETED|Treatment Period 3||0
9764441|NCT00403845|10868792|FG002|NOT COMPLETED|Treatment Period 3||0
9764442|NCT00403845|10868793|FG003|NOT COMPLETED|Treatment Period 3||2
9764443|NCT00403845|10868790|FG000|STARTED|Treatment Period 4||10
9764444|NCT00403845|10868791|FG001|STARTED|Treatment Period 4||13
9764445|NCT00403845|10868792|FG002|STARTED|Treatment Period 4||11
9764446|NCT00403845|10868793|FG003|STARTED|Treatment Period 4||11
9764447|NCT00403845|10868790|FG000|COMPLETED|Treatment Period 4||10
9764448|NCT00403845|10868791|FG001|COMPLETED|Treatment Period 4||13
9764449|NCT00403845|10868792|FG002|COMPLETED|Treatment Period 4||11
9764450|NCT00403845|10868793|FG003|COMPLETED|Treatment Period 4||11
9764451|NCT00403845|10868790|FG000|NOT COMPLETED|Treatment Period 4||0
9764452|NCT00403845|10868791|FG001|NOT COMPLETED|Treatment Period 4||0
9764453|NCT00403845|10868792|FG002|NOT COMPLETED|Treatment Period 4||0
9764454|NCT00403845|10868793|FG003|NOT COMPLETED|Treatment Period 4||0
9764455|NCT00404066|10868803|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
9764456|NCT00404066|10868803|FG000|COMPLETED|Overall Study||18
9764457|NCT00404066|10868803|FG000|NOT COMPLETED|Overall Study||3
9764458|NCT00404079|10868809|FG000|STARTED|Overall Study||125
9764459|NCT00404079|10868810|FG001|STARTED|Overall Study||125
9764460|NCT00404079|10868809|FG000|COMPLETED|Overall Study||103
9764461|NCT00404079|10868810|FG001|COMPLETED|Overall Study||105
9764462|NCT00404079|10868809|FG000|NOT COMPLETED|Overall Study||22
9764463|NCT00404079|10868810|FG001|NOT COMPLETED|Overall Study||20
9764464|NCT00404092|10868820|FG000|STARTED|Overall Study||9
9764465|NCT00404092|10868821|FG001|STARTED|Overall Study||8
9764466|NCT00404092|10868822|FG002|STARTED|Overall Study||9
9764467|NCT00404092|10868823|FG003|STARTED|Overall Study||20
9764468|NCT00404092|10868820|FG000|COMPLETED|Overall Study||8
9764469|NCT00404092|10868821|FG001|COMPLETED|Overall Study||8
9764470|NCT00404092|10868822|FG002|COMPLETED|Overall Study||8
9764471|NCT00404092|10868823|FG003|COMPLETED|Overall Study||20
9764472|NCT00404092|10868820|FG000|NOT COMPLETED|Overall Study||1
9764473|NCT00404092|10868821|FG001|NOT COMPLETED|Overall Study||0
9764474|NCT00404092|10868822|FG002|NOT COMPLETED|Overall Study||1
9764475|NCT00404092|10868823|FG003|NOT COMPLETED|Overall Study||0
9764476|NCT00404235|10868835|FG000|STARTED|Overall Study||35
9764477|NCT00404235|10868836|FG001|STARTED|Overall Study||41
9764478|NCT00404235|10868835|FG000|COMPLETED|Overall Study||34
9764479|NCT00404235|10868836|FG001|COMPLETED|Overall Study||39
9764480|NCT00404235|10868835|FG000|NOT COMPLETED|Overall Study||1
9764481|NCT00404235|10868836|FG001|NOT COMPLETED|Overall Study||2
9764482|NCT00404248|10868845|FG000|STARTED|Overall Study||3
9764483|NCT00404248|10868846|FG001|STARTED|Overall Study||4
9764484|NCT00404248|10868847|FG002|STARTED|Overall Study||5
9764485|NCT00404248|10868848|FG003|STARTED|Overall Study||2
9764486|NCT00404248|10868849|FG004|STARTED|Overall Study||3
9764487|NCT00404248|10868850|FG005|STARTED|Overall Study||3
9764488|NCT00404248|10868851|FG006|STARTED|Overall Study||6
9764489|NCT00404248|10868852|FG007|STARTED|Overall Study||6
9764490|NCT00404248|10868853|FG008|STARTED|Overall Study||3
9764491|NCT00404248|10868845|FG000|COMPLETED|Overall Study||3
9764492|NCT00404248|10868846|FG001|COMPLETED|Overall Study||3
9764493|NCT00404248|10868847|FG002|COMPLETED|Overall Study||5
9764494|NCT00404248|10868848|FG003|COMPLETED|Overall Study||2
9764495|NCT00404248|10868849|FG004|COMPLETED|Overall Study||3
9764496|NCT00404248|10868850|FG005|COMPLETED|Overall Study||3
9764497|NCT00404248|10868851|FG006|COMPLETED|Overall Study||6
9764498|NCT00404248|10868852|FG007|COMPLETED|Overall Study||6
9764499|NCT00404248|10868853|FG008|COMPLETED|Overall Study||3
9764500|NCT00404248|10868845|FG000|NOT COMPLETED|Overall Study||0
9764501|NCT00404248|10868846|FG001|NOT COMPLETED|Overall Study||1
9764502|NCT00404248|10868847|FG002|NOT COMPLETED|Overall Study||0
9764503|NCT00404248|10868848|FG003|NOT COMPLETED|Overall Study||0
9764504|NCT00404248|10868849|FG004|NOT COMPLETED|Overall Study||0
9764505|NCT00404248|10868850|FG005|NOT COMPLETED|Overall Study||0
9764506|NCT00404248|10868851|FG006|NOT COMPLETED|Overall Study||0
9764507|NCT00404248|10868852|FG007|NOT COMPLETED|Overall Study||0
10232258|NCT02284906|11361468|FG001|NOT COMPLETED|Overall Study||18
10232259|NCT02284906|11361469|FG002|NOT COMPLETED|Overall Study||19
10232260|NCT02287025|11361479|FG000|STARTED|Overall Study||12
10232261|NCT02287025|11361480|FG001|STARTED|Overall Study||11
9764508|NCT00404248|10868853|FG008|NOT COMPLETED|Overall Study||0
9764509|NCT00404352|10868882|FG000|STARTED|Double Blind (up to 24 Month)||171
9764510|NCT00404352|10868883|FG001|STARTED|Double Blind (up to 24 Month)||175
9764511|NCT00404352|10868884|FG002|STARTED|Double Blind (up to 24 Month)||171
9764512|NCT00404352|10868885|FG003|STARTED|Double Blind (up to 24 Month)||0
9764513|NCT00404352|10868886|FG004|STARTED|Double Blind (up to 24 Month)||0
9764514|NCT00404352|10868887|FG005|STARTED|Double Blind (up to 24 Month)||0
9764515|NCT00404352|10868888|FG006|STARTED|Double Blind (up to 24 Month)||0
9764516|NCT00404352|10868889|FG007|STARTED|Double Blind (up to 24 Month)||0
9764517|NCT00404352|10868890|FG008|STARTED|Double Blind (up to 24 Month)||0
9764518|NCT00404352|10868882|FG000|Treated|Double Blind (up to 24 Month)||171
9764519|NCT00404352|10868883|FG001|Treated|Double Blind (up to 24 Month)||173
9764520|NCT00404352|10868884|FG002|Treated|Double Blind (up to 24 Month)||171
9764521|NCT00404352|10868885|FG003|Treated|Double Blind (up to 24 Month)||0
9764522|NCT00404352|10868886|FG004|Treated|Double Blind (up to 24 Month)||0
9764523|NCT00404352|10868887|FG005|Treated|Double Blind (up to 24 Month)||0
9764524|NCT00404352|10868888|FG006|Treated|Double Blind (up to 24 Month)||0
9764525|NCT00404352|10868889|FG007|Treated|Double Blind (up to 24 Month)||0
9764526|NCT00404352|10868890|FG008|Treated|Double Blind (up to 24 Month)||0
9764527|NCT00404352|10868882|FG000|COMPLETED|Double Blind (up to 24 Month)||119
9764528|NCT00404352|10868883|FG001|COMPLETED|Double Blind (up to 24 Month)||128
9764529|NCT00404352|10868884|FG002|COMPLETED|Double Blind (up to 24 Month)||92
9764530|NCT00404352|10868885|FG003|COMPLETED|Double Blind (up to 24 Month)||0
9764531|NCT00404352|10868886|FG004|COMPLETED|Double Blind (up to 24 Month)||0
9764532|NCT00404352|10868887|FG005|COMPLETED|Double Blind (up to 24 Month)||0
9764533|NCT00404352|10868888|FG006|COMPLETED|Double Blind (up to 24 Month)||0
9764534|NCT00404352|10868889|FG007|COMPLETED|Double Blind (up to 24 Month)||0
9764535|NCT00404352|10868890|FG008|COMPLETED|Double Blind (up to 24 Month)||0
9764536|NCT00404352|10868882|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52
9764537|NCT00404352|10868883|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47
9764538|NCT00404352|10868884|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79
9764539|NCT00404352|10868885|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0
9764540|NCT00404352|10868886|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0
9764541|NCT00404352|10868887|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0
9764542|NCT00404352|10868888|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0
9764543|NCT00404352|10868889|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0
9764544|NCT00404352|10868890|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0
9764545|NCT00404352|10868882|FG000|STARTED|Open Label (up to 24 Month)||0
9764546|NCT00404352|10868883|FG001|STARTED|Open Label (up to 24 Month)||0
9764547|NCT00404352|10868884|FG002|STARTED|Open Label (up to 24 Month)||0
9764548|NCT00404352|10868885|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
9764549|NCT00404352|10868886|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
9764550|NCT00404352|10868887|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
9764551|NCT00404352|10868888|FG006|STARTED|Open Label (up to 24 Month)||0
9764552|NCT00404352|10868889|FG007|STARTED|Open Label (up to 24 Month)||0
9764553|NCT00404352|10868890|FG008|STARTED|Open Label (up to 24 Month)||0
9764554|NCT00404352|10868882|FG000|COMPLETED|Open Label (up to 24 Month)||0
9764555|NCT00404352|10868883|FG001|COMPLETED|Open Label (up to 24 Month)||0
9764556|NCT00404352|10868884|FG002|COMPLETED|Open Label (up to 24 Month)||0
10013850|NCT01795534|11136807|FG000|NOT COMPLETED|First Intervention (First Shot)||0
10013851|NCT01795534|11136808|FG001|NOT COMPLETED|First Intervention (First Shot)||0
9764557|NCT00404352|10868885|FG003|COMPLETED|Open Label (up to 24 Month)||28
9764558|NCT00404352|10868886|FG004|COMPLETED|Open Label (up to 24 Month)||28
9764559|NCT00404352|10868887|FG005|COMPLETED|Open Label (up to 24 Month)||52
9764560|NCT00404352|10868888|FG006|COMPLETED|Open Label (up to 24 Month)||0
9764561|NCT00404352|10868889|FG007|COMPLETED|Open Label (up to 24 Month)||0
9764562|NCT00404352|10868890|FG008|COMPLETED|Open Label (up to 24 Month)||0
9764563|NCT00404352|10868882|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0
9764564|NCT00404352|10868883|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0
9764565|NCT00404352|10868884|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0
9764566|NCT00404352|10868885|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3
9764567|NCT00404352|10868886|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2
9764568|NCT00404352|10868887|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7
9764569|NCT00404352|10868888|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0
9764570|NCT00404352|10868889|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0
9764571|NCT00404352|10868890|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0
9764572|NCT00404352|10868882|FG000|STARTED|Open Label Extension (up to 36 Months)||0
9764573|NCT00404352|10868883|FG001|STARTED|Open Label Extension (up to 36 Months)||0
9764574|NCT00404352|10868884|FG002|STARTED|Open Label Extension (up to 36 Months)||0
10232262|NCT02287025|11361479|FG000|COMPLETED|Overall Study||2
10232263|NCT02287025|11361480|FG001|COMPLETED|Overall Study||2
10232264|NCT02287025|11361479|FG000|NOT COMPLETED|Overall Study||10
10232265|NCT02287025|11361480|FG001|NOT COMPLETED|Overall Study||9
9764575|NCT00404352|10868885|FG003|STARTED|Open Label Extension (up to 36 Months)||0
9764576|NCT00404352|10868886|FG004|STARTED|Open Label Extension (up to 36 Months)||0
9764577|NCT00404352|10868887|FG005|STARTED|Open Label Extension (up to 36 Months)||0
9764578|NCT00404352|10868888|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
9764579|NCT00404352|10868889|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
9764580|NCT00404352|10868890|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
9764581|NCT00404352|10868882|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0
9764582|NCT00404352|10868883|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0
9764583|NCT00404352|10868884|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0
9764584|NCT00404352|10868885|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0
9764585|NCT00404352|10868886|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0
9764586|NCT00404352|10868887|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0
9764587|NCT00404352|10868888|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3
9764588|NCT00404352|10868889|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4
9764589|NCT00404352|10868890|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9
9764590|NCT00404352|10868882|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
9764591|NCT00404352|10868883|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
9764592|NCT00404352|10868884|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
9764593|NCT00404352|10868885|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
9764594|NCT00404352|10868886|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
9764595|NCT00404352|10868887|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
9764596|NCT00404352|10868888|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
9764597|NCT00404352|10868889|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
9764598|NCT00404352|10868890|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
9764599|NCT00404495|10868909|FG000|STARTED|Overall Study||66
9764600|NCT00404495|10868910|FG001|STARTED|Overall Study||17
9764601|NCT00404495|10868909|FG000|COMPLETED|Overall Study||22
9764602|NCT00404495|10868910|FG001|COMPLETED|Overall Study||6
9764603|NCT00404495|10868909|FG000|NOT COMPLETED|Overall Study||44
9764604|NCT00404495|10868910|FG001|NOT COMPLETED|Overall Study||11
9764605|NCT00404547|10868918|FG000|STARTED|Overall Study||762
9764606|NCT00404547|10868919|FG001|STARTED|Overall Study||359
9764607|NCT00404547|10868918|FG000|COMPLETED|Overall Study||672
9764608|NCT00404547|10868919|FG001|COMPLETED|Overall Study||334
9764609|NCT00404547|10868918|FG000|NOT COMPLETED|Overall Study||90
9764610|NCT00404547|10868919|FG001|NOT COMPLETED|Overall Study||25
9764611|NCT00404651|10868929|FG000|STARTED|Overall Study||340
9764612|NCT00404651|10868930|FG001|STARTED|Overall Study||343
9764613|NCT00404651|10868931|FG002|STARTED|Overall Study||339
9764614|NCT00404651|10868932|FG003|STARTED|Overall Study||167
9764615|NCT00404651|10868929|FG000|COMPLETED|Overall Study||301
9764616|NCT00404651|10868930|FG001|COMPLETED|Overall Study||315
9764617|NCT00404651|10868931|FG002|COMPLETED|Overall Study||294
9764618|NCT00404651|10868932|FG003|COMPLETED|Overall Study||146
9764619|NCT00404651|10868929|FG000|NOT COMPLETED|Overall Study||39
9764620|NCT00404651|10868930|FG001|NOT COMPLETED|Overall Study||28
9764621|NCT00404651|10868931|FG002|NOT COMPLETED|Overall Study||45
9764622|NCT00404651|10868932|FG003|NOT COMPLETED|Overall Study||21
9764623|NCT00404755|10868942|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
9764624|NCT00404755|10868942|FG000|COMPLETED|Phase I (Bupropion)||13
9764625|NCT00404755|10868942|FG000|NOT COMPLETED|Phase I (Bupropion)||4
9764626|NCT00404755|10868942|FG000|STARTED|Phase II (Escitalopram)||11
9764627|NCT00404755|10868942|FG000|COMPLETED|Phase II (Escitalopram)||9
9764628|NCT00404755|10868942|FG000|NOT COMPLETED|Phase II (Escitalopram)||2
9764629|NCT00404755|10868942|FG000|STARTED|Phase III (Imipramine)||3
9764630|NCT00404755|10868942|FG000|COMPLETED|Phase III (Imipramine)||3
9764631|NCT00404755|10868942|FG000|NOT COMPLETED|Phase III (Imipramine)||0
9764632|NCT00404768|10868954|FG000|STARTED|Part A and B||20
9764633|NCT00404768|10868955|FG001|STARTED|Part A and B||9
9764634|NCT00404768|10868956|FG002|STARTED|Part A and B||0
9764635|NCT00404768|10868957|FG003|STARTED|Part A and B||0
9764636|NCT00404768|10868954|FG000|COMPLETED|Part A and B||19
9764637|NCT00404768|10868955|FG001|COMPLETED|Part A and B||8
9764638|NCT00404768|10868956|FG002|COMPLETED|Part A and B||0
9764639|NCT00404768|10868957|FG003|COMPLETED|Part A and B||0
9764640|NCT00404768|10868954|FG000|NOT COMPLETED|Part A and B||1
9764641|NCT00404768|10868955|FG001|NOT COMPLETED|Part A and B||1
9764642|NCT00404768|10868956|FG002|NOT COMPLETED|Part A and B||0
9764643|NCT00404768|10868957|FG003|NOT COMPLETED|Part A and B||0
9764644|NCT00404768|10868954|FG000|STARTED|Part C||0
9764645|NCT00404768|10868955|FG001|STARTED|Part C||0
9764646|NCT00404768|10868956|FG002|STARTED|Part C||30
9764647|NCT00404768|10868957|FG003|STARTED|Part C||34
9764648|NCT00404768|10868954|FG000|COMPLETED|Part C||0
9764649|NCT00404768|10868955|FG001|COMPLETED|Part C||0
9764650|NCT00404768|10868956|FG002|COMPLETED|Part C||22
9764651|NCT00404768|10868957|FG003|COMPLETED|Part C||20
9764652|NCT00404768|10868954|FG000|NOT COMPLETED|Part C||0
9764653|NCT00404768|10868955|FG001|NOT COMPLETED|Part C||0
9764654|NCT00404768|10868956|FG002|NOT COMPLETED|Part C||8
9764655|NCT00404768|10868957|FG003|NOT COMPLETED|Part C||14
9764656|NCT00404820|10868974|FG000|STARTED|Overall Study||408
9764657|NCT00404820|10868975|FG001|STARTED|Overall Study||196
9764658|NCT00404820|10868974|FG000|Started Treatment|Overall Study||408
9764659|NCT00404820|10868975|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
9764660|NCT00404820|10868974|FG000|COMPLETED|Overall Study||389
9764661|NCT00404820|10868975|FG001|COMPLETED|Overall Study||172
9764662|NCT00404820|10868974|FG000|NOT COMPLETED|Overall Study||19
9764663|NCT00404820|10868975|FG001|NOT COMPLETED|Overall Study||24
9764664|NCT00404924|10868983|FG000|STARTED|Overall Study|randomised patients|617
9764665|NCT00404924|10868984|FG001|STARTED|Overall Study|randomised patients|307
9764666|NCT00404924|10868983|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
9764667|NCT00404924|10868984|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
9764668|NCT00404924|10868983|FG000|NOT COMPLETED|Overall Study||603
9764669|NCT00404924|10868984|FG001|NOT COMPLETED|Overall Study||306
9764670|NCT00405067|10868993|FG000|STARTED|Overall Study||28
9764671|NCT00405067|10868994|FG001|STARTED|Overall Study||28
9764672|NCT00405067|10868995|FG002|STARTED|Overall Study||29
9764673|NCT00405067|10868993|FG000|COMPLETED|Overall Study||24
9764674|NCT00405067|10868994|FG001|COMPLETED|Overall Study||19
9764675|NCT00405067|10868995|FG002|COMPLETED|Overall Study||24
9764676|NCT00405067|10868993|FG000|NOT COMPLETED|Overall Study||4
9764677|NCT00405067|10868994|FG001|NOT COMPLETED|Overall Study||9
9764678|NCT00405067|10868995|FG002|NOT COMPLETED|Overall Study||5
9764679|NCT00405275|10869005|FG000|STARTED|Overall Study||178
9764680|NCT00405275|10869006|FG001|STARTED|Overall Study||175
9764681|NCT00405275|10869005|FG000|24 Weeks (Total)|Overall Study||163
9764682|NCT00405275|10869006|FG001|24 Weeks (Total)|Overall Study||165
9764683|NCT00405275|10869005|FG000|24 Week (no Switch)|Overall Study||119
9764684|NCT00405275|10869006|FG001|24 Week (no Switch)|Overall Study||121
9764685|NCT00405275|10869005|FG000|24 Week (Switch)|Overall Study||44
9764686|NCT00405275|10869006|FG001|24 Week (Switch)|Overall Study||44
9764687|NCT00405275|10869005|FG000|COMPLETED|Overall Study||155
9764688|NCT00405275|10869006|FG001|COMPLETED|Overall Study||156
9764689|NCT00405275|10869005|FG000|NOT COMPLETED|Overall Study||23
9764690|NCT00405275|10869006|FG001|NOT COMPLETED|Overall Study||19
9764691|NCT00405288|10869014|FG000|STARTED|Overall Study||204
9764692|NCT00405288|10869015|FG001|STARTED|Overall Study||204
9764693|NCT00405288|10869014|FG000|COMPLETED|Overall Study||204
9764694|NCT00405288|10869015|FG001|COMPLETED|Overall Study||204
9764695|NCT00405288|10869014|FG000|NOT COMPLETED|Overall Study||0
9764696|NCT00405288|10869015|FG001|NOT COMPLETED|Overall Study||0
9764697|NCT00405353|10869021|FG000|STARTED|Overall Study||10
9764698|NCT00405353|10869021|FG000|COMPLETED|Overall Study||10
9764699|NCT00405353|10869021|FG000|NOT COMPLETED|Overall Study||0
9764700|NCT00405392|10869027|FG000|STARTED|Overall Study||183
9764701|NCT00405392|10869028|FG001|STARTED|Overall Study||182
9764702|NCT00405392|10869027|FG000|COMPLETED|Overall Study||153
9764703|NCT00405392|10869028|FG001|COMPLETED|Overall Study||155
9764704|NCT00405392|10869027|FG000|NOT COMPLETED|Overall Study||30
9764705|NCT00405392|10869028|FG001|NOT COMPLETED|Overall Study||27
9764706|NCT00405509|10869036|FG000|STARTED|Overall Study||11
9764707|NCT00405509|10869037|FG001|STARTED|Overall Study||22
9764708|NCT00405509|10869036|FG000|COMPLETED|Overall Study||11
9764709|NCT00405509|10869037|FG001|COMPLETED|Overall Study||22
9764710|NCT00405509|10869036|FG000|NOT COMPLETED|Overall Study||0
9764711|NCT00405509|10869037|FG001|NOT COMPLETED|Overall Study||0
9764712|NCT00405522|10869045|FG000|STARTED|Overall Study||17
9764713|NCT00405522|10869046|FG001|STARTED|Overall Study||17
9764714|NCT00405522|10869045|FG000|COMPLETED|Overall Study||17
9764715|NCT00405522|10869046|FG001|COMPLETED|Overall Study||17
9764716|NCT00405522|10869045|FG000|NOT COMPLETED|Overall Study||0
9764717|NCT00405522|10869046|FG001|NOT COMPLETED|Overall Study||0
9764718|NCT00405548|10869054|FG000|STARTED|Overall Study||28
9764719|NCT00405548|10869055|FG001|STARTED|Overall Study||13
9764720|NCT00405548|10869054|FG000|COMPLETED|Overall Study||24
9764721|NCT00405548|10869055|FG001|COMPLETED|Overall Study||12
9764722|NCT00405548|10869054|FG000|NOT COMPLETED|Overall Study||4
9764723|NCT00405548|10869055|FG001|NOT COMPLETED|Overall Study||1
9764724|NCT00405587|10869065|FG000|STARTED|Overall Study||26
9764725|NCT00405587|10869066|FG001|STARTED|Overall Study||30
9764726|NCT00405587|10869067|FG002|STARTED|Overall Study||32
9764727|NCT00405587|10869068|FG003|STARTED|Overall Study||21
9764728|NCT00405587|10869065|FG000|COMPLETED|Overall Study||0
9764729|NCT00405587|10869066|FG001|COMPLETED|Overall Study||2
9764730|NCT00405587|10869067|FG002|COMPLETED|Overall Study||10
9764731|NCT00405587|10869068|FG003|COMPLETED|Overall Study||1
9764732|NCT00405587|10869065|FG000|NOT COMPLETED|Overall Study||26
9764733|NCT00405587|10869066|FG001|NOT COMPLETED|Overall Study||28
9764734|NCT00405587|10869067|FG002|NOT COMPLETED|Overall Study||22
9764735|NCT00405587|10869068|FG003|NOT COMPLETED|Overall Study||20
9764736|NCT00405639|10869106|FG000|STARTED|Overall Study||25
9764737|NCT00405639|10869107|FG001|STARTED|Overall Study||12
9764738|NCT00405639|10869106|FG000|COMPLETED|Overall Study||22
9764739|NCT00405639|10869107|FG001|COMPLETED|Overall Study||12
9764740|NCT00405639|10869106|FG000|NOT COMPLETED|Overall Study||3
9764741|NCT00405639|10869107|FG001|NOT COMPLETED|Overall Study||0
9764742|NCT00405652|10869113|FG000|STARTED|Overall Study||34
9764743|NCT00405652|10869113|FG000|COMPLETED|Overall Study||30
9764744|NCT00405652|10869113|FG000|NOT COMPLETED|Overall Study||4
9764745|NCT00405704|10869119|FG000|STARTED|Overall Study||302
9764746|NCT00405704|10869120|FG001|STARTED|Overall Study||305
9764747|NCT00405704|10869119|FG000|Completed Outcome Renal Scan|Overall Study||227
9764748|NCT00405704|10869120|FG001|Completed Outcome Renal Scan|Overall Study||235
9764749|NCT00405704|10869119|FG000|Completed Assessments for New Scarring|Overall Study||220
9764750|NCT00405704|10869120|FG001|Completed Assessments for New Scarring|Overall Study||227
9764751|NCT00405704|10869119|FG000|Outcome Stool Assessed|Overall Study||203
9764752|NCT00405704|10869120|FG001|Outcome Stool Assessed|Overall Study||210
9764753|NCT00405704|10869119|FG000|Recurrent UTI With E. Coli|Overall Study||30
9764754|NCT00405704|10869120|FG001|Recurrent UTI With E. Coli|Overall Study||57
9764755|NCT00405704|10869119|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
9764756|NCT00405704|10869120|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
9764757|NCT00405704|10869119|FG000|COMPLETED|Overall Study||261
9764758|NCT00405704|10869120|FG001|COMPLETED|Overall Study||259
9764759|NCT00405704|10869119|FG000|NOT COMPLETED|Overall Study||41
9764760|NCT00405704|10869120|FG001|NOT COMPLETED|Overall Study||46
9764761|NCT00405756|10869130|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
9764762|NCT00405756|10869131|FG001|STARTED|Double-blind Treatment||153
9764763|NCT00405756|10869132|FG002|STARTED|Double-blind Treatment||154
9764764|NCT00405756|10869130|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
9764765|NCT00405756|10869131|FG001|Safety Population|Double-blind Treatment||152
9764766|NCT00405756|10869132|FG002|Safety Population|Double-blind Treatment||153
9764767|NCT00405756|10869130|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
9764768|NCT00405756|10869131|FG001|COMPLETED|Double-blind Treatment||0
9764769|NCT00405756|10869132|FG002|COMPLETED|Double-blind Treatment||0
9764770|NCT00405756|10869130|FG000|NOT COMPLETED|Double-blind Treatment||152
9764771|NCT00405756|10869131|FG001|NOT COMPLETED|Double-blind Treatment||153
9764772|NCT00405756|10869132|FG002|NOT COMPLETED|Double-blind Treatment||154
9764773|NCT00405756|10869130|FG000|STARTED|Open-label Extension||19
9764774|NCT00405756|10869131|FG001|STARTED|Open-label Extension||47
9764775|NCT00405756|10869132|FG002|STARTED|Open-label Extension||72
9764776|NCT00405756|10869130|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
9764777|NCT00405756|10869131|FG001|COMPLETED|Open-label Extension||0
9764778|NCT00405756|10869132|FG002|COMPLETED|Open-label Extension||0
9764779|NCT00405756|10869130|FG000|NOT COMPLETED|Open-label Extension||19
9764780|NCT00405756|10869131|FG001|NOT COMPLETED|Open-label Extension||47
9764781|NCT00405756|10869132|FG002|NOT COMPLETED|Open-label Extension||72
9764782|NCT00405756|10869130|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
9764783|NCT00405756|10869131|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
9764784|NCT00405756|10869132|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
9764785|NCT00405756|10869130|FG000|COMPLETED|Follow-up||0
9764786|NCT00405756|10869131|FG001|COMPLETED|Follow-up||0
9764787|NCT00405756|10869132|FG002|COMPLETED|Follow-up||0
9764788|NCT00405756|10869130|FG000|NOT COMPLETED|Follow-up||75
9764789|NCT00405756|10869131|FG001|NOT COMPLETED|Follow-up||90
9764790|NCT00405756|10869132|FG002|NOT COMPLETED|Follow-up||88
9764791|NCT00405821|10869142|FG000|STARTED|Overall Study||220
9764792|NCT00405821|10869143|FG001|STARTED|Overall Study||220
9764793|NCT00405821|10869142|FG000|COMPLETED|Overall Study||198
9764794|NCT00405821|10869143|FG001|COMPLETED|Overall Study||198
9764795|NCT00405821|10869142|FG000|NOT COMPLETED|Overall Study||22
9764796|NCT00405821|10869143|FG001|NOT COMPLETED|Overall Study||22
9764797|NCT00405912|10869152|FG000|STARTED|Overall Study||39
10013852|NCT01795534|11136807|FG000|STARTED|Wash Out Period (4 Days)||5
10013853|NCT01795534|11136808|FG001|STARTED|Wash Out Period (4 Days)||5
10013854|NCT01795534|11136807|FG000|COMPLETED|Wash Out Period (4 Days)||5
10013855|NCT01795534|11136808|FG001|COMPLETED|Wash Out Period (4 Days)||5
10013856|NCT01795534|11136807|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0
9764798|NCT00405912|10869153|FG001|STARTED|Overall Study||40
9764799|NCT00405912|10869154|FG002|STARTED|Overall Study||39
9764800|NCT00405912|10869152|FG000|COMPLETED|Overall Study||23
9764801|NCT00405912|10869153|FG001|COMPLETED|Overall Study||21
9764802|NCT00405912|10869154|FG002|COMPLETED|Overall Study||23
9764803|NCT00405912|10869152|FG000|NOT COMPLETED|Overall Study||16
9764804|NCT00405912|10869153|FG001|NOT COMPLETED|Overall Study||19
9764805|NCT00405912|10869154|FG002|NOT COMPLETED|Overall Study||16
9764806|NCT00405938|10869164|FG000|STARTED|Overall Study||38
9764807|NCT00405938|10869165|FG001|STARTED|Overall Study||41
9764808|NCT00405938|10869164|FG000|COMPLETED|Overall Study||38
9764809|NCT00405938|10869165|FG001|COMPLETED|Overall Study||41
9764810|NCT00405938|10869164|FG000|NOT COMPLETED|Overall Study||0
9764811|NCT00405938|10869165|FG001|NOT COMPLETED|Overall Study||0
9764812|NCT00406029|10869176|FG000|STARTED|Overall Study||49
9764813|NCT00406029|10869177|FG001|STARTED|Overall Study||49
9764814|NCT00406029|10869178|FG002|STARTED|Overall Study||49
9764815|NCT00406029|10869179|FG003|STARTED|Overall Study||57
9764816|NCT00406029|10869180|FG004|STARTED|Overall Study||49
9764817|NCT00406029|10869176|FG000|Treated|Overall Study||49
9764818|NCT00406029|10869177|FG001|Treated|Overall Study||49
9764819|NCT00406029|10869178|FG002|Treated|Overall Study||47
9764820|NCT00406029|10869179|FG003|Treated|Overall Study||54
9764821|NCT00406029|10869180|FG004|Treated|Overall Study||47
9764822|NCT00406029|10869176|FG000|COMPLETED|Overall Study||33
9764823|NCT00406029|10869177|FG001|COMPLETED|Overall Study||41
9764824|NCT00406029|10869178|FG002|COMPLETED|Overall Study||39
10013857|NCT01795534|11136808|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0
10013858|NCT01795534|11136807|FG000|STARTED|Second Intervention (Second Shot)||5
9764825|NCT00406029|10869179|FG003|COMPLETED|Overall Study||40
9764826|NCT00406029|10869180|FG004|COMPLETED|Overall Study||41
9764827|NCT00406029|10869176|FG000|NOT COMPLETED|Overall Study||16
9764828|NCT00406029|10869177|FG001|NOT COMPLETED|Overall Study||8
9764829|NCT00406029|10869178|FG002|NOT COMPLETED|Overall Study||10
9764830|NCT00406029|10869179|FG003|NOT COMPLETED|Overall Study||17
9764831|NCT00406029|10869180|FG004|NOT COMPLETED|Overall Study||8
9764832|NCT00406107|10869194|FG000|STARTED|Overall Study||15
9764833|NCT00406107|10869195|FG001|STARTED|Overall Study||5
9764834|NCT00406107|10869194|FG000|COMPLETED|Overall Study||14
9764835|NCT00406107|10869195|FG001|COMPLETED|Overall Study||4
9764836|NCT00406107|10869194|FG000|NOT COMPLETED|Overall Study||1
9764837|NCT00406107|10869195|FG001|NOT COMPLETED|Overall Study||1
9764838|NCT00406133|10869206|FG000|STARTED|Phase 1 (First 26 Week Period)||165
9764839|NCT00406133|10869207|FG001|STARTED|Phase 1 (First 26 Week Period)||157
9764840|NCT00406133|10869208|FG002|STARTED|Phase 1 (First 26 Week Period)||67
9764841|NCT00406133|10869209|FG003|STARTED|Phase 1 (First 26 Week Period)||62
9764842|NCT00406133|10869206|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162
9764843|NCT00406133|10869207|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155
9764844|NCT00406133|10869208|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67
9764845|NCT00406133|10869209|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60
9764846|NCT00406133|10869206|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
9764847|NCT00406133|10869207|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
9764848|NCT00406133|10869208|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
9764849|NCT00406133|10869209|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
9764850|NCT00406133|10869206|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
9764851|NCT00406133|10869207|FG001|STARTED|Phase 2 (Second 26 Week Period)||155
9764852|NCT00406133|10869208|FG002|STARTED|Phase 2 (Second 26 Week Period)||67
9764853|NCT00406133|10869209|FG003|STARTED|Phase 2 (Second 26 Week Period)||60
9764854|NCT00406133|10869206|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157
9764855|NCT00406133|10869207|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152
9764856|NCT00406133|10869208|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67
9764857|NCT00406133|10869209|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60
9764858|NCT00406133|10869206|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
9764859|NCT00406133|10869207|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
9764860|NCT00406133|10869208|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
9764861|NCT00406133|10869209|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
9764862|NCT00406276|10869224|FG000|STARTED|Overall Study||28
9764863|NCT00406276|10869224|FG000|COMPLETED|Overall Study||24
9764864|NCT00406276|10869224|FG000|NOT COMPLETED|Overall Study||4
9764865|NCT00406315|10869229|FG000|STARTED|Overall Study|Started = Treated|241
9764866|NCT00406315|10869229|FG000|COMPLETED|Overall Study||100
9764867|NCT00406315|10869229|FG000|NOT COMPLETED|Overall Study||141
9764868|NCT00406354|10869236|FG000|STARTED|All Randomized Patients||60
9764869|NCT00406354|10869237|FG001|STARTED|All Randomized Patients||61
9764870|NCT00406354|10869238|FG002|STARTED|All Randomized Patients||60
9764871|NCT00406354|10869236|FG000|COMPLETED|All Randomized Patients||60
9764872|NCT00406354|10869237|FG001|COMPLETED|All Randomized Patients||61
9764873|NCT00406354|10869238|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
9764874|NCT00406354|10869236|FG000|NOT COMPLETED|All Randomized Patients||0
9764875|NCT00406354|10869237|FG001|NOT COMPLETED|All Randomized Patients||0
9764876|NCT00406354|10869238|FG002|NOT COMPLETED|All Randomized Patients||1
9764877|NCT00406354|10869236|FG000|STARTED|All Randomized and Treated Patients||60
9764878|NCT00406354|10869237|FG001|STARTED|All Randomized and Treated Patients||61
9764879|NCT00406354|10869238|FG002|STARTED|All Randomized and Treated Patients||59
9764880|NCT00406354|10869236|FG000|COMPLETED|All Randomized and Treated Patients||44
9764881|NCT00406354|10869237|FG001|COMPLETED|All Randomized and Treated Patients||48
9764882|NCT00406354|10869238|FG002|COMPLETED|All Randomized and Treated Patients||37
9764883|NCT00406354|10869236|FG000|NOT COMPLETED|All Randomized and Treated Patients||16
9764884|NCT00406354|10869237|FG001|NOT COMPLETED|All Randomized and Treated Patients||13
9764885|NCT00406354|10869238|FG002|NOT COMPLETED|All Randomized and Treated Patients||22
9764886|NCT00406367|10869248|FG000|STARTED|Main Period - 6 to 20 Weeks||75
9764887|NCT00406367|10869249|FG001|STARTED|Main Period - 6 to 20 Weeks||34
9764888|NCT00406367|10869248|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70
9764889|NCT00406367|10869249|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32
9764890|NCT00406367|10869248|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
9764891|NCT00406367|10869249|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
9764892|NCT00406367|10869248|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
9764893|NCT00406367|10869249|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
9764894|NCT00406367|10869248|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
9764895|NCT00406367|10869249|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
9764896|NCT00406367|10869248|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
9764897|NCT00406367|10869249|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
9764898|NCT00406393|10869257|FG000|STARTED|Overall Study||151
9764899|NCT00406393|10869258|FG001|STARTED|Overall Study||153
9764900|NCT00406393|10869257|FG000|COMPLETED|Overall Study||149
9764901|NCT00406393|10869258|FG001|COMPLETED|Overall Study||152
9764902|NCT00406393|10869257|FG000|NOT COMPLETED|Overall Study||2
9764903|NCT00406393|10869258|FG001|NOT COMPLETED|Overall Study||1
9764904|NCT00406419|10869267|FG000|STARTED|Overall Study||324
9764905|NCT00406419|10869268|FG001|STARTED|Overall Study||344
9764906|NCT00406419|10869269|FG002|STARTED|Overall Study||347
9764907|NCT00406419|10869267|FG000|COMPLETED|Overall Study||0
9764908|NCT00406419|10869268|FG001|COMPLETED|Overall Study||0
9764909|NCT00406419|10869269|FG002|COMPLETED|Overall Study||0
9764910|NCT00406419|10869267|FG000|NOT COMPLETED|Overall Study||324
9764911|NCT00406419|10869268|FG001|NOT COMPLETED|Overall Study||344
9764912|NCT00406419|10869269|FG002|NOT COMPLETED|Overall Study||347
9764913|NCT00406640|10869279|FG000|STARTED|Acute Phase||296
9764914|NCT00406640|10869280|FG001|STARTED|Acute Phase||299
9764915|NCT00406640|10869279|FG000|COMPLETED|Acute Phase||245
9764916|NCT00406640|10869280|FG001|COMPLETED|Acute Phase||256
9764917|NCT00406640|10869279|FG000|NOT COMPLETED|Acute Phase||51
9764918|NCT00406640|10869280|FG001|NOT COMPLETED|Acute Phase||43
9764919|NCT00406640|10869279|FG000|STARTED|DB Continuation Phase for Responders||172
9764920|NCT00406640|10869280|FG001|STARTED|DB Continuation Phase for Responders||188
9764921|NCT00406640|10869279|FG000|COMPLETED|DB Continuation Phase for Responders||139
9764922|NCT00406640|10869280|FG001|COMPLETED|DB Continuation Phase for Responders||151
9764923|NCT00406640|10869279|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33
9764924|NCT00406640|10869280|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37
9764925|NCT00406640|10869279|FG000|STARTED|OL Extension Phase for Non-Responders||69
9764926|NCT00406640|10869280|FG001|STARTED|OL Extension Phase for Non-Responders||60
9764927|NCT00406640|10869279|FG000|COMPLETED|OL Extension Phase for Non-Responders||47
9764928|NCT00406640|10869280|FG001|COMPLETED|OL Extension Phase for Non-Responders||36
9764929|NCT00406640|10869279|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22
9764930|NCT00406640|10869280|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24
9764931|NCT00406653|10869296|FG000|STARTED|Induction Period||65
9764932|NCT00406653|10869297|FG001|STARTED|Induction Period||128
9764933|NCT00406653|10869298|FG002|STARTED|Induction Period||130
9764934|NCT00406653|10869299|FG003|STARTED|Induction Period||128
9764935|NCT00406653|10869300|FG004|STARTED|Induction Period||0
9764936|NCT00406653|10869301|FG005|STARTED|Induction Period||0
9764937|NCT00406653|10869302|FG006|STARTED|Induction Period||0
9764938|NCT00406653|10869296|FG000|COMPLETED|Induction Period||50
9764939|NCT00406653|10869297|FG001|COMPLETED|Induction Period||94
9764940|NCT00406653|10869298|FG002|COMPLETED|Induction Period||112
9764941|NCT00406653|10869299|FG003|COMPLETED|Induction Period||102
9764942|NCT00406653|10869300|FG004|COMPLETED|Induction Period||0
9764943|NCT00406653|10869301|FG005|COMPLETED|Induction Period||0
9764944|NCT00406653|10869302|FG006|COMPLETED|Induction Period||0
9764945|NCT00406653|10869296|FG000|NOT COMPLETED|Induction Period||15
9764946|NCT00406653|10869297|FG001|NOT COMPLETED|Induction Period||34
9764947|NCT00406653|10869298|FG002|NOT COMPLETED|Induction Period||18
9764948|NCT00406653|10869299|FG003|NOT COMPLETED|Induction Period||26
9764949|NCT00406653|10869300|FG004|NOT COMPLETED|Induction Period||0
9764950|NCT00406653|10869301|FG005|NOT COMPLETED|Induction Period||0
9764951|NCT00406653|10869302|FG006|NOT COMPLETED|Induction Period||0
9764952|NCT00406653|10869296|FG000|STARTED|Maintenance Period||0
9764953|NCT00406653|10869297|FG001|STARTED|Maintenance Period||0
9764954|NCT00406653|10869298|FG002|STARTED|Maintenance Period||0
9764955|NCT00406653|10869299|FG003|STARTED|Maintenance Period||0
9764956|NCT00406653|10869300|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
9764957|NCT00406653|10869301|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
9764958|NCT00406653|10869302|FG006|STARTED|Maintenance Period||0
9764959|NCT00406653|10869296|FG000|COMPLETED|Maintenance Period||0
9764960|NCT00406653|10869297|FG001|COMPLETED|Maintenance Period||0
9764961|NCT00406653|10869298|FG002|COMPLETED|Maintenance Period||0
9764962|NCT00406653|10869299|FG003|COMPLETED|Maintenance Period||0
9764963|NCT00406653|10869300|FG004|COMPLETED|Maintenance Period||14
9764964|NCT00406653|10869301|FG005|COMPLETED|Maintenance Period||10
9764965|NCT00406653|10869302|FG006|COMPLETED|Maintenance Period||0
9764966|NCT00406653|10869296|FG000|NOT COMPLETED|Maintenance Period||0
9764967|NCT00406653|10869297|FG001|NOT COMPLETED|Maintenance Period||0
9764968|NCT00406653|10869298|FG002|NOT COMPLETED|Maintenance Period||0
9764969|NCT00406653|10869299|FG003|NOT COMPLETED|Maintenance Period||0
9764970|NCT00406653|10869300|FG004|NOT COMPLETED|Maintenance Period||30
9764971|NCT00406653|10869301|FG005|NOT COMPLETED|Maintenance Period||36
9764972|NCT00406653|10869302|FG006|NOT COMPLETED|Maintenance Period||0
9764973|NCT00406653|10869296|FG000|STARTED|Open-Label Period||0
9764974|NCT00406653|10869297|FG001|STARTED|Open-Label Period||0
9764975|NCT00406653|10869298|FG002|STARTED|Open-Label Period||0
9764976|NCT00406653|10869299|FG003|STARTED|Open-Label Period||0
9764977|NCT00406653|10869300|FG004|STARTED|Open-Label Period||0
9764978|NCT00406653|10869301|FG005|STARTED|Open-Label Period||0
9764979|NCT00406653|10869302|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
9764980|NCT00406653|10869296|FG000|COMPLETED|Open-Label Period||0
9764981|NCT00406653|10869297|FG001|COMPLETED|Open-Label Period||0
9764982|NCT00406653|10869298|FG002|COMPLETED|Open-Label Period||0
9764983|NCT00406653|10869299|FG003|COMPLETED|Open-Label Period||0
9764984|NCT00406653|10869300|FG004|COMPLETED|Open-Label Period||0
9764985|NCT00406653|10869301|FG005|COMPLETED|Open-Label Period||0
9764986|NCT00406653|10869302|FG006|COMPLETED|Open-Label Period||0
9764987|NCT00406653|10869296|FG000|NOT COMPLETED|Open-Label Period||0
9764988|NCT00406653|10869297|FG001|NOT COMPLETED|Open-Label Period||0
9764989|NCT00406653|10869298|FG002|NOT COMPLETED|Open-Label Period||0
9764990|NCT00406653|10869299|FG003|NOT COMPLETED|Open-Label Period||0
9764991|NCT00406653|10869300|FG004|NOT COMPLETED|Open-Label Period||0
9764992|NCT00406653|10869301|FG005|NOT COMPLETED|Open-Label Period||0
9764993|NCT00406653|10869302|FG006|NOT COMPLETED|Open-Label Period||324
9764994|NCT00406692|10869322|FG000|STARTED|Overall Study||16
9764995|NCT00406692|10869322|FG000|COMPLETED|Overall Study||9
9764996|NCT00406692|10869322|FG000|NOT COMPLETED|Overall Study||7
9764997|NCT00406718|10869329|FG000|STARTED|Overall Study||47
9764998|NCT00406718|10869330|FG001|STARTED|Overall Study||48
9764999|NCT00406718|10869331|FG002|STARTED|Overall Study||47
9765000|NCT00406718|10869329|FG000|COMPLETED|Overall Study||43
9765001|NCT00406718|10869330|FG001|COMPLETED|Overall Study||34
9765002|NCT00406718|10869331|FG002|COMPLETED|Overall Study||39
9765003|NCT00406718|10869329|FG000|NOT COMPLETED|Overall Study||4
9765004|NCT00406718|10869330|FG001|NOT COMPLETED|Overall Study||14
9765005|NCT00406718|10869331|FG002|NOT COMPLETED|Overall Study||8
9765006|NCT00406848|10869343|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
9765007|NCT00406848|10869344|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
9765008|NCT00406848|10869343|FG000|COMPLETED|Overall Study||156
9765009|NCT00406848|10869344|FG001|COMPLETED|Overall Study||67
9765010|NCT00406848|10869343|FG000|NOT COMPLETED|Overall Study||93
9765011|NCT00406848|10869344|FG001|NOT COMPLETED|Overall Study||54
9765012|NCT00407030|10869356|FG000|STARTED|Main Period - 8 to 20 Weeks||81
9765013|NCT00407030|10869357|FG001|STARTED|Main Period - 8 to 20 Weeks||78
9765014|NCT00407030|10869358|FG002|STARTED|Main Period - 8 to 20 Weeks||74
9765015|NCT00407030|10869356|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76
9765016|NCT00407030|10869357|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75
9765017|NCT00407030|10869358|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68
9765018|NCT00407030|10869356|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
9765019|NCT00407030|10869357|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
9765020|NCT00407030|10869358|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
9765021|NCT00407030|10869356|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
9765022|NCT00407030|10869357|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
9765023|NCT00407030|10869358|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
9765024|NCT00407030|10869356|FG000|COMPLETED|Extension Period - up to 68 Weeks||84
9765025|NCT00407030|10869357|FG001|COMPLETED|Extension Period - up to 68 Weeks||74
9765026|NCT00407030|10869358|FG002|COMPLETED|Extension Period - up to 68 Weeks||0
9765027|NCT00407030|10869356|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27
9765028|NCT00407030|10869357|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29
9765029|NCT00407030|10869358|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0
9765030|NCT00407355|10869370|FG000|STARTED|Overall Study||20
9765031|NCT00407355|10869371|FG001|STARTED|Overall Study||20
9765032|NCT00407355|10869370|FG000|COMPLETED|Overall Study||10
9765033|NCT00407355|10869371|FG001|COMPLETED|Overall Study||9
9765034|NCT00407355|10869370|FG000|NOT COMPLETED|Overall Study||10
9765035|NCT00407355|10869371|FG001|NOT COMPLETED|Overall Study||11
9765036|NCT00407381|10869380|FG000|STARTED|Overall Study||42
9765037|NCT00407381|10869381|FG001|STARTED|Overall Study||42
9765038|NCT00407381|10869382|FG002|STARTED|Overall Study||42
9765039|NCT00407381|10869380|FG000|COMPLETED|Overall Study||39
9765040|NCT00407381|10869381|FG001|COMPLETED|Overall Study||38
9765041|NCT00407381|10869382|FG002|COMPLETED|Overall Study||40
9765042|NCT00407381|10869380|FG000|NOT COMPLETED|Overall Study||3
9765043|NCT00407381|10869381|FG001|NOT COMPLETED|Overall Study||4
9765044|NCT00407381|10869382|FG002|NOT COMPLETED|Overall Study||2
9765045|NCT00407420|10869392|FG000|STARTED|Overall Study||54
9765046|NCT00407420|10869393|FG001|STARTED|Overall Study||52
9765047|NCT00407420|10869392|FG000|COMPLETED|Overall Study||45
9765048|NCT00407420|10869393|FG001|COMPLETED|Overall Study||46
9765049|NCT00407420|10869392|FG000|NOT COMPLETED|Overall Study||9
9765050|NCT00407420|10869393|FG001|NOT COMPLETED|Overall Study||6
9765051|NCT00407485|10869401|FG000|STARTED|Overall Study||22
9765052|NCT00407485|10869401|FG000|COMPLETED|Overall Study||22
9765053|NCT00407485|10869401|FG000|NOT COMPLETED|Overall Study||0
9765054|NCT00407511|10869406|FG000|STARTED|Overall Study||121
9765055|NCT00407511|10869406|FG000|COMPLETED|Overall Study||99
9765056|NCT00407511|10869406|FG000|NOT COMPLETED|Overall Study||22
9765057|NCT00407537|10869412|FG000|STARTED|Overall Study||779
9765058|NCT00407537|10869413|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
9765059|NCT00407537|10869412|FG000|Eligible for Efficacy Analysis|Overall Study||760
9765060|NCT00407537|10869413|FG001|Eligible for Efficacy Analysis|Overall Study||657
9765061|NCT00407537|10869412|FG000|COMPLETED|Overall Study||686
9765062|NCT00407537|10869413|FG001|COMPLETED|Overall Study||638
9765063|NCT00407537|10869412|FG000|NOT COMPLETED|Overall Study||93
9765064|NCT00407537|10869413|FG001|NOT COMPLETED|Overall Study||44
9765065|NCT00407550|10869421|FG000|STARTED|Overall Study||10
9765066|NCT00407550|10869422|FG001|STARTED|Overall Study||9
9765067|NCT00407550|10869421|FG000|COMPLETED|Overall Study||7
9765068|NCT00407550|10869422|FG001|COMPLETED|Overall Study||5
9765069|NCT00407550|10869421|FG000|NOT COMPLETED|Overall Study||3
9765070|NCT00407550|10869422|FG001|NOT COMPLETED|Overall Study||4
9765071|NCT00407563|10869428|FG000|STARTED|Overall Study||48
9765072|NCT00407563|10869428|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47
9765073|NCT00407563|10869428|FG000|NOT COMPLETED|Overall Study||1
9765074|NCT00407654|10869432|FG000|STARTED|Overall Study||75
9765075|NCT00407654|10869432|FG000|COMPLETED|Overall Study||75
9765076|NCT00407654|10869432|FG000|NOT COMPLETED|Overall Study||0
9765077|NCT00407745|10869439|FG000|STARTED|Overall Study||112
9765078|NCT00407745|10869440|FG001|STARTED|Overall Study||108
9765079|NCT00407745|10869439|FG000|Treated|Overall Study||112
9765080|NCT00407745|10869440|FG001|Treated|Overall Study||107
9765081|NCT00407745|10869439|FG000|COMPLETED|Overall Study||93
9765082|NCT00407745|10869440|FG001|COMPLETED|Overall Study||91
9765083|NCT00407745|10869439|FG000|NOT COMPLETED|Overall Study||19
9765084|NCT00407745|10869440|FG001|NOT COMPLETED|Overall Study||17
9765085|NCT00407758|10869446|FG000|STARTED|Overall Study||28
9765086|NCT00407758|10869446|FG000|COMPLETED|Overall Study||27
9765087|NCT00407758|10869446|FG000|NOT COMPLETED|Overall Study||1
9765088|NCT00407797|10869450|FG000|STARTED|Overall Study||136
9765089|NCT00407797|10869450|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
9765090|NCT00407797|10869450|FG000|COMPLETED|Overall Study||118
9765091|NCT00407797|10869450|FG000|NOT COMPLETED|Overall Study||18
9765092|NCT00407888|10869454|FG000|STARTED|Overall Study||60
9765093|NCT00407888|10869454|FG000|COMPLETED|Overall Study||60
9765094|NCT00407888|10869454|FG000|NOT COMPLETED|Overall Study||0
9765095|NCT00407966|10869458|FG000|STARTED|Overall Study||45
9765096|NCT00407966|10869458|FG000|CR|Overall Study||30
9765097|NCT00407966|10869458|FG000|COMPLETED|Overall Study||45
9765098|NCT00407966|10869458|FG000|NOT COMPLETED|Overall Study||0
9765099|NCT00408070|10869462|FG000|STARTED|Overall Study||5
9765100|NCT00408070|10869462|FG000|COMPLETED|Overall Study||5
9765101|NCT00408070|10869462|FG000|NOT COMPLETED|Overall Study||0
9765102|NCT00408200|10869468|FG000|STARTED|Overall Study||57
9765103|NCT00408200|10869469|FG001|STARTED|Overall Study||53
9765104|NCT00408200|10869468|FG000|COMPLETED|Overall Study||57
9765105|NCT00408200|10869469|FG001|COMPLETED|Overall Study||53
9765106|NCT00408200|10869468|FG000|NOT COMPLETED|Overall Study||0
9765107|NCT00408200|10869469|FG001|NOT COMPLETED|Overall Study||0
9765108|NCT00408317|10869475|FG000|STARTED|First Intervention Period||14
9765109|NCT00408317|10869476|FG001|STARTED|First Intervention Period||17
9765110|NCT00408317|10869475|FG000|COMPLETED|First Intervention Period||14
9765111|NCT00408317|10869476|FG001|COMPLETED|First Intervention Period||16
9765112|NCT00408317|10869475|FG000|NOT COMPLETED|First Intervention Period||0
9765113|NCT00408317|10869476|FG001|NOT COMPLETED|First Intervention Period||1
9765114|NCT00408317|10869475|FG000|STARTED|Second Intervention Period||14
9765115|NCT00408317|10869476|FG001|STARTED|Second Intervention Period||16
9765116|NCT00408317|10869475|FG000|COMPLETED|Second Intervention Period||12
9765117|NCT00408317|10869476|FG001|COMPLETED|Second Intervention Period||14
9765118|NCT00408317|10869475|FG000|NOT COMPLETED|Second Intervention Period||2
9765119|NCT00408317|10869476|FG001|NOT COMPLETED|Second Intervention Period||2
9765120|NCT00408408|10869488|FG000|STARTED|Overall Study||201
9765121|NCT00408408|10869489|FG001|STARTED|Overall Study||199
9765122|NCT00408408|10869490|FG002|STARTED|Overall Study||204
9765123|NCT00408408|10869491|FG003|STARTED|Overall Study||201
9765124|NCT00408408|10869492|FG004|STARTED|Overall Study||197
9765125|NCT00408408|10869493|FG005|STARTED|Overall Study||204
9765126|NCT00408408|10869488|FG000|COMPLETED|Overall Study||199
9765127|NCT00408408|10869489|FG001|COMPLETED|Overall Study||196
9765128|NCT00408408|10869490|FG002|COMPLETED|Overall Study||204
9765129|NCT00408408|10869491|FG003|COMPLETED|Overall Study||194
9765130|NCT00408408|10869492|FG004|COMPLETED|Overall Study||192
9765131|NCT00408408|10869493|FG005|COMPLETED|Overall Study||201
9765132|NCT00408408|10869488|FG000|NOT COMPLETED|Overall Study||2
9765133|NCT00408408|10869489|FG001|NOT COMPLETED|Overall Study||3
9765134|NCT00408408|10869490|FG002|NOT COMPLETED|Overall Study||0
9765135|NCT00408408|10869491|FG003|NOT COMPLETED|Overall Study||7
9765136|NCT00408408|10869492|FG004|NOT COMPLETED|Overall Study||5
9765137|NCT00408408|10869493|FG005|NOT COMPLETED|Overall Study||3
9765138|NCT00408421|10869509|FG000|STARTED|Treatment Initial Randomization||120
9765139|NCT00408421|10869510|FG001|STARTED|Treatment Initial Randomization||111
9765140|NCT00408421|10869511|FG002|STARTED|Treatment Initial Randomization||0
9765141|NCT00408421|10869509|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
9765142|NCT00408421|10869510|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
9765143|NCT00408421|10869511|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
9765144|NCT00408421|10869509|FG000|NOT COMPLETED|Treatment Initial Randomization||17
9765145|NCT00408421|10869510|FG001|NOT COMPLETED|Treatment Initial Randomization||22
9765146|NCT00408421|10869511|FG002|NOT COMPLETED|Treatment Initial Randomization||0
9765147|NCT00408421|10869509|FG000|STARTED|Treatment Re-Randomization||103
9765148|NCT00408421|10869510|FG001|STARTED|Treatment Re-Randomization||46
9765149|NCT00408421|10869511|FG002|STARTED|Treatment Re-Randomization||43
9765150|NCT00408421|10869509|FG000|COMPLETED|Treatment Re-Randomization||96
9765151|NCT00408421|10869510|FG001|COMPLETED|Treatment Re-Randomization||39
9765152|NCT00408421|10869511|FG002|COMPLETED|Treatment Re-Randomization||38
9765153|NCT00408421|10869509|FG000|NOT COMPLETED|Treatment Re-Randomization||7
9765154|NCT00408421|10869510|FG001|NOT COMPLETED|Treatment Re-Randomization||7
9765155|NCT00408421|10869511|FG002|NOT COMPLETED|Treatment Re-Randomization||5
9765156|NCT00408434|10869526|FG000|STARTED|Overall Study||6
9765157|NCT00408434|10869527|FG001|STARTED|Overall Study||3
9765158|NCT00408434|10869528|FG002|STARTED|Overall Study||6
9765159|NCT00408434|10869529|FG003|STARTED|Overall Study||3
9765160|NCT00408434|10869530|FG004|STARTED|Overall Study||6
9765161|NCT00408434|10869531|FG005|STARTED|Overall Study||3
9765162|NCT00408434|10869532|FG006|STARTED|Overall Study||4
9765163|NCT00408434|10869526|FG000|COMPLETED|Overall Study||0
9765164|NCT00408434|10869527|FG001|COMPLETED|Overall Study||0
9765165|NCT00408434|10869528|FG002|COMPLETED|Overall Study||0
9765166|NCT00408434|10869529|FG003|COMPLETED|Overall Study||0
9765167|NCT00408434|10869530|FG004|COMPLETED|Overall Study||0
9765168|NCT00408434|10869531|FG005|COMPLETED|Overall Study||0
9765169|NCT00408434|10869532|FG006|COMPLETED|Overall Study||0
9765170|NCT00408434|10869526|FG000|NOT COMPLETED|Overall Study||6
9765171|NCT00408434|10869527|FG001|NOT COMPLETED|Overall Study||3
9765172|NCT00408434|10869528|FG002|NOT COMPLETED|Overall Study||6
9765173|NCT00408434|10869529|FG003|NOT COMPLETED|Overall Study||3
9765174|NCT00408434|10869530|FG004|NOT COMPLETED|Overall Study||6
9765175|NCT00408434|10869531|FG005|NOT COMPLETED|Overall Study||3
9765176|NCT00408434|10869532|FG006|NOT COMPLETED|Overall Study||4
9765177|NCT00408460|10869549|FG000|STARTED|Overall Study||34
9765178|NCT00408460|10869549|FG000|COMPLETED|Overall Study||34
9765179|NCT00408460|10869549|FG000|NOT COMPLETED|Overall Study||0
9765180|NCT00408499|10869553|FG000|STARTED|Phase 1: Dose Levels 1-4||4
9765181|NCT00408499|10869554|FG001|STARTED|Phase 1: Dose Levels 1-4||7
9765182|NCT00408499|10869555|FG002|STARTED|Phase 1: Dose Levels 1-4||3
9765183|NCT00408499|10869556|FG003|STARTED|Phase 1: Dose Levels 1-4||6
9765184|NCT00408499|10869557|FG004|STARTED|Phase 1: Dose Levels 1-4||0
9765185|NCT00408499|10869553|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2
9765186|NCT00408499|10869554|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5
9765187|NCT00408499|10869555|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2
9765188|NCT00408499|10869556|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6
9765189|NCT00408499|10869557|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0
9765190|NCT00408499|10869553|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
9765191|NCT00408499|10869554|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
9765192|NCT00408499|10869555|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
9765193|NCT00408499|10869556|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
9765194|NCT00408499|10869557|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
9765195|NCT00408499|10869553|FG000|STARTED|Phase II- MTD Expansion||0
9765196|NCT00408499|10869554|FG001|STARTED|Phase II- MTD Expansion||0
9765197|NCT00408499|10869555|FG002|STARTED|Phase II- MTD Expansion||0
9765198|NCT00408499|10869556|FG003|STARTED|Phase II- MTD Expansion||0
9765199|NCT00408499|10869557|FG004|STARTED|Phase II- MTD Expansion||44
9765200|NCT00408499|10869553|FG000|COMPLETED|Phase II- MTD Expansion||0
9765201|NCT00408499|10869554|FG001|COMPLETED|Phase II- MTD Expansion||0
9765202|NCT00408499|10869555|FG002|COMPLETED|Phase II- MTD Expansion||0
9765203|NCT00408499|10869556|FG003|COMPLETED|Phase II- MTD Expansion||0
9765204|NCT00408499|10869557|FG004|COMPLETED|Phase II- MTD Expansion||24
9765205|NCT00408499|10869553|FG000|NOT COMPLETED|Phase II- MTD Expansion||0
9765206|NCT00408499|10869554|FG001|NOT COMPLETED|Phase II- MTD Expansion||0
9765207|NCT00408499|10869555|FG002|NOT COMPLETED|Phase II- MTD Expansion||0
9765208|NCT00408499|10869556|FG003|NOT COMPLETED|Phase II- MTD Expansion||0
9765209|NCT00408499|10869557|FG004|NOT COMPLETED|Phase II- MTD Expansion||20
9765210|NCT00408564|10869566|FG000|STARTED|Overall Study||39
9765211|NCT00408564|10869566|FG000|COMPLETED|Overall Study||39
9765212|NCT00408564|10869566|FG000|NOT COMPLETED|Overall Study||0
9765213|NCT00408590|10869573|FG000|STARTED|Overall Study||3
9765214|NCT00408590|10869574|FG001|STARTED|Overall Study||3
9765215|NCT00408590|10869575|FG002|STARTED|Overall Study||3
9765216|NCT00408590|10869576|FG003|STARTED|Overall Study||3
9765217|NCT00408590|10869577|FG004|STARTED|Overall Study||3
9765218|NCT00408590|10869578|FG005|STARTED|Overall Study||3
9765219|NCT00408590|10869579|FG006|STARTED|Overall Study||3
9765220|NCT00408590|10869580|FG007|STARTED|Overall Study||3
9765221|NCT00408590|10869581|FG008|STARTED|Overall Study||13
9765222|NCT00408590|10869573|FG000|COMPLETED|Overall Study||3
9765223|NCT00408590|10869574|FG001|COMPLETED|Overall Study||3
9765224|NCT00408590|10869575|FG002|COMPLETED|Overall Study||3
9765225|NCT00408590|10869576|FG003|COMPLETED|Overall Study||3
9765226|NCT00408590|10869577|FG004|COMPLETED|Overall Study||3
9765227|NCT00408590|10869578|FG005|COMPLETED|Overall Study||3
9765228|NCT00408590|10869579|FG006|COMPLETED|Overall Study||3
9765229|NCT00408590|10869580|FG007|COMPLETED|Overall Study||3
9765230|NCT00408590|10869581|FG008|COMPLETED|Overall Study||13
9765231|NCT00408590|10869573|FG000|NOT COMPLETED|Overall Study||0
9765232|NCT00408590|10869574|FG001|NOT COMPLETED|Overall Study||0
9765233|NCT00408590|10869575|FG002|NOT COMPLETED|Overall Study||0
9765234|NCT00408590|10869576|FG003|NOT COMPLETED|Overall Study||0
9765235|NCT00408590|10869577|FG004|NOT COMPLETED|Overall Study||0
9765236|NCT00408590|10869578|FG005|NOT COMPLETED|Overall Study||0
9765237|NCT00408590|10869579|FG006|NOT COMPLETED|Overall Study||0
9765238|NCT00408590|10869580|FG007|NOT COMPLETED|Overall Study||0
9765239|NCT00408590|10869581|FG008|NOT COMPLETED|Overall Study||0
9765240|NCT00408603|10869599|FG000|STARTED|Overall Study||69
9765241|NCT00408603|10869600|FG001|STARTED|Overall Study||39
9765242|NCT00408603|10869601|FG002|STARTED|Overall Study||75
9765243|NCT00408603|10869599|FG000|COMPLETED|Overall Study||65
9765244|NCT00408603|10869600|FG001|COMPLETED|Overall Study||37
9765245|NCT00408603|10869601|FG002|COMPLETED|Overall Study||35
9765246|NCT00408603|10869599|FG000|NOT COMPLETED|Overall Study||4
9765247|NCT00408603|10869600|FG001|NOT COMPLETED|Overall Study||2
9765248|NCT00408603|10869601|FG002|NOT COMPLETED|Overall Study||40
9765249|NCT00408629|10869613|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
9765250|NCT00408629|10869614|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
9765251|NCT00408629|10869613|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
9765252|NCT00408629|10869614|FG001|COMPLETED|Overall Study||135
9765253|NCT00408629|10869613|FG000|NOT COMPLETED|Overall Study||97
9765254|NCT00408629|10869614|FG001|NOT COMPLETED|Overall Study||125
9765255|NCT00408681|10869621|FG000|STARTED|Overall Study||20
9765256|NCT00408681|10869621|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
9765257|NCT00408681|10869621|FG000|NOT COMPLETED|Overall Study||9
9765258|NCT00408694|10869626|FG000|STARTED|Overall Study||46
9765259|NCT00408694|10869626|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
9765260|NCT00408694|10869626|FG000|NOT COMPLETED|Overall Study||2
9765261|NCT00408876|10869634|FG000|STARTED|Overall Study||59
9765262|NCT00408876|10869635|FG001|STARTED|Overall Study||116
9765263|NCT00408876|10869636|FG002|STARTED|Overall Study||112
9765264|NCT00408876|10869637|FG003|STARTED|Overall Study||117
9765265|NCT00408876|10869634|FG000|COMPLETED|Overall Study||43
9765266|NCT00408876|10869635|FG001|COMPLETED|Overall Study||80
9765267|NCT00408876|10869636|FG002|COMPLETED|Overall Study||62
9765268|NCT00408876|10869637|FG003|COMPLETED|Overall Study||82
9765269|NCT00408876|10869634|FG000|NOT COMPLETED|Overall Study||16
9765270|NCT00408876|10869635|FG001|NOT COMPLETED|Overall Study||36
9765271|NCT00408876|10869636|FG002|NOT COMPLETED|Overall Study||50
9765272|NCT00408876|10869637|FG003|NOT COMPLETED|Overall Study||35
9765273|NCT00408902|10869647|FG000|STARTED|Overall Study||10
9765274|NCT00408902|10869647|FG000|COMPLETED|Overall Study||0
9765275|NCT00408902|10869647|FG000|NOT COMPLETED|Overall Study||10
9765276|NCT00408928|10869652|FG000|STARTED|Overall Study||11
9765277|NCT00408928|10869652|FG000|COMPLETED|Overall Study||8
9765278|NCT00408928|10869652|FG000|NOT COMPLETED|Overall Study||3
9765279|NCT00408993|10869658|FG000|STARTED|Overall Study||106
9765280|NCT00408993|10869659|FG001|STARTED|Overall Study||109
9765281|NCT00408993|10869658|FG000|COMPLETED|Overall Study||87
9765282|NCT00408993|10869659|FG001|COMPLETED|Overall Study||92
9765283|NCT00408993|10869658|FG000|NOT COMPLETED|Overall Study||19
9765284|NCT00408993|10869659|FG001|NOT COMPLETED|Overall Study||17
9765285|NCT00409006|10869671|FG000|STARTED|Overall Study||39
9765286|NCT00409006|10869672|FG001|STARTED|Overall Study||31
9765287|NCT00409006|10869671|FG000|COMPLETED|Overall Study||19
9765288|NCT00409006|10869672|FG001|COMPLETED|Overall Study||19
9765289|NCT00409006|10869671|FG000|NOT COMPLETED|Overall Study||20
9765290|NCT00409006|10869672|FG001|NOT COMPLETED|Overall Study||12
9765291|NCT00409175|10869680|FG000|STARTED|Overall Study||65
9765292|NCT00409175|10869681|FG001|STARTED|Overall Study||63
9765293|NCT00409175|10869680|FG000|COMPLETED|Overall Study||47
9765294|NCT00409175|10869681|FG001|COMPLETED|Overall Study||44
9765295|NCT00409175|10869680|FG000|NOT COMPLETED|Overall Study||18
9765296|NCT00409175|10869681|FG001|NOT COMPLETED|Overall Study||19
9765297|NCT00409188|10869689|FG000|STARTED|Overall Study||1006
9765298|NCT00409188|10869690|FG001|STARTED|Overall Study||507
9765299|NCT00409188|10869689|FG000|COMPLETED|Overall Study||623
9765300|NCT00409188|10869690|FG001|COMPLETED|Overall Study||332
9765301|NCT00409188|10869689|FG000|NOT COMPLETED|Overall Study||383
9765302|NCT00409188|10869690|FG001|NOT COMPLETED|Overall Study||175
9765303|NCT00409240|10869698|FG000|STARTED|Overall Study||53
9765304|NCT00409240|10869699|FG001|STARTED|Overall Study||50
9765305|NCT00409240|10869698|FG000|COMPLETED|Overall Study||50
9765306|NCT00409240|10869699|FG001|COMPLETED|Overall Study||49
9765307|NCT00409240|10869698|FG000|NOT COMPLETED|Overall Study||3
9765308|NCT00409240|10869699|FG001|NOT COMPLETED|Overall Study||1
9765309|NCT00409292|10869705|FG000|STARTED|Overall Study||33
9765310|NCT00409292|10869705|FG000|COMPLETED|Overall Study||33
9765311|NCT00409292|10869705|FG000|NOT COMPLETED|Overall Study||0
9765312|NCT00409409|10869713|FG000|STARTED|Overall Study||139
9765313|NCT00409409|10869714|FG001|STARTED|Overall Study||139
9765314|NCT00409409|10869713|FG000|COMPLETED|Overall Study||131
9765315|NCT00409409|10869714|FG001|COMPLETED|Overall Study||135
9765316|NCT00409409|10869713|FG000|NOT COMPLETED|Overall Study||8
9765317|NCT00409409|10869714|FG001|NOT COMPLETED|Overall Study||4
9765318|NCT00409539|10869725|FG000|STARTED|Overall Study||111
9765319|NCT00409539|10869726|FG001|STARTED|Overall Study||111
9765320|NCT00409539|10869727|FG002|STARTED|Overall Study||109
9765321|NCT00409539|10869728|FG003|STARTED|Overall Study||109
9765322|NCT00409539|10869729|FG004|STARTED|Overall Study||110
9765323|NCT00409539|10869725|FG000|COMPLETED|Overall Study||100
9765324|NCT00409539|10869726|FG001|COMPLETED|Overall Study||100
9765325|NCT00409539|10869727|FG002|COMPLETED|Overall Study||95
9765326|NCT00409539|10869728|FG003|COMPLETED|Overall Study||97
9765327|NCT00409539|10869729|FG004|COMPLETED|Overall Study||85
9765328|NCT00409539|10869725|FG000|NOT COMPLETED|Overall Study||11
9765329|NCT00409539|10869726|FG001|NOT COMPLETED|Overall Study||11
9765330|NCT00409539|10869727|FG002|NOT COMPLETED|Overall Study||14
9765331|NCT00409539|10869728|FG003|NOT COMPLETED|Overall Study||12
9765332|NCT00409539|10869729|FG004|NOT COMPLETED|Overall Study||25
9765333|NCT00409565|10869741|FG000|STARTED|Overall Study||46
9765334|NCT00409565|10869741|FG000|Overall Response Rate|Overall Study||7
9765335|NCT00409565|10869741|FG000|COMPLETED|Overall Study||45
9765336|NCT00409565|10869741|FG000|NOT COMPLETED|Overall Study||1
9765337|NCT00409578|10869749|FG000|STARTED|Overall Study||280
9765338|NCT00409578|10869750|FG001|STARTED|Overall Study||271
9765339|NCT00409578|10869751|FG002|STARTED|Overall Study||269
9765340|NCT00409578|10869752|FG003|STARTED|Overall Study||281
9765341|NCT00409578|10869749|FG000|COMPLETED|Overall Study||228
9765342|NCT00409578|10869750|FG001|COMPLETED|Overall Study||201
9765343|NCT00409578|10869751|FG002|COMPLETED|Overall Study||215
9765344|NCT00409578|10869752|FG003|COMPLETED|Overall Study||214
9765345|NCT00409578|10869749|FG000|NOT COMPLETED|Overall Study||52
9765346|NCT00409578|10869750|FG001|NOT COMPLETED|Overall Study||70
9765347|NCT00409578|10869751|FG002|NOT COMPLETED|Overall Study||54
9765348|NCT00409578|10869752|FG003|NOT COMPLETED|Overall Study||67
9765349|NCT00409617|10869762|FG000|STARTED|Overall Study||945
9765350|NCT00409617|10869762|FG000|COMPLETED|Overall Study||785
9765351|NCT00409617|10869762|FG000|NOT COMPLETED|Overall Study||160
9765352|NCT00409682|10869769|FG000|STARTED|Open-label Induction Period||192
9765353|NCT00409682|10869770|FG001|STARTED|Open-label Induction Period||0
9765354|NCT00409682|10869771|FG002|STARTED|Open-label Induction Period||0
9765355|NCT00409682|10869769|FG000|COMPLETED|Open-label Induction Period||188
9765356|NCT00409682|10869770|FG001|COMPLETED|Open-label Induction Period||0
9765357|NCT00409682|10869771|FG002|COMPLETED|Open-label Induction Period||0
9765358|NCT00409682|10869769|FG000|NOT COMPLETED|Open-label Induction Period||4
9765359|NCT00409682|10869770|FG001|NOT COMPLETED|Open-label Induction Period||0
9765360|NCT00409682|10869771|FG002|NOT COMPLETED|Open-label Induction Period||0
9765361|NCT00409682|10869769|FG000|STARTED|EOW Double-blind Maintenance Period||0
9765362|NCT00409682|10869770|FG001|STARTED|EOW Double-blind Maintenance Period||95
9765363|NCT00409682|10869771|FG002|STARTED|EOW Double-blind Maintenance Period||93
9765364|NCT00409682|10869769|FG000|COMPLETED|EOW Double-blind Maintenance Period||0
9765365|NCT00409682|10869770|FG001|COMPLETED|EOW Double-blind Maintenance Period||58
9765366|NCT00409682|10869771|FG002|COMPLETED|EOW Double-blind Maintenance Period||66
9765367|NCT00409682|10869769|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0
9765368|NCT00409682|10869770|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37
9765369|NCT00409682|10869771|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27
9765370|NCT00409708|10869780|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
9765371|NCT00409708|10869781|FG001|STARTED|Treatment||56
9765372|NCT00409708|10869780|FG000|COMPLETED|Treatment||38
9765373|NCT00409708|10869781|FG001|COMPLETED|Treatment||39
9765374|NCT00409708|10869780|FG000|NOT COMPLETED|Treatment||15
9765375|NCT00409708|10869781|FG001|NOT COMPLETED|Treatment||17
9765376|NCT00409708|10869780|FG000|STARTED|Washout||38
9765377|NCT00409708|10869781|FG001|STARTED|Washout||39
9765378|NCT00409708|10869780|FG000|COMPLETED|Washout||17
9765379|NCT00409708|10869781|FG001|COMPLETED|Washout||29
9765380|NCT00409708|10869780|FG000|NOT COMPLETED|Washout||21
9765381|NCT00409708|10869781|FG001|NOT COMPLETED|Washout||10
9765382|NCT00409747|10869787|FG000|STARTED|Overall Study||11
9765383|NCT00409747|10869787|FG000|COMPLETED|Overall Study||10
9765384|NCT00409747|10869787|FG000|NOT COMPLETED|Overall Study||1
9765385|NCT00409786|10869791|FG000|STARTED|Overall Study||50
9765386|NCT00409786|10869791|FG000|COMPLETED|Overall Study||47
9765387|NCT00409786|10869791|FG000|NOT COMPLETED|Overall Study||3
9765388|NCT00409825|10869795|FG000|STARTED|Overall Study||61
9765389|NCT00409825|10869795|FG000|COMPLETED|Overall Study||61
9765390|NCT00409825|10869795|FG000|NOT COMPLETED|Overall Study||0
9765391|NCT00409838|10869801|FG000|STARTED|Short-term Period|Randomized|56
9765392|NCT00409838|10869802|FG001|STARTED|Short-term Period|Randomized|57
9765393|NCT00409838|10869801|FG000|Treated (Baseline) Population|Short-term Period||55
9765394|NCT00409838|10869802|FG001|Treated (Baseline) Population|Short-term Period||57
9765395|NCT00409838|10869801|FG000|COMPLETED|Short-term Period||53
9765396|NCT00409838|10869802|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
9765397|NCT00409838|10869801|FG000|NOT COMPLETED|Short-term Period||3
9765398|NCT00409838|10869802|FG001|NOT COMPLETED|Short-term Period||5
9765399|NCT00409838|10869801|FG000|STARTED|Long-term Extension Period||105
9765400|NCT00409838|10869802|FG001|STARTED|Long-term Extension Period||0
9765401|NCT00409838|10869801|FG000|COMPLETED|Long-term Extension Period||87
9765402|NCT00409838|10869802|FG001|COMPLETED|Long-term Extension Period||0
9765403|NCT00409838|10869801|FG000|NOT COMPLETED|Long-term Extension Period||18
9765404|NCT00409838|10869802|FG001|NOT COMPLETED|Long-term Extension Period||0
9765405|NCT00410046|10869825|FG000|STARTED|Overall Study||84
9765406|NCT00410046|10869825|FG000|COMPLETED|Overall Study||79
9765407|NCT00410046|10869825|FG000|NOT COMPLETED|Overall Study||5
9765408|NCT00410059|10869830|FG000|STARTED|Overall Study||59
9765409|NCT00410059|10869830|FG000|COMPLETED|Overall Study||59
9765410|NCT00410059|10869830|FG000|NOT COMPLETED|Overall Study||0
9765411|NCT00410072|10869836|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
9765412|NCT00410072|10869837|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
9765413|NCT00410072|10869836|FG000|COMPLETED|Day 1 to Week 48||176
9765414|NCT00410072|10869837|FG001|COMPLETED|Day 1 to Week 48||185
9765415|NCT00410072|10869836|FG000|NOT COMPLETED|Day 1 to Week 48||6
9765416|NCT00410072|10869837|FG001|NOT COMPLETED|Day 1 to Week 48||12
9765417|NCT00410072|10869836|FG000|STARTED|After Week 48 to Week 96||176
9765418|NCT00410072|10869837|FG001|STARTED|After Week 48 to Week 96||185
9765419|NCT00410072|10869836|FG000|COMPLETED|After Week 48 to Week 96||170
10013859|NCT01795534|11136808|FG001|STARTED|Second Intervention (Second Shot)||5
10013860|NCT01795534|11136807|FG000|COMPLETED|Second Intervention (Second Shot)||5
10013861|NCT01795534|11136808|FG001|COMPLETED|Second Intervention (Second Shot)||5
9765420|NCT00410072|10869837|FG001|COMPLETED|After Week 48 to Week 96||174
9765421|NCT00410072|10869836|FG000|NOT COMPLETED|After Week 48 to Week 96||6
9765422|NCT00410072|10869837|FG001|NOT COMPLETED|After Week 48 to Week 96||11
9765423|NCT00410124|10869845|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
9765424|NCT00410124|10869846|FG001|STARTED|Core Phase Double Blind (15 Months)||139
9765425|NCT00410124|10869845|FG000|Ongoing|Core Phase Double Blind (15 Months)||13
9765426|NCT00410124|10869846|FG001|Ongoing|Core Phase Double Blind (15 Months)||4
9765427|NCT00410124|10869845|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
9765428|NCT00410124|10869846|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
9765429|NCT00410124|10869845|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
9765430|NCT00410124|10869846|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
9765431|NCT00410124|10869845|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
9765432|NCT00410124|10869846|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
9765433|NCT00410124|10869845|FG000|STARTED|Extension Phase - Open Label (45 Months)||67
9765434|NCT00410124|10869846|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
9765435|NCT00410124|10869845|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0
9765436|NCT00410124|10869846|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0
9765437|NCT00410124|10869845|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
9765438|NCT00410124|10869846|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
9829477|NCT00759876|10940115|FG000|STARTED|Overall Study||36
9829478|NCT00759876|10940115|FG000|As-Treated Population|Overall Study||36
9829479|NCT00759876|10940115|FG000|Evaluable Population|Overall Study||35
9829480|NCT00759876|10940115|FG000|Ambulatory Evaluable Population|Overall Study||24
9829481|NCT00759876|10940115|FG000|COMPLETED|Overall Study||0
9829482|NCT00759876|10940115|FG000|NOT COMPLETED|Overall Study||36
9829483|NCT00759902|10940121|FG000|STARTED|Overall Study||18
9829484|NCT00759902|10940122|FG001|STARTED|Overall Study||18
9829485|NCT00759902|10940121|FG000|COMPLETED|Overall Study||18
9829486|NCT00759902|10940122|FG001|COMPLETED|Overall Study||17
9829487|NCT00759902|10940121|FG000|NOT COMPLETED|Overall Study||0
9829488|NCT00759902|10940122|FG001|NOT COMPLETED|Overall Study||1
9829489|NCT00759915|10940130|FG000|STARTED|Overall Study||18
9829490|NCT00759915|10940131|FG001|STARTED|Overall Study||18
9829491|NCT00759915|10940130|FG000|COMPLETED|Overall Study||17
9829492|NCT00759915|10940131|FG001|COMPLETED|Overall Study||17
9829493|NCT00759915|10940130|FG000|NOT COMPLETED|Overall Study||1
9829494|NCT00759915|10940131|FG001|NOT COMPLETED|Overall Study||1
9829495|NCT00759941|10940139|FG000|STARTED|Overall Study||42
9829496|NCT00759941|10940140|FG001|STARTED|Overall Study||44
9829497|NCT00759941|10940139|FG000|COMPLETED|Overall Study||39
9829498|NCT00759941|10940140|FG001|COMPLETED|Overall Study||43
9829499|NCT00759941|10940139|FG000|NOT COMPLETED|Overall Study||3
9829500|NCT00759941|10940140|FG001|NOT COMPLETED|Overall Study||1
9829501|NCT00759954|10940148|FG000|STARTED|Overall Study|All assigned participants entered trial|18
9829502|NCT00759954|10940149|FG001|STARTED|Overall Study|All assigned participants entered trial|18
9829503|NCT00759954|10940148|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
9829504|NCT00759954|10940149|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
9829505|NCT00759954|10940148|FG000|NOT COMPLETED|Overall Study||2
9829506|NCT00759954|10940149|FG001|NOT COMPLETED|Overall Study||2
9829507|NCT00759967|10940155|FG000|STARTED|First Intervention||10
9829508|NCT00759967|10940156|FG001|STARTED|First Intervention||9
9829509|NCT00759967|10940155|FG000|COMPLETED|First Intervention||10
9829510|NCT00759967|10940156|FG001|COMPLETED|First Intervention||9
9829511|NCT00759967|10940155|FG000|NOT COMPLETED|First Intervention||0
9829512|NCT00759967|10940156|FG001|NOT COMPLETED|First Intervention||0
9829513|NCT00759967|10940155|FG000|STARTED|Second Intervention||10
9829514|NCT00759967|10940156|FG001|STARTED|Second Intervention||9
9829515|NCT00759967|10940155|FG000|COMPLETED|Second Intervention||8
9829516|NCT00759967|10940156|FG001|COMPLETED|Second Intervention||9
9829517|NCT00759967|10940155|FG000|NOT COMPLETED|Second Intervention||2
9829518|NCT00759967|10940156|FG001|NOT COMPLETED|Second Intervention||0
9829519|NCT00760006|10940168|FG000|STARTED|Overall Study||86
9829520|NCT00760006|10940169|FG001|STARTED|Overall Study||138
9829521|NCT00760006|10940168|FG000|COMPLETED|Overall Study||86
9829522|NCT00760006|10940169|FG001|COMPLETED|Overall Study||138
9829523|NCT00760006|10940168|FG000|NOT COMPLETED|Overall Study||0
9829524|NCT00760006|10940169|FG001|NOT COMPLETED|Overall Study||0
9829525|NCT00760019|10940177|FG000|STARTED|Overall Study||15
9829526|NCT00760019|10940178|FG001|STARTED|Overall Study||15
9829527|NCT00760019|10940179|FG002|STARTED|Overall Study||14
9829528|NCT00760019|10940180|FG003|STARTED|Overall Study||14
10013862|NCT01795534|11136807|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0
9829529|NCT00760019|10940177|FG000|COMPLETED|Overall Study||15
9829530|NCT00760019|10940178|FG001|COMPLETED|Overall Study||15
9829531|NCT00760019|10940179|FG002|COMPLETED|Overall Study||14
9765439|NCT00410150|10869858|FG000|STARTED|Overall Study||22
9765440|NCT00410150|10869859|FG001|STARTED|Overall Study||20
9765441|NCT00410150|10869858|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
9765442|NCT00410150|10869859|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
9765443|NCT00410150|10869858|FG000|NOT COMPLETED|Overall Study||2
9765444|NCT00410150|10869859|FG001|NOT COMPLETED|Overall Study||3
9765445|NCT00410163|10869867|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31
9765446|NCT00410163|10869868|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30
9765447|NCT00410163|10869867|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
9765448|NCT00410163|10869868|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
9765449|NCT00410163|10869867|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
9765450|NCT00410163|10869868|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
9765451|NCT00410163|10869867|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
9765452|NCT00410163|10869868|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
9765453|NCT00410163|10869867|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
9765454|NCT00410163|10869868|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
9765455|NCT00410163|10869867|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
9765456|NCT00410163|10869868|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
9765457|NCT00410189|10869878|FG000|STARTED|Overall Study||54
9765458|NCT00410189|10869878|FG000|COMPLETED|Overall Study||54
9765459|NCT00410189|10869878|FG000|NOT COMPLETED|Overall Study||0
9765460|NCT00410202|10869885|FG000|STARTED|On-Treatment||138
9765461|NCT00410202|10869886|FG001|STARTED|On-Treatment||140
9765462|NCT00410202|10869887|FG002|STARTED|On-Treatment||137
10013863|NCT01795534|11136808|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0
10013864|NCT01795547|11136816|FG000|STARTED|Overall Study||148
10013865|NCT01795547|11136817|FG001|STARTED|Overall Study||147
10013866|NCT01795547|11136816|FG000|COMPLETED|Overall Study||100
10013867|NCT01795547|11136817|FG001|COMPLETED|Overall Study||83
10013868|NCT01795547|11136816|FG000|NOT COMPLETED|Overall Study||48
10013869|NCT01795547|11136817|FG001|NOT COMPLETED|Overall Study||64
10013870|NCT01795638|11136827|FG000|STARTED|Overall Study||27
10013871|NCT01795638|11136828|FG001|STARTED|Overall Study||26
10013872|NCT01795638|11136827|FG000|COMPLETED|Overall Study||14
10013873|NCT01795638|11136828|FG001|COMPLETED|Overall Study||15
10013874|NCT01795638|11136827|FG000|NOT COMPLETED|Overall Study||13
9765463|NCT00410202|10869885|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4
9765464|NCT00410202|10869886|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2
9765465|NCT00410202|10869887|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2
9765466|NCT00410202|10869885|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2
9765467|NCT00410202|10869886|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6
9765468|NCT00410202|10869887|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3
9765469|NCT00410202|10869885|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63
9765470|NCT00410202|10869886|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61
9765471|NCT00410202|10869887|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66
9765472|NCT00410202|10869885|FG000|NOT COMPLETED|On-Treatment||75
10013875|NCT01795638|11136828|FG001|NOT COMPLETED|Overall Study||11
10013876|NCT01795716|11136836|FG000|STARTED|First Intervention (13 Days)||10
10013877|NCT01795716|11136837|FG001|STARTED|First Intervention (13 Days)||11
10013878|NCT01795716|11136836|FG000|COMPLETED|First Intervention (13 Days)||10
10013879|NCT01795716|11136837|FG001|COMPLETED|First Intervention (13 Days)||11
10013880|NCT01795716|11136836|FG000|NOT COMPLETED|First Intervention (13 Days)||0
10013881|NCT01795716|11136837|FG001|NOT COMPLETED|First Intervention (13 Days)||0
10013882|NCT01795716|11136836|FG000|STARTED|Washout (10 Days)||10
10013883|NCT01795716|11136837|FG001|STARTED|Washout (10 Days)||11
10013884|NCT01795716|11136836|FG000|COMPLETED|Washout (10 Days)||10
10013885|NCT01795716|11136837|FG001|COMPLETED|Washout (10 Days)||11
10013886|NCT01795716|11136836|FG000|NOT COMPLETED|Washout (10 Days)||0
10013887|NCT01795716|11136837|FG001|NOT COMPLETED|Washout (10 Days)||0
10013888|NCT01795716|11136836|FG000|STARTED|Second Intervention (13 Days)||10
10013889|NCT01795716|11136837|FG001|STARTED|Second Intervention (13 Days)||11
10013890|NCT01795716|11136836|FG000|COMPLETED|Second Intervention (13 Days)||10
10013891|NCT01795716|11136837|FG001|COMPLETED|Second Intervention (13 Days)||11
10013892|NCT01795716|11136836|FG000|NOT COMPLETED|Second Intervention (13 Days)||0
10013893|NCT01795716|11136837|FG001|NOT COMPLETED|Second Intervention (13 Days)||0
10013894|NCT01795833|11136847|FG000|STARTED|Overall Study||1031
10013895|NCT01795833|11136848|FG001|STARTED|Overall Study||1031
10013896|NCT01795833|11136847|FG000|COMPLETED|Overall Study||881
10013897|NCT01795833|11136848|FG001|COMPLETED|Overall Study||882
10013898|NCT01795833|11136847|FG000|NOT COMPLETED|Overall Study||150
10013899|NCT01795833|11136848|FG001|NOT COMPLETED|Overall Study||149
10013900|NCT01795859|11136856|FG000|STARTED|Overall Study||45
10013901|NCT01795859|11136857|FG001|STARTED|Overall Study||45
10013902|NCT01795859|11136856|FG000|COMPLETED|Overall Study||44
10013903|NCT01795859|11136857|FG001|COMPLETED|Overall Study||43
10013904|NCT01795859|11136856|FG000|NOT COMPLETED|Overall Study||1
10013905|NCT01795859|11136857|FG001|NOT COMPLETED|Overall Study||2
10013906|NCT01795898|11136863|FG000|STARTED|Overall Study||237
10013907|NCT01795898|11136863|FG000|COMPLETED|Overall Study||177
10013908|NCT01795898|11136863|FG000|NOT COMPLETED|Overall Study||60
10013909|NCT01795937|11136870|FG000|STARTED|Overall Study||18
10013910|NCT01795937|11136871|FG001|STARTED|Overall Study||16
10013911|NCT01795937|11136872|FG002|STARTED|Overall Study||17
10013912|NCT01795937|11136870|FG000|COMPLETED|Overall Study||17
10013913|NCT01795937|11136871|FG001|COMPLETED|Overall Study||15
10013914|NCT01795937|11136872|FG002|COMPLETED|Overall Study||17
10013915|NCT01795937|11136870|FG000|NOT COMPLETED|Overall Study||1
10013916|NCT01795937|11136871|FG001|NOT COMPLETED|Overall Study||1
10013917|NCT01795937|11136872|FG002|NOT COMPLETED|Overall Study||0
10013918|NCT01796236|11136890|FG000|STARTED|Overall Study||51
10013919|NCT01796236|11136891|FG001|STARTED|Overall Study||52
10013920|NCT01796236|11136890|FG000|COMPLETED|Overall Study||49
10013921|NCT01796236|11136891|FG001|COMPLETED|Overall Study||50
10013922|NCT01796236|11136890|FG000|NOT COMPLETED|Overall Study||2
10013923|NCT01796236|11136891|FG001|NOT COMPLETED|Overall Study||2
10013924|NCT01796301|11136900|FG000|STARTED|Overall Study||218
10013925|NCT01796301|11136901|FG001|STARTED|Overall Study||218
10013926|NCT01796301|11136900|FG000|Received Treatment|Overall Study||214
10013927|NCT01796301|11136901|FG001|Received Treatment|Overall Study||218
10013928|NCT01796301|11136900|FG000|COMPLETED|Overall Study||200
10013929|NCT01796301|11136901|FG001|COMPLETED|Overall Study||198
10013930|NCT01796301|11136900|FG000|NOT COMPLETED|Overall Study||18
10013931|NCT01796301|11136901|FG001|NOT COMPLETED|Overall Study||20
10013932|NCT01796392|11136909|FG000|STARTED|Overall Study||128
10013933|NCT01796392|11136910|FG001|STARTED|Overall Study||62
10013934|NCT01796392|11136909|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119
10013935|NCT01796392|11136910|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59
10013936|NCT01796392|11136909|FG000|NOT COMPLETED|Overall Study||9
10013937|NCT01796392|11136910|FG001|NOT COMPLETED|Overall Study||3
10013938|NCT01796470|11136921|FG000|STARTED|Overall Study||35
10013939|NCT01796470|11136922|FG001|STARTED|Overall Study||14
10013940|NCT01796470|11136923|FG002|STARTED|Overall Study||6
10013941|NCT01796470|11136924|FG003|STARTED|Overall Study||3
10013942|NCT01796470|11136925|FG004|STARTED|Overall Study||8
10013943|NCT01796470|11136921|FG000|Entospletinib Monotherapy|Overall Study||4
10013944|NCT01796470|11136922|FG001|Entospletinib Monotherapy|Overall Study||4
10013945|NCT01796470|11136923|FG002|Entospletinib Monotherapy|Overall Study||0
10013946|NCT01796470|11136924|FG003|Entospletinib Monotherapy|Overall Study||0
10013947|NCT01796470|11136925|FG004|Entospletinib Monotherapy|Overall Study||0
10013948|NCT01796470|11136921|FG000|COMPLETED|Overall Study||0
10013949|NCT01796470|11136922|FG001|COMPLETED|Overall Study||0
10013950|NCT01796470|11136923|FG002|COMPLETED|Overall Study||0
10013951|NCT01796470|11136924|FG003|COMPLETED|Overall Study||0
10013952|NCT01796470|11136925|FG004|COMPLETED|Overall Study||0
10013953|NCT01796470|11136921|FG000|NOT COMPLETED|Overall Study||35
9765473|NCT00410202|10869886|FG001|NOT COMPLETED|On-Treatment||79
9765474|NCT00410202|10869887|FG002|NOT COMPLETED|On-Treatment||71
9765475|NCT00410202|10869885|FG000|STARTED|Off-treatment Follow up||15
9765476|NCT00410202|10869886|FG001|STARTED|Off-treatment Follow up||8
9765477|NCT00410202|10869887|FG002|STARTED|Off-treatment Follow up||14
9765478|NCT00410202|10869885|FG000|COMPLETED|Off-treatment Follow up||1
9765479|NCT00410202|10869886|FG001|COMPLETED|Off-treatment Follow up||0
9765480|NCT00410202|10869887|FG002|COMPLETED|Off-treatment Follow up||2
9765481|NCT00410202|10869885|FG000|NOT COMPLETED|Off-treatment Follow up||14
9765482|NCT00410202|10869886|FG001|NOT COMPLETED|Off-treatment Follow up||8
9765483|NCT00410202|10869887|FG002|NOT COMPLETED|Off-treatment Follow up||12
9765484|NCT00410280|10869898|FG000|STARTED|Overall Study||14
9765485|NCT00410280|10869899|FG001|STARTED|Overall Study||13
9765486|NCT00410280|10869898|FG000|COMPLETED|Overall Study||14
9765487|NCT00410280|10869899|FG001|COMPLETED|Overall Study||13
9765488|NCT00410280|10869898|FG000|NOT COMPLETED|Overall Study||0
9765489|NCT00410280|10869899|FG001|NOT COMPLETED|Overall Study||0
10013954|NCT01796470|11136922|FG001|NOT COMPLETED|Overall Study||14
10013955|NCT01796470|11136923|FG002|NOT COMPLETED|Overall Study||6
10013956|NCT01796470|11136924|FG003|NOT COMPLETED|Overall Study||3
10013957|NCT01796470|11136925|FG004|NOT COMPLETED|Overall Study||8
9765490|NCT00410384|10869908|FG000|STARTED|Overall Study||275
9765491|NCT00410384|10869909|FG001|STARTED|Overall Study||271
9765492|NCT00410384|10869910|FG002|STARTED|Overall Study||273
9765493|NCT00410384|10869908|FG000|COMPLETED|Overall Study||186
9765494|NCT00410384|10869909|FG001|COMPLETED|Overall Study||199
9765495|NCT00410384|10869910|FG002|COMPLETED|Overall Study||191
9765496|NCT00410384|10869908|FG000|NOT COMPLETED|Overall Study||89
9765497|NCT00410384|10869909|FG001|NOT COMPLETED|Overall Study||72
9765498|NCT00410384|10869910|FG002|NOT COMPLETED|Overall Study||82
9765499|NCT00410410|10869924|FG000|STARTED|Induction Period (IP)||141
10013958|NCT01796548|11136941|FG000|STARTED|Overall Study||17
10013959|NCT01796548|11136941|FG000|Treated|Overall Study||15
10013960|NCT01796548|11136941|FG000|COMPLETED|Overall Study||14
10013961|NCT01796548|11136941|FG000|NOT COMPLETED|Overall Study||3
10013962|NCT01796665|11136948|FG000|STARTED|Overall Study||474
10013963|NCT01796665|11136949|FG001|STARTED|Overall Study||469
10013964|NCT01796665|11136950|FG002|STARTED|Overall Study||237
10013965|NCT01796665|11136948|FG000|COMPLETED|Overall Study||416
10013966|NCT01796665|11136949|FG001|COMPLETED|Overall Study||396
10013967|NCT01796665|11136950|FG002|COMPLETED|Overall Study||195
10013968|NCT01796665|11136948|FG000|NOT COMPLETED|Overall Study||58
10013969|NCT01796665|11136949|FG001|NOT COMPLETED|Overall Study||73
10013970|NCT01796665|11136950|FG002|NOT COMPLETED|Overall Study||42
9765500|NCT00410410|10869925|FG001|STARTED|Induction Period (IP)||139
10013971|NCT01796860|11136958|FG000|STARTED|Overall Study||10
10013972|NCT01796860|11136958|FG000|COMPLETED|Overall Study||7
9765501|NCT00410410|10869926|FG002|STARTED|Induction Period (IP)||70
9765502|NCT00410410|10869927|FG003|STARTED|Induction Period (IP)||140
9765503|NCT00410410|10869928|FG004|STARTED|Induction Period (IP)||51
9765504|NCT00410410|10869929|FG005|STARTED|Induction Period (IP)||50
9765505|NCT00410410|10869930|FG006|STARTED|Induction Period (IP)||0
9765506|NCT00410410|10869931|FG007|STARTED|Induction Period (IP)||0
9765507|NCT00410410|10869932|FG008|STARTED|Induction Period (IP)||0
9765508|NCT00410410|10869924|FG000|COMPLETED|Induction Period (IP)||106
9765509|NCT00410410|10869925|FG001|COMPLETED|Induction Period (IP)||104
9765510|NCT00410410|10869926|FG002|COMPLETED|Induction Period (IP)||53
9765511|NCT00410410|10869927|FG003|COMPLETED|Induction Period (IP)||120
9765512|NCT00410410|10869928|FG004|COMPLETED|Induction Period (IP)||19
9765513|NCT00410410|10869929|FG005|COMPLETED|Induction Period (IP)||21
9765514|NCT00410410|10869930|FG006|COMPLETED|Induction Period (IP)||0
9765515|NCT00410410|10869931|FG007|COMPLETED|Induction Period (IP)||0
9765516|NCT00410410|10869932|FG008|COMPLETED|Induction Period (IP)||0
9765517|NCT00410410|10869924|FG000|NOT COMPLETED|Induction Period (IP)||35
9765518|NCT00410410|10869925|FG001|NOT COMPLETED|Induction Period (IP)||35
9765519|NCT00410410|10869926|FG002|NOT COMPLETED|Induction Period (IP)||17
9765520|NCT00410410|10869927|FG003|NOT COMPLETED|Induction Period (IP)||20
9765521|NCT00410410|10869928|FG004|NOT COMPLETED|Induction Period (IP)||32
9765522|NCT00410410|10869929|FG005|NOT COMPLETED|Induction Period (IP)||29
9765523|NCT00410410|10869930|FG006|NOT COMPLETED|Induction Period (IP)||0
9765524|NCT00410410|10869931|FG007|NOT COMPLETED|Induction Period (IP)||0
9765525|NCT00410410|10869932|FG008|NOT COMPLETED|Induction Period (IP)||0
9765526|NCT00410410|10869924|FG000|STARTED|Maintenance Period (MP)||0
9765527|NCT00410410|10869925|FG001|STARTED|Maintenance Period (MP)||0
9765528|NCT00410410|10869926|FG002|STARTED|Maintenance Period (MP)||0
9765529|NCT00410410|10869927|FG003|STARTED|Maintenance Period (MP)||0
9765530|NCT00410410|10869928|FG004|STARTED|Maintenance Period (MP)||0
9765531|NCT00410410|10869929|FG005|STARTED|Maintenance Period (MP)||0
9765532|NCT00410410|10869930|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
9765533|NCT00410410|10869931|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
9765534|NCT00410410|10869932|FG008|STARTED|Maintenance Period (MP)||0
9765535|NCT00410410|10869924|FG000|COMPLETED|Maintenance Period (MP)||0
9765536|NCT00410410|10869925|FG001|COMPLETED|Maintenance Period (MP)||0
9765537|NCT00410410|10869926|FG002|COMPLETED|Maintenance Period (MP)||0
9765538|NCT00410410|10869927|FG003|COMPLETED|Maintenance Period (MP)||0
9765539|NCT00410410|10869928|FG004|COMPLETED|Maintenance Period (MP)||0
9765540|NCT00410410|10869929|FG005|COMPLETED|Maintenance Period (MP)||0
9765541|NCT00410410|10869930|FG006|COMPLETED|Maintenance Period (MP)||15
9765542|NCT00410410|10869931|FG007|COMPLETED|Maintenance Period (MP)||11
9765543|NCT00410410|10869932|FG008|COMPLETED|Maintenance Period (MP)||0
9765544|NCT00410410|10869924|FG000|NOT COMPLETED|Maintenance Period (MP)||0
9765545|NCT00410410|10869925|FG001|NOT COMPLETED|Maintenance Period (MP)||0
9765546|NCT00410410|10869926|FG002|NOT COMPLETED|Maintenance Period (MP)||0
9765547|NCT00410410|10869927|FG003|NOT COMPLETED|Maintenance Period (MP)||0
9765548|NCT00410410|10869928|FG004|NOT COMPLETED|Maintenance Period (MP)||0
9765549|NCT00410410|10869929|FG005|NOT COMPLETED|Maintenance Period (MP)||0
9765550|NCT00410410|10869930|FG006|NOT COMPLETED|Maintenance Period (MP)||50
9765551|NCT00410410|10869931|FG007|NOT COMPLETED|Maintenance Period (MP)||55
9765552|NCT00410410|10869932|FG008|NOT COMPLETED|Maintenance Period (MP)||0
9765553|NCT00410410|10869924|FG000|STARTED|Open-Label Period (OL)||0
9765554|NCT00410410|10869925|FG001|STARTED|Open-Label Period (OL)||0
9765555|NCT00410410|10869926|FG002|STARTED|Open-Label Period (OL)||0
10013973|NCT01796860|11136958|FG000|NOT COMPLETED|Overall Study||3
10013974|NCT01796912|11136962|FG000|STARTED|First Intervention||10
10013975|NCT01796912|11136963|FG001|STARTED|First Intervention||10
10013976|NCT01796912|11136962|FG000|COMPLETED|First Intervention||10
9765556|NCT00410410|10869927|FG003|STARTED|Open-Label Period (OL)||0
9765557|NCT00410410|10869928|FG004|STARTED|Open-Label Period (OL)||0
9765558|NCT00410410|10869929|FG005|STARTED|Open-Label Period (OL)||0
9765559|NCT00410410|10869930|FG006|STARTED|Open-Label Period (OL)||0
9765560|NCT00410410|10869931|FG007|STARTED|Open-Label Period (OL)||0
9765561|NCT00410410|10869932|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
9765562|NCT00410410|10869924|FG000|COMPLETED|Open-Label Period (OL)||0
9765563|NCT00410410|10869925|FG001|COMPLETED|Open-Label Period (OL)||0
9765564|NCT00410410|10869926|FG002|COMPLETED|Open-Label Period (OL)||0
9765565|NCT00410410|10869927|FG003|COMPLETED|Open-Label Period (OL)||0
9765566|NCT00410410|10869928|FG004|COMPLETED|Open-Label Period (OL)||0
9765567|NCT00410410|10869929|FG005|COMPLETED|Open-Label Period (OL)||0
9765568|NCT00410410|10869930|FG006|COMPLETED|Open-Label Period (OL)||0
9765569|NCT00410410|10869931|FG007|COMPLETED|Open-Label Period (OL)||0
9765570|NCT00410410|10869932|FG008|COMPLETED|Open-Label Period (OL)||0
9765571|NCT00410410|10869924|FG000|NOT COMPLETED|Open-Label Period (OL)||0
9765572|NCT00410410|10869925|FG001|NOT COMPLETED|Open-Label Period (OL)||0
9765573|NCT00410410|10869926|FG002|NOT COMPLETED|Open-Label Period (OL)||0
9765574|NCT00410410|10869927|FG003|NOT COMPLETED|Open-Label Period (OL)||0
9765575|NCT00410410|10869928|FG004|NOT COMPLETED|Open-Label Period (OL)||0
9765576|NCT00410410|10869929|FG005|NOT COMPLETED|Open-Label Period (OL)||0
10013977|NCT01796912|11136963|FG001|COMPLETED|First Intervention||10
10013978|NCT01796912|11136962|FG000|NOT COMPLETED|First Intervention||0
9765577|NCT00410410|10869930|FG006|NOT COMPLETED|Open-Label Period (OL)||0
9765578|NCT00410410|10869931|FG007|NOT COMPLETED|Open-Label Period (OL)||0
9765579|NCT00410410|10869932|FG008|NOT COMPLETED|Open-Label Period (OL)||349
9765580|NCT00410423|10869967|FG000|STARTED|Phase 1 - Dose Level 1||3
9765581|NCT00410423|10869968|FG001|STARTED|Phase 1 - Dose Level 1||0
9765582|NCT00410423|10869969|FG002|STARTED|Phase 1 - Dose Level 1||0
9765583|NCT00410423|10869970|FG003|STARTED|Phase 1 - Dose Level 1||0
9765584|NCT00410423|10869967|FG000|COMPLETED|Phase 1 - Dose Level 1||3
9765585|NCT00410423|10869968|FG001|COMPLETED|Phase 1 - Dose Level 1||0
9765586|NCT00410423|10869969|FG002|COMPLETED|Phase 1 - Dose Level 1||0
9765587|NCT00410423|10869970|FG003|COMPLETED|Phase 1 - Dose Level 1||0
9765588|NCT00410423|10869967|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0
9765589|NCT00410423|10869968|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0
9765590|NCT00410423|10869969|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0
9765591|NCT00410423|10869970|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0
9765592|NCT00410423|10869967|FG000|STARTED|Phase 1 - Dose Level 2||0
9765593|NCT00410423|10869968|FG001|STARTED|Phase 1 - Dose Level 2||5
9765594|NCT00410423|10869969|FG002|STARTED|Phase 1 - Dose Level 2||0
9765595|NCT00410423|10869970|FG003|STARTED|Phase 1 - Dose Level 2||0
9765596|NCT00410423|10869967|FG000|COMPLETED|Phase 1 - Dose Level 2||0
9765597|NCT00410423|10869968|FG001|COMPLETED|Phase 1 - Dose Level 2||5
9765598|NCT00410423|10869969|FG002|COMPLETED|Phase 1 - Dose Level 2||0
9765599|NCT00410423|10869970|FG003|COMPLETED|Phase 1 - Dose Level 2||0
9765600|NCT00410423|10869967|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0
9765601|NCT00410423|10869968|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0
9765602|NCT00410423|10869969|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0
9765603|NCT00410423|10869970|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0
9765604|NCT00410423|10869967|FG000|STARTED|Phase 1 - Dose Level 3||0
9765605|NCT00410423|10869968|FG001|STARTED|Phase 1 - Dose Level 3||0
9765606|NCT00410423|10869969|FG002|STARTED|Phase 1 - Dose Level 3||3
9765607|NCT00410423|10869970|FG003|STARTED|Phase 1 - Dose Level 3||0
9765608|NCT00410423|10869967|FG000|COMPLETED|Phase 1 - Dose Level 3||0
9765609|NCT00410423|10869968|FG001|COMPLETED|Phase 1 - Dose Level 3||0
9765610|NCT00410423|10869969|FG002|COMPLETED|Phase 1 - Dose Level 3||3
9765611|NCT00410423|10869970|FG003|COMPLETED|Phase 1 - Dose Level 3||0
9765612|NCT00410423|10869967|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0
9765613|NCT00410423|10869968|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0
9765614|NCT00410423|10869969|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0
9765615|NCT00410423|10869970|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0
9765616|NCT00410423|10869967|FG000|STARTED|Phase 2||0
9765617|NCT00410423|10869968|FG001|STARTED|Phase 2||0
9765618|NCT00410423|10869969|FG002|STARTED|Phase 2||0
9765619|NCT00410423|10869970|FG003|STARTED|Phase 2||44
9765620|NCT00410423|10869967|FG000|COMPLETED|Phase 2||0
9765621|NCT00410423|10869968|FG001|COMPLETED|Phase 2||0
9765622|NCT00410423|10869969|FG002|COMPLETED|Phase 2||0
9765623|NCT00410423|10869970|FG003|COMPLETED|Phase 2||44
9765624|NCT00410423|10869967|FG000|NOT COMPLETED|Phase 2||0
9765625|NCT00410423|10869968|FG001|NOT COMPLETED|Phase 2||0
9765626|NCT00410423|10869969|FG002|NOT COMPLETED|Phase 2||0
9765627|NCT00410423|10869970|FG003|NOT COMPLETED|Phase 2||0
9765628|NCT00410488|10869979|FG000|STARTED|Overall Study||16
9765629|NCT00410488|10869980|FG001|STARTED|Overall Study||34
9765630|NCT00410488|10869979|FG000|COMPLETED|Overall Study||16
9765631|NCT00410488|10869980|FG001|COMPLETED|Overall Study||34
9765632|NCT00410488|10869979|FG000|NOT COMPLETED|Overall Study||0
9765633|NCT00410488|10869980|FG001|NOT COMPLETED|Overall Study||0
9765634|NCT00410514|10869988|FG000|STARTED|Overall Study||65
9765635|NCT00410514|10869989|FG001|STARTED|Overall Study||70
9765636|NCT00410514|10869990|FG002|STARTED|Overall Study||65
9765637|NCT00410514|10869988|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
9765638|NCT00410514|10869989|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
9765639|NCT00410514|10869990|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
9765640|NCT00410514|10869988|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
9765641|NCT00410514|10869989|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
9765642|NCT00410514|10869990|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
9765643|NCT00410514|10869988|FG000|COMPLETED|Overall Study||63
9765644|NCT00410514|10869989|FG001|COMPLETED|Overall Study||67
9765645|NCT00410514|10869990|FG002|COMPLETED|Overall Study||58
9765646|NCT00410514|10869988|FG000|NOT COMPLETED|Overall Study||2
9765647|NCT00410514|10869989|FG001|NOT COMPLETED|Overall Study||3
9765648|NCT00410514|10869990|FG002|NOT COMPLETED|Overall Study||7
10013979|NCT01796912|11136963|FG001|NOT COMPLETED|First Intervention||0
10013980|NCT01796912|11136962|FG000|STARTED|Washout||10
10013981|NCT01796912|11136963|FG001|STARTED|Washout||10
10013982|NCT01796912|11136962|FG000|COMPLETED|Washout||10
9765649|NCT00410605|10869998|FG000|STARTED|Overall Study||39
9765650|NCT00410605|10869998|FG000|COMPLETED|Overall Study||14
9765651|NCT00410605|10869998|FG000|NOT COMPLETED|Overall Study||25
9765652|NCT00410761|10870004|FG000|STARTED|Overall Study|randomised patients|231
9765653|NCT00410761|10870005|FG001|STARTED|Overall Study|randomised patients|100
9829532|NCT00760019|10940180|FG003|COMPLETED|Overall Study||14
10013983|NCT01796912|11136963|FG001|COMPLETED|Washout||10
9765654|NCT00410761|10870004|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
9765655|NCT00410761|10870005|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
9765656|NCT00410761|10870004|FG000|NOT COMPLETED|Overall Study||120
9765657|NCT00410761|10870005|FG001|NOT COMPLETED|Overall Study||72
9765658|NCT00410813|10870013|FG000|STARTED|Overall Study||43
9765659|NCT00410813|10870014|FG001|STARTED|Overall Study||42
9765660|NCT00410813|10870013|FG000|Eligible|Overall Study||41
9765661|NCT00410813|10870014|FG001|Eligible|Overall Study||38
9765662|NCT00410813|10870013|FG000|COMPLETED|Overall Study|Patients treated until progression.|0
9765663|NCT00410813|10870014|FG001|COMPLETED|Overall Study||0
9765664|NCT00410813|10870013|FG000|NOT COMPLETED|Overall Study||43
9765665|NCT00410813|10870014|FG001|NOT COMPLETED|Overall Study||42
9765666|NCT00410826|10870045|FG000|STARTED|Overall Study||105
9765667|NCT00410826|10870046|FG001|STARTED|Overall Study||99
9765668|NCT00410826|10870045|FG000|COMPLETED|Overall Study||96
9765669|NCT00410826|10870046|FG001|COMPLETED|Overall Study||95
9765670|NCT00410826|10870045|FG000|NOT COMPLETED|Overall Study||9
9952269|NCT01421186|11071192|FG003|STARTED|Overall Study||21
9952270|NCT01421186|11071193|FG004|STARTED|Overall Study||17
9952271|NCT01421186|11071189|FG000|COMPLETED|Overall Study||31
9952272|NCT01421186|11071190|FG001|COMPLETED|Overall Study||4
9952273|NCT01421186|11071191|FG002|COMPLETED|Overall Study||18
9952274|NCT01421186|11071192|FG003|COMPLETED|Overall Study||21
9765671|NCT00410826|10870046|FG001|NOT COMPLETED|Overall Study||4
9765672|NCT00410891|10870052|FG000|STARTED|Overall Study||129
9765673|NCT00410891|10870052|FG000|COMPLETED|Overall Study||129
9765674|NCT00410891|10870052|FG000|NOT COMPLETED|Overall Study||0
9765675|NCT00410904|10870058|FG000|STARTED|Overall Study||40
9765676|NCT00410904|10870059|FG001|STARTED|Overall Study||20
9765677|NCT00410904|10870058|FG000|COMPLETED|Overall Study||40
9765678|NCT00410904|10870059|FG001|COMPLETED|Overall Study||20
9765679|NCT00410904|10870058|FG000|NOT COMPLETED|Overall Study||0
9765680|NCT00410904|10870059|FG001|NOT COMPLETED|Overall Study||0
9765681|NCT00411086|10870066|FG000|STARTED|Overall Study||52
9765682|NCT00411086|10870066|FG000|COMPLETED|Overall Study||52
9765683|NCT00411086|10870066|FG000|NOT COMPLETED|Overall Study||0
9765684|NCT00411151|10870070|FG000|STARTED|Overall Study||52
9765685|NCT00411151|10870070|FG000|COMPLETED|Overall Study||5
9765686|NCT00411151|10870070|FG000|NOT COMPLETED|Overall Study||47
9765687|NCT00411216|10870076|FG000|STARTED|Overall Study||13
9765688|NCT00411216|10870077|FG001|STARTED|Overall Study||10
9765689|NCT00411216|10870076|FG000|COMPLETED|Overall Study||13
9765690|NCT00411216|10870077|FG001|COMPLETED|Overall Study||8
9765691|NCT00411216|10870076|FG000|NOT COMPLETED|Overall Study||0
9765692|NCT00411216|10870077|FG001|NOT COMPLETED|Overall Study||2
9765693|NCT00411398|10870083|FG000|STARTED|Overall Study||15
9765694|NCT00411398|10870083|FG000|COMPLETED|Overall Study||10
9765695|NCT00411398|10870083|FG000|NOT COMPLETED|Overall Study||5
9765696|NCT00411411|10870089|FG000|STARTED|Overall Study||24
9765697|NCT00411411|10870090|FG001|STARTED|Overall Study||25
9765698|NCT00411411|10870089|FG000|COMPLETED|Overall Study||24
9765699|NCT00411411|10870090|FG001|COMPLETED|Overall Study||25
9765700|NCT00411411|10870089|FG000|NOT COMPLETED|Overall Study||0
9765701|NCT00411411|10870090|FG001|NOT COMPLETED|Overall Study||0
9765702|NCT00411450|10870097|FG000|STARTED|Overall Study||116
9765703|NCT00411450|10870097|FG000|Received Treatment|Overall Study||115
9765704|NCT00411450|10870097|FG000|COMPLETED|Overall Study|Ended second-line treatment|113
9765705|NCT00411450|10870097|FG000|NOT COMPLETED|Overall Study||3
9765706|NCT00411463|10870105|FG000|STARTED|Overall Study||14
9765707|NCT00411463|10870106|FG001|STARTED|Overall Study||11
9765708|NCT00411463|10870105|FG000|COMPLETED|Overall Study||11
9765709|NCT00411463|10870106|FG001|COMPLETED|Overall Study||8
9765710|NCT00411463|10870105|FG000|NOT COMPLETED|Overall Study||3
9765711|NCT00411463|10870106|FG001|NOT COMPLETED|Overall Study||3
9765712|NCT00411554|10870117|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
9765713|NCT00411554|10870118|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
9765714|NCT00411554|10870117|FG000|COMPLETED|Overall Study||155
9765715|NCT00411554|10870118|FG001|COMPLETED|Overall Study||147
9765716|NCT00411554|10870117|FG000|NOT COMPLETED|Overall Study||8
9765717|NCT00411554|10870118|FG001|NOT COMPLETED|Overall Study||9
9765718|NCT00411619|10870124|FG000|STARTED|Overall Study||28
9765719|NCT00411619|10870124|FG000|COMPLETED|Overall Study||22
9765720|NCT00411619|10870124|FG000|NOT COMPLETED|Overall Study||6
9765721|NCT00411632|10870129|FG000|STARTED|Overall Study||37
9765722|NCT00411632|10870129|FG000|COMPLETED|Overall Study||36
9765723|NCT00411632|10870129|FG000|NOT COMPLETED|Overall Study||1
9765724|NCT00411645|10870135|FG000|STARTED|Overall Study||227
9765725|NCT00411645|10870136|FG001|STARTED|Overall Study||454
9765726|NCT00411645|10870135|FG000|COMPLETED|Overall Study||146
9765727|NCT00411645|10870136|FG001|COMPLETED|Overall Study||290
9765728|NCT00411645|10870135|FG000|NOT COMPLETED|Overall Study||81
9765729|NCT00411645|10870136|FG001|NOT COMPLETED|Overall Study||164
9765730|NCT00411671|10870143|FG000|STARTED|Overall Study||105
9765731|NCT00411671|10870143|FG000|COMPLETED|Overall Study||85
9765732|NCT00411671|10870143|FG000|NOT COMPLETED|Overall Study||20
9765733|NCT00411684|10870147|FG000|STARTED|Overall Study||1533
9765734|NCT00411684|10870147|FG000|COMPLETED|Overall Study||1241
9765735|NCT00411684|10870147|FG000|NOT COMPLETED|Overall Study||292
9765736|NCT00411749|10870153|FG000|STARTED|Overall Study||82
9765737|NCT00411749|10870154|FG001|STARTED|Overall Study||25
9952275|NCT01421186|11071193|FG004|COMPLETED|Overall Study||17
9765738|NCT00411749|10870153|FG000|Vaccinated|Overall Study||82
9765739|NCT00411749|10870154|FG001|Vaccinated|Overall Study||25
9765740|NCT00411749|10870153|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
9765741|NCT00411749|10870154|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
9765742|NCT00411749|10870153|FG000|NOT COMPLETED|Overall Study||0
9765743|NCT00411749|10870154|FG001|NOT COMPLETED|Overall Study||0
9765744|NCT00411762|10870164|FG000|STARTED|Overall Study||25
9765745|NCT00411762|10870164|FG000|COMPLETED|Overall Study||20
9765746|NCT00411762|10870164|FG000|NOT COMPLETED|Overall Study||5
9765747|NCT00411788|10870168|FG000|STARTED|Overall Study||11
9765748|NCT00411788|10870168|FG000|COMPLETED|Overall Study||9
9765749|NCT00411788|10870168|FG000|NOT COMPLETED|Overall Study||2
9765750|NCT00412061|10870174|FG000|STARTED|Double Blind Phase||216
9765751|NCT00412061|10870175|FG001|STARTED|Double Blind Phase||213
9765752|NCT00412061|10870174|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
9765753|NCT00412061|10870175|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
9765754|NCT00412061|10870174|FG000|COMPLETED|Double Blind Phase||0
9765755|NCT00412061|10870175|FG001|COMPLETED|Double Blind Phase||0
9765756|NCT00412061|10870174|FG000|NOT COMPLETED|Double Blind Phase||216
9765757|NCT00412061|10870175|FG001|NOT COMPLETED|Double Blind Phase||213
9765758|NCT00412061|10870174|FG000|STARTED|Open Label Phase||0
9765759|NCT00412061|10870175|FG001|STARTED|Open Label Phase||170
9765760|NCT00412061|10870174|FG000|COMPLETED|Open Label Phase||0
9765761|NCT00412061|10870175|FG001|COMPLETED|Open Label Phase||0
9765762|NCT00412061|10870174|FG000|NOT COMPLETED|Open Label Phase||0
9765763|NCT00412061|10870175|FG001|NOT COMPLETED|Open Label Phase||170
9765764|NCT00412074|10870187|FG000|STARTED|Overall Study||199
9765765|NCT00412074|10870188|FG001|STARTED|Overall Study||66
9765766|NCT00412074|10870189|FG002|STARTED|Overall Study||195
9765767|NCT00412074|10870187|FG000|COMPLETED|Overall Study||122
9765768|NCT00412074|10870188|FG001|COMPLETED|Overall Study||44
9765769|NCT00412074|10870189|FG002|COMPLETED|Overall Study||128
9765770|NCT00412074|10870187|FG000|NOT COMPLETED|Overall Study||77
9765771|NCT00412074|10870188|FG001|NOT COMPLETED|Overall Study||22
9765772|NCT00412074|10870189|FG002|NOT COMPLETED|Overall Study||67
9765773|NCT00412087|10870202|FG000|STARTED|Overall Study||134
9765774|NCT00412087|10870203|FG001|STARTED|Overall Study||131
9765775|NCT00412087|10870202|FG000|COMPLETED|Overall Study||72
9765776|NCT00412087|10870203|FG001|COMPLETED|Overall Study||66
9765777|NCT00412087|10870202|FG000|NOT COMPLETED|Overall Study||62
9765778|NCT00412087|10870203|FG001|NOT COMPLETED|Overall Study||65
9765779|NCT00412113|10870211|FG000|STARTED|Overall Study|15-January-2007|123
9765780|NCT00412113|10870212|FG001|STARTED|Overall Study|15-January-2007|122
9765781|NCT00412113|10870211|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
9765782|NCT00412113|10870212|FG001|Received Treatment|Overall Study||122
9765783|NCT00412113|10870211|FG000|COMPLETED|Overall Study|15-April-2008|111
9765784|NCT00412113|10870212|FG001|COMPLETED|Overall Study|15-April-2008|107
9765785|NCT00412113|10870211|FG000|NOT COMPLETED|Overall Study||12
9765786|NCT00412113|10870212|FG001|NOT COMPLETED|Overall Study||15
9765787|NCT00412217|10870220|FG000|STARTED|Overall Study||46
9765788|NCT00412217|10870221|FG001|STARTED|Overall Study||48
9765789|NCT00412217|10870220|FG000|COMPLETED|Overall Study||0
9765790|NCT00412217|10870221|FG001|COMPLETED|Overall Study||0
9765791|NCT00412217|10870220|FG000|NOT COMPLETED|Overall Study||46
9765792|NCT00412217|10870221|FG001|NOT COMPLETED|Overall Study||48
9765793|NCT00412243|10870227|FG000|STARTED|Overall Study||50
9765794|NCT00412243|10870227|FG000|COMPLETED|Overall Study||50
9765795|NCT00412243|10870227|FG000|NOT COMPLETED|Overall Study||0
9765796|NCT00412360|10870233|FG000|STARTED|Overall Study||113
9765797|NCT00412360|10870234|FG001|STARTED|Overall Study||111
9765798|NCT00412360|10870233|FG000|COMPLETED|Overall Study||112
9765799|NCT00412360|10870234|FG001|COMPLETED|Overall Study||108
9765800|NCT00412360|10870233|FG000|NOT COMPLETED|Overall Study||1
9765801|NCT00412360|10870234|FG001|NOT COMPLETED|Overall Study||3
9765802|NCT00412373|10870242|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
9765803|NCT00412373|10870243|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
9765804|NCT00412373|10870242|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
9765805|NCT00412373|10870243|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
9765806|NCT00412373|10870242|FG000|NOT COMPLETED|Overall Study||41
9765807|NCT00412373|10870243|FG001|NOT COMPLETED|Overall Study||77
9765808|NCT00412425|10870251|FG000|STARTED|Overall Study||15
9765809|NCT00412425|10870252|FG001|STARTED|Overall Study||15
9765810|NCT00412425|10870251|FG000|COMPLETED|Overall Study||15
9765811|NCT00412425|10870252|FG001|COMPLETED|Overall Study||15
9765812|NCT00412425|10870251|FG000|NOT COMPLETED|Overall Study||0
9765813|NCT00412425|10870252|FG001|NOT COMPLETED|Overall Study||0
9765814|NCT00412451|10870262|FG000|STARTED|Overall Study||8
9765815|NCT00412451|10870263|FG001|STARTED|Overall Study||15
9765816|NCT00412451|10870264|FG002|STARTED|Overall Study||15
9765817|NCT00412451|10870265|FG003|STARTED|Overall Study||13
9765818|NCT00412451|10870262|FG000|COMPLETED|Overall Study||8
9765819|NCT00412451|10870263|FG001|COMPLETED|Overall Study||15
9765820|NCT00412451|10870264|FG002|COMPLETED|Overall Study||14
9765821|NCT00412451|10870265|FG003|COMPLETED|Overall Study||11
9765822|NCT00412451|10870262|FG000|NOT COMPLETED|Overall Study||0
9765823|NCT00412451|10870263|FG001|NOT COMPLETED|Overall Study||0
9765824|NCT00412451|10870264|FG002|NOT COMPLETED|Overall Study||1
9765825|NCT00412451|10870265|FG003|NOT COMPLETED|Overall Study||2
9765826|NCT00412464|10870275|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
9765827|NCT00412464|10870275|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
9765828|NCT00412464|10870275|FG000|NOT COMPLETED|Overall Study||0
10013984|NCT01796912|11136962|FG000|NOT COMPLETED|Washout||0
10013985|NCT01796912|11136963|FG001|NOT COMPLETED|Washout||0
10013986|NCT01796912|11136962|FG000|STARTED|Second Intervention||10
10013987|NCT01796912|11136963|FG001|STARTED|Second Intervention||10
10013988|NCT01796912|11136962|FG000|COMPLETED|Second Intervention||10
9765829|NCT00412516|10870282|FG000|STARTED|Overall Study||93
9765830|NCT00412516|10870283|FG001|STARTED|Overall Study||212
9765831|NCT00412516|10870284|FG002|STARTED|Overall Study||214
9765832|NCT00412516|10870282|FG000|COMPLETED|Overall Study||93
9765833|NCT00412516|10870283|FG001|COMPLETED|Overall Study||212
9765834|NCT00412516|10870284|FG002|COMPLETED|Overall Study||214
9765835|NCT00412516|10870282|FG000|NOT COMPLETED|Overall Study||0
9765836|NCT00412516|10870283|FG001|NOT COMPLETED|Overall Study||0
9765837|NCT00412516|10870284|FG002|NOT COMPLETED|Overall Study||0
9765838|NCT00412529|10870294|FG000|STARTED|Overall Study||23
9765839|NCT00412529|10870295|FG001|STARTED|Overall Study||21
9765840|NCT00412529|10870294|FG000|COMPLETED|Overall Study||23
9765841|NCT00412529|10870295|FG001|COMPLETED|Overall Study||21
9765842|NCT00412529|10870294|FG000|NOT COMPLETED|Overall Study||0
9765843|NCT00412529|10870295|FG001|NOT COMPLETED|Overall Study||0
9765844|NCT00412542|10870303|FG000|STARTED|Overall Study||33
9765845|NCT00412542|10870304|FG001|STARTED|Overall Study||45
9765846|NCT00412542|10870303|FG000|COMPLETED|Overall Study||33
9765847|NCT00412542|10870304|FG001|COMPLETED|Overall Study||42
9765848|NCT00412542|10870303|FG000|NOT COMPLETED|Overall Study||0
9765849|NCT00412542|10870304|FG001|NOT COMPLETED|Overall Study||3
9765850|NCT00412607|10870308|FG000|STARTED|Overall Study||249
9765851|NCT00412607|10870308|FG000|Started Study Catheter|Overall Study||233
9765852|NCT00412607|10870308|FG000|COMPLETED|Overall Study||145
9765853|NCT00412607|10870308|FG000|NOT COMPLETED|Overall Study||104
9765854|NCT00412737|10870317|FG000|STARTED|Overall Study||237
9765855|NCT00412737|10870318|FG001|STARTED|Overall Study||238
9765856|NCT00412737|10870317|FG000|COMPLETED|Overall Study||221
9765857|NCT00412737|10870318|FG001|COMPLETED|Overall Study||232
9765858|NCT00412737|10870317|FG000|NOT COMPLETED|Overall Study||16
9765859|NCT00412737|10870318|FG001|NOT COMPLETED|Overall Study||6
9765860|NCT00412750|10870327|FG000|STARTED|Overall Study||50
9765861|NCT00412750|10870328|FG001|STARTED|Overall Study||55
9765862|NCT00412750|10870329|FG002|STARTED|Overall Study||54
9765863|NCT00412750|10870327|FG000|COMPLETED|Overall Study||19
9765864|NCT00412750|10870328|FG001|COMPLETED|Overall Study||34
9765865|NCT00412750|10870329|FG002|COMPLETED|Overall Study||31
9765866|NCT00412750|10870327|FG000|NOT COMPLETED|Overall Study||31
9765867|NCT00412750|10870328|FG001|NOT COMPLETED|Overall Study||21
9765868|NCT00412750|10870329|FG002|NOT COMPLETED|Overall Study||23
9765869|NCT00412841|10870341|FG000|STARTED|Overall Study||22
9765870|NCT00412841|10870342|FG001|STARTED|Overall Study||21
9765871|NCT00412841|10870341|FG000|COMPLETED|Overall Study||12
9765872|NCT00412841|10870342|FG001|COMPLETED|Overall Study||16
9765873|NCT00412841|10870341|FG000|NOT COMPLETED|Overall Study||10
9765874|NCT00412841|10870342|FG001|NOT COMPLETED|Overall Study||5
9765875|NCT00412854|10870351|FG000|STARTED|Overall Study||330
9765876|NCT00412854|10870352|FG001|STARTED|Overall Study||330
9765877|NCT00412854|10870351|FG000|COMPLETED|Overall Study||316
9952276|NCT01421186|11071189|FG000|NOT COMPLETED|Overall Study||0
9952277|NCT01421186|11071190|FG001|NOT COMPLETED|Overall Study||0
9952278|NCT01421186|11071191|FG002|NOT COMPLETED|Overall Study||0
9952279|NCT01421186|11071192|FG003|NOT COMPLETED|Overall Study||0
9952280|NCT01421186|11071193|FG004|NOT COMPLETED|Overall Study||0
9952281|NCT01421225|11071213|FG000|STARTED|Overall Study||4
9952282|NCT01421225|11071214|FG001|STARTED|Overall Study||6
9952283|NCT01421225|11071213|FG000|COMPLETED|Overall Study||4
9952284|NCT01421225|11071214|FG001|COMPLETED|Overall Study||5
9952285|NCT01421225|11071213|FG000|NOT COMPLETED|Overall Study||0
9952286|NCT01421225|11071214|FG001|NOT COMPLETED|Overall Study||1
10013989|NCT01796912|11136963|FG001|COMPLETED|Second Intervention||10
9765878|NCT00412854|10870352|FG001|COMPLETED|Overall Study||314
9765879|NCT00412854|10870351|FG000|NOT COMPLETED|Overall Study||14
9765880|NCT00412854|10870352|FG001|NOT COMPLETED|Overall Study||16
9765881|NCT00412867|10870358|FG000|STARTED|Overall Study||58
9765882|NCT00412867|10870358|FG000|COMPLETED|Overall Study||58
9765883|NCT00412867|10870358|FG000|NOT COMPLETED|Overall Study||0
9765884|NCT00412893|10870365|FG000|STARTED|Overall Study||263
9765885|NCT00412893|10870366|FG001|STARTED|Overall Study||264
9765886|NCT00412893|10870365|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
9765887|NCT00412893|10870366|FG001|Received Treatment|Overall Study||258
9765888|NCT00412893|10870365|FG000|COMPLETED|Overall Study|Defined as completed treatment|118
9765889|NCT00412893|10870366|FG001|COMPLETED|Overall Study|Defined as completed treatment|120
9765890|NCT00412893|10870365|FG000|NOT COMPLETED|Overall Study||145
9765891|NCT00412893|10870366|FG001|NOT COMPLETED|Overall Study||144
9765892|NCT00412958|10870376|FG000|STARTED|Overall Study||29
9765893|NCT00412958|10870377|FG001|STARTED|Overall Study||33
9765894|NCT00412958|10870378|FG002|STARTED|Overall Study||32
9765895|NCT00412958|10870379|FG003|STARTED|Overall Study||31
9765896|NCT00412958|10870376|FG000|COMPLETED|Overall Study||26
9765897|NCT00412958|10870377|FG001|COMPLETED|Overall Study||29
9765898|NCT00412958|10870378|FG002|COMPLETED|Overall Study||32
9765899|NCT00412958|10870379|FG003|COMPLETED|Overall Study||30
9765900|NCT00412958|10870376|FG000|NOT COMPLETED|Overall Study||3
9765901|NCT00412958|10870377|FG001|NOT COMPLETED|Overall Study||4
9765902|NCT00412958|10870378|FG002|NOT COMPLETED|Overall Study||0
9765903|NCT00412958|10870379|FG003|NOT COMPLETED|Overall Study||1
9765904|NCT00412971|10870391|FG000|STARTED|Overall Study||115
9765905|NCT00412971|10870392|FG001|STARTED|Overall Study||118
9765906|NCT00412971|10870391|FG000|COMPLETED|Overall Study||85
9765907|NCT00412971|10870392|FG001|COMPLETED|Overall Study||108
9765908|NCT00412971|10870391|FG000|NOT COMPLETED|Overall Study||30
9765909|NCT00412971|10870392|FG001|NOT COMPLETED|Overall Study||10
9765910|NCT00412984|10870400|FG000|STARTED|Overall Study|Randomized participants|9120
9765911|NCT00412984|10870401|FG001|STARTED|Overall Study|Randomized participants|9081
9765912|NCT00412984|10870400|FG000|COMPLETED|Overall Study||6810
9765913|NCT00412984|10870401|FG001|COMPLETED|Overall Study||6588
9765914|NCT00412984|10870400|FG000|NOT COMPLETED|Overall Study||2310
9765915|NCT00412984|10870401|FG001|NOT COMPLETED|Overall Study||2493
9765916|NCT00413010|10870409|FG000|STARTED|Overall Study||180
9765917|NCT00413010|10870410|FG001|STARTED|Overall Study||176
9765918|NCT00413010|10870409|FG000|COMPLETED|Overall Study||108
9765919|NCT00413010|10870410|FG001|COMPLETED|Overall Study||113
9765920|NCT00413010|10870409|FG000|NOT COMPLETED|Overall Study||72
9765921|NCT00413010|10870410|FG001|NOT COMPLETED|Overall Study||63
9765922|NCT00413036|10870416|FG000|STARTED|Overall Study||217
9765923|NCT00413036|10870416|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
9765924|NCT00413036|10870416|FG000|NOT COMPLETED|Overall Study||217
9765925|NCT00413049|10870422|FG000|STARTED|Overall Study||349
9765926|NCT00413049|10870423|FG001|STARTED|Overall Study||349
9765927|NCT00413049|10870422|FG000|COMPLETED|Overall Study||325
9765928|NCT00413049|10870423|FG001|COMPLETED|Overall Study||331
9765929|NCT00413049|10870422|FG000|NOT COMPLETED|Overall Study||24
9765930|NCT00413049|10870423|FG001|NOT COMPLETED|Overall Study||18
9765931|NCT00413153|10870431|FG000|STARTED|Overall Study||7
9765932|NCT00413153|10870432|FG001|STARTED|Overall Study||8
9765933|NCT00413153|10870431|FG000|COMPLETED|Overall Study||5
9765934|NCT00413153|10870432|FG001|COMPLETED|Overall Study||7
9765935|NCT00413153|10870431|FG000|NOT COMPLETED|Overall Study||2
9765936|NCT00413153|10870432|FG001|NOT COMPLETED|Overall Study||1
9765937|NCT00413166|10870441|FG000|STARTED|Overall Study||57
9765938|NCT00413166|10870442|FG001|STARTED|Overall Study||5
9765939|NCT00413166|10870443|FG002|STARTED|Overall Study||16
9765940|NCT00413166|10870441|FG000|COMPLETED|Overall Study||57
9765941|NCT00413166|10870442|FG001|COMPLETED|Overall Study||5
9765942|NCT00413166|10870443|FG002|COMPLETED|Overall Study||16
9765943|NCT00413166|10870441|FG000|NOT COMPLETED|Overall Study||0
9765944|NCT00413166|10870442|FG001|NOT COMPLETED|Overall Study||0
9765945|NCT00413166|10870443|FG002|NOT COMPLETED|Overall Study||0
9765946|NCT00413192|10870455|FG000|STARTED|Overall Study||37
9765947|NCT00413192|10870456|FG001|STARTED|Overall Study||40
9765948|NCT00413192|10870457|FG002|STARTED|Overall Study||19
9765949|NCT00413192|10870458|FG003|STARTED|Overall Study||32
9765950|NCT00413192|10870455|FG000|COMPLETED|Overall Study||0
9765951|NCT00413192|10870456|FG001|COMPLETED|Overall Study||0
9765952|NCT00413192|10870457|FG002|COMPLETED|Overall Study||0
9765953|NCT00413192|10870458|FG003|COMPLETED|Overall Study||0
9765954|NCT00413192|10870455|FG000|NOT COMPLETED|Overall Study||37
9765955|NCT00413192|10870456|FG001|NOT COMPLETED|Overall Study||40
9765956|NCT00413192|10870457|FG002|NOT COMPLETED|Overall Study||19
9765957|NCT00413192|10870458|FG003|NOT COMPLETED|Overall Study||32
9765958|NCT00413218|10870470|FG000|STARTED|Overall Study||223
9765959|NCT00413218|10870471|FG001|STARTED|Overall Study||227
9765960|NCT00413218|10870470|FG000|Intent to Treat Population (ITT)|Overall Study||221
9765961|NCT00413218|10870471|FG001|Intent to Treat Population (ITT)|Overall Study||219
9765962|NCT00413218|10870470|FG000|COMPLETED|Overall Study||120
9765963|NCT00413218|10870471|FG001|COMPLETED|Overall Study||131
9765964|NCT00413218|10870470|FG000|NOT COMPLETED|Overall Study||103
9765965|NCT00413218|10870471|FG001|NOT COMPLETED|Overall Study||96
9765966|NCT00413231|10870478|FG000|STARTED|0 to 30-day Post Treatment||160
9765967|NCT00413231|10870478|FG000|COMPLETED|0 to 30-day Post Treatment||152
10232266|NCT02282332|11361484|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10239572|NCT00113386|11371199|FG000|NOT COMPLETED|Overall Study||7
10239573|NCT00113386|11371200|FG001|NOT COMPLETED|Overall Study||4
9765968|NCT00413231|10870478|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8
9765969|NCT00413231|10870478|FG000|STARTED|30-day to 365-day Post Treatment||152
9765970|NCT00413231|10870478|FG000|COMPLETED|30-day to 365-day Post Treatment||139
9765971|NCT00413231|10870478|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13
9765972|NCT00413231|10870478|FG000|STARTED|365-day to 60-month Post Treatment||139
9765973|NCT00413231|10870478|FG000|COMPLETED|365-day to 60-month Post Treatment||93
9765974|NCT00413231|10870478|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46
9765975|NCT00413244|10870485|FG000|STARTED|Overall Study||31
9765976|NCT00413244|10870486|FG001|STARTED|Overall Study||20
9765977|NCT00413244|10870485|FG000|COMPLETED|Overall Study||21
9765978|NCT00413244|10870486|FG001|COMPLETED|Overall Study||19
9765979|NCT00413244|10870485|FG000|NOT COMPLETED|Overall Study||10
9765980|NCT00413244|10870486|FG001|NOT COMPLETED|Overall Study||1
9765981|NCT00413283|10870496|FG000|STARTED|Overall Study||12
9765982|NCT00413283|10870497|FG001|STARTED|Overall Study||16
9765983|NCT00413283|10870498|FG002|STARTED|Overall Study||18
9765984|NCT00413283|10870499|FG003|STARTED|Overall Study||17
9765985|NCT00413283|10870496|FG000|Received Study Drug|Overall Study||12
9765986|NCT00413283|10870497|FG001|Received Study Drug|Overall Study||16
9765987|NCT00413283|10870498|FG002|Received Study Drug|Overall Study||18
9765988|NCT00413283|10870499|FG003|Received Study Drug|Overall Study||16
9765989|NCT00413283|10870496|FG000|COMPLETED|Overall Study||11
9765990|NCT00413283|10870497|FG001|COMPLETED|Overall Study||13
9765991|NCT00413283|10870498|FG002|COMPLETED|Overall Study||16
9765992|NCT00413283|10870499|FG003|COMPLETED|Overall Study||13
9765993|NCT00413283|10870496|FG000|NOT COMPLETED|Overall Study||1
9765994|NCT00413283|10870497|FG001|NOT COMPLETED|Overall Study||3
9765995|NCT00413283|10870498|FG002|NOT COMPLETED|Overall Study||2
9765996|NCT00413283|10870499|FG003|NOT COMPLETED|Overall Study||4
9765997|NCT00413335|10870511|FG000|STARTED|Overall Study||12
9765998|NCT00413335|10870512|FG001|STARTED|Overall Study||9
9765999|NCT00413335|10870511|FG000|COMPLETED|Overall Study||12
9766000|NCT00413335|10870512|FG001|COMPLETED|Overall Study||9
9766001|NCT00413335|10870511|FG000|NOT COMPLETED|Overall Study||0
9766002|NCT00413335|10870512|FG001|NOT COMPLETED|Overall Study||0
9766003|NCT00413374|10870520|FG000|STARTED|Overall Study||40
9766004|NCT00413374|10870521|FG001|STARTED|Overall Study||80
9766005|NCT00413374|10870520|FG000|COMPLETED|Overall Study||34
9766006|NCT00413374|10870521|FG001|COMPLETED|Overall Study||80
9766007|NCT00413374|10870520|FG000|NOT COMPLETED|Overall Study||6
9766008|NCT00413374|10870521|FG001|NOT COMPLETED|Overall Study||0
9766009|NCT00413400|10870532|FG000|STARTED|Overall Study||24
9766010|NCT00413400|10870533|FG001|STARTED|Overall Study||16
9766011|NCT00413400|10870532|FG000|3 Month Visit|Overall Study||22
9766012|NCT00413400|10870533|FG001|3 Month Visit|Overall Study||12
9766013|NCT00413400|10870532|FG000|COMPLETED|Overall Study||22
9766014|NCT00413400|10870533|FG001|COMPLETED|Overall Study||12
9766015|NCT00413400|10870532|FG000|NOT COMPLETED|Overall Study||2
9766016|NCT00413400|10870533|FG001|NOT COMPLETED|Overall Study||4
9766017|NCT00413413|10870542|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
9766018|NCT00413413|10870543|FG001|STARTED|Single-Blind||1134
9766019|NCT00413413|10870544|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
9766020|NCT00413413|10870542|FG000|COMPLETED|Single-Blind||0
9766021|NCT00413413|10870543|FG001|COMPLETED|Single-Blind||918
9766022|NCT00413413|10870544|FG002|COMPLETED|Single-Blind||0
9766023|NCT00413413|10870542|FG000|NOT COMPLETED|Single-Blind||0
9766024|NCT00413413|10870543|FG001|NOT COMPLETED|Single-Blind||216
9766025|NCT00413413|10870544|FG002|NOT COMPLETED|Single-Blind||0
9766026|NCT00413413|10870542|FG000|STARTED|Double-Blind||308
9766027|NCT00413413|10870543|FG001|STARTED|Double-Blind||307
9766028|NCT00413413|10870544|FG002|STARTED|Double-Blind||303
9766029|NCT00413413|10870542|FG000|COMPLETED|Double-Blind||293
9766030|NCT00413413|10870543|FG001|COMPLETED|Double-Blind||293
9766031|NCT00413413|10870544|FG002|COMPLETED|Double-Blind||285
9766032|NCT00413413|10870542|FG000|NOT COMPLETED|Double-Blind||15
9766033|NCT00413413|10870543|FG001|NOT COMPLETED|Double-Blind||14
9766034|NCT00413413|10870544|FG002|NOT COMPLETED|Double-Blind||18
9766035|NCT00413478|10870552|FG000|STARTED|Overall Study||9
9766036|NCT00413478|10870552|FG000|COMPLETED|Overall Study||9
9766037|NCT00413478|10870552|FG000|NOT COMPLETED|Overall Study||0
9766038|NCT00413582|10870558|FG000|STARTED|Overall Study|all enrolled completed|55
9766039|NCT00413582|10870559|FG001|STARTED|Overall Study|all enrolled completed|55
9766040|NCT00413582|10870558|FG000|Completion of Study|Overall Study|all enrolled completed|55
9766041|NCT00413582|10870559|FG001|Completion of Study|Overall Study|all enrolled completed|55
9766042|NCT00413582|10870558|FG000|COMPLETED|Overall Study|all enrolled completed|55
9766043|NCT00413582|10870559|FG001|COMPLETED|Overall Study|all enrolled completed|55
9766044|NCT00413582|10870558|FG000|NOT COMPLETED|Overall Study||0
9766045|NCT00413582|10870559|FG001|NOT COMPLETED|Overall Study||0
9766046|NCT00413634|10870567|FG000|STARTED|Overall Study||12
9766047|NCT00413634|10870568|FG001|STARTED|Overall Study||12
9766048|NCT00413634|10870567|FG000|COMPLETED|Overall Study||12
9766049|NCT00413634|10870568|FG001|COMPLETED|Overall Study||12
9766050|NCT00413634|10870567|FG000|NOT COMPLETED|Overall Study||0
9766051|NCT00413634|10870568|FG001|NOT COMPLETED|Overall Study||0
9766052|NCT00413660|10870583|FG000|STARTED|Up To Week 12||71
9766053|NCT00413660|10870584|FG001|STARTED|Up To Week 12||68
9766054|NCT00413660|10870585|FG002|STARTED|Up To Week 12||71
9766055|NCT00413660|10870586|FG003|STARTED|Up To Week 12||75
9766056|NCT00413660|10870587|FG004|STARTED|Up To Week 12||75
9766057|NCT00413660|10870588|FG005|STARTED|Up To Week 12||80
9766058|NCT00413660|10870589|FG006|STARTED|Up To Week 12||69
9766059|NCT00413660|10870590|FG007|STARTED|Up To Week 12||0
9766060|NCT00413660|10870591|FG008|STARTED|Up To Week 12||0
9766061|NCT00413660|10870592|FG009|STARTED|Up To Week 12||0
9766062|NCT00413660|10870593|FG010|STARTED|Up To Week 12||0
9766063|NCT00413660|10870583|FG000|Treated|Up To Week 12||70
9766064|NCT00413660|10870584|FG001|Treated|Up To Week 12||68
9766065|NCT00413660|10870585|FG002|Treated|Up To Week 12||71
9766066|NCT00413660|10870586|FG003|Treated|Up To Week 12||74
9766067|NCT00413660|10870587|FG004|Treated|Up To Week 12||75
9766068|NCT00413660|10870588|FG005|Treated|Up To Week 12||80
9766069|NCT00413660|10870589|FG006|Treated|Up To Week 12||69
9766070|NCT00413660|10870590|FG007|Treated|Up To Week 12||0
9766071|NCT00413660|10870591|FG008|Treated|Up To Week 12||0
9766072|NCT00413660|10870592|FG009|Treated|Up To Week 12||0
9766073|NCT00413660|10870593|FG010|Treated|Up To Week 12||0
9766074|NCT00413660|10870583|FG000|COMPLETED|Up To Week 12||64
9766075|NCT00413660|10870584|FG001|COMPLETED|Up To Week 12||61
9766076|NCT00413660|10870585|FG002|COMPLETED|Up To Week 12||64
9766077|NCT00413660|10870586|FG003|COMPLETED|Up To Week 12||67
9766078|NCT00413660|10870587|FG004|COMPLETED|Up To Week 12||66
9766079|NCT00413660|10870588|FG005|COMPLETED|Up To Week 12||70
9766080|NCT00413660|10870589|FG006|COMPLETED|Up To Week 12||58
9766081|NCT00413660|10870590|FG007|COMPLETED|Up To Week 12||0
9766082|NCT00413660|10870591|FG008|COMPLETED|Up To Week 12||0
10013990|NCT01796912|11136962|FG000|NOT COMPLETED|Second Intervention||0
10013991|NCT01796912|11136963|FG001|NOT COMPLETED|Second Intervention||0
10013992|NCT01796964|11136973|FG000|STARTED|Overall Study||44
10013993|NCT01796964|11136974|FG001|STARTED|Overall Study||45
10013994|NCT01796964|11136973|FG000|COMPLETED|Overall Study||41
10013995|NCT01796964|11136974|FG001|COMPLETED|Overall Study||42
10013996|NCT01796964|11136973|FG000|NOT COMPLETED|Overall Study||3
10013997|NCT01796964|11136974|FG001|NOT COMPLETED|Overall Study||3
10013998|NCT01796977|11136981|FG000|STARTED|Overall Study||27
10013999|NCT01796977|11136981|FG000|COMPLETED|Overall Study||27
10014000|NCT01796977|11136981|FG000|NOT COMPLETED|Overall Study||0
10014001|NCT01797029|11136992|FG000|STARTED|Overall Study||1174
10014002|NCT01797029|11136993|FG001|STARTED|Overall Study||587
10239574|NCT00138151|11371206|FG000|STARTED|Overall Study||33
9766083|NCT00413660|10870592|FG009|COMPLETED|Up To Week 12||0
9766084|NCT00413660|10870593|FG010|COMPLETED|Up To Week 12||0
9766085|NCT00413660|10870583|FG000|NOT COMPLETED|Up To Week 12||7
9766086|NCT00413660|10870584|FG001|NOT COMPLETED|Up To Week 12||7
9766087|NCT00413660|10870585|FG002|NOT COMPLETED|Up To Week 12||7
9766088|NCT00413660|10870586|FG003|NOT COMPLETED|Up To Week 12||8
9766089|NCT00413660|10870587|FG004|NOT COMPLETED|Up To Week 12||9
9766090|NCT00413660|10870588|FG005|NOT COMPLETED|Up To Week 12||10
9766091|NCT00413660|10870589|FG006|NOT COMPLETED|Up To Week 12||11
9766092|NCT00413660|10870590|FG007|NOT COMPLETED|Up To Week 12||0
9766093|NCT00413660|10870591|FG008|NOT COMPLETED|Up To Week 12||0
9766094|NCT00413660|10870592|FG009|NOT COMPLETED|Up To Week 12||0
9766095|NCT00413660|10870593|FG010|NOT COMPLETED|Up To Week 12||0
9766096|NCT00413660|10870583|FG000|STARTED|Post Week 12||43
9766097|NCT00413660|10870584|FG001|STARTED|Post Week 12||48
9766098|NCT00413660|10870585|FG002|STARTED|Post Week 12||64
9766099|NCT00413660|10870586|FG003|STARTED|Post Week 12||67
9766100|NCT00413660|10870587|FG004|STARTED|Post Week 12||66
9766101|NCT00413660|10870588|FG005|STARTED|Post Week 12||57
9766102|NCT00413660|10870589|FG006|STARTED|Post Week 12||40
9766103|NCT00413660|10870590|FG007|STARTED|Post Week 12||21
9766104|NCT00413660|10870591|FG008|STARTED|Post Week 12||13
9766105|NCT00413660|10870592|FG009|STARTED|Post Week 12||13
9766106|NCT00413660|10870593|FG010|STARTED|Post Week 12||18
9766107|NCT00413660|10870583|FG000|COMPLETED|Post Week 12||40
9766108|NCT00413660|10870584|FG001|COMPLETED|Post Week 12||44
9766109|NCT00413660|10870585|FG002|COMPLETED|Post Week 12||56
9766110|NCT00413660|10870586|FG003|COMPLETED|Post Week 12||66
9766111|NCT00413660|10870587|FG004|COMPLETED|Post Week 12||60
9766112|NCT00413660|10870588|FG005|COMPLETED|Post Week 12||54
9766113|NCT00413660|10870589|FG006|COMPLETED|Post Week 12||37
9766114|NCT00413660|10870590|FG007|COMPLETED|Post Week 12||21
9766115|NCT00413660|10870591|FG008|COMPLETED|Post Week 12||13
9766116|NCT00413660|10870592|FG009|COMPLETED|Post Week 12||12
9766117|NCT00413660|10870593|FG010|COMPLETED|Post Week 12||17
9766118|NCT00413660|10870583|FG000|NOT COMPLETED|Post Week 12||3
9766119|NCT00413660|10870584|FG001|NOT COMPLETED|Post Week 12||4
9766120|NCT00413660|10870585|FG002|NOT COMPLETED|Post Week 12||8
9766121|NCT00413660|10870586|FG003|NOT COMPLETED|Post Week 12||1
9766122|NCT00413660|10870587|FG004|NOT COMPLETED|Post Week 12||6
9766123|NCT00413660|10870588|FG005|NOT COMPLETED|Post Week 12||3
9766124|NCT00413660|10870589|FG006|NOT COMPLETED|Post Week 12||3
9766125|NCT00413660|10870590|FG007|NOT COMPLETED|Post Week 12||0
9766126|NCT00413660|10870591|FG008|NOT COMPLETED|Post Week 12||0
9766127|NCT00413660|10870592|FG009|NOT COMPLETED|Post Week 12||1
9766128|NCT00413660|10870593|FG010|NOT COMPLETED|Post Week 12||1
9766129|NCT00413777|10870625|FG000|STARTED|Fixed-dose Period||22
9766130|NCT00413777|10870626|FG001|STARTED|Fixed-dose Period||24
9766131|NCT00413777|10870625|FG000|COMPLETED|Fixed-dose Period||18
9766132|NCT00413777|10870626|FG001|COMPLETED|Fixed-dose Period||21
9766133|NCT00413777|10870625|FG000|NOT COMPLETED|Fixed-dose Period||4
10014003|NCT01797029|11136992|FG000|COMPLETED|Overall Study||1015
9766134|NCT00413777|10870626|FG001|NOT COMPLETED|Fixed-dose Period||3
9766135|NCT00413777|10870625|FG000|STARTED|Extension Period||17
9766136|NCT00413777|10870626|FG001|STARTED|Extension Period||18
10014004|NCT01797029|11136993|FG001|COMPLETED|Overall Study||526
10014005|NCT01797029|11136992|FG000|NOT COMPLETED|Overall Study||159
10014006|NCT01797029|11136993|FG001|NOT COMPLETED|Overall Study||61
9766137|NCT00413777|10870625|FG000|COMPLETED|Extension Period||17
9766138|NCT00413777|10870626|FG001|COMPLETED|Extension Period||18
9766139|NCT00413777|10870625|FG000|NOT COMPLETED|Extension Period||0
9766140|NCT00413777|10870626|FG001|NOT COMPLETED|Extension Period||0
9766141|NCT00413894|10870632|FG000|STARTED|Overall Study||424
9766142|NCT00413894|10870632|FG000|COMPLETED|Overall Study||344
9766143|NCT00413894|10870632|FG000|NOT COMPLETED|Overall Study||80
9766144|NCT00413920|10870641|FG000|STARTED|Overall Study||112
9766145|NCT00413920|10870642|FG001|STARTED|Overall Study||110
9766146|NCT00413920|10870641|FG000|COMPLETED|Overall Study||84
9766147|NCT00413920|10870642|FG001|COMPLETED|Overall Study||82
9766148|NCT00413920|10870641|FG000|NOT COMPLETED|Overall Study||28
9766149|NCT00413920|10870642|FG001|NOT COMPLETED|Overall Study||28
9766150|NCT00413959|10870648|FG000|STARTED|Overall Study||12
9766151|NCT00413959|10870648|FG000|COMPLETED|Overall Study||11
9766152|NCT00413959|10870648|FG000|NOT COMPLETED|Overall Study||1
9766153|NCT00414011|10870652|FG000|STARTED|Overall Study||40
9766154|NCT00414011|10870652|FG000|COMPLETED|Overall Study||35
9766155|NCT00414011|10870652|FG000|NOT COMPLETED|Overall Study||5
9766156|NCT00414050|10870661|FG000|STARTED|Overall Study||431
9766157|NCT00414050|10870662|FG001|STARTED|Overall Study||427
9766158|NCT00414050|10870663|FG002|STARTED|Overall Study||429
9766159|NCT00414050|10870664|FG003|STARTED|Overall Study||431
9766160|NCT00414050|10870661|FG000|Received Vaccination 1|Overall Study||431
9766161|NCT00414050|10870662|FG001|Received Vaccination 1|Overall Study||426
9766162|NCT00414050|10870663|FG002|Received Vaccination 1|Overall Study||429
9766163|NCT00414050|10870664|FG003|Received Vaccination 1|Overall Study||431
9766164|NCT00414050|10870661|FG000|Received Vaccination 2|Overall Study||425
9766165|NCT00414050|10870662|FG001|Received Vaccination 2|Overall Study||421
9766166|NCT00414050|10870663|FG002|Received Vaccination 2|Overall Study||425
9766167|NCT00414050|10870664|FG003|Received Vaccination 2|Overall Study||425
9766168|NCT00414050|10870661|FG000|Received Vaccination 3|Overall Study||424
9766169|NCT00414050|10870662|FG001|Received Vaccination 3|Overall Study||419
9766170|NCT00414050|10870663|FG002|Received Vaccination 3|Overall Study||425
9766171|NCT00414050|10870664|FG003|Received Vaccination 3|Overall Study||424
9766172|NCT00414050|10870661|FG000|COMPLETED|Overall Study||422
9766173|NCT00414050|10870662|FG001|COMPLETED|Overall Study||419
9766174|NCT00414050|10870663|FG002|COMPLETED|Overall Study||423
9766175|NCT00414050|10870664|FG003|COMPLETED|Overall Study||423
9766176|NCT00414050|10870661|FG000|NOT COMPLETED|Overall Study||9
9766177|NCT00414050|10870662|FG001|NOT COMPLETED|Overall Study||8
9766178|NCT00414050|10870663|FG002|NOT COMPLETED|Overall Study||6
9766179|NCT00414050|10870664|FG003|NOT COMPLETED|Overall Study||8
9766180|NCT00414076|10870676|FG000|STARTED|Overall Study||4
9766181|NCT00414076|10870677|FG001|STARTED|Overall Study||5
9766182|NCT00414076|10870676|FG000|COMPLETED|Overall Study||1
9766183|NCT00414076|10870677|FG001|COMPLETED|Overall Study||0
9766184|NCT00414076|10870676|FG000|NOT COMPLETED|Overall Study||3
9766185|NCT00414076|10870677|FG001|NOT COMPLETED|Overall Study||5
9766186|NCT00414167|10870685|FG000|STARTED|Overall Study||31
9766187|NCT00414167|10870686|FG001|STARTED|Overall Study||30
9766188|NCT00414167|10870685|FG000|COMPLETED|Overall Study||27
9766189|NCT00414167|10870686|FG001|COMPLETED|Overall Study||27
9766190|NCT00414167|10870685|FG000|NOT COMPLETED|Overall Study||4
9766191|NCT00414167|10870686|FG001|NOT COMPLETED|Overall Study||3
9766192|NCT00414206|10870697|FG000|STARTED|Overall Study||115
9766193|NCT00414206|10870698|FG001|STARTED|Overall Study||114
9766194|NCT00414206|10870699|FG002|STARTED|Overall Study||114
9766195|NCT00414206|10870697|FG000|COMPLETED|Overall Study||57
9766196|NCT00414206|10870698|FG001|COMPLETED|Overall Study||58
9766197|NCT00414206|10870699|FG002|COMPLETED|Overall Study||59
9766198|NCT00414206|10870697|FG000|NOT COMPLETED|Overall Study||58
9766199|NCT00414206|10870698|FG001|NOT COMPLETED|Overall Study||56
9766200|NCT00414206|10870699|FG002|NOT COMPLETED|Overall Study||55
9766201|NCT00414271|10870707|FG000|STARTED|Overall Study||18
9766202|NCT00414271|10870707|FG000|COMPLETED|Overall Study||18
9766203|NCT00414271|10870707|FG000|NOT COMPLETED|Overall Study||0
9766204|NCT00414310|10870713|FG000|STARTED|Overall Study||71
9766205|NCT00414310|10870714|FG001|STARTED|Overall Study||79
9766206|NCT00414310|10870713|FG000|COMPLETED|Overall Study||70
9766207|NCT00414310|10870714|FG001|COMPLETED|Overall Study||79
9766208|NCT00414310|10870713|FG000|NOT COMPLETED|Overall Study||1
9766209|NCT00414310|10870714|FG001|NOT COMPLETED|Overall Study||0
9766210|NCT00414388|10870722|FG000|STARTED|Overall Study||22
9766211|NCT00414388|10870722|FG000|COMPLETED|Overall Study||21
9766212|NCT00414388|10870722|FG000|NOT COMPLETED|Overall Study||1
9766213|NCT00414440|10870729|FG000|STARTED|Core Period|Core period|214
9766214|NCT00414440|10870730|FG001|STARTED|Core Period|Core period|217
9766215|NCT00414440|10870729|FG000|COMPLETED|Core Period|Core period|144
9766216|NCT00414440|10870730|FG001|COMPLETED|Core Period|Core period|185
9766217|NCT00414440|10870729|FG000|NOT COMPLETED|Core Period||70
9766218|NCT00414440|10870730|FG001|NOT COMPLETED|Core Period||32
9766219|NCT00414440|10870729|FG000|STARTED|Extension Period|Extension|214
9766220|NCT00414440|10870730|FG001|STARTED|Extension Period|Extension|217
9766221|NCT00414440|10870729|FG000|COMPLETED|Extension Period|Extension|64
9766222|NCT00414440|10870730|FG001|COMPLETED|Extension Period|Extension|77
9766223|NCT00414440|10870729|FG000|NOT COMPLETED|Extension Period||150
9766224|NCT00414440|10870730|FG001|NOT COMPLETED|Extension Period||140
9766225|NCT00414466|10870740|FG000|STARTED|Overall Study||44
9766226|NCT00414466|10870741|FG001|STARTED|Overall Study||42
9766227|NCT00414466|10870742|FG002|STARTED|Overall Study||41
9766228|NCT00414466|10870743|FG003|STARTED|Overall Study||43
9766229|NCT00414466|10870740|FG000|COMPLETED|Overall Study||42
9766230|NCT00414466|10870741|FG001|COMPLETED|Overall Study||42
9766231|NCT00414466|10870742|FG002|COMPLETED|Overall Study||40
9766232|NCT00414466|10870743|FG003|COMPLETED|Overall Study||42
9766233|NCT00414466|10870740|FG000|NOT COMPLETED|Overall Study||2
9766234|NCT00414466|10870741|FG001|NOT COMPLETED|Overall Study||0
9766235|NCT00414466|10870742|FG002|NOT COMPLETED|Overall Study||1
9766236|NCT00414466|10870743|FG003|NOT COMPLETED|Overall Study||1
9766237|NCT00414518|10870758|FG000|STARTED|Overall Study||7
9766238|NCT00414518|10870759|FG001|STARTED|Overall Study||9
9766239|NCT00414518|10870758|FG000|COMPLETED|Overall Study||7
9766240|NCT00414518|10870759|FG001|COMPLETED|Overall Study||9
9766241|NCT00414518|10870758|FG000|NOT COMPLETED|Overall Study||0
9766242|NCT00414518|10870759|FG001|NOT COMPLETED|Overall Study||0
9766243|NCT00414544|10870769|FG000|STARTED|Overall Study||145
9766244|NCT00414544|10870769|FG000|COMPLETED|Overall Study||131
9766245|NCT00414544|10870769|FG000|NOT COMPLETED|Overall Study||14
9766246|NCT00414596|10870775|FG000|STARTED|Overall Study|December 2006|20
9766247|NCT00414596|10870775|FG000|COMPLETED|Overall Study|April 2007|18
9766248|NCT00414596|10870775|FG000|NOT COMPLETED|Overall Study||2
9766249|NCT00414609|10870781|FG000|STARTED|Core Study||397
9766250|NCT00414609|10870782|FG001|STARTED|Core Study||423
9766251|NCT00414609|10870783|FG002|STARTED|Core Study||0
9766252|NCT00414609|10870781|FG000|Received Study Drug|Core Study||397
9766253|NCT00414609|10870782|FG001|Received Study Drug|Core Study||422
9766254|NCT00414609|10870783|FG002|Received Study Drug|Core Study||0
9766255|NCT00414609|10870781|FG000|Echocardiogram Evaluable Set|Core Study||330
9766256|NCT00414609|10870782|FG001|Echocardiogram Evaluable Set|Core Study||343
9766257|NCT00414609|10870783|FG002|Echocardiogram Evaluable Set|Core Study||0
9766258|NCT00414609|10870781|FG000|COMPLETED|Core Study||363
9766259|NCT00414609|10870782|FG001|COMPLETED|Core Study||378
9766260|NCT00414609|10870783|FG002|COMPLETED|Core Study||0
9766261|NCT00414609|10870781|FG000|NOT COMPLETED|Core Study||34
9766262|NCT00414609|10870782|FG001|NOT COMPLETED|Core Study||45
9766263|NCT00414609|10870783|FG002|NOT COMPLETED|Core Study||0
9766264|NCT00414609|10870781|FG000|STARTED|Extension Study||0
9766265|NCT00414609|10870782|FG001|STARTED|Extension Study||0
9766266|NCT00414609|10870783|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
9766267|NCT00414609|10870781|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0
9766268|NCT00414609|10870782|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0
9766269|NCT00414609|10870783|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400
9766270|NCT00414609|10870781|FG000|COMPLETED|Extension Study||0
9766271|NCT00414609|10870782|FG001|COMPLETED|Extension Study||0
9766272|NCT00414609|10870783|FG002|COMPLETED|Extension Study||365
9766273|NCT00414609|10870781|FG000|NOT COMPLETED|Extension Study||0
9766274|NCT00414609|10870782|FG001|NOT COMPLETED|Extension Study||0
9766275|NCT00414609|10870783|FG002|NOT COMPLETED|Extension Study||57
9766276|NCT00414635|10870794|FG000|STARTED|Overall Study||30
9766277|NCT00414635|10870795|FG001|STARTED|Overall Study||30
9766278|NCT00414635|10870794|FG000|COMPLETED|Overall Study||25
9766279|NCT00414635|10870795|FG001|COMPLETED|Overall Study||28
9766280|NCT00414635|10870794|FG000|NOT COMPLETED|Overall Study||5
9766281|NCT00414635|10870795|FG001|NOT COMPLETED|Overall Study||2
9766282|NCT00414661|10870805|FG000|STARTED|Overall Study||48
9766283|NCT00414661|10870806|FG001|STARTED|Overall Study||89
9766284|NCT00414661|10870807|FG002|STARTED|Overall Study||22
9766285|NCT00414661|10870808|FG003|STARTED|Overall Study||3
9766286|NCT00414661|10870805|FG000|COMPLETED|Overall Study||34
9766287|NCT00414661|10870806|FG001|COMPLETED|Overall Study||75
9766288|NCT00414661|10870807|FG002|COMPLETED|Overall Study||20
9766289|NCT00414661|10870808|FG003|COMPLETED|Overall Study||0
9766290|NCT00414661|10870805|FG000|NOT COMPLETED|Overall Study||14
9766291|NCT00414661|10870806|FG001|NOT COMPLETED|Overall Study||14
9766292|NCT00414661|10870807|FG002|NOT COMPLETED|Overall Study||2
9766293|NCT00414661|10870808|FG003|NOT COMPLETED|Overall Study||3
9766294|NCT00414700|10870820|FG000|STARTED|Overall Study||57
9766295|NCT00414700|10870821|FG001|STARTED|Overall Study||61
9766296|NCT00414700|10870820|FG000|COMPLETED|Overall Study||51
9766297|NCT00414700|10870821|FG001|COMPLETED|Overall Study||58
9766298|NCT00414700|10870820|FG000|NOT COMPLETED|Overall Study||6
9766299|NCT00414700|10870821|FG001|NOT COMPLETED|Overall Study||3
9766300|NCT00414726|10870829|FG000|STARTED|Overall Study||43
9766301|NCT00414726|10870830|FG001|STARTED|Overall Study||42
9766302|NCT00414726|10870829|FG000|COMPLETED|Overall Study||43
9766303|NCT00414726|10870830|FG001|COMPLETED|Overall Study||41
9766304|NCT00414726|10870829|FG000|NOT COMPLETED|Overall Study||0
9766305|NCT00414726|10870830|FG001|NOT COMPLETED|Overall Study||1
9766306|NCT00414765|10870838|FG000|STARTED|Overall Study||7
9766307|NCT00414765|10870839|FG001|STARTED|Overall Study||19
9766308|NCT00414765|10870838|FG000|Completed Study|Overall Study||7
9766309|NCT00414765|10870839|FG001|Completed Study|Overall Study||18
9766310|NCT00414765|10870838|FG000|Completed Cycle 1|Overall Study||7
9766311|NCT00414765|10870839|FG001|Completed Cycle 1|Overall Study||19
9766312|NCT00414765|10870838|FG000|Completed Cycle 2|Overall Study||4
9766313|NCT00414765|10870839|FG001|Completed Cycle 2|Overall Study||16
9766314|NCT00414765|10870838|FG000|COMPLETED|Overall Study||1
9766315|NCT00414765|10870839|FG001|COMPLETED|Overall Study||8
9766316|NCT00414765|10870838|FG000|NOT COMPLETED|Overall Study||6
9766317|NCT00414765|10870839|FG001|NOT COMPLETED|Overall Study||11
9766318|NCT00414817|10870847|FG000|STARTED|Overall Study||7033
9766319|NCT00414817|10870848|FG001|STARTED|Overall Study||7031
9766320|NCT00414817|10870847|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
9829533|NCT00760019|10940177|FG000|NOT COMPLETED|Overall Study||0
9766321|NCT00414817|10870848|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
9766322|NCT00414817|10870847|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
9766323|NCT00414817|10870848|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
9766324|NCT00414817|10870847|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
9766325|NCT00414817|10870848|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
9766326|NCT00414817|10870847|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
9766327|NCT00414817|10870848|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
9766328|NCT00414817|10870847|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
9766329|NCT00414817|10870848|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
9766330|NCT00414817|10870847|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
9766331|NCT00414817|10870848|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
9766332|NCT00414817|10870847|FG000|NOT COMPLETED|Overall Study||3130
9766333|NCT00414817|10870848|FG001|NOT COMPLETED|Overall Study||3016
9766334|NCT00414908|10870856|FG000|STARTED|Overall Study||25
9766335|NCT00414908|10870857|FG001|STARTED|Overall Study||29
9766336|NCT00414908|10870856|FG000|COMPLETED|Overall Study||24
9766337|NCT00414908|10870857|FG001|COMPLETED|Overall Study||28
9766338|NCT00414908|10870856|FG000|NOT COMPLETED|Overall Study||1
9766339|NCT00414908|10870857|FG001|NOT COMPLETED|Overall Study||1
9766340|NCT00414960|10870867|FG000|STARTED|Overall Study||25
9766341|NCT00414960|10870868|FG001|STARTED|Overall Study||15
9766342|NCT00414960|10870867|FG000|Received at Least One Dose of Study Drug|Overall Study||24
9766343|NCT00414960|10870868|FG001|Received at Least One Dose of Study Drug|Overall Study||15
9766344|NCT00414960|10870867|FG000|COMPLETED|Overall Study||18
9766345|NCT00414960|10870868|FG001|COMPLETED|Overall Study||14
9766346|NCT00414960|10870867|FG000|NOT COMPLETED|Overall Study||7
9766347|NCT00414960|10870868|FG001|NOT COMPLETED|Overall Study||1
9829534|NCT00760019|10940178|FG001|NOT COMPLETED|Overall Study||0
9829535|NCT00760019|10940179|FG002|NOT COMPLETED|Overall Study||0
9829536|NCT00760019|10940180|FG003|NOT COMPLETED|Overall Study||0
9829537|NCT00760084|10940186|FG000|STARTED|Overall Study||10
9829538|NCT00760084|10940186|FG000|COMPLETED|Overall Study||0
9829539|NCT00760084|10940186|FG000|NOT COMPLETED|Overall Study||10
9829540|NCT00760214|10940193|FG000|STARTED|Overall Study||295
9829541|NCT00760214|10940194|FG001|STARTED|Overall Study||294
9829542|NCT00760214|10940195|FG002|STARTED|Overall Study||296
9829543|NCT00760214|10940193|FG000|COMPLETED|Overall Study||265
9829544|NCT00760214|10940194|FG001|COMPLETED|Overall Study||264
9829545|NCT00760214|10940195|FG002|COMPLETED|Overall Study||255
9829546|NCT00760214|10940193|FG000|NOT COMPLETED|Overall Study||30
9829547|NCT00760214|10940194|FG001|NOT COMPLETED|Overall Study||30
9829548|NCT00760214|10940195|FG002|NOT COMPLETED|Overall Study||41
9829549|NCT00760266|10940205|FG000|STARTED|Overall Study||228
9829550|NCT00760266|10940206|FG001|STARTED|Overall Study||223
9829551|NCT00760266|10940205|FG000|COMPLETED|Overall Study||204
9829552|NCT00760266|10940206|FG001|COMPLETED|Overall Study||205
9829553|NCT00760266|10940205|FG000|NOT COMPLETED|Overall Study||24
9829554|NCT00760266|10940206|FG001|NOT COMPLETED|Overall Study||18
9829555|NCT00760383|10940214|FG000|STARTED|Overall Study||21
9829556|NCT00760383|10940215|FG001|STARTED|Overall Study||19
9829557|NCT00760383|10940214|FG000|COMPLETED|Overall Study||16
9829558|NCT00760383|10940215|FG001|COMPLETED|Overall Study||12
9829559|NCT00760383|10940214|FG000|NOT COMPLETED|Overall Study||5
9829560|NCT00760383|10940215|FG001|NOT COMPLETED|Overall Study||7
9829561|NCT00760435|10940223|FG000|STARTED|Overall Study||98
9829562|NCT00760435|10940224|FG001|STARTED|Overall Study||98
9829563|NCT00760435|10940223|FG000|COMPLETED|Overall Study||94
9829564|NCT00760435|10940224|FG001|COMPLETED|Overall Study||93
9829565|NCT00760435|10940223|FG000|NOT COMPLETED|Overall Study||4
9829566|NCT00760435|10940224|FG001|NOT COMPLETED|Overall Study||5
9829567|NCT00760474|10940230|FG000|STARTED|Period 1 (P1)||13
9829568|NCT00760474|10940231|FG001|STARTED|Period 1 (P1)||14
9829569|NCT00760474|10940230|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
9829570|NCT00760474|10940231|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
9829571|NCT00760474|10940230|FG000|Overall Number of Unique Participants|Period 1 (P1)||12
9829572|NCT00760474|10940231|FG001|Overall Number of Unique Participants|Period 1 (P1)||13
9829573|NCT00760474|10940230|FG000|COMPLETED|Period 1 (P1)||12
9829574|NCT00760474|10940231|FG001|COMPLETED|Period 1 (P1)||13
9829575|NCT00760474|10940230|FG000|NOT COMPLETED|Period 1 (P1)||1
9829576|NCT00760474|10940231|FG001|NOT COMPLETED|Period 1 (P1)||1
9829577|NCT00760474|10940230|FG000|STARTED|Placebo Washout Period||12
9829578|NCT00760474|10940231|FG001|STARTED|Placebo Washout Period||13
9829579|NCT00760474|10940230|FG000|COMPLETED|Placebo Washout Period||12
10239575|NCT00138151|11371206|FG000|COMPLETED|Overall Study||29
10239576|NCT00138151|11371206|FG000|NOT COMPLETED|Overall Study||4
10239577|NCT00129974|11371210|FG000|STARTED|Overall Study||1
9766348|NCT00414973|10870878|FG000|STARTED|Overall Study||218
9766349|NCT00414973|10870879|FG001|STARTED|Overall Study||109
9766350|NCT00414973|10870880|FG002|STARTED|Overall Study||24
9766351|NCT00414973|10870881|FG003|STARTED|Overall Study||11
9766352|NCT00414973|10870878|FG000|COMPLETED|Overall Study||190
9766353|NCT00414973|10870879|FG001|COMPLETED|Overall Study||99
9766354|NCT00414973|10870880|FG002|COMPLETED|Overall Study||21
9766355|NCT00414973|10870881|FG003|COMPLETED|Overall Study||11
9766356|NCT00414973|10870878|FG000|NOT COMPLETED|Overall Study||28
9766357|NCT00414973|10870879|FG001|NOT COMPLETED|Overall Study||10
9766358|NCT00414973|10870880|FG002|NOT COMPLETED|Overall Study||3
9766359|NCT00414973|10870881|FG003|NOT COMPLETED|Overall Study||0
9766360|NCT00415051|10870891|FG000|STARTED|Overall Study||20
9766361|NCT00415051|10870891|FG000|COMPLETED|Overall Study||19
9766362|NCT00415051|10870891|FG000|NOT COMPLETED|Overall Study||1
9766363|NCT00415168|10870895|FG000|STARTED|Overall Study||53
9766364|NCT00415168|10870895|FG000|Completed Treatment|Overall Study||15
9766365|NCT00415168|10870895|FG000|COMPLETED|Overall Study||1
9766366|NCT00415168|10870895|FG000|NOT COMPLETED|Overall Study||52
9766367|NCT00415194|10870901|FG000|STARTED|Overall Study||398
9766368|NCT00415194|10870902|FG001|STARTED|Overall Study||397
9766369|NCT00415194|10870901|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392
9766370|NCT00415194|10870902|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385
9766371|NCT00415194|10870901|FG000|COMPLETED|Overall Study||70
9766372|NCT00415194|10870902|FG001|COMPLETED|Overall Study||55
9766373|NCT00415194|10870901|FG000|NOT COMPLETED|Overall Study||328
9766374|NCT00415194|10870902|FG001|NOT COMPLETED|Overall Study||342
9766375|NCT00415363|10870910|FG000|STARTED|Overall Study||55
9766376|NCT00415363|10870911|FG001|STARTED|Overall Study||54
9766377|NCT00415363|10870910|FG000|Safety Population|Overall Study||54
9766378|NCT00415363|10870911|FG001|Safety Population|Overall Study||53
9766379|NCT00415363|10870910|FG000|COMPLETED|Overall Study||0
9766380|NCT00415363|10870911|FG001|COMPLETED|Overall Study||0
9766381|NCT00415363|10870910|FG000|NOT COMPLETED|Overall Study||55
9766382|NCT00415363|10870911|FG001|NOT COMPLETED|Overall Study||54
9766383|NCT00415493|10870920|FG000|STARTED|Overall Study||12
9766384|NCT00415493|10870921|FG001|STARTED|Overall Study||12
9766385|NCT00415493|10870920|FG000|COMPLETED|Overall Study||12
9766386|NCT00415493|10870921|FG001|COMPLETED|Overall Study||12
9766387|NCT00415493|10870920|FG000|NOT COMPLETED|Overall Study||0
9766388|NCT00415493|10870921|FG001|NOT COMPLETED|Overall Study||0
9766389|NCT00415506|10870929|FG000|STARTED|Overall Study||12
9766390|NCT00415506|10870930|FG001|STARTED|Overall Study||10
9766391|NCT00415506|10870929|FG000|COMPLETED|Overall Study||9
9766392|NCT00415506|10870930|FG001|COMPLETED|Overall Study||9
9766393|NCT00415506|10870929|FG000|NOT COMPLETED|Overall Study||3
9766394|NCT00415506|10870930|FG001|NOT COMPLETED|Overall Study||1
9766395|NCT00415519|10870938|FG000|STARTED|Overall Study||13
9766396|NCT00415519|10870939|FG001|STARTED|Overall Study||12
9766397|NCT00415519|10870938|FG000|COMPLETED|Overall Study||9
9766398|NCT00415519|10870939|FG001|COMPLETED|Overall Study||12
9766399|NCT00415519|10870938|FG000|NOT COMPLETED|Overall Study||4
9766400|NCT00415519|10870939|FG001|NOT COMPLETED|Overall Study||0
9766401|NCT00415532|10870947|FG000|STARTED|Treatment Period||77
9766402|NCT00415532|10870948|FG001|STARTED|Treatment Period||157
9766403|NCT00415532|10870947|FG000|Received Treatment|Treatment Period||75
9766404|NCT00415532|10870948|FG001|Received Treatment|Treatment Period||154
9766405|NCT00415532|10870947|FG000|Switched to Romiplostim Group|Treatment Period||2
9766406|NCT00415532|10870948|FG001|Switched to Romiplostim Group|Treatment Period||0
9766407|NCT00415532|10870947|FG000|COMPLETED|Treatment Period||60
9766408|NCT00415532|10870948|FG001|COMPLETED|Treatment Period||142
9766409|NCT00415532|10870947|FG000|NOT COMPLETED|Treatment Period||17
9766410|NCT00415532|10870948|FG001|NOT COMPLETED|Treatment Period||15
9766411|NCT00415532|10870947|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
9766412|NCT00415532|10870948|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
9766413|NCT00415532|10870947|FG000|COMPLETED|Safety Follow Up Period||34
9766414|NCT00415532|10870948|FG001|COMPLETED|Safety Follow Up Period||18
9766415|NCT00415532|10870947|FG000|NOT COMPLETED|Safety Follow Up Period||9
9766416|NCT00415532|10870948|FG001|NOT COMPLETED|Safety Follow Up Period||12
9766417|NCT00415597|10870954|FG000|STARTED|Enrollment||467
9766418|NCT00415597|10870954|FG000|COMPLETED|Enrollment||465
9766419|NCT00415597|10870954|FG000|NOT COMPLETED|Enrollment||2
9766420|NCT00415597|10870954|FG000|STARTED|Treatment||465
9766421|NCT00415597|10870954|FG000|COMPLETED|Treatment||160
9766422|NCT00415597|10870954|FG000|NOT COMPLETED|Treatment||305
9766423|NCT00415610|10870961|FG000|STARTED|Overall Study||18
9766424|NCT00415610|10870962|FG001|STARTED|Overall Study||20
9766425|NCT00415610|10870963|FG002|STARTED|Overall Study||22
9766426|NCT00415610|10870961|FG000|COMPLETED|Overall Study||15
9766427|NCT00415610|10870962|FG001|COMPLETED|Overall Study||18
9766428|NCT00415610|10870963|FG002|COMPLETED|Overall Study||17
9766429|NCT00415610|10870961|FG000|NOT COMPLETED|Overall Study||3
9766430|NCT00415610|10870962|FG001|NOT COMPLETED|Overall Study||2
9766431|NCT00415610|10870963|FG002|NOT COMPLETED|Overall Study||5
9766432|NCT00415636|10870977|FG000|STARTED|Overall Study||3
9766433|NCT00415636|10870978|FG001|STARTED|Overall Study||3
9766434|NCT00415636|10870979|FG002|STARTED|Overall Study||3
9766435|NCT00415636|10870980|FG003|STARTED|Overall Study||13
9766436|NCT00415636|10870981|FG004|STARTED|Overall Study||6
9766437|NCT00415636|10870982|FG005|STARTED|Overall Study||3
9766438|NCT00415636|10870977|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
9766439|NCT00415636|10870978|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
9766440|NCT00415636|10870979|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
9766441|NCT00415636|10870980|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
9766442|NCT00415636|10870981|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
9766443|NCT00415636|10870982|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
9766444|NCT00415636|10870977|FG000|NOT COMPLETED|Overall Study||1
9766445|NCT00415636|10870978|FG001|NOT COMPLETED|Overall Study||0
9766446|NCT00415636|10870979|FG002|NOT COMPLETED|Overall Study||1
9766447|NCT00415636|10870980|FG003|NOT COMPLETED|Overall Study||6
9766448|NCT00415636|10870981|FG004|NOT COMPLETED|Overall Study||2
9766449|NCT00415636|10870982|FG005|NOT COMPLETED|Overall Study||2
9766450|NCT00415857|10871006|FG000|STARTED|Overall Study||2
9766451|NCT00415857|10871007|FG001|STARTED|Overall Study||3
9766452|NCT00415857|10871006|FG000|COMPLETED|Overall Study||2
9766453|NCT00415857|10871007|FG001|COMPLETED|Overall Study||3
9766454|NCT00415857|10871006|FG000|NOT COMPLETED|Overall Study||0
9766455|NCT00415857|10871007|FG001|NOT COMPLETED|Overall Study||0
9766456|NCT00415870|10871015|FG000|STARTED|Overall Study||32
9766457|NCT00415870|10871016|FG001|STARTED|Overall Study||33
9766458|NCT00415870|10871015|FG000|COMPLETED|Overall Study||26
9766459|NCT00415870|10871016|FG001|COMPLETED|Overall Study||26
9766460|NCT00415870|10871015|FG000|NOT COMPLETED|Overall Study||6
9766461|NCT00415870|10871016|FG001|NOT COMPLETED|Overall Study||7
9766462|NCT00415909|10871022|FG000|STARTED|Overall Study||3
9766463|NCT00415909|10871022|FG000|COMPLETED|Overall Study||0
9766464|NCT00415909|10871022|FG000|NOT COMPLETED|Overall Study||3
9766465|NCT00416078|10871028|FG000|STARTED|Overall Study||29
9766466|NCT00416078|10871029|FG001|STARTED|Overall Study||24
9766467|NCT00416078|10871028|FG000|COMPLETED|Overall Study||18
9766468|NCT00416078|10871029|FG001|COMPLETED|Overall Study||16
9766469|NCT00416078|10871028|FG000|NOT COMPLETED|Overall Study||11
9766470|NCT00416078|10871029|FG001|NOT COMPLETED|Overall Study||8
9766471|NCT00416182|10871037|FG000|STARTED|Overall Study||8
9766472|NCT00416182|10871038|FG001|STARTED|Overall Study||8
9766473|NCT00416182|10871037|FG000|COMPLETED|Overall Study||5
9766474|NCT00416182|10871038|FG001|COMPLETED|Overall Study||6
9766475|NCT00416182|10871037|FG000|NOT COMPLETED|Overall Study||3
9766476|NCT00416182|10871038|FG001|NOT COMPLETED|Overall Study||2
9766477|NCT00416195|10871052|FG000|STARTED|Overall Study||10
9766478|NCT00416195|10871053|FG001|STARTED|Overall Study||38
9766479|NCT00416195|10871052|FG000|COMPLETED|Overall Study||8
9766480|NCT00416195|10871053|FG001|COMPLETED|Overall Study||34
9766481|NCT00416195|10871052|FG000|NOT COMPLETED|Overall Study||2
9766482|NCT00416195|10871053|FG001|NOT COMPLETED|Overall Study||4
9766483|NCT00416312|10871059|FG000|STARTED|Overall Study||9
9766484|NCT00416312|10871059|FG000|Conventional Dosimetry|Overall Study||9
9766485|NCT00416312|10871059|FG000|Patient-specific Dosimetry|Overall Study||9
9766486|NCT00416312|10871059|FG000|COMPLETED|Overall Study||7
9766487|NCT00416312|10871059|FG000|NOT COMPLETED|Overall Study||2
9766488|NCT00416455|10871065|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169
9766489|NCT00416455|10871066|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215
9766490|NCT00416455|10871065|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
9766491|NCT00416455|10871066|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
9766492|NCT00416455|10871065|FG000|NOT COMPLETED|Overall Study||16
9766493|NCT00416455|10871066|FG001|NOT COMPLETED|Overall Study||8
9766494|NCT00416494|10871085|FG000|STARTED|Overall Study||19
9766495|NCT00416494|10871086|FG001|STARTED|Overall Study||31
9766496|NCT00416494|10871085|FG000|COMPLETED|Overall Study||19
9766497|NCT00416494|10871086|FG001|COMPLETED|Overall Study||31
9766498|NCT00416494|10871085|FG000|NOT COMPLETED|Overall Study||0
9766499|NCT00416494|10871086|FG001|NOT COMPLETED|Overall Study||0
9766500|NCT00416520|10871094|FG000|STARTED|Open-label Period||165
9766501|NCT00416520|10871095|FG001|STARTED|Open-label Period||171
9766502|NCT00416520|10871096|FG002|STARTED|Open-label Period||0
9766503|NCT00416520|10871097|FG003|STARTED|Open-label Period||0
9766504|NCT00416520|10871094|FG000|COMPLETED|Open-label Period||105
9766505|NCT00416520|10871095|FG001|COMPLETED|Open-label Period||139
9766506|NCT00416520|10871096|FG002|COMPLETED|Open-label Period||0
9766507|NCT00416520|10871097|FG003|COMPLETED|Open-label Period||0
9766508|NCT00416520|10871094|FG000|NOT COMPLETED|Open-label Period||60
9766509|NCT00416520|10871095|FG001|NOT COMPLETED|Open-label Period||32
9766510|NCT00416520|10871096|FG002|NOT COMPLETED|Open-label Period||0
9766511|NCT00416520|10871097|FG003|NOT COMPLETED|Open-label Period||0
9766512|NCT00416520|10871094|FG000|STARTED|Placebo-controlled Withdrawal Period||0
9766513|NCT00416520|10871095|FG001|STARTED|Placebo-controlled Withdrawal Period||0
9766514|NCT00416520|10871096|FG002|STARTED|Placebo-controlled Withdrawal Period||50
9766515|NCT00416520|10871097|FG003|STARTED|Placebo-controlled Withdrawal Period||54
9766516|NCT00416520|10871094|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0
9766517|NCT00416520|10871095|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0
9766518|NCT00416520|10871096|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49
9766519|NCT00416520|10871097|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49
9766520|NCT00416520|10871094|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
9766521|NCT00416520|10871095|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
9766522|NCT00416520|10871096|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
9766523|NCT00416520|10871097|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
9766524|NCT00416572|10871110|FG000|STARTED|Overall Study||83
9766525|NCT00416572|10871111|FG001|STARTED|Overall Study||85
9766526|NCT00416572|10871112|FG002|STARTED|Overall Study||84
9766527|NCT00416572|10871110|FG000|COMPLETED|Overall Study||70
9766528|NCT00416572|10871111|FG001|COMPLETED|Overall Study||78
9766529|NCT00416572|10871112|FG002|COMPLETED|Overall Study||76
9766530|NCT00416572|10871110|FG000|NOT COMPLETED|Overall Study||13
9766531|NCT00416572|10871111|FG001|NOT COMPLETED|Overall Study||7
9766532|NCT00416572|10871112|FG002|NOT COMPLETED|Overall Study||8
9766533|NCT00416598|10871120|FG000|STARTED|Induction & Intensification||546
9766534|NCT00416598|10871120|FG000|COMPLETED|Induction & Intensification||134
9766535|NCT00416598|10871120|FG000|NOT COMPLETED|Induction & Intensification||412
9766536|NCT00416598|10871120|FG000|STARTED|Decitabine Maintenance||134
9766537|NCT00416598|10871120|FG000|COMPLETED|Decitabine Maintenance||62
9766538|NCT00416598|10871120|FG000|NOT COMPLETED|Decitabine Maintenance||72
9766539|NCT00416624|10871128|FG000|STARTED|Overall Study||61
9766540|NCT00416624|10871129|FG001|STARTED|Overall Study||60
9766541|NCT00416624|10871130|FG002|STARTED|Overall Study||58
9766542|NCT00416624|10871131|FG003|STARTED|Overall Study||57
9766543|NCT00416624|10871128|FG000|COMPLETED|Overall Study||39
9766544|NCT00416624|10871129|FG001|COMPLETED|Overall Study||33
9766545|NCT00416624|10871130|FG002|COMPLETED|Overall Study||40
9766546|NCT00416624|10871131|FG003|COMPLETED|Overall Study||40
9766547|NCT00416624|10871128|FG000|NOT COMPLETED|Overall Study||22
9766548|NCT00416624|10871129|FG001|NOT COMPLETED|Overall Study||27
9766549|NCT00416624|10871130|FG002|NOT COMPLETED|Overall Study||18
9766550|NCT00416624|10871131|FG003|NOT COMPLETED|Overall Study||17
9766551|NCT00416715|10871141|FG000|STARTED|Overall Study||100
9766552|NCT00416715|10871141|FG000|COMPLETED|Overall Study||85
9766553|NCT00416715|10871141|FG000|NOT COMPLETED|Overall Study||15
9766554|NCT00416793|10871148|FG000|STARTED|Overall Study||9
9766555|NCT00416793|10871148|FG000|COMPLETED|Overall Study||9
9766556|NCT00416793|10871148|FG000|NOT COMPLETED|Overall Study||0
9766557|NCT00416884|10871152|FG000|STARTED|Overall Study||1
9766558|NCT00416884|10871152|FG000|COMPLETED|Overall Study||0
9766559|NCT00416884|10871152|FG000|NOT COMPLETED|Overall Study||1
9766560|NCT00416949|10871156|FG000|STARTED|Overall Study||9
9766561|NCT00416949|10871156|FG000|COMPLETED|Overall Study||4
9766562|NCT00416949|10871156|FG000|NOT COMPLETED|Overall Study||5
9766563|NCT00417027|10871163|FG000|STARTED|Overall Study||66
9766564|NCT00417027|10871164|FG001|STARTED|Overall Study||65
9766565|NCT00417027|10871165|FG002|STARTED|Overall Study||59
9766566|NCT00417027|10871163|FG000|COMPLETED|Overall Study||66
9766567|NCT00417027|10871164|FG001|COMPLETED|Overall Study||60
9766568|NCT00417027|10871165|FG002|COMPLETED|Overall Study||54
9766569|NCT00417027|10871163|FG000|NOT COMPLETED|Overall Study||0
9766570|NCT00417027|10871164|FG001|NOT COMPLETED|Overall Study||5
9766571|NCT00417027|10871165|FG002|NOT COMPLETED|Overall Study||5
9766572|NCT00417079|10871175|FG000|STARTED|Overall Study|Randomized patients|377
9766573|NCT00417079|10871176|FG001|STARTED|Overall Study|Randomized patients|378
9766574|NCT00417079|10871175|FG000|COMPLETED|Overall Study|Randomized patients|46
9766575|NCT00417079|10871176|FG001|COMPLETED|Overall Study|Randomized patients|105
9766576|NCT00417079|10871175|FG000|NOT COMPLETED|Overall Study||331
9766577|NCT00417079|10871176|FG001|NOT COMPLETED|Overall Study||273
9766578|NCT00417170|10871184|FG000|STARTED|Overall Study|"Started indicates Safety population."|23
9766579|NCT00417170|10871185|FG001|STARTED|Overall Study||25
9766580|NCT00417170|10871184|FG000|Pharmacodynamics Population|Overall Study||21
9766581|NCT00417170|10871185|FG001|Pharmacodynamics Population|Overall Study||23
9766582|NCT00417170|10871184|FG000|COMPLETED|Overall Study||21
9766583|NCT00417170|10871185|FG001|COMPLETED|Overall Study||22
9766584|NCT00417170|10871184|FG000|NOT COMPLETED|Overall Study||2
10014007|NCT01797081|11137003|FG000|STARTED|Overall Study||104
10014008|NCT01797081|11137004|FG001|STARTED|Overall Study||99
10014009|NCT01797081|11137005|FG002|STARTED|Overall Study||48
10014010|NCT01797081|11137006|FG003|STARTED|Overall Study||49
10014011|NCT01797081|11137003|FG000|COMPLETED|Overall Study||90
10014012|NCT01797081|11137004|FG001|COMPLETED|Overall Study||95
10014013|NCT01797081|11137005|FG002|COMPLETED|Overall Study||43
10014014|NCT01797081|11137006|FG003|COMPLETED|Overall Study||40
10014015|NCT01797081|11137003|FG000|NOT COMPLETED|Overall Study||14
10014016|NCT01797081|11137004|FG001|NOT COMPLETED|Overall Study||4
10014017|NCT01797081|11137005|FG002|NOT COMPLETED|Overall Study||5
9766585|NCT00417170|10871185|FG001|NOT COMPLETED|Overall Study||3
9766586|NCT00417274|10871191|FG000|STARTED|Overall Study||31
10014018|NCT01797081|11137006|FG003|NOT COMPLETED|Overall Study||9
9766587|NCT00417274|10871191|FG000|COMPLETED|Overall Study||31
9766588|NCT00417274|10871191|FG000|NOT COMPLETED|Overall Study||0
9766589|NCT00417417|10871197|FG000|STARTED|Overall Study||4
9766590|NCT00417417|10871198|FG001|STARTED|Overall Study||6
9766591|NCT00417417|10871197|FG000|COMPLETED|Overall Study||4
9766592|NCT00417417|10871198|FG001|COMPLETED|Overall Study||6
9766593|NCT00417417|10871197|FG000|NOT COMPLETED|Overall Study||0
10014019|NCT01797094|11137016|FG000|STARTED|Overall Study||48
10014020|NCT01797094|11137017|FG001|STARTED|Overall Study||53
9766594|NCT00417417|10871198|FG001|NOT COMPLETED|Overall Study||0
9766595|NCT00417482|10871209|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
10014021|NCT01797094|11137016|FG000|COMPLETED|Overall Study||42
9766596|NCT00417482|10871210|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
9766597|NCT00417482|10871211|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
9766598|NCT00417482|10871209|FG000|COMPLETED|Phase B 1st 16 Weeks||13
9766599|NCT00417482|10871210|FG001|COMPLETED|Phase B 1st 16 Weeks||27
9766600|NCT00417482|10871211|FG002|COMPLETED|Phase B 1st 16 Weeks||13
9766601|NCT00417482|10871209|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19
9766602|NCT00417482|10871210|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11
9766603|NCT00417482|10871211|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27
9766604|NCT00417482|10871209|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
9766605|NCT00417482|10871210|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
9766606|NCT00417482|10871211|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
9766607|NCT00417482|10871209|FG000|COMPLETED|Phase B 2nd 16 Weeks||10
9766608|NCT00417482|10871210|FG001|COMPLETED|Phase B 2nd 16 Weeks||14
9766609|NCT00417482|10871211|FG002|COMPLETED|Phase B 2nd 16 Weeks||10
9766610|NCT00417482|10871209|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3
9766611|NCT00417482|10871210|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13
9766612|NCT00417482|10871211|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3
9766613|NCT00417612|10871227|FG000|STARTED|Overall Study||22
9766614|NCT00417612|10871228|FG001|STARTED|Overall Study||11
9766615|NCT00417612|10871227|FG000|COMPLETED|Overall Study||19
9766616|NCT00417612|10871228|FG001|COMPLETED|Overall Study||8
9766617|NCT00417612|10871227|FG000|NOT COMPLETED|Overall Study||3
9766618|NCT00417612|10871228|FG001|NOT COMPLETED|Overall Study||3
9766619|NCT00417859|10871238|FG000|STARTED|Overall Study||26
9766620|NCT00417859|10871239|FG001|STARTED|Overall Study||30
9766621|NCT00417859|10871238|FG000|COMPLETED|Overall Study||26
9766622|NCT00417859|10871239|FG001|COMPLETED|Overall Study||29
9766623|NCT00417859|10871238|FG000|NOT COMPLETED|Overall Study||0
9766624|NCT00417859|10871239|FG001|NOT COMPLETED|Overall Study||1
9766625|NCT00417885|10871247|FG000|STARTED|Overall Study||6
9766626|NCT00417885|10871247|FG000|COMPLETED|Overall Study||0
9766627|NCT00417885|10871247|FG000|NOT COMPLETED|Overall Study||6
9766628|NCT00417963|10871251|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
9766629|NCT00417963|10871251|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
9766630|NCT00417963|10871251|FG000|NOT COMPLETED|Overall Study||41
9766631|NCT00417976|10871260|FG000|STARTED|Overall Study||42
9766632|NCT00417976|10871260|FG000|COMPLETED|Overall Study||39
9766633|NCT00417976|10871260|FG000|NOT COMPLETED|Overall Study||3
9766634|NCT00417989|10871267|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
9766635|NCT00417989|10871268|FG001|STARTED|Overall Study||241
9766636|NCT00417989|10871267|FG000|COMPLETED|Overall Study||224
9766637|NCT00417989|10871268|FG001|COMPLETED|Overall Study||219
9766638|NCT00417989|10871267|FG000|NOT COMPLETED|Overall Study||20
9766639|NCT00417989|10871268|FG001|NOT COMPLETED|Overall Study||22
9766640|NCT00418015|10871280|FG000|STARTED|Overall Study||144
9766641|NCT00418015|10871281|FG001|STARTED|Overall Study||46
9766642|NCT00418015|10871282|FG002|STARTED|Overall Study||78
9766643|NCT00418015|10871283|FG003|STARTED|Overall Study||25
9766644|NCT00418015|10871280|FG000|COMPLETED|Overall Study||144
9766645|NCT00418015|10871281|FG001|COMPLETED|Overall Study||46
9766646|NCT00418015|10871282|FG002|COMPLETED|Overall Study||78
9766647|NCT00418015|10871283|FG003|COMPLETED|Overall Study||25
9766648|NCT00418015|10871280|FG000|NOT COMPLETED|Overall Study||0
9766649|NCT00418015|10871281|FG001|NOT COMPLETED|Overall Study||0
9766650|NCT00418015|10871282|FG002|NOT COMPLETED|Overall Study||0
9766651|NCT00418015|10871283|FG003|NOT COMPLETED|Overall Study||0
9766652|NCT00418028|10871295|FG000|STARTED|Overall Study||97
9766653|NCT00418028|10871296|FG001|STARTED|Overall Study||98
9766654|NCT00418028|10871295|FG000|COMPLETED|Overall Study||95
9766655|NCT00418028|10871296|FG001|COMPLETED|Overall Study||97
9766656|NCT00418028|10871295|FG000|NOT COMPLETED|Overall Study||2
9766657|NCT00418028|10871296|FG001|NOT COMPLETED|Overall Study||1
9766658|NCT00418093|10871302|FG000|STARTED|Overall Study||19
9766659|NCT00418093|10871302|FG000|Completed Study|Overall Study||19
9766660|NCT00418093|10871302|FG000|COMPLETED|Overall Study||19
9766661|NCT00418093|10871302|FG000|NOT COMPLETED|Overall Study||0
9766662|NCT00418184|10871308|FG000|STARTED|Double-blind Phase||137
9766663|NCT00418184|10871309|FG001|STARTED|Double-blind Phase||63
9766664|NCT00418184|10871308|FG000|COMPLETED|Double-blind Phase||110
9766665|NCT00418184|10871309|FG001|COMPLETED|Double-blind Phase||52
9766666|NCT00418184|10871308|FG000|NOT COMPLETED|Double-blind Phase||27
10014022|NCT01797094|11137017|FG001|COMPLETED|Overall Study||51
10014023|NCT01797094|11137016|FG000|NOT COMPLETED|Overall Study||6
9766667|NCT00418184|10871309|FG001|NOT COMPLETED|Double-blind Phase||11
9766668|NCT00418184|10871308|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
9766669|NCT00418184|10871309|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
9766670|NCT00418184|10871308|FG000|COMPLETED|Open-label Phase|5 dropped out|97
9766671|NCT00418184|10871309|FG001|COMPLETED|Open-label Phase|5 dropped out|43
9766672|NCT00418184|10871308|FG000|NOT COMPLETED|Open-label Phase||5
9766673|NCT00418184|10871309|FG001|NOT COMPLETED|Open-label Phase||5
9766674|NCT00418262|10871315|FG000|STARTED|Visits 1 (Baseline) Thru 5||27
9766675|NCT00418262|10871315|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25
10014024|NCT01797094|11137017|FG001|NOT COMPLETED|Overall Study||2
10014025|NCT01797120|11137025|FG000|STARTED|Overall Study||66
9766676|NCT00418262|10871315|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
9766677|NCT00418262|10871315|FG000|STARTED|Visits 5 Thru 8||25
9766678|NCT00418262|10871315|FG000|COMPLETED|Visits 5 Thru 8||16
9766679|NCT00418262|10871315|FG000|NOT COMPLETED|Visits 5 Thru 8||9
9766680|NCT00418262|10871315|FG000|STARTED|Visits 8 Thru 10||16
9766681|NCT00418262|10871315|FG000|COMPLETED|Visits 8 Thru 10||11
9766682|NCT00418262|10871315|FG000|NOT COMPLETED|Visits 8 Thru 10||5
9766683|NCT00418314|10871325|FG000|STARTED|Overall Study||817
9766684|NCT00418314|10871326|FG001|STARTED|Overall Study||830
9766685|NCT00418314|10871325|FG000|COMPLETED|Overall Study||816
9766686|NCT00418314|10871326|FG001|COMPLETED|Overall Study||828
9766687|NCT00418314|10871325|FG000|NOT COMPLETED|Overall Study||1
9766688|NCT00418314|10871326|FG001|NOT COMPLETED|Overall Study||2
9766689|NCT00418379|10871335|FG000|STARTED|Year 1||207
9766690|NCT00418379|10871336|FG001|STARTED|Year 1||207
9766691|NCT00418379|10871337|FG002|STARTED|Year 1||219
9766692|NCT00418379|10871335|FG000|COMPLETED|Year 1||189
9766693|NCT00418379|10871336|FG001|COMPLETED|Year 1||179
9766694|NCT00418379|10871337|FG002|COMPLETED|Year 1||204
9766695|NCT00418379|10871335|FG000|NOT COMPLETED|Year 1||18
9766696|NCT00418379|10871336|FG001|NOT COMPLETED|Year 1||28
9766697|NCT00418379|10871337|FG002|NOT COMPLETED|Year 1||15
9766698|NCT00418379|10871335|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
9766699|NCT00418379|10871336|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
9766700|NCT00418379|10871337|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
9766701|NCT00418379|10871335|FG000|COMPLETED|Year 2||159
9766702|NCT00418379|10871336|FG001|COMPLETED|Year 2||155
9766703|NCT00418379|10871337|FG002|COMPLETED|Year 2||172
9766704|NCT00418379|10871335|FG000|NOT COMPLETED|Year 2||8
9766705|NCT00418379|10871336|FG001|NOT COMPLETED|Year 2||4
9766706|NCT00418379|10871337|FG002|NOT COMPLETED|Year 2||10
9766707|NCT00418379|10871335|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
9766708|NCT00418379|10871336|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
9766709|NCT00418379|10871337|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
9766710|NCT00418379|10871335|FG000|COMPLETED|Year 3||148
9766711|NCT00418379|10871336|FG001|COMPLETED|Year 3||146
9766712|NCT00418379|10871337|FG002|COMPLETED|Year 3||163
9766713|NCT00418379|10871335|FG000|NOT COMPLETED|Year 3||3
9766714|NCT00418379|10871336|FG001|NOT COMPLETED|Year 3||2
9766715|NCT00418379|10871337|FG002|NOT COMPLETED|Year 3||3
9766716|NCT00418379|10871335|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
9766717|NCT00418379|10871336|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
9766718|NCT00418379|10871337|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
9766719|NCT00418379|10871335|FG000|COMPLETED|Year 4||142
9766720|NCT00418379|10871336|FG001|COMPLETED|Year 4||136
9766721|NCT00418379|10871337|FG002|COMPLETED|Year 4||154
9766722|NCT00418379|10871335|FG000|NOT COMPLETED|Year 4||3
9766723|NCT00418379|10871336|FG001|NOT COMPLETED|Year 4||5
9766724|NCT00418379|10871337|FG002|NOT COMPLETED|Year 4||2
9766725|NCT00418379|10871335|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
9766726|NCT00418379|10871336|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
9766727|NCT00418379|10871337|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
9766728|NCT00418379|10871335|FG000|COMPLETED|Year 5||126
9766729|NCT00418379|10871336|FG001|COMPLETED|Year 5||115
9766730|NCT00418379|10871337|FG002|COMPLETED|Year 5||131
9766731|NCT00418379|10871335|FG000|NOT COMPLETED|Year 5||2
9766732|NCT00418379|10871336|FG001|NOT COMPLETED|Year 5||5
9766733|NCT00418379|10871337|FG002|NOT COMPLETED|Year 5||3
9766734|NCT00418457|10871347|FG000|STARTED|Overall Study||1065
9766735|NCT00418457|10871348|FG001|STARTED|Overall Study||1043
9766736|NCT00418457|10871347|FG000|COMPLETED|Overall Study||1065
9766737|NCT00418457|10871348|FG001|COMPLETED|Overall Study||1043
9766738|NCT00418457|10871347|FG000|NOT COMPLETED|Overall Study||0
9766739|NCT00418457|10871348|FG001|NOT COMPLETED|Overall Study||0
9766740|NCT00418522|10871356|FG000|STARTED|Overall Study||219
9766741|NCT00418522|10871357|FG001|STARTED|Overall Study||194
9766742|NCT00418522|10871356|FG000|Received Treatment|Overall Study||212
9766743|NCT00418522|10871357|FG001|Received Treatment|Overall Study||190
9766744|NCT00418522|10871356|FG000|COMPLETED|Overall Study||136
9766745|NCT00418522|10871357|FG001|COMPLETED|Overall Study||152
9766746|NCT00418522|10871356|FG000|NOT COMPLETED|Overall Study||83
9766747|NCT00418522|10871357|FG001|NOT COMPLETED|Overall Study||42
9766748|NCT00418561|10871366|FG000|STARTED|Overall Study||4
9766749|NCT00418561|10871367|FG001|STARTED|Overall Study||5
9766750|NCT00418561|10871368|FG002|STARTED|Overall Study||4
9766751|NCT00418561|10871366|FG000|COMPLETED|Overall Study||4
9766752|NCT00418561|10871367|FG001|COMPLETED|Overall Study||4
9766753|NCT00418561|10871368|FG002|COMPLETED|Overall Study||4
9766754|NCT00418561|10871366|FG000|NOT COMPLETED|Overall Study||0
9766755|NCT00418561|10871367|FG001|NOT COMPLETED|Overall Study||1
9766756|NCT00418561|10871368|FG002|NOT COMPLETED|Overall Study||0
9766757|NCT00418574|10871378|FG000|STARTED|Overall Study||593
9766758|NCT00418574|10871379|FG001|STARTED|Overall Study||295
9766759|NCT00418574|10871378|FG000|TREATED|Overall Study||592
9766760|NCT00418574|10871379|FG001|TREATED|Overall Study||294
9766761|NCT00418574|10871378|FG000|COMPLETED|Overall Study||545
9766762|NCT00418574|10871379|FG001|COMPLETED|Overall Study||272
9766763|NCT00418574|10871378|FG000|NOT COMPLETED|Overall Study||48
9766764|NCT00418574|10871379|FG001|NOT COMPLETED|Overall Study||23
9766765|NCT00418665|10871388|FG000|STARTED|Treatment Period||12
9766766|NCT00418665|10871389|FG001|STARTED|Treatment Period||14
9766767|NCT00418665|10871390|FG002|STARTED|Treatment Period||13
9766768|NCT00418665|10871388|FG000|Received Study Medication|Treatment Period||11
9766769|NCT00418665|10871389|FG001|Received Study Medication|Treatment Period||13
9766770|NCT00418665|10871390|FG002|Received Study Medication|Treatment Period||13
9766771|NCT00418665|10871388|FG000|COMPLETED|Treatment Period||7
9766772|NCT00418665|10871389|FG001|COMPLETED|Treatment Period||8
9766773|NCT00418665|10871390|FG002|COMPLETED|Treatment Period||9
9766774|NCT00418665|10871388|FG000|NOT COMPLETED|Treatment Period||5
9766775|NCT00418665|10871389|FG001|NOT COMPLETED|Treatment Period||6
9766776|NCT00418665|10871390|FG002|NOT COMPLETED|Treatment Period||4
9766777|NCT00418665|10871388|FG000|STARTED|Treatment Extension||7
9766778|NCT00418665|10871389|FG001|STARTED|Treatment Extension||8
9766779|NCT00418665|10871390|FG002|STARTED|Treatment Extension||9
9766780|NCT00418665|10871388|FG000|COMPLETED|Treatment Extension||1
9766781|NCT00418665|10871389|FG001|COMPLETED|Treatment Extension||4
9766782|NCT00418665|10871390|FG002|COMPLETED|Treatment Extension||7
9766783|NCT00418665|10871388|FG000|NOT COMPLETED|Treatment Extension||6
9766784|NCT00418665|10871389|FG001|NOT COMPLETED|Treatment Extension||4
9766785|NCT00418665|10871390|FG002|NOT COMPLETED|Treatment Extension||2
9766786|NCT00418691|10871401|FG000|STARTED|Overall Study||11
9766787|NCT00418691|10871402|FG001|STARTED|Overall Study||12
9766788|NCT00418691|10871403|FG002|STARTED|Overall Study||10
9766789|NCT00418691|10871401|FG000|COMPLETED|Overall Study||9
9766790|NCT00418691|10871402|FG001|COMPLETED|Overall Study||10
9766791|NCT00418691|10871403|FG002|COMPLETED|Overall Study||5
9766792|NCT00418691|10871401|FG000|NOT COMPLETED|Overall Study||2
9766793|NCT00418691|10871402|FG001|NOT COMPLETED|Overall Study||2
9766794|NCT00418691|10871403|FG002|NOT COMPLETED|Overall Study||5
9766795|NCT00418717|10871411|FG000|STARTED|Treatment Period A - Weeks 1-4||42
9766796|NCT00418717|10871411|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41
9766797|NCT00418717|10871411|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
9766798|NCT00418717|10871411|FG000|STARTED|Treatment Period B - Weeks 5-12||41
9766799|NCT00418717|10871411|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39
9766800|NCT00418717|10871411|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
9766801|NCT00418886|10871417|FG000|STARTED|Overall Study|randomised patients|256
9766802|NCT00418886|10871418|FG001|STARTED|Overall Study|randomised patients|278
9766803|NCT00418886|10871417|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
9766804|NCT00418886|10871418|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
9766805|NCT00418886|10871417|FG000|NOT COMPLETED|Overall Study||226
9766806|NCT00418886|10871418|FG001|NOT COMPLETED|Overall Study||255
9766807|NCT00418938|10871426|FG000|STARTED|Overall Study||133
9766808|NCT00418938|10871427|FG001|STARTED|Overall Study||131
9766809|NCT00418938|10871426|FG000|COMPLETED|Overall Study||109
9766810|NCT00418938|10871427|FG001|COMPLETED|Overall Study||108
9766811|NCT00418938|10871426|FG000|NOT COMPLETED|Overall Study||24
9766812|NCT00418938|10871427|FG001|NOT COMPLETED|Overall Study||23
9766813|NCT00418951|10871436|FG000|STARTED|Overall Study||39
9766814|NCT00418951|10871437|FG001|STARTED|Overall Study||33
9766815|NCT00418951|10871438|FG002|STARTED|Overall Study||40
9766816|NCT00418951|10871436|FG000|COMPLETED|Overall Study||39
9766817|NCT00418951|10871437|FG001|COMPLETED|Overall Study||33
9766818|NCT00418951|10871438|FG002|COMPLETED|Overall Study||40
9766819|NCT00418951|10871436|FG000|NOT COMPLETED|Overall Study||0
9766820|NCT00418951|10871437|FG001|NOT COMPLETED|Overall Study||0
9766821|NCT00418951|10871438|FG002|NOT COMPLETED|Overall Study||0
9766822|NCT00418964|10871449|FG000|STARTED|Overall Study||22
9766823|NCT00418964|10871450|FG001|STARTED|Overall Study||20
9766824|NCT00418964|10871451|FG002|STARTED|Overall Study||20
9766825|NCT00418964|10871449|FG000|COMPLETED|Overall Study||21
9766826|NCT00418964|10871450|FG001|COMPLETED|Overall Study||17
9766827|NCT00418964|10871451|FG002|COMPLETED|Overall Study||14
9766828|NCT00418964|10871449|FG000|NOT COMPLETED|Overall Study||1
9766829|NCT00418964|10871450|FG001|NOT COMPLETED|Overall Study||3
9766830|NCT00418964|10871451|FG002|NOT COMPLETED|Overall Study||6
9766831|NCT00418977|10871461|FG000|STARTED|Overall Study||43
9766832|NCT00418977|10871462|FG001|STARTED|Overall Study||16
9766833|NCT00418977|10871461|FG000|COMPLETED|Overall Study||40
9766834|NCT00418977|10871462|FG001|COMPLETED|Overall Study||13
9766835|NCT00418977|10871461|FG000|NOT COMPLETED|Overall Study||3
9766836|NCT00418977|10871462|FG001|NOT COMPLETED|Overall Study||3
9766837|NCT00419003|10871470|FG000|STARTED|Phase I, Ketamine Infusion||13
9766838|NCT00419003|10871471|FG001|STARTED|Phase I, Ketamine Infusion||13
9766839|NCT00419003|10871470|FG000|COMPLETED|Phase I, Ketamine Infusion||7
9766840|NCT00419003|10871471|FG001|COMPLETED|Phase I, Ketamine Infusion||7
9766841|NCT00419003|10871470|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6
9766842|NCT00419003|10871471|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6
9766843|NCT00419003|10871470|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
9766844|NCT00419003|10871471|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
9766845|NCT00419003|10871470|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
9766846|NCT00419003|10871471|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
9766847|NCT00419003|10871470|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
9829580|NCT00760474|10940231|FG001|COMPLETED|Placebo Washout Period||12
9766848|NCT00419003|10871471|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
9766849|NCT00419094|10871482|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
9766850|NCT00419094|10871483|FG001|STARTED|Overall Study||171
9766851|NCT00419094|10871482|FG000|COMPLETED|Overall Study||50
9766852|NCT00419094|10871483|FG001|COMPLETED|Overall Study||141
9766853|NCT00419094|10871482|FG000|NOT COMPLETED|Overall Study||7
9766854|NCT00419094|10871483|FG001|NOT COMPLETED|Overall Study||30
9766855|NCT00419120|10871489|FG000|STARTED|Primary Study Period||10
9766856|NCT00419120|10871489|FG000|COMPLETED|Primary Study Period||10
9766857|NCT00419120|10871489|FG000|NOT COMPLETED|Primary Study Period||0
9766858|NCT00419120|10871489|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
9766859|NCT00419120|10871489|FG000|COMPLETED|Long Term Follow up Period||0
9766860|NCT00419120|10871489|FG000|NOT COMPLETED|Long Term Follow up Period||10
9766861|NCT00419159|10871495|FG000|STARTED|Overall Study|Full Analysis Set|99
9766862|NCT00419159|10871496|FG001|STARTED|Overall Study||100
9766863|NCT00419159|10871495|FG000|COMPLETED|Overall Study||0
9766864|NCT00419159|10871496|FG001|COMPLETED|Overall Study||0
9766865|NCT00419159|10871495|FG000|NOT COMPLETED|Overall Study||99
9766866|NCT00419159|10871496|FG001|NOT COMPLETED|Overall Study||100
9766867|NCT00419263|10871513|FG000|STARTED|Overall Study||115
9766868|NCT00419263|10871514|FG001|STARTED|Overall Study||114
9766869|NCT00419263|10871515|FG002|STARTED|Overall Study||115
9766870|NCT00419263|10871513|FG000|COMPLETED|Overall Study||112
9766871|NCT00419263|10871514|FG001|COMPLETED|Overall Study||112
9766872|NCT00419263|10871515|FG002|COMPLETED|Overall Study||112
9766873|NCT00419263|10871513|FG000|NOT COMPLETED|Overall Study||3
9766874|NCT00419263|10871514|FG001|NOT COMPLETED|Overall Study||2
9766875|NCT00419263|10871515|FG002|NOT COMPLETED|Overall Study||3
9766876|NCT00419315|10871526|FG000|STARTED|Overall Study||85
9766877|NCT00419315|10871527|FG001|STARTED|Overall Study||78
9766878|NCT00419315|10871526|FG000|COMPLETED|Overall Study||85
9766879|NCT00419315|10871527|FG001|COMPLETED|Overall Study||78
9766880|NCT00419315|10871526|FG000|NOT COMPLETED|Overall Study||0
9766881|NCT00419315|10871527|FG001|NOT COMPLETED|Overall Study||0
9766882|NCT00419341|10871533|FG000|STARTED|Wash in/Wash Out Period||49
9766883|NCT00419341|10871533|FG000|COMPLETED|Wash in/Wash Out Period||38
9766884|NCT00419341|10871533|FG000|NOT COMPLETED|Wash in/Wash Out Period||11
9766885|NCT00419341|10871533|FG000|STARTED|Efficacy Period||38
9766886|NCT00419341|10871533|FG000|COMPLETED|Efficacy Period||28
9766887|NCT00419341|10871533|FG000|NOT COMPLETED|Efficacy Period||10
9766888|NCT00419380|10871541|FG000|STARTED|Overall Study||19
9766889|NCT00419380|10871542|FG001|STARTED|Overall Study||22
9766890|NCT00419380|10871541|FG000|COMPLETED|Overall Study||18
9766891|NCT00419380|10871542|FG001|COMPLETED|Overall Study||12
9766892|NCT00419380|10871541|FG000|NOT COMPLETED|Overall Study||1
9766893|NCT00419380|10871542|FG001|NOT COMPLETED|Overall Study||10
9766894|NCT00419393|10871548|FG000|STARTED|Overall Study|One subject did not receive medication|190
9766895|NCT00419393|10871548|FG000|COMPLETED|Overall Study||166
9766896|NCT00419393|10871548|FG000|NOT COMPLETED|Overall Study||24
9766897|NCT00419445|10871555|FG000|STARTED|Overall Study||8
9766898|NCT00419445|10871556|FG001|STARTED|Overall Study||16
9766899|NCT00419445|10871557|FG002|STARTED|Overall Study||8
9766900|NCT00419445|10871555|FG000|COMPLETED|Overall Study||7
9766901|NCT00419445|10871556|FG001|COMPLETED|Overall Study||14
9766902|NCT00419445|10871557|FG002|COMPLETED|Overall Study||7
9766903|NCT00419445|10871555|FG000|NOT COMPLETED|Overall Study||1
9766904|NCT00419445|10871556|FG001|NOT COMPLETED|Overall Study||2
9766905|NCT00419445|10871557|FG002|NOT COMPLETED|Overall Study||1
9766906|NCT00419562|10871567|FG000|STARTED|Overall Study||283
9766907|NCT00419562|10871568|FG001|STARTED|Overall Study||277
9766908|NCT00419562|10871567|FG000|COMPLETED|Overall Study||250
9766909|NCT00419562|10871568|FG001|COMPLETED|Overall Study||246
9766910|NCT00419562|10871567|FG000|NOT COMPLETED|Overall Study||33
9766911|NCT00419562|10871568|FG001|NOT COMPLETED|Overall Study||31
9766912|NCT00419666|10871574|FG000|STARTED|Overall Study||25
9766913|NCT00419666|10871574|FG000|COMPLETED|Overall Study||25
9766914|NCT00419666|10871574|FG000|NOT COMPLETED|Overall Study||0
9766915|NCT00419744|10871581|FG000|STARTED|Overall Study||407
9766916|NCT00419744|10871582|FG001|STARTED|Overall Study||408
9766917|NCT00419744|10871583|FG002|STARTED|Overall Study||404
9766918|NCT00419744|10871581|FG000|COMPLETED|Overall Study||290
9766919|NCT00419744|10871582|FG001|COMPLETED|Overall Study||290
9766920|NCT00419744|10871583|FG002|COMPLETED|Overall Study||271
9766921|NCT00419744|10871581|FG000|NOT COMPLETED|Overall Study||117
9766922|NCT00419744|10871582|FG001|NOT COMPLETED|Overall Study||118
9766923|NCT00419744|10871583|FG002|NOT COMPLETED|Overall Study||133
9766924|NCT00419757|10871593|FG000|STARTED|Overall Study|Randomized patients|127
9766925|NCT00419757|10871594|FG001|STARTED|Overall Study|Randomized patients|123
9766926|NCT00419757|10871593|FG000|COMPLETED|Overall Study|Randomized patients|109
9766927|NCT00419757|10871594|FG001|COMPLETED|Overall Study|Randomized patients|102
9766928|NCT00419757|10871593|FG000|NOT COMPLETED|Overall Study||18
9766929|NCT00419757|10871594|FG001|NOT COMPLETED|Overall Study||21
9766930|NCT00419770|10871604|FG000|STARTED|Overall Study||11
9766931|NCT00419770|10871605|FG001|STARTED|Overall Study||9
9766932|NCT00419770|10871604|FG000|COMPLETED|Overall Study||6
9766933|NCT00419770|10871605|FG001|COMPLETED|Overall Study||8
9766934|NCT00419770|10871604|FG000|NOT COMPLETED|Overall Study||5
9766935|NCT00419770|10871605|FG001|NOT COMPLETED|Overall Study||1
9829581|NCT00760474|10940230|FG000|NOT COMPLETED|Placebo Washout Period||0
9766936|NCT00419926|10871613|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
9766937|NCT00419926|10871614|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
9766938|NCT00419926|10871613|FG000|COMPLETED|Overall Study||141
9766939|NCT00419926|10871614|FG001|COMPLETED|Overall Study||148
9766940|NCT00419926|10871613|FG000|NOT COMPLETED|Overall Study||14
9766941|NCT00419926|10871614|FG001|NOT COMPLETED|Overall Study||10
9766942|NCT00419952|10871622|FG000|STARTED|Overall Study||377
9766943|NCT00419952|10871623|FG001|STARTED|Overall Study||365
9766944|NCT00419952|10871622|FG000|COMPLETED|Overall Study||228
9766945|NCT00419952|10871623|FG001|COMPLETED|Overall Study||240
9766946|NCT00419952|10871622|FG000|NOT COMPLETED|Overall Study||149
9766947|NCT00419952|10871623|FG001|NOT COMPLETED|Overall Study||125
9766948|NCT00420004|10871632|FG000|STARTED|Overall Study||269
9766949|NCT00420004|10871633|FG001|STARTED|Overall Study||138
9766950|NCT00420004|10871634|FG002|STARTED|Overall Study||62
9766951|NCT00420004|10871632|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
9766952|NCT00420004|10871633|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
9766953|NCT00420004|10871634|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
9766954|NCT00420004|10871632|FG000|COMPLETED|Overall Study||140
9766955|NCT00420004|10871633|FG001|COMPLETED|Overall Study||67
9766956|NCT00420004|10871634|FG002|COMPLETED|Overall Study||30
9766957|NCT00420004|10871632|FG000|NOT COMPLETED|Overall Study||129
9766958|NCT00420004|10871633|FG001|NOT COMPLETED|Overall Study||71
9766959|NCT00420004|10871634|FG002|NOT COMPLETED|Overall Study||32
9766960|NCT00420017|10871648|FG000|STARTED|Overall Study||40
9766961|NCT00420017|10871649|FG001|STARTED|Overall Study||40
9766962|NCT00420017|10871648|FG000|COMPLETED|Overall Study|40 completed analysis|38
9766963|NCT00420017|10871649|FG001|COMPLETED|Overall Study||40
9766964|NCT00420017|10871648|FG000|NOT COMPLETED|Overall Study||2
9766965|NCT00420017|10871649|FG001|NOT COMPLETED|Overall Study||0
9766966|NCT00420056|10871655|FG000|STARTED|Overall Study||17
9766967|NCT00420056|10871655|FG000|COMPLETED|Overall Study||0
9766968|NCT00420056|10871655|FG000|NOT COMPLETED|Overall Study||17
9766969|NCT00420095|10871661|FG000|STARTED|Overall Study||57
9766970|NCT00420095|10871662|FG001|STARTED|Overall Study||60
9766971|NCT00420095|10871661|FG000|COMPLETED|Overall Study||54
9766972|NCT00420095|10871662|FG001|COMPLETED|Overall Study||59
9766973|NCT00420095|10871661|FG000|NOT COMPLETED|Overall Study||3
9766974|NCT00420095|10871662|FG001|NOT COMPLETED|Overall Study||1
9766975|NCT00420147|10871670|FG000|STARTED|Overall Study||19
9766976|NCT00420147|10871671|FG001|STARTED|Overall Study||19
9766977|NCT00420147|10871670|FG000|COMPLETED|Overall Study||19
9766978|NCT00420147|10871671|FG001|COMPLETED|Overall Study||19
9766979|NCT00420147|10871670|FG000|NOT COMPLETED|Overall Study||0
9766980|NCT00420147|10871671|FG001|NOT COMPLETED|Overall Study||0
9766981|NCT00420199|10871679|FG000|STARTED|Overall Study||27
9766982|NCT00420199|10871680|FG001|STARTED|Overall Study||23
9766983|NCT00420199|10871679|FG000|COMPLETED|Overall Study||26
9766984|NCT00420199|10871680|FG001|COMPLETED|Overall Study||23
9766985|NCT00420199|10871679|FG000|NOT COMPLETED|Overall Study||1
9766986|NCT00420199|10871680|FG001|NOT COMPLETED|Overall Study||0
9766987|NCT00420212|10871694|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
9766988|NCT00420212|10871695|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
9766989|NCT00420212|10871696|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
9766990|NCT00420212|10871694|FG000|COMPLETED|Overall Study||317
9766991|NCT00420212|10871695|FG001|COMPLETED|Overall Study||315
10014026|NCT01797120|11137026|FG001|STARTED|Overall Study||65
10014027|NCT01797120|11137025|FG000|COMPLETED|Overall Study||0
10014028|NCT01797120|11137026|FG001|COMPLETED|Overall Study||0
10014029|NCT01797120|11137025|FG000|NOT COMPLETED|Overall Study||66
10014030|NCT01797120|11137026|FG001|NOT COMPLETED|Overall Study||65
10014031|NCT01797159|11137032|FG000|STARTED|Overall Study||20
10014032|NCT01797159|11137032|FG000|COMPLETED|Overall Study||20
10014033|NCT01797159|11137032|FG000|NOT COMPLETED|Overall Study||0
10014034|NCT01797185|11137040|FG000|STARTED|Overall Study||162
10014035|NCT01797185|11137041|FG001|STARTED|Overall Study||163
9766992|NCT00420212|10871696|FG002|COMPLETED|Overall Study||320
9766993|NCT00420212|10871694|FG000|NOT COMPLETED|Overall Study||91
9766994|NCT00420212|10871695|FG001|NOT COMPLETED|Overall Study||95
9766995|NCT00420212|10871696|FG002|NOT COMPLETED|Overall Study||96
9766996|NCT00420238|10871709|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39
9766997|NCT00420238|10871710|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43
9766998|NCT00420238|10871709|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38
9766999|NCT00420238|10871710|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39
9767000|NCT00420238|10871709|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
10014036|NCT01797185|11137042|FG002|STARTED|Overall Study||50
10014037|NCT01797185|11137040|FG000|COMPLETED|Overall Study||134
9767001|NCT00420238|10871710|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
10014038|NCT01797185|11137041|FG001|COMPLETED|Overall Study||125
10014039|NCT01797185|11137042|FG002|COMPLETED|Overall Study||38
10014040|NCT01797185|11137040|FG000|NOT COMPLETED|Overall Study||28
9767002|NCT00420238|10871709|FG000|STARTED|12 Week Open-Label Treatment Period 2||38
9767003|NCT00420238|10871710|FG001|STARTED|12 Week Open-Label Treatment Period 2||39
9767004|NCT00420238|10871709|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36
9767005|NCT00420238|10871710|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38
9767006|NCT00420238|10871709|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
9767007|NCT00420238|10871710|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
9767008|NCT00420290|10871724|FG000|STARTED|Overall Study||11
9767009|NCT00420290|10871725|FG001|STARTED|Overall Study||11
9767010|NCT00420290|10871724|FG000|COMPLETED|Overall Study||7
9767011|NCT00420290|10871725|FG001|COMPLETED|Overall Study||7
9767012|NCT00420290|10871724|FG000|NOT COMPLETED|Overall Study||4
9767013|NCT00420290|10871725|FG001|NOT COMPLETED|Overall Study||4
9767014|NCT00420303|10871733|FG000|STARTED|Overall Study||12
9767015|NCT00420303|10871734|FG001|STARTED|Overall Study||12
9767016|NCT00420303|10871733|FG000|COMPLETED|Overall Study||11
9767017|NCT00420303|10871734|FG001|COMPLETED|Overall Study||8
9767018|NCT00420303|10871733|FG000|NOT COMPLETED|Overall Study||1
9767019|NCT00420303|10871734|FG001|NOT COMPLETED|Overall Study||4
9767020|NCT00420316|10871742|FG000|STARTED|Overall Study||1082
9767021|NCT00420316|10871743|FG001|STARTED|Overall Study||531
9767022|NCT00420316|10871742|FG000|COMPLETED|Overall Study||1070
9767023|NCT00420316|10871743|FG001|COMPLETED|Overall Study||522
9767024|NCT00420316|10871742|FG000|NOT COMPLETED|Overall Study||12
9767025|NCT00420316|10871743|FG001|NOT COMPLETED|Overall Study||9
9767026|NCT00420342|10871752|FG000|STARTED|Overall Study||30
9767027|NCT00420342|10871753|FG001|STARTED|Overall Study||33
9767028|NCT00420342|10871754|FG002|STARTED|Overall Study||29
9767029|NCT00420342|10871752|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
9767030|NCT00420342|10871753|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
9767031|NCT00420342|10871754|FG002|Received Treatment|Overall Study||29
9767032|NCT00420342|10871752|FG000|COMPLETED|Overall Study||29
9767033|NCT00420342|10871753|FG001|COMPLETED|Overall Study||31
9767034|NCT00420342|10871754|FG002|COMPLETED|Overall Study||28
9767035|NCT00420342|10871752|FG000|NOT COMPLETED|Overall Study||1
9767036|NCT00420342|10871753|FG001|NOT COMPLETED|Overall Study||2
9767037|NCT00420342|10871754|FG002|NOT COMPLETED|Overall Study||1
9767038|NCT00420381|10871762|FG000|STARTED|Overall Study||28
9767039|NCT00420381|10871762|FG000|Received at Least One Dose of Study Drug|Overall Study||27
9767040|NCT00420381|10871762|FG000|COMPLETED|Overall Study||27
9767041|NCT00420381|10871762|FG000|NOT COMPLETED|Overall Study||1
9767042|NCT00420407|10871768|FG000|STARTED|Overall Study||41
9767043|NCT00420407|10871769|FG001|STARTED|Overall Study||40
9767044|NCT00420407|10871768|FG000|COMPLETED|Overall Study||37
9767045|NCT00420407|10871769|FG001|COMPLETED|Overall Study||34
10014041|NCT01797185|11137041|FG001|NOT COMPLETED|Overall Study||38
10014042|NCT01797185|11137042|FG002|NOT COMPLETED|Overall Study||12
10014043|NCT01797263|11137052|FG000|STARTED|Overall Study||129
10014044|NCT01797263|11137053|FG001|STARTED|Overall Study||127
10014045|NCT01797263|11137052|FG000|1 Month|Overall Study||96
10014046|NCT01797263|11137053|FG001|1 Month|Overall Study||87
10014047|NCT01797263|11137052|FG000|3 Month|Overall Study||87
10014048|NCT01797263|11137053|FG001|3 Month|Overall Study||84
10014049|NCT01797263|11137052|FG000|6 Month|Overall Study||90
9767046|NCT00420407|10871768|FG000|NOT COMPLETED|Overall Study||4
9767047|NCT00420407|10871769|FG001|NOT COMPLETED|Overall Study||6
9767048|NCT00420420|10871778|FG000|STARTED|Overall Study|Number of patients randomized.|73
9767049|NCT00420420|10871779|FG001|STARTED|Overall Study|Number of patients randomized.|71
9767050|NCT00420420|10871778|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
9767051|NCT00420420|10871779|FG001|COMPLETED|Overall Study||67
9767052|NCT00420420|10871778|FG000|NOT COMPLETED|Overall Study||8
9767053|NCT00420420|10871779|FG001|NOT COMPLETED|Overall Study||4
9767054|NCT00420459|10871785|FG000|STARTED|Overall Study||12
9767055|NCT00420459|10871785|FG000|COMPLETED|Overall Study||12
9767056|NCT00420459|10871785|FG000|NOT COMPLETED|Overall Study||0
9767057|NCT00420511|10871793|FG000|STARTED|Overall Study||10
9767058|NCT00420511|10871794|FG001|STARTED|Overall Study||11
9767059|NCT00420511|10871793|FG000|COMPLETED|Overall Study||8
9767060|NCT00420511|10871794|FG001|COMPLETED|Overall Study||10
9767061|NCT00420511|10871793|FG000|NOT COMPLETED|Overall Study||2
9767062|NCT00420511|10871794|FG001|NOT COMPLETED|Overall Study||1
9767063|NCT00420628|10871804|FG000|STARTED|Overall Study||72
10014050|NCT01797263|11137053|FG001|6 Month|Overall Study||85
10014051|NCT01797263|11137052|FG000|9 Month|Overall Study||92
9767064|NCT00420628|10871805|FG001|STARTED|Overall Study||36
9767065|NCT00420628|10871804|FG000|COMPLETED|Overall Study||63
9767066|NCT00420628|10871805|FG001|COMPLETED|Overall Study||32
9767067|NCT00420628|10871804|FG000|NOT COMPLETED|Overall Study||9
9767068|NCT00420628|10871805|FG001|NOT COMPLETED|Overall Study||4
9767069|NCT00420641|10871814|FG000|STARTED|Overall Study||160
9767070|NCT00420641|10871815|FG001|STARTED|Overall Study||172
9767071|NCT00420641|10871816|FG002|STARTED|Overall Study||172
9767072|NCT00420641|10871814|FG000|COMPLETED|Overall Study||115
9767073|NCT00420641|10871815|FG001|COMPLETED|Overall Study||100
9767074|NCT00420641|10871816|FG002|COMPLETED|Overall Study||128
9767075|NCT00420641|10871814|FG000|NOT COMPLETED|Overall Study||45
9767076|NCT00420641|10871815|FG001|NOT COMPLETED|Overall Study||72
9767077|NCT00420641|10871816|FG002|NOT COMPLETED|Overall Study||44
9767078|NCT00420745|10871826|FG000|STARTED|Overall Study||670
9767079|NCT00420745|10871827|FG001|STARTED|Overall Study||339
9767080|NCT00420745|10871826|FG000|COMPLETED|Overall Study||655
9767081|NCT00420745|10871827|FG001|COMPLETED|Overall Study||333
9767082|NCT00420745|10871826|FG000|NOT COMPLETED|Overall Study||15
9767083|NCT00420745|10871827|FG001|NOT COMPLETED|Overall Study||6
9767084|NCT00420771|10871835|FG000|STARTED|Overall Study||8
9767085|NCT00420771|10871836|FG001|STARTED|Overall Study||11
9767086|NCT00420771|10871835|FG000|COMPLETED|Overall Study||5
9767087|NCT00420771|10871836|FG001|COMPLETED|Overall Study||7
9767088|NCT00420771|10871835|FG000|NOT COMPLETED|Overall Study||3
9767089|NCT00420771|10871836|FG001|NOT COMPLETED|Overall Study||4
9767090|NCT00420784|10871846|FG000|STARTED|Overall Study||115
9767091|NCT00420784|10871847|FG001|STARTED|Overall Study||113
9767092|NCT00420784|10871848|FG002|STARTED|Overall Study||111
9767093|NCT00420784|10871849|FG003|STARTED|Overall Study||114
9767094|NCT00420784|10871846|FG000|COMPLETED|Overall Study||86
9767095|NCT00420784|10871847|FG001|COMPLETED|Overall Study||55
9767096|NCT00420784|10871848|FG002|COMPLETED|Overall Study||58
9767097|NCT00420784|10871849|FG003|COMPLETED|Overall Study||36
9767098|NCT00420784|10871846|FG000|NOT COMPLETED|Overall Study||29
9767099|NCT00420784|10871847|FG001|NOT COMPLETED|Overall Study||58
9767100|NCT00420784|10871848|FG002|NOT COMPLETED|Overall Study||53
9767101|NCT00420784|10871849|FG003|NOT COMPLETED|Overall Study||78
9767102|NCT00420849|10871860|FG000|STARTED|Overall Study||587
9767103|NCT00420849|10871860|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
9767104|NCT00420849|10871860|FG000|NOT COMPLETED|Overall Study||331
9829582|NCT00760474|10940231|FG001|NOT COMPLETED|Placebo Washout Period||1
9829583|NCT00760474|10940230|FG000|STARTED|Period 2 (P2)||12
9829584|NCT00760474|10940231|FG001|STARTED|Period 2 (P2)||12
9829585|NCT00760474|10940230|FG000|COMPLETED|Period 2 (P2)||11
9829586|NCT00760474|10940231|FG001|COMPLETED|Period 2 (P2)||11
9829587|NCT00760474|10940230|FG000|NOT COMPLETED|Period 2 (P2)||1
9829588|NCT00760474|10940231|FG001|NOT COMPLETED|Period 2 (P2)||1
9829589|NCT00760487|10940238|FG000|STARTED|Overall Study||120
9829590|NCT00760487|10940238|FG000|COMPLETED|Overall Study||117
9829591|NCT00760487|10940238|FG000|NOT COMPLETED|Overall Study||3
9829592|NCT00760513|10940244|FG000|STARTED|Overall Study||51
9829593|NCT00760513|10940245|FG001|STARTED|Overall Study||52
9829594|NCT00760513|10940244|FG000|COMPLETED|Overall Study||46
9829595|NCT00760513|10940245|FG001|COMPLETED|Overall Study||45
9829596|NCT00760513|10940244|FG000|NOT COMPLETED|Overall Study||5
9829597|NCT00760513|10940245|FG001|NOT COMPLETED|Overall Study||7
9829598|NCT00760526|10940255|FG000|STARTED|Overall Study||74
9829599|NCT00760526|10940256|FG001|STARTED|Overall Study||72
9829600|NCT00760526|10940255|FG000|COMPLETED|Overall Study||69
9829601|NCT00760526|10940256|FG001|COMPLETED|Overall Study||68
9829602|NCT00760526|10940255|FG000|NOT COMPLETED|Overall Study||5
9829603|NCT00760526|10940256|FG001|NOT COMPLETED|Overall Study||4
9829604|NCT00760552|10940271|FG000|STARTED|Overall Study||61
9829605|NCT00760552|10940272|FG001|STARTED|Overall Study||62
9829606|NCT00760552|10940271|FG000|COMPLETED|Overall Study||48
9829607|NCT00760552|10940272|FG001|COMPLETED|Overall Study||52
9829608|NCT00760552|10940271|FG000|NOT COMPLETED|Overall Study||13
9829609|NCT00760552|10940272|FG001|NOT COMPLETED|Overall Study||10
9829610|NCT00760578|10940282|FG000|STARTED|Overall Study||22
9829611|NCT00760578|10940283|FG001|STARTED|Overall Study||21
9829612|NCT00760578|10940284|FG002|STARTED|Overall Study||21
9829613|NCT00760578|10940285|FG003|STARTED|Overall Study||22
9829614|NCT00760578|10940282|FG000|Entered Drug Treatment Period|Overall Study||21
9829615|NCT00760578|10940283|FG001|Entered Drug Treatment Period|Overall Study||20
9829616|NCT00760578|10940284|FG002|Entered Drug Treatment Period|Overall Study||19
9829617|NCT00760578|10940285|FG003|Entered Drug Treatment Period|Overall Study||22
9829618|NCT00760578|10940282|FG000|COMPLETED|Overall Study||19
9829619|NCT00760578|10940283|FG001|COMPLETED|Overall Study||19
9829620|NCT00760578|10940284|FG002|COMPLETED|Overall Study||16
9829621|NCT00760578|10940285|FG003|COMPLETED|Overall Study||18
9829622|NCT00760578|10940282|FG000|NOT COMPLETED|Overall Study||3
9829623|NCT00760578|10940283|FG001|NOT COMPLETED|Overall Study||2
9829624|NCT00760578|10940284|FG002|NOT COMPLETED|Overall Study||5
9829625|NCT00760578|10940285|FG003|NOT COMPLETED|Overall Study||4
9829626|NCT00760617|10940303|FG000|STARTED|Overall Study||266
9829627|NCT00760617|10940304|FG001|STARTED|Overall Study||144
9829628|NCT00760617|10940305|FG002|STARTED|Overall Study||116
9829629|NCT00760617|10940303|FG000|COMPLETED|Overall Study||261
9829630|NCT00760617|10940304|FG001|COMPLETED|Overall Study||142
9829631|NCT00760617|10940305|FG002|COMPLETED|Overall Study||111
9829632|NCT00760617|10940303|FG000|NOT COMPLETED|Overall Study||5
9829633|NCT00760617|10940304|FG001|NOT COMPLETED|Overall Study||2
9829634|NCT00760617|10940305|FG002|NOT COMPLETED|Overall Study||5
9829635|NCT00760669|10940313|FG000|STARTED|Overall Study||1061
9829636|NCT00760669|10940313|FG000|COMPLETED|Overall Study||1031
9829637|NCT00760669|10940313|FG000|NOT COMPLETED|Overall Study||30
9829638|NCT00760747|10940319|FG000|STARTED|Study Period II||57
9829639|NCT00760747|10940320|FG001|STARTED|Study Period II||55
9829640|NCT00760747|10940319|FG000|Received at Least One Dose of Study Drug|Study Period II||57
9829641|NCT00760747|10940320|FG001|Received at Least One Dose of Study Drug|Study Period II||54
9829642|NCT00760747|10940319|FG000|COMPLETED|Study Period II||44
9829643|NCT00760747|10940320|FG001|COMPLETED|Study Period II||41
9829644|NCT00760747|10940319|FG000|NOT COMPLETED|Study Period II||13
9829645|NCT00760747|10940320|FG001|NOT COMPLETED|Study Period II||14
9829646|NCT00760747|10940319|FG000|STARTED|Study Period III||44
9829647|NCT00760747|10940320|FG001|STARTED|Study Period III||41
9829648|NCT00760747|10940319|FG000|COMPLETED|Study Period III||41
9829649|NCT00760747|10940320|FG001|COMPLETED|Study Period III||38
9767105|NCT00420927|10871874|FG000|STARTED|Period 1||515
9767106|NCT00420927|10871875|FG001|STARTED|Period 1||517
9767107|NCT00420927|10871876|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
9767108|NCT00420927|10871877|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
9767109|NCT00420927|10871878|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
9767110|NCT00420927|10871879|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
9767111|NCT00420927|10871880|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
9767112|NCT00420927|10871874|FG000|COMPLETED|Period 1||466
9767113|NCT00420927|10871875|FG001|COMPLETED|Period 1||460
9767114|NCT00420927|10871876|FG002|COMPLETED|Period 1||0
9767115|NCT00420927|10871877|FG003|COMPLETED|Period 1||0
9767116|NCT00420927|10871878|FG004|COMPLETED|Period 1||0
9767117|NCT00420927|10871879|FG005|COMPLETED|Period 1||0
9767118|NCT00420927|10871880|FG006|COMPLETED|Period 1||0
9767119|NCT00420927|10871874|FG000|NOT COMPLETED|Period 1||49
9767120|NCT00420927|10871875|FG001|NOT COMPLETED|Period 1||57
9767121|NCT00420927|10871876|FG002|NOT COMPLETED|Period 1||0
9767122|NCT00420927|10871877|FG003|NOT COMPLETED|Period 1||0
9767123|NCT00420927|10871878|FG004|NOT COMPLETED|Period 1||0
9767124|NCT00420927|10871879|FG005|NOT COMPLETED|Period 1||0
9767125|NCT00420927|10871880|FG006|NOT COMPLETED|Period 1||0
9767126|NCT00420927|10871874|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
9767127|NCT00420927|10871875|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
9767128|NCT00420927|10871876|FG002|STARTED|Period 2||102
9767129|NCT00420927|10871877|FG003|STARTED|Period 2||105
9767130|NCT00420927|10871878|FG004|STARTED|Period 2||259
9767131|NCT00420927|10871879|FG005|STARTED|Period 2||112
9767132|NCT00420927|10871880|FG006|STARTED|Period 2||348
9767133|NCT00420927|10871874|FG000|COMPLETED|Period 2||0
9767134|NCT00420927|10871875|FG001|COMPLETED|Period 2||0
9767135|NCT00420927|10871876|FG002|COMPLETED|Period 2||89
9767136|NCT00420927|10871877|FG003|COMPLETED|Period 2||95
9767137|NCT00420927|10871878|FG004|COMPLETED|Period 2||216
9767138|NCT00420927|10871879|FG005|COMPLETED|Period 2||97
9767139|NCT00420927|10871880|FG006|COMPLETED|Period 2||295
9767140|NCT00420927|10871874|FG000|NOT COMPLETED|Period 2||0
9767141|NCT00420927|10871875|FG001|NOT COMPLETED|Period 2||0
9767142|NCT00420927|10871876|FG002|NOT COMPLETED|Period 2||13
9767143|NCT00420927|10871877|FG003|NOT COMPLETED|Period 2||10
9767144|NCT00420927|10871878|FG004|NOT COMPLETED|Period 2||43
9767145|NCT00420927|10871879|FG005|NOT COMPLETED|Period 2||15
9767146|NCT00420927|10871880|FG006|NOT COMPLETED|Period 2||53
9767147|NCT00420992|10871896|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
9767148|NCT00420992|10871897|FG001|STARTED|Titration Phase||0
9767149|NCT00420992|10871896|FG000|COMPLETED|Titration Phase||344
9767150|NCT00420992|10871897|FG001|COMPLETED|Titration Phase||0
9767151|NCT00420992|10871896|FG000|NOT COMPLETED|Titration Phase||203
9767152|NCT00420992|10871897|FG001|NOT COMPLETED|Titration Phase||0
9767153|NCT00420992|10871896|FG000|STARTED|Maintenance Phase||171
9767154|NCT00420992|10871897|FG001|STARTED|Maintenance Phase||173
9767155|NCT00420992|10871896|FG000|COMPLETED|Maintenance Phase||110
9767156|NCT00420992|10871897|FG001|COMPLETED|Maintenance Phase||98
9767157|NCT00420992|10871896|FG000|NOT COMPLETED|Maintenance Phase||61
9767158|NCT00420992|10871897|FG001|NOT COMPLETED|Maintenance Phase||75
9767159|NCT00421148|10871924|FG000|STARTED|Overall Study||2
9767160|NCT00421148|10871925|FG001|STARTED|Overall Study||2
9767161|NCT00421148|10871926|FG002|STARTED|Overall Study||2
9767162|NCT00421148|10871927|FG003|STARTED|Overall Study||1
9767163|NCT00421148|10871928|FG004|STARTED|Overall Study||1
9767164|NCT00421148|10871929|FG005|STARTED|Overall Study||5
9767165|NCT00421148|10871930|FG006|STARTED|Overall Study||6
9767166|NCT00421148|10871931|FG007|STARTED|Overall Study||5
9767167|NCT00421148|10871932|FG008|STARTED|Overall Study||5
9767168|NCT00421148|10871933|FG009|STARTED|Overall Study||5
9767169|NCT00421148|10871934|FG010|STARTED|Overall Study||6
9767170|NCT00421148|10871935|FG011|STARTED|Overall Study||6
9767171|NCT00421148|10871936|FG012|STARTED|Overall Study||6
9767172|NCT00421148|10871937|FG013|STARTED|Overall Study||6
9767173|NCT00421148|10871938|FG014|STARTED|Overall Study||6
9767174|NCT00421148|10871939|FG015|STARTED|Overall Study||6
9767175|NCT00421148|10871940|FG016|STARTED|Overall Study||6
9767176|NCT00421148|10871941|FG017|STARTED|Overall Study||6
9767177|NCT00421148|10871942|FG018|STARTED|Overall Study||6
9767178|NCT00421148|10871943|FG019|STARTED|Overall Study||6
9767179|NCT00421148|10871924|FG000|Treated|Overall Study||2
9767180|NCT00421148|10871925|FG001|Treated|Overall Study||2
9767181|NCT00421148|10871926|FG002|Treated|Overall Study||2
9767182|NCT00421148|10871927|FG003|Treated|Overall Study||1
9767183|NCT00421148|10871928|FG004|Treated|Overall Study||1
9767184|NCT00421148|10871929|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
9767185|NCT00421148|10871930|FG006|Treated|Overall Study||6
9767186|NCT00421148|10871931|FG007|Treated|Overall Study||5
9767187|NCT00421148|10871932|FG008|Treated|Overall Study||5
9767188|NCT00421148|10871933|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
9767189|NCT00421148|10871934|FG010|Treated|Overall Study||6
9767190|NCT00421148|10871935|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
9767191|NCT00421148|10871936|FG012|Treated|Overall Study||6
9767192|NCT00421148|10871937|FG013|Treated|Overall Study||6
9767193|NCT00421148|10871938|FG014|Treated|Overall Study||6
9767194|NCT00421148|10871939|FG015|Treated|Overall Study||6
9767195|NCT00421148|10871940|FG016|Treated|Overall Study||6
9767196|NCT00421148|10871941|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
9767197|NCT00421148|10871942|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
9767198|NCT00421148|10871943|FG019|Treated|Overall Study||6
9767199|NCT00421148|10871924|FG000|COMPLETED|Overall Study||2
9767200|NCT00421148|10871925|FG001|COMPLETED|Overall Study||2
9767201|NCT00421148|10871926|FG002|COMPLETED|Overall Study||2
9767202|NCT00421148|10871927|FG003|COMPLETED|Overall Study||1
9767203|NCT00421148|10871928|FG004|COMPLETED|Overall Study||1
9767204|NCT00421148|10871929|FG005|COMPLETED|Overall Study||4
9767205|NCT00421148|10871930|FG006|COMPLETED|Overall Study||6
9767206|NCT00421148|10871931|FG007|COMPLETED|Overall Study||5
9767207|NCT00421148|10871932|FG008|COMPLETED|Overall Study||5
9767208|NCT00421148|10871933|FG009|COMPLETED|Overall Study||5
9767209|NCT00421148|10871934|FG010|COMPLETED|Overall Study||6
9767210|NCT00421148|10871935|FG011|COMPLETED|Overall Study||6
9767211|NCT00421148|10871936|FG012|COMPLETED|Overall Study||6
9767212|NCT00421148|10871937|FG013|COMPLETED|Overall Study||6
9767213|NCT00421148|10871938|FG014|COMPLETED|Overall Study||6
9767214|NCT00421148|10871939|FG015|COMPLETED|Overall Study||6
9767215|NCT00421148|10871940|FG016|COMPLETED|Overall Study||6
9767216|NCT00421148|10871941|FG017|COMPLETED|Overall Study||4
9767217|NCT00421148|10871942|FG018|COMPLETED|Overall Study||5
9767218|NCT00421148|10871943|FG019|COMPLETED|Overall Study||6
9767219|NCT00421148|10871924|FG000|NOT COMPLETED|Overall Study||0
9767220|NCT00421148|10871925|FG001|NOT COMPLETED|Overall Study||0
9767221|NCT00421148|10871926|FG002|NOT COMPLETED|Overall Study||0
9767222|NCT00421148|10871927|FG003|NOT COMPLETED|Overall Study||0
9767223|NCT00421148|10871928|FG004|NOT COMPLETED|Overall Study||0
9767224|NCT00421148|10871929|FG005|NOT COMPLETED|Overall Study||1
9767225|NCT00421148|10871930|FG006|NOT COMPLETED|Overall Study||0
9767226|NCT00421148|10871931|FG007|NOT COMPLETED|Overall Study||0
9767227|NCT00421148|10871932|FG008|NOT COMPLETED|Overall Study||0
9767228|NCT00421148|10871933|FG009|NOT COMPLETED|Overall Study||0
9767229|NCT00421148|10871934|FG010|NOT COMPLETED|Overall Study||0
9767230|NCT00421148|10871935|FG011|NOT COMPLETED|Overall Study||0
9767231|NCT00421148|10871936|FG012|NOT COMPLETED|Overall Study||0
9767232|NCT00421148|10871937|FG013|NOT COMPLETED|Overall Study||0
9767233|NCT00421148|10871938|FG014|NOT COMPLETED|Overall Study||0
9767234|NCT00421148|10871939|FG015|NOT COMPLETED|Overall Study||0
9767235|NCT00421148|10871940|FG016|NOT COMPLETED|Overall Study||0
9767236|NCT00421148|10871941|FG017|NOT COMPLETED|Overall Study||2
9767237|NCT00421148|10871942|FG018|NOT COMPLETED|Overall Study||1
9767238|NCT00421148|10871943|FG019|NOT COMPLETED|Overall Study||0
9767239|NCT00421174|10871987|FG000|STARTED|Overall Study||18
9767240|NCT00421174|10871988|FG001|STARTED|Overall Study||19
9767241|NCT00421174|10871987|FG000|COMPLETED|Overall Study||16
9767242|NCT00421174|10871988|FG001|COMPLETED|Overall Study||18
9767243|NCT00421174|10871987|FG000|NOT COMPLETED|Overall Study||2
9767244|NCT00421174|10871988|FG001|NOT COMPLETED|Overall Study||1
9767245|NCT00421304|10871997|FG000|STARTED|Overall Study||40
9767246|NCT00421304|10871998|FG001|STARTED|Overall Study||39
9767247|NCT00421304|10871999|FG002|STARTED|Overall Study||39
9767248|NCT00421304|10871997|FG000|COMPLETED|Overall Study||32
9767249|NCT00421304|10871998|FG001|COMPLETED|Overall Study||35
9767250|NCT00421304|10871999|FG002|COMPLETED|Overall Study||31
9767251|NCT00421304|10871997|FG000|NOT COMPLETED|Overall Study||8
9767252|NCT00421304|10871998|FG001|NOT COMPLETED|Overall Study||4
9767253|NCT00421304|10871999|FG002|NOT COMPLETED|Overall Study||8
9767254|NCT00421343|10872009|FG000|STARTED|Overall Study||29
9767255|NCT00421343|10872009|FG000|COMPLETED|Overall Study||23
9767256|NCT00421343|10872009|FG000|NOT COMPLETED|Overall Study||6
9767257|NCT00421408|10872015|FG000|STARTED|Overall Study||102
9767258|NCT00421408|10872016|FG001|STARTED|Overall Study||106
9767259|NCT00421408|10872015|FG000|COMPLETED|Overall Study||60
9767260|NCT00421408|10872016|FG001|COMPLETED|Overall Study||61
9767261|NCT00421408|10872015|FG000|NOT COMPLETED|Overall Study||42
9767262|NCT00421408|10872016|FG001|NOT COMPLETED|Overall Study||45
9767263|NCT00421603|10872024|FG000|STARTED|Overall Study||39
9767264|NCT00421603|10872025|FG001|STARTED|Overall Study||42
9767265|NCT00421603|10872024|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28
9767266|NCT00421603|10872025|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30
9767267|NCT00421603|10872024|FG000|NOT COMPLETED|Overall Study||11
9767268|NCT00421603|10872025|FG001|NOT COMPLETED|Overall Study||12
9767269|NCT00421707|10872033|FG000|STARTED|Period 1: Treatment Period 1||67
9767270|NCT00421707|10872034|FG001|STARTED|Period 1: Treatment Period 1||65
9767271|NCT00421707|10872033|FG000|COMPLETED|Period 1: Treatment Period 1||56
9767272|NCT00421707|10872034|FG001|COMPLETED|Period 1: Treatment Period 1||56
9767273|NCT00421707|10872033|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11
9767274|NCT00421707|10872034|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9
9767275|NCT00421707|10872033|FG000|STARTED|Period 2: Washout||56
9767276|NCT00421707|10872034|FG001|STARTED|Period 2: Washout||56
9767277|NCT00421707|10872033|FG000|COMPLETED|Period 2: Washout||55
9767278|NCT00421707|10872034|FG001|COMPLETED|Period 2: Washout||52
9767279|NCT00421707|10872033|FG000|NOT COMPLETED|Period 2: Washout||1
9767280|NCT00421707|10872034|FG001|NOT COMPLETED|Period 2: Washout||4
9767281|NCT00421707|10872033|FG000|STARTED|Period 3:Treatment Period 2||55
9767282|NCT00421707|10872034|FG001|STARTED|Period 3:Treatment Period 2||52
9767283|NCT00421707|10872033|FG000|COMPLETED|Period 3:Treatment Period 2||53
9767284|NCT00421707|10872034|FG001|COMPLETED|Period 3:Treatment Period 2||49
9767285|NCT00421707|10872033|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2
9767286|NCT00421707|10872034|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3
9767287|NCT00421733|10872046|FG000|STARTED|Overall Study||93
9767288|NCT00421733|10872047|FG001|STARTED|Overall Study||95
9767289|NCT00421733|10872048|FG002|STARTED|Overall Study||93
9767290|NCT00421733|10872046|FG000|COMPLETED|Overall Study||78
9767291|NCT00421733|10872047|FG001|COMPLETED|Overall Study||69
9767292|NCT00421733|10872048|FG002|COMPLETED|Overall Study||73
9767293|NCT00421733|10872046|FG000|NOT COMPLETED|Overall Study||15
9767294|NCT00421733|10872047|FG001|NOT COMPLETED|Overall Study||26
9767295|NCT00421733|10872048|FG002|NOT COMPLETED|Overall Study||20
9767296|NCT00421889|10872069|FG000|STARTED|Overall Study||5
9767297|NCT00421889|10872070|FG001|STARTED|Overall Study||5
9767298|NCT00421889|10872071|FG002|STARTED|Overall Study||3
9767299|NCT00421889|10872072|FG003|STARTED|Overall Study||4
9767300|NCT00421889|10872073|FG004|STARTED|Overall Study||6
9767301|NCT00421889|10872074|FG005|STARTED|Overall Study||35
9767302|NCT00421889|10872075|FG006|STARTED|Overall Study||4
9767303|NCT00421889|10872076|FG007|STARTED|Overall Study||3
9767304|NCT00421889|10872077|FG008|STARTED|Overall Study||15
9767305|NCT00421889|10872069|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
9767306|NCT00421889|10872070|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
9767307|NCT00421889|10872071|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
9767308|NCT00421889|10872072|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
9767309|NCT00421889|10872073|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
9767310|NCT00421889|10872074|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
9767311|NCT00421889|10872075|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
9767312|NCT00421889|10872076|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
9767313|NCT00421889|10872077|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
9767314|NCT00421889|10872069|FG000|NOT COMPLETED|Overall Study||5
9767315|NCT00421889|10872070|FG001|NOT COMPLETED|Overall Study||5
9767316|NCT00421889|10872071|FG002|NOT COMPLETED|Overall Study||3
9767317|NCT00421889|10872072|FG003|NOT COMPLETED|Overall Study||4
9767318|NCT00421889|10872073|FG004|NOT COMPLETED|Overall Study||6
9767319|NCT00421889|10872074|FG005|NOT COMPLETED|Overall Study||35
9767320|NCT00421889|10872075|FG006|NOT COMPLETED|Overall Study||4
9767321|NCT00421889|10872076|FG007|NOT COMPLETED|Overall Study||2
9767322|NCT00421889|10872077|FG008|NOT COMPLETED|Overall Study||11
9767323|NCT00421928|10872104|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
9767324|NCT00421928|10872105|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
9767325|NCT00421928|10872106|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
9767326|NCT00421928|10872104|FG000|COMPLETED|Overall Study||181
10014052|NCT01797263|11137053|FG001|9 Month|Overall Study||87
10014053|NCT01797263|11137052|FG000|COMPLETED|Overall Study||92
10014054|NCT01797263|11137053|FG001|COMPLETED|Overall Study||87
10014055|NCT01797263|11137052|FG000|NOT COMPLETED|Overall Study||37
10014056|NCT01797263|11137053|FG001|NOT COMPLETED|Overall Study||40
10014057|NCT01797302|11137062|FG000|STARTED|Overall Study||75
9767327|NCT00421928|10872105|FG001|COMPLETED|Overall Study||118
9767328|NCT00421928|10872106|FG002|COMPLETED|Overall Study||203
9767329|NCT00421928|10872104|FG000|NOT COMPLETED|Overall Study||163
9767330|NCT00421928|10872105|FG001|NOT COMPLETED|Overall Study||224
9767331|NCT00421928|10872106|FG002|NOT COMPLETED|Overall Study||134
9767332|NCT00421993|10872118|FG000|STARTED|Overall Study||419
9767333|NCT00421993|10872119|FG001|STARTED|Overall Study||418
9767334|NCT00421993|10872120|FG002|STARTED|Overall Study||415
9767335|NCT00421993|10872121|FG003|STARTED|Overall Study||418
9767336|NCT00421993|10872118|FG000|COMPLETED|Overall Study||366
9767337|NCT00421993|10872119|FG001|COMPLETED|Overall Study||369
9767338|NCT00421993|10872120|FG002|COMPLETED|Overall Study||363
9767339|NCT00421993|10872121|FG003|COMPLETED|Overall Study||361
9767340|NCT00421993|10872118|FG000|NOT COMPLETED|Overall Study||53
9767341|NCT00421993|10872119|FG001|NOT COMPLETED|Overall Study||49
9767342|NCT00421993|10872120|FG002|NOT COMPLETED|Overall Study||52
9767343|NCT00421993|10872121|FG003|NOT COMPLETED|Overall Study||57
9767344|NCT00422032|10872133|FG000|STARTED|Overall Study||37
9767345|NCT00422032|10872134|FG001|STARTED|Overall Study||21
9767346|NCT00422032|10872133|FG000|COMPLETED|Overall Study||37
9767347|NCT00422032|10872134|FG001|COMPLETED|Overall Study||21
9767348|NCT00422032|10872133|FG000|NOT COMPLETED|Overall Study||0
9767349|NCT00422032|10872134|FG001|NOT COMPLETED|Overall Study||0
9767350|NCT00422058|10872146|FG000|STARTED|Double-Blind, Week 0-20||98
9767351|NCT00422058|10872147|FG001|STARTED|Double-Blind, Week 0-20||95
9767352|NCT00422058|10872148|FG002|STARTED|Double-Blind, Week 0-20||90
9767353|NCT00422058|10872149|FG003|STARTED|Double-Blind, Week 0-20||93
9767354|NCT00422058|10872150|FG004|STARTED|Double-Blind, Week 0-20||93
9767355|NCT00422058|10872151|FG005|STARTED|Double-Blind, Week 0-20||95
9767356|NCT00422058|10872146|FG000|COMPLETED|Double-Blind, Week 0-20||79
9767357|NCT00422058|10872147|FG001|COMPLETED|Double-Blind, Week 0-20||85
9767358|NCT00422058|10872148|FG002|COMPLETED|Double-Blind, Week 0-20||74
10014058|NCT01797302|11137063|FG001|STARTED|Overall Study||74
10014059|NCT01797302|11137064|FG002|STARTED|Overall Study||76
10014060|NCT01797302|11137062|FG000|3 Month Visit|Overall Study||60
9767359|NCT00422058|10872149|FG003|COMPLETED|Double-Blind, Week 0-20||73
9767360|NCT00422058|10872150|FG004|COMPLETED|Double-Blind, Week 0-20||82
9767361|NCT00422058|10872151|FG005|COMPLETED|Double-Blind, Week 0-20||79
9767362|NCT00422058|10872146|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19
9767363|NCT00422058|10872147|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10
9767364|NCT00422058|10872148|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16
9767365|NCT00422058|10872149|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20
9767366|NCT00422058|10872150|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11
9767367|NCT00422058|10872151|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16
9767368|NCT00422058|10872146|FG000|STARTED|Open-Label Extension, Week 20-104||79
9767369|NCT00422058|10872147|FG001|STARTED|Open-Label Extension, Week 20-104||85
9767370|NCT00422058|10872148|FG002|STARTED|Open-Label Extension, Week 20-104||74
9767371|NCT00422058|10872149|FG003|STARTED|Open-Label Extension, Week 20-104||73
9767372|NCT00422058|10872150|FG004|STARTED|Open-Label Extension, Week 20-104||82
9767373|NCT00422058|10872151|FG005|STARTED|Open-Label Extension, Week 20-104||79
9767374|NCT00422058|10872146|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67
9767375|NCT00422058|10872147|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68
9767376|NCT00422058|10872148|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59
9767377|NCT00422058|10872149|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65
9767378|NCT00422058|10872150|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72
9767379|NCT00422058|10872151|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67
9767380|NCT00422058|10872146|FG000|COMPLETED|Open-Label Extension, Week 20-104||47
9767381|NCT00422058|10872147|FG001|COMPLETED|Open-Label Extension, Week 20-104||46
9767382|NCT00422058|10872148|FG002|COMPLETED|Open-Label Extension, Week 20-104||38
9767383|NCT00422058|10872149|FG003|COMPLETED|Open-Label Extension, Week 20-104||45
9767384|NCT00422058|10872150|FG004|COMPLETED|Open-Label Extension, Week 20-104||47
9767385|NCT00422058|10872151|FG005|COMPLETED|Open-Label Extension, Week 20-104||45
9767386|NCT00422058|10872146|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32
9767387|NCT00422058|10872147|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39
9767388|NCT00422058|10872148|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36
9767389|NCT00422058|10872149|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28
9767390|NCT00422058|10872150|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35
9767391|NCT00422058|10872151|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34
9767392|NCT00422084|10872167|FG000|STARTED|Overall Study||849
9767393|NCT00422084|10872168|FG001|STARTED|Overall Study||423
9767394|NCT00422084|10872167|FG000|COMPLETED|Overall Study||751
9767395|NCT00422084|10872168|FG001|COMPLETED|Overall Study||347
9767396|NCT00422084|10872167|FG000|NOT COMPLETED|Overall Study||98
9767397|NCT00422084|10872168|FG001|NOT COMPLETED|Overall Study||76
9767398|NCT00422097|10872180|FG000|STARTED|Dose Level 1||3
9767399|NCT00422097|10872181|FG001|STARTED|Dose Level 1||0
9767400|NCT00422097|10872182|FG002|STARTED|Dose Level 1||0
9767401|NCT00422097|10872183|FG003|STARTED|Dose Level 1||0
9767402|NCT00422097|10872184|FG004|STARTED|Dose Level 1||0
9767403|NCT00422097|10872185|FG005|STARTED|Dose Level 1||0
9767404|NCT00422097|10872186|FG006|STARTED|Dose Level 1||0
9767405|NCT00422097|10872187|FG007|STARTED|Dose Level 1||0
9767406|NCT00422097|10872180|FG000|COMPLETED|Dose Level 1||3
9767407|NCT00422097|10872181|FG001|COMPLETED|Dose Level 1||0
9767408|NCT00422097|10872182|FG002|COMPLETED|Dose Level 1||0
9767409|NCT00422097|10872183|FG003|COMPLETED|Dose Level 1||0
9767410|NCT00422097|10872184|FG004|COMPLETED|Dose Level 1||0
9767411|NCT00422097|10872185|FG005|COMPLETED|Dose Level 1||0
9767412|NCT00422097|10872186|FG006|COMPLETED|Dose Level 1||0
9767413|NCT00422097|10872187|FG007|COMPLETED|Dose Level 1||0
9767414|NCT00422097|10872180|FG000|NOT COMPLETED|Dose Level 1||0
9767415|NCT00422097|10872181|FG001|NOT COMPLETED|Dose Level 1||0
9767416|NCT00422097|10872182|FG002|NOT COMPLETED|Dose Level 1||0
9767417|NCT00422097|10872183|FG003|NOT COMPLETED|Dose Level 1||0
9767418|NCT00422097|10872184|FG004|NOT COMPLETED|Dose Level 1||0
9767419|NCT00422097|10872185|FG005|NOT COMPLETED|Dose Level 1||0
9767420|NCT00422097|10872186|FG006|NOT COMPLETED|Dose Level 1||0
9767421|NCT00422097|10872187|FG007|NOT COMPLETED|Dose Level 1||0
9767422|NCT00422097|10872180|FG000|STARTED|Dose Level 2||0
9767423|NCT00422097|10872181|FG001|STARTED|Dose Level 2||6
9767424|NCT00422097|10872182|FG002|STARTED|Dose Level 2||0
9767425|NCT00422097|10872183|FG003|STARTED|Dose Level 2||0
9767426|NCT00422097|10872184|FG004|STARTED|Dose Level 2||0
9767427|NCT00422097|10872185|FG005|STARTED|Dose Level 2||0
9767428|NCT00422097|10872186|FG006|STARTED|Dose Level 2||0
9767429|NCT00422097|10872187|FG007|STARTED|Dose Level 2||0
9767430|NCT00422097|10872180|FG000|COMPLETED|Dose Level 2||0
9767431|NCT00422097|10872181|FG001|COMPLETED|Dose Level 2||5
9767432|NCT00422097|10872182|FG002|COMPLETED|Dose Level 2||0
9767433|NCT00422097|10872183|FG003|COMPLETED|Dose Level 2||0
9767434|NCT00422097|10872184|FG004|COMPLETED|Dose Level 2||0
9767435|NCT00422097|10872185|FG005|COMPLETED|Dose Level 2||0
9767436|NCT00422097|10872186|FG006|COMPLETED|Dose Level 2||0
9767437|NCT00422097|10872187|FG007|COMPLETED|Dose Level 2||0
9767438|NCT00422097|10872180|FG000|NOT COMPLETED|Dose Level 2||0
9767439|NCT00422097|10872181|FG001|NOT COMPLETED|Dose Level 2||1
9767440|NCT00422097|10872182|FG002|NOT COMPLETED|Dose Level 2||0
9767441|NCT00422097|10872183|FG003|NOT COMPLETED|Dose Level 2||0
9767442|NCT00422097|10872184|FG004|NOT COMPLETED|Dose Level 2||0
9767443|NCT00422097|10872185|FG005|NOT COMPLETED|Dose Level 2||0
9767444|NCT00422097|10872186|FG006|NOT COMPLETED|Dose Level 2||0
9767445|NCT00422097|10872187|FG007|NOT COMPLETED|Dose Level 2||0
9767446|NCT00422097|10872180|FG000|STARTED|Dose Level 3||0
9767447|NCT00422097|10872181|FG001|STARTED|Dose Level 3||0
9767448|NCT00422097|10872182|FG002|STARTED|Dose Level 3||3
9767449|NCT00422097|10872183|FG003|STARTED|Dose Level 3||0
9767450|NCT00422097|10872184|FG004|STARTED|Dose Level 3||0
9767451|NCT00422097|10872185|FG005|STARTED|Dose Level 3||0
9767452|NCT00422097|10872186|FG006|STARTED|Dose Level 3||0
9767453|NCT00422097|10872187|FG007|STARTED|Dose Level 3||0
9767454|NCT00422097|10872180|FG000|COMPLETED|Dose Level 3||0
9767455|NCT00422097|10872181|FG001|COMPLETED|Dose Level 3||0
9767456|NCT00422097|10872182|FG002|COMPLETED|Dose Level 3||3
9767457|NCT00422097|10872183|FG003|COMPLETED|Dose Level 3||0
9767458|NCT00422097|10872184|FG004|COMPLETED|Dose Level 3||0
9767459|NCT00422097|10872185|FG005|COMPLETED|Dose Level 3||0
9767460|NCT00422097|10872186|FG006|COMPLETED|Dose Level 3||0
9767461|NCT00422097|10872187|FG007|COMPLETED|Dose Level 3||0
9767462|NCT00422097|10872180|FG000|NOT COMPLETED|Dose Level 3||0
9767463|NCT00422097|10872181|FG001|NOT COMPLETED|Dose Level 3||0
9767464|NCT00422097|10872182|FG002|NOT COMPLETED|Dose Level 3||0
9767465|NCT00422097|10872183|FG003|NOT COMPLETED|Dose Level 3||0
9767466|NCT00422097|10872184|FG004|NOT COMPLETED|Dose Level 3||0
9767467|NCT00422097|10872185|FG005|NOT COMPLETED|Dose Level 3||0
9767468|NCT00422097|10872186|FG006|NOT COMPLETED|Dose Level 3||0
9767469|NCT00422097|10872187|FG007|NOT COMPLETED|Dose Level 3||0
9767470|NCT00422097|10872180|FG000|STARTED|Dose Level 4||0
9767471|NCT00422097|10872181|FG001|STARTED|Dose Level 4||0
9767472|NCT00422097|10872182|FG002|STARTED|Dose Level 4||0
9767473|NCT00422097|10872183|FG003|STARTED|Dose Level 4||3
9767474|NCT00422097|10872184|FG004|STARTED|Dose Level 4||0
9767475|NCT00422097|10872185|FG005|STARTED|Dose Level 4||0
9767476|NCT00422097|10872186|FG006|STARTED|Dose Level 4||0
9767477|NCT00422097|10872187|FG007|STARTED|Dose Level 4||0
9767478|NCT00422097|10872180|FG000|COMPLETED|Dose Level 4||0
9767479|NCT00422097|10872181|FG001|COMPLETED|Dose Level 4||0
9767480|NCT00422097|10872182|FG002|COMPLETED|Dose Level 4||0
9767481|NCT00422097|10872183|FG003|COMPLETED|Dose Level 4||3
9767482|NCT00422097|10872184|FG004|COMPLETED|Dose Level 4||0
9767483|NCT00422097|10872185|FG005|COMPLETED|Dose Level 4||0
9767484|NCT00422097|10872186|FG006|COMPLETED|Dose Level 4||0
9767485|NCT00422097|10872187|FG007|COMPLETED|Dose Level 4||0
9767486|NCT00422097|10872180|FG000|NOT COMPLETED|Dose Level 4||0
9767487|NCT00422097|10872181|FG001|NOT COMPLETED|Dose Level 4||0
9767488|NCT00422097|10872182|FG002|NOT COMPLETED|Dose Level 4||0
9767489|NCT00422097|10872183|FG003|NOT COMPLETED|Dose Level 4||0
9767490|NCT00422097|10872184|FG004|NOT COMPLETED|Dose Level 4||0
9767491|NCT00422097|10872185|FG005|NOT COMPLETED|Dose Level 4||0
9767492|NCT00422097|10872186|FG006|NOT COMPLETED|Dose Level 4||0
9767493|NCT00422097|10872187|FG007|NOT COMPLETED|Dose Level 4||0
9767494|NCT00422097|10872180|FG000|STARTED|Dose Level 5||0
9767495|NCT00422097|10872181|FG001|STARTED|Dose Level 5||0
9767496|NCT00422097|10872182|FG002|STARTED|Dose Level 5||0
9767497|NCT00422097|10872183|FG003|STARTED|Dose Level 5||0
9767498|NCT00422097|10872184|FG004|STARTED|Dose Level 5||23
9767499|NCT00422097|10872185|FG005|STARTED|Dose Level 5||0
9767500|NCT00422097|10872186|FG006|STARTED|Dose Level 5||0
9767501|NCT00422097|10872187|FG007|STARTED|Dose Level 5||0
9767502|NCT00422097|10872180|FG000|COMPLETED|Dose Level 5||0
9767503|NCT00422097|10872181|FG001|COMPLETED|Dose Level 5||0
9767504|NCT00422097|10872182|FG002|COMPLETED|Dose Level 5||0
9767505|NCT00422097|10872183|FG003|COMPLETED|Dose Level 5||0
9767506|NCT00422097|10872184|FG004|COMPLETED|Dose Level 5||23
9767507|NCT00422097|10872185|FG005|COMPLETED|Dose Level 5||0
9767508|NCT00422097|10872186|FG006|COMPLETED|Dose Level 5||0
9767509|NCT00422097|10872187|FG007|COMPLETED|Dose Level 5||0
9767510|NCT00422097|10872180|FG000|NOT COMPLETED|Dose Level 5||0
9767511|NCT00422097|10872181|FG001|NOT COMPLETED|Dose Level 5||0
9767512|NCT00422097|10872182|FG002|NOT COMPLETED|Dose Level 5||0
9767513|NCT00422097|10872183|FG003|NOT COMPLETED|Dose Level 5||0
9767514|NCT00422097|10872184|FG004|NOT COMPLETED|Dose Level 5||0
9767515|NCT00422097|10872185|FG005|NOT COMPLETED|Dose Level 5||0
9767516|NCT00422097|10872186|FG006|NOT COMPLETED|Dose Level 5||0
9767517|NCT00422097|10872187|FG007|NOT COMPLETED|Dose Level 5||0
9767518|NCT00422097|10872180|FG000|STARTED|Dose Level 6||0
9767519|NCT00422097|10872181|FG001|STARTED|Dose Level 6||0
9767520|NCT00422097|10872182|FG002|STARTED|Dose Level 6||0
9767521|NCT00422097|10872183|FG003|STARTED|Dose Level 6||0
9767522|NCT00422097|10872184|FG004|STARTED|Dose Level 6||0
9767523|NCT00422097|10872185|FG005|STARTED|Dose Level 6||6
9767524|NCT00422097|10872186|FG006|STARTED|Dose Level 6||0
9767525|NCT00422097|10872187|FG007|STARTED|Dose Level 6||0
9767526|NCT00422097|10872180|FG000|COMPLETED|Dose Level 6||0
9767527|NCT00422097|10872181|FG001|COMPLETED|Dose Level 6||0
9767528|NCT00422097|10872182|FG002|COMPLETED|Dose Level 6||0
9767529|NCT00422097|10872183|FG003|COMPLETED|Dose Level 6||0
9767530|NCT00422097|10872184|FG004|COMPLETED|Dose Level 6||0
9767531|NCT00422097|10872185|FG005|COMPLETED|Dose Level 6||6
9767532|NCT00422097|10872186|FG006|COMPLETED|Dose Level 6||0
9767533|NCT00422097|10872187|FG007|COMPLETED|Dose Level 6||0
9767534|NCT00422097|10872180|FG000|NOT COMPLETED|Dose Level 6||0
9767535|NCT00422097|10872181|FG001|NOT COMPLETED|Dose Level 6||0
9767536|NCT00422097|10872182|FG002|NOT COMPLETED|Dose Level 6||0
9767537|NCT00422097|10872183|FG003|NOT COMPLETED|Dose Level 6||0
9767538|NCT00422097|10872184|FG004|NOT COMPLETED|Dose Level 6||0
9767539|NCT00422097|10872185|FG005|NOT COMPLETED|Dose Level 6||0
9767540|NCT00422097|10872186|FG006|NOT COMPLETED|Dose Level 6||0
9767541|NCT00422097|10872187|FG007|NOT COMPLETED|Dose Level 6||0
9767542|NCT00422097|10872180|FG000|STARTED|Ixabepilone With Famotidine or Food||0
9767543|NCT00422097|10872181|FG001|STARTED|Ixabepilone With Famotidine or Food||0
9767544|NCT00422097|10872182|FG002|STARTED|Ixabepilone With Famotidine or Food||0
9767545|NCT00422097|10872183|FG003|STARTED|Ixabepilone With Famotidine or Food||0
9767546|NCT00422097|10872184|FG004|STARTED|Ixabepilone With Famotidine or Food||0
9767547|NCT00422097|10872185|FG005|STARTED|Ixabepilone With Famotidine or Food||0
9767548|NCT00422097|10872186|FG006|STARTED|Ixabepilone With Famotidine or Food||8
9767549|NCT00422097|10872187|FG007|STARTED|Ixabepilone With Famotidine or Food||7
9767550|NCT00422097|10872180|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0
9767551|NCT00422097|10872181|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0
9767552|NCT00422097|10872182|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0
9767553|NCT00422097|10872183|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0
10014061|NCT01797302|11137063|FG001|3 Month Visit|Overall Study||57
10014062|NCT01797302|11137064|FG002|3 Month Visit|Overall Study||57
10014063|NCT01797302|11137062|FG000|COMPLETED|Overall Study||58
10014064|NCT01797302|11137063|FG001|COMPLETED|Overall Study||48
10014065|NCT01797302|11137064|FG002|COMPLETED|Overall Study||50
10014066|NCT01797302|11137062|FG000|NOT COMPLETED|Overall Study||17
10014067|NCT01797302|11137063|FG001|NOT COMPLETED|Overall Study||26
10014068|NCT01797302|11137064|FG002|NOT COMPLETED|Overall Study||26
10014069|NCT01797328|11137074|FG000|STARTED|Overall Study||16
10014070|NCT01797328|11137075|FG001|STARTED|Overall Study||12
10014071|NCT01797328|11137074|FG000|COMPLETED|Overall Study||14
10014072|NCT01797328|11137075|FG001|COMPLETED|Overall Study||12
10014073|NCT01797328|11137074|FG000|NOT COMPLETED|Overall Study||2
10014074|NCT01797328|11137075|FG001|NOT COMPLETED|Overall Study||0
10014075|NCT01797432|11137081|FG000|STARTED|Overall Study||14
10014076|NCT01797432|11137081|FG000|COMPLETED|Overall Study||10
10014077|NCT01797432|11137081|FG000|NOT COMPLETED|Overall Study||4
10014078|NCT01797445|11137087|FG000|STARTED|Double-Blind Phase||435
10014079|NCT01797445|11137088|FG001|STARTED|Double-Blind Phase||437
10014080|NCT01797445|11137087|FG000|COMPLETED|Double-Blind Phase||348
10232267|NCT02282332|11361484|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10232268|NCT02282332|11361484|FG000|NOT COMPLETED|Overall Study||0
10232269|NCT02287636|11361488|FG000|STARTED|Overall Study||13
10232270|NCT02287636|11361488|FG000|COMPLETED|Overall Study||13
9767554|NCT00422097|10872184|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0
9767555|NCT00422097|10872185|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0
9767556|NCT00422097|10872186|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8
9767557|NCT00422097|10872187|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7
9767558|NCT00422097|10872180|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767559|NCT00422097|10872181|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767560|NCT00422097|10872182|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767561|NCT00422097|10872183|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767562|NCT00422097|10872184|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767563|NCT00422097|10872185|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767564|NCT00422097|10872186|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767565|NCT00422097|10872187|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
9767566|NCT00422162|10872213|FG000|STARTED|Overall Study||167
9767567|NCT00422162|10872214|FG001|STARTED|Overall Study||172
9767568|NCT00422162|10872213|FG000|Received Treatment|Overall Study||167
9767569|NCT00422162|10872214|FG001|Received Treatment|Overall Study||171
9767570|NCT00422162|10872213|FG000|COMPLETED|Overall Study||143
9767571|NCT00422162|10872214|FG001|COMPLETED|Overall Study||142
9767572|NCT00422162|10872213|FG000|NOT COMPLETED|Overall Study||24
9767573|NCT00422162|10872214|FG001|NOT COMPLETED|Overall Study||30
9767574|NCT00422201|10872230|FG000|STARTED|Overall Study||18
9767575|NCT00422201|10872230|FG000|COMPLETED|Overall Study||7
9767576|NCT00422201|10872230|FG000|NOT COMPLETED|Overall Study||11
9767577|NCT00422227|10872237|FG000|STARTED|Overall Study||197
9767578|NCT00422227|10872238|FG001|STARTED|Overall Study||103
9767579|NCT00422227|10872237|FG000|COMPLETED|Overall Study||193
10232271|NCT02287636|11361488|FG000|NOT COMPLETED|Overall Study||0
10232272|NCT02276560|11361495|FG000|STARTED|Overall Study||1
10232273|NCT02276560|11361496|FG001|STARTED|Overall Study||0
9767580|NCT00422227|10872238|FG001|COMPLETED|Overall Study||88
9767581|NCT00422227|10872237|FG000|NOT COMPLETED|Overall Study||4
9767582|NCT00422227|10872238|FG001|NOT COMPLETED|Overall Study||15
9767583|NCT00422279|10872246|FG000|STARTED|Overall Study||2
9767584|NCT00422279|10872247|FG001|STARTED|Overall Study||2
9767585|NCT00422279|10872246|FG000|24 Month After Loading Period|Overall Study||2
9767586|NCT00422279|10872247|FG001|24 Month After Loading Period|Overall Study||2
9767587|NCT00422279|10872246|FG000|COMPLETED|Overall Study||2
10014081|NCT01797445|11137088|FG001|COMPLETED|Double-Blind Phase||348
10014082|NCT01797445|11137087|FG000|NOT COMPLETED|Double-Blind Phase||87
10014083|NCT01797445|11137088|FG001|NOT COMPLETED|Double-Blind Phase||89
10014084|NCT01797445|11137087|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
9767588|NCT00422279|10872247|FG001|COMPLETED|Overall Study||2
9767589|NCT00422279|10872246|FG000|NOT COMPLETED|Overall Study||0
9767590|NCT00422279|10872247|FG001|NOT COMPLETED|Overall Study||0
9767591|NCT00422292|10872259|FG000|STARTED|Overall Study||257
9767592|NCT00422292|10872260|FG001|STARTED|Overall Study||664
9767593|NCT00422292|10872261|FG002|STARTED|Overall Study||246
9767594|NCT00422292|10872262|FG003|STARTED|Overall Study||476
9767595|NCT00422292|10872259|FG000|COMPLETED|Overall Study||239
9767596|NCT00422292|10872260|FG001|COMPLETED|Overall Study||598
9767597|NCT00422292|10872261|FG002|COMPLETED|Overall Study||224
9767598|NCT00422292|10872262|FG003|COMPLETED|Overall Study||452
9767599|NCT00422292|10872259|FG000|NOT COMPLETED|Overall Study||18
9767600|NCT00422292|10872260|FG001|NOT COMPLETED|Overall Study||66
9767601|NCT00422292|10872261|FG002|NOT COMPLETED|Overall Study||22
9767602|NCT00422292|10872262|FG003|NOT COMPLETED|Overall Study||24
9767603|NCT00422383|10872277|FG000|STARTED|Overall Study||134
9767604|NCT00422383|10872278|FG001|STARTED|Overall Study||120
9767605|NCT00422383|10872279|FG002|STARTED|Overall Study||93
9767606|NCT00422383|10872280|FG003|STARTED|Overall Study||6
9767607|NCT00422383|10872281|FG004|STARTED|Overall Study||25
9767608|NCT00422383|10872277|FG000|COMPLETED|Overall Study||119
9767609|NCT00422383|10872278|FG001|COMPLETED|Overall Study||106
10014085|NCT01797445|11137088|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
10014086|NCT01797445|11137087|FG000|COMPLETED|Open-Label Extension Phase||140
10014087|NCT01797445|11137088|FG001|COMPLETED|Open-Label Extension Phase||119
10014088|NCT01797445|11137087|FG000|NOT COMPLETED|Open-Label Extension Phase||1
10232274|NCT02276560|11361497|FG002|STARTED|Overall Study||0
10232275|NCT02276560|11361495|FG000|COMPLETED|Overall Study||0
10232276|NCT02276560|11361496|FG001|COMPLETED|Overall Study||0
10232277|NCT02276560|11361497|FG002|COMPLETED|Overall Study||0
10232278|NCT02276560|11361495|FG000|NOT COMPLETED|Overall Study||1
10232279|NCT02276560|11361496|FG001|NOT COMPLETED|Overall Study||0
10232280|NCT02276560|11361497|FG002|NOT COMPLETED|Overall Study||0
10232281|NCT02280252|11361505|FG000|STARTED|Overall Study||0
10232282|NCT02280252|11361505|FG000|COMPLETED|Overall Study||0
10232283|NCT02280252|11361505|FG000|NOT COMPLETED|Overall Study||0
10232284|NCT02284373|11361512|FG000|STARTED|Overall Study||5
10232285|NCT02284373|11361513|FG001|STARTED|Overall Study||5
10232286|NCT02284373|11361514|FG002|STARTED|Overall Study||29
10232287|NCT02284373|11361512|FG000|COMPLETED|Overall Study||5
10232288|NCT02284373|11361513|FG001|COMPLETED|Overall Study||2
10232289|NCT02284373|11361514|FG002|COMPLETED|Overall Study||29
10232290|NCT02284373|11361512|FG000|NOT COMPLETED|Overall Study||0
10232291|NCT02284373|11361513|FG001|NOT COMPLETED|Overall Study||3
10232292|NCT02284373|11361514|FG002|NOT COMPLETED|Overall Study||0
10232293|NCT02285270|11361522|FG000|STARTED|Overall Study||10
10232294|NCT02285270|11361522|FG000|COMPLETED|Overall Study||5
10232295|NCT02285270|11361522|FG000|NOT COMPLETED|Overall Study||5
10232296|NCT02275481|11361528|FG000|STARTED|Overall Study||32
10232297|NCT02275481|11361529|FG001|STARTED|Overall Study||34
10232298|NCT02275481|11361528|FG000|COMPLETED|Overall Study||23
10232299|NCT02275481|11361529|FG001|COMPLETED|Overall Study||31
10232300|NCT02275481|11361528|FG000|NOT COMPLETED|Overall Study||9
10232301|NCT02275481|11361529|FG001|NOT COMPLETED|Overall Study||3
10232302|NCT02266914|11361535|FG000|STARTED|Overall Study||9
10232303|NCT02266914|11361535|FG000|COMPLETED|Overall Study||0
10232304|NCT02266914|11361535|FG000|NOT COMPLETED|Overall Study||9
10232305|NCT02273752|11361539|FG000|STARTED|Overall Study||2
10232306|NCT02273752|11361539|FG000|COMPLETED|Overall Study||0
10232307|NCT02273752|11361539|FG000|NOT COMPLETED|Overall Study||2
10232308|NCT02270684|11361545|FG000|STARTED|Overall Study||1
10232309|NCT02270684|11361546|FG001|STARTED|Overall Study||3
10232310|NCT02270684|11361545|FG000|COMPLETED|Overall Study||0
10232311|NCT02270684|11361546|FG001|COMPLETED|Overall Study||0
10232312|NCT02270684|11361545|FG000|NOT COMPLETED|Overall Study||1
10232313|NCT02270684|11361546|FG001|NOT COMPLETED|Overall Study||3
10232314|NCT02262000|11361554|FG000|STARTED|Overall Study||3
10232315|NCT02262000|11361555|FG001|STARTED|Overall Study||0
9767610|NCT00422383|10872279|FG002|COMPLETED|Overall Study||89
9767611|NCT00422383|10872280|FG003|COMPLETED|Overall Study||4
9767612|NCT00422383|10872281|FG004|COMPLETED|Overall Study||22
9767613|NCT00422383|10872277|FG000|NOT COMPLETED|Overall Study||15
9767614|NCT00422383|10872278|FG001|NOT COMPLETED|Overall Study||14
9767615|NCT00422383|10872279|FG002|NOT COMPLETED|Overall Study||4
9767616|NCT00422383|10872280|FG003|NOT COMPLETED|Overall Study||2
9767617|NCT00422383|10872281|FG004|NOT COMPLETED|Overall Study||3
9767618|NCT00422422|10872299|FG000|STARTED|Overall Study||100
9767619|NCT00422422|10872299|FG000|COMPLETED|Overall Study||90
10232316|NCT02262000|11361554|FG000|COMPLETED|Overall Study||3
10232317|NCT02262000|11361555|FG001|COMPLETED|Overall Study||0
10232318|NCT02262000|11361554|FG000|NOT COMPLETED|Overall Study||0
10232319|NCT02262000|11361555|FG001|NOT COMPLETED|Overall Study||0
10232320|NCT02271594|11361563|FG000|STARTED|Overall Study||19
10232321|NCT02271594|11361564|FG001|STARTED|Overall Study||12
10232322|NCT02271594|11361563|FG000|COMPLETED|Overall Study|Study closed down|0
10232323|NCT02271594|11361564|FG001|COMPLETED|Overall Study|Study closed down|0
10232324|NCT02271594|11361563|FG000|NOT COMPLETED|Overall Study||19
10232325|NCT02271594|11361564|FG001|NOT COMPLETED|Overall Study||12
10232326|NCT02263365|11361574|FG000|STARTED|Overall Study||22
10232327|NCT02263365|11361575|FG001|STARTED|Overall Study||18
10232328|NCT02263365|11361574|FG000|COMPLETED|Overall Study||0
10232329|NCT02263365|11361575|FG001|COMPLETED|Overall Study||0
9767620|NCT00422422|10872299|FG000|NOT COMPLETED|Overall Study||10
9767621|NCT00422448|10872305|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
9767622|NCT00422448|10872305|FG000|COMPLETED|Overall Study||43
9767623|NCT00422448|10872305|FG000|NOT COMPLETED|Overall Study||0
9767624|NCT00422461|10872313|FG000|STARTED|Overall Study||35
9767625|NCT00422461|10872314|FG001|STARTED|Overall Study||35
9767626|NCT00422461|10872315|FG002|STARTED|Overall Study||32
9767627|NCT00422461|10872316|FG003|STARTED|Overall Study||33
9767628|NCT00422461|10872313|FG000|Treated|Overall Study||34
9767629|NCT00422461|10872314|FG001|Treated|Overall Study||34
9767630|NCT00422461|10872315|FG002|Treated|Overall Study||32
9767631|NCT00422461|10872316|FG003|Treated|Overall Study||33
9767632|NCT00422461|10872313|FG000|Full Analysis Set|Overall Study||34
9767633|NCT00422461|10872314|FG001|Full Analysis Set|Overall Study||34
9767634|NCT00422461|10872315|FG002|Full Analysis Set|Overall Study||31
9767635|NCT00422461|10872316|FG003|Full Analysis Set|Overall Study||33
9767636|NCT00422461|10872313|FG000|COMPLETED|Overall Study||32
9767637|NCT00422461|10872314|FG001|COMPLETED|Overall Study||32
9767638|NCT00422461|10872315|FG002|COMPLETED|Overall Study||31
9767639|NCT00422461|10872316|FG003|COMPLETED|Overall Study||30
9767640|NCT00422461|10872313|FG000|NOT COMPLETED|Overall Study||3
9767641|NCT00422461|10872314|FG001|NOT COMPLETED|Overall Study||3
9767642|NCT00422461|10872315|FG002|NOT COMPLETED|Overall Study||1
9767643|NCT00422461|10872316|FG003|NOT COMPLETED|Overall Study||3
9767644|NCT00422513|10872328|FG000|STARTED|Overall Study||130
9767645|NCT00422513|10872329|FG001|STARTED|Overall Study||130
9767646|NCT00422513|10872328|FG000|COMPLETED|Overall Study||23
9767647|NCT00422513|10872329|FG001|COMPLETED|Overall Study||24
9767648|NCT00422513|10872328|FG000|NOT COMPLETED|Overall Study||107
9767649|NCT00422513|10872329|FG001|NOT COMPLETED|Overall Study||106
9767650|NCT00422591|10872335|FG000|STARTED|Overall Study||175
9767651|NCT00422591|10872335|FG000|COMPLETED|Overall Study||169
10232330|NCT02263365|11361574|FG000|NOT COMPLETED|Overall Study||22
10232331|NCT02263365|11361575|FG001|NOT COMPLETED|Overall Study||18
10232332|NCT02266797|11361584|FG000|STARTED|Overall Study||1
10232333|NCT02266797|11361585|FG001|STARTED|Overall Study||3
10232334|NCT02266797|11361584|FG000|COMPLETED|Overall Study||1
10232335|NCT02266797|11361585|FG001|COMPLETED|Overall Study||2
10232336|NCT02266797|11361584|FG000|NOT COMPLETED|Overall Study||0
10232337|NCT02266797|11361585|FG001|NOT COMPLETED|Overall Study||1
10232338|NCT02249377|11361593|FG000|STARTED|Overall Study||25
10232339|NCT02249377|11361594|FG001|STARTED|Overall Study||25
10232340|NCT02249377|11361593|FG000|COMPLETED|Overall Study||0
10232341|NCT02249377|11361594|FG001|COMPLETED|Overall Study||1
10232342|NCT02249377|11361593|FG000|NOT COMPLETED|Overall Study||25
10232343|NCT02249377|11361594|FG001|NOT COMPLETED|Overall Study||24
10232344|NCT02253394|11361600|FG000|STARTED|Overall Study||0
10232345|NCT02253394|11361601|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
10232346|NCT02253394|11361600|FG000|COMPLETED|Overall Study||0
10232347|NCT02253394|11361601|FG001|COMPLETED|Overall Study||2
10232348|NCT02253394|11361600|FG000|NOT COMPLETED|Overall Study||0
10232349|NCT02253394|11361601|FG001|NOT COMPLETED|Overall Study||0
10232350|NCT02241551|11361609|FG000|STARTED|Overall Study||1
10232351|NCT02241551|11361610|FG001|STARTED|Overall Study||0
10232352|NCT02241551|11361609|FG000|COMPLETED|Overall Study||0
10232353|NCT02241551|11361610|FG001|COMPLETED|Overall Study||0
10232354|NCT02241551|11361609|FG000|NOT COMPLETED|Overall Study||1
10232355|NCT02241551|11361610|FG001|NOT COMPLETED|Overall Study||0
10232356|NCT02246114|11361620|FG000|STARTED|Overall Study||1
10232357|NCT02246114|11361621|FG001|STARTED|Overall Study||0
10232358|NCT02246114|11361620|FG000|COMPLETED|Overall Study||0
10232359|NCT02246114|11361621|FG001|COMPLETED|Overall Study||0
10232360|NCT02246114|11361620|FG000|NOT COMPLETED|Overall Study||1
10232361|NCT02246114|11361621|FG001|NOT COMPLETED|Overall Study||0
10232362|NCT02232880|11361627|FG000|STARTED|Overall Study||1
10232363|NCT02232880|11361627|FG000|COMPLETED|Overall Study||0
10232364|NCT02232880|11361627|FG000|NOT COMPLETED|Overall Study||1
10232365|NCT02248740|11361633|FG000|STARTED|Overall Study||18
10232366|NCT02248740|11361634|FG001|STARTED|Overall Study||18
10232367|NCT02248740|11361633|FG000|COMPLETED|Overall Study||0
10232368|NCT02248740|11361634|FG001|COMPLETED|Overall Study||0
10232369|NCT02248740|11361633|FG000|NOT COMPLETED|Overall Study||18
10232370|NCT02248740|11361634|FG001|NOT COMPLETED|Overall Study||18
10232371|NCT02239627|11361642|FG000|STARTED|Overall Study||0
10232372|NCT02239627|11361643|FG001|STARTED|Overall Study||0
10232373|NCT02239627|11361642|FG000|COMPLETED|Overall Study||0
10232374|NCT02239627|11361643|FG001|COMPLETED|Overall Study||0
9767652|NCT00422591|10872335|FG000|NOT COMPLETED|Overall Study||6
9767653|NCT00422656|10872339|FG000|STARTED|Overall Study||37
9767654|NCT00422656|10872339|FG000|COMPLETED|Overall Study||37
9767655|NCT00422656|10872339|FG000|NOT COMPLETED|Overall Study||0
9767656|NCT00422695|10872345|FG000|STARTED|Overall Study||105
10232375|NCT02239627|11361642|FG000|NOT COMPLETED|Overall Study||0
10232376|NCT02239627|11361643|FG001|NOT COMPLETED|Overall Study||0
10232377|NCT02244944|11361649|FG000|STARTED|Overall Study||2
10232378|NCT02244944|11361649|FG000|COMPLETED|Overall Study||0
10232379|NCT02244944|11361649|FG000|NOT COMPLETED|Overall Study||2
10232380|NCT02241187|11361653|FG000|STARTED|Overall Study||2
10232381|NCT02241187|11361653|FG000|COMPLETED|Overall Study||0
10232382|NCT02241187|11361653|FG000|NOT COMPLETED|Overall Study||2
10232383|NCT02239926|11361659|FG000|STARTED|Overall Study||0
9767657|NCT00422695|10872346|FG001|STARTED|Overall Study||38
9767658|NCT00422695|10872345|FG000|COMPLETED|Overall Study||105
9767659|NCT00422695|10872346|FG001|COMPLETED|Overall Study||38
9767660|NCT00422695|10872345|FG000|NOT COMPLETED|Overall Study||0
9767661|NCT00422695|10872346|FG001|NOT COMPLETED|Overall Study||0
9767662|NCT00422734|10872354|FG000|STARTED|Overall Study||78
9767663|NCT00422734|10872355|FG001|STARTED|Overall Study||264
9767664|NCT00422734|10872354|FG000|COMPLETED|Overall Study||64
9767665|NCT00422734|10872355|FG001|COMPLETED|Overall Study||243
9767666|NCT00422734|10872354|FG000|NOT COMPLETED|Overall Study||14
9767667|NCT00422734|10872355|FG001|NOT COMPLETED|Overall Study||21
9767668|NCT00422799|10872361|FG000|STARTED|Overall Study||63
9767669|NCT00422799|10872361|FG000|COMPLETED|Overall Study||50
9767670|NCT00422799|10872361|FG000|NOT COMPLETED|Overall Study||13
9767671|NCT00422812|10872369|FG000|STARTED|Overall Study||98
9767672|NCT00422812|10872370|FG001|STARTED|Overall Study||104
9767673|NCT00422812|10872371|FG002|STARTED|Overall Study||93
9767674|NCT00422812|10872372|FG003|STARTED|Overall Study||105
9767675|NCT00422812|10872369|FG000|COMPLETED|Overall Study||98
9767676|NCT00422812|10872370|FG001|COMPLETED|Overall Study||103
9767677|NCT00422812|10872371|FG002|COMPLETED|Overall Study||91
9767678|NCT00422812|10872372|FG003|COMPLETED|Overall Study||103
9767679|NCT00422812|10872369|FG000|NOT COMPLETED|Overall Study||0
9767680|NCT00422812|10872370|FG001|NOT COMPLETED|Overall Study||1
9767681|NCT00422812|10872371|FG002|NOT COMPLETED|Overall Study||2
9767682|NCT00422812|10872372|FG003|NOT COMPLETED|Overall Study||2
9767683|NCT00422903|10872384|FG000|STARTED|Overall Study||49
9767684|NCT00422903|10872385|FG001|STARTED|Overall Study||43
9767685|NCT00422903|10872384|FG000|COMPLETED|Overall Study||45
9767686|NCT00422903|10872385|FG001|COMPLETED|Overall Study||38
9767687|NCT00422903|10872384|FG000|NOT COMPLETED|Overall Study||4
9767688|NCT00422903|10872385|FG001|NOT COMPLETED|Overall Study||5
9767689|NCT00423046|10872393|FG000|STARTED|Overall Study||553
9767690|NCT00423046|10872394|FG001|STARTED|Overall Study||553
9767691|NCT00423046|10872393|FG000|COMPLETED|Overall Study|Completed until Month 60|213
9767692|NCT00423046|10872394|FG001|COMPLETED|Overall Study|Completed until Month 60|208
9767693|NCT00423046|10872393|FG000|NOT COMPLETED|Overall Study||340
9767694|NCT00423046|10872394|FG001|NOT COMPLETED|Overall Study||345
9767695|NCT00423085|10872405|FG000|STARTED|24-Week Double-Blind Treatment Phase||288
9767696|NCT00423085|10872406|FG001|STARTED|24-Week Double-Blind Treatment Phase||284
9767697|NCT00423085|10872407|FG002|STARTED|24-Week Double-Blind Treatment Phase||287
9767698|NCT00423085|10872408|FG003|STARTED|24-Week Double-Blind Treatment Phase||0
9767699|NCT00423085|10872405|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242
9767700|NCT00423085|10872406|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220
9767701|NCT00423085|10872407|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228
9767702|NCT00423085|10872408|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0
9767703|NCT00423085|10872405|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
9767704|NCT00423085|10872406|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
9767705|NCT00423085|10872407|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
9767706|NCT00423085|10872408|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
9767707|NCT00423085|10872405|FG000|STARTED|52-Week Open-Label Extension Phase||0
9767708|NCT00423085|10872406|FG001|STARTED|52-Week Open-Label Extension Phase||0
9767709|NCT00423085|10872407|FG002|STARTED|52-Week Open-Label Extension Phase||0
9767710|NCT00423085|10872408|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
9767711|NCT00423085|10872405|FG000|COMPLETED|52-Week Open-Label Extension Phase||0
9767712|NCT00423085|10872406|FG001|COMPLETED|52-Week Open-Label Extension Phase||0
9767713|NCT00423085|10872407|FG002|COMPLETED|52-Week Open-Label Extension Phase||0
9767714|NCT00423085|10872408|FG003|COMPLETED|52-Week Open-Label Extension Phase||474
9767715|NCT00423085|10872405|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0
9767716|NCT00423085|10872406|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0
9767717|NCT00423085|10872407|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0
9767718|NCT00423085|10872408|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163
9767719|NCT00423098|10872420|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
9767720|NCT00423098|10872421|FG001|STARTED|Overall Study||39
9767721|NCT00423098|10872420|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
9767722|NCT00423098|10872421|FG001|COMPLETED|Overall Study||35
9767723|NCT00423098|10872420|FG000|NOT COMPLETED|Overall Study||3
9767724|NCT00423098|10872421|FG001|NOT COMPLETED|Overall Study||4
9767725|NCT00423137|10872431|FG000|STARTED|Overall Study||11
9767726|NCT00423137|10872432|FG001|STARTED|Overall Study||12
9767727|NCT00423137|10872433|FG002|STARTED|Overall Study||13
9767728|NCT00423137|10872434|FG003|STARTED|Overall Study||12
9767729|NCT00423137|10872431|FG000|COMPLETED|Overall Study||10
9767730|NCT00423137|10872432|FG001|COMPLETED|Overall Study||12
9767731|NCT00423137|10872433|FG002|COMPLETED|Overall Study||7
9767732|NCT00423137|10872434|FG003|COMPLETED|Overall Study||10
9767733|NCT00423137|10872431|FG000|NOT COMPLETED|Overall Study||1
9767734|NCT00423137|10872432|FG001|NOT COMPLETED|Overall Study||0
9767735|NCT00423137|10872433|FG002|NOT COMPLETED|Overall Study||6
9767736|NCT00423137|10872434|FG003|NOT COMPLETED|Overall Study||2
9767737|NCT00423150|10872447|FG000|STARTED|Overall Study||86
9767738|NCT00423150|10872447|FG000|COMPLETED|Overall Study||0
9767739|NCT00423150|10872447|FG000|NOT COMPLETED|Overall Study||86
9767740|NCT00423189|10872454|FG000|STARTED|Overall Study||2
9767741|NCT00423189|10872455|FG001|STARTED|Overall Study||3
9767742|NCT00423189|10872456|FG002|STARTED|Overall Study||2
9767743|NCT00423189|10872454|FG000|COMPLETED|Overall Study||2
9767744|NCT00423189|10872455|FG001|COMPLETED|Overall Study||2
9767745|NCT00423189|10872456|FG002|COMPLETED|Overall Study||2
9767746|NCT00423189|10872454|FG000|NOT COMPLETED|Overall Study||0
9767747|NCT00423189|10872455|FG001|NOT COMPLETED|Overall Study||1
9767748|NCT00423189|10872456|FG002|NOT COMPLETED|Overall Study||0
9767749|NCT00423267|10872471|FG000|STARTED|Period A||9
9767750|NCT00423267|10872472|FG001|STARTED|Period A||7
9767751|NCT00423267|10872471|FG000|COMPLETED|Period A||7
9767752|NCT00423267|10872472|FG001|COMPLETED|Period A||6
9767753|NCT00423267|10872471|FG000|NOT COMPLETED|Period A||2
9767754|NCT00423267|10872472|FG001|NOT COMPLETED|Period A||1
9767755|NCT00423267|10872471|FG000|STARTED|Period B||12
9767756|NCT00423267|10872472|FG001|STARTED|Period B||0
9767757|NCT00423267|10872471|FG000|COMPLETED|Period B||12
9767758|NCT00423267|10872472|FG001|COMPLETED|Period B||0
9767759|NCT00423267|10872471|FG000|NOT COMPLETED|Period B||0
9767760|NCT00423267|10872472|FG001|NOT COMPLETED|Period B||0
9767761|NCT00423293|10872480|FG000|STARTED|Overall Study||63
9767762|NCT00423293|10872480|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
9767763|NCT00423293|10872480|FG000|NOT COMPLETED|Overall Study||11
9767764|NCT00423319|10872486|FG000|STARTED|Overall Study|Randomized|2708
9767765|NCT00423319|10872487|FG001|STARTED|Overall Study|Randomized|2699
9767766|NCT00423319|10872486|FG000|Participants Who Received Treatment|Overall Study||2673
9767767|NCT00423319|10872487|FG001|Participants Who Received Treatment|Overall Study||2659
9767768|NCT00423319|10872486|FG000|COMPLETED|Overall Study||2484
9767769|NCT00423319|10872487|FG001|COMPLETED|Overall Study||2447
10232384|NCT02239926|11361660|FG001|STARTED|Overall Study||2
10232385|NCT02239926|11361659|FG000|COMPLETED|Overall Study||0
10232386|NCT02239926|11361660|FG001|COMPLETED|Overall Study||1
10232387|NCT02239926|11361659|FG000|NOT COMPLETED|Overall Study||0
10232388|NCT02239926|11361660|FG001|NOT COMPLETED|Overall Study||1
10232389|NCT02231892|11361669|FG000|STARTED|Overall Study||17
10232390|NCT02231892|11361670|FG001|STARTED|Overall Study||17
10232391|NCT02231892|11361671|FG002|STARTED|Overall Study||70
10232392|NCT02231892|11361669|FG000|Sham|Overall Study||8
10232393|NCT02231892|11361670|FG001|Sham|Overall Study||5
10232394|NCT02231892|11361671|FG002|Sham|Overall Study||26
10232395|NCT02231892|11361669|FG000|100% MT|Overall Study||7
10232396|NCT02231892|11361670|FG001|100% MT|Overall Study||6
10232397|NCT02231892|11361671|FG002|100% MT|Overall Study||25
10232398|NCT02231892|11361669|FG000|110% MT|Overall Study||7
10232399|NCT02231892|11361670|FG001|110% MT|Overall Study||5
10232400|NCT02231892|11361671|FG002|110% MT|Overall Study||27
10232401|NCT02231892|11361669|FG000|COMPLETED|Overall Study||6
10232402|NCT02231892|11361670|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
10232403|NCT02231892|11361671|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
10232404|NCT02231892|11361669|FG000|NOT COMPLETED|Overall Study||11
10232405|NCT02231892|11361670|FG001|NOT COMPLETED|Overall Study||12
10232406|NCT02231892|11361671|FG002|NOT COMPLETED|Overall Study||45
10232407|NCT02241343|11361685|FG000|STARTED|Overall Study||1
10232408|NCT02241343|11361685|FG000|COMPLETED|Overall Study||0
10232409|NCT02241343|11361685|FG000|NOT COMPLETED|Overall Study||1
10232410|NCT02242578|11361692|FG000|STARTED|Overall Study||0
10232411|NCT02242578|11361693|FG001|STARTED|Overall Study||0
10232412|NCT02242578|11361692|FG000|COMPLETED|Overall Study||0
10232413|NCT02242578|11361693|FG001|COMPLETED|Overall Study||0
10232414|NCT02242578|11361692|FG000|NOT COMPLETED|Overall Study||0
10232415|NCT02242578|11361693|FG001|NOT COMPLETED|Overall Study||0
10232416|NCT02234011|11361699|FG000|STARTED|Overall Study||0
10232417|NCT02234011|11361699|FG000|COMPLETED|Overall Study||0
10232418|NCT02234011|11361699|FG000|NOT COMPLETED|Overall Study||0
10232419|NCT02236546|11361703|FG000|STARTED|Overall Study||3
10232420|NCT02236546|11361703|FG000|COMPLETED|Overall Study||3
10232421|NCT02236546|11361703|FG000|NOT COMPLETED|Overall Study||0
10232422|NCT02234687|11361710|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
10232423|NCT02234687|11361711|FG001|STARTED|Overall Study||4
10232424|NCT02234687|11361712|FG002|STARTED|Overall Study||4
10232425|NCT02234687|11361710|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
10232426|NCT02234687|11361711|FG001|COMPLETED|Overall Study||0
9767770|NCT00423319|10872486|FG000|NOT COMPLETED|Overall Study||224
9767771|NCT00423319|10872487|FG001|NOT COMPLETED|Overall Study||252
9767772|NCT00423332|10872496|FG000|STARTED|Overall Study|Randomised|53
9767773|NCT00423332|10872497|FG001|STARTED|Overall Study|Number randomised|18
10232427|NCT02234687|11361712|FG002|COMPLETED|Overall Study||0
9767774|NCT00423332|10872496|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
9767775|NCT00423332|10872497|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
10232428|NCT02234687|11361710|FG000|NOT COMPLETED|Overall Study||6
10232429|NCT02234687|11361711|FG001|NOT COMPLETED|Overall Study||4
10232430|NCT02234687|11361712|FG002|NOT COMPLETED|Overall Study||4
10232431|NCT02224599|11361720|FG000|STARTED|Overall Study||3
10232432|NCT02224599|11361720|FG000|COMPLETED|Overall Study||1
10232433|NCT02224599|11361720|FG000|NOT COMPLETED|Overall Study||2
10232434|NCT02201472|11361724|FG000|STARTED|Overall Study||2
10232435|NCT02201472|11361724|FG000|COMPLETED|Overall Study||0
9767776|NCT00423332|10872496|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
9767777|NCT00423332|10872497|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
9767778|NCT00423332|10872496|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
9767779|NCT00423332|10872497|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
9767780|NCT00423332|10872496|FG000|NOT COMPLETED|Overall Study||9
9767781|NCT00423332|10872497|FG001|NOT COMPLETED|Overall Study||7
9767782|NCT00423358|10872506|FG000|STARTED|Overall Study||11
9767783|NCT00423358|10872507|FG001|STARTED|Overall Study||11
9767784|NCT00423358|10872506|FG000|COMPLETED|Overall Study||11
9767785|NCT00423358|10872507|FG001|COMPLETED|Overall Study||11
9767786|NCT00423358|10872506|FG000|NOT COMPLETED|Overall Study||0
9767787|NCT00423358|10872507|FG001|NOT COMPLETED|Overall Study||0
9767788|NCT00423436|10872515|FG000|STARTED|Overall Study||35
9767789|NCT00423436|10872516|FG001|STARTED|Overall Study||33
9767790|NCT00423436|10872515|FG000|COMPLETED|Overall Study||35
9767791|NCT00423436|10872516|FG001|COMPLETED|Overall Study||33
9767792|NCT00423436|10872515|FG000|NOT COMPLETED|Overall Study||0
9767793|NCT00423436|10872516|FG001|NOT COMPLETED|Overall Study||0
9767794|NCT00423449|10872522|FG000|STARTED|Overall Study||4
9767795|NCT00423449|10872523|FG001|STARTED|Overall Study||6
9767796|NCT00423449|10872524|FG002|STARTED|Overall Study||17
9767797|NCT00423449|10872525|FG003|STARTED|Overall Study||27
9767798|NCT00423449|10872526|FG004|STARTED|Overall Study||7
9767799|NCT00423449|10872522|FG000|COMPLETED|Overall Study||1
9767800|NCT00423449|10872523|FG001|COMPLETED|Overall Study||2
9767801|NCT00423449|10872524|FG002|COMPLETED|Overall Study||2
9767802|NCT00423449|10872525|FG003|COMPLETED|Overall Study||5
9767803|NCT00423449|10872526|FG004|COMPLETED|Overall Study||0
9767804|NCT00423449|10872522|FG000|NOT COMPLETED|Overall Study||3
9767805|NCT00423449|10872523|FG001|NOT COMPLETED|Overall Study||4
9767806|NCT00423449|10872524|FG002|NOT COMPLETED|Overall Study||15
9767807|NCT00423449|10872525|FG003|NOT COMPLETED|Overall Study||22
9767808|NCT00423449|10872526|FG004|NOT COMPLETED|Overall Study||7
9767809|NCT00423592|10872539|FG000|STARTED|Overall Study|Enrolled|36
9767810|NCT00423592|10872539|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
9767811|NCT00423592|10872539|FG000|COMPLETED|Overall Study|Completed study|29
9767812|NCT00423592|10872539|FG000|NOT COMPLETED|Overall Study||7
9767813|NCT00423605|10872543|FG000|STARTED|Overall Study||560
9767814|NCT00423605|10872543|FG000|COMPLETED|Overall Study||319
9767815|NCT00423605|10872543|FG000|NOT COMPLETED|Overall Study||241
9767816|NCT00423657|10872549|FG000|STARTED|Overall Study||342
9767817|NCT00423657|10872550|FG001|STARTED|Overall Study||338
9767818|NCT00423657|10872549|FG000|COMPLETED|Overall Study||316
9767819|NCT00423657|10872550|FG001|COMPLETED|Overall Study||313
9767820|NCT00423657|10872549|FG000|NOT COMPLETED|Overall Study||26
9767821|NCT00423657|10872550|FG001|NOT COMPLETED|Overall Study||25
10232436|NCT02201472|11361724|FG000|NOT COMPLETED|Overall Study||2
10232437|NCT02202044|11361728|FG000|STARTED|Overall Study||0
10232438|NCT02202044|11361728|FG000|COMPLETED|Overall Study||0
10232439|NCT02202044|11361728|FG000|NOT COMPLETED|Overall Study||0
10232440|NCT02192775|11361732|FG000|STARTED|Overall Study||2
10232441|NCT02192775|11361732|FG000|COMPLETED|Overall Study||0
10232442|NCT02192775|11361732|FG000|NOT COMPLETED|Overall Study||2
10232443|NCT02200328|11361738|FG000|STARTED|Overall Study||43
10232444|NCT02200328|11361739|FG001|STARTED|Overall Study||33
10232445|NCT02200328|11361738|FG000|COMPLETED|Overall Study||0
10232446|NCT02200328|11361739|FG001|COMPLETED|Overall Study||0
10232447|NCT02200328|11361738|FG000|NOT COMPLETED|Overall Study||43
10232448|NCT02200328|11361739|FG001|NOT COMPLETED|Overall Study||33
10232449|NCT02200042|11361747|FG000|STARTED|Overall Study||0
10232450|NCT02200042|11361748|FG001|STARTED|Overall Study||1
10232451|NCT02200042|11361747|FG000|COMPLETED|Overall Study||0
10232452|NCT02200042|11361748|FG001|COMPLETED|Overall Study||0
10232453|NCT02200042|11361747|FG000|NOT COMPLETED|Overall Study||0
10232454|NCT02200042|11361748|FG001|NOT COMPLETED|Overall Study||1
10232455|NCT02181790|11361756|FG000|STARTED|Overall Study||2
10232456|NCT02181790|11361757|FG001|STARTED|Overall Study||0
10232457|NCT02181790|11361756|FG000|COMPLETED|Overall Study||0
10232458|NCT02181790|11361757|FG001|COMPLETED|Overall Study||0
10232459|NCT02181790|11361756|FG000|NOT COMPLETED|Overall Study||2
10232460|NCT02181790|11361757|FG001|NOT COMPLETED|Overall Study||0
10232461|NCT02198833|11361767|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
10232462|NCT02198833|11361768|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
10232463|NCT02198833|11361767|FG000|COMPLETED|Overall Study||1
10232464|NCT02198833|11361768|FG001|COMPLETED|Overall Study||1
10232465|NCT02198833|11361767|FG000|NOT COMPLETED|Overall Study||0
10232466|NCT02198833|11361768|FG001|NOT COMPLETED|Overall Study||0
9767822|NCT00423670|10872563|FG000|STARTED|Treatment Period||104
9767823|NCT00423670|10872564|FG001|STARTED|Treatment Period||107
9767824|NCT00423670|10872565|FG002|STARTED|Treatment Period||103
9767825|NCT00423670|10872566|FG003|STARTED|Treatment Period||103
10232467|NCT02175628|11361776|FG000|STARTED|Overall Study||6
10232468|NCT02175628|11361777|FG001|STARTED|Overall Study||17
10232469|NCT02175628|11361776|FG000|COMPLETED|Overall Study||6
10232470|NCT02175628|11361777|FG001|COMPLETED|Overall Study||17
10232471|NCT02175628|11361776|FG000|NOT COMPLETED|Overall Study||0
10232472|NCT02175628|11361777|FG001|NOT COMPLETED|Overall Study||0
9767826|NCT00423670|10872567|FG004|STARTED|Treatment Period||103
9767827|NCT00423670|10872568|FG005|STARTED|Treatment Period||16
9767828|NCT00423670|10872569|FG006|STARTED|Treatment Period||59
9767829|NCT00423670|10872570|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
9767830|NCT00423670|10872563|FG000|COMPLETED|Treatment Period||52
9767831|NCT00423670|10872564|FG001|COMPLETED|Treatment Period||77
9767832|NCT00423670|10872565|FG002|COMPLETED|Treatment Period||76
9767833|NCT00423670|10872566|FG003|COMPLETED|Treatment Period||63
9767834|NCT00423670|10872567|FG004|COMPLETED|Treatment Period||76
9767835|NCT00423670|10872568|FG005|COMPLETED|Treatment Period||8
9767836|NCT00423670|10872569|FG006|COMPLETED|Treatment Period||28
9767837|NCT00423670|10872570|FG007|COMPLETED|Treatment Period||15
9767838|NCT00423670|10872563|FG000|NOT COMPLETED|Treatment Period||52
9767839|NCT00423670|10872564|FG001|NOT COMPLETED|Treatment Period||30
9767840|NCT00423670|10872565|FG002|NOT COMPLETED|Treatment Period||27
9767841|NCT00423670|10872566|FG003|NOT COMPLETED|Treatment Period||40
9767842|NCT00423670|10872567|FG004|NOT COMPLETED|Treatment Period||27
9767843|NCT00423670|10872568|FG005|NOT COMPLETED|Treatment Period||8
9767844|NCT00423670|10872569|FG006|NOT COMPLETED|Treatment Period||31
9767845|NCT00423670|10872570|FG007|NOT COMPLETED|Treatment Period||21
9767846|NCT00423670|10872563|FG000|STARTED|Follow-up Period||97
9767847|NCT00423670|10872564|FG001|STARTED|Follow-up Period||100
9767848|NCT00423670|10872565|FG002|STARTED|Follow-up Period||96
9767849|NCT00423670|10872566|FG003|STARTED|Follow-up Period||96
9767850|NCT00423670|10872567|FG004|STARTED|Follow-up Period||91
9767851|NCT00423670|10872568|FG005|STARTED|Follow-up Period||14
9767852|NCT00423670|10872569|FG006|STARTED|Follow-up Period||50
9767853|NCT00423670|10872570|FG007|STARTED|Follow-up Period||35
9767854|NCT00423670|10872563|FG000|COMPLETED|Follow-up Period||94
9767855|NCT00423670|10872564|FG001|COMPLETED|Follow-up Period||84
9767856|NCT00423670|10872565|FG002|COMPLETED|Follow-up Period||85
9767857|NCT00423670|10872566|FG003|COMPLETED|Follow-up Period||91
9767858|NCT00423670|10872567|FG004|COMPLETED|Follow-up Period||89
9767859|NCT00423670|10872568|FG005|COMPLETED|Follow-up Period||14
9767860|NCT00423670|10872569|FG006|COMPLETED|Follow-up Period||41
9767861|NCT00423670|10872570|FG007|COMPLETED|Follow-up Period||32
9767862|NCT00423670|10872563|FG000|NOT COMPLETED|Follow-up Period||3
9767863|NCT00423670|10872564|FG001|NOT COMPLETED|Follow-up Period||16
9767864|NCT00423670|10872565|FG002|NOT COMPLETED|Follow-up Period||11
9767865|NCT00423670|10872566|FG003|NOT COMPLETED|Follow-up Period||5
9767866|NCT00423670|10872567|FG004|NOT COMPLETED|Follow-up Period||2
9767867|NCT00423670|10872568|FG005|NOT COMPLETED|Follow-up Period||0
9767868|NCT00423670|10872569|FG006|NOT COMPLETED|Follow-up Period||9
9767869|NCT00423670|10872570|FG007|NOT COMPLETED|Follow-up Period||3
9767870|NCT00423683|10872593|FG000|STARTED|Overall Study||31
9767871|NCT00423683|10872594|FG001|STARTED|Overall Study||33
9767872|NCT00423683|10872593|FG000|COMPLETED|Overall Study||30
9767873|NCT00423683|10872594|FG001|COMPLETED|Overall Study||33
9767874|NCT00423683|10872593|FG000|NOT COMPLETED|Overall Study||1
9767875|NCT00423683|10872594|FG001|NOT COMPLETED|Overall Study||0
9767876|NCT00423722|10872604|FG000|STARTED|Overall Study||63
9767877|NCT00423722|10872605|FG001|STARTED|Overall Study||66
9767878|NCT00423722|10872604|FG000|COMPLETED|Overall Study||49
9767879|NCT00423722|10872605|FG001|COMPLETED|Overall Study||53
9767880|NCT00423722|10872604|FG000|NOT COMPLETED|Overall Study||14
9767881|NCT00423722|10872605|FG001|NOT COMPLETED|Overall Study||13
9767882|NCT00423735|10872620|FG000|STARTED|Overall Study||29
9767883|NCT00423735|10872621|FG001|STARTED|Overall Study||35
10014089|NCT01797445|11137088|FG001|NOT COMPLETED|Open-Label Extension Phase||0
9767884|NCT00423735|10872622|FG002|STARTED|Overall Study||0
9767885|NCT00423735|10872620|FG000|COMPLETED|Overall Study||21
9767886|NCT00423735|10872621|FG001|COMPLETED|Overall Study||29
9767887|NCT00423735|10872622|FG002|COMPLETED|Overall Study||0
9767888|NCT00423735|10872620|FG000|NOT COMPLETED|Overall Study||8
9767889|NCT00423735|10872621|FG001|NOT COMPLETED|Overall Study||6
9767890|NCT00423735|10872622|FG002|NOT COMPLETED|Overall Study||0
9767891|NCT00423800|10872634|FG000|STARTED|Overall Study||3
9767892|NCT00423800|10872635|FG001|STARTED|Overall Study||2
9767893|NCT00423800|10872634|FG000|COMPLETED|Overall Study||3
9767894|NCT00423800|10872635|FG001|COMPLETED|Overall Study||1
9767895|NCT00423800|10872634|FG000|NOT COMPLETED|Overall Study||0
9767896|NCT00423800|10872635|FG001|NOT COMPLETED|Overall Study||1
9767897|NCT00423813|10872645|FG000|STARTED|Overall Study||188
9767898|NCT00423813|10872646|FG001|STARTED|Overall Study||195
9767899|NCT00423813|10872647|FG002|STARTED|Overall Study||190
9767900|NCT00423813|10872645|FG000|Treated|Overall Study||188
10014090|NCT01797458|11137099|FG000|STARTED|Overall Study||52
9767901|NCT00423813|10872646|FG001|Treated|Overall Study||194
9767902|NCT00423813|10872647|FG002|Treated|Overall Study||189
9767903|NCT00423813|10872645|FG000|COMPLETED|Overall Study||131
9767904|NCT00423813|10872646|FG001|COMPLETED|Overall Study||129
9767905|NCT00423813|10872647|FG002|COMPLETED|Overall Study||116
9767906|NCT00423813|10872645|FG000|NOT COMPLETED|Overall Study||57
9767907|NCT00423813|10872646|FG001|NOT COMPLETED|Overall Study||66
9767908|NCT00423813|10872647|FG002|NOT COMPLETED|Overall Study||74
9767909|NCT00423852|10872655|FG000|STARTED|Overall Study||26
9767910|NCT00423852|10872655|FG000|COMPLETED|Overall Study||23
9767911|NCT00423852|10872655|FG000|NOT COMPLETED|Overall Study||3
9767912|NCT00423878|10872661|FG000|STARTED|Overall Study||109
9767913|NCT00423878|10872662|FG001|STARTED|Overall Study||106
10014091|NCT01797458|11137100|FG001|STARTED|Overall Study||52
9767914|NCT00423878|10872661|FG000|COMPLETED|Overall Study||89
9767915|NCT00423878|10872662|FG001|COMPLETED|Overall Study||98
9767916|NCT00423878|10872661|FG000|NOT COMPLETED|Overall Study||20
9767917|NCT00423878|10872662|FG001|NOT COMPLETED|Overall Study||8
9767918|NCT00423891|10872671|FG000|STARTED|Enrolled||35
9767919|NCT00423891|10872672|FG001|STARTED|Enrolled||21
9767920|NCT00423891|10872673|FG002|STARTED|Enrolled||8
9767921|NCT00423891|10872671|FG000|COMPLETED|Enrolled||24
9767922|NCT00423891|10872672|FG001|COMPLETED|Enrolled||19
9767923|NCT00423891|10872673|FG002|COMPLETED|Enrolled||5
9767924|NCT00423891|10872671|FG000|NOT COMPLETED|Enrolled||11
9767925|NCT00423891|10872672|FG001|NOT COMPLETED|Enrolled||2
9767926|NCT00423891|10872673|FG002|NOT COMPLETED|Enrolled||3
9767927|NCT00423891|10872671|FG000|STARTED|Treatment||24
9767928|NCT00423891|10872672|FG001|STARTED|Treatment||19
9767929|NCT00423891|10872673|FG002|STARTED|Treatment||5
9767930|NCT00423891|10872671|FG000|COMPLETED|Treatment||22
9767931|NCT00423891|10872672|FG001|COMPLETED|Treatment||19
9767932|NCT00423891|10872673|FG002|COMPLETED|Treatment||5
9767933|NCT00423891|10872671|FG000|NOT COMPLETED|Treatment||2
9767934|NCT00423891|10872672|FG001|NOT COMPLETED|Treatment||0
9767935|NCT00423891|10872673|FG002|NOT COMPLETED|Treatment||0
9767936|NCT00423891|10872671|FG000|STARTED|Post-Dosing Follow Up||22
9767937|NCT00423891|10872672|FG001|STARTED|Post-Dosing Follow Up||18
9767938|NCT00423891|10872673|FG002|STARTED|Post-Dosing Follow Up||5
9767939|NCT00423891|10872671|FG000|COMPLETED|Post-Dosing Follow Up||20
9767940|NCT00423891|10872672|FG001|COMPLETED|Post-Dosing Follow Up||15
9767941|NCT00423891|10872673|FG002|COMPLETED|Post-Dosing Follow Up||3
9767942|NCT00423891|10872671|FG000|NOT COMPLETED|Post-Dosing Follow Up||2
9767943|NCT00423891|10872672|FG001|NOT COMPLETED|Post-Dosing Follow Up||3
9767944|NCT00423891|10872673|FG002|NOT COMPLETED|Post-Dosing Follow Up||2
9767945|NCT00423917|10872683|FG000|STARTED|Overall Study||36
9767946|NCT00423917|10872683|FG000|COMPLETED|Overall Study||33
9767947|NCT00423917|10872683|FG000|NOT COMPLETED|Overall Study||3
9767948|NCT00423930|10872687|FG000|STARTED|Overall Study||44
9767949|NCT00423930|10872687|FG000|COMPLETED|Overall Study||42
9767950|NCT00423930|10872687|FG000|NOT COMPLETED|Overall Study||2
10232473|NCT02177266|11361785|FG000|STARTED|Overall Study||1
10232474|NCT02177266|11361786|FG001|STARTED|Overall Study||1
10232475|NCT02177266|11361785|FG000|COMPLETED|Overall Study||0
10232476|NCT02177266|11361786|FG001|COMPLETED|Overall Study||0
10232477|NCT02177266|11361785|FG000|NOT COMPLETED|Overall Study||1
10232478|NCT02177266|11361786|FG001|NOT COMPLETED|Overall Study||1
10232479|NCT02184520|11361794|FG000|STARTED|Overall Study||0
10232480|NCT02184520|11361795|FG001|STARTED|Overall Study||0
10232481|NCT02184520|11361794|FG000|COMPLETED|Overall Study||0
10232482|NCT02184520|11361795|FG001|COMPLETED|Overall Study||0
10232483|NCT02184520|11361794|FG000|NOT COMPLETED|Overall Study||0
10232484|NCT02184520|11361795|FG001|NOT COMPLETED|Overall Study||0
10232485|NCT02170298|11361803|FG000|STARTED|Overall Study||1
10232486|NCT02170298|11361804|FG001|STARTED|Overall Study||5
10232487|NCT02170298|11361803|FG000|COMPLETED|Overall Study||0
10232488|NCT02170298|11361804|FG001|COMPLETED|Overall Study||4
10232489|NCT02170298|11361803|FG000|NOT COMPLETED|Overall Study||1
10232490|NCT02170298|11361804|FG001|NOT COMPLETED|Overall Study||1
10232491|NCT02177773|11361810|FG000|STARTED|Overall Study||300
10232492|NCT02177773|11361810|FG000|COMPLETED|Overall Study||300
10232493|NCT02177773|11361810|FG000|NOT COMPLETED|Overall Study||0
10232494|NCT02162979|11361816|FG000|STARTED|Overall Study||0
10232495|NCT02162979|11361817|FG001|STARTED|Overall Study||0
10232496|NCT02162979|11361816|FG000|COMPLETED|Overall Study||0
10232497|NCT02162979|11361817|FG001|COMPLETED|Overall Study||0
10232498|NCT02162979|11361816|FG000|NOT COMPLETED|Overall Study||0
10232499|NCT02162979|11361817|FG001|NOT COMPLETED|Overall Study||0
10232500|NCT02169830|11361826|FG000|STARTED|Diet Intervention (4 Weeks)||0
10232501|NCT02169830|11361827|FG001|STARTED|Diet Intervention (4 Weeks)||0
10232502|NCT02169830|11361828|FG002|STARTED|Diet Intervention (4 Weeks)||33
10232503|NCT02169830|11361826|FG000|COMPLETED|Diet Intervention (4 Weeks)||0
10232504|NCT02169830|11361827|FG001|COMPLETED|Diet Intervention (4 Weeks)||0
10232505|NCT02169830|11361828|FG002|COMPLETED|Diet Intervention (4 Weeks)||32
10232506|NCT02169830|11361826|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0
10232507|NCT02169830|11361827|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0
10232508|NCT02169830|11361828|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1
10232509|NCT02169830|11361826|FG000|STARTED|Second Intervention (8 Weeks)||12
10232510|NCT02169830|11361827|FG001|STARTED|Second Intervention (8 Weeks)||5
9767951|NCT00423943|10872693|FG000|STARTED|Overall Study||19
9767952|NCT00423943|10872694|FG001|STARTED|Overall Study||14
9767953|NCT00423943|10872693|FG000|COMPLETED|Overall Study||16
9767954|NCT00423943|10872694|FG001|COMPLETED|Overall Study||13
9767955|NCT00423943|10872693|FG000|NOT COMPLETED|Overall Study||3
9767956|NCT00423943|10872694|FG001|NOT COMPLETED|Overall Study||1
9767957|NCT00424021|10872704|FG000|STARTED|NCT00046319 Study Period||16
9767958|NCT00424021|10872705|FG001|STARTED|NCT00046319 Study Period||19
9767959|NCT00424021|10872706|FG002|STARTED|NCT00046319 Study Period||16
9767960|NCT00424021|10872707|FG003|STARTED|NCT00046319 Study Period||13
9767961|NCT00424021|10872704|FG000|COMPLETED|NCT00046319 Study Period||15
9767962|NCT00424021|10872705|FG001|COMPLETED|NCT00046319 Study Period||16
9767963|NCT00424021|10872706|FG002|COMPLETED|NCT00046319 Study Period||15
9767964|NCT00424021|10872707|FG003|COMPLETED|NCT00046319 Study Period||12
9767965|NCT00424021|10872704|FG000|NOT COMPLETED|NCT00046319 Study Period||1
10232511|NCT02169830|11361828|FG002|STARTED|Second Intervention (8 Weeks)||0
9767966|NCT00424021|10872705|FG001|NOT COMPLETED|NCT00046319 Study Period||3
9767967|NCT00424021|10872706|FG002|NOT COMPLETED|NCT00046319 Study Period||1
9767968|NCT00424021|10872707|FG003|NOT COMPLETED|NCT00046319 Study Period||1
9767969|NCT00424021|10872704|FG000|STARTED|AMB-220-E Study Period||2
9767970|NCT00424021|10872705|FG001|STARTED|AMB-220-E Study Period||7
9767971|NCT00424021|10872706|FG002|STARTED|AMB-220-E Study Period||19
9767972|NCT00424021|10872707|FG003|STARTED|AMB-220-E Study Period||26
9767973|NCT00424021|10872704|FG000|COMPLETED|AMB-220-E Study Period||1
9767974|NCT00424021|10872705|FG001|COMPLETED|AMB-220-E Study Period||5
9767975|NCT00424021|10872706|FG002|COMPLETED|AMB-220-E Study Period||14
9767976|NCT00424021|10872707|FG003|COMPLETED|AMB-220-E Study Period||16
9767977|NCT00424021|10872704|FG000|NOT COMPLETED|AMB-220-E Study Period||1
9767978|NCT00424021|10872705|FG001|NOT COMPLETED|AMB-220-E Study Period||2
9767979|NCT00424021|10872706|FG002|NOT COMPLETED|AMB-220-E Study Period||5
9767980|NCT00424021|10872707|FG003|NOT COMPLETED|AMB-220-E Study Period||10
9767981|NCT00424047|10872726|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
9767982|NCT00424047|10872727|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
9767983|NCT00424047|10872726|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
9767984|NCT00424047|10872727|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
9767985|NCT00424047|10872726|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
9767986|NCT00424047|10872727|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
9767987|NCT00424047|10872726|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
9767988|NCT00424047|10872727|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
9767989|NCT00424047|10872726|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
9767990|NCT00424047|10872727|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
9767991|NCT00424047|10872726|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
9767992|NCT00424047|10872727|FG001|STARTED|On Study at Time of Unblinding||175
9767993|NCT00424047|10872726|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
9767994|NCT00424047|10872727|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
9767995|NCT00424047|10872726|FG000|NOT COMPLETED|On Study at Time of Unblinding||155
9767996|NCT00424047|10872727|FG001|NOT COMPLETED|On Study at Time of Unblinding||167
9767997|NCT00424047|10872726|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
9767998|NCT00424047|10872727|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
9767999|NCT00424047|10872726|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
9768000|NCT00424047|10872727|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
9768001|NCT00424047|10872726|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
9768002|NCT00424047|10872727|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
9768003|NCT00424177|10872738|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
9768004|NCT00424177|10872738|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
9768005|NCT00424177|10872738|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
9768006|NCT00424177|10872738|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
10232512|NCT02169830|11361826|FG000|COMPLETED|Second Intervention (8 Weeks)||9
10232513|NCT02169830|11361827|FG001|COMPLETED|Second Intervention (8 Weeks)||0
10232514|NCT02169830|11361828|FG002|COMPLETED|Second Intervention (8 Weeks)||0
10232515|NCT02169830|11361826|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3
10232516|NCT02169830|11361827|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5
10232517|NCT02169830|11361828|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0
10232518|NCT02169830|11361826|FG000|STARTED|Third Intervention (8 Weeks)||0
10232519|NCT02169830|11361827|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
10232520|NCT02169830|11361828|FG002|STARTED|Third Intervention (8 Weeks)||0
10232521|NCT02169830|11361826|FG000|COMPLETED|Third Intervention (8 Weeks)||0
10232522|NCT02169830|11361827|FG001|COMPLETED|Third Intervention (8 Weeks)||2
10232523|NCT02169830|11361828|FG002|COMPLETED|Third Intervention (8 Weeks)||0
10232524|NCT02169830|11361826|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0
10232525|NCT02169830|11361827|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2
10232526|NCT02169830|11361828|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0
10232527|NCT02163187|11361838|FG000|STARTED|Overall Study||4
10232528|NCT02163187|11361839|FG001|STARTED|Overall Study||0
10232529|NCT02163187|11361838|FG000|Treatment|Overall Study||2
10232530|NCT02163187|11361839|FG001|Treatment|Overall Study||0
10232531|NCT02163187|11361838|FG000|COMPLETED|Overall Study||2
10232532|NCT02163187|11361839|FG001|COMPLETED|Overall Study||0
10232533|NCT02163187|11361838|FG000|NOT COMPLETED|Overall Study||2
10232534|NCT02163187|11361839|FG001|NOT COMPLETED|Overall Study||0
10232535|NCT02161016|11361845|FG000|STARTED|Overall Study||1
10232536|NCT02161016|11361845|FG000|COMPLETED|Overall Study||0
10232537|NCT02161016|11361845|FG000|NOT COMPLETED|Overall Study||1
10232538|NCT02159040|11361849|FG000|STARTED|Overall Study||1
10232539|NCT02159040|11361849|FG000|COMPLETED|Overall Study||0
10232540|NCT02159040|11361849|FG000|NOT COMPLETED|Overall Study||1
9768007|NCT00424177|10872738|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
9768008|NCT00424177|10872738|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
9768009|NCT00424177|10872738|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
9768010|NCT00424177|10872738|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
9768011|NCT00424177|10872738|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
9768012|NCT00424190|10872752|FG000|STARTED|Overall Study||351
9768013|NCT00424190|10872753|FG001|STARTED|Overall Study||347
9768014|NCT00424190|10872752|FG000|COMPLETED|Overall Study||329
9768015|NCT00424190|10872753|FG001|COMPLETED|Overall Study||317
9768016|NCT00424190|10872752|FG000|NOT COMPLETED|Overall Study||22
9768017|NCT00424190|10872753|FG001|NOT COMPLETED|Overall Study||30
9768018|NCT00424255|10872761|FG000|STARTED|Overall Study||342
9768019|NCT00424255|10872762|FG001|STARTED|Overall Study||346
9768020|NCT00424255|10872761|FG000|COMPLETED|Overall Study||0
9768021|NCT00424255|10872762|FG001|COMPLETED|Overall Study||0
9768022|NCT00424255|10872761|FG000|NOT COMPLETED|Overall Study||342
9768023|NCT00424255|10872762|FG001|NOT COMPLETED|Overall Study||346
9768024|NCT00424268|10872770|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
9768025|NCT00424268|10872771|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
9768026|NCT00424268|10872770|FG000|COMPLETED|Overall Study||309
9768027|NCT00424268|10872771|FG001|COMPLETED|Overall Study||333
9768028|NCT00424268|10872770|FG000|NOT COMPLETED|Overall Study||62
9768029|NCT00424268|10872771|FG001|NOT COMPLETED|Overall Study||39
9768030|NCT00424294|10872779|FG000|STARTED|Overall Study||36
9768031|NCT00424294|10872780|FG001|STARTED|Overall Study||34
9768032|NCT00424294|10872779|FG000|Treated|Overall Study||35
9768033|NCT00424294|10872780|FG001|Treated|Overall Study||34
9768034|NCT00424294|10872779|FG000|COMPLETED|Overall Study||28
9768035|NCT00424294|10872780|FG001|COMPLETED|Overall Study||19
9768036|NCT00424294|10872779|FG000|NOT COMPLETED|Overall Study||8
9768037|NCT00424294|10872780|FG001|NOT COMPLETED|Overall Study||15
9768038|NCT00424346|10872790|FG000|STARTED|Core Study||71
9768039|NCT00424346|10872791|FG001|STARTED|Core Study||64
9768040|NCT00424346|10872792|FG002|STARTED|Core Study||69
9768041|NCT00424346|10872793|FG003|STARTED|Core Study||70
9768042|NCT00424346|10872790|FG000|COMPLETED|Core Study||62
9768043|NCT00424346|10872791|FG001|COMPLETED|Core Study||56
9768044|NCT00424346|10872792|FG002|COMPLETED|Core Study||65
9768045|NCT00424346|10872793|FG003|COMPLETED|Core Study||63
9768046|NCT00424346|10872790|FG000|NOT COMPLETED|Core Study||9
9768047|NCT00424346|10872791|FG001|NOT COMPLETED|Core Study||8
9768048|NCT00424346|10872792|FG002|NOT COMPLETED|Core Study||4
9768049|NCT00424346|10872793|FG003|NOT COMPLETED|Core Study||7
9768050|NCT00424346|10872790|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
9768051|NCT00424346|10872791|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
9768052|NCT00424346|10872792|FG002|STARTED|Extension Phase||59
9768053|NCT00424346|10872793|FG003|STARTED|Extension Phase||58
9768054|NCT00424346|10872790|FG000|COMPLETED|Extension Phase||0
9768055|NCT00424346|10872791|FG001|COMPLETED|Extension Phase||8
9768056|NCT00424346|10872792|FG002|COMPLETED|Extension Phase||4
10232541|NCT02168270|11361853|FG000|STARTED|Overall Study||4
10232542|NCT02168270|11361853|FG000|COMPLETED|Overall Study||0
10232543|NCT02168270|11361853|FG000|NOT COMPLETED|Overall Study||4
10232544|NCT02157116|11361857|FG000|STARTED|Overall Study|signed consent form|13
10232545|NCT02157116|11361857|FG000|COMPLETED|Overall Study||4
10232546|NCT02157116|11361857|FG000|NOT COMPLETED|Overall Study||9
10232547|NCT02154087|11361861|FG000|STARTED|Overall Study||1
10232548|NCT02154087|11361861|FG000|COMPLETED|Overall Study||0
10232549|NCT02154087|11361861|FG000|NOT COMPLETED|Overall Study||1
10232550|NCT02152670|11361865|FG000|STARTED|Overall Study||1
10232551|NCT02152670|11361865|FG000|COMPLETED|Overall Study||1
10232552|NCT02152670|11361865|FG000|NOT COMPLETED|Overall Study||0
10232553|NCT02152566|11361869|FG000|STARTED|Overall Study||6
10232554|NCT02152566|11361869|FG000|COMPLETED|Overall Study||3
10232555|NCT02152566|11361869|FG000|NOT COMPLETED|Overall Study||3
10232556|NCT02137096|11361873|FG000|STARTED|Overall Study||1
10232557|NCT02137096|11361873|FG000|COMPLETED|Overall Study||1
10232558|NCT02137096|11361873|FG000|NOT COMPLETED|Overall Study||0
10232559|NCT02147834|11361879|FG000|STARTED|Overall Study||3
10232560|NCT02147834|11361880|FG001|STARTED|Overall Study||2
10232561|NCT02147834|11361879|FG000|COMPLETED|Overall Study||3
10232562|NCT02147834|11361880|FG001|COMPLETED|Overall Study||2
10232563|NCT02147834|11361879|FG000|NOT COMPLETED|Overall Study||0
10232564|NCT02147834|11361880|FG001|NOT COMPLETED|Overall Study||0
10232565|NCT02145390|11361886|FG000|STARTED|Overall Study||1
10232566|NCT02145390|11361886|FG000|COMPLETED|Overall Study||0
10232567|NCT02145390|11361886|FG000|NOT COMPLETED|Overall Study||1
10232568|NCT02132884|11361892|FG000|STARTED|Overall Study||0
9768057|NCT00424346|10872793|FG003|COMPLETED|Extension Phase||3
10232569|NCT02132884|11361893|FG001|STARTED|Overall Study||0
9768058|NCT00424346|10872790|FG000|NOT COMPLETED|Extension Phase||0
9768059|NCT00424346|10872791|FG001|NOT COMPLETED|Extension Phase||102
9768060|NCT00424346|10872792|FG002|NOT COMPLETED|Extension Phase||55
10232570|NCT02132884|11361892|FG000|COMPLETED|Overall Study||0
10232571|NCT02132884|11361893|FG001|COMPLETED|Overall Study||0
10232572|NCT02132884|11361892|FG000|NOT COMPLETED|Overall Study||0
10232573|NCT02132884|11361893|FG001|NOT COMPLETED|Overall Study||0
10232574|NCT02144155|11361899|FG000|STARTED|Overall Study||14
10232575|NCT02144155|11361899|FG000|COMPLETED|Overall Study||14
9768061|NCT00424346|10872793|FG003|NOT COMPLETED|Extension Phase||55
9768062|NCT00424372|10872806|FG000|STARTED|Overall Study||126
9768063|NCT00424372|10872806|FG000|COMPLETED|Overall Study||95
9768064|NCT00424372|10872806|FG000|NOT COMPLETED|Overall Study||31
9768065|NCT00424385|10872810|FG000|STARTED|Cohort 0||12
9768066|NCT00424385|10872810|FG000|COMPLETED|Cohort 0||6
9768067|NCT00424385|10872810|FG000|NOT COMPLETED|Cohort 0||6
9768068|NCT00424385|10872810|FG000|STARTED|Cohort 1||5
9768069|NCT00424385|10872810|FG000|COMPLETED|Cohort 1||4
9768070|NCT00424385|10872810|FG000|NOT COMPLETED|Cohort 1||1
9768071|NCT00424398|10872819|FG000|STARTED|Overall Study||35
9768072|NCT00424398|10872820|FG001|STARTED|Overall Study||36
9768073|NCT00424398|10872821|FG002|STARTED|Overall Study||36
9768074|NCT00424398|10872819|FG000|COMPLETED|Overall Study||32
9768075|NCT00424398|10872820|FG001|COMPLETED|Overall Study||35
9768076|NCT00424398|10872821|FG002|COMPLETED|Overall Study||36
9768077|NCT00424398|10872819|FG000|NOT COMPLETED|Overall Study||3
9768078|NCT00424398|10872820|FG001|NOT COMPLETED|Overall Study||1
9768079|NCT00424398|10872821|FG002|NOT COMPLETED|Overall Study||0
9768080|NCT00424463|10872832|FG000|STARTED|Overall Study||45
9768081|NCT00424463|10872833|FG001|STARTED|Overall Study||48
9768082|NCT00424463|10872834|FG002|STARTED|Overall Study||88
9768083|NCT00424463|10872832|FG000|COMPLETED|Overall Study||38
9768084|NCT00424463|10872833|FG001|COMPLETED|Overall Study||34
9768085|NCT00424463|10872834|FG002|COMPLETED|Overall Study||72
9768086|NCT00424463|10872832|FG000|NOT COMPLETED|Overall Study||7
9768087|NCT00424463|10872833|FG001|NOT COMPLETED|Overall Study||14
9768088|NCT00424463|10872834|FG002|NOT COMPLETED|Overall Study||16
9768089|NCT00424476|10872845|FG000|STARTED|Overall Study||287
9768090|NCT00424476|10872846|FG001|STARTED|Overall Study||288
9768091|NCT00424476|10872847|FG002|STARTED|Overall Study||290
9768092|NCT00424476|10872845|FG000|COMPLETED|Overall Study||226
9768093|NCT00424476|10872846|FG001|COMPLETED|Overall Study||240
9768094|NCT00424476|10872847|FG002|COMPLETED|Overall Study||241
9768095|NCT00424476|10872845|FG000|NOT COMPLETED|Overall Study||61
9768096|NCT00424476|10872846|FG001|NOT COMPLETED|Overall Study||48
9768097|NCT00424476|10872847|FG002|NOT COMPLETED|Overall Study||49
9768098|NCT00424489|10872855|FG000|STARTED|Overall Study||9
9768099|NCT00424489|10872855|FG000|COMPLETED|Overall Study||6
9768100|NCT00424489|10872855|FG000|NOT COMPLETED|Overall Study||3
9768101|NCT00424502|10872859|FG000|STARTED|Overall Study||20
9768102|NCT00424502|10872859|FG000|COMPLETED|Overall Study||20
9768103|NCT00424502|10872859|FG000|NOT COMPLETED|Overall Study||0
9768104|NCT00424515|10872865|FG000|STARTED|Overall Study||11
9768105|NCT00424515|10872866|FG001|STARTED|Overall Study||13
9768106|NCT00424515|10872865|FG000|COMPLETED|Overall Study||0
9768107|NCT00424515|10872866|FG001|COMPLETED|Overall Study||0
9768108|NCT00424515|10872865|FG000|NOT COMPLETED|Overall Study||11
9768109|NCT00424515|10872866|FG001|NOT COMPLETED|Overall Study||13
9768110|NCT00424528|10872875|FG000|STARTED|Overall Study||76
9768111|NCT00424528|10872876|FG001|STARTED|Overall Study||80
9768112|NCT00424528|10872877|FG002|STARTED|Overall Study||78
9768113|NCT00424528|10872875|FG000|COMPLETED|Overall Study||71
9768114|NCT00424528|10872876|FG001|COMPLETED|Overall Study||76
9768115|NCT00424528|10872877|FG002|COMPLETED|Overall Study||74
9768116|NCT00424528|10872875|FG000|NOT COMPLETED|Overall Study||5
9768117|NCT00424528|10872876|FG001|NOT COMPLETED|Overall Study||4
9768118|NCT00424528|10872877|FG002|NOT COMPLETED|Overall Study||4
9768119|NCT00424554|10872887|FG000|STARTED|Overall Study||34
9768120|NCT00424554|10872888|FG001|STARTED|Overall Study||6
9768121|NCT00424554|10872887|FG000|COMPLETED|Overall Study||34
9768122|NCT00424554|10872888|FG001|COMPLETED|Overall Study||6
9768123|NCT00424554|10872887|FG000|NOT COMPLETED|Overall Study||0
9768124|NCT00424554|10872888|FG001|NOT COMPLETED|Overall Study||0
9768125|NCT00424593|10872896|FG000|STARTED|Acute Double-Blind Period||115
9768126|NCT00424593|10872897|FG001|STARTED|Acute Double-Blind Period||121
9768127|NCT00424593|10872896|FG000|COMPLETED|Acute Double-Blind Period||84
9768128|NCT00424593|10872897|FG001|COMPLETED|Acute Double-Blind Period||98
9768129|NCT00424593|10872896|FG000|NOT COMPLETED|Acute Double-Blind Period||31
9768130|NCT00424593|10872897|FG001|NOT COMPLETED|Acute Double-Blind Period||23
9768131|NCT00424593|10872896|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
9768132|NCT00424593|10872897|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
9768133|NCT00424593|10872896|FG000|COMPLETED|Dose-Blind Extension Period||117
9768134|NCT00424593|10872897|FG001|COMPLETED|Dose-Blind Extension Period||0
9768135|NCT00424593|10872896|FG000|NOT COMPLETED|Dose-Blind Extension Period||64
9768136|NCT00424593|10872897|FG001|NOT COMPLETED|Dose-Blind Extension Period||0
9768137|NCT00424619|10872906|FG000|STARTED|Baseline||22
9768138|NCT00424619|10872907|FG001|STARTED|Baseline||22
9768139|NCT00424619|10872908|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
9768140|NCT00424619|10872906|FG000|COMPLETED|Baseline||22
9768141|NCT00424619|10872907|FG001|COMPLETED|Baseline||22
9768142|NCT00424619|10872908|FG002|COMPLETED|Baseline||20
9768143|NCT00424619|10872906|FG000|NOT COMPLETED|Baseline||0
9768144|NCT00424619|10872907|FG001|NOT COMPLETED|Baseline||0
9768145|NCT00424619|10872908|FG002|NOT COMPLETED|Baseline||1
9768146|NCT00424619|10872906|FG000|STARTED|4 Week||18
9768147|NCT00424619|10872907|FG001|STARTED|4 Week||17
9768148|NCT00424619|10872908|FG002|STARTED|4 Week||17
9768149|NCT00424619|10872906|FG000|COMPLETED|4 Week||18
9768150|NCT00424619|10872907|FG001|COMPLETED|4 Week||17
9768151|NCT00424619|10872908|FG002|COMPLETED|4 Week||17
9768152|NCT00424619|10872906|FG000|NOT COMPLETED|4 Week||0
9768153|NCT00424619|10872907|FG001|NOT COMPLETED|4 Week||0
9768154|NCT00424619|10872908|FG002|NOT COMPLETED|4 Week||0
9768155|NCT00424619|10872906|FG000|STARTED|3 Month||12
9768156|NCT00424619|10872907|FG001|STARTED|3 Month||18
9768157|NCT00424619|10872908|FG002|STARTED|3 Month||17
9768158|NCT00424619|10872906|FG000|COMPLETED|3 Month||12
9768159|NCT00424619|10872907|FG001|COMPLETED|3 Month||18
9768160|NCT00424619|10872908|FG002|COMPLETED|3 Month||17
9768161|NCT00424619|10872906|FG000|NOT COMPLETED|3 Month||0
9768162|NCT00424619|10872907|FG001|NOT COMPLETED|3 Month||0
9768163|NCT00424619|10872908|FG002|NOT COMPLETED|3 Month||0
9768164|NCT00424632|10872918|FG000|STARTED|Overall Study||1
9768165|NCT00424632|10872919|FG001|STARTED|Overall Study||1
9768166|NCT00424632|10872920|FG002|STARTED|Overall Study||1
9768167|NCT00424632|10872921|FG003|STARTED|Overall Study||4
9768168|NCT00424632|10872922|FG004|STARTED|Overall Study||3
9768169|NCT00424632|10872923|FG005|STARTED|Overall Study||15
9768170|NCT00424632|10872924|FG006|STARTED|Overall Study||7
9768171|NCT00424632|10872925|FG007|STARTED|Overall Study||3
9768172|NCT00424632|10872926|FG008|STARTED|Overall Study||16
9768173|NCT00424632|10872927|FG009|STARTED|Overall Study||6
9768174|NCT00424632|10872918|FG000|COMPLETED|Overall Study||0
9768175|NCT00424632|10872919|FG001|COMPLETED|Overall Study||0
9768176|NCT00424632|10872920|FG002|COMPLETED|Overall Study||0
9768177|NCT00424632|10872921|FG003|COMPLETED|Overall Study||0
9768178|NCT00424632|10872922|FG004|COMPLETED|Overall Study||0
9768179|NCT00424632|10872923|FG005|COMPLETED|Overall Study||0
9768180|NCT00424632|10872924|FG006|COMPLETED|Overall Study||0
9768181|NCT00424632|10872925|FG007|COMPLETED|Overall Study||0
9768182|NCT00424632|10872926|FG008|COMPLETED|Overall Study||0
9768183|NCT00424632|10872927|FG009|COMPLETED|Overall Study||0
9768184|NCT00424632|10872918|FG000|NOT COMPLETED|Overall Study||1
9768185|NCT00424632|10872919|FG001|NOT COMPLETED|Overall Study||1
9768186|NCT00424632|10872920|FG002|NOT COMPLETED|Overall Study||1
9768187|NCT00424632|10872921|FG003|NOT COMPLETED|Overall Study||4
9768188|NCT00424632|10872922|FG004|NOT COMPLETED|Overall Study||3
10014092|NCT01797458|11137101|FG002|STARTED|Overall Study||65
10014093|NCT01797458|11137099|FG000|COMPLETED|Overall Study||40
9768189|NCT00424632|10872923|FG005|NOT COMPLETED|Overall Study||15
9768190|NCT00424632|10872924|FG006|NOT COMPLETED|Overall Study||7
9768191|NCT00424632|10872925|FG007|NOT COMPLETED|Overall Study||3
9768192|NCT00424632|10872926|FG008|NOT COMPLETED|Overall Study||16
9768193|NCT00424632|10872927|FG009|NOT COMPLETED|Overall Study||6
9768194|NCT00424749|10872958|FG000|STARTED|Overall Study||4
9768195|NCT00424749|10872958|FG000|COMPLETED|Overall Study||3
9768196|NCT00424749|10872958|FG000|NOT COMPLETED|Overall Study||1
9768197|NCT00424762|10872964|FG000|STARTED|Overall Study||74
9768198|NCT00424762|10872965|FG001|STARTED|Overall Study||76
9768199|NCT00424762|10872964|FG000|COMPLETED|Overall Study||54
9768200|NCT00424762|10872965|FG001|COMPLETED|Overall Study||54
9768201|NCT00424762|10872964|FG000|NOT COMPLETED|Overall Study||20
9768202|NCT00424762|10872965|FG001|NOT COMPLETED|Overall Study||22
9768203|NCT00424775|10872971|FG000|STARTED|Overall Study||3
9768204|NCT00424775|10872972|FG001|STARTED|Overall Study||0
9768205|NCT00424775|10872971|FG000|COMPLETED|Overall Study||0
9768206|NCT00424775|10872972|FG001|COMPLETED|Overall Study||0
9768207|NCT00424775|10872971|FG000|NOT COMPLETED|Overall Study||3
9768208|NCT00424775|10872972|FG001|NOT COMPLETED|Overall Study||0
9768209|NCT00424827|10872976|FG000|STARTED|Overall Study||11
9768210|NCT00424827|10872976|FG000|COMPLETED|Overall Study||10
9768211|NCT00424827|10872976|FG000|NOT COMPLETED|Overall Study||1
9768212|NCT00424840|10872981|FG000|STARTED|Overall Study||3
9768213|NCT00424840|10872982|FG001|STARTED|Overall Study||4
9768214|NCT00424840|10872983|FG002|STARTED|Overall Study||5
9768215|NCT00424840|10872981|FG000|COMPLETED|Overall Study||3
9768216|NCT00424840|10872982|FG001|COMPLETED|Overall Study||4
9768217|NCT00424840|10872983|FG002|COMPLETED|Overall Study||5
9768218|NCT00424840|10872981|FG000|NOT COMPLETED|Overall Study||0
9768219|NCT00424840|10872982|FG001|NOT COMPLETED|Overall Study||0
9768220|NCT00424840|10872983|FG002|NOT COMPLETED|Overall Study||0
9768221|NCT00425061|10872996|FG000|STARTED|Overall Study||16
9768222|NCT00425061|10872997|FG001|STARTED|Overall Study||17
9768223|NCT00425061|10872998|FG002|STARTED|Overall Study||16
9768224|NCT00425061|10872999|FG003|STARTED|Overall Study||16
10014094|NCT01797458|11137100|FG001|COMPLETED|Overall Study||43
9768225|NCT00425061|10873000|FG004|STARTED|Overall Study||45
9768226|NCT00425061|10873001|FG005|STARTED|Overall Study||4
9768227|NCT00425061|10873002|FG006|STARTED|Overall Study||45
10014095|NCT01797458|11137101|FG002|COMPLETED|Overall Study||58
9768228|NCT00425061|10872996|FG000|COMPLETED|Overall Study||14
9768229|NCT00425061|10872997|FG001|COMPLETED|Overall Study||15
9768230|NCT00425061|10872998|FG002|COMPLETED|Overall Study||16
9768231|NCT00425061|10872999|FG003|COMPLETED|Overall Study||14
9768232|NCT00425061|10873000|FG004|COMPLETED|Overall Study||19
9768233|NCT00425061|10873001|FG005|COMPLETED|Overall Study||0
9768234|NCT00425061|10873002|FG006|COMPLETED|Overall Study||26
9768235|NCT00425061|10872996|FG000|NOT COMPLETED|Overall Study||2
9768236|NCT00425061|10872997|FG001|NOT COMPLETED|Overall Study||2
9768237|NCT00425061|10872998|FG002|NOT COMPLETED|Overall Study||0
9768238|NCT00425061|10872999|FG003|NOT COMPLETED|Overall Study||2
9768239|NCT00425061|10873000|FG004|NOT COMPLETED|Overall Study||26
9768240|NCT00425061|10873001|FG005|NOT COMPLETED|Overall Study||4
9768241|NCT00425061|10873002|FG006|NOT COMPLETED|Overall Study||19
10014096|NCT01797458|11137099|FG000|NOT COMPLETED|Overall Study||12
9768242|NCT00425113|10873022|FG000|STARTED|Overall Study||17
9768243|NCT00425113|10873023|FG001|STARTED|Overall Study||18
9768244|NCT00425113|10873022|FG000|Exposed to Study Drug|Overall Study||16
9768245|NCT00425113|10873023|FG001|Exposed to Study Drug|Overall Study||17
9768246|NCT00425113|10873022|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
9768247|NCT00425113|10873023|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
9768248|NCT00425113|10873022|FG000|NOT COMPLETED|Overall Study||2
9768249|NCT00425113|10873023|FG001|NOT COMPLETED|Overall Study||2
9768250|NCT00425269|10873032|FG000|STARTED|Overall Study||101
9768251|NCT00425269|10873033|FG001|STARTED|Overall Study||97
9768252|NCT00425269|10873032|FG000|COMPLETED|Overall Study||82
9768253|NCT00425269|10873033|FG001|COMPLETED|Overall Study||77
9768254|NCT00425269|10873032|FG000|NOT COMPLETED|Overall Study||19
9768255|NCT00425269|10873033|FG001|NOT COMPLETED|Overall Study||20
9768256|NCT00425308|10873041|FG000|STARTED|Overall Study||15
9768257|NCT00425308|10873042|FG001|STARTED|Overall Study||15
9768258|NCT00425308|10873041|FG000|COMPLETED|Overall Study||11
9768259|NCT00425308|10873042|FG001|COMPLETED|Overall Study||14
9768260|NCT00425308|10873041|FG000|NOT COMPLETED|Overall Study||4
9768261|NCT00425308|10873042|FG001|NOT COMPLETED|Overall Study||1
9768262|NCT00425373|10873057|FG000|STARTED|Overall Study||159
9768263|NCT00425373|10873058|FG001|STARTED|Overall Study||167
9768264|NCT00425373|10873059|FG002|STARTED|Overall Study||160
9768265|NCT00425373|10873060|FG003|STARTED|Overall Study||162
9768266|NCT00425373|10873061|FG004|STARTED|Overall Study||169
9768267|NCT00425373|10873062|FG005|STARTED|Overall Study||163
9768268|NCT00425373|10873063|FG006|STARTED|Overall Study||161
9768269|NCT00425373|10873064|FG007|STARTED|Overall Study||161
9768270|NCT00425373|10873065|FG008|STARTED|Overall Study||166
9768271|NCT00425373|10873057|FG000|COMPLETED|Overall Study||154
9768272|NCT00425373|10873058|FG001|COMPLETED|Overall Study||164
9768273|NCT00425373|10873059|FG002|COMPLETED|Overall Study||157
9768274|NCT00425373|10873060|FG003|COMPLETED|Overall Study||160
9768275|NCT00425373|10873061|FG004|COMPLETED|Overall Study||159
9768276|NCT00425373|10873062|FG005|COMPLETED|Overall Study||154
9768277|NCT00425373|10873063|FG006|COMPLETED|Overall Study||154
9768278|NCT00425373|10873064|FG007|COMPLETED|Overall Study||151
9768279|NCT00425373|10873065|FG008|COMPLETED|Overall Study||148
9768280|NCT00425373|10873057|FG000|NOT COMPLETED|Overall Study||5
9768281|NCT00425373|10873058|FG001|NOT COMPLETED|Overall Study||3
9768282|NCT00425373|10873059|FG002|NOT COMPLETED|Overall Study||3
9768283|NCT00425373|10873060|FG003|NOT COMPLETED|Overall Study||2
9768284|NCT00425373|10873061|FG004|NOT COMPLETED|Overall Study||10
9768285|NCT00425373|10873062|FG005|NOT COMPLETED|Overall Study||9
9768286|NCT00425373|10873063|FG006|NOT COMPLETED|Overall Study||7
9768287|NCT00425373|10873064|FG007|NOT COMPLETED|Overall Study||10
9768288|NCT00425373|10873065|FG008|NOT COMPLETED|Overall Study||18
9768289|NCT00425386|10873085|FG000|STARTED|Overall Study||46
9768290|NCT00425386|10873085|FG000|COMPLETED|Overall Study||43
9768291|NCT00425386|10873085|FG000|NOT COMPLETED|Overall Study||3
9768292|NCT00425477|10873089|FG000|STARTED|Overall Study||26
9768293|NCT00425477|10873089|FG000|COMPLETED|Overall Study||13
9768294|NCT00425477|10873089|FG000|NOT COMPLETED|Overall Study||13
9768295|NCT00425503|10873093|FG000|STARTED|Overall Study||40
9768296|NCT00425503|10873093|FG000|COMPLETED|Overall Study||37
10232576|NCT02144155|11361899|FG000|NOT COMPLETED|Overall Study||0
10232577|NCT02140788|11361903|FG000|STARTED|Overall Study||0
10232578|NCT02140788|11361904|FG001|STARTED|Overall Study||0
10232579|NCT02140788|11361905|FG002|STARTED|Overall Study||0
10232580|NCT02140788|11361906|FG003|STARTED|Overall Study||0
10232581|NCT02140788|11361903|FG000|COMPLETED|Overall Study||0
10232582|NCT02140788|11361904|FG001|COMPLETED|Overall Study||0
10232583|NCT02140788|11361905|FG002|COMPLETED|Overall Study||0
10232584|NCT02140788|11361906|FG003|COMPLETED|Overall Study||0
10232585|NCT02140788|11361903|FG000|NOT COMPLETED|Overall Study||0
10232586|NCT02140788|11361904|FG001|NOT COMPLETED|Overall Study||0
10232587|NCT02140788|11361905|FG002|NOT COMPLETED|Overall Study||0
10232588|NCT02140788|11361906|FG003|NOT COMPLETED|Overall Study||0
10232589|NCT02150863|11361919|FG000|STARTED|Overall Study||0
10232590|NCT02150863|11361920|FG001|STARTED|Overall Study||1
10232591|NCT02150863|11361921|FG002|STARTED|Overall Study||0
10232592|NCT02150863|11361919|FG000|COMPLETED|Overall Study||0
10232593|NCT02150863|11361920|FG001|COMPLETED|Overall Study||0
10232594|NCT02150863|11361921|FG002|COMPLETED|Overall Study||0
10232595|NCT02150863|11361919|FG000|NOT COMPLETED|Overall Study||0
10232596|NCT02150863|11361920|FG001|NOT COMPLETED|Overall Study||1
9768297|NCT00425503|10873093|FG000|NOT COMPLETED|Overall Study||3
9768298|NCT00425555|10873099|FG000|STARTED|Overall Study||79
9768299|NCT00425555|10873100|FG001|STARTED|Overall Study||60
9768300|NCT00425555|10873099|FG000|COMPLETED|Overall Study||0
9768301|NCT00425555|10873100|FG001|COMPLETED|Overall Study||0
9768302|NCT00425555|10873099|FG000|NOT COMPLETED|Overall Study||79
9768303|NCT00425555|10873100|FG001|NOT COMPLETED|Overall Study||60
9768304|NCT00425607|10873109|FG000|STARTED|Overall Study||29
9768305|NCT00425607|10873109|FG000|Received Treatment|Overall Study||28
9768306|NCT00425607|10873109|FG000|COMPLETED|Overall Study||27
10232597|NCT02150863|11361921|FG002|NOT COMPLETED|Overall Study||0
10232598|NCT02145169|11361929|FG000|STARTED|Overall Study||0
10232599|NCT02145169|11361929|FG000|COMPLETED|Overall Study||0
10232600|NCT02145169|11361929|FG000|NOT COMPLETED|Overall Study||0
10232601|NCT02130622|11361935|FG000|STARTED|Overall Study||2
10232602|NCT02130622|11361936|FG001|STARTED|Overall Study||1
9768307|NCT00425607|10873109|FG000|NOT COMPLETED|Overall Study||2
9768308|NCT00425672|10873113|FG000|STARTED|Overall Study||15
9768309|NCT00425672|10873113|FG000|COMPLETED|Overall Study||14
9768310|NCT00425672|10873113|FG000|NOT COMPLETED|Overall Study||1
9768311|NCT00425698|10873119|FG000|STARTED|Overall Study||44
9768312|NCT00425698|10873120|FG001|STARTED|Overall Study||44
9768313|NCT00425698|10873119|FG000|COMPLETED|Overall Study||41
9768314|NCT00425698|10873120|FG001|COMPLETED|Overall Study||42
9768315|NCT00425698|10873119|FG000|NOT COMPLETED|Overall Study||3
9768316|NCT00425698|10873120|FG001|NOT COMPLETED|Overall Study||2
9829650|NCT00760747|10940319|FG000|NOT COMPLETED|Study Period III||3
9829651|NCT00760747|10940320|FG001|NOT COMPLETED|Study Period III||3
9829652|NCT00760838|10940328|FG000|STARTED|Overall Study||54
9829653|NCT00760838|10940329|FG001|STARTED|Overall Study||55
9829654|NCT00760838|10940328|FG000|COMPLETED|Overall Study||49
9829655|NCT00760838|10940329|FG001|COMPLETED|Overall Study||53
9829656|NCT00760838|10940328|FG000|NOT COMPLETED|Overall Study||5
9829657|NCT00760838|10940329|FG001|NOT COMPLETED|Overall Study||2
9829658|NCT00760877|10940337|FG000|STARTED|Overall Study||104
9829659|NCT00760877|10940338|FG001|STARTED|Overall Study||103
9829660|NCT00760877|10940337|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
9829661|NCT00760877|10940338|FG001|Cross-over to Nilotinib|Overall Study||46
9829662|NCT00760877|10940337|FG000|Safety Set|Overall Study||101
9829663|NCT00760877|10940338|FG001|Safety Set|Overall Study||103
9829664|NCT00760877|10940337|FG000|COMPLETED|Overall Study||59
10232603|NCT02130622|11361935|FG000|COMPLETED|Overall Study||2
10232604|NCT02130622|11361936|FG001|COMPLETED|Overall Study||1
10232605|NCT02130622|11361935|FG000|NOT COMPLETED|Overall Study||0
10232606|NCT02130622|11361936|FG001|NOT COMPLETED|Overall Study||0
10232607|NCT02133534|11361942|FG000|STARTED|Overall Study||1
10232608|NCT02133534|11361942|FG000|COMPLETED|Overall Study||1
10232609|NCT02133534|11361942|FG000|NOT COMPLETED|Overall Study||0
10232610|NCT02134912|11361948|FG000|STARTED|Overall Study||0
10232611|NCT02134912|11361949|FG001|STARTED|Overall Study||0
10232612|NCT02134912|11361948|FG000|COMPLETED|Overall Study||0
10232613|NCT02134912|11361949|FG001|COMPLETED|Overall Study||0
10232614|NCT02134912|11361948|FG000|NOT COMPLETED|Overall Study||0
10232615|NCT02134912|11361949|FG001|NOT COMPLETED|Overall Study||0
10232616|NCT02131155|11361957|FG000|STARTED|Overall Study|Started are treated patients.|25
10232617|NCT02131155|11361958|FG001|STARTED|Overall Study|Started are treated patients.|11
10232618|NCT02131155|11361957|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
10232619|NCT02131155|11361958|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
10232620|NCT02131155|11361957|FG000|NOT COMPLETED|Overall Study||25
10232621|NCT02131155|11361958|FG001|NOT COMPLETED|Overall Study||11
10232622|NCT02117050|11361964|FG000|STARTED|Overall Study||1
10232623|NCT02117050|11361964|FG000|COMPLETED|Overall Study||0
10232624|NCT02117050|11361964|FG000|NOT COMPLETED|Overall Study||1
10232625|NCT02110069|11361971|FG000|STARTED|Overall Study||2
10232626|NCT02110069|11361972|FG001|STARTED|Overall Study||2
10232627|NCT02110069|11361971|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
10232628|NCT02110069|11361972|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
10232629|NCT02110069|11361971|FG000|NOT COMPLETED|Overall Study||2
10232630|NCT02110069|11361972|FG001|NOT COMPLETED|Overall Study||0
10232631|NCT02110277|11361978|FG000|STARTED|Overall Study||2
10232632|NCT02110277|11361978|FG000|COMPLETED|Overall Study||0
10232633|NCT02110277|11361978|FG000|NOT COMPLETED|Overall Study||2
10232634|NCT02109809|11361982|FG000|STARTED|Overall Study||4
10232635|NCT02109809|11361982|FG000|COMPLETED|Overall Study||1
10232636|NCT02109809|11361982|FG000|NOT COMPLETED|Overall Study||3
10232637|NCT02105116|11361986|FG000|STARTED|Overall Study||6
10232638|NCT02105116|11361986|FG000|COMPLETED|Overall Study||0
10232639|NCT02105116|11361986|FG000|NOT COMPLETED|Overall Study||6
10232640|NCT02099318|11361992|FG000|STARTED|Overall Study||20
10232641|NCT02099318|11361993|FG001|STARTED|Overall Study||20
10232642|NCT02099318|11361992|FG000|COMPLETED|Overall Study||20
10232643|NCT02099318|11361993|FG001|COMPLETED|Overall Study||20
10232644|NCT02099318|11361992|FG000|NOT COMPLETED|Overall Study||0
10232645|NCT02099318|11361993|FG001|NOT COMPLETED|Overall Study||0
10232646|NCT02099344|11362003|FG000|STARTED|Overall Study||1
10232647|NCT02099344|11362004|FG001|STARTED|Overall Study||0
10232648|NCT02099344|11362003|FG000|COMPLETED|Overall Study||0
10232649|NCT02099344|11362004|FG001|COMPLETED|Overall Study||0
10232650|NCT02099344|11362003|FG000|NOT COMPLETED|Overall Study||1
10232651|NCT02099344|11362004|FG001|NOT COMPLETED|Overall Study||0
10232652|NCT02094352|11362014|FG000|STARTED|Overall Study||2
10232653|NCT02094352|11362015|FG001|STARTED|Overall Study||1
9829665|NCT00760877|10940338|FG001|COMPLETED|Overall Study||77
9829666|NCT00760877|10940337|FG000|NOT COMPLETED|Overall Study||45
9829667|NCT00760877|10940338|FG001|NOT COMPLETED|Overall Study||26
10232654|NCT02094352|11362014|FG000|COMPLETED|Overall Study||2
10232655|NCT02094352|11362015|FG001|COMPLETED|Overall Study||1
10232656|NCT02094352|11362014|FG000|NOT COMPLETED|Overall Study||0
10232657|NCT02094352|11362015|FG001|NOT COMPLETED|Overall Study||0
10232658|NCT02096042|11362021|FG000|STARTED|Overall Study||1
10232659|NCT02096042|11362022|FG001|STARTED|Overall Study||0
10232660|NCT02096042|11362023|FG002|STARTED|Overall Study||0
9829668|NCT00760929|10940349|FG000|STARTED|Overall Study||26
9829669|NCT00760929|10940350|FG001|STARTED|Overall Study||29
9768317|NCT00425750|10873126|FG000|STARTED|Overall Study||25
9768318|NCT00425750|10873126|FG000|COMPLETED|Overall Study||0
9768319|NCT00425750|10873126|FG000|NOT COMPLETED|Overall Study||25
9768320|NCT00425802|10873130|FG000|STARTED|Overall Study||61
9768321|NCT00425802|10873130|FG000|COMPLETED|Overall Study||61
9768322|NCT00425802|10873130|FG000|NOT COMPLETED|Overall Study||0
9768323|NCT00425854|10873136|FG000|STARTED|Overall Study|Treated|29
9768324|NCT00425854|10873137|FG001|STARTED|Overall Study|Treated|21
9768325|NCT00425854|10873136|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
9768326|NCT00425854|10873137|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
9768327|NCT00425854|10873136|FG000|NOT COMPLETED|Overall Study||29
9768328|NCT00425854|10873137|FG001|NOT COMPLETED|Overall Study||21
9768329|NCT00425945|10873146|FG000|STARTED|Overall Study||64
9768330|NCT00425945|10873147|FG001|STARTED|Overall Study||66
9768331|NCT00425945|10873146|FG000|COMPLETED|Overall Study||60
9768332|NCT00425945|10873147|FG001|COMPLETED|Overall Study||61
9768333|NCT00425945|10873146|FG000|NOT COMPLETED|Overall Study||4
9768334|NCT00425945|10873147|FG001|NOT COMPLETED|Overall Study||5
9768335|NCT00426127|10873155|FG000|STARTED|Overall Study||2
9768336|NCT00426127|10873155|FG000|COMPLETED|Overall Study||0
9768337|NCT00426127|10873155|FG000|NOT COMPLETED|Overall Study||2
9768338|NCT00426153|10873161|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
9768339|NCT00426153|10873162|FG001|STARTED|Overall Study||14
9768340|NCT00426153|10873161|FG000|COMPLETED|Overall Study||28
9768341|NCT00426153|10873162|FG001|COMPLETED|Overall Study||14
9768342|NCT00426153|10873161|FG000|NOT COMPLETED|Overall Study||0
9768343|NCT00426153|10873162|FG001|NOT COMPLETED|Overall Study||0
9768344|NCT00426231|10873170|FG000|STARTED|Overall Study||36
9768345|NCT00426231|10873171|FG001|STARTED|Overall Study||37
9768346|NCT00426231|10873170|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27
9768347|NCT00426231|10873171|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25
9768348|NCT00426231|10873170|FG000|NOT COMPLETED|Overall Study||9
9768349|NCT00426231|10873171|FG001|NOT COMPLETED|Overall Study||12
9768350|NCT00426270|10873177|FG000|STARTED|Overall Study||116
10232661|NCT02096042|11362021|FG000|COMPLETED|Overall Study||0
10232662|NCT02096042|11362022|FG001|COMPLETED|Overall Study||0
10232663|NCT02096042|11362023|FG002|COMPLETED|Overall Study||0
10232664|NCT02096042|11362021|FG000|NOT COMPLETED|Overall Study||1
10232665|NCT02096042|11362022|FG001|NOT COMPLETED|Overall Study||0
10232666|NCT02096042|11362023|FG002|NOT COMPLETED|Overall Study||0
10232667|NCT02088957|11362030|FG000|STARTED|Overall Study||1
10232668|NCT02088957|11362031|FG001|STARTED|Overall Study||0
10232669|NCT02088957|11362030|FG000|COMPLETED|Overall Study||0
10232670|NCT02088957|11362031|FG001|COMPLETED|Overall Study||0
10232671|NCT02088957|11362030|FG000|NOT COMPLETED|Overall Study||1
10232672|NCT02088957|11362031|FG001|NOT COMPLETED|Overall Study||0
10239578|NCT00129974|11371210|FG000|COMPLETED|Overall Study||0
10239579|NCT00129974|11371210|FG000|NOT COMPLETED|Overall Study||1
10239580|NCT00126659|11371217|FG000|STARTED|Overall Study||3
10239581|NCT00126659|11371218|FG001|STARTED|Overall Study||3
10239582|NCT00126659|11371219|FG002|STARTED|Overall Study||4
10239583|NCT00126659|11371217|FG000|COMPLETED|Overall Study||3
10239584|NCT00126659|11371218|FG001|COMPLETED|Overall Study||3
10239585|NCT00126659|11371219|FG002|COMPLETED|Overall Study||2
10239586|NCT00126659|11371217|FG000|NOT COMPLETED|Overall Study||0
10239587|NCT00126659|11371218|FG001|NOT COMPLETED|Overall Study||0
10239588|NCT00126659|11371219|FG002|NOT COMPLETED|Overall Study||2
10239589|NCT00133679|11371227|FG000|STARTED|Overall Study||0
10239590|NCT00133679|11371228|FG001|STARTED|Overall Study||0
10239591|NCT00133679|11371227|FG000|COMPLETED|Overall Study||0
10239592|NCT00133679|11371228|FG001|COMPLETED|Overall Study||0
10239593|NCT00133679|11371227|FG000|NOT COMPLETED|Overall Study||0
10239594|NCT00133679|11371228|FG001|NOT COMPLETED|Overall Study||0
10239595|NCT00125268|11371236|FG000|STARTED|Overall Study||16
10239596|NCT00125268|11371237|FG001|STARTED|Overall Study||14
10239597|NCT00125268|11371236|FG000|COMPLETED|Overall Study||15
10239598|NCT00125268|11371237|FG001|COMPLETED|Overall Study||13
10239599|NCT00125268|11371236|FG000|NOT COMPLETED|Overall Study||1
9768351|NCT00426270|10873177|FG000|COMPLETED|Overall Study||110
9768352|NCT00426270|10873177|FG000|NOT COMPLETED|Overall Study||6
9768353|NCT00426283|10873183|FG000|STARTED|Overall Study||28
9768354|NCT00426283|10873184|FG001|STARTED|Overall Study||14
9768355|NCT00426283|10873183|FG000|COMPLETED|Overall Study||23
9768356|NCT00426283|10873184|FG001|COMPLETED|Overall Study||13
10239600|NCT00125268|11371237|FG001|NOT COMPLETED|Overall Study||1
10239601|NCT00113399|11371245|FG000|STARTED|Overall Study||7
9768357|NCT00426283|10873183|FG000|NOT COMPLETED|Overall Study||5
9768358|NCT00426283|10873184|FG001|NOT COMPLETED|Overall Study||1
10239602|NCT00113399|11371246|FG001|STARTED|Overall Study||8
9768359|NCT00426361|10873197|FG000|STARTED|Overall Study||248
10239603|NCT00113399|11371245|FG000|COMPLETED|Overall Study||5
10239604|NCT00113399|11371246|FG001|COMPLETED|Overall Study||3
9768360|NCT00426361|10873198|FG001|STARTED|Overall Study||255
9768361|NCT00426361|10873199|FG002|STARTED|Overall Study||248
10239605|NCT00113399|11371245|FG000|NOT COMPLETED|Overall Study||2
10239606|NCT00113399|11371246|FG001|NOT COMPLETED|Overall Study||5
10239607|NCT00118053|11371252|FG000|STARTED|Overall Study||5
9768362|NCT00426361|10873197|FG000|COMPLETED|Overall Study||244
9768363|NCT00426361|10873198|FG001|COMPLETED|Overall Study||250
10239608|NCT00118053|11371252|FG000|COMPLETED|Overall Study||5
10239609|NCT00118053|11371252|FG000|NOT COMPLETED|Overall Study||0
9768364|NCT00426361|10873199|FG002|COMPLETED|Overall Study||243
9768365|NCT00426361|10873197|FG000|NOT COMPLETED|Overall Study||4
9768366|NCT00426361|10873198|FG001|NOT COMPLETED|Overall Study||5
9768367|NCT00426361|10873199|FG002|NOT COMPLETED|Overall Study||5
9768368|NCT00426517|10873211|FG000|STARTED|Overall Study||7
9768369|NCT00426517|10873212|FG001|STARTED|Overall Study||36
9768370|NCT00426517|10873213|FG002|STARTED|Overall Study||3
9768371|NCT00426517|10873214|FG003|STARTED|Overall Study||2
9768372|NCT00426517|10873211|FG000|COMPLETED|Overall Study||7
9768373|NCT00426517|10873212|FG001|COMPLETED|Overall Study||36
9768374|NCT00426517|10873213|FG002|COMPLETED|Overall Study||3
9768375|NCT00426517|10873214|FG003|COMPLETED|Overall Study||2
9768376|NCT00426517|10873211|FG000|NOT COMPLETED|Overall Study||0
9768377|NCT00426517|10873212|FG001|NOT COMPLETED|Overall Study||0
9768378|NCT00426517|10873213|FG002|NOT COMPLETED|Overall Study||0
10014097|NCT01797458|11137100|FG001|NOT COMPLETED|Overall Study||9
9768379|NCT00426517|10873214|FG003|NOT COMPLETED|Overall Study||0
9768380|NCT00426556|10873228|FG000|STARTED|Phase I - Core Phase||6
9768381|NCT00426556|10873229|FG001|STARTED|Phase I - Core Phase||17
9768382|NCT00426556|10873230|FG002|STARTED|Phase I - Core Phase||10
9768383|NCT00426556|10873231|FG003|STARTED|Phase I - Core Phase||0
9768384|NCT00426556|10873228|FG000|COMPLETED|Phase I - Core Phase||5
9768385|NCT00426556|10873229|FG001|COMPLETED|Phase I - Core Phase||7
9768386|NCT00426556|10873230|FG002|COMPLETED|Phase I - Core Phase||7
9768387|NCT00426556|10873231|FG003|COMPLETED|Phase I - Core Phase||0
9768388|NCT00426556|10873228|FG000|NOT COMPLETED|Phase I - Core Phase||1
10232673|NCT02093689|11362040|FG000|STARTED|Overall Study||18
10232674|NCT02093689|11362041|FG001|STARTED|Overall Study||0
10232675|NCT02093689|11362042|FG002|STARTED|Overall Study||0
10232676|NCT02093689|11362040|FG000|COMPLETED|Overall Study||14
10232677|NCT02093689|11362041|FG001|COMPLETED|Overall Study||0
10232678|NCT02093689|11362042|FG002|COMPLETED|Overall Study||0
10232679|NCT02093689|11362040|FG000|NOT COMPLETED|Overall Study||4
10232680|NCT02093689|11362041|FG001|NOT COMPLETED|Overall Study||0
10232681|NCT02093689|11362042|FG002|NOT COMPLETED|Overall Study||0
10232682|NCT02091752|11362048|FG000|STARTED|Overall Study||3
10232683|NCT02091752|11362048|FG000|COMPLETED|Overall Study||0
10232684|NCT02091752|11362048|FG000|NOT COMPLETED|Overall Study||3
10232685|NCT02068547|11362054|FG000|STARTED|Overall Study||4
10232686|NCT02068547|11362055|FG001|STARTED|Overall Study||4
10232687|NCT02068547|11362054|FG000|COMPLETED|Overall Study||0
10232688|NCT02068547|11362055|FG001|COMPLETED|Overall Study||1
10232689|NCT02068547|11362054|FG000|NOT COMPLETED|Overall Study||4
10232690|NCT02068547|11362055|FG001|NOT COMPLETED|Overall Study||3
10232691|NCT02075411|11362065|FG000|STARTED|Overall Study||0
10232692|NCT02075411|11362066|FG001|STARTED|Overall Study||0
10232693|NCT02075411|11362067|FG002|STARTED|Overall Study||0
10232694|NCT02075411|11362068|FG003|STARTED|Overall Study||1
10232695|NCT02075411|11362065|FG000|COMPLETED|Overall Study||0
10232696|NCT02075411|11362066|FG001|COMPLETED|Overall Study||0
10232697|NCT02075411|11362067|FG002|COMPLETED|Overall Study||0
10232698|NCT02075411|11362068|FG003|COMPLETED|Overall Study||1
10232699|NCT02075411|11362065|FG000|NOT COMPLETED|Overall Study||0
10232700|NCT02075411|11362066|FG001|NOT COMPLETED|Overall Study||0
10232701|NCT02075411|11362067|FG002|NOT COMPLETED|Overall Study||0
10232702|NCT02075411|11362068|FG003|NOT COMPLETED|Overall Study||0
10232703|NCT02074904|11362080|FG000|STARTED|Overall Study||1
10232704|NCT02074904|11362081|FG001|STARTED|Overall Study||0
10232705|NCT02074904|11362080|FG000|COMPLETED|Overall Study||1
10232706|NCT02074904|11362081|FG001|COMPLETED|Overall Study||0
10232707|NCT02074904|11362080|FG000|NOT COMPLETED|Overall Study||0
10232708|NCT02074904|11362081|FG001|NOT COMPLETED|Overall Study||0
10232709|NCT02084147|11362087|FG000|STARTED|Overall Study||72
10232710|NCT02084147|11362087|FG000|COMPLETED|Overall Study||72
10232711|NCT02084147|11362087|FG000|NOT COMPLETED|Overall Study||0
10232712|NCT02081183|11362093|FG000|STARTED|Overall Study||5
10232713|NCT02081183|11362094|FG001|STARTED|Overall Study||6
10232714|NCT02081183|11362093|FG000|COMPLETED|Overall Study||1
10232715|NCT02081183|11362094|FG001|COMPLETED|Overall Study||2
9768389|NCT00426556|10873229|FG001|NOT COMPLETED|Phase I - Core Phase||10
9768390|NCT00426556|10873230|FG002|NOT COMPLETED|Phase I - Core Phase||3
10232716|NCT02081183|11362093|FG000|NOT COMPLETED|Overall Study||4
10232717|NCT02081183|11362094|FG001|NOT COMPLETED|Overall Study||4
10232718|NCT02067611|11362100|FG000|STARTED|Overall Study||72
10232719|NCT02067611|11362101|FG001|STARTED|Overall Study||72
10232720|NCT02067611|11362102|FG002|STARTED|Overall Study||72
10232721|NCT02067611|11362100|FG000|COMPLETED|Overall Study||66
10232722|NCT02067611|11362101|FG001|COMPLETED|Overall Study||66
10232723|NCT02067611|11362102|FG002|COMPLETED|Overall Study||68
10232724|NCT02067611|11362100|FG000|NOT COMPLETED|Overall Study||6
10232725|NCT02067611|11362101|FG001|NOT COMPLETED|Overall Study||6
10232726|NCT02067611|11362102|FG002|NOT COMPLETED|Overall Study||4
10232727|NCT02067104|11362114|FG000|STARTED|Overall Study||4
10232728|NCT02067104|11362115|FG001|STARTED|Overall Study||5
10014098|NCT01797458|11137101|FG002|NOT COMPLETED|Overall Study||7
9768391|NCT00426556|10873231|FG003|NOT COMPLETED|Phase I - Core Phase||0
10232729|NCT02067104|11362114|FG000|COMPLETED|Overall Study||0
10232730|NCT02067104|11362115|FG001|COMPLETED|Overall Study||0
10232731|NCT02067104|11362114|FG000|NOT COMPLETED|Overall Study||4
10232732|NCT02067104|11362115|FG001|NOT COMPLETED|Overall Study||5
10232733|NCT02075021|11362121|FG000|STARTED|Overall Study||3
10232734|NCT02075021|11362121|FG000|COMPLETED|Overall Study||3
9768392|NCT00426556|10873228|FG000|STARTED|Phase I - Extension Phase||5
9768393|NCT00426556|10873229|FG001|STARTED|Phase I - Extension Phase||7
9768394|NCT00426556|10873230|FG002|STARTED|Phase I - Extension Phase||7
9768395|NCT00426556|10873231|FG003|STARTED|Phase I - Extension Phase||0
9768396|NCT00426556|10873228|FG000|COMPLETED|Phase I - Extension Phase||0
9768397|NCT00426556|10873229|FG001|COMPLETED|Phase I - Extension Phase||1
9768398|NCT00426556|10873230|FG002|COMPLETED|Phase I - Extension Phase||0
9768399|NCT00426556|10873231|FG003|COMPLETED|Phase I - Extension Phase||0
9768400|NCT00426556|10873228|FG000|NOT COMPLETED|Phase I - Extension Phase||5
9768401|NCT00426556|10873229|FG001|NOT COMPLETED|Phase I - Extension Phase||6
9768402|NCT00426556|10873230|FG002|NOT COMPLETED|Phase I - Extension Phase||7
9768403|NCT00426556|10873231|FG003|NOT COMPLETED|Phase I - Extension Phase||0
9768404|NCT00426556|10873228|FG000|STARTED|Phase II - Core Phase||0
9768405|NCT00426556|10873229|FG001|STARTED|Phase II - Core Phase||0
9768406|NCT00426556|10873230|FG002|STARTED|Phase II - Core Phase||0
9768407|NCT00426556|10873231|FG003|STARTED|Phase II - Core Phase||55
9768408|NCT00426556|10873228|FG000|COMPLETED|Phase II - Core Phase||0
9768409|NCT00426556|10873229|FG001|COMPLETED|Phase II - Core Phase||0
9768410|NCT00426556|10873230|FG002|COMPLETED|Phase II - Core Phase||0
9768411|NCT00426556|10873231|FG003|COMPLETED|Phase II - Core Phase||28
9768412|NCT00426556|10873228|FG000|NOT COMPLETED|Phase II - Core Phase||0
9768413|NCT00426556|10873229|FG001|NOT COMPLETED|Phase II - Core Phase||0
9768414|NCT00426556|10873230|FG002|NOT COMPLETED|Phase II - Core Phase||0
9768415|NCT00426556|10873231|FG003|NOT COMPLETED|Phase II - Core Phase||27
9768416|NCT00426556|10873228|FG000|STARTED|Phase II - Extension Phase||0
9768417|NCT00426556|10873229|FG001|STARTED|Phase II - Extension Phase||0
9768418|NCT00426556|10873230|FG002|STARTED|Phase II - Extension Phase||0
9768419|NCT00426556|10873231|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
9768420|NCT00426556|10873228|FG000|COMPLETED|Phase II - Extension Phase||0
9768421|NCT00426556|10873229|FG001|COMPLETED|Phase II - Extension Phase||0
9768422|NCT00426556|10873230|FG002|COMPLETED|Phase II - Extension Phase||0
9768423|NCT00426556|10873231|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
10232735|NCT02075021|11362121|FG000|NOT COMPLETED|Overall Study||0
10232736|NCT02057874|11362125|FG000|STARTED|Overall Study||2
10232737|NCT02057874|11362125|FG000|COMPLETED|Overall Study||1
10232738|NCT02057874|11362125|FG000|NOT COMPLETED|Overall Study||1
10232739|NCT02057237|11362130|FG000|STARTED|Overall Study||1
10232740|NCT02057237|11362130|FG000|COMPLETED|Overall Study||1
10232741|NCT02057237|11362130|FG000|NOT COMPLETED|Overall Study||0
10232742|NCT02047747|11362135|FG000|STARTED|Overall Study||4
10232743|NCT02047747|11362135|FG000|COMPLETED|Overall Study||1
10232744|NCT02047747|11362135|FG000|NOT COMPLETED|Overall Study||3
10232745|NCT02058537|11362139|FG000|STARTED|Overall Study||3
10232746|NCT02058537|11362139|FG000|COMPLETED|Overall Study||2
10232747|NCT02058537|11362139|FG000|NOT COMPLETED|Overall Study||1
10232748|NCT02057276|11362145|FG000|STARTED|Overall Study||0
10232749|NCT02057276|11362146|FG001|STARTED|Overall Study||0
10232750|NCT02057276|11362145|FG000|COMPLETED|Overall Study||0
10232751|NCT02057276|11362146|FG001|COMPLETED|Overall Study||0
10232752|NCT02057276|11362145|FG000|NOT COMPLETED|Overall Study||0
10232753|NCT02057276|11362146|FG001|NOT COMPLETED|Overall Study||0
10232754|NCT02038153|11362152|FG000|STARTED|Overall Study||3
10232755|NCT02038153|11362152|FG000|COMPLETED|Overall Study||2
10232756|NCT02038153|11362152|FG000|NOT COMPLETED|Overall Study||1
10232757|NCT02054910|11362158|FG000|STARTED|Overall Study||4
10232758|NCT02054910|11362159|FG001|STARTED|Overall Study||1
10232759|NCT02054910|11362158|FG000|COMPLETED|Overall Study||0
10232760|NCT02054910|11362159|FG001|COMPLETED|Overall Study||0
10232761|NCT02054910|11362158|FG000|NOT COMPLETED|Overall Study||4
10232762|NCT02054910|11362159|FG001|NOT COMPLETED|Overall Study||1
10232763|NCT02044302|11362169|FG000|STARTED|Overall Study||2
10232764|NCT02044302|11362170|FG001|STARTED|Overall Study||0
10232765|NCT02044302|11362169|FG000|COMPLETED|Overall Study||0
10232766|NCT02044302|11362170|FG001|COMPLETED|Overall Study||0
10232767|NCT02044302|11362169|FG000|NOT COMPLETED|Overall Study||2
10232768|NCT02044302|11362170|FG001|NOT COMPLETED|Overall Study||0
10232769|NCT02046226|11362174|FG000|STARTED|Overall Study||7
10232770|NCT02046226|11362174|FG000|COMPLETED|Overall Study||0
10232771|NCT02046226|11362174|FG000|NOT COMPLETED|Overall Study||7
10232772|NCT02044848|11362181|FG000|STARTED|Overall Study||2
10232773|NCT02044848|11362182|FG001|STARTED|Overall Study||3
10232774|NCT02044848|11362181|FG000|COMPLETED|Overall Study||0
10232775|NCT02044848|11362182|FG001|COMPLETED|Overall Study||0
10232776|NCT02044848|11362181|FG000|NOT COMPLETED|Overall Study||2
9768424|NCT00426556|10873228|FG000|NOT COMPLETED|Phase II - Extension Phase||0
9768425|NCT00426556|10873229|FG001|NOT COMPLETED|Phase II - Extension Phase||0
9768426|NCT00426556|10873230|FG002|NOT COMPLETED|Phase II - Extension Phase||0
9768427|NCT00426556|10873231|FG003|NOT COMPLETED|Phase II - Extension Phase||23
9768428|NCT00426660|10873241|FG000|STARTED|Overall Study||1047
9768429|NCT00426660|10873241|FG000|Treated|Overall Study||1032
9768430|NCT00426660|10873241|FG000|Safety Analysis Set|Overall Study||1032
10232777|NCT02044848|11362182|FG001|NOT COMPLETED|Overall Study||3
10232778|NCT02042950|11362188|FG000|STARTED|Overall Study||4
10232779|NCT02042950|11362188|FG000|COMPLETED|Overall Study||0
10232780|NCT02042950|11362188|FG000|NOT COMPLETED|Overall Study||4
10232781|NCT02048904|11362192|FG000|STARTED|Overall Study||142
10232782|NCT02048904|11362192|FG000|COMPLETED|Overall Study||65
10232783|NCT02048904|11362192|FG000|NOT COMPLETED|Overall Study||77
9768431|NCT00426660|10873241|FG000|COMPLETED|Overall Study||916
9768432|NCT00426660|10873241|FG000|NOT COMPLETED|Overall Study||131
9768433|NCT00426751|10873247|FG000|STARTED|Overall Study||226
9768434|NCT00426751|10873248|FG001|STARTED|Overall Study||203
9768435|NCT00426751|10873247|FG000|COMPLETED|Overall Study||204
9768436|NCT00426751|10873248|FG001|COMPLETED|Overall Study||183
9768437|NCT00426751|10873247|FG000|NOT COMPLETED|Overall Study||22
9768438|NCT00426751|10873248|FG001|NOT COMPLETED|Overall Study||20
9768439|NCT00426764|10873254|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
9768440|NCT00426764|10873254|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98
9768441|NCT00426764|10873254|FG000|Discontinued at End of or After Cycle 6|Overall Study||33
9768442|NCT00426764|10873254|FG000|COMPLETED|Overall Study||0
9768443|NCT00426764|10873254|FG000|NOT COMPLETED|Overall Study||131
9768444|NCT00426842|10873264|FG000|STARTED|Overall Study||11
9768445|NCT00426842|10873264|FG000|COMPLETED|Overall Study||10
9768446|NCT00426842|10873264|FG000|NOT COMPLETED|Overall Study||1
9768447|NCT00426855|10873270|FG000|STARTED|Overall Study||12
9768448|NCT00426855|10873270|FG000|COMPLETED|Overall Study||12
9768449|NCT00426855|10873270|FG000|NOT COMPLETED|Overall Study||0
9768450|NCT00427011|10873274|FG000|STARTED|Overall Study||25
9768451|NCT00427011|10873274|FG000|COMPLETED|Overall Study||0
9768452|NCT00427011|10873274|FG000|NOT COMPLETED|Overall Study||25
9768453|NCT00427037|10873281|FG000|STARTED|Overall Study||17
9768454|NCT00427037|10873282|FG001|STARTED|Overall Study||17
9768455|NCT00427037|10873281|FG000|COMPLETED|Overall Study||10
9768456|NCT00427037|10873282|FG001|COMPLETED|Overall Study||10
9768457|NCT00427037|10873281|FG000|NOT COMPLETED|Overall Study||7
9768458|NCT00427037|10873282|FG001|NOT COMPLETED|Overall Study||7
9768459|NCT00427297|10873292|FG000|STARTED|Overall Study||17
9768460|NCT00427297|10873293|FG001|STARTED|Overall Study||17
9768461|NCT00427297|10873292|FG000|COMPLETED|Overall Study||17
9768462|NCT00427297|10873293|FG001|COMPLETED|Overall Study||17
9768463|NCT00427297|10873292|FG000|NOT COMPLETED|Overall Study||0
10232784|NCT02044822|11362196|FG000|STARTED|Overall Study||102
10232785|NCT02044822|11362196|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
10232786|NCT02044822|11362196|FG000|NOT COMPLETED|Overall Study||93
10232787|NCT02042924|11362200|FG000|STARTED|Overall Study||2
10232788|NCT02042924|11362200|FG000|COMPLETED|Overall Study||1
10232789|NCT02042924|11362200|FG000|NOT COMPLETED|Overall Study||1
10232790|NCT02043860|11362204|FG000|STARTED|Overall Study||2
10232791|NCT02043860|11362204|FG000|COMPLETED|Overall Study||2
10232792|NCT02043860|11362204|FG000|NOT COMPLETED|Overall Study||0
10232793|NCT02017522|11362208|FG000|STARTED|Overall Study||3
10232794|NCT02017522|11362208|FG000|Scan|Overall Study||2
10232795|NCT02017522|11362208|FG000|COMPLETED|Overall Study||2
10232796|NCT02017522|11362208|FG000|NOT COMPLETED|Overall Study||1
10232797|NCT02030015|11362213|FG000|STARTED|Overall Study||16
10232798|NCT02030015|11362213|FG000|COMPLETED|Overall Study||0
10232799|NCT02030015|11362213|FG000|NOT COMPLETED|Overall Study||16
10232800|NCT02015663|11362219|FG000|STARTED|Overall Study||16
10232801|NCT02015663|11362220|FG001|STARTED|Overall Study||16
10232802|NCT02015663|11362219|FG000|COMPLETED|Overall Study||1
10232803|NCT02015663|11362220|FG001|COMPLETED|Overall Study||4
10232804|NCT02015663|11362219|FG000|NOT COMPLETED|Overall Study||15
10232805|NCT02015663|11362220|FG001|NOT COMPLETED|Overall Study||12
10232806|NCT02029846|11362229|FG000|STARTED|Overall Study||1
10232807|NCT02029846|11362230|FG001|STARTED|Overall Study||1
10232808|NCT02029846|11362229|FG000|COMPLETED|Overall Study||0
10232809|NCT02029846|11362230|FG001|COMPLETED|Overall Study||0
10232810|NCT02029846|11362229|FG000|NOT COMPLETED|Overall Study||1
10232811|NCT02029846|11362230|FG001|NOT COMPLETED|Overall Study||1
10232812|NCT02027272|11362238|FG000|STARTED|Overall Study||0
10232813|NCT02027272|11362239|FG001|STARTED|Overall Study||1
10232814|NCT02027272|11362238|FG000|COMPLETED|Overall Study||0
10232815|NCT02027272|11362239|FG001|COMPLETED|Overall Study||0
10232816|NCT02027272|11362238|FG000|NOT COMPLETED|Overall Study||0
10232817|NCT02027272|11362239|FG001|NOT COMPLETED|Overall Study||1
10232818|NCT02012608|11362247|FG000|STARTED|Overall Study||7
10232819|NCT02012608|11362248|FG001|STARTED|Overall Study||7
10232820|NCT02012608|11362247|FG000|COMPLETED|Overall Study||4
10232821|NCT02012608|11362248|FG001|COMPLETED|Overall Study||7
10232822|NCT02012608|11362247|FG000|NOT COMPLETED|Overall Study||3
10232823|NCT02012608|11362248|FG001|NOT COMPLETED|Overall Study||0
10232824|NCT02017379|11362257|FG000|STARTED|Overall Study||0
10232825|NCT02017379|11362258|FG001|STARTED|Overall Study||0
10232826|NCT02017379|11362259|FG002|STARTED|Overall Study||0
10232827|NCT02017379|11362257|FG000|COMPLETED|Overall Study||0
10232828|NCT02017379|11362258|FG001|COMPLETED|Overall Study||0
9768464|NCT00427297|10873293|FG001|NOT COMPLETED|Overall Study||0
10232829|NCT02017379|11362259|FG002|COMPLETED|Overall Study||0
10232830|NCT02017379|11362257|FG000|NOT COMPLETED|Overall Study||0
10232831|NCT02017379|11362258|FG001|NOT COMPLETED|Overall Study||0
10232832|NCT02017379|11362259|FG002|NOT COMPLETED|Overall Study||0
9768465|NCT00427336|10873299|FG000|STARTED|Overall Study||9
9768466|NCT00427336|10873299|FG000|COMPLETED|Overall Study||9
9768467|NCT00427336|10873299|FG000|NOT COMPLETED|Overall Study||0
9768468|NCT00427349|10873303|FG000|STARTED|Overall Study||46
9768469|NCT00427349|10873303|FG000|Eligible|Overall Study||45
10232833|NCT02011542|11362267|FG000|STARTED|Overall Study||30
10232834|NCT02011542|11362267|FG000|COMPLETED|Overall Study||29
10232835|NCT02011542|11362267|FG000|NOT COMPLETED|Overall Study||1
9768470|NCT00427349|10873303|FG000|Treated|Overall Study||45
9768471|NCT00427349|10873303|FG000|Eligible and Treated|Overall Study||44
9768472|NCT00427349|10873303|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
9768473|NCT00427349|10873303|FG000|NOT COMPLETED|Overall Study||46
9768474|NCT00427557|10873307|FG000|STARTED|Overall Study||30
9768475|NCT00427557|10873307|FG000|COMPLETED|Overall Study||30
9768476|NCT00427557|10873307|FG000|NOT COMPLETED|Overall Study||0
9768477|NCT00427635|10873313|FG000|STARTED|Treatment Phase|Randomised|26
9768478|NCT00427635|10873314|FG001|STARTED|Treatment Phase|Randomised|26
9768479|NCT00427635|10873313|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
9768480|NCT00427635|10873314|FG001|COMPLETED|Treatment Phase|ITT population|26
9768481|NCT00427635|10873313|FG000|NOT COMPLETED|Treatment Phase||1
9768482|NCT00427635|10873314|FG001|NOT COMPLETED|Treatment Phase||0
9768483|NCT00427635|10873313|FG000|STARTED|Study Completion to Safety Follow-up||25
9768484|NCT00427635|10873314|FG001|STARTED|Study Completion to Safety Follow-up||26
9768485|NCT00427635|10873313|FG000|COMPLETED|Study Completion to Safety Follow-up||25
10232836|NCT02008370|11362271|FG000|STARTED|Overall Study||7
10232837|NCT02008370|11362271|FG000|COMPLETED|Overall Study||0
10232838|NCT02008370|11362271|FG000|NOT COMPLETED|Overall Study||7
10232839|NCT02009982|11362277|FG000|STARTED|Overall Study||1
10232840|NCT02009982|11362278|FG001|STARTED|Overall Study||2
10232841|NCT02009982|11362277|FG000|COMPLETED|Overall Study||1
10232842|NCT02009982|11362278|FG001|COMPLETED|Overall Study||2
10232843|NCT02009982|11362277|FG000|NOT COMPLETED|Overall Study||0
10232844|NCT02009982|11362278|FG001|NOT COMPLETED|Overall Study||0
10232845|NCT02013414|11362284|FG000|STARTED|Overall Study||9
10232846|NCT02013414|11362284|FG000|COMPLETED|Overall Study||9
10232847|NCT02013414|11362284|FG000|NOT COMPLETED|Overall Study||0
10232848|NCT02005445|11362292|FG000|STARTED|Overall Study||2
10232849|NCT02005445|11362293|FG001|STARTED|Overall Study||2
10232850|NCT02005445|11362292|FG000|COMPLETED|Overall Study||2
10232851|NCT02005445|11362293|FG001|COMPLETED|Overall Study||1
10232852|NCT02005445|11362292|FG000|NOT COMPLETED|Overall Study||0
10232853|NCT02005445|11362293|FG001|NOT COMPLETED|Overall Study||1
10232854|NCT02020837|11362299|FG000|STARTED|Overall Study||2
10232855|NCT02020837|11362299|FG000|COMPLETED|Overall Study||2
10232856|NCT02020837|11362299|FG000|NOT COMPLETED|Overall Study||0
10232857|NCT02015910|11362305|FG000|STARTED|Overall Study||0
10232858|NCT02015910|11362306|FG001|STARTED|Overall Study||1
10232859|NCT02015910|11362305|FG000|COMPLETED|Overall Study||0
10232860|NCT02015910|11362306|FG001|COMPLETED|Overall Study||1
10232861|NCT02015910|11362305|FG000|NOT COMPLETED|Overall Study||0
10232862|NCT02015910|11362306|FG001|NOT COMPLETED|Overall Study||0
10232863|NCT02006927|11362312|FG000|STARTED|Overall Study||3
10232864|NCT02006927|11362312|FG000|COMPLETED|Overall Study||0
10232865|NCT02006927|11362312|FG000|NOT COMPLETED|Overall Study||3
10232866|NCT01996982|11362316|FG000|STARTED|Overall Study||7
10232867|NCT01996982|11362316|FG000|COMPLETED|Overall Study||0
10232868|NCT01996982|11362316|FG000|NOT COMPLETED|Overall Study||7
10232869|NCT02006407|11362320|FG000|STARTED|Overall Study||5
10232870|NCT02006407|11362320|FG000|COMPLETED|Overall Study||5
10232871|NCT02006407|11362320|FG000|NOT COMPLETED|Overall Study||0
10232872|NCT01986751|11362326|FG000|STARTED|Overall Study||10
10232873|NCT01986751|11362327|FG001|STARTED|Overall Study||4
10232874|NCT01986751|11362326|FG000|COMPLETED|Overall Study||0
10232875|NCT01986751|11362327|FG001|COMPLETED|Overall Study||2
10232876|NCT01986751|11362326|FG000|NOT COMPLETED|Overall Study||10
10232877|NCT01986751|11362327|FG001|NOT COMPLETED|Overall Study||2
10232878|NCT01996410|11362345|FG000|STARTED|Overall Study||3
10232879|NCT01996410|11362346|FG001|STARTED|Overall Study||3
10232880|NCT01996410|11362347|FG002|STARTED|Overall Study||0
10232881|NCT01996410|11362348|FG003|STARTED|Overall Study||0
10232882|NCT01996410|11362349|FG004|STARTED|Overall Study||2
10232883|NCT01996410|11362350|FG005|STARTED|Overall Study||2
10232884|NCT01996410|11362351|FG006|STARTED|Overall Study||0
10232885|NCT01996410|11362352|FG007|STARTED|Overall Study||0
10232886|NCT01996410|11362345|FG000|COMPLETED|Overall Study||3
10232887|NCT01996410|11362346|FG001|COMPLETED|Overall Study||3
10232888|NCT01996410|11362347|FG002|COMPLETED|Overall Study||0
10232889|NCT01996410|11362348|FG003|COMPLETED|Overall Study||0
10232890|NCT01996410|11362349|FG004|COMPLETED|Overall Study||2
10232891|NCT01996410|11362350|FG005|COMPLETED|Overall Study||2
10232892|NCT01996410|11362351|FG006|COMPLETED|Overall Study||0
10232893|NCT01996410|11362352|FG007|COMPLETED|Overall Study||0
10232894|NCT01996410|11362345|FG000|NOT COMPLETED|Overall Study||0
10232895|NCT01996410|11362346|FG001|NOT COMPLETED|Overall Study||0
10232896|NCT01996410|11362347|FG002|NOT COMPLETED|Overall Study||0
10232897|NCT01996410|11362348|FG003|NOT COMPLETED|Overall Study||0
10232898|NCT01996410|11362349|FG004|NOT COMPLETED|Overall Study||0
10232899|NCT01996410|11362350|FG005|NOT COMPLETED|Overall Study||0
10232900|NCT01996410|11362351|FG006|NOT COMPLETED|Overall Study||0
10232901|NCT01996410|11362352|FG007|NOT COMPLETED|Overall Study||0
9768486|NCT00427635|10873314|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
10232902|NCT01996852|11362367|FG000|STARTED|Overall Study||0
10232903|NCT01996852|11362368|FG001|STARTED|Overall Study||0
10232904|NCT01996852|11362369|FG002|STARTED|Overall Study||0
10232905|NCT01996852|11362367|FG000|COMPLETED|Overall Study||0
10232906|NCT01996852|11362368|FG001|COMPLETED|Overall Study||0
10232907|NCT01996852|11362369|FG002|COMPLETED|Overall Study||0
10232908|NCT01996852|11362367|FG000|NOT COMPLETED|Overall Study||0
9768487|NCT00427635|10873313|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0
9768488|NCT00427635|10873314|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1
9768489|NCT00427648|10873322|FG000|STARTED|Overall Study||12
9768490|NCT00427648|10873323|FG001|STARTED|Overall Study||10
9768491|NCT00427648|10873322|FG000|COMPLETED|Overall Study||11
9768492|NCT00427648|10873323|FG001|COMPLETED|Overall Study||7
9768493|NCT00427648|10873322|FG000|NOT COMPLETED|Overall Study||1
9768494|NCT00427648|10873323|FG001|NOT COMPLETED|Overall Study||3
9768495|NCT00427661|10873331|FG000|STARTED|Overall Study||8
9768496|NCT00427661|10873331|FG000|COMPLETED|Overall Study||8
9768497|NCT00427661|10873331|FG000|NOT COMPLETED|Overall Study||0
9768498|NCT00427700|10873338|FG000|STARTED|Overall Study||40
9768499|NCT00427700|10873339|FG001|STARTED|Overall Study||42
9768500|NCT00427700|10873338|FG000|COMPLETED|Overall Study||37
9768501|NCT00427700|10873339|FG001|COMPLETED|Overall Study||31
9768502|NCT00427700|10873338|FG000|NOT COMPLETED|Overall Study||3
9768503|NCT00427700|10873339|FG001|NOT COMPLETED|Overall Study||11
9768504|NCT00427765|10873346|FG000|STARTED|Overall Study||164
9768505|NCT00427765|10873346|FG000|COMPLETED|Overall Study||164
9768506|NCT00427765|10873346|FG000|NOT COMPLETED|Overall Study||0
9768507|NCT00427778|10873350|FG000|STARTED|First Intervention (4 Weeks)||14
9768508|NCT00427778|10873351|FG001|STARTED|First Intervention (4 Weeks)||15
9768509|NCT00427778|10873350|FG000|COMPLETED|First Intervention (4 Weeks)||10
9768510|NCT00427778|10873351|FG001|COMPLETED|First Intervention (4 Weeks)||14
9768511|NCT00427778|10873350|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4
9768512|NCT00427778|10873351|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
9768513|NCT00427778|10873350|FG000|STARTED|Wash Out (2 Weeks)||10
9768514|NCT00427778|10873351|FG001|STARTED|Wash Out (2 Weeks)||14
9768515|NCT00427778|10873350|FG000|COMPLETED|Wash Out (2 Weeks)||10
9768516|NCT00427778|10873351|FG001|COMPLETED|Wash Out (2 Weeks)||14
9768517|NCT00427778|10873350|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
9768518|NCT00427778|10873351|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
9768519|NCT00427778|10873350|FG000|STARTED|Second Intervention (4 Weeks)||10
9768520|NCT00427778|10873351|FG001|STARTED|Second Intervention (4 Weeks)||14
9952287|NCT01421277|11071223|FG000|STARTED|Overall Study||25
9952288|NCT01421277|11071224|FG001|STARTED|Overall Study||191
9952289|NCT01421277|11071223|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
10232909|NCT01996852|11362368|FG001|NOT COMPLETED|Overall Study||0
10232910|NCT01996852|11362369|FG002|NOT COMPLETED|Overall Study||0
10232911|NCT01997567|11362379|FG000|STARTED|Overall Study||0
10232912|NCT01997567|11362380|FG001|STARTED|Overall Study||0
10232913|NCT01997567|11362379|FG000|COMPLETED|Overall Study||0
10232914|NCT01997567|11362380|FG001|COMPLETED|Overall Study||0
10232915|NCT01997567|11362379|FG000|NOT COMPLETED|Overall Study||0
10232916|NCT01997567|11362380|FG001|NOT COMPLETED|Overall Study||0
10232917|NCT01977729|11362386|FG000|STARTED|Overall Study||1
10232918|NCT01977729|11362386|FG000|COMPLETED|Overall Study||0
10232919|NCT01977729|11362386|FG000|NOT COMPLETED|Overall Study||1
10232920|NCT01973062|11362392|FG000|STARTED|Overall Study||1
10232921|NCT01973062|11362392|FG000|COMPLETED|Overall Study||1
10232922|NCT01973062|11362392|FG000|NOT COMPLETED|Overall Study||0
10232923|NCT01982253|11362399|FG000|STARTED|Overall Study||2
10232924|NCT01982253|11362400|FG001|STARTED|Overall Study||4
10232925|NCT01982253|11362401|FG002|STARTED|Overall Study||4
10232926|NCT01982253|11362399|FG000|COMPLETED|Overall Study||0
10232927|NCT01982253|11362400|FG001|COMPLETED|Overall Study||0
10232928|NCT01982253|11362401|FG002|COMPLETED|Overall Study||0
10232929|NCT01982253|11362399|FG000|NOT COMPLETED|Overall Study||2
10232930|NCT01982253|11362400|FG001|NOT COMPLETED|Overall Study||4
10232931|NCT01982253|11362401|FG002|NOT COMPLETED|Overall Study||4
10232932|NCT01984268|11362409|FG000|STARTED|Overall Study||15
10232933|NCT01984268|11362409|FG000|COMPLETED|Overall Study||0
9768521|NCT00427778|10873350|FG000|COMPLETED|Second Intervention (4 Weeks)||10
9768522|NCT00427778|10873351|FG001|COMPLETED|Second Intervention (4 Weeks)||14
9768523|NCT00427778|10873350|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
9768524|NCT00427778|10873351|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
9768525|NCT00427791|10873372|FG000|STARTED|Overall Study||10
9768526|NCT00427791|10873373|FG001|STARTED|Overall Study||13
9768527|NCT00427791|10873372|FG000|COMPLETED|Overall Study||10
10232934|NCT01984268|11362409|FG000|NOT COMPLETED|Overall Study||15
10232935|NCT01974284|11362413|FG000|STARTED|Overall Study||7
10232936|NCT01974284|11362413|FG000|COMPLETED|Overall Study||0
10232937|NCT01974284|11362413|FG000|NOT COMPLETED|Overall Study||7
9768528|NCT00427791|10873373|FG001|COMPLETED|Overall Study||13
9768529|NCT00427791|10873372|FG000|NOT COMPLETED|Overall Study||0
9768530|NCT00427791|10873373|FG001|NOT COMPLETED|Overall Study||0
9768531|NCT00427804|10873381|FG000|STARTED|Overall Study||4
9768532|NCT00427804|10873382|FG001|STARTED|Overall Study||5
9768533|NCT00427804|10873381|FG000|COMPLETED|Overall Study||4
9768534|NCT00427804|10873382|FG001|COMPLETED|Overall Study||5
9768535|NCT00427804|10873381|FG000|NOT COMPLETED|Overall Study||0
9768536|NCT00427804|10873382|FG001|NOT COMPLETED|Overall Study||0
9768537|NCT00427895|10873392|FG000|STARTED|Between 6-Month Follow-up - Year 1||411
9768538|NCT00427895|10873393|FG001|STARTED|Between 6-Month Follow-up - Year 1||411
9768539|NCT00427895|10873394|FG002|STARTED|Between 6-Month Follow-up - Year 1||392
9957081|NCT01449370|11076256|FG021|COMPLETED|Overall Study||0
10232938|NCT01971853|11362419|FG000|STARTED|Overall Study||0
10232939|NCT01971853|11362420|FG001|STARTED|Overall Study||0
9768540|NCT00427895|10873395|FG003|STARTED|Between 6-Month Follow-up - Year 1||854
9768541|NCT00427895|10873396|FG004|STARTED|Between 6-Month Follow-up - Year 1||0
9768542|NCT00427895|10873397|FG005|STARTED|Between 6-Month Follow-up - Year 1||0
9768543|NCT00427895|10873398|FG006|STARTED|Between 6-Month Follow-up - Year 1||0
9768544|NCT00427895|10873399|FG007|STARTED|Between 6-Month Follow-up - Year 1||0
9768545|NCT00427895|10873392|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411
9768546|NCT00427895|10873393|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411
10232940|NCT01971853|11362419|FG000|COMPLETED|Overall Study||0
10232941|NCT01971853|11362420|FG001|COMPLETED|Overall Study||0
10232942|NCT01971853|11362419|FG000|NOT COMPLETED|Overall Study||0
10232943|NCT01971853|11362420|FG001|NOT COMPLETED|Overall Study||0
10232944|NCT01980875|11362429|FG000|STARTED|Overall Study||8
10232945|NCT01980875|11362430|FG001|STARTED|Overall Study||25
10232946|NCT01980875|11362431|FG002|STARTED|Overall Study||24
10232947|NCT01980875|11362429|FG000|COMPLETED|Overall Study||0
10232948|NCT01980875|11362430|FG001|COMPLETED|Overall Study||0
10232949|NCT01980875|11362431|FG002|COMPLETED|Overall Study||0
10232950|NCT01980875|11362429|FG000|NOT COMPLETED|Overall Study||8
10232951|NCT01980875|11362430|FG001|NOT COMPLETED|Overall Study||25
10232952|NCT01980875|11362431|FG002|NOT COMPLETED|Overall Study||24
10232953|NCT01982383|11362441|FG000|STARTED|Overall Study||2
10232954|NCT01982383|11362442|FG001|STARTED|Overall Study||0
10232955|NCT01982383|11362441|FG000|COMPLETED|Overall Study||2
10232956|NCT01982383|11362442|FG001|COMPLETED|Overall Study||0
10232957|NCT01982383|11362441|FG000|NOT COMPLETED|Overall Study||0
10232958|NCT01982383|11362442|FG001|NOT COMPLETED|Overall Study||0
10232959|NCT01980342|11362448|FG000|STARTED|Overall Study||1
10232960|NCT01980342|11362448|FG000|COMPLETED|Overall Study||0
10232961|NCT01980342|11362448|FG000|NOT COMPLETED|Overall Study||1
10232962|NCT01978535|11362454|FG000|STARTED|Overall Study||1
10232963|NCT01978535|11362455|FG001|STARTED|Overall Study||2
10232964|NCT01978535|11362454|FG000|COMPLETED|Overall Study||1
10232965|NCT01978535|11362455|FG001|COMPLETED|Overall Study||2
10232966|NCT01978535|11362454|FG000|NOT COMPLETED|Overall Study||0
10232967|NCT01978535|11362455|FG001|NOT COMPLETED|Overall Study||0
10232968|NCT01974635|11362461|FG000|STARTED|Overall Study||2
10232969|NCT01974635|11362461|FG000|COMPLETED|Overall Study||2
10232970|NCT01974635|11362461|FG000|NOT COMPLETED|Overall Study||0
10232971|NCT01975467|11362468|FG000|STARTED|Overall Study|Study terminated before enrollment|0
10232972|NCT01975467|11362469|FG001|STARTED|Overall Study|Study terminated before enrollment|0
10232973|NCT01975467|11362468|FG000|COMPLETED|Overall Study||0
10232974|NCT01975467|11362469|FG001|COMPLETED|Overall Study||0
10232975|NCT01975467|11362468|FG000|NOT COMPLETED|Overall Study||0
10232976|NCT01975467|11362469|FG001|NOT COMPLETED|Overall Study||0
10232977|NCT01970462|11362477|FG000|STARTED|Overall Study||1
10232978|NCT01970462|11362478|FG001|STARTED|Overall Study||4
10232979|NCT01970462|11362477|FG000|COMPLETED|Overall Study||1
10232980|NCT01970462|11362478|FG001|COMPLETED|Overall Study||2
10232981|NCT01970462|11362477|FG000|NOT COMPLETED|Overall Study||0
10232982|NCT01970462|11362478|FG001|NOT COMPLETED|Overall Study||2
10232983|NCT01969565|11362484|FG000|STARTED|Overall Study||1
10232984|NCT01969565|11362484|FG000|COMPLETED|Overall Study||0
10232985|NCT01969565|11362484|FG000|NOT COMPLETED|Overall Study||1
10232986|NCT01968226|11362489|FG000|STARTED|Overall Study||3
10232987|NCT01968226|11362489|FG000|COMPLETED|Overall Study||1
10232988|NCT01968226|11362489|FG000|NOT COMPLETED|Overall Study||2
10232989|NCT01965782|11362493|FG000|STARTED|Overall Study||0
10232990|NCT01965782|11362493|FG000|COMPLETED|Overall Study||0
10232991|NCT01965782|11362493|FG000|NOT COMPLETED|Overall Study||0
10232992|NCT01962675|11362499|FG000|STARTED|Overall Study||7
10232993|NCT01962675|11362500|FG001|STARTED|Overall Study||7
10232994|NCT01962675|11362499|FG000|COMPLETED|Overall Study||7
10232995|NCT01962675|11362500|FG001|COMPLETED|Overall Study||7
10232996|NCT01962675|11362499|FG000|NOT COMPLETED|Overall Study||0
10232997|NCT01962675|11362500|FG001|NOT COMPLETED|Overall Study||0
10232998|NCT01962974|11362508|FG000|STARTED|Overall Study||7
10232999|NCT01962974|11362508|FG000|COMPLETED|Overall Study||0
10233000|NCT01962974|11362508|FG000|NOT COMPLETED|Overall Study||7
10233001|NCT01954160|11362514|FG000|STARTED|Overall Study||5
10233002|NCT01954160|11362515|FG001|STARTED|Overall Study|Not started|0
10233003|NCT01954160|11362514|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
10233004|NCT01954160|11362515|FG001|COMPLETED|Overall Study||0
10233005|NCT01954160|11362514|FG000|NOT COMPLETED|Overall Study||5
10233006|NCT01954160|11362515|FG001|NOT COMPLETED|Overall Study||0
10233007|NCT01951378|11362525|FG000|STARTED|Overall Study||23
10233008|NCT01951378|11362526|FG001|STARTED|Overall Study||17
9768547|NCT00427895|10873394|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392
10233009|NCT01951378|11362525|FG000|COMPLETED|Overall Study||0
10233010|NCT01951378|11362526|FG001|COMPLETED|Overall Study||0
10233011|NCT01951378|11362525|FG000|NOT COMPLETED|Overall Study||23
10233012|NCT01951378|11362526|FG001|NOT COMPLETED|Overall Study||17
10233013|NCT01941615|11362532|FG000|STARTED|Run in Treatment: Microgynon®||16
10233014|NCT01941615|11362532|FG000|COMPLETED|Run in Treatment: Microgynon®||16
9768548|NCT00427895|10873395|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502
10233015|NCT01941615|11362532|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0
10233016|NCT01941615|11362532|FG000|STARTED|Reference Treatment: Microgynon®||0
10233017|NCT01941615|11362532|FG000|COMPLETED|Reference Treatment: Microgynon®||0
10233018|NCT01941615|11362532|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0
9768549|NCT00427895|10873396|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0
9768550|NCT00427895|10873397|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0
9768551|NCT00427895|10873398|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0
9768552|NCT00427895|10873399|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0
9768553|NCT00427895|10873392|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
9768554|NCT00427895|10873393|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
9768555|NCT00427895|10873394|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
9768556|NCT00427895|10873395|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
9768557|NCT00427895|10873396|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
9768558|NCT00427895|10873397|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
9768559|NCT00427895|10873398|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
9768560|NCT00427895|10873399|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
9768561|NCT00427895|10873392|FG000|STARTED|Vax 2/Year 3 to 4||0
9768562|NCT00427895|10873393|FG001|STARTED|Vax 2/Year 3 to 4||0
9768563|NCT00427895|10873394|FG002|STARTED|Vax 2/Year 3 to 4||0
9768564|NCT00427895|10873395|FG003|STARTED|Vax 2/Year 3 to 4||0
9768565|NCT00427895|10873396|FG004|STARTED|Vax 2/Year 3 to 4||108
9768566|NCT00427895|10873397|FG005|STARTED|Vax 2/Year 3 to 4||108
9768567|NCT00427895|10873398|FG006|STARTED|Vax 2/Year 3 to 4||189
9768568|NCT00427895|10873399|FG007|STARTED|Vax 2/Year 3 to 4||214
9768569|NCT00427895|10873392|FG000|COMPLETED|Vax 2/Year 3 to 4||0
9768570|NCT00427895|10873393|FG001|COMPLETED|Vax 2/Year 3 to 4||0
9768571|NCT00427895|10873394|FG002|COMPLETED|Vax 2/Year 3 to 4||0
9768572|NCT00427895|10873395|FG003|COMPLETED|Vax 2/Year 3 to 4||0
9768573|NCT00427895|10873396|FG004|COMPLETED|Vax 2/Year 3 to 4||107
9768574|NCT00427895|10873397|FG005|COMPLETED|Vax 2/Year 3 to 4||108
9768575|NCT00427895|10873398|FG006|COMPLETED|Vax 2/Year 3 to 4||189
9768576|NCT00427895|10873399|FG007|COMPLETED|Vax 2/Year 3 to 4||212
9768577|NCT00427895|10873392|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0
9768578|NCT00427895|10873393|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0
9768579|NCT00427895|10873394|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0
9768580|NCT00427895|10873395|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0
9768581|NCT00427895|10873396|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1
10233019|NCT01941615|11362532|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
10233020|NCT01941615|11362532|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
10233021|NCT01941615|11362532|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
10233022|NCT01946542|11362538|FG000|STARTED|Testing Visit 1||1
10233023|NCT01946542|11362539|FG001|STARTED|Testing Visit 1||1
10233024|NCT01946542|11362538|FG000|COMPLETED|Testing Visit 1||1
10233025|NCT01946542|11362539|FG001|COMPLETED|Testing Visit 1||1
10233026|NCT01946542|11362538|FG000|NOT COMPLETED|Testing Visit 1||0
10233027|NCT01946542|11362539|FG001|NOT COMPLETED|Testing Visit 1||0
10233028|NCT01946542|11362538|FG000|STARTED|Testing Visit 2||1
10233029|NCT01946542|11362539|FG001|STARTED|Testing Visit 2||1
10233030|NCT01946542|11362538|FG000|COMPLETED|Testing Visit 2||1
10233031|NCT01946542|11362539|FG001|COMPLETED|Testing Visit 2||1
10233032|NCT01946542|11362538|FG000|NOT COMPLETED|Testing Visit 2||0
10233033|NCT01946542|11362539|FG001|NOT COMPLETED|Testing Visit 2||0
10233034|NCT01937507|11362545|FG000|STARTED|Overall Study||2
10233035|NCT01937507|11362545|FG000|COMPLETED|Overall Study||0
10233036|NCT01937507|11362545|FG000|NOT COMPLETED|Overall Study||2
10233037|NCT01944059|11362549|FG000|STARTED|Overall Study||31
10233038|NCT01944059|11362549|FG000|COMPLETED|Overall Study||24
10233039|NCT01944059|11362549|FG000|NOT COMPLETED|Overall Study||7
10233040|NCT01935947|11362557|FG000|STARTED|Overall Study||4
10233041|NCT01935947|11362558|FG001|STARTED|Overall Study||4
10233042|NCT01935947|11362559|FG002|STARTED|Overall Study||2
10233043|NCT01935947|11362557|FG000|Epigenetic Therapy|Overall Study||4
10233044|NCT01935947|11362558|FG001|Epigenetic Therapy|Overall Study||4
10233045|NCT01935947|11362559|FG002|Epigenetic Therapy|Overall Study||0
10233046|NCT01935947|11362557|FG000|Cytotoxic Therapy|Overall Study||3
10233047|NCT01935947|11362558|FG001|Cytotoxic Therapy|Overall Study||3
10233048|NCT01935947|11362559|FG002|Cytotoxic Therapy|Overall Study||2
10233049|NCT01935947|11362557|FG000|COMPLETED|Overall Study||1
10233050|NCT01935947|11362558|FG001|COMPLETED|Overall Study||0
10233051|NCT01935947|11362559|FG002|COMPLETED|Overall Study||0
10233052|NCT01935947|11362557|FG000|NOT COMPLETED|Overall Study||3
10233053|NCT01935947|11362558|FG001|NOT COMPLETED|Overall Study||4
10233054|NCT01935947|11362559|FG002|NOT COMPLETED|Overall Study||2
10233055|NCT01939223|11362572|FG000|STARTED|Overall Study||14
10233056|NCT01939223|11362573|FG001|STARTED|Overall Study||11
10233057|NCT01939223|11362572|FG000|Participants Received Treatment|Overall Study||14
9768582|NCT00427895|10873397|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0
9768583|NCT00427895|10873398|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0
9768584|NCT00427895|10873399|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2
9768585|NCT00427895|10873392|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418
9768586|NCT00427895|10873393|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417
9768587|NCT00427895|10873394|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406
10233058|NCT01939223|11362573|FG001|Participants Received Treatment|Overall Study||11
10233059|NCT01939223|11362572|FG000|COMPLETED|Overall Study||1
10233060|NCT01939223|11362573|FG001|COMPLETED|Overall Study||0
10233061|NCT01939223|11362572|FG000|NOT COMPLETED|Overall Study||13
10233062|NCT01939223|11362573|FG001|NOT COMPLETED|Overall Study||11
10233063|NCT01938716|11362579|FG000|STARTED|Overall Study||12
10233064|NCT01938716|11362579|FG000|COMPLETED|Overall Study||8
10233065|NCT01938716|11362579|FG000|NOT COMPLETED|Overall Study||4
10233066|NCT01936974|11362585|FG000|STARTED|Overall Study||2
9768588|NCT00427895|10873395|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900
9768589|NCT00427895|10873396|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0
9768590|NCT00427895|10873397|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0
9768591|NCT00427895|10873398|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0
9768592|NCT00427895|10873399|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0
9768593|NCT00427895|10873392|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
9768594|NCT00427895|10873393|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
9768595|NCT00427895|10873394|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
9768596|NCT00427895|10873395|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
9768597|NCT00427895|10873396|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
9768598|NCT00427895|10873397|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
9768599|NCT00427895|10873398|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
9768600|NCT00427895|10873399|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
9768601|NCT00427895|10873392|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
9768602|NCT00427895|10873393|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
9768603|NCT00427895|10873394|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
9768604|NCT00427895|10873395|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
9768605|NCT00427895|10873396|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768606|NCT00427895|10873397|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768607|NCT00427895|10873398|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768608|NCT00427895|10873399|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768609|NCT00427895|10873392|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
9768610|NCT00427895|10873393|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
9768611|NCT00427895|10873394|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
9768612|NCT00427895|10873395|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
9768613|NCT00427895|10873396|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768614|NCT00427895|10873397|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768615|NCT00427895|10873398|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768616|NCT00427895|10873399|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
9768617|NCT00427895|10873392|FG000|STARTED|Vax 1/Year 1 Follow-up||411
9768618|NCT00427895|10873393|FG001|STARTED|Vax 1/Year 1 Follow-up||411
9768619|NCT00427895|10873394|FG002|STARTED|Vax 1/Year 1 Follow-up||392
9768620|NCT00427895|10873395|FG003|STARTED|Vax 1/Year 1 Follow-up||502
10233067|NCT01936974|11362586|FG001|STARTED|Overall Study||5
10233068|NCT01936974|11362585|FG000|COMPLETED|Overall Study||0
10233069|NCT01936974|11362586|FG001|COMPLETED|Overall Study||0
10233070|NCT01936974|11362585|FG000|NOT COMPLETED|Overall Study||2
10233071|NCT01936974|11362586|FG001|NOT COMPLETED|Overall Study||5
10233072|NCT01938833|11362592|FG000|STARTED|Overall Study||9
10233073|NCT01938833|11362592|FG000|COMPLETED|Overall Study||9
10233074|NCT01938833|11362592|FG000|NOT COMPLETED|Overall Study||0
10233075|NCT01934647|11362599|FG000|STARTED|Overall Study||2
10233076|NCT01934647|11362600|FG001|STARTED|Overall Study||2
10233077|NCT01934647|11362601|FG002|STARTED|Overall Study||3
10233078|NCT01934647|11362599|FG000|COMPLETED|Overall Study||2
10233079|NCT01934647|11362600|FG001|COMPLETED|Overall Study||2
10233080|NCT01934647|11362601|FG002|COMPLETED|Overall Study||3
10233081|NCT01934647|11362599|FG000|NOT COMPLETED|Overall Study||0
10233082|NCT01934647|11362600|FG001|NOT COMPLETED|Overall Study||0
10233083|NCT01934647|11362601|FG002|NOT COMPLETED|Overall Study||0
10233084|NCT01934504|11362613|FG000|STARTED|Overall Study||6
10233085|NCT01934504|11362614|FG001|STARTED|Overall Study||3
10233086|NCT01934504|11362615|FG002|STARTED|Overall Study||16
10233087|NCT01934504|11362616|FG003|STARTED|Overall Study||8
10233088|NCT01934504|11362613|FG000|COMPLETED|Overall Study||5
10233089|NCT01934504|11362614|FG001|COMPLETED|Overall Study||3
10233090|NCT01934504|11362615|FG002|COMPLETED|Overall Study||11
10233091|NCT01934504|11362616|FG003|COMPLETED|Overall Study||1
10233092|NCT01934504|11362613|FG000|NOT COMPLETED|Overall Study||1
10233093|NCT01934504|11362614|FG001|NOT COMPLETED|Overall Study||0
10233094|NCT01934504|11362615|FG002|NOT COMPLETED|Overall Study||5
10233095|NCT01934504|11362616|FG003|NOT COMPLETED|Overall Study||7
10233096|NCT01928082|11362626|FG000|STARTED|Overall Study||1
10233097|NCT01928082|11362626|FG000|COMPLETED|Overall Study||0
10233098|NCT01928082|11362626|FG000|NOT COMPLETED|Overall Study||1
10233099|NCT01928615|11362630|FG000|STARTED|Overall Study||2
10233100|NCT01928615|11362630|FG000|COMPLETED|Overall Study||0
10233101|NCT01928615|11362630|FG000|NOT COMPLETED|Overall Study||2
10233102|NCT01911793|11362637|FG000|STARTED|Overall Study||1
10233103|NCT01911793|11362638|FG001|STARTED|Overall Study||5
10233104|NCT01911793|11362637|FG000|COMPLETED|Overall Study||0
10233105|NCT01911793|11362638|FG001|COMPLETED|Overall Study||0
10233106|NCT01911793|11362637|FG000|NOT COMPLETED|Overall Study||1
10233107|NCT01911793|11362638|FG001|NOT COMPLETED|Overall Study||5
10233108|NCT01912404|11362646|FG000|STARTED|Overall Study||3
10233109|NCT01912404|11362647|FG001|STARTED|Overall Study||2
10233110|NCT01912404|11362646|FG000|COMPLETED|Overall Study||2
10233111|NCT01912404|11362647|FG001|COMPLETED|Overall Study||2
10233112|NCT01912404|11362646|FG000|NOT COMPLETED|Overall Study||1
9768621|NCT00427895|10873396|FG004|STARTED|Vax 1/Year 1 Follow-up||0
9768622|NCT00427895|10873397|FG005|STARTED|Vax 1/Year 1 Follow-up||0
10233113|NCT01912404|11362647|FG001|NOT COMPLETED|Overall Study||0
10233114|NCT01910389|11362655|FG000|STARTED|Overall Study||15
10233115|NCT01910389|11362656|FG001|STARTED|Overall Study||8
10233116|NCT01910389|11362655|FG000|COMPLETED|Overall Study||0
10233117|NCT01910389|11362656|FG001|COMPLETED|Overall Study||0
9768623|NCT00427895|10873398|FG006|STARTED|Vax 1/Year 1 Follow-up||0
9768624|NCT00427895|10873399|FG007|STARTED|Vax 1/Year 1 Follow-up||0
9768625|NCT00427895|10873392|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404
9768626|NCT00427895|10873393|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396
9768627|NCT00427895|10873394|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373
9768628|NCT00427895|10873395|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469
9768629|NCT00427895|10873396|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0
9768630|NCT00427895|10873397|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0
9768631|NCT00427895|10873398|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0
9768632|NCT00427895|10873399|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0
9768633|NCT00427895|10873392|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
9768634|NCT00427895|10873393|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
9768635|NCT00427895|10873394|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
9768636|NCT00427895|10873395|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
9768637|NCT00427895|10873396|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
9768638|NCT00427895|10873397|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
9768639|NCT00427895|10873398|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
9768640|NCT00427895|10873399|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
9768641|NCT00427895|10873392|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
9768642|NCT00427895|10873393|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
9768643|NCT00427895|10873394|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
10233118|NCT01910389|11362655|FG000|NOT COMPLETED|Overall Study||15
10233119|NCT01910389|11362656|FG001|NOT COMPLETED|Overall Study||8
10233120|NCT01921114|11362664|FG000|STARTED|Overall Study||0
10233121|NCT01921114|11362665|FG001|STARTED|Overall Study||0
10233122|NCT01921114|11362664|FG000|COMPLETED|Overall Study||0
10233123|NCT01921114|11362665|FG001|COMPLETED|Overall Study||0
10233124|NCT01921114|11362664|FG000|NOT COMPLETED|Overall Study||0
10233125|NCT01921114|11362665|FG001|NOT COMPLETED|Overall Study||0
10233126|NCT01916590|11362673|FG000|STARTED|Overall Study||4
10233127|NCT01916590|11362674|FG001|STARTED|Overall Study||3
10233128|NCT01916590|11362673|FG000|COMPLETED|Overall Study||4
10233129|NCT01916590|11362674|FG001|COMPLETED|Overall Study||3
10233130|NCT01916590|11362673|FG000|NOT COMPLETED|Overall Study||0
10233131|NCT01916590|11362674|FG001|NOT COMPLETED|Overall Study||0
10233132|NCT01913327|11362682|FG000|STARTED|Overall Study||1
10233133|NCT01913327|11362683|FG001|STARTED|Overall Study||2
10233134|NCT01913327|11362682|FG000|COMPLETED|Overall Study||1
10233135|NCT01913327|11362683|FG001|COMPLETED|Overall Study||1
10233136|NCT01913327|11362682|FG000|NOT COMPLETED|Overall Study||0
10233137|NCT01913327|11362683|FG001|NOT COMPLETED|Overall Study||1
10233138|NCT01902888|11362689|FG000|STARTED|Overall Study||3
10233139|NCT01902888|11362689|FG000|COMPLETED|Overall Study||0
10233140|NCT01902888|11362689|FG000|NOT COMPLETED|Overall Study||3
10233141|NCT01901224|11362693|FG000|STARTED|Overall Study||2
10233142|NCT01901224|11362693|FG000|COMPLETED|Overall Study||0
10233143|NCT01901224|11362693|FG000|NOT COMPLETED|Overall Study||2
10233144|NCT01910441|11362699|FG000|STARTED|Overall Study||48
10233145|NCT01910441|11362700|FG001|STARTED|Overall Study||47
10233146|NCT01910441|11362699|FG000|COMPLETED|Overall Study||41
10233147|NCT01910441|11362700|FG001|COMPLETED|Overall Study||37
10233148|NCT01910441|11362699|FG000|NOT COMPLETED|Overall Study||7
10233149|NCT01910441|11362700|FG001|NOT COMPLETED|Overall Study||10
10233150|NCT01902966|11362706|FG000|STARTED|Overall Study||5
10233151|NCT01902966|11362706|FG000|COMPLETED|Overall Study||2
10233152|NCT01902966|11362706|FG000|NOT COMPLETED|Overall Study||3
10233153|NCT01901679|11362712|FG000|STARTED|Overall Study||5
10233154|NCT01901679|11362713|FG001|STARTED|Overall Study||5
10233155|NCT01901679|11362712|FG000|COMPLETED|Overall Study||5
10233156|NCT01901679|11362713|FG001|COMPLETED|Overall Study||5
10233157|NCT01901679|11362712|FG000|NOT COMPLETED|Overall Study||0
10233158|NCT01901679|11362713|FG001|NOT COMPLETED|Overall Study||0
10233159|NCT01900730|11362721|FG000|STARTED|Overall Study||3
10233160|NCT01900730|11362722|FG001|STARTED|Overall Study||0
10233161|NCT01900730|11362721|FG000|COMPLETED|Overall Study||1
10233162|NCT01900730|11362722|FG001|COMPLETED|Overall Study||0
10233163|NCT01900730|11362721|FG000|NOT COMPLETED|Overall Study||2
10233164|NCT01900730|11362722|FG001|NOT COMPLETED|Overall Study||0
10233165|NCT01877564|11362730|FG000|STARTED|Overall Study||6
10233166|NCT01877564|11362731|FG001|STARTED|Overall Study||4
10233167|NCT01877564|11362730|FG000|COMPLETED|Overall Study||6
10233168|NCT01877564|11362731|FG001|COMPLETED|Overall Study||4
10233169|NCT01877564|11362730|FG000|NOT COMPLETED|Overall Study||0
10233170|NCT01877564|11362731|FG001|NOT COMPLETED|Overall Study||0
10233171|NCT01890694|11362739|FG000|STARTED|Overall Study||1
10233172|NCT01890694|11362740|FG001|STARTED|Overall Study||1
10233173|NCT01890694|11362739|FG000|COMPLETED|Overall Study||0
10233174|NCT01890694|11362740|FG001|COMPLETED|Overall Study||0
10233175|NCT01890694|11362739|FG000|NOT COMPLETED|Overall Study||1
10233176|NCT01890694|11362740|FG001|NOT COMPLETED|Overall Study||1
10233177|NCT01900626|11362750|FG000|STARTED|Overall Study||1
9768644|NCT00427895|10873395|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
10233178|NCT01900626|11362751|FG001|STARTED|Overall Study||1
10233179|NCT01900626|11362750|FG000|COMPLETED|Overall Study||0
10233180|NCT01900626|11362751|FG001|COMPLETED|Overall Study||0
10233181|NCT01900626|11362750|FG000|NOT COMPLETED|Overall Study||1
10233182|NCT01900626|11362751|FG001|NOT COMPLETED|Overall Study||1
10233183|NCT01890577|11362759|FG000|STARTED|Overall Study||28
10233184|NCT01890577|11362759|FG000|COMPLETED|Overall Study||0
10233185|NCT01890577|11362759|FG000|NOT COMPLETED|Overall Study||28
10233186|NCT01895959|11362763|FG000|STARTED|Overall Study||12
9768645|NCT00427895|10873396|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
9768646|NCT00427895|10873397|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
9768647|NCT00427895|10873398|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
9768648|NCT00427895|10873399|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
9768649|NCT00427895|10873392|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
9768650|NCT00427895|10873393|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
9768651|NCT00427895|10873394|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
9768652|NCT00427895|10873395|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
9768653|NCT00427895|10873396|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
9768654|NCT00427895|10873397|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10233187|NCT01895959|11362763|FG000|COMPLETED|Overall Study||10
10233188|NCT01895959|11362763|FG000|NOT COMPLETED|Overall Study||2
10233189|NCT01889420|11362767|FG000|STARTED|Overall Study||1
10233190|NCT01889420|11362767|FG000|COMPLETED|Overall Study||1
10233191|NCT01889420|11362767|FG000|NOT COMPLETED|Overall Study||0
10233192|NCT01884077|11362773|FG000|STARTED|Overall Study||8
10233193|NCT01884077|11362774|FG001|STARTED|Overall Study||11
10233194|NCT01884077|11362773|FG000|COMPLETED|Overall Study||0
10233195|NCT01884077|11362774|FG001|COMPLETED|Overall Study||1
10233196|NCT01884077|11362773|FG000|NOT COMPLETED|Overall Study||8
10233197|NCT01884077|11362774|FG001|NOT COMPLETED|Overall Study||10
10233198|NCT01881984|11362780|FG000|STARTED|Overall Study||4
10233199|NCT01881984|11362780|FG000|COMPLETED|Overall Study||4
10233200|NCT01881984|11362780|FG000|NOT COMPLETED|Overall Study||0
10233201|NCT01893359|11362787|FG000|STARTED|Overall Study||0
10233202|NCT01893359|11362788|FG001|STARTED|Overall Study||2
10233203|NCT01893359|11362789|FG002|STARTED|Overall Study||0
10233204|NCT01893359|11362787|FG000|COMPLETED|Overall Study||0
10233205|NCT01893359|11362788|FG001|COMPLETED|Overall Study||2
10233206|NCT01893359|11362789|FG002|COMPLETED|Overall Study||0
10233207|NCT01893359|11362787|FG000|NOT COMPLETED|Overall Study||0
10233208|NCT01893359|11362788|FG001|NOT COMPLETED|Overall Study||0
10233209|NCT01893359|11362789|FG002|NOT COMPLETED|Overall Study||0
10239610|NCT00107614|11371256|FG000|STARTED|Overall Study||12
10239611|NCT00107614|11371256|FG000|COMPLETED|Overall Study||0
10239612|NCT00107614|11371256|FG000|NOT COMPLETED|Overall Study||12
10239613|NCT00107315|11371260|FG000|STARTED|Overall Study||16
10239614|NCT00107315|11371260|FG000|COMPLETED|Overall Study||1
10239615|NCT00107315|11371260|FG000|NOT COMPLETED|Overall Study||15
10239616|NCT00108433|11371266|FG000|STARTED|Overall Study||30
10239617|NCT00108433|11371267|FG001|STARTED|Overall Study||31
10239618|NCT00108433|11371266|FG000|COMPLETED|Overall Study||9
10239619|NCT00108433|11371267|FG001|COMPLETED|Overall Study||14
10239620|NCT00108433|11371266|FG000|NOT COMPLETED|Overall Study||21
10239621|NCT00108433|11371267|FG001|NOT COMPLETED|Overall Study||17
10239622|NCT00113919|11371273|FG000|STARTED|Overall Study||14
10239623|NCT00113919|11371273|FG000|COMPLETED|Overall Study||0
10239624|NCT00113919|11371273|FG000|NOT COMPLETED|Overall Study||14
10239625|NCT00108342|11371279|FG000|STARTED|Overall Study||8
10239626|NCT00108342|11371280|FG001|STARTED|Overall Study||9
10239627|NCT00108342|11371279|FG000|COMPLETED|Overall Study||7
10239628|NCT00108342|11371280|FG001|COMPLETED|Overall Study||9
10239629|NCT00108342|11371279|FG000|NOT COMPLETED|Overall Study||1
10239630|NCT00108342|11371280|FG001|NOT COMPLETED|Overall Study||0
10239631|NCT00100828|11371286|FG000|STARTED|Overall Study||6
10239632|NCT00100828|11371286|FG000|COMPLETED|Overall Study||0
10239633|NCT00100828|11371286|FG000|NOT COMPLETED|Overall Study||6
10239634|NCT00104728|11371290|FG000|STARTED|Overall Study|42 consented on study|42
10239635|NCT00104728|11371290|FG000|COMPLETED|Overall Study||23
10239636|NCT00104728|11371290|FG000|NOT COMPLETED|Overall Study||19
10239637|NCT00089414|11371297|FG000|STARTED|Overall Study||2
10239638|NCT00089414|11371298|FG001|STARTED|Overall Study||1
10239639|NCT00089414|11371299|FG002|STARTED|Overall Study||2
10239640|NCT00089414|11371297|FG000|COMPLETED|Overall Study||2
10239641|NCT00089414|11371298|FG001|COMPLETED|Overall Study||1
10239642|NCT00089414|11371299|FG002|COMPLETED|Overall Study||2
10239643|NCT00089414|11371297|FG000|NOT COMPLETED|Overall Study||0
10239644|NCT00089414|11371298|FG001|NOT COMPLETED|Overall Study||0
10239645|NCT00089414|11371299|FG002|NOT COMPLETED|Overall Study||0
10239646|NCT00083915|11371309|FG000|STARTED|Overall Study||52
10239647|NCT00083915|11371310|FG001|STARTED|Overall Study||45
10239648|NCT00083915|11371309|FG000|COMPLETED|Overall Study||2
10239649|NCT00083915|11371310|FG001|COMPLETED|Overall Study||8
10239650|NCT00083915|11371309|FG000|NOT COMPLETED|Overall Study||50
10239651|NCT00083915|11371310|FG001|NOT COMPLETED|Overall Study||37
10239652|NCT00090870|11371316|FG000|STARTED|Overall Study||10
10239653|NCT00090870|11371316|FG000|COMPLETED|Overall Study||10
10239654|NCT00090870|11371316|FG000|NOT COMPLETED|Overall Study||0
10239655|NCT00088972|11371322|FG000|STARTED|Overall Study||3
10239656|NCT00088972|11371323|FG001|STARTED|Overall Study||5
10239657|NCT00088972|11371322|FG000|COMPLETED|Overall Study||1
10239658|NCT00088972|11371323|FG001|COMPLETED|Overall Study||1
10239659|NCT00088972|11371322|FG000|NOT COMPLETED|Overall Study||2
10239660|NCT00088972|11371323|FG001|NOT COMPLETED|Overall Study||4
10239661|NCT00088829|11371329|FG000|STARTED|Overall Study||22
9768655|NCT00427895|10873398|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10239662|NCT00088829|11371329|FG000|COMPLETED|Overall Study||0
10239663|NCT00088829|11371329|FG000|NOT COMPLETED|Overall Study||22
10239664|NCT00089128|11371333|FG000|STARTED|Overall Study||16
10239665|NCT00089128|11371333|FG000|COMPLETED|Overall Study||16
9768656|NCT00427895|10873399|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
9768657|NCT00427895|10873392|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
9768658|NCT00427895|10873393|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
9768659|NCT00427895|10873394|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
9768660|NCT00427895|10873395|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
9768661|NCT00427895|10873396|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
9768662|NCT00427895|10873397|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
9768663|NCT00427895|10873398|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
9768664|NCT00427895|10873399|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
9768665|NCT00427908|10873442|FG000|STARTED|Primary Phase||229
9768666|NCT00427908|10873443|FG001|STARTED|Primary Phase||231
9768667|NCT00427908|10873444|FG002|STARTED|Primary Phase||75
9768668|NCT00427908|10873445|FG003|STARTED|Primary Phase||78
9768669|NCT00427908|10873442|FG000|COMPLETED|Primary Phase||224
9768670|NCT00427908|10873443|FG001|COMPLETED|Primary Phase||228
9768671|NCT00427908|10873444|FG002|COMPLETED|Primary Phase||72
9768672|NCT00427908|10873445|FG003|COMPLETED|Primary Phase||78
9768673|NCT00427908|10873442|FG000|NOT COMPLETED|Primary Phase||5
9768674|NCT00427908|10873443|FG001|NOT COMPLETED|Primary Phase||3
9768675|NCT00427908|10873444|FG002|NOT COMPLETED|Primary Phase||3
10233210|NCT01883908|11362799|FG000|STARTED|Overall Study||3
10233211|NCT01883908|11362800|FG001|STARTED|Overall Study||1
10233212|NCT01883908|11362799|FG000|COMPLETED|Overall Study||3
10233213|NCT01883908|11362800|FG001|COMPLETED|Overall Study||1
10233214|NCT01883908|11362799|FG000|NOT COMPLETED|Overall Study||0
10233215|NCT01883908|11362800|FG001|NOT COMPLETED|Overall Study||0
10233216|NCT01887288|11362806|FG000|STARTED|Overall Study||16
10233217|NCT01887288|11362806|FG000|COMPLETED|Overall Study||0
10233218|NCT01887288|11362806|FG000|NOT COMPLETED|Overall Study||16
10233219|NCT01881932|11362813|FG000|STARTED|Overall Study||2
10233220|NCT01881932|11362814|FG001|STARTED|Overall Study||4
10233221|NCT01881932|11362815|FG002|STARTED|Overall Study||13
10233222|NCT01881932|11362813|FG000|COMPLETED|Overall Study||2
10233223|NCT01881932|11362814|FG001|COMPLETED|Overall Study||4
10233224|NCT01881932|11362815|FG002|COMPLETED|Overall Study||13
10233225|NCT01881932|11362813|FG000|NOT COMPLETED|Overall Study||0
10233226|NCT01881932|11362814|FG001|NOT COMPLETED|Overall Study||0
10233227|NCT01881932|11362815|FG002|NOT COMPLETED|Overall Study||0
10233228|NCT01878786|11362826|FG000|STARTED|Overall Study||9
10233229|NCT01878786|11362827|FG001|STARTED|Overall Study||9
10233230|NCT01878786|11362828|FG002|STARTED|Overall Study||7
10233231|NCT01878786|11362826|FG000|COMPLETED|Overall Study|Study closed prematurely|0
10233232|NCT01878786|11362827|FG001|COMPLETED|Overall Study|Study closed prematurely|0
10233233|NCT01878786|11362828|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
10233234|NCT01878786|11362826|FG000|NOT COMPLETED|Overall Study||9
10233235|NCT01878786|11362827|FG001|NOT COMPLETED|Overall Study||9
10233236|NCT01878786|11362828|FG002|NOT COMPLETED|Overall Study||7
10233237|NCT01877343|11362839|FG000|STARTED|Overall Study||2
10233238|NCT01877343|11362840|FG001|STARTED|Overall Study||3
10233239|NCT01877343|11362841|FG002|STARTED|Overall Study||0
10233240|NCT01877343|11362842|FG003|STARTED|Overall Study||0
10233241|NCT01877343|11362843|FG004|STARTED|Overall Study||0
10233242|NCT01877343|11362844|FG005|STARTED|Overall Study||5
10233243|NCT01877343|11362845|FG006|STARTED|Overall Study||0
10233244|NCT01877343|11362839|FG000|COMPLETED|Overall Study||2
10233245|NCT01877343|11362840|FG001|COMPLETED|Overall Study||3
10233246|NCT01877343|11362841|FG002|COMPLETED|Overall Study||0
10233247|NCT01877343|11362842|FG003|COMPLETED|Overall Study||0
10233248|NCT01877343|11362843|FG004|COMPLETED|Overall Study||0
10233249|NCT01877343|11362844|FG005|COMPLETED|Overall Study||5
10233250|NCT01877343|11362845|FG006|COMPLETED|Overall Study||0
10233251|NCT01877343|11362839|FG000|NOT COMPLETED|Overall Study||0
10233252|NCT01877343|11362840|FG001|NOT COMPLETED|Overall Study||0
10233253|NCT01877343|11362841|FG002|NOT COMPLETED|Overall Study||0
10233254|NCT01877343|11362842|FG003|NOT COMPLETED|Overall Study||0
10233255|NCT01877343|11362843|FG004|NOT COMPLETED|Overall Study||0
10233256|NCT01877343|11362844|FG005|NOT COMPLETED|Overall Study||0
10233257|NCT01877343|11362845|FG006|NOT COMPLETED|Overall Study||0
10233258|NCT01861717|11362849|FG000|STARTED|Overall Study||4
10233259|NCT01861717|11362849|FG000|COMPLETED|Overall Study||2
10233260|NCT01861717|11362849|FG000|NOT COMPLETED|Overall Study||2
10233261|NCT01866709|11362856|FG000|STARTED|Overall Study||15
10233262|NCT01866709|11362857|FG001|STARTED|Overall Study||17
10233263|NCT01866709|11362856|FG000|COMPLETED|Overall Study||14
10233264|NCT01866709|11362857|FG001|COMPLETED|Overall Study||17
10233265|NCT01866709|11362856|FG000|NOT COMPLETED|Overall Study||1
10233266|NCT01866709|11362857|FG001|NOT COMPLETED|Overall Study||0
10233267|NCT01860040|11362865|FG000|STARTED|Overall Study|did not meet recruitment goal|1
10233268|NCT01860040|11362866|FG001|STARTED|Overall Study|did not meet recruitment goal|0
10233269|NCT01860040|11362865|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0
10233270|NCT01860040|11362866|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0
10233271|NCT01860040|11362865|FG000|NOT COMPLETED|Overall Study||1
10233272|NCT01860040|11362866|FG001|NOT COMPLETED|Overall Study||0
10233273|NCT01869478|11362873|FG000|STARTED|Overall Study||0
10233274|NCT01869478|11362874|FG001|STARTED|Overall Study||1
9768676|NCT00427908|10873445|FG003|NOT COMPLETED|Primary Phase||0
10233275|NCT01869478|11362873|FG000|COMPLETED|Overall Study||0
10233276|NCT01869478|11362874|FG001|COMPLETED|Overall Study||1
9768677|NCT00427908|10873442|FG000|STARTED|Persistence Phase Year 1||222
9768678|NCT00427908|10873443|FG001|STARTED|Persistence Phase Year 1||221
9768679|NCT00427908|10873444|FG002|STARTED|Persistence Phase Year 1||71
10233277|NCT01869478|11362873|FG000|NOT COMPLETED|Overall Study||0
10233278|NCT01869478|11362874|FG001|NOT COMPLETED|Overall Study||0
10233279|NCT01851174|11362880|FG000|STARTED|Overall Study||15
10233280|NCT01851174|11362880|FG000|COMPLETED|Overall Study||15
10233281|NCT01851174|11362880|FG000|NOT COMPLETED|Overall Study||0
10233282|NCT01846182|11362887|FG000|STARTED|Overall Study|Unclear due to assignment records.|0
10233283|NCT01846182|11362888|FG001|STARTED|Overall Study|Unclear due to assignment records.|0
10233284|NCT01846182|11362889|FG002|STARTED|Overall Study|Unclear due to assignment records.|0
10233285|NCT01846182|11362887|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
10233286|NCT01846182|11362888|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
10233287|NCT01846182|11362889|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
10233288|NCT01846182|11362887|FG000|NOT COMPLETED|Overall Study||0
10233289|NCT01846182|11362888|FG001|NOT COMPLETED|Overall Study||0
10233290|NCT01846182|11362889|FG002|NOT COMPLETED|Overall Study||0
10233291|NCT01844206|11362901|FG000|STARTED|Overall Study||2
10233292|NCT01844206|11362902|FG001|STARTED|Overall Study||3
10233293|NCT01844206|11362901|FG000|COMPLETED|Overall Study||2
10233294|NCT01844206|11362902|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
10233295|NCT01844206|11362901|FG000|NOT COMPLETED|Overall Study||0
10233296|NCT01844206|11362902|FG001|NOT COMPLETED|Overall Study||1
10233297|NCT01856322|11362911|FG000|STARTED|Overall Study||0
10233298|NCT01856322|11362912|FG001|STARTED|Overall Study||0
10233299|NCT01856322|11362913|FG002|STARTED|Overall Study||3
10233300|NCT01856322|11362911|FG000|COMPLETED|Overall Study||0
10233301|NCT01856322|11362912|FG001|COMPLETED|Overall Study||0
10233302|NCT01856322|11362913|FG002|COMPLETED|Overall Study||0
10233303|NCT01856322|11362911|FG000|NOT COMPLETED|Overall Study||0
10233304|NCT01856322|11362912|FG001|NOT COMPLETED|Overall Study||0
10233305|NCT01856322|11362913|FG002|NOT COMPLETED|Overall Study||3
10233306|NCT01853176|11362922|FG000|STARTED|Overall Study||4
10233307|NCT01853176|11362923|FG001|STARTED|Overall Study||0
10233308|NCT01853176|11362922|FG000|COMPLETED|Overall Study||0
10233309|NCT01853176|11362923|FG001|COMPLETED|Overall Study||0
10233310|NCT01853176|11362922|FG000|NOT COMPLETED|Overall Study||4
10233311|NCT01853176|11362923|FG001|NOT COMPLETED|Overall Study||0
10233312|NCT01857271|11362929|FG000|STARTED|Overall Study||3
10233313|NCT01857271|11362929|FG000|COMPLETED|Overall Study||2
10233314|NCT01857271|11362929|FG000|NOT COMPLETED|Overall Study||1
10233315|NCT01856361|11362935|FG000|STARTED|Overall Study||1
10233316|NCT01856361|11362936|FG001|STARTED|Overall Study||1
10233317|NCT01856361|11362935|FG000|COMPLETED|Overall Study||1
10233318|NCT01856361|11362936|FG001|COMPLETED|Overall Study||1
10233319|NCT01856361|11362935|FG000|NOT COMPLETED|Overall Study||0
10233320|NCT01856361|11362936|FG001|NOT COMPLETED|Overall Study||0
10233321|NCT01853982|11362944|FG000|STARTED|Overall Study||2
10233322|NCT01853982|11362945|FG001|STARTED|Overall Study||2
10233323|NCT01853982|11362944|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10233324|NCT01853982|11362945|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
10233325|NCT01853982|11362944|FG000|COMPLETED|Overall Study||0
10233326|NCT01853982|11362945|FG001|COMPLETED|Overall Study||1
10233327|NCT01853982|11362944|FG000|NOT COMPLETED|Overall Study||2
10233328|NCT01853982|11362945|FG001|NOT COMPLETED|Overall Study||1
10233329|NCT01841931|11362951|FG000|STARTED|Overall Study||4
10233330|NCT01841931|11362951|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
10233331|NCT01841931|11362951|FG000|NOT COMPLETED|Overall Study||4
10233332|NCT01836809|11362959|FG000|STARTED|Overall Study||0
10233333|NCT01836809|11362960|FG001|STARTED|Overall Study||0
10233334|NCT01836809|11362961|FG002|STARTED|Overall Study||0
10233335|NCT01836809|11362962|FG003|STARTED|Overall Study||2
10233336|NCT01836809|11362959|FG000|COMPLETED|Overall Study||0
10233337|NCT01836809|11362960|FG001|COMPLETED|Overall Study||0
10233338|NCT01836809|11362961|FG002|COMPLETED|Overall Study||0
10233339|NCT01836809|11362962|FG003|COMPLETED|Overall Study||0
10233340|NCT01836809|11362959|FG000|NOT COMPLETED|Overall Study||0
10233341|NCT01836809|11362960|FG001|NOT COMPLETED|Overall Study||0
10233342|NCT01836809|11362961|FG002|NOT COMPLETED|Overall Study||0
10233343|NCT01836809|11362962|FG003|NOT COMPLETED|Overall Study||2
10233344|NCT01831596|11362976|FG000|STARTED|Overall Study||59
10233345|NCT01831596|11362976|FG000|COMPLETED|Overall Study||51
10233346|NCT01831596|11362976|FG000|NOT COMPLETED|Overall Study||8
10233347|NCT01834144|11362982|FG000|STARTED|Overall Study||1
10233348|NCT01834144|11362983|FG001|STARTED|Overall Study||3
10233349|NCT01834144|11362982|FG000|COMPLETED|Overall Study||1
10233350|NCT01834144|11362983|FG001|COMPLETED|Overall Study||2
10233351|NCT01834144|11362982|FG000|NOT COMPLETED|Overall Study||0
10233352|NCT01834144|11362983|FG001|NOT COMPLETED|Overall Study||1
10233353|NCT01821963|11362989|FG000|STARTED|Overall Study||1
10233354|NCT01821963|11362989|FG000|COMPLETED|Overall Study||0
10233355|NCT01821963|11362989|FG000|NOT COMPLETED|Overall Study||1
10233356|NCT01821898|11362995|FG000|STARTED|Overall Study||2
9768680|NCT00427908|10873445|FG003|STARTED|Persistence Phase Year 1||78
9768681|NCT00427908|10873442|FG000|COMPLETED|Persistence Phase Year 1||222
10233357|NCT01821898|11362996|FG001|STARTED|Overall Study||1
9768682|NCT00427908|10873443|FG001|COMPLETED|Persistence Phase Year 1||221
9768683|NCT00427908|10873444|FG002|COMPLETED|Persistence Phase Year 1||71
9768684|NCT00427908|10873445|FG003|COMPLETED|Persistence Phase Year 1||78
9768685|NCT00427908|10873442|FG000|NOT COMPLETED|Persistence Phase Year 1||0
9768686|NCT00427908|10873443|FG001|NOT COMPLETED|Persistence Phase Year 1||0
9768687|NCT00427908|10873444|FG002|NOT COMPLETED|Persistence Phase Year 1||0
9768688|NCT00427908|10873445|FG003|NOT COMPLETED|Persistence Phase Year 1||0
9768689|NCT00427908|10873442|FG000|STARTED|Persistence Phase Year 2||208
9768690|NCT00427908|10873443|FG001|STARTED|Persistence Phase Year 2||215
9768691|NCT00427908|10873444|FG002|STARTED|Persistence Phase Year 2||53
9768692|NCT00427908|10873445|FG003|STARTED|Persistence Phase Year 2||61
9768693|NCT00427908|10873442|FG000|COMPLETED|Persistence Phase Year 2||208
9768694|NCT00427908|10873443|FG001|COMPLETED|Persistence Phase Year 2||215
9768695|NCT00427908|10873444|FG002|COMPLETED|Persistence Phase Year 2||53
9768696|NCT00427908|10873445|FG003|COMPLETED|Persistence Phase Year 2||61
9768697|NCT00427908|10873442|FG000|NOT COMPLETED|Persistence Phase Year 2||0
9768698|NCT00427908|10873443|FG001|NOT COMPLETED|Persistence Phase Year 2||0
9768699|NCT00427908|10873444|FG002|NOT COMPLETED|Persistence Phase Year 2||0
10233358|NCT01821898|11362995|FG000|COMPLETED|Overall Study||0
10233359|NCT01821898|11362996|FG001|COMPLETED|Overall Study||0
10233360|NCT01821898|11362995|FG000|NOT COMPLETED|Overall Study||2
10233361|NCT01821898|11362996|FG001|NOT COMPLETED|Overall Study||1
10233362|NCT01814722|11363006|FG000|STARTED|Overall Study||36
10233363|NCT01814722|11363007|FG001|STARTED|Overall Study||21
10233364|NCT01814722|11363008|FG002|STARTED|Overall Study||6
10233365|NCT01814722|11363006|FG000|COMPLETED|Overall Study||36
10233366|NCT01814722|11363007|FG001|COMPLETED|Overall Study||21
10233367|NCT01814722|11363008|FG002|COMPLETED|Overall Study||6
10233368|NCT01814722|11363006|FG000|NOT COMPLETED|Overall Study||0
10233369|NCT01814722|11363007|FG001|NOT COMPLETED|Overall Study||0
10233370|NCT01814722|11363008|FG002|NOT COMPLETED|Overall Study||0
10233371|NCT01830790|11363018|FG000|STARTED|Overall Study||0
10233372|NCT01830790|11363019|FG001|STARTED|Overall Study||10
10233373|NCT01830790|11363018|FG000|COMPLETED|Overall Study||0
10233374|NCT01830790|11363019|FG001|COMPLETED|Overall Study||10
10233375|NCT01830790|11363018|FG000|NOT COMPLETED|Overall Study||0
10233376|NCT01830790|11363019|FG001|NOT COMPLETED|Overall Study||0
10233377|NCT01829477|11363027|FG000|STARTED|Overall Study||17
10233378|NCT01829477|11363028|FG001|STARTED|Overall Study||16
10233379|NCT01829477|11363027|FG000|COMPLETED|Overall Study||1
10233380|NCT01829477|11363028|FG001|COMPLETED|Overall Study||1
10233381|NCT01829477|11363027|FG000|NOT COMPLETED|Overall Study||16
10233382|NCT01829477|11363028|FG001|NOT COMPLETED|Overall Study||15
10233383|NCT01803711|11363036|FG000|STARTED|Overall Study||2
10233384|NCT01803711|11363037|FG001|STARTED|Overall Study||3
10233385|NCT01803711|11363036|FG000|COMPLETED|Overall Study||1
10233386|NCT01803711|11363037|FG001|COMPLETED|Overall Study||2
10233387|NCT01803711|11363036|FG000|NOT COMPLETED|Overall Study||1
10233388|NCT01803711|11363037|FG001|NOT COMPLETED|Overall Study||1
10233389|NCT01821859|11363045|FG000|STARTED|Overall Study||5
10233390|NCT01821859|11363045|FG000|COMPLETED|Overall Study||0
10233391|NCT01821859|11363045|FG000|NOT COMPLETED|Overall Study||5
10233392|NCT01808950|11363052|FG000|STARTED|Overall Study||1
10233393|NCT01808950|11363053|FG001|STARTED|Overall Study||3
10233394|NCT01808950|11363054|FG002|STARTED|Overall Study||0
10233395|NCT01808950|11363052|FG000|COMPLETED|Overall Study||1
10233396|NCT01808950|11363053|FG001|COMPLETED|Overall Study||3
10233397|NCT01808950|11363054|FG002|COMPLETED|Overall Study||0
10233398|NCT01808950|11363052|FG000|NOT COMPLETED|Overall Study||0
10233399|NCT01808950|11363053|FG001|NOT COMPLETED|Overall Study||0
10233400|NCT01808950|11363054|FG002|NOT COMPLETED|Overall Study||0
10233401|NCT01806051|11363065|FG000|STARTED|Overall Study||6
10233402|NCT01806051|11363065|FG000|COMPLETED|Overall Study||0
10233403|NCT01806051|11363065|FG000|NOT COMPLETED|Overall Study||6
10233404|NCT01808794|11363073|FG000|STARTED|Overall Study||0
10233405|NCT01808794|11363074|FG001|STARTED|Overall Study||0
10233406|NCT01808794|11363073|FG000|COMPLETED|Overall Study||0
10233407|NCT01808794|11363074|FG001|COMPLETED|Overall Study||0
10233408|NCT01808794|11363073|FG000|NOT COMPLETED|Overall Study||0
10233409|NCT01808794|11363074|FG001|NOT COMPLETED|Overall Study||0
10233410|NCT01809899|11363082|FG000|STARTED|Overall Study||8
10233411|NCT01809899|11363083|FG001|STARTED|Overall Study||4
10233412|NCT01809899|11363082|FG000|COMPLETED|Overall Study||8
10233413|NCT01809899|11363083|FG001|COMPLETED|Overall Study||4
10233414|NCT01809899|11363082|FG000|NOT COMPLETED|Overall Study||0
10233415|NCT01809899|11363083|FG001|NOT COMPLETED|Overall Study||0
10233416|NCT01810302|11363092|FG000|STARTED|Overall Study||1
10233417|NCT01810302|11363093|FG001|STARTED|Overall Study||1
10233418|NCT01810302|11363092|FG000|COMPLETED|Overall Study||0
10233419|NCT01810302|11363093|FG001|COMPLETED|Overall Study||0
10233420|NCT01810302|11363092|FG000|NOT COMPLETED|Overall Study||1
10233421|NCT01810302|11363093|FG001|NOT COMPLETED|Overall Study||1
10233422|NCT01806961|11363099|FG000|STARTED|Overall Study||16
10233423|NCT01806961|11363099|FG000|COMPLETED|Overall Study||0
10233424|NCT01806961|11363099|FG000|NOT COMPLETED|Overall Study||16
10233425|NCT01804166|11363103|FG000|STARTED|Overall Study||1
10233426|NCT01804166|11363103|FG000|COMPLETED|Overall Study||1
10233427|NCT01804166|11363103|FG000|NOT COMPLETED|Overall Study||0
10233428|NCT01783015|11363109|FG000|STARTED|Blinded Treatment||11
10233429|NCT01783015|11363110|FG001|STARTED|Blinded Treatment||5
10233430|NCT01783015|11363111|FG002|STARTED|Blinded Treatment||0
9768700|NCT00427908|10873445|FG003|NOT COMPLETED|Persistence Phase Year 2||0
9768701|NCT00427908|10873442|FG000|STARTED|Persistence Phase Year 3||185
9768702|NCT00427908|10873443|FG001|STARTED|Persistence Phase Year 3||201
9768703|NCT00427908|10873444|FG002|STARTED|Persistence Phase Year 3||38
9768704|NCT00427908|10873445|FG003|STARTED|Persistence Phase Year 3||38
9768705|NCT00427908|10873442|FG000|COMPLETED|Persistence Phase Year 3||185
9768706|NCT00427908|10873443|FG001|COMPLETED|Persistence Phase Year 3||201
9768707|NCT00427908|10873444|FG002|COMPLETED|Persistence Phase Year 3||38
9768708|NCT00427908|10873445|FG003|COMPLETED|Persistence Phase Year 3||38
9768709|NCT00427908|10873442|FG000|NOT COMPLETED|Persistence Phase Year 3||0
9768710|NCT00427908|10873443|FG001|NOT COMPLETED|Persistence Phase Year 3||0
9768711|NCT00427908|10873444|FG002|NOT COMPLETED|Persistence Phase Year 3||0
9768712|NCT00427908|10873445|FG003|NOT COMPLETED|Persistence Phase Year 3||0
9768713|NCT00427908|10873442|FG000|STARTED|Persistence Phase Year 4||165
9768714|NCT00427908|10873443|FG001|STARTED|Persistence Phase Year 4||192
9768715|NCT00427908|10873444|FG002|STARTED|Persistence Phase Year 4||34
9768716|NCT00427908|10873445|FG003|STARTED|Persistence Phase Year 4||32
9768717|NCT00427908|10873442|FG000|COMPLETED|Persistence Phase Year 4||165
9768718|NCT00427908|10873443|FG001|COMPLETED|Persistence Phase Year 4||192
9768719|NCT00427908|10873444|FG002|COMPLETED|Persistence Phase Year 4||34
10233431|NCT01783015|11363109|FG000|Treated|Blinded Treatment||11
10233432|NCT01783015|11363110|FG001|Treated|Blinded Treatment||5
10233433|NCT01783015|11363111|FG002|Treated|Blinded Treatment||0
10233434|NCT01783015|11363109|FG000|COMPLETED|Blinded Treatment||9
10233435|NCT01783015|11363110|FG001|COMPLETED|Blinded Treatment||2
10233436|NCT01783015|11363111|FG002|COMPLETED|Blinded Treatment||0
10233437|NCT01783015|11363109|FG000|NOT COMPLETED|Blinded Treatment||2
10233438|NCT01783015|11363110|FG001|NOT COMPLETED|Blinded Treatment||3
10233439|NCT01783015|11363111|FG002|NOT COMPLETED|Blinded Treatment||0
10233440|NCT01783015|11363109|FG000|STARTED|Open Label Treatment||0
10233441|NCT01783015|11363110|FG001|STARTED|Open Label Treatment||0
10233442|NCT01783015|11363111|FG002|STARTED|Open Label Treatment||11
10233443|NCT01783015|11363109|FG000|COMPLETED|Open Label Treatment||0
10233444|NCT01783015|11363110|FG001|COMPLETED|Open Label Treatment||0
10233445|NCT01783015|11363111|FG002|COMPLETED|Open Label Treatment||5
10233446|NCT01783015|11363109|FG000|NOT COMPLETED|Open Label Treatment||0
10233447|NCT01783015|11363110|FG001|NOT COMPLETED|Open Label Treatment||0
10233448|NCT01783015|11363111|FG002|NOT COMPLETED|Open Label Treatment||6
10233449|NCT01800162|11363122|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
10233450|NCT01800162|11363123|FG001|STARTED|Overall Study||0
10233451|NCT01800162|11363124|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
10233452|NCT01800162|11363122|FG000|COMPLETED|Overall Study||1
10233453|NCT01800162|11363123|FG001|COMPLETED|Overall Study||0
10233454|NCT01800162|11363124|FG002|COMPLETED|Overall Study||1
10233455|NCT01800162|11363122|FG000|NOT COMPLETED|Overall Study||0
10233456|NCT01800162|11363123|FG001|NOT COMPLETED|Overall Study||0
10233457|NCT01800162|11363124|FG002|NOT COMPLETED|Overall Study||0
10233458|NCT01794936|11363132|FG000|STARTED|Overall Study||9
10233459|NCT01794936|11363132|FG000|COMPLETED|Overall Study||9
10233460|NCT01794936|11363132|FG000|NOT COMPLETED|Overall Study||0
10233461|NCT01797380|11363138|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3
10233462|NCT01797380|11363139|FG001|STARTED|Overall Study||2
10233463|NCT01797380|11363138|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
10233464|NCT01797380|11363139|FG001|COMPLETED|Overall Study||0
10233465|NCT01797380|11363138|FG000|NOT COMPLETED|Overall Study||3
10233466|NCT01797380|11363139|FG001|NOT COMPLETED|Overall Study||2
10233467|NCT01781026|11363145|FG000|STARTED|Overall Study||2
10233468|NCT01781026|11363145|FG000|COMPLETED|Overall Study||0
10233469|NCT01781026|11363145|FG000|NOT COMPLETED|Overall Study||2
10233470|NCT01788475|11363152|FG000|STARTED|Overall Study||3
10233471|NCT01788475|11363153|FG001|STARTED|Overall Study||0
10233472|NCT01788475|11363154|FG002|STARTED|Overall Study||0
10233473|NCT01788475|11363152|FG000|COMPLETED|Overall Study||0
10233474|NCT01788475|11363153|FG001|COMPLETED|Overall Study||0
10233475|NCT01788475|11363154|FG002|COMPLETED|Overall Study||0
10233476|NCT01788475|11363152|FG000|NOT COMPLETED|Overall Study||3
10233477|NCT01788475|11363153|FG001|NOT COMPLETED|Overall Study||0
10233478|NCT01788475|11363154|FG002|NOT COMPLETED|Overall Study||0
10233479|NCT01784991|11363164|FG000|STARTED|Overall Study||0
10233480|NCT01784991|11363165|FG001|STARTED|Overall Study||0
10233481|NCT01784991|11363164|FG000|COMPLETED|Overall Study||0
10233482|NCT01784991|11363165|FG001|COMPLETED|Overall Study||0
10233483|NCT01784991|11363164|FG000|NOT COMPLETED|Overall Study||0
10233484|NCT01784991|11363165|FG001|NOT COMPLETED|Overall Study||0
10233485|NCT01777854|11363171|FG000|STARTED|Overall Study||3
10233486|NCT01777854|11363172|FG001|STARTED|Overall Study||3
10233487|NCT01777854|11363171|FG000|COMPLETED|Overall Study||0
9768720|NCT00427908|10873445|FG003|COMPLETED|Persistence Phase Year 4||32
10233488|NCT01777854|11363172|FG001|COMPLETED|Overall Study||0
10233489|NCT01777854|11363171|FG000|NOT COMPLETED|Overall Study||3
10233490|NCT01777854|11363172|FG001|NOT COMPLETED|Overall Study||3
10233491|NCT01760993|11363176|FG000|STARTED|Overall Study||0
10233492|NCT01760993|11363176|FG000|COMPLETED|Overall Study||0
10233493|NCT01760993|11363176|FG000|NOT COMPLETED|Overall Study||0
10233494|NCT01772719|11363180|FG000|STARTED|Overall Study||7
10233495|NCT01772719|11363180|FG000|COMPLETED|Overall Study||0
10233496|NCT01772719|11363180|FG000|NOT COMPLETED|Overall Study||7
10233497|NCT01764997|11363192|FG000|STARTED|Run-in Period||776
9768721|NCT00427908|10873442|FG000|NOT COMPLETED|Persistence Phase Year 4||0
9768722|NCT00427908|10873443|FG001|NOT COMPLETED|Persistence Phase Year 4||0
9768723|NCT00427908|10873444|FG002|NOT COMPLETED|Persistence Phase Year 4||0
9768724|NCT00427908|10873445|FG003|NOT COMPLETED|Persistence Phase Year 4||0
9768725|NCT00427908|10873442|FG000|STARTED|Persistence Phase Year 5||52
9768726|NCT00427908|10873443|FG001|STARTED|Persistence Phase Year 5||99
9768727|NCT00427908|10873444|FG002|STARTED|Persistence Phase Year 5||12
9768728|NCT00427908|10873445|FG003|STARTED|Persistence Phase Year 5||13
10233498|NCT01764997|11363193|FG001|STARTED|Run-in Period||0
10233499|NCT01764997|11363194|FG002|STARTED|Run-in Period||0
10233500|NCT01764997|11363195|FG003|STARTED|Run-in Period||0
10233501|NCT01764997|11363196|FG004|STARTED|Run-in Period||0
10233502|NCT01764997|11363192|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
10233503|NCT01764997|11363193|FG001|COMPLETED|Run-in Period||0
10233504|NCT01764997|11363194|FG002|COMPLETED|Run-in Period||0
10233505|NCT01764997|11363195|FG003|COMPLETED|Run-in Period||0
10233506|NCT01764997|11363196|FG004|COMPLETED|Run-in Period||0
10233507|NCT01764997|11363192|FG000|NOT COMPLETED|Run-in Period||38
10233508|NCT01764997|11363193|FG001|NOT COMPLETED|Run-in Period||0
10233509|NCT01764997|11363194|FG002|NOT COMPLETED|Run-in Period||0
10233510|NCT01764997|11363195|FG003|NOT COMPLETED|Run-in Period||0
10233511|NCT01764997|11363196|FG004|NOT COMPLETED|Run-in Period||0
10233512|NCT01764997|11363192|FG000|STARTED|Study Drug Treatment Period||0
10233513|NCT01764997|11363193|FG001|STARTED|Study Drug Treatment Period||17
10233514|NCT01764997|11363194|FG002|STARTED|Study Drug Treatment Period||13
10233515|NCT01764997|11363195|FG003|STARTED|Study Drug Treatment Period||13
10233516|NCT01764997|11363196|FG004|STARTED|Study Drug Treatment Period||322
10233517|NCT01764997|11363192|FG000|COMPLETED|Study Drug Treatment Period||0
10233518|NCT01764997|11363193|FG001|COMPLETED|Study Drug Treatment Period||16
10233519|NCT01764997|11363194|FG002|COMPLETED|Study Drug Treatment Period||13
10233520|NCT01764997|11363195|FG003|COMPLETED|Study Drug Treatment Period||13
10233521|NCT01764997|11363196|FG004|COMPLETED|Study Drug Treatment Period||286
10233522|NCT01764997|11363192|FG000|NOT COMPLETED|Study Drug Treatment Period||0
10233523|NCT01764997|11363193|FG001|NOT COMPLETED|Study Drug Treatment Period||1
10233524|NCT01764997|11363194|FG002|NOT COMPLETED|Study Drug Treatment Period||0
10233525|NCT01764997|11363195|FG003|NOT COMPLETED|Study Drug Treatment Period||0
10233526|NCT01764997|11363196|FG004|NOT COMPLETED|Study Drug Treatment Period||36
10233527|NCT01760941|11363206|FG000|STARTED|Overall Study||1
10233528|NCT01760941|11363206|FG000|COMPLETED|Overall Study||1
10233529|NCT01760941|11363206|FG000|NOT COMPLETED|Overall Study||0
10233530|NCT01769443|11363212|FG000|STARTED|Overall Study||1
10233531|NCT01769443|11363213|FG001|STARTED|Overall Study||1
10233532|NCT01769443|11363212|FG000|COMPLETED|Overall Study||0
10233533|NCT01769443|11363213|FG001|COMPLETED|Overall Study||1
10233534|NCT01769443|11363212|FG000|NOT COMPLETED|Overall Study||1
10233535|NCT01769443|11363213|FG001|NOT COMPLETED|Overall Study||0
10233536|NCT01760889|11363223|FG000|STARTED|Overall Study||0
10233537|NCT01760889|11363224|FG001|STARTED|Overall Study||0
10233538|NCT01760889|11363225|FG002|STARTED|Overall Study||0
10233539|NCT01760889|11363223|FG000|COMPLETED|Overall Study||0
10233540|NCT01760889|11363224|FG001|COMPLETED|Overall Study||0
10233541|NCT01760889|11363225|FG002|COMPLETED|Overall Study||0
10233542|NCT01760889|11363223|FG000|NOT COMPLETED|Overall Study||0
10233543|NCT01760889|11363224|FG001|NOT COMPLETED|Overall Study||0
10233544|NCT01760889|11363225|FG002|NOT COMPLETED|Overall Study||0
10233545|NCT01749826|11363235|FG000|STARTED|Overall Study||20
10233546|NCT01749826|11363236|FG001|STARTED|Overall Study||0
10233547|NCT01749826|11363235|FG000|COMPLETED|Overall Study||0
10233548|NCT01749826|11363236|FG001|COMPLETED|Overall Study||0
10233549|NCT01749826|11363235|FG000|NOT COMPLETED|Overall Study||20
10233550|NCT01749826|11363236|FG001|NOT COMPLETED|Overall Study||0
10233551|NCT01756586|11363244|FG000|STARTED|Overall Study||2
10233552|NCT01756586|11363245|FG001|STARTED|Overall Study||2
10233553|NCT01756586|11363244|FG000|COMPLETED|Overall Study||0
10233554|NCT01756586|11363245|FG001|COMPLETED|Overall Study||0
10233555|NCT01756586|11363244|FG000|NOT COMPLETED|Overall Study||2
10233556|NCT01756586|11363245|FG001|NOT COMPLETED|Overall Study||2
10233557|NCT01754987|11363253|FG000|STARTED|Overall Study||5
10233558|NCT01754987|11363254|FG001|STARTED|Overall Study||0
10233559|NCT01754987|11363253|FG000|COMPLETED|Overall Study||5
10233560|NCT01754987|11363254|FG001|COMPLETED|Overall Study||0
10233561|NCT01754987|11363253|FG000|NOT COMPLETED|Overall Study||0
10233562|NCT01754987|11363254|FG001|NOT COMPLETED|Overall Study||0
10233563|NCT01756560|11363262|FG000|STARTED|Overall Study||2
10233564|NCT01756560|11363263|FG001|STARTED|Overall Study||0
10233565|NCT01756560|11363262|FG000|COMPLETED|Overall Study||0
10233566|NCT01756560|11363263|FG001|COMPLETED|Overall Study||0
10233567|NCT01756560|11363262|FG000|NOT COMPLETED|Overall Study||2
10233568|NCT01756560|11363263|FG001|NOT COMPLETED|Overall Study||0
10233569|NCT01756573|11363272|FG000|STARTED|Overall Study||3
10233570|NCT01756573|11363273|FG001|STARTED|Overall Study||1
10233571|NCT01756573|11363274|FG002|STARTED|Overall Study||1
10233572|NCT01756573|11363272|FG000|COMPLETED|Overall Study||3
10233573|NCT01756573|11363273|FG001|COMPLETED|Overall Study||1
10233574|NCT01756573|11363274|FG002|COMPLETED|Overall Study||1
10233575|NCT01756573|11363272|FG000|NOT COMPLETED|Overall Study||0
10233576|NCT01756573|11363273|FG001|NOT COMPLETED|Overall Study||0
10233577|NCT01756573|11363274|FG002|NOT COMPLETED|Overall Study||0
10233578|NCT01745913|11363284|FG000|STARTED|Overall Study||1
10233579|NCT01745913|11363285|FG001|STARTED|Overall Study||1
10233580|NCT01745913|11363284|FG000|COMPLETED|Overall Study||0
10233581|NCT01745913|11363285|FG001|COMPLETED|Overall Study||0
10233582|NCT01745913|11363284|FG000|NOT COMPLETED|Overall Study||1
10233583|NCT01745913|11363285|FG001|NOT COMPLETED|Overall Study||1
10233584|NCT01752023|11363297|FG000|STARTED|Overall Study||2
10233585|NCT01752023|11363298|FG001|STARTED|Overall Study||1
10233586|NCT01752023|11363297|FG000|COMPLETED|Overall Study||0
10233587|NCT01752023|11363298|FG001|COMPLETED|Overall Study||0
10233588|NCT01752023|11363297|FG000|NOT COMPLETED|Overall Study||2
10233589|NCT01752023|11363298|FG001|NOT COMPLETED|Overall Study||1
10233590|NCT01740154|11363308|FG000|STARTED|Overall Study||13
10233591|NCT01740154|11363308|FG000|COMPLETED|Overall Study||12
10233592|NCT01740154|11363308|FG000|NOT COMPLETED|Overall Study||1
10233593|NCT01748890|11363312|FG000|STARTED|Overall Study||4
10233594|NCT01748890|11363312|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
10233595|NCT01748890|11363312|FG000|NOT COMPLETED|Overall Study||4
10233596|NCT01748162|11363318|FG000|STARTED|Overall Study||5
10233597|NCT01748162|11363319|FG001|STARTED|Overall Study||5
10233598|NCT01748162|11363318|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2
10233599|NCT01748162|11363319|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2
10233600|NCT01748162|11363318|FG000|Completed 6 Month Initial Treatment|Overall Study||0
10233601|NCT01748162|11363319|FG001|Completed 6 Month Initial Treatment|Overall Study||0
10233602|NCT01748162|11363318|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
10233603|NCT01748162|11363319|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
10233604|NCT01748162|11363318|FG000|COMPLETED|Overall Study||0
10233605|NCT01748162|11363319|FG001|COMPLETED|Overall Study||0
10233606|NCT01748162|11363318|FG000|NOT COMPLETED|Overall Study||5
10233607|NCT01748162|11363319|FG001|NOT COMPLETED|Overall Study||5
10233608|NCT01738698|11363329|FG000|STARTED|Overall Study||0
10233609|NCT01738698|11363330|FG001|STARTED|Overall Study||0
10233610|NCT01738698|11363331|FG002|STARTED|Overall Study||0
9768729|NCT00427908|10873442|FG000|COMPLETED|Persistence Phase Year 5||52
9768730|NCT00427908|10873443|FG001|COMPLETED|Persistence Phase Year 5||99
9768731|NCT00427908|10873444|FG002|COMPLETED|Persistence Phase Year 5||12
10233611|NCT01738698|11363332|FG003|STARTED|Overall Study||0
10233612|NCT01738698|11363329|FG000|COMPLETED|Overall Study||0
10233613|NCT01738698|11363330|FG001|COMPLETED|Overall Study||0
10233614|NCT01738698|11363331|FG002|COMPLETED|Overall Study||0
10233615|NCT01738698|11363332|FG003|COMPLETED|Overall Study||0
10233616|NCT01738698|11363329|FG000|NOT COMPLETED|Overall Study||0
10233617|NCT01738698|11363330|FG001|NOT COMPLETED|Overall Study||0
10233618|NCT01738698|11363331|FG002|NOT COMPLETED|Overall Study||0
10233619|NCT01738698|11363332|FG003|NOT COMPLETED|Overall Study||0
10233620|NCT01732926|11363344|FG000|STARTED|Overall Study||320
10233621|NCT01732926|11363345|FG001|STARTED|Overall Study||155
10233622|NCT01732926|11363344|FG000|COMPLETED|Overall Study||53
10233623|NCT01732926|11363345|FG001|COMPLETED|Overall Study||45
10233624|NCT01732926|11363344|FG000|NOT COMPLETED|Overall Study||267
10233625|NCT01732926|11363345|FG001|NOT COMPLETED|Overall Study||110
10233626|NCT01727167|11363353|FG000|STARTED|Overall Study||1
10233627|NCT01727167|11363354|FG001|STARTED|Overall Study||0
10233628|NCT01727167|11363353|FG000|COMPLETED|Overall Study||1
10233629|NCT01727167|11363354|FG001|COMPLETED|Overall Study||0
10233630|NCT01727167|11363353|FG000|NOT COMPLETED|Overall Study||0
10233631|NCT01727167|11363354|FG001|NOT COMPLETED|Overall Study||0
10233632|NCT01732913|11363362|FG000|STARTED|Overall Study||198
10233633|NCT01732913|11363363|FG001|STARTED|Overall Study||97
10233634|NCT01732913|11363362|FG000|COMPLETED|Overall Study||42
10233635|NCT01732913|11363363|FG001|COMPLETED|Overall Study||28
10233636|NCT01732913|11363362|FG000|NOT COMPLETED|Overall Study||156
10014099|NCT01797471|11137118|FG000|STARTED|Overall Study||1
10014100|NCT01797471|11137118|FG000|COMPLETED|Overall Study||1
10014101|NCT01797471|11137118|FG000|NOT COMPLETED|Overall Study||0
10014102|NCT01797484|11137124|FG000|STARTED|Overall Study||10
10014103|NCT01797484|11137125|FG001|STARTED|Overall Study||10
10014104|NCT01797484|11137124|FG000|COMPLETED|Overall Study||10
10014105|NCT01797484|11137125|FG001|COMPLETED|Overall Study||10
10014106|NCT01797484|11137124|FG000|NOT COMPLETED|Overall Study||0
10014107|NCT01797484|11137125|FG001|NOT COMPLETED|Overall Study||0
10014108|NCT01797536|11137135|FG000|STARTED|Overall Study||8
10014109|NCT01797536|11137136|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
10014110|NCT01797536|11137137|FG002|STARTED|Overall Study||7
10233637|NCT01732913|11363363|FG001|NOT COMPLETED|Overall Study||69
10233638|NCT01732211|11363369|FG000|STARTED|Overall Study||1
10233639|NCT01732211|11363369|FG000|COMPLETED|Overall Study||1
10233640|NCT01732211|11363369|FG000|NOT COMPLETED|Overall Study||0
10233641|NCT01716052|11363375|FG000|STARTED|Overall Study||1
10233642|NCT01716052|11363376|FG001|STARTED|Overall Study||1
10233643|NCT01716052|11363375|FG000|COMPLETED|Overall Study||0
10233644|NCT01716052|11363376|FG001|COMPLETED|Overall Study||0
10233645|NCT01716052|11363375|FG000|NOT COMPLETED|Overall Study||1
9768732|NCT00427908|10873445|FG003|COMPLETED|Persistence Phase Year 5||13
10014111|NCT01797536|11137138|FG003|STARTED|Overall Study||8
10014112|NCT01797536|11137135|FG000|COMPLETED|Overall Study||8
10014113|NCT01797536|11137136|FG001|COMPLETED|Overall Study||10
10014114|NCT01797536|11137137|FG002|COMPLETED|Overall Study||7
9768733|NCT00427908|10873442|FG000|NOT COMPLETED|Persistence Phase Year 5||0
9768734|NCT00427908|10873443|FG001|NOT COMPLETED|Persistence Phase Year 5||0
9768735|NCT00427908|10873444|FG002|NOT COMPLETED|Persistence Phase Year 5||0
9768736|NCT00427908|10873445|FG003|NOT COMPLETED|Persistence Phase Year 5||0
9768737|NCT00427921|10873480|FG000|STARTED|Overall Study||304
9768738|NCT00427921|10873480|FG000|COMPLETED|Overall Study||254
9768739|NCT00427921|10873480|FG000|NOT COMPLETED|Overall Study||50
9768740|NCT00427934|10873488|FG000|STARTED|Overall Study||8
9768741|NCT00427934|10873489|FG001|STARTED|Overall Study||8
9768742|NCT00427934|10873490|FG002|STARTED|Overall Study||78
9768743|NCT00427934|10873491|FG003|STARTED|Overall Study||34
9768744|NCT00427934|10873488|FG000|Treated|Overall Study||8
9768745|NCT00427934|10873489|FG001|Treated|Overall Study||8
9768746|NCT00427934|10873490|FG002|Treated|Overall Study||77
9768747|NCT00427934|10873491|FG003|Treated|Overall Study||33
9768748|NCT00427934|10873488|FG000|COMPLETED|Overall Study||7
9768749|NCT00427934|10873489|FG001|COMPLETED|Overall Study||8
9768750|NCT00427934|10873490|FG002|COMPLETED|Overall Study||55
9768751|NCT00427934|10873491|FG003|COMPLETED|Overall Study||19
9768752|NCT00427934|10873488|FG000|NOT COMPLETED|Overall Study||1
9768753|NCT00427934|10873489|FG001|NOT COMPLETED|Overall Study||0
9768754|NCT00427934|10873490|FG002|NOT COMPLETED|Overall Study||23
9768755|NCT00427934|10873491|FG003|NOT COMPLETED|Overall Study||15
9768756|NCT00427960|10873505|FG000|STARTED|Overall Study||30
9768757|NCT00427960|10873506|FG001|STARTED|Overall Study||25
9768758|NCT00427960|10873505|FG000|COMPLETED|Overall Study||28
9768759|NCT00427960|10873506|FG001|COMPLETED|Overall Study||21
9768760|NCT00427960|10873505|FG000|NOT COMPLETED|Overall Study||2
10233646|NCT01716052|11363376|FG001|NOT COMPLETED|Overall Study||1
10233647|NCT01718444|11363384|FG000|STARTED|Overall Study||0
10233648|NCT01718444|11363385|FG001|STARTED|Overall Study||0
10233649|NCT01718444|11363384|FG000|COMPLETED|Overall Study||0
10233650|NCT01718444|11363385|FG001|COMPLETED|Overall Study||0
10233651|NCT01718444|11363384|FG000|NOT COMPLETED|Overall Study||0
10233652|NCT01718444|11363385|FG001|NOT COMPLETED|Overall Study||0
10233653|NCT01712854|11363391|FG000|STARTED|Overall Study||9
10233654|NCT01712854|11363391|FG000|COMPLETED|Overall Study||8
10233655|NCT01712854|11363391|FG000|NOT COMPLETED|Overall Study||1
10233656|NCT01717482|11363397|FG000|STARTED|Overall Study||4
10233657|NCT01717482|11363398|FG001|STARTED|Overall Study||2
10233658|NCT01717482|11363397|FG000|COMPLETED|Overall Study||0
10233659|NCT01717482|11363398|FG001|COMPLETED|Overall Study||2
10233660|NCT01717482|11363397|FG000|NOT COMPLETED|Overall Study||4
10233661|NCT01717482|11363398|FG001|NOT COMPLETED|Overall Study||0
10233662|NCT01702896|11363405|FG000|STARTED|Overall Study||8
10233663|NCT01702896|11363405|FG000|COMPLETED|Overall Study||0
10233664|NCT01702896|11363405|FG000|NOT COMPLETED|Overall Study||8
10233665|NCT01709136|11363411|FG000|STARTED|Overall Study||3
10233666|NCT01709136|11363411|FG000|COMPLETED|Overall Study||3
10233667|NCT01709136|11363411|FG000|NOT COMPLETED|Overall Study||0
10233668|NCT01708057|11363418|FG000|STARTED|Overall Study||1
10233669|NCT01708057|11363419|FG001|STARTED|Overall Study||1
10233670|NCT01708057|11363420|FG002|STARTED|Overall Study||1
10233671|NCT01708057|11363418|FG000|COMPLETED|Overall Study||0
10233672|NCT01708057|11363419|FG001|COMPLETED|Overall Study||0
10233673|NCT01708057|11363420|FG002|COMPLETED|Overall Study||0
10233674|NCT01708057|11363418|FG000|NOT COMPLETED|Overall Study||1
10233675|NCT01708057|11363419|FG001|NOT COMPLETED|Overall Study||1
10233676|NCT01708057|11363420|FG002|NOT COMPLETED|Overall Study||1
10233677|NCT01697332|11363434|FG000|STARTED|Overall Study||1
10233678|NCT01697332|11363434|FG000|COMPLETED|Overall Study||1
10233679|NCT01697332|11363434|FG000|NOT COMPLETED|Overall Study||0
10233680|NCT01693367|11363440|FG000|STARTED|Overall Study||2
10233681|NCT01693367|11363441|FG001|STARTED|Overall Study||3
10233682|NCT01693367|11363440|FG000|COMPLETED|Overall Study||1
10233683|NCT01693367|11363441|FG001|COMPLETED|Overall Study||1
10233684|NCT01693367|11363440|FG000|NOT COMPLETED|Overall Study||1
10233685|NCT01693367|11363441|FG001|NOT COMPLETED|Overall Study||2
10233686|NCT01705106|11363447|FG000|STARTED|Overall Study||21
10233687|NCT01705106|11363447|FG000|COMPLETED|Overall Study||21
10233688|NCT01705106|11363447|FG000|NOT COMPLETED|Overall Study||0
10233689|NCT01702909|11363451|FG000|STARTED|Overall Study||7
10233690|NCT01702909|11363451|FG000|COMPLETED|Overall Study||7
10233691|NCT01702909|11363451|FG000|NOT COMPLETED|Overall Study||0
10233692|NCT01701622|11363455|FG000|STARTED|Overall Study||1
10233693|NCT01701622|11363455|FG000|COMPLETED|Overall Study||1
10233694|NCT01701622|11363455|FG000|NOT COMPLETED|Overall Study||0
10233695|NCT01697800|11363462|FG000|STARTED|Overall Study||15
10233696|NCT01697800|11363463|FG001|STARTED|Overall Study||25
10233697|NCT01697800|11363462|FG000|COMPLETED|Overall Study||15
10233698|NCT01697800|11363463|FG001|COMPLETED|Overall Study||24
10233699|NCT01697800|11363462|FG000|NOT COMPLETED|Overall Study||0
10233700|NCT01697800|11363463|FG001|NOT COMPLETED|Overall Study||1
9768761|NCT00427960|10873506|FG001|NOT COMPLETED|Overall Study||4
9768762|NCT00427973|10873512|FG000|STARTED|Overall Study||17
9768763|NCT00427973|10873512|FG000|COMPLETED|Overall Study||17
9768764|NCT00427973|10873512|FG000|NOT COMPLETED|Overall Study||0
10233701|NCT01700348|11363469|FG000|STARTED|Overall Study||116
10233702|NCT01700348|11363469|FG000|COMPLETED|Overall Study||93
10233703|NCT01700348|11363469|FG000|NOT COMPLETED|Overall Study||23
10233704|NCT01693484|11363475|FG000|STARTED|Overall Study||13
10233705|NCT01693484|11363475|FG000|COMPLETED|Overall Study|Study closed by PI|0
10233706|NCT01693484|11363475|FG000|NOT COMPLETED|Overall Study||13
9768765|NCT00427999|10873516|FG000|STARTED|Overall Study||65
9768766|NCT00427999|10873516|FG000|Intent to Treat (ITT)|Overall Study||61
9768767|NCT00427999|10873516|FG000|Extension Follow-up|Overall Study||19
9768768|NCT00427999|10873516|FG000|COMPLETED|Overall Study||33
9768769|NCT00427999|10873516|FG000|NOT COMPLETED|Overall Study||32
9768770|NCT00428077|10873521|FG000|STARTED|Overall Study||4
9768771|NCT00428077|10873521|FG000|COMPLETED|Overall Study||4
9768772|NCT00428077|10873521|FG000|NOT COMPLETED|Overall Study||0
9768773|NCT00428090|10873529|FG000|STARTED|Overall Study||165
9768774|NCT00428090|10873530|FG001|STARTED|Overall Study||166
9768775|NCT00428090|10873531|FG002|STARTED|Overall Study||165
9768776|NCT00428090|10873532|FG003|STARTED|Overall Study||83
9768777|NCT00428090|10873529|FG000|COMPLETED|Overall Study||131
9768778|NCT00428090|10873530|FG001|COMPLETED|Overall Study||135
9768779|NCT00428090|10873531|FG002|COMPLETED|Overall Study||127
9768780|NCT00428090|10873532|FG003|COMPLETED|Overall Study||55
9768781|NCT00428090|10873529|FG000|NOT COMPLETED|Overall Study||34
9768782|NCT00428090|10873530|FG001|NOT COMPLETED|Overall Study||31
9768783|NCT00428090|10873531|FG002|NOT COMPLETED|Overall Study||38
9768784|NCT00428090|10873532|FG003|NOT COMPLETED|Overall Study||28
9768785|NCT00428116|10873552|FG000|STARTED|Overall Study||21
9768786|NCT00428116|10873553|FG001|STARTED|Overall Study||21
9768787|NCT00428116|10873552|FG000|COMPLETED|Overall Study||18
9768788|NCT00428116|10873553|FG001|COMPLETED|Overall Study||21
9768789|NCT00428116|10873552|FG000|NOT COMPLETED|Overall Study||3
9768790|NCT00428116|10873553|FG001|NOT COMPLETED|Overall Study||0
9768791|NCT00428220|10873560|FG000|STARTED|Overall Study||223
9768792|NCT00428220|10873560|FG000|COMPLETED|Overall Study||0
9768793|NCT00428220|10873560|FG000|NOT COMPLETED|Overall Study||223
9768794|NCT00428246|10873578|FG000|STARTED|Overall Study||8
9768795|NCT00428246|10873579|FG001|STARTED|Overall Study||8
9768796|NCT00428246|10873580|FG002|STARTED|Overall Study||8
9768797|NCT00428246|10873578|FG000|COMPLETED|Overall Study||7
9768798|NCT00428246|10873579|FG001|COMPLETED|Overall Study||8
9768799|NCT00428246|10873580|FG002|COMPLETED|Overall Study||7
9768800|NCT00428246|10873578|FG000|NOT COMPLETED|Overall Study||1
9768801|NCT00428246|10873579|FG001|NOT COMPLETED|Overall Study||0
9768802|NCT00428246|10873580|FG002|NOT COMPLETED|Overall Study||1
9768803|NCT00428298|10873590|FG000|STARTED|Overall Study||30
9768804|NCT00428298|10873591|FG001|STARTED|Overall Study||30
9768805|NCT00428298|10873590|FG000|Second RBANS at Study Exit|Overall Study||3
9768806|NCT00428298|10873591|FG001|Second RBANS at Study Exit|Overall Study||3
9768807|NCT00428298|10873590|FG000|COMPLETED|Overall Study||16
9768808|NCT00428298|10873591|FG001|COMPLETED|Overall Study||19
9768809|NCT00428298|10873590|FG000|NOT COMPLETED|Overall Study||14
9768810|NCT00428298|10873591|FG001|NOT COMPLETED|Overall Study||11
9768811|NCT00428389|10873601|FG000|STARTED|Core Phase||131
9768812|NCT00428389|10873602|FG001|STARTED|Core Phase||131
9768813|NCT00428389|10873601|FG000|Intent-to-treat Population|Core Phase||131
10014115|NCT01797536|11137138|FG003|COMPLETED|Overall Study||8
10014116|NCT01797536|11137135|FG000|NOT COMPLETED|Overall Study||0
10014117|NCT01797536|11137136|FG001|NOT COMPLETED|Overall Study||1
9768814|NCT00428389|10873602|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
9768815|NCT00428389|10873601|FG000|COMPLETED|Core Phase||120
9768816|NCT00428389|10873602|FG001|COMPLETED|Core Phase||120
9768817|NCT00428389|10873601|FG000|NOT COMPLETED|Core Phase||11
9768818|NCT00428389|10873602|FG001|NOT COMPLETED|Core Phase||11
9768819|NCT00428389|10873601|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
9768820|NCT00428389|10873602|FG001|STARTED|Extension Phase||117
9768821|NCT00428389|10873601|FG000|COMPLETED|Extension Phase||85
9768822|NCT00428389|10873602|FG001|COMPLETED|Extension Phase||91
9768823|NCT00428389|10873601|FG000|NOT COMPLETED|Extension Phase||32
9768824|NCT00428389|10873602|FG001|NOT COMPLETED|Extension Phase||26
9768825|NCT00428441|10873608|FG000|STARTED|Overall Study||75
9768826|NCT00428441|10873608|FG000|COMPLETED|Overall Study||74
9768827|NCT00428441|10873608|FG000|NOT COMPLETED|Overall Study||1
9768828|NCT00428584|10873614|FG000|STARTED|Comparative Phase||65
9768829|NCT00428584|10873615|FG001|STARTED|Comparative Phase||64
9768830|NCT00428584|10873614|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
9768831|NCT00428584|10873615|FG001|COMPLETED|Comparative Phase||63
9768832|NCT00428584|10873614|FG000|NOT COMPLETED|Comparative Phase||9
9768833|NCT00428584|10873615|FG001|NOT COMPLETED|Comparative Phase||1
9768834|NCT00428584|10873614|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
9768835|NCT00428584|10873615|FG001|STARTED|Extension Phase||63
9768836|NCT00428584|10873614|FG000|COMPLETED|Extension Phase||35
9768837|NCT00428584|10873615|FG001|COMPLETED|Extension Phase||34
9768838|NCT00428584|10873614|FG000|NOT COMPLETED|Extension Phase||21
9768839|NCT00428584|10873615|FG001|NOT COMPLETED|Extension Phase||29
9768840|NCT00428597|10873627|FG000|STARTED|Overall Study||86
9768841|NCT00428597|10873628|FG001|STARTED|Overall Study||85
9768842|NCT00428597|10873627|FG000|Received Treatment|Overall Study||83
9768843|NCT00428597|10873628|FG001|Received Treatment|Overall Study||82
9768844|NCT00428597|10873627|FG000|COMPLETED|Overall Study||0
9768845|NCT00428597|10873628|FG001|COMPLETED|Overall Study||0
9768846|NCT00428597|10873627|FG000|NOT COMPLETED|Overall Study||86
9768847|NCT00428597|10873628|FG001|NOT COMPLETED|Overall Study||85
9768848|NCT00428610|10873637|FG000|STARTED|Overall Study||53
9768849|NCT00428610|10873638|FG001|STARTED|Overall Study||18
10014118|NCT01797536|11137137|FG002|NOT COMPLETED|Overall Study||0
9768850|NCT00428610|10873639|FG002|STARTED|Overall Study||32
9768851|NCT00428610|10873637|FG000|Received at Least One Dose of Study Drug|Overall Study||53
9768852|NCT00428610|10873638|FG001|Received at Least One Dose of Study Drug|Overall Study||18
9768853|NCT00428610|10873639|FG002|Received at Least One Dose of Study Drug|Overall Study||32
9768854|NCT00428610|10873637|FG000|COMPLETED|Overall Study||0
9768855|NCT00428610|10873638|FG001|COMPLETED|Overall Study||0
10014119|NCT01797536|11137138|FG003|NOT COMPLETED|Overall Study||0
10233707|NCT01693653|11363481|FG000|STARTED|Overall Study||1
10233708|NCT01693653|11363482|FG001|STARTED|Overall Study||0
10233709|NCT01693653|11363481|FG000|COMPLETED|Overall Study||1
10233710|NCT01693653|11363482|FG001|COMPLETED|Overall Study||0
10233711|NCT01693653|11363481|FG000|NOT COMPLETED|Overall Study||0
10233712|NCT01693653|11363482|FG001|NOT COMPLETED|Overall Study||0
10233713|NCT01692691|11363488|FG000|STARTED|Overall Study||1
10233714|NCT01692691|11363488|FG000|COMPLETED|Overall Study||1
10233715|NCT01692691|11363488|FG000|NOT COMPLETED|Overall Study||0
10233716|NCT01691079|11363496|FG000|STARTED|Overall Study||0
10233717|NCT01691079|11363497|FG001|STARTED|Overall Study||0
10233718|NCT01691079|11363496|FG000|COMPLETED|Overall Study||0
10233719|NCT01691079|11363497|FG001|COMPLETED|Overall Study||0
10233720|NCT01691079|11363496|FG000|NOT COMPLETED|Overall Study||0
10233721|NCT01691079|11363497|FG001|NOT COMPLETED|Overall Study||0
10233722|NCT01690910|11363505|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
10233723|NCT01690910|11363506|FG001|STARTED|Overall Study||0
10233724|NCT01690910|11363505|FG000|COMPLETED|Overall Study||0
10233725|NCT01690910|11363506|FG001|COMPLETED|Overall Study||0
10233726|NCT01690910|11363505|FG000|NOT COMPLETED|Overall Study||0
10233727|NCT01690910|11363506|FG001|NOT COMPLETED|Overall Study||0
10233728|NCT01689974|11363514|FG000|STARTED|Overall Study||5
10233729|NCT01689974|11363515|FG001|STARTED|Overall Study||5
10233730|NCT01689974|11363514|FG000|COMPLETED|Overall Study||0
10233731|NCT01689974|11363515|FG001|COMPLETED|Overall Study||0
10233732|NCT01689974|11363514|FG000|NOT COMPLETED|Overall Study||5
10233733|NCT01689974|11363515|FG001|NOT COMPLETED|Overall Study||5
10233734|NCT01676961|11363521|FG000|STARTED|Overall Study||5
10233735|NCT01676961|11363521|FG000|COMPLETED|Overall Study||0
10233736|NCT01676961|11363521|FG000|NOT COMPLETED|Overall Study||5
10233737|NCT01681589|11363528|FG000|STARTED|Overall Study||0
10233738|NCT01681589|11363529|FG001|STARTED|Overall Study||0
10233739|NCT01681589|11363530|FG002|STARTED|Overall Study||0
10233740|NCT01681589|11363528|FG000|COMPLETED|Overall Study||0
10233741|NCT01681589|11363529|FG001|COMPLETED|Overall Study||0
10233742|NCT01681589|11363530|FG002|COMPLETED|Overall Study||0
10233743|NCT01681589|11363528|FG000|NOT COMPLETED|Overall Study||0
10233744|NCT01681589|11363529|FG001|NOT COMPLETED|Overall Study||0
10233745|NCT01681589|11363530|FG002|NOT COMPLETED|Overall Study||0
10233746|NCT01681745|11363538|FG000|STARTED|Overall Study||0
10233747|NCT01681745|11363538|FG000|COMPLETED|Overall Study||0
10233748|NCT01681745|11363538|FG000|NOT COMPLETED|Overall Study||0
10233749|NCT01682928|11363544|FG000|STARTED|Overall Study|2 subjects in this Arm|2
10233750|NCT01682928|11363545|FG001|STARTED|Overall Study|2 subjects in this Arm|2
10233751|NCT01682928|11363544|FG000|COMPLETED|Overall Study||2
10233752|NCT01682928|11363545|FG001|COMPLETED|Overall Study||2
10233753|NCT01682928|11363544|FG000|NOT COMPLETED|Overall Study||0
10233754|NCT01682928|11363545|FG001|NOT COMPLETED|Overall Study||0
10233755|NCT01668940|11363557|FG000|STARTED|Overall Study||17
10233756|NCT01668940|11363558|FG001|STARTED|Overall Study||14
10233757|NCT01668940|11363559|FG002|STARTED|Overall Study||9
10233758|NCT01668940|11363560|FG003|STARTED|Overall Study||14
10233759|NCT01668940|11363557|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
10233760|NCT01668940|11363558|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
10233761|NCT01668940|11363559|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
10233762|NCT01668940|11363560|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
10233763|NCT01668940|11363557|FG000|NOT COMPLETED|Overall Study||0
10233764|NCT01668940|11363558|FG001|NOT COMPLETED|Overall Study||0
10233765|NCT01668940|11363559|FG002|NOT COMPLETED|Overall Study||0
10233766|NCT01668940|11363560|FG003|NOT COMPLETED|Overall Study||0
10233767|NCT01663285|11363570|FG000|STARTED|Overall Study||1
10233768|NCT01663285|11363570|FG000|COMPLETED|Overall Study||1
10233769|NCT01663285|11363570|FG000|NOT COMPLETED|Overall Study||0
10233770|NCT01683864|11363577|FG000|STARTED|Overall Study||0
10233771|NCT01683864|11363578|FG001|STARTED|Overall Study||0
10233772|NCT01683864|11363579|FG002|STARTED|Overall Study||0
10233773|NCT01683864|11363577|FG000|COMPLETED|Overall Study||0
10233774|NCT01683864|11363578|FG001|COMPLETED|Overall Study||0
10233775|NCT01683864|11363579|FG002|COMPLETED|Overall Study||0
10233776|NCT01683864|11363577|FG000|NOT COMPLETED|Overall Study||0
10233777|NCT01683864|11363578|FG001|NOT COMPLETED|Overall Study||0
10233778|NCT01683864|11363579|FG002|NOT COMPLETED|Overall Study||0
10233779|NCT01675011|11363589|FG000|STARTED|Overall Study||3
10233780|NCT01675011|11363590|FG001|STARTED|Overall Study||1
10233781|NCT01675011|11363589|FG000|COMPLETED|Overall Study||0
10014120|NCT01797562|11137148|FG000|STARTED|Overall Study||116
10233782|NCT01675011|11363590|FG001|COMPLETED|Overall Study||0
10014121|NCT01797562|11137148|FG000|COMPLETED|Overall Study||111
10233783|NCT01675011|11363589|FG000|NOT COMPLETED|Overall Study||3
10233784|NCT01675011|11363590|FG001|NOT COMPLETED|Overall Study||1
9768856|NCT00428610|10873639|FG002|COMPLETED|Overall Study||0
9768857|NCT00428610|10873637|FG000|NOT COMPLETED|Overall Study||53
9768858|NCT00428610|10873638|FG001|NOT COMPLETED|Overall Study||18
9768859|NCT00428610|10873639|FG002|NOT COMPLETED|Overall Study||32
9768860|NCT00428714|10873649|FG000|STARTED|Overall Study||31
10233785|NCT01673425|11363596|FG000|STARTED|Overall Study||5
10233786|NCT01673425|11363596|FG000|COMPLETED|Overall Study||4
10233787|NCT01673425|11363596|FG000|NOT COMPLETED|Overall Study||1
10233788|NCT01673061|11363602|FG000|STARTED|Overall Study||0
10233789|NCT01673061|11363603|FG001|STARTED|Overall Study||0
10233790|NCT01673061|11363602|FG000|COMPLETED|Overall Study||0
10233791|NCT01673061|11363603|FG001|COMPLETED|Overall Study||0
10233792|NCT01673061|11363602|FG000|NOT COMPLETED|Overall Study||0
10233793|NCT01673061|11363603|FG001|NOT COMPLETED|Overall Study||0
10233794|NCT01675960|11363611|FG000|STARTED|Overall Study||2
10233795|NCT01675960|11363612|FG001|STARTED|Overall Study||0
10233796|NCT01675960|11363611|FG000|COMPLETED|Overall Study||2
10233797|NCT01675960|11363612|FG001|COMPLETED|Overall Study||0
10233798|NCT01675960|11363611|FG000|NOT COMPLETED|Overall Study||0
10233799|NCT01675960|11363612|FG001|NOT COMPLETED|Overall Study||0
10233800|NCT01668147|11363618|FG000|STARTED|Overall Study||13
10233801|NCT01668147|11363618|FG000|COMPLETED|Overall Study||7
10233802|NCT01668147|11363618|FG000|NOT COMPLETED|Overall Study||6
10233803|NCT01676701|11363628|FG000|STARTED|Overall Study||4
10233804|NCT01676701|11363629|FG001|STARTED|Overall Study||4
10233805|NCT01676701|11363628|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10233806|NCT01676701|11363629|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10233807|NCT01676701|11363628|FG000|Completed Post-Treatment Follow-Up|Overall Study||4
10233808|NCT01676701|11363629|FG001|Completed Post-Treatment Follow-Up|Overall Study||4
10233809|NCT01676701|11363628|FG000|COMPLETED|Overall Study||0
10233810|NCT01676701|11363629|FG001|COMPLETED|Overall Study||0
10233811|NCT01676701|11363628|FG000|NOT COMPLETED|Overall Study||4
10233812|NCT01676701|11363629|FG001|NOT COMPLETED|Overall Study||4
10233813|NCT01669148|11363637|FG000|STARTED|Overall Study||496
10233814|NCT01669148|11363637|FG000|COMPLETED|Overall Study||426
10233815|NCT01669148|11363637|FG000|NOT COMPLETED|Overall Study||70
10233816|NCT01662102|11363644|FG000|STARTED|Overall Study||1
10233817|NCT01662102|11363645|FG001|STARTED|Overall Study||0
10233818|NCT01662102|11363644|FG000|COMPLETED|Overall Study||0
10233819|NCT01662102|11363645|FG001|COMPLETED|Overall Study||0
10233820|NCT01662102|11363644|FG000|NOT COMPLETED|Overall Study||1
10233821|NCT01662102|11363645|FG001|NOT COMPLETED|Overall Study||0
10233822|NCT01659554|11363652|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
10233823|NCT01659554|11363652|FG000|COMPLETED|Overall Study||0
10233824|NCT01659554|11363652|FG000|NOT COMPLETED|Overall Study||4
10239666|NCT00089128|11371333|FG000|NOT COMPLETED|Overall Study||0
10239667|NCT00075608|11371337|FG000|STARTED|Overall Study||12
10239668|NCT00075608|11371337|FG000|COMPLETED|Overall Study||12
10239669|NCT00075608|11371337|FG000|NOT COMPLETED|Overall Study||0
10239670|NCT00074724|11371345|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10239671|NCT00074724|11371346|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10239672|NCT00074724|11371345|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10239673|NCT00074724|11371346|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10239674|NCT00074724|11371345|FG000|NOT COMPLETED|Overall Study||0
10239675|NCT00074724|11371346|FG001|NOT COMPLETED|Overall Study||0
10239676|NCT00085631|11371352|FG000|STARTED|Overall Study||13
10239677|NCT00085631|11371353|FG001|STARTED|Overall Study||49
10239678|NCT00085631|11371354|FG002|STARTED|Overall Study||39
10239679|NCT00085631|11371352|FG000|COMPLETED|Overall Study||9
10239680|NCT00085631|11371353|FG001|COMPLETED|Overall Study||38
10239681|NCT00085631|11371354|FG002|COMPLETED|Overall Study||32
10239682|NCT00085631|11371352|FG000|NOT COMPLETED|Overall Study||4
10239683|NCT00085631|11371353|FG001|NOT COMPLETED|Overall Study||11
10239684|NCT00085631|11371354|FG002|NOT COMPLETED|Overall Study||7
10239685|NCT00062751|11371366|FG000|STARTED|Overall Study||33
10239686|NCT00062751|11371367|FG001|STARTED|Overall Study||30
10239687|NCT00062751|11371368|FG002|STARTED|Overall Study||33
9768861|NCT00428714|10873650|FG001|STARTED|Overall Study||42
9768862|NCT00428714|10873649|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10239688|NCT00062751|11371369|FG003|STARTED|Overall Study||6
10239689|NCT00062751|11371370|FG004|STARTED|Overall Study||6
10239690|NCT00062751|11371366|FG000|COMPLETED|Overall Study||0
10239691|NCT00062751|11371367|FG001|COMPLETED|Overall Study||0
10239692|NCT00062751|11371368|FG002|COMPLETED|Overall Study||3
10239693|NCT00062751|11371369|FG003|COMPLETED|Overall Study||1
10239694|NCT00062751|11371370|FG004|COMPLETED|Overall Study||0
10239695|NCT00062751|11371366|FG000|NOT COMPLETED|Overall Study||33
10239696|NCT00062751|11371367|FG001|NOT COMPLETED|Overall Study||30
9768863|NCT00428714|10873650|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
9768864|NCT00428714|10873649|FG000|COMPLETED|Overall Study||0
9768865|NCT00428714|10873650|FG001|COMPLETED|Overall Study||0
9768866|NCT00428714|10873649|FG000|NOT COMPLETED|Overall Study||31
9768867|NCT00428714|10873650|FG001|NOT COMPLETED|Overall Study||42
10014122|NCT01797562|11137148|FG000|NOT COMPLETED|Overall Study||5
9768868|NCT00428792|10873659|FG000|STARTED|Overall Study||80
9768869|NCT00428792|10873660|FG001|STARTED|Overall Study||70
9768870|NCT00428792|10873659|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
9768871|NCT00428792|10873660|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
9768872|NCT00428792|10873659|FG000|NOT COMPLETED|Overall Study||1
9768873|NCT00428792|10873660|FG001|NOT COMPLETED|Overall Study||4
9768874|NCT00428844|10873669|FG000|STARTED|Completed Study Drug Treatment||25
9768875|NCT00428844|10873670|FG001|STARTED|Completed Study Drug Treatment||24
9768876|NCT00428844|10873671|FG002|STARTED|Completed Study Drug Treatment||26
9768877|NCT00428844|10873669|FG000|Received First Dose|Completed Study Drug Treatment||25
9768878|NCT00428844|10873670|FG001|Received First Dose|Completed Study Drug Treatment||24
9768879|NCT00428844|10873671|FG002|Received First Dose|Completed Study Drug Treatment||25
9768880|NCT00428844|10873669|FG000|COMPLETED|Completed Study Drug Treatment||23
9768881|NCT00428844|10873670|FG001|COMPLETED|Completed Study Drug Treatment||18
9768882|NCT00428844|10873671|FG002|COMPLETED|Completed Study Drug Treatment||19
9768883|NCT00428844|10873669|FG000|NOT COMPLETED|Completed Study Drug Treatment||2
9768884|NCT00428844|10873670|FG001|NOT COMPLETED|Completed Study Drug Treatment||6
9768885|NCT00428844|10873671|FG002|NOT COMPLETED|Completed Study Drug Treatment||7
9768886|NCT00428844|10873669|FG000|STARTED|Completed Test of Cure (TOC) Visit||23
9768887|NCT00428844|10873670|FG001|STARTED|Completed Test of Cure (TOC) Visit||18
9768888|NCT00428844|10873671|FG002|STARTED|Completed Test of Cure (TOC) Visit||19
9768889|NCT00428844|10873669|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20
9768890|NCT00428844|10873670|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16
9768891|NCT00428844|10873671|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17
9768892|NCT00428844|10873669|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
9768893|NCT00428844|10873670|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
9768894|NCT00428844|10873671|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
9768895|NCT00428922|10873679|FG000|STARTED|Overall Study||26
9768896|NCT00428922|10873679|FG000|COMPLETED|Overall Study||26
9768897|NCT00428922|10873679|FG000|NOT COMPLETED|Overall Study||0
9768898|NCT00428948|10873685|FG000|STARTED|Overall Study||961
9768899|NCT00428948|10873686|FG001|STARTED|Overall Study||484
9768900|NCT00428948|10873685|FG000|Received Treatment|Overall Study||961
9768901|NCT00428948|10873686|FG001|Received Treatment|Overall Study||483
9768902|NCT00428948|10873685|FG000|COMPLETED|Overall Study||740
9768903|NCT00428948|10873686|FG001|COMPLETED|Overall Study||417
9768904|NCT00428948|10873685|FG000|NOT COMPLETED|Overall Study||221
9768905|NCT00428948|10873686|FG001|NOT COMPLETED|Overall Study||67
9768906|NCT00428974|10873696|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25
9768907|NCT00428974|10873697|FG001|STARTED|Overall Study||17
9768908|NCT00428974|10873698|FG002|STARTED|Overall Study||15
9768909|NCT00428974|10873699|FG003|STARTED|Overall Study||19
9768910|NCT00428974|10873696|FG000|COMPLETED|Overall Study||17
9768911|NCT00428974|10873697|FG001|COMPLETED|Overall Study||17
9768912|NCT00428974|10873698|FG002|COMPLETED|Overall Study||14
9768913|NCT00428974|10873699|FG003|COMPLETED|Overall Study||16
9768914|NCT00428974|10873696|FG000|NOT COMPLETED|Overall Study||8
9768915|NCT00428974|10873697|FG001|NOT COMPLETED|Overall Study||0
9768916|NCT00428974|10873698|FG002|NOT COMPLETED|Overall Study||1
9768917|NCT00428974|10873699|FG003|NOT COMPLETED|Overall Study||3
9768918|NCT00429104|10873710|FG000|STARTED|Overall Study||18
9768919|NCT00429104|10873710|FG000|COMPLETED|Overall Study||17
9768920|NCT00429104|10873710|FG000|NOT COMPLETED|Overall Study||1
9768921|NCT00429143|10873714|FG000|STARTED|Overall Study||27
9768922|NCT00429143|10873714|FG000|COMPLETED|Overall Study||27
9768923|NCT00429143|10873714|FG000|NOT COMPLETED|Overall Study||0
9768924|NCT00429169|10873720|FG000|STARTED|Overall Study||38
9768925|NCT00429169|10873721|FG001|STARTED|Overall Study||40
9768926|NCT00429169|10873720|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
9768927|NCT00429169|10873721|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
9768928|NCT00429169|10873720|FG000|NOT COMPLETED|Overall Study||2
9768929|NCT00429169|10873721|FG001|NOT COMPLETED|Overall Study||2
9768930|NCT00429182|10873729|FG000|STARTED|Overall Study||32
9768931|NCT00429182|10873729|FG000|COMPLETED|Overall Study||25
9768932|NCT00429182|10873729|FG000|NOT COMPLETED|Overall Study||7
9768933|NCT00429273|10873736|FG000|STARTED|Overall Study||68
9768934|NCT00429273|10873737|FG001|STARTED|Overall Study||69
9768935|NCT00429273|10873738|FG002|STARTED|Overall Study||70
9768936|NCT00429273|10873736|FG000|COMPLETED|Overall Study||60
9768937|NCT00429273|10873737|FG001|COMPLETED|Overall Study||61
9768938|NCT00429273|10873738|FG002|COMPLETED|Overall Study||61
9768939|NCT00429273|10873736|FG000|NOT COMPLETED|Overall Study||8
9768940|NCT00429273|10873737|FG001|NOT COMPLETED|Overall Study||8
9768941|NCT00429273|10873738|FG002|NOT COMPLETED|Overall Study||9
9768942|NCT00429299|10873749|FG000|STARTED|Overall Study||36
9768943|NCT00429299|10873750|FG001|STARTED|Overall Study||39
9768944|NCT00429299|10873751|FG002|STARTED|Overall Study||46
9768945|NCT00429299|10873749|FG000|COMPLETED|Overall Study||32
9768946|NCT00429299|10873750|FG001|COMPLETED|Overall Study||32
9768947|NCT00429299|10873751|FG002|COMPLETED|Overall Study||42
9768948|NCT00429299|10873749|FG000|NOT COMPLETED|Overall Study||4
9768949|NCT00429299|10873750|FG001|NOT COMPLETED|Overall Study||7
9768950|NCT00429299|10873751|FG002|NOT COMPLETED|Overall Study||4
9768951|NCT00429364|10873761|FG000|STARTED|Overall Study||303
9768952|NCT00429364|10873762|FG001|STARTED|Overall Study||305
9768953|NCT00429364|10873761|FG000|COMPLETED|Overall Study||271
9768954|NCT00429364|10873762|FG001|COMPLETED|Overall Study||272
9768955|NCT00429364|10873761|FG000|NOT COMPLETED|Overall Study||32
9768956|NCT00429364|10873762|FG001|NOT COMPLETED|Overall Study||33
9768957|NCT00429403|10873770|FG000|STARTED|Overall Study||1
9768958|NCT00429403|10873771|FG001|STARTED|Overall Study||0
9768959|NCT00429403|10873770|FG000|COMPLETED|Overall Study||1
9768960|NCT00429403|10873771|FG001|COMPLETED|Overall Study||0
9768961|NCT00429403|10873770|FG000|NOT COMPLETED|Overall Study||0
9768962|NCT00429403|10873771|FG001|NOT COMPLETED|Overall Study||0
9768963|NCT00429416|10873777|FG000|STARTED|Overall Study||14
9768964|NCT00429416|10873777|FG000|COMPLETED|Overall Study||13
9768965|NCT00429416|10873777|FG000|NOT COMPLETED|Overall Study||1
9768966|NCT00429494|10873781|FG000|STARTED|Overall Study||59
9768967|NCT00429494|10873781|FG000|COMPLETED|Overall Study||44
9768968|NCT00429494|10873781|FG000|NOT COMPLETED|Overall Study||15
9768969|NCT00429507|10873785|FG000|STARTED|Overall Study||12
9768970|NCT00429507|10873785|FG000|COMPLETED|Overall Study||12
9768971|NCT00429507|10873785|FG000|NOT COMPLETED|Overall Study||0
9768972|NCT00429572|10873789|FG000|STARTED|Overall Study||19
9768973|NCT00429572|10873789|FG000|COMPLETED|Overall Study||18
9768974|NCT00429572|10873789|FG000|NOT COMPLETED|Overall Study||1
9768975|NCT00429585|10873795|FG000|STARTED|Overall Study||52
9768976|NCT00429585|10873796|FG001|STARTED|Overall Study||47
9768977|NCT00429585|10873795|FG000|COMPLETED|Overall Study||22
9768978|NCT00429585|10873796|FG001|COMPLETED|Overall Study||27
9768979|NCT00429585|10873795|FG000|NOT COMPLETED|Overall Study||30
9768980|NCT00429585|10873796|FG001|NOT COMPLETED|Overall Study||20
9768981|NCT00429663|10873804|FG000|STARTED|Overall Study||76
9768982|NCT00429663|10873805|FG001|STARTED|Overall Study||80
9768983|NCT00429663|10873804|FG000|COMPLETED|Overall Study||40
9768984|NCT00429663|10873805|FG001|COMPLETED|Overall Study||41
9768985|NCT00429663|10873804|FG000|NOT COMPLETED|Overall Study||36
9768986|NCT00429663|10873805|FG001|NOT COMPLETED|Overall Study||39
9768987|NCT00429702|10873813|FG000|STARTED|Overall Study||3
9768988|NCT00429702|10873814|FG001|STARTED|Overall Study||4
9768989|NCT00429702|10873813|FG000|COMPLETED|Overall Study||3
9768990|NCT00429702|10873814|FG001|COMPLETED|Overall Study||4
9768991|NCT00429702|10873813|FG000|NOT COMPLETED|Overall Study||0
9768992|NCT00429702|10873814|FG001|NOT COMPLETED|Overall Study||0
9768993|NCT00429793|10873820|FG000|STARTED|Overall Study||60
9768994|NCT00429793|10873820|FG000|COMPLETED|Overall Study||54
9768995|NCT00429793|10873820|FG000|NOT COMPLETED|Overall Study||6
9768996|NCT00429949|10873829|FG000|STARTED|Overall Study||21
9768997|NCT00429949|10873829|FG000|COMPLETED|Overall Study||21
10233825|NCT01658813|11363656|FG000|STARTED|Overall Study||18
10233826|NCT01658813|11363656|FG000|Eligible|Overall Study||18
10233827|NCT01658813|11363656|FG000|Treated|Overall Study||18
9768998|NCT00429949|10873829|FG000|NOT COMPLETED|Overall Study||0
9768999|NCT00430183|10873837|FG000|STARTED|Overall Study||391
9769000|NCT00430183|10873838|FG001|STARTED|Overall Study||397
9769001|NCT00430183|10873837|FG000|COMPLETED|Overall Study||391
9769002|NCT00430183|10873838|FG001|COMPLETED|Overall Study||397
9769003|NCT00430183|10873837|FG000|NOT COMPLETED|Overall Study||0
10233828|NCT01658813|11363656|FG000|COMPLETED|Overall Study||15
10233829|NCT01658813|11363656|FG000|NOT COMPLETED|Overall Study||3
10233830|NCT01648296|11363666|FG000|STARTED|Overall Study||11
10233831|NCT01648296|11363667|FG001|STARTED|Overall Study||17
10233832|NCT01648296|11363666|FG000|COMPLETED|Overall Study||11
10233833|NCT01648296|11363667|FG001|COMPLETED|Overall Study||17
10233834|NCT01648296|11363666|FG000|NOT COMPLETED|Overall Study||0
10233835|NCT01648296|11363667|FG001|NOT COMPLETED|Overall Study||0
10233836|NCT01649505|11363677|FG000|STARTED|Overall Study||1
9769004|NCT00430183|10873838|FG001|NOT COMPLETED|Overall Study||0
9769005|NCT00430248|10873847|FG000|STARTED|Overall Study||757
9769006|NCT00430248|10873848|FG001|STARTED|Overall Study||756
10233837|NCT01649505|11363678|FG001|STARTED|Overall Study||1
10233838|NCT01649505|11363677|FG000|COMPLETED|Overall Study||0
9769007|NCT00430248|10873849|FG002|STARTED|Overall Study||756
9769008|NCT00430248|10873847|FG000|COMPLETED|Overall Study||632
9769009|NCT00430248|10873848|FG001|COMPLETED|Overall Study||598
9769010|NCT00430248|10873849|FG002|COMPLETED|Overall Study||621
9769011|NCT00430248|10873847|FG000|NOT COMPLETED|Overall Study||125
9769012|NCT00430248|10873848|FG001|NOT COMPLETED|Overall Study||158
9769013|NCT00430248|10873849|FG002|NOT COMPLETED|Overall Study||135
9769014|NCT00430300|10873861|FG000|STARTED|Overall Study||17
9769015|NCT00430300|10873862|FG001|STARTED|Overall Study||18
9769016|NCT00430300|10873863|FG002|STARTED|Overall Study||35
9769017|NCT00430300|10873864|FG003|STARTED|Overall Study||17
9769018|NCT00430300|10873861|FG000|COMPLETED|Overall Study||15
9769019|NCT00430300|10873862|FG001|COMPLETED|Overall Study||16
9769020|NCT00430300|10873863|FG002|COMPLETED|Overall Study||29
9769021|NCT00430300|10873864|FG003|COMPLETED|Overall Study||15
9769022|NCT00430300|10873861|FG000|NOT COMPLETED|Overall Study||2
9769023|NCT00430300|10873862|FG001|NOT COMPLETED|Overall Study||2
10233839|NCT01649505|11363678|FG001|COMPLETED|Overall Study||0
9769024|NCT00430300|10873863|FG002|NOT COMPLETED|Overall Study||6
9769025|NCT00430300|10873864|FG003|NOT COMPLETED|Overall Study||2
9769026|NCT00430352|10873874|FG000|STARTED|Overall Study||545
9769027|NCT00430352|10873874|FG000|COMPLETED|Overall Study||407
9769028|NCT00430352|10873874|FG000|NOT COMPLETED|Overall Study||138
9769029|NCT00430482|10873880|FG000|STARTED|Completed Treatment||41
9769030|NCT00430482|10873881|FG001|STARTED|Completed Treatment||37
9769031|NCT00430482|10873880|FG000|Completed ASI at Midpoint|Completed Treatment||35
9769032|NCT00430482|10873881|FG001|Completed ASI at Midpoint|Completed Treatment||29
9769033|NCT00430482|10873880|FG000|COMPLETED|Completed Treatment||34
9769034|NCT00430482|10873881|FG001|COMPLETED|Completed Treatment||26
9769035|NCT00430482|10873880|FG000|NOT COMPLETED|Completed Treatment||7
9769036|NCT00430482|10873881|FG001|NOT COMPLETED|Completed Treatment||11
9769037|NCT00430482|10873880|FG000|STARTED|Completed 2 Follow-Up Visits||34
9769038|NCT00430482|10873881|FG001|STARTED|Completed 2 Follow-Up Visits||26
9769039|NCT00430482|10873880|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
9769040|NCT00430482|10873881|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
9769041|NCT00430482|10873880|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
9769042|NCT00430482|10873881|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
9769043|NCT00430482|10873880|FG000|COMPLETED|Completed 2 Follow-Up Visits||29
9769044|NCT00430482|10873881|FG001|COMPLETED|Completed 2 Follow-Up Visits||20
9769045|NCT00430482|10873880|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5
9769046|NCT00430482|10873881|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6
9769047|NCT00430495|10873891|FG000|STARTED|Overall Study||64
9769048|NCT00430495|10873892|FG001|STARTED|Overall Study||66
9769049|NCT00430495|10873893|FG002|STARTED|Overall Study||62
9769050|NCT00430495|10873894|FG003|STARTED|Overall Study||64
9769051|NCT00430495|10873891|FG000|Treated|Overall Study||62
9769052|NCT00430495|10873892|FG001|Treated|Overall Study||66
9769053|NCT00430495|10873893|FG002|Treated|Overall Study||62
9769054|NCT00430495|10873894|FG003|Treated|Overall Study||64
9769055|NCT00430495|10873891|FG000|COMPLETED|Overall Study||50
9769056|NCT00430495|10873892|FG001|COMPLETED|Overall Study||59
9769057|NCT00430495|10873893|FG002|COMPLETED|Overall Study||49
9769058|NCT00430495|10873894|FG003|COMPLETED|Overall Study||60
9769059|NCT00430495|10873891|FG000|NOT COMPLETED|Overall Study||14
9769060|NCT00430495|10873892|FG001|NOT COMPLETED|Overall Study||7
9769061|NCT00430495|10873893|FG002|NOT COMPLETED|Overall Study||13
9769062|NCT00430495|10873894|FG003|NOT COMPLETED|Overall Study||4
9769063|NCT00430521|10873912|FG000|STARTED|Overall Study||63
9769064|NCT00430521|10873913|FG001|STARTED|Overall Study||66
9769065|NCT00430521|10873914|FG002|STARTED|Overall Study||64
9769066|NCT00430521|10873915|FG003|STARTED|Overall Study||63
9769067|NCT00430521|10873916|FG004|STARTED|Overall Study||64
9769068|NCT00430521|10873917|FG005|STARTED|Overall Study||64
9769069|NCT00430521|10873918|FG006|STARTED|Overall Study||65
9769070|NCT00430521|10873919|FG007|STARTED|Overall Study||63
9769071|NCT00430521|10873912|FG000|COMPLETED|Overall Study||52
9769072|NCT00430521|10873913|FG001|COMPLETED|Overall Study||57
9769073|NCT00430521|10873914|FG002|COMPLETED|Overall Study||61
9769074|NCT00430521|10873915|FG003|COMPLETED|Overall Study||55
9769075|NCT00430521|10873916|FG004|COMPLETED|Overall Study||59
9769076|NCT00430521|10873917|FG005|COMPLETED|Overall Study||59
9769077|NCT00430521|10873918|FG006|COMPLETED|Overall Study||55
9769078|NCT00430521|10873919|FG007|COMPLETED|Overall Study||51
9769079|NCT00430521|10873912|FG000|NOT COMPLETED|Overall Study||11
9769080|NCT00430521|10873913|FG001|NOT COMPLETED|Overall Study||9
9769081|NCT00430521|10873914|FG002|NOT COMPLETED|Overall Study||3
9769082|NCT00430521|10873915|FG003|NOT COMPLETED|Overall Study||8
9769083|NCT00430521|10873916|FG004|NOT COMPLETED|Overall Study||5
9769084|NCT00430521|10873917|FG005|NOT COMPLETED|Overall Study||5
9769085|NCT00430521|10873918|FG006|NOT COMPLETED|Overall Study||10
9769086|NCT00430521|10873919|FG007|NOT COMPLETED|Overall Study||12
9769087|NCT00430573|10873950|FG000|STARTED|Overall Study||10
9769088|NCT00430573|10873950|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
9769089|NCT00430573|10873950|FG000|NOT COMPLETED|Overall Study||5
9769090|NCT00430625|10873957|FG000|STARTED|Overall Study||13
9769091|NCT00430625|10873958|FG001|STARTED|Overall Study||12
9769092|NCT00430625|10873957|FG000|COMPLETED|Overall Study||13
9769093|NCT00430625|10873958|FG001|COMPLETED|Overall Study||12
9769094|NCT00430625|10873957|FG000|NOT COMPLETED|Overall Study||0
9769095|NCT00430625|10873958|FG001|NOT COMPLETED|Overall Study||0
9769096|NCT00430638|10873967|FG000|STARTED|Overall Study||138
9769097|NCT00430638|10873968|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
9769098|NCT00430638|10873967|FG000|COMPLETED|Overall Study||60
9769099|NCT00430638|10873968|FG001|COMPLETED|Overall Study||92
9769100|NCT00430638|10873967|FG000|NOT COMPLETED|Overall Study||78
9769101|NCT00430638|10873968|FG001|NOT COMPLETED|Overall Study||48
9769102|NCT00430677|10873981|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
9769103|NCT00430677|10873982|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
9769104|NCT00430677|10873983|FG002|STARTED|Short-term Period||100
9769105|NCT00430677|10873981|FG000|COMPLETED|Short-term Period|Completed the short-term period|76
9769106|NCT00430677|10873982|FG001|COMPLETED|Short-term Period|Completed the short-term period|74
9769107|NCT00430677|10873983|FG002|COMPLETED|Short-term Period|Completed the short-term period|78
9769108|NCT00430677|10873981|FG000|NOT COMPLETED|Short-term Period||23
9769109|NCT00430677|10873982|FG001|NOT COMPLETED|Short-term Period||25
9769110|NCT00430677|10873983|FG002|NOT COMPLETED|Short-term Period||22
9769111|NCT00430677|10873981|FG000|STARTED|Long-term Extension Period||70
9769112|NCT00430677|10873982|FG001|STARTED|Long-term Extension Period||67
9769113|NCT00430677|10873983|FG002|STARTED|Long-term Extension Period||74
9769114|NCT00430677|10873981|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
9769115|NCT00430677|10873982|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
9769116|NCT00430677|10873983|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
9769117|NCT00430677|10873981|FG000|NOT COMPLETED|Long-term Extension Period||60
9769118|NCT00430677|10873982|FG001|NOT COMPLETED|Long-term Extension Period||58
9769119|NCT00430677|10873983|FG002|NOT COMPLETED|Long-term Extension Period||63
9769120|NCT00430716|10874012|FG000|STARTED|Double Blind Phase||42
9769121|NCT00430716|10874013|FG001|STARTED|Double Blind Phase||43
9769122|NCT00430716|10874014|FG002|STARTED|Double Blind Phase||45
9769123|NCT00430716|10874012|FG000|Treated|Double Blind Phase||41
9769124|NCT00430716|10874013|FG001|Treated|Double Blind Phase||43
9769125|NCT00430716|10874014|FG002|Treated|Double Blind Phase||45
9769126|NCT00430716|10874012|FG000|COMPLETED|Double Blind Phase||36
9769127|NCT00430716|10874013|FG001|COMPLETED|Double Blind Phase||38
9769128|NCT00430716|10874014|FG002|COMPLETED|Double Blind Phase||39
9769129|NCT00430716|10874012|FG000|NOT COMPLETED|Double Blind Phase||6
9769130|NCT00430716|10874013|FG001|NOT COMPLETED|Double Blind Phase||5
9769131|NCT00430716|10874014|FG002|NOT COMPLETED|Double Blind Phase||6
9769132|NCT00430716|10874012|FG000|STARTED|Open Label Phase||36
9769133|NCT00430716|10874013|FG001|STARTED|Open Label Phase||38
9769134|NCT00430716|10874014|FG002|STARTED|Open Label Phase||39
9769135|NCT00430716|10874012|FG000|COMPLETED|Open Label Phase||27
9769136|NCT00430716|10874013|FG001|COMPLETED|Open Label Phase||31
9769137|NCT00430716|10874014|FG002|COMPLETED|Open Label Phase||32
9769138|NCT00430716|10874012|FG000|NOT COMPLETED|Open Label Phase||9
9769139|NCT00430716|10874013|FG001|NOT COMPLETED|Open Label Phase||7
9769140|NCT00430716|10874014|FG002|NOT COMPLETED|Open Label Phase||7
9769141|NCT00430755|10874022|FG000|STARTED|Overall Study||98
9769142|NCT00430755|10874022|FG000|COMPLETED|Overall Study||45
9769143|NCT00430755|10874022|FG000|NOT COMPLETED|Overall Study||53
9769144|NCT00430768|10874029|FG000|STARTED|Overall Study||3
9769145|NCT00430768|10874030|FG001|STARTED|Overall Study||3
9769146|NCT00430768|10874031|FG002|STARTED|Overall Study||3
9769147|NCT00430768|10874029|FG000|COMPLETED|Overall Study||3
9769148|NCT00430768|10874030|FG001|COMPLETED|Overall Study||3
9769149|NCT00430768|10874031|FG002|COMPLETED|Overall Study||3
9769150|NCT00430768|10874029|FG000|NOT COMPLETED|Overall Study||0
9769151|NCT00430768|10874030|FG001|NOT COMPLETED|Overall Study||0
9769152|NCT00430768|10874031|FG002|NOT COMPLETED|Overall Study||0
9769153|NCT00430781|10874048|FG000|STARTED|Interim Analysis; 11 February 2008||59
9769154|NCT00430781|10874049|FG001|STARTED|Interim Analysis; 11 February 2008||58
9769155|NCT00430781|10874050|FG002|STARTED|Interim Analysis; 11 February 2008||60
9769156|NCT00430781|10874048|FG000|Ongoing|Interim Analysis; 11 February 2008||23
9769157|NCT00430781|10874049|FG001|Ongoing|Interim Analysis; 11 February 2008||20
9769158|NCT00430781|10874050|FG002|Ongoing|Interim Analysis; 11 February 2008||25
9769159|NCT00430781|10874048|FG000|COMPLETED|Interim Analysis; 11 February 2008||0
9769160|NCT00430781|10874049|FG001|COMPLETED|Interim Analysis; 11 February 2008||0
9769161|NCT00430781|10874050|FG002|COMPLETED|Interim Analysis; 11 February 2008||0
9769162|NCT00430781|10874048|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59
9769163|NCT00430781|10874049|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58
9769164|NCT00430781|10874050|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60
9769165|NCT00430781|10874048|FG000|STARTED|Final Analysis; 31 July 2008||0
9769166|NCT00430781|10874049|FG001|STARTED|Final Analysis; 31 July 2008||78
9769167|NCT00430781|10874050|FG002|STARTED|Final Analysis; 31 July 2008||74
9769168|NCT00430781|10874048|FG000|Ongoing|Final Analysis; 31 July 2008||0
9769169|NCT00430781|10874049|FG001|Ongoing|Final Analysis; 31 July 2008||29
9769170|NCT00430781|10874050|FG002|Ongoing|Final Analysis; 31 July 2008||32
9769171|NCT00430781|10874048|FG000|COMPLETED|Final Analysis; 31 July 2008||0
9769172|NCT00430781|10874049|FG001|COMPLETED|Final Analysis; 31 July 2008||39
9769173|NCT00430781|10874050|FG002|COMPLETED|Final Analysis; 31 July 2008||26
9769174|NCT00430781|10874048|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0
9769175|NCT00430781|10874049|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39
9769176|NCT00430781|10874050|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48
9769177|NCT00430781|10874048|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
9769178|NCT00430781|10874049|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
9769179|NCT00430781|10874050|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74
9769180|NCT00430781|10874048|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53
9769181|NCT00430781|10874049|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59
9769182|NCT00430781|10874050|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54
9769183|NCT00430781|10874048|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
9769184|NCT00430781|10874049|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
9769185|NCT00430781|10874050|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
9829670|NCT00760929|10940351|FG002|STARTED|Overall Study||59
9829671|NCT00760929|10940352|FG003|STARTED|Overall Study||57
9769186|NCT00430937|10874063|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
9769187|NCT00430937|10874064|FG001|STARTED|Overall Study||92
9769188|NCT00430937|10874063|FG000|COMPLETED|Overall Study||70
9769189|NCT00430937|10874064|FG001|COMPLETED|Overall Study||64
9769190|NCT00430937|10874063|FG000|NOT COMPLETED|Overall Study||27
9769191|NCT00430937|10874064|FG001|NOT COMPLETED|Overall Study||28
9769192|NCT00430989|10874072|FG000|STARTED|Overall Study||3543
9769193|NCT00430989|10874073|FG001|STARTED|Overall Study||3569
9769194|NCT00430989|10874072|FG000|COMPLETED|Overall Study||3483
9769195|NCT00430989|10874073|FG001|COMPLETED|Overall Study||3509
9769196|NCT00430989|10874072|FG000|NOT COMPLETED|Overall Study||60
9769197|NCT00430989|10874073|FG001|NOT COMPLETED|Overall Study||60
9769198|NCT00431041|10874083|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
9769199|NCT00431041|10874084|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
9769200|NCT00431041|10874083|FG000|COMPLETED|Overall Study||52
9769201|NCT00431041|10874084|FG001|COMPLETED|Overall Study||40
9769202|NCT00431041|10874083|FG000|NOT COMPLETED|Overall Study||16
9769203|NCT00431041|10874084|FG001|NOT COMPLETED|Overall Study||24
9769204|NCT00431067|10874090|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41
9769205|NCT00431067|10874090|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
9769206|NCT00431067|10874090|FG000|NOT COMPLETED|Overall Study||41
9769207|NCT00431132|10874094|FG000|STARTED|Overall Study||336
9769208|NCT00431132|10874094|FG000|COMPLETED|Overall Study||292
9769209|NCT00431132|10874094|FG000|NOT COMPLETED|Overall Study||44
9769210|NCT00431184|10874100|FG000|STARTED|1st Intervention (Day 1)||10
9769211|NCT00431184|10874101|FG001|STARTED|1st Intervention (Day 1)||9
9769212|NCT00431184|10874100|FG000|COMPLETED|1st Intervention (Day 1)||10
9769213|NCT00431184|10874101|FG001|COMPLETED|1st Intervention (Day 1)||9
9769214|NCT00431184|10874100|FG000|NOT COMPLETED|1st Intervention (Day 1)||0
9769215|NCT00431184|10874101|FG001|NOT COMPLETED|1st Intervention (Day 1)||0
9769216|NCT00431184|10874100|FG000|STARTED|Second Intervention (Day 2)||10
9769217|NCT00431184|10874101|FG001|STARTED|Second Intervention (Day 2)||9
9769218|NCT00431184|10874100|FG000|COMPLETED|Second Intervention (Day 2)||10
9769219|NCT00431184|10874101|FG001|COMPLETED|Second Intervention (Day 2)||9
9769220|NCT00431184|10874100|FG000|NOT COMPLETED|Second Intervention (Day 2)||0
9769221|NCT00431184|10874101|FG001|NOT COMPLETED|Second Intervention (Day 2)||0
9769222|NCT00431444|10874111|FG000|STARTED|Overall Study||56
9769223|NCT00431444|10874112|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
9769224|NCT00431444|10874111|FG000|COMPLETED|Overall Study||51
9769225|NCT00431444|10874112|FG001|COMPLETED|Overall Study||46
9769226|NCT00431444|10874111|FG000|NOT COMPLETED|Overall Study||5
9769227|NCT00431444|10874112|FG001|NOT COMPLETED|Overall Study||7
9769228|NCT00431496|10874118|FG000|STARTED|Overall Study||71
9769229|NCT00431496|10874118|FG000|COMPLETED|Overall Study||60
9769230|NCT00431496|10874118|FG000|NOT COMPLETED|Overall Study||11
9769231|NCT00431626|10874124|FG000|STARTED|Overall Study||4
9769232|NCT00431626|10874125|FG001|STARTED|Overall Study||0
9769233|NCT00431626|10874124|FG000|COMPLETED|Overall Study||4
9769234|NCT00431626|10874125|FG001|COMPLETED|Overall Study||0
9769235|NCT00431626|10874124|FG000|NOT COMPLETED|Overall Study||0
9769236|NCT00431626|10874125|FG001|NOT COMPLETED|Overall Study||0
9769237|NCT00431834|10874131|FG000|STARTED|Overall Study||75
9769238|NCT00431834|10874131|FG000|COMPLETED|Overall Study||62
9769239|NCT00431834|10874131|FG000|NOT COMPLETED|Overall Study||13
9769240|NCT00431847|10874142|FG000|STARTED|Overall Study||132
9769241|NCT00431847|10874143|FG001|STARTED|Overall Study||45
9769242|NCT00431847|10874144|FG002|STARTED|Overall Study||24
9769243|NCT00431847|10874145|FG003|STARTED|Overall Study||184
9769244|NCT00431847|10874146|FG004|STARTED|Overall Study||1
9769245|NCT00431847|10874142|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
9769246|NCT00431847|10874143|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
9769247|NCT00431847|10874144|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
9769248|NCT00431847|10874145|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
9769249|NCT00431847|10874146|FG004|COMPLETED|Overall Study||0
9769250|NCT00431847|10874142|FG000|NOT COMPLETED|Overall Study||6
9769251|NCT00431847|10874143|FG001|NOT COMPLETED|Overall Study||3
9769252|NCT00431847|10874144|FG002|NOT COMPLETED|Overall Study||4
9769253|NCT00431847|10874145|FG003|NOT COMPLETED|Overall Study||14
9769254|NCT00431847|10874146|FG004|NOT COMPLETED|Overall Study||1
9769255|NCT00431951|10874160|FG000|STARTED|Overall Study||8
9769256|NCT00431951|10874161|FG001|STARTED|Overall Study||8
9769257|NCT00431951|10874162|FG002|STARTED|Overall Study||8
9769258|NCT00431951|10874163|FG003|STARTED|Overall Study||6
9769259|NCT00431951|10874160|FG000|COMPLETED|Overall Study||7
9769260|NCT00431951|10874161|FG001|COMPLETED|Overall Study||6
9769261|NCT00431951|10874162|FG002|COMPLETED|Overall Study||6
9769262|NCT00431951|10874163|FG003|COMPLETED|Overall Study||4
9769263|NCT00431951|10874160|FG000|NOT COMPLETED|Overall Study||1
9769264|NCT00431951|10874161|FG001|NOT COMPLETED|Overall Study||2
9769265|NCT00431951|10874162|FG002|NOT COMPLETED|Overall Study||2
9769266|NCT00431951|10874163|FG003|NOT COMPLETED|Overall Study||2
9769267|NCT00431964|10874179|FG000|STARTED|Overall Study||131
9769268|NCT00431964|10874180|FG001|STARTED|Overall Study||132
9769269|NCT00431964|10874179|FG000|Randomized/Received Drug|Overall Study||131
9769270|NCT00431964|10874180|FG001|Randomized/Received Drug|Overall Study||129
9769271|NCT00431964|10874179|FG000|Did Not Receive Drug|Overall Study||0
9769272|NCT00431964|10874180|FG001|Did Not Receive Drug|Overall Study||3
9769273|NCT00431964|10874179|FG000|Withdrew From Study|Overall Study||6
9769274|NCT00431964|10874180|FG001|Withdrew From Study|Overall Study||5
9769275|NCT00431964|10874179|FG000|COMPLETED|Overall Study||125
9769276|NCT00431964|10874180|FG001|COMPLETED|Overall Study||124
9769277|NCT00431964|10874179|FG000|NOT COMPLETED|Overall Study||6
9769278|NCT00431964|10874180|FG001|NOT COMPLETED|Overall Study||8
9829672|NCT00760929|10940349|FG000|COMPLETED|Overall Study||0
9829673|NCT00760929|10940350|FG001|COMPLETED|Overall Study||1
9829674|NCT00760929|10940351|FG002|COMPLETED|Overall Study||1
9829675|NCT00760929|10940352|FG003|COMPLETED|Overall Study||2
9829676|NCT00760929|10940349|FG000|NOT COMPLETED|Overall Study||26
9829677|NCT00760929|10940350|FG001|NOT COMPLETED|Overall Study||28
9829678|NCT00760929|10940351|FG002|NOT COMPLETED|Overall Study||58
9829679|NCT00760929|10940352|FG003|NOT COMPLETED|Overall Study||55
9829680|NCT00760994|10940364|FG000|STARTED|Overall Study||29
9829681|NCT00760994|10940365|FG001|STARTED|Overall Study||31
9829682|NCT00760994|10940366|FG002|STARTED|Overall Study||20
9829683|NCT00760994|10940364|FG000|COMPLETED|Overall Study||25
9829684|NCT00760994|10940365|FG001|COMPLETED|Overall Study||27
9829685|NCT00760994|10940366|FG002|COMPLETED|Overall Study||17
9829686|NCT00760994|10940364|FG000|NOT COMPLETED|Overall Study||4
9829687|NCT00760994|10940365|FG001|NOT COMPLETED|Overall Study||4
9829688|NCT00760994|10940366|FG002|NOT COMPLETED|Overall Study||3
9829689|NCT00761007|10940380|FG000|STARTED|Overall Study||142
9829690|NCT00761007|10940381|FG001|STARTED|Overall Study||135
9829691|NCT00761007|10940382|FG002|STARTED|Overall Study||139
9829692|NCT00761007|10940383|FG003|STARTED|Overall Study||138
9829693|NCT00761007|10940380|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140
9829694|NCT00761007|10940381|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135
9829695|NCT00761007|10940382|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139
9829696|NCT00761007|10940383|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137
9829697|NCT00761007|10940380|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
9829698|NCT00761007|10940381|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
9829699|NCT00761007|10940382|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
9829700|NCT00761007|10940383|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
9829701|NCT00761007|10940380|FG000|COMPLETED|Overall Study||129
9829702|NCT00761007|10940381|FG001|COMPLETED|Overall Study||124
9829703|NCT00761007|10940382|FG002|COMPLETED|Overall Study||121
9829704|NCT00761007|10940383|FG003|COMPLETED|Overall Study||131
9829705|NCT00761007|10940380|FG000|NOT COMPLETED|Overall Study||13
9829706|NCT00761007|10940381|FG001|NOT COMPLETED|Overall Study||11
9829707|NCT00761007|10940382|FG002|NOT COMPLETED|Overall Study||18
9829708|NCT00761007|10940383|FG003|NOT COMPLETED|Overall Study||7
9829709|NCT00761085|10940397|FG000|STARTED|Overall Study||12
9829710|NCT00761085|10940398|FG001|STARTED|Overall Study||12
9829711|NCT00761085|10940399|FG002|STARTED|Overall Study||11
9829712|NCT00761085|10940400|FG003|STARTED|Overall Study||12
9829713|NCT00761085|10940397|FG000|COMPLETED|Overall Study||12
9829714|NCT00761085|10940398|FG001|COMPLETED|Overall Study||6
9829715|NCT00761085|10940399|FG002|COMPLETED|Overall Study||11
9829716|NCT00761085|10940400|FG003|COMPLETED|Overall Study||8
9829717|NCT00761085|10940397|FG000|NOT COMPLETED|Overall Study||0
9829718|NCT00761085|10940398|FG001|NOT COMPLETED|Overall Study||6
9829719|NCT00761085|10940399|FG002|NOT COMPLETED|Overall Study||0
9829720|NCT00761085|10940400|FG003|NOT COMPLETED|Overall Study||4
9829721|NCT00761137|10940410|FG000|STARTED|Overall Study||19
10014123|NCT01797575|11137157|FG000|STARTED|Baseline Allocation||5
9829722|NCT00761137|10940410|FG000|Placebo|Overall Study||19
9829723|NCT00761137|10940410|FG000|0.3 mg Tropicamide|Overall Study||19
9829724|NCT00761137|10940410|FG000|1 mg Tropicamide|Overall Study||19
9829725|NCT00761137|10940410|FG000|3 mg Tropicamide|Overall Study||19
9829726|NCT00761137|10940410|FG000|COMPLETED|Overall Study||19
9829727|NCT00761137|10940410|FG000|NOT COMPLETED|Overall Study||0
9829728|NCT00761150|10940420|FG000|STARTED|Open-label Period||308
9829729|NCT00761150|10940421|FG001|STARTED|Open-label Period||0
9829730|NCT00761150|10940422|FG002|STARTED|Open-label Period||0
9829731|NCT00761150|10940420|FG000|COMPLETED|Open-label Period||238
9829732|NCT00761150|10940421|FG001|COMPLETED|Open-label Period||0
9829733|NCT00761150|10940422|FG002|COMPLETED|Open-label Period||0
9829734|NCT00761150|10940420|FG000|NOT COMPLETED|Open-label Period||70
9829735|NCT00761150|10940421|FG001|NOT COMPLETED|Open-label Period||0
9829736|NCT00761150|10940422|FG002|NOT COMPLETED|Open-label Period||0
9829737|NCT00761150|10940420|FG000|STARTED|Double-blind Period||0
9829738|NCT00761150|10940421|FG001|STARTED|Double-blind Period||120
9829739|NCT00761150|10940422|FG002|STARTED|Double-blind Period||118
9829740|NCT00761150|10940420|FG000|COMPLETED|Double-blind Period||0
9829741|NCT00761150|10940421|FG001|COMPLETED|Double-blind Period||106
9829742|NCT00761150|10940422|FG002|COMPLETED|Double-blind Period||89
9829743|NCT00761150|10940420|FG000|NOT COMPLETED|Double-blind Period||0
9829744|NCT00761150|10940421|FG001|NOT COMPLETED|Double-blind Period||14
9829745|NCT00761150|10940422|FG002|NOT COMPLETED|Double-blind Period||29
9829746|NCT00761189|10940429|FG000|STARTED|Overall Study||491
9829747|NCT00761189|10940429|FG000|COMPLETED|Overall Study||306
9829748|NCT00761189|10940429|FG000|NOT COMPLETED|Overall Study||185
9829749|NCT00761202|10940435|FG000|STARTED|Overall Study||22
9769279|NCT00432042|10874189|FG000|STARTED|Overall Study|Number randomized.|479
9769280|NCT00432042|10874190|FG001|STARTED|Overall Study|Number randomized.|235
9769281|NCT00432042|10874191|FG002|STARTED|Overall Study|Number randomized.|241
9769282|NCT00432042|10874189|FG000|Vaccinated|Overall Study||477
9769283|NCT00432042|10874190|FG001|Vaccinated|Overall Study||235
9769284|NCT00432042|10874191|FG002|Vaccinated|Overall Study||240
9769285|NCT00432042|10874189|FG000|COMPLETED|Overall Study||472
9769286|NCT00432042|10874190|FG001|COMPLETED|Overall Study||234
9769287|NCT00432042|10874191|FG002|COMPLETED|Overall Study||239
9769288|NCT00432042|10874189|FG000|NOT COMPLETED|Overall Study||7
9769289|NCT00432042|10874190|FG001|NOT COMPLETED|Overall Study||1
9769290|NCT00432042|10874191|FG002|NOT COMPLETED|Overall Study||2
9769291|NCT00432159|10874204|FG000|STARTED|Overall Study||185
9769292|NCT00432159|10874205|FG001|STARTED|Overall Study||167
9769293|NCT00432159|10874206|FG002|STARTED|Overall Study||39
9769294|NCT00432159|10874207|FG003|STARTED|Overall Study||20
9769295|NCT00432159|10874208|FG004|STARTED|Overall Study||89
9769296|NCT00432159|10874204|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163
9769297|NCT00432159|10874205|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137
9769298|NCT00432159|10874206|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35
9769299|NCT00432159|10874207|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15
9769300|NCT00432159|10874208|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79
9769301|NCT00432159|10874204|FG000|NOT COMPLETED|Overall Study||22
9769302|NCT00432159|10874205|FG001|NOT COMPLETED|Overall Study||30
10014124|NCT01797575|11137158|FG001|STARTED|Baseline Allocation||9
10014125|NCT01797575|11137159|FG002|STARTED|Baseline Allocation||9
10014126|NCT01797575|11137160|FG003|STARTED|Baseline Allocation||15
10014127|NCT01797575|11137157|FG000|COMPLETED|Baseline Allocation||4
9769303|NCT00432159|10874206|FG002|NOT COMPLETED|Overall Study||4
9769304|NCT00432159|10874207|FG003|NOT COMPLETED|Overall Study||5
9769305|NCT00432159|10874208|FG004|NOT COMPLETED|Overall Study||10
9769306|NCT00432172|10874224|FG000|STARTED|Overall Study||47
9769307|NCT00432172|10874225|FG001|STARTED|Overall Study||48
9769308|NCT00432172|10874226|FG002|STARTED|Overall Study||46
9769309|NCT00432172|10874227|FG003|STARTED|Overall Study||48
9769310|NCT00432172|10874224|FG000|COMPLETED|Overall Study||41
9769311|NCT00432172|10874225|FG001|COMPLETED|Overall Study||41
9769312|NCT00432172|10874226|FG002|COMPLETED|Overall Study||35
9769313|NCT00432172|10874227|FG003|COMPLETED|Overall Study||41
9769314|NCT00432172|10874224|FG000|NOT COMPLETED|Overall Study||6
9769315|NCT00432172|10874225|FG001|NOT COMPLETED|Overall Study||7
9769316|NCT00432172|10874226|FG002|NOT COMPLETED|Overall Study||11
9769317|NCT00432172|10874227|FG003|NOT COMPLETED|Overall Study||7
9769318|NCT00432237|10874243|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
9769319|NCT00432237|10874244|FG001|STARTED|Overall Study||485
9769320|NCT00432237|10874245|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
9769321|NCT00432237|10874246|FG003|STARTED|Overall Study||490
9769322|NCT00432237|10874243|FG000|Completed--With Data|Overall Study||176
9769323|NCT00432237|10874244|FG001|Completed--With Data|Overall Study||381
9769324|NCT00432237|10874245|FG002|Completed--With Data|Overall Study||370
9769325|NCT00432237|10874246|FG003|Completed--With Data|Overall Study||365
9769326|NCT00432237|10874243|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
9769327|NCT00432237|10874244|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
9769328|NCT00432237|10874245|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
9769329|NCT00432237|10874246|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
9769330|NCT00432237|10874243|FG000|COMPLETED|Overall Study||177
9769331|NCT00432237|10874244|FG001|COMPLETED|Overall Study||384
9769332|NCT00432237|10874245|FG002|COMPLETED|Overall Study||375
9769333|NCT00432237|10874246|FG003|COMPLETED|Overall Study||366
9769334|NCT00432237|10874243|FG000|NOT COMPLETED|Overall Study||67
9769335|NCT00432237|10874244|FG001|NOT COMPLETED|Overall Study||101
9769336|NCT00432237|10874245|FG002|NOT COMPLETED|Overall Study||109
9769337|NCT00432237|10874246|FG003|NOT COMPLETED|Overall Study||124
9769338|NCT00432276|10874258|FG000|STARTED|Overall Study||404
9769339|NCT00432276|10874259|FG001|STARTED|Overall Study||399
9769340|NCT00432276|10874258|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
9769341|NCT00432276|10874259|FG001|Per Protocol Set|Overall Study||306
9769342|NCT00432276|10874258|FG000|COMPLETED|Overall Study||283
9769343|NCT00432276|10874259|FG001|COMPLETED|Overall Study||243
9769344|NCT00432276|10874258|FG000|NOT COMPLETED|Overall Study||121
9769345|NCT00432276|10874259|FG001|NOT COMPLETED|Overall Study||156
9769346|NCT00432341|10874267|FG000|STARTED|Overall Study||24
9769347|NCT00432341|10874268|FG001|STARTED|Overall Study||30
9769348|NCT00432341|10874267|FG000|COMPLETED|Overall Study||24
9769349|NCT00432341|10874268|FG001|COMPLETED|Overall Study||30
9769350|NCT00432341|10874267|FG000|NOT COMPLETED|Overall Study||0
9769351|NCT00432341|10874268|FG001|NOT COMPLETED|Overall Study||0
9769352|NCT00432380|10874277|FG000|STARTED|Overall Study||150
9769353|NCT00432380|10874278|FG001|STARTED|Overall Study||150
9769354|NCT00432380|10874279|FG002|STARTED|Overall Study||75
9769355|NCT00432380|10874277|FG000|COMPLETED|Overall Study||146
9769356|NCT00432380|10874278|FG001|COMPLETED|Overall Study||146
10014128|NCT01797575|11137158|FG001|COMPLETED|Baseline Allocation||8
9769357|NCT00432380|10874279|FG002|COMPLETED|Overall Study||74
9769358|NCT00432380|10874277|FG000|NOT COMPLETED|Overall Study||4
9769359|NCT00432380|10874278|FG001|NOT COMPLETED|Overall Study||4
9769360|NCT00432380|10874279|FG002|NOT COMPLETED|Overall Study||1
9769361|NCT00432458|10874290|FG000|STARTED|Overall Study||35
9769362|NCT00432458|10874291|FG001|STARTED|Overall Study||33
9769363|NCT00432458|10874290|FG000|COMPLETED|Overall Study||30
9769364|NCT00432458|10874291|FG001|COMPLETED|Overall Study||32
9769365|NCT00432458|10874290|FG000|NOT COMPLETED|Overall Study||5
9769366|NCT00432458|10874291|FG001|NOT COMPLETED|Overall Study||1
9769367|NCT00432562|10874299|FG000|STARTED|Overall Study||16
9769368|NCT00432562|10874300|FG001|STARTED|Overall Study||15
9769369|NCT00432562|10874299|FG000|COMPLETED|Overall Study||13
9769370|NCT00432562|10874300|FG001|COMPLETED|Overall Study||15
9769371|NCT00432562|10874299|FG000|NOT COMPLETED|Overall Study||3
9769372|NCT00432562|10874300|FG001|NOT COMPLETED|Overall Study||0
9769373|NCT00432601|10874308|FG000|STARTED|Time 1 to Time 2||510
9769374|NCT00432601|10874309|FG001|STARTED|Time 1 to Time 2||512
9769375|NCT00432601|10874308|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
9769376|NCT00432601|10874309|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
9769377|NCT00432601|10874308|FG000|NOT COMPLETED|Time 1 to Time 2||369
9769378|NCT00432601|10874309|FG001|NOT COMPLETED|Time 1 to Time 2||368
9769379|NCT00432601|10874308|FG000|STARTED|Time 2 to Time 3||141
9769380|NCT00432601|10874309|FG001|STARTED|Time 2 to Time 3||144
9769381|NCT00432601|10874308|FG000|COMPLETED|Time 2 to Time 3||122
9769382|NCT00432601|10874309|FG001|COMPLETED|Time 2 to Time 3||122
9769383|NCT00432601|10874308|FG000|NOT COMPLETED|Time 2 to Time 3||19
9769384|NCT00432601|10874309|FG001|NOT COMPLETED|Time 2 to Time 3||22
9769385|NCT00432666|10874317|FG000|STARTED|Main Period||73
9769386|NCT00432666|10874318|FG001|STARTED|Main Period||75
9769387|NCT00432666|10874317|FG000|COMPLETED|Main Period||71
9769388|NCT00432666|10874318|FG001|COMPLETED|Main Period||74
9769389|NCT00432666|10874317|FG000|NOT COMPLETED|Main Period||2
9769390|NCT00432666|10874318|FG001|NOT COMPLETED|Main Period||1
9769391|NCT00432666|10874317|FG000|STARTED|Open-Label Extension Period||145
9769392|NCT00432666|10874318|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
9769393|NCT00432666|10874317|FG000|COMPLETED|Open-Label Extension Period||120
9769394|NCT00432666|10874318|FG001|COMPLETED|Open-Label Extension Period||0
9769395|NCT00432666|10874317|FG000|NOT COMPLETED|Open-Label Extension Period||25
9769396|NCT00432666|10874318|FG001|NOT COMPLETED|Open-Label Extension Period||0
9769397|NCT00432679|10874326|FG000|STARTED|Overall Study||74
9769398|NCT00432679|10874327|FG001|STARTED|Overall Study||75
9769399|NCT00432679|10874326|FG000|COMPLETED|Overall Study||69
9769400|NCT00432679|10874327|FG001|COMPLETED|Overall Study||72
9769401|NCT00432679|10874326|FG000|NOT COMPLETED|Overall Study||5
9769402|NCT00432679|10874327|FG001|NOT COMPLETED|Overall Study||3
9769403|NCT00432744|10874335|FG000|STARTED|Months 0-6||12
9769404|NCT00432744|10874336|FG001|STARTED|Months 0-6||12
9769405|NCT00432744|10874335|FG000|COMPLETED|Months 0-6||7
9769406|NCT00432744|10874336|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
9769407|NCT00432744|10874335|FG000|NOT COMPLETED|Months 0-6||5
9769408|NCT00432744|10874336|FG001|NOT COMPLETED|Months 0-6||4
9769409|NCT00432744|10874335|FG000|STARTED|Months 7 - 12||7
9769410|NCT00432744|10874336|FG001|STARTED|Months 7 - 12||8
9769411|NCT00432744|10874335|FG000|COMPLETED|Months 7 - 12||6
9769412|NCT00432744|10874336|FG001|COMPLETED|Months 7 - 12||7
9769413|NCT00432744|10874335|FG000|NOT COMPLETED|Months 7 - 12||1
9769414|NCT00432744|10874336|FG001|NOT COMPLETED|Months 7 - 12||1
9769415|NCT00432809|10874345|FG000|STARTED|1 Year Follow-up||50
9769416|NCT00432809|10874346|FG001|STARTED|1 Year Follow-up||50
9769417|NCT00432809|10874347|FG002|STARTED|1 Year Follow-up||50
9769418|NCT00432809|10874345|FG000|COMPLETED|1 Year Follow-up||41
9769419|NCT00432809|10874346|FG001|COMPLETED|1 Year Follow-up||50
9769420|NCT00432809|10874347|FG002|COMPLETED|1 Year Follow-up||49
9769421|NCT00432809|10874345|FG000|NOT COMPLETED|1 Year Follow-up||9
9769422|NCT00432809|10874346|FG001|NOT COMPLETED|1 Year Follow-up||0
9769423|NCT00432809|10874347|FG002|NOT COMPLETED|1 Year Follow-up||1
9769424|NCT00432809|10874345|FG000|STARTED|2 Year Sub-study||20
9769425|NCT00432809|10874346|FG001|STARTED|2 Year Sub-study||20
9769426|NCT00432809|10874347|FG002|STARTED|2 Year Sub-study||20
9769427|NCT00432809|10874345|FG000|COMPLETED|2 Year Sub-study||17
9769428|NCT00432809|10874346|FG001|COMPLETED|2 Year Sub-study||18
9769429|NCT00432809|10874347|FG002|COMPLETED|2 Year Sub-study||19
9769430|NCT00432809|10874345|FG000|NOT COMPLETED|2 Year Sub-study||3
9769431|NCT00432809|10874346|FG001|NOT COMPLETED|2 Year Sub-study||2
9769432|NCT00432809|10874347|FG002|NOT COMPLETED|2 Year Sub-study||1
9769433|NCT00432835|10874357|FG000|STARTED|Overall Study||28
9769434|NCT00432835|10874358|FG001|STARTED|Overall Study||30
9769435|NCT00432835|10874357|FG000|Completed 1st Intervention|Overall Study||22
9769436|NCT00432835|10874358|FG001|Completed 1st Intervention|Overall Study||23
9769437|NCT00432835|10874357|FG000|Completed 2nd Intervention|Overall Study||22
9769438|NCT00432835|10874358|FG001|Completed 2nd Intervention|Overall Study||23
9769439|NCT00432835|10874357|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
9769440|NCT00432835|10874358|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
9769441|NCT00432835|10874357|FG000|NOT COMPLETED|Overall Study||6
9769442|NCT00432835|10874358|FG001|NOT COMPLETED|Overall Study||7
9769443|NCT00432965|10874366|FG000|STARTED|Overall Study||169
9769444|NCT00432965|10874367|FG001|STARTED|Overall Study||166
9769445|NCT00432965|10874366|FG000|COMPLETED|Overall Study||75
9769446|NCT00432965|10874367|FG001|COMPLETED|Overall Study||80
9769447|NCT00432965|10874366|FG000|NOT COMPLETED|Overall Study||94
9769448|NCT00432965|10874367|FG001|NOT COMPLETED|Overall Study||86
9769449|NCT00432991|10874375|FG000|STARTED|Overall Study||22
9769450|NCT00432991|10874376|FG001|STARTED|Overall Study||31
9769451|NCT00432991|10874375|FG000|COMPLETED|Overall Study||15
9769452|NCT00432991|10874376|FG001|COMPLETED|Overall Study||19
9769453|NCT00432991|10874375|FG000|NOT COMPLETED|Overall Study||7
9769454|NCT00432991|10874376|FG001|NOT COMPLETED|Overall Study||12
9769455|NCT00433004|10874384|FG000|STARTED|Overall Study||27
9769456|NCT00433004|10874385|FG001|STARTED|Overall Study||23
9769457|NCT00433004|10874384|FG000|COMPLETED|Overall Study||22
9769458|NCT00433004|10874385|FG001|COMPLETED|Overall Study||16
9769459|NCT00433004|10874384|FG000|NOT COMPLETED|Overall Study||5
9769460|NCT00433004|10874385|FG001|NOT COMPLETED|Overall Study||7
9769461|NCT00433017|10874393|FG000|STARTED|Overall Study||122
9769462|NCT00433017|10874394|FG001|STARTED|Overall Study||133
9769463|NCT00433017|10874393|FG000|Completed 12 Month Phase|Overall Study||114
9769464|NCT00433017|10874394|FG001|Completed 12 Month Phase|Overall Study||126
9769465|NCT00433017|10874393|FG000|COMPLETED|Overall Study||26
9769466|NCT00433017|10874394|FG001|COMPLETED|Overall Study||32
9769467|NCT00433017|10874393|FG000|NOT COMPLETED|Overall Study||96
9769468|NCT00433017|10874394|FG001|NOT COMPLETED|Overall Study||101
9769469|NCT00433147|10874404|FG000|STARTED|Overall Study||7
9769470|NCT00433147|10874405|FG001|STARTED|Overall Study||7
9769471|NCT00433147|10874406|FG002|STARTED|Overall Study||9
9769472|NCT00433147|10874407|FG003|STARTED|Overall Study||7
9769473|NCT00433147|10874404|FG000|Safety Population|Overall Study||7
9769474|NCT00433147|10874405|FG001|Safety Population|Overall Study||7
9769475|NCT00433147|10874406|FG002|Safety Population|Overall Study||9
9769476|NCT00433147|10874407|FG003|Safety Population|Overall Study||7
9769477|NCT00433147|10874404|FG000|PD Population|Overall Study||7
9769478|NCT00433147|10874405|FG001|PD Population|Overall Study||6
9769479|NCT00433147|10874406|FG002|PD Population|Overall Study||9
9769480|NCT00433147|10874407|FG003|PD Population|Overall Study||7
9769481|NCT00433147|10874404|FG000|Received at Least One Dose of Study Drug|Overall Study||7
9769482|NCT00433147|10874405|FG001|Received at Least One Dose of Study Drug|Overall Study||7
9769483|NCT00433147|10874406|FG002|Received at Least One Dose of Study Drug|Overall Study||9
9769484|NCT00433147|10874407|FG003|Received at Least One Dose of Study Drug|Overall Study||7
9769485|NCT00433147|10874404|FG000|COMPLETED|Overall Study||7
9769486|NCT00433147|10874405|FG001|COMPLETED|Overall Study||6
9769487|NCT00433147|10874406|FG002|COMPLETED|Overall Study||9
9769488|NCT00433147|10874407|FG003|COMPLETED|Overall Study||7
9769489|NCT00433147|10874404|FG000|NOT COMPLETED|Overall Study||0
9769490|NCT00433147|10874405|FG001|NOT COMPLETED|Overall Study||1
9769491|NCT00433147|10874406|FG002|NOT COMPLETED|Overall Study||0
9769492|NCT00433147|10874407|FG003|NOT COMPLETED|Overall Study||0
9769493|NCT00433160|10874419|FG000|STARTED|52-Week Double-Blind (DB) Period||137
9769494|NCT00433160|10874420|FG001|STARTED|52-Week Double-Blind (DB) Period||70
9769495|NCT00433160|10874419|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136
9769496|NCT00433160|10874420|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68
9769497|NCT00433160|10874419|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120
9769498|NCT00433160|10874420|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60
9769499|NCT00433160|10874419|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
9769500|NCT00433160|10874420|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
9769501|NCT00433160|10874419|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
9769502|NCT00433160|10874420|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
9769503|NCT00433160|10874419|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
9769504|NCT00433160|10874420|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
10014129|NCT01797575|11137159|FG002|COMPLETED|Baseline Allocation||4
10014130|NCT01797575|11137160|FG003|COMPLETED|Baseline Allocation||8
10233840|NCT01649505|11363677|FG000|NOT COMPLETED|Overall Study||1
9769505|NCT00433160|10874419|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
9769506|NCT00433160|10874420|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
9769507|NCT00433160|10874419|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
10233841|NCT01649505|11363678|FG001|NOT COMPLETED|Overall Study||1
10233842|NCT01642732|11363684|FG000|STARTED|Overall Study||1
10233843|NCT01642732|11363684|FG000|COMPLETED|Overall Study||0
9769508|NCT00433160|10874420|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
9769509|NCT00433160|10874419|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
9769510|NCT00433160|10874420|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
9769511|NCT00433160|10874419|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102
9769512|NCT00433160|10874420|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50
10014131|NCT01797575|11137157|FG000|NOT COMPLETED|Baseline Allocation||1
10233844|NCT01642732|11363684|FG000|NOT COMPLETED|Overall Study||1
10233845|NCT01645709|11363690|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0
10233846|NCT01645709|11363691|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0
10233847|NCT01645709|11363690|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0
10233848|NCT01645709|11363691|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0
10233849|NCT01645709|11363690|FG000|NOT COMPLETED|Overall Study||0
10233850|NCT01645709|11363691|FG001|NOT COMPLETED|Overall Study||0
10233851|NCT01648270|11363697|FG000|STARTED|Intravenous Buprenorphine||25
10233852|NCT01648270|11363697|FG000|COMPLETED|Intravenous Buprenorphine||13
10233853|NCT01648270|11363697|FG000|NOT COMPLETED|Intravenous Buprenorphine||12
10233854|NCT01648270|11363697|FG000|STARTED|Sublingual Buprenorphine||13
10233855|NCT01648270|11363697|FG000|COMPLETED|Sublingual Buprenorphine||13
10233856|NCT01648270|11363697|FG000|NOT COMPLETED|Sublingual Buprenorphine||0
10233857|NCT01648270|11363697|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13
10233858|NCT01648270|11363697|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
9769513|NCT00433160|10874419|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92
9769514|NCT00433160|10874420|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47
9769515|NCT00433160|10874419|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
9769516|NCT00433160|10874420|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
9769517|NCT00433199|10874432|FG000|STARTED|Double-Blind Period||40
9769518|NCT00433199|10874433|FG001|STARTED|Double-Blind Period||234
9769519|NCT00433199|10874432|FG000|COMPLETED|Double-Blind Period||28
9769520|NCT00433199|10874433|FG001|COMPLETED|Double-Blind Period||168
9769521|NCT00433199|10874432|FG000|NOT COMPLETED|Double-Blind Period||12
9769522|NCT00433199|10874433|FG001|NOT COMPLETED|Double-Blind Period||66
9769523|NCT00433199|10874432|FG000|STARTED|Open-Label Period||0
9769524|NCT00433199|10874433|FG001|STARTED|Open-Label Period||219
9769525|NCT00433199|10874432|FG000|COMPLETED|Open-Label Period||0
9769526|NCT00433199|10874433|FG001|COMPLETED|Open-Label Period||185
9769527|NCT00433199|10874432|FG000|NOT COMPLETED|Open-Label Period||0
10014132|NCT01797575|11137158|FG001|NOT COMPLETED|Baseline Allocation||1
10014133|NCT01797575|11137159|FG002|NOT COMPLETED|Baseline Allocation||5
9769528|NCT00433199|10874433|FG001|NOT COMPLETED|Open-Label Period||34
9769529|NCT00433290|10874446|FG000|STARTED|Overall Study||128
9769530|NCT00433290|10874447|FG001|STARTED|Overall Study||128
9769531|NCT00433290|10874446|FG000|COMPLETED|Overall Study||93
9769532|NCT00433290|10874447|FG001|COMPLETED|Overall Study||111
9769533|NCT00433290|10874446|FG000|NOT COMPLETED|Overall Study||35
9769534|NCT00433290|10874447|FG001|NOT COMPLETED|Overall Study||17
9769535|NCT00433329|10874453|FG000|STARTED|Overall Study||100
9769536|NCT00433329|10874453|FG000|COMPLETED|Overall Study||79
9769537|NCT00433329|10874453|FG000|NOT COMPLETED|Overall Study||21
9769538|NCT00433381|10874459|FG000|STARTED|Overall Study||63
9769539|NCT00433381|10874460|FG001|STARTED|Overall Study||60
9769540|NCT00433381|10874459|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
9769541|NCT00433381|10874460|FG001|COMPLETED|Overall Study||57
9769542|NCT00433381|10874459|FG000|NOT COMPLETED|Overall Study||3
9769543|NCT00433381|10874460|FG001|NOT COMPLETED|Overall Study||3
9769544|NCT00433446|10874474|FG000|STARTED|Overall Study||62
9769545|NCT00433446|10874474|FG000|Eligible|Overall Study||53
9769546|NCT00433446|10874474|FG000|Eligible and Began Protocol Therapy|Overall Study||53
9769547|NCT00433446|10874474|FG000|COMPLETED|Overall Study||1
9769548|NCT00433446|10874474|FG000|NOT COMPLETED|Overall Study||61
9769549|NCT00433537|10874478|FG000|STARTED|Step 1 - VcR-CVAD Induction||45
9769550|NCT00433537|10874479|FG001|STARTED|Step 1 - VcR-CVAD Induction||22
9769551|NCT00433537|10874480|FG002|STARTED|Step 1 - VcR-CVAD Induction||10
9769552|NCT00433537|10874478|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
9769553|NCT00433537|10874479|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
9769554|NCT00433537|10874480|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
9769555|NCT00433537|10874478|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44
9769556|NCT00433537|10874479|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22
9769557|NCT00433537|10874480|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1
9769558|NCT00433537|10874478|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
9769559|NCT00433537|10874479|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
9769560|NCT00433537|10874480|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
9769561|NCT00433537|10874478|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
9769562|NCT00433537|10874479|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
9769563|NCT00433537|10874480|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
9769564|NCT00433537|10874478|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
9769565|NCT00433537|10874479|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
9769566|NCT00433537|10874480|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
10014134|NCT01797575|11137160|FG003|NOT COMPLETED|Baseline Allocation||7
9769567|NCT00433537|10874478|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
9769568|NCT00433537|10874479|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
9769569|NCT00433537|10874480|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
9769570|NCT00433537|10874478|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
9769571|NCT00433537|10874479|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
9769572|NCT00433537|10874480|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
9769573|NCT00433550|10874490|FG000|STARTED|Overall Study||17
10233859|NCT01648270|11363697|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
10233860|NCT01648270|11363697|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13
9769574|NCT00433550|10874491|FG001|STARTED|Overall Study||10
9769575|NCT00433550|10874492|FG002|STARTED|Overall Study||6
9769576|NCT00433550|10874490|FG000|COMPLETED|Overall Study||17
9769577|NCT00433550|10874491|FG001|COMPLETED|Overall Study||10
9769578|NCT00433550|10874492|FG002|COMPLETED|Overall Study||6
9769579|NCT00433550|10874490|FG000|NOT COMPLETED|Overall Study||0
9769580|NCT00433550|10874491|FG001|NOT COMPLETED|Overall Study||0
9769581|NCT00433550|10874492|FG002|NOT COMPLETED|Overall Study||0
9769582|NCT00433654|10874502|FG000|STARTED|Overall Study||258
9769583|NCT00433654|10874503|FG001|STARTED|Overall Study||206
9769584|NCT00433654|10874502|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
9769585|NCT00433654|10874503|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
9769586|NCT00433654|10874502|FG000|NOT COMPLETED|Overall Study||15
9769587|NCT00433654|10874503|FG001|NOT COMPLETED|Overall Study||5
9769588|NCT00433745|10874515|FG000|STARTED|Overall Study||4
9769589|NCT00433745|10874515|FG000|COMPLETED|Overall Study||4
9769590|NCT00433745|10874515|FG000|NOT COMPLETED|Overall Study||0
9769591|NCT00433771|10874520|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
9769592|NCT00433771|10874520|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
9769593|NCT00433771|10874520|FG000|NOT COMPLETED|Overall Study||19
9769594|NCT00433836|10874526|FG000|STARTED|Overall Study||151
9769595|NCT00433836|10874527|FG001|STARTED|Overall Study||149
9769596|NCT00433836|10874526|FG000|COMPLETED|Overall Study||138
9769597|NCT00433836|10874527|FG001|COMPLETED|Overall Study||143
9769598|NCT00433836|10874526|FG000|NOT COMPLETED|Overall Study||13
9769599|NCT00433836|10874527|FG001|NOT COMPLETED|Overall Study||6
9769600|NCT00433914|10874535|FG000|STARTED|Overall Study||30
9769601|NCT00433914|10874536|FG001|STARTED|Overall Study||30
9769602|NCT00433914|10874535|FG000|COMPLETED|Overall Study||30
9769603|NCT00433914|10874536|FG001|COMPLETED|Overall Study||27
9769604|NCT00433914|10874535|FG000|NOT COMPLETED|Overall Study||0
9769605|NCT00433914|10874536|FG001|NOT COMPLETED|Overall Study||3
9769606|NCT00433966|10874544|FG000|STARTED|Pharmacology Intervention/Randomization||1800
9769607|NCT00433966|10874545|FG001|STARTED|Pharmacology Intervention/Randomization||1802
9769608|NCT00433966|10874546|FG002|STARTED|Pharmacology Intervention/Randomization||0
9769609|NCT00433966|10874547|FG003|STARTED|Pharmacology Intervention/Randomization||0
9769610|NCT00433966|10874544|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
9769611|NCT00433966|10874545|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
9769612|NCT00433966|10874546|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0
9769613|NCT00433966|10874547|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0
9769614|NCT00433966|10874544|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
9769615|NCT00433966|10874545|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
9769616|NCT00433966|10874546|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0
9769617|NCT00433966|10874547|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0
9769618|NCT00433966|10874544|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
9769619|NCT00433966|10874545|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
9769620|NCT00433966|10874546|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0
9769621|NCT00433966|10874547|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0
9769622|NCT00433966|10874544|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634
9769623|NCT00433966|10874545|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628
9769624|NCT00433966|10874546|FG002|COMPLETED|Pharmacology Intervention/Randomization||0
9769625|NCT00433966|10874547|FG003|COMPLETED|Pharmacology Intervention/Randomization||0
9769626|NCT00433966|10874544|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166
9769627|NCT00433966|10874545|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174
9769628|NCT00433966|10874546|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0
9769629|NCT00433966|10874547|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0
9769630|NCT00433966|10874544|FG000|STARTED|Stent Intervention/Randomization||0
9769631|NCT00433966|10874545|FG001|STARTED|Stent Intervention/Randomization||0
9769632|NCT00433966|10874546|FG002|STARTED|Stent Intervention/Randomization||2257
9769633|NCT00433966|10874547|FG003|STARTED|Stent Intervention/Randomization||749
9769634|NCT00433966|10874544|FG000|1-Year Follow-up|Stent Intervention/Randomization||0
9769635|NCT00433966|10874545|FG001|1-Year Follow-up|Stent Intervention/Randomization||0
9769636|NCT00433966|10874546|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186
9769637|NCT00433966|10874547|FG003|1-Year Follow-up|Stent Intervention/Randomization||715
9769638|NCT00433966|10874544|FG000|3-Year Follow-up|Stent Intervention/Randomization||0
9769639|NCT00433966|10874545|FG001|3-Year Follow-up|Stent Intervention/Randomization||0
9769640|NCT00433966|10874546|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103
9769641|NCT00433966|10874547|FG003|3-Year Follow-up|Stent Intervention/Randomization||687
9769642|NCT00433966|10874544|FG000|COMPLETED|Stent Intervention/Randomization||0
9769643|NCT00433966|10874545|FG001|COMPLETED|Stent Intervention/Randomization||0
9769644|NCT00433966|10874546|FG002|COMPLETED|Stent Intervention/Randomization||2103
9769645|NCT00433966|10874547|FG003|COMPLETED|Stent Intervention/Randomization||687
9769646|NCT00433966|10874544|FG000|NOT COMPLETED|Stent Intervention/Randomization||0
9769647|NCT00433966|10874545|FG001|NOT COMPLETED|Stent Intervention/Randomization||0
9769648|NCT00433966|10874546|FG002|NOT COMPLETED|Stent Intervention/Randomization||154
9769649|NCT00433966|10874547|FG003|NOT COMPLETED|Stent Intervention/Randomization||62
9769650|NCT00433992|10874559|FG000|STARTED|Overall Study||28
9769651|NCT00433992|10874560|FG001|STARTED|Overall Study||28
9769652|NCT00433992|10874559|FG000|COMPLETED|Overall Study||19
9769653|NCT00433992|10874560|FG001|COMPLETED|Overall Study||20
9769654|NCT00433992|10874559|FG000|NOT COMPLETED|Overall Study||9
9769655|NCT00433992|10874560|FG001|NOT COMPLETED|Overall Study||8
9769656|NCT00434018|10874572|FG000|STARTED|Overall Study||69
9769657|NCT00434018|10874573|FG001|STARTED|Overall Study||69
9769658|NCT00434018|10874572|FG000|COMPLETED|Overall Study||52
9769659|NCT00434018|10874573|FG001|COMPLETED|Overall Study||57
9769660|NCT00434018|10874572|FG000|NOT COMPLETED|Overall Study||17
9769661|NCT00434018|10874573|FG001|NOT COMPLETED|Overall Study||12
9769662|NCT00434057|10874580|FG000|STARTED|Overall Study||1383
9769663|NCT00434057|10874580|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
9769664|NCT00434057|10874580|FG000|NOT COMPLETED|Overall Study||1
9769665|NCT00434109|10874584|FG000|STARTED|Overall Study||39
9769666|NCT00434109|10874584|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
9769667|NCT00434109|10874584|FG000|NOT COMPLETED|Overall Study||18
9769668|NCT00434122|10874590|FG000|STARTED|Overall Study|Randomised|42
9769669|NCT00434122|10874591|FG001|STARTED|Overall Study|Randomised|43
9769670|NCT00434122|10874590|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
9769671|NCT00434122|10874591|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
9769672|NCT00434122|10874590|FG000|COMPLETED|Overall Study||36
9769673|NCT00434122|10874591|FG001|COMPLETED|Overall Study||36
9769674|NCT00434122|10874590|FG000|NOT COMPLETED|Overall Study||6
9769675|NCT00434122|10874591|FG001|NOT COMPLETED|Overall Study||7
9769676|NCT00434148|10874601|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
9769677|NCT00434148|10874602|FG001|STARTED|Overall Study||80
9769678|NCT00434148|10874601|FG000|Completed Month 12|Overall Study||39
9769679|NCT00434148|10874602|FG001|Completed Month 12|Overall Study||39
9769680|NCT00434148|10874601|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13
9769681|NCT00434148|10874602|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7
9769682|NCT00434148|10874601|FG000|Completed Month 12; Entered Extension|Overall Study||26
9769683|NCT00434148|10874602|FG001|Completed Month 12; Entered Extension|Overall Study||32
9769684|NCT00434148|10874601|FG000|COMPLETED|Overall Study||13
9769685|NCT00434148|10874602|FG001|COMPLETED|Overall Study||7
9769686|NCT00434148|10874601|FG000|NOT COMPLETED|Overall Study||69
9769687|NCT00434148|10874602|FG001|NOT COMPLETED|Overall Study||73
9769688|NCT00434161|10874611|FG000|STARTED|Overall Study||109
9769689|NCT00434161|10874612|FG001|STARTED|Overall Study||57
9769690|NCT00434161|10874613|FG002|STARTED|Overall Study||115
9769691|NCT00434161|10874611|FG000|COMPLETED|Overall Study||99
9769692|NCT00434161|10874612|FG001|COMPLETED|Overall Study||54
9769693|NCT00434161|10874613|FG002|COMPLETED|Overall Study||104
9769694|NCT00434161|10874611|FG000|NOT COMPLETED|Overall Study||10
9769695|NCT00434161|10874612|FG001|NOT COMPLETED|Overall Study||3
9769696|NCT00434161|10874613|FG002|NOT COMPLETED|Overall Study||11
9769697|NCT00434213|10874628|FG000|STARTED|Overall Study||309
9769698|NCT00434213|10874628|FG000|COMPLETED|Overall Study||260
9769699|NCT00434213|10874628|FG000|NOT COMPLETED|Overall Study||49
9769700|NCT00434252|10874634|FG000|STARTED|Overall Study||71
9769701|NCT00434252|10874635|FG001|STARTED|Overall Study||143
9769702|NCT00434252|10874634|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
9769703|NCT00434252|10874635|FG001|Treated|Overall Study||143
9769704|NCT00434252|10874634|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
9769705|NCT00434252|10874635|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
9769706|NCT00434252|10874634|FG000|NOT COMPLETED|Overall Study||64
9769707|NCT00434252|10874635|FG001|NOT COMPLETED|Overall Study||131
9769708|NCT00434278|10874643|FG000|STARTED|Overall Study||14
9769709|NCT00434278|10874644|FG001|STARTED|Overall Study||13
9769710|NCT00434278|10874643|FG000|COMPLETED|Overall Study||12
9769711|NCT00434278|10874644|FG001|COMPLETED|Overall Study||13
9769712|NCT00434278|10874643|FG000|NOT COMPLETED|Overall Study||2
9769713|NCT00434278|10874644|FG001|NOT COMPLETED|Overall Study||0
9769714|NCT00434304|10874650|FG000|STARTED|Overall Study||62
9769715|NCT00434304|10874650|FG000|COMPLETED|Overall Study||42
9769716|NCT00434304|10874650|FG000|NOT COMPLETED|Overall Study||20
9769717|NCT00434330|10874661|FG000|STARTED|Overall Study||15
9769718|NCT00434330|10874662|FG001|STARTED|Overall Study||15
9769719|NCT00434330|10874663|FG002|STARTED|Overall Study||16
9769720|NCT00434330|10874664|FG003|STARTED|Overall Study||15
9769721|NCT00434330|10874665|FG004|STARTED|Overall Study||15
9769722|NCT00434330|10874666|FG005|STARTED|Overall Study||15
9769723|NCT00434330|10874661|FG000|COMPLETED|Overall Study||14
9769724|NCT00434330|10874662|FG001|COMPLETED|Overall Study||15
9769725|NCT00434330|10874663|FG002|COMPLETED|Overall Study||13
9769726|NCT00434330|10874664|FG003|COMPLETED|Overall Study||13
9769727|NCT00434330|10874665|FG004|COMPLETED|Overall Study||14
9769728|NCT00434330|10874666|FG005|COMPLETED|Overall Study||14
9769729|NCT00434330|10874661|FG000|NOT COMPLETED|Overall Study||1
9769730|NCT00434330|10874662|FG001|NOT COMPLETED|Overall Study||0
9769731|NCT00434330|10874663|FG002|NOT COMPLETED|Overall Study||3
9769732|NCT00434330|10874664|FG003|NOT COMPLETED|Overall Study||2
9769733|NCT00434330|10874665|FG004|NOT COMPLETED|Overall Study||1
9769734|NCT00434330|10874666|FG005|NOT COMPLETED|Overall Study||1
9769735|NCT00434356|10874682|FG000|STARTED|Overall Study||23
9769736|NCT00434356|10874683|FG001|STARTED|Overall Study||23
9769737|NCT00434356|10874682|FG000|COMPLETED|Overall Study||0
9769738|NCT00434356|10874683|FG001|COMPLETED|Overall Study||0
9769739|NCT00434356|10874682|FG000|NOT COMPLETED|Overall Study||23
9769740|NCT00434356|10874683|FG001|NOT COMPLETED|Overall Study||23
9769741|NCT00434421|10874689|FG000|STARTED|Overall Study||28
9769742|NCT00434421|10874689|FG000|COMPLETED|Overall Study||26
9769743|NCT00434421|10874689|FG000|NOT COMPLETED|Overall Study||2
9769744|NCT00434434|10874696|FG000|STARTED|Overall Study||23
9769745|NCT00434434|10874697|FG001|STARTED|Overall Study||24
9769746|NCT00434434|10874698|FG002|STARTED|Overall Study||14
9769747|NCT00434434|10874696|FG000|COMPLETED|Overall Study||21
9769748|NCT00434434|10874697|FG001|COMPLETED|Overall Study||24
9769749|NCT00434434|10874698|FG002|COMPLETED|Overall Study||13
9769750|NCT00434434|10874696|FG000|NOT COMPLETED|Overall Study||2
9769751|NCT00434434|10874697|FG001|NOT COMPLETED|Overall Study||0
9769752|NCT00434434|10874698|FG002|NOT COMPLETED|Overall Study||1
9769753|NCT00434512|10874712|FG000|STARTED|Overall Study||10
9769754|NCT00434512|10874713|FG001|STARTED|Overall Study||10
9769755|NCT00434512|10874714|FG002|STARTED|Overall Study||10
9769756|NCT00434512|10874715|FG003|STARTED|Overall Study||50
9769757|NCT00434512|10874716|FG004|STARTED|Overall Study||50
9769758|NCT00434512|10874717|FG005|STARTED|Overall Study||50
9769759|NCT00434512|10874712|FG000|COMPLETED|Overall Study||10
9769760|NCT00434512|10874713|FG001|COMPLETED|Overall Study||9
9769761|NCT00434512|10874714|FG002|COMPLETED|Overall Study||10
9769762|NCT00434512|10874715|FG003|COMPLETED|Overall Study||49
9769763|NCT00434512|10874716|FG004|COMPLETED|Overall Study||49
9769764|NCT00434512|10874717|FG005|COMPLETED|Overall Study||49
9769765|NCT00434512|10874712|FG000|NOT COMPLETED|Overall Study||0
9769766|NCT00434512|10874713|FG001|NOT COMPLETED|Overall Study||1
9769767|NCT00434512|10874714|FG002|NOT COMPLETED|Overall Study||0
9769768|NCT00434512|10874715|FG003|NOT COMPLETED|Overall Study||1
9769769|NCT00434512|10874716|FG004|NOT COMPLETED|Overall Study||1
9769770|NCT00434512|10874717|FG005|NOT COMPLETED|Overall Study||1
9769771|NCT00434577|10874740|FG000|STARTED|Months 0-3||164
9769772|NCT00434577|10874741|FG001|STARTED|Months 0-3||166
9769773|NCT00434577|10874742|FG002|STARTED|Months 0-3||165
9769774|NCT00434577|10874743|FG003|STARTED|Months 0-3||165
9769775|NCT00434577|10874744|FG004|STARTED|Months 0-3||54
9769776|NCT00434577|10874740|FG000|COMPLETED|Months 0-3||161
9769777|NCT00434577|10874741|FG001|COMPLETED|Months 0-3||164
9769778|NCT00434577|10874742|FG002|COMPLETED|Months 0-3||161
9769779|NCT00434577|10874743|FG003|COMPLETED|Months 0-3||164
9769780|NCT00434577|10874744|FG004|COMPLETED|Months 0-3||51
9769781|NCT00434577|10874740|FG000|NOT COMPLETED|Months 0-3||3
9769782|NCT00434577|10874741|FG001|NOT COMPLETED|Months 0-3||2
9769783|NCT00434577|10874742|FG002|NOT COMPLETED|Months 0-3||4
9769784|NCT00434577|10874743|FG003|NOT COMPLETED|Months 0-3||1
9769785|NCT00434577|10874744|FG004|NOT COMPLETED|Months 0-3||3
9769786|NCT00434577|10874740|FG000|STARTED|Month 12||156
9769787|NCT00434577|10874741|FG001|STARTED|Month 12||159
9769788|NCT00434577|10874742|FG002|STARTED|Month 12||159
9769789|NCT00434577|10874743|FG003|STARTED|Month 12||161
9769790|NCT00434577|10874744|FG004|STARTED|Month 12||50
9769791|NCT00434577|10874740|FG000|COMPLETED|Month 12||156
9769792|NCT00434577|10874741|FG001|COMPLETED|Month 12||159
9769793|NCT00434577|10874742|FG002|COMPLETED|Month 12||159
9769794|NCT00434577|10874743|FG003|COMPLETED|Month 12||161
9769795|NCT00434577|10874744|FG004|COMPLETED|Month 12||50
9769796|NCT00434577|10874740|FG000|NOT COMPLETED|Month 12||0
9769797|NCT00434577|10874741|FG001|NOT COMPLETED|Month 12||0
9769798|NCT00434577|10874742|FG002|NOT COMPLETED|Month 12||0
9769799|NCT00434577|10874743|FG003|NOT COMPLETED|Month 12||0
9769800|NCT00434577|10874744|FG004|NOT COMPLETED|Month 12||0
9769801|NCT00434577|10874740|FG000|STARTED|Month 24||150
9769802|NCT00434577|10874741|FG001|STARTED|Month 24||155
9769803|NCT00434577|10874742|FG002|STARTED|Month 24||154
9769804|NCT00434577|10874743|FG003|STARTED|Month 24||157
9769805|NCT00434577|10874744|FG004|STARTED|Month 24||49
9769806|NCT00434577|10874740|FG000|COMPLETED|Month 24||150
9769807|NCT00434577|10874741|FG001|COMPLETED|Month 24||155
9769808|NCT00434577|10874742|FG002|COMPLETED|Month 24||154
9769809|NCT00434577|10874743|FG003|COMPLETED|Month 24||157
9769810|NCT00434577|10874744|FG004|COMPLETED|Month 24||49
9769811|NCT00434577|10874740|FG000|NOT COMPLETED|Month 24||0
9769812|NCT00434577|10874741|FG001|NOT COMPLETED|Month 24||0
9769813|NCT00434577|10874742|FG002|NOT COMPLETED|Month 24||0
9769814|NCT00434577|10874743|FG003|NOT COMPLETED|Month 24||0
9769815|NCT00434577|10874744|FG004|NOT COMPLETED|Month 24||0
9769816|NCT00434577|10874740|FG000|STARTED|Month 36||147
9769817|NCT00434577|10874741|FG001|STARTED|Month 36||147
9769818|NCT00434577|10874742|FG002|STARTED|Month 36||150
9769819|NCT00434577|10874743|FG003|STARTED|Month 36||155
9769820|NCT00434577|10874744|FG004|STARTED|Month 36||47
9769821|NCT00434577|10874740|FG000|COMPLETED|Month 36||147
9769822|NCT00434577|10874741|FG001|COMPLETED|Month 36||147
9769823|NCT00434577|10874742|FG002|COMPLETED|Month 36||150
9769824|NCT00434577|10874743|FG003|COMPLETED|Month 36||155
9769825|NCT00434577|10874744|FG004|COMPLETED|Month 36||47
9769826|NCT00434577|10874740|FG000|NOT COMPLETED|Month 36||0
9769827|NCT00434577|10874741|FG001|NOT COMPLETED|Month 36||0
9769828|NCT00434577|10874742|FG002|NOT COMPLETED|Month 36||0
9769829|NCT00434577|10874743|FG003|NOT COMPLETED|Month 36||0
9769830|NCT00434577|10874744|FG004|NOT COMPLETED|Month 36||0
9769831|NCT00434642|10874758|FG000|STARTED|Blinded Treatment Phase||242
9769832|NCT00434642|10874759|FG001|STARTED|Blinded Treatment Phase||242
9769833|NCT00434642|10874758|FG000|COMPLETED|Blinded Treatment Phase||0
9769834|NCT00434642|10874759|FG001|COMPLETED|Blinded Treatment Phase||13
9769835|NCT00434642|10874758|FG000|NOT COMPLETED|Blinded Treatment Phase||242
9769836|NCT00434642|10874759|FG001|NOT COMPLETED|Blinded Treatment Phase||229
9769837|NCT00434642|10874758|FG000|STARTED|Open-label Treatment Phase||0
9769838|NCT00434642|10874759|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
9769839|NCT00434642|10874758|FG000|COMPLETED|Open-label Treatment Phase||0
9769840|NCT00434642|10874759|FG001|COMPLETED|Open-label Treatment Phase||1
9769841|NCT00434642|10874758|FG000|NOT COMPLETED|Open-label Treatment Phase||0
9769842|NCT00434642|10874759|FG001|NOT COMPLETED|Open-label Treatment Phase||11
9769843|NCT00434759|10874767|FG000|STARTED|Overall Study||46
9769844|NCT00434759|10874768|FG001|STARTED|Overall Study||43
9769845|NCT00434759|10874767|FG000|COMPLETED|Overall Study||22
9769846|NCT00434759|10874768|FG001|COMPLETED|Overall Study||38
9769847|NCT00434759|10874767|FG000|NOT COMPLETED|Overall Study||24
9769848|NCT00434759|10874768|FG001|NOT COMPLETED|Overall Study||5
9769849|NCT00434876|10874778|FG000|STARTED|Overall Study||11
9769850|NCT00434876|10874779|FG001|STARTED|Overall Study||11
9769851|NCT00434876|10874778|FG000|COMPLETED|Overall Study||10
9769852|NCT00434876|10874779|FG001|COMPLETED|Overall Study||10
9769853|NCT00434876|10874778|FG000|NOT COMPLETED|Overall Study||1
9769854|NCT00434876|10874779|FG001|NOT COMPLETED|Overall Study||1
9769855|NCT00434954|10874787|FG000|STARTED|Overall Study||248
9769856|NCT00434954|10874788|FG001|STARTED|Overall Study||246
9769857|NCT00434954|10874787|FG000|Started - Previous Treatment MET Only|Overall Study||182
9769858|NCT00434954|10874788|FG001|Started - Previous Treatment MET Only|Overall Study||181
9769859|NCT00434954|10874787|FG000|Started - Previous Treatment MET + SU|Overall Study||66
9769860|NCT00434954|10874788|FG001|Started - Previous Treatment MET + SU|Overall Study||65
9769861|NCT00434954|10874787|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
9769862|NCT00434954|10874788|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
9769863|NCT00434954|10874787|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
9769864|NCT00434954|10874788|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
9769865|NCT00434954|10874787|FG000|FAS - Previous Treatment MET + SU|Overall Study||66
9769866|NCT00434954|10874788|FG001|FAS - Previous Treatment MET + SU|Overall Study||60
9769867|NCT00434954|10874787|FG000|Completed - Previous Treatment MET Only|Overall Study||135
9769868|NCT00434954|10874788|FG001|Completed - Previous Treatment MET Only|Overall Study||137
9769869|NCT00434954|10874787|FG000|Completed - Previous Treatment MET + SU|Overall Study||31
9769870|NCT00434954|10874788|FG001|Completed - Previous Treatment MET + SU|Overall Study||38
9769871|NCT00434954|10874787|FG000|COMPLETED|Overall Study||166
9769872|NCT00434954|10874788|FG001|COMPLETED|Overall Study||175
9769873|NCT00434954|10874787|FG000|NOT COMPLETED|Overall Study||82
9769874|NCT00434954|10874788|FG001|NOT COMPLETED|Overall Study||71
9769875|NCT00434967|10874798|FG000|STARTED|Overall Study||97
9769876|NCT00434967|10874799|FG001|STARTED|Overall Study||465
9769877|NCT00434967|10874800|FG002|STARTED|Overall Study||470
9769878|NCT00434967|10874801|FG003|STARTED|Overall Study||492
9769879|NCT00434967|10874798|FG000|COMPLETED|Overall Study||90
9769880|NCT00434967|10874799|FG001|COMPLETED|Overall Study||457
9769881|NCT00434967|10874800|FG002|COMPLETED|Overall Study||461
9769882|NCT00434967|10874801|FG003|COMPLETED|Overall Study||478
9769883|NCT00434967|10874798|FG000|NOT COMPLETED|Overall Study||7
9769884|NCT00434967|10874799|FG001|NOT COMPLETED|Overall Study||8
9769885|NCT00434967|10874800|FG002|NOT COMPLETED|Overall Study||9
9769886|NCT00434967|10874801|FG003|NOT COMPLETED|Overall Study||14
9769887|NCT00434993|10874813|FG000|STARTED|Overall Study||152
9769888|NCT00434993|10874814|FG001|STARTED|Overall Study||130
9769889|NCT00434993|10874813|FG000|COMPLETED|Overall Study||152
9769890|NCT00434993|10874814|FG001|COMPLETED|Overall Study||130
9769891|NCT00434993|10874813|FG000|NOT COMPLETED|Overall Study||0
9769892|NCT00434993|10874814|FG001|NOT COMPLETED|Overall Study||0
9769893|NCT00435019|10874822|FG000|STARTED|Overall Study|Randomised|177
9769894|NCT00435019|10874823|FG001|STARTED|Overall Study|Randomised|171
9769895|NCT00435019|10874822|FG000|Exposed to Study Drug|Overall Study||177
9769896|NCT00435019|10874823|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
9769897|NCT00435019|10874822|FG000|COMPLETED|Overall Study||164
9769898|NCT00435019|10874823|FG001|COMPLETED|Overall Study||161
9769899|NCT00435019|10874822|FG000|NOT COMPLETED|Overall Study||13
9769900|NCT00435019|10874823|FG001|NOT COMPLETED|Overall Study||10
9769901|NCT00435045|10874831|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123
9769902|NCT00435045|10874832|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122
9769903|NCT00435045|10874831|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
9769904|NCT00435045|10874832|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
9769905|NCT00435045|10874831|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
9769906|NCT00435045|10874832|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
9769907|NCT00435045|10874831|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118
9769908|NCT00435045|10874832|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118
9769909|NCT00435045|10874831|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
9769910|NCT00435045|10874832|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
9769911|NCT00435045|10874831|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
9769912|NCT00435045|10874832|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
9769913|NCT00435045|10874831|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113
9769914|NCT00435045|10874832|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113
9769915|NCT00435045|10874831|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
9769916|NCT00435045|10874832|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
9769917|NCT00435045|10874831|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
9769918|NCT00435045|10874832|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
9769919|NCT00435162|10874841|FG000|STARTED|Period 1 (6 Weeks)||15
9769920|NCT00435162|10874842|FG001|STARTED|Period 1 (6 Weeks)||15
9769921|NCT00435162|10874843|FG002|STARTED|Period 1 (6 Weeks)||6
9769922|NCT00435162|10874844|FG003|STARTED|Period 1 (6 Weeks)||8
9769923|NCT00435162|10874845|FG004|STARTED|Period 1 (6 Weeks)||15
9769924|NCT00435162|10874846|FG005|STARTED|Period 1 (6 Weeks)||15
9769925|NCT00435162|10874841|FG000|COMPLETED|Period 1 (6 Weeks)||15
9769926|NCT00435162|10874842|FG001|COMPLETED|Period 1 (6 Weeks)||15
9769927|NCT00435162|10874843|FG002|COMPLETED|Period 1 (6 Weeks)||6
9769928|NCT00435162|10874844|FG003|COMPLETED|Period 1 (6 Weeks)||8
9769929|NCT00435162|10874845|FG004|COMPLETED|Period 1 (6 Weeks)||15
9769930|NCT00435162|10874846|FG005|COMPLETED|Period 1 (6 Weeks)||15
9769931|NCT00435162|10874841|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
9769932|NCT00435162|10874842|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
9769933|NCT00435162|10874843|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0
9769934|NCT00435162|10874844|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0
9769935|NCT00435162|10874845|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0
9769936|NCT00435162|10874846|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0
9769937|NCT00435162|10874841|FG000|STARTED|Period 2 (2 Weeks)||15
9769938|NCT00435162|10874842|FG001|STARTED|Period 2 (2 Weeks)||15
9769939|NCT00435162|10874843|FG002|STARTED|Period 2 (2 Weeks)||6
9769940|NCT00435162|10874844|FG003|STARTED|Period 2 (2 Weeks)||8
9769941|NCT00435162|10874845|FG004|STARTED|Period 2 (2 Weeks)||15
9769942|NCT00435162|10874846|FG005|STARTED|Period 2 (2 Weeks)||15
9769943|NCT00435162|10874841|FG000|COMPLETED|Period 2 (2 Weeks)||15
9769944|NCT00435162|10874842|FG001|COMPLETED|Period 2 (2 Weeks)||14
9769945|NCT00435162|10874843|FG002|COMPLETED|Period 2 (2 Weeks)||6
9769946|NCT00435162|10874844|FG003|COMPLETED|Period 2 (2 Weeks)||8
9769947|NCT00435162|10874845|FG004|COMPLETED|Period 2 (2 Weeks)||15
9769948|NCT00435162|10874846|FG005|COMPLETED|Period 2 (2 Weeks)||15
9769949|NCT00435162|10874841|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0
9769950|NCT00435162|10874842|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1
9769951|NCT00435162|10874843|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0
9769952|NCT00435162|10874844|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0
9769953|NCT00435162|10874845|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0
9769954|NCT00435162|10874846|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0
9769955|NCT00435188|10874861|FG000|STARTED|Overall Study||199
9769956|NCT00435188|10874862|FG001|STARTED|Overall Study||199
9769957|NCT00435188|10874861|FG000|COMPLETED|Overall Study||177
9769958|NCT00435188|10874862|FG001|COMPLETED|Overall Study||176
9769959|NCT00435188|10874861|FG000|NOT COMPLETED|Overall Study||22
9769960|NCT00435188|10874862|FG001|NOT COMPLETED|Overall Study||23
9769961|NCT00435370|10874872|FG000|STARTED|Overall Study||90
9769962|NCT00435370|10874873|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
9769963|NCT00435370|10874872|FG000|COMPLETED|Overall Study||68
9769964|NCT00435370|10874873|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
9769965|NCT00435370|10874872|FG000|NOT COMPLETED|Overall Study||22
9769966|NCT00435370|10874873|FG001|NOT COMPLETED|Overall Study||20
9769967|NCT00435409|10874881|FG000|STARTED|Overall Study||221
9769968|NCT00435409|10874882|FG001|STARTED|Overall Study||143
9769969|NCT00435409|10874883|FG002|STARTED|Overall Study||78
9769970|NCT00435409|10874881|FG000|Treated|Overall Study||217
9769971|NCT00435409|10874882|FG001|Treated|Overall Study||139
9769972|NCT00435409|10874883|FG002|Treated|Overall Study||78
9769973|NCT00435409|10874881|FG000|COMPLETED|Overall Study||0
9769974|NCT00435409|10874882|FG001|COMPLETED|Overall Study||0
9769975|NCT00435409|10874883|FG002|COMPLETED|Overall Study||0
9769976|NCT00435409|10874881|FG000|NOT COMPLETED|Overall Study||221
9769977|NCT00435409|10874882|FG001|NOT COMPLETED|Overall Study||143
9769978|NCT00435409|10874883|FG002|NOT COMPLETED|Overall Study||78
9769979|NCT00435461|10874892|FG000|STARTED|Overall Study||313
9769980|NCT00435461|10874893|FG001|STARTED|Overall Study||312
9769981|NCT00435461|10874894|FG002|STARTED|Overall Study||311
9769982|NCT00435461|10874892|FG000|COMPLETED|Overall Study||290
9769983|NCT00435461|10874893|FG001|COMPLETED|Overall Study||298
9769984|NCT00435461|10874894|FG002|COMPLETED|Overall Study||287
9769985|NCT00435461|10874892|FG000|NOT COMPLETED|Overall Study||23
9769986|NCT00435461|10874893|FG001|NOT COMPLETED|Overall Study||14
9769987|NCT00435461|10874894|FG002|NOT COMPLETED|Overall Study||24
9769988|NCT00435487|10874904|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
9769989|NCT00435487|10874905|FG001|STARTED|Overall Study||86
9769990|NCT00435487|10874904|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
9769991|NCT00435487|10874905|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
9769992|NCT00435487|10874904|FG000|COMPLETED|Overall Study||76
9769993|NCT00435487|10874905|FG001|COMPLETED|Overall Study||71
9769994|NCT00435487|10874904|FG000|NOT COMPLETED|Overall Study||12
9769995|NCT00435487|10874905|FG001|NOT COMPLETED|Overall Study||15
9769996|NCT00435539|10874916|FG000|STARTED|Overall Study||12
9769997|NCT00435539|10874917|FG001|STARTED|Overall Study||13
9769998|NCT00435539|10874918|FG002|STARTED|Overall Study||11
9769999|NCT00435539|10874919|FG003|STARTED|Overall Study||12
9770000|NCT00435539|10874920|FG004|STARTED|Overall Study||12
9770001|NCT00435539|10874916|FG000|COMPLETED|Overall Study||12
9770002|NCT00435539|10874917|FG001|COMPLETED|Overall Study||13
9770003|NCT00435539|10874918|FG002|COMPLETED|Overall Study||11
9770004|NCT00435539|10874919|FG003|COMPLETED|Overall Study||12
9770005|NCT00435539|10874920|FG004|COMPLETED|Overall Study||12
9770006|NCT00435539|10874916|FG000|NOT COMPLETED|Overall Study||0
9770007|NCT00435539|10874917|FG001|NOT COMPLETED|Overall Study||0
9770008|NCT00435539|10874918|FG002|NOT COMPLETED|Overall Study||0
9770009|NCT00435539|10874919|FG003|NOT COMPLETED|Overall Study||0
9770010|NCT00435539|10874920|FG004|NOT COMPLETED|Overall Study||0
9770011|NCT00435591|10874935|FG000|STARTED|Overall Study||30
9770012|NCT00435591|10874936|FG001|STARTED|Overall Study||31
9770013|NCT00435591|10874937|FG002|STARTED|Overall Study||30
9770014|NCT00435591|10874938|FG003|STARTED|Overall Study||30
9770015|NCT00435591|10874935|FG000|Safety Analysis Set|Overall Study||28
9770016|NCT00435591|10874936|FG001|Safety Analysis Set|Overall Study||30
9770017|NCT00435591|10874937|FG002|Safety Analysis Set|Overall Study||30
9770018|NCT00435591|10874938|FG003|Safety Analysis Set|Overall Study||29
9770019|NCT00435591|10874935|FG000|Full Analysis Set|Overall Study||28
9770020|NCT00435591|10874936|FG001|Full Analysis Set|Overall Study||29
9770021|NCT00435591|10874937|FG002|Full Analysis Set|Overall Study||30
9770022|NCT00435591|10874938|FG003|Full Analysis Set|Overall Study||29
9770023|NCT00435591|10874935|FG000|End of Treatment|Overall Study||25
9770024|NCT00435591|10874936|FG001|End of Treatment|Overall Study||27
9770025|NCT00435591|10874937|FG002|End of Treatment|Overall Study||27
9770026|NCT00435591|10874938|FG003|End of Treatment|Overall Study||23
9770027|NCT00435591|10874935|FG000|COMPLETED|Overall Study||23
9770028|NCT00435591|10874936|FG001|COMPLETED|Overall Study||27
9770029|NCT00435591|10874937|FG002|COMPLETED|Overall Study||25
9770030|NCT00435591|10874938|FG003|COMPLETED|Overall Study||19
9770031|NCT00435591|10874935|FG000|NOT COMPLETED|Overall Study||7
9770032|NCT00435591|10874936|FG001|NOT COMPLETED|Overall Study||4
9770033|NCT00435591|10874937|FG002|NOT COMPLETED|Overall Study||5
9770034|NCT00435591|10874938|FG003|NOT COMPLETED|Overall Study||11
9770035|NCT00435812|10874953|FG000|STARTED|Overall Study||1820
9770036|NCT00435812|10874954|FG001|STARTED|Overall Study||608
9770037|NCT00435812|10874953|FG000|COMPLETED|Overall Study||1757
9770038|NCT00435812|10874954|FG001|COMPLETED|Overall Study||590
9770039|NCT00435812|10874953|FG000|NOT COMPLETED|Overall Study||63
9770040|NCT00435812|10874954|FG001|NOT COMPLETED|Overall Study||18
9770041|NCT00435825|10874964|FG000|STARTED|Overall Study||141
9770042|NCT00435825|10874965|FG001|STARTED|Overall Study||136
9770043|NCT00435825|10874966|FG002|STARTED|Overall Study||138
9770044|NCT00435825|10874967|FG003|STARTED|Overall Study||136
9770045|NCT00435825|10874964|FG000|Received Study Drug|Overall Study||140
9770046|NCT00435825|10874965|FG001|Received Study Drug|Overall Study||136
9770047|NCT00435825|10874966|FG002|Received Study Drug|Overall Study||136
9770048|NCT00435825|10874967|FG003|Received Study Drug|Overall Study||136
9770049|NCT00435825|10874964|FG000|Entered Follow-up|Overall Study||140
9770050|NCT00435825|10874965|FG001|Entered Follow-up|Overall Study||132
9770051|NCT00435825|10874966|FG002|Entered Follow-up|Overall Study||135
9770052|NCT00435825|10874967|FG003|Entered Follow-up|Overall Study||133
9770053|NCT00435825|10874964|FG000|Completed 24 Weeks Treatment|Overall Study||128
9770054|NCT00435825|10874965|FG001|Completed 24 Weeks Treatment|Overall Study||126
9770055|NCT00435825|10874966|FG002|Completed 24 Weeks Treatment|Overall Study||134
9770056|NCT00435825|10874967|FG003|Completed 24 Weeks Treatment|Overall Study||131
9770057|NCT00435825|10874964|FG000|Completed 48 Weeks Treatment|Overall Study||0
9770058|NCT00435825|10874965|FG001|Completed 48 Weeks Treatment|Overall Study||0
9770059|NCT00435825|10874966|FG002|Completed 48 Weeks Treatment|Overall Study||124
9770060|NCT00435825|10874967|FG003|Completed 48 Weeks Treatment|Overall Study||117
9770061|NCT00435825|10874964|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
9770062|NCT00435825|10874965|FG001|COMPLETED|Overall Study||124
9770063|NCT00435825|10874966|FG002|COMPLETED|Overall Study||127
9770064|NCT00435825|10874967|FG003|COMPLETED|Overall Study||120
9770065|NCT00435825|10874964|FG000|NOT COMPLETED|Overall Study||18
9770066|NCT00435825|10874965|FG001|NOT COMPLETED|Overall Study||12
9770067|NCT00435825|10874966|FG002|NOT COMPLETED|Overall Study||11
9770068|NCT00435825|10874967|FG003|NOT COMPLETED|Overall Study||16
9770069|NCT00435929|10874979|FG000|STARTED|Overall Study||7
9770070|NCT00435929|10874980|FG001|STARTED|Overall Study||9
9770071|NCT00435929|10874979|FG000|COMPLETED|Overall Study||7
9770072|NCT00435929|10874980|FG001|COMPLETED|Overall Study||9
9770073|NCT00435929|10874979|FG000|NOT COMPLETED|Overall Study||0
9770074|NCT00435929|10874980|FG001|NOT COMPLETED|Overall Study||0
9770075|NCT00435942|10874988|FG000|STARTED|Overall Study||120
9770076|NCT00435942|10874989|FG001|STARTED|Overall Study||60
9770077|NCT00435942|10874988|FG000|COMPLETED|Overall Study||97
9770078|NCT00435942|10874989|FG001|COMPLETED|Overall Study||33
9770079|NCT00435942|10874988|FG000|NOT COMPLETED|Overall Study||23
9770080|NCT00435942|10874989|FG001|NOT COMPLETED|Overall Study||27
9770081|NCT00435994|10874998|FG000|STARTED|Overall Study||22
9770082|NCT00435994|10874999|FG001|STARTED|Overall Study||25
9770083|NCT00435994|10875000|FG002|STARTED|Overall Study||12
9770084|NCT00435994|10874998|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
9770085|NCT00435994|10874999|FG001|COMPLETED|Overall Study||25
9770086|NCT00435994|10875000|FG002|COMPLETED|Overall Study||12
9770087|NCT00435994|10874998|FG000|NOT COMPLETED|Overall Study||7
9770088|NCT00435994|10874999|FG001|NOT COMPLETED|Overall Study||0
9770089|NCT00435994|10875000|FG002|NOT COMPLETED|Overall Study||0
9770090|NCT00436007|10875012|FG000|STARTED|Overall Study||170
9770091|NCT00436007|10875013|FG001|STARTED|Overall Study||170
9770092|NCT00436007|10875014|FG002|STARTED|Overall Study||171
9770093|NCT00436007|10875012|FG000|COMPLETED|Overall Study||151
9770094|NCT00436007|10875013|FG001|COMPLETED|Overall Study||156
9770095|NCT00436007|10875014|FG002|COMPLETED|Overall Study||148
9770096|NCT00436007|10875012|FG000|NOT COMPLETED|Overall Study||19
9770097|NCT00436007|10875013|FG001|NOT COMPLETED|Overall Study||14
9770098|NCT00436007|10875014|FG002|NOT COMPLETED|Overall Study||23
9770099|NCT00436046|10875030|FG000|STARTED|Overall Study||32
9770100|NCT00436046|10875031|FG001|STARTED|Overall Study||32
9770101|NCT00436046|10875032|FG002|STARTED|Overall Study||31
9770102|NCT00436046|10875030|FG000|COMPLETED|Overall Study||32
9770103|NCT00436046|10875031|FG001|COMPLETED|Overall Study||32
9770104|NCT00436046|10875032|FG002|COMPLETED|Overall Study||31
9770105|NCT00436046|10875030|FG000|NOT COMPLETED|Overall Study||0
9770106|NCT00436046|10875031|FG001|NOT COMPLETED|Overall Study||0
9770107|NCT00436046|10875032|FG002|NOT COMPLETED|Overall Study||0
9770108|NCT00436163|10875040|FG000|STARTED|Overall Study||39
9770109|NCT00436163|10875040|FG000|COMPLETED|Overall Study||36
9770110|NCT00436163|10875040|FG000|NOT COMPLETED|Overall Study||3
9770111|NCT00436215|10875045|FG000|STARTED|Overall Study||55
9770112|NCT00436215|10875045|FG000|COMPLETED|Overall Study||51
9770113|NCT00436215|10875045|FG000|NOT COMPLETED|Overall Study||4
9770114|NCT00436280|10875049|FG000|STARTED|Period 1: Induction||68
9770115|NCT00436280|10875049|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
9770116|NCT00436280|10875049|FG000|COMPLETED|Period 1: Induction||40
9770117|NCT00436280|10875049|FG000|NOT COMPLETED|Period 1: Induction||28
9770118|NCT00436280|10875049|FG000|STARTED|Period 2: Consolidation||40
9770119|NCT00436280|10875049|FG000|COMPLETED|Period 2: Consolidation||23
9770120|NCT00436280|10875049|FG000|NOT COMPLETED|Period 2: Consolidation||17
9770121|NCT00436280|10875049|FG000|STARTED|Period 3: Maintenance||23
9770122|NCT00436280|10875049|FG000|COMPLETED|Period 3: Maintenance||5
9770123|NCT00436280|10875049|FG000|NOT COMPLETED|Period 3: Maintenance||18
9770124|NCT00436332|10875053|FG000|STARTED|Overall Study||84
9770125|NCT00436332|10875053|FG000|Eligible|Overall Study||82
9770126|NCT00436332|10875053|FG000|Eligible and Began Protocol Therapy|Overall Study||79
9770127|NCT00436332|10875053|FG000|COMPLETED|Overall Study||1
9770128|NCT00436332|10875053|FG000|NOT COMPLETED|Overall Study||83
9770129|NCT00436345|10875059|FG000|STARTED|Overall Study||21
9770130|NCT00436345|10875060|FG001|STARTED|Overall Study||18
9770131|NCT00436345|10875059|FG000|COMPLETED|Overall Study||18
9770132|NCT00436345|10875060|FG001|COMPLETED|Overall Study||18
9770133|NCT00436345|10875059|FG000|NOT COMPLETED|Overall Study||3
9770134|NCT00436345|10875060|FG001|NOT COMPLETED|Overall Study||0
9770135|NCT00436436|10875067|FG000|STARTED|Overall Study||12
9770136|NCT00436436|10875067|FG000|COMPLETED|Overall Study||0
9770137|NCT00436436|10875067|FG000|NOT COMPLETED|Overall Study||12
9770138|NCT00436475|10875075|FG000|STARTED|Overall Study||23
9770139|NCT00436475|10875076|FG001|STARTED|Overall Study||23
9770140|NCT00436475|10875077|FG002|STARTED|Overall Study||22
9770141|NCT00436475|10875078|FG003|STARTED|Overall Study||24
9770142|NCT00436475|10875075|FG000|COMPLETED|Overall Study||23
9770143|NCT00436475|10875076|FG001|COMPLETED|Overall Study||22
9770144|NCT00436475|10875077|FG002|COMPLETED|Overall Study||21
9770145|NCT00436475|10875078|FG003|COMPLETED|Overall Study||22
9770146|NCT00436475|10875075|FG000|NOT COMPLETED|Overall Study||0
9770147|NCT00436475|10875076|FG001|NOT COMPLETED|Overall Study||1
9770148|NCT00436475|10875077|FG002|NOT COMPLETED|Overall Study||1
9770149|NCT00436475|10875078|FG003|NOT COMPLETED|Overall Study||2
9770150|NCT00436501|10875090|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
9770151|NCT00436501|10875091|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
9770152|NCT00436501|10875090|FG000|COMPLETED|Complete Study Participation||9
9770153|NCT00436501|10875091|FG001|COMPLETED|Complete Study Participation||49
9770154|NCT00436501|10875090|FG000|NOT COMPLETED|Complete Study Participation||0
9770155|NCT00436501|10875091|FG001|NOT COMPLETED|Complete Study Participation||0
9770156|NCT00436501|10875090|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
9770157|NCT00436501|10875091|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
9770158|NCT00436501|10875090|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
9770159|NCT00436501|10875091|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
9770160|NCT00436501|10875090|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
9770161|NCT00436501|10875091|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
9770162|NCT00436501|10875090|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
9770163|NCT00436501|10875091|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
9770164|NCT00436501|10875090|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
9770165|NCT00436501|10875091|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
9770166|NCT00436501|10875090|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
9770167|NCT00436501|10875091|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
9770168|NCT00436553|10875101|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
9770169|NCT00436553|10875102|FG001|STARTED|Overall Study||105
9770170|NCT00436553|10875103|FG002|STARTED|Overall Study||112
9770171|NCT00436553|10875101|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91
9770172|NCT00436553|10875102|FG001|COMPLETED|Overall Study||93
9770173|NCT00436553|10875103|FG002|COMPLETED|Overall Study||102
9770174|NCT00436553|10875101|FG000|NOT COMPLETED|Overall Study||13
9770175|NCT00436553|10875102|FG001|NOT COMPLETED|Overall Study||12
9770176|NCT00436553|10875103|FG002|NOT COMPLETED|Overall Study||10
9770177|NCT00436566|10875111|FG000|STARTED|Overall Study||112
9770178|NCT00436566|10875111|FG000|COMPLETED|Overall Study||109
9770179|NCT00436566|10875111|FG000|NOT COMPLETED|Overall Study||3
9770180|NCT00436605|10875115|FG000|STARTED|Overall Study||39
9770181|NCT00436605|10875115|FG000|COMPLETED|Overall Study||36
9770182|NCT00436605|10875115|FG000|NOT COMPLETED|Overall Study||3
9770183|NCT00436618|10875122|FG000|STARTED|Overall Study||114
9770184|NCT00436618|10875123|FG001|STARTED|Overall Study||55
9770185|NCT00436618|10875124|FG002|STARTED|Overall Study||107
9770186|NCT00436618|10875122|FG000|COMPLETED|Overall Study||84
9770187|NCT00436618|10875123|FG001|COMPLETED|Overall Study||28
9770188|NCT00436618|10875124|FG002|COMPLETED|Overall Study||46
9770189|NCT00436618|10875122|FG000|NOT COMPLETED|Overall Study||30
9770190|NCT00436618|10875123|FG001|NOT COMPLETED|Overall Study||27
9770191|NCT00436618|10875124|FG002|NOT COMPLETED|Overall Study||61
9770192|NCT00436644|10875132|FG000|STARTED|Overall Study||18
9770193|NCT00436644|10875132|FG000|COMPLETED|Overall Study||15
9770194|NCT00436644|10875132|FG000|NOT COMPLETED|Overall Study||3
9770195|NCT00436748|10875138|FG000|STARTED|Overall Study||59
9770196|NCT00436748|10875139|FG001|STARTED|Overall Study||57
9770197|NCT00436748|10875138|FG000|Received Treatment|Overall Study||58
9770198|NCT00436748|10875139|FG001|Received Treatment|Overall Study||56
9770199|NCT00436748|10875138|FG000|COMPLETED|Overall Study||48
9770200|NCT00436748|10875139|FG001|COMPLETED|Overall Study||45
9770201|NCT00436748|10875138|FG000|NOT COMPLETED|Overall Study||11
9770202|NCT00436748|10875139|FG001|NOT COMPLETED|Overall Study||12
9770203|NCT00436852|10875147|FG000|STARTED|Overall Study||45
9770204|NCT00436852|10875148|FG001|STARTED|Overall Study||47
9770205|NCT00436852|10875147|FG000|COMPLETED|Overall Study||10
9770206|NCT00436852|10875148|FG001|COMPLETED|Overall Study||2
9770207|NCT00436852|10875147|FG000|NOT COMPLETED|Overall Study||35
9770208|NCT00436852|10875148|FG001|NOT COMPLETED|Overall Study||45
9770209|NCT00436904|10875157|FG000|STARTED|Overall Study||30
9770210|NCT00436904|10875157|FG000|COMPLETED|Overall Study||30
9770211|NCT00436904|10875157|FG000|NOT COMPLETED|Overall Study||0
9770212|NCT00436917|10875161|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
9770213|NCT00436917|10875161|FG000|COMPLETED|Overall Study||32
9770214|NCT00436917|10875161|FG000|NOT COMPLETED|Overall Study||21
9770215|NCT00436956|10875165|FG000|STARTED|Overall Study||36
9770216|NCT00436956|10875166|FG001|STARTED|Overall Study||23
9770217|NCT00436956|10875165|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
9770218|NCT00436956|10875166|FG001|COMPLETED|Overall Study||23
9770219|NCT00436956|10875165|FG000|NOT COMPLETED|Overall Study||1
9770220|NCT00436956|10875166|FG001|NOT COMPLETED|Overall Study||0
9770221|NCT00436969|10875175|FG000|STARTED|Overall Study||88
9770222|NCT00436969|10875176|FG001|STARTED|Overall Study||186
9770223|NCT00436969|10875175|FG000|Randomized But Not Treated|Overall Study||1
10019097|NCT01827475|11142201|FG002|NOT COMPLETED|Overall Study||0
9770224|NCT00436969|10875176|FG001|Randomized But Not Treated|Overall Study||3
9770225|NCT00436969|10875175|FG000|COMPLETED|Overall Study||66
9770226|NCT00436969|10875176|FG001|COMPLETED|Overall Study||134
9770227|NCT00436969|10875175|FG000|NOT COMPLETED|Overall Study||22
9770228|NCT00436969|10875176|FG001|NOT COMPLETED|Overall Study||52
9770229|NCT00436982|10875184|FG000|STARTED|Overall Study||30
9770230|NCT00436982|10875185|FG001|STARTED|Overall Study||30
9770231|NCT00436982|10875184|FG000|COMPLETED|Overall Study||26
9770232|NCT00436982|10875185|FG001|COMPLETED|Overall Study||26
9770233|NCT00436982|10875184|FG000|NOT COMPLETED|Overall Study||4
9770234|NCT00436982|10875185|FG001|NOT COMPLETED|Overall Study||4
9770235|NCT00437034|10875195|FG000|STARTED|Overall Study||6
9770236|NCT00437034|10875195|FG000|COMPLETED|Overall Study||0
9770237|NCT00437034|10875195|FG000|NOT COMPLETED|Overall Study||6
9770238|NCT00437073|10875201|FG000|STARTED|Overall Study||13
9770239|NCT00437073|10875202|FG001|STARTED|Overall Study||9
9770240|NCT00437073|10875201|FG000|COMPLETED|Overall Study||12
9770241|NCT00437073|10875202|FG001|COMPLETED|Overall Study||8
9770242|NCT00437073|10875201|FG000|NOT COMPLETED|Overall Study||1
9770243|NCT00437073|10875202|FG001|NOT COMPLETED|Overall Study||1
9770244|NCT00437125|10875208|FG000|STARTED|Overall Study||151
9770245|NCT00437125|10875208|FG000|COMPLETED|Overall Study||119
9770246|NCT00437125|10875208|FG000|NOT COMPLETED|Overall Study||32
9770247|NCT00437203|10875222|FG000|STARTED|Overall Study||6
9770248|NCT00437203|10875223|FG001|STARTED|Overall Study||8
9770249|NCT00437203|10875224|FG002|STARTED|Overall Study||3
9770250|NCT00437203|10875225|FG003|STARTED|Overall Study||3
9770251|NCT00437203|10875226|FG004|STARTED|Overall Study||3
9770252|NCT00437203|10875227|FG005|STARTED|Overall Study||3
9770253|NCT00437203|10875228|FG006|STARTED|Overall Study||7
9770254|NCT00437203|10875229|FG007|STARTED|Overall Study||3
9770255|NCT00437203|10875230|FG008|STARTED|Overall Study||3
9770256|NCT00437203|10875231|FG009|STARTED|Overall Study||4
9770257|NCT00437203|10875222|FG000|COMPLETED|Overall Study||0
9770258|NCT00437203|10875223|FG001|COMPLETED|Overall Study||0
9770259|NCT00437203|10875224|FG002|COMPLETED|Overall Study||0
9770260|NCT00437203|10875225|FG003|COMPLETED|Overall Study||0
10014135|NCT01797575|11137157|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
10014136|NCT01797575|11137158|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
10014137|NCT01797575|11137159|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
10019098|NCT01827592|11142212|FG000|STARTED|Overall Study|Randomized patients.|126
9770261|NCT00437203|10875226|FG004|COMPLETED|Overall Study||0
9770262|NCT00437203|10875227|FG005|COMPLETED|Overall Study||0
9770263|NCT00437203|10875228|FG006|COMPLETED|Overall Study||0
9770264|NCT00437203|10875229|FG007|COMPLETED|Overall Study||0
9770265|NCT00437203|10875230|FG008|COMPLETED|Overall Study||0
9770266|NCT00437203|10875231|FG009|COMPLETED|Overall Study||0
9770267|NCT00437203|10875222|FG000|NOT COMPLETED|Overall Study||6
9770268|NCT00437203|10875223|FG001|NOT COMPLETED|Overall Study||8
9770269|NCT00437203|10875224|FG002|NOT COMPLETED|Overall Study||3
9770270|NCT00437203|10875225|FG003|NOT COMPLETED|Overall Study||3
9770271|NCT00437203|10875226|FG004|NOT COMPLETED|Overall Study||3
9770272|NCT00437203|10875227|FG005|NOT COMPLETED|Overall Study||3
9770273|NCT00437203|10875228|FG006|NOT COMPLETED|Overall Study||7
9770274|NCT00437203|10875229|FG007|NOT COMPLETED|Overall Study||3
9770275|NCT00437203|10875230|FG008|NOT COMPLETED|Overall Study||3
9770276|NCT00437203|10875231|FG009|NOT COMPLETED|Overall Study||4
9770277|NCT00437268|10875264|FG000|STARTED|Overall Study||13
9770278|NCT00437268|10875265|FG001|STARTED|Overall Study||13
9770279|NCT00437268|10875264|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
9770280|NCT00437268|10875265|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
9770281|NCT00437268|10875264|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
9770282|NCT00437268|10875265|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
9770283|NCT00437268|10875264|FG000|COMPLETED|Overall Study||0
9770284|NCT00437268|10875265|FG001|COMPLETED|Overall Study||0
9770285|NCT00437268|10875264|FG000|NOT COMPLETED|Overall Study||13
9770286|NCT00437268|10875265|FG001|NOT COMPLETED|Overall Study||13
9770287|NCT00437281|10875293|FG000|STARTED|Overall Study||3
9770288|NCT00437281|10875294|FG001|STARTED|Overall Study||3
9770289|NCT00437281|10875295|FG002|STARTED|Overall Study||3
9770290|NCT00437281|10875296|FG003|STARTED|Overall Study||3
9770291|NCT00437281|10875297|FG004|STARTED|Overall Study||4
9770292|NCT00437281|10875298|FG005|STARTED|Overall Study||4
9770293|NCT00437281|10875299|FG006|STARTED|Overall Study||3
9770294|NCT00437281|10875300|FG007|STARTED|Overall Study||3
9770295|NCT00437281|10875301|FG008|STARTED|Overall Study||3
9770296|NCT00437281|10875302|FG009|STARTED|Overall Study||5
9770297|NCT00437281|10875303|FG010|STARTED|Overall Study||3
9770298|NCT00437281|10875304|FG011|STARTED|Overall Study||3
9770299|NCT00437281|10875305|FG012|STARTED|Overall Study||2
9770300|NCT00437281|10875306|FG013|STARTED|Overall Study||3
9770301|NCT00437281|10875307|FG014|STARTED|Overall Study||5
9770302|NCT00437281|10875308|FG015|STARTED|Overall Study||3
9770303|NCT00437281|10875309|FG016|STARTED|Overall Study||3
9770304|NCT00437281|10875310|FG017|STARTED|Overall Study||4
9770305|NCT00437281|10875311|FG018|STARTED|Overall Study||2
9770306|NCT00437281|10875312|FG019|STARTED|Overall Study||3
9770307|NCT00437281|10875293|FG000|COMPLETED|Overall Study||3
9770308|NCT00437281|10875294|FG001|COMPLETED|Overall Study||3
9770309|NCT00437281|10875295|FG002|COMPLETED|Overall Study||3
9770310|NCT00437281|10875296|FG003|COMPLETED|Overall Study||2
9770311|NCT00437281|10875297|FG004|COMPLETED|Overall Study||4
9770312|NCT00437281|10875298|FG005|COMPLETED|Overall Study||3
9770313|NCT00437281|10875299|FG006|COMPLETED|Overall Study||3
9770314|NCT00437281|10875300|FG007|COMPLETED|Overall Study||3
9770315|NCT00437281|10875301|FG008|COMPLETED|Overall Study||3
9770316|NCT00437281|10875302|FG009|COMPLETED|Overall Study||4
9770317|NCT00437281|10875303|FG010|COMPLETED|Overall Study||3
9770318|NCT00437281|10875304|FG011|COMPLETED|Overall Study||3
9770319|NCT00437281|10875305|FG012|COMPLETED|Overall Study||2
9770320|NCT00437281|10875306|FG013|COMPLETED|Overall Study||2
9770321|NCT00437281|10875307|FG014|COMPLETED|Overall Study||4
9770322|NCT00437281|10875308|FG015|COMPLETED|Overall Study||3
9770323|NCT00437281|10875309|FG016|COMPLETED|Overall Study||3
9770324|NCT00437281|10875310|FG017|COMPLETED|Overall Study||4
9770325|NCT00437281|10875311|FG018|COMPLETED|Overall Study||1
9770326|NCT00437281|10875312|FG019|COMPLETED|Overall Study||2
9770327|NCT00437281|10875293|FG000|NOT COMPLETED|Overall Study||0
9770328|NCT00437281|10875294|FG001|NOT COMPLETED|Overall Study||0
9770329|NCT00437281|10875295|FG002|NOT COMPLETED|Overall Study||0
9770330|NCT00437281|10875296|FG003|NOT COMPLETED|Overall Study||1
9770331|NCT00437281|10875297|FG004|NOT COMPLETED|Overall Study||0
9770332|NCT00437281|10875298|FG005|NOT COMPLETED|Overall Study||1
9770333|NCT00437281|10875299|FG006|NOT COMPLETED|Overall Study||0
9770334|NCT00437281|10875300|FG007|NOT COMPLETED|Overall Study||0
9770335|NCT00437281|10875301|FG008|NOT COMPLETED|Overall Study||0
9770336|NCT00437281|10875302|FG009|NOT COMPLETED|Overall Study||1
9770337|NCT00437281|10875303|FG010|NOT COMPLETED|Overall Study||0
9770338|NCT00437281|10875304|FG011|NOT COMPLETED|Overall Study||0
9770339|NCT00437281|10875305|FG012|NOT COMPLETED|Overall Study||0
9770340|NCT00437281|10875306|FG013|NOT COMPLETED|Overall Study||1
9770341|NCT00437281|10875307|FG014|NOT COMPLETED|Overall Study||1
9770342|NCT00437281|10875308|FG015|NOT COMPLETED|Overall Study||0
9770343|NCT00437281|10875309|FG016|NOT COMPLETED|Overall Study||0
9770344|NCT00437281|10875310|FG017|NOT COMPLETED|Overall Study||0
9770345|NCT00437281|10875311|FG018|NOT COMPLETED|Overall Study||1
9770346|NCT00437281|10875312|FG019|NOT COMPLETED|Overall Study||1
9829750|NCT00761202|10940436|FG001|STARTED|Overall Study||28
9829751|NCT00761202|10940435|FG000|COMPLETED|Overall Study||21
9829752|NCT00761202|10940436|FG001|COMPLETED|Overall Study||26
9829753|NCT00761202|10940435|FG000|NOT COMPLETED|Overall Study||1
9829754|NCT00761202|10940436|FG001|NOT COMPLETED|Overall Study||2
9829755|NCT00761215|10940445|FG000|STARTED|Overall Study||64
9829756|NCT00761215|10940446|FG001|STARTED|Overall Study||64
9829757|NCT00761215|10940447|FG002|STARTED|Overall Study||64
9829758|NCT00761215|10940445|FG000|COMPLETED|Overall Study||55
9829759|NCT00761215|10940446|FG001|COMPLETED|Overall Study||60
9829760|NCT00761215|10940447|FG002|COMPLETED|Overall Study||56
9829761|NCT00761215|10940445|FG000|NOT COMPLETED|Overall Study||9
9829762|NCT00761215|10940446|FG001|NOT COMPLETED|Overall Study||4
9829763|NCT00761215|10940447|FG002|NOT COMPLETED|Overall Study||8
9829764|NCT00761267|10940461|FG000|STARTED|Overall Study||20
9829765|NCT00761267|10940462|FG001|STARTED|Overall Study||20
9829766|NCT00761267|10940463|FG002|STARTED|Overall Study||30
9829767|NCT00761267|10940461|FG000|Treated|Overall Study||19
9829768|NCT00761267|10940462|FG001|Treated|Overall Study||19
9829769|NCT00761267|10940463|FG002|Treated|Overall Study||30
9829770|NCT00761267|10940461|FG000|COMPLETED|Overall Study||18
9829771|NCT00761267|10940462|FG001|COMPLETED|Overall Study||16
9829772|NCT00761267|10940463|FG002|COMPLETED|Overall Study||24
9829773|NCT00761267|10940461|FG000|NOT COMPLETED|Overall Study||2
9829774|NCT00761267|10940462|FG001|NOT COMPLETED|Overall Study||4
9829775|NCT00761267|10940463|FG002|NOT COMPLETED|Overall Study||6
9829776|NCT00761280|10940484|FG000|STARTED|Randomization to First Dose||14
9829777|NCT00761280|10940485|FG001|STARTED|Randomization to First Dose||13
9829778|NCT00761280|10940484|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13
9829779|NCT00761280|10940485|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
9829780|NCT00761280|10940484|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
9829781|NCT00761280|10940485|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
9829782|NCT00761280|10940484|FG000|COMPLETED|Randomization to First Dose||12
9829783|NCT00761280|10940485|FG001|COMPLETED|Randomization to First Dose||11
9829784|NCT00761280|10940484|FG000|NOT COMPLETED|Randomization to First Dose||2
9829785|NCT00761280|10940485|FG001|NOT COMPLETED|Randomization to First Dose||2
9829786|NCT00761280|10940484|FG000|STARTED|First Dose to End of Study||12
9829787|NCT00761280|10940485|FG001|STARTED|First Dose to End of Study||11
9829788|NCT00761280|10940484|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
10014138|NCT01797575|11137160|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
9829789|NCT00761280|10940485|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
9829790|NCT00761280|10940484|FG000|NOT COMPLETED|First Dose to End of Study||12
9829791|NCT00761280|10940485|FG001|NOT COMPLETED|First Dose to End of Study||11
9829792|NCT00761306|10940491|FG000|STARTED|Overall Study||74
9829793|NCT00761306|10940491|FG000|COMPLETED|Overall Study||54
9829794|NCT00761306|10940491|FG000|NOT COMPLETED|Overall Study||20
9829795|NCT00761319|10940497|FG000|STARTED|Overall Study||353
9829796|NCT00761319|10940498|FG001|STARTED|Overall Study||352
9829797|NCT00761319|10940497|FG000|COMPLETED|Overall Study||305
9829798|NCT00761319|10940498|FG001|COMPLETED|Overall Study||318
9829799|NCT00761319|10940497|FG000|NOT COMPLETED|Overall Study||48
9829800|NCT00761319|10940498|FG001|NOT COMPLETED|Overall Study||34
9829801|NCT00761345|10940504|FG000|STARTED|Overall Study||27
9829802|NCT00761345|10940504|FG000|COMPLETED|Overall Study||24
9829803|NCT00761345|10940504|FG000|NOT COMPLETED|Overall Study||3
9829804|NCT00761462|10940510|FG000|STARTED|Treatment|Patients enrolled in study group|510
9829805|NCT00761462|10940511|FG001|STARTED|Treatment|Patients enrolled in study group|519
9829806|NCT00761462|10940510|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
9829807|NCT00761462|10940511|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
9829808|NCT00761462|10940510|FG000|NOT COMPLETED|Treatment||23
9829809|NCT00761462|10940511|FG001|NOT COMPLETED|Treatment||12
9829810|NCT00761462|10940510|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
9952290|NCT01421277|11071224|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
9952291|NCT01421277|11071223|FG000|NOT COMPLETED|Overall Study||0
9952292|NCT01421277|11071224|FG001|NOT COMPLETED|Overall Study||92
9952293|NCT01421303|11071230|FG000|STARTED|Overall Study||80
9952294|NCT01421303|11071230|FG000|COMPLETED|Overall Study||58
9952295|NCT01421303|11071230|FG000|NOT COMPLETED|Overall Study||22
9952296|NCT01421342|11071237|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511
9952297|NCT01421342|11071238|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506
9952298|NCT01421342|11071239|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505
9952299|NCT01421342|11071237|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353
9952300|NCT01421342|11071238|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378
9952301|NCT01421342|11071239|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406
9770347|NCT00437294|10875386|FG000|STARTED|Overall Study||43
9770348|NCT00437294|10875387|FG001|STARTED|Overall Study||43
9770349|NCT00437294|10875386|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
9770350|NCT00437294|10875387|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43
9770351|NCT00437294|10875386|FG000|COMPLETED|Overall Study||0
9770352|NCT00437294|10875387|FG001|COMPLETED|Overall Study||0
9770353|NCT00437294|10875386|FG000|NOT COMPLETED|Overall Study||43
9770354|NCT00437294|10875387|FG001|NOT COMPLETED|Overall Study||43
9770355|NCT00437489|10875401|FG000|STARTED|Overall Study||25
9770356|NCT00437489|10875402|FG001|STARTED|Overall Study||24
9770357|NCT00437489|10875401|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
9770358|NCT00437489|10875402|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
9770359|NCT00437489|10875401|FG000|NOT COMPLETED|Overall Study||23
9770360|NCT00437489|10875402|FG001|NOT COMPLETED|Overall Study||22
9770361|NCT00437645|10875410|FG000|STARTED|Overall Study||592
9770362|NCT00437645|10875411|FG001|STARTED|Overall Study||591
9770363|NCT00437645|10875410|FG000|COMPLETED|Overall Study||557
9770364|NCT00437645|10875411|FG001|COMPLETED|Overall Study||476
9770365|NCT00437645|10875410|FG000|NOT COMPLETED|Overall Study||35
9770366|NCT00437645|10875411|FG001|NOT COMPLETED|Overall Study||115
9770367|NCT00437658|10875420|FG000|STARTED|Treatment Period (24 Weeks)||84
9770368|NCT00437658|10875421|FG001|STARTED|Treatment Period (24 Weeks)||84
9770369|NCT00437658|10875422|FG002|STARTED|Treatment Period (24 Weeks)||84
9770370|NCT00437658|10875420|FG000|Received Study Drug|Treatment Period (24 Weeks)||84
9770371|NCT00437658|10875421|FG001|Received Study Drug|Treatment Period (24 Weeks)||84
9770372|NCT00437658|10875422|FG002|Received Study Drug|Treatment Period (24 Weeks)||84
9770373|NCT00437658|10875420|FG000|COMPLETED|Treatment Period (24 Weeks)||56
9770374|NCT00437658|10875421|FG001|COMPLETED|Treatment Period (24 Weeks)||62
9770375|NCT00437658|10875422|FG002|COMPLETED|Treatment Period (24 Weeks)||51
9770376|NCT00437658|10875420|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28
9770377|NCT00437658|10875421|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22
9770378|NCT00437658|10875422|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33
9770379|NCT00437658|10875420|FG000|STARTED|Post-treatment Period (24 Weeks)||56
9770380|NCT00437658|10875421|FG001|STARTED|Post-treatment Period (24 Weeks)||62
9770381|NCT00437658|10875422|FG002|STARTED|Post-treatment Period (24 Weeks)||51
9770382|NCT00437658|10875420|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32
9770383|NCT00437658|10875421|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54
9770384|NCT00437658|10875422|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37
9770385|NCT00437658|10875420|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
9770386|NCT00437658|10875421|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
9770387|NCT00437658|10875422|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
9770388|NCT00437983|10875432|FG000|STARTED|Overall Study||79
9770389|NCT00437983|10875433|FG001|STARTED|Overall Study||78
9770390|NCT00437983|10875432|FG000|COMPLETED|Overall Study||66
9770391|NCT00437983|10875433|FG001|COMPLETED|Overall Study||65
9770392|NCT00437983|10875432|FG000|NOT COMPLETED|Overall Study||13
9770393|NCT00437983|10875433|FG001|NOT COMPLETED|Overall Study||13
9770394|NCT00438100|10875441|FG000|STARTED|Overall Study||73
9770395|NCT00438100|10875442|FG001|STARTED|Overall Study||69
9770396|NCT00438100|10875441|FG000|COMPLETED|Overall Study||71
9770397|NCT00438100|10875442|FG001|COMPLETED|Overall Study||65
9770398|NCT00438100|10875441|FG000|NOT COMPLETED|Overall Study||2
9770399|NCT00438100|10875442|FG001|NOT COMPLETED|Overall Study||4
9770400|NCT00438191|10875450|FG000|STARTED|Overall Study||43
9770401|NCT00438191|10875451|FG001|STARTED|Overall Study||40
9770402|NCT00438191|10875450|FG000|COMPLETED|Overall Study||32
9770403|NCT00438191|10875451|FG001|COMPLETED|Overall Study||26
9770404|NCT00438191|10875450|FG000|NOT COMPLETED|Overall Study||11
9770405|NCT00438191|10875451|FG001|NOT COMPLETED|Overall Study||14
9770406|NCT00438204|10875457|FG000|STARTED|Overall Study||39
9770407|NCT00438204|10875457|FG000|COMPLETED|Overall Study||39
9770408|NCT00438204|10875457|FG000|NOT COMPLETED|Overall Study||0
9770409|NCT00438256|10875462|FG000|STARTED|Overall Study||3
9770410|NCT00438256|10875463|FG001|STARTED|Overall Study||3
9770411|NCT00438256|10875464|FG002|STARTED|Overall Study||3
9770412|NCT00438256|10875465|FG003|STARTED|Overall Study||41
9770413|NCT00438256|10875462|FG000|Surgical Resection|Overall Study||1
9770414|NCT00438256|10875463|FG001|Surgical Resection|Overall Study||2
9770415|NCT00438256|10875464|FG002|Surgical Resection|Overall Study||2
9770416|NCT00438256|10875465|FG003|Surgical Resection|Overall Study||34
9770417|NCT00438256|10875462|FG000|COMPLETED|Overall Study||1
9770418|NCT00438256|10875463|FG001|COMPLETED|Overall Study||2
9770419|NCT00438256|10875464|FG002|COMPLETED|Overall Study||2
9770420|NCT00438256|10875465|FG003|COMPLETED|Overall Study||32
9770421|NCT00438256|10875462|FG000|NOT COMPLETED|Overall Study||2
9770422|NCT00438256|10875463|FG001|NOT COMPLETED|Overall Study||1
9770423|NCT00438256|10875464|FG002|NOT COMPLETED|Overall Study||1
9770424|NCT00438256|10875465|FG003|NOT COMPLETED|Overall Study||9
9770425|NCT00438360|10875480|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162
9770426|NCT00438360|10875481|FG001|STARTED|Overall Study||81
9770427|NCT00438360|10875480|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
9770428|NCT00438360|10875481|FG001|Intention to Treat (ITT) Population|Overall Study||79
9770429|NCT00438360|10875480|FG000|COMPLETED|Overall Study||90
9770430|NCT00438360|10875481|FG001|COMPLETED|Overall Study||38
9770431|NCT00438360|10875480|FG000|NOT COMPLETED|Overall Study||72
9770432|NCT00438360|10875481|FG001|NOT COMPLETED|Overall Study||43
9770433|NCT00438399|10875490|FG000|STARTED|Overall Study||38
9770434|NCT00438399|10875491|FG001|STARTED|Overall Study||40
9770435|NCT00438399|10875492|FG002|STARTED|Overall Study||35
9770436|NCT00438399|10875493|FG003|STARTED|Overall Study||36
9770437|NCT00438399|10875494|FG004|STARTED|Overall Study||33
9770438|NCT00438399|10875495|FG005|STARTED|Overall Study||37
9770439|NCT00438399|10875490|FG000|TREATED & ANALYZED|Overall Study||30
9770440|NCT00438399|10875491|FG001|TREATED & ANALYZED|Overall Study||32
9770441|NCT00438399|10875492|FG002|TREATED & ANALYZED|Overall Study||28
9770442|NCT00438399|10875493|FG003|TREATED & ANALYZED|Overall Study||32
9770443|NCT00438399|10875494|FG004|TREATED & ANALYZED|Overall Study||30
9770444|NCT00438399|10875495|FG005|TREATED & ANALYZED|Overall Study||31
9770445|NCT00438399|10875490|FG000|COMPLETED|Overall Study||30
9770446|NCT00438399|10875491|FG001|COMPLETED|Overall Study||32
9770447|NCT00438399|10875492|FG002|COMPLETED|Overall Study||28
9770448|NCT00438399|10875493|FG003|COMPLETED|Overall Study||32
9770449|NCT00438399|10875494|FG004|COMPLETED|Overall Study||30
9770450|NCT00438399|10875495|FG005|COMPLETED|Overall Study||31
9770451|NCT00438399|10875490|FG000|NOT COMPLETED|Overall Study||8
9770452|NCT00438399|10875491|FG001|NOT COMPLETED|Overall Study||8
9770453|NCT00438399|10875492|FG002|NOT COMPLETED|Overall Study||7
9770454|NCT00438399|10875493|FG003|NOT COMPLETED|Overall Study||4
9770455|NCT00438399|10875494|FG004|NOT COMPLETED|Overall Study||3
9770456|NCT00438399|10875495|FG005|NOT COMPLETED|Overall Study||6
9770457|NCT00438451|10875507|FG000|STARTED|Overall Study||122
9770458|NCT00438451|10875508|FG001|STARTED|Overall Study||121
9770459|NCT00438451|10875509|FG002|STARTED|Overall Study||118
9770460|NCT00438451|10875507|FG000|Safety Population|Overall Study||122
9770461|NCT00438451|10875508|FG001|Safety Population|Overall Study||121
9770462|NCT00438451|10875509|FG002|Safety Population|Overall Study||117
9770463|NCT00438451|10875507|FG000|ITT Population|Overall Study||122
9770464|NCT00438451|10875508|FG001|ITT Population|Overall Study||120
9770465|NCT00438451|10875509|FG002|ITT Population|Overall Study||117
9770466|NCT00438451|10875507|FG000|Maintenance Phase (Week 7-58)|Overall Study||93
9770467|NCT00438451|10875508|FG001|Maintenance Phase (Week 7-58)|Overall Study||89
9770468|NCT00438451|10875509|FG002|Maintenance Phase (Week 7-58)|Overall Study||93
9770469|NCT00438451|10875507|FG000|COMPLETED|Overall Study||75
9770470|NCT00438451|10875508|FG001|COMPLETED|Overall Study||55
9770471|NCT00438451|10875509|FG002|COMPLETED|Overall Study||65
9770472|NCT00438451|10875507|FG000|NOT COMPLETED|Overall Study||47
9770473|NCT00438451|10875508|FG001|NOT COMPLETED|Overall Study||66
9770474|NCT00438451|10875509|FG002|NOT COMPLETED|Overall Study||53
9770475|NCT00438464|10875519|FG000|STARTED|Overall Study||103
9770476|NCT00438464|10875520|FG001|STARTED|Overall Study||101
9770477|NCT00438464|10875519|FG000|Received Assigned Intervention|Overall Study||89
9770478|NCT00438464|10875520|FG001|Received Assigned Intervention|Overall Study||94
9770479|NCT00438464|10875519|FG000|COMPLETED|Overall Study||89
9770480|NCT00438464|10875520|FG001|COMPLETED|Overall Study||94
9770481|NCT00438464|10875519|FG000|NOT COMPLETED|Overall Study||14
9770482|NCT00438464|10875520|FG001|NOT COMPLETED|Overall Study||7
9770483|NCT00438490|10875540|FG000|STARTED|Overall Study||12
9770484|NCT00438490|10875541|FG001|STARTED|Overall Study||9
9770485|NCT00438490|10875540|FG000|COMPLETED|Overall Study||12
9770486|NCT00438490|10875541|FG001|COMPLETED|Overall Study||9
9770487|NCT00438490|10875540|FG000|NOT COMPLETED|Overall Study||0
9770488|NCT00438490|10875541|FG001|NOT COMPLETED|Overall Study||0
9770489|NCT00438633|10875553|FG000|STARTED|Overall Study||32
9770490|NCT00438633|10875554|FG001|STARTED|Overall Study||31
9770491|NCT00438633|10875553|FG000|3-month Follow-up|Overall Study||26
9770492|NCT00438633|10875554|FG001|3-month Follow-up|Overall Study||24
9770493|NCT00438633|10875553|FG000|COMPLETED|Overall Study||16
9770494|NCT00438633|10875554|FG001|COMPLETED|Overall Study||14
9770495|NCT00438633|10875553|FG000|NOT COMPLETED|Overall Study||16
9770496|NCT00438633|10875554|FG001|NOT COMPLETED|Overall Study||17
9770497|NCT00438659|10875562|FG000|STARTED|Overall Study||90
9770498|NCT00438659|10875563|FG001|STARTED|Overall Study||86
9770499|NCT00438659|10875562|FG000|COMPLETED|Overall Study||84
9770500|NCT00438659|10875563|FG001|COMPLETED|Overall Study||82
9770501|NCT00438659|10875562|FG000|NOT COMPLETED|Overall Study||6
9770502|NCT00438659|10875563|FG001|NOT COMPLETED|Overall Study||4
9770503|NCT00438672|10875572|FG000|STARTED|Overall Study||31
9770504|NCT00438672|10875573|FG001|STARTED|Overall Study||33
9770505|NCT00438672|10875572|FG000|COMPLETED|Overall Study||24
9770506|NCT00438672|10875573|FG001|COMPLETED|Overall Study||24
9770507|NCT00438672|10875572|FG000|NOT COMPLETED|Overall Study||7
9770508|NCT00438672|10875573|FG001|NOT COMPLETED|Overall Study||9
9770509|NCT00438750|10875581|FG000|STARTED|Overall Study||48
9770510|NCT00438750|10875582|FG001|STARTED|Overall Study||46
9770511|NCT00438750|10875581|FG000|COMPLETED|Overall Study||39
9770512|NCT00438750|10875582|FG001|COMPLETED|Overall Study||37
9770513|NCT00438750|10875581|FG000|NOT COMPLETED|Overall Study||9
9770514|NCT00438750|10875582|FG001|NOT COMPLETED|Overall Study||9
9770515|NCT00438802|10875591|FG000|STARTED|Overall Study||6
9770516|NCT00438802|10875592|FG001|STARTED|Overall Study||8
9770517|NCT00438802|10875593|FG002|STARTED|Overall Study||9
9770518|NCT00438802|10875591|FG000|COMPLETED|Overall Study||6
9770519|NCT00438802|10875592|FG001|COMPLETED|Overall Study||8
9770520|NCT00438802|10875593|FG002|COMPLETED|Overall Study||9
9770521|NCT00438802|10875591|FG000|NOT COMPLETED|Overall Study||0
9770522|NCT00438802|10875592|FG001|NOT COMPLETED|Overall Study||0
9770523|NCT00438802|10875593|FG002|NOT COMPLETED|Overall Study||0
9770524|NCT00438815|10875603|FG000|STARTED|Overall Study||113
9770525|NCT00438815|10875603|FG000|COMPLETED|Overall Study||43
10233861|NCT01648270|11363697|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
10233862|NCT01648270|11363697|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
10233863|NCT01643525|11363707|FG000|STARTED|Overall Study||29
10233864|NCT01643525|11363707|FG000|COMPLETED|Overall Study||29
10233865|NCT01643525|11363707|FG000|NOT COMPLETED|Overall Study||0
10233866|NCT01641601|11363713|FG000|STARTED|Overall Study||3
10233867|NCT01641601|11363714|FG001|STARTED|Overall Study||5
10233868|NCT01641601|11363713|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
10233869|NCT01641601|11363714|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
10233870|NCT01641601|11363713|FG000|NOT COMPLETED|Overall Study||3
10233871|NCT01641601|11363714|FG001|NOT COMPLETED|Overall Study||5
9770526|NCT00438815|10875603|FG000|NOT COMPLETED|Overall Study||70
9770527|NCT00438854|10875607|FG000|STARTED|Overall Study||15
9770528|NCT00438854|10875607|FG000|COMPLETED|Overall Study||15
9770529|NCT00438854|10875607|FG000|NOT COMPLETED|Overall Study||0
9770530|NCT00438880|10875613|FG000|STARTED|Overall Study||30
9770531|NCT00438880|10875614|FG001|STARTED|Overall Study||8
9770532|NCT00438880|10875613|FG000|COMPLETED|Overall Study||30
9770533|NCT00438880|10875614|FG001|COMPLETED|Overall Study||8
9770534|NCT00438880|10875613|FG000|NOT COMPLETED|Overall Study||0
9770535|NCT00438880|10875614|FG001|NOT COMPLETED|Overall Study||0
9770536|NCT00438932|10875624|FG000|STARTED|Overall Study||4
9770537|NCT00438932|10875625|FG001|STARTED|Overall Study||4
9770538|NCT00438932|10875626|FG002|STARTED|Overall Study||4
9770539|NCT00438932|10875627|FG003|STARTED|Overall Study||4
9770540|NCT00438932|10875624|FG000|COMPLETED|Overall Study||4
9770541|NCT00438932|10875625|FG001|COMPLETED|Overall Study||4
9770542|NCT00438932|10875626|FG002|COMPLETED|Overall Study||4
9770543|NCT00438932|10875627|FG003|COMPLETED|Overall Study||4
9770544|NCT00438932|10875624|FG000|NOT COMPLETED|Overall Study||0
9770545|NCT00438932|10875625|FG001|NOT COMPLETED|Overall Study||0
9770546|NCT00438932|10875626|FG002|NOT COMPLETED|Overall Study||0
9770547|NCT00438932|10875627|FG003|NOT COMPLETED|Overall Study||0
9770548|NCT00438971|10875637|FG000|STARTED|Overall Study||17
9770549|NCT00438971|10875637|FG000|COMPLETED|Overall Study||15
9770550|NCT00438971|10875637|FG000|NOT COMPLETED|Overall Study||2
9770551|NCT00439140|10875645|FG000|STARTED|Treatment Cycle 1||15
9770552|NCT00439140|10875646|FG001|STARTED|Treatment Cycle 1||14
9770553|NCT00439140|10875647|FG002|STARTED|Treatment Cycle 1||12
9770554|NCT00439140|10875645|FG000|COMPLETED|Treatment Cycle 1||14
9770555|NCT00439140|10875646|FG001|COMPLETED|Treatment Cycle 1||10
9770556|NCT00439140|10875647|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
9770557|NCT00439140|10875645|FG000|NOT COMPLETED|Treatment Cycle 1||1
9770558|NCT00439140|10875646|FG001|NOT COMPLETED|Treatment Cycle 1||4
9770559|NCT00439140|10875647|FG002|NOT COMPLETED|Treatment Cycle 1||1
9770560|NCT00439140|10875645|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
9770561|NCT00439140|10875646|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
9770562|NCT00439140|10875647|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
9770563|NCT00439140|10875645|FG000|COMPLETED|Treatment Cycle 2||11
9770564|NCT00439140|10875646|FG001|COMPLETED|Treatment Cycle 2||6
9770565|NCT00439140|10875647|FG002|COMPLETED|Treatment Cycle 2||0
9770566|NCT00439140|10875645|FG000|NOT COMPLETED|Treatment Cycle 2||2
9770567|NCT00439140|10875646|FG001|NOT COMPLETED|Treatment Cycle 2||1
9770568|NCT00439140|10875647|FG002|NOT COMPLETED|Treatment Cycle 2||0
9770569|NCT00439179|10875659|FG000|STARTED|Overall Study|1 with biliary|3
9770570|NCT00439179|10875660|FG001|STARTED|Overall Study|2 with biliary|13
9770571|NCT00439179|10875661|FG002|STARTED|Overall Study|2 with biliary|6
9770572|NCT00439179|10875662|FG003|STARTED|Overall Study|2 with biliry|5
9770573|NCT00439179|10875659|FG000|COMPLETED|Overall Study||3
9770574|NCT00439179|10875660|FG001|COMPLETED|Overall Study||11
9770575|NCT00439179|10875661|FG002|COMPLETED|Overall Study||6
9770576|NCT00439179|10875662|FG003|COMPLETED|Overall Study||5
9770577|NCT00439179|10875659|FG000|NOT COMPLETED|Overall Study||0
9770578|NCT00439179|10875660|FG001|NOT COMPLETED|Overall Study||2
9770579|NCT00439179|10875661|FG002|NOT COMPLETED|Overall Study||0
9770580|NCT00439179|10875662|FG003|NOT COMPLETED|Overall Study||0
9770581|NCT00439218|10875675|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4
9770582|NCT00439218|10875675|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
9770583|NCT00439218|10875675|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
9770584|NCT00439218|10875675|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
9770585|NCT00439218|10875675|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
9770586|NCT00439218|10875675|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
9770587|NCT00439231|10875679|FG000|STARTED|Overall Study||33
9770588|NCT00439231|10875679|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
9770589|NCT00439231|10875679|FG000|NOT COMPLETED|Overall Study||28
9770590|NCT00439244|10875686|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
9770591|NCT00439244|10875687|FG001|STARTED|Overall Study||137
9770592|NCT00439244|10875688|FG002|STARTED|Overall Study||138
9770593|NCT00439244|10875686|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
9770594|NCT00439244|10875687|FG001|Safety Population|Overall Study||137
9770595|NCT00439244|10875688|FG002|Safety Population|Overall Study||137
9770596|NCT00439244|10875686|FG000|COMPLETED|Overall Study||126
9770597|NCT00439244|10875687|FG001|COMPLETED|Overall Study||131
9770598|NCT00439244|10875688|FG002|COMPLETED|Overall Study||131
9770599|NCT00439244|10875686|FG000|NOT COMPLETED|Overall Study||11
9770600|NCT00439244|10875687|FG001|NOT COMPLETED|Overall Study||6
9770601|NCT00439244|10875688|FG002|NOT COMPLETED|Overall Study||7
9770602|NCT00439270|10875701|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
9770603|NCT00439270|10875702|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
9770604|NCT00439270|10875703|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
9770605|NCT00439270|10875704|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
9770606|NCT00439270|10875705|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
9770607|NCT00439270|10875701|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
9770608|NCT00439270|10875702|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
9770609|NCT00439270|10875703|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
9770610|NCT00439270|10875704|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
9770611|NCT00439270|10875705|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
9770612|NCT00439270|10875701|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3
9770613|NCT00439270|10875702|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3
9770614|NCT00439270|10875703|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3
9770615|NCT00439270|10875704|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0
9770616|NCT00439270|10875705|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3
9770617|NCT00439270|10875701|FG000|STARTED|Phase 2 (51.6 Months)||0
9770618|NCT00439270|10875702|FG001|STARTED|Phase 2 (51.6 Months)||0
9770619|NCT00439270|10875703|FG002|STARTED|Phase 2 (51.6 Months)||0
9770620|NCT00439270|10875704|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
9770621|NCT00439270|10875705|FG004|STARTED|Phase 2 (51.6 Months)||0
9770622|NCT00439270|10875701|FG000|COMPLETED|Phase 2 (51.6 Months)||0
9770623|NCT00439270|10875702|FG001|COMPLETED|Phase 2 (51.6 Months)||0
9770624|NCT00439270|10875703|FG002|COMPLETED|Phase 2 (51.6 Months)||0
9770625|NCT00439270|10875704|FG003|COMPLETED|Phase 2 (51.6 Months)||0
9770626|NCT00439270|10875705|FG004|COMPLETED|Phase 2 (51.6 Months)||0
9770627|NCT00439270|10875701|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0
9770628|NCT00439270|10875702|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0
9770629|NCT00439270|10875703|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0
9770630|NCT00439270|10875704|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34
9770631|NCT00439270|10875705|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0
9770632|NCT00439296|10875726|FG000|STARTED|Overall Study||5
9770633|NCT00439296|10875727|FG001|STARTED|Overall Study||4
9770634|NCT00439296|10875726|FG000|Treatment Course 1|Overall Study||5
9770635|NCT00439296|10875727|FG001|Treatment Course 1|Overall Study||3
9770636|NCT00439296|10875726|FG000|Treatment Course 2|Overall Study||1
9770637|NCT00439296|10875727|FG001|Treatment Course 2|Overall Study||1
9770638|NCT00439296|10875726|FG000|COMPLETED|Overall Study||5
9770639|NCT00439296|10875727|FG001|COMPLETED|Overall Study||4
9770640|NCT00439296|10875726|FG000|NOT COMPLETED|Overall Study||0
9770641|NCT00439296|10875727|FG001|NOT COMPLETED|Overall Study||0
9770642|NCT00439309|10875735|FG000|STARTED|Treatment||54
9770643|NCT00439309|10875736|FG001|STARTED|Treatment||15
9770644|NCT00439309|10875735|FG000|COMPLETED|Treatment||54
9770645|NCT00439309|10875736|FG001|COMPLETED|Treatment||15
9770646|NCT00439309|10875735|FG000|NOT COMPLETED|Treatment||0
9770647|NCT00439309|10875736|FG001|NOT COMPLETED|Treatment||0
9770648|NCT00439309|10875735|FG000|STARTED|Follow-Up||54
9770649|NCT00439309|10875736|FG001|STARTED|Follow-Up||15
9770650|NCT00439309|10875735|FG000|COMPLETED|Follow-Up||51
9770651|NCT00439309|10875736|FG001|COMPLETED|Follow-Up||13
9770652|NCT00439309|10875735|FG000|NOT COMPLETED|Follow-Up||3
9770653|NCT00439309|10875736|FG001|NOT COMPLETED|Follow-Up||2
9770654|NCT00439335|10875744|FG000|STARTED|Overall Study||113
9770655|NCT00439335|10875745|FG001|STARTED|Overall Study||114
9770656|NCT00439335|10875744|FG000|COMPLETED|Overall Study||111
9770657|NCT00439335|10875745|FG001|COMPLETED|Overall Study||114
9770658|NCT00439335|10875744|FG000|NOT COMPLETED|Overall Study||2
9770659|NCT00439335|10875745|FG001|NOT COMPLETED|Overall Study||0
9770660|NCT00439374|10875753|FG000|STARTED|Overall Study||327
9770661|NCT00439374|10875754|FG001|STARTED|Overall Study||330
9770662|NCT00439374|10875753|FG000|COMPLETED|Overall Study||327
9770663|NCT00439374|10875754|FG001|COMPLETED|Overall Study||330
10014139|NCT01797575|11137157|FG000|COMPLETED|Week 8 Re-Randomization||4
10014140|NCT01797575|11137158|FG001|COMPLETED|Week 8 Re-Randomization||5
10014141|NCT01797575|11137159|FG002|COMPLETED|Week 8 Re-Randomization||4
9770664|NCT00439374|10875753|FG000|NOT COMPLETED|Overall Study||0
9770665|NCT00439374|10875754|FG001|NOT COMPLETED|Overall Study||0
9770666|NCT00439413|10875762|FG000|STARTED|Overall Study||121
9770667|NCT00439413|10875763|FG001|STARTED|Overall Study||125
9770668|NCT00439413|10875762|FG000|COMPLETED|Overall Study||90
9770669|NCT00439413|10875763|FG001|COMPLETED|Overall Study||88
9770670|NCT00439413|10875762|FG000|NOT COMPLETED|Overall Study||31
9770671|NCT00439413|10875763|FG001|NOT COMPLETED|Overall Study||37
10014142|NCT01797575|11137160|FG003|COMPLETED|Week 8 Re-Randomization||7
10014143|NCT01797575|11137157|FG000|NOT COMPLETED|Week 8 Re-Randomization||0
10014144|NCT01797575|11137158|FG001|NOT COMPLETED|Week 8 Re-Randomization||0
9770672|NCT00439465|10875771|FG000|STARTED|Overall Study||23
9770673|NCT00439465|10875771|FG000|COMPLETED|Overall Study||19
9770674|NCT00439465|10875771|FG000|NOT COMPLETED|Overall Study||4
9770675|NCT00439517|10875780|FG000|STARTED|Overall Study||152
9770676|NCT00439517|10875781|FG001|STARTED|Overall Study||150
9770677|NCT00439517|10875780|FG000|COMPLETED|Overall Study||150
9770678|NCT00439517|10875781|FG001|COMPLETED|Overall Study||150
9770679|NCT00439517|10875780|FG000|NOT COMPLETED|Overall Study||2
9770680|NCT00439517|10875781|FG001|NOT COMPLETED|Overall Study||0
9770681|NCT00439556|10875790|FG000|STARTED|Overall Study||36
9770682|NCT00439556|10875791|FG001|STARTED|Overall Study||4
9770683|NCT00439556|10875792|FG002|STARTED|Overall Study||0
9770684|NCT00439556|10875790|FG000|COMPLETED|Overall Study||36
9770685|NCT00439556|10875791|FG001|COMPLETED|Overall Study||3
9770686|NCT00439556|10875792|FG002|COMPLETED|Overall Study||0
9770687|NCT00439556|10875790|FG000|NOT COMPLETED|Overall Study||0
9770688|NCT00439556|10875791|FG001|NOT COMPLETED|Overall Study||1
9770689|NCT00439556|10875792|FG002|NOT COMPLETED|Overall Study||0
9770690|NCT00439608|10875801|FG000|STARTED|Overall Study||60
9770691|NCT00439608|10875801|FG000|COMPLETED|Overall Study||60
9770692|NCT00439608|10875801|FG000|NOT COMPLETED|Overall Study||0
9770693|NCT00439647|10875807|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
9770694|NCT00439647|10875808|FG001|STARTED|Overall Study||611
9770695|NCT00439647|10875807|FG000|Modified Intent to Treat (mITT)|Overall Study||553
9770696|NCT00439647|10875808|FG001|Modified Intent to Treat (mITT)|Overall Study||574
9770697|NCT00439647|10875807|FG000|COMPLETED|Overall Study||530
9770698|NCT00439647|10875808|FG001|COMPLETED|Overall Study||540
9770699|NCT00439647|10875807|FG000|NOT COMPLETED|Overall Study||58
9770700|NCT00439647|10875808|FG001|NOT COMPLETED|Overall Study||71
9770701|NCT00439673|10875814|FG000|STARTED|Overall Study||62
9770702|NCT00439673|10875814|FG000|COMPLETED|Overall Study||26
9770703|NCT00439673|10875814|FG000|NOT COMPLETED|Overall Study||36
9770704|NCT00439725|10875820|FG000|STARTED|Treatment Period||602
9770705|NCT00439725|10875821|FG001|STARTED|Treatment Period||595
9770706|NCT00439725|10875820|FG000|Participants Received Treatment|Treatment Period|Safety population|598
9770707|NCT00439725|10875821|FG001|Participants Received Treatment|Treatment Period|Safety population|590
9770708|NCT00439725|10875820|FG000|COMPLETED|Treatment Period||366
9770709|NCT00439725|10875821|FG001|COMPLETED|Treatment Period||349
9770710|NCT00439725|10875820|FG000|NOT COMPLETED|Treatment Period||236
9770711|NCT00439725|10875821|FG001|NOT COMPLETED|Treatment Period||246
9770712|NCT00439725|10875820|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
9770713|NCT00439725|10875821|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
9770714|NCT00439725|10875820|FG000|COMPLETED|Observational Period||569
9770715|NCT00439725|10875821|FG001|COMPLETED|Observational Period||553
9770716|NCT00439725|10875820|FG000|NOT COMPLETED|Observational Period||8
9770717|NCT00439725|10875821|FG001|NOT COMPLETED|Observational Period||7
9770718|NCT00439777|10875829|FG000|STARTED|Treatment Period||2420
9770719|NCT00439777|10875830|FG001|STARTED|Treatment Period||2413
9770720|NCT00439777|10875829|FG000|Participants Received Treatment|Treatment Period||2412
9770721|NCT00439777|10875830|FG001|Participants Received Treatment|Treatment Period||2405
9770722|NCT00439777|10875829|FG000|COMPLETED|Treatment Period||2001
9770723|NCT00439777|10875830|FG001|COMPLETED|Treatment Period||1954
9770724|NCT00439777|10875829|FG000|NOT COMPLETED|Treatment Period||419
9770725|NCT00439777|10875830|FG001|NOT COMPLETED|Treatment Period||459
9770726|NCT00439777|10875829|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
9770727|NCT00439777|10875830|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
9770728|NCT00439777|10875829|FG000|COMPLETED|Observational Period||2165
9770729|NCT00439777|10875830|FG001|COMPLETED|Observational Period||2156
9770730|NCT00439777|10875829|FG000|NOT COMPLETED|Observational Period||41
9770731|NCT00439777|10875830|FG001|NOT COMPLETED|Observational Period||41
9770732|NCT00439946|10875836|FG000|STARTED|Overall Study||8
9770733|NCT00439946|10875836|FG000|COMPLETED|Overall Study||8
9770734|NCT00439946|10875836|FG000|NOT COMPLETED|Overall Study||0
10014145|NCT01797575|11137159|FG002|NOT COMPLETED|Week 8 Re-Randomization||1
10014146|NCT01797575|11137160|FG003|NOT COMPLETED|Week 8 Re-Randomization||3
10014147|NCT01797705|11137174|FG000|STARTED|Overall Study||33
10014148|NCT01797705|11137174|FG000|COMPLETED|Overall Study||28
10014149|NCT01797705|11137174|FG000|NOT COMPLETED|Overall Study||5
10014150|NCT01797731|11137180|FG000|STARTED|Overall Study||50
9770735|NCT00440011|10875842|FG000|STARTED|Overall Study||131
9770736|NCT00440011|10875843|FG001|STARTED|Overall Study||135
9770737|NCT00440011|10875842|FG000|COMPLETED|Overall Study||127
9770738|NCT00440011|10875843|FG001|COMPLETED|Overall Study||132
9770739|NCT00440011|10875842|FG000|NOT COMPLETED|Overall Study||4
9770740|NCT00440011|10875843|FG001|NOT COMPLETED|Overall Study||3
9770741|NCT00440037|10875849|FG000|STARTED|Overall Study||44
9770742|NCT00440037|10875849|FG000|COMPLETED|Overall Study||35
9770743|NCT00440037|10875849|FG000|NOT COMPLETED|Overall Study||9
9770744|NCT00440050|10875855|FG000|STARTED|Overall Study||164
9770745|NCT00440050|10875856|FG001|STARTED|Overall Study||238
9770746|NCT00440050|10875855|FG000|COMPLETED|Overall Study||124
9770747|NCT00440050|10875856|FG001|COMPLETED|Overall Study||171
9770748|NCT00440050|10875855|FG000|NOT COMPLETED|Overall Study||40
9770749|NCT00440050|10875856|FG001|NOT COMPLETED|Overall Study||67
9770750|NCT00440115|10875865|FG000|STARTED|Overall Study||251
9770751|NCT00440115|10875866|FG001|STARTED|Overall Study||249
9770752|NCT00440115|10875867|FG002|STARTED|Overall Study||250
9770753|NCT00440115|10875865|FG000|COMPLETED|Overall Study||244
9770754|NCT00440115|10875866|FG001|COMPLETED|Overall Study||238
9770755|NCT00440115|10875867|FG002|COMPLETED|Overall Study||244
9770756|NCT00440115|10875865|FG000|NOT COMPLETED|Overall Study||7
9770757|NCT00440115|10875866|FG001|NOT COMPLETED|Overall Study||11
9770758|NCT00440115|10875867|FG002|NOT COMPLETED|Overall Study||6
9770759|NCT00440180|10875877|FG000|STARTED|Overall Study||10
9770760|NCT00440180|10875878|FG001|STARTED|Overall Study||10
9770761|NCT00440180|10875877|FG000|COMPLETED|Overall Study||10
9770762|NCT00440180|10875878|FG001|COMPLETED|Overall Study||10
9770763|NCT00440180|10875877|FG000|NOT COMPLETED|Overall Study||0
9770764|NCT00440180|10875878|FG001|NOT COMPLETED|Overall Study||0
9770765|NCT00440193|10875886|FG000|STARTED|Treatment Period||1731
9770766|NCT00440193|10875887|FG001|STARTED|Treatment Period||1718
9770767|NCT00440193|10875886|FG000|Participants Received Treatment|Treatment Period||1718
9770768|NCT00440193|10875887|FG001|Participants Received Treatment|Treatment Period||1711
9770769|NCT00440193|10875886|FG000|COMPLETED|Treatment Period||1426
9770770|NCT00440193|10875887|FG001|COMPLETED|Treatment Period||1367
9770771|NCT00440193|10875886|FG000|NOT COMPLETED|Treatment Period||305
9770772|NCT00440193|10875887|FG001|NOT COMPLETED|Treatment Period||351
9770773|NCT00440193|10875886|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
9770774|NCT00440193|10875887|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
9770775|NCT00440193|10875886|FG000|COMPLETED|Observational Period||1380
9770776|NCT00440193|10875887|FG001|COMPLETED|Observational Period||1369
9770777|NCT00440193|10875886|FG000|NOT COMPLETED|Observational Period||45
9770778|NCT00440193|10875887|FG001|NOT COMPLETED|Observational Period||38
9770779|NCT00440232|10875895|FG000|STARTED|Overall Study||36
9770780|NCT00440232|10875896|FG001|STARTED|Overall Study||38
9770781|NCT00440232|10875895|FG000|COMPLETED|Overall Study||33
9770782|NCT00440232|10875896|FG001|COMPLETED|Overall Study||34
9770783|NCT00440232|10875895|FG000|NOT COMPLETED|Overall Study||3
9770784|NCT00440232|10875896|FG001|NOT COMPLETED|Overall Study||4
9770785|NCT00440297|10875904|FG000|STARTED|Overall Study||139
9770786|NCT00440297|10875905|FG001|STARTED|Overall Study||138
10014151|NCT01797731|11137181|FG001|STARTED|Overall Study||50
10014152|NCT01797731|11137180|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
10014153|NCT01797731|11137181|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
10014154|NCT01797731|11137180|FG000|NOT COMPLETED|Overall Study||3
10014155|NCT01797731|11137181|FG001|NOT COMPLETED|Overall Study||3
10014156|NCT01797783|11137189|FG000|STARTED|Overall Study||52
10014157|NCT01797783|11137190|FG001|STARTED|Overall Study||27
10014158|NCT01797783|11137189|FG000|COMPLETED|Overall Study||50
10014159|NCT01797783|11137190|FG001|COMPLETED|Overall Study||26
10014160|NCT01797783|11137189|FG000|NOT COMPLETED|Overall Study||2
10014161|NCT01797783|11137190|FG001|NOT COMPLETED|Overall Study||1
10014162|NCT01797822|11137204|FG000|STARTED|Overall Study||20
10014163|NCT01797822|11137204|FG000|COMPLETED|Overall Study|The protocol is now closed.|20
9770787|NCT00440297|10875904|FG000|Vaccination Visit 1|Overall Study||138
9770788|NCT00440297|10875905|FG001|Vaccination Visit 1|Overall Study||138
9770789|NCT00440297|10875904|FG000|Vaccination Visit 2|Overall Study||136
9770790|NCT00440297|10875905|FG001|Vaccination Visit 2|Overall Study||134
9770791|NCT00440297|10875904|FG000|Vaccination Visit 3|Overall Study||124
9770792|NCT00440297|10875905|FG001|Vaccination Visit 3|Overall Study||125
9770793|NCT00440297|10875904|FG000|Vaccination Visit 4|Overall Study||116
9770794|NCT00440297|10875905|FG001|Vaccination Visit 4|Overall Study||122
9770795|NCT00440297|10875904|FG000|COMPLETED|Overall Study||116
9770796|NCT00440297|10875905|FG001|COMPLETED|Overall Study||120
9770797|NCT00440297|10875904|FG000|NOT COMPLETED|Overall Study||23
9770798|NCT00440297|10875905|FG001|NOT COMPLETED|Overall Study||18
9770799|NCT00440310|10875913|FG000|STARTED|Overall Study||244
9770800|NCT00440310|10875914|FG001|STARTED|Overall Study||239
9770801|NCT00440310|10875913|FG000|Treated|Overall Study||222
9770802|NCT00440310|10875914|FG001|Treated|Overall Study||232
9770803|NCT00440310|10875913|FG000|COMPLETED|Overall Study||216
9770804|NCT00440310|10875914|FG001|COMPLETED|Overall Study||209
9770805|NCT00440310|10875913|FG000|NOT COMPLETED|Overall Study||28
9770806|NCT00440310|10875914|FG001|NOT COMPLETED|Overall Study||30
9770807|NCT00440401|10875922|FG000|STARTED|Overall Study||59
9770808|NCT00440401|10875923|FG001|STARTED|Overall Study||60
10014164|NCT01797822|11137204|FG000|NOT COMPLETED|Overall Study||0
9770809|NCT00440401|10875922|FG000|COMPLETED|Overall Study||55
9770810|NCT00440401|10875923|FG001|COMPLETED|Overall Study||54
9770811|NCT00440401|10875922|FG000|NOT COMPLETED|Overall Study||4
9770812|NCT00440401|10875923|FG001|NOT COMPLETED|Overall Study||6
9770813|NCT00440466|10875932|FG000|STARTED|Overall Study||108
9770814|NCT00440466|10875933|FG001|STARTED|Overall Study||107
9770815|NCT00440466|10875934|FG002|STARTED|Overall Study||215
9770816|NCT00440466|10875932|FG000|COMPLETED|Overall Study||95
9770817|NCT00440466|10875933|FG001|COMPLETED|Overall Study||92
9770818|NCT00440466|10875934|FG002|COMPLETED|Overall Study||174
9770819|NCT00440466|10875932|FG000|NOT COMPLETED|Overall Study||13
9770820|NCT00440466|10875933|FG001|NOT COMPLETED|Overall Study||15
9770821|NCT00440466|10875934|FG002|NOT COMPLETED|Overall Study||41
9770822|NCT00440505|10875942|FG000|STARTED|First Intervention||5
9770823|NCT00440505|10875943|FG001|STARTED|First Intervention||2
9770824|NCT00440505|10875944|FG002|STARTED|First Intervention||1
9770825|NCT00440505|10875945|FG003|STARTED|First Intervention||2
9770826|NCT00440505|10875946|FG004|STARTED|First Intervention||5
9770827|NCT00440505|10875947|FG005|STARTED|First Intervention||5
9770828|NCT00440505|10875942|FG000|COMPLETED|First Intervention||5
9770829|NCT00440505|10875943|FG001|COMPLETED|First Intervention||2
9770830|NCT00440505|10875944|FG002|COMPLETED|First Intervention||1
9770831|NCT00440505|10875945|FG003|COMPLETED|First Intervention||2
9770832|NCT00440505|10875946|FG004|COMPLETED|First Intervention||5
9770833|NCT00440505|10875947|FG005|COMPLETED|First Intervention||5
9770834|NCT00440505|10875942|FG000|NOT COMPLETED|First Intervention||0
9770835|NCT00440505|10875943|FG001|NOT COMPLETED|First Intervention||0
9770836|NCT00440505|10875944|FG002|NOT COMPLETED|First Intervention||0
9770837|NCT00440505|10875945|FG003|NOT COMPLETED|First Intervention||0
9770838|NCT00440505|10875946|FG004|NOT COMPLETED|First Intervention||0
9770839|NCT00440505|10875947|FG005|NOT COMPLETED|First Intervention||0
9770840|NCT00440505|10875942|FG000|STARTED|Second Intervention||5
9770841|NCT00440505|10875943|FG001|STARTED|Second Intervention||2
9770842|NCT00440505|10875944|FG002|STARTED|Second Intervention||1
9770843|NCT00440505|10875945|FG003|STARTED|Second Intervention||2
9770844|NCT00440505|10875946|FG004|STARTED|Second Intervention||5
9770845|NCT00440505|10875947|FG005|STARTED|Second Intervention||5
9770846|NCT00440505|10875942|FG000|COMPLETED|Second Intervention||5
9770847|NCT00440505|10875943|FG001|COMPLETED|Second Intervention||2
9770848|NCT00440505|10875944|FG002|COMPLETED|Second Intervention||1
9770849|NCT00440505|10875945|FG003|COMPLETED|Second Intervention||2
9770850|NCT00440505|10875946|FG004|COMPLETED|Second Intervention||5
9770851|NCT00440505|10875947|FG005|COMPLETED|Second Intervention||5
9770852|NCT00440505|10875942|FG000|NOT COMPLETED|Second Intervention||0
9770853|NCT00440505|10875943|FG001|NOT COMPLETED|Second Intervention||0
9770854|NCT00440505|10875944|FG002|NOT COMPLETED|Second Intervention||0
9770855|NCT00440505|10875945|FG003|NOT COMPLETED|Second Intervention||0
9770856|NCT00440505|10875946|FG004|NOT COMPLETED|Second Intervention||0
10014165|NCT01797835|11137212|FG000|STARTED|Overall Study||153
10014166|NCT01797835|11137213|FG001|STARTED|Overall Study||141
10014167|NCT01797835|11137212|FG000|COMPLETED|Overall Study||122
10014168|NCT01797835|11137213|FG001|COMPLETED|Overall Study||114
10014169|NCT01797835|11137212|FG000|NOT COMPLETED|Overall Study||31
9770857|NCT00440505|10875947|FG005|NOT COMPLETED|Second Intervention||0
9770858|NCT00440505|10875942|FG000|STARTED|Third Intervention||5
9770859|NCT00440505|10875943|FG001|STARTED|Third Intervention||2
9770860|NCT00440505|10875944|FG002|STARTED|Third Intervention||1
9770861|NCT00440505|10875945|FG003|STARTED|Third Intervention||2
9770862|NCT00440505|10875946|FG004|STARTED|Third Intervention||5
9770863|NCT00440505|10875947|FG005|STARTED|Third Intervention||5
9770864|NCT00440505|10875942|FG000|COMPLETED|Third Intervention||5
9770865|NCT00440505|10875943|FG001|COMPLETED|Third Intervention||2
9770866|NCT00440505|10875944|FG002|COMPLETED|Third Intervention||1
9770867|NCT00440505|10875945|FG003|COMPLETED|Third Intervention||1
9770868|NCT00440505|10875946|FG004|COMPLETED|Third Intervention||5
9770869|NCT00440505|10875947|FG005|COMPLETED|Third Intervention||5
9770870|NCT00440505|10875942|FG000|NOT COMPLETED|Third Intervention||0
9770871|NCT00440505|10875943|FG001|NOT COMPLETED|Third Intervention||0
9770872|NCT00440505|10875944|FG002|NOT COMPLETED|Third Intervention||0
9770873|NCT00440505|10875945|FG003|NOT COMPLETED|Third Intervention||1
9770874|NCT00440505|10875946|FG004|NOT COMPLETED|Third Intervention||0
9770875|NCT00440505|10875947|FG005|NOT COMPLETED|Third Intervention||0
9770876|NCT00440518|10875958|FG000|STARTED|Randomized /Titration Period||72
9770877|NCT00440518|10875959|FG001|STARTED|Randomized /Titration Period||72
9770878|NCT00440518|10875960|FG002|STARTED|Randomized /Titration Period||74
9770879|NCT00440518|10875958|FG000|COMPLETED|Randomized /Titration Period||59
9770880|NCT00440518|10875959|FG001|COMPLETED|Randomized /Titration Period||63
9770881|NCT00440518|10875960|FG002|COMPLETED|Randomized /Titration Period||70
9770882|NCT00440518|10875958|FG000|NOT COMPLETED|Randomized /Titration Period||13
9770883|NCT00440518|10875959|FG001|NOT COMPLETED|Randomized /Titration Period||9
9770884|NCT00440518|10875960|FG002|NOT COMPLETED|Randomized /Titration Period||4
9770885|NCT00440518|10875958|FG000|STARTED|Maintenance and Safety Follow-up Periods||59
9770886|NCT00440518|10875959|FG001|STARTED|Maintenance and Safety Follow-up Periods||63
9770887|NCT00440518|10875960|FG002|STARTED|Maintenance and Safety Follow-up Periods||70
9770888|NCT00440518|10875958|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52
9770889|NCT00440518|10875959|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51
9770890|NCT00440518|10875960|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55
10014170|NCT01797835|11137213|FG001|NOT COMPLETED|Overall Study||27
10014171|NCT01797965|11137223|FG000|STARTED|Overall Study||597
9770891|NCT00440518|10875958|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
9770892|NCT00440518|10875959|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
9770893|NCT00440518|10875960|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
9770894|NCT00440557|10875971|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
9770895|NCT00440557|10875972|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
9770896|NCT00440557|10875973|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
9770897|NCT00440557|10875971|FG000|COMPLETED|Overall Study||98
9770898|NCT00440557|10875972|FG001|COMPLETED|Overall Study||96
9770899|NCT00440557|10875973|FG002|COMPLETED|Overall Study||90
10014172|NCT01797965|11137224|FG001|STARTED|Overall Study||607
9770900|NCT00440557|10875971|FG000|NOT COMPLETED|Overall Study||25
9770901|NCT00440557|10875972|FG001|NOT COMPLETED|Overall Study||29
9770902|NCT00440557|10875973|FG002|NOT COMPLETED|Overall Study||35
9770903|NCT00440596|10875983|FG000|STARTED|Overall Study||28
9770904|NCT00440596|10875984|FG001|STARTED|Overall Study||28
9770905|NCT00440596|10875983|FG000|COMPLETED|Overall Study||21
9770906|NCT00440596|10875984|FG001|COMPLETED|Overall Study||17
9770907|NCT00440596|10875983|FG000|NOT COMPLETED|Overall Study||7
9770908|NCT00440596|10875984|FG001|NOT COMPLETED|Overall Study||11
9770909|NCT00440700|10875995|FG000|STARTED|Overall Study||122
9770910|NCT00440700|10875996|FG001|STARTED|Overall Study||118
9770911|NCT00440700|10875997|FG002|STARTED|Overall Study||124
9770912|NCT00440700|10875995|FG000|COMPLETED|Overall Study||114
9770913|NCT00440700|10875996|FG001|COMPLETED|Overall Study||110
9770914|NCT00440700|10875997|FG002|COMPLETED|Overall Study||120
9770915|NCT00440700|10875995|FG000|NOT COMPLETED|Overall Study||8
9770916|NCT00440700|10875996|FG001|NOT COMPLETED|Overall Study||8
9770917|NCT00440700|10875997|FG002|NOT COMPLETED|Overall Study||4
9770918|NCT00440726|10876008|FG000|STARTED|Phase 1||4
9770919|NCT00440726|10876009|FG001|STARTED|Phase 1||6
9770920|NCT00440726|10876010|FG002|STARTED|Phase 1||0
9770921|NCT00440726|10876008|FG000|COMPLETED|Phase 1||3
9770922|NCT00440726|10876009|FG001|COMPLETED|Phase 1||5
9770923|NCT00440726|10876010|FG002|COMPLETED|Phase 1||0
9770924|NCT00440726|10876008|FG000|NOT COMPLETED|Phase 1||1
9770925|NCT00440726|10876009|FG001|NOT COMPLETED|Phase 1||1
9770926|NCT00440726|10876010|FG002|NOT COMPLETED|Phase 1||0
9770927|NCT00440726|10876008|FG000|STARTED|Phase 2||0
9770928|NCT00440726|10876009|FG001|STARTED|Phase 2||0
9770929|NCT00440726|10876010|FG002|STARTED|Phase 2||22
9770930|NCT00440726|10876008|FG000|COMPLETED|Phase 2||0
9770931|NCT00440726|10876009|FG001|COMPLETED|Phase 2||0
9770932|NCT00440726|10876010|FG002|COMPLETED|Phase 2||20
9770933|NCT00440726|10876008|FG000|NOT COMPLETED|Phase 2||0
9770934|NCT00440726|10876009|FG001|NOT COMPLETED|Phase 2||0
9770935|NCT00440726|10876010|FG002|NOT COMPLETED|Phase 2||2
9770936|NCT00440830|10876025|FG000|STARTED|Overall Study||20
9770937|NCT00440830|10876026|FG001|STARTED|Overall Study||8
9770938|NCT00440830|10876027|FG002|STARTED|Overall Study||30
9770939|NCT00440830|10876028|FG003|STARTED|Overall Study||10
9770940|NCT00440830|10876025|FG000|COMPLETED|Overall Study||20
9770941|NCT00440830|10876026|FG001|COMPLETED|Overall Study||8
9770942|NCT00440830|10876027|FG002|COMPLETED|Overall Study||30
9770943|NCT00440830|10876028|FG003|COMPLETED|Overall Study||10
9770944|NCT00440830|10876025|FG000|NOT COMPLETED|Overall Study||0
9770945|NCT00440830|10876026|FG001|NOT COMPLETED|Overall Study||0
9770946|NCT00440830|10876027|FG002|NOT COMPLETED|Overall Study||0
9770947|NCT00440830|10876028|FG003|NOT COMPLETED|Overall Study||0
9770948|NCT00440947|10876042|FG000|STARTED|36-Week Induction Phase||515
9770949|NCT00440947|10876043|FG001|STARTED|36-Week Induction Phase||0
9770950|NCT00440947|10876044|FG002|STARTED|36-Week Induction Phase||0
9770951|NCT00440947|10876045|FG003|STARTED|36-Week Induction Phase||0
9770952|NCT00440947|10876046|FG004|STARTED|36-Week Induction Phase||0
9770953|NCT00440947|10876042|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
9770954|NCT00440947|10876043|FG001|COMPLETED|36-Week Induction Phase||0
9770955|NCT00440947|10876044|FG002|COMPLETED|36-Week Induction Phase||0
9770956|NCT00440947|10876045|FG003|COMPLETED|36-Week Induction Phase||0
9770957|NCT00440947|10876046|FG004|COMPLETED|36-Week Induction Phase||0
9770958|NCT00440947|10876042|FG000|NOT COMPLETED|36-Week Induction Phase||73
9770959|NCT00440947|10876043|FG001|NOT COMPLETED|36-Week Induction Phase||0
9770960|NCT00440947|10876044|FG002|NOT COMPLETED|36-Week Induction Phase||0
9770961|NCT00440947|10876045|FG003|NOT COMPLETED|36-Week Induction Phase||0
9770962|NCT00440947|10876046|FG004|NOT COMPLETED|36-Week Induction Phase||0
9770963|NCT00440947|10876042|FG000|STARTED|48-Week Randomization Phase||0
9770964|NCT00440947|10876043|FG001|STARTED|48-Week Randomization Phase||210
9770965|NCT00440947|10876044|FG002|STARTED|48-Week Randomization Phase||209
9770966|NCT00440947|10876045|FG003|STARTED|48-Week Randomization Phase||0
9770967|NCT00440947|10876046|FG004|STARTED|48-Week Randomization Phase||0
9770968|NCT00440947|10876042|FG000|COMPLETED|48-Week Randomization Phase||0
9770969|NCT00440947|10876043|FG001|COMPLETED|48-Week Randomization Phase||194
9770970|NCT00440947|10876044|FG002|COMPLETED|48-Week Randomization Phase||185
9770971|NCT00440947|10876045|FG003|COMPLETED|48-Week Randomization Phase||0
9770972|NCT00440947|10876046|FG004|COMPLETED|48-Week Randomization Phase||0
9770973|NCT00440947|10876042|FG000|NOT COMPLETED|48-Week Randomization Phase||0
9770974|NCT00440947|10876043|FG001|NOT COMPLETED|48-Week Randomization Phase||16
9770975|NCT00440947|10876044|FG002|NOT COMPLETED|48-Week Randomization Phase||24
9770976|NCT00440947|10876045|FG003|NOT COMPLETED|48-Week Randomization Phase||0
9770977|NCT00440947|10876046|FG004|NOT COMPLETED|48-Week Randomization Phase||0
9770978|NCT00440947|10876042|FG000|STARTED|Optional 60-Week Extension Phase||0
9770979|NCT00440947|10876043|FG001|STARTED|Optional 60-Week Extension Phase||0
9770980|NCT00440947|10876044|FG002|STARTED|Optional 60-Week Extension Phase||0
9770981|NCT00440947|10876045|FG003|STARTED|Optional 60-Week Extension Phase||189
9770982|NCT00440947|10876046|FG004|STARTED|Optional 60-Week Extension Phase||180
9770983|NCT00440947|10876042|FG000|COMPLETED|Optional 60-Week Extension Phase||0
9770984|NCT00440947|10876043|FG001|COMPLETED|Optional 60-Week Extension Phase||0
9770985|NCT00440947|10876044|FG002|COMPLETED|Optional 60-Week Extension Phase||0
9770986|NCT00440947|10876045|FG003|COMPLETED|Optional 60-Week Extension Phase||160
9770987|NCT00440947|10876046|FG004|COMPLETED|Optional 60-Week Extension Phase||154
9770988|NCT00440947|10876042|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0
9770989|NCT00440947|10876043|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0
9770990|NCT00440947|10876044|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0
9770991|NCT00440947|10876045|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29
9770992|NCT00440947|10876046|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26
9770993|NCT00440999|10876060|FG000|STARTED|Overall Study||228
9770994|NCT00440999|10876061|FG001|STARTED|Overall Study||228
9770995|NCT00440999|10876060|FG000|COMPLETED|Overall Study||193
9770996|NCT00440999|10876061|FG001|COMPLETED|Overall Study||187
9770997|NCT00440999|10876060|FG000|NOT COMPLETED|Overall Study||35
9770998|NCT00440999|10876061|FG001|NOT COMPLETED|Overall Study||41
9770999|NCT00441012|10876071|FG000|STARTED|Overall Study||270
9771000|NCT00441012|10876072|FG001|STARTED|Overall Study||276
9771001|NCT00441012|10876071|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
9771002|NCT00441012|10876072|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
9771003|NCT00441012|10876071|FG000|Vaccination Visit 2|Overall Study||267
9771004|NCT00441012|10876072|FG001|Vaccination Visit 2|Overall Study||272
9771005|NCT00441012|10876071|FG000|Vaccination Visit 3|Overall Study||265
9771006|NCT00441012|10876072|FG001|Vaccination Visit 3|Overall Study||269
9771007|NCT00441012|10876071|FG000|COMPLETED|Overall Study||252
9771008|NCT00441012|10876072|FG001|COMPLETED|Overall Study||263
9771009|NCT00441012|10876071|FG000|NOT COMPLETED|Overall Study||18
9771010|NCT00441012|10876072|FG001|NOT COMPLETED|Overall Study||13
9771011|NCT00441064|10876080|FG000|STARTED|Overall Study||69
9771012|NCT00441064|10876081|FG001|STARTED|Overall Study||63
9771013|NCT00441064|10876080|FG000|Safety Population (SP)|Overall Study||69
9771014|NCT00441064|10876081|FG001|Safety Population (SP)|Overall Study||63
9771015|NCT00441064|10876080|FG000|Intent-to-treat (ITT) Population|Overall Study||61
9771016|NCT00441064|10876081|FG001|Intent-to-treat (ITT) Population|Overall Study||57
9771017|NCT00441064|10876080|FG000|COMPLETED|Overall Study||59
9771018|NCT00441064|10876081|FG001|COMPLETED|Overall Study||56
9771019|NCT00441064|10876080|FG000|NOT COMPLETED|Overall Study||10
9771020|NCT00441064|10876081|FG001|NOT COMPLETED|Overall Study||7
9771021|NCT00441090|10876092|FG000|STARTED|Overall Study||15
10014173|NCT01797965|11137225|FG002|STARTED|Overall Study||70
10014174|NCT01797965|11137226|FG003|STARTED|Overall Study||227
10014175|NCT01797965|11137223|FG000|COMPLETED|Overall Study||48
10014176|NCT01797965|11137224|FG001|COMPLETED|Overall Study||38
10014177|NCT01797965|11137225|FG002|COMPLETED|Overall Study||62
9771022|NCT00441090|10876093|FG001|STARTED|Overall Study||15
9771023|NCT00441090|10876094|FG002|STARTED|Overall Study||14
9771024|NCT00441090|10876095|FG003|STARTED|Overall Study||15
9771025|NCT00441090|10876096|FG004|STARTED|Overall Study||5
9771026|NCT00441090|10876092|FG000|COMPLETED|Overall Study||13
9771027|NCT00441090|10876093|FG001|COMPLETED|Overall Study||14
9771028|NCT00441090|10876094|FG002|COMPLETED|Overall Study||12
9771029|NCT00441090|10876095|FG003|COMPLETED|Overall Study||13
9771030|NCT00441090|10876096|FG004|COMPLETED|Overall Study||5
9771031|NCT00441090|10876092|FG000|NOT COMPLETED|Overall Study||2
9771032|NCT00441090|10876093|FG001|NOT COMPLETED|Overall Study||1
9771033|NCT00441090|10876094|FG002|NOT COMPLETED|Overall Study||2
9771034|NCT00441090|10876095|FG003|NOT COMPLETED|Overall Study||2
9771035|NCT00441090|10876096|FG004|NOT COMPLETED|Overall Study||0
9771036|NCT00441103|10876110|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
9771037|NCT00441103|10876111|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
9771038|NCT00441103|10876110|FG000|COMPLETED|Overall Study||109
9771039|NCT00441103|10876111|FG001|COMPLETED|Overall Study||56
9771040|NCT00441103|10876110|FG000|NOT COMPLETED|Overall Study||11
9771041|NCT00441103|10876111|FG001|NOT COMPLETED|Overall Study||4
9771042|NCT00441116|10876120|FG000|STARTED|Overall Study||76
9771043|NCT00441116|10876121|FG001|STARTED|Overall Study||77
9771044|NCT00441116|10876120|FG000|COMPLETED|Overall Study||73
9771045|NCT00441116|10876121|FG001|COMPLETED|Overall Study||75
9771046|NCT00441116|10876120|FG000|NOT COMPLETED|Overall Study||3
9771047|NCT00441116|10876121|FG001|NOT COMPLETED|Overall Study||2
9771048|NCT00441129|10876129|FG000|STARTED|Overall Study||60
9771049|NCT00441129|10876130|FG001|STARTED|Overall Study||55
9771050|NCT00441129|10876129|FG000|COMPLETED|Overall Study||54
9771051|NCT00441129|10876130|FG001|COMPLETED|Overall Study||41
9771052|NCT00441129|10876129|FG000|NOT COMPLETED|Overall Study||6
9771053|NCT00441129|10876130|FG001|NOT COMPLETED|Overall Study||14
9771054|NCT00441142|10876140|FG000|STARTED|Overall Study||6
9771055|NCT00441142|10876141|FG001|STARTED|Overall Study||7
9771056|NCT00441142|10876142|FG002|STARTED|Overall Study||29
9771057|NCT00441142|10876143|FG003|STARTED|Overall Study||69
9771058|NCT00441142|10876140|FG000|COMPLETED|Overall Study||0
10014178|NCT01797965|11137226|FG003|COMPLETED|Overall Study||154
9771059|NCT00441142|10876141|FG001|COMPLETED|Overall Study||0
9771060|NCT00441142|10876142|FG002|COMPLETED|Overall Study||7
9771061|NCT00441142|10876143|FG003|COMPLETED|Overall Study||1
9771062|NCT00441142|10876140|FG000|NOT COMPLETED|Overall Study||6
9771063|NCT00441142|10876141|FG001|NOT COMPLETED|Overall Study||7
9771064|NCT00441142|10876142|FG002|NOT COMPLETED|Overall Study||22
9771065|NCT00441142|10876143|FG003|NOT COMPLETED|Overall Study||68
9771066|NCT00441168|10876157|FG000|STARTED|Treatment Period||17
9771067|NCT00441168|10876158|FG001|STARTED|Treatment Period||13
9771068|NCT00441168|10876157|FG000|TREATED|Treatment Period||16
9771069|NCT00441168|10876158|FG001|TREATED|Treatment Period||13
9771070|NCT00441168|10876157|FG000|COMPLETED|Treatment Period||6
9771071|NCT00441168|10876158|FG001|COMPLETED|Treatment Period||7
9771072|NCT00441168|10876157|FG000|NOT COMPLETED|Treatment Period||11
9771073|NCT00441168|10876158|FG001|NOT COMPLETED|Treatment Period||6
9771074|NCT00441168|10876157|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
9771075|NCT00441168|10876158|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
9771076|NCT00441168|10876157|FG000|COMPLETED|Follow-up Period||5
9771077|NCT00441168|10876158|FG001|COMPLETED|Follow-up Period||4
9771078|NCT00441168|10876157|FG000|NOT COMPLETED|Follow-up Period||12
9771079|NCT00441168|10876158|FG001|NOT COMPLETED|Follow-up Period||9
9771080|NCT00441259|10876166|FG000|STARTED|Overall Study||48
9771081|NCT00441259|10876167|FG001|STARTED|Overall Study||48
9771082|NCT00441259|10876166|FG000|COMPLETED|Overall Study||48
9771083|NCT00441259|10876167|FG001|COMPLETED|Overall Study||48
9771084|NCT00441259|10876166|FG000|NOT COMPLETED|Overall Study||0
9771085|NCT00441259|10876167|FG001|NOT COMPLETED|Overall Study||0
9771086|NCT00441285|10876178|FG000|STARTED|Overall Study||16
9771087|NCT00441285|10876179|FG001|STARTED|Overall Study||16
9771088|NCT00441285|10876180|FG002|STARTED|Overall Study||41
9771089|NCT00441285|10876181|FG003|STARTED|Overall Study||40
9771090|NCT00441285|10876182|FG004|STARTED|Overall Study||43
9771091|NCT00441285|10876178|FG000|COMPLETED|Overall Study||16
9771092|NCT00441285|10876179|FG001|COMPLETED|Overall Study||16
9771093|NCT00441285|10876180|FG002|COMPLETED|Overall Study||41
9771094|NCT00441285|10876181|FG003|COMPLETED|Overall Study||40
9771095|NCT00441285|10876182|FG004|COMPLETED|Overall Study||43
9771096|NCT00441285|10876178|FG000|NOT COMPLETED|Overall Study||0
9771097|NCT00441285|10876179|FG001|NOT COMPLETED|Overall Study||0
9771098|NCT00441285|10876180|FG002|NOT COMPLETED|Overall Study||0
9771099|NCT00441285|10876181|FG003|NOT COMPLETED|Overall Study||0
9771100|NCT00441285|10876182|FG004|NOT COMPLETED|Overall Study||0
9771101|NCT00441337|10876198|FG000|STARTED|Overall Study||6
9771102|NCT00441337|10876199|FG001|STARTED|Overall Study||6
9771103|NCT00441337|10876200|FG002|STARTED|Overall Study||6
9771104|NCT00441337|10876201|FG003|STARTED|Overall Study||21
9771105|NCT00441337|10876198|FG000|COMPLETED|Overall Study||0
9771106|NCT00441337|10876199|FG001|COMPLETED|Overall Study||0
9771107|NCT00441337|10876200|FG002|COMPLETED|Overall Study||0
9771108|NCT00441337|10876201|FG003|COMPLETED|Overall Study||0
9771109|NCT00441337|10876198|FG000|NOT COMPLETED|Overall Study||6
9771110|NCT00441337|10876199|FG001|NOT COMPLETED|Overall Study||6
9771111|NCT00441337|10876200|FG002|NOT COMPLETED|Overall Study||6
9771112|NCT00441337|10876201|FG003|NOT COMPLETED|Overall Study||21
9771113|NCT00441350|10876221|FG000|STARTED|Phase A: Randomization to Week 8||285
9771114|NCT00441350|10876222|FG001|STARTED|Phase A: Randomization to Week 8||561
9771115|NCT00441350|10876223|FG002|STARTED|Phase A: Randomization to Week 8||0
9771116|NCT00441350|10876224|FG003|STARTED|Phase A: Randomization to Week 8||0
9771117|NCT00441350|10876225|FG004|STARTED|Phase A: Randomization to Week 8||0
9771118|NCT00441350|10876226|FG005|STARTED|Phase A: Randomization to Week 8||0
9771119|NCT00441350|10876221|FG000|COMPLETED|Phase A: Randomization to Week 8||268
9771120|NCT00441350|10876222|FG001|COMPLETED|Phase A: Randomization to Week 8||524
9771121|NCT00441350|10876223|FG002|COMPLETED|Phase A: Randomization to Week 8||0
9771122|NCT00441350|10876224|FG003|COMPLETED|Phase A: Randomization to Week 8||0
9771123|NCT00441350|10876225|FG004|COMPLETED|Phase A: Randomization to Week 8||0
9771124|NCT00441350|10876226|FG005|COMPLETED|Phase A: Randomization to Week 8||0
9771125|NCT00441350|10876221|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17
9771126|NCT00441350|10876222|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37
9771127|NCT00441350|10876223|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0
9771128|NCT00441350|10876224|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0
9771129|NCT00441350|10876225|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0
9771130|NCT00441350|10876226|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0
9771131|NCT00441350|10876221|FG000|STARTED|Phase B: Week 8 to Week 16||0
9771132|NCT00441350|10876222|FG001|STARTED|Phase B: Week 8 to Week 16||0
9771133|NCT00441350|10876223|FG002|STARTED|Phase B: Week 8 to Week 16||129
9771134|NCT00441350|10876224|FG003|STARTED|Phase B: Week 8 to Week 16||139
9771135|NCT00441350|10876225|FG004|STARTED|Phase B: Week 8 to Week 16||336
9771136|NCT00441350|10876226|FG005|STARTED|Phase B: Week 8 to Week 16||188
9771137|NCT00441350|10876221|FG000|COMPLETED|Phase B: Week 8 to Week 16||0
9771138|NCT00441350|10876222|FG001|COMPLETED|Phase B: Week 8 to Week 16||0
9771139|NCT00441350|10876223|FG002|COMPLETED|Phase B: Week 8 to Week 16||128
9771140|NCT00441350|10876224|FG003|COMPLETED|Phase B: Week 8 to Week 16||137
9771141|NCT00441350|10876225|FG004|COMPLETED|Phase B: Week 8 to Week 16||333
9771142|NCT00441350|10876226|FG005|COMPLETED|Phase B: Week 8 to Week 16||186
9771143|NCT00441350|10876221|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0
9771144|NCT00441350|10876222|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0
9771145|NCT00441350|10876223|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1
9771146|NCT00441350|10876224|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2
9771147|NCT00441350|10876225|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3
9771148|NCT00441350|10876226|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2
9771149|NCT00441363|10876242|FG000|STARTED|Overall Study||32
9771150|NCT00441363|10876243|FG001|STARTED|Overall Study||34
9771151|NCT00441363|10876242|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
9771152|NCT00441363|10876243|FG001|COMPLETED|Overall Study||19
9771153|NCT00441363|10876242|FG000|NOT COMPLETED|Overall Study||17
9771154|NCT00441363|10876243|FG001|NOT COMPLETED|Overall Study||15
9771155|NCT00441441|10876251|FG000|STARTED|Overall Study||173
9771156|NCT00441441|10876252|FG001|STARTED|Overall Study||177
9771157|NCT00441441|10876251|FG000|COMPLETED|Overall Study||162
9771158|NCT00441441|10876252|FG001|COMPLETED|Overall Study||163
9771159|NCT00441441|10876251|FG000|NOT COMPLETED|Overall Study||11
9771160|NCT00441441|10876252|FG001|NOT COMPLETED|Overall Study||14
9771161|NCT00441467|10876272|FG000|STARTED|Overall Study||22
9771162|NCT00441467|10876272|FG000|2 Cycles|Overall Study||17
9771163|NCT00441467|10876272|FG000|4 Cycles|Overall Study||7
9771164|NCT00441467|10876272|FG000|COMPLETED|Overall Study||4
9771165|NCT00441467|10876272|FG000|NOT COMPLETED|Overall Study||18
9771166|NCT00441480|10876278|FG000|STARTED|Overall Study||46
9771167|NCT00441480|10876279|FG001|STARTED|Overall Study||45
9771168|NCT00441480|10876278|FG000|COMPLETED|Overall Study||43
9771169|NCT00441480|10876279|FG001|COMPLETED|Overall Study||41
9771170|NCT00441480|10876278|FG000|NOT COMPLETED|Overall Study||3
9771171|NCT00441480|10876279|FG001|NOT COMPLETED|Overall Study||4
9771172|NCT00441545|10876285|FG000|STARTED|First Intervention||95
9771173|NCT00441545|10876286|FG001|STARTED|First Intervention||87
9771174|NCT00441545|10876285|FG000|COMPLETED|First Intervention||77
9771175|NCT00441545|10876286|FG001|COMPLETED|First Intervention||75
9771176|NCT00441545|10876285|FG000|NOT COMPLETED|First Intervention||18
9771177|NCT00441545|10876286|FG001|NOT COMPLETED|First Intervention||12
9771178|NCT00441545|10876285|FG000|STARTED|Washout||77
9771179|NCT00441545|10876286|FG001|STARTED|Washout||75
9771180|NCT00441545|10876285|FG000|COMPLETED|Washout||77
9771181|NCT00441545|10876286|FG001|COMPLETED|Washout||75
9771182|NCT00441545|10876285|FG000|NOT COMPLETED|Washout||0
9771183|NCT00441545|10876286|FG001|NOT COMPLETED|Washout||0
9771184|NCT00441545|10876285|FG000|STARTED|Second Intervention||77
9771185|NCT00441545|10876286|FG001|STARTED|Second Intervention||75
9771186|NCT00441545|10876285|FG000|COMPLETED|Second Intervention||65
9771187|NCT00441545|10876286|FG001|COMPLETED|Second Intervention||68
9771188|NCT00441545|10876285|FG000|NOT COMPLETED|Second Intervention||12
9771189|NCT00441545|10876286|FG001|NOT COMPLETED|Second Intervention||7
9771190|NCT00441558|10876292|FG000|STARTED|Overall Study||1723
9771191|NCT00441558|10876292|FG000|COMPLETED|Overall Study||667
9771192|NCT00441558|10876292|FG000|NOT COMPLETED|Overall Study||1056
9771193|NCT00441584|10876296|FG000|STARTED|Overall Study||117
9771194|NCT00441584|10876296|FG000|COMPLETED|Overall Study||12
9771195|NCT00441584|10876296|FG000|NOT COMPLETED|Overall Study||105
9771196|NCT00441701|10876310|FG000|STARTED|Overall Study||22
9771197|NCT00441701|10876311|FG001|STARTED|Overall Study||11
9771198|NCT00441701|10876312|FG002|STARTED|Overall Study||22
9771199|NCT00441701|10876313|FG003|STARTED|Overall Study||11
9771200|NCT00441701|10876314|FG004|STARTED|Overall Study||22
9771201|NCT00441701|10876315|FG005|STARTED|Overall Study||11
10014179|NCT01797965|11137223|FG000|NOT COMPLETED|Overall Study||549
10014180|NCT01797965|11137224|FG001|NOT COMPLETED|Overall Study||569
9771202|NCT00441701|10876316|FG006|STARTED|Overall Study||0
9771203|NCT00441701|10876317|FG007|STARTED|Overall Study||0
9771204|NCT00441701|10876318|FG008|STARTED|Overall Study||0
9771205|NCT00441701|10876319|FG009|STARTED|Overall Study||0
9771206|NCT00441701|10876310|FG000|COMPLETED|Overall Study||17
9771207|NCT00441701|10876311|FG001|COMPLETED|Overall Study||7
9771208|NCT00441701|10876312|FG002|COMPLETED|Overall Study||18
9771209|NCT00441701|10876313|FG003|COMPLETED|Overall Study||8
9771210|NCT00441701|10876314|FG004|COMPLETED|Overall Study||20
9771211|NCT00441701|10876315|FG005|COMPLETED|Overall Study||8
9771212|NCT00441701|10876316|FG006|COMPLETED|Overall Study||0
9771213|NCT00441701|10876317|FG007|COMPLETED|Overall Study||0
9771214|NCT00441701|10876318|FG008|COMPLETED|Overall Study||0
9771215|NCT00441701|10876319|FG009|COMPLETED|Overall Study||0
9771216|NCT00441701|10876310|FG000|NOT COMPLETED|Overall Study||5
9771217|NCT00441701|10876311|FG001|NOT COMPLETED|Overall Study||4
9771218|NCT00441701|10876312|FG002|NOT COMPLETED|Overall Study||4
9771219|NCT00441701|10876313|FG003|NOT COMPLETED|Overall Study||3
9771220|NCT00441701|10876314|FG004|NOT COMPLETED|Overall Study||2
9771221|NCT00441701|10876315|FG005|NOT COMPLETED|Overall Study||3
9771222|NCT00441701|10876316|FG006|NOT COMPLETED|Overall Study||0
9771223|NCT00441701|10876317|FG007|NOT COMPLETED|Overall Study||0
9771224|NCT00441701|10876318|FG008|NOT COMPLETED|Overall Study||0
9771225|NCT00441701|10876319|FG009|NOT COMPLETED|Overall Study||0
9771226|NCT00441727|10876340|FG000|STARTED|Overall Study|ITT/randomised|817
10014181|NCT01797965|11137225|FG002|NOT COMPLETED|Overall Study||8
10014182|NCT01797965|11137226|FG003|NOT COMPLETED|Overall Study||73
10014183|NCT01798056|11137239|FG000|STARTED|Overall Study||117
10014184|NCT01798056|11137240|FG001|STARTED|Overall Study||115
9771227|NCT00441727|10876341|FG001|STARTED|Overall Study|ITT/randomised|804
9771228|NCT00441727|10876342|FG002|STARTED|Overall Study|ITT/randomised|805
9771229|NCT00441727|10876340|FG000|COMPLETED|Overall Study|ITT/randomised|711
9771230|NCT00441727|10876341|FG001|COMPLETED|Overall Study|ITT/randomised|686
9771231|NCT00441727|10876342|FG002|COMPLETED|Overall Study|ITT/randomised|637
9771232|NCT00441727|10876340|FG000|NOT COMPLETED|Overall Study||106
9771233|NCT00441727|10876341|FG001|NOT COMPLETED|Overall Study||118
9771234|NCT00441727|10876342|FG002|NOT COMPLETED|Overall Study||168
9771235|NCT00441766|10876359|FG000|STARTED|Overall Study||53
9771236|NCT00441766|10876360|FG001|STARTED|Overall Study||53
9771237|NCT00441766|10876361|FG002|STARTED|Overall Study||53
9771238|NCT00441766|10876362|FG003|STARTED|Overall Study||54
9771239|NCT00441766|10876359|FG000|COMPLETED|Overall Study||39
9771240|NCT00441766|10876360|FG001|COMPLETED|Overall Study||46
9771241|NCT00441766|10876361|FG002|COMPLETED|Overall Study||44
9771242|NCT00441766|10876362|FG003|COMPLETED|Overall Study||48
9771243|NCT00441766|10876359|FG000|NOT COMPLETED|Overall Study||14
9771244|NCT00441766|10876360|FG001|NOT COMPLETED|Overall Study||7
9771245|NCT00441766|10876361|FG002|NOT COMPLETED|Overall Study||9
9771246|NCT00441766|10876362|FG003|NOT COMPLETED|Overall Study||6
9771247|NCT00441792|10876374|FG000|STARTED|Overall Study||59
9771248|NCT00441792|10876375|FG001|STARTED|Overall Study||63
9771249|NCT00441792|10876374|FG000|COMPLETED|Overall Study||59
9771250|NCT00441792|10876375|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
9771251|NCT00441792|10876374|FG000|NOT COMPLETED|Overall Study||0
9771252|NCT00441792|10876375|FG001|NOT COMPLETED|Overall Study||2
9771253|NCT00441883|10876386|FG000|STARTED|Overall Study||43
9771254|NCT00441883|10876387|FG001|STARTED|Overall Study||32
9771255|NCT00441883|10876388|FG002|STARTED|Overall Study||28
9771256|NCT00441883|10876389|FG003|STARTED|Overall Study||28
9771257|NCT00441883|10876390|FG004|STARTED|Overall Study||45
9771258|NCT00441883|10876386|FG000|ITT Population|Overall Study||43
9771259|NCT00441883|10876387|FG001|ITT Population|Overall Study||30
9771260|NCT00441883|10876388|FG002|ITT Population|Overall Study||30
9771261|NCT00441883|10876389|FG003|ITT Population|Overall Study||30
9771262|NCT00441883|10876390|FG004|ITT Population|Overall Study||43
9771263|NCT00441883|10876386|FG000|Per Protocol Population|Overall Study||38
9771264|NCT00441883|10876387|FG001|Per Protocol Population|Overall Study||29
9771265|NCT00441883|10876388|FG002|Per Protocol Population|Overall Study||25
9771266|NCT00441883|10876389|FG003|Per Protocol Population|Overall Study||24
9771267|NCT00441883|10876390|FG004|Per Protocol Population|Overall Study||38
9771268|NCT00441883|10876386|FG000|Safety Population|Overall Study||43
9771269|NCT00441883|10876387|FG001|Safety Population|Overall Study||32
9771270|NCT00441883|10876388|FG002|Safety Population|Overall Study||28
9771271|NCT00441883|10876389|FG003|Safety Population|Overall Study||28
9771272|NCT00441883|10876390|FG004|Safety Population|Overall Study||45
9771273|NCT00441883|10876386|FG000|COMPLETED|Overall Study||42
9771274|NCT00441883|10876387|FG001|COMPLETED|Overall Study||32
9771275|NCT00441883|10876388|FG002|COMPLETED|Overall Study||28
9771276|NCT00441883|10876389|FG003|COMPLETED|Overall Study||28
9771277|NCT00441883|10876390|FG004|COMPLETED|Overall Study||43
9771278|NCT00441883|10876386|FG000|NOT COMPLETED|Overall Study||1
9771279|NCT00441883|10876387|FG001|NOT COMPLETED|Overall Study||0
9771280|NCT00441883|10876388|FG002|NOT COMPLETED|Overall Study||0
9771281|NCT00441883|10876389|FG003|NOT COMPLETED|Overall Study||0
9771282|NCT00441883|10876390|FG004|NOT COMPLETED|Overall Study||2
9771283|NCT00441974|10876402|FG000|STARTED|Overall Study||1470
9771284|NCT00441974|10876402|FG000|COMPLETED|Overall Study||1342
9771285|NCT00441974|10876402|FG000|NOT COMPLETED|Overall Study||128
9771286|NCT00442013|10876411|FG000|STARTED|Overall Study||157
9771287|NCT00442013|10876412|FG001|STARTED|Overall Study||149
9771288|NCT00442013|10876411|FG000|COMPLETED|Overall Study||131
9771289|NCT00442013|10876412|FG001|COMPLETED|Overall Study||132
9771290|NCT00442013|10876411|FG000|NOT COMPLETED|Overall Study||26
9771291|NCT00442013|10876412|FG001|NOT COMPLETED|Overall Study||17
9771292|NCT00442169|10876425|FG000|STARTED|Part 1||17
9771293|NCT00442169|10876426|FG001|STARTED|Part 1||24
9771294|NCT00442169|10876427|FG002|STARTED|Part 1||40
9771295|NCT00442169|10876428|FG003|STARTED|Part 1||31
9771296|NCT00442169|10876429|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
9771297|NCT00442169|10876430|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
9771298|NCT00442169|10876425|FG000|COMPLETED|Part 1||17
9771299|NCT00442169|10876426|FG001|COMPLETED|Part 1||24
9771300|NCT00442169|10876427|FG002|COMPLETED|Part 1||40
9771301|NCT00442169|10876428|FG003|COMPLETED|Part 1||31
9771302|NCT00442169|10876429|FG004|COMPLETED|Part 1||0
9771303|NCT00442169|10876430|FG005|COMPLETED|Part 1||0
9771304|NCT00442169|10876425|FG000|NOT COMPLETED|Part 1||0
9771305|NCT00442169|10876426|FG001|NOT COMPLETED|Part 1||0
9771306|NCT00442169|10876427|FG002|NOT COMPLETED|Part 1||0
9771307|NCT00442169|10876428|FG003|NOT COMPLETED|Part 1||0
9771308|NCT00442169|10876429|FG004|NOT COMPLETED|Part 1||0
9771309|NCT00442169|10876430|FG005|NOT COMPLETED|Part 1||0
9771310|NCT00442169|10876425|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
9771311|NCT00442169|10876426|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
9771312|NCT00442169|10876427|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
9771313|NCT00442169|10876428|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
9771314|NCT00442169|10876429|FG004|STARTED|Part 2||25
9771315|NCT00442169|10876430|FG005|STARTED|Part 2||57
9771316|NCT00442169|10876425|FG000|COMPLETED|Part 2||0
9771317|NCT00442169|10876426|FG001|COMPLETED|Part 2||0
9771318|NCT00442169|10876427|FG002|COMPLETED|Part 2||0
9771319|NCT00442169|10876428|FG003|COMPLETED|Part 2||0
9771320|NCT00442169|10876429|FG004|COMPLETED|Part 2||25
9771321|NCT00442169|10876430|FG005|COMPLETED|Part 2||57
9771322|NCT00442169|10876425|FG000|NOT COMPLETED|Part 2||0
9771323|NCT00442169|10876426|FG001|NOT COMPLETED|Part 2||0
9771324|NCT00442169|10876427|FG002|NOT COMPLETED|Part 2||0
9771325|NCT00442169|10876428|FG003|NOT COMPLETED|Part 2||0
9771326|NCT00442169|10876429|FG004|NOT COMPLETED|Part 2||0
9771327|NCT00442169|10876430|FG005|NOT COMPLETED|Part 2||0
9771328|NCT00442286|10876447|FG000|STARTED|Overall Study||181
9771329|NCT00442286|10876448|FG001|STARTED|Overall Study||84
9771330|NCT00442286|10876447|FG000|6 Months|Overall Study||177
9771331|NCT00442286|10876448|FG001|6 Months|Overall Study||83
9771332|NCT00442286|10876447|FG000|12 Months|Overall Study||174
9771333|NCT00442286|10876448|FG001|12 Months|Overall Study||82
9771334|NCT00442286|10876447|FG000|COMPLETED|Overall Study||174
9771335|NCT00442286|10876448|FG001|COMPLETED|Overall Study||82
9771336|NCT00442286|10876447|FG000|NOT COMPLETED|Overall Study||7
9771337|NCT00442286|10876448|FG001|NOT COMPLETED|Overall Study||2
9771338|NCT00442364|10876456|FG000|STARTED|Overall Study||60
9771339|NCT00442364|10876456|FG000|COMPLETED|Overall Study||60
9771340|NCT00442364|10876456|FG000|NOT COMPLETED|Overall Study||0
9771341|NCT00442416|10876462|FG000|STARTED|Overall Study||39
9771342|NCT00442416|10876463|FG001|STARTED|Overall Study||41
9771343|NCT00442416|10876462|FG000|COMPLETED|Overall Study||2
9771344|NCT00442416|10876463|FG001|COMPLETED|Overall Study||2
9771345|NCT00442416|10876462|FG000|NOT COMPLETED|Overall Study||37
9771346|NCT00442416|10876463|FG001|NOT COMPLETED|Overall Study||39
9771347|NCT00442468|10876469|FG000|STARTED|Overall Study||1283
9771348|NCT00442468|10876469|FG000|COMPLETED|Overall Study||1100
9771349|NCT00442468|10876469|FG000|NOT COMPLETED|Overall Study||183
9771350|NCT00442507|10876473|FG000|STARTED|Overall Study||6
9771351|NCT00442507|10876473|FG000|COMPLETED|Overall Study||6
9771352|NCT00442507|10876473|FG000|NOT COMPLETED|Overall Study||0
9771353|NCT00442572|10876479|FG000|STARTED|Overall Study||17
9771354|NCT00442572|10876480|FG001|STARTED|Overall Study||4
9771355|NCT00442572|10876479|FG000|COMPLETED|Overall Study||9
9771356|NCT00442572|10876480|FG001|COMPLETED|Overall Study||1
9771357|NCT00442572|10876479|FG000|NOT COMPLETED|Overall Study||8
9771358|NCT00442572|10876480|FG001|NOT COMPLETED|Overall Study||3
9771359|NCT00442598|10876490|FG000|STARTED|Overall Study||7
9771360|NCT00442598|10876491|FG001|STARTED|Overall Study||10
9771361|NCT00442598|10876492|FG002|STARTED|Overall Study||0
9771362|NCT00442598|10876490|FG000|Two Cycles|Overall Study||5
9771363|NCT00442598|10876491|FG001|Two Cycles|Overall Study||6
9771364|NCT00442598|10876492|FG002|Two Cycles|Overall Study||0
9771365|NCT00442598|10876490|FG000|COMPLETED|Overall Study||1
9771366|NCT00442598|10876491|FG001|COMPLETED|Overall Study||2
9771367|NCT00442598|10876492|FG002|COMPLETED|Overall Study||0
9771368|NCT00442598|10876490|FG000|NOT COMPLETED|Overall Study||6
9771369|NCT00442598|10876491|FG001|NOT COMPLETED|Overall Study||8
9771370|NCT00442598|10876492|FG002|NOT COMPLETED|Overall Study||0
9771371|NCT00442611|10876501|FG000|STARTED|Overall Study||7
9771372|NCT00442611|10876502|FG001|STARTED|Overall Study||3
9771373|NCT00442611|10876501|FG000|COMPLETED|Overall Study||6
9771374|NCT00442611|10876502|FG001|COMPLETED|Overall Study||3
9771375|NCT00442611|10876501|FG000|NOT COMPLETED|Overall Study||1
9771376|NCT00442611|10876502|FG001|NOT COMPLETED|Overall Study||0
9771377|NCT00442689|10876511|FG000|STARTED|Overall Study||21
9771378|NCT00442689|10876512|FG001|STARTED|Overall Study||24
9771379|NCT00442689|10876513|FG002|STARTED|Overall Study||22
9771380|NCT00442689|10876511|FG000|COMPLETED|Overall Study||11
9771381|NCT00442689|10876512|FG001|COMPLETED|Overall Study||13
9771382|NCT00442689|10876513|FG002|COMPLETED|Overall Study||13
9771383|NCT00442689|10876511|FG000|NOT COMPLETED|Overall Study||10
9771384|NCT00442689|10876512|FG001|NOT COMPLETED|Overall Study||11
9771385|NCT00442689|10876513|FG002|NOT COMPLETED|Overall Study||9
9829811|NCT00761462|10940511|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
9829812|NCT00761462|10940510|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
9829813|NCT00761462|10940511|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
10014185|NCT01798056|11137239|FG000|COMPLETED|Overall Study||90
10014186|NCT01798056|11137240|FG001|COMPLETED|Overall Study||90
10014187|NCT01798056|11137239|FG000|NOT COMPLETED|Overall Study||27
9829814|NCT00761462|10940510|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
9829815|NCT00761462|10940511|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
9829816|NCT00761462|10940510|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
9829817|NCT00761462|10940511|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
10014188|NCT01798056|11137240|FG001|NOT COMPLETED|Overall Study||25
10014189|NCT01798134|11137248|FG000|STARTED|Overall Study||25
10014190|NCT01798134|11137248|FG000|COMPLETED|Overall Study||9
10014191|NCT01798134|11137248|FG000|NOT COMPLETED|Overall Study||16
10014192|NCT01798186|11137256|FG000|STARTED|Overall Study||6
9829818|NCT00761462|10940510|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
9829819|NCT00761462|10940511|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
9829820|NCT00761514|10940517|FG000|STARTED|Overall Study||14
9829821|NCT00761514|10940517|FG000|COMPLETED|Overall Study||7
9829822|NCT00761514|10940517|FG000|NOT COMPLETED|Overall Study||7
9829823|NCT00761579|10940521|FG000|STARTED|Overall Study||190
9829824|NCT00761579|10940521|FG000|COMPLETED|Overall Study||98
10014193|NCT01798186|11137257|FG001|STARTED|Overall Study||6
10014194|NCT01798186|11137258|FG002|STARTED|Overall Study||6
10014195|NCT01798186|11137259|FG003|STARTED|Overall Study||8
10014196|NCT01798186|11137256|FG000|COMPLETED|Overall Study||6
9829825|NCT00761579|10940521|FG000|NOT COMPLETED|Overall Study||92
9829826|NCT00761592|10940529|FG000|STARTED|Overall Study||32
9829827|NCT00761592|10940530|FG001|STARTED|Overall Study||33
9829828|NCT00761592|10940529|FG000|COMPLETED|Overall Study||31
10014197|NCT01798186|11137257|FG001|COMPLETED|Overall Study||6
10014198|NCT01798186|11137258|FG002|COMPLETED|Overall Study||6
10014199|NCT01798186|11137259|FG003|COMPLETED|Overall Study||8
10014200|NCT01798186|11137256|FG000|NOT COMPLETED|Overall Study||0
10014201|NCT01798186|11137257|FG001|NOT COMPLETED|Overall Study||0
10014202|NCT01798186|11137258|FG002|NOT COMPLETED|Overall Study||0
10014203|NCT01798186|11137259|FG003|NOT COMPLETED|Overall Study||0
10014204|NCT01798225|11137274|FG000|STARTED|Overall Study||57
10014205|NCT01798225|11137275|FG001|STARTED|Overall Study||56
10014206|NCT01798225|11137274|FG000|COMPLETED|Overall Study||57
10014207|NCT01798225|11137275|FG001|COMPLETED|Overall Study||53
10014208|NCT01798225|11137274|FG000|NOT COMPLETED|Overall Study||0
9771386|NCT00442702|10876523|FG000|STARTED|Titration Period||114
9771387|NCT00442702|10876524|FG001|STARTED|Titration Period||114
9771388|NCT00442702|10876523|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
9771389|NCT00442702|10876524|FG001|Safety Population|Titration Period||113
9771390|NCT00442702|10876523|FG000|COMPLETED|Titration Period||102
9771391|NCT00442702|10876524|FG001|COMPLETED|Titration Period||111
9771392|NCT00442702|10876523|FG000|NOT COMPLETED|Titration Period||12
9771393|NCT00442702|10876524|FG001|NOT COMPLETED|Titration Period||3
9771394|NCT00442702|10876523|FG000|STARTED|Evaluation Period||102
9771395|NCT00442702|10876524|FG001|STARTED|Evaluation Period||111
9771396|NCT00442702|10876523|FG000|COMPLETED|Evaluation Period||97
9771397|NCT00442702|10876524|FG001|COMPLETED|Evaluation Period||107
9771398|NCT00442702|10876523|FG000|NOT COMPLETED|Evaluation Period||5
9771399|NCT00442702|10876524|FG001|NOT COMPLETED|Evaluation Period||4
9771400|NCT00442767|10876530|FG000|STARTED|Overall Study||8
9771401|NCT00442767|10876530|FG000|COMPLETED|Overall Study||8
9771402|NCT00442767|10876530|FG000|NOT COMPLETED|Overall Study||0
9771403|NCT00442936|10876540|FG000|STARTED|Overall Study||333
9771404|NCT00442936|10876541|FG001|STARTED|Overall Study||354
9771405|NCT00442936|10876542|FG002|STARTED|Overall Study||345
9771406|NCT00442936|10876543|FG003|STARTED|Overall Study||348
9771407|NCT00442936|10876540|FG000|COMPLETED|Overall Study||332
9771408|NCT00442936|10876541|FG001|COMPLETED|Overall Study||354
9771409|NCT00442936|10876542|FG002|COMPLETED|Overall Study||344
9771410|NCT00442936|10876543|FG003|COMPLETED|Overall Study||347
9771411|NCT00442936|10876540|FG000|NOT COMPLETED|Overall Study||1
9771412|NCT00442936|10876541|FG001|NOT COMPLETED|Overall Study||0
9771413|NCT00442936|10876542|FG002|NOT COMPLETED|Overall Study||1
9771414|NCT00442936|10876543|FG003|NOT COMPLETED|Overall Study||1
9771415|NCT00442962|10876553|FG000|STARTED|Overall Study||54
9771416|NCT00442962|10876553|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
9771417|NCT00442962|10876553|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
9771418|NCT00442962|10876553|FG000|NOT COMPLETED|Overall Study||8
9771419|NCT00443053|10876559|FG000|STARTED|Overall Study||1502
9771420|NCT00443053|10876560|FG001|STARTED|Overall Study||1500
9771421|NCT00443053|10876559|FG000|COMPLETED|Overall Study||1481
9771422|NCT00443053|10876560|FG001|COMPLETED|Overall Study||1467
9771423|NCT00443053|10876559|FG000|NOT COMPLETED|Overall Study||21
9771424|NCT00443053|10876560|FG001|NOT COMPLETED|Overall Study||33
9771425|NCT00443079|10876568|FG000|STARTED|Overall Study||3
9771426|NCT00443079|10876569|FG001|STARTED|Overall Study||3
9771427|NCT00443079|10876568|FG000|COMPLETED|Overall Study||3
9771428|NCT00443079|10876569|FG001|COMPLETED|Overall Study||2
9771429|NCT00443079|10876568|FG000|NOT COMPLETED|Overall Study||0
9771430|NCT00443079|10876569|FG001|NOT COMPLETED|Overall Study||1
9771431|NCT00443118|10876580|FG000|STARTED|Overall Study||515
9771432|NCT00443118|10876581|FG001|STARTED|Overall Study||291
9771433|NCT00443118|10876582|FG002|STARTED|Overall Study||226
9771434|NCT00443118|10876580|FG000|COMPLETED|Overall Study||511
9771435|NCT00443118|10876581|FG001|COMPLETED|Overall Study||290
9771436|NCT00443118|10876582|FG002|COMPLETED|Overall Study||226
9771437|NCT00443118|10876580|FG000|NOT COMPLETED|Overall Study||4
9771438|NCT00443118|10876581|FG001|NOT COMPLETED|Overall Study||1
9771439|NCT00443118|10876582|FG002|NOT COMPLETED|Overall Study||0
9771440|NCT00443209|10876610|FG000|STARTED|Months 1 to 12 Treatment Period||712
9771441|NCT00443209|10876611|FG001|STARTED|Months 1 to 12 Treatment Period||356
9771442|NCT00443209|10876610|FG000|Treated|Months 1 to 12 Treatment Period||641
9771443|NCT00443209|10876611|FG001|Treated|Months 1 to 12 Treatment Period||313
9771444|NCT00443209|10876610|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
9771445|NCT00443209|10876611|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
9771446|NCT00443209|10876610|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345
9771447|NCT00443209|10876611|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154
9771448|NCT00443209|10876610|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
9771449|NCT00443209|10876611|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
9829829|NCT00761592|10940530|FG001|COMPLETED|Overall Study||32
10014209|NCT01798225|11137275|FG001|NOT COMPLETED|Overall Study||3
10014210|NCT01798264|11137285|FG000|STARTED|Overall Study||12
10014211|NCT01798264|11137286|FG001|STARTED|Overall Study||11
10014212|NCT01798264|11137287|FG002|STARTED|Overall Study||10
10014213|NCT01798264|11137288|FG003|STARTED|Overall Study||11
10014214|NCT01798264|11137285|FG000|COMPLETED|Overall Study||11
10014215|NCT01798264|11137286|FG001|COMPLETED|Overall Study||11
9771450|NCT00443209|10876610|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
9771451|NCT00443209|10876611|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
9771452|NCT00443209|10876610|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99
9771453|NCT00443209|10876611|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47
9771454|NCT00443261|10876617|FG000|STARTED|Overall Study||1
9771455|NCT00443261|10876617|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
9771456|NCT00443261|10876617|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
9771457|NCT00443261|10876617|FG000|NOT COMPLETED|Overall Study||1
9771458|NCT00443352|10876621|FG000|STARTED|Overall Study||27
9771459|NCT00443352|10876621|FG000|COMPLETED|Overall Study||22
9771460|NCT00443352|10876621|FG000|NOT COMPLETED|Overall Study||5
9771461|NCT00443430|10876627|FG000|STARTED|Overall Study||43
9771462|NCT00443430|10876628|FG001|STARTED|Overall Study||42
9771463|NCT00443430|10876627|FG000|COMPLETED|Overall Study||39
9771464|NCT00443430|10876628|FG001|COMPLETED|Overall Study||38
9771465|NCT00443430|10876627|FG000|NOT COMPLETED|Overall Study||4
9771466|NCT00443430|10876628|FG001|NOT COMPLETED|Overall Study||4
9771467|NCT00443456|10876634|FG000|STARTED|Overall Study||134
9771468|NCT00443456|10876634|FG000|COMPLETED|Overall Study||116
9771469|NCT00443456|10876634|FG000|NOT COMPLETED|Overall Study||18
9771470|NCT00443534|10876642|FG000|STARTED|Overall Study||123
10014216|NCT01798264|11137287|FG002|COMPLETED|Overall Study||10
10014217|NCT01798264|11137288|FG003|COMPLETED|Overall Study||7
10014218|NCT01798264|11137285|FG000|NOT COMPLETED|Overall Study||1
9771471|NCT00443534|10876642|FG000|Treated|Overall Study||122
9771472|NCT00443534|10876642|FG000|COMPLETED|Overall Study||0
9771473|NCT00443534|10876642|FG000|NOT COMPLETED|Overall Study||123
9771474|NCT00443547|10876650|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
9771475|NCT00443547|10876651|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
9771476|NCT00443547|10876652|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
9771477|NCT00443547|10876653|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
9771478|NCT00443547|10876650|FG000|Evaluated at 12 Months|Overall Study||58
9771479|NCT00443547|10876651|FG001|Evaluated at 12 Months|Overall Study||55
9771480|NCT00443547|10876652|FG002|Evaluated at 12 Months|Overall Study||37
9771481|NCT00443547|10876653|FG003|Evaluated at 12 Months|Overall Study||5
9771482|NCT00443547|10876650|FG000|COMPLETED|Overall Study||44
9771483|NCT00443547|10876651|FG001|COMPLETED|Overall Study||46
9771484|NCT00443547|10876652|FG002|COMPLETED|Overall Study||27
9771485|NCT00443547|10876653|FG003|COMPLETED|Overall Study||4
9771486|NCT00443547|10876650|FG000|NOT COMPLETED|Overall Study||45
9771487|NCT00443547|10876651|FG001|NOT COMPLETED|Overall Study||42
9771488|NCT00443547|10876652|FG002|NOT COMPLETED|Overall Study||21
9771489|NCT00443547|10876653|FG003|NOT COMPLETED|Overall Study||2
9771490|NCT00443560|10876665|FG000|STARTED|Overall Study||1081
9771491|NCT00443560|10876666|FG001|STARTED|Overall Study||1081
9771492|NCT00443560|10876665|FG000|COMPLETED|Overall Study||1021
9771493|NCT00443560|10876666|FG001|COMPLETED|Overall Study||1051
9771494|NCT00443560|10876665|FG000|NOT COMPLETED|Overall Study||60
9771495|NCT00443560|10876666|FG001|NOT COMPLETED|Overall Study||30
9771496|NCT00443599|10876674|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
9771497|NCT00443599|10876675|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493
9771498|NCT00443599|10876674|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490
9771499|NCT00443599|10876675|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490
9771500|NCT00443599|10876674|FG000|NOT COMPLETED|Overall Study||6
9771501|NCT00443599|10876675|FG001|NOT COMPLETED|Overall Study||3
9771502|NCT00443651|10876683|FG000|STARTED|Overall Study||401
9771503|NCT00443651|10876684|FG001|STARTED|Overall Study||176
9771504|NCT00443651|10876683|FG000|Week 24|Overall Study||376
9771505|NCT00443651|10876684|FG001|Week 24|Overall Study||160
9771506|NCT00443651|10876683|FG000|Week 48|Overall Study||338
9771507|NCT00443651|10876684|FG001|Week 48|Overall Study||134
9771508|NCT00443651|10876683|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
9771509|NCT00443651|10876684|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
9771510|NCT00443651|10876683|FG000|NOT COMPLETED|Overall Study||95
9771511|NCT00443651|10876684|FG001|NOT COMPLETED|Overall Study||58
9771512|NCT00443703|10876692|FG000|STARTED|Overall Study||177
9771513|NCT00443703|10876693|FG001|STARTED|Overall Study||175
9771514|NCT00443703|10876692|FG000|Treated|Overall Study||174
9771515|NCT00443703|10876693|FG001|Treated|Overall Study||174
9771516|NCT00443703|10876692|FG000|COMPLETED|Overall Study||149
9771517|NCT00443703|10876693|FG001|COMPLETED|Overall Study||157
9771518|NCT00443703|10876692|FG000|NOT COMPLETED|Overall Study||28
9771519|NCT00443703|10876693|FG001|NOT COMPLETED|Overall Study||18
9771520|NCT00443729|10876701|FG000|STARTED|Overall Study||176
9771521|NCT00443729|10876702|FG001|STARTED|Overall Study||179
9771522|NCT00443729|10876701|FG000|Treated|Overall Study||176
9771523|NCT00443729|10876702|FG001|Treated|Overall Study||178
9771524|NCT00443729|10876701|FG000|COMPLETED|Overall Study||166
9771525|NCT00443729|10876702|FG001|COMPLETED|Overall Study||172
9771526|NCT00443729|10876701|FG000|NOT COMPLETED|Overall Study||10
10014219|NCT01798264|11137286|FG001|NOT COMPLETED|Overall Study||0
10014220|NCT01798264|11137287|FG002|NOT COMPLETED|Overall Study||0
10014221|NCT01798264|11137288|FG003|NOT COMPLETED|Overall Study||4
10014222|NCT01798316|11137300|FG000|STARTED|Overall Study||52
9771527|NCT00443729|10876702|FG001|NOT COMPLETED|Overall Study||7
9771528|NCT00443755|10876710|FG000|STARTED|Overall Study||14
9771529|NCT00443755|10876711|FG001|STARTED|Overall Study||14
9771530|NCT00443755|10876710|FG000|COMPLETED|Overall Study||12
9771531|NCT00443755|10876711|FG001|COMPLETED|Overall Study||13
9771532|NCT00443755|10876710|FG000|NOT COMPLETED|Overall Study||2
9771533|NCT00443755|10876711|FG001|NOT COMPLETED|Overall Study||1
9771534|NCT00443781|10876717|FG000|STARTED|Overall Study||62
9771535|NCT00443781|10876717|FG000|COMPLETED|Overall Study||37
9771536|NCT00443781|10876717|FG000|NOT COMPLETED|Overall Study||25
9771537|NCT00443820|10876725|FG000|STARTED|Overall Study||133
9771538|NCT00443820|10876726|FG001|STARTED|Overall Study||130
9771539|NCT00443820|10876727|FG002|STARTED|Overall Study||135
9771540|NCT00443820|10876728|FG003|STARTED|Overall Study||128
9771541|NCT00443820|10876725|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
9771542|NCT00443820|10876726|FG001|Safety Population|Overall Study||129
9771543|NCT00443820|10876727|FG002|Safety Population|Overall Study||134
9771544|NCT00443820|10876728|FG003|Safety Population|Overall Study||126
9771545|NCT00443820|10876725|FG000|COMPLETED|Overall Study||112
9771546|NCT00443820|10876726|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
9771547|NCT00443820|10876727|FG002|COMPLETED|Overall Study||117
9771548|NCT00443820|10876728|FG003|COMPLETED|Overall Study||111
9771549|NCT00443820|10876725|FG000|NOT COMPLETED|Overall Study||21
9771550|NCT00443820|10876726|FG001|NOT COMPLETED|Overall Study||19
9771551|NCT00443820|10876727|FG002|NOT COMPLETED|Overall Study||18
9771552|NCT00443820|10876728|FG003|NOT COMPLETED|Overall Study||17
9771553|NCT00443846|10876740|FG000|STARTED|Overall Study||124
9771554|NCT00443846|10876741|FG001|STARTED|Overall Study||123
9771555|NCT00443846|10876740|FG000|Vaccinated|Overall Study||116
9771556|NCT00443846|10876741|FG001|Vaccinated|Overall Study||123
9771557|NCT00443846|10876740|FG000|COMPLETED|Overall Study||113
9771558|NCT00443846|10876741|FG001|COMPLETED|Overall Study||117
9771559|NCT00443846|10876740|FG000|NOT COMPLETED|Overall Study||11
9771560|NCT00443846|10876741|FG001|NOT COMPLETED|Overall Study||6
9771561|NCT00443872|10876747|FG000|STARTED|Overall Study||77
9771562|NCT00443872|10876747|FG000|COMPLETED|Overall Study||60
9771563|NCT00443872|10876747|FG000|NOT COMPLETED|Overall Study||17
9771564|NCT00443898|10876764|FG000|STARTED|Overall Study||126
9771565|NCT00443898|10876765|FG001|STARTED|Overall Study||128
9771566|NCT00443898|10876766|FG002|STARTED|Overall Study||136
9771567|NCT00443898|10876767|FG003|STARTED|Overall Study||128
9771568|NCT00443898|10876764|FG000|COMPLETED|Overall Study||102
9771569|NCT00443898|10876765|FG001|COMPLETED|Overall Study||103
9771570|NCT00443898|10876766|FG002|COMPLETED|Overall Study||107
9771571|NCT00443898|10876767|FG003|COMPLETED|Overall Study||110
9771572|NCT00443898|10876764|FG000|NOT COMPLETED|Overall Study||24
9771573|NCT00443898|10876765|FG001|NOT COMPLETED|Overall Study||25
9771574|NCT00443898|10876766|FG002|NOT COMPLETED|Overall Study||29
9771575|NCT00443898|10876767|FG003|NOT COMPLETED|Overall Study||18
9771576|NCT00444028|10876783|FG000|STARTED|Overall Study||14
9771577|NCT00444028|10876784|FG001|STARTED|Overall Study||7
9771578|NCT00444028|10876785|FG002|STARTED|Overall Study||8
9771579|NCT00444028|10876786|FG003|STARTED|Overall Study||6
9771580|NCT00444028|10876787|FG004|STARTED|Overall Study||7
9771581|NCT00444028|10876788|FG005|STARTED|Overall Study||8
9771582|NCT00444028|10876783|FG000|COMPLETED|Overall Study||14
9771583|NCT00444028|10876784|FG001|COMPLETED|Overall Study||7
9771584|NCT00444028|10876785|FG002|COMPLETED|Overall Study||8
9771585|NCT00444028|10876786|FG003|COMPLETED|Overall Study||6
9771586|NCT00444028|10876787|FG004|COMPLETED|Overall Study||7
9771587|NCT00444028|10876788|FG005|COMPLETED|Overall Study||8
9771588|NCT00444028|10876783|FG000|NOT COMPLETED|Overall Study||0
9771589|NCT00444028|10876784|FG001|NOT COMPLETED|Overall Study||0
9771590|NCT00444028|10876785|FG002|NOT COMPLETED|Overall Study||0
9771591|NCT00444028|10876786|FG003|NOT COMPLETED|Overall Study||0
9771592|NCT00444028|10876787|FG004|NOT COMPLETED|Overall Study||0
9771593|NCT00444028|10876788|FG005|NOT COMPLETED|Overall Study||0
9771594|NCT00444067|10876803|FG000|STARTED|Overall Study||74
9771595|NCT00444067|10876804|FG001|STARTED|Overall Study||24
9771596|NCT00444067|10876803|FG000|COMPLETED|Overall Study||74
9771597|NCT00444067|10876804|FG001|COMPLETED|Overall Study||23
9771598|NCT00444067|10876803|FG000|NOT COMPLETED|Overall Study||0
9771599|NCT00444067|10876804|FG001|NOT COMPLETED|Overall Study||1
9771600|NCT00444080|10876812|FG000|STARTED|Overall Study||61
9771601|NCT00444080|10876813|FG001|STARTED|Overall Study||59
9771602|NCT00444080|10876812|FG000|COMPLETED|Overall Study||61
9771603|NCT00444080|10876813|FG001|COMPLETED|Overall Study||59
9771604|NCT00444080|10876812|FG000|NOT COMPLETED|Overall Study||0
9771605|NCT00444080|10876813|FG001|NOT COMPLETED|Overall Study||0
9771606|NCT00444106|10876825|FG000|STARTED|Overall Study||159
9771607|NCT00444106|10876826|FG001|STARTED|Overall Study||53
9771608|NCT00444106|10876827|FG002|STARTED|Overall Study||53
9771609|NCT00444106|10876825|FG000|Completed Treatment Period|Overall Study||159
9771610|NCT00444106|10876826|FG001|Completed Treatment Period|Overall Study||53
9771611|NCT00444106|10876827|FG002|Completed Treatment Period|Overall Study||53
9771612|NCT00444106|10876825|FG000|COMPLETED|Overall Study||157
9771613|NCT00444106|10876826|FG001|COMPLETED|Overall Study||52
9771614|NCT00444106|10876827|FG002|COMPLETED|Overall Study||52
9771615|NCT00444106|10876825|FG000|NOT COMPLETED|Overall Study||2
9771616|NCT00444106|10876826|FG001|NOT COMPLETED|Overall Study||1
9771617|NCT00444106|10876827|FG002|NOT COMPLETED|Overall Study||1
9771618|NCT00444145|10876838|FG000|STARTED|Overall Study||38
9771619|NCT00444145|10876838|FG000|COMPLETED|Overall Study||19
9771620|NCT00444145|10876838|FG000|NOT COMPLETED|Overall Study||19
9771621|NCT00444275|10876845|FG000|STARTED|Initial Treatment Phase||2156
9771622|NCT00444275|10876846|FG001|STARTED|Initial Treatment Phase||873
9771623|NCT00444275|10876847|FG002|STARTED|Initial Treatment Phase||0
9771624|NCT00444275|10876848|FG003|STARTED|Initial Treatment Phase||0
9771625|NCT00444275|10876849|FG004|STARTED|Initial Treatment Phase||0
9771626|NCT00444275|10876845|FG000|COMPLETED|Initial Treatment Phase||1908
9771627|NCT00444275|10876846|FG001|COMPLETED|Initial Treatment Phase||777
9771628|NCT00444275|10876847|FG002|COMPLETED|Initial Treatment Phase||0
9771629|NCT00444275|10876848|FG003|COMPLETED|Initial Treatment Phase||0
10014223|NCT01798316|11137301|FG001|STARTED|Overall Study||53
10014224|NCT01798316|11137300|FG000|COMPLETED|Overall Study||52
10014225|NCT01798316|11137301|FG001|COMPLETED|Overall Study||53
9771630|NCT00444275|10876849|FG004|COMPLETED|Initial Treatment Phase||0
9771631|NCT00444275|10876845|FG000|NOT COMPLETED|Initial Treatment Phase||248
9771632|NCT00444275|10876846|FG001|NOT COMPLETED|Initial Treatment Phase||96
9771633|NCT00444275|10876847|FG002|NOT COMPLETED|Initial Treatment Phase||0
9771634|NCT00444275|10876848|FG003|NOT COMPLETED|Initial Treatment Phase||0
9771635|NCT00444275|10876849|FG004|NOT COMPLETED|Initial Treatment Phase||0
9771636|NCT00444275|10876845|FG000|STARTED|Maintenance Treatment Phase||0
9771637|NCT00444275|10876846|FG001|STARTED|Maintenance Treatment Phase||0
9771638|NCT00444275|10876847|FG002|STARTED|Maintenance Treatment Phase||908
9771639|NCT00444275|10876848|FG003|STARTED|Maintenance Treatment Phase||897
9771640|NCT00444275|10876849|FG004|STARTED|Maintenance Treatment Phase||880
9771641|NCT00444275|10876845|FG000|COMPLETED|Maintenance Treatment Phase||0
9771642|NCT00444275|10876846|FG001|COMPLETED|Maintenance Treatment Phase||0
9771643|NCT00444275|10876847|FG002|COMPLETED|Maintenance Treatment Phase||747
9771644|NCT00444275|10876848|FG003|COMPLETED|Maintenance Treatment Phase||764
9771645|NCT00444275|10876849|FG004|COMPLETED|Maintenance Treatment Phase||701
9771646|NCT00444275|10876845|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
9771647|NCT00444275|10876846|FG001|NOT COMPLETED|Maintenance Treatment Phase||0
9771648|NCT00444275|10876847|FG002|NOT COMPLETED|Maintenance Treatment Phase||161
9771649|NCT00444275|10876848|FG003|NOT COMPLETED|Maintenance Treatment Phase||133
9771650|NCT00444275|10876849|FG004|NOT COMPLETED|Maintenance Treatment Phase||179
9771651|NCT00444457|10876868|FG000|STARTED|Infant Series||489
9771652|NCT00444457|10876869|FG001|STARTED|Infant Series||488
9771653|NCT00444457|10876870|FG002|STARTED|Infant Series||489
9771654|NCT00444457|10876871|FG003|STARTED|Infant Series||246
9771655|NCT00444457|10876868|FG000|Vaccinated Dose 1|Infant Series||486
9771656|NCT00444457|10876869|FG001|Vaccinated Dose 1|Infant Series||484
9771657|NCT00444457|10876870|FG002|Vaccinated Dose 1|Infant Series||485
9771658|NCT00444457|10876871|FG003|Vaccinated Dose 1|Infant Series||244
9771659|NCT00444457|10876868|FG000|Vaccinated Dose 2|Infant Series||455
9771660|NCT00444457|10876869|FG001|Vaccinated Dose 2|Infant Series||447
9771661|NCT00444457|10876870|FG002|Vaccinated Dose 2|Infant Series||455
9771662|NCT00444457|10876871|FG003|Vaccinated Dose 2|Infant Series||228
9771663|NCT00444457|10876868|FG000|Vaccinated Dose 3|Infant Series||442
9771664|NCT00444457|10876869|FG001|Vaccinated Dose 3|Infant Series||435
9771665|NCT00444457|10876870|FG002|Vaccinated Dose 3|Infant Series||438
9771666|NCT00444457|10876871|FG003|Vaccinated Dose 3|Infant Series||225
9771667|NCT00444457|10876868|FG000|COMPLETED|Infant Series||435
9771668|NCT00444457|10876869|FG001|COMPLETED|Infant Series||427
9771669|NCT00444457|10876870|FG002|COMPLETED|Infant Series||428
9771670|NCT00444457|10876871|FG003|COMPLETED|Infant Series||218
9771671|NCT00444457|10876868|FG000|NOT COMPLETED|Infant Series||54
9771672|NCT00444457|10876869|FG001|NOT COMPLETED|Infant Series||61
9771673|NCT00444457|10876870|FG002|NOT COMPLETED|Infant Series||61
9771674|NCT00444457|10876871|FG003|NOT COMPLETED|Infant Series||28
9771675|NCT00444457|10876868|FG000|STARTED|After Infant Series||435
9771676|NCT00444457|10876869|FG001|STARTED|After Infant Series||427
9771677|NCT00444457|10876870|FG002|STARTED|After Infant Series||427
10014226|NCT01798316|11137300|FG000|NOT COMPLETED|Overall Study||0
9771678|NCT00444457|10876871|FG003|STARTED|After Infant Series||218
9771679|NCT00444457|10876868|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
9771680|NCT00444457|10876869|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
9771681|NCT00444457|10876870|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
9771682|NCT00444457|10876871|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
9771683|NCT00444457|10876868|FG000|NOT COMPLETED|After Infant Series||20
9771684|NCT00444457|10876869|FG001|NOT COMPLETED|After Infant Series||30
9771685|NCT00444457|10876870|FG002|NOT COMPLETED|After Infant Series||19
9771686|NCT00444457|10876871|FG003|NOT COMPLETED|After Infant Series||10
9771687|NCT00444457|10876868|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415
9771688|NCT00444457|10876869|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397
9771689|NCT00444457|10876870|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408
9771690|NCT00444457|10876871|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208
9771691|NCT00444457|10876868|FG000|COMPLETED|Toddler Dose||408
9771692|NCT00444457|10876869|FG001|COMPLETED|Toddler Dose||391
10014227|NCT01798316|11137301|FG001|NOT COMPLETED|Overall Study||0
10014228|NCT01798394|11137311|FG000|STARTED|Overall Study||24
9771693|NCT00444457|10876870|FG002|COMPLETED|Toddler Dose||404
9771694|NCT00444457|10876871|FG003|COMPLETED|Toddler Dose||200
9771695|NCT00444457|10876868|FG000|NOT COMPLETED|Toddler Dose||7
9771696|NCT00444457|10876869|FG001|NOT COMPLETED|Toddler Dose||6
9771697|NCT00444457|10876870|FG002|NOT COMPLETED|Toddler Dose||4
9771698|NCT00444457|10876871|FG003|NOT COMPLETED|Toddler Dose||8
9771699|NCT00444535|10876892|FG000|STARTED|Overall Study||52
9771700|NCT00444535|10876892|FG000|COMPLETED|Overall Study||39
9771701|NCT00444535|10876892|FG000|NOT COMPLETED|Overall Study||13
9771702|NCT00444587|10876898|FG000|STARTED|Overall Study||93
9771703|NCT00444587|10876899|FG001|STARTED|Overall Study||16
9771704|NCT00444587|10876898|FG000|COMPLETED|Overall Study||10
9771705|NCT00444587|10876899|FG001|COMPLETED|Overall Study||1
9771706|NCT00444587|10876898|FG000|NOT COMPLETED|Overall Study||83
9771707|NCT00444587|10876899|FG001|NOT COMPLETED|Overall Study||15
9771708|NCT00444600|10876911|FG000|STARTED|Overall Study|Number of eyes|293
9771709|NCT00444600|10876912|FG001|STARTED|Overall Study|Number of eyes|187
9771710|NCT00444600|10876913|FG002|STARTED|Overall Study|Number of eyes|188
9771711|NCT00444600|10876914|FG003|STARTED|Overall Study|Number of eyes|186
9771712|NCT00444600|10876911|FG000|COMPLETED|Overall Study|Number of eyes|274
9771713|NCT00444600|10876912|FG001|COMPLETED|Overall Study|Number of eyes|171
9771714|NCT00444600|10876913|FG002|COMPLETED|Overall Study|Number of eyes|178
9771715|NCT00444600|10876914|FG003|COMPLETED|Overall Study|Number of eyes|176
9771716|NCT00444600|10876911|FG000|NOT COMPLETED|Overall Study||19
9771717|NCT00444600|10876912|FG001|NOT COMPLETED|Overall Study||16
9771718|NCT00444600|10876913|FG002|NOT COMPLETED|Overall Study||10
9771719|NCT00444600|10876914|FG003|NOT COMPLETED|Overall Study||10
9771720|NCT00444626|10876930|FG000|STARTED|Initial Treatment Period||140
9771721|NCT00444626|10876930|FG000|COMPLETED|Initial Treatment Period||128
9771722|NCT00444626|10876930|FG000|NOT COMPLETED|Initial Treatment Period||12
9771723|NCT00444626|10876930|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
9771724|NCT00444626|10876930|FG000|COMPLETED|Repeat Treatment Period||105
9771725|NCT00444626|10876930|FG000|NOT COMPLETED|Repeat Treatment Period||0
9771726|NCT00444678|10876943|FG000|STARTED|Overall Study||36
9771727|NCT00444678|10876943|FG000|COMPLETED|Overall Study||5
9771728|NCT00444678|10876943|FG000|NOT COMPLETED|Overall Study||31
9771729|NCT00444795|10876947|FG000|STARTED|Overall Study||620
9771730|NCT00444795|10876947|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
9771731|NCT00444795|10876947|FG000|NOT COMPLETED|Overall Study||3
9771732|NCT00444821|10876953|FG000|STARTED|Overall Study||362
9771733|NCT00444821|10876954|FG001|STARTED|Overall Study||366
9771734|NCT00444821|10876953|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
9771735|NCT00444821|10876954|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
9771736|NCT00444821|10876953|FG000|COMPLETED|Overall Study||0
9771737|NCT00444821|10876954|FG001|COMPLETED|Overall Study||0
9771738|NCT00444821|10876953|FG000|NOT COMPLETED|Overall Study||362
9771739|NCT00444821|10876954|FG001|NOT COMPLETED|Overall Study||366
9771740|NCT00444912|10876962|FG000|STARTED|Overall Study||15
9771741|NCT00444912|10876963|FG001|STARTED|Overall Study||15
9771742|NCT00444912|10876962|FG000|Received Plerixafor|Overall Study||15
9771743|NCT00444912|10876963|FG001|Received Plerixafor|Overall Study||15
9771744|NCT00444912|10876962|FG000|Received Transplant|Overall Study||14
9771745|NCT00444912|10876963|FG001|Received Transplant|Overall Study||14
9771746|NCT00444912|10876962|FG000|COMPLETED|Overall Study||12
9771747|NCT00444912|10876963|FG001|COMPLETED|Overall Study||13
9771748|NCT00444912|10876962|FG000|NOT COMPLETED|Overall Study||3
9771749|NCT00444912|10876963|FG001|NOT COMPLETED|Overall Study||2
9771750|NCT00444925|10876972|FG000|STARTED|Single-blind Placebo Run-In Period||2446
9771751|NCT00444925|10876973|FG001|STARTED|Single-blind Placebo Run-In Period||0
9771752|NCT00444925|10876974|FG002|STARTED|Single-blind Placebo Run-In Period||0
9771753|NCT00444925|10876972|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
9771754|NCT00444925|10876973|FG001|COMPLETED|Single-blind Placebo Run-In Period||0
9771755|NCT00444925|10876974|FG002|COMPLETED|Single-blind Placebo Run-In Period||0
9771756|NCT00444925|10876972|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734
9771757|NCT00444925|10876973|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0
9771758|NCT00444925|10876974|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0
9771759|NCT00444925|10876972|FG000|STARTED|Randomized to Double-blind Treatment||337
9771760|NCT00444925|10876973|FG001|STARTED|Randomized to Double-blind Treatment||690
9771761|NCT00444925|10876974|FG002|STARTED|Randomized to Double-blind Treatment||685
9771762|NCT00444925|10876972|FG000|COMPLETED|Randomized to Double-blind Treatment||334
9771763|NCT00444925|10876973|FG001|COMPLETED|Randomized to Double-blind Treatment||684
9771764|NCT00444925|10876974|FG002|COMPLETED|Randomized to Double-blind Treatment||679
9771765|NCT00444925|10876972|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3
9771766|NCT00444925|10876973|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6
9771767|NCT00444925|10876974|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6
9771768|NCT00444925|10876972|FG000|STARTED|Double-blind Treatment Period||334
9771769|NCT00444925|10876973|FG001|STARTED|Double-blind Treatment Period||684
9771770|NCT00444925|10876974|FG002|STARTED|Double-blind Treatment Period||679
9771771|NCT00444925|10876972|FG000|COMPLETED|Double-blind Treatment Period||304
9771772|NCT00444925|10876973|FG001|COMPLETED|Double-blind Treatment Period||628
9771773|NCT00444925|10876974|FG002|COMPLETED|Double-blind Treatment Period||598
9771774|NCT00444925|10876972|FG000|NOT COMPLETED|Double-blind Treatment Period||30
9771775|NCT00444925|10876973|FG001|NOT COMPLETED|Double-blind Treatment Period||56
9771776|NCT00444925|10876974|FG002|NOT COMPLETED|Double-blind Treatment Period||81
9771777|NCT00444951|10876985|FG000|STARTED|Overall Study||145
9771778|NCT00444951|10876986|FG001|STARTED|Overall Study||142
9771779|NCT00444951|10876987|FG002|STARTED|Overall Study||163
9771780|NCT00444951|10876985|FG000|COMPLETED|Overall Study||140
9771781|NCT00444951|10876986|FG001|COMPLETED|Overall Study||136
9771782|NCT00444951|10876987|FG002|COMPLETED|Overall Study||160
9771783|NCT00444951|10876985|FG000|NOT COMPLETED|Overall Study||5
9771784|NCT00444951|10876986|FG001|NOT COMPLETED|Overall Study||6
9771785|NCT00444951|10876987|FG002|NOT COMPLETED|Overall Study||3
9771786|NCT00444964|10876995|FG000|STARTED|Overall Study||11
9771787|NCT00444964|10876995|FG000|COMPLETED|Overall Study||11
9771788|NCT00444964|10876995|FG000|NOT COMPLETED|Overall Study||0
9771789|NCT00445003|10877002|FG000|STARTED|Overall Study||123
9771790|NCT00445003|10877003|FG001|STARTED|Overall Study||113
9771791|NCT00445003|10877004|FG002|STARTED|Overall Study||109
9771792|NCT00445003|10877002|FG000|COMPLETED|Overall Study||118
9771793|NCT00445003|10877003|FG001|COMPLETED|Overall Study||103
9771794|NCT00445003|10877004|FG002|COMPLETED|Overall Study||105
9771795|NCT00445003|10877002|FG000|NOT COMPLETED|Overall Study||5
9771796|NCT00445003|10877003|FG001|NOT COMPLETED|Overall Study||10
9771797|NCT00445003|10877004|FG002|NOT COMPLETED|Overall Study||4
9771798|NCT00445068|10877012|FG000|STARTED|Overall Study||38
9771799|NCT00445068|10877012|FG000|COMPLETED|Overall Study||2
9771800|NCT00445068|10877012|FG000|NOT COMPLETED|Overall Study||36
9771801|NCT00445146|10877016|FG000|STARTED|Overall Study||192
9771802|NCT00445146|10877016|FG000|COMPLETED|Overall Study||73
9771803|NCT00445146|10877016|FG000|NOT COMPLETED|Overall Study||119
9771804|NCT00445211|10877022|FG000|STARTED|Overall Study||23
9771805|NCT00445211|10877023|FG001|STARTED|Overall Study||23
9771806|NCT00445211|10877022|FG000|COMPLETED|Overall Study||23
9771807|NCT00445211|10877023|FG001|COMPLETED|Overall Study||23
9771808|NCT00445211|10877022|FG000|NOT COMPLETED|Overall Study||0
9771809|NCT00445211|10877023|FG001|NOT COMPLETED|Overall Study||0
9771810|NCT00445224|10877031|FG000|STARTED|Specific Exercises||17
9771811|NCT00445224|10877032|FG001|STARTED|Specific Exercises||16
9771812|NCT00445224|10877031|FG000|Baseline|Specific Exercises||17
9771813|NCT00445224|10877032|FG001|Baseline|Specific Exercises||16
9771814|NCT00445224|10877031|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
9771815|NCT00445224|10877032|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
9771816|NCT00445224|10877031|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13
9771817|NCT00445224|10877032|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13
9771818|NCT00445224|10877031|FG000|NOT COMPLETED|Specific Exercises||4
9771819|NCT00445224|10877032|FG001|NOT COMPLETED|Specific Exercises||3
9771820|NCT00445224|10877031|FG000|STARTED|Combined Exercises||13
9771821|NCT00445224|10877032|FG001|STARTED|Combined Exercises||13
9771822|NCT00445224|10877031|FG000|COMPLETED|Combined Exercises||13
9771823|NCT00445224|10877032|FG001|COMPLETED|Combined Exercises||13
9771824|NCT00445224|10877031|FG000|NOT COMPLETED|Combined Exercises||0
9771825|NCT00445224|10877032|FG001|NOT COMPLETED|Combined Exercises||0
9771826|NCT00445263|10877040|FG000|STARTED|Overall Study||83
9771827|NCT00445263|10877041|FG001|STARTED|Overall Study||87
9771828|NCT00445263|10877040|FG000|COMPLETED|Overall Study||83
9771829|NCT00445263|10877041|FG001|COMPLETED|Overall Study||86
9771830|NCT00445263|10877040|FG000|NOT COMPLETED|Overall Study||0
9771831|NCT00445263|10877041|FG001|NOT COMPLETED|Overall Study||1
9771832|NCT00445302|10877051|FG000|STARTED|Overall Study||6
9771833|NCT00445302|10877052|FG001|STARTED|Overall Study||5
9771834|NCT00445302|10877053|FG002|STARTED|Overall Study||6
9771835|NCT00445302|10877054|FG003|STARTED|Overall Study||6
9771836|NCT00445302|10877051|FG000|COMPLETED|Overall Study||6
9771837|NCT00445302|10877052|FG001|COMPLETED|Overall Study||5
9771838|NCT00445302|10877053|FG002|COMPLETED|Overall Study||6
9771839|NCT00445302|10877054|FG003|COMPLETED|Overall Study||6
9771840|NCT00445302|10877051|FG000|NOT COMPLETED|Overall Study||0
9771841|NCT00445302|10877052|FG001|NOT COMPLETED|Overall Study||0
9771842|NCT00445302|10877053|FG002|NOT COMPLETED|Overall Study||0
9771843|NCT00445302|10877054|FG003|NOT COMPLETED|Overall Study||0
9771844|NCT00445315|10877069|FG000|STARTED|Overall Study||6
9771845|NCT00445315|10877070|FG001|STARTED|Overall Study||6
9771846|NCT00445315|10877071|FG002|STARTED|Overall Study||6
9771847|NCT00445315|10877072|FG003|STARTED|Overall Study||6
9771848|NCT00445315|10877073|FG004|STARTED|Overall Study||8
9771849|NCT00445315|10877069|FG000|COMPLETED|Overall Study||6
9771850|NCT00445315|10877070|FG001|COMPLETED|Overall Study||6
9771851|NCT00445315|10877071|FG002|COMPLETED|Overall Study||6
9771852|NCT00445315|10877072|FG003|COMPLETED|Overall Study||6
9771853|NCT00445315|10877073|FG004|COMPLETED|Overall Study||8
9771854|NCT00445315|10877069|FG000|NOT COMPLETED|Overall Study||0
9771855|NCT00445315|10877070|FG001|NOT COMPLETED|Overall Study||0
9771856|NCT00445315|10877071|FG002|NOT COMPLETED|Overall Study||0
9771857|NCT00445315|10877072|FG003|NOT COMPLETED|Overall Study||0
9771858|NCT00445315|10877073|FG004|NOT COMPLETED|Overall Study||0
9771859|NCT00445328|10877088|FG000|STARTED|Overall Study||42
9771860|NCT00445328|10877089|FG001|STARTED|Overall Study||42
9771861|NCT00445328|10877088|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
9771862|NCT00445328|10877089|FG001|Received Treatment|Overall Study||42
9771863|NCT00445328|10877088|FG000|COMPLETED|Overall Study||39
9771864|NCT00445328|10877089|FG001|COMPLETED|Overall Study||36
9771865|NCT00445328|10877088|FG000|NOT COMPLETED|Overall Study||3
9771866|NCT00445328|10877089|FG001|NOT COMPLETED|Overall Study||6
9771867|NCT00445341|10877095|FG000|STARTED|Overall Study||28
9771868|NCT00445341|10877095|FG000|COMPLETED|Overall Study||26
9771869|NCT00445341|10877095|FG000|NOT COMPLETED|Overall Study||2
9771870|NCT00445432|10877102|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
9771871|NCT00445432|10877103|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
9771872|NCT00445432|10877104|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
9771873|NCT00445432|10877105|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
9771874|NCT00445432|10877102|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
9771875|NCT00445432|10877103|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
9771876|NCT00445432|10877104|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
9771877|NCT00445432|10877105|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
9771878|NCT00445432|10877102|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
9771879|NCT00445432|10877103|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
9771880|NCT00445432|10877104|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
9771881|NCT00445432|10877105|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
9771882|NCT00445432|10877102|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
9771883|NCT00445432|10877103|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
9771884|NCT00445432|10877104|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
9771885|NCT00445432|10877105|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
9771886|NCT00445432|10877102|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0
9771887|NCT00445432|10877103|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0
9771888|NCT00445432|10877104|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0
9771889|NCT00445432|10877105|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35
9771890|NCT00445432|10877102|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
9771891|NCT00445432|10877103|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
9771892|NCT00445432|10877104|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
9771893|NCT00445432|10877105|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
10014229|NCT01798394|11137312|FG001|STARTED|Overall Study||22
10014230|NCT01798394|11137311|FG000|COMPLETED|Overall Study||21
10014231|NCT01798394|11137312|FG001|COMPLETED|Overall Study||19
10014232|NCT01798394|11137311|FG000|NOT COMPLETED|Overall Study||3
10014233|NCT01798394|11137312|FG001|NOT COMPLETED|Overall Study||3
10014234|NCT01798485|11137320|FG000|STARTED|Overall Study||347
10014235|NCT01798485|11137321|FG001|STARTED|Overall Study||349
10014236|NCT01798485|11137320|FG000|Safety Population as of 23 Dec 2015|Overall Study||338
10014237|NCT01798485|11137321|FG001|Safety Population as of 23 Dec 2015|Overall Study||342
10014238|NCT01798485|11137320|FG000|Randomized as of 19 October 2015|Overall Study||335
9771894|NCT00445458|10877120|FG000|STARTED|Overall Study||3
9771895|NCT00445458|10877121|FG001|STARTED|Overall Study||5
9771896|NCT00445458|10877122|FG002|STARTED|Overall Study||71
9771897|NCT00445458|10877123|FG003|STARTED|Overall Study||31
9771898|NCT00445458|10877120|FG000|COMPLETED|Overall Study||0
9771899|NCT00445458|10877121|FG001|COMPLETED|Overall Study||0
9771900|NCT00445458|10877122|FG002|COMPLETED|Overall Study||3
9771901|NCT00445458|10877123|FG003|COMPLETED|Overall Study||3
9771902|NCT00445458|10877120|FG000|NOT COMPLETED|Overall Study||3
9771903|NCT00445458|10877121|FG001|NOT COMPLETED|Overall Study||5
9771904|NCT00445458|10877122|FG002|NOT COMPLETED|Overall Study||68
9771905|NCT00445458|10877123|FG003|NOT COMPLETED|Overall Study||28
9771906|NCT00445484|10877138|FG000|STARTED|Overall Study||11
9771907|NCT00445484|10877139|FG001|STARTED|Overall Study||11
9771908|NCT00445484|10877138|FG000|COMPLETED|Overall Study||7
9771909|NCT00445484|10877139|FG001|COMPLETED|Overall Study||10
9771910|NCT00445484|10877138|FG000|NOT COMPLETED|Overall Study||4
9771911|NCT00445484|10877139|FG001|NOT COMPLETED|Overall Study||1
9771912|NCT00445549|10877145|FG000|STARTED|Overall Study||12
9771913|NCT00445549|10877145|FG000|COMPLETED|Overall Study||0
9771914|NCT00445549|10877145|FG000|NOT COMPLETED|Overall Study||12
9771915|NCT00445588|10877149|FG000|STARTED|Overall Study||56
9771916|NCT00445588|10877149|FG000|COMPLETED|Overall Study||56
9771917|NCT00445588|10877149|FG000|NOT COMPLETED|Overall Study||0
9771918|NCT00445601|10877156|FG000|STARTED|Overall Study||201
9771919|NCT00445601|10877157|FG001|STARTED|Overall Study||205
9771920|NCT00445601|10877156|FG000|Received TURBT|Overall Study||190
9771921|NCT00445601|10877157|FG001|Received TURBT|Overall Study||193
9771922|NCT00445601|10877156|FG000|COMPLETED|Overall Study||168
9771923|NCT00445601|10877157|FG001|COMPLETED|Overall Study||177
9771924|NCT00445601|10877156|FG000|NOT COMPLETED|Overall Study||33
9771925|NCT00445601|10877157|FG001|NOT COMPLETED|Overall Study||28
9771926|NCT00445679|10877171|FG000|STARTED|Overall Study||203
9771927|NCT00445679|10877172|FG001|STARTED|Overall Study||203
9771928|NCT00445679|10877173|FG002|STARTED|Overall Study||205
9771929|NCT00445679|10877174|FG003|STARTED|Overall Study||196
9771930|NCT00445679|10877171|FG000|COMPLETED|Overall Study||155
9771931|NCT00445679|10877172|FG001|COMPLETED|Overall Study||157
9771932|NCT00445679|10877173|FG002|COMPLETED|Overall Study||139
9771933|NCT00445679|10877174|FG003|COMPLETED|Overall Study||149
9771934|NCT00445679|10877171|FG000|NOT COMPLETED|Overall Study||48
9771935|NCT00445679|10877172|FG001|NOT COMPLETED|Overall Study||46
9771936|NCT00445679|10877173|FG002|NOT COMPLETED|Overall Study||66
9771937|NCT00445679|10877174|FG003|NOT COMPLETED|Overall Study||47
10014239|NCT01798485|11137321|FG001|Randomized as of 19 October 2015|Overall Study||337
10014240|NCT01798485|11137320|FG000|COMPLETED|Overall Study||1
9771938|NCT00445692|10877184|FG000|STARTED|Overall Study||31
9771939|NCT00445692|10877184|FG000|COMPLETED|Overall Study||15
9771940|NCT00445692|10877184|FG000|NOT COMPLETED|Overall Study||16
9771941|NCT00445705|10877194|FG000|STARTED|Overall Study||53
9771942|NCT00445705|10877195|FG001|STARTED|Overall Study||53
9771943|NCT00445705|10877196|FG002|STARTED|Overall Study||52
9771944|NCT00445705|10877197|FG003|STARTED|Overall Study||53
9771945|NCT00445705|10877194|FG000|COMPLETED|Overall Study||44
9771946|NCT00445705|10877195|FG001|COMPLETED|Overall Study||42
9771947|NCT00445705|10877196|FG002|COMPLETED|Overall Study||41
9771948|NCT00445705|10877197|FG003|COMPLETED|Overall Study||39
9771949|NCT00445705|10877194|FG000|NOT COMPLETED|Overall Study||9
9771950|NCT00445705|10877195|FG001|NOT COMPLETED|Overall Study||11
9771951|NCT00445705|10877196|FG002|NOT COMPLETED|Overall Study||11
9771952|NCT00445705|10877197|FG003|NOT COMPLETED|Overall Study||14
9771953|NCT00445744|10877207|FG000|STARTED|Overall Study||52
9771954|NCT00445744|10877207|FG000|COMPLETED|Overall Study||51
9771955|NCT00445744|10877207|FG000|NOT COMPLETED|Overall Study||1
9771956|NCT00445770|10877214|FG000|STARTED|Overall Study||176
9771957|NCT00445770|10877215|FG001|STARTED|Overall Study||192
9771958|NCT00445770|10877216|FG002|STARTED|Overall Study||182
9771959|NCT00445770|10877214|FG000|COMPLETED|Overall Study||123
9771960|NCT00445770|10877215|FG001|COMPLETED|Overall Study||157
9771961|NCT00445770|10877216|FG002|COMPLETED|Overall Study||151
9771962|NCT00445770|10877214|FG000|NOT COMPLETED|Overall Study||53
9771963|NCT00445770|10877215|FG001|NOT COMPLETED|Overall Study||35
9771964|NCT00445770|10877216|FG002|NOT COMPLETED|Overall Study||31
9771965|NCT00445848|10877226|FG000|STARTED|Overall Study||85
9771966|NCT00445848|10877226|FG000|COMPLETED|Overall Study||0
9771967|NCT00445848|10877226|FG000|NOT COMPLETED|Overall Study||85
9771968|NCT00445887|10877232|FG000|STARTED|Overall Study||33
9771969|NCT00445887|10877233|FG001|STARTED|Overall Study||31
9771970|NCT00445887|10877232|FG000|COMPLETED|Overall Study||33
9771971|NCT00445887|10877233|FG001|COMPLETED|Overall Study||31
9771972|NCT00445887|10877232|FG000|NOT COMPLETED|Overall Study||0
9771973|NCT00445887|10877233|FG001|NOT COMPLETED|Overall Study||0
9771974|NCT00445939|10877252|FG000|STARTED|Period A - Week 0 - Week 4||33
9771975|NCT00445939|10877253|FG001|STARTED|Period A - Week 0 - Week 4||34
9771976|NCT00445939|10877254|FG002|STARTED|Period A - Week 0 - Week 4||23
9771977|NCT00445939|10877255|FG003|STARTED|Period A - Week 0 - Week 4||0
9771978|NCT00445939|10877252|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
9771979|NCT00445939|10877253|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
9771980|NCT00445939|10877254|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
9771981|NCT00445939|10877255|FG003|COMPLETED|Period A - Week 0 - Week 4||0
9771982|NCT00445939|10877252|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1
9771983|NCT00445939|10877253|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2
9771984|NCT00445939|10877254|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0
9771985|NCT00445939|10877255|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0
9771986|NCT00445939|10877252|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
9771987|NCT00445939|10877253|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
9771988|NCT00445939|10877254|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
9771989|NCT00445939|10877255|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
9771990|NCT00445939|10877252|FG000|COMPLETED|Period B - Week 4 - Week 8||14
9771991|NCT00445939|10877253|FG001|COMPLETED|Period B - Week 4 - Week 8||0
9771992|NCT00445939|10877254|FG002|COMPLETED|Period B - Week 4 - Week 8||0
9771993|NCT00445939|10877255|FG003|COMPLETED|Period B - Week 4 - Week 8||20
9771994|NCT00445939|10877252|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2
9771995|NCT00445939|10877253|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0
9771996|NCT00445939|10877254|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0
9771997|NCT00445939|10877255|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1
9771998|NCT00445978|10877275|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
9771999|NCT00445978|10877275|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
9772000|NCT00445978|10877275|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
9772001|NCT00445978|10877275|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
9772002|NCT00445978|10877275|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
9772003|NCT00445978|10877275|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
9772004|NCT00445978|10877275|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
9772005|NCT00445978|10877275|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
9772006|NCT00445978|10877275|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
9772007|NCT00445978|10877275|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
9772008|NCT00445978|10877275|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
9772009|NCT00445978|10877275|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
9772010|NCT00445978|10877275|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
9772011|NCT00445978|10877275|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
9772012|NCT00445978|10877275|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
9772013|NCT00446030|10877288|FG000|STARTED|TREATMENT (up to 52 Weeks)||93
9772014|NCT00446030|10877289|FG001|STARTED|TREATMENT (up to 52 Weeks)||34
9772015|NCT00446030|10877288|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
9772016|NCT00446030|10877289|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
9772017|NCT00446030|10877288|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
9772018|NCT00446030|10877289|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
9772019|NCT00446030|10877288|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
9772020|NCT00446030|10877289|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
9772021|NCT00446030|10877288|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
9772022|NCT00446030|10877289|FG001|STARTED|FOLLOW-UP (up to 2-years)||34
9772023|NCT00446030|10877288|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63
9772024|NCT00446030|10877289|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25
9772025|NCT00446030|10877288|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
9772026|NCT00446030|10877289|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
9772027|NCT00446095|10877300|FG000|STARTED|Phase II (8 Weeks)||23
9772028|NCT00446095|10877301|FG001|STARTED|Phase II (8 Weeks)||21
9772029|NCT00446095|10877302|FG002|STARTED|Phase II (8 Weeks)||24
9772030|NCT00446095|10877303|FG003|STARTED|Phase II (8 Weeks)||0
9772031|NCT00446095|10877304|FG004|STARTED|Phase II (8 Weeks)||0
9772032|NCT00446095|10877300|FG000|COMPLETED|Phase II (8 Weeks)||11
9772033|NCT00446095|10877301|FG001|COMPLETED|Phase II (8 Weeks)||18
9772034|NCT00446095|10877302|FG002|COMPLETED|Phase II (8 Weeks)||21
9772035|NCT00446095|10877303|FG003|COMPLETED|Phase II (8 Weeks)||0
9772036|NCT00446095|10877304|FG004|COMPLETED|Phase II (8 Weeks)||0
9772037|NCT00446095|10877300|FG000|NOT COMPLETED|Phase II (8 Weeks)||12
9772038|NCT00446095|10877301|FG001|NOT COMPLETED|Phase II (8 Weeks)||3
9772039|NCT00446095|10877302|FG002|NOT COMPLETED|Phase II (8 Weeks)||3
9772040|NCT00446095|10877303|FG003|NOT COMPLETED|Phase II (8 Weeks)||0
9772041|NCT00446095|10877304|FG004|NOT COMPLETED|Phase II (8 Weeks)||0
9772042|NCT00446095|10877300|FG000|STARTED|Phase I (28 Days)||0
9772043|NCT00446095|10877301|FG001|STARTED|Phase I (28 Days)||0
9772044|NCT00446095|10877302|FG002|STARTED|Phase I (28 Days)||0
9772045|NCT00446095|10877303|FG003|STARTED|Phase I (28 Days)||6
9772046|NCT00446095|10877304|FG004|STARTED|Phase I (28 Days)||7
9772047|NCT00446095|10877300|FG000|COMPLETED|Phase I (28 Days)||0
9772048|NCT00446095|10877301|FG001|COMPLETED|Phase I (28 Days)||0
9772049|NCT00446095|10877302|FG002|COMPLETED|Phase I (28 Days)||0
9772050|NCT00446095|10877303|FG003|COMPLETED|Phase I (28 Days)||5
9772051|NCT00446095|10877304|FG004|COMPLETED|Phase I (28 Days)||4
9772052|NCT00446095|10877300|FG000|NOT COMPLETED|Phase I (28 Days)||0
9772053|NCT00446095|10877301|FG001|NOT COMPLETED|Phase I (28 Days)||0
9772054|NCT00446095|10877302|FG002|NOT COMPLETED|Phase I (28 Days)||0
9772055|NCT00446095|10877303|FG003|NOT COMPLETED|Phase I (28 Days)||1
9772056|NCT00446095|10877304|FG004|NOT COMPLETED|Phase I (28 Days)||3
9772057|NCT00446134|10877319|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
9772058|NCT00446134|10877320|FG001|STARTED|Overall Study||70
9772059|NCT00446134|10877321|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
9772060|NCT00446134|10877322|FG003|STARTED|Overall Study||70
9772061|NCT00446134|10877319|FG000|COMPLETED|Overall Study||35
9772062|NCT00446134|10877320|FG001|COMPLETED|Overall Study||25
9772063|NCT00446134|10877321|FG002|COMPLETED|Overall Study||26
9772064|NCT00446134|10877322|FG003|COMPLETED|Overall Study||25
9772065|NCT00446134|10877319|FG000|NOT COMPLETED|Overall Study||34
9772066|NCT00446134|10877320|FG001|NOT COMPLETED|Overall Study||45
9772067|NCT00446134|10877321|FG002|NOT COMPLETED|Overall Study||43
9772068|NCT00446134|10877322|FG003|NOT COMPLETED|Overall Study||45
9772069|NCT00446147|10877334|FG000|STARTED|Overall Study||195
9772070|NCT00446147|10877335|FG001|STARTED|Overall Study||194
9772071|NCT00446147|10877334|FG000|COMPLETED|Overall Study||180
9772072|NCT00446147|10877335|FG001|COMPLETED|Overall Study||180
9772073|NCT00446147|10877334|FG000|NOT COMPLETED|Overall Study||15
9772074|NCT00446147|10877335|FG001|NOT COMPLETED|Overall Study||14
9772075|NCT00446199|10877345|FG000|STARTED|Overall Study||183
9772076|NCT00446199|10877346|FG001|STARTED|Overall Study||184
9772077|NCT00446199|10877347|FG002|STARTED|Overall Study||185
9772078|NCT00446199|10877348|FG003|STARTED|Overall Study||183
10014241|NCT01798485|11137321|FG001|COMPLETED|Overall Study||59
10014242|NCT01798485|11137320|FG000|NOT COMPLETED|Overall Study||346
10014243|NCT01798485|11137321|FG001|NOT COMPLETED|Overall Study||290
10014244|NCT01798550|11137329|FG000|STARTED|Overall Study||30
10014245|NCT01798550|11137330|FG001|STARTED|Overall Study||32
10014246|NCT01798550|11137329|FG000|COMPLETED|Overall Study||28
9772079|NCT00446199|10877345|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
9772080|NCT00446199|10877346|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
9772081|NCT00446199|10877347|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
9772082|NCT00446199|10877348|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
9772083|NCT00446199|10877345|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
9772084|NCT00446199|10877346|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
9829830|NCT00761592|10940529|FG000|NOT COMPLETED|Overall Study||1
10014247|NCT01798550|11137330|FG001|COMPLETED|Overall Study||26
10014248|NCT01798550|11137329|FG000|NOT COMPLETED|Overall Study||2
9772085|NCT00446199|10877347|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
9772086|NCT00446199|10877348|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
9772087|NCT00446199|10877345|FG000|COMPLETED|Overall Study||160
9772088|NCT00446199|10877346|FG001|COMPLETED|Overall Study||164
9772089|NCT00446199|10877347|FG002|COMPLETED|Overall Study||158
9772090|NCT00446199|10877348|FG003|COMPLETED|Overall Study||153
9772091|NCT00446199|10877345|FG000|NOT COMPLETED|Overall Study||23
9772092|NCT00446199|10877346|FG001|NOT COMPLETED|Overall Study||20
9772093|NCT00446199|10877347|FG002|NOT COMPLETED|Overall Study||27
9772094|NCT00446199|10877348|FG003|NOT COMPLETED|Overall Study||30
9772095|NCT00446251|10877358|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
9772096|NCT00446251|10877358|FG000|COMPLETED|Overall Study||9
9772097|NCT00446251|10877358|FG000|NOT COMPLETED|Overall Study||5
9772098|NCT00446264|10877362|FG000|STARTED|Overall Study||14
10014249|NCT01798550|11137330|FG001|NOT COMPLETED|Overall Study||6
10014250|NCT01798589|11137336|FG000|STARTED|Overall Study||16
10014251|NCT01798589|11137336|FG000|COMPLETED|Overall Study||16
10014252|NCT01798589|11137336|FG000|NOT COMPLETED|Overall Study||0
10014253|NCT01798641|11137346|FG000|STARTED|First Intervention (6 Weeks)||19
10014254|NCT01798641|11137347|FG001|STARTED|First Intervention (6 Weeks)||19
9772099|NCT00446264|10877362|FG000|COMPLETED|Overall Study||14
9772100|NCT00446264|10877362|FG000|NOT COMPLETED|Overall Study||0
9772101|NCT00446290|10877366|FG000|STARTED|Overall Study||22
9772102|NCT00446290|10877366|FG000|COMPLETED|Overall Study||22
9772103|NCT00446290|10877366|FG000|NOT COMPLETED|Overall Study||0
9772104|NCT00446446|10877370|FG000|STARTED|Overall Study||52
10014255|NCT01798641|11137346|FG000|COMPLETED|First Intervention (6 Weeks)||19
10014256|NCT01798641|11137347|FG001|COMPLETED|First Intervention (6 Weeks)||19
10014257|NCT01798641|11137346|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10014258|NCT01798641|11137347|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10014259|NCT01798641|11137346|FG000|STARTED|Second Intervention (6 Weeks)||19
10014260|NCT01798641|11137347|FG001|STARTED|Second Intervention (6 Weeks)||19
10014261|NCT01798641|11137346|FG000|COMPLETED|Second Intervention (6 Weeks)||19
10014262|NCT01798641|11137347|FG001|COMPLETED|Second Intervention (6 Weeks)||19
9772105|NCT00446446|10877370|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
9772106|NCT00446446|10877370|FG000|NOT COMPLETED|Overall Study||24
9772107|NCT00446459|10877374|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34
9772108|NCT00446459|10877374|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22
9772109|NCT00446459|10877374|FG000|NOT COMPLETED|8 Months||12
9772110|NCT00446459|10877374|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22
9772111|NCT00446459|10877374|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4
9772112|NCT00446459|10877374|FG000|NOT COMPLETED|12 Months||18
9772113|NCT00446511|10877382|FG000|STARTED|Overall Study||21
9772114|NCT00446511|10877383|FG001|STARTED|Overall Study||17
9772115|NCT00446511|10877384|FG002|STARTED|Overall Study||103
9772116|NCT00446511|10877385|FG003|STARTED|Overall Study||109
9772117|NCT00446511|10877382|FG000|COMPLETED|Overall Study||11
9772118|NCT00446511|10877383|FG001|COMPLETED|Overall Study||15
9772119|NCT00446511|10877384|FG002|COMPLETED|Overall Study||96
9772120|NCT00446511|10877385|FG003|COMPLETED|Overall Study||103
9772121|NCT00446511|10877382|FG000|NOT COMPLETED|Overall Study||10
9772122|NCT00446511|10877383|FG001|NOT COMPLETED|Overall Study||2
9772123|NCT00446511|10877384|FG002|NOT COMPLETED|Overall Study||7
9772124|NCT00446511|10877385|FG003|NOT COMPLETED|Overall Study||6
9772125|NCT00446550|10877399|FG000|STARTED|Overall Study||11
9772126|NCT00446550|10877400|FG001|STARTED|Overall Study||8
9772127|NCT00446550|10877399|FG000|Safety Population|Overall Study||11
9772128|NCT00446550|10877400|FG001|Safety Population|Overall Study||8
9772129|NCT00446550|10877399|FG000|PD Population|Overall Study||11
9772130|NCT00446550|10877400|FG001|PD Population|Overall Study||8
9772131|NCT00446550|10877399|FG000|COMPLETED|Overall Study||10
9772132|NCT00446550|10877400|FG001|COMPLETED|Overall Study||8
9772133|NCT00446550|10877399|FG000|NOT COMPLETED|Overall Study||1
9772134|NCT00446550|10877400|FG001|NOT COMPLETED|Overall Study||0
9772135|NCT00446563|10877409|FG000|STARTED|Overall Study||43
9772136|NCT00446563|10877410|FG001|STARTED|Overall Study||47
9772137|NCT00446563|10877409|FG000|COMPLETED|Overall Study||36
9772138|NCT00446563|10877410|FG001|COMPLETED|Overall Study||38
9772139|NCT00446563|10877409|FG000|NOT COMPLETED|Overall Study||7
9772140|NCT00446563|10877410|FG001|NOT COMPLETED|Overall Study||9
9772141|NCT00446641|10877418|FG000|STARTED|Overall Study||125
9772142|NCT00446641|10877419|FG001|STARTED|Overall Study||119
9772143|NCT00446641|10877418|FG000|COMPLETED|Overall Study||108
9772144|NCT00446641|10877419|FG001|COMPLETED|Overall Study||109
9772145|NCT00446641|10877418|FG000|NOT COMPLETED|Overall Study||17
9772146|NCT00446641|10877419|FG001|NOT COMPLETED|Overall Study||10
9772147|NCT00446654|10877427|FG000|STARTED|Overall Study||21
9772148|NCT00446654|10877428|FG001|STARTED|Overall Study||22
9772149|NCT00446654|10877427|FG000|COMPLETED|Overall Study||19
10014263|NCT01798641|11137346|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10014264|NCT01798641|11137347|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9772150|NCT00446654|10877428|FG001|COMPLETED|Overall Study||22
9772151|NCT00446654|10877427|FG000|NOT COMPLETED|Overall Study||2
9772152|NCT00446654|10877428|FG001|NOT COMPLETED|Overall Study||0
9772153|NCT00446797|10877436|FG000|STARTED|Overall Study||141
9772154|NCT00446797|10877437|FG001|STARTED|Overall Study||137
9772155|NCT00446797|10877436|FG000|COMPLETED|Overall Study||133
9772156|NCT00446797|10877437|FG001|COMPLETED|Overall Study||125
9772157|NCT00446797|10877436|FG000|NOT COMPLETED|Overall Study||8
9772158|NCT00446797|10877437|FG001|NOT COMPLETED|Overall Study||12
10014265|NCT01798706|11137356|FG000|STARTED|Overall Study||176
10014266|NCT01798706|11137357|FG001|STARTED|Overall Study||174
10014267|NCT01798706|11137356|FG000|COMPLETED|Overall Study||155
10014268|NCT01798706|11137357|FG001|COMPLETED|Overall Study||153
10014269|NCT01798706|11137356|FG000|NOT COMPLETED|Overall Study||21
10014270|NCT01798706|11137357|FG001|NOT COMPLETED|Overall Study||21
9772159|NCT00446849|10877443|FG000|STARTED|Acute Phase||138
9772160|NCT00446849|10877443|FG000|COMPLETED|Acute Phase||56
9772161|NCT00446849|10877443|FG000|NOT COMPLETED|Acute Phase||82
9772162|NCT00446849|10877443|FG000|STARTED|Maintenance Phase||208
9772163|NCT00446849|10877443|FG000|COMPLETED|Maintenance Phase||138
9772164|NCT00446849|10877443|FG000|NOT COMPLETED|Maintenance Phase||70
9772165|NCT00446966|10877450|FG000|STARTED|Overall Study||130
9772166|NCT00446966|10877451|FG001|STARTED|Overall Study||130
9772167|NCT00446966|10877450|FG000|COMPLETED|Overall Study||120
9772168|NCT00446966|10877451|FG001|COMPLETED|Overall Study||123
9772169|NCT00446966|10877450|FG000|NOT COMPLETED|Overall Study||10
9772170|NCT00446966|10877451|FG001|NOT COMPLETED|Overall Study||7
10014271|NCT01798849|11137366|FG000|STARTED|Overall Study||8
10014272|NCT01798849|11137367|FG001|STARTED|Overall Study||8
10014273|NCT01798849|11137368|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
10014274|NCT01798849|11137366|FG000|COMPLETED|Overall Study||8
9772171|NCT00446992|10877457|FG000|STARTED|Overall Study|Beginning of Intervention|30
9772172|NCT00446992|10877457|FG000|COMPLETED|Overall Study|Intervention Completion|14
9772173|NCT00446992|10877457|FG000|NOT COMPLETED|Overall Study||16
9772174|NCT00447005|10877461|FG000|STARTED|Overall Study||12
9772175|NCT00447005|10877461|FG000|COMPLETED|Overall Study||0
9772176|NCT00447005|10877461|FG000|NOT COMPLETED|Overall Study||12
9772177|NCT00447057|10877469|FG000|STARTED|Overall Study||83
9772178|NCT00447057|10877470|FG001|STARTED|Overall Study||76
9772179|NCT00447057|10877471|FG002|STARTED|Overall Study||19
9772180|NCT00447057|10877472|FG003|STARTED|Overall Study||26
9772181|NCT00447057|10877469|FG000|COMPLETED|Overall Study||0
9772182|NCT00447057|10877470|FG001|COMPLETED|Overall Study||3
9772183|NCT00447057|10877471|FG002|COMPLETED|Overall Study||0
9772184|NCT00447057|10877472|FG003|COMPLETED|Overall Study||0
9772185|NCT00447057|10877469|FG000|NOT COMPLETED|Overall Study||83
9772186|NCT00447057|10877470|FG001|NOT COMPLETED|Overall Study||73
9772187|NCT00447057|10877471|FG002|NOT COMPLETED|Overall Study||19
9772188|NCT00447057|10877472|FG003|NOT COMPLETED|Overall Study||26
9772189|NCT00447083|10877482|FG000|STARTED|Phase I||10
9772190|NCT00447083|10877483|FG001|STARTED|Phase I||9
9772191|NCT00447083|10877484|FG002|STARTED|Phase I||0
9772192|NCT00447083|10877485|FG003|STARTED|Phase I||0
9772193|NCT00447083|10877482|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
9772194|NCT00447083|10877483|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
9772195|NCT00447083|10877484|FG002|COMPLETED|Phase I||0
9772196|NCT00447083|10877485|FG003|COMPLETED|Phase I||0
9772197|NCT00447083|10877482|FG000|NOT COMPLETED|Phase I||0
9772198|NCT00447083|10877483|FG001|NOT COMPLETED|Phase I||0
9772199|NCT00447083|10877484|FG002|NOT COMPLETED|Phase I||0
9772200|NCT00447083|10877485|FG003|NOT COMPLETED|Phase I||0
9772201|NCT00447083|10877482|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
9772202|NCT00447083|10877483|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
9772203|NCT00447083|10877484|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
9772204|NCT00447083|10877485|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
9772205|NCT00447083|10877482|FG000|COMPLETED|Phase II||0
9772206|NCT00447083|10877483|FG001|COMPLETED|Phase II||0
9772207|NCT00447083|10877484|FG002|COMPLETED|Phase II||7
9772208|NCT00447083|10877485|FG003|COMPLETED|Phase II||7
9772209|NCT00447083|10877482|FG000|NOT COMPLETED|Phase II||0
9772210|NCT00447083|10877483|FG001|NOT COMPLETED|Phase II||0
9772211|NCT00447083|10877484|FG002|NOT COMPLETED|Phase II||1
9772212|NCT00447083|10877485|FG003|NOT COMPLETED|Phase II||1
9772213|NCT00447226|10877493|FG000|STARTED|12-Week Open-label Phase||0
9772214|NCT00447226|10877494|FG001|STARTED|12-Week Open-label Phase||32
9772215|NCT00447226|10877493|FG000|COMPLETED|12-Week Open-label Phase||0
9772216|NCT00447226|10877494|FG001|COMPLETED|12-Week Open-label Phase||7
9772217|NCT00447226|10877493|FG000|NOT COMPLETED|12-Week Open-label Phase||0
9772218|NCT00447226|10877494|FG001|NOT COMPLETED|12-Week Open-label Phase||25
9772219|NCT00447226|10877493|FG000|STARTED|Double-blind Phase||4
9772220|NCT00447226|10877494|FG001|STARTED|Double-blind Phase||3
9772221|NCT00447226|10877493|FG000|COMPLETED|Double-blind Phase||0
9772222|NCT00447226|10877494|FG001|COMPLETED|Double-blind Phase||0
9772223|NCT00447226|10877493|FG000|NOT COMPLETED|Double-blind Phase||4
9772224|NCT00447226|10877494|FG001|NOT COMPLETED|Double-blind Phase||3
9772225|NCT00447265|10877509|FG000|STARTED|Overall Study||1
9772226|NCT00447265|10877510|FG001|STARTED|Overall Study||0
9772227|NCT00447265|10877509|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
9772228|NCT00447265|10877510|FG001|COMPLETED|Overall Study||0
9772229|NCT00447265|10877509|FG000|NOT COMPLETED|Overall Study||1
9772230|NCT00447265|10877510|FG001|NOT COMPLETED|Overall Study||0
10014275|NCT01798849|11137367|FG001|COMPLETED|Overall Study||8
9772231|NCT00447278|10877516|FG000|STARTED|Period II (6 Month Open-Label)||199
9772232|NCT00447278|10877517|FG001|STARTED|Period II (6 Month Open-Label)||200
9772233|NCT00447278|10877516|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
9772234|NCT00447278|10877517|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
9772235|NCT00447278|10877516|FG000|COMPLETED|Period II (6 Month Open-Label)||157
9772236|NCT00447278|10877517|FG001|COMPLETED|Period II (6 Month Open-Label)||171
9772237|NCT00447278|10877516|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42
9772238|NCT00447278|10877517|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29
9772239|NCT00447278|10877516|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
9772240|NCT00447278|10877517|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
9772241|NCT00447278|10877516|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109
9772242|NCT00447278|10877517|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140
9772243|NCT00447278|10877516|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
9772244|NCT00447278|10877517|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
9772245|NCT00447330|10877524|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
9772246|NCT00447330|10877524|FG000|COMPLETED|Overall Study||58
9772247|NCT00447330|10877524|FG000|NOT COMPLETED|Overall Study||2
9772248|NCT00447382|10877531|FG000|STARTED|Overall Study||164
9772249|NCT00447382|10877532|FG001|STARTED|Overall Study||166
9772250|NCT00447382|10877531|FG000|COMPLETED|Overall Study||158
9772251|NCT00447382|10877532|FG001|COMPLETED|Overall Study||160
9772252|NCT00447382|10877531|FG000|NOT COMPLETED|Overall Study||6
9772253|NCT00447382|10877532|FG001|NOT COMPLETED|Overall Study||6
9772254|NCT00447499|10877538|FG000|STARTED|Overall Study||59
9772255|NCT00447499|10877538|FG000|COMPLETED|Overall Study||52
9772256|NCT00447499|10877538|FG000|NOT COMPLETED|Overall Study||7
9772257|NCT00447590|10877544|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
9772258|NCT00447590|10877544|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
9772259|NCT00447590|10877544|FG000|NOT COMPLETED|Overall Study||60
9772260|NCT00447694|10877548|FG000|STARTED|Overall Study||28
9772261|NCT00447694|10877548|FG000|COMPLETED|Overall Study||22
9772262|NCT00447694|10877548|FG000|NOT COMPLETED|Overall Study||6
9772263|NCT00447772|10877552|FG000|STARTED|Overall Study||516
9772264|NCT00447772|10877552|FG000|COMPLETED|Overall Study||489
9772265|NCT00447772|10877552|FG000|NOT COMPLETED|Overall Study||27
9772266|NCT00447876|10877561|FG000|STARTED|Overall Study||20
9772267|NCT00447876|10877562|FG001|STARTED|Overall Study||20
9772268|NCT00447876|10877561|FG000|COMPLETED|Overall Study||17
9772269|NCT00447876|10877562|FG001|COMPLETED|Overall Study||16
9772270|NCT00447876|10877561|FG000|NOT COMPLETED|Overall Study||3
9772271|NCT00447876|10877562|FG001|NOT COMPLETED|Overall Study||4
9829831|NCT00761592|10940530|FG001|NOT COMPLETED|Overall Study||1
9829832|NCT00761605|10940536|FG000|STARTED|Overall Study||387
9829833|NCT00761605|10940536|FG000|COMPLETED|Overall Study||246
9829834|NCT00761605|10940536|FG000|NOT COMPLETED|Overall Study||141
9829835|NCT00761631|10940548|FG000|STARTED|Overall Study||126
9829836|NCT00761631|10940549|FG001|STARTED|Overall Study||181
9829837|NCT00761631|10940550|FG002|STARTED|Overall Study||176
9829838|NCT00761631|10940551|FG003|STARTED|Overall Study||119
9829839|NCT00761631|10940552|FG004|STARTED|Overall Study||299
9829840|NCT00761631|10940553|FG005|STARTED|Overall Study||299
9829841|NCT00761631|10940548|FG000|Vaccinated Dose 1|Overall Study||124
9829842|NCT00761631|10940549|FG001|Vaccinated Dose 1|Overall Study||179
9829843|NCT00761631|10940550|FG002|Vaccinated Dose 1|Overall Study||175
9829844|NCT00761631|10940551|FG003|Vaccinated Dose 1|Overall Study||118
9829845|NCT00761631|10940552|FG004|Vaccinated Dose 1|Overall Study||294
9829846|NCT00761631|10940553|FG005|Vaccinated Dose 1|Overall Study||298
9829847|NCT00761631|10940548|FG000|Vaccinated Dose 2|Overall Study||112
9829848|NCT00761631|10940549|FG001|Vaccinated Dose 2|Overall Study||0
9829849|NCT00761631|10940550|FG002|Vaccinated Dose 2|Overall Study||165
9829850|NCT00761631|10940551|FG003|Vaccinated Dose 2|Overall Study||0
9829851|NCT00761631|10940552|FG004|Vaccinated Dose 2|Overall Study||0
9829852|NCT00761631|10940553|FG005|Vaccinated Dose 2|Overall Study||0
9829853|NCT00761631|10940548|FG000|COMPLETED|Overall Study||111
9829854|NCT00761631|10940549|FG001|COMPLETED|Overall Study||174
9829855|NCT00761631|10940550|FG002|COMPLETED|Overall Study||160
9829856|NCT00761631|10940551|FG003|COMPLETED|Overall Study||116
9829857|NCT00761631|10940552|FG004|COMPLETED|Overall Study||277
9829858|NCT00761631|10940553|FG005|COMPLETED|Overall Study||294
9829859|NCT00761631|10940548|FG000|NOT COMPLETED|Overall Study||15
9829860|NCT00761631|10940549|FG001|NOT COMPLETED|Overall Study||7
9829861|NCT00761631|10940550|FG002|NOT COMPLETED|Overall Study||16
9829862|NCT00761631|10940551|FG003|NOT COMPLETED|Overall Study||3
9829863|NCT00761631|10940552|FG004|NOT COMPLETED|Overall Study||22
9829864|NCT00761631|10940553|FG005|NOT COMPLETED|Overall Study||5
9829865|NCT00761657|10940585|FG000|STARTED|Part 1 (up to Day 57)||0
9829866|NCT00761657|10940586|FG001|STARTED|Part 1 (up to Day 57)||0
9829867|NCT00761657|10940587|FG002|STARTED|Part 1 (up to Day 57)||12
9829868|NCT00761657|10940588|FG003|STARTED|Part 1 (up to Day 57)||10
9829869|NCT00761657|10940589|FG004|STARTED|Part 1 (up to Day 57)||0
9829870|NCT00761657|10940590|FG005|STARTED|Part 1 (up to Day 57)||0
9829871|NCT00761657|10940591|FG006|STARTED|Part 1 (up to Day 57)||1
9829872|NCT00761657|10940592|FG007|STARTED|Part 1 (up to Day 57)||2
9772272|NCT00447902|10877570|FG000|STARTED|Overall Study||5
9772273|NCT00447902|10877571|FG001|STARTED|Overall Study||6
9772274|NCT00447902|10877570|FG000|COMPLETED|Overall Study||1
9772275|NCT00447902|10877571|FG001|COMPLETED|Overall Study||0
9772276|NCT00447902|10877570|FG000|NOT COMPLETED|Overall Study||4
9772277|NCT00447902|10877571|FG001|NOT COMPLETED|Overall Study||6
9772278|NCT00448019|10877577|FG000|STARTED|Overall Study||64
9772279|NCT00448019|10877577|FG000|COMPLETED|Overall Study||57
9772280|NCT00448019|10877577|FG000|NOT COMPLETED|Overall Study||7
9772281|NCT00448123|10877583|FG000|STARTED|Overall Study||62
9772282|NCT00448123|10877584|FG001|STARTED|Overall Study||65
9772283|NCT00448123|10877583|FG000|COMPLETED|Overall Study||47
9772284|NCT00448123|10877584|FG001|COMPLETED|Overall Study||53
9772285|NCT00448123|10877583|FG000|NOT COMPLETED|Overall Study||15
9772286|NCT00448123|10877584|FG001|NOT COMPLETED|Overall Study||12
9772287|NCT00448136|10877595|FG000|STARTED|Overall Study||34
9772288|NCT00448136|10877596|FG001|STARTED|Overall Study||49
9772289|NCT00448136|10877595|FG000|COMPLETED|Overall Study||30
9772290|NCT00448136|10877596|FG001|COMPLETED|Overall Study||41
9772291|NCT00448136|10877595|FG000|NOT COMPLETED|Overall Study||4
9772292|NCT00448136|10877596|FG001|NOT COMPLETED|Overall Study||8
9772293|NCT00448175|10877604|FG000|STARTED|12 Weeks PTNS vs. Drug||50
9772294|NCT00448175|10877605|FG001|STARTED|12 Weeks PTNS vs. Drug||50
9772295|NCT00448175|10877604|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41
9772296|NCT00448175|10877605|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43
9772297|NCT00448175|10877604|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
9772298|NCT00448175|10877605|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
9772299|NCT00448175|10877604|FG000|STARTED|Continued PTNS Through 12 Months||35
9772300|NCT00448175|10877605|FG001|STARTED|Continued PTNS Through 12 Months||0
9772301|NCT00448175|10877604|FG000|COMPLETED|Continued PTNS Through 12 Months||25
9772302|NCT00448175|10877605|FG001|COMPLETED|Continued PTNS Through 12 Months||0
9772303|NCT00448175|10877604|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10
9772304|NCT00448175|10877605|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0
9772305|NCT00448201|10877611|FG000|STARTED|Overall Study||71
9772306|NCT00448201|10877611|FG000|COMPLETED|Overall Study||71
9772307|NCT00448201|10877611|FG000|NOT COMPLETED|Overall Study||0
9772308|NCT00448227|10877617|FG000|STARTED|Overall Study||18
9772309|NCT00448227|10877617|FG000|COMPLETED|Overall Study||18
9772310|NCT00448227|10877617|FG000|NOT COMPLETED|Overall Study||0
9772311|NCT00448279|10877626|FG000|STARTED|Overall Study||29
9772312|NCT00448279|10877627|FG001|STARTED|Overall Study||29
9772313|NCT00448279|10877626|FG000|COMPLETED|Overall Study||0
9772314|NCT00448279|10877627|FG001|COMPLETED|Overall Study||0
9772315|NCT00448279|10877626|FG000|NOT COMPLETED|Overall Study||29
9772316|NCT00448279|10877627|FG001|NOT COMPLETED|Overall Study||29
9772317|NCT00448344|10877635|FG000|STARTED|Overall Study||235
9772318|NCT00448344|10877636|FG001|STARTED|Overall Study||236
9772319|NCT00448344|10877635|FG000|COMPLETED|Overall Study||205
9772320|NCT00448344|10877636|FG001|COMPLETED|Overall Study||200
9772321|NCT00448344|10877635|FG000|NOT COMPLETED|Overall Study||30
9772322|NCT00448344|10877636|FG001|NOT COMPLETED|Overall Study||36
9772323|NCT00448357|10877642|FG000|STARTED|Overall Study||54
9772324|NCT00448357|10877642|FG000|COMPLETED|Overall Study||54
9772325|NCT00448357|10877642|FG000|NOT COMPLETED|Overall Study||0
9772326|NCT00448435|10877658|FG000|STARTED|Treatment Period I - 4 Weeks||26
9772327|NCT00448435|10877659|FG001|STARTED|Treatment Period I - 4 Weeks||25
9772328|NCT00448435|10877658|FG000|COMPLETED|Treatment Period I - 4 Weeks||26
9772329|NCT00448435|10877659|FG001|COMPLETED|Treatment Period I - 4 Weeks||25
9772330|NCT00448435|10877658|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0
9772331|NCT00448435|10877659|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0
9772332|NCT00448435|10877658|FG000|STARTED|Washout Period - 2 Weeks||26
9772333|NCT00448435|10877659|FG001|STARTED|Washout Period - 2 Weeks||25
9772334|NCT00448435|10877658|FG000|COMPLETED|Washout Period - 2 Weeks||25
9772335|NCT00448435|10877659|FG001|COMPLETED|Washout Period - 2 Weeks||25
9772336|NCT00448435|10877658|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1
9772337|NCT00448435|10877659|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0
9772338|NCT00448435|10877658|FG000|STARTED|Treatment Period II - 4 Weeks||25
9772339|NCT00448435|10877659|FG001|STARTED|Treatment Period II - 4 Weeks||25
9772340|NCT00448435|10877658|FG000|COMPLETED|Treatment Period II - 4 Weeks||25
9772341|NCT00448435|10877659|FG001|COMPLETED|Treatment Period II - 4 Weeks||25
9772342|NCT00448435|10877658|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0
9772343|NCT00448435|10877659|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0
9772344|NCT00448435|10877658|FG000|STARTED|Extension Period - 20 Weeks||50
9772345|NCT00448435|10877659|FG001|STARTED|Extension Period - 20 Weeks||0
9772346|NCT00448435|10877658|FG000|COMPLETED|Extension Period - 20 Weeks||50
9772347|NCT00448435|10877659|FG001|COMPLETED|Extension Period - 20 Weeks||0
9772348|NCT00448435|10877658|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0
9772349|NCT00448435|10877659|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0
9772350|NCT00448448|10877670|FG000|STARTED|Overall Study||246
9772351|NCT00448448|10877671|FG001|STARTED|Overall Study||137
9772352|NCT00448448|10877670|FG000|COMPLETED|Overall Study||146
9772353|NCT00448448|10877671|FG001|COMPLETED|Overall Study||96
9772354|NCT00448448|10877670|FG000|NOT COMPLETED|Overall Study||100
9772355|NCT00448448|10877671|FG001|NOT COMPLETED|Overall Study||41
9772356|NCT00448539|10877679|FG000|STARTED|Overall Study||134
9772357|NCT00448539|10877680|FG001|STARTED|Overall Study||152
9772358|NCT00448539|10877679|FG000|COMPLETED|Overall Study||0
9772359|NCT00448539|10877680|FG001|COMPLETED|Overall Study||0
9772360|NCT00448539|10877679|FG000|NOT COMPLETED|Overall Study||134
9772361|NCT00448539|10877680|FG001|NOT COMPLETED|Overall Study||152
9772362|NCT00448591|10877686|FG000|STARTED|Overall Study||2296
9772363|NCT00448591|10877686|FG000|COMPLETED|Overall Study||0
9772364|NCT00448591|10877686|FG000|NOT COMPLETED|Overall Study||2296
9772365|NCT00448669|10877694|FG000|STARTED|Overall Study||611
9772366|NCT00448669|10877695|FG001|STARTED|Overall Study||608
9772367|NCT00448669|10877694|FG000|COMPLETED|Overall Study||393
9772368|NCT00448669|10877695|FG001|COMPLETED|Overall Study||410
9772369|NCT00448669|10877694|FG000|NOT COMPLETED|Overall Study||218
9772370|NCT00448669|10877695|FG001|NOT COMPLETED|Overall Study||198
9772371|NCT00448708|10877705|FG000|STARTED|Overall Study||112
9772372|NCT00448708|10877706|FG001|STARTED|Overall Study||110
9772373|NCT00448708|10877705|FG000|COMPLETED|Overall Study||77
9772374|NCT00448708|10877706|FG001|COMPLETED|Overall Study||79
9772375|NCT00448708|10877705|FG000|NOT COMPLETED|Overall Study||35
9772376|NCT00448708|10877706|FG001|NOT COMPLETED|Overall Study||31
9772377|NCT00448747|10877714|FG000|STARTED|Overall Study||53
9772378|NCT00448747|10877715|FG001|STARTED|Overall Study||48
9772379|NCT00448747|10877714|FG000|Received First Drug Administration|Overall Study||53
9772380|NCT00448747|10877715|FG001|Received First Drug Administration|Overall Study||48
9772381|NCT00448747|10877714|FG000|Received Second Drug Administration|Overall Study||42
9772382|NCT00448747|10877715|FG001|Received Second Drug Administration|Overall Study||10
9772383|NCT00448747|10877714|FG000|Received AEZS-130|Overall Study||52
9772384|NCT00448747|10877715|FG001|Received AEZS-130|Overall Study||48
9772385|NCT00448747|10877714|FG000|Received L-ARG-GHRH|Overall Study||43
9772386|NCT00448747|10877715|FG001|Received L-ARG-GHRH|Overall Study||10
9772387|NCT00448747|10877714|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42
9772388|NCT00448747|10877715|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10
9772389|NCT00448747|10877714|FG000|Per Protocol Population (PPS)|Overall Study||50
9772390|NCT00448747|10877715|FG001|Per Protocol Population (PPS)|Overall Study||48
9772391|NCT00448747|10877714|FG000|COMPLETED|Overall Study||52
9772392|NCT00448747|10877715|FG001|COMPLETED|Overall Study||48
9772393|NCT00448747|10877714|FG000|NOT COMPLETED|Overall Study||1
9772394|NCT00448747|10877715|FG001|NOT COMPLETED|Overall Study||0
9772395|NCT00448760|10877731|FG000|STARTED|Overall Study||29
9772396|NCT00448760|10877731|FG000|COMPLETED|Overall Study||26
9772397|NCT00448760|10877731|FG000|NOT COMPLETED|Overall Study||3
9772398|NCT00448812|10877737|FG000|STARTED|Year 1||45
9772399|NCT00448812|10877738|FG001|STARTED|Year 1||24
9772400|NCT00448812|10877737|FG000|COMPLETED|Year 1||45
9772401|NCT00448812|10877738|FG001|COMPLETED|Year 1||24
9772402|NCT00448812|10877737|FG000|NOT COMPLETED|Year 1||0
9772403|NCT00448812|10877738|FG001|NOT COMPLETED|Year 1||0
9772404|NCT00448812|10877737|FG000|STARTED|Year 2||45
9772405|NCT00448812|10877738|FG001|STARTED|Year 2||24
9772406|NCT00448812|10877737|FG000|COMPLETED|Year 2||41
9772407|NCT00448812|10877738|FG001|COMPLETED|Year 2||23
9772408|NCT00448812|10877737|FG000|NOT COMPLETED|Year 2||4
9772409|NCT00448812|10877738|FG001|NOT COMPLETED|Year 2||1
9772410|NCT00448812|10877737|FG000|STARTED|Year 3||45
9772411|NCT00448812|10877738|FG001|STARTED|Year 3||24
9772412|NCT00448812|10877737|FG000|COMPLETED|Year 3||41
9772413|NCT00448812|10877738|FG001|COMPLETED|Year 3||21
9772414|NCT00448812|10877737|FG000|NOT COMPLETED|Year 3||4
9772415|NCT00448812|10877738|FG001|NOT COMPLETED|Year 3||3
9772416|NCT00448812|10877737|FG000|STARTED|Year 4||43
9772417|NCT00448812|10877738|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
9772418|NCT00448812|10877737|FG000|COMPLETED|Year 4||43
9772419|NCT00448812|10877738|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
9772420|NCT00448812|10877737|FG000|NOT COMPLETED|Year 4||0
9772421|NCT00448812|10877738|FG001|NOT COMPLETED|Year 4||0
9772422|NCT00448812|10877737|FG000|STARTED|Year 5||43
9772423|NCT00448812|10877738|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
9772424|NCT00448812|10877737|FG000|COMPLETED|Year 5||42
9772425|NCT00448812|10877738|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
9772426|NCT00448812|10877737|FG000|NOT COMPLETED|Year 5||1
9772427|NCT00448812|10877738|FG001|NOT COMPLETED|Year 5||0
9772428|NCT00448864|10877759|FG000|STARTED|Overall Study||27
9772429|NCT00448864|10877760|FG001|STARTED|Overall Study||29
9772430|NCT00448864|10877761|FG002|STARTED|Overall Study||19
9772431|NCT00448864|10877759|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
9772432|NCT00448864|10877760|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25
9772433|NCT00448864|10877761|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18
9772434|NCT00448864|10877759|FG000|Started Post-operative Period|Overall Study||26
9772435|NCT00448864|10877760|FG001|Started Post-operative Period|Overall Study||25
9772436|NCT00448864|10877761|FG002|Started Post-operative Period|Overall Study||18
9772437|NCT00448864|10877759|FG000|Completed Post-operative Period|Overall Study||26
9772438|NCT00448864|10877760|FG001|Completed Post-operative Period|Overall Study||25
9772439|NCT00448864|10877761|FG002|Completed Post-operative Period|Overall Study||18
9772440|NCT00448864|10877759|FG000|COMPLETED|Overall Study||22
9772441|NCT00448864|10877760|FG001|COMPLETED|Overall Study||24
9772442|NCT00448864|10877761|FG002|COMPLETED|Overall Study||18
9772443|NCT00448864|10877759|FG000|NOT COMPLETED|Overall Study||5
9772444|NCT00448864|10877760|FG001|NOT COMPLETED|Overall Study||5
9772445|NCT00448864|10877761|FG002|NOT COMPLETED|Overall Study||1
9772446|NCT00448916|10877775|FG000|STARTED|Overall Study||16
9772447|NCT00448916|10877776|FG001|STARTED|Overall Study||15
9772448|NCT00448916|10877777|FG002|STARTED|Overall Study||12
9772449|NCT00448916|10877778|FG003|STARTED|Overall Study||11
9772450|NCT00448916|10877775|FG000|COMPLETED|Overall Study||9
9772451|NCT00448916|10877776|FG001|COMPLETED|Overall Study||9
9772452|NCT00448916|10877777|FG002|COMPLETED|Overall Study||6
9772453|NCT00448916|10877778|FG003|COMPLETED|Overall Study||5
9772454|NCT00448916|10877775|FG000|NOT COMPLETED|Overall Study||7
9772455|NCT00448916|10877776|FG001|NOT COMPLETED|Overall Study||6
9772456|NCT00448916|10877777|FG002|NOT COMPLETED|Overall Study||6
9772457|NCT00448916|10877778|FG003|NOT COMPLETED|Overall Study||6
9772458|NCT00449007|10877792|FG000|STARTED|Overall Study||2
9772459|NCT00449007|10877793|FG001|STARTED|Overall Study||3
9772460|NCT00449007|10877792|FG000|COMPLETED|Overall Study||2
9772461|NCT00449007|10877793|FG001|COMPLETED|Overall Study||3
9772462|NCT00449007|10877792|FG000|NOT COMPLETED|Overall Study||0
9772463|NCT00449007|10877793|FG001|NOT COMPLETED|Overall Study||0
9772464|NCT00449033|10877803|FG000|STARTED|Treatment Period||452
9772465|NCT00449033|10877804|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
9772466|NCT00449033|10877803|FG000|Received Treatment|Treatment Period||452
9772467|NCT00449033|10877804|FG001|Received Treatment|Treatment Period||449
9772468|NCT00449033|10877803|FG000|COMPLETED|Treatment Period||0
9772469|NCT00449033|10877804|FG001|COMPLETED|Treatment Period||0
9772470|NCT00449033|10877803|FG000|NOT COMPLETED|Treatment Period||452
9772471|NCT00449033|10877804|FG001|NOT COMPLETED|Treatment Period||452
9772472|NCT00449033|10877803|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
9772473|NCT00449033|10877804|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
9772474|NCT00449033|10877803|FG000|COMPLETED|Follow-up Period||0
9772475|NCT00449033|10877804|FG001|COMPLETED|Follow-up Period||0
9772476|NCT00449033|10877803|FG000|NOT COMPLETED|Follow-up Period||425
9772477|NCT00449033|10877804|FG001|NOT COMPLETED|Follow-up Period||434
9772478|NCT00449046|10877810|FG000|STARTED|Overall Study||40
9772479|NCT00449046|10877810|FG000|COMPLETED|Overall Study||40
9772480|NCT00449046|10877810|FG000|NOT COMPLETED|Overall Study||0
9772481|NCT00449072|10877816|FG000|STARTED|Overall Study||148
9772482|NCT00449072|10877817|FG001|STARTED|Overall Study||151
9772483|NCT00449072|10877816|FG000|COMPLETED|Overall Study||107
9772484|NCT00449072|10877817|FG001|COMPLETED|Overall Study||109
9772485|NCT00449072|10877816|FG000|NOT COMPLETED|Overall Study||41
9772486|NCT00449072|10877817|FG001|NOT COMPLETED|Overall Study||42
9772487|NCT00449150|10877826|FG000|STARTED|Overall Study||219
9772488|NCT00449150|10877827|FG001|STARTED|Overall Study||230
9772489|NCT00449150|10877828|FG002|STARTED|Overall Study||218
9772490|NCT00449150|10877826|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
9772491|NCT00449150|10877827|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
9772492|NCT00449150|10877828|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
9772493|NCT00449150|10877826|FG000|NOT COMPLETED|Overall Study||46
9772494|NCT00449150|10877827|FG001|NOT COMPLETED|Overall Study||53
9772495|NCT00449150|10877828|FG002|NOT COMPLETED|Overall Study||47
9772496|NCT00449163|10877839|FG000|STARTED|Overall Study||25
9772497|NCT00449163|10877839|FG000|COMPLETED|Overall Study||22
9772498|NCT00449163|10877839|FG000|NOT COMPLETED|Overall Study||3
9772499|NCT00449176|10877846|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
9772500|NCT00449176|10877847|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
9772501|NCT00449176|10877848|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
9772502|NCT00449176|10877846|FG000|COMPLETED|Overall Study||166
9772503|NCT00449176|10877847|FG001|COMPLETED|Overall Study||133
9772504|NCT00449176|10877848|FG002|COMPLETED|Overall Study||152
9772505|NCT00449176|10877846|FG000|NOT COMPLETED|Overall Study||152
9772506|NCT00449176|10877847|FG001|NOT COMPLETED|Overall Study||195
9772507|NCT00449176|10877848|FG002|NOT COMPLETED|Overall Study||167
9772508|NCT00449540|10877858|FG000|STARTED|Pretreatment Phase||267
9772509|NCT00449540|10877859|FG001|STARTED|Pretreatment Phase||0
9772510|NCT00449540|10877860|FG002|STARTED|Pretreatment Phase||0
9772511|NCT00449540|10877858|FG000|COMPLETED|Pretreatment Phase||201
9772512|NCT00449540|10877859|FG001|COMPLETED|Pretreatment Phase||0
9772513|NCT00449540|10877860|FG002|COMPLETED|Pretreatment Phase||0
9772514|NCT00449540|10877858|FG000|NOT COMPLETED|Pretreatment Phase||66
9772515|NCT00449540|10877859|FG001|NOT COMPLETED|Pretreatment Phase||0
9772516|NCT00449540|10877860|FG002|NOT COMPLETED|Pretreatment Phase||0
9772517|NCT00449540|10877858|FG000|STARTED|Treatment Phase||0
9772518|NCT00449540|10877859|FG001|STARTED|Treatment Phase||102
9772519|NCT00449540|10877860|FG002|STARTED|Treatment Phase||99
9772520|NCT00449540|10877858|FG000|COMPLETED|Treatment Phase||0
9772521|NCT00449540|10877859|FG001|COMPLETED|Treatment Phase||82
9772522|NCT00449540|10877860|FG002|COMPLETED|Treatment Phase||82
10014276|NCT01798849|11137368|FG002|COMPLETED|Overall Study||8
10014277|NCT01798849|11137366|FG000|NOT COMPLETED|Overall Study||0
10014278|NCT01798849|11137367|FG001|NOT COMPLETED|Overall Study||0
10014279|NCT01798849|11137368|FG002|NOT COMPLETED|Overall Study||1
9772523|NCT00449540|10877858|FG000|NOT COMPLETED|Treatment Phase||0
9772524|NCT00449540|10877859|FG001|NOT COMPLETED|Treatment Phase||20
10014280|NCT01798927|11137405|FG000|STARTED|Overall Study||4
10014281|NCT01798927|11137405|FG000|COMPLETED|Overall Study||3
9772525|NCT00449540|10877860|FG002|NOT COMPLETED|Treatment Phase||17
9772526|NCT00449644|10877872|FG000|STARTED|Overall Study||23
9772527|NCT00449644|10877873|FG001|STARTED|Overall Study||24
9772528|NCT00449644|10877874|FG002|STARTED|Overall Study||79
9772529|NCT00449644|10877875|FG003|STARTED|Overall Study||81
9772530|NCT00449644|10877872|FG000|Rollover|Overall Study||0
9772531|NCT00449644|10877873|FG001|Rollover|Overall Study||0
9772532|NCT00449644|10877874|FG002|Rollover|Overall Study||0
9772533|NCT00449644|10877875|FG003|Rollover|Overall Study||1
9772534|NCT00449644|10877872|FG000|COMPLETED|Overall Study||13
9772535|NCT00449644|10877873|FG001|COMPLETED|Overall Study||11
9772536|NCT00449644|10877874|FG002|COMPLETED|Overall Study||50
9772537|NCT00449644|10877875|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
9772538|NCT00449644|10877872|FG000|NOT COMPLETED|Overall Study||10
9772539|NCT00449644|10877873|FG001|NOT COMPLETED|Overall Study||13
9772540|NCT00449644|10877874|FG002|NOT COMPLETED|Overall Study||29
9772541|NCT00449644|10877875|FG003|NOT COMPLETED|Overall Study||32
9772542|NCT00449670|10877890|FG000|STARTED|Primary Phase (Study no.109630)||961
9772543|NCT00449670|10877891|FG001|STARTED|Primary Phase (Study no.109630)||245
9772544|NCT00449670|10877890|FG000|COMPLETED|Primary Phase (Study no.109630)||947
9772545|NCT00449670|10877891|FG001|COMPLETED|Primary Phase (Study no.109630)||243
9772546|NCT00449670|10877890|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14
9772547|NCT00449670|10877891|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2
9772548|NCT00449670|10877890|FG000|STARTED|Booster Phase (Study no.109873)||265
9772549|NCT00449670|10877891|FG001|STARTED|Booster Phase (Study no.109873)||236
9772550|NCT00449670|10877890|FG000|COMPLETED|Booster Phase (Study no.109873)||265
9772551|NCT00449670|10877891|FG001|COMPLETED|Booster Phase (Study no.109873)||233
9772552|NCT00449670|10877890|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0
9772553|NCT00449670|10877891|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3
9772554|NCT00449696|10877906|FG000|STARTED|Overall Study||251
9772555|NCT00449696|10877907|FG001|STARTED|Overall Study||128
9772556|NCT00449696|10877906|FG000|Received Injection|Overall Study||249
9772557|NCT00449696|10877907|FG001|Received Injection|Overall Study||128
9772558|NCT00449696|10877906|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
9772559|NCT00449696|10877907|FG001|Analyzed Participants|Overall Study||128
9772560|NCT00449696|10877906|FG000|COMPLETED|Overall Study||231
9772561|NCT00449696|10877907|FG001|COMPLETED|Overall Study||119
9772562|NCT00449696|10877906|FG000|NOT COMPLETED|Overall Study||20
9772563|NCT00449696|10877907|FG001|NOT COMPLETED|Overall Study||9
9772564|NCT00449748|10877913|FG000|STARTED|Overall Study||10
9772565|NCT00449748|10877913|FG000|COMPLETED|Overall Study||10
9772566|NCT00449748|10877913|FG000|NOT COMPLETED|Overall Study||0
9772567|NCT00449761|10877917|FG000|STARTED|Overall Study||27
9772568|NCT00449761|10877917|FG000|COMPLETED|Overall Study||9
9772569|NCT00449761|10877917|FG000|NOT COMPLETED|Overall Study||18
9772570|NCT00449787|10877924|FG000|STARTED|Overall Study||203
9772571|NCT00449787|10877925|FG001|STARTED|Overall Study||198
9772572|NCT00449787|10877924|FG000|COMPLETED|Overall Study||98
9772573|NCT00449787|10877925|FG001|COMPLETED|Overall Study||98
9772574|NCT00449787|10877924|FG000|NOT COMPLETED|Overall Study||105
9772575|NCT00449787|10877925|FG001|NOT COMPLETED|Overall Study||100
9772576|NCT00449865|10877935|FG000|STARTED|Overall Study||867
9772577|NCT00449865|10877936|FG001|STARTED|Overall Study||874
9772578|NCT00449865|10877935|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802
9772579|NCT00449865|10877936|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822
9772580|NCT00449865|10877935|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768
9772581|NCT00449865|10877936|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766
9772582|NCT00449865|10877935|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719
9772583|NCT00449865|10877936|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715
9772584|NCT00449865|10877935|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521
9772585|NCT00449865|10877936|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523
9772586|NCT00449865|10877935|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345
9772587|NCT00449865|10877936|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340
9772588|NCT00449865|10877935|FG000|NOT COMPLETED|Overall Study||522
9772589|NCT00449865|10877936|FG001|NOT COMPLETED|Overall Study||534
9772590|NCT00449930|10877944|FG000|STARTED|Overall Study||528
9772591|NCT00449930|10877945|FG001|STARTED|Overall Study||522
9772592|NCT00449930|10877944|FG000|COMPLETED|Overall Study||467
9772593|NCT00449930|10877945|FG001|COMPLETED|Overall Study||447
9772594|NCT00449930|10877944|FG000|NOT COMPLETED|Overall Study||61
9772595|NCT00449930|10877945|FG001|NOT COMPLETED|Overall Study||75
9772596|NCT00449956|10877954|FG000|STARTED|Overall Study||189
9772597|NCT00449956|10877955|FG001|STARTED|Overall Study||92
9772598|NCT00449956|10877956|FG002|STARTED|Overall Study||193
9772599|NCT00449956|10877954|FG000|COMPLETED|Overall Study||179
9772600|NCT00449956|10877955|FG001|COMPLETED|Overall Study||88
9772601|NCT00449956|10877956|FG002|COMPLETED|Overall Study||184
9772602|NCT00449956|10877954|FG000|NOT COMPLETED|Overall Study||10
9772603|NCT00449956|10877955|FG001|NOT COMPLETED|Overall Study||4
9772604|NCT00449956|10877956|FG002|NOT COMPLETED|Overall Study||9
9772605|NCT00450073|10877967|FG000|STARTED|Overall Study||10
9772606|NCT00450073|10877968|FG001|STARTED|Overall Study||10
9772607|NCT00450073|10877969|FG002|STARTED|Overall Study||10
9772608|NCT00450073|10877967|FG000|COMPLETED|Overall Study||9
9772609|NCT00450073|10877968|FG001|COMPLETED|Overall Study||10
9772610|NCT00450073|10877969|FG002|COMPLETED|Overall Study||9
9772611|NCT00450073|10877967|FG000|NOT COMPLETED|Overall Study||1
9772612|NCT00450073|10877968|FG001|NOT COMPLETED|Overall Study||0
9772613|NCT00450073|10877969|FG002|NOT COMPLETED|Overall Study||1
9772614|NCT00450112|10877979|FG000|STARTED|Overall Study||125
9772615|NCT00450112|10877980|FG001|STARTED|Overall Study||77
9772616|NCT00450112|10877979|FG000|Received Injection|Overall Study||125
9772617|NCT00450112|10877980|FG001|Received Injection|Overall Study||74
9772618|NCT00450112|10877979|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
9772619|NCT00450112|10877980|FG001|Analyzed Participants|Overall Study||74
9772620|NCT00450112|10877979|FG000|COMPLETED|Overall Study||112
9772621|NCT00450112|10877980|FG001|COMPLETED|Overall Study||71
9772622|NCT00450112|10877979|FG000|NOT COMPLETED|Overall Study||13
9772623|NCT00450112|10877980|FG001|NOT COMPLETED|Overall Study||6
9772624|NCT00450177|10877988|FG000|STARTED|Overall Study||97
9772625|NCT00450177|10877989|FG001|STARTED|Overall Study||103
9772626|NCT00450177|10877988|FG000|COMPLETED|Overall Study||88
9772627|NCT00450177|10877989|FG001|COMPLETED|Overall Study||92
9772628|NCT00450177|10877988|FG000|NOT COMPLETED|Overall Study||9
9772629|NCT00450177|10877989|FG001|NOT COMPLETED|Overall Study||11
9772630|NCT00450190|10877995|FG000|STARTED|Overall Study||20
9772631|NCT00450190|10877995|FG000|COMPLETED|Overall Study||18
9772632|NCT00450190|10877995|FG000|NOT COMPLETED|Overall Study||2
9772633|NCT00450216|10878001|FG000|STARTED|Overall Study||607
9772634|NCT00450216|10878002|FG001|STARTED|Overall Study||299
9772635|NCT00450216|10878001|FG000|COMPLETED|Overall Study||433
9772636|NCT00450216|10878002|FG001|COMPLETED|Overall Study||170
9772637|NCT00450216|10878001|FG000|NOT COMPLETED|Overall Study||174
9772638|NCT00450216|10878002|FG001|NOT COMPLETED|Overall Study||129
9772639|NCT00450242|10878010|FG000|STARTED|Overall Study||7
9772640|NCT00450242|10878011|FG001|STARTED|Overall Study||7
9772641|NCT00450242|10878010|FG000|COMPLETED|Overall Study||4
9772642|NCT00450242|10878011|FG001|COMPLETED|Overall Study||6
9772643|NCT00450242|10878010|FG000|NOT COMPLETED|Overall Study||3
9772644|NCT00450242|10878011|FG001|NOT COMPLETED|Overall Study||1
9772645|NCT00450255|10878019|FG000|STARTED|Overall Study||41
9772646|NCT00450255|10878019|FG000|COMPLETED|Overall Study||40
9772647|NCT00450255|10878019|FG000|NOT COMPLETED|Overall Study||1
9772648|NCT00450294|10878024|FG000|STARTED|Overall Study||10
9772649|NCT00450294|10878024|FG000|COMPLETED|Overall Study||10
9772650|NCT00450294|10878024|FG000|NOT COMPLETED|Overall Study||0
9772651|NCT00450372|10878029|FG000|STARTED|Overall Study||38
9772652|NCT00450372|10878029|FG000|COMPLETED|Overall Study||37
9772653|NCT00450372|10878029|FG000|NOT COMPLETED|Overall Study||1
9772654|NCT00450385|10878036|FG000|STARTED|Overall Study||57
9772655|NCT00450385|10878036|FG000|COMPLETED|Overall Study||44
9772656|NCT00450385|10878036|FG000|NOT COMPLETED|Overall Study||13
9772657|NCT00450424|10878043|FG000|STARTED|Overall Study||122
9772658|NCT00450424|10878044|FG001|STARTED|Overall Study||117
9772659|NCT00450424|10878043|FG000|COMPLETED|Overall Study||102
9772660|NCT00450424|10878044|FG001|COMPLETED|Overall Study||106
9772661|NCT00450424|10878043|FG000|NOT COMPLETED|Overall Study||20
9772662|NCT00450424|10878044|FG001|NOT COMPLETED|Overall Study||11
9772663|NCT00450437|10878052|FG000|STARTED|Overall Study||1640
9772664|NCT00450437|10878053|FG001|STARTED|Overall Study||540
9772665|NCT00450437|10878054|FG002|STARTED|Overall Study||1023
9772666|NCT00450437|10878055|FG003|STARTED|Overall Study||336
9772667|NCT00450437|10878052|FG000|COMPLETED|Overall Study||1594
9772668|NCT00450437|10878053|FG001|COMPLETED|Overall Study||524
9772669|NCT00450437|10878054|FG002|COMPLETED|Overall Study||999
9772670|NCT00450437|10878055|FG003|COMPLETED|Overall Study||325
9772671|NCT00450437|10878052|FG000|NOT COMPLETED|Overall Study||46
9772672|NCT00450437|10878053|FG001|NOT COMPLETED|Overall Study||16
9772673|NCT00450437|10878054|FG002|NOT COMPLETED|Overall Study||24
9772674|NCT00450437|10878055|FG003|NOT COMPLETED|Overall Study||11
9772675|NCT00450463|10878071|FG000|STARTED|Initial Drug Administration||33
9772676|NCT00450463|10878072|FG001|STARTED|Initial Drug Administration||31
9772677|NCT00450463|10878071|FG000|COMPLETED|Initial Drug Administration||33
9772678|NCT00450463|10878072|FG001|COMPLETED|Initial Drug Administration||31
9772679|NCT00450463|10878071|FG000|NOT COMPLETED|Initial Drug Administration||0
9772680|NCT00450463|10878072|FG001|NOT COMPLETED|Initial Drug Administration||0
9772681|NCT00450463|10878071|FG000|STARTED|Progressed to Receive Vaccine Alone||11
9772682|NCT00450463|10878072|FG001|STARTED|Progressed to Receive Vaccine Alone||0
9772683|NCT00450463|10878071|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11
9772684|NCT00450463|10878072|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0
9772685|NCT00450463|10878071|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
9772686|NCT00450463|10878072|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
9772687|NCT00450580|10878083|FG000|STARTED|Overall Study||106
9772688|NCT00450580|10878084|FG001|STARTED|Overall Study||106
9772689|NCT00450580|10878083|FG000|COMPLETED|Overall Study||90
9772690|NCT00450580|10878084|FG001|COMPLETED|Overall Study||90
9772691|NCT00450580|10878083|FG000|NOT COMPLETED|Overall Study||16
9772692|NCT00450580|10878084|FG001|NOT COMPLETED|Overall Study||16
9772693|NCT00450619|10878092|FG000|STARTED|Overall Study||22
9772694|NCT00450619|10878093|FG001|STARTED|Overall Study||22
9772695|NCT00450619|10878092|FG000|COMPLETED|Overall Study||18
9772696|NCT00450619|10878093|FG001|COMPLETED|Overall Study||21
9772697|NCT00450619|10878092|FG000|NOT COMPLETED|Overall Study||4
9772698|NCT00450619|10878093|FG001|NOT COMPLETED|Overall Study||1
9772699|NCT00450658|10878102|FG000|STARTED|Overall Study||415
9772700|NCT00450658|10878103|FG001|STARTED|Overall Study||212
9772701|NCT00450658|10878102|FG000|COMPLETED|Overall Study||272
9772702|NCT00450658|10878103|FG001|COMPLETED|Overall Study||122
9772703|NCT00450658|10878102|FG000|NOT COMPLETED|Overall Study||143
9772704|NCT00450658|10878103|FG001|NOT COMPLETED|Overall Study||90
9772705|NCT00450723|10878109|FG000|STARTED|Overall Study||39
9772706|NCT00450723|10878109|FG000|COMPLETED|Overall Study||34
9772707|NCT00450723|10878109|FG000|NOT COMPLETED|Overall Study||5
9772708|NCT00450749|10878117|FG000|STARTED|Overall Study||3
9772709|NCT00450749|10878118|FG001|STARTED|Overall Study||3
9772710|NCT00450749|10878119|FG002|STARTED|Overall Study||4
9772711|NCT00450749|10878117|FG000|COMPLETED|Overall Study||3
9772712|NCT00450749|10878118|FG001|COMPLETED|Overall Study||2
9772713|NCT00450749|10878119|FG002|COMPLETED|Overall Study||2
9772714|NCT00450749|10878117|FG000|NOT COMPLETED|Overall Study||0
9772715|NCT00450749|10878118|FG001|NOT COMPLETED|Overall Study||1
9772716|NCT00450749|10878119|FG002|NOT COMPLETED|Overall Study||2
9772717|NCT00450801|10878127|FG000|STARTED|Overall Study||22
9772718|NCT00450801|10878127|FG000|COMPLETED|Overall Study||21
9772719|NCT00450801|10878127|FG000|NOT COMPLETED|Overall Study||1
9772720|NCT00450814|10878146|FG000|STARTED|Overall Study||3
9772721|NCT00450814|10878147|FG001|STARTED|Overall Study||3
9772722|NCT00450814|10878148|FG002|STARTED|Overall Study||3
9772723|NCT00450814|10878149|FG003|STARTED|Overall Study||4
9772724|NCT00450814|10878150|FG004|STARTED|Overall Study||4
9772725|NCT00450814|10878151|FG005|STARTED|Overall Study||7
9772726|NCT00450814|10878152|FG006|STARTED|Overall Study||3
9772727|NCT00450814|10878153|FG007|STARTED|Overall Study||3
9772728|NCT00450814|10878154|FG008|STARTED|Overall Study||2
9772729|NCT00450814|10878155|FG009|STARTED|Overall Study||12
9772730|NCT00450814|10878156|FG010|STARTED|Overall Study||4
9772731|NCT00450814|10878146|FG000|COMPLETED|Overall Study||3
9772732|NCT00450814|10878147|FG001|COMPLETED|Overall Study||3
9772733|NCT00450814|10878148|FG002|COMPLETED|Overall Study||3
9772734|NCT00450814|10878149|FG003|COMPLETED|Overall Study||3
9772735|NCT00450814|10878150|FG004|COMPLETED|Overall Study||3
9772736|NCT00450814|10878151|FG005|COMPLETED|Overall Study||6
9772737|NCT00450814|10878152|FG006|COMPLETED|Overall Study||3
9772738|NCT00450814|10878153|FG007|COMPLETED|Overall Study||3
9772739|NCT00450814|10878154|FG008|COMPLETED|Overall Study||2
9772740|NCT00450814|10878155|FG009|COMPLETED|Overall Study||11
9772741|NCT00450814|10878156|FG010|COMPLETED|Overall Study||4
9772742|NCT00450814|10878146|FG000|NOT COMPLETED|Overall Study||0
9772743|NCT00450814|10878147|FG001|NOT COMPLETED|Overall Study||0
9772744|NCT00450814|10878148|FG002|NOT COMPLETED|Overall Study||0
9772745|NCT00450814|10878149|FG003|NOT COMPLETED|Overall Study||1
9772746|NCT00450814|10878150|FG004|NOT COMPLETED|Overall Study||1
9772747|NCT00450814|10878151|FG005|NOT COMPLETED|Overall Study||1
9772748|NCT00450814|10878152|FG006|NOT COMPLETED|Overall Study||0
9772749|NCT00450814|10878153|FG007|NOT COMPLETED|Overall Study||0
9772750|NCT00450814|10878154|FG008|NOT COMPLETED|Overall Study||0
9772751|NCT00450814|10878155|FG009|NOT COMPLETED|Overall Study||1
9772752|NCT00450814|10878156|FG010|NOT COMPLETED|Overall Study||0
9772753|NCT00450866|10878181|FG000|STARTED|Overall Study||45
9772754|NCT00450866|10878182|FG001|STARTED|Overall Study||10
9772755|NCT00450866|10878181|FG000|COMPLETED|Overall Study||38
9772756|NCT00450866|10878182|FG001|COMPLETED|Overall Study||7
9772757|NCT00450866|10878181|FG000|NOT COMPLETED|Overall Study||7
9772758|NCT00450866|10878182|FG001|NOT COMPLETED|Overall Study||3
9772759|NCT00450983|10878188|FG000|STARTED|Overall Study||1
9772760|NCT00450983|10878188|FG000|COMPLETED|Overall Study||1
9772761|NCT00450983|10878188|FG000|NOT COMPLETED|Overall Study||0
9772762|NCT00451035|10878192|FG000|STARTED|Overall Study||29
9772763|NCT00451035|10878192|FG000|COMPLETED|Overall Study||12
9772764|NCT00451035|10878192|FG000|NOT COMPLETED|Overall Study||17
9772765|NCT00451048|10878197|FG000|STARTED|Overall Study||10
9772766|NCT00451048|10878197|FG000|COMPLETED|Overall Study||10
9772767|NCT00451048|10878197|FG000|NOT COMPLETED|Overall Study||0
9772768|NCT00451178|10878203|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
9772769|NCT00451178|10878204|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
9772770|NCT00451178|10878203|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
9772771|NCT00451178|10878204|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
9772772|NCT00451178|10878203|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
9772773|NCT00451178|10878204|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
9772774|NCT00451178|10878203|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
9772775|NCT00451178|10878204|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
9772776|NCT00451178|10878203|FG000|STARTED|Prior to Maintenance Therapy||40
9772777|NCT00451178|10878204|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
9772778|NCT00451178|10878203|FG000|COMPLETED|Prior to Maintenance Therapy||36
9772779|NCT00451178|10878204|FG001|COMPLETED|Prior to Maintenance Therapy||0
9772780|NCT00451178|10878203|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4
9772781|NCT00451178|10878204|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0
9772782|NCT00451178|10878203|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36
9772783|NCT00451178|10878204|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
9772784|NCT00451178|10878203|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6
9772785|NCT00451178|10878204|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0
9772786|NCT00451178|10878203|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
9772787|NCT00451178|10878204|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
9772788|NCT00451178|10878203|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
9772789|NCT00451178|10878204|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
9772790|NCT00451178|10878203|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
9772791|NCT00451178|10878204|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
9772792|NCT00451178|10878203|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
9772793|NCT00451178|10878204|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
9772794|NCT00451191|10878216|FG000|STARTED|Overall Study||68
9772795|NCT00451191|10878217|FG001|STARTED|Overall Study||66
9772796|NCT00451191|10878216|FG000|COMPLETED|Overall Study||53
9772797|NCT00451191|10878217|FG001|COMPLETED|Overall Study||55
9772798|NCT00451191|10878216|FG000|NOT COMPLETED|Overall Study||15
9772799|NCT00451191|10878217|FG001|NOT COMPLETED|Overall Study||11
9772800|NCT00451204|10878225|FG000|STARTED|Overall Study||82
9772801|NCT00451204|10878226|FG001|STARTED|Overall Study||76
9772802|NCT00451204|10878225|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
9772803|NCT00451204|10878226|FG001|COMPLETED|Overall Study||56
9772804|NCT00451204|10878225|FG000|NOT COMPLETED|Overall Study||22
9772805|NCT00451204|10878226|FG001|NOT COMPLETED|Overall Study||20
9772806|NCT00451217|10878239|FG000|STARTED|Overall Study||49
9772807|NCT00451217|10878240|FG001|STARTED|Overall Study||49
9772808|NCT00451217|10878241|FG002|STARTED|Overall Study||51
9772809|NCT00451217|10878242|FG003|STARTED|Overall Study||49
9772810|NCT00451217|10878239|FG000|Treated|Overall Study||48
9772811|NCT00451217|10878240|FG001|Treated|Overall Study||48
9772812|NCT00451217|10878241|FG002|Treated|Overall Study||48
9772813|NCT00451217|10878242|FG003|Treated|Overall Study||45
9772814|NCT00451217|10878239|FG000|COMPLETED|Overall Study||47
9772815|NCT00451217|10878240|FG001|COMPLETED|Overall Study||47
9772816|NCT00451217|10878241|FG002|COMPLETED|Overall Study||47
9772817|NCT00451217|10878242|FG003|COMPLETED|Overall Study||44
9772818|NCT00451217|10878239|FG000|NOT COMPLETED|Overall Study||2
9772819|NCT00451217|10878240|FG001|NOT COMPLETED|Overall Study||2
10233872|NCT01633814|11363720|FG000|STARTED|Overall Study||4
10233873|NCT01633814|11363720|FG000|COMPLETED|Overall Study||4
10233874|NCT01633814|11363720|FG000|NOT COMPLETED|Overall Study||0
10233875|NCT01636466|11363726|FG000|STARTED|Overall Study||1
10233876|NCT01636466|11363727|FG001|STARTED|Overall Study||0
10233877|NCT01636466|11363726|FG000|COMPLETED|Overall Study||0
10233878|NCT01636466|11363727|FG001|COMPLETED|Overall Study||0
10233879|NCT01636466|11363726|FG000|NOT COMPLETED|Overall Study||1
10014282|NCT01798927|11137405|FG000|NOT COMPLETED|Overall Study||1
10014283|NCT01798966|11137409|FG000|STARTED|Overall Study||10
10014284|NCT01798966|11137409|FG000|COMPLETED|Overall Study||10
10014285|NCT01798966|11137409|FG000|NOT COMPLETED|Overall Study||0
10014286|NCT01798992|11137418|FG000|STARTED|Overall Study||4
10014287|NCT01798992|11137419|FG001|STARTED|Overall Study||19
10233880|NCT01636466|11363727|FG001|NOT COMPLETED|Overall Study||0
10233881|NCT01629329|11363735|FG000|STARTED|Overall Study||0
10233882|NCT01629329|11363736|FG001|STARTED|Overall Study||0
10233883|NCT01629329|11363735|FG000|COMPLETED|Overall Study||0
10233884|NCT01629329|11363736|FG001|COMPLETED|Overall Study||0
10233885|NCT01629329|11363735|FG000|NOT COMPLETED|Overall Study||0
10233886|NCT01629329|11363736|FG001|NOT COMPLETED|Overall Study||0
9772820|NCT00451217|10878241|FG002|NOT COMPLETED|Overall Study||4
9772821|NCT00451217|10878242|FG003|NOT COMPLETED|Overall Study||5
9772822|NCT00451282|10878254|FG000|STARTED|Overall Study||46
9772823|NCT00451282|10878255|FG001|STARTED|Overall Study||39
9772824|NCT00451282|10878254|FG000|COMPLETED|Overall Study||40
9772825|NCT00451282|10878255|FG001|COMPLETED|Overall Study||34
10014288|NCT01798992|11137420|FG002|STARTED|Overall Study||16
10014289|NCT01798992|11137421|FG003|STARTED|Overall Study||17
10233887|NCT01627899|11363742|FG000|STARTED|Overall Study||5
10233888|NCT01627899|11363742|FG000|COMPLETED|Overall Study||0
9772826|NCT00451282|10878254|FG000|NOT COMPLETED|Overall Study||6
9772827|NCT00451282|10878255|FG001|NOT COMPLETED|Overall Study||5
9772828|NCT00451321|10878269|FG000|STARTED|Overall Study||8
9772829|NCT00451321|10878270|FG001|STARTED|Overall Study||15
9772830|NCT00451321|10878271|FG002|STARTED|Overall Study||18
9772831|NCT00451321|10878272|FG003|STARTED|Overall Study||19
9772832|NCT00451321|10878273|FG004|STARTED|Overall Study||7
9772833|NCT00451321|10878274|FG005|STARTED|Overall Study||9
9772834|NCT00451321|10878275|FG006|STARTED|Overall Study||6
9772835|NCT00451321|10878276|FG007|STARTED|Overall Study||6
10014290|NCT01798992|11137418|FG000|COMPLETED|Overall Study||4
10014291|NCT01798992|11137419|FG001|COMPLETED|Overall Study||17
10233889|NCT01627899|11363742|FG000|NOT COMPLETED|Overall Study||5
10233890|NCT01632020|11363748|FG000|STARTED|Overall Study||4
9772836|NCT00451321|10878269|FG000|COMPLETED|Overall Study||1
9772837|NCT00451321|10878270|FG001|COMPLETED|Overall Study||10
9772838|NCT00451321|10878271|FG002|COMPLETED|Overall Study||0
9772839|NCT00451321|10878272|FG003|COMPLETED|Overall Study||7
9772840|NCT00451321|10878273|FG004|COMPLETED|Overall Study||0
9772841|NCT00451321|10878274|FG005|COMPLETED|Overall Study||0
9772842|NCT00451321|10878275|FG006|COMPLETED|Overall Study||0
9772843|NCT00451321|10878276|FG007|COMPLETED|Overall Study||0
10233891|NCT01632020|11363749|FG001|STARTED|Overall Study||3
10233892|NCT01632020|11363748|FG000|COMPLETED|Overall Study||2
10014292|NCT01798992|11137420|FG002|COMPLETED|Overall Study||14
9772844|NCT00451321|10878269|FG000|NOT COMPLETED|Overall Study||7
9772845|NCT00451321|10878270|FG001|NOT COMPLETED|Overall Study||5
9772846|NCT00451321|10878271|FG002|NOT COMPLETED|Overall Study||18
9772847|NCT00451321|10878272|FG003|NOT COMPLETED|Overall Study||12
9772848|NCT00451321|10878273|FG004|NOT COMPLETED|Overall Study||7
9772849|NCT00451321|10878274|FG005|NOT COMPLETED|Overall Study||9
9772850|NCT00451321|10878275|FG006|NOT COMPLETED|Overall Study||6
9772851|NCT00451321|10878276|FG007|NOT COMPLETED|Overall Study||6
9772852|NCT00451451|10878298|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
9772853|NCT00451451|10878299|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
9772854|NCT00451451|10878300|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
9772855|NCT00451451|10878301|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
9772856|NCT00451451|10878298|FG000|COMPLETED|Overall Study||278
9772857|NCT00451451|10878299|FG001|COMPLETED|Overall Study||284
9772858|NCT00451451|10878300|FG002|COMPLETED|Overall Study||273
9772859|NCT00451451|10878301|FG003|COMPLETED|Overall Study||292
9772860|NCT00451451|10878298|FG000|NOT COMPLETED|Overall Study||85
9772861|NCT00451451|10878299|FG001|NOT COMPLETED|Overall Study||75
9772862|NCT00451451|10878300|FG002|NOT COMPLETED|Overall Study||72
9772863|NCT00451451|10878301|FG003|NOT COMPLETED|Overall Study||58
9772864|NCT00451555|10878316|FG000|STARTED|Overall Study||96
9772865|NCT00451555|10878317|FG001|STARTED|Overall Study||60
9772866|NCT00451555|10878316|FG000|Received at Least One Dose of Study Drug|Overall Study||94
9772867|NCT00451555|10878317|FG001|Received at Least One Dose of Study Drug|Overall Study||58
9772868|NCT00451555|10878316|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
9772869|NCT00451555|10878317|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
9772870|NCT00451555|10878316|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
9772871|NCT00451555|10878317|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
9772872|NCT00451555|10878316|FG000|Progressive Disease|Overall Study||75
9772873|NCT00451555|10878317|FG001|Progressive Disease|Overall Study||54
9772874|NCT00451555|10878316|FG000|Death|Overall Study||2
9772875|NCT00451555|10878317|FG001|Death|Overall Study||0
9772876|NCT00451555|10878316|FG000|COMPLETED|Overall Study||83
9772877|NCT00451555|10878317|FG001|COMPLETED|Overall Study||56
9772878|NCT00451555|10878316|FG000|NOT COMPLETED|Overall Study||13
9772879|NCT00451555|10878317|FG001|NOT COMPLETED|Overall Study||4
9772880|NCT00451698|10878334|FG000|STARTED|Overall Study||3
9772881|NCT00451698|10878335|FG001|STARTED|Overall Study||6
9772882|NCT00451698|10878334|FG000|COMPLETED|Overall Study||3
9772883|NCT00451698|10878335|FG001|COMPLETED|Overall Study||6
9772884|NCT00451698|10878334|FG000|NOT COMPLETED|Overall Study||0
9772885|NCT00451698|10878335|FG001|NOT COMPLETED|Overall Study||0
9772886|NCT00451906|10878343|FG000|STARTED|Overall Study||2252
9772887|NCT00451906|10878343|FG000|COMPLETED|Overall Study||13
9772888|NCT00451906|10878343|FG000|NOT COMPLETED|Overall Study||2239
9772889|NCT00451958|10878351|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
9772890|NCT00451958|10878352|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
9772891|NCT00451958|10878353|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
9772892|NCT00451958|10878354|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
9772893|NCT00451958|10878355|FG004|STARTED|CS21 (NCT00295750)||204
9772894|NCT00451958|10878351|FG000|COMPLETED|CS21 (NCT00295750)||169
9772895|NCT00451958|10878352|FG001|COMPLETED|CS21 (NCT00295750)||163
9772896|NCT00451958|10878353|FG002|COMPLETED|CS21 (NCT00295750)||0
9772897|NCT00451958|10878354|FG003|COMPLETED|CS21 (NCT00295750)||0
9772898|NCT00451958|10878355|FG004|COMPLETED|CS21 (NCT00295750)||172
9772899|NCT00451958|10878351|FG000|NOT COMPLETED|CS21 (NCT00295750)||41
9772900|NCT00451958|10878352|FG001|NOT COMPLETED|CS21 (NCT00295750)||43
9772901|NCT00451958|10878353|FG002|NOT COMPLETED|CS21 (NCT00295750)||0
9772902|NCT00451958|10878354|FG003|NOT COMPLETED|CS21 (NCT00295750)||0
9772903|NCT00451958|10878355|FG004|NOT COMPLETED|CS21 (NCT00295750)||32
9772904|NCT00451958|10878351|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
9772905|NCT00451958|10878352|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
9772906|NCT00451958|10878353|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
9772907|NCT00451958|10878354|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
9772908|NCT00451958|10878355|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
9772909|NCT00451958|10878351|FG000|COMPLETED|CS21A (NCT00451958)||60
9772910|NCT00451958|10878352|FG001|COMPLETED|CS21A (NCT00451958)||49
9772911|NCT00451958|10878353|FG002|COMPLETED|CS21A (NCT00451958)||27
9772912|NCT00451958|10878354|FG003|COMPLETED|CS21A (NCT00451958)||27
10233893|NCT01632020|11363749|FG001|COMPLETED|Overall Study||3
10233894|NCT01632020|11363748|FG000|NOT COMPLETED|Overall Study||2
10233895|NCT01632020|11363749|FG001|NOT COMPLETED|Overall Study||0
10233896|NCT01602471|11363755|FG000|STARTED|Overall Study||4
10233897|NCT01602471|11363755|FG000|COMPLETED|Overall Study||4
10233898|NCT01602471|11363755|FG000|NOT COMPLETED|Overall Study||0
10233899|NCT01619800|11363761|FG000|STARTED|Overall Study||2
9772913|NCT00451958|10878355|FG004|COMPLETED|CS21A (NCT00451958)||0
9772914|NCT00451958|10878351|FG000|NOT COMPLETED|CS21A (NCT00451958)||65
9772915|NCT00451958|10878352|FG001|NOT COMPLETED|CS21A (NCT00451958)||77
9772916|NCT00451958|10878353|FG002|NOT COMPLETED|CS21A (NCT00451958)||42
9772917|NCT00451958|10878354|FG003|NOT COMPLETED|CS21A (NCT00451958)||39
9772918|NCT00451958|10878355|FG004|NOT COMPLETED|CS21A (NCT00451958)||0
9772919|NCT00452114|10878371|FG000|STARTED|Overall Study||15
9772920|NCT00452114|10878372|FG001|STARTED|Overall Study||13
9772921|NCT00452114|10878371|FG000|COMPLETED|Overall Study||12
9772922|NCT00452114|10878372|FG001|COMPLETED|Overall Study||10
9772923|NCT00452114|10878371|FG000|NOT COMPLETED|Overall Study||3
9772924|NCT00452114|10878372|FG001|NOT COMPLETED|Overall Study||3
9772925|NCT00452335|10878381|FG000|STARTED|Overall Study||27
9772926|NCT00452335|10878382|FG001|STARTED|Overall Study||65
9772927|NCT00452335|10878383|FG002|STARTED|Overall Study||32
9772928|NCT00452335|10878381|FG000|COMPLETED|Overall Study||25
9772929|NCT00452335|10878382|FG001|COMPLETED|Overall Study||61
9772930|NCT00452335|10878383|FG002|COMPLETED|Overall Study||23
9772931|NCT00452335|10878381|FG000|NOT COMPLETED|Overall Study||2
9772932|NCT00452335|10878382|FG001|NOT COMPLETED|Overall Study||4
9772933|NCT00452335|10878383|FG002|NOT COMPLETED|Overall Study||9
9772934|NCT00452348|10878396|FG000|STARTED|Overall Study||310
9772935|NCT00452348|10878397|FG001|STARTED|Overall Study||318
9772936|NCT00452348|10878396|FG000|COMPLETED|Overall Study||231
9772937|NCT00452348|10878397|FG001|COMPLETED|Overall Study||234
9772938|NCT00452348|10878396|FG000|NOT COMPLETED|Overall Study||79
9772939|NCT00452348|10878397|FG001|NOT COMPLETED|Overall Study||84
9772940|NCT00452374|10878403|FG000|STARTED|Overall Study||48
9772941|NCT00452374|10878403|FG000|COMPLETED|Overall Study||48
9772942|NCT00452374|10878403|FG000|NOT COMPLETED|Overall Study||0
9772943|NCT00452387|10878407|FG000|STARTED|Overall Study||22
9772944|NCT00452387|10878407|FG000|COMPLETED|Overall Study||22
9772945|NCT00452387|10878407|FG000|NOT COMPLETED|Overall Study||0
9772946|NCT00452400|10878418|FG000|STARTED|Overall Study||79
9772947|NCT00452400|10878419|FG001|STARTED|Overall Study||81
9772948|NCT00452400|10878420|FG002|STARTED|Overall Study||80
9772949|NCT00452400|10878421|FG003|STARTED|Overall Study||86
9772950|NCT00452400|10878422|FG004|STARTED|Overall Study||79
9772951|NCT00452400|10878418|FG000|COMPLETED|Overall Study||74
9772952|NCT00452400|10878419|FG001|COMPLETED|Overall Study||80
9772953|NCT00452400|10878420|FG002|COMPLETED|Overall Study||73
9772954|NCT00452400|10878421|FG003|COMPLETED|Overall Study||85
9772955|NCT00452400|10878422|FG004|COMPLETED|Overall Study||76
9772956|NCT00452400|10878418|FG000|NOT COMPLETED|Overall Study||5
9772957|NCT00452400|10878419|FG001|NOT COMPLETED|Overall Study||1
9772958|NCT00452400|10878420|FG002|NOT COMPLETED|Overall Study||7
9772959|NCT00452400|10878421|FG003|NOT COMPLETED|Overall Study||1
9772960|NCT00452400|10878422|FG004|NOT COMPLETED|Overall Study||3
9772961|NCT00452413|10878437|FG000|STARTED|Overall Study||4
9772962|NCT00452413|10878438|FG001|STARTED|Overall Study||12
9772963|NCT00452413|10878439|FG002|STARTED|Overall Study||49
9772964|NCT00452413|10878437|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
9772965|NCT00452413|10878438|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
9772966|NCT00452413|10878439|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
9772967|NCT00452413|10878437|FG000|COMPLETED|Overall Study||0
9772968|NCT00452413|10878438|FG001|COMPLETED|Overall Study||0
9772969|NCT00452413|10878439|FG002|COMPLETED|Overall Study||0
9772970|NCT00452413|10878437|FG000|NOT COMPLETED|Overall Study||4
9772971|NCT00452413|10878438|FG001|NOT COMPLETED|Overall Study||12
9772972|NCT00452413|10878439|FG002|NOT COMPLETED|Overall Study||49
9772973|NCT00452426|10878450|FG000|STARTED|Overall Study||496
9772974|NCT00452426|10878451|FG001|STARTED|Overall Study||504
9772975|NCT00452426|10878450|FG000|COMPLETED|Overall Study||489
9772976|NCT00452426|10878451|FG001|COMPLETED|Overall Study||493
9772977|NCT00452426|10878450|FG000|NOT COMPLETED|Overall Study||7
9772978|NCT00452426|10878451|FG001|NOT COMPLETED|Overall Study||11
9772979|NCT00452439|10878459|FG000|STARTED|Overall Study||36
9772980|NCT00452439|10878460|FG001|STARTED|Overall Study||36
9772981|NCT00452439|10878459|FG000|COMPLETED|Overall Study||22
9772982|NCT00452439|10878460|FG001|COMPLETED|Overall Study||29
9772983|NCT00452439|10878459|FG000|NOT COMPLETED|Overall Study||14
9772984|NCT00452439|10878460|FG001|NOT COMPLETED|Overall Study||7
9772985|NCT00452452|10878469|FG000|STARTED|Overall Study||90
9772986|NCT00452452|10878470|FG001|STARTED|Overall Study||112
9772987|NCT00452452|10878471|FG002|STARTED|Overall Study||153
9772988|NCT00452452|10878469|FG000|Vaccinated Dose 1|Overall Study||90
10014293|NCT01798992|11137421|FG003|COMPLETED|Overall Study||16
10014294|NCT01798992|11137418|FG000|NOT COMPLETED|Overall Study||0
10014295|NCT01798992|11137419|FG001|NOT COMPLETED|Overall Study||2
10014296|NCT01798992|11137420|FG002|NOT COMPLETED|Overall Study||2
10014297|NCT01798992|11137421|FG003|NOT COMPLETED|Overall Study||1
9772989|NCT00452452|10878470|FG001|Vaccinated Dose 1|Overall Study||112
9772990|NCT00452452|10878471|FG002|Vaccinated Dose 1|Overall Study||152
10014298|NCT01799135|11137430|FG000|STARTED|Overall Study||6
10014299|NCT01799135|11137430|FG000|COMPLETED|Overall Study||6
9772991|NCT00452452|10878469|FG000|Vaccinated Dose 2|Overall Study||90
9772992|NCT00452452|10878470|FG001|Vaccinated Dose 2|Overall Study||112
9772993|NCT00452452|10878471|FG002|Vaccinated Dose 2|Overall Study||0
9772994|NCT00452452|10878469|FG000|Vaccinated Dose 3|Overall Study||89
9772995|NCT00452452|10878470|FG001|Vaccinated Dose 3|Overall Study||0
9772996|NCT00452452|10878471|FG002|Vaccinated Dose 3|Overall Study||0
9772997|NCT00452452|10878469|FG000|COMPLETED|Overall Study||88
9772998|NCT00452452|10878470|FG001|COMPLETED|Overall Study||112
9772999|NCT00452452|10878471|FG002|COMPLETED|Overall Study||152
9773000|NCT00452452|10878469|FG000|NOT COMPLETED|Overall Study||2
10014300|NCT01799135|11137430|FG000|NOT COMPLETED|Overall Study||0
9773001|NCT00452452|10878470|FG001|NOT COMPLETED|Overall Study||0
9773002|NCT00452452|10878471|FG002|NOT COMPLETED|Overall Study||1
9773003|NCT00452530|10878487|FG000|STARTED|Overall Study|Randomized|1528
9773004|NCT00452530|10878488|FG001|STARTED|Overall Study|Randomized|1529
9773005|NCT00452530|10878487|FG000|Received Treatment|Overall Study||1501
9773006|NCT00452530|10878488|FG001|Received Treatment|Overall Study||1508
9773007|NCT00452530|10878487|FG000|Evaluable Participants|Overall Study||907
9773008|NCT00452530|10878488|FG001|Evaluable Participants|Overall Study||921
9773009|NCT00452530|10878487|FG000|Primary Participants|Overall Study||976
9773010|NCT00452530|10878488|FG001|Primary Participants|Overall Study||997
9773011|NCT00452530|10878487|FG000|COMPLETED|Overall Study||1392
9773012|NCT00452530|10878488|FG001|COMPLETED|Overall Study||1393
9773013|NCT00452530|10878487|FG000|NOT COMPLETED|Overall Study||136
9773014|NCT00452530|10878488|FG001|NOT COMPLETED|Overall Study||136
9773015|NCT00452543|10878500|FG000|STARTED|Overall Study||12
9773016|NCT00452543|10878501|FG001|STARTED|Overall Study||11
9773017|NCT00452543|10878500|FG000|COMPLETED|Overall Study||7
9773018|NCT00452543|10878501|FG001|COMPLETED|Overall Study||5
9773019|NCT00452543|10878500|FG000|NOT COMPLETED|Overall Study||5
9773020|NCT00452543|10878501|FG001|NOT COMPLETED|Overall Study||6
9773021|NCT00452673|10878511|FG000|STARTED|Dose Escalation Period||7
9773022|NCT00452673|10878512|FG001|STARTED|Dose Escalation Period||9
9773023|NCT00452673|10878513|FG002|STARTED|Dose Escalation Period||6
9773024|NCT00452673|10878514|FG003|STARTED|Dose Escalation Period||9
9773025|NCT00452673|10878515|FG004|STARTED|Dose Escalation Period||0
9773026|NCT00452673|10878511|FG000|COMPLETED|Dose Escalation Period||0
9773027|NCT00452673|10878512|FG001|COMPLETED|Dose Escalation Period||0
9773028|NCT00452673|10878513|FG002|COMPLETED|Dose Escalation Period||0
9773029|NCT00452673|10878514|FG003|COMPLETED|Dose Escalation Period||0
9773030|NCT00452673|10878515|FG004|COMPLETED|Dose Escalation Period||0
9773031|NCT00452673|10878511|FG000|NOT COMPLETED|Dose Escalation Period||7
9773032|NCT00452673|10878512|FG001|NOT COMPLETED|Dose Escalation Period||9
9773033|NCT00452673|10878513|FG002|NOT COMPLETED|Dose Escalation Period||6
9773034|NCT00452673|10878514|FG003|NOT COMPLETED|Dose Escalation Period||9
9773035|NCT00452673|10878515|FG004|NOT COMPLETED|Dose Escalation Period||0
9773036|NCT00452673|10878511|FG000|STARTED|Dose Expansion Period||0
9773037|NCT00452673|10878512|FG001|STARTED|Dose Expansion Period||0
9773038|NCT00452673|10878513|FG002|STARTED|Dose Expansion Period||0
9773039|NCT00452673|10878514|FG003|STARTED|Dose Expansion Period||0
9773040|NCT00452673|10878515|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
9773041|NCT00452673|10878511|FG000|COMPLETED|Dose Expansion Period||0
9773042|NCT00452673|10878512|FG001|COMPLETED|Dose Expansion Period||0
9773043|NCT00452673|10878513|FG002|COMPLETED|Dose Expansion Period||0
9773044|NCT00452673|10878514|FG003|COMPLETED|Dose Expansion Period||0
9773045|NCT00452673|10878515|FG004|COMPLETED|Dose Expansion Period||0
9773046|NCT00452673|10878511|FG000|NOT COMPLETED|Dose Expansion Period||0
9773047|NCT00452673|10878512|FG001|NOT COMPLETED|Dose Expansion Period||0
9773048|NCT00452673|10878513|FG002|NOT COMPLETED|Dose Expansion Period||0
9773049|NCT00452673|10878514|FG003|NOT COMPLETED|Dose Expansion Period||0
9773050|NCT00452673|10878515|FG004|NOT COMPLETED|Dose Expansion Period||21
9773051|NCT00452699|10878528|FG000|STARTED|Overall Study||306
9773052|NCT00452699|10878529|FG001|STARTED|Overall Study||315
9773053|NCT00452699|10878528|FG000|COMPLETED|Overall Study||225
9773054|NCT00452699|10878529|FG001|COMPLETED|Overall Study||242
9773055|NCT00452699|10878528|FG000|NOT COMPLETED|Overall Study||81
9773056|NCT00452699|10878529|FG001|NOT COMPLETED|Overall Study||73
9773057|NCT00452790|10878537|FG000|STARTED|Infant Series||354
9773058|NCT00452790|10878538|FG001|STARTED|Infant Series||355
9773059|NCT00452790|10878537|FG000|Vaccinated Dose 1|Infant Series||353
9773060|NCT00452790|10878538|FG001|Vaccinated Dose 1|Infant Series||353
9773061|NCT00452790|10878537|FG000|Vaccinated Dose 2|Infant Series||300
9773062|NCT00452790|10878538|FG001|Vaccinated Dose 2|Infant Series||300
9773063|NCT00452790|10878537|FG000|Vaccinated Dose 3|Infant Series||221
9773064|NCT00452790|10878538|FG001|Vaccinated Dose 3|Infant Series||218
9773065|NCT00452790|10878537|FG000|COMPLETED|Infant Series||219
9773066|NCT00452790|10878538|FG001|COMPLETED|Infant Series||214
9773067|NCT00452790|10878537|FG000|NOT COMPLETED|Infant Series||135
9773068|NCT00452790|10878538|FG001|NOT COMPLETED|Infant Series||141
9773069|NCT00452790|10878537|FG000|STARTED|After Infant Series||219
9773070|NCT00452790|10878538|FG001|STARTED|After Infant Series||214
9773071|NCT00452790|10878537|FG000|COMPLETED|After Infant Series||198
9773072|NCT00452790|10878538|FG001|COMPLETED|After Infant Series||200
9773073|NCT00452790|10878537|FG000|NOT COMPLETED|After Infant Series||21
9773074|NCT00452790|10878538|FG001|NOT COMPLETED|After Infant Series||14
9773075|NCT00452790|10878537|FG000|STARTED|Toddler Dose||198
9773076|NCT00452790|10878538|FG001|STARTED|Toddler Dose||200
9773077|NCT00452790|10878537|FG000|COMPLETED|Toddler Dose||198
9773078|NCT00452790|10878538|FG001|COMPLETED|Toddler Dose||198
9773079|NCT00452790|10878537|FG000|NOT COMPLETED|Toddler Dose||0
9773080|NCT00452790|10878538|FG001|NOT COMPLETED|Toddler Dose||2
9773081|NCT00452868|10878548|FG000|STARTED|Overall Study||13
9773082|NCT00452868|10878548|FG000|COMPLETED|Overall Study||11
9773083|NCT00452868|10878548|FG000|NOT COMPLETED|Overall Study||2
9773084|NCT00453102|10878552|FG000|STARTED|Overall Study||18
9773085|NCT00453102|10878552|FG000|COMPLETED|Overall Study||16
9773086|NCT00453102|10878552|FG000|NOT COMPLETED|Overall Study||2
9773087|NCT00453154|10878559|FG000|STARTED|Combination Chemotherapy||12
9773088|NCT00453154|10878560|FG001|STARTED|Combination Chemotherapy||144
9773089|NCT00453154|10878561|FG002|STARTED|Combination Chemotherapy||0
9773090|NCT00453154|10878562|FG003|STARTED|Combination Chemotherapy||0
9773091|NCT00453154|10878559|FG000|COMPLETED|Combination Chemotherapy||12
9773092|NCT00453154|10878560|FG001|COMPLETED|Combination Chemotherapy||95
9773093|NCT00453154|10878561|FG002|COMPLETED|Combination Chemotherapy||0
9773094|NCT00453154|10878562|FG003|COMPLETED|Combination Chemotherapy||0
9773095|NCT00453154|10878559|FG000|NOT COMPLETED|Combination Chemotherapy||0
9773096|NCT00453154|10878560|FG001|NOT COMPLETED|Combination Chemotherapy||49
9773097|NCT00453154|10878561|FG002|NOT COMPLETED|Combination Chemotherapy||0
9773098|NCT00453154|10878562|FG003|NOT COMPLETED|Combination Chemotherapy||0
9773099|NCT00453154|10878559|FG000|STARTED|Double BIind Maintenance||0
9773100|NCT00453154|10878560|FG001|STARTED|Double BIind Maintenance||0
9773101|NCT00453154|10878561|FG002|STARTED|Double BIind Maintenance||46
9773102|NCT00453154|10878562|FG003|STARTED|Double BIind Maintenance||49
9773103|NCT00453154|10878559|FG000|COMPLETED|Double BIind Maintenance||0
9773104|NCT00453154|10878560|FG001|COMPLETED|Double BIind Maintenance||0
9773105|NCT00453154|10878561|FG002|COMPLETED|Double BIind Maintenance||0
9773106|NCT00453154|10878562|FG003|COMPLETED|Double BIind Maintenance||0
9773107|NCT00453154|10878559|FG000|NOT COMPLETED|Double BIind Maintenance||0
9773108|NCT00453154|10878560|FG001|NOT COMPLETED|Double BIind Maintenance||0
9773109|NCT00453154|10878561|FG002|NOT COMPLETED|Double BIind Maintenance||46
9773110|NCT00453154|10878562|FG003|NOT COMPLETED|Double BIind Maintenance||49
9773111|NCT00453154|10878559|FG000|STARTED|Open Label Sunitinib Crossover||0
9773112|NCT00453154|10878560|FG001|STARTED|Open Label Sunitinib Crossover||0
9773113|NCT00453154|10878561|FG002|STARTED|Open Label Sunitinib Crossover||18
9773114|NCT00453154|10878562|FG003|STARTED|Open Label Sunitinib Crossover||0
9773115|NCT00453154|10878559|FG000|COMPLETED|Open Label Sunitinib Crossover||0
9773116|NCT00453154|10878560|FG001|COMPLETED|Open Label Sunitinib Crossover||0
9773117|NCT00453154|10878561|FG002|COMPLETED|Open Label Sunitinib Crossover||18
9773118|NCT00453154|10878562|FG003|COMPLETED|Open Label Sunitinib Crossover||0
9773119|NCT00453154|10878559|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0
9773120|NCT00453154|10878560|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0
9773121|NCT00453154|10878561|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0
9773122|NCT00453154|10878562|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0
9773123|NCT00453180|10878573|FG000|STARTED|Overall Study||16
9773124|NCT00453180|10878574|FG001|STARTED|Overall Study||15
9773125|NCT00453180|10878573|FG000|COMPLETED|Overall Study||13
9773126|NCT00453180|10878574|FG001|COMPLETED|Overall Study||12
9773127|NCT00453180|10878573|FG000|NOT COMPLETED|Overall Study||3
9773128|NCT00453180|10878574|FG001|NOT COMPLETED|Overall Study||3
9773129|NCT00453193|10878580|FG000|STARTED|Overall Study||24
9773130|NCT00453193|10878580|FG000|COMPLETED|Overall Study||24
9773131|NCT00453193|10878580|FG000|NOT COMPLETED|Overall Study||0
9773132|NCT00453206|10878584|FG000|STARTED|Overall Study||66
9773133|NCT00453206|10878584|FG000|COMPLETED|Overall Study||65
9773134|NCT00453206|10878584|FG000|NOT COMPLETED|Overall Study||1
9773135|NCT00453310|10878588|FG000|STARTED|Overall Study||10
9773136|NCT00453310|10878588|FG000|COMPLETED|Overall Study||0
9773137|NCT00453310|10878588|FG000|NOT COMPLETED|Overall Study||10
9773138|NCT00453336|10878592|FG000|STARTED|Overall Study||45
9773139|NCT00453336|10878592|FG000|COMPLETED|Overall Study||45
9773140|NCT00453336|10878592|FG000|NOT COMPLETED|Overall Study||0
9773141|NCT00453349|10878598|FG000|STARTED|Randomized||228
9773142|NCT00453349|10878599|FG001|STARTED|Randomized||232
9773143|NCT00453349|10878598|FG000|COMPLETED|Randomized||203
9773144|NCT00453349|10878599|FG001|COMPLETED|Randomized||209
9773145|NCT00453349|10878598|FG000|NOT COMPLETED|Randomized||25
9773146|NCT00453349|10878599|FG001|NOT COMPLETED|Randomized||23
9773147|NCT00453349|10878598|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
9773148|NCT00453349|10878599|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
9773149|NCT00453349|10878598|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
9773150|NCT00453349|10878599|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
9773151|NCT00453349|10878598|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
9773152|NCT00453349|10878599|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219
9773153|NCT00453349|10878598|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
9773154|NCT00453349|10878599|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
9773155|NCT00453349|10878598|FG000|STARTED|Completed Study||228
9773156|NCT00453349|10878599|FG001|STARTED|Completed Study||232
9773157|NCT00453349|10878598|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203
9773158|NCT00453349|10878599|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209
9773159|NCT00453349|10878598|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
9773160|NCT00453349|10878599|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
9773161|NCT00453349|10878598|FG000|NOT COMPLETED|Completed Study||27
9773162|NCT00453349|10878599|FG001|NOT COMPLETED|Completed Study||34
9773163|NCT00453362|10878605|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
9773164|NCT00453362|10878605|FG000|Treated With Erlotinib|Overall Study||74
9773165|NCT00453362|10878605|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
9773166|NCT00453362|10878605|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
9773167|NCT00453362|10878605|FG000|COMPLETED|Overall Study||1
9773168|NCT00453362|10878605|FG000|NOT COMPLETED|Overall Study||87
9773169|NCT00453388|10878625|FG000|STARTED|Overall Study||0
9773170|NCT00453388|10878626|FG001|STARTED|Overall Study||5
9773171|NCT00453388|10878627|FG002|STARTED|Overall Study||1
9773172|NCT00453388|10878628|FG003|STARTED|Overall Study||0
9773173|NCT00453388|10878625|FG000|COMPLETED|Overall Study||0
9773174|NCT00453388|10878626|FG001|COMPLETED|Overall Study||5
9773175|NCT00453388|10878627|FG002|COMPLETED|Overall Study||1
9773176|NCT00453388|10878628|FG003|COMPLETED|Overall Study||0
9773177|NCT00453388|10878625|FG000|NOT COMPLETED|Overall Study||0
9773178|NCT00453388|10878626|FG001|NOT COMPLETED|Overall Study||0
9773179|NCT00453388|10878627|FG002|NOT COMPLETED|Overall Study||0
9773180|NCT00453388|10878628|FG003|NOT COMPLETED|Overall Study||0
9773181|NCT00453479|10878641|FG000|STARTED|Overall Study||6
9773182|NCT00453479|10878642|FG001|STARTED|Overall Study||9
9773183|NCT00453479|10878643|FG002|STARTED|Overall Study||8
9773184|NCT00453479|10878641|FG000|COMPLETED|Overall Study||6
9773185|NCT00453479|10878642|FG001|COMPLETED|Overall Study||9
9773186|NCT00453479|10878643|FG002|COMPLETED|Overall Study||8
9773187|NCT00453479|10878641|FG000|NOT COMPLETED|Overall Study||0
9773188|NCT00453479|10878642|FG001|NOT COMPLETED|Overall Study||0
9773189|NCT00453479|10878643|FG002|NOT COMPLETED|Overall Study||0
9829873|NCT00761657|10940593|FG008|STARTED|Part 1 (up to Day 57)||10
9829874|NCT00761657|10940585|FG000|Safety Population|Part 1 (up to Day 57)||0
9829875|NCT00761657|10940586|FG001|Safety Population|Part 1 (up to Day 57)||0
9829876|NCT00761657|10940587|FG002|Safety Population|Part 1 (up to Day 57)||12
9829877|NCT00761657|10940588|FG003|Safety Population|Part 1 (up to Day 57)||9
9829878|NCT00761657|10940589|FG004|Safety Population|Part 1 (up to Day 57)||0
9829879|NCT00761657|10940590|FG005|Safety Population|Part 1 (up to Day 57)||0
9829880|NCT00761657|10940591|FG006|Safety Population|Part 1 (up to Day 57)||1
9829881|NCT00761657|10940592|FG007|Safety Population|Part 1 (up to Day 57)||2
9829882|NCT00761657|10940593|FG008|Safety Population|Part 1 (up to Day 57)||10
9829883|NCT00761657|10940585|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
9829884|NCT00761657|10940586|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
9829885|NCT00761657|10940587|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
9829886|NCT00761657|10940588|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
9829887|NCT00761657|10940589|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
9829888|NCT00761657|10940590|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
9829889|NCT00761657|10940591|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
9829890|NCT00761657|10940592|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1
9829891|NCT00761657|10940593|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6
9829892|NCT00761657|10940585|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
9829893|NCT00761657|10940586|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
9829894|NCT00761657|10940587|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5
9829895|NCT00761657|10940588|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3
9829896|NCT00761657|10940589|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
9829897|NCT00761657|10940590|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
9829898|NCT00761657|10940591|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1
9829899|NCT00761657|10940592|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2
9829900|NCT00761657|10940593|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
9829901|NCT00761657|10940585|FG000|COMPLETED|Part 1 (up to Day 57)||0
9829902|NCT00761657|10940586|FG001|COMPLETED|Part 1 (up to Day 57)||0
9829903|NCT00761657|10940587|FG002|COMPLETED|Part 1 (up to Day 57)||8
9829904|NCT00761657|10940588|FG003|COMPLETED|Part 1 (up to Day 57)||4
9829905|NCT00761657|10940589|FG004|COMPLETED|Part 1 (up to Day 57)||0
9829906|NCT00761657|10940590|FG005|COMPLETED|Part 1 (up to Day 57)||0
9829907|NCT00761657|10940591|FG006|COMPLETED|Part 1 (up to Day 57)||0
9829908|NCT00761657|10940592|FG007|COMPLETED|Part 1 (up to Day 57)||1
9829909|NCT00761657|10940593|FG008|COMPLETED|Part 1 (up to Day 57)||9
9829910|NCT00761657|10940585|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0
9829911|NCT00761657|10940586|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0
9829912|NCT00761657|10940587|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4
9829913|NCT00761657|10940588|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6
9829914|NCT00761657|10940589|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0
9829915|NCT00761657|10940590|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0
9829916|NCT00761657|10940591|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1
9829917|NCT00761657|10940592|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1
9829918|NCT00761657|10940593|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1
9829919|NCT00761657|10940585|FG000|STARTED|Part 2 (up to Day 114)||10
9829920|NCT00761657|10940586|FG001|STARTED|Part 2 (up to Day 114)||13
9829921|NCT00761657|10940587|FG002|STARTED|Part 2 (up to Day 114)||0
9829922|NCT00761657|10940588|FG003|STARTED|Part 2 (up to Day 114)||0
9829923|NCT00761657|10940589|FG004|STARTED|Part 2 (up to Day 114)||10
9829924|NCT00761657|10940590|FG005|STARTED|Part 2 (up to Day 114)||11
9829925|NCT00761657|10940591|FG006|STARTED|Part 2 (up to Day 114)||10
9829926|NCT00761657|10940592|FG007|STARTED|Part 2 (up to Day 114)||10
9829927|NCT00761657|10940593|FG008|STARTED|Part 2 (up to Day 114)||18
9829928|NCT00761657|10940585|FG000|Safety Population|Part 2 (up to Day 114)||10
9829929|NCT00761657|10940586|FG001|Safety Population|Part 2 (up to Day 114)||13
9829930|NCT00761657|10940587|FG002|Safety Population|Part 2 (up to Day 114)||0
9829931|NCT00761657|10940588|FG003|Safety Population|Part 2 (up to Day 114)||0
9773190|NCT00453895|10878653|FG000|STARTED|Overall Study||39
9773191|NCT00453895|10878653|FG000|COMPLETED|Overall Study||39
9773192|NCT00453895|10878653|FG000|NOT COMPLETED|Overall Study||0
9773193|NCT00453921|10878661|FG000|STARTED|Overall Study||19
9773194|NCT00453921|10878662|FG001|STARTED|Overall Study||18
9773195|NCT00453921|10878663|FG002|STARTED|Overall Study||20
9773196|NCT00453921|10878664|FG003|STARTED|Overall Study||19
9773197|NCT00453921|10878661|FG000|COMPLETED|Overall Study||18
9773198|NCT00453921|10878662|FG001|COMPLETED|Overall Study||17
9773199|NCT00453921|10878663|FG002|COMPLETED|Overall Study||18
9773200|NCT00453921|10878664|FG003|COMPLETED|Overall Study||18
9773201|NCT00453921|10878661|FG000|NOT COMPLETED|Overall Study||1
9773202|NCT00453921|10878662|FG001|NOT COMPLETED|Overall Study||1
9773203|NCT00453921|10878663|FG002|NOT COMPLETED|Overall Study||2
9773204|NCT00453921|10878664|FG003|NOT COMPLETED|Overall Study||1
9773205|NCT00453973|10878680|FG000|STARTED|Overall Study||51
9773206|NCT00453973|10878681|FG001|STARTED|Overall Study||63
9773207|NCT00453973|10878680|FG000|COMPLETED|Overall Study||0
9773208|NCT00453973|10878681|FG001|COMPLETED|Overall Study||15
9773209|NCT00453973|10878680|FG000|NOT COMPLETED|Overall Study||51
9773210|NCT00453973|10878681|FG001|NOT COMPLETED|Overall Study||48
9773211|NCT00453986|10878692|FG000|STARTED|Overall Study||311
9773212|NCT00453986|10878693|FG001|STARTED|Overall Study||311
9773213|NCT00453986|10878694|FG002|STARTED|Overall Study||313
9773214|NCT00453986|10878695|FG003|STARTED|Overall Study||312
9773215|NCT00453986|10878696|FG004|STARTED|Overall Study||105
9773216|NCT00453986|10878692|FG000|COMPLETED|Overall Study||305
9773217|NCT00453986|10878693|FG001|COMPLETED|Overall Study||306
9773218|NCT00453986|10878694|FG002|COMPLETED|Overall Study||307
9773219|NCT00453986|10878695|FG003|COMPLETED|Overall Study||310
9773220|NCT00453986|10878696|FG004|COMPLETED|Overall Study||105
9773221|NCT00453986|10878692|FG000|NOT COMPLETED|Overall Study||6
9773222|NCT00453986|10878693|FG001|NOT COMPLETED|Overall Study||5
9773223|NCT00453986|10878694|FG002|NOT COMPLETED|Overall Study||6
9773224|NCT00453986|10878695|FG003|NOT COMPLETED|Overall Study||2
9773225|NCT00453986|10878696|FG004|NOT COMPLETED|Overall Study||0
9773226|NCT00453999|10878715|FG000|STARTED|Overall Study||45
9773227|NCT00453999|10878716|FG001|STARTED|Overall Study||46
9773228|NCT00453999|10878717|FG002|STARTED|Overall Study||46
9773229|NCT00453999|10878715|FG000|COMPLETED|Overall Study||40
9773230|NCT00453999|10878716|FG001|COMPLETED|Overall Study||41
9773231|NCT00453999|10878717|FG002|COMPLETED|Overall Study||43
9773232|NCT00453999|10878715|FG000|NOT COMPLETED|Overall Study||5
9773233|NCT00453999|10878716|FG001|NOT COMPLETED|Overall Study||5
9773234|NCT00453999|10878717|FG002|NOT COMPLETED|Overall Study||3
9773235|NCT00454051|10878728|FG000|STARTED|Overall Study||20
9773236|NCT00454051|10878729|FG001|STARTED|Overall Study||11
9773237|NCT00454051|10878728|FG000|COMPLETED|Overall Study||17
9773238|NCT00454051|10878729|FG001|COMPLETED|Overall Study||8
9773239|NCT00454051|10878728|FG000|NOT COMPLETED|Overall Study||3
9773240|NCT00454051|10878729|FG001|NOT COMPLETED|Overall Study||3
9773241|NCT00454116|10878738|FG000|STARTED|Overall Study|randomised patients|35
9773242|NCT00454116|10878739|FG001|STARTED|Overall Study|randomised patients|36
9773243|NCT00454116|10878740|FG002|STARTED|Overall Study|randomised patients|35
9773244|NCT00454116|10878738|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
9773245|NCT00454116|10878739|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
9773246|NCT00454116|10878740|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
9773247|NCT00454116|10878738|FG000|NOT COMPLETED|Overall Study||27
9773248|NCT00454116|10878739|FG001|NOT COMPLETED|Overall Study||29
9773249|NCT00454116|10878740|FG002|NOT COMPLETED|Overall Study||28
9773250|NCT00454142|10878748|FG000|STARTED|Overall Study||33
9773251|NCT00454142|10878748|FG000|COMPLETED|Overall Study||32
9773252|NCT00454142|10878748|FG000|NOT COMPLETED|Overall Study||1
9773253|NCT00454181|10878756|FG000|STARTED|Overall Study||45
9773254|NCT00454181|10878757|FG001|STARTED|Overall Study||14
9773255|NCT00454181|10878756|FG000|COMPLETED|Overall Study||30
9773256|NCT00454181|10878757|FG001|COMPLETED|Overall Study||11
9773257|NCT00454181|10878756|FG000|NOT COMPLETED|Overall Study||15
9773258|NCT00454181|10878757|FG001|NOT COMPLETED|Overall Study||3
9773259|NCT00454194|10878765|FG000|STARTED|Overall Study||47
9773260|NCT00454194|10878766|FG001|STARTED|Overall Study||51
9773261|NCT00454194|10878765|FG000|COMPLETED|Overall Study||25
9773262|NCT00454194|10878766|FG001|COMPLETED|Overall Study||37
9773263|NCT00454194|10878765|FG000|NOT COMPLETED|Overall Study||22
9773264|NCT00454194|10878766|FG001|NOT COMPLETED|Overall Study||14
9773265|NCT00454207|10878774|FG000|STARTED|Overall Study||21
9773266|NCT00454207|10878775|FG001|STARTED|Overall Study||23
9773267|NCT00454207|10878774|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
9773268|NCT00454207|10878775|FG001|COMPLETED|Overall Study||21
9773269|NCT00454207|10878774|FG000|NOT COMPLETED|Overall Study||4
9773270|NCT00454207|10878775|FG001|NOT COMPLETED|Overall Study||2
9773271|NCT00454246|10878796|FG000|STARTED|Overall Study||73
9773272|NCT00454246|10878797|FG001|STARTED|Overall Study||29
9773273|NCT00454246|10878798|FG002|STARTED|Overall Study||9
9773274|NCT00454246|10878796|FG000|COMPLETED|Overall Study||0
9773275|NCT00454246|10878797|FG001|COMPLETED|Overall Study||0
9773276|NCT00454246|10878798|FG002|COMPLETED|Overall Study||0
9773277|NCT00454246|10878796|FG000|NOT COMPLETED|Overall Study||73
9773278|NCT00454246|10878797|FG001|NOT COMPLETED|Overall Study||29
9773279|NCT00454246|10878798|FG002|NOT COMPLETED|Overall Study||9
9773280|NCT00454324|10878808|FG000|STARTED|Overall Study||14
9773281|NCT00454324|10878809|FG001|STARTED|Overall Study||13
9773282|NCT00454324|10878808|FG000|COMPLETED|Overall Study||14
9773283|NCT00454324|10878809|FG001|COMPLETED|Overall Study||13
9773284|NCT00454324|10878808|FG000|NOT COMPLETED|Overall Study||0
9773285|NCT00454324|10878809|FG001|NOT COMPLETED|Overall Study||0
9773286|NCT00454363|10878817|FG000|STARTED|Overall Study||20
9773287|NCT00454363|10878818|FG001|STARTED|Overall Study||31
9773288|NCT00454363|10878817|FG000|COMPLETED|Overall Study||15
9773289|NCT00454363|10878818|FG001|COMPLETED|Overall Study||29
9773290|NCT00454363|10878817|FG000|NOT COMPLETED|Overall Study||5
9773291|NCT00454363|10878818|FG001|NOT COMPLETED|Overall Study||2
9773292|NCT00454532|10878827|FG000|STARTED|Overall Study||11
9773293|NCT00454532|10878828|FG001|STARTED|Overall Study||6
9773294|NCT00454532|10878829|FG002|STARTED|Overall Study||3
9773295|NCT00454532|10878830|FG003|STARTED|Overall Study||7
9773296|NCT00454532|10878827|FG000|COMPLETED|Overall Study||11
9773297|NCT00454532|10878828|FG001|COMPLETED|Overall Study||6
9773298|NCT00454532|10878829|FG002|COMPLETED|Overall Study||3
9773299|NCT00454532|10878830|FG003|COMPLETED|Overall Study||7
9773300|NCT00454532|10878827|FG000|NOT COMPLETED|Overall Study||0
9773301|NCT00454532|10878828|FG001|NOT COMPLETED|Overall Study||0
9773302|NCT00454532|10878829|FG002|NOT COMPLETED|Overall Study||0
9773303|NCT00454532|10878830|FG003|NOT COMPLETED|Overall Study||0
9773304|NCT00454584|10878843|FG000|STARTED|Controlled Period||347
9773305|NCT00454584|10878844|FG001|STARTED|Controlled Period||209
9773306|NCT00454584|10878845|FG002|STARTED|Controlled Period||347
9773307|NCT00454584|10878846|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9773308|NCT00454584|10878847|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9773309|NCT00454584|10878848|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
9773310|NCT00454584|10878843|FG000|COMPLETED|Controlled Period||336
9773311|NCT00454584|10878844|FG001|COMPLETED|Controlled Period||201
9773312|NCT00454584|10878845|FG002|COMPLETED|Controlled Period||342
9773313|NCT00454584|10878846|FG003|COMPLETED|Controlled Period||0
9773314|NCT00454584|10878847|FG004|COMPLETED|Controlled Period||0
9773315|NCT00454584|10878848|FG005|COMPLETED|Controlled Period||0
9773316|NCT00454584|10878843|FG000|NOT COMPLETED|Controlled Period||11
9773317|NCT00454584|10878844|FG001|NOT COMPLETED|Controlled Period||8
9773318|NCT00454584|10878845|FG002|NOT COMPLETED|Controlled Period||5
9773319|NCT00454584|10878846|FG003|NOT COMPLETED|Controlled Period||0
9773320|NCT00454584|10878847|FG004|NOT COMPLETED|Controlled Period||0
9773321|NCT00454584|10878848|FG005|NOT COMPLETED|Controlled Period||0
9773322|NCT00454584|10878843|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9773323|NCT00454584|10878844|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9773324|NCT00454584|10878845|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
9773325|NCT00454584|10878846|FG003|STARTED|After Controlled Period||336
9773326|NCT00454584|10878847|FG004|STARTED|After Controlled Period||201
9773327|NCT00454584|10878848|FG005|STARTED|After Controlled Period||342
9773328|NCT00454584|10878843|FG000|COMPLETED|After Controlled Period||0
9773329|NCT00454584|10878844|FG001|COMPLETED|After Controlled Period||0
9773330|NCT00454584|10878845|FG002|COMPLETED|After Controlled Period||0
9773331|NCT00454584|10878846|FG003|COMPLETED|After Controlled Period||310
9773332|NCT00454584|10878847|FG004|COMPLETED|After Controlled Period||189
9773333|NCT00454584|10878848|FG005|COMPLETED|After Controlled Period||310
9773334|NCT00454584|10878843|FG000|NOT COMPLETED|After Controlled Period||0
9773335|NCT00454584|10878844|FG001|NOT COMPLETED|After Controlled Period||0
9773336|NCT00454584|10878845|FG002|NOT COMPLETED|After Controlled Period||0
9773337|NCT00454584|10878846|FG003|NOT COMPLETED|After Controlled Period||26
9773338|NCT00454584|10878847|FG004|NOT COMPLETED|After Controlled Period||12
9773339|NCT00454584|10878848|FG005|NOT COMPLETED|After Controlled Period||32
9773340|NCT00454636|10878866|FG000|STARTED|Overall Study||41
9773341|NCT00454636|10878867|FG001|STARTED|Overall Study||32
9773342|NCT00454636|10878868|FG002|STARTED|Overall Study||27
9773343|NCT00454636|10878869|FG003|STARTED|Overall Study||58
9773344|NCT00454636|10878866|FG000|COMPLETED|Overall Study||10
9773345|NCT00454636|10878867|FG001|COMPLETED|Overall Study||9
9773346|NCT00454636|10878868|FG002|COMPLETED|Overall Study||7
9773347|NCT00454636|10878869|FG003|COMPLETED|Overall Study||26
9773348|NCT00454636|10878866|FG000|NOT COMPLETED|Overall Study||31
9773349|NCT00454636|10878867|FG001|NOT COMPLETED|Overall Study||23
9773350|NCT00454636|10878868|FG002|NOT COMPLETED|Overall Study||20
9773351|NCT00454636|10878869|FG003|NOT COMPLETED|Overall Study||32
9773352|NCT00454649|10878889|FG000|STARTED|Overall Study||3
9773353|NCT00454649|10878890|FG001|STARTED|Overall Study||5
9773354|NCT00454649|10878891|FG002|STARTED|Overall Study||20
9773355|NCT00454649|10878892|FG003|STARTED|Overall Study||7
9773356|NCT00454649|10878893|FG004|STARTED|Overall Study||1
9773357|NCT00454649|10878894|FG005|STARTED|Overall Study||7
9773358|NCT00454649|10878895|FG006|STARTED|Overall Study||9
9773359|NCT00454649|10878896|FG007|STARTED|Overall Study||19
9773360|NCT00454649|10878897|FG008|STARTED|Overall Study||21
9773361|NCT00454649|10878898|FG009|STARTED|Overall Study||6
9773362|NCT00454649|10878889|FG000|COMPLETED|Overall Study||0
9773363|NCT00454649|10878890|FG001|COMPLETED|Overall Study||1
9773364|NCT00454649|10878891|FG002|COMPLETED|Overall Study||1
9773365|NCT00454649|10878892|FG003|COMPLETED|Overall Study||1
9773366|NCT00454649|10878893|FG004|COMPLETED|Overall Study||0
9773367|NCT00454649|10878894|FG005|COMPLETED|Overall Study||0
9773368|NCT00454649|10878895|FG006|COMPLETED|Overall Study||0
9773369|NCT00454649|10878896|FG007|COMPLETED|Overall Study||0
9773370|NCT00454649|10878897|FG008|COMPLETED|Overall Study||1
9773371|NCT00454649|10878898|FG009|COMPLETED|Overall Study||1
9773372|NCT00454649|10878889|FG000|NOT COMPLETED|Overall Study||3
9773373|NCT00454649|10878890|FG001|NOT COMPLETED|Overall Study||4
9773374|NCT00454649|10878891|FG002|NOT COMPLETED|Overall Study||19
9773375|NCT00454649|10878892|FG003|NOT COMPLETED|Overall Study||6
9773376|NCT00454649|10878893|FG004|NOT COMPLETED|Overall Study||1
9773377|NCT00454649|10878894|FG005|NOT COMPLETED|Overall Study||7
9773378|NCT00454649|10878895|FG006|NOT COMPLETED|Overall Study||9
9773379|NCT00454649|10878896|FG007|NOT COMPLETED|Overall Study||19
9773380|NCT00454649|10878897|FG008|NOT COMPLETED|Overall Study||20
9773381|NCT00454649|10878898|FG009|NOT COMPLETED|Overall Study||5
9773382|NCT00454779|10878941|FG000|STARTED|First-line Treatment Phase||56
9773383|NCT00454779|10878942|FG001|STARTED|First-line Treatment Phase||57
9773384|NCT00454779|10878941|FG000|Received Study Medication|First-line Treatment Phase||56
9773385|NCT00454779|10878942|FG001|Received Study Medication|First-line Treatment Phase||55
9773386|NCT00454779|10878941|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
9773387|NCT00454779|10878942|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
9773388|NCT00454779|10878941|FG000|NOT COMPLETED|First-line Treatment Phase||5
9773389|NCT00454779|10878942|FG001|NOT COMPLETED|First-line Treatment Phase||8
9773390|NCT00454779|10878941|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
9773391|NCT00454779|10878942|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
9773392|NCT00454779|10878941|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
9773393|NCT00454779|10878942|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
9773394|NCT00454779|10878941|FG000|NOT COMPLETED|Second-line Treatment Phase||0
9773395|NCT00454779|10878942|FG001|NOT COMPLETED|Second-line Treatment Phase||3
9773396|NCT00454805|10878950|FG000|STARTED|Overall Study|Randomised|31
9773397|NCT00454805|10878951|FG001|STARTED|Overall Study|Randomised|31
9773398|NCT00454805|10878950|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5
9773399|NCT00454805|10878951|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8
9773400|NCT00454805|10878950|FG000|NOT COMPLETED|Overall Study||26
9773401|NCT00454805|10878951|FG001|NOT COMPLETED|Overall Study||23
9773402|NCT00454818|10878965|FG000|STARTED|Phase I: Open-label Dose-escalation||3
9773403|NCT00454818|10878966|FG001|STARTED|Phase I: Open-label Dose-escalation||3
9773404|NCT00454818|10878967|FG002|STARTED|Phase I: Open-label Dose-escalation||3
9773405|NCT00454818|10878968|FG003|STARTED|Phase I: Open-label Dose-escalation||3
9773406|NCT00454818|10878969|FG004|STARTED|Phase I: Open-label Dose-escalation||0
9773407|NCT00454818|10878965|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2
9773408|NCT00454818|10878966|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2
9773409|NCT00454818|10878967|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2
9773410|NCT00454818|10878968|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2
9773411|NCT00454818|10878969|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0
9773412|NCT00454818|10878965|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
9773413|NCT00454818|10878966|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
9773414|NCT00454818|10878967|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
9773415|NCT00454818|10878968|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
9773416|NCT00454818|10878969|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
9773417|NCT00454818|10878965|FG000|STARTED|Phase 2: Randomized Double-blind||0
9773418|NCT00454818|10878966|FG001|STARTED|Phase 2: Randomized Double-blind||8
9773419|NCT00454818|10878967|FG002|STARTED|Phase 2: Randomized Double-blind||8
9773420|NCT00454818|10878968|FG003|STARTED|Phase 2: Randomized Double-blind||9
9773421|NCT00454818|10878969|FG004|STARTED|Phase 2: Randomized Double-blind||14
9773422|NCT00454818|10878965|FG000|COMPLETED|Phase 2: Randomized Double-blind||0
9773423|NCT00454818|10878966|FG001|COMPLETED|Phase 2: Randomized Double-blind||6
9773424|NCT00454818|10878967|FG002|COMPLETED|Phase 2: Randomized Double-blind||5
9773425|NCT00454818|10878968|FG003|COMPLETED|Phase 2: Randomized Double-blind||8
9773426|NCT00454818|10878969|FG004|COMPLETED|Phase 2: Randomized Double-blind||10
9773427|NCT00454818|10878965|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0
9773428|NCT00454818|10878966|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2
9773429|NCT00454818|10878967|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3
9773430|NCT00454818|10878968|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1
9773431|NCT00454818|10878969|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4
9773432|NCT00454857|10878986|FG000|STARTED|Overall Study||326
9773433|NCT00454857|10878986|FG000|Completed Retrospective Chart Review|Overall Study||324
9773434|NCT00454857|10878986|FG000|Completed ≥1 Observational Study Visit|Overall Study||319
9773435|NCT00454857|10878986|FG000|COMPLETED|Overall Study||272
9773436|NCT00454857|10878986|FG000|NOT COMPLETED|Overall Study||54
9773437|NCT00454909|10878993|FG000|STARTED|Overall Study||587
9773438|NCT00454909|10878994|FG001|STARTED|Overall Study||197
9773439|NCT00454909|10878995|FG002|STARTED|Overall Study||88
9773440|NCT00454909|10878993|FG000|COMPLETED|Overall Study||580
9773441|NCT00454909|10878994|FG001|COMPLETED|Overall Study||194
9773442|NCT00454909|10878995|FG002|COMPLETED|Overall Study||86
9773443|NCT00454909|10878993|FG000|NOT COMPLETED|Overall Study||7
9773444|NCT00454909|10878994|FG001|NOT COMPLETED|Overall Study||3
9773445|NCT00454909|10878995|FG002|NOT COMPLETED|Overall Study||2
9773446|NCT00454987|10879007|FG000|STARTED|Booster Period (NCT00258700)||359
9773447|NCT00454987|10879008|FG001|STARTED|Booster Period (NCT00258700)||117
9773448|NCT00454987|10879009|FG002|STARTED|Booster Period (NCT00258700)||0
9773449|NCT00454987|10879007|FG000|COMPLETED|Booster Period (NCT00258700)||357
9773450|NCT00454987|10879008|FG001|COMPLETED|Booster Period (NCT00258700)||116
9773451|NCT00454987|10879009|FG002|COMPLETED|Booster Period (NCT00258700)||0
9773452|NCT00454987|10879007|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2
9773453|NCT00454987|10879008|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1
9773454|NCT00454987|10879009|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0
9773455|NCT00454987|10879007|FG000|STARTED|Year 1 (NCT00454987)||221
9773456|NCT00454987|10879008|FG001|STARTED|Year 1 (NCT00454987)||67
9773457|NCT00454987|10879009|FG002|STARTED|Year 1 (NCT00454987)||0
9773458|NCT00454987|10879007|FG000|COMPLETED|Year 1 (NCT00454987)||221
9773459|NCT00454987|10879008|FG001|COMPLETED|Year 1 (NCT00454987)||67
9773460|NCT00454987|10879009|FG002|COMPLETED|Year 1 (NCT00454987)||0
9773461|NCT00454987|10879007|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0
9773462|NCT00454987|10879008|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0
9773463|NCT00454987|10879009|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0
9773464|NCT00454987|10879007|FG000|STARTED|Year 2 (NCT00454987)||235
9773465|NCT00454987|10879008|FG001|STARTED|Year 2 (NCT00454987)||77
9773466|NCT00454987|10879009|FG002|STARTED|Year 2 (NCT00454987)||74
9773467|NCT00454987|10879007|FG000|COMPLETED|Year 2 (NCT00454987)||235
9773468|NCT00454987|10879008|FG001|COMPLETED|Year 2 (NCT00454987)||77
9773469|NCT00454987|10879009|FG002|COMPLETED|Year 2 (NCT00454987)||74
9773470|NCT00454987|10879007|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0
9773471|NCT00454987|10879008|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0
9773472|NCT00454987|10879009|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0
9773473|NCT00454987|10879007|FG000|STARTED|Year 4 (NCT00454987)||206
9773474|NCT00454987|10879008|FG001|STARTED|Year 4 (NCT00454987)||62
9773475|NCT00454987|10879009|FG002|STARTED|Year 4 (NCT00454987)||0
9773476|NCT00454987|10879007|FG000|COMPLETED|Year 4 (NCT00454987)||206
9773477|NCT00454987|10879008|FG001|COMPLETED|Year 4 (NCT00454987)||62
9773478|NCT00454987|10879009|FG002|COMPLETED|Year 4 (NCT00454987)||0
9773479|NCT00454987|10879007|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0
9773480|NCT00454987|10879008|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0
9773481|NCT00454987|10879009|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0
9773482|NCT00455013|10879021|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
9773483|NCT00455013|10879022|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
9773484|NCT00455013|10879023|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
9773485|NCT00455013|10879021|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
9773486|NCT00455013|10879022|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
9773487|NCT00455013|10879023|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
9773488|NCT00455013|10879021|FG000|NOT COMPLETED|Short Term Period||6
9773489|NCT00455013|10879022|FG001|NOT COMPLETED|Short Term Period||5
9773490|NCT00455013|10879023|FG002|NOT COMPLETED|Short Term Period||2
9773491|NCT00455013|10879021|FG000|STARTED|Long Term Extension (LTE)||27
9773492|NCT00455013|10879022|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
9773493|NCT00455013|10879023|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
9773494|NCT00455013|10879021|FG000|COMPLETED|Long Term Extension (LTE)||25
9773495|NCT00455013|10879022|FG001|COMPLETED|Long Term Extension (LTE)||16
9773496|NCT00455013|10879023|FG002|COMPLETED|Long Term Extension (LTE)||20
9773497|NCT00455013|10879021|FG000|NOT COMPLETED|Long Term Extension (LTE)||2
9773498|NCT00455013|10879022|FG001|NOT COMPLETED|Long Term Extension (LTE)||3
9773499|NCT00455013|10879023|FG002|NOT COMPLETED|Long Term Extension (LTE)||7
9773500|NCT00455195|10879033|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
9773501|NCT00455195|10879034|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
9773502|NCT00455195|10879033|FG000|COMPLETED|Double-blind Study AGLU02704||55
9773503|NCT00455195|10879034|FG001|COMPLETED|Double-blind Study AGLU02704||26
9773504|NCT00455195|10879033|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5
9773505|NCT00455195|10879034|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4
9773506|NCT00455195|10879033|FG000|STARTED|Extension Study AGLU03206||55
9773507|NCT00455195|10879034|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
9773508|NCT00455195|10879033|FG000|COMPLETED|Extension Study AGLU03206||55
9773509|NCT00455195|10879034|FG001|COMPLETED|Extension Study AGLU03206||26
9773510|NCT00455195|10879033|FG000|NOT COMPLETED|Extension Study AGLU03206||0
9773511|NCT00455195|10879034|FG001|NOT COMPLETED|Extension Study AGLU03206||0
9773512|NCT00455312|10879042|FG000|STARTED|Overall Study||15
9773513|NCT00455312|10879043|FG001|STARTED|Overall Study||21
9773514|NCT00455312|10879042|FG000|COMPLETED|Overall Study||15
9773515|NCT00455312|10879043|FG001|COMPLETED|Overall Study||20
9773516|NCT00455312|10879042|FG000|NOT COMPLETED|Overall Study||0
9773517|NCT00455312|10879043|FG001|NOT COMPLETED|Overall Study||1
9773518|NCT00455429|10879053|FG000|STARTED|Overall Study||18
9773519|NCT00455429|10879054|FG001|STARTED|Overall Study||15
9773520|NCT00455429|10879055|FG002|STARTED|Overall Study||17
9773521|NCT00455429|10879056|FG003|STARTED|Overall Study||34
9773522|NCT00455429|10879053|FG000|Treated|Overall Study||18
9773523|NCT00455429|10879054|FG001|Treated|Overall Study||15
9773524|NCT00455429|10879055|FG002|Treated|Overall Study||17
9773525|NCT00455429|10879056|FG003|Treated|Overall Study||32
9773526|NCT00455429|10879053|FG000|COMPLETED|Overall Study||16
9773527|NCT00455429|10879054|FG001|COMPLETED|Overall Study||10
9773528|NCT00455429|10879055|FG002|COMPLETED|Overall Study||16
9773529|NCT00455429|10879056|FG003|COMPLETED|Overall Study||20
9773530|NCT00455429|10879053|FG000|NOT COMPLETED|Overall Study||2
9773531|NCT00455429|10879054|FG001|NOT COMPLETED|Overall Study||5
9773532|NCT00455429|10879055|FG002|NOT COMPLETED|Overall Study||1
9773533|NCT00455429|10879056|FG003|NOT COMPLETED|Overall Study||14
9773534|NCT00455455|10879069|FG000|STARTED|Washout||25
9773535|NCT00455455|10879070|FG001|STARTED|Washout||25
9773536|NCT00455455|10879069|FG000|COMPLETED|Washout||25
9773537|NCT00455455|10879070|FG001|COMPLETED|Washout||24
9773538|NCT00455455|10879069|FG000|NOT COMPLETED|Washout||0
9773539|NCT00455455|10879070|FG001|NOT COMPLETED|Washout||1
9773540|NCT00455455|10879069|FG000|STARTED|First Intervention||25
9773541|NCT00455455|10879070|FG001|STARTED|First Intervention||24
9773542|NCT00455455|10879069|FG000|COMPLETED|First Intervention||25
9773543|NCT00455455|10879070|FG001|COMPLETED|First Intervention||24
9773544|NCT00455455|10879069|FG000|NOT COMPLETED|First Intervention||0
9773545|NCT00455455|10879070|FG001|NOT COMPLETED|First Intervention||0
9773546|NCT00455455|10879069|FG000|STARTED|Washout||25
9773547|NCT00455455|10879070|FG001|STARTED|Washout||24
9773548|NCT00455455|10879069|FG000|COMPLETED|Washout||24
9773549|NCT00455455|10879070|FG001|COMPLETED|Washout||24
9773550|NCT00455455|10879069|FG000|NOT COMPLETED|Washout||1
9773551|NCT00455455|10879070|FG001|NOT COMPLETED|Washout||0
9773552|NCT00455455|10879069|FG000|STARTED|Second Intervention||24
9773553|NCT00455455|10879070|FG001|STARTED|Second Intervention||24
9773554|NCT00455455|10879069|FG000|COMPLETED|Second Intervention||24
9773555|NCT00455455|10879070|FG001|COMPLETED|Second Intervention||24
9773556|NCT00455455|10879069|FG000|NOT COMPLETED|Second Intervention||0
9773557|NCT00455455|10879070|FG001|NOT COMPLETED|Second Intervention||0
9773558|NCT00455520|10879081|FG000|STARTED|Open Label Tapentadol Extended Release||591
9773559|NCT00455520|10879082|FG001|STARTED|Open Label Tapentadol Extended Release||0
9773560|NCT00455520|10879081|FG000|COMPLETED|Open Label Tapentadol Extended Release||395
9773561|NCT00455520|10879082|FG001|COMPLETED|Open Label Tapentadol Extended Release||0
9773562|NCT00455520|10879081|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196
9773563|NCT00455520|10879082|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0
9773564|NCT00455520|10879081|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
9773565|NCT00455520|10879082|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
9773566|NCT00455520|10879081|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
9773567|NCT00455520|10879082|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
9773568|NCT00455520|10879081|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
9773569|NCT00455520|10879082|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
9773570|NCT00455533|10879090|FG000|STARTED|Period One: Initial Chemotherapy||313
9773571|NCT00455533|10879091|FG001|STARTED|Period One: Initial Chemotherapy||0
9773572|NCT00455533|10879092|FG002|STARTED|Period One: Initial Chemotherapy||0
9773573|NCT00455533|10879090|FG000|COMPLETED|Period One: Initial Chemotherapy||295
9773574|NCT00455533|10879091|FG001|COMPLETED|Period One: Initial Chemotherapy||0
9773575|NCT00455533|10879092|FG002|COMPLETED|Period One: Initial Chemotherapy||0
9773576|NCT00455533|10879090|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18
9773577|NCT00455533|10879091|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0
9773578|NCT00455533|10879092|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0
10014301|NCT01799213|11137436|FG000|STARTED|Overall Study||180
10014302|NCT01799213|11137437|FG001|STARTED|Overall Study||184
9773579|NCT00455533|10879090|FG000|STARTED|Period Two: Randomized Period||0
9773580|NCT00455533|10879091|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
9773581|NCT00455533|10879092|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
9773582|NCT00455533|10879090|FG000|COMPLETED|Period Two: Randomized Period||0
9773583|NCT00455533|10879091|FG001|COMPLETED|Period Two: Randomized Period||139
9773584|NCT00455533|10879092|FG002|COMPLETED|Period Two: Randomized Period||138
9773585|NCT00455533|10879090|FG000|NOT COMPLETED|Period Two: Randomized Period||0
9773586|NCT00455533|10879091|FG001|NOT COMPLETED|Period Two: Randomized Period||6
9773587|NCT00455533|10879092|FG002|NOT COMPLETED|Period Two: Randomized Period||6
9773588|NCT00455650|10879102|FG000|STARTED|Week 1||10
9773589|NCT00455650|10879103|FG001|STARTED|Week 1||10
9773590|NCT00455650|10879104|FG002|STARTED|Week 1||10
9773591|NCT00455650|10879105|FG003|STARTED|Week 1||14
9773592|NCT00455650|10879106|FG004|STARTED|Week 1||14
9773593|NCT00455650|10879107|FG005|STARTED|Week 1||13
9773594|NCT00455650|10879102|FG000|COMPLETED|Week 1||10
9773595|NCT00455650|10879103|FG001|COMPLETED|Week 1||10
9773596|NCT00455650|10879104|FG002|COMPLETED|Week 1||10
9773597|NCT00455650|10879105|FG003|COMPLETED|Week 1||14
9773598|NCT00455650|10879106|FG004|COMPLETED|Week 1||14
9773599|NCT00455650|10879107|FG005|COMPLETED|Week 1||13
9773600|NCT00455650|10879102|FG000|NOT COMPLETED|Week 1||0
9773601|NCT00455650|10879103|FG001|NOT COMPLETED|Week 1||0
10014303|NCT01799213|11137436|FG000|COMPLETED|Overall Study||173
9773602|NCT00455650|10879104|FG002|NOT COMPLETED|Week 1||0
9773603|NCT00455650|10879105|FG003|NOT COMPLETED|Week 1||0
9773604|NCT00455650|10879106|FG004|NOT COMPLETED|Week 1||0
9773605|NCT00455650|10879107|FG005|NOT COMPLETED|Week 1||0
9773606|NCT00455650|10879102|FG000|STARTED|Week 2||10
9773607|NCT00455650|10879103|FG001|STARTED|Week 2||10
9773608|NCT00455650|10879104|FG002|STARTED|Week 2||10
9773609|NCT00455650|10879105|FG003|STARTED|Week 2||14
9773610|NCT00455650|10879106|FG004|STARTED|Week 2||14
9773611|NCT00455650|10879107|FG005|STARTED|Week 2||13
9773612|NCT00455650|10879102|FG000|COMPLETED|Week 2||10
9773613|NCT00455650|10879103|FG001|COMPLETED|Week 2||10
9773614|NCT00455650|10879104|FG002|COMPLETED|Week 2||10
9773615|NCT00455650|10879105|FG003|COMPLETED|Week 2||14
9773616|NCT00455650|10879106|FG004|COMPLETED|Week 2||14
9773617|NCT00455650|10879107|FG005|COMPLETED|Week 2||13
9773618|NCT00455650|10879102|FG000|NOT COMPLETED|Week 2||0
9773619|NCT00455650|10879103|FG001|NOT COMPLETED|Week 2||0
9773620|NCT00455650|10879104|FG002|NOT COMPLETED|Week 2||0
9773621|NCT00455650|10879105|FG003|NOT COMPLETED|Week 2||0
9773622|NCT00455650|10879106|FG004|NOT COMPLETED|Week 2||0
9773623|NCT00455650|10879107|FG005|NOT COMPLETED|Week 2||0
9773624|NCT00455650|10879102|FG000|STARTED|Week 3||10
9773625|NCT00455650|10879103|FG001|STARTED|Week 3||10
9773626|NCT00455650|10879104|FG002|STARTED|Week 3||10
9773627|NCT00455650|10879105|FG003|STARTED|Week 3||14
9773628|NCT00455650|10879106|FG004|STARTED|Week 3||14
9773629|NCT00455650|10879107|FG005|STARTED|Week 3||13
9773630|NCT00455650|10879102|FG000|COMPLETED|Week 3||10
9773631|NCT00455650|10879103|FG001|COMPLETED|Week 3||10
9773632|NCT00455650|10879104|FG002|COMPLETED|Week 3||10
9773633|NCT00455650|10879105|FG003|COMPLETED|Week 3||14
9773634|NCT00455650|10879106|FG004|COMPLETED|Week 3||14
9773635|NCT00455650|10879107|FG005|COMPLETED|Week 3||13
9773636|NCT00455650|10879102|FG000|NOT COMPLETED|Week 3||0
9773637|NCT00455650|10879103|FG001|NOT COMPLETED|Week 3||0
9773638|NCT00455650|10879104|FG002|NOT COMPLETED|Week 3||0
9773639|NCT00455650|10879105|FG003|NOT COMPLETED|Week 3||0
9773640|NCT00455650|10879106|FG004|NOT COMPLETED|Week 3||0
9773641|NCT00455650|10879107|FG005|NOT COMPLETED|Week 3||0
9773642|NCT00455663|10879120|FG000|STARTED|Overall Study||37
9773643|NCT00455663|10879121|FG001|STARTED|Overall Study||36
9773644|NCT00455663|10879122|FG002|STARTED|Overall Study||32
9773645|NCT00455663|10879120|FG000|COMPLETED|Overall Study||34
9773646|NCT00455663|10879121|FG001|COMPLETED|Overall Study||32
9773647|NCT00455663|10879122|FG002|COMPLETED|Overall Study||29
9773648|NCT00455663|10879120|FG000|NOT COMPLETED|Overall Study||3
9773649|NCT00455663|10879121|FG001|NOT COMPLETED|Overall Study||4
9773650|NCT00455663|10879122|FG002|NOT COMPLETED|Overall Study||3
9773651|NCT00455689|10879136|FG000|STARTED|Overall Study||14
9773652|NCT00455689|10879137|FG001|STARTED|Overall Study||6
9773653|NCT00455689|10879136|FG000|COMPLETED|Overall Study||14
9773654|NCT00455689|10879137|FG001|COMPLETED|Overall Study||6
9773655|NCT00455689|10879136|FG000|NOT COMPLETED|Overall Study||0
9773656|NCT00455689|10879137|FG001|NOT COMPLETED|Overall Study||0
9773657|NCT00455702|10879144|FG000|STARTED|Overall Study||19
9773658|NCT00455702|10879145|FG001|STARTED|Overall Study||19
9773659|NCT00455702|10879144|FG000|COMPLETED|Overall Study||16
9773660|NCT00455702|10879145|FG001|COMPLETED|Overall Study||16
9773661|NCT00455702|10879144|FG000|NOT COMPLETED|Overall Study||3
9773662|NCT00455702|10879145|FG001|NOT COMPLETED|Overall Study||3
9773663|NCT00455741|10879155|FG000|STARTED|Overall Study||13
9773664|NCT00455741|10879156|FG001|STARTED|Overall Study||12
9773665|NCT00455741|10879155|FG000|COMPLETED|Overall Study||13
9773666|NCT00455741|10879156|FG001|COMPLETED|Overall Study||11
9773667|NCT00455741|10879155|FG000|NOT COMPLETED|Overall Study||0
9773668|NCT00455741|10879156|FG001|NOT COMPLETED|Overall Study||1
9773669|NCT00455858|10879172|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
9773670|NCT00455858|10879172|FG000|COMPLETED|Overall Study||81
9773671|NCT00455858|10879172|FG000|NOT COMPLETED|Overall Study||6
9773672|NCT00455923|10879178|FG000|STARTED|Overall Study||50
9773673|NCT00455923|10879179|FG001|STARTED|Overall Study||50
9773674|NCT00455923|10879178|FG000|COMPLETED|Overall Study||47
9773675|NCT00455923|10879179|FG001|COMPLETED|Overall Study||47
9773676|NCT00455923|10879178|FG000|NOT COMPLETED|Overall Study||3
9773677|NCT00455923|10879179|FG001|NOT COMPLETED|Overall Study||3
9773678|NCT00455962|10879187|FG000|STARTED|Overall Study||10
9773679|NCT00455962|10879188|FG001|STARTED|Overall Study||13
9773680|NCT00455962|10879187|FG000|COMPLETED|Overall Study||10
9773681|NCT00455962|10879188|FG001|COMPLETED|Overall Study||13
9773682|NCT00455962|10879187|FG000|NOT COMPLETED|Overall Study||0
9773683|NCT00455962|10879188|FG001|NOT COMPLETED|Overall Study||0
9773684|NCT00455975|10879196|FG000|STARTED|Overall Study||58
9773685|NCT00455975|10879197|FG001|STARTED|Overall Study||61
9773686|NCT00455975|10879196|FG000|COMPLETED|Overall Study||40
9773687|NCT00455975|10879197|FG001|COMPLETED|Overall Study||40
9773688|NCT00455975|10879196|FG000|NOT COMPLETED|Overall Study||18
9773689|NCT00455975|10879197|FG001|NOT COMPLETED|Overall Study||21
9773690|NCT00456014|10879203|FG000|STARTED|SSRI Phase||37
9773691|NCT00456014|10879203|FG000|COMPLETED|SSRI Phase||28
9773692|NCT00456014|10879203|FG000|NOT COMPLETED|SSRI Phase||9
9773693|NCT00456014|10879203|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
9773694|NCT00456014|10879203|FG000|COMPLETED|Tricyclic Phase||1
9773695|NCT00456014|10879203|FG000|NOT COMPLETED|Tricyclic Phase||3
9773696|NCT00456092|10879212|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
9773697|NCT00456092|10879213|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
9773698|NCT00456092|10879214|FG002|STARTED|Extension Phase||0
9773699|NCT00456092|10879215|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
9773700|NCT00456092|10879216|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
9773701|NCT00456092|10879212|FG000|COMPLETED|Extension Phase||35
9773702|NCT00456092|10879213|FG001|COMPLETED|Extension Phase||36
9773703|NCT00456092|10879214|FG002|COMPLETED|Extension Phase||0
9773704|NCT00456092|10879215|FG003|COMPLETED|Extension Phase||19
9773705|NCT00456092|10879216|FG004|COMPLETED|Extension Phase||13
9773706|NCT00456092|10879212|FG000|NOT COMPLETED|Extension Phase||11
9773707|NCT00456092|10879213|FG001|NOT COMPLETED|Extension Phase||4
9773708|NCT00456092|10879214|FG002|NOT COMPLETED|Extension Phase||0
9773709|NCT00456092|10879215|FG003|NOT COMPLETED|Extension Phase||1
9773710|NCT00456092|10879216|FG004|NOT COMPLETED|Extension Phase||7
9773711|NCT00456092|10879212|FG000|STARTED|Treatment Phase (12 Weeks)||67
9773712|NCT00456092|10879213|FG001|STARTED|Treatment Phase (12 Weeks)||69
9773713|NCT00456092|10879214|FG002|STARTED|Treatment Phase (12 Weeks)||68
9773714|NCT00456092|10879215|FG003|STARTED|Treatment Phase (12 Weeks)||0
9773715|NCT00456092|10879216|FG004|STARTED|Treatment Phase (12 Weeks)||0
9773716|NCT00456092|10879212|FG000|COMPLETED|Treatment Phase (12 Weeks)||60
9773717|NCT00456092|10879213|FG001|COMPLETED|Treatment Phase (12 Weeks)||55
9773718|NCT00456092|10879214|FG002|COMPLETED|Treatment Phase (12 Weeks)||50
9773719|NCT00456092|10879215|FG003|COMPLETED|Treatment Phase (12 Weeks)||0
9773720|NCT00456092|10879216|FG004|COMPLETED|Treatment Phase (12 Weeks)||0
9773721|NCT00456092|10879212|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7
9773722|NCT00456092|10879213|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14
9773723|NCT00456092|10879214|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18
9773724|NCT00456092|10879215|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0
9773725|NCT00456092|10879216|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0
9773726|NCT00456300|10879230|FG000|STARTED|Overall Study||5
9773727|NCT00456300|10879231|FG001|STARTED|Overall Study||4
9773728|NCT00456300|10879230|FG000|COMPLETED|Overall Study||4
9773729|NCT00456300|10879231|FG001|COMPLETED|Overall Study||4
9773730|NCT00456300|10879230|FG000|NOT COMPLETED|Overall Study||1
9773731|NCT00456300|10879231|FG001|NOT COMPLETED|Overall Study||0
9773732|NCT00456365|10879241|FG000|STARTED|Overall Study||56
9773733|NCT00456365|10879242|FG001|STARTED|Overall Study||54
9773734|NCT00456365|10879241|FG000|COMPLETED|Overall Study||49
9773735|NCT00456365|10879242|FG001|COMPLETED|Overall Study||42
9773736|NCT00456365|10879241|FG000|NOT COMPLETED|Overall Study||7
9773737|NCT00456365|10879242|FG001|NOT COMPLETED|Overall Study||12
9773738|NCT00456495|10879250|FG000|STARTED|Overall Study||5
9773739|NCT00456495|10879250|FG000|COMPLETED|Overall Study||3
9773740|NCT00456495|10879250|FG000|NOT COMPLETED|Overall Study||2
9773741|NCT00456508|10879255|FG000|STARTED|Overall Study||147
9773742|NCT00456508|10879255|FG000|COMPLETED|Overall Study||147
9773743|NCT00456508|10879255|FG000|NOT COMPLETED|Overall Study||0
9773744|NCT00456521|10879261|FG000|STARTED|Overall Study||591
9773745|NCT00456521|10879262|FG001|STARTED|Overall Study||202
9773746|NCT00456521|10879261|FG000|COMPLETED|Overall Study||342
9773747|NCT00456521|10879262|FG001|COMPLETED|Overall Study||118
9773748|NCT00456521|10879261|FG000|NOT COMPLETED|Overall Study||249
9773749|NCT00456521|10879262|FG001|NOT COMPLETED|Overall Study||84
9773750|NCT00456547|10879271|FG000|STARTED|Overall Study||12
9773751|NCT00456547|10879272|FG001|STARTED|Overall Study||12
9773752|NCT00456547|10879271|FG000|COMPLETED|Overall Study||12
9773753|NCT00456547|10879272|FG001|COMPLETED|Overall Study||12
9773754|NCT00456547|10879271|FG000|NOT COMPLETED|Overall Study||0
9773755|NCT00456547|10879272|FG001|NOT COMPLETED|Overall Study||0
9773756|NCT00456599|10879278|FG000|STARTED|Overall Study||71
9773757|NCT00456599|10879278|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
9773758|NCT00456599|10879278|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
9773759|NCT00456599|10879278|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
9773760|NCT00456599|10879278|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43
9773761|NCT00456599|10879278|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
9773762|NCT00456599|10879278|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
9773763|NCT00456599|10879278|FG000|COMPLETED|Overall Study||68
9773764|NCT00456599|10879278|FG000|NOT COMPLETED|Overall Study||3
9773765|NCT00456625|10879282|FG000|STARTED|Overall Study||76
9773766|NCT00456625|10879282|FG000|COMPLETED|Overall Study||76
9773767|NCT00456625|10879282|FG000|NOT COMPLETED|Overall Study||0
9773768|NCT00456755|10879288|FG000|STARTED|Overall Study||63
9773769|NCT00456755|10879289|FG001|STARTED|Overall Study||63
9773770|NCT00456755|10879288|FG000|COMPLETED|Overall Study||61
9773771|NCT00456755|10879289|FG001|COMPLETED|Overall Study||62
9773772|NCT00456755|10879288|FG000|NOT COMPLETED|Overall Study||2
9773773|NCT00456755|10879289|FG001|NOT COMPLETED|Overall Study||1
9773774|NCT00456807|10879297|FG000|STARTED|Overall Study||53
9773775|NCT00456807|10879298|FG001|STARTED|Overall Study||47
9773776|NCT00456807|10879297|FG000|COMPLETED|Overall Study||52
9773777|NCT00456807|10879298|FG001|COMPLETED|Overall Study||47
9773778|NCT00456807|10879297|FG000|NOT COMPLETED|Overall Study||1
9773779|NCT00456807|10879298|FG001|NOT COMPLETED|Overall Study||0
9773780|NCT00456846|10879306|FG000|STARTED|Overall Study||47
9773781|NCT00456846|10879307|FG001|STARTED|Overall Study||76
9773782|NCT00456846|10879306|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
9773783|NCT00456846|10879307|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
9773784|NCT00456846|10879306|FG000|NOT COMPLETED|Overall Study||16
9773785|NCT00456846|10879307|FG001|NOT COMPLETED|Overall Study||28
9773786|NCT00456885|10879313|FG000|STARTED|First Treatment Period, 16 Weeks||24
9773787|NCT00456885|10879314|FG001|STARTED|First Treatment Period, 16 Weeks||17
9773788|NCT00456885|10879313|FG000|COMPLETED|First Treatment Period, 16 Weeks||24
9773789|NCT00456885|10879314|FG001|COMPLETED|First Treatment Period, 16 Weeks||17
9773790|NCT00456885|10879313|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0
9773791|NCT00456885|10879314|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0
9773792|NCT00456885|10879313|FG000|STARTED|Washout, 3 Weeks||24
9773793|NCT00456885|10879314|FG001|STARTED|Washout, 3 Weeks||17
9773794|NCT00456885|10879313|FG000|COMPLETED|Washout, 3 Weeks||24
9773795|NCT00456885|10879314|FG001|COMPLETED|Washout, 3 Weeks||17
9773796|NCT00456885|10879313|FG000|NOT COMPLETED|Washout, 3 Weeks||0
9773797|NCT00456885|10879314|FG001|NOT COMPLETED|Washout, 3 Weeks||0
9773798|NCT00456885|10879313|FG000|STARTED|Second Treatment Period, 16 Weeks||24
9773799|NCT00456885|10879314|FG001|STARTED|Second Treatment Period, 16 Weeks||17
9773800|NCT00456885|10879313|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23
9773801|NCT00456885|10879314|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17
9773802|NCT00456885|10879313|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
9773803|NCT00456885|10879314|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
9773804|NCT00457002|10879321|FG000|STARTED|Overall Study||3255
9773805|NCT00457002|10879322|FG001|STARTED|Overall Study||3273
9773806|NCT00457002|10879321|FG000|COMPLETED|Overall Study||2442
9773807|NCT00457002|10879322|FG001|COMPLETED|Overall Study||2516
9773808|NCT00457002|10879321|FG000|NOT COMPLETED|Overall Study||813
9773809|NCT00457002|10879322|FG001|NOT COMPLETED|Overall Study||757
9773810|NCT00457015|10879330|FG000|STARTED|Overall Study||48
9773811|NCT00457015|10879331|FG001|STARTED|Overall Study||48
9773812|NCT00457015|10879330|FG000|COMPLETED|Overall Study||48
9773813|NCT00457015|10879331|FG001|COMPLETED|Overall Study||47
9773814|NCT00457015|10879330|FG000|NOT COMPLETED|Overall Study||0
9773815|NCT00457015|10879331|FG001|NOT COMPLETED|Overall Study||1
9773816|NCT00457197|10879339|FG000|STARTED|Overall Study||45
9773817|NCT00457197|10879340|FG001|STARTED|Overall Study||45
9773818|NCT00457197|10879339|FG000|COMPLETED|Overall Study||44
9773819|NCT00457197|10879340|FG001|COMPLETED|Overall Study||44
9773820|NCT00457197|10879339|FG000|NOT COMPLETED|Overall Study||1
9773821|NCT00457197|10879340|FG001|NOT COMPLETED|Overall Study||1
9773822|NCT00457249|10879348|FG000|STARTED|Overall Study||1170
9773823|NCT00457249|10879349|FG001|STARTED|Overall Study||391
9773824|NCT00457249|10879348|FG000|COMPLETED|Overall Study||1158
9773825|NCT00457249|10879349|FG001|COMPLETED|Overall Study||389
9773826|NCT00457249|10879348|FG000|NOT COMPLETED|Overall Study||12
9773827|NCT00457249|10879349|FG001|NOT COMPLETED|Overall Study||2
9773828|NCT00457301|10879359|FG000|STARTED|Overall Study||105
9773829|NCT00457301|10879360|FG001|STARTED|Overall Study||108
9773830|NCT00457301|10879359|FG000|COMPLETED|Overall Study||82
9773831|NCT00457301|10879360|FG001|COMPLETED|Overall Study||84
9773832|NCT00457301|10879359|FG000|NOT COMPLETED|Overall Study||23
9773833|NCT00457301|10879360|FG001|NOT COMPLETED|Overall Study||24
9773834|NCT00457366|10879368|FG000|STARTED|Overall Study||40
9773835|NCT00457366|10879369|FG001|STARTED|Overall Study||32
9773836|NCT00457366|10879368|FG000|COMPLETED|Overall Study||40
9773837|NCT00457366|10879369|FG001|COMPLETED|Overall Study||32
9773838|NCT00457366|10879368|FG000|NOT COMPLETED|Overall Study||0
9773839|NCT00457366|10879369|FG001|NOT COMPLETED|Overall Study||0
9773840|NCT00457392|10879377|FG000|STARTED|Overall Study||480
9773841|NCT00457392|10879378|FG001|STARTED|Overall Study||480
9773842|NCT00457392|10879377|FG000|Treated|Overall Study||473
9773843|NCT00457392|10879378|FG001|Treated|Overall Study||477
9773844|NCT00457392|10879377|FG000|COMPLETED|Overall Study||0
9773845|NCT00457392|10879378|FG001|COMPLETED|Overall Study||0
9773846|NCT00457392|10879377|FG000|NOT COMPLETED|Overall Study||480
9773847|NCT00457392|10879378|FG001|NOT COMPLETED|Overall Study||480
9773848|NCT00457418|10879384|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32
9773849|NCT00457418|10879384|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
9773850|NCT00457418|10879384|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
9773851|NCT00457418|10879384|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
9773852|NCT00457418|10879384|FG000|COMPLETED|Post PK Maintenance||3
9773853|NCT00457418|10879384|FG000|NOT COMPLETED|Post PK Maintenance||28
9773854|NCT00457626|10879388|FG000|STARTED|Overall Study||66
9773855|NCT00457626|10879388|FG000|COMPLETED|Overall Study||60
9773856|NCT00457626|10879388|FG000|NOT COMPLETED|Overall Study||6
9773857|NCT00457639|10879392|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
9773858|NCT00457639|10879393|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
9773859|NCT00457639|10879392|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
9773860|NCT00457639|10879393|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
9773861|NCT00457639|10879392|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3
9773862|NCT00457639|10879393|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2
9773863|NCT00457639|10879392|FG000|STARTED|Intervention 2 (6 Months)||6
9773864|NCT00457639|10879393|FG001|STARTED|Intervention 2 (6 Months)||7
9773865|NCT00457639|10879392|FG000|COMPLETED|Intervention 2 (6 Months)||6
9773866|NCT00457639|10879393|FG001|COMPLETED|Intervention 2 (6 Months)||6
9773867|NCT00457639|10879392|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0
9773868|NCT00457639|10879393|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1
9773869|NCT00457665|10879401|FG000|STARTED|12 Months||28
9773870|NCT00457665|10879402|FG001|STARTED|12 Months||28
9773871|NCT00457665|10879401|FG000|COMPLETED|12 Months||20
9773872|NCT00457665|10879402|FG001|COMPLETED|12 Months||19
9773873|NCT00457665|10879401|FG000|NOT COMPLETED|12 Months||8
9773874|NCT00457665|10879402|FG001|NOT COMPLETED|12 Months||9
9773875|NCT00457665|10879401|FG000|STARTED|24 Months||20
9773876|NCT00457665|10879402|FG001|STARTED|24 Months||19
9773877|NCT00457665|10879401|FG000|COMPLETED|24 Months||15
9773878|NCT00457665|10879402|FG001|COMPLETED|24 Months||11
9773879|NCT00457665|10879401|FG000|NOT COMPLETED|24 Months||5
9773880|NCT00457665|10879402|FG001|NOT COMPLETED|24 Months||8
9773881|NCT00457691|10879410|FG000|STARTED|Overall Study||386
9773882|NCT00457691|10879411|FG001|STARTED|Overall Study||382
9773883|NCT00457691|10879410|FG000|COMPLETED|Overall Study||0
9773884|NCT00457691|10879411|FG001|COMPLETED|Overall Study||0
9773885|NCT00457691|10879410|FG000|NOT COMPLETED|Overall Study||386
9773886|NCT00457691|10879411|FG001|NOT COMPLETED|Overall Study||382
9773887|NCT00457730|10879419|FG000|STARTED|Overall Study||18
9773888|NCT00457730|10879420|FG001|STARTED|Overall Study||20
9773889|NCT00457730|10879419|FG000|COMPLETED|Overall Study||14
9773890|NCT00457730|10879420|FG001|COMPLETED|Overall Study||19
9773891|NCT00457730|10879419|FG000|NOT COMPLETED|Overall Study||4
9773892|NCT00457730|10879420|FG001|NOT COMPLETED|Overall Study||1
9773893|NCT00457743|10879433|FG000|STARTED|Overall Study|Overall study|3
9773894|NCT00457743|10879434|FG001|STARTED|Overall Study|Overall study|30
9773895|NCT00457743|10879435|FG002|STARTED|Overall Study|Overall study|3
9773896|NCT00457743|10879433|FG000|Enrolled in Phase 1|Overall Study||3
9773897|NCT00457743|10879434|FG001|Enrolled in Phase 1|Overall Study||6
9773898|NCT00457743|10879435|FG002|Enrolled in Phase 1|Overall Study||3
9773899|NCT00457743|10879433|FG000|Completed Phase 1|Overall Study||3
9773900|NCT00457743|10879434|FG001|Completed Phase 1|Overall Study||6
9773901|NCT00457743|10879435|FG002|Completed Phase 1|Overall Study||3
9773902|NCT00457743|10879433|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
9773903|NCT00457743|10879434|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
9773904|NCT00457743|10879435|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
9773905|NCT00457743|10879433|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
9773906|NCT00457743|10879434|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
9773907|NCT00457743|10879435|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
10014304|NCT01799213|11137437|FG001|COMPLETED|Overall Study||178
10014305|NCT01799213|11137436|FG000|NOT COMPLETED|Overall Study||7
9773908|NCT00457743|10879433|FG000|NOT COMPLETED|Overall Study||3
9773909|NCT00457743|10879434|FG001|NOT COMPLETED|Overall Study||27
9773910|NCT00457743|10879435|FG002|NOT COMPLETED|Overall Study||3
9773911|NCT00457795|10879444|FG000|STARTED|Overall Study||15
9773912|NCT00457795|10879444|FG000|COMPLETED|Overall Study||15
9773913|NCT00457795|10879444|FG000|NOT COMPLETED|Overall Study||0
9773914|NCT00457821|10879456|FG000|STARTED|Part 1|Number of subjects randomized|4
9773915|NCT00457821|10879457|FG001|STARTED|Part 1|Number of subjects randomized|4
9773916|NCT00457821|10879458|FG002|STARTED|Part 1|Number of subjects randomized|5
9773917|NCT00457821|10879459|FG003|STARTED|Part 1|Number of subjects randomized|4
9773918|NCT00457821|10879460|FG004|STARTED|Part 1|Number of subjects randomized|4
9773919|NCT00457821|10879461|FG005|STARTED|Part 1|Arm in Part 2 only|0
9773920|NCT00457821|10879462|FG006|STARTED|Part 1|Arm in Part 2 only|0
9773921|NCT00457821|10879463|FG007|STARTED|Part 1|Arm in Part 2 only|0
9773922|NCT00457821|10879456|FG000|COMPLETED|Part 1||4
9773923|NCT00457821|10879457|FG001|COMPLETED|Part 1||4
9773924|NCT00457821|10879458|FG002|COMPLETED|Part 1||4
9773925|NCT00457821|10879459|FG003|COMPLETED|Part 1||4
9773926|NCT00457821|10879460|FG004|COMPLETED|Part 1||4
9773927|NCT00457821|10879461|FG005|COMPLETED|Part 1||0
9773928|NCT00457821|10879462|FG006|COMPLETED|Part 1||0
10014306|NCT01799213|11137437|FG001|NOT COMPLETED|Overall Study||6
9773929|NCT00457821|10879463|FG007|COMPLETED|Part 1||0
9773930|NCT00457821|10879456|FG000|NOT COMPLETED|Part 1||0
9773931|NCT00457821|10879457|FG001|NOT COMPLETED|Part 1||0
9773932|NCT00457821|10879458|FG002|NOT COMPLETED|Part 1||1
9773933|NCT00457821|10879459|FG003|NOT COMPLETED|Part 1||0
9773934|NCT00457821|10879460|FG004|NOT COMPLETED|Part 1||0
9773935|NCT00457821|10879461|FG005|NOT COMPLETED|Part 1||0
9773936|NCT00457821|10879462|FG006|NOT COMPLETED|Part 1||0
9773937|NCT00457821|10879463|FG007|NOT COMPLETED|Part 1||0
9773938|NCT00457821|10879456|FG000|STARTED|Part 2|Arm in Part 1 only|0
9773939|NCT00457821|10879457|FG001|STARTED|Part 2|Arm in Part 1 only|0
9773940|NCT00457821|10879458|FG002|STARTED|Part 2|Arm in Part 1 only|0
9773941|NCT00457821|10879459|FG003|STARTED|Part 2|Arm in Part 1 only|0
9773942|NCT00457821|10879460|FG004|STARTED|Part 2|Arm in Part 1 only|0
9829932|NCT00761657|10940589|FG004|Safety Population|Part 2 (up to Day 114)||10
10014307|NCT01799226|11137451|FG000|STARTED|Overall Study||16
10014308|NCT01799226|11137452|FG001|STARTED|Overall Study||16
9773943|NCT00457821|10879461|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
9773944|NCT00457821|10879462|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
9773945|NCT00457821|10879463|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
9773946|NCT00457821|10879456|FG000|Completed Study Drug Treatment|Part 2||0
9773947|NCT00457821|10879457|FG001|Completed Study Drug Treatment|Part 2||0
9773948|NCT00457821|10879458|FG002|Completed Study Drug Treatment|Part 2||0
9773949|NCT00457821|10879459|FG003|Completed Study Drug Treatment|Part 2||0
9773950|NCT00457821|10879460|FG004|Completed Study Drug Treatment|Part 2||0
9773951|NCT00457821|10879461|FG005|Completed Study Drug Treatment|Part 2||8
9773952|NCT00457821|10879462|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
9773953|NCT00457821|10879463|FG007|Completed Study Drug Treatment|Part 2||4
9773954|NCT00457821|10879456|FG000|COMPLETED|Part 2||0
9773955|NCT00457821|10879457|FG001|COMPLETED|Part 2||0
9773956|NCT00457821|10879458|FG002|COMPLETED|Part 2||0
9773957|NCT00457821|10879459|FG003|COMPLETED|Part 2||0
9773958|NCT00457821|10879460|FG004|COMPLETED|Part 2||0
9773959|NCT00457821|10879461|FG005|COMPLETED|Part 2||8
9773960|NCT00457821|10879462|FG006|COMPLETED|Part 2||7
9773961|NCT00457821|10879463|FG007|COMPLETED|Part 2||4
9773962|NCT00457821|10879456|FG000|NOT COMPLETED|Part 2||0
9773963|NCT00457821|10879457|FG001|NOT COMPLETED|Part 2||0
9773964|NCT00457821|10879458|FG002|NOT COMPLETED|Part 2||0
9773965|NCT00457821|10879459|FG003|NOT COMPLETED|Part 2||0
9773966|NCT00457821|10879460|FG004|NOT COMPLETED|Part 2||0
9773967|NCT00457821|10879461|FG005|NOT COMPLETED|Part 2||0
9773968|NCT00457821|10879462|FG006|NOT COMPLETED|Part 2||0
9773969|NCT00457821|10879463|FG007|NOT COMPLETED|Part 2||1
9773970|NCT00457977|10879482|FG000|STARTED|Overall Study||90
9773971|NCT00457977|10879483|FG001|STARTED|Overall Study||91
9773972|NCT00457977|10879482|FG000|1-Month|Overall Study||88
9773973|NCT00457977|10879483|FG001|1-Month|Overall Study||87
9773974|NCT00457977|10879482|FG000|1-Year|Overall Study||69
9773975|NCT00457977|10879483|FG001|1-Year|Overall Study||76
9773976|NCT00457977|10879482|FG000|2-Year|Overall Study||62
9773977|NCT00457977|10879483|FG001|2-Year|Overall Study||66
9773978|NCT00457977|10879482|FG000|COMPLETED|Overall Study||62
9773979|NCT00457977|10879483|FG001|COMPLETED|Overall Study||66
9773980|NCT00457977|10879482|FG000|NOT COMPLETED|Overall Study||28
9773981|NCT00457977|10879483|FG001|NOT COMPLETED|Overall Study||25
9773982|NCT00458211|10879489|FG000|STARTED|Overall Study||40
9773983|NCT00458211|10879489|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
9773984|NCT00458211|10879489|FG000|NOT COMPLETED|Overall Study||16
9773985|NCT00458237|10879500|FG000|STARTED|Overall Study||3
9773986|NCT00458237|10879501|FG001|STARTED|Overall Study||3
9773987|NCT00458237|10879502|FG002|STARTED|Overall Study||5
9773988|NCT00458237|10879500|FG000|COMPLETED|Overall Study||3
9773989|NCT00458237|10879501|FG001|COMPLETED|Overall Study||3
9773990|NCT00458237|10879502|FG002|COMPLETED|Overall Study||5
9773991|NCT00458237|10879500|FG000|NOT COMPLETED|Overall Study||0
9773992|NCT00458237|10879501|FG001|NOT COMPLETED|Overall Study||0
9773993|NCT00458237|10879502|FG002|NOT COMPLETED|Overall Study||0
9773994|NCT00458302|10879513|FG000|STARTED|Overall Study||129
9773995|NCT00458302|10879514|FG001|STARTED|Overall Study||127
9773996|NCT00458302|10879513|FG000|COMPLETED|Overall Study||109
9773997|NCT00458302|10879514|FG001|COMPLETED|Overall Study||103
9773998|NCT00458302|10879513|FG000|NOT COMPLETED|Overall Study||20
9773999|NCT00458302|10879514|FG001|NOT COMPLETED|Overall Study||24
9774000|NCT00458341|10879523|FG000|STARTED|Cycle 1||15
9774001|NCT00458341|10879524|FG001|STARTED|Cycle 1||15
9774002|NCT00458341|10879523|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15
9774003|NCT00458341|10879524|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15
9774004|NCT00458341|10879523|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
9774005|NCT00458341|10879524|FG001|COMPLETED|Cycle 1||15
9774006|NCT00458341|10879523|FG000|NOT COMPLETED|Cycle 1||1
9774007|NCT00458341|10879524|FG001|NOT COMPLETED|Cycle 1||0
9774008|NCT00458341|10879523|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
9774009|NCT00458341|10879524|FG001|STARTED|Cycle 2||15
9774010|NCT00458341|10879523|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15
9774011|NCT00458341|10879524|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15
9774012|NCT00458341|10879523|FG000|COMPLETED|Cycle 2||15
9774013|NCT00458341|10879524|FG001|COMPLETED|Cycle 2||15
9774014|NCT00458341|10879523|FG000|NOT COMPLETED|Cycle 2||0
9774015|NCT00458341|10879524|FG001|NOT COMPLETED|Cycle 2||0
9774016|NCT00458393|10879532|FG000|STARTED|Overall Study||1251
9774017|NCT00458393|10879533|FG001|STARTED|Overall Study||1248
9774018|NCT00458393|10879532|FG000|COMPLETED|Overall Study||942
9774019|NCT00458393|10879533|FG001|COMPLETED|Overall Study||953
9774020|NCT00458393|10879532|FG000|NOT COMPLETED|Overall Study||309
9774021|NCT00458393|10879533|FG001|NOT COMPLETED|Overall Study||295
9774022|NCT00458406|10879543|FG000|STARTED|Month 1||43
9774023|NCT00458406|10879544|FG001|STARTED|Month 1||13
9774024|NCT00458406|10879543|FG000|COMPLETED|Month 1||43
9774025|NCT00458406|10879544|FG001|COMPLETED|Month 1||13
9774026|NCT00458406|10879543|FG000|NOT COMPLETED|Month 1||0
9774027|NCT00458406|10879544|FG001|NOT COMPLETED|Month 1||0
9774028|NCT00458406|10879543|FG000|STARTED|Month 3||43
9774029|NCT00458406|10879544|FG001|STARTED|Month 3||13
9774030|NCT00458406|10879543|FG000|COMPLETED|Month 3||43
9774031|NCT00458406|10879544|FG001|COMPLETED|Month 3||13
10233900|NCT01619800|11363762|FG001|STARTED|Overall Study||0
10233901|NCT01619800|11363761|FG000|COMPLETED|Overall Study||0
10233902|NCT01619800|11363762|FG001|COMPLETED|Overall Study||0
10233903|NCT01619800|11363761|FG000|NOT COMPLETED|Overall Study||2
10233904|NCT01619800|11363762|FG001|NOT COMPLETED|Overall Study||0
9774032|NCT00458406|10879543|FG000|NOT COMPLETED|Month 3||0
9774033|NCT00458406|10879544|FG001|NOT COMPLETED|Month 3||0
9774034|NCT00458484|10879564|FG000|STARTED|Overall Study||4
9774035|NCT00458484|10879565|FG001|STARTED|Overall Study||6
9774036|NCT00458484|10879566|FG002|STARTED|Overall Study||3
9774037|NCT00458484|10879567|FG003|STARTED|Overall Study||6
9774038|NCT00458484|10879568|FG004|STARTED|Overall Study||4
9774039|NCT00458484|10879569|FG005|STARTED|Overall Study||5
9774040|NCT00458484|10879570|FG006|STARTED|Overall Study||3
9774041|NCT00458484|10879564|FG000|COMPLETED|Overall Study||4
9774042|NCT00458484|10879565|FG001|COMPLETED|Overall Study||6
9774043|NCT00458484|10879566|FG002|COMPLETED|Overall Study||3
9774044|NCT00458484|10879567|FG003|COMPLETED|Overall Study||6
9774045|NCT00458484|10879568|FG004|COMPLETED|Overall Study||4
9774046|NCT00458484|10879569|FG005|COMPLETED|Overall Study||4
9774047|NCT00458484|10879570|FG006|COMPLETED|Overall Study||3
9774048|NCT00458484|10879564|FG000|NOT COMPLETED|Overall Study||0
9774049|NCT00458484|10879565|FG001|NOT COMPLETED|Overall Study||0
9774050|NCT00458484|10879566|FG002|NOT COMPLETED|Overall Study||0
9774051|NCT00458484|10879567|FG003|NOT COMPLETED|Overall Study||0
9774052|NCT00458484|10879568|FG004|NOT COMPLETED|Overall Study||0
9774053|NCT00458484|10879569|FG005|NOT COMPLETED|Overall Study||1
9774054|NCT00458484|10879570|FG006|NOT COMPLETED|Overall Study||0
9774055|NCT00458705|10879595|FG000|STARTED|Overall Study||45
9774056|NCT00458705|10879595|FG000|COMPLETED|Overall Study||40
9774057|NCT00458705|10879595|FG000|NOT COMPLETED|Overall Study||5
9774058|NCT00458783|10879601|FG000|STARTED|Overall Study||1914
9774059|NCT00458783|10879602|FG001|STARTED|Overall Study||1921
9774060|NCT00458783|10879601|FG000|COMPLETED|Overall Study||686
9774061|NCT00458783|10879602|FG001|COMPLETED|Overall Study||701
9774062|NCT00458783|10879601|FG000|NOT COMPLETED|Overall Study||1228
9774063|NCT00458783|10879602|FG001|NOT COMPLETED|Overall Study||1220
9774064|NCT00458822|10879608|FG000|STARTED|Overall Study||40
9774065|NCT00458822|10879608|FG000|COMPLETED|Overall Study||40
9774066|NCT00458822|10879608|FG000|NOT COMPLETED|Overall Study||0
9774067|NCT00458848|10879612|FG000|STARTED|Overall Study||51
9774068|NCT00458848|10879612|FG000|COMPLETED|Overall Study||51
9774069|NCT00458848|10879612|FG000|NOT COMPLETED|Overall Study||0
9774070|NCT00458952|10879618|FG000|STARTED|Overall Study||7
9774071|NCT00458952|10879619|FG001|STARTED|Overall Study||14
9774072|NCT00458952|10879618|FG000|COMPLETED|Overall Study||5
9774073|NCT00458952|10879619|FG001|COMPLETED|Overall Study||9
9774074|NCT00458952|10879618|FG000|NOT COMPLETED|Overall Study||2
9774075|NCT00458952|10879619|FG001|NOT COMPLETED|Overall Study||5
9774076|NCT00459043|10879625|FG000|STARTED|Overall Study||15
9774077|NCT00459043|10879626|FG001|STARTED|Overall Study||15
9774078|NCT00459043|10879625|FG000|COMPLETED|Overall Study||14
9774079|NCT00459043|10879626|FG001|COMPLETED|Overall Study||15
9774080|NCT00459043|10879625|FG000|NOT COMPLETED|Overall Study||1
9774081|NCT00459043|10879626|FG001|NOT COMPLETED|Overall Study||0
9774082|NCT00459056|10879634|FG000|STARTED|First Intervention (First Three Months)||10
9774083|NCT00459056|10879635|FG001|STARTED|First Intervention (First Three Months)||15
9774084|NCT00459056|10879634|FG000|COMPLETED|First Intervention (First Three Months)||9
9774085|NCT00459056|10879635|FG001|COMPLETED|First Intervention (First Three Months)||14
9774086|NCT00459056|10879634|FG000|NOT COMPLETED|First Intervention (First Three Months)||1
9774087|NCT00459056|10879635|FG001|NOT COMPLETED|First Intervention (First Three Months)||1
9774088|NCT00459056|10879634|FG000|STARTED|Washout (1 Month)||9
9774089|NCT00459056|10879635|FG001|STARTED|Washout (1 Month)||14
9774090|NCT00459056|10879634|FG000|COMPLETED|Washout (1 Month)||9
9774091|NCT00459056|10879635|FG001|COMPLETED|Washout (1 Month)||14
9774092|NCT00459056|10879634|FG000|NOT COMPLETED|Washout (1 Month)||0
9774093|NCT00459056|10879635|FG001|NOT COMPLETED|Washout (1 Month)||0
9774094|NCT00459056|10879634|FG000|STARTED|Second Intervention (Final Three Months)||9
9774095|NCT00459056|10879635|FG001|STARTED|Second Intervention (Final Three Months)||14
9774096|NCT00459056|10879634|FG000|COMPLETED|Second Intervention (Final Three Months)||9
9774097|NCT00459056|10879635|FG001|COMPLETED|Second Intervention (Final Three Months)||14
9774098|NCT00459056|10879634|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0
9774099|NCT00459056|10879635|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0
9774100|NCT00459108|10879641|FG000|STARTED|Overall Study||25
9774101|NCT00459108|10879641|FG000|COMPLETED|Overall Study||14
9774102|NCT00459108|10879641|FG000|NOT COMPLETED|Overall Study||11
9774103|NCT00459134|10879648|FG000|STARTED|Overall Study||94
9774104|NCT00459134|10879649|FG001|STARTED|Overall Study||92
10233905|NCT01608906|11363768|FG000|STARTED|Overall Study||152
10233906|NCT01608906|11363768|FG000|COMPLETED|Overall Study||113
9774105|NCT00459134|10879648|FG000|COMPLETED|Overall Study||71
9774106|NCT00459134|10879649|FG001|COMPLETED|Overall Study||67
9774107|NCT00459134|10879648|FG000|NOT COMPLETED|Overall Study||23
9774108|NCT00459134|10879649|FG001|NOT COMPLETED|Overall Study||25
9774109|NCT00459186|10879655|FG000|STARTED|Single Agent RAD001||19
9774110|NCT00459186|10879655|FG000|COMPLETED|Single Agent RAD001||18
9774111|NCT00459186|10879655|FG000|NOT COMPLETED|Single Agent RAD001||1
9774112|NCT00459186|10879655|FG000|STARTED|PET Imaging and Assessment||18
9774113|NCT00459186|10879655|FG000|COMPLETED|PET Imaging and Assessment||15
9774114|NCT00459186|10879655|FG000|NOT COMPLETED|PET Imaging and Assessment||3
9774115|NCT00459186|10879655|FG000|STARTED|Combination RAD001 + Docetaxel||15
9774116|NCT00459186|10879655|FG000|COMPLETED|Combination RAD001 + Docetaxel||15
9774117|NCT00459186|10879655|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0
9774118|NCT00459290|10879659|FG000|STARTED|Overall Study||24
9774119|NCT00459290|10879659|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
9774120|NCT00459290|10879659|FG000|NOT COMPLETED|Overall Study||5
9774121|NCT00459303|10879670|FG000|STARTED|Overall Study||20
9774122|NCT00459303|10879670|FG000|COMPLETED|Overall Study||20
9774123|NCT00459303|10879670|FG000|NOT COMPLETED|Overall Study||0
9774124|NCT00459316|10879682|FG000|STARTED|Steps 1 & 2||280
9774125|NCT00459316|10879683|FG001|STARTED|Steps 1 & 2||39
9774126|NCT00459316|10879684|FG002|STARTED|Steps 1 & 2||59
9774127|NCT00459316|10879682|FG000|COMPLETED|Steps 1 & 2||259
9774128|NCT00459316|10879683|FG001|COMPLETED|Steps 1 & 2||32
9774129|NCT00459316|10879684|FG002|COMPLETED|Steps 1 & 2||57
9774130|NCT00459316|10879682|FG000|NOT COMPLETED|Steps 1 & 2||21
9774131|NCT00459316|10879683|FG001|NOT COMPLETED|Steps 1 & 2||7
9774132|NCT00459316|10879684|FG002|NOT COMPLETED|Steps 1 & 2||2
9774133|NCT00459316|10879682|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
9774134|NCT00459316|10879683|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
9774135|NCT00459316|10879684|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
9774136|NCT00459316|10879682|FG000|COMPLETED|Step 3||149
9774137|NCT00459316|10879683|FG001|COMPLETED|Step 3||0
9774138|NCT00459316|10879684|FG002|COMPLETED|Step 3||39
9774139|NCT00459316|10879682|FG000|NOT COMPLETED|Step 3||3
9774140|NCT00459316|10879683|FG001|NOT COMPLETED|Step 3||0
9774141|NCT00459316|10879684|FG002|NOT COMPLETED|Step 3||1
9774142|NCT00459342|10879707|FG000|STARTED|Overall Study||35
9774143|NCT00459342|10879707|FG000|COMPLETED|Overall Study||34
9774144|NCT00459342|10879707|FG000|NOT COMPLETED|Overall Study||1
9774145|NCT00459355|10879713|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
9774146|NCT00459355|10879714|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
9774147|NCT00459355|10879713|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
9774148|NCT00459355|10879714|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
9774149|NCT00459355|10879713|FG000|NOT COMPLETED|Overall Study||20
9774150|NCT00459355|10879714|FG001|NOT COMPLETED|Overall Study||18
9774151|NCT00459368|10879726|FG000|STARTED|Overall Study||1335
9774152|NCT00459368|10879727|FG001|STARTED|Overall Study||1363
9774153|NCT00459368|10879726|FG000|COMPLETED|Overall Study||1040
9774154|NCT00459368|10879727|FG001|COMPLETED|Overall Study||1034
9774155|NCT00459368|10879726|FG000|NOT COMPLETED|Overall Study||295
9774156|NCT00459368|10879727|FG001|NOT COMPLETED|Overall Study||329
9774157|NCT00459381|10879733|FG000|STARTED|Overall Study||35
9774158|NCT00459381|10879733|FG000|COMPLETED|Overall Study||35
9774159|NCT00459381|10879733|FG000|NOT COMPLETED|Overall Study||0
9774160|NCT00459537|10879739|FG000|STARTED|Overall Study||507
9774161|NCT00459537|10879740|FG001|STARTED|Overall Study||522
9774162|NCT00459537|10879739|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
9774163|NCT00459537|10879740|FG001|Safety Population|Overall Study||512
9774164|NCT00459537|10879739|FG000|COMPLETED|Overall Study||441
9774165|NCT00459537|10879740|FG001|COMPLETED|Overall Study||446
9774166|NCT00459537|10879739|FG000|NOT COMPLETED|Overall Study||66
9774167|NCT00459537|10879740|FG001|NOT COMPLETED|Overall Study||76
9774168|NCT00459667|10879749|FG000|STARTED|Overall Study||592
9774169|NCT00459667|10879750|FG001|STARTED|Overall Study||647
9774170|NCT00459667|10879751|FG002|STARTED|Overall Study||181
9774171|NCT00459667|10879749|FG000|Study Medication Dispensed|Overall Study||586
9774172|NCT00459667|10879750|FG001|Study Medication Dispensed|Overall Study||645
9774173|NCT00459667|10879751|FG002|Study Medication Dispensed|Overall Study||180
9774174|NCT00459667|10879749|FG000|Started Treatment|Overall Study||586
9774175|NCT00459667|10879750|FG001|Started Treatment|Overall Study||644
9774176|NCT00459667|10879751|FG002|Started Treatment|Overall Study||180
9774177|NCT00459667|10879749|FG000|COMPLETED|Overall Study||554
9774178|NCT00459667|10879750|FG001|COMPLETED|Overall Study||600
9774179|NCT00459667|10879751|FG002|COMPLETED|Overall Study||161
9774180|NCT00459667|10879749|FG000|NOT COMPLETED|Overall Study||38
9774181|NCT00459667|10879750|FG001|NOT COMPLETED|Overall Study||47
9774182|NCT00459667|10879751|FG002|NOT COMPLETED|Overall Study||20
9774183|NCT00459706|10879761|FG000|STARTED|Overall Study||325
9774184|NCT00459706|10879762|FG001|STARTED|Overall Study||315
9774185|NCT00459706|10879761|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
10014309|NCT01799226|11137451|FG000|Right Stent Side|Overall Study||8
10014310|NCT01799226|11137452|FG001|Right Stent Side|Overall Study||8
9774186|NCT00459706|10879762|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
9774187|NCT00459706|10879761|FG000|COMPLETED|Overall Study||299
9774188|NCT00459706|10879762|FG001|COMPLETED|Overall Study||294
9774189|NCT00459706|10879761|FG000|NOT COMPLETED|Overall Study||26
9774190|NCT00459706|10879762|FG001|NOT COMPLETED|Overall Study||21
9774191|NCT00459732|10879770|FG000|STARTED|Overall Study||23
9774192|NCT00459732|10879771|FG001|STARTED|Overall Study||17
9774193|NCT00459732|10879770|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
9829933|NCT00761657|10940590|FG005|Safety Population|Part 2 (up to Day 114)||11
9774194|NCT00459732|10879771|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
9774195|NCT00459732|10879770|FG000|NOT COMPLETED|Overall Study||4
9774196|NCT00459732|10879771|FG001|NOT COMPLETED|Overall Study||3
9774197|NCT00459810|10879777|FG000|STARTED|Overall Study||21
9774198|NCT00459810|10879777|FG000|COMPLETED|Overall Study||21
9774199|NCT00459810|10879777|FG000|NOT COMPLETED|Overall Study||0
9829934|NCT00761657|10940591|FG006|Safety Population|Part 2 (up to Day 114)||10
9829935|NCT00761657|10940592|FG007|Safety Population|Part 2 (up to Day 114)||10
9829936|NCT00761657|10940593|FG008|Safety Population|Part 2 (up to Day 114)||18
9829937|NCT00761657|10940585|FG000|EE Population|Part 2 (up to Day 114)||10
9829938|NCT00761657|10940586|FG001|EE Population|Part 2 (up to Day 114)||12
9829939|NCT00761657|10940587|FG002|EE Population|Part 2 (up to Day 114)||0
9829940|NCT00761657|10940588|FG003|EE Population|Part 2 (up to Day 114)||0
9829941|NCT00761657|10940589|FG004|EE Population|Part 2 (up to Day 114)||10
9829942|NCT00761657|10940590|FG005|EE Population|Part 2 (up to Day 114)||11
9829943|NCT00761657|10940591|FG006|EE Population|Part 2 (up to Day 114)||10
9829944|NCT00761657|10940592|FG007|EE Population|Part 2 (up to Day 114)||10
9829945|NCT00761657|10940593|FG008|EE Population|Part 2 (up to Day 114)||11
9829946|NCT00761657|10940585|FG000|PK Population|Part 2 (up to Day 114)||10
9829947|NCT00761657|10940586|FG001|PK Population|Part 2 (up to Day 114)||13
9829948|NCT00761657|10940587|FG002|PK Population|Part 2 (up to Day 114)||0
9829949|NCT00761657|10940588|FG003|PK Population|Part 2 (up to Day 114)||0
9829950|NCT00761657|10940589|FG004|PK Population|Part 2 (up to Day 114)||10
9829951|NCT00761657|10940590|FG005|PK Population|Part 2 (up to Day 114)||11
9829952|NCT00761657|10940591|FG006|PK Population|Part 2 (up to Day 114)||10
9829953|NCT00761657|10940592|FG007|PK Population|Part 2 (up to Day 114)||10
9829954|NCT00761657|10940593|FG008|PK Population|Part 2 (up to Day 114)||0
9829955|NCT00761657|10940585|FG000|COMPLETED|Part 2 (up to Day 114)||10
9829956|NCT00761657|10940586|FG001|COMPLETED|Part 2 (up to Day 114)||13
9829957|NCT00761657|10940587|FG002|COMPLETED|Part 2 (up to Day 114)||0
9829958|NCT00761657|10940588|FG003|COMPLETED|Part 2 (up to Day 114)||0
9829959|NCT00761657|10940589|FG004|COMPLETED|Part 2 (up to Day 114)||10
9829960|NCT00761657|10940590|FG005|COMPLETED|Part 2 (up to Day 114)||11
9829961|NCT00761657|10940591|FG006|COMPLETED|Part 2 (up to Day 114)||10
9829962|NCT00761657|10940592|FG007|COMPLETED|Part 2 (up to Day 114)||10
9829963|NCT00761657|10940593|FG008|COMPLETED|Part 2 (up to Day 114)||17
9829964|NCT00761657|10940585|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0
9829965|NCT00761657|10940586|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0
9829966|NCT00761657|10940587|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0
9829967|NCT00761657|10940588|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0
9829968|NCT00761657|10940589|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0
9829969|NCT00761657|10940590|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0
9829970|NCT00761657|10940591|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0
9829971|NCT00761657|10940592|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0
9829972|NCT00761657|10940593|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1
9829973|NCT00761735|10940623|FG000|STARTED|Overall Study||94
9829974|NCT00761735|10940623|FG000|COMPLETED|Overall Study||80
9829975|NCT00761735|10940623|FG000|NOT COMPLETED|Overall Study||14
9829976|NCT00761748|10940631|FG000|STARTED|First Intervention (21 +/- 3 Days)||20
9829977|NCT00761748|10940632|FG001|STARTED|First Intervention (21 +/- 3 Days)||10
9829978|NCT00761748|10940631|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17
9829979|NCT00761748|10940632|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7
9829980|NCT00761748|10940631|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
9829981|NCT00761748|10940632|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
9829982|NCT00761748|10940631|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17
9829983|NCT00761748|10940632|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7
9829984|NCT00761748|10940631|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17
9829985|NCT00761748|10940632|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7
9829986|NCT00761748|10940631|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
9829987|NCT00761748|10940632|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
9829988|NCT00761761|10940640|FG000|STARTED|Overall Study||30
9829989|NCT00761761|10940641|FG001|STARTED|Overall Study||30
9829990|NCT00761761|10940640|FG000|COMPLETED|Overall Study||24
9829991|NCT00761761|10940641|FG001|COMPLETED|Overall Study||29
9829992|NCT00761761|10940640|FG000|NOT COMPLETED|Overall Study||6
9829993|NCT00761761|10940641|FG001|NOT COMPLETED|Overall Study||1
9829994|NCT00761774|10940649|FG000|STARTED|Overall Study||108
9829995|NCT00761774|10940649|FG000|COMPLETED|Overall Study||29
9829996|NCT00761774|10940649|FG000|NOT COMPLETED|Overall Study||79
9829997|NCT00761813|10940657|FG000|STARTED|Overall Study||557
9829998|NCT00761813|10940658|FG001|STARTED|Overall Study||551
9829999|NCT00761813|10940657|FG000|COMPLETED|Overall Study||542
9830000|NCT00761813|10940658|FG001|COMPLETED|Overall Study||537
9830001|NCT00761813|10940657|FG000|NOT COMPLETED|Overall Study||15
9830002|NCT00761813|10940658|FG001|NOT COMPLETED|Overall Study||14
9830003|NCT00761865|10940666|FG000|STARTED|Overall Study||16
9830004|NCT00761865|10940667|FG001|STARTED|Overall Study||18
9830005|NCT00761865|10940666|FG000|COMPLETED|Overall Study||8
9830006|NCT00761865|10940667|FG001|COMPLETED|Overall Study||11
9830007|NCT00761865|10940666|FG000|NOT COMPLETED|Overall Study||8
9830008|NCT00761865|10940667|FG001|NOT COMPLETED|Overall Study||7
9830009|NCT00761891|10940673|FG000|STARTED|Overall Study||64
9830010|NCT00761891|10940673|FG000|COMPLETED|Overall Study||54
9830011|NCT00761891|10940673|FG000|NOT COMPLETED|Overall Study||10
9774200|NCT00459862|10879781|FG000|STARTED|Overall Study||34
9774201|NCT00459862|10879781|FG000|COMPLETED|Overall Study||34
9774202|NCT00459862|10879781|FG000|NOT COMPLETED|Overall Study||0
9774203|NCT00459875|10879785|FG000|STARTED|Overall Study||24
9774204|NCT00459875|10879785|FG000|COMPLETED|Overall Study||21
9774205|NCT00459875|10879785|FG000|NOT COMPLETED|Overall Study||3
9774206|NCT00459953|10879791|FG000|STARTED|Overall Study||72
9774207|NCT00459953|10879792|FG001|STARTED|Overall Study||71
9774208|NCT00459953|10879791|FG000|COMPLETED|Overall Study||71
9774209|NCT00459953|10879792|FG001|COMPLETED|Overall Study||70
9774210|NCT00459953|10879791|FG000|NOT COMPLETED|Overall Study||1
9774211|NCT00459953|10879792|FG001|NOT COMPLETED|Overall Study||1
9774212|NCT00459979|10879798|FG000|STARTED|Overall Study||30
9774213|NCT00459979|10879798|FG000|COMPLETED|Overall Study||28
9774214|NCT00459979|10879798|FG000|NOT COMPLETED|Overall Study||2
10014311|NCT01799226|11137451|FG000|Left Stent Side|Overall Study||8
10014312|NCT01799226|11137452|FG001|Left Stent Side|Overall Study||8
10014313|NCT01799226|11137451|FG000|COMPLETED|Overall Study||14
10014314|NCT01799226|11137452|FG001|COMPLETED|Overall Study||16
10014315|NCT01799226|11137451|FG000|NOT COMPLETED|Overall Study||2
10014316|NCT01799226|11137452|FG001|NOT COMPLETED|Overall Study||0
10014317|NCT01799239|11137458|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
10014318|NCT01799239|11137459|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
10014319|NCT01799239|11137458|FG000|COMPLETED|Period 1 (7 Days)||12
10014320|NCT01799239|11137459|FG001|COMPLETED|Period 1 (7 Days)||15
10014321|NCT01799239|11137458|FG000|NOT COMPLETED|Period 1 (7 Days)||3
10014322|NCT01799239|11137459|FG001|NOT COMPLETED|Period 1 (7 Days)||1
10014323|NCT01799239|11137458|FG000|STARTED|Period 2 (7 Days)||13
10014324|NCT01799239|11137459|FG001|STARTED|Period 2 (7 Days)||15
10014325|NCT01799239|11137458|FG000|COMPLETED|Period 2 (7 Days)||11
10014326|NCT01799239|11137459|FG001|COMPLETED|Period 2 (7 Days)||14
10014327|NCT01799239|11137458|FG000|NOT COMPLETED|Period 2 (7 Days)||2
10014328|NCT01799239|11137459|FG001|NOT COMPLETED|Period 2 (7 Days)||1
10014329|NCT01799278|11137465|FG000|STARTED|Overall Study||60
10014330|NCT01799278|11137465|FG000|COMPLETED|Overall Study||60
10014331|NCT01799278|11137465|FG000|NOT COMPLETED|Overall Study||0
9774215|NCT00460031|10879802|FG000|STARTED|Overall Study||34
9774216|NCT00460031|10879802|FG000|COMPLETED|Overall Study||23
9774217|NCT00460031|10879802|FG000|NOT COMPLETED|Overall Study||11
9774218|NCT00460109|10879806|FG000|STARTED|Overall Study||24
9774219|NCT00460109|10879806|FG000|COMPLETED|Overall Study||23
9774220|NCT00460109|10879806|FG000|NOT COMPLETED|Overall Study||1
9774221|NCT00460239|10879810|FG000|STARTED|Overall Study||0
9774222|NCT00460239|10879811|FG001|STARTED|Overall Study||3
9774223|NCT00460239|10879812|FG002|STARTED|Overall Study||1
9774224|NCT00460239|10879813|FG003|STARTED|Overall Study||0
9774225|NCT00460239|10879814|FG004|STARTED|Overall Study||1
9774226|NCT00460239|10879815|FG005|STARTED|Overall Study||4
9774227|NCT00460239|10879816|FG006|STARTED|Overall Study||1
9774228|NCT00460239|10879817|FG007|STARTED|Overall Study||1
9774229|NCT00460239|10879818|FG008|STARTED|Overall Study||1
9774230|NCT00460239|10879810|FG000|COMPLETED|Overall Study||0
9774231|NCT00460239|10879811|FG001|COMPLETED|Overall Study||2
9774232|NCT00460239|10879812|FG002|COMPLETED|Overall Study||1
9774233|NCT00460239|10879813|FG003|COMPLETED|Overall Study||0
9774234|NCT00460239|10879814|FG004|COMPLETED|Overall Study||1
9774235|NCT00460239|10879815|FG005|COMPLETED|Overall Study||1
9774236|NCT00460239|10879816|FG006|COMPLETED|Overall Study||1
9774237|NCT00460239|10879817|FG007|COMPLETED|Overall Study||1
9774238|NCT00460239|10879818|FG008|COMPLETED|Overall Study||1
9774239|NCT00460239|10879810|FG000|NOT COMPLETED|Overall Study||0
9774240|NCT00460239|10879811|FG001|NOT COMPLETED|Overall Study||1
9774241|NCT00460239|10879812|FG002|NOT COMPLETED|Overall Study||0
9774242|NCT00460239|10879813|FG003|NOT COMPLETED|Overall Study||0
9774243|NCT00460239|10879814|FG004|NOT COMPLETED|Overall Study||0
9774244|NCT00460239|10879815|FG005|NOT COMPLETED|Overall Study||3
9774245|NCT00460239|10879816|FG006|NOT COMPLETED|Overall Study||0
9774246|NCT00460239|10879817|FG007|NOT COMPLETED|Overall Study||0
9774247|NCT00460239|10879818|FG008|NOT COMPLETED|Overall Study||0
9774248|NCT00460265|10879833|FG000|STARTED|Overall Study||328
9774249|NCT00460265|10879834|FG001|STARTED|Overall Study||330
9774250|NCT00460265|10879833|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
9774251|NCT00460265|10879834|FG001|Randomized While Alive|Overall Study||330
9774252|NCT00460265|10879833|FG000|Received Study Medication|Overall Study||325
9774253|NCT00460265|10879834|FG001|Received Study Medication|Overall Study||325
9774254|NCT00460265|10879833|FG000|COMPLETED|Overall Study|Completed study=death|243
9774255|NCT00460265|10879834|FG001|COMPLETED|Overall Study|Completed study=death|241
9774256|NCT00460265|10879833|FG000|NOT COMPLETED|Overall Study||85
9774257|NCT00460265|10879834|FG001|NOT COMPLETED|Overall Study||89
9774258|NCT00460408|10879844|FG000|STARTED|Overall Study||403
9774259|NCT00460408|10879845|FG001|STARTED|Overall Study||16
9774260|NCT00460408|10879846|FG002|STARTED|Overall Study||75
9774261|NCT00460408|10879847|FG003|STARTED|Overall Study||7
10014332|NCT01799590|11137476|FG000|STARTED|Overall Study||111
10014333|NCT01799590|11137477|FG001|STARTED|Overall Study||94
9774262|NCT00460408|10879844|FG000|COMPLETED|Overall Study||336
9774263|NCT00460408|10879845|FG001|COMPLETED|Overall Study||13
9774264|NCT00460408|10879846|FG002|COMPLETED|Overall Study||69
9774265|NCT00460408|10879847|FG003|COMPLETED|Overall Study||7
10014334|NCT01799590|11137478|FG002|STARTED|Overall Study||91
9774266|NCT00460408|10879844|FG000|NOT COMPLETED|Overall Study||67
9774267|NCT00460408|10879845|FG001|NOT COMPLETED|Overall Study||3
9774268|NCT00460408|10879846|FG002|NOT COMPLETED|Overall Study||6
9774269|NCT00460408|10879847|FG003|NOT COMPLETED|Overall Study||0
9774270|NCT00460421|10879860|FG000|STARTED|Overall Study||9
9774271|NCT00460421|10879861|FG001|STARTED|Overall Study||9
9774272|NCT00460421|10879862|FG002|STARTED|Overall Study||9
9774273|NCT00460421|10879860|FG000|COMPLETED|Overall Study||9
9774274|NCT00460421|10879861|FG001|COMPLETED|Overall Study||9
9774275|NCT00460421|10879862|FG002|COMPLETED|Overall Study||9
9774276|NCT00460421|10879860|FG000|NOT COMPLETED|Overall Study||0
9774277|NCT00460421|10879861|FG001|NOT COMPLETED|Overall Study||0
9774278|NCT00460421|10879862|FG002|NOT COMPLETED|Overall Study||0
9774279|NCT00460434|10879871|FG000|STARTED|Overall Study||165
9774280|NCT00460434|10879872|FG001|STARTED|Overall Study||172
9774281|NCT00460434|10879871|FG000|3 Months|Overall Study||163
9774282|NCT00460434|10879872|FG001|3 Months|Overall Study||171
9774283|NCT00460434|10879871|FG000|12 Months|Overall Study||162
9774284|NCT00460434|10879872|FG001|12 Months|Overall Study||165
9774285|NCT00460434|10879871|FG000|COMPLETED|Overall Study||162
9774286|NCT00460434|10879872|FG001|COMPLETED|Overall Study||165
9774287|NCT00460434|10879871|FG000|NOT COMPLETED|Overall Study||3
9774288|NCT00460434|10879872|FG001|NOT COMPLETED|Overall Study||7
9774289|NCT00460525|10879880|FG000|STARTED|Overall Study||201
9774290|NCT00460525|10879881|FG001|STARTED|Overall Study||199
9774291|NCT00460525|10879880|FG000|COMPLETED|Overall Study||190
9774292|NCT00460525|10879881|FG001|COMPLETED|Overall Study||194
9774293|NCT00460525|10879880|FG000|NOT COMPLETED|Overall Study||11
9774294|NCT00460525|10879881|FG001|NOT COMPLETED|Overall Study||5
9774295|NCT00460551|10879887|FG000|STARTED|Overall Study||13
10014335|NCT01799590|11137476|FG000|COMPLETED|Overall Study||85
10014336|NCT01799590|11137477|FG001|COMPLETED|Overall Study||78
10014337|NCT01799590|11137478|FG002|COMPLETED|Overall Study||77
10014338|NCT01799590|11137476|FG000|NOT COMPLETED|Overall Study||26
10014339|NCT01799590|11137477|FG001|NOT COMPLETED|Overall Study||16
10014340|NCT01799590|11137478|FG002|NOT COMPLETED|Overall Study||14
10019099|NCT01827592|11142213|FG001|STARTED|Overall Study|Randomized patients.|126
9774296|NCT00460551|10879887|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
9774297|NCT00460551|10879887|FG000|NOT COMPLETED|Overall Study||0
9774298|NCT00460564|10879895|FG000|STARTED|Double-Blind Phase (12 Weeks)||51
9774299|NCT00460564|10879896|FG001|STARTED|Double-Blind Phase (12 Weeks)||26
9774300|NCT00460564|10879897|FG002|STARTED|Double-Blind Phase (12 Weeks)||21
9774301|NCT00460564|10879898|FG003|STARTED|Double-Blind Phase (12 Weeks)||11
9774302|NCT00460564|10879899|FG004|STARTED|Double-Blind Phase (12 Weeks)||0
9774303|NCT00460564|10879900|FG005|STARTED|Double-Blind Phase (12 Weeks)||0
9774304|NCT00460564|10879901|FG006|STARTED|Double-Blind Phase (12 Weeks)||0
9774305|NCT00460564|10879902|FG007|STARTED|Double-Blind Phase (12 Weeks)||0
9774306|NCT00460564|10879895|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47
9774307|NCT00460564|10879896|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25
9774308|NCT00460564|10879897|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21
9774309|NCT00460564|10879898|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11
9774310|NCT00460564|10879899|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0
9774311|NCT00460564|10879900|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0
9774312|NCT00460564|10879901|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0
9774313|NCT00460564|10879902|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0
9774314|NCT00460564|10879895|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
9774315|NCT00460564|10879896|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
9774316|NCT00460564|10879897|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774317|NCT00460564|10879898|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774318|NCT00460564|10879899|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774319|NCT00460564|10879900|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774320|NCT00460564|10879901|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774321|NCT00460564|10879902|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774322|NCT00460564|10879895|FG000|STARTED|Open-Label Phase (36 Weeks)||0
9774323|NCT00460564|10879896|FG001|STARTED|Open-Label Phase (36 Weeks)||0
9774324|NCT00460564|10879897|FG002|STARTED|Open-Label Phase (36 Weeks)||0
9774325|NCT00460564|10879898|FG003|STARTED|Open-Label Phase (36 Weeks)||0
9774326|NCT00460564|10879899|FG004|STARTED|Open-Label Phase (36 Weeks)||47
9774327|NCT00460564|10879900|FG005|STARTED|Open-Label Phase (36 Weeks)||25
9774328|NCT00460564|10879901|FG006|STARTED|Open-Label Phase (36 Weeks)||21
9774329|NCT00460564|10879902|FG007|STARTED|Open-Label Phase (36 Weeks)||11
9774330|NCT00460564|10879895|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
9774331|NCT00460564|10879896|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
9774332|NCT00460564|10879897|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0
9774333|NCT00460564|10879898|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0
10019100|NCT01827592|11142214|FG002|STARTED|Overall Study|Randomized patients.|124
9774334|NCT00460564|10879899|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38
9774335|NCT00460564|10879900|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19
9774336|NCT00460564|10879901|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19
9774337|NCT00460564|10879902|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11
9774338|NCT00460564|10879895|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
9774339|NCT00460564|10879896|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10019101|NCT01827592|11142212|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
9774340|NCT00460564|10879897|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
9774341|NCT00460564|10879898|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
9774342|NCT00460564|10879899|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
9774343|NCT00460564|10879900|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
9774344|NCT00460564|10879901|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
9774345|NCT00460564|10879902|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
9774346|NCT00460577|10879924|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
9774347|NCT00460577|10879925|FG001|STARTED|Overall Study||30
9774348|NCT00460577|10879924|FG000|COMPLETED|Overall Study||28
9774349|NCT00460577|10879925|FG001|COMPLETED|Overall Study||24
9774350|NCT00460577|10879924|FG000|NOT COMPLETED|Overall Study||2
9774351|NCT00460577|10879925|FG001|NOT COMPLETED|Overall Study||6
9774352|NCT00460603|10879943|FG000|STARTED|Phase 1||6
9774353|NCT00460603|10879944|FG001|STARTED|Phase 1||6
9774354|NCT00460603|10879945|FG002|STARTED|Phase 1||4
9774355|NCT00460603|10879946|FG003|STARTED|Phase 1||8
9774356|NCT00460603|10879947|FG004|STARTED|Phase 1||6
9774357|NCT00460603|10879948|FG005|STARTED|Phase 1||4
9774358|NCT00460603|10879949|FG006|STARTED|Phase 1||6
9774359|NCT00460603|10879950|FG007|STARTED|Phase 1||3
9774360|NCT00460603|10879951|FG008|STARTED|Phase 1||18
9774361|NCT00460603|10879952|FG009|STARTED|Phase 1||0
9774362|NCT00460603|10879953|FG010|STARTED|Phase 1||0
9774363|NCT00460603|10879954|FG011|STARTED|Phase 1||0
9774364|NCT00460603|10879943|FG000|COMPLETED|Phase 1||0
9774365|NCT00460603|10879944|FG001|COMPLETED|Phase 1||0
9774366|NCT00460603|10879945|FG002|COMPLETED|Phase 1||0
9774367|NCT00460603|10879946|FG003|COMPLETED|Phase 1||0
9774368|NCT00460603|10879947|FG004|COMPLETED|Phase 1||0
9774369|NCT00460603|10879948|FG005|COMPLETED|Phase 1||0
9774370|NCT00460603|10879949|FG006|COMPLETED|Phase 1||0
9774371|NCT00460603|10879950|FG007|COMPLETED|Phase 1||0
9774372|NCT00460603|10879951|FG008|COMPLETED|Phase 1||0
10014341|NCT01799720|11137489|FG000|STARTED|Overall Study||20
10014342|NCT01799720|11137490|FG001|STARTED|Overall Study||18
9774373|NCT00460603|10879952|FG009|COMPLETED|Phase 1||0
9774374|NCT00460603|10879953|FG010|COMPLETED|Phase 1||0
9774375|NCT00460603|10879954|FG011|COMPLETED|Phase 1||0
9774376|NCT00460603|10879943|FG000|NOT COMPLETED|Phase 1||6
9774377|NCT00460603|10879944|FG001|NOT COMPLETED|Phase 1||6
9774378|NCT00460603|10879945|FG002|NOT COMPLETED|Phase 1||4
9774379|NCT00460603|10879946|FG003|NOT COMPLETED|Phase 1||8
9774380|NCT00460603|10879947|FG004|NOT COMPLETED|Phase 1||6
9774381|NCT00460603|10879948|FG005|NOT COMPLETED|Phase 1||4
9774382|NCT00460603|10879949|FG006|NOT COMPLETED|Phase 1||6
9774383|NCT00460603|10879950|FG007|NOT COMPLETED|Phase 1||3
9774384|NCT00460603|10879951|FG008|NOT COMPLETED|Phase 1||18
9774385|NCT00460603|10879952|FG009|NOT COMPLETED|Phase 1||0
9774386|NCT00460603|10879953|FG010|NOT COMPLETED|Phase 1||0
9774387|NCT00460603|10879954|FG011|NOT COMPLETED|Phase 1||0
9774388|NCT00460603|10879943|FG000|STARTED|Phase 2||0
9774389|NCT00460603|10879944|FG001|STARTED|Phase 2||0
9774390|NCT00460603|10879945|FG002|STARTED|Phase 2||0
9774391|NCT00460603|10879946|FG003|STARTED|Phase 2||0
9774392|NCT00460603|10879947|FG004|STARTED|Phase 2||0
9774393|NCT00460603|10879948|FG005|STARTED|Phase 2||0
9774394|NCT00460603|10879949|FG006|STARTED|Phase 2||0
9774395|NCT00460603|10879950|FG007|STARTED|Phase 2||0
9774396|NCT00460603|10879951|FG008|STARTED|Phase 2||0
9774397|NCT00460603|10879952|FG009|STARTED|Phase 2||42
9774398|NCT00460603|10879953|FG010|STARTED|Phase 2||43
9774399|NCT00460603|10879954|FG011|STARTED|Phase 2||41
9774400|NCT00460603|10879943|FG000|Treated|Phase 2||0
9774401|NCT00460603|10879944|FG001|Treated|Phase 2||0
9774402|NCT00460603|10879945|FG002|Treated|Phase 2||0
9774403|NCT00460603|10879946|FG003|Treated|Phase 2||0
9774404|NCT00460603|10879947|FG004|Treated|Phase 2||0
9774405|NCT00460603|10879948|FG005|Treated|Phase 2||0
9774406|NCT00460603|10879949|FG006|Treated|Phase 2||0
9774407|NCT00460603|10879950|FG007|Treated|Phase 2||0
9774408|NCT00460603|10879951|FG008|Treated|Phase 2||0
9774409|NCT00460603|10879952|FG009|Treated|Phase 2||39
9774410|NCT00460603|10879953|FG010|Treated|Phase 2||43
9774411|NCT00460603|10879954|FG011|Treated|Phase 2||41
9774412|NCT00460603|10879943|FG000|COMPLETED|Phase 2||0
9774413|NCT00460603|10879944|FG001|COMPLETED|Phase 2||0
9774414|NCT00460603|10879945|FG002|COMPLETED|Phase 2||0
10014343|NCT01799720|11137491|FG002|STARTED|Overall Study||19
10014344|NCT01799720|11137489|FG000|Began the Treatment|Overall Study||20
9774415|NCT00460603|10879946|FG003|COMPLETED|Phase 2||0
9774416|NCT00460603|10879947|FG004|COMPLETED|Phase 2||0
9774417|NCT00460603|10879948|FG005|COMPLETED|Phase 2||0
9774418|NCT00460603|10879949|FG006|COMPLETED|Phase 2||0
9774419|NCT00460603|10879950|FG007|COMPLETED|Phase 2||0
9774420|NCT00460603|10879951|FG008|COMPLETED|Phase 2||0
9774421|NCT00460603|10879952|FG009|COMPLETED|Phase 2||0
9774422|NCT00460603|10879953|FG010|COMPLETED|Phase 2||0
9774423|NCT00460603|10879954|FG011|COMPLETED|Phase 2||0
9774424|NCT00460603|10879943|FG000|NOT COMPLETED|Phase 2||0
9774425|NCT00460603|10879944|FG001|NOT COMPLETED|Phase 2||0
9774426|NCT00460603|10879945|FG002|NOT COMPLETED|Phase 2||0
9774427|NCT00460603|10879946|FG003|NOT COMPLETED|Phase 2||0
9774428|NCT00460603|10879947|FG004|NOT COMPLETED|Phase 2||0
9774429|NCT00460603|10879948|FG005|NOT COMPLETED|Phase 2||0
9774430|NCT00460603|10879949|FG006|NOT COMPLETED|Phase 2||0
9774431|NCT00460603|10879950|FG007|NOT COMPLETED|Phase 2||0
9774432|NCT00460603|10879951|FG008|NOT COMPLETED|Phase 2||0
9774433|NCT00460603|10879952|FG009|NOT COMPLETED|Phase 2||42
9774434|NCT00460603|10879953|FG010|NOT COMPLETED|Phase 2||43
9774435|NCT00460603|10879954|FG011|NOT COMPLETED|Phase 2||41
9774436|NCT00460655|10879982|FG000|STARTED|Double-Blind Phase (12 Weeks)||58
9774437|NCT00460655|10879983|FG001|STARTED|Double-Blind Phase (12 Weeks)||62
9774438|NCT00460655|10879984|FG002|STARTED|Double-Blind Phase (12 Weeks)||0
9774439|NCT00460655|10879985|FG003|STARTED|Double-Blind Phase (12 Weeks)||0
9774440|NCT00460655|10879982|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52
9774441|NCT00460655|10879983|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61
9774442|NCT00460655|10879984|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0
9774443|NCT00460655|10879985|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0
9774444|NCT00460655|10879982|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
9774445|NCT00460655|10879983|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
9774446|NCT00460655|10879984|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774447|NCT00460655|10879985|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
9774448|NCT00460655|10879982|FG000|STARTED|Open-Label Phase (36 Weeks)||0
9774449|NCT00460655|10879983|FG001|STARTED|Open-Label Phase (36 Weeks)||0
9774450|NCT00460655|10879984|FG002|STARTED|Open-Label Phase (36 Weeks)||52
9774451|NCT00460655|10879985|FG003|STARTED|Open-Label Phase (36 Weeks)||61
9774452|NCT00460655|10879982|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
9774453|NCT00460655|10879983|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
9774454|NCT00460655|10879984|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45
9774455|NCT00460655|10879985|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52
9774456|NCT00460655|10879982|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
9774457|NCT00460655|10879983|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
9774458|NCT00460655|10879984|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
9774459|NCT00460655|10879985|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
9774460|NCT00460746|10879995|FG000|STARTED|Overall Study||10
9774461|NCT00460746|10879995|FG000|COMPLETED|Overall Study||8
9774462|NCT00460746|10879995|FG000|NOT COMPLETED|Overall Study||2
9774463|NCT00460798|10879999|FG000|STARTED|Overall Study||448
9774464|NCT00460798|10879999|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
9774465|NCT00460798|10879999|FG000|COMPLETED|Overall Study||108
9774466|NCT00460798|10879999|FG000|NOT COMPLETED|Overall Study||340
9774467|NCT00460811|10880008|FG000|STARTED|Overall Study||79
9774468|NCT00460811|10880009|FG001|STARTED|Overall Study||82
9774469|NCT00460811|10880010|FG002|STARTED|Overall Study||85
9774470|NCT00460811|10880011|FG003|STARTED|Overall Study||89
9774471|NCT00460811|10880012|FG004|STARTED|Overall Study||85
9774472|NCT00460811|10880008|FG000|COMPLETED|Overall Study||63
9774473|NCT00460811|10880009|FG001|COMPLETED|Overall Study||67
9774474|NCT00460811|10880010|FG002|COMPLETED|Overall Study||71
9774475|NCT00460811|10880011|FG003|COMPLETED|Overall Study||71
9774476|NCT00460811|10880012|FG004|COMPLETED|Overall Study||65
9774477|NCT00460811|10880008|FG000|NOT COMPLETED|Overall Study||16
9774478|NCT00460811|10880009|FG001|NOT COMPLETED|Overall Study||15
9774479|NCT00460811|10880010|FG002|NOT COMPLETED|Overall Study||14
9774480|NCT00460811|10880011|FG003|NOT COMPLETED|Overall Study||18
9774481|NCT00460811|10880012|FG004|NOT COMPLETED|Overall Study||20
9774482|NCT00460993|10880031|FG000|STARTED|Phase 1 (6 Days)||14
9774483|NCT00460993|10880032|FG001|STARTED|Phase 1 (6 Days)||17
9774484|NCT00460993|10880031|FG000|COMPLETED|Phase 1 (6 Days)||14
9774485|NCT00460993|10880032|FG001|COMPLETED|Phase 1 (6 Days)||17
9774486|NCT00460993|10880031|FG000|NOT COMPLETED|Phase 1 (6 Days)||0
9774487|NCT00460993|10880032|FG001|NOT COMPLETED|Phase 1 (6 Days)||0
9774488|NCT00460993|10880031|FG000|STARTED|Phase 2 (6 Days)||14
9774489|NCT00460993|10880032|FG001|STARTED|Phase 2 (6 Days)||17
9774490|NCT00460993|10880031|FG000|COMPLETED|Phase 2 (6 Days)||14
9774491|NCT00460993|10880032|FG001|COMPLETED|Phase 2 (6 Days)||17
9774492|NCT00460993|10880031|FG000|NOT COMPLETED|Phase 2 (6 Days)||0
9774493|NCT00460993|10880032|FG001|NOT COMPLETED|Phase 2 (6 Days)||0
9774494|NCT00461045|10880038|FG000|STARTED|Overall Study||15
9774495|NCT00461045|10880038|FG000|COMPLETED|Overall Study||15
9774496|NCT00461045|10880038|FG000|NOT COMPLETED|Overall Study||0
9774497|NCT00461097|10880044|FG000|STARTED|Overall Study||40
9774498|NCT00461097|10880045|FG001|STARTED|Overall Study||15
9774499|NCT00461097|10880044|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
9774500|NCT00461097|10880045|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
9774501|NCT00461097|10880044|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
9774502|NCT00461097|10880045|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
9774503|NCT00461097|10880044|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
9774504|NCT00461097|10880045|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
9774505|NCT00461097|10880044|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
9774506|NCT00461097|10880045|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
9774507|NCT00461097|10880044|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
9774508|NCT00461097|10880045|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
9774509|NCT00461097|10880044|FG000|NOT COMPLETED|Overall Study||0
9774510|NCT00461097|10880045|FG001|NOT COMPLETED|Overall Study||0
9774511|NCT00461123|10880054|FG000|STARTED|Overall Study||25
9774512|NCT00461123|10880055|FG001|STARTED|Overall Study||25
9774513|NCT00461123|10880054|FG000|COMPLETED|Overall Study||19
9774514|NCT00461123|10880055|FG001|COMPLETED|Overall Study||19
9774515|NCT00461123|10880054|FG000|NOT COMPLETED|Overall Study||6
9774516|NCT00461123|10880055|FG001|NOT COMPLETED|Overall Study||6
9774517|NCT00461175|10880063|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
9774518|NCT00461175|10880064|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
9774519|NCT00461175|10880063|FG000|COMPLETED|Overall Study||43078
9774520|NCT00461175|10880064|FG001|COMPLETED|Overall Study||18370
9774521|NCT00461175|10880063|FG000|NOT COMPLETED|Overall Study||522
9774522|NCT00461175|10880064|FG001|NOT COMPLETED|Overall Study||365
9774523|NCT00461253|10880072|FG000|STARTED|Overall Study|Identified cases|10093
9774524|NCT00461253|10880073|FG001|STARTED|Overall Study|Identified controls|40250
9774525|NCT00461253|10880072|FG000|COMPLETED|Overall Study|Analyzed cases|5113
9774526|NCT00461253|10880073|FG001|COMPLETED|Overall Study|Analyzed controls|20452
9774527|NCT00461253|10880072|FG000|NOT COMPLETED|Overall Study||4980
9774528|NCT00461253|10880073|FG001|NOT COMPLETED|Overall Study||19798
9774529|NCT00461292|10880082|FG000|STARTED|Treatment Cycle 1||91
9774530|NCT00461292|10880083|FG001|STARTED|Treatment Cycle 1||92
9774531|NCT00461292|10880084|FG002|STARTED|Treatment Cycle 1||92
9774532|NCT00461292|10880082|FG000|COMPLETED|Treatment Cycle 1||76
9774533|NCT00461292|10880083|FG001|COMPLETED|Treatment Cycle 1||80
9774534|NCT00461292|10880084|FG002|COMPLETED|Treatment Cycle 1||81
9774535|NCT00461292|10880082|FG000|NOT COMPLETED|Treatment Cycle 1||15
9774536|NCT00461292|10880083|FG001|NOT COMPLETED|Treatment Cycle 1||12
9774537|NCT00461292|10880084|FG002|NOT COMPLETED|Treatment Cycle 1||11
9774538|NCT00461292|10880082|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
9774539|NCT00461292|10880083|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
9774540|NCT00461292|10880084|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
9774541|NCT00461292|10880082|FG000|COMPLETED|Treatment Cycle 2||58
9774542|NCT00461292|10880083|FG001|COMPLETED|Treatment Cycle 2||72
9774543|NCT00461292|10880084|FG002|COMPLETED|Treatment Cycle 2||0
10014345|NCT01799720|11137490|FG001|Began the Treatment|Overall Study||18
10014346|NCT01799720|11137491|FG002|Began the Treatment|Overall Study||19
10014347|NCT01799720|11137489|FG000|Began the Treatment and Finished it|Overall Study||17
10014348|NCT01799720|11137490|FG001|Began the Treatment and Finished it|Overall Study||17
10019102|NCT01827592|11142213|FG001|Safety Analysis Set|Overall Study||126
9774544|NCT00461292|10880082|FG000|NOT COMPLETED|Treatment Cycle 2||5
9774545|NCT00461292|10880083|FG001|NOT COMPLETED|Treatment Cycle 2||2
9774546|NCT00461292|10880084|FG002|NOT COMPLETED|Treatment Cycle 2||0
9774547|NCT00461305|10880094|FG000|STARTED|Treatment|Enrolled|355
9774548|NCT00461305|10880095|FG001|STARTED|Treatment|Enrolled|65
9774549|NCT00461305|10880094|FG000|Subjects Dispensed Drugs|Treatment||350
9774550|NCT00461305|10880095|FG001|Subjects Dispensed Drugs|Treatment||65
9774551|NCT00461305|10880094|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349
9774552|NCT00461305|10880095|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65
9774553|NCT00461305|10880094|FG000|COMPLETED|Treatment||254
9774554|NCT00461305|10880095|FG001|COMPLETED|Treatment||56
9774555|NCT00461305|10880094|FG000|NOT COMPLETED|Treatment||101
9774556|NCT00461305|10880095|FG001|NOT COMPLETED|Treatment||9
9774557|NCT00461305|10880094|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
9774558|NCT00461305|10880095|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
9774559|NCT00461305|10880094|FG000|COMPLETED|Continued Treatment||254
9774560|NCT00461305|10880095|FG001|COMPLETED|Continued Treatment||0
9774561|NCT00461305|10880094|FG000|NOT COMPLETED|Continued Treatment||95
9774562|NCT00461305|10880095|FG001|NOT COMPLETED|Continued Treatment||0
9774563|NCT00461331|10880102|FG000|STARTED|Intervention 1||10
9774564|NCT00461331|10880103|FG001|STARTED|Intervention 1||10
9774565|NCT00461331|10880102|FG000|COMPLETED|Intervention 1||10
9774566|NCT00461331|10880103|FG001|COMPLETED|Intervention 1||10
9774567|NCT00461331|10880102|FG000|NOT COMPLETED|Intervention 1||0
9774568|NCT00461331|10880103|FG001|NOT COMPLETED|Intervention 1||0
9774569|NCT00461331|10880102|FG000|STARTED|Washout||10
9774570|NCT00461331|10880103|FG001|STARTED|Washout||10
9774571|NCT00461331|10880102|FG000|COMPLETED|Washout||10
9774572|NCT00461331|10880103|FG001|COMPLETED|Washout||10
9774573|NCT00461331|10880102|FG000|NOT COMPLETED|Washout||0
9774574|NCT00461331|10880103|FG001|NOT COMPLETED|Washout||0
9774575|NCT00461331|10880102|FG000|STARTED|Intervention 2||10
9774576|NCT00461331|10880103|FG001|STARTED|Intervention 2||10
9774577|NCT00461331|10880102|FG000|COMPLETED|Intervention 2||10
9774578|NCT00461331|10880103|FG001|COMPLETED|Intervention 2||10
9774579|NCT00461331|10880102|FG000|NOT COMPLETED|Intervention 2||0
9774580|NCT00461331|10880103|FG001|NOT COMPLETED|Intervention 2||0
9774581|NCT00461500|10880112|FG000|STARTED|Overall Study||37
9774582|NCT00461500|10880113|FG001|STARTED|Overall Study||44
9774583|NCT00461500|10880112|FG000|COMPLETED|Overall Study||30
9774584|NCT00461500|10880113|FG001|COMPLETED|Overall Study||38
9774585|NCT00461500|10880112|FG000|NOT COMPLETED|Overall Study||7
9774586|NCT00461500|10880113|FG001|NOT COMPLETED|Overall Study||6
9774587|NCT00461513|10880121|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187
9774588|NCT00461513|10880122|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197
9774589|NCT00461513|10880121|FG000|COMPLETED|Overall Study||165
9774590|NCT00461513|10880122|FG001|COMPLETED|Overall Study||172
9774591|NCT00461513|10880121|FG000|NOT COMPLETED|Overall Study||22
9774592|NCT00461513|10880122|FG001|NOT COMPLETED|Overall Study||25
9774593|NCT00461552|10880134|FG000|STARTED|Overall Study||7
9774594|NCT00461552|10880135|FG001|STARTED|Overall Study||7
9774595|NCT00461552|10880134|FG000|COMPLETED|Overall Study||7
9774596|NCT00461552|10880135|FG001|COMPLETED|Overall Study||5
9774597|NCT00461552|10880134|FG000|NOT COMPLETED|Overall Study||0
9774598|NCT00461552|10880135|FG001|NOT COMPLETED|Overall Study||2
9774599|NCT00461591|10880143|FG000|STARTED|Overall Study||406
9774600|NCT00461591|10880144|FG001|STARTED|Overall Study||396
9774601|NCT00461591|10880143|FG000|COMPLETED|Overall Study||317
9774602|NCT00461591|10880144|FG001|COMPLETED|Overall Study||311
9774603|NCT00461591|10880143|FG000|NOT COMPLETED|Overall Study||89
9774604|NCT00461591|10880144|FG001|NOT COMPLETED|Overall Study||85
9774605|NCT00461630|10880152|FG000|STARTED|Overall Study||12838
9774606|NCT00461630|10880153|FG001|STARTED|Overall Study||12835
9774607|NCT00461630|10880152|FG000|COMPLETED|Overall Study||11932
9774608|NCT00461630|10880153|FG001|COMPLETED|Overall Study||12008
9774609|NCT00461630|10880152|FG000|NOT COMPLETED|Overall Study||906
9774610|NCT00461630|10880153|FG001|NOT COMPLETED|Overall Study||827
9774611|NCT00461708|10880161|FG000|STARTED|Overall Study||115
9774612|NCT00461708|10880162|FG001|STARTED|Overall Study||38
9774613|NCT00461708|10880161|FG000|COMPLETED|Overall Study||0
9774614|NCT00461708|10880162|FG001|COMPLETED|Overall Study||0
9774615|NCT00461708|10880161|FG000|NOT COMPLETED|Overall Study||115
9774616|NCT00461708|10880162|FG001|NOT COMPLETED|Overall Study||38
9774617|NCT00461734|10880173|FG000|STARTED|Overall Study||120
9774618|NCT00461734|10880174|FG001|STARTED|Overall Study||120
9774619|NCT00461734|10880173|FG000|COMPLETED|Overall Study||62
9774620|NCT00461734|10880174|FG001|COMPLETED|Overall Study||60
9774621|NCT00461734|10880173|FG000|NOT COMPLETED|Overall Study||58
9774622|NCT00461734|10880174|FG001|NOT COMPLETED|Overall Study||60
9774623|NCT00461773|10880187|FG000|STARTED|Overall Study||3
9774624|NCT00461773|10880188|FG001|STARTED|Overall Study||2
9774625|NCT00461773|10880187|FG000|COMPLETED|Overall Study||3
9774626|NCT00461773|10880188|FG001|COMPLETED|Overall Study||2
9774627|NCT00461773|10880187|FG000|NOT COMPLETED|Overall Study||0
9774628|NCT00461773|10880188|FG001|NOT COMPLETED|Overall Study||0
9774629|NCT00461786|10880194|FG000|STARTED|Overall Study||51
9774630|NCT00461786|10880194|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
9774631|NCT00461786|10880194|FG000|NOT COMPLETED|Overall Study||3
9774632|NCT00461851|10880198|FG000|STARTED|Overall Study||17
9774633|NCT00461851|10880198|FG000|COMPLETED|Overall Study||17
9774634|NCT00461851|10880198|FG000|NOT COMPLETED|Overall Study||0
9774635|NCT00461981|10880204|FG000|STARTED|Overall Study||50
9774636|NCT00461981|10880205|FG001|STARTED|Overall Study||51
9774637|NCT00461981|10880204|FG000|COMPLETED|Overall Study||39
9774638|NCT00461981|10880205|FG001|COMPLETED|Overall Study||42
9774639|NCT00461981|10880204|FG000|NOT COMPLETED|Overall Study||11
9774640|NCT00461981|10880205|FG001|NOT COMPLETED|Overall Study||9
9774641|NCT00462020|10880213|FG000|STARTED|Overall Study||52
9774642|NCT00462020|10880214|FG001|STARTED|Overall Study||50
9774643|NCT00462020|10880213|FG000|COMPLETED|Overall Study||52
9774644|NCT00462020|10880214|FG001|COMPLETED|Overall Study||50
9774645|NCT00462020|10880213|FG000|NOT COMPLETED|Overall Study||0
9774646|NCT00462020|10880214|FG001|NOT COMPLETED|Overall Study||0
9774647|NCT00462072|10880223|FG000|STARTED|Baseline (Week 0)||10
9774648|NCT00462072|10880224|FG001|STARTED|Baseline (Week 0)||12
9774649|NCT00462072|10880225|FG002|STARTED|Baseline (Week 0)||9
9774650|NCT00462072|10880223|FG000|COMPLETED|Baseline (Week 0)||10
9774651|NCT00462072|10880224|FG001|COMPLETED|Baseline (Week 0)||12
9774652|NCT00462072|10880225|FG002|COMPLETED|Baseline (Week 0)||9
9774653|NCT00462072|10880223|FG000|NOT COMPLETED|Baseline (Week 0)||0
9774654|NCT00462072|10880224|FG001|NOT COMPLETED|Baseline (Week 0)||0
9774655|NCT00462072|10880225|FG002|NOT COMPLETED|Baseline (Week 0)||0
9774656|NCT00462072|10880223|FG000|STARTED|Week 10||10
9774657|NCT00462072|10880224|FG001|STARTED|Week 10||12
9774658|NCT00462072|10880225|FG002|STARTED|Week 10||9
9774659|NCT00462072|10880223|FG000|COMPLETED|Week 10||10
9774660|NCT00462072|10880224|FG001|COMPLETED|Week 10||12
9774661|NCT00462072|10880225|FG002|COMPLETED|Week 10||9
9774662|NCT00462072|10880223|FG000|NOT COMPLETED|Week 10||0
9774663|NCT00462072|10880224|FG001|NOT COMPLETED|Week 10||0
9774664|NCT00462072|10880225|FG002|NOT COMPLETED|Week 10||0
9774665|NCT00462124|10880237|FG000|STARTED|Overall Study||7
9774666|NCT00462124|10880237|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
9774667|NCT00462124|10880237|FG000|NOT COMPLETED|Overall Study||1
9774668|NCT00462228|10880242|FG000|STARTED|Memantine or Placebo 12 Weeks||11
9774669|NCT00462228|10880242|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11
9774670|NCT00462228|10880242|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
9774671|NCT00462228|10880242|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
9774672|NCT00462228|10880242|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
9774673|NCT00462228|10880242|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
9774674|NCT00462228|10880242|FG000|STARTED|Placebo or Memantine 12 Weeks||11
9774675|NCT00462228|10880242|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11
9774676|NCT00462228|10880242|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
9774677|NCT00462228|10880242|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
9774678|NCT00462228|10880242|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
9774679|NCT00462228|10880242|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
9774680|NCT00462280|10880253|FG000|STARTED|Overall Study||34
9774681|NCT00462280|10880254|FG001|STARTED|Overall Study||32
9774682|NCT00462280|10880255|FG002|STARTED|Overall Study||7
9774683|NCT00462280|10880256|FG003|STARTED|Overall Study||7
9774684|NCT00462280|10880253|FG000|COMPLETED|Overall Study||24
9774685|NCT00462280|10880254|FG001|COMPLETED|Overall Study||25
9774686|NCT00462280|10880255|FG002|COMPLETED|Overall Study||7
9774687|NCT00462280|10880256|FG003|COMPLETED|Overall Study||4
9774688|NCT00462280|10880253|FG000|NOT COMPLETED|Overall Study||10
9774689|NCT00462280|10880254|FG001|NOT COMPLETED|Overall Study||7
9774690|NCT00462280|10880255|FG002|NOT COMPLETED|Overall Study||0
9774691|NCT00462280|10880256|FG003|NOT COMPLETED|Overall Study||3
9774692|NCT00462306|10880270|FG000|STARTED|Overall Study||4074
9774693|NCT00462306|10880271|FG001|STARTED|Overall Study||503
9774694|NCT00462306|10880270|FG000|COMPLETED|Overall Study||4074
9774695|NCT00462306|10880271|FG001|COMPLETED|Overall Study||490
9774696|NCT00462306|10880270|FG000|NOT COMPLETED|Overall Study||0
9774697|NCT00462306|10880271|FG001|NOT COMPLETED|Overall Study||13
9774698|NCT00462332|10880281|FG000|STARTED|Overall Study||45
9774699|NCT00462332|10880282|FG001|STARTED|Overall Study||41
9774700|NCT00462332|10880281|FG000|COMPLETED|Overall Study||45
9774701|NCT00462332|10880282|FG001|COMPLETED|Overall Study||41
9774702|NCT00462332|10880281|FG000|NOT COMPLETED|Overall Study||0
9774703|NCT00462332|10880282|FG001|NOT COMPLETED|Overall Study||0
9774704|NCT00462345|10880290|FG000|STARTED|Overall Study||40
9774705|NCT00462345|10880290|FG000|Completed First Course|Overall Study||38
9774706|NCT00462345|10880290|FG000|COMPLETED|Overall Study||37
9774707|NCT00462345|10880290|FG000|NOT COMPLETED|Overall Study||3
9774708|NCT00462384|10880294|FG000|STARTED|Overall Study||39
9774709|NCT00462384|10880294|FG000|COMPLETED|Overall Study||30
9774710|NCT00462384|10880294|FG000|NOT COMPLETED|Overall Study||9
9774711|NCT00462423|10880298|FG000|STARTED|Overall Study||50
9774712|NCT00462423|10880298|FG000|COMPLETED|Overall Study||50
9774713|NCT00462423|10880298|FG000|NOT COMPLETED|Overall Study||0
9774714|NCT00462449|10880305|FG000|STARTED|Overall Study||13
9774715|NCT00462449|10880306|FG001|STARTED|Overall Study||10
9774716|NCT00462449|10880305|FG000|COMPLETED|Overall Study||13
9774717|NCT00462449|10880306|FG001|COMPLETED|Overall Study||10
9774718|NCT00462449|10880305|FG000|NOT COMPLETED|Overall Study||0
9774719|NCT00462449|10880306|FG001|NOT COMPLETED|Overall Study||0
9774720|NCT00462462|10880314|FG000|STARTED|Overall Study||17
9774721|NCT00462462|10880315|FG001|STARTED|Overall Study||14
9774722|NCT00462462|10880314|FG000|COMPLETED|Overall Study||17
9774723|NCT00462462|10880315|FG001|COMPLETED|Overall Study||13
9774724|NCT00462462|10880314|FG000|NOT COMPLETED|Overall Study||0
9774725|NCT00462462|10880315|FG001|NOT COMPLETED|Overall Study||1
9774726|NCT00462488|10880325|FG000|STARTED|Overall Study||23
9774727|NCT00462488|10880326|FG001|STARTED|Overall Study||23
9774728|NCT00462488|10880325|FG000|Completed Induction Phase|Overall Study||22
9774729|NCT00462488|10880326|FG001|Completed Induction Phase|Overall Study||23
9774730|NCT00462488|10880325|FG000|Completed Induction 2/Maintenance 1|Overall Study||18
9774731|NCT00462488|10880326|FG001|Completed Induction 2/Maintenance 1|Overall Study||9
9774732|NCT00462488|10880325|FG000|Completed Maintenance 2|Overall Study||7
9774733|NCT00462488|10880326|FG001|Completed Maintenance 2|Overall Study||6
9774734|NCT00462488|10880325|FG000|COMPLETED|Overall Study||3
10014349|NCT01799720|11137491|FG002|Began the Treatment and Finished it|Overall Study||18
10014350|NCT01799720|11137489|FG000|COMPLETED|Overall Study||17
10014351|NCT01799720|11137490|FG001|COMPLETED|Overall Study||17
9774735|NCT00462488|10880326|FG001|COMPLETED|Overall Study||6
9774736|NCT00462488|10880325|FG000|NOT COMPLETED|Overall Study||20
9774737|NCT00462488|10880326|FG001|NOT COMPLETED|Overall Study||17
9774738|NCT00462501|10880332|FG000|STARTED|Overall Study||35
9774739|NCT00462501|10880332|FG000|COMPLETED|Overall Study||30
9774740|NCT00462501|10880332|FG000|NOT COMPLETED|Overall Study||5
10014352|NCT01799720|11137491|FG002|COMPLETED|Overall Study||18
10014353|NCT01799720|11137489|FG000|NOT COMPLETED|Overall Study||3
10014354|NCT01799720|11137490|FG001|NOT COMPLETED|Overall Study||1
10014355|NCT01799720|11137491|FG002|NOT COMPLETED|Overall Study||1
10014356|NCT01799889|11137511|FG000|STARTED|Overall Study||41
10014357|NCT01799889|11137512|FG001|STARTED|Overall Study||41
10014358|NCT01799889|11137513|FG002|STARTED|Overall Study||44
10014359|NCT01799889|11137514|FG003|STARTED|Overall Study||39
9774741|NCT00462605|10880336|FG000|STARTED|Overall Study||24
9774742|NCT00462605|10880336|FG000|COMPLETED|Overall Study||10
9774743|NCT00462605|10880336|FG000|NOT COMPLETED|Overall Study||14
9774744|NCT00462644|10880342|FG000|STARTED|Overall Study||18
9774745|NCT00462644|10880343|FG001|STARTED|Overall Study||12
9774746|NCT00462644|10880342|FG000|COMPLETED|Overall Study||18
10014360|NCT01799889|11137515|FG004|STARTED|Overall Study||49
10014361|NCT01799889|11137516|FG005|STARTED|Overall Study||20
10014362|NCT01799889|11137517|FG006|STARTED|Overall Study||21
9774747|NCT00462644|10880343|FG001|COMPLETED|Overall Study||12
9774748|NCT00462644|10880342|FG000|NOT COMPLETED|Overall Study||0
9774749|NCT00462644|10880343|FG001|NOT COMPLETED|Overall Study||0
9774750|NCT00462670|10880351|FG000|STARTED|Overall Study||57
9774751|NCT00462670|10880352|FG001|STARTED|Overall Study||53
10014363|NCT01799889|11137518|FG007|STARTED|Overall Study||20
9774752|NCT00462670|10880351|FG000|COMPLETED|Overall Study||52
9774753|NCT00462670|10880352|FG001|COMPLETED|Overall Study||46
9774754|NCT00462670|10880351|FG000|NOT COMPLETED|Overall Study||5
9774755|NCT00462670|10880352|FG001|NOT COMPLETED|Overall Study||7
9774756|NCT00462709|10880358|FG000|STARTED|Overall Study||146
9774757|NCT00462709|10880358|FG000|COMPLETED|Overall Study||79
9774758|NCT00462709|10880358|FG000|NOT COMPLETED|Overall Study||67
9774759|NCT00462722|10880365|FG000|STARTED|Overall Study||50
10014364|NCT01799889|11137519|FG008|STARTED|Overall Study||33
10233907|NCT01608906|11363768|FG000|NOT COMPLETED|Overall Study||39
10233908|NCT01621737|11363773|FG000|STARTED|Overall Study||0
9774760|NCT00462722|10880366|FG001|STARTED|Overall Study||55
10014365|NCT01799889|11137520|FG009|STARTED|Overall Study||8
10014366|NCT01799889|11137521|FG010|STARTED|Overall Study||7
10014367|NCT01799889|11137522|FG011|STARTED|Overall Study||3
10014368|NCT01799889|11137511|FG000|COMPLETED|Overall Study||0
10233909|NCT01621737|11363773|FG000|COMPLETED|Overall Study||0
10233910|NCT01621737|11363773|FG000|NOT COMPLETED|Overall Study||0
9774761|NCT00462722|10880367|FG002|STARTED|Overall Study||54
9774762|NCT00462722|10880365|FG000|COMPLETED|Overall Study||37
9774763|NCT00462722|10880366|FG001|COMPLETED|Overall Study||51
9774764|NCT00462722|10880367|FG002|COMPLETED|Overall Study||42
9774765|NCT00462722|10880365|FG000|NOT COMPLETED|Overall Study||13
9774766|NCT00462722|10880366|FG001|NOT COMPLETED|Overall Study||4
9774767|NCT00462722|10880367|FG002|NOT COMPLETED|Overall Study||12
9774768|NCT00462735|10880375|FG000|STARTED|Overall Study||33
9774769|NCT00462735|10880375|FG000|COMPLETED|Overall Study||33
9774770|NCT00462735|10880375|FG000|NOT COMPLETED|Overall Study||0
9774771|NCT00462761|10880380|FG000|STARTED|Overall Study||76
9774772|NCT00462761|10880380|FG000|COMPLETED|Overall Study||0
9774773|NCT00462761|10880380|FG000|NOT COMPLETED|Overall Study||76
9774774|NCT00462826|10880412|FG000|STARTED|Overall Study||49
9774775|NCT00462826|10880412|FG000|COMPLETED|Overall Study||44
9774776|NCT00462826|10880412|FG000|NOT COMPLETED|Overall Study||5
9774777|NCT00462839|10880424|FG000|STARTED|Viewed First||53
9774778|NCT00462839|10880425|FG001|STARTED|Viewed First||53
9774779|NCT00462839|10880424|FG000|COMPLETED|Viewed First||53
9774780|NCT00462839|10880425|FG001|COMPLETED|Viewed First||53
9774781|NCT00462839|10880424|FG000|NOT COMPLETED|Viewed First||0
9774782|NCT00462839|10880425|FG001|NOT COMPLETED|Viewed First||0
9774783|NCT00462839|10880424|FG000|STARTED|Viewed Second||53
9774784|NCT00462839|10880425|FG001|STARTED|Viewed Second||53
9774785|NCT00462839|10880424|FG000|COMPLETED|Viewed Second||53
9774786|NCT00462839|10880425|FG001|COMPLETED|Viewed Second||53
9774787|NCT00462839|10880424|FG000|NOT COMPLETED|Viewed Second||0
9774788|NCT00462839|10880425|FG001|NOT COMPLETED|Viewed Second||0
9774789|NCT00462865|10880431|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
9774790|NCT00462865|10880431|FG000|COMPLETED|Overall Study||17
9774791|NCT00462865|10880431|FG000|NOT COMPLETED|Overall Study||1
9774792|NCT00462917|10880439|FG000|STARTED|Overall Study||72
9774793|NCT00462917|10880440|FG001|STARTED|Overall Study||75
9774794|NCT00462917|10880441|FG002|STARTED|Overall Study||66
9774795|NCT00462917|10880442|FG003|STARTED|Overall Study||77
9774796|NCT00462917|10880439|FG000|Met With Genetic Counselor|Overall Study||66
9774797|NCT00462917|10880440|FG001|Met With Genetic Counselor|Overall Study||71
9774798|NCT00462917|10880441|FG002|Met With Genetic Counselor|Overall Study||56
9774799|NCT00462917|10880442|FG003|Met With Genetic Counselor|Overall Study||71
9774800|NCT00462917|10880439|FG000|Received Risk Information|Overall Study||64
9774801|NCT00462917|10880440|FG001|Received Risk Information|Overall Study||70
9774802|NCT00462917|10880441|FG002|Received Risk Information|Overall Study||55
9774803|NCT00462917|10880442|FG003|Received Risk Information|Overall Study||68
9774804|NCT00462917|10880439|FG000|Completed 6 Week Follow-up|Overall Study||63
9774805|NCT00462917|10880440|FG001|Completed 6 Week Follow-up|Overall Study||70
9774806|NCT00462917|10880441|FG002|Completed 6 Week Follow-up|Overall Study||55
9774807|NCT00462917|10880442|FG003|Completed 6 Week Follow-up|Overall Study||68
9774808|NCT00462917|10880439|FG000|Completed 6 Month Follow-up|Overall Study||63
9774809|NCT00462917|10880440|FG001|Completed 6 Month Follow-up|Overall Study||68
9774810|NCT00462917|10880441|FG002|Completed 6 Month Follow-up|Overall Study||55
9774811|NCT00462917|10880442|FG003|Completed 6 Month Follow-up|Overall Study||66
9774812|NCT00462917|10880439|FG000|COMPLETED|Overall Study||62
9774813|NCT00462917|10880440|FG001|COMPLETED|Overall Study||65
9774814|NCT00462917|10880441|FG002|COMPLETED|Overall Study||54
9774815|NCT00462917|10880442|FG003|COMPLETED|Overall Study||66
9774816|NCT00462917|10880439|FG000|NOT COMPLETED|Overall Study||10
9952302|NCT01421342|11071237|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
9952303|NCT01421342|11071238|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
9952304|NCT01421342|11071239|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
9952305|NCT01421342|11071237|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353
9952306|NCT01421342|11071238|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378
9952307|NCT01421342|11071239|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406
9952308|NCT01421342|11071237|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204
10233911|NCT01614067|11363779|FG000|STARTED|Overall Study||15
10233912|NCT01614067|11363780|FG001|STARTED|Overall Study||15
9774817|NCT00462917|10880440|FG001|NOT COMPLETED|Overall Study||10
9952309|NCT01421342|11071238|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253
9952310|NCT01421342|11071239|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268
10233913|NCT01614067|11363779|FG000|COMPLETED|Overall Study||0
10233914|NCT01614067|11363780|FG001|COMPLETED|Overall Study||0
10233915|NCT01614067|11363779|FG000|NOT COMPLETED|Overall Study||15
9774818|NCT00462917|10880441|FG002|NOT COMPLETED|Overall Study||12
9774819|NCT00462917|10880442|FG003|NOT COMPLETED|Overall Study||11
9774820|NCT00462982|10880452|FG000|STARTED|Overall Study||8
9774821|NCT00462982|10880452|FG000|COMPLETED|Overall Study||5
9952311|NCT01421342|11071237|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
9952312|NCT01421342|11071238|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
10233916|NCT01614067|11363780|FG001|NOT COMPLETED|Overall Study||15
9774822|NCT00462982|10880452|FG000|NOT COMPLETED|Overall Study||3
9774823|NCT00463047|10880456|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
9774824|NCT00463047|10880457|FG001|STARTED|Titration Period 1||160
9774825|NCT00463047|10880456|FG000|COMPLETED|Titration Period 1||123
9774826|NCT00463047|10880457|FG001|COMPLETED|Titration Period 1||121
9774827|NCT00463047|10880456|FG000|NOT COMPLETED|Titration Period 1||37
9774828|NCT00463047|10880457|FG001|NOT COMPLETED|Titration Period 1||39
9774829|NCT00463047|10880456|FG000|STARTED|Titration Period 2||123
9774830|NCT00463047|10880457|FG001|STARTED|Titration Period 2||121
9774831|NCT00463047|10880456|FG000|COMPLETED|Titration Period 2||93
9774832|NCT00463047|10880457|FG001|COMPLETED|Titration Period 2||98
9774833|NCT00463047|10880456|FG000|NOT COMPLETED|Titration Period 2||30
10014369|NCT01799889|11137512|FG001|COMPLETED|Overall Study||0
10014370|NCT01799889|11137513|FG002|COMPLETED|Overall Study||0
10014371|NCT01799889|11137514|FG003|COMPLETED|Overall Study||0
10014372|NCT01799889|11137515|FG004|COMPLETED|Overall Study||0
10014373|NCT01799889|11137516|FG005|COMPLETED|Overall Study||0
10014374|NCT01799889|11137517|FG006|COMPLETED|Overall Study||0
10014375|NCT01799889|11137518|FG007|COMPLETED|Overall Study||0
10014376|NCT01799889|11137519|FG008|COMPLETED|Overall Study||0
10014377|NCT01799889|11137520|FG009|COMPLETED|Overall Study||0
10014378|NCT01799889|11137521|FG010|COMPLETED|Overall Study||0
9774834|NCT00463047|10880457|FG001|NOT COMPLETED|Titration Period 2||23
9774835|NCT00463047|10880456|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
9774836|NCT00463047|10880457|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
9774837|NCT00463047|10880456|FG000|COMPLETED|Double-Blind Treatment Period 1||93
9774838|NCT00463047|10880457|FG001|COMPLETED|Double-Blind Treatment Period 1||90
9774839|NCT00463047|10880456|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3
9774840|NCT00463047|10880457|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4
9774841|NCT00463047|10880456|FG000|STARTED|Double-Blind Treatment Period 2||93
9774842|NCT00463047|10880457|FG001|STARTED|Double-Blind Treatment Period 2||90
9774843|NCT00463047|10880456|FG000|COMPLETED|Double-Blind Treatment Period 2||92
9774844|NCT00463047|10880457|FG001|COMPLETED|Double-Blind Treatment Period 2||88
9774845|NCT00463047|10880456|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
9774846|NCT00463047|10880457|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2
9774847|NCT00463060|10880466|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
9774848|NCT00463060|10880466|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
9774849|NCT00463060|10880466|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
9774850|NCT00463060|10880466|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
9774851|NCT00463060|10880466|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
9774852|NCT00463060|10880466|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
9774853|NCT00463060|10880466|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
9774854|NCT00463060|10880466|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
9774855|NCT00463060|10880466|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
9774856|NCT00463060|10880466|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
9774857|NCT00463060|10880466|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
9774858|NCT00463060|10880466|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
9774859|NCT00463060|10880466|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
9774860|NCT00463060|10880466|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
9774861|NCT00463060|10880466|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
9774862|NCT00463151|10880479|FG000|STARTED|Overall Study||35
9774863|NCT00463151|10880480|FG001|STARTED|Overall Study||29
9774864|NCT00463151|10880481|FG002|STARTED|Overall Study||29
9774865|NCT00463151|10880482|FG003|STARTED|Overall Study||31
9774866|NCT00463151|10880479|FG000|COMPLETED|Overall Study||33
9774867|NCT00463151|10880480|FG001|COMPLETED|Overall Study||24
9774868|NCT00463151|10880481|FG002|COMPLETED|Overall Study||26
9774869|NCT00463151|10880482|FG003|COMPLETED|Overall Study||24
9774870|NCT00463151|10880479|FG000|NOT COMPLETED|Overall Study||2
9774871|NCT00463151|10880480|FG001|NOT COMPLETED|Overall Study||5
9774872|NCT00463151|10880481|FG002|NOT COMPLETED|Overall Study||3
10014379|NCT01799889|11137522|FG011|COMPLETED|Overall Study||0
10014380|NCT01799889|11137511|FG000|NOT COMPLETED|Overall Study||41
10014381|NCT01799889|11137512|FG001|NOT COMPLETED|Overall Study||41
10014382|NCT01799889|11137513|FG002|NOT COMPLETED|Overall Study||44
10014383|NCT01799889|11137514|FG003|NOT COMPLETED|Overall Study||39
10014384|NCT01799889|11137515|FG004|NOT COMPLETED|Overall Study||49
10014385|NCT01799889|11137516|FG005|NOT COMPLETED|Overall Study||20
10014386|NCT01799889|11137517|FG006|NOT COMPLETED|Overall Study||21
10014387|NCT01799889|11137518|FG007|NOT COMPLETED|Overall Study||20
10014388|NCT01799889|11137519|FG008|NOT COMPLETED|Overall Study||33
10014389|NCT01799889|11137520|FG009|NOT COMPLETED|Overall Study||8
10014390|NCT01799889|11137521|FG010|NOT COMPLETED|Overall Study||7
10014391|NCT01799889|11137522|FG011|NOT COMPLETED|Overall Study||3
10014392|NCT01799941|11137559|FG000|STARTED|Overall Study||367
10014393|NCT01799941|11137559|FG000|COMPLETED|Overall Study||271
10014394|NCT01799941|11137559|FG000|NOT COMPLETED|Overall Study||96
10014395|NCT01799993|11137571|FG000|STARTED|Overall Study||362
10014396|NCT01799993|11137572|FG001|STARTED|Overall Study||363
10014397|NCT01799993|11137571|FG000|ITT Population|Overall Study||354
10014398|NCT01799993|11137572|FG001|ITT Population|Overall Study||358
10014399|NCT01799993|11137571|FG000|mITT Population|Overall Study||255
10014400|NCT01799993|11137572|FG001|mITT Population|Overall Study||253
10014401|NCT01799993|11137571|FG000|COMPLETED|Overall Study||229
10014402|NCT01799993|11137572|FG001|COMPLETED|Overall Study||235
10014403|NCT01799993|11137571|FG000|NOT COMPLETED|Overall Study||133
10014404|NCT01799993|11137572|FG001|NOT COMPLETED|Overall Study||128
10014405|NCT01800058|11137578|FG000|STARTED|Overall Study||66
10014406|NCT01800058|11137578|FG000|COMPLETED|Overall Study||65
10014407|NCT01800058|11137578|FG000|NOT COMPLETED|Overall Study||1
10014408|NCT01800201|11137585|FG000|STARTED|Overall Study||506
10014409|NCT01800201|11137586|FG001|STARTED|Overall Study||1003
10014410|NCT01800201|11137585|FG000|COMPLETED|Overall Study||503
10014411|NCT01800201|11137586|FG001|COMPLETED|Overall Study||1000
10014412|NCT01800201|11137585|FG000|NOT COMPLETED|Overall Study||3
10014413|NCT01800201|11137586|FG001|NOT COMPLETED|Overall Study||3
10014414|NCT01800318|11137597|FG000|STARTED|Overall Study||39
10014415|NCT01800318|11137598|FG001|STARTED|Overall Study||42
10014416|NCT01800318|11137599|FG002|STARTED|Overall Study||41
10014417|NCT01800318|11137600|FG003|STARTED|Overall Study||40
10014418|NCT01800318|11137597|FG000|COMPLETED|Overall Study||37
10014419|NCT01800318|11137598|FG001|COMPLETED|Overall Study||37
10014420|NCT01800318|11137599|FG002|COMPLETED|Overall Study||40
10014421|NCT01800318|11137600|FG003|COMPLETED|Overall Study||39
10014422|NCT01800318|11137597|FG000|NOT COMPLETED|Overall Study||2
10014423|NCT01800318|11137598|FG001|NOT COMPLETED|Overall Study||5
10014424|NCT01800318|11137599|FG002|NOT COMPLETED|Overall Study||1
10014425|NCT01800318|11137600|FG003|NOT COMPLETED|Overall Study||1
10014426|NCT01800786|11137616|FG000|STARTED|Overall Study||17
10014427|NCT01800786|11137617|FG001|STARTED|Overall Study||16
10014428|NCT01800786|11137616|FG000|COMPLETED|Overall Study||15
10014429|NCT01800786|11137617|FG001|COMPLETED|Overall Study||15
10014430|NCT01800786|11137616|FG000|NOT COMPLETED|Overall Study||2
10014431|NCT01800786|11137617|FG001|NOT COMPLETED|Overall Study||1
10014432|NCT01800838|11137627|FG000|STARTED|Overall Study||1
10014433|NCT01800838|11137628|FG001|STARTED|Overall Study||1
10014434|NCT01800838|11137629|FG002|STARTED|Overall Study||7
10014435|NCT01800838|11137630|FG003|STARTED|Overall Study||2
10014436|NCT01800838|11137627|FG000|COMPLETED|Overall Study||1
10014437|NCT01800838|11137628|FG001|COMPLETED|Overall Study||1
10014438|NCT01800838|11137629|FG002|COMPLETED|Overall Study||7
10014439|NCT01800838|11137630|FG003|COMPLETED|Overall Study||2
10014440|NCT01800838|11137627|FG000|NOT COMPLETED|Overall Study||0
10014441|NCT01800838|11137628|FG001|NOT COMPLETED|Overall Study||0
10014442|NCT01800838|11137629|FG002|NOT COMPLETED|Overall Study||0
10014443|NCT01800838|11137630|FG003|NOT COMPLETED|Overall Study||0
9774873|NCT00463151|10880482|FG003|NOT COMPLETED|Overall Study||7
9774874|NCT00463229|10880494|FG000|STARTED|Overall Study||52
9774875|NCT00463229|10880495|FG001|STARTED|Overall Study||49
9774876|NCT00463229|10880494|FG000|COMPLETED|Overall Study||43
9774877|NCT00463229|10880495|FG001|COMPLETED|Overall Study||39
9774878|NCT00463229|10880494|FG000|NOT COMPLETED|Overall Study||9
9774879|NCT00463229|10880495|FG001|NOT COMPLETED|Overall Study||10
9774880|NCT00463346|10880504|FG000|STARTED|Overall Study||12
9774881|NCT00463346|10880505|FG001|STARTED|Overall Study||11
9774882|NCT00463346|10880504|FG000|COMPLETED|Overall Study||9
9774883|NCT00463346|10880505|FG001|COMPLETED|Overall Study||8
9774884|NCT00463346|10880504|FG000|NOT COMPLETED|Overall Study||3
9774885|NCT00463346|10880505|FG001|NOT COMPLETED|Overall Study||3
9774886|NCT00463385|10880517|FG000|STARTED|Overall Study||22
9774887|NCT00463385|10880518|FG001|STARTED|Overall Study||22
9774888|NCT00463385|10880519|FG002|STARTED|Overall Study||22
9774889|NCT00463385|10880520|FG003|STARTED|Overall Study||22
9774890|NCT00463385|10880517|FG000|Treated|Overall Study||22
9774891|NCT00463385|10880518|FG001|Treated|Overall Study||22
9774892|NCT00463385|10880519|FG002|Treated|Overall Study||19
9774893|NCT00463385|10880520|FG003|Treated|Overall Study||22
9774894|NCT00463385|10880517|FG000|COMPLETED|Overall Study||0
9774895|NCT00463385|10880518|FG001|COMPLETED|Overall Study||0
9774896|NCT00463385|10880519|FG002|COMPLETED|Overall Study||0
9774897|NCT00463385|10880520|FG003|COMPLETED|Overall Study||0
9774898|NCT00463385|10880517|FG000|NOT COMPLETED|Overall Study||22
9774899|NCT00463385|10880518|FG001|NOT COMPLETED|Overall Study||22
9774900|NCT00463385|10880519|FG002|NOT COMPLETED|Overall Study||22
9774901|NCT00463385|10880520|FG003|NOT COMPLETED|Overall Study||22
9774902|NCT00463437|10880542|FG000|STARTED|Overall Study||359
9774903|NCT00463437|10880543|FG001|STARTED|Overall Study||363
9774904|NCT00463437|10880544|FG002|STARTED|Overall Study||358
9774905|NCT00463437|10880545|FG003|STARTED|Overall Study||357
9774906|NCT00463437|10880542|FG000|COMPLETED|Overall Study||355
9774907|NCT00463437|10880543|FG001|COMPLETED|Overall Study||352
9774908|NCT00463437|10880544|FG002|COMPLETED|Overall Study||352
9774909|NCT00463437|10880545|FG003|COMPLETED|Overall Study||350
9774910|NCT00463437|10880542|FG000|NOT COMPLETED|Overall Study||4
9774911|NCT00463437|10880543|FG001|NOT COMPLETED|Overall Study||11
9774912|NCT00463437|10880544|FG002|NOT COMPLETED|Overall Study||6
10014444|NCT01800877|11137636|FG000|STARTED|Overall Study||60
10014445|NCT01800877|11137637|FG001|STARTED|Overall Study||60
10014446|NCT01800877|11137636|FG000|COMPLETED|Overall Study||58
9774913|NCT00463437|10880545|FG003|NOT COMPLETED|Overall Study||7
9774914|NCT00463476|10880557|FG000|STARTED|Overall Study||151
9774915|NCT00463476|10880558|FG001|STARTED|Overall Study||154
9774916|NCT00463476|10880557|FG000|COMPLETED|Overall Study||149
10014447|NCT01800877|11137637|FG001|COMPLETED|Overall Study||60
10014448|NCT01800877|11137636|FG000|NOT COMPLETED|Overall Study||2
9774917|NCT00463476|10880558|FG001|COMPLETED|Overall Study||151
9774918|NCT00463476|10880557|FG000|NOT COMPLETED|Overall Study||2
9774919|NCT00463476|10880558|FG001|NOT COMPLETED|Overall Study||3
9774920|NCT00463567|10880571|FG000|STARTED|Overall Study|Randomized Participants|420
9774921|NCT00463567|10880572|FG001|STARTED|Overall Study||418
9774922|NCT00463567|10880573|FG002|STARTED|Overall Study||420
9774923|NCT00463567|10880574|FG003|STARTED|Overall Study||425
9774924|NCT00463567|10880575|FG004|STARTED|Overall Study||130
9774925|NCT00463567|10880576|FG005|STARTED|Overall Study||123
9774926|NCT00463567|10880577|FG006|STARTED|Overall Study||123
9774927|NCT00463567|10880571|FG000|Safety Population: Received Study Drug|Overall Study||416
9774928|NCT00463567|10880572|FG001|Safety Population: Received Study Drug|Overall Study||416
9774929|NCT00463567|10880573|FG002|Safety Population: Received Study Drug|Overall Study||415
9774930|NCT00463567|10880574|FG003|Safety Population: Received Study Drug|Overall Study||418
9774931|NCT00463567|10880575|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
9774932|NCT00463567|10880576|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
9774933|NCT00463567|10880577|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
9774934|NCT00463567|10880571|FG000|COMPLETED|Overall Study||325
9774935|NCT00463567|10880572|FG001|COMPLETED|Overall Study||341
9774936|NCT00463567|10880573|FG002|COMPLETED|Overall Study||331
9774937|NCT00463567|10880574|FG003|COMPLETED|Overall Study||294
9774938|NCT00463567|10880575|FG004|COMPLETED|Overall Study||107
9774939|NCT00463567|10880576|FG005|COMPLETED|Overall Study||102
9774940|NCT00463567|10880577|FG006|COMPLETED|Overall Study||112
9774941|NCT00463567|10880571|FG000|NOT COMPLETED|Overall Study||95
9774942|NCT00463567|10880572|FG001|NOT COMPLETED|Overall Study||77
9774943|NCT00463567|10880573|FG002|NOT COMPLETED|Overall Study||89
9774944|NCT00463567|10880574|FG003|NOT COMPLETED|Overall Study||131
9774945|NCT00463567|10880575|FG004|NOT COMPLETED|Overall Study||23
9774946|NCT00463567|10880576|FG005|NOT COMPLETED|Overall Study||21
9774947|NCT00463567|10880577|FG006|NOT COMPLETED|Overall Study||11
9774948|NCT00463580|10880601|FG000|STARTED|Overall Study||30
9774949|NCT00463580|10880602|FG001|STARTED|Overall Study||30
9774950|NCT00463580|10880601|FG000|COMPLETED|Overall Study||27
9774951|NCT00463580|10880602|FG001|COMPLETED|Overall Study||28
9774952|NCT00463580|10880601|FG000|NOT COMPLETED|Overall Study||3
9774953|NCT00463580|10880602|FG001|NOT COMPLETED|Overall Study||2
9774954|NCT00463606|10880617|FG000|STARTED|Overall Study||253
9774955|NCT00463606|10880618|FG001|STARTED|Overall Study||254
9774956|NCT00463606|10880619|FG002|STARTED|Overall Study||251
9774957|NCT00463606|10880617|FG000|COMPLETED|Overall Study||212
9774958|NCT00463606|10880618|FG001|COMPLETED|Overall Study||220
9774959|NCT00463606|10880619|FG002|COMPLETED|Overall Study||231
9774960|NCT00463606|10880617|FG000|NOT COMPLETED|Overall Study||41
9774961|NCT00463606|10880618|FG001|NOT COMPLETED|Overall Study||34
9774962|NCT00463606|10880619|FG002|NOT COMPLETED|Overall Study||20
9774963|NCT00463684|10880627|FG000|STARTED|Overall Study||278
9774964|NCT00463684|10880627|FG000|COMPLETED|Overall Study||274
9774965|NCT00463684|10880627|FG000|NOT COMPLETED|Overall Study||4
9774966|NCT00463788|10880633|FG000|STARTED|Overall Study||115
9774967|NCT00463788|10880634|FG001|STARTED|Overall Study||58
9774968|NCT00463788|10880633|FG000|Treated|Overall Study||114
9774969|NCT00463788|10880634|FG001|Treated|Overall Study||57
9774970|NCT00463788|10880633|FG000|COMPLETED|Overall Study||6
9774971|NCT00463788|10880634|FG001|COMPLETED|Overall Study||4
9774972|NCT00463788|10880633|FG000|NOT COMPLETED|Overall Study||109
9774973|NCT00463788|10880634|FG001|NOT COMPLETED|Overall Study||54
9774974|NCT00463801|10880641|FG000|STARTED|Overall Study||52
9774975|NCT00463801|10880641|FG000|COMPLETED|Overall Study||39
9774976|NCT00463801|10880641|FG000|NOT COMPLETED|Overall Study||13
9774977|NCT00463840|10880645|FG000|STARTED|Overall Study||24
9774978|NCT00463840|10880645|FG000|COMPLETED|Overall Study||12
9774979|NCT00463840|10880645|FG000|NOT COMPLETED|Overall Study||12
9774980|NCT00463866|10880651|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
9774981|NCT00463866|10880652|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
9774982|NCT00463866|10880651|FG000|COMPLETED|Overall Study||3699
9774983|NCT00463866|10880652|FG001|COMPLETED|Overall Study||3705
9774984|NCT00463866|10880651|FG000|NOT COMPLETED|Overall Study||309
9774985|NCT00463866|10880652|FG001|NOT COMPLETED|Overall Study||340
9774986|NCT00464087|10880661|FG000|STARTED|Overall Study||49
9774987|NCT00464087|10880662|FG001|STARTED|Overall Study||51
9774988|NCT00464087|10880663|FG002|STARTED|Overall Study||29
9774989|NCT00464087|10880661|FG000|COMPLETED|Overall Study||49
9774990|NCT00464087|10880662|FG001|COMPLETED|Overall Study||51
9774991|NCT00464087|10880663|FG002|COMPLETED|Overall Study||0
9774992|NCT00464087|10880661|FG000|NOT COMPLETED|Overall Study||0
9774993|NCT00464087|10880662|FG001|NOT COMPLETED|Overall Study||0
9774994|NCT00464087|10880663|FG002|NOT COMPLETED|Overall Study||29
9774995|NCT00464204|10880673|FG000|STARTED|Overall Study||100
9774996|NCT00464204|10880674|FG001|STARTED|Overall Study||96
9774997|NCT00464204|10880673|FG000|Completed Treatment|Overall Study||81
9774998|NCT00464204|10880674|FG001|Completed Treatment|Overall Study||83
9774999|NCT00464204|10880673|FG000|Day 30 Follow-up Performed|Overall Study||89
9775000|NCT00464204|10880674|FG001|Day 30 Follow-up Performed|Overall Study||83
9775001|NCT00464204|10880673|FG000|Day 90 Follow-up Performed|Overall Study||69
9775002|NCT00464204|10880674|FG001|Day 90 Follow-up Performed|Overall Study||74
9775003|NCT00464204|10880673|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18
9775004|NCT00464204|10880674|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11
9775005|NCT00464204|10880673|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
9775006|NCT00464204|10880674|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
9775007|NCT00464204|10880673|FG000|NOT COMPLETED|Overall Study||49
9775008|NCT00464204|10880674|FG001|NOT COMPLETED|Overall Study||32
9775009|NCT00464269|10880686|FG000|STARTED|Overall Study||99
9775010|NCT00464269|10880687|FG001|STARTED|Overall Study||99
9775011|NCT00464269|10880688|FG002|STARTED|Overall Study||100
9775012|NCT00464269|10880689|FG003|STARTED|Overall Study||102
9775013|NCT00464269|10880686|FG000|COMPLETED|Overall Study||93
9775014|NCT00464269|10880687|FG001|COMPLETED|Overall Study||82
9775015|NCT00464269|10880688|FG002|COMPLETED|Overall Study||93
9775016|NCT00464269|10880689|FG003|COMPLETED|Overall Study||93
9775017|NCT00464269|10880686|FG000|NOT COMPLETED|Overall Study||6
9775018|NCT00464269|10880687|FG001|NOT COMPLETED|Overall Study||17
9775019|NCT00464269|10880688|FG002|NOT COMPLETED|Overall Study||7
9775020|NCT00464269|10880689|FG003|NOT COMPLETED|Overall Study||9
9775021|NCT00464308|10880704|FG000|STARTED|Overall Study||464
9775022|NCT00464308|10880705|FG001|STARTED|Overall Study||469
9775023|NCT00464308|10880706|FG002|STARTED|Overall Study||459
9775024|NCT00464308|10880704|FG000|COMPLETED|Overall Study||395
9775025|NCT00464308|10880705|FG001|COMPLETED|Overall Study||406
9775026|NCT00464308|10880706|FG002|COMPLETED|Overall Study||400
9775027|NCT00464308|10880704|FG000|NOT COMPLETED|Overall Study||69
9775028|NCT00464308|10880705|FG001|NOT COMPLETED|Overall Study||63
9775029|NCT00464308|10880706|FG002|NOT COMPLETED|Overall Study||59
9775030|NCT00464334|10880725|FG000|STARTED|Overall Study||5
9775031|NCT00464334|10880726|FG001|STARTED|Overall Study||13
9775032|NCT00464334|10880727|FG002|STARTED|Overall Study||8
9775033|NCT00464334|10880728|FG003|STARTED|Overall Study||8
9775034|NCT00464334|10880729|FG004|STARTED|Overall Study||7
9775035|NCT00464334|10880730|FG005|STARTED|Overall Study||7
9775036|NCT00464334|10880731|FG006|STARTED|Overall Study||9
9775037|NCT00464334|10880732|FG007|STARTED|Overall Study||8
9775038|NCT00464334|10880733|FG008|STARTED|Overall Study||8
9775039|NCT00464334|10880734|FG009|STARTED|Overall Study||5
9775040|NCT00464334|10880735|FG010|STARTED|Overall Study||8
9775041|NCT00464334|10880725|FG000|COMPLETED|Overall Study||4
9775042|NCT00464334|10880726|FG001|COMPLETED|Overall Study||5
9775043|NCT00464334|10880727|FG002|COMPLETED|Overall Study||3
9775044|NCT00464334|10880728|FG003|COMPLETED|Overall Study||4
9775045|NCT00464334|10880729|FG004|COMPLETED|Overall Study||3
9775046|NCT00464334|10880730|FG005|COMPLETED|Overall Study||3
9775047|NCT00464334|10880731|FG006|COMPLETED|Overall Study||6
10233917|NCT01607320|11363786|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
10239697|NCT00062751|11371368|FG002|NOT COMPLETED|Overall Study||30
9775048|NCT00464334|10880732|FG007|COMPLETED|Overall Study||7
9775049|NCT00464334|10880733|FG008|COMPLETED|Overall Study||2
9775050|NCT00464334|10880734|FG009|COMPLETED|Overall Study||4
9775051|NCT00464334|10880735|FG010|COMPLETED|Overall Study||4
9775052|NCT00464334|10880725|FG000|NOT COMPLETED|Overall Study||1
9775053|NCT00464334|10880726|FG001|NOT COMPLETED|Overall Study||8
9775054|NCT00464334|10880727|FG002|NOT COMPLETED|Overall Study||5
9775055|NCT00464334|10880728|FG003|NOT COMPLETED|Overall Study||4
9775056|NCT00464334|10880729|FG004|NOT COMPLETED|Overall Study||4
9775057|NCT00464334|10880730|FG005|NOT COMPLETED|Overall Study||4
9775058|NCT00464334|10880731|FG006|NOT COMPLETED|Overall Study||3
9775059|NCT00464334|10880732|FG007|NOT COMPLETED|Overall Study||1
9775060|NCT00464334|10880733|FG008|NOT COMPLETED|Overall Study||6
9775061|NCT00464334|10880734|FG009|NOT COMPLETED|Overall Study||1
9775062|NCT00464334|10880735|FG010|NOT COMPLETED|Overall Study||4
9775063|NCT00464438|10880772|FG000|STARTED|Overall Study||85
9775064|NCT00464438|10880773|FG001|STARTED|Overall Study||86
9775065|NCT00464438|10880772|FG000|COMPLETED|Overall Study||83
9775066|NCT00464438|10880773|FG001|COMPLETED|Overall Study||80
9775067|NCT00464438|10880772|FG000|NOT COMPLETED|Overall Study||2
9775068|NCT00464438|10880773|FG001|NOT COMPLETED|Overall Study||6
9775069|NCT00464464|10880781|FG000|STARTED|Overall Study||41
9775070|NCT00464464|10880782|FG001|STARTED|Overall Study||39
9775071|NCT00464464|10880781|FG000|COMPLETED|Overall Study||36
9775072|NCT00464464|10880782|FG001|COMPLETED|Overall Study||36
9775073|NCT00464464|10880781|FG000|NOT COMPLETED|Overall Study||5
9775074|NCT00464464|10880782|FG001|NOT COMPLETED|Overall Study||3
9775075|NCT00464490|10880790|FG000|STARTED|Overall Study||21
9775076|NCT00464490|10880791|FG001|STARTED|Overall Study||21
9775077|NCT00464490|10880790|FG000|COMPLETED|Overall Study||10
9775078|NCT00464490|10880791|FG001|COMPLETED|Overall Study||10
9775079|NCT00464490|10880790|FG000|NOT COMPLETED|Overall Study||11
9775080|NCT00464490|10880791|FG001|NOT COMPLETED|Overall Study||11
9775081|NCT00464542|10880797|FG000|STARTED|Pre-treatment||12
9775082|NCT00464542|10880797|FG000|COMPLETED|Pre-treatment||10
9775083|NCT00464542|10880797|FG000|NOT COMPLETED|Pre-treatment||2
9775084|NCT00464542|10880797|FG000|STARTED|Post-treatment||10
9775085|NCT00464542|10880797|FG000|COMPLETED|Post-treatment||10
9775086|NCT00464542|10880797|FG000|NOT COMPLETED|Post-treatment||0
9775087|NCT00464568|10880801|FG000|STARTED|Overall Study||32
9775088|NCT00464568|10880801|FG000|COMPLETED|Overall Study||30
9775089|NCT00464568|10880801|FG000|NOT COMPLETED|Overall Study||2
9775090|NCT00464620|10880818|FG000|STARTED|Overall Study||50
9775091|NCT00464620|10880819|FG001|STARTED|Overall Study||200
9775092|NCT00464620|10880820|FG002|STARTED|Overall Study||116
9775093|NCT00464620|10880818|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48
9775094|NCT00464620|10880819|FG001|COMPLETED|Overall Study||198
9775095|NCT00464620|10880820|FG002|COMPLETED|Overall Study||109
9775096|NCT00464620|10880818|FG000|NOT COMPLETED|Overall Study||2
9775097|NCT00464620|10880819|FG001|NOT COMPLETED|Overall Study||2
9775098|NCT00464620|10880820|FG002|NOT COMPLETED|Overall Study||7
9775099|NCT00464646|10880835|FG000|STARTED|Overall Study||76
9775100|NCT00464646|10880836|FG001|STARTED|Overall Study||29
9775101|NCT00464646|10880835|FG000|COMPLETED|Overall Study||76
9775102|NCT00464646|10880836|FG001|COMPLETED|Overall Study||29
9775103|NCT00464646|10880835|FG000|NOT COMPLETED|Overall Study||0
9775104|NCT00464646|10880836|FG001|NOT COMPLETED|Overall Study||0
9775105|NCT00464672|10880845|FG000|STARTED|Overall Study||460
9775106|NCT00464672|10880846|FG001|STARTED|Overall Study||232
9775107|NCT00464672|10880847|FG002|STARTED|Overall Study||400
9775108|NCT00464672|10880848|FG003|STARTED|Overall Study||200
9775109|NCT00464672|10880849|FG004|STARTED|Overall Study||402
9775110|NCT00464672|10880850|FG005|STARTED|Overall Study||199
9775111|NCT00464672|10880845|FG000|COMPLETED|Overall Study||435
9775112|NCT00464672|10880846|FG001|COMPLETED|Overall Study||222
9775113|NCT00464672|10880847|FG002|COMPLETED|Overall Study||400
9775114|NCT00464672|10880848|FG003|COMPLETED|Overall Study||199
9775115|NCT00464672|10880849|FG004|COMPLETED|Overall Study||392
9775116|NCT00464672|10880850|FG005|COMPLETED|Overall Study||195
9775117|NCT00464672|10880845|FG000|NOT COMPLETED|Overall Study||25
9775118|NCT00464672|10880846|FG001|NOT COMPLETED|Overall Study||10
9775119|NCT00464672|10880847|FG002|NOT COMPLETED|Overall Study||0
9775120|NCT00464672|10880848|FG003|NOT COMPLETED|Overall Study||1
9775121|NCT00464672|10880849|FG004|NOT COMPLETED|Overall Study||10
9775122|NCT00464672|10880850|FG005|NOT COMPLETED|Overall Study||4
9775123|NCT00464685|10880880|FG000|STARTED|Overall Study||126
9775124|NCT00464685|10880881|FG001|STARTED|Overall Study||127
9775125|NCT00464685|10880880|FG000|COMPLETED|Overall Study||103
9775126|NCT00464685|10880881|FG001|COMPLETED|Overall Study||94
9775127|NCT00464685|10880880|FG000|NOT COMPLETED|Overall Study||23
9775128|NCT00464685|10880881|FG001|NOT COMPLETED|Overall Study||33
9775129|NCT00464698|10880887|FG000|STARTED|Period 1: 30 mg||20
9775130|NCT00464698|10880887|FG000|COMPLETED|Period 1: 30 mg||17
9775131|NCT00464698|10880887|FG000|NOT COMPLETED|Period 1: 30 mg||3
9775132|NCT00464698|10880887|FG000|STARTED|Period 2: 60 mg||17
9775133|NCT00464698|10880887|FG000|COMPLETED|Period 2: 60 mg||17
9775134|NCT00464698|10880887|FG000|NOT COMPLETED|Period 2: 60 mg||0
9775135|NCT00464698|10880887|FG000|STARTED|Period 3: 120mg||14
9775136|NCT00464698|10880887|FG000|COMPLETED|Period 3: 120mg||12
9775137|NCT00464698|10880887|FG000|NOT COMPLETED|Period 3: 120mg||2
9775138|NCT00464711|10880893|FG000|STARTED|Overall Study||40
9775139|NCT00464711|10880893|FG000|COMPLETED|Overall Study||25
9775140|NCT00464711|10880893|FG000|NOT COMPLETED|Overall Study||15
9775141|NCT00464737|10880900|FG000|STARTED|Overall Study||82
9775142|NCT00464737|10880901|FG001|STARTED|Overall Study||74
9775143|NCT00464737|10880902|FG002|STARTED|Overall Study||74
9775144|NCT00464737|10880900|FG000|COMPLETED|Overall Study||50
9775145|NCT00464737|10880901|FG001|COMPLETED|Overall Study||42
9775146|NCT00464737|10880902|FG002|COMPLETED|Overall Study||19
9775147|NCT00464737|10880900|FG000|NOT COMPLETED|Overall Study||32
9775148|NCT00464737|10880901|FG001|NOT COMPLETED|Overall Study||32
9775149|NCT00464737|10880902|FG002|NOT COMPLETED|Overall Study||55
9775150|NCT00464815|10880912|FG000|STARTED|Overall Study||768
9775151|NCT00464815|10880913|FG001|STARTED|Overall Study||257
9775152|NCT00464815|10880912|FG000|COMPLETED|Overall Study||762
9775153|NCT00464815|10880913|FG001|COMPLETED|Overall Study||254
9775154|NCT00464815|10880912|FG000|NOT COMPLETED|Overall Study||6
9775155|NCT00464815|10880913|FG001|NOT COMPLETED|Overall Study||3
9830012|NCT00761930|10940681|FG000|STARTED|Overall Study||34
9830013|NCT00761930|10940682|FG001|STARTED|Overall Study||34
9830014|NCT00761930|10940683|FG002|STARTED|Overall Study||35
9830015|NCT00761930|10940681|FG000|COMPLETED|Overall Study||34
9830016|NCT00761930|10940682|FG001|COMPLETED|Overall Study||34
9830017|NCT00761930|10940683|FG002|COMPLETED|Overall Study||35
9830018|NCT00761930|10940681|FG000|NOT COMPLETED|Overall Study||0
9830019|NCT00761930|10940682|FG001|NOT COMPLETED|Overall Study||0
9830020|NCT00761930|10940683|FG002|NOT COMPLETED|Overall Study||0
9830021|NCT00761956|10940693|FG000|STARTED|Overall Study||87
9830022|NCT00761956|10940694|FG001|STARTED|Overall Study||102
9830023|NCT00761956|10940693|FG000|COMPLETED|Overall Study||52
9830024|NCT00761956|10940694|FG001|COMPLETED|Overall Study||48
9830025|NCT00761956|10940693|FG000|NOT COMPLETED|Overall Study||35
9830026|NCT00761956|10940694|FG001|NOT COMPLETED|Overall Study||54
9830027|NCT00761969|10940702|FG000|STARTED|Overall Study||742
9830028|NCT00761969|10940703|FG001|STARTED|Overall Study||713
9830029|NCT00761969|10940702|FG000|COMPLETED|Overall Study||542
9830030|NCT00761969|10940703|FG001|COMPLETED|Overall Study||573
9830031|NCT00761969|10940702|FG000|NOT COMPLETED|Overall Study||200
9830032|NCT00761969|10940703|FG001|NOT COMPLETED|Overall Study||140
9830033|NCT00762021|10940711|FG000|STARTED|Overall Study||52
9830034|NCT00762021|10940712|FG001|STARTED|Overall Study||52
9830035|NCT00762021|10940711|FG000|COMPLETED|Overall Study||44
9830036|NCT00762021|10940712|FG001|COMPLETED|Overall Study||44
9830037|NCT00762021|10940711|FG000|NOT COMPLETED|Overall Study||8
9830038|NCT00762021|10940712|FG001|NOT COMPLETED|Overall Study||8
9830039|NCT00762034|10940720|FG000|STARTED|Induction Period||472
9830040|NCT00762034|10940721|FG001|STARTED|Induction Period||467
9775156|NCT00464945|10880921|FG000|STARTED|Infant Series||135
9775157|NCT00464945|10880922|FG001|STARTED|Infant Series||134
9775158|NCT00464945|10880921|FG000|Vaccinated Dose 1|Infant Series||134
9775159|NCT00464945|10880922|FG001|Vaccinated Dose 1|Infant Series||134
9775160|NCT00464945|10880921|FG000|Vaccinated Dose 2|Infant Series||132
9775161|NCT00464945|10880922|FG001|Vaccinated Dose 2|Infant Series||133
9775162|NCT00464945|10880921|FG000|Vaccinated Dose 3|Infant Series||132
9775163|NCT00464945|10880922|FG001|Vaccinated Dose 3|Infant Series||133
9775164|NCT00464945|10880921|FG000|COMPLETED|Infant Series||131
9775165|NCT00464945|10880922|FG001|COMPLETED|Infant Series||133
9775166|NCT00464945|10880921|FG000|NOT COMPLETED|Infant Series||4
9775167|NCT00464945|10880922|FG001|NOT COMPLETED|Infant Series||1
9775168|NCT00464945|10880921|FG000|STARTED|After Infant Series||131
9775169|NCT00464945|10880922|FG001|STARTED|After Infant Series||133
9775170|NCT00464945|10880921|FG000|COMPLETED|After Infant Series||131
9775171|NCT00464945|10880922|FG001|COMPLETED|After Infant Series||131
9775172|NCT00464945|10880921|FG000|NOT COMPLETED|After Infant Series||0
9775173|NCT00464945|10880922|FG001|NOT COMPLETED|After Infant Series||2
9775174|NCT00464945|10880921|FG000|STARTED|Toddler Dose||131
9775175|NCT00464945|10880922|FG001|STARTED|Toddler Dose||131
9775176|NCT00464945|10880921|FG000|COMPLETED|Toddler Dose||131
9775177|NCT00464945|10880922|FG001|COMPLETED|Toddler Dose||130
9775178|NCT00464945|10880921|FG000|NOT COMPLETED|Toddler Dose||0
9775179|NCT00464945|10880922|FG001|NOT COMPLETED|Toddler Dose||1
9775180|NCT00465088|10880946|FG000|STARTED|Overall Study|For both arms, started means treated.|114
9775181|NCT00465088|10880947|FG001|STARTED|Overall Study||79
9775182|NCT00465088|10880946|FG000|COMPLETED|Overall Study||82
9775183|NCT00465088|10880947|FG001|COMPLETED|Overall Study||70
9775184|NCT00465088|10880946|FG000|NOT COMPLETED|Overall Study||32
9775185|NCT00465088|10880947|FG001|NOT COMPLETED|Overall Study||9
9775186|NCT00465101|10880953|FG000|STARTED|Overall Study||150
9775187|NCT00465101|10880953|FG000|COMPLETED|Overall Study||91
9775188|NCT00465101|10880953|FG000|NOT COMPLETED|Overall Study||59
9775189|NCT00465179|10880979|FG000|STARTED|Overall Study||57
9775190|NCT00465179|10880979|FG000|COMPLETED|Overall Study||4
9775191|NCT00465179|10880979|FG000|NOT COMPLETED|Overall Study||53
9775192|NCT00465270|10880985|FG000|STARTED|Overall Study||499
9775193|NCT00465270|10880986|FG001|STARTED|Overall Study||481
9775194|NCT00465270|10880985|FG000|COMPLETED|Overall Study||395
9775195|NCT00465270|10880986|FG001|COMPLETED|Overall Study||321
9775196|NCT00465270|10880985|FG000|NOT COMPLETED|Overall Study||104
9775197|NCT00465270|10880986|FG001|NOT COMPLETED|Overall Study||160
9775198|NCT00465361|10880992|FG000|STARTED|Baseline Assessment||7
9775199|NCT00465361|10880992|FG000|COMPLETED|Baseline Assessment||3
9775200|NCT00465361|10880992|FG000|NOT COMPLETED|Baseline Assessment||4
9775201|NCT00465361|10880992|FG000|STARTED|Post-Intervention Assessment||3
9775202|NCT00465361|10880992|FG000|COMPLETED|Post-Intervention Assessment||3
9775203|NCT00465361|10880992|FG000|NOT COMPLETED|Post-Intervention Assessment||0
9775204|NCT00465530|10880998|FG000|STARTED|Overall Study||21
9775205|NCT00465530|10880999|FG001|STARTED|Overall Study||19
9775206|NCT00465530|10880998|FG000|COMPLETED|Overall Study||19
9775207|NCT00465530|10880999|FG001|COMPLETED|Overall Study||15
9775208|NCT00465530|10880998|FG000|NOT COMPLETED|Overall Study||2
9775209|NCT00465530|10880999|FG001|NOT COMPLETED|Overall Study||4
9775210|NCT00465569|10881007|FG000|STARTED|Overall Study||13
9775211|NCT00465569|10881008|FG001|STARTED|Overall Study||7
9775212|NCT00465569|10881007|FG000|COMPLETED|Overall Study||12
9775213|NCT00465569|10881008|FG001|COMPLETED|Overall Study||7
9775214|NCT00465569|10881007|FG000|NOT COMPLETED|Overall Study||1
9775215|NCT00465569|10881008|FG001|NOT COMPLETED|Overall Study||0
9775216|NCT00465595|10881016|FG000|STARTED|Overall Study||27
9775217|NCT00465595|10881017|FG001|STARTED|Overall Study||29
9775218|NCT00465595|10881016|FG000|COMPLETED|Overall Study||22
9775219|NCT00465595|10881017|FG001|COMPLETED|Overall Study||24
9775220|NCT00465595|10881016|FG000|NOT COMPLETED|Overall Study||5
9775221|NCT00465595|10881017|FG001|NOT COMPLETED|Overall Study||5
9775222|NCT00465647|10881033|FG000|STARTED|Overall Study||39
9775223|NCT00465647|10881034|FG001|STARTED|Overall Study||23
9775224|NCT00465647|10881035|FG002|STARTED|Overall Study||29
9775225|NCT00465647|10881036|FG003|STARTED|Overall Study||25
9775226|NCT00465647|10881033|FG000|COMPLETED|Overall Study||26
9775227|NCT00465647|10881034|FG001|COMPLETED|Overall Study||15
9775228|NCT00465647|10881035|FG002|COMPLETED|Overall Study||18
9775229|NCT00465647|10881036|FG003|COMPLETED|Overall Study||12
9775230|NCT00465647|10881033|FG000|NOT COMPLETED|Overall Study||13
9775231|NCT00465647|10881034|FG001|NOT COMPLETED|Overall Study||8
9775232|NCT00465647|10881035|FG002|NOT COMPLETED|Overall Study||11
9775233|NCT00465647|10881036|FG003|NOT COMPLETED|Overall Study||13
9775234|NCT00465738|10881058|FG000|STARTED|Overall Study||97
9775235|NCT00465738|10881059|FG001|STARTED|Overall Study||95
9775236|NCT00465738|10881058|FG000|COMPLETED|Overall Study||91
9775237|NCT00465738|10881059|FG001|COMPLETED|Overall Study||89
9775238|NCT00465738|10881058|FG000|NOT COMPLETED|Overall Study||6
9775239|NCT00465738|10881059|FG001|NOT COMPLETED|Overall Study||6
9775240|NCT00465816|10881068|FG000|STARTED|Overall Study||367
9775241|NCT00465816|10881069|FG001|STARTED|Overall Study||122
9775242|NCT00465816|10881070|FG002|STARTED|Overall Study||122
9775243|NCT00465816|10881068|FG000|COMPLETED|Overall Study||367
9775244|NCT00465816|10881069|FG001|COMPLETED|Overall Study||122
9775245|NCT00465816|10881070|FG002|COMPLETED|Overall Study||120
9775246|NCT00465816|10881068|FG000|NOT COMPLETED|Overall Study||0
9775247|NCT00465816|10881069|FG001|NOT COMPLETED|Overall Study||0
9775248|NCT00465816|10881070|FG002|NOT COMPLETED|Overall Study||2
9775249|NCT00465894|10881081|FG000|STARTED|Treatment For 12 Weeks||30
9775250|NCT00465894|10881082|FG001|STARTED|Treatment For 12 Weeks||28
9775251|NCT00465894|10881081|FG000|COMPLETED|Treatment For 12 Weeks||25
9775252|NCT00465894|10881082|FG001|COMPLETED|Treatment For 12 Weeks||25
9775253|NCT00465894|10881081|FG000|NOT COMPLETED|Treatment For 12 Weeks||5
9775254|NCT00465894|10881082|FG001|NOT COMPLETED|Treatment For 12 Weeks||3
9775255|NCT00465894|10881081|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
9775256|NCT00465894|10881082|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
9775257|NCT00465894|10881081|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
9775258|NCT00465894|10881082|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
9775259|NCT00465894|10881081|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
9775260|NCT00465894|10881082|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
9775261|NCT00465894|10881081|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
9775262|NCT00465894|10881082|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14
9775263|NCT00465894|10881081|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
9775264|NCT00465894|10881082|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
9775265|NCT00465894|10881081|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
9775266|NCT00465894|10881082|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
9775267|NCT00465972|10881106|FG000|STARTED|Overall Study||20
9775268|NCT00465972|10881107|FG001|STARTED|Overall Study||24
9775269|NCT00465972|10881106|FG000|COMPLETED|Overall Study||18
9775270|NCT00465972|10881107|FG001|COMPLETED|Overall Study||23
9775271|NCT00465972|10881106|FG000|NOT COMPLETED|Overall Study||2
9775272|NCT00465972|10881107|FG001|NOT COMPLETED|Overall Study||1
9775273|NCT00465985|10881115|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
9775274|NCT00465985|10881116|FG001|STARTED|Part I - Open-label Treatment Period||0
9775275|NCT00465985|10881115|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
9775276|NCT00465985|10881116|FG001|COMPLETED|Part I - Open-label Treatment Period||0
9775277|NCT00465985|10881115|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4
9775278|NCT00465985|10881116|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0
9775279|NCT00465985|10881115|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
9775280|NCT00465985|10881116|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16
9775281|NCT00465985|10881115|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
9775282|NCT00465985|10881116|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
9775283|NCT00465985|10881115|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
9775284|NCT00465985|10881116|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
9775285|NCT00465985|10881115|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
9775286|NCT00465985|10881116|FG001|STARTED|Part III - Open-label Treatment Period||0
9775287|NCT00465985|10881115|FG000|COMPLETED|Part III - Open-label Treatment Period||29
9775288|NCT00465985|10881116|FG001|COMPLETED|Part III - Open-label Treatment Period||0
9775289|NCT00465985|10881115|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2
9775290|NCT00465985|10881116|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0
9775291|NCT00465998|10881125|FG000|STARTED|Overall Study||275
9775292|NCT00465998|10881125|FG000|COMPLETED|Overall Study||275
9775293|NCT00465998|10881125|FG000|NOT COMPLETED|Overall Study||0
9775294|NCT00466167|10881133|FG000|STARTED|Overall Study||165
9775295|NCT00466167|10881134|FG001|STARTED|Overall Study||175
9775296|NCT00466167|10881135|FG002|STARTED|Overall Study||178
9775297|NCT00466167|10881133|FG000|COMPLETED|Overall Study||145
9775298|NCT00466167|10881134|FG001|COMPLETED|Overall Study||163
9775299|NCT00466167|10881135|FG002|COMPLETED|Overall Study||157
9775300|NCT00466167|10881133|FG000|NOT COMPLETED|Overall Study||20
9775301|NCT00466167|10881134|FG001|NOT COMPLETED|Overall Study||12
9775302|NCT00466167|10881135|FG002|NOT COMPLETED|Overall Study||21
9775303|NCT00466193|10881145|FG000|STARTED|Overall Study||150
9775304|NCT00466193|10881146|FG001|STARTED|Overall Study||145
9775305|NCT00466193|10881145|FG000|COMPLETED|Overall Study||138
9775306|NCT00466193|10881146|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
9775307|NCT00466193|10881145|FG000|NOT COMPLETED|Overall Study||12
9775308|NCT00466193|10881146|FG001|NOT COMPLETED|Overall Study||8
9775309|NCT00466206|10881152|FG000|STARTED|Overall Study||10
9775310|NCT00466206|10881152|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
9775311|NCT00466206|10881152|FG000|NOT COMPLETED|Overall Study||0
9775312|NCT00466310|10881162|FG000|STARTED|Overall Study||20
9775313|NCT00466310|10881163|FG001|STARTED|Overall Study||20
9775314|NCT00466310|10881164|FG002|STARTED|Overall Study||31
9775315|NCT00466310|10881162|FG000|COMPLETED|Overall Study||20
9775316|NCT00466310|10881163|FG001|COMPLETED|Overall Study||20
10014449|NCT01800877|11137637|FG001|NOT COMPLETED|Overall Study||0
10014450|NCT01800890|11137643|FG000|STARTED|Test Period 1||3
10014451|NCT01800890|11137644|FG001|STARTED|Test Period 1||3
9775317|NCT00466310|10881164|FG002|COMPLETED|Overall Study||31
9775318|NCT00466310|10881162|FG000|NOT COMPLETED|Overall Study||0
10014452|NCT01800890|11137645|FG002|STARTED|Test Period 1||3
10014453|NCT01800890|11137646|FG003|STARTED|Test Period 1||3
10014454|NCT01800890|11137647|FG004|STARTED|Test Period 1||4
9775319|NCT00466310|10881163|FG001|NOT COMPLETED|Overall Study||0
9775320|NCT00466310|10881164|FG002|NOT COMPLETED|Overall Study||0
9775321|NCT00466323|10881174|FG000|STARTED|Overall Study||117
9775322|NCT00466323|10881175|FG001|STARTED|Overall Study||115
9775323|NCT00466323|10881174|FG000|COMPLETED|Overall Study||89
9775324|NCT00466323|10881175|FG001|COMPLETED|Overall Study||92
9775325|NCT00466323|10881174|FG000|NOT COMPLETED|Overall Study||28
9775326|NCT00466323|10881175|FG001|NOT COMPLETED|Overall Study||23
9775327|NCT00466440|10881184|FG000|STARTED|Overall Study||14
9775328|NCT00466440|10881185|FG001|STARTED|Overall Study||48
9775329|NCT00466440|10881186|FG002|STARTED|Overall Study||46
9775330|NCT00466440|10881184|FG000|Received at Least One Dose of Study Drug|Overall Study||14
9775331|NCT00466440|10881185|FG001|Received at Least One Dose of Study Drug|Overall Study||47
9775332|NCT00466440|10881186|FG002|Received at Least One Dose of Study Drug|Overall Study||41
9775333|NCT00466440|10881184|FG000|COMPLETED|Overall Study||0
9775334|NCT00466440|10881185|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
9775335|NCT00466440|10881186|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
9775336|NCT00466440|10881184|FG000|NOT COMPLETED|Overall Study||14
9775337|NCT00466440|10881185|FG001|NOT COMPLETED|Overall Study||12
9775338|NCT00466440|10881186|FG002|NOT COMPLETED|Overall Study||12
9775339|NCT00466505|10881203|FG000|STARTED|Overall Study||17
9775340|NCT00466505|10881203|FG000|COMPLETED|Overall Study||0
9775341|NCT00466505|10881203|FG000|NOT COMPLETED|Overall Study||17
9775342|NCT00466661|10881209|FG000|STARTED|Overall Study||16
9775343|NCT00466661|10881210|FG001|STARTED|Overall Study||17
9775344|NCT00466661|10881209|FG000|At Least 1 Postrandomization Visit|Overall Study||14
9775345|NCT00466661|10881210|FG001|At Least 1 Postrandomization Visit|Overall Study||16
9775346|NCT00466661|10881209|FG000|COMPLETED|Overall Study||12
9775347|NCT00466661|10881210|FG001|COMPLETED|Overall Study||11
9775348|NCT00466661|10881209|FG000|NOT COMPLETED|Overall Study||4
9775349|NCT00466661|10881210|FG001|NOT COMPLETED|Overall Study||6
9775350|NCT00466687|10881216|FG000|STARTED|Overall Study||34
9775351|NCT00466687|10881216|FG000|COMPLETED|Overall Study||0
9775352|NCT00466687|10881216|FG000|NOT COMPLETED|Overall Study||34
9775353|NCT00466726|10881222|FG000|STARTED|Overall Study||57
9775354|NCT00466726|10881222|FG000|COMPLETED|Overall Study||43
9775355|NCT00466726|10881222|FG000|NOT COMPLETED|Overall Study||14
9775356|NCT00466752|10881228|FG000|STARTED|Overall Study||5
9775357|NCT00466752|10881229|FG001|STARTED|Overall Study||0
9775358|NCT00466752|10881228|FG000|COMPLETED|Overall Study||5
9775359|NCT00466752|10881229|FG001|COMPLETED|Overall Study||0
9775360|NCT00466752|10881228|FG000|NOT COMPLETED|Overall Study||0
9775361|NCT00466752|10881229|FG001|NOT COMPLETED|Overall Study||0
9775362|NCT00466817|10881237|FG000|STARTED|Overall Study||49
9775363|NCT00466817|10881238|FG001|STARTED|Overall Study||47
9775364|NCT00466817|10881237|FG000|COMPLETED|Overall Study||44
9775365|NCT00466817|10881238|FG001|COMPLETED|Overall Study||43
9775366|NCT00466817|10881237|FG000|NOT COMPLETED|Overall Study||5
9775367|NCT00466817|10881238|FG001|NOT COMPLETED|Overall Study||4
9775368|NCT00466921|10881253|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
9775369|NCT00466921|10881253|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32
9775370|NCT00466921|10881253|FG000|Started Cycle 2|First 3 Cycles of Treatment||31
9775371|NCT00466921|10881253|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26
9775372|NCT00466921|10881253|FG000|COMPLETED|First 3 Cycles of Treatment||26
9775373|NCT00466921|10881253|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7
9775374|NCT00466921|10881253|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26
9775375|NCT00466921|10881253|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
9775376|NCT00466921|10881253|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
9775377|NCT00466921|10881253|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
9775378|NCT00466921|10881253|FG000|STARTED|Continued Treatment||21
9775379|NCT00466921|10881253|FG000|COMPLETED|Continued Treatment||21
9775380|NCT00466921|10881253|FG000|NOT COMPLETED|Continued Treatment||0
9775381|NCT00466921|10881253|FG000|STARTED|Follow up for a Minimum of 1 Year||33
9775382|NCT00466921|10881253|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27
9775383|NCT00466921|10881253|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
9775384|NCT00466947|10881259|FG000|STARTED|Primary Outcome Analysis Period||11875
9775385|NCT00466947|10881260|FG001|STARTED|Primary Outcome Analysis Period||11863
9775386|NCT00466947|10881259|FG000|Ongoing|Primary Outcome Analysis Period||11875
9775387|NCT00466947|10881260|FG001|Ongoing|Primary Outcome Analysis Period||11863
9775388|NCT00466947|10881259|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
9775389|NCT00466947|10881260|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
9775390|NCT00466947|10881259|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875
9775391|NCT00466947|10881260|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863
9775392|NCT00466947|10881259|FG000|STARTED|Study End Analysis Period||11798
9775393|NCT00466947|10881260|FG001|STARTED|Study End Analysis Period||11799
9775394|NCT00466947|10881259|FG000|COMPLETED|Study End Analysis Period||9302
9775395|NCT00466947|10881260|FG001|COMPLETED|Study End Analysis Period||9265
9775396|NCT00466947|10881259|FG000|NOT COMPLETED|Study End Analysis Period||2496
9775397|NCT00466947|10881260|FG001|NOT COMPLETED|Study End Analysis Period||2534
9775398|NCT00466960|10881267|FG000|STARTED|Overall Study||21
9775399|NCT00466960|10881267|FG000|COMPLETED|Overall Study||21
9775400|NCT00466960|10881267|FG000|NOT COMPLETED|Overall Study||0
9775401|NCT00467038|10881273|FG000|STARTED|Overall Study||11
9775402|NCT00467038|10881274|FG001|STARTED|Overall Study||11
9775403|NCT00467038|10881273|FG000|COMPLETED|Overall Study||11
9775404|NCT00467038|10881274|FG001|COMPLETED|Overall Study||11
9775405|NCT00467038|10881273|FG000|NOT COMPLETED|Overall Study||0
9775406|NCT00467038|10881274|FG001|NOT COMPLETED|Overall Study||0
9775407|NCT00467051|10881281|FG000|STARTED|Overall Study||20
9775408|NCT00467051|10881281|FG000|COMPLETED|Overall Study||18
9775409|NCT00467051|10881281|FG000|NOT COMPLETED|Overall Study||2
9775410|NCT00467077|10881286|FG000|STARTED|Overall Study||21
9775411|NCT00467077|10881286|FG000|COMPLETED|Overall Study||21
9775412|NCT00467077|10881286|FG000|NOT COMPLETED|Overall Study||0
9775413|NCT00467259|10881292|FG000|STARTED|Overall Study||251
9775414|NCT00467259|10881293|FG001|STARTED|Overall Study||1020
9775415|NCT00467259|10881292|FG000|ITT Population|Overall Study||251
9775416|NCT00467259|10881293|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
9775417|NCT00467259|10881292|FG000|COMPLETED|Overall Study||176
9775418|NCT00467259|10881293|FG001|COMPLETED|Overall Study||778
9775419|NCT00467259|10881292|FG000|NOT COMPLETED|Overall Study||75
9775420|NCT00467259|10881293|FG001|NOT COMPLETED|Overall Study||242
9775421|NCT00467272|10881299|FG000|STARTED|Overall Study||41
9775422|NCT00467272|10881299|FG000|COMPLETED|Overall Study||38
9775423|NCT00467272|10881299|FG000|NOT COMPLETED|Overall Study||3
9775424|NCT00467285|10881305|FG000|STARTED|Overall Study||32
9775425|NCT00467285|10881306|FG001|STARTED|Overall Study||64
9775426|NCT00467285|10881305|FG000|COMPLETED|Overall Study||28
9775427|NCT00467285|10881306|FG001|COMPLETED|Overall Study||60
9775428|NCT00467285|10881305|FG000|NOT COMPLETED|Overall Study||4
9775429|NCT00467285|10881306|FG001|NOT COMPLETED|Overall Study||4
9775430|NCT00467298|10881316|FG000|STARTED|Overall Study||46
9775431|NCT00467298|10881317|FG001|STARTED|Overall Study||44
9775432|NCT00467298|10881316|FG000|COMPLETED|Overall Study||42
9775433|NCT00467298|10881317|FG001|COMPLETED|Overall Study||38
9775434|NCT00467298|10881316|FG000|NOT COMPLETED|Overall Study||4
9775435|NCT00467298|10881317|FG001|NOT COMPLETED|Overall Study||6
9775436|NCT00467350|10881325|FG000|STARTED|Overall Study||41
9775437|NCT00467350|10881326|FG001|STARTED|Overall Study||39
9775438|NCT00467350|10881325|FG000|COMPLETED|Overall Study||40
9775439|NCT00467350|10881326|FG001|COMPLETED|Overall Study||39
9775440|NCT00467350|10881325|FG000|NOT COMPLETED|Overall Study||1
9775441|NCT00467350|10881326|FG001|NOT COMPLETED|Overall Study||0
9775442|NCT00467363|10881334|FG000|STARTED|Overall Study||615
9775443|NCT00467363|10881335|FG001|STARTED|Overall Study||613
9775444|NCT00467363|10881334|FG000|COMPLETED|Overall Study||535
9775445|NCT00467363|10881335|FG001|COMPLETED|Overall Study||543
9775446|NCT00467363|10881334|FG000|NOT COMPLETED|Overall Study||80
9775447|NCT00467363|10881335|FG001|NOT COMPLETED|Overall Study||70
9775448|NCT00467389|10881341|FG000|STARTED|Overall Study||6
9775449|NCT00467389|10881342|FG001|STARTED|Overall Study||6
9775450|NCT00467389|10881341|FG000|COMPLETED|Overall Study||6
9775451|NCT00467389|10881342|FG001|COMPLETED|Overall Study||6
9775452|NCT00467389|10881341|FG000|NOT COMPLETED|Overall Study||0
9775453|NCT00467389|10881342|FG001|NOT COMPLETED|Overall Study||0
9775454|NCT00467519|10881350|FG000|STARTED|Overall Study||531
9775455|NCT00467519|10881351|FG001|STARTED|Overall Study||511
9775456|NCT00467519|10881350|FG000|COMPLETED|Overall Study||517
9775457|NCT00467519|10881351|FG001|COMPLETED|Overall Study||488
9775458|NCT00467519|10881350|FG000|NOT COMPLETED|Overall Study||14
9775459|NCT00467519|10881351|FG001|NOT COMPLETED|Overall Study||23
9775460|NCT00467558|10881359|FG000|STARTED|Overall Study||4
9775461|NCT00467558|10881360|FG001|STARTED|Overall Study||3
9775462|NCT00467558|10881359|FG000|COMPLETED|Overall Study||2
9775463|NCT00467558|10881360|FG001|COMPLETED|Overall Study||3
9775464|NCT00467558|10881359|FG000|NOT COMPLETED|Overall Study||2
9775465|NCT00467558|10881360|FG001|NOT COMPLETED|Overall Study||0
9775466|NCT00467584|10881369|FG000|STARTED|Overall Study||21
9775467|NCT00467584|10881370|FG001|STARTED|Overall Study||20
9775468|NCT00467584|10881371|FG002|STARTED|Overall Study||21
9775469|NCT00467584|10881369|FG000|COMPLETED|Overall Study||17
9775470|NCT00467584|10881370|FG001|COMPLETED|Overall Study||15
9775471|NCT00467584|10881371|FG002|COMPLETED|Overall Study||20
9775472|NCT00467584|10881369|FG000|NOT COMPLETED|Overall Study||4
9775473|NCT00467584|10881370|FG001|NOT COMPLETED|Overall Study||5
9775474|NCT00467584|10881371|FG002|NOT COMPLETED|Overall Study||1
9775475|NCT00467597|10881383|FG000|STARTED|Overall Study||26
9775476|NCT00467597|10881384|FG001|STARTED|Overall Study||6
9775477|NCT00467597|10881383|FG000|COMPLETED|Overall Study||24
9775478|NCT00467597|10881384|FG001|COMPLETED|Overall Study||6
9775479|NCT00467597|10881383|FG000|NOT COMPLETED|Overall Study||2
9775480|NCT00467597|10881384|FG001|NOT COMPLETED|Overall Study||0
9775481|NCT00467610|10881394|FG000|STARTED|Overall Study||6
9775482|NCT00467610|10881394|FG000|COMPLETED|Overall Study||5
9775483|NCT00467610|10881394|FG000|NOT COMPLETED|Overall Study||1
9775484|NCT00467649|10881400|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
9775485|NCT00467649|10881401|FG001|STARTED|Phase 1 (Randomized Population)||56
9775486|NCT00467649|10881402|FG002|STARTED|Phase 1 (Randomized Population)||0
9775487|NCT00467649|10881403|FG003|STARTED|Phase 1 (Randomized Population)||0
9775488|NCT00467649|10881404|FG004|STARTED|Phase 1 (Randomized Population)||0
9775489|NCT00467649|10881405|FG005|STARTED|Phase 1 (Randomized Population)||0
9775490|NCT00467649|10881400|FG000|Intent to Treat|Phase 1 (Randomized Population)||56
9775491|NCT00467649|10881401|FG001|Intent to Treat|Phase 1 (Randomized Population)||56
9775492|NCT00467649|10881402|FG002|Intent to Treat|Phase 1 (Randomized Population)||0
9775493|NCT00467649|10881403|FG003|Intent to Treat|Phase 1 (Randomized Population)||0
9775494|NCT00467649|10881404|FG004|Intent to Treat|Phase 1 (Randomized Population)||0
9775495|NCT00467649|10881405|FG005|Intent to Treat|Phase 1 (Randomized Population)||0
9775496|NCT00467649|10881400|FG000|COMPLETED|Phase 1 (Randomized Population)||48
9775497|NCT00467649|10881401|FG001|COMPLETED|Phase 1 (Randomized Population)||50
9775498|NCT00467649|10881402|FG002|COMPLETED|Phase 1 (Randomized Population)||0
9775499|NCT00467649|10881403|FG003|COMPLETED|Phase 1 (Randomized Population)||0
9775500|NCT00467649|10881404|FG004|COMPLETED|Phase 1 (Randomized Population)||0
9775501|NCT00467649|10881405|FG005|COMPLETED|Phase 1 (Randomized Population)||0
9775502|NCT00467649|10881400|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9
9775503|NCT00467649|10881401|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6
9775504|NCT00467649|10881402|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0
9775505|NCT00467649|10881403|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0
9775506|NCT00467649|10881404|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0
9775507|NCT00467649|10881405|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0
9775508|NCT00467649|10881400|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0
9775509|NCT00467649|10881401|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0
9775510|NCT00467649|10881402|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17
9775511|NCT00467649|10881403|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31
9775512|NCT00467649|10881404|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14
9775513|NCT00467649|10881405|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36
9775514|NCT00467649|10881400|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
9775515|NCT00467649|10881401|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
9775516|NCT00467649|10881402|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
9775517|NCT00467649|10881403|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
9775518|NCT00467649|10881404|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
9775519|NCT00467649|10881405|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
10014455|NCT01800890|11137648|FG005|STARTED|Test Period 1||4
10014456|NCT01800890|11137649|FG006|STARTED|Test Period 1||3
10014457|NCT01800890|11137650|FG007|STARTED|Test Period 1||3
9775520|NCT00467649|10881400|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
9775521|NCT00467649|10881401|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
9775522|NCT00467649|10881402|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
9775523|NCT00467649|10881403|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
9775524|NCT00467649|10881404|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
9775525|NCT00467649|10881405|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
9775526|NCT00467740|10881428|FG000|STARTED|Overall Study||54
9775527|NCT00467740|10881429|FG001|STARTED|Overall Study||61
9775528|NCT00467740|10881430|FG002|STARTED|Overall Study||60
9775529|NCT00467740|10881431|FG003|STARTED|Overall Study||60
9775530|NCT00467740|10881432|FG004|STARTED|Overall Study||61
9775531|NCT00467740|10881428|FG000|COMPLETED|Overall Study||53
9775532|NCT00467740|10881429|FG001|COMPLETED|Overall Study||58
9775533|NCT00467740|10881430|FG002|COMPLETED|Overall Study||58
9775534|NCT00467740|10881431|FG003|COMPLETED|Overall Study||59
9775535|NCT00467740|10881432|FG004|COMPLETED|Overall Study||61
9775536|NCT00467740|10881428|FG000|NOT COMPLETED|Overall Study||1
9775537|NCT00467740|10881429|FG001|NOT COMPLETED|Overall Study||3
9775538|NCT00467740|10881430|FG002|NOT COMPLETED|Overall Study||2
9775539|NCT00467740|10881431|FG003|NOT COMPLETED|Overall Study||1
9775540|NCT00467740|10881432|FG004|NOT COMPLETED|Overall Study||0
9775541|NCT00467779|10881459|FG000|STARTED|Stage 1||4
9775542|NCT00467779|10881460|FG001|STARTED|Stage 1||3
9775543|NCT00467779|10881461|FG002|STARTED|Stage 1||3
9775544|NCT00467779|10881462|FG003|STARTED|Stage 1||3
9775545|NCT00467779|10881463|FG004|STARTED|Stage 1||3
9775546|NCT00467779|10881464|FG005|STARTED|Stage 1||6
9775547|NCT00467779|10881465|FG006|STARTED|Stage 1||7
9775548|NCT00467779|10881466|FG007|STARTED|Stage 1||7
9775549|NCT00467779|10881467|FG008|STARTED|Stage 1||0
9775550|NCT00467779|10881468|FG009|STARTED|Stage 1||0
9775551|NCT00467779|10881469|FG010|STARTED|Stage 1||0
9775552|NCT00467779|10881470|FG011|STARTED|Stage 1||0
9775553|NCT00467779|10881471|FG012|STARTED|Stage 1||0
9775554|NCT00467779|10881472|FG013|STARTED|Stage 1||0
9775555|NCT00467779|10881473|FG014|STARTED|Stage 1||0
9775556|NCT00467779|10881459|FG000|COMPLETED|Stage 1||0
9775557|NCT00467779|10881460|FG001|COMPLETED|Stage 1||0
9775558|NCT00467779|10881461|FG002|COMPLETED|Stage 1||0
9775559|NCT00467779|10881462|FG003|COMPLETED|Stage 1||0
9775560|NCT00467779|10881463|FG004|COMPLETED|Stage 1||0
9775561|NCT00467779|10881464|FG005|COMPLETED|Stage 1||1
9775562|NCT00467779|10881465|FG006|COMPLETED|Stage 1||0
9775563|NCT00467779|10881466|FG007|COMPLETED|Stage 1||0
9775564|NCT00467779|10881467|FG008|COMPLETED|Stage 1||0
9775565|NCT00467779|10881468|FG009|COMPLETED|Stage 1||0
10014458|NCT01800890|11137651|FG008|STARTED|Test Period 1||3
9775566|NCT00467779|10881469|FG010|COMPLETED|Stage 1||0
9775567|NCT00467779|10881470|FG011|COMPLETED|Stage 1||0
9775568|NCT00467779|10881471|FG012|COMPLETED|Stage 1||0
9775569|NCT00467779|10881472|FG013|COMPLETED|Stage 1||0
9775570|NCT00467779|10881473|FG014|COMPLETED|Stage 1||0
9775571|NCT00467779|10881459|FG000|NOT COMPLETED|Stage 1||4
9775572|NCT00467779|10881460|FG001|NOT COMPLETED|Stage 1||3
9775573|NCT00467779|10881461|FG002|NOT COMPLETED|Stage 1||3
9775574|NCT00467779|10881462|FG003|NOT COMPLETED|Stage 1||3
9775575|NCT00467779|10881463|FG004|NOT COMPLETED|Stage 1||3
9775576|NCT00467779|10881464|FG005|NOT COMPLETED|Stage 1||5
9775577|NCT00467779|10881465|FG006|NOT COMPLETED|Stage 1||7
9775578|NCT00467779|10881466|FG007|NOT COMPLETED|Stage 1||7
9775579|NCT00467779|10881467|FG008|NOT COMPLETED|Stage 1||0
9775580|NCT00467779|10881468|FG009|NOT COMPLETED|Stage 1||0
9775581|NCT00467779|10881469|FG010|NOT COMPLETED|Stage 1||0
9775582|NCT00467779|10881470|FG011|NOT COMPLETED|Stage 1||0
9775583|NCT00467779|10881471|FG012|NOT COMPLETED|Stage 1||0
9775584|NCT00467779|10881472|FG013|NOT COMPLETED|Stage 1||0
9775585|NCT00467779|10881473|FG014|NOT COMPLETED|Stage 1||0
9775586|NCT00467779|10881459|FG000|STARTED|Stage 1A||0
9775587|NCT00467779|10881460|FG001|STARTED|Stage 1A||0
9775588|NCT00467779|10881461|FG002|STARTED|Stage 1A||0
9775589|NCT00467779|10881462|FG003|STARTED|Stage 1A||0
9775590|NCT00467779|10881463|FG004|STARTED|Stage 1A||0
9775591|NCT00467779|10881464|FG005|STARTED|Stage 1A||0
9775592|NCT00467779|10881465|FG006|STARTED|Stage 1A||0
9775593|NCT00467779|10881466|FG007|STARTED|Stage 1A||0
9775594|NCT00467779|10881467|FG008|STARTED|Stage 1A||0
9775595|NCT00467779|10881468|FG009|STARTED|Stage 1A||3
9775596|NCT00467779|10881469|FG010|STARTED|Stage 1A||3
9775597|NCT00467779|10881470|FG011|STARTED|Stage 1A||8
9775598|NCT00467779|10881471|FG012|STARTED|Stage 1A||6
9775599|NCT00467779|10881472|FG013|STARTED|Stage 1A||0
9775600|NCT00467779|10881473|FG014|STARTED|Stage 1A||0
9775601|NCT00467779|10881459|FG000|COMPLETED|Stage 1A||0
9775602|NCT00467779|10881460|FG001|COMPLETED|Stage 1A||0
9775603|NCT00467779|10881461|FG002|COMPLETED|Stage 1A||0
9775604|NCT00467779|10881462|FG003|COMPLETED|Stage 1A||0
9775605|NCT00467779|10881463|FG004|COMPLETED|Stage 1A||0
9775606|NCT00467779|10881464|FG005|COMPLETED|Stage 1A||0
9775607|NCT00467779|10881465|FG006|COMPLETED|Stage 1A||0
9775608|NCT00467779|10881466|FG007|COMPLETED|Stage 1A||0
9775609|NCT00467779|10881467|FG008|COMPLETED|Stage 1A||0
9775610|NCT00467779|10881468|FG009|COMPLETED|Stage 1A||0
9775611|NCT00467779|10881469|FG010|COMPLETED|Stage 1A||0
9775612|NCT00467779|10881470|FG011|COMPLETED|Stage 1A||0
9775613|NCT00467779|10881471|FG012|COMPLETED|Stage 1A||0
9775614|NCT00467779|10881472|FG013|COMPLETED|Stage 1A||0
9775615|NCT00467779|10881473|FG014|COMPLETED|Stage 1A||0
9775616|NCT00467779|10881459|FG000|NOT COMPLETED|Stage 1A||0
9775617|NCT00467779|10881460|FG001|NOT COMPLETED|Stage 1A||0
9775618|NCT00467779|10881461|FG002|NOT COMPLETED|Stage 1A||0
9775619|NCT00467779|10881462|FG003|NOT COMPLETED|Stage 1A||0
9775620|NCT00467779|10881463|FG004|NOT COMPLETED|Stage 1A||0
9775621|NCT00467779|10881464|FG005|NOT COMPLETED|Stage 1A||0
9775622|NCT00467779|10881465|FG006|NOT COMPLETED|Stage 1A||0
9775623|NCT00467779|10881466|FG007|NOT COMPLETED|Stage 1A||0
9775624|NCT00467779|10881467|FG008|NOT COMPLETED|Stage 1A||0
9775625|NCT00467779|10881468|FG009|NOT COMPLETED|Stage 1A||3
9775626|NCT00467779|10881469|FG010|NOT COMPLETED|Stage 1A||3
9775627|NCT00467779|10881470|FG011|NOT COMPLETED|Stage 1A||8
9775628|NCT00467779|10881471|FG012|NOT COMPLETED|Stage 1A||6
9775629|NCT00467779|10881472|FG013|NOT COMPLETED|Stage 1A||0
9775630|NCT00467779|10881473|FG014|NOT COMPLETED|Stage 1A||0
9775631|NCT00467779|10881459|FG000|STARTED|Stage 2||0
9775632|NCT00467779|10881460|FG001|STARTED|Stage 2||0
9775633|NCT00467779|10881461|FG002|STARTED|Stage 2||0
9775634|NCT00467779|10881462|FG003|STARTED|Stage 2||0
9775635|NCT00467779|10881463|FG004|STARTED|Stage 2||0
9775636|NCT00467779|10881464|FG005|STARTED|Stage 2||0
9775637|NCT00467779|10881465|FG006|STARTED|Stage 2||0
9775638|NCT00467779|10881466|FG007|STARTED|Stage 2||0
9775639|NCT00467779|10881467|FG008|STARTED|Stage 2||21
9775640|NCT00467779|10881468|FG009|STARTED|Stage 2||0
9775641|NCT00467779|10881469|FG010|STARTED|Stage 2||0
9775642|NCT00467779|10881470|FG011|STARTED|Stage 2||0
9775643|NCT00467779|10881471|FG012|STARTED|Stage 2||0
9775644|NCT00467779|10881472|FG013|STARTED|Stage 2||0
9775645|NCT00467779|10881473|FG014|STARTED|Stage 2||0
9775646|NCT00467779|10881459|FG000|COMPLETED|Stage 2||0
9775647|NCT00467779|10881460|FG001|COMPLETED|Stage 2||0
9775648|NCT00467779|10881461|FG002|COMPLETED|Stage 2||0
9775649|NCT00467779|10881462|FG003|COMPLETED|Stage 2||0
9775650|NCT00467779|10881463|FG004|COMPLETED|Stage 2||0
9775651|NCT00467779|10881464|FG005|COMPLETED|Stage 2||0
9775652|NCT00467779|10881465|FG006|COMPLETED|Stage 2||0
9775653|NCT00467779|10881466|FG007|COMPLETED|Stage 2||0
9775654|NCT00467779|10881467|FG008|COMPLETED|Stage 2||0
9775655|NCT00467779|10881468|FG009|COMPLETED|Stage 2||0
9775656|NCT00467779|10881469|FG010|COMPLETED|Stage 2||0
9775657|NCT00467779|10881470|FG011|COMPLETED|Stage 2||0
9775658|NCT00467779|10881471|FG012|COMPLETED|Stage 2||0
9775659|NCT00467779|10881472|FG013|COMPLETED|Stage 2||0
9775660|NCT00467779|10881473|FG014|COMPLETED|Stage 2||0
9775661|NCT00467779|10881459|FG000|NOT COMPLETED|Stage 2||0
9775662|NCT00467779|10881460|FG001|NOT COMPLETED|Stage 2||0
9775663|NCT00467779|10881461|FG002|NOT COMPLETED|Stage 2||0
9775664|NCT00467779|10881462|FG003|NOT COMPLETED|Stage 2||0
9775665|NCT00467779|10881463|FG004|NOT COMPLETED|Stage 2||0
9775666|NCT00467779|10881464|FG005|NOT COMPLETED|Stage 2||0
9775667|NCT00467779|10881465|FG006|NOT COMPLETED|Stage 2||0
9775668|NCT00467779|10881466|FG007|NOT COMPLETED|Stage 2||0
9775669|NCT00467779|10881467|FG008|NOT COMPLETED|Stage 2||21
9775670|NCT00467779|10881468|FG009|NOT COMPLETED|Stage 2||0
9775671|NCT00467779|10881469|FG010|NOT COMPLETED|Stage 2||0
9775672|NCT00467779|10881470|FG011|NOT COMPLETED|Stage 2||0
9775673|NCT00467779|10881471|FG012|NOT COMPLETED|Stage 2||0
9775674|NCT00467779|10881472|FG013|NOT COMPLETED|Stage 2||0
9775675|NCT00467779|10881473|FG014|NOT COMPLETED|Stage 2||0
9775676|NCT00467779|10881459|FG000|STARTED|Stage 2A||0
9775677|NCT00467779|10881460|FG001|STARTED|Stage 2A||0
9775678|NCT00467779|10881461|FG002|STARTED|Stage 2A||0
9775679|NCT00467779|10881462|FG003|STARTED|Stage 2A||0
9775680|NCT00467779|10881463|FG004|STARTED|Stage 2A||0
9775681|NCT00467779|10881464|FG005|STARTED|Stage 2A||0
10014459|NCT01800890|11137643|FG000|COMPLETED|Test Period 1||3
10014460|NCT01800890|11137644|FG001|COMPLETED|Test Period 1||3
10014461|NCT01800890|11137645|FG002|COMPLETED|Test Period 1||3
10014462|NCT01800890|11137646|FG003|COMPLETED|Test Period 1||2
10014463|NCT01800890|11137647|FG004|COMPLETED|Test Period 1||4
10014464|NCT01800890|11137648|FG005|COMPLETED|Test Period 1||4
9775682|NCT00467779|10881465|FG006|STARTED|Stage 2A||0
9775683|NCT00467779|10881466|FG007|STARTED|Stage 2A||0
9775684|NCT00467779|10881467|FG008|STARTED|Stage 2A||0
9775685|NCT00467779|10881468|FG009|STARTED|Stage 2A||0
9775686|NCT00467779|10881469|FG010|STARTED|Stage 2A||0
9775687|NCT00467779|10881470|FG011|STARTED|Stage 2A||0
9775688|NCT00467779|10881471|FG012|STARTED|Stage 2A||0
9775689|NCT00467779|10881472|FG013|STARTED|Stage 2A||22
9775690|NCT00467779|10881473|FG014|STARTED|Stage 2A||0
9775691|NCT00467779|10881459|FG000|COMPLETED|Stage 2A||0
9775692|NCT00467779|10881460|FG001|COMPLETED|Stage 2A||0
9775693|NCT00467779|10881461|FG002|COMPLETED|Stage 2A||0
9775694|NCT00467779|10881462|FG003|COMPLETED|Stage 2A||0
9775695|NCT00467779|10881463|FG004|COMPLETED|Stage 2A||0
9775696|NCT00467779|10881464|FG005|COMPLETED|Stage 2A||0
9775697|NCT00467779|10881465|FG006|COMPLETED|Stage 2A||0
9775698|NCT00467779|10881466|FG007|COMPLETED|Stage 2A||0
9775699|NCT00467779|10881467|FG008|COMPLETED|Stage 2A||0
9775700|NCT00467779|10881468|FG009|COMPLETED|Stage 2A||0
9775701|NCT00467779|10881469|FG010|COMPLETED|Stage 2A||0
9775702|NCT00467779|10881470|FG011|COMPLETED|Stage 2A||0
9775703|NCT00467779|10881471|FG012|COMPLETED|Stage 2A||0
9775704|NCT00467779|10881472|FG013|COMPLETED|Stage 2A||1
9775705|NCT00467779|10881473|FG014|COMPLETED|Stage 2A||0
9775706|NCT00467779|10881459|FG000|NOT COMPLETED|Stage 2A||0
9775707|NCT00467779|10881460|FG001|NOT COMPLETED|Stage 2A||0
9775708|NCT00467779|10881461|FG002|NOT COMPLETED|Stage 2A||0
9775709|NCT00467779|10881462|FG003|NOT COMPLETED|Stage 2A||0
9775710|NCT00467779|10881463|FG004|NOT COMPLETED|Stage 2A||0
9775711|NCT00467779|10881464|FG005|NOT COMPLETED|Stage 2A||0
9775712|NCT00467779|10881465|FG006|NOT COMPLETED|Stage 2A||0
9775713|NCT00467779|10881466|FG007|NOT COMPLETED|Stage 2A||0
9775714|NCT00467779|10881467|FG008|NOT COMPLETED|Stage 2A||0
9775715|NCT00467779|10881468|FG009|NOT COMPLETED|Stage 2A||0
9775716|NCT00467779|10881469|FG010|NOT COMPLETED|Stage 2A||0
9775717|NCT00467779|10881470|FG011|NOT COMPLETED|Stage 2A||0
9775718|NCT00467779|10881471|FG012|NOT COMPLETED|Stage 2A||0
9775719|NCT00467779|10881472|FG013|NOT COMPLETED|Stage 2A||21
9775720|NCT00467779|10881473|FG014|NOT COMPLETED|Stage 2A||0
9775721|NCT00467779|10881459|FG000|STARTED|Stage 3||0
9775722|NCT00467779|10881460|FG001|STARTED|Stage 3||0
9775723|NCT00467779|10881461|FG002|STARTED|Stage 3||0
9775724|NCT00467779|10881462|FG003|STARTED|Stage 3||0
9775725|NCT00467779|10881463|FG004|STARTED|Stage 3||0
9775726|NCT00467779|10881464|FG005|STARTED|Stage 3||0
9775727|NCT00467779|10881465|FG006|STARTED|Stage 3||0
9775728|NCT00467779|10881466|FG007|STARTED|Stage 3||0
9775729|NCT00467779|10881467|FG008|STARTED|Stage 3||0
9775730|NCT00467779|10881468|FG009|STARTED|Stage 3||0
9775731|NCT00467779|10881469|FG010|STARTED|Stage 3||0
9775732|NCT00467779|10881470|FG011|STARTED|Stage 3||0
9775733|NCT00467779|10881471|FG012|STARTED|Stage 3||0
9775734|NCT00467779|10881472|FG013|STARTED|Stage 3||0
9775735|NCT00467779|10881473|FG014|STARTED|Stage 3||20
9775736|NCT00467779|10881459|FG000|COMPLETED|Stage 3||0
9775737|NCT00467779|10881460|FG001|COMPLETED|Stage 3||0
9775738|NCT00467779|10881461|FG002|COMPLETED|Stage 3||0
9775739|NCT00467779|10881462|FG003|COMPLETED|Stage 3||0
9775740|NCT00467779|10881463|FG004|COMPLETED|Stage 3||0
9775741|NCT00467779|10881464|FG005|COMPLETED|Stage 3||0
9775742|NCT00467779|10881465|FG006|COMPLETED|Stage 3||0
9775743|NCT00467779|10881466|FG007|COMPLETED|Stage 3||0
9775744|NCT00467779|10881467|FG008|COMPLETED|Stage 3||0
9775745|NCT00467779|10881468|FG009|COMPLETED|Stage 3||0
9775746|NCT00467779|10881469|FG010|COMPLETED|Stage 3||0
9775747|NCT00467779|10881470|FG011|COMPLETED|Stage 3||0
9775748|NCT00467779|10881471|FG012|COMPLETED|Stage 3||0
9775749|NCT00467779|10881472|FG013|COMPLETED|Stage 3||0
9775750|NCT00467779|10881473|FG014|COMPLETED|Stage 3||3
9775751|NCT00467779|10881459|FG000|NOT COMPLETED|Stage 3||0
9775752|NCT00467779|10881460|FG001|NOT COMPLETED|Stage 3||0
9775753|NCT00467779|10881461|FG002|NOT COMPLETED|Stage 3||0
9775754|NCT00467779|10881462|FG003|NOT COMPLETED|Stage 3||0
9775755|NCT00467779|10881463|FG004|NOT COMPLETED|Stage 3||0
9775756|NCT00467779|10881464|FG005|NOT COMPLETED|Stage 3||0
9775757|NCT00467779|10881465|FG006|NOT COMPLETED|Stage 3||0
9775758|NCT00467779|10881466|FG007|NOT COMPLETED|Stage 3||0
10014465|NCT01800890|11137649|FG006|COMPLETED|Test Period 1||3
9775759|NCT00467779|10881467|FG008|NOT COMPLETED|Stage 3||0
9775760|NCT00467779|10881468|FG009|NOT COMPLETED|Stage 3||0
9775761|NCT00467779|10881469|FG010|NOT COMPLETED|Stage 3||0
9775762|NCT00467779|10881470|FG011|NOT COMPLETED|Stage 3||0
9775763|NCT00467779|10881471|FG012|NOT COMPLETED|Stage 3||0
9775764|NCT00467779|10881472|FG013|NOT COMPLETED|Stage 3||0
9775765|NCT00467779|10881473|FG014|NOT COMPLETED|Stage 3||17
9775766|NCT00467818|10881513|FG000|STARTED|Overall Study||9
9775767|NCT00467818|10881514|FG001|STARTED|Overall Study||8
9775768|NCT00467818|10881513|FG000|COMPLETED|Overall Study||6
9775769|NCT00467818|10881514|FG001|COMPLETED|Overall Study||6
9775770|NCT00467818|10881513|FG000|NOT COMPLETED|Overall Study||3
9775771|NCT00467818|10881514|FG001|NOT COMPLETED|Overall Study||2
9775772|NCT00467831|10881522|FG000|STARTED|Overall Study||3
9775773|NCT00467831|10881522|FG000|COMPLETED|Overall Study||0
9775774|NCT00467831|10881522|FG000|NOT COMPLETED|Overall Study||3
9775775|NCT00467844|10881529|FG000|STARTED|Overall Study||53
9775776|NCT00467844|10881530|FG001|STARTED|Overall Study||54
9775777|NCT00467844|10881531|FG002|STARTED|Overall Study||52
9775778|NCT00467844|10881529|FG000|COMPLETED|Overall Study||34
9775779|NCT00467844|10881530|FG001|COMPLETED|Overall Study||34
9775780|NCT00467844|10881531|FG002|COMPLETED|Overall Study||38
9775781|NCT00467844|10881529|FG000|NOT COMPLETED|Overall Study||19
9775782|NCT00467844|10881530|FG001|NOT COMPLETED|Overall Study||20
9775783|NCT00467844|10881531|FG002|NOT COMPLETED|Overall Study||14
9775784|NCT00467857|10881544|FG000|STARTED|Overall Study||146
9775785|NCT00467857|10881545|FG001|STARTED|Overall Study||147
9775786|NCT00467857|10881544|FG000|COMPLETED|Overall Study||143
9775787|NCT00467857|10881545|FG001|COMPLETED|Overall Study||139
9775788|NCT00467857|10881544|FG000|NOT COMPLETED|Overall Study||3
9775789|NCT00467857|10881545|FG001|NOT COMPLETED|Overall Study||8
9775790|NCT00467870|10881557|FG000|STARTED|Overall Study||120
9775791|NCT00467870|10881558|FG001|STARTED|Overall Study||117
9775792|NCT00467870|10881559|FG002|STARTED|Overall Study||22
9775793|NCT00467870|10881560|FG003|STARTED|Overall Study||112
9775794|NCT00467870|10881561|FG004|STARTED|Overall Study||130
9775795|NCT00467870|10881562|FG005|STARTED|Overall Study||23
9775796|NCT00467870|10881557|FG000|COMPLETED|Overall Study||75
9775797|NCT00467870|10881558|FG001|COMPLETED|Overall Study||74
9775798|NCT00467870|10881559|FG002|COMPLETED|Overall Study||18
9775799|NCT00467870|10881560|FG003|COMPLETED|Overall Study||79
9775800|NCT00467870|10881561|FG004|COMPLETED|Overall Study||93
9775801|NCT00467870|10881562|FG005|COMPLETED|Overall Study||21
9775802|NCT00467870|10881557|FG000|NOT COMPLETED|Overall Study||45
9775803|NCT00467870|10881558|FG001|NOT COMPLETED|Overall Study||43
9775804|NCT00467870|10881559|FG002|NOT COMPLETED|Overall Study||4
9775805|NCT00467870|10881560|FG003|NOT COMPLETED|Overall Study||33
9775806|NCT00467870|10881561|FG004|NOT COMPLETED|Overall Study||37
9775807|NCT00467870|10881562|FG005|NOT COMPLETED|Overall Study||2
9775808|NCT00467896|10881572|FG000|STARTED|Overall Study||62
9775809|NCT00467896|10881572|FG000|COMPLETED|Overall Study||11
9775810|NCT00467896|10881572|FG000|NOT COMPLETED|Overall Study||51
9775811|NCT00467961|10881578|FG000|STARTED|Overall Study||31
9775812|NCT00467961|10881578|FG000|COMPLETED|Overall Study||24
9775813|NCT00467961|10881578|FG000|NOT COMPLETED|Overall Study||7
9775814|NCT00468052|10881584|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
9775815|NCT00468052|10881585|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
9775816|NCT00468052|10881584|FG000|Target Enrollment|Overall Study||70
9775817|NCT00468052|10881585|FG001|Target Enrollment|Overall Study||70
9775818|NCT00468052|10881584|FG000|COMPLETED|Overall Study||61
9775819|NCT00468052|10881585|FG001|COMPLETED|Overall Study||61
9775820|NCT00468052|10881584|FG000|NOT COMPLETED|Overall Study||7
9775821|NCT00468052|10881585|FG001|NOT COMPLETED|Overall Study||8
9775822|NCT00468104|10881593|FG000|STARTED|First Intervention||54
9775823|NCT00468104|10881594|FG001|STARTED|First Intervention||46
9775824|NCT00468104|10881593|FG000|COMPLETED|First Intervention||45
9775825|NCT00468104|10881594|FG001|COMPLETED|First Intervention||45
9775826|NCT00468104|10881593|FG000|NOT COMPLETED|First Intervention||9
9775827|NCT00468104|10881594|FG001|NOT COMPLETED|First Intervention||1
9775828|NCT00468104|10881593|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
9775829|NCT00468104|10881594|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
9775830|NCT00468104|10881593|FG000|COMPLETED|Second Intervention||3
9775831|NCT00468104|10881594|FG001|COMPLETED|Second Intervention||37
9775832|NCT00468104|10881593|FG000|NOT COMPLETED|Second Intervention||5
9775833|NCT00468104|10881594|FG001|NOT COMPLETED|Second Intervention||4
9775834|NCT00468143|10881603|FG000|STARTED|First Intervention (3 Weeks)||31
9775835|NCT00468143|10881604|FG001|STARTED|First Intervention (3 Weeks)||31
9775836|NCT00468143|10881603|FG000|COMPLETED|First Intervention (3 Weeks)||28
9775837|NCT00468143|10881604|FG001|COMPLETED|First Intervention (3 Weeks)||27
9775838|NCT00468143|10881603|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3
9775839|NCT00468143|10881604|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4
9775840|NCT00468143|10881603|FG000|STARTED|Second Intervention (3 Weeks)||28
9775841|NCT00468143|10881604|FG001|STARTED|Second Intervention (3 Weeks)||27
9775842|NCT00468143|10881603|FG000|COMPLETED|Second Intervention (3 Weeks)||25
9775843|NCT00468143|10881604|FG001|COMPLETED|Second Intervention (3 Weeks)||24
9957082|NCT01449370|11076257|FG022|COMPLETED|Overall Study||0
9775844|NCT00468143|10881603|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3
9775845|NCT00468143|10881604|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3
9775846|NCT00468169|10881612|FG000|STARTED|Overall Study||57
9775847|NCT00468169|10881613|FG001|STARTED|Overall Study||53
9775848|NCT00468169|10881612|FG000|COMPLETED|Overall Study||56
9775849|NCT00468169|10881613|FG001|COMPLETED|Overall Study||53
9775850|NCT00468169|10881612|FG000|NOT COMPLETED|Overall Study||1
9775851|NCT00468169|10881613|FG001|NOT COMPLETED|Overall Study||0
9775852|NCT00468208|10881621|FG000|STARTED|Overall Study||20
9775853|NCT00468208|10881621|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20
9775854|NCT00468208|10881621|FG000|NOT COMPLETED|Overall Study||0
9775855|NCT00468286|10881627|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
9775856|NCT00468286|10881628|FG001|STARTED|Overall Study||66
9775857|NCT00468286|10881627|FG000|COMPLETED|Overall Study||60
9775858|NCT00468286|10881628|FG001|COMPLETED|Overall Study||54
9775859|NCT00468286|10881627|FG000|NOT COMPLETED|Overall Study||7
9775860|NCT00468286|10881628|FG001|NOT COMPLETED|Overall Study||12
9775861|NCT00468299|10881636|FG000|STARTED|Overall Study||9
9775862|NCT00468299|10881637|FG001|STARTED|Overall Study||8
9775863|NCT00468299|10881636|FG000|COMPLETED|Overall Study||9
9775864|NCT00468299|10881637|FG001|COMPLETED|Overall Study||7
9775865|NCT00468299|10881636|FG000|NOT COMPLETED|Overall Study||0
9775866|NCT00468299|10881637|FG001|NOT COMPLETED|Overall Study||1
9775867|NCT00468481|10881647|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
9775868|NCT00468481|10881648|FG001|STARTED|Overall Study||94
9775869|NCT00468481|10881647|FG000|Subjects Treated|Overall Study||285
9775870|NCT00468481|10881648|FG001|Subjects Treated|Overall Study||94
9775871|NCT00468481|10881647|FG000|COMPLETED|Overall Study||203
9775872|NCT00468481|10881648|FG001|COMPLETED|Overall Study||70
9775873|NCT00468481|10881647|FG000|NOT COMPLETED|Overall Study||88
9775874|NCT00468481|10881648|FG001|NOT COMPLETED|Overall Study||24
9775875|NCT00468546|10881656|FG000|STARTED|Week 24 Analysis||208
9775876|NCT00468546|10881657|FG001|STARTED|Week 24 Analysis||308
9775877|NCT00468546|10881656|FG000|COMPLETED|Week 24 Analysis||111
9775878|NCT00468546|10881657|FG001|COMPLETED|Week 24 Analysis||253
9775879|NCT00468546|10881656|FG000|NOT COMPLETED|Week 24 Analysis||97
9775880|NCT00468546|10881657|FG001|NOT COMPLETED|Week 24 Analysis||55
9775881|NCT00468546|10881656|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
9775882|NCT00468546|10881657|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
9775883|NCT00468546|10881656|FG000|COMPLETED|Week 24 to Week 104 Analysis||103
9775884|NCT00468546|10881657|FG001|COMPLETED|Week 24 to Week 104 Analysis||83
9775885|NCT00468546|10881656|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105
9775886|NCT00468546|10881657|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225
9775887|NCT00468559|10881665|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
9775888|NCT00468559|10881666|FG001|STARTED|Open-label Treatment Phase||0
9775889|NCT00468559|10881667|FG002|STARTED|Open-label Treatment Phase||0
9775890|NCT00468559|10881665|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
9775891|NCT00468559|10881666|FG001|COMPLETED|Open-label Treatment Phase||0
9775892|NCT00468559|10881667|FG002|COMPLETED|Open-label Treatment Phase||0
9775893|NCT00468559|10881665|FG000|NOT COMPLETED|Open-label Treatment Phase||18
9775894|NCT00468559|10881666|FG001|NOT COMPLETED|Open-label Treatment Phase||0
9775895|NCT00468559|10881667|FG002|NOT COMPLETED|Open-label Treatment Phase||0
9775896|NCT00468559|10881665|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0
9775897|NCT00468559|10881666|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39
9775898|NCT00468559|10881667|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41
9775899|NCT00468559|10881665|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
9775900|NCT00468559|10881666|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
9775901|NCT00468559|10881667|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
9775902|NCT00468559|10881665|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
9775903|NCT00468559|10881666|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
9775904|NCT00468559|10881667|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
9775905|NCT00468585|10881679|FG000|STARTED|Overall Study||4
9775906|NCT00468585|10881680|FG001|STARTED|Overall Study||3
9775907|NCT00468585|10881681|FG002|STARTED|Overall Study||50
9775908|NCT00468585|10881682|FG003|STARTED|Overall Study||6
9775909|NCT00468585|10881679|FG000|COMPLETED|Overall Study||3
9775910|NCT00468585|10881680|FG001|COMPLETED|Overall Study||3
9775911|NCT00468585|10881681|FG002|COMPLETED|Overall Study||45
9775912|NCT00468585|10881682|FG003|COMPLETED|Overall Study||5
9775913|NCT00468585|10881679|FG000|NOT COMPLETED|Overall Study||1
9775914|NCT00468585|10881680|FG001|NOT COMPLETED|Overall Study||0
9775915|NCT00468585|10881681|FG002|NOT COMPLETED|Overall Study||5
9775916|NCT00468585|10881682|FG003|NOT COMPLETED|Overall Study||1
9775917|NCT00468650|10881692|FG000|STARTED|Overall Study||117
9775918|NCT00468650|10881692|FG000|COMPLETED|Overall Study||110
9775919|NCT00468650|10881692|FG000|NOT COMPLETED|Overall Study||7
9775920|NCT00468676|10881699|FG000|STARTED|Overall Study||108
9775921|NCT00468676|10881700|FG001|STARTED|Overall Study||106
9775922|NCT00468676|10881699|FG000|COMPLETED|Overall Study||92
9775923|NCT00468676|10881700|FG001|COMPLETED|Overall Study||94
9775924|NCT00468676|10881699|FG000|NOT COMPLETED|Overall Study||16
9775925|NCT00468676|10881700|FG001|NOT COMPLETED|Overall Study||12
9775926|NCT00468728|10881710|FG000|STARTED|Enrollment||264
9775927|NCT00468728|10881711|FG001|STARTED|Enrollment||271
9775928|NCT00468728|10881710|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
9775929|NCT00468728|10881711|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
10014466|NCT01800890|11137650|FG007|COMPLETED|Test Period 1||3
10014467|NCT01800890|11137651|FG008|COMPLETED|Test Period 1||3
10014468|NCT01800890|11137643|FG000|NOT COMPLETED|Test Period 1||0
10014469|NCT01800890|11137644|FG001|NOT COMPLETED|Test Period 1||0
10014470|NCT01800890|11137645|FG002|NOT COMPLETED|Test Period 1||0
10014471|NCT01800890|11137646|FG003|NOT COMPLETED|Test Period 1||1
10014472|NCT01800890|11137647|FG004|NOT COMPLETED|Test Period 1||0
10014473|NCT01800890|11137648|FG005|NOT COMPLETED|Test Period 1||0
10014474|NCT01800890|11137649|FG006|NOT COMPLETED|Test Period 1||0
10014475|NCT01800890|11137650|FG007|NOT COMPLETED|Test Period 1||0
10014476|NCT01800890|11137651|FG008|NOT COMPLETED|Test Period 1||0
10014477|NCT01800890|11137643|FG000|STARTED|Test Period 2||3
10014478|NCT01800890|11137644|FG001|STARTED|Test Period 2||3
10014479|NCT01800890|11137645|FG002|STARTED|Test Period 2||3
10014480|NCT01800890|11137646|FG003|STARTED|Test Period 2||2
10014481|NCT01800890|11137647|FG004|STARTED|Test Period 2||4
10014482|NCT01800890|11137648|FG005|STARTED|Test Period 2||4
10014483|NCT01800890|11137649|FG006|STARTED|Test Period 2||3
10014484|NCT01800890|11137650|FG007|STARTED|Test Period 2||3
10014485|NCT01800890|11137651|FG008|STARTED|Test Period 2||3
10014486|NCT01800890|11137643|FG000|COMPLETED|Test Period 2||3
10014487|NCT01800890|11137644|FG001|COMPLETED|Test Period 2||3
10014488|NCT01800890|11137645|FG002|COMPLETED|Test Period 2||3
10014489|NCT01800890|11137646|FG003|COMPLETED|Test Period 2||2
10014490|NCT01800890|11137647|FG004|COMPLETED|Test Period 2||4
10014491|NCT01800890|11137648|FG005|COMPLETED|Test Period 2||4
10014492|NCT01800890|11137649|FG006|COMPLETED|Test Period 2||3
10014493|NCT01800890|11137650|FG007|COMPLETED|Test Period 2||3
10014494|NCT01800890|11137651|FG008|COMPLETED|Test Period 2||3
10014495|NCT01800890|11137643|FG000|NOT COMPLETED|Test Period 2||0
10014496|NCT01800890|11137644|FG001|NOT COMPLETED|Test Period 2||0
10014497|NCT01800890|11137645|FG002|NOT COMPLETED|Test Period 2||0
10014498|NCT01800890|11137646|FG003|NOT COMPLETED|Test Period 2||0
10014499|NCT01800890|11137647|FG004|NOT COMPLETED|Test Period 2||0
10014500|NCT01800890|11137648|FG005|NOT COMPLETED|Test Period 2||0
10014501|NCT01800890|11137649|FG006|NOT COMPLETED|Test Period 2||0
10014502|NCT01800890|11137650|FG007|NOT COMPLETED|Test Period 2||0
10014503|NCT01800890|11137651|FG008|NOT COMPLETED|Test Period 2||0
10014504|NCT01800890|11137643|FG000|STARTED|Test Period 3||3
10014505|NCT01800890|11137644|FG001|STARTED|Test Period 3||3
10014506|NCT01800890|11137645|FG002|STARTED|Test Period 3||3
10014507|NCT01800890|11137646|FG003|STARTED|Test Period 3||2
10014508|NCT01800890|11137647|FG004|STARTED|Test Period 3||4
10014509|NCT01800890|11137648|FG005|STARTED|Test Period 3||4
10014510|NCT01800890|11137649|FG006|STARTED|Test Period 3||3
10014511|NCT01800890|11137650|FG007|STARTED|Test Period 3||3
10014512|NCT01800890|11137651|FG008|STARTED|Test Period 3||3
10014513|NCT01800890|11137643|FG000|COMPLETED|Test Period 3||3
10014514|NCT01800890|11137644|FG001|COMPLETED|Test Period 3||3
10014515|NCT01800890|11137645|FG002|COMPLETED|Test Period 3||3
10014516|NCT01800890|11137646|FG003|COMPLETED|Test Period 3||2
10014517|NCT01800890|11137647|FG004|COMPLETED|Test Period 3||4
10014518|NCT01800890|11137648|FG005|COMPLETED|Test Period 3||4
10014519|NCT01800890|11137649|FG006|COMPLETED|Test Period 3||3
10014520|NCT01800890|11137650|FG007|COMPLETED|Test Period 3||3
10014521|NCT01800890|11137651|FG008|COMPLETED|Test Period 3||3
10014522|NCT01800890|11137643|FG000|NOT COMPLETED|Test Period 3||0
10014523|NCT01800890|11137644|FG001|NOT COMPLETED|Test Period 3||0
10014524|NCT01800890|11137645|FG002|NOT COMPLETED|Test Period 3||0
10014525|NCT01800890|11137646|FG003|NOT COMPLETED|Test Period 3||0
9775930|NCT00468728|10881710|FG000|NOT COMPLETED|Enrollment||4
9775931|NCT00468728|10881711|FG001|NOT COMPLETED|Enrollment||7
9775932|NCT00468728|10881710|FG000|STARTED|Treatment||260
9775933|NCT00468728|10881711|FG001|STARTED|Treatment||264
9775934|NCT00468728|10881710|FG000|COMPLETED|Treatment||256
9775935|NCT00468728|10881711|FG001|COMPLETED|Treatment||253
9775936|NCT00468728|10881710|FG000|NOT COMPLETED|Treatment||4
9775937|NCT00468728|10881711|FG001|NOT COMPLETED|Treatment||11
10014526|NCT01800890|11137647|FG004|NOT COMPLETED|Test Period 3||0
10014527|NCT01800890|11137648|FG005|NOT COMPLETED|Test Period 3||0
10014528|NCT01800890|11137649|FG006|NOT COMPLETED|Test Period 3||0
10014529|NCT01800890|11137650|FG007|NOT COMPLETED|Test Period 3||0
10014530|NCT01800890|11137651|FG008|NOT COMPLETED|Test Period 3||0
9775938|NCT00468728|10881710|FG000|STARTED|Follow-up||256
9775939|NCT00468728|10881711|FG001|STARTED|Follow-up||253
9775940|NCT00468728|10881710|FG000|COMPLETED|Follow-up||222
9775941|NCT00468728|10881711|FG001|COMPLETED|Follow-up||222
10014531|NCT01800903|11137661|FG000|STARTED|First Test Period||7
10014532|NCT01800903|11137662|FG001|STARTED|First Test Period||6
10014533|NCT01800903|11137663|FG002|STARTED|First Test Period||4
10014534|NCT01800903|11137664|FG003|STARTED|First Test Period||7
10014535|NCT01800903|11137665|FG004|STARTED|First Test Period||6
10014536|NCT01800903|11137666|FG005|STARTED|First Test Period||6
10014537|NCT01800903|11137661|FG000|COMPLETED|First Test Period||7
10014538|NCT01800903|11137662|FG001|COMPLETED|First Test Period||6
10014539|NCT01800903|11137663|FG002|COMPLETED|First Test Period||4
10014540|NCT01800903|11137664|FG003|COMPLETED|First Test Period||7
9775942|NCT00468728|10881710|FG000|NOT COMPLETED|Follow-up||34
9775943|NCT00468728|10881711|FG001|NOT COMPLETED|Follow-up||31
9775944|NCT00468819|10881722|FG000|STARTED|Overall Study|Enrolled participants|48
9775945|NCT00468819|10881723|FG001|STARTED|Overall Study|Enrolled participants|44
9775946|NCT00468819|10881724|FG002|STARTED|Overall Study|Enrolled participants|48
9775947|NCT00468819|10881722|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
9775948|NCT00468819|10881723|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
9775949|NCT00468819|10881724|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
9775950|NCT00468819|10881722|FG000|COMPLETED|Overall Study||42
9775951|NCT00468819|10881723|FG001|COMPLETED|Overall Study||44
9775952|NCT00468819|10881724|FG002|COMPLETED|Overall Study||46
9775953|NCT00468819|10881722|FG000|NOT COMPLETED|Overall Study||6
9775954|NCT00468819|10881723|FG001|NOT COMPLETED|Overall Study||0
9775955|NCT00468819|10881724|FG002|NOT COMPLETED|Overall Study||2
9775956|NCT00468845|10881737|FG000|STARTED|Overall Study||162
9775957|NCT00468845|10881738|FG001|STARTED|Overall Study||170
9775958|NCT00468845|10881739|FG002|STARTED|Overall Study||169
9775959|NCT00468845|10881737|FG000|Received Treatment|Overall Study||161
9775960|NCT00468845|10881738|FG001|Received Treatment|Overall Study||166
9775961|NCT00468845|10881739|FG002|Received Treatment|Overall Study||167
9775962|NCT00468845|10881737|FG000|COMPLETED|Overall Study||141
9775963|NCT00468845|10881738|FG001|COMPLETED|Overall Study||136
9775964|NCT00468845|10881739|FG002|COMPLETED|Overall Study||139
9775965|NCT00468845|10881737|FG000|NOT COMPLETED|Overall Study||21
9775966|NCT00468845|10881738|FG001|NOT COMPLETED|Overall Study||34
9775967|NCT00468845|10881739|FG002|NOT COMPLETED|Overall Study||30
9775968|NCT00468858|10881750|FG000|STARTED|Overall Study||211
9775969|NCT00468858|10881751|FG001|STARTED|Overall Study||212
9775970|NCT00468858|10881752|FG002|STARTED|Overall Study||213
9775971|NCT00468858|10881750|FG000|COMPLETED|Overall Study||202
9775972|NCT00468858|10881751|FG001|COMPLETED|Overall Study||202
9775973|NCT00468858|10881752|FG002|COMPLETED|Overall Study||199
9775974|NCT00468858|10881750|FG000|NOT COMPLETED|Overall Study||9
9775975|NCT00468858|10881751|FG001|NOT COMPLETED|Overall Study||10
9775976|NCT00468858|10881752|FG002|NOT COMPLETED|Overall Study||14
9775977|NCT00468910|10881816|FG000|STARTED|Overall Study||40
9775978|NCT00468910|10881817|FG001|STARTED|Overall Study||39
9775979|NCT00468910|10881816|FG000|Randomization|Overall Study||40
9775980|NCT00468910|10881817|FG001|Randomization|Overall Study||39
9775981|NCT00468910|10881816|FG000|Treatment|Overall Study||36
9775982|NCT00468910|10881817|FG001|Treatment|Overall Study||36
9775983|NCT00468910|10881816|FG000|Post-Treatment Biopsy|Overall Study||36
9775984|NCT00468910|10881817|FG001|Post-Treatment Biopsy|Overall Study||36
9775985|NCT00468910|10881816|FG000|Follow-up|Overall Study||36
9775986|NCT00468910|10881817|FG001|Follow-up|Overall Study||36
9775987|NCT00468910|10881816|FG000|COMPLETED|Overall Study||36
9775988|NCT00468910|10881817|FG001|COMPLETED|Overall Study||36
9775989|NCT00468910|10881816|FG000|NOT COMPLETED|Overall Study||4
9775990|NCT00468910|10881817|FG001|NOT COMPLETED|Overall Study||3
9775991|NCT00469014|10881828|FG000|STARTED|Initial Phase Randomization||5
9775992|NCT00469014|10881829|FG001|STARTED|Initial Phase Randomization||4
9775993|NCT00469014|10881830|FG002|STARTED|Initial Phase Randomization||5
9775994|NCT00469014|10881831|FG003|STARTED|Initial Phase Randomization||6
9775995|NCT00469014|10881828|FG000|COMPLETED|Initial Phase Randomization||4
9775996|NCT00469014|10881829|FG001|COMPLETED|Initial Phase Randomization||3
9775997|NCT00469014|10881830|FG002|COMPLETED|Initial Phase Randomization||4
9775998|NCT00469014|10881831|FG003|COMPLETED|Initial Phase Randomization||5
9775999|NCT00469014|10881828|FG000|NOT COMPLETED|Initial Phase Randomization||1
9776000|NCT00469014|10881829|FG001|NOT COMPLETED|Initial Phase Randomization||1
9776001|NCT00469014|10881830|FG002|NOT COMPLETED|Initial Phase Randomization||1
9776002|NCT00469014|10881831|FG003|NOT COMPLETED|Initial Phase Randomization||1
9776003|NCT00469014|10881828|FG000|STARTED|Adaptive Randomization||13
9776004|NCT00469014|10881829|FG001|STARTED|Adaptive Randomization||3
9776005|NCT00469014|10881830|FG002|STARTED|Adaptive Randomization||24
9776006|NCT00469014|10881831|FG003|STARTED|Adaptive Randomization||11
9776007|NCT00469014|10881828|FG000|COMPLETED|Adaptive Randomization||12
9776008|NCT00469014|10881829|FG001|COMPLETED|Adaptive Randomization||2
9776009|NCT00469014|10881830|FG002|COMPLETED|Adaptive Randomization||23
9776010|NCT00469014|10881831|FG003|COMPLETED|Adaptive Randomization||10
9776011|NCT00469014|10881828|FG000|NOT COMPLETED|Adaptive Randomization||1
9776012|NCT00469014|10881829|FG001|NOT COMPLETED|Adaptive Randomization||1
9776013|NCT00469014|10881830|FG002|NOT COMPLETED|Adaptive Randomization||1
9776014|NCT00469014|10881831|FG003|NOT COMPLETED|Adaptive Randomization||1
9776015|NCT00469079|10881844|FG000|STARTED|Overall Study||27
9776016|NCT00469079|10881845|FG001|STARTED|Overall Study||52
9776017|NCT00469079|10881846|FG002|STARTED|Overall Study||51
9776018|NCT00469079|10881844|FG000|COMPLETED|Overall Study||18
9776019|NCT00469079|10881845|FG001|COMPLETED|Overall Study||30
9776020|NCT00469079|10881846|FG002|COMPLETED|Overall Study||32
9776021|NCT00469079|10881844|FG000|NOT COMPLETED|Overall Study||9
9776022|NCT00469079|10881845|FG001|NOT COMPLETED|Overall Study||22
9776023|NCT00469079|10881846|FG002|NOT COMPLETED|Overall Study||19
9776024|NCT00469092|10881862|FG000|STARTED|Overall Study||239
9776025|NCT00469092|10881863|FG001|STARTED|Overall Study||241
9776026|NCT00469092|10881862|FG000|Exposed to Study Drug|Overall Study||231
9776027|NCT00469092|10881863|FG001|Exposed to Study Drug|Overall Study||238
9776028|NCT00469092|10881862|FG000|COMPLETED|Overall Study||213
9776029|NCT00469092|10881863|FG001|COMPLETED|Overall Study||220
9776030|NCT00469092|10881862|FG000|NOT COMPLETED|Overall Study||26
9776031|NCT00469092|10881863|FG001|NOT COMPLETED|Overall Study||21
9776032|NCT00469144|10881871|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
9776033|NCT00469144|10881872|FG001|STARTED|Overall Study||111
9776034|NCT00469144|10881871|FG000|COMPLETED|Overall Study||108
9776035|NCT00469144|10881872|FG001|COMPLETED|Overall Study||105
9776036|NCT00469144|10881871|FG000|NOT COMPLETED|Overall Study||6
9776037|NCT00469144|10881872|FG001|NOT COMPLETED|Overall Study||6
9776038|NCT00469209|10881885|FG000|STARTED|Overall Study||20
9776039|NCT00469209|10881886|FG001|STARTED|Overall Study||20
9776040|NCT00469209|10881887|FG002|STARTED|Overall Study||20
9776041|NCT00469209|10881885|FG000|COMPLETED|Overall Study||19
9776042|NCT00469209|10881886|FG001|COMPLETED|Overall Study||20
9776043|NCT00469209|10881887|FG002|COMPLETED|Overall Study||19
9776044|NCT00469209|10881885|FG000|NOT COMPLETED|Overall Study||1
9776045|NCT00469209|10881886|FG001|NOT COMPLETED|Overall Study||0
9776046|NCT00469209|10881887|FG002|NOT COMPLETED|Overall Study||1
9776047|NCT00469274|10881897|FG000|STARTED|Overall Study||44
9776048|NCT00469274|10881898|FG001|STARTED|Overall Study||42
9776049|NCT00469274|10881897|FG000|COMPLETED|Overall Study||44
9776050|NCT00469274|10881898|FG001|COMPLETED|Overall Study||42
9776051|NCT00469274|10881897|FG000|NOT COMPLETED|Overall Study||0
9776052|NCT00469274|10881898|FG001|NOT COMPLETED|Overall Study||0
9776053|NCT00469391|10881906|FG000|STARTED|Overall Study||27
9776054|NCT00469391|10881907|FG001|STARTED|Overall Study||29
9776055|NCT00469391|10881906|FG000|Discontinued Prior to Procedure|Overall Study||2
9776056|NCT00469391|10881907|FG001|Discontinued Prior to Procedure|Overall Study||3
9776057|NCT00469391|10881906|FG000|Unsuccessful Implant Procedure|Overall Study||4
9776058|NCT00469391|10881907|FG001|Unsuccessful Implant Procedure|Overall Study||0
9776059|NCT00469391|10881906|FG000|Adverse Event|Overall Study||8
9776060|NCT00469391|10881907|FG001|Adverse Event|Overall Study||0
9776061|NCT00469391|10881906|FG000|Lost to Follow up|Overall Study||0
9776062|NCT00469391|10881907|FG001|Lost to Follow up|Overall Study||1
9776063|NCT00469391|10881906|FG000|Patient Preference|Overall Study||0
9776064|NCT00469391|10881907|FG001|Patient Preference|Overall Study||1
9776065|NCT00469391|10881906|FG000|COMPLETED|Overall Study||13
9776066|NCT00469391|10881907|FG001|COMPLETED|Overall Study||24
9776067|NCT00469391|10881906|FG000|NOT COMPLETED|Overall Study||14
9776068|NCT00469391|10881907|FG001|NOT COMPLETED|Overall Study||5
9776069|NCT00469456|10881915|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
9776070|NCT00469456|10881916|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
9776071|NCT00469456|10881915|FG000|COMPLETED|Overall Study||120
9776072|NCT00469456|10881916|FG001|COMPLETED|Overall Study||131
9776073|NCT00469456|10881915|FG000|NOT COMPLETED|Overall Study||9
10014541|NCT01800903|11137665|FG004|COMPLETED|First Test Period||6
10014542|NCT01800903|11137666|FG005|COMPLETED|First Test Period||6
10014543|NCT01800903|11137661|FG000|NOT COMPLETED|First Test Period||0
10014544|NCT01800903|11137662|FG001|NOT COMPLETED|First Test Period||0
10014545|NCT01800903|11137663|FG002|NOT COMPLETED|First Test Period||0
9776074|NCT00469456|10881916|FG001|NOT COMPLETED|Overall Study||4
9776075|NCT00469508|10881924|FG000|STARTED|Overall Study||34
9776076|NCT00469508|10881925|FG001|STARTED|Overall Study||37
9776077|NCT00469508|10881924|FG000|COMPLETED|Overall Study||14
9776078|NCT00469508|10881925|FG001|COMPLETED|Overall Study||13
9776079|NCT00469508|10881924|FG000|NOT COMPLETED|Overall Study||20
9776080|NCT00469508|10881925|FG001|NOT COMPLETED|Overall Study||24
9776081|NCT00469833|10881931|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
9776082|NCT00469833|10881931|FG000|COMPLETED|Overall Study||15
9776083|NCT00469833|10881931|FG000|NOT COMPLETED|Overall Study||2
9776084|NCT00469859|10881943|FG000|STARTED|Overall Study||6
9776085|NCT00469859|10881944|FG001|STARTED|Overall Study||8
9776086|NCT00469859|10881943|FG000|COMPLETED|Overall Study||6
9776087|NCT00469859|10881944|FG001|COMPLETED|Overall Study||6
9776088|NCT00469859|10881943|FG000|NOT COMPLETED|Overall Study||0
9776089|NCT00469859|10881944|FG001|NOT COMPLETED|Overall Study||2
9776090|NCT00469898|10881950|FG000|STARTED|Overall Study||50
9776091|NCT00469898|10881950|FG000|COMPLETED|Overall Study||25
9776092|NCT00469898|10881950|FG000|NOT COMPLETED|Overall Study||25
9776093|NCT00469911|10881956|FG000|STARTED|Overall Study||8
9776094|NCT00469911|10881957|FG001|STARTED|Overall Study||10
9776095|NCT00469911|10881956|FG000|COMPLETED|Overall Study||8
10014546|NCT01800903|11137664|FG003|NOT COMPLETED|First Test Period||0
9776096|NCT00469911|10881957|FG001|COMPLETED|Overall Study||10
9776097|NCT00469911|10881956|FG000|NOT COMPLETED|Overall Study||0
9776098|NCT00469911|10881957|FG001|NOT COMPLETED|Overall Study||0
9776099|NCT00470054|10881962|FG000|STARTED|Overall Study||44
9776100|NCT00470054|10881962|FG000|COMPLETED|Overall Study||43
9776101|NCT00470054|10881962|FG000|NOT COMPLETED|Overall Study||1
9776102|NCT00470093|10881966|FG000|STARTED|Overall Study||2
9776103|NCT00470093|10881966|FG000|COMPLETED|Overall Study||0
9776104|NCT00470093|10881966|FG000|NOT COMPLETED|Overall Study||2
9776105|NCT00470106|10881974|FG000|STARTED|Overall Study||19
9776106|NCT00470106|10881975|FG001|STARTED|Overall Study||24
9776107|NCT00470106|10881976|FG002|STARTED|Overall Study||21
9776108|NCT00470106|10881977|FG003|STARTED|Overall Study||21
9776109|NCT00470106|10881974|FG000|COMPLETED|Overall Study||16
9776110|NCT00470106|10881975|FG001|COMPLETED|Overall Study||19
9776111|NCT00470106|10881976|FG002|COMPLETED|Overall Study||14
9776112|NCT00470106|10881977|FG003|COMPLETED|Overall Study||19
9776113|NCT00470106|10881974|FG000|NOT COMPLETED|Overall Study||3
9776114|NCT00470106|10881975|FG001|NOT COMPLETED|Overall Study||5
9776115|NCT00470106|10881976|FG002|NOT COMPLETED|Overall Study||7
9776116|NCT00470106|10881977|FG003|NOT COMPLETED|Overall Study||2
9776117|NCT00470158|10881996|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
9776118|NCT00470158|10881997|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
9776119|NCT00470158|10881998|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
9776120|NCT00470158|10881999|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
9776121|NCT00470158|10882000|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
9776122|NCT00470158|10881996|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
9776123|NCT00470158|10881997|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
9776124|NCT00470158|10881998|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
9776125|NCT00470158|10881999|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
9776126|NCT00470158|10882000|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
9776127|NCT00470158|10881996|FG000|NOT COMPLETED|Overall Study||8
9776128|NCT00470158|10881997|FG001|NOT COMPLETED|Overall Study||8
9776129|NCT00470158|10881998|FG002|NOT COMPLETED|Overall Study||8
9776130|NCT00470158|10881999|FG003|NOT COMPLETED|Overall Study||5
9776131|NCT00470158|10882000|FG004|NOT COMPLETED|Overall Study||6
9776132|NCT00470184|10882012|FG000|STARTED|Overall Study||41
9776133|NCT00470184|10882012|FG000|Treated With Study Therapy|Overall Study||36
9776134|NCT00470184|10882012|FG000|COMPLETED|Overall Study||19
9776135|NCT00470184|10882012|FG000|NOT COMPLETED|Overall Study||22
9776136|NCT00470262|10882019|FG000|STARTED|Overall Study||15
9776137|NCT00470262|10882020|FG001|STARTED|Overall Study||12
9776138|NCT00470262|10882019|FG000|COMPLETED|Overall Study||13
9776139|NCT00470262|10882020|FG001|COMPLETED|Overall Study||12
9776140|NCT00470262|10882019|FG000|NOT COMPLETED|Overall Study||2
9776141|NCT00470262|10882020|FG001|NOT COMPLETED|Overall Study||0
9776142|NCT00470275|10882027|FG000|STARTED|Overall Study||10
9776143|NCT00470275|10882027|FG000|COMPLETED|Overall Study||0
9776144|NCT00470275|10882027|FG000|NOT COMPLETED|Overall Study||10
9776145|NCT00470301|10882031|FG000|STARTED|Overall Study||60
9776146|NCT00470301|10882031|FG000|COMPLETED|Overall Study||55
9776147|NCT00470301|10882031|FG000|NOT COMPLETED|Overall Study||5
9776148|NCT00470366|10882036|FG000|STARTED|Overall Study||60
9776149|NCT00470366|10882036|FG000|COMPLETED|Overall Study||56
9776150|NCT00470366|10882036|FG000|NOT COMPLETED|Overall Study||4
9776151|NCT00470392|10882042|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
9776152|NCT00470392|10882043|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
9776153|NCT00470392|10882042|FG000|COMPLETED|Overall Study||7
9776154|NCT00470392|10882043|FG001|COMPLETED|Overall Study||2
9776155|NCT00470392|10882042|FG000|NOT COMPLETED|Overall Study||0
9776156|NCT00470392|10882043|FG001|NOT COMPLETED|Overall Study||0
9776157|NCT00470418|10882052|FG000|STARTED|Overall Study||7
9776158|NCT00470418|10882053|FG001|STARTED|Overall Study||3
9776159|NCT00470418|10882052|FG000|COMPLETED|Overall Study||6
9776160|NCT00470418|10882053|FG001|COMPLETED|Overall Study||3
9776161|NCT00470418|10882052|FG000|NOT COMPLETED|Overall Study||1
9776162|NCT00470418|10882053|FG001|NOT COMPLETED|Overall Study||0
9776163|NCT00470470|10882059|FG000|STARTED|Overall Study||30
9776164|NCT00470470|10882059|FG000|COMPLETED|Overall Study||25
9776165|NCT00470470|10882059|FG000|NOT COMPLETED|Overall Study||5
10014547|NCT01800903|11137665|FG004|NOT COMPLETED|First Test Period||0
10014548|NCT01800903|11137666|FG005|NOT COMPLETED|First Test Period||0
10014549|NCT01800903|11137661|FG000|STARTED|Second Test Period||7
10014550|NCT01800903|11137662|FG001|STARTED|Second Test Period||6
9776166|NCT00470535|10882063|FG000|STARTED|Overall Study||18
9776167|NCT00470535|10882063|FG000|COMPLETED|Overall Study||0
9776168|NCT00470535|10882063|FG000|NOT COMPLETED|Overall Study||18
9830041|NCT00762034|10940720|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442
9830042|NCT00762034|10940721|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443
9830043|NCT00762034|10940720|FG000|COMPLETED|Induction Period||294
9830044|NCT00762034|10940721|FG001|COMPLETED|Induction Period||298
9830045|NCT00762034|10940720|FG000|NOT COMPLETED|Induction Period||178
9830046|NCT00762034|10940721|FG001|NOT COMPLETED|Induction Period||169
9830047|NCT00762034|10940720|FG000|STARTED|Maintenance Period||294
9830048|NCT00762034|10940721|FG001|STARTED|Maintenance Period||298
9830049|NCT00762034|10940720|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294
9830050|NCT00762034|10940721|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298
9830051|NCT00762034|10940720|FG000|COMPLETED|Maintenance Period||0
9830052|NCT00762034|10940721|FG001|COMPLETED|Maintenance Period||0
9830053|NCT00762034|10940720|FG000|NOT COMPLETED|Maintenance Period||294
9830054|NCT00762034|10940721|FG001|NOT COMPLETED|Maintenance Period||298
9830055|NCT00762073|10940739|FG000|STARTED|Overall Study||21
9830056|NCT00762073|10940740|FG001|STARTED|Overall Study||21
9830057|NCT00762073|10940741|FG002|STARTED|Overall Study||20
9830058|NCT00762073|10940742|FG003|STARTED|Overall Study||20
9830059|NCT00762073|10940739|FG000|COMPLETED|Overall Study||17
9830060|NCT00762073|10940740|FG001|COMPLETED|Overall Study||17
9776169|NCT00470548|10882069|FG000|STARTED|Overall Study||3
9776170|NCT00470548|10882070|FG001|STARTED|Overall Study||3
9776171|NCT00470548|10882071|FG002|STARTED|Overall Study||6
9776172|NCT00470548|10882072|FG003|STARTED|Overall Study||37
9776173|NCT00470548|10882069|FG000|COMPLETED|Overall Study||3
9776174|NCT00470548|10882070|FG001|COMPLETED|Overall Study||3
9776175|NCT00470548|10882071|FG002|COMPLETED|Overall Study||6
9776176|NCT00470548|10882072|FG003|COMPLETED|Overall Study||37
9776177|NCT00470548|10882069|FG000|NOT COMPLETED|Overall Study||0
9776178|NCT00470548|10882070|FG001|NOT COMPLETED|Overall Study||0
9776179|NCT00470548|10882071|FG002|NOT COMPLETED|Overall Study||0
9776180|NCT00470548|10882072|FG003|NOT COMPLETED|Overall Study||0
9776181|NCT00470600|10882084|FG000|STARTED|Overall Study||86
9776182|NCT00470600|10882085|FG001|STARTED|Overall Study||99
9776183|NCT00470600|10882084|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
9776184|NCT00470600|10882085|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
10233918|NCT01607320|11363787|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
10233919|NCT01607320|11363786|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
10233920|NCT01607320|11363787|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
10233921|NCT01607320|11363786|FG000|NOT COMPLETED|Overall Study||0
10233922|NCT01607320|11363787|FG001|NOT COMPLETED|Overall Study||0
10233923|NCT01605019|11363793|FG000|STARTED|Overall Study||4
10233924|NCT01605019|11363794|FG001|STARTED|Overall Study||0
10233925|NCT01605019|11363793|FG000|COMPLETED|Overall Study||1
9776185|NCT00470600|10882084|FG000|NOT COMPLETED|Overall Study||0
9776186|NCT00470600|10882085|FG001|NOT COMPLETED|Overall Study||0
9776187|NCT00470626|10882091|FG000|STARTED|Overall Study||129
9776188|NCT00470626|10882091|FG000|COMPLETED|Overall Study||112
9776189|NCT00470626|10882091|FG000|NOT COMPLETED|Overall Study||17
9776190|NCT00470717|10882095|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38
9776191|NCT00470717|10882095|FG000|COMPLETED|Overall Study||38
9776192|NCT00470717|10882095|FG000|NOT COMPLETED|Overall Study||0
9776193|NCT00470834|10882101|FG000|STARTED|Treatment Period (18 Months)||65
9776194|NCT00470834|10882102|FG001|STARTED|Treatment Period (18 Months)||62
9776195|NCT00470834|10882101|FG000|COMPLETED|Treatment Period (18 Months)||27
9776196|NCT00470834|10882102|FG001|COMPLETED|Treatment Period (18 Months)||31
9776197|NCT00470834|10882101|FG000|NOT COMPLETED|Treatment Period (18 Months)||38
9776198|NCT00470834|10882102|FG001|NOT COMPLETED|Treatment Period (18 Months)||31
9776199|NCT00470834|10882101|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
9776200|NCT00470834|10882102|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
9776201|NCT00470834|10882101|FG000|COMPLETED|Extension Period (24 Months)||11
9776202|NCT00470834|10882102|FG001|COMPLETED|Extension Period (24 Months)||7
9776203|NCT00470834|10882101|FG000|NOT COMPLETED|Extension Period (24 Months)||15
9776204|NCT00470834|10882102|FG001|NOT COMPLETED|Extension Period (24 Months)||23
9776205|NCT00470847|10882108|FG000|STARTED|Overall Study||35
9776206|NCT00470847|10882108|FG000|COMPLETED|Overall Study||34
9776207|NCT00470847|10882108|FG000|NOT COMPLETED|Overall Study||1
9776208|NCT00471068|10882116|FG000|STARTED|Overall Study||21
9776209|NCT00471068|10882117|FG001|STARTED|Overall Study||25
9776210|NCT00471068|10882116|FG000|COMPLETED|Overall Study||20
9776211|NCT00471068|10882117|FG001|COMPLETED|Overall Study||24
9776212|NCT00471068|10882116|FG000|NOT COMPLETED|Overall Study||1
9776213|NCT00471068|10882117|FG001|NOT COMPLETED|Overall Study||1
9776214|NCT00471081|10882125|FG000|STARTED|Active Phase||160
9776215|NCT00471081|10882126|FG001|STARTED|Active Phase||189
9776216|NCT00471081|10882125|FG000|COMPLETED|Active Phase||158
9776217|NCT00471081|10882126|FG001|COMPLETED|Active Phase||176
9776218|NCT00471081|10882125|FG000|NOT COMPLETED|Active Phase||2
9776219|NCT00471081|10882126|FG001|NOT COMPLETED|Active Phase||13
9776220|NCT00471081|10882125|FG000|STARTED|Extended Safety Follow-Up||160
9776221|NCT00471081|10882126|FG001|STARTED|Extended Safety Follow-Up||189
9776222|NCT00471081|10882125|FG000|COMPLETED|Extended Safety Follow-Up||158
9776223|NCT00471081|10882126|FG001|COMPLETED|Extended Safety Follow-Up||176
9776224|NCT00471081|10882125|FG000|NOT COMPLETED|Extended Safety Follow-Up||2
9776225|NCT00471081|10882126|FG001|NOT COMPLETED|Extended Safety Follow-Up||13
9776226|NCT00471107|10882136|FG000|STARTED|Overall Study||15
9776227|NCT00471107|10882137|FG001|STARTED|Overall Study||15
9776228|NCT00471107|10882138|FG002|STARTED|Overall Study||15
9776229|NCT00471107|10882136|FG000|COMPLETED|Overall Study||12
9776230|NCT00471107|10882137|FG001|COMPLETED|Overall Study||14
9776231|NCT00471107|10882138|FG002|COMPLETED|Overall Study||12
9776232|NCT00471107|10882136|FG000|NOT COMPLETED|Overall Study||3
9776233|NCT00471107|10882137|FG001|NOT COMPLETED|Overall Study||1
10233926|NCT01605019|11363794|FG001|COMPLETED|Overall Study||0
10233927|NCT01605019|11363793|FG000|NOT COMPLETED|Overall Study||3
9776234|NCT00471107|10882138|FG002|NOT COMPLETED|Overall Study||3
9776235|NCT00471146|10882148|FG000|STARTED|Overall Study||314
9776236|NCT00471146|10882149|FG001|STARTED|Overall Study||316
9776237|NCT00471146|10882148|FG000|Treated|Overall Study||305
9776238|NCT00471146|10882149|FG001|Treated|Overall Study||308
9776239|NCT00471146|10882148|FG000|COMPLETED|Overall Study||142
9776240|NCT00471146|10882149|FG001|COMPLETED|Overall Study||142
10014551|NCT01800903|11137663|FG002|STARTED|Second Test Period||4
10014552|NCT01800903|11137664|FG003|STARTED|Second Test Period||7
10014553|NCT01800903|11137665|FG004|STARTED|Second Test Period||6
10014554|NCT01800903|11137666|FG005|STARTED|Second Test Period||6
9776241|NCT00471146|10882148|FG000|NOT COMPLETED|Overall Study||172
9776242|NCT00471146|10882149|FG001|NOT COMPLETED|Overall Study||174
9776243|NCT00471237|10882162|FG000|STARTED|Overall Study||90
9776244|NCT00471237|10882163|FG001|STARTED|Overall Study||87
9776245|NCT00471237|10882164|FG002|STARTED|Overall Study||82
9776246|NCT00471237|10882165|FG003|STARTED|Overall Study||88
9776247|NCT00471237|10882166|FG004|STARTED|Overall Study||87
9776248|NCT00471237|10882167|FG005|STARTED|Overall Study||89
9776249|NCT00471237|10882168|FG006|STARTED|Overall Study||41
9776250|NCT00471237|10882162|FG000|COMPLETED|Overall Study||49
9776251|NCT00471237|10882163|FG001|COMPLETED|Overall Study||45
9776252|NCT00471237|10882164|FG002|COMPLETED|Overall Study||48
9776253|NCT00471237|10882165|FG003|COMPLETED|Overall Study||43
9776254|NCT00471237|10882166|FG004|COMPLETED|Overall Study||46
9776255|NCT00471237|10882167|FG005|COMPLETED|Overall Study||50
9776256|NCT00471237|10882168|FG006|COMPLETED|Overall Study||38
9776257|NCT00471237|10882162|FG000|NOT COMPLETED|Overall Study||41
9776258|NCT00471237|10882163|FG001|NOT COMPLETED|Overall Study||42
9776259|NCT00471237|10882164|FG002|NOT COMPLETED|Overall Study||34
9776260|NCT00471237|10882165|FG003|NOT COMPLETED|Overall Study||45
9776261|NCT00471237|10882166|FG004|NOT COMPLETED|Overall Study||41
9776262|NCT00471237|10882167|FG005|NOT COMPLETED|Overall Study||39
9776263|NCT00471237|10882168|FG006|NOT COMPLETED|Overall Study||3
9776264|NCT00471276|10882188|FG000|STARTED|Overall Study||83
9776265|NCT00471276|10882188|FG000|COMPLETED|Overall Study||0
9776266|NCT00471276|10882188|FG000|NOT COMPLETED|Overall Study||83
9776267|NCT00471315|10882192|FG000|STARTED|Overall Study||18
9776268|NCT00471315|10882192|FG000|COMPLETED|Overall Study||10
9776269|NCT00471315|10882192|FG000|NOT COMPLETED|Overall Study||8
9776270|NCT00471328|10882198|FG000|STARTED|Core Phase||165
9776271|NCT00471328|10882199|FG001|STARTED|Core Phase||83
9776272|NCT00471328|10882198|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0
9776273|NCT00471328|10882199|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53
9776274|NCT00471328|10882198|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
9776275|NCT00471328|10882199|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
9776276|NCT00471328|10882198|FG000|NOT COMPLETED|Core Phase||107
9776277|NCT00471328|10882199|FG001|NOT COMPLETED|Core Phase||67
9776278|NCT00471328|10882198|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
9776279|NCT00471328|10882199|FG001|STARTED|Extension Phase||67
9776280|NCT00471328|10882198|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
9776281|NCT00471328|10882199|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
9776282|NCT00471328|10882198|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
9776283|NCT00471328|10882199|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
9776284|NCT00471328|10882198|FG000|Started:CrossOver During Extension|Extension Phase||0
9776285|NCT00471328|10882199|FG001|Started:CrossOver During Extension|Extension Phase||10
9776286|NCT00471328|10882198|FG000|COMPLETED|Extension Phase||0
9776287|NCT00471328|10882199|FG001|COMPLETED|Extension Phase||0
9776288|NCT00471328|10882198|FG000|NOT COMPLETED|Extension Phase||41
9776289|NCT00471328|10882199|FG001|NOT COMPLETED|Extension Phase||67
9776290|NCT00471354|10882207|FG000|STARTED|Overall Study||228
9776291|NCT00471354|10882207|FG000|COMPLETED|Overall Study||176
9776292|NCT00471354|10882207|FG000|NOT COMPLETED|Overall Study||52
9776293|NCT00471380|10882211|FG000|STARTED|First Intervention||22
9776294|NCT00471380|10882212|FG001|STARTED|First Intervention||24
9776295|NCT00471380|10882211|FG000|COMPLETED|First Intervention||18
9776296|NCT00471380|10882212|FG001|COMPLETED|First Intervention||20
9776297|NCT00471380|10882211|FG000|NOT COMPLETED|First Intervention||4
9776298|NCT00471380|10882212|FG001|NOT COMPLETED|First Intervention||4
9776299|NCT00471380|10882211|FG000|STARTED|Second Intervention||18
9776300|NCT00471380|10882212|FG001|STARTED|Second Intervention||20
9776301|NCT00471380|10882211|FG000|COMPLETED|Second Intervention||18
9776302|NCT00471380|10882212|FG001|COMPLETED|Second Intervention||16
9776303|NCT00471380|10882211|FG000|NOT COMPLETED|Second Intervention||0
9776304|NCT00471380|10882212|FG001|NOT COMPLETED|Second Intervention||4
9776305|NCT00471380|10882211|FG000|STARTED|Third Intervention||18
9776306|NCT00471380|10882212|FG001|STARTED|Third Intervention||16
9776307|NCT00471380|10882211|FG000|COMPLETED|Third Intervention||17
9776308|NCT00471380|10882212|FG001|COMPLETED|Third Intervention||14
9776309|NCT00471380|10882211|FG000|NOT COMPLETED|Third Intervention||1
9776310|NCT00471380|10882212|FG001|NOT COMPLETED|Third Intervention||2
9776311|NCT00471445|10882220|FG000|STARTED|Overall Study||229
9776312|NCT00471445|10882221|FG001|STARTED|Overall Study||233
9776313|NCT00471445|10882220|FG000|COMPLETED|Overall Study||227
9776314|NCT00471445|10882221|FG001|COMPLETED|Overall Study||231
10014555|NCT01800903|11137661|FG000|COMPLETED|Second Test Period||6
9776315|NCT00471445|10882220|FG000|NOT COMPLETED|Overall Study||2
9776316|NCT00471445|10882221|FG001|NOT COMPLETED|Overall Study||2
9776317|NCT00471497|10882230|FG000|STARTED|Core Treatment Phase||283
9776318|NCT00471497|10882231|FG001|STARTED|Core Treatment Phase||282
9776319|NCT00471497|10882232|FG002|STARTED|Core Treatment Phase||281
9776320|NCT00471497|10882230|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
9776321|NCT00471497|10882231|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
9776322|NCT00471497|10882232|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
9776323|NCT00471497|10882230|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
9776324|NCT00471497|10882231|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
9776325|NCT00471497|10882232|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
9776326|NCT00471497|10882230|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48
9776327|NCT00471497|10882231|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26
9776328|NCT00471497|10882232|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3
9776329|NCT00471497|10882230|FG000|COMPLETED|Core Treatment Phase||99
9776330|NCT00471497|10882231|FG001|COMPLETED|Core Treatment Phase||107
9776331|NCT00471497|10882232|FG002|COMPLETED|Core Treatment Phase||99
9776332|NCT00471497|10882230|FG000|NOT COMPLETED|Core Treatment Phase||184
9776333|NCT00471497|10882231|FG001|NOT COMPLETED|Core Treatment Phase||175
9776334|NCT00471497|10882232|FG002|NOT COMPLETED|Core Treatment Phase||182
9776335|NCT00471497|10882230|FG000|STARTED|Extension Phase||48
9776336|NCT00471497|10882231|FG001|STARTED|Extension Phase||26
9776337|NCT00471497|10882232|FG002|STARTED|Extension Phase||3
9776338|NCT00471497|10882230|FG000|COMPLETED|Extension Phase||21
10014556|NCT01800903|11137662|FG001|COMPLETED|Second Test Period||6
10014557|NCT01800903|11137663|FG002|COMPLETED|Second Test Period||4
10014558|NCT01800903|11137664|FG003|COMPLETED|Second Test Period||7
10014559|NCT01800903|11137665|FG004|COMPLETED|Second Test Period||6
9776339|NCT00471497|10882231|FG001|COMPLETED|Extension Phase||12
9776340|NCT00471497|10882232|FG002|COMPLETED|Extension Phase||2
9776341|NCT00471497|10882230|FG000|NOT COMPLETED|Extension Phase||27
9776342|NCT00471497|10882231|FG001|NOT COMPLETED|Extension Phase||14
9776343|NCT00471497|10882232|FG002|NOT COMPLETED|Extension Phase||1
9776344|NCT00471536|10882243|FG000|STARTED|Overall Study||19
9776345|NCT00471536|10882243|FG000|COMPLETED|Overall Study||18
9776346|NCT00471536|10882243|FG000|NOT COMPLETED|Overall Study||1
9776347|NCT00471705|10882250|FG000|STARTED|Overall Study||145
9776348|NCT00471705|10882251|FG001|STARTED|Overall Study||143
9776349|NCT00471705|10882252|FG002|STARTED|Overall Study||149
9776350|NCT00471705|10882250|FG000|COMPLETED|Overall Study||121
9776351|NCT00471705|10882251|FG001|COMPLETED|Overall Study||121
9776352|NCT00471705|10882252|FG002|COMPLETED|Overall Study||134
9776353|NCT00471705|10882250|FG000|NOT COMPLETED|Overall Study||24
9776354|NCT00471705|10882251|FG001|NOT COMPLETED|Overall Study||22
9776355|NCT00471705|10882252|FG002|NOT COMPLETED|Overall Study||15
9776356|NCT00471718|10882260|FG000|STARTED|Overall Study||27
9776357|NCT00471718|10882260|FG000|COMPLETED|Overall Study||0
9776358|NCT00471718|10882260|FG000|NOT COMPLETED|Overall Study||27
9776359|NCT00471822|10882268|FG000|STARTED|Overall Study||9707
9776360|NCT00471822|10882268|FG000|Treated|Overall Study||9705
9776361|NCT00471822|10882268|FG000|COMPLETED|Overall Study||9705
9776362|NCT00471822|10882268|FG000|NOT COMPLETED|Overall Study||2
9776363|NCT00471848|10882272|FG000|STARTED|Overall Study||35
9776364|NCT00471848|10882272|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globuline (RATG) treatment|35
9776365|NCT00471848|10882272|FG000|NOT COMPLETED|Overall Study||0
9776366|NCT00471887|10882276|FG000|STARTED|Overall Study||32
9776367|NCT00471887|10882276|FG000|COMPLETED|Overall Study||23
9776368|NCT00471887|10882276|FG000|NOT COMPLETED|Overall Study||9
9776369|NCT00472030|10882282|FG000|STARTED|Overall Study||2
9776370|NCT00472030|10882283|FG001|STARTED|Overall Study||0
9776371|NCT00472030|10882282|FG000|COMPLETED|Overall Study||1
9776372|NCT00472030|10882283|FG001|COMPLETED|Overall Study||0
9776373|NCT00472030|10882282|FG000|NOT COMPLETED|Overall Study||1
9776374|NCT00472030|10882283|FG001|NOT COMPLETED|Overall Study||0
9776375|NCT00472056|10882297|FG000|STARTED|Overall Study||25
9776376|NCT00472056|10882298|FG001|STARTED|Overall Study||19
9776377|NCT00472056|10882299|FG002|STARTED|Overall Study||32
9776378|NCT00472056|10882300|FG003|STARTED|Overall Study||17
9776379|NCT00472056|10882297|FG000|COMPLETED|Overall Study||25
9776380|NCT00472056|10882298|FG001|COMPLETED|Overall Study||19
9776381|NCT00472056|10882299|FG002|COMPLETED|Overall Study||32
9776382|NCT00472056|10882300|FG003|COMPLETED|Overall Study||17
9776383|NCT00472056|10882297|FG000|NOT COMPLETED|Overall Study||0
9776384|NCT00472056|10882298|FG001|NOT COMPLETED|Overall Study||0
9776385|NCT00472056|10882299|FG002|NOT COMPLETED|Overall Study||0
9776386|NCT00472056|10882300|FG003|NOT COMPLETED|Overall Study||0
9776387|NCT00472199|10882310|FG000|STARTED|Overall Study||166
9776388|NCT00472199|10882311|FG001|STARTED|Overall Study||163
9776389|NCT00472199|10882310|FG000|COMPLETED|Overall Study||131
9776390|NCT00472199|10882311|FG001|COMPLETED|Overall Study||103
9776391|NCT00472199|10882310|FG000|NOT COMPLETED|Overall Study||35
9776392|NCT00472199|10882311|FG001|NOT COMPLETED|Overall Study||60
9776393|NCT00472290|10882317|FG000|STARTED|Overall Study||72
9776394|NCT00472290|10882317|FG000|COMPLETED|Overall Study||0
9776395|NCT00472290|10882317|FG000|NOT COMPLETED|Overall Study||72
9776396|NCT00472303|10882323|FG000|STARTED|Titration Phase||338
10014560|NCT01800903|11137666|FG005|COMPLETED|Second Test Period||6
9776397|NCT00472303|10882324|FG001|STARTED|Titration Phase||158
9776398|NCT00472303|10882325|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
9776399|NCT00472303|10882323|FG000|COMPLETED|Titration Phase||279
9776400|NCT00472303|10882324|FG001|COMPLETED|Titration Phase||129
9776401|NCT00472303|10882325|FG002|COMPLETED|Titration Phase||0
9776402|NCT00472303|10882323|FG000|NOT COMPLETED|Titration Phase||59
9776403|NCT00472303|10882324|FG001|NOT COMPLETED|Titration Phase||29
9776404|NCT00472303|10882325|FG002|NOT COMPLETED|Titration Phase||0
9776405|NCT00472303|10882323|FG000|STARTED|Discontinuations After Titration Phase||279
9776406|NCT00472303|10882324|FG001|STARTED|Discontinuations After Titration Phase||129
9776407|NCT00472303|10882325|FG002|STARTED|Discontinuations After Titration Phase||0
9776408|NCT00472303|10882323|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
9776409|NCT00472303|10882324|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
9776410|NCT00472303|10882325|FG002|COMPLETED|Discontinuations After Titration Phase||0
9776411|NCT00472303|10882323|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61
9776412|NCT00472303|10882324|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20
9776413|NCT00472303|10882325|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0
9776414|NCT00472303|10882323|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
9776415|NCT00472303|10882324|FG001|STARTED|Maintenance Phase||109
9776416|NCT00472303|10882325|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
9776417|NCT00472303|10882323|FG000|COMPLETED|Maintenance Phase||89
9776418|NCT00472303|10882324|FG001|COMPLETED|Maintenance Phase||93
9776419|NCT00472303|10882325|FG002|COMPLETED|Maintenance Phase||95
9776420|NCT00472303|10882323|FG000|NOT COMPLETED|Maintenance Phase||17
9776421|NCT00472303|10882324|FG001|NOT COMPLETED|Maintenance Phase||16
9776422|NCT00472303|10882325|FG002|NOT COMPLETED|Maintenance Phase||17
9776423|NCT00472420|10882353|FG000|STARTED|Induction Treatment Period||48
9776424|NCT00472420|10882353|FG000|COMPLETED|Induction Treatment Period||32
9776425|NCT00472420|10882353|FG000|NOT COMPLETED|Induction Treatment Period||16
9776426|NCT00472420|10882353|FG000|STARTED|Follow-up Period||32
9776427|NCT00472420|10882353|FG000|COMPLETED|Follow-up Period||15
9776428|NCT00472420|10882353|FG000|NOT COMPLETED|Follow-up Period||17
9776429|NCT00472446|10882361|FG000|STARTED|Overall Study||46
9776430|NCT00472446|10882362|FG001|STARTED|Overall Study||47
9776431|NCT00472446|10882363|FG002|STARTED|Overall Study||45
9776432|NCT00472446|10882364|FG003|STARTED|Overall Study||45
9776433|NCT00472446|10882361|FG000|COMPLETED|Overall Study||41
9776434|NCT00472446|10882362|FG001|COMPLETED|Overall Study||41
9776435|NCT00472446|10882363|FG002|COMPLETED|Overall Study||38
9776436|NCT00472446|10882364|FG003|COMPLETED|Overall Study||39
9776437|NCT00472446|10882361|FG000|NOT COMPLETED|Overall Study||5
9776438|NCT00472446|10882362|FG001|NOT COMPLETED|Overall Study||6
9776439|NCT00472446|10882363|FG002|NOT COMPLETED|Overall Study||7
9776440|NCT00472446|10882364|FG003|NOT COMPLETED|Overall Study||6
9776441|NCT00472576|10882376|FG000|STARTED|First Intervention||2
9776442|NCT00472576|10882377|FG001|STARTED|First Intervention||3
9776443|NCT00472576|10882376|FG000|COMPLETED|First Intervention||2
9776444|NCT00472576|10882377|FG001|COMPLETED|First Intervention||3
9776445|NCT00472576|10882376|FG000|NOT COMPLETED|First Intervention||0
9776446|NCT00472576|10882377|FG001|NOT COMPLETED|First Intervention||0
9776447|NCT00472576|10882376|FG000|STARTED|Second Intervention||2
9776448|NCT00472576|10882377|FG001|STARTED|Second Intervention||3
9776449|NCT00472576|10882376|FG000|COMPLETED|Second Intervention||2
9776450|NCT00472576|10882377|FG001|COMPLETED|Second Intervention||3
9776451|NCT00472576|10882376|FG000|NOT COMPLETED|Second Intervention||0
9776452|NCT00472576|10882377|FG001|NOT COMPLETED|Second Intervention||0
9776453|NCT00472641|10882383|FG000|STARTED|Overall Study||25
9776454|NCT00472641|10882383|FG000|COMPLETED|Overall Study||18
9776455|NCT00472641|10882383|FG000|NOT COMPLETED|Overall Study||7
9776456|NCT00472732|10882389|FG000|STARTED|Overall Study||24
9776457|NCT00472732|10882390|FG001|STARTED|Overall Study||22
9776458|NCT00472732|10882389|FG000|COMPLETED|Overall Study||24
9776459|NCT00472732|10882390|FG001|COMPLETED|Overall Study||22
9776460|NCT00472732|10882389|FG000|NOT COMPLETED|Overall Study||0
9776461|NCT00472732|10882390|FG001|NOT COMPLETED|Overall Study||0
9776462|NCT00472797|10882398|FG000|STARTED|Overall Study||119
9776463|NCT00472797|10882399|FG001|STARTED|Overall Study||113
9776464|NCT00472797|10882398|FG000|COMPLETED|Overall Study||115
9776465|NCT00472797|10882399|FG001|COMPLETED|Overall Study||112
9776466|NCT00472797|10882398|FG000|NOT COMPLETED|Overall Study||4
9776467|NCT00472797|10882399|FG001|NOT COMPLETED|Overall Study||1
9776468|NCT00472849|10882410|FG000|STARTED|Overall Study||12
9776469|NCT00472849|10882411|FG001|STARTED|Overall Study||78
9776470|NCT00472849|10882410|FG000|COMPLETED|Overall Study||12
9776471|NCT00472849|10882411|FG001|COMPLETED|Overall Study||78
9776472|NCT00472849|10882410|FG000|NOT COMPLETED|Overall Study||0
9776473|NCT00472849|10882411|FG001|NOT COMPLETED|Overall Study||0
9776474|NCT00473083|10882420|FG000|STARTED|Overall Study||50
9776475|NCT00473083|10882421|FG001|STARTED|Overall Study||50
9776476|NCT00473083|10882422|FG002|STARTED|Overall Study||50
9776477|NCT00473083|10882420|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
9776478|NCT00473083|10882421|FG001|COMPLETED|Overall Study||50
9776479|NCT00473083|10882422|FG002|COMPLETED|Overall Study||50
9776480|NCT00473083|10882420|FG000|NOT COMPLETED|Overall Study||1
9776481|NCT00473083|10882421|FG001|NOT COMPLETED|Overall Study||0
9776482|NCT00473083|10882422|FG002|NOT COMPLETED|Overall Study||0
9776483|NCT00473265|10882433|FG000|STARTED|Overall Study||68
9776484|NCT00473265|10882433|FG000|COMPLETED|Overall Study||48
9776485|NCT00473265|10882433|FG000|NOT COMPLETED|Overall Study||20
9776486|NCT00473330|10882440|FG000|STARTED|Core Study||125
9776487|NCT00473330|10882441|FG001|STARTED|Core Study||125
9776488|NCT00473330|10882442|FG002|STARTED|Core Study||127
9776489|NCT00473330|10882440|FG000|COMPLETED|Core Study||98
9776490|NCT00473330|10882441|FG001|COMPLETED|Core Study||100
9776491|NCT00473330|10882442|FG002|COMPLETED|Core Study||86
9776492|NCT00473330|10882440|FG000|NOT COMPLETED|Core Study||27
9776493|NCT00473330|10882441|FG001|NOT COMPLETED|Core Study||25
9776494|NCT00473330|10882442|FG002|NOT COMPLETED|Core Study||41
9776495|NCT00473330|10882440|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
9776496|NCT00473330|10882441|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
9776497|NCT00473330|10882442|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
9776498|NCT00473330|10882440|FG000|COMPLETED|Open-label Extension Through Month 48||63
9776499|NCT00473330|10882441|FG001|COMPLETED|Open-label Extension Through Month 48||59
9776500|NCT00473330|10882442|FG002|COMPLETED|Open-label Extension Through Month 48||50
9776501|NCT00473330|10882440|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26
9776502|NCT00473330|10882441|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20
9776503|NCT00473330|10882442|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27
9776504|NCT00473330|10882440|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
9776505|NCT00473330|10882441|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
9776506|NCT00473330|10882442|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
9776507|NCT00473330|10882440|FG000|COMPLETED|Open-label Extension Through Month 60||1
9776508|NCT00473330|10882441|FG001|COMPLETED|Open-label Extension Through Month 60||1
9776509|NCT00473330|10882442|FG002|COMPLETED|Open-label Extension Through Month 60||0
9776510|NCT00473330|10882440|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88
9776511|NCT00473330|10882441|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78
9776512|NCT00473330|10882442|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77
9776513|NCT00473382|10882473|FG000|STARTED|Core Study||130
9776514|NCT00473382|10882474|FG001|STARTED|Core Study||125
9776515|NCT00473382|10882475|FG002|STARTED|Core Study||127
9776516|NCT00473382|10882473|FG000|COMPLETED|Core Study||102
9776517|NCT00473382|10882474|FG001|COMPLETED|Core Study||98
9776518|NCT00473382|10882475|FG002|COMPLETED|Core Study||98
9776519|NCT00473382|10882473|FG000|NOT COMPLETED|Core Study||28
9776520|NCT00473382|10882474|FG001|NOT COMPLETED|Core Study||27
9776521|NCT00473382|10882475|FG002|NOT COMPLETED|Core Study||29
10014561|NCT01800903|11137661|FG000|NOT COMPLETED|Second Test Period||1
10014562|NCT01800903|11137662|FG001|NOT COMPLETED|Second Test Period||0
10014563|NCT01800903|11137663|FG002|NOT COMPLETED|Second Test Period||0
10014564|NCT01800903|11137664|FG003|NOT COMPLETED|Second Test Period||0
10014565|NCT01800903|11137665|FG004|NOT COMPLETED|Second Test Period||0
10014566|NCT01800903|11137666|FG005|NOT COMPLETED|Second Test Period||0
10014567|NCT01800903|11137661|FG000|STARTED|Third Test Period||6
10014568|NCT01800903|11137662|FG001|STARTED|Third Test Period||6
10014569|NCT01800903|11137663|FG002|STARTED|Third Test Period||4
10014570|NCT01800903|11137664|FG003|STARTED|Third Test Period||7
10014571|NCT01800903|11137665|FG004|STARTED|Third Test Period||6
10014572|NCT01800903|11137666|FG005|STARTED|Third Test Period||6
9776522|NCT00473382|10882473|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
9776523|NCT00473382|10882474|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
9776524|NCT00473382|10882475|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
9776525|NCT00473382|10882473|FG000|COMPLETED|Open-label Extension Through Month 48||38
9776526|NCT00473382|10882474|FG001|COMPLETED|Open-label Extension Through Month 48||42
9776527|NCT00473382|10882475|FG002|COMPLETED|Open-label Extension Through Month 48||37
9776528|NCT00473382|10882473|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50
9776529|NCT00473382|10882474|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41
9776530|NCT00473382|10882475|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47
9776531|NCT00473382|10882473|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
9776532|NCT00473382|10882474|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
9776533|NCT00473382|10882475|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
9776534|NCT00473382|10882473|FG000|COMPLETED|Open-label Extension Through Month 60||2
9776535|NCT00473382|10882474|FG001|COMPLETED|Open-label Extension Through Month 60||1
9776536|NCT00473382|10882475|FG002|COMPLETED|Open-label Extension Through Month 60||2
9776537|NCT00473382|10882473|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86
9776538|NCT00473382|10882474|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82
10014573|NCT01800903|11137661|FG000|COMPLETED|Third Test Period||6
10014574|NCT01800903|11137662|FG001|COMPLETED|Third Test Period||6
10014575|NCT01800903|11137663|FG002|COMPLETED|Third Test Period||4
10014576|NCT01800903|11137664|FG003|COMPLETED|Third Test Period||7
9776539|NCT00473382|10882475|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82
9776540|NCT00473434|10882501|FG000|STARTED|Overall Study||64
9776541|NCT00473434|10882501|FG000|COMPLETED|Overall Study||32
9776542|NCT00473434|10882501|FG000|NOT COMPLETED|Overall Study||32
9776543|NCT00473512|10882523|FG000|STARTED|Period 1 (Phase 1)||3
9776544|NCT00473512|10882524|FG001|STARTED|Period 1 (Phase 1)||3
10233928|NCT01605019|11363794|FG001|NOT COMPLETED|Overall Study||0
10233929|NCT01609231|11363802|FG000|STARTED|Overall Study||6
9776545|NCT00473512|10882525|FG002|STARTED|Period 1 (Phase 1)||3
9776546|NCT00473512|10882526|FG003|STARTED|Period 1 (Phase 1)||42
9776547|NCT00473512|10882527|FG004|STARTED|Period 1 (Phase 1)||3
9776548|NCT00473512|10882523|FG000|COMPLETED|Period 1 (Phase 1)||2
9776549|NCT00473512|10882524|FG001|COMPLETED|Period 1 (Phase 1)||2
9776550|NCT00473512|10882525|FG002|COMPLETED|Period 1 (Phase 1)||3
9776551|NCT00473512|10882526|FG003|COMPLETED|Period 1 (Phase 1)||25
9776552|NCT00473512|10882527|FG004|COMPLETED|Period 1 (Phase 1)||2
9776553|NCT00473512|10882523|FG000|NOT COMPLETED|Period 1 (Phase 1)||1
9776554|NCT00473512|10882524|FG001|NOT COMPLETED|Period 1 (Phase 1)||1
9776555|NCT00473512|10882525|FG002|NOT COMPLETED|Period 1 (Phase 1)||0
9776556|NCT00473512|10882526|FG003|NOT COMPLETED|Period 1 (Phase 1)||17
9776557|NCT00473512|10882527|FG004|NOT COMPLETED|Period 1 (Phase 1)||1
9776558|NCT00473512|10882523|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
9776559|NCT00473512|10882524|FG001|STARTED|Period 2 (Phase 2)||2
9776560|NCT00473512|10882525|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
9776561|NCT00473512|10882526|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
9776562|NCT00473512|10882527|FG004|STARTED|Period 2 (Phase 2)||2
9776563|NCT00473512|10882523|FG000|COMPLETED|Period 2 (Phase 2)||0
9776564|NCT00473512|10882524|FG001|COMPLETED|Period 2 (Phase 2)||0
9776565|NCT00473512|10882525|FG002|COMPLETED|Period 2 (Phase 2)||0
9776566|NCT00473512|10882526|FG003|COMPLETED|Period 2 (Phase 2)||0
9776567|NCT00473512|10882527|FG004|COMPLETED|Period 2 (Phase 2)||0
9776568|NCT00473512|10882523|FG000|NOT COMPLETED|Period 2 (Phase 2)||1
9776569|NCT00473512|10882524|FG001|NOT COMPLETED|Period 2 (Phase 2)||2
9776570|NCT00473512|10882525|FG002|NOT COMPLETED|Period 2 (Phase 2)||2
9776571|NCT00473512|10882526|FG003|NOT COMPLETED|Period 2 (Phase 2)||23
9776572|NCT00473512|10882527|FG004|NOT COMPLETED|Period 2 (Phase 2)||2
9776573|NCT00473564|10882547|FG000|STARTED|Overall Study||170
9776574|NCT00473564|10882547|FG000|COMPLETED|Overall Study||147
9776575|NCT00473564|10882547|FG000|NOT COMPLETED|Overall Study||23
9776576|NCT00473590|10882553|FG000|STARTED|Overall Study||53
9776577|NCT00473590|10882554|FG001|STARTED|Overall Study||49
9776578|NCT00473590|10882553|FG000|Treated|Overall Study||52
9776579|NCT00473590|10882554|FG001|Treated|Overall Study||48
9776580|NCT00473590|10882553|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
9776581|NCT00473590|10882554|FG001|Safety Population|Overall Study||50
9776582|NCT00473590|10882553|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
9776583|NCT00473590|10882554|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
9776584|NCT00473590|10882553|FG000|NOT COMPLETED|Overall Study||45
9776585|NCT00473590|10882554|FG001|NOT COMPLETED|Overall Study||38
9776586|NCT00473642|10882563|FG000|STARTED|Overall Study||10
9776587|NCT00473642|10882564|FG001|STARTED|Overall Study||11
9776588|NCT00473642|10882565|FG002|STARTED|Overall Study||10
9776589|NCT00473642|10882563|FG000|COMPLETED|Overall Study||8
9776590|NCT00473642|10882564|FG001|COMPLETED|Overall Study||10
9776591|NCT00473642|10882565|FG002|COMPLETED|Overall Study||8
9776592|NCT00473642|10882563|FG000|NOT COMPLETED|Overall Study||2
9776593|NCT00473642|10882564|FG001|NOT COMPLETED|Overall Study||1
9776594|NCT00473642|10882565|FG002|NOT COMPLETED|Overall Study||2
9776595|NCT00473655|10882579|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
9776596|NCT00473655|10882580|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
9776597|NCT00473655|10882581|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
9776598|NCT00473655|10882579|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102
9776599|NCT00473655|10882580|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107
9776600|NCT00473655|10882581|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103
9776601|NCT00473655|10882579|FG000|NOT COMPLETED|Overall Study||9
9776602|NCT00473655|10882580|FG001|NOT COMPLETED|Overall Study||5
9776603|NCT00473655|10882581|FG002|NOT COMPLETED|Overall Study||8
9776604|NCT00473668|10882592|FG000|STARTED|Overall Study||100
9776605|NCT00473668|10882593|FG001|STARTED|Overall Study||100
9776606|NCT00473668|10882594|FG002|STARTED|Overall Study||99
9776607|NCT00473668|10882592|FG000|COMPLETED|Overall Study||95
9776608|NCT00473668|10882593|FG001|COMPLETED|Overall Study||89
9776609|NCT00473668|10882594|FG002|COMPLETED|Overall Study||89
9776610|NCT00473668|10882592|FG000|NOT COMPLETED|Overall Study||5
9776611|NCT00473668|10882593|FG001|NOT COMPLETED|Overall Study||11
9776612|NCT00473668|10882594|FG002|NOT COMPLETED|Overall Study||10
9776613|NCT00473694|10882606|FG000|STARTED|Overall Study||48
9776614|NCT00473694|10882607|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
9776615|NCT00473694|10882608|FG002|STARTED|Overall Study||51
9776616|NCT00473694|10882609|FG003|STARTED|Overall Study||42
10233930|NCT01609231|11363803|FG001|STARTED|Overall Study||5
10233931|NCT01609231|11363802|FG000|COMPLETED|Overall Study||3
10233932|NCT01609231|11363803|FG001|COMPLETED|Overall Study||2
10233933|NCT01609231|11363802|FG000|NOT COMPLETED|Overall Study||3
9776617|NCT00473694|10882606|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
9776618|NCT00473694|10882607|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
9776619|NCT00473694|10882608|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
9776620|NCT00473694|10882609|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
9776621|NCT00473694|10882606|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
9776622|NCT00473694|10882607|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
9776623|NCT00473694|10882608|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
9776624|NCT00473694|10882609|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
9776625|NCT00473694|10882606|FG000|NOT COMPLETED|Overall Study||11
9776626|NCT00473694|10882607|FG001|NOT COMPLETED|Overall Study||4
9776627|NCT00473694|10882608|FG002|NOT COMPLETED|Overall Study||5
9776628|NCT00473694|10882609|FG003|NOT COMPLETED|Overall Study||7
9776629|NCT00473746|10882627|FG000|STARTED|Period 1 (Phase 1)||6
9776630|NCT00473746|10882628|FG001|STARTED|Period 1 (Phase 1)||9
9776631|NCT00473746|10882629|FG002|STARTED|Period 1 (Phase 1)||6
9776632|NCT00473746|10882630|FG003|STARTED|Period 1 (Phase 1)||12
9776633|NCT00473746|10882631|FG004|STARTED|Period 1 (Phase 1)||0
9776634|NCT00473746|10882627|FG000|COMPLETED|Period 1 (Phase 1)||0
9776635|NCT00473746|10882628|FG001|COMPLETED|Period 1 (Phase 1)||0
9776636|NCT00473746|10882629|FG002|COMPLETED|Period 1 (Phase 1)||0
9776637|NCT00473746|10882630|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
9776638|NCT00473746|10882631|FG004|COMPLETED|Period 1 (Phase 1)||0
9776639|NCT00473746|10882627|FG000|NOT COMPLETED|Period 1 (Phase 1)||6
9776640|NCT00473746|10882628|FG001|NOT COMPLETED|Period 1 (Phase 1)||9
9776641|NCT00473746|10882629|FG002|NOT COMPLETED|Period 1 (Phase 1)||6
9776642|NCT00473746|10882630|FG003|NOT COMPLETED|Period 1 (Phase 1)||10
9776643|NCT00473746|10882631|FG004|NOT COMPLETED|Period 1 (Phase 1)||0
9776644|NCT00473746|10882627|FG000|STARTED|Period 2 (Phase 2)||0
9776645|NCT00473746|10882628|FG001|STARTED|Period 2 (Phase 2)||0
9776646|NCT00473746|10882629|FG002|STARTED|Period 2 (Phase 2)||0
9776647|NCT00473746|10882630|FG003|STARTED|Period 2 (Phase 2)||0
9776648|NCT00473746|10882631|FG004|STARTED|Period 2 (Phase 2)||33
9776649|NCT00473746|10882627|FG000|COMPLETED|Period 2 (Phase 2)||0
9776650|NCT00473746|10882628|FG001|COMPLETED|Period 2 (Phase 2)||0
9776651|NCT00473746|10882629|FG002|COMPLETED|Period 2 (Phase 2)||0
9776652|NCT00473746|10882630|FG003|COMPLETED|Period 2 (Phase 2)||0
9776653|NCT00473746|10882631|FG004|COMPLETED|Period 2 (Phase 2)||6
9776654|NCT00473746|10882627|FG000|NOT COMPLETED|Period 2 (Phase 2)||0
9776655|NCT00473746|10882628|FG001|NOT COMPLETED|Period 2 (Phase 2)||0
9776656|NCT00473746|10882629|FG002|NOT COMPLETED|Period 2 (Phase 2)||0
9776657|NCT00473746|10882630|FG003|NOT COMPLETED|Period 2 (Phase 2)||0
9776658|NCT00473746|10882631|FG004|NOT COMPLETED|Period 2 (Phase 2)||27
9776659|NCT00473824|10882647|FG000|STARTED|Overall Study||5
9776660|NCT00473824|10882648|FG001|STARTED|Overall Study||2
9776661|NCT00473824|10882647|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
9776662|NCT00473824|10882648|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
9776663|NCT00473824|10882647|FG000|NOT COMPLETED|Overall Study||5
9776664|NCT00473824|10882648|FG001|NOT COMPLETED|Overall Study||0
9776665|NCT00473837|10882656|FG000|STARTED|Overall Study||50
9776666|NCT00473837|10882657|FG001|STARTED|Overall Study||46
9776667|NCT00473837|10882656|FG000|COMPLETED|Overall Study||49
9776668|NCT00473837|10882657|FG001|COMPLETED|Overall Study||43
9776669|NCT00473837|10882656|FG000|NOT COMPLETED|Overall Study||1
9776670|NCT00473837|10882657|FG001|NOT COMPLETED|Overall Study||3
9776671|NCT00473876|10882665|FG000|STARTED|Overall Study||39
9776672|NCT00473876|10882666|FG001|STARTED|Overall Study||23
9776673|NCT00473876|10882665|FG000|COMPLETED|Overall Study||36
9776674|NCT00473876|10882666|FG001|COMPLETED|Overall Study||22
9776675|NCT00473876|10882665|FG000|NOT COMPLETED|Overall Study||3
9776676|NCT00473876|10882666|FG001|NOT COMPLETED|Overall Study||1
9776677|NCT00473889|10882676|FG000|STARTED|Overall Study||126
9776678|NCT00473889|10882677|FG001|STARTED|Overall Study||127
9776679|NCT00473889|10882676|FG000|COMPLETED|Overall Study||43
9776680|NCT00473889|10882677|FG001|COMPLETED|Overall Study||63
9776681|NCT00473889|10882676|FG000|NOT COMPLETED|Overall Study||83
9776682|NCT00473889|10882677|FG001|NOT COMPLETED|Overall Study||64
9776683|NCT00474045|10882685|FG000|STARTED|Overall Study||233
9776684|NCT00474045|10882686|FG001|STARTED|Overall Study||237
9776685|NCT00474045|10882685|FG000|Exposed-All Subjects|Overall Study||233
9776686|NCT00474045|10882686|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
9776687|NCT00474045|10882685|FG000|Exposed-Pregnant Subjects|Overall Study||152
9776688|NCT00474045|10882686|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
9776689|NCT00474045|10882685|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152
9776690|NCT00474045|10882686|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
9776691|NCT00474045|10882685|FG000|COMPLETED|Overall Study||127
9776692|NCT00474045|10882686|FG001|COMPLETED|Overall Study||136
9776693|NCT00474045|10882685|FG000|NOT COMPLETED|Overall Study||106
10233934|NCT01609231|11363803|FG001|NOT COMPLETED|Overall Study||3
10233935|NCT01602198|11363811|FG000|STARTED|Overall Study||0
9776694|NCT00474045|10882686|FG001|NOT COMPLETED|Overall Study||101
9776695|NCT00474058|10882694|FG000|STARTED|Overall Study||190
9776696|NCT00474058|10882695|FG001|STARTED|Overall Study||97
9776697|NCT00474058|10882694|FG000|COMPLETED|Overall Study||166
9776698|NCT00474058|10882695|FG001|COMPLETED|Overall Study||80
9776699|NCT00474058|10882694|FG000|NOT COMPLETED|Overall Study||24
9776700|NCT00474058|10882695|FG001|NOT COMPLETED|Overall Study||17
9776701|NCT00474123|10882703|FG000|STARTED|Overall Study||38
9776702|NCT00474123|10882704|FG001|STARTED|Overall Study||40
9776703|NCT00474123|10882703|FG000|COMPLETED|Overall Study||38
9776704|NCT00474123|10882704|FG001|COMPLETED|Overall Study||40
9776705|NCT00474123|10882703|FG000|NOT COMPLETED|Overall Study||0
9776706|NCT00474123|10882704|FG001|NOT COMPLETED|Overall Study||0
9776707|NCT00474175|10882713|FG000|STARTED|Overall Study||115
9776708|NCT00474175|10882714|FG001|STARTED|Overall Study||233
9776709|NCT00474175|10882715|FG002|STARTED|Overall Study||229
9776710|NCT00474175|10882713|FG000|Treated|Overall Study||115
9776711|NCT00474175|10882714|FG001|Treated|Overall Study||233
9776712|NCT00474175|10882715|FG002|Treated|Overall Study||228
9776713|NCT00474175|10882713|FG000|COMPLETED|Overall Study||114
9776714|NCT00474175|10882714|FG001|COMPLETED|Overall Study||226
9776715|NCT00474175|10882715|FG002|COMPLETED|Overall Study||225
9776716|NCT00474175|10882713|FG000|NOT COMPLETED|Overall Study||1
9776717|NCT00474175|10882714|FG001|NOT COMPLETED|Overall Study||7
9776718|NCT00474175|10882715|FG002|NOT COMPLETED|Overall Study||4
9776719|NCT00474201|10882723|FG000|STARTED|Overall Study||15
9776720|NCT00474201|10882723|FG000|COMPLETED|Overall Study||15
9776721|NCT00474201|10882723|FG000|NOT COMPLETED|Overall Study||0
9776722|NCT00474240|10882734|FG000|STARTED|Overall Study||27
9776723|NCT00474240|10882735|FG001|STARTED|Overall Study||26
9776724|NCT00474240|10882736|FG002|STARTED|Overall Study||26
9776725|NCT00474240|10882737|FG003|STARTED|Overall Study||26
9776726|NCT00474240|10882738|FG004|STARTED|Overall Study||26
9776727|NCT00474240|10882739|FG005|STARTED|Overall Study||26
9776728|NCT00474240|10882734|FG000|COMPLETED|Overall Study||26
9776729|NCT00474240|10882735|FG001|COMPLETED|Overall Study||25
9776730|NCT00474240|10882736|FG002|COMPLETED|Overall Study||17
9776731|NCT00474240|10882737|FG003|COMPLETED|Overall Study||10
9776732|NCT00474240|10882738|FG004|COMPLETED|Overall Study||18
9776733|NCT00474240|10882739|FG005|COMPLETED|Overall Study||8
9776734|NCT00474240|10882734|FG000|NOT COMPLETED|Overall Study||1
9776735|NCT00474240|10882735|FG001|NOT COMPLETED|Overall Study||1
9776736|NCT00474240|10882736|FG002|NOT COMPLETED|Overall Study||9
9776737|NCT00474240|10882737|FG003|NOT COMPLETED|Overall Study||16
9776738|NCT00474240|10882738|FG004|NOT COMPLETED|Overall Study||8
9776739|NCT00474240|10882739|FG005|NOT COMPLETED|Overall Study||18
9776740|NCT00474253|10882755|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
9776741|NCT00474253|10882756|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
9776742|NCT00474253|10882755|FG000|Treated|Overall Study|Based on actual treatment received.|56
9776743|NCT00474253|10882756|FG001|Treated|Overall Study|Based on actual treatment received.|54
9776744|NCT00474253|10882755|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55
9776745|NCT00474253|10882756|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53
9776746|NCT00474253|10882755|FG000|NOT COMPLETED|Overall Study||3
9776747|NCT00474253|10882756|FG001|NOT COMPLETED|Overall Study||4
9776748|NCT00474266|10882766|FG000|STARTED|Overall Study||375
9776749|NCT00474266|10882767|FG001|STARTED|Overall Study||374
9776750|NCT00474266|10882768|FG002|STARTED|Overall Study||126
9776751|NCT00474266|10882769|FG003|STARTED|Overall Study||125
9776752|NCT00474266|10882766|FG000|COMPLETED|Overall Study||368
9776753|NCT00474266|10882767|FG001|COMPLETED|Overall Study||354
9776754|NCT00474266|10882768|FG002|COMPLETED|Overall Study||122
9776755|NCT00474266|10882769|FG003|COMPLETED|Overall Study||118
9776756|NCT00474266|10882766|FG000|NOT COMPLETED|Overall Study||7
9776757|NCT00474266|10882767|FG001|NOT COMPLETED|Overall Study||20
9776758|NCT00474266|10882768|FG002|NOT COMPLETED|Overall Study||4
9776759|NCT00474266|10882769|FG003|NOT COMPLETED|Overall Study||7
9776760|NCT00474383|10882782|FG000|STARTED|Main Study||47
9776761|NCT00474383|10882783|FG001|STARTED|Main Study||0
9776762|NCT00474383|10882782|FG000|COMPLETED|Main Study||11
9776763|NCT00474383|10882783|FG001|COMPLETED|Main Study||0
9776764|NCT00474383|10882782|FG000|NOT COMPLETED|Main Study||36
9776765|NCT00474383|10882783|FG001|NOT COMPLETED|Main Study||0
9776766|NCT00474383|10882782|FG000|STARTED|Between Main Study and Extension||11
9776767|NCT00474383|10882783|FG001|STARTED|Between Main Study and Extension||0
9776768|NCT00474383|10882782|FG000|COMPLETED|Between Main Study and Extension||5
9776769|NCT00474383|10882783|FG001|COMPLETED|Between Main Study and Extension||0
9776770|NCT00474383|10882782|FG000|NOT COMPLETED|Between Main Study and Extension||6
9776771|NCT00474383|10882783|FG001|NOT COMPLETED|Between Main Study and Extension||0
9776772|NCT00474383|10882782|FG000|STARTED|Extension||0
9776773|NCT00474383|10882783|FG001|STARTED|Extension||5
9776774|NCT00474383|10882782|FG000|COMPLETED|Extension||0
9776775|NCT00474383|10882783|FG001|COMPLETED|Extension||0
9776776|NCT00474383|10882782|FG000|NOT COMPLETED|Extension||0
9776777|NCT00474383|10882783|FG001|NOT COMPLETED|Extension||5
9776778|NCT00474487|10882791|FG000|STARTED|Overall Study||1606
9776779|NCT00474487|10882792|FG001|STARTED|Overall Study||217
9776780|NCT00474487|10882793|FG002|STARTED|Overall Study||899
9776781|NCT00474487|10882794|FG003|STARTED|Overall Study||109
9776782|NCT00474487|10882791|FG000|COMPLETED|Overall Study||1576
9776783|NCT00474487|10882792|FG001|COMPLETED|Overall Study||215
9776784|NCT00474487|10882793|FG002|COMPLETED|Overall Study||885
9776785|NCT00474487|10882794|FG003|COMPLETED|Overall Study||109
9776786|NCT00474487|10882791|FG000|NOT COMPLETED|Overall Study||30
9776787|NCT00474487|10882792|FG001|NOT COMPLETED|Overall Study||2
9776788|NCT00474487|10882793|FG002|NOT COMPLETED|Overall Study||14
9776789|NCT00474487|10882794|FG003|NOT COMPLETED|Overall Study||0
9776790|NCT00474526|10882821|FG000|STARTED|Overall Study||154
9776791|NCT00474526|10882822|FG001|STARTED|Overall Study||166
9776792|NCT00474526|10882823|FG002|STARTED|Overall Study||159
9776793|NCT00474526|10882824|FG003|STARTED|Overall Study||680
9776794|NCT00474526|10882825|FG004|STARTED|Overall Study||76
9776795|NCT00474526|10882826|FG005|STARTED|Overall Study||70
9776796|NCT00474526|10882827|FG006|STARTED|Overall Study||203
9776797|NCT00474526|10882828|FG007|STARTED|Overall Study||151
9776798|NCT00474526|10882829|FG008|STARTED|Overall Study||150
9776799|NCT00474526|10882830|FG009|STARTED|Overall Study||148
9776800|NCT00474526|10882831|FG010|STARTED|Overall Study||151
9776801|NCT00474526|10882832|FG011|STARTED|Overall Study||150
9776802|NCT00474526|10882833|FG012|STARTED|Overall Study||150
9776803|NCT00474526|10882834|FG013|STARTED|Overall Study||1426
9776804|NCT00474526|10882835|FG014|STARTED|Overall Study||358
9776805|NCT00474526|10882836|FG015|STARTED|Overall Study||170
9776806|NCT00474526|10882837|FG016|STARTED|Overall Study||183
9776807|NCT00474526|10882821|FG000|COMPLETED|Overall Study||121
9776808|NCT00474526|10882822|FG001|COMPLETED|Overall Study||120
9776809|NCT00474526|10882823|FG002|COMPLETED|Overall Study||110
9776810|NCT00474526|10882824|FG003|COMPLETED|Overall Study||561
9776811|NCT00474526|10882825|FG004|COMPLETED|Overall Study||8
9776812|NCT00474526|10882826|FG005|COMPLETED|Overall Study||54
9776813|NCT00474526|10882827|FG006|COMPLETED|Overall Study||178
9776814|NCT00474526|10882828|FG007|COMPLETED|Overall Study||145
9776815|NCT00474526|10882829|FG008|COMPLETED|Overall Study||144
9776816|NCT00474526|10882830|FG009|COMPLETED|Overall Study||121
9776817|NCT00474526|10882831|FG010|COMPLETED|Overall Study||141
9776818|NCT00474526|10882832|FG011|COMPLETED|Overall Study||139
9776819|NCT00474526|10882833|FG012|COMPLETED|Overall Study||135
9776820|NCT00474526|10882834|FG013|COMPLETED|Overall Study||1270
9776821|NCT00474526|10882835|FG014|COMPLETED|Overall Study||281
9776822|NCT00474526|10882836|FG015|COMPLETED|Overall Study||152
9776823|NCT00474526|10882837|FG016|COMPLETED|Overall Study||174
9776824|NCT00474526|10882821|FG000|NOT COMPLETED|Overall Study||33
9776825|NCT00474526|10882822|FG001|NOT COMPLETED|Overall Study||46
9776826|NCT00474526|10882823|FG002|NOT COMPLETED|Overall Study||49
9776827|NCT00474526|10882824|FG003|NOT COMPLETED|Overall Study||119
9776828|NCT00474526|10882825|FG004|NOT COMPLETED|Overall Study||68
9776829|NCT00474526|10882826|FG005|NOT COMPLETED|Overall Study||16
9776830|NCT00474526|10882827|FG006|NOT COMPLETED|Overall Study||25
9776831|NCT00474526|10882828|FG007|NOT COMPLETED|Overall Study||6
9776832|NCT00474526|10882829|FG008|NOT COMPLETED|Overall Study||6
9776833|NCT00474526|10882830|FG009|NOT COMPLETED|Overall Study||27
9776834|NCT00474526|10882831|FG010|NOT COMPLETED|Overall Study||10
9776835|NCT00474526|10882832|FG011|NOT COMPLETED|Overall Study||11
9776836|NCT00474526|10882833|FG012|NOT COMPLETED|Overall Study||15
9776837|NCT00474526|10882834|FG013|NOT COMPLETED|Overall Study||156
9776838|NCT00474526|10882835|FG014|NOT COMPLETED|Overall Study||77
9776839|NCT00474526|10882836|FG015|NOT COMPLETED|Overall Study||18
9776840|NCT00474526|10882837|FG016|NOT COMPLETED|Overall Study||9
9776841|NCT00474539|10882925|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
9776842|NCT00474539|10882926|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
9776843|NCT00474539|10882925|FG000|Vaccinated Dose 1|Infant Series||218
9776844|NCT00474539|10882926|FG001|Vaccinated Dose 1|Infant Series||226
9776845|NCT00474539|10882925|FG000|Vaccinated Dose 2|Infant Series||217
9776846|NCT00474539|10882926|FG001|Vaccinated Dose 2|Infant Series||222
9776847|NCT00474539|10882925|FG000|Vaccinated Dose 3|Infant Series||214
9776848|NCT00474539|10882926|FG001|Vaccinated Dose 3|Infant Series||221
9776849|NCT00474539|10882925|FG000|COMPLETED|Infant Series||213
9776850|NCT00474539|10882926|FG001|COMPLETED|Infant Series||220
9776851|NCT00474539|10882925|FG000|NOT COMPLETED|Infant Series||10
9776852|NCT00474539|10882926|FG001|NOT COMPLETED|Infant Series||6
9776853|NCT00474539|10882925|FG000|STARTED|After Infant Series||213
9776854|NCT00474539|10882926|FG001|STARTED|After Infant Series||220
9776855|NCT00474539|10882925|FG000|COMPLETED|After Infant Series||209
9776856|NCT00474539|10882926|FG001|COMPLETED|After Infant Series||220
9776857|NCT00474539|10882925|FG000|NOT COMPLETED|After Infant Series||4
9776858|NCT00474539|10882926|FG001|NOT COMPLETED|After Infant Series||0
9776859|NCT00474539|10882925|FG000|STARTED|Toddler Dose||209
9776860|NCT00474539|10882926|FG001|STARTED|Toddler Dose||220
9776861|NCT00474539|10882925|FG000|COMPLETED|Toddler Dose||208
9776862|NCT00474539|10882926|FG001|COMPLETED|Toddler Dose||220
9776863|NCT00474539|10882925|FG000|NOT COMPLETED|Toddler Dose||1
9776864|NCT00474539|10882926|FG001|NOT COMPLETED|Toddler Dose||0
9776865|NCT00474617|10882960|FG000|STARTED|Overall Study||56
9776866|NCT00474617|10882961|FG001|STARTED|Overall Study||64
9776867|NCT00474617|10882962|FG002|STARTED|Overall Study||42
9776868|NCT00474617|10882960|FG000|Treated|Overall Study||48
9776869|NCT00474617|10882961|FG001|Treated|Overall Study||62
9776870|NCT00474617|10882962|FG002|Treated|Overall Study||40
9776871|NCT00474617|10882960|FG000|COMPLETED|Overall Study||48
9776872|NCT00474617|10882961|FG001|COMPLETED|Overall Study||61
9776873|NCT00474617|10882962|FG002|COMPLETED|Overall Study||40
9776874|NCT00474617|10882960|FG000|NOT COMPLETED|Overall Study||8
9776875|NCT00474617|10882961|FG001|NOT COMPLETED|Overall Study||3
9776876|NCT00474617|10882962|FG002|NOT COMPLETED|Overall Study||2
9776877|NCT00474630|10882972|FG000|STARTED|Overall Study||335
9776878|NCT00474630|10882973|FG001|STARTED|Overall Study||170
9776879|NCT00474630|10882972|FG000|COMPLETED|Overall Study||175
9776880|NCT00474630|10882973|FG001|COMPLETED|Overall Study||100
9776881|NCT00474630|10882972|FG000|NOT COMPLETED|Overall Study||160
9776882|NCT00474630|10882973|FG001|NOT COMPLETED|Overall Study||70
9776883|NCT00474708|10882982|FG000|STARTED|Overall Study||791
9776884|NCT00474708|10882983|FG001|STARTED|Overall Study||367
9776885|NCT00474708|10882982|FG000|COMPLETED|Overall Study||734
9776886|NCT00474708|10882983|FG001|COMPLETED|Overall Study||342
9776887|NCT00474708|10882982|FG000|NOT COMPLETED|Overall Study||57
9776888|NCT00474708|10882983|FG001|NOT COMPLETED|Overall Study||25
9776889|NCT00474760|10882996|FG000|STARTED|Overall Study||3
9776890|NCT00474760|10882997|FG001|STARTED|Overall Study||3
9776891|NCT00474760|10882998|FG002|STARTED|Overall Study||3
9776892|NCT00474760|10882999|FG003|STARTED|Overall Study||3
9776893|NCT00474760|10883000|FG004|STARTED|Overall Study||13
9776894|NCT00474760|10883001|FG005|STARTED|Overall Study||29
9776895|NCT00474760|10883002|FG006|STARTED|Overall Study||11
9776896|NCT00474760|10882996|FG000|COMPLETED|Overall Study||0
9776897|NCT00474760|10882997|FG001|COMPLETED|Overall Study||0
9776898|NCT00474760|10882998|FG002|COMPLETED|Overall Study||0
9776899|NCT00474760|10882999|FG003|COMPLETED|Overall Study||0
9776900|NCT00474760|10883000|FG004|COMPLETED|Overall Study||1
9776901|NCT00474760|10883001|FG005|COMPLETED|Overall Study||0
9776902|NCT00474760|10883002|FG006|COMPLETED|Overall Study||1
9776903|NCT00474760|10882996|FG000|NOT COMPLETED|Overall Study||3
9776904|NCT00474760|10882997|FG001|NOT COMPLETED|Overall Study||3
9776905|NCT00474760|10882998|FG002|NOT COMPLETED|Overall Study||3
9776906|NCT00474760|10882999|FG003|NOT COMPLETED|Overall Study||3
9776907|NCT00474760|10883000|FG004|NOT COMPLETED|Overall Study||12
9776908|NCT00474760|10883001|FG005|NOT COMPLETED|Overall Study||29
9776909|NCT00474760|10883002|FG006|NOT COMPLETED|Overall Study||10
9776910|NCT00474786|10883027|FG000|STARTED|Overall Study||259
9776911|NCT00474786|10883028|FG001|STARTED|Overall Study||253
9776912|NCT00474786|10883027|FG000|COMPLETED|Overall Study||0
9776913|NCT00474786|10883028|FG001|COMPLETED|Overall Study||0
9776914|NCT00474786|10883027|FG000|NOT COMPLETED|Overall Study||259
9776915|NCT00474786|10883028|FG001|NOT COMPLETED|Overall Study||253
9776916|NCT00474812|10883034|FG000|STARTED|Overall Study||51
9776917|NCT00474812|10883034|FG000|COMPLETED|Overall Study||44
9776918|NCT00474812|10883034|FG000|NOT COMPLETED|Overall Study||7
9776919|NCT00474851|10883040|FG000|STARTED|Overall Study||26
9776920|NCT00474851|10883041|FG001|STARTED|Overall Study||27
9776921|NCT00474851|10883040|FG000|Completed Baseline|Overall Study||25
9776922|NCT00474851|10883041|FG001|Completed Baseline|Overall Study||26
9776923|NCT00474851|10883040|FG000|COMPLETED|Overall Study||18
9776924|NCT00474851|10883041|FG001|COMPLETED|Overall Study||16
9776925|NCT00474851|10883040|FG000|NOT COMPLETED|Overall Study||8
9776926|NCT00474851|10883041|FG001|NOT COMPLETED|Overall Study||11
9776927|NCT00474903|10883051|FG000|STARTED|Overall Study||30
9776928|NCT00474903|10883052|FG001|STARTED|Overall Study||47
9776929|NCT00474903|10883053|FG002|STARTED|Overall Study||45
9776930|NCT00474903|10883051|FG000|COMPLETED|Overall Study||29
9776931|NCT00474903|10883052|FG001|COMPLETED|Overall Study||42
9776932|NCT00474903|10883053|FG002|COMPLETED|Overall Study||43
9776933|NCT00474903|10883051|FG000|NOT COMPLETED|Overall Study||1
9776934|NCT00474903|10883052|FG001|NOT COMPLETED|Overall Study||5
9776935|NCT00474903|10883053|FG002|NOT COMPLETED|Overall Study||2
9776936|NCT00474929|10883066|FG000|STARTED|Overall Study||6
9776937|NCT00474929|10883067|FG001|STARTED|Overall Study||6
9776938|NCT00474929|10883068|FG002|STARTED|Overall Study||7
9776939|NCT00474929|10883069|FG003|STARTED|Overall Study||7
9776940|NCT00474929|10883070|FG004|STARTED|Overall Study||77
9776941|NCT00474929|10883066|FG000|COMPLETED|Overall Study||6
9776942|NCT00474929|10883067|FG001|COMPLETED|Overall Study||5
9776943|NCT00474929|10883068|FG002|COMPLETED|Overall Study||5
9776944|NCT00474929|10883069|FG003|COMPLETED|Overall Study||5
9776945|NCT00474929|10883070|FG004|COMPLETED|Overall Study||77
9776946|NCT00474929|10883066|FG000|NOT COMPLETED|Overall Study||0
9776947|NCT00474929|10883067|FG001|NOT COMPLETED|Overall Study||1
9776948|NCT00474929|10883068|FG002|NOT COMPLETED|Overall Study||2
9776949|NCT00474929|10883069|FG003|NOT COMPLETED|Overall Study||2
9776950|NCT00474929|10883070|FG004|NOT COMPLETED|Overall Study||0
9776951|NCT00474955|10883083|FG000|STARTED|Overall Study||27
9776952|NCT00474955|10883083|FG000|COMPLETED|Overall Study||19
9776953|NCT00474955|10883083|FG000|NOT COMPLETED|Overall Study||8
9776954|NCT00474968|10883089|FG000|STARTED|Overall Study||366
9776955|NCT00474968|10883090|FG001|STARTED|Overall Study||371
9776956|NCT00474968|10883089|FG000|COMPLETED|Overall Study||348
9776957|NCT00474968|10883090|FG001|COMPLETED|Overall Study||355
9776958|NCT00474968|10883089|FG000|NOT COMPLETED|Overall Study||18
9776959|NCT00474968|10883090|FG001|NOT COMPLETED|Overall Study||16
9776960|NCT00474994|10883096|FG000|STARTED|Overall Study||53
9776961|NCT00474994|10883096|FG000|COMPLETED|Overall Study||48
9776962|NCT00474994|10883096|FG000|NOT COMPLETED|Overall Study||5
9776963|NCT00475020|10883100|FG000|STARTED|Overall Study||63
9776964|NCT00475020|10883100|FG000|COMPLETED|Overall Study||58
9776965|NCT00475020|10883100|FG000|NOT COMPLETED|Overall Study||5
9776966|NCT00475033|10883106|FG000|STARTED|Infant Series||300
9776967|NCT00475033|10883107|FG001|STARTED|Infant Series||303
9776968|NCT00475033|10883106|FG000|Vaccinated Dose 1|Infant Series||300
9776969|NCT00475033|10883107|FG001|Vaccinated Dose 1|Infant Series||303
9776970|NCT00475033|10883106|FG000|Vaccinated Dose 2|Infant Series||297
9776971|NCT00475033|10883107|FG001|Vaccinated Dose 2|Infant Series||296
9776972|NCT00475033|10883106|FG000|Vaccinated Dose 3|Infant Series||293
9776973|NCT00475033|10883107|FG001|Vaccinated Dose 3|Infant Series||294
9776974|NCT00475033|10883106|FG000|COMPLETED|Infant Series||293
9776975|NCT00475033|10883107|FG001|COMPLETED|Infant Series||290
9776976|NCT00475033|10883106|FG000|NOT COMPLETED|Infant Series||7
9776977|NCT00475033|10883107|FG001|NOT COMPLETED|Infant Series||13
9776978|NCT00475033|10883106|FG000|STARTED|After the Infant Series||293
9776979|NCT00475033|10883107|FG001|STARTED|After the Infant Series||290
9776980|NCT00475033|10883106|FG000|Withdrawn After Infant Series|After the Infant Series||6
9776981|NCT00475033|10883107|FG001|Withdrawn After Infant Series|After the Infant Series||8
9776982|NCT00475033|10883106|FG000|COMPLETED|After the Infant Series||287
9776983|NCT00475033|10883107|FG001|COMPLETED|After the Infant Series||282
9776984|NCT00475033|10883106|FG000|NOT COMPLETED|After the Infant Series||6
9776985|NCT00475033|10883107|FG001|NOT COMPLETED|After the Infant Series||8
9776986|NCT00475033|10883106|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
9776987|NCT00475033|10883107|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
9776988|NCT00475033|10883106|FG000|COMPLETED|Toddler Dose||283
9776989|NCT00475033|10883107|FG001|COMPLETED|Toddler Dose||282
9776990|NCT00475033|10883106|FG000|NOT COMPLETED|Toddler Dose||4
9776991|NCT00475033|10883107|FG001|NOT COMPLETED|Toddler Dose||0
9776992|NCT00475085|10883124|FG000|STARTED|Overall Study||253
9776993|NCT00475085|10883125|FG001|STARTED|Overall Study||254
9776994|NCT00475085|10883126|FG002|STARTED|Overall Study||260
9776995|NCT00475085|10883127|FG003|STARTED|Overall Study||254
9776996|NCT00475085|10883124|FG000|COMPLETED|Overall Study||235
9776997|NCT00475085|10883125|FG001|COMPLETED|Overall Study||234
9776998|NCT00475085|10883126|FG002|COMPLETED|Overall Study||241
9776999|NCT00475085|10883127|FG003|COMPLETED|Overall Study||234
9777000|NCT00475085|10883124|FG000|NOT COMPLETED|Overall Study||18
9777001|NCT00475085|10883125|FG001|NOT COMPLETED|Overall Study||20
9777002|NCT00475085|10883126|FG002|NOT COMPLETED|Overall Study||19
9777003|NCT00475085|10883127|FG003|NOT COMPLETED|Overall Study||20
9777004|NCT00475150|10883139|FG000|STARTED|Overall Study||23
9777005|NCT00475150|10883140|FG001|STARTED|Overall Study||16
9777006|NCT00475150|10883139|FG000|COMPLETED|Overall Study||23
9777007|NCT00475150|10883140|FG001|COMPLETED|Overall Study||16
9777008|NCT00475150|10883139|FG000|NOT COMPLETED|Overall Study||0
9777009|NCT00475150|10883140|FG001|NOT COMPLETED|Overall Study||0
9777010|NCT00475176|10883145|FG000|STARTED|Overall Study||24
9777011|NCT00475176|10883145|FG000|COMPLETED|Overall Study||20
9777012|NCT00475176|10883145|FG000|NOT COMPLETED|Overall Study||4
9777013|NCT00475215|10883151|FG000|STARTED|Overall Study||44
9777014|NCT00475215|10883152|FG001|STARTED|Overall Study||42
9777015|NCT00475215|10883151|FG000|Treated|Overall Study||39
9777016|NCT00475215|10883152|FG001|Treated|Overall Study||38
9777017|NCT00475215|10883151|FG000|COMPLETED|Overall Study||39
9777018|NCT00475215|10883152|FG001|COMPLETED|Overall Study||38
9777019|NCT00475215|10883151|FG000|NOT COMPLETED|Overall Study||5
9777020|NCT00475215|10883152|FG001|NOT COMPLETED|Overall Study||4
9777021|NCT00475228|10883160|FG000|STARTED|Overall Study||44
9777022|NCT00475228|10883161|FG001|STARTED|Overall Study||44
9777023|NCT00475228|10883160|FG000|COMPLETED|Overall Study||27
9777024|NCT00475228|10883161|FG001|COMPLETED|Overall Study||27
9777025|NCT00475228|10883160|FG000|NOT COMPLETED|Overall Study||17
9777026|NCT00475228|10883161|FG001|NOT COMPLETED|Overall Study||17
9777027|NCT00475241|10883173|FG000|STARTED|Overall Study||18
9777028|NCT00475241|10883174|FG001|STARTED|Overall Study||18
9777029|NCT00475241|10883173|FG000|COMPLETED|Overall Study||11
9777030|NCT00475241|10883174|FG001|COMPLETED|Overall Study||15
9777031|NCT00475241|10883173|FG000|NOT COMPLETED|Overall Study||7
9777032|NCT00475241|10883174|FG001|NOT COMPLETED|Overall Study||3
9777033|NCT00475306|10883185|FG000|STARTED|Overall Study||73
9777034|NCT00475306|10883186|FG001|STARTED|Overall Study||72
9777035|NCT00475306|10883187|FG002|STARTED|Overall Study||72
9777036|NCT00475306|10883188|FG003|STARTED|Overall Study||72
9777037|NCT00475306|10883185|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
9777038|NCT00475306|10883186|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
9777039|NCT00475306|10883187|FG002|COMPLETED|Overall Study||72
9777040|NCT00475306|10883188|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
9777041|NCT00475306|10883185|FG000|NOT COMPLETED|Overall Study||1
9777042|NCT00475306|10883186|FG001|NOT COMPLETED|Overall Study||1
9777043|NCT00475306|10883187|FG002|NOT COMPLETED|Overall Study||0
9777044|NCT00475306|10883188|FG003|NOT COMPLETED|Overall Study||1
9777045|NCT00475319|10883201|FG000|STARTED|Overall Study||103
9777046|NCT00475319|10883202|FG001|STARTED|Overall Study||102
9777047|NCT00475319|10883203|FG002|STARTED|Overall Study||103
9777048|NCT00475319|10883201|FG000|COMPLETED|Overall Study||101
9777049|NCT00475319|10883202|FG001|COMPLETED|Overall Study||101
9777050|NCT00475319|10883203|FG002|COMPLETED|Overall Study||99
9777051|NCT00475319|10883201|FG000|NOT COMPLETED|Overall Study||2
9777052|NCT00475319|10883202|FG001|NOT COMPLETED|Overall Study||1
9777053|NCT00475319|10883203|FG002|NOT COMPLETED|Overall Study||4
9777054|NCT00475423|10883214|FG000|STARTED|Overall Study||122
9777055|NCT00475423|10883214|FG000|COMPLETED|Overall Study||90
9777056|NCT00475423|10883214|FG000|NOT COMPLETED|Overall Study||32
9777057|NCT00475501|10883222|FG000|STARTED|Overall Study||14
9777058|NCT00475501|10883223|FG001|STARTED|Overall Study||13
9777059|NCT00475501|10883224|FG002|STARTED|Overall Study||17
9777060|NCT00475501|10883225|FG003|STARTED|Overall Study||16
9777061|NCT00475501|10883222|FG000|COMPLETED|Overall Study||7
9777062|NCT00475501|10883223|FG001|COMPLETED|Overall Study||8
9777063|NCT00475501|10883224|FG002|COMPLETED|Overall Study||13
9777064|NCT00475501|10883225|FG003|COMPLETED|Overall Study||12
9777065|NCT00475501|10883222|FG000|NOT COMPLETED|Overall Study||7
9777066|NCT00475501|10883223|FG001|NOT COMPLETED|Overall Study||5
9777067|NCT00475501|10883224|FG002|NOT COMPLETED|Overall Study||4
9777068|NCT00475501|10883225|FG003|NOT COMPLETED|Overall Study||4
9777069|NCT00475644|10883267|FG000|STARTED|Overall Study||66
9777070|NCT00475644|10883267|FG000|Received at Least One Dose of Study Drug|Overall Study||66
9777071|NCT00475644|10883267|FG000|COMPLETED|Overall Study||53
9777072|NCT00475644|10883267|FG000|NOT COMPLETED|Overall Study||13
9777073|NCT00475670|10883273|FG000|STARTED|Overall Study||3
9777074|NCT00475670|10883274|FG001|STARTED|Overall Study||41
9777075|NCT00475670|10883273|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
9777076|NCT00475670|10883274|FG001|COMPLETED|Overall Study||0
9777077|NCT00475670|10883273|FG000|NOT COMPLETED|Overall Study||3
9777078|NCT00475670|10883274|FG001|NOT COMPLETED|Overall Study||41
9777079|NCT00475709|10883280|FG000|STARTED|Overall Study||1022
9777080|NCT00475709|10883280|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
9777081|NCT00475709|10883280|FG000|COMPLETED|Overall Study||946
9777082|NCT00475709|10883280|FG000|NOT COMPLETED|Overall Study||76
9777083|NCT00475722|10883286|FG000|STARTED|Overall Study||61
9777084|NCT00475722|10883287|FG001|STARTED|Overall Study||59
9777085|NCT00475722|10883286|FG000|COMPLETED|Overall Study||46
9777086|NCT00475722|10883287|FG001|COMPLETED|Overall Study||47
9777087|NCT00475722|10883286|FG000|NOT COMPLETED|Overall Study||15
9777088|NCT00475722|10883287|FG001|NOT COMPLETED|Overall Study||12
9777089|NCT00475735|10883299|FG000|STARTED|Treatment Period 1||14
9777090|NCT00475735|10883300|FG001|STARTED|Treatment Period 1||13
9777091|NCT00475735|10883301|FG002|STARTED|Treatment Period 1||7
9777092|NCT00475735|10883302|FG003|STARTED|Treatment Period 1||7
9777093|NCT00475735|10883303|FG004|STARTED|Treatment Period 1||16
9777094|NCT00475735|10883304|FG005|STARTED|Treatment Period 1||15
9777095|NCT00475735|10883299|FG000|COMPLETED|Treatment Period 1||10
9777096|NCT00475735|10883300|FG001|COMPLETED|Treatment Period 1||11
9777097|NCT00475735|10883301|FG002|COMPLETED|Treatment Period 1||7
9777098|NCT00475735|10883302|FG003|COMPLETED|Treatment Period 1||5
9777099|NCT00475735|10883303|FG004|COMPLETED|Treatment Period 1||14
9777100|NCT00475735|10883304|FG005|COMPLETED|Treatment Period 1||12
9777101|NCT00475735|10883299|FG000|NOT COMPLETED|Treatment Period 1||4
9777102|NCT00475735|10883300|FG001|NOT COMPLETED|Treatment Period 1||2
9777103|NCT00475735|10883301|FG002|NOT COMPLETED|Treatment Period 1||0
9777104|NCT00475735|10883302|FG003|NOT COMPLETED|Treatment Period 1||2
9777105|NCT00475735|10883303|FG004|NOT COMPLETED|Treatment Period 1||2
9777106|NCT00475735|10883304|FG005|NOT COMPLETED|Treatment Period 1||3
9777107|NCT00475735|10883299|FG000|STARTED|Treatment Washout||10
9777108|NCT00475735|10883300|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
9777109|NCT00475735|10883301|FG002|STARTED|Treatment Washout||7
9777110|NCT00475735|10883302|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
9777111|NCT00475735|10883303|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
9777112|NCT00475735|10883304|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
9777113|NCT00475735|10883299|FG000|COMPLETED|Treatment Washout||10
9777114|NCT00475735|10883300|FG001|COMPLETED|Treatment Washout||10
9777115|NCT00475735|10883301|FG002|COMPLETED|Treatment Washout||7
9777116|NCT00475735|10883302|FG003|COMPLETED|Treatment Washout||6
9777117|NCT00475735|10883303|FG004|COMPLETED|Treatment Washout||16
9777118|NCT00475735|10883304|FG005|COMPLETED|Treatment Washout||14
9777119|NCT00475735|10883299|FG000|NOT COMPLETED|Treatment Washout||0
9777120|NCT00475735|10883300|FG001|NOT COMPLETED|Treatment Washout||2
9777121|NCT00475735|10883301|FG002|NOT COMPLETED|Treatment Washout||0
9777122|NCT00475735|10883302|FG003|NOT COMPLETED|Treatment Washout||0
9777123|NCT00475735|10883303|FG004|NOT COMPLETED|Treatment Washout||0
9777124|NCT00475735|10883304|FG005|NOT COMPLETED|Treatment Washout||0
9777125|NCT00475735|10883299|FG000|STARTED|Treatment Period 2||10
9777126|NCT00475735|10883300|FG001|STARTED|Treatment Period 2||10
9777127|NCT00475735|10883301|FG002|STARTED|Treatment Period 2||7
9777128|NCT00475735|10883302|FG003|STARTED|Treatment Period 2||6
9777129|NCT00475735|10883303|FG004|STARTED|Treatment Period 2||16
9777130|NCT00475735|10883304|FG005|STARTED|Treatment Period 2||14
9777131|NCT00475735|10883299|FG000|COMPLETED|Treatment Period 2||10
9777132|NCT00475735|10883300|FG001|COMPLETED|Treatment Period 2||9
9777133|NCT00475735|10883301|FG002|COMPLETED|Treatment Period 2||7
9777134|NCT00475735|10883302|FG003|COMPLETED|Treatment Period 2||4
9777135|NCT00475735|10883303|FG004|COMPLETED|Treatment Period 2||15
9777136|NCT00475735|10883304|FG005|COMPLETED|Treatment Period 2||13
9777137|NCT00475735|10883299|FG000|NOT COMPLETED|Treatment Period 2||0
9777138|NCT00475735|10883300|FG001|NOT COMPLETED|Treatment Period 2||1
9777139|NCT00475735|10883301|FG002|NOT COMPLETED|Treatment Period 2||0
9777140|NCT00475735|10883302|FG003|NOT COMPLETED|Treatment Period 2||2
9777141|NCT00475735|10883303|FG004|NOT COMPLETED|Treatment Period 2||1
9777142|NCT00475735|10883304|FG005|NOT COMPLETED|Treatment Period 2||1
9777143|NCT00475787|10883314|FG000|STARTED|Overall Study||69
9777144|NCT00475787|10883315|FG001|STARTED|Overall Study||67
9777145|NCT00475787|10883314|FG000|COMPLETED|Overall Study||61
9777146|NCT00475787|10883315|FG001|COMPLETED|Overall Study||60
9777147|NCT00475787|10883314|FG000|NOT COMPLETED|Overall Study||8
9777148|NCT00475787|10883315|FG001|NOT COMPLETED|Overall Study||7
9777149|NCT00475852|10883325|FG000|STARTED|Overall Study||3564
9777150|NCT00475852|10883326|FG001|STARTED|Overall Study||3577
9777151|NCT00475852|10883325|FG000|COMPLETED|Overall Study||3047
9777152|NCT00475852|10883326|FG001|COMPLETED|Overall Study||3029
9777153|NCT00475852|10883325|FG000|NOT COMPLETED|Overall Study||517
9777154|NCT00475852|10883326|FG001|NOT COMPLETED|Overall Study||548
9777155|NCT00475865|10883335|FG000|STARTED|Overall Study|randomized|41
9777156|NCT00475865|10883336|FG001|STARTED|Overall Study|randomized|42
9777157|NCT00475865|10883337|FG002|STARTED|Overall Study|randomized|40
9777158|NCT00475865|10883335|FG000|Treated|Overall Study|completed treatment period|41
9777159|NCT00475865|10883336|FG001|Treated|Overall Study||42
9777160|NCT00475865|10883337|FG002|Treated|Overall Study||40
9777161|NCT00475865|10883335|FG000|COMPLETED|Overall Study||39
9777162|NCT00475865|10883336|FG001|COMPLETED|Overall Study|completed treatment period|37
9777163|NCT00475865|10883337|FG002|COMPLETED|Overall Study|completed treatment period|34
9777164|NCT00475865|10883335|FG000|NOT COMPLETED|Overall Study||2
9777165|NCT00475865|10883336|FG001|NOT COMPLETED|Overall Study||5
9777166|NCT00475865|10883337|FG002|NOT COMPLETED|Overall Study||6
9777167|NCT00475878|10883349|FG000|STARTED|Overall Study||75
9777168|NCT00475878|10883350|FG001|STARTED|Overall Study||72
9777169|NCT00475878|10883349|FG000|COMPLETED|Overall Study||75
9777170|NCT00475878|10883350|FG001|COMPLETED|Overall Study||72
9777171|NCT00475878|10883349|FG000|NOT COMPLETED|Overall Study||0
9777172|NCT00475878|10883350|FG001|NOT COMPLETED|Overall Study||0
9777173|NCT00475904|10883361|FG000|STARTED|Overall Study||140
9777174|NCT00475904|10883362|FG001|STARTED|Overall Study||144
9777175|NCT00475904|10883363|FG002|STARTED|Overall Study||76
9777176|NCT00475904|10883361|FG000|COMPLETED|Overall Study||125
9777177|NCT00475904|10883362|FG001|COMPLETED|Overall Study||131
9777178|NCT00475904|10883363|FG002|COMPLETED|Overall Study||72
9777179|NCT00475904|10883361|FG000|NOT COMPLETED|Overall Study||15
9777180|NCT00475904|10883362|FG001|NOT COMPLETED|Overall Study||13
9777181|NCT00475904|10883363|FG002|NOT COMPLETED|Overall Study||4
9777182|NCT00475982|10883373|FG000|STARTED|Overall Study||23
9777183|NCT00475982|10883374|FG001|STARTED|Overall Study||21
9777184|NCT00475982|10883373|FG000|COMPLETED|Overall Study||16
9777185|NCT00475982|10883374|FG001|COMPLETED|Overall Study||18
9777186|NCT00475982|10883373|FG000|NOT COMPLETED|Overall Study||7
9777187|NCT00475982|10883374|FG001|NOT COMPLETED|Overall Study||3
9830061|NCT00762073|10940741|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
9830062|NCT00762073|10940742|FG003|COMPLETED|Overall Study||17
9830063|NCT00762073|10940739|FG000|NOT COMPLETED|Overall Study||4
9830064|NCT00762073|10940740|FG001|NOT COMPLETED|Overall Study||4
9830065|NCT00762073|10940741|FG002|NOT COMPLETED|Overall Study||2
9830066|NCT00762073|10940742|FG003|NOT COMPLETED|Overall Study||3
9830067|NCT00762086|10940761|FG000|STARTED|Overall Study||39
9830068|NCT00762086|10940762|FG001|STARTED|Overall Study||28
9830069|NCT00762086|10940761|FG000|COMPLETED|Overall Study||33
9830070|NCT00762086|10940762|FG001|COMPLETED|Overall Study||24
9830071|NCT00762086|10940761|FG000|NOT COMPLETED|Overall Study||6
9830072|NCT00762086|10940762|FG001|NOT COMPLETED|Overall Study||4
9830073|NCT00762164|10940770|FG000|STARTED|Overall Study||17
9830074|NCT00762164|10940771|FG001|STARTED|Overall Study||17
9830075|NCT00762164|10940770|FG000|COMPLETED|Overall Study||14
9830076|NCT00762164|10940771|FG001|COMPLETED|Overall Study||15
9830077|NCT00762164|10940770|FG000|NOT COMPLETED|Overall Study||3
9830078|NCT00762164|10940771|FG001|NOT COMPLETED|Overall Study||2
9830079|NCT00762177|10940780|FG000|STARTED|1st Treatment Period||8
9830080|NCT00762177|10940781|FG001|STARTED|1st Treatment Period||8
9830081|NCT00762177|10940782|FG002|STARTED|1st Treatment Period||8
9830082|NCT00762177|10940780|FG000|COMPLETED|1st Treatment Period||8
9830083|NCT00762177|10940781|FG001|COMPLETED|1st Treatment Period||8
9830084|NCT00762177|10940782|FG002|COMPLETED|1st Treatment Period||8
9830085|NCT00762177|10940780|FG000|NOT COMPLETED|1st Treatment Period||0
9830086|NCT00762177|10940781|FG001|NOT COMPLETED|1st Treatment Period||0
9830087|NCT00762177|10940782|FG002|NOT COMPLETED|1st Treatment Period||0
9830088|NCT00762177|10940780|FG000|STARTED|Washout After 1st Treatment||8
9830089|NCT00762177|10940781|FG001|STARTED|Washout After 1st Treatment||8
9830090|NCT00762177|10940782|FG002|STARTED|Washout After 1st Treatment||8
9830091|NCT00762177|10940780|FG000|COMPLETED|Washout After 1st Treatment||8
9830092|NCT00762177|10940781|FG001|COMPLETED|Washout After 1st Treatment||8
9830093|NCT00762177|10940782|FG002|COMPLETED|Washout After 1st Treatment||8
9830094|NCT00762177|10940780|FG000|NOT COMPLETED|Washout After 1st Treatment||0
9830095|NCT00762177|10940781|FG001|NOT COMPLETED|Washout After 1st Treatment||0
9830096|NCT00762177|10940782|FG002|NOT COMPLETED|Washout After 1st Treatment||0
9830097|NCT00762177|10940780|FG000|STARTED|2nd Treatment Period||8
9830098|NCT00762177|10940781|FG001|STARTED|2nd Treatment Period||8
9830099|NCT00762177|10940782|FG002|STARTED|2nd Treatment Period||8
9830100|NCT00762177|10940780|FG000|COMPLETED|2nd Treatment Period||8
9830101|NCT00762177|10940781|FG001|COMPLETED|2nd Treatment Period||8
9830102|NCT00762177|10940782|FG002|COMPLETED|2nd Treatment Period||8
9777188|NCT00476008|10883382|FG000|STARTED|Overall Study||22
9777189|NCT00476008|10883383|FG001|STARTED|Overall Study||21
9777190|NCT00476008|10883382|FG000|6 Month Testing|Overall Study||15
9777191|NCT00476008|10883383|FG001|6 Month Testing|Overall Study||14
9777192|NCT00476008|10883382|FG000|COMPLETED|Overall Study||13
9777193|NCT00476008|10883383|FG001|COMPLETED|Overall Study||13
9777194|NCT00476008|10883382|FG000|NOT COMPLETED|Overall Study||9
9777195|NCT00476008|10883383|FG001|NOT COMPLETED|Overall Study||8
9777196|NCT00476021|10883395|FG000|STARTED|Overall Study||51
9777197|NCT00476021|10883396|FG001|STARTED|Overall Study||51
9777198|NCT00476021|10883395|FG000|COMPLETED|Overall Study||51
9777199|NCT00476021|10883396|FG001|COMPLETED|Overall Study||51
9777200|NCT00476021|10883395|FG000|NOT COMPLETED|Overall Study||0
9777201|NCT00476021|10883396|FG001|NOT COMPLETED|Overall Study||0
9777202|NCT00476047|10883408|FG000|STARTED|Overall Study||16
9777203|NCT00476047|10883408|FG000|Completed Treatment|Overall Study||16
9777204|NCT00476047|10883408|FG000|COMPLETED|Overall Study||15
9777205|NCT00476047|10883408|FG000|NOT COMPLETED|Overall Study||1
9777206|NCT00476086|10883414|FG000|STARTED|Overall Study||20
9777207|NCT00476086|10883414|FG000|Received Chemotherapy|Overall Study||19
9777208|NCT00476086|10883414|FG000|Received Radiation|Overall Study||15
9777209|NCT00476086|10883414|FG000|COMPLETED|Overall Study||15
9777210|NCT00476086|10883414|FG000|NOT COMPLETED|Overall Study||5
9777211|NCT00476151|10883422|FG000|STARTED|Overall Study||112
9777212|NCT00476151|10883423|FG001|STARTED|Overall Study||114
9777213|NCT00476151|10883422|FG000|COMPLETED|Overall Study||109
9777214|NCT00476151|10883423|FG001|COMPLETED|Overall Study||107
9777215|NCT00476151|10883422|FG000|NOT COMPLETED|Overall Study||3
9777216|NCT00476151|10883423|FG001|NOT COMPLETED|Overall Study||7
9777217|NCT00476229|10883429|FG000|STARTED|Overall Study||20
9777218|NCT00476229|10883429|FG000|COMPLETED|Overall Study||19
9777219|NCT00476229|10883429|FG000|NOT COMPLETED|Overall Study||1
9777220|NCT00476242|10883435|FG000|STARTED|Overall Study||27
9777221|NCT00476242|10883436|FG001|STARTED|Overall Study||28
9777222|NCT00476242|10883435|FG000|COMPLETED|Overall Study||19
9777223|NCT00476242|10883436|FG001|COMPLETED|Overall Study||12
9777224|NCT00476242|10883435|FG000|NOT COMPLETED|Overall Study||8
9777225|NCT00476242|10883436|FG001|NOT COMPLETED|Overall Study||16
9777226|NCT00476476|10883446|FG000|STARTED|Overall Study||17
9777227|NCT00476476|10883447|FG001|STARTED|Overall Study||24
9777228|NCT00476476|10883446|FG000|Response Evaluable|Overall Study||17
9777229|NCT00476476|10883447|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
9777230|NCT00476476|10883446|FG000|COMPLETED|Overall Study||15
9777231|NCT00476476|10883447|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
9777232|NCT00476476|10883446|FG000|NOT COMPLETED|Overall Study||2
9777233|NCT00476476|10883447|FG001|NOT COMPLETED|Overall Study||24
9777234|NCT00476593|10883456|FG000|STARTED|Overall Study||32
9777235|NCT00476593|10883457|FG001|STARTED|Overall Study||19
9777236|NCT00476593|10883458|FG002|STARTED|Overall Study||38
9777237|NCT00476593|10883459|FG003|STARTED|Overall Study||129
9777238|NCT00476593|10883456|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
9777239|NCT00476593|10883457|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
9777240|NCT00476593|10883458|FG002|COMPLETED|Overall Study||30
9777241|NCT00476593|10883459|FG003|COMPLETED|Overall Study||107
9777242|NCT00476593|10883456|FG000|NOT COMPLETED|Overall Study||10
9777243|NCT00476593|10883457|FG001|NOT COMPLETED|Overall Study||2
9777244|NCT00476593|10883458|FG002|NOT COMPLETED|Overall Study||8
9777245|NCT00476593|10883459|FG003|NOT COMPLETED|Overall Study||22
9777246|NCT00476645|10883469|FG000|STARTED|Overall Study||10
9777247|NCT00476645|10883469|FG000|COMPLETED|Overall Study||10
9777248|NCT00476645|10883469|FG000|NOT COMPLETED|Overall Study||0
9777249|NCT00476788|10883473|FG000|STARTED|Overall Study||14
9777250|NCT00476788|10883473|FG000|COMPLETED|Overall Study||11
9777251|NCT00476788|10883473|FG000|NOT COMPLETED|Overall Study||3
9777252|NCT00476957|10883479|FG000|STARTED|Overall Study||4357
9777253|NCT00476957|10883480|FG001|STARTED|Overall Study||4352
9777254|NCT00476957|10883479|FG000|COMPLETED|Overall Study||4181
9777255|NCT00476957|10883480|FG001|COMPLETED|Overall Study||4159
9777256|NCT00476957|10883479|FG000|NOT COMPLETED|Overall Study||176
9777257|NCT00476957|10883480|FG001|NOT COMPLETED|Overall Study||193
9777258|NCT00476996|10883489|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277
9777259|NCT00476996|10883490|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277
9777260|NCT00476996|10883491|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282
9777261|NCT00476996|10883492|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0
9777262|NCT00476996|10883489|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
9777263|NCT00476996|10883490|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
9777264|NCT00476996|10883491|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
9777265|NCT00476996|10883492|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
9777266|NCT00476996|10883489|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
9777267|NCT00476996|10883490|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
9777268|NCT00476996|10883491|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
9777269|NCT00476996|10883492|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
9777270|NCT00476996|10883489|FG000|STARTED|OLE Phase (From Week 48)||0
9777271|NCT00476996|10883490|FG001|STARTED|OLE Phase (From Week 48)||0
9777272|NCT00476996|10883491|FG002|STARTED|OLE Phase (From Week 48)||0
9777273|NCT00476996|10883492|FG003|STARTED|OLE Phase (From Week 48)||664
9777274|NCT00476996|10883489|FG000|COMPLETED|OLE Phase (From Week 48)||0
9777275|NCT00476996|10883490|FG001|COMPLETED|OLE Phase (From Week 48)||0
9777276|NCT00476996|10883491|FG002|COMPLETED|OLE Phase (From Week 48)||0
9777277|NCT00476996|10883492|FG003|COMPLETED|OLE Phase (From Week 48)||0
9777278|NCT00476996|10883489|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0
9777279|NCT00476996|10883490|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0
9777280|NCT00476996|10883491|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0
9777281|NCT00476996|10883492|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664
9777282|NCT00477087|10883501|FG000|STARTED|Overall Study||10
9777283|NCT00477087|10883501|FG000|COMPLETED|Overall Study||10
9777284|NCT00477087|10883501|FG000|NOT COMPLETED|Overall Study||0
9777285|NCT00477152|10883505|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
9777286|NCT00477152|10883505|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
9777287|NCT00477152|10883505|FG000|NOT COMPLETED|Overall Study||3
9777288|NCT00477165|10883511|FG000|STARTED|Overall Study||27
9777289|NCT00477165|10883512|FG001|STARTED|Overall Study||27
9777290|NCT00477165|10883511|FG000|COMPLETED|Overall Study||20
9777291|NCT00477165|10883512|FG001|COMPLETED|Overall Study||25
9777292|NCT00477165|10883511|FG000|NOT COMPLETED|Overall Study||7
9777293|NCT00477165|10883512|FG001|NOT COMPLETED|Overall Study||2
9777294|NCT00477191|10883518|FG000|STARTED|Overall Study||18
9777295|NCT00477191|10883518|FG000|COMPLETED|Overall Study||13
9777296|NCT00477191|10883518|FG000|NOT COMPLETED|Overall Study||5
9777297|NCT00477204|10883524|FG000|STARTED|Overall Study||4
9777298|NCT00477204|10883525|FG001|STARTED|Overall Study||5
9777299|NCT00477204|10883524|FG000|COMPLETED|Overall Study||4
9777300|NCT00477204|10883525|FG001|COMPLETED|Overall Study||5
9777301|NCT00477204|10883524|FG000|NOT COMPLETED|Overall Study||0
9777302|NCT00477204|10883525|FG001|NOT COMPLETED|Overall Study||0
9777303|NCT00477269|10883533|FG000|STARTED|Core Study||28
9777304|NCT00477269|10883534|FG001|STARTED|Core Study||31
9777305|NCT00477269|10883535|FG002|STARTED|Core Study||0
9777306|NCT00477269|10883533|FG000|COMPLETED|Core Study||19
9777307|NCT00477269|10883534|FG001|COMPLETED|Core Study||23
9777308|NCT00477269|10883535|FG002|COMPLETED|Core Study||0
9777309|NCT00477269|10883533|FG000|NOT COMPLETED|Core Study||9
9777310|NCT00477269|10883534|FG001|NOT COMPLETED|Core Study||8
9777311|NCT00477269|10883535|FG002|NOT COMPLETED|Core Study||0
9777312|NCT00477269|10883533|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0
9777313|NCT00477269|10883534|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0
9777314|NCT00477269|10883535|FG002|STARTED|Open Label Extension||22
9777315|NCT00477269|10883533|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
9777316|NCT00477269|10883534|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
9777317|NCT00477269|10883535|FG002|COMPLETED|Open Label Extension||9
9777318|NCT00477269|10883533|FG000|NOT COMPLETED|Open Label Extension||0
9777319|NCT00477269|10883534|FG001|NOT COMPLETED|Open Label Extension||0
9777320|NCT00477269|10883535|FG002|NOT COMPLETED|Open Label Extension||13
9777321|NCT00477295|10883545|FG000|STARTED|Overall Study||282
9777322|NCT00477295|10883546|FG001|STARTED|Overall Study||301
9777323|NCT00477295|10883545|FG000|COMPLETED|Overall Study||161
9777324|NCT00477295|10883546|FG001|COMPLETED|Overall Study||192
9777325|NCT00477295|10883545|FG000|NOT COMPLETED|Overall Study||121
9777326|NCT00477295|10883546|FG001|NOT COMPLETED|Overall Study||109
9777327|NCT00477334|10883556|FG000|STARTED|Overall Study||312
9777328|NCT00477334|10883557|FG001|STARTED|Overall Study||151
9777329|NCT00477334|10883556|FG000|Randomized and Took Study Drug|Overall Study||206
9777330|NCT00477334|10883557|FG001|Randomized and Took Study Drug|Overall Study||98
9777331|NCT00477334|10883556|FG000|Intent to Treat Population|Overall Study||201
9777332|NCT00477334|10883557|FG001|Intent to Treat Population|Overall Study||98
9777333|NCT00477334|10883556|FG000|Participants Completing First Recurrence|Overall Study||187
9777334|NCT00477334|10883557|FG001|Participants Completing First Recurrence|Overall Study||92
9777335|NCT00477334|10883556|FG000|Modified Intent to Treat Population|Overall Study||152
9777336|NCT00477334|10883557|FG001|Modified Intent to Treat Population|Overall Study||78
9777337|NCT00477334|10883556|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
9777338|NCT00477334|10883557|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
9777339|NCT00477334|10883556|FG000|NOT COMPLETED|Overall Study||170
9777340|NCT00477334|10883557|FG001|NOT COMPLETED|Overall Study||76
9777341|NCT00477386|10883569|FG000|STARTED|Overall Study||11
9777342|NCT00477386|10883570|FG001|STARTED|Overall Study||17
9777343|NCT00477386|10883569|FG000|COMPLETED|Overall Study||0
9777344|NCT00477386|10883570|FG001|COMPLETED|Overall Study||0
9777345|NCT00477386|10883569|FG000|NOT COMPLETED|Overall Study||11
9777346|NCT00477386|10883570|FG001|NOT COMPLETED|Overall Study||17
9777347|NCT00477451|10883580|FG000|STARTED|Overall Study||20
9777348|NCT00477451|10883581|FG001|STARTED|Overall Study||20
9777349|NCT00477451|10883582|FG002|STARTED|Overall Study||7
9777350|NCT00477451|10883583|FG003|STARTED|Overall Study||2
9777351|NCT00477451|10883580|FG000|COMPLETED|Overall Study||20
9777352|NCT00477451|10883581|FG001|COMPLETED|Overall Study||20
9777353|NCT00477451|10883582|FG002|COMPLETED|Overall Study||7
9777354|NCT00477451|10883583|FG003|COMPLETED|Overall Study||2
9777355|NCT00477451|10883580|FG000|NOT COMPLETED|Overall Study||0
9777356|NCT00477451|10883581|FG001|NOT COMPLETED|Overall Study||0
9777357|NCT00477451|10883582|FG002|NOT COMPLETED|Overall Study||0
9777358|NCT00477451|10883583|FG003|NOT COMPLETED|Overall Study||0
9777359|NCT00477464|10883591|FG000|STARTED|Overall Study||51
9777360|NCT00477464|10883591|FG000|COMPLETED|Overall Study||0
9777361|NCT00477464|10883591|FG000|NOT COMPLETED|Overall Study||51
9777362|NCT00477490|10883602|FG000|STARTED|Part I: 4 Week Efficacy||160
9777363|NCT00477490|10883603|FG001|STARTED|Part I: 4 Week Efficacy||163
9777364|NCT00477490|10883604|FG002|STARTED|Part I: 4 Week Efficacy||158
9777365|NCT00477490|10883605|FG003|STARTED|Part I: 4 Week Efficacy||158
9777366|NCT00477490|10883606|FG004|STARTED|Part I: 4 Week Efficacy||160
9777367|NCT00477490|10883607|FG005|STARTED|Part I: 4 Week Efficacy||0
9777368|NCT00477490|10883608|FG006|STARTED|Part I: 4 Week Efficacy||0
9777369|NCT00477490|10883609|FG007|STARTED|Part I: 4 Week Efficacy||0
9777370|NCT00477490|10883610|FG008|STARTED|Part I: 4 Week Efficacy||0
9777371|NCT00477490|10883602|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
9777372|NCT00477490|10883603|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
9777373|NCT00477490|10883604|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
9777374|NCT00477490|10883605|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
9777375|NCT00477490|10883606|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
9777376|NCT00477490|10883607|FG005|ITT Population|Part I: 4 Week Efficacy||0
9777377|NCT00477490|10883608|FG006|ITT Population|Part I: 4 Week Efficacy||0
9777378|NCT00477490|10883609|FG007|ITT Population|Part I: 4 Week Efficacy||0
9777379|NCT00477490|10883610|FG008|ITT Population|Part I: 4 Week Efficacy||0
9777380|NCT00477490|10883602|FG000|COMPLETED|Part I: 4 Week Efficacy||145
9777381|NCT00477490|10883603|FG001|COMPLETED|Part I: 4 Week Efficacy||144
9777382|NCT00477490|10883604|FG002|COMPLETED|Part I: 4 Week Efficacy||148
9777383|NCT00477490|10883605|FG003|COMPLETED|Part I: 4 Week Efficacy||138
9777384|NCT00477490|10883606|FG004|COMPLETED|Part I: 4 Week Efficacy||135
9777385|NCT00477490|10883607|FG005|COMPLETED|Part I: 4 Week Efficacy||0
9777386|NCT00477490|10883608|FG006|COMPLETED|Part I: 4 Week Efficacy||0
9777387|NCT00477490|10883609|FG007|COMPLETED|Part I: 4 Week Efficacy||0
9777388|NCT00477490|10883610|FG008|COMPLETED|Part I: 4 Week Efficacy||0
9777389|NCT00477490|10883602|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15
9777390|NCT00477490|10883603|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19
9777391|NCT00477490|10883604|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10
9777392|NCT00477490|10883605|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20
9777393|NCT00477490|10883606|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25
9777394|NCT00477490|10883607|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0
9777395|NCT00477490|10883608|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0
9777396|NCT00477490|10883609|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0
9777397|NCT00477490|10883610|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0
9777398|NCT00477490|10883602|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0
9777399|NCT00477490|10883603|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135
9777400|NCT00477490|10883604|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135
9777401|NCT00477490|10883605|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132
9777402|NCT00477490|10883606|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127
9777403|NCT00477490|10883607|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31
9777404|NCT00477490|10883608|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37
10014577|NCT01800903|11137665|FG004|COMPLETED|Third Test Period||6
10014578|NCT01800903|11137666|FG005|COMPLETED|Third Test Period||6
9777405|NCT00477490|10883609|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34
9777406|NCT00477490|10883610|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34
9777407|NCT00477490|10883602|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0
9777408|NCT00477490|10883603|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107
9777409|NCT00477490|10883604|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120
9777410|NCT00477490|10883605|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120
9777411|NCT00477490|10883606|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107
9777412|NCT00477490|10883607|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25
9777413|NCT00477490|10883608|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32
9777414|NCT00477490|10883609|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29
9777415|NCT00477490|10883610|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26
9777416|NCT00477490|10883602|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
9777417|NCT00477490|10883603|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
9777418|NCT00477490|10883604|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
9777419|NCT00477490|10883605|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
9777420|NCT00477490|10883606|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
9777421|NCT00477490|10883607|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
9777422|NCT00477490|10883608|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
9777423|NCT00477490|10883609|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
9777424|NCT00477490|10883610|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
9777425|NCT00477594|10883640|FG000|STARTED|Year 1 and Year 2||16
9777426|NCT00477594|10883641|FG001|STARTED|Year 1 and Year 2||5
10014579|NCT01800903|11137661|FG000|NOT COMPLETED|Third Test Period||0
10014580|NCT01800903|11137662|FG001|NOT COMPLETED|Third Test Period||0
10014581|NCT01800903|11137663|FG002|NOT COMPLETED|Third Test Period||0
9777427|NCT00477594|10883640|FG000|COMPLETED|Year 1 and Year 2||7
9777428|NCT00477594|10883641|FG001|COMPLETED|Year 1 and Year 2||1
9777429|NCT00477594|10883640|FG000|NOT COMPLETED|Year 1 and Year 2||9
9777430|NCT00477594|10883641|FG001|NOT COMPLETED|Year 1 and Year 2||4
9777431|NCT00477594|10883640|FG000|STARTED|Year 3||4
9777432|NCT00477594|10883641|FG001|STARTED|Year 3||0
9777433|NCT00477594|10883640|FG000|COMPLETED|Year 3||2
9777434|NCT00477594|10883641|FG001|COMPLETED|Year 3||0
9777435|NCT00477594|10883640|FG000|NOT COMPLETED|Year 3||2
9777436|NCT00477594|10883641|FG001|NOT COMPLETED|Year 3||0
9777437|NCT00477594|10883640|FG000|STARTED|Follow-up Period||16
9777438|NCT00477594|10883641|FG001|STARTED|Follow-up Period||5
9777439|NCT00477594|10883640|FG000|COMPLETED|Follow-up Period||13
9777440|NCT00477594|10883641|FG001|COMPLETED|Follow-up Period||4
9777441|NCT00477594|10883640|FG000|NOT COMPLETED|Follow-up Period||3
9777442|NCT00477594|10883641|FG001|NOT COMPLETED|Follow-up Period||1
9777443|NCT00477607|10883649|FG000|STARTED|Overall Study||19
9777444|NCT00477607|10883650|FG001|STARTED|Overall Study||20
9777445|NCT00477607|10883649|FG000|COMPLETED|Overall Study||12
9777446|NCT00477607|10883650|FG001|COMPLETED|Overall Study||13
9777447|NCT00477607|10883649|FG000|NOT COMPLETED|Overall Study||7
9777448|NCT00477607|10883650|FG001|NOT COMPLETED|Overall Study||7
9777449|NCT00477633|10883656|FG000|STARTED|Overall Study||1700
9777450|NCT00477633|10883656|FG000|COMPLETED|Overall Study||991
9777451|NCT00477633|10883656|FG000|NOT COMPLETED|Overall Study||709
9777452|NCT00477659|10883660|FG000|STARTED|Overall Study||14
9777453|NCT00477659|10883660|FG000|COMPLETED|Overall Study||14
9777454|NCT00477659|10883660|FG000|NOT COMPLETED|Overall Study||0
9777455|NCT00477672|10883667|FG000|STARTED|Overall Study||98
9777456|NCT00477672|10883668|FG001|STARTED|Overall Study||101
9777457|NCT00477672|10883669|FG002|STARTED|Overall Study||99
9777458|NCT00477672|10883667|FG000|COMPLETED|Overall Study||91
9777459|NCT00477672|10883668|FG001|COMPLETED|Overall Study||85
9777460|NCT00477672|10883669|FG002|COMPLETED|Overall Study||83
9777461|NCT00477672|10883667|FG000|NOT COMPLETED|Overall Study||7
9777462|NCT00477672|10883668|FG001|NOT COMPLETED|Overall Study||16
9777463|NCT00477672|10883669|FG002|NOT COMPLETED|Overall Study||16
9777464|NCT00477685|10883677|FG000|STARTED|Overall Study||10
9777465|NCT00477685|10883677|FG000|COMPLETED|Overall Study||10
9777466|NCT00477685|10883677|FG000|NOT COMPLETED|Overall Study||0
9777467|NCT00477750|10883681|FG000|STARTED|Overall Study||26
9777468|NCT00477750|10883681|FG000|COMPLETED|Overall Study||15
9777469|NCT00477750|10883681|FG000|NOT COMPLETED|Overall Study||11
9777470|NCT00477971|10883689|FG000|STARTED|Overall Study||34
9777471|NCT00477971|10883690|FG001|STARTED|Overall Study||55
9777472|NCT00477971|10883689|FG000|COMPLETED|Overall Study||17
9777473|NCT00477971|10883690|FG001|COMPLETED|Overall Study||49
9777474|NCT00477971|10883689|FG000|NOT COMPLETED|Overall Study||17
9777475|NCT00477971|10883690|FG001|NOT COMPLETED|Overall Study||6
9777476|NCT00478023|10883701|FG000|STARTED|Overall Study||170
9777477|NCT00478023|10883702|FG001|STARTED|Overall Study||168
9777478|NCT00478023|10883703|FG002|STARTED|Overall Study||171
9777479|NCT00478023|10883704|FG003|STARTED|Overall Study||176
9777480|NCT00478023|10883705|FG004|STARTED|Overall Study||169
9777481|NCT00478023|10883701|FG000|COMPLETED|Overall Study||135
9777482|NCT00478023|10883702|FG001|COMPLETED|Overall Study||144
9777483|NCT00478023|10883703|FG002|COMPLETED|Overall Study||151
9777484|NCT00478023|10883704|FG003|COMPLETED|Overall Study||146
9777485|NCT00478023|10883705|FG004|COMPLETED|Overall Study||114
10014582|NCT01800903|11137664|FG003|NOT COMPLETED|Third Test Period||0
10014583|NCT01800903|11137665|FG004|NOT COMPLETED|Third Test Period||0
10014584|NCT01800903|11137666|FG005|NOT COMPLETED|Third Test Period||0
10014585|NCT01800916|11137672|FG000|STARTED|Test Period 1 (1 Week)||7
10014586|NCT01800916|11137673|FG001|STARTED|Test Period 1 (1 Week)||7
10014587|NCT01800916|11137674|FG002|STARTED|Test Period 1 (1 Week)||7
10014588|NCT01800916|11137675|FG003|STARTED|Test Period 1 (1 Week)||7
10014589|NCT01800916|11137676|FG004|STARTED|Test Period 1 (1 Week)||8
10014590|NCT01800916|11137677|FG005|STARTED|Test Period 1 (1 Week)||7
9777486|NCT00478023|10883701|FG000|NOT COMPLETED|Overall Study||35
9777487|NCT00478023|10883702|FG001|NOT COMPLETED|Overall Study||24
9777488|NCT00478023|10883703|FG002|NOT COMPLETED|Overall Study||20
9777489|NCT00478023|10883704|FG003|NOT COMPLETED|Overall Study||30
9777490|NCT00478023|10883705|FG004|NOT COMPLETED|Overall Study||55
10014591|NCT01800916|11137678|FG006|STARTED|Test Period 1 (1 Week)||7
9777491|NCT00478036|10883720|FG000|STARTED|Overall Study||10
9777492|NCT00478036|10883721|FG001|STARTED|Overall Study||7
10014592|NCT01800916|11137679|FG007|STARTED|Test Period 1 (1 Week)||7
10014593|NCT01800916|11137680|FG008|STARTED|Test Period 1 (1 Week)||7
9777493|NCT00478036|10883722|FG002|STARTED|Overall Study||14
9777494|NCT00478036|10883720|FG000|COMPLETED|Overall Study||10
9777495|NCT00478036|10883721|FG001|COMPLETED|Overall Study||7
9777496|NCT00478036|10883722|FG002|COMPLETED|Overall Study||14
9777497|NCT00478036|10883720|FG000|NOT COMPLETED|Overall Study||0
9777498|NCT00478036|10883721|FG001|NOT COMPLETED|Overall Study||0
9777499|NCT00478036|10883722|FG002|NOT COMPLETED|Overall Study||0
9777500|NCT00478140|10883730|FG000|STARTED|Overall Study||4
9777501|NCT00478140|10883730|FG000|COMPLETED|Overall Study||3
9777502|NCT00478140|10883730|FG000|NOT COMPLETED|Overall Study||1
9777503|NCT00478192|10883737|FG000|STARTED|Overall Study||20
9777504|NCT00478192|10883738|FG001|STARTED|Overall Study||20
9777505|NCT00478192|10883739|FG002|STARTED|Overall Study||10
9777506|NCT00478192|10883737|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20
10014594|NCT01800916|11137672|FG000|COMPLETED|Test Period 1 (1 Week)||7
9777507|NCT00478192|10883738|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20
9777508|NCT00478192|10883739|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9
9777509|NCT00478192|10883737|FG000|End of Treatment|Overall Study||18
9777510|NCT00478192|10883738|FG001|End of Treatment|Overall Study||16
9777511|NCT00478192|10883739|FG002|End of Treatment|Overall Study||8
9777512|NCT00478192|10883737|FG000|COMPLETED|Overall Study||16
9777513|NCT00478192|10883738|FG001|COMPLETED|Overall Study||15
9777514|NCT00478192|10883739|FG002|COMPLETED|Overall Study||8
9777515|NCT00478192|10883737|FG000|NOT COMPLETED|Overall Study||4
9777516|NCT00478192|10883738|FG001|NOT COMPLETED|Overall Study||5
9777517|NCT00478192|10883739|FG002|NOT COMPLETED|Overall Study||2
9777518|NCT00478205|10883750|FG000|STARTED|Overall Study||981
9777519|NCT00478205|10883751|FG001|STARTED|Overall Study||486
9777520|NCT00478205|10883750|FG000|COMPLETED|Overall Study||685
9777521|NCT00478205|10883751|FG001|COMPLETED|Overall Study||399
9777522|NCT00478205|10883750|FG000|NOT COMPLETED|Overall Study||296
9777523|NCT00478205|10883751|FG001|NOT COMPLETED|Overall Study||87
9777524|NCT00478218|10883759|FG000|STARTED|Overall Study||34
9777525|NCT00478218|10883760|FG001|STARTED|Overall Study||19
9777526|NCT00478218|10883759|FG000|COMPLETED|Overall Study||34
9777527|NCT00478218|10883760|FG001|COMPLETED|Overall Study||19
9777528|NCT00478218|10883759|FG000|NOT COMPLETED|Overall Study||0
9777529|NCT00478218|10883760|FG001|NOT COMPLETED|Overall Study||0
9777530|NCT00478231|10883766|FG000|STARTED|Overall Study||209
9777531|NCT00478231|10883766|FG000|Treated|Overall Study||206
9777532|NCT00478231|10883766|FG000|COMPLETED|Overall Study||125
9777533|NCT00478231|10883766|FG000|NOT COMPLETED|Overall Study||84
9777534|NCT00478244|10883770|FG000|STARTED|Overall Study||7
9777535|NCT00478244|10883770|FG000|COMPLETED|Overall Study||6
9777536|NCT00478244|10883770|FG000|NOT COMPLETED|Overall Study||1
9777537|NCT00478257|10883776|FG000|STARTED|Overall Study||23
9777538|NCT00478257|10883777|FG001|STARTED|Overall Study||16
9777539|NCT00478257|10883776|FG000|COMPLETED|Overall Study||15
9777540|NCT00478257|10883777|FG001|COMPLETED|Overall Study||13
9777541|NCT00478257|10883776|FG000|NOT COMPLETED|Overall Study||8
9777542|NCT00478257|10883777|FG001|NOT COMPLETED|Overall Study||3
9777543|NCT00478335|10883785|FG000|STARTED|Period 1 (4 Days)||2
9777544|NCT00478335|10883786|FG001|STARTED|Period 1 (4 Days)||2
9777545|NCT00478335|10883785|FG000|COMPLETED|Period 1 (4 Days)||2
9777546|NCT00478335|10883786|FG001|COMPLETED|Period 1 (4 Days)||2
9777547|NCT00478335|10883785|FG000|NOT COMPLETED|Period 1 (4 Days)||0
9777548|NCT00478335|10883786|FG001|NOT COMPLETED|Period 1 (4 Days)||0
9777549|NCT00478335|10883785|FG000|STARTED|Period 2 (4 Days)||2
9777550|NCT00478335|10883786|FG001|STARTED|Period 2 (4 Days)||2
9777551|NCT00478335|10883785|FG000|COMPLETED|Period 2 (4 Days)||2
9777552|NCT00478335|10883786|FG001|COMPLETED|Period 2 (4 Days)||2
9777553|NCT00478335|10883785|FG000|NOT COMPLETED|Period 2 (4 Days)||0
9777554|NCT00478335|10883786|FG001|NOT COMPLETED|Period 2 (4 Days)||0
9777555|NCT00478361|10883792|FG000|STARTED|Overall Study||39
9777556|NCT00478361|10883792|FG000|COMPLETED|Overall Study||39
9777557|NCT00478361|10883792|FG000|NOT COMPLETED|Overall Study||0
9777558|NCT00478426|10883796|FG000|STARTED|Overall Study||34
9777559|NCT00478426|10883796|FG000|COMPLETED|Overall Study||33
9777560|NCT00478426|10883796|FG000|NOT COMPLETED|Overall Study||1
9777561|NCT00478556|10883802|FG000|STARTED|Overall Study||151
9777562|NCT00478556|10883803|FG001|STARTED|Overall Study||149
9777563|NCT00478556|10883802|FG000|COMPLETED|Overall Study||151
9777564|NCT00478556|10883803|FG001|COMPLETED|Overall Study||149
9777565|NCT00478556|10883802|FG000|NOT COMPLETED|Overall Study||0
9777566|NCT00478556|10883803|FG001|NOT COMPLETED|Overall Study||0
9777567|NCT00478569|10883809|FG000|STARTED|Overall Study||1170
9777568|NCT00478569|10883809|FG000|COMPLETED|Overall Study||761
9777569|NCT00478569|10883809|FG000|NOT COMPLETED|Overall Study||409
9777570|NCT00478608|10883821|FG000|STARTED|Overall Study||79
9777571|NCT00478608|10883821|FG000|COMPLETED|Overall Study||59
9777572|NCT00478608|10883821|FG000|NOT COMPLETED|Overall Study||20
9777573|NCT00478647|10883825|FG000|STARTED|Overall Study||40
9777574|NCT00478647|10883825|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
9777575|NCT00478647|10883825|FG000|NOT COMPLETED|Overall Study||2
9777576|NCT00478673|10883829|FG000|STARTED|30-Days Post-Procedure||298
9777577|NCT00478673|10883829|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
9777578|NCT00478673|10883829|FG000|NOT COMPLETED|30-Days Post-Procedure||10
9777579|NCT00478673|10883829|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
9777580|NCT00478673|10883829|FG000|COMPLETED|12-Months Post-Procedure||231
9777581|NCT00478673|10883829|FG000|NOT COMPLETED|12-Months Post-Procedure||64
9777582|NCT00478777|10883833|FG000|STARTED|Overall Study||150
9952313|NCT01421342|11071239|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
9777583|NCT00478777|10883833|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
9777584|NCT00478777|10883833|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
9952314|NCT01421342|11071237|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204
9952315|NCT01421342|11071238|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253
9952316|NCT01421342|11071239|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268
9952317|NCT01421342|11071237|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
9952318|NCT01421342|11071238|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
9777585|NCT00478777|10883833|FG000|NOT COMPLETED|Overall Study||77
9777586|NCT00478881|10883839|FG000|STARTED|Overall Study||199
9777587|NCT00478881|10883840|FG001|STARTED|Overall Study||198
9777588|NCT00478881|10883839|FG000|Received Medication|Overall Study||198
9777589|NCT00478881|10883840|FG001|Received Medication|Overall Study||198
9777590|NCT00478881|10883839|FG000|COMPLETED|Overall Study||160
9777591|NCT00478881|10883840|FG001|COMPLETED|Overall Study||176
9777592|NCT00478881|10883839|FG000|NOT COMPLETED|Overall Study||39
9777593|NCT00478881|10883840|FG001|NOT COMPLETED|Overall Study||22
9777594|NCT00478933|10883846|FG000|STARTED|Overall Study||1223
9777595|NCT00478933|10883846|FG000|COMPLETED|Overall Study||1145
9777596|NCT00478933|10883846|FG000|NOT COMPLETED|Overall Study||78
9777597|NCT00479037|10883872|FG000|STARTED|Overall Study||41
9777598|NCT00479037|10883873|FG001|STARTED|Overall Study||40
9777599|NCT00479037|10883872|FG000|COMPLETED|Overall Study||38
9777600|NCT00479037|10883873|FG001|COMPLETED|Overall Study||34
9777601|NCT00479037|10883872|FG000|NOT COMPLETED|Overall Study||3
9777602|NCT00479037|10883873|FG001|NOT COMPLETED|Overall Study||6
9777603|NCT00479089|10883881|FG000|STARTED|Overall Study||25
9777604|NCT00479089|10883882|FG001|STARTED|Overall Study||25
9777605|NCT00479089|10883881|FG000|COMPLETED|Overall Study||25
9777606|NCT00479089|10883882|FG001|COMPLETED|Overall Study||25
9777607|NCT00479089|10883881|FG000|NOT COMPLETED|Overall Study||0
9777608|NCT00479089|10883882|FG001|NOT COMPLETED|Overall Study||0
9777609|NCT00479115|10883888|FG000|STARTED|Overall Study||1
9777610|NCT00479115|10883888|FG000|COMPLETED|Overall Study||1
9777611|NCT00479115|10883888|FG000|NOT COMPLETED|Overall Study||0
9777612|NCT00479154|10883894|FG000|STARTED|Overall Study||3
9777613|NCT00479154|10883895|FG001|STARTED|Overall Study||3
9777614|NCT00479154|10883894|FG000|COMPLETED|Overall Study||3
9777615|NCT00479154|10883895|FG001|COMPLETED|Overall Study||3
9777616|NCT00479154|10883894|FG000|NOT COMPLETED|Overall Study||0
9777617|NCT00479154|10883895|FG001|NOT COMPLETED|Overall Study||0
9777618|NCT00479232|10883903|FG000|STARTED|Overall Study||3
9777619|NCT00479232|10883904|FG001|STARTED|Overall Study||3
9777620|NCT00479232|10883905|FG002|STARTED|Overall Study||28
9777621|NCT00479232|10883906|FG003|STARTED|Overall Study||3
9777622|NCT00479232|10883907|FG004|STARTED|Overall Study||4
9777623|NCT00479232|10883908|FG005|STARTED|Overall Study||30
9777624|NCT00479232|10883903|FG000|COMPLETED|Overall Study||0
9777625|NCT00479232|10883904|FG001|COMPLETED|Overall Study||0
9777626|NCT00479232|10883905|FG002|COMPLETED|Overall Study||0
9777627|NCT00479232|10883906|FG003|COMPLETED|Overall Study||0
9777628|NCT00479232|10883907|FG004|COMPLETED|Overall Study||0
9777629|NCT00479232|10883908|FG005|COMPLETED|Overall Study||0
9777630|NCT00479232|10883903|FG000|NOT COMPLETED|Overall Study||3
9777631|NCT00479232|10883904|FG001|NOT COMPLETED|Overall Study||3
9777632|NCT00479232|10883905|FG002|NOT COMPLETED|Overall Study||28
9777633|NCT00479232|10883906|FG003|NOT COMPLETED|Overall Study||3
9777634|NCT00479232|10883907|FG004|NOT COMPLETED|Overall Study||4
9777635|NCT00479232|10883908|FG005|NOT COMPLETED|Overall Study||30
9777636|NCT00479336|10883930|FG000|STARTED|Overall Study||27
9777637|NCT00479336|10883931|FG001|STARTED|Overall Study||26
9777638|NCT00479336|10883932|FG002|STARTED|Overall Study||25
9777639|NCT00479336|10883933|FG003|STARTED|Overall Study||26
9777640|NCT00479336|10883930|FG000|COMPLETED|Overall Study||23
9777641|NCT00479336|10883931|FG001|COMPLETED|Overall Study||20
9777642|NCT00479336|10883932|FG002|COMPLETED|Overall Study||24
9777643|NCT00479336|10883933|FG003|COMPLETED|Overall Study||21
9777644|NCT00479336|10883930|FG000|NOT COMPLETED|Overall Study||4
9777645|NCT00479336|10883931|FG001|NOT COMPLETED|Overall Study||6
9777646|NCT00479336|10883932|FG002|NOT COMPLETED|Overall Study||1
9777647|NCT00479336|10883933|FG003|NOT COMPLETED|Overall Study||5
9777648|NCT00479388|10883945|FG000|STARTED|Overall Study||606
9777649|NCT00479388|10883946|FG001|STARTED|Overall Study||610
9777650|NCT00479388|10883945|FG000|COMPLETED|Overall Study||474
9777651|NCT00479388|10883946|FG001|COMPLETED|Overall Study||537
9777652|NCT00479388|10883945|FG000|NOT COMPLETED|Overall Study||132
9777653|NCT00479388|10883946|FG001|NOT COMPLETED|Overall Study||73
9777654|NCT00479401|10883955|FG000|STARTED|Overall Study||223
9777655|NCT00479401|10883956|FG001|STARTED|Overall Study||213
9777656|NCT00479401|10883957|FG002|STARTED|Overall Study||103
9777657|NCT00479401|10883955|FG000|COMPLETED|Overall Study||174
9777658|NCT00479401|10883956|FG001|COMPLETED|Overall Study||176
9777659|NCT00479401|10883957|FG002|COMPLETED|Overall Study||91
9777660|NCT00479401|10883955|FG000|NOT COMPLETED|Overall Study||49
9777661|NCT00479401|10883956|FG001|NOT COMPLETED|Overall Study||37
9777662|NCT00479401|10883957|FG002|NOT COMPLETED|Overall Study||12
9777663|NCT00479466|10883971|FG000|STARTED|Overall Study||57
9777664|NCT00479466|10883972|FG001|STARTED|Overall Study||57
9777665|NCT00479466|10883973|FG002|STARTED|Overall Study||57
9777666|NCT00479466|10883974|FG003|STARTED|Overall Study||58
9777667|NCT00479466|10883975|FG004|STARTED|Overall Study||56
9777668|NCT00479466|10883976|FG005|STARTED|Overall Study||57
9777669|NCT00479466|10883971|FG000|COMPLETED|Overall Study||44
9777670|NCT00479466|10883972|FG001|COMPLETED|Overall Study||49
9777671|NCT00479466|10883973|FG002|COMPLETED|Overall Study||54
9777672|NCT00479466|10883974|FG003|COMPLETED|Overall Study||55
9777673|NCT00479466|10883975|FG004|COMPLETED|Overall Study||48
9777674|NCT00479466|10883976|FG005|COMPLETED|Overall Study||53
9777675|NCT00479466|10883971|FG000|NOT COMPLETED|Overall Study||13
9777676|NCT00479466|10883972|FG001|NOT COMPLETED|Overall Study||8
9777677|NCT00479466|10883973|FG002|NOT COMPLETED|Overall Study||3
9777678|NCT00479466|10883974|FG003|NOT COMPLETED|Overall Study||3
9777679|NCT00479466|10883975|FG004|NOT COMPLETED|Overall Study||8
9777680|NCT00479466|10883976|FG005|NOT COMPLETED|Overall Study||4
9777681|NCT00479557|10883997|FG000|STARTED|Overall Study||36
9777682|NCT00479557|10883998|FG001|STARTED|Overall Study||61
9777683|NCT00479557|10883999|FG002|STARTED|Overall Study||40
9777684|NCT00479557|10884000|FG003|STARTED|Overall Study||35
9777685|NCT00479557|10884001|FG004|STARTED|Overall Study||12
9777686|NCT00479557|10884002|FG005|STARTED|Overall Study||44
9777687|NCT00479557|10884003|FG006|STARTED|Overall Study||17
9777688|NCT00479557|10883997|FG000|Treated|Overall Study||36
9777689|NCT00479557|10883998|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
9777690|NCT00479557|10883999|FG002|Treated|Overall Study||40
9777691|NCT00479557|10884000|FG003|Treated|Overall Study||35
9777692|NCT00479557|10884001|FG004|Treated|Overall Study||12
9777693|NCT00479557|10884002|FG005|Treated|Overall Study||44
9777694|NCT00479557|10884003|FG006|Treated|Overall Study||17
9777695|NCT00479557|10883997|FG000|COMPLETED|Overall Study||26
9777696|NCT00479557|10883998|FG001|COMPLETED|Overall Study||51
9777697|NCT00479557|10883999|FG002|COMPLETED|Overall Study||32
9777698|NCT00479557|10884000|FG003|COMPLETED|Overall Study||30
9777699|NCT00479557|10884001|FG004|COMPLETED|Overall Study||8
9777700|NCT00479557|10884002|FG005|COMPLETED|Overall Study||31
9777701|NCT00479557|10884003|FG006|COMPLETED|Overall Study||15
9777702|NCT00479557|10883997|FG000|NOT COMPLETED|Overall Study||10
10014595|NCT01800916|11137673|FG001|COMPLETED|Test Period 1 (1 Week)||7
10014596|NCT01800916|11137674|FG002|COMPLETED|Test Period 1 (1 Week)||7
10014597|NCT01800916|11137675|FG003|COMPLETED|Test Period 1 (1 Week)||6
10014598|NCT01800916|11137676|FG004|COMPLETED|Test Period 1 (1 Week)||7
10233936|NCT01602198|11363812|FG001|STARTED|Overall Study||1
9777703|NCT00479557|10883998|FG001|NOT COMPLETED|Overall Study||10
9777704|NCT00479557|10883999|FG002|NOT COMPLETED|Overall Study||8
9777705|NCT00479557|10884000|FG003|NOT COMPLETED|Overall Study||5
9777706|NCT00479557|10884001|FG004|NOT COMPLETED|Overall Study||4
9777707|NCT00479557|10884002|FG005|NOT COMPLETED|Overall Study||13
9777708|NCT00479557|10884003|FG006|NOT COMPLETED|Overall Study||2
9777709|NCT00479674|10884025|FG000|STARTED|Overall Study||41
9777710|NCT00479674|10884025|FG000|COMPLETED|Overall Study||0
9777711|NCT00479674|10884025|FG000|NOT COMPLETED|Overall Study||41
9777712|NCT00479687|10884031|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150
9777713|NCT00479687|10884032|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150
9777714|NCT00479687|10884033|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0
9777715|NCT00479687|10884031|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
9777716|NCT00479687|10884032|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
9777717|NCT00479687|10884033|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
9777718|NCT00479687|10884031|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
9777719|NCT00479687|10884032|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
9777720|NCT00479687|10884033|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
9777721|NCT00479687|10884031|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
9777722|NCT00479687|10884032|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
9777723|NCT00479687|10884033|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
9777724|NCT00479687|10884031|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
9777725|NCT00479687|10884032|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
9777726|NCT00479687|10884033|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
9777727|NCT00479687|10884031|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
9777728|NCT00479687|10884032|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
9777729|NCT00479687|10884033|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
9777730|NCT00479856|10884040|FG000|STARTED|Overall Study||9
9777731|NCT00479856|10884040|FG000|COMPLETED|Overall Study||6
9777732|NCT00479856|10884040|FG000|NOT COMPLETED|Overall Study||3
9777733|NCT00479882|10884048|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
9777734|NCT00479882|10884049|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
9777735|NCT00479882|10884050|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
9777736|NCT00479882|10884051|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
9777737|NCT00479882|10884048|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
9777738|NCT00479882|10884049|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
9777739|NCT00479882|10884050|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
9777740|NCT00479882|10884051|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
9777741|NCT00479882|10884048|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
9777742|NCT00479882|10884049|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
9777743|NCT00479882|10884050|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
9777744|NCT00479882|10884051|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
9777745|NCT00479882|10884048|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472
10014599|NCT01800916|11137677|FG005|COMPLETED|Test Period 1 (1 Week)||7
10233937|NCT01602198|11363811|FG000|COMPLETED|Overall Study||0
9777746|NCT00479882|10884049|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440
9777747|NCT00479882|10884050|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440
9777748|NCT00479882|10884051|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465
10014600|NCT01800916|11137678|FG006|COMPLETED|Test Period 1 (1 Week)||7
10014601|NCT01800916|11137679|FG007|COMPLETED|Test Period 1 (1 Week)||7
10014602|NCT01800916|11137680|FG008|COMPLETED|Test Period 1 (1 Week)||7
9777749|NCT00479882|10884048|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447
9777750|NCT00479882|10884049|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419
9777751|NCT00479882|10884050|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420
9777752|NCT00479882|10884051|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447
9777753|NCT00479882|10884048|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
9777754|NCT00479882|10884049|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
9777755|NCT00479882|10884050|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
9777756|NCT00479882|10884051|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
9777757|NCT00480025|10884079|FG000|STARTED|Overall Study||1515
9777758|NCT00480025|10884080|FG001|STARTED|Overall Study||757
9777759|NCT00480025|10884079|FG000|COMPLETED|Overall Study||763
9777760|NCT00480025|10884080|FG001|COMPLETED|Overall Study||388
9777761|NCT00480025|10884079|FG000|NOT COMPLETED|Overall Study||752
9777762|NCT00480025|10884080|FG001|NOT COMPLETED|Overall Study||369
9777763|NCT00480077|10884094|FG000|STARTED|Overall Study||168
9777764|NCT00480077|10884095|FG001|STARTED|Overall Study||167
9777765|NCT00480077|10884094|FG000|COMPLETED|Overall Study||137
9777766|NCT00480077|10884095|FG001|COMPLETED|Overall Study||141
9777767|NCT00480077|10884094|FG000|NOT COMPLETED|Overall Study||31
9777768|NCT00480077|10884095|FG001|NOT COMPLETED|Overall Study||26
9777769|NCT00480324|10884103|FG000|STARTED|Overall Study||508
9777770|NCT00480324|10884104|FG001|STARTED|Overall Study||257
9777771|NCT00480324|10884103|FG000|COMPLETED|Overall Study||476
9777772|NCT00480324|10884104|FG001|COMPLETED|Overall Study||241
9777773|NCT00480324|10884103|FG000|NOT COMPLETED|Overall Study||32
9777774|NCT00480324|10884104|FG001|NOT COMPLETED|Overall Study||16
9777775|NCT00480441|10884112|FG000|STARTED|Screening||61
9777776|NCT00480441|10884113|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
9777777|NCT00480441|10884114|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
9777778|NCT00480441|10884112|FG000|COMPLETED|Screening||24
9777779|NCT00480441|10884113|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
9777780|NCT00480441|10884114|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
9777781|NCT00480441|10884112|FG000|NOT COMPLETED|Screening||37
9777782|NCT00480441|10884113|FG001|NOT COMPLETED|Screening||0
9777783|NCT00480441|10884114|FG002|NOT COMPLETED|Screening||0
9777784|NCT00480441|10884112|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
9777785|NCT00480441|10884113|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
9777786|NCT00480441|10884114|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
9777787|NCT00480441|10884112|FG000|COMPLETED|Baseline Functional MRI||12
9777788|NCT00480441|10884113|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
9777789|NCT00480441|10884114|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
9777790|NCT00480441|10884112|FG000|NOT COMPLETED|Baseline Functional MRI||12
9777791|NCT00480441|10884113|FG001|NOT COMPLETED|Baseline Functional MRI||0
9777792|NCT00480441|10884114|FG002|NOT COMPLETED|Baseline Functional MRI||0
9777793|NCT00480441|10884112|FG000|STARTED|Randomization||0
9777794|NCT00480441|10884113|FG001|STARTED|Randomization||13
9777795|NCT00480441|10884114|FG002|STARTED|Randomization||11
9777796|NCT00480441|10884112|FG000|COMPLETED|Randomization||0
9777797|NCT00480441|10884113|FG001|COMPLETED|Randomization||6
9777798|NCT00480441|10884114|FG002|COMPLETED|Randomization||9
9777799|NCT00480441|10884112|FG000|NOT COMPLETED|Randomization||0
9777800|NCT00480441|10884113|FG001|NOT COMPLETED|Randomization||7
9777801|NCT00480441|10884114|FG002|NOT COMPLETED|Randomization||2
9777802|NCT00480493|10884123|FG000|STARTED|Overall Study||32
9777803|NCT00480493|10884124|FG001|STARTED|Overall Study||28
9777804|NCT00480493|10884123|FG000|Randomized|Overall Study||32
9777805|NCT00480493|10884124|FG001|Randomized|Overall Study||28
9777806|NCT00480493|10884123|FG000|COMPLETED|Overall Study||30
9777807|NCT00480493|10884124|FG001|COMPLETED|Overall Study||21
9777808|NCT00480493|10884123|FG000|NOT COMPLETED|Overall Study||2
9777809|NCT00480493|10884124|FG001|NOT COMPLETED|Overall Study||7
9777810|NCT00480532|10884136|FG000|STARTED|Overall Study||33
9777811|NCT00480532|10884137|FG001|STARTED|Overall Study||33
9777812|NCT00480532|10884138|FG002|STARTED|Overall Study||33
9777813|NCT00480532|10884139|FG003|STARTED|Overall Study||32
9777814|NCT00480532|10884136|FG000|COMPLETED|Overall Study||31
9777815|NCT00480532|10884137|FG001|COMPLETED|Overall Study||29
9777816|NCT00480532|10884138|FG002|COMPLETED|Overall Study||29
9777817|NCT00480532|10884139|FG003|COMPLETED|Overall Study||31
9777818|NCT00480532|10884136|FG000|NOT COMPLETED|Overall Study||2
9777819|NCT00480532|10884137|FG001|NOT COMPLETED|Overall Study||4
9777820|NCT00480532|10884138|FG002|NOT COMPLETED|Overall Study||4
9777821|NCT00480532|10884139|FG003|NOT COMPLETED|Overall Study||1
9777822|NCT00480636|10884149|FG000|STARTED|Overall Study||102
9777823|NCT00480636|10884149|FG000|COMPLETED|Overall Study||83
9777824|NCT00480636|10884149|FG000|NOT COMPLETED|Overall Study||19
9777825|NCT00480740|10884156|FG000|STARTED|Overall Study||26
9777826|NCT00480740|10884157|FG001|STARTED|Overall Study||9
9777827|NCT00480740|10884158|FG002|STARTED|Overall Study||6
9777828|NCT00480740|10884156|FG000|COMPLETED|Overall Study||26
9777829|NCT00480740|10884157|FG001|COMPLETED|Overall Study||9
9777830|NCT00480740|10884158|FG002|COMPLETED|Overall Study||6
9777831|NCT00480740|10884156|FG000|NOT COMPLETED|Overall Study||0
9777832|NCT00480740|10884157|FG001|NOT COMPLETED|Overall Study||0
9777833|NCT00480740|10884158|FG002|NOT COMPLETED|Overall Study||0
9777834|NCT00480779|10884168|FG000|STARTED|Overall Study||26
9777835|NCT00480779|10884169|FG001|STARTED|Overall Study||22
9777836|NCT00480779|10884168|FG000|COMPLETED|Overall Study||24
9777837|NCT00480779|10884169|FG001|COMPLETED|Overall Study||19
9777838|NCT00480779|10884168|FG000|NOT COMPLETED|Overall Study||2
9777839|NCT00480779|10884169|FG001|NOT COMPLETED|Overall Study||3
9777840|NCT00480857|10884175|FG000|STARTED|Overall Study||19
9777841|NCT00480857|10884175|FG000|COMPLETED|Overall Study||17
9777842|NCT00480857|10884175|FG000|NOT COMPLETED|Overall Study||2
9777843|NCT00480987|10884179|FG000|STARTED|Overall Study||27
9777844|NCT00480987|10884179|FG000|COMPLETED|Overall Study||27
9777845|NCT00480987|10884179|FG000|NOT COMPLETED|Overall Study||0
9777846|NCT00481065|10884191|FG000|STARTED|Overall Study||51
9777847|NCT00481065|10884192|FG001|STARTED|Overall Study||50
9777848|NCT00481065|10884193|FG002|STARTED|Overall Study||51
9777849|NCT00481065|10884194|FG003|STARTED|Overall Study||52
9777850|NCT00481065|10884195|FG004|STARTED|Overall Study||51
9777851|NCT00481065|10884196|FG005|STARTED|Overall Study||51
9777852|NCT00481065|10884197|FG006|STARTED|Overall Study||50
9777853|NCT00481065|10884198|FG007|STARTED|Overall Study||49
9777854|NCT00481065|10884191|FG000|COMPLETED|Overall Study||29
9777855|NCT00481065|10884192|FG001|COMPLETED|Overall Study||33
9777856|NCT00481065|10884193|FG002|COMPLETED|Overall Study||32
9777857|NCT00481065|10884194|FG003|COMPLETED|Overall Study||37
9777858|NCT00481065|10884195|FG004|COMPLETED|Overall Study||28
9777859|NCT00481065|10884196|FG005|COMPLETED|Overall Study||27
9777860|NCT00481065|10884197|FG006|COMPLETED|Overall Study||34
9777861|NCT00481065|10884198|FG007|COMPLETED|Overall Study||30
9777862|NCT00481065|10884191|FG000|NOT COMPLETED|Overall Study||22
9777863|NCT00481065|10884192|FG001|NOT COMPLETED|Overall Study||17
9777864|NCT00481065|10884193|FG002|NOT COMPLETED|Overall Study||19
9777865|NCT00481065|10884194|FG003|NOT COMPLETED|Overall Study||15
9777866|NCT00481065|10884195|FG004|NOT COMPLETED|Overall Study||23
9777867|NCT00481065|10884196|FG005|NOT COMPLETED|Overall Study||24
9777868|NCT00481065|10884197|FG006|NOT COMPLETED|Overall Study||16
9777869|NCT00481065|10884198|FG007|NOT COMPLETED|Overall Study||19
9777870|NCT00481078|10884220|FG000|STARTED|Overall Study||62
9777871|NCT00481078|10884221|FG001|STARTED|Overall Study||32
9777872|NCT00481078|10884220|FG000|COMPLETED|Overall Study||20
9777873|NCT00481078|10884221|FG001|COMPLETED|Overall Study||12
9777874|NCT00481078|10884220|FG000|NOT COMPLETED|Overall Study||42
9777875|NCT00481078|10884221|FG001|NOT COMPLETED|Overall Study||20
9777876|NCT00481195|10884229|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
9777877|NCT00481195|10884230|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
9777878|NCT00481195|10884229|FG000|COMPLETED|Overall Study||89
9777879|NCT00481195|10884230|FG001|COMPLETED|Overall Study||90
9777880|NCT00481195|10884229|FG000|NOT COMPLETED|Overall Study||39
9777881|NCT00481195|10884230|FG001|NOT COMPLETED|Overall Study||39
9777882|NCT00481247|10884238|FG000|STARTED|Overall Study|Randomized|259
9777883|NCT00481247|10884239|FG001|STARTED|Overall Study|Randomized|260
9777884|NCT00481247|10884238|FG000|Received Treatment|Overall Study||258
9777885|NCT00481247|10884239|FG001|Received Treatment|Overall Study||258
9777886|NCT00481247|10884238|FG000|COMPLETED|Overall Study||0
9777887|NCT00481247|10884239|FG001|COMPLETED|Overall Study||0
9777888|NCT00481247|10884238|FG000|NOT COMPLETED|Overall Study||259
9777889|NCT00481247|10884239|FG001|NOT COMPLETED|Overall Study||260
9777890|NCT00481351|10884247|FG000|STARTED|Overall Study||13
9777891|NCT00481351|10884248|FG001|STARTED|Overall Study||12
9777892|NCT00481351|10884247|FG000|COMPLETED|Overall Study||13
9777893|NCT00481351|10884248|FG001|COMPLETED|Overall Study||12
9777894|NCT00481351|10884247|FG000|NOT COMPLETED|Overall Study||0
9777895|NCT00481351|10884248|FG001|NOT COMPLETED|Overall Study||0
9777896|NCT00481507|10884256|FG000|STARTED|Overall Study||64
9777897|NCT00481507|10884257|FG001|STARTED|Overall Study||61
9777898|NCT00481507|10884256|FG000|COMPLETED|Overall Study||64
9777899|NCT00481507|10884257|FG001|COMPLETED|Overall Study||61
9777900|NCT00481507|10884256|FG000|NOT COMPLETED|Overall Study||0
9777901|NCT00481507|10884257|FG001|NOT COMPLETED|Overall Study||0
9777902|NCT00481676|10884265|FG000|STARTED|Overall Study||27
9777903|NCT00481676|10884266|FG001|STARTED|Overall Study||22
9777904|NCT00481676|10884265|FG000|COMPLETED|Overall Study||25
9777905|NCT00481676|10884266|FG001|COMPLETED|Overall Study||17
9777906|NCT00481676|10884265|FG000|NOT COMPLETED|Overall Study||2
9777907|NCT00481676|10884266|FG001|NOT COMPLETED|Overall Study||5
9777908|NCT00481767|10884274|FG000|STARTED|Overall Study||450
9777909|NCT00481767|10884275|FG001|STARTED|Overall Study||226
9777910|NCT00481767|10884274|FG000|COMPLETED|Overall Study||418
9777911|NCT00481767|10884275|FG001|COMPLETED|Overall Study||205
9777912|NCT00481767|10884274|FG000|NOT COMPLETED|Overall Study||32
9777913|NCT00481767|10884275|FG001|NOT COMPLETED|Overall Study||21
9777914|NCT00481832|10884281|FG000|STARTED|Enrollment||50
9777915|NCT00481832|10884281|FG000|COMPLETED|Enrollment||40
9777916|NCT00481832|10884281|FG000|NOT COMPLETED|Enrollment||10
9777917|NCT00481832|10884281|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40
9777918|NCT00481832|10884281|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40
9777919|NCT00481832|10884281|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
9777920|NCT00481832|10884281|FG000|STARTED|Inter-transplant Period||40
9777921|NCT00481832|10884281|FG000|COMPLETED|Inter-transplant Period||13
9777922|NCT00481832|10884281|FG000|NOT COMPLETED|Inter-transplant Period||27
9777923|NCT00481832|10884281|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13
9777924|NCT00481832|10884281|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
9777925|NCT00481832|10884281|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
9777926|NCT00481845|10884287|FG000|STARTED|Overall Study||1
9777927|NCT00481845|10884288|FG001|STARTED|Overall Study||0
9777928|NCT00481845|10884287|FG000|COMPLETED|Overall Study||1
9777929|NCT00481845|10884288|FG001|COMPLETED|Overall Study||0
9777930|NCT00481845|10884287|FG000|NOT COMPLETED|Overall Study||0
9777931|NCT00481845|10884288|FG001|NOT COMPLETED|Overall Study||0
9777932|NCT00481871|10884299|FG000|STARTED|Overall Study||7
9777933|NCT00481871|10884300|FG001|STARTED|Overall Study||10
9777934|NCT00481871|10884301|FG002|STARTED|Overall Study||18
9777935|NCT00481871|10884302|FG003|STARTED|Overall Study||38
9777936|NCT00481871|10884303|FG004|STARTED|Overall Study||34
9777937|NCT00481871|10884299|FG000|COMPLETED|Overall Study||7
9777938|NCT00481871|10884300|FG001|COMPLETED|Overall Study||10
9777939|NCT00481871|10884301|FG002|COMPLETED|Overall Study||17
9777940|NCT00481871|10884302|FG003|COMPLETED|Overall Study||38
9777941|NCT00481871|10884303|FG004|COMPLETED|Overall Study||34
9777942|NCT00481871|10884299|FG000|NOT COMPLETED|Overall Study||0
9777943|NCT00481871|10884300|FG001|NOT COMPLETED|Overall Study||0
9777944|NCT00481871|10884301|FG002|NOT COMPLETED|Overall Study||1
9777945|NCT00481871|10884302|FG003|NOT COMPLETED|Overall Study||0
9777946|NCT00481871|10884303|FG004|NOT COMPLETED|Overall Study||0
9777947|NCT00481988|10884313|FG000|STARTED|Overall Study||12
9777948|NCT00481988|10884314|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9
9777949|NCT00481988|10884313|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
9777950|NCT00481988|10884314|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
9777951|NCT00481988|10884313|FG000|COMPLETED|Overall Study||11
9777952|NCT00481988|10884314|FG001|COMPLETED|Overall Study||8
9777953|NCT00481988|10884313|FG000|NOT COMPLETED|Overall Study||1
9777954|NCT00481988|10884314|FG001|NOT COMPLETED|Overall Study||1
9777955|NCT00482001|10884322|FG000|STARTED|Overall Study||11
9777956|NCT00482001|10884323|FG001|STARTED|Overall Study||11
9777957|NCT00482001|10884322|FG000|COMPLETED|Overall Study||10
9777958|NCT00482001|10884323|FG001|COMPLETED|Overall Study||10
9777959|NCT00482001|10884322|FG000|NOT COMPLETED|Overall Study||1
9777960|NCT00482001|10884323|FG001|NOT COMPLETED|Overall Study||1
9777961|NCT00482014|10884335|FG000|STARTED|Overall Study||9
9777962|NCT00482014|10884336|FG001|STARTED|Overall Study||13
9777963|NCT00482014|10884337|FG002|STARTED|Overall Study||46
9777964|NCT00482014|10884338|FG003|STARTED|Overall Study||52
9777965|NCT00482014|10884335|FG000|COMPLETED|Overall Study||2
9777966|NCT00482014|10884336|FG001|COMPLETED|Overall Study||7
9777967|NCT00482014|10884337|FG002|COMPLETED|Overall Study||35
9777968|NCT00482014|10884338|FG003|COMPLETED|Overall Study||29
9777969|NCT00482014|10884335|FG000|NOT COMPLETED|Overall Study||7
9777970|NCT00482014|10884336|FG001|NOT COMPLETED|Overall Study||6
9777971|NCT00482014|10884337|FG002|NOT COMPLETED|Overall Study||11
9777972|NCT00482014|10884338|FG003|NOT COMPLETED|Overall Study||23
9777973|NCT00482053|10884350|FG000|STARTED|Autologous Peripheral Stem Cells||3
9777974|NCT00482053|10884350|FG000|COMPLETED|Autologous Peripheral Stem Cells||3
9777975|NCT00482053|10884350|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0
9777976|NCT00482053|10884350|FG000|STARTED|Inter-treatment Period||3
9777977|NCT00482053|10884350|FG000|COMPLETED|Inter-treatment Period||2
9777978|NCT00482053|10884350|FG000|NOT COMPLETED|Inter-treatment Period||1
9777979|NCT00482053|10884350|FG000|STARTED|Allogeneic Peripheral Stem Cells||2
9777980|NCT00482053|10884350|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2
9777981|NCT00482053|10884350|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
9777982|NCT00482170|10884356|FG000|STARTED|Overall Study||207
10014603|NCT01800916|11137672|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0
10014604|NCT01800916|11137673|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0
9777983|NCT00482170|10884357|FG001|STARTED|Overall Study||214
9777984|NCT00482170|10884356|FG000|Treated|Overall Study||207
9777985|NCT00482170|10884357|FG001|Treated|Overall Study||211
9777986|NCT00482170|10884356|FG000|COMPLETED|Overall Study||192
9777987|NCT00482170|10884357|FG001|COMPLETED|Overall Study||194
9777988|NCT00482170|10884356|FG000|NOT COMPLETED|Overall Study||15
9777989|NCT00482170|10884357|FG001|NOT COMPLETED|Overall Study||20
9777990|NCT00482274|10884363|FG000|STARTED|Overall Study||3
9777991|NCT00482274|10884363|FG000|COMPLETED|Overall Study||2
9777992|NCT00482274|10884363|FG000|NOT COMPLETED|Overall Study||1
9777993|NCT00482391|10884367|FG000|STARTED|Overall Study||95
9777994|NCT00482391|10884367|FG000|COMPLETED|Overall Study||92
9777995|NCT00482391|10884367|FG000|NOT COMPLETED|Overall Study||3
9777996|NCT00482547|10884374|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
9777997|NCT00482547|10884375|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
9777998|NCT00482547|10884374|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
9777999|NCT00482547|10884375|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
9778000|NCT00482547|10884374|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
9830103|NCT00762177|10940780|FG000|NOT COMPLETED|2nd Treatment Period||0
10014605|NCT01800916|11137674|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0
9778001|NCT00482547|10884375|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
9778002|NCT00482547|10884374|FG000|COMPLETED|Overall Study||426
9778003|NCT00482547|10884375|FG001|COMPLETED|Overall Study||428
9778004|NCT00482547|10884374|FG000|NOT COMPLETED|Overall Study||173
9778005|NCT00482547|10884375|FG001|NOT COMPLETED|Overall Study||161
9778006|NCT00482612|10884385|FG000|STARTED|In-treatment Period||137
9778007|NCT00482612|10884386|FG001|STARTED|In-treatment Period||125
9778008|NCT00482612|10884387|FG002|STARTED|In-treatment Period||129
9778009|NCT00482612|10884388|FG003|STARTED|In-treatment Period||135
9778010|NCT00482612|10884385|FG000|Treated|In-treatment Period||137
9778011|NCT00482612|10884386|FG001|Treated|In-treatment Period||125
9778012|NCT00482612|10884387|FG002|Treated|In-treatment Period||128
9778013|NCT00482612|10884388|FG003|Treated|In-treatment Period||135
9778014|NCT00482612|10884385|FG000|COMPLETED|In-treatment Period||137
9778015|NCT00482612|10884386|FG001|COMPLETED|In-treatment Period||125
9778016|NCT00482612|10884387|FG002|COMPLETED|In-treatment Period||128
9778017|NCT00482612|10884388|FG003|COMPLETED|In-treatment Period||135
9778018|NCT00482612|10884385|FG000|NOT COMPLETED|In-treatment Period||0
9778019|NCT00482612|10884386|FG001|NOT COMPLETED|In-treatment Period||0
9778020|NCT00482612|10884387|FG002|NOT COMPLETED|In-treatment Period||1
9778021|NCT00482612|10884388|FG003|NOT COMPLETED|In-treatment Period||0
9778022|NCT00482612|10884385|FG000|STARTED|Follow-up Period||137
9778023|NCT00482612|10884386|FG001|STARTED|Follow-up Period||125
9778024|NCT00482612|10884387|FG002|STARTED|Follow-up Period||128
9778025|NCT00482612|10884388|FG003|STARTED|Follow-up Period||135
9778026|NCT00482612|10884385|FG000|COMPLETED|Follow-up Period||123
9778027|NCT00482612|10884386|FG001|COMPLETED|Follow-up Period||107
9778028|NCT00482612|10884387|FG002|COMPLETED|Follow-up Period||106
9778029|NCT00482612|10884388|FG003|COMPLETED|Follow-up Period||127
9778030|NCT00482612|10884385|FG000|NOT COMPLETED|Follow-up Period||14
9778031|NCT00482612|10884386|FG001|NOT COMPLETED|Follow-up Period||18
9778032|NCT00482612|10884387|FG002|NOT COMPLETED|Follow-up Period||22
9778033|NCT00482612|10884388|FG003|NOT COMPLETED|Follow-up Period||8
9778034|NCT00482625|10884402|FG000|STARTED|Overall Study||6
9778035|NCT00482625|10884402|FG000|COMPLETED|Overall Study||6
9778036|NCT00482625|10884402|FG000|NOT COMPLETED|Overall Study||0
9778037|NCT00482677|10884408|FG000|STARTED|Overall Study||281
9778038|NCT00482677|10884409|FG001|STARTED|Overall Study||281
9778039|NCT00482677|10884408|FG000|COMPLETED|Overall Study||281
9778040|NCT00482677|10884409|FG001|COMPLETED|Overall Study||281
9778041|NCT00482677|10884408|FG000|NOT COMPLETED|Overall Study||0
9778042|NCT00482677|10884409|FG001|NOT COMPLETED|Overall Study||0
9830104|NCT00762177|10940781|FG001|NOT COMPLETED|2nd Treatment Period||0
9830105|NCT00762177|10940782|FG002|NOT COMPLETED|2nd Treatment Period||0
9830106|NCT00762177|10940780|FG000|STARTED|Washout After 2nd Treatment||8
9830107|NCT00762177|10940781|FG001|STARTED|Washout After 2nd Treatment||8
9830108|NCT00762177|10940782|FG002|STARTED|Washout After 2nd Treatment||8
9830109|NCT00762177|10940780|FG000|COMPLETED|Washout After 2nd Treatment||8
9830110|NCT00762177|10940781|FG001|COMPLETED|Washout After 2nd Treatment||8
9830111|NCT00762177|10940782|FG002|COMPLETED|Washout After 2nd Treatment||8
9830112|NCT00762177|10940780|FG000|NOT COMPLETED|Washout After 2nd Treatment||0
9830113|NCT00762177|10940781|FG001|NOT COMPLETED|Washout After 2nd Treatment||0
9830114|NCT00762177|10940782|FG002|NOT COMPLETED|Washout After 2nd Treatment||0
9830115|NCT00762177|10940780|FG000|STARTED|3rd Treatment Period||8
10014606|NCT01800916|11137675|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1
10014607|NCT01800916|11137676|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1
10014608|NCT01800916|11137677|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0
10014609|NCT01800916|11137678|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0
10014610|NCT01800916|11137679|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0
10014611|NCT01800916|11137680|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0
9830116|NCT00762177|10940781|FG001|STARTED|3rd Treatment Period||8
9830117|NCT00762177|10940782|FG002|STARTED|3rd Treatment Period||8
9830118|NCT00762177|10940780|FG000|COMPLETED|3rd Treatment Period||8
10014612|NCT01800916|11137672|FG000|STARTED|Test Period 2 (1 Week)||7
10014613|NCT01800916|11137673|FG001|STARTED|Test Period 2 (1 Week)||7
9830119|NCT00762177|10940781|FG001|COMPLETED|3rd Treatment Period||8
9830120|NCT00762177|10940782|FG002|COMPLETED|3rd Treatment Period||8
9830121|NCT00762177|10940780|FG000|NOT COMPLETED|3rd Treatment Period||0
9830122|NCT00762177|10940781|FG001|NOT COMPLETED|3rd Treatment Period||0
9830123|NCT00762177|10940782|FG002|NOT COMPLETED|3rd Treatment Period||0
9830124|NCT00762216|10940793|FG000|STARTED|Overall Study||71
9830125|NCT00762216|10940793|FG000|COMPLETED|Overall Study||71
9830126|NCT00762216|10940793|FG000|NOT COMPLETED|Overall Study||0
9830127|NCT00762229|10940799|FG000|STARTED|Overall Study||15
9830128|NCT00762229|10940800|FG001|STARTED|Overall Study||24
9830129|NCT00762229|10940799|FG000|COMPLETED|Overall Study||14
9830130|NCT00762229|10940800|FG001|COMPLETED|Overall Study||22
9830131|NCT00762229|10940799|FG000|NOT COMPLETED|Overall Study||1
9830132|NCT00762229|10940800|FG001|NOT COMPLETED|Overall Study||2
9830133|NCT00762268|10940808|FG000|STARTED|Overall Study||12
9830134|NCT00762268|10940809|FG001|STARTED|Overall Study||11
9830135|NCT00762268|10940808|FG000|COMPLETED|Overall Study||9
9830136|NCT00762268|10940809|FG001|COMPLETED|Overall Study||8
9830137|NCT00762268|10940808|FG000|NOT COMPLETED|Overall Study||3
9830138|NCT00762268|10940809|FG001|NOT COMPLETED|Overall Study||3
9830139|NCT00762307|10940819|FG000|STARTED|Overall Study||28
9830140|NCT00762307|10940820|FG001|STARTED|Overall Study||11
9778043|NCT00482703|10884417|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11
9778044|NCT00482703|10884418|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12
9778045|NCT00482703|10884417|FG000|COMPLETED|Overall Study||10
9778046|NCT00482703|10884418|FG001|COMPLETED|Overall Study||12
9778047|NCT00482703|10884417|FG000|NOT COMPLETED|Overall Study||1
9778048|NCT00482703|10884418|FG001|NOT COMPLETED|Overall Study||0
9778049|NCT00482729|10884433|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
9778050|NCT00482729|10884434|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
9778051|NCT00482729|10884433|FG000|Completed Phase A|Overall Study||484
9778052|NCT00482729|10884434|FG001|Completed Phase A|Overall Study||482
9778053|NCT00482729|10884433|FG000|Completed Phase B|Overall Study||409
9778054|NCT00482729|10884434|FG001|Completed Phase B|Overall Study||406
9778055|NCT00482729|10884433|FG000|COMPLETED|Overall Study||409
9778056|NCT00482729|10884434|FG001|COMPLETED|Overall Study||406
9778057|NCT00482729|10884433|FG000|NOT COMPLETED|Overall Study||217
9778058|NCT00482729|10884434|FG001|NOT COMPLETED|Overall Study||218
9778059|NCT00482911|10884442|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
9778060|NCT00482911|10884443|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0
9778061|NCT00482911|10884442|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3
9778062|NCT00482911|10884443|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0
9778063|NCT00482911|10884442|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
9778064|NCT00482911|10884443|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
9778065|NCT00482911|10884442|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
9778066|NCT00482911|10884443|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
9778067|NCT00482911|10884442|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
9778068|NCT00482911|10884443|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
9778069|NCT00482911|10884442|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
9778070|NCT00482911|10884443|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
9778071|NCT00482911|10884442|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
9778072|NCT00482911|10884443|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
9778073|NCT00482911|10884442|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
9778074|NCT00482911|10884443|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
9778075|NCT00482911|10884442|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
9778076|NCT00482911|10884443|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
9778077|NCT00483002|10884449|FG000|STARTED|Overall Study||3719
9778078|NCT00483002|10884449|FG000|COMPLETED|Overall Study||1165
9778079|NCT00483002|10884449|FG000|NOT COMPLETED|Overall Study||2554
9778080|NCT00483041|10884455|FG000|STARTED|Overall Study||5
9778081|NCT00483041|10884456|FG001|STARTED|Overall Study||6
9778082|NCT00483041|10884455|FG000|COMPLETED|Overall Study||5
9778083|NCT00483041|10884456|FG001|COMPLETED|Overall Study||5
9778084|NCT00483041|10884455|FG000|NOT COMPLETED|Overall Study||0
9778085|NCT00483041|10884456|FG001|NOT COMPLETED|Overall Study||1
9778086|NCT00483184|10884465|FG000|STARTED|Overall Study||27
9778087|NCT00483184|10884466|FG001|STARTED|Overall Study||31
9778088|NCT00483184|10884467|FG002|STARTED|Overall Study||26
9778089|NCT00483184|10884465|FG000|COMPLETED|Overall Study||22
9778090|NCT00483184|10884466|FG001|COMPLETED|Overall Study||27
9778091|NCT00483184|10884467|FG002|COMPLETED|Overall Study||23
9778092|NCT00483184|10884465|FG000|NOT COMPLETED|Overall Study||5
9778093|NCT00483184|10884466|FG001|NOT COMPLETED|Overall Study||4
9778094|NCT00483184|10884467|FG002|NOT COMPLETED|Overall Study||3
9778095|NCT00483223|10884475|FG000|STARTED|Overall Study||86
9778096|NCT00483223|10884475|FG000|COMPLETED|Overall Study||86
9778097|NCT00483223|10884475|FG000|NOT COMPLETED|Overall Study||0
9778098|NCT00483262|10884481|FG000|STARTED|Overall Study||20
9778099|NCT00483262|10884482|FG001|STARTED|Overall Study||43
9778100|NCT00483262|10884481|FG000|COMPLETED|Overall Study||20
9778101|NCT00483262|10884482|FG001|COMPLETED|Overall Study||43
9778102|NCT00483262|10884481|FG000|NOT COMPLETED|Overall Study||0
9778103|NCT00483262|10884482|FG001|NOT COMPLETED|Overall Study||0
9778104|NCT00483327|10884492|FG000|STARTED|Overall Study||30
9778105|NCT00483327|10884492|FG000|COMPLETED|Overall Study||20
9778106|NCT00483327|10884492|FG000|NOT COMPLETED|Overall Study||10
9778107|NCT00483379|10884500|FG000|STARTED|Treatment Period||6
9778108|NCT00483379|10884501|FG001|STARTED|Treatment Period||7
9778109|NCT00483379|10884500|FG000|COMPLETED|Treatment Period||4
9778110|NCT00483379|10884501|FG001|COMPLETED|Treatment Period||7
9778111|NCT00483379|10884500|FG000|NOT COMPLETED|Treatment Period||2
9778112|NCT00483379|10884501|FG001|NOT COMPLETED|Treatment Period||0
10014614|NCT01800916|11137674|FG002|STARTED|Test Period 2 (1 Week)||7
10014615|NCT01800916|11137675|FG003|STARTED|Test Period 2 (1 Week)||6
10014616|NCT01800916|11137676|FG004|STARTED|Test Period 2 (1 Week)||7
10014617|NCT01800916|11137677|FG005|STARTED|Test Period 2 (1 Week)||7
9778113|NCT00483379|10884500|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
9778114|NCT00483379|10884501|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
9778115|NCT00483379|10884500|FG000|COMPLETED|Extension Period||1
9778116|NCT00483379|10884501|FG001|COMPLETED|Extension Period||2
9778117|NCT00483379|10884500|FG000|NOT COMPLETED|Extension Period||0
9778118|NCT00483379|10884501|FG001|NOT COMPLETED|Extension Period||0
9778119|NCT00483405|10884509|FG000|STARTED|Overall Study||28
9778120|NCT00483405|10884509|FG000|COMPLETED|Overall Study||0
9778121|NCT00483405|10884509|FG000|NOT COMPLETED|Overall Study||28
9778122|NCT00483496|10884513|FG000|STARTED|Overall Study||16
9778123|NCT00483496|10884513|FG000|COMPLETED|Overall Study||15
9778124|NCT00483496|10884513|FG000|NOT COMPLETED|Overall Study||1
9778125|NCT00483509|10884525|FG000|STARTED|Overall Study||28
9778126|NCT00483509|10884525|FG000|COMPLETED|Overall Study||28
9778127|NCT00483509|10884525|FG000|NOT COMPLETED|Overall Study||0
9778128|NCT00483548|10884531|FG000|STARTED|Overall Study||148
9778129|NCT00483548|10884532|FG001|STARTED|Overall Study||150
9778130|NCT00483548|10884531|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
9778131|NCT00483548|10884532|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
9778132|NCT00483548|10884531|FG000|COMPLETED|Overall Study||88
9778133|NCT00483548|10884532|FG001|COMPLETED|Overall Study||104
9778134|NCT00483548|10884531|FG000|NOT COMPLETED|Overall Study||60
9778135|NCT00483548|10884532|FG001|NOT COMPLETED|Overall Study||46
9778136|NCT00483561|10884538|FG000|STARTED|Overall Study||26
9778137|NCT00483561|10884538|FG000|COMPLETED|Overall Study||15
9778138|NCT00483561|10884538|FG000|NOT COMPLETED|Overall Study||11
9778139|NCT00483574|10884544|FG000|STARTED|Overall Study||1053
9778140|NCT00483574|10884545|FG001|STARTED|Overall Study||321
9778141|NCT00483574|10884544|FG000|COMPLETED|Overall Study||951
9778142|NCT00483574|10884545|FG001|COMPLETED|Overall Study||308
9778143|NCT00483574|10884544|FG000|NOT COMPLETED|Overall Study||102
9778144|NCT00483574|10884545|FG001|NOT COMPLETED|Overall Study||13
9778145|NCT00483652|10884555|FG000|STARTED|Double-blind Treatment Period||120
9778146|NCT00483652|10884556|FG001|STARTED|Double-blind Treatment Period||119
9778147|NCT00483652|10884555|FG000|COMPLETED|Double-blind Treatment Period||113
9778148|NCT00483652|10884556|FG001|COMPLETED|Double-blind Treatment Period||114
9778149|NCT00483652|10884555|FG000|NOT COMPLETED|Double-blind Treatment Period||7
9778150|NCT00483652|10884556|FG001|NOT COMPLETED|Double-blind Treatment Period||5
9778151|NCT00483652|10884555|FG000|STARTED|Post-study Follow-up||113
9778152|NCT00483652|10884556|FG001|STARTED|Post-study Follow-up||114
9778153|NCT00483652|10884555|FG000|COMPLETED|Post-study Follow-up||113
9778154|NCT00483652|10884556|FG001|COMPLETED|Post-study Follow-up||114
9778155|NCT00483652|10884555|FG000|NOT COMPLETED|Post-study Follow-up||0
9778156|NCT00483652|10884556|FG001|NOT COMPLETED|Post-study Follow-up||0
9778157|NCT00483704|10884565|FG000|STARTED|Randomization||644
9778158|NCT00483704|10884566|FG001|STARTED|Randomization||645
9778159|NCT00483704|10884567|FG002|STARTED|Randomization||646
9778160|NCT00483704|10884565|FG000|COMPLETED|Randomization||573
9778161|NCT00483704|10884566|FG001|COMPLETED|Randomization||549
9778162|NCT00483704|10884567|FG002|COMPLETED|Randomization||555
9778163|NCT00483704|10884565|FG000|NOT COMPLETED|Randomization||71
9778164|NCT00483704|10884566|FG001|NOT COMPLETED|Randomization||96
9778165|NCT00483704|10884567|FG002|NOT COMPLETED|Randomization||91
9778166|NCT00483704|10884565|FG000|STARTED|Treatment||573
9778167|NCT00483704|10884566|FG001|STARTED|Treatment||549
9778168|NCT00483704|10884567|FG002|STARTED|Treatment||555
9778169|NCT00483704|10884565|FG000|COMPLETED|Treatment||444
9778170|NCT00483704|10884566|FG001|COMPLETED|Treatment||420
9778171|NCT00483704|10884567|FG002|COMPLETED|Treatment||399
9778172|NCT00483704|10884565|FG000|NOT COMPLETED|Treatment||129
9778173|NCT00483704|10884566|FG001|NOT COMPLETED|Treatment||129
9778174|NCT00483704|10884567|FG002|NOT COMPLETED|Treatment||156
9778175|NCT00483717|10884580|FG000|STARTED|Overall Study||87
9778176|NCT00483717|10884581|FG001|STARTED|Overall Study||86
9778177|NCT00483717|10884580|FG000|COMPLETED|Overall Study||63
9778178|NCT00483717|10884581|FG001|COMPLETED|Overall Study||65
9778179|NCT00483717|10884580|FG000|NOT COMPLETED|Overall Study||24
9778180|NCT00483717|10884581|FG001|NOT COMPLETED|Overall Study||21
9778181|NCT00483756|10884590|FG000|STARTED|Overall Study||110
9778182|NCT00483756|10884591|FG001|STARTED|Overall Study||110
9778183|NCT00483756|10884592|FG002|STARTED|Overall Study||111
9778184|NCT00483756|10884590|FG000|Treated|Overall Study||109
9778185|NCT00483756|10884591|FG001|Treated|Overall Study||106
9778186|NCT00483756|10884592|FG002|Treated|Overall Study||107
9778187|NCT00483756|10884590|FG000|COMPLETED|Overall Study||77
9778188|NCT00483756|10884591|FG001|COMPLETED|Overall Study||60
9778189|NCT00483756|10884592|FG002|COMPLETED|Overall Study||59
9778190|NCT00483756|10884590|FG000|NOT COMPLETED|Overall Study||33
9778191|NCT00483756|10884591|FG001|NOT COMPLETED|Overall Study||50
9778192|NCT00483756|10884592|FG002|NOT COMPLETED|Overall Study||52
9778193|NCT00483938|10884607|FG000|STARTED|Overall Study||41
9778194|NCT00483938|10884608|FG001|STARTED|Overall Study||43
9778195|NCT00483938|10884609|FG002|STARTED|Overall Study||30
9778196|NCT00483938|10884610|FG003|STARTED|Overall Study||31
9778197|NCT00483938|10884611|FG004|STARTED|Overall Study||25
9778198|NCT00483938|10884612|FG005|STARTED|Overall Study||26
9778199|NCT00483938|10884613|FG006|STARTED|Overall Study||40
9778200|NCT00483938|10884607|FG000|COMPLETED|Overall Study||36
9778201|NCT00483938|10884608|FG001|COMPLETED|Overall Study||24
9778202|NCT00483938|10884609|FG002|COMPLETED|Overall Study||30
9778203|NCT00483938|10884610|FG003|COMPLETED|Overall Study||25
9778204|NCT00483938|10884611|FG004|COMPLETED|Overall Study||23
9778205|NCT00483938|10884612|FG005|COMPLETED|Overall Study||18
9778206|NCT00483938|10884613|FG006|COMPLETED|Overall Study||0
9778207|NCT00483938|10884607|FG000|NOT COMPLETED|Overall Study||5
9778208|NCT00483938|10884608|FG001|NOT COMPLETED|Overall Study||19
9778209|NCT00483938|10884609|FG002|NOT COMPLETED|Overall Study||0
9778210|NCT00483938|10884610|FG003|NOT COMPLETED|Overall Study||6
9778211|NCT00483938|10884611|FG004|NOT COMPLETED|Overall Study||2
9778212|NCT00483938|10884612|FG005|NOT COMPLETED|Overall Study||8
9778213|NCT00483938|10884613|FG006|NOT COMPLETED|Overall Study||40
9778214|NCT00484094|10884632|FG000|STARTED|Overall Study||209
9778215|NCT00484094|10884632|FG000|COMPLETED|Overall Study||167
9778216|NCT00484094|10884632|FG000|NOT COMPLETED|Overall Study||42
9778217|NCT00484159|10884639|FG000|STARTED|Overall Study||50
9778218|NCT00484159|10884640|FG001|STARTED|Overall Study||50
9778219|NCT00484159|10884641|FG002|STARTED|Overall Study||51
9778220|NCT00484159|10884639|FG000|COMPLETED|Overall Study||49
9778221|NCT00484159|10884640|FG001|COMPLETED|Overall Study||49
9778222|NCT00484159|10884641|FG002|COMPLETED|Overall Study||51
9778223|NCT00484159|10884639|FG000|NOT COMPLETED|Overall Study||1
9778224|NCT00484159|10884640|FG001|NOT COMPLETED|Overall Study||1
9778225|NCT00484159|10884641|FG002|NOT COMPLETED|Overall Study||0
9778226|NCT00484185|10884649|FG000|STARTED|Overall Study||183
9778227|NCT00484185|10884649|FG000|Treated|Overall Study||178
9778228|NCT00484185|10884649|FG000|COMPLETED|Overall Study||112
9778229|NCT00484185|10884649|FG000|NOT COMPLETED|Overall Study||71
9778230|NCT00484198|10884657|FG000|STARTED|Overall Study||137
9778231|NCT00484198|10884658|FG001|STARTED|Overall Study||274
9778232|NCT00484198|10884659|FG002|STARTED|Overall Study||750
9778233|NCT00484198|10884660|FG003|STARTED|Overall Study||751
9778234|NCT00484198|10884657|FG000|COMPLETED|Overall Study||96
9778235|NCT00484198|10884658|FG001|COMPLETED|Overall Study||208
9778236|NCT00484198|10884659|FG002|COMPLETED|Overall Study||599
9778237|NCT00484198|10884660|FG003|COMPLETED|Overall Study||579
9778238|NCT00484198|10884657|FG000|NOT COMPLETED|Overall Study||41
9778239|NCT00484198|10884658|FG001|NOT COMPLETED|Overall Study||66
9778240|NCT00484198|10884659|FG002|NOT COMPLETED|Overall Study||151
9778241|NCT00484198|10884660|FG003|NOT COMPLETED|Overall Study||172
9778242|NCT00484289|10884678|FG000|STARTED|Long Term Phase||13
9778243|NCT00484289|10884679|FG001|STARTED|Long Term Phase||178
9778244|NCT00484289|10884680|FG002|STARTED|Long Term Phase||26
9778245|NCT00484289|10884678|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
9778246|NCT00484289|10884679|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
9778247|NCT00484289|10884680|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
9778248|NCT00484289|10884678|FG000|NOT COMPLETED|Long Term Phase||3
9778249|NCT00484289|10884679|FG001|NOT COMPLETED|Long Term Phase||36
9778250|NCT00484289|10884680|FG002|NOT COMPLETED|Long Term Phase||16
9778251|NCT00484289|10884678|FG000|STARTED|Post Marketing Phase||10
9778252|NCT00484289|10884679|FG001|STARTED|Post Marketing Phase||142
9778253|NCT00484289|10884680|FG002|STARTED|Post Marketing Phase||10
9778254|NCT00484289|10884678|FG000|COMPLETED|Post Marketing Phase||10
9778255|NCT00484289|10884679|FG001|COMPLETED|Post Marketing Phase||141
9778256|NCT00484289|10884680|FG002|COMPLETED|Post Marketing Phase||10
9778257|NCT00484289|10884678|FG000|NOT COMPLETED|Post Marketing Phase||0
9778258|NCT00484289|10884679|FG001|NOT COMPLETED|Post Marketing Phase||1
9778259|NCT00484289|10884680|FG002|NOT COMPLETED|Post Marketing Phase||0
9778260|NCT00484315|10884691|FG000|STARTED|12-Month Clinical Follow-up||942
9778261|NCT00484315|10884692|FG001|STARTED|12-Month Clinical Follow-up||320
9778262|NCT00484315|10884691|FG000|COMPLETED|12-Month Clinical Follow-up||914
9778263|NCT00484315|10884692|FG001|COMPLETED|12-Month Clinical Follow-up||311
9778264|NCT00484315|10884691|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28
9778265|NCT00484315|10884692|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9
9778266|NCT00484315|10884691|FG000|STARTED|9-Month Angiographic Follow-up||256
9778267|NCT00484315|10884692|FG001|STARTED|9-Month Angiographic Follow-up||74
9778268|NCT00484315|10884691|FG000|COMPLETED|9-Month Angiographic Follow-up||228
9778269|NCT00484315|10884692|FG001|COMPLETED|9-Month Angiographic Follow-up||61
9778270|NCT00484315|10884691|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28
9778271|NCT00484315|10884692|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13
9778272|NCT00484354|10884700|FG000|STARTED|Overall Study||64
9778273|NCT00484354|10884701|FG001|STARTED|Overall Study||59
9778274|NCT00484354|10884700|FG000|COMPLETED|Overall Study||63
9778275|NCT00484354|10884701|FG001|COMPLETED|Overall Study||57
9778276|NCT00484354|10884700|FG000|NOT COMPLETED|Overall Study||1
9778277|NCT00484354|10884701|FG001|NOT COMPLETED|Overall Study||2
9778278|NCT00484393|10884709|FG000|STARTED|Overall Study||4
9778279|NCT00484393|10884710|FG001|STARTED|Overall Study||3
9778280|NCT00484393|10884709|FG000|COMPLETED|Overall Study||4
9778281|NCT00484393|10884710|FG001|COMPLETED|Overall Study||3
9778282|NCT00484393|10884709|FG000|NOT COMPLETED|Overall Study||0
9778283|NCT00484393|10884710|FG001|NOT COMPLETED|Overall Study||0
9778284|NCT00484679|10884716|FG000|STARTED|Overall Study||18
9778285|NCT00484679|10884716|FG000|COMPLETED|Overall Study||15
9778286|NCT00484679|10884716|FG000|NOT COMPLETED|Overall Study||3
9778287|NCT00484874|10884720|FG000|STARTED|Overall Study||12
9778288|NCT00484874|10884720|FG000|COMPLETED|Overall Study||12
9778289|NCT00484874|10884720|FG000|NOT COMPLETED|Overall Study||0
9778290|NCT00484939|10884729|FG000|STARTED|Overall Study||140
9778291|NCT00484939|10884730|FG001|STARTED|Overall Study||140
9778292|NCT00484939|10884729|FG000|COMPLETED|Overall Study||0
9778293|NCT00484939|10884730|FG001|COMPLETED|Overall Study||0
9778294|NCT00484939|10884729|FG000|NOT COMPLETED|Overall Study||140
9778295|NCT00484939|10884730|FG001|NOT COMPLETED|Overall Study||140
9778296|NCT00485069|10884738|FG000|STARTED|Overall Study||65
9778297|NCT00485069|10884739|FG001|STARTED|Overall Study||58
9778298|NCT00485069|10884738|FG000|COMPLETED|Overall Study||47
9778299|NCT00485069|10884739|FG001|COMPLETED|Overall Study||46
9778300|NCT00485069|10884738|FG000|NOT COMPLETED|Overall Study||18
9778301|NCT00485069|10884739|FG001|NOT COMPLETED|Overall Study||12
9778302|NCT00485134|10884760|FG000|STARTED|Overall Study||12
9778303|NCT00485134|10884761|FG001|STARTED|Overall Study||12
9778304|NCT00485134|10884762|FG002|STARTED|Overall Study||12
9778305|NCT00485134|10884763|FG003|STARTED|Overall Study||8
9778306|NCT00485134|10884764|FG004|STARTED|Overall Study||10
9778307|NCT00485134|10884765|FG005|STARTED|Overall Study||7
9778308|NCT00485134|10884766|FG006|STARTED|Overall Study||31
9778309|NCT00485134|10884767|FG007|STARTED|Overall Study||21
9778310|NCT00485134|10884760|FG000|COMPLETED|Overall Study||11
9778311|NCT00485134|10884761|FG001|COMPLETED|Overall Study||10
9778312|NCT00485134|10884762|FG002|COMPLETED|Overall Study||9
9778313|NCT00485134|10884763|FG003|COMPLETED|Overall Study||7
9778314|NCT00485134|10884764|FG004|COMPLETED|Overall Study||7
9778315|NCT00485134|10884765|FG005|COMPLETED|Overall Study||3
9778316|NCT00485134|10884766|FG006|COMPLETED|Overall Study||28
9778317|NCT00485134|10884767|FG007|COMPLETED|Overall Study||20
9778318|NCT00485134|10884760|FG000|NOT COMPLETED|Overall Study||1
9778319|NCT00485134|10884761|FG001|NOT COMPLETED|Overall Study||2
9778320|NCT00485134|10884762|FG002|NOT COMPLETED|Overall Study||3
9778321|NCT00485134|10884763|FG003|NOT COMPLETED|Overall Study||1
9778322|NCT00485134|10884764|FG004|NOT COMPLETED|Overall Study||3
9778323|NCT00485134|10884765|FG005|NOT COMPLETED|Overall Study||4
9778324|NCT00485134|10884766|FG006|NOT COMPLETED|Overall Study||3
9778325|NCT00485134|10884767|FG007|NOT COMPLETED|Overall Study||1
9778326|NCT00485173|10884781|FG000|STARTED|Overall Study||224
9778327|NCT00485173|10884782|FG001|STARTED|Overall Study||486
9778328|NCT00485173|10884781|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
9778329|NCT00485173|10884782|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
9778330|NCT00485173|10884781|FG000|NOT COMPLETED|Overall Study||36
9778331|NCT00485173|10884782|FG001|NOT COMPLETED|Overall Study||64
9778332|NCT00485264|10884794|FG000|STARTED|Overall Study||71
9778333|NCT00485264|10884795|FG001|STARTED|Overall Study||16
9778334|NCT00485264|10884796|FG002|STARTED|Overall Study||18
9778335|NCT00485264|10884797|FG003|STARTED|Overall Study||21
9778336|NCT00485264|10884798|FG004|STARTED|Overall Study||15
9778337|NCT00485264|10884799|FG005|STARTED|Overall Study||12
9778338|NCT00485264|10884794|FG000|Completed Week 24|Overall Study||67
9778339|NCT00485264|10884795|FG001|Completed Week 24|Overall Study||16
9778340|NCT00485264|10884796|FG002|Completed Week 24|Overall Study||18
9778341|NCT00485264|10884797|FG003|Completed Week 24|Overall Study||21
9778342|NCT00485264|10884798|FG004|Completed Week 24|Overall Study||14
9778343|NCT00485264|10884799|FG005|Completed Week 24|Overall Study||11
9778344|NCT00485264|10884794|FG000|COMPLETED|Overall Study||35
9778345|NCT00485264|10884795|FG001|COMPLETED|Overall Study||9
9778346|NCT00485264|10884796|FG002|COMPLETED|Overall Study||12
9778347|NCT00485264|10884797|FG003|COMPLETED|Overall Study||17
9778348|NCT00485264|10884798|FG004|COMPLETED|Overall Study||9
9778349|NCT00485264|10884799|FG005|COMPLETED|Overall Study||5
9778350|NCT00485264|10884794|FG000|NOT COMPLETED|Overall Study||36
9778351|NCT00485264|10884795|FG001|NOT COMPLETED|Overall Study||7
9778352|NCT00485264|10884796|FG002|NOT COMPLETED|Overall Study||6
9778353|NCT00485264|10884797|FG003|NOT COMPLETED|Overall Study||4
9778354|NCT00485264|10884798|FG004|NOT COMPLETED|Overall Study||6
9778355|NCT00485264|10884799|FG005|NOT COMPLETED|Overall Study||7
9778356|NCT00485303|10884818|FG000|STARTED|Overall Study||58
9778357|NCT00485303|10884818|FG000|COMPLETED|Overall Study||2
9778358|NCT00485303|10884818|FG000|NOT COMPLETED|Overall Study||56
9778359|NCT00485433|10884826|FG000|STARTED|Overall Study||24
9778360|NCT00485433|10884827|FG001|STARTED|Overall Study||25
9778361|NCT00485433|10884828|FG002|STARTED|Overall Study||24
9778362|NCT00485433|10884829|FG003|STARTED|Overall Study||25
9778363|NCT00485433|10884826|FG000|COMPLETED|Overall Study||24
9778364|NCT00485433|10884827|FG001|COMPLETED|Overall Study||25
9778365|NCT00485433|10884828|FG002|COMPLETED|Overall Study||24
9778366|NCT00485433|10884829|FG003|COMPLETED|Overall Study||25
9778367|NCT00485433|10884826|FG000|NOT COMPLETED|Overall Study||0
9778368|NCT00485433|10884827|FG001|NOT COMPLETED|Overall Study||0
9778369|NCT00485433|10884828|FG002|NOT COMPLETED|Overall Study||0
9778370|NCT00485433|10884829|FG003|NOT COMPLETED|Overall Study||0
9778371|NCT00485472|10884839|FG000|STARTED|Overall Study||73
9778372|NCT00485472|10884840|FG001|STARTED|Overall Study||76
9778373|NCT00485472|10884839|FG000|Entered Maintenance Phase|Overall Study||65
9778374|NCT00485472|10884840|FG001|Entered Maintenance Phase|Overall Study||67
9778375|NCT00485472|10884839|FG000|COMPLETED|Overall Study||57
9778376|NCT00485472|10884840|FG001|COMPLETED|Overall Study||64
9778377|NCT00485472|10884839|FG000|NOT COMPLETED|Overall Study||16
9778378|NCT00485472|10884840|FG001|NOT COMPLETED|Overall Study||12
9778379|NCT00485485|10884846|FG000|STARTED|Overall Study||7
9778380|NCT00485485|10884846|FG000|COMPLETED|Overall Study||7
9778381|NCT00485485|10884846|FG000|NOT COMPLETED|Overall Study||0
9778382|NCT00485589|10884853|FG000|STARTED|Overall Study||210
9778383|NCT00485589|10884854|FG001|STARTED|Overall Study||200
9778384|NCT00485589|10884855|FG002|STARTED|Overall Study||203
9778385|NCT00485589|10884853|FG000|COMPLETED|Overall Study||183
9778386|NCT00485589|10884854|FG001|COMPLETED|Overall Study||180
9778387|NCT00485589|10884855|FG002|COMPLETED|Overall Study||185
9778388|NCT00485589|10884853|FG000|NOT COMPLETED|Overall Study||27
9778389|NCT00485589|10884854|FG001|NOT COMPLETED|Overall Study||20
9778390|NCT00485589|10884855|FG002|NOT COMPLETED|Overall Study||18
9778391|NCT00485732|10884874|FG000|STARTED|Overall Study||149
9778392|NCT00485732|10884875|FG001|STARTED|Overall Study||76
9778393|NCT00485732|10884874|FG000|COMPLETED|Overall Study||141
9778394|NCT00485732|10884875|FG001|COMPLETED|Overall Study||67
9778395|NCT00485732|10884874|FG000|NOT COMPLETED|Overall Study||8
9778396|NCT00485732|10884875|FG001|NOT COMPLETED|Overall Study||9
9778397|NCT00485758|10884883|FG000|STARTED|Overall Study||454
9778398|NCT00485758|10884884|FG001|STARTED|Overall Study||342
9778399|NCT00485758|10884883|FG000|COMPLETED|Overall Study||298
9778400|NCT00485758|10884884|FG001|COMPLETED|Overall Study||277
9778401|NCT00485758|10884883|FG000|NOT COMPLETED|Overall Study||156
9778402|NCT00485758|10884884|FG001|NOT COMPLETED|Overall Study||65
9778403|NCT00485836|10884893|FG000|STARTED|Overall Study||130
9778404|NCT00485836|10884894|FG001|STARTED|Overall Study||132
9778405|NCT00485836|10884895|FG002|STARTED|Overall Study||130
9778406|NCT00485836|10884893|FG000|Received Study Drug (Safety Population)|Overall Study||129
9778407|NCT00485836|10884894|FG001|Received Study Drug (Safety Population)|Overall Study||132
9778408|NCT00485836|10884895|FG002|Received Study Drug (Safety Population)|Overall Study||129
9778409|NCT00485836|10884893|FG000|COMPLETED|Overall Study||115
9778410|NCT00485836|10884894|FG001|COMPLETED|Overall Study||129
9778411|NCT00485836|10884895|FG002|COMPLETED|Overall Study||119
9778412|NCT00485836|10884893|FG000|NOT COMPLETED|Overall Study||15
9778413|NCT00485836|10884894|FG001|NOT COMPLETED|Overall Study||3
9778414|NCT00485836|10884895|FG002|NOT COMPLETED|Overall Study||11
9778415|NCT00485953|10884905|FG000|STARTED|Overall Study||55
9778416|NCT00485953|10884906|FG001|STARTED|Overall Study||54
9778417|NCT00485953|10884905|FG000|COMPLETED|Overall Study||48
9778418|NCT00485953|10884906|FG001|COMPLETED|Overall Study||47
9778419|NCT00485953|10884905|FG000|NOT COMPLETED|Overall Study||7
9778420|NCT00485953|10884906|FG001|NOT COMPLETED|Overall Study||7
9778421|NCT00486018|10884917|FG000|STARTED|Overall Study||132
9778422|NCT00486018|10884918|FG001|STARTED|Overall Study||134
9778423|NCT00486018|10884919|FG002|STARTED|Overall Study||131
9778424|NCT00486018|10884917|FG000|Received Drug (Safety Population)|Overall Study||131
9778425|NCT00486018|10884918|FG001|Received Drug (Safety Population)|Overall Study||134
9778426|NCT00486018|10884919|FG002|Received Drug (Safety Population)|Overall Study||130
9778427|NCT00486018|10884917|FG000|COMPLETED|Overall Study||123
9778428|NCT00486018|10884918|FG001|COMPLETED|Overall Study||128
9778429|NCT00486018|10884919|FG002|COMPLETED|Overall Study||125
9778430|NCT00486018|10884917|FG000|NOT COMPLETED|Overall Study||9
9778431|NCT00486018|10884918|FG001|NOT COMPLETED|Overall Study||6
9778432|NCT00486018|10884919|FG002|NOT COMPLETED|Overall Study||6
9778433|NCT00486031|10884927|FG000|STARTED|Overall Study||443
9778434|NCT00486031|10884927|FG000|COMPLETED|Overall Study||440
9778435|NCT00486031|10884927|FG000|NOT COMPLETED|Overall Study||3
9778436|NCT00486044|10884934|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
9778437|NCT00486044|10884935|FG001|STARTED|Overall Study|23 in MRI sub-study|49
9778438|NCT00486044|10884934|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49
9778439|NCT00486044|10884935|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46
9778440|NCT00486044|10884934|FG000|NOT COMPLETED|Overall Study||2
9778441|NCT00486044|10884935|FG001|NOT COMPLETED|Overall Study||3
9778442|NCT00486226|10884941|FG000|STARTED|Overall Study||105
9778443|NCT00486226|10884941|FG000|COMPLETED|Overall Study||92
9778444|NCT00486226|10884941|FG000|NOT COMPLETED|Overall Study||13
9778445|NCT00486252|10884948|FG000|STARTED|Overall Study||996
9778446|NCT00486252|10884948|FG000|COMPLETED|Overall Study||938
9778447|NCT00486252|10884948|FG000|NOT COMPLETED|Overall Study||58
9778448|NCT00486265|10884954|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9
9778449|NCT00486265|10884954|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
9778450|NCT00486265|10884954|FG000|NOT COMPLETED|Overall Study||9
9778451|NCT00486278|10884958|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
9778452|NCT00486278|10884958|FG000|COMPLETED|Overall Study||42
9778453|NCT00486278|10884958|FG000|NOT COMPLETED|Overall Study||9
9778454|NCT00486291|10884974|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
9778455|NCT00486291|10884975|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105
9778456|NCT00486291|10884974|FG000|COMPLETED|Overall Study||89
9778457|NCT00486291|10884975|FG001|COMPLETED|Overall Study||76
9778458|NCT00486291|10884974|FG000|NOT COMPLETED|Overall Study||16
9778459|NCT00486291|10884975|FG001|NOT COMPLETED|Overall Study||29
9778460|NCT00486330|10884981|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
9778461|NCT00486330|10884981|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
9778462|NCT00486330|10884981|FG000|NOT COMPLETED|Overall Study||2
9778463|NCT00486434|10884987|FG000|STARTED|Overall Study||588
9778464|NCT00486434|10884988|FG001|STARTED|Overall Study||588
9778465|NCT00486434|10884987|FG000|COMPLETED|Overall Study||394
9778466|NCT00486434|10884988|FG001|COMPLETED|Overall Study||454
9778467|NCT00486434|10884987|FG000|NOT COMPLETED|Overall Study||194
9778468|NCT00486434|10884988|FG001|NOT COMPLETED|Overall Study||134
9778469|NCT00486447|10884995|FG000|STARTED|Overall Study||249
9778470|NCT00486447|10884995|FG000|COMPLETED|Overall Study||249
9778471|NCT00486447|10884995|FG000|NOT COMPLETED|Overall Study||0
9778472|NCT00486525|10885002|FG000|STARTED|Overall Study||100
9778473|NCT00486525|10885003|FG001|STARTED|Overall Study||100
9778474|NCT00486525|10885002|FG000|COMPLETED|Overall Study||94
9778475|NCT00486525|10885003|FG001|COMPLETED|Overall Study||87
9778476|NCT00486525|10885002|FG000|NOT COMPLETED|Overall Study||6
9778477|NCT00486525|10885003|FG001|NOT COMPLETED|Overall Study||13
9778478|NCT00486603|10885011|FG000|STARTED|Overall Study||3
9778479|NCT00486603|10885012|FG001|STARTED|Overall Study||7
9778480|NCT00486603|10885013|FG002|STARTED|Overall Study||3
9778481|NCT00486603|10885014|FG003|STARTED|Overall Study||3
9778482|NCT00486603|10885015|FG004|STARTED|Overall Study||76
9778483|NCT00486603|10885011|FG000|COMPLETED|Overall Study||2
10233938|NCT01602198|11363812|FG001|COMPLETED|Overall Study||1
10233939|NCT01602198|11363811|FG000|NOT COMPLETED|Overall Study||0
10233940|NCT01602198|11363812|FG001|NOT COMPLETED|Overall Study||0
9778484|NCT00486603|10885012|FG001|COMPLETED|Overall Study||6
9778485|NCT00486603|10885013|FG002|COMPLETED|Overall Study||3
9778486|NCT00486603|10885014|FG003|COMPLETED|Overall Study||3
9778487|NCT00486603|10885015|FG004|COMPLETED|Overall Study||76
9778488|NCT00486603|10885011|FG000|NOT COMPLETED|Overall Study||1
9778489|NCT00486603|10885012|FG001|NOT COMPLETED|Overall Study||1
9778490|NCT00486603|10885013|FG002|NOT COMPLETED|Overall Study||0
9778491|NCT00486603|10885014|FG003|NOT COMPLETED|Overall Study||0
9778492|NCT00486603|10885015|FG004|NOT COMPLETED|Overall Study||0
9778493|NCT00486642|10885032|FG000|STARTED|Overall Study||10
9778494|NCT00486642|10885033|FG001|STARTED|Overall Study||13
9778495|NCT00486642|10885032|FG000|COMPLETED|Overall Study||10
9778496|NCT00486642|10885033|FG001|COMPLETED|Overall Study||13
9778497|NCT00486642|10885032|FG000|NOT COMPLETED|Overall Study||0
9778498|NCT00486642|10885033|FG001|NOT COMPLETED|Overall Study||0
9778499|NCT00486720|10885043|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
9778500|NCT00486720|10885044|FG001|STARTED|Overall Study||12
9778501|NCT00486720|10885043|FG000|COMPLETED|Overall Study||0
9778502|NCT00486720|10885044|FG001|COMPLETED|Overall Study||0
9778503|NCT00486720|10885043|FG000|NOT COMPLETED|Overall Study||10
9778504|NCT00486720|10885044|FG001|NOT COMPLETED|Overall Study||12
9778505|NCT00486759|10885052|FG000|STARTED|Treatment||390
9778506|NCT00486759|10885053|FG001|STARTED|Treatment||397
9778507|NCT00486759|10885052|FG000|COMPLETED|Treatment||203
9778508|NCT00486759|10885053|FG001|COMPLETED|Treatment||260
9778509|NCT00486759|10885052|FG000|NOT COMPLETED|Treatment||187
9778510|NCT00486759|10885053|FG001|NOT COMPLETED|Treatment||137
9778511|NCT00486759|10885052|FG000|STARTED|Safety Follow-up||203
9778512|NCT00486759|10885053|FG001|STARTED|Safety Follow-up||260
9778513|NCT00486759|10885052|FG000|COMPLETED|Safety Follow-up||64
9778514|NCT00486759|10885053|FG001|COMPLETED|Safety Follow-up||142
9778515|NCT00486759|10885052|FG000|NOT COMPLETED|Safety Follow-up||139
9778516|NCT00486759|10885053|FG001|NOT COMPLETED|Safety Follow-up||118
9778517|NCT00486811|10885062|FG000|STARTED|Overall Study||337
9778518|NCT00486811|10885063|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320
9778519|NCT00486811|10885064|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
9778520|NCT00486811|10885062|FG000|COMPLETED|Overall Study||215
9778521|NCT00486811|10885063|FG001|COMPLETED|Overall Study||179
9778522|NCT00486811|10885064|FG002|COMPLETED|Overall Study||119
9778523|NCT00486811|10885062|FG000|NOT COMPLETED|Overall Study||122
9778524|NCT00486811|10885063|FG001|NOT COMPLETED|Overall Study||141
9778525|NCT00486811|10885064|FG002|NOT COMPLETED|Overall Study||214
9778526|NCT00486824|10885074|FG000|STARTED|Overall Study||5
9778527|NCT00486824|10885075|FG001|STARTED|Overall Study||5
9778528|NCT00486824|10885074|FG000|COMPLETED|Overall Study||3
9778529|NCT00486824|10885075|FG001|COMPLETED|Overall Study||3
9778530|NCT00486824|10885074|FG000|NOT COMPLETED|Overall Study||2
9778531|NCT00486824|10885075|FG001|NOT COMPLETED|Overall Study||2
10014618|NCT01800916|11137678|FG006|STARTED|Test Period 2 (1 Week)||7
10014619|NCT01800916|11137679|FG007|STARTED|Test Period 2 (1 Week)||7
10014620|NCT01800916|11137680|FG008|STARTED|Test Period 2 (1 Week)||7
9778532|NCT00486837|10885083|FG000|STARTED|Overall Study||37
9778533|NCT00486837|10885084|FG001|STARTED|Overall Study||35
10233941|NCT01606150|11363820|FG000|STARTED|Overall Study||0
10233942|NCT01606150|11363821|FG001|STARTED|Overall Study||0
9778534|NCT00486837|10885083|FG000|COMPLETED|Overall Study||28
9778535|NCT00486837|10885084|FG001|COMPLETED|Overall Study||28
9778536|NCT00486837|10885083|FG000|NOT COMPLETED|Overall Study||9
9778537|NCT00486837|10885084|FG001|NOT COMPLETED|Overall Study||7
9778538|NCT00486863|10885094|FG000|STARTED|Overall Study||184
9778539|NCT00486863|10885095|FG001|STARTED|Overall Study||186
9778540|NCT00486863|10885094|FG000|COMPLETED|Overall Study||183
9778541|NCT00486863|10885095|FG001|COMPLETED|Overall Study||183
9778542|NCT00486863|10885094|FG000|NOT COMPLETED|Overall Study||1
9778543|NCT00486863|10885095|FG001|NOT COMPLETED|Overall Study||3
9778544|NCT00486902|10885104|FG000|STARTED|Overall Study||94
9778545|NCT00486902|10885105|FG001|STARTED|Overall Study||94
9778546|NCT00486902|10885104|FG000|COMPLETED|Overall Study||85
9778547|NCT00486902|10885105|FG001|COMPLETED|Overall Study||89
9778548|NCT00486902|10885104|FG000|NOT COMPLETED|Overall Study||9
9778549|NCT00486902|10885105|FG001|NOT COMPLETED|Overall Study||5
9778550|NCT00486954|10885115|FG000|STARTED|Pilot Part||6
9778551|NCT00486954|10885116|FG001|STARTED|Pilot Part||0
9778552|NCT00486954|10885117|FG002|STARTED|Pilot Part||6
9778553|NCT00486954|10885118|FG003|STARTED|Pilot Part||0
9778554|NCT00486954|10885119|FG004|STARTED|Pilot Part||0
9778555|NCT00486954|10885115|FG000|COMPLETED|Pilot Part||0
9778556|NCT00486954|10885116|FG001|COMPLETED|Pilot Part||0
9778557|NCT00486954|10885117|FG002|COMPLETED|Pilot Part||0
9778558|NCT00486954|10885118|FG003|COMPLETED|Pilot Part||0
9778559|NCT00486954|10885119|FG004|COMPLETED|Pilot Part||0
9778560|NCT00486954|10885115|FG000|NOT COMPLETED|Pilot Part||6
9778561|NCT00486954|10885116|FG001|NOT COMPLETED|Pilot Part||0
9778562|NCT00486954|10885117|FG002|NOT COMPLETED|Pilot Part||6
9778563|NCT00486954|10885118|FG003|NOT COMPLETED|Pilot Part||0
9778564|NCT00486954|10885119|FG004|NOT COMPLETED|Pilot Part||0
9778565|NCT00486954|10885115|FG000|STARTED|Randomized Part||0
9778566|NCT00486954|10885116|FG001|STARTED|Randomized Part||0
9778567|NCT00486954|10885117|FG002|STARTED|Randomized Part||0
9778568|NCT00486954|10885118|FG003|STARTED|Randomized Part||132
9778569|NCT00486954|10885119|FG004|STARTED|Randomized Part||129
9778570|NCT00486954|10885115|FG000|COMPLETED|Randomized Part||0
9778571|NCT00486954|10885116|FG001|COMPLETED|Randomized Part||0
9778572|NCT00486954|10885117|FG002|COMPLETED|Randomized Part||0
9778573|NCT00486954|10885118|FG003|COMPLETED|Randomized Part||112
9778574|NCT00486954|10885119|FG004|COMPLETED|Randomized Part||115
9778575|NCT00486954|10885115|FG000|NOT COMPLETED|Randomized Part||0
9778576|NCT00486954|10885116|FG001|NOT COMPLETED|Randomized Part||0
9778577|NCT00486954|10885117|FG002|NOT COMPLETED|Randomized Part||0
9778578|NCT00486954|10885118|FG003|NOT COMPLETED|Randomized Part||20
9778579|NCT00486954|10885119|FG004|NOT COMPLETED|Randomized Part||14
9778580|NCT00487084|10885132|FG000|STARTED|Overall Study||33
9778581|NCT00487084|10885133|FG001|STARTED|Overall Study||33
9778582|NCT00487084|10885134|FG002|STARTED|Overall Study||33
9778583|NCT00487084|10885132|FG000|COMPLETED|Overall Study||29
10014621|NCT01800916|11137672|FG000|COMPLETED|Test Period 2 (1 Week)||7
10014622|NCT01800916|11137673|FG001|COMPLETED|Test Period 2 (1 Week)||7
10014623|NCT01800916|11137674|FG002|COMPLETED|Test Period 2 (1 Week)||7
9778584|NCT00487084|10885133|FG001|COMPLETED|Overall Study||30
9778585|NCT00487084|10885134|FG002|COMPLETED|Overall Study||28
9778586|NCT00487084|10885132|FG000|NOT COMPLETED|Overall Study||4
9778587|NCT00487084|10885133|FG001|NOT COMPLETED|Overall Study||3
9778588|NCT00487084|10885134|FG002|NOT COMPLETED|Overall Study||5
9778589|NCT00487188|10885144|FG000|STARTED|Induction Phase||31
9778590|NCT00487188|10885145|FG001|STARTED|Induction Phase||16
9778591|NCT00487188|10885146|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
9778592|NCT00487188|10885144|FG000|Safety Population|Induction Phase||29
9778593|NCT00487188|10885145|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
9778594|NCT00487188|10885146|FG002|Safety Population|Induction Phase||0
9778595|NCT00487188|10885144|FG000|COMPLETED|Induction Phase||22
9778596|NCT00487188|10885145|FG001|COMPLETED|Induction Phase||9
9778597|NCT00487188|10885146|FG002|COMPLETED|Induction Phase||0
9778598|NCT00487188|10885144|FG000|NOT COMPLETED|Induction Phase||9
9778599|NCT00487188|10885145|FG001|NOT COMPLETED|Induction Phase||7
9778600|NCT00487188|10885146|FG002|NOT COMPLETED|Induction Phase||0
9778601|NCT00487188|10885144|FG000|STARTED|Maintenance Phase||10
10014624|NCT01800916|11137675|FG003|COMPLETED|Test Period 2 (1 Week)||6
10014625|NCT01800916|11137676|FG004|COMPLETED|Test Period 2 (1 Week)||7
10014626|NCT01800916|11137677|FG005|COMPLETED|Test Period 2 (1 Week)||7
10014627|NCT01800916|11137678|FG006|COMPLETED|Test Period 2 (1 Week)||7
10014628|NCT01800916|11137679|FG007|COMPLETED|Test Period 2 (1 Week)||7
10014629|NCT01800916|11137680|FG008|COMPLETED|Test Period 2 (1 Week)||7
10014630|NCT01800916|11137672|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0
10014631|NCT01800916|11137673|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0
10014632|NCT01800916|11137674|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0
10014633|NCT01800916|11137675|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0
10014634|NCT01800916|11137676|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0
10014635|NCT01800916|11137677|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0
10014636|NCT01800916|11137678|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0
10014637|NCT01800916|11137679|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0
10014638|NCT01800916|11137680|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0
10014639|NCT01800916|11137672|FG000|STARTED|Test Period 3 (1 Week)||7
10014640|NCT01800916|11137673|FG001|STARTED|Test Period 3 (1 Week)||7
9778602|NCT00487188|10885145|FG001|STARTED|Maintenance Phase||8
9778603|NCT00487188|10885146|FG002|STARTED|Maintenance Phase||9
9778604|NCT00487188|10885144|FG000|COMPLETED|Maintenance Phase||7
9778605|NCT00487188|10885145|FG001|COMPLETED|Maintenance Phase||8
9778606|NCT00487188|10885146|FG002|COMPLETED|Maintenance Phase||8
9778607|NCT00487188|10885144|FG000|NOT COMPLETED|Maintenance Phase||3
9778608|NCT00487188|10885145|FG001|NOT COMPLETED|Maintenance Phase||0
9778609|NCT00487188|10885146|FG002|NOT COMPLETED|Maintenance Phase||1
9778610|NCT00487240|10885164|FG000|STARTED|Overall Study||195
9778611|NCT00487240|10885165|FG001|STARTED|Overall Study||192
9778612|NCT00487240|10885164|FG000|Full Analysis Set (ITT Population)|Overall Study||192
9778613|NCT00487240|10885165|FG001|Full Analysis Set (ITT Population)|Overall Study||189
9778614|NCT00487240|10885164|FG000|COMPLETED|Overall Study||164
10014641|NCT01800916|11137674|FG002|STARTED|Test Period 3 (1 Week)||7
10014642|NCT01800916|11137675|FG003|STARTED|Test Period 3 (1 Week)||6
10014643|NCT01800916|11137676|FG004|STARTED|Test Period 3 (1 Week)||7
10014644|NCT01800916|11137677|FG005|STARTED|Test Period 3 (1 Week)||7
9778615|NCT00487240|10885165|FG001|COMPLETED|Overall Study||166
9778616|NCT00487240|10885164|FG000|NOT COMPLETED|Overall Study||31
9778617|NCT00487240|10885165|FG001|NOT COMPLETED|Overall Study||26
9778618|NCT00487279|10885173|FG000|STARTED|Overall Study||44
10014645|NCT01800916|11137678|FG006|STARTED|Test Period 3 (1 Week)||7
10014646|NCT01800916|11137679|FG007|STARTED|Test Period 3 (1 Week)||7
9778619|NCT00487279|10885174|FG001|STARTED|Overall Study||37
9778620|NCT00487279|10885173|FG000|COMPLETED|Overall Study||43
9778621|NCT00487279|10885174|FG001|COMPLETED|Overall Study||35
9778622|NCT00487279|10885173|FG000|NOT COMPLETED|Overall Study||1
9778623|NCT00487279|10885174|FG001|NOT COMPLETED|Overall Study||2
9778624|NCT00487396|10885180|FG000|STARTED|Overall Study||98
9778625|NCT00487396|10885180|FG000|COMPLETED|Overall Study||95
9778626|NCT00487396|10885180|FG000|NOT COMPLETED|Overall Study||3
9778627|NCT00487435|10885189|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
9778628|NCT00487435|10885189|FG000|COMPLETED|Overall Study||669
9778629|NCT00487435|10885189|FG000|NOT COMPLETED|Overall Study||485
9778630|NCT00487539|10885197|FG000|STARTED|Overall Study||331
9778631|NCT00487539|10885198|FG001|STARTED|Overall Study||72
9778632|NCT00487539|10885199|FG002|STARTED|Overall Study||331
9778633|NCT00487539|10885200|FG003|STARTED|Overall Study||331
9778634|NCT00487539|10885197|FG000|COMPLETED|Overall Study||324
9778635|NCT00487539|10885198|FG001|COMPLETED|Overall Study||69
9778636|NCT00487539|10885199|FG002|COMPLETED|Overall Study||328
9778637|NCT00487539|10885200|FG003|COMPLETED|Overall Study||327
9778638|NCT00487539|10885197|FG000|NOT COMPLETED|Overall Study||7
9778639|NCT00487539|10885198|FG001|NOT COMPLETED|Overall Study||3
9778640|NCT00487539|10885199|FG002|NOT COMPLETED|Overall Study||3
9778641|NCT00487539|10885200|FG003|NOT COMPLETED|Overall Study||4
9778642|NCT00487552|10885209|FG000|STARTED|Overall Study||18
9778643|NCT00487552|10885209|FG000|COMPLETED|Overall Study||12
9778644|NCT00487552|10885209|FG000|NOT COMPLETED|Overall Study||6
9778645|NCT00487565|10885214|FG000|STARTED|Overall Study||210
9778646|NCT00487565|10885214|FG000|COMPLETED|Overall Study||182
9778647|NCT00487565|10885214|FG000|NOT COMPLETED|Overall Study||28
9778648|NCT00487669|10885218|FG000|STARTED|Overall Study||12
9778649|NCT00487669|10885218|FG000|COMPLETED|Overall Study||12
9778650|NCT00487669|10885218|FG000|NOT COMPLETED|Overall Study||0
9778651|NCT00487695|10885224|FG000|STARTED|First Procedure||23
9778652|NCT00487695|10885225|FG001|STARTED|First Procedure||23
9778653|NCT00487695|10885224|FG000|COMPLETED|First Procedure||20
9778654|NCT00487695|10885225|FG001|COMPLETED|First Procedure||23
9778655|NCT00487695|10885224|FG000|NOT COMPLETED|First Procedure||3
9778656|NCT00487695|10885225|FG001|NOT COMPLETED|First Procedure||0
9778657|NCT00487695|10885224|FG000|STARTED|Second Procedure||20
9778658|NCT00487695|10885225|FG001|STARTED|Second Procedure||23
9778659|NCT00487695|10885224|FG000|COMPLETED|Second Procedure||19
9778660|NCT00487695|10885225|FG001|COMPLETED|Second Procedure||20
9778661|NCT00487695|10885224|FG000|NOT COMPLETED|Second Procedure||1
9778662|NCT00487695|10885225|FG001|NOT COMPLETED|Second Procedure||3
9778663|NCT00487721|10885233|FG000|STARTED|Overall Study||6
9778664|NCT00487721|10885234|FG001|STARTED|Overall Study||6
9778665|NCT00487721|10885233|FG000|COMPLETED|Overall Study||6
9778666|NCT00487721|10885234|FG001|COMPLETED|Overall Study||6
9778667|NCT00487721|10885233|FG000|NOT COMPLETED|Overall Study||0
9778668|NCT00487721|10885234|FG001|NOT COMPLETED|Overall Study||0
9778669|NCT00487747|10885239|FG000|STARTED|Overall Study||18
9778670|NCT00487747|10885239|FG000|COMPLETED|Overall Study||7
9778671|NCT00487747|10885239|FG000|NOT COMPLETED|Overall Study||11
9778672|NCT00487825|10885245|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
9778673|NCT00487825|10885246|FG001|STARTED|Overall Study||26
9778674|NCT00487825|10885245|FG000|COMPLETED|Overall Study||46
9778675|NCT00487825|10885246|FG001|COMPLETED|Overall Study||21
9778676|NCT00487825|10885245|FG000|NOT COMPLETED|Overall Study||6
9778677|NCT00487825|10885246|FG001|NOT COMPLETED|Overall Study||5
9778678|NCT00487942|10885256|FG000|STARTED|Overall Study||15
9778679|NCT00487942|10885257|FG001|STARTED|Overall Study||15
9778680|NCT00487942|10885258|FG002|STARTED|Overall Study||15
9778681|NCT00487942|10885259|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
9778682|NCT00487942|10885256|FG000|COMPLETED|Overall Study||12
9778683|NCT00487942|10885257|FG001|COMPLETED|Overall Study||12
9778684|NCT00487942|10885258|FG002|COMPLETED|Overall Study||12
9778685|NCT00487942|10885259|FG003|COMPLETED|Overall Study||13
9778686|NCT00487942|10885256|FG000|NOT COMPLETED|Overall Study||3
9778687|NCT00487942|10885257|FG001|NOT COMPLETED|Overall Study||3
9778688|NCT00487942|10885258|FG002|NOT COMPLETED|Overall Study||3
9778689|NCT00487942|10885259|FG003|NOT COMPLETED|Overall Study||2
9778690|NCT00488033|10885271|FG000|STARTED|Overall Study||448
9778691|NCT00488033|10885272|FG001|STARTED|Overall Study||452
9778692|NCT00488033|10885271|FG000|COMPLETED|Overall Study||447
9778693|NCT00488033|10885272|FG001|COMPLETED|Overall Study||452
9778694|NCT00488033|10885271|FG000|NOT COMPLETED|Overall Study||1
9778695|NCT00488033|10885272|FG001|NOT COMPLETED|Overall Study||0
9778696|NCT00488059|10885278|FG000|STARTED|Phase I: ENF 90mg SC BID||29
9778697|NCT00488059|10885279|FG001|STARTED|Phase I: ENF 90mg SC BID||0
9778698|NCT00488059|10885280|FG002|STARTED|Phase I: ENF 90mg SC BID||0
9778699|NCT00488059|10885278|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14
9778700|NCT00488059|10885279|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0
9778701|NCT00488059|10885280|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0
9778702|NCT00488059|10885278|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
9778703|NCT00488059|10885279|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
9778704|NCT00488059|10885280|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
9778705|NCT00488059|10885278|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
9778706|NCT00488059|10885279|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
9778707|NCT00488059|10885280|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
9778708|NCT00488059|10885278|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
9778709|NCT00488059|10885279|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
9778710|NCT00488059|10885280|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
9778711|NCT00488059|10885278|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
9778712|NCT00488059|10885279|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
9778713|NCT00488059|10885280|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
9778714|NCT00488059|10885278|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
9778715|NCT00488059|10885279|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
9778716|NCT00488059|10885280|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
9778717|NCT00488059|10885278|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
9778718|NCT00488059|10885279|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
9778719|NCT00488059|10885280|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
9778720|NCT00488059|10885278|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
9778721|NCT00488059|10885279|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
9778722|NCT00488059|10885280|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
9778723|NCT00488293|10885295|FG000|STARTED|Overall Study||196
9778724|NCT00488293|10885296|FG001|STARTED|Overall Study||196
9778725|NCT00488293|10885295|FG000|COMPLETED|Overall Study||160
9778726|NCT00488293|10885296|FG001|COMPLETED|Overall Study||166
9778727|NCT00488293|10885295|FG000|NOT COMPLETED|Overall Study||36
9778728|NCT00488293|10885296|FG001|NOT COMPLETED|Overall Study||30
9778729|NCT00488319|10885305|FG000|STARTED|Overall Study||39
9778730|NCT00488319|10885306|FG001|STARTED|Overall Study||118
9778731|NCT00488319|10885307|FG002|STARTED|Overall Study||243
9778732|NCT00488319|10885305|FG000|COMPLETED|Overall Study||24
9778733|NCT00488319|10885306|FG001|COMPLETED|Overall Study||75
9778734|NCT00488319|10885307|FG002|COMPLETED|Overall Study||121
9778735|NCT00488319|10885305|FG000|NOT COMPLETED|Overall Study||15
9778736|NCT00488319|10885306|FG001|NOT COMPLETED|Overall Study||43
9778737|NCT00488319|10885307|FG002|NOT COMPLETED|Overall Study||122
9778738|NCT00488345|10885319|FG000|STARTED|Overall Study||17
9778739|NCT00488345|10885320|FG001|STARTED|Overall Study||21
9778740|NCT00488345|10885321|FG002|STARTED|Overall Study||20
9778741|NCT00488345|10885319|FG000|COMPLETED|Overall Study||17
10014647|NCT01800916|11137680|FG008|STARTED|Test Period 3 (1 Week)||7
10014648|NCT01800916|11137672|FG000|COMPLETED|Test Period 3 (1 Week)||7
10014649|NCT01800916|11137673|FG001|COMPLETED|Test Period 3 (1 Week)||7
10014650|NCT01800916|11137674|FG002|COMPLETED|Test Period 3 (1 Week)||7
10014651|NCT01800916|11137675|FG003|COMPLETED|Test Period 3 (1 Week)||6
10014652|NCT01800916|11137676|FG004|COMPLETED|Test Period 3 (1 Week)||7
10014653|NCT01800916|11137677|FG005|COMPLETED|Test Period 3 (1 Week)||7
10014654|NCT01800916|11137678|FG006|COMPLETED|Test Period 3 (1 Week)||7
10014655|NCT01800916|11137679|FG007|COMPLETED|Test Period 3 (1 Week)||7
10014656|NCT01800916|11137680|FG008|COMPLETED|Test Period 3 (1 Week)||7
10014657|NCT01800916|11137672|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0
9778742|NCT00488345|10885320|FG001|COMPLETED|Overall Study||17
9778743|NCT00488345|10885321|FG002|COMPLETED|Overall Study||17
9778744|NCT00488345|10885319|FG000|NOT COMPLETED|Overall Study||0
9778745|NCT00488345|10885320|FG001|NOT COMPLETED|Overall Study||4
9778746|NCT00488345|10885321|FG002|NOT COMPLETED|Overall Study||3
9778747|NCT00488475|10885330|FG000|STARTED|Overall Study||4945
9778748|NCT00488475|10885330|FG000|COMPLETED|Overall Study||3191
9778749|NCT00488475|10885330|FG000|NOT COMPLETED|Overall Study||1754
9778750|NCT00488488|10885334|FG000|STARTED|Overall Study||1028
9778751|NCT00488488|10885334|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
9778752|NCT00488488|10885334|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
9778753|NCT00488488|10885334|FG000|NOT COMPLETED|Overall Study||268
9778754|NCT00488514|10885338|FG000|STARTED|Overall Study||656
9778755|NCT00488514|10885338|FG000|COMPLETED|Overall Study||363
9778756|NCT00488514|10885338|FG000|NOT COMPLETED|Overall Study||293
9778757|NCT00488592|10885359|FG000|STARTED|Overall Study|10 subjects were accrued|10
9778758|NCT00488592|10885359|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
9778759|NCT00488592|10885359|FG000|NOT COMPLETED|Overall Study||3
9778760|NCT00488618|10885365|FG000|STARTED|Overall Study||120
9778761|NCT00488618|10885366|FG001|STARTED|Overall Study||118
9778762|NCT00488618|10885365|FG000|Safety Population: Received Study Drug|Overall Study||118
9778763|NCT00488618|10885366|FG001|Safety Population: Received Study Drug|Overall Study||118
9778764|NCT00488618|10885365|FG000|COMPLETED|Overall Study||73
9778765|NCT00488618|10885366|FG001|COMPLETED|Overall Study||75
9778766|NCT00488618|10885365|FG000|NOT COMPLETED|Overall Study||47
9778767|NCT00488618|10885366|FG001|NOT COMPLETED|Overall Study||43
9778768|NCT00488631|10885378|FG000|STARTED|Double Blind Period (Week 0-54)||156
9778769|NCT00488631|10885379|FG001|STARTED|Double Blind Period (Week 0-54)||154
9778770|NCT00488631|10885380|FG002|STARTED|Double Blind Period (Week 0-54)||154
9778771|NCT00488631|10885381|FG003|STARTED|Double Blind Period (Week 0-54)||129
10014658|NCT01800916|11137673|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0
10014659|NCT01800916|11137674|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0
9778772|NCT00488631|10885382|FG004|STARTED|Double Blind Period (Week 0-54)||230
9778773|NCT00488631|10885383|FG005|STARTED|Double Blind Period (Week 0-54)||405
9778774|NCT00488631|10885384|FG006|STARTED|Double Blind Period (Week 0-54)||0
9778775|NCT00488631|10885385|FG007|STARTED|Double Blind Period (Week 0-54)||0
9778776|NCT00488631|10885386|FG008|STARTED|Double Blind Period (Week 0-54)||0
10014660|NCT01800916|11137675|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0
9778777|NCT00488631|10885387|FG009|STARTED|Double Blind Period (Week 0-54)||0
9778778|NCT00488631|10885378|FG000|COMPLETED|Double Blind Period (Week 0-54)||113
9778779|NCT00488631|10885379|FG001|COMPLETED|Double Blind Period (Week 0-54)||111
9778780|NCT00488631|10885380|FG002|COMPLETED|Double Blind Period (Week 0-54)||109
9778781|NCT00488631|10885381|FG003|COMPLETED|Double Blind Period (Week 0-54)||88
9778782|NCT00488631|10885382|FG004|COMPLETED|Double Blind Period (Week 0-54)||127
9778783|NCT00488631|10885383|FG005|COMPLETED|Double Blind Period (Week 0-54)||189
9778784|NCT00488631|10885384|FG006|COMPLETED|Double Blind Period (Week 0-54)||0
9778785|NCT00488631|10885385|FG007|COMPLETED|Double Blind Period (Week 0-54)||0
9778786|NCT00488631|10885386|FG008|COMPLETED|Double Blind Period (Week 0-54)||0
9778787|NCT00488631|10885387|FG009|COMPLETED|Double Blind Period (Week 0-54)||0
9778788|NCT00488631|10885378|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43
9778789|NCT00488631|10885379|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43
9778790|NCT00488631|10885380|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45
9778791|NCT00488631|10885381|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41
9778792|NCT00488631|10885382|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103
9778793|NCT00488631|10885383|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216
9778794|NCT00488631|10885384|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0
9778795|NCT00488631|10885385|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0
9778796|NCT00488631|10885386|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0
9778797|NCT00488631|10885387|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0
9778798|NCT00488631|10885378|FG000|STARTED|Open Label Study Extension (Week 54-228)||0
9778799|NCT00488631|10885379|FG001|STARTED|Open Label Study Extension (Week 54-228)||0
9778800|NCT00488631|10885380|FG002|STARTED|Open Label Study Extension (Week 54-228)||0
9778801|NCT00488631|10885381|FG003|STARTED|Open Label Study Extension (Week 54-228)||0
9778802|NCT00488631|10885382|FG004|STARTED|Open Label Study Extension (Week 54-228)||0
9778803|NCT00488631|10885383|FG005|STARTED|Open Label Study Extension (Week 54-228)||0
9778804|NCT00488631|10885384|FG006|STARTED|Open Label Study Extension (Week 54-228)||96
9778805|NCT00488631|10885385|FG007|STARTED|Open Label Study Extension (Week 54-228)||93
9778806|NCT00488631|10885386|FG008|STARTED|Open Label Study Extension (Week 54-228)||470
9778807|NCT00488631|10885387|FG009|STARTED|Open Label Study Extension (Week 54-228)||7
9778808|NCT00488631|10885378|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0
9778809|NCT00488631|10885379|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0
9778810|NCT00488631|10885380|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0
9778811|NCT00488631|10885381|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0
9778812|NCT00488631|10885382|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0
9778813|NCT00488631|10885383|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0
9778814|NCT00488631|10885384|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16
9778815|NCT00488631|10885385|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66
9778816|NCT00488631|10885386|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288
9778817|NCT00488631|10885387|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4
9778818|NCT00488631|10885378|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
9778819|NCT00488631|10885379|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
9778820|NCT00488631|10885380|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
9778821|NCT00488631|10885381|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
9778822|NCT00488631|10885382|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
9778823|NCT00488631|10885383|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
9778824|NCT00488631|10885384|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
9778825|NCT00488631|10885385|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
9778826|NCT00488631|10885386|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
9778827|NCT00488631|10885387|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
9778828|NCT00488644|10885410|FG000|STARTED|Overall Study||12
9778829|NCT00488644|10885410|FG000|COMPLETED|Overall Study||10
9778830|NCT00488644|10885410|FG000|NOT COMPLETED|Overall Study||2
9778831|NCT00488683|10885417|FG000|STARTED|Overall Study||108
9778832|NCT00488683|10885418|FG001|STARTED|Overall Study||54
9778833|NCT00488683|10885419|FG002|STARTED|Overall Study||54
9778834|NCT00488683|10885417|FG000|COMPLETED|Overall Study||96
9778835|NCT00488683|10885418|FG001|COMPLETED|Overall Study||48
9778836|NCT00488683|10885419|FG002|COMPLETED|Overall Study||52
9778837|NCT00488683|10885417|FG000|NOT COMPLETED|Overall Study||12
9778838|NCT00488683|10885418|FG001|NOT COMPLETED|Overall Study||6
9778839|NCT00488683|10885419|FG002|NOT COMPLETED|Overall Study||2
9778840|NCT00488774|10885435|FG000|STARTED|Overall Study||77
9778841|NCT00488774|10885436|FG001|STARTED|Overall Study||62
9778842|NCT00488774|10885437|FG002|STARTED|Overall Study||75
9778843|NCT00488774|10885438|FG003|STARTED|Overall Study||77
9778844|NCT00488774|10885435|FG000|COMPLETED|Overall Study||69
9778845|NCT00488774|10885436|FG001|COMPLETED|Overall Study||57
9778846|NCT00488774|10885437|FG002|COMPLETED|Overall Study||70
9778847|NCT00488774|10885438|FG003|COMPLETED|Overall Study||74
9778848|NCT00488774|10885435|FG000|NOT COMPLETED|Overall Study||8
9778849|NCT00488774|10885436|FG001|NOT COMPLETED|Overall Study||5
9778850|NCT00488774|10885437|FG002|NOT COMPLETED|Overall Study||5
9778851|NCT00488774|10885438|FG003|NOT COMPLETED|Overall Study||3
9778852|NCT00488826|10885452|FG000|STARTED|Overall Study||300
9778853|NCT00488826|10885453|FG001|STARTED|Overall Study||296
9778854|NCT00488826|10885454|FG002|STARTED|Overall Study||204
9778855|NCT00488826|10885452|FG000|COMPLETED|Overall Study||244
9778856|NCT00488826|10885453|FG001|COMPLETED|Overall Study||244
9778857|NCT00488826|10885454|FG002|COMPLETED|Overall Study||178
9778858|NCT00488826|10885452|FG000|NOT COMPLETED|Overall Study||56
9778859|NCT00488826|10885453|FG001|NOT COMPLETED|Overall Study||52
9778860|NCT00488826|10885454|FG002|NOT COMPLETED|Overall Study||26
9778861|NCT00488865|10885462|FG000|STARTED|Overall Study||100
9778862|NCT00488865|10885462|FG000|COMPLETED|Overall Study||100
9778863|NCT00488865|10885462|FG000|NOT COMPLETED|Overall Study||0
9778864|NCT00488982|10885466|FG000|STARTED|Induction Chemotherapy||125
9778865|NCT00488982|10885467|FG001|STARTED|Induction Chemotherapy||0
9778866|NCT00488982|10885468|FG002|STARTED|Induction Chemotherapy||0
9778867|NCT00488982|10885466|FG000|6 Cycles Completed|Induction Chemotherapy||94
9778868|NCT00488982|10885467|FG001|6 Cycles Completed|Induction Chemotherapy||0
9778869|NCT00488982|10885468|FG002|6 Cycles Completed|Induction Chemotherapy||0
9778870|NCT00488982|10885466|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
9778871|NCT00488982|10885467|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
9778872|NCT00488982|10885468|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
9778873|NCT00488982|10885466|FG000|COMPLETED|Induction Chemotherapy||52
9778874|NCT00488982|10885467|FG001|COMPLETED|Induction Chemotherapy||0
9778875|NCT00488982|10885468|FG002|COMPLETED|Induction Chemotherapy||0
9778876|NCT00488982|10885466|FG000|NOT COMPLETED|Induction Chemotherapy||73
9778877|NCT00488982|10885467|FG001|NOT COMPLETED|Induction Chemotherapy||0
9778878|NCT00488982|10885468|FG002|NOT COMPLETED|Induction Chemotherapy||0
9778879|NCT00488982|10885466|FG000|STARTED|Course 1||0
9778880|NCT00488982|10885467|FG001|STARTED|Course 1||25
9778881|NCT00488982|10885468|FG002|STARTED|Course 1||27
9778882|NCT00488982|10885466|FG000|COMPLETED|Course 1||0
9778883|NCT00488982|10885467|FG001|COMPLETED|Course 1||13
9778884|NCT00488982|10885468|FG002|COMPLETED|Course 1||13
9778885|NCT00488982|10885466|FG000|NOT COMPLETED|Course 1||0
9778886|NCT00488982|10885467|FG001|NOT COMPLETED|Course 1||12
9778887|NCT00488982|10885468|FG002|NOT COMPLETED|Course 1||14
9778888|NCT00488982|10885466|FG000|STARTED|Course 2||0
9778889|NCT00488982|10885467|FG001|STARTED|Course 2||13
9778890|NCT00488982|10885468|FG002|STARTED|Course 2||13
9778891|NCT00488982|10885466|FG000|COMPLETED|Course 2||0
9778892|NCT00488982|10885467|FG001|COMPLETED|Course 2||4
9778893|NCT00488982|10885468|FG002|COMPLETED|Course 2||8
9778894|NCT00488982|10885466|FG000|NOT COMPLETED|Course 2||0
9778895|NCT00488982|10885467|FG001|NOT COMPLETED|Course 2||9
9778896|NCT00488982|10885468|FG002|NOT COMPLETED|Course 2||5
9778897|NCT00488982|10885466|FG000|STARTED|Course 3||0
9778898|NCT00488982|10885467|FG001|STARTED|Course 3||4
9778899|NCT00488982|10885468|FG002|STARTED|Course 3||8
9778900|NCT00488982|10885466|FG000|COMPLETED|Course 3||0
9778901|NCT00488982|10885467|FG001|COMPLETED|Course 3||2
9778902|NCT00488982|10885468|FG002|COMPLETED|Course 3||3
9778903|NCT00488982|10885466|FG000|NOT COMPLETED|Course 3||0
9778904|NCT00488982|10885467|FG001|NOT COMPLETED|Course 3||2
9778905|NCT00488982|10885468|FG002|NOT COMPLETED|Course 3||5
9778906|NCT00488982|10885466|FG000|STARTED|Response to Course 3||0
9778907|NCT00488982|10885467|FG001|STARTED|Response to Course 3||2
9778908|NCT00488982|10885468|FG002|STARTED|Response to Course 3||3
9778909|NCT00488982|10885466|FG000|COMPLETED|Response to Course 3||0
9778910|NCT00488982|10885467|FG001|COMPLETED|Response to Course 3||1
9778911|NCT00488982|10885468|FG002|COMPLETED|Response to Course 3||0
9778912|NCT00488982|10885466|FG000|NOT COMPLETED|Response to Course 3||0
9778913|NCT00488982|10885467|FG001|NOT COMPLETED|Response to Course 3||1
10014661|NCT01800916|11137676|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0
10014662|NCT01800916|11137677|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0
10014663|NCT01800916|11137678|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0
10014664|NCT01800916|11137679|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0
9778914|NCT00488982|10885468|FG002|NOT COMPLETED|Response to Course 3||3
9778915|NCT00489086|10885482|FG000|STARTED|Overall Study||36
9778916|NCT00489086|10885482|FG000|Completed 18 Months|Overall Study||23
9778917|NCT00489086|10885482|FG000|COMPLETED|Overall Study||13
9778918|NCT00489086|10885482|FG000|NOT COMPLETED|Overall Study||23
9830141|NCT00762307|10940821|FG002|STARTED|Overall Study||11
9830142|NCT00762307|10940822|FG003|STARTED|Overall Study||10
9830143|NCT00762307|10940819|FG000|COMPLETED|Overall Study||26
9830144|NCT00762307|10940820|FG001|COMPLETED|Overall Study||11
9830145|NCT00762307|10940821|FG002|COMPLETED|Overall Study||11
9830146|NCT00762307|10940822|FG003|COMPLETED|Overall Study||9
9830147|NCT00762307|10940819|FG000|NOT COMPLETED|Overall Study||2
9830148|NCT00762307|10940820|FG001|NOT COMPLETED|Overall Study||0
9830149|NCT00762307|10940821|FG002|NOT COMPLETED|Overall Study||0
9830150|NCT00762307|10940822|FG003|NOT COMPLETED|Overall Study||1
9830151|NCT00762320|10940843|FG000|STARTED|Overall Study||8
9830152|NCT00762320|10940843|FG000|COMPLETED|Overall Study||8
9830153|NCT00762320|10940843|FG000|NOT COMPLETED|Overall Study||0
9830154|NCT00762359|10940854|FG000|STARTED|Overall Study||226
9830155|NCT00762359|10940855|FG001|STARTED|Overall Study||235
9830156|NCT00762359|10940854|FG000|COMPLETED|Overall Study||167
9830157|NCT00762359|10940855|FG001|COMPLETED|Overall Study||178
9830158|NCT00762359|10940854|FG000|NOT COMPLETED|Overall Study||59
9830159|NCT00762359|10940855|FG001|NOT COMPLETED|Overall Study||57
9830160|NCT00762372|10940864|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
9830161|NCT00762372|10940865|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
9832479|NCT00773253|10943242|FG000|COMPLETED|Second Intervention (Week 24-48)||5
9778919|NCT00489216|10885486|FG000|STARTED|Overall Study||2
9778920|NCT00489216|10885486|FG000|COMPLETED|Overall Study||1
9778921|NCT00489216|10885486|FG000|NOT COMPLETED|Overall Study||1
9778922|NCT00489255|10885492|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
9778923|NCT00489255|10885493|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
10014665|NCT01800916|11137680|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0
10014666|NCT01800968|11137692|FG000|STARTED|Overall Study||154
10014667|NCT01800968|11137693|FG001|STARTED|Overall Study||146
10014668|NCT01800968|11137692|FG000|COMPLETED|Overall Study||118
10014669|NCT01800968|11137693|FG001|COMPLETED|Overall Study||114
10014670|NCT01800968|11137692|FG000|NOT COMPLETED|Overall Study||36
10014671|NCT01800968|11137693|FG001|NOT COMPLETED|Overall Study||32
10014672|NCT01801007|11137699|FG000|STARTED|Overall Study||145
9778924|NCT00489255|10885492|FG000|COMPLETED|Screening and Initial Randomization||136
9778925|NCT00489255|10885493|FG001|COMPLETED|Screening and Initial Randomization||46
9778926|NCT00489255|10885492|FG000|NOT COMPLETED|Screening and Initial Randomization||9
9778927|NCT00489255|10885493|FG001|NOT COMPLETED|Screening and Initial Randomization||3
9778928|NCT00489255|10885492|FG000|STARTED|Period 1: Days 1 to 28||136
9778929|NCT00489255|10885493|FG001|STARTED|Period 1: Days 1 to 28||46
9778930|NCT00489255|10885492|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94
9778931|NCT00489255|10885493|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29
9778932|NCT00489255|10885492|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13
9778933|NCT00489255|10885493|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5
9778934|NCT00489255|10885492|FG000|COMPLETED|Period 1: Days 1 to 28||107
9778935|NCT00489255|10885493|FG001|COMPLETED|Period 1: Days 1 to 28||34
9778936|NCT00489255|10885492|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29
9778937|NCT00489255|10885493|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12
9778938|NCT00489255|10885492|FG000|STARTED|Period 2: Days 29 to 56||64
9778939|NCT00489255|10885493|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
9778940|NCT00489255|10885492|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58
9778941|NCT00489255|10885493|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
9778942|NCT00489255|10885492|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3
9778943|NCT00489255|10885493|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
9778944|NCT00489255|10885492|FG000|COMPLETED|Period 2: Days 29 to 56||61
9778945|NCT00489255|10885493|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
9778946|NCT00489255|10885492|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3
9778947|NCT00489255|10885493|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4
9778948|NCT00489255|10885492|FG000|STARTED|Period 3: Days 57 to 84||28
9778949|NCT00489255|10885493|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
9778950|NCT00489255|10885492|FG000|COMPLETED|Period 3: Days 57 to 84||24
9778951|NCT00489255|10885493|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
9778952|NCT00489255|10885492|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4
9778953|NCT00489255|10885493|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4
9778954|NCT00489268|10885504|FG000|STARTED|Overall Study||1
9778955|NCT00489268|10885505|FG001|STARTED|Overall Study||10
9778956|NCT00489268|10885506|FG002|STARTED|Overall Study||10
9778957|NCT00489268|10885507|FG003|STARTED|Overall Study||11
9778958|NCT00489268|10885508|FG004|STARTED|Overall Study||70
9778959|NCT00489268|10885504|FG000|COMPLETED|Overall Study||1
9778960|NCT00489268|10885505|FG001|COMPLETED|Overall Study||10
9778961|NCT00489268|10885506|FG002|COMPLETED|Overall Study||9
9778962|NCT00489268|10885507|FG003|COMPLETED|Overall Study||11
9778963|NCT00489268|10885508|FG004|COMPLETED|Overall Study||50
9778964|NCT00489268|10885504|FG000|NOT COMPLETED|Overall Study||0
9778965|NCT00489268|10885505|FG001|NOT COMPLETED|Overall Study||0
9778966|NCT00489268|10885506|FG002|NOT COMPLETED|Overall Study||1
9778967|NCT00489268|10885507|FG003|NOT COMPLETED|Overall Study||0
9778968|NCT00489268|10885508|FG004|NOT COMPLETED|Overall Study||20
9778969|NCT00489281|10885522|FG000|STARTED|Overall Study||29
9778970|NCT00489281|10885523|FG001|STARTED|Overall Study||13
9778971|NCT00489281|10885522|FG000|COMPLETED|Overall Study||29
9778972|NCT00489281|10885523|FG001|COMPLETED|Overall Study||13
9778973|NCT00489281|10885522|FG000|NOT COMPLETED|Overall Study||0
9778974|NCT00489281|10885523|FG001|NOT COMPLETED|Overall Study||0
9778975|NCT00489359|10885531|FG000|STARTED|Overall Study||20
9778976|NCT00489359|10885532|FG001|STARTED|Overall Study||66
9778977|NCT00489359|10885531|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
9778978|NCT00489359|10885532|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
9778979|NCT00489359|10885531|FG000|NOT COMPLETED|Overall Study||7
9778980|NCT00489359|10885532|FG001|NOT COMPLETED|Overall Study||29
9778981|NCT00489411|10885545|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115
9778982|NCT00489411|10885546|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116
9778983|NCT00489411|10885545|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
9778984|NCT00489411|10885546|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
10014673|NCT01801007|11137699|FG000|COMPLETED|Overall Study||134
10014674|NCT01801007|11137699|FG000|NOT COMPLETED|Overall Study||11
9778985|NCT00489411|10885545|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
9778986|NCT00489411|10885546|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
9778987|NCT00489411|10885545|FG000|STARTED|Washout Period (Weeks 6-7)||87
9778988|NCT00489411|10885546|FG001|STARTED|Washout Period (Weeks 6-7)||94
9778989|NCT00489411|10885545|FG000|COMPLETED|Washout Period (Weeks 6-7)||85
9778990|NCT00489411|10885546|FG001|COMPLETED|Washout Period (Weeks 6-7)||93
9778991|NCT00489411|10885545|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2
9778992|NCT00489411|10885546|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1
9778993|NCT00489411|10885545|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85
9778994|NCT00489411|10885546|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93
9778995|NCT00489411|10885545|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
9778996|NCT00489411|10885546|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
9778997|NCT00489411|10885545|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
9778998|NCT00489411|10885546|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
9778999|NCT00489424|10885555|FG000|STARTED|Overall Study||267
9779000|NCT00489424|10885556|FG001|STARTED|Overall Study||264
9779001|NCT00489424|10885557|FG002|STARTED|Overall Study||262
9779002|NCT00489424|10885555|FG000|COMPLETED|Overall Study||263
9779003|NCT00489424|10885556|FG001|COMPLETED|Overall Study||259
9779004|NCT00489424|10885557|FG002|COMPLETED|Overall Study||257
9779005|NCT00489424|10885555|FG000|NOT COMPLETED|Overall Study||4
9779006|NCT00489424|10885556|FG001|NOT COMPLETED|Overall Study||5
9779007|NCT00489424|10885557|FG002|NOT COMPLETED|Overall Study||5
9779008|NCT00489476|10885569|FG000|STARTED|Overall Study||39
9779009|NCT00489476|10885570|FG001|STARTED|Overall Study||43
9779010|NCT00489476|10885571|FG002|STARTED|Overall Study||43
9779011|NCT00489476|10885572|FG003|STARTED|Overall Study||43
9779012|NCT00489476|10885569|FG000|COMPLETED|Overall Study||39
9779013|NCT00489476|10885570|FG001|COMPLETED|Overall Study||42
9779014|NCT00489476|10885571|FG002|COMPLETED|Overall Study||43
9779015|NCT00489476|10885572|FG003|COMPLETED|Overall Study||43
9779016|NCT00489476|10885569|FG000|NOT COMPLETED|Overall Study||0
9779017|NCT00489476|10885570|FG001|NOT COMPLETED|Overall Study||1
9779018|NCT00489476|10885571|FG002|NOT COMPLETED|Overall Study||0
9779019|NCT00489476|10885572|FG003|NOT COMPLETED|Overall Study||0
9779020|NCT00489489|10885585|FG000|STARTED|Overall Study|randomized|41
9779021|NCT00489489|10885586|FG001|STARTED|Overall Study|randomized|37
9779022|NCT00489489|10885587|FG002|STARTED|Overall Study|randomized|40
9779023|NCT00489489|10885585|FG000|Treated|Overall Study||41
9779024|NCT00489489|10885586|FG001|Treated|Overall Study||36
9779025|NCT00489489|10885587|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
9779026|NCT00489489|10885585|FG000|COMPLETED|Overall Study|completed treatment period|38
9779027|NCT00489489|10885586|FG001|COMPLETED|Overall Study|completed treatment period|32
9779028|NCT00489489|10885587|FG002|COMPLETED|Overall Study|completed treatment period|37
9779029|NCT00489489|10885585|FG000|NOT COMPLETED|Overall Study||3
9779030|NCT00489489|10885586|FG001|NOT COMPLETED|Overall Study||5
10014675|NCT01801111|11137703|FG000|STARTED|Overall Study||138
10233943|NCT01606150|11363820|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
10233944|NCT01606150|11363821|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
9779031|NCT00489489|10885587|FG002|NOT COMPLETED|Overall Study||3
9779032|NCT00489541|10885599|FG000|STARTED|12-Month Clinical Follow-up||224
9779033|NCT00489541|10885600|FG001|STARTED|12-Month Clinical Follow-up||125
9779034|NCT00489541|10885599|FG000|COMPLETED|12-Month Clinical Follow-up||215
9779035|NCT00489541|10885600|FG001|COMPLETED|12-Month Clinical Follow-up||120
9779036|NCT00489541|10885599|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9
9779037|NCT00489541|10885600|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5
9779038|NCT00489541|10885599|FG000|STARTED|9-Month Angiographic Follow-up||224
9779039|NCT00489541|10885600|FG001|STARTED|9-Month Angiographic Follow-up||125
9779040|NCT00489541|10885599|FG000|COMPLETED|9-Month Angiographic Follow-up||197
9779041|NCT00489541|10885600|FG001|COMPLETED|9-Month Angiographic Follow-up||108
9779042|NCT00489541|10885599|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27
9779043|NCT00489541|10885600|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17
9779044|NCT00489554|10885606|FG000|STARTED|Overall Study||230
9779045|NCT00489554|10885606|FG000|COMPLETED|Overall Study||226
9779046|NCT00489554|10885606|FG000|NOT COMPLETED|Overall Study||4
9779047|NCT00489736|10885612|FG000|STARTED|Overall Study|Randomized and treated patients|249
9779048|NCT00489736|10885613|FG001|STARTED|Overall Study|Randomized and treated patients|255
9779049|NCT00489736|10885612|FG000|COMPLETED|Overall Study|completed study drug period|153
9779050|NCT00489736|10885613|FG001|COMPLETED|Overall Study|completed study drug period|186
9779051|NCT00489736|10885612|FG000|NOT COMPLETED|Overall Study||96
9779052|NCT00489736|10885613|FG001|NOT COMPLETED|Overall Study||69
9779053|NCT00489853|10885619|FG000|STARTED|Treatment Period 1||36
9779054|NCT00489853|10885620|FG001|STARTED|Treatment Period 1||37
9779055|NCT00489853|10885621|FG002|STARTED|Treatment Period 1||38
9779056|NCT00489853|10885619|FG000|COMPLETED|Treatment Period 1||36
9779057|NCT00489853|10885620|FG001|COMPLETED|Treatment Period 1||37
9779058|NCT00489853|10885621|FG002|COMPLETED|Treatment Period 1||38
9779059|NCT00489853|10885619|FG000|NOT COMPLETED|Treatment Period 1||0
9779060|NCT00489853|10885620|FG001|NOT COMPLETED|Treatment Period 1||0
9779061|NCT00489853|10885621|FG002|NOT COMPLETED|Treatment Period 1||0
9779062|NCT00489853|10885619|FG000|STARTED|Wash-out Period 1||36
10014676|NCT01801111|11137703|FG000|COMPLETED|Overall Study||0
9779063|NCT00489853|10885620|FG001|STARTED|Wash-out Period 1||37
9779064|NCT00489853|10885621|FG002|STARTED|Wash-out Period 1||38
9779065|NCT00489853|10885619|FG000|COMPLETED|Wash-out Period 1||35
9779066|NCT00489853|10885620|FG001|COMPLETED|Wash-out Period 1||34
9779067|NCT00489853|10885621|FG002|COMPLETED|Wash-out Period 1||32
9779068|NCT00489853|10885619|FG000|NOT COMPLETED|Wash-out Period 1||1
9779069|NCT00489853|10885620|FG001|NOT COMPLETED|Wash-out Period 1||3
9779070|NCT00489853|10885621|FG002|NOT COMPLETED|Wash-out Period 1||6
9779071|NCT00489853|10885619|FG000|STARTED|Treatment Period 2||33
9779072|NCT00489853|10885620|FG001|STARTED|Treatment Period 2||35
9779073|NCT00489853|10885621|FG002|STARTED|Treatment Period 2||33
9779074|NCT00489853|10885619|FG000|COMPLETED|Treatment Period 2||33
9779075|NCT00489853|10885620|FG001|COMPLETED|Treatment Period 2||35
9779076|NCT00489853|10885621|FG002|COMPLETED|Treatment Period 2||33
9779077|NCT00489853|10885619|FG000|NOT COMPLETED|Treatment Period 2||0
9779078|NCT00489853|10885620|FG001|NOT COMPLETED|Treatment Period 2||0
9779079|NCT00489853|10885621|FG002|NOT COMPLETED|Treatment Period 2||0
9779080|NCT00489853|10885619|FG000|STARTED|Wash-out Period 2||33
9779081|NCT00489853|10885620|FG001|STARTED|Wash-out Period 2||35
9779082|NCT00489853|10885621|FG002|STARTED|Wash-out Period 2||33
9779083|NCT00489853|10885619|FG000|COMPLETED|Wash-out Period 2||29
9779084|NCT00489853|10885620|FG001|COMPLETED|Wash-out Period 2||32
9779085|NCT00489853|10885621|FG002|COMPLETED|Wash-out Period 2||31
9779086|NCT00489853|10885619|FG000|NOT COMPLETED|Wash-out Period 2||4
9779087|NCT00489853|10885620|FG001|NOT COMPLETED|Wash-out Period 2||3
9779088|NCT00489853|10885621|FG002|NOT COMPLETED|Wash-out Period 2||2
9779089|NCT00489853|10885619|FG000|STARTED|Treatment Period 3||29
9779090|NCT00489853|10885620|FG001|STARTED|Treatment Period 3||30
9779091|NCT00489853|10885621|FG002|STARTED|Treatment Period 3||33
9779092|NCT00489853|10885619|FG000|COMPLETED|Treatment Period 3||29
9779093|NCT00489853|10885620|FG001|COMPLETED|Treatment Period 3||29
9779094|NCT00489853|10885621|FG002|COMPLETED|Treatment Period 3||33
9779095|NCT00489853|10885619|FG000|NOT COMPLETED|Treatment Period 3||0
9779096|NCT00489853|10885620|FG001|NOT COMPLETED|Treatment Period 3||1
9779097|NCT00489853|10885621|FG002|NOT COMPLETED|Treatment Period 3||0
9779098|NCT00489853|10885619|FG000|STARTED|Follow-up Period||29
9779099|NCT00489853|10885620|FG001|STARTED|Follow-up Period||29
9779100|NCT00489853|10885621|FG002|STARTED|Follow-up Period||33
9779101|NCT00489853|10885619|FG000|COMPLETED|Follow-up Period||29
9779102|NCT00489853|10885620|FG001|COMPLETED|Follow-up Period||29
9779103|NCT00489853|10885621|FG002|COMPLETED|Follow-up Period||33
9779104|NCT00489853|10885619|FG000|NOT COMPLETED|Follow-up Period||0
9779105|NCT00489853|10885620|FG001|NOT COMPLETED|Follow-up Period||0
9779106|NCT00489853|10885621|FG002|NOT COMPLETED|Follow-up Period||0
9779107|NCT00489866|10885631|FG000|STARTED|Overall Study||7
9779108|NCT00489866|10885632|FG001|STARTED|Overall Study||7
9779109|NCT00489866|10885631|FG000|COMPLETED|Overall Study||5
9779110|NCT00489866|10885632|FG001|COMPLETED|Overall Study||7
9779111|NCT00489866|10885631|FG000|NOT COMPLETED|Overall Study||2
9779112|NCT00489866|10885632|FG001|NOT COMPLETED|Overall Study||0
9779113|NCT00489918|10885651|FG000|STARTED|Overall Study||33
9779114|NCT00489918|10885652|FG001|STARTED|Overall Study||34
9779115|NCT00489918|10885653|FG002|STARTED|Overall Study||32
9779116|NCT00489918|10885654|FG003|STARTED|Overall Study||33
9779117|NCT00489918|10885655|FG004|STARTED|Overall Study||33
9779118|NCT00489918|10885651|FG000|COMPLETED|Overall Study||31
9779119|NCT00489918|10885652|FG001|COMPLETED|Overall Study||32
9779120|NCT00489918|10885653|FG002|COMPLETED|Overall Study||28
9779121|NCT00489918|10885654|FG003|COMPLETED|Overall Study||32
9779122|NCT00489918|10885655|FG004|COMPLETED|Overall Study||32
9779123|NCT00489918|10885651|FG000|NOT COMPLETED|Overall Study||2
9779124|NCT00489918|10885652|FG001|NOT COMPLETED|Overall Study||2
9779125|NCT00489918|10885653|FG002|NOT COMPLETED|Overall Study||4
9779126|NCT00489918|10885654|FG003|NOT COMPLETED|Overall Study||1
9779127|NCT00489918|10885655|FG004|NOT COMPLETED|Overall Study||1
9779128|NCT00489970|10885670|FG000|STARTED|Persistence Year 1||1069
9779129|NCT00489970|10885671|FG001|STARTED|Persistence Year 1||523
9779130|NCT00489970|10885672|FG002|STARTED|Persistence Year 1||0
9779131|NCT00489970|10885670|FG000|COMPLETED|Persistence Year 1||1069
9779132|NCT00489970|10885671|FG001|COMPLETED|Persistence Year 1||523
9779133|NCT00489970|10885672|FG002|COMPLETED|Persistence Year 1||0
9779134|NCT00489970|10885670|FG000|NOT COMPLETED|Persistence Year 1||0
9779135|NCT00489970|10885671|FG001|NOT COMPLETED|Persistence Year 1||0
9779136|NCT00489970|10885672|FG002|NOT COMPLETED|Persistence Year 1||0
9779137|NCT00489970|10885670|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
9779138|NCT00489970|10885671|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
9779139|NCT00489970|10885672|FG002|STARTED|Persistence Year 3||0
9779140|NCT00489970|10885670|FG000|COMPLETED|Persistence Year 3||1019
9779141|NCT00489970|10885671|FG001|COMPLETED|Persistence Year 3||486
9779142|NCT00489970|10885672|FG002|COMPLETED|Persistence Year 3||0
9779143|NCT00489970|10885670|FG000|NOT COMPLETED|Persistence Year 3||0
9779144|NCT00489970|10885671|FG001|NOT COMPLETED|Persistence Year 3||0
9779145|NCT00489970|10885672|FG002|NOT COMPLETED|Persistence Year 3||0
9779146|NCT00489970|10885670|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
9779147|NCT00489970|10885671|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
9779148|NCT00489970|10885672|FG002|STARTED|Persistence Year 5||0
9779149|NCT00489970|10885670|FG000|COMPLETED|Persistence Year 5||856
9779150|NCT00489970|10885671|FG001|COMPLETED|Persistence Year 5||401
9779151|NCT00489970|10885672|FG002|COMPLETED|Persistence Year 5||0
9779152|NCT00489970|10885670|FG000|NOT COMPLETED|Persistence Year 5||0
9779153|NCT00489970|10885671|FG001|NOT COMPLETED|Persistence Year 5||0
9779154|NCT00489970|10885672|FG002|NOT COMPLETED|Persistence Year 5||0
9779155|NCT00489970|10885670|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
9779156|NCT00489970|10885671|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
9779157|NCT00489970|10885672|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
9779158|NCT00489970|10885670|FG000|COMPLETED|Persistence Year 9||306
9779159|NCT00489970|10885671|FG001|COMPLETED|Persistence Year 9||136
9779160|NCT00489970|10885672|FG002|COMPLETED|Persistence Year 9||357
9779161|NCT00489970|10885670|FG000|NOT COMPLETED|Persistence Year 9||3
9779162|NCT00489970|10885671|FG001|NOT COMPLETED|Persistence Year 9||2
9779163|NCT00489970|10885672|FG002|NOT COMPLETED|Persistence Year 9||5
9779164|NCT00490009|10885683|FG000|STARTED|Overall Study||9
9779165|NCT00490009|10885683|FG000|COMPLETED|Overall Study||9
9779166|NCT00490009|10885683|FG000|NOT COMPLETED|Overall Study||0
9779167|NCT00490022|10885690|FG000|STARTED|Overall Study||16
9779168|NCT00490022|10885691|FG001|STARTED|Overall Study||15
9779169|NCT00490022|10885690|FG000|COMPLETED|Overall Study||15
9779170|NCT00490022|10885691|FG001|COMPLETED|Overall Study||12
9779171|NCT00490022|10885690|FG000|NOT COMPLETED|Overall Study||1
9779172|NCT00490022|10885691|FG001|NOT COMPLETED|Overall Study||3
9779173|NCT00490035|10885701|FG000|STARTED|Overall Study||100
9779174|NCT00490035|10885702|FG001|STARTED|Overall Study||99
9779175|NCT00490035|10885703|FG002|STARTED|Overall Study||100
9779176|NCT00490035|10885704|FG003|STARTED|Overall Study||100
9779177|NCT00490035|10885701|FG000|COMPLETED|Overall Study||92
9779178|NCT00490035|10885702|FG001|COMPLETED|Overall Study||93
9779179|NCT00490035|10885703|FG002|COMPLETED|Overall Study||88
9779180|NCT00490035|10885704|FG003|COMPLETED|Overall Study||94
9779181|NCT00490035|10885701|FG000|NOT COMPLETED|Overall Study||8
9779182|NCT00490035|10885702|FG001|NOT COMPLETED|Overall Study||6
9779183|NCT00490035|10885703|FG002|NOT COMPLETED|Overall Study||12
9779184|NCT00490035|10885704|FG003|NOT COMPLETED|Overall Study||6
9779185|NCT00490061|10885714|FG000|STARTED|Overall Study||17
9779186|NCT00490061|10885714|FG000|COMPLETED|Overall Study||16
9779187|NCT00490061|10885714|FG000|NOT COMPLETED|Overall Study||1
9779188|NCT00490100|10885718|FG000|STARTED|Overall Study||6
9779189|NCT00490100|10885718|FG000|COMPLETED|Overall Study||3
9779190|NCT00490100|10885718|FG000|NOT COMPLETED|Overall Study||3
9779191|NCT00490139|10885727|FG000|STARTED|Overall Study||2093
9779192|NCT00490139|10885728|FG001|STARTED|Overall Study||2091
9779193|NCT00490139|10885729|FG002|STARTED|Overall Study||2100
9779194|NCT00490139|10885730|FG003|STARTED|Overall Study||2097
9779195|NCT00490139|10885727|FG000|COMPLETED|Overall Study||1785
9779196|NCT00490139|10885728|FG001|COMPLETED|Overall Study||1816
9779197|NCT00490139|10885729|FG002|COMPLETED|Overall Study||1666
9779198|NCT00490139|10885730|FG003|COMPLETED|Overall Study||1790
9779199|NCT00490139|10885727|FG000|NOT COMPLETED|Overall Study||308
9779200|NCT00490139|10885728|FG001|NOT COMPLETED|Overall Study||275
9779201|NCT00490139|10885729|FG002|NOT COMPLETED|Overall Study||434
9779202|NCT00490139|10885730|FG003|NOT COMPLETED|Overall Study||307
9779203|NCT00490256|10885744|FG000|STARTED|Overall Study||7
9779204|NCT00490256|10885745|FG001|STARTED|Overall Study||7
9779205|NCT00490256|10885744|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
9779206|NCT00490256|10885745|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
9779207|NCT00490256|10885744|FG000|COMPLETED|Overall Study||7
9779208|NCT00490256|10885745|FG001|COMPLETED|Overall Study||7
9779209|NCT00490256|10885744|FG000|NOT COMPLETED|Overall Study||0
9779210|NCT00490256|10885745|FG001|NOT COMPLETED|Overall Study||0
9779211|NCT00490269|10885753|FG000|STARTED|Dronabinol Then Placebo||6
9779212|NCT00490269|10885754|FG001|STARTED|Dronabinol Then Placebo||6
9779213|NCT00490269|10885753|FG000|COMPLETED|Dronabinol Then Placebo||6
9779214|NCT00490269|10885754|FG001|COMPLETED|Dronabinol Then Placebo||6
9779215|NCT00490269|10885753|FG000|NOT COMPLETED|Dronabinol Then Placebo||0
9779216|NCT00490269|10885754|FG001|NOT COMPLETED|Dronabinol Then Placebo||0
9779217|NCT00490269|10885753|FG000|STARTED|Placebo Then Dronabinol||6
9779218|NCT00490269|10885754|FG001|STARTED|Placebo Then Dronabinol||6
9779219|NCT00490269|10885753|FG000|COMPLETED|Placebo Then Dronabinol||6
9779220|NCT00490269|10885754|FG001|COMPLETED|Placebo Then Dronabinol||6
9779221|NCT00490269|10885753|FG000|NOT COMPLETED|Placebo Then Dronabinol||0
9779222|NCT00490269|10885754|FG001|NOT COMPLETED|Placebo Then Dronabinol||0
9779223|NCT00490282|10885760|FG000|STARTED|Overall Study||25
9779224|NCT00490282|10885760|FG000|COMPLETED|Overall Study||22
9779225|NCT00490282|10885760|FG000|NOT COMPLETED|Overall Study||3
9779226|NCT00490451|10885767|FG000|STARTED|Overall Study||63
9779227|NCT00490451|10885768|FG001|STARTED|Overall Study||38
9779228|NCT00490451|10885767|FG000|COMPLETED|Overall Study||0
9779229|NCT00490451|10885768|FG001|COMPLETED|Overall Study||0
9779230|NCT00490451|10885767|FG000|NOT COMPLETED|Overall Study||63
9779231|NCT00490451|10885768|FG001|NOT COMPLETED|Overall Study||38
9779232|NCT00490477|10885776|FG000|STARTED|Overall Study||8
9779233|NCT00490477|10885777|FG001|STARTED|Overall Study||8
9779234|NCT00490477|10885776|FG000|COMPLETED|Overall Study||8
9779235|NCT00490477|10885777|FG001|COMPLETED|Overall Study||8
9779236|NCT00490477|10885776|FG000|NOT COMPLETED|Overall Study||0
9779237|NCT00490477|10885777|FG001|NOT COMPLETED|Overall Study||0
9779238|NCT00490490|10885783|FG000|STARTED|Completed Assessment for CR||8
9779239|NCT00490490|10885783|FG000|COMPLETED|Completed Assessment for CR||8
9779240|NCT00490490|10885783|FG000|NOT COMPLETED|Completed Assessment for CR||0
9779241|NCT00490490|10885783|FG000|STARTED|Completed Assessment for TTP||8
9779242|NCT00490490|10885783|FG000|COMPLETED|Completed Assessment for TTP||5
9779243|NCT00490490|10885783|FG000|NOT COMPLETED|Completed Assessment for TTP||3
9779244|NCT00490529|10885787|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
9779245|NCT00490529|10885787|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
9779246|NCT00490529|10885787|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
9779247|NCT00490529|10885787|FG000|STARTED|Treatment With CpG-MCL Vaccine||48
9779248|NCT00490529|10885787|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47
9779249|NCT00490529|10885787|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
9779250|NCT00490542|10885793|FG000|STARTED|Overall Study||38
9779251|NCT00490542|10885794|FG001|STARTED|Overall Study||35
9779252|NCT00490542|10885793|FG000|COMPLETED|Overall Study||31
9779253|NCT00490542|10885794|FG001|COMPLETED|Overall Study||31
9779254|NCT00490542|10885793|FG000|NOT COMPLETED|Overall Study||7
9779255|NCT00490542|10885794|FG001|NOT COMPLETED|Overall Study||4
9779256|NCT00490555|10885804|FG000|STARTED|Overall Study||8
9779257|NCT00490555|10885805|FG001|STARTED|Overall Study||8
9779258|NCT00490555|10885806|FG002|STARTED|Overall Study||9
9779259|NCT00490555|10885807|FG003|STARTED|Overall Study||7
9779260|NCT00490555|10885804|FG000|COMPLETED|Overall Study||8
9779261|NCT00490555|10885805|FG001|COMPLETED|Overall Study||8
9779262|NCT00490555|10885806|FG002|COMPLETED|Overall Study||7
9779263|NCT00490555|10885807|FG003|COMPLETED|Overall Study||7
9779264|NCT00490555|10885804|FG000|NOT COMPLETED|Overall Study||0
9779265|NCT00490555|10885805|FG001|NOT COMPLETED|Overall Study||0
9779266|NCT00490555|10885806|FG002|NOT COMPLETED|Overall Study||2
9779267|NCT00490555|10885807|FG003|NOT COMPLETED|Overall Study||0
9779268|NCT00490568|10885817|FG000|STARTED|Overall Study||1461
9779269|NCT00490568|10885817|FG000|COMPLETED|Overall Study||97
9779270|NCT00490568|10885817|FG000|NOT COMPLETED|Overall Study||1364
9779271|NCT00490646|10885824|FG000|STARTED|Overall Study||25
9779272|NCT00490646|10885825|FG001|STARTED|Overall Study||25
9779273|NCT00490646|10885824|FG000|Treated|Overall Study||24
9779274|NCT00490646|10885825|FG001|Treated|Overall Study||24
9779275|NCT00490646|10885824|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
9779276|NCT00490646|10885825|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
9779277|NCT00490646|10885824|FG000|NOT COMPLETED|Overall Study||2
9779278|NCT00490646|10885825|FG001|NOT COMPLETED|Overall Study||2
9779279|NCT00490698|10885831|FG000|STARTED|Overall Study||11
9779280|NCT00490698|10885831|FG000|COMPLETED|Overall Study||1
9779281|NCT00490698|10885831|FG000|NOT COMPLETED|Overall Study||10
9779282|NCT00490724|10885838|FG000|STARTED|Period I||21
9779283|NCT00490724|10885839|FG001|STARTED|Period I||20
9779284|NCT00490724|10885840|FG002|STARTED|Period I||20
9779285|NCT00490724|10885838|FG000|COMPLETED|Period I||21
9779286|NCT00490724|10885839|FG001|COMPLETED|Period I||20
9779287|NCT00490724|10885840|FG002|COMPLETED|Period I||19
9779288|NCT00490724|10885838|FG000|NOT COMPLETED|Period I||0
9779289|NCT00490724|10885839|FG001|NOT COMPLETED|Period I||0
9779290|NCT00490724|10885840|FG002|NOT COMPLETED|Period I||1
9779291|NCT00490724|10885838|FG000|STARTED|Period II||21
9779292|NCT00490724|10885839|FG001|STARTED|Period II||20
9779293|NCT00490724|10885840|FG002|STARTED|Period II||19
9779294|NCT00490724|10885838|FG000|COMPLETED|Period II||18
9779295|NCT00490724|10885839|FG001|COMPLETED|Period II||19
9779296|NCT00490724|10885840|FG002|COMPLETED|Period II||16
9779297|NCT00490724|10885838|FG000|NOT COMPLETED|Period II||3
9779298|NCT00490724|10885839|FG001|NOT COMPLETED|Period II||1
9779299|NCT00490724|10885840|FG002|NOT COMPLETED|Period II||3
9779300|NCT00490802|10885850|FG000|STARTED|Overall Study||10
9779301|NCT00490802|10885851|FG001|STARTED|Overall Study||9
9779302|NCT00490802|10885850|FG000|COMPLETED|Overall Study||9
9779303|NCT00490802|10885851|FG001|COMPLETED|Overall Study||7
9779304|NCT00490802|10885850|FG000|NOT COMPLETED|Overall Study||1
9779305|NCT00490802|10885851|FG001|NOT COMPLETED|Overall Study||2
9779306|NCT00490815|10885860|FG000|STARTED|Overall Study||20
9779307|NCT00490815|10885861|FG001|STARTED|Overall Study||17
9779308|NCT00490815|10885860|FG000|COMPLETED|Overall Study||12
9779309|NCT00490815|10885861|FG001|COMPLETED|Overall Study||8
9779310|NCT00490815|10885860|FG000|NOT COMPLETED|Overall Study||8
9779311|NCT00490815|10885861|FG001|NOT COMPLETED|Overall Study||9
9779312|NCT00490841|10885867|FG000|STARTED|Overall Study||202
9779313|NCT00490841|10885867|FG000|COMPLETED|Overall Study||189
9779314|NCT00490841|10885867|FG000|NOT COMPLETED|Overall Study||13
9779315|NCT00490919|10885874|FG000|STARTED|Open-label Run-in Period||1024
9779316|NCT00490919|10885875|FG001|STARTED|Open-label Run-in Period||0
9779317|NCT00490919|10885876|FG002|STARTED|Open-label Run-in Period||0
9779318|NCT00490919|10885874|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
9779319|NCT00490919|10885875|FG001|COMPLETED|Open-label Run-in Period||0
9779320|NCT00490919|10885876|FG002|COMPLETED|Open-label Run-in Period||0
9779321|NCT00490919|10885874|FG000|NOT COMPLETED|Open-label Run-in Period||483
9779322|NCT00490919|10885875|FG001|NOT COMPLETED|Open-label Run-in Period||0
9779323|NCT00490919|10885876|FG002|NOT COMPLETED|Open-label Run-in Period||0
9779324|NCT00490919|10885874|FG000|STARTED|Double-blind Phase||0
9779325|NCT00490919|10885875|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
9779326|NCT00490919|10885876|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
9779327|NCT00490919|10885874|FG000|COMPLETED|Double-blind Phase||0
9779328|NCT00490919|10885875|FG001|COMPLETED|Double-blind Phase||170
9779329|NCT00490919|10885876|FG002|COMPLETED|Double-blind Phase||199
9779330|NCT00490919|10885874|FG000|NOT COMPLETED|Double-blind Phase||0
9779331|NCT00490919|10885875|FG001|NOT COMPLETED|Double-blind Phase||86
9779332|NCT00490919|10885876|FG002|NOT COMPLETED|Double-blind Phase||84
9779333|NCT00490945|10885888|FG000|STARTED|Overall Study||8
9779334|NCT00490945|10885889|FG001|STARTED|Overall Study||9
9779335|NCT00490945|10885890|FG002|STARTED|Overall Study||8
9779336|NCT00490945|10885891|FG003|STARTED|Overall Study||7
9779337|NCT00490945|10885892|FG004|STARTED|Overall Study||7
9779338|NCT00490945|10885888|FG000|COMPLETED|Overall Study||8
9779339|NCT00490945|10885889|FG001|COMPLETED|Overall Study||8
9779340|NCT00490945|10885890|FG002|COMPLETED|Overall Study||8
9779341|NCT00490945|10885891|FG003|COMPLETED|Overall Study||7
9779342|NCT00490945|10885892|FG004|COMPLETED|Overall Study||7
9779343|NCT00490945|10885888|FG000|NOT COMPLETED|Overall Study||0
9779344|NCT00490945|10885889|FG001|NOT COMPLETED|Overall Study||1
9779345|NCT00490945|10885890|FG002|NOT COMPLETED|Overall Study||0
9779346|NCT00490945|10885891|FG003|NOT COMPLETED|Overall Study||0
9779347|NCT00490945|10885892|FG004|NOT COMPLETED|Overall Study||0
9779348|NCT00490971|10885912|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
9779349|NCT00490971|10885913|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
9779350|NCT00490971|10885914|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
9779351|NCT00490971|10885915|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
9779352|NCT00490971|10885916|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
9779353|NCT00490971|10885912|FG000|COMPLETED|Acute/Continuation||308
9779354|NCT00490971|10885913|FG001|COMPLETED|Acute/Continuation||86
9779355|NCT00490971|10885914|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
9779356|NCT00490971|10885915|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
9779357|NCT00490971|10885916|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
9779358|NCT00490971|10885912|FG000|NOT COMPLETED|Acute/Continuation||306
9779359|NCT00490971|10885913|FG001|NOT COMPLETED|Acute/Continuation||62
9779360|NCT00490971|10885914|FG002|NOT COMPLETED|Acute/Continuation||0
9779361|NCT00490971|10885915|FG003|NOT COMPLETED|Acute/Continuation||0
9779362|NCT00490971|10885916|FG004|NOT COMPLETED|Acute/Continuation||0
9779363|NCT00490971|10885912|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
9779364|NCT00490971|10885913|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
9779365|NCT00490971|10885914|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
9779366|NCT00490971|10885915|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
9779367|NCT00490971|10885916|FG004|STARTED|Maintenance||83
9779368|NCT00490971|10885912|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
9779369|NCT00490971|10885913|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
9779370|NCT00490971|10885914|FG002|COMPLETED|Maintenance||96
9779371|NCT00490971|10885915|FG003|COMPLETED|Maintenance||96
9779372|NCT00490971|10885916|FG004|COMPLETED|Maintenance||44
9779373|NCT00490971|10885912|FG000|NOT COMPLETED|Maintenance||0
9779374|NCT00490971|10885913|FG001|NOT COMPLETED|Maintenance||0
9779375|NCT00490971|10885914|FG002|NOT COMPLETED|Maintenance||51
9779376|NCT00490971|10885915|FG003|NOT COMPLETED|Maintenance||53
9779377|NCT00490971|10885916|FG004|NOT COMPLETED|Maintenance||39
9779378|NCT00491075|10885928|FG000|STARTED|Overall Study||16
9779379|NCT00491075|10885928|FG000|COMPLETED|Overall Study||14
9779380|NCT00491075|10885928|FG000|NOT COMPLETED|Overall Study||2
9779381|NCT00491179|10885934|FG000|STARTED|Overall Study||25
9779382|NCT00491179|10885935|FG001|STARTED|Overall Study||10
9779383|NCT00491179|10885934|FG000|COMPLETED|Overall Study||18
9779384|NCT00491179|10885935|FG001|COMPLETED|Overall Study||8
9779385|NCT00491179|10885934|FG000|NOT COMPLETED|Overall Study||7
9779386|NCT00491179|10885935|FG001|NOT COMPLETED|Overall Study||2
9779387|NCT00491244|10885943|FG000|STARTED|Overall Study||189
9779388|NCT00491244|10885944|FG001|STARTED|Overall Study||188
9779389|NCT00491244|10885943|FG000|COMPLETED|Overall Study||162
9779390|NCT00491244|10885944|FG001|COMPLETED|Overall Study||168
9779391|NCT00491244|10885943|FG000|NOT COMPLETED|Overall Study||27
9779392|NCT00491244|10885944|FG001|NOT COMPLETED|Overall Study||20
9779393|NCT00491322|10885952|FG000|STARTED|Overall Study||41
9779394|NCT00491322|10885953|FG001|STARTED|Overall Study||51
10014677|NCT01801111|11137703|FG000|NOT COMPLETED|Overall Study||138
9779395|NCT00491322|10885952|FG000|COMPLETED|Overall Study||40
9779396|NCT00491322|10885953|FG001|COMPLETED|Overall Study||50
9779397|NCT00491322|10885952|FG000|NOT COMPLETED|Overall Study||1
9779398|NCT00491322|10885953|FG001|NOT COMPLETED|Overall Study||1
9779399|NCT00491374|10885961|FG000|STARTED|Overall Study||0
9779400|NCT00491374|10885962|FG001|STARTED|Overall Study||0
9779401|NCT00491374|10885961|FG000|COMPLETED|Overall Study||0
10014678|NCT01801124|11137707|FG000|STARTED|Overall Study||13
10014679|NCT01801124|11137707|FG000|COMPLETED|Overall Study||13
9779402|NCT00491374|10885962|FG001|COMPLETED|Overall Study||0
9779403|NCT00491374|10885961|FG000|NOT COMPLETED|Overall Study||0
9779404|NCT00491374|10885962|FG001|NOT COMPLETED|Overall Study||0
9779405|NCT00491491|10885970|FG000|STARTED|Overall Study||22
9779406|NCT00491491|10885971|FG001|STARTED|Overall Study||21
9779407|NCT00491491|10885970|FG000|COMPLETED|Overall Study||22
9779408|NCT00491491|10885971|FG001|COMPLETED|Overall Study||21
9779409|NCT00491491|10885970|FG000|NOT COMPLETED|Overall Study||0
9779410|NCT00491491|10885971|FG001|NOT COMPLETED|Overall Study||0
9779411|NCT00491530|10885980|FG000|STARTED|Overall Study||174
9779412|NCT00491530|10885981|FG001|STARTED|Overall Study||50
9779413|NCT00491530|10885982|FG002|STARTED|Overall Study||86
9779414|NCT00491530|10885980|FG000|COMPLETED|Overall Study||162
9779415|NCT00491530|10885981|FG001|COMPLETED|Overall Study||44
9779416|NCT00491530|10885982|FG002|COMPLETED|Overall Study||81
9779417|NCT00491530|10885980|FG000|NOT COMPLETED|Overall Study||12
9779418|NCT00491530|10885981|FG001|NOT COMPLETED|Overall Study||6
9779419|NCT00491530|10885982|FG002|NOT COMPLETED|Overall Study||5
9779420|NCT00491556|10885992|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
9779421|NCT00491556|10885993|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
9779422|NCT00491556|10885992|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
9779423|NCT00491556|10885993|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
9779424|NCT00491556|10885992|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
9779425|NCT00491556|10885993|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
9779426|NCT00491556|10885992|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
9779427|NCT00491556|10885993|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
9779428|NCT00491556|10885992|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
9779429|NCT00491556|10885993|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
9779430|NCT00491556|10885992|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
9779431|NCT00491556|10885993|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
9779432|NCT00491556|10885992|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
9779433|NCT00491556|10885993|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
9779434|NCT00491608|10885999|FG000|STARTED|Overall Study|Participants who received treatment|209
9779435|NCT00491608|10885999|FG000|COMPLETED|Overall Study||206
9779436|NCT00491608|10885999|FG000|NOT COMPLETED|Overall Study||3
9779437|NCT00491751|10886006|FG000|STARTED|Overall Study||22
9779438|NCT00491751|10886007|FG001|STARTED|Overall Study||44
9779439|NCT00491751|10886008|FG002|STARTED|Overall Study||42
9779440|NCT00491751|10886006|FG000|COMPLETED|Overall Study||22
9779441|NCT00491751|10886007|FG001|COMPLETED|Overall Study||44
9779442|NCT00491751|10886008|FG002|COMPLETED|Overall Study||42
9779443|NCT00491751|10886006|FG000|NOT COMPLETED|Overall Study||0
9779444|NCT00491751|10886007|FG001|NOT COMPLETED|Overall Study||0
9779445|NCT00491751|10886008|FG002|NOT COMPLETED|Overall Study||0
9779446|NCT00491764|10886024|FG000|STARTED|Overall Study||37
9779447|NCT00491764|10886025|FG001|STARTED|Overall Study||37
9779448|NCT00491764|10886026|FG002|STARTED|Overall Study||36
9779449|NCT00491764|10886027|FG003|STARTED|Overall Study||36
9779450|NCT00491764|10886028|FG004|STARTED|Overall Study||36
9779451|NCT00491764|10886029|FG005|STARTED|Overall Study||36
9779452|NCT00491764|10886024|FG000|COMPLETED|Overall Study||32
9779453|NCT00491764|10886025|FG001|COMPLETED|Overall Study||30
9779454|NCT00491764|10886026|FG002|COMPLETED|Overall Study||28
9779455|NCT00491764|10886027|FG003|COMPLETED|Overall Study||28
9779456|NCT00491764|10886028|FG004|COMPLETED|Overall Study||33
9779457|NCT00491764|10886029|FG005|COMPLETED|Overall Study||27
9779458|NCT00491764|10886024|FG000|NOT COMPLETED|Overall Study||5
9779459|NCT00491764|10886025|FG001|NOT COMPLETED|Overall Study||7
9779460|NCT00491764|10886026|FG002|NOT COMPLETED|Overall Study||8
9779461|NCT00491764|10886027|FG003|NOT COMPLETED|Overall Study||8
9779462|NCT00491764|10886028|FG004|NOT COMPLETED|Overall Study||3
9779463|NCT00491764|10886029|FG005|NOT COMPLETED|Overall Study||9
9779464|NCT00491829|10886046|FG000|STARTED|Overall Study||311
9779465|NCT00491829|10886047|FG001|STARTED|Overall Study||316
9779466|NCT00491829|10886048|FG002|STARTED|Overall Study||318
9779467|NCT00491829|10886046|FG000|COMPLETED|Overall Study||216
9779468|NCT00491829|10886047|FG001|COMPLETED|Overall Study||202
9779469|NCT00491829|10886048|FG002|COMPLETED|Overall Study||243
9779470|NCT00491829|10886046|FG000|NOT COMPLETED|Overall Study||95
9779471|NCT00491829|10886047|FG001|NOT COMPLETED|Overall Study||114
9779472|NCT00491829|10886048|FG002|NOT COMPLETED|Overall Study||75
9779473|NCT00491894|10886056|FG000|STARTED|Overall Study||137
9779474|NCT00491894|10886056|FG000|COMPLETED|Overall Study||103
9779475|NCT00491894|10886056|FG000|NOT COMPLETED|Overall Study||34
9779476|NCT00492024|10886062|FG000|STARTED|Treatment||251
9779477|NCT00492024|10886063|FG001|STARTED|Treatment||123
9779478|NCT00492024|10886062|FG000|COMPLETED|Treatment||222
9779479|NCT00492024|10886063|FG001|COMPLETED|Treatment||101
9779480|NCT00492024|10886062|FG000|NOT COMPLETED|Treatment||29
9779481|NCT00492024|10886063|FG001|NOT COMPLETED|Treatment||22
9779482|NCT00492024|10886062|FG000|STARTED|Follow up||222
9779483|NCT00492024|10886063|FG001|STARTED|Follow up||101
9779484|NCT00492024|10886062|FG000|COMPLETED|Follow up||221
9779485|NCT00492024|10886063|FG001|COMPLETED|Follow up||99
9779486|NCT00492024|10886062|FG000|NOT COMPLETED|Follow up||1
9779487|NCT00492024|10886063|FG001|NOT COMPLETED|Follow up||2
9779488|NCT00492063|10886073|FG000|STARTED|Overall Study||652
9779489|NCT00492063|10886074|FG001|STARTED|Overall Study||648
9779490|NCT00492063|10886075|FG002|STARTED|Overall Study||678
9779491|NCT00492063|10886076|FG003|STARTED|Overall Study||676
9779492|NCT00492063|10886073|FG000|COMPLETED|Overall Study||642
9779493|NCT00492063|10886074|FG001|COMPLETED|Overall Study||634
9779494|NCT00492063|10886075|FG002|COMPLETED|Overall Study||667
9779495|NCT00492063|10886076|FG003|COMPLETED|Overall Study||666
9779496|NCT00492063|10886073|FG000|NOT COMPLETED|Overall Study||10
9779497|NCT00492063|10886074|FG001|NOT COMPLETED|Overall Study||14
9779498|NCT00492063|10886075|FG002|NOT COMPLETED|Overall Study||11
9779499|NCT00492063|10886076|FG003|NOT COMPLETED|Overall Study||10
9779500|NCT00492089|10886088|FG000|STARTED|First Intervention (6 Weeks)||5
9779501|NCT00492089|10886089|FG001|STARTED|First Intervention (6 Weeks)||6
9779502|NCT00492089|10886088|FG000|COMPLETED|First Intervention (6 Weeks)||5
9779503|NCT00492089|10886089|FG001|COMPLETED|First Intervention (6 Weeks)||6
9779504|NCT00492089|10886088|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
9779505|NCT00492089|10886089|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
9779506|NCT00492089|10886088|FG000|STARTED|Second Intervention (6 Weeks)||5
9779507|NCT00492089|10886089|FG001|STARTED|Second Intervention (6 Weeks)||6
9779508|NCT00492089|10886088|FG000|COMPLETED|Second Intervention (6 Weeks)||5
9779509|NCT00492089|10886089|FG001|COMPLETED|Second Intervention (6 Weeks)||6
9779510|NCT00492089|10886088|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9779511|NCT00492089|10886089|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9779512|NCT00492115|10886097|FG000|STARTED|Overall Study||19
9779513|NCT00492115|10886098|FG001|STARTED|Overall Study||19
9779514|NCT00492115|10886097|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
9779515|NCT00492115|10886098|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
9779516|NCT00492115|10886097|FG000|NOT COMPLETED|Overall Study||3
9779517|NCT00492115|10886098|FG001|NOT COMPLETED|Overall Study||4
9779518|NCT00492206|10886104|FG000|STARTED|Overall Study||40
9779519|NCT00492206|10886104|FG000|COMPLETED|Overall Study||40
9779520|NCT00492206|10886104|FG000|NOT COMPLETED|Overall Study||0
9779521|NCT00492232|10886112|FG000|STARTED|Placebo Run-in||0
9779522|NCT00492232|10886113|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
9779523|NCT00492232|10886112|FG000|COMPLETED|Placebo Run-in||0
9779524|NCT00492232|10886113|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
9779525|NCT00492232|10886112|FG000|NOT COMPLETED|Placebo Run-in||0
9779526|NCT00492232|10886113|FG001|NOT COMPLETED|Placebo Run-in||70
9779527|NCT00492232|10886112|FG000|STARTED|Double-Blind Treatment||65
9779528|NCT00492232|10886113|FG001|STARTED|Double-Blind Treatment||70
9779529|NCT00492232|10886112|FG000|COMPLETED|Double-Blind Treatment||47
9779530|NCT00492232|10886113|FG001|COMPLETED|Double-Blind Treatment||45
9779531|NCT00492232|10886112|FG000|NOT COMPLETED|Double-Blind Treatment||18
9779532|NCT00492232|10886113|FG001|NOT COMPLETED|Double-Blind Treatment||25
9779533|NCT00492232|10886112|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
9779534|NCT00492232|10886113|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
9779535|NCT00492232|10886112|FG000|COMPLETED|Open-Label Treatment||88
9779536|NCT00492232|10886113|FG001|COMPLETED|Open-Label Treatment||0
9779537|NCT00492232|10886112|FG000|NOT COMPLETED|Open-Label Treatment||1
9779538|NCT00492232|10886113|FG001|NOT COMPLETED|Open-Label Treatment||0
9779539|NCT00492284|10886123|FG000|STARTED|Overall Study||39
9779540|NCT00492284|10886124|FG001|STARTED|Overall Study||39
9779541|NCT00492284|10886125|FG002|STARTED|Overall Study||43
9779542|NCT00492284|10886126|FG003|STARTED|Overall Study||41
9779543|NCT00492284|10886123|FG000|COMPLETED|Overall Study||38
9779544|NCT00492284|10886124|FG001|COMPLETED|Overall Study||35
9779545|NCT00492284|10886125|FG002|COMPLETED|Overall Study||37
9779546|NCT00492284|10886126|FG003|COMPLETED|Overall Study||31
9779547|NCT00492284|10886123|FG000|NOT COMPLETED|Overall Study||1
9779548|NCT00492284|10886124|FG001|NOT COMPLETED|Overall Study||4
9779549|NCT00492284|10886125|FG002|NOT COMPLETED|Overall Study||6
9779550|NCT00492284|10886126|FG003|NOT COMPLETED|Overall Study||10
9779551|NCT00492297|10886136|FG000|STARTED|Treatment||83
9779552|NCT00492297|10886136|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
9779553|NCT00492297|10886136|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
9779554|NCT00492297|10886136|FG000|COMPLETED|Treatment||78
9779555|NCT00492297|10886136|FG000|NOT COMPLETED|Treatment||5
9779556|NCT00492297|10886136|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
9779557|NCT00492297|10886136|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59
9779558|NCT00492297|10886136|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
9779559|NCT00492297|10886136|FG000|STARTED|Survival Only Follow-up||59
9779560|NCT00492297|10886136|FG000|COMPLETED|Survival Only Follow-up||0
9779561|NCT00492297|10886136|FG000|NOT COMPLETED|Survival Only Follow-up||59
9779562|NCT00492336|10886142|FG000|STARTED|Overall Study||28
9779563|NCT00492336|10886143|FG001|STARTED|Overall Study||29
9779564|NCT00492336|10886142|FG000|COMPLETED|Overall Study||26
9779565|NCT00492336|10886143|FG001|COMPLETED|Overall Study||23
9779566|NCT00492336|10886142|FG000|NOT COMPLETED|Overall Study||2
9779567|NCT00492336|10886143|FG001|NOT COMPLETED|Overall Study||6
9779568|NCT00492401|10886149|FG000|STARTED|Overall Study||55
9779569|NCT00492401|10886149|FG000|COMPLETED|Overall Study||55
9779570|NCT00492401|10886149|FG000|NOT COMPLETED|Overall Study||0
9779571|NCT00492531|10886157|FG000|STARTED|Overall Study||37
9779572|NCT00492531|10886158|FG001|STARTED|Overall Study||37
9779573|NCT00492531|10886157|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
9779574|NCT00492531|10886158|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
9779575|NCT00492531|10886157|FG000|NOT COMPLETED|Overall Study||22
9779576|NCT00492531|10886158|FG001|NOT COMPLETED|Overall Study||23
9779577|NCT00492544|10886164|FG000|STARTED|Overall Study||100
9779578|NCT00492544|10886164|FG000|COMPLETED|Overall Study||100
9779579|NCT00492544|10886164|FG000|NOT COMPLETED|Overall Study||0
9779580|NCT00492557|10886170|FG000|STARTED|Overall Study||580
9779581|NCT00492557|10886171|FG001|STARTED|Overall Study||580
9779582|NCT00492557|10886170|FG000|Vaccinated Dose 1|Overall Study||577
9779583|NCT00492557|10886171|FG001|Vaccinated Dose 1|Overall Study||575
9779584|NCT00492557|10886170|FG000|Vaccinated Dose 2|Overall Study||560
9779585|NCT00492557|10886171|FG001|Vaccinated Dose 2|Overall Study||558
9779586|NCT00492557|10886170|FG000|COMPLETED|Overall Study||556
9779587|NCT00492557|10886171|FG001|COMPLETED|Overall Study||557
9779588|NCT00492557|10886170|FG000|NOT COMPLETED|Overall Study||24
9779589|NCT00492557|10886171|FG001|NOT COMPLETED|Overall Study||23
9779590|NCT00492583|10886182|FG000|STARTED|Overall Study||95
9779591|NCT00492583|10886183|FG001|STARTED|Overall Study||87
9779592|NCT00492583|10886182|FG000|COMPLETED|Overall Study||95
9779593|NCT00492583|10886183|FG001|COMPLETED|Overall Study||87
9779594|NCT00492583|10886182|FG000|NOT COMPLETED|Overall Study||0
9779595|NCT00492583|10886183|FG001|NOT COMPLETED|Overall Study||0
9779596|NCT00492622|10886189|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12
9779597|NCT00492622|10886189|FG000|COMPLETED|Overall Study||12
9779598|NCT00492622|10886189|FG000|NOT COMPLETED|Overall Study||0
9779599|NCT00492648|10886199|FG000|STARTED|Month 30 (109671 Study)||4
9779600|NCT00492648|10886200|FG001|STARTED|Month 30 (109671 Study)||30
9779601|NCT00492648|10886199|FG000|COMPLETED|Month 30 (109671 Study)||4
9779602|NCT00492648|10886200|FG001|COMPLETED|Month 30 (109671 Study)||29
9779603|NCT00492648|10886199|FG000|NOT COMPLETED|Month 30 (109671 Study)||0
9779604|NCT00492648|10886200|FG001|NOT COMPLETED|Month 30 (109671 Study)||1
9779605|NCT00492648|10886199|FG000|STARTED|Month 42 (109674 Study)||3
9779606|NCT00492648|10886200|FG001|STARTED|Month 42 (109674 Study)||20
9779607|NCT00492648|10886199|FG000|COMPLETED|Month 42 (109674 Study)||3
9779608|NCT00492648|10886200|FG001|COMPLETED|Month 42 (109674 Study)||20
9779609|NCT00492648|10886199|FG000|NOT COMPLETED|Month 42 (109674 Study)||0
9779610|NCT00492648|10886200|FG001|NOT COMPLETED|Month 42 (109674 Study)||0
9779611|NCT00492726|10886208|FG000|STARTED|Overall Study||410
9779612|NCT00492726|10886209|FG001|STARTED|Overall Study||394
9779613|NCT00492726|10886208|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
9779614|NCT00492726|10886209|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
9779615|NCT00492726|10886208|FG000|End of Study|Overall Study||360
9779616|NCT00492726|10886209|FG001|End of Study|Overall Study||358
9779617|NCT00492726|10886208|FG000|COMPLETED|Overall Study||360
9779618|NCT00492726|10886209|FG001|COMPLETED|Overall Study||358
9779619|NCT00492726|10886208|FG000|NOT COMPLETED|Overall Study||50
9779620|NCT00492726|10886209|FG001|NOT COMPLETED|Overall Study||36
9779621|NCT00492752|10886217|FG000|STARTED|Double Blind Treatment||134
9779622|NCT00492752|10886218|FG001|STARTED|Double Blind Treatment||16
9779623|NCT00492752|10886219|FG002|STARTED|Double Blind Treatment||70
9779624|NCT00492752|10886220|FG003|STARTED|Double Blind Treatment||6
9779625|NCT00492752|10886217|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
9779626|NCT00492752|10886218|FG001|Received Treatment|Double Blind Treatment|Safety Population|16
9779627|NCT00492752|10886219|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
9779628|NCT00492752|10886220|FG003|Received Treatment|Double Blind Treatment|Safety Population|6
9779629|NCT00492752|10886217|FG000|COMPLETED|Double Blind Treatment||120
9779630|NCT00492752|10886218|FG001|COMPLETED|Double Blind Treatment||16
9779631|NCT00492752|10886219|FG002|COMPLETED|Double Blind Treatment||67
9779632|NCT00492752|10886220|FG003|COMPLETED|Double Blind Treatment||6
9779633|NCT00492752|10886217|FG000|NOT COMPLETED|Double Blind Treatment||14
9779634|NCT00492752|10886218|FG001|NOT COMPLETED|Double Blind Treatment||0
9779635|NCT00492752|10886219|FG002|NOT COMPLETED|Double Blind Treatment||3
9779636|NCT00492752|10886220|FG003|NOT COMPLETED|Double Blind Treatment||0
9779637|NCT00492752|10886217|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120
9779638|NCT00492752|10886218|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16
9779639|NCT00492752|10886219|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67
9779640|NCT00492752|10886220|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6
9779641|NCT00492752|10886217|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
9779642|NCT00492752|10886218|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
9779643|NCT00492752|10886219|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
9779644|NCT00492752|10886220|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
9779645|NCT00492752|10886217|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
9779646|NCT00492752|10886218|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
9779647|NCT00492752|10886219|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
9779648|NCT00492752|10886220|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
9832480|NCT00773253|10943243|FG001|COMPLETED|Second Intervention (Week 24-48)||4
9779649|NCT00492752|10886217|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
9779650|NCT00492752|10886218|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0
9779651|NCT00492752|10886219|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
9779652|NCT00492752|10886220|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0
9779653|NCT00492752|10886217|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
9779654|NCT00492752|10886218|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
9779655|NCT00492752|10886219|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
9779656|NCT00492752|10886220|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
9779657|NCT00492856|10886227|FG000|STARTED|Induction||105
9779658|NCT00492856|10886228|FG001|STARTED|Induction||0
9779659|NCT00492856|10886229|FG002|STARTED|Induction||0
9779660|NCT00492856|10886230|FG003|STARTED|Induction||0
9779661|NCT00492856|10886227|FG000|COMPLETED|Induction||99
9779662|NCT00492856|10886228|FG001|COMPLETED|Induction||0
9779663|NCT00492856|10886229|FG002|COMPLETED|Induction||0
9779664|NCT00492856|10886230|FG003|COMPLETED|Induction||0
9779665|NCT00492856|10886227|FG000|NOT COMPLETED|Induction||6
9779666|NCT00492856|10886228|FG001|NOT COMPLETED|Induction||0
9779667|NCT00492856|10886229|FG002|NOT COMPLETED|Induction||0
9779668|NCT00492856|10886230|FG003|NOT COMPLETED|Induction||0
9779669|NCT00492856|10886227|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
9779670|NCT00492856|10886228|FG001|STARTED|Consolidation||0
9779671|NCT00492856|10886229|FG002|STARTED|Consolidation||0
9779672|NCT00492856|10886230|FG003|STARTED|Consolidation||0
9779673|NCT00492856|10886227|FG000|COMPLETED|Consolidation||83
9779674|NCT00492856|10886228|FG001|COMPLETED|Consolidation||0
9779675|NCT00492856|10886229|FG002|COMPLETED|Consolidation||0
9779676|NCT00492856|10886230|FG003|COMPLETED|Consolidation||0
9779677|NCT00492856|10886227|FG000|NOT COMPLETED|Consolidation||9
9779678|NCT00492856|10886228|FG001|NOT COMPLETED|Consolidation||0
9779679|NCT00492856|10886229|FG002|NOT COMPLETED|Consolidation||0
9779680|NCT00492856|10886230|FG003|NOT COMPLETED|Consolidation||0
9779681|NCT00492856|10886227|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
9779682|NCT00492856|10886228|FG001|STARTED|Post-consolidation||41
9779683|NCT00492856|10886229|FG002|STARTED|Post-consolidation||27
9779684|NCT00492856|10886230|FG003|STARTED|Post-consolidation||1
9779685|NCT00492856|10886227|FG000|COMPLETED|Post-consolidation||0
9779686|NCT00492856|10886228|FG001|COMPLETED|Post-consolidation||29
9779687|NCT00492856|10886229|FG002|COMPLETED|Post-consolidation||0
9779688|NCT00492856|10886230|FG003|COMPLETED|Post-consolidation||0
9779689|NCT00492856|10886227|FG000|NOT COMPLETED|Post-consolidation||0
9779690|NCT00492856|10886228|FG001|NOT COMPLETED|Post-consolidation||12
9779691|NCT00492856|10886229|FG002|NOT COMPLETED|Post-consolidation||27
9779692|NCT00492856|10886230|FG003|NOT COMPLETED|Post-consolidation||1
9779693|NCT00492921|10886242|FG000|STARTED|Overall Study||5
9779694|NCT00492921|10886243|FG001|STARTED|Overall Study||4
9779695|NCT00492921|10886244|FG002|STARTED|Overall Study||3
9779696|NCT00492921|10886242|FG000|COMPLETED|Overall Study||4
9779697|NCT00492921|10886243|FG001|COMPLETED|Overall Study||4
9779698|NCT00492921|10886244|FG002|COMPLETED|Overall Study||2
9779699|NCT00492921|10886242|FG000|NOT COMPLETED|Overall Study||1
9779700|NCT00492921|10886243|FG001|NOT COMPLETED|Overall Study||0
9779701|NCT00492921|10886244|FG002|NOT COMPLETED|Overall Study||1
9779702|NCT00492973|10886254|FG000|STARTED|Overall Study||37
9779703|NCT00492973|10886255|FG001|STARTED|Overall Study||39
9779704|NCT00492973|10886254|FG000|COMPLETED|Overall Study||37
9779705|NCT00492973|10886255|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
9779706|NCT00492973|10886254|FG000|NOT COMPLETED|Overall Study||0
9779707|NCT00492973|10886255|FG001|NOT COMPLETED|Overall Study||1
9779708|NCT00493012|10886263|FG000|STARTED|Overall Study||100
9779709|NCT00493012|10886264|FG001|STARTED|Overall Study||100
9779710|NCT00493012|10886263|FG000|COMPLETED|Overall Study||82
9779711|NCT00493012|10886264|FG001|COMPLETED|Overall Study||83
9779712|NCT00493012|10886263|FG000|NOT COMPLETED|Overall Study||18
9779713|NCT00493012|10886264|FG001|NOT COMPLETED|Overall Study||17
9779714|NCT00493038|10886272|FG000|STARTED|Treatment||147
9779715|NCT00493038|10886273|FG001|STARTED|Treatment||146
9779716|NCT00493038|10886272|FG000|Randomization|Treatment||147
9779717|NCT00493038|10886273|FG001|Randomization|Treatment||146
9779718|NCT00493038|10886272|FG000|Treated With Study Medication|Treatment||145
9779719|NCT00493038|10886273|FG001|Treated With Study Medication|Treatment||142
9779720|NCT00493038|10886272|FG000|Test-of-Cure Visit|Treatment||123
9779721|NCT00493038|10886273|FG001|Test-of-Cure Visit|Treatment||126
9779722|NCT00493038|10886272|FG000|COMPLETED|Treatment||123
9779723|NCT00493038|10886273|FG001|COMPLETED|Treatment||126
9779724|NCT00493038|10886272|FG000|NOT COMPLETED|Treatment||24
9779725|NCT00493038|10886273|FG001|NOT COMPLETED|Treatment||20
9779726|NCT00493038|10886272|FG000|STARTED|Follow-up||123
9779727|NCT00493038|10886273|FG001|STARTED|Follow-up||126
9779728|NCT00493038|10886272|FG000|COMPLETED|Follow-up||122
9779729|NCT00493038|10886273|FG001|COMPLETED|Follow-up||126
9779730|NCT00493038|10886272|FG000|NOT COMPLETED|Follow-up||1
9779731|NCT00493038|10886273|FG001|NOT COMPLETED|Follow-up||0
9779732|NCT00493064|10886279|FG000|STARTED|Overall Study||63
9779733|NCT00493064|10886279|FG000|COMPLETED|Overall Study||52
9779734|NCT00493064|10886279|FG000|NOT COMPLETED|Overall Study||11
9779735|NCT00493181|10886283|FG000|STARTED|Overall Study||8
9779736|NCT00493181|10886283|FG000|COMPLETED|Overall Study||8
9779737|NCT00493181|10886283|FG000|NOT COMPLETED|Overall Study||0
9779738|NCT00493220|10886293|FG000|STARTED|First Intervention||5
9779739|NCT00493220|10886294|FG001|STARTED|First Intervention||5
9779740|NCT00493220|10886295|FG002|STARTED|First Intervention||5
9779741|NCT00493220|10886296|FG003|STARTED|First Intervention||5
9779742|NCT00493220|10886297|FG004|STARTED|First Intervention||5
9779743|NCT00493220|10886298|FG005|STARTED|First Intervention||5
9779744|NCT00493220|10886293|FG000|COMPLETED|First Intervention||5
9779745|NCT00493220|10886294|FG001|COMPLETED|First Intervention||5
9779746|NCT00493220|10886295|FG002|COMPLETED|First Intervention||5
9779747|NCT00493220|10886296|FG003|COMPLETED|First Intervention||5
9779748|NCT00493220|10886297|FG004|COMPLETED|First Intervention||5
9779749|NCT00493220|10886298|FG005|COMPLETED|First Intervention||5
9779750|NCT00493220|10886293|FG000|NOT COMPLETED|First Intervention||0
9779751|NCT00493220|10886294|FG001|NOT COMPLETED|First Intervention||0
9779752|NCT00493220|10886295|FG002|NOT COMPLETED|First Intervention||0
9779753|NCT00493220|10886296|FG003|NOT COMPLETED|First Intervention||0
9779754|NCT00493220|10886297|FG004|NOT COMPLETED|First Intervention||0
9779755|NCT00493220|10886298|FG005|NOT COMPLETED|First Intervention||0
9779756|NCT00493220|10886293|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5
9779757|NCT00493220|10886294|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5
9779758|NCT00493220|10886295|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5
9779759|NCT00493220|10886296|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5
9779760|NCT00493220|10886297|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5
9779761|NCT00493220|10886298|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5
9779762|NCT00493220|10886293|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5
9779763|NCT00493220|10886294|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5
9779764|NCT00493220|10886295|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5
9779765|NCT00493220|10886296|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5
9779766|NCT00493220|10886297|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5
9779767|NCT00493220|10886298|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5
9779768|NCT00493220|10886293|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
9779769|NCT00493220|10886294|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
9779770|NCT00493220|10886295|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
9779771|NCT00493220|10886296|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
9779772|NCT00493220|10886297|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
9779773|NCT00493220|10886298|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
9779774|NCT00493220|10886293|FG000|STARTED|Second Intervention||5
9779775|NCT00493220|10886294|FG001|STARTED|Second Intervention||5
9779776|NCT00493220|10886295|FG002|STARTED|Second Intervention||5
9779777|NCT00493220|10886296|FG003|STARTED|Second Intervention||5
9779778|NCT00493220|10886297|FG004|STARTED|Second Intervention||5
9779779|NCT00493220|10886298|FG005|STARTED|Second Intervention||5
9779780|NCT00493220|10886293|FG000|COMPLETED|Second Intervention||5
9779781|NCT00493220|10886294|FG001|COMPLETED|Second Intervention||5
9779782|NCT00493220|10886295|FG002|COMPLETED|Second Intervention||5
9779783|NCT00493220|10886296|FG003|COMPLETED|Second Intervention||5
9779784|NCT00493220|10886297|FG004|COMPLETED|Second Intervention||5
9779785|NCT00493220|10886298|FG005|COMPLETED|Second Intervention||5
9779786|NCT00493220|10886293|FG000|NOT COMPLETED|Second Intervention||0
9779787|NCT00493220|10886294|FG001|NOT COMPLETED|Second Intervention||0
9779788|NCT00493220|10886295|FG002|NOT COMPLETED|Second Intervention||0
9779789|NCT00493220|10886296|FG003|NOT COMPLETED|Second Intervention||0
10233945|NCT01606150|11363820|FG000|NOT COMPLETED|Overall Study||0
10233946|NCT01606150|11363821|FG001|NOT COMPLETED|Overall Study||0
10233947|NCT01603043|11363829|FG000|STARTED|Overall Study||7
10233948|NCT01603043|11363830|FG001|STARTED|Overall Study||3
10233949|NCT01603043|11363829|FG000|COMPLETED|Overall Study||0
10233950|NCT01603043|11363830|FG001|COMPLETED|Overall Study||0
10233951|NCT01603043|11363829|FG000|NOT COMPLETED|Overall Study||7
10233952|NCT01603043|11363830|FG001|NOT COMPLETED|Overall Study||3
10233953|NCT01605370|11363838|FG000|STARTED|Overall Study||1
10233954|NCT01605370|11363839|FG001|STARTED|Overall Study||0
10233955|NCT01605370|11363838|FG000|COMPLETED|Overall Study||0
10233956|NCT01605370|11363839|FG001|COMPLETED|Overall Study||0
10233957|NCT01605370|11363838|FG000|NOT COMPLETED|Overall Study||1
10233958|NCT01605370|11363839|FG001|NOT COMPLETED|Overall Study||0
10233959|NCT01605617|11363847|FG000|STARTED|First Intervention||2
9779790|NCT00493220|10886297|FG004|NOT COMPLETED|Second Intervention||0
9779791|NCT00493220|10886298|FG005|NOT COMPLETED|Second Intervention||0
9779792|NCT00493220|10886293|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5
9779793|NCT00493220|10886294|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5
9779794|NCT00493220|10886295|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5
9779795|NCT00493220|10886296|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5
9779796|NCT00493220|10886297|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5
9779797|NCT00493220|10886298|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5
9779798|NCT00493220|10886293|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
9779799|NCT00493220|10886294|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10233960|NCT01605617|11363848|FG001|STARTED|First Intervention||2
10233961|NCT01605617|11363847|FG000|COMPLETED|First Intervention||2
10233962|NCT01605617|11363848|FG001|COMPLETED|First Intervention||1
10233963|NCT01605617|11363847|FG000|NOT COMPLETED|First Intervention||0
10233964|NCT01605617|11363848|FG001|NOT COMPLETED|First Intervention||1
9779800|NCT00493220|10886295|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
9779801|NCT00493220|10886296|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
9779802|NCT00493220|10886297|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
9779803|NCT00493220|10886298|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
9779804|NCT00493220|10886293|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
9779805|NCT00493220|10886294|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
9779806|NCT00493220|10886295|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
9779807|NCT00493220|10886296|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
9779808|NCT00493220|10886297|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
9779809|NCT00493220|10886298|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
9779810|NCT00493220|10886293|FG000|STARTED|Third Intervention||5
9779811|NCT00493220|10886294|FG001|STARTED|Third Intervention||5
9779812|NCT00493220|10886295|FG002|STARTED|Third Intervention||5
9779813|NCT00493220|10886296|FG003|STARTED|Third Intervention||5
9779814|NCT00493220|10886297|FG004|STARTED|Third Intervention||5
9779815|NCT00493220|10886298|FG005|STARTED|Third Intervention||5
9779816|NCT00493220|10886293|FG000|COMPLETED|Third Intervention||4
9779817|NCT00493220|10886294|FG001|COMPLETED|Third Intervention||5
9779818|NCT00493220|10886295|FG002|COMPLETED|Third Intervention||5
9779819|NCT00493220|10886296|FG003|COMPLETED|Third Intervention||5
9779820|NCT00493220|10886297|FG004|COMPLETED|Third Intervention||5
9779821|NCT00493220|10886298|FG005|COMPLETED|Third Intervention||5
9779822|NCT00493220|10886293|FG000|NOT COMPLETED|Third Intervention||1
9779823|NCT00493220|10886294|FG001|NOT COMPLETED|Third Intervention||0
9779824|NCT00493220|10886295|FG002|NOT COMPLETED|Third Intervention||0
9779825|NCT00493220|10886296|FG003|NOT COMPLETED|Third Intervention||0
9779826|NCT00493220|10886297|FG004|NOT COMPLETED|Third Intervention||0
9779827|NCT00493220|10886298|FG005|NOT COMPLETED|Third Intervention||0
9779828|NCT00493220|10886293|FG000|STARTED|Final 7-Day Safety Follow-up||4
10014680|NCT01801124|11137707|FG000|NOT COMPLETED|Overall Study||0
10014681|NCT01801241|11137713|FG000|STARTED|Overall Study||29
10014682|NCT01801241|11137714|FG001|STARTED|Overall Study||27
10014683|NCT01801241|11137713|FG000|COMPLETED|Overall Study||21
9779829|NCT00493220|10886294|FG001|STARTED|Final 7-Day Safety Follow-up||5
9779830|NCT00493220|10886295|FG002|STARTED|Final 7-Day Safety Follow-up||5
9779831|NCT00493220|10886296|FG003|STARTED|Final 7-Day Safety Follow-up||5
9779832|NCT00493220|10886297|FG004|STARTED|Final 7-Day Safety Follow-up||5
9779833|NCT00493220|10886298|FG005|STARTED|Final 7-Day Safety Follow-up||5
9779834|NCT00493220|10886293|FG000|COMPLETED|Final 7-Day Safety Follow-up||4
9779835|NCT00493220|10886294|FG001|COMPLETED|Final 7-Day Safety Follow-up||5
9779836|NCT00493220|10886295|FG002|COMPLETED|Final 7-Day Safety Follow-up||5
9779837|NCT00493220|10886296|FG003|COMPLETED|Final 7-Day Safety Follow-up||5
9779838|NCT00493220|10886297|FG004|COMPLETED|Final 7-Day Safety Follow-up||5
9779839|NCT00493220|10886298|FG005|COMPLETED|Final 7-Day Safety Follow-up||5
9779840|NCT00493220|10886293|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0
9779841|NCT00493220|10886294|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0
9779842|NCT00493220|10886295|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0
9779843|NCT00493220|10886296|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0
9779844|NCT00493220|10886297|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0
9779845|NCT00493220|10886298|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0
9779846|NCT00493246|10886316|FG000|STARTED|Overall Study||2
9779847|NCT00493246|10886317|FG001|STARTED|Overall Study||1
9779848|NCT00493246|10886318|FG002|STARTED|Overall Study||12
9779849|NCT00493246|10886319|FG003|STARTED|Overall Study||13
9779850|NCT00493246|10886320|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
9779851|NCT00493246|10886321|FG005|STARTED|Overall Study|All subjects who were randomized.|16
9779852|NCT00493246|10886322|FG006|STARTED|Overall Study|All subjects who were randomized.|12
9779853|NCT00493246|10886323|FG007|STARTED|Overall Study|All subjects who were randomized.|10
9779854|NCT00493246|10886316|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
9779855|NCT00493246|10886317|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
9779856|NCT00493246|10886318|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
9779857|NCT00493246|10886319|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
9779858|NCT00493246|10886320|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
9779859|NCT00493246|10886321|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
9779860|NCT00493246|10886322|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
9779861|NCT00493246|10886323|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
9779862|NCT00493246|10886316|FG000|NOT COMPLETED|Overall Study||0
9779863|NCT00493246|10886317|FG001|NOT COMPLETED|Overall Study||0
9779864|NCT00493246|10886318|FG002|NOT COMPLETED|Overall Study||0
9779865|NCT00493246|10886319|FG003|NOT COMPLETED|Overall Study||0
9779866|NCT00493246|10886320|FG004|NOT COMPLETED|Overall Study||1
9779867|NCT00493246|10886321|FG005|NOT COMPLETED|Overall Study||1
9779868|NCT00493246|10886322|FG006|NOT COMPLETED|Overall Study||1
9779869|NCT00493246|10886323|FG007|NOT COMPLETED|Overall Study||0
9779870|NCT00493285|10886347|FG000|STARTED|Overall Study||13
9779871|NCT00493285|10886348|FG001|STARTED|Overall Study||6
9779872|NCT00493285|10886349|FG002|STARTED|Overall Study||9
10014684|NCT01801241|11137714|FG001|COMPLETED|Overall Study||25
10014685|NCT01801241|11137713|FG000|NOT COMPLETED|Overall Study||8
9779873|NCT00493285|10886350|FG003|STARTED|Overall Study||6
9779874|NCT00493285|10886351|FG004|STARTED|Overall Study||10
9779875|NCT00493285|10886352|FG005|STARTED|Overall Study||5
9779876|NCT00493285|10886347|FG000|COMPLETED|Overall Study||13
9779877|NCT00493285|10886348|FG001|COMPLETED|Overall Study||6
9779878|NCT00493285|10886349|FG002|COMPLETED|Overall Study||9
9779879|NCT00493285|10886350|FG003|COMPLETED|Overall Study||6
9779880|NCT00493285|10886351|FG004|COMPLETED|Overall Study||9
9779881|NCT00493285|10886352|FG005|COMPLETED|Overall Study||5
9779882|NCT00493285|10886347|FG000|NOT COMPLETED|Overall Study||0
9779883|NCT00493285|10886348|FG001|NOT COMPLETED|Overall Study||0
9779884|NCT00493285|10886349|FG002|NOT COMPLETED|Overall Study||0
9779885|NCT00493285|10886350|FG003|NOT COMPLETED|Overall Study||0
9779886|NCT00493285|10886351|FG004|NOT COMPLETED|Overall Study||1
9779887|NCT00493285|10886352|FG005|NOT COMPLETED|Overall Study||0
9779888|NCT00493311|10886368|FG000|STARTED|Overall Study||29
9779889|NCT00493311|10886369|FG001|STARTED|Overall Study||31
9779890|NCT00493311|10886368|FG000|COMPLETED|Overall Study||27
9779891|NCT00493311|10886369|FG001|COMPLETED|Overall Study||29
9779892|NCT00493311|10886368|FG000|NOT COMPLETED|Overall Study||2
9779893|NCT00493311|10886369|FG001|NOT COMPLETED|Overall Study||2
9779894|NCT00493454|10886375|FG000|STARTED|Overall Study||6
9779895|NCT00493454|10886375|FG000|COMPLETED|Overall Study||5
9779896|NCT00493454|10886375|FG000|NOT COMPLETED|Overall Study||1
9779897|NCT00493467|10886379|FG000|STARTED|Overall Study||31
9779898|NCT00493467|10886379|FG000|COMPLETED|Overall Study||30
9779899|NCT00493467|10886379|FG000|NOT COMPLETED|Overall Study||1
9779900|NCT00493636|10886385|FG000|STARTED|Overall Study||81
9779901|NCT00493636|10886386|FG001|STARTED|Overall Study||79
9779902|NCT00493636|10886385|FG000|COMPLETED|Overall Study||79
9779903|NCT00493636|10886386|FG001|COMPLETED|Overall Study||77
9779904|NCT00493636|10886385|FG000|NOT COMPLETED|Overall Study||2
9779905|NCT00493636|10886386|FG001|NOT COMPLETED|Overall Study||2
9779906|NCT00493649|10886392|FG000|STARTED|Overall Study||493
9779907|NCT00493649|10886392|FG000|COMPLETED|Overall Study||411
9779908|NCT00493649|10886392|FG000|NOT COMPLETED|Overall Study||82
9779909|NCT00493779|10886399|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
9779910|NCT00493779|10886399|FG000|COMPLETED|Overall Study|Completed follow-up phase|97
9779911|NCT00493779|10886399|FG000|NOT COMPLETED|Overall Study||1
9779912|NCT00493805|10886404|FG000|STARTED|Overall Study||17
9779913|NCT00493805|10886405|FG001|STARTED|Overall Study||42
9779914|NCT00493805|10886404|FG000|COMPLETED|Overall Study||17
9779915|NCT00493805|10886405|FG001|COMPLETED|Overall Study||42
9779916|NCT00493805|10886404|FG000|NOT COMPLETED|Overall Study||0
9779917|NCT00493805|10886405|FG001|NOT COMPLETED|Overall Study||0
9779918|NCT00493974|10886413|FG000|STARTED|Overall Study||60
9779919|NCT00493974|10886414|FG001|STARTED|Overall Study||59
9779920|NCT00493974|10886413|FG000|COMPLETED|Overall Study||47
9779921|NCT00493974|10886414|FG001|COMPLETED|Overall Study||45
9779922|NCT00493974|10886413|FG000|NOT COMPLETED|Overall Study||13
9779923|NCT00493974|10886414|FG001|NOT COMPLETED|Overall Study||14
9779924|NCT00494013|10886422|FG000|STARTED|Overall Study||223
9779925|NCT00494013|10886423|FG001|STARTED|Overall Study||219
9779926|NCT00494013|10886422|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219
9779927|NCT00494013|10886423|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210
9779928|NCT00494013|10886422|FG000|COMPLETED|Overall Study||193
9779929|NCT00494013|10886423|FG001|COMPLETED|Overall Study||183
9779930|NCT00494013|10886422|FG000|NOT COMPLETED|Overall Study||30
9779931|NCT00494013|10886423|FG001|NOT COMPLETED|Overall Study||36
9779932|NCT00494026|10886429|FG000|STARTED|Overall Study||4
9779933|NCT00494026|10886429|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
9779934|NCT00494026|10886429|FG000|NOT COMPLETED|Overall Study||4
9779935|NCT00494091|10886435|FG000|STARTED|Overall Study||6
9779936|NCT00494091|10886436|FG001|STARTED|Overall Study||76
9779937|NCT00494091|10886435|FG000|COMPLETED|Overall Study||0
9779938|NCT00494091|10886436|FG001|COMPLETED|Overall Study||0
9779939|NCT00494091|10886435|FG000|NOT COMPLETED|Overall Study||6
9779940|NCT00494091|10886436|FG001|NOT COMPLETED|Overall Study||76
9779941|NCT00494143|10886443|FG000|STARTED|Overall Study||1
9779942|NCT00494143|10886444|FG001|STARTED|Overall Study||2
9779943|NCT00494143|10886445|FG002|STARTED|Overall Study||3
9779944|NCT00494143|10886446|FG003|STARTED|Overall Study||0
9779945|NCT00494143|10886447|FG004|STARTED|Overall Study||1
9779946|NCT00494143|10886448|FG005|STARTED|Overall Study||0
9779947|NCT00494143|10886443|FG000|COMPLETED|Overall Study||1
9779948|NCT00494143|10886444|FG001|COMPLETED|Overall Study||2
9779949|NCT00494143|10886445|FG002|COMPLETED|Overall Study||3
9779950|NCT00494143|10886446|FG003|COMPLETED|Overall Study||0
9779951|NCT00494143|10886447|FG004|COMPLETED|Overall Study||1
9779952|NCT00494143|10886448|FG005|COMPLETED|Overall Study||0
9779953|NCT00494143|10886443|FG000|NOT COMPLETED|Overall Study||0
9779954|NCT00494143|10886444|FG001|NOT COMPLETED|Overall Study||0
9779955|NCT00494143|10886445|FG002|NOT COMPLETED|Overall Study||0
9779956|NCT00494143|10886446|FG003|NOT COMPLETED|Overall Study||0
9779957|NCT00494143|10886447|FG004|NOT COMPLETED|Overall Study||0
9779958|NCT00494143|10886448|FG005|NOT COMPLETED|Overall Study||0
9779959|NCT00494221|10886463|FG000|STARTED|Overall Study||58
9779960|NCT00494221|10886464|FG001|STARTED|Overall Study||56
9779961|NCT00494221|10886465|FG002|STARTED|Overall Study||58
9779962|NCT00494221|10886463|FG000|COMPLETED|Overall Study||42
9779963|NCT00494221|10886464|FG001|COMPLETED|Overall Study||45
9779964|NCT00494221|10886465|FG002|COMPLETED|Overall Study||44
9779965|NCT00494221|10886463|FG000|NOT COMPLETED|Overall Study||16
9779966|NCT00494221|10886464|FG001|NOT COMPLETED|Overall Study||11
9779967|NCT00494221|10886465|FG002|NOT COMPLETED|Overall Study||14
9779968|NCT00494299|10886475|FG000|STARTED|Overall Study||229
9779969|NCT00494299|10886476|FG001|STARTED|Overall Study||229
9779970|NCT00494299|10886475|FG000|Received Treatment|Overall Study||229
9779971|NCT00494299|10886476|FG001|Received Treatment|Overall Study||227
9779972|NCT00494299|10886475|FG000|COMPLETED|Overall Study||0
9779973|NCT00494299|10886476|FG001|COMPLETED|Overall Study||0
9779974|NCT00494299|10886475|FG000|NOT COMPLETED|Overall Study||229
9779975|NCT00494299|10886476|FG001|NOT COMPLETED|Overall Study||229
9779976|NCT00494442|10886484|FG000|STARTED|Overall Study|Patients received treatment|24
9779977|NCT00494442|10886485|FG001|STARTED|Overall Study|Patients received treatment|33
9779978|NCT00494442|10886484|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
9779979|NCT00494442|10886485|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
9779980|NCT00494442|10886484|FG000|NOT COMPLETED|Overall Study||17
9779981|NCT00494442|10886485|FG001|NOT COMPLETED|Overall Study||16
9779982|NCT00494481|10886493|FG000|STARTED|Overall Study|randomised patients|35
9779983|NCT00494481|10886494|FG001|STARTED|Overall Study|randomised patients|29
9779984|NCT00494481|10886493|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
9779985|NCT00494481|10886494|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
9779986|NCT00494481|10886493|FG000|NOT COMPLETED|Overall Study||29
9779987|NCT00494481|10886494|FG001|NOT COMPLETED|Overall Study||24
9779988|NCT00494494|10886502|FG000|STARTED|Overall Study||40
9779989|NCT00494494|10886503|FG001|STARTED|Overall Study||39
9779990|NCT00494494|10886502|FG000|COMPLETED|Overall Study||40
9779991|NCT00494494|10886503|FG001|COMPLETED|Overall Study||39
9779992|NCT00494494|10886502|FG000|NOT COMPLETED|Overall Study||0
9779993|NCT00494494|10886503|FG001|NOT COMPLETED|Overall Study||0
9779994|NCT00494507|10886513|FG000|STARTED|Double-Blind Phase||12
9779995|NCT00494507|10886514|FG001|STARTED|Double-Blind Phase||9
9779996|NCT00494507|10886515|FG002|STARTED|Double-Blind Phase||24
9779997|NCT00494507|10886516|FG003|STARTED|Double-Blind Phase||20
9779998|NCT00494507|10886513|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
9779999|NCT00494507|10886514|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
9780000|NCT00494507|10886515|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
9780001|NCT00494507|10886516|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
9780002|NCT00494507|10886513|FG000|COMPLETED|Double-Blind Phase||9
9780003|NCT00494507|10886514|FG001|COMPLETED|Double-Blind Phase||9
9780004|NCT00494507|10886515|FG002|COMPLETED|Double-Blind Phase||22
9780005|NCT00494507|10886516|FG003|COMPLETED|Double-Blind Phase||19
9780006|NCT00494507|10886513|FG000|NOT COMPLETED|Double-Blind Phase||3
9780007|NCT00494507|10886514|FG001|NOT COMPLETED|Double-Blind Phase||0
9780008|NCT00494507|10886515|FG002|NOT COMPLETED|Double-Blind Phase||2
9780009|NCT00494507|10886516|FG003|NOT COMPLETED|Double-Blind Phase||1
9780010|NCT00494507|10886513|FG000|STARTED|Open-Label Phase||9
9780011|NCT00494507|10886514|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
9780012|NCT00494507|10886515|FG002|STARTED|Open-Label Phase||22
9780013|NCT00494507|10886516|FG003|STARTED|Open-Label Phase||19
9780014|NCT00494507|10886513|FG000|COMPLETED|Open-Label Phase||9
9780015|NCT00494507|10886514|FG001|COMPLETED|Open-Label Phase||7
9780016|NCT00494507|10886515|FG002|COMPLETED|Open-Label Phase||17
9780017|NCT00494507|10886516|FG003|COMPLETED|Open-Label Phase||14
9780018|NCT00494507|10886513|FG000|NOT COMPLETED|Open-Label Phase||0
9780019|NCT00494507|10886514|FG001|NOT COMPLETED|Open-Label Phase||1
9780020|NCT00494507|10886515|FG002|NOT COMPLETED|Open-Label Phase||5
9780021|NCT00494507|10886516|FG003|NOT COMPLETED|Open-Label Phase||5
9830162|NCT00762372|10940866|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
9830163|NCT00762372|10940864|FG000|COMPLETED|Overall Study||110
9830164|NCT00762372|10940865|FG001|COMPLETED|Overall Study||55
9830165|NCT00762372|10940866|FG002|COMPLETED|Overall Study||50
10014686|NCT01801241|11137714|FG001|NOT COMPLETED|Overall Study||2
10014687|NCT01801280|11137724|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5
9830166|NCT00762372|10940864|FG000|NOT COMPLETED|Overall Study||1
9830167|NCT00762372|10940865|FG001|NOT COMPLETED|Overall Study||0
9830168|NCT00762372|10940866|FG002|NOT COMPLETED|Overall Study||0
9830169|NCT00762385|10940880|FG000|STARTED|First Intervention||51
9830170|NCT00762385|10940881|FG001|STARTED|First Intervention||46
9830171|NCT00762385|10940880|FG000|COMPLETED|First Intervention||49
9830172|NCT00762385|10940881|FG001|COMPLETED|First Intervention||42
9830173|NCT00762385|10940880|FG000|NOT COMPLETED|First Intervention||2
9830174|NCT00762385|10940881|FG001|NOT COMPLETED|First Intervention||4
9830175|NCT00762385|10940880|FG000|STARTED|Second Intervention||49
9830176|NCT00762385|10940881|FG001|STARTED|Second Intervention||42
9830177|NCT00762385|10940880|FG000|COMPLETED|Second Intervention||46
9830178|NCT00762385|10940881|FG001|COMPLETED|Second Intervention||39
9830179|NCT00762385|10940880|FG000|NOT COMPLETED|Second Intervention||3
9830180|NCT00762385|10940881|FG001|NOT COMPLETED|Second Intervention||3
9830181|NCT00762411|10940892|FG000|STARTED|Initial Treatment||556
9830182|NCT00762411|10940893|FG001|STARTED|Initial Treatment||555
9830183|NCT00762411|10940892|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
9780022|NCT00494585|10886536|FG000|STARTED|Overall Study||22
9780023|NCT00494585|10886536|FG000|COMPLETED|Overall Study||22
9780024|NCT00494585|10886536|FG000|NOT COMPLETED|Overall Study||0
9780025|NCT00494676|10886540|FG000|STARTED|Allocation||37
9780026|NCT00494676|10886541|FG001|STARTED|Allocation||36
9780027|NCT00494676|10886540|FG000|COMPLETED|Allocation||35
9780028|NCT00494676|10886541|FG001|COMPLETED|Allocation||32
9780029|NCT00494676|10886540|FG000|NOT COMPLETED|Allocation||2
9780030|NCT00494676|10886541|FG001|NOT COMPLETED|Allocation||4
9780031|NCT00494676|10886540|FG000|STARTED|First Intervention||35
9780032|NCT00494676|10886541|FG001|STARTED|First Intervention||32
9780033|NCT00494676|10886540|FG000|COMPLETED|First Intervention||34
9780034|NCT00494676|10886541|FG001|COMPLETED|First Intervention||29
9780035|NCT00494676|10886540|FG000|NOT COMPLETED|First Intervention||1
9780036|NCT00494676|10886541|FG001|NOT COMPLETED|First Intervention||3
9780037|NCT00494676|10886540|FG000|STARTED|Second Intervention||34
9780038|NCT00494676|10886541|FG001|STARTED|Second Intervention||29
9780039|NCT00494676|10886540|FG000|COMPLETED|Second Intervention||33
9780040|NCT00494676|10886541|FG001|COMPLETED|Second Intervention||28
9780041|NCT00494676|10886540|FG000|NOT COMPLETED|Second Intervention||1
9780042|NCT00494676|10886541|FG001|NOT COMPLETED|Second Intervention||1
9780043|NCT00494780|10886549|FG000|STARTED|Overall Study||29
9780044|NCT00494780|10886550|FG001|STARTED|Overall Study||30
9780045|NCT00494780|10886549|FG000|COMPLETED|Overall Study||18
9780046|NCT00494780|10886550|FG001|COMPLETED|Overall Study||17
9780047|NCT00494780|10886549|FG000|NOT COMPLETED|Overall Study||11
9780048|NCT00494780|10886550|FG001|NOT COMPLETED|Overall Study||13
9780049|NCT00494806|10886560|FG000|STARTED|Overall Study||34
9780050|NCT00494806|10886561|FG001|STARTED|Overall Study||32
9780051|NCT00494806|10886560|FG000|COMPLETED|Overall Study||34
9780052|NCT00494806|10886561|FG001|COMPLETED|Overall Study||32
9780053|NCT00494806|10886560|FG000|NOT COMPLETED|Overall Study||0
9780054|NCT00494806|10886561|FG001|NOT COMPLETED|Overall Study||0
9780055|NCT00494871|10886569|FG000|STARTED|Double-blind (DB) Treatment Period||640
9780056|NCT00494871|10886570|FG001|STARTED|Double-blind (DB) Treatment Period||640
9780057|NCT00494871|10886569|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
9780058|NCT00494871|10886570|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
9780059|NCT00494871|10886569|FG000|COMPLETED|Double-blind (DB) Treatment Period||480
9780060|NCT00494871|10886570|FG001|COMPLETED|Double-blind (DB) Treatment Period||468
9780061|NCT00494871|10886569|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160
9780062|NCT00494871|10886570|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172
9780063|NCT00494871|10886569|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
9780064|NCT00494871|10886570|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
9780065|NCT00494871|10886569|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
9780066|NCT00494871|10886570|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
9780067|NCT00494871|10886569|FG000|COMPLETED|Follow-up (FU) Period||610
9780068|NCT00494871|10886570|FG001|COMPLETED|Follow-up (FU) Period||616
9780069|NCT00494871|10886569|FG000|NOT COMPLETED|Follow-up (FU) Period||29
9780070|NCT00494871|10886570|FG001|NOT COMPLETED|Follow-up (FU) Period||23
9780071|NCT00494975|10886580|FG000|STARTED|Overall Study||10
9780072|NCT00494975|10886581|FG001|STARTED|Overall Study||11
9780073|NCT00494975|10886580|FG000|COMPLETED|Overall Study||8
9780074|NCT00494975|10886581|FG001|COMPLETED|Overall Study||10
9780075|NCT00494975|10886580|FG000|NOT COMPLETED|Overall Study||2
9780076|NCT00494975|10886581|FG001|NOT COMPLETED|Overall Study||1
9780077|NCT00495040|10886587|FG000|STARTED|Overall Study||38
9780078|NCT00495040|10886587|FG000|COMPLETED|Overall Study||35
9780079|NCT00495040|10886587|FG000|NOT COMPLETED|Overall Study||3
9780080|NCT00495079|10886591|FG000|STARTED|Overall Study||65
9780081|NCT00495079|10886591|FG000|COMPLETED|Overall Study||65
9780082|NCT00495079|10886591|FG000|NOT COMPLETED|Overall Study||0
9780083|NCT00495157|10886601|FG000|STARTED|Overall Study||113
9780084|NCT00495157|10886602|FG001|STARTED|Overall Study||115
9780085|NCT00495157|10886603|FG002|STARTED|Overall Study||114
9780086|NCT00495157|10886601|FG000|COMPLETED|Overall Study||97
9780087|NCT00495157|10886602|FG001|COMPLETED|Overall Study||92
9780088|NCT00495157|10886603|FG002|COMPLETED|Overall Study||101
9780089|NCT00495157|10886601|FG000|NOT COMPLETED|Overall Study||16
9780090|NCT00495157|10886602|FG001|NOT COMPLETED|Overall Study||23
9780091|NCT00495157|10886603|FG002|NOT COMPLETED|Overall Study||13
9780092|NCT00495170|10886611|FG000|STARTED|Overall Study||84
9780093|NCT00495170|10886611|FG000|COMPLETED|Overall Study||64
9780094|NCT00495170|10886611|FG000|NOT COMPLETED|Overall Study||20
9780095|NCT00495391|10886617|FG000|STARTED|Overall Study||42
9780096|NCT00495391|10886618|FG001|STARTED|Overall Study||22
9780097|NCT00495391|10886617|FG000|From Baseline to Week 8|Overall Study||31
9780098|NCT00495391|10886618|FG001|From Baseline to Week 8|Overall Study||20
9780099|NCT00495391|10886617|FG000|From Baseline to Week 16|Overall Study||24
9780100|NCT00495391|10886618|FG001|From Baseline to Week 16|Overall Study||11
9780101|NCT00495391|10886617|FG000|From Baseline to End of Treatment|Overall Study||6
9780102|NCT00495391|10886618|FG001|From Baseline to End of Treatment|Overall Study||1
9780103|NCT00495391|10886617|FG000|From Baseline to End of Follow up|Overall Study||6
9780104|NCT00495391|10886618|FG001|From Baseline to End of Follow up|Overall Study||1
9780105|NCT00495391|10886617|FG000|COMPLETED|Overall Study||6
9780106|NCT00495391|10886618|FG001|COMPLETED|Overall Study||1
9780107|NCT00495391|10886617|FG000|NOT COMPLETED|Overall Study||36
9780108|NCT00495391|10886618|FG001|NOT COMPLETED|Overall Study||21
9780109|NCT00495469|10886631|FG000|STARTED|Overall Study||36
9780110|NCT00495469|10886632|FG001|STARTED|Overall Study||37
9780111|NCT00495469|10886633|FG002|STARTED|Overall Study||34
10014688|NCT01801280|11137725|FG001|STARTED|Period 1||5
10014689|NCT01801280|11137726|FG002|STARTED|Period 1||5
10014690|NCT01801280|11137727|FG003|STARTED|Period 1||5
10014691|NCT01801280|11137724|FG000|COMPLETED|Period 1||5
10014692|NCT01801280|11137725|FG001|COMPLETED|Period 1||4
10014693|NCT01801280|11137726|FG002|COMPLETED|Period 1||5
10014694|NCT01801280|11137727|FG003|COMPLETED|Period 1||5
10014695|NCT01801280|11137724|FG000|NOT COMPLETED|Period 1||0
10014696|NCT01801280|11137725|FG001|NOT COMPLETED|Period 1||1
9780112|NCT00495469|10886634|FG003|STARTED|Overall Study||36
9780113|NCT00495469|10886635|FG004|STARTED|Overall Study||36
9780114|NCT00495469|10886636|FG005|STARTED|Overall Study||36
9780115|NCT00495469|10886637|FG006|STARTED|Overall Study||35
9780116|NCT00495469|10886631|FG000|COMPLETED|Overall Study||30
9780117|NCT00495469|10886632|FG001|COMPLETED|Overall Study||30
9780118|NCT00495469|10886633|FG002|COMPLETED|Overall Study||27
9780119|NCT00495469|10886634|FG003|COMPLETED|Overall Study||32
9780120|NCT00495469|10886635|FG004|COMPLETED|Overall Study||31
9780121|NCT00495469|10886636|FG005|COMPLETED|Overall Study||31
9780122|NCT00495469|10886637|FG006|COMPLETED|Overall Study||30
9780123|NCT00495469|10886631|FG000|NOT COMPLETED|Overall Study||6
9780124|NCT00495469|10886632|FG001|NOT COMPLETED|Overall Study||7
9780125|NCT00495469|10886633|FG002|NOT COMPLETED|Overall Study||7
9780126|NCT00495469|10886634|FG003|NOT COMPLETED|Overall Study||4
10014697|NCT01801280|11137726|FG002|NOT COMPLETED|Period 1||0
10014698|NCT01801280|11137727|FG003|NOT COMPLETED|Period 1||0
9780127|NCT00495469|10886635|FG004|NOT COMPLETED|Overall Study||5
9780128|NCT00495469|10886636|FG005|NOT COMPLETED|Overall Study||5
9780129|NCT00495469|10886637|FG006|NOT COMPLETED|Overall Study||5
9780130|NCT00495495|10886660|FG000|STARTED|Overall Study||394
9780131|NCT00495495|10886660|FG000|COMPLETED|Overall Study||295
9780132|NCT00495495|10886660|FG000|NOT COMPLETED|Overall Study||99
9780133|NCT00495521|10886667|FG000|STARTED|Overall Study||1
9780134|NCT00495521|10886668|FG001|STARTED|Overall Study||1
9780135|NCT00495521|10886667|FG000|COMPLETED|Overall Study||1
9780136|NCT00495521|10886668|FG001|COMPLETED|Overall Study||0
9780137|NCT00495521|10886667|FG000|NOT COMPLETED|Overall Study||0
9780138|NCT00495521|10886668|FG001|NOT COMPLETED|Overall Study||1
9780139|NCT00495586|10886676|FG000|STARTED|Overall Study||156
9780140|NCT00495586|10886677|FG001|STARTED|Overall Study||162
9780141|NCT00495586|10886676|FG000|COMPLETED|Overall Study||152
9780142|NCT00495586|10886677|FG001|COMPLETED|Overall Study||158
9780143|NCT00495586|10886676|FG000|NOT COMPLETED|Overall Study||4
9780144|NCT00495586|10886677|FG001|NOT COMPLETED|Overall Study||4
9780145|NCT00495612|10886687|FG000|STARTED|Overall Study||36
9780146|NCT00495612|10886688|FG001|STARTED|Overall Study||33
9780147|NCT00495612|10886687|FG000|COMPLETED|Overall Study||32
9780148|NCT00495612|10886688|FG001|COMPLETED|Overall Study||33
9780149|NCT00495612|10886687|FG000|NOT COMPLETED|Overall Study||4
9780150|NCT00495612|10886688|FG001|NOT COMPLETED|Overall Study||0
9780151|NCT00495625|10886694|FG000|STARTED|Overall Study||33
9780152|NCT00495625|10886694|FG000|COMPLETED|Overall Study||23
9780153|NCT00495625|10886694|FG000|NOT COMPLETED|Overall Study||10
9780154|NCT00495677|10886705|FG000|STARTED|Stage 1 (25 Days)||2
9780155|NCT00495677|10886706|FG001|STARTED|Stage 1 (25 Days)||6
9780156|NCT00495677|10886707|FG002|STARTED|Stage 1 (25 Days)||6
9780157|NCT00495677|10886708|FG003|STARTED|Stage 1 (25 Days)||6
9780158|NCT00495677|10886709|FG004|STARTED|Stage 1 (25 Days)||0
9780159|NCT00495677|10886710|FG005|STARTED|Stage 1 (25 Days)||0
9780160|NCT00495677|10886711|FG006|STARTED|Stage 1 (25 Days)||0
9780161|NCT00495677|10886705|FG000|COMPLETED|Stage 1 (25 Days)||2
9780162|NCT00495677|10886706|FG001|COMPLETED|Stage 1 (25 Days)||6
9780163|NCT00495677|10886707|FG002|COMPLETED|Stage 1 (25 Days)||5
9780164|NCT00495677|10886708|FG003|COMPLETED|Stage 1 (25 Days)||6
9780165|NCT00495677|10886709|FG004|COMPLETED|Stage 1 (25 Days)||0
9780166|NCT00495677|10886710|FG005|COMPLETED|Stage 1 (25 Days)||0
10014699|NCT01801280|11137724|FG000|STARTED|Period 2||5
10014700|NCT01801280|11137725|FG001|STARTED|Period 2||4
10014701|NCT01801280|11137726|FG002|STARTED|Period 2||5
9780167|NCT00495677|10886711|FG006|COMPLETED|Stage 1 (25 Days)||0
9780168|NCT00495677|10886705|FG000|NOT COMPLETED|Stage 1 (25 Days)||0
9780169|NCT00495677|10886706|FG001|NOT COMPLETED|Stage 1 (25 Days)||0
9780170|NCT00495677|10886707|FG002|NOT COMPLETED|Stage 1 (25 Days)||1
9780171|NCT00495677|10886708|FG003|NOT COMPLETED|Stage 1 (25 Days)||0
9780172|NCT00495677|10886709|FG004|NOT COMPLETED|Stage 1 (25 Days)||0
9780173|NCT00495677|10886710|FG005|NOT COMPLETED|Stage 1 (25 Days)||0
9780174|NCT00495677|10886711|FG006|NOT COMPLETED|Stage 1 (25 Days)||0
9780175|NCT00495677|10886705|FG000|STARTED|Stage 2 (25 Days)||0
9780176|NCT00495677|10886706|FG001|STARTED|Stage 2 (25 Days)||0
9780177|NCT00495677|10886707|FG002|STARTED|Stage 2 (25 Days)||0
9780178|NCT00495677|10886708|FG003|STARTED|Stage 2 (25 Days)||0
9780179|NCT00495677|10886709|FG004|STARTED|Stage 2 (25 Days)||8
9780180|NCT00495677|10886710|FG005|STARTED|Stage 2 (25 Days)||8
9780181|NCT00495677|10886711|FG006|STARTED|Stage 2 (25 Days)||7
9780182|NCT00495677|10886705|FG000|COMPLETED|Stage 2 (25 Days)||0
9780183|NCT00495677|10886706|FG001|COMPLETED|Stage 2 (25 Days)||0
10014702|NCT01801280|11137727|FG003|STARTED|Period 2||5
10014703|NCT01801280|11137724|FG000|COMPLETED|Period 2||4
10014704|NCT01801280|11137725|FG001|COMPLETED|Period 2||4
9780184|NCT00495677|10886707|FG002|COMPLETED|Stage 2 (25 Days)||0
9780185|NCT00495677|10886708|FG003|COMPLETED|Stage 2 (25 Days)||0
9780186|NCT00495677|10886709|FG004|COMPLETED|Stage 2 (25 Days)||8
9780187|NCT00495677|10886710|FG005|COMPLETED|Stage 2 (25 Days)||8
9780188|NCT00495677|10886711|FG006|COMPLETED|Stage 2 (25 Days)||7
9780189|NCT00495677|10886705|FG000|NOT COMPLETED|Stage 2 (25 Days)||0
9780190|NCT00495677|10886706|FG001|NOT COMPLETED|Stage 2 (25 Days)||0
9780191|NCT00495677|10886707|FG002|NOT COMPLETED|Stage 2 (25 Days)||0
9780192|NCT00495677|10886708|FG003|NOT COMPLETED|Stage 2 (25 Days)||0
9780193|NCT00495677|10886709|FG004|NOT COMPLETED|Stage 2 (25 Days)||0
9780194|NCT00495677|10886710|FG005|NOT COMPLETED|Stage 2 (25 Days)||0
9780195|NCT00495677|10886711|FG006|NOT COMPLETED|Stage 2 (25 Days)||0
9780196|NCT00495755|10886727|FG000|STARTED|Overall Study||13
9780197|NCT00495755|10886727|FG000|COMPLETED|Overall Study||10
9780198|NCT00495755|10886727|FG000|NOT COMPLETED|Overall Study||3
9780199|NCT00495794|10886734|FG000|STARTED|Overall Study||2319
9780200|NCT00495794|10886735|FG001|STARTED|Overall Study||2303
9780201|NCT00495794|10886734|FG000|COMPLETED|Overall Study||1797
9780202|NCT00495794|10886735|FG001|COMPLETED|Overall Study||2303
9780203|NCT00495794|10886734|FG000|NOT COMPLETED|Overall Study||522
9780204|NCT00495794|10886735|FG001|NOT COMPLETED|Overall Study||0
9780205|NCT00495820|10886743|FG000|STARTED|Overall Study||30
9780206|NCT00495820|10886744|FG001|STARTED|Overall Study||30
9780207|NCT00495820|10886743|FG000|COMPLETED|Overall Study||29
9780208|NCT00495820|10886744|FG001|COMPLETED|Overall Study||29
9780209|NCT00495820|10886743|FG000|NOT COMPLETED|Overall Study||1
9780210|NCT00495820|10886744|FG001|NOT COMPLETED|Overall Study||1
9780211|NCT00496015|10886755|FG000|STARTED|Overall Study||178
9780212|NCT00496015|10886756|FG001|STARTED|Overall Study||27
9780213|NCT00496015|10886757|FG002|STARTED|Overall Study||172
9780214|NCT00496015|10886758|FG003|STARTED|Overall Study||37
9780215|NCT00496015|10886759|FG004|STARTED|Overall Study||336
9780216|NCT00496015|10886755|FG000|COMPLETED|Overall Study||177
9780217|NCT00496015|10886756|FG001|COMPLETED|Overall Study||27
9780218|NCT00496015|10886757|FG002|COMPLETED|Overall Study||172
9780219|NCT00496015|10886758|FG003|COMPLETED|Overall Study||36
9780220|NCT00496015|10886759|FG004|COMPLETED|Overall Study||336
9780221|NCT00496015|10886755|FG000|NOT COMPLETED|Overall Study||1
9780222|NCT00496015|10886756|FG001|NOT COMPLETED|Overall Study||0
9780223|NCT00496015|10886757|FG002|NOT COMPLETED|Overall Study||0
9780224|NCT00496015|10886758|FG003|NOT COMPLETED|Overall Study||1
9780225|NCT00496015|10886759|FG004|NOT COMPLETED|Overall Study||0
9780226|NCT00496054|10886779|FG000|STARTED|Overall Study||110
9780227|NCT00496054|10886779|FG000|COMPLETED|Overall Study||102
9780228|NCT00496054|10886779|FG000|NOT COMPLETED|Overall Study||8
9780229|NCT00496080|10886783|FG000|STARTED|Overall Study||87
9780230|NCT00496080|10886783|FG000|COMPLETED|Overall Study||60
9780231|NCT00496080|10886783|FG000|NOT COMPLETED|Overall Study||27
9780232|NCT00496197|10886788|FG000|STARTED|Overall Study||282
9780233|NCT00496197|10886788|FG000|COMPLETED|Overall Study||160
9780234|NCT00496197|10886788|FG000|NOT COMPLETED|Overall Study||122
9780235|NCT00496262|10886792|FG000|STARTED|Overall Study||15
9780236|NCT00496262|10886792|FG000|COMPLETED|Overall Study||15
9780237|NCT00496262|10886792|FG000|NOT COMPLETED|Overall Study||0
9780238|NCT00496340|10886798|FG000|STARTED|Overall Study||42
9780239|NCT00496340|10886798|FG000|COMPLETED|Overall Study||42
9780240|NCT00496340|10886798|FG000|NOT COMPLETED|Overall Study||0
9780241|NCT00496366|10886802|FG000|STARTED|Overall Study||11
9780242|NCT00496366|10886802|FG000|COMPLETED|Overall Study||10
9780243|NCT00496366|10886802|FG000|NOT COMPLETED|Overall Study||1
9780244|NCT00496379|10886806|FG000|STARTED|Overall Study||15
9780245|NCT00496379|10886806|FG000|COMPLETED|Overall Study||15
9780246|NCT00496379|10886806|FG000|NOT COMPLETED|Overall Study||0
9780247|NCT00496470|10886812|FG000|STARTED|Overall Study||329
9780248|NCT00496470|10886813|FG001|STARTED|Overall Study||331
9780249|NCT00496470|10886812|FG000|Received Study Medication|Overall Study||329
9780250|NCT00496470|10886813|FG001|Received Study Medication|Overall Study||330
10014705|NCT01801280|11137726|FG002|COMPLETED|Period 2||5
10014706|NCT01801280|11137727|FG003|COMPLETED|Period 2||5
9780251|NCT00496470|10886812|FG000|COMPLETED|Overall Study||303
9780252|NCT00496470|10886813|FG001|COMPLETED|Overall Study||302
9780253|NCT00496470|10886812|FG000|NOT COMPLETED|Overall Study||26
9780254|NCT00496470|10886813|FG001|NOT COMPLETED|Overall Study||29
9780255|NCT00496483|10886819|FG000|STARTED|Overall Study||60
9780256|NCT00496483|10886819|FG000|Dosed|Overall Study||51
9780257|NCT00496483|10886819|FG000|COMPLETED|Overall Study||48
9780258|NCT00496483|10886819|FG000|NOT COMPLETED|Overall Study||12
9780259|NCT00496587|10886826|FG000|STARTED|Overall Study||34
9780260|NCT00496587|10886826|FG000|COMPLETED|Overall Study||3
9780261|NCT00496587|10886826|FG000|NOT COMPLETED|Overall Study||31
9780262|NCT00496626|10886832|FG000|STARTED|Overall Study||302
9780263|NCT00496626|10886833|FG001|STARTED|Overall Study||298
9780264|NCT00496626|10886832|FG000|COMPLETED|Overall Study||296
9780265|NCT00496626|10886833|FG001|COMPLETED|Overall Study||292
9780266|NCT00496626|10886832|FG000|NOT COMPLETED|Overall Study||6
9780267|NCT00496626|10886833|FG001|NOT COMPLETED|Overall Study||6
9780268|NCT00496769|10886845|FG000|STARTED|Double Blind|Randomized|2807
9780269|NCT00496769|10886846|FG001|STARTED|Double Blind|Randomized|2791
9780270|NCT00496769|10886847|FG002|STARTED|Double Blind||0
9780271|NCT00496769|10886845|FG000|Received Treatment|Double Blind||2798
9780272|NCT00496769|10886846|FG001|Received Treatment|Double Blind||2708
9780273|NCT00496769|10886847|FG002|Received Treatment|Double Blind||0
9780274|NCT00496769|10886845|FG000|COMPLETED|Double Blind||2249
9780275|NCT00496769|10886846|FG001|COMPLETED|Double Blind||2142
9780276|NCT00496769|10886847|FG002|COMPLETED|Double Blind||0
9780277|NCT00496769|10886845|FG000|NOT COMPLETED|Double Blind||558
9780278|NCT00496769|10886846|FG001|NOT COMPLETED|Double Blind||649
9780279|NCT00496769|10886847|FG002|NOT COMPLETED|Double Blind||0
9780280|NCT00496769|10886845|FG000|STARTED|Open Label||0
9780281|NCT00496769|10886846|FG001|STARTED|Open Label||0
9780282|NCT00496769|10886847|FG002|STARTED|Open Label||3275
9780283|NCT00496769|10886845|FG000|COMPLETED|Open Label||0
9780284|NCT00496769|10886846|FG001|COMPLETED|Open Label||0
9780285|NCT00496769|10886847|FG002|COMPLETED|Open Label||2264
9780286|NCT00496769|10886845|FG000|NOT COMPLETED|Open Label||0
9780287|NCT00496769|10886846|FG001|NOT COMPLETED|Open Label||0
9780288|NCT00496769|10886847|FG002|NOT COMPLETED|Open Label||1011
9780289|NCT00496808|10886856|FG000|STARTED|Overall Study||69
9780290|NCT00496808|10886856|FG000|COMPLETED|Overall Study||69
9780291|NCT00496808|10886856|FG000|NOT COMPLETED|Overall Study||0
9780292|NCT00496860|10886863|FG000|STARTED|Overall Study||4
9780293|NCT00496860|10886864|FG001|STARTED|Overall Study||16
9780294|NCT00496860|10886865|FG002|STARTED|Overall Study||6
9780295|NCT00496860|10886863|FG000|COMPLETED|Overall Study||3
9780296|NCT00496860|10886864|FG001|COMPLETED|Overall Study||15
9780297|NCT00496860|10886865|FG002|COMPLETED|Overall Study||6
9780298|NCT00496860|10886863|FG000|NOT COMPLETED|Overall Study||1
9780299|NCT00496860|10886864|FG001|NOT COMPLETED|Overall Study||1
9780300|NCT00496860|10886865|FG002|NOT COMPLETED|Overall Study||0
9780301|NCT00496873|10886873|FG000|STARTED|Overall Study||85
9780302|NCT00496873|10886873|FG000|COMPLETED|Overall Study||78
9780303|NCT00496873|10886873|FG000|NOT COMPLETED|Overall Study||7
9780304|NCT00496964|10886879|FG000|STARTED|Overall Study||1
9780305|NCT00496964|10886880|FG001|STARTED|Overall Study||4
9780306|NCT00496964|10886879|FG000|COMPLETED|Overall Study||1
9780307|NCT00496964|10886880|FG001|COMPLETED|Overall Study||3
9780308|NCT00496964|10886879|FG000|NOT COMPLETED|Overall Study||0
9780309|NCT00496964|10886880|FG001|NOT COMPLETED|Overall Study||1
9780310|NCT00497055|10886890|FG000|STARTED|Overall Study||45
9780311|NCT00497055|10886891|FG001|STARTED|Overall Study||45
9780312|NCT00497055|10886890|FG000|COMPLETED|Overall Study||35
9780313|NCT00497055|10886891|FG001|COMPLETED|Overall Study||40
9780314|NCT00497055|10886890|FG000|NOT COMPLETED|Overall Study||10
9780315|NCT00497055|10886891|FG001|NOT COMPLETED|Overall Study||5
9780316|NCT00497081|10886899|FG000|STARTED|Overall Study||30
9780317|NCT00497081|10886900|FG001|STARTED|Overall Study||30
9780318|NCT00497081|10886899|FG000|COMPLETED|Overall Study||28
9780319|NCT00497081|10886900|FG001|COMPLETED|Overall Study||28
9780320|NCT00497081|10886899|FG000|NOT COMPLETED|Overall Study||2
9780321|NCT00497081|10886900|FG001|NOT COMPLETED|Overall Study||2
9780322|NCT00497146|10886908|FG000|STARTED|Treatment Period||115
9780323|NCT00497146|10886909|FG001|STARTED|Treatment Period||112
9780324|NCT00497146|10886908|FG000|COMPLETED|Treatment Period||88
9780325|NCT00497146|10886909|FG001|COMPLETED|Treatment Period||91
9780326|NCT00497146|10886908|FG000|NOT COMPLETED|Treatment Period||27
9780327|NCT00497146|10886909|FG001|NOT COMPLETED|Treatment Period||21
9780328|NCT00497146|10886908|FG000|STARTED|Long-term Follow-up Period||65
9780329|NCT00497146|10886909|FG001|STARTED|Long-term Follow-up Period||72
9780330|NCT00497146|10886908|FG000|COMPLETED|Long-term Follow-up Period||50
9780331|NCT00497146|10886909|FG001|COMPLETED|Long-term Follow-up Period||66
9780332|NCT00497146|10886908|FG000|NOT COMPLETED|Long-term Follow-up Period||15
9780333|NCT00497146|10886909|FG001|NOT COMPLETED|Long-term Follow-up Period||6
9780334|NCT00497198|10886919|FG000|STARTED|Overall Study||92
9780335|NCT00497198|10886920|FG001|STARTED|Overall Study||91
9780336|NCT00497198|10886919|FG000|COMPLETED|Overall Study||87
9780337|NCT00497198|10886920|FG001|COMPLETED|Overall Study||86
9780338|NCT00497198|10886919|FG000|NOT COMPLETED|Overall Study||5
9780339|NCT00497198|10886920|FG001|NOT COMPLETED|Overall Study||5
9780340|NCT00497289|10886928|FG000|STARTED|Overall Study||24
9780341|NCT00497289|10886929|FG001|STARTED|Overall Study||24
9780342|NCT00497289|10886928|FG000|COMPLETED|Overall Study||19
9780343|NCT00497289|10886929|FG001|COMPLETED|Overall Study||18
9780344|NCT00497289|10886928|FG000|NOT COMPLETED|Overall Study||5
9780345|NCT00497289|10886929|FG001|NOT COMPLETED|Overall Study||6
9780346|NCT00497770|10886941|FG000|STARTED|Overall Study||304
9780347|NCT00497770|10886942|FG001|STARTED|Overall Study||65
9780348|NCT00497770|10886943|FG002|STARTED|Overall Study||37
9780349|NCT00497770|10886944|FG003|STARTED|Overall Study||28
9780350|NCT00497770|10886941|FG000|COMPLETED|Overall Study||304
9780351|NCT00497770|10886942|FG001|COMPLETED|Overall Study||65
9780352|NCT00497770|10886943|FG002|COMPLETED|Overall Study||37
9780353|NCT00497770|10886944|FG003|COMPLETED|Overall Study||28
9780354|NCT00497770|10886941|FG000|NOT COMPLETED|Overall Study||0
9780355|NCT00497770|10886942|FG001|NOT COMPLETED|Overall Study||0
9780356|NCT00497770|10886943|FG002|NOT COMPLETED|Overall Study||0
9780357|NCT00497770|10886944|FG003|NOT COMPLETED|Overall Study||0
9780358|NCT00497796|10886957|FG000|STARTED|Overall Study||147
9780359|NCT00497796|10886958|FG001|STARTED|Overall Study||160
9780360|NCT00497796|10886957|FG000|COMPLETED|Overall Study||62
9780361|NCT00497796|10886958|FG001|COMPLETED|Overall Study||101
9780362|NCT00497796|10886957|FG000|NOT COMPLETED|Overall Study||85
9780363|NCT00497796|10886958|FG001|NOT COMPLETED|Overall Study||59
9780364|NCT00497874|10886966|FG000|STARTED|Overall Study||443
9780365|NCT00497874|10886967|FG001|STARTED|Overall Study||459
9780366|NCT00497874|10886966|FG000|COMPLETED|Overall Study||296
9952319|NCT01421342|11071239|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
9952320|NCT01421342|11071237|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
9952321|NCT01421342|11071238|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
9952322|NCT01421342|11071239|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
9952323|NCT01421355|11071247|FG000|STARTED|Overall Study||21
9952324|NCT01421355|11071247|FG000|COMPLETED|Overall Study||15
9952325|NCT01421355|11071247|FG000|NOT COMPLETED|Overall Study||6
9952326|NCT01421459|11071253|FG000|STARTED|Overall Study||379
9952327|NCT01421459|11071254|FG001|STARTED|Overall Study||380
9957083|NCT01449370|11076258|FG023|COMPLETED|Overall Study||0
9780367|NCT00497874|10886967|FG001|COMPLETED|Overall Study||343
9780368|NCT00497874|10886966|FG000|NOT COMPLETED|Overall Study||147
9780369|NCT00497874|10886967|FG001|NOT COMPLETED|Overall Study||116
9780370|NCT00498173|10886977|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
9780371|NCT00498173|10886978|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
9780372|NCT00498173|10886979|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
9780373|NCT00498173|10886977|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
9780374|NCT00498173|10886978|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
9780375|NCT00498173|10886979|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
9780376|NCT00498173|10886977|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
9780377|NCT00498173|10886978|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
9780378|NCT00498173|10886979|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
9780379|NCT00498173|10886977|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
9780380|NCT00498173|10886978|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
9780381|NCT00498173|10886979|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
9780382|NCT00498173|10886977|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
9780383|NCT00498173|10886978|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
9780384|NCT00498173|10886979|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
9780385|NCT00498173|10886977|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
9780386|NCT00498173|10886978|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
9780387|NCT00498173|10886979|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
9780388|NCT00498186|10886987|FG000|STARTED|Overall Study||295
9780389|NCT00498186|10886987|FG000|COMPLETED|Overall Study||122
9780390|NCT00498186|10886987|FG000|NOT COMPLETED|Overall Study||173
9780391|NCT00498355|10886991|FG000|STARTED|Overall Study||7
9780392|NCT00498355|10886991|FG000|COMPLETED|Overall Study||6
9780393|NCT00498355|10886991|FG000|NOT COMPLETED|Overall Study||1
9780394|NCT00498368|10886998|FG000|STARTED|Overall Study||17
9780395|NCT00498368|10886999|FG001|STARTED|Overall Study||17
9780396|NCT00498368|10886998|FG000|COMPLETED|Overall Study||14
9780397|NCT00498368|10886999|FG001|COMPLETED|Overall Study||15
9780398|NCT00498368|10886998|FG000|NOT COMPLETED|Overall Study||3
9780399|NCT00498368|10886999|FG001|NOT COMPLETED|Overall Study||2
9780400|NCT00498433|10887008|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
9780401|NCT00498433|10887009|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9780402|NCT00498433|10887010|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9780403|NCT00498433|10887008|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
9780404|NCT00498433|10887009|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9780405|NCT00498433|10887010|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9780406|NCT00498433|10887008|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9780407|NCT00498433|10887009|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9780408|NCT00498433|10887010|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9780409|NCT00498433|10887008|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
9780410|NCT00498433|10887009|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
9780411|NCT00498433|10887010|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
9780412|NCT00498433|10887008|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
9780413|NCT00498433|10887009|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
9780414|NCT00498433|10887010|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
9780415|NCT00498433|10887008|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
9780416|NCT00498433|10887009|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
9780417|NCT00498433|10887010|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
9780418|NCT00498433|10887008|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
9780419|NCT00498433|10887009|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
9780420|NCT00498433|10887010|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
9780421|NCT00498433|10887008|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
9780422|NCT00498433|10887009|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
9780423|NCT00498433|10887010|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
9780424|NCT00498433|10887008|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
9780425|NCT00498433|10887009|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
9780426|NCT00498433|10887010|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
9780427|NCT00498433|10887008|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
9780428|NCT00498433|10887009|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
9780429|NCT00498433|10887010|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
9780430|NCT00498433|10887008|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
9780431|NCT00498433|10887009|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10014707|NCT01801280|11137724|FG000|NOT COMPLETED|Period 2||1
10014708|NCT01801280|11137725|FG001|NOT COMPLETED|Period 2||0
10014709|NCT01801280|11137726|FG002|NOT COMPLETED|Period 2||0
10014710|NCT01801280|11137727|FG003|NOT COMPLETED|Period 2||0
10014711|NCT01801280|11137724|FG000|STARTED|Period 3||4
10014712|NCT01801280|11137725|FG001|STARTED|Period 3||4
10014713|NCT01801280|11137726|FG002|STARTED|Period 3||5
10014714|NCT01801280|11137727|FG003|STARTED|Period 3||5
10014715|NCT01801280|11137724|FG000|COMPLETED|Period 3||4
10014716|NCT01801280|11137725|FG001|COMPLETED|Period 3||4
10014717|NCT01801280|11137726|FG002|COMPLETED|Period 3||5
10014718|NCT01801280|11137727|FG003|COMPLETED|Period 3||5
10014719|NCT01801280|11137724|FG000|NOT COMPLETED|Period 3||0
10014720|NCT01801280|11137725|FG001|NOT COMPLETED|Period 3||0
10014721|NCT01801280|11137726|FG002|NOT COMPLETED|Period 3||0
10014722|NCT01801280|11137727|FG003|NOT COMPLETED|Period 3||0
10014723|NCT01801280|11137724|FG000|STARTED|Period 4||4
10014724|NCT01801280|11137725|FG001|STARTED|Period 4||4
10014725|NCT01801280|11137726|FG002|STARTED|Period 4||5
10014726|NCT01801280|11137727|FG003|STARTED|Period 4||5
10014727|NCT01801280|11137724|FG000|COMPLETED|Period 4||4
10014728|NCT01801280|11137725|FG001|COMPLETED|Period 4||4
10014729|NCT01801280|11137726|FG002|COMPLETED|Period 4||4
10014730|NCT01801280|11137727|FG003|COMPLETED|Period 4||5
10014731|NCT01801280|11137724|FG000|NOT COMPLETED|Period 4||0
10014732|NCT01801280|11137725|FG001|NOT COMPLETED|Period 4||0
10014733|NCT01801280|11137726|FG002|NOT COMPLETED|Period 4||1
10014734|NCT01801280|11137727|FG003|NOT COMPLETED|Period 4||0
10014735|NCT01801358|11137743|FG000|STARTED|Overall Study||6
10014736|NCT01801358|11137744|FG001|STARTED|Overall Study||6
10014737|NCT01801358|11137745|FG002|STARTED|Overall Study||6
10014738|NCT01801358|11137746|FG003|STARTED|Overall Study||6
10014739|NCT01801358|11137747|FG004|STARTED|Overall Study||6
10014740|NCT01801358|11137748|FG005|STARTED|Overall Study||8
10014741|NCT01801358|11137743|FG000|COMPLETED|Overall Study||0
10014742|NCT01801358|11137744|FG001|COMPLETED|Overall Study||0
10014743|NCT01801358|11137745|FG002|COMPLETED|Overall Study||0
10014744|NCT01801358|11137746|FG003|COMPLETED|Overall Study||0
10014745|NCT01801358|11137747|FG004|COMPLETED|Overall Study||0
10014746|NCT01801358|11137748|FG005|COMPLETED|Overall Study||0
10014747|NCT01801358|11137743|FG000|NOT COMPLETED|Overall Study||6
10014748|NCT01801358|11137744|FG001|NOT COMPLETED|Overall Study||6
10014749|NCT01801358|11137745|FG002|NOT COMPLETED|Overall Study||6
10014750|NCT01801358|11137746|FG003|NOT COMPLETED|Overall Study||6
10014751|NCT01801358|11137747|FG004|NOT COMPLETED|Overall Study||6
10014752|NCT01801358|11137748|FG005|NOT COMPLETED|Overall Study||8
10014753|NCT01801436|11137783|FG000|STARTED|Overall Study||14
10014754|NCT01801436|11137783|FG000|COMPLETED|Overall Study||5
10014755|NCT01801436|11137783|FG000|NOT COMPLETED|Overall Study||9
10014756|NCT01801449|11137787|FG000|STARTED|Overall Study||6
10014757|NCT01801449|11137787|FG000|COMPLETED|Overall Study||6
10014758|NCT01801449|11137787|FG000|NOT COMPLETED|Overall Study||0
10014759|NCT01801475|11137795|FG000|STARTED|Overall Study||10
10014760|NCT01801475|11137796|FG001|STARTED|Overall Study||30
10014761|NCT01801475|11137797|FG002|STARTED|Overall Study||10
10014762|NCT01801475|11137798|FG003|STARTED|Overall Study||10
10014763|NCT01801475|11137799|FG004|STARTED|Overall Study||40
10014764|NCT01801475|11137795|FG000|COMPLETED|Overall Study||10
10014765|NCT01801475|11137796|FG001|COMPLETED|Overall Study||30
10014766|NCT01801475|11137797|FG002|COMPLETED|Overall Study||10
10014767|NCT01801475|11137798|FG003|COMPLETED|Overall Study||10
10014768|NCT01801475|11137799|FG004|COMPLETED|Overall Study||39
10014769|NCT01801475|11137795|FG000|NOT COMPLETED|Overall Study||0
9780432|NCT00498433|10887010|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
9780433|NCT00498433|10887008|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
9780434|NCT00498433|10887009|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
9780435|NCT00498433|10887010|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
9780436|NCT00498433|10887008|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0
9780437|NCT00498433|10887009|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8
9780438|NCT00498433|10887010|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8
9780439|NCT00498433|10887008|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0
9780440|NCT00498433|10887009|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8
9780441|NCT00498433|10887010|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8
9780442|NCT00498433|10887008|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
9780443|NCT00498433|10887009|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
9780444|NCT00498433|10887010|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
9780445|NCT00498485|10887029|FG000|STARTED|Overall Study||7
9780446|NCT00498485|10887030|FG001|STARTED|Overall Study||10
9780447|NCT00498485|10887029|FG000|COMPLETED|Overall Study||6
9780448|NCT00498485|10887030|FG001|COMPLETED|Overall Study||5
9780449|NCT00498485|10887029|FG000|NOT COMPLETED|Overall Study||1
9780450|NCT00498485|10887030|FG001|NOT COMPLETED|Overall Study||5
9780451|NCT00498550|10887040|FG000|STARTED|Overall Study||15
9780452|NCT00498550|10887041|FG001|STARTED|Overall Study||16
9780453|NCT00498550|10887040|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
9780454|NCT00498550|10887041|FG001|COMPLETED|Overall Study||15
9780455|NCT00498550|10887040|FG000|NOT COMPLETED|Overall Study||0
9780456|NCT00498550|10887041|FG001|NOT COMPLETED|Overall Study||1
9780457|NCT00498602|10887054|FG000|STARTED|Overall Study||36
9780458|NCT00498602|10887055|FG001|STARTED|Overall Study||61
9780459|NCT00498602|10887056|FG002|STARTED|Overall Study||40
9780460|NCT00498602|10887057|FG003|STARTED|Overall Study||35
9780461|NCT00498602|10887058|FG004|STARTED|Overall Study||12
9780462|NCT00498602|10887059|FG005|STARTED|Overall Study||44
9780463|NCT00498602|10887060|FG006|STARTED|Overall Study||17
9780464|NCT00498602|10887054|FG000|Treated|Overall Study||36
9780465|NCT00498602|10887055|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
9780466|NCT00498602|10887056|FG002|Treated|Overall Study||40
9780467|NCT00498602|10887057|FG003|Treated|Overall Study||35
9780468|NCT00498602|10887058|FG004|Treated|Overall Study||12
9780469|NCT00498602|10887059|FG005|Treated|Overall Study||44
9780470|NCT00498602|10887060|FG006|Treated|Overall Study||17
9780471|NCT00498602|10887054|FG000|COMPLETED|Overall Study||26
9780472|NCT00498602|10887055|FG001|COMPLETED|Overall Study||51
9780473|NCT00498602|10887056|FG002|COMPLETED|Overall Study||32
9780474|NCT00498602|10887057|FG003|COMPLETED|Overall Study||30
9780475|NCT00498602|10887058|FG004|COMPLETED|Overall Study||8
9780476|NCT00498602|10887059|FG005|COMPLETED|Overall Study||31
9780477|NCT00498602|10887060|FG006|COMPLETED|Overall Study||15
9780478|NCT00498602|10887054|FG000|NOT COMPLETED|Overall Study||10
9780479|NCT00498602|10887055|FG001|NOT COMPLETED|Overall Study||10
9780480|NCT00498602|10887056|FG002|NOT COMPLETED|Overall Study||8
9780481|NCT00498602|10887057|FG003|NOT COMPLETED|Overall Study||5
9780482|NCT00498602|10887058|FG004|NOT COMPLETED|Overall Study||4
9780483|NCT00498602|10887059|FG005|NOT COMPLETED|Overall Study||13
9780484|NCT00498602|10887060|FG006|NOT COMPLETED|Overall Study||2
9780485|NCT00498615|10887076|FG000|STARTED|Fasudil 80mg||2
9780486|NCT00498615|10887077|FG001|STARTED|Fasudil 80mg||4
9780487|NCT00498615|10887078|FG002|STARTED|Fasudil 80mg||3
9780488|NCT00498615|10887079|FG003|STARTED|Fasudil 80mg||2
9780489|NCT00498615|10887080|FG004|STARTED|Fasudil 80mg||3
9780490|NCT00498615|10887081|FG005|STARTED|Fasudil 80mg||3
9780491|NCT00498615|10887076|FG000|COMPLETED|Fasudil 80mg||2
9780492|NCT00498615|10887077|FG001|COMPLETED|Fasudil 80mg||4
10014770|NCT01801475|11137796|FG001|NOT COMPLETED|Overall Study||0
10014771|NCT01801475|11137797|FG002|NOT COMPLETED|Overall Study||0
9780493|NCT00498615|10887078|FG002|COMPLETED|Fasudil 80mg||3
10014772|NCT01801475|11137798|FG003|NOT COMPLETED|Overall Study||0
10014773|NCT01801475|11137799|FG004|NOT COMPLETED|Overall Study||1
10014774|NCT01801735|11137808|FG000|STARTED|Overall Study||600
9780494|NCT00498615|10887079|FG003|COMPLETED|Fasudil 80mg||2
9780495|NCT00498615|10887080|FG004|COMPLETED|Fasudil 80mg||3
9780496|NCT00498615|10887081|FG005|COMPLETED|Fasudil 80mg||3
9780497|NCT00498615|10887076|FG000|NOT COMPLETED|Fasudil 80mg||0
9780498|NCT00498615|10887077|FG001|NOT COMPLETED|Fasudil 80mg||0
9780499|NCT00498615|10887078|FG002|NOT COMPLETED|Fasudil 80mg||0
9780500|NCT00498615|10887079|FG003|NOT COMPLETED|Fasudil 80mg||0
9780501|NCT00498615|10887080|FG004|NOT COMPLETED|Fasudil 80mg||0
9780502|NCT00498615|10887081|FG005|NOT COMPLETED|Fasudil 80mg||0
9780503|NCT00498615|10887076|FG000|STARTED|Fasudil 40mg||2
9780504|NCT00498615|10887077|FG001|STARTED|Fasudil 40mg||4
9780505|NCT00498615|10887078|FG002|STARTED|Fasudil 40mg||3
9780506|NCT00498615|10887079|FG003|STARTED|Fasudil 40mg||2
9780507|NCT00498615|10887080|FG004|STARTED|Fasudil 40mg||3
9780508|NCT00498615|10887081|FG005|STARTED|Fasudil 40mg||3
9780509|NCT00498615|10887076|FG000|COMPLETED|Fasudil 40mg||2
9780510|NCT00498615|10887077|FG001|COMPLETED|Fasudil 40mg||4
9780511|NCT00498615|10887078|FG002|COMPLETED|Fasudil 40mg||3
9780512|NCT00498615|10887079|FG003|COMPLETED|Fasudil 40mg||2
9780513|NCT00498615|10887080|FG004|COMPLETED|Fasudil 40mg||3
9780514|NCT00498615|10887081|FG005|COMPLETED|Fasudil 40mg||3
9780515|NCT00498615|10887076|FG000|NOT COMPLETED|Fasudil 40mg||0
9780516|NCT00498615|10887077|FG001|NOT COMPLETED|Fasudil 40mg||0
9780517|NCT00498615|10887078|FG002|NOT COMPLETED|Fasudil 40mg||0
9780518|NCT00498615|10887079|FG003|NOT COMPLETED|Fasudil 40mg||0
9780519|NCT00498615|10887080|FG004|NOT COMPLETED|Fasudil 40mg||0
9780520|NCT00498615|10887081|FG005|NOT COMPLETED|Fasudil 40mg||0
9780521|NCT00498615|10887076|FG000|STARTED|Placebo||2
9780522|NCT00498615|10887077|FG001|STARTED|Placebo||4
9780523|NCT00498615|10887078|FG002|STARTED|Placebo||3
9780524|NCT00498615|10887079|FG003|STARTED|Placebo||2
9780525|NCT00498615|10887080|FG004|STARTED|Placebo||3
9780526|NCT00498615|10887081|FG005|STARTED|Placebo||3
9780527|NCT00498615|10887076|FG000|COMPLETED|Placebo||2
9780528|NCT00498615|10887077|FG001|COMPLETED|Placebo||4
9780529|NCT00498615|10887078|FG002|COMPLETED|Placebo||3
9780530|NCT00498615|10887079|FG003|COMPLETED|Placebo||2
9780531|NCT00498615|10887080|FG004|COMPLETED|Placebo||3
9780532|NCT00498615|10887081|FG005|COMPLETED|Placebo||3
9780533|NCT00498615|10887076|FG000|NOT COMPLETED|Placebo||0
9780534|NCT00498615|10887077|FG001|NOT COMPLETED|Placebo||0
9780535|NCT00498615|10887078|FG002|NOT COMPLETED|Placebo||0
9780536|NCT00498615|10887079|FG003|NOT COMPLETED|Placebo||0
9780537|NCT00498615|10887080|FG004|NOT COMPLETED|Placebo||0
9780538|NCT00498615|10887081|FG005|NOT COMPLETED|Placebo||0
9780539|NCT00498628|10887097|FG000|STARTED|Overall Study||105
9780540|NCT00498628|10887098|FG001|STARTED|Overall Study||113
9780541|NCT00498628|10887097|FG000|COMPLETED|Overall Study||90
9780542|NCT00498628|10887098|FG001|COMPLETED|Overall Study||92
9780543|NCT00498628|10887097|FG000|NOT COMPLETED|Overall Study||15
9780544|NCT00498628|10887098|FG001|NOT COMPLETED|Overall Study||21
9780545|NCT00498706|10887108|FG000|STARTED|Overall Study||163
9780546|NCT00498706|10887109|FG001|STARTED|Overall Study||162
9780547|NCT00498706|10887108|FG000|Post Treatment Week 18|Overall Study||163
9780548|NCT00498706|10887109|FG001|Post Treatment Week 18|Overall Study||162
9780549|NCT00498706|10887108|FG000|COMPLETED|Overall Study||163
9780550|NCT00498706|10887109|FG001|COMPLETED|Overall Study||162
9780551|NCT00498706|10887108|FG000|NOT COMPLETED|Overall Study||0
9780552|NCT00498706|10887109|FG001|NOT COMPLETED|Overall Study||0
9780553|NCT00498797|10887119|FG000|STARTED|Overall Study|randomised patients|43
9780554|NCT00498797|10887120|FG001|STARTED|Overall Study|randomised patients|43
9780555|NCT00498797|10887119|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
9780556|NCT00498797|10887120|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
9780557|NCT00498797|10887119|FG000|NOT COMPLETED|Overall Study||38
9780558|NCT00498797|10887120|FG001|NOT COMPLETED|Overall Study||29
9780559|NCT00498927|10887126|FG000|STARTED|Overall Study||47
9780560|NCT00498927|10887126|FG000|COMPLETED|Overall Study||47
9780561|NCT00498927|10887126|FG000|NOT COMPLETED|Overall Study||0
9780562|NCT00498940|10887132|FG000|STARTED|Overall Study||30
9780563|NCT00498940|10887133|FG001|STARTED|Overall Study||31
9780564|NCT00498940|10887132|FG000|COMPLETED|Overall Study||30
9780565|NCT00498940|10887133|FG001|COMPLETED|Overall Study||31
9780566|NCT00498940|10887132|FG000|NOT COMPLETED|Overall Study||0
9780567|NCT00498940|10887133|FG001|NOT COMPLETED|Overall Study||0
9780568|NCT00499031|10887139|FG000|STARTED|Overall Study|Total number participants enrolled on study|38
9780569|NCT00499031|10887139|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
9780570|NCT00499031|10887139|FG000|NOT COMPLETED|Overall Study||3
9780571|NCT00499083|10887143|FG000|STARTED|Overall Study||17
9780572|NCT00499083|10887143|FG000|Participants at UNMC|Overall Study||3
9780573|NCT00499083|10887143|FG000|Participants at Moffitt Cancer Center|Overall Study||14
9780574|NCT00499083|10887143|FG000|COMPLETED|Overall Study||14
9780575|NCT00499083|10887143|FG000|NOT COMPLETED|Overall Study||3
9780576|NCT00499096|10887149|FG000|STARTED|Overall Study||58
9780577|NCT00499096|10887150|FG001|STARTED|Overall Study||60
9780578|NCT00499096|10887149|FG000|COMPLETED|Overall Study||35
9780579|NCT00499096|10887150|FG001|COMPLETED|Overall Study||40
9780580|NCT00499096|10887149|FG000|NOT COMPLETED|Overall Study||23
9780581|NCT00499096|10887150|FG001|NOT COMPLETED|Overall Study||20
9780582|NCT00499109|10887160|FG000|STARTED|Overall Study||183
9780583|NCT00499109|10887161|FG001|STARTED|Overall Study||92
9780584|NCT00499109|10887160|FG000|COMPLETED|Overall Study||165
9780585|NCT00499109|10887161|FG001|COMPLETED|Overall Study||85
9780586|NCT00499109|10887160|FG000|NOT COMPLETED|Overall Study||18
9780587|NCT00499109|10887161|FG001|NOT COMPLETED|Overall Study||7
9780588|NCT00499122|10887170|FG000|STARTED|Overall Study||41
9780589|NCT00499122|10887170|FG000|COMPLETED|Overall Study||39
9780590|NCT00499122|10887170|FG000|NOT COMPLETED|Overall Study||2
9780591|NCT00499174|10887177|FG000|STARTED|Overall Study||78
9780592|NCT00499174|10887178|FG001|STARTED|Overall Study||102
9780593|NCT00499174|10887177|FG000|COMPLETED|Overall Study||0
10233965|NCT01605617|11363847|FG000|STARTED|Washout Period of 4 Weeks||2
10233966|NCT01605617|11363848|FG001|STARTED|Washout Period of 4 Weeks||1
10233967|NCT01605617|11363847|FG000|COMPLETED|Washout Period of 4 Weeks||0
10233968|NCT01605617|11363848|FG001|COMPLETED|Washout Period of 4 Weeks||0
9780594|NCT00499174|10887178|FG001|COMPLETED|Overall Study||93
9780595|NCT00499174|10887177|FG000|NOT COMPLETED|Overall Study||78
9780596|NCT00499174|10887178|FG001|NOT COMPLETED|Overall Study||9
9780597|NCT00499252|10887186|FG000|STARTED|Overall Study||51
9780598|NCT00499252|10887186|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
9780599|NCT00499252|10887186|FG000|NOT COMPLETED|Overall Study||12
9780600|NCT00499343|10887196|FG000|STARTED|Overall Study||41
9780601|NCT00499343|10887197|FG001|STARTED|Overall Study||43
9780602|NCT00499343|10887196|FG000|COMPLETED|Overall Study||41
9780603|NCT00499343|10887197|FG001|COMPLETED|Overall Study||43
10014775|NCT01801735|11137808|FG000|COMPLETED|Overall Study||390
10014776|NCT01801735|11137808|FG000|NOT COMPLETED|Overall Study||210
10014777|NCT01801865|11137812|FG000|STARTED|Overall Study||657
10233969|NCT01605617|11363847|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2
10233970|NCT01605617|11363848|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
9780604|NCT00499343|10887196|FG000|NOT COMPLETED|Overall Study||0
9780605|NCT00499343|10887197|FG001|NOT COMPLETED|Overall Study||0
9780606|NCT00499369|10887208|FG000|STARTED|Overall Study||16
9780607|NCT00499369|10887209|FG001|STARTED|Overall Study||18
9780608|NCT00499369|10887210|FG002|STARTED|Overall Study||17
9780609|NCT00499369|10887211|FG003|STARTED|Overall Study||9
9780610|NCT00499369|10887212|FG004|STARTED|Overall Study||12
9780611|NCT00499369|10887208|FG000|Eligible|Overall Study||14
9780612|NCT00499369|10887209|FG001|Eligible|Overall Study||16
9780613|NCT00499369|10887210|FG002|Eligible|Overall Study||16
9780614|NCT00499369|10887211|FG003|Eligible|Overall Study||8
9780615|NCT00499369|10887212|FG004|Eligible|Overall Study||12
9780616|NCT00499369|10887208|FG000|COMPLETED|Overall Study||0
9780617|NCT00499369|10887209|FG001|COMPLETED|Overall Study||0
9780618|NCT00499369|10887210|FG002|COMPLETED|Overall Study||0
9780619|NCT00499369|10887211|FG003|COMPLETED|Overall Study||0
9780620|NCT00499369|10887212|FG004|COMPLETED|Overall Study||0
9780621|NCT00499369|10887208|FG000|NOT COMPLETED|Overall Study||16
9780622|NCT00499369|10887209|FG001|NOT COMPLETED|Overall Study||18
9780623|NCT00499369|10887210|FG002|NOT COMPLETED|Overall Study||17
9780624|NCT00499369|10887211|FG003|NOT COMPLETED|Overall Study||9
9780625|NCT00499369|10887212|FG004|NOT COMPLETED|Overall Study||12
9780626|NCT00499408|10887224|FG000|STARTED|Overall Study||26
9780627|NCT00499408|10887224|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
9780628|NCT00499408|10887224|FG000|NOT COMPLETED|Overall Study||0
9780629|NCT00499447|10887228|FG000|STARTED|Overall Study||13
9780630|NCT00499447|10887228|FG000|COMPLETED|Overall Study||13
9780631|NCT00499447|10887228|FG000|NOT COMPLETED|Overall Study||0
9780632|NCT00499460|10887234|FG000|STARTED|Intervention 1 (30 Days)||8
9780633|NCT00499460|10887235|FG001|STARTED|Intervention 1 (30 Days)||7
9780634|NCT00499460|10887234|FG000|COMPLETED|Intervention 1 (30 Days)||6
9780635|NCT00499460|10887235|FG001|COMPLETED|Intervention 1 (30 Days)||7
9780636|NCT00499460|10887234|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2
9780637|NCT00499460|10887235|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0
9780638|NCT00499460|10887234|FG000|STARTED|Intervention 2 (30 Days)||6
9780639|NCT00499460|10887235|FG001|STARTED|Intervention 2 (30 Days)||7
9780640|NCT00499460|10887234|FG000|COMPLETED|Intervention 2 (30 Days)||6
9780641|NCT00499460|10887235|FG001|COMPLETED|Intervention 2 (30 Days)||6
9780642|NCT00499460|10887234|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0
9780643|NCT00499460|10887235|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1
9780644|NCT00499473|10887253|FG000|STARTED|Overall Study||27
9780645|NCT00499473|10887254|FG001|STARTED|Overall Study||4
9780646|NCT00499473|10887253|FG000|COMPLETED|Overall Study|Patients evaluable|21
9780647|NCT00499473|10887254|FG001|COMPLETED|Overall Study||4
9780648|NCT00499473|10887253|FG000|NOT COMPLETED|Overall Study||6
9780649|NCT00499473|10887254|FG001|NOT COMPLETED|Overall Study||0
9780650|NCT00499486|10887260|FG000|STARTED|Overall Study||47
9780651|NCT00499486|10887260|FG000|COMPLETED|Overall Study||31
9780652|NCT00499486|10887260|FG000|NOT COMPLETED|Overall Study||16
9780653|NCT00499603|10887266|FG000|STARTED|Overall Study||27
10233971|NCT01605617|11363847|FG000|STARTED|Second Intervention||0
9780654|NCT00499603|10887267|FG001|STARTED|Overall Study||23
9780655|NCT00499603|10887266|FG000|COMPLETED|Overall Study||27
9780656|NCT00499603|10887267|FG001|COMPLETED|Overall Study||22
9780657|NCT00499603|10887266|FG000|NOT COMPLETED|Overall Study||0
9780658|NCT00499603|10887267|FG001|NOT COMPLETED|Overall Study||1
10014778|NCT01801865|11137812|FG000|COMPLETED|Overall Study||615
10014779|NCT01801865|11137812|FG000|NOT COMPLETED|Overall Study||42
9780659|NCT00499616|10887279|FG000|STARTED|Overall Study||176
9780660|NCT00499616|10887280|FG001|STARTED|Overall Study||142
9780661|NCT00499616|10887281|FG002|STARTED|Overall Study||89
9780662|NCT00499616|10887282|FG003|STARTED|Overall Study||57
9780663|NCT00499616|10887279|FG000|COMPLETED|Overall Study||161
9780664|NCT00499616|10887280|FG001|COMPLETED|Overall Study||114
9780665|NCT00499616|10887281|FG002|COMPLETED|Overall Study||53
9780666|NCT00499616|10887282|FG003|COMPLETED|Overall Study||0
9780667|NCT00499616|10887279|FG000|NOT COMPLETED|Overall Study||15
9780668|NCT00499616|10887280|FG001|NOT COMPLETED|Overall Study||28
9780669|NCT00499616|10887281|FG002|NOT COMPLETED|Overall Study||36
9780670|NCT00499616|10887282|FG003|NOT COMPLETED|Overall Study||57
9780671|NCT00499655|10887297|FG000|STARTED|Overall Study||53
9780672|NCT00499655|10887298|FG001|STARTED|Overall Study||54
9780673|NCT00499655|10887297|FG000|COMPLETED|Overall Study||53
9780674|NCT00499655|10887298|FG001|COMPLETED|Overall Study||54
9780675|NCT00499655|10887297|FG000|NOT COMPLETED|Overall Study||0
9780676|NCT00499655|10887298|FG001|NOT COMPLETED|Overall Study||0
9780677|NCT00499681|10887307|FG000|STARTED|Overall Study||4
9780678|NCT00499681|10887308|FG001|STARTED|Overall Study||2
9780679|NCT00499681|10887307|FG000|COMPLETED|Overall Study||4
9780680|NCT00499681|10887308|FG001|COMPLETED|Overall Study||0
9780681|NCT00499681|10887307|FG000|NOT COMPLETED|Overall Study||0
9780682|NCT00499681|10887308|FG001|NOT COMPLETED|Overall Study||2
9780683|NCT00499694|10887314|FG000|STARTED|Overall Study||31
9780684|NCT00499694|10887314|FG000|COMPLETED|Overall Study||30
9780685|NCT00499694|10887314|FG000|NOT COMPLETED|Overall Study||1
9780686|NCT00499746|10887319|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20
9780687|NCT00499746|10887319|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8
9780688|NCT00499746|10887319|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
9780689|NCT00499746|10887319|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8
9780690|NCT00499746|10887319|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
9780691|NCT00499746|10887319|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
9780692|NCT00499746|10887319|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8
9780693|NCT00499746|10887319|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
9780694|NCT00499746|10887319|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
9780695|NCT00499863|10887335|FG000|STARTED|Overall Study||145
9780696|NCT00499863|10887336|FG001|STARTED|Overall Study||72
9780697|NCT00499863|10887335|FG000|COMPLETED|Overall Study||95
9780698|NCT00499863|10887336|FG001|COMPLETED|Overall Study||29
9780699|NCT00499863|10887335|FG000|NOT COMPLETED|Overall Study||50
9780700|NCT00499863|10887336|FG001|NOT COMPLETED|Overall Study||43
9780701|NCT00499889|10887342|FG000|STARTED|Overall Study||42
9780702|NCT00499889|10887342|FG000|COMPLETED|Overall Study||41
9780703|NCT00499889|10887342|FG000|NOT COMPLETED|Overall Study||1
9780704|NCT00499915|10887348|FG000|STARTED|Overall Study||83
9780705|NCT00499915|10887349|FG001|STARTED|Overall Study||82
9780706|NCT00499915|10887348|FG000|COMPLETED|Overall Study||68
9780707|NCT00499915|10887349|FG001|COMPLETED|Overall Study||76
9780708|NCT00499915|10887348|FG000|NOT COMPLETED|Overall Study||15
9780709|NCT00499915|10887349|FG001|NOT COMPLETED|Overall Study||6
9780710|NCT00500110|10887355|FG000|STARTED|Overall Study||39
9780711|NCT00500110|10887355|FG000|COMPLETED|Overall Study||36
9780712|NCT00500110|10887355|FG000|NOT COMPLETED|Overall Study||3
9780713|NCT00500149|10887359|FG000|STARTED|Enrolled (Dose-optimization Phase)||129
9780714|NCT00500149|10887360|FG001|STARTED|Enrolled (Dose-optimization Phase)||0
9780715|NCT00500149|10887359|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117
9780716|NCT00500149|10887360|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0
9780717|NCT00500149|10887359|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
9780718|NCT00500149|10887360|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
9780719|NCT00500149|10887359|FG000|STARTED|First Intervention (Cross-over Phase)||58
9780720|NCT00500149|10887360|FG001|STARTED|First Intervention (Cross-over Phase)||59
9780721|NCT00500149|10887359|FG000|COMPLETED|First Intervention (Cross-over Phase)||56
9780722|NCT00500149|10887360|FG001|COMPLETED|First Intervention (Cross-over Phase)||57
9780723|NCT00500149|10887359|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2
9780724|NCT00500149|10887360|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2
9780725|NCT00500149|10887359|FG000|STARTED|Second Intervention (Cross-over Phase)||56
9780726|NCT00500149|10887360|FG001|STARTED|Second Intervention (Cross-over Phase)||57
9780727|NCT00500149|10887359|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54
9780728|NCT00500149|10887360|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57
9780729|NCT00500149|10887359|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
9780730|NCT00500149|10887360|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
9780731|NCT00500240|10887368|FG000|STARTED|Overall Study||25
9780732|NCT00500240|10887369|FG001|STARTED|Overall Study||26
9780733|NCT00500240|10887368|FG000|COMPLETED|Overall Study||25
9780734|NCT00500240|10887369|FG001|COMPLETED|Overall Study||26
9780735|NCT00500240|10887368|FG000|NOT COMPLETED|Overall Study||0
9780736|NCT00500240|10887369|FG001|NOT COMPLETED|Overall Study||0
9780737|NCT00500266|10887377|FG000|STARTED|Overall Study||1053
9780738|NCT00500266|10887377|FG000|Treated|Overall Study||1049
9780739|NCT00500266|10887377|FG000|COMPLETED|Overall Study||1040
9780740|NCT00500266|10887377|FG000|NOT COMPLETED|Overall Study||13
9780741|NCT00500292|10887385|FG000|STARTED|Overall Study|randomised patients|32
9780742|NCT00500292|10887386|FG001|STARTED|Overall Study|randomised patients|35
9780743|NCT00500292|10887387|FG002|STARTED|Overall Study|randomised patients|37
9780744|NCT00500292|10887385|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
9780745|NCT00500292|10887386|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
9780746|NCT00500292|10887387|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
10014780|NCT01801917|11137820|FG000|STARTED|Period 1 - Randomized||7
10014781|NCT01801917|11137821|FG001|STARTED|Period 1 - Randomized||2
9780747|NCT00500292|10887385|FG000|NOT COMPLETED|Overall Study||25
9780748|NCT00500292|10887386|FG001|NOT COMPLETED|Overall Study||31
9780749|NCT00500292|10887387|FG002|NOT COMPLETED|Overall Study||27
9780750|NCT00500318|10887397|FG000|STARTED|Overall Study||86
9780751|NCT00500318|10887398|FG001|STARTED|Overall Study||95
9780752|NCT00500318|10887397|FG000|COMPLETED|Overall Study||81
9780753|NCT00500318|10887398|FG001|COMPLETED|Overall Study||78
9780754|NCT00500318|10887397|FG000|NOT COMPLETED|Overall Study||5
9780755|NCT00500318|10887398|FG001|NOT COMPLETED|Overall Study||17
9780756|NCT00500331|10887411|FG000|STARTED|Overall Study||48
9780757|NCT00500331|10887412|FG001|STARTED|Overall Study||47
9780758|NCT00500331|10887413|FG002|STARTED|Overall Study||48
9780759|NCT00500331|10887414|FG003|STARTED|Overall Study||48
9780760|NCT00500331|10887415|FG004|STARTED|Overall Study||48
9780761|NCT00500331|10887416|FG005|STARTED|Overall Study||47
9780762|NCT00500331|10887417|FG006|STARTED|Overall Study||48
9780763|NCT00500331|10887411|FG000|COMPLETED|Overall Study||33
9780764|NCT00500331|10887412|FG001|COMPLETED|Overall Study||42
9780765|NCT00500331|10887413|FG002|COMPLETED|Overall Study||43
9780766|NCT00500331|10887414|FG003|COMPLETED|Overall Study||38
9780767|NCT00500331|10887415|FG004|COMPLETED|Overall Study||44
9780768|NCT00500331|10887416|FG005|COMPLETED|Overall Study||42
9780769|NCT00500331|10887417|FG006|COMPLETED|Overall Study||46
9780770|NCT00500331|10887411|FG000|NOT COMPLETED|Overall Study||15
9780771|NCT00500331|10887412|FG001|NOT COMPLETED|Overall Study||5
9780772|NCT00500331|10887413|FG002|NOT COMPLETED|Overall Study||5
9780773|NCT00500331|10887414|FG003|NOT COMPLETED|Overall Study||10
9780774|NCT00500331|10887415|FG004|NOT COMPLETED|Overall Study||4
9780775|NCT00500331|10887416|FG005|NOT COMPLETED|Overall Study||5
9780776|NCT00500331|10887417|FG006|NOT COMPLETED|Overall Study||2
9780777|NCT00500357|10887434|FG000|STARTED|Overall Study||105
9780778|NCT00500357|10887434|FG000|Received 13vPnC (Vax 3)|Overall Study||105
9780779|NCT00500357|10887434|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
9780780|NCT00500357|10887434|FG000|COMPLETED|Overall Study||104
9780781|NCT00500357|10887434|FG000|NOT COMPLETED|Overall Study||1
9780782|NCT00500370|10887451|FG000|STARTED|Overall Study||80
9780783|NCT00500370|10887452|FG001|STARTED|Overall Study||83
9780784|NCT00500370|10887451|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73
9780785|NCT00500370|10887452|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79
9780786|NCT00500370|10887451|FG000|Treatment Complete (Week 24)|Overall Study||48
9780787|NCT00500370|10887452|FG001|Treatment Complete (Week 24)|Overall Study||54
9780788|NCT00500370|10887451|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
9780789|NCT00500370|10887452|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
9780790|NCT00500370|10887451|FG000|NOT COMPLETED|Overall Study||33
9780791|NCT00500370|10887452|FG001|NOT COMPLETED|Overall Study||34
9780792|NCT00500448|10887460|FG000|STARTED|Overall Study||14
9780793|NCT00500448|10887461|FG001|STARTED|Overall Study||16
9780794|NCT00500448|10887460|FG000|COMPLETED|Overall Study||14
9780795|NCT00500448|10887461|FG001|COMPLETED|Overall Study||16
9780796|NCT00500448|10887460|FG000|NOT COMPLETED|Overall Study||0
9780797|NCT00500448|10887461|FG001|NOT COMPLETED|Overall Study||0
9780798|NCT00500539|10887467|FG000|STARTED|Treatment Period (24 Weeks)||155
9780799|NCT00500539|10887467|FG000|COMPLETED|Treatment Period (24 Weeks)||140
9780800|NCT00500539|10887467|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15
9780801|NCT00500539|10887467|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
9780802|NCT00500539|10887467|FG000|COMPLETED|Follow-up Period (16 Weeks)||136
9780803|NCT00500539|10887467|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12
9780804|NCT00500578|10887476|FG000|STARTED|Overall Study||18
9780805|NCT00500578|10887477|FG001|STARTED|Overall Study||32
9780806|NCT00500578|10887476|FG000|COMPLETED|Overall Study|All completed|18
9780807|NCT00500578|10887477|FG001|COMPLETED|Overall Study|All completed|32
9780808|NCT00500578|10887476|FG000|NOT COMPLETED|Overall Study||0
9780809|NCT00500578|10887477|FG001|NOT COMPLETED|Overall Study||0
9780810|NCT00500656|10887487|FG000|STARTED|Controlled Phase||36
9780811|NCT00500656|10887488|FG001|STARTED|Controlled Phase||38
9780812|NCT00500656|10887489|FG002|STARTED|Controlled Phase||3
9780813|NCT00500656|10887490|FG003|STARTED|Controlled Phase||8
9780814|NCT00500656|10887487|FG000|COMPLETED|Controlled Phase||26
9780815|NCT00500656|10887488|FG001|COMPLETED|Controlled Phase||28
9780816|NCT00500656|10887489|FG002|COMPLETED|Controlled Phase||2
9780817|NCT00500656|10887490|FG003|COMPLETED|Controlled Phase||0
9780818|NCT00500656|10887487|FG000|NOT COMPLETED|Controlled Phase||10
9780819|NCT00500656|10887488|FG001|NOT COMPLETED|Controlled Phase||10
9780820|NCT00500656|10887489|FG002|NOT COMPLETED|Controlled Phase||1
9780821|NCT00500656|10887490|FG003|NOT COMPLETED|Controlled Phase||8
9780822|NCT00500656|10887487|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
9780823|NCT00500656|10887488|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
9780824|NCT00500656|10887489|FG002|STARTED|Open Label Extension (OLE) Phase||2
9780825|NCT00500656|10887490|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
10014782|NCT01801917|11137822|FG002|STARTED|Period 1 - Randomized||4
9780826|NCT00500656|10887487|FG000|COMPLETED|Open Label Extension (OLE) Phase||16
9780827|NCT00500656|10887488|FG001|COMPLETED|Open Label Extension (OLE) Phase||9
9780828|NCT00500656|10887489|FG002|COMPLETED|Open Label Extension (OLE) Phase||1
9780829|NCT00500656|10887490|FG003|COMPLETED|Open Label Extension (OLE) Phase||6
9780830|NCT00500656|10887487|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7
9780831|NCT00500656|10887488|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12
9780832|NCT00500656|10887489|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1
9780833|NCT00500656|10887490|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2
9780834|NCT00500760|10887502|FG000|STARTED|Overall Study||89
9780835|NCT00500760|10887503|FG001|STARTED|Overall Study||64
9780836|NCT00500760|10887502|FG000|Received Treatment|Overall Study||87
9780837|NCT00500760|10887503|FG001|Received Treatment|Overall Study||63
9780838|NCT00500760|10887502|FG000|COMPLETED|Overall Study||46
9780839|NCT00500760|10887503|FG001|COMPLETED|Overall Study||40
9780840|NCT00500760|10887502|FG000|NOT COMPLETED|Overall Study||43
9780841|NCT00500760|10887503|FG001|NOT COMPLETED|Overall Study||24
9780842|NCT00500903|10887512|FG000|STARTED|Overall Study||65
9780843|NCT00500903|10887513|FG001|STARTED|Overall Study||2
9780844|NCT00500903|10887514|FG002|STARTED|Overall Study||20
9780845|NCT00500903|10887512|FG000|COMPLETED|Overall Study||0
9780846|NCT00500903|10887513|FG001|COMPLETED|Overall Study||0
9780847|NCT00500903|10887514|FG002|COMPLETED|Overall Study||0
9780848|NCT00500903|10887512|FG000|NOT COMPLETED|Overall Study||65
9780849|NCT00500903|10887513|FG001|NOT COMPLETED|Overall Study||2
9780850|NCT00500903|10887514|FG002|NOT COMPLETED|Overall Study||20
9780851|NCT00501007|10887552|FG000|STARTED|Overall Study||100
9780852|NCT00501007|10887553|FG001|STARTED|Overall Study||103
9780853|NCT00501007|10887552|FG000|COMPLETED|Overall Study||71
9780854|NCT00501007|10887553|FG001|COMPLETED|Overall Study||78
9780855|NCT00501007|10887552|FG000|NOT COMPLETED|Overall Study||29
9780856|NCT00501007|10887553|FG001|NOT COMPLETED|Overall Study||25
9780857|NCT00501059|10887561|FG000|STARTED|Overall Study||6270
9780858|NCT00501059|10887562|FG001|STARTED|Overall Study||6276
9780859|NCT00501059|10887561|FG000|COMPLETED|Overall Study||4402
9780860|NCT00501059|10887562|FG001|COMPLETED|Overall Study||4384
9780861|NCT00501059|10887561|FG000|NOT COMPLETED|Overall Study||1868
9780862|NCT00501059|10887562|FG001|NOT COMPLETED|Overall Study||1892
9830184|NCT00762411|10940893|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
9830185|NCT00762411|10940892|FG000|COMPLETED|Initial Treatment||22
9830186|NCT00762411|10940893|FG001|COMPLETED|Initial Treatment||34
9830187|NCT00762411|10940892|FG000|NOT COMPLETED|Initial Treatment||534
9830188|NCT00762411|10940893|FG001|NOT COMPLETED|Initial Treatment||521
9830189|NCT00762411|10940892|FG000|STARTED|Delayed Start||22
9830190|NCT00762411|10940893|FG001|STARTED|Delayed Start||34
9830191|NCT00762411|10940892|FG000|COMPLETED|Delayed Start||5
9830192|NCT00762411|10940893|FG001|COMPLETED|Delayed Start||8
9830193|NCT00762411|10940892|FG000|NOT COMPLETED|Delayed Start||17
9830194|NCT00762411|10940893|FG001|NOT COMPLETED|Delayed Start||26
9830195|NCT00762411|10940892|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
9830196|NCT00762411|10940893|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
9830197|NCT00762411|10940892|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228
9830198|NCT00762411|10940893|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312
9830199|NCT00762411|10940892|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
9830200|NCT00762411|10940893|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
9830201|NCT00762424|10940905|FG000|STARTED|Overall Study||28
9830202|NCT00762424|10940906|FG001|STARTED|Overall Study||25
9830203|NCT00762424|10940905|FG000|COMPLETED|Overall Study||28
9830204|NCT00762424|10940906|FG001|COMPLETED|Overall Study||25
9830205|NCT00762424|10940905|FG000|NOT COMPLETED|Overall Study||0
9830206|NCT00762424|10940906|FG001|NOT COMPLETED|Overall Study||0
9830207|NCT00762450|10940915|FG000|STARTED|1st Treatment Period||2
9830208|NCT00762450|10940916|FG001|STARTED|1st Treatment Period||2
9830209|NCT00762450|10940917|FG002|STARTED|1st Treatment Period||2
9830210|NCT00762450|10940915|FG000|COMPLETED|1st Treatment Period||2
9830211|NCT00762450|10940916|FG001|COMPLETED|1st Treatment Period||2
9830212|NCT00762450|10940917|FG002|COMPLETED|1st Treatment Period||2
9830213|NCT00762450|10940915|FG000|NOT COMPLETED|1st Treatment Period||0
9830214|NCT00762450|10940916|FG001|NOT COMPLETED|1st Treatment Period||0
9830215|NCT00762450|10940917|FG002|NOT COMPLETED|1st Treatment Period||0
9830216|NCT00762450|10940915|FG000|STARTED|Washout After 1st Treatment Period||2
9830217|NCT00762450|10940916|FG001|STARTED|Washout After 1st Treatment Period||2
9830218|NCT00762450|10940917|FG002|STARTED|Washout After 1st Treatment Period||2
9830219|NCT00762450|10940915|FG000|COMPLETED|Washout After 1st Treatment Period||2
9830220|NCT00762450|10940916|FG001|COMPLETED|Washout After 1st Treatment Period||2
9830221|NCT00762450|10940917|FG002|COMPLETED|Washout After 1st Treatment Period||2
9830222|NCT00762450|10940915|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0
9830223|NCT00762450|10940916|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0
9830224|NCT00762450|10940917|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0
9830225|NCT00762450|10940915|FG000|STARTED|2nd Treatment Period||2
9830226|NCT00762450|10940916|FG001|STARTED|2nd Treatment Period||2
9830227|NCT00762450|10940917|FG002|STARTED|2nd Treatment Period||2
9830228|NCT00762450|10940915|FG000|COMPLETED|2nd Treatment Period||2
9830229|NCT00762450|10940916|FG001|COMPLETED|2nd Treatment Period||2
9780863|NCT00501085|10887570|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
9780864|NCT00501085|10887570|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
9780865|NCT00501085|10887570|FG000|NOT COMPLETED|Overall Study||432
9780866|NCT00501293|10887576|FG000|STARTED|Optimization Period||110
9780867|NCT00501293|10887577|FG001|STARTED|Optimization Period||53
9780868|NCT00501293|10887576|FG000|COMPLETED|Optimization Period||109
9780869|NCT00501293|10887577|FG001|COMPLETED|Optimization Period||53
9780870|NCT00501293|10887576|FG000|NOT COMPLETED|Optimization Period||1
9780871|NCT00501293|10887577|FG001|NOT COMPLETED|Optimization Period||0
9780872|NCT00501293|10887576|FG000|STARTED|Maintenance Period||109
9780873|NCT00501293|10887577|FG001|STARTED|Maintenance Period||53
9780874|NCT00501293|10887576|FG000|COMPLETED|Maintenance Period||63
9780875|NCT00501293|10887577|FG001|COMPLETED|Maintenance Period||25
9780876|NCT00501293|10887576|FG000|NOT COMPLETED|Maintenance Period||46
9780877|NCT00501293|10887577|FG001|NOT COMPLETED|Maintenance Period||28
9780878|NCT00501540|10887584|FG000|STARTED|Overall Study||15
9780879|NCT00501540|10887584|FG000|COMPLETED|Overall Study||10
9780880|NCT00501540|10887584|FG000|NOT COMPLETED|Overall Study||5
9780881|NCT00501592|10887591|FG000|STARTED|Overall Study||20
9780882|NCT00501592|10887592|FG001|STARTED|Overall Study||21
9780883|NCT00501592|10887593|FG002|STARTED|Overall Study||23
9780884|NCT00501592|10887591|FG000|COMPLETED|Overall Study||20
9780885|NCT00501592|10887592|FG001|COMPLETED|Overall Study||16
9780886|NCT00501592|10887593|FG002|COMPLETED|Overall Study||20
9780887|NCT00501592|10887591|FG000|NOT COMPLETED|Overall Study||0
9780888|NCT00501592|10887592|FG001|NOT COMPLETED|Overall Study||5
9780889|NCT00501592|10887593|FG002|NOT COMPLETED|Overall Study||3
9780890|NCT00501631|10887603|FG000|STARTED|Part A (Double-blind Period)||152
9780891|NCT00501631|10887604|FG001|STARTED|Part A (Double-blind Period)||148
9780892|NCT00501631|10887603|FG000|COMPLETED|Part A (Double-blind Period)||90
9780893|NCT00501631|10887604|FG001|COMPLETED|Part A (Double-blind Period)||99
9780894|NCT00501631|10887603|FG000|NOT COMPLETED|Part A (Double-blind Period)||62
9780895|NCT00501631|10887604|FG001|NOT COMPLETED|Part A (Double-blind Period)||49
9780896|NCT00501631|10887603|FG000|STARTED|Part B (Open-label Period)||90
9780897|NCT00501631|10887604|FG001|STARTED|Part B (Open-label Period)||99
9780898|NCT00501631|10887603|FG000|COMPLETED|Part B (Open-label Period)||37
9780899|NCT00501631|10887604|FG001|COMPLETED|Part B (Open-label Period)||48
9780900|NCT00501631|10887603|FG000|NOT COMPLETED|Part B (Open-label Period)||53
9780901|NCT00501631|10887604|FG001|NOT COMPLETED|Part B (Open-label Period)||51
9780902|NCT00501644|10887610|FG000|STARTED|Overall Study||59
9780903|NCT00501644|10887610|FG000|COMPLETED|Overall Study||54
9780904|NCT00501644|10887610|FG000|NOT COMPLETED|Overall Study||5
9780905|NCT00501852|10887614|FG000|STARTED|Overall Study||83
9780906|NCT00501852|10887614|FG000|NVA237 12.5µg|Overall Study||55
9780907|NCT00501852|10887614|FG000|NVA237 25µg|Overall Study||51
9780908|NCT00501852|10887614|FG000|NVA237 50µg|Overall Study||53
9780909|NCT00501852|10887614|FG000|NVA237 100µg|Overall Study||54
9780910|NCT00501852|10887614|FG000|Placebo|Overall Study||55
9780911|NCT00501852|10887614|FG000|Tiotropium|Overall Study||55
9780912|NCT00501852|10887614|FG000|COMPLETED|Overall Study||78
9780913|NCT00501852|10887614|FG000|NOT COMPLETED|Overall Study||5
9780914|NCT00501891|10887628|FG000|STARTED|Overall Study||32
9780915|NCT00501891|10887628|FG000|COMPLETED|Overall Study||32
9780916|NCT00501891|10887628|FG000|NOT COMPLETED|Overall Study||0
9780917|NCT00501943|10887635|FG000|STARTED|Overall Study||22
9780918|NCT00501943|10887636|FG001|STARTED|Overall Study||21
9780919|NCT00501943|10887635|FG000|COMPLETED|Overall Study||20
9780920|NCT00501943|10887636|FG001|COMPLETED|Overall Study||18
9780921|NCT00501943|10887635|FG000|NOT COMPLETED|Overall Study||2
9780922|NCT00501943|10887636|FG001|NOT COMPLETED|Overall Study||3
9780923|NCT00501969|10887644|FG000|STARTED|Overall Study||395
9780924|NCT00501969|10887644|FG000|COMPLETED|Overall Study||189
9780925|NCT00501969|10887644|FG000|NOT COMPLETED|Overall Study||206
9780926|NCT00501995|10887648|FG000|STARTED|Overall Study||6
9780927|NCT00501995|10887648|FG000|COMPLETED|Overall Study||5
9780928|NCT00501995|10887648|FG000|NOT COMPLETED|Overall Study||1
10014783|NCT01801917|11137823|FG003|STARTED|Period 1 - Randomized||1
10014784|NCT01801917|11137820|FG000|COMPLETED|Period 1 - Randomized||6
10014785|NCT01801917|11137821|FG001|COMPLETED|Period 1 - Randomized||2
10014786|NCT01801917|11137822|FG002|COMPLETED|Period 1 - Randomized||3
9780929|NCT00502203|10887652|FG000|STARTED|Overall Study||23
9780930|NCT00502203|10887652|FG000|COMPLETED|Overall Study||22
9780931|NCT00502203|10887652|FG000|NOT COMPLETED|Overall Study||1
9780932|NCT00502216|10887658|FG000|STARTED|Overall Study||21
9780933|NCT00502216|10887659|FG001|STARTED|Overall Study||19
9780934|NCT00502216|10887658|FG000|COMPLETED|Overall Study||21
10014787|NCT01801917|11137823|FG003|COMPLETED|Period 1 - Randomized||1
9780935|NCT00502216|10887659|FG001|COMPLETED|Overall Study||19
9780936|NCT00502216|10887658|FG000|NOT COMPLETED|Overall Study||0
9780937|NCT00502216|10887659|FG001|NOT COMPLETED|Overall Study||0
9780938|NCT00502242|10887667|FG000|STARTED|Overall Study||155
9780939|NCT00502242|10887668|FG001|STARTED|Overall Study||140
9780940|NCT00502242|10887667|FG000|COMPLETED|Overall Study||104
9780941|NCT00502242|10887668|FG001|COMPLETED|Overall Study||84
9780942|NCT00502242|10887667|FG000|NOT COMPLETED|Overall Study||51
9780943|NCT00502242|10887668|FG001|NOT COMPLETED|Overall Study||56
9780944|NCT00502307|10887674|FG000|STARTED|Open Label Period (16 Weeks)||272
9780945|NCT00502307|10887675|FG001|STARTED|Open Label Period (16 Weeks)||0
9780946|NCT00502307|10887676|FG002|STARTED|Open Label Period (16 Weeks)||0
9780947|NCT00502307|10887674|FG000|COMPLETED|Open Label Period (16 Weeks)||196
9780948|NCT00502307|10887675|FG001|COMPLETED|Open Label Period (16 Weeks)||0
9780949|NCT00502307|10887676|FG002|COMPLETED|Open Label Period (16 Weeks)||0
9780950|NCT00502307|10887674|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76
9780951|NCT00502307|10887675|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0
9780952|NCT00502307|10887676|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0
9780953|NCT00502307|10887674|FG000|STARTED|Double-Blind Period (12 Weeks)||0
9780954|NCT00502307|10887675|FG001|STARTED|Double-Blind Period (12 Weeks)||61
9780955|NCT00502307|10887676|FG002|STARTED|Double-Blind Period (12 Weeks)||57
9780956|NCT00502307|10887674|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0
9780957|NCT00502307|10887675|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35
9780958|NCT00502307|10887676|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48
9780959|NCT00502307|10887674|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
9780960|NCT00502307|10887675|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
9780961|NCT00502307|10887676|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
9780962|NCT00502307|10887674|FG000|STARTED|Maintenance Period||148
9780963|NCT00502307|10887675|FG001|STARTED|Maintenance Period||0
10014788|NCT01801917|11137820|FG000|NOT COMPLETED|Period 1 - Randomized||1
10014789|NCT01801917|11137821|FG001|NOT COMPLETED|Period 1 - Randomized||0
10014790|NCT01801917|11137822|FG002|NOT COMPLETED|Period 1 - Randomized||1
10014791|NCT01801917|11137823|FG003|NOT COMPLETED|Period 1 - Randomized||0
10014792|NCT01801917|11137820|FG000|STARTED|Extension - All Active||6
10014793|NCT01801917|11137821|FG001|STARTED|Extension - All Active||0
9780964|NCT00502307|10887676|FG002|STARTED|Maintenance Period||0
9780965|NCT00502307|10887674|FG000|COMPLETED|Maintenance Period||0
9780966|NCT00502307|10887675|FG001|COMPLETED|Maintenance Period||0
9780967|NCT00502307|10887676|FG002|COMPLETED|Maintenance Period||0
9780968|NCT00502307|10887674|FG000|NOT COMPLETED|Maintenance Period||148
9780969|NCT00502307|10887675|FG001|NOT COMPLETED|Maintenance Period||0
9780970|NCT00502307|10887676|FG002|NOT COMPLETED|Maintenance Period||0
9780971|NCT00502320|10887695|FG000|STARTED|Overall Study||25
9780972|NCT00502320|10887696|FG001|STARTED|Overall Study||25
9780973|NCT00502320|10887695|FG000|Screening Visit|Overall Study||25
9780974|NCT00502320|10887696|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
9780975|NCT00502320|10887695|FG000|COMPLETED|Overall Study||19
9780976|NCT00502320|10887696|FG001|COMPLETED|Overall Study||18
9780977|NCT00502320|10887695|FG000|NOT COMPLETED|Overall Study||6
9780978|NCT00502320|10887696|FG001|NOT COMPLETED|Overall Study||7
9830230|NCT00762450|10940917|FG002|COMPLETED|2nd Treatment Period||2
9830231|NCT00762450|10940915|FG000|NOT COMPLETED|2nd Treatment Period||0
9830232|NCT00762450|10940916|FG001|NOT COMPLETED|2nd Treatment Period||0
9830233|NCT00762450|10940917|FG002|NOT COMPLETED|2nd Treatment Period||0
9830234|NCT00762450|10940915|FG000|STARTED|Washout After 2nd Treatment Period||2
9830235|NCT00762450|10940916|FG001|STARTED|Washout After 2nd Treatment Period||2
9830236|NCT00762450|10940917|FG002|STARTED|Washout After 2nd Treatment Period||2
9830237|NCT00762450|10940915|FG000|COMPLETED|Washout After 2nd Treatment Period||2
9830238|NCT00762450|10940916|FG001|COMPLETED|Washout After 2nd Treatment Period||2
9830239|NCT00762450|10940917|FG002|COMPLETED|Washout After 2nd Treatment Period||2
9830240|NCT00762450|10940915|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0
9830241|NCT00762450|10940916|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0
9830242|NCT00762450|10940917|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0
9830243|NCT00762450|10940915|FG000|STARTED|3rd Treatment Period||2
9830244|NCT00762450|10940916|FG001|STARTED|3rd Treatment Period||2
9830245|NCT00762450|10940917|FG002|STARTED|3rd Treatment Period||2
9830246|NCT00762450|10940915|FG000|COMPLETED|3rd Treatment Period||2
9830247|NCT00762450|10940916|FG001|COMPLETED|3rd Treatment Period||2
9830248|NCT00762450|10940917|FG002|COMPLETED|3rd Treatment Period||2
9830249|NCT00762450|10940915|FG000|NOT COMPLETED|3rd Treatment Period||0
9830250|NCT00762450|10940916|FG001|NOT COMPLETED|3rd Treatment Period||0
9830251|NCT00762450|10940917|FG002|NOT COMPLETED|3rd Treatment Period||0
9830252|NCT00762463|10940927|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120
9830253|NCT00762463|10940928|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120
9830254|NCT00762463|10940929|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0
9830255|NCT00762463|10940930|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0
9830256|NCT00762463|10940927|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
9830257|NCT00762463|10940928|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
9830258|NCT00762463|10940929|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
9830259|NCT00762463|10940930|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
9830260|NCT00762463|10940927|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
9830261|NCT00762463|10940928|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
9830262|NCT00762463|10940929|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
9830263|NCT00762463|10940930|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
9830264|NCT00762463|10940927|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113
9830265|NCT00762463|10940928|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110
9830266|NCT00762463|10940929|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0
9830267|NCT00762463|10940930|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0
9830268|NCT00762463|10940927|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109
10014794|NCT01801917|11137822|FG002|STARTED|Extension - All Active||3
9780979|NCT00502593|10887714|FG000|STARTED|Overall Study||51
9780980|NCT00502593|10887715|FG001|STARTED|Overall Study||18
9780981|NCT00502593|10887716|FG002|STARTED|Overall Study||51
9780982|NCT00502593|10887717|FG003|STARTED|Overall Study||18
9780983|NCT00502593|10887718|FG004|STARTED|Overall Study||51
9780984|NCT00502593|10887719|FG005|STARTED|Overall Study||17
9780985|NCT00502593|10887720|FG006|STARTED|Overall Study||49
9780986|NCT00502593|10887721|FG007|STARTED|Overall Study||17
9780987|NCT00502593|10887722|FG008|STARTED|Overall Study||49
9780988|NCT00502593|10887723|FG009|STARTED|Overall Study||17
9780989|NCT00502593|10887724|FG010|STARTED|Overall Study||49
9780990|NCT00502593|10887725|FG011|STARTED|Overall Study||18
9780991|NCT00502593|10887714|FG000|COMPLETED|Overall Study||48
9780992|NCT00502593|10887715|FG001|COMPLETED|Overall Study||16
9780993|NCT00502593|10887716|FG002|COMPLETED|Overall Study||41
9780994|NCT00502593|10887717|FG003|COMPLETED|Overall Study||14
9780995|NCT00502593|10887718|FG004|COMPLETED|Overall Study||47
9780996|NCT00502593|10887719|FG005|COMPLETED|Overall Study||17
9780997|NCT00502593|10887720|FG006|COMPLETED|Overall Study||44
9780998|NCT00502593|10887721|FG007|COMPLETED|Overall Study||17
9780999|NCT00502593|10887722|FG008|COMPLETED|Overall Study||43
9781000|NCT00502593|10887723|FG009|COMPLETED|Overall Study||17
9781001|NCT00502593|10887724|FG010|COMPLETED|Overall Study||47
9781002|NCT00502593|10887725|FG011|COMPLETED|Overall Study||18
9781003|NCT00502593|10887714|FG000|NOT COMPLETED|Overall Study||3
9781004|NCT00502593|10887715|FG001|NOT COMPLETED|Overall Study||2
9781005|NCT00502593|10887716|FG002|NOT COMPLETED|Overall Study||10
9781006|NCT00502593|10887717|FG003|NOT COMPLETED|Overall Study||4
9781007|NCT00502593|10887718|FG004|NOT COMPLETED|Overall Study||4
9781008|NCT00502593|10887719|FG005|NOT COMPLETED|Overall Study||0
9781009|NCT00502593|10887720|FG006|NOT COMPLETED|Overall Study||5
9781010|NCT00502593|10887721|FG007|NOT COMPLETED|Overall Study||0
9781011|NCT00502593|10887722|FG008|NOT COMPLETED|Overall Study||6
9781012|NCT00502593|10887723|FG009|NOT COMPLETED|Overall Study||0
9781013|NCT00502593|10887724|FG010|NOT COMPLETED|Overall Study||2
9781014|NCT00502593|10887725|FG011|NOT COMPLETED|Overall Study||0
9781015|NCT00502671|10887774|FG000|STARTED|Overall Study||228
9781016|NCT00502671|10887774|FG000|COMPLETED|Overall Study||151
9781017|NCT00502671|10887774|FG000|NOT COMPLETED|Overall Study||77
9781018|NCT00502697|10887780|FG000|STARTED|Overall Study||122
9781019|NCT00502697|10887781|FG001|STARTED|Overall Study||114
9781020|NCT00502697|10887780|FG000|COMPLETED|Overall Study||109
9781021|NCT00502697|10887781|FG001|COMPLETED|Overall Study||102
9781022|NCT00502697|10887780|FG000|NOT COMPLETED|Overall Study||13
9781023|NCT00502697|10887781|FG001|NOT COMPLETED|Overall Study||12
9781024|NCT00502775|10887790|FG000|STARTED|Overall Study||229
9781025|NCT00502775|10887791|FG001|STARTED|Overall Study||224
9781026|NCT00502775|10887792|FG002|STARTED|Overall Study||227
9781027|NCT00502775|10887790|FG000|COMPLETED|Overall Study||219
9781028|NCT00502775|10887791|FG001|COMPLETED|Overall Study||209
9781029|NCT00502775|10887792|FG002|COMPLETED|Overall Study||214
9781030|NCT00502775|10887790|FG000|NOT COMPLETED|Overall Study||10
9781031|NCT00502775|10887791|FG001|NOT COMPLETED|Overall Study||15
9781032|NCT00502775|10887792|FG002|NOT COMPLETED|Overall Study||13
9781033|NCT00502801|10887800|FG000|STARTED|Treatment Period||183
10014795|NCT01801917|11137823|FG003|STARTED|Extension - All Active||0
10014796|NCT01801917|11137820|FG000|COMPLETED|Extension - All Active||6
10014797|NCT01801917|11137821|FG001|COMPLETED|Extension - All Active||0
9781034|NCT00502801|10887800|FG000|COMPLETED|Treatment Period||129
9781035|NCT00502801|10887800|FG000|NOT COMPLETED|Treatment Period||54
9781036|NCT00502801|10887800|FG000|STARTED|End of Therapy to Test of Cure||129
9781037|NCT00502801|10887800|FG000|COMPLETED|End of Therapy to Test of Cure||121
9781038|NCT00502801|10887800|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8
9781039|NCT00502840|10887804|FG000|STARTED|Overall Study||193
9781040|NCT00502840|10887804|FG000|COMPLETED|Overall Study||93
9781041|NCT00502840|10887804|FG000|NOT COMPLETED|Overall Study||100
9781042|NCT00502853|10887809|FG000|STARTED|Overall Study||10
9781043|NCT00502853|10887809|FG000|COMPLETED|Overall Study||10
9781044|NCT00502853|10887809|FG000|NOT COMPLETED|Overall Study||0
9781045|NCT00502905|10887814|FG000|STARTED|Overall Study||196
9781046|NCT00502905|10887814|FG000|COMPLETED|Overall Study||196
9781047|NCT00502905|10887814|FG000|NOT COMPLETED|Overall Study||0
9781048|NCT00502944|10887820|FG000|STARTED|Overall Study||2446
9781049|NCT00502944|10887821|FG001|STARTED|Overall Study||2409
9781050|NCT00502944|10887820|FG000|COMPLETED|Overall Study||1382
9781051|NCT00502944|10887821|FG001|COMPLETED|Overall Study||643
9781052|NCT00502944|10887820|FG000|NOT COMPLETED|Overall Study||1064
9781053|NCT00502944|10887821|FG001|NOT COMPLETED|Overall Study||1766
9952328|NCT01421459|11071253|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376
9952329|NCT01421459|11071254|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380
9952330|NCT01421459|11071253|FG000|COMPLETED|Overall Study||334
9952331|NCT01421459|11071254|FG001|COMPLETED|Overall Study||328
9952332|NCT01421459|11071253|FG000|NOT COMPLETED|Overall Study||45
10014798|NCT01801917|11137822|FG002|COMPLETED|Extension - All Active||3
9781054|NCT00502996|10887827|FG000|STARTED|Overall Study||232
10014799|NCT01801917|11137823|FG003|COMPLETED|Extension - All Active||0
9781055|NCT00502996|10887827|FG000|COMPLETED|Overall Study||188
9781056|NCT00502996|10887827|FG000|NOT COMPLETED|Overall Study||44
9781057|NCT00503113|10887834|FG000|STARTED|Overall Study||268
9781058|NCT00503113|10887835|FG001|STARTED|Overall Study||264
9781059|NCT00503113|10887836|FG002|STARTED|Overall Study||269
9781060|NCT00503113|10887834|FG000|Intent to Treat Population (ITT)|Overall Study||262
9781061|NCT00503113|10887835|FG001|Intent to Treat Population (ITT)|Overall Study||261
9781062|NCT00503113|10887836|FG002|Intent to Treat Population (ITT)|Overall Study||268
9781063|NCT00503113|10887834|FG000|Per Protocol Population (PP)|Overall Study||246
9781064|NCT00503113|10887835|FG001|Per Protocol Population (PP)|Overall Study||243
9781065|NCT00503113|10887836|FG002|Per Protocol Population (PP)|Overall Study||241
9781066|NCT00503113|10887834|FG000|Safety Population|Overall Study||263
9781067|NCT00503113|10887835|FG001|Safety Population|Overall Study||263
9781068|NCT00503113|10887836|FG002|Safety Population|Overall Study||267
9781069|NCT00503113|10887834|FG000|COMPLETED|Overall Study||235
9781070|NCT00503113|10887835|FG001|COMPLETED|Overall Study||236
9781071|NCT00503113|10887836|FG002|COMPLETED|Overall Study||241
9781072|NCT00503113|10887834|FG000|NOT COMPLETED|Overall Study||33
9781073|NCT00503113|10887835|FG001|NOT COMPLETED|Overall Study||28
9781074|NCT00503113|10887836|FG002|NOT COMPLETED|Overall Study||28
9781075|NCT00503139|10887844|FG000|STARTED|Overall Study||684
9781076|NCT00503139|10887844|FG000|COMPLETED|Overall Study||676
9781077|NCT00503139|10887844|FG000|NOT COMPLETED|Overall Study||8
10014800|NCT01801917|11137820|FG000|NOT COMPLETED|Extension - All Active||0
10014801|NCT01801917|11137821|FG001|NOT COMPLETED|Extension - All Active||0
10014802|NCT01801917|11137822|FG002|NOT COMPLETED|Extension - All Active||0
10014803|NCT01801917|11137823|FG003|NOT COMPLETED|Extension - All Active||0
10014804|NCT01801930|11137838|FG000|STARTED|Overall Study||6
10014805|NCT01801930|11137839|FG001|STARTED|Overall Study||6
10014806|NCT01801930|11137840|FG002|STARTED|Overall Study||6
10014807|NCT01801930|11137841|FG003|STARTED|Overall Study||6
10014808|NCT01801930|11137838|FG000|COMPLETED|Overall Study||0
10014809|NCT01801930|11137839|FG001|COMPLETED|Overall Study||0
10014810|NCT01801930|11137840|FG002|COMPLETED|Overall Study||0
10014811|NCT01801930|11137841|FG003|COMPLETED|Overall Study||0
10014812|NCT01801930|11137838|FG000|NOT COMPLETED|Overall Study||6
10014813|NCT01801930|11137839|FG001|NOT COMPLETED|Overall Study||6
10014814|NCT01801930|11137840|FG002|NOT COMPLETED|Overall Study||6
10014815|NCT01801930|11137841|FG003|NOT COMPLETED|Overall Study||6
10014816|NCT01801982|11137851|FG000|STARTED|Overall Study||1
10014817|NCT01801982|11137851|FG000|COMPLETED|Overall Study||0
10014818|NCT01801982|11137851|FG000|NOT COMPLETED|Overall Study||1
10014819|NCT01802073|11137857|FG000|STARTED|Overall Study||14
10014820|NCT01802073|11137858|FG001|STARTED|Overall Study||20
10014821|NCT01802073|11137857|FG000|COMPLETED|Overall Study||9
10014822|NCT01802073|11137858|FG001|COMPLETED|Overall Study||9
10014823|NCT01802073|11137857|FG000|NOT COMPLETED|Overall Study||5
10014824|NCT01802073|11137858|FG001|NOT COMPLETED|Overall Study||11
10014825|NCT01802151|11137868|FG000|STARTED|Overall Study||20
10014826|NCT01802151|11137869|FG001|STARTED|Overall Study||21
10014827|NCT01802151|11137870|FG002|STARTED|Overall Study||22
10014828|NCT01802151|11137871|FG003|STARTED|Overall Study||20
9781078|NCT00503308|10887850|FG000|STARTED|Overall Study||146
9781079|NCT00503308|10887851|FG001|STARTED|Overall Study||135
9781080|NCT00503308|10887850|FG000|COMPLETED|Overall Study||144
9781081|NCT00503308|10887851|FG001|COMPLETED|Overall Study||134
9781082|NCT00503308|10887850|FG000|NOT COMPLETED|Overall Study||2
9781083|NCT00503308|10887851|FG001|NOT COMPLETED|Overall Study||1
9781084|NCT00503399|10887859|FG000|STARTED|Overall Study||45
9781085|NCT00503399|10887860|FG001|STARTED|Overall Study||47
9781086|NCT00503399|10887859|FG000|COMPLETED|Overall Study||38
9781087|NCT00503399|10887860|FG001|COMPLETED|Overall Study||39
9781088|NCT00503399|10887859|FG000|NOT COMPLETED|Overall Study||7
9781089|NCT00503399|10887860|FG001|NOT COMPLETED|Overall Study||8
9781090|NCT00503425|10887866|FG000|STARTED|Overall Study||215
9781091|NCT00503425|10887866|FG000|COMPLETED|Overall Study||161
9781092|NCT00503425|10887866|FG000|NOT COMPLETED|Overall Study||54
9781093|NCT00503685|10887874|FG000|STARTED|Overall Study||23
9781094|NCT00503685|10887875|FG001|STARTED|Overall Study||22
9781095|NCT00503685|10887876|FG002|STARTED|Overall Study||20
9781096|NCT00503685|10887874|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
9781097|NCT00503685|10887875|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
9781098|NCT00503685|10887876|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
9781099|NCT00503685|10887874|FG000|COMPLETED|Overall Study||23
9781100|NCT00503685|10887875|FG001|COMPLETED|Overall Study||19
9781101|NCT00503685|10887876|FG002|COMPLETED|Overall Study||18
9781102|NCT00503685|10887874|FG000|NOT COMPLETED|Overall Study||0
9781103|NCT00503685|10887875|FG001|NOT COMPLETED|Overall Study||3
9781104|NCT00503685|10887876|FG002|NOT COMPLETED|Overall Study||2
9781105|NCT00503698|10887887|FG000|STARTED|Overall Study|Randomised|357
9781106|NCT00503698|10887888|FG001|STARTED|Overall Study|Randomised|355
9781107|NCT00503698|10887887|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
9781108|NCT00503698|10887888|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
9781109|NCT00503698|10887887|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0
9781110|NCT00503698|10887888|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0
10014829|NCT01802151|11137868|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
10014830|NCT01802151|11137869|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
9781111|NCT00503698|10887887|FG000|NOT COMPLETED|Overall Study||357
10014831|NCT01802151|11137870|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
9781112|NCT00503698|10887888|FG001|NOT COMPLETED|Overall Study||355
9781113|NCT00503750|10887894|FG000|STARTED|Overall Study||27
9781114|NCT00503750|10887894|FG000|COMPLETED|Overall Study||27
9781115|NCT00503750|10887894|FG000|NOT COMPLETED|Overall Study||0
9781116|NCT00503776|10887902|FG000|STARTED|Overall Study||8
9781117|NCT00503776|10887903|FG001|STARTED|Overall Study||12
9781118|NCT00503776|10887904|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
9781119|NCT00503776|10887905|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
9781120|NCT00503776|10887902|FG000|COMPLETED|Overall Study||7
9781121|NCT00503776|10887903|FG001|COMPLETED|Overall Study||12
9781122|NCT00503776|10887904|FG002|COMPLETED|Overall Study||10
9781123|NCT00503776|10887905|FG003|COMPLETED|Overall Study||8
9781124|NCT00503776|10887902|FG000|NOT COMPLETED|Overall Study||1
9781125|NCT00503776|10887903|FG001|NOT COMPLETED|Overall Study||0
9781126|NCT00503776|10887904|FG002|NOT COMPLETED|Overall Study||2
9781127|NCT00503776|10887905|FG003|NOT COMPLETED|Overall Study||2
9781128|NCT00503867|10887920|FG000|STARTED|Overall Study||10
9781129|NCT00503867|10887920|FG000|COMPLETED|Overall Study||8
9781130|NCT00503867|10887920|FG000|NOT COMPLETED|Overall Study||2
9781131|NCT00503906|10887924|FG000|STARTED|Overall Study||30
9781132|NCT00503906|10887924|FG000|COMPLETED|Overall Study||29
9781133|NCT00503906|10887924|FG000|NOT COMPLETED|Overall Study||1
9781134|NCT00503984|10887931|FG000|STARTED|Overall Study||3
9781135|NCT00503984|10887932|FG001|STARTED|Overall Study||3
9781136|NCT00503984|10887933|FG002|STARTED|Overall Study||3
9781137|NCT00503984|10887934|FG003|STARTED|Overall Study||6
9781138|NCT00503984|10887935|FG004|STARTED|Overall Study||6
9781139|NCT00503984|10887936|FG005|STARTED|Overall Study||1
9781140|NCT00503984|10887931|FG000|COMPLETED|Overall Study||3
9781141|NCT00503984|10887932|FG001|COMPLETED|Overall Study||1
9781142|NCT00503984|10887933|FG002|COMPLETED|Overall Study||3
9781143|NCT00503984|10887934|FG003|COMPLETED|Overall Study||6
9781144|NCT00503984|10887935|FG004|COMPLETED|Overall Study||5
9781145|NCT00503984|10887936|FG005|COMPLETED|Overall Study||1
9781146|NCT00503984|10887931|FG000|NOT COMPLETED|Overall Study||0
9781147|NCT00503984|10887932|FG001|NOT COMPLETED|Overall Study||2
9781148|NCT00503984|10887933|FG002|NOT COMPLETED|Overall Study||0
9781149|NCT00503984|10887934|FG003|NOT COMPLETED|Overall Study||0
9781150|NCT00503984|10887935|FG004|NOT COMPLETED|Overall Study||1
9781151|NCT00503984|10887936|FG005|NOT COMPLETED|Overall Study||0
9781152|NCT00503997|10887960|FG000|STARTED|Overall Study||42
9781153|NCT00503997|10887960|FG000|COMPLETED|Overall Study||34
9781154|NCT00503997|10887960|FG000|NOT COMPLETED|Overall Study||8
9781155|NCT00504023|10887964|FG000|STARTED|Overall Study||8
9781156|NCT00504023|10887964|FG000|COMPLETED|Overall Study||8
9781157|NCT00504023|10887964|FG000|NOT COMPLETED|Overall Study||0
9781158|NCT00504075|10887968|FG000|STARTED|Overall Study||35
9781159|NCT00504075|10887968|FG000|COMPLETED|Overall Study||27
9781160|NCT00504075|10887968|FG000|NOT COMPLETED|Overall Study||8
9781161|NCT00504153|10887973|FG000|STARTED|Overall Study||19
9781162|NCT00504153|10887973|FG000|COMPLETED|Overall Study||13
9781163|NCT00504153|10887973|FG000|NOT COMPLETED|Overall Study||6
9781164|NCT00504166|10887979|FG000|STARTED|Overall Study||26
9781165|NCT00504166|10887980|FG001|STARTED|Overall Study||27
9781166|NCT00504166|10887979|FG000|COMPLETED|Overall Study||20
9781167|NCT00504166|10887980|FG001|COMPLETED|Overall Study||13
9781168|NCT00504166|10887979|FG000|NOT COMPLETED|Overall Study||6
9781169|NCT00504166|10887980|FG001|NOT COMPLETED|Overall Study||14
9781170|NCT00504231|10887990|FG000|STARTED|Overall Study||65
9781171|NCT00504231|10887991|FG001|STARTED|Overall Study||64
9781172|NCT00504231|10887992|FG002|STARTED|Overall Study||64
9781173|NCT00504231|10887993|FG003|STARTED|Overall Study||65
9781174|NCT00504231|10887990|FG000|COMPLETED|Overall Study||65
9781175|NCT00504231|10887991|FG001|COMPLETED|Overall Study||64
9781176|NCT00504231|10887992|FG002|COMPLETED|Overall Study||63
9781177|NCT00504231|10887993|FG003|COMPLETED|Overall Study||65
9781178|NCT00504231|10887990|FG000|NOT COMPLETED|Overall Study||0
9781179|NCT00504231|10887991|FG001|NOT COMPLETED|Overall Study||0
9781180|NCT00504231|10887992|FG002|NOT COMPLETED|Overall Study||1
9781181|NCT00504231|10887993|FG003|NOT COMPLETED|Overall Study||0
9781182|NCT00504257|10888007|FG000|STARTED|Overall Study||45
9781183|NCT00504257|10888007|FG000|COMPLETED|Overall Study||41
9781184|NCT00504257|10888007|FG000|NOT COMPLETED|Overall Study||4
9781185|NCT00504309|10888017|FG000|STARTED|Overall Study||7
9781186|NCT00504309|10888018|FG001|STARTED|Overall Study||5
9781187|NCT00504309|10888019|FG002|STARTED|Overall Study||2
9781188|NCT00504309|10888020|FG003|STARTED|Overall Study||3
9781189|NCT00504309|10888021|FG004|STARTED|Overall Study||8
9781190|NCT00504309|10888022|FG005|STARTED|Overall Study||3
9781191|NCT00504309|10888017|FG000|COMPLETED|Overall Study||7
9781192|NCT00504309|10888018|FG001|COMPLETED|Overall Study||5
9781193|NCT00504309|10888019|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1
9781194|NCT00504309|10888020|FG003|COMPLETED|Overall Study||3
9781195|NCT00504309|10888021|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
9781196|NCT00504309|10888022|FG005|COMPLETED|Overall Study||3
9781197|NCT00504309|10888017|FG000|NOT COMPLETED|Overall Study||0
9781198|NCT00504309|10888018|FG001|NOT COMPLETED|Overall Study||0
9781199|NCT00504309|10888019|FG002|NOT COMPLETED|Overall Study||1
9781200|NCT00504309|10888020|FG003|NOT COMPLETED|Overall Study||0
9781201|NCT00504309|10888021|FG004|NOT COMPLETED|Overall Study||1
9781202|NCT00504309|10888022|FG005|NOT COMPLETED|Overall Study||0
9781203|NCT00504348|10888034|FG000|STARTED|Overall Study||25
9781204|NCT00504348|10888034|FG000|COMPLETED|Overall Study||17
9781205|NCT00504348|10888034|FG000|NOT COMPLETED|Overall Study||8
9781206|NCT00504426|10888042|FG000|STARTED|Overall Study||32
9781207|NCT00504426|10888043|FG001|STARTED|Overall Study||23
9781208|NCT00504426|10888044|FG002|STARTED|Overall Study||22
9781209|NCT00504426|10888045|FG003|STARTED|Overall Study||24
9781210|NCT00504426|10888042|FG000|COMPLETED|Overall Study||29
9781211|NCT00504426|10888043|FG001|COMPLETED|Overall Study||22
9781212|NCT00504426|10888044|FG002|COMPLETED|Overall Study||18
9781213|NCT00504426|10888045|FG003|COMPLETED|Overall Study||24
9781214|NCT00504426|10888042|FG000|NOT COMPLETED|Overall Study||3
9781215|NCT00504426|10888043|FG001|NOT COMPLETED|Overall Study||1
9781216|NCT00504426|10888044|FG002|NOT COMPLETED|Overall Study||4
9781217|NCT00504426|10888045|FG003|NOT COMPLETED|Overall Study||0
9781218|NCT00504504|10888058|FG000|STARTED|Overall Study||82
9781219|NCT00504504|10888058|FG000|COMPLETED|Overall Study||82
9781220|NCT00504504|10888058|FG000|NOT COMPLETED|Overall Study||0
9781221|NCT00504556|10888067|FG000|STARTED|Overall Study||235
9781222|NCT00504556|10888068|FG001|STARTED|Overall Study||245
9781223|NCT00504556|10888069|FG002|STARTED|Overall Study||235
9781224|NCT00504556|10888070|FG003|STARTED|Overall Study||180
9781225|NCT00504556|10888071|FG004|STARTED|Overall Study||251
9781226|NCT00504556|10888067|FG000|Safety Analysis Set|Overall Study||235
9781227|NCT00504556|10888068|FG001|Safety Analysis Set|Overall Study||244
9781228|NCT00504556|10888069|FG002|Safety Analysis Set|Overall Study||234
9781229|NCT00504556|10888070|FG003|Safety Analysis Set|Overall Study||180
9781230|NCT00504556|10888071|FG004|Safety Analysis Set|Overall Study||250
9781231|NCT00504556|10888067|FG000|Per Protocol Analysis Set|Overall Study||235
9781232|NCT00504556|10888068|FG001|Per Protocol Analysis Set|Overall Study||243
9781233|NCT00504556|10888069|FG002|Per Protocol Analysis Set|Overall Study||234
9781234|NCT00504556|10888070|FG003|Per Protocol Analysis Set|Overall Study||180
9781235|NCT00504556|10888071|FG004|Per Protocol Analysis Set|Overall Study||250
9781236|NCT00504556|10888067|FG000|Pharmacodynamic Analysis Set|Overall Study||230
9781237|NCT00504556|10888068|FG001|Pharmacodynamic Analysis Set|Overall Study||236
9781238|NCT00504556|10888069|FG002|Pharmacodynamic Analysis Set|Overall Study||228
9781239|NCT00504556|10888070|FG003|Pharmacodynamic Analysis Set|Overall Study||170
9781240|NCT00504556|10888071|FG004|Pharmacodynamic Analysis Set|Overall Study||244
9781241|NCT00504556|10888067|FG000|COMPLETED|Overall Study||200
9781242|NCT00504556|10888068|FG001|COMPLETED|Overall Study||207
9781243|NCT00504556|10888069|FG002|COMPLETED|Overall Study||204
9781244|NCT00504556|10888070|FG003|COMPLETED|Overall Study||52
9781245|NCT00504556|10888071|FG004|COMPLETED|Overall Study||226
9781246|NCT00504556|10888067|FG000|NOT COMPLETED|Overall Study||35
9781247|NCT00504556|10888068|FG001|NOT COMPLETED|Overall Study||38
9781248|NCT00504556|10888069|FG002|NOT COMPLETED|Overall Study||31
9781249|NCT00504556|10888070|FG003|NOT COMPLETED|Overall Study||128
9781250|NCT00504556|10888071|FG004|NOT COMPLETED|Overall Study||25
9781251|NCT00504595|10888087|FG000|STARTED|Overall Study||50
9781252|NCT00504595|10888088|FG001|STARTED|Overall Study||10
9781253|NCT00504595|10888089|FG002|STARTED|Overall Study||10
9781254|NCT00504595|10888090|FG003|STARTED|Overall Study||10
9781255|NCT00504595|10888087|FG000|COMPLETED|Overall Study||49
9781256|NCT00504595|10888088|FG001|COMPLETED|Overall Study||10
9781257|NCT00504595|10888089|FG002|COMPLETED|Overall Study||8
9781258|NCT00504595|10888090|FG003|COMPLETED|Overall Study||10
9781259|NCT00504595|10888087|FG000|NOT COMPLETED|Overall Study||1
9781260|NCT00504595|10888088|FG001|NOT COMPLETED|Overall Study||0
9781261|NCT00504595|10888089|FG002|NOT COMPLETED|Overall Study||2
9781262|NCT00504595|10888090|FG003|NOT COMPLETED|Overall Study||0
9781263|NCT00504660|10888102|FG000|STARTED|Overall Study||31
9781264|NCT00504660|10888103|FG001|STARTED|Overall Study||43
9781265|NCT00504660|10888102|FG000|COMPLETED|Overall Study||31
9781266|NCT00504660|10888103|FG001|COMPLETED|Overall Study||43
9781267|NCT00504660|10888102|FG000|NOT COMPLETED|Overall Study||0
9781268|NCT00504660|10888103|FG001|NOT COMPLETED|Overall Study||0
9781269|NCT00504725|10888111|FG000|STARTED|Overall Study||21
9781270|NCT00504725|10888112|FG001|STARTED|Overall Study||20
10014832|NCT01802151|11137871|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
10014833|NCT01802151|11137868|FG000|NOT COMPLETED|Overall Study||0
10014834|NCT01802151|11137869|FG001|NOT COMPLETED|Overall Study||0
10014835|NCT01802151|11137870|FG002|NOT COMPLETED|Overall Study||2
10014836|NCT01802151|11137871|FG003|NOT COMPLETED|Overall Study||0
10014837|NCT01802216|11137883|FG000|STARTED|Baseline||17
10014838|NCT01802216|11137884|FG001|STARTED|Baseline||34
9781271|NCT00504725|10888111|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
9781272|NCT00504725|10888112|FG001|COMPLETED|Overall Study||20
9781273|NCT00504725|10888111|FG000|NOT COMPLETED|Overall Study||1
9781274|NCT00504725|10888112|FG001|NOT COMPLETED|Overall Study||0
9781275|NCT00504751|10888118|FG000|STARTED|Overall Study||15
9781276|NCT00504751|10888118|FG000|COMPLETED|Overall Study||15
9781277|NCT00504751|10888118|FG000|NOT COMPLETED|Overall Study||0
9781278|NCT00504777|10888122|FG000|STARTED|Overall Study||36
9781279|NCT00504777|10888122|FG000|COMPLETED|Overall Study||35
9781280|NCT00504777|10888122|FG000|NOT COMPLETED|Overall Study||1
9781281|NCT00504829|10888129|FG000|STARTED|Overall Study||73
9781282|NCT00504829|10888130|FG001|STARTED|Overall Study||74
9781283|NCT00504829|10888131|FG002|STARTED|Overall Study||73
9781284|NCT00504829|10888129|FG000|COMPLETED|Overall Study||67
9781285|NCT00504829|10888130|FG001|COMPLETED|Overall Study||70
9781286|NCT00504829|10888131|FG002|COMPLETED|Overall Study||63
9781287|NCT00504829|10888129|FG000|NOT COMPLETED|Overall Study||6
9781288|NCT00504829|10888130|FG001|NOT COMPLETED|Overall Study||4
9781289|NCT00504829|10888131|FG002|NOT COMPLETED|Overall Study||10
9781290|NCT00504881|10888141|FG000|STARTED|Overall Study||121
9781291|NCT00504881|10888142|FG001|STARTED|Overall Study||359
9781292|NCT00504881|10888141|FG000|COMPLETED|Overall Study||111
9781293|NCT00504881|10888142|FG001|COMPLETED|Overall Study||323
9781294|NCT00504881|10888141|FG000|NOT COMPLETED|Overall Study||10
9781295|NCT00504881|10888142|FG001|NOT COMPLETED|Overall Study||36
9781296|NCT00504894|10888153|FG000|STARTED|Overall Study||20
9781297|NCT00504894|10888154|FG001|STARTED|Overall Study||21
9781298|NCT00504894|10888155|FG002|STARTED|Overall Study||19
9781299|NCT00504894|10888153|FG000|COMPLETED|Overall Study||17
9781300|NCT00504894|10888154|FG001|COMPLETED|Overall Study||18
9781301|NCT00504894|10888155|FG002|COMPLETED|Overall Study||19
9781302|NCT00504894|10888153|FG000|NOT COMPLETED|Overall Study||3
9781303|NCT00504894|10888154|FG001|NOT COMPLETED|Overall Study||3
9781304|NCT00504894|10888155|FG002|NOT COMPLETED|Overall Study||0
9781305|NCT00505076|10888166|FG000|STARTED|Overall Study||22
9781306|NCT00505076|10888167|FG001|STARTED|Overall Study||19
9781307|NCT00505076|10888168|FG002|STARTED|Overall Study||22
9781308|NCT00505076|10888166|FG000|COMPLETED|Overall Study||19
9781309|NCT00505076|10888167|FG001|COMPLETED|Overall Study||17
9781310|NCT00505076|10888168|FG002|COMPLETED|Overall Study||17
9781311|NCT00505076|10888166|FG000|NOT COMPLETED|Overall Study||3
9781312|NCT00505076|10888167|FG001|NOT COMPLETED|Overall Study||2
9781313|NCT00505076|10888168|FG002|NOT COMPLETED|Overall Study||5
9781314|NCT00505284|10888181|FG000|STARTED|Overall Study||73
9781315|NCT00505284|10888182|FG001|STARTED|Overall Study||72
9781316|NCT00505284|10888183|FG002|STARTED|Overall Study||69
9781317|NCT00505284|10888184|FG003|STARTED|Overall Study||68
9781318|NCT00505284|10888185|FG004|STARTED|Overall Study||70
9781319|NCT00505284|10888181|FG000|COMPLETED|Overall Study||63
9781320|NCT00505284|10888182|FG001|COMPLETED|Overall Study||56
9781321|NCT00505284|10888183|FG002|COMPLETED|Overall Study||57
9781322|NCT00505284|10888184|FG003|COMPLETED|Overall Study||49
9781323|NCT00505284|10888185|FG004|COMPLETED|Overall Study||37
9781324|NCT00505284|10888181|FG000|NOT COMPLETED|Overall Study||10
9781325|NCT00505284|10888182|FG001|NOT COMPLETED|Overall Study||16
9781326|NCT00505284|10888183|FG002|NOT COMPLETED|Overall Study||12
9781327|NCT00505284|10888184|FG003|NOT COMPLETED|Overall Study||19
9781328|NCT00505284|10888185|FG004|NOT COMPLETED|Overall Study||33
9781329|NCT00505362|10888199|FG000|STARTED|Overall Study||35
9781330|NCT00505362|10888200|FG001|STARTED|Overall Study||28
9781331|NCT00505362|10888199|FG000|COMPLETED|Overall Study||35
9781332|NCT00505362|10888200|FG001|COMPLETED|Overall Study||28
9781333|NCT00505362|10888199|FG000|NOT COMPLETED|Overall Study||0
9781334|NCT00505362|10888200|FG001|NOT COMPLETED|Overall Study||0
9781335|NCT00505375|10888208|FG000|STARTED|Overall Study||77
9781336|NCT00505375|10888209|FG001|STARTED|Overall Study||35
9781337|NCT00505375|10888208|FG000|COMPLETED|Overall Study||73
9781338|NCT00505375|10888209|FG001|COMPLETED|Overall Study||30
9781339|NCT00505375|10888208|FG000|NOT COMPLETED|Overall Study||4
9781340|NCT00505375|10888209|FG001|NOT COMPLETED|Overall Study||5
9781341|NCT00505414|10888217|FG000|STARTED|Titration Phase||0
9781342|NCT00505414|10888218|FG001|STARTED|Titration Phase||0
9781343|NCT00505414|10888219|FG002|STARTED|Titration Phase||0
9781344|NCT00505414|10888220|FG003|STARTED|Titration Phase||62
9781345|NCT00505414|10888221|FG004|STARTED|Titration Phase||31
9781346|NCT00505414|10888217|FG000|COMPLETED|Titration Phase||0
9781347|NCT00505414|10888218|FG001|COMPLETED|Titration Phase||0
9781348|NCT00505414|10888219|FG002|COMPLETED|Titration Phase||0
9781349|NCT00505414|10888220|FG003|COMPLETED|Titration Phase||32
9781350|NCT00505414|10888221|FG004|COMPLETED|Titration Phase||19
9781351|NCT00505414|10888217|FG000|NOT COMPLETED|Titration Phase||0
9781352|NCT00505414|10888218|FG001|NOT COMPLETED|Titration Phase||0
9781353|NCT00505414|10888219|FG002|NOT COMPLETED|Titration Phase||0
9781354|NCT00505414|10888220|FG003|NOT COMPLETED|Titration Phase||30
9781355|NCT00505414|10888221|FG004|NOT COMPLETED|Titration Phase||12
9781356|NCT00505414|10888217|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
9781357|NCT00505414|10888218|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
9781358|NCT00505414|10888219|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
9781359|NCT00505414|10888220|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
9781360|NCT00505414|10888221|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
9781361|NCT00505414|10888217|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
9781362|NCT00505414|10888218|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
9781363|NCT00505414|10888219|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
9781364|NCT00505414|10888220|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
9781365|NCT00505414|10888221|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
9781366|NCT00505414|10888217|FG000|COMPLETED|Maintenance Phase||12
9781367|NCT00505414|10888218|FG001|COMPLETED|Maintenance Phase||10
9781368|NCT00505414|10888219|FG002|COMPLETED|Maintenance Phase||6
9781369|NCT00505414|10888220|FG003|COMPLETED|Maintenance Phase||0
9781370|NCT00505414|10888221|FG004|COMPLETED|Maintenance Phase||0
9781371|NCT00505414|10888217|FG000|NOT COMPLETED|Maintenance Phase||6
9781372|NCT00505414|10888218|FG001|NOT COMPLETED|Maintenance Phase||5
9781373|NCT00505414|10888219|FG002|NOT COMPLETED|Maintenance Phase||8
9781374|NCT00505414|10888220|FG003|NOT COMPLETED|Maintenance Phase||0
9781375|NCT00505414|10888221|FG004|NOT COMPLETED|Maintenance Phase||0
9781376|NCT00505518|10888233|FG000|STARTED|Overall Study||9
9781377|NCT00505518|10888233|FG000|COMPLETED|Overall Study||9
9781378|NCT00505518|10888233|FG000|NOT COMPLETED|Overall Study||0
9781379|NCT00505622|10888240|FG000|STARTED|Overall Study||121
9781380|NCT00505622|10888241|FG001|STARTED|Overall Study||108
9781381|NCT00505622|10888242|FG002|STARTED|Overall Study||96
9781382|NCT00505622|10888240|FG000|COMPLETED|Overall Study||0
9781383|NCT00505622|10888241|FG001|COMPLETED|Overall Study||0
9781384|NCT00505622|10888242|FG002|COMPLETED|Overall Study||0
9781385|NCT00505622|10888240|FG000|NOT COMPLETED|Overall Study||121
9781386|NCT00505622|10888241|FG001|NOT COMPLETED|Overall Study||108
9781387|NCT00505622|10888242|FG002|NOT COMPLETED|Overall Study||96
9781388|NCT00505635|10888250|FG000|STARTED|Overall Study||5
9781389|NCT00505635|10888250|FG000|COMPLETED|Overall Study||5
9781390|NCT00505635|10888250|FG000|NOT COMPLETED|Overall Study||0
9781391|NCT00505661|10888254|FG000|STARTED|Overall Study||16
9781392|NCT00505661|10888254|FG000|COMPLETED|Overall Study||12
9781393|NCT00505661|10888254|FG000|NOT COMPLETED|Overall Study||4
9781394|NCT00505687|10888258|FG000|STARTED|Overall Study||186
9781395|NCT00505687|10888258|FG000|COMPLETED|Overall Study||91
9781396|NCT00505687|10888258|FG000|NOT COMPLETED|Overall Study||95
9781397|NCT00505752|10888266|FG000|STARTED|Overall Study||132
9781398|NCT00505752|10888267|FG001|STARTED|Overall Study||128
9781399|NCT00505752|10888268|FG002|STARTED|Overall Study||128
9781400|NCT00505752|10888269|FG003|STARTED|Overall Study||132
9781401|NCT00505752|10888266|FG000|COMPLETED|Overall Study||126
9781402|NCT00505752|10888267|FG001|COMPLETED|Overall Study||119
9781403|NCT00505752|10888268|FG002|COMPLETED|Overall Study||120
9781404|NCT00505752|10888269|FG003|COMPLETED|Overall Study||126
9781405|NCT00505752|10888266|FG000|NOT COMPLETED|Overall Study||6
9781406|NCT00505752|10888267|FG001|NOT COMPLETED|Overall Study||9
9781407|NCT00505752|10888268|FG002|NOT COMPLETED|Overall Study||8
9781408|NCT00505752|10888269|FG003|NOT COMPLETED|Overall Study||6
9781409|NCT00505765|10888282|FG000|STARTED|Overall Study||21
9781410|NCT00505765|10888283|FG001|STARTED|Overall Study||20
9781411|NCT00505765|10888284|FG002|STARTED|Overall Study||22
9781412|NCT00505765|10888282|FG000|Mid-Point Assessment|Overall Study||20
9781413|NCT00505765|10888283|FG001|Mid-Point Assessment|Overall Study||19
9781414|NCT00505765|10888284|FG002|Mid-Point Assessment|Overall Study||21
9781415|NCT00505765|10888282|FG000|COMPLETED|Overall Study||19
9781416|NCT00505765|10888283|FG001|COMPLETED|Overall Study||17
9781417|NCT00505765|10888284|FG002|COMPLETED|Overall Study||19
9781418|NCT00505765|10888282|FG000|NOT COMPLETED|Overall Study||2
9781419|NCT00505765|10888283|FG001|NOT COMPLETED|Overall Study||3
9781420|NCT00505765|10888284|FG002|NOT COMPLETED|Overall Study||3
9781421|NCT00505778|10888294|FG000|STARTED|Overall Study||514
9781422|NCT00505778|10888295|FG001|STARTED|Overall Study||513
9781423|NCT00505778|10888294|FG000|Intent to Treat (ITT) Population|Overall Study||512
9781424|NCT00505778|10888295|FG001|Intent to Treat (ITT) Population|Overall Study||511
9781425|NCT00505778|10888294|FG000|COMPLETED|Overall Study||380
9781426|NCT00505778|10888295|FG001|COMPLETED|Overall Study||378
9781427|NCT00505778|10888294|FG000|NOT COMPLETED|Overall Study||134
9781428|NCT00505778|10888295|FG001|NOT COMPLETED|Overall Study||135
9781429|NCT00505895|10888303|FG000|STARTED|Overall Study||27
9781430|NCT00505895|10888304|FG001|STARTED|Overall Study||23
9781431|NCT00505895|10888303|FG000|COMPLETED|Overall Study||27
9781432|NCT00505895|10888304|FG001|COMPLETED|Overall Study||23
9781433|NCT00505895|10888303|FG000|NOT COMPLETED|Overall Study||0
9781434|NCT00505895|10888304|FG001|NOT COMPLETED|Overall Study||0
9781435|NCT00505921|10888310|FG000|STARTED|Overall Study||27
9781436|NCT00505921|10888310|FG000|COMPLETED|Overall Study||18
9781437|NCT00505921|10888310|FG000|NOT COMPLETED|Overall Study||9
9781438|NCT00505934|10888314|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
9781439|NCT00505934|10888314|FG000|COMPLETED|Overall Study||16
9781440|NCT00505934|10888314|FG000|NOT COMPLETED|Overall Study||3
9781441|NCT00506025|10888321|FG000|STARTED|Overall Study||10
9781442|NCT00506025|10888322|FG001|STARTED|Overall Study||9
9781443|NCT00506025|10888323|FG002|STARTED|Overall Study||8
9781444|NCT00506025|10888321|FG000|COMPLETED|Overall Study||10
9781445|NCT00506025|10888322|FG001|COMPLETED|Overall Study||9
9781446|NCT00506025|10888323|FG002|COMPLETED|Overall Study||8
9781447|NCT00506025|10888321|FG000|NOT COMPLETED|Overall Study||0
9781448|NCT00506025|10888322|FG001|NOT COMPLETED|Overall Study||0
9781449|NCT00506025|10888323|FG002|NOT COMPLETED|Overall Study||0
9781450|NCT00506077|10888333|FG000|STARTED|Treatment Period 1||28
9781451|NCT00506077|10888334|FG001|STARTED|Treatment Period 1||27
9781452|NCT00506077|10888333|FG000|COMPLETED|Treatment Period 1||24
9781453|NCT00506077|10888334|FG001|COMPLETED|Treatment Period 1||24
9781454|NCT00506077|10888333|FG000|NOT COMPLETED|Treatment Period 1||4
9781455|NCT00506077|10888334|FG001|NOT COMPLETED|Treatment Period 1||3
9781456|NCT00506077|10888333|FG000|STARTED|Washout||24
9781457|NCT00506077|10888334|FG001|STARTED|Washout||24
9781458|NCT00506077|10888333|FG000|COMPLETED|Washout||24
9781459|NCT00506077|10888334|FG001|COMPLETED|Washout||24
9781460|NCT00506077|10888333|FG000|NOT COMPLETED|Washout||0
9781461|NCT00506077|10888334|FG001|NOT COMPLETED|Washout||0
9781462|NCT00506077|10888333|FG000|STARTED|Treatment Period 2||24
9781463|NCT00506077|10888334|FG001|STARTED|Treatment Period 2||24
9781464|NCT00506077|10888333|FG000|COMPLETED|Treatment Period 2||23
9781465|NCT00506077|10888334|FG001|COMPLETED|Treatment Period 2||23
9781466|NCT00506077|10888333|FG000|NOT COMPLETED|Treatment Period 2||1
9781467|NCT00506077|10888334|FG001|NOT COMPLETED|Treatment Period 2||1
9781468|NCT00506129|10888340|FG000|STARTED|Overall Study||33
9781469|NCT00506129|10888340|FG000|COMPLETED|Overall Study||11
9781470|NCT00506129|10888340|FG000|NOT COMPLETED|Overall Study||22
9781471|NCT00506142|10888346|FG000|STARTED|Overall Study||35
9781472|NCT00506142|10888347|FG001|STARTED|Overall Study||19
9781473|NCT00506142|10888346|FG000|COMPLETED|Overall Study||0
9781474|NCT00506142|10888347|FG001|COMPLETED|Overall Study||0
9781475|NCT00506142|10888346|FG000|NOT COMPLETED|Overall Study||35
9781476|NCT00506142|10888347|FG001|NOT COMPLETED|Overall Study||19
9781477|NCT00506155|10888353|FG000|STARTED|Overall Study||60
9781478|NCT00506155|10888353|FG000|COMPLETED|Overall Study||60
9781479|NCT00506155|10888353|FG000|NOT COMPLETED|Overall Study||0
9781480|NCT00506285|10888359|FG000|STARTED|3 Week Screening Phase||46
9781481|NCT00506285|10888360|FG001|STARTED|3 Week Screening Phase||46
10014839|NCT01802216|11137883|FG000|COMPLETED|Baseline||17
10014840|NCT01802216|11137884|FG001|COMPLETED|Baseline||34
10014841|NCT01802216|11137883|FG000|NOT COMPLETED|Baseline||0
10014842|NCT01802216|11137884|FG001|NOT COMPLETED|Baseline||0
10014843|NCT01802216|11137883|FG000|STARTED|4 Month Visit||17
9781482|NCT00506285|10888359|FG000|COMPLETED|3 Week Screening Phase||29
9781483|NCT00506285|10888360|FG001|COMPLETED|3 Week Screening Phase||36
9781484|NCT00506285|10888359|FG000|NOT COMPLETED|3 Week Screening Phase||17
9781485|NCT00506285|10888360|FG001|NOT COMPLETED|3 Week Screening Phase||10
9781486|NCT00506285|10888359|FG000|STARTED|Double Blind Cross-Over Phase||29
9781487|NCT00506285|10888360|FG001|STARTED|Double Blind Cross-Over Phase||36
9781488|NCT00506285|10888359|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
9781489|NCT00506285|10888360|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
9781490|NCT00506285|10888359|FG000|COMPLETED|Double Blind Cross-Over Phase||20
9781491|NCT00506285|10888360|FG001|COMPLETED|Double Blind Cross-Over Phase||31
9781492|NCT00506285|10888359|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9
9781493|NCT00506285|10888360|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5
9781494|NCT00506285|10888359|FG000|STARTED|6-month Open Label Phase||20
9781495|NCT00506285|10888360|FG001|STARTED|6-month Open Label Phase||31
9781496|NCT00506285|10888359|FG000|COMPLETED|6-month Open Label Phase||10
9781497|NCT00506285|10888360|FG001|COMPLETED|6-month Open Label Phase||19
9781498|NCT00506285|10888359|FG000|NOT COMPLETED|6-month Open Label Phase||10
9781499|NCT00506285|10888360|FG001|NOT COMPLETED|6-month Open Label Phase||12
9781500|NCT00506350|10888377|FG000|STARTED|Overall Study||36
9781501|NCT00506350|10888378|FG001|STARTED|Overall Study||40
9781502|NCT00506350|10888379|FG002|STARTED|Overall Study||37
9781503|NCT00506350|10888380|FG003|STARTED|Overall Study||36
9781504|NCT00506350|10888381|FG004|STARTED|Overall Study||50
9781505|NCT00506350|10888382|FG005|STARTED|Overall Study||40
9781506|NCT00506350|10888383|FG006|STARTED|Overall Study||35
9781507|NCT00506350|10888384|FG007|STARTED|Overall Study||41
9781508|NCT00506350|10888385|FG008|STARTED|Overall Study||35
9781509|NCT00506350|10888377|FG000|COMPLETED|Overall Study||33
9781510|NCT00506350|10888378|FG001|COMPLETED|Overall Study||37
9781511|NCT00506350|10888379|FG002|COMPLETED|Overall Study||31
9781512|NCT00506350|10888380|FG003|COMPLETED|Overall Study||34
9781513|NCT00506350|10888381|FG004|COMPLETED|Overall Study||40
9781514|NCT00506350|10888382|FG005|COMPLETED|Overall Study||38
9781515|NCT00506350|10888383|FG006|COMPLETED|Overall Study||33
9781516|NCT00506350|10888384|FG007|COMPLETED|Overall Study||36
9781517|NCT00506350|10888385|FG008|COMPLETED|Overall Study||30
9781518|NCT00506350|10888377|FG000|NOT COMPLETED|Overall Study||3
9781519|NCT00506350|10888378|FG001|NOT COMPLETED|Overall Study||3
9781520|NCT00506350|10888379|FG002|NOT COMPLETED|Overall Study||6
9781521|NCT00506350|10888380|FG003|NOT COMPLETED|Overall Study||2
9781522|NCT00506350|10888381|FG004|NOT COMPLETED|Overall Study||10
9781523|NCT00506350|10888382|FG005|NOT COMPLETED|Overall Study||2
9781524|NCT00506350|10888383|FG006|NOT COMPLETED|Overall Study||2
9781525|NCT00506350|10888384|FG007|NOT COMPLETED|Overall Study||5
9781526|NCT00506350|10888385|FG008|NOT COMPLETED|Overall Study||5
9781527|NCT00506389|10888415|FG000|STARTED|In-treatment Period||143
9781528|NCT00506389|10888416|FG001|STARTED|In-treatment Period||139
9781529|NCT00506389|10888417|FG002|STARTED|In-treatment Period||137
9781530|NCT00506389|10888415|FG000|All Participants Treated|In-treatment Period||139
9781531|NCT00506389|10888416|FG001|All Participants Treated|In-treatment Period||138
9781532|NCT00506389|10888417|FG002|All Participants Treated|In-treatment Period||136
9781533|NCT00506389|10888415|FG000|COMPLETED|In-treatment Period||117
9781534|NCT00506389|10888416|FG001|COMPLETED|In-treatment Period||124
9781535|NCT00506389|10888417|FG002|COMPLETED|In-treatment Period||125
9781536|NCT00506389|10888415|FG000|NOT COMPLETED|In-treatment Period||26
9781537|NCT00506389|10888416|FG001|NOT COMPLETED|In-treatment Period||15
9781538|NCT00506389|10888417|FG002|NOT COMPLETED|In-treatment Period||12
9781539|NCT00506389|10888415|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
9781540|NCT00506389|10888416|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
9781541|NCT00506389|10888417|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
10014844|NCT01802216|11137884|FG001|STARTED|4 Month Visit||34
9781542|NCT00506389|10888415|FG000|COMPLETED|Follow-up Period||139
9781543|NCT00506389|10888416|FG001|COMPLETED|Follow-up Period||138
9781544|NCT00506389|10888417|FG002|COMPLETED|Follow-up Period||136
9781545|NCT00506389|10888415|FG000|NOT COMPLETED|Follow-up Period||0
9781546|NCT00506389|10888416|FG001|NOT COMPLETED|Follow-up Period||0
9781547|NCT00506389|10888417|FG002|NOT COMPLETED|Follow-up Period||0
9781548|NCT00506415|10888428|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
9781549|NCT00506415|10888429|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0
9781550|NCT00506415|10888430|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0
9781551|NCT00506415|10888431|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0
9781552|NCT00506415|10888428|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
9781553|NCT00506415|10888429|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
9781554|NCT00506415|10888430|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
9781555|NCT00506415|10888431|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
9781556|NCT00506415|10888428|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
9781557|NCT00506415|10888429|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
9781558|NCT00506415|10888430|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10014845|NCT01802216|11137883|FG000|COMPLETED|4 Month Visit||14
10014846|NCT01802216|11137884|FG001|COMPLETED|4 Month Visit||30
10014847|NCT01802216|11137883|FG000|NOT COMPLETED|4 Month Visit||3
10014848|NCT01802216|11137884|FG001|NOT COMPLETED|4 Month Visit||4
10014849|NCT01802216|11137883|FG000|STARTED|8 Month Visit||17
10014850|NCT01802216|11137884|FG001|STARTED|8 Month Visit||34
10014851|NCT01802216|11137883|FG000|COMPLETED|8 Month Visit||14
10014852|NCT01802216|11137884|FG001|COMPLETED|8 Month Visit||29
10014853|NCT01802216|11137883|FG000|NOT COMPLETED|8 Month Visit||3
10014854|NCT01802216|11137884|FG001|NOT COMPLETED|8 Month Visit||5
10014855|NCT01802216|11137883|FG000|STARTED|12 Month Visit||17
10014856|NCT01802216|11137884|FG001|STARTED|12 Month Visit||34
10014857|NCT01802216|11137883|FG000|COMPLETED|12 Month Visit||14
10014858|NCT01802216|11137884|FG001|COMPLETED|12 Month Visit||30
10014859|NCT01802216|11137883|FG000|NOT COMPLETED|12 Month Visit||3
9781559|NCT00506415|10888431|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
9781560|NCT00506415|10888428|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
9781561|NCT00506415|10888429|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
9781562|NCT00506415|10888430|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
9781563|NCT00506415|10888431|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
9781564|NCT00506415|10888428|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0
9781565|NCT00506415|10888429|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
9781566|NCT00506415|10888430|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280
9781567|NCT00506415|10888431|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0
9781568|NCT00506415|10888428|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0
9781569|NCT00506415|10888429|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203
9781570|NCT00506415|10888430|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207
9781571|NCT00506415|10888431|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0
9781572|NCT00506415|10888428|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
9781573|NCT00506415|10888429|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
9781574|NCT00506415|10888430|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
9781575|NCT00506415|10888431|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
9781576|NCT00506415|10888428|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0
9781577|NCT00506415|10888429|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0
9781578|NCT00506415|10888430|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0
9781579|NCT00506415|10888431|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
9781580|NCT00506415|10888428|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
9781581|NCT00506415|10888429|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
9781582|NCT00506415|10888430|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
9781583|NCT00506415|10888431|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
9781584|NCT00506415|10888428|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
9781585|NCT00506415|10888429|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
9781586|NCT00506415|10888430|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
9781587|NCT00506415|10888431|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
9781588|NCT00506441|10888444|FG000|STARTED|Period 1; Open-label Period||245
9781589|NCT00506441|10888445|FG001|STARTED|Period 1; Open-label Period||0
9781590|NCT00506441|10888444|FG000|COMPLETED|Period 1; Open-label Period||169
9781591|NCT00506441|10888445|FG001|COMPLETED|Period 1; Open-label Period||0
9781592|NCT00506441|10888444|FG000|NOT COMPLETED|Period 1; Open-label Period||76
9781593|NCT00506441|10888445|FG001|NOT COMPLETED|Period 1; Open-label Period||0
9781594|NCT00506441|10888444|FG000|STARTED|Period 2; Double-blind Period||85
9781595|NCT00506441|10888445|FG001|STARTED|Period 2; Double-blind Period||84
9781596|NCT00506441|10888444|FG000|COMPLETED|Period 2; Double-blind Period||82
9781597|NCT00506441|10888445|FG001|COMPLETED|Period 2; Double-blind Period||79
9781598|NCT00506441|10888444|FG000|NOT COMPLETED|Period 2; Double-blind Period||3
9781599|NCT00506441|10888445|FG001|NOT COMPLETED|Period 2; Double-blind Period||5
9781600|NCT00506454|10888455|FG000|STARTED|Overall Study||11
9781601|NCT00506454|10888456|FG001|STARTED|Overall Study||11
10014860|NCT01802216|11137884|FG001|NOT COMPLETED|12 Month Visit||4
10014861|NCT01802320|11137890|FG000|STARTED|Overall Study||18
10014862|NCT01802320|11137890|FG000|COMPLETED|Overall Study||16
9781602|NCT00506454|10888455|FG000|COMPLETED|Overall Study||10
9781603|NCT00506454|10888456|FG001|COMPLETED|Overall Study||10
9781604|NCT00506454|10888455|FG000|NOT COMPLETED|Overall Study||1
9781605|NCT00506454|10888456|FG001|NOT COMPLETED|Overall Study||1
9781606|NCT00506493|10888462|FG000|STARTED|Overall Study||75
9781607|NCT00506493|10888462|FG000|COMPLETED|Overall Study||64
9781608|NCT00506493|10888462|FG000|NOT COMPLETED|Overall Study||11
9781609|NCT00506519|10888471|FG000|STARTED|Overall Study||10
9781610|NCT00506519|10888472|FG001|STARTED|Overall Study||10
9781611|NCT00506519|10888473|FG002|STARTED|Overall Study||5
9781612|NCT00506519|10888471|FG000|Completed Treatment (Day 5)|Overall Study||8
9781613|NCT00506519|10888472|FG001|Completed Treatment (Day 5)|Overall Study||7
9781614|NCT00506519|10888473|FG002|Completed Treatment (Day 5)|Overall Study||5
9781615|NCT00506519|10888471|FG000|Day 28 Follow up|Overall Study||8
9781616|NCT00506519|10888472|FG001|Day 28 Follow up|Overall Study||6
9781617|NCT00506519|10888473|FG002|Day 28 Follow up|Overall Study||5
9781618|NCT00506519|10888471|FG000|COMPLETED|Overall Study||5
9781619|NCT00506519|10888472|FG001|COMPLETED|Overall Study||4
9781620|NCT00506519|10888473|FG002|COMPLETED|Overall Study||5
9781621|NCT00506519|10888471|FG000|NOT COMPLETED|Overall Study||5
9781622|NCT00506519|10888472|FG001|NOT COMPLETED|Overall Study||6
9781623|NCT00506519|10888473|FG002|NOT COMPLETED|Overall Study||0
9781624|NCT00506597|10888484|FG000|STARTED|Overall Study||33
9781625|NCT00506597|10888484|FG000|COMPLETED|Overall Study||33
9781626|NCT00506597|10888484|FG000|NOT COMPLETED|Overall Study||0
9781627|NCT00506662|10888490|FG000|STARTED|Overall Study||38
9781628|NCT00506662|10888491|FG001|STARTED|Overall Study||48
9781629|NCT00506662|10888490|FG000|COMPLETED|Overall Study||21
9781630|NCT00506662|10888491|FG001|COMPLETED|Overall Study||20
9781631|NCT00506662|10888490|FG000|NOT COMPLETED|Overall Study||17
9781632|NCT00506662|10888491|FG001|NOT COMPLETED|Overall Study||28
9781633|NCT00506675|10888499|FG000|STARTED|Overall Study||27
9781634|NCT00506675|10888500|FG001|STARTED|Overall Study||28
9781635|NCT00506675|10888499|FG000|COMPLETED|Overall Study||27
9781636|NCT00506675|10888500|FG001|COMPLETED|Overall Study||28
9781637|NCT00506675|10888499|FG000|NOT COMPLETED|Overall Study||0
9781638|NCT00506675|10888500|FG001|NOT COMPLETED|Overall Study||0
9781639|NCT00506714|10888508|FG000|STARTED|Overall Study||13
9781640|NCT00506714|10888509|FG001|STARTED|Overall Study||13
9781641|NCT00506714|10888508|FG000|COMPLETED|Overall Study||13
9781642|NCT00506714|10888509|FG001|COMPLETED|Overall Study||13
9781643|NCT00506714|10888508|FG000|NOT COMPLETED|Overall Study||0
9781644|NCT00506714|10888509|FG001|NOT COMPLETED|Overall Study||0
9781645|NCT00506753|10888519|FG000|STARTED|Overall Study||100
9781646|NCT00506753|10888520|FG001|STARTED|Overall Study||99
9781647|NCT00506753|10888519|FG000|COMPLETED|Overall Study||79
9781648|NCT00506753|10888520|FG001|COMPLETED|Overall Study||84
9781649|NCT00506753|10888519|FG000|NOT COMPLETED|Overall Study||21
9781650|NCT00506753|10888520|FG001|NOT COMPLETED|Overall Study||15
9781651|NCT00506779|10888528|FG000|STARTED|Overall Study||4
9781652|NCT00506779|10888529|FG001|STARTED|Overall Study||6
9781653|NCT00506779|10888530|FG002|STARTED|Overall Study||2
9781654|NCT00506779|10888531|FG003|STARTED|Overall Study||5
9781655|NCT00506779|10888528|FG000|COMPLETED|Overall Study||3
9781656|NCT00506779|10888529|FG001|COMPLETED|Overall Study||5
9781657|NCT00506779|10888530|FG002|COMPLETED|Overall Study||0
9781658|NCT00506779|10888531|FG003|COMPLETED|Overall Study||4
9781659|NCT00506779|10888528|FG000|NOT COMPLETED|Overall Study||1
9781660|NCT00506779|10888529|FG001|NOT COMPLETED|Overall Study||1
9781661|NCT00506779|10888530|FG002|NOT COMPLETED|Overall Study||2
9781662|NCT00506779|10888531|FG003|NOT COMPLETED|Overall Study||1
9781663|NCT00506831|10888542|FG000|STARTED|Overall Study||9
9781664|NCT00506831|10888542|FG000|COMPLETED|Overall Study||7
9781665|NCT00506831|10888542|FG000|NOT COMPLETED|Overall Study||2
9781666|NCT00506857|10888546|FG000|STARTED|Overall Study||80
9781667|NCT00506857|10888546|FG000|COMPLETED|Overall Study||80
9781668|NCT00506857|10888546|FG000|NOT COMPLETED|Overall Study||0
10233972|NCT01605617|11363848|FG001|STARTED|Second Intervention||0
10233973|NCT01605617|11363847|FG000|COMPLETED|Second Intervention||0
10233974|NCT01605617|11363848|FG001|COMPLETED|Second Intervention||0
10233975|NCT01605617|11363847|FG000|NOT COMPLETED|Second Intervention||0
10233976|NCT01605617|11363848|FG001|NOT COMPLETED|Second Intervention||0
10233977|NCT01606709|11363858|FG000|STARTED|Overall Study||4
10233978|NCT01606709|11363859|FG001|STARTED|Overall Study||3
10233979|NCT01606709|11363858|FG000|COMPLETED|Overall Study||4
9781669|NCT00506883|10888554|FG000|STARTED|Overall Study||52
9781670|NCT00506883|10888555|FG001|STARTED|Overall Study||74
9781671|NCT00506883|10888556|FG002|STARTED|Overall Study||59
9781672|NCT00506883|10888554|FG000|COMPLETED|Overall Study||45
9781673|NCT00506883|10888555|FG001|COMPLETED|Overall Study||71
9781674|NCT00506883|10888556|FG002|COMPLETED|Overall Study||55
9781675|NCT00506883|10888554|FG000|NOT COMPLETED|Overall Study||7
9781676|NCT00506883|10888555|FG001|NOT COMPLETED|Overall Study||3
9781677|NCT00506883|10888556|FG002|NOT COMPLETED|Overall Study||4
9781678|NCT00506922|10888569|FG000|STARTED|Overall Study||37
9781679|NCT00506922|10888570|FG001|STARTED|Overall Study||10
9781680|NCT00506922|10888571|FG002|STARTED|Overall Study||29
9781681|NCT00506922|10888572|FG003|STARTED|Overall Study||63
9781682|NCT00506922|10888573|FG004|STARTED|Overall Study||11
9781683|NCT00506922|10888569|FG000|COMPLETED|Overall Study||37
9781684|NCT00506922|10888570|FG001|COMPLETED|Overall Study||10
9781685|NCT00506922|10888571|FG002|COMPLETED|Overall Study||29
9781686|NCT00506922|10888572|FG003|COMPLETED|Overall Study||61
9781687|NCT00506922|10888573|FG004|COMPLETED|Overall Study||10
9781688|NCT00506922|10888569|FG000|NOT COMPLETED|Overall Study||0
9781689|NCT00506922|10888570|FG001|NOT COMPLETED|Overall Study||0
9781690|NCT00506922|10888571|FG002|NOT COMPLETED|Overall Study||0
9781691|NCT00506922|10888572|FG003|NOT COMPLETED|Overall Study||2
9781692|NCT00506922|10888573|FG004|NOT COMPLETED|Overall Study||1
9781693|NCT00506948|10888581|FG000|STARTED|Overall Study||10
9781694|NCT00506948|10888581|FG000|COMPLETED|Overall Study||0
9781695|NCT00506948|10888581|FG000|NOT COMPLETED|Overall Study||10
9781696|NCT00507026|10888588|FG000|STARTED|Overall Study||145
9781697|NCT00507026|10888589|FG001|STARTED|Overall Study||60
9781698|NCT00507026|10888590|FG002|STARTED|Overall Study||72
9781699|NCT00507026|10888588|FG000|COMPLETED|Overall Study||132
9781700|NCT00507026|10888589|FG001|COMPLETED|Overall Study||56
9781701|NCT00507026|10888590|FG002|COMPLETED|Overall Study||51
9781702|NCT00507026|10888588|FG000|NOT COMPLETED|Overall Study||13
9781703|NCT00507026|10888589|FG001|NOT COMPLETED|Overall Study||4
9781704|NCT00507026|10888590|FG002|NOT COMPLETED|Overall Study||21
9781705|NCT00507130|10888602|FG000|STARTED|Overall Study||9
9781706|NCT00507130|10888603|FG001|STARTED|Overall Study||9
9781707|NCT00507130|10888604|FG002|STARTED|Overall Study||9
9781708|NCT00507130|10888605|FG003|STARTED|Overall Study||9
9781709|NCT00507130|10888602|FG000|COMPLETED|Overall Study||8
9781710|NCT00507130|10888603|FG001|COMPLETED|Overall Study||9
9781711|NCT00507130|10888604|FG002|COMPLETED|Overall Study||8
9781712|NCT00507130|10888605|FG003|COMPLETED|Overall Study||8
9781713|NCT00507130|10888602|FG000|NOT COMPLETED|Overall Study||1
9781714|NCT00507130|10888603|FG001|NOT COMPLETED|Overall Study||0
9781715|NCT00507130|10888604|FG002|NOT COMPLETED|Overall Study||1
9781716|NCT00507130|10888605|FG003|NOT COMPLETED|Overall Study||1
9830269|NCT00762463|10940928|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109
9830270|NCT00762463|10940929|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0
9830271|NCT00762463|10940930|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0
9830272|NCT00762463|10940927|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
9830273|NCT00762463|10940928|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
9830274|NCT00762463|10940929|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
9830275|NCT00762463|10940930|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
9830276|NCT00762463|10940927|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55
9830277|NCT00762463|10940928|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55
9830278|NCT00762463|10940929|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54
9830279|NCT00762463|10940930|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54
9830280|NCT00762463|10940927|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52
9830281|NCT00762463|10940928|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54
9830282|NCT00762463|10940929|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50
9830283|NCT00762463|10940930|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52
9830284|NCT00762463|10940927|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
9830285|NCT00762463|10940928|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
9830286|NCT00762463|10940929|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
9830287|NCT00762463|10940930|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
9830288|NCT00762476|10940945|FG000|STARTED|Overall Study||206
9830289|NCT00762476|10940946|FG001|STARTED|Overall Study||205
9830290|NCT00762476|10940945|FG000|COMPLETED|Overall Study||183
9830291|NCT00762476|10940946|FG001|COMPLETED|Overall Study||169
9830292|NCT00762476|10940945|FG000|NOT COMPLETED|Overall Study||23
9830293|NCT00762476|10940946|FG001|NOT COMPLETED|Overall Study||36
9830294|NCT00762502|10940956|FG000|STARTED|Baseline to Month 3 (Period 1)||36
9830295|NCT00762502|10940957|FG001|STARTED|Baseline to Month 3 (Period 1)||25
9830296|NCT00762502|10940958|FG002|STARTED|Baseline to Month 3 (Period 1)||51
9830297|NCT00762502|10940956|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26
9830298|NCT00762502|10940957|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19
9830299|NCT00762502|10940958|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32
9830300|NCT00762502|10940956|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
9830301|NCT00762502|10940957|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
9830302|NCT00762502|10940958|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
9830303|NCT00762502|10940956|FG000|STARTED|Month 3 to Month 6 (Period 2)||9
9830304|NCT00762502|10940957|FG001|STARTED|Month 3 to Month 6 (Period 2)||5
9830305|NCT00762502|10940958|FG002|STARTED|Month 3 to Month 6 (Period 2)||23
9830306|NCT00762502|10940956|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9
9830307|NCT00762502|10940957|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4
9830308|NCT00762502|10940958|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23
9830309|NCT00762502|10940956|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
9830310|NCT00762502|10940957|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
9830311|NCT00762502|10940958|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
9830312|NCT00762515|10940966|FG000|STARTED|Overall Study||22
9830313|NCT00762515|10940967|FG001|STARTED|Overall Study||22
9830314|NCT00762515|10940966|FG000|COMPLETED|Overall Study||22
9830315|NCT00762515|10940967|FG001|COMPLETED|Overall Study||22
9830316|NCT00762515|10940966|FG000|NOT COMPLETED|Overall Study||0
9830317|NCT00762515|10940967|FG001|NOT COMPLETED|Overall Study||0
9830318|NCT00762528|10940975|FG000|STARTED|Overall Study||24
9830319|NCT00762528|10940976|FG001|STARTED|Overall Study||25
9830320|NCT00762528|10940975|FG000|COMPLETED|Overall Study||24
9830321|NCT00762528|10940976|FG001|COMPLETED|Overall Study||25
9830322|NCT00762528|10940975|FG000|NOT COMPLETED|Overall Study||0
9830323|NCT00762528|10940976|FG001|NOT COMPLETED|Overall Study||0
9781717|NCT00507208|10888617|FG000|STARTED|Overall Study||27
9781718|NCT00507208|10888618|FG001|STARTED|Overall Study||26
9781719|NCT00507208|10888617|FG000|Received Dynasplint in Crossover|Overall Study||0
9781720|NCT00507208|10888618|FG001|Received Dynasplint in Crossover|Overall Study||3
9781721|NCT00507208|10888617|FG000|COMPLETED|Overall Study||27
9781722|NCT00507208|10888618|FG001|COMPLETED|Overall Study||26
9781723|NCT00507208|10888617|FG000|NOT COMPLETED|Overall Study||0
9781724|NCT00507208|10888618|FG001|NOT COMPLETED|Overall Study||0
9781725|NCT00507416|10888627|FG000|STARTED|Overall Study||168
9781726|NCT00507416|10888628|FG001|STARTED|Overall Study||167
9781727|NCT00507416|10888629|FG002|STARTED|Overall Study||167
9781728|NCT00507416|10888627|FG000|Treated (Safety Population)|Overall Study||165
9781729|NCT00507416|10888628|FG001|Treated (Safety Population)|Overall Study||158
9781730|NCT00507416|10888629|FG002|Treated (Safety Population)|Overall Study||163
9781731|NCT00507416|10888627|FG000|Completed 8 Treatment Cycles|Overall Study||82
9781732|NCT00507416|10888628|FG001|Completed 8 Treatment Cycles|Overall Study||60
9781733|NCT00507416|10888629|FG002|Completed 8 Treatment Cycles|Overall Study||69
9781734|NCT00507416|10888627|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
9781735|NCT00507416|10888628|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
9781736|NCT00507416|10888629|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
9781737|NCT00507416|10888627|FG000|NOT COMPLETED|Overall Study||118
9781738|NCT00507416|10888628|FG001|NOT COMPLETED|Overall Study||125
9781739|NCT00507416|10888629|FG002|NOT COMPLETED|Overall Study||114
9781740|NCT00507429|10888639|FG000|STARTED|Treatment Phase|Randomized|55
9781741|NCT00507429|10888640|FG001|STARTED|Treatment Phase|Randomized|25
9781742|NCT00507429|10888639|FG000|COMPLETED|Treatment Phase||18
9781743|NCT00507429|10888640|FG001|COMPLETED|Treatment Phase||7
9781744|NCT00507429|10888639|FG000|NOT COMPLETED|Treatment Phase||37
9781745|NCT00507429|10888640|FG001|NOT COMPLETED|Treatment Phase||18
9781746|NCT00507429|10888639|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
9781747|NCT00507429|10888640|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
9781748|NCT00507429|10888639|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
9781749|NCT00507429|10888640|FG001|COMPLETED|Maintenance Phase||0
9781750|NCT00507429|10888639|FG000|NOT COMPLETED|Maintenance Phase||14
9781751|NCT00507429|10888640|FG001|NOT COMPLETED|Maintenance Phase||0
9781752|NCT00507442|10888652|FG000|STARTED|Overall Study||42
9781753|NCT00507442|10888653|FG001|STARTED|Overall Study||66
9781754|NCT00507442|10888654|FG002|STARTED|Overall Study||33
9781755|NCT00507442|10888655|FG003|STARTED|Overall Study||17
9781756|NCT00507442|10888652|FG000|COMPLETED|Overall Study||26
9781757|NCT00507442|10888653|FG001|COMPLETED|Overall Study||39
9781758|NCT00507442|10888654|FG002|COMPLETED|Overall Study||18
9781759|NCT00507442|10888655|FG003|COMPLETED|Overall Study||12
10014863|NCT01802320|11137890|FG000|NOT COMPLETED|Overall Study||2
10014864|NCT01802333|11137897|FG000|STARTED|Overall Study||263
10014865|NCT01802333|11137898|FG001|STARTED|Overall Study||267
10014866|NCT01802333|11137899|FG002|STARTED|Overall Study||224
9781760|NCT00507442|10888652|FG000|NOT COMPLETED|Overall Study||16
9781761|NCT00507442|10888653|FG001|NOT COMPLETED|Overall Study||27
9781762|NCT00507442|10888654|FG002|NOT COMPLETED|Overall Study||15
9781763|NCT00507442|10888655|FG003|NOT COMPLETED|Overall Study||5
9781764|NCT00507455|10888672|FG000|STARTED|Overall Study||74
9781765|NCT00507455|10888673|FG001|STARTED|Overall Study||74
9781766|NCT00507455|10888674|FG002|STARTED|Overall Study||74
9781767|NCT00507455|10888672|FG000|COMPLETED|Overall Study||62
9781768|NCT00507455|10888673|FG001|COMPLETED|Overall Study||68
9781769|NCT00507455|10888674|FG002|COMPLETED|Overall Study||62
9781770|NCT00507455|10888672|FG000|NOT COMPLETED|Overall Study||12
9781771|NCT00507455|10888673|FG001|NOT COMPLETED|Overall Study||6
9781772|NCT00507455|10888674|FG002|NOT COMPLETED|Overall Study||12
9781773|NCT00507507|10888684|FG000|STARTED|Treatment Period||64
9781774|NCT00507507|10888685|FG001|STARTED|Treatment Period||62
9781775|NCT00507507|10888684|FG000|Completed 192 Weeks of Treatment|Treatment Period||52
9781776|NCT00507507|10888685|FG001|Completed 192 Weeks of Treatment|Treatment Period||52
9781777|NCT00507507|10888684|FG000|COMPLETED|Treatment Period||12
9781778|NCT00507507|10888685|FG001|COMPLETED|Treatment Period||9
9781779|NCT00507507|10888684|FG000|NOT COMPLETED|Treatment Period||52
9781780|NCT00507507|10888685|FG001|NOT COMPLETED|Treatment Period||53
9781781|NCT00507507|10888684|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
9781782|NCT00507507|10888685|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
9781783|NCT00507507|10888684|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16
9781784|NCT00507507|10888685|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12
9781785|NCT00507507|10888684|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
9781786|NCT00507507|10888685|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
9781787|NCT00507546|10888695|FG000|STARTED|Overall Study||4
9781788|NCT00507546|10888696|FG001|STARTED|Overall Study||4
9781789|NCT00507546|10888695|FG000|COMPLETED|Overall Study||2
9781790|NCT00507546|10888696|FG001|COMPLETED|Overall Study||3
9781791|NCT00507546|10888695|FG000|NOT COMPLETED|Overall Study||2
10014867|NCT01802333|11137897|FG000|High Risk Patients|Overall Study||60
9781792|NCT00507546|10888696|FG001|NOT COMPLETED|Overall Study||1
9781793|NCT00507559|10888704|FG000|STARTED|Overall Study||155
9781794|NCT00507559|10888704|FG000|COMPLETED|Overall Study||84
9781795|NCT00507559|10888704|FG000|NOT COMPLETED|Overall Study||71
9781796|NCT00507689|10888711|FG000|STARTED|Pre-Randomization Period||40
9781797|NCT00507689|10888712|FG001|STARTED|Pre-Randomization Period||0
9781798|NCT00507689|10888711|FG000|COMPLETED|Pre-Randomization Period||37
9781799|NCT00507689|10888712|FG001|COMPLETED|Pre-Randomization Period||0
9781800|NCT00507689|10888711|FG000|NOT COMPLETED|Pre-Randomization Period||3
9781801|NCT00507689|10888712|FG001|NOT COMPLETED|Pre-Randomization Period||0
9781802|NCT00507689|10888711|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
9781803|NCT00507689|10888712|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
9781804|NCT00507689|10888711|FG000|COMPLETED|Randomized Period||18
9781805|NCT00507689|10888712|FG001|COMPLETED|Randomized Period||16
9781806|NCT00507689|10888711|FG000|NOT COMPLETED|Randomized Period||1
9781807|NCT00507689|10888712|FG001|NOT COMPLETED|Randomized Period||2
9781808|NCT00507728|10888722|FG000|STARTED|Randomization to Month 3||75
9781809|NCT00507728|10888723|FG001|STARTED|Randomization to Month 3||89
9781810|NCT00507728|10888724|FG002|STARTED|Randomization to Month 3||90
9781811|NCT00507728|10888722|FG000|COMPLETED|Randomization to Month 3||60
9781812|NCT00507728|10888723|FG001|COMPLETED|Randomization to Month 3||75
9781813|NCT00507728|10888724|FG002|COMPLETED|Randomization to Month 3||70
9781814|NCT00507728|10888722|FG000|NOT COMPLETED|Randomization to Month 3||15
9781815|NCT00507728|10888723|FG001|NOT COMPLETED|Randomization to Month 3||14
9781816|NCT00507728|10888724|FG002|NOT COMPLETED|Randomization to Month 3||20
9781817|NCT00507728|10888722|FG000|STARTED|From 3 Months to 6 Months||60
9781818|NCT00507728|10888723|FG001|STARTED|From 3 Months to 6 Months||75
9781819|NCT00507728|10888724|FG002|STARTED|From 3 Months to 6 Months||70
9781820|NCT00507728|10888722|FG000|COMPLETED|From 3 Months to 6 Months||54
9781821|NCT00507728|10888723|FG001|COMPLETED|From 3 Months to 6 Months||65
9781822|NCT00507728|10888724|FG002|COMPLETED|From 3 Months to 6 Months||61
9781823|NCT00507728|10888722|FG000|NOT COMPLETED|From 3 Months to 6 Months||6
9781824|NCT00507728|10888723|FG001|NOT COMPLETED|From 3 Months to 6 Months||10
9781825|NCT00507728|10888724|FG002|NOT COMPLETED|From 3 Months to 6 Months||9
9781826|NCT00507767|10888738|FG000|STARTED|Overall Study||15
9781827|NCT00507767|10888738|FG000|COMPLETED|Overall Study||15
9781828|NCT00507767|10888738|FG000|NOT COMPLETED|Overall Study||0
9781829|NCT00507819|10888742|FG000|STARTED|First Intervention (6 Weeks)||14
9781830|NCT00507819|10888743|FG001|STARTED|First Intervention (6 Weeks)||14
9781831|NCT00507819|10888742|FG000|COMPLETED|First Intervention (6 Weeks)||14
9781832|NCT00507819|10888743|FG001|COMPLETED|First Intervention (6 Weeks)||14
9781833|NCT00507819|10888742|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
9781834|NCT00507819|10888743|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
9781835|NCT00507819|10888742|FG000|STARTED|Washout (6 Weeks)||14
9781836|NCT00507819|10888743|FG001|STARTED|Washout (6 Weeks)||14
9781837|NCT00507819|10888742|FG000|COMPLETED|Washout (6 Weeks)||13
9781838|NCT00507819|10888743|FG001|COMPLETED|Washout (6 Weeks)||14
9781839|NCT00507819|10888742|FG000|NOT COMPLETED|Washout (6 Weeks)||1
9781840|NCT00507819|10888743|FG001|NOT COMPLETED|Washout (6 Weeks)||0
9781841|NCT00507819|10888742|FG000|STARTED|Second Intervention (6 Weeks)||13
9781842|NCT00507819|10888743|FG001|STARTED|Second Intervention (6 Weeks)||14
9781843|NCT00507819|10888742|FG000|COMPLETED|Second Intervention (6 Weeks)||13
9781844|NCT00507819|10888743|FG001|COMPLETED|Second Intervention (6 Weeks)||14
9781845|NCT00507819|10888742|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9781846|NCT00507819|10888743|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9781847|NCT00508001|10888752|FG000|STARTED|Overall Study||19
9781848|NCT00508001|10888753|FG001|STARTED|Overall Study||25
9781849|NCT00508001|10888754|FG002|STARTED|Overall Study||23
9781850|NCT00508001|10888752|FG000|Secondary Treatment Phase|Overall Study||0
9781851|NCT00508001|10888753|FG001|Secondary Treatment Phase|Overall Study||13
9781852|NCT00508001|10888754|FG002|Secondary Treatment Phase|Overall Study||16
9781853|NCT00508001|10888752|FG000|COMPLETED|Overall Study||0
9781854|NCT00508001|10888753|FG001|COMPLETED|Overall Study||13
9781855|NCT00508001|10888754|FG002|COMPLETED|Overall Study||16
9781856|NCT00508001|10888752|FG000|NOT COMPLETED|Overall Study||19
9781857|NCT00508001|10888753|FG001|NOT COMPLETED|Overall Study||12
9781858|NCT00508001|10888754|FG002|NOT COMPLETED|Overall Study||7
9781859|NCT00508027|10888762|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
9781860|NCT00508027|10888762|FG000|COMPLETED|Dose Level 1||12
9781861|NCT00508027|10888762|FG000|NOT COMPLETED|Dose Level 1||8
9781862|NCT00508027|10888762|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
9781863|NCT00508027|10888762|FG000|COMPLETED|Dose Level 2||16
9781864|NCT00508027|10888762|FG000|NOT COMPLETED|Dose Level 2||4
9781865|NCT00508027|10888762|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
9781866|NCT00508027|10888762|FG000|COMPLETED|Dose Level 3||2
10014868|NCT01802333|11137898|FG001|High Risk Patients|Overall Study||61
9781867|NCT00508027|10888762|FG000|NOT COMPLETED|Dose Level 3||0
9781868|NCT00508105|10888777|FG000|STARTED|Overall Study||44
9781869|NCT00508105|10888778|FG001|STARTED|Overall Study||43
9781870|NCT00508105|10888777|FG000|COMPLETED|Overall Study||40
9781871|NCT00508105|10888778|FG001|COMPLETED|Overall Study||37
9781872|NCT00508105|10888777|FG000|NOT COMPLETED|Overall Study||4
9781873|NCT00508105|10888778|FG001|NOT COMPLETED|Overall Study||6
9781874|NCT00508118|10888787|FG000|STARTED|Overall Study||3
9781875|NCT00508118|10888788|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
9781876|NCT00508118|10888787|FG000|COMPLETED|Overall Study||3
9781877|NCT00508118|10888788|FG001|COMPLETED|Overall Study||4
9781878|NCT00508118|10888787|FG000|NOT COMPLETED|Overall Study||0
9781879|NCT00508118|10888788|FG001|NOT COMPLETED|Overall Study||0
9781880|NCT00508144|10888795|FG000|STARTED|Overall Study||64
9781881|NCT00508144|10888795|FG000|COMPLETED|Overall Study||53
9781882|NCT00508144|10888795|FG000|NOT COMPLETED|Overall Study||11
9781883|NCT00508157|10888801|FG000|STARTED|Overall Study||26
9781884|NCT00508157|10888802|FG001|STARTED|Overall Study||26
9781885|NCT00508157|10888801|FG000|Randomized Sample|Overall Study||26
9781886|NCT00508157|10888802|FG001|Randomized Sample|Overall Study||26
9781887|NCT00508157|10888801|FG000|Safety Sample|Overall Study||26
9781888|NCT00508157|10888802|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
9781889|NCT00508157|10888801|FG000|COMPLETED|Overall Study||24
9781890|NCT00508157|10888802|FG001|COMPLETED|Overall Study||23
9781891|NCT00508157|10888801|FG000|NOT COMPLETED|Overall Study||2
9781892|NCT00508157|10888802|FG001|NOT COMPLETED|Overall Study||3
9781893|NCT00508183|10888810|FG000|STARTED|Overall Study||48
9781894|NCT00508183|10888811|FG001|STARTED|Overall Study||42
9781895|NCT00508183|10888810|FG000|COMPLETED|Overall Study||39
9781896|NCT00508183|10888811|FG001|COMPLETED|Overall Study||34
9781897|NCT00508183|10888810|FG000|NOT COMPLETED|Overall Study||9
9781898|NCT00508183|10888811|FG001|NOT COMPLETED|Overall Study||8
9781899|NCT00508196|10888817|FG000|STARTED|Overall Study||11
9781900|NCT00508196|10888818|FG001|STARTED|Overall Study||11
9781901|NCT00508196|10888817|FG000|COMPLETED|Overall Study||11
9781902|NCT00508196|10888818|FG001|COMPLETED|Overall Study||11
9781903|NCT00508196|10888817|FG000|NOT COMPLETED|Overall Study||0
9781904|NCT00508196|10888818|FG001|NOT COMPLETED|Overall Study||0
9781905|NCT00508261|10888828|FG000|STARTED|Overall Study||222
9781906|NCT00508261|10888829|FG001|STARTED|Overall Study||220
9781907|NCT00508261|10888830|FG002|STARTED|Overall Study||224
9781908|NCT00508261|10888831|FG003|STARTED|Overall Study||127
9781909|NCT00508261|10888828|FG000|COMPLETED|Overall Study||219
9781910|NCT00508261|10888829|FG001|COMPLETED|Overall Study||212
9781911|NCT00508261|10888830|FG002|COMPLETED|Overall Study||218
9781912|NCT00508261|10888831|FG003|COMPLETED|Overall Study||126
10014869|NCT01802333|11137899|FG002|High Risk Patients|Overall Study||38
10014870|NCT01802333|11137897|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38
10014871|NCT01802333|11137898|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40
10014872|NCT01802333|11137899|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29
10014873|NCT01802333|11137897|FG000|Known NPM1 Status at Baseline|Overall Study||169
10014874|NCT01802333|11137898|FG001|Known NPM1 Status at Baseline|Overall Study||156
10014875|NCT01802333|11137899|FG002|Known NPM1 Status at Baseline|Overall Study||142
10014876|NCT01802333|11137897|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252
9781913|NCT00508261|10888828|FG000|NOT COMPLETED|Overall Study||3
9781914|NCT00508261|10888829|FG001|NOT COMPLETED|Overall Study||8
9781915|NCT00508261|10888830|FG002|NOT COMPLETED|Overall Study||6
9781916|NCT00508261|10888831|FG003|NOT COMPLETED|Overall Study||1
9781917|NCT00508274|10888845|FG000|STARTED|Overall Study||52
9781918|NCT00508274|10888845|FG000|COMPLETED|Overall Study||2
9781919|NCT00508274|10888845|FG000|NOT COMPLETED|Overall Study||50
9781920|NCT00508300|10888851|FG000|STARTED|Overall Study||67
9781921|NCT00508300|10888852|FG001|STARTED|Overall Study||61
9781922|NCT00508300|10888851|FG000|COMPLETED|Overall Study||65
9781923|NCT00508300|10888852|FG001|COMPLETED|Overall Study||57
9781924|NCT00508300|10888851|FG000|NOT COMPLETED|Overall Study||2
9781925|NCT00508300|10888852|FG001|NOT COMPLETED|Overall Study||4
9781926|NCT00508391|10888860|FG000|STARTED|First Treatment||60
9781927|NCT00508391|10888861|FG001|STARTED|First Treatment||62
9781928|NCT00508391|10888860|FG000|COMPLETED|First Treatment||54
9781929|NCT00508391|10888861|FG001|COMPLETED|First Treatment||59
9781930|NCT00508391|10888860|FG000|NOT COMPLETED|First Treatment||6
9781931|NCT00508391|10888861|FG001|NOT COMPLETED|First Treatment||3
9781932|NCT00508391|10888860|FG000|STARTED|Second Treatment||54
9781933|NCT00508391|10888861|FG001|STARTED|Second Treatment||59
9781934|NCT00508391|10888860|FG000|COMPLETED|Second Treatment||52
10014877|NCT01802333|11137898|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250
10014878|NCT01802333|11137899|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210
10014879|NCT01802333|11137897|FG000|COMPLETED|Overall Study||214
10014880|NCT01802333|11137898|FG001|COMPLETED|Overall Study||206
9781935|NCT00508391|10888861|FG001|COMPLETED|Second Treatment||59
9781936|NCT00508391|10888860|FG000|NOT COMPLETED|Second Treatment||2
9781937|NCT00508391|10888861|FG001|NOT COMPLETED|Second Treatment||0
9781938|NCT00508404|10888869|FG000|STARTED|Overall Study||154
9781939|NCT00508404|10888869|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
10014881|NCT01802333|11137899|FG002|COMPLETED|Overall Study||161
9781940|NCT00508404|10888869|FG000|NOT COMPLETED|Overall Study||42
9781941|NCT00508469|10888876|FG000|STARTED|Overall Study||52
9781942|NCT00508469|10888877|FG001|STARTED|Overall Study||50
9781943|NCT00508469|10888876|FG000|COMPLETED|Overall Study||35
9781944|NCT00508469|10888877|FG001|COMPLETED|Overall Study||40
9781945|NCT00508469|10888876|FG000|NOT COMPLETED|Overall Study||17
9781946|NCT00508469|10888877|FG001|NOT COMPLETED|Overall Study||10
9781947|NCT00508482|10888886|FG000|STARTED|Over 4 Weeks of Treatment||237
9781948|NCT00508482|10888887|FG001|STARTED|Over 4 Weeks of Treatment||119
9781949|NCT00508482|10888888|FG002|STARTED|Over 4 Weeks of Treatment||119
9781950|NCT00508482|10888886|FG000|COMPLETED|Over 4 Weeks of Treatment||216
9781951|NCT00508482|10888887|FG001|COMPLETED|Over 4 Weeks of Treatment||102
9781952|NCT00508482|10888888|FG002|COMPLETED|Over 4 Weeks of Treatment||99
9781953|NCT00508482|10888886|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21
9781954|NCT00508482|10888887|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17
9781955|NCT00508482|10888888|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20
9781956|NCT00508482|10888886|FG000|STARTED|at the 4th Week of Follow-up||216
9781957|NCT00508482|10888887|FG001|STARTED|at the 4th Week of Follow-up||102
9781958|NCT00508482|10888888|FG002|STARTED|at the 4th Week of Follow-up||99
9781959|NCT00508482|10888886|FG000|COMPLETED|at the 4th Week of Follow-up||196
9781960|NCT00508482|10888887|FG001|COMPLETED|at the 4th Week of Follow-up||96
9781961|NCT00508482|10888888|FG002|COMPLETED|at the 4th Week of Follow-up||98
9781962|NCT00508482|10888886|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20
9781963|NCT00508482|10888887|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6
9781964|NCT00508482|10888888|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1
9781965|NCT00508482|10888886|FG000|STARTED|at the 12th Week of Follow-up||196
9781966|NCT00508482|10888887|FG001|STARTED|at the 12th Week of Follow-up||96
9781967|NCT00508482|10888888|FG002|STARTED|at the 12th Week of Follow-up||98
9781968|NCT00508482|10888886|FG000|COMPLETED|at the 12th Week of Follow-up||196
9781969|NCT00508482|10888887|FG001|COMPLETED|at the 12th Week of Follow-up||96
9781970|NCT00508482|10888888|FG002|COMPLETED|at the 12th Week of Follow-up||98
9781971|NCT00508482|10888886|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0
9781972|NCT00508482|10888887|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0
9781973|NCT00508482|10888888|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0
9781974|NCT00508521|10888897|FG000|STARTED|Overall Study||4
9781975|NCT00508521|10888897|FG000|COMPLETED|Overall Study||4
9781976|NCT00508521|10888897|FG000|NOT COMPLETED|Overall Study||0
9781977|NCT00508651|10888903|FG000|STARTED|Overall Study||20
9781978|NCT00508651|10888904|FG001|STARTED|Overall Study||10
9781979|NCT00508651|10888903|FG000|COMPLETED|Overall Study||16
9781980|NCT00508651|10888904|FG001|COMPLETED|Overall Study||8
9781981|NCT00508651|10888903|FG000|NOT COMPLETED|Overall Study||4
9781982|NCT00508651|10888904|FG001|NOT COMPLETED|Overall Study||2
9781983|NCT00508716|10888912|FG000|STARTED|Overall Study||61
9781984|NCT00508716|10888913|FG001|STARTED|Overall Study||63
9781985|NCT00508716|10888912|FG000|COMPLETED|Overall Study||61
9781986|NCT00508716|10888913|FG001|COMPLETED|Overall Study||63
9781987|NCT00508716|10888912|FG000|NOT COMPLETED|Overall Study||0
9781988|NCT00508716|10888913|FG001|NOT COMPLETED|Overall Study||0
9781989|NCT00508742|10888921|FG000|STARTED|Period 1: Infant Series||932
9781990|NCT00508742|10888922|FG001|STARTED|Period 1: Infant Series||934
9781991|NCT00508742|10888921|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
9781992|NCT00508742|10888922|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
9781993|NCT00508742|10888921|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
9781994|NCT00508742|10888922|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
9781995|NCT00508742|10888921|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
9781996|NCT00508742|10888922|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
9781997|NCT00508742|10888921|FG000|COMPLETED|Period 1: Infant Series||890
9781998|NCT00508742|10888922|FG001|COMPLETED|Period 1: Infant Series||889
9781999|NCT00508742|10888921|FG000|NOT COMPLETED|Period 1: Infant Series||42
9782000|NCT00508742|10888922|FG001|NOT COMPLETED|Period 1: Infant Series||45
9782001|NCT00508742|10888921|FG000|STARTED|Period 2: After Infant Series||890
9782002|NCT00508742|10888922|FG001|STARTED|Period 2: After Infant Series||889
9782003|NCT00508742|10888921|FG000|COMPLETED|Period 2: After Infant Series||883
9782004|NCT00508742|10888922|FG001|COMPLETED|Period 2: After Infant Series||878
9782005|NCT00508742|10888921|FG000|NOT COMPLETED|Period 2: After Infant Series||7
9782006|NCT00508742|10888922|FG001|NOT COMPLETED|Period 2: After Infant Series||11
9782007|NCT00508742|10888921|FG000|STARTED|Period 3: Toddler Dose||883
9782008|NCT00508742|10888922|FG001|STARTED|Period 3: Toddler Dose||878
9782009|NCT00508742|10888921|FG000|COMPLETED|Period 3: Toddler Dose||858
9782010|NCT00508742|10888922|FG001|COMPLETED|Period 3: Toddler Dose||863
9782011|NCT00508742|10888921|FG000|NOT COMPLETED|Period 3: Toddler Dose||25
9782012|NCT00508742|10888922|FG001|NOT COMPLETED|Period 3: Toddler Dose||15
9782013|NCT00508755|10888934|FG000|STARTED|Overall Study||6
9782014|NCT00508755|10888934|FG000|COMPLETED|Overall Study||5
9782015|NCT00508755|10888934|FG000|NOT COMPLETED|Overall Study||1
9782016|NCT00508820|10888942|FG000|STARTED|Overall Study||168
9782017|NCT00508820|10888943|FG001|STARTED|Overall Study||239
9782018|NCT00508820|10888942|FG000|COMPLETED|Overall Study||113
9782019|NCT00508820|10888943|FG001|COMPLETED|Overall Study||175
9782020|NCT00508820|10888942|FG000|NOT COMPLETED|Overall Study||55
9782021|NCT00508820|10888943|FG001|NOT COMPLETED|Overall Study||64
9782022|NCT00508924|10888953|FG000|STARTED|Overall Study||36
9782023|NCT00508924|10888954|FG001|STARTED|Overall Study||38
9782024|NCT00508924|10888955|FG002|STARTED|Overall Study||32
9782025|NCT00508924|10888956|FG003|STARTED|Overall Study||34
9782026|NCT00508924|10888953|FG000|COMPLETED|Overall Study||36
9782027|NCT00508924|10888954|FG001|COMPLETED|Overall Study||38
9782028|NCT00508924|10888955|FG002|COMPLETED|Overall Study||31
10014882|NCT01802333|11137897|FG000|NOT COMPLETED|Overall Study||49
10014883|NCT01802333|11137898|FG001|NOT COMPLETED|Overall Study||61
9782029|NCT00508924|10888956|FG003|COMPLETED|Overall Study||33
9782030|NCT00508924|10888953|FG000|NOT COMPLETED|Overall Study||0
9782031|NCT00508924|10888954|FG001|NOT COMPLETED|Overall Study||0
9782032|NCT00508924|10888955|FG002|NOT COMPLETED|Overall Study||1
9782033|NCT00508924|10888956|FG003|NOT COMPLETED|Overall Study||1
9782034|NCT00509002|10888966|FG000|STARTED|Overall Study||37
9782035|NCT00509002|10888966|FG000|COMPLETED|Overall Study||37
9782036|NCT00509002|10888966|FG000|NOT COMPLETED|Overall Study||0
9782037|NCT00509028|10888972|FG000|STARTED|Overall Study||121
9782038|NCT00509028|10888973|FG001|STARTED|Overall Study||120
9782039|NCT00509028|10888972|FG000|COMPLETED|Overall Study||109
9782040|NCT00509028|10888973|FG001|COMPLETED|Overall Study||113
9782041|NCT00509028|10888972|FG000|NOT COMPLETED|Overall Study||12
9782042|NCT00509028|10888973|FG001|NOT COMPLETED|Overall Study||7
9782043|NCT00509041|10888979|FG000|STARTED|Overall Study||43
9782044|NCT00509041|10888979|FG000|COMPLETED|Overall Study||43
9782045|NCT00509041|10888979|FG000|NOT COMPLETED|Overall Study||0
9782046|NCT00509067|10888985|FG000|STARTED|Overall Study||19
9782047|NCT00509067|10888986|FG001|STARTED|Overall Study||24
9782048|NCT00509067|10888985|FG000|COMPLETED|Overall Study||15
9782049|NCT00509067|10888986|FG001|COMPLETED|Overall Study||19
9782050|NCT00509067|10888985|FG000|NOT COMPLETED|Overall Study||4
9782051|NCT00509067|10888986|FG001|NOT COMPLETED|Overall Study||5
9782052|NCT00509093|10888996|FG000|STARTED|Overall Study||32
9782053|NCT00509093|10888996|FG000|COMPLETED|Overall Study||8
9782054|NCT00509093|10888996|FG000|NOT COMPLETED|Overall Study||24
9782055|NCT00509106|10889002|FG000|STARTED|Overall Study||315
9782056|NCT00509106|10889003|FG001|STARTED|Overall Study||307
9782057|NCT00509106|10889002|FG000|COMPLETED|Overall Study||284
9782058|NCT00509106|10889003|FG001|COMPLETED|Overall Study||278
9782059|NCT00509106|10889002|FG000|NOT COMPLETED|Overall Study||31
9782060|NCT00509106|10889003|FG001|NOT COMPLETED|Overall Study||29
9782061|NCT00509145|10889011|FG000|STARTED|Overall Study||550
9782062|NCT00509145|10889012|FG001|STARTED|Overall Study||556
9782063|NCT00509145|10889011|FG000|COMPLETED|Overall Study||437
9782064|NCT00509145|10889012|FG001|COMPLETED|Overall Study||427
9782065|NCT00509145|10889011|FG000|NOT COMPLETED|Overall Study||113
9782066|NCT00509145|10889012|FG001|NOT COMPLETED|Overall Study||129
9782067|NCT00509171|10889020|FG000|STARTED|Overall Study||11
9782068|NCT00509171|10889021|FG001|STARTED|Overall Study||11
9782069|NCT00509171|10889020|FG000|COMPLETED|Overall Study||11
9782070|NCT00509171|10889021|FG001|COMPLETED|Overall Study||11
9782071|NCT00509171|10889020|FG000|NOT COMPLETED|Overall Study||0
9782072|NCT00509171|10889021|FG001|NOT COMPLETED|Overall Study||0
9782073|NCT00509197|10889029|FG000|STARTED|Overall Study||6
9782074|NCT00509197|10889030|FG001|STARTED|Overall Study||6
9782075|NCT00509197|10889029|FG000|COMPLETED|Overall Study||6
9782076|NCT00509197|10889030|FG001|COMPLETED|Overall Study||6
9782077|NCT00509197|10889029|FG000|NOT COMPLETED|Overall Study||0
9782078|NCT00509197|10889030|FG001|NOT COMPLETED|Overall Study||0
9782079|NCT00509223|10889040|FG000|STARTED|Overall Study||207
9782080|NCT00509223|10889041|FG001|STARTED|Overall Study||209
9782081|NCT00509223|10889040|FG000|COMPLETED|Overall Study||119
9782082|NCT00509223|10889041|FG001|COMPLETED|Overall Study||137
9782083|NCT00509223|10889040|FG000|NOT COMPLETED|Overall Study||88
9782084|NCT00509223|10889041|FG001|NOT COMPLETED|Overall Study||72
9782085|NCT00509236|10889049|FG000|STARTED|Overall Study||64
9782086|NCT00509236|10889050|FG001|STARTED|Overall Study||65
9782087|NCT00509236|10889049|FG000|COMPLETED|Overall Study||47
9782088|NCT00509236|10889050|FG001|COMPLETED|Overall Study||45
9782089|NCT00509236|10889049|FG000|NOT COMPLETED|Overall Study||17
9782090|NCT00509236|10889050|FG001|NOT COMPLETED|Overall Study||20
9782091|NCT00509249|10889056|FG000|STARTED|Overall Study||18
9782092|NCT00509249|10889056|FG000|COMPLETED|Overall Study||18
9782093|NCT00509249|10889056|FG000|NOT COMPLETED|Overall Study||0
9782094|NCT00509262|10889062|FG000|STARTED|Overall Study||211
9782095|NCT00509262|10889063|FG001|STARTED|Overall Study||212
9782096|NCT00509262|10889062|FG000|COMPLETED|Overall Study||164
9782097|NCT00509262|10889063|FG001|COMPLETED|Overall Study||170
9782098|NCT00509262|10889062|FG000|NOT COMPLETED|Overall Study||47
9782099|NCT00509262|10889063|FG001|NOT COMPLETED|Overall Study||42
9782100|NCT00509288|10889071|FG000|STARTED|Overall Study||21
9782101|NCT00509288|10889072|FG001|STARTED|Overall Study||3
9782102|NCT00509288|10889071|FG000|COMPLETED|Overall Study||21
9782103|NCT00509288|10889072|FG001|COMPLETED|Overall Study||3
9782104|NCT00509288|10889071|FG000|NOT COMPLETED|Overall Study||0
9782105|NCT00509288|10889072|FG001|NOT COMPLETED|Overall Study||0
9782106|NCT00509366|10889083|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
9782107|NCT00509366|10889084|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
9782108|NCT00509366|10889085|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
9782109|NCT00509366|10889086|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
9782110|NCT00509366|10889087|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
9782111|NCT00509366|10889083|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
9782112|NCT00509366|10889084|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
9782113|NCT00509366|10889085|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
9782114|NCT00509366|10889086|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
9782115|NCT00509366|10889087|FG004|Assigned Treatment|Overall Study||0
9782116|NCT00509366|10889083|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
9782117|NCT00509366|10889084|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
9782118|NCT00509366|10889085|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
9782119|NCT00509366|10889086|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
9782120|NCT00509366|10889087|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
9782121|NCT00509366|10889083|FG000|NOT COMPLETED|Overall Study||1
9782122|NCT00509366|10889084|FG001|NOT COMPLETED|Overall Study||1
9782123|NCT00509366|10889085|FG002|NOT COMPLETED|Overall Study||1
9782124|NCT00509366|10889086|FG003|NOT COMPLETED|Overall Study||0
9782125|NCT00509366|10889087|FG004|NOT COMPLETED|Overall Study||0
9782126|NCT00509392|10889099|FG000|STARTED|Overall Study||32
9782127|NCT00509392|10889100|FG001|STARTED|Overall Study||33
9782128|NCT00509392|10889101|FG002|STARTED|Overall Study||4
9782129|NCT00509392|10889099|FG000|COMPLETED|Overall Study||32
9782130|NCT00509392|10889100|FG001|COMPLETED|Overall Study||33
9782131|NCT00509392|10889101|FG002|COMPLETED|Overall Study||4
9782132|NCT00509392|10889099|FG000|NOT COMPLETED|Overall Study||0
9782133|NCT00509392|10889100|FG001|NOT COMPLETED|Overall Study||0
9782134|NCT00509392|10889101|FG002|NOT COMPLETED|Overall Study||0
9782135|NCT00509496|10889109|FG000|STARTED|Overall Study||19
9782136|NCT00509496|10889110|FG001|STARTED|Overall Study||2
9782137|NCT00509496|10889109|FG000|COMPLETED|Overall Study||19
9782138|NCT00509496|10889110|FG001|COMPLETED|Overall Study||2
9782139|NCT00509496|10889109|FG000|NOT COMPLETED|Overall Study||0
9782140|NCT00509496|10889110|FG001|NOT COMPLETED|Overall Study||0
9782141|NCT00509587|10889116|FG000|STARTED|Overall Study||21
9782142|NCT00509587|10889116|FG000|COMPLETED|Overall Study||21
9782143|NCT00509587|10889116|FG000|NOT COMPLETED|Overall Study||0
9782144|NCT00509665|10889120|FG000|STARTED|Overall Study||18
9782145|NCT00509665|10889120|FG000|COMPLETED|Overall Study||18
9782146|NCT00509665|10889120|FG000|NOT COMPLETED|Overall Study||0
9782147|NCT00509769|10889124|FG000|STARTED|Overall Study||112
9782148|NCT00509769|10889124|FG000|COMPLETED|Overall Study||21
9782149|NCT00509769|10889124|FG000|NOT COMPLETED|Overall Study||91
9782150|NCT00509795|10889132|FG000|STARTED|Overall Study||306
9782151|NCT00509795|10889133|FG001|STARTED|Overall Study||304
9782152|NCT00509795|10889134|FG002|STARTED|Overall Study||304
9782153|NCT00509795|10889135|FG003|STARTED|Overall Study||303
9782154|NCT00509795|10889132|FG000|Patients Received Treatment (SAF)|Overall Study||304
9782155|NCT00509795|10889133|FG001|Patients Received Treatment (SAF)|Overall Study||304
9782156|NCT00509795|10889134|FG002|Patients Received Treatment (SAF)|Overall Study||304
9782157|NCT00509795|10889135|FG003|Patients Received Treatment (SAF)|Overall Study||303
9782158|NCT00509795|10889132|FG000|Full Analysis Set (FAS) Population|Overall Study||304
9782159|NCT00509795|10889133|FG001|Full Analysis Set (FAS) Population|Overall Study||304
9782160|NCT00509795|10889134|FG002|Full Analysis Set (FAS) Population|Overall Study||301
9782161|NCT00509795|10889135|FG003|Full Analysis Set (FAS) Population|Overall Study||301
9782162|NCT00509795|10889132|FG000|Per Protocol Set (PPS) Population|Overall Study||269
9782163|NCT00509795|10889133|FG001|Per Protocol Set (PPS) Population|Overall Study||285
9782164|NCT00509795|10889134|FG002|Per Protocol Set (PPS) Population|Overall Study||270
9782165|NCT00509795|10889135|FG003|Per Protocol Set (PPS) Population|Overall Study||265
9782166|NCT00509795|10889132|FG000|COMPLETED|Overall Study||284
9782167|NCT00509795|10889133|FG001|COMPLETED|Overall Study||293
9782168|NCT00509795|10889134|FG002|COMPLETED|Overall Study||277
9782169|NCT00509795|10889135|FG003|COMPLETED|Overall Study||276
9782170|NCT00509795|10889132|FG000|NOT COMPLETED|Overall Study||22
9782171|NCT00509795|10889133|FG001|NOT COMPLETED|Overall Study||11
9782172|NCT00509795|10889134|FG002|NOT COMPLETED|Overall Study||27
9782173|NCT00509795|10889135|FG003|NOT COMPLETED|Overall Study||27
9782174|NCT00509821|10889148|FG000|STARTED|Study Period 1 (Induction)||3
9782175|NCT00509821|10889149|FG001|STARTED|Study Period 1 (Induction)||57
9782176|NCT00509821|10889148|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
9782177|NCT00509821|10889149|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
9782178|NCT00509821|10889148|FG000|COMPLETED|Study Period 1 (Induction)||3
9782179|NCT00509821|10889149|FG001|COMPLETED|Study Period 1 (Induction)||53
9782180|NCT00509821|10889148|FG000|NOT COMPLETED|Study Period 1 (Induction)||0
9782181|NCT00509821|10889149|FG001|NOT COMPLETED|Study Period 1 (Induction)||4
9782182|NCT00509821|10889148|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
9782183|NCT00509821|10889149|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
9782184|NCT00509821|10889148|FG000|COMPLETED|Study Period 2 (Radiation)||3
9782185|NCT00509821|10889149|FG001|COMPLETED|Study Period 2 (Radiation)||0
9782186|NCT00509821|10889148|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0
9782187|NCT00509821|10889149|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53
9782188|NCT00509821|10889148|FG000|STARTED|Study Period 3 (Maintenance)||3
9830324|NCT00762606|10940984|FG000|STARTED|Overall Study||55
9782189|NCT00509821|10889149|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
9782190|NCT00509821|10889148|FG000|COMPLETED|Study Period 3 (Maintenance)||3
9782191|NCT00509821|10889149|FG001|COMPLETED|Study Period 3 (Maintenance)||0
9782192|NCT00509821|10889148|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0
9782193|NCT00509821|10889149|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49
9782194|NCT00509821|10889148|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
9782195|NCT00509821|10889149|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
9782196|NCT00509821|10889148|FG000|COMPLETED|Study Period 4 (Follow Up)||2
9782197|NCT00509821|10889149|FG001|COMPLETED|Study Period 4 (Follow Up)||50
9782198|NCT00509821|10889148|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0
9782199|NCT00509821|10889149|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0
9782200|NCT00509873|10889162|FG000|STARTED|Overall Study||287
9782201|NCT00509873|10889163|FG001|STARTED|Overall Study||291
9782202|NCT00509873|10889162|FG000|COMPLETED|Overall Study||276
9782203|NCT00509873|10889163|FG001|COMPLETED|Overall Study||276
9782204|NCT00509873|10889162|FG000|NOT COMPLETED|Overall Study||11
9782205|NCT00509873|10889163|FG001|NOT COMPLETED|Overall Study||15
9782206|NCT00509899|10889177|FG000|STARTED|Overall Study||30
9782207|NCT00509899|10889178|FG001|STARTED|Overall Study||35
9782208|NCT00509899|10889179|FG002|STARTED|Overall Study||47
9782209|NCT00509899|10889180|FG003|STARTED|Overall Study||5
9782210|NCT00509899|10889181|FG004|STARTED|Overall Study||6
9782211|NCT00509899|10889182|FG005|STARTED|Overall Study||22
9782212|NCT00509899|10889183|FG006|STARTED|Overall Study||6
9782213|NCT00509899|10889184|FG007|STARTED|Overall Study||3
9782214|NCT00509899|10889177|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
9782215|NCT00509899|10889178|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
9782216|NCT00509899|10889179|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
9782217|NCT00509899|10889180|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
9782218|NCT00509899|10889181|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
9782219|NCT00509899|10889182|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
9782220|NCT00509899|10889183|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
9782221|NCT00509899|10889184|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
9782222|NCT00509899|10889177|FG000|NOT COMPLETED|Overall Study||16
9782223|NCT00509899|10889178|FG001|NOT COMPLETED|Overall Study||9
9782224|NCT00509899|10889179|FG002|NOT COMPLETED|Overall Study||20
9782225|NCT00509899|10889180|FG003|NOT COMPLETED|Overall Study||4
9782226|NCT00509899|10889181|FG004|NOT COMPLETED|Overall Study||5
9782227|NCT00509899|10889182|FG005|NOT COMPLETED|Overall Study||10
9782228|NCT00509899|10889183|FG006|NOT COMPLETED|Overall Study||1
9782229|NCT00509899|10889184|FG007|NOT COMPLETED|Overall Study||1
9782230|NCT00509925|10889198|FG000|STARTED|Overall Study||12
9782231|NCT00509925|10889199|FG001|STARTED|Overall Study||11
9782232|NCT00509925|10889198|FG000|COMPLETED|Overall Study||12
9782233|NCT00509925|10889199|FG001|COMPLETED|Overall Study||10
9782234|NCT00509925|10889198|FG000|NOT COMPLETED|Overall Study||0
9782235|NCT00509925|10889199|FG001|NOT COMPLETED|Overall Study||1
9782236|NCT00510068|10889209|FG000|STARTED|Double-blind Period||207
9782237|NCT00510068|10889210|FG001|STARTED|Double-blind Period||203
9782238|NCT00510068|10889209|FG000|Safety Population|Double-blind Period||204
9782239|NCT00510068|10889210|FG001|Safety Population|Double-blind Period||203
9782240|NCT00510068|10889209|FG000|COMPLETED|Double-blind Period||0
9782241|NCT00510068|10889210|FG001|COMPLETED|Double-blind Period||0
9782242|NCT00510068|10889209|FG000|NOT COMPLETED|Double-blind Period||207
9782243|NCT00510068|10889210|FG001|NOT COMPLETED|Double-blind Period||203
9782244|NCT00510068|10889209|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
9782245|NCT00510068|10889210|FG001|STARTED|Open-label Period||0
9782246|NCT00510068|10889209|FG000|COMPLETED|Open-label Period||0
9782247|NCT00510068|10889210|FG001|COMPLETED|Open-label Period||0
9782248|NCT00510068|10889209|FG000|NOT COMPLETED|Open-label Period||225
9782249|NCT00510068|10889210|FG001|NOT COMPLETED|Open-label Period||0
9782250|NCT00510146|10889220|FG000|STARTED|Double-Blind Treatment||343
9782251|NCT00510146|10889221|FG001|STARTED|Double-Blind Treatment||171
9782252|NCT00510146|10889220|FG000|COMPLETED|Double-Blind Treatment||267
9782253|NCT00510146|10889221|FG001|COMPLETED|Double-Blind Treatment||122
9782254|NCT00510146|10889220|FG000|NOT COMPLETED|Double-Blind Treatment||76
9782255|NCT00510146|10889221|FG001|NOT COMPLETED|Double-Blind Treatment||49
9782256|NCT00510146|10889220|FG000|STARTED|Open-Label Treatment||267
9782257|NCT00510146|10889221|FG001|STARTED|Open-Label Treatment||122
9782258|NCT00510146|10889220|FG000|COMPLETED|Open-Label Treatment||196
9782259|NCT00510146|10889221|FG001|COMPLETED|Open-Label Treatment||96
9782260|NCT00510146|10889220|FG000|NOT COMPLETED|Open-Label Treatment||71
9782261|NCT00510146|10889221|FG001|NOT COMPLETED|Open-Label Treatment||26
9782262|NCT00510198|10889231|FG000|STARTED|Overall Study||59
9782263|NCT00510198|10889232|FG001|STARTED|Overall Study||58
9782264|NCT00510198|10889231|FG000|COMPLETED|Overall Study||54
9782265|NCT00510198|10889232|FG001|COMPLETED|Overall Study||54
9782266|NCT00510198|10889231|FG000|NOT COMPLETED|Overall Study||5
9782267|NCT00510198|10889232|FG001|NOT COMPLETED|Overall Study||4
9782268|NCT00510224|10889240|FG000|STARTED|Overall Study||13
9782269|NCT00510224|10889240|FG000|COMPLETED|Overall Study||10
9782270|NCT00510224|10889240|FG000|NOT COMPLETED|Overall Study||3
9782271|NCT00510276|10889246|FG000|STARTED|Acute Double-Blind Phase||220
9782272|NCT00510276|10889247|FG001|STARTED|Acute Double-Blind Phase||225
9782273|NCT00510276|10889246|FG000|COMPLETED|Acute Double-Blind Phase||115
9782274|NCT00510276|10889247|FG001|COMPLETED|Acute Double-Blind Phase||130
9782275|NCT00510276|10889246|FG000|NOT COMPLETED|Acute Double-Blind Phase||105
9782276|NCT00510276|10889247|FG001|NOT COMPLETED|Acute Double-Blind Phase||95
9782277|NCT00510276|10889246|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
9782278|NCT00510276|10889247|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
9782279|NCT00510276|10889246|FG000|COMPLETED|Extension Open-Label Phase||78
10014884|NCT01802333|11137899|FG002|NOT COMPLETED|Overall Study||63
10014885|NCT01802385|11137915|FG000|STARTED|Overall Study||231
10014886|NCT01802385|11137916|FG001|STARTED|Overall Study||229
10014887|NCT01802385|11137915|FG000|COMPLETED|Overall Study||125
10014888|NCT01802385|11137916|FG001|COMPLETED|Overall Study||109
10014889|NCT01802385|11137915|FG000|NOT COMPLETED|Overall Study||106
10014890|NCT01802385|11137916|FG001|NOT COMPLETED|Overall Study||120
10014891|NCT01802411|11137924|FG000|STARTED|Overall Study||96
10014892|NCT01802411|11137925|FG001|STARTED|Overall Study||95
9782280|NCT00510276|10889247|FG001|COMPLETED|Extension Open-Label Phase||81
9782281|NCT00510276|10889246|FG000|NOT COMPLETED|Extension Open-Label Phase||33
9782282|NCT00510276|10889247|FG001|NOT COMPLETED|Extension Open-Label Phase||48
10014893|NCT01802411|11137924|FG000|COMPLETED|Overall Study||82
10014894|NCT01802411|11137925|FG001|COMPLETED|Overall Study||74
10014895|NCT01802411|11137924|FG000|NOT COMPLETED|Overall Study||14
10014896|NCT01802411|11137925|FG001|NOT COMPLETED|Overall Study||21
10014897|NCT01802437|11137933|FG000|STARTED|Overall Study||20
10014898|NCT01802437|11137934|FG001|STARTED|Overall Study||20
10014899|NCT01802437|11137933|FG000|COMPLETED|Overall Study||16
10014900|NCT01802437|11137934|FG001|COMPLETED|Overall Study||16
10014901|NCT01802437|11137933|FG000|NOT COMPLETED|Overall Study||4
9782283|NCT00510289|10889260|FG000|STARTED|Overall Study|All patients who consented|19
9782284|NCT00510289|10889260|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
9782285|NCT00510289|10889260|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
9782286|NCT00510289|10889260|FG000|NOT COMPLETED|Overall Study||12
9782287|NCT00510458|10889265|FG000|STARTED|Overall Study||74
9782288|NCT00510458|10889265|FG000|COMPLETED|Overall Study||27
9782289|NCT00510458|10889265|FG000|NOT COMPLETED|Overall Study||47
9782290|NCT00510484|10889272|FG000|STARTED|Period 1||16
9782291|NCT00510484|10889273|FG001|STARTED|Period 1||16
9782292|NCT00510484|10889272|FG000|COMPLETED|Period 1||16
9782293|NCT00510484|10889273|FG001|COMPLETED|Period 1||16
9782294|NCT00510484|10889272|FG000|NOT COMPLETED|Period 1||0
9782295|NCT00510484|10889273|FG001|NOT COMPLETED|Period 1||0
9782296|NCT00510484|10889272|FG000|STARTED|Wash-out Period||16
9782297|NCT00510484|10889273|FG001|STARTED|Wash-out Period||16
9782298|NCT00510484|10889272|FG000|COMPLETED|Wash-out Period||16
9782299|NCT00510484|10889273|FG001|COMPLETED|Wash-out Period||15
9782300|NCT00510484|10889272|FG000|NOT COMPLETED|Wash-out Period||0
9782301|NCT00510484|10889273|FG001|NOT COMPLETED|Wash-out Period||1
9782302|NCT00510484|10889272|FG000|STARTED|Period 2||16
9782303|NCT00510484|10889273|FG001|STARTED|Period 2||15
9782304|NCT00510484|10889272|FG000|COMPLETED|Period 2||16
9782305|NCT00510484|10889273|FG001|COMPLETED|Period 2||15
9782306|NCT00510484|10889272|FG000|NOT COMPLETED|Period 2||0
9782307|NCT00510484|10889273|FG001|NOT COMPLETED|Period 2||0
9782308|NCT00510497|10889279|FG000|STARTED|Overall Study||11
9782309|NCT00510497|10889279|FG000|COMPLETED|Overall Study||8
9782310|NCT00510497|10889279|FG000|NOT COMPLETED|Overall Study||3
9782311|NCT00510510|10889286|FG000|STARTED|Overall Study||92
9782312|NCT00510510|10889287|FG001|STARTED|Overall Study||98
9782313|NCT00510510|10889288|FG002|STARTED|Overall Study||91
9782314|NCT00510510|10889286|FG000|COMPLETED|Overall Study||87
9782315|NCT00510510|10889287|FG001|COMPLETED|Overall Study||89
9782316|NCT00510510|10889288|FG002|COMPLETED|Overall Study||74
9782317|NCT00510510|10889286|FG000|NOT COMPLETED|Overall Study||5
9782318|NCT00510510|10889287|FG001|NOT COMPLETED|Overall Study||9
9782319|NCT00510510|10889288|FG002|NOT COMPLETED|Overall Study||17
9782320|NCT00510653|10889296|FG000|STARTED|Overall Study||24
9782321|NCT00510653|10889296|FG000|COMPLETED|Overall Study||13
9782322|NCT00510653|10889296|FG000|NOT COMPLETED|Overall Study||11
9782323|NCT00510692|10889302|FG000|STARTED|Overall Study||29
9782324|NCT00510692|10889303|FG001|STARTED|Overall Study||29
9782325|NCT00510692|10889302|FG000|COMPLETED|Overall Study||27
9782326|NCT00510692|10889303|FG001|COMPLETED|Overall Study||26
10014902|NCT01802437|11137934|FG001|NOT COMPLETED|Overall Study||4
10014903|NCT01802515|11137943|FG000|STARTED|Overall Study||5
10014904|NCT01802515|11137944|FG001|STARTED|Overall Study||5
9782327|NCT00510692|10889302|FG000|NOT COMPLETED|Overall Study||2
9782328|NCT00510692|10889303|FG001|NOT COMPLETED|Overall Study||3
9782329|NCT00510718|10889318|FG000|STARTED|Single Dose Period: 1 Week||15
10014905|NCT01802515|11137945|FG002|STARTED|Overall Study||4
10014906|NCT01802515|11137943|FG000|COMPLETED|Overall Study||2
10014907|NCT01802515|11137944|FG001|COMPLETED|Overall Study||5
10014908|NCT01802515|11137945|FG002|COMPLETED|Overall Study||4
10014909|NCT01802515|11137943|FG000|NOT COMPLETED|Overall Study||3
10014910|NCT01802515|11137944|FG001|NOT COMPLETED|Overall Study||0
10014911|NCT01802515|11137945|FG002|NOT COMPLETED|Overall Study||0
10014912|NCT01802554|11137955|FG000|STARTED|Overall Study||51
10014913|NCT01802554|11137956|FG001|STARTED|Overall Study||49
10014914|NCT01802554|11137955|FG000|COMPLETED|Overall Study||43
10014915|NCT01802554|11137956|FG001|COMPLETED|Overall Study||43
10014916|NCT01802554|11137955|FG000|NOT COMPLETED|Overall Study||8
10014917|NCT01802554|11137956|FG001|NOT COMPLETED|Overall Study||6
10014918|NCT01802580|11137964|FG000|STARTED|Overall Study||20
10014919|NCT01802580|11137965|FG001|STARTED|Overall Study||20
10014920|NCT01802580|11137964|FG000|COMPLETED|Overall Study||11
10014921|NCT01802580|11137965|FG001|COMPLETED|Overall Study||9
10014922|NCT01802580|11137964|FG000|NOT COMPLETED|Overall Study||9
10014923|NCT01802580|11137965|FG001|NOT COMPLETED|Overall Study||11
10014924|NCT01802710|11137973|FG000|STARTED|From T0 to T1||76
10014925|NCT01802710|11137974|FG001|STARTED|From T0 to T1||82
10014926|NCT01802710|11137973|FG000|COMPLETED|From T0 to T1||60
10014927|NCT01802710|11137974|FG001|COMPLETED|From T0 to T1||72
10014928|NCT01802710|11137973|FG000|NOT COMPLETED|From T0 to T1||16
10014929|NCT01802710|11137974|FG001|NOT COMPLETED|From T0 to T1||10
10014930|NCT01802710|11137973|FG000|STARTED|From T1 to T2||60
10014931|NCT01802710|11137974|FG001|STARTED|From T1 to T2||72
10014932|NCT01802710|11137973|FG000|COMPLETED|From T1 to T2||58
10014933|NCT01802710|11137974|FG001|COMPLETED|From T1 to T2||70
10014934|NCT01802710|11137973|FG000|NOT COMPLETED|From T1 to T2||2
9782330|NCT00510718|10889319|FG001|STARTED|Single Dose Period: 1 Week||12
9782331|NCT00510718|10889318|FG000|30 mg/Day|Single Dose Period: 1 Week||3
9782332|NCT00510718|10889319|FG001|30 mg/Day|Single Dose Period: 1 Week||0
9782333|NCT00510718|10889318|FG000|60 mg/Day|Single Dose Period: 1 Week||3
9782334|NCT00510718|10889319|FG001|60 mg/Day|Single Dose Period: 1 Week||0
9782335|NCT00510718|10889318|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2
9782336|NCT00510718|10889319|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1
9782337|NCT00510718|10889318|FG000|240 mg/Day|Single Dose Period: 1 Week||3
9782338|NCT00510718|10889319|FG001|240 mg/Day|Single Dose Period: 1 Week||0
9782339|NCT00510718|10889318|FG000|360 mg/Day|Single Dose Period: 1 Week||4
9782340|NCT00510718|10889319|FG001|360 mg/Day|Single Dose Period: 1 Week||2
9782341|NCT00510718|10889318|FG000|480 mg/Day|Single Dose Period: 1 Week||0
9782342|NCT00510718|10889319|FG001|480 mg/Day|Single Dose Period: 1 Week||6
9782343|NCT00510718|10889318|FG000|600 mg/Day|Single Dose Period: 1 Week||0
9782344|NCT00510718|10889319|FG001|600 mg/Day|Single Dose Period: 1 Week||3
9782345|NCT00510718|10889318|FG000|COMPLETED|Single Dose Period: 1 Week||15
9782346|NCT00510718|10889319|FG001|COMPLETED|Single Dose Period: 1 Week||12
9782347|NCT00510718|10889318|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0
9782348|NCT00510718|10889319|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0
9782349|NCT00510718|10889318|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
9782350|NCT00510718|10889319|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
9782351|NCT00510718|10889318|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3
9782352|NCT00510718|10889319|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0
9782353|NCT00510718|10889318|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15
9782354|NCT00510718|10889319|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12
9782355|NCT00510718|10889318|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
9782356|NCT00510718|10889319|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
9782357|NCT00510718|10889318|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17
10014935|NCT01802710|11137974|FG001|NOT COMPLETED|From T1 to T2||2
10014936|NCT01802775|11137984|FG000|STARTED|Overall Study||102
10014937|NCT01802775|11137985|FG001|STARTED|Overall Study||101
10014938|NCT01802775|11137984|FG000|Received Drug (Safety Analysis Set)|Overall Study||101
10014939|NCT01802775|11137985|FG001|Received Drug (Safety Analysis Set)|Overall Study||100
10014940|NCT01802775|11137984|FG000|COMPLETED|Overall Study||96
10014941|NCT01802775|11137985|FG001|COMPLETED|Overall Study||89
10014942|NCT01802775|11137984|FG000|NOT COMPLETED|Overall Study||6
10014943|NCT01802775|11137985|FG001|NOT COMPLETED|Overall Study||12
9782358|NCT00510718|10889319|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12
9782359|NCT00510718|10889318|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15
9782360|NCT00510718|10889319|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13
9782361|NCT00510718|10889318|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0
10014944|NCT01802879|11137991|FG000|STARTED|Overall Study||8
10014945|NCT01802879|11137991|FG000|COMPLETED|Overall Study||0
10014946|NCT01802879|11137991|FG000|NOT COMPLETED|Overall Study||8
10014947|NCT01803074|11138009|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10014948|NCT01803074|11138010|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10014949|NCT01803074|11138011|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10014950|NCT01803074|11138012|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10014951|NCT01803074|11138013|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10014952|NCT01803074|11138014|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10014953|NCT01803074|11138015|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12
9782362|NCT00510718|10889319|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22
9782363|NCT00510718|10889318|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0
9782364|NCT00510718|10889319|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3
10014954|NCT01803074|11138016|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0
9782365|NCT00510718|10889318|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50
9782366|NCT00510718|10889319|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43
9782367|NCT00510718|10889318|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
9782368|NCT00510718|10889319|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
9782369|NCT00510744|10889338|FG000|STARTED|Overall Study||5
9782370|NCT00510744|10889338|FG000|COMPLETED|Overall Study||5
9782371|NCT00510744|10889338|FG000|NOT COMPLETED|Overall Study||0
9782372|NCT00510783|10889344|FG000|STARTED|Overall Study||82
9782373|NCT00510783|10889345|FG001|STARTED|Overall Study||76
9782374|NCT00510783|10889344|FG000|COMPLETED|Overall Study||51
9782375|NCT00510783|10889345|FG001|COMPLETED|Overall Study||47
9782376|NCT00510783|10889344|FG000|NOT COMPLETED|Overall Study||31
9782377|NCT00510783|10889345|FG001|NOT COMPLETED|Overall Study||29
9782378|NCT00510809|10889354|FG000|STARTED|Overall Study||18
9782379|NCT00510809|10889355|FG001|STARTED|Overall Study||18
9782380|NCT00510809|10889356|FG002|STARTED|Overall Study||18
9782381|NCT00510809|10889354|FG000|COMPLETED|Overall Study||18
9782382|NCT00510809|10889355|FG001|COMPLETED|Overall Study||18
9782383|NCT00510809|10889356|FG002|COMPLETED|Overall Study||18
9782384|NCT00510809|10889354|FG000|NOT COMPLETED|Overall Study||0
9782385|NCT00510809|10889355|FG001|NOT COMPLETED|Overall Study||0
9782386|NCT00510809|10889356|FG002|NOT COMPLETED|Overall Study||0
9782387|NCT00510835|10889367|FG000|STARTED|Overall Study||445
9782388|NCT00510835|10889368|FG001|STARTED|Overall Study||448
9782389|NCT00510835|10889369|FG002|STARTED|Overall Study||458
9782390|NCT00510835|10889367|FG000|COMPLETED|Overall Study||439
9782391|NCT00510835|10889368|FG001|COMPLETED|Overall Study||446
9782392|NCT00510835|10889369|FG002|COMPLETED|Overall Study||456
9782393|NCT00510835|10889367|FG000|NOT COMPLETED|Overall Study||6
9782394|NCT00510835|10889368|FG001|NOT COMPLETED|Overall Study||2
9782395|NCT00510835|10889369|FG002|NOT COMPLETED|Overall Study||2
9782396|NCT00510874|10889384|FG000|STARTED|Overall Study||78
9782397|NCT00510874|10889385|FG001|STARTED|Overall Study||152
9782398|NCT00510874|10889386|FG002|STARTED|Overall Study||151
9782399|NCT00510874|10889387|FG003|STARTED|Overall Study||151
9782400|NCT00510874|10889388|FG004|STARTED|Overall Study||148
9782401|NCT00510874|10889389|FG005|STARTED|Overall Study||50
9782402|NCT00510874|10889390|FG006|STARTED|Overall Study||50
9782403|NCT00510874|10889384|FG000|COMPLETED|Overall Study|Upto Day 182|75
9782404|NCT00510874|10889385|FG001|COMPLETED|Overall Study|Upto Day 182|148
9782405|NCT00510874|10889386|FG002|COMPLETED|Overall Study|Upto Day 182|150
9782406|NCT00510874|10889387|FG003|COMPLETED|Overall Study|Upto Day 182|148
9782407|NCT00510874|10889388|FG004|COMPLETED|Overall Study|Upto Day 182|141
9782408|NCT00510874|10889389|FG005|COMPLETED|Overall Study|Upto Day 182|50
9782409|NCT00510874|10889390|FG006|COMPLETED|Overall Study|Upto Day 182|49
9782410|NCT00510874|10889384|FG000|NOT COMPLETED|Overall Study||3
9782411|NCT00510874|10889385|FG001|NOT COMPLETED|Overall Study||4
9782412|NCT00510874|10889386|FG002|NOT COMPLETED|Overall Study||1
9782413|NCT00510874|10889387|FG003|NOT COMPLETED|Overall Study||3
9782414|NCT00510874|10889388|FG004|NOT COMPLETED|Overall Study||7
9782415|NCT00510874|10889389|FG005|NOT COMPLETED|Overall Study||0
9782416|NCT00510874|10889390|FG006|NOT COMPLETED|Overall Study||1
9782417|NCT00510887|10889407|FG000|STARTED|Overall Study||12
9782418|NCT00510887|10889407|FG000|COMPLETED|Overall Study||11
9782419|NCT00510887|10889407|FG000|NOT COMPLETED|Overall Study||1
9782420|NCT00510952|10889413|FG000|STARTED|Overall Study||235
9782421|NCT00510952|10889414|FG001|STARTED|Overall Study||236
9782422|NCT00510952|10889413|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229
9782423|NCT00510952|10889414|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229
9782424|NCT00510952|10889413|FG000|COMPLETED|Overall Study||209
9782425|NCT00510952|10889414|FG001|COMPLETED|Overall Study||220
9782426|NCT00510952|10889413|FG000|NOT COMPLETED|Overall Study||26
9782427|NCT00510952|10889414|FG001|NOT COMPLETED|Overall Study||16
9782428|NCT00511004|10889423|FG000|STARTED|Overall Study||13
9782429|NCT00511004|10889424|FG001|STARTED|Overall Study||13
9782430|NCT00511004|10889425|FG002|STARTED|Overall Study||14
9782431|NCT00511004|10889423|FG000|COMPLETED|Overall Study||13
9782432|NCT00511004|10889424|FG001|COMPLETED|Overall Study||13
9782433|NCT00511004|10889425|FG002|COMPLETED|Overall Study||10
9782434|NCT00511004|10889423|FG000|NOT COMPLETED|Overall Study||0
9782435|NCT00511004|10889424|FG001|NOT COMPLETED|Overall Study||0
9782436|NCT00511004|10889425|FG002|NOT COMPLETED|Overall Study||4
9782437|NCT00511095|10889436|FG000|STARTED|Overall Study||207
9782438|NCT00511095|10889436|FG000|COMPLETED|Overall Study||196
9782439|NCT00511095|10889436|FG000|NOT COMPLETED|Overall Study||11
9782440|NCT00511108|10889450|FG000|STARTED|Overall Study||52
9782441|NCT00511108|10889451|FG001|STARTED|Overall Study||54
9782442|NCT00511108|10889452|FG002|STARTED|Overall Study||52
9782443|NCT00511108|10889453|FG003|STARTED|Overall Study||53
9782444|NCT00511108|10889450|FG000|COMPLETED|Overall Study||46
9782445|NCT00511108|10889451|FG001|COMPLETED|Overall Study||52
9782446|NCT00511108|10889452|FG002|COMPLETED|Overall Study||47
9782447|NCT00511108|10889453|FG003|COMPLETED|Overall Study||48
9782448|NCT00511108|10889450|FG000|NOT COMPLETED|Overall Study||6
9782449|NCT00511108|10889451|FG001|NOT COMPLETED|Overall Study||2
9782450|NCT00511108|10889452|FG002|NOT COMPLETED|Overall Study||5
9782451|NCT00511108|10889453|FG003|NOT COMPLETED|Overall Study||5
9782452|NCT00511147|10889463|FG000|STARTED|Overall Study||64
9782453|NCT00511147|10889463|FG000|COMPLETED|Overall Study||57
9782454|NCT00511147|10889463|FG000|NOT COMPLETED|Overall Study||7
9782455|NCT00511173|10889467|FG000|STARTED|Overall Study||102
10233980|NCT01606709|11363859|FG001|COMPLETED|Overall Study||3
10233981|NCT01606709|11363858|FG000|NOT COMPLETED|Overall Study||0
10233982|NCT01606709|11363859|FG001|NOT COMPLETED|Overall Study||0
9782456|NCT00511173|10889467|FG000|COMPLETED|Overall Study||102
9782457|NCT00511173|10889467|FG000|NOT COMPLETED|Overall Study||0
9782458|NCT00511238|10889474|FG000|STARTED|Overall Study||46
9782459|NCT00511238|10889475|FG001|STARTED|Overall Study||266
9782460|NCT00511238|10889474|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
9782461|NCT00511238|10889475|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
9782462|NCT00511238|10889474|FG000|NOT COMPLETED|Overall Study||42
9782463|NCT00511238|10889475|FG001|NOT COMPLETED|Overall Study||226
9782464|NCT00511472|10889493|FG000|STARTED|Overall Study||47
9782465|NCT00511472|10889494|FG001|STARTED|Overall Study||23
9782466|NCT00511472|10889493|FG000|COMPLETED|Overall Study||44
9782467|NCT00511472|10889494|FG001|COMPLETED|Overall Study||17
9782468|NCT00511472|10889493|FG000|NOT COMPLETED|Overall Study||3
9782469|NCT00511472|10889494|FG001|NOT COMPLETED|Overall Study||6
9782470|NCT00511667|10889511|FG000|STARTED|Overall Study||52
9782471|NCT00511667|10889512|FG001|STARTED|Overall Study||18
9782472|NCT00511667|10889511|FG000|COMPLETED|Overall Study||40
9782473|NCT00511667|10889512|FG001|COMPLETED|Overall Study||15
9782474|NCT00511667|10889511|FG000|NOT COMPLETED|Overall Study||12
9782475|NCT00511667|10889512|FG001|NOT COMPLETED|Overall Study||3
9782476|NCT00511706|10889526|FG000|STARTED|Overall Study||123
9782477|NCT00511706|10889527|FG001|STARTED|Overall Study||120
9782478|NCT00511706|10889526|FG000|COMPLETED|Overall Study||115
9782479|NCT00511706|10889527|FG001|COMPLETED|Overall Study||115
9782480|NCT00511706|10889526|FG000|NOT COMPLETED|Overall Study||8
9782481|NCT00511706|10889527|FG001|NOT COMPLETED|Overall Study||5
9782482|NCT00511797|10889537|FG000|STARTED|Overall Study||62
9782483|NCT00511797|10889538|FG001|STARTED|Overall Study||63
9782484|NCT00511797|10889539|FG002|STARTED|Overall Study||62
9782485|NCT00511797|10889540|FG003|STARTED|Overall Study||62
9782486|NCT00511797|10889537|FG000|Subjects Dispensed Drugs|Overall Study||61
9782487|NCT00511797|10889538|FG001|Subjects Dispensed Drugs|Overall Study||63
9782488|NCT00511797|10889539|FG002|Subjects Dispensed Drugs|Overall Study||61
9782489|NCT00511797|10889540|FG003|Subjects Dispensed Drugs|Overall Study||59
10014955|NCT01803074|11138017|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10014956|NCT01803074|11138018|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10014957|NCT01803074|11138019|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10014958|NCT01803074|11138020|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10014959|NCT01803074|11138021|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10014960|NCT01803074|11138022|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10014961|NCT01803074|11138009|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10014962|NCT01803074|11138010|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10014963|NCT01803074|11138011|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10014964|NCT01803074|11138012|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10014965|NCT01803074|11138013|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10014966|NCT01803074|11138014|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10014967|NCT01803074|11138015|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
10014968|NCT01803074|11138016|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
9782490|NCT00511797|10889537|FG000|Subjects Received Treatment|Overall Study|FAS|61
9782491|NCT00511797|10889538|FG001|Subjects Received Treatment|Overall Study|FAS|62
9782492|NCT00511797|10889539|FG002|Subjects Received Treatment|Overall Study|FAS|61
9782493|NCT00511797|10889540|FG003|Subjects Received Treatment|Overall Study|FAS|58
9782494|NCT00511797|10889537|FG000|COMPLETED|Overall Study||55
9782495|NCT00511797|10889538|FG001|COMPLETED|Overall Study||55
9782496|NCT00511797|10889539|FG002|COMPLETED|Overall Study||51
9782497|NCT00511797|10889540|FG003|COMPLETED|Overall Study||47
9782498|NCT00511797|10889537|FG000|NOT COMPLETED|Overall Study||7
9782499|NCT00511797|10889538|FG001|NOT COMPLETED|Overall Study||8
9782500|NCT00511797|10889539|FG002|NOT COMPLETED|Overall Study||11
9782501|NCT00511797|10889540|FG003|NOT COMPLETED|Overall Study||15
9782502|NCT00511810|10889552|FG000|STARTED|Overall Study||8
9782503|NCT00511810|10889553|FG001|STARTED|Overall Study||12
9782504|NCT00511810|10889552|FG000|COMPLETED|Overall Study||7
9782505|NCT00511810|10889553|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
9782506|NCT00511810|10889552|FG000|NOT COMPLETED|Overall Study||1
9782507|NCT00511810|10889553|FG001|NOT COMPLETED|Overall Study||5
9782508|NCT00511836|10889561|FG000|STARTED|Double-blind Period||16
9782509|NCT00511836|10889562|FG001|STARTED|Double-blind Period||15
9782510|NCT00511836|10889561|FG000|COMPLETED|Double-blind Period||15
10233983|NCT01603121|11363865|FG000|STARTED|First Intervention, 10 Hours||1
9782511|NCT00511836|10889562|FG001|COMPLETED|Double-blind Period||15
9782512|NCT00511836|10889561|FG000|NOT COMPLETED|Double-blind Period||1
10014969|NCT01803074|11138017|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014970|NCT01803074|11138018|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014971|NCT01803074|11138019|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014972|NCT01803074|11138020|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
9782513|NCT00511836|10889562|FG001|NOT COMPLETED|Double-blind Period||0
9782514|NCT00511836|10889561|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
9782515|NCT00511836|10889562|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
10014973|NCT01803074|11138021|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014974|NCT01803074|11138022|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
9782516|NCT00511836|10889561|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
9782517|NCT00511836|10889562|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
9782518|NCT00511836|10889561|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
9782519|NCT00511836|10889562|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
9782520|NCT00511862|10889572|FG000|STARTED|Overall Study||61
9782521|NCT00511862|10889573|FG001|STARTED|Overall Study||43
9782522|NCT00511862|10889574|FG002|STARTED|Overall Study||47
9782523|NCT00511862|10889572|FG000|COMPLETED|Overall Study||61
9782524|NCT00511862|10889573|FG001|COMPLETED|Overall Study||43
9782525|NCT00511862|10889574|FG002|COMPLETED|Overall Study||47
9782526|NCT00511862|10889572|FG000|NOT COMPLETED|Overall Study||0
9782527|NCT00511862|10889573|FG001|NOT COMPLETED|Overall Study||0
9782528|NCT00511862|10889574|FG002|NOT COMPLETED|Overall Study||0
9782529|NCT00511875|10889586|FG000|STARTED|Overall Study||15
9782530|NCT00511875|10889587|FG001|STARTED|Overall Study||15
9782531|NCT00511875|10889586|FG000|COMPLETED|Overall Study||10
9782532|NCT00511875|10889587|FG001|COMPLETED|Overall Study||15
9782533|NCT00511875|10889586|FG000|NOT COMPLETED|Overall Study||5
9782534|NCT00511875|10889587|FG001|NOT COMPLETED|Overall Study||0
9782535|NCT00511901|10889595|FG000|STARTED|Overall Study||11
9782536|NCT00511901|10889596|FG001|STARTED|Overall Study||11
9782537|NCT00511901|10889595|FG000|COMPLETED|Overall Study||10
9782538|NCT00511901|10889596|FG001|COMPLETED|Overall Study||8
9782539|NCT00511901|10889595|FG000|NOT COMPLETED|Overall Study||1
9782540|NCT00511901|10889596|FG001|NOT COMPLETED|Overall Study||3
9782541|NCT00511914|10889604|FG000|STARTED|Overall Study||68
9782542|NCT00511914|10889605|FG001|STARTED|Overall Study||67
9782543|NCT00511914|10889604|FG000|COMPLETED|Overall Study||68
9782544|NCT00511914|10889605|FG001|COMPLETED|Overall Study||67
9782545|NCT00511914|10889604|FG000|NOT COMPLETED|Overall Study||0
9782546|NCT00511914|10889605|FG001|NOT COMPLETED|Overall Study||0
9782547|NCT00511992|10889611|FG000|STARTED|Overall Study||20
9782548|NCT00511992|10889611|FG000|COMPLETED|Overall Study||13
9782549|NCT00511992|10889611|FG000|NOT COMPLETED|Overall Study||7
9782550|NCT00512096|10889615|FG000|STARTED|Overall Study||30
9782551|NCT00512096|10889615|FG000|COMPLETED|Overall Study||23
9782552|NCT00512096|10889615|FG000|NOT COMPLETED|Overall Study||7
9782553|NCT00512135|10889619|FG000|STARTED|Overall Study||801
9782554|NCT00512135|10889619|FG000|Treated|Overall Study||796
9782555|NCT00512135|10889619|FG000|COMPLETED|Overall Study||717
9782556|NCT00512135|10889619|FG000|NOT COMPLETED|Overall Study||84
9782557|NCT00512148|10889624|FG000|STARTED|Primay Study Period||7
10233984|NCT01603121|11363866|FG001|STARTED|First Intervention, 10 Hours||0
10233985|NCT01603121|11363865|FG000|COMPLETED|First Intervention, 10 Hours||1
10233986|NCT01603121|11363866|FG001|COMPLETED|First Intervention, 10 Hours||0
10233987|NCT01603121|11363865|FG000|NOT COMPLETED|First Intervention, 10 Hours||0
10233988|NCT01603121|11363866|FG001|NOT COMPLETED|First Intervention, 10 Hours||0
10233989|NCT01603121|11363865|FG000|STARTED|Second Intervention, 10 Hours||1
10233990|NCT01603121|11363866|FG001|STARTED|Second Intervention, 10 Hours||0
9782558|NCT00512148|10889624|FG000|COMPLETED|Primay Study Period||6
9782559|NCT00512148|10889624|FG000|NOT COMPLETED|Primay Study Period||1
9782560|NCT00512148|10889624|FG000|STARTED|Long Term Follow Up Period||6
9782561|NCT00512148|10889624|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
9782562|NCT00512148|10889624|FG000|NOT COMPLETED|Long Term Follow Up Period||6
10014975|NCT01803074|11138009|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014976|NCT01803074|11138010|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10233991|NCT01603121|11363865|FG000|COMPLETED|Second Intervention, 10 Hours||0
9782563|NCT00512252|10889633|FG000|STARTED|Overall Study||3
9782564|NCT00512252|10889634|FG001|STARTED|Overall Study||3
9782565|NCT00512252|10889635|FG002|STARTED|Overall Study||46
9782566|NCT00512252|10889633|FG000|COMPLETED|Overall Study||3
9782567|NCT00512252|10889634|FG001|COMPLETED|Overall Study||3
9782568|NCT00512252|10889635|FG002|COMPLETED|Overall Study||43
9782569|NCT00512252|10889633|FG000|NOT COMPLETED|Overall Study||0
9782570|NCT00512252|10889634|FG001|NOT COMPLETED|Overall Study||0
9782571|NCT00512252|10889635|FG002|NOT COMPLETED|Overall Study||3
9830325|NCT00762606|10940985|FG001|STARTED|Overall Study||51
9830326|NCT00762606|10940984|FG000|COMPLETED|Overall Study||37
9830327|NCT00762606|10940985|FG001|COMPLETED|Overall Study||38
9830328|NCT00762606|10940984|FG000|NOT COMPLETED|Overall Study||18
9830329|NCT00762606|10940985|FG001|NOT COMPLETED|Overall Study||13
9830330|NCT00762619|10940993|FG000|STARTED|Overall Study||55
9830331|NCT00762619|10940994|FG001|STARTED|Overall Study||50
9830332|NCT00762619|10940993|FG000|COMPLETED|Overall Study||55
9830333|NCT00762619|10940994|FG001|COMPLETED|Overall Study||50
9830334|NCT00762619|10940993|FG000|NOT COMPLETED|Overall Study||0
9830335|NCT00762619|10940994|FG001|NOT COMPLETED|Overall Study||0
10233992|NCT01603121|11363866|FG001|COMPLETED|Second Intervention, 10 Hours||0
9830336|NCT00762645|10941004|FG000|STARTED|Overall Study||16
9830337|NCT00762645|10941005|FG001|STARTED|Overall Study||14
9830338|NCT00762645|10941004|FG000|COMPLETED|Overall Study||12
9830339|NCT00762645|10941005|FG001|COMPLETED|Overall Study||12
9830340|NCT00762645|10941004|FG000|NOT COMPLETED|Overall Study||4
9830341|NCT00762645|10941005|FG001|NOT COMPLETED|Overall Study||2
9830342|NCT00762710|10941013|FG000|STARTED|Overall Study||48
9830343|NCT00762710|10941014|FG001|STARTED|Overall Study||44
9830344|NCT00762710|10941013|FG000|COMPLETED|Overall Study||27
9782572|NCT00512278|10889652|FG000|STARTED|Overall Study||73
9782573|NCT00512278|10889653|FG001|STARTED|Overall Study||73
9782574|NCT00512278|10889652|FG000|COMPLETED|Overall Study||45
9782575|NCT00512278|10889653|FG001|COMPLETED|Overall Study||56
9782576|NCT00512278|10889652|FG000|NOT COMPLETED|Overall Study||28
9782577|NCT00512278|10889653|FG001|NOT COMPLETED|Overall Study||17
9782578|NCT00512707|10889663|FG000|STARTED|Overall Study||70
9782579|NCT00512707|10889664|FG001|STARTED|Overall Study||70
9782580|NCT00512707|10889663|FG000|COMPLETED|Overall Study||60
9782581|NCT00512707|10889664|FG001|COMPLETED|Overall Study||58
9782582|NCT00512707|10889663|FG000|NOT COMPLETED|Overall Study||10
9782583|NCT00512707|10889664|FG001|NOT COMPLETED|Overall Study||12
9782584|NCT00512798|10889672|FG000|STARTED|Overall Study||19
9782585|NCT00512798|10889673|FG001|STARTED|Overall Study||28
10233993|NCT01603121|11363865|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1
10233994|NCT01603121|11363866|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0
10233995|NCT01602016|11363872|FG000|STARTED|Overall Study||0
10233996|NCT01602016|11363872|FG000|COMPLETED|Overall Study||0
10233997|NCT01602016|11363872|FG000|NOT COMPLETED|Overall Study||0
9782586|NCT00512798|10889672|FG000|COMPLETED|Overall Study||0
9782587|NCT00512798|10889673|FG001|COMPLETED|Overall Study||1
9782588|NCT00512798|10889672|FG000|NOT COMPLETED|Overall Study||19
9782589|NCT00512798|10889673|FG001|NOT COMPLETED|Overall Study||27
9782590|NCT00512876|10889680|FG000|STARTED|Overall Study||24
9782591|NCT00512876|10889680|FG000|COMPLETED|Overall Study||20
9782592|NCT00512876|10889680|FG000|NOT COMPLETED|Overall Study||4
9782593|NCT00512902|10889684|FG000|STARTED|Overall Study||20
9782594|NCT00512902|10889684|FG000|COMPLETED|Overall Study||12
9782595|NCT00512902|10889684|FG000|NOT COMPLETED|Overall Study||8
9782596|NCT00513019|10889690|FG000|STARTED|Overall Study||17
9782597|NCT00513019|10889691|FG001|STARTED|Overall Study||18
9782598|NCT00513019|10889690|FG000|COMPLETED|Overall Study||12
9782599|NCT00513019|10889691|FG001|COMPLETED|Overall Study||13
9782600|NCT00513019|10889690|FG000|NOT COMPLETED|Overall Study||5
9782601|NCT00513019|10889691|FG001|NOT COMPLETED|Overall Study||5
9782602|NCT00513071|10889697|FG000|STARTED|Overall Study||28
9782603|NCT00513071|10889697|FG000|COMPLETED|Overall Study||23
9782604|NCT00513071|10889697|FG000|NOT COMPLETED|Overall Study||5
9782605|NCT00513240|10889703|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
9782606|NCT00513240|10889704|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
9782607|NCT00513240|10889703|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
9782608|NCT00513240|10889704|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
9782609|NCT00513240|10889703|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
9782610|NCT00513240|10889704|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
9782611|NCT00513240|10889703|FG000|NOT COMPLETED|Overall Study||13
9782612|NCT00513240|10889704|FG001|NOT COMPLETED|Overall Study||7
9782613|NCT00513292|10889715|FG000|STARTED|Overall Study||138
9782614|NCT00513292|10889716|FG001|STARTED|Overall Study||142
9782615|NCT00513292|10889715|FG000|COMPLETED|Overall Study||138
9782616|NCT00513292|10889716|FG001|COMPLETED|Overall Study||142
9782617|NCT00513292|10889715|FG000|NOT COMPLETED|Overall Study||0
9782618|NCT00513292|10889716|FG001|NOT COMPLETED|Overall Study||0
9782619|NCT00513305|10889724|FG000|STARTED|Overall Study||33
9782620|NCT00513305|10889725|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
9782621|NCT00513305|10889724|FG000|COMPLETED|Overall Study||5
9782622|NCT00513305|10889725|FG001|COMPLETED|Overall Study||7
9782623|NCT00513305|10889724|FG000|NOT COMPLETED|Overall Study||28
9782624|NCT00513305|10889725|FG001|NOT COMPLETED|Overall Study||27
9782625|NCT00513344|10889731|FG000|STARTED|Diet Restriction (3 Days)||5
9782626|NCT00513344|10889731|FG000|COMPLETED|Diet Restriction (3 Days)||5
9782627|NCT00513344|10889731|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0
9782628|NCT00513344|10889731|FG000|STARTED|1st Intervention 1 Day||5
9782629|NCT00513344|10889731|FG000|COMPLETED|1st Intervention 1 Day||5
9782630|NCT00513344|10889731|FG000|NOT COMPLETED|1st Intervention 1 Day||0
9782631|NCT00513344|10889731|FG000|STARTED|Washout Period 3 Days||5
9782632|NCT00513344|10889731|FG000|COMPLETED|Washout Period 3 Days||5
9782633|NCT00513344|10889731|FG000|NOT COMPLETED|Washout Period 3 Days||0
9782634|NCT00513344|10889731|FG000|STARTED|2nd Intervention 1 Day||5
9782635|NCT00513344|10889731|FG000|COMPLETED|2nd Intervention 1 Day||5
9782636|NCT00513344|10889731|FG000|NOT COMPLETED|2nd Intervention 1 Day||0
9782637|NCT00513344|10889731|FG000|STARTED|Washout Period 3 Days||5
10014977|NCT01803074|11138011|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014978|NCT01803074|11138012|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014979|NCT01803074|11138013|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014980|NCT01803074|11138014|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014981|NCT01803074|11138015|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014982|NCT01803074|11138016|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014983|NCT01803074|11138017|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014984|NCT01803074|11138018|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014985|NCT01803074|11138019|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10233998|NCT01603394|11363879|FG000|STARTED|Overall Study||9
10233999|NCT01603394|11363879|FG000|COMPLETED|Overall Study||8
10014986|NCT01803074|11138020|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
9782638|NCT00513344|10889731|FG000|COMPLETED|Washout Period 3 Days||5
9782639|NCT00513344|10889731|FG000|NOT COMPLETED|Washout Period 3 Days||0
10014987|NCT01803074|11138021|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014988|NCT01803074|11138022|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10014989|NCT01803074|11138009|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0
9782640|NCT00513344|10889731|FG000|STARTED|3rd Intervention 1 Day||5
9782641|NCT00513344|10889731|FG000|COMPLETED|3rd Intervention 1 Day||5
9782642|NCT00513344|10889731|FG000|NOT COMPLETED|3rd Intervention 1 Day||0
9782643|NCT00513357|10889741|FG000|STARTED|Overall Study||38
9782644|NCT00513357|10889742|FG001|STARTED|Overall Study||35
9782645|NCT00513357|10889741|FG000|COMPLETED|Overall Study||23
9782646|NCT00513357|10889742|FG001|COMPLETED|Overall Study||25
9782647|NCT00513357|10889741|FG000|NOT COMPLETED|Overall Study||15
9782648|NCT00513357|10889742|FG001|NOT COMPLETED|Overall Study||10
9782649|NCT00513370|10889748|FG000|STARTED|Overall Study||203
9782650|NCT00513370|10889748|FG000|COMPLETED|Overall Study||179
9782651|NCT00513370|10889748|FG000|NOT COMPLETED|Overall Study||24
9782652|NCT00513409|10889756|FG000|STARTED|Overall Study||84
9782653|NCT00513409|10889757|FG001|STARTED|Overall Study||79
9782654|NCT00513409|10889756|FG000|COMPLETED|Overall Study||82
9782655|NCT00513409|10889757|FG001|COMPLETED|Overall Study||73
9782656|NCT00513409|10889756|FG000|NOT COMPLETED|Overall Study||2
9782657|NCT00513409|10889757|FG001|NOT COMPLETED|Overall Study||6
9782658|NCT00513435|10889763|FG000|STARTED|Overall Study||9
9782659|NCT00513435|10889763|FG000|COMPLETED|Overall Study||9
9782660|NCT00513435|10889763|FG000|NOT COMPLETED|Overall Study||0
9782661|NCT00513461|10889769|FG000|STARTED|Overall Study||57
9782662|NCT00513461|10889770|FG001|STARTED|Overall Study||53
9782663|NCT00513461|10889769|FG000|COMPLETED|Overall Study||44
9782664|NCT00513461|10889770|FG001|COMPLETED|Overall Study||43
9782665|NCT00513461|10889769|FG000|NOT COMPLETED|Overall Study||13
9782666|NCT00513461|10889770|FG001|NOT COMPLETED|Overall Study||10
9782667|NCT00513474|10889778|FG000|STARTED|Overall Study||25
9782668|NCT00513474|10889779|FG001|STARTED|Overall Study||21
9782669|NCT00513474|10889778|FG000|Received Rasburicase Per Protocol|Overall Study||24
9782670|NCT00513474|10889779|FG001|Received Rasburicase Per Protocol|Overall Study||0
9782671|NCT00513474|10889778|FG000|COMPLETED|Overall Study||18
9782672|NCT00513474|10889779|FG001|COMPLETED|Overall Study||12
9782673|NCT00513474|10889778|FG000|NOT COMPLETED|Overall Study||7
9782674|NCT00513474|10889779|FG001|NOT COMPLETED|Overall Study||9
9782675|NCT00513500|10889787|FG000|STARTED|Overall Study||1017
9782676|NCT00513500|10889788|FG001|STARTED|Overall Study||2108
9782677|NCT00513500|10889787|FG000|COMPLETED|Overall Study||976
9782678|NCT00513500|10889788|FG001|COMPLETED|Overall Study||2054
9782679|NCT00513500|10889787|FG000|NOT COMPLETED|Overall Study||41
9782680|NCT00513500|10889788|FG001|NOT COMPLETED|Overall Study||54
9782681|NCT00513526|10889794|FG000|STARTED|Overall Study||109
9782682|NCT00513526|10889794|FG000|COMPLETED|Overall Study||92
9782683|NCT00513526|10889794|FG000|NOT COMPLETED|Overall Study||17
9782684|NCT00513604|10889805|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26
9782685|NCT00513604|10889806|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
9782686|NCT00513604|10889807|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
9782687|NCT00513604|10889808|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
9782688|NCT00513604|10889809|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
9782689|NCT00513604|10889805|FG000|COMPLETED|Overall Study||24
9782690|NCT00513604|10889806|FG001|COMPLETED|Overall Study||36
9782691|NCT00513604|10889807|FG002|COMPLETED|Overall Study||21
9782692|NCT00513604|10889808|FG003|COMPLETED|Overall Study||34
9782693|NCT00513604|10889809|FG004|COMPLETED|Overall Study||35
9782694|NCT00513604|10889805|FG000|NOT COMPLETED|Overall Study||2
9782695|NCT00513604|10889806|FG001|NOT COMPLETED|Overall Study||3
9782696|NCT00513604|10889807|FG002|NOT COMPLETED|Overall Study||3
9782697|NCT00513604|10889808|FG003|NOT COMPLETED|Overall Study||0
9782698|NCT00513604|10889809|FG004|NOT COMPLETED|Overall Study||0
9782699|NCT00513682|10889821|FG000|STARTED|Screening Phase||9
9782700|NCT00513682|10889821|FG000|COMPLETED|Screening Phase||9
9782701|NCT00513682|10889821|FG000|NOT COMPLETED|Screening Phase||0
9782702|NCT00513682|10889821|FG000|STARTED|Washout Phase||9
9782703|NCT00513682|10889821|FG000|COMPLETED|Washout Phase||7
9782704|NCT00513682|10889821|FG000|NOT COMPLETED|Washout Phase||2
9782705|NCT00513682|10889821|FG000|STARTED|Treatment Phase||7
9782706|NCT00513682|10889821|FG000|COMPLETED|Treatment Phase||7
9782707|NCT00513682|10889821|FG000|NOT COMPLETED|Treatment Phase||0
9782708|NCT00513695|10889828|FG000|STARTED|Overall Study||68
9782709|NCT00513695|10889828|FG000|COMPLETED|Overall Study||63
9782710|NCT00513695|10889828|FG000|NOT COMPLETED|Overall Study||5
9782711|NCT00513708|10889835|FG000|STARTED|Overall Study||50
9782712|NCT00513708|10889836|FG001|STARTED|Overall Study||50
9782713|NCT00513708|10889837|FG002|STARTED|Overall Study||50
9782714|NCT00513708|10889835|FG000|COMPLETED|Overall Study||46
9782715|NCT00513708|10889836|FG001|COMPLETED|Overall Study||46
9782716|NCT00513708|10889837|FG002|COMPLETED|Overall Study||46
9782717|NCT00513708|10889835|FG000|NOT COMPLETED|Overall Study||4
9782718|NCT00513708|10889836|FG001|NOT COMPLETED|Overall Study||4
9782719|NCT00513708|10889837|FG002|NOT COMPLETED|Overall Study||4
9782720|NCT00513747|10889848|FG000|STARTED|Overall Study||17
9782721|NCT00513747|10889849|FG001|STARTED|Overall Study||11
9782722|NCT00513747|10889850|FG002|STARTED|Overall Study||55
9782723|NCT00513747|10889848|FG000|Received at Least One Dose of Treatment|Overall Study||9
9782724|NCT00513747|10889849|FG001|Received at Least One Dose of Treatment|Overall Study||11
9782725|NCT00513747|10889850|FG002|Received at Least One Dose of Treatment|Overall Study||40
10014990|NCT01803074|11138010|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10014991|NCT01803074|11138011|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10014992|NCT01803074|11138012|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10014993|NCT01803074|11138013|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10014994|NCT01803074|11138014|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10014995|NCT01803074|11138015|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10014996|NCT01803074|11138016|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8
10014997|NCT01803074|11138017|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8
9782726|NCT00513747|10889848|FG000|COMPLETED|Overall Study||17
9782727|NCT00513747|10889849|FG001|COMPLETED|Overall Study||11
9782728|NCT00513747|10889850|FG002|COMPLETED|Overall Study||55
9782729|NCT00513747|10889848|FG000|NOT COMPLETED|Overall Study||0
9782730|NCT00513747|10889849|FG001|NOT COMPLETED|Overall Study||0
9782731|NCT00513747|10889850|FG002|NOT COMPLETED|Overall Study||0
10014998|NCT01803074|11138018|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4
10014999|NCT01803074|11138019|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8
10015000|NCT01803074|11138020|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10015001|NCT01803074|11138021|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10015002|NCT01803074|11138022|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0
9782732|NCT00513799|10889864|FG000|STARTED|One-Month Follow-Up||75
9782733|NCT00513799|10889865|FG001|STARTED|One-Month Follow-Up||75
9782734|NCT00513799|10889866|FG002|STARTED|One-Month Follow-Up||75
9782735|NCT00513799|10889867|FG003|STARTED|One-Month Follow-Up||75
9782736|NCT00513799|10889864|FG000|COMPLETED|One-Month Follow-Up||64
9782737|NCT00513799|10889865|FG001|COMPLETED|One-Month Follow-Up||62
9782738|NCT00513799|10889866|FG002|COMPLETED|One-Month Follow-Up||64
9782739|NCT00513799|10889867|FG003|COMPLETED|One-Month Follow-Up||54
9782740|NCT00513799|10889864|FG000|NOT COMPLETED|One-Month Follow-Up||11
9782741|NCT00513799|10889865|FG001|NOT COMPLETED|One-Month Follow-Up||13
9782742|NCT00513799|10889866|FG002|NOT COMPLETED|One-Month Follow-Up||11
9782743|NCT00513799|10889867|FG003|NOT COMPLETED|One-Month Follow-Up||21
9782744|NCT00513799|10889864|FG000|STARTED|Four-Month Follow-Up||64
9782745|NCT00513799|10889865|FG001|STARTED|Four-Month Follow-Up||62
9782746|NCT00513799|10889866|FG002|STARTED|Four-Month Follow-Up||64
9782747|NCT00513799|10889867|FG003|STARTED|Four-Month Follow-Up||54
9782748|NCT00513799|10889864|FG000|COMPLETED|Four-Month Follow-Up||64
9782749|NCT00513799|10889865|FG001|COMPLETED|Four-Month Follow-Up||57
9782750|NCT00513799|10889866|FG002|COMPLETED|Four-Month Follow-Up||57
9782751|NCT00513799|10889867|FG003|COMPLETED|Four-Month Follow-Up||51
9782752|NCT00513799|10889864|FG000|NOT COMPLETED|Four-Month Follow-Up||0
9782753|NCT00513799|10889865|FG001|NOT COMPLETED|Four-Month Follow-Up||5
9782754|NCT00513799|10889866|FG002|NOT COMPLETED|Four-Month Follow-Up||7
9782755|NCT00513799|10889867|FG003|NOT COMPLETED|Four-Month Follow-Up||3
9782756|NCT00514020|10889881|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
9782757|NCT00514020|10889881|FG000|COMPLETED|Overall Study||5
9782758|NCT00514020|10889881|FG000|NOT COMPLETED|Overall Study||28
9782759|NCT00514046|10889894|FG000|STARTED|Overall Study||5
9782760|NCT00514046|10889895|FG001|STARTED|Overall Study||1
9782761|NCT00514046|10889896|FG002|STARTED|Overall Study||5
9782762|NCT00514046|10889897|FG003|STARTED|Overall Study||1
9782763|NCT00514046|10889898|FG004|STARTED|Overall Study||1
9782764|NCT00514046|10889899|FG005|STARTED|Overall Study||1
9782765|NCT00514046|10889900|FG006|STARTED|Overall Study||1
9782766|NCT00514046|10889901|FG007|STARTED|Overall Study||1
9782767|NCT00514046|10889902|FG008|STARTED|Overall Study||1
9782768|NCT00514046|10889894|FG000|COMPLETED|Overall Study||2
9782769|NCT00514046|10889895|FG001|COMPLETED|Overall Study||0
9782770|NCT00514046|10889896|FG002|COMPLETED|Overall Study||0
9782771|NCT00514046|10889897|FG003|COMPLETED|Overall Study||1
9782772|NCT00514046|10889898|FG004|COMPLETED|Overall Study||0
9782773|NCT00514046|10889899|FG005|COMPLETED|Overall Study||0
9782774|NCT00514046|10889900|FG006|COMPLETED|Overall Study||1
9782775|NCT00514046|10889901|FG007|COMPLETED|Overall Study||0
9782776|NCT00514046|10889902|FG008|COMPLETED|Overall Study||0
9782777|NCT00514046|10889894|FG000|NOT COMPLETED|Overall Study||3
9782778|NCT00514046|10889895|FG001|NOT COMPLETED|Overall Study||1
9782779|NCT00514046|10889896|FG002|NOT COMPLETED|Overall Study||5
9782780|NCT00514046|10889897|FG003|NOT COMPLETED|Overall Study||0
9782781|NCT00514046|10889898|FG004|NOT COMPLETED|Overall Study||1
9782782|NCT00514046|10889899|FG005|NOT COMPLETED|Overall Study||1
9782783|NCT00514046|10889900|FG006|NOT COMPLETED|Overall Study||0
9782784|NCT00514046|10889901|FG007|NOT COMPLETED|Overall Study||1
9782785|NCT00514046|10889902|FG008|NOT COMPLETED|Overall Study||1
9782786|NCT00514137|10889924|FG000|STARTED|Overall Study||13
9782787|NCT00514137|10889924|FG000|COMPLETED|Overall Study||13
9782788|NCT00514137|10889924|FG000|NOT COMPLETED|Overall Study||0
9782789|NCT00514215|10889928|FG000|STARTED|Overall Study||8
10015003|NCT01803074|11138009|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
9782790|NCT00514215|10889928|FG000|COMPLETED|Overall Study||8
9782791|NCT00514215|10889928|FG000|NOT COMPLETED|Overall Study||0
9782792|NCT00514449|10889934|FG000|STARTED|Overall Study||12
9782793|NCT00514449|10889935|FG001|STARTED|Overall Study||12
9782794|NCT00514449|10889934|FG000|COMPLETED|Overall Study||9
9782795|NCT00514449|10889935|FG001|COMPLETED|Overall Study||8
9782796|NCT00514449|10889934|FG000|NOT COMPLETED|Overall Study||3
9782797|NCT00514449|10889935|FG001|NOT COMPLETED|Overall Study||4
9782798|NCT00514501|10889944|FG000|STARTED|Overall Study||510
9782799|NCT00514501|10889944|FG000|COMPLETED|Overall Study||507
9782800|NCT00514501|10889944|FG000|NOT COMPLETED|Overall Study||3
9782801|NCT00514514|10889951|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
9782802|NCT00514514|10889952|FG001|STARTED|Pre-phase||0
9782803|NCT00514514|10889953|FG002|STARTED|Pre-phase||0
9782804|NCT00514514|10889951|FG000|COMPLETED|Pre-phase||499
9782805|NCT00514514|10889952|FG001|COMPLETED|Pre-phase||0
9782806|NCT00514514|10889953|FG002|COMPLETED|Pre-phase||0
9782807|NCT00514514|10889951|FG000|NOT COMPLETED|Pre-phase||303
9782808|NCT00514514|10889952|FG001|NOT COMPLETED|Pre-phase||0
9782809|NCT00514514|10889953|FG002|NOT COMPLETED|Pre-phase||0
9782810|NCT00514514|10889951|FG000|STARTED|Randomized - 9 Month||166
9782811|NCT00514514|10889952|FG001|STARTED|Randomized - 9 Month||171
9782812|NCT00514514|10889953|FG002|STARTED|Randomized - 9 Month||162
9782813|NCT00514514|10889951|FG000|Randomized - Received Treatment|Randomized - 9 Month||165
9782814|NCT00514514|10889952|FG001|Randomized - Received Treatment|Randomized - 9 Month||171
9782815|NCT00514514|10889953|FG002|Randomized - Received Treatment|Randomized - 9 Month||161
9782816|NCT00514514|10889951|FG000|COMPLETED|Randomized - 9 Month||127
9782817|NCT00514514|10889952|FG001|COMPLETED|Randomized - 9 Month||110
9782818|NCT00514514|10889953|FG002|COMPLETED|Randomized - 9 Month||124
9782819|NCT00514514|10889951|FG000|NOT COMPLETED|Randomized - 9 Month||39
9782820|NCT00514514|10889952|FG001|NOT COMPLETED|Randomized - 9 Month||61
9782821|NCT00514514|10889953|FG002|NOT COMPLETED|Randomized - 9 Month||38
9782822|NCT00514514|10889951|FG000|STARTED|Extension - 4 Years||145
9782823|NCT00514514|10889952|FG001|STARTED|Extension - 4 Years||139
9782824|NCT00514514|10889953|FG002|STARTED|Extension - 4 Years||134
9782825|NCT00514514|10889951|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
9782826|NCT00514514|10889952|FG001|Non-randomized (Followed)|Extension - 4 Years||0
9782827|NCT00514514|10889953|FG002|Non-randomized (Followed)|Extension - 4 Years||0
9782828|NCT00514514|10889951|FG000|COMPLETED|Extension - 4 Years||108
9782829|NCT00514514|10889952|FG001|COMPLETED|Extension - 4 Years||117
9782830|NCT00514514|10889953|FG002|COMPLETED|Extension - 4 Years||113
10015004|NCT01803074|11138010|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015005|NCT01803074|11138011|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015006|NCT01803074|11138012|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015007|NCT01803074|11138013|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015008|NCT01803074|11138014|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015009|NCT01803074|11138015|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
9782831|NCT00514514|10889951|FG000|NOT COMPLETED|Extension - 4 Years||37
9782832|NCT00514514|10889952|FG001|NOT COMPLETED|Extension - 4 Years||22
9782833|NCT00514514|10889953|FG002|NOT COMPLETED|Extension - 4 Years||21
9782834|NCT00514540|10889961|FG000|STARTED|First-Line Chemo||113
9782835|NCT00514540|10889961|FG000|COMPLETED|First-Line Chemo||105
9782836|NCT00514540|10889961|FG000|NOT COMPLETED|First-Line Chemo||8
9782837|NCT00514540|10889961|FG000|STARTED|Second-Line||105
9782838|NCT00514540|10889961|FG000|COMPLETED|Second-Line||74
9782839|NCT00514540|10889961|FG000|NOT COMPLETED|Second-Line||31
10015010|NCT01803074|11138016|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
10015011|NCT01803074|11138017|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
10015012|NCT01803074|11138018|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
10015013|NCT01803074|11138019|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
10015014|NCT01803074|11138020|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015015|NCT01803074|11138021|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015016|NCT01803074|11138022|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015017|NCT01803074|11138009|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015018|NCT01803074|11138010|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
9782840|NCT00514592|10889969|FG000|STARTED|Overall Study||230
9782841|NCT00514592|10889969|FG000|COMPLETED|Overall Study||230
9782842|NCT00514592|10889969|FG000|NOT COMPLETED|Overall Study||0
9782843|NCT00514683|10889978|FG000|STARTED|Overall Study|Randomised|87
9782844|NCT00514683|10889979|FG001|STARTED|Overall Study|Randomised|87
9782845|NCT00514683|10889980|FG002|STARTED|Overall Study|Randomised|86
9782846|NCT00514683|10889981|FG003|STARTED|Overall Study|Randomised|86
9782847|NCT00514683|10889982|FG004|STARTED|Overall Study|Randomised|86
9782848|NCT00514683|10889978|FG000|COMPLETED|Overall Study||61
9782849|NCT00514683|10889979|FG001|COMPLETED|Overall Study||62
9782850|NCT00514683|10889980|FG002|COMPLETED|Overall Study||68
9782851|NCT00514683|10889981|FG003|COMPLETED|Overall Study||72
9782852|NCT00514683|10889982|FG004|COMPLETED|Overall Study||53
9782853|NCT00514683|10889978|FG000|NOT COMPLETED|Overall Study||26
9782854|NCT00514683|10889979|FG001|NOT COMPLETED|Overall Study||25
9782855|NCT00514683|10889980|FG002|NOT COMPLETED|Overall Study||18
9782856|NCT00514683|10889981|FG003|NOT COMPLETED|Overall Study||14
9782857|NCT00514683|10889982|FG004|NOT COMPLETED|Overall Study||33
9782858|NCT00514709|10890000|FG000|STARTED|Overall Study||1230
9782859|NCT00514709|10890001|FG001|STARTED|Overall Study||613
9782860|NCT00514709|10890000|FG000|COMPLETED|Overall Study||1230
9782861|NCT00514709|10890001|FG001|COMPLETED|Overall Study||613
9782862|NCT00514709|10890000|FG000|NOT COMPLETED|Overall Study||0
9782863|NCT00514709|10890001|FG001|NOT COMPLETED|Overall Study||0
10015019|NCT01803074|11138011|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
9782864|NCT00514735|10890011|FG000|STARTED|Overall Study||138
9782865|NCT00514735|10890012|FG001|STARTED|Overall Study||72
9782866|NCT00514735|10890011|FG000|COMPLETED|Overall Study||124
9782867|NCT00514735|10890012|FG001|COMPLETED|Overall Study||66
9782868|NCT00514735|10890011|FG000|NOT COMPLETED|Overall Study||14
9782869|NCT00514735|10890012|FG001|NOT COMPLETED|Overall Study||6
9782870|NCT00514852|10890022|FG000|STARTED|Overall Study||157
9782871|NCT00514852|10890023|FG001|STARTED|Overall Study||159
9782872|NCT00514852|10890022|FG000|COMPLETED|Overall Study||152
9782873|NCT00514852|10890023|FG001|COMPLETED|Overall Study||154
9782874|NCT00514852|10890022|FG000|NOT COMPLETED|Overall Study||5
9782875|NCT00514852|10890023|FG001|NOT COMPLETED|Overall Study||5
9782876|NCT00514904|10890031|FG000|STARTED|Overall Study||1125
9782877|NCT00514904|10890032|FG001|STARTED|Overall Study||376
9782878|NCT00514904|10890031|FG000|COMPLETED|Overall Study||1101
9782879|NCT00514904|10890032|FG001|COMPLETED|Overall Study||371
9782880|NCT00514904|10890031|FG000|NOT COMPLETED|Overall Study||24
9782881|NCT00514904|10890032|FG001|NOT COMPLETED|Overall Study||5
9782882|NCT00514917|10890040|FG000|STARTED|Overall Study||207
9782883|NCT00514917|10890041|FG001|STARTED|Overall Study||206
9782884|NCT00514917|10890040|FG000|Treated|Overall Study||196
9782885|NCT00514917|10890041|FG001|Treated|Overall Study||204
9782886|NCT00514917|10890040|FG000|Completed Study Treatment|Overall Study||170
9782887|NCT00514917|10890041|FG001|Completed Study Treatment|Overall Study||182
9782888|NCT00514917|10890040|FG000|Testosterone-Specific Evaluable|Overall Study||122
9782889|NCT00514917|10890041|FG001|Testosterone-Specific Evaluable|Overall Study||124
9782890|NCT00514917|10890040|FG000|COMPLETED|Overall Study||81
9782891|NCT00514917|10890041|FG001|COMPLETED|Overall Study||91
9782892|NCT00514917|10890040|FG000|NOT COMPLETED|Overall Study||126
9782893|NCT00514917|10890041|FG001|NOT COMPLETED|Overall Study||115
9782894|NCT00514943|10890051|FG000|STARTED|Stage 1|1 randomized patient was not treated|62
9782895|NCT00514943|10890052|FG001|STARTED|Stage 1|2 randomized patients were not treated|62
9782896|NCT00514943|10890051|FG000|COMPLETED|Stage 1||32
9782897|NCT00514943|10890052|FG001|COMPLETED|Stage 1||36
9782898|NCT00514943|10890051|FG000|NOT COMPLETED|Stage 1||30
9782899|NCT00514943|10890052|FG001|NOT COMPLETED|Stage 1||26
9782900|NCT00514943|10890051|FG000|STARTED|Stage 2||32
9782901|NCT00514943|10890052|FG001|STARTED|Stage 2||36
9782902|NCT00514943|10890051|FG000|COMPLETED|Stage 2||0
9782903|NCT00514943|10890052|FG001|COMPLETED|Stage 2||0
9782904|NCT00514943|10890051|FG000|NOT COMPLETED|Stage 2||32
9782905|NCT00514943|10890052|FG001|NOT COMPLETED|Stage 2||36
9782906|NCT00515008|10890075|FG000|STARTED|Overall Study||33
9782907|NCT00515008|10890076|FG001|STARTED|Overall Study||33
9782908|NCT00515008|10890075|FG000|Completed 12 Week Evaluation|Overall Study||32
9782909|NCT00515008|10890076|FG001|Completed 12 Week Evaluation|Overall Study||29
9782910|NCT00515008|10890075|FG000|COMPLETED|Overall Study||30
9782911|NCT00515008|10890076|FG001|COMPLETED|Overall Study||29
9782912|NCT00515008|10890075|FG000|NOT COMPLETED|Overall Study||3
9782913|NCT00515008|10890076|FG001|NOT COMPLETED|Overall Study||4
9782914|NCT00515021|10890087|FG000|STARTED|Overall Study||9
9782915|NCT00515021|10890088|FG001|STARTED|Overall Study||11
9782916|NCT00515021|10890087|FG000|COMPLETED|Overall Study||9
9782917|NCT00515021|10890088|FG001|COMPLETED|Overall Study||11
9782918|NCT00515021|10890087|FG000|NOT COMPLETED|Overall Study||0
9782919|NCT00515021|10890088|FG001|NOT COMPLETED|Overall Study||0
9782920|NCT00515034|10890100|FG000|STARTED|Overall Study||49
9782921|NCT00515034|10890101|FG001|STARTED|Overall Study||15
9782922|NCT00515034|10890102|FG002|STARTED|Overall Study||62
9782923|NCT00515034|10890103|FG003|STARTED|Overall Study||20
9782924|NCT00515034|10890100|FG000|TREATED|Overall Study||48
9782925|NCT00515034|10890101|FG001|TREATED|Overall Study||15
9782926|NCT00515034|10890102|FG002|TREATED|Overall Study||61
9782927|NCT00515034|10890103|FG003|TREATED|Overall Study||19
9782928|NCT00515034|10890100|FG000|COMPLETED|Overall Study||41
9782929|NCT00515034|10890101|FG001|COMPLETED|Overall Study||13
9782930|NCT00515034|10890102|FG002|COMPLETED|Overall Study||54
9782931|NCT00515034|10890103|FG003|COMPLETED|Overall Study||15
9782932|NCT00515034|10890100|FG000|NOT COMPLETED|Overall Study||8
9782933|NCT00515034|10890101|FG001|NOT COMPLETED|Overall Study||2
9782934|NCT00515034|10890102|FG002|NOT COMPLETED|Overall Study||8
9782935|NCT00515034|10890103|FG003|NOT COMPLETED|Overall Study||5
9782936|NCT00515073|10890113|FG000|STARTED|Overall Study||30
9782937|NCT00515073|10890113|FG000|COMPLETED|Overall Study||28
9782938|NCT00515073|10890113|FG000|NOT COMPLETED|Overall Study||2
9782939|NCT00515086|10890121|FG000|STARTED|Overall Study||24
9782940|NCT00515086|10890122|FG001|STARTED|Overall Study||6
9782941|NCT00515086|10890123|FG002|STARTED|Overall Study||5
9782942|NCT00515086|10890124|FG003|STARTED|Overall Study||6
9782943|NCT00515086|10890121|FG000|COMPLETED|Overall Study||0
9782944|NCT00515086|10890122|FG001|COMPLETED|Overall Study||0
9782945|NCT00515086|10890123|FG002|COMPLETED|Overall Study||0
9782946|NCT00515086|10890124|FG003|COMPLETED|Overall Study||0
9782947|NCT00515086|10890121|FG000|NOT COMPLETED|Overall Study||24
9782948|NCT00515086|10890122|FG001|NOT COMPLETED|Overall Study||6
9782949|NCT00515086|10890123|FG002|NOT COMPLETED|Overall Study||5
9782950|NCT00515086|10890124|FG003|NOT COMPLETED|Overall Study||6
9782951|NCT00515099|10890142|FG000|STARTED|Overall Study||38
9782952|NCT00515099|10890143|FG001|STARTED|Overall Study||20
9782953|NCT00515099|10890142|FG000|COMPLETED|Overall Study||35
9782954|NCT00515099|10890143|FG001|COMPLETED|Overall Study||16
9782955|NCT00515099|10890142|FG000|NOT COMPLETED|Overall Study||3
9782956|NCT00515099|10890143|FG001|NOT COMPLETED|Overall Study||4
9782957|NCT00515177|10890151|FG000|STARTED|Overall Study||20
9782958|NCT00515177|10890152|FG001|STARTED|Overall Study||10
9782959|NCT00515177|10890151|FG000|COMPLETED|Overall Study||18
9782960|NCT00515177|10890152|FG001|COMPLETED|Overall Study||9
9782961|NCT00515177|10890151|FG000|NOT COMPLETED|Overall Study||2
9782962|NCT00515177|10890152|FG001|NOT COMPLETED|Overall Study||1
9782963|NCT00515203|10890161|FG000|STARTED|Overall Study||17
9782964|NCT00515203|10890162|FG001|STARTED|Overall Study||5
9782965|NCT00515203|10890161|FG000|COMPLETED|Overall Study||17
9782966|NCT00515203|10890162|FG001|COMPLETED|Overall Study||5
9782967|NCT00515203|10890161|FG000|NOT COMPLETED|Overall Study||0
9782968|NCT00515203|10890162|FG001|NOT COMPLETED|Overall Study||0
9782969|NCT00515216|10890168|FG000|STARTED|Overall Study||26
9782970|NCT00515216|10890168|FG000|COMPLETED|Overall Study||25
9782971|NCT00515216|10890168|FG000|NOT COMPLETED|Overall Study||1
9782972|NCT00515294|10890177|FG000|STARTED|Overall Study||38
9782973|NCT00515294|10890178|FG001|STARTED|Overall Study||39
9782974|NCT00515294|10890179|FG002|STARTED|Overall Study||38
9782975|NCT00515294|10890180|FG003|STARTED|Overall Study||39
9782976|NCT00515294|10890177|FG000|COMPLETED|Overall Study||29
9782977|NCT00515294|10890178|FG001|COMPLETED|Overall Study||36
9782978|NCT00515294|10890179|FG002|COMPLETED|Overall Study||27
9782979|NCT00515294|10890180|FG003|COMPLETED|Overall Study||35
9782980|NCT00515294|10890177|FG000|NOT COMPLETED|Overall Study||9
9782981|NCT00515294|10890178|FG001|NOT COMPLETED|Overall Study||3
9782982|NCT00515294|10890179|FG002|NOT COMPLETED|Overall Study||11
9782983|NCT00515294|10890180|FG003|NOT COMPLETED|Overall Study||4
9782984|NCT00515411|10890193|FG000|STARTED|Overall Study||54
9782985|NCT00515411|10890194|FG001|STARTED|Overall Study||31
9782986|NCT00515411|10890195|FG002|STARTED|Overall Study||26
9782987|NCT00515411|10890193|FG000|COMPLETED|Overall Study||54
9782988|NCT00515411|10890194|FG001|COMPLETED|Overall Study||31
9782989|NCT00515411|10890195|FG002|COMPLETED|Overall Study||26
9782990|NCT00515411|10890193|FG000|NOT COMPLETED|Overall Study||0
9782991|NCT00515411|10890194|FG001|NOT COMPLETED|Overall Study||0
9782992|NCT00515411|10890195|FG002|NOT COMPLETED|Overall Study||0
9782993|NCT00515437|10890207|FG000|STARTED|Overall Study||14
9782994|NCT00515437|10890208|FG001|STARTED|Overall Study||12
9782995|NCT00515437|10890209|FG002|STARTED|Overall Study||13
9782996|NCT00515437|10890210|FG003|STARTED|Overall Study||15
9782997|NCT00515437|10890207|FG000|COMPLETED|Overall Study||14
9782998|NCT00515437|10890208|FG001|COMPLETED|Overall Study||12
9782999|NCT00515437|10890209|FG002|COMPLETED|Overall Study||13
9783000|NCT00515437|10890210|FG003|COMPLETED|Overall Study||14
9783001|NCT00515437|10890207|FG000|NOT COMPLETED|Overall Study||0
9783002|NCT00515437|10890208|FG001|NOT COMPLETED|Overall Study||0
9783003|NCT00515437|10890209|FG002|NOT COMPLETED|Overall Study||0
9783004|NCT00515437|10890210|FG003|NOT COMPLETED|Overall Study||1
9783005|NCT00515463|10890222|FG000|STARTED|Overall Study||155
9783006|NCT00515463|10890223|FG001|STARTED|Overall Study||156
9783007|NCT00515463|10890222|FG000|Received Study Medication|Overall Study||154
9783008|NCT00515463|10890223|FG001|Received Study Medication|Overall Study||156
9783009|NCT00515463|10890222|FG000|COMPLETED|Overall Study||141
9783010|NCT00515463|10890223|FG001|COMPLETED|Overall Study||142
9783011|NCT00515463|10890222|FG000|NOT COMPLETED|Overall Study||14
9783012|NCT00515463|10890223|FG001|NOT COMPLETED|Overall Study||14
9783013|NCT00515502|10890230|FG000|STARTED|Treatment Period 1||1
9952333|NCT01421459|11071254|FG001|NOT COMPLETED|Overall Study||52
9952334|NCT01421472|11071264|FG000|STARTED|Overall Study||67
9952335|NCT01421472|11071265|FG001|STARTED|Overall Study||33
9952336|NCT01421472|11071266|FG002|STARTED|Overall Study||64
9952337|NCT01421472|11071267|FG003|STARTED|Overall Study||32
9952338|NCT01421472|11071264|FG000|COMPLETED|Overall Study||67
9952339|NCT01421472|11071265|FG001|COMPLETED|Overall Study||33
9952340|NCT01421472|11071266|FG002|COMPLETED|Overall Study||64
9952341|NCT01421472|11071267|FG003|COMPLETED|Overall Study||32
9952342|NCT01421472|11071264|FG000|NOT COMPLETED|Overall Study||0
9952343|NCT01421472|11071265|FG001|NOT COMPLETED|Overall Study||0
9952344|NCT01421472|11071266|FG002|NOT COMPLETED|Overall Study||0
9952345|NCT01421472|11071267|FG003|NOT COMPLETED|Overall Study||0
9952346|NCT01421498|11071279|FG000|STARTED|Overall Study||293
9952347|NCT01421498|11071280|FG001|STARTED|Overall Study||295
9952348|NCT01421498|11071279|FG000|COMPLETED|Overall Study||281
9952349|NCT01421498|11071280|FG001|COMPLETED|Overall Study||284
9952350|NCT01421498|11071279|FG000|NOT COMPLETED|Overall Study||12
9783014|NCT00515502|10890231|FG001|STARTED|Treatment Period 1||4
9783015|NCT00515502|10890232|FG002|STARTED|Treatment Period 1||4
9783016|NCT00515502|10890233|FG003|STARTED|Treatment Period 1||3
9783017|NCT00515502|10890234|FG004|STARTED|Treatment Period 1||3
9783018|NCT00515502|10890235|FG005|STARTED|Treatment Period 1||1
9783019|NCT00515502|10890236|FG006|STARTED|Treatment Period 1||2
9952351|NCT01421498|11071280|FG001|NOT COMPLETED|Overall Study||11
9952352|NCT01421511|11071288|FG000|STARTED|Overall Study||332
9952353|NCT01421511|11071289|FG001|STARTED|Overall Study||334
9783020|NCT00515502|10890237|FG007|STARTED|Treatment Period 1||1
9783021|NCT00515502|10890238|FG008|STARTED|Treatment Period 1||1
9783022|NCT00515502|10890239|FG009|STARTED|Treatment Period 1||2
9783023|NCT00515502|10890240|FG010|STARTED|Treatment Period 1||1
9783024|NCT00515502|10890241|FG011|STARTED|Treatment Period 1||1
9783025|NCT00515502|10890230|FG000|COMPLETED|Treatment Period 1||1
9783026|NCT00515502|10890231|FG001|COMPLETED|Treatment Period 1||4
9952354|NCT01421511|11071288|FG000|COMPLETED|Overall Study||313
9783027|NCT00515502|10890232|FG002|COMPLETED|Treatment Period 1||4
9783028|NCT00515502|10890233|FG003|COMPLETED|Treatment Period 1||3
9783029|NCT00515502|10890234|FG004|COMPLETED|Treatment Period 1||3
9783030|NCT00515502|10890235|FG005|COMPLETED|Treatment Period 1||1
9783031|NCT00515502|10890236|FG006|COMPLETED|Treatment Period 1||1
9783032|NCT00515502|10890237|FG007|COMPLETED|Treatment Period 1||1
9783033|NCT00515502|10890238|FG008|COMPLETED|Treatment Period 1||0
9783034|NCT00515502|10890239|FG009|COMPLETED|Treatment Period 1||2
9783035|NCT00515502|10890240|FG010|COMPLETED|Treatment Period 1||1
9783036|NCT00515502|10890241|FG011|COMPLETED|Treatment Period 1||0
9783037|NCT00515502|10890230|FG000|NOT COMPLETED|Treatment Period 1||0
9783038|NCT00515502|10890231|FG001|NOT COMPLETED|Treatment Period 1||0
9783039|NCT00515502|10890232|FG002|NOT COMPLETED|Treatment Period 1||0
9783040|NCT00515502|10890233|FG003|NOT COMPLETED|Treatment Period 1||0
9783041|NCT00515502|10890234|FG004|NOT COMPLETED|Treatment Period 1||0
9783042|NCT00515502|10890235|FG005|NOT COMPLETED|Treatment Period 1||0
9783043|NCT00515502|10890236|FG006|NOT COMPLETED|Treatment Period 1||1
9783044|NCT00515502|10890237|FG007|NOT COMPLETED|Treatment Period 1||0
9783045|NCT00515502|10890238|FG008|NOT COMPLETED|Treatment Period 1||1
9783046|NCT00515502|10890239|FG009|NOT COMPLETED|Treatment Period 1||0
9783047|NCT00515502|10890240|FG010|NOT COMPLETED|Treatment Period 1||0
9783048|NCT00515502|10890241|FG011|NOT COMPLETED|Treatment Period 1||1
9783049|NCT00515502|10890230|FG000|STARTED|Washout Period 1||1
9783050|NCT00515502|10890231|FG001|STARTED|Washout Period 1||4
9783051|NCT00515502|10890232|FG002|STARTED|Washout Period 1||4
9783052|NCT00515502|10890233|FG003|STARTED|Washout Period 1||3
9783053|NCT00515502|10890234|FG004|STARTED|Washout Period 1||3
9783054|NCT00515502|10890235|FG005|STARTED|Washout Period 1||1
9783055|NCT00515502|10890236|FG006|STARTED|Washout Period 1||1
9783056|NCT00515502|10890237|FG007|STARTED|Washout Period 1||1
9783057|NCT00515502|10890238|FG008|STARTED|Washout Period 1||0
9783058|NCT00515502|10890239|FG009|STARTED|Washout Period 1||2
9783059|NCT00515502|10890240|FG010|STARTED|Washout Period 1||1
9783060|NCT00515502|10890241|FG011|STARTED|Washout Period 1||0
9783061|NCT00515502|10890230|FG000|COMPLETED|Washout Period 1||1
9783062|NCT00515502|10890231|FG001|COMPLETED|Washout Period 1||4
9783063|NCT00515502|10890232|FG002|COMPLETED|Washout Period 1||4
9783064|NCT00515502|10890233|FG003|COMPLETED|Washout Period 1||3
9783065|NCT00515502|10890234|FG004|COMPLETED|Washout Period 1||3
9783066|NCT00515502|10890235|FG005|COMPLETED|Washout Period 1||1
9783067|NCT00515502|10890236|FG006|COMPLETED|Washout Period 1||1
9783068|NCT00515502|10890237|FG007|COMPLETED|Washout Period 1||1
9783069|NCT00515502|10890238|FG008|COMPLETED|Washout Period 1||0
9783070|NCT00515502|10890239|FG009|COMPLETED|Washout Period 1||2
9783071|NCT00515502|10890240|FG010|COMPLETED|Washout Period 1||1
9783072|NCT00515502|10890241|FG011|COMPLETED|Washout Period 1||0
9783073|NCT00515502|10890230|FG000|NOT COMPLETED|Washout Period 1||0
9783074|NCT00515502|10890231|FG001|NOT COMPLETED|Washout Period 1||0
9783075|NCT00515502|10890232|FG002|NOT COMPLETED|Washout Period 1||0
9783076|NCT00515502|10890233|FG003|NOT COMPLETED|Washout Period 1||0
9783077|NCT00515502|10890234|FG004|NOT COMPLETED|Washout Period 1||0
9783078|NCT00515502|10890235|FG005|NOT COMPLETED|Washout Period 1||0
9783079|NCT00515502|10890236|FG006|NOT COMPLETED|Washout Period 1||0
9783080|NCT00515502|10890237|FG007|NOT COMPLETED|Washout Period 1||0
9783081|NCT00515502|10890238|FG008|NOT COMPLETED|Washout Period 1||0
9783082|NCT00515502|10890239|FG009|NOT COMPLETED|Washout Period 1||0
9783083|NCT00515502|10890240|FG010|NOT COMPLETED|Washout Period 1||0
9783084|NCT00515502|10890241|FG011|NOT COMPLETED|Washout Period 1||0
9783085|NCT00515502|10890230|FG000|STARTED|Treatment Period 2||1
9783086|NCT00515502|10890231|FG001|STARTED|Treatment Period 2||4
9783087|NCT00515502|10890232|FG002|STARTED|Treatment Period 2||4
9783088|NCT00515502|10890233|FG003|STARTED|Treatment Period 2||3
9783089|NCT00515502|10890234|FG004|STARTED|Treatment Period 2||3
9783090|NCT00515502|10890235|FG005|STARTED|Treatment Period 2||1
9783091|NCT00515502|10890236|FG006|STARTED|Treatment Period 2||1
9783092|NCT00515502|10890237|FG007|STARTED|Treatment Period 2||1
9783093|NCT00515502|10890238|FG008|STARTED|Treatment Period 2||0
9783094|NCT00515502|10890239|FG009|STARTED|Treatment Period 2||2
9783095|NCT00515502|10890240|FG010|STARTED|Treatment Period 2||1
9783096|NCT00515502|10890241|FG011|STARTED|Treatment Period 2||0
9783097|NCT00515502|10890230|FG000|COMPLETED|Treatment Period 2||1
9783098|NCT00515502|10890231|FG001|COMPLETED|Treatment Period 2||3
9783099|NCT00515502|10890232|FG002|COMPLETED|Treatment Period 2||4
9783100|NCT00515502|10890233|FG003|COMPLETED|Treatment Period 2||3
9783101|NCT00515502|10890234|FG004|COMPLETED|Treatment Period 2||3
9783102|NCT00515502|10890235|FG005|COMPLETED|Treatment Period 2||1
9783103|NCT00515502|10890236|FG006|COMPLETED|Treatment Period 2||1
9783104|NCT00515502|10890237|FG007|COMPLETED|Treatment Period 2||1
9783105|NCT00515502|10890238|FG008|COMPLETED|Treatment Period 2||0
9783106|NCT00515502|10890239|FG009|COMPLETED|Treatment Period 2||2
9783107|NCT00515502|10890240|FG010|COMPLETED|Treatment Period 2||1
9783108|NCT00515502|10890241|FG011|COMPLETED|Treatment Period 2||0
9783109|NCT00515502|10890230|FG000|NOT COMPLETED|Treatment Period 2||0
9783110|NCT00515502|10890231|FG001|NOT COMPLETED|Treatment Period 2||1
9783111|NCT00515502|10890232|FG002|NOT COMPLETED|Treatment Period 2||0
9783112|NCT00515502|10890233|FG003|NOT COMPLETED|Treatment Period 2||0
9783113|NCT00515502|10890234|FG004|NOT COMPLETED|Treatment Period 2||0
9783114|NCT00515502|10890235|FG005|NOT COMPLETED|Treatment Period 2||0
9783115|NCT00515502|10890236|FG006|NOT COMPLETED|Treatment Period 2||0
9783116|NCT00515502|10890237|FG007|NOT COMPLETED|Treatment Period 2||0
9783117|NCT00515502|10890238|FG008|NOT COMPLETED|Treatment Period 2||0
9783118|NCT00515502|10890239|FG009|NOT COMPLETED|Treatment Period 2||0
9783119|NCT00515502|10890240|FG010|NOT COMPLETED|Treatment Period 2||0
9783120|NCT00515502|10890241|FG011|NOT COMPLETED|Treatment Period 2||0
9783121|NCT00515502|10890230|FG000|STARTED|Washout Period 2||1
9783122|NCT00515502|10890231|FG001|STARTED|Washout Period 2||3
9783123|NCT00515502|10890232|FG002|STARTED|Washout Period 2||4
9783124|NCT00515502|10890233|FG003|STARTED|Washout Period 2||3
9783125|NCT00515502|10890234|FG004|STARTED|Washout Period 2||3
9783126|NCT00515502|10890235|FG005|STARTED|Washout Period 2||1
9783127|NCT00515502|10890236|FG006|STARTED|Washout Period 2||1
9783128|NCT00515502|10890237|FG007|STARTED|Washout Period 2||1
9783129|NCT00515502|10890238|FG008|STARTED|Washout Period 2||0
9783130|NCT00515502|10890239|FG009|STARTED|Washout Period 2||2
9783131|NCT00515502|10890240|FG010|STARTED|Washout Period 2||1
9783132|NCT00515502|10890241|FG011|STARTED|Washout Period 2||0
9783133|NCT00515502|10890230|FG000|COMPLETED|Washout Period 2||1
9783134|NCT00515502|10890231|FG001|COMPLETED|Washout Period 2||3
9783135|NCT00515502|10890232|FG002|COMPLETED|Washout Period 2||4
9783136|NCT00515502|10890233|FG003|COMPLETED|Washout Period 2||3
9783137|NCT00515502|10890234|FG004|COMPLETED|Washout Period 2||3
9783138|NCT00515502|10890235|FG005|COMPLETED|Washout Period 2||1
9783139|NCT00515502|10890236|FG006|COMPLETED|Washout Period 2||1
9783140|NCT00515502|10890237|FG007|COMPLETED|Washout Period 2||1
9783141|NCT00515502|10890238|FG008|COMPLETED|Washout Period 2||0
9783142|NCT00515502|10890239|FG009|COMPLETED|Washout Period 2||2
9783143|NCT00515502|10890240|FG010|COMPLETED|Washout Period 2||1
9783144|NCT00515502|10890241|FG011|COMPLETED|Washout Period 2||0
9783145|NCT00515502|10890230|FG000|NOT COMPLETED|Washout Period 2||0
9783146|NCT00515502|10890231|FG001|NOT COMPLETED|Washout Period 2||0
9783147|NCT00515502|10890232|FG002|NOT COMPLETED|Washout Period 2||0
9783148|NCT00515502|10890233|FG003|NOT COMPLETED|Washout Period 2||0
9783149|NCT00515502|10890234|FG004|NOT COMPLETED|Washout Period 2||0
9783150|NCT00515502|10890235|FG005|NOT COMPLETED|Washout Period 2||0
9783151|NCT00515502|10890236|FG006|NOT COMPLETED|Washout Period 2||0
9783152|NCT00515502|10890237|FG007|NOT COMPLETED|Washout Period 2||0
9783153|NCT00515502|10890238|FG008|NOT COMPLETED|Washout Period 2||0
9783154|NCT00515502|10890239|FG009|NOT COMPLETED|Washout Period 2||0
9783155|NCT00515502|10890240|FG010|NOT COMPLETED|Washout Period 2||0
9783156|NCT00515502|10890241|FG011|NOT COMPLETED|Washout Period 2||0
9783157|NCT00515502|10890230|FG000|STARTED|Treatment Period 3||1
9783158|NCT00515502|10890231|FG001|STARTED|Treatment Period 3||3
9783159|NCT00515502|10890232|FG002|STARTED|Treatment Period 3||4
9783160|NCT00515502|10890233|FG003|STARTED|Treatment Period 3||3
9783161|NCT00515502|10890234|FG004|STARTED|Treatment Period 3||3
9783162|NCT00515502|10890235|FG005|STARTED|Treatment Period 3||1
9783163|NCT00515502|10890236|FG006|STARTED|Treatment Period 3||1
9783164|NCT00515502|10890237|FG007|STARTED|Treatment Period 3||1
9783165|NCT00515502|10890238|FG008|STARTED|Treatment Period 3||0
9783166|NCT00515502|10890239|FG009|STARTED|Treatment Period 3||2
9783167|NCT00515502|10890240|FG010|STARTED|Treatment Period 3||1
9783168|NCT00515502|10890241|FG011|STARTED|Treatment Period 3||0
9783169|NCT00515502|10890230|FG000|COMPLETED|Treatment Period 3||1
9783170|NCT00515502|10890231|FG001|COMPLETED|Treatment Period 3||3
9783171|NCT00515502|10890232|FG002|COMPLETED|Treatment Period 3||4
9783172|NCT00515502|10890233|FG003|COMPLETED|Treatment Period 3||3
9783173|NCT00515502|10890234|FG004|COMPLETED|Treatment Period 3||3
9783174|NCT00515502|10890235|FG005|COMPLETED|Treatment Period 3||1
9783175|NCT00515502|10890236|FG006|COMPLETED|Treatment Period 3||1
9783176|NCT00515502|10890237|FG007|COMPLETED|Treatment Period 3||1
9783177|NCT00515502|10890238|FG008|COMPLETED|Treatment Period 3||0
9783178|NCT00515502|10890239|FG009|COMPLETED|Treatment Period 3||2
9783179|NCT00515502|10890240|FG010|COMPLETED|Treatment Period 3||1
9783180|NCT00515502|10890241|FG011|COMPLETED|Treatment Period 3||0
9783181|NCT00515502|10890230|FG000|NOT COMPLETED|Treatment Period 3||0
9783182|NCT00515502|10890231|FG001|NOT COMPLETED|Treatment Period 3||0
9783183|NCT00515502|10890232|FG002|NOT COMPLETED|Treatment Period 3||0
9783184|NCT00515502|10890233|FG003|NOT COMPLETED|Treatment Period 3||0
9783185|NCT00515502|10890234|FG004|NOT COMPLETED|Treatment Period 3||0
9783186|NCT00515502|10890235|FG005|NOT COMPLETED|Treatment Period 3||0
9783187|NCT00515502|10890236|FG006|NOT COMPLETED|Treatment Period 3||0
9783188|NCT00515502|10890237|FG007|NOT COMPLETED|Treatment Period 3||0
9783189|NCT00515502|10890238|FG008|NOT COMPLETED|Treatment Period 3||0
9783190|NCT00515502|10890239|FG009|NOT COMPLETED|Treatment Period 3||0
9783191|NCT00515502|10890240|FG010|NOT COMPLETED|Treatment Period 3||0
9783192|NCT00515502|10890241|FG011|NOT COMPLETED|Treatment Period 3||0
9783193|NCT00515502|10890230|FG000|STARTED|Washout Period 3||1
9783194|NCT00515502|10890231|FG001|STARTED|Washout Period 3||3
9783195|NCT00515502|10890232|FG002|STARTED|Washout Period 3||4
9783196|NCT00515502|10890233|FG003|STARTED|Washout Period 3||3
9783197|NCT00515502|10890234|FG004|STARTED|Washout Period 3||3
9783198|NCT00515502|10890235|FG005|STARTED|Washout Period 3||1
9783199|NCT00515502|10890236|FG006|STARTED|Washout Period 3||1
9783200|NCT00515502|10890237|FG007|STARTED|Washout Period 3||1
9783201|NCT00515502|10890238|FG008|STARTED|Washout Period 3||0
9783202|NCT00515502|10890239|FG009|STARTED|Washout Period 3||2
9783203|NCT00515502|10890240|FG010|STARTED|Washout Period 3||1
9783204|NCT00515502|10890241|FG011|STARTED|Washout Period 3||0
9783205|NCT00515502|10890230|FG000|COMPLETED|Washout Period 3||1
10015020|NCT01803074|11138012|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015021|NCT01803074|11138013|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
9783206|NCT00515502|10890231|FG001|COMPLETED|Washout Period 3||3
9783207|NCT00515502|10890232|FG002|COMPLETED|Washout Period 3||4
9783208|NCT00515502|10890233|FG003|COMPLETED|Washout Period 3||3
9783209|NCT00515502|10890234|FG004|COMPLETED|Washout Period 3||3
9783210|NCT00515502|10890235|FG005|COMPLETED|Washout Period 3||1
9783211|NCT00515502|10890236|FG006|COMPLETED|Washout Period 3||1
9783212|NCT00515502|10890237|FG007|COMPLETED|Washout Period 3||1
9783213|NCT00515502|10890238|FG008|COMPLETED|Washout Period 3||0
9783214|NCT00515502|10890239|FG009|COMPLETED|Washout Period 3||2
9783215|NCT00515502|10890240|FG010|COMPLETED|Washout Period 3||1
9783216|NCT00515502|10890241|FG011|COMPLETED|Washout Period 3||0
9783217|NCT00515502|10890230|FG000|NOT COMPLETED|Washout Period 3||0
9783218|NCT00515502|10890231|FG001|NOT COMPLETED|Washout Period 3||0
9783219|NCT00515502|10890232|FG002|NOT COMPLETED|Washout Period 3||0
9783220|NCT00515502|10890233|FG003|NOT COMPLETED|Washout Period 3||0
9783221|NCT00515502|10890234|FG004|NOT COMPLETED|Washout Period 3||0
9783222|NCT00515502|10890235|FG005|NOT COMPLETED|Washout Period 3||0
9783223|NCT00515502|10890236|FG006|NOT COMPLETED|Washout Period 3||0
9783224|NCT00515502|10890237|FG007|NOT COMPLETED|Washout Period 3||0
9783225|NCT00515502|10890238|FG008|NOT COMPLETED|Washout Period 3||0
9783226|NCT00515502|10890239|FG009|NOT COMPLETED|Washout Period 3||0
9783227|NCT00515502|10890240|FG010|NOT COMPLETED|Washout Period 3||0
9783228|NCT00515502|10890241|FG011|NOT COMPLETED|Washout Period 3||0
9783229|NCT00515502|10890230|FG000|STARTED|Treatment Period 4||1
9783230|NCT00515502|10890231|FG001|STARTED|Treatment Period 4||3
9783231|NCT00515502|10890232|FG002|STARTED|Treatment Period 4||4
9783232|NCT00515502|10890233|FG003|STARTED|Treatment Period 4||3
9783233|NCT00515502|10890234|FG004|STARTED|Treatment Period 4||3
9783234|NCT00515502|10890235|FG005|STARTED|Treatment Period 4||1
9783235|NCT00515502|10890236|FG006|STARTED|Treatment Period 4||1
9783236|NCT00515502|10890237|FG007|STARTED|Treatment Period 4||1
9783237|NCT00515502|10890238|FG008|STARTED|Treatment Period 4||0
9783238|NCT00515502|10890239|FG009|STARTED|Treatment Period 4||2
9783239|NCT00515502|10890240|FG010|STARTED|Treatment Period 4||1
9783240|NCT00515502|10890241|FG011|STARTED|Treatment Period 4||0
9783241|NCT00515502|10890230|FG000|COMPLETED|Treatment Period 4||1
9783242|NCT00515502|10890231|FG001|COMPLETED|Treatment Period 4||3
9783243|NCT00515502|10890232|FG002|COMPLETED|Treatment Period 4||4
9783244|NCT00515502|10890233|FG003|COMPLETED|Treatment Period 4||3
9783245|NCT00515502|10890234|FG004|COMPLETED|Treatment Period 4||3
9783246|NCT00515502|10890235|FG005|COMPLETED|Treatment Period 4||1
9783247|NCT00515502|10890236|FG006|COMPLETED|Treatment Period 4||1
9783248|NCT00515502|10890237|FG007|COMPLETED|Treatment Period 4||1
9783249|NCT00515502|10890238|FG008|COMPLETED|Treatment Period 4||0
9783250|NCT00515502|10890239|FG009|COMPLETED|Treatment Period 4||2
9783251|NCT00515502|10890240|FG010|COMPLETED|Treatment Period 4||1
9783252|NCT00515502|10890241|FG011|COMPLETED|Treatment Period 4||0
10112093|NCT02501473|11243155|FG001|NOT COMPLETED|Overall Study||3
9783253|NCT00515502|10890230|FG000|NOT COMPLETED|Treatment Period 4||0
9783254|NCT00515502|10890231|FG001|NOT COMPLETED|Treatment Period 4||0
9783255|NCT00515502|10890232|FG002|NOT COMPLETED|Treatment Period 4||0
9783256|NCT00515502|10890233|FG003|NOT COMPLETED|Treatment Period 4||0
9783257|NCT00515502|10890234|FG004|NOT COMPLETED|Treatment Period 4||0
9783258|NCT00515502|10890235|FG005|NOT COMPLETED|Treatment Period 4||0
9783259|NCT00515502|10890236|FG006|NOT COMPLETED|Treatment Period 4||0
9783260|NCT00515502|10890237|FG007|NOT COMPLETED|Treatment Period 4||0
9783261|NCT00515502|10890238|FG008|NOT COMPLETED|Treatment Period 4||0
9783262|NCT00515502|10890239|FG009|NOT COMPLETED|Treatment Period 4||0
9783263|NCT00515502|10890240|FG010|NOT COMPLETED|Treatment Period 4||0
9783264|NCT00515502|10890241|FG011|NOT COMPLETED|Treatment Period 4||0
9783265|NCT00515528|10890260|FG000|STARTED|Overall Study||10
9783266|NCT00515528|10890261|FG001|STARTED|Overall Study||7
9783267|NCT00515528|10890260|FG000|COMPLETED|Overall Study||10
9783268|NCT00515528|10890261|FG001|COMPLETED|Overall Study||7
9783269|NCT00515528|10890260|FG000|NOT COMPLETED|Overall Study||0
9783270|NCT00515528|10890261|FG001|NOT COMPLETED|Overall Study||0
9783271|NCT00515541|10890271|FG000|STARTED|Overall Study||10
9783272|NCT00515541|10890272|FG001|STARTED|Overall Study||12
9783273|NCT00515541|10890273|FG002|STARTED|Overall Study||10
10015022|NCT01803074|11138014|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015023|NCT01803074|11138015|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015024|NCT01803074|11138016|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015025|NCT01803074|11138017|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015026|NCT01803074|11138018|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015027|NCT01803074|11138019|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015028|NCT01803074|11138020|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015029|NCT01803074|11138021|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015030|NCT01803074|11138022|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10015031|NCT01803074|11138009|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10112094|NCT02501473|11243156|FG002|NOT COMPLETED|Overall Study||13
9783274|NCT00515541|10890274|FG003|STARTED|Overall Study||11
9783275|NCT00515541|10890271|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10
9830345|NCT00762710|10941014|FG001|COMPLETED|Overall Study||29
10015032|NCT01803074|11138010|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
9783276|NCT00515541|10890272|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
9783277|NCT00515541|10890273|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10
9783278|NCT00515541|10890274|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
9783279|NCT00515541|10890271|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10
9783280|NCT00515541|10890272|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10
9783281|NCT00515541|10890273|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10
9783282|NCT00515541|10890274|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10
9783283|NCT00515541|10890271|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10
9783284|NCT00515541|10890272|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
9783285|NCT00515541|10890273|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10
9783286|NCT00515541|10890274|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
9783287|NCT00515541|10890271|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10
9783288|NCT00515541|10890272|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
9783289|NCT00515541|10890273|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10
9783290|NCT00515541|10890274|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
9783291|NCT00515541|10890271|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
9783292|NCT00515541|10890272|FG001|COMPLETED|Overall Study||7
9783293|NCT00515541|10890273|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
9783294|NCT00515541|10890274|FG003|COMPLETED|Overall Study||6
9783295|NCT00515541|10890271|FG000|NOT COMPLETED|Overall Study||0
9783296|NCT00515541|10890272|FG001|NOT COMPLETED|Overall Study||5
9783297|NCT00515541|10890273|FG002|NOT COMPLETED|Overall Study||0
9783298|NCT00515541|10890274|FG003|NOT COMPLETED|Overall Study||5
9783299|NCT00515619|10890284|FG000|STARTED|Overall Study||376
9783300|NCT00515619|10890284|FG000|Safety Set|Overall Study||376
9783301|NCT00515619|10890284|FG000|COMPLETED|Overall Study||160
9783302|NCT00515619|10890284|FG000|NOT COMPLETED|Overall Study||216
9783303|NCT00515697|10890288|FG000|STARTED|Overall Study||39
9783304|NCT00515697|10890288|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39
9783305|NCT00515697|10890288|FG000|COMPLETED|Overall Study||39
10015033|NCT01803074|11138011|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015034|NCT01803074|11138012|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015035|NCT01803074|11138013|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015036|NCT01803074|11138014|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015037|NCT01803074|11138015|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015038|NCT01803074|11138016|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015039|NCT01803074|11138017|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015040|NCT01803074|11138018|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015041|NCT01803074|11138019|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10015042|NCT01803074|11138020|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
10015043|NCT01803074|11138021|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
10015044|NCT01803074|11138022|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
10015045|NCT01803074|11138009|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015046|NCT01803074|11138010|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015047|NCT01803074|11138011|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015048|NCT01803074|11138012|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015049|NCT01803074|11138013|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015050|NCT01803074|11138014|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015051|NCT01803074|11138015|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015052|NCT01803074|11138016|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015053|NCT01803074|11138017|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015054|NCT01803074|11138018|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015055|NCT01803074|11138019|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015056|NCT01803074|11138020|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
10234000|NCT01603394|11363879|FG000|NOT COMPLETED|Overall Study||1
10234001|NCT01592383|11363883|FG000|STARTED|Overall Study||2
10234002|NCT01592383|11363883|FG000|COMPLETED|Overall Study||1
10234003|NCT01592383|11363883|FG000|NOT COMPLETED|Overall Study||1
10234004|NCT01598025|11363890|FG000|STARTED|Overall Study||0
10234005|NCT01598025|11363891|FG001|STARTED|Overall Study||3
10015057|NCT01803074|11138021|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
10015058|NCT01803074|11138022|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
10015059|NCT01803074|11138009|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015060|NCT01803074|11138010|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015061|NCT01803074|11138011|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015062|NCT01803074|11138012|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015063|NCT01803074|11138013|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015064|NCT01803074|11138014|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015065|NCT01803074|11138015|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015066|NCT01803074|11138016|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015067|NCT01803074|11138017|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015068|NCT01803074|11138018|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10234006|NCT01598025|11363890|FG000|COMPLETED|Overall Study||0
10234007|NCT01598025|11363891|FG001|COMPLETED|Overall Study||0
9783306|NCT00515697|10890288|FG000|NOT COMPLETED|Overall Study||0
9783307|NCT00515723|10890296|FG000|STARTED|Overall Study||25
9783308|NCT00515723|10890297|FG001|STARTED|Overall Study||22
9783309|NCT00515723|10890298|FG002|STARTED|Overall Study||22
9783310|NCT00515723|10890299|FG003|STARTED|Overall Study||27
9783311|NCT00515723|10890296|FG000|COMPLETED|Overall Study||20
9783312|NCT00515723|10890297|FG001|COMPLETED|Overall Study||21
9783313|NCT00515723|10890298|FG002|COMPLETED|Overall Study||21
9783314|NCT00515723|10890299|FG003|COMPLETED|Overall Study||21
9783315|NCT00515723|10890296|FG000|NOT COMPLETED|Overall Study||5
9783316|NCT00515723|10890297|FG001|NOT COMPLETED|Overall Study||1
9783317|NCT00515723|10890298|FG002|NOT COMPLETED|Overall Study||1
9783318|NCT00515723|10890299|FG003|NOT COMPLETED|Overall Study||6
9783319|NCT00515827|10890312|FG000|STARTED|First Intervention (12 Weeks)||27
9783320|NCT00515827|10890313|FG001|STARTED|First Intervention (12 Weeks)||26
9783321|NCT00515827|10890312|FG000|COMPLETED|First Intervention (12 Weeks)||26
9783322|NCT00515827|10890313|FG001|COMPLETED|First Intervention (12 Weeks)||25
9783323|NCT00515827|10890312|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
9783324|NCT00515827|10890313|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
9783325|NCT00515827|10890312|FG000|STARTED|Second Intervention (12 Weeks)||26
9783326|NCT00515827|10890313|FG001|STARTED|Second Intervention (12 Weeks)||25
9783327|NCT00515827|10890312|FG000|COMPLETED|Second Intervention (12 Weeks)||25
9783328|NCT00515827|10890313|FG001|COMPLETED|Second Intervention (12 Weeks)||25
9783329|NCT00515827|10890312|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
9783330|NCT00515827|10890313|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
9783331|NCT00515879|10890323|FG000|STARTED|Overall Study||87
9783332|NCT00515879|10890324|FG001|STARTED|Overall Study||82
9783333|NCT00515879|10890323|FG000|COMPLETED|Overall Study||62
9783334|NCT00515879|10890324|FG001|COMPLETED|Overall Study||62
9783335|NCT00515879|10890323|FG000|NOT COMPLETED|Overall Study||25
9783336|NCT00515879|10890324|FG001|NOT COMPLETED|Overall Study||20
9783337|NCT00516048|10890334|FG000|STARTED|Overall Study||15
9783338|NCT00516048|10890335|FG001|STARTED|Overall Study||42
9783339|NCT00516048|10890336|FG002|STARTED|Overall Study||1
9783340|NCT00516048|10890334|FG000|COMPLETED|Overall Study||15
9783341|NCT00516048|10890335|FG001|COMPLETED|Overall Study||40
9783342|NCT00516048|10890336|FG002|COMPLETED|Overall Study||0
9783343|NCT00516048|10890334|FG000|NOT COMPLETED|Overall Study||0
9783344|NCT00516048|10890335|FG001|NOT COMPLETED|Overall Study||2
9783345|NCT00516048|10890336|FG002|NOT COMPLETED|Overall Study||1
9783346|NCT00516074|10890346|FG000|STARTED|Overall Study||28
9783347|NCT00516074|10890347|FG001|STARTED|Overall Study||26
9783348|NCT00516074|10890346|FG000|COMPLETED|Overall Study||22
9783349|NCT00516074|10890347|FG001|COMPLETED|Overall Study||23
9783350|NCT00516074|10890346|FG000|NOT COMPLETED|Overall Study||6
9783351|NCT00516074|10890347|FG001|NOT COMPLETED|Overall Study||3
9783352|NCT00516139|10890353|FG000|STARTED|Overall Study||122
9783353|NCT00516139|10890353|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
9783354|NCT00516139|10890353|FG000|NOT COMPLETED|Overall Study||38
9783355|NCT00516165|10890361|FG000|STARTED|Overall Study||28
9783356|NCT00516165|10890361|FG000|COMPLETED|Overall Study||28
9783357|NCT00516165|10890361|FG000|NOT COMPLETED|Overall Study||0
9783358|NCT00516217|10890365|FG000|STARTED|Overall Study||29
9783359|NCT00516217|10890365|FG000|COMPLETED|Overall Study||29
9783360|NCT00516217|10890365|FG000|NOT COMPLETED|Overall Study||0
9783361|NCT00516269|10890371|FG000|STARTED|Overall Study||19
9783362|NCT00516269|10890372|FG001|STARTED|Overall Study||19
9783363|NCT00516269|10890371|FG000|COMPLETED|Overall Study|2 patients had an early termination|17
9783364|NCT00516269|10890372|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
9783365|NCT00516269|10890371|FG000|NOT COMPLETED|Overall Study||2
9783366|NCT00516269|10890372|FG001|NOT COMPLETED|Overall Study||3
9783367|NCT00516295|10890381|FG000|STARTED|Overall Study||7
9783368|NCT00516295|10890382|FG001|STARTED|Overall Study||0
9783369|NCT00516295|10890383|FG002|STARTED|Overall Study||0
9783370|NCT00516295|10890381|FG000|COMPLETED|Overall Study||4
9783371|NCT00516295|10890382|FG001|COMPLETED|Overall Study||0
9783372|NCT00516295|10890383|FG002|COMPLETED|Overall Study||0
9783373|NCT00516295|10890381|FG000|NOT COMPLETED|Overall Study||3
9783374|NCT00516295|10890382|FG001|NOT COMPLETED|Overall Study||0
9783375|NCT00516295|10890383|FG002|NOT COMPLETED|Overall Study||0
9783376|NCT00516321|10890393|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
9783377|NCT00516321|10890394|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
9783378|NCT00516321|10890395|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
9783379|NCT00516321|10890393|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
9783380|NCT00516321|10890394|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
9783381|NCT00516321|10890395|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
9783382|NCT00516321|10890393|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
9783383|NCT00516321|10890394|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
9783384|NCT00516321|10890395|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
9783385|NCT00516321|10890393|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0
9783386|NCT00516321|10890394|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232
10015069|NCT01803074|11138019|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015070|NCT01803074|11138020|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10015071|NCT01803074|11138021|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
9783387|NCT00516321|10890395|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450
9783388|NCT00516321|10890393|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0
9783389|NCT00516321|10890394|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197
9783390|NCT00516321|10890395|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396
9783391|NCT00516321|10890393|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
9783392|NCT00516321|10890394|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
9783393|NCT00516321|10890395|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
9783394|NCT00516386|10890403|FG000|STARTED|Overall Study||16
9783395|NCT00516386|10890403|FG000|COMPLETED|Overall Study||10
9783396|NCT00516386|10890403|FG000|NOT COMPLETED|Overall Study||6
9783397|NCT00516503|10890409|FG000|STARTED|Overall Study||101
9783398|NCT00516503|10890410|FG001|STARTED|Overall Study||102
9783399|NCT00516503|10890409|FG000|COMPLETED|Overall Study||101
9783400|NCT00516503|10890410|FG001|COMPLETED|Overall Study||102
9783401|NCT00516503|10890409|FG000|NOT COMPLETED|Overall Study||0
9783402|NCT00516503|10890410|FG001|NOT COMPLETED|Overall Study||0
9783403|NCT00516893|10890416|FG000|STARTED|Overall Study||113
9783404|NCT00516893|10890416|FG000|Received Study Treatment|Overall Study||112
9783405|NCT00516893|10890416|FG000|COMPLETED|Overall Study||92
9783406|NCT00516893|10890416|FG000|NOT COMPLETED|Overall Study||21
9783407|NCT00516906|10890422|FG000|STARTED|Overall Study||36
9783408|NCT00516906|10890423|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
9783409|NCT00516906|10890422|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
9783410|NCT00516906|10890423|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
9783411|NCT00516906|10890422|FG000|NOT COMPLETED|Overall Study||6
9783412|NCT00516906|10890423|FG001|NOT COMPLETED|Overall Study||2
9783413|NCT00516919|10890429|FG000|STARTED|Overall Study||40
9783414|NCT00516919|10890430|FG001|STARTED|Overall Study||39
9783415|NCT00516919|10890429|FG000|COMPLETED|Overall Study||30
9783416|NCT00516919|10890430|FG001|COMPLETED|Overall Study||32
9783417|NCT00516919|10890429|FG000|NOT COMPLETED|Overall Study||10
9783418|NCT00516919|10890430|FG001|NOT COMPLETED|Overall Study||7
9783419|NCT00517010|10890436|FG000|STARTED|Overall Study||6
9783420|NCT00517010|10890436|FG000|COMPLETED|Overall Study||5
9783421|NCT00517010|10890436|FG000|NOT COMPLETED|Overall Study||1
9783422|NCT00517296|10890442|FG000|STARTED|Overall Study||10
9783423|NCT00517296|10890443|FG001|STARTED|Overall Study||11
9783424|NCT00517296|10890442|FG000|COMPLETED|Overall Study||9
9783425|NCT00517296|10890443|FG001|COMPLETED|Overall Study||11
9783426|NCT00517296|10890442|FG000|NOT COMPLETED|Overall Study||1
9783427|NCT00517296|10890443|FG001|NOT COMPLETED|Overall Study||0
9783428|NCT00517413|10890449|FG000|STARTED|Overall Study||163
9783429|NCT00517413|10890449|FG000|COMPLETED|Overall Study||102
9783430|NCT00517413|10890449|FG000|NOT COMPLETED|Overall Study||61
9783431|NCT00517530|10890460|FG000|STARTED|Overall Study||21
9783432|NCT00517530|10890461|FG001|STARTED|Overall Study||13
9783433|NCT00517530|10890462|FG002|STARTED|Overall Study||18
9783434|NCT00517530|10890463|FG003|STARTED|Overall Study||22
9783435|NCT00517530|10890464|FG004|STARTED|Overall Study||21
9783436|NCT00517530|10890465|FG005|STARTED|Overall Study||19
9783437|NCT00517530|10890466|FG006|STARTED|Overall Study||20
9783438|NCT00517530|10890460|FG000|Completed Treatment|Overall Study||11
9783439|NCT00517530|10890461|FG001|Completed Treatment|Overall Study||13
9783440|NCT00517530|10890462|FG002|Completed Treatment|Overall Study||13
9783441|NCT00517530|10890463|FG003|Completed Treatment|Overall Study||18
9783442|NCT00517530|10890464|FG004|Completed Treatment|Overall Study||9
9783443|NCT00517530|10890465|FG005|Completed Treatment|Overall Study||9
9783444|NCT00517530|10890466|FG006|Completed Treatment|Overall Study||13
9783445|NCT00517530|10890460|FG000|Started Follow-up|Overall Study||20
9783446|NCT00517530|10890461|FG001|Started Follow-up|Overall Study||13
9783447|NCT00517530|10890462|FG002|Started Follow-up|Overall Study||17
9783448|NCT00517530|10890463|FG003|Started Follow-up|Overall Study||21
9783449|NCT00517530|10890464|FG004|Started Follow-up|Overall Study||17
9783450|NCT00517530|10890465|FG005|Started Follow-up|Overall Study||16
9783451|NCT00517530|10890466|FG006|Started Follow-up|Overall Study||19
9783452|NCT00517530|10890460|FG000|Completed Follow-up|Overall Study||2
9783453|NCT00517530|10890461|FG001|Completed Follow-up|Overall Study||0
9783454|NCT00517530|10890462|FG002|Completed Follow-up|Overall Study||0
9783455|NCT00517530|10890463|FG003|Completed Follow-up|Overall Study||1
9783456|NCT00517530|10890464|FG004|Completed Follow-up|Overall Study||0
9783457|NCT00517530|10890465|FG005|Completed Follow-up|Overall Study||0
9783458|NCT00517530|10890466|FG006|Completed Follow-up|Overall Study||1
9783459|NCT00517530|10890460|FG000|Retreated Population|Overall Study||2
9783460|NCT00517530|10890461|FG001|Retreated Population|Overall Study||2
9783461|NCT00517530|10890462|FG002|Retreated Population|Overall Study||1
9783462|NCT00517530|10890463|FG003|Retreated Population|Overall Study||4
9783463|NCT00517530|10890464|FG004|Retreated Population|Overall Study||2
10015072|NCT01803074|11138022|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
9783464|NCT00517530|10890465|FG005|Retreated Population|Overall Study||2
9783465|NCT00517530|10890466|FG006|Retreated Population|Overall Study||0
9783466|NCT00517530|10890460|FG000|COMPLETED|Overall Study||2
9783467|NCT00517530|10890461|FG001|COMPLETED|Overall Study||0
9783468|NCT00517530|10890462|FG002|COMPLETED|Overall Study||0
9783469|NCT00517530|10890463|FG003|COMPLETED|Overall Study||1
9783470|NCT00517530|10890464|FG004|COMPLETED|Overall Study||1
9783471|NCT00517530|10890465|FG005|COMPLETED|Overall Study||0
9783472|NCT00517530|10890466|FG006|COMPLETED|Overall Study||1
9783473|NCT00517530|10890460|FG000|NOT COMPLETED|Overall Study||19
9783474|NCT00517530|10890461|FG001|NOT COMPLETED|Overall Study||13
9783475|NCT00517530|10890462|FG002|NOT COMPLETED|Overall Study||18
9783476|NCT00517530|10890463|FG003|NOT COMPLETED|Overall Study||21
9783477|NCT00517530|10890464|FG004|NOT COMPLETED|Overall Study||20
9783478|NCT00517530|10890465|FG005|NOT COMPLETED|Overall Study||19
9783479|NCT00517530|10890466|FG006|NOT COMPLETED|Overall Study||19
9783480|NCT00517556|10890499|FG000|STARTED|Overall Study||19
9783481|NCT00517556|10890500|FG001|STARTED|Overall Study||19
9783482|NCT00517556|10890499|FG000|COMPLETED|Overall Study||15
9783483|NCT00517556|10890500|FG001|COMPLETED|Overall Study||14
9783484|NCT00517556|10890499|FG000|NOT COMPLETED|Overall Study||4
9783485|NCT00517556|10890500|FG001|NOT COMPLETED|Overall Study||5
9783486|NCT00517595|10890506|FG000|STARTED|Overall Study||48
9783487|NCT00517595|10890506|FG000|COMPLETED|Overall Study||48
9783488|NCT00517595|10890506|FG000|NOT COMPLETED|Overall Study||0
9783489|NCT00517634|10890510|FG000|STARTED|First Treatment Period||4
9783490|NCT00517634|10890511|FG001|STARTED|First Treatment Period||4
9783491|NCT00517634|10890512|FG002|STARTED|First Treatment Period||4
9783492|NCT00517634|10890513|FG003|STARTED|First Treatment Period||3
9783493|NCT00517634|10890514|FG004|STARTED|First Treatment Period||4
9783494|NCT00517634|10890515|FG005|STARTED|First Treatment Period||4
9783495|NCT00517634|10890510|FG000|COMPLETED|First Treatment Period||4
9783496|NCT00517634|10890511|FG001|COMPLETED|First Treatment Period||4
9783497|NCT00517634|10890512|FG002|COMPLETED|First Treatment Period||4
9783498|NCT00517634|10890513|FG003|COMPLETED|First Treatment Period||3
9783499|NCT00517634|10890514|FG004|COMPLETED|First Treatment Period||4
9783500|NCT00517634|10890515|FG005|COMPLETED|First Treatment Period||4
9783501|NCT00517634|10890510|FG000|NOT COMPLETED|First Treatment Period||0
9783502|NCT00517634|10890511|FG001|NOT COMPLETED|First Treatment Period||0
9783503|NCT00517634|10890512|FG002|NOT COMPLETED|First Treatment Period||0
9783504|NCT00517634|10890513|FG003|NOT COMPLETED|First Treatment Period||0
9783505|NCT00517634|10890514|FG004|NOT COMPLETED|First Treatment Period||0
9783506|NCT00517634|10890515|FG005|NOT COMPLETED|First Treatment Period||0
9783507|NCT00517634|10890510|FG000|STARTED|Second Treatment Period||4
9783508|NCT00517634|10890511|FG001|STARTED|Second Treatment Period||4
9783509|NCT00517634|10890512|FG002|STARTED|Second Treatment Period||4
9783510|NCT00517634|10890513|FG003|STARTED|Second Treatment Period||3
9783511|NCT00517634|10890514|FG004|STARTED|Second Treatment Period||4
9783512|NCT00517634|10890515|FG005|STARTED|Second Treatment Period||4
9783513|NCT00517634|10890510|FG000|COMPLETED|Second Treatment Period||4
9783514|NCT00517634|10890511|FG001|COMPLETED|Second Treatment Period||4
9783515|NCT00517634|10890512|FG002|COMPLETED|Second Treatment Period||4
9783516|NCT00517634|10890513|FG003|COMPLETED|Second Treatment Period||3
9783517|NCT00517634|10890514|FG004|COMPLETED|Second Treatment Period||3
9783518|NCT00517634|10890515|FG005|COMPLETED|Second Treatment Period||4
9783519|NCT00517634|10890510|FG000|NOT COMPLETED|Second Treatment Period||0
9783520|NCT00517634|10890511|FG001|NOT COMPLETED|Second Treatment Period||0
9783521|NCT00517634|10890512|FG002|NOT COMPLETED|Second Treatment Period||0
9783522|NCT00517634|10890513|FG003|NOT COMPLETED|Second Treatment Period||0
9783523|NCT00517634|10890514|FG004|NOT COMPLETED|Second Treatment Period||1
9783524|NCT00517634|10890515|FG005|NOT COMPLETED|Second Treatment Period||0
9783525|NCT00517634|10890510|FG000|STARTED|Third Treatment Period||4
9783526|NCT00517634|10890511|FG001|STARTED|Third Treatment Period||4
9783527|NCT00517634|10890512|FG002|STARTED|Third Treatment Period||4
9783528|NCT00517634|10890513|FG003|STARTED|Third Treatment Period||3
9783529|NCT00517634|10890514|FG004|STARTED|Third Treatment Period||3
9783530|NCT00517634|10890515|FG005|STARTED|Third Treatment Period||4
9783531|NCT00517634|10890510|FG000|COMPLETED|Third Treatment Period||4
9783532|NCT00517634|10890511|FG001|COMPLETED|Third Treatment Period||4
9783533|NCT00517634|10890512|FG002|COMPLETED|Third Treatment Period||4
9783534|NCT00517634|10890513|FG003|COMPLETED|Third Treatment Period||3
9783535|NCT00517634|10890514|FG004|COMPLETED|Third Treatment Period||3
9783536|NCT00517634|10890515|FG005|COMPLETED|Third Treatment Period||4
9783537|NCT00517634|10890510|FG000|NOT COMPLETED|Third Treatment Period||0
9783538|NCT00517634|10890511|FG001|NOT COMPLETED|Third Treatment Period||0
9783539|NCT00517634|10890512|FG002|NOT COMPLETED|Third Treatment Period||0
9783540|NCT00517634|10890513|FG003|NOT COMPLETED|Third Treatment Period||0
9783541|NCT00517634|10890514|FG004|NOT COMPLETED|Third Treatment Period||0
9783542|NCT00517634|10890515|FG005|NOT COMPLETED|Third Treatment Period||0
9783543|NCT00517751|10890523|FG000|STARTED|Overall Study||162
9783544|NCT00517751|10890523|FG000|COMPLETED|Overall Study||33
9783545|NCT00517751|10890523|FG000|NOT COMPLETED|Overall Study||129
9783546|NCT00517829|10890529|FG000|STARTED|Overall Study||75
9783547|NCT00517829|10890530|FG001|STARTED|Overall Study||75
9783548|NCT00517829|10890529|FG000|COMPLETED|Overall Study||0
9783549|NCT00517829|10890530|FG001|COMPLETED|Overall Study||0
9783550|NCT00517829|10890529|FG000|NOT COMPLETED|Overall Study||75
9783551|NCT00517829|10890530|FG001|NOT COMPLETED|Overall Study||75
9783552|NCT00517881|10890536|FG000|STARTED|Overall Study||29
9783553|NCT00517881|10890536|FG000|COMPLETED|Overall Study||24
9783554|NCT00517881|10890536|FG000|NOT COMPLETED|Overall Study||5
9783555|NCT00517933|10890542|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
9783556|NCT00517933|10890543|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
9783557|NCT00517933|10890542|FG000|COMPLETED|Period 1||81
9783558|NCT00517933|10890543|FG001|COMPLETED|Period 1||85
9783559|NCT00517933|10890542|FG000|NOT COMPLETED|Period 1||8
9783560|NCT00517933|10890543|FG001|NOT COMPLETED|Period 1||6
9783561|NCT00517933|10890542|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
9783562|NCT00517933|10890543|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
9783563|NCT00517933|10890542|FG000|COMPLETED|Period 2||73
9783564|NCT00517933|10890543|FG001|COMPLETED|Period 2||70
9783565|NCT00517933|10890542|FG000|NOT COMPLETED|Period 2||6
9783566|NCT00517933|10890543|FG001|NOT COMPLETED|Period 2||13
9783567|NCT00518011|10890554|FG000|STARTED|Overall Study||9
9783568|NCT00518011|10890555|FG001|STARTED|Overall Study||8
9783569|NCT00518011|10890554|FG000|COMPLETED|Overall Study||0
9783570|NCT00518011|10890555|FG001|COMPLETED|Overall Study||0
9783571|NCT00518011|10890554|FG000|NOT COMPLETED|Overall Study||9
9783572|NCT00518011|10890555|FG001|NOT COMPLETED|Overall Study||8
9783573|NCT00518089|10890564|FG000|STARTED|Overall Study||430
9783574|NCT00518089|10890565|FG001|STARTED|Overall Study||429
9783575|NCT00518089|10890564|FG000|COMPLETED|Overall Study||402
9783576|NCT00518089|10890565|FG001|COMPLETED|Overall Study||398
9783577|NCT00518089|10890564|FG000|NOT COMPLETED|Overall Study||28
9783578|NCT00518089|10890565|FG001|NOT COMPLETED|Overall Study||31
9783579|NCT00518115|10890581|FG000|STARTED|Overall Study||52
9783580|NCT00518115|10890582|FG001|STARTED|Overall Study||35
9783581|NCT00518115|10890583|FG002|STARTED|Overall Study||36
9783582|NCT00518115|10890584|FG003|STARTED|Overall Study||35
9783583|NCT00518115|10890585|FG004|STARTED|Overall Study||31
9783584|NCT00518115|10890586|FG005|STARTED|Overall Study||34
9783585|NCT00518115|10890587|FG006|STARTED|Overall Study||33
9783586|NCT00518115|10890588|FG007|STARTED|Overall Study||35
9783587|NCT00518115|10890589|FG008|STARTED|Overall Study||35
9783588|NCT00518115|10890590|FG009|STARTED|Overall Study||35
9783589|NCT00518115|10890581|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
9783590|NCT00518115|10890582|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
9783591|NCT00518115|10890583|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
9783592|NCT00518115|10890584|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
9783593|NCT00518115|10890585|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
9783594|NCT00518115|10890586|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
9783595|NCT00518115|10890587|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
9783596|NCT00518115|10890588|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
9783597|NCT00518115|10890589|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
9783598|NCT00518115|10890590|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
9783599|NCT00518115|10890581|FG000|COMPLETED|Overall Study||40
9783600|NCT00518115|10890582|FG001|COMPLETED|Overall Study||29
9783601|NCT00518115|10890583|FG002|COMPLETED|Overall Study||19
9783602|NCT00518115|10890584|FG003|COMPLETED|Overall Study||24
9783603|NCT00518115|10890585|FG004|COMPLETED|Overall Study||21
9783604|NCT00518115|10890586|FG005|COMPLETED|Overall Study||19
9783605|NCT00518115|10890587|FG006|COMPLETED|Overall Study||25
9783606|NCT00518115|10890588|FG007|COMPLETED|Overall Study||20
9783607|NCT00518115|10890589|FG008|COMPLETED|Overall Study||30
9783608|NCT00518115|10890590|FG009|COMPLETED|Overall Study||20
9783609|NCT00518115|10890581|FG000|NOT COMPLETED|Overall Study||12
9783610|NCT00518115|10890582|FG001|NOT COMPLETED|Overall Study||6
9783611|NCT00518115|10890583|FG002|NOT COMPLETED|Overall Study||17
9783612|NCT00518115|10890584|FG003|NOT COMPLETED|Overall Study||11
9783613|NCT00518115|10890585|FG004|NOT COMPLETED|Overall Study||10
9783614|NCT00518115|10890586|FG005|NOT COMPLETED|Overall Study||15
9783615|NCT00518115|10890587|FG006|NOT COMPLETED|Overall Study||8
9783616|NCT00518115|10890588|FG007|NOT COMPLETED|Overall Study||15
9783617|NCT00518115|10890589|FG008|NOT COMPLETED|Overall Study||5
9783618|NCT00518115|10890590|FG009|NOT COMPLETED|Overall Study||15
9783619|NCT00518154|10890613|FG000|STARTED|Overall Study||7
9783620|NCT00518154|10890613|FG000|COMPLETED|Overall Study||7
9783621|NCT00518154|10890613|FG000|NOT COMPLETED|Overall Study||0
9783622|NCT00518180|10890620|FG000|STARTED|Overall Study||540
9783623|NCT00518180|10890621|FG001|STARTED|Overall Study||541
9783624|NCT00518180|10890622|FG002|STARTED|Overall Study||539
9783625|NCT00518180|10890620|FG000|COMPLETED|Overall Study||475
9783626|NCT00518180|10890621|FG001|COMPLETED|Overall Study||472
9783627|NCT00518180|10890622|FG002|COMPLETED|Overall Study||457
9783628|NCT00518180|10890620|FG000|NOT COMPLETED|Overall Study||65
9783629|NCT00518180|10890621|FG001|NOT COMPLETED|Overall Study||69
9783630|NCT00518180|10890622|FG002|NOT COMPLETED|Overall Study||82
9783631|NCT00518206|10890641|FG000|STARTED|Overall Study||27
9783632|NCT00518206|10890642|FG001|STARTED|Overall Study||19
9783633|NCT00518206|10890641|FG000|COMPLETED|Overall Study||16
9783634|NCT00518206|10890642|FG001|COMPLETED|Overall Study||13
9783635|NCT00518206|10890641|FG000|NOT COMPLETED|Overall Study||11
9783636|NCT00518206|10890642|FG001|NOT COMPLETED|Overall Study||6
9783637|NCT00518284|10890652|FG000|STARTED|Overall Study||0
9783638|NCT00518284|10890653|FG001|STARTED|Overall Study||3
9783639|NCT00518284|10890654|FG002|STARTED|Overall Study||1
9783640|NCT00518284|10890655|FG003|STARTED|Overall Study||2
9783641|NCT00518284|10890652|FG000|COMPLETED|Overall Study||0
9783642|NCT00518284|10890653|FG001|COMPLETED|Overall Study||0
9783643|NCT00518284|10890654|FG002|COMPLETED|Overall Study||0
9783644|NCT00518284|10890655|FG003|COMPLETED|Overall Study||0
9783645|NCT00518284|10890652|FG000|NOT COMPLETED|Overall Study||0
9783646|NCT00518284|10890653|FG001|NOT COMPLETED|Overall Study||3
9783647|NCT00518284|10890654|FG002|NOT COMPLETED|Overall Study||1
9783648|NCT00518284|10890655|FG003|NOT COMPLETED|Overall Study||2
9783649|NCT00518323|10890669|FG000|STARTED|Overall Study||54
9783650|NCT00518323|10890670|FG001|STARTED|Overall Study||48
9783651|NCT00518323|10890671|FG002|STARTED|Overall Study||48
9783652|NCT00518323|10890672|FG003|STARTED|Overall Study||51
9783653|NCT00518323|10890669|FG000|COMPLETED|Overall Study||35
9783654|NCT00518323|10890670|FG001|COMPLETED|Overall Study||40
9783655|NCT00518323|10890671|FG002|COMPLETED|Overall Study||37
9783656|NCT00518323|10890672|FG003|COMPLETED|Overall Study||26
9783657|NCT00518323|10890669|FG000|NOT COMPLETED|Overall Study||19
9783658|NCT00518323|10890670|FG001|NOT COMPLETED|Overall Study||8
9783659|NCT00518323|10890671|FG002|NOT COMPLETED|Overall Study||11
9783660|NCT00518323|10890672|FG003|NOT COMPLETED|Overall Study||25
9783661|NCT00518336|10890684|FG000|STARTED|Year 7||222
9783662|NCT00518336|10890685|FG001|STARTED|Year 7||211
9783663|NCT00518336|10890684|FG000|COMPLETED|Year 7||220
9783664|NCT00518336|10890685|FG001|COMPLETED|Year 7||208
9783665|NCT00518336|10890684|FG000|NOT COMPLETED|Year 7||2
9783666|NCT00518336|10890685|FG001|NOT COMPLETED|Year 7||3
9783667|NCT00518336|10890684|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
9783668|NCT00518336|10890685|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
9783669|NCT00518336|10890684|FG000|COMPLETED|Year 8||222
9783670|NCT00518336|10890685|FG001|COMPLETED|Year 8||211
9783671|NCT00518336|10890684|FG000|NOT COMPLETED|Year 8||1
9783672|NCT00518336|10890685|FG001|NOT COMPLETED|Year 8||2
9783673|NCT00518336|10890684|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
9783674|NCT00518336|10890685|FG001|STARTED|Year 9||213
9783675|NCT00518336|10890684|FG000|COMPLETED|Year 9||219
9783676|NCT00518336|10890685|FG001|COMPLETED|Year 9||212
9783677|NCT00518336|10890684|FG000|NOT COMPLETED|Year 9||5
9783678|NCT00518336|10890685|FG001|NOT COMPLETED|Year 9||1
9783679|NCT00518349|10890693|FG000|STARTED|Overall Study||60
9783680|NCT00518349|10890694|FG001|STARTED|Overall Study||60
9783681|NCT00518349|10890693|FG000|COMPLETED|Overall Study||60
9783682|NCT00518349|10890694|FG001|COMPLETED|Overall Study||60
9783683|NCT00518349|10890693|FG000|NOT COMPLETED|Overall Study||0
9783684|NCT00518349|10890694|FG001|NOT COMPLETED|Overall Study||0
9783685|NCT00518531|10890702|FG000|STARTED|Treatment Period 1||124
9783686|NCT00518531|10890703|FG001|STARTED|Treatment Period 1||126
9783687|NCT00518531|10890702|FG000|Received Treatment|Treatment Period 1||119
9783688|NCT00518531|10890703|FG001|Received Treatment|Treatment Period 1||124
9783689|NCT00518531|10890702|FG000|COMPLETED|Treatment Period 1||106
9783690|NCT00518531|10890703|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
9783691|NCT00518531|10890702|FG000|NOT COMPLETED|Treatment Period 1||18
9783692|NCT00518531|10890703|FG001|NOT COMPLETED|Treatment Period 1||12
9783693|NCT00518531|10890702|FG000|STARTED|Treatment Period 2||106
9783694|NCT00518531|10890703|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
9783695|NCT00518531|10890702|FG000|Received Treatment|Treatment Period 2||106
9783696|NCT00518531|10890703|FG001|Received Treatment|Treatment Period 2||110
9783697|NCT00518531|10890702|FG000|COMPLETED|Treatment Period 2||103
9783698|NCT00518531|10890703|FG001|COMPLETED|Treatment Period 2||95
9783699|NCT00518531|10890702|FG000|NOT COMPLETED|Treatment Period 2||3
9783700|NCT00518531|10890703|FG001|NOT COMPLETED|Treatment Period 2||20
9783701|NCT00518622|10890719|FG000|STARTED|Overall Study||3
9783702|NCT00518622|10890720|FG001|STARTED|Overall Study||6
9783703|NCT00518622|10890721|FG002|STARTED|Overall Study||6
9783704|NCT00518622|10890722|FG003|STARTED|Overall Study||5
9783705|NCT00518622|10890723|FG004|STARTED|Overall Study||6
9783706|NCT00518622|10890724|FG005|STARTED|Overall Study||5
9783707|NCT00518622|10890725|FG006|STARTED|Overall Study||4
9783708|NCT00518622|10890726|FG007|STARTED|Overall Study||5
9783709|NCT00518622|10890719|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
9783710|NCT00518622|10890720|FG001|Completed Therapy|Overall Study||5
9783711|NCT00518622|10890721|FG002|Completed Therapy|Overall Study||6
9783712|NCT00518622|10890722|FG003|Completed Therapy|Overall Study||5
9783713|NCT00518622|10890723|FG004|Completed Therapy|Overall Study||6
9783714|NCT00518622|10890724|FG005|Completed Therapy|Overall Study||5
9783715|NCT00518622|10890725|FG006|Completed Therapy|Overall Study||4
9783716|NCT00518622|10890726|FG007|Completed Therapy|Overall Study||5
9783717|NCT00518622|10890719|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
9783718|NCT00518622|10890720|FG001|Discontinued Therapy|Overall Study||1
9783719|NCT00518622|10890721|FG002|Discontinued Therapy|Overall Study||0
9783720|NCT00518622|10890722|FG003|Discontinued Therapy|Overall Study||0
9783721|NCT00518622|10890723|FG004|Discontinued Therapy|Overall Study||0
9783722|NCT00518622|10890724|FG005|Discontinued Therapy|Overall Study||0
9783723|NCT00518622|10890725|FG006|Discontinued Therapy|Overall Study||0
9783724|NCT00518622|10890726|FG007|Discontinued Therapy|Overall Study||0
9783725|NCT00518622|10890719|FG000|COMPLETED|Overall Study||3
9783726|NCT00518622|10890720|FG001|COMPLETED|Overall Study||5
9783727|NCT00518622|10890721|FG002|COMPLETED|Overall Study||5
9783728|NCT00518622|10890722|FG003|COMPLETED|Overall Study||5
9783729|NCT00518622|10890723|FG004|COMPLETED|Overall Study||6
9783730|NCT00518622|10890724|FG005|COMPLETED|Overall Study||5
9783731|NCT00518622|10890725|FG006|COMPLETED|Overall Study||4
9783732|NCT00518622|10890726|FG007|COMPLETED|Overall Study||5
9783733|NCT00518622|10890719|FG000|NOT COMPLETED|Overall Study||0
9783734|NCT00518622|10890720|FG001|NOT COMPLETED|Overall Study||1
9783735|NCT00518622|10890721|FG002|NOT COMPLETED|Overall Study||1
9783736|NCT00518622|10890722|FG003|NOT COMPLETED|Overall Study||0
9783737|NCT00518622|10890723|FG004|NOT COMPLETED|Overall Study||0
9783738|NCT00518622|10890724|FG005|NOT COMPLETED|Overall Study||0
9783739|NCT00518622|10890725|FG006|NOT COMPLETED|Overall Study||0
9783740|NCT00518622|10890726|FG007|NOT COMPLETED|Overall Study||0
9783741|NCT00518687|10890746|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
9783742|NCT00518687|10890747|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
9783743|NCT00518687|10890746|FG000|Vaccinated|Overall Study||3981
9783744|NCT00518687|10890747|FG001|Vaccinated|Overall Study||3982
9783745|NCT00518687|10890746|FG000|COMPLETED|Overall Study||2568
9783746|NCT00518687|10890747|FG001|COMPLETED|Overall Study||2585
9783747|NCT00518687|10890746|FG000|NOT COMPLETED|Overall Study||1437
9783748|NCT00518687|10890747|FG001|NOT COMPLETED|Overall Study||1420
9783749|NCT00518713|10890757|FG000|STARTED|Overall Study||58
9783750|NCT00518713|10890758|FG001|STARTED|Overall Study||62
9783751|NCT00518713|10890759|FG002|STARTED|Overall Study||59
9783752|NCT00518713|10890760|FG003|STARTED|Overall Study||59
9783753|NCT00518713|10890757|FG000|Modified Intent-to-Treat Population|Overall Study||53
9783754|NCT00518713|10890758|FG001|Modified Intent-to-Treat Population|Overall Study||58
9783755|NCT00518713|10890759|FG002|Modified Intent-to-Treat Population|Overall Study||49
9783756|NCT00518713|10890760|FG003|Modified Intent-to-Treat Population|Overall Study||57
9783757|NCT00518713|10890757|FG000|COMPLETED|Overall Study||50
9783758|NCT00518713|10890758|FG001|COMPLETED|Overall Study||45
9783759|NCT00518713|10890759|FG002|COMPLETED|Overall Study||41
9783760|NCT00518713|10890760|FG003|COMPLETED|Overall Study||41
9783761|NCT00518713|10890757|FG000|NOT COMPLETED|Overall Study||8
9783762|NCT00518713|10890758|FG001|NOT COMPLETED|Overall Study||17
9783763|NCT00518713|10890759|FG002|NOT COMPLETED|Overall Study||18
9783764|NCT00518713|10890760|FG003|NOT COMPLETED|Overall Study||18
9830346|NCT00762710|10941013|FG000|NOT COMPLETED|Overall Study||21
9830347|NCT00762710|10941014|FG001|NOT COMPLETED|Overall Study||15
9830348|NCT00762762|10941022|FG000|STARTED|Overall Study||30
9830349|NCT00762762|10941023|FG001|STARTED|Overall Study||30
9830350|NCT00762762|10941022|FG000|COMPLETED|Overall Study||22
9830351|NCT00762762|10941023|FG001|COMPLETED|Overall Study||20
9830352|NCT00762762|10941022|FG000|NOT COMPLETED|Overall Study||8
9830353|NCT00762762|10941023|FG001|NOT COMPLETED|Overall Study||10
9830354|NCT00762788|10941035|FG000|STARTED|Overall Study||55
9830355|NCT00762788|10941036|FG001|STARTED|Overall Study||58
9830356|NCT00762788|10941037|FG002|STARTED|Overall Study||42
9830357|NCT00762788|10941038|FG003|STARTED|Overall Study||64
9830358|NCT00762788|10941039|FG004|STARTED|Overall Study||43
9830359|NCT00762788|10941040|FG005|STARTED|Overall Study||52
9830360|NCT00762788|10941035|FG000|COMPLETED|Overall Study||29
9830361|NCT00762788|10941036|FG001|COMPLETED|Overall Study||21
9830362|NCT00762788|10941037|FG002|COMPLETED|Overall Study||21
9830363|NCT00762788|10941038|FG003|COMPLETED|Overall Study||38
9830364|NCT00762788|10941039|FG004|COMPLETED|Overall Study||30
9830365|NCT00762788|10941040|FG005|COMPLETED|Overall Study||31
9830366|NCT00762788|10941035|FG000|NOT COMPLETED|Overall Study||26
9830367|NCT00762788|10941036|FG001|NOT COMPLETED|Overall Study||37
9830368|NCT00762788|10941037|FG002|NOT COMPLETED|Overall Study||21
9830369|NCT00762788|10941038|FG003|NOT COMPLETED|Overall Study||26
9830370|NCT00762788|10941039|FG004|NOT COMPLETED|Overall Study||13
9830371|NCT00762788|10941040|FG005|NOT COMPLETED|Overall Study||21
9830372|NCT00762853|10941056|FG000|STARTED|First Treatment Period||10
9830373|NCT00762853|10941057|FG001|STARTED|First Treatment Period||10
9830374|NCT00762853|10941056|FG000|COMPLETED|First Treatment Period||10
9830375|NCT00762853|10941057|FG001|COMPLETED|First Treatment Period||10
9830376|NCT00762853|10941056|FG000|NOT COMPLETED|First Treatment Period||0
9830377|NCT00762853|10941057|FG001|NOT COMPLETED|First Treatment Period||0
9830378|NCT00762853|10941056|FG000|STARTED|1 Week Washout After Treatment 1||10
9830379|NCT00762853|10941057|FG001|STARTED|1 Week Washout After Treatment 1||10
9830380|NCT00762853|10941056|FG000|COMPLETED|1 Week Washout After Treatment 1||10
9830381|NCT00762853|10941057|FG001|COMPLETED|1 Week Washout After Treatment 1||10
9830382|NCT00762853|10941056|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0
9830383|NCT00762853|10941057|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0
9830384|NCT00762853|10941056|FG000|STARTED|Second Treatment Period||10
9830385|NCT00762853|10941057|FG001|STARTED|Second Treatment Period||10
9830386|NCT00762853|10941056|FG000|COMPLETED|Second Treatment Period||10
9783765|NCT00518882|10890772|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
9783766|NCT00518882|10890773|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
9783767|NCT00518882|10890772|FG000|Randomised|Double-Blind, Week 0-26||233
9783768|NCT00518882|10890773|FG001|Randomised|Double-Blind, Week 0-26||231
9783769|NCT00518882|10890772|FG000|COMPLETED|Double-Blind, Week 0-26||202
9783770|NCT00518882|10890773|FG001|COMPLETED|Double-Blind, Week 0-26||187
9783771|NCT00518882|10890772|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33
9783772|NCT00518882|10890773|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45
9783773|NCT00518882|10890772|FG000|STARTED|Open-Label Extension, Week 26-78||202
9783774|NCT00518882|10890773|FG001|STARTED|Open-Label Extension, Week 26-78||187
9783775|NCT00518882|10890772|FG000|COMPLETED|Open-Label Extension, Week 26-78||161
9783776|NCT00518882|10890773|FG001|COMPLETED|Open-Label Extension, Week 26-78||138
9783777|NCT00518882|10890772|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41
9783778|NCT00518882|10890773|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49
9783779|NCT00518973|10890781|FG000|STARTED|Overall Study||9
9783780|NCT00518973|10890782|FG001|STARTED|Overall Study||6
9783781|NCT00518973|10890781|FG000|COMPLETED|Overall Study||6
9783782|NCT00518973|10890782|FG001|COMPLETED|Overall Study||4
9783783|NCT00518973|10890781|FG000|NOT COMPLETED|Overall Study||3
9783784|NCT00518973|10890782|FG001|NOT COMPLETED|Overall Study||2
9783785|NCT00518986|10890790|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
9783786|NCT00518986|10890791|FG001|STARTED|Overall Study||124
9783787|NCT00518986|10890790|FG000|COMPLETED|Overall Study||99
9783788|NCT00518986|10890791|FG001|COMPLETED|Overall Study||98
9783789|NCT00518986|10890790|FG000|NOT COMPLETED|Overall Study||26
9783790|NCT00518986|10890791|FG001|NOT COMPLETED|Overall Study||26
9783791|NCT00519077|10890797|FG000|STARTED|Overall Study||44
9783792|NCT00519077|10890797|FG000|COMPLETED|Overall Study||36
9783793|NCT00519077|10890797|FG000|NOT COMPLETED|Overall Study||8
9783794|NCT00519194|10890801|FG000|STARTED|Overall Study||112
9783795|NCT00519194|10890801|FG000|COMPLETED|Overall Study||91
9783796|NCT00519194|10890801|FG000|NOT COMPLETED|Overall Study||21
9783797|NCT00519285|10890807|FG000|STARTED|Overall Study|Randomized|612
9783798|NCT00519285|10890808|FG001|STARTED|Overall Study|Randomized|612
9783799|NCT00519285|10890807|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604
9783800|NCT00519285|10890808|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
9783801|NCT00519285|10890807|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
9783802|NCT00519285|10890808|FG001|Still Treated at Cut-off Date|Overall Study||2
9783803|NCT00519285|10890807|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
9783804|NCT00519285|10890808|FG001|COMPLETED|Overall Study||0
9783805|NCT00519285|10890807|FG000|NOT COMPLETED|Overall Study||612
9783806|NCT00519285|10890808|FG001|NOT COMPLETED|Overall Study||612
9783807|NCT00519376|10890814|FG000|STARTED|Treatment Period 1||2
9783808|NCT00519376|10890815|FG001|STARTED|Treatment Period 1||2
9783809|NCT00519376|10890816|FG002|STARTED|Treatment Period 1||2
9783810|NCT00519376|10890817|FG003|STARTED|Treatment Period 1||2
9783811|NCT00519376|10890818|FG004|STARTED|Treatment Period 1||1
9783812|NCT00519376|10890819|FG005|STARTED|Treatment Period 1||1
9783813|NCT00519376|10890820|FG006|STARTED|Treatment Period 1||1
9783814|NCT00519376|10890821|FG007|STARTED|Treatment Period 1||1
9783815|NCT00519376|10890822|FG008|STARTED|Treatment Period 1||1
9783816|NCT00519376|10890823|FG009|STARTED|Treatment Period 1||1
9783817|NCT00519376|10890824|FG010|STARTED|Treatment Period 1||1
9783818|NCT00519376|10890825|FG011|STARTED|Treatment Period 1||1
9783819|NCT00519376|10890826|FG012|STARTED|Treatment Period 1||1
9783820|NCT00519376|10890827|FG013|STARTED|Treatment Period 1||1
9783821|NCT00519376|10890828|FG014|STARTED|Treatment Period 1||1
9783822|NCT00519376|10890829|FG015|STARTED|Treatment Period 1||1
9783823|NCT00519376|10890814|FG000|COMPLETED|Treatment Period 1||2
9783824|NCT00519376|10890815|FG001|COMPLETED|Treatment Period 1||2
9783825|NCT00519376|10890816|FG002|COMPLETED|Treatment Period 1||2
9783826|NCT00519376|10890817|FG003|COMPLETED|Treatment Period 1||2
9783827|NCT00519376|10890818|FG004|COMPLETED|Treatment Period 1||1
9783828|NCT00519376|10890819|FG005|COMPLETED|Treatment Period 1||1
9783829|NCT00519376|10890820|FG006|COMPLETED|Treatment Period 1||1
9783830|NCT00519376|10890821|FG007|COMPLETED|Treatment Period 1||1
9783831|NCT00519376|10890822|FG008|COMPLETED|Treatment Period 1||1
9783832|NCT00519376|10890823|FG009|COMPLETED|Treatment Period 1||1
9783833|NCT00519376|10890824|FG010|COMPLETED|Treatment Period 1||1
9783834|NCT00519376|10890825|FG011|COMPLETED|Treatment Period 1||1
9783835|NCT00519376|10890826|FG012|COMPLETED|Treatment Period 1||1
9783836|NCT00519376|10890827|FG013|COMPLETED|Treatment Period 1||1
9783837|NCT00519376|10890828|FG014|COMPLETED|Treatment Period 1||1
9783838|NCT00519376|10890829|FG015|COMPLETED|Treatment Period 1||1
9783839|NCT00519376|10890814|FG000|NOT COMPLETED|Treatment Period 1||0
9783840|NCT00519376|10890815|FG001|NOT COMPLETED|Treatment Period 1||0
9783841|NCT00519376|10890816|FG002|NOT COMPLETED|Treatment Period 1||0
9783842|NCT00519376|10890817|FG003|NOT COMPLETED|Treatment Period 1||0
9783843|NCT00519376|10890818|FG004|NOT COMPLETED|Treatment Period 1||0
9783844|NCT00519376|10890819|FG005|NOT COMPLETED|Treatment Period 1||0
9783845|NCT00519376|10890820|FG006|NOT COMPLETED|Treatment Period 1||0
9783846|NCT00519376|10890821|FG007|NOT COMPLETED|Treatment Period 1||0
9783847|NCT00519376|10890822|FG008|NOT COMPLETED|Treatment Period 1||0
9783848|NCT00519376|10890823|FG009|NOT COMPLETED|Treatment Period 1||0
9783849|NCT00519376|10890824|FG010|NOT COMPLETED|Treatment Period 1||0
9783850|NCT00519376|10890825|FG011|NOT COMPLETED|Treatment Period 1||0
9783851|NCT00519376|10890826|FG012|NOT COMPLETED|Treatment Period 1||0
9783852|NCT00519376|10890827|FG013|NOT COMPLETED|Treatment Period 1||0
9783853|NCT00519376|10890828|FG014|NOT COMPLETED|Treatment Period 1||0
9783854|NCT00519376|10890829|FG015|NOT COMPLETED|Treatment Period 1||0
9783855|NCT00519376|10890814|FG000|STARTED|Washout Period 1||2
9783856|NCT00519376|10890815|FG001|STARTED|Washout Period 1||2
9783857|NCT00519376|10890816|FG002|STARTED|Washout Period 1||2
9783858|NCT00519376|10890817|FG003|STARTED|Washout Period 1||2
9783859|NCT00519376|10890818|FG004|STARTED|Washout Period 1||1
9783860|NCT00519376|10890819|FG005|STARTED|Washout Period 1||1
9783861|NCT00519376|10890820|FG006|STARTED|Washout Period 1||1
9783862|NCT00519376|10890821|FG007|STARTED|Washout Period 1||1
9783863|NCT00519376|10890822|FG008|STARTED|Washout Period 1||1
9783864|NCT00519376|10890823|FG009|STARTED|Washout Period 1||1
9783865|NCT00519376|10890824|FG010|STARTED|Washout Period 1||1
9783866|NCT00519376|10890825|FG011|STARTED|Washout Period 1||1
9783867|NCT00519376|10890826|FG012|STARTED|Washout Period 1||1
9783868|NCT00519376|10890827|FG013|STARTED|Washout Period 1||1
9783869|NCT00519376|10890828|FG014|STARTED|Washout Period 1||1
9783870|NCT00519376|10890829|FG015|STARTED|Washout Period 1||1
9783871|NCT00519376|10890814|FG000|COMPLETED|Washout Period 1||2
9783872|NCT00519376|10890815|FG001|COMPLETED|Washout Period 1||2
9783873|NCT00519376|10890816|FG002|COMPLETED|Washout Period 1||2
9783874|NCT00519376|10890817|FG003|COMPLETED|Washout Period 1||2
9783875|NCT00519376|10890818|FG004|COMPLETED|Washout Period 1||1
9783876|NCT00519376|10890819|FG005|COMPLETED|Washout Period 1||1
9783877|NCT00519376|10890820|FG006|COMPLETED|Washout Period 1||1
9783878|NCT00519376|10890821|FG007|COMPLETED|Washout Period 1||1
9783879|NCT00519376|10890822|FG008|COMPLETED|Washout Period 1||1
9783880|NCT00519376|10890823|FG009|COMPLETED|Washout Period 1||1
9783881|NCT00519376|10890824|FG010|COMPLETED|Washout Period 1||1
9783882|NCT00519376|10890825|FG011|COMPLETED|Washout Period 1||1
9783883|NCT00519376|10890826|FG012|COMPLETED|Washout Period 1||1
9783884|NCT00519376|10890827|FG013|COMPLETED|Washout Period 1||1
9783885|NCT00519376|10890828|FG014|COMPLETED|Washout Period 1||1
9783886|NCT00519376|10890829|FG015|COMPLETED|Washout Period 1||1
9783887|NCT00519376|10890814|FG000|NOT COMPLETED|Washout Period 1||0
9783888|NCT00519376|10890815|FG001|NOT COMPLETED|Washout Period 1||0
9783889|NCT00519376|10890816|FG002|NOT COMPLETED|Washout Period 1||0
9783890|NCT00519376|10890817|FG003|NOT COMPLETED|Washout Period 1||0
9783891|NCT00519376|10890818|FG004|NOT COMPLETED|Washout Period 1||0
9783892|NCT00519376|10890819|FG005|NOT COMPLETED|Washout Period 1||0
9783893|NCT00519376|10890820|FG006|NOT COMPLETED|Washout Period 1||0
9783894|NCT00519376|10890821|FG007|NOT COMPLETED|Washout Period 1||0
9783895|NCT00519376|10890822|FG008|NOT COMPLETED|Washout Period 1||0
9783896|NCT00519376|10890823|FG009|NOT COMPLETED|Washout Period 1||0
9783897|NCT00519376|10890824|FG010|NOT COMPLETED|Washout Period 1||0
9783898|NCT00519376|10890825|FG011|NOT COMPLETED|Washout Period 1||0
9783899|NCT00519376|10890826|FG012|NOT COMPLETED|Washout Period 1||0
9783900|NCT00519376|10890827|FG013|NOT COMPLETED|Washout Period 1||0
9783901|NCT00519376|10890828|FG014|NOT COMPLETED|Washout Period 1||0
9783902|NCT00519376|10890829|FG015|NOT COMPLETED|Washout Period 1||0
9783903|NCT00519376|10890814|FG000|STARTED|Treatment Period 2||2
9783904|NCT00519376|10890815|FG001|STARTED|Treatment Period 2||2
9783905|NCT00519376|10890816|FG002|STARTED|Treatment Period 2||2
9783906|NCT00519376|10890817|FG003|STARTED|Treatment Period 2||2
9783907|NCT00519376|10890818|FG004|STARTED|Treatment Period 2||1
9783908|NCT00519376|10890819|FG005|STARTED|Treatment Period 2||1
9783909|NCT00519376|10890820|FG006|STARTED|Treatment Period 2||1
9783910|NCT00519376|10890821|FG007|STARTED|Treatment Period 2||1
9783911|NCT00519376|10890822|FG008|STARTED|Treatment Period 2||1
9783912|NCT00519376|10890823|FG009|STARTED|Treatment Period 2||1
9783913|NCT00519376|10890824|FG010|STARTED|Treatment Period 2||1
9783914|NCT00519376|10890825|FG011|STARTED|Treatment Period 2||1
9783915|NCT00519376|10890826|FG012|STARTED|Treatment Period 2||1
9783916|NCT00519376|10890827|FG013|STARTED|Treatment Period 2||1
9783917|NCT00519376|10890828|FG014|STARTED|Treatment Period 2||1
9783918|NCT00519376|10890829|FG015|STARTED|Treatment Period 2||1
9783919|NCT00519376|10890814|FG000|COMPLETED|Treatment Period 2||2
9783920|NCT00519376|10890815|FG001|COMPLETED|Treatment Period 2||2
9783921|NCT00519376|10890816|FG002|COMPLETED|Treatment Period 2||2
9783922|NCT00519376|10890817|FG003|COMPLETED|Treatment Period 2||2
9783923|NCT00519376|10890818|FG004|COMPLETED|Treatment Period 2||1
9783924|NCT00519376|10890819|FG005|COMPLETED|Treatment Period 2||1
9783925|NCT00519376|10890820|FG006|COMPLETED|Treatment Period 2||1
9783926|NCT00519376|10890821|FG007|COMPLETED|Treatment Period 2||1
9783927|NCT00519376|10890822|FG008|COMPLETED|Treatment Period 2||1
9783928|NCT00519376|10890823|FG009|COMPLETED|Treatment Period 2||1
9783929|NCT00519376|10890824|FG010|COMPLETED|Treatment Period 2||1
9783930|NCT00519376|10890825|FG011|COMPLETED|Treatment Period 2||1
9783931|NCT00519376|10890826|FG012|COMPLETED|Treatment Period 2||0
9783932|NCT00519376|10890827|FG013|COMPLETED|Treatment Period 2||1
9783933|NCT00519376|10890828|FG014|COMPLETED|Treatment Period 2||1
9783934|NCT00519376|10890829|FG015|COMPLETED|Treatment Period 2||1
9783935|NCT00519376|10890814|FG000|NOT COMPLETED|Treatment Period 2||0
9783936|NCT00519376|10890815|FG001|NOT COMPLETED|Treatment Period 2||0
9783937|NCT00519376|10890816|FG002|NOT COMPLETED|Treatment Period 2||0
9783938|NCT00519376|10890817|FG003|NOT COMPLETED|Treatment Period 2||0
9783939|NCT00519376|10890818|FG004|NOT COMPLETED|Treatment Period 2||0
9783940|NCT00519376|10890819|FG005|NOT COMPLETED|Treatment Period 2||0
9783941|NCT00519376|10890820|FG006|NOT COMPLETED|Treatment Period 2||0
9783942|NCT00519376|10890821|FG007|NOT COMPLETED|Treatment Period 2||0
9783943|NCT00519376|10890822|FG008|NOT COMPLETED|Treatment Period 2||0
9783944|NCT00519376|10890823|FG009|NOT COMPLETED|Treatment Period 2||0
9783945|NCT00519376|10890824|FG010|NOT COMPLETED|Treatment Period 2||0
9783946|NCT00519376|10890825|FG011|NOT COMPLETED|Treatment Period 2||0
9783947|NCT00519376|10890826|FG012|NOT COMPLETED|Treatment Period 2||1
9783948|NCT00519376|10890827|FG013|NOT COMPLETED|Treatment Period 2||0
9783949|NCT00519376|10890828|FG014|NOT COMPLETED|Treatment Period 2||0
9783950|NCT00519376|10890829|FG015|NOT COMPLETED|Treatment Period 2||0
9783951|NCT00519376|10890814|FG000|STARTED|Washout Period 2||2
9783952|NCT00519376|10890815|FG001|STARTED|Washout Period 2||2
9783953|NCT00519376|10890816|FG002|STARTED|Washout Period 2||2
9783954|NCT00519376|10890817|FG003|STARTED|Washout Period 2||2
9783955|NCT00519376|10890818|FG004|STARTED|Washout Period 2||1
9783956|NCT00519376|10890819|FG005|STARTED|Washout Period 2||1
9783957|NCT00519376|10890820|FG006|STARTED|Washout Period 2||1
9783958|NCT00519376|10890821|FG007|STARTED|Washout Period 2||1
9783959|NCT00519376|10890822|FG008|STARTED|Washout Period 2||1
9783960|NCT00519376|10890823|FG009|STARTED|Washout Period 2||1
9783961|NCT00519376|10890824|FG010|STARTED|Washout Period 2||1
9783962|NCT00519376|10890825|FG011|STARTED|Washout Period 2||1
9783963|NCT00519376|10890826|FG012|STARTED|Washout Period 2||0
9783964|NCT00519376|10890827|FG013|STARTED|Washout Period 2||1
9783965|NCT00519376|10890828|FG014|STARTED|Washout Period 2||1
9783966|NCT00519376|10890829|FG015|STARTED|Washout Period 2||1
9783967|NCT00519376|10890814|FG000|COMPLETED|Washout Period 2||2
9783968|NCT00519376|10890815|FG001|COMPLETED|Washout Period 2||2
9783969|NCT00519376|10890816|FG002|COMPLETED|Washout Period 2||2
9783970|NCT00519376|10890817|FG003|COMPLETED|Washout Period 2||2
9783971|NCT00519376|10890818|FG004|COMPLETED|Washout Period 2||1
9783972|NCT00519376|10890819|FG005|COMPLETED|Washout Period 2||1
9783973|NCT00519376|10890820|FG006|COMPLETED|Washout Period 2||1
9783974|NCT00519376|10890821|FG007|COMPLETED|Washout Period 2||1
9783975|NCT00519376|10890822|FG008|COMPLETED|Washout Period 2||1
9783976|NCT00519376|10890823|FG009|COMPLETED|Washout Period 2||1
9783977|NCT00519376|10890824|FG010|COMPLETED|Washout Period 2||1
9783978|NCT00519376|10890825|FG011|COMPLETED|Washout Period 2||1
9783979|NCT00519376|10890826|FG012|COMPLETED|Washout Period 2||0
9783980|NCT00519376|10890827|FG013|COMPLETED|Washout Period 2||1
9783981|NCT00519376|10890828|FG014|COMPLETED|Washout Period 2||1
9783982|NCT00519376|10890829|FG015|COMPLETED|Washout Period 2||1
9783983|NCT00519376|10890814|FG000|NOT COMPLETED|Washout Period 2||0
9783984|NCT00519376|10890815|FG001|NOT COMPLETED|Washout Period 2||0
9783985|NCT00519376|10890816|FG002|NOT COMPLETED|Washout Period 2||0
9783986|NCT00519376|10890817|FG003|NOT COMPLETED|Washout Period 2||0
9783987|NCT00519376|10890818|FG004|NOT COMPLETED|Washout Period 2||0
9783988|NCT00519376|10890819|FG005|NOT COMPLETED|Washout Period 2||0
9783989|NCT00519376|10890820|FG006|NOT COMPLETED|Washout Period 2||0
9783990|NCT00519376|10890821|FG007|NOT COMPLETED|Washout Period 2||0
9783991|NCT00519376|10890822|FG008|NOT COMPLETED|Washout Period 2||0
9783992|NCT00519376|10890823|FG009|NOT COMPLETED|Washout Period 2||0
9783993|NCT00519376|10890824|FG010|NOT COMPLETED|Washout Period 2||0
9783994|NCT00519376|10890825|FG011|NOT COMPLETED|Washout Period 2||0
9783995|NCT00519376|10890826|FG012|NOT COMPLETED|Washout Period 2||0
9783996|NCT00519376|10890827|FG013|NOT COMPLETED|Washout Period 2||0
9783997|NCT00519376|10890828|FG014|NOT COMPLETED|Washout Period 2||0
9783998|NCT00519376|10890829|FG015|NOT COMPLETED|Washout Period 2||0
9783999|NCT00519376|10890814|FG000|STARTED|Treatment Period 3||2
9784000|NCT00519376|10890815|FG001|STARTED|Treatment Period 3||2
9784001|NCT00519376|10890816|FG002|STARTED|Treatment Period 3||2
9784002|NCT00519376|10890817|FG003|STARTED|Treatment Period 3||2
9784003|NCT00519376|10890818|FG004|STARTED|Treatment Period 3||1
9784004|NCT00519376|10890819|FG005|STARTED|Treatment Period 3||1
9784005|NCT00519376|10890820|FG006|STARTED|Treatment Period 3||1
9784006|NCT00519376|10890821|FG007|STARTED|Treatment Period 3||1
9784007|NCT00519376|10890822|FG008|STARTED|Treatment Period 3||1
9784008|NCT00519376|10890823|FG009|STARTED|Treatment Period 3||1
9784009|NCT00519376|10890824|FG010|STARTED|Treatment Period 3||1
9784010|NCT00519376|10890825|FG011|STARTED|Treatment Period 3||1
9784011|NCT00519376|10890826|FG012|STARTED|Treatment Period 3||0
9784012|NCT00519376|10890827|FG013|STARTED|Treatment Period 3||1
9784013|NCT00519376|10890828|FG014|STARTED|Treatment Period 3||1
9784014|NCT00519376|10890829|FG015|STARTED|Treatment Period 3||1
9784015|NCT00519376|10890814|FG000|COMPLETED|Treatment Period 3||2
9784016|NCT00519376|10890815|FG001|COMPLETED|Treatment Period 3||2
9784017|NCT00519376|10890816|FG002|COMPLETED|Treatment Period 3||2
9784018|NCT00519376|10890817|FG003|COMPLETED|Treatment Period 3||2
9784019|NCT00519376|10890818|FG004|COMPLETED|Treatment Period 3||1
9784020|NCT00519376|10890819|FG005|COMPLETED|Treatment Period 3||1
9784021|NCT00519376|10890820|FG006|COMPLETED|Treatment Period 3||1
9784022|NCT00519376|10890821|FG007|COMPLETED|Treatment Period 3||1
9784023|NCT00519376|10890822|FG008|COMPLETED|Treatment Period 3||1
9784024|NCT00519376|10890823|FG009|COMPLETED|Treatment Period 3||1
9784025|NCT00519376|10890824|FG010|COMPLETED|Treatment Period 3||1
9784026|NCT00519376|10890825|FG011|COMPLETED|Treatment Period 3||1
9784027|NCT00519376|10890826|FG012|COMPLETED|Treatment Period 3||0
9784028|NCT00519376|10890827|FG013|COMPLETED|Treatment Period 3||1
9784029|NCT00519376|10890828|FG014|COMPLETED|Treatment Period 3||1
9784030|NCT00519376|10890829|FG015|COMPLETED|Treatment Period 3||1
9784031|NCT00519376|10890814|FG000|NOT COMPLETED|Treatment Period 3||0
9784032|NCT00519376|10890815|FG001|NOT COMPLETED|Treatment Period 3||0
9784033|NCT00519376|10890816|FG002|NOT COMPLETED|Treatment Period 3||0
9784034|NCT00519376|10890817|FG003|NOT COMPLETED|Treatment Period 3||0
9784035|NCT00519376|10890818|FG004|NOT COMPLETED|Treatment Period 3||0
9784036|NCT00519376|10890819|FG005|NOT COMPLETED|Treatment Period 3||0
9784037|NCT00519376|10890820|FG006|NOT COMPLETED|Treatment Period 3||0
9784038|NCT00519376|10890821|FG007|NOT COMPLETED|Treatment Period 3||0
9784039|NCT00519376|10890822|FG008|NOT COMPLETED|Treatment Period 3||0
9784040|NCT00519376|10890823|FG009|NOT COMPLETED|Treatment Period 3||0
9784041|NCT00519376|10890824|FG010|NOT COMPLETED|Treatment Period 3||0
9784042|NCT00519376|10890825|FG011|NOT COMPLETED|Treatment Period 3||0
9784043|NCT00519376|10890826|FG012|NOT COMPLETED|Treatment Period 3||0
9784044|NCT00519376|10890827|FG013|NOT COMPLETED|Treatment Period 3||0
9784045|NCT00519376|10890828|FG014|NOT COMPLETED|Treatment Period 3||0
9784046|NCT00519376|10890829|FG015|NOT COMPLETED|Treatment Period 3||0
9784047|NCT00519376|10890814|FG000|STARTED|Washout Period 3||2
9784048|NCT00519376|10890815|FG001|STARTED|Washout Period 3||2
9784049|NCT00519376|10890816|FG002|STARTED|Washout Period 3||2
9784050|NCT00519376|10890817|FG003|STARTED|Washout Period 3||2
9784051|NCT00519376|10890818|FG004|STARTED|Washout Period 3||1
9784052|NCT00519376|10890819|FG005|STARTED|Washout Period 3||1
9784053|NCT00519376|10890820|FG006|STARTED|Washout Period 3||1
9784054|NCT00519376|10890821|FG007|STARTED|Washout Period 3||1
9784055|NCT00519376|10890822|FG008|STARTED|Washout Period 3||1
9784056|NCT00519376|10890823|FG009|STARTED|Washout Period 3||1
9784057|NCT00519376|10890824|FG010|STARTED|Washout Period 3||1
9784058|NCT00519376|10890825|FG011|STARTED|Washout Period 3||1
9784059|NCT00519376|10890826|FG012|STARTED|Washout Period 3||0
9784060|NCT00519376|10890827|FG013|STARTED|Washout Period 3||1
9784061|NCT00519376|10890828|FG014|STARTED|Washout Period 3||1
9784062|NCT00519376|10890829|FG015|STARTED|Washout Period 3||1
9784063|NCT00519376|10890814|FG000|COMPLETED|Washout Period 3||2
9784064|NCT00519376|10890815|FG001|COMPLETED|Washout Period 3||2
9784065|NCT00519376|10890816|FG002|COMPLETED|Washout Period 3||2
9784066|NCT00519376|10890817|FG003|COMPLETED|Washout Period 3||2
9784067|NCT00519376|10890818|FG004|COMPLETED|Washout Period 3||1
9784068|NCT00519376|10890819|FG005|COMPLETED|Washout Period 3||1
9784069|NCT00519376|10890820|FG006|COMPLETED|Washout Period 3||1
9784070|NCT00519376|10890821|FG007|COMPLETED|Washout Period 3||1
9784071|NCT00519376|10890822|FG008|COMPLETED|Washout Period 3||1
9784072|NCT00519376|10890823|FG009|COMPLETED|Washout Period 3||1
9784073|NCT00519376|10890824|FG010|COMPLETED|Washout Period 3||1
9784074|NCT00519376|10890825|FG011|COMPLETED|Washout Period 3||1
9784075|NCT00519376|10890826|FG012|COMPLETED|Washout Period 3||0
9784076|NCT00519376|10890827|FG013|COMPLETED|Washout Period 3||1
9784077|NCT00519376|10890828|FG014|COMPLETED|Washout Period 3||1
9784078|NCT00519376|10890829|FG015|COMPLETED|Washout Period 3||1
9784079|NCT00519376|10890814|FG000|NOT COMPLETED|Washout Period 3||0
9784080|NCT00519376|10890815|FG001|NOT COMPLETED|Washout Period 3||0
9784081|NCT00519376|10890816|FG002|NOT COMPLETED|Washout Period 3||0
9784082|NCT00519376|10890817|FG003|NOT COMPLETED|Washout Period 3||0
9784083|NCT00519376|10890818|FG004|NOT COMPLETED|Washout Period 3||0
9784084|NCT00519376|10890819|FG005|NOT COMPLETED|Washout Period 3||0
9784085|NCT00519376|10890820|FG006|NOT COMPLETED|Washout Period 3||0
9784086|NCT00519376|10890821|FG007|NOT COMPLETED|Washout Period 3||0
9784087|NCT00519376|10890822|FG008|NOT COMPLETED|Washout Period 3||0
9784088|NCT00519376|10890823|FG009|NOT COMPLETED|Washout Period 3||0
9784089|NCT00519376|10890824|FG010|NOT COMPLETED|Washout Period 3||0
9784090|NCT00519376|10890825|FG011|NOT COMPLETED|Washout Period 3||0
9784091|NCT00519376|10890826|FG012|NOT COMPLETED|Washout Period 3||0
9784092|NCT00519376|10890827|FG013|NOT COMPLETED|Washout Period 3||0
9784093|NCT00519376|10890828|FG014|NOT COMPLETED|Washout Period 3||0
9784094|NCT00519376|10890829|FG015|NOT COMPLETED|Washout Period 3||0
9784095|NCT00519376|10890814|FG000|STARTED|Treatment Period 4||2
9784096|NCT00519376|10890815|FG001|STARTED|Treatment Period 4||2
9784097|NCT00519376|10890816|FG002|STARTED|Treatment Period 4||2
9784098|NCT00519376|10890817|FG003|STARTED|Treatment Period 4||2
9784099|NCT00519376|10890818|FG004|STARTED|Treatment Period 4||1
9784100|NCT00519376|10890819|FG005|STARTED|Treatment Period 4||1
9784101|NCT00519376|10890820|FG006|STARTED|Treatment Period 4||1
9784102|NCT00519376|10890821|FG007|STARTED|Treatment Period 4||1
9784103|NCT00519376|10890822|FG008|STARTED|Treatment Period 4||1
9784104|NCT00519376|10890823|FG009|STARTED|Treatment Period 4||1
9784105|NCT00519376|10890824|FG010|STARTED|Treatment Period 4||1
9784106|NCT00519376|10890825|FG011|STARTED|Treatment Period 4||1
9784107|NCT00519376|10890826|FG012|STARTED|Treatment Period 4||0
9784108|NCT00519376|10890827|FG013|STARTED|Treatment Period 4||1
9784109|NCT00519376|10890828|FG014|STARTED|Treatment Period 4||1
9784110|NCT00519376|10890829|FG015|STARTED|Treatment Period 4||1
9784111|NCT00519376|10890814|FG000|COMPLETED|Treatment Period 4||2
9784112|NCT00519376|10890815|FG001|COMPLETED|Treatment Period 4||2
9784113|NCT00519376|10890816|FG002|COMPLETED|Treatment Period 4||1
9784114|NCT00519376|10890817|FG003|COMPLETED|Treatment Period 4||2
9784115|NCT00519376|10890818|FG004|COMPLETED|Treatment Period 4||1
9784116|NCT00519376|10890819|FG005|COMPLETED|Treatment Period 4||1
9784117|NCT00519376|10890820|FG006|COMPLETED|Treatment Period 4||1
9784118|NCT00519376|10890821|FG007|COMPLETED|Treatment Period 4||1
9784119|NCT00519376|10890822|FG008|COMPLETED|Treatment Period 4||1
9784120|NCT00519376|10890823|FG009|COMPLETED|Treatment Period 4||1
9784121|NCT00519376|10890824|FG010|COMPLETED|Treatment Period 4||1
9784122|NCT00519376|10890825|FG011|COMPLETED|Treatment Period 4||1
9784123|NCT00519376|10890826|FG012|COMPLETED|Treatment Period 4||0
9784124|NCT00519376|10890827|FG013|COMPLETED|Treatment Period 4||1
9784125|NCT00519376|10890828|FG014|COMPLETED|Treatment Period 4||1
9784126|NCT00519376|10890829|FG015|COMPLETED|Treatment Period 4||1
9784127|NCT00519376|10890814|FG000|NOT COMPLETED|Treatment Period 4||0
9784128|NCT00519376|10890815|FG001|NOT COMPLETED|Treatment Period 4||0
9784129|NCT00519376|10890816|FG002|NOT COMPLETED|Treatment Period 4||1
9784130|NCT00519376|10890817|FG003|NOT COMPLETED|Treatment Period 4||0
9784131|NCT00519376|10890818|FG004|NOT COMPLETED|Treatment Period 4||0
9784132|NCT00519376|10890819|FG005|NOT COMPLETED|Treatment Period 4||0
9784133|NCT00519376|10890820|FG006|NOT COMPLETED|Treatment Period 4||0
9784134|NCT00519376|10890821|FG007|NOT COMPLETED|Treatment Period 4||0
9784135|NCT00519376|10890822|FG008|NOT COMPLETED|Treatment Period 4||0
9784136|NCT00519376|10890823|FG009|NOT COMPLETED|Treatment Period 4||0
9784137|NCT00519376|10890824|FG010|NOT COMPLETED|Treatment Period 4||0
9784138|NCT00519376|10890825|FG011|NOT COMPLETED|Treatment Period 4||0
9784139|NCT00519376|10890826|FG012|NOT COMPLETED|Treatment Period 4||0
9784140|NCT00519376|10890827|FG013|NOT COMPLETED|Treatment Period 4||0
9784141|NCT00519376|10890828|FG014|NOT COMPLETED|Treatment Period 4||0
9784142|NCT00519376|10890829|FG015|NOT COMPLETED|Treatment Period 4||0
9784143|NCT00519428|10890844|FG000|STARTED|Overall Study||78
9784144|NCT00519428|10890845|FG001|STARTED|Overall Study||84
9784145|NCT00519428|10890846|FG002|STARTED|Overall Study||83
9784146|NCT00519428|10890844|FG000|COMPLETED|Overall Study||57
9784147|NCT00519428|10890845|FG001|COMPLETED|Overall Study||69
9784148|NCT00519428|10890846|FG002|COMPLETED|Overall Study||58
9784149|NCT00519428|10890844|FG000|NOT COMPLETED|Overall Study||21
9784150|NCT00519428|10890845|FG001|NOT COMPLETED|Overall Study||15
9784151|NCT00519428|10890846|FG002|NOT COMPLETED|Overall Study||25
9784152|NCT00519532|10890857|FG000|STARTED|Overall Study||84
9784153|NCT00519532|10890857|FG000|COMPLETED|Overall Study||66
9784154|NCT00519532|10890857|FG000|NOT COMPLETED|Overall Study||18
9784155|NCT00519584|10890865|FG000|STARTED|Overall Study||54
9784156|NCT00519584|10890866|FG001|STARTED|Overall Study||54
9784157|NCT00519584|10890867|FG002|STARTED|Overall Study||54
9784158|NCT00519584|10890868|FG003|STARTED|Overall Study||56
9784159|NCT00519584|10890865|FG000|COMPLETED|Overall Study||54
9784160|NCT00519584|10890866|FG001|COMPLETED|Overall Study||54
9784161|NCT00519584|10890867|FG002|COMPLETED|Overall Study||54
9784162|NCT00519584|10890868|FG003|COMPLETED|Overall Study||56
9784163|NCT00519584|10890865|FG000|NOT COMPLETED|Overall Study||0
9784164|NCT00519584|10890866|FG001|NOT COMPLETED|Overall Study||0
9784165|NCT00519584|10890867|FG002|NOT COMPLETED|Overall Study||0
9784166|NCT00519584|10890868|FG003|NOT COMPLETED|Overall Study||0
9784167|NCT00519623|10890878|FG000|STARTED|Overall Study||9
9784168|NCT00519623|10890878|FG000|COMPLETED|Overall Study||8
9784169|NCT00519623|10890878|FG000|NOT COMPLETED|Overall Study||1
9784170|NCT00519636|10890886|FG000|STARTED|Treatment Period 1||91
9784171|NCT00519636|10890887|FG001|STARTED|Treatment Period 1||86
9784172|NCT00519636|10890888|FG002|STARTED|Treatment Period 1||90
9784173|NCT00519636|10890889|FG003|STARTED|Treatment Period 1||93
9784174|NCT00519636|10890886|FG000|COMPLETED|Treatment Period 1||89
9784175|NCT00519636|10890887|FG001|COMPLETED|Treatment Period 1||86
9784176|NCT00519636|10890888|FG002|COMPLETED|Treatment Period 1||89
9784177|NCT00519636|10890889|FG003|COMPLETED|Treatment Period 1||93
9784178|NCT00519636|10890886|FG000|NOT COMPLETED|Treatment Period 1||2
9784179|NCT00519636|10890887|FG001|NOT COMPLETED|Treatment Period 1||0
9784180|NCT00519636|10890888|FG002|NOT COMPLETED|Treatment Period 1||1
10015073|NCT01803204|11138063|FG000|STARTED|Overall Study||20
10015074|NCT01803204|11138064|FG001|STARTED|Overall Study||20
10015075|NCT01803204|11138063|FG000|COMPLETED|Overall Study||20
10015076|NCT01803204|11138064|FG001|COMPLETED|Overall Study||20
9784181|NCT00519636|10890889|FG003|NOT COMPLETED|Treatment Period 1||0
9784182|NCT00519636|10890886|FG000|STARTED|Washout Period||89
9784183|NCT00519636|10890887|FG001|STARTED|Washout Period||86
9784184|NCT00519636|10890888|FG002|STARTED|Washout Period||89
9784185|NCT00519636|10890889|FG003|STARTED|Washout Period||93
9784186|NCT00519636|10890886|FG000|COMPLETED|Washout Period||69
9784187|NCT00519636|10890887|FG001|COMPLETED|Washout Period||72
9784188|NCT00519636|10890888|FG002|COMPLETED|Washout Period||75
10015077|NCT01803204|11138063|FG000|NOT COMPLETED|Overall Study||0
10015078|NCT01803204|11138064|FG001|NOT COMPLETED|Overall Study||0
9784189|NCT00519636|10890889|FG003|COMPLETED|Washout Period||88
9784190|NCT00519636|10890886|FG000|NOT COMPLETED|Washout Period||20
9784191|NCT00519636|10890887|FG001|NOT COMPLETED|Washout Period||14
9784192|NCT00519636|10890888|FG002|NOT COMPLETED|Washout Period||14
9784193|NCT00519636|10890889|FG003|NOT COMPLETED|Washout Period||5
9784194|NCT00519636|10890886|FG000|STARTED|Treatment Period 2||69
9784195|NCT00519636|10890887|FG001|STARTED|Treatment Period 2||72
9784196|NCT00519636|10890888|FG002|STARTED|Treatment Period 2||75
10015079|NCT01803269|11138073|FG000|STARTED|Overall Study||7
9784197|NCT00519636|10890889|FG003|STARTED|Treatment Period 2||88
9784198|NCT00519636|10890886|FG000|COMPLETED|Treatment Period 2||69
9784199|NCT00519636|10890887|FG001|COMPLETED|Treatment Period 2||71
9784200|NCT00519636|10890888|FG002|COMPLETED|Treatment Period 2||74
9784201|NCT00519636|10890889|FG003|COMPLETED|Treatment Period 2||86
9784202|NCT00519636|10890886|FG000|NOT COMPLETED|Treatment Period 2||0
9784203|NCT00519636|10890887|FG001|NOT COMPLETED|Treatment Period 2||1
9784204|NCT00519636|10890888|FG002|NOT COMPLETED|Treatment Period 2||1
9784205|NCT00519636|10890889|FG003|NOT COMPLETED|Treatment Period 2||2
9784206|NCT00519636|10890886|FG000|STARTED|Post Study Period||69
9784207|NCT00519636|10890887|FG001|STARTED|Post Study Period||71
9784208|NCT00519636|10890888|FG002|STARTED|Post Study Period||74
9784209|NCT00519636|10890889|FG003|STARTED|Post Study Period||86
9784210|NCT00519636|10890886|FG000|COMPLETED|Post Study Period||69
9784211|NCT00519636|10890887|FG001|COMPLETED|Post Study Period||71
9784212|NCT00519636|10890888|FG002|COMPLETED|Post Study Period||74
9784213|NCT00519636|10890889|FG003|COMPLETED|Post Study Period||85
9784214|NCT00519636|10890886|FG000|NOT COMPLETED|Post Study Period||0
9784215|NCT00519636|10890887|FG001|NOT COMPLETED|Post Study Period||0
9784216|NCT00519636|10890888|FG002|NOT COMPLETED|Post Study Period||0
9784217|NCT00519636|10890889|FG003|NOT COMPLETED|Post Study Period||1
9784218|NCT00519649|10890903|FG000|STARTED|Overall Study||300
9784219|NCT00519649|10890903|FG000|COMPLETED|Overall Study||299
9784220|NCT00519649|10890903|FG000|NOT COMPLETED|Overall Study||1
9784221|NCT00519779|10890909|FG000|STARTED|Overall Study||34
9784222|NCT00519779|10890910|FG001|STARTED|Overall Study||34
9784223|NCT00519779|10890909|FG000|COMPLETED|Overall Study||34
9784224|NCT00519779|10890910|FG001|COMPLETED|Overall Study||33
9784225|NCT00519779|10890909|FG000|NOT COMPLETED|Overall Study||0
9784226|NCT00519779|10890910|FG001|NOT COMPLETED|Overall Study||1
9784227|NCT00519831|10890916|FG000|STARTED|Overall Study||16
9784228|NCT00519831|10890916|FG000|COMPLETED|Overall Study||13
9784229|NCT00519831|10890916|FG000|NOT COMPLETED|Overall Study||3
9784230|NCT00519896|10890920|FG000|STARTED|Overall Study||35
9784231|NCT00519896|10890920|FG000|COMPLETED|Overall Study||33
9784232|NCT00519896|10890920|FG000|NOT COMPLETED|Overall Study||2
9784233|NCT00520013|10890927|FG000|STARTED|Overall Study||23
9784234|NCT00520013|10890928|FG001|STARTED|Overall Study||25
9784235|NCT00520013|10890929|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
9784236|NCT00520013|10890927|FG000|Treated|Overall Study||23
9784237|NCT00520013|10890928|FG001|Treated|Overall Study||25
9784238|NCT00520013|10890929|FG002|Treated|Overall Study||11
9784239|NCT00520013|10890927|FG000|COMPLETED|Overall Study||11
9784240|NCT00520013|10890928|FG001|COMPLETED|Overall Study||10
9784241|NCT00520013|10890929|FG002|COMPLETED|Overall Study||0
9784242|NCT00520013|10890927|FG000|NOT COMPLETED|Overall Study||12
9784243|NCT00520013|10890928|FG001|NOT COMPLETED|Overall Study||15
9784244|NCT00520013|10890929|FG002|NOT COMPLETED|Overall Study||11
9784245|NCT00520039|10890937|FG000|STARTED|Overall Study||28
9784246|NCT00520039|10890938|FG001|STARTED|Overall Study||24
9784247|NCT00520039|10890937|FG000|COMPLETED|Overall Study||21
9784248|NCT00520039|10890938|FG001|COMPLETED|Overall Study||19
9784249|NCT00520039|10890937|FG000|NOT COMPLETED|Overall Study||7
10015080|NCT01803269|11138074|FG001|STARTED|Overall Study||8
10015081|NCT01803269|11138075|FG002|STARTED|Overall Study||14
9784250|NCT00520039|10890938|FG001|NOT COMPLETED|Overall Study||5
9784251|NCT00520130|10890948|FG000|STARTED|Overall Study||44
9784252|NCT00520130|10890949|FG001|STARTED|Overall Study||45
9784253|NCT00520130|10890948|FG000|COMPLETED|Overall Study||39
9784254|NCT00520130|10890949|FG001|COMPLETED|Overall Study||44
9784255|NCT00520130|10890948|FG000|NOT COMPLETED|Overall Study||5
9784256|NCT00520130|10890949|FG001|NOT COMPLETED|Overall Study||1
9784257|NCT00520234|10890961|FG000|STARTED|Overall Study||118
9784258|NCT00520234|10890962|FG001|STARTED|Overall Study||104
9784259|NCT00520234|10890961|FG000|COMPLETED|Overall Study||117
9784260|NCT00520234|10890962|FG001|COMPLETED|Overall Study||102
9784261|NCT00520234|10890961|FG000|NOT COMPLETED|Overall Study||1
9784262|NCT00520234|10890962|FG001|NOT COMPLETED|Overall Study||2
9784263|NCT00520286|10890971|FG000|STARTED|Overall Study||142
9784264|NCT00520286|10890972|FG001|STARTED|Overall Study||68
9784265|NCT00520286|10890971|FG000|COMPLETED|Overall Study||76
9784266|NCT00520286|10890972|FG001|COMPLETED|Overall Study||36
9784267|NCT00520286|10890971|FG000|NOT COMPLETED|Overall Study||66
10015082|NCT01803269|11138073|FG000|COMPLETED|Overall Study||4
9784268|NCT00520286|10890972|FG001|NOT COMPLETED|Overall Study||32
9784269|NCT00520299|10890981|FG000|STARTED|Overall Study||6
9784270|NCT00520299|10890982|FG001|STARTED|Overall Study||6
9784271|NCT00520299|10890983|FG002|STARTED|Overall Study||19
9784272|NCT00520299|10890981|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
9784273|NCT00520299|10890982|FG001|COMPLETED|Overall Study||3
9784274|NCT00520299|10890983|FG002|COMPLETED|Overall Study||13
9784275|NCT00520299|10890981|FG000|NOT COMPLETED|Overall Study||0
9784276|NCT00520299|10890982|FG001|NOT COMPLETED|Overall Study||3
9784277|NCT00520299|10890983|FG002|NOT COMPLETED|Overall Study||6
9784278|NCT00520351|10890993|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15
9784279|NCT00520351|10890994|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15
9784280|NCT00520351|10890993|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14
9784281|NCT00520351|10890994|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14
9784282|NCT00520351|10890993|FG000|NOT COMPLETED|First Intervention||1
10015083|NCT01803269|11138074|FG001|COMPLETED|Overall Study||8
9784283|NCT00520351|10890994|FG001|NOT COMPLETED|First Intervention||1
9784284|NCT00520351|10890993|FG000|STARTED|Second Intervention||14
9784285|NCT00520351|10890994|FG001|STARTED|Second Intervention||14
9784286|NCT00520351|10890993|FG000|COMPLETED|Second Intervention||14
9784287|NCT00520351|10890994|FG001|COMPLETED|Second Intervention||14
9784288|NCT00520351|10890993|FG000|NOT COMPLETED|Second Intervention||0
9784289|NCT00520351|10890994|FG001|NOT COMPLETED|Second Intervention||0
9784290|NCT00520403|10891000|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25
9784291|NCT00520403|10891000|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7
9784292|NCT00520403|10891000|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
9784293|NCT00520403|10891000|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
9784294|NCT00520403|10891000|FG000|COMPLETED|Bevacizumab Monotherapy||0
9784295|NCT00520403|10891000|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2
9784296|NCT00520468|10891004|FG000|STARTED|Overall Study||14
9784297|NCT00520468|10891004|FG000|COMPLETED|Overall Study||14
9784298|NCT00520468|10891004|FG000|NOT COMPLETED|Overall Study||0
9784299|NCT00520481|10891010|FG000|STARTED|Overall Study||31
9784300|NCT00520481|10891011|FG001|STARTED|Overall Study||10
9784301|NCT00520481|10891010|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
9784302|NCT00520481|10891011|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
9784303|NCT00520481|10891010|FG000|COMPLETED|Overall Study||24
9784304|NCT00520481|10891011|FG001|COMPLETED|Overall Study||9
9784305|NCT00520481|10891010|FG000|NOT COMPLETED|Overall Study||7
9784306|NCT00520481|10891011|FG001|NOT COMPLETED|Overall Study||1
9784307|NCT00520494|10891019|FG000|STARTED|Overall Study||18
9784308|NCT00520494|10891019|FG000|COMPLETED|Overall Study||17
9784309|NCT00520494|10891019|FG000|NOT COMPLETED|Overall Study||1
9784310|NCT00520533|10891023|FG000|STARTED|Overall Study||8
9784311|NCT00520533|10891023|FG000|COMPLETED|Overall Study||4
9784312|NCT00520533|10891023|FG000|NOT COMPLETED|Overall Study||4
9784313|NCT00520546|10891028|FG000|STARTED|Overall Study||44
9784314|NCT00520546|10891028|FG000|COMPLETED|Overall Study||38
9784315|NCT00520546|10891028|FG000|NOT COMPLETED|Overall Study||6
9784316|NCT00520572|10891043|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
9784317|NCT00520572|10891044|FG001|STARTED|Overall Study|Participants randomised.|64
9784318|NCT00520572|10891045|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
9784319|NCT00520572|10891046|FG003|STARTED|Overall Study|Participants randomised.|64
9784320|NCT00520572|10891047|FG004|STARTED|Overall Study|Participants randomised.|65
9784321|NCT00520572|10891048|FG005|STARTED|Overall Study|Participants randomised.|64
9784322|NCT00520572|10891043|FG000|COMPLETED|Overall Study|Participants completed the study.|52
9784323|NCT00520572|10891044|FG001|COMPLETED|Overall Study|Participants completed the study.|50
9784324|NCT00520572|10891045|FG002|COMPLETED|Overall Study|Participants completed the study.|49
9784325|NCT00520572|10891046|FG003|COMPLETED|Overall Study|Participants completed the study.|50
9784326|NCT00520572|10891047|FG004|COMPLETED|Overall Study|Participants completed the study.|53
9784327|NCT00520572|10891048|FG005|COMPLETED|Overall Study|Participants completed the study.|62
9784328|NCT00520572|10891043|FG000|NOT COMPLETED|Overall Study||12
9784329|NCT00520572|10891044|FG001|NOT COMPLETED|Overall Study||14
9784330|NCT00520572|10891045|FG002|NOT COMPLETED|Overall Study||15
9784331|NCT00520572|10891046|FG003|NOT COMPLETED|Overall Study||14
9784332|NCT00520572|10891047|FG004|NOT COMPLETED|Overall Study||12
9784333|NCT00520572|10891048|FG005|NOT COMPLETED|Overall Study||2
9784334|NCT00520676|10891064|FG000|STARTED|Overall Study||128
9784335|NCT00520676|10891065|FG001|STARTED|Overall Study||132
9784336|NCT00520676|10891064|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
9784337|NCT00520676|10891065|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
9784338|NCT00520676|10891064|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
9784339|NCT00520676|10891065|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
9784340|NCT00520676|10891064|FG000|COMPLETED|Overall Study||27
9784341|NCT00520676|10891065|FG001|COMPLETED|Overall Study||29
9784342|NCT00520676|10891064|FG000|NOT COMPLETED|Overall Study||101
9784343|NCT00520676|10891065|FG001|NOT COMPLETED|Overall Study||103
9784344|NCT00520741|10891073|FG000|STARTED|Overall Study||106
9784345|NCT00520741|10891074|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
9784346|NCT00520741|10891073|FG000|COMPLETED|Overall Study||69
9784347|NCT00520741|10891074|FG001|COMPLETED|Overall Study||194
9784348|NCT00520741|10891073|FG000|NOT COMPLETED|Overall Study||37
9784349|NCT00520741|10891074|FG001|NOT COMPLETED|Overall Study||125
9784350|NCT00520845|10891082|FG000|STARTED|Overall Study||23
9784351|NCT00520845|10891082|FG000|COMPLETED|Overall Study||1
9784352|NCT00520845|10891082|FG000|NOT COMPLETED|Overall Study||22
10015084|NCT01803269|11138075|FG002|COMPLETED|Overall Study||14
10015085|NCT01803269|11138073|FG000|NOT COMPLETED|Overall Study||3
9784353|NCT00520884|10891088|FG000|STARTED|Overall Study||3
9784354|NCT00520884|10891089|FG001|STARTED|Overall Study||2
9784355|NCT00520884|10891090|FG002|STARTED|Overall Study||2
9784356|NCT00520884|10891091|FG003|STARTED|Overall Study||3
9784357|NCT00520884|10891088|FG000|COMPLETED|Overall Study||3
9784358|NCT00520884|10891089|FG001|COMPLETED|Overall Study||2
9784359|NCT00520884|10891090|FG002|COMPLETED|Overall Study||2
9784360|NCT00520884|10891091|FG003|COMPLETED|Overall Study||3
9784361|NCT00520884|10891088|FG000|NOT COMPLETED|Overall Study||0
9784362|NCT00520884|10891089|FG001|NOT COMPLETED|Overall Study||0
10015086|NCT01803269|11138074|FG001|NOT COMPLETED|Overall Study||0
10015087|NCT01803269|11138075|FG002|NOT COMPLETED|Overall Study||0
10015088|NCT01803282|11138095|FG000|STARTED|Overall Study||4
10015089|NCT01803282|11138096|FG001|STARTED|Overall Study||3
10015090|NCT01803282|11138097|FG002|STARTED|Overall Study||6
10015091|NCT01803282|11138098|FG003|STARTED|Overall Study||36
10015092|NCT01803282|11138099|FG004|STARTED|Overall Study||11
10015093|NCT01803282|11138100|FG005|STARTED|Overall Study||10
10015094|NCT01803282|11138101|FG006|STARTED|Overall Study||41
10015095|NCT01803282|11138102|FG007|STARTED|Overall Study||46
10015096|NCT01803282|11138103|FG008|STARTED|Overall Study||11
10015097|NCT01803282|11138104|FG009|STARTED|Overall Study||45
10015098|NCT01803282|11138105|FG010|STARTED|Overall Study||8
10015099|NCT01803282|11138106|FG011|STARTED|Overall Study||15
10015100|NCT01803282|11138095|FG000|COMPLETED|Overall Study||0
10015101|NCT01803282|11138096|FG001|COMPLETED|Overall Study||0
10015102|NCT01803282|11138097|FG002|COMPLETED|Overall Study||0
10015103|NCT01803282|11138098|FG003|COMPLETED|Overall Study||0
10015104|NCT01803282|11138099|FG004|COMPLETED|Overall Study||0
10015105|NCT01803282|11138100|FG005|COMPLETED|Overall Study||0
10015106|NCT01803282|11138101|FG006|COMPLETED|Overall Study||0
10015107|NCT01803282|11138102|FG007|COMPLETED|Overall Study||0
10015108|NCT01803282|11138103|FG008|COMPLETED|Overall Study||0
10015109|NCT01803282|11138104|FG009|COMPLETED|Overall Study||0
10015110|NCT01803282|11138105|FG010|COMPLETED|Overall Study||0
10015111|NCT01803282|11138106|FG011|COMPLETED|Overall Study||0
9784363|NCT00520884|10891090|FG002|NOT COMPLETED|Overall Study||0
9784364|NCT00520884|10891091|FG003|NOT COMPLETED|Overall Study||0
9784365|NCT00520910|10891100|FG000|STARTED|Overall Study||5
10015112|NCT01803282|11138095|FG000|NOT COMPLETED|Overall Study||4
10015113|NCT01803282|11138096|FG001|NOT COMPLETED|Overall Study||3
10015114|NCT01803282|11138097|FG002|NOT COMPLETED|Overall Study||6
10015115|NCT01803282|11138098|FG003|NOT COMPLETED|Overall Study||36
10015116|NCT01803282|11138099|FG004|NOT COMPLETED|Overall Study||11
10015117|NCT01803282|11138100|FG005|NOT COMPLETED|Overall Study||10
10015118|NCT01803282|11138101|FG006|NOT COMPLETED|Overall Study||41
10015119|NCT01803282|11138102|FG007|NOT COMPLETED|Overall Study||46
9784366|NCT00520910|10891101|FG001|STARTED|Overall Study||5
9784367|NCT00520910|10891100|FG000|COMPLETED|Overall Study||5
9784368|NCT00520910|10891101|FG001|COMPLETED|Overall Study||5
9784369|NCT00520910|10891100|FG000|NOT COMPLETED|Overall Study||0
9784370|NCT00520910|10891101|FG001|NOT COMPLETED|Overall Study||0
9784371|NCT00520936|10891115|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
9784372|NCT00520936|10891116|FG001|STARTED|Overall Study||11
9784373|NCT00520936|10891117|FG002|STARTED|Overall Study||9
9784374|NCT00520936|10891118|FG003|STARTED|Overall Study||5
9784375|NCT00520936|10891119|FG004|STARTED|Overall Study||6
9784376|NCT00520936|10891120|FG005|STARTED|Overall Study||10
9784377|NCT00520936|10891121|FG006|STARTED|Overall Study||11
9784378|NCT00520936|10891122|FG007|STARTED|Overall Study||10
9784379|NCT00520936|10891115|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
9784380|NCT00520936|10891116|FG001|COMPLETED|Overall Study||7
9784381|NCT00520936|10891117|FG002|COMPLETED|Overall Study||7
9784382|NCT00520936|10891118|FG003|COMPLETED|Overall Study||5
9784383|NCT00520936|10891119|FG004|COMPLETED|Overall Study||5
9784384|NCT00520936|10891120|FG005|COMPLETED|Overall Study||10
9784385|NCT00520936|10891121|FG006|COMPLETED|Overall Study||7
9784386|NCT00520936|10891122|FG007|COMPLETED|Overall Study||9
9784387|NCT00520936|10891115|FG000|NOT COMPLETED|Overall Study||0
9784388|NCT00520936|10891116|FG001|NOT COMPLETED|Overall Study||4
9784389|NCT00520936|10891117|FG002|NOT COMPLETED|Overall Study||2
9784390|NCT00520936|10891118|FG003|NOT COMPLETED|Overall Study||0
9784391|NCT00520936|10891119|FG004|NOT COMPLETED|Overall Study||1
9784392|NCT00520936|10891120|FG005|NOT COMPLETED|Overall Study||0
9784393|NCT00520936|10891121|FG006|NOT COMPLETED|Overall Study||4
9784394|NCT00520936|10891122|FG007|NOT COMPLETED|Overall Study||1
9784395|NCT00520975|10891135|FG000|STARTED|Overall Study||48
9784396|NCT00520975|10891136|FG001|STARTED|Overall Study||48
9784397|NCT00520975|10891135|FG000|Treated and Reported Adverse Events Data|Overall Study||47
9784398|NCT00520975|10891136|FG001|Treated and Reported Adverse Events Data|Overall Study||45
9784399|NCT00520975|10891135|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
9784400|NCT00520975|10891136|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
9784401|NCT00520975|10891135|FG000|NOT COMPLETED|Overall Study||48
9784402|NCT00520975|10891136|FG001|NOT COMPLETED|Overall Study||48
9784403|NCT00521001|10891142|FG000|STARTED|Overall Study||49
9784404|NCT00521001|10891142|FG000|COMPLETED|Overall Study||48
9784405|NCT00521001|10891142|FG000|NOT COMPLETED|Overall Study||1
9784406|NCT00521014|10891146|FG000|STARTED|Overall Study||14
9784407|NCT00521014|10891146|FG000|COMPLETED|Overall Study||13
10015120|NCT01803282|11138103|FG008|NOT COMPLETED|Overall Study||11
10015121|NCT01803282|11138104|FG009|NOT COMPLETED|Overall Study||45
10015122|NCT01803282|11138105|FG010|NOT COMPLETED|Overall Study||8
10015123|NCT01803282|11138106|FG011|NOT COMPLETED|Overall Study||15
10015124|NCT01803464|11138136|FG000|STARTED|Overall Study||5
10015125|NCT01803464|11138137|FG001|STARTED|Overall Study||4
10015126|NCT01803464|11138138|FG002|STARTED|Overall Study||10
10015127|NCT01803464|11138139|FG003|STARTED|Overall Study||10
10015128|NCT01803464|11138136|FG000|COMPLETED|Overall Study||4
10015129|NCT01803464|11138137|FG001|COMPLETED|Overall Study||4
9784408|NCT00521014|10891146|FG000|NOT COMPLETED|Overall Study||1
9784409|NCT00521053|10891150|FG000|STARTED|Treatment Phase||80
9784410|NCT00521053|10891150|FG000|Received 1 Cycle of PV-10|Treatment Phase||35
9784411|NCT00521053|10891150|FG000|Received 2 Cycles of PV-10|Treatment Phase||26
9784412|NCT00521053|10891150|FG000|Received 3 Cycles of PV-10|Treatment Phase||16
9784413|NCT00521053|10891150|FG000|Received 4 Cycles of PV-10|Treatment Phase||3
9784414|NCT00521053|10891150|FG000|COMPLETED|Treatment Phase||80
9784415|NCT00521053|10891150|FG000|NOT COMPLETED|Treatment Phase||0
9784416|NCT00521053|10891150|FG000|STARTED|Observation Phase||80
9784417|NCT00521053|10891150|FG000|COMPLETED|Observation Phase||12
9784418|NCT00521053|10891150|FG000|NOT COMPLETED|Observation Phase||68
9784419|NCT00521079|10891159|FG000|STARTED|Overall Study||192
9784420|NCT00521079|10891160|FG001|STARTED|Overall Study||102
9784421|NCT00521079|10891159|FG000|Surgical Roll-In|Overall Study||9
9784422|NCT00521079|10891160|FG001|Surgical Roll-In|Overall Study||5
9784423|NCT00521079|10891159|FG000|COMPLETED|Overall Study||178
9784424|NCT00521079|10891160|FG001|COMPLETED|Overall Study||97
9784425|NCT00521079|10891159|FG000|NOT COMPLETED|Overall Study||14
9784426|NCT00521079|10891160|FG001|NOT COMPLETED|Overall Study||5
9784427|NCT00521144|10891171|FG000|STARTED|Overall Study||6
9784428|NCT00521144|10891172|FG001|STARTED|Overall Study||5
9784429|NCT00521144|10891173|FG002|STARTED|Overall Study||3
9784430|NCT00521144|10891174|FG003|STARTED|Overall Study||1
9784431|NCT00521144|10891175|FG004|STARTED|Overall Study||7
9784432|NCT00521144|10891171|FG000|COMPLETED|Overall Study||2
9784433|NCT00521144|10891172|FG001|COMPLETED|Overall Study||2
9784434|NCT00521144|10891173|FG002|COMPLETED|Overall Study||1
9784435|NCT00521144|10891174|FG003|COMPLETED|Overall Study||0
9784436|NCT00521144|10891175|FG004|COMPLETED|Overall Study||0
9784437|NCT00521144|10891171|FG000|NOT COMPLETED|Overall Study||4
9784438|NCT00521144|10891172|FG001|NOT COMPLETED|Overall Study||3
9784439|NCT00521144|10891173|FG002|NOT COMPLETED|Overall Study||2
9784440|NCT00521144|10891174|FG003|NOT COMPLETED|Overall Study||1
9784441|NCT00521144|10891175|FG004|NOT COMPLETED|Overall Study||7
9784442|NCT00521339|10891187|FG000|STARTED|Treatment Phase||31
9784443|NCT00521339|10891188|FG001|STARTED|Treatment Phase||0
9784444|NCT00521339|10891189|FG002|STARTED|Treatment Phase||0
9784445|NCT00521339|10891187|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
9784446|NCT00521339|10891188|FG001|Received Apremilast|Treatment Phase||0
9784447|NCT00521339|10891189|FG002|Received Apremilast|Treatment Phase||0
9784448|NCT00521339|10891187|FG000|COMPLETED|Treatment Phase||19
9784449|NCT00521339|10891188|FG001|COMPLETED|Treatment Phase||0
9784450|NCT00521339|10891189|FG002|COMPLETED|Treatment Phase||0
9784451|NCT00521339|10891187|FG000|NOT COMPLETED|Treatment Phase||12
9784452|NCT00521339|10891188|FG001|NOT COMPLETED|Treatment Phase||0
9784453|NCT00521339|10891189|FG002|NOT COMPLETED|Treatment Phase||0
9784454|NCT00521339|10891187|FG000|STARTED|Treatment Extension Phase||0
9784455|NCT00521339|10891188|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
9784456|NCT00521339|10891189|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
9784457|NCT00521339|10891187|FG000|COMPLETED|Treatment Extension Phase||0
9784458|NCT00521339|10891188|FG001|COMPLETED|Treatment Extension Phase||4
9784459|NCT00521339|10891189|FG002|COMPLETED|Treatment Extension Phase||4
9784460|NCT00521339|10891187|FG000|NOT COMPLETED|Treatment Extension Phase||0
9784461|NCT00521339|10891188|FG001|NOT COMPLETED|Treatment Extension Phase||0
9784462|NCT00521339|10891189|FG002|NOT COMPLETED|Treatment Extension Phase||3
9784463|NCT00521339|10891187|FG000|STARTED|Observational Follow Up Phase||14
9784464|NCT00521339|10891188|FG001|STARTED|Observational Follow Up Phase||4
9784465|NCT00521339|10891189|FG002|STARTED|Observational Follow Up Phase||4
9784466|NCT00521339|10891187|FG000|COMPLETED|Observational Follow Up Phase||14
9784467|NCT00521339|10891188|FG001|COMPLETED|Observational Follow Up Phase||4
9784468|NCT00521339|10891189|FG002|COMPLETED|Observational Follow Up Phase||4
9784469|NCT00521339|10891187|FG000|NOT COMPLETED|Observational Follow Up Phase||0
9784470|NCT00521339|10891188|FG001|NOT COMPLETED|Observational Follow Up Phase||0
9784471|NCT00521339|10891189|FG002|NOT COMPLETED|Observational Follow Up Phase||0
9784472|NCT00521352|10891212|FG000|STARTED|Overall Study||12
9784473|NCT00521352|10891213|FG001|STARTED|Overall Study||13
9784474|NCT00521352|10891212|FG000|COMPLETED|Overall Study||11
9784475|NCT00521352|10891213|FG001|COMPLETED|Overall Study||10
9784476|NCT00521352|10891212|FG000|NOT COMPLETED|Overall Study||1
9784477|NCT00521352|10891213|FG001|NOT COMPLETED|Overall Study||3
9784478|NCT00521365|10891219|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
9784479|NCT00521365|10891219|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
9784480|NCT00521365|10891219|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
9784481|NCT00521365|10891219|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88
9784482|NCT00521365|10891219|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
9784483|NCT00521365|10891219|FG000|NOT COMPLETED|Overall Study||20
9784484|NCT00521404|10891223|FG000|STARTED|Overall Study||62
9784485|NCT00521404|10891223|FG000|COMPLETED|Overall Study||0
9784486|NCT00521404|10891223|FG000|NOT COMPLETED|Overall Study||62
9784487|NCT00521456|10891229|FG000|STARTED|Overall Study||176
9784488|NCT00521456|10891230|FG001|STARTED|Overall Study||87
9784489|NCT00521456|10891229|FG000|COMPLETED|Overall Study||163
9784490|NCT00521456|10891230|FG001|COMPLETED|Overall Study||59
9784491|NCT00521456|10891229|FG000|NOT COMPLETED|Overall Study||13
9784492|NCT00521456|10891230|FG001|NOT COMPLETED|Overall Study||28
9784493|NCT00521586|10891238|FG000|STARTED|Initial Vaccination (Year 0)||554
9784494|NCT00521586|10891239|FG001|STARTED|Initial Vaccination (Year 0)||562
9784495|NCT00521586|10891238|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
9784496|NCT00521586|10891239|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
9784497|NCT00521586|10891238|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
9784498|NCT00521586|10891239|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
9784499|NCT00521586|10891238|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
9784500|NCT00521586|10891239|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
9784501|NCT00521586|10891238|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
9784502|NCT00521586|10891239|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
9784503|NCT00521586|10891238|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21
9784504|NCT00521586|10891239|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29
9784505|NCT00521586|10891238|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
9784506|NCT00521586|10891239|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
9784507|NCT00521586|10891238|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
9784508|NCT00521586|10891239|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
9784509|NCT00521586|10891238|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
9784510|NCT00521586|10891239|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
9784511|NCT00521586|10891238|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364
9784512|NCT00521586|10891239|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363
9784513|NCT00521586|10891238|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
9784514|NCT00521586|10891239|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
9784515|NCT00521586|10891238|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
9784516|NCT00521586|10891239|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
9784517|NCT00521586|10891238|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
9784518|NCT00521586|10891239|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
9784519|NCT00521586|10891238|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361
9784520|NCT00521586|10891239|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351
9784521|NCT00521586|10891238|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
9784522|NCT00521586|10891239|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
9784523|NCT00521976|10891257|FG000|STARTED|Overall Study||871
9784524|NCT00521976|10891257|FG000|COMPLETED|Overall Study||871
9784525|NCT00521976|10891257|FG000|NOT COMPLETED|Overall Study||0
9784526|NCT00521989|10891266|FG000|STARTED|Overall Study||56
9784527|NCT00521989|10891267|FG001|STARTED|Overall Study||54
9784528|NCT00521989|10891268|FG002|STARTED|Overall Study||57
9784529|NCT00521989|10891269|FG003|STARTED|Overall Study||54
9784530|NCT00521989|10891270|FG004|STARTED|Overall Study||58
9784531|NCT00521989|10891266|FG000|COMPLETED|Overall Study||36
9784532|NCT00521989|10891267|FG001|COMPLETED|Overall Study||37
9784533|NCT00521989|10891268|FG002|COMPLETED|Overall Study||41
9784534|NCT00521989|10891269|FG003|COMPLETED|Overall Study||42
9784535|NCT00521989|10891270|FG004|COMPLETED|Overall Study||35
9784536|NCT00521989|10891266|FG000|NOT COMPLETED|Overall Study||20
9784537|NCT00521989|10891267|FG001|NOT COMPLETED|Overall Study||17
9784538|NCT00521989|10891268|FG002|NOT COMPLETED|Overall Study||16
9784539|NCT00521989|10891269|FG003|NOT COMPLETED|Overall Study||12
9784540|NCT00521989|10891270|FG004|NOT COMPLETED|Overall Study||23
9784541|NCT00522041|10891284|FG000|STARTED|Overall Study||123
9784542|NCT00522041|10891285|FG001|STARTED|Overall Study||125
9784543|NCT00522041|10891284|FG000|Received Treatment|Overall Study||123
9784544|NCT00522041|10891285|FG001|Received Treatment|Overall Study||124
9784545|NCT00522041|10891284|FG000|COMPLETED|Overall Study||106
9784546|NCT00522041|10891285|FG001|COMPLETED|Overall Study||113
9784547|NCT00522041|10891284|FG000|NOT COMPLETED|Overall Study||17
9784548|NCT00522041|10891285|FG001|NOT COMPLETED|Overall Study||12
9784549|NCT00522171|10891294|FG000|STARTED|Overall Study||15
9784550|NCT00522171|10891295|FG001|STARTED|Overall Study||15
9784551|NCT00522171|10891294|FG000|COMPLETED|Overall Study||15
9784552|NCT00522171|10891295|FG001|COMPLETED|Overall Study||15
9784553|NCT00522171|10891294|FG000|NOT COMPLETED|Overall Study||0
10015130|NCT01803464|11138138|FG002|COMPLETED|Overall Study||6
10015131|NCT01803464|11138139|FG003|COMPLETED|Overall Study||10
10015132|NCT01803464|11138136|FG000|NOT COMPLETED|Overall Study||1
10015133|NCT01803464|11138137|FG001|NOT COMPLETED|Overall Study||0
10015134|NCT01803464|11138138|FG002|NOT COMPLETED|Overall Study||4
10015135|NCT01803464|11138139|FG003|NOT COMPLETED|Overall Study||0
10015136|NCT01803607|11138155|FG000|STARTED|Overall Study||68
10015137|NCT01803607|11138156|FG001|STARTED|Overall Study||67
10015138|NCT01803607|11138155|FG000|COMPLETED|Overall Study||0
10015139|NCT01803607|11138156|FG001|COMPLETED|Overall Study||0
10015140|NCT01803607|11138155|FG000|NOT COMPLETED|Overall Study||68
10015141|NCT01803607|11138156|FG001|NOT COMPLETED|Overall Study||67
10015142|NCT01803646|11138164|FG000|STARTED|Overall Study||204
10015143|NCT01803646|11138165|FG001|STARTED|Overall Study||139
10015144|NCT01803646|11138164|FG000|COMPLETED|Overall Study||187
10015145|NCT01803646|11138165|FG001|COMPLETED|Overall Study||129
10015146|NCT01803646|11138164|FG000|NOT COMPLETED|Overall Study||17
10015147|NCT01803646|11138165|FG001|NOT COMPLETED|Overall Study||10
10015148|NCT01803737|11138173|FG000|STARTED|Overall Study||13
10015149|NCT01803737|11138174|FG001|STARTED|Overall Study||13
10015150|NCT01803737|11138173|FG000|COMPLETED|Overall Study||12
9784554|NCT00522171|10891295|FG001|NOT COMPLETED|Overall Study||0
9784555|NCT00522275|10891301|FG000|STARTED|Overall Study||308
9784556|NCT00522275|10891301|FG000|COMPLETED|Overall Study||138
9784557|NCT00522275|10891301|FG000|NOT COMPLETED|Overall Study||170
9784558|NCT00522379|10891310|FG000|STARTED|Overall Study||101
9784559|NCT00522379|10891311|FG001|STARTED|Overall Study||107
9784560|NCT00522379|10891312|FG002|STARTED|Overall Study||104
9784561|NCT00522379|10891313|FG003|STARTED|Overall Study||94
9784562|NCT00522379|10891314|FG004|STARTED|Overall Study||108
9784563|NCT00522379|10891310|FG000|COMPLETED|Overall Study||79
9784564|NCT00522379|10891311|FG001|COMPLETED|Overall Study||84
9784565|NCT00522379|10891312|FG002|COMPLETED|Overall Study||82
9784566|NCT00522379|10891313|FG003|COMPLETED|Overall Study||80
9784567|NCT00522379|10891314|FG004|COMPLETED|Overall Study||81
9784568|NCT00522379|10891310|FG000|NOT COMPLETED|Overall Study||22
9784569|NCT00522379|10891311|FG001|NOT COMPLETED|Overall Study||23
9784570|NCT00522379|10891312|FG002|NOT COMPLETED|Overall Study||22
9784571|NCT00522379|10891313|FG003|NOT COMPLETED|Overall Study||14
9784572|NCT00522379|10891314|FG004|NOT COMPLETED|Overall Study||27
9784573|NCT00522392|10891328|FG000|STARTED|Overall Study||23
9784574|NCT00522392|10891329|FG001|STARTED|Overall Study||25
9784575|NCT00522392|10891328|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16
9784576|NCT00522392|10891329|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16
9784577|NCT00522392|10891328|FG000|Pts w/ QOL Assessments Complete|Overall Study||12
9784578|NCT00522392|10891329|FG001|Pts w/ QOL Assessments Complete|Overall Study||8
9784579|NCT00522392|10891328|FG000|COMPLETED|Overall Study||15
9784580|NCT00522392|10891329|FG001|COMPLETED|Overall Study||12
9784581|NCT00522392|10891328|FG000|NOT COMPLETED|Overall Study||8
9784582|NCT00522392|10891329|FG001|NOT COMPLETED|Overall Study||13
9784583|NCT00522418|10891337|FG000|STARTED|Overall Study||59
9784584|NCT00522418|10891338|FG001|STARTED|Overall Study||63
9784585|NCT00522418|10891337|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
9784586|NCT00522418|10891338|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
9784587|NCT00522418|10891337|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
9784588|NCT00522418|10891338|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
9784589|NCT00522418|10891337|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
9784590|NCT00522418|10891338|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
9784591|NCT00522418|10891337|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
9784592|NCT00522418|10891338|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
9784593|NCT00522418|10891337|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
9784594|NCT00522418|10891338|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
9784595|NCT00522418|10891337|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
9784596|NCT00522418|10891338|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
9784597|NCT00522418|10891337|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2
9784598|NCT00522418|10891338|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5
9784599|NCT00522418|10891337|FG000|NOT COMPLETED|Overall Study||57
9784600|NCT00522418|10891338|FG001|NOT COMPLETED|Overall Study||58
9784601|NCT00522431|10891346|FG000|STARTED|Overall Study||149
9784602|NCT00522431|10891346|FG000|COMPLETED|Overall Study||138
9784603|NCT00522431|10891346|FG000|NOT COMPLETED|Overall Study||11
9784604|NCT00522548|10891352|FG000|STARTED|Overall Study||18
9784605|NCT00522548|10891353|FG001|STARTED|Overall Study||19
9784606|NCT00522548|10891352|FG000|Consented to Pharmacokinetic Study|Overall Study||11
9784607|NCT00522548|10891353|FG001|Consented to Pharmacokinetic Study|Overall Study||10
9784608|NCT00522548|10891352|FG000|Completed 0/2 PK Visits|Overall Study||3
9784609|NCT00522548|10891353|FG001|Completed 0/2 PK Visits|Overall Study||4
9784610|NCT00522548|10891352|FG000|Completed 1/2 PK Visits|Overall Study||1
9784611|NCT00522548|10891353|FG001|Completed 1/2 PK Visits|Overall Study||1
9784612|NCT00522548|10891352|FG000|Completed 2/2 PK Visits|Overall Study||7
9784613|NCT00522548|10891353|FG001|Completed 2/2 PK Visits|Overall Study||5
9784614|NCT00522548|10891352|FG000|COMPLETED|Overall Study||16
9784615|NCT00522548|10891353|FG001|COMPLETED|Overall Study||15
9784616|NCT00522548|10891352|FG000|NOT COMPLETED|Overall Study||2
9784617|NCT00522548|10891353|FG001|NOT COMPLETED|Overall Study||4
9784618|NCT00522626|10891359|FG000|STARTED|Overall Study||19
9784619|NCT00522626|10891359|FG000|COMPLETED|Overall Study||12
9784620|NCT00522626|10891359|FG000|NOT COMPLETED|Overall Study||7
9784621|NCT00522795|10891363|FG000|STARTED|Overall Study||40
9784622|NCT00522795|10891363|FG000|COMPLETED|Overall Study||40
9784623|NCT00522795|10891363|FG000|NOT COMPLETED|Overall Study||0
9784624|NCT00522873|10891369|FG000|STARTED|Overall Study||490
9784625|NCT00522873|10891370|FG001|STARTED|Overall Study||172
10015151|NCT01803737|11138174|FG001|COMPLETED|Overall Study||10
10015152|NCT01803737|11138173|FG000|NOT COMPLETED|Overall Study||1
9784626|NCT00522873|10891369|FG000|Received Treatment|Overall Study||489
9784627|NCT00522873|10891370|FG001|Received Treatment|Overall Study||172
9784628|NCT00522873|10891369|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
9784629|NCT00522873|10891370|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
9784630|NCT00522873|10891369|FG000|NOT COMPLETED|Overall Study||96
9784631|NCT00522873|10891370|FG001|NOT COMPLETED|Overall Study||44
9784632|NCT00522925|10891379|FG000|STARTED|Overall Study||36
9784633|NCT00522925|10891380|FG001|STARTED|Overall Study||39
9784634|NCT00522925|10891381|FG002|STARTED|Overall Study||38
9784635|NCT00522925|10891379|FG000|COMPLETED|Overall Study||28
9784636|NCT00522925|10891380|FG001|COMPLETED|Overall Study||38
9784637|NCT00522925|10891381|FG002|COMPLETED|Overall Study||36
9784638|NCT00522925|10891379|FG000|NOT COMPLETED|Overall Study||8
9784639|NCT00522925|10891380|FG001|NOT COMPLETED|Overall Study||1
9784640|NCT00522925|10891381|FG002|NOT COMPLETED|Overall Study||2
9784641|NCT00522951|10891389|FG000|STARTED|Period 1||86
9784642|NCT00522951|10891390|FG001|STARTED|Period 1||79
9784643|NCT00522951|10891389|FG000|Received Treatment|Period 1||86
9784644|NCT00522951|10891390|FG001|Received Treatment|Period 1||78
9784645|NCT00522951|10891389|FG000|COMPLETED|Period 1||86
9784646|NCT00522951|10891390|FG001|COMPLETED|Period 1||78
9784647|NCT00522951|10891389|FG000|NOT COMPLETED|Period 1||0
9784648|NCT00522951|10891390|FG001|NOT COMPLETED|Period 1||1
9784649|NCT00522951|10891389|FG000|STARTED|Washout Period||86
9784650|NCT00522951|10891390|FG001|STARTED|Washout Period||78
9784651|NCT00522951|10891389|FG000|COMPLETED|Washout Period||86
9784652|NCT00522951|10891390|FG001|COMPLETED|Washout Period||76
9784653|NCT00522951|10891389|FG000|NOT COMPLETED|Washout Period||0
9784654|NCT00522951|10891390|FG001|NOT COMPLETED|Washout Period||2
9784655|NCT00522951|10891389|FG000|STARTED|Period 2||86
9784656|NCT00522951|10891390|FG001|STARTED|Period 2||76
9784657|NCT00522951|10891389|FG000|Subjects Received Treatment|Period 2||84
9784658|NCT00522951|10891390|FG001|Subjects Received Treatment|Period 2||75
9784659|NCT00522951|10891389|FG000|COMPLETED|Period 2||84
9784660|NCT00522951|10891390|FG001|COMPLETED|Period 2||75
9784661|NCT00522951|10891389|FG000|NOT COMPLETED|Period 2||2
9784662|NCT00522951|10891390|FG001|NOT COMPLETED|Period 2||1
9784663|NCT00523237|10891400|FG000|STARTED|Overall Study||14
9784664|NCT00523237|10891400|FG000|COMPLETED|Overall Study||14
9784665|NCT00523237|10891400|FG000|NOT COMPLETED|Overall Study||0
9784666|NCT00523302|10891406|FG000|STARTED|Overall Study||10
9784667|NCT00523302|10891407|FG001|STARTED|Overall Study||10
9784668|NCT00523302|10891406|FG000|COMPLETED|Overall Study||10
9784669|NCT00523302|10891407|FG001|COMPLETED|Overall Study||10
9784670|NCT00523302|10891406|FG000|NOT COMPLETED|Overall Study||0
9784671|NCT00523302|10891407|FG001|NOT COMPLETED|Overall Study||0
9784672|NCT00523341|10891415|FG000|STARTED|Overall Study||2207
9784673|NCT00523341|10891416|FG001|STARTED|Overall Study||2343
9784674|NCT00523341|10891415|FG000|Received Treatment|Overall Study||2206
9784675|NCT00523341|10891416|FG001|Received Treatment|Overall Study||2343
9784676|NCT00523341|10891415|FG000|COMPLETED|Overall Study||1283
9784677|NCT00523341|10891416|FG001|COMPLETED|Overall Study||1343
9784678|NCT00523341|10891415|FG000|NOT COMPLETED|Overall Study||924
9784679|NCT00523341|10891416|FG001|NOT COMPLETED|Overall Study||1000
9784680|NCT00523367|10891422|FG000|STARTED|Overall Study||25
9784681|NCT00523367|10891422|FG000|COMPLETED|Overall Study||2
9784682|NCT00523367|10891422|FG000|NOT COMPLETED|Overall Study||23
9784683|NCT00523419|10891426|FG000|STARTED|Overall Study||32
9784684|NCT00523419|10891426|FG000|COMPLETED|Overall Study||0
9784685|NCT00523419|10891426|FG000|NOT COMPLETED|Overall Study||32
9784686|NCT00523549|10891432|FG000|STARTED|Overall Study||114
9784687|NCT00523549|10891433|FG001|STARTED|Overall Study||115
9784688|NCT00523549|10891432|FG000|COMPLETED|Overall Study||95
9784689|NCT00523549|10891433|FG001|COMPLETED|Overall Study||99
9784690|NCT00523549|10891432|FG000|NOT COMPLETED|Overall Study||19
9784691|NCT00523549|10891433|FG001|NOT COMPLETED|Overall Study||16
9784692|NCT00523614|10891441|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
9784693|NCT00523614|10891442|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
9784694|NCT00523614|10891441|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
9784695|NCT00523614|10891442|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
9784696|NCT00523614|10891441|FG000|NOT COMPLETED|Overall Study||0
9784697|NCT00523614|10891442|FG001|NOT COMPLETED|Overall Study||0
9784698|NCT00523640|10891448|FG000|STARTED|Overall Study||30
9784699|NCT00523640|10891448|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29
9784700|NCT00523640|10891448|FG000|NOT COMPLETED|Overall Study||1
9784701|NCT00523705|10891454|FG000|STARTED|Overall Study||7
9784702|NCT00523705|10891455|FG001|STARTED|Overall Study||4
9784703|NCT00523705|10891454|FG000|COMPLETED|Overall Study||7
9784704|NCT00523705|10891455|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3
9784705|NCT00523705|10891454|FG000|NOT COMPLETED|Overall Study||0
9784706|NCT00523705|10891455|FG001|NOT COMPLETED|Overall Study||1
9784707|NCT00523718|10891463|FG000|STARTED|Overall Study||20
9784708|NCT00523718|10891464|FG001|STARTED|Overall Study||18
9784709|NCT00523718|10891463|FG000|COMPLETED|Overall Study||17
9784710|NCT00523718|10891464|FG001|COMPLETED|Overall Study||18
9784711|NCT00523718|10891463|FG000|NOT COMPLETED|Overall Study||3
9784712|NCT00523718|10891464|FG001|NOT COMPLETED|Overall Study||0
9784713|NCT00523744|10891470|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257
10015153|NCT01803737|11138174|FG001|NOT COMPLETED|Overall Study||3
10015154|NCT01803880|11138183|FG000|STARTED|Overall Study||19
10015155|NCT01803880|11138184|FG001|STARTED|Overall Study||28
10015156|NCT01803880|11138185|FG002|STARTED|Overall Study||29
9784714|NCT00523744|10891470|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
9784715|NCT00523744|10891470|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
9784716|NCT00523744|10891470|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
9784717|NCT00523744|10891470|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
9784718|NCT00523744|10891470|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
9784719|NCT00523744|10891470|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
9784720|NCT00523744|10891470|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
9784721|NCT00523744|10891470|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
9784722|NCT00523848|10891477|FG000|STARTED|Overall Study||46
9784723|NCT00523848|10891477|FG000|Treated With Study Therapy|Overall Study||44
9784724|NCT00523848|10891477|FG000|COMPLETED|Overall Study||22
9784725|NCT00523848|10891477|FG000|NOT COMPLETED|Overall Study||24
9784726|NCT00523978|10891483|FG000|STARTED|Overall Study||171
9784727|NCT00523978|10891484|FG001|STARTED|Overall Study||87
9784728|NCT00523978|10891483|FG000|COMPLETED|Overall Study||162
9784729|NCT00523978|10891484|FG001|COMPLETED|Overall Study||79
9784730|NCT00523978|10891483|FG000|NOT COMPLETED|Overall Study||9
9784731|NCT00523978|10891484|FG001|NOT COMPLETED|Overall Study||8
9784732|NCT00523991|10891493|FG000|STARTED|Overall Study||219
9784733|NCT00523991|10891494|FG001|STARTED|Overall Study||238
9784734|NCT00523991|10891493|FG000|COMPLETED|Overall Study||198
9784735|NCT00523991|10891494|FG001|COMPLETED|Overall Study||211
9784736|NCT00523991|10891493|FG000|NOT COMPLETED|Overall Study||21
9784737|NCT00523991|10891494|FG001|NOT COMPLETED|Overall Study||27
9784738|NCT00524017|10891502|FG000|STARTED|Overall Study||13
9784739|NCT00524017|10891503|FG001|STARTED|Overall Study||6
9784740|NCT00524017|10891502|FG000|COMPLETED|Overall Study||13
9784741|NCT00524017|10891503|FG001|COMPLETED|Overall Study||5
9784742|NCT00524017|10891502|FG000|NOT COMPLETED|Overall Study||0
9784743|NCT00524017|10891503|FG001|NOT COMPLETED|Overall Study||1
9784744|NCT00524030|10891511|FG000|STARTED|Overall Study||32
9784745|NCT00524030|10891512|FG001|STARTED|Overall Study||129
9784746|NCT00524030|10891511|FG000|Completed Double-Blind Treatment Phase|Overall Study||15
9784747|NCT00524030|10891512|FG001|Completed Double-Blind Treatment Phase|Overall Study||70
9784748|NCT00524030|10891511|FG000|Completed Taper/Titration Phase|Overall Study||15
9784749|NCT00524030|10891512|FG001|Completed Taper/Titration Phase|Overall Study||70
9784750|NCT00524030|10891511|FG000|COMPLETED|Overall Study||15
9784751|NCT00524030|10891512|FG001|COMPLETED|Overall Study||70
9784752|NCT00524030|10891511|FG000|NOT COMPLETED|Overall Study||17
9784753|NCT00524030|10891512|FG001|NOT COMPLETED|Overall Study||59
9784754|NCT00524043|10891522|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
9784755|NCT00524043|10891523|FG001|STARTED|Overall Study||70
9784756|NCT00524043|10891524|FG002|STARTED|Overall Study||66
9784757|NCT00524043|10891522|FG000|COMPLETED|Overall Study||34
9784758|NCT00524043|10891523|FG001|COMPLETED|Overall Study||42
9784759|NCT00524043|10891524|FG002|COMPLETED|Overall Study||35
9784760|NCT00524043|10891522|FG000|NOT COMPLETED|Overall Study||30
9784761|NCT00524043|10891523|FG001|NOT COMPLETED|Overall Study||28
9784762|NCT00524043|10891524|FG002|NOT COMPLETED|Overall Study||31
9784763|NCT00524121|10891532|FG000|STARTED|Overall Study||22
9784764|NCT00524121|10891532|FG000|COMPLETED|Overall Study||3
9784765|NCT00524121|10891532|FG000|NOT COMPLETED|Overall Study||19
9784766|NCT00524173|10891549|FG000|STARTED|Overall Study||17
9784767|NCT00524173|10891550|FG001|STARTED|Overall Study||15
9784768|NCT00524173|10891549|FG000|COMPLETED|Overall Study||12
9784769|NCT00524173|10891550|FG001|COMPLETED|Overall Study||13
9784770|NCT00524173|10891549|FG000|NOT COMPLETED|Overall Study||5
9784771|NCT00524173|10891550|FG001|NOT COMPLETED|Overall Study||2
9784772|NCT00524225|10891556|FG000|STARTED|Overall Study||3
9784773|NCT00524225|10891556|FG000|COMPLETED|Overall Study||3
9784774|NCT00524225|10891556|FG000|NOT COMPLETED|Overall Study||0
9784775|NCT00524264|10891563|FG000|STARTED|Overall Study||164
9784776|NCT00524264|10891564|FG001|STARTED|Overall Study||84
9784777|NCT00524264|10891563|FG000|COMPLETED|Overall Study||144
9784778|NCT00524264|10891564|FG001|COMPLETED|Overall Study||57
10015157|NCT01803880|11138183|FG000|COMPLETED|Overall Study||13
9784779|NCT00524264|10891563|FG000|NOT COMPLETED|Overall Study||20
9784780|NCT00524264|10891564|FG001|NOT COMPLETED|Overall Study||27
9784781|NCT00524303|10891573|FG000|STARTED|Overall Study||33
9784782|NCT00524303|10891574|FG001|STARTED|Overall Study||34
9784783|NCT00524303|10891575|FG002|STARTED|Overall Study||33
9784784|NCT00524303|10891573|FG000|COMPLETED|Overall Study||21
9784785|NCT00524303|10891574|FG001|COMPLETED|Overall Study||24
9784786|NCT00524303|10891575|FG002|COMPLETED|Overall Study||15
9784787|NCT00524303|10891573|FG000|NOT COMPLETED|Overall Study||12
9784788|NCT00524303|10891574|FG001|NOT COMPLETED|Overall Study||10
9784789|NCT00524303|10891575|FG002|NOT COMPLETED|Overall Study||18
9784790|NCT00524316|10891586|FG000|STARTED|Overall Study||16
9784791|NCT00524316|10891586|FG000|COMPLETED|Overall Study||0
9784792|NCT00524316|10891586|FG000|NOT COMPLETED|Overall Study||16
9784793|NCT00524342|10891590|FG000|STARTED|Overall Study||7
9784794|NCT00524342|10891590|FG000|COMPLETED|Overall Study||7
9784795|NCT00524342|10891590|FG000|NOT COMPLETED|Overall Study||0
9784796|NCT00524368|10891596|FG000|STARTED|Overall Study||294
9784797|NCT00524368|10891597|FG001|STARTED|Overall Study||296
9784798|NCT00524368|10891596|FG000|COMPLETED|Overall Study||253
9784799|NCT00524368|10891597|FG001|COMPLETED|Overall Study||248
9784800|NCT00524368|10891596|FG000|NOT COMPLETED|Overall Study||41
9784801|NCT00524368|10891597|FG001|NOT COMPLETED|Overall Study||48
9784802|NCT00524420|10891605|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
9784803|NCT00524420|10891606|FG001|STARTED|Overall Study||11
9784804|NCT00524420|10891605|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
9784805|NCT00524420|10891606|FG001|COMPLETED|Overall Study||11
9784806|NCT00524420|10891605|FG000|NOT COMPLETED|Overall Study||1
9784807|NCT00524420|10891606|FG001|NOT COMPLETED|Overall Study||0
9784808|NCT00524472|10891616|FG000|STARTED|Overall Study||709
9784809|NCT00524472|10891617|FG001|STARTED|Overall Study||730
9784810|NCT00524472|10891616|FG000|COMPLETED|Overall Study||709
9784811|NCT00524472|10891617|FG001|COMPLETED|Overall Study||730
9784812|NCT00524472|10891616|FG000|NOT COMPLETED|Overall Study||0
9784813|NCT00524472|10891617|FG001|NOT COMPLETED|Overall Study||0
9784814|NCT00524537|10891623|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
9784815|NCT00524537|10891623|FG000|Discontinued|Overall Study|Discontinued from study|2811
9784816|NCT00524537|10891623|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
9784817|NCT00524537|10891623|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
9784818|NCT00524537|10891623|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
9784819|NCT00524537|10891623|FG000|NOT COMPLETED|Overall Study||2574
9784820|NCT00524576|10891629|FG000|STARTED|Overall Study||97
9784821|NCT00524576|10891630|FG001|STARTED|Overall Study||47
9784822|NCT00524576|10891629|FG000|COMPLETED|Overall Study||97
9784823|NCT00524576|10891630|FG001|COMPLETED|Overall Study||47
9784824|NCT00524576|10891629|FG000|NOT COMPLETED|Overall Study||0
9784825|NCT00524576|10891630|FG001|NOT COMPLETED|Overall Study||0
9784826|NCT00524589|10891636|FG000|STARTED|Overall Study||18
10234008|NCT01598025|11363890|FG000|NOT COMPLETED|Overall Study||0
10234009|NCT01598025|11363891|FG001|NOT COMPLETED|Overall Study||3
10234010|NCT01587963|11363898|FG000|STARTED|Overall Study||7
10234011|NCT01587963|11363899|FG001|STARTED|Overall Study||4
9784827|NCT00524589|10891636|FG000|COMPLETED|Overall Study||0
9784828|NCT00524589|10891636|FG000|NOT COMPLETED|Overall Study||18
9784829|NCT00524680|10891644|FG000|STARTED|Overall Study||37
9784830|NCT00524680|10891645|FG001|STARTED|Overall Study||35
9784831|NCT00524680|10891646|FG002|STARTED|Overall Study||36
9784832|NCT00524680|10891647|FG003|STARTED|Overall Study||40
9784833|NCT00524680|10891644|FG000|COMPLETED|Overall Study||34
9784834|NCT00524680|10891645|FG001|COMPLETED|Overall Study||34
9784835|NCT00524680|10891646|FG002|COMPLETED|Overall Study||33
9784836|NCT00524680|10891647|FG003|COMPLETED|Overall Study||34
9784837|NCT00524680|10891644|FG000|NOT COMPLETED|Overall Study||3
9784838|NCT00524680|10891645|FG001|NOT COMPLETED|Overall Study||1
9784839|NCT00524680|10891646|FG002|NOT COMPLETED|Overall Study||3
9784840|NCT00524680|10891647|FG003|NOT COMPLETED|Overall Study||6
9784841|NCT00524745|10891661|FG000|STARTED|Overall Study||229
9784842|NCT00524745|10891662|FG001|STARTED|Overall Study||206
9784843|NCT00524745|10891663|FG002|STARTED|Overall Study||241
9784844|NCT00524745|10891664|FG003|STARTED|Overall Study||227
10015158|NCT01803880|11138184|FG001|COMPLETED|Overall Study||18
10015159|NCT01803880|11138185|FG002|COMPLETED|Overall Study||14
10015160|NCT01803880|11138183|FG000|NOT COMPLETED|Overall Study||6
10234012|NCT01587963|11363898|FG000|COMPLETED|Overall Study||6
9784845|NCT00524745|10891661|FG000|COMPLETED|Overall Study||195
9784846|NCT00524745|10891662|FG001|COMPLETED|Overall Study||193
9784847|NCT00524745|10891663|FG002|COMPLETED|Overall Study||212
9784848|NCT00524745|10891664|FG003|COMPLETED|Overall Study||205
9784849|NCT00524745|10891661|FG000|NOT COMPLETED|Overall Study||34
9784850|NCT00524745|10891662|FG001|NOT COMPLETED|Overall Study||13
9784851|NCT00524745|10891663|FG002|NOT COMPLETED|Overall Study||29
9784852|NCT00524745|10891664|FG003|NOT COMPLETED|Overall Study||22
9784853|NCT00524771|10891676|FG000|STARTED|Overall Study||17084
9784854|NCT00524771|10891677|FG001|STARTED|Overall Study||17016
9784855|NCT00524771|10891676|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
9784856|NCT00524771|10891677|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
9784857|NCT00524771|10891676|FG000|NOT COMPLETED|Overall Study||220
9784858|NCT00524771|10891677|FG001|NOT COMPLETED|Overall Study||585
9784859|NCT00524940|10891684|FG000|STARTED|Overall Study||124
9784860|NCT00524940|10891684|FG000|COMPLETED|Overall Study||124
10015161|NCT01803880|11138184|FG001|NOT COMPLETED|Overall Study||10
10234013|NCT01587963|11363899|FG001|COMPLETED|Overall Study||4
9784861|NCT00524940|10891684|FG000|NOT COMPLETED|Overall Study||0
9784862|NCT00525031|10891690|FG000|STARTED|Overall Study||27
9784863|NCT00525031|10891691|FG001|STARTED|Overall Study||25
9784864|NCT00525031|10891690|FG000|COMPLETED|Overall Study||26
9784865|NCT00525031|10891691|FG001|COMPLETED|Overall Study||24
9784866|NCT00525031|10891690|FG000|NOT COMPLETED|Overall Study||1
9784867|NCT00525031|10891691|FG001|NOT COMPLETED|Overall Study||1
9784868|NCT00525044|10891700|FG000|STARTED|Overall Study||124
9784869|NCT00525044|10891701|FG001|STARTED|Overall Study||125
9784870|NCT00525044|10891700|FG000|COMPLETED|Overall Study||124
9784871|NCT00525044|10891701|FG001|COMPLETED|Overall Study||124
9784872|NCT00525044|10891700|FG000|NOT COMPLETED|Overall Study||0
9784873|NCT00525044|10891701|FG001|NOT COMPLETED|Overall Study||1
9784874|NCT00525057|10891709|FG000|STARTED|Overall Study||25
9784875|NCT00525057|10891710|FG001|STARTED|Overall Study||25
9784876|NCT00525057|10891709|FG000|COMPLETED|Overall Study||25
9784877|NCT00525057|10891710|FG001|COMPLETED|Overall Study||25
9784878|NCT00525057|10891709|FG000|NOT COMPLETED|Overall Study||0
9784879|NCT00525057|10891710|FG001|NOT COMPLETED|Overall Study||0
9830387|NCT00762853|10941057|FG001|COMPLETED|Second Treatment Period||10
9830388|NCT00762853|10941056|FG000|NOT COMPLETED|Second Treatment Period||0
9830389|NCT00762853|10941057|FG001|NOT COMPLETED|Second Treatment Period||0
9830390|NCT00762892|10941065|FG000|STARTED|Overall Study||14
9830391|NCT00762892|10941066|FG001|STARTED|Overall Study||14
9830392|NCT00762892|10941065|FG000|COMPLETED|Overall Study||9
9830393|NCT00762892|10941066|FG001|COMPLETED|Overall Study||8
9830394|NCT00762892|10941065|FG000|NOT COMPLETED|Overall Study||5
9830395|NCT00762892|10941066|FG001|NOT COMPLETED|Overall Study||6
9830396|NCT00762931|10941072|FG000|STARTED|Overall Study||25
9830397|NCT00762931|10941072|FG000|COMPLETED|Overall Study||23
9830398|NCT00762931|10941072|FG000|NOT COMPLETED|Overall Study||2
9830399|NCT00762970|10941079|FG000|STARTED|Overall Study||46
9830400|NCT00762970|10941080|FG001|STARTED|Overall Study||44
9830401|NCT00762970|10941081|FG002|STARTED|Overall Study||47
9830402|NCT00762970|10941079|FG000|COMPLETED|Overall Study||34
9830403|NCT00762970|10941080|FG001|COMPLETED|Overall Study||35
9830404|NCT00762970|10941081|FG002|COMPLETED|Overall Study||46
9830405|NCT00762970|10941079|FG000|NOT COMPLETED|Overall Study||12
9830406|NCT00762970|10941080|FG001|NOT COMPLETED|Overall Study||9
9830407|NCT00762970|10941081|FG002|NOT COMPLETED|Overall Study||1
9830408|NCT00762996|10941089|FG000|STARTED|Period One||15
9830409|NCT00762996|10941090|FG001|STARTED|Period One||16
9830410|NCT00762996|10941091|FG002|STARTED|Period One||17
10015162|NCT01803880|11138185|FG002|NOT COMPLETED|Overall Study||15
10015163|NCT01804036|11138197|FG000|STARTED|Overall Study||31
10015164|NCT01804036|11138198|FG001|STARTED|Overall Study||41
10015165|NCT01804036|11138197|FG000|COMPLETED|Overall Study||18
10015166|NCT01804036|11138198|FG001|COMPLETED|Overall Study||21
10015167|NCT01804036|11138197|FG000|NOT COMPLETED|Overall Study||13
10015168|NCT01804036|11138198|FG001|NOT COMPLETED|Overall Study||20
10015169|NCT01804049|11138207|FG000|STARTED|Overall Study||43
9830411|NCT00762996|10941092|FG003|STARTED|Period One||17
9830412|NCT00762996|10941089|FG000|COMPLETED|Period One||15
9830413|NCT00762996|10941090|FG001|COMPLETED|Period One||16
9830414|NCT00762996|10941091|FG002|COMPLETED|Period One||13
9830415|NCT00762996|10941092|FG003|COMPLETED|Period One||16
9830416|NCT00762996|10941089|FG000|NOT COMPLETED|Period One||0
9830417|NCT00762996|10941090|FG001|NOT COMPLETED|Period One||0
9830418|NCT00762996|10941091|FG002|NOT COMPLETED|Period One||4
9830419|NCT00762996|10941092|FG003|NOT COMPLETED|Period One||1
9830420|NCT00762996|10941089|FG000|STARTED|Period Two||15
9830421|NCT00762996|10941090|FG001|STARTED|Period Two||16
9830422|NCT00762996|10941091|FG002|STARTED|Period Two||13
9830423|NCT00762996|10941092|FG003|STARTED|Period Two||16
10015170|NCT01804049|11138208|FG001|STARTED|Overall Study||77
10015171|NCT01804049|11138207|FG000|COMPLETED|Overall Study||32
10015172|NCT01804049|11138208|FG001|COMPLETED|Overall Study||45
10015173|NCT01804049|11138207|FG000|NOT COMPLETED|Overall Study||11
10015174|NCT01804049|11138208|FG001|NOT COMPLETED|Overall Study||32
10015175|NCT01804062|11138216|FG000|STARTED|Overall Study||30
10015176|NCT01804062|11138216|FG000|COMPLETED|Overall Study||30
10015177|NCT01804062|11138216|FG000|NOT COMPLETED|Overall Study||0
10015178|NCT01804075|11138222|FG000|STARTED|Overall Study||15
10015179|NCT01804075|11138223|FG001|STARTED|Overall Study||16
10015180|NCT01804075|11138222|FG000|COMPLETED|Overall Study||15
10015181|NCT01804075|11138223|FG001|COMPLETED|Overall Study||16
10234014|NCT01587963|11363898|FG000|NOT COMPLETED|Overall Study||1
10234015|NCT01587963|11363899|FG001|NOT COMPLETED|Overall Study||0
10234016|NCT01591096|11363905|FG000|STARTED|Overall Study||1
10234017|NCT01591096|11363905|FG000|COMPLETED|Overall Study||0
10234018|NCT01591096|11363905|FG000|NOT COMPLETED|Overall Study||1
10234019|NCT01591954|11363909|FG000|STARTED|Overall Study||1
10234020|NCT01591954|11363909|FG000|COMPLETED|Overall Study||1
10234021|NCT01591954|11363909|FG000|NOT COMPLETED|Overall Study||0
9830424|NCT00762996|10941089|FG000|COMPLETED|Period Two||15
9830425|NCT00762996|10941090|FG001|COMPLETED|Period Two||16
9830426|NCT00762996|10941091|FG002|COMPLETED|Period Two||13
9830427|NCT00762996|10941092|FG003|COMPLETED|Period Two||16
9830428|NCT00762996|10941089|FG000|NOT COMPLETED|Period Two||0
9830429|NCT00762996|10941090|FG001|NOT COMPLETED|Period Two||0
9830430|NCT00762996|10941091|FG002|NOT COMPLETED|Period Two||0
9830431|NCT00762996|10941092|FG003|NOT COMPLETED|Period Two||0
9830432|NCT00763035|10941100|FG000|STARTED|First Intervention||10
9830433|NCT00763035|10941101|FG001|STARTED|First Intervention||4
10234022|NCT01589926|11363915|FG000|STARTED|Overall Study||0
10234023|NCT01589926|11363916|FG001|STARTED|Overall Study||0
10234024|NCT01589926|11363915|FG000|COMPLETED|Overall Study||0
9830434|NCT00763035|10941100|FG000|COMPLETED|First Intervention||9
9830435|NCT00763035|10941101|FG001|COMPLETED|First Intervention||3
9830436|NCT00763035|10941100|FG000|NOT COMPLETED|First Intervention||1
9830437|NCT00763035|10941101|FG001|NOT COMPLETED|First Intervention||1
10234025|NCT01589926|11363916|FG001|COMPLETED|Overall Study||0
9784880|NCT00525135|10891716|FG000|STARTED|Overall Study||5
9784881|NCT00525135|10891716|FG000|COMPLETED|Overall Study||5
9784882|NCT00525135|10891716|FG000|NOT COMPLETED|Overall Study||0
9784883|NCT00525148|10891724|FG000|STARTED|Overall Study|entered and treated|23
9784884|NCT00525148|10891725|FG001|STARTED|Overall Study|entered and treated|38
9784885|NCT00525148|10891726|FG002|STARTED|Overall Study|entered and treated|7
9784886|NCT00525148|10891727|FG003|STARTED|Overall Study|entered and treated|61
9784887|NCT00525148|10891724|FG000|COMPLETED|Overall Study||0
9784888|NCT00525148|10891725|FG001|COMPLETED|Overall Study||0
9784889|NCT00525148|10891726|FG002|COMPLETED|Overall Study||0
9784890|NCT00525148|10891727|FG003|COMPLETED|Overall Study||0
9784891|NCT00525148|10891724|FG000|NOT COMPLETED|Overall Study||23
9784892|NCT00525148|10891725|FG001|NOT COMPLETED|Overall Study||38
9784893|NCT00525148|10891726|FG002|NOT COMPLETED|Overall Study||7
9784894|NCT00525148|10891727|FG003|NOT COMPLETED|Overall Study||61
9784895|NCT00525161|10891737|FG000|STARTED|Overall Study||11
9784896|NCT00525161|10891737|FG000|COMPLETED|Overall Study||10
9784897|NCT00525161|10891737|FG000|NOT COMPLETED|Overall Study||1
9784898|NCT00525174|10891743|FG000|STARTED|Overall Study||97
9784899|NCT00525174|10891744|FG001|STARTED|Overall Study||89
9784900|NCT00525174|10891743|FG000|COMPLETED|Overall Study||88
9784901|NCT00525174|10891744|FG001|COMPLETED|Overall Study||81
9784902|NCT00525174|10891743|FG000|NOT COMPLETED|Overall Study||9
9784903|NCT00525174|10891744|FG001|NOT COMPLETED|Overall Study||8
9784904|NCT00525265|10891752|FG000|STARTED|Overall Study||10
9784905|NCT00525265|10891753|FG001|STARTED|Overall Study||10
9784906|NCT00525265|10891752|FG000|COMPLETED|Overall Study||9
9784907|NCT00525265|10891753|FG001|COMPLETED|Overall Study||10
9784908|NCT00525265|10891752|FG000|NOT COMPLETED|Overall Study||1
9784909|NCT00525265|10891753|FG001|NOT COMPLETED|Overall Study||0
9784910|NCT00525421|10891761|FG000|STARTED|Overall Study|Enrollment started october 2007|10
9784911|NCT00525421|10891762|FG001|STARTED|Overall Study||10
9784912|NCT00525421|10891761|FG000|COMPLETED|Overall Study||10
9784913|NCT00525421|10891762|FG001|COMPLETED|Overall Study||10
9784914|NCT00525421|10891761|FG000|NOT COMPLETED|Overall Study||0
9784915|NCT00525421|10891762|FG001|NOT COMPLETED|Overall Study||0
9784916|NCT00525499|10891772|FG000|STARTED|Overall Study||47
9784917|NCT00525499|10891773|FG001|STARTED|Overall Study||46
9784918|NCT00525499|10891774|FG002|STARTED|Overall Study||47
9784919|NCT00525499|10891775|FG003|STARTED|Overall Study||46
9784920|NCT00525499|10891772|FG000|COMPLETED|Overall Study||40
9784921|NCT00525499|10891773|FG001|COMPLETED|Overall Study||39
9784922|NCT00525499|10891774|FG002|COMPLETED|Overall Study||40
9784923|NCT00525499|10891775|FG003|COMPLETED|Overall Study||39
9784924|NCT00525499|10891772|FG000|NOT COMPLETED|Overall Study||7
9784925|NCT00525499|10891773|FG001|NOT COMPLETED|Overall Study||7
9784926|NCT00525499|10891774|FG002|NOT COMPLETED|Overall Study||7
9784927|NCT00525499|10891775|FG003|NOT COMPLETED|Overall Study||7
9784928|NCT00525512|10891787|FG000|STARTED|Double-Blind Phase||259
9784929|NCT00525512|10891788|FG001|STARTED|Double-Blind Phase||260
9784930|NCT00525512|10891789|FG002|STARTED|Double-Blind Phase||0
9784931|NCT00525512|10891790|FG003|STARTED|Double-Blind Phase||0
9784932|NCT00525512|10891787|FG000|COMPLETED|Double-Blind Phase||163
9784933|NCT00525512|10891788|FG001|COMPLETED|Double-Blind Phase||194
9784934|NCT00525512|10891789|FG002|COMPLETED|Double-Blind Phase||0
9784935|NCT00525512|10891790|FG003|COMPLETED|Double-Blind Phase||0
9784936|NCT00525512|10891787|FG000|NOT COMPLETED|Double-Blind Phase||96
9784937|NCT00525512|10891788|FG001|NOT COMPLETED|Double-Blind Phase||66
9784938|NCT00525512|10891789|FG002|NOT COMPLETED|Double-Blind Phase||0
9784939|NCT00525512|10891790|FG003|NOT COMPLETED|Double-Blind Phase||0
9784940|NCT00525512|10891787|FG000|STARTED|Open-Label Phase||0
9784941|NCT00525512|10891788|FG001|STARTED|Open-Label Phase||0
9784942|NCT00525512|10891789|FG002|STARTED|Open-Label Phase||164
9784943|NCT00525512|10891790|FG003|STARTED|Open-Label Phase||194
9784944|NCT00525512|10891787|FG000|COMPLETED|Open-Label Phase||0
9784945|NCT00525512|10891788|FG001|COMPLETED|Open-Label Phase||0
9784946|NCT00525512|10891789|FG002|COMPLETED|Open-Label Phase||158
9784947|NCT00525512|10891790|FG003|COMPLETED|Open-Label Phase||189
9784948|NCT00525512|10891787|FG000|NOT COMPLETED|Open-Label Phase||0
9784949|NCT00525512|10891788|FG001|NOT COMPLETED|Open-Label Phase||0
9784950|NCT00525512|10891789|FG002|NOT COMPLETED|Open-Label Phase||6
9784951|NCT00525512|10891790|FG003|NOT COMPLETED|Open-Label Phase||5
9784952|NCT00525525|10891804|FG000|STARTED|Overall Study||59
9784953|NCT00525525|10891805|FG001|STARTED|Overall Study||15
9784954|NCT00525525|10891804|FG000|COMPLETED|Overall Study||59
9784955|NCT00525525|10891805|FG001|COMPLETED|Overall Study||15
9784956|NCT00525525|10891804|FG000|NOT COMPLETED|Overall Study||0
9784957|NCT00525525|10891805|FG001|NOT COMPLETED|Overall Study||0
9784958|NCT00525590|10891811|FG000|STARTED|Overall Study||59
9784959|NCT00525590|10891811|FG000|COMPLETED|Overall Study||14
9784960|NCT00525590|10891811|FG000|NOT COMPLETED|Overall Study||45
9784961|NCT00525603|10891815|FG000|STARTED|Overall Study||60
9784962|NCT00525603|10891815|FG000|COMPLETED|Overall Study||60
9784963|NCT00525603|10891815|FG000|NOT COMPLETED|Overall Study||0
9784964|NCT00525629|10891819|FG000|STARTED|First Intervention||20
9784965|NCT00525629|10891820|FG001|STARTED|First Intervention||20
9784966|NCT00525629|10891819|FG000|COMPLETED|First Intervention||15
9784967|NCT00525629|10891820|FG001|COMPLETED|First Intervention||15
9784968|NCT00525629|10891819|FG000|NOT COMPLETED|First Intervention||5
9784969|NCT00525629|10891820|FG001|NOT COMPLETED|First Intervention||5
9784970|NCT00525629|10891819|FG000|STARTED|Washout||15
9784971|NCT00525629|10891820|FG001|STARTED|Washout||15
9784972|NCT00525629|10891819|FG000|COMPLETED|Washout||15
9784973|NCT00525629|10891820|FG001|COMPLETED|Washout||15
9784974|NCT00525629|10891819|FG000|NOT COMPLETED|Washout||0
9784975|NCT00525629|10891820|FG001|NOT COMPLETED|Washout||0
9784976|NCT00525629|10891819|FG000|STARTED|Second Intervention||15
9784977|NCT00525629|10891820|FG001|STARTED|Second Intervention||15
9784978|NCT00525629|10891819|FG000|COMPLETED|Second Intervention||0
9784979|NCT00525629|10891820|FG001|COMPLETED|Second Intervention||0
9784980|NCT00525629|10891819|FG000|NOT COMPLETED|Second Intervention||15
9784981|NCT00525629|10891820|FG001|NOT COMPLETED|Second Intervention||15
9784982|NCT00525733|10891828|FG000|STARTED|Overall Study||14
9784983|NCT00525733|10891829|FG001|STARTED|Overall Study||26
9784984|NCT00525733|10891828|FG000|COMPLETED|Overall Study||11
9784985|NCT00525733|10891829|FG001|COMPLETED|Overall Study||23
9784986|NCT00525733|10891828|FG000|NOT COMPLETED|Overall Study||3
9784987|NCT00525733|10891829|FG001|NOT COMPLETED|Overall Study||3
9784988|NCT00525785|10891835|FG000|STARTED|Overall Study||58
9784989|NCT00525785|10891835|FG000|COMPLETED|Overall Study||55
9784990|NCT00525785|10891835|FG000|NOT COMPLETED|Overall Study||3
9784991|NCT00525798|10891841|FG000|STARTED|Overall Study||2334
9784992|NCT00525798|10891842|FG001|STARTED|Overall Study||2331
9784993|NCT00525798|10891841|FG000|COMPLETED|Overall Study||1578
9784994|NCT00525798|10891842|FG001|COMPLETED|Overall Study||1732
9784995|NCT00525798|10891841|FG000|NOT COMPLETED|Overall Study||756
9784996|NCT00525798|10891842|FG001|NOT COMPLETED|Overall Study||599
9784997|NCT00525824|10891852|FG000|STARTED|Overall Study|Randomized population|214
9784998|NCT00525824|10891853|FG001|STARTED|Overall Study|Randomized population|214
9784999|NCT00525824|10891854|FG002|STARTED|Overall Study|Randomized population|202
9785000|NCT00525824|10891855|FG003|STARTED|Overall Study|Randomized population|203
9785001|NCT00525824|10891852|FG000|COMPLETED|Overall Study||195
9785002|NCT00525824|10891853|FG001|COMPLETED|Overall Study||186
9785003|NCT00525824|10891854|FG002|COMPLETED|Overall Study||183
9785004|NCT00525824|10891855|FG003|COMPLETED|Overall Study||188
9785005|NCT00525824|10891852|FG000|NOT COMPLETED|Overall Study||19
9785006|NCT00525824|10891853|FG001|NOT COMPLETED|Overall Study||28
9785007|NCT00525824|10891854|FG002|NOT COMPLETED|Overall Study||19
9785008|NCT00525824|10891855|FG003|NOT COMPLETED|Overall Study||15
9785009|NCT00525837|10891869|FG000|STARTED|Overall Study||18
9785010|NCT00525837|10891869|FG000|COMPLETED|Overall Study||14
9785011|NCT00525837|10891869|FG000|NOT COMPLETED|Overall Study||4
9785012|NCT00525876|10891876|FG000|STARTED|Overall Study||16
9785013|NCT00525876|10891877|FG001|STARTED|Overall Study||20
9785014|NCT00525876|10891876|FG000|COMPLETED|Overall Study||16
9785015|NCT00525876|10891877|FG001|COMPLETED|Overall Study||20
9785016|NCT00525876|10891876|FG000|NOT COMPLETED|Overall Study||0
9785017|NCT00525876|10891877|FG001|NOT COMPLETED|Overall Study||0
9785018|NCT00525902|10891883|FG000|STARTED|Overall Study||31
9785019|NCT00525902|10891883|FG000|10 Weeks|Overall Study||30
9785020|NCT00525902|10891883|FG000|50 Weeks|Overall Study||12
9785021|NCT00525902|10891883|FG000|COMPLETED|Overall Study||30
9785022|NCT00525902|10891883|FG000|NOT COMPLETED|Overall Study||1
9785023|NCT00525915|10891889|FG000|STARTED|Overall Study||63
9785024|NCT00525915|10891890|FG001|STARTED|Overall Study||63
9785025|NCT00525915|10891889|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55
9785026|NCT00525915|10891890|FG001|COMPLETED|Overall Study||54
9785027|NCT00525915|10891889|FG000|NOT COMPLETED|Overall Study||8
9785028|NCT00525915|10891890|FG001|NOT COMPLETED|Overall Study||9
9785029|NCT00526058|10891898|FG000|STARTED|Period: First Intervention||9
9785030|NCT00526058|10891899|FG001|STARTED|Period: First Intervention||9
9785031|NCT00526058|10891898|FG000|COMPLETED|Period: First Intervention||9
9785032|NCT00526058|10891899|FG001|COMPLETED|Period: First Intervention||9
9785033|NCT00526058|10891898|FG000|NOT COMPLETED|Period: First Intervention||0
9785034|NCT00526058|10891899|FG001|NOT COMPLETED|Period: First Intervention||0
9785035|NCT00526058|10891898|FG000|STARTED|Period: Second Intervention||9
9785036|NCT00526058|10891899|FG001|STARTED|Period: Second Intervention||9
9785037|NCT00526058|10891898|FG000|COMPLETED|Period: Second Intervention||9
9785038|NCT00526058|10891899|FG001|COMPLETED|Period: Second Intervention||9
9785039|NCT00526058|10891898|FG000|NOT COMPLETED|Period: Second Intervention||0
9785040|NCT00526058|10891899|FG001|NOT COMPLETED|Period: Second Intervention||0
9785041|NCT00526071|10891905|FG000|STARTED|Overall Study||23
9785042|NCT00526071|10891905|FG000|Safety Population|Overall Study||23
9785043|NCT00526071|10891905|FG000|Pharmacodynamic (PD) Population|Overall Study||23
9785044|NCT00526071|10891905|FG000|Amenable Population; Men|Overall Study||11
9785045|NCT00526071|10891905|FG000|Amenable Population; Women|Overall Study||5
9785046|NCT00526071|10891905|FG000|Non-amenable Population; Men|Overall Study||3
9785047|NCT00526071|10891905|FG000|Non-amenable Population; Women|Overall Study||4
9785048|NCT00526071|10891905|FG000|COMPLETED|Overall Study||17
9785049|NCT00526071|10891905|FG000|NOT COMPLETED|Overall Study||6
9785050|NCT00526097|10891915|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
9785051|NCT00526097|10891916|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
9785052|NCT00526097|10891915|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
9785053|NCT00526097|10891916|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
9785054|NCT00526097|10891915|FG000|NOT COMPLETED|Overall Study||15
9785055|NCT00526097|10891916|FG001|NOT COMPLETED|Overall Study||56
9785056|NCT00526110|10891924|FG000|STARTED|Overall Study||53
9785057|NCT00526110|10891925|FG001|STARTED|Overall Study||45
9785058|NCT00526110|10891924|FG000|COMPLETED|Overall Study||51
9785059|NCT00526110|10891925|FG001|COMPLETED|Overall Study||4
9785060|NCT00526110|10891924|FG000|NOT COMPLETED|Overall Study||2
9785061|NCT00526110|10891925|FG001|NOT COMPLETED|Overall Study||41
9785062|NCT00526123|10891933|FG000|STARTED|Overall Study|Intent-to-Treat population|303
9785063|NCT00526123|10891934|FG001|STARTED|Overall Study|Intent-to-Treat population|296
9785064|NCT00526123|10891933|FG000|COMPLETED|Overall Study||39
9785065|NCT00526123|10891934|FG001|COMPLETED|Overall Study||50
9785066|NCT00526123|10891933|FG000|NOT COMPLETED|Overall Study||264
9785067|NCT00526123|10891934|FG001|NOT COMPLETED|Overall Study||246
9785068|NCT00526162|10891940|FG000|STARTED|Overall Study||83
9785069|NCT00526162|10891940|FG000|COMPLETED|Overall Study||80
9785070|NCT00526162|10891940|FG000|NOT COMPLETED|Overall Study||3
9785071|NCT00526188|10891948|FG000|STARTED|Overall Study||234
9785072|NCT00526188|10891948|FG000|COMPLETED|Overall Study||234
9785073|NCT00526188|10891948|FG000|NOT COMPLETED|Overall Study||0
9785074|NCT00526292|10891952|FG000|STARTED|Overall Study||6
9785075|NCT00526292|10891952|FG000|COMPLETED|Overall Study||6
9785076|NCT00526292|10891952|FG000|NOT COMPLETED|Overall Study||0
9785077|NCT00526474|10891958|FG000|STARTED|Overall Study||13224
9785078|NCT00526474|10891959|FG001|STARTED|Overall Study||13225
9785079|NCT00526474|10891958|FG000|Received Study Drug|Overall Study||13166
9785080|NCT00526474|10891959|FG001|Received Study Drug|Overall Study||13186
9785081|NCT00526474|10891958|FG000|COMPLETED|Overall Study||12932
9785082|NCT00526474|10891959|FG001|COMPLETED|Overall Study||12953
9785083|NCT00526474|10891958|FG000|NOT COMPLETED|Overall Study||292
9785084|NCT00526474|10891959|FG001|NOT COMPLETED|Overall Study||272
9785085|NCT00526591|10891967|FG000|STARTED|Overall Study||8
9785086|NCT00526591|10891968|FG001|STARTED|Overall Study||9
9785087|NCT00526591|10891967|FG000|COMPLETED|Overall Study||8
9785088|NCT00526591|10891968|FG001|COMPLETED|Overall Study||9
9785089|NCT00526591|10891967|FG000|NOT COMPLETED|Overall Study||0
9785090|NCT00526591|10891968|FG001|NOT COMPLETED|Overall Study||0
9785091|NCT00526630|10891976|FG000|STARTED|First Intervention Period - 12 Weeks||12
9785092|NCT00526630|10891977|FG001|STARTED|First Intervention Period - 12 Weeks||11
9785093|NCT00526630|10891976|FG000|COMPLETED|First Intervention Period - 12 Weeks||12
9785094|NCT00526630|10891977|FG001|COMPLETED|First Intervention Period - 12 Weeks||8
9785095|NCT00526630|10891976|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0
9785096|NCT00526630|10891977|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3
9785097|NCT00526630|10891976|FG000|STARTED|Second Intervention Period - 12 Weeks||12
9785098|NCT00526630|10891977|FG001|STARTED|Second Intervention Period - 12 Weeks||8
9785099|NCT00526630|10891976|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10
9785100|NCT00526630|10891977|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7
9785101|NCT00526630|10891976|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
9785102|NCT00526630|10891977|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
9785103|NCT00526656|10891985|FG000|STARTED|Overall Study||9
9785104|NCT00526656|10891985|FG000|COMPLETED|Overall Study||7
9785105|NCT00526656|10891985|FG000|NOT COMPLETED|Overall Study||2
9785106|NCT00526669|10891990|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
9785107|NCT00526669|10891991|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
9785108|NCT00526669|10891990|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
9785109|NCT00526669|10891991|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
9785110|NCT00526669|10891990|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
9785111|NCT00526669|10891991|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
9785112|NCT00526669|10891990|FG000|STARTED|Combined Treatment Phase||0
9785113|NCT00526669|10891991|FG001|STARTED|Combined Treatment Phase||67
9785114|NCT00526669|10891990|FG000|COMPLETED|Combined Treatment Phase||0
9785115|NCT00526669|10891991|FG001|COMPLETED|Combined Treatment Phase||59
9785116|NCT00526669|10891990|FG000|NOT COMPLETED|Combined Treatment Phase||0
9785117|NCT00526669|10891991|FG001|NOT COMPLETED|Combined Treatment Phase||8
9785118|NCT00526799|10891999|FG000|STARTED|Overall Study||16
9785119|NCT00526799|10892000|FG001|STARTED|Overall Study||14
9785120|NCT00526799|10891999|FG000|COMPLETED|Overall Study||15
9785121|NCT00526799|10892000|FG001|COMPLETED|Overall Study||13
9785122|NCT00526799|10891999|FG000|NOT COMPLETED|Overall Study||1
9785123|NCT00526799|10892000|FG001|NOT COMPLETED|Overall Study||1
9785124|NCT00526890|10892006|FG000|STARTED|Overall Study||16
9785125|NCT00526890|10892006|FG000|COMPLETED|Overall Study||14
9785126|NCT00526890|10892006|FG000|NOT COMPLETED|Overall Study||2
9785127|NCT00526994|10892013|FG000|STARTED|Overall Study||909
9785128|NCT00526994|10892014|FG001|STARTED|Overall Study||893
9785129|NCT00526994|10892015|FG002|STARTED|Overall Study||898
9785130|NCT00526994|10892013|FG000|COMPLETED|Overall Study||801
9785131|NCT00526994|10892014|FG001|COMPLETED|Overall Study||772
9785132|NCT00526994|10892015|FG002|COMPLETED|Overall Study||791
9785133|NCT00526994|10892013|FG000|NOT COMPLETED|Overall Study||108
9785134|NCT00526994|10892014|FG001|NOT COMPLETED|Overall Study||121
9785135|NCT00526994|10892015|FG002|NOT COMPLETED|Overall Study||107
9785136|NCT00527072|10892023|FG000|STARTED|Overall Study||215
9785137|NCT00527072|10892023|FG000|COMPLETED|Overall Study||179
9785138|NCT00527072|10892023|FG000|NOT COMPLETED|Overall Study||36
9785139|NCT00527098|10892030|FG000|STARTED|Overall Study||36
9785140|NCT00527098|10892031|FG001|STARTED|Overall Study||83
9785141|NCT00527098|10892030|FG000|COMPLETED|Overall Study||36
9785142|NCT00527098|10892031|FG001|COMPLETED|Overall Study||83
9785143|NCT00527098|10892030|FG000|NOT COMPLETED|Overall Study||0
9785144|NCT00527098|10892031|FG001|NOT COMPLETED|Overall Study||0
9785145|NCT00527111|10892038|FG000|STARTED|Overall Study||70
9785146|NCT00527111|10892039|FG001|STARTED|Overall Study||69
9785147|NCT00527111|10892038|FG000|COMPLETED|Overall Study||50
9785148|NCT00527111|10892039|FG001|COMPLETED|Overall Study||47
9785149|NCT00527111|10892038|FG000|NOT COMPLETED|Overall Study||20
9785150|NCT00527111|10892039|FG001|NOT COMPLETED|Overall Study||22
9785151|NCT00527124|10892047|FG000|STARTED|Overall Study||29
9785152|NCT00527124|10892048|FG001|STARTED|Overall Study||28
9785153|NCT00527124|10892047|FG000|COMPLETED|Overall Study||29
9785154|NCT00527124|10892048|FG001|COMPLETED|Overall Study||28
9785155|NCT00527124|10892047|FG000|NOT COMPLETED|Overall Study||0
9785156|NCT00527124|10892048|FG001|NOT COMPLETED|Overall Study||0
9785157|NCT00527319|10892057|FG000|STARTED|Overall Study||12
9785158|NCT00527319|10892058|FG001|STARTED|Overall Study||12
9785159|NCT00527319|10892059|FG002|STARTED|Overall Study||13
9785160|NCT00527319|10892057|FG000|COMPLETED|Overall Study||6
9785161|NCT00527319|10892058|FG001|COMPLETED|Overall Study||8
9785162|NCT00527319|10892059|FG002|COMPLETED|Overall Study||7
9785163|NCT00527319|10892057|FG000|NOT COMPLETED|Overall Study||6
9785164|NCT00527319|10892058|FG001|NOT COMPLETED|Overall Study||4
9785165|NCT00527319|10892059|FG002|NOT COMPLETED|Overall Study||6
9785166|NCT00527332|10892069|FG000|STARTED|Overall Study||91
9785167|NCT00527332|10892070|FG001|STARTED|Overall Study||89
9785168|NCT00527332|10892069|FG000|COMPLETED|Overall Study||82
9785169|NCT00527332|10892070|FG001|COMPLETED|Overall Study||80
9785170|NCT00527332|10892069|FG000|NOT COMPLETED|Overall Study||9
9785171|NCT00527332|10892070|FG001|NOT COMPLETED|Overall Study||9
9785172|NCT00527397|10892076|FG000|STARTED|Overall Study||24
9785173|NCT00527397|10892076|FG000|COMPLETED|Overall Study||0
9785174|NCT00527397|10892076|FG000|NOT COMPLETED|Overall Study||24
9785175|NCT00527423|10892083|FG000|STARTED|Overall Study||157
9785176|NCT00527423|10892083|FG000|COMPLETED|Overall Study||120
9785177|NCT00527423|10892083|FG000|NOT COMPLETED|Overall Study||37
9785178|NCT00527475|10892091|FG000|STARTED|Overall Study||30
9785179|NCT00527475|10892092|FG001|STARTED|Overall Study||30
9785180|NCT00527475|10892091|FG000|COMPLETED|Overall Study||27
9785181|NCT00527475|10892092|FG001|COMPLETED|Overall Study||29
9785182|NCT00527475|10892091|FG000|NOT COMPLETED|Overall Study||3
9785183|NCT00527475|10892092|FG001|NOT COMPLETED|Overall Study||1
9785184|NCT00527488|10892102|FG000|STARTED|Overall Study||13
9785185|NCT00527488|10892103|FG001|STARTED|Overall Study||13
9785186|NCT00527488|10892104|FG002|STARTED|Overall Study||13
9785187|NCT00527488|10892105|FG003|STARTED|Overall Study||13
9785188|NCT00527488|10892102|FG000|COMPLETED|Overall Study||13
9785189|NCT00527488|10892103|FG001|COMPLETED|Overall Study||12
9785190|NCT00527488|10892104|FG002|COMPLETED|Overall Study||12
9785191|NCT00527488|10892105|FG003|COMPLETED|Overall Study||13
9785192|NCT00527488|10892102|FG000|NOT COMPLETED|Overall Study||0
10015182|NCT01804075|11138222|FG000|NOT COMPLETED|Overall Study||0
10015183|NCT01804075|11138223|FG001|NOT COMPLETED|Overall Study||0
10015184|NCT01804101|11138233|FG000|STARTED|Overall Study||38
9785193|NCT00527488|10892103|FG001|NOT COMPLETED|Overall Study||1
9785194|NCT00527488|10892104|FG002|NOT COMPLETED|Overall Study||1
9785195|NCT00527488|10892105|FG003|NOT COMPLETED|Overall Study||0
9785196|NCT00527514|10892115|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
9785197|NCT00527514|10892115|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
9785198|NCT00527514|10892115|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
9785199|NCT00527514|10892115|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
9785200|NCT00527514|10892115|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
9785201|NCT00527514|10892115|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
9785202|NCT00527514|10892115|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
9785203|NCT00527514|10892115|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
9785204|NCT00527514|10892115|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
9785205|NCT00527514|10892115|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
9785206|NCT00527514|10892115|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
9785207|NCT00527514|10892115|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
9785208|NCT00527566|10892126|FG000|STARTED|Overall Study||10
9785209|NCT00527566|10892126|FG000|COMPLETED|Overall Study||10
10015185|NCT01804101|11138234|FG001|STARTED|Overall Study||10
10015186|NCT01804101|11138233|FG000|COMPLETED|Overall Study||38
10015187|NCT01804101|11138234|FG001|COMPLETED|Overall Study||10
10015188|NCT01804101|11138233|FG000|NOT COMPLETED|Overall Study||0
10015189|NCT01804101|11138234|FG001|NOT COMPLETED|Overall Study||0
10015190|NCT01804114|11138244|FG000|STARTED|Overall Study||17
10015191|NCT01804114|11138245|FG001|STARTED|Overall Study||12
10015192|NCT01804114|11138244|FG000|COMPLETED|Overall Study||17
9785210|NCT00527566|10892126|FG000|NOT COMPLETED|Overall Study||0
9785211|NCT00527592|10892132|FG000|STARTED|Overall Study||54
9785212|NCT00527592|10892132|FG000|COMPLETED|Overall Study||54
9785213|NCT00527592|10892132|FG000|NOT COMPLETED|Overall Study||0
9785214|NCT00527605|10892140|FG000|STARTED|Overall Study||126
9785215|NCT00527605|10892141|FG001|STARTED|Overall Study||127
9785216|NCT00527605|10892140|FG000|COMPLETED|Overall Study||113
9785217|NCT00527605|10892141|FG001|COMPLETED|Overall Study||116
9785218|NCT00527605|10892140|FG000|NOT COMPLETED|Overall Study||13
9785219|NCT00527605|10892141|FG001|NOT COMPLETED|Overall Study||11
9785220|NCT00527618|10892147|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
9785221|NCT00527618|10892148|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
9785222|NCT00527618|10892147|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
9785223|NCT00527618|10892148|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
10015193|NCT01804114|11138245|FG001|COMPLETED|Overall Study||12
10015194|NCT01804114|11138244|FG000|NOT COMPLETED|Overall Study||0
9785224|NCT00527618|10892147|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3
9785225|NCT00527618|10892148|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2
9785226|NCT00527618|10892147|FG000|STARTED|Week 13-14 (Washout)||13
9785227|NCT00527618|10892148|FG001|STARTED|Week 13-14 (Washout)||16
9785228|NCT00527618|10892147|FG000|COMPLETED|Week 13-14 (Washout)||12
9785229|NCT00527618|10892148|FG001|COMPLETED|Week 13-14 (Washout)||16
9785230|NCT00527618|10892147|FG000|NOT COMPLETED|Week 13-14 (Washout)||1
9785231|NCT00527618|10892148|FG001|NOT COMPLETED|Week 13-14 (Washout)||0
9785232|NCT00527618|10892147|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
9785233|NCT00527618|10892148|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
9785234|NCT00527618|10892147|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
9785235|NCT00527618|10892148|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
9785236|NCT00527618|10892147|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0
9785237|NCT00527618|10892148|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3
9785238|NCT00527644|10892155|FG000|STARTED|Overall Study||14
9785239|NCT00527644|10892155|FG000|COMPLETED|Overall Study||14
9785240|NCT00527644|10892155|FG000|NOT COMPLETED|Overall Study||0
9785241|NCT00527722|10892161|FG000|STARTED|Overall Study||22
9785242|NCT00527722|10892162|FG001|STARTED|Overall Study||25
9785243|NCT00527722|10892161|FG000|COMPLETED|Overall Study||22
9785244|NCT00527722|10892162|FG001|COMPLETED|Overall Study||25
9785245|NCT00527722|10892161|FG000|NOT COMPLETED|Overall Study||0
9785246|NCT00527722|10892162|FG001|NOT COMPLETED|Overall Study||0
9785247|NCT00527735|10892171|FG000|STARTED|Overall Study|Treated|113
9785248|NCT00527735|10892172|FG001|STARTED|Overall Study|Treated|109
9785249|NCT00527735|10892173|FG002|STARTED|Overall Study|Treated|109
9785250|NCT00527735|10892171|FG000|COMPLETED|Overall Study|Still on treatment|5
9785251|NCT00527735|10892172|FG001|COMPLETED|Overall Study|Still on treatment|2
9785252|NCT00527735|10892173|FG002|COMPLETED|Overall Study|Still on treatment|2
9785253|NCT00527735|10892171|FG000|NOT COMPLETED|Overall Study||108
9785254|NCT00527735|10892172|FG001|NOT COMPLETED|Overall Study||107
9785255|NCT00527735|10892173|FG002|NOT COMPLETED|Overall Study||107
9785256|NCT00527787|10892195|FG000|STARTED|Overall Study||218
9785257|NCT00527787|10892196|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
9785258|NCT00527787|10892195|FG000|COMPLETED|Overall Study||180
9785259|NCT00527787|10892196|FG001|COMPLETED|Overall Study||153
9785260|NCT00527787|10892195|FG000|NOT COMPLETED|Overall Study||38
9785261|NCT00527787|10892196|FG001|NOT COMPLETED|Overall Study||63
9785262|NCT00527826|10892204|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
9785263|NCT00527826|10892205|FG001|STARTED|Overall Study||106
9785264|NCT00527826|10892204|FG000|COMPLETED|Overall Study||87
9785265|NCT00527826|10892205|FG001|COMPLETED|Overall Study||80
9785266|NCT00527826|10892204|FG000|NOT COMPLETED|Overall Study||21
9785267|NCT00527826|10892205|FG001|NOT COMPLETED|Overall Study||26
9785268|NCT00527878|10892214|FG000|STARTED|Intervention 1||7
9785269|NCT00527878|10892215|FG001|STARTED|Intervention 1||7
9785270|NCT00527878|10892214|FG000|COMPLETED|Intervention 1||5
9785271|NCT00527878|10892215|FG001|COMPLETED|Intervention 1||4
9785272|NCT00527878|10892214|FG000|NOT COMPLETED|Intervention 1||2
9785273|NCT00527878|10892215|FG001|NOT COMPLETED|Intervention 1||3
9785274|NCT00527878|10892214|FG000|STARTED|Intervention 2||5
9785275|NCT00527878|10892215|FG001|STARTED|Intervention 2||4
9785276|NCT00527878|10892214|FG000|COMPLETED|Intervention 2||5
9785277|NCT00527878|10892215|FG001|COMPLETED|Intervention 2||4
9785278|NCT00527878|10892214|FG000|NOT COMPLETED|Intervention 2||0
9785279|NCT00527878|10892215|FG001|NOT COMPLETED|Intervention 2||0
9785280|NCT00527904|10892221|FG000|STARTED|Overall Study||239
9785281|NCT00527904|10892221|FG000|COMPLETED|Overall Study||143
9785282|NCT00527904|10892221|FG000|NOT COMPLETED|Overall Study||96
9785283|NCT00527943|10892227|FG000|STARTED|Overall Study||6471
9785284|NCT00527943|10892228|FG001|STARTED|Overall Study||6473
9785285|NCT00527943|10892227|FG000|Received Treatment|Overall Study||6441
9785286|NCT00527943|10892228|FG001|Received Treatment|Overall Study||6446
9785287|NCT00527943|10892227|FG000|COMPLETED|Overall Study||6311
9785288|NCT00527943|10892228|FG001|COMPLETED|Overall Study||6327
9785289|NCT00527943|10892227|FG000|NOT COMPLETED|Overall Study||160
9785290|NCT00527943|10892228|FG001|NOT COMPLETED|Overall Study||146
10015195|NCT01804114|11138245|FG001|NOT COMPLETED|Overall Study||0
9785303|NCT00528112|10892253|FG000|STARTED|Treatment up to 3 Years||1432
9785304|NCT00528112|10892254|FG001|STARTED|Treatment up to 3 Years||1453
9785305|NCT00528112|10892253|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
9785306|NCT00528112|10892254|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
9785307|NCT00528112|10892253|FG000|COMPLETED|Treatment up to 3 Years||819
9785308|NCT00528112|10892254|FG001|COMPLETED|Treatment up to 3 Years||870
9785309|NCT00528112|10892253|FG000|NOT COMPLETED|Treatment up to 3 Years||613
9785310|NCT00528112|10892254|FG001|NOT COMPLETED|Treatment up to 3 Years||583
9785311|NCT00528112|10892253|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
9785312|NCT00528112|10892254|FG001|STARTED|Extension Phase||707
10015196|NCT01804140|11138251|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
10015197|NCT01804140|11138251|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
10015198|NCT01804140|11138251|FG000|NOT COMPLETED|Overall Study||114
9785313|NCT00528112|10892253|FG000|COMPLETED|Extension Phase||0
9785314|NCT00528112|10892254|FG001|COMPLETED|Extension Phase||550
9785315|NCT00528112|10892253|FG000|NOT COMPLETED|Extension Phase||0
9785316|NCT00528112|10892254|FG001|NOT COMPLETED|Extension Phase||157
9785317|NCT00528190|10892264|FG000|STARTED|Overall Study||18
9785318|NCT00528190|10892265|FG001|STARTED|Overall Study||17
9785319|NCT00528190|10892264|FG000|COMPLETED|Overall Study||18
9785320|NCT00528190|10892265|FG001|COMPLETED|Overall Study||16
9785321|NCT00528190|10892264|FG000|NOT COMPLETED|Overall Study||0
9785322|NCT00528190|10892265|FG001|NOT COMPLETED|Overall Study||1
9785323|NCT00528268|10892273|FG000|STARTED|Overall Study||6
9785324|NCT00528268|10892274|FG001|STARTED|Overall Study||8
9785325|NCT00528268|10892273|FG000|COMPLETED|Overall Study||5
9785326|NCT00528268|10892274|FG001|COMPLETED|Overall Study||7
9785327|NCT00528268|10892273|FG000|NOT COMPLETED|Overall Study||1
9785328|NCT00528268|10892274|FG001|NOT COMPLETED|Overall Study||1
9785329|NCT00528372|10892289|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
9785330|NCT00528372|10892290|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
9785331|NCT00528372|10892291|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
9785332|NCT00528372|10892292|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
9785333|NCT00528372|10892293|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
9785334|NCT00528372|10892294|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
9785335|NCT00528372|10892295|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
9785336|NCT00528372|10892296|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
9785337|NCT00528372|10892297|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
9785338|NCT00528372|10892289|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
9785339|NCT00528372|10892290|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
9785340|NCT00528372|10892291|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
9785341|NCT00528372|10892292|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
9785342|NCT00528372|10892293|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
9785343|NCT00528372|10892294|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
9785344|NCT00528372|10892295|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
9785345|NCT00528372|10892296|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
9785346|NCT00528372|10892297|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
9785347|NCT00528372|10892289|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
9785348|NCT00528372|10892290|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
9785349|NCT00528372|10892291|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
9785350|NCT00528372|10892292|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
9785351|NCT00528372|10892293|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
9785352|NCT00528372|10892294|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
9785353|NCT00528372|10892295|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
9785354|NCT00528372|10892296|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
9785355|NCT00528372|10892297|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
9785356|NCT00528372|10892289|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62
9785357|NCT00528372|10892290|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59
9785358|NCT00528372|10892291|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51
9785359|NCT00528372|10892292|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56
9785360|NCT00528372|10892293|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58
9785361|NCT00528372|10892294|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57
9785362|NCT00528372|10892295|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65
9785363|NCT00528372|10892296|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28
9785364|NCT00528372|10892297|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
9785365|NCT00528372|10892289|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
9785366|NCT00528372|10892290|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
9785367|NCT00528372|10892291|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
9785368|NCT00528372|10892292|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
9785369|NCT00528372|10892293|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
9785370|NCT00528372|10892294|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
9785371|NCT00528372|10892295|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
9785372|NCT00528372|10892296|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
9785373|NCT00528372|10892297|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
9785374|NCT00528372|10892289|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
9785375|NCT00528372|10892290|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
9785376|NCT00528372|10892291|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
9785377|NCT00528372|10892292|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
9785378|NCT00528372|10892293|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
9785379|NCT00528372|10892294|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
9785380|NCT00528372|10892295|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
9785381|NCT00528372|10892296|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
10015199|NCT01804257|11138255|FG000|STARTED|Overall Study||28
10015200|NCT01804257|11138255|FG000|COMPLETED|Overall Study||27
10015201|NCT01804257|11138255|FG000|NOT COMPLETED|Overall Study||1
9785382|NCT00528372|10892297|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
9785383|NCT00528398|10892343|FG000|STARTED|Overall Study||111
9785384|NCT00528398|10892343|FG000|COMPLETED|Overall Study||111
9785385|NCT00528398|10892343|FG000|NOT COMPLETED|Overall Study||0
9785386|NCT00528411|10892350|FG000|STARTED|Overall Study||57
9785387|NCT00528411|10892351|FG001|STARTED|Overall Study||54
9785388|NCT00528411|10892352|FG002|STARTED|Overall Study||12
9785389|NCT00528411|10892350|FG000|COMPLETED|Overall Study||52
9785390|NCT00528411|10892351|FG001|COMPLETED|Overall Study||51
9785391|NCT00528411|10892352|FG002|COMPLETED|Overall Study||11
9785392|NCT00528411|10892350|FG000|NOT COMPLETED|Overall Study||5
9785393|NCT00528411|10892351|FG001|NOT COMPLETED|Overall Study||3
9785394|NCT00528411|10892352|FG002|NOT COMPLETED|Overall Study||1
9785395|NCT00528424|10892360|FG000|STARTED|Overall Study||286
9785396|NCT00528424|10892360|FG000|COMPLETED|Overall Study||257
9785397|NCT00528424|10892360|FG000|NOT COMPLETED|Overall Study||29
9785398|NCT00528450|10892364|FG000|STARTED|Overall Study||1
9785399|NCT00528450|10892364|FG000|COMPLETED|Overall Study||1
9785400|NCT00528450|10892364|FG000|NOT COMPLETED|Overall Study||0
9785401|NCT00528528|10892372|FG000|STARTED|Overall Study||40
9785402|NCT00528528|10892373|FG001|STARTED|Overall Study||42
9785403|NCT00528528|10892374|FG002|STARTED|Overall Study||40
9785404|NCT00528528|10892375|FG003|STARTED|Overall Study||39
9785405|NCT00528528|10892372|FG000|Ongoing at Time of Cut-off|Overall Study||0
9785406|NCT00528528|10892373|FG001|Ongoing at Time of Cut-off|Overall Study||0
9785407|NCT00528528|10892374|FG002|Ongoing at Time of Cut-off|Overall Study||1
9785408|NCT00528528|10892375|FG003|Ongoing at Time of Cut-off|Overall Study||0
9785409|NCT00528528|10892372|FG000|COMPLETED|Overall Study||37
9785410|NCT00528528|10892373|FG001|COMPLETED|Overall Study||39
9785411|NCT00528528|10892374|FG002|COMPLETED|Overall Study||37
9785412|NCT00528528|10892375|FG003|COMPLETED|Overall Study||36
9785413|NCT00528528|10892372|FG000|NOT COMPLETED|Overall Study||3
9785414|NCT00528528|10892373|FG001|NOT COMPLETED|Overall Study||3
9785415|NCT00528528|10892374|FG002|NOT COMPLETED|Overall Study||3
9785416|NCT00528528|10892375|FG003|NOT COMPLETED|Overall Study||3
9785417|NCT00528541|10892389|FG000|STARTED|Overall Study||75
9785418|NCT00528541|10892390|FG001|STARTED|Overall Study||70
9785419|NCT00528541|10892389|FG000|COMPLETED|Overall Study||73
9785420|NCT00528541|10892390|FG001|COMPLETED|Overall Study||69
9785421|NCT00528541|10892389|FG000|NOT COMPLETED|Overall Study||2
9785422|NCT00528541|10892390|FG001|NOT COMPLETED|Overall Study||1
9785423|NCT00528567|10892398|FG000|STARTED|Overall Study||1301
9785424|NCT00528567|10892399|FG001|STARTED|Overall Study||1290
9785425|NCT00528567|10892398|FG000|Intention to Treat|Overall Study||1301
9785426|NCT00528567|10892399|FG001|Intention to Treat|Overall Study||1290
9785427|NCT00528567|10892398|FG000|Safety Population|Overall Study||1288
9785428|NCT00528567|10892399|FG001|Safety Population|Overall Study||1271
9785429|NCT00528567|10892398|FG000|COMPLETED|Overall Study||870
9785430|NCT00528567|10892399|FG001|COMPLETED|Overall Study||982
9785431|NCT00528567|10892398|FG000|NOT COMPLETED|Overall Study||431
9785432|NCT00528567|10892399|FG001|NOT COMPLETED|Overall Study||308
9785433|NCT00528580|10892414|FG000|STARTED|Overall Study||34
9785434|NCT00528580|10892415|FG001|STARTED|Overall Study||34
9785435|NCT00528580|10892414|FG000|COMPLETED|Overall Study||34
9785436|NCT00528580|10892415|FG001|COMPLETED|Overall Study||34
9785437|NCT00528580|10892414|FG000|NOT COMPLETED|Overall Study||0
9785438|NCT00528580|10892415|FG001|NOT COMPLETED|Overall Study||0
9785439|NCT00528606|10892423|FG000|STARTED|Overall Study||204
9785440|NCT00528606|10892424|FG001|STARTED|Overall Study||104
9785441|NCT00528606|10892423|FG000|COMPLETED|Overall Study||191
9785442|NCT00528606|10892424|FG001|COMPLETED|Overall Study||100
9785443|NCT00528606|10892423|FG000|NOT COMPLETED|Overall Study||13
9785444|NCT00528606|10892424|FG001|NOT COMPLETED|Overall Study||4
9785445|NCT00528645|10892430|FG000|STARTED|Overall Study||23
9785446|NCT00528645|10892430|FG000|COMPLETED|Overall Study||20
9785447|NCT00528645|10892430|FG000|NOT COMPLETED|Overall Study||3
9785448|NCT00528788|10892435|FG000|STARTED|Overall Study||24
9785449|NCT00528788|10892435|FG000|COMPLETED|Overall Study||20
9785450|NCT00528788|10892435|FG000|NOT COMPLETED|Overall Study||4
9785451|NCT00528801|10892441|FG000|STARTED|Overall Study||160
9785452|NCT00528801|10892442|FG001|STARTED|Overall Study||52
9785453|NCT00528801|10892441|FG000|COMPLETED|Overall Study||133
9785454|NCT00528801|10892442|FG001|COMPLETED|Overall Study||41
9785455|NCT00528801|10892441|FG000|NOT COMPLETED|Overall Study||27
9785456|NCT00528801|10892442|FG001|NOT COMPLETED|Overall Study||11
10015202|NCT01804465|11138261|FG000|STARTED|Overall Study||24
10015203|NCT01804465|11138262|FG001|STARTED|Overall Study||26
9785457|NCT00528840|10892448|FG000|STARTED|Overall Study||201
9785458|NCT00528840|10892448|FG000|COMPLETED|Overall Study||168
9785459|NCT00528840|10892448|FG000|NOT COMPLETED|Overall Study||33
9785460|NCT00528866|10892452|FG000|STARTED|Overall Study||80
9785461|NCT00528866|10892452|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
9785462|NCT00528866|10892452|FG000|NOT COMPLETED|Overall Study||6
9785463|NCT00528879|10892461|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137
9785464|NCT00528879|10892462|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137
9785465|NCT00528879|10892463|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137
9785466|NCT00528879|10892464|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135
9785467|NCT00528879|10892461|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119
9785468|NCT00528879|10892462|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121
9785469|NCT00528879|10892463|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122
9785470|NCT00528879|10892464|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121
9785471|NCT00528879|10892461|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
9785472|NCT00528879|10892462|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
9785473|NCT00528879|10892463|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
9785474|NCT00528879|10892464|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
9785475|NCT00528879|10892461|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
9785476|NCT00528879|10892462|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
9785477|NCT00528879|10892463|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
9785478|NCT00528879|10892464|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
9785479|NCT00528879|10892461|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115
9785480|NCT00528879|10892462|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120
9785481|NCT00528879|10892463|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122
9785482|NCT00528879|10892464|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119
9785483|NCT00528879|10892461|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73
9785484|NCT00528879|10892462|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82
9785485|NCT00528879|10892463|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89
9785486|NCT00528879|10892464|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95
9785487|NCT00528879|10892461|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
9785488|NCT00528879|10892462|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
9785489|NCT00528879|10892463|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
9785490|NCT00528879|10892464|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
9785491|NCT00528931|10892474|FG000|STARTED|Overall Study||16
9785492|NCT00528931|10892474|FG000|COMPLETED|Overall Study||15
9785493|NCT00528931|10892474|FG000|NOT COMPLETED|Overall Study||1
9785494|NCT00528957|10892481|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48
9785495|NCT00528957|10892482|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49
9785496|NCT00528957|10892481|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44
9785497|NCT00528957|10892482|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48
9785498|NCT00528957|10892481|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
9785499|NCT00528957|10892482|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
9785500|NCT00528957|10892481|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
9785501|NCT00528957|10892482|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
9785502|NCT00528957|10892481|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35
9785503|NCT00528957|10892482|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40
9785504|NCT00528957|10892481|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
9785505|NCT00528957|10892482|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
9785506|NCT00528957|10892481|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
9785507|NCT00528957|10892482|FG001|STARTED|Second Extension (Week 144 to Week 240)||40
9785508|NCT00528957|10892481|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27
9785509|NCT00528957|10892482|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37
9785510|NCT00528957|10892481|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
9785511|NCT00528957|10892482|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
9785512|NCT00528957|10892481|FG000|STARTED|Third Extension (Week 240 to Week 336)||27
9785513|NCT00528957|10892482|FG001|STARTED|Third Extension (Week 240 to Week 336)||37
9785514|NCT00528957|10892481|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21
9785515|NCT00528957|10892482|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27
9785516|NCT00528957|10892481|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
9785517|NCT00528957|10892482|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
9785518|NCT00528957|10892481|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
9785519|NCT00528957|10892482|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
9785520|NCT00528957|10892481|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9
9785521|NCT00528957|10892482|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8
9785522|NCT00528957|10892481|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
9785523|NCT00528957|10892482|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
9785524|NCT00528970|10892501|FG000|STARTED|Overall Study||124
9785525|NCT00528970|10892502|FG001|STARTED|Overall Study||125
9785526|NCT00528970|10892503|FG002|STARTED|Overall Study||125
9785527|NCT00528970|10892501|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124
9785528|NCT00528970|10892502|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125
9785529|NCT00528970|10892503|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124
9785530|NCT00528970|10892501|FG000|COMPLETED|Overall Study||110
9785531|NCT00528970|10892502|FG001|COMPLETED|Overall Study||110
9785532|NCT00528970|10892503|FG002|COMPLETED|Overall Study||105
9785533|NCT00528970|10892501|FG000|NOT COMPLETED|Overall Study||14
9785534|NCT00528970|10892502|FG001|NOT COMPLETED|Overall Study||15
9785535|NCT00528970|10892503|FG002|NOT COMPLETED|Overall Study||20
9785536|NCT00528996|10892516|FG000|STARTED|Overall Study||429
9785537|NCT00528996|10892517|FG001|STARTED|Overall Study||419
9785538|NCT00528996|10892518|FG002|STARTED|Overall Study||415
9785539|NCT00528996|10892519|FG003|STARTED|Overall Study||390
9785540|NCT00528996|10892520|FG004|STARTED|Overall Study||427
9785541|NCT00528996|10892516|FG000|COMPLETED|Overall Study||365
9785542|NCT00528996|10892517|FG001|COMPLETED|Overall Study||395
10234026|NCT01589926|11363915|FG000|NOT COMPLETED|Overall Study||0
10234027|NCT01589926|11363916|FG001|NOT COMPLETED|Overall Study||0
10234028|NCT01576575|11363922|FG000|STARTED|Buprenorphine Control||21
9785543|NCT00528996|10892518|FG002|COMPLETED|Overall Study||372
9785544|NCT00528996|10892519|FG003|COMPLETED|Overall Study||340
9785545|NCT00528996|10892520|FG004|COMPLETED|Overall Study||390
9785546|NCT00528996|10892516|FG000|NOT COMPLETED|Overall Study||64
9785547|NCT00528996|10892517|FG001|NOT COMPLETED|Overall Study||24
9785548|NCT00528996|10892518|FG002|NOT COMPLETED|Overall Study||43
9785549|NCT00528996|10892519|FG003|NOT COMPLETED|Overall Study||50
9785550|NCT00528996|10892520|FG004|NOT COMPLETED|Overall Study||37
9785551|NCT00529035|10892535|FG000|STARTED|Overall Study|29 enrolled|29
9785552|NCT00529035|10892535|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
9785553|NCT00529035|10892535|FG000|NOT COMPLETED|Overall Study||1
9785554|NCT00529087|10892549|FG000|STARTED|Overall Study||150
9785555|NCT00529087|10892550|FG001|STARTED|Overall Study||148
9785556|NCT00529087|10892551|FG002|STARTED|Overall Study||162
9785557|NCT00529087|10892549|FG000|COMPLETED|Overall Study||122
9785558|NCT00529087|10892550|FG001|COMPLETED|Overall Study||120
9785559|NCT00529087|10892551|FG002|COMPLETED|Overall Study||146
10234029|NCT01576575|11363922|FG000|COMPLETED|Buprenorphine Control||18
10234030|NCT01576575|11363922|FG000|NOT COMPLETED|Buprenorphine Control||3
10234031|NCT01576575|11363922|FG000|STARTED|Buprenorphine + Rifampin||18
10234032|NCT01576575|11363922|FG000|COMPLETED|Buprenorphine + Rifampin||15
10234033|NCT01576575|11363922|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3
10234034|NCT01576575|11363922|FG000|STARTED|Buprenorphine + Grapefruit||15
10234035|NCT01576575|11363922|FG000|COMPLETED|Buprenorphine + Grapefruit||14
10234036|NCT01576575|11363922|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1
10234037|NCT01576575|11363922|FG000|STARTED|Buprenorphine + Ketoconazole||14
10234038|NCT01576575|11363922|FG000|COMPLETED|Buprenorphine + Ketoconazole||14
10234039|NCT01576575|11363922|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0
10234040|NCT01590394|11363932|FG000|STARTED|Overall Study||3
10234041|NCT01590394|11363932|FG000|COMPLETED|Overall Study||3
10234042|NCT01590394|11363932|FG000|NOT COMPLETED|Overall Study||0
10234043|NCT01577628|11363938|FG000|STARTED|Overall Study||0
10234044|NCT01577628|11363939|FG001|STARTED|Overall Study||0
10234045|NCT01577628|11363940|FG002|STARTED|Overall Study||2
10234046|NCT01577628|11363938|FG000|COMPLETED|Overall Study||0
10234047|NCT01577628|11363939|FG001|COMPLETED|Overall Study||0
10234048|NCT01577628|11363940|FG002|COMPLETED|Overall Study||0
10234049|NCT01577628|11363938|FG000|NOT COMPLETED|Overall Study||0
9785560|NCT00529087|10892549|FG000|NOT COMPLETED|Overall Study||28
9785561|NCT00529087|10892550|FG001|NOT COMPLETED|Overall Study||28
9785562|NCT00529087|10892551|FG002|NOT COMPLETED|Overall Study||16
9785563|NCT00529100|10892572|FG000|STARTED|Overall Study||16
9785564|NCT00529100|10892573|FG001|STARTED|Overall Study||33
9785565|NCT00529100|10892572|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
9785566|NCT00529100|10892573|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33
9785567|NCT00529100|10892572|FG000|COMPLETED|Overall Study||16
9785568|NCT00529100|10892573|FG001|COMPLETED|Overall Study||24
9785569|NCT00529100|10892572|FG000|NOT COMPLETED|Overall Study||0
9785570|NCT00529100|10892573|FG001|NOT COMPLETED|Overall Study||9
9785571|NCT00529126|10892587|FG000|STARTED|Overall Study||25
9785572|NCT00529126|10892588|FG001|STARTED|Overall Study||25
9785573|NCT00529126|10892589|FG002|STARTED|Overall Study||24
9785574|NCT00529126|10892590|FG003|STARTED|Overall Study||26
9785575|NCT00529126|10892587|FG000|COMPLETED|Overall Study||25
9785576|NCT00529126|10892588|FG001|COMPLETED|Overall Study||25
9785577|NCT00529126|10892589|FG002|COMPLETED|Overall Study||24
9785578|NCT00529126|10892590|FG003|COMPLETED|Overall Study||26
10234050|NCT01577628|11363939|FG001|NOT COMPLETED|Overall Study||0
9785579|NCT00529126|10892587|FG000|NOT COMPLETED|Overall Study||0
9785580|NCT00529126|10892588|FG001|NOT COMPLETED|Overall Study||0
9785581|NCT00529126|10892589|FG002|NOT COMPLETED|Overall Study||0
9785582|NCT00529126|10892590|FG003|NOT COMPLETED|Overall Study||0
9785583|NCT00529191|10892602|FG000|STARTED|Overall Study||27
9785584|NCT00529191|10892603|FG001|STARTED|Overall Study||13
10234051|NCT01577628|11363940|FG002|NOT COMPLETED|Overall Study||2
10234052|NCT01582100|11363946|FG000|STARTED|Overall Study||2
10234053|NCT01582100|11363946|FG000|COMPLETED|Overall Study||0
10234054|NCT01582100|11363946|FG000|NOT COMPLETED|Overall Study||2
9785585|NCT00529191|10892602|FG000|COMPLETED|Overall Study||24
9785586|NCT00529191|10892603|FG001|COMPLETED|Overall Study||13
9785587|NCT00529191|10892602|FG000|NOT COMPLETED|Overall Study||3
9785588|NCT00529191|10892603|FG001|NOT COMPLETED|Overall Study||0
9785589|NCT00529204|10892618|FG000|STARTED|Overall Study||1
9785590|NCT00529204|10892618|FG000|COMPLETED|Overall Study||1
9785591|NCT00529204|10892618|FG000|NOT COMPLETED|Overall Study||0
9785592|NCT00529217|10892622|FG000|STARTED|Overall Study||12
9785593|NCT00529217|10892622|FG000|COMPLETED|Overall Study||8
9785594|NCT00529217|10892622|FG000|NOT COMPLETED|Overall Study||4
9785595|NCT00529243|10892627|FG000|STARTED|Overall Study||52
9785596|NCT00529243|10892627|FG000|COMPLETED|Overall Study||49
9785597|NCT00529243|10892627|FG000|NOT COMPLETED|Overall Study||3
9785598|NCT00529308|10892633|FG000|STARTED|Overall Study||9
9785599|NCT00529308|10892634|FG001|STARTED|Overall Study||11
9785600|NCT00529308|10892633|FG000|COMPLETED|Overall Study||8
9785601|NCT00529308|10892634|FG001|COMPLETED|Overall Study||10
9785602|NCT00529308|10892633|FG000|NOT COMPLETED|Overall Study||1
9785603|NCT00529308|10892634|FG001|NOT COMPLETED|Overall Study||1
9785604|NCT00529373|10892642|FG000|STARTED|Base Study||8043
9785605|NCT00529373|10892643|FG001|STARTED|Base Study||8028
9785606|NCT00529373|10892642|FG000|COMPLETED|Base Study||4297
9785607|NCT00529373|10892643|FG001|COMPLETED|Base Study||3960
9785608|NCT00529373|10892642|FG000|NOT COMPLETED|Base Study||3746
9785609|NCT00529373|10892643|FG001|NOT COMPLETED|Base Study||4068
9785610|NCT00529373|10892642|FG000|STARTED|First Extension Study||4297
9785611|NCT00529373|10892643|FG001|STARTED|First Extension Study||3960
9785612|NCT00529373|10892642|FG000|COMPLETED|First Extension Study||3144
9785613|NCT00529373|10892643|FG001|COMPLETED|First Extension Study||2309
9785614|NCT00529373|10892642|FG000|NOT COMPLETED|First Extension Study||1153
9785615|NCT00529373|10892643|FG001|NOT COMPLETED|First Extension Study||1651
9785616|NCT00529373|10892642|FG000|STARTED|Second Extension Study||3144
9785617|NCT00529373|10892643|FG001|STARTED|Second Extension Study||2309
9785618|NCT00529373|10892642|FG000|COMPLETED|Second Extension Study||2844
9785619|NCT00529373|10892643|FG001|COMPLETED|Second Extension Study||2112
9785620|NCT00529373|10892642|FG000|NOT COMPLETED|Second Extension Study||300
9785621|NCT00529373|10892643|FG001|NOT COMPLETED|Second Extension Study||197
9785622|NCT00529386|10892657|FG000|STARTED|Overall Study|Study has been discontinued|7
9785623|NCT00529386|10892657|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
9785624|NCT00529386|10892657|FG000|NOT COMPLETED|Overall Study||1
9785625|NCT00529399|10892664|FG000|STARTED|Overall Study||48
9785626|NCT00529399|10892665|FG001|STARTED|Overall Study||49
9785627|NCT00529399|10892666|FG002|STARTED|Overall Study||48
9785628|NCT00529399|10892664|FG000|COMPLETED|Overall Study||46
9785629|NCT00529399|10892665|FG001|COMPLETED|Overall Study||48
9785630|NCT00529399|10892666|FG002|COMPLETED|Overall Study||46
9785631|NCT00529399|10892664|FG000|NOT COMPLETED|Overall Study||2
9785632|NCT00529399|10892665|FG001|NOT COMPLETED|Overall Study||1
9785633|NCT00529399|10892666|FG002|NOT COMPLETED|Overall Study||2
9785634|NCT00529451|10892678|FG000|STARTED|Overall Study||331
9785635|NCT00529451|10892679|FG001|STARTED|Overall Study||323
9785636|NCT00529451|10892680|FG002|STARTED|Overall Study||332
9785637|NCT00529451|10892681|FG003|STARTED|Overall Study||330
9785638|NCT00529451|10892678|FG000|COMPLETED|Overall Study||294
9785639|NCT00529451|10892679|FG001|COMPLETED|Overall Study||275
9785640|NCT00529451|10892680|FG002|COMPLETED|Overall Study||292
9785641|NCT00529451|10892681|FG003|COMPLETED|Overall Study||299
9785642|NCT00529451|10892678|FG000|NOT COMPLETED|Overall Study||37
9785643|NCT00529451|10892679|FG001|NOT COMPLETED|Overall Study||48
9785644|NCT00529451|10892680|FG002|NOT COMPLETED|Overall Study||40
9785645|NCT00529451|10892681|FG003|NOT COMPLETED|Overall Study||31
9785646|NCT00529516|10892697|FG000|STARTED|Overall Study||475
9785647|NCT00529516|10892698|FG001|STARTED|Overall Study||488
9785648|NCT00529516|10892699|FG002|STARTED|Overall Study||289
9785649|NCT00529516|10892697|FG000|COMPLETED|Overall Study||472
9785650|NCT00529516|10892698|FG001|COMPLETED|Overall Study||486
9785651|NCT00529516|10892699|FG002|COMPLETED|Overall Study||288
9785652|NCT00529516|10892697|FG000|NOT COMPLETED|Overall Study||3
9785653|NCT00529516|10892698|FG001|NOT COMPLETED|Overall Study||2
9785654|NCT00529516|10892699|FG002|NOT COMPLETED|Overall Study||1
9785655|NCT00529529|10892710|FG000|STARTED|Overall Study||268
9785656|NCT00529529|10892711|FG001|STARTED|Overall Study||268
9785657|NCT00529529|10892712|FG002|STARTED|Overall Study||269
9785658|NCT00529529|10892710|FG000|COMPLETED|Overall Study||225
9785659|NCT00529529|10892711|FG001|COMPLETED|Overall Study||225
9785660|NCT00529529|10892712|FG002|COMPLETED|Overall Study||238
9785661|NCT00529529|10892710|FG000|NOT COMPLETED|Overall Study||43
9785662|NCT00529529|10892711|FG001|NOT COMPLETED|Overall Study||43
9785663|NCT00529529|10892712|FG002|NOT COMPLETED|Overall Study||31
9785664|NCT00529542|10892722|FG000|STARTED|Overall Study||9
9785665|NCT00529542|10892723|FG001|STARTED|Overall Study||11
9785666|NCT00529542|10892722|FG000|COMPLETED|Overall Study||8
9785667|NCT00529542|10892723|FG001|COMPLETED|Overall Study||10
9785668|NCT00529542|10892722|FG000|NOT COMPLETED|Overall Study||1
9785669|NCT00529542|10892723|FG001|NOT COMPLETED|Overall Study||1
9785670|NCT00529555|10892732|FG000|STARTED|Overall Study||200
9785671|NCT00529555|10892733|FG001|STARTED|Overall Study||202
9785672|NCT00529555|10892734|FG002|STARTED|Overall Study||200
9785673|NCT00529555|10892732|FG000|COMPLETED|Overall Study||171
9785674|NCT00529555|10892733|FG001|COMPLETED|Overall Study||172
9785675|NCT00529555|10892734|FG002|COMPLETED|Overall Study||174
9785676|NCT00529555|10892732|FG000|NOT COMPLETED|Overall Study||29
9785677|NCT00529555|10892733|FG001|NOT COMPLETED|Overall Study||30
9785678|NCT00529555|10892734|FG002|NOT COMPLETED|Overall Study||26
9830438|NCT00763035|10941100|FG000|STARTED|Second Intervention||9
9830439|NCT00763035|10941101|FG001|STARTED|Second Intervention||3
9830440|NCT00763035|10941100|FG000|COMPLETED|Second Intervention||6
9830441|NCT00763035|10941101|FG001|COMPLETED|Second Intervention||3
9830442|NCT00763035|10941100|FG000|NOT COMPLETED|Second Intervention||3
9830443|NCT00763035|10941101|FG001|NOT COMPLETED|Second Intervention||0
9830444|NCT00763048|10941109|FG000|STARTED|Overall Study||21
9830445|NCT00763048|10941110|FG001|STARTED|Overall Study||18
9830446|NCT00763048|10941109|FG000|COMPLETED|Overall Study||21
9830447|NCT00763048|10941110|FG001|COMPLETED|Overall Study||18
9830448|NCT00763048|10941109|FG000|NOT COMPLETED|Overall Study||0
10015204|NCT01804465|11138261|FG000|COMPLETED|Overall Study||24
10015205|NCT01804465|11138262|FG001|COMPLETED|Overall Study||26
10015206|NCT01804465|11138261|FG000|NOT COMPLETED|Overall Study||0
10015207|NCT01804465|11138262|FG001|NOT COMPLETED|Overall Study||0
10015208|NCT01804582|11138270|FG000|STARTED|Overall Study||177
10015209|NCT01804582|11138271|FG001|STARTED|Overall Study||173
10015210|NCT01804582|11138270|FG000|COMPLETED|Overall Study||128
10015211|NCT01804582|11138271|FG001|COMPLETED|Overall Study||117
10015212|NCT01804582|11138270|FG000|NOT COMPLETED|Overall Study||49
10015213|NCT01804582|11138271|FG001|NOT COMPLETED|Overall Study||56
9830449|NCT00763048|10941110|FG001|NOT COMPLETED|Overall Study||0
9830450|NCT00763061|10941118|FG000|STARTED|Overall Study||54
9830451|NCT00763061|10941119|FG001|STARTED|Overall Study||57
9830452|NCT00763061|10941118|FG000|COMPLETED|Overall Study||49
9830453|NCT00763061|10941119|FG001|COMPLETED|Overall Study||44
9830454|NCT00763061|10941118|FG000|NOT COMPLETED|Overall Study||5
9830455|NCT00763061|10941119|FG001|NOT COMPLETED|Overall Study||13
9830456|NCT00763139|10941125|FG000|STARTED|Overall Study||17
9830457|NCT00763139|10941126|FG001|STARTED|Overall Study||17
9830458|NCT00763139|10941125|FG000|COMPLETED|Overall Study||12
9830459|NCT00763139|10941126|FG001|COMPLETED|Overall Study||14
9830460|NCT00763139|10941125|FG000|NOT COMPLETED|Overall Study||5
9830461|NCT00763139|10941126|FG001|NOT COMPLETED|Overall Study||3
9830462|NCT00763243|10941137|FG000|STARTED|Waiting Period||9
9830463|NCT00763243|10941137|FG000|COMPLETED|Waiting Period||9
9830464|NCT00763243|10941137|FG000|NOT COMPLETED|Waiting Period||0
9830465|NCT00763243|10941137|FG000|STARTED|Training Period||9
9830466|NCT00763243|10941137|FG000|COMPLETED|Training Period||9
9830467|NCT00763243|10941137|FG000|NOT COMPLETED|Training Period||0
9830468|NCT00763243|10941137|FG000|STARTED|1-Month Follow-Up Period||9
9830469|NCT00763243|10941137|FG000|COMPLETED|1-Month Follow-Up Period||9
9830470|NCT00763243|10941137|FG000|NOT COMPLETED|1-Month Follow-Up Period||0
9830471|NCT00763243|10941137|FG000|STARTED|6-Month Follow-Up Period||9
9830472|NCT00763243|10941137|FG000|COMPLETED|6-Month Follow-Up Period||9
9830473|NCT00763243|10941137|FG000|NOT COMPLETED|6-Month Follow-Up Period||0
9830474|NCT00763256|10941151|FG000|STARTED|Overall Study||15
9830475|NCT00763256|10941152|FG001|STARTED|Overall Study||18
9830476|NCT00763256|10941151|FG000|COMPLETED|Overall Study||8
9830477|NCT00763256|10941152|FG001|COMPLETED|Overall Study||8
9830478|NCT00763256|10941151|FG000|NOT COMPLETED|Overall Study||7
9830479|NCT00763256|10941152|FG001|NOT COMPLETED|Overall Study||10
9830480|NCT00763269|10941160|FG000|STARTED|Overall Study||314
9830481|NCT00763269|10941161|FG001|STARTED|Overall Study||312
9830482|NCT00763269|10941160|FG000|COMPLETED|Overall Study||302
9830483|NCT00763269|10941161|FG001|COMPLETED|Overall Study||299
9830484|NCT00763269|10941160|FG000|NOT COMPLETED|Overall Study||12
9830485|NCT00763269|10941161|FG001|NOT COMPLETED|Overall Study||13
9832481|NCT00773253|10943242|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0
9832482|NCT00773253|10943243|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0
9832483|NCT00773279|10943251|FG000|STARTED|Period 1||121
9832484|NCT00773279|10943252|FG001|STARTED|Period 1||121
9832485|NCT00773279|10943251|FG000|COMPLETED|Period 1||114
9832486|NCT00773279|10943252|FG001|COMPLETED|Period 1||117
9832487|NCT00773279|10943251|FG000|NOT COMPLETED|Period 1||7
9832488|NCT00773279|10943252|FG001|NOT COMPLETED|Period 1||4
9832489|NCT00773279|10943251|FG000|STARTED|Period 2||114
9832490|NCT00773279|10943252|FG001|STARTED|Period 2||117
9832491|NCT00773279|10943251|FG000|COMPLETED|Period 2||111
9832492|NCT00773279|10943252|FG001|COMPLETED|Period 2||111
9832493|NCT00773279|10943251|FG000|NOT COMPLETED|Period 2||3
9832494|NCT00773279|10943252|FG001|NOT COMPLETED|Period 2||6
9832495|NCT00773292|10943259|FG000|STARTED|Pre-treatment 4 Weeks||7
9832496|NCT00773292|10943259|FG000|COMPLETED|Pre-treatment 4 Weeks||7
10015214|NCT01804673|11138278|FG000|STARTED|Overall Study||174
10015215|NCT01804673|11138278|FG000|Completed Hour 24|Overall Study||170
10015216|NCT01804673|11138278|FG000|Completed Hour 48|Overall Study||79
10015217|NCT01804673|11138278|FG000|Completed Hour 72|Overall Study||36
10015218|NCT01804673|11138278|FG000|COMPLETED|Overall Study||34
10015219|NCT01804673|11138278|FG000|NOT COMPLETED|Overall Study||140
9832497|NCT00773292|10943259|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0
9832498|NCT00773292|10943259|FG000|STARTED|Treatment 48 Weeks||7
9832499|NCT00773292|10943259|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5
9832500|NCT00773292|10943259|FG000|NOT COMPLETED|Treatment 48 Weeks||2
9832501|NCT00773292|10943259|FG000|STARTED|Post Treatment 24 Weeks||7
9832502|NCT00773292|10943259|FG000|COMPLETED|Post Treatment 24 Weeks||7
9832503|NCT00773292|10943259|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0
9832504|NCT00773370|10943265|FG000|STARTED|Overall Study||43
9832505|NCT00773370|10943266|FG001|STARTED|Overall Study||33
9785679|NCT00529568|10892744|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805
9785680|NCT00529568|10892745|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0
9785681|NCT00529568|10892746|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0
9785682|NCT00529568|10892744|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
9785683|NCT00529568|10892745|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
9785684|NCT00529568|10892746|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
9785685|NCT00529568|10892744|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
9785686|NCT00529568|10892745|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
9785687|NCT00529568|10892746|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
9785688|NCT00529568|10892744|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0
9785689|NCT00529568|10892745|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253
9785690|NCT00529568|10892746|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506
9785691|NCT00529568|10892744|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
9785692|NCT00529568|10892745|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
9785693|NCT00529568|10892746|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
9785694|NCT00529568|10892744|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
9785695|NCT00529568|10892745|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
9785696|NCT00529568|10892746|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
9785697|NCT00529633|10892757|FG000|STARTED|Overall Study||2
9785698|NCT00529633|10892758|FG001|STARTED|Overall Study||2
9785699|NCT00529633|10892757|FG000|COMPLETED|Overall Study||1
9785700|NCT00529633|10892758|FG001|COMPLETED|Overall Study||1
9785701|NCT00529633|10892757|FG000|NOT COMPLETED|Overall Study||1
9785702|NCT00529633|10892758|FG001|NOT COMPLETED|Overall Study||1
9785703|NCT00529659|10892766|FG000|STARTED|Overall Study||81
9785704|NCT00529659|10892767|FG001|STARTED|Overall Study||89
9785705|NCT00529659|10892766|FG000|COMPLETED|Overall Study||70
9785706|NCT00529659|10892767|FG001|COMPLETED|Overall Study||66
9785707|NCT00529659|10892766|FG000|NOT COMPLETED|Overall Study||11
9785708|NCT00529659|10892767|FG001|NOT COMPLETED|Overall Study||23
9785709|NCT00529789|10892773|FG000|STARTED|Study Period II/III||72
9785710|NCT00529789|10892773|FG000|COMPLETED|Study Period II/III||48
9785711|NCT00529789|10892773|FG000|NOT COMPLETED|Study Period II/III||24
9785712|NCT00529789|10892773|FG000|STARTED|Study Period IV||48
9785713|NCT00529789|10892773|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
9785714|NCT00529789|10892773|FG000|NOT COMPLETED|Study Period IV||6
9785715|NCT00529802|10892783|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
9785716|NCT00529802|10892783|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
9785717|NCT00529802|10892783|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10
9785718|NCT00529802|10892783|FG000|STARTED|Evaluable for Secondary Endpoint||50
9785719|NCT00529802|10892783|FG000|COMPLETED|Evaluable for Secondary Endpoint||48
9785720|NCT00529802|10892783|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2
9785721|NCT00529958|10892792|FG000|STARTED|2-Year Follow-up||110
9785722|NCT00529958|10892793|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
9785723|NCT00529958|10892794|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
9785724|NCT00529958|10892792|FG000|COMPLETED|2-Year Follow-up||106
9785725|NCT00529958|10892793|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
9785726|NCT00529958|10892794|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
9785727|NCT00529958|10892792|FG000|NOT COMPLETED|2-Year Follow-up||4
9785728|NCT00529958|10892793|FG001|NOT COMPLETED|2-Year Follow-up||2
9785729|NCT00529958|10892794|FG002|NOT COMPLETED|2-Year Follow-up||2
9785730|NCT00529958|10892792|FG000|STARTED|5-Year Follow-up||106
9785731|NCT00529958|10892793|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
9785732|NCT00529958|10892794|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
9785733|NCT00529958|10892792|FG000|COMPLETED|5-Year Follow-up||103
9785734|NCT00529958|10892793|FG001|COMPLETED|5-Year Follow-up||105
9785735|NCT00529958|10892794|FG002|COMPLETED|5-Year Follow-up||107
9785736|NCT00529958|10892792|FG000|NOT COMPLETED|5-Year Follow-up||3
9785737|NCT00529958|10892793|FG001|NOT COMPLETED|5-Year Follow-up||3
9785738|NCT00529958|10892794|FG002|NOT COMPLETED|5-Year Follow-up||1
9785739|NCT00530023|10892804|FG000|STARTED|Overall Study||14
9785740|NCT00530023|10892805|FG001|STARTED|Overall Study||15
9785741|NCT00530023|10892804|FG000|COMPLETED|Overall Study||14
9785742|NCT00530023|10892805|FG001|COMPLETED|Overall Study||14
9785743|NCT00530023|10892804|FG000|NOT COMPLETED|Overall Study||0
9785744|NCT00530023|10892805|FG001|NOT COMPLETED|Overall Study||1
9785745|NCT00530075|10892811|FG000|STARTED|Overall Study||45
9785746|NCT00530075|10892811|FG000|COMPLETED|Overall Study||38
9785747|NCT00530075|10892811|FG000|NOT COMPLETED|Overall Study||7
9785748|NCT00530088|10892815|FG000|STARTED|Overall Study||30
9785749|NCT00530088|10892815|FG000|COMPLETED|Overall Study||20
9785750|NCT00530088|10892815|FG000|NOT COMPLETED|Overall Study||10
9785751|NCT00530218|10892819|FG000|STARTED|Overall Study||61
9785752|NCT00530218|10892819|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
9785753|NCT00530218|10892819|FG000|NOT COMPLETED|Overall Study||25
9785754|NCT00530257|10892826|FG000|STARTED|Overall Study||31
9785755|NCT00530257|10892826|FG000|COMPLETED|Overall Study||30
9785756|NCT00530257|10892826|FG000|NOT COMPLETED|Overall Study||1
9785757|NCT00530270|10892835|FG000|STARTED|Overall Study||6
9785758|NCT00530270|10892836|FG001|STARTED|Overall Study||6
9785759|NCT00530270|10892835|FG000|COMPLETED|Overall Study||5
9785760|NCT00530270|10892836|FG001|COMPLETED|Overall Study||6
9785761|NCT00530270|10892835|FG000|NOT COMPLETED|Overall Study||1
9785762|NCT00530270|10892836|FG001|NOT COMPLETED|Overall Study||0
9785763|NCT00530335|10892842|FG000|STARTED|Overall Study||45
9785764|NCT00530335|10892842|FG000|COMPLETED|Overall Study||39
9785765|NCT00530335|10892842|FG000|NOT COMPLETED|Overall Study||6
9785766|NCT00530348|10892848|FG000|STARTED|Overall Study|Randomized.|195
9785767|NCT00530348|10892849|FG001|STARTED|Overall Study|Randomized.|386
9785768|NCT00530348|10892848|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
9785769|NCT00530348|10892849|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
9785770|NCT00530348|10892848|FG000|COMPLETED|Overall Study||173
9785771|NCT00530348|10892849|FG001|COMPLETED|Overall Study||367
9785772|NCT00530348|10892848|FG000|NOT COMPLETED|Overall Study||22
9785773|NCT00530348|10892849|FG001|NOT COMPLETED|Overall Study||19
9785774|NCT00530439|10892857|FG000|STARTED|Overall Study||180
9785775|NCT00530439|10892858|FG001|STARTED|Overall Study||180
9785776|NCT00530439|10892857|FG000|COMPLETED|Overall Study||150
9785777|NCT00530439|10892858|FG001|COMPLETED|Overall Study||154
9785778|NCT00530439|10892857|FG000|NOT COMPLETED|Overall Study||30
9785779|NCT00530439|10892858|FG001|NOT COMPLETED|Overall Study||26
9785780|NCT00530504|10892864|FG000|STARTED|Overall Study||1500
9785781|NCT00530504|10892864|FG000|COMPLETED|Overall Study||1348
9785782|NCT00530504|10892864|FG000|NOT COMPLETED|Overall Study||152
9785783|NCT00530621|10892870|FG000|STARTED|Overall Study||80
9785784|NCT00530621|10892871|FG001|STARTED|Overall Study||80
9785785|NCT00530621|10892870|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79
9785786|NCT00530621|10892871|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
9785787|NCT00530621|10892870|FG000|COMPLETED|Overall Study||0
9785788|NCT00530621|10892871|FG001|COMPLETED|Overall Study||0
9785789|NCT00530621|10892870|FG000|NOT COMPLETED|Overall Study||80
9785790|NCT00530621|10892871|FG001|NOT COMPLETED|Overall Study||80
9785791|NCT00530634|10892881|FG000|STARTED|Overall Study||3
9785792|NCT00530634|10892881|FG000|COMPLETED|Overall Study||3
9785793|NCT00530634|10892881|FG000|NOT COMPLETED|Overall Study||0
9785794|NCT00530712|10892885|FG000|STARTED|Enrollment|Total Enrolled Subjects|287
9785795|NCT00530712|10892885|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287
9785796|NCT00530712|10892885|FG000|NOT COMPLETED|Enrollment||0
9785797|NCT00530712|10892885|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
9785798|NCT00530712|10892885|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
9785799|NCT00530712|10892885|FG000|NOT COMPLETED|30 Day Follow-up Visit||7
9785800|NCT00530712|10892885|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
9785801|NCT00530712|10892885|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
9785802|NCT00530712|10892885|FG000|NOT COMPLETED|6 Month Follow-up Visit||12
9785803|NCT00530712|10892885|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
9785804|NCT00530712|10892885|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
9785805|NCT00530712|10892885|FG000|NOT COMPLETED|12 Month Follow-up Visit||24
9785806|NCT00530764|10892894|FG000|STARTED|Overall Study||90
9785807|NCT00530764|10892895|FG001|STARTED|Overall Study||88
9785808|NCT00530764|10892896|FG002|STARTED|Overall Study||91
9785809|NCT00530764|10892897|FG003|STARTED|Overall Study||91
9785810|NCT00530764|10892894|FG000|COMPLETED|Overall Study||59
9785811|NCT00530764|10892895|FG001|COMPLETED|Overall Study||67
9785812|NCT00530764|10892896|FG002|COMPLETED|Overall Study||71
9785813|NCT00530764|10892897|FG003|COMPLETED|Overall Study||66
9785814|NCT00530764|10892894|FG000|NOT COMPLETED|Overall Study||31
9785815|NCT00530764|10892895|FG001|NOT COMPLETED|Overall Study||21
9785816|NCT00530764|10892896|FG002|NOT COMPLETED|Overall Study||20
9785817|NCT00530764|10892897|FG003|NOT COMPLETED|Overall Study||25
9785818|NCT00530777|10892912|FG000|STARTED|Overall Study||74
9785819|NCT00530777|10892913|FG001|STARTED|Overall Study||74
9785820|NCT00530777|10892912|FG000|COMPLETED|Overall Study||67
9785821|NCT00530777|10892913|FG001|COMPLETED|Overall Study||69
9785822|NCT00530777|10892912|FG000|NOT COMPLETED|Overall Study||7
9785823|NCT00530777|10892913|FG001|NOT COMPLETED|Overall Study||5
9785824|NCT00530790|10892919|FG000|STARTED|Overall Study||35
9785825|NCT00530790|10892919|FG000|COMPLETED|Overall Study||30
9785826|NCT00530790|10892919|FG000|NOT COMPLETED|Overall Study||5
9785827|NCT00530803|10892925|FG000|STARTED|Overall Study||50
9785828|NCT00530803|10892926|FG001|STARTED|Overall Study||50
9785829|NCT00530803|10892925|FG000|COMPLETED|Overall Study||50
9785830|NCT00530803|10892926|FG001|COMPLETED|Overall Study||50
9785831|NCT00530803|10892925|FG000|NOT COMPLETED|Overall Study||0
9785832|NCT00530803|10892926|FG001|NOT COMPLETED|Overall Study||0
9785833|NCT00530816|10892935|FG000|STARTED|Overall Study||35
9785834|NCT00530816|10892936|FG001|STARTED|Overall Study||59
9785835|NCT00530816|10892937|FG002|STARTED|Overall Study||70
9785836|NCT00530816|10892935|FG000|COMPLETED|Overall Study||9
9785837|NCT00530816|10892936|FG001|COMPLETED|Overall Study||17
9785838|NCT00530816|10892937|FG002|COMPLETED|Overall Study||29
9785839|NCT00530816|10892935|FG000|NOT COMPLETED|Overall Study||26
9785840|NCT00530816|10892936|FG001|NOT COMPLETED|Overall Study||42
9785841|NCT00530816|10892937|FG002|NOT COMPLETED|Overall Study||41
9785842|NCT00530842|10892947|FG000|STARTED|Overall Study||172
9785843|NCT00530842|10892948|FG001|STARTED|Overall Study||172
9785844|NCT00530842|10892947|FG000|COMPLETED|Overall Study||149
9785845|NCT00530842|10892948|FG001|COMPLETED|Overall Study||151
9785846|NCT00530842|10892947|FG000|NOT COMPLETED|Overall Study||23
9785847|NCT00530842|10892948|FG001|NOT COMPLETED|Overall Study||21
9785848|NCT00530842|10892947|FG000|STARTED|Period 1||172
9785849|NCT00530842|10892948|FG001|STARTED|Period 1||172
9785850|NCT00530842|10892947|FG000|COMPLETED|Period 1||158
9785851|NCT00530842|10892948|FG001|COMPLETED|Period 1||161
9785852|NCT00530842|10892947|FG000|NOT COMPLETED|Period 1||14
9785853|NCT00530842|10892948|FG001|NOT COMPLETED|Period 1||11
9785854|NCT00530842|10892947|FG000|STARTED|Period 2||157
9785855|NCT00530842|10892948|FG001|STARTED|Period 2||160
9785856|NCT00530842|10892947|FG000|COMPLETED|Period 2||149
9785857|NCT00530842|10892948|FG001|COMPLETED|Period 2||151
9785858|NCT00530842|10892947|FG000|NOT COMPLETED|Period 2||8
9785859|NCT00530842|10892948|FG001|NOT COMPLETED|Period 2||9
9785860|NCT00530855|10892956|FG000|STARTED|Overall Study||322
9785861|NCT00530855|10892956|FG000|COMPLETED|Overall Study||210
9785862|NCT00530855|10892956|FG000|NOT COMPLETED|Overall Study||112
9785863|NCT00530894|10892964|FG000|STARTED|Overall Study||348
9785864|NCT00530894|10892965|FG001|STARTED|Overall Study||351
9785865|NCT00530894|10892966|FG002|STARTED|Overall Study||179
9785866|NCT00530894|10892967|FG003|STARTED|Overall Study||179
9785867|NCT00530894|10892964|FG000|COMPLETED|Overall Study||260
9785868|NCT00530894|10892965|FG001|COMPLETED|Overall Study||236
9785869|NCT00530894|10892966|FG002|COMPLETED|Overall Study||124
9785870|NCT00530894|10892967|FG003|COMPLETED|Overall Study||85
9785871|NCT00530894|10892964|FG000|NOT COMPLETED|Overall Study||88
9785872|NCT00530894|10892965|FG001|NOT COMPLETED|Overall Study||115
9785873|NCT00530894|10892966|FG002|NOT COMPLETED|Overall Study||55
9785874|NCT00530894|10892967|FG003|NOT COMPLETED|Overall Study||94
9785875|NCT00530920|10892982|FG000|STARTED|Overall Study||30
9785876|NCT00530920|10892983|FG001|STARTED|Overall Study||27
9785877|NCT00530920|10892984|FG002|STARTED|Overall Study||28
9785878|NCT00530920|10892982|FG000|COMPLETED|Overall Study||30
9785879|NCT00530920|10892983|FG001|COMPLETED|Overall Study||25
9785880|NCT00530920|10892984|FG002|COMPLETED|Overall Study||24
10234055|NCT01583647|11363950|FG000|STARTED|Overall Study||10
10234056|NCT01583647|11363951|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
10234057|NCT01583647|11363950|FG000|COMPLETED|Overall Study||10
10234058|NCT01583647|11363951|FG001|COMPLETED|Overall Study||0
10234059|NCT01583647|11363950|FG000|NOT COMPLETED|Overall Study||0
9785881|NCT00530920|10892982|FG000|NOT COMPLETED|Overall Study||0
9785882|NCT00530920|10892983|FG001|NOT COMPLETED|Overall Study||2
9785883|NCT00530920|10892984|FG002|NOT COMPLETED|Overall Study||4
9785884|NCT00530946|10892997|FG000|STARTED|Overall Study||43
9785885|NCT00530946|10892998|FG001|STARTED|Overall Study||41
9785886|NCT00530946|10892999|FG002|STARTED|Overall Study||41
9785887|NCT00530946|10893000|FG003|STARTED|Overall Study||40
9785888|NCT00530946|10892997|FG000|COMPLETED|Overall Study||41
9785889|NCT00530946|10892998|FG001|COMPLETED|Overall Study||39
9785890|NCT00530946|10892999|FG002|COMPLETED|Overall Study||40
9785891|NCT00530946|10893000|FG003|COMPLETED|Overall Study||38
9785892|NCT00530946|10892997|FG000|NOT COMPLETED|Overall Study||2
9785893|NCT00530946|10892998|FG001|NOT COMPLETED|Overall Study||2
9785894|NCT00530946|10892999|FG002|NOT COMPLETED|Overall Study||1
9785895|NCT00530946|10893000|FG003|NOT COMPLETED|Overall Study||2
9785896|NCT00531011|10893012|FG000|STARTED|Overall Study||103
9785897|NCT00531011|10893013|FG001|STARTED|Overall Study||97
9785898|NCT00531011|10893012|FG000|COMPLETED|Overall Study||99
9785899|NCT00531011|10893013|FG001|COMPLETED|Overall Study||90
9785900|NCT00531011|10893012|FG000|NOT COMPLETED|Overall Study||4
9785901|NCT00531011|10893013|FG001|NOT COMPLETED|Overall Study||7
9785902|NCT00531050|10893025|FG000|STARTED|Part 1: Period 1||4
9785903|NCT00531050|10893026|FG001|STARTED|Part 1: Period 1||5
9785904|NCT00531050|10893027|FG002|STARTED|Part 1: Period 1||4
9785905|NCT00531050|10893028|FG003|STARTED|Part 1: Period 1||5
9785906|NCT00531050|10893029|FG004|STARTED|Part 1: Period 1||4
9785907|NCT00531050|10893030|FG005|STARTED|Part 1: Period 1||5
9785908|NCT00531050|10893025|FG000|COMPLETED|Part 1: Period 1||4
9785909|NCT00531050|10893026|FG001|COMPLETED|Part 1: Period 1||4
9785910|NCT00531050|10893027|FG002|COMPLETED|Part 1: Period 1||4
9785911|NCT00531050|10893028|FG003|COMPLETED|Part 1: Period 1||4
9785912|NCT00531050|10893029|FG004|COMPLETED|Part 1: Period 1||4
9785913|NCT00531050|10893030|FG005|COMPLETED|Part 1: Period 1||5
9785914|NCT00531050|10893025|FG000|NOT COMPLETED|Part 1: Period 1||0
9785915|NCT00531050|10893026|FG001|NOT COMPLETED|Part 1: Period 1||1
9785916|NCT00531050|10893027|FG002|NOT COMPLETED|Part 1: Period 1||0
9785917|NCT00531050|10893028|FG003|NOT COMPLETED|Part 1: Period 1||1
9785918|NCT00531050|10893029|FG004|NOT COMPLETED|Part 1: Period 1||0
9785919|NCT00531050|10893030|FG005|NOT COMPLETED|Part 1: Period 1||0
10234060|NCT01583647|11363951|FG001|NOT COMPLETED|Overall Study||0
9785920|NCT00531050|10893025|FG000|STARTED|Part 1: Period 2||4
9785921|NCT00531050|10893026|FG001|STARTED|Part 1: Period 2||4
9785922|NCT00531050|10893027|FG002|STARTED|Part 1: Period 2||4
9785923|NCT00531050|10893028|FG003|STARTED|Part 1: Period 2||4
9785924|NCT00531050|10893029|FG004|STARTED|Part 1: Period 2||4
9785925|NCT00531050|10893030|FG005|STARTED|Part 1: Period 2||5
9785926|NCT00531050|10893025|FG000|COMPLETED|Part 1: Period 2||4
9785927|NCT00531050|10893026|FG001|COMPLETED|Part 1: Period 2||4
9785928|NCT00531050|10893027|FG002|COMPLETED|Part 1: Period 2||4
9785929|NCT00531050|10893028|FG003|COMPLETED|Part 1: Period 2||4
9785930|NCT00531050|10893029|FG004|COMPLETED|Part 1: Period 2||4
9785931|NCT00531050|10893030|FG005|COMPLETED|Part 1: Period 2||5
9785932|NCT00531050|10893025|FG000|NOT COMPLETED|Part 1: Period 2||0
9785933|NCT00531050|10893026|FG001|NOT COMPLETED|Part 1: Period 2||0
9785934|NCT00531050|10893027|FG002|NOT COMPLETED|Part 1: Period 2||0
9785935|NCT00531050|10893028|FG003|NOT COMPLETED|Part 1: Period 2||0
9785936|NCT00531050|10893029|FG004|NOT COMPLETED|Part 1: Period 2||0
9785937|NCT00531050|10893030|FG005|NOT COMPLETED|Part 1: Period 2||0
9785938|NCT00531050|10893025|FG000|STARTED|Part 1: Period 3||4
9785939|NCT00531050|10893026|FG001|STARTED|Part 1: Period 3||4
9785940|NCT00531050|10893027|FG002|STARTED|Part 1: Period 3||4
9785941|NCT00531050|10893028|FG003|STARTED|Part 1: Period 3||4
9785942|NCT00531050|10893029|FG004|STARTED|Part 1: Period 3||4
9785943|NCT00531050|10893030|FG005|STARTED|Part 1: Period 3||5
9785944|NCT00531050|10893025|FG000|COMPLETED|Part 1: Period 3||3
9785945|NCT00531050|10893026|FG001|COMPLETED|Part 1: Period 3||4
9785946|NCT00531050|10893027|FG002|COMPLETED|Part 1: Period 3||4
9785947|NCT00531050|10893028|FG003|COMPLETED|Part 1: Period 3||4
9785948|NCT00531050|10893029|FG004|COMPLETED|Part 1: Period 3||4
9785949|NCT00531050|10893030|FG005|COMPLETED|Part 1: Period 3||5
9785950|NCT00531050|10893025|FG000|NOT COMPLETED|Part 1: Period 3||1
9785951|NCT00531050|10893026|FG001|NOT COMPLETED|Part 1: Period 3||0
9785952|NCT00531050|10893027|FG002|NOT COMPLETED|Part 1: Period 3||0
9785953|NCT00531050|10893028|FG003|NOT COMPLETED|Part 1: Period 3||0
9785954|NCT00531050|10893029|FG004|NOT COMPLETED|Part 1: Period 3||0
9785955|NCT00531050|10893030|FG005|NOT COMPLETED|Part 1: Period 3||0
9785956|NCT00531050|10893025|FG000|STARTED|Part 2: Period 1||3
9785957|NCT00531050|10893026|FG001|STARTED|Part 2: Period 1||4
9785958|NCT00531050|10893027|FG002|STARTED|Part 2: Period 1||4
9785959|NCT00531050|10893028|FG003|STARTED|Part 2: Period 1||4
9785960|NCT00531050|10893029|FG004|STARTED|Part 2: Period 1||4
9785961|NCT00531050|10893030|FG005|STARTED|Part 2: Period 1||5
9785962|NCT00531050|10893025|FG000|COMPLETED|Part 2: Period 1||3
9785963|NCT00531050|10893026|FG001|COMPLETED|Part 2: Period 1||4
9785964|NCT00531050|10893027|FG002|COMPLETED|Part 2: Period 1||4
9952355|NCT01421511|11071289|FG001|COMPLETED|Overall Study||306
9952356|NCT01421511|11071288|FG000|NOT COMPLETED|Overall Study||19
9952357|NCT01421511|11071289|FG001|NOT COMPLETED|Overall Study||28
9952358|NCT01421589|11071296|FG000|STARTED|Overall Study||15
9952359|NCT01421589|11071296|FG000|COMPLETED|Overall Study||15
9952360|NCT01421589|11071296|FG000|NOT COMPLETED|Overall Study||0
9952361|NCT01421641|11071303|FG000|STARTED|Overall Study||37
9952362|NCT01421641|11071304|FG001|STARTED|Overall Study||37
9952363|NCT01421641|11071303|FG000|COMPLETED|Overall Study||35
9785965|NCT00531050|10893028|FG003|COMPLETED|Part 2: Period 1||4
9785966|NCT00531050|10893029|FG004|COMPLETED|Part 2: Period 1||4
9785967|NCT00531050|10893030|FG005|COMPLETED|Part 2: Period 1||4
9785968|NCT00531050|10893025|FG000|NOT COMPLETED|Part 2: Period 1||0
9785969|NCT00531050|10893026|FG001|NOT COMPLETED|Part 2: Period 1||0
9785970|NCT00531050|10893027|FG002|NOT COMPLETED|Part 2: Period 1||0
10234061|NCT01575028|11363959|FG000|STARTED|Overall Study||2
10234062|NCT01575028|11363960|FG001|STARTED|Overall Study||1
10234063|NCT01575028|11363959|FG000|COMPLETED|Overall Study||2
10234064|NCT01575028|11363960|FG001|COMPLETED|Overall Study||0
10234065|NCT01575028|11363959|FG000|NOT COMPLETED|Overall Study||0
10234066|NCT01575028|11363960|FG001|NOT COMPLETED|Overall Study||1
10234067|NCT01578785|11363968|FG000|STARTED|Overall Study||59
10234068|NCT01578785|11363969|FG001|STARTED|Overall Study||119
10234069|NCT01578785|11363968|FG000|COMPLETED|Overall Study||0
10234070|NCT01578785|11363969|FG001|COMPLETED|Overall Study||0
9785971|NCT00531050|10893028|FG003|NOT COMPLETED|Part 2: Period 1||0
9785972|NCT00531050|10893029|FG004|NOT COMPLETED|Part 2: Period 1||0
9785973|NCT00531050|10893030|FG005|NOT COMPLETED|Part 2: Period 1||1
9785974|NCT00531050|10893025|FG000|STARTED|Part 2: Period 2||3
9785975|NCT00531050|10893026|FG001|STARTED|Part 2: Period 2||4
9785976|NCT00531050|10893027|FG002|STARTED|Part 2: Period 2||4
9785977|NCT00531050|10893028|FG003|STARTED|Part 2: Period 2||4
9785978|NCT00531050|10893029|FG004|STARTED|Part 2: Period 2||4
9785979|NCT00531050|10893030|FG005|STARTED|Part 2: Period 2||4
9785980|NCT00531050|10893025|FG000|COMPLETED|Part 2: Period 2||3
9785981|NCT00531050|10893026|FG001|COMPLETED|Part 2: Period 2||4
9785982|NCT00531050|10893027|FG002|COMPLETED|Part 2: Period 2||4
9785983|NCT00531050|10893028|FG003|COMPLETED|Part 2: Period 2||4
9785984|NCT00531050|10893029|FG004|COMPLETED|Part 2: Period 2||4
9785985|NCT00531050|10893030|FG005|COMPLETED|Part 2: Period 2||4
9785986|NCT00531050|10893025|FG000|NOT COMPLETED|Part 2: Period 2||0
9785987|NCT00531050|10893026|FG001|NOT COMPLETED|Part 2: Period 2||0
9785988|NCT00531050|10893027|FG002|NOT COMPLETED|Part 2: Period 2||0
9785989|NCT00531050|10893028|FG003|NOT COMPLETED|Part 2: Period 2||0
10234071|NCT01578785|11363968|FG000|NOT COMPLETED|Overall Study||59
10234072|NCT01578785|11363969|FG001|NOT COMPLETED|Overall Study||119
9785990|NCT00531050|10893029|FG004|NOT COMPLETED|Part 2: Period 2||0
9785991|NCT00531050|10893030|FG005|NOT COMPLETED|Part 2: Period 2||0
10234073|NCT01576549|11363975|FG000|STARTED|Overall Study||2
9785992|NCT00531050|10893025|FG000|STARTED|Part 2: Period 3||3
9785993|NCT00531050|10893026|FG001|STARTED|Part 2: Period 3||4
9785994|NCT00531050|10893027|FG002|STARTED|Part 2: Period 3||4
9785995|NCT00531050|10893028|FG003|STARTED|Part 2: Period 3||4
9785996|NCT00531050|10893029|FG004|STARTED|Part 2: Period 3||4
9785997|NCT00531050|10893030|FG005|STARTED|Part 2: Period 3||4
9785998|NCT00531050|10893025|FG000|COMPLETED|Part 2: Period 3||2
10239698|NCT00062751|11371369|FG003|NOT COMPLETED|Overall Study||5
9785999|NCT00531050|10893026|FG001|COMPLETED|Part 2: Period 3||4
9786000|NCT00531050|10893027|FG002|COMPLETED|Part 2: Period 3||4
9786001|NCT00531050|10893028|FG003|COMPLETED|Part 2: Period 3||4
9786002|NCT00531050|10893029|FG004|COMPLETED|Part 2: Period 3||4
9786003|NCT00531050|10893030|FG005|COMPLETED|Part 2: Period 3||3
9786004|NCT00531050|10893025|FG000|NOT COMPLETED|Part 2: Period 3||1
9786005|NCT00531050|10893026|FG001|NOT COMPLETED|Part 2: Period 3||0
9786006|NCT00531050|10893027|FG002|NOT COMPLETED|Part 2: Period 3||0
9786007|NCT00531050|10893028|FG003|NOT COMPLETED|Part 2: Period 3||0
9786008|NCT00531050|10893029|FG004|NOT COMPLETED|Part 2: Period 3||0
9786009|NCT00531050|10893030|FG005|NOT COMPLETED|Part 2: Period 3||1
9786010|NCT00531206|10893047|FG000|STARTED|Overall Study||65
9786011|NCT00531206|10893047|FG000|COMPLETED|Overall Study||45
9786012|NCT00531206|10893047|FG000|NOT COMPLETED|Overall Study||20
9786013|NCT00531284|10893068|FG000|STARTED|Overall Study||3
9786014|NCT00531284|10893069|FG001|STARTED|Overall Study||4
9786015|NCT00531284|10893070|FG002|STARTED|Overall Study||7
9786016|NCT00531284|10893071|FG003|STARTED|Overall Study||65
9786017|NCT00531284|10893072|FG004|STARTED|Overall Study||6
9786018|NCT00531284|10893073|FG005|STARTED|Overall Study||7
9786019|NCT00531284|10893074|FG006|STARTED|Overall Study||6
9786020|NCT00531284|10893075|FG007|STARTED|Overall Study||10
9786021|NCT00531284|10893076|FG008|STARTED|Overall Study||11
9786022|NCT00531284|10893077|FG009|STARTED|Overall Study||4
9786023|NCT00531284|10893078|FG010|STARTED|Overall Study||3
9786024|NCT00531284|10893079|FG011|STARTED|Overall Study||24
10234074|NCT01576549|11363975|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10234075|NCT01576549|11363975|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
10234076|NCT01576549|11363975|FG000|COMPLETED|Overall Study||0
10234077|NCT01576549|11363975|FG000|NOT COMPLETED|Overall Study||2
10234078|NCT01570634|11363980|FG000|STARTED|Overall Study||2
10234079|NCT01570634|11363980|FG000|COMPLETED|Overall Study||2
10234080|NCT01570634|11363980|FG000|NOT COMPLETED|Overall Study||0
10234081|NCT01566370|11363986|FG000|STARTED|Overall Study||2
10234082|NCT01566370|11363987|FG001|STARTED|Overall Study||1
9786025|NCT00531284|10893080|FG012|STARTED|Overall Study||2
9786026|NCT00531284|10893081|FG013|STARTED|Overall Study||3
9786027|NCT00531284|10893082|FG014|STARTED|Overall Study||7
9786028|NCT00531284|10893083|FG015|STARTED|Overall Study||14
9786029|NCT00531284|10893084|FG016|STARTED|Overall Study||8
9786030|NCT00531284|10893068|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
9786031|NCT00531284|10893069|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
9786032|NCT00531284|10893070|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
9786033|NCT00531284|10893071|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
9786034|NCT00531284|10893072|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786035|NCT00531284|10893073|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786036|NCT00531284|10893074|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786037|NCT00531284|10893075|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786038|NCT00531284|10893076|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786039|NCT00531284|10893077|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786040|NCT00531284|10893078|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786041|NCT00531284|10893079|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786042|NCT00531284|10893080|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786043|NCT00531284|10893081|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786044|NCT00531284|10893082|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
9786045|NCT00531284|10893083|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
9786046|NCT00531284|10893084|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
9786047|NCT00531284|10893068|FG000|NOT COMPLETED|Overall Study||3
10234083|NCT01566370|11363986|FG000|COMPLETED|Overall Study||0
10234084|NCT01566370|11363987|FG001|COMPLETED|Overall Study||0
9786048|NCT00531284|10893069|FG001|NOT COMPLETED|Overall Study||4
9786049|NCT00531284|10893070|FG002|NOT COMPLETED|Overall Study||6
9786050|NCT00531284|10893071|FG003|NOT COMPLETED|Overall Study||63
9786051|NCT00531284|10893072|FG004|NOT COMPLETED|Overall Study||6
9786052|NCT00531284|10893073|FG005|NOT COMPLETED|Overall Study||7
9786053|NCT00531284|10893074|FG006|NOT COMPLETED|Overall Study||6
9786054|NCT00531284|10893075|FG007|NOT COMPLETED|Overall Study||10
9786055|NCT00531284|10893076|FG008|NOT COMPLETED|Overall Study||11
9786056|NCT00531284|10893077|FG009|NOT COMPLETED|Overall Study||4
9786057|NCT00531284|10893078|FG010|NOT COMPLETED|Overall Study||3
9786058|NCT00531284|10893079|FG011|NOT COMPLETED|Overall Study||24
9786059|NCT00531284|10893080|FG012|NOT COMPLETED|Overall Study||2
9786060|NCT00531284|10893081|FG013|NOT COMPLETED|Overall Study||3
9786061|NCT00531284|10893082|FG014|NOT COMPLETED|Overall Study||4
9786062|NCT00531284|10893083|FG015|NOT COMPLETED|Overall Study||12
9786063|NCT00531284|10893084|FG016|NOT COMPLETED|Overall Study||8
9786064|NCT00531427|10893142|FG000|STARTED|Overall Study||282
9786065|NCT00531427|10893143|FG001|STARTED|Overall Study||285
9786066|NCT00531427|10893142|FG000|COMPLETED|Overall Study||209
9786067|NCT00531427|10893143|FG001|COMPLETED|Overall Study||191
9786068|NCT00531427|10893142|FG000|NOT COMPLETED|Overall Study||73
9786069|NCT00531427|10893143|FG001|NOT COMPLETED|Overall Study||94
9786070|NCT00531453|10893152|FG000|STARTED|Overall Study|02 October 2007|49
9786071|NCT00531453|10893153|FG001|STARTED|Overall Study|02 October 2007|49
9786072|NCT00531453|10893152|FG000|COMPLETED|Overall Study|10 April 2009|49
9786073|NCT00531453|10893153|FG001|COMPLETED|Overall Study|10 April 2009|49
9786074|NCT00531453|10893152|FG000|NOT COMPLETED|Overall Study||0
9786075|NCT00531453|10893153|FG001|NOT COMPLETED|Overall Study||0
9786076|NCT00531479|10893161|FG000|STARTED|Overall Study||230
9786077|NCT00531479|10893162|FG001|STARTED|Overall Study||229
9786078|NCT00531479|10893161|FG000|Treated|Overall Study||228
9786079|NCT00531479|10893162|FG001|Treated|Overall Study||226
9786080|NCT00531479|10893161|FG000|COMPLETED|Overall Study||154
9786081|NCT00531479|10893162|FG001|COMPLETED|Overall Study||146
9786082|NCT00531479|10893161|FG000|NOT COMPLETED|Overall Study||76
9786083|NCT00531479|10893162|FG001|NOT COMPLETED|Overall Study||83
9786084|NCT00531518|10893170|FG000|STARTED|Overall Study||87
9786085|NCT00531518|10893171|FG001|STARTED|Overall Study||205
9786086|NCT00531518|10893170|FG000|COMPLETED|Overall Study||55
9786087|NCT00531518|10893171|FG001|COMPLETED|Overall Study||134
9786088|NCT00531518|10893170|FG000|NOT COMPLETED|Overall Study||32
9786089|NCT00531518|10893171|FG001|NOT COMPLETED|Overall Study||71
9786090|NCT00531661|10893179|FG000|STARTED|6 Months||270
9786091|NCT00531661|10893180|FG001|STARTED|6 Months||280
9786092|NCT00531661|10893179|FG000|COMPLETED|6 Months||244
9786093|NCT00531661|10893180|FG001|COMPLETED|6 Months||254
9786094|NCT00531661|10893179|FG000|NOT COMPLETED|6 Months||26
9786095|NCT00531661|10893180|FG001|NOT COMPLETED|6 Months||26
9786096|NCT00531661|10893179|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244
9786097|NCT00531661|10893180|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254
9786098|NCT00531661|10893179|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
9786099|NCT00531661|10893180|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
9786100|NCT00531661|10893179|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
9786101|NCT00531661|10893180|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
9786102|NCT00531752|10893193|FG000|STARTED|First Double-blind Intervention Period||17
9786103|NCT00531752|10893194|FG001|STARTED|First Double-blind Intervention Period||17
9786104|NCT00531752|10893195|FG002|STARTED|First Double-blind Intervention Period||16
9786105|NCT00531752|10893196|FG003|STARTED|First Double-blind Intervention Period||16
9786106|NCT00531752|10893193|FG000|Treated|First Double-blind Intervention Period||16
9786107|NCT00531752|10893194|FG001|Treated|First Double-blind Intervention Period||17
9786108|NCT00531752|10893195|FG002|Treated|First Double-blind Intervention Period||16
9786109|NCT00531752|10893196|FG003|Treated|First Double-blind Intervention Period||16
9786110|NCT00531752|10893193|FG000|COMPLETED|First Double-blind Intervention Period||11
9786111|NCT00531752|10893194|FG001|COMPLETED|First Double-blind Intervention Period||13
9786112|NCT00531752|10893195|FG002|COMPLETED|First Double-blind Intervention Period||9
9786113|NCT00531752|10893196|FG003|COMPLETED|First Double-blind Intervention Period||13
9786114|NCT00531752|10893193|FG000|NOT COMPLETED|First Double-blind Intervention Period||6
9786115|NCT00531752|10893194|FG001|NOT COMPLETED|First Double-blind Intervention Period||4
9786116|NCT00531752|10893195|FG002|NOT COMPLETED|First Double-blind Intervention Period||7
9786117|NCT00531752|10893196|FG003|NOT COMPLETED|First Double-blind Intervention Period||3
9786118|NCT00531752|10893193|FG000|STARTED|Wash-out Period (at Least 7 Days)||11
10015220|NCT01804842|11138285|FG000|STARTED|Overall Study||9
10015221|NCT01804842|11138286|FG001|STARTED|Overall Study||8
10015222|NCT01804842|11138287|FG002|STARTED|Overall Study||9
9786119|NCT00531752|10893194|FG001|STARTED|Wash-out Period (at Least 7 Days)||13
9786120|NCT00531752|10893195|FG002|STARTED|Wash-out Period (at Least 7 Days)||9
9786121|NCT00531752|10893196|FG003|STARTED|Wash-out Period (at Least 7 Days)||13
9786122|NCT00531752|10893193|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11
9786123|NCT00531752|10893194|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13
9786124|NCT00531752|10893195|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9
10015223|NCT01804842|11138285|FG000|Completed Treatment A|Overall Study||9
10015224|NCT01804842|11138286|FG001|Completed Treatment A|Overall Study||6
10015225|NCT01804842|11138287|FG002|Completed Treatment A|Overall Study||8
10015226|NCT01804842|11138285|FG000|Completed Treatment B|Overall Study||8
9786125|NCT00531752|10893196|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13
9786126|NCT00531752|10893193|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
9786127|NCT00531752|10893194|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
9786128|NCT00531752|10893195|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
9786129|NCT00531752|10893196|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10015227|NCT01804842|11138286|FG001|Completed Treatment B|Overall Study||8
9786130|NCT00531752|10893193|FG000|STARTED|Second Double-blind Intervention Period||11
9786131|NCT00531752|10893194|FG001|STARTED|Second Double-blind Intervention Period||13
9786132|NCT00531752|10893195|FG002|STARTED|Second Double-blind Intervention Period||9
9786133|NCT00531752|10893196|FG003|STARTED|Second Double-blind Intervention Period||13
10015228|NCT01804842|11138287|FG002|Completed Treatment B|Overall Study||8
9786134|NCT00531752|10893193|FG000|COMPLETED|Second Double-blind Intervention Period||9
9786135|NCT00531752|10893194|FG001|COMPLETED|Second Double-blind Intervention Period||11
9786136|NCT00531752|10893195|FG002|COMPLETED|Second Double-blind Intervention Period||9
9786137|NCT00531752|10893196|FG003|COMPLETED|Second Double-blind Intervention Period||11
9786138|NCT00531752|10893193|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
9786139|NCT00531752|10893194|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2
9786140|NCT00531752|10893195|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
9786141|NCT00531752|10893196|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2
9786142|NCT00531817|10893206|FG000|STARTED|Randomized||412
9786143|NCT00531817|10893207|FG001|STARTED|Randomized||207
9786144|NCT00531817|10893206|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
9786145|NCT00531817|10893207|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
9786146|NCT00531817|10893206|FG000|COMPLETED|Randomized||353
9786147|NCT00531817|10893207|FG001|COMPLETED|Randomized||173
9786148|NCT00531817|10893206|FG000|NOT COMPLETED|Randomized||59
9786149|NCT00531817|10893207|FG001|NOT COMPLETED|Randomized||34
9786150|NCT00531817|10893206|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
9786151|NCT00531817|10893207|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
9786152|NCT00531817|10893206|FG000|COMPLETED|Entered Extended Treatment Period||206
9786153|NCT00531817|10893207|FG001|COMPLETED|Entered Extended Treatment Period||113
9786154|NCT00531817|10893206|FG000|NOT COMPLETED|Entered Extended Treatment Period||137
9786155|NCT00531817|10893207|FG001|NOT COMPLETED|Entered Extended Treatment Period||57
9786156|NCT00531843|10893216|FG000|STARTED|Overall Study||81
9786157|NCT00531843|10893217|FG001|STARTED|Overall Study||6
9786158|NCT00531843|10893216|FG000|COMPLETED|Overall Study||81
9786159|NCT00531843|10893217|FG001|COMPLETED|Overall Study||6
9786160|NCT00531843|10893216|FG000|NOT COMPLETED|Overall Study||0
9786161|NCT00531843|10893217|FG001|NOT COMPLETED|Overall Study||0
9786162|NCT00531882|10893226|FG000|STARTED|Overall Study||10
9786163|NCT00531882|10893227|FG001|STARTED|Overall Study||10
9786164|NCT00531882|10893228|FG002|STARTED|Overall Study||5
9786165|NCT00531882|10893226|FG000|COMPLETED|Overall Study||10
9786166|NCT00531882|10893227|FG001|COMPLETED|Overall Study||10
9786167|NCT00531882|10893228|FG002|COMPLETED|Overall Study||5
9786168|NCT00531882|10893226|FG000|NOT COMPLETED|Overall Study||0
9786169|NCT00531882|10893227|FG001|NOT COMPLETED|Overall Study||0
9786170|NCT00531882|10893228|FG002|NOT COMPLETED|Overall Study||0
9786171|NCT00531934|10893238|FG000|STARTED|Overall Study||73
9786172|NCT00531934|10893239|FG001|STARTED|Overall Study||74
9786173|NCT00531934|10893238|FG000|COMPLETED|Overall Study||7
9786174|NCT00531934|10893239|FG001|COMPLETED|Overall Study||11
9786175|NCT00531934|10893238|FG000|NOT COMPLETED|Overall Study||66
9786176|NCT00531934|10893239|FG001|NOT COMPLETED|Overall Study||63
9786177|NCT00531947|10893247|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
9786178|NCT00531947|10893248|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
9786179|NCT00531947|10893247|FG000|COMPLETED|Overall Study||114
9786180|NCT00531947|10893248|FG001|COMPLETED|Overall Study||101
9786181|NCT00531947|10893247|FG000|NOT COMPLETED|Overall Study||42
9786182|NCT00531947|10893248|FG001|NOT COMPLETED|Overall Study||51
9786183|NCT00531960|10893256|FG000|STARTED|Overall Study||61
9786184|NCT00531960|10893257|FG001|STARTED|Overall Study||63
9786185|NCT00531960|10893256|FG000|COMPLETED|Overall Study||0
9786186|NCT00531960|10893257|FG001|COMPLETED|Overall Study||0
9786187|NCT00531960|10893256|FG000|NOT COMPLETED|Overall Study||61
9786188|NCT00531960|10893257|FG001|NOT COMPLETED|Overall Study||63
9786189|NCT00532129|10893263|FG000|STARTED|Treatment Period||100
9786190|NCT00532129|10893263|FG000|COMPLETED|Treatment Period||51
9786191|NCT00532129|10893263|FG000|NOT COMPLETED|Treatment Period||49
9786192|NCT00532129|10893263|FG000|STARTED|Follow-up Period||98
9786193|NCT00532129|10893263|FG000|COMPLETED|Follow-up Period||33
9786194|NCT00532129|10893263|FG000|NOT COMPLETED|Follow-up Period||65
9786195|NCT00532155|10893269|FG000|STARTED|Overall Study||457
9786196|NCT00532155|10893270|FG001|STARTED|Overall Study||456
9786197|NCT00532155|10893269|FG000|SAFETY POPULATION|Overall Study||455
9786198|NCT00532155|10893270|FG001|SAFETY POPULATION|Overall Study||450
9786199|NCT00532155|10893269|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
9786200|NCT00532155|10893270|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
9786201|NCT00532155|10893269|FG000|NOT COMPLETED|Overall Study||457
9786202|NCT00532155|10893270|FG001|NOT COMPLETED|Overall Study||456
9786203|NCT00532259|10893276|FG000|STARTED|Overall Study||72
9786204|NCT00532259|10893276|FG000|COMPLETED|Overall Study||40
9786205|NCT00532259|10893276|FG000|NOT COMPLETED|Overall Study||32
10015229|NCT01804842|11138285|FG000|Completed Treatment C|Overall Study||7
9786206|NCT00532298|10893287|FG000|STARTED|Overall Study||269
9786207|NCT00532298|10893288|FG001|STARTED|Overall Study||266
9786208|NCT00532298|10893289|FG002|STARTED|Overall Study||264
9786209|NCT00532298|10893290|FG003|STARTED|Overall Study||264
9786210|NCT00532298|10893291|FG004|STARTED|Overall Study||268
9786211|NCT00532298|10893292|FG005|STARTED|Overall Study||263
9786212|NCT00532298|10893287|FG000|COMPLETED|Overall Study||267
9786213|NCT00532298|10893288|FG001|COMPLETED|Overall Study||265
9786214|NCT00532298|10893289|FG002|COMPLETED|Overall Study||263
9786215|NCT00532298|10893290|FG003|COMPLETED|Overall Study||264
9786216|NCT00532298|10893291|FG004|COMPLETED|Overall Study||267
9786217|NCT00532298|10893292|FG005|COMPLETED|Overall Study||261
9786218|NCT00532298|10893287|FG000|NOT COMPLETED|Overall Study||2
9786219|NCT00532298|10893288|FG001|NOT COMPLETED|Overall Study||1
9786220|NCT00532298|10893289|FG002|NOT COMPLETED|Overall Study||1
9786221|NCT00532298|10893290|FG003|NOT COMPLETED|Overall Study||0
9786222|NCT00532298|10893291|FG004|NOT COMPLETED|Overall Study||1
9786223|NCT00532298|10893292|FG005|NOT COMPLETED|Overall Study||2
9786224|NCT00532441|10893306|FG000|STARTED|Overall Study||14
10234085|NCT01566370|11363986|FG000|NOT COMPLETED|Overall Study||2
10234086|NCT01566370|11363987|FG001|NOT COMPLETED|Overall Study||1
10234087|NCT01561989|11363995|FG000|STARTED|Overall Study||5
10234088|NCT01561989|11363996|FG001|STARTED|Overall Study||6
10234089|NCT01561989|11363995|FG000|COMPLETED|Overall Study||0
10234090|NCT01561989|11363996|FG001|COMPLETED|Overall Study||0
9786225|NCT00532441|10893307|FG001|STARTED|Overall Study||11
9786226|NCT00532441|10893306|FG000|COMPLETED|Overall Study||13
9786227|NCT00532441|10893307|FG001|COMPLETED|Overall Study||11
9786228|NCT00532441|10893306|FG000|NOT COMPLETED|Overall Study||1
9786229|NCT00532441|10893307|FG001|NOT COMPLETED|Overall Study||0
9786230|NCT00532480|10893316|FG000|STARTED|Overall Study||10
9786231|NCT00532480|10893316|FG000|COMPLETED|Overall Study||7
9786232|NCT00532480|10893316|FG000|NOT COMPLETED|Overall Study||3
9786233|NCT00532493|10893322|FG000|STARTED|Overall Study||152
9786234|NCT00532493|10893323|FG001|STARTED|Overall Study||152
9786235|NCT00532493|10893322|FG000|COMPLETED|Overall Study||122
9786236|NCT00532493|10893323|FG001|COMPLETED|Overall Study||123
9786237|NCT00532493|10893322|FG000|NOT COMPLETED|Overall Study||30
9786238|NCT00532493|10893323|FG001|NOT COMPLETED|Overall Study||29
9786239|NCT00532779|10893334|FG000|STARTED|Overall Study||578
9786240|NCT00532779|10893335|FG001|STARTED|Overall Study||583
9786241|NCT00532779|10893336|FG002|STARTED|Overall Study||581
9786242|NCT00532779|10893334|FG000|COMPLETED|Overall Study||284
9786243|NCT00532779|10893335|FG001|COMPLETED|Overall Study||296
9786244|NCT00532779|10893336|FG002|COMPLETED|Overall Study||290
9786245|NCT00532779|10893334|FG000|NOT COMPLETED|Overall Study||294
9786246|NCT00532779|10893335|FG001|NOT COMPLETED|Overall Study||287
9786247|NCT00532779|10893336|FG002|NOT COMPLETED|Overall Study||291
10015230|NCT01804842|11138286|FG001|Completed Treatment C|Overall Study||7
10015231|NCT01804842|11138287|FG002|Completed Treatment C|Overall Study||9
10015232|NCT01804842|11138285|FG000|COMPLETED|Overall Study||6
10015233|NCT01804842|11138286|FG001|COMPLETED|Overall Study||6
10015234|NCT01804842|11138287|FG002|COMPLETED|Overall Study||8
10015235|NCT01804842|11138285|FG000|NOT COMPLETED|Overall Study||3
10015236|NCT01804842|11138286|FG001|NOT COMPLETED|Overall Study||2
10015237|NCT01804842|11138287|FG002|NOT COMPLETED|Overall Study||1
10015238|NCT01804881|11138297|FG000|STARTED|Overall Study||16
10015239|NCT01804881|11138298|FG001|STARTED|Overall Study||14
10015240|NCT01804881|11138297|FG000|COMPLETED|Overall Study||11
10015241|NCT01804881|11138298|FG001|COMPLETED|Overall Study||10
10015242|NCT01804881|11138297|FG000|NOT COMPLETED|Overall Study||5
10015243|NCT01804881|11138298|FG001|NOT COMPLETED|Overall Study||4
10015244|NCT01804946|11138308|FG000|STARTED|Overall Study||81
10015245|NCT01804946|11138309|FG001|STARTED|Overall Study||80
10015246|NCT01804946|11138308|FG000|COMPLETED|Overall Study||79
10015247|NCT01804946|11138309|FG001|COMPLETED|Overall Study||76
10015248|NCT01804946|11138308|FG000|NOT COMPLETED|Overall Study||2
10015249|NCT01804946|11138309|FG001|NOT COMPLETED|Overall Study||4
10015250|NCT01805024|11138321|FG000|STARTED|Overall Study||4
10015251|NCT01805024|11138322|FG001|STARTED|Overall Study||4
10015252|NCT01805024|11138323|FG002|STARTED|Overall Study||4
10015253|NCT01805024|11138324|FG003|STARTED|Overall Study||8
9786248|NCT00532844|10893346|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
9786249|NCT00532844|10893347|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
9786250|NCT00532844|10893346|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24
9786251|NCT00532844|10893347|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23
10234091|NCT01561989|11363995|FG000|NOT COMPLETED|Overall Study||5
9786252|NCT00532844|10893346|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
9786253|NCT00532844|10893347|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
9786254|NCT00532844|10893346|FG000|STARTED|Washout (1 Day)||24
9786255|NCT00532844|10893347|FG001|STARTED|Washout (1 Day)||23
9786256|NCT00532844|10893346|FG000|COMPLETED|Washout (1 Day)||24
9786257|NCT00532844|10893347|FG001|COMPLETED|Washout (1 Day)||23
9786258|NCT00532844|10893346|FG000|NOT COMPLETED|Washout (1 Day)||0
9786259|NCT00532844|10893347|FG001|NOT COMPLETED|Washout (1 Day)||0
9786260|NCT00532844|10893346|FG000|STARTED|Treatment Period - Day 15 to Day 28||24
9786261|NCT00532844|10893347|FG001|STARTED|Treatment Period - Day 15 to Day 28||23
9786262|NCT00532844|10893346|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20
9786263|NCT00532844|10893347|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23
10015254|NCT01805024|11138321|FG000|COMPLETED|Overall Study||4
10015255|NCT01805024|11138322|FG001|COMPLETED|Overall Study||4
10015256|NCT01805024|11138323|FG002|COMPLETED|Overall Study||4
10015257|NCT01805024|11138324|FG003|COMPLETED|Overall Study||8
10015258|NCT01805024|11138321|FG000|NOT COMPLETED|Overall Study||0
10015259|NCT01805024|11138322|FG001|NOT COMPLETED|Overall Study||0
10015260|NCT01805024|11138323|FG002|NOT COMPLETED|Overall Study||0
10015261|NCT01805024|11138324|FG003|NOT COMPLETED|Overall Study||0
10234092|NCT01561989|11363996|FG001|NOT COMPLETED|Overall Study||6
9786264|NCT00532844|10893346|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
9786265|NCT00532844|10893347|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
9786266|NCT00532883|10893370|FG000|STARTED|Overall Study||11
9786267|NCT00532883|10893371|FG001|STARTED|Overall Study||12
9786268|NCT00532883|10893372|FG002|STARTED|Overall Study||10
9786269|NCT00532883|10893373|FG003|STARTED|Overall Study||11
9786270|NCT00532883|10893370|FG000|COMPLETED|Overall Study|Study terminated early.|5
9786271|NCT00532883|10893371|FG001|COMPLETED|Overall Study|Study terminated early.|5
9786272|NCT00532883|10893372|FG002|COMPLETED|Overall Study|Study terminated early.|6
9786273|NCT00532883|10893373|FG003|COMPLETED|Overall Study|Study terminated early.|6
9786274|NCT00532883|10893370|FG000|NOT COMPLETED|Overall Study||6
9786275|NCT00532883|10893371|FG001|NOT COMPLETED|Overall Study||7
9786276|NCT00532883|10893372|FG002|NOT COMPLETED|Overall Study||4
9786277|NCT00532883|10893373|FG003|NOT COMPLETED|Overall Study||5
9786278|NCT00532935|10893385|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
9786279|NCT00532935|10893386|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
9786280|NCT00532935|10893385|FG000|COMPLETED|Overall Study||210
9786281|NCT00532935|10893386|FG001|COMPLETED|Overall Study||204
9786282|NCT00532935|10893385|FG000|NOT COMPLETED|Overall Study||51
9786283|NCT00532935|10893386|FG001|NOT COMPLETED|Overall Study||52
9786284|NCT00532948|10893395|FG000|STARTED|Overall Study||4
9786285|NCT00532948|10893396|FG001|STARTED|Overall Study||14
9786286|NCT00532948|10893397|FG002|STARTED|Overall Study||6
9786287|NCT00532948|10893395|FG000|COMPLETED|Overall Study||0
9786288|NCT00532948|10893396|FG001|COMPLETED|Overall Study||9
9786289|NCT00532948|10893397|FG002|COMPLETED|Overall Study||2
9786290|NCT00532948|10893395|FG000|NOT COMPLETED|Overall Study||4
9786291|NCT00532948|10893396|FG001|NOT COMPLETED|Overall Study||5
9786292|NCT00532948|10893397|FG002|NOT COMPLETED|Overall Study||4
9786293|NCT00533117|10893413|FG000|STARTED|Overall Study||18
9786294|NCT00533117|10893414|FG001|STARTED|Overall Study||19
9786295|NCT00533117|10893415|FG002|STARTED|Overall Study||20
9786296|NCT00533117|10893416|FG003|STARTED|Overall Study||18
9786297|NCT00533117|10893413|FG000|COMPLETED|Overall Study||14
9786298|NCT00533117|10893414|FG001|COMPLETED|Overall Study||14
9786299|NCT00533117|10893415|FG002|COMPLETED|Overall Study||14
9786300|NCT00533117|10893416|FG003|COMPLETED|Overall Study||13
9786301|NCT00533117|10893413|FG000|NOT COMPLETED|Overall Study||4
9786302|NCT00533117|10893414|FG001|NOT COMPLETED|Overall Study||5
9786303|NCT00533117|10893415|FG002|NOT COMPLETED|Overall Study||6
9786304|NCT00533117|10893416|FG003|NOT COMPLETED|Overall Study||5
9786305|NCT00533273|10893428|FG000|STARTED|Double-blind||45
9786306|NCT00533273|10893429|FG001|STARTED|Double-blind||21
9786307|NCT00533273|10893428|FG000|COMPLETED|Double-blind||45
9786308|NCT00533273|10893429|FG001|COMPLETED|Double-blind||19
9786309|NCT00533273|10893428|FG000|NOT COMPLETED|Double-blind||0
9786310|NCT00533273|10893429|FG001|NOT COMPLETED|Double-blind||2
9786311|NCT00533273|10893428|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
9786312|NCT00533273|10893429|FG001|STARTED|Open-label|no placebo - this phase was open label|0
9786313|NCT00533273|10893428|FG000|COMPLETED|Open-label||58
9786314|NCT00533273|10893429|FG001|COMPLETED|Open-label||0
9786315|NCT00533273|10893428|FG000|NOT COMPLETED|Open-label||6
9786316|NCT00533273|10893429|FG001|NOT COMPLETED|Open-label||0
9786317|NCT00533429|10893437|FG000|STARTED|Overall Study||20
9786318|NCT00533429|10893438|FG001|STARTED|Overall Study||20
9786319|NCT00533429|10893437|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
9786320|NCT00533429|10893438|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
9786321|NCT00533429|10893437|FG000|Entered Maintenance|Overall Study||8
9786322|NCT00533429|10893438|FG001|Entered Maintenance|Overall Study||10
9786323|NCT00533429|10893437|FG000|COMPLETED|Overall Study||1
9786324|NCT00533429|10893438|FG001|COMPLETED|Overall Study||4
9786325|NCT00533429|10893437|FG000|NOT COMPLETED|Overall Study||19
9786326|NCT00533429|10893438|FG001|NOT COMPLETED|Overall Study||16
9786327|NCT00533442|10893448|FG000|STARTED|Allocation and Intent to Treat Analysis||86
9786328|NCT00533442|10893449|FG001|STARTED|Allocation and Intent to Treat Analysis||84
9786329|NCT00533442|10893448|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86
9786330|NCT00533442|10893449|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84
9786331|NCT00533442|10893448|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
9786332|NCT00533442|10893449|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
9786333|NCT00533442|10893448|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
9786334|NCT00533442|10893449|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
9786335|NCT00533442|10893448|FG000|COMPLETED|Follow-up||77
9786336|NCT00533442|10893449|FG001|COMPLETED|Follow-up||74
9786337|NCT00533442|10893448|FG000|NOT COMPLETED|Follow-up||9
9786338|NCT00533442|10893449|FG001|NOT COMPLETED|Follow-up||10
9786339|NCT00533507|10893457|FG000|STARTED|Overall Study||230
9786340|NCT00533507|10893457|FG000|COMPLETED|Overall Study||229
9786341|NCT00533507|10893457|FG000|NOT COMPLETED|Overall Study||1
9786342|NCT00533546|10893461|FG000|STARTED|Overall Study||12
9786343|NCT00533546|10893461|FG000|COMPLETED|Overall Study||12
9786344|NCT00533546|10893461|FG000|NOT COMPLETED|Overall Study||0
9786345|NCT00533702|10893468|FG000|STARTED|Overall Study||54
9786346|NCT00533702|10893469|FG001|STARTED|Overall Study||52
9786347|NCT00533702|10893468|FG000|Received Any Quantity of Study Drug|Overall Study||52
9786348|NCT00533702|10893469|FG001|Received Any Quantity of Study Drug|Overall Study||50
9786349|NCT00533702|10893468|FG000|COMPLETED|Overall Study||49
9786350|NCT00533702|10893469|FG001|COMPLETED|Overall Study||50
9786351|NCT00533702|10893468|FG000|NOT COMPLETED|Overall Study||5
9786352|NCT00533702|10893469|FG001|NOT COMPLETED|Overall Study||2
9786353|NCT00533845|10893477|FG000|STARTED|Overall Study||15
9786354|NCT00533845|10893478|FG001|STARTED|Overall Study||15
9786355|NCT00533845|10893477|FG000|COMPLETED|Overall Study||14
9786356|NCT00533845|10893478|FG001|COMPLETED|Overall Study||15
9786357|NCT00533845|10893477|FG000|NOT COMPLETED|Overall Study||1
9786358|NCT00533845|10893478|FG001|NOT COMPLETED|Overall Study||0
10234093|NCT01564732|11364004|FG000|STARTED|Overall Study||6
9786359|NCT00533897|10893487|FG000|STARTED|Lead-in (LI) Period 1||167
9786360|NCT00533897|10893488|FG001|STARTED|Lead-in (LI) Period 1||0
9786361|NCT00533897|10893489|FG002|STARTED|Lead-in (LI) Period 1||0
9786362|NCT00533897|10893490|FG003|STARTED|Lead-in (LI) Period 1||0
9786363|NCT00533897|10893491|FG004|STARTED|Lead-in (LI) Period 1||0
9786364|NCT00533897|10893492|FG005|STARTED|Lead-in (LI) Period 1||0
9786365|NCT00533897|10893493|FG006|STARTED|Lead-in (LI) Period 1||0
9786366|NCT00533897|10893494|FG007|STARTED|Lead-in (LI) Period 1||0
9786367|NCT00533897|10893487|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
9786368|NCT00533897|10893488|FG001|COMPLETED|Lead-in (LI) Period 1||0
9786369|NCT00533897|10893489|FG002|COMPLETED|Lead-in (LI) Period 1||0
9786370|NCT00533897|10893490|FG003|COMPLETED|Lead-in (LI) Period 1||0
9786371|NCT00533897|10893491|FG004|COMPLETED|Lead-in (LI) Period 1||0
9786372|NCT00533897|10893492|FG005|COMPLETED|Lead-in (LI) Period 1||0
10015262|NCT01805037|11138334|FG000|STARTED|Induction (4 Weeks)||0
10015263|NCT01805037|11138335|FG001|STARTED|Induction (4 Weeks)||20
10015264|NCT01805037|11138334|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0
10015265|NCT01805037|11138335|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20
10015266|NCT01805037|11138334|FG000|COMPLETED|Induction (4 Weeks)||0
10015267|NCT01805037|11138335|FG001|COMPLETED|Induction (4 Weeks)||20
10015268|NCT01805037|11138334|FG000|NOT COMPLETED|Induction (4 Weeks)||0
10015269|NCT01805037|11138335|FG001|NOT COMPLETED|Induction (4 Weeks)||0
10015270|NCT01805037|11138334|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0
10015271|NCT01805037|11138335|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
10015272|NCT01805037|11138334|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
10015273|NCT01805037|11138335|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
10015274|NCT01805037|11138334|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0
9786373|NCT00533897|10893493|FG006|COMPLETED|Lead-in (LI) Period 1||0
9786374|NCT00533897|10893494|FG007|COMPLETED|Lead-in (LI) Period 1||0
9786375|NCT00533897|10893487|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10
9786376|NCT00533897|10893488|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0
9786377|NCT00533897|10893489|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0
9786378|NCT00533897|10893490|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0
9786379|NCT00533897|10893491|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0
9786380|NCT00533897|10893492|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0
9786381|NCT00533897|10893493|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0
9786382|NCT00533897|10893494|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0
9786383|NCT00533897|10893487|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0
9786384|NCT00533897|10893488|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40
9786385|NCT00533897|10893489|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80
9786386|NCT00533897|10893490|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0
9786387|NCT00533897|10893491|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0
9786388|NCT00533897|10893492|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0
9786389|NCT00533897|10893493|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0
9786390|NCT00533897|10893494|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0
9786391|NCT00533897|10893487|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786392|NCT00533897|10893488|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
9786393|NCT00533897|10893489|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
9786394|NCT00533897|10893490|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786395|NCT00533897|10893491|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786396|NCT00533897|10893492|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786397|NCT00533897|10893493|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786398|NCT00533897|10893494|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10015275|NCT01805037|11138335|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6
10015276|NCT01805037|11138334|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
10015277|NCT01805037|11138335|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
10015278|NCT01805037|11138334|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0
10015279|NCT01805037|11138335|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
10015280|NCT01805037|11138334|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
10015281|NCT01805037|11138335|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
10234094|NCT01564732|11364005|FG001|STARTED|Overall Study||5
10234095|NCT01564732|11364004|FG000|COMPLETED|Overall Study||0
9786399|NCT00533897|10893487|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786400|NCT00533897|10893488|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
9786401|NCT00533897|10893489|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
9786402|NCT00533897|10893490|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786403|NCT00533897|10893491|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786404|NCT00533897|10893492|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786405|NCT00533897|10893493|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786406|NCT00533897|10893494|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
9786407|NCT00533897|10893487|FG000|STARTED|Re-introduction (RI) Period 3||0
9786408|NCT00533897|10893488|FG001|STARTED|Re-introduction (RI) Period 3||0
9786409|NCT00533897|10893489|FG002|STARTED|Re-introduction (RI) Period 3||0
9786410|NCT00533897|10893490|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
9786411|NCT00533897|10893491|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
9786412|NCT00533897|10893492|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
9786413|NCT00533897|10893493|FG006|STARTED|Re-introduction (RI) Period 3||0
9786414|NCT00533897|10893494|FG007|STARTED|Re-introduction (RI) Period 3||0
9786415|NCT00533897|10893487|FG000|COMPLETED|Re-introduction (RI) Period 3||0
9786416|NCT00533897|10893488|FG001|COMPLETED|Re-introduction (RI) Period 3||0
9786417|NCT00533897|10893489|FG002|COMPLETED|Re-introduction (RI) Period 3||0
9786418|NCT00533897|10893490|FG003|COMPLETED|Re-introduction (RI) Period 3||40
9786419|NCT00533897|10893491|FG004|COMPLETED|Re-introduction (RI) Period 3||35
9786420|NCT00533897|10893492|FG005|COMPLETED|Re-introduction (RI) Period 3||42
9786421|NCT00533897|10893493|FG006|COMPLETED|Re-introduction (RI) Period 3||0
9786422|NCT00533897|10893494|FG007|COMPLETED|Re-introduction (RI) Period 3||0
9786423|NCT00533897|10893487|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0
9786424|NCT00533897|10893488|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0
9786425|NCT00533897|10893489|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0
9786426|NCT00533897|10893490|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0
9786427|NCT00533897|10893491|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0
9786428|NCT00533897|10893492|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2
9786429|NCT00533897|10893493|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0
9786430|NCT00533897|10893494|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0
9786431|NCT00533897|10893487|FG000|STARTED|Long Term Extension (LTE)||0
9786432|NCT00533897|10893488|FG001|STARTED|Long Term Extension (LTE)||0
9786433|NCT00533897|10893489|FG002|STARTED|Long Term Extension (LTE)||0
9786434|NCT00533897|10893490|FG003|STARTED|Long Term Extension (LTE)||0
9786435|NCT00533897|10893491|FG004|STARTED|Long Term Extension (LTE)||0
9786436|NCT00533897|10893492|FG005|STARTED|Long Term Extension (LTE)||0
9786437|NCT00533897|10893493|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
9786438|NCT00533897|10893494|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
9786439|NCT00533897|10893487|FG000|COMPLETED|Long Term Extension (LTE)||0
9786440|NCT00533897|10893488|FG001|COMPLETED|Long Term Extension (LTE)||0
9786441|NCT00533897|10893489|FG002|COMPLETED|Long Term Extension (LTE)||0
9786442|NCT00533897|10893490|FG003|COMPLETED|Long Term Extension (LTE)||0
9786443|NCT00533897|10893491|FG004|COMPLETED|Long Term Extension (LTE)||0
9786444|NCT00533897|10893492|FG005|COMPLETED|Long Term Extension (LTE)||0
9786445|NCT00533897|10893493|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
9786446|NCT00533897|10893494|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
9786447|NCT00533897|10893487|FG000|NOT COMPLETED|Long Term Extension (LTE)||0
9786448|NCT00533897|10893488|FG001|NOT COMPLETED|Long Term Extension (LTE)||0
9786449|NCT00533897|10893489|FG002|NOT COMPLETED|Long Term Extension (LTE)||0
9786450|NCT00533897|10893490|FG003|NOT COMPLETED|Long Term Extension (LTE)||0
9786451|NCT00533897|10893491|FG004|NOT COMPLETED|Long Term Extension (LTE)||0
9786452|NCT00533897|10893492|FG005|NOT COMPLETED|Long Term Extension (LTE)||0
9786453|NCT00533897|10893493|FG006|NOT COMPLETED|Long Term Extension (LTE)||13
9786454|NCT00533897|10893494|FG007|NOT COMPLETED|Long Term Extension (LTE)||25
9786455|NCT00533910|10893527|FG000|STARTED|Overall Study||21
9786456|NCT00533910|10893528|FG001|STARTED|Overall Study||21
9786457|NCT00533910|10893527|FG000|COMPLETED|Overall Study||21
9786458|NCT00533910|10893528|FG001|COMPLETED|Overall Study||21
9786459|NCT00533910|10893527|FG000|NOT COMPLETED|Overall Study||0
9786460|NCT00533910|10893528|FG001|NOT COMPLETED|Overall Study||0
9786461|NCT00534001|10893536|FG000|STARTED|Overall Study||48
9786462|NCT00534001|10893537|FG001|STARTED|Overall Study||47
9786463|NCT00534001|10893536|FG000|COMPLETED|Overall Study||43
9786464|NCT00534001|10893537|FG001|COMPLETED|Overall Study||43
9786465|NCT00534001|10893536|FG000|NOT COMPLETED|Overall Study||5
9786466|NCT00534001|10893537|FG001|NOT COMPLETED|Overall Study||4
9786467|NCT00534092|10893545|FG000|STARTED|Overall Study||55
9786468|NCT00534092|10893546|FG001|STARTED|Overall Study||14
9786469|NCT00534092|10893545|FG000|COMPLETED|Overall Study||53
9786470|NCT00534092|10893546|FG001|COMPLETED|Overall Study||14
9786471|NCT00534092|10893545|FG000|NOT COMPLETED|Overall Study||2
9786472|NCT00534092|10893546|FG001|NOT COMPLETED|Overall Study||0
9786473|NCT00534105|10893556|FG000|STARTED|Overall Study||47
9786474|NCT00534105|10893557|FG001|STARTED|Overall Study||59
9786475|NCT00534105|10893556|FG000|COMPLETED|Overall Study||24
9786476|NCT00534105|10893557|FG001|COMPLETED|Overall Study||20
9786477|NCT00534105|10893556|FG000|NOT COMPLETED|Overall Study||23
9786478|NCT00534105|10893557|FG001|NOT COMPLETED|Overall Study||39
9786479|NCT00534118|10893565|FG000|STARTED|Overall Study||17
9786480|NCT00534118|10893566|FG001|STARTED|Overall Study||22
9786481|NCT00534118|10893565|FG000|COMPLETED|Overall Study||17
9786482|NCT00534118|10893566|FG001|COMPLETED|Overall Study||22
9786483|NCT00534118|10893565|FG000|NOT COMPLETED|Overall Study||0
9786484|NCT00534118|10893566|FG001|NOT COMPLETED|Overall Study||0
9786485|NCT00534209|10893574|FG000|STARTED|Overall Study||1
9786486|NCT00534209|10893574|FG000|COMPLETED|Overall Study||1
9786487|NCT00534209|10893574|FG000|NOT COMPLETED|Overall Study||0
9786488|NCT00534235|10893582|FG000|STARTED|Overall Study||107
9786489|NCT00534235|10893583|FG001|STARTED|Overall Study||215
9786490|NCT00534235|10893582|FG000|COMPLETED|Overall Study||91
9786491|NCT00534235|10893583|FG001|COMPLETED|Overall Study||192
9786492|NCT00534235|10893582|FG000|NOT COMPLETED|Overall Study||16
9786493|NCT00534235|10893583|FG001|NOT COMPLETED|Overall Study||23
9786494|NCT00534248|10893592|FG000|STARTED|Overall Study||11211
9786495|NCT00534248|10893593|FG001|STARTED|Overall Study||11228
9786496|NCT00534248|10893592|FG000|VACCINATED|Overall Study||11186
9786497|NCT00534248|10893593|FG001|VACCINATED|Overall Study||11210
9786498|NCT00534248|10893592|FG000|COMPLETED|Overall Study||10550
9786499|NCT00534248|10893593|FG001|COMPLETED|Overall Study||10555
9786500|NCT00534248|10893592|FG000|NOT COMPLETED|Overall Study||661
9786501|NCT00534248|10893593|FG001|NOT COMPLETED|Overall Study||673
9786502|NCT00534313|10893603|FG000|STARTED|Short-term Period||43
9786503|NCT00534313|10893604|FG001|STARTED|Short-term Period||40
9786504|NCT00534313|10893605|FG002|STARTED|Short-term Period||45
9786505|NCT00534313|10893606|FG003|STARTED|Short-term Period||42
9786506|NCT00534313|10893603|FG000|COMPLETED|Short-term Period|Completed the short-term study|37
9786507|NCT00534313|10893604|FG001|COMPLETED|Short-term Period|Completed the short-term study|34
9786508|NCT00534313|10893605|FG002|COMPLETED|Short-term Period|Completed the short-term study|43
9786509|NCT00534313|10893606|FG003|COMPLETED|Short-term Period|Completed the short-term study|33
9786510|NCT00534313|10893603|FG000|NOT COMPLETED|Short-term Period||6
9786511|NCT00534313|10893604|FG001|NOT COMPLETED|Short-term Period||6
9786512|NCT00534313|10893605|FG002|NOT COMPLETED|Short-term Period||2
9786513|NCT00534313|10893606|FG003|NOT COMPLETED|Short-term Period||9
9786514|NCT00534313|10893603|FG000|STARTED|Long-term Period||37
9786515|NCT00534313|10893604|FG001|STARTED|Long-term Period||34
9786516|NCT00534313|10893605|FG002|STARTED|Long-term Period||43
9786517|NCT00534313|10893606|FG003|STARTED|Long-term Period||33
9786518|NCT00534313|10893603|FG000|COMPLETED|Long-term Period||0
9786519|NCT00534313|10893604|FG001|COMPLETED|Long-term Period||0
9786520|NCT00534313|10893605|FG002|COMPLETED|Long-term Period||0
9786521|NCT00534313|10893606|FG003|COMPLETED|Long-term Period||0
9786522|NCT00534313|10893603|FG000|NOT COMPLETED|Long-term Period||37
9786523|NCT00534313|10893604|FG001|NOT COMPLETED|Long-term Period||34
9786524|NCT00534313|10893605|FG002|NOT COMPLETED|Long-term Period||43
9786525|NCT00534313|10893606|FG003|NOT COMPLETED|Long-term Period||33
9786526|NCT00534352|10893651|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23
9786527|NCT00534352|10893651|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
9786528|NCT00534352|10893651|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
9786529|NCT00534352|10893651|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
9786530|NCT00534352|10893651|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
9786531|NCT00534352|10893651|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
9786532|NCT00534352|10893651|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
9786533|NCT00534352|10893651|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
9786534|NCT00534352|10893651|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
9786535|NCT00534352|10893651|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
9786536|NCT00534352|10893651|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
9786537|NCT00534352|10893651|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
9786538|NCT00534365|10893666|FG000|STARTED|Overall Study||127
9786539|NCT00534365|10893667|FG001|STARTED|Overall Study||136
9786540|NCT00534365|10893666|FG000|Received Procedure|Overall Study||127
9786541|NCT00534365|10893667|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
9786542|NCT00534365|10893666|FG000|Any Follow up|Overall Study||126
9786543|NCT00534365|10893667|FG001|Any Follow up|Overall Study||135
9786544|NCT00534365|10893666|FG000|Follow up at 12 Months or More|Overall Study||119
9786545|NCT00534365|10893667|FG001|Follow up at 12 Months or More|Overall Study||128
9786546|NCT00534365|10893666|FG000|Included in Intent to Treat Analysis|Overall Study||127
9786547|NCT00534365|10893667|FG001|Included in Intent to Treat Analysis|Overall Study||136
9786548|NCT00534365|10893666|FG000|COMPLETED|Overall Study||127
9786549|NCT00534365|10893667|FG001|COMPLETED|Overall Study||129
9786550|NCT00534365|10893666|FG000|NOT COMPLETED|Overall Study||0
9786551|NCT00534365|10893667|FG001|NOT COMPLETED|Overall Study||7
9786552|NCT00534404|10893678|FG000|STARTED|Overall Study||827
9786553|NCT00534404|10893679|FG001|STARTED|Overall Study||830
9786554|NCT00534404|10893680|FG002|STARTED|Overall Study||828
9786555|NCT00534404|10893678|FG000|Completed at Least 1 Online Session|Overall Study||781
9786556|NCT00534404|10893679|FG001|Completed at Least 1 Online Session|Overall Study||813
9786557|NCT00534404|10893680|FG002|Completed at Least 1 Online Session|Overall Study||658
9786558|NCT00534404|10893678|FG000|Completed First NRT Order|Overall Study||765
9786559|NCT00534404|10893679|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
9786560|NCT00534404|10893680|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
9786561|NCT00534404|10893678|FG000|Completed Second NRT Order|Overall Study||640
9786562|NCT00534404|10893679|FG001|Completed Second NRT Order|Overall Study||789
9786563|NCT00534404|10893680|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
9786564|NCT00534404|10893678|FG000|Completed at Least 1 Counseling Call|Overall Study||813
9786565|NCT00534404|10893679|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
9786566|NCT00534404|10893680|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
9786567|NCT00534404|10893678|FG000|1-month Follow up Completed|Overall Study||742
9786568|NCT00534404|10893679|FG001|1-month Follow up Completed|Overall Study||781
9786569|NCT00534404|10893680|FG002|1-month Follow up Completed|Overall Study||626
9786570|NCT00534404|10893678|FG000|3-month Follow up Completed|Overall Study||682
9786571|NCT00534404|10893679|FG001|3-month Follow up Completed|Overall Study||731
9786572|NCT00534404|10893680|FG002|3-month Follow up Completed|Overall Study||593
9786573|NCT00534404|10893678|FG000|COMPLETED|Overall Study||647
9786574|NCT00534404|10893679|FG001|COMPLETED|Overall Study||687
9786575|NCT00534404|10893680|FG002|COMPLETED|Overall Study||586
9786576|NCT00534404|10893678|FG000|NOT COMPLETED|Overall Study||180
9786577|NCT00534404|10893679|FG001|NOT COMPLETED|Overall Study||143
9786578|NCT00534404|10893680|FG002|NOT COMPLETED|Overall Study||242
9786579|NCT00534417|10893688|FG000|STARTED|Overall Study||41
9786580|NCT00534417|10893688|FG000|COMPLETED|Overall Study||41
9786581|NCT00534417|10893688|FG000|NOT COMPLETED|Overall Study||0
9786582|NCT00534495|10893694|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36
9786583|NCT00534495|10893695|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35
9786584|NCT00534495|10893696|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0
9786585|NCT00534495|10893694|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36
9786586|NCT00534495|10893695|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34
9786587|NCT00534495|10893696|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0
9786588|NCT00534495|10893694|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
9786589|NCT00534495|10893695|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
9786590|NCT00534495|10893696|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
9786591|NCT00534495|10893694|FG000|STARTED|All Active Treatment Phase Week 4-24||36
9786592|NCT00534495|10893695|FG001|STARTED|All Active Treatment Phase Week 4-24||34
9786593|NCT00534495|10893696|FG002|STARTED|All Active Treatment Phase Week 4-24||0
9786594|NCT00534495|10893694|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32
9786595|NCT00534495|10893695|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25
9786596|NCT00534495|10893696|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0
9786597|NCT00534495|10893694|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
9786598|NCT00534495|10893695|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
9786599|NCT00534495|10893696|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
9786600|NCT00534495|10893694|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0
9786601|NCT00534495|10893695|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0
9786602|NCT00534495|10893696|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40
9786603|NCT00534495|10893694|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
9786604|NCT00534495|10893695|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
9786605|NCT00534495|10893696|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
9786606|NCT00534495|10893694|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
9786607|NCT00534495|10893695|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
9786608|NCT00534495|10893696|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
9786609|NCT00534599|10893709|FG000|STARTED|Overall Study|Randomized|209
9786610|NCT00534599|10893710|FG001|STARTED|Overall Study|Randomized|200
9786611|NCT00534599|10893709|FG000|COMPLETED|Overall Study||152
9786612|NCT00534599|10893710|FG001|COMPLETED|Overall Study||168
9786613|NCT00534599|10893709|FG000|NOT COMPLETED|Overall Study||57
9786614|NCT00534599|10893710|FG001|NOT COMPLETED|Overall Study||32
9786615|NCT00534638|10893718|FG000|STARTED|Overall Study||14837
9786616|NCT00534638|10893719|FG001|STARTED|Overall Study||17338
9786617|NCT00534638|10893718|FG000|COMPLETED|Overall Study||8346
9786618|NCT00534638|10893719|FG001|COMPLETED|Overall Study||5547
9786619|NCT00534638|10893718|FG000|NOT COMPLETED|Overall Study||6491
9786620|NCT00534638|10893719|FG001|NOT COMPLETED|Overall Study||11791
9786621|NCT00534703|10893732|FG000|STARTED|Overall Study||4
9786622|NCT00534703|10893733|FG001|STARTED|Overall Study||1
9786623|NCT00534703|10893732|FG000|COMPLETED|Overall Study||4
9786624|NCT00534703|10893733|FG001|COMPLETED|Overall Study||1
9786625|NCT00534703|10893732|FG000|NOT COMPLETED|Overall Study||0
9786626|NCT00534703|10893733|FG001|NOT COMPLETED|Overall Study||0
9786627|NCT00534794|10893743|FG000|STARTED|Overall Study||40
9786628|NCT00534794|10893744|FG001|STARTED|Overall Study||39
9786629|NCT00534794|10893743|FG000|COMPLETED|Overall Study||40
9786630|NCT00534794|10893744|FG001|COMPLETED|Overall Study||39
9786631|NCT00534794|10893743|FG000|NOT COMPLETED|Overall Study||0
9786632|NCT00534794|10893744|FG001|NOT COMPLETED|Overall Study||0
9786633|NCT00534833|10893752|FG000|STARTED|Overall Study||182
9786634|NCT00534833|10893753|FG001|STARTED|Overall Study||180
9786635|NCT00534833|10893752|FG000|COMPLETED|Overall Study||182
9786636|NCT00534833|10893753|FG001|COMPLETED|Overall Study||180
9786637|NCT00534833|10893752|FG000|NOT COMPLETED|Overall Study||0
9786638|NCT00534833|10893753|FG001|NOT COMPLETED|Overall Study||0
9786639|NCT00534937|10893763|FG000|STARTED|Overall Study||42
9786640|NCT00534937|10893764|FG001|STARTED|Overall Study||47
9786641|NCT00534937|10893763|FG000|COMPLETED|Overall Study||34
9786642|NCT00534937|10893764|FG001|COMPLETED|Overall Study||35
9786643|NCT00534937|10893763|FG000|NOT COMPLETED|Overall Study||8
9786644|NCT00534937|10893764|FG001|NOT COMPLETED|Overall Study||12
9786645|NCT00535002|10893780|FG000|STARTED|Overall Study||19
9786646|NCT00535002|10893781|FG001|STARTED|Overall Study||12
9786647|NCT00535002|10893782|FG002|STARTED|Overall Study||13
9786648|NCT00535002|10893783|FG003|STARTED|Overall Study||14
9786649|NCT00535002|10893784|FG004|STARTED|Overall Study||9
9786650|NCT00535002|10893785|FG005|STARTED|Overall Study||17
9786651|NCT00535002|10893786|FG006|STARTED|Overall Study||12
9786652|NCT00535002|10893787|FG007|STARTED|Overall Study||16
9786653|NCT00535002|10893780|FG000|COMPLETED|Overall Study||19
9786654|NCT00535002|10893781|FG001|COMPLETED|Overall Study||12
9786655|NCT00535002|10893782|FG002|COMPLETED|Overall Study||13
9786656|NCT00535002|10893783|FG003|COMPLETED|Overall Study||14
9786657|NCT00535002|10893784|FG004|COMPLETED|Overall Study||9
9786658|NCT00535002|10893785|FG005|COMPLETED|Overall Study||17
10234096|NCT01564732|11364005|FG001|COMPLETED|Overall Study||0
10234097|NCT01564732|11364004|FG000|NOT COMPLETED|Overall Study||6
9786659|NCT00535002|10893786|FG006|COMPLETED|Overall Study||12
9786660|NCT00535002|10893787|FG007|COMPLETED|Overall Study||16
9786661|NCT00535002|10893780|FG000|NOT COMPLETED|Overall Study||0
9786662|NCT00535002|10893781|FG001|NOT COMPLETED|Overall Study||0
9786663|NCT00535002|10893782|FG002|NOT COMPLETED|Overall Study||0
9786664|NCT00535002|10893783|FG003|NOT COMPLETED|Overall Study||0
9786665|NCT00535002|10893784|FG004|NOT COMPLETED|Overall Study||0
9786666|NCT00535002|10893785|FG005|NOT COMPLETED|Overall Study||0
9786667|NCT00535002|10893786|FG006|NOT COMPLETED|Overall Study||0
9786668|NCT00535002|10893787|FG007|NOT COMPLETED|Overall Study||0
9786669|NCT00535132|10893803|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100
9786670|NCT00535132|10893804|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101
9786671|NCT00535132|10893803|FG000|COMPLETED|Randomized Population||100
9786672|NCT00535132|10893804|FG001|COMPLETED|Randomized Population||101
9786673|NCT00535132|10893803|FG000|NOT COMPLETED|Randomized Population||0
9786674|NCT00535132|10893804|FG001|NOT COMPLETED|Randomized Population||0
9786675|NCT00535132|10893803|FG000|STARTED|Safety Analysis Set||100
9786676|NCT00535132|10893804|FG001|STARTED|Safety Analysis Set||101
9786677|NCT00535132|10893803|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
9786678|NCT00535132|10893804|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
9786679|NCT00535132|10893803|FG000|NOT COMPLETED|Safety Analysis Set||2
9786680|NCT00535132|10893804|FG001|NOT COMPLETED|Safety Analysis Set||2
9786681|NCT00535132|10893803|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98
9786682|NCT00535132|10893804|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99
9786683|NCT00535132|10893803|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
9786684|NCT00535132|10893804|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
9786685|NCT00535132|10893803|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
9786686|NCT00535132|10893804|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
9786687|NCT00535145|10893812|FG000|STARTED|Phase I||114
9786688|NCT00535145|10893812|FG000|COMPLETED|Phase I||85
9786689|NCT00535145|10893812|FG000|NOT COMPLETED|Phase I||29
9786690|NCT00535145|10893812|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
9786691|NCT00535145|10893812|FG000|COMPLETED|Phase II||69
9786692|NCT00535145|10893812|FG000|NOT COMPLETED|Phase II||15
9786693|NCT00535223|10893822|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
9786694|NCT00535223|10893823|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
9786695|NCT00535223|10893822|FG000|COMPLETED|Overall Study||37
9786696|NCT00535223|10893823|FG001|COMPLETED|Overall Study||39
9786697|NCT00535223|10893822|FG000|NOT COMPLETED|Overall Study||4
9786698|NCT00535223|10893823|FG001|NOT COMPLETED|Overall Study||1
9786699|NCT00535236|10893839|FG000|STARTED|Overall Study||40
9786700|NCT00535236|10893840|FG001|STARTED|Overall Study||10
9786701|NCT00535236|10893841|FG002|STARTED|Overall Study||41
9786702|NCT00535236|10893842|FG003|STARTED|Overall Study||10
9786703|NCT00535236|10893843|FG004|STARTED|Overall Study||59
9786704|NCT00535236|10893844|FG005|STARTED|Overall Study||20
9786705|NCT00535236|10893845|FG006|STARTED|Overall Study||62
9786706|NCT00535236|10893846|FG007|STARTED|Overall Study||19
10234098|NCT01564732|11364005|FG001|NOT COMPLETED|Overall Study||5
9786707|NCT00535236|10893847|FG008|STARTED|Overall Study||60
10234099|NCT01560507|11364014|FG000|STARTED|Overall Study||5
9786708|NCT00535236|10893848|FG009|STARTED|Overall Study||20
9786709|NCT00535236|10893839|FG000|Vaccination 1|Overall Study||40
9786710|NCT00535236|10893840|FG001|Vaccination 1|Overall Study||10
9786711|NCT00535236|10893841|FG002|Vaccination 1|Overall Study||40
9786712|NCT00535236|10893842|FG003|Vaccination 1|Overall Study||10
9786713|NCT00535236|10893843|FG004|Vaccination 1|Overall Study||58
9786714|NCT00535236|10893844|FG005|Vaccination 1|Overall Study||19
9786715|NCT00535236|10893845|FG006|Vaccination 1|Overall Study||61
9786716|NCT00535236|10893846|FG007|Vaccination 1|Overall Study||19
9786717|NCT00535236|10893847|FG008|Vaccination 1|Overall Study||60
9786718|NCT00535236|10893848|FG009|Vaccination 1|Overall Study||20
9786719|NCT00535236|10893839|FG000|Vaccination 2|Overall Study||35
9786720|NCT00535236|10893840|FG001|Vaccination 2|Overall Study||10
9786721|NCT00535236|10893841|FG002|Vaccination 2|Overall Study||37
9786722|NCT00535236|10893842|FG003|Vaccination 2|Overall Study||8
9786723|NCT00535236|10893843|FG004|Vaccination 2|Overall Study||52
9786724|NCT00535236|10893844|FG005|Vaccination 2|Overall Study||19
9786725|NCT00535236|10893845|FG006|Vaccination 2|Overall Study||58
9786726|NCT00535236|10893846|FG007|Vaccination 2|Overall Study||19
9786727|NCT00535236|10893847|FG008|Vaccination 2|Overall Study||57
9786728|NCT00535236|10893848|FG009|Vaccination 2|Overall Study||19
9786729|NCT00535236|10893839|FG000|Vaccination 3|Overall Study||34
9786730|NCT00535236|10893840|FG001|Vaccination 3|Overall Study||10
9786731|NCT00535236|10893841|FG002|Vaccination 3|Overall Study||35
9786732|NCT00535236|10893842|FG003|Vaccination 3|Overall Study||8
9786733|NCT00535236|10893843|FG004|Vaccination 3|Overall Study||48
9786734|NCT00535236|10893844|FG005|Vaccination 3|Overall Study||19
9786735|NCT00535236|10893845|FG006|Vaccination 3|Overall Study||51
9786736|NCT00535236|10893846|FG007|Vaccination 3|Overall Study||18
9786737|NCT00535236|10893847|FG008|Vaccination 3|Overall Study||53
9786738|NCT00535236|10893848|FG009|Vaccination 3|Overall Study||18
9786739|NCT00535236|10893839|FG000|Vaccination 4|Overall Study||34
9786740|NCT00535236|10893840|FG001|Vaccination 4|Overall Study||10
9786741|NCT00535236|10893841|FG002|Vaccination 4|Overall Study||32
9786742|NCT00535236|10893842|FG003|Vaccination 4|Overall Study||6
9786743|NCT00535236|10893843|FG004|Vaccination 4|Overall Study||47
9786744|NCT00535236|10893844|FG005|Vaccination 4|Overall Study||19
9786745|NCT00535236|10893845|FG006|Vaccination 4|Overall Study||51
9786746|NCT00535236|10893846|FG007|Vaccination 4|Overall Study||18
9786747|NCT00535236|10893847|FG008|Vaccination 4|Overall Study||50
9786748|NCT00535236|10893848|FG009|Vaccination 4|Overall Study||17
9786749|NCT00535236|10893839|FG000|COMPLETED|Overall Study||33
9786750|NCT00535236|10893840|FG001|COMPLETED|Overall Study||8
9786751|NCT00535236|10893841|FG002|COMPLETED|Overall Study||29
9786752|NCT00535236|10893842|FG003|COMPLETED|Overall Study||6
9786753|NCT00535236|10893843|FG004|COMPLETED|Overall Study||47
9786754|NCT00535236|10893844|FG005|COMPLETED|Overall Study||19
9786755|NCT00535236|10893845|FG006|COMPLETED|Overall Study||51
9786756|NCT00535236|10893846|FG007|COMPLETED|Overall Study||18
9786757|NCT00535236|10893847|FG008|COMPLETED|Overall Study||47
9786758|NCT00535236|10893848|FG009|COMPLETED|Overall Study||16
9786759|NCT00535236|10893839|FG000|NOT COMPLETED|Overall Study||7
9786760|NCT00535236|10893840|FG001|NOT COMPLETED|Overall Study||2
9786761|NCT00535236|10893841|FG002|NOT COMPLETED|Overall Study||12
9786762|NCT00535236|10893842|FG003|NOT COMPLETED|Overall Study||4
9786763|NCT00535236|10893843|FG004|NOT COMPLETED|Overall Study||12
9786764|NCT00535236|10893844|FG005|NOT COMPLETED|Overall Study||1
9786765|NCT00535236|10893845|FG006|NOT COMPLETED|Overall Study||11
9786766|NCT00535236|10893846|FG007|NOT COMPLETED|Overall Study||1
9786767|NCT00535236|10893847|FG008|NOT COMPLETED|Overall Study||13
9786768|NCT00535236|10893848|FG009|NOT COMPLETED|Overall Study||4
9786769|NCT00535288|10893878|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
9786770|NCT00535288|10893879|FG001|STARTED|Overall Study||162
9786771|NCT00535288|10893880|FG002|STARTED|Overall Study||160
9786772|NCT00535288|10893881|FG003|STARTED|Overall Study||151
9786773|NCT00535288|10893882|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
9786774|NCT00535288|10893878|FG000|COMPLETED|Overall Study||260
9786775|NCT00535288|10893879|FG001|COMPLETED|Overall Study||130
9786776|NCT00535288|10893880|FG002|COMPLETED|Overall Study||127
9786777|NCT00535288|10893881|FG003|COMPLETED|Overall Study||122
10015282|NCT01805037|11138334|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
10015283|NCT01805037|11138335|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
10015284|NCT01805037|11138334|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
10015285|NCT01805037|11138335|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
10015286|NCT01805037|11138334|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0
10015287|NCT01805037|11138335|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14
10015288|NCT01805037|11138334|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
10015289|NCT01805037|11138335|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
10015290|NCT01805037|11138334|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0
10015291|NCT01805037|11138335|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2
10015292|NCT01805037|11138334|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
10015293|NCT01805037|11138335|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
10015294|NCT01805037|11138334|FG000|STARTED|Follow Up (up to 3 Years)||0
10015295|NCT01805037|11138335|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
10015296|NCT01805037|11138334|FG000|COMPLETED|Follow Up (up to 3 Years)||0
10015297|NCT01805037|11138335|FG001|COMPLETED|Follow Up (up to 3 Years)||14
10015298|NCT01805037|11138334|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0
9786778|NCT00535288|10893882|FG004|COMPLETED|Overall Study||116
9786779|NCT00535288|10893878|FG000|NOT COMPLETED|Overall Study||54
9786780|NCT00535288|10893879|FG001|NOT COMPLETED|Overall Study||32
9786781|NCT00535288|10893880|FG002|NOT COMPLETED|Overall Study||33
9786782|NCT00535288|10893881|FG003|NOT COMPLETED|Overall Study||29
9786783|NCT00535288|10893882|FG004|NOT COMPLETED|Overall Study||42
9786784|NCT00535301|10893901|FG000|STARTED|Overall Study||38
9786785|NCT00535301|10893902|FG001|STARTED|Overall Study||38
9786786|NCT00535301|10893901|FG000|COMPLETED|Overall Study||33
10015299|NCT01805037|11138335|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6
10015300|NCT01805089|11138341|FG000|STARTED|Overall Study||48
10015301|NCT01805089|11138342|FG001|STARTED|Overall Study||47
10015302|NCT01805089|11138341|FG000|COMPLETED|Overall Study||43
10015303|NCT01805089|11138342|FG001|COMPLETED|Overall Study||43
10015304|NCT01805089|11138341|FG000|NOT COMPLETED|Overall Study||5
10015305|NCT01805089|11138342|FG001|NOT COMPLETED|Overall Study||4
9786787|NCT00535301|10893902|FG001|COMPLETED|Overall Study||33
9786788|NCT00535301|10893901|FG000|NOT COMPLETED|Overall Study||5
9786789|NCT00535301|10893902|FG001|NOT COMPLETED|Overall Study||5
9786790|NCT00535392|10893910|FG000|STARTED|Overall Study||33
9786791|NCT00535392|10893910|FG000|COMPLETED|Overall Study||33
9786792|NCT00535392|10893910|FG000|NOT COMPLETED|Overall Study||0
9786793|NCT00535496|10893916|FG000|STARTED|Overall Study||15
9786794|NCT00535496|10893917|FG001|STARTED|Overall Study||15
9786795|NCT00535496|10893918|FG002|STARTED|Overall Study||30
9786796|NCT00535496|10893919|FG003|STARTED|Overall Study||31
9786797|NCT00535496|10893916|FG000|All-Subjects-Treated (AST) Group|Overall Study||15
9786798|NCT00535496|10893917|FG001|All-Subjects-Treated (AST) Group|Overall Study||14
10015306|NCT01805154|11138348|FG000|STARTED|Overall Study||1529
10015307|NCT01805154|11138348|FG000|COMPLETED|Overall Study||1175
10015308|NCT01805154|11138348|FG000|NOT COMPLETED|Overall Study||354
9786799|NCT00535496|10893918|FG002|All-Subjects-Treated (AST) Group|Overall Study||30
9786800|NCT00535496|10893919|FG003|All-Subjects-Treated (AST) Group|Overall Study||31
9786801|NCT00535496|10893916|FG000|COMPLETED|Overall Study||15
9786802|NCT00535496|10893917|FG001|COMPLETED|Overall Study||13
9786803|NCT00535496|10893918|FG002|COMPLETED|Overall Study||30
9786804|NCT00535496|10893919|FG003|COMPLETED|Overall Study||31
9786805|NCT00535496|10893916|FG000|NOT COMPLETED|Overall Study||0
9786806|NCT00535496|10893917|FG001|NOT COMPLETED|Overall Study||2
9786807|NCT00535496|10893918|FG002|NOT COMPLETED|Overall Study||0
9786808|NCT00535496|10893919|FG003|NOT COMPLETED|Overall Study||0
9786809|NCT00535587|10893930|FG000|STARTED|Overall Study||53
9786810|NCT00535587|10893931|FG001|STARTED|Overall Study||53
9786811|NCT00535587|10893932|FG002|STARTED|Overall Study||47
9786812|NCT00535587|10893933|FG003|STARTED|Overall Study||54
9786813|NCT00535587|10893930|FG000|COMPLETED|Overall Study||43
9786814|NCT00535587|10893931|FG001|COMPLETED|Overall Study||42
9786815|NCT00535587|10893932|FG002|COMPLETED|Overall Study||39
9786816|NCT00535587|10893933|FG003|COMPLETED|Overall Study||41
9786817|NCT00535587|10893930|FG000|NOT COMPLETED|Overall Study||10
9786818|NCT00535587|10893931|FG001|NOT COMPLETED|Overall Study||11
9786819|NCT00535587|10893932|FG002|NOT COMPLETED|Overall Study||8
9786820|NCT00535587|10893933|FG003|NOT COMPLETED|Overall Study||13
9786821|NCT00535613|10893943|FG000|STARTED|Overall Study||49
9786822|NCT00535613|10893944|FG001|STARTED|Overall Study||50
9786823|NCT00535613|10893943|FG000|COMPLETED|Overall Study||49
9786824|NCT00535613|10893944|FG001|COMPLETED|Overall Study||50
9786825|NCT00535613|10893943|FG000|NOT COMPLETED|Overall Study||0
9786826|NCT00535613|10893944|FG001|NOT COMPLETED|Overall Study||0
9786827|NCT00535626|10893950|FG000|STARTED|Overall Study||190
9786828|NCT00535626|10893950|FG000|COMPLETED|Overall Study||85
9786829|NCT00535626|10893950|FG000|NOT COMPLETED|Overall Study||105
9786830|NCT00535652|10893955|FG000|STARTED|Overall Study||23
9786831|NCT00535652|10893955|FG000|COMPLETED|Overall Study||20
9786832|NCT00535652|10893955|FG000|NOT COMPLETED|Overall Study||3
9786833|NCT00535730|10893961|FG000|STARTED|Overall Study||236
9786834|NCT00535730|10893962|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
9786835|NCT00535730|10893961|FG000|COMPLETED|Overall Study||234
9786836|NCT00535730|10893962|FG001|COMPLETED|Overall Study||230
9786837|NCT00535730|10893961|FG000|NOT COMPLETED|Overall Study||2
9786838|NCT00535730|10893962|FG001|NOT COMPLETED|Overall Study||7
9830486|NCT00763282|10941169|FG000|STARTED|Overall Study||72
9830487|NCT00763282|10941170|FG001|STARTED|Overall Study||72
9830488|NCT00763282|10941169|FG000|COMPLETED|Overall Study||40
9830489|NCT00763282|10941170|FG001|COMPLETED|Overall Study||38
9830490|NCT00763282|10941169|FG000|NOT COMPLETED|Overall Study||32
9830491|NCT00763282|10941170|FG001|NOT COMPLETED|Overall Study||34
9830492|NCT00763321|10941181|FG000|STARTED|Open-label Period||285
9830493|NCT00763321|10941182|FG001|STARTED|Open-label Period||0
9830494|NCT00763321|10941183|FG002|STARTED|Open-label Period||0
9830495|NCT00763321|10941181|FG000|COMPLETED|Open-label Period||222
9830496|NCT00763321|10941182|FG001|COMPLETED|Open-label Period||0
9830497|NCT00763321|10941183|FG002|COMPLETED|Open-label Period||0
9830498|NCT00763321|10941181|FG000|NOT COMPLETED|Open-label Period||63
9830499|NCT00763321|10941182|FG001|NOT COMPLETED|Open-label Period||0
9830500|NCT00763321|10941183|FG002|NOT COMPLETED|Open-label Period||0
9830501|NCT00763321|10941181|FG000|STARTED|Double-blind Period||0
9830502|NCT00763321|10941182|FG001|STARTED|Double-blind Period||109
9830503|NCT00763321|10941183|FG002|STARTED|Double-blind Period||113
9830504|NCT00763321|10941181|FG000|COMPLETED|Double-blind Period||0
9830505|NCT00763321|10941182|FG001|COMPLETED|Double-blind Period||88
9830506|NCT00763321|10941183|FG002|COMPLETED|Double-blind Period||84
10015309|NCT01805180|11138357|FG000|STARTED|Lead-in Donor Phase||7
10015310|NCT01805180|11138358|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
10015311|NCT01805180|11138359|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
9830507|NCT00763321|10941181|FG000|NOT COMPLETED|Double-blind Period||0
9830508|NCT00763321|10941182|FG001|NOT COMPLETED|Double-blind Period||21
9830509|NCT00763321|10941183|FG002|NOT COMPLETED|Double-blind Period||29
9786839|NCT00535743|10893993|FG000|STARTED|Overall Study||5
9786840|NCT00535743|10893994|FG001|STARTED|Overall Study||11
9786841|NCT00535743|10893995|FG002|STARTED|Overall Study||11
9786842|NCT00535743|10893996|FG003|STARTED|Overall Study||11
9786843|NCT00535743|10893997|FG004|STARTED|Overall Study||11
9786844|NCT00535743|10893998|FG005|STARTED|Overall Study||10
9786845|NCT00535743|10893999|FG006|STARTED|Overall Study||3
9786846|NCT00535743|10894000|FG007|STARTED|Overall Study||5
9786847|NCT00535743|10894001|FG008|STARTED|Overall Study||5
9786848|NCT00535743|10894002|FG009|STARTED|Overall Study||5
9786849|NCT00535743|10894003|FG010|STARTED|Overall Study||5
9786850|NCT00535743|10894004|FG011|STARTED|Overall Study||5
9786851|NCT00535743|10894005|FG012|STARTED|Overall Study||5
9786852|NCT00535743|10894006|FG013|STARTED|Overall Study||10
9786853|NCT00535743|10894007|FG014|STARTED|Overall Study||9
9786854|NCT00535743|10894008|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
9786855|NCT00535743|10894009|FG016|STARTED|Overall Study||10
9786856|NCT00535743|10894010|FG017|STARTED|Overall Study||11
9786857|NCT00535743|10894011|FG018|STARTED|Overall Study||3
9786858|NCT00535743|10894012|FG019|STARTED|Overall Study||5
9786859|NCT00535743|10894013|FG020|STARTED|Overall Study||5
9786860|NCT00535743|10894014|FG021|STARTED|Overall Study||5
9786861|NCT00535743|10894015|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
9786862|NCT00535743|10894016|FG023|STARTED|Overall Study||5
9786863|NCT00535743|10893993|FG000|Treated|Overall Study||5
9786864|NCT00535743|10893994|FG001|Treated|Overall Study||11
9786865|NCT00535743|10893995|FG002|Treated|Overall Study||11
9786866|NCT00535743|10893996|FG003|Treated|Overall Study||11
9786867|NCT00535743|10893997|FG004|Treated|Overall Study||11
9786868|NCT00535743|10893998|FG005|Treated|Overall Study||10
9786869|NCT00535743|10893999|FG006|Treated|Overall Study||3
9786870|NCT00535743|10894000|FG007|Treated|Overall Study||5
9786871|NCT00535743|10894001|FG008|Treated|Overall Study||4
9786872|NCT00535743|10894002|FG009|Treated|Overall Study||5
9786873|NCT00535743|10894003|FG010|Treated|Overall Study||5
9786874|NCT00535743|10894004|FG011|Treated|Overall Study||5
9786875|NCT00535743|10894005|FG012|Treated|Overall Study||5
9786876|NCT00535743|10894006|FG013|Treated|Overall Study||10
9786877|NCT00535743|10894007|FG014|Treated|Overall Study||9
9786878|NCT00535743|10894008|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
9786879|NCT00535743|10894009|FG016|Treated|Overall Study||10
9786880|NCT00535743|10894010|FG017|Treated|Overall Study||11
9786881|NCT00535743|10894011|FG018|Treated|Overall Study||3
9786882|NCT00535743|10894012|FG019|Treated|Overall Study||5
9786883|NCT00535743|10894013|FG020|Treated|Overall Study||5
9786884|NCT00535743|10894014|FG021|Treated|Overall Study||5
9786885|NCT00535743|10894015|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
9786886|NCT00535743|10894016|FG023|Treated|Overall Study||5
9786887|NCT00535743|10893993|FG000|COMPLETED|Overall Study||5
9786888|NCT00535743|10893994|FG001|COMPLETED|Overall Study||11
9786889|NCT00535743|10893995|FG002|COMPLETED|Overall Study||11
9786890|NCT00535743|10893996|FG003|COMPLETED|Overall Study||11
9786891|NCT00535743|10893997|FG004|COMPLETED|Overall Study||11
9786892|NCT00535743|10893998|FG005|COMPLETED|Overall Study||10
9786893|NCT00535743|10893999|FG006|COMPLETED|Overall Study||3
9786894|NCT00535743|10894000|FG007|COMPLETED|Overall Study||5
9786895|NCT00535743|10894001|FG008|COMPLETED|Overall Study||4
9786896|NCT00535743|10894002|FG009|COMPLETED|Overall Study||4
9786897|NCT00535743|10894003|FG010|COMPLETED|Overall Study||5
9786898|NCT00535743|10894004|FG011|COMPLETED|Overall Study||5
9786899|NCT00535743|10894005|FG012|COMPLETED|Overall Study||5
9786900|NCT00535743|10894006|FG013|COMPLETED|Overall Study||10
9786901|NCT00535743|10894007|FG014|COMPLETED|Overall Study||9
9786902|NCT00535743|10894008|FG015|COMPLETED|Overall Study||13
9786903|NCT00535743|10894009|FG016|COMPLETED|Overall Study||10
9786904|NCT00535743|10894010|FG017|COMPLETED|Overall Study||11
9786905|NCT00535743|10894011|FG018|COMPLETED|Overall Study||3
9786906|NCT00535743|10894012|FG019|COMPLETED|Overall Study||5
9786907|NCT00535743|10894013|FG020|COMPLETED|Overall Study||5
9786908|NCT00535743|10894014|FG021|COMPLETED|Overall Study||4
9786909|NCT00535743|10894015|FG022|COMPLETED|Overall Study||6
9786910|NCT00535743|10894016|FG023|COMPLETED|Overall Study||5
9786911|NCT00535743|10893993|FG000|NOT COMPLETED|Overall Study||0
9786912|NCT00535743|10893994|FG001|NOT COMPLETED|Overall Study||0
9786913|NCT00535743|10893995|FG002|NOT COMPLETED|Overall Study||0
9786914|NCT00535743|10893996|FG003|NOT COMPLETED|Overall Study||0
9786915|NCT00535743|10893997|FG004|NOT COMPLETED|Overall Study||0
9786916|NCT00535743|10893998|FG005|NOT COMPLETED|Overall Study||0
9786917|NCT00535743|10893999|FG006|NOT COMPLETED|Overall Study||0
9786918|NCT00535743|10894000|FG007|NOT COMPLETED|Overall Study||0
9786919|NCT00535743|10894001|FG008|NOT COMPLETED|Overall Study||1
10234100|NCT01560507|11364015|FG001|STARTED|Overall Study||2
10234101|NCT01560507|11364016|FG002|STARTED|Overall Study||2
10234102|NCT01560507|11364014|FG000|COMPLETED|Overall Study||1
10234103|NCT01560507|11364015|FG001|COMPLETED|Overall Study||0
10234104|NCT01560507|11364016|FG002|COMPLETED|Overall Study||0
9786920|NCT00535743|10894002|FG009|NOT COMPLETED|Overall Study||1
9786921|NCT00535743|10894003|FG010|NOT COMPLETED|Overall Study||0
9786922|NCT00535743|10894004|FG011|NOT COMPLETED|Overall Study||0
9786923|NCT00535743|10894005|FG012|NOT COMPLETED|Overall Study||0
10234105|NCT01560507|11364014|FG000|NOT COMPLETED|Overall Study||4
9786924|NCT00535743|10894006|FG013|NOT COMPLETED|Overall Study||0
9786925|NCT00535743|10894007|FG014|NOT COMPLETED|Overall Study||0
9786926|NCT00535743|10894008|FG015|NOT COMPLETED|Overall Study||0
9786927|NCT00535743|10894009|FG016|NOT COMPLETED|Overall Study||0
9786928|NCT00535743|10894010|FG017|NOT COMPLETED|Overall Study||0
9786929|NCT00535743|10894011|FG018|NOT COMPLETED|Overall Study||0
9786930|NCT00535743|10894012|FG019|NOT COMPLETED|Overall Study||0
9786931|NCT00535743|10894013|FG020|NOT COMPLETED|Overall Study||0
9786932|NCT00535743|10894014|FG021|NOT COMPLETED|Overall Study||1
9786933|NCT00535743|10894015|FG022|NOT COMPLETED|Overall Study||0
9786934|NCT00535743|10894016|FG023|NOT COMPLETED|Overall Study||0
9786935|NCT00535769|10894068|FG000|STARTED|Overall Study||35
9786936|NCT00535769|10894069|FG001|STARTED|Overall Study||35
9786937|NCT00535769|10894068|FG000|COMPLETED|Overall Study||35
9786938|NCT00535769|10894069|FG001|COMPLETED|Overall Study||35
9786939|NCT00535769|10894068|FG000|NOT COMPLETED|Overall Study||0
9786940|NCT00535769|10894069|FG001|NOT COMPLETED|Overall Study||0
9786941|NCT00535782|10894078|FG000|STARTED|Part 1: 24-Week Double-blind Period||69
9786942|NCT00535782|10894079|FG001|STARTED|Part 1: 24-Week Double-blind Period||63
9786943|NCT00535782|10894080|FG002|STARTED|Part 1: 24-Week Double-blind Period||0
9786944|NCT00535782|10894078|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
9786945|NCT00535782|10894079|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
9786946|NCT00535782|10894080|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
9786947|NCT00535782|10894078|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
9786948|NCT00535782|10894079|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
9786949|NCT00535782|10894080|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
9786950|NCT00535782|10894078|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65
9786951|NCT00535782|10894079|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59
9786952|NCT00535782|10894080|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0
9786953|NCT00535782|10894078|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
9786954|NCT00535782|10894079|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
9786955|NCT00535782|10894080|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
9786956|NCT00535782|10894078|FG000|STARTED|Part 2: 80-Week Open-label Period||0
9786957|NCT00535782|10894079|FG001|STARTED|Part 2: 80-Week Open-label Period||0
9786958|NCT00535782|10894080|FG002|STARTED|Part 2: 80-Week Open-label Period||124
9786959|NCT00535782|10894078|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0
9786960|NCT00535782|10894079|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0
9786961|NCT00535782|10894080|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98
9786962|NCT00535782|10894078|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
9786963|NCT00535782|10894079|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
9786964|NCT00535782|10894080|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
9786965|NCT00535821|10894089|FG000|STARTED|Overall Study||2
9786966|NCT00535821|10894090|FG001|STARTED|Overall Study||3
9786967|NCT00535821|10894089|FG000|COMPLETED|Overall Study||2
9786968|NCT00535821|10894090|FG001|COMPLETED|Overall Study||3
9786969|NCT00535821|10894089|FG000|NOT COMPLETED|Overall Study||0
9786970|NCT00535821|10894090|FG001|NOT COMPLETED|Overall Study||0
9786971|NCT00535847|10894099|FG000|STARTED|Overall Study||81
9786972|NCT00535847|10894100|FG001|STARTED|Overall Study||34
9786973|NCT00535847|10894101|FG002|STARTED|Overall Study||2
9786974|NCT00535847|10894099|FG000|COMPLETED|Overall Study||59
9786975|NCT00535847|10894100|FG001|COMPLETED|Overall Study||20
9786976|NCT00535847|10894101|FG002|COMPLETED|Overall Study||0
9786977|NCT00535847|10894099|FG000|NOT COMPLETED|Overall Study||22
9786978|NCT00535847|10894100|FG001|NOT COMPLETED|Overall Study||14
9786979|NCT00535847|10894101|FG002|NOT COMPLETED|Overall Study||2
9786980|NCT00535873|10894113|FG000|STARTED|Overall Study||60
9786981|NCT00535873|10894113|FG000|COMPLETED|Overall Study||60
9786982|NCT00535873|10894113|FG000|NOT COMPLETED|Overall Study||0
9786983|NCT00535925|10894119|FG000|STARTED|Overall Study||188
9786984|NCT00535925|10894120|FG001|STARTED|Overall Study||207
9786985|NCT00535925|10894119|FG000|COMPLETED|Overall Study||169
9786986|NCT00535925|10894120|FG001|COMPLETED|Overall Study||199
9786987|NCT00535925|10894119|FG000|NOT COMPLETED|Overall Study||19
9786988|NCT00535925|10894120|FG001|NOT COMPLETED|Overall Study||8
9786989|NCT00535938|10894130|FG000|STARTED|Overall Study||506
9786990|NCT00535938|10894131|FG001|STARTED|Overall Study||866
9786991|NCT00535938|10894130|FG000|COMPLETED|Overall Study||115
9786992|NCT00535938|10894131|FG001|COMPLETED|Overall Study||404
9786993|NCT00535938|10894130|FG000|NOT COMPLETED|Overall Study||391
9786994|NCT00535938|10894131|FG001|NOT COMPLETED|Overall Study||462
9786995|NCT00536107|10894139|FG000|STARTED|Overall Study||8
9786996|NCT00536107|10894140|FG001|STARTED|Overall Study||6
9786997|NCT00536107|10894139|FG000|COMPLETED|Overall Study||0
9786998|NCT00536107|10894140|FG001|COMPLETED|Overall Study||0
9786999|NCT00536107|10894139|FG000|NOT COMPLETED|Overall Study||8
9787000|NCT00536107|10894140|FG001|NOT COMPLETED|Overall Study||6
9787001|NCT00536120|10894148|FG000|STARTED|Overall Study||30
9787002|NCT00536120|10894149|FG001|STARTED|Overall Study||30
9787003|NCT00536120|10894148|FG000|COMPLETED|Overall Study||24
9787004|NCT00536120|10894149|FG001|COMPLETED|Overall Study||27
9787005|NCT00536120|10894148|FG000|NOT COMPLETED|Overall Study||6
9787006|NCT00536120|10894149|FG001|NOT COMPLETED|Overall Study||3
9787007|NCT00536172|10894157|FG000|STARTED|Overall Study||74
9787008|NCT00536172|10894158|FG001|STARTED|Overall Study||74
9787009|NCT00536172|10894157|FG000|COMPLETED|Overall Study||60
9787010|NCT00536172|10894158|FG001|COMPLETED|Overall Study||65
9787011|NCT00536172|10894157|FG000|NOT COMPLETED|Overall Study||14
9787012|NCT00536172|10894158|FG001|NOT COMPLETED|Overall Study||9
9787013|NCT00536198|10894166|FG000|STARTED|Overall Study||125
9787014|NCT00536198|10894167|FG001|STARTED|Overall Study||127
9787015|NCT00536198|10894166|FG000|Cycle 1|Overall Study||110
9787016|NCT00536198|10894167|FG001|Cycle 1|Overall Study||123
9787017|NCT00536198|10894166|FG000|Cycle 2|Overall Study||104
9787018|NCT00536198|10894167|FG001|Cycle 2|Overall Study||112
9787019|NCT00536198|10894166|FG000|Cycle 3|Overall Study||100
9787020|NCT00536198|10894167|FG001|Cycle 3|Overall Study||101
9787021|NCT00536198|10894166|FG000|Cycle 4|Overall Study||95
9787022|NCT00536198|10894167|FG001|Cycle 4|Overall Study||98
9787023|NCT00536198|10894166|FG000|Cycle 5|Overall Study||88
9787024|NCT00536198|10894167|FG001|Cycle 5|Overall Study||85
9787025|NCT00536198|10894166|FG000|Cycle 6|Overall Study||88
9787026|NCT00536198|10894167|FG001|Cycle 6|Overall Study||88
9787027|NCT00536198|10894166|FG000|COMPLETED|Overall Study||88
9787028|NCT00536198|10894167|FG001|COMPLETED|Overall Study||88
9787029|NCT00536198|10894166|FG000|NOT COMPLETED|Overall Study||37
9787030|NCT00536198|10894167|FG001|NOT COMPLETED|Overall Study||39
9787031|NCT00536263|10894178|FG000|STARTED|Overall Study||225
9787032|NCT00536263|10894179|FG001|STARTED|Overall Study||221
9787033|NCT00536263|10894180|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
9787034|NCT00536263|10894178|FG000|COMPLETED|Overall Study||214
9787035|NCT00536263|10894179|FG001|COMPLETED|Overall Study||207
9787036|NCT00536263|10894180|FG002|COMPLETED|Overall Study||204
9787037|NCT00536263|10894178|FG000|NOT COMPLETED|Overall Study||11
9787038|NCT00536263|10894179|FG001|NOT COMPLETED|Overall Study||14
9787039|NCT00536263|10894180|FG002|NOT COMPLETED|Overall Study||21
9787040|NCT00536341|10894190|FG000|STARTED|Overall Study||10
9787041|NCT00536341|10894191|FG001|STARTED|Overall Study||54
9787042|NCT00536341|10894190|FG000|COMPLETED|Overall Study||5
9787043|NCT00536341|10894191|FG001|COMPLETED|Overall Study||43
9787044|NCT00536341|10894190|FG000|NOT COMPLETED|Overall Study||5
9787045|NCT00536341|10894191|FG001|NOT COMPLETED|Overall Study||11
9787046|NCT00536471|10894202|FG000|STARTED|Overall Study||257
9787047|NCT00536471|10894203|FG001|STARTED|Overall Study||127
9787048|NCT00536471|10894204|FG002|STARTED|Overall Study||261
9787049|NCT00536471|10894205|FG003|STARTED|Overall Study||131
9787050|NCT00536471|10894202|FG000|COMPLETED|Overall Study||101
9787051|NCT00536471|10894203|FG001|COMPLETED|Overall Study||43
9787052|NCT00536471|10894204|FG002|COMPLETED|Overall Study||122
9787053|NCT00536471|10894205|FG003|COMPLETED|Overall Study||57
9787054|NCT00536471|10894202|FG000|NOT COMPLETED|Overall Study||156
9787055|NCT00536471|10894203|FG001|NOT COMPLETED|Overall Study||84
9787056|NCT00536471|10894204|FG002|NOT COMPLETED|Overall Study||139
9787057|NCT00536471|10894205|FG003|NOT COMPLETED|Overall Study||74
9787058|NCT00536484|10894224|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445
9787059|NCT00536484|10894225|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438
9787060|NCT00536484|10894224|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
9787061|NCT00536484|10894225|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
9787062|NCT00536484|10894224|FG000|NOT COMPLETED|Overall Study||60
9787063|NCT00536484|10894225|FG001|NOT COMPLETED|Overall Study||56
9787064|NCT00536510|10894233|FG000|STARTED|Overall Study||322
9787065|NCT00536510|10894234|FG001|STARTED|Overall Study||324
9787066|NCT00536510|10894233|FG000|COMPLETED|Overall Study||240
9787067|NCT00536510|10894234|FG001|COMPLETED|Overall Study||295
9787068|NCT00536510|10894233|FG000|NOT COMPLETED|Overall Study||82
9787069|NCT00536510|10894234|FG001|NOT COMPLETED|Overall Study||29
9787070|NCT00536575|10894240|FG000|STARTED|Overall Study||13
9787071|NCT00536575|10894240|FG000|COMPLETED|Overall Study||11
9787072|NCT00536575|10894240|FG000|NOT COMPLETED|Overall Study||2
9787073|NCT00536601|10894249|FG000|STARTED|Overall Study||6
9787074|NCT00536601|10894250|FG001|STARTED|Overall Study||21
9787075|NCT00536601|10894251|FG002|STARTED|Overall Study||71
9787076|NCT00536601|10894252|FG003|STARTED|Overall Study||65
9787077|NCT00536601|10894253|FG004|STARTED|Overall Study||11
9787078|NCT00536601|10894249|FG000|COMPLETED|Overall Study||6
9787079|NCT00536601|10894250|FG001|COMPLETED|Overall Study||21
9787080|NCT00536601|10894251|FG002|COMPLETED|Overall Study||71
9787081|NCT00536601|10894252|FG003|COMPLETED|Overall Study||65
9787082|NCT00536601|10894253|FG004|COMPLETED|Overall Study||11
9787083|NCT00536601|10894249|FG000|NOT COMPLETED|Overall Study||0
9787084|NCT00536601|10894250|FG001|NOT COMPLETED|Overall Study||0
9787085|NCT00536601|10894251|FG002|NOT COMPLETED|Overall Study||0
9787086|NCT00536601|10894252|FG003|NOT COMPLETED|Overall Study||0
9787087|NCT00536601|10894253|FG004|NOT COMPLETED|Overall Study||0
9787088|NCT00536731|10894268|FG000|STARTED|Overall Study||253
9787089|NCT00536731|10894269|FG001|STARTED|Overall Study||246
9787090|NCT00536731|10894270|FG002|STARTED|Overall Study||243
9787091|NCT00536731|10894268|FG000|COMPLETED|Overall Study||249
9787092|NCT00536731|10894269|FG001|COMPLETED|Overall Study||241
9787093|NCT00536731|10894270|FG002|COMPLETED|Overall Study||238
9787094|NCT00536731|10894268|FG000|NOT COMPLETED|Overall Study||4
9787095|NCT00536731|10894269|FG001|NOT COMPLETED|Overall Study||5
9787096|NCT00536731|10894270|FG002|NOT COMPLETED|Overall Study||5
9787097|NCT00536744|10894280|FG000|STARTED|Overall Study||107
9787098|NCT00536744|10894281|FG001|STARTED|Overall Study||99
9787099|NCT00536744|10894280|FG000|COMPLETED|Overall Study||78
9787100|NCT00536744|10894281|FG001|COMPLETED|Overall Study||71
9787101|NCT00536744|10894280|FG000|NOT COMPLETED|Overall Study||29
9787102|NCT00536744|10894281|FG001|NOT COMPLETED|Overall Study||28
9787103|NCT00536809|10894287|FG000|STARTED|Phase I (Dose-finding Phase)||10
9787104|NCT00536809|10894287|FG000|COMPLETED|Phase I (Dose-finding Phase)||10
9787105|NCT00536809|10894287|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0
9787106|NCT00536809|10894287|FG000|STARTED|Phase II||2
9787107|NCT00536809|10894287|FG000|COMPLETED|Phase II||0
9787108|NCT00536809|10894287|FG000|NOT COMPLETED|Phase II||2
9787109|NCT00536874|10894291|FG000|STARTED|Overall Study||39
9787110|NCT00536874|10894291|FG000|COMPLETED|Overall Study||35
9787111|NCT00536874|10894291|FG000|NOT COMPLETED|Overall Study||4
9787112|NCT00536913|10894297|FG000|STARTED|Overall Study||55
9787113|NCT00536913|10894298|FG001|STARTED|Overall Study||52
9787114|NCT00536913|10894297|FG000|COMPLETED|Overall Study||55
9787115|NCT00536913|10894298|FG001|COMPLETED|Overall Study||52
9787116|NCT00536913|10894297|FG000|NOT COMPLETED|Overall Study||0
9787117|NCT00536913|10894298|FG001|NOT COMPLETED|Overall Study||0
9787118|NCT00536939|10894304|FG000|STARTED|Overall Study||2
9787119|NCT00536939|10894305|FG001|STARTED|Overall Study||0
9787120|NCT00536939|10894304|FG000|Entered Safety lead-in|Overall Study||2
9787121|NCT00536939|10894305|FG001|Entered Safety lead-in|Overall Study||0
9787122|NCT00536939|10894304|FG000|Randomized|Overall Study||0
9787123|NCT00536939|10894305|FG001|Randomized|Overall Study||0
9787124|NCT00536939|10894304|FG000|COMPLETED|Overall Study||0
9787125|NCT00536939|10894305|FG001|COMPLETED|Overall Study||0
9787126|NCT00536939|10894304|FG000|NOT COMPLETED|Overall Study||2
9787127|NCT00536939|10894305|FG001|NOT COMPLETED|Overall Study||0
9787128|NCT00536991|10894310|FG000|STARTED|Overall Study||51
9787129|NCT00536991|10894310|FG000|COMPLETED|Overall Study||38
9787130|NCT00536991|10894310|FG000|NOT COMPLETED|Overall Study||13
9787131|NCT00537017|10894315|FG000|STARTED|Treatment Phase||140
9787132|NCT00537017|10894315|FG000|COMPLETED|Treatment Phase||106
9787133|NCT00537017|10894315|FG000|NOT COMPLETED|Treatment Phase||34
9787134|NCT00537017|10894315|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
9787135|NCT00537017|10894315|FG000|COMPLETED|Follow-up Phase||126
9787136|NCT00537017|10894315|FG000|NOT COMPLETED|Follow-up Phase||9
9787137|NCT00537030|10894319|FG000|STARTED|Overall Study||59
9787138|NCT00537030|10894319|FG000|COMPLETED|Overall Study||43
9787139|NCT00537030|10894319|FG000|NOT COMPLETED|Overall Study||16
9787140|NCT00537056|10894323|FG000|STARTED|Baseline PET/CT||17
9787141|NCT00537056|10894323|FG000|COMPLETED|Baseline PET/CT||17
9787142|NCT00537056|10894323|FG000|NOT COMPLETED|Baseline PET/CT||0
9787143|NCT00537056|10894323|FG000|STARTED|Interim PET/CT||17
9787144|NCT00537056|10894323|FG000|COMPLETED|Interim PET/CT||12
9787145|NCT00537056|10894323|FG000|NOT COMPLETED|Interim PET/CT||5
9787146|NCT00537056|10894323|FG000|STARTED|12-month Follow-up||17
9787147|NCT00537056|10894323|FG000|COMPLETED|12-month Follow-up||17
9787148|NCT00537056|10894323|FG000|NOT COMPLETED|12-month Follow-up||0
9787149|NCT00537082|10894332|FG000|STARTED|Overall Study||57
9787150|NCT00537082|10894333|FG001|STARTED|Overall Study||57
9787151|NCT00537082|10894334|FG002|STARTED|Overall Study||57
9787152|NCT00537082|10894332|FG000|COMPLETED|Overall Study||48
9787153|NCT00537082|10894333|FG001|COMPLETED|Overall Study||48
9787154|NCT00537082|10894334|FG002|COMPLETED|Overall Study||51
9787155|NCT00537082|10894332|FG000|NOT COMPLETED|Overall Study||9
9787156|NCT00537082|10894333|FG001|NOT COMPLETED|Overall Study||9
9787157|NCT00537082|10894334|FG002|NOT COMPLETED|Overall Study||6
9787158|NCT00537095|10894344|FG000|STARTED|Overall Study||72
9787159|NCT00537095|10894345|FG001|STARTED|Overall Study||73
9787160|NCT00537095|10894344|FG000|COMPLETED|Overall Study||21
9787161|NCT00537095|10894345|FG001|COMPLETED|Overall Study||16
9787162|NCT00537095|10894344|FG000|NOT COMPLETED|Overall Study||51
9787163|NCT00537095|10894345|FG001|NOT COMPLETED|Overall Study||57
9787164|NCT00537238|10894353|FG000|STARTED|Overall Study||254
9787165|NCT00537238|10894354|FG001|STARTED|Overall Study||255
9787166|NCT00537238|10894353|FG000|Completed Titration Phase|Overall Study||226
9787167|NCT00537238|10894354|FG001|Completed Titration Phase|Overall Study||236
9787168|NCT00537238|10894353|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
9787169|NCT00537238|10894354|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
9787170|NCT00537238|10894353|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
9787171|NCT00537238|10894354|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
9787172|NCT00537238|10894353|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
9787173|NCT00537238|10894354|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
9787174|NCT00537238|10894353|FG000|NOT COMPLETED|Overall Study||174
9787175|NCT00537238|10894354|FG001|NOT COMPLETED|Overall Study||173
9787176|NCT00537277|10894360|FG000|STARTED|Overall Study||161
9787177|NCT00537277|10894360|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
9787178|NCT00537277|10894360|FG000|COMPLETED|Overall Study||112
9787179|NCT00537277|10894360|FG000|NOT COMPLETED|Overall Study||49
9787180|NCT00537290|10894364|FG000|STARTED|Overall Study||19
9787181|NCT00537290|10894364|FG000|COMPLETED|Overall Study||19
9787182|NCT00537290|10894364|FG000|NOT COMPLETED|Overall Study||0
9787183|NCT00537303|10894370|FG000|STARTED|Overall Study||146
9787184|NCT00537303|10894371|FG001|STARTED|Overall Study||150
9787185|NCT00537303|10894370|FG000|COMPLETED|Overall Study||120
9787186|NCT00537303|10894371|FG001|COMPLETED|Overall Study||125
9787187|NCT00537303|10894370|FG000|NOT COMPLETED|Overall Study||26
9787188|NCT00537303|10894371|FG001|NOT COMPLETED|Overall Study||25
9787189|NCT00537316|10894383|FG000|STARTED|Part 1||79
9787190|NCT00537316|10894384|FG001|STARTED|Part 1||80
9787191|NCT00537316|10894385|FG002|STARTED|Part 1||80
9787192|NCT00537316|10894386|FG003|STARTED|Part 1||0
9787193|NCT00537316|10894387|FG004|STARTED|Part 1||0
9787194|NCT00537316|10894388|FG005|STARTED|Part 1||0
9787195|NCT00537316|10894389|FG006|STARTED|Part 1||0
9787196|NCT00537316|10894383|FG000|COMPLETED|Part 1||65
9787197|NCT00537316|10894384|FG001|COMPLETED|Part 1||53
9787198|NCT00537316|10894385|FG002|COMPLETED|Part 1||63
9787199|NCT00537316|10894386|FG003|COMPLETED|Part 1||0
9787200|NCT00537316|10894387|FG004|COMPLETED|Part 1||0
9787201|NCT00537316|10894388|FG005|COMPLETED|Part 1||0
9787202|NCT00537316|10894389|FG006|COMPLETED|Part 1||0
9787203|NCT00537316|10894383|FG000|NOT COMPLETED|Part 1||14
9787204|NCT00537316|10894384|FG001|NOT COMPLETED|Part 1||27
9787205|NCT00537316|10894385|FG002|NOT COMPLETED|Part 1||17
9787206|NCT00537316|10894386|FG003|NOT COMPLETED|Part 1||0
9787207|NCT00537316|10894387|FG004|NOT COMPLETED|Part 1||0
9787208|NCT00537316|10894388|FG005|NOT COMPLETED|Part 1||0
9787209|NCT00537316|10894389|FG006|NOT COMPLETED|Part 1||0
9787210|NCT00537316|10894383|FG000|STARTED|Part 2||37
9787211|NCT00537316|10894384|FG001|STARTED|Part 2||10
9787212|NCT00537316|10894385|FG002|STARTED|Part 2||48
9787213|NCT00537316|10894386|FG003|STARTED|Part 2||5
9787214|NCT00537316|10894387|FG004|STARTED|Part 2||2
9787215|NCT00537316|10894388|FG005|STARTED|Part 2||4
9787216|NCT00537316|10894389|FG006|STARTED|Part 2||2
9787217|NCT00537316|10894383|FG000|COMPLETED|Part 2||11
9787218|NCT00537316|10894384|FG001|COMPLETED|Part 2||1
9787219|NCT00537316|10894385|FG002|COMPLETED|Part 2||16
9787220|NCT00537316|10894386|FG003|COMPLETED|Part 2||2
9787221|NCT00537316|10894387|FG004|COMPLETED|Part 2||1
9787222|NCT00537316|10894388|FG005|COMPLETED|Part 2||0
9787223|NCT00537316|10894389|FG006|COMPLETED|Part 2||0
9787224|NCT00537316|10894383|FG000|NOT COMPLETED|Part 2||26
9787225|NCT00537316|10894384|FG001|NOT COMPLETED|Part 2||9
9787226|NCT00537316|10894385|FG002|NOT COMPLETED|Part 2||32
9787227|NCT00537316|10894386|FG003|NOT COMPLETED|Part 2||3
9787228|NCT00537316|10894387|FG004|NOT COMPLETED|Part 2||1
9787229|NCT00537316|10894388|FG005|NOT COMPLETED|Part 2||4
9787230|NCT00537316|10894389|FG006|NOT COMPLETED|Part 2||2
9787231|NCT00537329|10894408|FG000|STARTED|Overall Study||43
9787232|NCT00537329|10894408|FG000|COMPLETED|Overall Study||17
9787233|NCT00537329|10894408|FG000|NOT COMPLETED|Overall Study||26
9787234|NCT00537381|10894414|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
9787235|NCT00537381|10894415|FG001|STARTED|Overall Study||66
9787236|NCT00537381|10894414|FG000|COMPLETED|Overall Study||9
9787237|NCT00537381|10894415|FG001|COMPLETED|Overall Study||4
9787238|NCT00537381|10894414|FG000|NOT COMPLETED|Overall Study||56
9787239|NCT00537381|10894415|FG001|NOT COMPLETED|Overall Study||62
9787240|NCT00537394|10894426|FG000|STARTED|First Year of Follow-up||181
9787241|NCT00537394|10894427|FG001|STARTED|First Year of Follow-up||179
9787242|NCT00537394|10894428|FG002|STARTED|First Year of Follow-up||53
9787243|NCT00537394|10894426|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
9787244|NCT00537394|10894427|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
9787245|NCT00537394|10894428|FG002|COMPLETED|First Year of Follow-up||50
9787246|NCT00537394|10894426|FG000|NOT COMPLETED|First Year of Follow-up||12
9787247|NCT00537394|10894427|FG001|NOT COMPLETED|First Year of Follow-up||11
9787248|NCT00537394|10894428|FG002|NOT COMPLETED|First Year of Follow-up||3
9787249|NCT00537394|10894426|FG000|STARTED|2nd Year of Follow-up||169
9787250|NCT00537394|10894427|FG001|STARTED|2nd Year of Follow-up||168
9787251|NCT00537394|10894428|FG002|STARTED|2nd Year of Follow-up||50
9787252|NCT00537394|10894426|FG000|COMPLETED|2nd Year of Follow-up||158
9787253|NCT00537394|10894427|FG001|COMPLETED|2nd Year of Follow-up||159
9787254|NCT00537394|10894428|FG002|COMPLETED|2nd Year of Follow-up||44
9787255|NCT00537394|10894426|FG000|NOT COMPLETED|2nd Year of Follow-up||11
9787256|NCT00537394|10894427|FG001|NOT COMPLETED|2nd Year of Follow-up||9
9787257|NCT00537394|10894428|FG002|NOT COMPLETED|2nd Year of Follow-up||6
9787258|NCT00537407|10894439|FG000|STARTED|Part 1 Weeks 1-4||10
9787259|NCT00537407|10894440|FG001|STARTED|Part 1 Weeks 1-4||9
9787260|NCT00537407|10894441|FG002|STARTED|Part 1 Weeks 1-4||11
9787261|NCT00537407|10894442|FG003|STARTED|Part 1 Weeks 1-4||10
9787262|NCT00537407|10894443|FG004|STARTED|Part 1 Weeks 1-4||10
9787263|NCT00537407|10894439|FG000|COMPLETED|Part 1 Weeks 1-4||10
9787264|NCT00537407|10894440|FG001|COMPLETED|Part 1 Weeks 1-4||9
9787265|NCT00537407|10894441|FG002|COMPLETED|Part 1 Weeks 1-4||11
9787266|NCT00537407|10894442|FG003|COMPLETED|Part 1 Weeks 1-4||10
9787267|NCT00537407|10894443|FG004|COMPLETED|Part 1 Weeks 1-4||10
9787268|NCT00537407|10894439|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0
9787269|NCT00537407|10894440|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0
9787270|NCT00537407|10894441|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0
9787271|NCT00537407|10894442|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0
9787272|NCT00537407|10894443|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0
9787273|NCT00537407|10894439|FG000|STARTED|Part 2 Weeks 5-48 or 72||10
9787274|NCT00537407|10894440|FG001|STARTED|Part 2 Weeks 5-48 or 72||9
9787275|NCT00537407|10894441|FG002|STARTED|Part 2 Weeks 5-48 or 72||11
9787276|NCT00537407|10894442|FG003|STARTED|Part 2 Weeks 5-48 or 72||10
9787277|NCT00537407|10894443|FG004|STARTED|Part 2 Weeks 5-48 or 72||10
9787278|NCT00537407|10894439|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2
9787279|NCT00537407|10894440|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1
9787280|NCT00537407|10894441|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2
9787281|NCT00537407|10894442|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4
9787282|NCT00537407|10894443|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3
9787283|NCT00537407|10894439|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
9787284|NCT00537407|10894440|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
9787285|NCT00537407|10894441|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
9787286|NCT00537407|10894442|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
9787287|NCT00537407|10894443|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
9787288|NCT00537485|10894461|FG000|STARTED|Overall Study||90
9787289|NCT00537485|10894462|FG001|STARTED|Overall Study||90
9787290|NCT00537485|10894461|FG000|COMPLETED|Overall Study||75
9787291|NCT00537485|10894462|FG001|COMPLETED|Overall Study||80
9787292|NCT00537485|10894461|FG000|NOT COMPLETED|Overall Study||15
9787293|NCT00537485|10894462|FG001|NOT COMPLETED|Overall Study||10
9787294|NCT00537511|10894468|FG000|STARTED|Treatment Period (Combination)||22
9787295|NCT00537511|10894468|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
9787296|NCT00537511|10894468|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
9787297|NCT00537511|10894468|FG000|COMPLETED|Treatment Period (Combination)||17
9787298|NCT00537511|10894468|FG000|NOT COMPLETED|Treatment Period (Combination)||5
9787299|NCT00537511|10894468|FG000|STARTED|Extension Period (Combination)||17
9787300|NCT00537511|10894468|FG000|COMPLETED|Extension Period (Combination)||11
9787301|NCT00537511|10894468|FG000|NOT COMPLETED|Extension Period (Combination)||6
9787302|NCT00537511|10894468|FG000|STARTED|Recovery Period (Monotherapy)||11
9787303|NCT00537511|10894468|FG000|COMPLETED|Recovery Period (Monotherapy)||3
9787304|NCT00537511|10894468|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8
9787305|NCT00537511|10894468|FG000|STARTED|Maintenance Phase (Monotherapy)||8
9787306|NCT00537511|10894468|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0
9787307|NCT00537511|10894468|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
9787308|NCT00537576|10894491|FG000|STARTED|Overall Study||3
9787309|NCT00537576|10894492|FG001|STARTED|Overall Study||3
9787310|NCT00537576|10894493|FG002|STARTED|Overall Study||3
9787311|NCT00537576|10894494|FG003|STARTED|Overall Study||1
9787312|NCT00537576|10894495|FG004|STARTED|Overall Study||1
9787313|NCT00537576|10894496|FG005|STARTED|Overall Study||1
9787314|NCT00537576|10894491|FG000|COMPLETED|Overall Study||3
9787315|NCT00537576|10894492|FG001|COMPLETED|Overall Study||3
9787316|NCT00537576|10894493|FG002|COMPLETED|Overall Study||3
9787317|NCT00537576|10894494|FG003|COMPLETED|Overall Study||1
9787318|NCT00537576|10894495|FG004|COMPLETED|Overall Study||1
9787319|NCT00537576|10894496|FG005|COMPLETED|Overall Study||1
9787320|NCT00537576|10894491|FG000|NOT COMPLETED|Overall Study||0
9787321|NCT00537576|10894492|FG001|NOT COMPLETED|Overall Study||0
9787322|NCT00537576|10894493|FG002|NOT COMPLETED|Overall Study||0
9787323|NCT00537576|10894494|FG003|NOT COMPLETED|Overall Study||0
9787324|NCT00537576|10894495|FG004|NOT COMPLETED|Overall Study||0
9787325|NCT00537576|10894496|FG005|NOT COMPLETED|Overall Study||0
9787326|NCT00537680|10894513|FG000|STARTED|Overall Study||22
9787327|NCT00537680|10894514|FG001|STARTED|Overall Study||24
9787328|NCT00537680|10894515|FG002|STARTED|Overall Study||24
9787329|NCT00537680|10894513|FG000|COMPLETED|Overall Study||22
9787330|NCT00537680|10894514|FG001|COMPLETED|Overall Study||22
9787331|NCT00537680|10894515|FG002|COMPLETED|Overall Study||24
9787332|NCT00537680|10894513|FG000|NOT COMPLETED|Overall Study||0
9787333|NCT00537680|10894514|FG001|NOT COMPLETED|Overall Study||2
9787334|NCT00537680|10894515|FG002|NOT COMPLETED|Overall Study||0
9787335|NCT00537745|10894523|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14
9787336|NCT00537745|10894523|FG000|Began Intervention|Overall Study||11
9787337|NCT00537745|10894523|FG000|COMPLETED|Overall Study||9
9787338|NCT00537745|10894523|FG000|NOT COMPLETED|Overall Study||5
9787339|NCT00537771|10894530|FG000|STARTED|Overall Study||178
9787340|NCT00537771|10894531|FG001|STARTED|Overall Study||175
9787341|NCT00537771|10894530|FG000|COMPLETED|Overall Study||149
9787342|NCT00537771|10894531|FG001|COMPLETED|Overall Study||114
9787343|NCT00537771|10894530|FG000|NOT COMPLETED|Overall Study||29
9787344|NCT00537771|10894531|FG001|NOT COMPLETED|Overall Study||61
9787345|NCT00537810|10894541|FG000|STARTED|Overall Study||26
9787346|NCT00537810|10894542|FG001|STARTED|Overall Study||27
9787347|NCT00537810|10894543|FG002|STARTED|Overall Study||25
9787348|NCT00537810|10894544|FG003|STARTED|Overall Study||26
9787349|NCT00537810|10894541|FG000|COMPLETED|Overall Study||20
9787350|NCT00537810|10894542|FG001|COMPLETED|Overall Study||14
9787351|NCT00537810|10894543|FG002|COMPLETED|Overall Study||21
9787352|NCT00537810|10894544|FG003|COMPLETED|Overall Study||22
9787353|NCT00537810|10894541|FG000|NOT COMPLETED|Overall Study||6
9787354|NCT00537810|10894542|FG001|NOT COMPLETED|Overall Study||13
9787355|NCT00537810|10894543|FG002|NOT COMPLETED|Overall Study||4
9787356|NCT00537810|10894544|FG003|NOT COMPLETED|Overall Study||4
9787357|NCT00537823|10894556|FG000|STARTED|Overall Study||7
9787358|NCT00537823|10894557|FG001|STARTED|Overall Study||2
9787359|NCT00537823|10894556|FG000|COMPLETED|Overall Study||5
9787360|NCT00537823|10894557|FG001|COMPLETED|Overall Study||2
9787361|NCT00537823|10894556|FG000|NOT COMPLETED|Overall Study||2
9787362|NCT00537823|10894557|FG001|NOT COMPLETED|Overall Study||0
9787363|NCT00537940|10894566|FG000|STARTED|Overall Study||241
9787364|NCT00537940|10894567|FG001|STARTED|Overall Study||241
9787365|NCT00537940|10894566|FG000|Completed Titration Phase|Overall Study||213
9787366|NCT00537940|10894567|FG001|Completed Titration Phase|Overall Study||210
9787367|NCT00537940|10894566|FG000|Completed Maintenance Phase|Overall Study||187
9787368|NCT00537940|10894567|FG001|Completed Maintenance Phase|Overall Study||172
9787369|NCT00537940|10894566|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140
9787370|NCT00537940|10894567|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139
9787371|NCT00537940|10894566|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
9787372|NCT00537940|10894567|FG001|COMPLETED|Overall Study||62
9787373|NCT00537940|10894566|FG000|NOT COMPLETED|Overall Study||183
9787374|NCT00537940|10894567|FG001|NOT COMPLETED|Overall Study||179
9787375|NCT00537979|10894575|FG000|STARTED|Overall Study||38
9787376|NCT00537979|10894576|FG001|STARTED|Overall Study||109
9787377|NCT00537979|10894575|FG000|COMPLETED|Overall Study||32
9787378|NCT00537979|10894576|FG001|COMPLETED|Overall Study||89
9787379|NCT00537979|10894575|FG000|NOT COMPLETED|Overall Study||6
9787380|NCT00537979|10894576|FG001|NOT COMPLETED|Overall Study||20
9787381|NCT00538213|10894586|FG000|STARTED|Overall Study||55
9787382|NCT00538213|10894587|FG001|STARTED|Overall Study||40
9787383|NCT00538213|10894588|FG002|STARTED|Overall Study||38
9787384|NCT00538213|10894586|FG000|COMPLETED|Overall Study||55
9787385|NCT00538213|10894587|FG001|COMPLETED|Overall Study||40
9787386|NCT00538213|10894588|FG002|COMPLETED|Overall Study||38
9787387|NCT00538213|10894586|FG000|NOT COMPLETED|Overall Study||0
9787388|NCT00538213|10894587|FG001|NOT COMPLETED|Overall Study||0
9787389|NCT00538213|10894588|FG002|NOT COMPLETED|Overall Study||0
9787390|NCT00538291|10894597|FG000|STARTED|Overall Study||13
9787391|NCT00538291|10894597|FG000|COMPLETED|Overall Study||10
9787392|NCT00538291|10894597|FG000|NOT COMPLETED|Overall Study||3
9787393|NCT00538304|10894603|FG000|STARTED|Overall Study||151
9787394|NCT00538304|10894604|FG001|STARTED|Overall Study||71
9787395|NCT00538304|10894603|FG000|COMPLETED|Overall Study||144
9787396|NCT00538304|10894604|FG001|COMPLETED|Overall Study||66
9787397|NCT00538304|10894603|FG000|NOT COMPLETED|Overall Study||7
9787398|NCT00538304|10894604|FG001|NOT COMPLETED|Overall Study||5
9787399|NCT00538434|10894614|FG000|STARTED|Overall Study||56
9787400|NCT00538434|10894615|FG001|STARTED|Overall Study||57
9787401|NCT00538434|10894616|FG002|STARTED|Overall Study||57
9787402|NCT00538434|10894617|FG003|STARTED|Overall Study||57
9787403|NCT00538434|10894614|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
9787404|NCT00538434|10894615|FG001|Intent-to-treat (ITT) Population|Overall Study||57
9787405|NCT00538434|10894616|FG002|Intent-to-treat (ITT) Population|Overall Study||57
9787406|NCT00538434|10894617|FG003|Intent-to-treat (ITT) Population|Overall Study||57
9787407|NCT00538434|10894614|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47
9787408|NCT00538434|10894615|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46
9787409|NCT00538434|10894616|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50
9787410|NCT00538434|10894617|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51
9787411|NCT00538434|10894614|FG000|NOT COMPLETED|Overall Study||9
9787412|NCT00538434|10894615|FG001|NOT COMPLETED|Overall Study||11
9787413|NCT00538434|10894616|FG002|NOT COMPLETED|Overall Study||7
9787414|NCT00538434|10894617|FG003|NOT COMPLETED|Overall Study||6
9787415|NCT00538473|10894630|FG000|STARTED|Overall Study||33
9787416|NCT00538473|10894631|FG001|STARTED|Overall Study||35
9787417|NCT00538473|10894630|FG000|COMPLETED|Overall Study||32
9787418|NCT00538473|10894631|FG001|COMPLETED|Overall Study||35
9787419|NCT00538473|10894630|FG000|NOT COMPLETED|Overall Study||1
10234106|NCT01560507|11364015|FG001|NOT COMPLETED|Overall Study||2
10234107|NCT01560507|11364016|FG002|NOT COMPLETED|Overall Study||2
10234108|NCT01557881|11364027|FG000|STARTED|Overall Study||98
10234109|NCT01557881|11364027|FG000|COMPLETED|Overall Study||98
10234110|NCT01557881|11364027|FG000|NOT COMPLETED|Overall Study||0
10234111|NCT01555489|11364031|FG000|STARTED|Overall Study||11
10234112|NCT01555489|11364031|FG000|COMPLETED|Overall Study||11
10234113|NCT01555489|11364031|FG000|NOT COMPLETED|Overall Study||0
10234114|NCT01549977|11364037|FG000|STARTED|Overall Study||1
10234115|NCT01549977|11364038|FG001|STARTED|Overall Study||0
10234116|NCT01549977|11364037|FG000|COMPLETED|Overall Study||1
10234117|NCT01549977|11364038|FG001|COMPLETED|Overall Study||0
10234118|NCT01549977|11364037|FG000|NOT COMPLETED|Overall Study||0
10234119|NCT01549977|11364038|FG001|NOT COMPLETED|Overall Study||0
10234120|NCT01558492|11364044|FG000|STARTED|Overall Study||3
10234121|NCT01558492|11364044|FG000|COMPLETED|Overall Study||3
10234122|NCT01558492|11364044|FG000|NOT COMPLETED|Overall Study||0
10234123|NCT01550562|11364048|FG000|STARTED|First Intervention, 4 - 5 Days||1
9787420|NCT00538473|10894631|FG001|NOT COMPLETED|Overall Study||0
9787421|NCT00538512|10894640|FG000|STARTED|Overall Study||814
9787422|NCT00538512|10894641|FG001|STARTED|Overall Study||813
9787423|NCT00538512|10894642|FG002|STARTED|Overall Study||325
9787424|NCT00538512|10894640|FG000|COMPLETED|Overall Study||787
9787425|NCT00538512|10894641|FG001|COMPLETED|Overall Study||783
9787426|NCT00538512|10894642|FG002|COMPLETED|Overall Study||312
9787427|NCT00538512|10894640|FG000|NOT COMPLETED|Overall Study||27
10234124|NCT01550562|11364048|FG000|COMPLETED|First Intervention, 4 - 5 Days||1
10234125|NCT01550562|11364048|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0
10234126|NCT01550562|11364048|FG000|STARTED|Second Intervention, 4 - 5 Days||1
9787428|NCT00538512|10894641|FG001|NOT COMPLETED|Overall Study||30
9787429|NCT00538512|10894642|FG002|NOT COMPLETED|Overall Study||13
9787430|NCT00538590|10894652|FG000|STARTED|Overall Study||10
9787431|NCT00538590|10894653|FG001|STARTED|Overall Study||10
9787432|NCT00538590|10894652|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
9787433|NCT00538590|10894653|FG001|COMPLETED|Overall Study||10
9787434|NCT00538590|10894652|FG000|NOT COMPLETED|Overall Study||1
9787435|NCT00538590|10894653|FG001|NOT COMPLETED|Overall Study||0
9787436|NCT00538616|10894661|FG000|STARTED|Overall Study||5
9787437|NCT00538616|10894662|FG001|STARTED|Overall Study||3
9787438|NCT00538616|10894661|FG000|COMPLETED|Overall Study||5
10234127|NCT01550562|11364048|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1
10234128|NCT01550562|11364048|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
10234129|NCT01550562|11364048|FG000|STARTED|Third Intervention, 4 - 5 Days||1
10234130|NCT01550562|11364048|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1
10234131|NCT01550562|11364048|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
10234132|NCT01561495|11364052|FG000|STARTED|Overall Study||1
9787439|NCT00538616|10894662|FG001|COMPLETED|Overall Study||3
9787440|NCT00538616|10894661|FG000|NOT COMPLETED|Overall Study||0
9787441|NCT00538616|10894662|FG001|NOT COMPLETED|Overall Study||0
9787442|NCT00538629|10894668|FG000|STARTED|Overall Study||471
9787443|NCT00538629|10894668|FG000|COMPLETED|Overall Study||449
9787444|NCT00538629|10894668|FG000|NOT COMPLETED|Overall Study||22
9787445|NCT00538642|10894674|FG000|STARTED|Overall Study||10
9787446|NCT00538642|10894675|FG001|STARTED|Overall Study||14
9787447|NCT00538642|10894674|FG000|COMPLETED|Overall Study||9
9787448|NCT00538642|10894675|FG001|COMPLETED|Overall Study||9
9787449|NCT00538642|10894674|FG000|NOT COMPLETED|Overall Study||1
9787450|NCT00538642|10894675|FG001|NOT COMPLETED|Overall Study||5
9787451|NCT00538681|10894686|FG000|STARTED|Overall Study||9
9787452|NCT00538681|10894687|FG001|STARTED|Overall Study||4
9787453|NCT00538681|10894688|FG002|STARTED|Overall Study||11
9787454|NCT00538681|10894689|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
9787455|NCT00538681|10894686|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9
9787456|NCT00538681|10894687|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4
9787457|NCT00538681|10894688|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11
9787458|NCT00538681|10894689|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11
9787459|NCT00538681|10894686|FG000|COMPLETED|Overall Study||0
9787460|NCT00538681|10894687|FG001|COMPLETED|Overall Study||0
9787461|NCT00538681|10894688|FG002|COMPLETED|Overall Study||0
9787462|NCT00538681|10894689|FG003|COMPLETED|Overall Study||0
9787463|NCT00538681|10894686|FG000|NOT COMPLETED|Overall Study||9
9787464|NCT00538681|10894687|FG001|NOT COMPLETED|Overall Study||4
9787465|NCT00538681|10894688|FG002|NOT COMPLETED|Overall Study||11
9787466|NCT00538681|10894689|FG003|NOT COMPLETED|Overall Study||11
9787467|NCT00538733|10894700|FG000|STARTED|Overall Study||26
9787468|NCT00538733|10894700|FG000|Removed Due to Progression of Disease|Overall Study||1
9787469|NCT00538733|10894700|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11
9787470|NCT00538733|10894700|FG000|Removed to Pursue Alternative Theray|Overall Study||2
9787471|NCT00538733|10894700|FG000|COMPLETED|Overall Study||14
9787472|NCT00538733|10894700|FG000|NOT COMPLETED|Overall Study||12
9787473|NCT00538759|10894709|FG000|STARTED|Overall Study||13
9787474|NCT00538759|10894710|FG001|STARTED|Overall Study||8
9787475|NCT00538759|10894709|FG000|COMPLETED|Overall Study||13
9787476|NCT00538759|10894710|FG001|COMPLETED|Overall Study||8
9787477|NCT00538759|10894709|FG000|NOT COMPLETED|Overall Study||0
9787478|NCT00538759|10894710|FG001|NOT COMPLETED|Overall Study||0
9787479|NCT00538785|10894718|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
9787480|NCT00538785|10894719|FG001|STARTED|Overall Study||612
9787481|NCT00538785|10894718|FG000|COMPLETED|Overall Study||604
9787482|NCT00538785|10894719|FG001|COMPLETED|Overall Study||595
10234133|NCT01561495|11364052|FG000|COMPLETED|Overall Study||1
10234134|NCT01561495|11364052|FG000|NOT COMPLETED|Overall Study||0
10234135|NCT01555073|11364060|FG000|STARTED|Overall Study||7
10234136|NCT01555073|11364061|FG001|STARTED|Overall Study||3
10234137|NCT01555073|11364062|FG002|STARTED|Overall Study||7
10234138|NCT01555073|11364063|FG003|STARTED|Overall Study||6
10234139|NCT01555073|11364060|FG000|COMPLETED|Overall Study||6
10234140|NCT01555073|11364061|FG001|COMPLETED|Overall Study||1
10234141|NCT01555073|11364062|FG002|COMPLETED|Overall Study||7
10234142|NCT01555073|11364063|FG003|COMPLETED|Overall Study||1
10234143|NCT01555073|11364060|FG000|NOT COMPLETED|Overall Study||1
10234144|NCT01555073|11364061|FG001|NOT COMPLETED|Overall Study||2
9787483|NCT00538785|10894718|FG000|NOT COMPLETED|Overall Study||19
9787484|NCT00538785|10894719|FG001|NOT COMPLETED|Overall Study||17
9787485|NCT00538824|10894725|FG000|STARTED|Overall Study||5
9787486|NCT00538824|10894725|FG000|Progression of Disease|Overall Study||2
9787487|NCT00538824|10894725|FG000|COMPLETED|Overall Study||5
9787488|NCT00538824|10894725|FG000|NOT COMPLETED|Overall Study||0
9787489|NCT00538850|10894729|FG000|STARTED|Titration Period||130
9787490|NCT00538850|10894730|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
9787491|NCT00538850|10894731|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
9787492|NCT00538850|10894729|FG000|COMPLETED|Titration Period||98
9787493|NCT00538850|10894730|FG001|COMPLETED|Titration Period||0
9787494|NCT00538850|10894731|FG002|COMPLETED|Titration Period||0
9787495|NCT00538850|10894729|FG000|NOT COMPLETED|Titration Period||32
9787496|NCT00538850|10894730|FG001|NOT COMPLETED|Titration Period||0
9787497|NCT00538850|10894731|FG002|NOT COMPLETED|Titration Period||0
9787498|NCT00538850|10894729|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
9787499|NCT00538850|10894730|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98
9787500|NCT00538850|10894731|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
9787501|NCT00538850|10894729|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
9787502|NCT00538850|10894730|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
9787503|NCT00538850|10894731|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
9787504|NCT00538850|10894729|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
9787505|NCT00538850|10894730|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
9787506|NCT00538850|10894731|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
9787507|NCT00538850|10894729|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
9787508|NCT00538850|10894730|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
9787509|NCT00538850|10894731|FG002|STARTED|Placebo - Double-blind||98
9787510|NCT00538850|10894729|FG000|COMPLETED|Placebo - Double-blind||0
9787511|NCT00538850|10894730|FG001|COMPLETED|Placebo - Double-blind||0
9787512|NCT00538850|10894731|FG002|COMPLETED|Placebo - Double-blind||95
9787513|NCT00538850|10894729|FG000|NOT COMPLETED|Placebo - Double-blind||0
9787514|NCT00538850|10894730|FG001|NOT COMPLETED|Placebo - Double-blind||0
9787515|NCT00538850|10894731|FG002|NOT COMPLETED|Placebo - Double-blind||3
9787516|NCT00538863|10894737|FG000|STARTED|Open-label Titration||229
9787517|NCT00538863|10894737|FG000|COMPLETED|Open-label Titration||184
9787518|NCT00538863|10894737|FG000|NOT COMPLETED|Open-label Titration||45
9787519|NCT00538863|10894737|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
9787520|NCT00538863|10894737|FG000|COMPLETED|Open-label Maintenance||163
9787521|NCT00538863|10894737|FG000|NOT COMPLETED|Open-label Maintenance||106
9787522|NCT00538902|10894746|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
9787523|NCT00538902|10894747|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
9787524|NCT00538902|10894748|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
9787525|NCT00538902|10894746|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
9787526|NCT00538902|10894747|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
9787527|NCT00538902|10894748|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
9787528|NCT00538902|10894746|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
9787529|NCT00538902|10894747|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
9787530|NCT00538902|10894748|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
9787531|NCT00538902|10894746|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
9787532|NCT00538902|10894747|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
9787533|NCT00538902|10894748|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
9787534|NCT00538902|10894746|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
9787535|NCT00538902|10894747|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
9787536|NCT00538902|10894748|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
9787537|NCT00538902|10894746|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
9787538|NCT00538902|10894747|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
9787539|NCT00538902|10894748|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
9787540|NCT00538915|10894758|FG000|STARTED|Overall Study||63
9787541|NCT00538915|10894758|FG000|COMPLETED|Overall Study||52
9787542|NCT00538915|10894758|FG000|NOT COMPLETED|Overall Study||11
9787543|NCT00539006|10894766|FG000|STARTED|Pre-treatment||96
9787544|NCT00539006|10894767|FG001|STARTED|Pre-treatment||95
9787545|NCT00539006|10894768|FG002|STARTED|Pre-treatment||95
9787546|NCT00539006|10894769|FG003|STARTED|Pre-treatment||91
9787547|NCT00539006|10894766|FG000|COMPLETED|Pre-treatment||96
9787548|NCT00539006|10894767|FG001|COMPLETED|Pre-treatment||94
9787549|NCT00539006|10894768|FG002|COMPLETED|Pre-treatment||95
9787550|NCT00539006|10894769|FG003|COMPLETED|Pre-treatment||91
9787551|NCT00539006|10894766|FG000|NOT COMPLETED|Pre-treatment||0
9787552|NCT00539006|10894767|FG001|NOT COMPLETED|Pre-treatment||1
9787553|NCT00539006|10894768|FG002|NOT COMPLETED|Pre-treatment||0
9787554|NCT00539006|10894769|FG003|NOT COMPLETED|Pre-treatment||0
9787555|NCT00539006|10894766|FG000|STARTED|Treatment Period 1||96
9787556|NCT00539006|10894767|FG001|STARTED|Treatment Period 1||94
9787557|NCT00539006|10894768|FG002|STARTED|Treatment Period 1||95
9787558|NCT00539006|10894769|FG003|STARTED|Treatment Period 1||91
9787559|NCT00539006|10894766|FG000|COMPLETED|Treatment Period 1||96
9787560|NCT00539006|10894767|FG001|COMPLETED|Treatment Period 1||94
9787561|NCT00539006|10894768|FG002|COMPLETED|Treatment Period 1||93
9787562|NCT00539006|10894769|FG003|COMPLETED|Treatment Period 1||90
9787563|NCT00539006|10894766|FG000|NOT COMPLETED|Treatment Period 1||0
9787564|NCT00539006|10894767|FG001|NOT COMPLETED|Treatment Period 1||0
9787565|NCT00539006|10894768|FG002|NOT COMPLETED|Treatment Period 1||2
9952364|NCT01421641|11071304|FG001|COMPLETED|Overall Study||35
9787566|NCT00539006|10894769|FG003|NOT COMPLETED|Treatment Period 1||1
9787567|NCT00539006|10894766|FG000|STARTED|Washout||96
9787568|NCT00539006|10894767|FG001|STARTED|Washout||94
9787569|NCT00539006|10894768|FG002|STARTED|Washout||93
9787570|NCT00539006|10894769|FG003|STARTED|Washout||90
9787571|NCT00539006|10894766|FG000|COMPLETED|Washout||76
9787572|NCT00539006|10894767|FG001|COMPLETED|Washout||84
9787573|NCT00539006|10894768|FG002|COMPLETED|Washout||77
9787574|NCT00539006|10894769|FG003|COMPLETED|Washout||81
9787575|NCT00539006|10894766|FG000|NOT COMPLETED|Washout||20
9787576|NCT00539006|10894767|FG001|NOT COMPLETED|Washout||10
9787577|NCT00539006|10894768|FG002|NOT COMPLETED|Washout||16
9787578|NCT00539006|10894769|FG003|NOT COMPLETED|Washout||9
9787579|NCT00539006|10894766|FG000|STARTED|Treatment Period 2||76
9787580|NCT00539006|10894767|FG001|STARTED|Treatment Period 2||84
9787581|NCT00539006|10894768|FG002|STARTED|Treatment Period 2||77
9787582|NCT00539006|10894769|FG003|STARTED|Treatment Period 2||81
9787583|NCT00539006|10894766|FG000|COMPLETED|Treatment Period 2||75
9787584|NCT00539006|10894767|FG001|COMPLETED|Treatment Period 2||83
9787585|NCT00539006|10894768|FG002|COMPLETED|Treatment Period 2||77
9787586|NCT00539006|10894769|FG003|COMPLETED|Treatment Period 2||81
9787587|NCT00539006|10894766|FG000|NOT COMPLETED|Treatment Period 2||1
9787588|NCT00539006|10894767|FG001|NOT COMPLETED|Treatment Period 2||1
9787589|NCT00539006|10894768|FG002|NOT COMPLETED|Treatment Period 2||0
9787590|NCT00539006|10894769|FG003|NOT COMPLETED|Treatment Period 2||0
9787591|NCT00539006|10894766|FG000|STARTED|Post-Study||75
9787592|NCT00539006|10894767|FG001|STARTED|Post-Study||83
9787593|NCT00539006|10894768|FG002|STARTED|Post-Study||77
9787594|NCT00539006|10894769|FG003|STARTED|Post-Study||81
9787595|NCT00539006|10894766|FG000|COMPLETED|Post-Study||75
9787596|NCT00539006|10894767|FG001|COMPLETED|Post-Study||83
9787597|NCT00539006|10894768|FG002|COMPLETED|Post-Study||77
9787598|NCT00539006|10894769|FG003|COMPLETED|Post-Study||81
9787599|NCT00539006|10894766|FG000|NOT COMPLETED|Post-Study||0
9787600|NCT00539006|10894767|FG001|NOT COMPLETED|Post-Study||0
9787601|NCT00539006|10894768|FG002|NOT COMPLETED|Post-Study||0
9787602|NCT00539006|10894769|FG003|NOT COMPLETED|Post-Study||0
9787603|NCT00539032|10894787|FG000|STARTED|Overall Study||153
9787604|NCT00539032|10894788|FG001|STARTED|Overall Study||85
9787605|NCT00539032|10894787|FG000|COMPLETED|Overall Study||151
9787606|NCT00539032|10894788|FG001|COMPLETED|Overall Study||84
9787607|NCT00539032|10894787|FG000|NOT COMPLETED|Overall Study||2
9787608|NCT00539032|10894788|FG001|NOT COMPLETED|Overall Study||1
9787609|NCT00539110|10894796|FG000|STARTED|Overall Study||5
9787610|NCT00539110|10894797|FG001|STARTED|Overall Study||5
9787611|NCT00539110|10894796|FG000|COMPLETED|Overall Study||5
9787612|NCT00539110|10894797|FG001|COMPLETED|Overall Study||5
9787613|NCT00539110|10894796|FG000|NOT COMPLETED|Overall Study||0
9787614|NCT00539110|10894797|FG001|NOT COMPLETED|Overall Study||0
9787615|NCT00539188|10894805|FG000|STARTED|Overall Study||4
9787616|NCT00539188|10894806|FG001|STARTED|Overall Study||2
9787617|NCT00539188|10894805|FG000|Received Allocated Intervention|Overall Study||3
9787618|NCT00539188|10894806|FG001|Received Allocated Intervention|Overall Study||2
9787619|NCT00539188|10894805|FG000|COMPLETED|Overall Study||1
9787620|NCT00539188|10894806|FG001|COMPLETED|Overall Study||1
9787621|NCT00539188|10894805|FG000|NOT COMPLETED|Overall Study||3
9787622|NCT00539188|10894806|FG001|NOT COMPLETED|Overall Study||1
9787623|NCT00539240|10894815|FG000|STARTED|Overall Study||59
9787624|NCT00539240|10894816|FG001|STARTED|Overall Study||55
9787625|NCT00539240|10894817|FG002|STARTED|Overall Study||54
9787626|NCT00539240|10894815|FG000|COMPLETED|Overall Study||53
9787627|NCT00539240|10894816|FG001|COMPLETED|Overall Study||48
9787628|NCT00539240|10894817|FG002|COMPLETED|Overall Study||39
9787629|NCT00539240|10894815|FG000|NOT COMPLETED|Overall Study||6
9787630|NCT00539240|10894816|FG001|NOT COMPLETED|Overall Study||7
9787631|NCT00539240|10894817|FG002|NOT COMPLETED|Overall Study||15
9787632|NCT00539253|10894825|FG000|STARTED|Overall Study||45
9787633|NCT00539253|10894825|FG000|COMPLETED|Overall Study||19
9787634|NCT00539253|10894825|FG000|NOT COMPLETED|Overall Study||26
9787635|NCT00539279|10894831|FG000|STARTED|Treatment||41
9787636|NCT00539279|10894832|FG001|STARTED|Treatment||46
9787637|NCT00539279|10894831|FG000|COMPLETED|Treatment||30
9787638|NCT00539279|10894832|FG001|COMPLETED|Treatment||38
9787639|NCT00539279|10894831|FG000|NOT COMPLETED|Treatment||11
9787640|NCT00539279|10894832|FG001|NOT COMPLETED|Treatment||8
9787641|NCT00539279|10894831|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
9787642|NCT00539279|10894832|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
9787643|NCT00539279|10894831|FG000|COMPLETED|Post-Treatment Assessment||18
9787644|NCT00539279|10894832|FG001|COMPLETED|Post-Treatment Assessment||29
9787645|NCT00539279|10894831|FG000|NOT COMPLETED|Post-Treatment Assessment||12
9787646|NCT00539279|10894832|FG001|NOT COMPLETED|Post-Treatment Assessment||9
9787647|NCT00539279|10894831|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
9787648|NCT00539279|10894832|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
9787649|NCT00539279|10894831|FG000|COMPLETED|6-Month Follow-Up Assessment||17
9787650|NCT00539279|10894832|FG001|COMPLETED|6-Month Follow-Up Assessment||22
9787651|NCT00539279|10894831|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1
9787652|NCT00539279|10894832|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7
9787653|NCT00539305|10894840|FG000|STARTED|Overall Study||10
9787654|NCT00539305|10894841|FG001|STARTED|Overall Study||12
9787655|NCT00539305|10894840|FG000|COMPLETED|Overall Study||9
9787656|NCT00539305|10894841|FG001|COMPLETED|Overall Study||10
9787657|NCT00539305|10894840|FG000|NOT COMPLETED|Overall Study||1
9787658|NCT00539305|10894841|FG001|NOT COMPLETED|Overall Study||2
9787659|NCT00539500|10894847|FG000|STARTED|Overall Study||3
9787660|NCT00539500|10894847|FG000|COMPLETED|Overall Study||0
9787661|NCT00539500|10894847|FG000|NOT COMPLETED|Overall Study||3
9787662|NCT00539513|10894853|FG000|STARTED|Overall Study||5
9787663|NCT00539513|10894854|FG001|STARTED|Overall Study||5
9787664|NCT00539513|10894853|FG000|Received Allocated Intervention|Overall Study||3
9787665|NCT00539513|10894854|FG001|Received Allocated Intervention|Overall Study||4
9787666|NCT00539513|10894853|FG000|COMPLETED|Overall Study||3
9787667|NCT00539513|10894854|FG001|COMPLETED|Overall Study||3
9787668|NCT00539513|10894853|FG000|NOT COMPLETED|Overall Study||2
9787669|NCT00539513|10894854|FG001|NOT COMPLETED|Overall Study||2
9787670|NCT00539526|10894863|FG000|STARTED|Overall Study||35
9787671|NCT00539526|10894864|FG001|STARTED|Overall Study||33
9787672|NCT00539526|10894865|FG002|STARTED|Overall Study||38
9787673|NCT00539526|10894863|FG000|COMPLETED|Overall Study||32
9787674|NCT00539526|10894864|FG001|COMPLETED|Overall Study||31
9787675|NCT00539526|10894865|FG002|COMPLETED|Overall Study||36
9787676|NCT00539526|10894863|FG000|NOT COMPLETED|Overall Study||3
9787677|NCT00539526|10894864|FG001|NOT COMPLETED|Overall Study||2
9787678|NCT00539526|10894865|FG002|NOT COMPLETED|Overall Study||2
9787679|NCT00539539|10894875|FG000|STARTED|Overall Study||815
9787680|NCT00539539|10894876|FG001|STARTED|Overall Study||771
9787681|NCT00539539|10894875|FG000|COMPLETED|Overall Study||815
9787682|NCT00539539|10894876|FG001|COMPLETED|Overall Study||771
9787683|NCT00539539|10894875|FG000|NOT COMPLETED|Overall Study||0
9787684|NCT00539539|10894876|FG001|NOT COMPLETED|Overall Study||0
9787685|NCT00539656|10894882|FG000|STARTED|Overall Study||3
9787686|NCT00539656|10894882|FG000|COMPLETED|Overall Study||3
9787687|NCT00539656|10894882|FG000|NOT COMPLETED|Overall Study||0
9787688|NCT00539695|10894886|FG000|STARTED|Overall Study||25
9787689|NCT00539695|10894886|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22
9787690|NCT00539695|10894886|FG000|COMPLETED|Overall Study||12
9787691|NCT00539695|10894886|FG000|NOT COMPLETED|Overall Study||13
9787692|NCT00539734|10894890|FG000|STARTED|Overall Study||26
9787693|NCT00539734|10894890|FG000|COMPLETED|Overall Study||25
9787694|NCT00539734|10894890|FG000|NOT COMPLETED|Overall Study||1
9787695|NCT00539864|10894896|FG000|STARTED|Overall Study||300
9787696|NCT00539864|10894897|FG001|STARTED|Overall Study||302
9787697|NCT00539864|10894896|FG000|COMPLETED|Overall Study||299
9787698|NCT00539864|10894897|FG001|COMPLETED|Overall Study||300
9787699|NCT00539864|10894896|FG000|NOT COMPLETED|Overall Study||1
9787700|NCT00539864|10894897|FG001|NOT COMPLETED|Overall Study||2
9787701|NCT00539942|10894905|FG000|STARTED|Overall Study||4
9787702|NCT00539942|10894906|FG001|STARTED|Overall Study||3
9787703|NCT00539942|10894905|FG000|COMPLETED|Overall Study||4
9787704|NCT00539942|10894906|FG001|COMPLETED|Overall Study||3
9787705|NCT00539942|10894905|FG000|NOT COMPLETED|Overall Study||0
9787706|NCT00539942|10894906|FG001|NOT COMPLETED|Overall Study||0
9787707|NCT00539994|10894915|FG000|STARTED|Overall Study||23
9787708|NCT00539994|10894916|FG001|STARTED|Overall Study||19
9787709|NCT00539994|10894917|FG002|STARTED|Overall Study||15
9787710|NCT00539994|10894915|FG000|COMPLETED|Overall Study||20
9787711|NCT00539994|10894916|FG001|COMPLETED|Overall Study||18
9787712|NCT00539994|10894917|FG002|COMPLETED|Overall Study||13
9787713|NCT00539994|10894915|FG000|NOT COMPLETED|Overall Study||3
9787714|NCT00539994|10894916|FG001|NOT COMPLETED|Overall Study||1
9787715|NCT00539994|10894917|FG002|NOT COMPLETED|Overall Study||2
9787716|NCT00540007|10894934|FG000|STARTED|Overall Study||38
9787717|NCT00540007|10894935|FG001|STARTED|Overall Study||42
9787718|NCT00540007|10894934|FG000|COMPLETED|Overall Study||38
9787719|NCT00540007|10894935|FG001|COMPLETED|Overall Study||42
9787720|NCT00540007|10894934|FG000|NOT COMPLETED|Overall Study||0
9787721|NCT00540007|10894935|FG001|NOT COMPLETED|Overall Study||0
9787722|NCT00540046|10894944|FG000|STARTED|Overall Study||104
9787723|NCT00540046|10894945|FG001|STARTED|Overall Study||111
9787724|NCT00540046|10894944|FG000|COMPLETED|Overall Study||71
9787725|NCT00540046|10894945|FG001|COMPLETED|Overall Study||88
9787726|NCT00540046|10894944|FG000|NOT COMPLETED|Overall Study||33
9787727|NCT00540046|10894945|FG001|NOT COMPLETED|Overall Study||23
9787728|NCT00540124|10894956|FG000|STARTED|Overall Study||51
9787729|NCT00540124|10894957|FG001|STARTED|Overall Study||51
9787730|NCT00540124|10894958|FG002|STARTED|Overall Study||49
9787731|NCT00540124|10894956|FG000|COMPLETED|Overall Study||47
9787732|NCT00540124|10894957|FG001|COMPLETED|Overall Study||48
9952365|NCT01421641|11071303|FG000|NOT COMPLETED|Overall Study||2
9952366|NCT01421641|11071304|FG001|NOT COMPLETED|Overall Study||2
9952367|NCT01421654|11071312|FG000|STARTED|Overall Study||11
9952368|NCT01421654|11071313|FG001|STARTED|Overall Study||9
9952369|NCT01421654|11071312|FG000|COMPLETED|Overall Study||11
9787733|NCT00540124|10894958|FG002|COMPLETED|Overall Study||48
9787734|NCT00540124|10894956|FG000|NOT COMPLETED|Overall Study||4
9787735|NCT00540124|10894957|FG001|NOT COMPLETED|Overall Study||3
9787736|NCT00540124|10894958|FG002|NOT COMPLETED|Overall Study||1
9787737|NCT00540228|10894971|FG000|STARTED|Overall Study||200
9787738|NCT00540228|10894972|FG001|STARTED|Overall Study||198
9787739|NCT00540228|10894973|FG002|STARTED|Overall Study||204
9787740|NCT00540228|10894974|FG003|STARTED|Overall Study||202
9787741|NCT00540228|10894975|FG004|STARTED|Overall Study||202
9787742|NCT00540228|10894971|FG000|COMPLETED|Overall Study||197
9787743|NCT00540228|10894972|FG001|COMPLETED|Overall Study||197
9787744|NCT00540228|10894973|FG002|COMPLETED|Overall Study||204
9787745|NCT00540228|10894974|FG003|COMPLETED|Overall Study||202
9956978|NCT01448824|11076147|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11
9787746|NCT00540228|10894975|FG004|COMPLETED|Overall Study||202
9787747|NCT00540228|10894971|FG000|NOT COMPLETED|Overall Study||3
9787748|NCT00540228|10894972|FG001|NOT COMPLETED|Overall Study||1
9787749|NCT00540228|10894973|FG002|NOT COMPLETED|Overall Study||0
9787750|NCT00540228|10894974|FG003|NOT COMPLETED|Overall Study||0
9787751|NCT00540228|10894975|FG004|NOT COMPLETED|Overall Study||0
9787752|NCT00540293|10894987|FG000|STARTED|Overall Study||425
9787753|NCT00540293|10894987|FG000|COMPLETED|Overall Study||390
9787754|NCT00540293|10894987|FG000|NOT COMPLETED|Overall Study||35
9787755|NCT00540423|10894999|FG000|STARTED|Double-Blind Treatment Period||8
9787756|NCT00540423|10895000|FG001|STARTED|Double-Blind Treatment Period||15
9787757|NCT00540423|10895001|FG002|STARTED|Double-Blind Treatment Period||0
9787758|NCT00540423|10894999|FG000|COMPLETED|Double-Blind Treatment Period||8
9787759|NCT00540423|10895000|FG001|COMPLETED|Double-Blind Treatment Period||14
9787760|NCT00540423|10895001|FG002|COMPLETED|Double-Blind Treatment Period||0
9787761|NCT00540423|10894999|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
9787762|NCT00540423|10895000|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
9787763|NCT00540423|10895001|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
9787764|NCT00540423|10894999|FG000|STARTED|Open-Label Treatment Period||0
9787765|NCT00540423|10895000|FG001|STARTED|Open-Label Treatment Period||0
9787766|NCT00540423|10895001|FG002|STARTED|Open-Label Treatment Period||22
9787767|NCT00540423|10894999|FG000|COMPLETED|Open-Label Treatment Period||0
9787768|NCT00540423|10895000|FG001|COMPLETED|Open-Label Treatment Period||0
9787769|NCT00540423|10895001|FG002|COMPLETED|Open-Label Treatment Period||20
9787770|NCT00540423|10894999|FG000|NOT COMPLETED|Open-Label Treatment Period||0
9787771|NCT00540423|10895000|FG001|NOT COMPLETED|Open-Label Treatment Period||0
9787772|NCT00540423|10895001|FG002|NOT COMPLETED|Open-Label Treatment Period||2
9787773|NCT00540436|10895019|FG000|STARTED|First 12-Week Treatment Period||25
9787774|NCT00540436|10895019|FG000|COMPLETED|First 12-Week Treatment Period||22
9787775|NCT00540436|10895019|FG000|NOT COMPLETED|First 12-Week Treatment Period||3
9787776|NCT00540436|10895019|FG000|STARTED|Second 12-Week Treatment Period||22
9787777|NCT00540436|10895019|FG000|COMPLETED|Second 12-Week Treatment Period||21
9787778|NCT00540436|10895019|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1
9787779|NCT00540449|10895025|FG000|STARTED|Overall Study||346
9787780|NCT00540449|10895026|FG001|STARTED|Overall Study||344
9787781|NCT00540449|10895025|FG000|COMPLETED|Overall Study||262
9787782|NCT00540449|10895026|FG001|COMPLETED|Overall Study||266
9787783|NCT00540449|10895025|FG000|NOT COMPLETED|Overall Study||84
9787784|NCT00540449|10895026|FG001|NOT COMPLETED|Overall Study||78
9787785|NCT00540514|10895034|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
9787786|NCT00540514|10895035|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
9787787|NCT00540514|10895034|FG000|Treated|Overall Study||514
9787788|NCT00540514|10895035|FG001|Treated|Overall Study||524
9787789|NCT00540514|10895034|FG000|Biomarker Population|Overall Study||35
9787790|NCT00540514|10895035|FG001|Biomarker Population|Overall Study||36
9787791|NCT00540514|10895034|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
9787792|NCT00540514|10895035|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
9787793|NCT00540514|10895034|FG000|NOT COMPLETED|Overall Study||246
9787794|NCT00540514|10895035|FG001|NOT COMPLETED|Overall Study||266
9787795|NCT00540579|10895042|FG000|STARTED|Overall Study||23
9787796|NCT00540579|10895042|FG000|COMPLETED|Overall Study||23
9787797|NCT00540579|10895042|FG000|NOT COMPLETED|Overall Study||0
9787798|NCT00540592|10895056|FG000|STARTED|Overall Study||204
9787799|NCT00540592|10895057|FG001|STARTED|Overall Study||202
9787800|NCT00540592|10895058|FG002|STARTED|Overall Study||202
9787801|NCT00540592|10895059|FG003|STARTED|Overall Study||202
9787802|NCT00540592|10895060|FG004|STARTED|Overall Study||199
9787803|NCT00540592|10895061|FG005|STARTED|Overall Study||198
9787804|NCT00540592|10895062|FG006|STARTED|Overall Study||198
9787805|NCT00540592|10895063|FG007|STARTED|Overall Study||199
9787806|NCT00540592|10895064|FG008|STARTED|Overall Study||200
9787807|NCT00540592|10895065|FG009|STARTED|Overall Study||203
9787808|NCT00540592|10895056|FG000|Completed at Day 180|Overall Study||200
9787809|NCT00540592|10895057|FG001|Completed at Day 180|Overall Study||201
9787810|NCT00540592|10895058|FG002|Completed at Day 180|Overall Study||197
9787811|NCT00540592|10895059|FG003|Completed at Day 180|Overall Study||197
9787812|NCT00540592|10895060|FG004|Completed at Day 180|Overall Study||195
9787813|NCT00540592|10895061|FG005|Completed at Day 180|Overall Study||198
9787814|NCT00540592|10895062|FG006|Completed at Day 180|Overall Study||196
9787815|NCT00540592|10895063|FG007|Completed at Day 180|Overall Study||193
9787816|NCT00540592|10895064|FG008|Completed at Day 180|Overall Study||198
9787817|NCT00540592|10895065|FG009|Completed at Day 180|Overall Study||189
10015312|NCT01805180|11138357|FG000|COMPLETED|Lead-in Donor Phase||6
10015313|NCT01805180|11138358|FG001|COMPLETED|Lead-in Donor Phase||0
10015314|NCT01805180|11138359|FG002|COMPLETED|Lead-in Donor Phase||0
9787818|NCT00540592|10895056|FG000|COMPLETED|Overall Study||202
9787819|NCT00540592|10895057|FG001|COMPLETED|Overall Study||201
10015315|NCT01805180|11138357|FG000|NOT COMPLETED|Lead-in Donor Phase||1
9787820|NCT00540592|10895058|FG002|COMPLETED|Overall Study||201
9787821|NCT00540592|10895059|FG003|COMPLETED|Overall Study||201
9787822|NCT00540592|10895060|FG004|COMPLETED|Overall Study||198
9787823|NCT00540592|10895061|FG005|COMPLETED|Overall Study||198
9787824|NCT00540592|10895062|FG006|COMPLETED|Overall Study||198
10015316|NCT01805180|11138358|FG001|NOT COMPLETED|Lead-in Donor Phase||0
10015317|NCT01805180|11138359|FG002|NOT COMPLETED|Lead-in Donor Phase||0
10015318|NCT01805180|11138357|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
9787825|NCT00540592|10895063|FG007|COMPLETED|Overall Study||198
9787826|NCT00540592|10895064|FG008|COMPLETED|Overall Study||199
9787827|NCT00540592|10895065|FG009|COMPLETED|Overall Study||201
9787828|NCT00540592|10895056|FG000|NOT COMPLETED|Overall Study||2
9952370|NCT01421654|11071313|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
9952371|NCT01421654|11071312|FG000|NOT COMPLETED|Overall Study||0
9952372|NCT01421654|11071313|FG001|NOT COMPLETED|Overall Study||0
9952373|NCT01421667|11071323|FG000|STARTED|Overall Study||35
9952374|NCT01421667|11071324|FG001|STARTED|Overall Study||68
9952375|NCT01421667|11071325|FG002|STARTED|Overall Study||53
9952376|NCT01421667|11071326|FG003|STARTED|Overall Study||16
9952377|NCT01421667|11071323|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
9787829|NCT00540592|10895057|FG001|NOT COMPLETED|Overall Study||1
9787830|NCT00540592|10895058|FG002|NOT COMPLETED|Overall Study||1
9787831|NCT00540592|10895059|FG003|NOT COMPLETED|Overall Study||1
9787832|NCT00540592|10895060|FG004|NOT COMPLETED|Overall Study||1
9787833|NCT00540592|10895061|FG005|NOT COMPLETED|Overall Study||0
9787834|NCT00540592|10895062|FG006|NOT COMPLETED|Overall Study||0
9787835|NCT00540592|10895063|FG007|NOT COMPLETED|Overall Study||1
9787836|NCT00540592|10895064|FG008|NOT COMPLETED|Overall Study||1
9787837|NCT00540592|10895065|FG009|NOT COMPLETED|Overall Study||2
9787838|NCT00540644|10895089|FG000|STARTED|Overall Study||48
9787839|NCT00540644|10895090|FG001|STARTED|Overall Study||22
9787840|NCT00540644|10895089|FG000|COMPLETED|Overall Study||39
9787841|NCT00540644|10895090|FG001|COMPLETED|Overall Study||13
9787842|NCT00540644|10895089|FG000|NOT COMPLETED|Overall Study||9
9787843|NCT00540644|10895090|FG001|NOT COMPLETED|Overall Study||9
9787844|NCT00540722|10895096|FG000|STARTED|Overall Study||56
9787845|NCT00540722|10895096|FG000|COMPLETED|Overall Study||56
9787846|NCT00540722|10895096|FG000|NOT COMPLETED|Overall Study||0
9830510|NCT00763360|10941193|FG000|STARTED|Overall Study||61
9830511|NCT00763360|10941194|FG001|STARTED|Overall Study||60
9830512|NCT00763360|10941195|FG002|STARTED|Overall Study||63
9830513|NCT00763360|10941193|FG000|COMPLETED|Overall Study||61
9830514|NCT00763360|10941194|FG001|COMPLETED|Overall Study||58
9830515|NCT00763360|10941195|FG002|COMPLETED|Overall Study||63
9830516|NCT00763360|10941193|FG000|NOT COMPLETED|Overall Study||0
9830517|NCT00763360|10941194|FG001|NOT COMPLETED|Overall Study||2
9830518|NCT00763360|10941195|FG002|NOT COMPLETED|Overall Study||0
9830519|NCT00763386|10941205|FG000|STARTED|Overall Study||164
9830520|NCT00763386|10941206|FG001|STARTED|Overall Study||167
9830521|NCT00763386|10941205|FG000|COMPLETED|Overall Study||116
9830522|NCT00763386|10941206|FG001|COMPLETED|Overall Study||127
9830523|NCT00763386|10941205|FG000|NOT COMPLETED|Overall Study||48
9830524|NCT00763386|10941206|FG001|NOT COMPLETED|Overall Study||40
9830525|NCT00763412|10941214|FG000|STARTED|Overall Study||8
9830526|NCT00763412|10941215|FG001|STARTED|Overall Study||8
9830527|NCT00763412|10941214|FG000|COMPLETED|Overall Study||4
9830528|NCT00763412|10941215|FG001|COMPLETED|Overall Study||4
9830529|NCT00763412|10941214|FG000|NOT COMPLETED|Overall Study||4
9830530|NCT00763412|10941215|FG001|NOT COMPLETED|Overall Study||4
9830531|NCT00763451|10941225|FG000|STARTED|Overall Study|Randomized.|80
9830532|NCT00763451|10941226|FG001|STARTED|Overall Study||82
9830533|NCT00763451|10941227|FG002|STARTED|Overall Study||161
9830534|NCT00763451|10941228|FG003|STARTED|Overall Study||161
9830535|NCT00763451|10941225|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
9830536|NCT00763451|10941226|FG001|Treated/Safety Population|Overall Study||81
9830537|NCT00763451|10941227|FG002|Treated/Safety Population|Overall Study||161
9830538|NCT00763451|10941228|FG003|Treated/Safety Population|Overall Study||161
9830539|NCT00763451|10941225|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
9830540|NCT00763451|10941226|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80
9830541|NCT00763451|10941227|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160
9830542|NCT00763451|10941228|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160
9830543|NCT00763451|10941225|FG000|COMPLETED|Overall Study||67
9830544|NCT00763451|10941226|FG001|COMPLETED|Overall Study||60
9830545|NCT00763451|10941227|FG002|COMPLETED|Overall Study||121
9830546|NCT00763451|10941228|FG003|COMPLETED|Overall Study||131
9830547|NCT00763451|10941225|FG000|NOT COMPLETED|Overall Study||13
9830548|NCT00763451|10941226|FG001|NOT COMPLETED|Overall Study||22
9830549|NCT00763451|10941227|FG002|NOT COMPLETED|Overall Study||40
9830550|NCT00763451|10941228|FG003|NOT COMPLETED|Overall Study||30
9830551|NCT00763490|10941239|FG000|STARTED|Overall Study||20
9830552|NCT00763490|10941239|FG000|COMPLETED|Overall Study||20
9830553|NCT00763490|10941239|FG000|NOT COMPLETED|Overall Study||0
9830554|NCT00763698|10941243|FG000|STARTED|Overall Study||86
9830555|NCT00763698|10941243|FG000|COMPLETED|Overall Study||76
9830556|NCT00763698|10941243|FG000|NOT COMPLETED|Overall Study||10
9830557|NCT00763750|10941248|FG000|STARTED|Overall Study||25
9830558|NCT00763750|10941248|FG000|COMPLETED|Overall Study||25
9952378|NCT01421667|11071324|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
9952379|NCT01421667|11071325|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
9787847|NCT00540982|10895101|FG000|STARTED|Overall Study||47
9787848|NCT00540982|10895101|FG000|Normal Liver Function|Overall Study||11
9787849|NCT00540982|10895101|FG000|Mild Liver Dysfunction|Overall Study||6
9787850|NCT00540982|10895101|FG000|Moderate Liver Dysfunction|Overall Study||18
9787851|NCT00540982|10895101|FG000|Severe Liver Dysfunction|Overall Study||12
9787852|NCT00540982|10895101|FG000|COMPLETED|Overall Study||47
9787853|NCT00540982|10895101|FG000|NOT COMPLETED|Overall Study||0
9787854|NCT00541034|10895123|FG000|STARTED|Overall Study||49
9787855|NCT00541034|10895123|FG000|COMPLETED|Overall Study||46
9787856|NCT00541034|10895123|FG000|NOT COMPLETED|Overall Study||3
9787857|NCT00541099|10895127|FG000|STARTED|Overall Study||11
9787858|NCT00541099|10895127|FG000|COMPLETED|Overall Study||8
9787859|NCT00541099|10895127|FG000|NOT COMPLETED|Overall Study||3
9787860|NCT00541190|10895133|FG000|STARTED|Overall Study||10
9787861|NCT00541190|10895134|FG001|STARTED|Overall Study||11
9787862|NCT00541190|10895133|FG000|COMPLETED|Overall Study||10
9787863|NCT00541190|10895134|FG001|COMPLETED|Overall Study||11
9787864|NCT00541190|10895133|FG000|NOT COMPLETED|Overall Study||0
9787865|NCT00541190|10895134|FG001|NOT COMPLETED|Overall Study||0
9787866|NCT00541229|10895148|FG000|STARTED|Treatment Period I (Week 1)||17
9787867|NCT00541229|10895149|FG001|STARTED|Treatment Period I (Week 1)||16
9787868|NCT00541229|10895150|FG002|STARTED|Treatment Period I (Week 1)||20
9787869|NCT00541229|10895151|FG003|STARTED|Treatment Period I (Week 1)||18
9787870|NCT00541229|10895152|FG004|STARTED|Treatment Period I (Week 1)||14
9787871|NCT00541229|10895153|FG005|STARTED|Treatment Period I (Week 1)||18
9787872|NCT00541229|10895148|FG000|COMPLETED|Treatment Period I (Week 1)||17
9787873|NCT00541229|10895149|FG001|COMPLETED|Treatment Period I (Week 1)||15
9787874|NCT00541229|10895150|FG002|COMPLETED|Treatment Period I (Week 1)||17
9787875|NCT00541229|10895151|FG003|COMPLETED|Treatment Period I (Week 1)||17
9787876|NCT00541229|10895152|FG004|COMPLETED|Treatment Period I (Week 1)||14
9787877|NCT00541229|10895153|FG005|COMPLETED|Treatment Period I (Week 1)||16
9787878|NCT00541229|10895148|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0
9787879|NCT00541229|10895149|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1
9787880|NCT00541229|10895150|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3
9787881|NCT00541229|10895151|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1
9787882|NCT00541229|10895152|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0
9787883|NCT00541229|10895153|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2
9787884|NCT00541229|10895148|FG000|STARTED|Washout Period I (Week 2-5)||17
9787885|NCT00541229|10895149|FG001|STARTED|Washout Period I (Week 2-5)||15
9787886|NCT00541229|10895150|FG002|STARTED|Washout Period I (Week 2-5)||17
9787887|NCT00541229|10895151|FG003|STARTED|Washout Period I (Week 2-5)||17
9787888|NCT00541229|10895152|FG004|STARTED|Washout Period I (Week 2-5)||14
9787889|NCT00541229|10895153|FG005|STARTED|Washout Period I (Week 2-5)||16
9787890|NCT00541229|10895148|FG000|COMPLETED|Washout Period I (Week 2-5)||13
9787891|NCT00541229|10895149|FG001|COMPLETED|Washout Period I (Week 2-5)||13
9787892|NCT00541229|10895150|FG002|COMPLETED|Washout Period I (Week 2-5)||13
9787893|NCT00541229|10895151|FG003|COMPLETED|Washout Period I (Week 2-5)||13
9787894|NCT00541229|10895152|FG004|COMPLETED|Washout Period I (Week 2-5)||13
9787895|NCT00541229|10895153|FG005|COMPLETED|Washout Period I (Week 2-5)||11
9787896|NCT00541229|10895148|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4
9787897|NCT00541229|10895149|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2
9787898|NCT00541229|10895150|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4
9787899|NCT00541229|10895151|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4
9787900|NCT00541229|10895152|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1
9787901|NCT00541229|10895153|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5
9787902|NCT00541229|10895148|FG000|STARTED|Treatment Period II (Week 6)||13
9787903|NCT00541229|10895149|FG001|STARTED|Treatment Period II (Week 6)||13
9787904|NCT00541229|10895150|FG002|STARTED|Treatment Period II (Week 6)||13
9787905|NCT00541229|10895151|FG003|STARTED|Treatment Period II (Week 6)||13
9787906|NCT00541229|10895152|FG004|STARTED|Treatment Period II (Week 6)||13
9787907|NCT00541229|10895153|FG005|STARTED|Treatment Period II (Week 6)||11
9787908|NCT00541229|10895148|FG000|COMPLETED|Treatment Period II (Week 6)||11
9787909|NCT00541229|10895149|FG001|COMPLETED|Treatment Period II (Week 6)||12
9787910|NCT00541229|10895150|FG002|COMPLETED|Treatment Period II (Week 6)||12
9787911|NCT00541229|10895151|FG003|COMPLETED|Treatment Period II (Week 6)||12
9787912|NCT00541229|10895152|FG004|COMPLETED|Treatment Period II (Week 6)||11
9787913|NCT00541229|10895153|FG005|COMPLETED|Treatment Period II (Week 6)||8
9787914|NCT00541229|10895148|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2
9787915|NCT00541229|10895149|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1
9787916|NCT00541229|10895150|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1
9787917|NCT00541229|10895151|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1
9787918|NCT00541229|10895152|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2
9787919|NCT00541229|10895153|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3
9787920|NCT00541229|10895148|FG000|STARTED|Washout Period II (Week 7-10)||11
9787921|NCT00541229|10895149|FG001|STARTED|Washout Period II (Week 7-10)||12
9787922|NCT00541229|10895150|FG002|STARTED|Washout Period II (Week 7-10)||12
9787923|NCT00541229|10895151|FG003|STARTED|Washout Period II (Week 7-10)||12
9787924|NCT00541229|10895152|FG004|STARTED|Washout Period II (Week 7-10)||11
9787925|NCT00541229|10895153|FG005|STARTED|Washout Period II (Week 7-10)||8
9787926|NCT00541229|10895148|FG000|COMPLETED|Washout Period II (Week 7-10)||7
9787927|NCT00541229|10895149|FG001|COMPLETED|Washout Period II (Week 7-10)||8
9787928|NCT00541229|10895150|FG002|COMPLETED|Washout Period II (Week 7-10)||10
10015319|NCT01805180|11138358|FG001|STARTED|Pivotal Randomization Through Study Exit||22
10015320|NCT01805180|11138359|FG002|STARTED|Pivotal Randomization Through Study Exit||20
10015321|NCT01805180|11138357|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0
10015322|NCT01805180|11138358|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17
10015323|NCT01805180|11138359|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15
9787929|NCT00541229|10895151|FG003|COMPLETED|Washout Period II (Week 7-10)||8
9787930|NCT00541229|10895152|FG004|COMPLETED|Washout Period II (Week 7-10)||7
9787931|NCT00541229|10895153|FG005|COMPLETED|Washout Period II (Week 7-10)||5
9787932|NCT00541229|10895148|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4
9787933|NCT00541229|10895149|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4
9787934|NCT00541229|10895150|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2
9787935|NCT00541229|10895151|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4
9787936|NCT00541229|10895152|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4
9787937|NCT00541229|10895153|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3
9787938|NCT00541229|10895148|FG000|STARTED|Treatment Period III (Week 11)||7
10234145|NCT01555073|11364062|FG002|NOT COMPLETED|Overall Study||0
10234146|NCT01555073|11364063|FG003|NOT COMPLETED|Overall Study||5
10234147|NCT01551082|11364073|FG000|STARTED|Overall Study||12
10234148|NCT01551082|11364073|FG000|COMPLETED|Overall Study||12
10234149|NCT01551082|11364073|FG000|NOT COMPLETED|Overall Study||0
10234150|NCT01556009|11364079|FG000|STARTED|Overall Study||0
9787939|NCT00541229|10895149|FG001|STARTED|Treatment Period III (Week 11)||8
9787940|NCT00541229|10895150|FG002|STARTED|Treatment Period III (Week 11)||10
9787941|NCT00541229|10895151|FG003|STARTED|Treatment Period III (Week 11)||8
9787942|NCT00541229|10895152|FG004|STARTED|Treatment Period III (Week 11)||7
9787943|NCT00541229|10895153|FG005|STARTED|Treatment Period III (Week 11)||5
9787944|NCT00541229|10895148|FG000|COMPLETED|Treatment Period III (Week 11)||7
9787945|NCT00541229|10895149|FG001|COMPLETED|Treatment Period III (Week 11)||8
9787946|NCT00541229|10895150|FG002|COMPLETED|Treatment Period III (Week 11)||9
9787947|NCT00541229|10895151|FG003|COMPLETED|Treatment Period III (Week 11)||8
9787948|NCT00541229|10895152|FG004|COMPLETED|Treatment Period III (Week 11)||6
9787949|NCT00541229|10895153|FG005|COMPLETED|Treatment Period III (Week 11)||4
9787950|NCT00541229|10895148|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0
9787951|NCT00541229|10895149|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0
9787952|NCT00541229|10895150|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1
9787953|NCT00541229|10895151|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0
9787954|NCT00541229|10895152|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1
9787955|NCT00541229|10895153|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1
9787956|NCT00541242|10895163|FG000|STARTED|Treatment Period 1||0
9787957|NCT00541242|10895164|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
9787958|NCT00541242|10895163|FG000|COMPLETED|Treatment Period 1||0
9787959|NCT00541242|10895164|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
10015324|NCT01805180|11138357|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
10015325|NCT01805180|11138358|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
10015326|NCT01805180|11138359|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
10015327|NCT01805297|11138369|FG000|STARTED|Overall Study||6
10234151|NCT01556009|11364080|FG001|STARTED|Overall Study||0
10234152|NCT01556009|11364079|FG000|COMPLETED|Overall Study||0
9787960|NCT00541242|10895163|FG000|NOT COMPLETED|Treatment Period 1||0
9787961|NCT00541242|10895164|FG001|NOT COMPLETED|Treatment Period 1||0
9787962|NCT00541242|10895163|FG000|STARTED|Treatment Period 2||270
9787963|NCT00541242|10895164|FG001|STARTED|Treatment Period 2||273
9787964|NCT00541242|10895163|FG000|COMPLETED|Treatment Period 2||261
9787965|NCT00541242|10895164|FG001|COMPLETED|Treatment Period 2||266
10234153|NCT01556009|11364080|FG001|COMPLETED|Overall Study||0
10234154|NCT01556009|11364079|FG000|NOT COMPLETED|Overall Study||0
10234155|NCT01556009|11364080|FG001|NOT COMPLETED|Overall Study||0
10234156|NCT01550510|11364088|FG000|STARTED|Overall Study||4
10234157|NCT01550510|11364089|FG001|STARTED|Overall Study||0
10234158|NCT01550510|11364088|FG000|COMPLETED|Overall Study||4
10234159|NCT01550510|11364089|FG001|COMPLETED|Overall Study||0
10234160|NCT01550510|11364088|FG000|NOT COMPLETED|Overall Study||0
10234161|NCT01550510|11364089|FG001|NOT COMPLETED|Overall Study||0
10234162|NCT01541397|11364098|FG000|STARTED|Overall Study||4
10234163|NCT01541397|11364099|FG001|STARTED|Overall Study||2
10234164|NCT01541397|11364098|FG000|COMPLETED|Overall Study||0
9787966|NCT00541242|10895163|FG000|NOT COMPLETED|Treatment Period 2||9
9787967|NCT00541242|10895164|FG001|NOT COMPLETED|Treatment Period 2||7
9787968|NCT00541307|10895170|FG000|STARTED|Overall Study||119
9787969|NCT00541307|10895170|FG000|COMPLETED|Overall Study||95
9787970|NCT00541307|10895170|FG000|NOT COMPLETED|Overall Study||24
10015328|NCT01805297|11138370|FG001|STARTED|Overall Study||6
10234165|NCT01541397|11364099|FG001|COMPLETED|Overall Study||0
9787971|NCT00541346|10895174|FG000|STARTED|Baseline||16
9787972|NCT00541346|10895174|FG000|COMPLETED|Baseline||16
9787973|NCT00541346|10895174|FG000|NOT COMPLETED|Baseline||0
9787974|NCT00541346|10895174|FG000|STARTED|Follow-up||16
9787975|NCT00541346|10895174|FG000|COMPLETED|Follow-up||15
9787976|NCT00541346|10895174|FG000|NOT COMPLETED|Follow-up||1
9787977|NCT00541385|10895180|FG000|STARTED|Overall Study||355
9787978|NCT00541385|10895181|FG001|STARTED|Overall Study||180
9787979|NCT00541385|10895180|FG000|COMPLETED|Overall Study||274
10234166|NCT01541397|11364098|FG000|NOT COMPLETED|Overall Study||4
9787980|NCT00541385|10895181|FG001|COMPLETED|Overall Study||142
9787981|NCT00541385|10895180|FG000|NOT COMPLETED|Overall Study||81
9787982|NCT00541385|10895181|FG001|NOT COMPLETED|Overall Study||38
9787983|NCT00541450|10895189|FG000|STARTED|Phase A||244
9787984|NCT00541450|10895190|FG001|STARTED|Phase A||248
9787985|NCT00541450|10895189|FG000|COMPLETED|Phase A||224
9787986|NCT00541450|10895190|FG001|COMPLETED|Phase A||231
9787987|NCT00541450|10895189|FG000|NOT COMPLETED|Phase A||20
9787988|NCT00541450|10895190|FG001|NOT COMPLETED|Phase A||17
9787989|NCT00541450|10895189|FG000|STARTED|Phase B||224
9787990|NCT00541450|10895190|FG001|STARTED|Phase B||231
9787991|NCT00541450|10895189|FG000|COMPLETED|Phase B||187
9787992|NCT00541450|10895190|FG001|COMPLETED|Phase B||200
9787993|NCT00541450|10895189|FG000|NOT COMPLETED|Phase B||37
9787994|NCT00541450|10895190|FG001|NOT COMPLETED|Phase B||31
9787995|NCT00541593|10895200|FG000|STARTED|Overall Study||5
9787996|NCT00541593|10895200|FG000|COMPLETED|Overall Study||5
9787997|NCT00541593|10895200|FG000|NOT COMPLETED|Overall Study||0
9787998|NCT00541658|10895207|FG000|STARTED|Overall Study||308
9787999|NCT00541658|10895208|FG001|STARTED|Overall Study||307
9788000|NCT00541658|10895209|FG002|STARTED|Overall Study||308
9788001|NCT00541658|10895207|FG000|ITT Population|Overall Study||307
9788002|NCT00541658|10895208|FG001|ITT Population|Overall Study||307
9788003|NCT00541658|10895209|FG002|ITT Population|Overall Study||308
9788004|NCT00541658|10895207|FG000|COMPLETED|Overall Study||248
9788005|NCT00541658|10895208|FG001|COMPLETED|Overall Study||234
9788006|NCT00541658|10895209|FG002|COMPLETED|Overall Study||240
9788007|NCT00541658|10895207|FG000|NOT COMPLETED|Overall Study||60
9788008|NCT00541658|10895208|FG001|NOT COMPLETED|Overall Study||73
9788009|NCT00541658|10895209|FG002|NOT COMPLETED|Overall Study||68
9788010|NCT00541671|10895221|FG000|STARTED|Overall Study||13
9788011|NCT00541671|10895222|FG001|STARTED|Overall Study||12
9788012|NCT00541671|10895221|FG000|COMPLETED|Overall Study||13
9788013|NCT00541671|10895222|FG001|COMPLETED|Overall Study||12
9788014|NCT00541671|10895221|FG000|NOT COMPLETED|Overall Study||0
9788015|NCT00541671|10895222|FG001|NOT COMPLETED|Overall Study||0
9788016|NCT00541775|10895231|FG000|STARTED|Overall Study||94
9788017|NCT00541775|10895232|FG001|STARTED|Overall Study||87
9788018|NCT00541775|10895233|FG002|STARTED|Overall Study||92
9788019|NCT00541775|10895231|FG000|COMPLETED|Overall Study||85
9788020|NCT00541775|10895232|FG001|COMPLETED|Overall Study||85
9788021|NCT00541775|10895233|FG002|COMPLETED|Overall Study||84
9788022|NCT00541775|10895231|FG000|NOT COMPLETED|Overall Study||9
9788023|NCT00541775|10895232|FG001|NOT COMPLETED|Overall Study||2
9788024|NCT00541775|10895233|FG002|NOT COMPLETED|Overall Study||8
9788025|NCT00541866|10895246|FG000|STARTED|Overall Study|41 started, but only 39 treated|41
9788026|NCT00541866|10895247|FG001|STARTED|Overall Study||18
9788027|NCT00541866|10895248|FG002|STARTED|Overall Study||17
9788028|NCT00541866|10895249|FG003|STARTED|Overall Study||16
9788029|NCT00541866|10895250|FG004|STARTED|Overall Study||18
9788030|NCT00541866|10895246|FG000|COMPLETED|Overall Study||7
9788031|NCT00541866|10895247|FG001|COMPLETED|Overall Study||0
9788032|NCT00541866|10895248|FG002|COMPLETED|Overall Study||2
9788033|NCT00541866|10895249|FG003|COMPLETED|Overall Study||0
9788034|NCT00541866|10895250|FG004|COMPLETED|Overall Study||3
9788035|NCT00541866|10895246|FG000|NOT COMPLETED|Overall Study||34
9788036|NCT00541866|10895247|FG001|NOT COMPLETED|Overall Study||18
9788037|NCT00541866|10895248|FG002|NOT COMPLETED|Overall Study||15
9788038|NCT00541866|10895249|FG003|NOT COMPLETED|Overall Study||16
9788039|NCT00541866|10895250|FG004|NOT COMPLETED|Overall Study||15
9788040|NCT00541931|10895280|FG000|STARTED|Overall Study||22
9788041|NCT00541931|10895281|FG001|STARTED|Overall Study||15
9788042|NCT00541931|10895280|FG000|COMPLETED|Overall Study||17
9788043|NCT00541931|10895281|FG001|COMPLETED|Overall Study||11
9788044|NCT00541931|10895280|FG000|NOT COMPLETED|Overall Study||5
9788045|NCT00541931|10895281|FG001|NOT COMPLETED|Overall Study||4
9788046|NCT00541970|10895293|FG000|STARTED|Month 7||240
9788047|NCT00541970|10895294|FG001|STARTED|Month 7||241
9788048|NCT00541970|10895295|FG002|STARTED|Month 7||240
9788049|NCT00541970|10895296|FG003|STARTED|Month 7||239
9788050|NCT00541970|10895293|FG000|COMPLETED|Month 7||231
9788051|NCT00541970|10895294|FG001|COMPLETED|Month 7||228
9788052|NCT00541970|10895295|FG002|COMPLETED|Month 7||229
9788053|NCT00541970|10895296|FG003|COMPLETED|Month 7||234
9788054|NCT00541970|10895293|FG000|NOT COMPLETED|Month 7||9
9788055|NCT00541970|10895294|FG001|NOT COMPLETED|Month 7||13
9788056|NCT00541970|10895295|FG002|NOT COMPLETED|Month 7||11
9788057|NCT00541970|10895296|FG003|NOT COMPLETED|Month 7||5
9788058|NCT00541970|10895293|FG000|STARTED|Month 12||240
9788059|NCT00541970|10895294|FG001|STARTED|Month 12||241
9788060|NCT00541970|10895295|FG002|STARTED|Month 12||240
9788061|NCT00541970|10895296|FG003|STARTED|Month 12||239
9788062|NCT00541970|10895293|FG000|COMPLETED|Month 12||228
9788063|NCT00541970|10895294|FG001|COMPLETED|Month 12||219
9788064|NCT00541970|10895295|FG002|COMPLETED|Month 12||219
9788065|NCT00541970|10895296|FG003|COMPLETED|Month 12||223
9788066|NCT00541970|10895293|FG000|NOT COMPLETED|Month 12||12
9788067|NCT00541970|10895294|FG001|NOT COMPLETED|Month 12||22
9788068|NCT00541970|10895295|FG002|NOT COMPLETED|Month 12||21
9788069|NCT00541970|10895296|FG003|NOT COMPLETED|Month 12||16
9788070|NCT00541970|10895293|FG000|STARTED|Month 18||240
9788071|NCT00541970|10895294|FG001|STARTED|Month 18||241
9788072|NCT00541970|10895295|FG002|STARTED|Month 18||240
9788073|NCT00541970|10895296|FG003|STARTED|Month 18||239
9788074|NCT00541970|10895293|FG000|COMPLETED|Month 18||226
9788075|NCT00541970|10895294|FG001|COMPLETED|Month 18||217
9788076|NCT00541970|10895295|FG002|COMPLETED|Month 18||215
9788077|NCT00541970|10895296|FG003|COMPLETED|Month 18||222
9788078|NCT00541970|10895293|FG000|NOT COMPLETED|Month 18||14
9788079|NCT00541970|10895294|FG001|NOT COMPLETED|Month 18||24
9788080|NCT00541970|10895295|FG002|NOT COMPLETED|Month 18||25
9788081|NCT00541970|10895296|FG003|NOT COMPLETED|Month 18||17
9788082|NCT00541970|10895293|FG000|STARTED|Month 24||240
9788083|NCT00541970|10895294|FG001|STARTED|Month 24||241
9788084|NCT00541970|10895295|FG002|STARTED|Month 24||240
9788085|NCT00541970|10895296|FG003|STARTED|Month 24||239
9788086|NCT00541970|10895293|FG000|COMPLETED|Month 24||211
9788087|NCT00541970|10895294|FG001|COMPLETED|Month 24||209
9788088|NCT00541970|10895295|FG002|COMPLETED|Month 24||208
9788089|NCT00541970|10895296|FG003|COMPLETED|Month 24||217
9788090|NCT00541970|10895293|FG000|NOT COMPLETED|Month 24||29
9788091|NCT00541970|10895294|FG001|NOT COMPLETED|Month 24||32
9788092|NCT00541970|10895295|FG002|NOT COMPLETED|Month 24||32
9788093|NCT00541970|10895296|FG003|NOT COMPLETED|Month 24||22
9788094|NCT00541970|10895293|FG000|STARTED|Month 36||240
9788095|NCT00541970|10895294|FG001|STARTED|Month 36||241
9788096|NCT00541970|10895295|FG002|STARTED|Month 36||240
9788097|NCT00541970|10895296|FG003|STARTED|Month 36||239
9788098|NCT00541970|10895293|FG000|COMPLETED|Month 36||179
9788099|NCT00541970|10895294|FG001|COMPLETED|Month 36||175
9788100|NCT00541970|10895295|FG002|COMPLETED|Month 36||174
9788101|NCT00541970|10895296|FG003|COMPLETED|Month 36||179
9788102|NCT00541970|10895293|FG000|NOT COMPLETED|Month 36||61
9788103|NCT00541970|10895294|FG001|NOT COMPLETED|Month 36||66
9788104|NCT00541970|10895295|FG002|NOT COMPLETED|Month 36||66
9788105|NCT00541970|10895296|FG003|NOT COMPLETED|Month 36||60
9788106|NCT00541970|10895293|FG000|STARTED|Month 48||240
9788107|NCT00541970|10895294|FG001|STARTED|Month 48||241
9788108|NCT00541970|10895295|FG002|STARTED|Month 48||240
9788109|NCT00541970|10895296|FG003|STARTED|Month 48||239
9788110|NCT00541970|10895293|FG000|COMPLETED|Month 48||169
9788111|NCT00541970|10895294|FG001|COMPLETED|Month 48||168
9788112|NCT00541970|10895295|FG002|COMPLETED|Month 48||167
9788113|NCT00541970|10895296|FG003|COMPLETED|Month 48||164
9788114|NCT00541970|10895293|FG000|NOT COMPLETED|Month 48||71
9788115|NCT00541970|10895294|FG001|NOT COMPLETED|Month 48||73
9788116|NCT00541970|10895295|FG002|NOT COMPLETED|Month 48||73
9788117|NCT00541970|10895296|FG003|NOT COMPLETED|Month 48||75
9788118|NCT00541970|10895293|FG000|STARTED|Month 60||240
9788119|NCT00541970|10895294|FG001|STARTED|Month 60||241
9788120|NCT00541970|10895295|FG002|STARTED|Month 60||240
9788121|NCT00541970|10895296|FG003|STARTED|Month 60||239
9788122|NCT00541970|10895293|FG000|COMPLETED|Month 60||162
9788123|NCT00541970|10895294|FG001|COMPLETED|Month 60||164
9788124|NCT00541970|10895295|FG002|COMPLETED|Month 60||158
9788125|NCT00541970|10895296|FG003|COMPLETED|Month 60||167
9788126|NCT00541970|10895293|FG000|NOT COMPLETED|Month 60||78
9788127|NCT00541970|10895294|FG001|NOT COMPLETED|Month 60||77
9788128|NCT00541970|10895295|FG002|NOT COMPLETED|Month 60||82
9788129|NCT00541970|10895296|FG003|NOT COMPLETED|Month 60||72
9788130|NCT00542178|10895312|FG000|STARTED|Overall Study||390
9788131|NCT00542178|10895313|FG001|STARTED|Overall Study||412
9788132|NCT00542178|10895314|FG002|STARTED|Overall Study||382
9788133|NCT00542178|10895315|FG003|STARTED|Overall Study||370
9788134|NCT00542178|10895316|FG004|STARTED|Overall Study||464
9788135|NCT00542178|10895317|FG005|STARTED|Overall Study||495
9788136|NCT00542178|10895318|FG006|STARTED|Overall Study||493
9788137|NCT00542178|10895319|FG007|STARTED|Overall Study||466
9788138|NCT00542178|10895312|FG000|COMPLETED|Overall Study||315
9788139|NCT00542178|10895313|FG001|COMPLETED|Overall Study||332
9788140|NCT00542178|10895314|FG002|COMPLETED|Overall Study||308
10234167|NCT01541397|11364099|FG001|NOT COMPLETED|Overall Study||2
10234168|NCT01546207|11364105|FG000|STARTED|Overall Study||4
9788141|NCT00542178|10895315|FG003|COMPLETED|Overall Study||308
9788142|NCT00542178|10895316|FG004|COMPLETED|Overall Study||400
9788143|NCT00542178|10895317|FG005|COMPLETED|Overall Study||406
9788144|NCT00542178|10895318|FG006|COMPLETED|Overall Study||406
9788145|NCT00542178|10895319|FG007|COMPLETED|Overall Study||381
9788146|NCT00542178|10895312|FG000|NOT COMPLETED|Overall Study||75
9788147|NCT00542178|10895313|FG001|NOT COMPLETED|Overall Study||80
9788148|NCT00542178|10895314|FG002|NOT COMPLETED|Overall Study||74
9788149|NCT00542178|10895315|FG003|NOT COMPLETED|Overall Study||62
9788150|NCT00542178|10895316|FG004|NOT COMPLETED|Overall Study||64
9788151|NCT00542178|10895317|FG005|NOT COMPLETED|Overall Study||89
9788152|NCT00542178|10895318|FG006|NOT COMPLETED|Overall Study||87
9788153|NCT00542178|10895319|FG007|NOT COMPLETED|Overall Study||85
9788154|NCT00542191|10895333|FG000|STARTED|Overall Study||21
9788155|NCT00542191|10895333|FG000|COMPLETED|Overall Study||18
9788156|NCT00542191|10895333|FG000|NOT COMPLETED|Overall Study||3
9788157|NCT00542269|10895340|FG000|STARTED|Overall Study||61
9788158|NCT00542269|10895341|FG001|STARTED|Overall Study||60
9788159|NCT00542269|10895342|FG002|STARTED|Overall Study||57
9788160|NCT00542269|10895340|FG000|COMPLETED|Overall Study||48
9788161|NCT00542269|10895341|FG001|COMPLETED|Overall Study||54
9788162|NCT00542269|10895342|FG002|COMPLETED|Overall Study||51
9788163|NCT00542269|10895340|FG000|NOT COMPLETED|Overall Study||13
9788164|NCT00542269|10895341|FG001|NOT COMPLETED|Overall Study||6
9788165|NCT00542269|10895342|FG002|NOT COMPLETED|Overall Study||6
9788166|NCT00542308|10895352|FG000|STARTED|Overall Study||90
9788167|NCT00542308|10895352|FG000|COMPLETED|Overall Study||90
9788168|NCT00542308|10895352|FG000|NOT COMPLETED|Overall Study||0
9788169|NCT00542321|10895358|FG000|STARTED|Overall Study||8
9788170|NCT00542321|10895359|FG001|STARTED|Overall Study||8
10234169|NCT01546207|11364105|FG000|COMPLETED|Overall Study||3
9788171|NCT00542321|10895358|FG000|COMPLETED|Overall Study||8
9788172|NCT00542321|10895359|FG001|COMPLETED|Overall Study||7
9788173|NCT00542321|10895358|FG000|NOT COMPLETED|Overall Study||0
9788174|NCT00542321|10895359|FG001|NOT COMPLETED|Overall Study||1
9788175|NCT00542386|10895371|FG000|STARTED|Overall Study||104
9788176|NCT00542386|10895372|FG001|STARTED|Overall Study||102
9788177|NCT00542386|10895373|FG002|STARTED|Overall Study||99
9788178|NCT00542386|10895374|FG003|STARTED|Overall Study||103
9788179|NCT00542386|10895375|FG004|STARTED|Overall Study||102
9788180|NCT00542386|10895376|FG005|STARTED|Overall Study||132
9788181|NCT00542386|10895371|FG000|COMPLETED|Overall Study||61
9788182|NCT00542386|10895372|FG001|COMPLETED|Overall Study||74
9788183|NCT00542386|10895373|FG002|COMPLETED|Overall Study||66
9788184|NCT00542386|10895374|FG003|COMPLETED|Overall Study||65
10015329|NCT01805297|11138369|FG000|COMPLETED|Overall Study||4
10015330|NCT01805297|11138370|FG001|COMPLETED|Overall Study||3
10015331|NCT01805297|11138369|FG000|NOT COMPLETED|Overall Study||2
10015332|NCT01805297|11138370|FG001|NOT COMPLETED|Overall Study||3
10015333|NCT01805323|11138377|FG000|STARTED|Overall Study||101
10015334|NCT01805323|11138377|FG000|COMPLETED|Overall Study||101
10015335|NCT01805323|11138377|FG000|NOT COMPLETED|Overall Study||0
9788185|NCT00542386|10895375|FG004|COMPLETED|Overall Study||62
9788186|NCT00542386|10895376|FG005|COMPLETED|Overall Study||82
9788187|NCT00542386|10895371|FG000|NOT COMPLETED|Overall Study||43
9788188|NCT00542386|10895372|FG001|NOT COMPLETED|Overall Study||28
9788189|NCT00542386|10895373|FG002|NOT COMPLETED|Overall Study||33
9788190|NCT00542386|10895374|FG003|NOT COMPLETED|Overall Study||38
9788191|NCT00542386|10895375|FG004|NOT COMPLETED|Overall Study||40
9788192|NCT00542386|10895376|FG005|NOT COMPLETED|Overall Study||50
9788193|NCT00542425|10895395|FG000|STARTED|Initial 24 Weeks||46
9788194|NCT00542425|10895396|FG001|STARTED|Initial 24 Weeks||43
9788195|NCT00542425|10895397|FG002|STARTED|Initial 24 Weeks||43
9788196|NCT00542425|10895398|FG003|STARTED|Initial 24 Weeks||45
9788197|NCT00542425|10895399|FG004|STARTED|Initial 24 Weeks||45
9788198|NCT00542425|10895395|FG000|COMPLETED|Initial 24 Weeks||42
9788199|NCT00542425|10895396|FG001|COMPLETED|Initial 24 Weeks||33
9788200|NCT00542425|10895397|FG002|COMPLETED|Initial 24 Weeks||36
9788201|NCT00542425|10895398|FG003|COMPLETED|Initial 24 Weeks||34
9788202|NCT00542425|10895399|FG004|COMPLETED|Initial 24 Weeks||39
9788203|NCT00542425|10895395|FG000|NOT COMPLETED|Initial 24 Weeks||4
9788204|NCT00542425|10895396|FG001|NOT COMPLETED|Initial 24 Weeks||10
9788205|NCT00542425|10895397|FG002|NOT COMPLETED|Initial 24 Weeks||7
9788206|NCT00542425|10895398|FG003|NOT COMPLETED|Initial 24 Weeks||11
9788207|NCT00542425|10895399|FG004|NOT COMPLETED|Initial 24 Weeks||6
9788208|NCT00542425|10895395|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
9788209|NCT00542425|10895396|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
9788210|NCT00542425|10895397|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
9788211|NCT00542425|10895398|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
9788212|NCT00542425|10895399|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
9788213|NCT00542425|10895395|FG000|COMPLETED|Extended 24 Weeks of Treatment||10
9788214|NCT00542425|10895396|FG001|COMPLETED|Extended 24 Weeks of Treatment||11
9788215|NCT00542425|10895397|FG002|COMPLETED|Extended 24 Weeks of Treatment||8
9788216|NCT00542425|10895398|FG003|COMPLETED|Extended 24 Weeks of Treatment||6
9788217|NCT00542425|10895399|FG004|COMPLETED|Extended 24 Weeks of Treatment||13
9788218|NCT00542425|10895395|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1
9788219|NCT00542425|10895396|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2
9788220|NCT00542425|10895397|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2
9788221|NCT00542425|10895398|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1
9788222|NCT00542425|10895399|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1
9788223|NCT00542490|10895411|FG000|STARTED|Overall Study||23
9788224|NCT00542490|10895411|FG000|COMPLETED|Overall Study||21
9788225|NCT00542490|10895411|FG000|NOT COMPLETED|Overall Study||2
9788226|NCT00542620|10895417|FG000|STARTED|Overall Study||13
9788227|NCT00542620|10895418|FG001|STARTED|Overall Study||12
9788228|NCT00542620|10895417|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
9788229|NCT00542620|10895418|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
9788230|NCT00542620|10895417|FG000|COMPLETED|Overall Study||13
9788231|NCT00542620|10895418|FG001|COMPLETED|Overall Study||12
9788232|NCT00542620|10895417|FG000|NOT COMPLETED|Overall Study||0
9788233|NCT00542620|10895418|FG001|NOT COMPLETED|Overall Study||0
9788234|NCT00542750|10895424|FG000|STARTED|Overall Study||24
10015336|NCT01805440|11138384|FG000|STARTED|Overall Study||19
9788235|NCT00542750|10895424|FG000|COMPLETED|Overall Study||24
9788236|NCT00542750|10895424|FG000|NOT COMPLETED|Overall Study||0
9788237|NCT00542789|10895430|FG000|STARTED|Overall Study|Randomised|175
9788238|NCT00542789|10895431|FG001|STARTED|Overall Study|Randomised|168
9788239|NCT00542789|10895430|FG000|COMPLETED|Overall Study||134
9788240|NCT00542789|10895431|FG001|COMPLETED|Overall Study||90
9788241|NCT00542789|10895430|FG000|NOT COMPLETED|Overall Study||41
9788242|NCT00542789|10895431|FG001|NOT COMPLETED|Overall Study||78
10015337|NCT01805440|11138385|FG001|STARTED|Overall Study||17
10015338|NCT01805440|11138386|FG002|STARTED|Overall Study||26
9788243|NCT00542815|10895440|FG000|STARTED|Overall Study||432
9788244|NCT00542815|10895441|FG001|STARTED|Overall Study||76
9788245|NCT00542815|10895442|FG002|STARTED|Overall Study||124
9788246|NCT00542815|10895440|FG000|COMPLETED|Overall Study||326
9788247|NCT00542815|10895441|FG001|COMPLETED|Overall Study||44
9788248|NCT00542815|10895442|FG002|COMPLETED|Overall Study||92
9788249|NCT00542815|10895440|FG000|NOT COMPLETED|Overall Study||106
9788250|NCT00542815|10895441|FG001|NOT COMPLETED|Overall Study||32
9788251|NCT00542815|10895442|FG002|NOT COMPLETED|Overall Study||32
9788252|NCT00542828|10895450|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
9788253|NCT00542828|10895450|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
9788254|NCT00542828|10895450|FG000|NOT COMPLETED|Overall Study||13
9788255|NCT00542880|10895456|FG000|STARTED|Period 1|This was a cross-over study|217
9788256|NCT00542880|10895457|FG001|STARTED|Period 1||225
9788257|NCT00542880|10895456|FG000|COMPLETED|Period 1||211
9788258|NCT00542880|10895457|FG001|COMPLETED|Period 1||213
9788259|NCT00542880|10895456|FG000|NOT COMPLETED|Period 1||6
9788260|NCT00542880|10895457|FG001|NOT COMPLETED|Period 1||12
9788261|NCT00542880|10895456|FG000|STARTED|Period 2||211
9788262|NCT00542880|10895457|FG001|STARTED|Period 2||213
9788263|NCT00542880|10895456|FG000|COMPLETED|Period 2||204
9788264|NCT00542880|10895457|FG001|COMPLETED|Period 2||203
9788265|NCT00542880|10895456|FG000|NOT COMPLETED|Period 2||7
9788266|NCT00542880|10895457|FG001|NOT COMPLETED|Period 2||10
9788267|NCT00542880|10895456|FG000|STARTED|Period 3||204
9788268|NCT00542880|10895457|FG001|STARTED|Period 3||203
9788269|NCT00542880|10895456|FG000|COMPLETED|Period 3||204
9788270|NCT00542880|10895457|FG001|COMPLETED|Period 3||201
9788271|NCT00542880|10895456|FG000|NOT COMPLETED|Period 3||0
9788272|NCT00542880|10895457|FG001|NOT COMPLETED|Period 3||2
9788273|NCT00542919|10895467|FG000|STARTED|Overall Study||23
9788274|NCT00542919|10895468|FG001|STARTED|Overall Study||19
9788275|NCT00542919|10895469|FG002|STARTED|Overall Study||15
9788276|NCT00542919|10895467|FG000|Received At Least One Dose of Study Drug|Overall Study||23
9788277|NCT00542919|10895468|FG001|Received At Least One Dose of Study Drug|Overall Study||19
9788278|NCT00542919|10895469|FG002|Received At Least One Dose of Study Drug|Overall Study||15
9788279|NCT00542919|10895467|FG000|Progressive Disease|Overall Study||15
9788280|NCT00542919|10895468|FG001|Progressive Disease|Overall Study||11
9788281|NCT00542919|10895469|FG002|Progressive Disease|Overall Study||7
9788282|NCT00542919|10895467|FG000|Death|Overall Study||1
9788283|NCT00542919|10895468|FG001|Death|Overall Study||1
9788284|NCT00542919|10895469|FG002|Death|Overall Study||2
9788285|NCT00542919|10895467|FG000|COMPLETED|Overall Study||16
9788286|NCT00542919|10895468|FG001|COMPLETED|Overall Study||12
9788287|NCT00542919|10895469|FG002|COMPLETED|Overall Study||9
9788288|NCT00542919|10895467|FG000|NOT COMPLETED|Overall Study||7
9788289|NCT00542919|10895468|FG001|NOT COMPLETED|Overall Study||7
9788290|NCT00542919|10895469|FG002|NOT COMPLETED|Overall Study||6
9788291|NCT00542971|10895492|FG000|STARTED|Overall Study||75
9788292|NCT00542971|10895492|FG000|COMPLETED|Overall Study||75
9788293|NCT00542971|10895492|FG000|NOT COMPLETED|Overall Study||0
9788294|NCT00542997|10895496|FG000|STARTED|Wash in / Wash Out Period||51
9788295|NCT00542997|10895496|FG000|COMPLETED|Wash in / Wash Out Period||46
9788296|NCT00542997|10895496|FG000|NOT COMPLETED|Wash in / Wash Out Period||5
9788297|NCT00542997|10895496|FG000|STARTED|Efficacy Period||46
9788298|NCT00542997|10895496|FG000|COMPLETED|Efficacy Period||43
9788299|NCT00542997|10895496|FG000|NOT COMPLETED|Efficacy Period||3
9788300|NCT00543062|10895503|FG000|STARTED|Overall Study||12
9788301|NCT00543062|10895504|FG001|STARTED|Overall Study||12
9788302|NCT00543062|10895505|FG002|STARTED|Overall Study||12
9788303|NCT00543062|10895506|FG003|STARTED|Overall Study||12
9788304|NCT00543062|10895503|FG000|COMPLETED|Overall Study||10
9788305|NCT00543062|10895504|FG001|COMPLETED|Overall Study||11
9788306|NCT00543062|10895505|FG002|COMPLETED|Overall Study||9
9788307|NCT00543062|10895506|FG003|COMPLETED|Overall Study||11
9788308|NCT00543062|10895503|FG000|NOT COMPLETED|Overall Study||2
9788309|NCT00543062|10895504|FG001|NOT COMPLETED|Overall Study||1
9788310|NCT00543062|10895505|FG002|NOT COMPLETED|Overall Study||3
9788311|NCT00543062|10895506|FG003|NOT COMPLETED|Overall Study||1
9788312|NCT00543101|10895526|FG000|STARTED|Overall Study||12
9788313|NCT00543101|10895527|FG001|STARTED|Overall Study||12
9788314|NCT00543101|10895526|FG000|COMPLETED|Overall Study||12
9788315|NCT00543101|10895527|FG001|COMPLETED|Overall Study||12
9788316|NCT00543101|10895526|FG000|NOT COMPLETED|Overall Study||0
9788317|NCT00543101|10895527|FG001|NOT COMPLETED|Overall Study||0
9788318|NCT00543127|10895536|FG000|STARTED|Overall Study||433
9788319|NCT00543127|10895537|FG001|STARTED|Overall Study||437
9788320|NCT00543127|10895536|FG000|COMPLETED|Overall Study||303
9788321|NCT00543127|10895537|FG001|COMPLETED|Overall Study||350
9788322|NCT00543127|10895536|FG000|NOT COMPLETED|Overall Study||130
9788323|NCT00543127|10895537|FG001|NOT COMPLETED|Overall Study||87
9788324|NCT00543140|10895543|FG000|STARTED|Overall Study||303
9788325|NCT00543140|10895543|FG000|COMPLETED|Overall Study||231
9788326|NCT00543140|10895543|FG000|NOT COMPLETED|Overall Study||72
9788327|NCT00543296|10895547|FG000|STARTED|Overall Study||21
9788328|NCT00543296|10895547|FG000|COMPLETED|Overall Study||14
9788329|NCT00543296|10895547|FG000|NOT COMPLETED|Overall Study||7
9788330|NCT00543309|10895554|FG000|STARTED|Overall Study||35
9788331|NCT00543309|10895555|FG001|STARTED|Overall Study||36
9788332|NCT00543309|10895556|FG002|STARTED|Overall Study||35
9788333|NCT00543309|10895554|FG000|COMPLETED|Overall Study||35
9788334|NCT00543309|10895555|FG001|COMPLETED|Overall Study||35
9788335|NCT00543309|10895556|FG002|COMPLETED|Overall Study||35
9788336|NCT00543309|10895554|FG000|NOT COMPLETED|Overall Study||0
9788337|NCT00543309|10895555|FG001|NOT COMPLETED|Overall Study||1
9788338|NCT00543309|10895556|FG002|NOT COMPLETED|Overall Study||0
9788339|NCT00543387|10895574|FG000|STARTED|Panel 1 + Panel 2||3
9788340|NCT00543387|10895575|FG001|STARTED|Panel 1 + Panel 2||3
9788341|NCT00543387|10895576|FG002|STARTED|Panel 1 + Panel 2||3
9788342|NCT00543387|10895577|FG003|STARTED|Panel 1 + Panel 2||3
9788343|NCT00543387|10895578|FG004|STARTED|Panel 1 + Panel 2||3
9788344|NCT00543387|10895579|FG005|STARTED|Panel 1 + Panel 2||3
9788345|NCT00543387|10895580|FG006|STARTED|Panel 1 + Panel 2||6
9788346|NCT00543387|10895581|FG007|STARTED|Panel 1 + Panel 2||6
9788347|NCT00543387|10895582|FG008|STARTED|Panel 1 + Panel 2||5
9788348|NCT00543387|10895583|FG009|STARTED|Panel 1 + Panel 2||0
9788349|NCT00543387|10895584|FG010|STARTED|Panel 1 + Panel 2||0
9788350|NCT00543387|10895574|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788351|NCT00543387|10895575|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
9788352|NCT00543387|10895576|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788353|NCT00543387|10895577|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788354|NCT00543387|10895578|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
9788355|NCT00543387|10895579|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
9788356|NCT00543387|10895580|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788357|NCT00543387|10895581|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788358|NCT00543387|10895582|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788359|NCT00543387|10895583|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788360|NCT00543387|10895584|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
9788361|NCT00543387|10895574|FG000|COMPLETED|Panel 1 + Panel 2||0
9788362|NCT00543387|10895575|FG001|COMPLETED|Panel 1 + Panel 2||0
9788363|NCT00543387|10895576|FG002|COMPLETED|Panel 1 + Panel 2||0
9788364|NCT00543387|10895577|FG003|COMPLETED|Panel 1 + Panel 2||0
9788365|NCT00543387|10895578|FG004|COMPLETED|Panel 1 + Panel 2||0
9788366|NCT00543387|10895579|FG005|COMPLETED|Panel 1 + Panel 2||0
9788367|NCT00543387|10895580|FG006|COMPLETED|Panel 1 + Panel 2||0
9788368|NCT00543387|10895581|FG007|COMPLETED|Panel 1 + Panel 2||0
9788369|NCT00543387|10895582|FG008|COMPLETED|Panel 1 + Panel 2||0
9788370|NCT00543387|10895583|FG009|COMPLETED|Panel 1 + Panel 2||0
9788371|NCT00543387|10895584|FG010|COMPLETED|Panel 1 + Panel 2||0
9788372|NCT00543387|10895574|FG000|NOT COMPLETED|Panel 1 + Panel 2||3
9788373|NCT00543387|10895575|FG001|NOT COMPLETED|Panel 1 + Panel 2||3
9788374|NCT00543387|10895576|FG002|NOT COMPLETED|Panel 1 + Panel 2||3
9788375|NCT00543387|10895577|FG003|NOT COMPLETED|Panel 1 + Panel 2||3
9788376|NCT00543387|10895578|FG004|NOT COMPLETED|Panel 1 + Panel 2||3
9788377|NCT00543387|10895579|FG005|NOT COMPLETED|Panel 1 + Panel 2||3
9788378|NCT00543387|10895580|FG006|NOT COMPLETED|Panel 1 + Panel 2||6
9788379|NCT00543387|10895581|FG007|NOT COMPLETED|Panel 1 + Panel 2||6
9788380|NCT00543387|10895582|FG008|NOT COMPLETED|Panel 1 + Panel 2||5
9788381|NCT00543387|10895583|FG009|NOT COMPLETED|Panel 1 + Panel 2||0
9788382|NCT00543387|10895584|FG010|NOT COMPLETED|Panel 1 + Panel 2||0
9788383|NCT00543387|10895574|FG000|STARTED|Crossover Participants||0
9788384|NCT00543387|10895575|FG001|STARTED|Crossover Participants||0
9788385|NCT00543387|10895576|FG002|STARTED|Crossover Participants||0
9788386|NCT00543387|10895577|FG003|STARTED|Crossover Participants||0
9788387|NCT00543387|10895578|FG004|STARTED|Crossover Participants||0
9788388|NCT00543387|10895579|FG005|STARTED|Crossover Participants||0
9788389|NCT00543387|10895580|FG006|STARTED|Crossover Participants||0
9788390|NCT00543387|10895581|FG007|STARTED|Crossover Participants||0
10015339|NCT01805440|11138384|FG000|COMPLETED|Overall Study||18
10015340|NCT01805440|11138385|FG001|COMPLETED|Overall Study||17
10015341|NCT01805440|11138386|FG002|COMPLETED|Overall Study||26
9788391|NCT00543387|10895582|FG008|STARTED|Crossover Participants||0
10015342|NCT01805440|11138384|FG000|NOT COMPLETED|Overall Study||1
10015343|NCT01805440|11138385|FG001|NOT COMPLETED|Overall Study||0
10015344|NCT01805440|11138386|FG002|NOT COMPLETED|Overall Study||0
10015345|NCT01805687|11138393|FG000|STARTED|Overall Study||25
10015346|NCT01805687|11138393|FG000|COMPLETED|Overall Study||25
10015347|NCT01805687|11138393|FG000|NOT COMPLETED|Overall Study||0
10015348|NCT01805791|11138400|FG000|STARTED|Overall Study||66
10015349|NCT01805791|11138401|FG001|STARTED|Overall Study||67
10015350|NCT01805791|11138402|FG002|STARTED|Overall Study||68
10015351|NCT01805791|11138400|FG000|COMPLETED|Overall Study||44
10015352|NCT01805791|11138401|FG001|COMPLETED|Overall Study||50
9788392|NCT00543387|10895583|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
9788393|NCT00543387|10895584|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
9788394|NCT00543387|10895574|FG000|COMPLETED|Crossover Participants||0
9788395|NCT00543387|10895575|FG001|COMPLETED|Crossover Participants||0
9788396|NCT00543387|10895576|FG002|COMPLETED|Crossover Participants||0
9788397|NCT00543387|10895577|FG003|COMPLETED|Crossover Participants||0
9788398|NCT00543387|10895578|FG004|COMPLETED|Crossover Participants||0
9788399|NCT00543387|10895579|FG005|COMPLETED|Crossover Participants||0
9788400|NCT00543387|10895580|FG006|COMPLETED|Crossover Participants||0
9788401|NCT00543387|10895581|FG007|COMPLETED|Crossover Participants||0
9788402|NCT00543387|10895582|FG008|COMPLETED|Crossover Participants||0
9788403|NCT00543387|10895583|FG009|COMPLETED|Crossover Participants||0
9788404|NCT00543387|10895584|FG010|COMPLETED|Crossover Participants||0
10015353|NCT01805791|11138402|FG002|COMPLETED|Overall Study||48
10015354|NCT01805791|11138400|FG000|NOT COMPLETED|Overall Study||22
10015355|NCT01805791|11138401|FG001|NOT COMPLETED|Overall Study||17
10015356|NCT01805791|11138402|FG002|NOT COMPLETED|Overall Study||20
10015357|NCT01805882|11138419|FG000|STARTED|Overall Study||20
10015358|NCT01805882|11138420|FG001|STARTED|Overall Study||20
10015359|NCT01805882|11138421|FG002|STARTED|Overall Study||20
9788405|NCT00543387|10895574|FG000|NOT COMPLETED|Crossover Participants||0
9788406|NCT00543387|10895575|FG001|NOT COMPLETED|Crossover Participants||0
9788407|NCT00543387|10895576|FG002|NOT COMPLETED|Crossover Participants||0
9788408|NCT00543387|10895577|FG003|NOT COMPLETED|Crossover Participants||0
9788409|NCT00543387|10895578|FG004|NOT COMPLETED|Crossover Participants||0
9788410|NCT00543387|10895579|FG005|NOT COMPLETED|Crossover Participants||0
9788411|NCT00543387|10895580|FG006|NOT COMPLETED|Crossover Participants||0
9788412|NCT00543387|10895581|FG007|NOT COMPLETED|Crossover Participants||0
9788413|NCT00543387|10895582|FG008|NOT COMPLETED|Crossover Participants||0
9788414|NCT00543387|10895583|FG009|NOT COMPLETED|Crossover Participants||1
9788415|NCT00543387|10895584|FG010|NOT COMPLETED|Crossover Participants||3
9788416|NCT00543400|10895612|FG000|STARTED|Overall Study||151
9788417|NCT00543400|10895613|FG001|STARTED|Overall Study||44
9788418|NCT00543400|10895614|FG002|STARTED|Overall Study||152
9788419|NCT00543400|10895615|FG003|STARTED|Overall Study||156
9788420|NCT00543400|10895612|FG000|COMPLETED|Overall Study||146
9788421|NCT00543400|10895613|FG001|COMPLETED|Overall Study||43
9788422|NCT00543400|10895614|FG002|COMPLETED|Overall Study||148
9788423|NCT00543400|10895615|FG003|COMPLETED|Overall Study||151
9788424|NCT00543400|10895612|FG000|NOT COMPLETED|Overall Study||5
9788425|NCT00543400|10895613|FG001|NOT COMPLETED|Overall Study||1
9788426|NCT00543400|10895614|FG002|NOT COMPLETED|Overall Study||4
9788427|NCT00543400|10895615|FG003|NOT COMPLETED|Overall Study||5
9788428|NCT00543439|10895628|FG000|STARTED|Period 1||10
9788429|NCT00543439|10895629|FG001|STARTED|Period 1||29
9788430|NCT00543439|10895630|FG002|STARTED|Period 1||27
9788431|NCT00543439|10895628|FG000|Treated|Period 1||9
9788432|NCT00543439|10895629|FG001|Treated|Period 1||29
9788433|NCT00543439|10895630|FG002|Treated|Period 1||27
9788434|NCT00543439|10895628|FG000|COMPLETED|Period 1||9
9788435|NCT00543439|10895629|FG001|COMPLETED|Period 1||26
9788436|NCT00543439|10895630|FG002|COMPLETED|Period 1||25
9788437|NCT00543439|10895628|FG000|NOT COMPLETED|Period 1||1
9788438|NCT00543439|10895629|FG001|NOT COMPLETED|Period 1||3
9788439|NCT00543439|10895630|FG002|NOT COMPLETED|Period 1||2
9788440|NCT00543439|10895628|FG000|STARTED|Period 2||9
9788441|NCT00543439|10895629|FG001|STARTED|Period 2||26
9788442|NCT00543439|10895630|FG002|STARTED|Period 2||25
9788443|NCT00543439|10895628|FG000|COMPLETED|Period 2||8
9788444|NCT00543439|10895629|FG001|COMPLETED|Period 2||25
9788445|NCT00543439|10895630|FG002|COMPLETED|Period 2||23
9788446|NCT00543439|10895628|FG000|NOT COMPLETED|Period 2||1
9788447|NCT00543439|10895629|FG001|NOT COMPLETED|Period 2||1
9788448|NCT00543439|10895630|FG002|NOT COMPLETED|Period 2||2
9788449|NCT00543543|10895651|FG000|STARTED|Base Study||315
9788450|NCT00543543|10895652|FG001|STARTED|Base Study||7106
9788451|NCT00543543|10895653|FG002|STARTED|Base Study||310
9788452|NCT00543543|10895654|FG003|STARTED|Base Study||7109
9788453|NCT00543543|10895651|FG000|Completed 3 Vaccinations|Base Study||300
9788454|NCT00543543|10895652|FG001|Completed 3 Vaccinations|Base Study||6928
9788455|NCT00543543|10895653|FG002|Completed 3 Vaccinations|Base Study||297
9788456|NCT00543543|10895654|FG003|Completed 3 Vaccinations|Base Study||6934
9788457|NCT00543543|10895651|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295
9788458|NCT00543543|10895652|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854
9788459|NCT00543543|10895653|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296
9788460|NCT00543543|10895654|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887
9788461|NCT00543543|10895651|FG000|NOT COMPLETED|Base Study||20
9788462|NCT00543543|10895652|FG001|NOT COMPLETED|Base Study||1252
9788463|NCT00543543|10895653|FG002|NOT COMPLETED|Base Study||14
9788464|NCT00543543|10895654|FG003|NOT COMPLETED|Base Study||1222
9788465|NCT00543543|10895651|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0
9788466|NCT00543543|10895652|FG001|STARTED|Extension Study|Cohort 1|150
9788467|NCT00543543|10895653|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0
9788468|NCT00543543|10895654|FG003|STARTED|Extension Study|Cohort 2|3050
9788469|NCT00543543|10895651|FG000|COMPLETED|Extension Study||0
9788470|NCT00543543|10895652|FG001|COMPLETED|Extension Study||150
9788471|NCT00543543|10895653|FG002|COMPLETED|Extension Study||0
9788472|NCT00543543|10895654|FG003|COMPLETED|Extension Study||2824
9788473|NCT00543543|10895651|FG000|NOT COMPLETED|Extension Study||0
9788474|NCT00543543|10895652|FG001|NOT COMPLETED|Extension Study||0
9788475|NCT00543543|10895653|FG002|NOT COMPLETED|Extension Study||0
9788476|NCT00543543|10895654|FG003|NOT COMPLETED|Extension Study||226
9788477|NCT00543569|10895673|FG000|STARTED|Overall Study||82
9788478|NCT00543569|10895674|FG001|STARTED|Overall Study||80
9788479|NCT00543569|10895675|FG002|STARTED|Overall Study||80
9788480|NCT00543569|10895676|FG003|STARTED|Overall Study||81
9788481|NCT00543569|10895673|FG000|Received Treatment|Overall Study||79
9788482|NCT00543569|10895674|FG001|Received Treatment|Overall Study||77
9788483|NCT00543569|10895675|FG002|Received Treatment|Overall Study||75
9788484|NCT00543569|10895676|FG003|Received Treatment|Overall Study||78
10015360|NCT01805882|11138422|FG003|STARTED|Overall Study||34
9788485|NCT00543569|10895673|FG000|COMPLETED|Overall Study||70
10015361|NCT01805882|11138423|FG004|STARTED|Overall Study||14
9788486|NCT00543569|10895674|FG001|COMPLETED|Overall Study||72
9788487|NCT00543569|10895675|FG002|COMPLETED|Overall Study||60
9788488|NCT00543569|10895676|FG003|COMPLETED|Overall Study||72
9788489|NCT00543569|10895673|FG000|NOT COMPLETED|Overall Study||12
9788490|NCT00543569|10895674|FG001|NOT COMPLETED|Overall Study||8
9788491|NCT00543569|10895675|FG002|NOT COMPLETED|Overall Study||20
9788492|NCT00543569|10895676|FG003|NOT COMPLETED|Overall Study||9
9788493|NCT00543725|10895688|FG000|STARTED|Overall Study||340
9788494|NCT00543725|10895689|FG001|STARTED|Overall Study||338
9788495|NCT00543725|10895688|FG000|COMPLETED|Overall Study||272
9788496|NCT00543725|10895689|FG001|COMPLETED|Overall Study||264
9788497|NCT00543725|10895688|FG000|NOT COMPLETED|Overall Study||68
9788498|NCT00543725|10895689|FG001|NOT COMPLETED|Overall Study||74
9788499|NCT00543764|10895697|FG000|STARTED|Overall Study||100
9788500|NCT00543764|10895698|FG001|STARTED|Overall Study||50
9788501|NCT00543764|10895697|FG000|COMPLETED|Overall Study||100
9788502|NCT00543764|10895698|FG001|COMPLETED|Overall Study||50
9788503|NCT00543764|10895697|FG000|NOT COMPLETED|Overall Study||0
9788504|NCT00543764|10895698|FG001|NOT COMPLETED|Overall Study||0
9788505|NCT00543777|10895704|FG000|STARTED|Overall Study||44
9788506|NCT00543777|10895704|FG000|COMPLETED|Overall Study||44
9788507|NCT00543777|10895704|FG000|NOT COMPLETED|Overall Study||0
9788508|NCT00543803|10895708|FG000|STARTED|Overall Study||334
9788509|NCT00543803|10895708|FG000|COMPLETED|Overall Study||192
9788510|NCT00543803|10895708|FG000|NOT COMPLETED|Overall Study||142
9788511|NCT00543855|10895718|FG000|STARTED|Overall Study||35
9788512|NCT00543855|10895719|FG001|STARTED|Overall Study||33
9788513|NCT00543855|10895720|FG002|STARTED|Overall Study||37
9788514|NCT00543855|10895721|FG003|STARTED|Overall Study||34
9788515|NCT00543855|10895718|FG000|COMPLETED|Overall Study||31
9788516|NCT00543855|10895719|FG001|COMPLETED|Overall Study||31
9788517|NCT00543855|10895720|FG002|COMPLETED|Overall Study||31
9788518|NCT00543855|10895721|FG003|COMPLETED|Overall Study||30
9788519|NCT00543855|10895718|FG000|NOT COMPLETED|Overall Study||4
9788520|NCT00543855|10895719|FG001|NOT COMPLETED|Overall Study||2
9788521|NCT00543855|10895720|FG002|NOT COMPLETED|Overall Study||6
9788522|NCT00543855|10895721|FG003|NOT COMPLETED|Overall Study||4
9788523|NCT00543985|10895731|FG000|STARTED|Overall Study||36
9788524|NCT00543985|10895731|FG000|COMPLETED|Overall Study||32
9788525|NCT00543985|10895731|FG000|NOT COMPLETED|Overall Study||4
9788526|NCT00544076|10895741|FG000|STARTED|Overall Study||34
9788527|NCT00544076|10895742|FG001|STARTED|Overall Study||35
9788528|NCT00544076|10895743|FG002|STARTED|Overall Study||31
9788529|NCT00544076|10895741|FG000|COMPLETED|Overall Study||17
9788530|NCT00544076|10895742|FG001|COMPLETED|Overall Study||19
9788531|NCT00544076|10895743|FG002|COMPLETED|Overall Study||20
9788532|NCT00544076|10895741|FG000|NOT COMPLETED|Overall Study||17
9788533|NCT00544076|10895742|FG001|NOT COMPLETED|Overall Study||16
9788534|NCT00544076|10895743|FG002|NOT COMPLETED|Overall Study||11
9788535|NCT00544167|10895752|FG000|STARTED|Overall Study||45
9788536|NCT00544167|10895752|FG000|COMPLETED|Overall Study||16
9788537|NCT00544167|10895752|FG000|NOT COMPLETED|Overall Study||29
9788538|NCT00544440|10895756|FG000|STARTED|Overall Study||57
9788539|NCT00544440|10895756|FG000|COMPLETED|Overall Study||0
9788540|NCT00544440|10895756|FG000|NOT COMPLETED|Overall Study||57
9788541|NCT00544544|10895760|FG000|STARTED|Overall Study||14
9788542|NCT00544544|10895760|FG000|COMPLETED|Overall Study||11
9788543|NCT00544544|10895760|FG000|NOT COMPLETED|Overall Study||3
9788544|NCT00544557|10895764|FG000|STARTED|Overall Study||1685
9788545|NCT00544557|10895764|FG000|COMPLETED|Overall Study||1251
9788546|NCT00544557|10895764|FG000|NOT COMPLETED|Overall Study||434
9788547|NCT00544648|10895770|FG000|STARTED|Overall Study||11
9788548|NCT00544648|10895771|FG001|STARTED|Overall Study||2
9788549|NCT00544648|10895770|FG000|COMPLETED|Overall Study||8
9788550|NCT00544648|10895771|FG001|COMPLETED|Overall Study||1
9788551|NCT00544648|10895770|FG000|NOT COMPLETED|Overall Study||3
9788552|NCT00544648|10895771|FG001|NOT COMPLETED|Overall Study||1
9788553|NCT00544674|10895779|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
9788554|NCT00544674|10895779|FG000|COMPLETED|Overall Study||4
9788555|NCT00544674|10895779|FG000|NOT COMPLETED|Overall Study||1
9788556|NCT00544713|10895785|FG000|STARTED|Overall Study||114
9788557|NCT00544713|10895786|FG001|STARTED|Overall Study||114
9788558|NCT00544713|10895785|FG000|COMPLETED|Overall Study||111
9788559|NCT00544713|10895786|FG001|COMPLETED|Overall Study||109
9788560|NCT00544713|10895785|FG000|NOT COMPLETED|Overall Study||3
9788561|NCT00544713|10895786|FG001|NOT COMPLETED|Overall Study||5
9788562|NCT00544778|10895792|FG000|STARTED|Overall Study||7
9788563|NCT00544778|10895792|FG000|COMPLETED|Overall Study||7
9788564|NCT00544778|10895792|FG000|NOT COMPLETED|Overall Study||0
9788565|NCT00544817|10895796|FG000|STARTED|Combined Modality||47
9788566|NCT00544817|10895796|FG000|COMPLETED|Combined Modality||40
9788567|NCT00544817|10895796|FG000|NOT COMPLETED|Combined Modality||7
9788568|NCT00544817|10895796|FG000|STARTED|No Treatment Interval||40
9788569|NCT00544817|10895796|FG000|COMPLETED|No Treatment Interval||28
9788570|NCT00544817|10895796|FG000|NOT COMPLETED|No Treatment Interval||12
9788571|NCT00544817|10895796|FG000|STARTED|Follow-up Systemic Therapy||28
9788572|NCT00544817|10895796|FG000|COMPLETED|Follow-up Systemic Therapy||9
9788573|NCT00544817|10895796|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19
9788574|NCT00544869|10895803|FG000|STARTED|Overall Study||36
9788575|NCT00544869|10895804|FG001|STARTED|Overall Study||14
9788576|NCT00544869|10895805|FG002|STARTED|Overall Study||2
9788577|NCT00544869|10895803|FG000|COMPLETED|Overall Study||24
9788578|NCT00544869|10895804|FG001|COMPLETED|Overall Study||12
9788579|NCT00544869|10895805|FG002|COMPLETED|Overall Study||2
9788580|NCT00544869|10895803|FG000|NOT COMPLETED|Overall Study||12
9788581|NCT00544869|10895804|FG001|NOT COMPLETED|Overall Study||2
9788582|NCT00544869|10895805|FG002|NOT COMPLETED|Overall Study||0
9788583|NCT00544882|10895815|FG000|STARTED|Cycle 1: Run-in Cycle||61
9788584|NCT00544882|10895816|FG001|STARTED|Cycle 1: Run-in Cycle||0
9788585|NCT00544882|10895817|FG002|STARTED|Cycle 1: Run-in Cycle||0
9788586|NCT00544882|10895815|FG000|COMPLETED|Cycle 1: Run-in Cycle||58
9788587|NCT00544882|10895816|FG001|COMPLETED|Cycle 1: Run-in Cycle||0
9788588|NCT00544882|10895817|FG002|COMPLETED|Cycle 1: Run-in Cycle||0
9788589|NCT00544882|10895815|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3
9788590|NCT00544882|10895816|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0
9788591|NCT00544882|10895817|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0
9788592|NCT00544882|10895815|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0
9788593|NCT00544882|10895816|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29
9788594|NCT00544882|10895817|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29
9788595|NCT00544882|10895815|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0
9788596|NCT00544882|10895816|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
9788597|NCT00544882|10895817|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
9788598|NCT00544882|10895815|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
9788599|NCT00544882|10895816|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
9788600|NCT00544882|10895817|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
9788601|NCT00544882|10895815|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
9788602|NCT00544882|10895816|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
9788603|NCT00544882|10895817|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
9788604|NCT00544882|10895815|FG000|STARTED|Cycle 3: Follow-up||0
9788605|NCT00544882|10895816|FG001|STARTED|Cycle 3: Follow-up||28
9788606|NCT00544882|10895817|FG002|STARTED|Cycle 3: Follow-up||28
9788607|NCT00544882|10895815|FG000|COMPLETED|Cycle 3: Follow-up||0
9788608|NCT00544882|10895816|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
9788609|NCT00544882|10895817|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
9788610|NCT00544882|10895815|FG000|NOT COMPLETED|Cycle 3: Follow-up||0
9788611|NCT00544882|10895816|FG001|NOT COMPLETED|Cycle 3: Follow-up||2
9788612|NCT00544882|10895817|FG002|NOT COMPLETED|Cycle 3: Follow-up||0
9788613|NCT00544908|10895823|FG000|STARTED|Overall Study||7
9788614|NCT00544908|10895823|FG000|COMPLETED|Overall Study||7
9788615|NCT00544908|10895823|FG000|NOT COMPLETED|Overall Study||0
9788616|NCT00545025|10895829|FG000|STARTED|Overall Study||160
9788617|NCT00545025|10895830|FG001|STARTED|Overall Study||83
9788618|NCT00545025|10895829|FG000|COMPLETED|Overall Study||160
9788619|NCT00545025|10895830|FG001|COMPLETED|Overall Study||83
9788620|NCT00545025|10895829|FG000|NOT COMPLETED|Overall Study||0
9788621|NCT00545025|10895830|FG001|NOT COMPLETED|Overall Study||0
9788622|NCT00545051|10895838|FG000|STARTED|Overall Study||68
9788623|NCT00545051|10895839|FG001|STARTED|Overall Study||72
9788624|NCT00545051|10895838|FG000|COMPLETED|Overall Study||59
9788625|NCT00545051|10895839|FG001|COMPLETED|Overall Study||65
9788626|NCT00545051|10895838|FG000|NOT COMPLETED|Overall Study||9
9788627|NCT00545051|10895839|FG001|NOT COMPLETED|Overall Study||7
9788628|NCT00545064|10895845|FG000|STARTED|Overall Study||178
9788629|NCT00545064|10895845|FG000|Visit 1 (Baseline)|Overall Study||178
9788630|NCT00545064|10895845|FG000|Visit 2 (Week 4)|Overall Study||169
9788631|NCT00545064|10895845|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
9788632|NCT00545064|10895845|FG000|COMPLETED|Overall Study||170
9788633|NCT00545064|10895845|FG000|NOT COMPLETED|Overall Study||8
9788634|NCT00545077|10895853|FG000|STARTED|Overall Study||189
9788635|NCT00545077|10895854|FG001|STARTED|Overall Study||191
9788636|NCT00545077|10895853|FG000|COMPLETED|Overall Study||41
9788637|NCT00545077|10895854|FG001|COMPLETED|Overall Study||36
10015362|NCT01805882|11138424|FG005|STARTED|Overall Study||21
10015363|NCT01805882|11138425|FG006|STARTED|Overall Study||50
10015364|NCT01805882|11138426|FG007|STARTED|Overall Study||25
10015365|NCT01805882|11138427|FG008|STARTED|Overall Study||25
10015366|NCT01805882|11138419|FG000|COMPLETED|Overall Study||20
10015367|NCT01805882|11138420|FG001|COMPLETED|Overall Study||20
10015368|NCT01805882|11138421|FG002|COMPLETED|Overall Study||19
9788638|NCT00545077|10895853|FG000|NOT COMPLETED|Overall Study||148
9788639|NCT00545077|10895854|FG001|NOT COMPLETED|Overall Study||155
9788640|NCT00545103|10895864|FG000|STARTED|Overall Study||148
9788641|NCT00545103|10895865|FG001|STARTED|Overall Study||148
9788642|NCT00545103|10895866|FG002|STARTED|Overall Study||150
9788643|NCT00545103|10895867|FG003|STARTED|Overall Study||146
9788644|NCT00545103|10895864|FG000|COMPLETED|Overall Study||73
9788645|NCT00545103|10895865|FG001|COMPLETED|Overall Study||70
9788646|NCT00545103|10895866|FG002|COMPLETED|Overall Study||74
9788647|NCT00545103|10895867|FG003|COMPLETED|Overall Study||76
9788648|NCT00545103|10895864|FG000|NOT COMPLETED|Overall Study||75
9788649|NCT00545103|10895865|FG001|NOT COMPLETED|Overall Study||78
9788650|NCT00545103|10895866|FG002|NOT COMPLETED|Overall Study||76
9788651|NCT00545103|10895867|FG003|NOT COMPLETED|Overall Study||70
9788652|NCT00545155|10895877|FG000|STARTED|Overall Study||187
9788653|NCT00545155|10895877|FG000|COMPLETED|Overall Study||187
10015369|NCT01805882|11138422|FG003|COMPLETED|Overall Study||32
10015370|NCT01805882|11138423|FG004|COMPLETED|Overall Study||14
10015371|NCT01805882|11138424|FG005|COMPLETED|Overall Study||20
9788654|NCT00545155|10895877|FG000|NOT COMPLETED|Overall Study||0
9788655|NCT00545168|10895884|FG000|STARTED|Overall Study||203
9788656|NCT00545168|10895885|FG001|STARTED|Overall Study||63
9788657|NCT00545168|10895886|FG002|STARTED|Overall Study||214
9788658|NCT00545168|10895884|FG000|COMPLETED|Overall Study||187
9788659|NCT00545168|10895885|FG001|COMPLETED|Overall Study||58
9788660|NCT00545168|10895886|FG002|COMPLETED|Overall Study||193
9788661|NCT00545168|10895884|FG000|NOT COMPLETED|Overall Study||16
9788662|NCT00545168|10895885|FG001|NOT COMPLETED|Overall Study||5
9788663|NCT00545168|10895886|FG002|NOT COMPLETED|Overall Study||21
9788664|NCT00545181|10895897|FG000|STARTED|Overall Study||29
9788665|NCT00545181|10895898|FG001|STARTED|Overall Study||25
9788666|NCT00545181|10895897|FG000|COMPLETED|Overall Study||29
9788667|NCT00545181|10895898|FG001|COMPLETED|Overall Study||25
9788668|NCT00545181|10895897|FG000|NOT COMPLETED|Overall Study||0
9788669|NCT00545181|10895898|FG001|NOT COMPLETED|Overall Study||0
9788670|NCT00545233|10895906|FG000|STARTED|Overall Study||79
9788671|NCT00545233|10895907|FG001|STARTED|Overall Study||76
9788672|NCT00545233|10895906|FG000|Safety Set|Overall Study||77
9788673|NCT00545233|10895907|FG001|Safety Set|Overall Study||75
9788674|NCT00545233|10895906|FG000|Intent-to-Treat (ITT)|Overall Study||77
9788675|NCT00545233|10895907|FG001|Intent-to-Treat (ITT)|Overall Study||73
9788676|NCT00545233|10895906|FG000|COMPLETED|Overall Study||33
9788677|NCT00545233|10895907|FG001|COMPLETED|Overall Study||41
9788678|NCT00545233|10895906|FG000|NOT COMPLETED|Overall Study||46
9788679|NCT00545233|10895907|FG001|NOT COMPLETED|Overall Study||35
9788680|NCT00545272|10895920|FG000|STARTED|Overall Study||61
9788681|NCT00545272|10895921|FG001|STARTED|Overall Study||68
9788682|NCT00545272|10895922|FG002|STARTED|Overall Study||65
9788683|NCT00545272|10895923|FG003|STARTED|Overall Study||72
9788684|NCT00545272|10895924|FG004|STARTED|Overall Study||64
9788685|NCT00545272|10895925|FG005|STARTED|Overall Study||62
9788686|NCT00545272|10895920|FG000|COMPLETED|Overall Study||61
9788687|NCT00545272|10895921|FG001|COMPLETED|Overall Study||67
9788688|NCT00545272|10895922|FG002|COMPLETED|Overall Study||64
9788689|NCT00545272|10895923|FG003|COMPLETED|Overall Study||71
9788690|NCT00545272|10895924|FG004|COMPLETED|Overall Study||62
9788691|NCT00545272|10895925|FG005|COMPLETED|Overall Study||59
9788692|NCT00545272|10895920|FG000|NOT COMPLETED|Overall Study||0
9788693|NCT00545272|10895921|FG001|NOT COMPLETED|Overall Study||1
9788694|NCT00545272|10895922|FG002|NOT COMPLETED|Overall Study||1
9788695|NCT00545272|10895923|FG003|NOT COMPLETED|Overall Study||1
9788696|NCT00545272|10895924|FG004|NOT COMPLETED|Overall Study||2
9788697|NCT00545272|10895925|FG005|NOT COMPLETED|Overall Study||3
9788698|NCT00545298|10895942|FG000|STARTED|Overall Study||2
9788699|NCT00545298|10895943|FG001|STARTED|Overall Study||1
9788700|NCT00545298|10895944|FG002|STARTED|Overall Study||1
9788701|NCT00545298|10895942|FG000|COMPLETED|Overall Study||0
9788702|NCT00545298|10895943|FG001|COMPLETED|Overall Study||1
9788703|NCT00545298|10895944|FG002|COMPLETED|Overall Study||0
9788704|NCT00545298|10895942|FG000|NOT COMPLETED|Overall Study||2
9788705|NCT00545298|10895943|FG001|NOT COMPLETED|Overall Study||0
9788706|NCT00545298|10895944|FG002|NOT COMPLETED|Overall Study||1
9788707|NCT00545363|10895957|FG000|STARTED|Overall Study||358
9788708|NCT00545363|10895958|FG001|STARTED|Overall Study||358
9788709|NCT00545363|10895957|FG000|Treated|Overall Study||354
9788710|NCT00545363|10895958|FG001|Treated|Overall Study||357
9788711|NCT00545363|10895957|FG000|COMPLETED|Overall Study||339
9788712|NCT00545363|10895958|FG001|COMPLETED|Overall Study||343
9788713|NCT00545363|10895957|FG000|NOT COMPLETED|Overall Study||19
9788714|NCT00545363|10895958|FG001|NOT COMPLETED|Overall Study||15
9788715|NCT00545402|10895966|FG000|STARTED|Overall Study||90
9788716|NCT00545402|10895967|FG001|STARTED|Overall Study||90
9788717|NCT00545402|10895966|FG000|COMPLETED|Overall Study||56
9788718|NCT00545402|10895967|FG001|COMPLETED|Overall Study||61
9788719|NCT00545402|10895966|FG000|NOT COMPLETED|Overall Study||34
9788720|NCT00545402|10895967|FG001|NOT COMPLETED|Overall Study||29
9788721|NCT00545441|10895975|FG000|STARTED|Overall Study||44
9788722|NCT00545441|10895976|FG001|STARTED|Overall Study||42
9788723|NCT00545441|10895975|FG000|COMPLETED|Overall Study||26
9788724|NCT00545441|10895976|FG001|COMPLETED|Overall Study||26
9788725|NCT00545441|10895975|FG000|NOT COMPLETED|Overall Study||18
9788726|NCT00545441|10895976|FG001|NOT COMPLETED|Overall Study||16
9788727|NCT00545532|10895984|FG000|STARTED|Overall Study||105
9788728|NCT00545532|10895985|FG001|STARTED|Overall Study||110
9788729|NCT00545532|10895984|FG000|COMPLETED|Overall Study||99
9788730|NCT00545532|10895985|FG001|COMPLETED|Overall Study||100
9788731|NCT00545532|10895984|FG000|NOT COMPLETED|Overall Study||6
9788732|NCT00545532|10895985|FG001|NOT COMPLETED|Overall Study||10
9788733|NCT00545571|10895993|FG000|STARTED|Overall Study||120
9788734|NCT00545571|10895993|FG000|COMPLETED|Overall Study||53
9788735|NCT00545571|10895993|FG000|NOT COMPLETED|Overall Study||67
9788736|NCT00545584|10896000|FG000|STARTED|Overall Study||412
9788737|NCT00545584|10896001|FG001|STARTED|Overall Study||414
9788738|NCT00545584|10896002|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
9788739|NCT00545584|10896000|FG000|COMPLETED|Overall Study||333
9788740|NCT00545584|10896001|FG001|COMPLETED|Overall Study||334
9788741|NCT00545584|10896002|FG002|COMPLETED|Overall Study||250
9788742|NCT00545584|10896000|FG000|NOT COMPLETED|Overall Study||79
9788743|NCT00545584|10896001|FG001|NOT COMPLETED|Overall Study||80
9788744|NCT00545584|10896002|FG002|NOT COMPLETED|Overall Study||56
9788745|NCT00545623|10896014|FG000|STARTED|Overall Study||32
9788746|NCT00545623|10896015|FG001|STARTED|Overall Study||31
9788747|NCT00545623|10896016|FG002|STARTED|Overall Study||33
9788748|NCT00545623|10896017|FG003|STARTED|Overall Study||34
9788749|NCT00545623|10896014|FG000|COMPLETED|Overall Study||25
9788750|NCT00545623|10896015|FG001|COMPLETED|Overall Study||21
9788751|NCT00545623|10896016|FG002|COMPLETED|Overall Study||20
9788752|NCT00545623|10896017|FG003|COMPLETED|Overall Study||23
9788753|NCT00545623|10896014|FG000|NOT COMPLETED|Overall Study||7
9788754|NCT00545623|10896015|FG001|NOT COMPLETED|Overall Study||10
9788755|NCT00545623|10896016|FG002|NOT COMPLETED|Overall Study||13
9788756|NCT00545623|10896017|FG003|NOT COMPLETED|Overall Study||11
9788757|NCT00545662|10896029|FG000|STARTED|Overall Study||606
9788758|NCT00545662|10896030|FG001|STARTED|Overall Study||607
10015372|NCT01805882|11138425|FG006|COMPLETED|Overall Study||48
10015373|NCT01805882|11138426|FG007|COMPLETED|Overall Study||25
10015374|NCT01805882|11138427|FG008|COMPLETED|Overall Study||24
10015375|NCT01805882|11138419|FG000|NOT COMPLETED|Overall Study||0
10015376|NCT01805882|11138420|FG001|NOT COMPLETED|Overall Study||0
10015377|NCT01805882|11138421|FG002|NOT COMPLETED|Overall Study||1
10015378|NCT01805882|11138422|FG003|NOT COMPLETED|Overall Study||2
10015379|NCT01805882|11138423|FG004|NOT COMPLETED|Overall Study||0
10015380|NCT01805882|11138424|FG005|NOT COMPLETED|Overall Study||1
10015381|NCT01805882|11138425|FG006|NOT COMPLETED|Overall Study||2
10015382|NCT01805882|11138426|FG007|NOT COMPLETED|Overall Study||0
10015383|NCT01805882|11138427|FG008|NOT COMPLETED|Overall Study||1
10015384|NCT01805895|11138449|FG000|STARTED|Overall Study||8
10015385|NCT01805895|11138450|FG001|STARTED|Overall Study||8
10015386|NCT01805895|11138449|FG000|COMPLETED|Overall Study||8
10234170|NCT01546207|11364105|FG000|NOT COMPLETED|Overall Study||1
10234171|NCT01553240|11364109|FG000|STARTED|Overall Study||0
10234172|NCT01553240|11364109|FG000|COMPLETED|Overall Study||0
9788759|NCT00545662|10896029|FG000|COMPLETED|Overall Study||521
9788760|NCT00545662|10896030|FG001|COMPLETED|Overall Study||528
9788761|NCT00545662|10896029|FG000|NOT COMPLETED|Overall Study||85
9788762|NCT00545662|10896030|FG001|NOT COMPLETED|Overall Study||79
9788763|NCT00545688|10896040|FG000|STARTED|Neo-Adjuvant Treatment Period||107
9788764|NCT00545688|10896041|FG001|STARTED|Neo-Adjuvant Treatment Period||107
9788765|NCT00545688|10896042|FG002|STARTED|Neo-Adjuvant Treatment Period||108
9788766|NCT00545688|10896043|FG003|STARTED|Neo-Adjuvant Treatment Period||94
9788767|NCT00545688|10896040|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103
9788768|NCT00545688|10896041|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102
9788769|NCT00545688|10896042|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94
9788770|NCT00545688|10896043|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88
9788771|NCT00545688|10896040|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
9788772|NCT00545688|10896041|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
9788773|NCT00545688|10896042|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
9788774|NCT00545688|10896043|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
9788775|NCT00545688|10896040|FG000|STARTED|Adjuvant Treatment Period||103
9788776|NCT00545688|10896041|FG001|STARTED|Adjuvant Treatment Period||102
9788777|NCT00545688|10896042|FG002|STARTED|Adjuvant Treatment Period||94
9788778|NCT00545688|10896043|FG003|STARTED|Adjuvant Treatment Period||88
9788779|NCT00545688|10896040|FG000|COMPLETED|Adjuvant Treatment Period||98
9788780|NCT00545688|10896041|FG001|COMPLETED|Adjuvant Treatment Period||94
9788781|NCT00545688|10896042|FG002|COMPLETED|Adjuvant Treatment Period||90
9788782|NCT00545688|10896043|FG003|COMPLETED|Adjuvant Treatment Period||74
9788783|NCT00545688|10896040|FG000|NOT COMPLETED|Adjuvant Treatment Period||5
9788784|NCT00545688|10896041|FG001|NOT COMPLETED|Adjuvant Treatment Period||8
9788785|NCT00545688|10896042|FG002|NOT COMPLETED|Adjuvant Treatment Period||4
9788786|NCT00545688|10896043|FG003|NOT COMPLETED|Adjuvant Treatment Period||14
9788787|NCT00545688|10896040|FG000|STARTED|Follow-Up Period||98
9788788|NCT00545688|10896041|FG001|STARTED|Follow-Up Period||102
9788789|NCT00545688|10896042|FG002|STARTED|Follow-Up Period||98
9788790|NCT00545688|10896043|FG003|STARTED|Follow-Up Period||87
9788791|NCT00545688|10896040|FG000|COMPLETED|Follow-Up Period||77
9788792|NCT00545688|10896041|FG001|COMPLETED|Follow-Up Period||83
9788793|NCT00545688|10896042|FG002|COMPLETED|Follow-Up Period||78
9788794|NCT00545688|10896043|FG003|COMPLETED|Follow-Up Period||60
9788795|NCT00545688|10896040|FG000|NOT COMPLETED|Follow-Up Period||21
9788796|NCT00545688|10896041|FG001|NOT COMPLETED|Follow-Up Period||19
9788797|NCT00545688|10896042|FG002|NOT COMPLETED|Follow-Up Period||20
9788798|NCT00545688|10896043|FG003|NOT COMPLETED|Follow-Up Period||27
9788799|NCT00545714|10896056|FG000|STARTED|Induction Phase (6 Months)||86
9788800|NCT00545714|10896056|FG000|Safety Population|Induction Phase (6 Months)||86
9788801|NCT00545714|10896056|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
9788802|NCT00545714|10896056|FG000|COMPLETED|Induction Phase (6 Months)||74
9788803|NCT00545714|10896056|FG000|NOT COMPLETED|Induction Phase (6 Months)||12
9788804|NCT00545714|10896056|FG000|STARTED|Maintenance Phase (36 Months)||74
9788805|NCT00545714|10896056|FG000|COMPLETED|Maintenance Phase (36 Months)||42
9788806|NCT00545714|10896056|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32
9788807|NCT00545740|10896064|FG000|STARTED|Overall Study||145
9788808|NCT00545740|10896065|FG001|STARTED|Overall Study||145
10015387|NCT01805895|11138450|FG001|COMPLETED|Overall Study||8
10015388|NCT01805895|11138449|FG000|NOT COMPLETED|Overall Study||0
10015389|NCT01805895|11138450|FG001|NOT COMPLETED|Overall Study||0
10015390|NCT01806064|11138461|FG000|STARTED|Overall Study||3
10015391|NCT01806064|11138462|FG001|STARTED|Overall Study||15
10015392|NCT01806064|11138463|FG002|STARTED|Overall Study||5
10234173|NCT01553240|11364109|FG000|NOT COMPLETED|Overall Study||0
9788809|NCT00545740|10896066|FG002|STARTED|Overall Study||151
9788810|NCT00545740|10896067|FG003|STARTED|Overall Study||149
9788811|NCT00545740|10896064|FG000|COMPLETED|Overall Study||70
9788812|NCT00545740|10896065|FG001|COMPLETED|Overall Study||62
9788813|NCT00545740|10896066|FG002|COMPLETED|Overall Study||55
9788814|NCT00545740|10896067|FG003|COMPLETED|Overall Study||78
9788815|NCT00545740|10896064|FG000|NOT COMPLETED|Overall Study||75
9788816|NCT00545740|10896065|FG001|NOT COMPLETED|Overall Study||83
9788817|NCT00545740|10896066|FG002|NOT COMPLETED|Overall Study||96
9788818|NCT00545740|10896067|FG003|NOT COMPLETED|Overall Study||71
9788819|NCT00545753|10896080|FG000|STARTED|Overall Study||243
9788820|NCT00545753|10896081|FG001|STARTED|Overall Study||59
9788821|NCT00545753|10896082|FG002|STARTED|Overall Study||256
9788822|NCT00545753|10896080|FG000|COMPLETED|Overall Study||227
9788823|NCT00545753|10896081|FG001|COMPLETED|Overall Study||54
9788824|NCT00545753|10896082|FG002|COMPLETED|Overall Study||230
9788825|NCT00545753|10896080|FG000|NOT COMPLETED|Overall Study||16
9788826|NCT00545753|10896081|FG001|NOT COMPLETED|Overall Study||5
9788827|NCT00545753|10896082|FG002|NOT COMPLETED|Overall Study||26
9788828|NCT00545779|10896091|FG000|STARTED|Overall Study||677
9788829|NCT00545779|10896091|FG000|COMPLETED|Overall Study||633
9788830|NCT00545779|10896091|FG000|NOT COMPLETED|Overall Study||44
9788831|NCT00545792|10896095|FG000|STARTED|Overall Study||21
9788832|NCT00545792|10896095|FG000|COMPLETED|Overall Study||20
9788833|NCT00545792|10896095|FG000|NOT COMPLETED|Overall Study||1
9788834|NCT00545818|10896101|FG000|STARTED|Overall Study||49
9788835|NCT00545818|10896102|FG001|STARTED|Overall Study||46
9788836|NCT00545818|10896101|FG000|COMPLETED|Overall Study||46
9788837|NCT00545818|10896102|FG001|COMPLETED|Overall Study||39
9788838|NCT00545818|10896101|FG000|NOT COMPLETED|Overall Study||3
9788839|NCT00545818|10896102|FG001|NOT COMPLETED|Overall Study||7
9788840|NCT00545948|10896111|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
9788841|NCT00545948|10896112|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
9788842|NCT00545948|10896113|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
9788843|NCT00545948|10896111|FG000|Assigned Treatment|Overall Study||9
9788844|NCT00545948|10896112|FG001|Assigned Treatment|Overall Study||15
9788845|NCT00545948|10896113|FG002|Assigned Treatment|Overall Study||0
9788846|NCT00545948|10896111|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
9788847|NCT00545948|10896112|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
9788848|NCT00545948|10896113|FG002|COMPLETED|Overall Study||0
9788849|NCT00545948|10896111|FG000|NOT COMPLETED|Overall Study||1
9788850|NCT00545948|10896112|FG001|NOT COMPLETED|Overall Study||1
9788851|NCT00545948|10896113|FG002|NOT COMPLETED|Overall Study||7
9788852|NCT00545974|10896124|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39
9788853|NCT00545974|10896125|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42
9788854|NCT00545974|10896124|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
9788855|NCT00545974|10896125|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
9788856|NCT00545974|10896124|FG000|NOT COMPLETED|Overall Study||2
9788857|NCT00545974|10896125|FG001|NOT COMPLETED|Overall Study||3
9788858|NCT00546000|10896131|FG000|STARTED|Overall Study||56
9788859|NCT00546000|10896131|FG000|COMPLETED|Overall Study||52
9788860|NCT00546000|10896131|FG000|NOT COMPLETED|Overall Study||4
9788861|NCT00546078|10896137|FG000|STARTED|Overall Study||65
9788862|NCT00546078|10896138|FG001|STARTED|Overall Study||50
9788863|NCT00546078|10896137|FG000|Month 18|Overall Study||61
9788864|NCT00546078|10896138|FG001|Month 18|Overall Study||45
9788865|NCT00546078|10896137|FG000|COMPLETED|Overall Study||61
9788866|NCT00546078|10896138|FG001|COMPLETED|Overall Study||43
9788867|NCT00546078|10896137|FG000|NOT COMPLETED|Overall Study||4
9788868|NCT00546078|10896138|FG001|NOT COMPLETED|Overall Study||7
9788869|NCT00546104|10896144|FG000|STARTED|Overall Study||31
9788870|NCT00546104|10896144|FG000|COMPLETED|Overall Study||31
9788871|NCT00546104|10896144|FG000|NOT COMPLETED|Overall Study||0
9788872|NCT00546117|10896150|FG000|STARTED|Overall Study||9
9788873|NCT00546117|10896151|FG001|STARTED|Overall Study||7
9788874|NCT00546117|10896150|FG000|COMPLETED|Overall Study||5
9788875|NCT00546117|10896151|FG001|COMPLETED|Overall Study||7
10234174|NCT01547728|11364113|FG000|STARTED|Overall Study||42
10234175|NCT01547728|11364113|FG000|COMPLETED|Overall Study||1
10234176|NCT01547728|11364113|FG000|NOT COMPLETED|Overall Study||41
9788876|NCT00546117|10896150|FG000|NOT COMPLETED|Overall Study||4
9788877|NCT00546117|10896151|FG001|NOT COMPLETED|Overall Study||0
9788878|NCT00546156|10896161|FG000|STARTED|Overall Study||84
9788879|NCT00546156|10896162|FG001|STARTED|Overall Study||20
9788880|NCT00546156|10896161|FG000|COMPLETED|Overall Study||70
9788881|NCT00546156|10896162|FG001|COMPLETED|Overall Study||19
9788882|NCT00546156|10896161|FG000|NOT COMPLETED|Overall Study||14
9788883|NCT00546156|10896162|FG001|NOT COMPLETED|Overall Study||1
9788884|NCT00546260|10896169|FG000|STARTED|Overall Study||36
10234177|NCT01548651|11364119|FG000|STARTED|Overall Study||4
9788885|NCT00546260|10896170|FG001|STARTED|Overall Study||34
9788886|NCT00546260|10896169|FG000|COMPLETED|Overall Study||28
9788887|NCT00546260|10896170|FG001|COMPLETED|Overall Study||32
9788888|NCT00546260|10896169|FG000|NOT COMPLETED|Overall Study||8
9788889|NCT00546260|10896170|FG001|NOT COMPLETED|Overall Study||2
9788890|NCT00546351|10896176|FG000|STARTED|Overall Study||621
10234178|NCT01548651|11364120|FG001|STARTED|Overall Study||4
9788891|NCT00546351|10896176|FG000|COMPLETED|Overall Study||385
9788892|NCT00546351|10896176|FG000|NOT COMPLETED|Overall Study||236
9788893|NCT00546364|10896183|FG000|STARTED|Overall Study||20
9788894|NCT00546364|10896184|FG001|STARTED|Overall Study||22
9788895|NCT00546364|10896185|FG002|STARTED|Overall Study||20
9788896|NCT00546364|10896183|FG000|Never Treated|Overall Study||0
9788897|NCT00546364|10896184|FG001|Never Treated|Overall Study||0
9788898|NCT00546364|10896185|FG002|Never Treated|Overall Study||0
9788899|NCT00546364|10896183|FG000|COMPLETED|Overall Study|Still on treatment|3
9788900|NCT00546364|10896184|FG001|COMPLETED|Overall Study|Still on treatment|4
9788901|NCT00546364|10896185|FG002|COMPLETED|Overall Study|Still on treatment|3
9788902|NCT00546364|10896183|FG000|NOT COMPLETED|Overall Study||17
9788903|NCT00546364|10896184|FG001|NOT COMPLETED|Overall Study||18
9788904|NCT00546364|10896185|FG002|NOT COMPLETED|Overall Study||17
9830559|NCT00763750|10941248|FG000|NOT COMPLETED|Overall Study||0
9830560|NCT00763815|10941254|FG000|STARTED|Overall Study|Randomized.|161
9830561|NCT00763815|10941255|FG001|STARTED|Overall Study||323
9830562|NCT00763815|10941254|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
9830563|NCT00763815|10941255|FG001|Treated/Safety Population|Overall Study||323
9830564|NCT00763815|10941254|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
9830565|NCT00763815|10941255|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320
9830566|NCT00763815|10941254|FG000|COMPLETED|Overall Study||109
9830567|NCT00763815|10941255|FG001|COMPLETED|Overall Study||239
9830568|NCT00763815|10941254|FG000|NOT COMPLETED|Overall Study||52
9830569|NCT00763815|10941255|FG001|NOT COMPLETED|Overall Study||84
9830570|NCT00763867|10941263|FG000|STARTED|Overall Study||103
9830571|NCT00763867|10941264|FG001|STARTED|Overall Study||113
9830572|NCT00763867|10941263|FG000|COMPLETED|Overall Study||98
9830573|NCT00763867|10941264|FG001|COMPLETED|Overall Study||101
9830574|NCT00763867|10941263|FG000|NOT COMPLETED|Overall Study||5
9830575|NCT00763867|10941264|FG001|NOT COMPLETED|Overall Study||12
9830576|NCT00763919|10941270|FG000|STARTED|Overall Study||43
9830577|NCT00763919|10941270|FG000|COMPLETED|Overall Study||30
9830578|NCT00763919|10941270|FG000|NOT COMPLETED|Overall Study||13
9830579|NCT00763958|10941276|FG000|STARTED|Overall Study||28
9830580|NCT00763958|10941277|FG001|STARTED|Overall Study||16
9830581|NCT00763958|10941276|FG000|COMPLETED|Overall Study||14
9830582|NCT00763958|10941277|FG001|COMPLETED|Overall Study||5
9830583|NCT00763958|10941276|FG000|NOT COMPLETED|Overall Study||14
9830584|NCT00763958|10941277|FG001|NOT COMPLETED|Overall Study||11
9830585|NCT00763971|10941287|FG000|STARTED|Overall Study||113
9830586|NCT00763971|10941288|FG001|STARTED|Overall Study||112
9830587|NCT00763971|10941289|FG002|STARTED|Overall Study||111
9830588|NCT00763971|10941287|FG000|COMPLETED|Overall Study||80
9830589|NCT00763971|10941288|FG001|COMPLETED|Overall Study||74
9830590|NCT00763971|10941289|FG002|COMPLETED|Overall Study||42
9830591|NCT00763971|10941287|FG000|NOT COMPLETED|Overall Study||33
9830592|NCT00763971|10941288|FG001|NOT COMPLETED|Overall Study||38
10234179|NCT01548651|11364119|FG000|COMPLETED|Overall Study||3
10234180|NCT01548651|11364120|FG001|COMPLETED|Overall Study||4
10234181|NCT01548651|11364119|FG000|NOT COMPLETED|Overall Study||1
10234182|NCT01548651|11364120|FG001|NOT COMPLETED|Overall Study||0
10234183|NCT01545648|11364126|FG000|STARTED|Overall Study||4
10234184|NCT01545648|11364126|FG000|6 Months of Treatment|Overall Study||4
10234185|NCT01545648|11364126|FG000|COMPLETED|Overall Study||4
10234186|NCT01545648|11364126|FG000|NOT COMPLETED|Overall Study||0
10234187|NCT01546883|11364130|FG000|STARTED|Overall Study||14
10234188|NCT01546883|11364130|FG000|COMPLETED|Overall Study||2
10234189|NCT01546883|11364130|FG000|NOT COMPLETED|Overall Study||12
10234190|NCT01545518|11364134|FG000|STARTED|Overall Study||20
10234191|NCT01545518|11364134|FG000|COMPLETED|Overall Study||20
10234192|NCT01545518|11364134|FG000|NOT COMPLETED|Overall Study||0
10234193|NCT01536015|11364140|FG000|STARTED|Overall Study||12
10234194|NCT01536015|11364141|FG001|STARTED|Overall Study||13
10234195|NCT01536015|11364140|FG000|COMPLETED|Overall Study||4
10234196|NCT01536015|11364141|FG001|COMPLETED|Overall Study||3
10234197|NCT01536015|11364140|FG000|NOT COMPLETED|Overall Study||8
10234198|NCT01536015|11364141|FG001|NOT COMPLETED|Overall Study||10
10234199|NCT01539590|11364149|FG000|STARTED|Overall Study||3
9830593|NCT00763971|10941289|FG002|NOT COMPLETED|Overall Study||69
9830594|NCT00764309|10941297|FG000|STARTED|Overall Study|Number of participants treated.|31
9830595|NCT00764309|10941297|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
9830596|NCT00764309|10941297|FG000|NOT COMPLETED|Overall Study||0
10234200|NCT01539590|11364150|FG001|STARTED|Overall Study||2
10234201|NCT01539590|11364149|FG000|Complete Study Treatment|Overall Study||1
10234202|NCT01539590|11364150|FG001|Complete Study Treatment|Overall Study||2
10234203|NCT01539590|11364149|FG000|COMPLETED|Overall Study||0
10234204|NCT01539590|11364150|FG001|COMPLETED|Overall Study||2
10234205|NCT01539590|11364149|FG000|NOT COMPLETED|Overall Study||3
10234206|NCT01539590|11364150|FG001|NOT COMPLETED|Overall Study||0
10234207|NCT01539811|11364158|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10234208|NCT01539811|11364159|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
9830597|NCT00764322|10941303|FG000|STARTED|Overall Study||500
9830598|NCT00764322|10941303|FG000|COMPLETED|Overall Study||480
10239699|NCT00062751|11371370|FG004|NOT COMPLETED|Overall Study||6
9788905|NCT00546377|10896193|FG000|STARTED|Overall Study||50
9788906|NCT00546377|10896193|FG000|COMPLETED|Overall Study||43
9788907|NCT00546377|10896193|FG000|NOT COMPLETED|Overall Study||7
9788908|NCT00546390|10896199|FG000|STARTED|Overall Study||27
9788909|NCT00546390|10896200|FG001|STARTED|Overall Study||28
9788910|NCT00546390|10896199|FG000|COMPLETED|Overall Study||27
9788911|NCT00546390|10896200|FG001|COMPLETED|Overall Study||28
9788912|NCT00546390|10896199|FG000|NOT COMPLETED|Overall Study||0
9788913|NCT00546390|10896200|FG001|NOT COMPLETED|Overall Study||0
9788914|NCT00546429|10896207|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
9788915|NCT00546429|10896207|FG000|COMPLETED|Overall Study||32
9788916|NCT00546429|10896207|FG000|NOT COMPLETED|Overall Study||30
9788917|NCT00546481|10896213|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39
9788918|NCT00546481|10896214|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41
9788919|NCT00546481|10896215|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0
9788920|NCT00546481|10896213|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
9788921|NCT00546481|10896214|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
9788922|NCT00546481|10896215|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
9788923|NCT00546481|10896213|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
9788924|NCT00546481|10896214|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
9788925|NCT00546481|10896215|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
9788926|NCT00546481|10896213|FG000|STARTED|Maintenance Phase (CERA)||0
9788927|NCT00546481|10896214|FG001|STARTED|Maintenance Phase (CERA)||0
9788928|NCT00546481|10896215|FG002|STARTED|Maintenance Phase (CERA)||54
9788929|NCT00546481|10896213|FG000|COMPLETED|Maintenance Phase (CERA)||0
9788930|NCT00546481|10896214|FG001|COMPLETED|Maintenance Phase (CERA)||0
9788931|NCT00546481|10896215|FG002|COMPLETED|Maintenance Phase (CERA)||50
9788932|NCT00546481|10896213|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0
9788933|NCT00546481|10896214|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0
9788934|NCT00546481|10896215|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4
9788935|NCT00546572|10896225|FG000|STARTED|Vax 1 / Year 0||464
9788936|NCT00546572|10896226|FG001|STARTED|Vax 1 / Year 0||474
9788937|NCT00546572|10896225|FG000|Received Vax 1|Vax 1 / Year 0||463
9788938|NCT00546572|10896226|FG001|Received Vax 1|Vax 1 / Year 0||473
9788939|NCT00546572|10896225|FG000|COMPLETED|Vax 1 / Year 0||391
9788940|NCT00546572|10896226|FG001|COMPLETED|Vax 1 / Year 0||404
9788941|NCT00546572|10896225|FG000|NOT COMPLETED|Vax 1 / Year 0||73
9788942|NCT00546572|10896226|FG001|NOT COMPLETED|Vax 1 / Year 0||70
9788943|NCT00546572|10896225|FG000|STARTED|Vax 2 / Year 1||391
9788944|NCT00546572|10896226|FG001|STARTED|Vax 2 / Year 1||404
9788945|NCT00546572|10896225|FG000|Received Vax 2|Vax 2 / Year 1||391
9788946|NCT00546572|10896226|FG001|Received Vax 2|Vax 2 / Year 1||404
9788947|NCT00546572|10896225|FG000|COMPLETED|Vax 2 / Year 1||387
9788948|NCT00546572|10896226|FG001|COMPLETED|Vax 2 / Year 1||402
9788949|NCT00546572|10896225|FG000|NOT COMPLETED|Vax 2 / Year 1||4
9788950|NCT00546572|10896226|FG001|NOT COMPLETED|Vax 2 / Year 1||2
9788951|NCT00546637|10896245|FG000|STARTED|Overall Study||474
9788952|NCT00546637|10896246|FG001|STARTED|Overall Study||473
9788953|NCT00546637|10896245|FG000|Received Treatment|Overall Study||471
9788954|NCT00546637|10896246|FG001|Received Treatment|Overall Study||472
9788955|NCT00546637|10896245|FG000|COMPLETED|Overall Study||401
9788956|NCT00546637|10896246|FG001|COMPLETED|Overall Study||424
9788957|NCT00546637|10896245|FG000|NOT COMPLETED|Overall Study||73
9788958|NCT00546637|10896246|FG001|NOT COMPLETED|Overall Study||49
9788959|NCT00546715|10896256|FG000|STARTED|Overall Study||6
9788960|NCT00546715|10896257|FG001|STARTED|Overall Study||5
9788961|NCT00546715|10896258|FG002|STARTED|Overall Study||5
9788962|NCT00546715|10896259|FG003|STARTED|Overall Study||2
9788963|NCT00546715|10896256|FG000|COMPLETED|Overall Study||6
9788964|NCT00546715|10896257|FG001|COMPLETED|Overall Study||4
9788965|NCT00546715|10896258|FG002|COMPLETED|Overall Study||5
9788966|NCT00546715|10896259|FG003|COMPLETED|Overall Study||2
9788967|NCT00546715|10896256|FG000|NOT COMPLETED|Overall Study||0
9788968|NCT00546715|10896257|FG001|NOT COMPLETED|Overall Study||1
9788969|NCT00546715|10896258|FG002|NOT COMPLETED|Overall Study||0
9788970|NCT00546715|10896259|FG003|NOT COMPLETED|Overall Study||0
9788971|NCT00546728|10896271|FG000|STARTED|Overall Study||25
9788972|NCT00546728|10896272|FG001|STARTED|Overall Study||25
9788973|NCT00546728|10896271|FG000|COMPLETED|Overall Study||25
9788974|NCT00546728|10896272|FG001|COMPLETED|Overall Study||25
9788975|NCT00546728|10896271|FG000|NOT COMPLETED|Overall Study||0
9788976|NCT00546728|10896272|FG001|NOT COMPLETED|Overall Study||0
9788977|NCT00546819|10896280|FG000|STARTED|Overall Study||207
9788978|NCT00546819|10896281|FG001|STARTED|Overall Study||102
9788979|NCT00546819|10896280|FG000|VACCINATED|Overall Study||206
9788980|NCT00546819|10896281|FG001|VACCINATED|Overall Study||100
9788981|NCT00546819|10896280|FG000|COMPLETED|Overall Study||199
9788982|NCT00546819|10896281|FG001|COMPLETED|Overall Study||96
9788983|NCT00546819|10896280|FG000|NOT COMPLETED|Overall Study||8
9788984|NCT00546819|10896281|FG001|NOT COMPLETED|Overall Study||6
9788985|NCT00546871|10896287|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14
9788986|NCT00546871|10896288|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35
9788987|NCT00546871|10896287|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
9788988|NCT00546871|10896288|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
9788989|NCT00546871|10896287|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
9788990|NCT00546871|10896288|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
9788991|NCT00546871|10896287|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
9788992|NCT00546871|10896288|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
9788993|NCT00546871|10896287|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
9788994|NCT00546871|10896288|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
9788995|NCT00546871|10896287|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
9788996|NCT00546871|10896288|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
9788997|NCT00546871|10896287|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
9788998|NCT00546871|10896288|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
9788999|NCT00546871|10896287|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
9789000|NCT00546871|10896288|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
9789001|NCT00546871|10896287|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
9789002|NCT00546871|10896288|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
9789003|NCT00546871|10896287|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12
9789004|NCT00546871|10896288|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32
9789005|NCT00546871|10896287|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
9789006|NCT00546871|10896288|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
9789007|NCT00546871|10896287|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
9789008|NCT00546871|10896288|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
9789009|NCT00546871|10896287|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
9789010|NCT00546871|10896288|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
9789011|NCT00546871|10896287|FG000|COMPLETED|Study Extension Period||9
9789012|NCT00546871|10896288|FG001|COMPLETED|Study Extension Period||25
9789013|NCT00546871|10896287|FG000|NOT COMPLETED|Study Extension Period||1
9789014|NCT00546871|10896288|FG001|NOT COMPLETED|Study Extension Period||1
9789015|NCT00546884|10896319|FG000|STARTED|Overall Study||145
9789016|NCT00546884|10896320|FG001|STARTED|Overall Study||117
9789017|NCT00546884|10896319|FG000|COMPLETED|Overall Study||145
9789018|NCT00546884|10896320|FG001|COMPLETED|Overall Study||117
9789019|NCT00546884|10896319|FG000|NOT COMPLETED|Overall Study||0
9789020|NCT00546884|10896320|FG001|NOT COMPLETED|Overall Study||0
9789021|NCT00546897|10896328|FG000|STARTED|Overall Study||15
9789022|NCT00546897|10896329|FG001|STARTED|Overall Study||33
9789023|NCT00546897|10896328|FG000|COMPLETED|Overall Study||15
9789024|NCT00546897|10896329|FG001|COMPLETED|Overall Study||33
9789025|NCT00546897|10896328|FG000|NOT COMPLETED|Overall Study||0
9789026|NCT00546897|10896329|FG001|NOT COMPLETED|Overall Study||0
9789027|NCT00546910|10896337|FG000|STARTED|Overall Study||63
9789028|NCT00546910|10896338|FG001|STARTED|Overall Study||62
9789029|NCT00546910|10896337|FG000|COMPLETED|Overall Study||54
9789030|NCT00546910|10896338|FG001|COMPLETED|Overall Study||51
9789031|NCT00546910|10896337|FG000|NOT COMPLETED|Overall Study||9
9789032|NCT00546910|10896338|FG001|NOT COMPLETED|Overall Study||11
9789033|NCT00547105|10896344|FG000|STARTED|Overall Study||24
9789034|NCT00547105|10896344|FG000|COMPLETED|Overall Study||24
9789035|NCT00547105|10896344|FG000|NOT COMPLETED|Overall Study||0
9789036|NCT00547118|10896350|FG000|STARTED|Overall Study||8
9789037|NCT00547118|10896351|FG001|STARTED|Overall Study||9
9952380|NCT01421667|11071326|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
9952381|NCT01421667|11071323|FG000|NOT COMPLETED|Overall Study||0
9952382|NCT01421667|11071324|FG001|NOT COMPLETED|Overall Study||2
9952383|NCT01421667|11071325|FG002|NOT COMPLETED|Overall Study||2
9952384|NCT01421667|11071326|FG003|NOT COMPLETED|Overall Study||1
9952385|NCT01421719|11071344|FG000|STARTED|Overall Study||20
9789038|NCT00547118|10896350|FG000|COMPLETED|Overall Study||0
9789039|NCT00547118|10896351|FG001|COMPLETED|Overall Study||0
9789040|NCT00547118|10896350|FG000|NOT COMPLETED|Overall Study||8
9789041|NCT00547118|10896351|FG001|NOT COMPLETED|Overall Study||9
10015393|NCT01806064|11138464|FG003|STARTED|Overall Study||75
10015394|NCT01806064|11138465|FG004|STARTED|Overall Study||75
10015395|NCT01806064|11138461|FG000|COMPLETED|Overall Study||3
10015396|NCT01806064|11138462|FG001|COMPLETED|Overall Study||15
10015397|NCT01806064|11138463|FG002|COMPLETED|Overall Study||5
10015398|NCT01806064|11138464|FG003|COMPLETED|Overall Study||74
10015399|NCT01806064|11138465|FG004|COMPLETED|Overall Study||73
9789042|NCT00547157|10896361|FG000|STARTED|Overall Study||90
9789043|NCT00547157|10896362|FG001|STARTED|Overall Study||62
9789044|NCT00547157|10896361|FG000|COMPLETED|Overall Study||41
9789045|NCT00547157|10896362|FG001|COMPLETED|Overall Study||39
9789046|NCT00547157|10896361|FG000|NOT COMPLETED|Overall Study||49
9789047|NCT00547157|10896362|FG001|NOT COMPLETED|Overall Study||23
9789048|NCT00547248|10896372|FG000|STARTED|Overall Study||280
9789049|NCT00547248|10896373|FG001|STARTED|Overall Study||93
9789050|NCT00547248|10896374|FG002|STARTED|Overall Study||285
9789051|NCT00547248|10896375|FG003|STARTED|Overall Study||98
9952386|NCT01421719|11071344|FG000|COMPLETED|Overall Study||16
9952387|NCT01421719|11071344|FG000|NOT COMPLETED|Overall Study||4
9952388|NCT01422070|11071351|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
9952389|NCT01422070|11071352|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
9952390|NCT01422070|11071351|FG000|COMPLETED|Overall Study||5031
9952391|NCT01422070|11071352|FG001|COMPLETED|Overall Study||803
10015400|NCT01806064|11138461|FG000|NOT COMPLETED|Overall Study||0
10015401|NCT01806064|11138462|FG001|NOT COMPLETED|Overall Study||0
10015402|NCT01806064|11138463|FG002|NOT COMPLETED|Overall Study||0
9789052|NCT00547248|10896372|FG000|COMPLETED|Overall Study||280
9952392|NCT01422070|11071351|FG000|NOT COMPLETED|Overall Study||0
9952393|NCT01422070|11071352|FG001|NOT COMPLETED|Overall Study||0
10015403|NCT01806064|11138464|FG003|NOT COMPLETED|Overall Study||1
9789053|NCT00547248|10896373|FG001|COMPLETED|Overall Study||93
9789054|NCT00547248|10896374|FG002|COMPLETED|Overall Study||275
9789055|NCT00547248|10896375|FG003|COMPLETED|Overall Study||96
9789056|NCT00547248|10896372|FG000|NOT COMPLETED|Overall Study||0
9789057|NCT00547248|10896373|FG001|NOT COMPLETED|Overall Study||0
9789058|NCT00547248|10896374|FG002|NOT COMPLETED|Overall Study||10
9789059|NCT00547248|10896375|FG003|NOT COMPLETED|Overall Study||2
9789060|NCT00547365|10896388|FG000|STARTED|Overall Study||10
9789061|NCT00547365|10896388|FG000|COMPLETED|Overall Study||2
9789062|NCT00547365|10896388|FG000|NOT COMPLETED|Overall Study||8
9789063|NCT00547378|10896396|FG000|STARTED|Randomized Cohort||70
9789064|NCT00547378|10896397|FG001|STARTED|Randomized Cohort||77
9789065|NCT00547378|10896398|FG002|STARTED|Randomized Cohort||0
9789066|NCT00547378|10896396|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
9789067|NCT00547378|10896397|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
9789068|NCT00547378|10896398|FG002|Month 3|Randomized Cohort||0
9789069|NCT00547378|10896396|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
9789070|NCT00547378|10896397|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
9789071|NCT00547378|10896398|FG002|Month 6|Randomized Cohort||0
9789072|NCT00547378|10896396|FG000|COMPLETED|Randomized Cohort||59
9789073|NCT00547378|10896397|FG001|COMPLETED|Randomized Cohort||71
9789074|NCT00547378|10896398|FG002|COMPLETED|Randomized Cohort||0
9789075|NCT00547378|10896396|FG000|NOT COMPLETED|Randomized Cohort||11
9789076|NCT00547378|10896397|FG001|NOT COMPLETED|Randomized Cohort||6
9789077|NCT00547378|10896398|FG002|NOT COMPLETED|Randomized Cohort||0
9789078|NCT00547378|10896396|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
9789079|NCT00547378|10896397|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
9789080|NCT00547378|10896398|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
9789081|NCT00547378|10896396|FG000|Month 3|All Implanted Cohort||51
9789082|NCT00547378|10896397|FG001|Month 3|All Implanted Cohort||39
9789083|NCT00547378|10896398|FG002|Month 3|All Implanted Cohort||178
9789084|NCT00547378|10896396|FG000|Month 6|All Implanted Cohort||50
9789085|NCT00547378|10896397|FG001|Month 6|All Implanted Cohort||36
9789086|NCT00547378|10896398|FG002|Month 6|All Implanted Cohort||178
9789087|NCT00547378|10896396|FG000|Month 12|All Implanted Cohort||48
9789088|NCT00547378|10896397|FG001|Month 12|All Implanted Cohort||32
9789089|NCT00547378|10896398|FG002|Month 12|All Implanted Cohort||175
9789090|NCT00547378|10896396|FG000|Month 24|All Implanted Cohort||42
9789091|NCT00547378|10896397|FG001|Month 24|All Implanted Cohort||30
9789092|NCT00547378|10896398|FG002|Month 24|All Implanted Cohort||161
9789093|NCT00547378|10896396|FG000|Month 36|All Implanted Cohort||42
9789094|NCT00547378|10896397|FG001|Month 36|All Implanted Cohort||29
9789095|NCT00547378|10896398|FG002|Month 36|All Implanted Cohort||146
9789096|NCT00547378|10896396|FG000|Month 48|All Implanted Cohort||38
9789097|NCT00547378|10896397|FG001|Month 48|All Implanted Cohort||27
9789098|NCT00547378|10896398|FG002|Month 48|All Implanted Cohort||136
9789099|NCT00547378|10896396|FG000|Month 60|All Implanted Cohort||36
9789100|NCT00547378|10896397|FG001|Month 60|All Implanted Cohort||23
9789101|NCT00547378|10896398|FG002|Month 60|All Implanted Cohort||114
9789102|NCT00547378|10896396|FG000|COMPLETED|All Implanted Cohort||36
9789103|NCT00547378|10896397|FG001|COMPLETED|All Implanted Cohort||22
9789104|NCT00547378|10896398|FG002|COMPLETED|All Implanted Cohort||111
9789105|NCT00547378|10896396|FG000|NOT COMPLETED|All Implanted Cohort||15
9789106|NCT00547378|10896397|FG001|NOT COMPLETED|All Implanted Cohort||18
9789107|NCT00547378|10896398|FG002|NOT COMPLETED|All Implanted Cohort||70
9789108|NCT00547521|10896408|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
9789109|NCT00547521|10896409|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
9789110|NCT00547521|10896408|FG000|COMPLETED|Short Term Study (4 Months)||50
9789111|NCT00547521|10896409|FG001|COMPLETED|Short Term Study (4 Months)||45
9789112|NCT00547521|10896408|FG000|NOT COMPLETED|Short Term Study (4 Months)||1
9789113|NCT00547521|10896409|FG001|NOT COMPLETED|Short Term Study (4 Months)||4
9789114|NCT00547521|10896408|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
9789115|NCT00547521|10896409|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
9789116|NCT00547521|10896408|FG000|COMPLETED|Long Term Extension (LTE) Study||0
9789117|NCT00547521|10896409|FG001|COMPLETED|Long Term Extension (LTE) Study||59
9789118|NCT00547521|10896408|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0
9789119|NCT00547521|10896409|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31
9789120|NCT00547534|10896422|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
9789121|NCT00547534|10896422|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
9789122|NCT00547534|10896422|FG000|NOT COMPLETED|Overall Study||11
9789123|NCT00547586|10896432|FG000|STARTED|Overall Study||33
9952394|NCT01422135|11071357|FG000|STARTED|Overall Study||4
9952395|NCT01422135|11071358|FG001|STARTED|Overall Study||4
9952396|NCT01422135|11071359|FG002|STARTED|Overall Study||4
9789124|NCT00547586|10896433|FG001|STARTED|Overall Study||7
9789125|NCT00547586|10896434|FG002|STARTED|Overall Study||14
9789126|NCT00547586|10896435|FG003|STARTED|Overall Study||33
9952397|NCT01422135|11071360|FG003|STARTED|Overall Study||4
9952398|NCT01422135|11071361|FG004|STARTED|Overall Study||4
9952399|NCT01422135|11071362|FG005|STARTED|Overall Study||4
10015404|NCT01806064|11138465|FG004|NOT COMPLETED|Overall Study||2
10015405|NCT01806168|11138484|FG000|STARTED|Overall Study||11
10015406|NCT01806168|11138485|FG001|STARTED|Overall Study||10
9952400|NCT01422135|11071357|FG000|COMPLETED|Overall Study||4
9952401|NCT01422135|11071358|FG001|COMPLETED|Overall Study||4
9952402|NCT01422135|11071359|FG002|COMPLETED|Overall Study||3
9952403|NCT01422135|11071360|FG003|COMPLETED|Overall Study||4
9952404|NCT01422135|11071361|FG004|COMPLETED|Overall Study||4
9952405|NCT01422135|11071362|FG005|COMPLETED|Overall Study||3
9952406|NCT01422135|11071357|FG000|NOT COMPLETED|Overall Study||0
9952407|NCT01422135|11071358|FG001|NOT COMPLETED|Overall Study||0
9952408|NCT01422135|11071359|FG002|NOT COMPLETED|Overall Study||1
9952409|NCT01422135|11071360|FG003|NOT COMPLETED|Overall Study||0
9952410|NCT01422135|11071361|FG004|NOT COMPLETED|Overall Study||0
9952411|NCT01422135|11071362|FG005|NOT COMPLETED|Overall Study||1
9789127|NCT00547586|10896436|FG004|STARTED|Overall Study||35
9789128|NCT00547586|10896432|FG000|COMPLETED|Overall Study||28
9789129|NCT00547586|10896433|FG001|COMPLETED|Overall Study||6
9789130|NCT00547586|10896434|FG002|COMPLETED|Overall Study||13
9789131|NCT00547586|10896435|FG003|COMPLETED|Overall Study||27
9789132|NCT00547586|10896436|FG004|COMPLETED|Overall Study||32
9789133|NCT00547586|10896432|FG000|NOT COMPLETED|Overall Study||5
9789134|NCT00547586|10896433|FG001|NOT COMPLETED|Overall Study||1
9789135|NCT00547586|10896434|FG002|NOT COMPLETED|Overall Study||1
9789136|NCT00547586|10896435|FG003|NOT COMPLETED|Overall Study||6
9789137|NCT00547586|10896436|FG004|NOT COMPLETED|Overall Study||3
9789138|NCT00547638|10896450|FG000|STARTED|Overall Study||143
9789139|NCT00547638|10896451|FG001|STARTED|Overall Study||73
9789140|NCT00547638|10896450|FG000|COMPLETED|Overall Study||119
9789141|NCT00547638|10896451|FG001|COMPLETED|Overall Study||59
9789142|NCT00547638|10896450|FG000|NOT COMPLETED|Overall Study||24
9789143|NCT00547638|10896451|FG001|NOT COMPLETED|Overall Study||14
9789144|NCT00547703|10896459|FG000|STARTED|Overall Study||4
10015407|NCT01806168|11138486|FG002|STARTED|Overall Study||10
10015408|NCT01806168|11138484|FG000|Received Allocated Intervention|Overall Study||11
10015409|NCT01806168|11138485|FG001|Received Allocated Intervention|Overall Study||9
10015410|NCT01806168|11138486|FG002|Received Allocated Intervention|Overall Study||9
10015411|NCT01806168|11138484|FG000|COMPLETED|Overall Study||10
10015412|NCT01806168|11138485|FG001|COMPLETED|Overall Study||9
10015413|NCT01806168|11138486|FG002|COMPLETED|Overall Study||7
10015414|NCT01806168|11138484|FG000|NOT COMPLETED|Overall Study||1
10015415|NCT01806168|11138485|FG001|NOT COMPLETED|Overall Study||1
10015416|NCT01806168|11138486|FG002|NOT COMPLETED|Overall Study||3
10015417|NCT01806259|11138499|FG000|STARTED|Overall Study||96
10015418|NCT01806259|11138500|FG001|STARTED|Overall Study||107
10112095|NCT02501473|11243157|FG003|NOT COMPLETED|Overall Study||14
10112096|NCT02501473|11243158|FG004|NOT COMPLETED|Overall Study||4
10234209|NCT01539811|11364158|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10234210|NCT01539811|11364159|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10234211|NCT01539811|11364158|FG000|NOT COMPLETED|Overall Study||0
10234212|NCT01539811|11364159|FG001|NOT COMPLETED|Overall Study||0
9789145|NCT00547703|10896460|FG001|STARTED|Overall Study||1
9789146|NCT00547703|10896459|FG000|COMPLETED|Overall Study||3
9789147|NCT00547703|10896460|FG001|COMPLETED|Overall Study||1
9789148|NCT00547703|10896459|FG000|NOT COMPLETED|Overall Study||1
10234213|NCT01534676|11364167|FG000|STARTED|Overall Study||2
10234214|NCT01534676|11364168|FG001|STARTED|Overall Study||1
10234215|NCT01534676|11364167|FG000|COMPLETED|Overall Study||0
10234216|NCT01534676|11364168|FG001|COMPLETED|Overall Study||0
10234217|NCT01534676|11364167|FG000|NOT COMPLETED|Overall Study||2
10234218|NCT01534676|11364168|FG001|NOT COMPLETED|Overall Study||1
10234219|NCT01533753|11364176|FG000|STARTED|Overall Study||2
10234220|NCT01533753|11364177|FG001|STARTED|Overall Study||3
10234221|NCT01533753|11364176|FG000|COMPLETED|Overall Study||2
10234222|NCT01533753|11364177|FG001|COMPLETED|Overall Study||3
10234223|NCT01533753|11364176|FG000|NOT COMPLETED|Overall Study||0
10112097|NCT02501473|11243159|FG005|NOT COMPLETED|Overall Study||14
10234224|NCT01533753|11364177|FG001|NOT COMPLETED|Overall Study||0
10234225|NCT01534143|11364183|FG000|STARTED|Overall Study||1
9789149|NCT00547703|10896460|FG001|NOT COMPLETED|Overall Study||0
9789150|NCT00547729|10896466|FG000|STARTED|Overall Study||71
9789151|NCT00547729|10896466|FG000|COMPLETED|Overall Study||71
9789152|NCT00547729|10896466|FG000|NOT COMPLETED|Overall Study||0
9789153|NCT00547898|10896474|FG000|STARTED|Overall Study||138
9789154|NCT00547898|10896475|FG001|STARTED|Overall Study||136
10112098|NCT02501473|11243160|FG006|NOT COMPLETED|Overall Study||1
10112099|NCT02501473|11243161|FG007|NOT COMPLETED|Overall Study||0
10112100|NCT02501538|11243177|FG000|STARTED|Overall Study||23
9789155|NCT00547898|10896476|FG002|STARTED|Overall Study||54
9952412|NCT01422161|11071370|FG000|STARTED|Overall Study||10
9952413|NCT01422161|11071371|FG001|STARTED|Overall Study||6
10015419|NCT01806259|11138499|FG000|COMPLETED|Overall Study||96
10015420|NCT01806259|11138500|FG001|COMPLETED|Overall Study||107
10015421|NCT01806259|11138499|FG000|NOT COMPLETED|Overall Study||0
10015422|NCT01806259|11138500|FG001|NOT COMPLETED|Overall Study||0
10112101|NCT02501538|11243177|FG000|COMPLETED|Overall Study||20
10234226|NCT01534143|11364183|FG000|COMPLETED|Overall Study||1
10234227|NCT01534143|11364183|FG000|NOT COMPLETED|Overall Study||0
10234228|NCT01530880|11364187|FG000|STARTED|Overall Study||35
9789156|NCT00547898|10896477|FG003|STARTED|Overall Study||46
9789157|NCT00547898|10896474|FG000|COMPLETED|Overall Study||129
9789158|NCT00547898|10896475|FG001|COMPLETED|Overall Study||126
9789159|NCT00547898|10896476|FG002|COMPLETED|Overall Study||54
9789160|NCT00547898|10896477|FG003|COMPLETED|Overall Study||40
9789161|NCT00547898|10896474|FG000|NOT COMPLETED|Overall Study||9
10015423|NCT01806298|11138507|FG000|STARTED|Overall Study||78
9789162|NCT00547898|10896475|FG001|NOT COMPLETED|Overall Study||10
9789163|NCT00547898|10896476|FG002|NOT COMPLETED|Overall Study||0
9789164|NCT00547898|10896477|FG003|NOT COMPLETED|Overall Study||6
9952414|NCT01422161|11071370|FG000|COMPLETED|Overall Study||10
9952415|NCT01422161|11071371|FG001|COMPLETED|Overall Study||6
9952416|NCT01422161|11071370|FG000|NOT COMPLETED|Overall Study||0
9952417|NCT01422161|11071371|FG001|NOT COMPLETED|Overall Study||0
9952418|NCT01422187|11071388|FG000|STARTED|Overall Study||8
9952419|NCT01422187|11071389|FG001|STARTED|Overall Study||9
9952420|NCT01422187|11071390|FG002|STARTED|Overall Study||2
9952421|NCT01422187|11071388|FG000|COMPLETED|Overall Study||7
9952422|NCT01422187|11071389|FG001|COMPLETED|Overall Study||8
9952423|NCT01422187|11071390|FG002|COMPLETED|Overall Study||2
9952424|NCT01422187|11071388|FG000|NOT COMPLETED|Overall Study||1
9952425|NCT01422187|11071389|FG001|NOT COMPLETED|Overall Study||1
9952426|NCT01422187|11071390|FG002|NOT COMPLETED|Overall Study||0
9952427|NCT01422200|11071400|FG000|STARTED|Overall Study||11
9952428|NCT01422200|11071401|FG001|STARTED|Overall Study||11
9952429|NCT01422200|11071400|FG000|COMPLETED|Overall Study||11
9952430|NCT01422200|11071401|FG001|COMPLETED|Overall Study||11
9952431|NCT01422200|11071400|FG000|NOT COMPLETED|Overall Study||0
9952432|NCT01422200|11071401|FG001|NOT COMPLETED|Overall Study||0
9952433|NCT01422213|11071412|FG000|STARTED|Overall Study||196
9952434|NCT01422213|11071413|FG001|STARTED|Overall Study||195
9952435|NCT01422213|11071414|FG002|STARTED|Overall Study||207
9952436|NCT01422213|11071412|FG000|COMPLETED|Overall Study||163
9952437|NCT01422213|11071413|FG001|COMPLETED|Overall Study||173
9952438|NCT01422213|11071414|FG002|COMPLETED|Overall Study||178
9952439|NCT01422213|11071412|FG000|NOT COMPLETED|Overall Study||33
9952440|NCT01422213|11071413|FG001|NOT COMPLETED|Overall Study||22
9952441|NCT01422213|11071414|FG002|NOT COMPLETED|Overall Study||29
9789165|NCT00547911|10896493|FG000|STARTED|Overall Study||2
9789166|NCT00547911|10896494|FG001|STARTED|Overall Study||2
9789167|NCT00547911|10896495|FG002|STARTED|Overall Study||2
9789168|NCT00547911|10896496|FG003|STARTED|Overall Study||2
9789169|NCT00547911|10896497|FG004|STARTED|Overall Study||3
9789170|NCT00547911|10896498|FG005|STARTED|Overall Study||3
9789171|NCT00547911|10896493|FG000|COMPLETED|Overall Study||2
9789172|NCT00547911|10896494|FG001|COMPLETED|Overall Study||2
9789173|NCT00547911|10896495|FG002|COMPLETED|Overall Study||2
9789174|NCT00547911|10896496|FG003|COMPLETED|Overall Study||1
9789175|NCT00547911|10896497|FG004|COMPLETED|Overall Study||3
9789176|NCT00547911|10896498|FG005|COMPLETED|Overall Study||3
9789177|NCT00547911|10896493|FG000|NOT COMPLETED|Overall Study||0
9789178|NCT00547911|10896494|FG001|NOT COMPLETED|Overall Study||0
9789179|NCT00547911|10896495|FG002|NOT COMPLETED|Overall Study||0
9789180|NCT00547911|10896496|FG003|NOT COMPLETED|Overall Study||1
9789181|NCT00547911|10896497|FG004|NOT COMPLETED|Overall Study||0
9789182|NCT00547911|10896498|FG005|NOT COMPLETED|Overall Study||0
9789183|NCT00548041|10896511|FG000|STARTED|Overall Study||100
9789184|NCT00548041|10896511|FG000|COMPLETED|Overall Study||100
9789185|NCT00548041|10896511|FG000|NOT COMPLETED|Overall Study||0
9789186|NCT00548132|10896517|FG000|STARTED|Overall Study||534
9789187|NCT00548132|10896518|FG001|STARTED|Overall Study||554
9789188|NCT00548132|10896517|FG000|Consented to Study|Overall Study||534
9789189|NCT00548132|10896518|FG001|Consented to Study|Overall Study||554
9789190|NCT00548132|10896517|FG000|COMPLETED|Overall Study||534
9789191|NCT00548132|10896518|FG001|COMPLETED|Overall Study||554
9789192|NCT00548132|10896517|FG000|NOT COMPLETED|Overall Study||0
9789193|NCT00548132|10896518|FG001|NOT COMPLETED|Overall Study||0
9952442|NCT01422226|11071424|FG000|STARTED|Overall Study||1
9952443|NCT01422226|11071425|FG001|STARTED|Overall Study||2
9952444|NCT01422226|11071424|FG000|COMPLETED|Overall Study||1
9952445|NCT01422226|11071425|FG001|COMPLETED|Overall Study||2
9952446|NCT01422226|11071424|FG000|NOT COMPLETED|Overall Study||0
9952447|NCT01422226|11071425|FG001|NOT COMPLETED|Overall Study||0
9952448|NCT01422239|11071433|FG000|STARTED|Overall Study||14
9952449|NCT01422239|11071434|FG001|STARTED|Overall Study||6
9952450|NCT01422239|11071433|FG000|COMPLETED|Overall Study||10
9952451|NCT01422239|11071434|FG001|COMPLETED|Overall Study||3
9952452|NCT01422239|11071433|FG000|NOT COMPLETED|Overall Study||4
10015424|NCT01806298|11138507|FG000|COMPLETED|Overall Study||68
9789194|NCT00548145|10896528|FG000|STARTED|Overall Study||18
9789195|NCT00548145|10896529|FG001|STARTED|Overall Study||20
9789196|NCT00548145|10896528|FG000|COMPLETED|Overall Study||17
9789197|NCT00548145|10896529|FG001|COMPLETED|Overall Study||16
9789198|NCT00548145|10896528|FG000|NOT COMPLETED|Overall Study||1
9789199|NCT00548145|10896529|FG001|NOT COMPLETED|Overall Study||4
9789200|NCT00548171|10896537|FG000|STARTED|Overall Study||164
9789201|NCT00548171|10896538|FG001|STARTED|Overall Study||39
9789202|NCT00548171|10896537|FG000|COMPLETED|Overall Study||164
9789203|NCT00548171|10896538|FG001|COMPLETED|Overall Study||39
9789204|NCT00548171|10896537|FG000|NOT COMPLETED|Overall Study||0
9789205|NCT00548171|10896538|FG001|NOT COMPLETED|Overall Study||0
9789206|NCT00548184|10896544|FG000|STARTED|Overall Study||65
9952453|NCT01422239|11071434|FG001|NOT COMPLETED|Overall Study||3
9789207|NCT00548184|10896544|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
9789208|NCT00548184|10896544|FG000|NOT COMPLETED|Overall Study||5
9789209|NCT00548197|10896550|FG000|STARTED|Overall Study||18
9789210|NCT00548197|10896551|FG001|STARTED|Overall Study||22
9789211|NCT00548197|10896550|FG000|COMPLETED|Overall Study||18
9789212|NCT00548197|10896551|FG001|COMPLETED|Overall Study||22
9789213|NCT00548197|10896550|FG000|NOT COMPLETED|Overall Study||0
9789214|NCT00548197|10896551|FG001|NOT COMPLETED|Overall Study||0
9789215|NCT00548249|10896564|FG000|STARTED|Overall Study||26
9789216|NCT00548249|10896565|FG001|STARTED|Overall Study||26
9789217|NCT00548249|10896566|FG002|STARTED|Overall Study||29
9789218|NCT00548249|10896567|FG003|STARTED|Overall Study||22
9789219|NCT00548249|10896568|FG004|STARTED|Overall Study||28
9789220|NCT00548249|10896564|FG000|COMPLETED|Overall Study||10
9789221|NCT00548249|10896565|FG001|COMPLETED|Overall Study||13
9789222|NCT00548249|10896566|FG002|COMPLETED|Overall Study||9
9789223|NCT00548249|10896567|FG003|COMPLETED|Overall Study||9
9789224|NCT00548249|10896568|FG004|COMPLETED|Overall Study||7
9789225|NCT00548249|10896564|FG000|NOT COMPLETED|Overall Study||16
9789226|NCT00548249|10896565|FG001|NOT COMPLETED|Overall Study||13
9789227|NCT00548249|10896566|FG002|NOT COMPLETED|Overall Study||20
9789228|NCT00548249|10896567|FG003|NOT COMPLETED|Overall Study||13
9789229|NCT00548249|10896568|FG004|NOT COMPLETED|Overall Study||21
9789230|NCT00548262|10896580|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
9789231|NCT00548262|10896580|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
9789232|NCT00548262|10896580|FG000|NOT COMPLETED|Overall Study||32
9789233|NCT00548340|10896587|FG000|STARTED|Overall Study||109
9789234|NCT00548340|10896588|FG001|STARTED|Overall Study||109
9789235|NCT00548340|10896589|FG002|STARTED|Overall Study||104
9789236|NCT00548340|10896587|FG000|COMPLETED|Overall Study||101
9789237|NCT00548340|10896588|FG001|COMPLETED|Overall Study||98
9789238|NCT00548340|10896589|FG002|COMPLETED|Overall Study||95
9789239|NCT00548340|10896587|FG000|NOT COMPLETED|Overall Study||8
9789240|NCT00548340|10896588|FG001|NOT COMPLETED|Overall Study||11
9789241|NCT00548340|10896589|FG002|NOT COMPLETED|Overall Study||9
9789242|NCT00548405|10896600|FG000|STARTED|Overall Study|Randomized.|231
9789243|NCT00548405|10896601|FG001|STARTED|Overall Study|Randomized.|436
9789244|NCT00548405|10896602|FG002|STARTED|Overall Study|Randomized.|173
9789245|NCT00548405|10896600|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
9789246|NCT00548405|10896601|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
9789247|NCT00548405|10896602|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
9789248|NCT00548405|10896600|FG000|COMPLETED|Overall Study||175
10015425|NCT01806298|11138507|FG000|NOT COMPLETED|Overall Study||10
10015426|NCT01806389|11138511|FG000|STARTED|Overall Study||14
10015427|NCT01806389|11138511|FG000|COMPLETED|Overall Study||10
10015428|NCT01806389|11138511|FG000|NOT COMPLETED|Overall Study||4
10015429|NCT01806506|11138527|FG000|STARTED|Overall Study||36
10015430|NCT01806506|11138528|FG001|STARTED|Overall Study||36
10015431|NCT01806506|11138527|FG000|1 Month|Overall Study||36
10015432|NCT01806506|11138528|FG001|1 Month|Overall Study||36
10015433|NCT01806506|11138527|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35
10015434|NCT01806506|11138528|FG001|3 Months|Overall Study||36
10015435|NCT01806506|11138527|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34
10015436|NCT01806506|11138528|FG001|6 Months|Overall Study||36
10015437|NCT01806506|11138527|FG000|9 Months|Overall Study||34
10015438|NCT01806506|11138528|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35
10015439|NCT01806506|11138527|FG000|COMPLETED|Overall Study||34
10015440|NCT01806506|11138528|FG001|COMPLETED|Overall Study||35
10015441|NCT01806506|11138527|FG000|NOT COMPLETED|Overall Study||2
10015442|NCT01806506|11138528|FG001|NOT COMPLETED|Overall Study||1
10015443|NCT01806545|11138536|FG000|STARTED|Overall Study||29
10015444|NCT01806545|11138537|FG001|STARTED|Overall Study||35
10015445|NCT01806545|11138536|FG000|COMPLETED|Overall Study||23
10015446|NCT01806545|11138537|FG001|COMPLETED|Overall Study||30
10015447|NCT01806545|11138536|FG000|NOT COMPLETED|Overall Study||6
10015448|NCT01806545|11138537|FG001|NOT COMPLETED|Overall Study||5
10112102|NCT02501538|11243177|FG000|NOT COMPLETED|Overall Study||3
10112103|NCT02501590|11243186|FG000|STARTED|Overall Study||13
10112104|NCT02501590|11243187|FG001|STARTED|Overall Study||35
10234229|NCT01530880|11364187|FG000|COMPLETED|Overall Study||35
10234230|NCT01530880|11364187|FG000|NOT COMPLETED|Overall Study||0
10234231|NCT01530087|11364192|FG000|STARTED|Overall Study||3
10234232|NCT01530087|11364192|FG000|COMPLETED|Overall Study||1
10234233|NCT01530087|11364192|FG000|NOT COMPLETED|Overall Study||2
10234234|NCT01527942|11364199|FG000|STARTED|Overall Study||16
10234235|NCT01527942|11364200|FG001|STARTED|Overall Study||18
10234236|NCT01527942|11364199|FG000|COMPLETED|Overall Study||16
10234237|NCT01527942|11364200|FG001|COMPLETED|Overall Study||18
9789249|NCT00548405|10896601|FG001|COMPLETED|Overall Study||416
9789250|NCT00548405|10896602|FG002|COMPLETED|Overall Study||164
9789251|NCT00548405|10896600|FG000|NOT COMPLETED|Overall Study||56
9789252|NCT00548405|10896601|FG001|NOT COMPLETED|Overall Study||20
10015449|NCT01806571|11138543|FG000|STARTED|Overall Study||34
10112105|NCT02501590|11243186|FG000|COMPLETED|Overall Study||13
10234238|NCT01527942|11364199|FG000|NOT COMPLETED|Overall Study||0
9789253|NCT00548405|10896602|FG002|NOT COMPLETED|Overall Study||9
9789254|NCT00548418|10896611|FG000|STARTED|Overall Study||27
9789255|NCT00548418|10896611|FG000|COMPLETED|Overall Study||27
9789256|NCT00548418|10896611|FG000|NOT COMPLETED|Overall Study||0
9789257|NCT00548431|10896615|FG000|STARTED|Overall Study||38
9789258|NCT00548431|10896615|FG000|COMPLETED|Overall Study||38
9789259|NCT00548431|10896615|FG000|NOT COMPLETED|Overall Study||0
9789260|NCT00548470|10896619|FG000|STARTED|Overall Study||14
9789261|NCT00548470|10896619|FG000|COMPLETED|Overall Study||12
9789262|NCT00548470|10896619|FG000|NOT COMPLETED|Overall Study||2
9789263|NCT00548548|10896625|FG000|STARTED|Overall Study||387
9789264|NCT00548548|10896626|FG001|STARTED|Overall Study||387
9789265|NCT00548548|10896625|FG000|Treated|Overall Study||383
9789266|NCT00548548|10896626|FG001|Treated|Overall Study||384
9789267|NCT00548548|10896625|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
9789268|NCT00548548|10896626|FG001|Safety Population|Overall Study||381
9789269|NCT00548548|10896625|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
9789270|NCT00548548|10896626|FG001|COMPLETED|Overall Study||21
9789271|NCT00548548|10896625|FG000|NOT COMPLETED|Overall Study||362
9789272|NCT00548548|10896626|FG001|NOT COMPLETED|Overall Study||366
9789273|NCT00548652|10896635|FG000|STARTED|Overall Study||18
9789274|NCT00548652|10896636|FG001|STARTED|Overall Study||38
9789275|NCT00548652|10896637|FG002|STARTED|Overall Study||45
9789276|NCT00548652|10896635|FG000|COMPLETED|Overall Study||16
9789277|NCT00548652|10896636|FG001|COMPLETED|Overall Study||29
9789278|NCT00548652|10896637|FG002|COMPLETED|Overall Study||34
9789279|NCT00548652|10896635|FG000|NOT COMPLETED|Overall Study||2
9789280|NCT00548652|10896636|FG001|NOT COMPLETED|Overall Study||9
9789281|NCT00548652|10896637|FG002|NOT COMPLETED|Overall Study||11
9789282|NCT00548691|10896647|FG000|STARTED|Overall Study||258
9789283|NCT00548691|10896648|FG001|STARTED|Overall Study||259
9789284|NCT00548691|10896647|FG000|COMPLETED|Overall Study||251
9789285|NCT00548691|10896648|FG001|COMPLETED|Overall Study||250
9789286|NCT00548691|10896647|FG000|NOT COMPLETED|Overall Study||7
9789287|NCT00548691|10896648|FG001|NOT COMPLETED|Overall Study||9
9789288|NCT00548717|10896656|FG000|STARTED|Overall Study||13
9789289|NCT00548717|10896657|FG001|STARTED|Overall Study||2
9789290|NCT00548717|10896656|FG000|COMPLETED|Overall Study||4
9789291|NCT00548717|10896657|FG001|COMPLETED|Overall Study||0
9789292|NCT00548717|10896656|FG000|NOT COMPLETED|Overall Study||9
9789293|NCT00548717|10896657|FG001|NOT COMPLETED|Overall Study||2
9789294|NCT00548808|10896668|FG000|STARTED|Overall Study||214
9789295|NCT00548808|10896669|FG001|STARTED|Overall Study||212
9789296|NCT00548808|10896668|FG000|Full Analysis Set|Overall Study||211
9789297|NCT00548808|10896669|FG001|Full Analysis Set|Overall Study||212
9789298|NCT00548808|10896668|FG000|Per-Protocol Set|Overall Study||177
9789299|NCT00548808|10896669|FG001|Per-Protocol Set|Overall Study||184
9789300|NCT00548808|10896668|FG000|COMPLETED|Overall Study||172
9789301|NCT00548808|10896669|FG001|COMPLETED|Overall Study||186
9789302|NCT00548808|10896668|FG000|NOT COMPLETED|Overall Study||42
9789303|NCT00548808|10896669|FG001|NOT COMPLETED|Overall Study||26
9789304|NCT00548847|10896675|FG000|STARTED|Overall Study||15
9789305|NCT00548847|10896675|FG000|COMPLETED|Overall Study||8
9789306|NCT00548847|10896675|FG000|NOT COMPLETED|Overall Study||7
9789307|NCT00548860|10896681|FG000|STARTED|Overall Study||996
9789308|NCT00548860|10896682|FG001|STARTED|Overall Study||1022
9789309|NCT00548860|10896681|FG000|COMPLETED|Overall Study||860
9789310|NCT00548860|10896682|FG001|COMPLETED|Overall Study||847
9789311|NCT00548860|10896681|FG000|NOT COMPLETED|Overall Study||136
9789312|NCT00548860|10896682|FG001|NOT COMPLETED|Overall Study||175
9789313|NCT00549042|10896690|FG000|STARTED|Conversion and Titration Phase||459
9789314|NCT00549042|10896691|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
9789315|NCT00549042|10896690|FG000|COMPLETED|Conversion and Titration Phase||268
9789316|NCT00549042|10896691|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
9789317|NCT00549042|10896690|FG000|NOT COMPLETED|Conversion and Titration Phase||191
9789318|NCT00549042|10896691|FG001|NOT COMPLETED|Conversion and Titration Phase||0
9789319|NCT00549042|10896690|FG000|STARTED|Double-blind Phase||134
9789320|NCT00549042|10896691|FG001|STARTED|Double-blind Phase||134
9789321|NCT00549042|10896690|FG000|COMPLETED|Double-blind Phase||66
9789322|NCT00549042|10896691|FG001|COMPLETED|Double-blind Phase||44
9789323|NCT00549042|10896690|FG000|NOT COMPLETED|Double-blind Phase||68
9789324|NCT00549042|10896691|FG001|NOT COMPLETED|Double-blind Phase||90
9789325|NCT00549055|10896698|FG000|STARTED|Overall Study||38
9789326|NCT00549055|10896698|FG000|COMPLETED|Overall Study||3
9789327|NCT00549055|10896698|FG000|NOT COMPLETED|Overall Study||35
9789328|NCT00549172|10896704|FG000|STARTED|Overall Study||70
9789329|NCT00549172|10896705|FG001|STARTED|Overall Study||76
9789330|NCT00549172|10896704|FG000|COMPLETED|Overall Study||70
9789331|NCT00549172|10896705|FG001|COMPLETED|Overall Study||76
9789332|NCT00549172|10896704|FG000|NOT COMPLETED|Overall Study||0
9789333|NCT00549172|10896705|FG001|NOT COMPLETED|Overall Study||0
9789334|NCT00549198|10896713|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
9789335|NCT00549198|10896714|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
9789336|NCT00549198|10896713|FG000|COMPLETED|Overall Study||115
9789337|NCT00549198|10896714|FG001|COMPLETED|Overall Study||134
9789338|NCT00549198|10896713|FG000|NOT COMPLETED|Overall Study||80
9789339|NCT00549198|10896714|FG001|NOT COMPLETED|Overall Study||63
9789340|NCT00549302|10896722|FG000|STARTED|Double-Blind||63
9789341|NCT00549302|10896723|FG001|STARTED|Double-Blind||294
9789342|NCT00549302|10896724|FG002|STARTED|Double-Blind||0
9789343|NCT00549302|10896722|FG000|Received at Least One Dose of Study Drug|Double-Blind||63
9789344|NCT00549302|10896723|FG001|Received at Least One Dose of Study Drug|Double-Blind||294
9789345|NCT00549302|10896724|FG002|Received at Least One Dose of Study Drug|Double-Blind||0
9789346|NCT00549302|10896722|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
9789347|NCT00549302|10896723|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
9789348|NCT00549302|10896724|FG002|COMPLETED|Double-Blind||0
9789349|NCT00549302|10896722|FG000|NOT COMPLETED|Double-Blind||11
9789350|NCT00549302|10896723|FG001|NOT COMPLETED|Double-Blind||53
9789351|NCT00549302|10896724|FG002|NOT COMPLETED|Double-Blind||0
9789352|NCT00549302|10896722|FG000|STARTED|Open-Label||0
9789353|NCT00549302|10896723|FG001|STARTED|Open-Label||0
9789354|NCT00549302|10896724|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
9789355|NCT00549302|10896722|FG000|COMPLETED|Open-Label||0
9789356|NCT00549302|10896723|FG001|COMPLETED|Open-Label||0
9789357|NCT00549302|10896724|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
9789358|NCT00549302|10896722|FG000|NOT COMPLETED|Open-Label||0
9789359|NCT00549302|10896723|FG001|NOT COMPLETED|Open-Label||0
9789360|NCT00549302|10896724|FG002|NOT COMPLETED|Open-Label||69
9789361|NCT00549393|10896734|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
9789362|NCT00549393|10896735|FG001|STARTED|Period 1 (6 Months)|ITT|1199
9789363|NCT00549393|10896734|FG000|Per Protocol|Period 1 (6 Months)||880
9789364|NCT00549393|10896735|FG001|Per Protocol|Period 1 (6 Months)||1199
9789365|NCT00549393|10896734|FG000|COMPLETED|Period 1 (6 Months)||1319
9789366|NCT00549393|10896735|FG001|COMPLETED|Period 1 (6 Months)||1199
9789367|NCT00549393|10896734|FG000|NOT COMPLETED|Period 1 (6 Months)||0
9789368|NCT00549393|10896735|FG001|NOT COMPLETED|Period 1 (6 Months)||0
9789369|NCT00549393|10896734|FG000|STARTED|Period 2 Washout (2 Weeks)||0
9789370|NCT00549393|10896735|FG001|STARTED|Period 2 Washout (2 Weeks)||0
9789371|NCT00549393|10896734|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0
9789372|NCT00549393|10896735|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0
9789373|NCT00549393|10896734|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
9789374|NCT00549393|10896735|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
9789375|NCT00549393|10896734|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
9789376|NCT00549393|10896735|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
9789377|NCT00549393|10896734|FG000|Per Protocol|Period 3 (6 Months)||667
9789378|NCT00549393|10896735|FG001|Per Protocol|Period 3 (6 Months)||1326
9789379|NCT00549393|10896734|FG000|COMPLETED|Period 3 (6 Months)||1103
9789380|NCT00549393|10896735|FG001|COMPLETED|Period 3 (6 Months)||1326
9789381|NCT00549393|10896734|FG000|NOT COMPLETED|Period 3 (6 Months)||0
9789382|NCT00549393|10896735|FG001|NOT COMPLETED|Period 3 (6 Months)||0
9789383|NCT00549445|10896745|FG000|STARTED|Overall Study||23
9789384|NCT00549445|10896746|FG001|STARTED|Overall Study||30
9789385|NCT00549445|10896745|FG000|COMPLETED|Overall Study||8
9789386|NCT00549445|10896746|FG001|COMPLETED|Overall Study||13
9789387|NCT00549445|10896745|FG000|NOT COMPLETED|Overall Study||15
9789388|NCT00549445|10896746|FG001|NOT COMPLETED|Overall Study||17
9789389|NCT00549549|10896756|FG000|STARTED|Overall Study||101
9789390|NCT00549549|10896757|FG001|STARTED|Overall Study||99
9789391|NCT00549549|10896758|FG002|STARTED|Overall Study||99
9789392|NCT00549549|10896759|FG003|STARTED|Overall Study||103
9789393|NCT00549549|10896756|FG000|Treated|Overall Study||101
9789394|NCT00549549|10896757|FG001|Treated|Overall Study||99
9789395|NCT00549549|10896758|FG002|Treated|Overall Study||98
9789396|NCT00549549|10896759|FG003|Treated|Overall Study||102
9789397|NCT00549549|10896756|FG000|COMPLETED|Overall Study||77
9789398|NCT00549549|10896757|FG001|COMPLETED|Overall Study||77
9789399|NCT00549549|10896758|FG002|COMPLETED|Overall Study||82
9789400|NCT00549549|10896759|FG003|COMPLETED|Overall Study||78
9789401|NCT00549549|10896756|FG000|NOT COMPLETED|Overall Study||24
9789402|NCT00549549|10896757|FG001|NOT COMPLETED|Overall Study||22
9789403|NCT00549549|10896758|FG002|NOT COMPLETED|Overall Study||17
9789404|NCT00549549|10896759|FG003|NOT COMPLETED|Overall Study||25
9789405|NCT00549562|10896769|FG000|STARTED|Overall Study||25
9789406|NCT00549562|10896769|FG000|COMPLETED|Overall Study||23
9789407|NCT00549562|10896769|FG000|NOT COMPLETED|Overall Study||2
9789408|NCT00549601|10896776|FG000|STARTED|Randomized||43
9789409|NCT00549601|10896777|FG001|STARTED|Randomized||48
9789410|NCT00549601|10896778|FG002|STARTED|Randomized||51
9789411|NCT00549601|10896776|FG000|COMPLETED|Randomized||43
9789412|NCT00549601|10896777|FG001|COMPLETED|Randomized||47
9789413|NCT00549601|10896778|FG002|COMPLETED|Randomized||49
9789414|NCT00549601|10896776|FG000|NOT COMPLETED|Randomized||0
9789415|NCT00549601|10896777|FG001|NOT COMPLETED|Randomized||1
9789416|NCT00549601|10896778|FG002|NOT COMPLETED|Randomized||2
9789417|NCT00549601|10896776|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
9789418|NCT00549601|10896777|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
9789419|NCT00549601|10896778|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
9789420|NCT00549601|10896776|FG000|COMPLETED|Received Study Drug||36
9789421|NCT00549601|10896777|FG001|COMPLETED|Received Study Drug||36
9789422|NCT00549601|10896778|FG002|COMPLETED|Received Study Drug||45
9789423|NCT00549601|10896776|FG000|NOT COMPLETED|Received Study Drug||7
9789424|NCT00549601|10896777|FG001|NOT COMPLETED|Received Study Drug||11
9789425|NCT00549601|10896778|FG002|NOT COMPLETED|Received Study Drug||4
9789426|NCT00549640|10896790|FG000|STARTED|Overall Study||40
9789427|NCT00549640|10896791|FG001|STARTED|Overall Study||40
9789428|NCT00549640|10896790|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
9789429|NCT00549640|10896791|FG001|COMPLETED|Overall Study||24
9789430|NCT00549640|10896790|FG000|NOT COMPLETED|Overall Study||18
9789431|NCT00549640|10896791|FG001|NOT COMPLETED|Overall Study||16
9789432|NCT00549718|10896801|FG000|STARTED|Overall Study||125
9789433|NCT00549718|10896802|FG001|STARTED|Overall Study||123
9789434|NCT00549718|10896803|FG002|STARTED|Overall Study||124
9789435|NCT00549718|10896804|FG003|STARTED|Overall Study||128
9789436|NCT00549718|10896801|FG000|COMPLETED|Overall Study||84
9789437|NCT00549718|10896802|FG001|COMPLETED|Overall Study||86
9789438|NCT00549718|10896803|FG002|COMPLETED|Overall Study||85
9789439|NCT00549718|10896804|FG003|COMPLETED|Overall Study||73
9789440|NCT00549718|10896801|FG000|NOT COMPLETED|Overall Study||41
9789441|NCT00549718|10896802|FG001|NOT COMPLETED|Overall Study||37
9789442|NCT00549718|10896803|FG002|NOT COMPLETED|Overall Study||39
9789443|NCT00549718|10896804|FG003|NOT COMPLETED|Overall Study||55
9789444|NCT00549757|10896816|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
9789445|NCT00549757|10896817|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310
9789446|NCT00549757|10896816|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
9789447|NCT00549757|10896817|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
9789448|NCT00549757|10896816|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272
9789449|NCT00549757|10896817|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285
9789450|NCT00549757|10896816|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0
9789451|NCT00549757|10896817|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0
9789452|NCT00549757|10896816|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
9789453|NCT00549757|10896817|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
9789454|NCT00549757|10896816|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
9789455|NCT00549757|10896817|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
9789456|NCT00549757|10896816|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148
9789457|NCT00549757|10896817|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182
9789458|NCT00549757|10896816|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625
9789459|NCT00549757|10896817|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635
9789460|NCT00549770|10896837|FG000|STARTED|Overall Study||156
9789461|NCT00549770|10896838|FG001|STARTED|Overall Study||169
9789462|NCT00549770|10896839|FG002|STARTED|Overall Study||172
9789463|NCT00549770|10896840|FG003|STARTED|Overall Study||163
9789464|NCT00549770|10896841|FG004|STARTED|Overall Study||166
9789465|NCT00549770|10896842|FG005|STARTED|Overall Study||164
9789466|NCT00549770|10896843|FG006|STARTED|Overall Study||165
9789467|NCT00549770|10896844|FG007|STARTED|Overall Study||173
9789468|NCT00549770|10896837|FG000|Intent-to-treat Population|Overall Study||154
9789469|NCT00549770|10896838|FG001|Intent-to-treat Population|Overall Study||168
10015450|NCT01806571|11138543|FG000|COMPLETED|Overall Study||34
10015451|NCT01806571|11138543|FG000|NOT COMPLETED|Overall Study||0
10015452|NCT01806584|11138549|FG000|STARTED|Overall Study||14
10015453|NCT01806584|11138550|FG001|STARTED|Overall Study||18
10015454|NCT01806584|11138549|FG000|COMPLETED|Overall Study||0
10015455|NCT01806584|11138550|FG001|COMPLETED|Overall Study||0
10015456|NCT01806584|11138549|FG000|NOT COMPLETED|Overall Study||14
10015457|NCT01806584|11138550|FG001|NOT COMPLETED|Overall Study||18
10015458|NCT01806597|11138559|FG000|STARTED|Period 1 (Baseline to Week 16)||68
10015459|NCT01806597|11138560|FG001|STARTED|Period 1 (Baseline to Week 16)||69
10015460|NCT01806597|11138561|FG002|STARTED|Period 1 (Baseline to Week 16)||0
10234239|NCT01527942|11364200|FG001|NOT COMPLETED|Overall Study||0
10234240|NCT01521143|11364210|FG000|STARTED|Overall Study||40
10234241|NCT01521143|11364211|FG001|STARTED|Overall Study||36
10234242|NCT01521143|11364212|FG002|STARTED|Overall Study||8
10234243|NCT01521143|11364213|FG003|STARTED|Overall Study||7
10234244|NCT01521143|11364210|FG000|Received Treatment|Overall Study||20
10234245|NCT01521143|11364211|FG001|Received Treatment|Overall Study||20
10234246|NCT01521143|11364212|FG002|Received Treatment|Overall Study||3
10234247|NCT01521143|11364213|FG003|Received Treatment|Overall Study||4
10234248|NCT01521143|11364210|FG000|COMPLETED|Overall Study||11
10234249|NCT01521143|11364211|FG001|COMPLETED|Overall Study||10
10234250|NCT01521143|11364212|FG002|COMPLETED|Overall Study||0
10234251|NCT01521143|11364213|FG003|COMPLETED|Overall Study||0
9789470|NCT00549770|10896839|FG002|Intent-to-treat Population|Overall Study||170
9789471|NCT00549770|10896840|FG003|Intent-to-treat Population|Overall Study||163
9789472|NCT00549770|10896841|FG004|Intent-to-treat Population|Overall Study||163
9789473|NCT00549770|10896842|FG005|Intent-to-treat Population|Overall Study||163
10015461|NCT01806597|11138562|FG003|STARTED|Period 1 (Baseline to Week 16)||0
10015462|NCT01806597|11138563|FG004|STARTED|Period 1 (Baseline to Week 16)||68
10234252|NCT01521143|11364210|FG000|NOT COMPLETED|Overall Study||29
10234253|NCT01521143|11364211|FG001|NOT COMPLETED|Overall Study||26
10234254|NCT01521143|11364212|FG002|NOT COMPLETED|Overall Study||8
10234255|NCT01521143|11364213|FG003|NOT COMPLETED|Overall Study||7
9789474|NCT00549770|10896843|FG006|Intent-to-treat Population|Overall Study||164
9789475|NCT00549770|10896844|FG007|Intent-to-treat Population|Overall Study||172
9789476|NCT00549770|10896837|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48
9789477|NCT00549770|10896838|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61
9789478|NCT00549770|10896839|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53
9789479|NCT00549770|10896840|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55
9789480|NCT00549770|10896841|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49
9789481|NCT00549770|10896842|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54
9789482|NCT00549770|10896843|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50
9789483|NCT00549770|10896844|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57
9789484|NCT00549770|10896837|FG000|COMPLETED|Overall Study||149
9789485|NCT00549770|10896838|FG001|COMPLETED|Overall Study||158
9789486|NCT00549770|10896839|FG002|COMPLETED|Overall Study||162
9789487|NCT00549770|10896840|FG003|COMPLETED|Overall Study||147
9789488|NCT00549770|10896841|FG004|COMPLETED|Overall Study||149
9789489|NCT00549770|10896842|FG005|COMPLETED|Overall Study||151
9789490|NCT00549770|10896843|FG006|COMPLETED|Overall Study||151
9789491|NCT00549770|10896844|FG007|COMPLETED|Overall Study||148
9789492|NCT00549770|10896837|FG000|NOT COMPLETED|Overall Study||7
9789493|NCT00549770|10896838|FG001|NOT COMPLETED|Overall Study||11
9789494|NCT00549770|10896839|FG002|NOT COMPLETED|Overall Study||10
9789495|NCT00549770|10896840|FG003|NOT COMPLETED|Overall Study||16
9789496|NCT00549770|10896841|FG004|NOT COMPLETED|Overall Study||17
9789497|NCT00549770|10896842|FG005|NOT COMPLETED|Overall Study||13
9789498|NCT00549770|10896843|FG006|NOT COMPLETED|Overall Study||14
9789499|NCT00549770|10896844|FG007|NOT COMPLETED|Overall Study||25
9789500|NCT00549783|10896864|FG000|STARTED|Overall Study||139
9789501|NCT00549783|10896865|FG001|STARTED|Overall Study||135
9789502|NCT00549783|10896864|FG000|COMPLETED|Overall Study||131
9789503|NCT00549783|10896865|FG001|COMPLETED|Overall Study||122
9789504|NCT00549783|10896864|FG000|NOT COMPLETED|Overall Study||8
9789505|NCT00549783|10896865|FG001|NOT COMPLETED|Overall Study||13
9789506|NCT00549822|10896871|FG000|STARTED|Overall Study||3
9789507|NCT00549822|10896871|FG000|COMPLETED|Overall Study||3
9789508|NCT00549822|10896871|FG000|NOT COMPLETED|Overall Study||0
9789509|NCT00549900|10896875|FG000|STARTED|Overall Study||30
9789510|NCT00549900|10896875|FG000|COMPLETED|Overall Study||29
9789511|NCT00549900|10896875|FG000|NOT COMPLETED|Overall Study||1
9789512|NCT00549939|10896882|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
9789513|NCT00549939|10896883|FG001|STARTED|12-week Double Blind Treatment Period||57
9789514|NCT00549939|10896884|FG002|STARTED|12-week Double Blind Treatment Period||58
9789515|NCT00549939|10896882|FG000|COMPLETED|12-week Double Blind Treatment Period||56
9789516|NCT00549939|10896883|FG001|COMPLETED|12-week Double Blind Treatment Period||55
9789517|NCT00549939|10896884|FG002|COMPLETED|12-week Double Blind Treatment Period||56
9789518|NCT00549939|10896882|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1
9789519|NCT00549939|10896883|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2
9789520|NCT00549939|10896884|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2
9789521|NCT00549939|10896882|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
10234256|NCT01532635|11364223|FG000|STARTED|Overall Study||4
10234257|NCT01532635|11364223|FG000|COMPLETED|Overall Study||4
10234258|NCT01532635|11364223|FG000|NOT COMPLETED|Overall Study||0
10234259|NCT01531387|11364229|FG000|STARTED|Overall Study||11
10234260|NCT01531387|11364230|FG001|STARTED|Overall Study||11
10234261|NCT01531387|11364229|FG000|COMPLETED|Overall Study||0
10234262|NCT01531387|11364230|FG001|COMPLETED|Overall Study||0
10234263|NCT01531387|11364229|FG000|NOT COMPLETED|Overall Study||11
10234264|NCT01531387|11364230|FG001|NOT COMPLETED|Overall Study||11
10234265|NCT01532362|11364238|FG000|STARTED|Overall Study||1
10234266|NCT01532362|11364239|FG001|STARTED|Overall Study||0
10234267|NCT01532362|11364238|FG000|COMPLETED|Overall Study||1
10234268|NCT01532362|11364239|FG001|COMPLETED|Overall Study||0
10234269|NCT01532362|11364238|FG000|NOT COMPLETED|Overall Study||0
10234270|NCT01532362|11364239|FG001|NOT COMPLETED|Overall Study||0
10234271|NCT01527292|11364249|FG000|STARTED|Overall Study||0
10234272|NCT01527292|11364250|FG001|STARTED|Overall Study||3
10234273|NCT01527292|11364249|FG000|COMPLETED|Overall Study||0
10234274|NCT01527292|11364250|FG001|COMPLETED|Overall Study||0
10234275|NCT01527292|11364249|FG000|NOT COMPLETED|Overall Study||0
10234276|NCT01527292|11364250|FG001|NOT COMPLETED|Overall Study||3
10234277|NCT01525745|11364258|FG000|STARTED|Overall Study||4
10234278|NCT01525745|11364259|FG001|STARTED|Overall Study||2
10234279|NCT01525745|11364258|FG000|COMPLETED|Overall Study||3
10234280|NCT01525745|11364259|FG001|COMPLETED|Overall Study||1
10234281|NCT01525745|11364258|FG000|NOT COMPLETED|Overall Study||1
10234282|NCT01525745|11364259|FG001|NOT COMPLETED|Overall Study||1
10234283|NCT01528696|11364269|FG000|STARTED|Overall Study||18
9789522|NCT00549939|10896883|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
9789523|NCT00549939|10896884|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
9789524|NCT00549939|10896882|FG000|COMPLETED|40-week Open Label Treatment Period||0
9789525|NCT00549939|10896883|FG001|COMPLETED|40-week Open Label Treatment Period||75
10234284|NCT01528696|11364270|FG001|STARTED|Overall Study||19
10234285|NCT01528696|11364269|FG000|Hospital Stay (2-5 Days)|Overall Study||18
9789526|NCT00549939|10896884|FG002|COMPLETED|40-week Open Label Treatment Period||78
9789527|NCT00549939|10896882|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0
9789528|NCT00549939|10896883|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5
9789529|NCT00549939|10896884|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5
9789530|NCT00550043|10896899|FG000|STARTED|Overall Study||9
9789531|NCT00550043|10896900|FG001|STARTED|Overall Study||12
9789532|NCT00550043|10896901|FG002|STARTED|Overall Study||9
9789533|NCT00550043|10896902|FG003|STARTED|Overall Study||10
9789534|NCT00550043|10896903|FG004|STARTED|Overall Study||10
10234286|NCT01528696|11364270|FG001|Hospital Stay (2-5 Days)|Overall Study||19
10234287|NCT01528696|11364269|FG000|COMPLETED|Overall Study||0
10234288|NCT01528696|11364270|FG001|COMPLETED|Overall Study||0
10234289|NCT01528696|11364269|FG000|NOT COMPLETED|Overall Study||18
10234290|NCT01528696|11364270|FG001|NOT COMPLETED|Overall Study||19
9789535|NCT00550043|10896899|FG000|COMPLETED|Overall Study||9
9789536|NCT00550043|10896900|FG001|COMPLETED|Overall Study||9
9789537|NCT00550043|10896901|FG002|COMPLETED|Overall Study||8
9789538|NCT00550043|10896902|FG003|COMPLETED|Overall Study||8
9789539|NCT00550043|10896903|FG004|COMPLETED|Overall Study||9
9789540|NCT00550043|10896899|FG000|NOT COMPLETED|Overall Study||0
9789541|NCT00550043|10896900|FG001|NOT COMPLETED|Overall Study||3
9789542|NCT00550043|10896901|FG002|NOT COMPLETED|Overall Study||1
9789543|NCT00550043|10896902|FG003|NOT COMPLETED|Overall Study||2
9789544|NCT00550043|10896903|FG004|NOT COMPLETED|Overall Study||1
9789545|NCT00550147|10896915|FG000|STARTED|OROS Methylphenidate Monotherapy||30
9789546|NCT00550147|10896915|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24
9789547|NCT00550147|10896915|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
9789548|NCT00550147|10896915|FG000|STARTED|Quetiapine Addition Treatment Period||24
9789549|NCT00550147|10896915|FG000|COMPLETED|Quetiapine Addition Treatment Period||18
9789550|NCT00550147|10896915|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6
9789551|NCT00550173|10896931|FG000|STARTED|Overall Study||81
9789552|NCT00550173|10896932|FG001|STARTED|Overall Study||82
9789553|NCT00550173|10896933|FG002|STARTED|Overall Study||84
9789554|NCT00550173|10896931|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
9789555|NCT00550173|10896932|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
9789556|NCT00550173|10896933|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
9789557|NCT00550173|10896931|FG000|Not Discontinued at 18 Months|Overall Study||9
9789558|NCT00550173|10896932|FG001|Not Discontinued at 18 Months|Overall Study||19
9789559|NCT00550173|10896933|FG002|Not Discontinued at 18 Months|Overall Study||11
9789560|NCT00550173|10896931|FG000|COMPLETED|Overall Study||9
9789561|NCT00550173|10896932|FG001|COMPLETED|Overall Study||19
9789562|NCT00550173|10896933|FG002|COMPLETED|Overall Study||11
9789563|NCT00550173|10896931|FG000|NOT COMPLETED|Overall Study||72
9789564|NCT00550173|10896932|FG001|NOT COMPLETED|Overall Study||63
9789565|NCT00550173|10896933|FG002|NOT COMPLETED|Overall Study||73
9789566|NCT00550238|10896942|FG000|STARTED|Overall Study||459
9789567|NCT00550238|10896942|FG000|COMPLETED|Overall Study||0
9789568|NCT00550238|10896942|FG000|NOT COMPLETED|Overall Study||459
9789569|NCT00550277|10896946|FG000|STARTED|Overall Study||20
9789570|NCT00550277|10896946|FG000|COMPLETED|Overall Study||11
9789571|NCT00550277|10896946|FG000|NOT COMPLETED|Overall Study||9
9789572|NCT00550290|10896952|FG000|STARTED|Overall Study||10
9789573|NCT00550290|10896953|FG001|STARTED|Overall Study||8
9789574|NCT00550290|10896952|FG000|COMPLETED|Overall Study||10
9789575|NCT00550290|10896953|FG001|COMPLETED|Overall Study||8
9789576|NCT00550290|10896952|FG000|NOT COMPLETED|Overall Study||0
9789577|NCT00550290|10896953|FG001|NOT COMPLETED|Overall Study||0
9789578|NCT00550368|10896961|FG000|STARTED|Overall Study||26
9789579|NCT00550368|10896962|FG001|STARTED|Overall Study||19
9789580|NCT00550368|10896961|FG000|COMPLETED|Overall Study||26
9789581|NCT00550368|10896962|FG001|COMPLETED|Overall Study||19
9789582|NCT00550368|10896961|FG000|NOT COMPLETED|Overall Study||0
9789583|NCT00550368|10896962|FG001|NOT COMPLETED|Overall Study||0
9789584|NCT00550394|10896970|FG000|STARTED|Overall Study||21
9789585|NCT00550394|10896971|FG001|STARTED|Overall Study||18
9789586|NCT00550394|10896970|FG000|COMPLETED|Overall Study||9
9789587|NCT00550394|10896971|FG001|COMPLETED|Overall Study||5
9789588|NCT00550394|10896970|FG000|NOT COMPLETED|Overall Study||12
9789589|NCT00550394|10896971|FG001|NOT COMPLETED|Overall Study||13
9789590|NCT00550407|10896981|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
9789591|NCT00550407|10896982|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
9789592|NCT00550407|10896983|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
9789593|NCT00550407|10896981|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
9789594|NCT00550407|10896982|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
9789595|NCT00550407|10896983|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
9789596|NCT00550407|10896981|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
9789597|NCT00550407|10896982|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
9789598|NCT00550407|10896983|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
9789599|NCT00550407|10896981|FG000|STARTED|26-Week Randomized Phase||0
9789600|NCT00550407|10896982|FG001|STARTED|26-Week Randomized Phase||58
9789601|NCT00550407|10896983|FG002|STARTED|26-Week Randomized Phase||45
9789602|NCT00550407|10896981|FG000|COMPLETED|26-Week Randomized Phase||0
9789603|NCT00550407|10896982|FG001|COMPLETED|26-Week Randomized Phase||15
9789604|NCT00550407|10896983|FG002|COMPLETED|26-Week Randomized Phase||21
9789605|NCT00550407|10896981|FG000|NOT COMPLETED|26-Week Randomized Phase||0
9789606|NCT00550407|10896982|FG001|NOT COMPLETED|26-Week Randomized Phase||43
9789607|NCT00550407|10896983|FG002|NOT COMPLETED|26-Week Randomized Phase||24
9789608|NCT00550420|10896991|FG000|STARTED|Overall Study||331
9789609|NCT00550420|10896991|FG000|COMPLETED|Overall Study||26
9789610|NCT00550420|10896991|FG000|NOT COMPLETED|Overall Study||305
9789611|NCT00550446|10897004|FG000|STARTED|Up To Week 12||54
9789612|NCT00550446|10897005|FG001|STARTED|Up To Week 12||52
9789613|NCT00550446|10897006|FG002|STARTED|Up To Week 12||50
9789614|NCT00550446|10897007|FG003|STARTED|Up To Week 12||61
9789615|NCT00550446|10897008|FG004|STARTED|Up To Week 12||57
9789616|NCT00550446|10897009|FG005|STARTED|Up To Week 12||53
9789617|NCT00550446|10897010|FG006|STARTED|Up To Week 12||59
9789618|NCT00550446|10897011|FG007|STARTED|Up To Week 12||0
9789619|NCT00550446|10897012|FG008|STARTED|Up To Week 12||0
9789620|NCT00550446|10897013|FG009|STARTED|Up To Week 12||0
9789621|NCT00550446|10897014|FG010|STARTED|Up To Week 12||0
9789622|NCT00550446|10897004|FG000|Treated|Up To Week 12||54
9789623|NCT00550446|10897005|FG001|Treated|Up To Week 12||51
9789624|NCT00550446|10897006|FG002|Treated|Up To Week 12||49
9789625|NCT00550446|10897007|FG003|Treated|Up To Week 12||61
9789626|NCT00550446|10897008|FG004|Treated|Up To Week 12||57
9789627|NCT00550446|10897009|FG005|Treated|Up To Week 12||53
9789628|NCT00550446|10897010|FG006|Treated|Up To Week 12||59
9789629|NCT00550446|10897011|FG007|Treated|Up To Week 12||0
9789630|NCT00550446|10897012|FG008|Treated|Up To Week 12||0
9789631|NCT00550446|10897013|FG009|Treated|Up To Week 12||0
9789632|NCT00550446|10897014|FG010|Treated|Up To Week 12||0
9789633|NCT00550446|10897004|FG000|COMPLETED|Up To Week 12||44
9789634|NCT00550446|10897005|FG001|COMPLETED|Up To Week 12||47
9789635|NCT00550446|10897006|FG002|COMPLETED|Up To Week 12||46
9789636|NCT00550446|10897007|FG003|COMPLETED|Up To Week 12||58
9789637|NCT00550446|10897008|FG004|COMPLETED|Up To Week 12||54
9789638|NCT00550446|10897009|FG005|COMPLETED|Up To Week 12||45
9789639|NCT00550446|10897010|FG006|COMPLETED|Up To Week 12||46
9789640|NCT00550446|10897011|FG007|COMPLETED|Up To Week 12||0
9789641|NCT00550446|10897012|FG008|COMPLETED|Up To Week 12||0
9789642|NCT00550446|10897013|FG009|COMPLETED|Up To Week 12||0
9789643|NCT00550446|10897014|FG010|COMPLETED|Up To Week 12||0
9789644|NCT00550446|10897004|FG000|NOT COMPLETED|Up To Week 12||10
9789645|NCT00550446|10897005|FG001|NOT COMPLETED|Up To Week 12||5
9789646|NCT00550446|10897006|FG002|NOT COMPLETED|Up To Week 12||4
9789647|NCT00550446|10897007|FG003|NOT COMPLETED|Up To Week 12||3
9789648|NCT00550446|10897008|FG004|NOT COMPLETED|Up To Week 12||3
9789649|NCT00550446|10897009|FG005|NOT COMPLETED|Up To Week 12||8
9789650|NCT00550446|10897010|FG006|NOT COMPLETED|Up To Week 12||13
9789651|NCT00550446|10897011|FG007|NOT COMPLETED|Up To Week 12||0
9789652|NCT00550446|10897012|FG008|NOT COMPLETED|Up To Week 12||0
9789653|NCT00550446|10897013|FG009|NOT COMPLETED|Up To Week 12||0
9789654|NCT00550446|10897014|FG010|NOT COMPLETED|Up To Week 12||0
9789655|NCT00550446|10897004|FG000|STARTED|Post Week 12||27
9789656|NCT00550446|10897005|FG001|STARTED|Post Week 12||30
9789657|NCT00550446|10897006|FG002|STARTED|Post Week 12||46
9789658|NCT00550446|10897007|FG003|STARTED|Post Week 12||58
9789659|NCT00550446|10897008|FG004|STARTED|Post Week 12||54
9789660|NCT00550446|10897009|FG005|STARTED|Post Week 12||1
9789661|NCT00550446|10897010|FG006|STARTED|Post Week 12||21
9789662|NCT00550446|10897011|FG007|STARTED|Post Week 12||17
9789663|NCT00550446|10897012|FG008|STARTED|Post Week 12||17
9789664|NCT00550446|10897013|FG009|STARTED|Post Week 12||44
9789665|NCT00550446|10897014|FG010|STARTED|Post Week 12||25
9789666|NCT00550446|10897004|FG000|COMPLETED|Post Week 12||24
9789667|NCT00550446|10897005|FG001|COMPLETED|Post Week 12||28
9789668|NCT00550446|10897006|FG002|COMPLETED|Post Week 12||43
9789669|NCT00550446|10897007|FG003|COMPLETED|Post Week 12||55
9789670|NCT00550446|10897008|FG004|COMPLETED|Post Week 12||52
9789671|NCT00550446|10897009|FG005|COMPLETED|Post Week 12||0
9789672|NCT00550446|10897010|FG006|COMPLETED|Post Week 12||19
9789673|NCT00550446|10897011|FG007|COMPLETED|Post Week 12||16
9789674|NCT00550446|10897012|FG008|COMPLETED|Post Week 12||15
9789675|NCT00550446|10897013|FG009|COMPLETED|Post Week 12||37
9789676|NCT00550446|10897014|FG010|COMPLETED|Post Week 12||24
9789677|NCT00550446|10897004|FG000|NOT COMPLETED|Post Week 12||3
9789678|NCT00550446|10897005|FG001|NOT COMPLETED|Post Week 12||2
9789679|NCT00550446|10897006|FG002|NOT COMPLETED|Post Week 12||3
9789680|NCT00550446|10897007|FG003|NOT COMPLETED|Post Week 12||3
9789681|NCT00550446|10897008|FG004|NOT COMPLETED|Post Week 12||2
9789682|NCT00550446|10897009|FG005|NOT COMPLETED|Post Week 12||1
9789683|NCT00550446|10897010|FG006|NOT COMPLETED|Post Week 12||2
9789684|NCT00550446|10897011|FG007|NOT COMPLETED|Post Week 12||1
9789685|NCT00550446|10897012|FG008|NOT COMPLETED|Post Week 12||2
9789686|NCT00550446|10897013|FG009|NOT COMPLETED|Post Week 12||7
9789687|NCT00550446|10897014|FG010|NOT COMPLETED|Post Week 12||1
9789688|NCT00550459|10897054|FG000|STARTED|Overall Study||28
9789689|NCT00550459|10897055|FG001|STARTED|Overall Study||29
9789690|NCT00550459|10897054|FG000|COMPLETED|Overall Study||27
9789691|NCT00550459|10897055|FG001|COMPLETED|Overall Study||26
9789692|NCT00550459|10897054|FG000|NOT COMPLETED|Overall Study||1
9789693|NCT00550459|10897055|FG001|NOT COMPLETED|Overall Study||3
9789694|NCT00550537|10897061|FG000|STARTED|Overall Study||116
9789695|NCT00550537|10897061|FG000|COMPLETED|Overall Study||12
9789696|NCT00550537|10897061|FG000|NOT COMPLETED|Overall Study||104
9789697|NCT00550550|10897072|FG000|STARTED|Overall Study||176
9789698|NCT00550550|10897073|FG001|STARTED|Overall Study||169
9789699|NCT00550550|10897072|FG000|Number Treated|Overall Study||175
9789700|NCT00550550|10897073|FG001|Number Treated|Overall Study||169
9789701|NCT00550550|10897072|FG000|COMPLETED|Overall Study||142
9789702|NCT00550550|10897073|FG001|COMPLETED|Overall Study||140
9789703|NCT00550550|10897072|FG000|NOT COMPLETED|Overall Study||34
9789704|NCT00550550|10897073|FG001|NOT COMPLETED|Overall Study||29
9789705|NCT00550589|10897079|FG000|STARTED|Overall Study||33
9789706|NCT00550589|10897079|FG000|COMPLETED|Overall Study||33
9789707|NCT00550589|10897079|FG000|NOT COMPLETED|Overall Study||0
9789708|NCT00550615|10897087|FG000|STARTED|Overall Study||3
9789709|NCT00550615|10897088|FG001|STARTED|Overall Study||3
9789710|NCT00550615|10897089|FG002|STARTED|Overall Study||10
9789711|NCT00550615|10897090|FG003|STARTED|Overall Study||22
9789712|NCT00550615|10897087|FG000|COMPLETED|Overall Study||3
9789713|NCT00550615|10897088|FG001|COMPLETED|Overall Study||3
9789714|NCT00550615|10897089|FG002|COMPLETED|Overall Study||6
9789715|NCT00550615|10897090|FG003|COMPLETED|Overall Study||12
9789716|NCT00550615|10897087|FG000|NOT COMPLETED|Overall Study||0
9789717|NCT00550615|10897088|FG001|NOT COMPLETED|Overall Study||0
9789718|NCT00550615|10897089|FG002|NOT COMPLETED|Overall Study||4
9789719|NCT00550615|10897090|FG003|NOT COMPLETED|Overall Study||10
9789720|NCT00550654|10897096|FG000|STARTED|Overall Study||1
9789721|NCT00550654|10897096|FG000|COMPLETED|Overall Study||1
9789722|NCT00550654|10897096|FG000|NOT COMPLETED|Overall Study||0
9789723|NCT00550680|10897100|FG000|STARTED|Overall Study||208
9789724|NCT00550680|10897100|FG000|COMPLETED|Overall Study||152
9789725|NCT00550680|10897100|FG000|NOT COMPLETED|Overall Study||56
9789726|NCT00550732|10897104|FG000|STARTED|Overall Study||40
9789727|NCT00550732|10897104|FG000|COMPLETED|Overall Study||29
9789728|NCT00550732|10897104|FG000|NOT COMPLETED|Overall Study||11
9789729|NCT00550745|10897111|FG000|STARTED|Overall Study||6000
9789730|NCT00550745|10897112|FG001|STARTED|Overall Study||5999
9789731|NCT00550745|10897111|FG000|COMPLETED|Overall Study||5913
9789732|NCT00550745|10897112|FG001|COMPLETED|Overall Study||5939
9789733|NCT00550745|10897111|FG000|NOT COMPLETED|Overall Study||87
9789734|NCT00550745|10897112|FG001|NOT COMPLETED|Overall Study||60
9789735|NCT00550771|10897120|FG000|STARTED|Overall Study||121
9789736|NCT00550771|10897121|FG001|STARTED|Overall Study||60
9789737|NCT00550771|10897120|FG000|COMPLETED|Overall Study||104
9789738|NCT00550771|10897121|FG001|COMPLETED|Overall Study||50
9789739|NCT00550771|10897120|FG000|NOT COMPLETED|Overall Study||17
9789740|NCT00550771|10897121|FG001|NOT COMPLETED|Overall Study||10
9789741|NCT00550836|10897129|FG000|STARTED|Overall Study||49
9789742|NCT00550836|10897130|FG001|STARTED|Overall Study||55
9789743|NCT00550836|10897129|FG000|COMPLETED|Overall Study||46
9789744|NCT00550836|10897130|FG001|COMPLETED|Overall Study||46
9789745|NCT00550836|10897129|FG000|NOT COMPLETED|Overall Study||3
9789746|NCT00550836|10897130|FG001|NOT COMPLETED|Overall Study||9
9789747|NCT00550862|10897140|FG000|STARTED|Overall Study||38
10234291|NCT01526408|11364278|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0
10234292|NCT01526408|11364279|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0
10234293|NCT01526408|11364278|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
10234294|NCT01526408|11364279|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
10234295|NCT01526408|11364278|FG000|NOT COMPLETED|Overall Study||0
10234296|NCT01526408|11364279|FG001|NOT COMPLETED|Overall Study||0
10234297|NCT01528293|11364287|FG000|STARTED|Overall Study||1
10234298|NCT01528293|11364288|FG001|STARTED|Overall Study||1
10234299|NCT01528293|11364287|FG000|COMPLETED|Overall Study||0
10234300|NCT01528293|11364288|FG001|COMPLETED|Overall Study||1
10234301|NCT01528293|11364287|FG000|NOT COMPLETED|Overall Study||1
10234302|NCT01528293|11364288|FG001|NOT COMPLETED|Overall Study||0
10234303|NCT01525927|11364296|FG000|STARTED|Overall Study||0
10234304|NCT01525927|11364296|FG000|COMPLETED|Overall Study||0
10234305|NCT01525927|11364296|FG000|NOT COMPLETED|Overall Study||0
10234306|NCT01520714|11364304|FG000|STARTED|Overall Study||0
10234307|NCT01520714|11364305|FG001|STARTED|Overall Study||11
10234308|NCT01520714|11364304|FG000|COMPLETED|Overall Study||0
10234309|NCT01520714|11364305|FG001|COMPLETED|Overall Study||5
10234310|NCT01520714|11364304|FG000|NOT COMPLETED|Overall Study||0
10234311|NCT01520714|11364305|FG001|NOT COMPLETED|Overall Study||6
10234312|NCT01507233|11364313|FG000|STARTED|Overall Study||5
10234313|NCT01507233|11364314|FG001|STARTED|Overall Study||0
10234314|NCT01507233|11364313|FG000|COMPLETED|Overall Study||5
10234315|NCT01507233|11364314|FG001|COMPLETED|Overall Study||0
10234316|NCT01507233|11364313|FG000|NOT COMPLETED|Overall Study||0
10234317|NCT01507233|11364314|FG001|NOT COMPLETED|Overall Study||0
10234318|NCT01516034|11364320|FG000|STARTED|Overall Study||8
10234319|NCT01516034|11364320|FG000|COMPLETED|Overall Study||0
10234320|NCT01516034|11364320|FG000|NOT COMPLETED|Overall Study||8
10234321|NCT01500772|11364324|FG000|STARTED|Overall Study||6
10234322|NCT01500772|11364324|FG000|COMPLETED|Overall Study||0
10234323|NCT01500772|11364324|FG000|NOT COMPLETED|Overall Study||6
9789748|NCT00550862|10897141|FG001|STARTED|Overall Study||48
9789749|NCT00550862|10897142|FG002|STARTED|Overall Study||41
9789750|NCT00550862|10897143|FG003|STARTED|Overall Study||38
9789751|NCT00550862|10897140|FG000|COMPLETED|Overall Study||32
10234324|NCT01517763|11364331|FG000|STARTED|Overall Study||0
10234325|NCT01517763|11364332|FG001|STARTED|Overall Study||0
9789752|NCT00550862|10897141|FG001|COMPLETED|Overall Study||42
9789753|NCT00550862|10897142|FG002|COMPLETED|Overall Study||25
9789754|NCT00550862|10897143|FG003|COMPLETED|Overall Study||37
9789755|NCT00550862|10897140|FG000|NOT COMPLETED|Overall Study||6
9789756|NCT00550862|10897141|FG001|NOT COMPLETED|Overall Study||6
9789757|NCT00550862|10897142|FG002|NOT COMPLETED|Overall Study||16
9789758|NCT00550862|10897143|FG003|NOT COMPLETED|Overall Study||1
9789759|NCT00550953|10897155|FG000|STARTED|Overall Study||156
9789760|NCT00550953|10897156|FG001|STARTED|Overall Study||158
9789761|NCT00550953|10897155|FG000|COMPLETED|Overall Study||150
9789762|NCT00550953|10897156|FG001|COMPLETED|Overall Study||152
9789763|NCT00550953|10897155|FG000|NOT COMPLETED|Overall Study||6
9789764|NCT00550953|10897156|FG001|NOT COMPLETED|Overall Study||6
9789765|NCT00551031|10897167|FG000|STARTED|Overall Study||637
9789766|NCT00551031|10897168|FG001|STARTED|Overall Study||636
9789767|NCT00551031|10897169|FG002|STARTED|Overall Study||319
9789768|NCT00551031|10897170|FG003|STARTED|Overall Study||320
9789769|NCT00551031|10897171|FG004|STARTED|Overall Study||186
9789770|NCT00551031|10897167|FG000|COMPLETED|Overall Study||635
9789771|NCT00551031|10897168|FG001|COMPLETED|Overall Study||625
9789772|NCT00551031|10897169|FG002|COMPLETED|Overall Study||317
9789773|NCT00551031|10897170|FG003|COMPLETED|Overall Study||317
9789774|NCT00551031|10897171|FG004|COMPLETED|Overall Study||185
9789775|NCT00551031|10897167|FG000|NOT COMPLETED|Overall Study||2
9789776|NCT00551031|10897168|FG001|NOT COMPLETED|Overall Study||11
9789777|NCT00551031|10897169|FG002|NOT COMPLETED|Overall Study||2
9789778|NCT00551031|10897170|FG003|NOT COMPLETED|Overall Study||3
10015463|NCT01806597|11138564|FG005|STARTED|Period 1 (Baseline to Week 16)||0
10015464|NCT01806597|11138559|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63
10015465|NCT01806597|11138560|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64
10015466|NCT01806597|11138561|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0
10015467|NCT01806597|11138562|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0
10015468|NCT01806597|11138563|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63
9789779|NCT00551031|10897171|FG004|NOT COMPLETED|Overall Study||1
9789780|NCT00551070|10897183|FG000|STARTED|Overall Study||52
9789781|NCT00551070|10897183|FG000|COMPLETED|Overall Study||52
9789782|NCT00551070|10897183|FG000|NOT COMPLETED|Overall Study||0
9789783|NCT00551135|10897191|FG000|STARTED|Overall Study||108
9789784|NCT00551135|10897192|FG001|STARTED|Overall Study||106
9789785|NCT00551135|10897193|FG002|STARTED|Overall Study||103
9789786|NCT00551135|10897194|FG003|STARTED|Overall Study||108
9789787|NCT00551135|10897191|FG000|COMPLETED|Overall Study||103
9789788|NCT00551135|10897192|FG001|COMPLETED|Overall Study||104
9789789|NCT00551135|10897193|FG002|COMPLETED|Overall Study||98
9789790|NCT00551135|10897194|FG003|COMPLETED|Overall Study||103
9789791|NCT00551135|10897191|FG000|NOT COMPLETED|Overall Study||5
9789792|NCT00551135|10897192|FG001|NOT COMPLETED|Overall Study||2
9789793|NCT00551135|10897193|FG002|NOT COMPLETED|Overall Study||5
9789794|NCT00551135|10897194|FG003|NOT COMPLETED|Overall Study||5
9789795|NCT00551161|10897204|FG000|STARTED|Overall Study||12
9789796|NCT00551161|10897204|FG000|COMPLETED|Overall Study||11
9789797|NCT00551161|10897204|FG000|NOT COMPLETED|Overall Study||1
9789798|NCT00551174|10897210|FG000|STARTED|Overall Study||381
9789799|NCT00551174|10897211|FG001|STARTED|Overall Study||400
9789800|NCT00551174|10897210|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
9789801|NCT00551174|10897211|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
9789802|NCT00551174|10897210|FG000|NOT COMPLETED|Overall Study||19
9789803|NCT00551174|10897211|FG001|NOT COMPLETED|Overall Study||6
9789804|NCT00551200|10897217|FG000|STARTED|Overall Study||14
9789805|NCT00551200|10897217|FG000|COMPLETED|Overall Study||10
9789806|NCT00551200|10897217|FG000|NOT COMPLETED|Overall Study||4
9789807|NCT00551213|10897229|FG000|STARTED|Overall Study||50
9789808|NCT00551213|10897230|FG001|STARTED|Overall Study||17
9789809|NCT00551213|10897229|FG000|Treated|Overall Study||49
9789810|NCT00551213|10897230|FG001|Treated|Overall Study||15
10015469|NCT01806597|11138564|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0
10234326|NCT01517763|11364333|FG002|STARTED|Overall Study||0
10015470|NCT01806597|11138559|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
10015471|NCT01806597|11138560|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
10015472|NCT01806597|11138561|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
10015473|NCT01806597|11138562|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
10015474|NCT01806597|11138563|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
10015475|NCT01806597|11138564|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
10112106|NCT02501590|11243187|FG001|COMPLETED|Overall Study||35
10112107|NCT02501590|11243186|FG000|NOT COMPLETED|Overall Study||0
10112108|NCT02501590|11243187|FG001|NOT COMPLETED|Overall Study||0
10112109|NCT02501629|11243195|FG000|STARTED|Overall Study||89
10112110|NCT02501629|11243196|FG001|STARTED|Overall Study||88
10112111|NCT02501629|11243195|FG000|COMPLETED|Overall Study||84
10112112|NCT02501629|11243196|FG001|COMPLETED|Overall Study||81
10112113|NCT02501629|11243195|FG000|NOT COMPLETED|Overall Study||5
10112114|NCT02501629|11243196|FG001|NOT COMPLETED|Overall Study||7
10234327|NCT01517763|11364331|FG000|COMPLETED|Overall Study||0
9789811|NCT00551213|10897229|FG000|COMPLETED|Overall Study||0
9789812|NCT00551213|10897230|FG001|COMPLETED|Overall Study||0
10112115|NCT02501642|11243204|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238
10112116|NCT02501642|11243205|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241
10112117|NCT02501642|11243204|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231
10234328|NCT01517763|11364332|FG001|COMPLETED|Overall Study||0
9789813|NCT00551213|10897229|FG000|NOT COMPLETED|Overall Study||50
9789814|NCT00551213|10897230|FG001|NOT COMPLETED|Overall Study||17
10112118|NCT02501642|11243205|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230
10112119|NCT02501642|11243204|FG000|NOT COMPLETED|Overall Study||7
10112120|NCT02501642|11243205|FG001|NOT COMPLETED|Overall Study||11
10112121|NCT02501811|11243215|FG000|STARTED|Overall Study||33
10234329|NCT01517763|11364333|FG002|COMPLETED|Overall Study||0
10234330|NCT01517763|11364331|FG000|NOT COMPLETED|Overall Study||0
10234331|NCT01517763|11364332|FG001|NOT COMPLETED|Overall Study||0
10234332|NCT01517763|11364333|FG002|NOT COMPLETED|Overall Study||0
10234333|NCT01507584|11364341|FG000|STARTED|Overall Study||0
10234334|NCT01507584|11364341|FG000|COMPLETED|Overall Study||0
10234335|NCT01507584|11364341|FG000|NOT COMPLETED|Overall Study||0
10234336|NCT01510756|11364345|FG000|STARTED|Overall Study||4
10234337|NCT01510756|11364345|FG000|COMPLETED|Overall Study||0
10234338|NCT01510756|11364345|FG000|NOT COMPLETED|Overall Study||4
10234339|NCT01511081|11364351|FG000|STARTED|Overall Study||8
10234340|NCT01511081|11364352|FG001|STARTED|Overall Study||9
10234341|NCT01511081|11364351|FG000|COMPLETED|Overall Study||8
10234342|NCT01511081|11364352|FG001|COMPLETED|Overall Study||9
10234343|NCT01511081|11364351|FG000|NOT COMPLETED|Overall Study||0
10234344|NCT01511081|11364352|FG001|NOT COMPLETED|Overall Study||0
9789815|NCT00551291|10897236|FG000|STARTED|Overall Study||10
9789816|NCT00551291|10897236|FG000|COMPLETED|Overall Study||9
9789817|NCT00551291|10897236|FG000|NOT COMPLETED|Overall Study||1
9789818|NCT00551369|10897240|FG000|STARTED|Overall Study||33
9789819|NCT00551369|10897240|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
9789820|NCT00551369|10897240|FG000|NOT COMPLETED|Overall Study||7
9789821|NCT00551421|10897244|FG000|STARTED|Original Protocol, Dose Level 1||3
9789822|NCT00551421|10897244|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
9789823|NCT00551421|10897244|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0
9789824|NCT00551421|10897244|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
9789825|NCT00551421|10897244|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
9789826|NCT00551421|10897244|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
9789827|NCT00551460|10897249|FG000|STARTED|Overall Study||78
9789828|NCT00551460|10897249|FG000|COMPLETED|Overall Study||60
9789829|NCT00551460|10897249|FG000|NOT COMPLETED|Overall Study||18
9830599|NCT00764322|10941303|FG000|NOT COMPLETED|Overall Study||20
9830600|NCT00764361|10941322|FG000|STARTED|Overall Study||8
9830601|NCT00764361|10941323|FG001|STARTED|Overall Study||7
9830602|NCT00764361|10941322|FG000|COMPLETED|Overall Study||6
9830603|NCT00764361|10941323|FG001|COMPLETED|Overall Study||3
9830604|NCT00764361|10941322|FG000|NOT COMPLETED|Overall Study||2
9830605|NCT00764361|10941323|FG001|NOT COMPLETED|Overall Study||4
9830606|NCT00764465|10941335|FG000|STARTED|Overall Study||9
9830607|NCT00764465|10941336|FG001|STARTED|Overall Study||7
9830608|NCT00764465|10941337|FG002|STARTED|Overall Study||7
9830609|NCT00764465|10941338|FG003|STARTED|Overall Study||7
9830610|NCT00764465|10941339|FG004|STARTED|Overall Study||7
9830611|NCT00764465|10941340|FG005|STARTED|Overall Study||8
9830612|NCT00764465|10941335|FG000|COMPLETED|Overall Study||7
9830613|NCT00764465|10941336|FG001|COMPLETED|Overall Study||6
9830614|NCT00764465|10941337|FG002|COMPLETED|Overall Study||6
9830615|NCT00764465|10941338|FG003|COMPLETED|Overall Study||6
9830616|NCT00764465|10941339|FG004|COMPLETED|Overall Study||6
9830617|NCT00764465|10941340|FG005|COMPLETED|Overall Study||7
9830618|NCT00764465|10941335|FG000|NOT COMPLETED|Overall Study||2
9830619|NCT00764465|10941336|FG001|NOT COMPLETED|Overall Study||1
9830620|NCT00764465|10941337|FG002|NOT COMPLETED|Overall Study||1
9830621|NCT00764465|10941338|FG003|NOT COMPLETED|Overall Study||1
9830622|NCT00764465|10941339|FG004|NOT COMPLETED|Overall Study||1
9830623|NCT00764465|10941340|FG005|NOT COMPLETED|Overall Study||1
9830624|NCT00764491|10941359|FG000|STARTED|Overall Study||123
9830625|NCT00764491|10941360|FG001|STARTED|Overall Study||33
9830626|NCT00764491|10941359|FG000|COMPLETED|Overall Study||88
9830627|NCT00764491|10941360|FG001|COMPLETED|Overall Study||16
9830628|NCT00764491|10941359|FG000|NOT COMPLETED|Overall Study||35
9830629|NCT00764491|10941360|FG001|NOT COMPLETED|Overall Study||17
9830630|NCT00764504|10941369|FG000|STARTED|Overall Study||141
9830631|NCT00764504|10941370|FG001|STARTED|Overall Study||141
9830632|NCT00764504|10941371|FG002|STARTED|Overall Study||234
9830633|NCT00764504|10941369|FG000|COMPLETED|Overall Study||75
9830634|NCT00764504|10941370|FG001|COMPLETED|Overall Study||71
9830635|NCT00764504|10941371|FG002|COMPLETED|Overall Study||131
9830636|NCT00764504|10941369|FG000|NOT COMPLETED|Overall Study||66
9830637|NCT00764504|10941370|FG001|NOT COMPLETED|Overall Study||70
9830638|NCT00764504|10941371|FG002|NOT COMPLETED|Overall Study||103
9830639|NCT00764517|10941381|FG000|STARTED|Overall Study||39
10112122|NCT02501811|11243216|FG001|STARTED|Overall Study||29
10234345|NCT01500109|11364361|FG000|STARTED|Overall Study||0
10234346|NCT01500109|11364362|FG001|STARTED|Overall Study||0
10234347|NCT01500109|11364363|FG002|STARTED|Overall Study||0
9830640|NCT00764517|10941382|FG001|STARTED|Overall Study||18
9830641|NCT00764517|10941381|FG000|COMPLETED|Overall Study||24
9830642|NCT00764517|10941382|FG001|COMPLETED|Overall Study||4
10234348|NCT01500109|11364361|FG000|COMPLETED|Overall Study||0
10234349|NCT01500109|11364362|FG001|COMPLETED|Overall Study||0
9830643|NCT00764517|10941381|FG000|NOT COMPLETED|Overall Study||15
10112123|NCT02501811|11243217|FG002|STARTED|Overall Study||31
10234350|NCT01500109|11364363|FG002|COMPLETED|Overall Study||0
10234351|NCT01500109|11364361|FG000|NOT COMPLETED|Overall Study||0
10234352|NCT01500109|11364362|FG001|NOT COMPLETED|Overall Study||0
9789830|NCT00551525|10897253|FG000|STARTED|Overall Study||67
9789831|NCT00551525|10897253|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
9789832|NCT00551525|10897253|FG000|NOT COMPLETED|Overall Study||5
9789833|NCT00551642|10897259|FG000|STARTED|Treatment Period||399
9789834|NCT00551642|10897260|FG001|STARTED|Treatment Period||401
9789835|NCT00551642|10897259|FG000|Safety Population|Treatment Period||395
9789836|NCT00551642|10897260|FG001|Safety Population|Treatment Period||397
9789837|NCT00551642|10897259|FG000|COMPLETED|Treatment Period||338
9789838|NCT00551642|10897260|FG001|COMPLETED|Treatment Period||338
9789839|NCT00551642|10897259|FG000|NOT COMPLETED|Treatment Period||61
9789840|NCT00551642|10897260|FG001|NOT COMPLETED|Treatment Period||63
9789841|NCT00551642|10897259|FG000|STARTED|7-Year Follow-up||152
9789842|NCT00551642|10897260|FG001|STARTED|7-Year Follow-up||153
9789843|NCT00551642|10897259|FG000|COMPLETED|7-Year Follow-up||152
9789844|NCT00551642|10897260|FG001|COMPLETED|7-Year Follow-up||153
9789845|NCT00551642|10897259|FG000|NOT COMPLETED|7-Year Follow-up||0
9789846|NCT00551642|10897260|FG001|NOT COMPLETED|7-Year Follow-up||0
9789847|NCT00551707|10897271|FG000|STARTED|Overall Study||4
9789848|NCT00551707|10897272|FG001|STARTED|Overall Study||22
9789849|NCT00551707|10897273|FG002|STARTED|Overall Study||13
9789850|NCT00551707|10897274|FG003|STARTED|Overall Study||8
9789851|NCT00551707|10897275|FG004|STARTED|Overall Study||4
9789852|NCT00551707|10897271|FG000|COMPLETED|Overall Study||4
9789853|NCT00551707|10897272|FG001|COMPLETED|Overall Study||16
9789854|NCT00551707|10897273|FG002|COMPLETED|Overall Study||10
9789855|NCT00551707|10897274|FG003|COMPLETED|Overall Study||4
9789856|NCT00551707|10897275|FG004|COMPLETED|Overall Study||3
9789857|NCT00551707|10897271|FG000|NOT COMPLETED|Overall Study||0
9789858|NCT00551707|10897272|FG001|NOT COMPLETED|Overall Study||6
9789859|NCT00551707|10897273|FG002|NOT COMPLETED|Overall Study||3
9789860|NCT00551707|10897274|FG003|NOT COMPLETED|Overall Study||4
9789861|NCT00551707|10897275|FG004|NOT COMPLETED|Overall Study||1
9789862|NCT00551746|10897291|FG000|STARTED|Overall Study||36
9789863|NCT00551746|10897292|FG001|STARTED|Overall Study||34
9789864|NCT00551746|10897291|FG000|COMPLETED|Overall Study||25
9789865|NCT00551746|10897292|FG001|COMPLETED|Overall Study||26
9789866|NCT00551746|10897291|FG000|NOT COMPLETED|Overall Study||11
9789867|NCT00551746|10897292|FG001|NOT COMPLETED|Overall Study||8
9789868|NCT00551759|10897298|FG000|STARTED|Overall Study||22
9789869|NCT00551759|10897298|FG000|Eligible and Began Treatment|Overall Study||21
9789870|NCT00551759|10897298|FG000|Underwent Surgery|Overall Study||17
9789871|NCT00551759|10897298|FG000|Received Adjuvant Therapy|Overall Study||12
9789872|NCT00551759|10897298|FG000|COMPLETED|Overall Study||9
9789873|NCT00551759|10897298|FG000|NOT COMPLETED|Overall Study||13
9789874|NCT00552058|10897304|FG000|STARTED|Overall Study||223
9789875|NCT00552058|10897305|FG001|STARTED|Overall Study||216
9789876|NCT00552058|10897304|FG000|COMPLETED|Overall Study||207
9789877|NCT00552058|10897305|FG001|COMPLETED|Overall Study||192
9789878|NCT00552058|10897304|FG000|NOT COMPLETED|Overall Study||16
9789879|NCT00552058|10897305|FG001|NOT COMPLETED|Overall Study||24
9789880|NCT00552071|10897313|FG000|STARTED|Overall Study||10
9789881|NCT00552071|10897314|FG001|STARTED|Overall Study||11
9789882|NCT00552071|10897313|FG000|COMPLETED|Overall Study||6
9789883|NCT00552071|10897314|FG001|COMPLETED|Overall Study||9
9789884|NCT00552071|10897313|FG000|NOT COMPLETED|Overall Study||4
9789885|NCT00552071|10897314|FG001|NOT COMPLETED|Overall Study||2
9789886|NCT00552084|10897324|FG000|STARTED|Overall Study||126
9789887|NCT00552084|10897325|FG001|STARTED|Overall Study||64
9789888|NCT00552084|10897324|FG000|COMPLETED|Overall Study||118
9789889|NCT00552084|10897325|FG001|COMPLETED|Overall Study||55
9789890|NCT00552084|10897324|FG000|NOT COMPLETED|Overall Study||8
9789891|NCT00552084|10897325|FG001|NOT COMPLETED|Overall Study||9
9789892|NCT00552110|10897336|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
9789893|NCT00552110|10897337|FG001|STARTED|Overall Study||139
9789894|NCT00552110|10897338|FG002|STARTED|Overall Study||139
9789895|NCT00552110|10897339|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
9789896|NCT00552110|10897340|FG004|STARTED|Overall Study||142
9789897|NCT00552110|10897336|FG000|COMPLETED|Overall Study||142
9789898|NCT00552110|10897337|FG001|COMPLETED|Overall Study||134
9789899|NCT00552110|10897338|FG002|COMPLETED|Overall Study||137
9789900|NCT00552110|10897339|FG003|COMPLETED|Overall Study||133
9789901|NCT00552110|10897340|FG004|COMPLETED|Overall Study||133
9789902|NCT00552110|10897336|FG000|NOT COMPLETED|Overall Study||4
9789903|NCT00552110|10897337|FG001|NOT COMPLETED|Overall Study||5
9789904|NCT00552110|10897338|FG002|NOT COMPLETED|Overall Study||2
9789905|NCT00552110|10897339|FG003|NOT COMPLETED|Overall Study||8
9789906|NCT00552110|10897340|FG004|NOT COMPLETED|Overall Study||9
9789907|NCT00552175|10897355|FG000|STARTED|Overall Study||167
9789908|NCT00552175|10897356|FG001|STARTED|Overall Study||86
9789909|NCT00552175|10897357|FG002|STARTED|Overall Study||86
9789910|NCT00552175|10897355|FG000|Full Analysis Set Population|Overall Study||167
9789911|NCT00552175|10897356|FG001|Full Analysis Set Population|Overall Study||85
9789912|NCT00552175|10897357|FG002|Full Analysis Set Population|Overall Study||86
9789913|NCT00552175|10897355|FG000|COMPLETED|Overall Study||150
9789914|NCT00552175|10897356|FG001|COMPLETED|Overall Study||73
9789915|NCT00552175|10897357|FG002|COMPLETED|Overall Study||72
9789916|NCT00552175|10897355|FG000|NOT COMPLETED|Overall Study||17
9789917|NCT00552175|10897356|FG001|NOT COMPLETED|Overall Study||13
9789918|NCT00552175|10897357|FG002|NOT COMPLETED|Overall Study||14
9789919|NCT00552188|10897368|FG000|STARTED|Overall Study||26
9789920|NCT00552188|10897369|FG001|STARTED|Overall Study||26
9789921|NCT00552188|10897368|FG000|COMPLETED|Overall Study||24
9789922|NCT00552188|10897369|FG001|COMPLETED|Overall Study||21
9789923|NCT00552188|10897368|FG000|NOT COMPLETED|Overall Study||2
9789924|NCT00552188|10897369|FG001|NOT COMPLETED|Overall Study||5
9789925|NCT00552240|10897377|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
9789926|NCT00552240|10897378|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
9789927|NCT00552240|10897377|FG000|COMPLETED|Overall Study||51
9789928|NCT00552240|10897378|FG001|COMPLETED|Overall Study||59
9789929|NCT00552240|10897377|FG000|NOT COMPLETED|Overall Study||24
9789930|NCT00552240|10897378|FG001|NOT COMPLETED|Overall Study||18
9789931|NCT00552279|10897386|FG000|STARTED|Overall Study||403
9789932|NCT00552279|10897387|FG001|STARTED|Overall Study||401
9789933|NCT00552279|10897386|FG000|COMPLETED|Overall Study||389
9789934|NCT00552279|10897387|FG001|COMPLETED|Overall Study||398
9789935|NCT00552279|10897386|FG000|NOT COMPLETED|Overall Study||14
9789936|NCT00552279|10897387|FG001|NOT COMPLETED|Overall Study||3
9789937|NCT00552305|10897393|FG000|STARTED|Overall Study||370
9789938|NCT00552305|10897393|FG000|COMPLETED|Overall Study||120
9789939|NCT00552305|10897393|FG000|NOT COMPLETED|Overall Study||250
9789940|NCT00552344|10897397|FG000|STARTED|Overall Study||402
9789941|NCT00552344|10897397|FG000|COMPLETED|Overall Study||87
9789942|NCT00552344|10897397|FG000|NOT COMPLETED|Overall Study||315
9789943|NCT00552396|10897409|FG000|STARTED|Overall Study||4
9789944|NCT00552396|10897410|FG001|STARTED|Overall Study||3
9789945|NCT00552396|10897411|FG002|STARTED|Overall Study||3
9789946|NCT00552396|10897412|FG003|STARTED|Overall Study||6
9789947|NCT00552396|10897413|FG004|STARTED|Overall Study||3
9789948|NCT00552396|10897414|FG005|STARTED|Overall Study||3
9789949|NCT00552396|10897415|FG006|STARTED|Overall Study||10
9789950|NCT00552396|10897409|FG000|COMPLETED|Overall Study||1
9789951|NCT00552396|10897410|FG001|COMPLETED|Overall Study||0
9789952|NCT00552396|10897411|FG002|COMPLETED|Overall Study||0
9789953|NCT00552396|10897412|FG003|COMPLETED|Overall Study||0
9789954|NCT00552396|10897413|FG004|COMPLETED|Overall Study||0
9789955|NCT00552396|10897414|FG005|COMPLETED|Overall Study||0
9789956|NCT00552396|10897415|FG006|COMPLETED|Overall Study||1
9789957|NCT00552396|10897409|FG000|NOT COMPLETED|Overall Study||3
9789958|NCT00552396|10897410|FG001|NOT COMPLETED|Overall Study||3
9789959|NCT00552396|10897411|FG002|NOT COMPLETED|Overall Study||3
9789960|NCT00552396|10897412|FG003|NOT COMPLETED|Overall Study||6
9789961|NCT00552396|10897413|FG004|NOT COMPLETED|Overall Study||3
9789962|NCT00552396|10897414|FG005|NOT COMPLETED|Overall Study||3
9789963|NCT00552396|10897415|FG006|NOT COMPLETED|Overall Study||9
9789964|NCT00552409|10897451|FG000|STARTED|Overall Study||11
9789965|NCT00552409|10897452|FG001|STARTED|Overall Study||11
9789966|NCT00552409|10897451|FG000|COMPLETED|Overall Study||10
9789967|NCT00552409|10897452|FG001|COMPLETED|Overall Study||9
9789968|NCT00552409|10897451|FG000|NOT COMPLETED|Overall Study||1
9789969|NCT00552409|10897452|FG001|NOT COMPLETED|Overall Study||2
9789970|NCT00552422|10897458|FG000|STARTED|Overall Study||6
9789971|NCT00552422|10897458|FG000|COMPLETED|Overall Study||6
9789972|NCT00552422|10897458|FG000|NOT COMPLETED|Overall Study||0
9789973|NCT00552448|10897464|FG000|STARTED|Overall Study||20
9789974|NCT00552448|10897465|FG001|STARTED|Overall Study||16
9789975|NCT00552448|10897464|FG000|COMPLETED|Overall Study||19
9789976|NCT00552448|10897465|FG001|COMPLETED|Overall Study||16
9789977|NCT00552448|10897464|FG000|NOT COMPLETED|Overall Study||1
9789978|NCT00552448|10897465|FG001|NOT COMPLETED|Overall Study||0
9789979|NCT00552578|10897473|FG000|STARTED|Overall Study||6
9789980|NCT00552578|10897474|FG001|STARTED|Overall Study||6
9789981|NCT00552578|10897473|FG000|COMPLETED|Overall Study||5
9789982|NCT00552578|10897474|FG001|COMPLETED|Overall Study||5
9789983|NCT00552578|10897473|FG000|NOT COMPLETED|Overall Study||1
9789984|NCT00552578|10897474|FG001|NOT COMPLETED|Overall Study||1
9789985|NCT00552617|10897490|FG000|STARTED|Overall Study||10
9789986|NCT00552617|10897491|FG001|STARTED|Overall Study||10
9789987|NCT00552617|10897492|FG002|STARTED|Overall Study||10
9789988|NCT00552617|10897493|FG003|STARTED|Overall Study||10
9789989|NCT00552617|10897494|FG004|STARTED|Overall Study||10
9789990|NCT00552617|10897495|FG005|STARTED|Overall Study||10
9789991|NCT00552617|10897496|FG006|STARTED|Overall Study||10
9789992|NCT00552617|10897497|FG007|STARTED|Overall Study||10
9789993|NCT00552617|10897498|FG008|STARTED|Overall Study||10
9789994|NCT00552617|10897499|FG009|STARTED|Overall Study||10
9789995|NCT00552617|10897490|FG000|Treated|Overall Study||10
9789996|NCT00552617|10897491|FG001|Treated|Overall Study||10
9789997|NCT00552617|10897492|FG002|Treated|Overall Study||9
9789998|NCT00552617|10897493|FG003|Treated|Overall Study||10
9789999|NCT00552617|10897494|FG004|Treated|Overall Study||10
9790000|NCT00552617|10897495|FG005|Treated|Overall Study||10
9790001|NCT00552617|10897496|FG006|Treated|Overall Study||10
9790002|NCT00552617|10897497|FG007|Treated|Overall Study||10
9790003|NCT00552617|10897498|FG008|Treated|Overall Study||10
9790004|NCT00552617|10897499|FG009|Treated|Overall Study||9
9790005|NCT00552617|10897490|FG000|COMPLETED|Overall Study||10
9790006|NCT00552617|10897491|FG001|COMPLETED|Overall Study||10
9790007|NCT00552617|10897492|FG002|COMPLETED|Overall Study||9
9790008|NCT00552617|10897493|FG003|COMPLETED|Overall Study||9
9790009|NCT00552617|10897494|FG004|COMPLETED|Overall Study||10
9790010|NCT00552617|10897495|FG005|COMPLETED|Overall Study||8
9790011|NCT00552617|10897496|FG006|COMPLETED|Overall Study||10
9790012|NCT00552617|10897497|FG007|COMPLETED|Overall Study||10
9790013|NCT00552617|10897498|FG008|COMPLETED|Overall Study||8
9790014|NCT00552617|10897499|FG009|COMPLETED|Overall Study||9
9790015|NCT00552617|10897490|FG000|NOT COMPLETED|Overall Study||0
9790016|NCT00552617|10897491|FG001|NOT COMPLETED|Overall Study||0
9790017|NCT00552617|10897492|FG002|NOT COMPLETED|Overall Study||1
9790018|NCT00552617|10897493|FG003|NOT COMPLETED|Overall Study||1
9790019|NCT00552617|10897494|FG004|NOT COMPLETED|Overall Study||0
9790020|NCT00552617|10897495|FG005|NOT COMPLETED|Overall Study||2
9790021|NCT00552617|10897496|FG006|NOT COMPLETED|Overall Study||0
9790022|NCT00552617|10897497|FG007|NOT COMPLETED|Overall Study||0
9790023|NCT00552617|10897498|FG008|NOT COMPLETED|Overall Study||2
9790024|NCT00552617|10897499|FG009|NOT COMPLETED|Overall Study||1
9790025|NCT00552669|10897523|FG000|STARTED|Overall Study|patients|100
9790026|NCT00552669|10897524|FG001|STARTED|Overall Study|patients|100
9790027|NCT00552669|10897523|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
9790028|NCT00552669|10897524|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
9790029|NCT00552669|10897523|FG000|NOT COMPLETED|Overall Study||3
9790030|NCT00552669|10897524|FG001|NOT COMPLETED|Overall Study||7
9790031|NCT00552695|10897532|FG000|STARTED|Overall Study|August 2007|22
9790032|NCT00552695|10897533|FG001|STARTED|Overall Study|August 2007|23
9790033|NCT00552695|10897532|FG000|COMPLETED|Overall Study|September 2007|22
9790034|NCT00552695|10897533|FG001|COMPLETED|Overall Study|September 2007|23
9790035|NCT00552695|10897532|FG000|NOT COMPLETED|Overall Study||0
9790036|NCT00552695|10897533|FG001|NOT COMPLETED|Overall Study||0
9790037|NCT00552760|10897541|FG000|STARTED|Overall Study||42
9790038|NCT00552760|10897542|FG001|STARTED|Overall Study||41
9790039|NCT00552760|10897541|FG000|COMPLETED|Overall Study||16
9790040|NCT00552760|10897542|FG001|COMPLETED|Overall Study||8
9790041|NCT00552760|10897541|FG000|NOT COMPLETED|Overall Study||26
9790042|NCT00552760|10897542|FG001|NOT COMPLETED|Overall Study||33
9790043|NCT00552786|10897550|FG000|STARTED|First Intervention||25
9790044|NCT00552786|10897551|FG001|STARTED|First Intervention||28
9790045|NCT00552786|10897550|FG000|Medication and Hearing Evaluation|First Intervention||25
9790046|NCT00552786|10897551|FG001|Medication and Hearing Evaluation|First Intervention||28
9790047|NCT00552786|10897550|FG000|COMPLETED|First Intervention||25
9790048|NCT00552786|10897551|FG001|COMPLETED|First Intervention||28
9790049|NCT00552786|10897550|FG000|NOT COMPLETED|First Intervention||0
9790050|NCT00552786|10897551|FG001|NOT COMPLETED|First Intervention||0
9790051|NCT00552786|10897550|FG000|STARTED|Washout Period of 2 Weeks||25
9790052|NCT00552786|10897551|FG001|STARTED|Washout Period of 2 Weeks||28
9790053|NCT00552786|10897550|FG000|COMPLETED|Washout Period of 2 Weeks||25
9790054|NCT00552786|10897551|FG001|COMPLETED|Washout Period of 2 Weeks||28
9790055|NCT00552786|10897550|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9790056|NCT00552786|10897551|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9790057|NCT00552786|10897550|FG000|STARTED|Second Intervention||25
9790058|NCT00552786|10897551|FG001|STARTED|Second Intervention||28
9790059|NCT00552786|10897550|FG000|COMPLETED|Second Intervention||25
9790060|NCT00552786|10897551|FG001|COMPLETED|Second Intervention||28
9790061|NCT00552786|10897550|FG000|NOT COMPLETED|Second Intervention||0
9790062|NCT00552786|10897551|FG001|NOT COMPLETED|Second Intervention||0
9790063|NCT00552812|10897557|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
9790064|NCT00552812|10897557|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
9790065|NCT00552812|10897557|FG000|NOT COMPLETED|Overall Study||20
9790066|NCT00552929|10897571|FG000|STARTED|Overall Study||9
9790067|NCT00552929|10897572|FG001|STARTED|Overall Study||10
9790068|NCT00552929|10897573|FG002|STARTED|Overall Study||10
10234353|NCT01500109|11364363|FG002|NOT COMPLETED|Overall Study||0
10234354|NCT01509053|11364371|FG000|STARTED|Oral Aripirazole (Phase A)||19
10234355|NCT01509053|11364371|FG000|COMPLETED|Oral Aripirazole (Phase A)||8
10234356|NCT01509053|11364371|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11
10234357|NCT01509053|11364371|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
10234358|NCT01509053|11364371|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
10234359|NCT01509053|11364371|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
10234360|NCT01509053|11364371|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
10234361|NCT01509053|11364371|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
10234362|NCT01509053|11364371|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
10234363|NCT01495988|11364383|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0
10234364|NCT01495988|11364384|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0
10234365|NCT01495988|11364385|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5
10234366|NCT01495988|11364386|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3
10234367|NCT01495988|11364383|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10234368|NCT01495988|11364384|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
9790069|NCT00552929|10897574|FG003|STARTED|Overall Study||11
9790070|NCT00552929|10897575|FG004|STARTED|Overall Study||10
9790071|NCT00552929|10897576|FG005|STARTED|Overall Study||10
9790072|NCT00552929|10897577|FG006|STARTED|Overall Study||10
10234369|NCT01495988|11364385|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
10234370|NCT01495988|11364386|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
9790073|NCT00552929|10897578|FG007|STARTED|Overall Study||11
9790074|NCT00552929|10897579|FG008|STARTED|Overall Study||10
9790075|NCT00552929|10897580|FG009|STARTED|Overall Study||11
9790076|NCT00552929|10897571|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
9790077|NCT00552929|10897572|FG001|Participants as Treated|Overall Study||10
9790078|NCT00552929|10897573|FG002|Participants as Treated|Overall Study||10
9790079|NCT00552929|10897574|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
9790080|NCT00552929|10897575|FG004|Participants as Treated|Overall Study||10
9790081|NCT00552929|10897576|FG005|Participants as Treated|Overall Study||9
9790082|NCT00552929|10897577|FG006|Participants as Treated|Overall Study||10
9790083|NCT00552929|10897578|FG007|Participants as Treated|Overall Study||11
9790084|NCT00552929|10897579|FG008|Participants as Treated|Overall Study||10
9790085|NCT00552929|10897580|FG009|Participants as Treated|Overall Study||11
9790086|NCT00552929|10897571|FG000|COMPLETED|Overall Study||9
9790087|NCT00552929|10897572|FG001|COMPLETED|Overall Study||10
9790088|NCT00552929|10897573|FG002|COMPLETED|Overall Study||10
9790089|NCT00552929|10897574|FG003|COMPLETED|Overall Study||11
9790090|NCT00552929|10897575|FG004|COMPLETED|Overall Study||10
9790091|NCT00552929|10897576|FG005|COMPLETED|Overall Study||9
9790092|NCT00552929|10897577|FG006|COMPLETED|Overall Study||10
9790093|NCT00552929|10897578|FG007|COMPLETED|Overall Study||11
9790094|NCT00552929|10897579|FG008|COMPLETED|Overall Study||9
9790095|NCT00552929|10897580|FG009|COMPLETED|Overall Study||11
9790096|NCT00552929|10897571|FG000|NOT COMPLETED|Overall Study||0
9790097|NCT00552929|10897572|FG001|NOT COMPLETED|Overall Study||0
9790098|NCT00552929|10897573|FG002|NOT COMPLETED|Overall Study||0
9790099|NCT00552929|10897574|FG003|NOT COMPLETED|Overall Study||0
9790100|NCT00552929|10897575|FG004|NOT COMPLETED|Overall Study||0
9790101|NCT00552929|10897576|FG005|NOT COMPLETED|Overall Study||1
9790102|NCT00552929|10897577|FG006|NOT COMPLETED|Overall Study||0
9790103|NCT00552929|10897578|FG007|NOT COMPLETED|Overall Study||0
9790104|NCT00552929|10897579|FG008|NOT COMPLETED|Overall Study||1
9790105|NCT00552929|10897580|FG009|NOT COMPLETED|Overall Study||0
9790106|NCT00553059|10897604|FG000|STARTED|Overall Study||31
9790107|NCT00553059|10897605|FG001|STARTED|Overall Study||31
9790108|NCT00553059|10897604|FG000|COMPLETED|Overall Study||30
9790109|NCT00553059|10897605|FG001|COMPLETED|Overall Study||29
9790110|NCT00553059|10897604|FG000|NOT COMPLETED|Overall Study||1
9790111|NCT00553059|10897605|FG001|NOT COMPLETED|Overall Study||2
9790112|NCT00553098|10897611|FG000|STARTED|Overall Study||29
9790113|NCT00553098|10897611|FG000|COMPLETED|Overall Study||28
9790114|NCT00553098|10897611|FG000|NOT COMPLETED|Overall Study||1
9790115|NCT00553150|10897621|FG000|STARTED|Overall Study||6
9790116|NCT00553150|10897622|FG001|STARTED|Overall Study||6
9790117|NCT00553150|10897623|FG002|STARTED|Overall Study||6
9790118|NCT00553150|10897624|FG003|STARTED|Overall Study||104
9790119|NCT00553150|10897621|FG000|COMPLETED|Overall Study||6
9790120|NCT00553150|10897622|FG001|COMPLETED|Overall Study||6
9790121|NCT00553150|10897623|FG002|COMPLETED|Overall Study||6
9790122|NCT00553150|10897624|FG003|COMPLETED|Overall Study||100
9790123|NCT00553150|10897621|FG000|NOT COMPLETED|Overall Study||0
9790124|NCT00553150|10897622|FG001|NOT COMPLETED|Overall Study||0
9790125|NCT00553150|10897623|FG002|NOT COMPLETED|Overall Study||0
9790126|NCT00553150|10897624|FG003|NOT COMPLETED|Overall Study||4
9790127|NCT00553163|10897634|FG000|STARTED|Overall Study||16
9790128|NCT00553163|10897635|FG001|STARTED|Overall Study||10
9952454|NCT01422304|11071442|FG000|STARTED|Overall Study|Randomized|598
9952455|NCT01422304|11071443|FG001|STARTED|Overall Study|Randomized|600
9952456|NCT01422304|11071442|FG000|Treated|Overall Study||595
9952457|NCT01422304|11071443|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
9790129|NCT00553163|10897634|FG000|COMPLETED|Overall Study||16
9790130|NCT00553163|10897635|FG001|COMPLETED|Overall Study||10
9790131|NCT00553163|10897634|FG000|NOT COMPLETED|Overall Study||0
9790132|NCT00553163|10897635|FG001|NOT COMPLETED|Overall Study||0
9790133|NCT00553202|10897646|FG000|STARTED|Overall Study||158
9790134|NCT00553202|10897646|FG000|COMPLETED|Overall Study||90
9790135|NCT00553202|10897646|FG000|NOT COMPLETED|Overall Study||68
9790136|NCT00553254|10897653|FG000|STARTED|Overall Study||6
9790137|NCT00553254|10897654|FG001|STARTED|Overall Study||6
9790138|NCT00553254|10897655|FG002|STARTED|Overall Study||43
9790139|NCT00553254|10897653|FG000|COMPLETED|Overall Study||0
9790140|NCT00553254|10897654|FG001|COMPLETED|Overall Study||0
9790141|NCT00553254|10897655|FG002|COMPLETED|Overall Study||0
9790142|NCT00553254|10897653|FG000|NOT COMPLETED|Overall Study||6
9790143|NCT00553254|10897654|FG001|NOT COMPLETED|Overall Study||6
9790144|NCT00553254|10897655|FG002|NOT COMPLETED|Overall Study||43
9790145|NCT00553267|10897670|FG000|STARTED|Overall Study||315
9790146|NCT00553267|10897671|FG001|STARTED|Overall Study||315
9790147|NCT00553267|10897672|FG002|STARTED|Overall Study||317
9790148|NCT00553267|10897670|FG000|COMPLETED|Overall Study||301
9790149|NCT00553267|10897671|FG001|COMPLETED|Overall Study||297
9790150|NCT00553267|10897672|FG002|COMPLETED|Overall Study||307
9790151|NCT00553267|10897670|FG000|NOT COMPLETED|Overall Study||14
9790152|NCT00553267|10897671|FG001|NOT COMPLETED|Overall Study||18
9790153|NCT00553267|10897672|FG002|NOT COMPLETED|Overall Study||10
9790154|NCT00553280|10897680|FG000|STARTED|Overall Study||123
9790155|NCT00553280|10897680|FG000|COMPLETED|Overall Study||97
9790156|NCT00553280|10897680|FG000|NOT COMPLETED|Overall Study||26
9790157|NCT00553319|10897687|FG000|STARTED|Overall Study||43
9790158|NCT00553319|10897688|FG001|STARTED|Overall Study||40
9790159|NCT00553319|10897689|FG002|STARTED|Overall Study||43
9790160|NCT00553319|10897687|FG000|COMPLETED|Overall Study||29
9790161|NCT00553319|10897688|FG001|COMPLETED|Overall Study||30
9790162|NCT00553319|10897689|FG002|COMPLETED|Overall Study||34
9790163|NCT00553319|10897687|FG000|NOT COMPLETED|Overall Study||14
9790164|NCT00553319|10897688|FG001|NOT COMPLETED|Overall Study||10
9790165|NCT00553319|10897689|FG002|NOT COMPLETED|Overall Study||9
9790166|NCT00553332|10897697|FG000|STARTED|Overall Study||29
9790167|NCT00553332|10897697|FG000|COMPLETED|Overall Study|evaluable for response|28
9790168|NCT00553332|10897697|FG000|NOT COMPLETED|Overall Study||1
9790169|NCT00553358|10897704|FG000|STARTED|Overall Study||152
9790170|NCT00553358|10897705|FG001|STARTED|Overall Study||154
9790171|NCT00553358|10897706|FG002|STARTED|Overall Study||149
9790172|NCT00553358|10897704|FG000|COMPLETED|Overall Study||73
9790173|NCT00553358|10897705|FG001|COMPLETED|Overall Study||58
9790174|NCT00553358|10897706|FG002|COMPLETED|Overall Study||61
9790175|NCT00553358|10897704|FG000|NOT COMPLETED|Overall Study||79
9790176|NCT00553358|10897705|FG001|NOT COMPLETED|Overall Study||96
9790177|NCT00553358|10897706|FG002|NOT COMPLETED|Overall Study||88
9790178|NCT00553410|10897722|FG000|STARTED|Overall Study||2441
9790179|NCT00553410|10897723|FG001|STARTED|Overall Study||2443
9790180|NCT00553410|10897722|FG000|COMPLETED|Overall Study||2426
9790181|NCT00553410|10897723|FG001|COMPLETED|Overall Study||2425
9790182|NCT00553410|10897722|FG000|NOT COMPLETED|Overall Study||15
9790183|NCT00553410|10897723|FG001|NOT COMPLETED|Overall Study||18
9790184|NCT00553436|10897729|FG000|STARTED|Overall Study|20 August 2007|7
9790185|NCT00553436|10897729|FG000|COMPLETED|Overall Study|09 April 2009|6
9790186|NCT00553436|10897729|FG000|NOT COMPLETED|Overall Study||1
9790187|NCT00553462|10897733|FG000|STARTED|Overall Study||75
9790188|NCT00553462|10897733|FG000|COMPLETED|Overall Study||61
9790189|NCT00553462|10897733|FG000|NOT COMPLETED|Overall Study||14
9790190|NCT00553475|10897740|FG000|STARTED|Overall Study||135
9790191|NCT00553475|10897741|FG001|STARTED|Overall Study||134
9790192|NCT00553475|10897742|FG002|STARTED|Overall Study||45
9790193|NCT00553475|10897740|FG000|COMPLETED|Overall Study||119
9790194|NCT00553475|10897741|FG001|COMPLETED|Overall Study||114
9790195|NCT00553475|10897742|FG002|COMPLETED|Overall Study||32
9790196|NCT00553475|10897740|FG000|NOT COMPLETED|Overall Study||16
9790197|NCT00553475|10897741|FG001|NOT COMPLETED|Overall Study||20
9790198|NCT00553475|10897742|FG002|NOT COMPLETED|Overall Study||13
9790199|NCT00553501|10897752|FG000|STARTED|Overall Study||59
9790200|NCT00553501|10897752|FG000|COMPLETED|Overall Study||55
9790201|NCT00553501|10897752|FG000|NOT COMPLETED|Overall Study||4
9790202|NCT00553514|10897761|FG000|STARTED|Overall Study||14
9790203|NCT00553514|10897762|FG001|STARTED|Overall Study||14
9790204|NCT00553514|10897763|FG002|STARTED|Overall Study||15
9790205|NCT00553514|10897764|FG003|STARTED|Overall Study||13
9790206|NCT00553514|10897765|FG004|STARTED|Overall Study||15
9790207|NCT00553514|10897761|FG000|COMPLETED|Overall Study||6
10234371|NCT01495988|11364383|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10234372|NCT01495988|11364384|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10234373|NCT01495988|11364385|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10234374|NCT01495988|11364386|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10234375|NCT01495988|11364383|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234376|NCT01495988|11364384|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
10234377|NCT01495988|11364385|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234378|NCT01495988|11364386|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234379|NCT01495988|11364383|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234380|NCT01495988|11364384|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
10234381|NCT01495988|11364385|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234382|NCT01495988|11364386|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234383|NCT01495988|11364383|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234384|NCT01495988|11364384|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234385|NCT01495988|11364385|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234386|NCT01495988|11364386|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10234387|NCT01498991|11364396|FG000|STARTED|Overall Study||2
10234388|NCT01498991|11364396|FG000|COMPLETED|Overall Study||2
10234389|NCT01498991|11364396|FG000|NOT COMPLETED|Overall Study||0
10234390|NCT01497171|11364402|FG000|STARTED|Overall Study||2
10234391|NCT01497171|11364403|FG001|STARTED|Overall Study||3
10234392|NCT01497171|11364402|FG000|COMPLETED|Overall Study||2
10234393|NCT01497171|11364403|FG001|COMPLETED|Overall Study||3
10234394|NCT01497171|11364402|FG000|NOT COMPLETED|Overall Study||0
10234395|NCT01497171|11364403|FG001|NOT COMPLETED|Overall Study||0
9790208|NCT00553514|10897762|FG001|COMPLETED|Overall Study||6
9790209|NCT00553514|10897763|FG002|COMPLETED|Overall Study||9
9790210|NCT00553514|10897764|FG003|COMPLETED|Overall Study||6
9790211|NCT00553514|10897765|FG004|COMPLETED|Overall Study||8
9790212|NCT00553514|10897761|FG000|NOT COMPLETED|Overall Study||8
9790213|NCT00553514|10897762|FG001|NOT COMPLETED|Overall Study||8
9790214|NCT00553514|10897763|FG002|NOT COMPLETED|Overall Study||6
9790215|NCT00553514|10897764|FG003|NOT COMPLETED|Overall Study||7
10234396|NCT01483872|11364409|FG000|STARTED|Overall Study||0
10234397|NCT01483872|11364410|FG001|STARTED|Overall Study||1
9790216|NCT00553514|10897765|FG004|NOT COMPLETED|Overall Study||7
9790217|NCT00553540|10897779|FG000|STARTED|Overall Study||25
9790218|NCT00553540|10897780|FG001|STARTED|Overall Study||25
9790219|NCT00553540|10897779|FG000|COMPLETED|Overall Study||23
10234398|NCT01483872|11364409|FG000|COMPLETED|Overall Study||0
9790220|NCT00553540|10897780|FG001|COMPLETED|Overall Study||20
9790221|NCT00553540|10897779|FG000|NOT COMPLETED|Overall Study||2
9952458|NCT01422304|11071442|FG000|COMPLETED|Overall Study||574
9952459|NCT01422304|11071443|FG001|COMPLETED|Overall Study||563
9952460|NCT01422304|11071442|FG000|NOT COMPLETED|Overall Study||24
9952461|NCT01422304|11071443|FG001|NOT COMPLETED|Overall Study||37
9952462|NCT01422356|11071449|FG000|STARTED|Overall Study||200
9952463|NCT01422356|11071449|FG000|COMPLETED|Overall Study||169
9952464|NCT01422356|11071449|FG000|NOT COMPLETED|Overall Study||31
9952465|NCT01422369|11071453|FG000|STARTED|NK-104 4mg QD||28
9952466|NCT01422369|11071453|FG000|COMPLETED|NK-104 4mg QD||28
9790222|NCT00553540|10897780|FG001|NOT COMPLETED|Overall Study||5
9790223|NCT00553605|10897788|FG000|STARTED|Overall Study||176
9790224|NCT00553605|10897789|FG001|STARTED|Overall Study||164
9790225|NCT00553605|10897788|FG000|Treated|Overall Study||174
9790226|NCT00553605|10897789|FG001|Treated|Overall Study||164
9790227|NCT00553605|10897788|FG000|COMPLETED|Overall Study||172
9790228|NCT00553605|10897789|FG001|COMPLETED|Overall Study||161
9790229|NCT00553605|10897788|FG000|NOT COMPLETED|Overall Study||4
9790230|NCT00553605|10897789|FG001|NOT COMPLETED|Overall Study||3
9790231|NCT00553631|10897797|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17
9790232|NCT00553631|10897798|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17
9790233|NCT00553631|10897797|FG000|COMPLETED|Overall Study||16
9790234|NCT00553631|10897798|FG001|COMPLETED|Overall Study||16
9790235|NCT00553631|10897797|FG000|NOT COMPLETED|Overall Study||1
9790236|NCT00553631|10897798|FG001|NOT COMPLETED|Overall Study||1
9790237|NCT00553644|10897804|FG000|STARTED|Overall Study||53
9790238|NCT00553644|10897804|FG000|COMPLETED|Overall Study||25
9790239|NCT00553644|10897804|FG000|NOT COMPLETED|Overall Study||28
9790240|NCT00553696|10897812|FG000|STARTED|Overall Study||4
9790241|NCT00553696|10897813|FG001|STARTED|Overall Study||16
9790242|NCT00553696|10897814|FG002|STARTED|Overall Study||6
9790243|NCT00553696|10897815|FG003|STARTED|Overall Study||1
9790244|NCT00553696|10897812|FG000|COMPLETED|Overall Study||0
9790245|NCT00553696|10897813|FG001|COMPLETED|Overall Study||0
9790246|NCT00553696|10897814|FG002|COMPLETED|Overall Study||0
9790247|NCT00553696|10897815|FG003|COMPLETED|Overall Study||0
9790248|NCT00553696|10897812|FG000|NOT COMPLETED|Overall Study||4
9790249|NCT00553696|10897813|FG001|NOT COMPLETED|Overall Study||16
9790250|NCT00553696|10897814|FG002|NOT COMPLETED|Overall Study||6
9790251|NCT00553696|10897815|FG003|NOT COMPLETED|Overall Study||1
9790252|NCT00553735|10897828|FG000|STARTED|Overall Study||8
9790253|NCT00553735|10897828|FG000|COMPLETED|Overall Study||1
9790254|NCT00553735|10897828|FG000|NOT COMPLETED|Overall Study||7
9790255|NCT00553787|10897838|FG000|STARTED|Overall Study||994
9790256|NCT00553787|10897839|FG001|STARTED|Overall Study||498
9790257|NCT00553787|10897840|FG002|STARTED|Overall Study||995
9790258|NCT00553787|10897838|FG000|COMPLETED|Overall Study||616
9790259|NCT00553787|10897839|FG001|COMPLETED|Overall Study||374
9790260|NCT00553787|10897840|FG002|COMPLETED|Overall Study||733
9790261|NCT00553787|10897838|FG000|NOT COMPLETED|Overall Study||378
9790262|NCT00553787|10897839|FG001|NOT COMPLETED|Overall Study||124
9790263|NCT00553787|10897840|FG002|NOT COMPLETED|Overall Study||262
9790264|NCT00553839|10897848|FG000|STARTED|Overall Study||21
9790265|NCT00553839|10897848|FG000|COMPLETED|Overall Study||21
9790266|NCT00553839|10897848|FG000|NOT COMPLETED|Overall Study||0
9790267|NCT00553969|10897856|FG000|STARTED|Overall Study||31
9790268|NCT00553969|10897857|FG001|STARTED|Overall Study||24
9790269|NCT00553969|10897858|FG002|STARTED|Overall Study||22
9790270|NCT00553969|10897859|FG003|STARTED|Overall Study||24
9790271|NCT00553969|10897856|FG000|COMPLETED|Overall Study||23
9790272|NCT00553969|10897857|FG001|COMPLETED|Overall Study||24
9790273|NCT00553969|10897858|FG002|COMPLETED|Overall Study||21
10015476|NCT01806597|11138559|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
10234399|NCT01483872|11364410|FG001|COMPLETED|Overall Study||1
10234400|NCT01483872|11364409|FG000|NOT COMPLETED|Overall Study||0
9790274|NCT00553969|10897859|FG003|COMPLETED|Overall Study||23
9790275|NCT00553969|10897856|FG000|NOT COMPLETED|Overall Study||8
9790276|NCT00553969|10897857|FG001|NOT COMPLETED|Overall Study||0
9790277|NCT00553969|10897858|FG002|NOT COMPLETED|Overall Study||1
9790278|NCT00553969|10897859|FG003|NOT COMPLETED|Overall Study||1
9790279|NCT00554099|10897872|FG000|STARTED|Treatment Period (12 Weeks)||41
9790280|NCT00554099|10897873|FG001|STARTED|Treatment Period (12 Weeks)||40
9790281|NCT00554099|10897874|FG002|STARTED|Treatment Period (12 Weeks)||36
9790282|NCT00554099|10897872|FG000|COMPLETED|Treatment Period (12 Weeks)||29
9790283|NCT00554099|10897873|FG001|COMPLETED|Treatment Period (12 Weeks)||32
9790284|NCT00554099|10897874|FG002|COMPLETED|Treatment Period (12 Weeks)||27
10234401|NCT01483872|11364410|FG001|NOT COMPLETED|Overall Study||0
10239700|NCT00066807|11371385|FG000|STARTED|Overall Study||14
10239701|NCT00066807|11371386|FG001|STARTED|Overall Study||15
10239702|NCT00066807|11371385|FG000|COMPLETED|Overall Study||0
10239703|NCT00066807|11371386|FG001|COMPLETED|Overall Study||0
9790285|NCT00554099|10897872|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12
9790286|NCT00554099|10897873|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8
9790287|NCT00554099|10897874|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9
9790288|NCT00554099|10897872|FG000|STARTED|Non-Treatment Phase (9 Months)||29
9790289|NCT00554099|10897873|FG001|STARTED|Non-Treatment Phase (9 Months)||32
9790290|NCT00554099|10897874|FG002|STARTED|Non-Treatment Phase (9 Months)||27
9790291|NCT00554099|10897872|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22
10015477|NCT01806597|11138560|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
9790292|NCT00554099|10897873|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27
10239704|NCT00066807|11371385|FG000|NOT COMPLETED|Overall Study||14
9790293|NCT00554099|10897874|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24
9790294|NCT00554099|10897872|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
9790295|NCT00554099|10897873|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
9790296|NCT00554099|10897874|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
9790297|NCT00554216|10897885|FG000|STARTED|Overall Study||514
9790298|NCT00554216|10897886|FG001|STARTED|Overall Study||241
9790299|NCT00554216|10897887|FG002|STARTED|Overall Study||512
9790300|NCT00554216|10897885|FG000|COMPLETED|Overall Study||272
9790301|NCT00554216|10897886|FG001|COMPLETED|Overall Study||147
9790302|NCT00554216|10897887|FG002|COMPLETED|Overall Study||340
9790303|NCT00554216|10897885|FG000|NOT COMPLETED|Overall Study||242
9790304|NCT00554216|10897886|FG001|NOT COMPLETED|Overall Study||94
9790305|NCT00554216|10897887|FG002|NOT COMPLETED|Overall Study||172
9790306|NCT00554229|10897897|FG000|STARTED|Overall Study||299
9790307|NCT00554229|10897898|FG001|STARTED|Overall Study||295
9790308|NCT00554229|10897897|FG000|Patients Who Received Treatment|Overall Study||298
9790309|NCT00554229|10897898|FG001|Patients Who Received Treatment|Overall Study||295
9790310|NCT00554229|10897897|FG000|COMPLETED|Overall Study||73
9790311|NCT00554229|10897898|FG001|COMPLETED|Overall Study||70
9790312|NCT00554229|10897897|FG000|NOT COMPLETED|Overall Study||226
9790313|NCT00554229|10897898|FG001|NOT COMPLETED|Overall Study||225
9790314|NCT00554372|10897906|FG000|STARTED|Overall Study||14
9790315|NCT00554372|10897907|FG001|STARTED|Overall Study||16
9790316|NCT00554372|10897906|FG000|COMPLETED|Overall Study||14
9790317|NCT00554372|10897907|FG001|COMPLETED|Overall Study||16
9790318|NCT00554372|10897906|FG000|NOT COMPLETED|Overall Study||0
9790319|NCT00554372|10897907|FG001|NOT COMPLETED|Overall Study||0
9790320|NCT00554463|10897915|FG000|STARTED|Overall Study||5
9790321|NCT00554463|10897915|FG000|COMPLETED|Overall Study||5
9790322|NCT00554463|10897915|FG000|NOT COMPLETED|Overall Study||0
9790323|NCT00554515|10897919|FG000|STARTED|Overall Study||123
9790324|NCT00554515|10897919|FG000|Treated|Overall Study||120
9790325|NCT00554515|10897919|FG000|COMPLETED|Overall Study||5
9790326|NCT00554515|10897919|FG000|NOT COMPLETED|Overall Study||118
9790327|NCT00554619|10897944|FG000|STARTED|Overall Study||21
9790328|NCT00554619|10897944|FG000|COMPLETED|Overall Study||18
9790329|NCT00554619|10897944|FG000|NOT COMPLETED|Overall Study||3
9790330|NCT00554671|10897950|FG000|STARTED|Overall Study||117
9790331|NCT00554671|10897951|FG001|STARTED|Overall Study||133
9790332|NCT00554671|10897950|FG000|COMPLETED|Overall Study||97
9790333|NCT00554671|10897951|FG001|COMPLETED|Overall Study||117
9790334|NCT00554671|10897950|FG000|NOT COMPLETED|Overall Study||20
9790335|NCT00554671|10897951|FG001|NOT COMPLETED|Overall Study||16
9790336|NCT00554749|10897958|FG000|STARTED|Overall Study||7
10234402|NCT01487499|11364414|FG000|STARTED|Overall Study||4
10234403|NCT01487499|11364414|FG000|COMPLETED|Overall Study||4
10234404|NCT01487499|11364414|FG000|NOT COMPLETED|Overall Study||0
9790337|NCT00554749|10897958|FG000|COMPLETED|Overall Study||7
9790338|NCT00554749|10897958|FG000|NOT COMPLETED|Overall Study||0
9790339|NCT00554788|10897965|FG000|STARTED|Overall Study||21
9790340|NCT00554788|10897966|FG001|STARTED|Overall Study||18
9790341|NCT00554788|10897967|FG002|STARTED|Overall Study||21
9790342|NCT00554788|10897965|FG000|COMPLETED|Overall Study||14
9790343|NCT00554788|10897966|FG001|COMPLETED|Overall Study||12
9790344|NCT00554788|10897967|FG002|COMPLETED|Overall Study||7
9790345|NCT00554788|10897965|FG000|NOT COMPLETED|Overall Study||7
9790346|NCT00554788|10897966|FG001|NOT COMPLETED|Overall Study||6
9790347|NCT00554788|10897967|FG002|NOT COMPLETED|Overall Study||14
9790348|NCT00554801|10897978|FG000|STARTED|Overall Study||55
9790349|NCT00554801|10897979|FG001|STARTED|Overall Study||29
9790350|NCT00554801|10897978|FG000|COMPLETED|Overall Study||36
9790351|NCT00554801|10897979|FG001|COMPLETED|Overall Study||29
9790352|NCT00554801|10897978|FG000|NOT COMPLETED|Overall Study||19
9790353|NCT00554801|10897979|FG001|NOT COMPLETED|Overall Study||0
9790354|NCT00554853|10897989|FG000|STARTED|First Arm of Study||72
9790355|NCT00554853|10897990|FG001|STARTED|First Arm of Study||71
9790356|NCT00554853|10897989|FG000|COMPLETED|First Arm of Study||56
9790357|NCT00554853|10897990|FG001|COMPLETED|First Arm of Study||64
9790358|NCT00554853|10897989|FG000|NOT COMPLETED|First Arm of Study||16
9790359|NCT00554853|10897990|FG001|NOT COMPLETED|First Arm of Study||7
9790360|NCT00554853|10897989|FG000|STARTED|Washout Period (2 Weeks)||56
10234405|NCT01478113|11364420|FG000|STARTED|Overall Study||2
10234406|NCT01478113|11364421|FG001|STARTED|Overall Study||2
10234407|NCT01478113|11364420|FG000|COMPLETED|Overall Study||1
10234408|NCT01478113|11364421|FG001|COMPLETED|Overall Study||1
9790361|NCT00554853|10897990|FG001|STARTED|Washout Period (2 Weeks)||64
9790362|NCT00554853|10897989|FG000|COMPLETED|Washout Period (2 Weeks)||56
9790363|NCT00554853|10897990|FG001|COMPLETED|Washout Period (2 Weeks)||57
9790364|NCT00554853|10897989|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
9790365|NCT00554853|10897990|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7
9790366|NCT00554853|10897989|FG000|STARTED|Crossover Arm (3 Months)||56
9790367|NCT00554853|10897990|FG001|STARTED|Crossover Arm (3 Months)||57
9790368|NCT00554853|10897989|FG000|COMPLETED|Crossover Arm (3 Months)||53
9790369|NCT00554853|10897990|FG001|COMPLETED|Crossover Arm (3 Months)||55
9790370|NCT00554853|10897989|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3
9790371|NCT00554853|10897990|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2
9790372|NCT00554970|10898006|FG000|STARTED|Period 1||8
9790373|NCT00554970|10898007|FG001|STARTED|Period 1||8
9790374|NCT00554970|10898008|FG002|STARTED|Period 1||8
9790375|NCT00554970|10898009|FG003|STARTED|Period 1||8
10234409|NCT01478113|11364420|FG000|NOT COMPLETED|Overall Study||1
9790376|NCT00554970|10898006|FG000|COMPLETED|Period 1||7
9790377|NCT00554970|10898007|FG001|COMPLETED|Period 1||8
9790378|NCT00554970|10898008|FG002|COMPLETED|Period 1||8
9790379|NCT00554970|10898009|FG003|COMPLETED|Period 1||8
9790380|NCT00554970|10898006|FG000|NOT COMPLETED|Period 1||1
9790381|NCT00554970|10898007|FG001|NOT COMPLETED|Period 1||0
9790382|NCT00554970|10898008|FG002|NOT COMPLETED|Period 1||0
9790383|NCT00554970|10898009|FG003|NOT COMPLETED|Period 1||0
9790384|NCT00554970|10898006|FG000|STARTED|Period 2||7
9790385|NCT00554970|10898007|FG001|STARTED|Period 2||8
9790386|NCT00554970|10898008|FG002|STARTED|Period 2||8
9790387|NCT00554970|10898009|FG003|STARTED|Period 2||8
9790388|NCT00554970|10898006|FG000|COMPLETED|Period 2||7
9790389|NCT00554970|10898007|FG001|COMPLETED|Period 2||8
9790390|NCT00554970|10898008|FG002|COMPLETED|Period 2||7
9790391|NCT00554970|10898009|FG003|COMPLETED|Period 2||8
9790392|NCT00554970|10898006|FG000|NOT COMPLETED|Period 2||0
9790393|NCT00554970|10898007|FG001|NOT COMPLETED|Period 2||0
9790394|NCT00554970|10898008|FG002|NOT COMPLETED|Period 2||1
9790395|NCT00554970|10898009|FG003|NOT COMPLETED|Period 2||0
9790396|NCT00554996|10898019|FG000|STARTED|Overall Study||10
9790397|NCT00554996|10898019|FG000|COMPLETED|Overall Study||10
9790398|NCT00554996|10898019|FG000|NOT COMPLETED|Overall Study||0
9790399|NCT00555048|10898023|FG000|STARTED|Overall Study||1
9790400|NCT00555048|10898023|FG000|COMPLETED|Overall Study||1
9790401|NCT00555048|10898023|FG000|NOT COMPLETED|Overall Study||0
9790402|NCT00555061|10898027|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
9790403|NCT00555061|10898027|FG000|COMPLETED|Overall Study||78
9790404|NCT00555061|10898027|FG000|NOT COMPLETED|Overall Study||9
9790405|NCT00555152|10898035|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
9790406|NCT00555152|10898036|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
9790407|NCT00555152|10898037|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
9790408|NCT00555152|10898038|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
9790409|NCT00555152|10898035|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
9790410|NCT00555152|10898036|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
9790411|NCT00555152|10898037|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
9790412|NCT00555152|10898038|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
9790413|NCT00555152|10898035|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
9790414|NCT00555152|10898036|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
9790415|NCT00555152|10898037|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
9790416|NCT00555152|10898038|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
9790417|NCT00555152|10898035|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
9790418|NCT00555152|10898036|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
9790419|NCT00555152|10898037|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
9790420|NCT00555152|10898038|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
9790421|NCT00555152|10898035|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
9790422|NCT00555152|10898036|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
9790423|NCT00555152|10898037|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
9790424|NCT00555152|10898038|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
9790425|NCT00555152|10898035|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
9790426|NCT00555152|10898036|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
9790427|NCT00555152|10898037|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
9790428|NCT00555152|10898038|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
9790429|NCT00555217|10898050|FG000|STARTED|Overall Study||724
9790430|NCT00555217|10898051|FG001|STARTED|Overall Study||724
9790431|NCT00555217|10898050|FG000|COMPLETED|Overall Study||649
9790432|NCT00555217|10898051|FG001|COMPLETED|Overall Study||656
9790433|NCT00555217|10898050|FG000|NOT COMPLETED|Overall Study||75
9790434|NCT00555217|10898051|FG001|NOT COMPLETED|Overall Study||68
9790435|NCT00555321|10898062|FG000|STARTED|Treatment Phase up to 12-months||52
9790436|NCT00555321|10898063|FG001|STARTED|Treatment Phase up to 12-months||51
9790437|NCT00555321|10898064|FG002|STARTED|Treatment Phase up to 12-months||50
9790438|NCT00555321|10898065|FG003|STARTED|Treatment Phase up to 12-months||53
9790439|NCT00555321|10898066|FG004|STARTED|Treatment Phase up to 12-months||54
9790440|NCT00555321|10898062|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50
9790441|NCT00555321|10898063|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48
9790442|NCT00555321|10898064|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49
9790443|NCT00555321|10898065|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53
9790444|NCT00555321|10898066|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50
9790445|NCT00555321|10898062|FG000|COMPLETED|Treatment Phase up to 12-months||31
9790446|NCT00555321|10898063|FG001|COMPLETED|Treatment Phase up to 12-months||29
9790447|NCT00555321|10898064|FG002|COMPLETED|Treatment Phase up to 12-months||26
9790448|NCT00555321|10898065|FG003|COMPLETED|Treatment Phase up to 12-months||46
9790449|NCT00555321|10898066|FG004|COMPLETED|Treatment Phase up to 12-months||32
9790450|NCT00555321|10898062|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21
9790451|NCT00555321|10898063|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22
9790452|NCT00555321|10898064|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24
9790453|NCT00555321|10898065|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7
9790454|NCT00555321|10898066|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22
9790455|NCT00555321|10898062|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
9790456|NCT00555321|10898063|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
9790457|NCT00555321|10898064|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
9790458|NCT00555321|10898065|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
9790459|NCT00555321|10898066|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
9790460|NCT00555321|10898062|FG000|COMPLETED|Long-term Extension Phase||0
9790461|NCT00555321|10898063|FG001|COMPLETED|Long-term Extension Phase||0
9790462|NCT00555321|10898064|FG002|COMPLETED|Long-term Extension Phase||0
9790463|NCT00555321|10898065|FG003|COMPLETED|Long-term Extension Phase||0
9790464|NCT00555321|10898066|FG004|COMPLETED|Long-term Extension Phase||0
9790465|NCT00555321|10898062|FG000|NOT COMPLETED|Long-term Extension Phase||30
9790466|NCT00555321|10898063|FG001|NOT COMPLETED|Long-term Extension Phase||27
9790467|NCT00555321|10898064|FG002|NOT COMPLETED|Long-term Extension Phase||24
10234410|NCT01478113|11364421|FG001|NOT COMPLETED|Overall Study||1
10234411|NCT01483209|11364429|FG000|STARTED|Overall Study||2
10234412|NCT01483209|11364429|FG000|COMPLETED|Overall Study||1
10234413|NCT01483209|11364429|FG000|NOT COMPLETED|Overall Study||1
10234414|NCT01484314|11364433|FG000|STARTED|Overall Study||1
10234415|NCT01484314|11364433|FG000|COMPLETED|Overall Study||1
9790468|NCT00555321|10898065|FG003|NOT COMPLETED|Long-term Extension Phase||38
9790469|NCT00555321|10898066|FG004|NOT COMPLETED|Long-term Extension Phase||26
9790470|NCT00555360|10898085|FG000|STARTED|Overall Study||183
9790471|NCT00555360|10898086|FG001|STARTED|Overall Study||189
9790472|NCT00555360|10898085|FG000|COMPLETED|Overall Study||156
9790473|NCT00555360|10898086|FG001|COMPLETED|Overall Study||153
9790474|NCT00555360|10898085|FG000|NOT COMPLETED|Overall Study||27
9790475|NCT00555360|10898086|FG001|NOT COMPLETED|Overall Study||36
9790476|NCT00555425|10898095|FG000|STARTED|Overall Study||57
9790477|NCT00555425|10898096|FG001|STARTED|Overall Study||56
9790478|NCT00555425|10898095|FG000|COMPLETED|Overall Study||6
9790479|NCT00555425|10898096|FG001|COMPLETED|Overall Study||37
9790480|NCT00555425|10898095|FG000|NOT COMPLETED|Overall Study||51
10234416|NCT01484314|11364433|FG000|NOT COMPLETED|Overall Study||0
10234417|NCT01482598|11364439|FG000|STARTED|Overall Study||66
10234418|NCT01482598|11364440|FG001|STARTED|Overall Study||73
10234419|NCT01482598|11364439|FG000|COMPLETED|Overall Study||50
10234420|NCT01482598|11364440|FG001|COMPLETED|Overall Study||51
10234421|NCT01482598|11364439|FG000|NOT COMPLETED|Overall Study||16
10234422|NCT01482598|11364440|FG001|NOT COMPLETED|Overall Study||22
10234423|NCT01479010|11364446|FG000|STARTED|Overall Study||2
10234424|NCT01479010|11364446|FG000|COMPLETED|Overall Study||1
10234425|NCT01479010|11364446|FG000|NOT COMPLETED|Overall Study||1
10234426|NCT01482325|11364450|FG000|STARTED|Overall Study||31
10234427|NCT01482325|11364450|FG000|COMPLETED|Overall Study||31
10234428|NCT01482325|11364450|FG000|NOT COMPLETED|Overall Study||0
10234429|NCT01477177|11364454|FG000|STARTED|Overall Study||4
10234430|NCT01477177|11364454|FG000|COMPLETED|Overall Study||4
10234431|NCT01477177|11364454|FG000|NOT COMPLETED|Overall Study||0
10234432|NCT01473732|11364460|FG000|STARTED|Overall Study||2
10234433|NCT01473732|11364461|FG001|STARTED|Overall Study||0
10234434|NCT01473732|11364460|FG000|COMPLETED|Overall Study||0
10234435|NCT01473732|11364461|FG001|COMPLETED|Overall Study||0
10234436|NCT01473732|11364460|FG000|NOT COMPLETED|Overall Study||2
10234437|NCT01473732|11364461|FG001|NOT COMPLETED|Overall Study||0
10234438|NCT01472692|11364469|FG000|STARTED|Overall Study||0
10234439|NCT01472692|11364470|FG001|STARTED|Overall Study||0
10234440|NCT01472692|11364469|FG000|COMPLETED|Overall Study||0
10234441|NCT01472692|11364470|FG001|COMPLETED|Overall Study||0
10234442|NCT01472692|11364469|FG000|NOT COMPLETED|Overall Study||0
10234443|NCT01472692|11364470|FG001|NOT COMPLETED|Overall Study||0
10234444|NCT01465230|11364476|FG000|STARTED|Overall Study||2
10234445|NCT01465230|11364476|FG000|COMPLETED|Overall Study||0
10234446|NCT01465230|11364476|FG000|NOT COMPLETED|Overall Study||2
10234447|NCT01464723|11364480|FG000|STARTED|Overall Study||0
10234448|NCT01464723|11364480|FG000|COMPLETED|Overall Study||0
10234449|NCT01464723|11364480|FG000|NOT COMPLETED|Overall Study||0
10234450|NCT01446250|11364484|FG000|STARTED|Treatment Period 1||5
10234451|NCT01446250|11364485|FG001|STARTED|Treatment Period 1||3
10234452|NCT01446250|11364486|FG002|STARTED|Treatment Period 1||0
10234453|NCT01446250|11364487|FG003|STARTED|Treatment Period 1||0
10234454|NCT01446250|11364484|FG000|COMPLETED|Treatment Period 1||5
10234455|NCT01446250|11364485|FG001|COMPLETED|Treatment Period 1||2
10234456|NCT01446250|11364486|FG002|COMPLETED|Treatment Period 1||0
10234457|NCT01446250|11364487|FG003|COMPLETED|Treatment Period 1||0
10234458|NCT01446250|11364484|FG000|NOT COMPLETED|Treatment Period 1||0
9790481|NCT00555425|10898096|FG001|NOT COMPLETED|Overall Study||19
10234459|NCT01446250|11364485|FG001|NOT COMPLETED|Treatment Period 1||1
10234460|NCT01446250|11364486|FG002|NOT COMPLETED|Treatment Period 1||0
10234461|NCT01446250|11364487|FG003|NOT COMPLETED|Treatment Period 1||0
10234462|NCT01446250|11364484|FG000|STARTED|Clinical Hold||0
10234463|NCT01446250|11364485|FG001|STARTED|Clinical Hold||2
10234464|NCT01446250|11364486|FG002|STARTED|Clinical Hold||5
10234465|NCT01446250|11364487|FG003|STARTED|Clinical Hold||0
10234466|NCT01446250|11364484|FG000|COMPLETED|Clinical Hold||0
10234467|NCT01446250|11364485|FG001|COMPLETED|Clinical Hold||2
10234468|NCT01446250|11364486|FG002|COMPLETED|Clinical Hold||5
10234469|NCT01446250|11364487|FG003|COMPLETED|Clinical Hold||0
10234470|NCT01446250|11364484|FG000|NOT COMPLETED|Clinical Hold||0
10234471|NCT01446250|11364485|FG001|NOT COMPLETED|Clinical Hold||0
9790482|NCT00555438|10898102|FG000|STARTED|10 Days Post-operative||442
9790483|NCT00555438|10898102|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
9790484|NCT00555438|10898102|FG000|NOT COMPLETED|10 Days Post-operative||4
9790485|NCT00555438|10898102|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438
9790486|NCT00555438|10898102|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
9790487|NCT00555438|10898102|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
9790488|NCT00555464|10898108|FG000|STARTED|Overall Study||4
9790489|NCT00555464|10898109|FG001|STARTED|Overall Study||4
9790490|NCT00555464|10898108|FG000|COMPLETED|Overall Study||4
9790491|NCT00555464|10898109|FG001|COMPLETED|Overall Study||1
9790492|NCT00555464|10898108|FG000|NOT COMPLETED|Overall Study||0
9790493|NCT00555464|10898109|FG001|NOT COMPLETED|Overall Study||3
9790494|NCT00555477|10898117|FG000|STARTED|Overall Study||14
9790495|NCT00555477|10898118|FG001|STARTED|Overall Study||45
9790496|NCT00555477|10898117|FG000|COMPLETED|Overall Study||12
9790497|NCT00555477|10898118|FG001|COMPLETED|Overall Study||32
9790498|NCT00555477|10898117|FG000|NOT COMPLETED|Overall Study||2
9790499|NCT00555477|10898118|FG001|NOT COMPLETED|Overall Study||13
9790500|NCT00555568|10898126|FG000|STARTED|Overall Study||100
9790501|NCT00555568|10898127|FG001|STARTED|Overall Study||98
9790502|NCT00555568|10898128|FG002|STARTED|Overall Study||100
9790503|NCT00555568|10898126|FG000|COMPLETED|Overall Study||74
9790504|NCT00555568|10898127|FG001|COMPLETED|Overall Study||82
9790505|NCT00555568|10898128|FG002|COMPLETED|Overall Study||84
9790506|NCT00555568|10898126|FG000|NOT COMPLETED|Overall Study||26
9790507|NCT00555568|10898127|FG001|NOT COMPLETED|Overall Study||16
9790508|NCT00555568|10898128|FG002|NOT COMPLETED|Overall Study||16
9790509|NCT00555581|10898136|FG000|STARTED|Overall Study||30
9790510|NCT00555581|10898136|FG000|COMPLETED|Overall Study||24
9790511|NCT00555581|10898136|FG000|NOT COMPLETED|Overall Study||6
9790512|NCT00555620|10898146|FG000|STARTED|Overall Study||6
9790513|NCT00555620|10898147|FG001|STARTED|Overall Study||7
9790514|NCT00555620|10898148|FG002|STARTED|Overall Study||15
9790515|NCT00555620|10898149|FG003|STARTED|Overall Study||23
10015478|NCT01806597|11138561|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
10015479|NCT01806597|11138562|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
10015480|NCT01806597|11138563|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
10015481|NCT01806597|11138564|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
10015482|NCT01806597|11138559|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
9790516|NCT00555620|10898150|FG004|STARTED|Overall Study||3
9790517|NCT00555620|10898151|FG005|STARTED|Overall Study||22
9790518|NCT00555620|10898146|FG000|COMPLETED|Overall Study||0
9790519|NCT00555620|10898147|FG001|COMPLETED|Overall Study||0
9790520|NCT00555620|10898148|FG002|COMPLETED|Overall Study||0
9790521|NCT00555620|10898149|FG003|COMPLETED|Overall Study||0
9790522|NCT00555620|10898150|FG004|COMPLETED|Overall Study||0
9790523|NCT00555620|10898151|FG005|COMPLETED|Overall Study||0
9790524|NCT00555620|10898146|FG000|NOT COMPLETED|Overall Study||6
9790525|NCT00555620|10898147|FG001|NOT COMPLETED|Overall Study||7
9790526|NCT00555620|10898148|FG002|NOT COMPLETED|Overall Study||15
9790527|NCT00555620|10898149|FG003|NOT COMPLETED|Overall Study||23
9790528|NCT00555620|10898150|FG004|NOT COMPLETED|Overall Study||3
9790529|NCT00555620|10898151|FG005|NOT COMPLETED|Overall Study||22
9790530|NCT00555672|10898171|FG000|STARTED|Overall Study||24
9790531|NCT00555672|10898172|FG001|STARTED|Overall Study||10
9790532|NCT00555672|10898171|FG000|COMPLETED|Overall Study||0
9790533|NCT00555672|10898172|FG001|COMPLETED|Overall Study||0
9790534|NCT00555672|10898171|FG000|NOT COMPLETED|Overall Study||24
9790535|NCT00555672|10898172|FG001|NOT COMPLETED|Overall Study||10
9790536|NCT00555750|10898180|FG000|STARTED|Overall Study||10
9790537|NCT00555750|10898181|FG001|STARTED|Overall Study||10
9790538|NCT00555750|10898180|FG000|COMPLETED|Overall Study||10
9790539|NCT00555750|10898181|FG001|COMPLETED|Overall Study||10
9790540|NCT00555750|10898180|FG000|NOT COMPLETED|Overall Study||0
9790541|NCT00555750|10898181|FG001|NOT COMPLETED|Overall Study||0
9790542|NCT00555880|10898189|FG000|STARTED|Treatment Period 1 (1 Day)||13
9790543|NCT00555880|10898190|FG001|STARTED|Treatment Period 1 (1 Day)||11
9790544|NCT00555880|10898189|FG000|COMPLETED|Treatment Period 1 (1 Day)||13
9790545|NCT00555880|10898190|FG001|COMPLETED|Treatment Period 1 (1 Day)||11
9790546|NCT00555880|10898189|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9790547|NCT00555880|10898190|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9790548|NCT00555880|10898189|FG000|STARTED|Washout (1 Day)||13
9790549|NCT00555880|10898190|FG001|STARTED|Washout (1 Day)||11
9790550|NCT00555880|10898189|FG000|COMPLETED|Washout (1 Day)||13
9790551|NCT00555880|10898190|FG001|COMPLETED|Washout (1 Day)||11
9790552|NCT00555880|10898189|FG000|NOT COMPLETED|Washout (1 Day)||0
9790553|NCT00555880|10898190|FG001|NOT COMPLETED|Washout (1 Day)||0
9790554|NCT00555880|10898189|FG000|STARTED|Treatment Period 2 (1 Day)||13
9790555|NCT00555880|10898190|FG001|STARTED|Treatment Period 2 (1 Day)||11
9790556|NCT00555880|10898189|FG000|COMPLETED|Treatment Period 2 (1 Day)||13
9790557|NCT00555880|10898190|FG001|COMPLETED|Treatment Period 2 (1 Day)||11
9790558|NCT00555880|10898189|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9790559|NCT00555880|10898190|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9790560|NCT00555893|10898199|FG000|STARTED|Overall Study||130
9790561|NCT00555893|10898200|FG001|STARTED|Overall Study||63
9830644|NCT00764517|10941382|FG001|NOT COMPLETED|Overall Study||14
10015483|NCT01806597|11138560|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
9790562|NCT00555893|10898199|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
9790563|NCT00555893|10898200|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
9790564|NCT00555893|10898199|FG000|COMPLETED|Overall Study||130
9790565|NCT00555893|10898200|FG001|COMPLETED|Overall Study||63
9790566|NCT00555893|10898199|FG000|NOT COMPLETED|Overall Study||0
9790567|NCT00555893|10898200|FG001|NOT COMPLETED|Overall Study||0
9790568|NCT00555906|10898209|FG000|STARTED|Phase 1||3
9790569|NCT00555906|10898210|FG001|STARTED|Phase 1||6
9790570|NCT00555906|10898211|FG002|STARTED|Phase 1||7
9790571|NCT00555906|10898212|FG003|STARTED|Phase 1||5
9790572|NCT00555906|10898213|FG004|STARTED|Phase 1||0
9790573|NCT00555906|10898209|FG000|COMPLETED|Phase 1||0
9790574|NCT00555906|10898210|FG001|COMPLETED|Phase 1||0
9790575|NCT00555906|10898211|FG002|COMPLETED|Phase 1||0
9790576|NCT00555906|10898212|FG003|COMPLETED|Phase 1||0
9790577|NCT00555906|10898213|FG004|COMPLETED|Phase 1||0
9790578|NCT00555906|10898209|FG000|NOT COMPLETED|Phase 1||3
9790579|NCT00555906|10898210|FG001|NOT COMPLETED|Phase 1||6
9790580|NCT00555906|10898211|FG002|NOT COMPLETED|Phase 1||7
9790581|NCT00555906|10898212|FG003|NOT COMPLETED|Phase 1||5
9790582|NCT00555906|10898213|FG004|NOT COMPLETED|Phase 1||0
9790583|NCT00555906|10898209|FG000|STARTED|Phase 2||0
9790584|NCT00555906|10898210|FG001|STARTED|Phase 2||0
9790585|NCT00555906|10898211|FG002|STARTED|Phase 2||0
9790586|NCT00555906|10898212|FG003|STARTED|Phase 2||0
9790587|NCT00555906|10898213|FG004|STARTED|Phase 2||32
9790588|NCT00555906|10898209|FG000|Treated|Phase 2||0
9790589|NCT00555906|10898210|FG001|Treated|Phase 2||0
9790590|NCT00555906|10898211|FG002|Treated|Phase 2||0
9790591|NCT00555906|10898212|FG003|Treated|Phase 2||0
9790592|NCT00555906|10898213|FG004|Treated|Phase 2||30
9790593|NCT00555906|10898209|FG000|COMPLETED|Phase 2||0
9790594|NCT00555906|10898210|FG001|COMPLETED|Phase 2||0
9790595|NCT00555906|10898211|FG002|COMPLETED|Phase 2||0
9790596|NCT00555906|10898212|FG003|COMPLETED|Phase 2||0
10234472|NCT01446250|11364486|FG002|NOT COMPLETED|Clinical Hold||0
10234473|NCT01446250|11364487|FG003|NOT COMPLETED|Clinical Hold||0
10234474|NCT01446250|11364484|FG000|STARTED|Treatment Period 2||0
10234475|NCT01446250|11364485|FG001|STARTED|Treatment Period 2||7
10234476|NCT01446250|11364486|FG002|STARTED|Treatment Period 2||0
10234477|NCT01446250|11364487|FG003|STARTED|Treatment Period 2||0
10234478|NCT01446250|11364484|FG000|COMPLETED|Treatment Period 2||0
10234479|NCT01446250|11364485|FG001|COMPLETED|Treatment Period 2||6
10234480|NCT01446250|11364486|FG002|COMPLETED|Treatment Period 2||0
10234481|NCT01446250|11364487|FG003|COMPLETED|Treatment Period 2||0
10234482|NCT01446250|11364484|FG000|NOT COMPLETED|Treatment Period 2||0
10234483|NCT01446250|11364485|FG001|NOT COMPLETED|Treatment Period 2||1
10234484|NCT01446250|11364486|FG002|NOT COMPLETED|Treatment Period 2||0
10234485|NCT01446250|11364487|FG003|NOT COMPLETED|Treatment Period 2||0
10234486|NCT01446250|11364484|FG000|STARTED|Follow-up||0
10234487|NCT01446250|11364485|FG001|STARTED|Follow-up||0
10234488|NCT01446250|11364486|FG002|STARTED|Follow-up||0
10234489|NCT01446250|11364487|FG003|STARTED|Follow-up||6
10234490|NCT01446250|11364484|FG000|COMPLETED|Follow-up||0
10234491|NCT01446250|11364485|FG001|COMPLETED|Follow-up||0
10234492|NCT01446250|11364486|FG002|COMPLETED|Follow-up||0
10234493|NCT01446250|11364487|FG003|COMPLETED|Follow-up||0
10234494|NCT01446250|11364484|FG000|NOT COMPLETED|Follow-up||0
10234495|NCT01446250|11364485|FG001|NOT COMPLETED|Follow-up||0
10234496|NCT01446250|11364486|FG002|NOT COMPLETED|Follow-up||0
10234497|NCT01446250|11364487|FG003|NOT COMPLETED|Follow-up||6
10234498|NCT01463293|11364498|FG000|STARTED|Overall Study||74
10234499|NCT01463293|11364499|FG001|STARTED|Overall Study||79
10234500|NCT01463293|11364500|FG002|STARTED|Overall Study||71
10234501|NCT01463293|11364498|FG000|COMPLETED|Overall Study||68
10234502|NCT01463293|11364499|FG001|COMPLETED|Overall Study||63
10234503|NCT01463293|11364500|FG002|COMPLETED|Overall Study||59
10234504|NCT01463293|11364498|FG000|NOT COMPLETED|Overall Study||6
10234505|NCT01463293|11364499|FG001|NOT COMPLETED|Overall Study||16
10234506|NCT01463293|11364500|FG002|NOT COMPLETED|Overall Study||12
10234507|NCT01457053|11364508|FG000|STARTED|Overall Study||2
10234508|NCT01457053|11364509|FG001|STARTED|Overall Study||2
10234509|NCT01457053|11364508|FG000|COMPLETED|Overall Study||1
10234510|NCT01457053|11364509|FG001|COMPLETED|Overall Study||1
10234511|NCT01457053|11364508|FG000|NOT COMPLETED|Overall Study||1
10234512|NCT01457053|11364509|FG001|NOT COMPLETED|Overall Study||1
9790597|NCT00555906|10898213|FG004|COMPLETED|Phase 2||0
9790598|NCT00555906|10898209|FG000|NOT COMPLETED|Phase 2||0
9790599|NCT00555906|10898210|FG001|NOT COMPLETED|Phase 2||0
9790600|NCT00555906|10898211|FG002|NOT COMPLETED|Phase 2||0
9790601|NCT00555906|10898212|FG003|NOT COMPLETED|Phase 2||0
9790602|NCT00555906|10898213|FG004|NOT COMPLETED|Phase 2||32
9790603|NCT00555971|10898230|FG000|STARTED|Overall Study||5
9790604|NCT00555971|10898231|FG001|STARTED|Overall Study||8
9790605|NCT00555971|10898230|FG000|COMPLETED|Overall Study||4
9790606|NCT00555971|10898231|FG001|COMPLETED|Overall Study||7
9790607|NCT00555971|10898230|FG000|NOT COMPLETED|Overall Study||1
9790608|NCT00555971|10898231|FG001|NOT COMPLETED|Overall Study||1
10234513|NCT01451723|11364517|FG000|STARTED|Overall Study||6
10234514|NCT01451723|11364518|FG001|STARTED|Overall Study||5
9790609|NCT00555997|10898240|FG000|STARTED|Phase 1 SPCD||29
9790610|NCT00555997|10898241|FG001|STARTED|Phase 1 SPCD||91
10234515|NCT01451723|11364517|FG000|COMPLETED|Overall Study||0
10234516|NCT01451723|11364518|FG001|COMPLETED|Overall Study||0
10234517|NCT01451723|11364517|FG000|NOT COMPLETED|Overall Study||6
10234518|NCT01451723|11364518|FG001|NOT COMPLETED|Overall Study||5
9790611|NCT00555997|10898242|FG002|STARTED|Phase 1 SPCD||0
9790612|NCT00555997|10898243|FG003|STARTED|Phase 1 SPCD||0
9790613|NCT00555997|10898240|FG000|COMPLETED|Phase 1 SPCD||17
9790614|NCT00555997|10898241|FG001|COMPLETED|Phase 1 SPCD||76
9790615|NCT00555997|10898242|FG002|COMPLETED|Phase 1 SPCD||0
9790616|NCT00555997|10898243|FG003|COMPLETED|Phase 1 SPCD||0
9790617|NCT00555997|10898240|FG000|NOT COMPLETED|Phase 1 SPCD||12
9790618|NCT00555997|10898241|FG001|NOT COMPLETED|Phase 1 SPCD||15
9790619|NCT00555997|10898242|FG002|NOT COMPLETED|Phase 1 SPCD||0
9790620|NCT00555997|10898243|FG003|NOT COMPLETED|Phase 1 SPCD||0
9790621|NCT00555997|10898240|FG000|STARTED|Phase 2 SPCD||0
9790622|NCT00555997|10898241|FG001|STARTED|Phase 2 SPCD||0
9790623|NCT00555997|10898242|FG002|STARTED|Phase 2 SPCD||38
9790624|NCT00555997|10898243|FG003|STARTED|Phase 2 SPCD||25
9790625|NCT00555997|10898240|FG000|COMPLETED|Phase 2 SPCD||0
9790626|NCT00555997|10898241|FG001|COMPLETED|Phase 2 SPCD||0
9790627|NCT00555997|10898242|FG002|COMPLETED|Phase 2 SPCD||31
10015484|NCT01806597|11138561|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
10015485|NCT01806597|11138562|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
10015486|NCT01806597|11138563|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
10019103|NCT01827592|11142214|FG002|Safety Analysis Set|Overall Study||124
10234519|NCT01452854|11364524|FG000|STARTED|Overall Study||2
10234520|NCT01452854|11364524|FG000|COMPLETED|Overall Study||2
9790628|NCT00555997|10898243|FG003|COMPLETED|Phase 2 SPCD||22
9790629|NCT00555997|10898240|FG000|NOT COMPLETED|Phase 2 SPCD||0
9790630|NCT00555997|10898241|FG001|NOT COMPLETED|Phase 2 SPCD||0
9790631|NCT00555997|10898242|FG002|NOT COMPLETED|Phase 2 SPCD||7
9790632|NCT00555997|10898243|FG003|NOT COMPLETED|Phase 2 SPCD||3
9790633|NCT00556049|10898255|FG000|STARTED|Overall Study||72
9790634|NCT00556049|10898255|FG000|COMPLETED|Overall Study||72
9790635|NCT00556049|10898255|FG000|NOT COMPLETED|Overall Study||0
9790636|NCT00556140|10898259|FG000|STARTED|Overall Study||16
9790637|NCT00556140|10898259|FG000|COMPLETED|Overall Study||13
9790638|NCT00556140|10898259|FG000|NOT COMPLETED|Overall Study||3
9790639|NCT00556322|10898265|FG000|STARTED|Overall Study||221
9790640|NCT00556322|10898266|FG001|STARTED|Overall Study||203
9790641|NCT00556322|10898265|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
9790642|NCT00556322|10898266|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
9790643|NCT00556322|10898265|FG000|NOT COMPLETED|Overall Study||221
9790644|NCT00556322|10898266|FG001|NOT COMPLETED|Overall Study||203
9790645|NCT00556374|10898277|FG000|STARTED|Overall Study||1709
9790646|NCT00556374|10898278|FG001|STARTED|Overall Study||1711
9790647|NCT00556374|10898277|FG000|Received Study Drug|Overall Study||1699
9790648|NCT00556374|10898278|FG001|Received Study Drug|Overall Study||1700
9790649|NCT00556374|10898277|FG000|COMPLETED|Overall Study|Indicates participants continuing study|1462
9790650|NCT00556374|10898278|FG001|COMPLETED|Overall Study|Indicates participants continuing study|1491
9790651|NCT00556374|10898277|FG000|NOT COMPLETED|Overall Study||247
9790652|NCT00556374|10898278|FG001|NOT COMPLETED|Overall Study||220
10234521|NCT01452854|11364524|FG000|NOT COMPLETED|Overall Study||0
10234522|NCT01440517|11364528|FG000|STARTED|Overall Study||5
10234523|NCT01440517|11364528|FG000|COMPLETED|Overall Study||4
10234524|NCT01440517|11364528|FG000|NOT COMPLETED|Overall Study||1
10234525|NCT01440595|11364534|FG000|STARTED|Overall Study||1
10234526|NCT01440595|11364535|FG001|STARTED|Overall Study||3
10234527|NCT01440595|11364536|FG002|STARTED|Overall Study||1
10234528|NCT01440595|11364534|FG000|COMPLETED|Overall Study||0
10234529|NCT01440595|11364535|FG001|COMPLETED|Overall Study||0
10234530|NCT01440595|11364536|FG002|COMPLETED|Overall Study||0
10234531|NCT01440595|11364534|FG000|NOT COMPLETED|Overall Study||1
10234532|NCT01440595|11364535|FG001|NOT COMPLETED|Overall Study||3
10234533|NCT01440595|11364536|FG002|NOT COMPLETED|Overall Study||1
10234534|NCT01446796|11364542|FG000|STARTED|Overall Study||3
10234535|NCT01446796|11364543|FG001|STARTED|Overall Study||0
10234536|NCT01446796|11364542|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
10234537|NCT01446796|11364543|FG001|COMPLETED|Overall Study|Study terminated early|0
10234538|NCT01446796|11364542|FG000|NOT COMPLETED|Overall Study||1
10234539|NCT01446796|11364543|FG001|NOT COMPLETED|Overall Study||0
10234540|NCT01443923|11364553|FG000|STARTED|Overall Study||3
10234541|NCT01443923|11364554|FG001|STARTED|Overall Study||1
10234542|NCT01443923|11364553|FG000|COMPLETED|Overall Study||2
10234543|NCT01443923|11364554|FG001|COMPLETED|Overall Study||1
10234544|NCT01443923|11364553|FG000|NOT COMPLETED|Overall Study||1
10234545|NCT01443923|11364554|FG001|NOT COMPLETED|Overall Study||0
10234546|NCT01439347|11364562|FG000|STARTED|Overall Study||13
10234547|NCT01439347|11364563|FG001|STARTED|Overall Study||13
10234548|NCT01439347|11364562|FG000|COMPLETED|Overall Study||0
10234549|NCT01439347|11364563|FG001|COMPLETED|Overall Study||0
10234550|NCT01439347|11364562|FG000|NOT COMPLETED|Overall Study||13
9790653|NCT00556426|10898284|FG000|STARTED|Overall Study||100
9790654|NCT00556426|10898284|FG000|COMPLETED|Overall Study||91
9790655|NCT00556426|10898284|FG000|NOT COMPLETED|Overall Study||9
9790656|NCT00556439|10898293|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
10234551|NCT01439347|11364563|FG001|NOT COMPLETED|Overall Study||13
10234552|NCT01440452|11364573|FG000|STARTED|Overall Study||6
10234553|NCT01440452|11364574|FG001|STARTED|Overall Study||7
10234554|NCT01440452|11364575|FG002|STARTED|Overall Study||8
10234555|NCT01440452|11364576|FG003|STARTED|Overall Study||4
10234556|NCT01440452|11364573|FG000|COMPLETED|Overall Study||6
9790657|NCT00556439|10898294|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
9790658|NCT00556439|10898295|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
9790659|NCT00556439|10898296|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
9790660|NCT00556439|10898293|FG000|COMPLETED|Study Entry to Week 12||41
9790661|NCT00556439|10898294|FG001|COMPLETED|Study Entry to Week 12||0
9790662|NCT00556439|10898295|FG002|COMPLETED|Study Entry to Week 12||26
9790663|NCT00556439|10898296|FG003|COMPLETED|Study Entry to Week 12||0
9790664|NCT00556439|10898293|FG000|NOT COMPLETED|Study Entry to Week 12||8
9790665|NCT00556439|10898294|FG001|NOT COMPLETED|Study Entry to Week 12||0
9790666|NCT00556439|10898295|FG002|NOT COMPLETED|Study Entry to Week 12||8
9790667|NCT00556439|10898296|FG003|NOT COMPLETED|Study Entry to Week 12||0
9790668|NCT00556439|10898293|FG000|STARTED|After Week 12 (Randomized Study Period)||20
9790669|NCT00556439|10898294|FG001|STARTED|After Week 12 (Randomized Study Period)||21
9790670|NCT00556439|10898295|FG002|STARTED|After Week 12 (Randomized Study Period)||11
9790671|NCT00556439|10898296|FG003|STARTED|After Week 12 (Randomized Study Period)||15
9790672|NCT00556439|10898293|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17
9790673|NCT00556439|10898294|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17
9790674|NCT00556439|10898295|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11
9790675|NCT00556439|10898296|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14
9790676|NCT00556439|10898293|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
9790677|NCT00556439|10898294|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
9790678|NCT00556439|10898295|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
9790679|NCT00556439|10898296|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
9790680|NCT00556452|10898309|FG000|STARTED|Overall Study||6
9790681|NCT00556452|10898310|FG001|STARTED|Overall Study||21
9790682|NCT00556452|10898311|FG002|STARTED|Overall Study||19
9790683|NCT00556452|10898309|FG000|COMPLETED|Overall Study||6
9790684|NCT00556452|10898310|FG001|COMPLETED|Overall Study||21
9790685|NCT00556452|10898311|FG002|COMPLETED|Overall Study||19
9790686|NCT00556452|10898309|FG000|NOT COMPLETED|Overall Study||0
9790687|NCT00556452|10898310|FG001|NOT COMPLETED|Overall Study||0
9790688|NCT00556452|10898311|FG002|NOT COMPLETED|Overall Study||0
9790689|NCT00556478|10898318|FG000|STARTED|Double-blind Phase||171
9790690|NCT00556478|10898319|FG001|STARTED|Double-blind Phase||85
9790691|NCT00556478|10898318|FG000|ITT|Double-blind Phase||167
9790692|NCT00556478|10898319|FG001|ITT|Double-blind Phase||82
9790693|NCT00556478|10898318|FG000|COMPLETED|Double-blind Phase||150
9790694|NCT00556478|10898319|FG001|COMPLETED|Double-blind Phase||77
9790695|NCT00556478|10898318|FG000|NOT COMPLETED|Double-blind Phase||21
9790696|NCT00556478|10898319|FG001|NOT COMPLETED|Double-blind Phase||8
9790697|NCT00556478|10898318|FG000|STARTED|Open-Label Phase||146
9790698|NCT00556478|10898319|FG001|STARTED|Open-Label Phase||77
9790699|NCT00556478|10898318|FG000|Treated in Open-label|Open-Label Phase||142
9790700|NCT00556478|10898319|FG001|Treated in Open-label|Open-Label Phase||71
9790701|NCT00556478|10898318|FG000|COMPLETED|Open-Label Phase||132
9790702|NCT00556478|10898319|FG001|COMPLETED|Open-Label Phase||67
9790703|NCT00556478|10898318|FG000|NOT COMPLETED|Open-Label Phase||14
9790704|NCT00556478|10898319|FG001|NOT COMPLETED|Open-Label Phase||10
9790705|NCT00556491|10898330|FG000|STARTED|Overall Study|January 2008|20
9790706|NCT00556491|10898331|FG001|STARTED|Overall Study||20
9790707|NCT00556491|10898330|FG000|COMPLETED|Overall Study||19
9790708|NCT00556491|10898331|FG001|COMPLETED|Overall Study||19
9790709|NCT00556491|10898330|FG000|NOT COMPLETED|Overall Study||1
9790710|NCT00556491|10898331|FG001|NOT COMPLETED|Overall Study||1
9790711|NCT00556504|10898349|FG000|STARTED|Overall Study||42
9790712|NCT00556504|10898350|FG001|STARTED|Overall Study||42
9790713|NCT00556504|10898349|FG000|Intend-to Treat Population|Overall Study||42
9790714|NCT00556504|10898350|FG001|Intend-to Treat Population|Overall Study||42
9790715|NCT00556504|10898349|FG000|Safety Population|Overall Study||41
9790716|NCT00556504|10898350|FG001|Safety Population|Overall Study||42
9790717|NCT00556504|10898349|FG000|COMPLETED|Overall Study||34
9790718|NCT00556504|10898350|FG001|COMPLETED|Overall Study||33
9790719|NCT00556504|10898349|FG000|NOT COMPLETED|Overall Study||8
9790720|NCT00556504|10898350|FG001|NOT COMPLETED|Overall Study||9
10234557|NCT01440452|11364574|FG001|COMPLETED|Overall Study||7
10234558|NCT01440452|11364575|FG002|COMPLETED|Overall Study||8
10234559|NCT01440452|11364576|FG003|COMPLETED|Overall Study||4
10234560|NCT01440452|11364573|FG000|NOT COMPLETED|Overall Study||0
10234561|NCT01440452|11364574|FG001|NOT COMPLETED|Overall Study||0
10234562|NCT01440452|11364575|FG002|NOT COMPLETED|Overall Study||0
9790721|NCT00556543|10898356|FG000|STARTED|Overall Study||10
9790722|NCT00556543|10898356|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
9790723|NCT00556543|10898356|FG000|NOT COMPLETED|Overall Study||0
9790724|NCT00556673|10898365|FG000|STARTED|Overall Study||16
9790725|NCT00556673|10898366|FG001|STARTED|Overall Study||15
9790726|NCT00556673|10898365|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
9790727|NCT00556673|10898366|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
9790728|NCT00556673|10898365|FG000|COMPLETED|Overall Study||13
10234563|NCT01440452|11364576|FG003|NOT COMPLETED|Overall Study||0
9790729|NCT00556673|10898366|FG001|COMPLETED|Overall Study||13
10234564|NCT01433471|11364588|FG000|STARTED|Overall Study||2
10234565|NCT01433471|11364589|FG001|STARTED|Overall Study||2
9790730|NCT00556673|10898365|FG000|NOT COMPLETED|Overall Study||3
9790731|NCT00556673|10898366|FG001|NOT COMPLETED|Overall Study||2
9790732|NCT00556712|10898376|FG000|STARTED|Overall Study||451
9790733|NCT00556712|10898377|FG001|STARTED|Overall Study||438
9790734|NCT00556712|10898376|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
9790735|NCT00556712|10898377|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
9790736|NCT00556712|10898376|FG000|NOT COMPLETED|Overall Study||451
9790737|NCT00556712|10898377|FG001|NOT COMPLETED|Overall Study||438
9830645|NCT00764660|10941390|FG000|STARTED|Overall Study||75
9830646|NCT00764660|10941391|FG001|STARTED|Overall Study||66
9830647|NCT00764660|10941390|FG000|COMPLETED|Overall Study||53
9830648|NCT00764660|10941391|FG001|COMPLETED|Overall Study||55
9830649|NCT00764660|10941390|FG000|NOT COMPLETED|Overall Study||22
9830650|NCT00764660|10941391|FG001|NOT COMPLETED|Overall Study||11
9830651|NCT00764673|10941397|FG000|STARTED|Overall Study||71
9830652|NCT00764673|10941397|FG000|COMPLETED|Overall Study||59
9830653|NCT00764673|10941397|FG000|NOT COMPLETED|Overall Study||12
9830654|NCT00764738|10941405|FG000|STARTED|Overall Study||24
9830655|NCT00764738|10941406|FG001|STARTED|Overall Study||28
9830656|NCT00764738|10941407|FG002|STARTED|Overall Study||15
9830657|NCT00764738|10941408|FG003|STARTED|Overall Study||24
9830658|NCT00764738|10941405|FG000|COMPLETED|Overall Study||22
9830659|NCT00764738|10941406|FG001|COMPLETED|Overall Study||25
9830660|NCT00764738|10941407|FG002|COMPLETED|Overall Study||12
9830661|NCT00764738|10941408|FG003|COMPLETED|Overall Study||18
9830662|NCT00764738|10941405|FG000|NOT COMPLETED|Overall Study||2
9830663|NCT00764738|10941406|FG001|NOT COMPLETED|Overall Study||3
9830664|NCT00764738|10941407|FG002|NOT COMPLETED|Overall Study||3
9830665|NCT00764738|10941408|FG003|NOT COMPLETED|Overall Study||6
9830666|NCT00764751|10941420|FG000|STARTED|Overall Study||39
9830667|NCT00764751|10941421|FG001|STARTED|Overall Study||12
9830668|NCT00764751|10941420|FG000|COMPLETED|Overall Study||37
9830669|NCT00764751|10941421|FG001|COMPLETED|Overall Study||11
9830670|NCT00764751|10941420|FG000|NOT COMPLETED|Overall Study||2
9830671|NCT00764751|10941421|FG001|NOT COMPLETED|Overall Study||1
9830672|NCT00764790|10941435|FG000|STARTED|Overall Study||1107
9830673|NCT00764790|10941436|FG001|STARTED|Overall Study||1106
9830674|NCT00764790|10941437|FG002|STARTED|Overall Study||1104
9830675|NCT00764790|10941435|FG000|COMPLETED|Overall Study||1069
9830676|NCT00764790|10941436|FG001|COMPLETED|Overall Study||1065
9830677|NCT00764790|10941437|FG002|COMPLETED|Overall Study||1074
9830678|NCT00764790|10941435|FG000|NOT COMPLETED|Overall Study||38
9830679|NCT00764790|10941436|FG001|NOT COMPLETED|Overall Study||41
9830680|NCT00764790|10941437|FG002|NOT COMPLETED|Overall Study||30
9830681|NCT00764868|10941445|FG000|STARTED|Overall Study||269
9830682|NCT00764868|10941445|FG000|COMPLETED|Overall Study||156
9830683|NCT00764868|10941445|FG000|NOT COMPLETED|Overall Study||113
9830684|NCT00764881|10941451|FG000|STARTED|Overall Study||108
9830685|NCT00764881|10941452|FG001|STARTED|Overall Study||109
9830686|NCT00764881|10941451|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
10234566|NCT01433471|11364588|FG000|COMPLETED|Overall Study||2
10234567|NCT01433471|11364589|FG001|COMPLETED|Overall Study||1
10234568|NCT01433471|11364588|FG000|NOT COMPLETED|Overall Study||0
10234569|NCT01433471|11364589|FG001|NOT COMPLETED|Overall Study||1
9830687|NCT00764881|10941452|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
10234570|NCT01436084|11364597|FG000|STARTED|Overall Study||4
10234571|NCT01436084|11364597|FG000|COMPLETED|Overall Study||0
10234572|NCT01436084|11364597|FG000|NOT COMPLETED|Overall Study||4
10234573|NCT01434511|11364601|FG000|STARTED|Overall Study||1
10234574|NCT01434511|11364601|FG000|COMPLETED|Overall Study||1
10234575|NCT01434511|11364601|FG000|NOT COMPLETED|Overall Study||0
10234576|NCT01426555|11364607|FG000|STARTED|Overall Study||35
10234577|NCT01426555|11364608|FG001|STARTED|Overall Study||35
10234578|NCT01426555|11364607|FG000|COMPLETED|Overall Study||17
10234579|NCT01426555|11364608|FG001|COMPLETED|Overall Study||20
10234580|NCT01426555|11364607|FG000|NOT COMPLETED|Overall Study||18
10234581|NCT01426555|11364608|FG001|NOT COMPLETED|Overall Study||15
10234582|NCT01434745|11364618|FG000|STARTED|Overall Study||0
10234583|NCT01434745|11364619|FG001|STARTED|Overall Study||0
10234584|NCT01434745|11364618|FG000|COMPLETED|Overall Study||0
10234585|NCT01434745|11364619|FG001|COMPLETED|Overall Study||0
10234586|NCT01434745|11364618|FG000|NOT COMPLETED|Overall Study||0
10234587|NCT01434745|11364619|FG001|NOT COMPLETED|Overall Study||0
10234588|NCT01415986|11364625|FG000|STARTED|Overall Study||1
10234589|NCT01415986|11364625|FG000|COMPLETED|Overall Study|Study terminated|0
10234590|NCT01415986|11364625|FG000|NOT COMPLETED|Overall Study||1
10234591|NCT01410799|11364630|FG000|STARTED|Overall Study||13
10234592|NCT01410799|11364630|FG000|COMPLETED|Overall Study||0
10234593|NCT01410799|11364630|FG000|NOT COMPLETED|Overall Study||13
9830688|NCT00764881|10941451|FG000|COMPLETED|Overall Study||92
9830689|NCT00764881|10941452|FG001|COMPLETED|Overall Study||99
9830690|NCT00764881|10941451|FG000|NOT COMPLETED|Overall Study||16
9830691|NCT00764881|10941452|FG001|NOT COMPLETED|Overall Study||10
10234594|NCT01426113|11364636|FG000|STARTED|Overall Study||3
10234595|NCT01426113|11364637|FG001|STARTED|Overall Study||3
10234596|NCT01426113|11364636|FG000|COMPLETED|Overall Study||2
10234597|NCT01426113|11364637|FG001|COMPLETED|Overall Study||1
10234598|NCT01426113|11364636|FG000|NOT COMPLETED|Overall Study||1
9830692|NCT00764946|10941461|FG000|STARTED|Overall Study||98
10234599|NCT01426113|11364637|FG001|NOT COMPLETED|Overall Study||2
10234600|NCT01426516|11364645|FG000|STARTED|Overall Study||12
10234601|NCT01426516|11364646|FG001|STARTED|Overall Study||17
9790738|NCT00556842|10898385|FG000|STARTED|Overall Study||749
9790739|NCT00556842|10898386|FG001|STARTED|Overall Study||746
9790740|NCT00556842|10898385|FG000|COMPLETED|Overall Study||718
9790741|NCT00556842|10898386|FG001|COMPLETED|Overall Study||723
9790742|NCT00556842|10898385|FG000|NOT COMPLETED|Overall Study||31
9790743|NCT00556842|10898386|FG001|NOT COMPLETED|Overall Study||23
9790744|NCT00556894|10898403|FG000|STARTED|Overall Study||82
9790745|NCT00556894|10898404|FG001|STARTED|Overall Study||87
9790746|NCT00556894|10898405|FG002|STARTED|Overall Study||84
9790747|NCT00556894|10898403|FG000|COMPLETED|Overall Study||66
9790748|NCT00556894|10898404|FG001|COMPLETED|Overall Study||68
9790749|NCT00556894|10898405|FG002|COMPLETED|Overall Study||65
9790750|NCT00556894|10898403|FG000|NOT COMPLETED|Overall Study||16
9790751|NCT00556894|10898404|FG001|NOT COMPLETED|Overall Study||19
9790752|NCT00556894|10898405|FG002|NOT COMPLETED|Overall Study||19
9790753|NCT00556933|10898417|FG000|STARTED|Single vs. Divided-dose rATG Induction||45
9790754|NCT00556933|10898418|FG001|STARTED|Single vs. Divided-dose rATG Induction||45
9790755|NCT00556933|10898419|FG002|STARTED|Single vs. Divided-dose rATG Induction||45
9790756|NCT00556933|10898420|FG003|STARTED|Single vs. Divided-dose rATG Induction||45
9790757|NCT00556933|10898417|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43
9790758|NCT00556933|10898418|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37
9790759|NCT00556933|10898419|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39
9790760|NCT00556933|10898420|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43
9790761|NCT00556933|10898417|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
9790762|NCT00556933|10898418|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
9790763|NCT00556933|10898419|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
9790764|NCT00556933|10898420|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
9790765|NCT00556933|10898417|FG000|STARTED|CNI Withdrawal vs. Minimization||43
9790766|NCT00556933|10898418|FG001|STARTED|CNI Withdrawal vs. Minimization||37
9790767|NCT00556933|10898419|FG002|STARTED|CNI Withdrawal vs. Minimization||39
9790768|NCT00556933|10898420|FG003|STARTED|CNI Withdrawal vs. Minimization||43
9790769|NCT00556933|10898417|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42
9790770|NCT00556933|10898418|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33
9790771|NCT00556933|10898419|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36
9790772|NCT00556933|10898420|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41
9790773|NCT00556933|10898417|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
9790774|NCT00556933|10898418|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
9790775|NCT00556933|10898419|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
9790776|NCT00556933|10898420|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
9790777|NCT00556946|10898439|FG000|STARTED|Overall Study||17
9790778|NCT00556946|10898439|FG000|COMPLETED|Overall Study||16
9790779|NCT00556946|10898439|FG000|NOT COMPLETED|Overall Study||1
9790780|NCT00556972|10898443|FG000|STARTED|Overall Study||4
9790781|NCT00556972|10898443|FG000|COMPLETED|Overall Study||4
9790782|NCT00556972|10898443|FG000|NOT COMPLETED|Overall Study||0
9790783|NCT00556998|10898447|FG000|STARTED|Voriconazole Intravenous (IV)||26
9790784|NCT00556998|10898447|FG000|Treated|Voriconazole Intravenous (IV)||26
9790785|NCT00556998|10898447|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
9790786|NCT00556998|10898447|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5
10234602|NCT01426516|11364645|FG000|COMPLETED|Overall Study||12
10234603|NCT01426516|11364646|FG001|COMPLETED|Overall Study||17
10234604|NCT01426516|11364645|FG000|NOT COMPLETED|Overall Study||0
10234605|NCT01426516|11364646|FG001|NOT COMPLETED|Overall Study||0
10234606|NCT01420965|11364655|FG000|STARTED|Overall Study||2
10234607|NCT01420965|11364656|FG001|STARTED|Overall Study||2
10234608|NCT01420965|11364657|FG002|STARTED|Overall Study||3
10234609|NCT01420965|11364655|FG000|COMPLETED|Overall Study||1
10234610|NCT01420965|11364656|FG001|COMPLETED|Overall Study||1
10234611|NCT01420965|11364657|FG002|COMPLETED|Overall Study||3
10234612|NCT01420965|11364655|FG000|NOT COMPLETED|Overall Study||1
10234613|NCT01420965|11364656|FG001|NOT COMPLETED|Overall Study||1
10234614|NCT01420965|11364657|FG002|NOT COMPLETED|Overall Study||0
10234615|NCT01417377|11364665|FG000|STARTED|Overall Study||22
10234616|NCT01417377|11364665|FG000|Treated|Overall Study||21
10234617|NCT01417377|11364665|FG000|COMPLETED|Overall Study||9
10234618|NCT01417377|11364665|FG000|NOT COMPLETED|Overall Study||13
10234619|NCT01416272|11364669|FG000|STARTED|Overall Study||12
10234620|NCT01416272|11364669|FG000|COMPLETED|Overall Study||8
10234621|NCT01416272|11364669|FG000|NOT COMPLETED|Overall Study||4
10234622|NCT01414166|11364675|FG000|STARTED|Overall Study||122
10234623|NCT01414166|11364676|FG001|STARTED|Overall Study||122
10234624|NCT01414166|11364675|FG000|Treated|Overall Study||120
10234625|NCT01414166|11364676|FG001|Treated|Overall Study||121
10234626|NCT01414166|11364675|FG000|COMPLETED|Overall Study||31
10234627|NCT01414166|11364676|FG001|COMPLETED|Overall Study||39
10234628|NCT01414166|11364675|FG000|NOT COMPLETED|Overall Study||91
10234629|NCT01414166|11364676|FG001|NOT COMPLETED|Overall Study||83
10234630|NCT01406860|11364684|FG000|STARTED|Overall Study||11
9790787|NCT00556998|10898447|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
9790788|NCT00556998|10898447|FG000|COMPLETED|Voriconazole Oral||20
10234631|NCT01406860|11364685|FG001|STARTED|Overall Study||8
10234632|NCT01406860|11364684|FG000|COMPLETED|Overall Study||11
10234633|NCT01406860|11364685|FG001|COMPLETED|Overall Study||8
10234634|NCT01406860|11364684|FG000|NOT COMPLETED|Overall Study||0
10234635|NCT01406860|11364685|FG001|NOT COMPLETED|Overall Study||0
9790789|NCT00556998|10898447|FG000|NOT COMPLETED|Voriconazole Oral||2
9790790|NCT00557076|10898457|FG000|STARTED|Overall Study||8
10015487|NCT01806597|11138564|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
10015488|NCT01806597|11138559|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
9790791|NCT00557076|10898458|FG001|STARTED|Overall Study||8
9790792|NCT00557076|10898457|FG000|COMPLETED|Overall Study||8
9790793|NCT00557076|10898458|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
9790794|NCT00557076|10898457|FG000|NOT COMPLETED|Overall Study||0
9790795|NCT00557076|10898458|FG001|NOT COMPLETED|Overall Study||1
9790796|NCT00557245|10898467|FG000|STARTED|Overall Study||1589
9790797|NCT00557245|10898468|FG001|STARTED|Overall Study||1583
9790798|NCT00557245|10898469|FG002|STARTED|Overall Study||1586
9790799|NCT00557245|10898467|FG000|COMPLETED|Overall Study||1577
9790800|NCT00557245|10898468|FG001|COMPLETED|Overall Study||1571
9790801|NCT00557245|10898469|FG002|COMPLETED|Overall Study||1574
9790802|NCT00557245|10898467|FG000|NOT COMPLETED|Overall Study||12
9790803|NCT00557245|10898468|FG001|NOT COMPLETED|Overall Study||12
9790804|NCT00557245|10898469|FG002|NOT COMPLETED|Overall Study||12
9790805|NCT00557284|10898482|FG000|STARTED|Overall Study||9
9790806|NCT00557284|10898483|FG001|STARTED|Overall Study||11
9790807|NCT00557284|10898482|FG000|COMPLETED|Overall Study||9
9790808|NCT00557284|10898483|FG001|COMPLETED|Overall Study||11
9790809|NCT00557284|10898482|FG000|NOT COMPLETED|Overall Study||0
9790810|NCT00557284|10898483|FG001|NOT COMPLETED|Overall Study||0
9790811|NCT00557310|10898489|FG000|STARTED|Main Study (0 - 18 Months)||35
9790812|NCT00557310|10898489|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
9790813|NCT00557310|10898489|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5
9790814|NCT00557310|10898489|FG000|STARTED|Extension Phase (18 - 24 Months)||30
9790815|NCT00557310|10898489|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
9790816|NCT00557310|10898489|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
9790817|NCT00557323|10898493|FG000|STARTED|Overall Study||34
9790818|NCT00557323|10898493|FG000|COMPLETED|Overall Study||27
9790819|NCT00557323|10898493|FG000|NOT COMPLETED|Overall Study||7
9790820|NCT00557349|10898499|FG000|STARTED|Overall Study|omeprazole/bicarb|22
9790821|NCT00557349|10898500|FG001|STARTED|Overall Study||18
9790822|NCT00557349|10898499|FG000|COMPLETED|Overall Study||17
9790823|NCT00557349|10898500|FG001|COMPLETED|Overall Study||13
9790824|NCT00557349|10898499|FG000|NOT COMPLETED|Overall Study||5
9790825|NCT00557349|10898500|FG001|NOT COMPLETED|Overall Study||5
9790826|NCT00557362|10898510|FG000|STARTED|Overall Study||30
9790827|NCT00557362|10898511|FG001|STARTED|Overall Study||30
9790828|NCT00557362|10898512|FG002|STARTED|Overall Study||30
9790829|NCT00557362|10898513|FG003|STARTED|Overall Study||30
9790830|NCT00557362|10898510|FG000|COMPLETED|Overall Study||28
9790831|NCT00557362|10898511|FG001|COMPLETED|Overall Study||28
9790832|NCT00557362|10898512|FG002|COMPLETED|Overall Study||26
9790833|NCT00557362|10898513|FG003|COMPLETED|Overall Study||27
9790834|NCT00557362|10898510|FG000|NOT COMPLETED|Overall Study||2
9790835|NCT00557362|10898511|FG001|NOT COMPLETED|Overall Study||2
9790836|NCT00557362|10898512|FG002|NOT COMPLETED|Overall Study||4
9790837|NCT00557362|10898513|FG003|NOT COMPLETED|Overall Study||3
9790838|NCT00557440|10898529|FG000|STARTED|Treatment Period 1||12
9790839|NCT00557440|10898530|FG001|STARTED|Treatment Period 1||12
9790840|NCT00557440|10898531|FG002|STARTED|Treatment Period 1||13
9790841|NCT00557440|10898529|FG000|COMPLETED|Treatment Period 1||12
9790842|NCT00557440|10898530|FG001|COMPLETED|Treatment Period 1||12
9790843|NCT00557440|10898531|FG002|COMPLETED|Treatment Period 1||12
9790844|NCT00557440|10898529|FG000|NOT COMPLETED|Treatment Period 1||0
9790845|NCT00557440|10898530|FG001|NOT COMPLETED|Treatment Period 1||0
9790846|NCT00557440|10898531|FG002|NOT COMPLETED|Treatment Period 1||1
9790847|NCT00557440|10898529|FG000|STARTED|Treatment Period 2||12
9790848|NCT00557440|10898530|FG001|STARTED|Treatment Period 2||12
9790849|NCT00557440|10898531|FG002|STARTED|Treatment Period 2||12
9790850|NCT00557440|10898529|FG000|COMPLETED|Treatment Period 2||12
9790851|NCT00557440|10898530|FG001|COMPLETED|Treatment Period 2||12
9790852|NCT00557440|10898531|FG002|COMPLETED|Treatment Period 2||12
9790853|NCT00557440|10898529|FG000|NOT COMPLETED|Treatment Period 2||0
9790854|NCT00557440|10898530|FG001|NOT COMPLETED|Treatment Period 2||0
9790855|NCT00557440|10898531|FG002|NOT COMPLETED|Treatment Period 2||0
9790856|NCT00557440|10898529|FG000|STARTED|Treatment Period 3||12
9790857|NCT00557440|10898530|FG001|STARTED|Treatment Period 3||12
9790858|NCT00557440|10898531|FG002|STARTED|Treatment Period 3||12
9790859|NCT00557440|10898529|FG000|COMPLETED|Treatment Period 3||12
9790860|NCT00557440|10898530|FG001|COMPLETED|Treatment Period 3||12
9790861|NCT00557440|10898531|FG002|COMPLETED|Treatment Period 3||12
9790862|NCT00557440|10898529|FG000|NOT COMPLETED|Treatment Period 3||0
9790863|NCT00557440|10898530|FG001|NOT COMPLETED|Treatment Period 3||0
9790864|NCT00557440|10898531|FG002|NOT COMPLETED|Treatment Period 3||0
9790865|NCT00557466|10898545|FG000|STARTED|Overall Study||98
9790866|NCT00557466|10898546|FG001|STARTED|Overall Study||92
9790867|NCT00557466|10898547|FG002|STARTED|Overall Study||101
9790868|NCT00557466|10898548|FG003|STARTED|Overall Study||96
9790869|NCT00557466|10898549|FG004|STARTED|Overall Study||90
9790870|NCT00557466|10898550|FG005|STARTED|Overall Study||91
9790871|NCT00557466|10898545|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
9830693|NCT00764946|10941462|FG001|STARTED|Overall Study||89
9790872|NCT00557466|10898546|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
9790873|NCT00557466|10898547|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
9790874|NCT00557466|10898548|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
9790875|NCT00557466|10898549|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
9790876|NCT00557466|10898550|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
9790877|NCT00557466|10898545|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
9790878|NCT00557466|10898546|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
9790879|NCT00557466|10898547|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
9790880|NCT00557466|10898548|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
9790881|NCT00557466|10898549|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
9790882|NCT00557466|10898550|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
9790883|NCT00557466|10898545|FG000|COMPLETED|Overall Study||94
9790884|NCT00557466|10898546|FG001|COMPLETED|Overall Study||87
9790885|NCT00557466|10898547|FG002|COMPLETED|Overall Study||95
9790886|NCT00557466|10898548|FG003|COMPLETED|Overall Study||92
9790887|NCT00557466|10898549|FG004|COMPLETED|Overall Study||87
9790888|NCT00557466|10898550|FG005|COMPLETED|Overall Study||85
9790889|NCT00557466|10898545|FG000|NOT COMPLETED|Overall Study||4
9790890|NCT00557466|10898546|FG001|NOT COMPLETED|Overall Study||5
9790891|NCT00557466|10898547|FG002|NOT COMPLETED|Overall Study||6
9790892|NCT00557466|10898548|FG003|NOT COMPLETED|Overall Study||4
9790893|NCT00557466|10898549|FG004|NOT COMPLETED|Overall Study||3
9790894|NCT00557466|10898550|FG005|NOT COMPLETED|Overall Study||6
9790895|NCT00557492|10898564|FG000|STARTED|Overall Study||59
9790896|NCT00557492|10898564|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58
9790897|NCT00557492|10898564|FG000|NOT COMPLETED|Overall Study||1
9790898|NCT00557505|10898577|FG000|STARTED|Overall Study||3
9790899|NCT00557505|10898578|FG001|STARTED|Overall Study||3
9790900|NCT00557505|10898579|FG002|STARTED|Overall Study||4
9790901|NCT00557505|10898580|FG003|STARTED|Overall Study||3
9790902|NCT00557505|10898581|FG004|STARTED|Overall Study||2
9790903|NCT00557505|10898582|FG005|STARTED|Overall Study||3
9790904|NCT00557505|10898583|FG006|STARTED|Overall Study||3
9790905|NCT00557505|10898584|FG007|STARTED|Overall Study||5
9790906|NCT00557505|10898585|FG008|STARTED|Overall Study||17
9790907|NCT00557505|10898577|FG000|COMPLETED|Overall Study||0
9790908|NCT00557505|10898578|FG001|COMPLETED|Overall Study||0
10234636|NCT01401049|11364694|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
10234637|NCT01401049|11364695|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
10234638|NCT01401049|11364694|FG000|COMPLETED|Overall Study||0
10234639|NCT01401049|11364695|FG001|COMPLETED|Overall Study||0
10234640|NCT01401049|11364694|FG000|NOT COMPLETED|Overall Study||0
10234641|NCT01401049|11364695|FG001|NOT COMPLETED|Overall Study||0
10234642|NCT01409031|11364703|FG000|STARTED|Overall Study||1
10234643|NCT01409031|11364704|FG001|STARTED|Overall Study||2
10234644|NCT01409031|11364703|FG000|COMPLETED|Overall Study||0
10234645|NCT01409031|11364704|FG001|COMPLETED|Overall Study||2
10234646|NCT01409031|11364703|FG000|NOT COMPLETED|Overall Study||1
10234647|NCT01409031|11364704|FG001|NOT COMPLETED|Overall Study||0
10234648|NCT01402531|11364710|FG000|STARTED|Overall Study||0
10234649|NCT01402531|11364710|FG000|COMPLETED|Overall Study||0
10234650|NCT01402531|11364710|FG000|NOT COMPLETED|Overall Study||0
10234651|NCT01394926|11364714|FG000|STARTED|Overall Study||21
10234652|NCT01394926|11364714|FG000|COMPLETED|Overall Study||21
10234653|NCT01394926|11364714|FG000|NOT COMPLETED|Overall Study||0
10234654|NCT01383681|11364723|FG000|STARTED|Overall Study||235
10234655|NCT01383681|11364723|FG000|COMPLETED|Overall Study||189
10234656|NCT01383681|11364723|FG000|NOT COMPLETED|Overall Study||46
10234657|NCT01403194|11364727|FG000|STARTED|Overall Study||11
10234658|NCT01403194|11364727|FG000|COMPLETED|Overall Study||1
10234659|NCT01403194|11364727|FG000|NOT COMPLETED|Overall Study||10
10234660|NCT01397552|11364733|FG000|STARTED|Overall Study||4
10234661|NCT01397552|11364734|FG001|STARTED|Overall Study||4
10234662|NCT01397552|11364733|FG000|COMPLETED|Overall Study||1
10234663|NCT01397552|11364734|FG001|COMPLETED|Overall Study||3
10234664|NCT01397552|11364733|FG000|NOT COMPLETED|Overall Study||3
10234665|NCT01397552|11364734|FG001|NOT COMPLETED|Overall Study||1
10234666|NCT01392170|11364740|FG000|STARTED|Overall Study||2
10234667|NCT01392170|11364740|FG000|COMPLETED|Overall Study||0
10234668|NCT01392170|11364740|FG000|NOT COMPLETED|Overall Study||2
10234669|NCT01389817|11364746|FG000|STARTED|Overall Study||4
10234670|NCT01389817|11364747|FG001|STARTED|Overall Study||0
10234671|NCT01389817|11364746|FG000|COMPLETED|Overall Study||0
10234672|NCT01389817|11364747|FG001|COMPLETED|Overall Study||0
10234673|NCT01389817|11364746|FG000|NOT COMPLETED|Overall Study||4
10234674|NCT01389817|11364747|FG001|NOT COMPLETED|Overall Study||0
10234675|NCT01397695|11364753|FG000|STARTED|Overall Study||0
10234676|NCT01397695|11364753|FG000|COMPLETED|Overall Study||0
10234677|NCT01397695|11364753|FG000|NOT COMPLETED|Overall Study||0
9790909|NCT00557505|10898579|FG002|COMPLETED|Overall Study||0
9790910|NCT00557505|10898580|FG003|COMPLETED|Overall Study||0
9790911|NCT00557505|10898581|FG004|COMPLETED|Overall Study||0
9790912|NCT00557505|10898582|FG005|COMPLETED|Overall Study||0
9790913|NCT00557505|10898583|FG006|COMPLETED|Overall Study||0
9790914|NCT00557505|10898584|FG007|COMPLETED|Overall Study||0
9790915|NCT00557505|10898585|FG008|COMPLETED|Overall Study||0
9790916|NCT00557505|10898577|FG000|NOT COMPLETED|Overall Study||3
9790917|NCT00557505|10898578|FG001|NOT COMPLETED|Overall Study||3
9790918|NCT00557505|10898579|FG002|NOT COMPLETED|Overall Study||4
9790919|NCT00557505|10898580|FG003|NOT COMPLETED|Overall Study||3
9790920|NCT00557505|10898581|FG004|NOT COMPLETED|Overall Study||2
9790921|NCT00557505|10898582|FG005|NOT COMPLETED|Overall Study||3
9790922|NCT00557505|10898583|FG006|NOT COMPLETED|Overall Study||3
9790923|NCT00557505|10898584|FG007|NOT COMPLETED|Overall Study||5
9790924|NCT00557505|10898585|FG008|NOT COMPLETED|Overall Study||17
9790925|NCT00557622|10898610|FG000|STARTED|4-Week Run-in Phase||5
9790926|NCT00557622|10898611|FG001|STARTED|4-Week Run-in Phase||0
9790927|NCT00557622|10898610|FG000|COMPLETED|4-Week Run-in Phase||3
9790928|NCT00557622|10898611|FG001|COMPLETED|4-Week Run-in Phase||0
9790929|NCT00557622|10898610|FG000|NOT COMPLETED|4-Week Run-in Phase||2
9790930|NCT00557622|10898611|FG001|NOT COMPLETED|4-Week Run-in Phase||0
9790931|NCT00557622|10898610|FG000|STARTED|12-Week Treatment Phase||1
10234678|NCT01390181|11364757|FG000|STARTED|Overall Study||4
10234679|NCT01390181|11364757|FG000|COMPLETED|Overall Study||0
10234680|NCT01390181|11364757|FG000|NOT COMPLETED|Overall Study||4
10234681|NCT01385033|11364763|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6
10234682|NCT01385033|11364764|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14
10234683|NCT01385033|11364765|FG002|STARTED|Part I||0
10234684|NCT01385033|11364766|FG003|STARTED|Part I||0
10234685|NCT01385033|11364767|FG004|STARTED|Part I||0
10234686|NCT01385033|11364768|FG005|STARTED|Part I||0
10234687|NCT01385033|11364763|FG000|COMPLETED|Part I||6
10234688|NCT01385033|11364764|FG001|COMPLETED|Part I||14
10234689|NCT01385033|11364765|FG002|COMPLETED|Part I||0
10234690|NCT01385033|11364766|FG003|COMPLETED|Part I||0
10234691|NCT01385033|11364767|FG004|COMPLETED|Part I||0
10234692|NCT01385033|11364768|FG005|COMPLETED|Part I||0
10234693|NCT01385033|11364763|FG000|NOT COMPLETED|Part I||0
10234694|NCT01385033|11364764|FG001|NOT COMPLETED|Part I||0
10234695|NCT01385033|11364765|FG002|NOT COMPLETED|Part I||0
10234696|NCT01385033|11364766|FG003|NOT COMPLETED|Part I||0
10234697|NCT01385033|11364767|FG004|NOT COMPLETED|Part I||0
10234698|NCT01385033|11364768|FG005|NOT COMPLETED|Part I||0
10234699|NCT01385033|11364763|FG000|STARTED|Part II||0
10234700|NCT01385033|11364764|FG001|STARTED|Part II||0
10234701|NCT01385033|11364765|FG002|STARTED|Part II||0
10234702|NCT01385033|11364766|FG003|STARTED|Part II||0
10234703|NCT01385033|11364767|FG004|STARTED|Part II||0
10234704|NCT01385033|11364768|FG005|STARTED|Part II||0
10234705|NCT01385033|11364763|FG000|COMPLETED|Part II||0
10234706|NCT01385033|11364764|FG001|COMPLETED|Part II||0
10234707|NCT01385033|11364765|FG002|COMPLETED|Part II||0
10234708|NCT01385033|11364766|FG003|COMPLETED|Part II||0
10234709|NCT01385033|11364767|FG004|COMPLETED|Part II||0
10234710|NCT01385033|11364768|FG005|COMPLETED|Part II||0
10234711|NCT01385033|11364763|FG000|NOT COMPLETED|Part II||0
10234712|NCT01385033|11364764|FG001|NOT COMPLETED|Part II||0
10234713|NCT01385033|11364765|FG002|NOT COMPLETED|Part II||0
10234714|NCT01385033|11364766|FG003|NOT COMPLETED|Part II||0
10234715|NCT01385033|11364767|FG004|NOT COMPLETED|Part II||0
10234716|NCT01385033|11364768|FG005|NOT COMPLETED|Part II||0
10234717|NCT01385033|11364763|FG000|STARTED|Part III||0
10234718|NCT01385033|11364764|FG001|STARTED|Part III||0
10234719|NCT01385033|11364765|FG002|STARTED|Part III||0
10234720|NCT01385033|11364766|FG003|STARTED|Part III||0
10234721|NCT01385033|11364767|FG004|STARTED|Part III||0
10234722|NCT01385033|11364768|FG005|STARTED|Part III||0
9790932|NCT00557622|10898611|FG001|STARTED|12-Week Treatment Phase||2
10234723|NCT01385033|11364763|FG000|COMPLETED|Part III||0
10234724|NCT01385033|11364764|FG001|COMPLETED|Part III||0
10234725|NCT01385033|11364765|FG002|COMPLETED|Part III||0
10234726|NCT01385033|11364766|FG003|COMPLETED|Part III||0
10234727|NCT01385033|11364767|FG004|COMPLETED|Part III||0
10234728|NCT01385033|11364768|FG005|COMPLETED|Part III||0
10234729|NCT01385033|11364763|FG000|NOT COMPLETED|Part III||0
9790933|NCT00557622|10898610|FG000|COMPLETED|12-Week Treatment Phase||1
10234730|NCT01385033|11364764|FG001|NOT COMPLETED|Part III||0
10234731|NCT01385033|11364765|FG002|NOT COMPLETED|Part III||0
10234732|NCT01385033|11364766|FG003|NOT COMPLETED|Part III||0
10234733|NCT01385033|11364767|FG004|NOT COMPLETED|Part III||0
10234734|NCT01385033|11364768|FG005|NOT COMPLETED|Part III||0
10234735|NCT01394211|11364775|FG000|STARTED|Overall Study||2
10234736|NCT01394211|11364775|FG000|COMPLETED|Overall Study||0
10234737|NCT01394211|11364775|FG000|NOT COMPLETED|Overall Study||2
10234738|NCT01377441|11364781|FG000|STARTED|Overall Study||0
9790934|NCT00557622|10898611|FG001|COMPLETED|12-Week Treatment Phase||1
9790935|NCT00557622|10898610|FG000|NOT COMPLETED|12-Week Treatment Phase||0
9790936|NCT00557622|10898611|FG001|NOT COMPLETED|12-Week Treatment Phase||1
9790937|NCT00557830|10898620|FG000|STARTED|Screening Treatment Phase||12
10234739|NCT01377441|11364782|FG001|STARTED|Overall Study||0
10234740|NCT01377441|11364781|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
10234741|NCT01377441|11364782|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
10234742|NCT01377441|11364781|FG000|NOT COMPLETED|Overall Study||0
9790938|NCT00557830|10898621|FG001|STARTED|Screening Treatment Phase||0
9790939|NCT00557830|10898622|FG002|STARTED|Screening Treatment Phase||0
9790940|NCT00557830|10898620|FG000|COMPLETED|Screening Treatment Phase||6
9790941|NCT00557830|10898621|FG001|COMPLETED|Screening Treatment Phase||0
9790942|NCT00557830|10898622|FG002|COMPLETED|Screening Treatment Phase||0
9790943|NCT00557830|10898620|FG000|NOT COMPLETED|Screening Treatment Phase||6
9790944|NCT00557830|10898621|FG001|NOT COMPLETED|Screening Treatment Phase||0
9790945|NCT00557830|10898622|FG002|NOT COMPLETED|Screening Treatment Phase||0
9790946|NCT00557830|10898620|FG000|STARTED|Treatment Phase||0
9790947|NCT00557830|10898621|FG001|STARTED|Treatment Phase||4
9790948|NCT00557830|10898622|FG002|STARTED|Treatment Phase||2
9790949|NCT00557830|10898620|FG000|COMPLETED|Treatment Phase||0
9790950|NCT00557830|10898621|FG001|COMPLETED|Treatment Phase||4
9790951|NCT00557830|10898622|FG002|COMPLETED|Treatment Phase||2
9790952|NCT00557830|10898620|FG000|NOT COMPLETED|Treatment Phase||0
9790953|NCT00557830|10898621|FG001|NOT COMPLETED|Treatment Phase||0
9790954|NCT00557830|10898622|FG002|NOT COMPLETED|Treatment Phase||0
9790955|NCT00557856|10898630|FG000|STARTED|Part 1: Dose Escalation Phase||7
9790956|NCT00557856|10898631|FG001|STARTED|Part 1: Dose Escalation Phase||5
9790957|NCT00557856|10898632|FG002|STARTED|Part 1: Dose Escalation Phase||6
10234743|NCT01377441|11364782|FG001|NOT COMPLETED|Overall Study||0
10234744|NCT01383447|11364788|FG000|STARTED|Overall Study||2
10234745|NCT01383447|11364788|FG000|COMPLETED|Overall Study||0
10234746|NCT01383447|11364788|FG000|NOT COMPLETED|Overall Study||2
10234747|NCT01372618|11364792|FG000|STARTED|Overall Study||9
10234748|NCT01372618|11364792|FG000|COMPLETED|Overall Study||0
10234749|NCT01372618|11364792|FG000|NOT COMPLETED|Overall Study||9
10234750|NCT01385280|11364796|FG000|STARTED|Overall Study||13
10234751|NCT01385280|11364796|FG000|COMPLETED|Overall Study||13
10234752|NCT01385280|11364796|FG000|NOT COMPLETED|Overall Study||0
10234753|NCT01379274|11364800|FG000|STARTED|Overall Study||2
10234754|NCT01379274|11364800|FG000|COMPLETED|Overall Study||1
10234755|NCT01379274|11364800|FG000|NOT COMPLETED|Overall Study||1
10234756|NCT01379469|11364806|FG000|STARTED|Overall Study||13
10234757|NCT01379469|11364807|FG001|STARTED|Overall Study||7
10234758|NCT01379469|11364806|FG000|COMPLETED|Overall Study||1
10234759|NCT01379469|11364807|FG001|COMPLETED|Overall Study||3
10234760|NCT01379469|11364806|FG000|NOT COMPLETED|Overall Study||12
10234761|NCT01379469|11364807|FG001|NOT COMPLETED|Overall Study||4
10234762|NCT01369641|11364813|FG000|STARTED|Overall Study||1
10234763|NCT01369641|11364813|FG000|COMPLETED|Overall Study||0
10234764|NCT01369641|11364813|FG000|NOT COMPLETED|Overall Study||1
10234765|NCT01365156|11364819|FG000|STARTED|Overall Study||14
10234766|NCT01365156|11364820|FG001|STARTED|Overall Study||14
10234767|NCT01365156|11364819|FG000|COMPLETED|Overall Study||14
10234768|NCT01365156|11364820|FG001|COMPLETED|Overall Study||14
10234769|NCT01365156|11364819|FG000|NOT COMPLETED|Overall Study||0
10234770|NCT01365156|11364820|FG001|NOT COMPLETED|Overall Study||0
10234771|NCT01359254|11364828|FG000|STARTED|Overall Study||1
10234772|NCT01359254|11364829|FG001|STARTED|Overall Study||0
10234773|NCT01359254|11364828|FG000|COMPLETED|Overall Study||0
10234774|NCT01359254|11364829|FG001|COMPLETED|Overall Study||0
10234775|NCT01359254|11364828|FG000|NOT COMPLETED|Overall Study||1
10234776|NCT01359254|11364829|FG001|NOT COMPLETED|Overall Study||0
10234777|NCT01347632|11364835|FG000|STARTED|Overall Study||35
10234778|NCT01347632|11364835|FG000|COMPLETED|Overall Study||33
10234779|NCT01347632|11364835|FG000|NOT COMPLETED|Overall Study||2
10234780|NCT01356667|11364841|FG000|STARTED|Overall Study||4
10234781|NCT01356667|11364842|FG001|STARTED|Overall Study||6
10234782|NCT01356667|11364841|FG000|COMPLETED|Overall Study||0
10234783|NCT01356667|11364842|FG001|COMPLETED|Overall Study||0
10234784|NCT01356667|11364841|FG000|NOT COMPLETED|Overall Study||4
10234785|NCT01356667|11364842|FG001|NOT COMPLETED|Overall Study||6
10234786|NCT01354951|11364850|FG000|STARTED|Overall Study||3
10234787|NCT01354951|11364850|FG000|COMPLETED|Overall Study||1
10234788|NCT01354951|11364850|FG000|NOT COMPLETED|Overall Study||2
10234789|NCT01350232|11364854|FG000|STARTED|Overall Study||2
10234790|NCT01350232|11364854|FG000|COMPLETED|Overall Study||2
10234791|NCT01350232|11364854|FG000|NOT COMPLETED|Overall Study||0
10234792|NCT01350583|11364858|FG000|STARTED|Overall Study||2
10234793|NCT01350583|11364858|FG000|COMPLETED|Overall Study||2
10234794|NCT01350583|11364858|FG000|NOT COMPLETED|Overall Study||0
10234795|NCT01352416|11364866|FG000|STARTED|Overall Study||4
10234796|NCT01352416|11364867|FG001|STARTED|Overall Study||7
10234797|NCT01352416|11364868|FG002|STARTED|Overall Study||2
10234798|NCT01352416|11364869|FG003|STARTED|Overall Study||2
10234799|NCT01352416|11364866|FG000|COMPLETED|Overall Study||3
10234800|NCT01352416|11364867|FG001|COMPLETED|Overall Study||5
10234801|NCT01352416|11364868|FG002|COMPLETED|Overall Study||0
10234802|NCT01352416|11364869|FG003|COMPLETED|Overall Study||1
10234803|NCT01352416|11364866|FG000|NOT COMPLETED|Overall Study||1
10234804|NCT01352416|11364867|FG001|NOT COMPLETED|Overall Study||2
10234805|NCT01352416|11364868|FG002|NOT COMPLETED|Overall Study||2
10234806|NCT01352416|11364869|FG003|NOT COMPLETED|Overall Study||1
10234807|NCT01350258|11364879|FG000|STARTED|Overall Study||8
9790958|NCT00557856|10898633|FG003|STARTED|Part 1: Dose Escalation Phase||3
9790959|NCT00557856|10898634|FG004|STARTED|Part 1: Dose Escalation Phase||4
9790960|NCT00557856|10898635|FG005|STARTED|Part 1: Dose Escalation Phase||8
9790961|NCT00557856|10898636|FG006|STARTED|Part 1: Dose Escalation Phase||7
9790962|NCT00557856|10898637|FG007|STARTED|Part 1: Dose Escalation Phase||6
10234808|NCT01350258|11364879|FG000|COMPLETED|Overall Study||8
9790963|NCT00557856|10898638|FG008|STARTED|Part 1: Dose Escalation Phase||0
9790964|NCT00557856|10898630|FG000|Treated|Part 1: Dose Escalation Phase||5
9790965|NCT00557856|10898631|FG001|Treated|Part 1: Dose Escalation Phase||5
9790966|NCT00557856|10898632|FG002|Treated|Part 1: Dose Escalation Phase||6
9790967|NCT00557856|10898633|FG003|Treated|Part 1: Dose Escalation Phase||3
9790968|NCT00557856|10898634|FG004|Treated|Part 1: Dose Escalation Phase||4
9790969|NCT00557856|10898635|FG005|Treated|Part 1: Dose Escalation Phase||8
9790970|NCT00557856|10898636|FG006|Treated|Part 1: Dose Escalation Phase||7
9790971|NCT00557856|10898637|FG007|Treated|Part 1: Dose Escalation Phase||6
9790972|NCT00557856|10898638|FG008|Treated|Part 1: Dose Escalation Phase||0
9790973|NCT00557856|10898630|FG000|COMPLETED|Part 1: Dose Escalation Phase||0
9790974|NCT00557856|10898631|FG001|COMPLETED|Part 1: Dose Escalation Phase||0
9790975|NCT00557856|10898632|FG002|COMPLETED|Part 1: Dose Escalation Phase||0
9790976|NCT00557856|10898633|FG003|COMPLETED|Part 1: Dose Escalation Phase||0
9790977|NCT00557856|10898634|FG004|COMPLETED|Part 1: Dose Escalation Phase||0
9790978|NCT00557856|10898635|FG005|COMPLETED|Part 1: Dose Escalation Phase||0
9790979|NCT00557856|10898636|FG006|COMPLETED|Part 1: Dose Escalation Phase||0
9790980|NCT00557856|10898637|FG007|COMPLETED|Part 1: Dose Escalation Phase||0
9790981|NCT00557856|10898638|FG008|COMPLETED|Part 1: Dose Escalation Phase||0
9790982|NCT00557856|10898630|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7
9790983|NCT00557856|10898631|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5
9790984|NCT00557856|10898632|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6
9790985|NCT00557856|10898633|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3
9790986|NCT00557856|10898634|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4
9790987|NCT00557856|10898635|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8
9790988|NCT00557856|10898636|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7
9790989|NCT00557856|10898637|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6
9790990|NCT00557856|10898638|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0
9790991|NCT00557856|10898630|FG000|STARTED|Part 2: Exploratory Phase||0
9790992|NCT00557856|10898631|FG001|STARTED|Part 2: Exploratory Phase||0
9790993|NCT00557856|10898632|FG002|STARTED|Part 2: Exploratory Phase||0
9790994|NCT00557856|10898633|FG003|STARTED|Part 2: Exploratory Phase||0
9790995|NCT00557856|10898634|FG004|STARTED|Part 2: Exploratory Phase||0
9790996|NCT00557856|10898635|FG005|STARTED|Part 2: Exploratory Phase||0
9790997|NCT00557856|10898636|FG006|STARTED|Part 2: Exploratory Phase||0
9790998|NCT00557856|10898637|FG007|STARTED|Part 2: Exploratory Phase||0
9790999|NCT00557856|10898638|FG008|STARTED|Part 2: Exploratory Phase||24
9791000|NCT00557856|10898630|FG000|COMPLETED|Part 2: Exploratory Phase||0
9791001|NCT00557856|10898631|FG001|COMPLETED|Part 2: Exploratory Phase||0
9791002|NCT00557856|10898632|FG002|COMPLETED|Part 2: Exploratory Phase||0
9791003|NCT00557856|10898633|FG003|COMPLETED|Part 2: Exploratory Phase||0
9791004|NCT00557856|10898634|FG004|COMPLETED|Part 2: Exploratory Phase||0
9791005|NCT00557856|10898635|FG005|COMPLETED|Part 2: Exploratory Phase||0
9791006|NCT00557856|10898636|FG006|COMPLETED|Part 2: Exploratory Phase||0
10234809|NCT01350258|11364879|FG000|NOT COMPLETED|Overall Study||0
10234810|NCT01349595|11364885|FG000|STARTED|Overall Study||2
10234811|NCT01349595|11364886|FG001|STARTED|Overall Study||2
10234812|NCT01349595|11364885|FG000|COMPLETED|Overall Study||0
10234813|NCT01349595|11364886|FG001|COMPLETED|Overall Study||0
10234814|NCT01349595|11364885|FG000|NOT COMPLETED|Overall Study||2
10234815|NCT01349595|11364886|FG001|NOT COMPLETED|Overall Study||2
10234816|NCT01337609|11364895|FG000|STARTED|Overall Study||1
10234817|NCT01337609|11364896|FG001|STARTED|Overall Study||2
10234818|NCT01337609|11364897|FG002|STARTED|Overall Study||2
10234819|NCT01337609|11364895|FG000|COMPLETED|Overall Study||0
10234820|NCT01337609|11364896|FG001|COMPLETED|Overall Study||2
10234821|NCT01337609|11364897|FG002|COMPLETED|Overall Study||2
10234822|NCT01337609|11364895|FG000|NOT COMPLETED|Overall Study||1
10234823|NCT01337609|11364896|FG001|NOT COMPLETED|Overall Study||0
10234824|NCT01337609|11364897|FG002|NOT COMPLETED|Overall Study||0
10234825|NCT01347840|11364905|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
10234826|NCT01347840|11364905|FG000|COMPLETED|Overall Study||0
10234827|NCT01347840|11364905|FG000|NOT COMPLETED|Overall Study||1
10234828|NCT01340573|11364909|FG000|STARTED|Overall Study||3
10234829|NCT01340573|11364909|FG000|COMPLETED|Overall Study||0
10234830|NCT01340573|11364909|FG000|NOT COMPLETED|Overall Study||3
10234831|NCT01335997|11364916|FG000|STARTED|Period I and II||577
10234832|NCT01335997|11364917|FG001|STARTED|Period I and II||562
10234833|NCT01335997|11364916|FG000|COMPLETED|Period I and II||84
10234834|NCT01335997|11364917|FG001|COMPLETED|Period I and II||83
10234835|NCT01335997|11364916|FG000|NOT COMPLETED|Period I and II||493
10234836|NCT01335997|11364917|FG001|NOT COMPLETED|Period I and II||479
10234837|NCT01335997|11364916|FG000|STARTED|Period III||84
10234838|NCT01335997|11364917|FG001|STARTED|Period III||83
9791007|NCT00557856|10898637|FG007|COMPLETED|Part 2: Exploratory Phase||0
10234839|NCT01335997|11364916|FG000|COMPLETED|Period III||6
10234840|NCT01335997|11364917|FG001|COMPLETED|Period III||4
10234841|NCT01335997|11364916|FG000|NOT COMPLETED|Period III||78
10234842|NCT01335997|11364917|FG001|NOT COMPLETED|Period III||79
10234843|NCT01340885|11364928|FG000|STARTED|Overall Study||0
10234844|NCT01340885|11364929|FG001|STARTED|Overall Study||0
10234845|NCT01340885|11364930|FG002|STARTED|Overall Study||0
10234846|NCT01340885|11364928|FG000|COMPLETED|Overall Study||0
9791008|NCT00557856|10898638|FG008|COMPLETED|Part 2: Exploratory Phase||0
10234847|NCT01340885|11364929|FG001|COMPLETED|Overall Study||0
10234848|NCT01340885|11364930|FG002|COMPLETED|Overall Study||0
9791009|NCT00557856|10898630|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0
9791010|NCT00557856|10898631|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0
9791011|NCT00557856|10898632|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0
9791012|NCT00557856|10898633|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0
9791013|NCT00557856|10898634|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0
9791014|NCT00557856|10898635|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0
10234849|NCT01340885|11364928|FG000|NOT COMPLETED|Overall Study||0
10234850|NCT01340885|11364929|FG001|NOT COMPLETED|Overall Study||0
10234851|NCT01340885|11364930|FG002|NOT COMPLETED|Overall Study||0
10234852|NCT01341587|11364940|FG000|STARTED|Overall Study||4
10234853|NCT01341587|11364941|FG001|STARTED|Overall Study||10
10234854|NCT01341587|11364940|FG000|COMPLETED|Overall Study||0
10234855|NCT01341587|11364941|FG001|COMPLETED|Overall Study||0
10234856|NCT01341587|11364940|FG000|NOT COMPLETED|Overall Study||4
10234857|NCT01341587|11364941|FG001|NOT COMPLETED|Overall Study||10
10234858|NCT01326923|11364947|FG000|STARTED|Overall Study||7
10234859|NCT01326923|11364947|FG000|COMPLETED|Overall Study||7
10234860|NCT01326923|11364947|FG000|NOT COMPLETED|Overall Study||0
10234861|NCT01332799|11364953|FG000|STARTED|Overall Study||10
10234862|NCT01332799|11364954|FG001|STARTED|Overall Study||10
10234863|NCT01332799|11364953|FG000|COMPLETED|Overall Study||0
10234864|NCT01332799|11364954|FG001|COMPLETED|Overall Study||0
10234865|NCT01332799|11364953|FG000|NOT COMPLETED|Overall Study||10
10234866|NCT01332799|11364954|FG001|NOT COMPLETED|Overall Study||10
10112124|NCT02501811|11243218|FG003|STARTED|Overall Study||32
10112125|NCT02501811|11243215|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
10112126|NCT02501811|11243216|FG001|COMPLETED|Overall Study||23
10112127|NCT02501811|11243217|FG002|COMPLETED|Overall Study||25
10112128|NCT02501811|11243218|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
10112129|NCT02501811|11243215|FG000|NOT COMPLETED|Overall Study||4
10112130|NCT02501811|11243216|FG001|NOT COMPLETED|Overall Study||6
10112131|NCT02501811|11243217|FG002|NOT COMPLETED|Overall Study||6
10112132|NCT02501811|11243218|FG003|NOT COMPLETED|Overall Study||7
10112133|NCT02501902|11243236|FG000|STARTED|Overall Study||3
10112134|NCT02501902|11243237|FG001|STARTED|Overall Study||7
10234867|NCT01329549|11364960|FG000|STARTED|Overall Study||2
10234868|NCT01329549|11364960|FG000|COMPLETED|Overall Study||0
10234869|NCT01329549|11364960|FG000|NOT COMPLETED|Overall Study||2
10234870|NCT01326845|11364966|FG000|STARTED|Overall Study||7
10234871|NCT01326845|11364967|FG001|STARTED|Overall Study||5
10234872|NCT01326845|11364966|FG000|COMPLETED|Overall Study|Study terminated early|0
10234873|NCT01326845|11364967|FG001|COMPLETED|Overall Study|Study terminated early|0
10234874|NCT01326845|11364966|FG000|NOT COMPLETED|Overall Study||7
10234875|NCT01326845|11364967|FG001|NOT COMPLETED|Overall Study||5
10234876|NCT01329341|11364973|FG000|STARTED|Overall Study||60
10234877|NCT01329341|11364973|FG000|COMPLETED|Overall Study||16
10234878|NCT01329341|11364973|FG000|NOT COMPLETED|Overall Study||44
10234879|NCT01319760|11364979|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
10234880|NCT01319760|11364980|FG001|STARTED|Overall Study||5
10234881|NCT01319760|11364979|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
10234882|NCT01319760|11364980|FG001|COMPLETED|Overall Study||5
10234883|NCT01319760|11364979|FG000|NOT COMPLETED|Overall Study||0
10234884|NCT01319760|11364980|FG001|NOT COMPLETED|Overall Study||0
10234885|NCT01320683|11364986|FG000|STARTED|Overall Study||1
10234886|NCT01320683|11364986|FG000|COMPLETED|Overall Study||0
10234887|NCT01320683|11364986|FG000|NOT COMPLETED|Overall Study||1
10234888|NCT01313273|11364992|FG000|STARTED|Overall Study||2
10234889|NCT01313273|11364993|FG001|STARTED|Overall Study||1
10234890|NCT01313273|11364992|FG000|COMPLETED|Overall Study||0
10234891|NCT01313273|11364993|FG001|COMPLETED|Overall Study||0
10234892|NCT01313273|11364992|FG000|NOT COMPLETED|Overall Study||2
10234893|NCT01313273|11364993|FG001|NOT COMPLETED|Overall Study||1
10234894|NCT01321008|11364999|FG000|STARTED|Overall Study||1
10234895|NCT01321008|11364999|FG000|COMPLETED|Overall Study||0
10234896|NCT01321008|11364999|FG000|NOT COMPLETED|Overall Study||1
10234897|NCT01310803|11365005|FG000|STARTED|Overall Study||1
10234898|NCT01310803|11365006|FG001|STARTED|Overall Study||0
10234899|NCT01310803|11365005|FG000|COMPLETED|Overall Study||0
10234900|NCT01310803|11365006|FG001|COMPLETED|Overall Study||0
10234901|NCT01310803|11365005|FG000|NOT COMPLETED|Overall Study||1
10234902|NCT01310803|11365006|FG001|NOT COMPLETED|Overall Study||0
10234903|NCT01309581|11365014|FG000|STARTED|Overall Study||2
10234904|NCT01309581|11365015|FG001|STARTED|Overall Study||1
10234905|NCT01309581|11365014|FG000|COMPLETED|Overall Study||2
10234906|NCT01309581|11365015|FG001|COMPLETED|Overall Study||1
10234907|NCT01309581|11365014|FG000|NOT COMPLETED|Overall Study||0
9791015|NCT00557856|10898636|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0
9791016|NCT00557856|10898637|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0
9791017|NCT00557856|10898638|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24
10234908|NCT01309581|11365015|FG001|NOT COMPLETED|Overall Study||0
10234909|NCT01315873|11365021|FG000|STARTED|Overall Study||24
10234910|NCT01315873|11365021|FG000|COMPLETED|Overall Study||24
9791018|NCT00557882|10898655|FG000|STARTED|Overall Study||32
10112135|NCT02501902|11243238|FG002|STARTED|Overall Study||4
10234911|NCT01315873|11365021|FG000|NOT COMPLETED|Overall Study||0
10234912|NCT01313923|11365025|FG000|STARTED|Overall Study||3
10234913|NCT01313923|11365025|FG000|COMPLETED|Overall Study||0
9791019|NCT00557882|10898656|FG001|STARTED|Overall Study||33
9791020|NCT00557882|10898655|FG000|COMPLETED|Overall Study||27
9791021|NCT00557882|10898656|FG001|COMPLETED|Overall Study||33
9791022|NCT00557882|10898655|FG000|NOT COMPLETED|Overall Study||5
9791023|NCT00557882|10898656|FG001|NOT COMPLETED|Overall Study||0
10234914|NCT01313923|11365025|FG000|NOT COMPLETED|Overall Study||3
10234915|NCT01321697|11365029|FG000|STARTED|Overall Study||7
10234916|NCT01321697|11365029|FG000|COMPLETED|Overall Study||0
10234917|NCT01321697|11365029|FG000|NOT COMPLETED|Overall Study||7
10234918|NCT01312428|11365035|FG000|STARTED|Overall Study||3
10234919|NCT01312428|11365036|FG001|STARTED|Overall Study||4
10234920|NCT01312428|11365035|FG000|COMPLETED|Overall Study||0
10234921|NCT01312428|11365036|FG001|COMPLETED|Overall Study||0
10234922|NCT01312428|11365035|FG000|NOT COMPLETED|Overall Study||3
10234923|NCT01312428|11365036|FG001|NOT COMPLETED|Overall Study||4
10234924|NCT01313416|11365044|FG000|STARTED|Overall Study||2
10234925|NCT01313416|11365044|FG000|COMPLETED|Overall Study||2
10234926|NCT01313416|11365044|FG000|NOT COMPLETED|Overall Study||0
10234927|NCT01303003|11365050|FG000|STARTED|Overall Study||0
10234928|NCT01303003|11365051|FG001|STARTED|Overall Study||0
10234929|NCT01303003|11365050|FG000|COMPLETED|Overall Study||0
10234930|NCT01303003|11365051|FG001|COMPLETED|Overall Study||0
10234931|NCT01303003|11365050|FG000|NOT COMPLETED|Overall Study||0
10234932|NCT01303003|11365051|FG001|NOT COMPLETED|Overall Study||0
10234933|NCT01302444|11365059|FG000|STARTED|Overall Study||1
10234934|NCT01302444|11365060|FG001|STARTED|Overall Study||0
10234935|NCT01302444|11365059|FG000|COMPLETED|Overall Study||1
10234936|NCT01302444|11365060|FG001|COMPLETED|Overall Study||0
10234937|NCT01302444|11365059|FG000|NOT COMPLETED|Overall Study||0
10234938|NCT01302444|11365060|FG001|NOT COMPLETED|Overall Study||0
10234939|NCT01301963|11365068|FG000|STARTED|Overall Study||5
10234940|NCT01301963|11365069|FG001|STARTED|Overall Study||4
10234941|NCT01301963|11365068|FG000|COMPLETED|Overall Study||5
10234942|NCT01301963|11365069|FG001|COMPLETED|Overall Study||4
10234943|NCT01301963|11365068|FG000|NOT COMPLETED|Overall Study||0
10234944|NCT01301963|11365069|FG001|NOT COMPLETED|Overall Study||0
10234945|NCT01298921|11365077|FG000|STARTED|Overall Study||0
10234946|NCT01298921|11365078|FG001|STARTED|Overall Study||0
10234947|NCT01298921|11365077|FG000|COMPLETED|Overall Study||0
10234948|NCT01298921|11365078|FG001|COMPLETED|Overall Study||0
10234949|NCT01298921|11365077|FG000|NOT COMPLETED|Overall Study||0
10234950|NCT01298921|11365078|FG001|NOT COMPLETED|Overall Study||0
10234951|NCT01292070|11365086|FG000|STARTED|Overall Study||4
10234952|NCT01292070|11365086|FG000|COMPLETED|Overall Study||4
10234953|NCT01292070|11365086|FG000|NOT COMPLETED|Overall Study||0
10234954|NCT01292265|11365090|FG000|STARTED|Overall Study||3
10234955|NCT01292265|11365090|FG000|COMPLETED|Overall Study||3
10234956|NCT01292265|11365090|FG000|NOT COMPLETED|Overall Study||0
10234957|NCT01290822|11365094|FG000|STARTED|Overall Study||12
10234958|NCT01290822|11365094|FG000|COMPLETED|Overall Study||1
10234959|NCT01290822|11365094|FG000|NOT COMPLETED|Overall Study||11
10234960|NCT01290718|11365098|FG000|STARTED|Overall Study||4
10234961|NCT01290718|11365098|FG000|COMPLETED|Overall Study||0
10234962|NCT01290718|11365098|FG000|NOT COMPLETED|Overall Study||4
10234963|NCT01293123|11365104|FG000|STARTED|Overall Study||1
10234964|NCT01293123|11365105|FG001|STARTED|Overall Study||1
10234965|NCT01293123|11365104|FG000|COMPLETED|Overall Study||1
10234966|NCT01293123|11365105|FG001|COMPLETED|Overall Study||0
10234967|NCT01293123|11365104|FG000|NOT COMPLETED|Overall Study||0
10234968|NCT01293123|11365105|FG001|NOT COMPLETED|Overall Study||1
10234969|NCT01294046|11365111|FG000|STARTED|Overall Study||3
10234970|NCT01294046|11365111|FG000|COMPLETED|Overall Study||0
10234971|NCT01294046|11365111|FG000|NOT COMPLETED|Overall Study||3
10234972|NCT01280643|11365127|FG000|STARTED|Overall Study||0
10234973|NCT01280643|11365128|FG001|STARTED|Overall Study||1
10234974|NCT01280643|11365129|FG002|STARTED|Overall Study||1
10234975|NCT01280643|11365130|FG003|STARTED|Overall Study||1
10234976|NCT01280643|11365131|FG004|STARTED|Overall Study||0
10234977|NCT01280643|11365132|FG005|STARTED|Overall Study||0
10234978|NCT01280643|11365133|FG006|STARTED|Overall Study||0
10234979|NCT01280643|11365134|FG007|STARTED|Overall Study||0
10234980|NCT01280643|11365135|FG008|STARTED|Overall Study||0
10234981|NCT01280643|11365127|FG000|COMPLETED|Overall Study||0
10234982|NCT01280643|11365128|FG001|COMPLETED|Overall Study||0
10234983|NCT01280643|11365129|FG002|COMPLETED|Overall Study||1
10234984|NCT01280643|11365130|FG003|COMPLETED|Overall Study||1
10234985|NCT01280643|11365131|FG004|COMPLETED|Overall Study||0
10234986|NCT01280643|11365132|FG005|COMPLETED|Overall Study||0
10234987|NCT01280643|11365133|FG006|COMPLETED|Overall Study||0
10234988|NCT01280643|11365134|FG007|COMPLETED|Overall Study||0
10234989|NCT01280643|11365135|FG008|COMPLETED|Overall Study||0
10234990|NCT01280643|11365127|FG000|NOT COMPLETED|Overall Study||0
10234991|NCT01280643|11365128|FG001|NOT COMPLETED|Overall Study||1
10234992|NCT01280643|11365129|FG002|NOT COMPLETED|Overall Study||0
10234993|NCT01280643|11365130|FG003|NOT COMPLETED|Overall Study||0
10234994|NCT01280643|11365131|FG004|NOT COMPLETED|Overall Study||0
9791024|NCT00557947|10898662|FG000|STARTED|Overall Study||83
10234995|NCT01280643|11365132|FG005|NOT COMPLETED|Overall Study||0
10234996|NCT01280643|11365133|FG006|NOT COMPLETED|Overall Study||0
10234997|NCT01280643|11365134|FG007|NOT COMPLETED|Overall Study||0
10234998|NCT01280643|11365135|FG008|NOT COMPLETED|Overall Study||0
10239705|NCT00066807|11371386|FG001|NOT COMPLETED|Overall Study||15
10239706|NCT00058188|11371394|FG000|STARTED|Overall Study||0
10239707|NCT00058188|11371395|FG001|STARTED|Overall Study||0
9791025|NCT00557947|10898662|FG000|COMPLETED|Overall Study||83
9791026|NCT00557947|10898662|FG000|NOT COMPLETED|Overall Study||0
9791027|NCT00558012|10898672|FG000|STARTED|Overall Study||89
9791028|NCT00558012|10898673|FG001|STARTED|Overall Study||92
9791029|NCT00558012|10898672|FG000|COMPLETED|Overall Study||64
9791030|NCT00558012|10898673|FG001|COMPLETED|Overall Study||74
9791031|NCT00558012|10898672|FG000|NOT COMPLETED|Overall Study||25
9791032|NCT00558012|10898673|FG001|NOT COMPLETED|Overall Study||18
9791033|NCT00558025|10898681|FG000|STARTED|Overall Study||104
9791034|NCT00558025|10898682|FG001|STARTED|Overall Study||52
9791035|NCT00558025|10898681|FG000|COMPLETED|Overall Study||100
9791036|NCT00558025|10898682|FG001|COMPLETED|Overall Study||49
9791037|NCT00558025|10898681|FG000|NOT COMPLETED|Overall Study||4
9791038|NCT00558025|10898682|FG001|NOT COMPLETED|Overall Study||3
9791039|NCT00558064|10898690|FG000|STARTED|Overall Study||269
9791040|NCT00558064|10898691|FG001|STARTED|Overall Study||262
10234999|NCT01281124|11365155|FG000|STARTED|Overall Study||1
10235000|NCT01281124|11365155|FG000|COMPLETED|Overall Study||0
10235001|NCT01281124|11365155|FG000|NOT COMPLETED|Overall Study||1
10235002|NCT01272141|11365161|FG000|STARTED|Overall Study||5
10235003|NCT01272141|11365161|FG000|COMPLETED|Overall Study||5
10235004|NCT01272141|11365161|FG000|NOT COMPLETED|Overall Study||0
10235005|NCT01282216|11365167|FG000|STARTED|Overall Study||18
10235006|NCT01282216|11365168|FG001|STARTED|Overall Study||26
10235007|NCT01282216|11365169|FG002|STARTED|Overall Study||52
10235008|NCT01282216|11365170|FG003|STARTED|Overall Study||8
10235009|NCT01282216|11365167|FG000|COMPLETED|Overall Study||18
10235010|NCT01282216|11365168|FG001|COMPLETED|Overall Study||26
10235011|NCT01282216|11365169|FG002|COMPLETED|Overall Study||19
10235012|NCT01282216|11365170|FG003|COMPLETED|Overall Study||0
10235013|NCT01282216|11365167|FG000|NOT COMPLETED|Overall Study||0
10235014|NCT01282216|11365168|FG001|NOT COMPLETED|Overall Study||0
10235015|NCT01282216|11365169|FG002|NOT COMPLETED|Overall Study||33
10235016|NCT01282216|11365170|FG003|NOT COMPLETED|Overall Study||8
10235017|NCT01284491|11365176|FG000|STARTED|Overall Study||13
10235018|NCT01284491|11365176|FG000|COMPLETED|Overall Study||0
10235019|NCT01284491|11365176|FG000|NOT COMPLETED|Overall Study||13
10235020|NCT01284504|11365184|FG000|STARTED|Overall Study||0
10235021|NCT01284504|11365185|FG001|STARTED|Overall Study||0
10235022|NCT01284504|11365184|FG000|COMPLETED|Overall Study||0
10235023|NCT01284504|11365185|FG001|COMPLETED|Overall Study||0
10235024|NCT01284504|11365184|FG000|NOT COMPLETED|Overall Study||0
10235025|NCT01284504|11365185|FG001|NOT COMPLETED|Overall Study||0
10235026|NCT01269034|11365195|FG000|STARTED|Overall Study||1
10235027|NCT01269034|11365196|FG001|STARTED|Overall Study||2
10235028|NCT01269034|11365197|FG002|STARTED|Overall Study||1
10235029|NCT01269034|11365198|FG003|STARTED|Overall Study||9
10235030|NCT01269034|11365195|FG000|COMPLETED|Overall Study||0
10235031|NCT01269034|11365196|FG001|COMPLETED|Overall Study||2
10235032|NCT01269034|11365197|FG002|COMPLETED|Overall Study||1
10235033|NCT01269034|11365198|FG003|COMPLETED|Overall Study||9
10235034|NCT01269034|11365195|FG000|NOT COMPLETED|Overall Study||1
10235035|NCT01269034|11365196|FG001|NOT COMPLETED|Overall Study||0
10235036|NCT01269034|11365197|FG002|NOT COMPLETED|Overall Study||0
10235037|NCT01269034|11365198|FG003|NOT COMPLETED|Overall Study||0
10235038|NCT01274533|11365208|FG000|STARTED|Overall Study||4
10235039|NCT01274533|11365208|FG000|COMPLETED|Overall Study||0
10235040|NCT01274533|11365208|FG000|NOT COMPLETED|Overall Study||4
10235041|NCT01279616|11365212|FG000|STARTED|Overall Study||8
10235042|NCT01279616|11365212|FG000|COMPLETED|Overall Study||1
10235043|NCT01279616|11365212|FG000|NOT COMPLETED|Overall Study||7
10235044|NCT01276054|11365218|FG000|STARTED|Overall Study||2
10235045|NCT01276054|11365219|FG001|STARTED|Overall Study||2
10235046|NCT01276054|11365218|FG000|COMPLETED|Overall Study||0
10235047|NCT01276054|11365219|FG001|COMPLETED|Overall Study||0
10235048|NCT01276054|11365218|FG000|NOT COMPLETED|Overall Study||2
10235049|NCT01276054|11365219|FG001|NOT COMPLETED|Overall Study||2
10235050|NCT01264965|11365225|FG000|STARTED|Overall Study||25
10235051|NCT01264965|11365225|FG000|COMPLETED|Overall Study||15
9791041|NCT00558064|10898690|FG000|COMPLETED|Overall Study||264
10235052|NCT01264965|11365225|FG000|NOT COMPLETED|Overall Study||10
10235053|NCT01266824|11365231|FG000|STARTED|Overall Study||2
10235054|NCT01266824|11365232|FG001|STARTED|Overall Study||3
10235055|NCT01266824|11365231|FG000|COMPLETED|Overall Study||0
10235056|NCT01266824|11365232|FG001|COMPLETED|Overall Study||0
10235057|NCT01266824|11365231|FG000|NOT COMPLETED|Overall Study||2
10235058|NCT01266824|11365232|FG001|NOT COMPLETED|Overall Study||3
10235059|NCT01264835|11365238|FG000|STARTED|Overall Study||2
10235060|NCT01264835|11365238|FG000|COMPLETED|Overall Study||1
10235061|NCT01264835|11365238|FG000|NOT COMPLETED|Overall Study||1
10235062|NCT01274429|11365242|FG000|STARTED|Overall Study||5
10235063|NCT01274429|11365242|FG000|COMPLETED|Overall Study||0
10235064|NCT01274429|11365242|FG000|NOT COMPLETED|Overall Study||5
10235065|NCT01273064|11365251|FG000|STARTED|Overall Study||23
10235066|NCT01273064|11365252|FG001|STARTED|Overall Study||30
9791042|NCT00558064|10898691|FG001|COMPLETED|Overall Study||257
10235067|NCT01273064|11365253|FG002|STARTED|Overall Study||31
10235068|NCT01273064|11365254|FG003|STARTED|Overall Study||20
10235069|NCT01273064|11365255|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
10235070|NCT01273064|11365251|FG000|COMPLETED|Overall Study||0
10235071|NCT01273064|11365252|FG001|COMPLETED|Overall Study||0
10235072|NCT01273064|11365253|FG002|COMPLETED|Overall Study||0
9791043|NCT00558064|10898690|FG000|NOT COMPLETED|Overall Study||5
9791044|NCT00558064|10898691|FG001|NOT COMPLETED|Overall Study||5
10235073|NCT01273064|11365254|FG003|COMPLETED|Overall Study||0
10235074|NCT01273064|11365255|FG004|COMPLETED|Overall Study||0
10235075|NCT01273064|11365251|FG000|NOT COMPLETED|Overall Study||23
10235076|NCT01273064|11365252|FG001|NOT COMPLETED|Overall Study||30
10235077|NCT01273064|11365253|FG002|NOT COMPLETED|Overall Study||31
10235078|NCT01273064|11365254|FG003|NOT COMPLETED|Overall Study||20
10235079|NCT01273064|11365255|FG004|NOT COMPLETED|Overall Study||10
10235080|NCT01274559|11365269|FG000|STARTED|Overall Study||587
10235081|NCT01274559|11365270|FG001|STARTED|Overall Study||586
10235082|NCT01274559|11365269|FG000|Treated|Overall Study||572
10235083|NCT01274559|11365270|FG001|Treated|Overall Study||572
10235084|NCT01274559|11365269|FG000|COMPLETED|Overall Study||390
10235085|NCT01274559|11365270|FG001|COMPLETED|Overall Study||441
10235086|NCT01274559|11365269|FG000|NOT COMPLETED|Overall Study||197
10235087|NCT01274559|11365270|FG001|NOT COMPLETED|Overall Study||145
10235088|NCT01270581|11365278|FG000|STARTED|Overall Study||4
10235089|NCT01270581|11365279|FG001|STARTED|Overall Study||3
10235090|NCT01270581|11365278|FG000|COMPLETED|Overall Study||3
10235091|NCT01270581|11365279|FG001|COMPLETED|Overall Study||3
10235092|NCT01270581|11365278|FG000|NOT COMPLETED|Overall Study||1
10235093|NCT01270581|11365279|FG001|NOT COMPLETED|Overall Study||0
10235094|NCT01269749|11365287|FG000|STARTED|Overall Study||16
10235095|NCT01269749|11365288|FG001|STARTED|Overall Study||3
10235096|NCT01269749|11365287|FG000|COMPLETED|Overall Study||16
10235097|NCT01269749|11365288|FG001|COMPLETED|Overall Study||3
10235098|NCT01269749|11365287|FG000|NOT COMPLETED|Overall Study||0
10235099|NCT01269749|11365288|FG001|NOT COMPLETED|Overall Study||0
10235100|NCT01270919|11365294|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0
10235101|NCT01270919|11365294|FG000|COMPLETED|Overall Study||0
10235102|NCT01270919|11365294|FG000|NOT COMPLETED|Overall Study||0
10235103|NCT01262339|11365298|FG000|STARTED|Overall Study||2
10235104|NCT01262339|11365298|FG000|COMPLETED|Overall Study||2
10235105|NCT01262339|11365298|FG000|NOT COMPLETED|Overall Study||0
10235106|NCT01267825|11365304|FG000|STARTED|Overall Study||1
10235107|NCT01267825|11365305|FG001|STARTED|Overall Study||0
10235108|NCT01267825|11365304|FG000|COMPLETED|Overall Study||0
10235109|NCT01267825|11365305|FG001|COMPLETED|Overall Study||0
10235110|NCT01267825|11365304|FG000|NOT COMPLETED|Overall Study||1
10235111|NCT01267825|11365305|FG001|NOT COMPLETED|Overall Study||0
10235112|NCT01259284|11365314|FG000|STARTED|Overall Study||2
10235113|NCT01259284|11365315|FG001|STARTED|Overall Study||0
10235114|NCT01259284|11365316|FG002|STARTED|Overall Study||0
10235115|NCT01259284|11365314|FG000|COMPLETED|Overall Study||0
10235116|NCT01259284|11365315|FG001|COMPLETED|Overall Study||0
10235117|NCT01259284|11365316|FG002|COMPLETED|Overall Study||0
10235118|NCT01259284|11365314|FG000|NOT COMPLETED|Overall Study||2
10235119|NCT01259284|11365315|FG001|NOT COMPLETED|Overall Study||0
10235120|NCT01259284|11365316|FG002|NOT COMPLETED|Overall Study||0
10235121|NCT01249157|11365324|FG000|STARTED|Overall Study||1
10235122|NCT01249157|11365324|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
10235123|NCT01249157|11365324|FG000|NOT COMPLETED|Overall Study||1
10235124|NCT01263028|11365328|FG000|STARTED|Overall Study||6
10235125|NCT01263028|11365328|FG000|COMPLETED|Overall Study||0
10235126|NCT01263028|11365328|FG000|NOT COMPLETED|Overall Study||6
10235127|NCT01256281|11365332|FG000|STARTED|Overall Study||2
10235128|NCT01256281|11365332|FG000|COMPLETED|Overall Study||2
10235129|NCT01256281|11365332|FG000|NOT COMPLETED|Overall Study||0
10235130|NCT01253668|11365336|FG000|STARTED|Overall Study||0
10235131|NCT01253668|11365336|FG000|COMPLETED|Overall Study||0
10235132|NCT01253668|11365336|FG000|NOT COMPLETED|Overall Study||0
10235133|NCT01259024|11365340|FG000|STARTED|Overall Study||1
10235134|NCT01259024|11365340|FG000|COMPLETED|Overall Study||0
10235135|NCT01259024|11365340|FG000|NOT COMPLETED|Overall Study||1
10235136|NCT01251952|11365344|FG000|STARTED|Overall Study||2
10235137|NCT01251952|11365344|FG000|COMPLETED|Overall Study||1
10235138|NCT01251952|11365344|FG000|NOT COMPLETED|Overall Study||1
10235139|NCT01251120|11365350|FG000|STARTED|Overall Study||1
10235140|NCT01251120|11365351|FG001|STARTED|Overall Study||1
10235141|NCT01251120|11365350|FG000|COMPLETED|Overall Study||1
10235142|NCT01251120|11365351|FG001|COMPLETED|Overall Study||0
10235143|NCT01251120|11365350|FG000|NOT COMPLETED|Overall Study||0
10235144|NCT01251120|11365351|FG001|NOT COMPLETED|Overall Study||1
10235145|NCT01248130|11365359|FG000|STARTED|Overall Study||3
9791045|NCT00558103|10898702|FG000|STARTED|Randomized Treatment Phase||38
9791046|NCT00558103|10898703|FG001|STARTED|Randomized Treatment Phase||38
10235146|NCT01248130|11365360|FG001|STARTED|Overall Study||4
10235147|NCT01248130|11365359|FG000|COMPLETED|Overall Study||1
10235148|NCT01248130|11365360|FG001|COMPLETED|Overall Study||4
10235149|NCT01248130|11365359|FG000|NOT COMPLETED|Overall Study||2
10235150|NCT01248130|11365360|FG001|NOT COMPLETED|Overall Study||0
10235151|NCT01243892|11365368|FG000|STARTED|Overall Study||15
10235152|NCT01243892|11365369|FG001|STARTED|Overall Study||3
10235153|NCT01243892|11365368|FG000|COMPLETED|Overall Study||13
10235154|NCT01243892|11365369|FG001|COMPLETED|Overall Study||3
10235155|NCT01243892|11365368|FG000|NOT COMPLETED|Overall Study||2
10235156|NCT01243892|11365369|FG001|NOT COMPLETED|Overall Study||0
10235157|NCT01246011|11365378|FG000|STARTED|Overall Study||0
10235158|NCT01246011|11365379|FG001|STARTED|Overall Study||0
10235159|NCT01246011|11365380|FG002|STARTED|Overall Study||9
10235160|NCT01246011|11365378|FG000|COMPLETED|Overall Study||0
10235161|NCT01246011|11365379|FG001|COMPLETED|Overall Study||0
9791047|NCT00558103|10898704|FG002|STARTED|Randomized Treatment Phase||36
9791048|NCT00558103|10898705|FG003|STARTED|Randomized Treatment Phase||13
9791049|NCT00558103|10898706|FG004|STARTED|Randomized Treatment Phase||38
9791050|NCT00558103|10898707|FG005|STARTED|Randomized Treatment Phase||0
9791051|NCT00558103|10898702|FG000|COMPLETED|Randomized Treatment Phase||33
9791052|NCT00558103|10898703|FG001|COMPLETED|Randomized Treatment Phase||34
9791053|NCT00558103|10898704|FG002|COMPLETED|Randomized Treatment Phase||33
9791054|NCT00558103|10898705|FG003|COMPLETED|Randomized Treatment Phase||11
9791055|NCT00558103|10898706|FG004|COMPLETED|Randomized Treatment Phase||33
9791056|NCT00558103|10898707|FG005|COMPLETED|Randomized Treatment Phase||0
9791057|NCT00558103|10898702|FG000|NOT COMPLETED|Randomized Treatment Phase||5
9791058|NCT00558103|10898703|FG001|NOT COMPLETED|Randomized Treatment Phase||4
9791059|NCT00558103|10898704|FG002|NOT COMPLETED|Randomized Treatment Phase||3
9791060|NCT00558103|10898705|FG003|NOT COMPLETED|Randomized Treatment Phase||2
9791061|NCT00558103|10898706|FG004|NOT COMPLETED|Randomized Treatment Phase||5
9791062|NCT00558103|10898707|FG005|NOT COMPLETED|Randomized Treatment Phase||0
9791063|NCT00558103|10898702|FG000|STARTED|Monotherapy Extension Phase||0
9791064|NCT00558103|10898703|FG001|STARTED|Monotherapy Extension Phase||0
9791065|NCT00558103|10898704|FG002|STARTED|Monotherapy Extension Phase||0
9791066|NCT00558103|10898705|FG003|STARTED|Monotherapy Extension Phase||0
9791067|NCT00558103|10898706|FG004|STARTED|Monotherapy Extension Phase||0
9791068|NCT00558103|10898707|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
9791069|NCT00558103|10898702|FG000|COMPLETED|Monotherapy Extension Phase||0
9791070|NCT00558103|10898703|FG001|COMPLETED|Monotherapy Extension Phase||0
9791071|NCT00558103|10898704|FG002|COMPLETED|Monotherapy Extension Phase||0
10015489|NCT01806597|11138560|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
10015490|NCT01806597|11138561|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
9791072|NCT00558103|10898705|FG003|COMPLETED|Monotherapy Extension Phase||0
9791073|NCT00558103|10898706|FG004|COMPLETED|Monotherapy Extension Phase||0
9791074|NCT00558103|10898707|FG005|COMPLETED|Monotherapy Extension Phase||0
9791075|NCT00558103|10898702|FG000|NOT COMPLETED|Monotherapy Extension Phase||0
9791076|NCT00558103|10898703|FG001|NOT COMPLETED|Monotherapy Extension Phase||0
9791077|NCT00558103|10898704|FG002|NOT COMPLETED|Monotherapy Extension Phase||0
9791078|NCT00558103|10898705|FG003|NOT COMPLETED|Monotherapy Extension Phase||0
9791079|NCT00558103|10898706|FG004|NOT COMPLETED|Monotherapy Extension Phase||0
9791080|NCT00558103|10898707|FG005|NOT COMPLETED|Monotherapy Extension Phase||9
9791081|NCT00558246|10898720|FG000|STARTED|Overall Study||79
9791082|NCT00558246|10898720|FG000|COMPLETED|Overall Study||79
9791083|NCT00558246|10898720|FG000|NOT COMPLETED|Overall Study||0
9791084|NCT00558259|10898729|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
9791085|NCT00558259|10898730|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
9791086|NCT00558259|10898729|FG000|COMPLETED|Overall Study|Completed treatment.|610
9791087|NCT00558259|10898730|FG001|COMPLETED|Overall Study|Completed treatment.|563
9791088|NCT00558259|10898729|FG000|NOT COMPLETED|Overall Study||71
9791089|NCT00558259|10898730|FG001|NOT COMPLETED|Overall Study||99
9791090|NCT00558272|10898738|FG000|STARTED|Overall Study|Randomised|69
9791091|NCT00558272|10898739|FG001|STARTED|Overall Study|Randomised|70
9791092|NCT00558272|10898738|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41
9791093|NCT00558272|10898739|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67
9791094|NCT00558272|10898738|FG000|COMPLETED|Overall Study|4-week treatment period|56
9791095|NCT00558272|10898739|FG001|COMPLETED|Overall Study|4-week treatment period|68
9791096|NCT00558272|10898738|FG000|NOT COMPLETED|Overall Study||13
9791097|NCT00558272|10898739|FG001|NOT COMPLETED|Overall Study||2
9791098|NCT00558285|10898750|FG000|STARTED|Overall Study||50
9791099|NCT00558285|10898751|FG001|STARTED|Overall Study||51
9791100|NCT00558285|10898752|FG002|STARTED|Overall Study||51
9791101|NCT00558285|10898753|FG003|STARTED|Overall Study||52
9791102|NCT00558285|10898754|FG004|STARTED|Overall Study||53
9791103|NCT00558285|10898750|FG000|Safety: Received Study Drug|Overall Study||49
9791104|NCT00558285|10898751|FG001|Safety: Received Study Drug|Overall Study||51
9791105|NCT00558285|10898752|FG002|Safety: Received Study Drug|Overall Study||51
9791106|NCT00558285|10898753|FG003|Safety: Received Study Drug|Overall Study||51
9791107|NCT00558285|10898754|FG004|Safety: Received Study Drug|Overall Study||53
9791108|NCT00558285|10898750|FG000|COMPLETED|Overall Study||44
9791109|NCT00558285|10898751|FG001|COMPLETED|Overall Study||48
9791110|NCT00558285|10898752|FG002|COMPLETED|Overall Study||46
9791111|NCT00558285|10898753|FG003|COMPLETED|Overall Study||48
9791112|NCT00558285|10898754|FG004|COMPLETED|Overall Study||49
9791113|NCT00558285|10898750|FG000|NOT COMPLETED|Overall Study||6
9791114|NCT00558285|10898751|FG001|NOT COMPLETED|Overall Study||3
9791115|NCT00558285|10898752|FG002|NOT COMPLETED|Overall Study||5
9791116|NCT00558285|10898753|FG003|NOT COMPLETED|Overall Study||4
9791117|NCT00558285|10898754|FG004|NOT COMPLETED|Overall Study||4
9791118|NCT00558363|10898768|FG000|STARTED|Overall Study||147
10015491|NCT01806597|11138562|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
10015492|NCT01806597|11138563|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
9791119|NCT00558363|10898769|FG001|STARTED|Overall Study||147
9791120|NCT00558363|10898768|FG000|COMPLETED|Overall Study||76
9791121|NCT00558363|10898769|FG001|COMPLETED|Overall Study||111
9791122|NCT00558363|10898768|FG000|NOT COMPLETED|Overall Study||71
9791123|NCT00558363|10898769|FG001|NOT COMPLETED|Overall Study||36
9791124|NCT00558428|10898779|FG000|STARTED|Overall Study||267
9791125|NCT00558428|10898780|FG001|STARTED|Overall Study||276
9791126|NCT00558428|10898781|FG002|STARTED|Overall Study||277
9791127|NCT00558428|10898782|FG003|STARTED|Overall Study||277
9791128|NCT00558428|10898779|FG000|COMPLETED|Overall Study||255
9791129|NCT00558428|10898780|FG001|COMPLETED|Overall Study||252
9791130|NCT00558428|10898781|FG002|COMPLETED|Overall Study||273
9791131|NCT00558428|10898782|FG003|COMPLETED|Overall Study||266
9791132|NCT00558428|10898779|FG000|NOT COMPLETED|Overall Study||12
9791133|NCT00558428|10898780|FG001|NOT COMPLETED|Overall Study||24
9791134|NCT00558428|10898781|FG002|NOT COMPLETED|Overall Study||4
9791135|NCT00558428|10898782|FG003|NOT COMPLETED|Overall Study||11
9791136|NCT00558467|10898794|FG000|STARTED|Overall Study||20
9791137|NCT00558467|10898795|FG001|STARTED|Overall Study||43
9791138|NCT00558467|10898794|FG000|COMPLETED|Overall Study||19
9791139|NCT00558467|10898795|FG001|COMPLETED|Overall Study||39
9791140|NCT00558467|10898794|FG000|NOT COMPLETED|Overall Study||1
9791141|NCT00558467|10898795|FG001|NOT COMPLETED|Overall Study||4
9791142|NCT00558519|10898801|FG000|STARTED|Overall Study||318
9791143|NCT00558519|10898801|FG000|COMPLETED|Overall Study||295
9791144|NCT00558519|10898801|FG000|NOT COMPLETED|Overall Study||23
9791145|NCT00558571|10898809|FG000|STARTED|Overall Study||16
9791146|NCT00558571|10898810|FG001|STARTED|Overall Study||16
9791147|NCT00558571|10898811|FG002|STARTED|Overall Study||16
9791148|NCT00558571|10898812|FG003|STARTED|Overall Study||30
9791149|NCT00558571|10898809|FG000|COMPLETED|Overall Study||16
9791150|NCT00558571|10898810|FG001|COMPLETED|Overall Study||16
9791151|NCT00558571|10898811|FG002|COMPLETED|Overall Study||16
9791152|NCT00558571|10898812|FG003|COMPLETED|Overall Study||30
9791153|NCT00558571|10898809|FG000|NOT COMPLETED|Overall Study||0
9791154|NCT00558571|10898810|FG001|NOT COMPLETED|Overall Study||0
9791155|NCT00558571|10898811|FG002|NOT COMPLETED|Overall Study||0
9791156|NCT00558571|10898812|FG003|NOT COMPLETED|Overall Study||0
9791157|NCT00558636|10898835|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47
9791158|NCT00558636|10898836|FG001|STARTED|Treatment||44
9791159|NCT00558636|10898835|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
9791160|NCT00558636|10898836|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
9791161|NCT00558636|10898835|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
9791162|NCT00558636|10898836|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
9791163|NCT00558636|10898835|FG000|NOT COMPLETED|Treatment||47
10235162|NCT01246011|11365380|FG002|COMPLETED|Overall Study||5
10235163|NCT01246011|11365378|FG000|NOT COMPLETED|Overall Study||0
10235164|NCT01246011|11365379|FG001|NOT COMPLETED|Overall Study||0
10235165|NCT01246011|11365380|FG002|NOT COMPLETED|Overall Study||4
10235166|NCT01242020|11365391|FG000|STARTED|Overall Study||6
10235167|NCT01242020|11365392|FG001|STARTED|Overall Study||0
10235168|NCT01242020|11365391|FG000|COMPLETED|Overall Study||3
10235169|NCT01242020|11365392|FG001|COMPLETED|Overall Study||0
10235170|NCT01242020|11365391|FG000|NOT COMPLETED|Overall Study||3
10235171|NCT01242020|11365392|FG001|NOT COMPLETED|Overall Study||0
10235172|NCT01244620|11365398|FG000|STARTED|Overall Study||4
10235173|NCT01244620|11365399|FG001|STARTED|Overall Study||4
10235174|NCT01244620|11365400|FG002|STARTED|Overall Study||4
10235175|NCT01244620|11365401|FG003|STARTED|Overall Study||4
10235176|NCT01244620|11365398|FG000|COMPLETED|Overall Study||0
10235177|NCT01244620|11365399|FG001|COMPLETED|Overall Study||0
10235178|NCT01244620|11365400|FG002|COMPLETED|Overall Study||0
10235179|NCT01244620|11365401|FG003|COMPLETED|Overall Study||0
10235180|NCT01244620|11365398|FG000|NOT COMPLETED|Overall Study||4
10235181|NCT01244620|11365399|FG001|NOT COMPLETED|Overall Study||4
10235182|NCT01244620|11365400|FG002|NOT COMPLETED|Overall Study||4
10235183|NCT01244620|11365401|FG003|NOT COMPLETED|Overall Study||4
10235184|NCT01240304|11365411|FG000|STARTED|Overall Study||10
10235185|NCT01240304|11365411|FG000|COMPLETED|Overall Study||0
10235186|NCT01240304|11365411|FG000|NOT COMPLETED|Overall Study||10
10235187|NCT01241279|11365417|FG000|STARTED|Overall Study||4
10235188|NCT01241279|11365418|FG001|STARTED|Overall Study||2
10235189|NCT01241279|11365417|FG000|COMPLETED|Overall Study||4
10235190|NCT01241279|11365418|FG001|COMPLETED|Overall Study||1
10235191|NCT01241279|11365417|FG000|NOT COMPLETED|Overall Study||0
10235192|NCT01241279|11365418|FG001|NOT COMPLETED|Overall Study||1
10235193|NCT01230788|11365424|FG000|STARTED|Overall Study||1
9791164|NCT00558636|10898836|FG001|NOT COMPLETED|Treatment||44
9791165|NCT00558636|10898835|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
9791166|NCT00558636|10898836|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
9791167|NCT00558636|10898835|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0
9791168|NCT00558636|10898836|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0
10235194|NCT01230788|11365424|FG000|COMPLETED|Overall Study||0
10235195|NCT01230788|11365424|FG000|NOT COMPLETED|Overall Study||1
10235196|NCT01239680|11365430|FG000|STARTED|Overall Study||3
10235197|NCT01239680|11365431|FG001|STARTED|Overall Study||2
10235198|NCT01239680|11365430|FG000|COMPLETED|Overall Study||1
10235199|NCT01239680|11365431|FG001|COMPLETED|Overall Study||2
10235200|NCT01239680|11365430|FG000|NOT COMPLETED|Overall Study||2
10235201|NCT01239680|11365431|FG001|NOT COMPLETED|Overall Study||0
10235202|NCT01237613|11365437|FG000|STARTED|Overall Study||4
10235203|NCT01237613|11365437|FG000|COMPLETED|Overall Study||4
9791169|NCT00558636|10898835|FG000|NOT COMPLETED|Follow-up||12
9791170|NCT00558636|10898836|FG001|NOT COMPLETED|Follow-up||7
9791171|NCT00558701|10898844|FG000|STARTED|Overall Study||15
9791172|NCT00558701|10898845|FG001|STARTED|Overall Study||15
9791173|NCT00558701|10898844|FG000|COMPLETED|Overall Study||14
9791174|NCT00558701|10898845|FG001|COMPLETED|Overall Study||11
9791175|NCT00558701|10898844|FG000|NOT COMPLETED|Overall Study||1
9791176|NCT00558701|10898845|FG001|NOT COMPLETED|Overall Study||4
9791177|NCT00558753|10898853|FG000|STARTED|Overall Study||120
9791178|NCT00558753|10898854|FG001|STARTED|Overall Study||120
9791179|NCT00558753|10898853|FG000|COMPLETED|Overall Study||115
9791180|NCT00558753|10898854|FG001|COMPLETED|Overall Study||113
9791181|NCT00558753|10898853|FG000|NOT COMPLETED|Overall Study||5
9791182|NCT00558753|10898854|FG001|NOT COMPLETED|Overall Study||7
9791183|NCT00558792|10898863|FG000|STARTED|Overall Study||68
9791184|NCT00558792|10898864|FG001|STARTED|Overall Study||63
9791185|NCT00558792|10898865|FG002|STARTED|Overall Study||60
9791186|NCT00558792|10898863|FG000|COMPLETED|Overall Study||68
9791187|NCT00558792|10898864|FG001|COMPLETED|Overall Study||63
9791188|NCT00558792|10898865|FG002|COMPLETED|Overall Study||60
9791189|NCT00558792|10898863|FG000|NOT COMPLETED|Overall Study||0
9791190|NCT00558792|10898864|FG001|NOT COMPLETED|Overall Study||0
9791191|NCT00558792|10898865|FG002|NOT COMPLETED|Overall Study||0
9791192|NCT00558831|10898876|FG000|STARTED|Overall Study||11
9791193|NCT00558831|10898876|FG000|COMPLETED|Overall Study||10
9791194|NCT00558831|10898876|FG000|NOT COMPLETED|Overall Study||1
9791195|NCT00558844|10898887|FG000|STARTED|Overall Study||15
9791196|NCT00558844|10898888|FG001|STARTED|Overall Study||7
9791197|NCT00558844|10898889|FG002|STARTED|Overall Study||7
9791198|NCT00558844|10898890|FG003|STARTED|Overall Study||5
9791199|NCT00558844|10898891|FG004|STARTED|Overall Study||7
9791200|NCT00558844|10898887|FG000|COMPLETED|Overall Study||12
9791201|NCT00558844|10898888|FG001|COMPLETED|Overall Study||7
9791202|NCT00558844|10898889|FG002|COMPLETED|Overall Study||6
9791203|NCT00558844|10898890|FG003|COMPLETED|Overall Study||5
9791204|NCT00558844|10898891|FG004|COMPLETED|Overall Study||6
9791205|NCT00558844|10898887|FG000|NOT COMPLETED|Overall Study||3
9791206|NCT00558844|10898888|FG001|NOT COMPLETED|Overall Study||0
9791207|NCT00558844|10898889|FG002|NOT COMPLETED|Overall Study||1
9791208|NCT00558844|10898890|FG003|NOT COMPLETED|Overall Study||0
9791209|NCT00558844|10898891|FG004|NOT COMPLETED|Overall Study||1
9791210|NCT00558896|10898911|FG000|STARTED|Overall Study||60
9791211|NCT00558896|10898912|FG001|STARTED|Overall Study||34
9791212|NCT00558896|10898913|FG002|STARTED|Overall Study||35
9791213|NCT00558896|10898914|FG003|STARTED|Overall Study||35
9791214|NCT00558896|10898915|FG004|STARTED|Overall Study||60
9791215|NCT00558896|10898916|FG005|STARTED|Overall Study||120
9791216|NCT00558896|10898917|FG006|STARTED|Overall Study||33
9791217|NCT00558896|10898911|FG000|COMPLETED|Overall Study||39
9791218|NCT00558896|10898912|FG001|COMPLETED|Overall Study||27
9791219|NCT00558896|10898913|FG002|COMPLETED|Overall Study||30
9791220|NCT00558896|10898914|FG003|COMPLETED|Overall Study||23
9791221|NCT00558896|10898915|FG004|COMPLETED|Overall Study||37
9791222|NCT00558896|10898916|FG005|COMPLETED|Overall Study||68
9791223|NCT00558896|10898917|FG006|COMPLETED|Overall Study||9
9791224|NCT00558896|10898911|FG000|NOT COMPLETED|Overall Study||21
9791225|NCT00558896|10898912|FG001|NOT COMPLETED|Overall Study||7
9791226|NCT00558896|10898913|FG002|NOT COMPLETED|Overall Study||5
9791227|NCT00558896|10898914|FG003|NOT COMPLETED|Overall Study||12
9791228|NCT00558896|10898915|FG004|NOT COMPLETED|Overall Study||23
9791229|NCT00558896|10898916|FG005|NOT COMPLETED|Overall Study||52
9791230|NCT00558896|10898917|FG006|NOT COMPLETED|Overall Study||24
9791231|NCT00559013|10898933|FG000|STARTED|Overall Study||38
9791232|NCT00559013|10898933|FG000|COMPLETED|Overall Study||38
9791233|NCT00559013|10898933|FG000|NOT COMPLETED|Overall Study||0
9791234|NCT00559104|10898939|FG000|STARTED|Overall Study||55
9791235|NCT00559104|10898940|FG001|STARTED|Overall Study||5
9791236|NCT00559104|10898939|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
9791237|NCT00559104|10898940|FG001|COMPLETED|Overall Study||5
9791238|NCT00559104|10898939|FG000|NOT COMPLETED|Overall Study||9
9791239|NCT00559104|10898940|FG001|NOT COMPLETED|Overall Study||0
9791240|NCT00559273|10898948|FG000|STARTED|Correction Period (20 Weeks)||153
9791241|NCT00559273|10898949|FG001|STARTED|Correction Period (20 Weeks)||154
9791242|NCT00559273|10898948|FG000|Treated|Correction Period (20 Weeks)||151
9791243|NCT00559273|10898949|FG001|Treated|Correction Period (20 Weeks)||154
9791244|NCT00559273|10898948|FG000|COMPLETED|Correction Period (20 Weeks)||144
9791245|NCT00559273|10898949|FG001|COMPLETED|Correction Period (20 Weeks)||142
9791246|NCT00559273|10898948|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9
9791247|NCT00559273|10898949|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12
9791248|NCT00559273|10898948|FG000|STARTED|Evaluation Period (8 Weeks)||144
9791249|NCT00559273|10898949|FG001|STARTED|Evaluation Period (8 Weeks)||142
9791250|NCT00559273|10898948|FG000|COMPLETED|Evaluation Period (8 Weeks)||141
9791251|NCT00559273|10898949|FG001|COMPLETED|Evaluation Period (8 Weeks)||137
9791252|NCT00559273|10898948|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3
9791253|NCT00559273|10898949|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5
9791254|NCT00559364|10898957|FG000|STARTED|Overall Study||30
9791255|NCT00559364|10898958|FG001|STARTED|Overall Study||20
9791256|NCT00559364|10898957|FG000|COMPLETED|Overall Study||29
9791257|NCT00559364|10898958|FG001|COMPLETED|Overall Study||20
9791258|NCT00559364|10898957|FG000|NOT COMPLETED|Overall Study||1
9791259|NCT00559364|10898958|FG001|NOT COMPLETED|Overall Study||0
9791260|NCT00559377|10898964|FG000|STARTED|Overall Study||16
9791261|NCT00559377|10898964|FG000|COMPLETED|Overall Study||7
9791262|NCT00559377|10898964|FG000|NOT COMPLETED|Overall Study||9
9791263|NCT00559468|10898973|FG000|STARTED|Overall Study||26
9791264|NCT00559468|10898974|FG001|STARTED|Overall Study||26
9791265|NCT00559468|10898973|FG000|Treated|Overall Study||26
9791266|NCT00559468|10898974|FG001|Treated|Overall Study||25
9791267|NCT00559468|10898973|FG000|COMPLETED|Overall Study||26
9791268|NCT00559468|10898974|FG001|COMPLETED|Overall Study||25
9791269|NCT00559468|10898973|FG000|NOT COMPLETED|Overall Study||0
9791270|NCT00559468|10898974|FG001|NOT COMPLETED|Overall Study||1
9791271|NCT00559507|10898980|FG000|STARTED|Overall Study||12
9791272|NCT00559507|10898980|FG000|COMPLETED|Overall Study||9
9791273|NCT00559507|10898980|FG000|NOT COMPLETED|Overall Study||3
9791274|NCT00559585|10898986|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
9791275|NCT00559585|10898987|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
9791276|NCT00559585|10898986|FG000|COMPLETED|Double Blind ST Period Main Study||693
9791277|NCT00559585|10898987|FG001|COMPLETED|Double Blind ST Period Main Study||676
9791278|NCT00559585|10898986|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43
9791279|NCT00559585|10898987|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45
9791280|NCT00559585|10898986|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
9791281|NCT00559585|10898987|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
9791282|NCT00559585|10898986|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7
9791283|NCT00559585|10898987|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9
9791284|NCT00559585|10898986|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
9791285|NCT00559585|10898987|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
9791286|NCT00559585|10898986|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
9791287|NCT00559585|10898987|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
9791288|NCT00559585|10898986|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945
9791289|NCT00559585|10898987|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0
9791290|NCT00559585|10898986|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
9791291|NCT00559585|10898987|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
9791292|NCT00559637|10899004|FG000|STARTED|Overall Study||184
9791293|NCT00559637|10899004|FG000|COMPLETED|Overall Study||130
9791294|NCT00559637|10899004|FG000|NOT COMPLETED|Overall Study||54
9791295|NCT00559754|10899008|FG000|STARTED|Overall Study||72
9791296|NCT00559754|10899008|FG000|COMPLETED|Overall Study||61
9791297|NCT00559754|10899008|FG000|NOT COMPLETED|Overall Study||11
9791298|NCT00559845|10899012|FG000|STARTED|Overall Study||56
9791299|NCT00559845|10899012|FG000|COMPLETED|Overall Study||49
9791300|NCT00559845|10899012|FG000|NOT COMPLETED|Overall Study||7
9791301|NCT00559949|10899016|FG000|STARTED|Overall Study||39
9791302|NCT00559949|10899016|FG000|COMPLETED|Overall Study||32
9791303|NCT00559949|10899016|FG000|NOT COMPLETED|Overall Study||7
9791304|NCT00559962|10899028|FG000|STARTED|Overall Study||33
9791305|NCT00559962|10899029|FG001|STARTED|Overall Study||34
9791306|NCT00559962|10899030|FG002|STARTED|Overall Study||34
9791307|NCT00559962|10899031|FG003|STARTED|Overall Study||34
9791308|NCT00559962|10899032|FG004|STARTED|Overall Study||35
9791309|NCT00559962|10899033|FG005|STARTED|Overall Study||28
9791310|NCT00559962|10899034|FG006|STARTED|Overall Study||33
9791311|NCT00559962|10899035|FG007|STARTED|Overall Study||29
9791312|NCT00559962|10899028|FG000|COMPLETED|Overall Study||31
9791313|NCT00559962|10899029|FG001|COMPLETED|Overall Study||25
9791314|NCT00559962|10899030|FG002|COMPLETED|Overall Study||24
9791315|NCT00559962|10899031|FG003|COMPLETED|Overall Study||29
9791316|NCT00559962|10899032|FG004|COMPLETED|Overall Study||21
9791317|NCT00559962|10899033|FG005|COMPLETED|Overall Study||23
9791318|NCT00559962|10899034|FG006|COMPLETED|Overall Study||28
9791319|NCT00559962|10899035|FG007|COMPLETED|Overall Study||25
9791320|NCT00559962|10899028|FG000|NOT COMPLETED|Overall Study||2
9791321|NCT00559962|10899029|FG001|NOT COMPLETED|Overall Study||9
9791322|NCT00559962|10899030|FG002|NOT COMPLETED|Overall Study||10
9791323|NCT00559962|10899031|FG003|NOT COMPLETED|Overall Study||5
9791324|NCT00559962|10899032|FG004|NOT COMPLETED|Overall Study||14
9791325|NCT00559962|10899033|FG005|NOT COMPLETED|Overall Study||5
9791326|NCT00559962|10899034|FG006|NOT COMPLETED|Overall Study||5
9791327|NCT00559962|10899035|FG007|NOT COMPLETED|Overall Study||4
9791328|NCT00559988|10899056|FG000|STARTED|Overall Study||1357
9791329|NCT00559988|10899057|FG001|STARTED|Overall Study||1361
9791330|NCT00559988|10899056|FG000|COMPLETED|Overall Study||1006
9791331|NCT00559988|10899057|FG001|COMPLETED|Overall Study||1009
9791332|NCT00559988|10899056|FG000|NOT COMPLETED|Overall Study||351
9791333|NCT00559988|10899057|FG001|NOT COMPLETED|Overall Study||352
9791334|NCT00560066|10899065|FG000|STARTED|Overall Study||396
9791335|NCT00560066|10899066|FG001|STARTED|Overall Study||1002
9791336|NCT00560066|10899065|FG000|COMPLETED|Overall Study||390
9791337|NCT00560066|10899066|FG001|COMPLETED|Overall Study||980
9791338|NCT00560066|10899065|FG000|NOT COMPLETED|Overall Study||6
9791339|NCT00560066|10899066|FG001|NOT COMPLETED|Overall Study||22
9791340|NCT00560105|10899079|FG000|STARTED|Overall Study||20
9791341|NCT00560105|10899080|FG001|STARTED|Overall Study||20
9791342|NCT00560105|10899079|FG000|COMPLETED|Overall Study||19
9791343|NCT00560105|10899080|FG001|COMPLETED|Overall Study||18
9791344|NCT00560105|10899079|FG000|NOT COMPLETED|Overall Study||1
9791345|NCT00560105|10899080|FG001|NOT COMPLETED|Overall Study||2
9791346|NCT00560235|10899089|FG000|STARTED|Phase 1||10
9791347|NCT00560235|10899090|FG001|STARTED|Phase 1||0
9791348|NCT00560235|10899091|FG002|STARTED|Phase 1||0
9791349|NCT00560235|10899089|FG000|COMPLETED|Phase 1||2
9791350|NCT00560235|10899090|FG001|COMPLETED|Phase 1||0
9791351|NCT00560235|10899091|FG002|COMPLETED|Phase 1||0
9791352|NCT00560235|10899089|FG000|NOT COMPLETED|Phase 1||8
9791353|NCT00560235|10899090|FG001|NOT COMPLETED|Phase 1||0
9791354|NCT00560235|10899091|FG002|NOT COMPLETED|Phase 1||0
9791355|NCT00560235|10899089|FG000|STARTED|Phase 1B||0
9791356|NCT00560235|10899090|FG001|STARTED|Phase 1B||21
9791357|NCT00560235|10899091|FG002|STARTED|Phase 1B||0
9791358|NCT00560235|10899089|FG000|COMPLETED|Phase 1B||0
9791359|NCT00560235|10899090|FG001|COMPLETED|Phase 1B||2
9791360|NCT00560235|10899091|FG002|COMPLETED|Phase 1B||0
9791361|NCT00560235|10899089|FG000|NOT COMPLETED|Phase 1B||0
9791362|NCT00560235|10899090|FG001|NOT COMPLETED|Phase 1B||19
9791363|NCT00560235|10899091|FG002|NOT COMPLETED|Phase 1B||0
9791364|NCT00560235|10899089|FG000|STARTED|Phase 2||0
9791365|NCT00560235|10899090|FG001|STARTED|Phase 2||0
9791366|NCT00560235|10899091|FG002|STARTED|Phase 2||107
9791367|NCT00560235|10899089|FG000|COMPLETED|Phase 2||0
9791368|NCT00560235|10899090|FG001|COMPLETED|Phase 2||0
9791369|NCT00560235|10899091|FG002|COMPLETED|Phase 2||10
9791370|NCT00560235|10899089|FG000|NOT COMPLETED|Phase 2||0
9791371|NCT00560235|10899090|FG001|NOT COMPLETED|Phase 2||0
9791372|NCT00560235|10899091|FG002|NOT COMPLETED|Phase 2||97
9791373|NCT00560313|10899109|FG000|STARTED|Overall Study||54
9791374|NCT00560313|10899109|FG000|COMPLETED|Overall Study||48
9791375|NCT00560313|10899109|FG000|NOT COMPLETED|Overall Study||6
9791376|NCT00560352|10899131|FG000|STARTED|Overall Study||7
9791377|NCT00560352|10899132|FG001|STARTED|Overall Study||3
9791378|NCT00560352|10899133|FG002|STARTED|Overall Study||4
9791379|NCT00560352|10899131|FG000|COMPLETED|Overall Study||0
9791380|NCT00560352|10899132|FG001|COMPLETED|Overall Study||0
9791381|NCT00560352|10899133|FG002|COMPLETED|Overall Study||0
9791382|NCT00560352|10899131|FG000|NOT COMPLETED|Overall Study||7
9791383|NCT00560352|10899132|FG001|NOT COMPLETED|Overall Study||3
9791384|NCT00560352|10899133|FG002|NOT COMPLETED|Overall Study||4
9791385|NCT00560391|10899150|FG000|STARTED|Overall Study|Participants who received treatment|6
9791386|NCT00560391|10899151|FG001|STARTED|Overall Study|Participants who received treatment|3
9791387|NCT00560391|10899152|FG002|STARTED|Overall Study|Participants who received treatment|3
9791388|NCT00560391|10899153|FG003|STARTED|Overall Study|Participants who received treatment|6
9791389|NCT00560391|10899154|FG004|STARTED|Overall Study|Participants who received treatment|17
9791390|NCT00560391|10899150|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
9791391|NCT00560391|10899151|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
9791392|NCT00560391|10899152|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
9791393|NCT00560391|10899153|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
9791394|NCT00560391|10899154|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
9791395|NCT00560391|10899150|FG000|NOT COMPLETED|Overall Study||0
9791396|NCT00560391|10899151|FG001|NOT COMPLETED|Overall Study||0
9791397|NCT00560391|10899152|FG002|NOT COMPLETED|Overall Study||0
9791398|NCT00560391|10899153|FG003|NOT COMPLETED|Overall Study||1
9791399|NCT00560391|10899154|FG004|NOT COMPLETED|Overall Study||2
9791400|NCT00560404|10899169|FG000|STARTED|Overall Study||112
9791401|NCT00560404|10899170|FG001|STARTED|Overall Study||121
9791402|NCT00560404|10899169|FG000|COMPLETED|Overall Study||76
9791403|NCT00560404|10899170|FG001|COMPLETED|Overall Study||100
9791404|NCT00560404|10899169|FG000|NOT COMPLETED|Overall Study||36
9791405|NCT00560404|10899170|FG001|NOT COMPLETED|Overall Study||21
9791406|NCT00560417|10899178|FG000|STARTED|Overall Study||171
9791407|NCT00560417|10899179|FG001|STARTED|Overall Study||168
10015493|NCT01806597|11138564|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
10015494|NCT01806597|11138559|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0
10015495|NCT01806597|11138560|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0
10015496|NCT01806597|11138561|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0
10015497|NCT01806597|11138562|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0
10015498|NCT01806597|11138563|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3
10015499|NCT01806597|11138564|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161
10015500|NCT01806597|11138559|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
9791408|NCT00560417|10899178|FG000|Intention to Treat (ITT) Population|Overall Study||170
9791409|NCT00560417|10899179|FG001|Intention to Treat (ITT) Population|Overall Study||167
9791410|NCT00560417|10899178|FG000|COMPLETED|Overall Study||154
9791411|NCT00560417|10899179|FG001|COMPLETED|Overall Study||151
9791412|NCT00560417|10899178|FG000|NOT COMPLETED|Overall Study||17
9791413|NCT00560417|10899179|FG001|NOT COMPLETED|Overall Study||17
9791414|NCT00560508|10899187|FG000|STARTED|12 Week Double-blind Period||56
9791415|NCT00560508|10899188|FG001|STARTED|12 Week Double-blind Period||56
9791416|NCT00560508|10899187|FG000|COMPLETED|12 Week Double-blind Period||51
9791417|NCT00560508|10899188|FG001|COMPLETED|12 Week Double-blind Period||53
9791418|NCT00560508|10899187|FG000|NOT COMPLETED|12 Week Double-blind Period||5
9791419|NCT00560508|10899188|FG001|NOT COMPLETED|12 Week Double-blind Period||3
10015501|NCT01806597|11138560|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
9791420|NCT00560508|10899187|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
9791421|NCT00560508|10899188|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
9791422|NCT00560508|10899187|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43
9791423|NCT00560508|10899188|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42
9791424|NCT00560508|10899187|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
9791425|NCT00560508|10899188|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
9791426|NCT00560560|10899201|FG000|STARTED|Overall Study||85
9791427|NCT00560560|10899202|FG001|STARTED|Overall Study||83
9791428|NCT00560560|10899201|FG000|COMPLETED|Overall Study||0
9791429|NCT00560560|10899202|FG001|COMPLETED|Overall Study||0
9791430|NCT00560560|10899201|FG000|NOT COMPLETED|Overall Study||85
9791431|NCT00560560|10899202|FG001|NOT COMPLETED|Overall Study||83
9791432|NCT00560573|10899208|FG000|STARTED|Overall Study||6
9791433|NCT00560573|10899209|FG001|STARTED|Overall Study||3
9791434|NCT00560573|10899210|FG002|STARTED|Overall Study||6
9791435|NCT00560573|10899211|FG003|STARTED|Overall Study||10
9791436|NCT00560573|10899212|FG004|STARTED|Overall Study||8
9791437|NCT00560573|10899213|FG005|STARTED|Overall Study||13
9791438|NCT00560573|10899208|FG000|Treated|Overall Study||6
9791439|NCT00560573|10899209|FG001|Treated|Overall Study||3
9791440|NCT00560573|10899210|FG002|Treated|Overall Study||6
9791441|NCT00560573|10899211|FG003|Treated|Overall Study||10
9791442|NCT00560573|10899212|FG004|Treated|Overall Study||7
9791443|NCT00560573|10899213|FG005|Treated|Overall Study||13
9791444|NCT00560573|10899208|FG000|COMPLETED|Overall Study||0
9791445|NCT00560573|10899209|FG001|COMPLETED|Overall Study||0
9791446|NCT00560573|10899210|FG002|COMPLETED|Overall Study||0
9791447|NCT00560573|10899211|FG003|COMPLETED|Overall Study||0
9791448|NCT00560573|10899212|FG004|COMPLETED|Overall Study||1
9791449|NCT00560573|10899213|FG005|COMPLETED|Overall Study||0
9791450|NCT00560573|10899208|FG000|NOT COMPLETED|Overall Study||6
9791451|NCT00560573|10899209|FG001|NOT COMPLETED|Overall Study||3
9791452|NCT00560573|10899210|FG002|NOT COMPLETED|Overall Study||6
9791453|NCT00560573|10899211|FG003|NOT COMPLETED|Overall Study||10
9791454|NCT00560573|10899212|FG004|NOT COMPLETED|Overall Study||7
10015502|NCT01806597|11138561|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10015503|NCT01806597|11138562|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
9791455|NCT00560573|10899213|FG005|NOT COMPLETED|Overall Study||13
9791456|NCT00560612|10899245|FG000|STARTED|Overall Study||5
9791457|NCT00560612|10899246|FG001|STARTED|Overall Study||7
9791458|NCT00560612|10899245|FG000|COMPLETED|Overall Study||5
9791459|NCT00560612|10899246|FG001|COMPLETED|Overall Study||7
9791460|NCT00560612|10899245|FG000|NOT COMPLETED|Overall Study||0
9791461|NCT00560612|10899246|FG001|NOT COMPLETED|Overall Study||0
9791462|NCT00560703|10899254|FG000|STARTED|Overall Study||46
9791463|NCT00560703|10899255|FG001|STARTED|Overall Study||24
9791464|NCT00560703|10899254|FG000|COMPLETED|Overall Study||46
9791465|NCT00560703|10899255|FG001|COMPLETED|Overall Study||18
9791466|NCT00560703|10899254|FG000|NOT COMPLETED|Overall Study||0
9791467|NCT00560703|10899255|FG001|NOT COMPLETED|Overall Study||6
9791468|NCT00560755|10899261|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
9791469|NCT00560755|10899261|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346
9791470|NCT00560755|10899261|FG000|COMPLETED|Overall Study||3328
9791471|NCT00560755|10899261|FG000|NOT COMPLETED|Overall Study||60
9791472|NCT00560794|10899266|FG000|STARTED|Overall Study||21
9791473|NCT00560794|10899266|FG000|Completed 1 Treatment Cycle|Overall Study||20
9791474|NCT00560794|10899266|FG000|COMPLETED|Overall Study||10
9791475|NCT00560794|10899266|FG000|NOT COMPLETED|Overall Study||11
9791476|NCT00560833|10899277|FG000|STARTED|Overall Study||317
9791477|NCT00560833|10899278|FG001|STARTED|Overall Study||155
9791478|NCT00560833|10899279|FG002|STARTED|Overall Study||160
9791479|NCT00560833|10899280|FG003|STARTED|Overall Study||155
9791480|NCT00560833|10899281|FG004|STARTED|Overall Study||156
9791481|NCT00560833|10899277|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
9791482|NCT00560833|10899278|FG001|Treated|Overall Study|One participant was randomized but not treated|154
9791483|NCT00560833|10899279|FG002|Treated|Overall Study||160
9791484|NCT00560833|10899280|FG003|Treated|Overall Study||155
9791485|NCT00560833|10899281|FG004|Treated|Overall Study|One participant was randomized but not treated|155
9791486|NCT00560833|10899277|FG000|COMPLETED|Overall Study||273
9791487|NCT00560833|10899278|FG001|COMPLETED|Overall Study||129
9791488|NCT00560833|10899279|FG002|COMPLETED|Overall Study||121
9791489|NCT00560833|10899280|FG003|COMPLETED|Overall Study||124
9791490|NCT00560833|10899281|FG004|COMPLETED|Overall Study||114
9791491|NCT00560833|10899277|FG000|NOT COMPLETED|Overall Study||44
9791492|NCT00560833|10899278|FG001|NOT COMPLETED|Overall Study||26
9791493|NCT00560833|10899279|FG002|NOT COMPLETED|Overall Study||39
9791494|NCT00560833|10899280|FG003|NOT COMPLETED|Overall Study||31
10015504|NCT01806597|11138563|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
10015505|NCT01806597|11138564|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
9791495|NCT00560833|10899281|FG004|NOT COMPLETED|Overall Study||42
9791496|NCT00560859|10899295|FG000|STARTED|Overall Study||226
9791497|NCT00560859|10899296|FG001|STARTED|Overall Study||227
9791498|NCT00560859|10899295|FG000|COMPLETED|Overall Study||194
9791499|NCT00560859|10899296|FG001|COMPLETED|Overall Study||203
9791500|NCT00560859|10899295|FG000|NOT COMPLETED|Overall Study||32
9791501|NCT00560859|10899296|FG001|NOT COMPLETED|Overall Study||24
9791502|NCT00560885|10899303|FG000|STARTED|Overall Study||55
9791503|NCT00560885|10899303|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
9791504|NCT00560885|10899303|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
9791505|NCT00560885|10899303|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
9791506|NCT00560885|10899303|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
9791507|NCT00560885|10899303|FG000|2 Year Follow-up|Overall Study||47
10015506|NCT01806597|11138559|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10015507|NCT01806597|11138560|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10015508|NCT01806597|11138561|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10015509|NCT01806597|11138562|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10015510|NCT01806597|11138563|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10015511|NCT01806597|11138564|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
9791508|NCT00560885|10899303|FG000|COMPLETED|Overall Study||47
10015512|NCT01806623|11138578|FG000|STARTED|Overall Study||157
10015513|NCT01806623|11138578|FG000|COMPLETED|Overall Study||99
10015514|NCT01806623|11138578|FG000|NOT COMPLETED|Overall Study||58
9791509|NCT00560885|10899303|FG000|NOT COMPLETED|Overall Study||8
9791510|NCT00560937|10899309|FG000|STARTED|Overall Study||10
9791511|NCT00560937|10899310|FG001|STARTED|Overall Study||11
9791512|NCT00560937|10899309|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
9791513|NCT00560937|10899310|FG001|COMPLETED|Overall Study||9
9791514|NCT00560937|10899309|FG000|NOT COMPLETED|Overall Study||1
9791515|NCT00560937|10899310|FG001|NOT COMPLETED|Overall Study||2
9791516|NCT00560950|10899318|FG000|STARTED|Overall Study||72
9791517|NCT00560950|10899319|FG001|STARTED|Overall Study||71
9791518|NCT00560950|10899318|FG000|COMPLETED|Overall Study||71
9791519|NCT00560950|10899319|FG001|COMPLETED|Overall Study||71
9791520|NCT00560950|10899318|FG000|NOT COMPLETED|Overall Study||1
9791521|NCT00560950|10899319|FG001|NOT COMPLETED|Overall Study||0
9791522|NCT00561002|10899329|FG000|STARTED|Overall Study||23
9791523|NCT00561002|10899330|FG001|STARTED|Overall Study||9
9791524|NCT00561002|10899329|FG000|COMPLETED|Overall Study||23
9791525|NCT00561002|10899330|FG001|COMPLETED|Overall Study||9
9791526|NCT00561002|10899329|FG000|NOT COMPLETED|Overall Study||0
9791527|NCT00561002|10899330|FG001|NOT COMPLETED|Overall Study||0
9791528|NCT00561015|10899342|FG000|STARTED|Overall Study||9
9791529|NCT00561015|10899343|FG001|STARTED|Overall Study||5
9791530|NCT00561015|10899344|FG002|STARTED|Overall Study||9
9791531|NCT00561015|10899345|FG003|STARTED|Overall Study||8
9791532|NCT00561015|10899346|FG004|STARTED|Overall Study||9
9791533|NCT00561015|10899347|FG005|STARTED|Overall Study||9
9791534|NCT00561015|10899342|FG000|COMPLETED|Overall Study||5
9791535|NCT00561015|10899343|FG001|COMPLETED|Overall Study||5
9791536|NCT00561015|10899344|FG002|COMPLETED|Overall Study||9
9791537|NCT00561015|10899345|FG003|COMPLETED|Overall Study||7
9791538|NCT00561015|10899346|FG004|COMPLETED|Overall Study||8
9791539|NCT00561015|10899347|FG005|COMPLETED|Overall Study||6
9791540|NCT00561015|10899342|FG000|NOT COMPLETED|Overall Study||4
9791541|NCT00561015|10899343|FG001|NOT COMPLETED|Overall Study||0
9791542|NCT00561015|10899344|FG002|NOT COMPLETED|Overall Study||0
9791543|NCT00561015|10899345|FG003|NOT COMPLETED|Overall Study||1
9791544|NCT00561015|10899346|FG004|NOT COMPLETED|Overall Study||1
9791545|NCT00561015|10899347|FG005|NOT COMPLETED|Overall Study||3
9791546|NCT00561080|10899368|FG000|STARTED|Vaccination Period (up to Month 4)||253
9791547|NCT00561080|10899369|FG001|STARTED|Vaccination Period (up to Month 4)||255
9791548|NCT00561080|10899370|FG002|STARTED|Vaccination Period (up to Month 4)||251
9791549|NCT00561080|10899368|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
10015515|NCT01806662|11138582|FG000|STARTED|First Intervention (Weeks 0-16)||16
10015516|NCT01806662|11138583|FG001|STARTED|First Intervention (Weeks 0-16)||16
10015517|NCT01806662|11138582|FG000|Received Intervention|First Intervention (Weeks 0-16)||12
10015518|NCT01806662|11138583|FG001|Received Intervention|First Intervention (Weeks 0-16)||15
10015519|NCT01806662|11138582|FG000|COMPLETED|First Intervention (Weeks 0-16)||12
10015520|NCT01806662|11138583|FG001|COMPLETED|First Intervention (Weeks 0-16)||15
9791550|NCT00561080|10899369|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
9791551|NCT00561080|10899370|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
9791552|NCT00561080|10899368|FG000|COMPLETED|Vaccination Period (up to Month 4)||250
9791553|NCT00561080|10899369|FG001|COMPLETED|Vaccination Period (up to Month 4)||229
9791554|NCT00561080|10899370|FG002|COMPLETED|Vaccination Period (up to Month 4)||225
9791555|NCT00561080|10899368|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3
9791556|NCT00561080|10899369|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26
9791557|NCT00561080|10899370|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26
9791558|NCT00561080|10899368|FG000|STARTED|12-month Post Last Dose Follow-up||250
9791559|NCT00561080|10899369|FG001|STARTED|12-month Post Last Dose Follow-up||229
9791560|NCT00561080|10899370|FG002|STARTED|12-month Post Last Dose Follow-up||225
10015521|NCT01806662|11138582|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4
10015522|NCT01806662|11138583|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1
10015523|NCT01806662|11138582|FG000|STARTED|Second Intervention (Weeks 16-32)||12
9791561|NCT00561080|10899368|FG000|COMPLETED|12-month Post Last Dose Follow-up||243
9791562|NCT00561080|10899369|FG001|COMPLETED|12-month Post Last Dose Follow-up||220
9791563|NCT00561080|10899370|FG002|COMPLETED|12-month Post Last Dose Follow-up||215
9791564|NCT00561080|10899368|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7
9791565|NCT00561080|10899369|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9
9791566|NCT00561080|10899370|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10
9791567|NCT00561080|10899368|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
9791568|NCT00561080|10899369|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
9791569|NCT00561080|10899370|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
9791570|NCT00561080|10899368|FG000|COMPLETED|24-month Post Last Dose Follow-up||0
9791571|NCT00561080|10899369|FG001|COMPLETED|24-month Post Last Dose Follow-up||0
9791572|NCT00561080|10899370|FG002|COMPLETED|24-month Post Last Dose Follow-up||0
9791573|NCT00561080|10899368|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0
9791574|NCT00561080|10899369|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0
9791575|NCT00561080|10899370|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0
9791576|NCT00561080|10899368|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
9791577|NCT00561080|10899369|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
9791578|NCT00561080|10899370|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
9791579|NCT00561080|10899368|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0
9791580|NCT00561080|10899369|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0
9791581|NCT00561080|10899370|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0
9791582|NCT00561080|10899368|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
9791583|NCT00561080|10899369|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
9791584|NCT00561080|10899370|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
9791585|NCT00561145|10899382|FG000|STARTED|Overall Study||15
9791586|NCT00561145|10899383|FG001|STARTED|Overall Study||17
9791587|NCT00561145|10899382|FG000|COMPLETED|Overall Study||15
9791588|NCT00561145|10899383|FG001|COMPLETED|Overall Study||17
9791589|NCT00561145|10899382|FG000|NOT COMPLETED|Overall Study||0
9791590|NCT00561145|10899383|FG001|NOT COMPLETED|Overall Study||0
9791591|NCT00561340|10899391|FG000|STARTED|Overall Study||13
9791592|NCT00561340|10899392|FG001|STARTED|Overall Study||16
9791593|NCT00561340|10899391|FG000|COMPLETED|Overall Study||7
9791594|NCT00561340|10899392|FG001|COMPLETED|Overall Study||16
9791595|NCT00561340|10899391|FG000|NOT COMPLETED|Overall Study||6
9791596|NCT00561340|10899392|FG001|NOT COMPLETED|Overall Study||0
9791597|NCT00561353|10899408|FG000|STARTED|Overall Study||18
9791598|NCT00561353|10899409|FG001|STARTED|Overall Study||19
9791599|NCT00561353|10899410|FG002|STARTED|Overall Study||13
9791600|NCT00561353|10899411|FG003|STARTED|Overall Study||18
9791601|NCT00561353|10899412|FG004|STARTED|Overall Study||6
9791602|NCT00561353|10899413|FG005|STARTED|Overall Study||9
9791603|NCT00561353|10899414|FG006|STARTED|Overall Study||9
9791604|NCT00561353|10899415|FG007|STARTED|Overall Study||10
9791605|NCT00561353|10899416|FG008|STARTED|Overall Study||9
9791606|NCT00561353|10899417|FG009|STARTED|Overall Study||5
9791607|NCT00561353|10899408|FG000|COMPLETED|Overall Study||13
9791608|NCT00561353|10899409|FG001|COMPLETED|Overall Study||16
9791609|NCT00561353|10899410|FG002|COMPLETED|Overall Study||10
9791610|NCT00561353|10899411|FG003|COMPLETED|Overall Study||12
9791611|NCT00561353|10899412|FG004|COMPLETED|Overall Study||5
9791612|NCT00561353|10899413|FG005|COMPLETED|Overall Study||3
9791613|NCT00561353|10899414|FG006|COMPLETED|Overall Study||3
9791614|NCT00561353|10899415|FG007|COMPLETED|Overall Study||6
9791615|NCT00561353|10899416|FG008|COMPLETED|Overall Study||2
9791616|NCT00561353|10899417|FG009|COMPLETED|Overall Study||3
9791617|NCT00561353|10899408|FG000|NOT COMPLETED|Overall Study||5
9791618|NCT00561353|10899409|FG001|NOT COMPLETED|Overall Study||3
9791619|NCT00561353|10899410|FG002|NOT COMPLETED|Overall Study||3
9791620|NCT00561353|10899411|FG003|NOT COMPLETED|Overall Study||6
9791621|NCT00561353|10899412|FG004|NOT COMPLETED|Overall Study||1
9791622|NCT00561353|10899413|FG005|NOT COMPLETED|Overall Study||6
9791623|NCT00561353|10899414|FG006|NOT COMPLETED|Overall Study||6
9791624|NCT00561353|10899415|FG007|NOT COMPLETED|Overall Study||4
9791625|NCT00561353|10899416|FG008|NOT COMPLETED|Overall Study||7
9791626|NCT00561353|10899417|FG009|NOT COMPLETED|Overall Study||2
9791627|NCT00561392|10899479|FG000|STARTED|Overall Study||208
9791628|NCT00561392|10899479|FG000|COMPLETED|Overall Study||155
9791629|NCT00561392|10899479|FG000|NOT COMPLETED|Overall Study||53
9791630|NCT00561418|10899483|FG000|STARTED|Overall Study||23
9791631|NCT00561418|10899483|FG000|COMPLETED|Overall Study||23
9791632|NCT00561418|10899483|FG000|NOT COMPLETED|Overall Study||0
9791633|NCT00561431|10899489|FG000|STARTED|Overall Study||100
9791634|NCT00561431|10899490|FG001|STARTED|Overall Study||100
9791635|NCT00561431|10899489|FG000|COMPLETED|Overall Study||100
9791636|NCT00561431|10899490|FG001|COMPLETED|Overall Study||100
9952467|NCT01422369|11071453|FG000|NOT COMPLETED|NK-104 4mg QD||0
9952468|NCT01422369|11071453|FG000|STARTED|Prezista 800mg/100mg QD||28
9952469|NCT01422369|11071453|FG000|COMPLETED|Prezista 800mg/100mg QD||28
9952470|NCT01422369|11071453|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0
9952471|NCT01422369|11071453|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
9952472|NCT01422369|11071453|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
9791637|NCT00561431|10899489|FG000|NOT COMPLETED|Overall Study||0
9791638|NCT00561431|10899490|FG001|NOT COMPLETED|Overall Study||0
9791639|NCT00561457|10899496|FG000|STARTED|Overall Study||134
9791640|NCT00561457|10899496|FG000|COMPLETED|Overall Study||110
9791641|NCT00561457|10899496|FG000|NOT COMPLETED|Overall Study||24
9791642|NCT00561470|10899502|FG000|STARTED|Overall Study||614
9791643|NCT00561470|10899503|FG001|STARTED|Overall Study||612
9791644|NCT00561470|10899502|FG000|TREATED|Overall Study||609
9791645|NCT00561470|10899503|FG001|TREATED|Overall Study||607
9791646|NCT00561470|10899502|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
9791647|NCT00561470|10899503|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
9791648|NCT00561470|10899502|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
9791649|NCT00561470|10899503|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
9791650|NCT00561470|10899502|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
9791651|NCT00561470|10899503|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
9791652|NCT00561470|10899502|FG000|NOT COMPLETED|Overall Study||614
9791653|NCT00561470|10899503|FG001|NOT COMPLETED|Overall Study||612
9791654|NCT00561574|10899513|FG000|STARTED|Overall Study||128
9791655|NCT00561574|10899514|FG001|STARTED|Overall Study||131
9791656|NCT00561574|10899513|FG000|COMPLETED|Overall Study||80
9791657|NCT00561574|10899514|FG001|COMPLETED|Overall Study||73
9791658|NCT00561574|10899513|FG000|NOT COMPLETED|Overall Study||48
9791659|NCT00561574|10899514|FG001|NOT COMPLETED|Overall Study||58
9791660|NCT00561600|10899522|FG000|STARTED|Overall Study||130
9791661|NCT00561600|10899523|FG001|STARTED|Overall Study||135
9791662|NCT00561600|10899522|FG000|COMPLETED|Overall Study||112
9791663|NCT00561600|10899523|FG001|COMPLETED|Overall Study||119
9791664|NCT00561600|10899522|FG000|NOT COMPLETED|Overall Study||18
9791665|NCT00561600|10899523|FG001|NOT COMPLETED|Overall Study||16
9791666|NCT00561652|10899533|FG000|STARTED|Overall Study||10
9791667|NCT00561652|10899534|FG001|STARTED|Overall Study||20
9791668|NCT00561652|10899533|FG000|COMPLETED|Overall Study||10
9791669|NCT00561652|10899534|FG001|COMPLETED|Overall Study||19
9791670|NCT00561652|10899533|FG000|NOT COMPLETED|Overall Study||0
9791671|NCT00561652|10899534|FG001|NOT COMPLETED|Overall Study||1
9791672|NCT00561678|10899542|FG000|STARTED|Overall Study||197
9791673|NCT00561678|10899543|FG001|STARTED|Overall Study||207
9791674|NCT00561678|10899542|FG000|COMPLETED|Overall Study||189
9791675|NCT00561678|10899543|FG001|COMPLETED|Overall Study||201
9791676|NCT00561678|10899542|FG000|NOT COMPLETED|Overall Study||8
9791677|NCT00561678|10899543|FG001|NOT COMPLETED|Overall Study||6
9791678|NCT00561730|10899549|FG000|STARTED|Overall Study||1995
9791679|NCT00561730|10899549|FG000|COMPLETED|Overall Study||1986
9791680|NCT00561730|10899549|FG000|NOT COMPLETED|Overall Study||9
9791681|NCT00561821|10899559|FG000|STARTED|Overall Study||132
9791682|NCT00561821|10899560|FG001|STARTED|Overall Study||136
9791683|NCT00561821|10899561|FG002|STARTED|Overall Study||134
9791684|NCT00561821|10899562|FG003|STARTED|Overall Study||136
9791685|NCT00561821|10899559|FG000|Treated|Overall Study||132
9791686|NCT00561821|10899560|FG001|Treated|Overall Study||136
9791687|NCT00561821|10899561|FG002|Treated|Overall Study||133
9791688|NCT00561821|10899562|FG003|Treated|Overall Study||136
9791689|NCT00561821|10899559|FG000|COMPLETED|Overall Study||127
9791690|NCT00561821|10899560|FG001|COMPLETED|Overall Study||130
9791691|NCT00561821|10899561|FG002|COMPLETED|Overall Study||132
9791692|NCT00561821|10899562|FG003|COMPLETED|Overall Study||133
9791693|NCT00561821|10899559|FG000|NOT COMPLETED|Overall Study||5
9791694|NCT00561821|10899560|FG001|NOT COMPLETED|Overall Study||6
9791695|NCT00561821|10899561|FG002|NOT COMPLETED|Overall Study||2
9791696|NCT00561821|10899562|FG003|NOT COMPLETED|Overall Study||3
9791697|NCT00561834|10899572|FG000|STARTED|Overall Study||2
9791698|NCT00561834|10899572|FG000|COMPLETED|Overall Study||2
9791699|NCT00561834|10899572|FG000|NOT COMPLETED|Overall Study||0
9791700|NCT00561925|10899579|FG000|STARTED|14 Day Lead-In Period||1068
9791701|NCT00561925|10899580|FG001|STARTED|14 Day Lead-In Period||0
9791702|NCT00561925|10899581|FG002|STARTED|14 Day Lead-In Period||0
9791703|NCT00561925|10899582|FG003|STARTED|14 Day Lead-In Period||0
9791704|NCT00561925|10899583|FG004|STARTED|14 Day Lead-In Period||0
9791705|NCT00561925|10899579|FG000|COMPLETED|14 Day Lead-In Period||1013
9791706|NCT00561925|10899580|FG001|COMPLETED|14 Day Lead-In Period||0
9791707|NCT00561925|10899581|FG002|COMPLETED|14 Day Lead-In Period||0
9791708|NCT00561925|10899582|FG003|COMPLETED|14 Day Lead-In Period||0
9791709|NCT00561925|10899583|FG004|COMPLETED|14 Day Lead-In Period||0
9791710|NCT00561925|10899579|FG000|NOT COMPLETED|14 Day Lead-In Period||55
9791711|NCT00561925|10899580|FG001|NOT COMPLETED|14 Day Lead-In Period||0
9791712|NCT00561925|10899581|FG002|NOT COMPLETED|14 Day Lead-In Period||0
9791713|NCT00561925|10899582|FG003|NOT COMPLETED|14 Day Lead-In Period||0
9791714|NCT00561925|10899583|FG004|NOT COMPLETED|14 Day Lead-In Period||0
9791715|NCT00561925|10899579|FG000|STARTED|144-week Double-blind, Double-dummy||0
9791716|NCT00561925|10899580|FG001|STARTED|144-week Double-blind, Double-dummy||508
9791717|NCT00561925|10899581|FG002|STARTED|144-week Double-blind, Double-dummy||505
9791718|NCT00561925|10899582|FG003|STARTED|144-week Double-blind, Double-dummy||0
9791719|NCT00561925|10899583|FG004|STARTED|144-week Double-blind, Double-dummy||0
9791720|NCT00561925|10899579|FG000|COMPLETED|144-week Double-blind, Double-dummy||0
9791721|NCT00561925|10899580|FG001|COMPLETED|144-week Double-blind, Double-dummy||358
9791722|NCT00561925|10899581|FG002|COMPLETED|144-week Double-blind, Double-dummy||378
9791723|NCT00561925|10899582|FG003|COMPLETED|144-week Double-blind, Double-dummy||0
9791724|NCT00561925|10899583|FG004|COMPLETED|144-week Double-blind, Double-dummy||0
9791725|NCT00561925|10899579|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0
9791726|NCT00561925|10899580|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150
9791727|NCT00561925|10899581|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127
9791728|NCT00561925|10899582|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0
9791729|NCT00561925|10899583|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0
9791730|NCT00561925|10899579|FG000|STARTED|Open-Label Extension Period||0
9791731|NCT00561925|10899580|FG001|STARTED|Open-Label Extension Period||1
9791732|NCT00561925|10899581|FG002|STARTED|Open-Label Extension Period||0
9791733|NCT00561925|10899582|FG003|STARTED|Open-Label Extension Period||358
9791734|NCT00561925|10899583|FG004|STARTED|Open-Label Extension Period||378
9791735|NCT00561925|10899579|FG000|COMPLETED|Open-Label Extension Period||0
9791736|NCT00561925|10899580|FG001|COMPLETED|Open-Label Extension Period||1
9791737|NCT00561925|10899581|FG002|COMPLETED|Open-Label Extension Period||0
9791738|NCT00561925|10899582|FG003|COMPLETED|Open-Label Extension Period||315
9791739|NCT00561925|10899583|FG004|COMPLETED|Open-Label Extension Period||328
9791740|NCT00561925|10899579|FG000|NOT COMPLETED|Open-Label Extension Period||0
9791741|NCT00561925|10899580|FG001|NOT COMPLETED|Open-Label Extension Period||0
9791742|NCT00561925|10899581|FG002|NOT COMPLETED|Open-Label Extension Period||0
9791743|NCT00561925|10899582|FG003|NOT COMPLETED|Open-Label Extension Period||43
9791744|NCT00561925|10899583|FG004|NOT COMPLETED|Open-Label Extension Period||50
9791745|NCT00561951|10899604|FG000|STARTED|Overall Study||318
9791746|NCT00561951|10899605|FG001|STARTED|Overall Study||320
9791747|NCT00561951|10899606|FG002|STARTED|Overall Study||313
9791748|NCT00561951|10899604|FG000|COMPLETED|Overall Study||285
9791749|NCT00561951|10899605|FG001|COMPLETED|Overall Study||286
9791750|NCT00561951|10899606|FG002|COMPLETED|Overall Study||281
9791751|NCT00561951|10899604|FG000|NOT COMPLETED|Overall Study||33
9791752|NCT00561951|10899605|FG001|NOT COMPLETED|Overall Study||34
9791753|NCT00561951|10899606|FG002|NOT COMPLETED|Overall Study||32
9791754|NCT00561977|10899617|FG000|STARTED|Overall Study||12
9791755|NCT00561977|10899618|FG001|STARTED|Overall Study||12
9791756|NCT00561977|10899619|FG002|STARTED|Overall Study||12
9791757|NCT00561977|10899617|FG000|COMPLETED|Overall Study||12
9791758|NCT00561977|10899618|FG001|COMPLETED|Overall Study||9
9791759|NCT00561977|10899619|FG002|COMPLETED|Overall Study||10
9791760|NCT00561977|10899617|FG000|NOT COMPLETED|Overall Study||0
9791761|NCT00561977|10899618|FG001|NOT COMPLETED|Overall Study||3
9791762|NCT00561977|10899619|FG002|NOT COMPLETED|Overall Study||2
9791763|NCT00562094|10899627|FG000|STARTED|Overall Study||8616
9791764|NCT00562094|10899627|FG000|COMPLETED|Overall Study||8554
9791765|NCT00562094|10899627|FG000|NOT COMPLETED|Overall Study||62
9791766|NCT00562120|10899635|FG000|STARTED|First Intervention Period||6
9791767|NCT00562120|10899636|FG001|STARTED|First Intervention Period||5
9791768|NCT00562120|10899637|FG002|STARTED|First Intervention Period||5
9791769|NCT00562120|10899638|FG003|STARTED|First Intervention Period||5
9791770|NCT00562120|10899635|FG000|Treated|First Intervention Period||5
9791771|NCT00562120|10899636|FG001|Treated|First Intervention Period||5
9791772|NCT00562120|10899637|FG002|Treated|First Intervention Period||5
9791773|NCT00562120|10899638|FG003|Treated|First Intervention Period||5
9791774|NCT00562120|10899635|FG000|COMPLETED|First Intervention Period||4
9791775|NCT00562120|10899636|FG001|COMPLETED|First Intervention Period||5
9791776|NCT00562120|10899637|FG002|COMPLETED|First Intervention Period||5
9791777|NCT00562120|10899638|FG003|COMPLETED|First Intervention Period||5
9791778|NCT00562120|10899635|FG000|NOT COMPLETED|First Intervention Period||2
9791779|NCT00562120|10899636|FG001|NOT COMPLETED|First Intervention Period||0
9791780|NCT00562120|10899637|FG002|NOT COMPLETED|First Intervention Period||0
9791781|NCT00562120|10899638|FG003|NOT COMPLETED|First Intervention Period||0
9791782|NCT00562120|10899635|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4
9791783|NCT00562120|10899636|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5
9791784|NCT00562120|10899637|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5
9791785|NCT00562120|10899638|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5
9791786|NCT00562120|10899635|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4
9791787|NCT00562120|10899636|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5
9791788|NCT00562120|10899637|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5
9791789|NCT00562120|10899638|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5
9791790|NCT00562120|10899635|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
9791791|NCT00562120|10899636|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
9791792|NCT00562120|10899637|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
9791793|NCT00562120|10899638|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
9791794|NCT00562120|10899635|FG000|STARTED|Second Intervention Period||4
9791795|NCT00562120|10899636|FG001|STARTED|Second Intervention Period||5
9791796|NCT00562120|10899637|FG002|STARTED|Second Intervention Period||5
9791797|NCT00562120|10899638|FG003|STARTED|Second Intervention Period||5
9791798|NCT00562120|10899635|FG000|COMPLETED|Second Intervention Period||4
9791799|NCT00562120|10899636|FG001|COMPLETED|Second Intervention Period||5
9791800|NCT00562120|10899637|FG002|COMPLETED|Second Intervention Period||5
9791801|NCT00562120|10899638|FG003|COMPLETED|Second Intervention Period||5
9791802|NCT00562120|10899635|FG000|NOT COMPLETED|Second Intervention Period||0
9791803|NCT00562120|10899636|FG001|NOT COMPLETED|Second Intervention Period||0
9791804|NCT00562120|10899637|FG002|NOT COMPLETED|Second Intervention Period||0
9791805|NCT00562120|10899638|FG003|NOT COMPLETED|Second Intervention Period||0
9791806|NCT00562120|10899635|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4
9791807|NCT00562120|10899636|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5
9791808|NCT00562120|10899637|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5
9791809|NCT00562120|10899638|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5
9791810|NCT00562120|10899635|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4
9791811|NCT00562120|10899636|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5
9791812|NCT00562120|10899637|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5
9791813|NCT00562120|10899638|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5
9791814|NCT00562120|10899635|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
9791815|NCT00562120|10899636|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
9791816|NCT00562120|10899637|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
9791817|NCT00562120|10899638|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
9791818|NCT00562120|10899635|FG000|STARTED|Third Intervention Period||4
9791819|NCT00562120|10899636|FG001|STARTED|Third Intervention Period||5
9791820|NCT00562120|10899637|FG002|STARTED|Third Intervention Period||5
9791821|NCT00562120|10899638|FG003|STARTED|Third Intervention Period||5
9791822|NCT00562120|10899635|FG000|COMPLETED|Third Intervention Period||4
9791823|NCT00562120|10899636|FG001|COMPLETED|Third Intervention Period||5
9791824|NCT00562120|10899637|FG002|COMPLETED|Third Intervention Period||5
9791825|NCT00562120|10899638|FG003|COMPLETED|Third Intervention Period||5
9791826|NCT00562120|10899635|FG000|NOT COMPLETED|Third Intervention Period||0
9791827|NCT00562120|10899636|FG001|NOT COMPLETED|Third Intervention Period||0
9791828|NCT00562120|10899637|FG002|NOT COMPLETED|Third Intervention Period||0
9791829|NCT00562120|10899638|FG003|NOT COMPLETED|Third Intervention Period||0
9791830|NCT00562120|10899635|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4
9791831|NCT00562120|10899636|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5
9791832|NCT00562120|10899637|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5
9791833|NCT00562120|10899638|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5
9791834|NCT00562120|10899635|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4
9791835|NCT00562120|10899636|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5
9791836|NCT00562120|10899637|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5
9791837|NCT00562120|10899638|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5
9791838|NCT00562120|10899635|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
9791839|NCT00562120|10899636|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
9791840|NCT00562120|10899637|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
9791841|NCT00562120|10899638|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
9791842|NCT00562120|10899635|FG000|STARTED|Fourth Intervention Period||4
9791843|NCT00562120|10899636|FG001|STARTED|Fourth Intervention Period||5
9791844|NCT00562120|10899637|FG002|STARTED|Fourth Intervention Period||5
9791845|NCT00562120|10899638|FG003|STARTED|Fourth Intervention Period||5
9791846|NCT00562120|10899635|FG000|COMPLETED|Fourth Intervention Period||4
9791847|NCT00562120|10899636|FG001|COMPLETED|Fourth Intervention Period||5
9791848|NCT00562120|10899637|FG002|COMPLETED|Fourth Intervention Period||5
9791849|NCT00562120|10899638|FG003|COMPLETED|Fourth Intervention Period||5
9791850|NCT00562120|10899635|FG000|NOT COMPLETED|Fourth Intervention Period||0
9791851|NCT00562120|10899636|FG001|NOT COMPLETED|Fourth Intervention Period||0
9791852|NCT00562120|10899637|FG002|NOT COMPLETED|Fourth Intervention Period||0
9791853|NCT00562120|10899638|FG003|NOT COMPLETED|Fourth Intervention Period||0
9791854|NCT00562159|10899650|FG000|STARTED|Overall Study||213
9791855|NCT00562159|10899651|FG001|STARTED|Overall Study||225
9791856|NCT00562159|10899650|FG000|COMPLETED|Overall Study||175
9791857|NCT00562159|10899651|FG001|COMPLETED|Overall Study||192
9791858|NCT00562159|10899650|FG000|NOT COMPLETED|Overall Study||38
9791859|NCT00562159|10899651|FG001|NOT COMPLETED|Overall Study||33
9830694|NCT00764946|10941463|FG002|STARTED|Overall Study||22
9830695|NCT00764946|10941461|FG000|TREATED|Overall Study||97
9830696|NCT00764946|10941462|FG001|TREATED|Overall Study||88
9830697|NCT00764946|10941463|FG002|TREATED|Overall Study||21
9830698|NCT00764946|10941461|FG000|COMPLETED|Overall Study||85
9830699|NCT00764946|10941462|FG001|COMPLETED|Overall Study||72
9830700|NCT00764946|10941463|FG002|COMPLETED|Overall Study||18
9830701|NCT00764946|10941461|FG000|NOT COMPLETED|Overall Study||13
9830702|NCT00764946|10941462|FG001|NOT COMPLETED|Overall Study||17
9830703|NCT00764946|10941463|FG002|NOT COMPLETED|Overall Study||4
9830704|NCT00765037|10941477|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
9830705|NCT00765037|10941477|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
9830706|NCT00765037|10941477|FG000|NOT COMPLETED|Overall Study||6
9830707|NCT00765063|10941481|FG000|STARTED|Overall Study||62
9830708|NCT00765063|10941481|FG000|COMPLETED|Overall Study||30
9830709|NCT00765063|10941481|FG000|NOT COMPLETED|Overall Study||32
9830710|NCT00765076|10941488|FG000|STARTED|Overall Study||69
9830711|NCT00765076|10941489|FG001|STARTED|Overall Study||73
9830712|NCT00765076|10941490|FG002|STARTED|Overall Study||50
9830713|NCT00765076|10941488|FG000|COMPLETED|Overall Study||68
9830714|NCT00765076|10941489|FG001|COMPLETED|Overall Study||73
9830715|NCT00765076|10941490|FG002|COMPLETED|Overall Study||49
9830716|NCT00765076|10941488|FG000|NOT COMPLETED|Overall Study||1
9830717|NCT00765076|10941489|FG001|NOT COMPLETED|Overall Study||0
9830718|NCT00765076|10941490|FG002|NOT COMPLETED|Overall Study||1
9830719|NCT00765102|10941498|FG000|STARTED|Overall Study||32
9830720|NCT00765102|10941498|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
9830721|NCT00765102|10941498|FG000|NOT COMPLETED|Overall Study||31
9830722|NCT00765128|10941506|FG000|STARTED|Overall Study||8
9830723|NCT00765128|10941507|FG001|STARTED|Overall Study||9
9830724|NCT00765128|10941506|FG000|COMPLETED|Overall Study||8
9830725|NCT00765128|10941507|FG001|COMPLETED|Overall Study||9
9830726|NCT00765128|10941506|FG000|NOT COMPLETED|Overall Study||0
9791860|NCT00562302|10899660|FG000|STARTED|Overall Study||170
9791861|NCT00562302|10899661|FG001|STARTED|Overall Study||169
9791862|NCT00562302|10899660|FG000|COMPLETED|Overall Study||150
9791863|NCT00562302|10899661|FG001|COMPLETED|Overall Study||137
9791864|NCT00562302|10899660|FG000|NOT COMPLETED|Overall Study||20
9791865|NCT00562302|10899661|FG001|NOT COMPLETED|Overall Study||32
9791866|NCT00562315|10899667|FG000|STARTED|Overall Study||93
9791867|NCT00562315|10899667|FG000|COMPLETED|Overall Study||93
9791868|NCT00562315|10899667|FG000|NOT COMPLETED|Overall Study||0
9791869|NCT00562328|10899673|FG000|STARTED|Overall Study||33
9791870|NCT00562328|10899673|FG000|COMPLETED|Overall Study||33
9791871|NCT00562328|10899673|FG000|NOT COMPLETED|Overall Study||0
9791872|NCT00562354|10899679|FG000|STARTED|Overall Study||134
9791873|NCT00562354|10899680|FG001|STARTED|Overall Study||137
9791874|NCT00562354|10899679|FG000|Received Study Treatment|Overall Study||134
9791875|NCT00562354|10899680|FG001|Received Study Treatment|Overall Study||136
9791876|NCT00562354|10899679|FG000|Evaluable Immunogenicity Population|Overall Study||134
9791877|NCT00562354|10899680|FG001|Evaluable Immunogenicity Population|Overall Study||134
9791878|NCT00562354|10899679|FG000|COMPLETED|Overall Study||134
9791879|NCT00562354|10899680|FG001|COMPLETED|Overall Study||135
9791880|NCT00562354|10899679|FG000|NOT COMPLETED|Overall Study||0
9791881|NCT00562354|10899680|FG001|NOT COMPLETED|Overall Study||2
9791882|NCT00562484|10899690|FG000|STARTED|Overall Study||10033
9791883|NCT00562484|10899691|FG001|STARTED|Overall Study||5011
9791884|NCT00562484|10899690|FG000|COMPLETED|Overall Study||9827
9791885|NCT00562484|10899691|FG001|COMPLETED|Overall Study||4907
9791886|NCT00562484|10899690|FG000|NOT COMPLETED|Overall Study||206
9791887|NCT00562484|10899691|FG001|NOT COMPLETED|Overall Study||104
9791888|NCT00562588|10899699|FG000|STARTED|Overall Study||260
9791889|NCT00562588|10899700|FG001|STARTED|Overall Study||283
9791890|NCT00562588|10899699|FG000|COMPLETED|Overall Study||168
9791891|NCT00562588|10899700|FG001|COMPLETED|Overall Study||184
9791892|NCT00562588|10899699|FG000|NOT COMPLETED|Overall Study||92
9791893|NCT00562588|10899700|FG001|NOT COMPLETED|Overall Study||99
9791894|NCT00562627|10899709|FG000|STARTED|Overall Study||34
9791895|NCT00562627|10899710|FG001|STARTED|Overall Study||34
9791896|NCT00562627|10899711|FG002|STARTED|Overall Study||34
9791897|NCT00562627|10899709|FG000|COMPLETED|Overall Study||33
9791898|NCT00562627|10899710|FG001|COMPLETED|Overall Study||33
9791899|NCT00562627|10899711|FG002|COMPLETED|Overall Study||33
9791900|NCT00562627|10899709|FG000|NOT COMPLETED|Overall Study||1
9791901|NCT00562627|10899710|FG001|NOT COMPLETED|Overall Study||1
9791902|NCT00562627|10899711|FG002|NOT COMPLETED|Overall Study||1
9791903|NCT00562718|10899719|FG000|STARTED|Overall Study||50
9791904|NCT00562718|10899719|FG000|COMPLETED|Overall Study||39
9791905|NCT00562718|10899719|FG000|NOT COMPLETED|Overall Study||11
9791906|NCT00562861|10899725|FG000|STARTED|Overall Study||60
9791907|NCT00562861|10899726|FG001|STARTED|Overall Study||59
9791908|NCT00562861|10899725|FG000|COMPLETED|Overall Study||40
9791909|NCT00562861|10899726|FG001|COMPLETED|Overall Study||48
9791910|NCT00562861|10899725|FG000|NOT COMPLETED|Overall Study||20
9791911|NCT00562861|10899726|FG001|NOT COMPLETED|Overall Study||11
9791912|NCT00562965|10899734|FG000|STARTED|Overall Study||15
9791913|NCT00562965|10899735|FG001|STARTED|Overall Study||14
9791914|NCT00562965|10899734|FG000|Treated|Overall Study||15
9791915|NCT00562965|10899735|FG001|Treated|Overall Study||13
9791916|NCT00562965|10899734|FG000|COMPLETED|Overall Study||12
9791917|NCT00562965|10899735|FG001|COMPLETED|Overall Study||8
9791918|NCT00562965|10899734|FG000|NOT COMPLETED|Overall Study||3
9791919|NCT00562965|10899735|FG001|NOT COMPLETED|Overall Study||6
9791920|NCT00562978|10899743|FG000|STARTED|Overall Study||6
9791921|NCT00562978|10899744|FG001|STARTED|Overall Study||48
9791922|NCT00562978|10899743|FG000|COMPLETED|Overall Study||5
9791923|NCT00562978|10899744|FG001|COMPLETED|Overall Study||37
9791924|NCT00562978|10899743|FG000|NOT COMPLETED|Overall Study||1
9791925|NCT00562978|10899744|FG001|NOT COMPLETED|Overall Study||11
9791926|NCT00563186|10899752|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
9791927|NCT00563186|10899753|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
9791928|NCT00563186|10899752|FG000|COMPLETED|Overall Study||910
9791929|NCT00563186|10899753|FG001|COMPLETED|Overall Study||604
9791930|NCT00563186|10899752|FG000|NOT COMPLETED|Overall Study||98
9791931|NCT00563186|10899753|FG001|NOT COMPLETED|Overall Study||75
9791932|NCT00563290|10899764|FG000|STARTED|Overall Study||3
9791933|NCT00563290|10899765|FG001|STARTED|Overall Study||4
9791934|NCT00563290|10899764|FG000|COMPLETED|Overall Study||3
9791935|NCT00563290|10899765|FG001|COMPLETED|Overall Study||4
9791936|NCT00563290|10899764|FG000|NOT COMPLETED|Overall Study||0
9791937|NCT00563290|10899765|FG001|NOT COMPLETED|Overall Study||0
9791938|NCT00563316|10899773|FG000|STARTED|Overall Study||28
9791939|NCT00563316|10899773|FG000|Received Investigational Product|Overall Study||27
9791940|NCT00563316|10899773|FG000|COMPLETED|Overall Study||16
9791941|NCT00563316|10899773|FG000|NOT COMPLETED|Overall Study||12
9791942|NCT00563368|10899788|FG000|STARTED|Overall Study||109
9791943|NCT00563368|10899789|FG001|STARTED|Overall Study||109
9791944|NCT00563368|10899790|FG002|STARTED|Overall Study||108
9791945|NCT00563368|10899791|FG003|STARTED|Overall Study||107
9791946|NCT00563368|10899792|FG004|STARTED|Overall Study||108
9791947|NCT00563368|10899793|FG005|STARTED|Overall Study||107
9791948|NCT00563368|10899794|FG006|STARTED|Overall Study||108
9791949|NCT00563368|10899788|FG000|COMPLETED|Overall Study||74
9791950|NCT00563368|10899789|FG001|COMPLETED|Overall Study||79
9791951|NCT00563368|10899790|FG002|COMPLETED|Overall Study||78
9791952|NCT00563368|10899791|FG003|COMPLETED|Overall Study||78
9791953|NCT00563368|10899792|FG004|COMPLETED|Overall Study||80
9791954|NCT00563368|10899793|FG005|COMPLETED|Overall Study||77
9791955|NCT00563368|10899794|FG006|COMPLETED|Overall Study||75
9791956|NCT00563368|10899788|FG000|NOT COMPLETED|Overall Study||35
9791957|NCT00563368|10899789|FG001|NOT COMPLETED|Overall Study||30
9791958|NCT00563368|10899790|FG002|NOT COMPLETED|Overall Study||30
9791959|NCT00563368|10899791|FG003|NOT COMPLETED|Overall Study||29
9791960|NCT00563368|10899792|FG004|NOT COMPLETED|Overall Study||28
9791961|NCT00563368|10899793|FG005|NOT COMPLETED|Overall Study||30
9791962|NCT00563368|10899794|FG006|NOT COMPLETED|Overall Study||33
9791963|NCT00563381|10899812|FG000|STARTED|Overall Study|Started treatment|3707
9791964|NCT00563381|10899813|FG001|STARTED|Overall Study|Started treatment|3669
9791965|NCT00563381|10899812|FG000|COMPLETED|Overall Study|Completed treatment|3122
9791966|NCT00563381|10899813|FG001|COMPLETED|Overall Study|Completed treatment|3021
9791967|NCT00563381|10899812|FG000|NOT COMPLETED|Overall Study||585
9791968|NCT00563381|10899813|FG001|NOT COMPLETED|Overall Study||648
9791969|NCT00563706|10899828|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
9791970|NCT00563706|10899829|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
9791971|NCT00563706|10899830|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
9791972|NCT00563706|10899831|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
9791973|NCT00563706|10899832|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
9791974|NCT00563706|10899833|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
9791975|NCT00563706|10899834|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
9791976|NCT00563706|10899835|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
9791977|NCT00563706|10899836|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
9791978|NCT00563706|10899828|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
9791979|NCT00563706|10899829|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
9791980|NCT00563706|10899830|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
9791981|NCT00563706|10899831|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
9791982|NCT00563706|10899832|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
9791983|NCT00563706|10899833|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
9791984|NCT00563706|10899834|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
9791985|NCT00563706|10899835|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
9791986|NCT00563706|10899836|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
9791987|NCT00563706|10899828|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
9791988|NCT00563706|10899829|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
9791989|NCT00563706|10899830|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
9791990|NCT00563706|10899831|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
9791991|NCT00563706|10899832|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
9791992|NCT00563706|10899833|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
9791993|NCT00563706|10899834|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
9791994|NCT00563706|10899835|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
9791995|NCT00563706|10899836|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
9791996|NCT00563706|10899828|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20
9791997|NCT00563706|10899829|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13
9791998|NCT00563706|10899830|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3
10015524|NCT01806662|11138583|FG001|STARTED|Second Intervention (Weeks 16-32)||15
10015525|NCT01806662|11138582|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10
10015526|NCT01806662|11138583|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11
10015527|NCT01806662|11138582|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
10015528|NCT01806662|11138583|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
10015529|NCT01806675|11138592|FG000|STARTED|Overall Study||11
10015530|NCT01806675|11138593|FG001|STARTED|Overall Study||6
10015531|NCT01806675|11138594|FG002|STARTED|Overall Study||8
10015532|NCT01806675|11138592|FG000|COMPLETED|Overall Study||11
9791999|NCT00563706|10899831|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9
9792000|NCT00563706|10899832|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11
9792001|NCT00563706|10899833|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14
9792002|NCT00563706|10899834|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9
9792003|NCT00563706|10899835|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16
9792004|NCT00563706|10899836|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32
9792005|NCT00563706|10899828|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
9792006|NCT00563706|10899829|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
9792007|NCT00563706|10899830|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
9792008|NCT00563706|10899831|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
9792009|NCT00563706|10899832|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
9792010|NCT00563706|10899833|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
9792011|NCT00563706|10899834|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
9792012|NCT00563706|10899835|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
9792013|NCT00563706|10899836|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
9792014|NCT00563706|10899828|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9792015|NCT00563706|10899829|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9792016|NCT00563706|10899830|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10015533|NCT01806675|11138593|FG001|COMPLETED|Overall Study||6
10015534|NCT01806675|11138594|FG002|COMPLETED|Overall Study||8
9792017|NCT00563706|10899831|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10015535|NCT01806675|11138592|FG000|NOT COMPLETED|Overall Study||0
9792018|NCT00563706|10899832|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9792019|NCT00563706|10899833|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9792020|NCT00563706|10899834|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9792021|NCT00563706|10899835|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9792022|NCT00563706|10899836|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9792023|NCT00563784|10899856|FG000|STARTED|Overall Study||68
9792024|NCT00563784|10899856|FG000|COMPLETED|Overall Study||46
9792025|NCT00563784|10899856|FG000|NOT COMPLETED|Overall Study||22
9792026|NCT00563797|10899862|FG000|STARTED|Overall Study||11
9792027|NCT00563797|10899863|FG001|STARTED|Overall Study||10
9792028|NCT00563797|10899862|FG000|Received Allocated Intervention|Overall Study||11
9792029|NCT00563797|10899863|FG001|Received Allocated Intervention|Overall Study||10
9792030|NCT00563797|10899862|FG000|Follow-Up|Overall Study||11
9792031|NCT00563797|10899863|FG001|Follow-Up|Overall Study||10
9792032|NCT00563797|10899862|FG000|COMPLETED|Overall Study||4
9792033|NCT00563797|10899863|FG001|COMPLETED|Overall Study||8
9792034|NCT00563797|10899862|FG000|NOT COMPLETED|Overall Study||7
9792035|NCT00563797|10899863|FG001|NOT COMPLETED|Overall Study||2
9792036|NCT00564018|10899874|FG000|STARTED|Overall Study||11
9792037|NCT00564018|10899875|FG001|STARTED|Overall Study||10
9792038|NCT00564018|10899876|FG002|STARTED|Overall Study||12
9792039|NCT00564018|10899874|FG000|COMPLETED|Overall Study||9
9792040|NCT00564018|10899875|FG001|COMPLETED|Overall Study||7
9792041|NCT00564018|10899876|FG002|COMPLETED|Overall Study||11
9792042|NCT00564018|10899874|FG000|NOT COMPLETED|Overall Study||2
9792043|NCT00564018|10899875|FG001|NOT COMPLETED|Overall Study||3
9792044|NCT00564018|10899876|FG002|NOT COMPLETED|Overall Study||1
9792045|NCT00564070|10899886|FG000|STARTED|Overall Study||42
9792046|NCT00564070|10899887|FG001|STARTED|Overall Study||45
9792047|NCT00564070|10899886|FG000|COMPLETED|Overall Study||30
9792048|NCT00564070|10899887|FG001|COMPLETED|Overall Study||38
9792049|NCT00564070|10899886|FG000|NOT COMPLETED|Overall Study||12
9792050|NCT00564070|10899887|FG001|NOT COMPLETED|Overall Study||7
9792051|NCT00564265|10899893|FG000|STARTED|Overall Study||24
9792052|NCT00564265|10899893|FG000|COMPLETED|Overall Study||24
9792053|NCT00564265|10899893|FG000|NOT COMPLETED|Overall Study||0
9792054|NCT00564278|10899899|FG000|STARTED|Overall Study||97
9792055|NCT00564278|10899900|FG001|STARTED|Overall Study||98
9792056|NCT00564278|10899899|FG000|COMPLETED|Overall Study||50
9792057|NCT00564278|10899900|FG001|COMPLETED|Overall Study||56
9792058|NCT00564278|10899899|FG000|NOT COMPLETED|Overall Study||47
9792059|NCT00564278|10899900|FG001|NOT COMPLETED|Overall Study||42
9792060|NCT00564395|10899906|FG000|STARTED|First Intervention (10 Days)||9
9792061|NCT00564395|10899907|FG001|STARTED|First Intervention (10 Days)||9
9792062|NCT00564395|10899906|FG000|Received Intervention|First Intervention (10 Days)||7
9792063|NCT00564395|10899907|FG001|Received Intervention|First Intervention (10 Days)||7
9792064|NCT00564395|10899906|FG000|COMPLETED|First Intervention (10 Days)||7
9792065|NCT00564395|10899907|FG001|COMPLETED|First Intervention (10 Days)||7
9792066|NCT00564395|10899906|FG000|NOT COMPLETED|First Intervention (10 Days)||2
9792067|NCT00564395|10899907|FG001|NOT COMPLETED|First Intervention (10 Days)||2
9792068|NCT00564395|10899906|FG000|STARTED|Second Intervention (10 Days)||7
9792069|NCT00564395|10899907|FG001|STARTED|Second Intervention (10 Days)||7
9792070|NCT00564395|10899906|FG000|COMPLETED|Second Intervention (10 Days)||7
9792071|NCT00564395|10899907|FG001|COMPLETED|Second Intervention (10 Days)||7
9792072|NCT00564395|10899906|FG000|NOT COMPLETED|Second Intervention (10 Days)||0
9792073|NCT00564395|10899907|FG001|NOT COMPLETED|Second Intervention (10 Days)||0
9792074|NCT00564447|10899921|FG000|STARTED|Overall Study||6
9792075|NCT00564447|10899922|FG001|STARTED|Overall Study||6
9792076|NCT00564447|10899923|FG002|STARTED|Overall Study||6
9792077|NCT00564447|10899924|FG003|STARTED|Overall Study||6
9792078|NCT00564447|10899925|FG004|STARTED|Overall Study||6
9792079|NCT00564447|10899926|FG005|STARTED|Overall Study||6
9792080|NCT00564447|10899927|FG006|STARTED|Overall Study||6
9792081|NCT00564447|10899928|FG007|STARTED|Overall Study||6
9792082|NCT00564447|10899921|FG000|COMPLETED|Overall Study||6
9792083|NCT00564447|10899922|FG001|COMPLETED|Overall Study||6
9792084|NCT00564447|10899923|FG002|COMPLETED|Overall Study||6
9792085|NCT00564447|10899924|FG003|COMPLETED|Overall Study||6
9792086|NCT00564447|10899925|FG004|COMPLETED|Overall Study||6
9792087|NCT00564447|10899926|FG005|COMPLETED|Overall Study||6
9792088|NCT00564447|10899927|FG006|COMPLETED|Overall Study||6
9792089|NCT00564447|10899928|FG007|COMPLETED|Overall Study||6
10015536|NCT01806675|11138593|FG001|NOT COMPLETED|Overall Study||0
9792090|NCT00564447|10899921|FG000|NOT COMPLETED|Overall Study||0
9792091|NCT00564447|10899922|FG001|NOT COMPLETED|Overall Study||0
10015537|NCT01806675|11138594|FG002|NOT COMPLETED|Overall Study||0
9792092|NCT00564447|10899923|FG002|NOT COMPLETED|Overall Study||0
9792093|NCT00564447|10899924|FG003|NOT COMPLETED|Overall Study||0
9792094|NCT00564447|10899925|FG004|NOT COMPLETED|Overall Study||0
9792095|NCT00564447|10899926|FG005|NOT COMPLETED|Overall Study||0
9792096|NCT00564447|10899927|FG006|NOT COMPLETED|Overall Study||0
9792097|NCT00564447|10899928|FG007|NOT COMPLETED|Overall Study||0
9792098|NCT00564486|10899949|FG000|STARTED|Overall Study||43
9830727|NCT00765128|10941507|FG001|NOT COMPLETED|Overall Study||0
9952473|NCT01422369|11071453|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
9952474|NCT01422382|11071458|FG000|STARTED|NK-104 4mg Once Daily (QD)||28
9952475|NCT01422382|11071458|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28
9952476|NCT01422382|11071458|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
9952477|NCT01422382|11071458|FG000|STARTED|Diltiazem 240 mg QD||28
9952478|NCT01422382|11071458|FG000|COMPLETED|Diltiazem 240 mg QD||28
9952479|NCT01422382|11071458|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0
9952480|NCT01422382|11071458|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
9952481|NCT01422382|11071458|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
9952482|NCT01422382|11071458|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
9952483|NCT01422408|11071462|FG000|STARTED|Overall Study||34
9952484|NCT01422408|11071462|FG000|COMPLETED|Overall Study||30
9792099|NCT00564486|10899950|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
9792100|NCT00564486|10899951|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
9792101|NCT00564486|10899952|FG003|STARTED|Overall Study||67
9792102|NCT00564486|10899949|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
9792103|NCT00564486|10899950|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
9792104|NCT00564486|10899951|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
9792105|NCT00564486|10899952|FG003|COMPLETED|Overall Study||60
9792106|NCT00564486|10899949|FG000|NOT COMPLETED|Overall Study||7
9792107|NCT00564486|10899950|FG001|NOT COMPLETED|Overall Study||1
9792108|NCT00564486|10899951|FG002|NOT COMPLETED|Overall Study||3
9792109|NCT00564486|10899952|FG003|NOT COMPLETED|Overall Study||7
9792110|NCT00564629|10899968|FG000|STARTED|Overall Study||51
9792111|NCT00564629|10899969|FG001|STARTED|Overall Study||54
9792112|NCT00564629|10899968|FG000|COMPLETED|Overall Study||36
9792113|NCT00564629|10899969|FG001|COMPLETED|Overall Study||45
9792114|NCT00564629|10899968|FG000|NOT COMPLETED|Overall Study||15
9792115|NCT00564629|10899969|FG001|NOT COMPLETED|Overall Study||9
9792116|NCT00564681|10899979|FG000|STARTED|Overall Study||117
9792117|NCT00564681|10899980|FG001|STARTED|Overall Study||61
9792118|NCT00564681|10899981|FG002|STARTED|Overall Study||43
9792119|NCT00564681|10899982|FG003|STARTED|Overall Study||21
9792120|NCT00564681|10899979|FG000|COMPLETED|Overall Study||106
9792121|NCT00564681|10899980|FG001|COMPLETED|Overall Study||58
9792122|NCT00564681|10899981|FG002|COMPLETED|Overall Study||40
9792123|NCT00564681|10899982|FG003|COMPLETED|Overall Study||19
9792124|NCT00564681|10899979|FG000|NOT COMPLETED|Overall Study||11
9792125|NCT00564681|10899980|FG001|NOT COMPLETED|Overall Study||3
9792126|NCT00564681|10899981|FG002|NOT COMPLETED|Overall Study||3
9792127|NCT00564681|10899982|FG003|NOT COMPLETED|Overall Study||2
10015538|NCT01806688|11138604|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
10015539|NCT01806688|11138605|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
10015540|NCT01806688|11138604|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
10015541|NCT01806688|11138605|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
10015542|NCT01806688|11138604|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
10015543|NCT01806688|11138605|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
10015544|NCT01806688|11138604|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
10015545|NCT01806688|11138605|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
10015546|NCT01806688|11138604|FG000|COMPLETED|First Intervention Seed Study||38
10015547|NCT01806688|11138605|FG001|COMPLETED|First Intervention Seed Study||0
10015548|NCT01806688|11138604|FG000|NOT COMPLETED|First Intervention Seed Study||0
10015549|NCT01806688|11138605|FG001|NOT COMPLETED|First Intervention Seed Study||0
10015550|NCT01806688|11138604|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38
10015551|NCT01806688|11138605|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0
9792128|NCT00564733|10899991|FG000|STARTED|Overall Study||55
9792129|NCT00564733|10899991|FG000|COMPLETED|Overall Study||46
9792130|NCT00564733|10899991|FG000|NOT COMPLETED|Overall Study||9
9792131|NCT00564850|10899995|FG000|STARTED|Overall Study||37
9792132|NCT00564850|10899995|FG000|COMPLETED|Overall Study||35
9952485|NCT01422408|11071462|FG000|NOT COMPLETED|Overall Study||4
9952486|NCT01422434|11071469|FG000|STARTED|Overall Study||227
9952487|NCT01422434|11071470|FG001|STARTED|Overall Study||226
9952488|NCT01422434|11071471|FG002|STARTED|Overall Study||223
9792133|NCT00564850|10899995|FG000|NOT COMPLETED|Overall Study||2
9792134|NCT00564889|10899999|FG000|STARTED|Overall Study||35
9792135|NCT00564889|10899999|FG000|COMPLETED|Overall Study||6
9792136|NCT00564889|10899999|FG000|NOT COMPLETED|Overall Study||29
9792137|NCT00564902|10900006|FG000|STARTED|Overall Study||10
9792138|NCT00564902|10900007|FG001|STARTED|Overall Study||25
9792139|NCT00564902|10900008|FG002|STARTED|Overall Study||25
9792140|NCT00564902|10900006|FG000|4 Months|Overall Study||9
9792141|NCT00564902|10900007|FG001|4 Months|Overall Study||24
9792142|NCT00564902|10900008|FG002|4 Months|Overall Study||23
9792143|NCT00564902|10900006|FG000|8 Months|Overall Study||9
9792144|NCT00564902|10900007|FG001|8 Months|Overall Study||22
9792145|NCT00564902|10900008|FG002|8 Months|Overall Study||21
9792146|NCT00564902|10900006|FG000|12 Months|Overall Study||9
9792147|NCT00564902|10900007|FG001|12 Months|Overall Study||21
9792148|NCT00564902|10900008|FG002|12 Months|Overall Study||21
9792149|NCT00564902|10900006|FG000|COMPLETED|Overall Study||9
9792150|NCT00564902|10900007|FG001|COMPLETED|Overall Study||21
9792151|NCT00564902|10900008|FG002|COMPLETED|Overall Study||21
9792152|NCT00564902|10900006|FG000|NOT COMPLETED|Overall Study||1
9792153|NCT00564902|10900007|FG001|NOT COMPLETED|Overall Study||4
9792154|NCT00564902|10900008|FG002|NOT COMPLETED|Overall Study||4
9792155|NCT00564954|10900018|FG000|STARTED|Period 1- 1 Week||44
9792156|NCT00564954|10900019|FG001|STARTED|Period 1- 1 Week||42
9792157|NCT00564954|10900018|FG000|COMPLETED|Period 1- 1 Week||44
9792158|NCT00564954|10900019|FG001|COMPLETED|Period 1- 1 Week||42
9792159|NCT00564954|10900018|FG000|NOT COMPLETED|Period 1- 1 Week||0
9792160|NCT00564954|10900019|FG001|NOT COMPLETED|Period 1- 1 Week||0
9792161|NCT00564954|10900018|FG000|STARTED|Period 2- 1 Week||44
9792162|NCT00564954|10900019|FG001|STARTED|Period 2- 1 Week||42
9792163|NCT00564954|10900018|FG000|COMPLETED|Period 2- 1 Week||44
9792164|NCT00564954|10900019|FG001|COMPLETED|Period 2- 1 Week||42
9792165|NCT00564954|10900018|FG000|NOT COMPLETED|Period 2- 1 Week||0
9792166|NCT00564954|10900019|FG001|NOT COMPLETED|Period 2- 1 Week||0
9792167|NCT00565045|10900027|FG000|STARTED|Overall Study||10
9792168|NCT00565045|10900028|FG001|STARTED|Overall Study||11
9792169|NCT00565045|10900027|FG000|COMPLETED|Overall Study||9
9792170|NCT00565045|10900028|FG001|COMPLETED|Overall Study||8
9792171|NCT00565045|10900027|FG000|NOT COMPLETED|Overall Study||1
9792172|NCT00565045|10900028|FG001|NOT COMPLETED|Overall Study||3
9792173|NCT00565058|10900036|FG000|STARTED|Overall Study||10
9792174|NCT00565058|10900037|FG001|STARTED|Overall Study||15
9792175|NCT00565058|10900036|FG000|COMPLETED|Overall Study||9
9792176|NCT00565058|10900037|FG001|COMPLETED|Overall Study||15
9792177|NCT00565058|10900036|FG000|NOT COMPLETED|Overall Study||1
9792178|NCT00565058|10900037|FG001|NOT COMPLETED|Overall Study||0
9792179|NCT00565084|10900043|FG000|STARTED|First Treatment Period||11
9792180|NCT00565084|10900044|FG001|STARTED|First Treatment Period||11
9792181|NCT00565084|10900045|FG002|STARTED|First Treatment Period||11
9792182|NCT00565084|10900043|FG000|COMPLETED|First Treatment Period||11
9792183|NCT00565084|10900044|FG001|COMPLETED|First Treatment Period||11
9792184|NCT00565084|10900045|FG002|COMPLETED|First Treatment Period||11
9792185|NCT00565084|10900043|FG000|NOT COMPLETED|First Treatment Period||0
9792186|NCT00565084|10900044|FG001|NOT COMPLETED|First Treatment Period||0
9792187|NCT00565084|10900045|FG002|NOT COMPLETED|First Treatment Period||0
9792188|NCT00565084|10900043|FG000|STARTED|Second Treatment Period||11
9792189|NCT00565084|10900044|FG001|STARTED|Second Treatment Period||11
9792190|NCT00565084|10900045|FG002|STARTED|Second Treatment Period||11
9792191|NCT00565084|10900043|FG000|COMPLETED|Second Treatment Period||11
9792192|NCT00565084|10900044|FG001|COMPLETED|Second Treatment Period||11
9792193|NCT00565084|10900045|FG002|COMPLETED|Second Treatment Period||11
9792194|NCT00565084|10900043|FG000|NOT COMPLETED|Second Treatment Period||0
9792195|NCT00565084|10900044|FG001|NOT COMPLETED|Second Treatment Period||0
9792196|NCT00565084|10900045|FG002|NOT COMPLETED|Second Treatment Period||0
9792197|NCT00565084|10900043|FG000|STARTED|Third Treatment Period||11
9792198|NCT00565084|10900044|FG001|STARTED|Third Treatment Period||11
9792199|NCT00565084|10900045|FG002|STARTED|Third Treatment Period||11
9792200|NCT00565084|10900043|FG000|COMPLETED|Third Treatment Period||11
9792201|NCT00565084|10900044|FG001|COMPLETED|Third Treatment Period||11
9792202|NCT00565084|10900045|FG002|COMPLETED|Third Treatment Period||11
10015552|NCT01806688|11138604|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
10015553|NCT01806688|11138605|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
10019104|NCT01827592|11142212|FG000|COMPLETED|Overall Study||52
10019105|NCT01827592|11142213|FG001|COMPLETED|Overall Study||46
9792203|NCT00565084|10900043|FG000|NOT COMPLETED|Third Treatment Period||0
9792204|NCT00565084|10900044|FG001|NOT COMPLETED|Third Treatment Period||0
9792205|NCT00565084|10900045|FG002|NOT COMPLETED|Third Treatment Period||0
9792206|NCT00565110|10900055|FG000|STARTED|Overall Study||230
9792207|NCT00565110|10900056|FG001|STARTED|Overall Study||242
9792208|NCT00565110|10900055|FG000|12-Month|Overall Study||114
9792209|NCT00565110|10900056|FG001|12-Month|Overall Study||144
9792210|NCT00565110|10900055|FG000|COMPLETED|Overall Study||99
9792211|NCT00565110|10900056|FG001|COMPLETED|Overall Study||111
9792212|NCT00565110|10900055|FG000|NOT COMPLETED|Overall Study||131
9792213|NCT00565110|10900056|FG001|NOT COMPLETED|Overall Study||131
9792214|NCT00565136|10900062|FG000|STARTED|Overall Study||29
9792215|NCT00565136|10900062|FG000|COMPLETED|Overall Study||26
9792216|NCT00565136|10900062|FG000|NOT COMPLETED|Overall Study||3
9792217|NCT00565266|10900066|FG000|STARTED|Overall Study||210
9792218|NCT00565266|10900066|FG000|COMPLETED|Overall Study||174
9792219|NCT00565266|10900066|FG000|NOT COMPLETED|Overall Study||36
9792220|NCT00565370|10900074|FG000|STARTED|Overall Study||21
9792221|NCT00565370|10900074|FG000|COMPLETED|Overall Study||21
9792222|NCT00565370|10900074|FG000|NOT COMPLETED|Overall Study||0
9792223|NCT00565409|10900078|FG000|STARTED|Period 1 Open Label||834
9792224|NCT00565409|10900079|FG001|STARTED|Period 1 Open Label||0
9792225|NCT00565409|10900080|FG002|STARTED|Period 1 Open Label||0
9792226|NCT00565409|10900081|FG003|STARTED|Period 1 Open Label||0
9792227|NCT00565409|10900078|FG000|COMPLETED|Period 1 Open Label||756
9792228|NCT00565409|10900079|FG001|COMPLETED|Period 1 Open Label||0
9792229|NCT00565409|10900080|FG002|COMPLETED|Period 1 Open Label||0
9792230|NCT00565409|10900081|FG003|COMPLETED|Period 1 Open Label||0
9792231|NCT00565409|10900078|FG000|NOT COMPLETED|Period 1 Open Label||78
9792232|NCT00565409|10900079|FG001|NOT COMPLETED|Period 1 Open Label||0
9792233|NCT00565409|10900080|FG002|NOT COMPLETED|Period 1 Open Label||0
9792234|NCT00565409|10900081|FG003|NOT COMPLETED|Period 1 Open Label||0
9792235|NCT00565409|10900078|FG000|STARTED|After Period 1, Prior to Period 2||756
9792236|NCT00565409|10900079|FG001|STARTED|After Period 1, Prior to Period 2||0
9792237|NCT00565409|10900080|FG002|STARTED|After Period 1, Prior to Period 2||0
9792238|NCT00565409|10900081|FG003|STARTED|After Period 1, Prior to Period 2||0
9792239|NCT00565409|10900078|FG000|COMPLETED|After Period 1, Prior to Period 2||604
9792240|NCT00565409|10900079|FG001|COMPLETED|After Period 1, Prior to Period 2||0
9792241|NCT00565409|10900080|FG002|COMPLETED|After Period 1, Prior to Period 2||0
9792242|NCT00565409|10900081|FG003|COMPLETED|After Period 1, Prior to Period 2||0
9792243|NCT00565409|10900078|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152
9792244|NCT00565409|10900079|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
9792245|NCT00565409|10900080|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0
9792246|NCT00565409|10900081|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
9792247|NCT00565409|10900078|FG000|STARTED|Period 2 Double-Blind||0
9792248|NCT00565409|10900079|FG001|STARTED|Period 2 Double-Blind||202
9792249|NCT00565409|10900080|FG002|STARTED|Period 2 Double-Blind||202
9792250|NCT00565409|10900081|FG003|STARTED|Period 2 Double-Blind||200
9792251|NCT00565409|10900078|FG000|COMPLETED|Period 2 Double-Blind||0
9792252|NCT00565409|10900079|FG001|COMPLETED|Period 2 Double-Blind||181
9792253|NCT00565409|10900080|FG002|COMPLETED|Period 2 Double-Blind||175
9792254|NCT00565409|10900081|FG003|COMPLETED|Period 2 Double-Blind||141
9792255|NCT00565409|10900078|FG000|NOT COMPLETED|Period 2 Double-Blind||0
9792256|NCT00565409|10900079|FG001|NOT COMPLETED|Period 2 Double-Blind||21
9792257|NCT00565409|10900080|FG002|NOT COMPLETED|Period 2 Double-Blind||27
9792258|NCT00565409|10900081|FG003|NOT COMPLETED|Period 2 Double-Blind||59
9792259|NCT00565448|10900093|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
10015554|NCT01806688|11138604|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
10015555|NCT01806688|11138605|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
10015556|NCT01806688|11138604|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
10015557|NCT01806688|11138605|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
10015558|NCT01806688|11138604|FG000|COMPLETED|Second Intervention Seed Study||38
10015559|NCT01806688|11138605|FG001|COMPLETED|Second Intervention Seed Study||0
10015560|NCT01806688|11138604|FG000|NOT COMPLETED|Second Intervention Seed Study||0
10015561|NCT01806688|11138605|FG001|NOT COMPLETED|Second Intervention Seed Study||0
10019106|NCT01827592|11142214|FG002|COMPLETED|Overall Study||48
10019107|NCT01827592|11142212|FG000|NOT COMPLETED|Overall Study||74
10019108|NCT01827592|11142213|FG001|NOT COMPLETED|Overall Study||80
10019109|NCT01827592|11142214|FG002|NOT COMPLETED|Overall Study||76
10019110|NCT01827670|11142224|FG000|STARTED|Overall Study||60
10235204|NCT01237613|11365437|FG000|NOT COMPLETED|Overall Study||0
10235205|NCT01234103|11365444|FG000|STARTED|Overall Study||542
9792260|NCT00565448|10900094|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
9792261|NCT00565448|10900093|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47
9792262|NCT00565448|10900094|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23
9792263|NCT00565448|10900093|FG000|NOT COMPLETED|Overall Study||3
9792264|NCT00565448|10900094|FG001|NOT COMPLETED|Overall Study||2
9792265|NCT00565604|10900103|FG000|STARTED|Overall Study||43
9792266|NCT00565604|10900103|FG000|7 Day|Overall Study||41
9792267|NCT00565604|10900103|FG000|2 Week|Overall Study||41
10235206|NCT01234103|11365445|FG001|STARTED|Overall Study||391
10235207|NCT01234103|11365444|FG000|COMPLETED|Overall Study||542
10235208|NCT01234103|11365445|FG001|COMPLETED|Overall Study||391
10235209|NCT01234103|11365444|FG000|NOT COMPLETED|Overall Study||0
10235210|NCT01234103|11365445|FG001|NOT COMPLETED|Overall Study||0
10235211|NCT01231750|11365453|FG000|STARTED|Overall Study||3
10235212|NCT01231750|11365454|FG001|STARTED|Overall Study||4
10235213|NCT01231750|11365453|FG000|COMPLETED|Overall Study||3
10235214|NCT01231750|11365454|FG001|COMPLETED|Overall Study||4
9792268|NCT00565604|10900103|FG000|6 Week|Overall Study||39
9792269|NCT00565604|10900103|FG000|6 Month|Overall Study||39
9792270|NCT00565604|10900103|FG000|COMPLETED|Overall Study||39
10235215|NCT01231750|11365453|FG000|NOT COMPLETED|Overall Study||0
9792271|NCT00565604|10900103|FG000|NOT COMPLETED|Overall Study||4
9792272|NCT00565643|10900109|FG000|STARTED|Overall Study||380
9792273|NCT00565643|10900110|FG001|STARTED|Overall Study||373
9792274|NCT00565643|10900109|FG000|Safety Data|Overall Study||380
9792275|NCT00565643|10900110|FG001|Safety Data|Overall Study||373
9792276|NCT00565643|10900109|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80
9792277|NCT00565643|10900110|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92
9792278|NCT00565643|10900109|FG000|COMPLETED|Overall Study||380
9792279|NCT00565643|10900110|FG001|COMPLETED|Overall Study||373
9792280|NCT00565643|10900109|FG000|NOT COMPLETED|Overall Study||0
9792281|NCT00565643|10900110|FG001|NOT COMPLETED|Overall Study||0
9792282|NCT00565669|10900119|FG000|STARTED|Overall Study||11
9792283|NCT00565669|10900120|FG001|STARTED|Overall Study||9
9792284|NCT00565669|10900119|FG000|COMPLETED|Overall Study||11
9792285|NCT00565669|10900120|FG001|COMPLETED|Overall Study||9
9792286|NCT00565669|10900119|FG000|NOT COMPLETED|Overall Study||0
9792287|NCT00565669|10900120|FG001|NOT COMPLETED|Overall Study||0
9792288|NCT00565721|10900126|FG000|STARTED|Overall Study||33
9792289|NCT00565721|10900126|FG000|COMPLETED|Overall Study||16
9792290|NCT00565721|10900126|FG000|NOT COMPLETED|Overall Study||17
9792291|NCT00565747|10900147|FG000|STARTED|Overall Study||654
9792292|NCT00565747|10900148|FG001|STARTED|Overall Study||678
9792293|NCT00565747|10900147|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587
9792294|NCT00565747|10900148|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605
9792295|NCT00565747|10900147|FG000|NOT COMPLETED|Overall Study||67
9792296|NCT00565747|10900148|FG001|NOT COMPLETED|Overall Study||73
9792297|NCT00565773|10900154|FG000|STARTED|Overall Study||40
9792298|NCT00565773|10900154|FG000|COMPLETED|Overall Study||38
9792299|NCT00565773|10900154|FG000|NOT COMPLETED|Overall Study||2
9792300|NCT00565812|10900161|FG000|STARTED|Overall Study||485
9792301|NCT00565812|10900162|FG001|STARTED|Overall Study||486
9792302|NCT00565812|10900163|FG002|STARTED|Overall Study||486
9792303|NCT00565812|10900161|FG000|COMPLETED|Overall Study||341
9792304|NCT00565812|10900162|FG001|COMPLETED|Overall Study||351
9792305|NCT00565812|10900163|FG002|COMPLETED|Overall Study||356
9792306|NCT00565812|10900161|FG000|NOT COMPLETED|Overall Study||144
9792307|NCT00565812|10900162|FG001|NOT COMPLETED|Overall Study||135
9792308|NCT00565812|10900163|FG002|NOT COMPLETED|Overall Study||130
9792309|NCT00565864|10900174|FG000|STARTED|Overall Study||58
9792310|NCT00565864|10900175|FG001|STARTED|Overall Study||59
9792311|NCT00565864|10900176|FG002|STARTED|Overall Study||56
9792312|NCT00565864|10900174|FG000|COMPLETED|Overall Study||46
9792313|NCT00565864|10900175|FG001|COMPLETED|Overall Study||47
9792314|NCT00565864|10900176|FG002|COMPLETED|Overall Study||45
9792315|NCT00565864|10900174|FG000|NOT COMPLETED|Overall Study||12
9792316|NCT00565864|10900175|FG001|NOT COMPLETED|Overall Study||12
9792317|NCT00565864|10900176|FG002|NOT COMPLETED|Overall Study||11
9792318|NCT00565916|10900188|FG000|STARTED|Overall Study||11
9792319|NCT00565916|10900189|FG001|STARTED|Overall Study||11
9792320|NCT00565916|10900188|FG000|COMPLETED|Overall Study||11
9792321|NCT00565916|10900189|FG001|COMPLETED|Overall Study||11
9792322|NCT00565916|10900188|FG000|NOT COMPLETED|Overall Study||0
9792323|NCT00565916|10900189|FG001|NOT COMPLETED|Overall Study||0
9792324|NCT00566020|10900195|FG000|STARTED|6-week Dosage Adjustment Phase||92
10235216|NCT01231750|11365454|FG001|NOT COMPLETED|Overall Study||0
10235217|NCT01230307|11365462|FG000|STARTED|Overall Study||6
10235218|NCT01230307|11365463|FG001|STARTED|Overall Study||6
10235219|NCT01230307|11365462|FG000|COMPLETED|Overall Study||6
10019111|NCT01827670|11142225|FG001|STARTED|Overall Study||59
10019112|NCT01827670|11142224|FG000|COMPLETED|Overall Study||57
10019113|NCT01827670|11142225|FG001|COMPLETED|Overall Study||56
10235220|NCT01230307|11365463|FG001|COMPLETED|Overall Study||4
10235221|NCT01230307|11365462|FG000|NOT COMPLETED|Overall Study||0
10235222|NCT01230307|11365463|FG001|NOT COMPLETED|Overall Study||2
9792325|NCT00566020|10900196|FG001|STARTED|6-week Dosage Adjustment Phase||0
9792326|NCT00566020|10900195|FG000|COMPLETED|6-week Dosage Adjustment Phase||85
9792327|NCT00566020|10900196|FG001|COMPLETED|6-week Dosage Adjustment Phase||0
9792328|NCT00566020|10900195|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7
9792329|NCT00566020|10900196|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0
9792330|NCT00566020|10900195|FG000|STARTED|46-week Long-term Administration Phase||0
9792331|NCT00566020|10900196|FG001|STARTED|46-week Long-term Administration Phase||85
9792332|NCT00566020|10900195|FG000|COMPLETED|46-week Long-term Administration Phase||0
9792333|NCT00566020|10900196|FG001|COMPLETED|46-week Long-term Administration Phase||68
9792334|NCT00566020|10900195|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0
10019114|NCT01827670|11142224|FG000|NOT COMPLETED|Overall Study||3
10235223|NCT01230489|11365469|FG000|STARTED|Overall Study||13
9792335|NCT00566020|10900196|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17
9792336|NCT00566098|10900201|FG000|STARTED|Collection of MILs||25
9792337|NCT00566098|10900201|FG000|COMPLETED|Collection of MILs||23
9792338|NCT00566098|10900201|FG000|NOT COMPLETED|Collection of MILs||2
9792339|NCT00566098|10900201|FG000|STARTED|Generation of MILs Product||23
9792340|NCT00566098|10900201|FG000|COMPLETED|Generation of MILs Product||22
9792341|NCT00566098|10900201|FG000|NOT COMPLETED|Generation of MILs Product||1
9792342|NCT00566098|10900201|FG000|STARTED|Administration of ASCT+MILs||22
9792343|NCT00566098|10900201|FG000|COMPLETED|Administration of ASCT+MILs||4
9792344|NCT00566098|10900201|FG000|NOT COMPLETED|Administration of ASCT+MILs||18
9792345|NCT00566111|10900208|FG000|STARTED|Overall Study||2
9792346|NCT00566111|10900209|FG001|STARTED|Overall Study||3
10235224|NCT01230489|11365469|FG000|COMPLETED|Overall Study||8
9792347|NCT00566111|10900208|FG000|COMPLETED|Overall Study||2
9792348|NCT00566111|10900209|FG001|COMPLETED|Overall Study||1
9792349|NCT00566111|10900208|FG000|NOT COMPLETED|Overall Study||0
9792350|NCT00566111|10900209|FG001|NOT COMPLETED|Overall Study||2
9792351|NCT00566150|10900217|FG000|STARTED|Overall Study||19
9792352|NCT00566150|10900218|FG001|STARTED|Overall Study||16
9792353|NCT00566150|10900217|FG000|COMPLETED|Overall Study||10
9792354|NCT00566150|10900218|FG001|COMPLETED|Overall Study||11
9792355|NCT00566150|10900217|FG000|NOT COMPLETED|Overall Study||9
9792356|NCT00566150|10900218|FG001|NOT COMPLETED|Overall Study||5
9792357|NCT00566228|10900226|FG000|STARTED|Overall Study||62
9792358|NCT00566228|10900227|FG001|STARTED|Overall Study||60
9792359|NCT00566228|10900226|FG000|COMPLETED|Overall Study||56
9792360|NCT00566228|10900227|FG001|COMPLETED|Overall Study||55
9792361|NCT00566228|10900226|FG000|NOT COMPLETED|Overall Study||6
9792362|NCT00566228|10900227|FG001|NOT COMPLETED|Overall Study||5
9792363|NCT00566254|10900235|FG000|STARTED|Overall Study||100
9792364|NCT00566254|10900236|FG001|STARTED|Overall Study||107
9792365|NCT00566254|10900235|FG000|COMPLETED|Overall Study||90
9792366|NCT00566254|10900236|FG001|COMPLETED|Overall Study||93
9792367|NCT00566254|10900235|FG000|NOT COMPLETED|Overall Study||10
9792368|NCT00566254|10900236|FG001|NOT COMPLETED|Overall Study||14
9792369|NCT00566501|10900244|FG000|STARTED|Overall Study||570
9792370|NCT00566501|10900245|FG001|STARTED|Overall Study||332
9792371|NCT00566501|10900244|FG000|COMPLETED|Overall Study||423
9792372|NCT00566501|10900245|FG001|COMPLETED|Overall Study||210
9792373|NCT00566501|10900244|FG000|NOT COMPLETED|Overall Study||147
9792374|NCT00566501|10900245|FG001|NOT COMPLETED|Overall Study||122
9792375|NCT00566527|10900254|FG000|STARTED|Overall Study|Number randomized.|541
9792376|NCT00566527|10900255|FG001|STARTED|Overall Study|Number randomized.|540
9792377|NCT00566527|10900256|FG002|STARTED|Overall Study|Number randomized.|539
9792378|NCT00566527|10900254|FG000|Received ProQuad® Dose 1|Overall Study||529
9792379|NCT00566527|10900255|FG001|Received ProQuad® Dose 1|Overall Study||484
9792380|NCT00566527|10900256|FG002|Received ProQuad® Dose 1|Overall Study||470
9792381|NCT00566527|10900254|FG000|Received ProQuad® Dose 2|Overall Study||525
9792382|NCT00566527|10900255|FG001|Received ProQuad® Dose 2|Overall Study||478
9792383|NCT00566527|10900256|FG002|Received ProQuad® Dose 2|Overall Study||462
9792384|NCT00566527|10900254|FG000|COMPLETED|Overall Study||524
9792385|NCT00566527|10900255|FG001|COMPLETED|Overall Study||474
9792386|NCT00566527|10900256|FG002|COMPLETED|Overall Study||461
9792387|NCT00566527|10900254|FG000|NOT COMPLETED|Overall Study||17
9792388|NCT00566527|10900255|FG001|NOT COMPLETED|Overall Study||66
9792389|NCT00566527|10900256|FG002|NOT COMPLETED|Overall Study||78
9792390|NCT00566540|10900266|FG000|STARTED|Overall Study||11
9792391|NCT00566540|10900266|FG000|COMPLETED|Overall Study||11
9792392|NCT00566540|10900266|FG000|NOT COMPLETED|Overall Study||0
9792393|NCT00566579|10900272|FG000|STARTED|Overall Study||29
9792394|NCT00566579|10900273|FG001|STARTED|Overall Study||31
9792395|NCT00566579|10900272|FG000|COMPLETED|Overall Study||29
9792396|NCT00566579|10900273|FG001|COMPLETED|Overall Study||31
9792397|NCT00566579|10900272|FG000|NOT COMPLETED|Overall Study||0
9792398|NCT00566579|10900273|FG001|NOT COMPLETED|Overall Study||0
9792399|NCT00566631|10900279|FG000|STARTED|Part 1: Core Treatment Phase||294
9792400|NCT00566631|10900279|FG000|COMPLETED|Part 1: Core Treatment Phase||234
9792401|NCT00566631|10900279|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60
9792402|NCT00566631|10900279|FG000|STARTED|Between Treatment and Extension Phase||234
9792403|NCT00566631|10900279|FG000|COMPLETED|Between Treatment and Extension Phase||139
9792404|NCT00566631|10900279|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95
9792405|NCT00566631|10900279|FG000|STARTED|Part 2: Extension Phase||139
9792406|NCT00566631|10900279|FG000|COMPLETED|Part 2: Extension Phase||57
9792407|NCT00566631|10900279|FG000|NOT COMPLETED|Part 2: Extension Phase||82
9792408|NCT00566696|10900283|FG000|STARTED|Overall Study||73
9792409|NCT00566696|10900283|FG000|COMPLETED|Overall Study||31
9792410|NCT00566696|10900283|FG000|NOT COMPLETED|Overall Study||42
9792411|NCT00566709|10900289|FG000|STARTED|Overall Study||51
9792412|NCT00566709|10900290|FG001|STARTED|Overall Study||51
9792413|NCT00566709|10900289|FG000|COMPLETED|Overall Study||46
9792414|NCT00566709|10900290|FG001|COMPLETED|Overall Study||51
9792415|NCT00566709|10900289|FG000|NOT COMPLETED|Overall Study||5
9792416|NCT00566709|10900290|FG001|NOT COMPLETED|Overall Study||0
9792417|NCT00566722|10900299|FG000|STARTED|Overall Study||41
9792418|NCT00566722|10900300|FG001|STARTED|Overall Study||29
9792419|NCT00566722|10900301|FG002|STARTED|Overall Study||82
9792420|NCT00566722|10900299|FG000|COMPLETED|Overall Study||39
9792421|NCT00566722|10900300|FG001|COMPLETED|Overall Study||24
9792422|NCT00566722|10900301|FG002|COMPLETED|Overall Study||73
9792423|NCT00566722|10900299|FG000|NOT COMPLETED|Overall Study||2
9792424|NCT00566722|10900300|FG001|NOT COMPLETED|Overall Study||5
9792425|NCT00566722|10900301|FG002|NOT COMPLETED|Overall Study||9
9792426|NCT00566735|10900314|FG000|STARTED|Overall Study||20
9792427|NCT00566735|10900315|FG001|STARTED|Overall Study||19
9792428|NCT00566735|10900314|FG000|Withdrew Before Baseline Measures|Overall Study||2
9792429|NCT00566735|10900315|FG001|Withdrew Before Baseline Measures|Overall Study||7
9792430|NCT00566735|10900314|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
9792431|NCT00566735|10900315|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
9792432|NCT00566735|10900314|FG000|NOT COMPLETED|Overall Study||2
9792433|NCT00566735|10900315|FG001|NOT COMPLETED|Overall Study||7
9792434|NCT00566813|10900323|FG000|STARTED|Overall Study||4
9792435|NCT00566813|10900324|FG001|STARTED|Overall Study||6
9792436|NCT00566813|10900323|FG000|COMPLETED|Overall Study||4
9792437|NCT00566813|10900324|FG001|COMPLETED|Overall Study||6
9792438|NCT00566813|10900323|FG000|NOT COMPLETED|Overall Study||0
9792439|NCT00566813|10900324|FG001|NOT COMPLETED|Overall Study||0
10019115|NCT01827670|11142225|FG001|NOT COMPLETED|Overall Study||3
10019116|NCT01827787|11142238|FG000|STARTED|Overall Study||45
10019117|NCT01827787|11142239|FG001|STARTED|Overall Study||38
9792440|NCT00566852|10900332|FG000|STARTED|Overall Study||278
9792441|NCT00566852|10900333|FG001|STARTED|Overall Study||276
9792442|NCT00566852|10900332|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
9792443|NCT00566852|10900333|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
9792444|NCT00566852|10900332|FG000|NOT COMPLETED|Overall Study||207
9792445|NCT00566852|10900333|FG001|NOT COMPLETED|Overall Study||198
9792446|NCT00566930|10900342|FG000|STARTED|Overall Study||29
9792447|NCT00566930|10900343|FG001|STARTED|Overall Study||36
9792448|NCT00566930|10900344|FG002|STARTED|Overall Study||33
9792449|NCT00566930|10900342|FG000|COMPLETED|Overall Study||27
9792450|NCT00566930|10900343|FG001|COMPLETED|Overall Study||32
9792451|NCT00566930|10900344|FG002|COMPLETED|Overall Study||32
9792452|NCT00566930|10900342|FG000|NOT COMPLETED|Overall Study||2
9792453|NCT00566930|10900343|FG001|NOT COMPLETED|Overall Study||4
9792454|NCT00566930|10900344|FG002|NOT COMPLETED|Overall Study||1
9792455|NCT00566943|10900354|FG000|STARTED|Overall Study||52
9792456|NCT00566943|10900355|FG001|STARTED|Overall Study||49
9792457|NCT00566943|10900354|FG000|COMPLETED|Overall Study||52
9792458|NCT00566943|10900355|FG001|COMPLETED|Overall Study||49
9792459|NCT00566943|10900354|FG000|NOT COMPLETED|Overall Study||0
9792460|NCT00566943|10900355|FG001|NOT COMPLETED|Overall Study||0
9792461|NCT00566969|10900370|FG000|STARTED|Overall Study||34
9792462|NCT00566969|10900371|FG001|STARTED|Overall Study||37
9792463|NCT00566969|10900372|FG002|STARTED|Overall Study||35
9792464|NCT00566969|10900370|FG000|COMPLETED|Overall Study||19
9792465|NCT00566969|10900371|FG001|COMPLETED|Overall Study||28
9792466|NCT00566969|10900372|FG002|COMPLETED|Overall Study||23
9792467|NCT00566969|10900370|FG000|NOT COMPLETED|Overall Study||15
9792468|NCT00566969|10900371|FG001|NOT COMPLETED|Overall Study||9
9792469|NCT00566969|10900372|FG002|NOT COMPLETED|Overall Study||12
9792470|NCT00566982|10900382|FG000|STARTED|Overall Study||63
9792471|NCT00566982|10900383|FG001|STARTED|Overall Study||363
9792472|NCT00566982|10900382|FG000|COMPLETED|Overall Study||55
9792473|NCT00566982|10900383|FG001|COMPLETED|Overall Study||294
9792474|NCT00566982|10900382|FG000|NOT COMPLETED|Overall Study||8
9792475|NCT00566982|10900383|FG001|NOT COMPLETED|Overall Study||69
9792476|NCT00567008|10900394|FG000|STARTED|Overall Study||18
9792477|NCT00567008|10900395|FG001|STARTED|Overall Study||19
9792478|NCT00567008|10900394|FG000|COMPLETED|Overall Study||17
9792479|NCT00567008|10900395|FG001|COMPLETED|Overall Study||18
9792480|NCT00567008|10900394|FG000|NOT COMPLETED|Overall Study||1
9792481|NCT00567008|10900395|FG001|NOT COMPLETED|Overall Study||1
9792482|NCT00567112|10900401|FG000|STARTED|Treatment Period 1 (3 Days)||7
9792483|NCT00567112|10900402|FG001|STARTED|Treatment Period 1 (3 Days)||8
9792484|NCT00567112|10900403|FG002|STARTED|Treatment Period 1 (3 Days)||0
9792485|NCT00567112|10900401|FG000|COMPLETED|Treatment Period 1 (3 Days)||7
9792486|NCT00567112|10900402|FG001|COMPLETED|Treatment Period 1 (3 Days)||8
9792487|NCT00567112|10900403|FG002|COMPLETED|Treatment Period 1 (3 Days)||0
9792488|NCT00567112|10900401|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9792489|NCT00567112|10900402|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9792490|NCT00567112|10900403|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9792491|NCT00567112|10900401|FG000|STARTED|Washout Period 1 (3 Days)||7
9792492|NCT00567112|10900402|FG001|STARTED|Washout Period 1 (3 Days)||8
9792493|NCT00567112|10900403|FG002|STARTED|Washout Period 1 (3 Days)||0
9792494|NCT00567112|10900401|FG000|COMPLETED|Washout Period 1 (3 Days)||7
9792495|NCT00567112|10900402|FG001|COMPLETED|Washout Period 1 (3 Days)||8
9792496|NCT00567112|10900403|FG002|COMPLETED|Washout Period 1 (3 Days)||0
9792497|NCT00567112|10900401|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
9792498|NCT00567112|10900402|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
9792499|NCT00567112|10900403|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0
9792500|NCT00567112|10900401|FG000|STARTED|Treatment Period 2 (3 Days)||7
9792501|NCT00567112|10900402|FG001|STARTED|Treatment Period 2 (3 Days)||8
9792502|NCT00567112|10900403|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
9792503|NCT00567112|10900401|FG000|COMPLETED|Treatment Period 2 (3 Days)||7
9792504|NCT00567112|10900402|FG001|COMPLETED|Treatment Period 2 (3 Days)||7
9792505|NCT00567112|10900403|FG002|COMPLETED|Treatment Period 2 (3 Days)||3
9792506|NCT00567112|10900401|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10019118|NCT01827787|11142238|FG000|COMPLETED|Overall Study||45
9792507|NCT00567112|10900402|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1
9792508|NCT00567112|10900403|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9792509|NCT00567112|10900401|FG000|STARTED|Washout Period 2 (3 Days)||7
9792510|NCT00567112|10900402|FG001|STARTED|Washout Period 2 (3 Days)||7
9792511|NCT00567112|10900403|FG002|STARTED|Washout Period 2 (3 Days)||3
9792512|NCT00567112|10900401|FG000|COMPLETED|Washout Period 2 (3 Days)||7
9792513|NCT00567112|10900402|FG001|COMPLETED|Washout Period 2 (3 Days)||7
9792514|NCT00567112|10900403|FG002|COMPLETED|Washout Period 2 (3 Days)||3
10019119|NCT01827787|11142239|FG001|COMPLETED|Overall Study||38
9792515|NCT00567112|10900401|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
9792516|NCT00567112|10900402|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
9792517|NCT00567112|10900403|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0
9792518|NCT00567112|10900401|FG000|STARTED|Treatment Period 3 (3 Days)||7
9792519|NCT00567112|10900402|FG001|STARTED|Treatment Period 3 (3 Days)||7
9792520|NCT00567112|10900403|FG002|STARTED|Treatment Period 3 (3 Days)||3
9792521|NCT00567112|10900401|FG000|COMPLETED|Treatment Period 3 (3 Days)||7
9792522|NCT00567112|10900402|FG001|COMPLETED|Treatment Period 3 (3 Days)||7
9792523|NCT00567112|10900403|FG002|COMPLETED|Treatment Period 3 (3 Days)||3
9792524|NCT00567112|10900401|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9792525|NCT00567112|10900402|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9792526|NCT00567112|10900403|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9792527|NCT00567112|10900401|FG000|STARTED|Washout Period 3 (3 Days)||7
9792528|NCT00567112|10900402|FG001|STARTED|Washout Period 3 (3 Days)||7
9792529|NCT00567112|10900403|FG002|STARTED|Washout Period 3 (3 Days)||3
9792530|NCT00567112|10900401|FG000|COMPLETED|Washout Period 3 (3 Days)||4
9792531|NCT00567112|10900402|FG001|COMPLETED|Washout Period 3 (3 Days)||7
9792532|NCT00567112|10900403|FG002|COMPLETED|Washout Period 3 (3 Days)||3
9792533|NCT00567112|10900401|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3
9792534|NCT00567112|10900402|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0
9792535|NCT00567112|10900403|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0
9792536|NCT00567112|10900401|FG000|STARTED|Treatment Period 4 (3 Days)||4
9792537|NCT00567112|10900402|FG001|STARTED|Treatment Period 4 (3 Days)||7
9792538|NCT00567112|10900403|FG002|STARTED|Treatment Period 4 (3 Days)||3
9792539|NCT00567112|10900401|FG000|COMPLETED|Treatment Period 4 (3 Days)||4
9792540|NCT00567112|10900402|FG001|COMPLETED|Treatment Period 4 (3 Days)||7
9792541|NCT00567112|10900403|FG002|COMPLETED|Treatment Period 4 (3 Days)||3
9792542|NCT00567112|10900401|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
9792543|NCT00567112|10900402|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
9792544|NCT00567112|10900403|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
9792545|NCT00567164|10900415|FG000|STARTED|Overall Study||1421
9792546|NCT00567164|10900416|FG001|STARTED|Overall Study||234
9792547|NCT00567164|10900417|FG002|STARTED|Overall Study||232
9792548|NCT00567164|10900415|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
9792549|NCT00567164|10900416|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232
9792550|NCT00567164|10900417|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226
9792551|NCT00567164|10900415|FG000|COMPLETED|Overall Study||875
9792552|NCT00567164|10900416|FG001|COMPLETED|Overall Study||161
9792553|NCT00567164|10900417|FG002|COMPLETED|Overall Study||160
9792554|NCT00567164|10900415|FG000|NOT COMPLETED|Overall Study||546
9792555|NCT00567164|10900416|FG001|NOT COMPLETED|Overall Study||73
9792556|NCT00567164|10900417|FG002|NOT COMPLETED|Overall Study||72
9792557|NCT00567190|10900431|FG000|STARTED|Overall Study||402
9792558|NCT00567190|10900432|FG001|STARTED|Overall Study||406
9792559|NCT00567190|10900431|FG000|Did Not Receive Any Study Treatment|Overall Study||2
9792560|NCT00567190|10900432|FG001|Did Not Receive Any Study Treatment|Overall Study||2
9792561|NCT00567190|10900431|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399
9792562|NCT00567190|10900432|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
9792563|NCT00567190|10900431|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
9792564|NCT00567190|10900432|FG001|Received at Least One Dose of Placebo|Overall Study||395
9792565|NCT00567190|10900431|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0
9792566|NCT00567190|10900432|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
9792567|NCT00567190|10900431|FG000|COMPLETED|Overall Study||119
9792568|NCT00567190|10900432|FG001|COMPLETED|Overall Study||73
9792569|NCT00567190|10900431|FG000|NOT COMPLETED|Overall Study||283
9792570|NCT00567190|10900432|FG001|NOT COMPLETED|Overall Study||333
9792571|NCT00567229|10900443|FG000|STARTED|Overall Study||3
9792572|NCT00567229|10900443|FG000|COMPLETED|Overall Study||3
9792573|NCT00567229|10900443|FG000|NOT COMPLETED|Overall Study||0
9792574|NCT00567242|10900449|FG000|STARTED|Overall Study||7
9792575|NCT00567242|10900450|FG001|STARTED|Overall Study||7
9792576|NCT00567242|10900449|FG000|COMPLETED|Overall Study||7
9792577|NCT00567242|10900450|FG001|COMPLETED|Overall Study||7
9792578|NCT00567242|10900449|FG000|NOT COMPLETED|Overall Study||0
9792579|NCT00567242|10900450|FG001|NOT COMPLETED|Overall Study||0
9792580|NCT00567255|10900458|FG000|STARTED|Overall Study||1001
9792581|NCT00567255|10900459|FG001|STARTED|Overall Study||495
9792582|NCT00567255|10900458|FG000|COMPLETED|Overall Study||538
9792583|NCT00567255|10900459|FG001|COMPLETED|Overall Study||267
9792584|NCT00567255|10900458|FG000|NOT COMPLETED|Overall Study||463
9792585|NCT00567255|10900459|FG001|NOT COMPLETED|Overall Study||228
9792586|NCT00567268|10900465|FG000|STARTED|Overall Study||1194
9792587|NCT00567268|10900465|FG000|COMPLETED|Overall Study||1144
9792588|NCT00567268|10900465|FG000|NOT COMPLETED|Overall Study||50
9792589|NCT00567307|10900506|FG000|STARTED|Overall Study||111
9792590|NCT00567307|10900507|FG001|STARTED|Overall Study||105
9792591|NCT00567307|10900506|FG000|COMPLETED|Overall Study||99
9792592|NCT00567307|10900507|FG001|COMPLETED|Overall Study||104
9792593|NCT00567307|10900506|FG000|NOT COMPLETED|Overall Study||12
9792594|NCT00567307|10900507|FG001|NOT COMPLETED|Overall Study||1
9792595|NCT00567320|10900515|FG000|STARTED|Overall Study||13
9792596|NCT00567320|10900516|FG001|STARTED|Overall Study||18
9792597|NCT00567320|10900515|FG000|COMPLETED|Overall Study||13
9792598|NCT00567320|10900516|FG001|COMPLETED|Overall Study||18
9792599|NCT00567320|10900515|FG000|NOT COMPLETED|Overall Study||0
9792600|NCT00567320|10900516|FG001|NOT COMPLETED|Overall Study||0
9792601|NCT00567359|10900522|FG000|STARTED|Overall Study||100
9792602|NCT00567359|10900522|FG000|COMPLETED|Overall Study||99
9792603|NCT00567359|10900522|FG000|NOT COMPLETED|Overall Study||1
9792604|NCT00567398|10900528|FG000|STARTED|Overall Study||127
9792605|NCT00567398|10900529|FG001|STARTED|Overall Study||124
9792606|NCT00567398|10900528|FG000|COMPLETED|Overall Study||120
9792607|NCT00567398|10900529|FG001|COMPLETED|Overall Study||101
9792608|NCT00567398|10900528|FG000|NOT COMPLETED|Overall Study||7
9792609|NCT00567398|10900529|FG001|NOT COMPLETED|Overall Study||23
9792610|NCT00567476|10900537|FG000|STARTED|Overall Study||78
9792611|NCT00567476|10900538|FG001|STARTED|Overall Study||38
9792612|NCT00567476|10900537|FG000|COMPLETED|Overall Study||70
9792613|NCT00567476|10900538|FG001|COMPLETED|Overall Study||34
9792614|NCT00567476|10900537|FG000|NOT COMPLETED|Overall Study||8
9792615|NCT00567476|10900538|FG001|NOT COMPLETED|Overall Study||4
9792616|NCT00567489|10900546|FG000|STARTED|Overall Study||127
9792617|NCT00567489|10900547|FG001|STARTED|Overall Study||124
9792618|NCT00567489|10900546|FG000|COMPLETED|Overall Study||120
9792619|NCT00567489|10900547|FG001|COMPLETED|Overall Study||101
9792620|NCT00567489|10900546|FG000|NOT COMPLETED|Overall Study||7
9792621|NCT00567489|10900547|FG001|NOT COMPLETED|Overall Study||23
9792622|NCT00567502|10900557|FG000|STARTED|Overall Study||804
9792623|NCT00567502|10900558|FG001|STARTED|Overall Study||141
9792624|NCT00567502|10900559|FG002|STARTED|Overall Study||2666
9792625|NCT00567502|10900560|FG003|STARTED|Overall Study||110
9792626|NCT00567502|10900557|FG000|Initiated Treatment|Overall Study||804
9792627|NCT00567502|10900558|FG001|Initiated Treatment|Overall Study||141
9792628|NCT00567502|10900559|FG002|Initiated Treatment|Overall Study||2666
9792629|NCT00567502|10900560|FG003|Initiated Treatment|Overall Study||38
9792630|NCT00567502|10900557|FG000|COMPLETED|Overall Study||563
9792631|NCT00567502|10900558|FG001|COMPLETED|Overall Study||108
9792632|NCT00567502|10900559|FG002|COMPLETED|Overall Study||1758
9792633|NCT00567502|10900560|FG003|COMPLETED|Overall Study||23
9792634|NCT00567502|10900557|FG000|NOT COMPLETED|Overall Study||241
9792635|NCT00567502|10900558|FG001|NOT COMPLETED|Overall Study||33
9792636|NCT00567502|10900559|FG002|NOT COMPLETED|Overall Study||908
9792637|NCT00567502|10900560|FG003|NOT COMPLETED|Overall Study||87
9792638|NCT00567541|10900583|FG000|STARTED|Overall Study||7
9792639|NCT00567541|10900584|FG001|STARTED|Overall Study||9
9792640|NCT00567541|10900583|FG000|COMPLETED|Overall Study||7
10015562|NCT01806688|11138604|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
10019120|NCT01827787|11142238|FG000|NOT COMPLETED|Overall Study||0
10019121|NCT01827787|11142239|FG001|NOT COMPLETED|Overall Study||0
10019122|NCT01827839|11142248|FG000|STARTED|Overall Study||96
10019123|NCT01827839|11142248|FG000|COMPLETED|Overall Study||93
9792641|NCT00567541|10900584|FG001|COMPLETED|Overall Study||8
9792642|NCT00567541|10900583|FG000|NOT COMPLETED|Overall Study||0
9792643|NCT00567541|10900584|FG001|NOT COMPLETED|Overall Study||1
9792644|NCT00567593|10900590|FG000|STARTED|Overall Study||12
9792645|NCT00567593|10900590|FG000|COMPLETED|Overall Study||10
9792646|NCT00567593|10900590|FG000|NOT COMPLETED|Overall Study||2
9792647|NCT00567840|10900599|FG000|STARTED|Overall Study||15
9792648|NCT00567840|10900600|FG001|STARTED|Overall Study||15
9792649|NCT00567840|10900601|FG002|STARTED|Overall Study||16
9792650|NCT00567840|10900602|FG003|STARTED|Overall Study||15
9792651|NCT00567840|10900603|FG004|STARTED|Overall Study||8
9792652|NCT00567840|10900599|FG000|COMPLETED|Overall Study||13
9792653|NCT00567840|10900600|FG001|COMPLETED|Overall Study||15
9792654|NCT00567840|10900601|FG002|COMPLETED|Overall Study||15
9792655|NCT00567840|10900602|FG003|COMPLETED|Overall Study||14
9792656|NCT00567840|10900603|FG004|COMPLETED|Overall Study||8
9792657|NCT00567840|10900599|FG000|NOT COMPLETED|Overall Study||2
9792658|NCT00567840|10900600|FG001|NOT COMPLETED|Overall Study||0
9792659|NCT00567840|10900601|FG002|NOT COMPLETED|Overall Study||1
9792660|NCT00567840|10900602|FG003|NOT COMPLETED|Overall Study||1
9792661|NCT00567840|10900603|FG004|NOT COMPLETED|Overall Study||0
9792662|NCT00567879|10900621|FG000|STARTED|Overall Study||7
9792663|NCT00567879|10900622|FG001|STARTED|Overall Study||7
9792664|NCT00567879|10900623|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
9792665|NCT00567879|10900624|FG003|STARTED|Overall Study||6
9792666|NCT00567879|10900625|FG004|STARTED|Overall Study||12
9792667|NCT00567879|10900626|FG005|STARTED|Overall Study||3
9792668|NCT00567879|10900621|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5
9792669|NCT00567879|10900622|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7
9792670|NCT00567879|10900623|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
9792671|NCT00567879|10900624|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6
9792672|NCT00567879|10900625|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12
9792673|NCT00567879|10900626|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3
9792674|NCT00567879|10900621|FG000|COMPLETED|Overall Study||0
9792675|NCT00567879|10900622|FG001|COMPLETED|Overall Study||0
9792676|NCT00567879|10900623|FG002|COMPLETED|Overall Study||0
9792677|NCT00567879|10900624|FG003|COMPLETED|Overall Study||0
9792678|NCT00567879|10900625|FG004|COMPLETED|Overall Study||0
9792679|NCT00567879|10900626|FG005|COMPLETED|Overall Study||0
9792680|NCT00567879|10900621|FG000|NOT COMPLETED|Overall Study||7
9792681|NCT00567879|10900622|FG001|NOT COMPLETED|Overall Study||7
9792682|NCT00567879|10900623|FG002|NOT COMPLETED|Overall Study||21
9792683|NCT00567879|10900624|FG003|NOT COMPLETED|Overall Study||6
9792684|NCT00567879|10900625|FG004|NOT COMPLETED|Overall Study||12
9792685|NCT00567879|10900626|FG005|NOT COMPLETED|Overall Study||3
9792686|NCT00567892|10900646|FG000|STARTED|First Treatment (2 or 4 Weeks)||7
9792687|NCT00567892|10900647|FG001|STARTED|First Treatment (2 or 4 Weeks)||7
9792688|NCT00567892|10900648|FG002|STARTED|First Treatment (2 or 4 Weeks)||10
9792689|NCT00567892|10900649|FG003|STARTED|First Treatment (2 or 4 Weeks)||10
9792690|NCT00567892|10900646|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7
9792691|NCT00567892|10900647|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7
9792692|NCT00567892|10900648|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9
9792693|NCT00567892|10900649|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6
9792694|NCT00567892|10900646|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
9792695|NCT00567892|10900647|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
9792696|NCT00567892|10900648|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
9792697|NCT00567892|10900649|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
9792698|NCT00567892|10900646|FG000|STARTED|Washout (2 Weeks)||7
9792699|NCT00567892|10900647|FG001|STARTED|Washout (2 Weeks)||7
9792700|NCT00567892|10900648|FG002|STARTED|Washout (2 Weeks)||9
9792701|NCT00567892|10900649|FG003|STARTED|Washout (2 Weeks)||6
9792702|NCT00567892|10900646|FG000|COMPLETED|Washout (2 Weeks)||7
9792703|NCT00567892|10900647|FG001|COMPLETED|Washout (2 Weeks)||7
9792704|NCT00567892|10900648|FG002|COMPLETED|Washout (2 Weeks)||9
9792705|NCT00567892|10900649|FG003|COMPLETED|Washout (2 Weeks)||6
9792706|NCT00567892|10900646|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9792707|NCT00567892|10900647|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9792708|NCT00567892|10900648|FG002|NOT COMPLETED|Washout (2 Weeks)||0
9792709|NCT00567892|10900649|FG003|NOT COMPLETED|Washout (2 Weeks)||0
9792710|NCT00567892|10900646|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7
9792711|NCT00567892|10900647|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7
9792712|NCT00567892|10900648|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9
9792713|NCT00567892|10900649|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6
9792714|NCT00567892|10900646|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7
9792715|NCT00567892|10900647|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7
9792716|NCT00567892|10900648|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9
9792717|NCT00567892|10900649|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5
9792718|NCT00567892|10900646|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
9792719|NCT00567892|10900647|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
9792720|NCT00567892|10900648|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
9792721|NCT00567892|10900649|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
9792722|NCT00567996|10900664|FG000|STARTED|Overall Study|Randomized participants|333
9792723|NCT00567996|10900665|FG001|STARTED|Overall Study||334
9792724|NCT00567996|10900666|FG002|STARTED|Overall Study||335
9792725|NCT00567996|10900664|FG000|Intent-to-treat: Received Study Drug|Overall Study||330
9792726|NCT00567996|10900665|FG001|Intent-to-treat: Received Study Drug|Overall Study||333
9792727|NCT00567996|10900666|FG002|Intent-to-treat: Received Study Drug|Overall Study||335
9792728|NCT00567996|10900664|FG000|COMPLETED|Overall Study||289
9792729|NCT00567996|10900665|FG001|COMPLETED|Overall Study||284
9792730|NCT00567996|10900666|FG002|COMPLETED|Overall Study||265
9792731|NCT00567996|10900664|FG000|NOT COMPLETED|Overall Study||44
9792732|NCT00567996|10900665|FG001|NOT COMPLETED|Overall Study||50
9792733|NCT00567996|10900666|FG002|NOT COMPLETED|Overall Study||70
9792734|NCT00568022|10900677|FG000|STARTED|Overall Study||3
9792735|NCT00568022|10900678|FG001|STARTED|Overall Study||3
9792736|NCT00568022|10900679|FG002|STARTED|Overall Study||3
9792737|NCT00568022|10900677|FG000|COMPLETED|Overall Study||3
9792738|NCT00568022|10900678|FG001|COMPLETED|Overall Study||3
9792739|NCT00568022|10900679|FG002|COMPLETED|Overall Study||3
9792740|NCT00568022|10900677|FG000|NOT COMPLETED|Overall Study||0
9792741|NCT00568022|10900678|FG001|NOT COMPLETED|Overall Study||0
9792742|NCT00568022|10900679|FG002|NOT COMPLETED|Overall Study||0
9792743|NCT00568061|10900690|FG000|STARTED|Overall Study||13
9792744|NCT00568061|10900691|FG001|STARTED|Overall Study||16
9792745|NCT00568061|10900690|FG000|COMPLETED|Overall Study||8
9792746|NCT00568061|10900691|FG001|COMPLETED|Overall Study||14
9792747|NCT00568061|10900690|FG000|NOT COMPLETED|Overall Study||5
9792748|NCT00568061|10900691|FG001|NOT COMPLETED|Overall Study||2
9792749|NCT00568087|10900700|FG000|STARTED|Overall Study||22
9792750|NCT00568087|10900701|FG001|STARTED|Overall Study||24
9792751|NCT00568087|10900700|FG000|Received Intervention|Overall Study||21
9792752|NCT00568087|10900701|FG001|Received Intervention|Overall Study||23
9792753|NCT00568087|10900700|FG000|COMPLETED|Overall Study||15
9792754|NCT00568087|10900701|FG001|COMPLETED|Overall Study||17
9792755|NCT00568087|10900700|FG000|NOT COMPLETED|Overall Study||7
9792756|NCT00568087|10900701|FG001|NOT COMPLETED|Overall Study||7
9792757|NCT00568126|10900709|FG000|STARTED|Overall Study||24
9792758|NCT00568126|10900710|FG001|STARTED|Overall Study||21
9792759|NCT00568126|10900709|FG000|COMPLETED|Overall Study||13
9792760|NCT00568126|10900710|FG001|COMPLETED|Overall Study||12
9792761|NCT00568126|10900709|FG000|NOT COMPLETED|Overall Study||11
9792762|NCT00568126|10900710|FG001|NOT COMPLETED|Overall Study||9
9792763|NCT00568321|10900719|FG000|STARTED|Overall Study||33
9792764|NCT00568321|10900720|FG001|STARTED|Overall Study||33
9792765|NCT00568321|10900721|FG002|STARTED|Overall Study||33
9792766|NCT00568321|10900719|FG000|Treated|Overall Study||31
9792767|NCT00568321|10900720|FG001|Treated|Overall Study||33
9792768|NCT00568321|10900721|FG002|Treated|Overall Study||32
9792769|NCT00568321|10900719|FG000|COMPLETED|Overall Study||20
9792770|NCT00568321|10900720|FG001|COMPLETED|Overall Study||28
9792771|NCT00568321|10900721|FG002|COMPLETED|Overall Study||24
9792772|NCT00568321|10900719|FG000|NOT COMPLETED|Overall Study||13
9792773|NCT00568321|10900720|FG001|NOT COMPLETED|Overall Study||5
9792774|NCT00568321|10900721|FG002|NOT COMPLETED|Overall Study||9
9792775|NCT00568334|10900733|FG000|STARTED|Overall Study||122
9792776|NCT00568334|10900734|FG001|STARTED|Overall Study||122
9792777|NCT00568334|10900733|FG000|COMPLETED|Overall Study||121
9792778|NCT00568334|10900734|FG001|COMPLETED|Overall Study||121
9792779|NCT00568334|10900733|FG000|NOT COMPLETED|Overall Study||1
9792780|NCT00568334|10900734|FG001|NOT COMPLETED|Overall Study||1
9792781|NCT00568386|10900742|FG000|STARTED|Overall Study||20
9792782|NCT00568386|10900743|FG001|STARTED|Overall Study||20
9792783|NCT00568386|10900742|FG000|COMPLETED|Overall Study||20
9792784|NCT00568386|10900743|FG001|COMPLETED|Overall Study||20
9792785|NCT00568386|10900742|FG000|NOT COMPLETED|Overall Study||0
9792786|NCT00568386|10900743|FG001|NOT COMPLETED|Overall Study||0
9830728|NCT00765193|10941513|FG000|STARTED|Problem Area Examination||14381
9830729|NCT00765193|10941513|FG000|COMPLETED|Problem Area Examination||14381
9830730|NCT00765193|10941513|FG000|NOT COMPLETED|Problem Area Examination||0
9830731|NCT00765193|10941513|FG000|STARTED|Full Body Examination||14381
9830732|NCT00765193|10941513|FG000|COMPLETED|Full Body Examination||14381
9830733|NCT00765193|10941513|FG000|NOT COMPLETED|Full Body Examination||0
9830734|NCT00765206|10941518|FG000|STARTED|First Intervention||15
9830735|NCT00765206|10941519|FG001|STARTED|First Intervention||15
9830736|NCT00765206|10941520|FG002|STARTED|First Intervention||15
9830737|NCT00765206|10941521|FG003|STARTED|First Intervention||15
9830738|NCT00765206|10941518|FG000|COMPLETED|First Intervention||15
9830739|NCT00765206|10941519|FG001|COMPLETED|First Intervention||15
9830740|NCT00765206|10941520|FG002|COMPLETED|First Intervention||15
9830741|NCT00765206|10941521|FG003|COMPLETED|First Intervention||15
9830742|NCT00765206|10941518|FG000|NOT COMPLETED|First Intervention||0
9830743|NCT00765206|10941519|FG001|NOT COMPLETED|First Intervention||0
9830744|NCT00765206|10941520|FG002|NOT COMPLETED|First Intervention||0
9830745|NCT00765206|10941521|FG003|NOT COMPLETED|First Intervention||0
9830746|NCT00765206|10941518|FG000|STARTED|Washout Period of 14 Days||15
9830747|NCT00765206|10941519|FG001|STARTED|Washout Period of 14 Days||15
9830748|NCT00765206|10941520|FG002|STARTED|Washout Period of 14 Days||15
9830749|NCT00765206|10941521|FG003|STARTED|Washout Period of 14 Days||15
9830750|NCT00765206|10941518|FG000|COMPLETED|Washout Period of 14 Days||15
9830751|NCT00765206|10941519|FG001|COMPLETED|Washout Period of 14 Days||15
9830752|NCT00765206|10941520|FG002|COMPLETED|Washout Period of 14 Days||15
9830753|NCT00765206|10941521|FG003|COMPLETED|Washout Period of 14 Days||15
9830754|NCT00765206|10941518|FG000|NOT COMPLETED|Washout Period of 14 Days||0
9830755|NCT00765206|10941519|FG001|NOT COMPLETED|Washout Period of 14 Days||0
9830756|NCT00765206|10941520|FG002|NOT COMPLETED|Washout Period of 14 Days||0
9830757|NCT00765206|10941521|FG003|NOT COMPLETED|Washout Period of 14 Days||0
9830758|NCT00765206|10941518|FG000|STARTED|Second Intervention||15
9830759|NCT00765206|10941519|FG001|STARTED|Second Intervention||15
9830760|NCT00765206|10941520|FG002|STARTED|Second Intervention||15
9830761|NCT00765206|10941521|FG003|STARTED|Second Intervention||15
9830762|NCT00765206|10941518|FG000|COMPLETED|Second Intervention||15
9830763|NCT00765206|10941519|FG001|COMPLETED|Second Intervention||15
9830764|NCT00765206|10941520|FG002|COMPLETED|Second Intervention||15
9830765|NCT00765206|10941521|FG003|COMPLETED|Second Intervention||15
9830766|NCT00765206|10941518|FG000|NOT COMPLETED|Second Intervention||0
9830767|NCT00765206|10941519|FG001|NOT COMPLETED|Second Intervention||0
9830768|NCT00765206|10941520|FG002|NOT COMPLETED|Second Intervention||0
9830769|NCT00765206|10941521|FG003|NOT COMPLETED|Second Intervention||0
9830770|NCT00765232|10941529|FG000|STARTED|Overall Study||57
9830771|NCT00765232|10941530|FG001|STARTED|Overall Study||54
9830772|NCT00765232|10941529|FG000|COMPLETED|Overall Study||57
9830773|NCT00765232|10941530|FG001|COMPLETED|Overall Study||54
9830774|NCT00765232|10941529|FG000|NOT COMPLETED|Overall Study||0
9830775|NCT00765232|10941530|FG001|NOT COMPLETED|Overall Study||0
9830776|NCT00765245|10941538|FG000|STARTED|Overall Study||22
9830777|NCT00765245|10941539|FG001|STARTED|Overall Study||22
9830778|NCT00765245|10941538|FG000|COMPLETED|Overall Study||9
9830779|NCT00765245|10941539|FG001|COMPLETED|Overall Study||20
9830780|NCT00765245|10941538|FG000|NOT COMPLETED|Overall Study||13
9830781|NCT00765245|10941539|FG001|NOT COMPLETED|Overall Study||2
9830782|NCT00765336|10941547|FG000|STARTED|Overall Study||91
9830783|NCT00765336|10941548|FG001|STARTED|Overall Study||89
9792787|NCT00568399|10900749|FG000|STARTED|Overall Study||37
9792788|NCT00568399|10900749|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
9792789|NCT00568399|10900749|FG000|NOT COMPLETED|Overall Study||15
9792790|NCT00568451|10900757|FG000|STARTED|Overall Study||0
9792791|NCT00568451|10900758|FG001|STARTED|Overall Study||0
9792792|NCT00568451|10900759|FG002|STARTED|Overall Study||2
9792793|NCT00568451|10900760|FG003|STARTED|Overall Study||9
9792794|NCT00568451|10900757|FG000|COMPLETED|Overall Study||0
9792795|NCT00568451|10900758|FG001|COMPLETED|Overall Study||0
9792796|NCT00568451|10900759|FG002|COMPLETED|Overall Study||0
9792797|NCT00568451|10900760|FG003|COMPLETED|Overall Study||2
9792798|NCT00568451|10900757|FG000|NOT COMPLETED|Overall Study||0
9792799|NCT00568451|10900758|FG001|NOT COMPLETED|Overall Study||0
9792800|NCT00568451|10900759|FG002|NOT COMPLETED|Overall Study||2
9792801|NCT00568451|10900760|FG003|NOT COMPLETED|Overall Study||7
9792802|NCT00568555|10900773|FG000|STARTED|Overall Study||16
9792803|NCT00568555|10900774|FG001|STARTED|Overall Study||15
9792804|NCT00568555|10900773|FG000|COMPLETED|Overall Study||15
9792805|NCT00568555|10900774|FG001|COMPLETED|Overall Study||14
9792806|NCT00568555|10900773|FG000|NOT COMPLETED|Overall Study||1
9792807|NCT00568555|10900774|FG001|NOT COMPLETED|Overall Study||1
9792808|NCT00568633|10900784|FG000|STARTED|Overall Study||25
9792809|NCT00568633|10900785|FG001|STARTED|Overall Study||33
9792810|NCT00568633|10900784|FG000|COMPLETED|Overall Study||25
9792811|NCT00568633|10900785|FG001|COMPLETED|Overall Study||33
9792812|NCT00568633|10900784|FG000|NOT COMPLETED|Overall Study||0
9792813|NCT00568633|10900785|FG001|NOT COMPLETED|Overall Study||0
9792814|NCT00568685|10900794|FG000|STARTED|Overall Study||51
9792815|NCT00568685|10900795|FG001|STARTED|Overall Study||51
9792816|NCT00568685|10900796|FG002|STARTED|Overall Study||51
9792817|NCT00568685|10900794|FG000|COMPLETED|Overall Study||41
9792818|NCT00568685|10900795|FG001|COMPLETED|Overall Study||46
9792819|NCT00568685|10900796|FG002|COMPLETED|Overall Study||46
9792820|NCT00568685|10900794|FG000|NOT COMPLETED|Overall Study||10
9792821|NCT00568685|10900795|FG001|NOT COMPLETED|Overall Study||5
9792822|NCT00568685|10900796|FG002|NOT COMPLETED|Overall Study||5
9792823|NCT00568776|10900812|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
9792824|NCT00568776|10900813|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
9792825|NCT00568776|10900814|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
9792826|NCT00568776|10900815|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
9792827|NCT00568776|10900812|FG000|COMPLETED|Overall Study||53
9792828|NCT00568776|10900813|FG001|COMPLETED|Overall Study||52
9792829|NCT00568776|10900814|FG002|COMPLETED|Overall Study||15
9792830|NCT00568776|10900815|FG003|COMPLETED|Overall Study||19
9792831|NCT00568776|10900812|FG000|NOT COMPLETED|Overall Study||30
9792832|NCT00568776|10900813|FG001|NOT COMPLETED|Overall Study||36
9792833|NCT00568776|10900814|FG002|NOT COMPLETED|Overall Study||74
9792834|NCT00568776|10900815|FG003|NOT COMPLETED|Overall Study||72
9830784|NCT00765336|10941547|FG000|COMPLETED|Overall Study||72
9830785|NCT00765336|10941548|FG001|COMPLETED|Overall Study||73
9830786|NCT00765336|10941547|FG000|NOT COMPLETED|Overall Study||19
9830787|NCT00765336|10941548|FG001|NOT COMPLETED|Overall Study||16
9830788|NCT00765362|10941554|FG000|STARTED|Overall Study||419
10015563|NCT01806688|11138605|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
10019124|NCT01827839|11142248|FG000|NOT COMPLETED|Overall Study||3
9830789|NCT00765362|10941554|FG000|COMPLETED|Overall Study||282
9830790|NCT00765362|10941554|FG000|NOT COMPLETED|Overall Study||137
9830791|NCT00765375|10941558|FG000|STARTED|Overall Study||5
9830792|NCT00765375|10941558|FG000|COMPLETED|Overall Study||5
9830793|NCT00765375|10941558|FG000|NOT COMPLETED|Overall Study||0
9830794|NCT00765388|10941564|FG000|STARTED|Period 1|A cross-over study|16
9830795|NCT00765388|10941565|FG001|STARTED|Period 1||11
9830796|NCT00765388|10941564|FG000|COMPLETED|Period 1||15
9830797|NCT00765388|10941565|FG001|COMPLETED|Period 1||6
9830798|NCT00765388|10941564|FG000|NOT COMPLETED|Period 1||1
9830799|NCT00765388|10941565|FG001|NOT COMPLETED|Period 1||5
9830800|NCT00765388|10941564|FG000|STARTED|Period 2||15
9830801|NCT00765388|10941565|FG001|STARTED|Period 2||6
9830802|NCT00765388|10941564|FG000|COMPLETED|Period 2||15
9830803|NCT00765388|10941565|FG001|COMPLETED|Period 2||6
9830804|NCT00765388|10941564|FG000|NOT COMPLETED|Period 2||0
9830805|NCT00765388|10941565|FG001|NOT COMPLETED|Period 2||0
9830806|NCT00765570|10941573|FG000|STARTED|Overall Study||9
9830807|NCT00765570|10941574|FG001|STARTED|Overall Study||3
9830808|NCT00765570|10941573|FG000|COMPLETED|Overall Study||7
9830809|NCT00765570|10941574|FG001|COMPLETED|Overall Study||3
9830810|NCT00765570|10941573|FG000|NOT COMPLETED|Overall Study||2
9830811|NCT00765570|10941574|FG001|NOT COMPLETED|Overall Study||0
9830812|NCT00765648|10941582|FG000|STARTED|Overall Study||110
9830813|NCT00765648|10941583|FG001|STARTED|Overall Study||116
9830814|NCT00765648|10941582|FG000|COMPLETED|Overall Study||109
9830815|NCT00765648|10941583|FG001|COMPLETED|Overall Study||114
9830816|NCT00765648|10941582|FG000|NOT COMPLETED|Overall Study||1
9830817|NCT00765648|10941583|FG001|NOT COMPLETED|Overall Study||2
9792835|NCT04274192|10900827|FG000|STARTED|Overall Study||1
9792836|NCT04274192|10900828|FG001|STARTED|Overall Study||0
9792837|NCT04274192|10900827|FG000|COMPLETED|Overall Study||0
9792838|NCT04274192|10900828|FG001|COMPLETED|Overall Study||0
9792839|NCT04274192|10900827|FG000|NOT COMPLETED|Overall Study||1
9792840|NCT04274192|10900828|FG001|NOT COMPLETED|Overall Study||0
9792841|NCT04200833|10900836|FG000|STARTED|Overall Study||10
9792842|NCT04200833|10900836|FG000|COMPLETED|Overall Study||10
9792843|NCT04200833|10900836|FG000|NOT COMPLETED|Overall Study||0
10235225|NCT01230489|11365469|FG000|NOT COMPLETED|Overall Study||5
10235226|NCT01222871|11365475|FG000|STARTED|Overall Study||0
9792844|NCT04110314|10900846|FG000|STARTED|Overall Study||71781
9792845|NCT04110314|10900847|FG001|STARTED|Overall Study||71492
9792846|NCT04110314|10900848|FG002|STARTED|Overall Study||72177
9792847|NCT04110314|10900849|FG003|STARTED|Overall Study||71512
9792848|NCT04110314|10900850|FG004|STARTED|Overall Study||71536
9792849|NCT04110314|10900851|FG005|STARTED|Overall Study||72138
9792850|NCT04110314|10900846|FG000|Patients Who Met Inclusion|Overall Study||36526
9792851|NCT04110314|10900847|FG001|Patients Who Met Inclusion|Overall Study||36388
9792852|NCT04110314|10900848|FG002|Patients Who Met Inclusion|Overall Study||36541
9792853|NCT04110314|10900849|FG003|Patients Who Met Inclusion|Overall Study||36377
9792854|NCT04110314|10900850|FG004|Patients Who Met Inclusion|Overall Study||36289
9792855|NCT04110314|10900851|FG005|Patients Who Met Inclusion|Overall Study||36411
9792856|NCT04110314|10900846|FG000|COMPLETED|Overall Study||36526
9792857|NCT04110314|10900847|FG001|COMPLETED|Overall Study||36388
9792858|NCT04110314|10900848|FG002|COMPLETED|Overall Study||36541
9792859|NCT04110314|10900849|FG003|COMPLETED|Overall Study||36377
9792860|NCT04110314|10900850|FG004|COMPLETED|Overall Study||36289
9792861|NCT04110314|10900851|FG005|COMPLETED|Overall Study||36411
9792862|NCT04110314|10900846|FG000|NOT COMPLETED|Overall Study||35255
9792863|NCT04110314|10900847|FG001|NOT COMPLETED|Overall Study||35104
9792864|NCT04110314|10900848|FG002|NOT COMPLETED|Overall Study||35636
9792865|NCT04110314|10900849|FG003|NOT COMPLETED|Overall Study||35135
9792866|NCT04110314|10900850|FG004|NOT COMPLETED|Overall Study||35247
9792867|NCT04110314|10900851|FG005|NOT COMPLETED|Overall Study||35727
9792868|NCT04086472|10900868|FG000|STARTED|Overall Study||16
9792869|NCT04086472|10900869|FG001|STARTED|Overall Study||16
9792870|NCT04086472|10900870|FG002|STARTED|Overall Study||16
9792871|NCT04086472|10900871|FG003|STARTED|Overall Study||16
9792872|NCT04086472|10900872|FG004|STARTED|Overall Study||16
9792873|NCT04086472|10900868|FG000|Received MK-1654 or Placebo|Overall Study||16
9792874|NCT04086472|10900869|FG001|Received MK-1654 or Placebo|Overall Study||16
9792875|NCT04086472|10900870|FG002|Received MK-1654 or Placebo|Overall Study||16
9792876|NCT04086472|10900871|FG003|Received MK-1654 or Placebo|Overall Study||16
9792877|NCT04086472|10900872|FG004|Received MK-1654 or Placebo|Overall Study||16
9792878|NCT04086472|10900868|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
9792879|NCT04086472|10900869|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
9792880|NCT04086472|10900870|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
9792881|NCT04086472|10900871|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
9792882|NCT04086472|10900872|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
9792883|NCT04086472|10900868|FG000|Not Inoculated|Overall Study||2
9792884|NCT04086472|10900869|FG001|Not Inoculated|Overall Study||2
9792885|NCT04086472|10900870|FG002|Not Inoculated|Overall Study||2
9792886|NCT04086472|10900871|FG003|Not Inoculated|Overall Study||3
9792887|NCT04086472|10900872|FG004|Not Inoculated|Overall Study||1
9792888|NCT04086472|10900868|FG000|COMPLETED|Overall Study||12
9792889|NCT04086472|10900869|FG001|COMPLETED|Overall Study||14
9792890|NCT04086472|10900870|FG002|COMPLETED|Overall Study||14
9792891|NCT04086472|10900871|FG003|COMPLETED|Overall Study||13
9792892|NCT04086472|10900872|FG004|COMPLETED|Overall Study||14
9792893|NCT04086472|10900868|FG000|NOT COMPLETED|Overall Study||4
9792894|NCT04086472|10900869|FG001|NOT COMPLETED|Overall Study||2
9792895|NCT04086472|10900870|FG002|NOT COMPLETED|Overall Study||2
9792896|NCT04086472|10900871|FG003|NOT COMPLETED|Overall Study||3
9792897|NCT04086472|10900872|FG004|NOT COMPLETED|Overall Study||2
9792898|NCT04084288|10900884|FG000|STARTED|Overall Study||41
9792899|NCT04084288|10900884|FG000|COMPLETED|Overall Study||41
9792900|NCT04084288|10900884|FG000|NOT COMPLETED|Overall Study||0
9792901|NCT03961204|10900893|FG000|STARTED|Overall Study||662
9792902|NCT03961204|10900893|FG000|COMPLETED|Overall Study||655
9792903|NCT03961204|10900893|FG000|NOT COMPLETED|Overall Study||7
9792904|NCT03895840|10900897|FG000|STARTED|Overall Study||70
9792905|NCT03895840|10900897|FG000|6-Week Follow-Up|Overall Study||70
9792906|NCT03895840|10900897|FG000|12-Week Follow-Up|Overall Study||65
9792907|NCT03895840|10900897|FG000|24-Week Follow-Up|Overall Study||49
9792908|NCT03895840|10900897|FG000|COMPLETED|Overall Study||49
9792909|NCT03895840|10900897|FG000|NOT COMPLETED|Overall Study||21
9792910|NCT03818399|10900901|FG000|STARTED|Overall Study||19
9792911|NCT03818399|10900901|FG000|COMPLETED|Overall Study||5
9792912|NCT03818399|10900901|FG000|NOT COMPLETED|Overall Study||14
9792913|NCT03603496|10900907|FG000|STARTED|Overall Study||706
9792914|NCT03603496|10900908|FG001|STARTED|Overall Study||703
9792915|NCT03603496|10900907|FG000|COMPLETED|Overall Study||520
9792916|NCT03603496|10900908|FG001|COMPLETED|Overall Study||518
9792917|NCT03603496|10900907|FG000|NOT COMPLETED|Overall Study||186
9792918|NCT03603496|10900908|FG001|NOT COMPLETED|Overall Study||185
9792919|NCT03480802|10900916|FG000|STARTED|Overall Study||152
10235227|NCT01222871|11365476|FG001|STARTED|Overall Study||0
9792920|NCT03480802|10900917|FG001|STARTED|Overall Study||150
9792921|NCT03480802|10900916|FG000|Week 8|Overall Study||150
9792922|NCT03480802|10900917|FG001|Week 8|Overall Study||148
9792923|NCT03480802|10900916|FG000|COMPLETED|Overall Study||145
9792924|NCT03480802|10900917|FG001|COMPLETED|Overall Study||147
9792925|NCT03480802|10900916|FG000|NOT COMPLETED|Overall Study||7
9792926|NCT03480802|10900917|FG001|NOT COMPLETED|Overall Study||3
9792927|NCT03472521|10900927|FG000|STARTED|Overall Study||41
9792928|NCT03472521|10900928|FG001|STARTED|Overall Study||37
9792929|NCT03472521|10900927|FG000|Received Allocated Intervention|Overall Study||41
9792930|NCT03472521|10900928|FG001|Received Allocated Intervention|Overall Study||37
9792931|NCT03472521|10900927|FG000|COMPLETED|Overall Study||35
9792932|NCT03472521|10900928|FG001|COMPLETED|Overall Study||34
9792933|NCT03472521|10900927|FG000|NOT COMPLETED|Overall Study||6
9792934|NCT03472521|10900928|FG001|NOT COMPLETED|Overall Study||3
9792941|NCT03303950|10900943|FG000|STARTED|Overall Study||6
9792942|NCT03303950|10900943|FG000|COMPLETED|Overall Study||6
9792943|NCT03303950|10900943|FG000|NOT COMPLETED|Overall Study||0
9792944|NCT02673203|10900950|FG000|STARTED|Overall Study||16
9792945|NCT02673203|10900951|FG001|STARTED|Overall Study||15
9792946|NCT02673203|10900950|FG000|COMPLETED|Overall Study||16
9792947|NCT02673203|10900951|FG001|COMPLETED|Overall Study||15
9792948|NCT02673203|10900950|FG000|NOT COMPLETED|Overall Study||0
9792949|NCT02673203|10900951|FG001|NOT COMPLETED|Overall Study||0
9792950|NCT02664441|10900959|FG000|STARTED|Randomization||23
9792951|NCT02664441|10900960|FG001|STARTED|Randomization||19
9792952|NCT02664441|10900959|FG000|COMPLETED|Randomization||23
9792953|NCT02664441|10900960|FG001|COMPLETED|Randomization||18
9792954|NCT02664441|10900959|FG000|NOT COMPLETED|Randomization||0
9792955|NCT02664441|10900960|FG001|NOT COMPLETED|Randomization||1
9792956|NCT02664441|10900959|FG000|STARTED|36-week Randomized Trial||23
9792957|NCT02664441|10900960|FG001|STARTED|36-week Randomized Trial||18
9792958|NCT02664441|10900959|FG000|COMPLETED|36-week Randomized Trial||20
9792959|NCT02664441|10900960|FG001|COMPLETED|36-week Randomized Trial||15
9792960|NCT02664441|10900959|FG000|NOT COMPLETED|36-week Randomized Trial||3
9792961|NCT02664441|10900960|FG001|NOT COMPLETED|36-week Randomized Trial||3
9792962|NCT02664441|10900959|FG000|STARTED|18-week Open Label Extension||20
9792963|NCT02664441|10900960|FG001|STARTED|18-week Open Label Extension||15
9792964|NCT02664441|10900959|FG000|COMPLETED|18-week Open Label Extension||17
9792965|NCT02664441|10900960|FG001|COMPLETED|18-week Open Label Extension||14
9792966|NCT02664441|10900959|FG000|NOT COMPLETED|18-week Open Label Extension||3
9792967|NCT02664441|10900960|FG001|NOT COMPLETED|18-week Open Label Extension||1
9830818|NCT00765661|10941591|FG000|STARTED|Overall Study||32
9830819|NCT00765661|10941592|FG001|STARTED|Overall Study||31
9830820|NCT00765661|10941591|FG000|COMPLETED|Overall Study||32
9830821|NCT00765661|10941592|FG001|COMPLETED|Overall Study||31
9830822|NCT00765661|10941591|FG000|NOT COMPLETED|Overall Study||0
9830823|NCT00765661|10941592|FG001|NOT COMPLETED|Overall Study||0
9830824|NCT00765674|10941602|FG000|STARTED|Overall Study||287
9830825|NCT00765674|10941603|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
9830826|NCT00765674|10941604|FG002|STARTED|Overall Study||296
9830827|NCT00765674|10941605|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
9830828|NCT00765674|10941602|FG000|COMPLETED|Overall Study||266
9830829|NCT00765674|10941603|FG001|COMPLETED|Overall Study||276
9830830|NCT00765674|10941604|FG002|COMPLETED|Overall Study||279
9830831|NCT00765674|10941605|FG003|COMPLETED|Overall Study||285
9830832|NCT00765674|10941602|FG000|NOT COMPLETED|Overall Study||21
9830833|NCT00765674|10941603|FG001|NOT COMPLETED|Overall Study||22
9830834|NCT00765674|10941604|FG002|NOT COMPLETED|Overall Study||17
9830835|NCT00765674|10941605|FG003|NOT COMPLETED|Overall Study||25
9830836|NCT00765726|10941615|FG000|STARTED|Overall Study||12
9830837|NCT00765726|10941615|FG000|COMPLETED|Overall Study||3
9830838|NCT00765726|10941615|FG000|NOT COMPLETED|Overall Study||9
9830839|NCT00765817|10941621|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
9830840|NCT00765817|10941622|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
9830841|NCT00765817|10941621|FG000|COMPLETED|Overall Study||112
9830842|NCT00765817|10941622|FG001|COMPLETED|Overall Study||101
9830843|NCT00765817|10941621|FG000|NOT COMPLETED|Overall Study||26
9830844|NCT00765817|10941622|FG001|NOT COMPLETED|Overall Study||22
9830845|NCT00765843|10941631|FG000|STARTED|Overall Study||26
9830846|NCT00765843|10941632|FG001|STARTED|Overall Study||25
9830847|NCT00765843|10941633|FG002|STARTED|Overall Study||26
9830848|NCT00765843|10941631|FG000|COMPLETED|Overall Study||25
9830849|NCT00765843|10941632|FG001|COMPLETED|Overall Study||21
9830850|NCT00765843|10941633|FG002|COMPLETED|Overall Study||23
9830851|NCT00765843|10941631|FG000|NOT COMPLETED|Overall Study||1
9830852|NCT00765843|10941632|FG001|NOT COMPLETED|Overall Study||4
9830853|NCT00765843|10941633|FG002|NOT COMPLETED|Overall Study||3
9830854|NCT00765856|10941641|FG000|STARTED|Titration Period||27
9830855|NCT00765856|10941641|FG000|COMPLETED|Titration Period||24
9792968|NCT02527187|10900969|FG000|STARTED|Overall Study||75
9792969|NCT02527187|10900970|FG001|STARTED|Overall Study||126
9792970|NCT02527187|10900969|FG000|COMPLETED|Overall Study||75
9792971|NCT02527187|10900970|FG001|COMPLETED|Overall Study||126
9792972|NCT02527187|10900969|FG000|NOT COMPLETED|Overall Study||0
9792973|NCT02527187|10900970|FG001|NOT COMPLETED|Overall Study||0
9792974|NCT02513472|10900980|FG000|STARTED|Overall Study||66
9792975|NCT02513472|10900981|FG001|STARTED|Overall Study||101
9792976|NCT02513472|10900980|FG000|Phase 1b Safety run-in|Overall Study||3
9792977|NCT02513472|10900981|FG001|Phase 1b Safety run-in|Overall Study||4
9792978|NCT02513472|10900980|FG000|Phase 2|Overall Study||63
9792979|NCT02513472|10900981|FG001|Phase 2|Overall Study||97
9792980|NCT02513472|10900980|FG000|COMPLETED|Overall Study||0
9792981|NCT02513472|10900981|FG001|COMPLETED|Overall Study||0
9792982|NCT02513472|10900980|FG000|NOT COMPLETED|Overall Study||66
9792983|NCT02513472|10900981|FG001|NOT COMPLETED|Overall Study||101
9792984|NCT02476409|10900991|FG000|STARTED|Overall Study||19
9792985|NCT02476409|10900992|FG001|STARTED|Overall Study||21
9792986|NCT02476409|10900991|FG000|COMPLETED|Overall Study||19
9792987|NCT02476409|10900992|FG001|COMPLETED|Overall Study||21
9792988|NCT02476409|10900991|FG000|NOT COMPLETED|Overall Study||0
9792989|NCT02476409|10900992|FG001|NOT COMPLETED|Overall Study||0
9792990|NCT02132650|10901004|FG000|STARTED|Overall Study||20
9792991|NCT02132650|10901005|FG001|STARTED|Overall Study||18
9792992|NCT02132650|10901004|FG000|Post-Intervention Assessment|Overall Study||19
9792993|NCT02132650|10901005|FG001|Post-Intervention Assessment|Overall Study||17
9792994|NCT02132650|10901004|FG000|COMPLETED|Overall Study||17
9792995|NCT02132650|10901005|FG001|COMPLETED|Overall Study||14
9792996|NCT02132650|10901004|FG000|NOT COMPLETED|Overall Study||3
9792997|NCT02132650|10901005|FG001|NOT COMPLETED|Overall Study||4
9792998|NCT01980355|10901013|FG000|STARTED|Overall Study||39
9792999|NCT01980355|10901014|FG001|STARTED|Overall Study||37
9793000|NCT01980355|10901013|FG000|COMPLETED|Overall Study||39
9793001|NCT01980355|10901014|FG001|COMPLETED|Overall Study||37
9793002|NCT01980355|10901013|FG000|NOT COMPLETED|Overall Study||0
9793003|NCT01980355|10901014|FG001|NOT COMPLETED|Overall Study||0
9793004|NCT01559935|10901020|FG000|STARTED|Car Phase||72
9793005|NCT01559935|10901020|FG000|COMPLETED|Car Phase||58
9793006|NCT01559935|10901020|FG000|NOT COMPLETED|Car Phase||14
9793007|NCT01559935|10901020|FG000|STARTED|BiRD Phase||58
9793008|NCT01559935|10901020|FG000|COMPLETED|BiRD Phase||54
9793009|NCT01559935|10901020|FG000|NOT COMPLETED|BiRD Phase||4
9793010|NCT01559935|10901020|FG000|STARTED|Maintenance Phase||54
9793011|NCT01559935|10901020|FG000|COMPLETED|Maintenance Phase||0
9793012|NCT01559935|10901020|FG000|NOT COMPLETED|Maintenance Phase||54
9793013|NCT01285362|10901026|FG000|STARTED|Overall Study||4
9793014|NCT01285362|10901027|FG001|STARTED|Overall Study||4
9793015|NCT01285362|10901026|FG000|COMPLETED|Overall Study||4
9793016|NCT01285362|10901027|FG001|COMPLETED|Overall Study||4
9793017|NCT01285362|10901026|FG000|NOT COMPLETED|Overall Study||0
9793018|NCT01285362|10901027|FG001|NOT COMPLETED|Overall Study||0
9793019|NCT01067144|10901035|FG000|STARTED|Treatment||207
9793020|NCT01067144|10901036|FG001|STARTED|Treatment||215
9793021|NCT01067144|10901035|FG000|COMPLETED|Treatment||203
9793022|NCT01067144|10901036|FG001|COMPLETED|Treatment||208
9793023|NCT01067144|10901035|FG000|NOT COMPLETED|Treatment||4
9793024|NCT01067144|10901036|FG001|NOT COMPLETED|Treatment||7
9793025|NCT01067144|10901035|FG000|STARTED|Follow-up||203
9793026|NCT01067144|10901036|FG001|STARTED|Follow-up||208
9793027|NCT01067144|10901035|FG000|Intention-to-Treat Analysis Set|Follow-up||202
9793028|NCT01067144|10901036|FG001|Intention-to-Treat Analysis Set|Follow-up||208
9793029|NCT01067144|10901035|FG000|COMPLETED|Follow-up||144
9793030|NCT01067144|10901036|FG001|COMPLETED|Follow-up||152
9793031|NCT01067144|10901035|FG000|NOT COMPLETED|Follow-up||59
9793032|NCT01067144|10901036|FG001|NOT COMPLETED|Follow-up||56
9793033|NCT00600483|10901044|FG000|STARTED|Overall Study||753
9793034|NCT00600483|10901045|FG001|STARTED|Overall Study||749
9793035|NCT00600483|10901044|FG000|COMPLETED|Overall Study||717
9793036|NCT00600483|10901045|FG001|COMPLETED|Overall Study||702
9793037|NCT00600483|10901044|FG000|NOT COMPLETED|Overall Study||36
9793038|NCT00600483|10901045|FG001|NOT COMPLETED|Overall Study||47
9793039|NCT00568854|10901053|FG000|STARTED|Overall Study||6
9793040|NCT00568854|10901054|FG001|STARTED|Overall Study||4
9793041|NCT00568854|10901053|FG000|COMPLETED|Overall Study||6
9793042|NCT00568854|10901054|FG001|COMPLETED|Overall Study||4
9793043|NCT00568854|10901053|FG000|NOT COMPLETED|Overall Study||0
9793044|NCT00568854|10901054|FG001|NOT COMPLETED|Overall Study||0
9793045|NCT00568958|10901062|FG000|STARTED|Allocation||70
9793046|NCT00568958|10901063|FG001|STARTED|Allocation||70
9793047|NCT00568958|10901062|FG000|COMPLETED|Allocation||61
9793048|NCT00568958|10901063|FG001|COMPLETED|Allocation||67
9793049|NCT00568958|10901062|FG000|NOT COMPLETED|Allocation||9
9793050|NCT00568958|10901063|FG001|NOT COMPLETED|Allocation||3
9793051|NCT00568958|10901062|FG000|STARTED|Follow-Up||61
9793052|NCT00568958|10901063|FG001|STARTED|Follow-Up||67
9793053|NCT00568958|10901062|FG000|COMPLETED|Follow-Up||52
9793054|NCT00568958|10901063|FG001|COMPLETED|Follow-Up||60
9793055|NCT00568958|10901062|FG000|NOT COMPLETED|Follow-Up||9
9793056|NCT00568958|10901063|FG001|NOT COMPLETED|Follow-Up||7
9793057|NCT00569010|10901073|FG000|STARTED|Overall Study||6
9793058|NCT00569010|10901074|FG001|STARTED|Overall Study||6
9793059|NCT00569010|10901075|FG002|STARTED|Overall Study||11
9793060|NCT00569010|10901076|FG003|STARTED|Overall Study||11
9793061|NCT00569010|10901073|FG000|COMPLETED|Overall Study||6
9793062|NCT00569010|10901074|FG001|COMPLETED|Overall Study||6
9793063|NCT00569010|10901075|FG002|COMPLETED|Overall Study||11
9793064|NCT00569010|10901076|FG003|COMPLETED|Overall Study||11
9793065|NCT00569010|10901073|FG000|NOT COMPLETED|Overall Study||0
9793066|NCT00569010|10901074|FG001|NOT COMPLETED|Overall Study||0
9793067|NCT00569010|10901075|FG002|NOT COMPLETED|Overall Study||0
9793068|NCT00569010|10901076|FG003|NOT COMPLETED|Overall Study||0
9793069|NCT00569166|10901089|FG000|STARTED|Overall Study||30
9793070|NCT00569166|10901090|FG001|STARTED|Overall Study||31
9793071|NCT00569166|10901091|FG002|STARTED|Overall Study||31
9793072|NCT00569166|10901089|FG000|COMPLETED|Overall Study||21
9793073|NCT00569166|10901090|FG001|COMPLETED|Overall Study||25
9793074|NCT00569166|10901091|FG002|COMPLETED|Overall Study||27
9793075|NCT00569166|10901089|FG000|NOT COMPLETED|Overall Study||9
9793076|NCT00569166|10901090|FG001|NOT COMPLETED|Overall Study||6
9793077|NCT00569166|10901091|FG002|NOT COMPLETED|Overall Study||4
9793078|NCT00569192|10901102|FG000|STARTED|Overall Study||111
9793079|NCT00569192|10901103|FG001|STARTED|Overall Study||125
9793080|NCT00569192|10901104|FG002|STARTED|Overall Study||124
9793081|NCT00569192|10901102|FG000|COMPLETED|Overall Study||88
9793082|NCT00569192|10901103|FG001|COMPLETED|Overall Study||105
9793083|NCT00569192|10901104|FG002|COMPLETED|Overall Study||99
9793084|NCT00569192|10901102|FG000|NOT COMPLETED|Overall Study||23
9793085|NCT00569192|10901103|FG001|NOT COMPLETED|Overall Study||20
9793086|NCT00569192|10901104|FG002|NOT COMPLETED|Overall Study||25
10015564|NCT01806688|11138604|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
10015565|NCT01806688|11138605|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
10015566|NCT01806688|11138604|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
10019125|NCT01827930|11142262|FG000|STARTED|Overall Study||24
9793087|NCT00569231|10901112|FG000|STARTED|Overall Study||18
9793088|NCT00569231|10901112|FG000|COMPLETED|Overall Study||11
9793089|NCT00569231|10901112|FG000|NOT COMPLETED|Overall Study||7
9793090|NCT00569270|10901116|FG000|STARTED|Period: First Intervention|randomized cross over study|15
9793091|NCT00569270|10901117|FG001|STARTED|Period: First Intervention||15
9793092|NCT00569270|10901116|FG000|COMPLETED|Period: First Intervention||15
9793093|NCT00569270|10901117|FG001|COMPLETED|Period: First Intervention||14
9793094|NCT00569270|10901116|FG000|NOT COMPLETED|Period: First Intervention||0
9793095|NCT00569270|10901117|FG001|NOT COMPLETED|Period: First Intervention||1
9793096|NCT00569270|10901116|FG000|STARTED|Period: Second Intervention||15
9793097|NCT00569270|10901117|FG001|STARTED|Period: Second Intervention||14
9793098|NCT00569270|10901116|FG000|29 Days|Period: Second Intervention||15
9793099|NCT00569270|10901117|FG001|29 Days|Period: Second Intervention||14
9793100|NCT00569270|10901116|FG000|COMPLETED|Period: Second Intervention||15
9793101|NCT00569270|10901117|FG001|COMPLETED|Period: Second Intervention||14
9793102|NCT00569270|10901116|FG000|NOT COMPLETED|Period: Second Intervention||0
9793103|NCT00569270|10901117|FG001|NOT COMPLETED|Period: Second Intervention||0
9793104|NCT00569309|10901132|FG000|STARTED|Overall Study||30
9793105|NCT00569309|10901132|FG000|COMPLETED|Overall Study||30
9793106|NCT00569309|10901132|FG000|NOT COMPLETED|Overall Study||0
9793107|NCT00569374|10901136|FG000|STARTED|Overall Study||8
9793108|NCT00569374|10901136|FG000|COMPLETED|Overall Study||4
9793109|NCT00569374|10901136|FG000|NOT COMPLETED|Overall Study||4
9793110|NCT00569530|10901142|FG000|STARTED|Overall Study||43
9793111|NCT00569530|10901143|FG001|STARTED|Overall Study||42
9793112|NCT00569530|10901142|FG000|COMPLETED|Overall Study||43
9793113|NCT00569530|10901143|FG001|COMPLETED|Overall Study||42
9793114|NCT00569530|10901142|FG000|NOT COMPLETED|Overall Study||0
9793115|NCT00569530|10901143|FG001|NOT COMPLETED|Overall Study||0
9793116|NCT00569582|10901149|FG000|STARTED|Overall Study||50
9793117|NCT00569582|10901149|FG000|COMPLETED|Overall Study||34
9793118|NCT00569582|10901149|FG000|NOT COMPLETED|Overall Study||16
9793119|NCT00569660|10901153|FG000|STARTED|Overall Study||34
9793120|NCT00569660|10901153|FG000|COMPLETED|Overall Study||34
9793121|NCT00569660|10901153|FG000|NOT COMPLETED|Overall Study||0
9793122|NCT00569673|10901157|FG000|STARTED|Overall Study|Total number participants enrolled on study|71
10019126|NCT01827930|11142263|FG001|STARTED|Overall Study||25
9793123|NCT00569673|10901157|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
9793124|NCT00569673|10901157|FG000|NOT COMPLETED|Overall Study||0
9793125|NCT00569777|10901163|FG000|STARTED|Overall Study||206
9793126|NCT00569777|10901164|FG001|STARTED|Overall Study||104
9793127|NCT00569777|10901163|FG000|COMPLETED|Overall Study||196
9793128|NCT00569777|10901164|FG001|COMPLETED|Overall Study||101
9793129|NCT00569777|10901163|FG000|NOT COMPLETED|Overall Study||10
9793130|NCT00569777|10901164|FG001|NOT COMPLETED|Overall Study||3
9793131|NCT00569803|10901178|FG000|STARTED|Overall Study||5
9793132|NCT00569803|10901179|FG001|STARTED|Overall Study||5
9793133|NCT00569803|10901180|FG002|STARTED|Overall Study||5
9793134|NCT00569803|10901181|FG003|STARTED|Overall Study||6
9793135|NCT00569803|10901182|FG004|STARTED|Overall Study||5
9793136|NCT00569803|10901183|FG005|STARTED|Overall Study||5
9793137|NCT00569803|10901184|FG006|STARTED|Overall Study||10
9793138|NCT00569803|10901185|FG007|STARTED|Overall Study||6
9793139|NCT00569803|10901178|FG000|COMPLETED|Overall Study||4
9793140|NCT00569803|10901179|FG001|COMPLETED|Overall Study||5
9793141|NCT00569803|10901180|FG002|COMPLETED|Overall Study||5
9793142|NCT00569803|10901181|FG003|COMPLETED|Overall Study||5
9793143|NCT00569803|10901182|FG004|COMPLETED|Overall Study||5
9793144|NCT00569803|10901183|FG005|COMPLETED|Overall Study||5
9793145|NCT00569803|10901184|FG006|COMPLETED|Overall Study||10
9793146|NCT00569803|10901185|FG007|COMPLETED|Overall Study||5
9793147|NCT00569803|10901178|FG000|NOT COMPLETED|Overall Study||1
9793148|NCT00569803|10901179|FG001|NOT COMPLETED|Overall Study||0
9793149|NCT00569803|10901180|FG002|NOT COMPLETED|Overall Study||0
9793150|NCT00569803|10901181|FG003|NOT COMPLETED|Overall Study||1
9793151|NCT00569803|10901182|FG004|NOT COMPLETED|Overall Study||0
9793152|NCT00569803|10901183|FG005|NOT COMPLETED|Overall Study||0
9793153|NCT00569803|10901184|FG006|NOT COMPLETED|Overall Study||0
9793154|NCT00569803|10901185|FG007|NOT COMPLETED|Overall Study||1
9793155|NCT00569855|10901207|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
9793156|NCT00569855|10901207|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785
9793157|NCT00569855|10901207|FG000|NOT COMPLETED|Overall Study||0
9793158|NCT00569946|10901211|FG000|STARTED|Overall Study||64
9793159|NCT00569946|10901211|FG000|COMPLETED|Overall Study||5
9793160|NCT00569946|10901211|FG000|NOT COMPLETED|Overall Study||59
9793161|NCT00570037|10901217|FG000|STARTED|Overall Study||238
9793162|NCT00570037|10901218|FG001|STARTED|Overall Study||306
9793163|NCT00570037|10901217|FG000|COMPLETED|Overall Study||194
9793164|NCT00570037|10901218|FG001|COMPLETED|Overall Study||237
9793165|NCT00570037|10901217|FG000|NOT COMPLETED|Overall Study||44
9793166|NCT00570037|10901218|FG001|NOT COMPLETED|Overall Study||69
9793167|NCT00570063|10901226|FG000|STARTED|Overall Study||24
9793168|NCT00570063|10901227|FG001|STARTED|Overall Study||11
9793169|NCT00570063|10901226|FG000|COMPLETED|Overall Study||9
9793170|NCT00570063|10901227|FG001|COMPLETED|Overall Study||3
9793171|NCT00570063|10901226|FG000|NOT COMPLETED|Overall Study||15
9793172|NCT00570063|10901227|FG001|NOT COMPLETED|Overall Study||8
9793173|NCT00570089|10901233|FG000|STARTED|Period 1||10
9793174|NCT00570089|10901234|FG001|STARTED|Period 1||10
9793175|NCT00570089|10901233|FG000|COMPLETED|Period 1||10
9793176|NCT00570089|10901234|FG001|COMPLETED|Period 1||10
9793177|NCT00570089|10901233|FG000|NOT COMPLETED|Period 1||0
9793178|NCT00570089|10901234|FG001|NOT COMPLETED|Period 1||0
9793179|NCT00570089|10901233|FG000|STARTED|Perod 2||10
9793180|NCT00570089|10901234|FG001|STARTED|Perod 2||10
9793181|NCT00570089|10901233|FG000|COMPLETED|Perod 2||10
9793182|NCT00570089|10901234|FG001|COMPLETED|Perod 2||10
9793183|NCT00570089|10901233|FG000|NOT COMPLETED|Perod 2||0
9793184|NCT00570089|10901234|FG001|NOT COMPLETED|Perod 2||0
9793185|NCT00570128|10901244|FG000|STARTED|Overall Study||64
9793186|NCT00570128|10901245|FG001|STARTED|Overall Study||65
9793187|NCT00570128|10901244|FG000|Intent to Treat (ITT) Population|Overall Study||62
9793188|NCT00570128|10901245|FG001|Intent to Treat (ITT) Population|Overall Study||65
9793189|NCT00570128|10901244|FG000|COMPLETED|Overall Study||60
9793190|NCT00570128|10901245|FG001|COMPLETED|Overall Study||65
9793191|NCT00570128|10901244|FG000|NOT COMPLETED|Overall Study||4
9793192|NCT00570128|10901245|FG001|NOT COMPLETED|Overall Study||0
9793193|NCT00570141|10901251|FG000|STARTED|Overall Study||13
9793194|NCT00570141|10901251|FG000|COMPLETED|Overall Study||10
9793195|NCT00570141|10901251|FG000|NOT COMPLETED|Overall Study||3
9793196|NCT00570232|10901255|FG000|STARTED|Overall Study||31
9793197|NCT00570232|10901255|FG000|COMPLETED|Overall Study||8
9793198|NCT00570232|10901255|FG000|NOT COMPLETED|Overall Study||23
9793199|NCT00570310|10901261|FG000|STARTED|Overall Study||53
9793200|NCT00570310|10901262|FG001|STARTED|Overall Study||51
9793201|NCT00570310|10901261|FG000|COMPLETED|Overall Study||51
9793202|NCT00570310|10901262|FG001|COMPLETED|Overall Study||45
9793203|NCT00570310|10901261|FG000|NOT COMPLETED|Overall Study||2
9793204|NCT00570310|10901262|FG001|NOT COMPLETED|Overall Study||6
9793205|NCT00570323|10901270|FG000|STARTED|Started Treatment After Randomization||36
9793206|NCT00570323|10901271|FG001|STARTED|Started Treatment After Randomization||36
9793207|NCT00570323|10901270|FG000|COMPLETED|Started Treatment After Randomization||34
9793208|NCT00570323|10901271|FG001|COMPLETED|Started Treatment After Randomization||35
9793209|NCT00570323|10901270|FG000|NOT COMPLETED|Started Treatment After Randomization||2
9793210|NCT00570323|10901271|FG001|NOT COMPLETED|Started Treatment After Randomization||1
10015567|NCT01806688|11138605|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
10015568|NCT01806688|11138604|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
9793211|NCT00570323|10901270|FG000|STARTED|Complete Study After Start||34
9793212|NCT00570323|10901271|FG001|STARTED|Complete Study After Start||35
9793213|NCT00570323|10901270|FG000|COMPLETED|Complete Study After Start||31
9793214|NCT00570323|10901271|FG001|COMPLETED|Complete Study After Start||34
9793215|NCT00570323|10901270|FG000|NOT COMPLETED|Complete Study After Start||3
9793216|NCT00570323|10901271|FG001|NOT COMPLETED|Complete Study After Start||1
9793217|NCT00570349|10901282|FG000|STARTED|Overall Study||6
9793218|NCT00570349|10901283|FG001|STARTED|Overall Study||6
9793219|NCT00570349|10901284|FG002|STARTED|Overall Study||6
9793220|NCT00570349|10901282|FG000|COMPLETED|Overall Study||6
9793221|NCT00570349|10901283|FG001|COMPLETED|Overall Study||6
9793222|NCT00570349|10901284|FG002|COMPLETED|Overall Study||6
9793223|NCT00570349|10901282|FG000|NOT COMPLETED|Overall Study||0
9793224|NCT00570349|10901283|FG001|NOT COMPLETED|Overall Study||0
9793225|NCT00570349|10901284|FG002|NOT COMPLETED|Overall Study||0
9793226|NCT00570362|10901294|FG000|STARTED|Overall Study||19
9793227|NCT00570362|10901295|FG001|STARTED|Overall Study||30
9793228|NCT00570362|10901294|FG000|COMPLETED|Overall Study||19
9793229|NCT00570362|10901295|FG001|COMPLETED|Overall Study||30
9793230|NCT00570362|10901294|FG000|NOT COMPLETED|Overall Study||0
9793231|NCT00570362|10901295|FG001|NOT COMPLETED|Overall Study||0
9793232|NCT00570401|10901301|FG000|STARTED|Overall Study||21
9793233|NCT00570401|10901301|FG000|COMPLETED|Overall Study||19
9793234|NCT00570401|10901301|FG000|NOT COMPLETED|Overall Study||2
9793235|NCT00570492|10901307|FG000|STARTED|16-week Single-blind Baseline Period||910
9793236|NCT00570492|10901308|FG001|STARTED|16-week Single-blind Baseline Period||0
9793237|NCT00570492|10901309|FG002|STARTED|16-week Single-blind Baseline Period||0
9793238|NCT00570492|10901307|FG000|COMPLETED|16-week Single-blind Baseline Period||474
9793239|NCT00570492|10901308|FG001|COMPLETED|16-week Single-blind Baseline Period||0
9793240|NCT00570492|10901309|FG002|COMPLETED|16-week Single-blind Baseline Period||0
9793241|NCT00570492|10901307|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436
9793242|NCT00570492|10901308|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0
9793243|NCT00570492|10901309|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0
9793244|NCT00570492|10901307|FG000|STARTED|52-week Double-blind Treatment Period||0
9793245|NCT00570492|10901308|FG001|STARTED|52-week Double-blind Treatment Period||237
9793246|NCT00570492|10901309|FG002|STARTED|52-week Double-blind Treatment Period||237
9793247|NCT00570492|10901307|FG000|COMPLETED|52-week Double-blind Treatment Period||0
9793248|NCT00570492|10901308|FG001|COMPLETED|52-week Double-blind Treatment Period||187
9793249|NCT00570492|10901309|FG002|COMPLETED|52-week Double-blind Treatment Period||186
9793250|NCT00570492|10901307|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
9793251|NCT00570492|10901308|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50
9793252|NCT00570492|10901309|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51
9952489|NCT01422434|11071469|FG000|COMPLETED|Overall Study||216
9952490|NCT01422434|11071470|FG001|COMPLETED|Overall Study||221
9952491|NCT01422434|11071471|FG002|COMPLETED|Overall Study||217
9952492|NCT01422434|11071469|FG000|NOT COMPLETED|Overall Study||11
9952493|NCT01422434|11071470|FG001|NOT COMPLETED|Overall Study||5
9952494|NCT01422434|11071471|FG002|NOT COMPLETED|Overall Study||6
9952495|NCT01422538|11071482|FG000|STARTED|Overall Study||10
9952496|NCT01422538|11071483|FG001|STARTED|Overall Study||10
9952497|NCT01422538|11071484|FG002|STARTED|Overall Study||10
9793253|NCT00570505|10901315|FG000|STARTED|Overall Study||149
9793254|NCT00570505|10901315|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
9793255|NCT00570505|10901315|FG000|NOT COMPLETED|Overall Study||41
9793256|NCT00570661|10901319|FG000|STARTED|Overall Study||17
9793257|NCT00570661|10901319|FG000|COMPLETED|Overall Study||10
9793258|NCT00570661|10901319|FG000|NOT COMPLETED|Overall Study||7
9793259|NCT00570674|10901324|FG000|STARTED|Overall Study||6
9793260|NCT00570674|10901325|FG001|STARTED|Overall Study||3
9793261|NCT00570674|10901326|FG002|STARTED|Overall Study||4
9793262|NCT00570674|10901327|FG003|STARTED|Overall Study||3
9793263|NCT00570674|10901328|FG004|STARTED|Overall Study||3
9793264|NCT00570674|10901329|FG005|STARTED|Overall Study||10
9793265|NCT00570674|10901330|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0
9793266|NCT00570674|10901324|FG000|Treated|Overall Study||6
9793267|NCT00570674|10901325|FG001|Treated|Overall Study||3
9793268|NCT00570674|10901326|FG002|Treated|Overall Study||3
9793269|NCT00570674|10901327|FG003|Treated|Overall Study||3
9793270|NCT00570674|10901328|FG004|Treated|Overall Study||3
9793271|NCT00570674|10901329|FG005|Treated|Overall Study||10
9793272|NCT00570674|10901330|FG006|Treated|Overall Study||0
9793273|NCT00570674|10901324|FG000|PEG Evaluable|Overall Study||6
9793274|NCT00570674|10901325|FG001|PEG Evaluable|Overall Study||3
9793275|NCT00570674|10901326|FG002|PEG Evaluable|Overall Study||3
9793276|NCT00570674|10901327|FG003|PEG Evaluable|Overall Study||3
9793277|NCT00570674|10901328|FG004|PEG Evaluable|Overall Study||2
9793278|NCT00570674|10901329|FG005|PEG Evaluable|Overall Study||10
9793279|NCT00570674|10901330|FG006|PEG Evaluable|Overall Study||0
9793280|NCT00570674|10901324|FG000|COMPLETED|Overall Study||6
9793281|NCT00570674|10901325|FG001|COMPLETED|Overall Study||3
9793282|NCT00570674|10901326|FG002|COMPLETED|Overall Study||3
9793283|NCT00570674|10901327|FG003|COMPLETED|Overall Study||3
9793284|NCT00570674|10901328|FG004|COMPLETED|Overall Study||3
9793285|NCT00570674|10901329|FG005|COMPLETED|Overall Study||10
9793286|NCT00570674|10901330|FG006|COMPLETED|Overall Study||0
9793287|NCT00570674|10901324|FG000|NOT COMPLETED|Overall Study||0
9793288|NCT00570674|10901325|FG001|NOT COMPLETED|Overall Study||0
9793289|NCT00570674|10901326|FG002|NOT COMPLETED|Overall Study||1
9793290|NCT00570674|10901327|FG003|NOT COMPLETED|Overall Study||0
9793291|NCT00570674|10901328|FG004|NOT COMPLETED|Overall Study||0
9793292|NCT00570674|10901329|FG005|NOT COMPLETED|Overall Study||0
9793293|NCT00570674|10901330|FG006|NOT COMPLETED|Overall Study||0
9793294|NCT00570687|10901343|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9952498|NCT01422538|11071482|FG000|COMPLETED|Overall Study||10
9952499|NCT01422538|11071483|FG001|COMPLETED|Overall Study||8
9952500|NCT01422538|11071484|FG002|COMPLETED|Overall Study||8
9793295|NCT00570687|10901344|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793296|NCT00570687|10901345|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793297|NCT00570687|10901346|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793298|NCT00570687|10901347|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793299|NCT00570687|10901348|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793300|NCT00570687|10901349|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793301|NCT00570687|10901350|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793302|NCT00570687|10901351|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793303|NCT00570687|10901352|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793304|NCT00570687|10901343|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793305|NCT00570687|10901344|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793306|NCT00570687|10901345|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793307|NCT00570687|10901346|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793308|NCT00570687|10901347|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793309|NCT00570687|10901348|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793310|NCT00570687|10901349|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793311|NCT00570687|10901350|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793312|NCT00570687|10901351|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793313|NCT00570687|10901352|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9793314|NCT00570687|10901343|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793315|NCT00570687|10901344|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793316|NCT00570687|10901345|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793317|NCT00570687|10901346|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793318|NCT00570687|10901347|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793319|NCT00570687|10901348|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793320|NCT00570687|10901349|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793321|NCT00570687|10901350|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793322|NCT00570687|10901351|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793323|NCT00570687|10901352|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9793324|NCT00570687|10901343|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
9793325|NCT00570687|10901344|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
9793326|NCT00570687|10901345|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
9793327|NCT00570687|10901346|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
9793328|NCT00570687|10901347|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
9793329|NCT00570687|10901348|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
9793330|NCT00570687|10901349|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
9793331|NCT00570687|10901350|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
9793332|NCT00570687|10901351|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
9793333|NCT00570687|10901352|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
9793334|NCT00570687|10901343|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793335|NCT00570687|10901344|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793336|NCT00570687|10901345|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793337|NCT00570687|10901346|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793338|NCT00570687|10901347|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
9793339|NCT00570687|10901348|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
9793340|NCT00570687|10901349|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
9793341|NCT00570687|10901350|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
9793342|NCT00570687|10901351|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
9793343|NCT00570687|10901352|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
9793344|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793345|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793346|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793347|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793348|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793349|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793350|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793351|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793352|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793353|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9793354|NCT00570687|10901343|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793355|NCT00570687|10901344|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793356|NCT00570687|10901345|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793357|NCT00570687|10901346|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793358|NCT00570687|10901347|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793359|NCT00570687|10901348|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793360|NCT00570687|10901349|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793361|NCT00570687|10901350|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793362|NCT00570687|10901351|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793363|NCT00570687|10901352|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793364|NCT00570687|10901343|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793365|NCT00570687|10901344|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793366|NCT00570687|10901345|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793367|NCT00570687|10901346|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793368|NCT00570687|10901347|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793369|NCT00570687|10901348|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793370|NCT00570687|10901349|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793371|NCT00570687|10901350|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793372|NCT00570687|10901351|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793373|NCT00570687|10901352|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9793374|NCT00570687|10901343|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793375|NCT00570687|10901344|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793376|NCT00570687|10901345|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793377|NCT00570687|10901346|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793378|NCT00570687|10901347|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793379|NCT00570687|10901348|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793380|NCT00570687|10901349|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793381|NCT00570687|10901350|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793382|NCT00570687|10901351|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793383|NCT00570687|10901352|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
9793384|NCT00570687|10901343|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
9793385|NCT00570687|10901344|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
9793386|NCT00570687|10901345|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
9793387|NCT00570687|10901346|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
9793388|NCT00570687|10901347|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
9793389|NCT00570687|10901348|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10235228|NCT01222871|11365475|FG000|COMPLETED|Overall Study||0
10235229|NCT01222871|11365476|FG001|COMPLETED|Overall Study||0
10235230|NCT01222871|11365475|FG000|NOT COMPLETED|Overall Study||0
10235231|NCT01222871|11365476|FG001|NOT COMPLETED|Overall Study||0
10235232|NCT01219673|11365491|FG000|STARTED|Overall Study||0
10235233|NCT01219673|11365492|FG001|STARTED|Overall Study||0
10235234|NCT01219673|11365493|FG002|STARTED|Overall Study||1
9793390|NCT00570687|10901349|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
9793391|NCT00570687|10901350|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
9793392|NCT00570687|10901351|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
9793393|NCT00570687|10901352|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
9793394|NCT00570687|10901343|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793395|NCT00570687|10901344|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793396|NCT00570687|10901345|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793397|NCT00570687|10901346|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793398|NCT00570687|10901347|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
9793399|NCT00570687|10901348|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
9793400|NCT00570687|10901349|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
9793401|NCT00570687|10901350|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
9793402|NCT00570687|10901351|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
9793403|NCT00570687|10901352|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
9793404|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793405|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793406|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793407|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793408|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793409|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793410|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793411|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793412|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793413|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
9793414|NCT00570687|10901343|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793415|NCT00570687|10901344|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793416|NCT00570687|10901345|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793417|NCT00570687|10901346|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793418|NCT00570687|10901347|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793419|NCT00570687|10901348|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793420|NCT00570687|10901349|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793421|NCT00570687|10901350|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793422|NCT00570687|10901351|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793423|NCT00570687|10901352|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793424|NCT00570687|10901343|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793425|NCT00570687|10901344|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793426|NCT00570687|10901345|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793427|NCT00570687|10901346|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793428|NCT00570687|10901347|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793429|NCT00570687|10901348|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793430|NCT00570687|10901349|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793431|NCT00570687|10901350|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793432|NCT00570687|10901351|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793433|NCT00570687|10901352|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
9793434|NCT00570687|10901343|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10235235|NCT01219673|11365494|FG003|STARTED|Overall Study||0
10235236|NCT01219673|11365495|FG004|STARTED|Overall Study||0
9793435|NCT00570687|10901344|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793436|NCT00570687|10901345|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793437|NCT00570687|10901346|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793438|NCT00570687|10901347|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793439|NCT00570687|10901348|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793440|NCT00570687|10901349|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793441|NCT00570687|10901350|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793442|NCT00570687|10901351|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793443|NCT00570687|10901352|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9793444|NCT00570687|10901343|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
9793445|NCT00570687|10901344|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
9793446|NCT00570687|10901345|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
9793447|NCT00570687|10901346|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
9793448|NCT00570687|10901347|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
9793449|NCT00570687|10901348|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
9793450|NCT00570687|10901349|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
9793451|NCT00570687|10901350|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
9793452|NCT00570687|10901351|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
9793453|NCT00570687|10901352|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
9793454|NCT00570687|10901343|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793455|NCT00570687|10901344|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793456|NCT00570687|10901345|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793457|NCT00570687|10901346|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793458|NCT00570687|10901347|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793459|NCT00570687|10901348|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793460|NCT00570687|10901349|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
9793461|NCT00570687|10901350|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793462|NCT00570687|10901351|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
9793463|NCT00570687|10901352|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793464|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793465|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793466|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793467|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
9793468|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
9793469|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
9793470|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
9793471|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
9793472|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
9793473|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
9793474|NCT00570687|10901343|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793475|NCT00570687|10901344|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793476|NCT00570687|10901345|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793477|NCT00570687|10901346|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793478|NCT00570687|10901347|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793479|NCT00570687|10901348|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793480|NCT00570687|10901349|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
9793481|NCT00570687|10901350|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793482|NCT00570687|10901351|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
9793483|NCT00570687|10901352|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9793484|NCT00570687|10901343|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793485|NCT00570687|10901344|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793486|NCT00570687|10901345|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793487|NCT00570687|10901346|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793488|NCT00570687|10901347|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793489|NCT00570687|10901348|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793490|NCT00570687|10901349|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
9793491|NCT00570687|10901350|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793492|NCT00570687|10901351|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
9793493|NCT00570687|10901352|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793494|NCT00570687|10901343|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793495|NCT00570687|10901344|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793496|NCT00570687|10901345|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793497|NCT00570687|10901346|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793498|NCT00570687|10901347|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793499|NCT00570687|10901348|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793500|NCT00570687|10901349|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10015569|NCT01806688|11138605|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
10015570|NCT01806688|11138604|FG000|COMPLETED|Third Intervention Seed Study||38
10015571|NCT01806688|11138605|FG001|COMPLETED|Third Intervention Seed Study||0
10015572|NCT01806688|11138604|FG000|NOT COMPLETED|Third Intervention Seed Study||0
10015573|NCT01806688|11138605|FG001|NOT COMPLETED|Third Intervention Seed Study||0
9793501|NCT00570687|10901350|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793502|NCT00570687|10901351|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793503|NCT00570687|10901352|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
9793504|NCT00570687|10901343|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793505|NCT00570687|10901344|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793506|NCT00570687|10901345|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793507|NCT00570687|10901346|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793508|NCT00570687|10901347|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793509|NCT00570687|10901348|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793510|NCT00570687|10901349|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
9793511|NCT00570687|10901350|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793512|NCT00570687|10901351|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
9793513|NCT00570687|10901352|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
9793514|NCT00570687|10901343|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793515|NCT00570687|10901344|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793516|NCT00570687|10901345|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793517|NCT00570687|10901346|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793518|NCT00570687|10901347|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793519|NCT00570687|10901348|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793520|NCT00570687|10901349|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
9793521|NCT00570687|10901350|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793522|NCT00570687|10901351|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793523|NCT00570687|10901352|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793524|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793525|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793526|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793527|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793528|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793529|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793530|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793531|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793532|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
9793533|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
9793534|NCT00570687|10901343|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793535|NCT00570687|10901344|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793536|NCT00570687|10901345|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793537|NCT00570687|10901346|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793538|NCT00570687|10901347|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793539|NCT00570687|10901348|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793540|NCT00570687|10901349|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
9793541|NCT00570687|10901350|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793542|NCT00570687|10901351|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793543|NCT00570687|10901352|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
9793544|NCT00570687|10901343|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793545|NCT00570687|10901344|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793546|NCT00570687|10901345|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793547|NCT00570687|10901346|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793548|NCT00570687|10901347|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793549|NCT00570687|10901348|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793550|NCT00570687|10901349|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
9793551|NCT00570687|10901350|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793552|NCT00570687|10901351|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793553|NCT00570687|10901352|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793554|NCT00570687|10901343|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793555|NCT00570687|10901344|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793556|NCT00570687|10901345|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793557|NCT00570687|10901346|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793558|NCT00570687|10901347|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793559|NCT00570687|10901348|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793560|NCT00570687|10901349|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793561|NCT00570687|10901350|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793562|NCT00570687|10901351|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793563|NCT00570687|10901352|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9793564|NCT00570687|10901343|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793565|NCT00570687|10901344|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793566|NCT00570687|10901345|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793567|NCT00570687|10901346|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793568|NCT00570687|10901347|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793569|NCT00570687|10901348|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793570|NCT00570687|10901349|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
9793571|NCT00570687|10901350|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793572|NCT00570687|10901351|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793573|NCT00570687|10901352|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
9793574|NCT00570687|10901343|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793575|NCT00570687|10901344|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793576|NCT00570687|10901345|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793577|NCT00570687|10901346|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793578|NCT00570687|10901347|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793579|NCT00570687|10901348|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793580|NCT00570687|10901349|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793581|NCT00570687|10901350|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793582|NCT00570687|10901351|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793583|NCT00570687|10901352|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793584|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793585|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793586|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793587|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793588|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793589|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793590|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
9793591|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793592|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793593|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9793594|NCT00570687|10901343|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
9793595|NCT00570687|10901344|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
9793596|NCT00570687|10901345|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
9793597|NCT00570687|10901346|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
9793598|NCT00570687|10901347|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793599|NCT00570687|10901348|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793600|NCT00570687|10901349|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793601|NCT00570687|10901350|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793602|NCT00570687|10901351|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793603|NCT00570687|10901352|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793604|NCT00570687|10901343|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
9793605|NCT00570687|10901344|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
9793606|NCT00570687|10901345|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
9793607|NCT00570687|10901346|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
9793608|NCT00570687|10901347|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793609|NCT00570687|10901348|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793610|NCT00570687|10901349|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793611|NCT00570687|10901350|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793612|NCT00570687|10901351|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793613|NCT00570687|10901352|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793614|NCT00570687|10901343|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793615|NCT00570687|10901344|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793616|NCT00570687|10901345|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793617|NCT00570687|10901346|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793618|NCT00570687|10901347|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793619|NCT00570687|10901348|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793620|NCT00570687|10901349|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793621|NCT00570687|10901350|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793622|NCT00570687|10901351|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793623|NCT00570687|10901352|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
9793624|NCT00570687|10901343|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
9793625|NCT00570687|10901344|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
9793626|NCT00570687|10901345|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
9793627|NCT00570687|10901346|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
9793628|NCT00570687|10901347|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
9793629|NCT00570687|10901348|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
9793630|NCT00570687|10901349|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
9793631|NCT00570687|10901350|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
9793632|NCT00570687|10901351|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10235237|NCT01219673|11365496|FG005|STARTED|Overall Study||0
10235238|NCT01219673|11365497|FG006|STARTED|Overall Study||0
10235239|NCT01219673|11365498|FG007|STARTED|Overall Study||0
10235240|NCT01219673|11365491|FG000|COMPLETED|Overall Study||0
10235241|NCT01219673|11365492|FG001|COMPLETED|Overall Study||0
9793633|NCT00570687|10901352|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
9793634|NCT00570687|10901343|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
9793635|NCT00570687|10901344|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
9952501|NCT01422538|11071482|FG000|NOT COMPLETED|Overall Study||0
10235242|NCT01219673|11365493|FG002|COMPLETED|Overall Study||1
9793636|NCT00570687|10901345|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
9793637|NCT00570687|10901346|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
9793638|NCT00570687|10901347|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793639|NCT00570687|10901348|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793640|NCT00570687|10901349|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793641|NCT00570687|10901350|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793642|NCT00570687|10901351|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793643|NCT00570687|10901352|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793644|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10235243|NCT01219673|11365494|FG003|COMPLETED|Overall Study||0
10235244|NCT01219673|11365495|FG004|COMPLETED|Overall Study||0
9793645|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793646|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793647|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793648|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793649|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793650|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793651|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793652|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793653|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9793654|NCT00570687|10901343|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
9793655|NCT00570687|10901344|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
9793656|NCT00570687|10901345|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
9793657|NCT00570687|10901346|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
9793658|NCT00570687|10901347|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793659|NCT00570687|10901348|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793660|NCT00570687|10901349|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793661|NCT00570687|10901350|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793662|NCT00570687|10901351|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793663|NCT00570687|10901352|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793664|NCT00570687|10901343|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
9793665|NCT00570687|10901344|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
9793666|NCT00570687|10901345|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
9793667|NCT00570687|10901346|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
9793668|NCT00570687|10901347|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793669|NCT00570687|10901348|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793670|NCT00570687|10901349|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793671|NCT00570687|10901350|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793672|NCT00570687|10901351|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793673|NCT00570687|10901352|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793674|NCT00570687|10901343|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793675|NCT00570687|10901344|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793676|NCT00570687|10901345|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793677|NCT00570687|10901346|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793678|NCT00570687|10901347|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793679|NCT00570687|10901348|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793680|NCT00570687|10901349|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793681|NCT00570687|10901350|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793682|NCT00570687|10901351|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793683|NCT00570687|10901352|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9793684|NCT00570687|10901343|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
9793685|NCT00570687|10901344|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
9793686|NCT00570687|10901345|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
9793687|NCT00570687|10901346|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
9793688|NCT00570687|10901347|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
9793689|NCT00570687|10901348|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
9793690|NCT00570687|10901349|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
9793691|NCT00570687|10901350|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
9793692|NCT00570687|10901351|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
9793693|NCT00570687|10901352|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
9793694|NCT00570687|10901343|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
9793695|NCT00570687|10901344|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
9793696|NCT00570687|10901345|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
9793697|NCT00570687|10901346|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
9793698|NCT00570687|10901347|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793699|NCT00570687|10901348|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793700|NCT00570687|10901349|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793701|NCT00570687|10901350|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793702|NCT00570687|10901351|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793703|NCT00570687|10901352|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793704|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793705|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793706|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793707|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793708|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793709|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793710|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793711|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793712|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793713|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
9793714|NCT00570687|10901343|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4
9793715|NCT00570687|10901344|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2
9793716|NCT00570687|10901345|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2
9793717|NCT00570687|10901346|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4
9793718|NCT00570687|10901347|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0
9793719|NCT00570687|10901348|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0
9793720|NCT00570687|10901349|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0
9793721|NCT00570687|10901350|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0
9793722|NCT00570687|10901351|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0
9793723|NCT00570687|10901352|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0
9793724|NCT00570687|10901343|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
9793725|NCT00570687|10901344|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
9793726|NCT00570687|10901345|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
9793727|NCT00570687|10901346|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
9793728|NCT00570687|10901347|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793729|NCT00570687|10901348|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793730|NCT00570687|10901349|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793731|NCT00570687|10901350|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793732|NCT00570687|10901351|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793733|NCT00570687|10901352|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793734|NCT00570687|10901343|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793735|NCT00570687|10901344|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793736|NCT00570687|10901345|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793737|NCT00570687|10901346|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793738|NCT00570687|10901347|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793739|NCT00570687|10901348|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793740|NCT00570687|10901349|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793741|NCT00570687|10901350|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793742|NCT00570687|10901351|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793743|NCT00570687|10901352|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9793744|NCT00570687|10901343|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
9793745|NCT00570687|10901344|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
9793746|NCT00570687|10901345|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
9793747|NCT00570687|10901346|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
9793748|NCT00570687|10901347|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
9793749|NCT00570687|10901348|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
9793750|NCT00570687|10901349|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
9793751|NCT00570687|10901350|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
9793752|NCT00570687|10901351|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
9793753|NCT00570687|10901352|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
9793754|NCT00570687|10901343|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
9793755|NCT00570687|10901344|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
9793756|NCT00570687|10901345|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
9793757|NCT00570687|10901346|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
9793758|NCT00570687|10901347|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793759|NCT00570687|10901348|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793760|NCT00570687|10901349|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793761|NCT00570687|10901350|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793762|NCT00570687|10901351|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793763|NCT00570687|10901352|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793764|NCT00570687|10901343|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793765|NCT00570687|10901344|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793766|NCT00570687|10901345|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793767|NCT00570687|10901346|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793768|NCT00570687|10901347|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793769|NCT00570687|10901348|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793770|NCT00570687|10901349|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793771|NCT00570687|10901350|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793772|NCT00570687|10901351|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793773|NCT00570687|10901352|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
9793774|NCT00570687|10901343|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4
9793775|NCT00570687|10901344|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2
9793776|NCT00570687|10901345|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2
9793777|NCT00570687|10901346|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4
9793778|NCT00570687|10901347|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0
9793779|NCT00570687|10901348|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0
9793780|NCT00570687|10901349|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0
9793781|NCT00570687|10901350|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0
9793782|NCT00570687|10901351|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0
9793783|NCT00570687|10901352|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0
9793784|NCT00570687|10901343|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
9793785|NCT00570687|10901344|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
9793786|NCT00570687|10901345|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
9793787|NCT00570687|10901346|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
9793788|NCT00570687|10901347|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793789|NCT00570687|10901348|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793790|NCT00570687|10901349|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793791|NCT00570687|10901350|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793792|NCT00570687|10901351|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793793|NCT00570687|10901352|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793794|NCT00570687|10901343|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793795|NCT00570687|10901344|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793796|NCT00570687|10901345|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793797|NCT00570687|10901346|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793798|NCT00570687|10901347|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793799|NCT00570687|10901348|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793800|NCT00570687|10901349|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793801|NCT00570687|10901350|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793802|NCT00570687|10901351|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793803|NCT00570687|10901352|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
9793804|NCT00570700|10901366|FG000|STARTED|Overall Study||38
9793805|NCT00570700|10901366|FG000|COMPLETED|Overall Study||27
9793806|NCT00570700|10901366|FG000|NOT COMPLETED|Overall Study||11
9793807|NCT00570713|10901372|FG000|STARTED|Overall Study||78
9793808|NCT00570713|10901373|FG001|STARTED|Overall Study||77
9793809|NCT00570713|10901372|FG000|COMPLETED|Overall Study||0
9793810|NCT00570713|10901373|FG001|COMPLETED|Overall Study||0
9793811|NCT00570713|10901372|FG000|NOT COMPLETED|Overall Study||78
9793812|NCT00570713|10901373|FG001|NOT COMPLETED|Overall Study||77
9793813|NCT00570739|10901383|FG000|STARTED|Overall Study||141
9793814|NCT00570739|10901384|FG001|STARTED|Overall Study||145
9793815|NCT00570739|10901385|FG002|STARTED|Overall Study||108
9793816|NCT00570739|10901386|FG003|STARTED|Overall Study||108
9793817|NCT00570739|10901383|FG000|COMPLETED|Overall Study||120
9793818|NCT00570739|10901384|FG001|COMPLETED|Overall Study||124
9793819|NCT00570739|10901385|FG002|COMPLETED|Overall Study||92
9793820|NCT00570739|10901386|FG003|COMPLETED|Overall Study||96
9793821|NCT00570739|10901383|FG000|NOT COMPLETED|Overall Study||21
9793822|NCT00570739|10901384|FG001|NOT COMPLETED|Overall Study||21
9793823|NCT00570739|10901385|FG002|NOT COMPLETED|Overall Study||16
9793824|NCT00570739|10901386|FG003|NOT COMPLETED|Overall Study||12
9830856|NCT00765856|10941641|FG000|NOT COMPLETED|Titration Period||3
9830857|NCT00765856|10941641|FG000|STARTED|Maintenance Period||24
9830858|NCT00765856|10941641|FG000|COMPLETED|Maintenance Period||18
9830859|NCT00765856|10941641|FG000|NOT COMPLETED|Maintenance Period||6
9830860|NCT00765882|10941651|FG000|STARTED|Overall Study||215
9830861|NCT00765882|10941652|FG001|STARTED|Overall Study||213
9830862|NCT00765882|10941653|FG002|STARTED|Overall Study||205
9830863|NCT00765882|10941651|FG000|COMPLETED|Overall Study||191
9830864|NCT00765882|10941652|FG001|COMPLETED|Overall Study||173
9830865|NCT00765882|10941653|FG002|COMPLETED|Overall Study||169
9830866|NCT00765882|10941651|FG000|NOT COMPLETED|Overall Study||24
9830867|NCT00765882|10941652|FG001|NOT COMPLETED|Overall Study||40
9830868|NCT00765882|10941653|FG002|NOT COMPLETED|Overall Study||36
9830869|NCT00765895|10941663|FG000|STARTED|Overall Study||65
9830870|NCT00765895|10941664|FG001|STARTED|Overall Study||65
9830871|NCT00765895|10941663|FG000|COMPLETED|Overall Study||65
9830872|NCT00765895|10941664|FG001|COMPLETED|Overall Study||65
9830873|NCT00765895|10941663|FG000|NOT COMPLETED|Overall Study||0
9830874|NCT00765895|10941664|FG001|NOT COMPLETED|Overall Study||0
9830875|NCT00765947|10941670|FG000|STARTED|Overall Study||256
9830876|NCT00765947|10941670|FG000|COMPLETED|Overall Study||232
9830877|NCT00765947|10941670|FG000|NOT COMPLETED|Overall Study||24
9830878|NCT00765999|10941676|FG000|STARTED|Overall Study||1554
9830879|NCT00765999|10941676|FG000|COMPLETED|Overall Study||770
9830880|NCT00765999|10941676|FG000|NOT COMPLETED|Overall Study||784
9830881|NCT00766038|10941684|FG000|STARTED|Overall Study||31
9830882|NCT00766038|10941685|FG001|STARTED|Overall Study||32
9830883|NCT00766038|10941684|FG000|COMPLETED|Overall Study||16
9830884|NCT00766038|10941685|FG001|COMPLETED|Overall Study||18
9830885|NCT00766038|10941684|FG000|NOT COMPLETED|Overall Study||15
9830886|NCT00766038|10941685|FG001|NOT COMPLETED|Overall Study||14
9830887|NCT00766051|10941695|FG000|STARTED|Overall Study||12
9830888|NCT00766051|10941696|FG001|STARTED|Overall Study||10
9830889|NCT00766051|10941695|FG000|COMPLETED|Overall Study||10
9830890|NCT00766051|10941696|FG001|COMPLETED|Overall Study||10
9830891|NCT00766051|10941695|FG000|NOT COMPLETED|Overall Study||2
9830892|NCT00766051|10941696|FG001|NOT COMPLETED|Overall Study||0
9830893|NCT00766090|10941706|FG000|STARTED|Treatment Period 1 (28 Days)||25
9830894|NCT00766090|10941707|FG001|STARTED|Treatment Period 1 (28 Days)||27
9830895|NCT00766090|10941708|FG002|STARTED|Treatment Period 1 (28 Days)||23
9830896|NCT00766090|10941709|FG003|STARTED|Treatment Period 1 (28 Days)||26
9830897|NCT00766090|10941710|FG004|STARTED|Treatment Period 1 (28 Days)||23
9830898|NCT00766090|10941711|FG005|STARTED|Treatment Period 1 (28 Days)||23
9830899|NCT00766090|10941712|FG006|STARTED|Treatment Period 1 (28 Days)||6
9830900|NCT00766090|10941713|FG007|STARTED|Treatment Period 1 (28 Days)||8
9830901|NCT00766090|10941714|FG008|STARTED|Treatment Period 1 (28 Days)||7
9830902|NCT00766090|10941715|FG009|STARTED|Treatment Period 1 (28 Days)||8
9830903|NCT00766090|10941716|FG010|STARTED|Treatment Period 1 (28 Days)||7
9830904|NCT00766090|10941717|FG011|STARTED|Treatment Period 1 (28 Days)||7
9830905|NCT00766090|10941706|FG000|COMPLETED|Treatment Period 1 (28 Days)||22
9830906|NCT00766090|10941707|FG001|COMPLETED|Treatment Period 1 (28 Days)||27
9830907|NCT00766090|10941708|FG002|COMPLETED|Treatment Period 1 (28 Days)||23
9830908|NCT00766090|10941709|FG003|COMPLETED|Treatment Period 1 (28 Days)||25
9830909|NCT00766090|10941710|FG004|COMPLETED|Treatment Period 1 (28 Days)||23
9830910|NCT00766090|10941711|FG005|COMPLETED|Treatment Period 1 (28 Days)||23
9830911|NCT00766090|10941712|FG006|COMPLETED|Treatment Period 1 (28 Days)||6
9830912|NCT00766090|10941713|FG007|COMPLETED|Treatment Period 1 (28 Days)||8
9830913|NCT00766090|10941714|FG008|COMPLETED|Treatment Period 1 (28 Days)||6
9830914|NCT00766090|10941715|FG009|COMPLETED|Treatment Period 1 (28 Days)||8
9830915|NCT00766090|10941716|FG010|COMPLETED|Treatment Period 1 (28 Days)||7
9793825|NCT00570765|10901419|FG000|STARTED|DB Phase||20
9793826|NCT00570765|10901420|FG001|STARTED|DB Phase||16
9793827|NCT00570765|10901421|FG002|STARTED|DB Phase||24
9793828|NCT00570765|10901422|FG003|STARTED|DB Phase||0
9793829|NCT00570765|10901419|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20
9793830|NCT00570765|10901420|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16
9793831|NCT00570765|10901421|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23
9793832|NCT00570765|10901422|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
9793833|NCT00570765|10901419|FG000|Safety Population|DB Phase||20
9793834|NCT00570765|10901420|FG001|Safety Population|DB Phase||16
9793835|NCT00570765|10901421|FG002|Safety Population|DB Phase||23
9793836|NCT00570765|10901422|FG003|Safety Population|DB Phase||0
9793837|NCT00570765|10901419|FG000|COMPLETED|DB Phase||16
9793838|NCT00570765|10901420|FG001|COMPLETED|DB Phase||9
9793839|NCT00570765|10901421|FG002|COMPLETED|DB Phase||23
9793840|NCT00570765|10901422|FG003|COMPLETED|DB Phase||0
9793841|NCT00570765|10901419|FG000|NOT COMPLETED|DB Phase||4
9793842|NCT00570765|10901420|FG001|NOT COMPLETED|DB Phase||7
9793843|NCT00570765|10901421|FG002|NOT COMPLETED|DB Phase||1
9793844|NCT00570765|10901422|FG003|NOT COMPLETED|DB Phase||0
9793845|NCT00570765|10901419|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
9793846|NCT00570765|10901420|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
9793847|NCT00570765|10901421|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
9793848|NCT00570765|10901422|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
9793849|NCT00570765|10901419|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0
9793850|NCT00570765|10901420|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0
9793851|NCT00570765|10901421|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0
9793852|NCT00570765|10901422|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28
9793853|NCT00570765|10901419|FG000|Safety Population|LTSE Phase||0
9793854|NCT00570765|10901420|FG001|Safety Population|LTSE Phase||0
9793855|NCT00570765|10901421|FG002|Safety Population|LTSE Phase||0
9793856|NCT00570765|10901422|FG003|Safety Population|LTSE Phase||28
9793857|NCT00570765|10901419|FG000|COMPLETED|LTSE Phase||0
9793858|NCT00570765|10901420|FG001|COMPLETED|LTSE Phase||0
9793859|NCT00570765|10901421|FG002|COMPLETED|LTSE Phase||0
9793860|NCT00570765|10901422|FG003|COMPLETED|LTSE Phase||16
9793861|NCT00570765|10901419|FG000|NOT COMPLETED|LTSE Phase||0
9793862|NCT00570765|10901420|FG001|NOT COMPLETED|LTSE Phase||0
9793863|NCT00570765|10901421|FG002|NOT COMPLETED|LTSE Phase||0
9793864|NCT00570765|10901422|FG003|NOT COMPLETED|LTSE Phase||12
9793865|NCT00570778|10901433|FG000|STARTED|Overall Study||41
9793866|NCT00570778|10901434|FG001|STARTED|Overall Study||38
9793867|NCT00570778|10901435|FG002|STARTED|Overall Study||37
9793868|NCT00570778|10901436|FG003|STARTED|Overall Study||38
9793869|NCT00570778|10901433|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
9793870|NCT00570778|10901434|FG001|Safety Population: Received Study Drug|Overall Study||38
9793871|NCT00570778|10901435|FG002|Safety Population: Received Study Drug|Overall Study||36
9793872|NCT00570778|10901436|FG003|Safety Population: Received Study Drug|Overall Study||38
9793873|NCT00570778|10901433|FG000|Modified Intent-to-treat Population|Overall Study||40
9793874|NCT00570778|10901434|FG001|Modified Intent-to-treat Population|Overall Study||37
9793875|NCT00570778|10901435|FG002|Modified Intent-to-treat Population|Overall Study||35
9793876|NCT00570778|10901436|FG003|Modified Intent-to-treat Population|Overall Study||37
9793877|NCT00570778|10901433|FG000|COMPLETED|Overall Study||37
9793878|NCT00570778|10901434|FG001|COMPLETED|Overall Study||34
9793879|NCT00570778|10901435|FG002|COMPLETED|Overall Study||30
9793880|NCT00570778|10901436|FG003|COMPLETED|Overall Study||34
9793881|NCT00570778|10901433|FG000|NOT COMPLETED|Overall Study||4
9793882|NCT00570778|10901434|FG001|NOT COMPLETED|Overall Study||4
9793883|NCT00570778|10901435|FG002|NOT COMPLETED|Overall Study||7
9793884|NCT00570778|10901436|FG003|NOT COMPLETED|Overall Study||4
9793885|NCT00570908|10901446|FG000|STARTED|Overall Study||12
9793886|NCT00570908|10901446|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
9793887|NCT00570908|10901446|FG000|NOT COMPLETED|Overall Study||7
9793888|NCT00570921|10901450|FG000|STARTED|Overall Study||33
9793889|NCT00570921|10901450|FG000|COMPLETED|Overall Study||31
9793890|NCT00570921|10901450|FG000|NOT COMPLETED|Overall Study||2
9793891|NCT00570960|10901456|FG000|STARTED|Overall Study||4
9793892|NCT00570960|10901457|FG001|STARTED|Overall Study||4
9793893|NCT00570960|10901456|FG000|COMPLETED|Overall Study||4
9793894|NCT00570960|10901457|FG001|COMPLETED|Overall Study||4
9793895|NCT00570960|10901456|FG000|NOT COMPLETED|Overall Study||0
9793896|NCT00570960|10901457|FG001|NOT COMPLETED|Overall Study||0
9793897|NCT00571038|10901465|FG000|STARTED|Overall Study||219
9793898|NCT00571038|10901466|FG001|STARTED|Overall Study||185
9793899|NCT00571038|10901465|FG000|6 Month Follow up|Overall Study||208
9793900|NCT00571038|10901466|FG001|6 Month Follow up|Overall Study||176
9793901|NCT00571038|10901465|FG000|18 Month Survey Only|Overall Study||199
9793902|NCT00571038|10901466|FG001|18 Month Survey Only|Overall Study||163
9793903|NCT00571038|10901465|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
9793904|NCT00571038|10901466|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
9793905|NCT00571038|10901465|FG000|NOT COMPLETED|Overall Study||11
9793906|NCT00571038|10901466|FG001|NOT COMPLETED|Overall Study||14
9793907|NCT00571064|10901472|FG000|STARTED|Overall Study||97
9793908|NCT00571064|10901472|FG000|COMPLETED|Overall Study||76
9793909|NCT00571064|10901472|FG000|NOT COMPLETED|Overall Study||21
9793910|NCT00571103|10901477|FG000|STARTED|Overall Study||28
9793911|NCT00571103|10901477|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
9793912|NCT00571103|10901477|FG000|NOT COMPLETED|Overall Study||2
9793913|NCT00571259|10901483|FG000|STARTED|Overall Study||148
9793914|NCT00571259|10901484|FG001|STARTED|Overall Study||155
9793915|NCT00571259|10901483|FG000|COMPLETED|Overall Study||4
9793916|NCT00571259|10901484|FG001|COMPLETED|Overall Study||14
9793917|NCT00571259|10901483|FG000|NOT COMPLETED|Overall Study||144
9793918|NCT00571259|10901484|FG001|NOT COMPLETED|Overall Study||141
9793919|NCT00571324|10901492|FG000|STARTED|Intervention 1 (7 Hours)||5
9793920|NCT00571324|10901493|FG001|STARTED|Intervention 1 (7 Hours)||4
9793921|NCT00571324|10901492|FG000|COMPLETED|Intervention 1 (7 Hours)||5
9793922|NCT00571324|10901493|FG001|COMPLETED|Intervention 1 (7 Hours)||4
9793923|NCT00571324|10901492|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0
9793924|NCT00571324|10901493|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0
9793925|NCT00571324|10901492|FG000|STARTED|Intervention 2 (7 Hours)||5
9793926|NCT00571324|10901493|FG001|STARTED|Intervention 2 (7 Hours)||4
9793927|NCT00571324|10901492|FG000|COMPLETED|Intervention 2 (7 Hours)||5
9793928|NCT00571324|10901493|FG001|COMPLETED|Intervention 2 (7 Hours)||4
9793929|NCT00571324|10901492|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0
9793930|NCT00571324|10901493|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0
9793931|NCT00571428|10901501|FG000|STARTED|Overall Study||15
9793932|NCT00571428|10901502|FG001|STARTED|Overall Study||18
9793933|NCT00571428|10901501|FG000|COMPLETED|Overall Study||15
9793934|NCT00571428|10901502|FG001|COMPLETED|Overall Study||18
9793935|NCT00571428|10901501|FG000|NOT COMPLETED|Overall Study||0
9793936|NCT00571428|10901502|FG001|NOT COMPLETED|Overall Study||0
9793937|NCT00571493|10901508|FG000|STARTED|Overall Study||3
9793938|NCT00571493|10901509|FG001|STARTED|Overall Study||4
9793939|NCT00571493|10901510|FG002|STARTED|Overall Study||3
9793940|NCT00571493|10901511|FG003|STARTED|Overall Study||3
9793941|NCT00571493|10901512|FG004|STARTED|Overall Study||11
9793942|NCT00571493|10901513|FG005|STARTED|Overall Study||12
9793943|NCT00571493|10901514|FG006|STARTED|Overall Study||6
9793944|NCT00571493|10901508|FG000|COMPLETED|Overall Study||3
9793945|NCT00571493|10901509|FG001|COMPLETED|Overall Study||4
9793946|NCT00571493|10901510|FG002|COMPLETED|Overall Study||3
9793947|NCT00571493|10901511|FG003|COMPLETED|Overall Study||3
9793948|NCT00571493|10901512|FG004|COMPLETED|Overall Study||11
9793949|NCT00571493|10901513|FG005|COMPLETED|Overall Study||12
9793950|NCT00571493|10901514|FG006|COMPLETED|Overall Study||6
9793951|NCT00571493|10901508|FG000|NOT COMPLETED|Overall Study||0
9793952|NCT00571493|10901509|FG001|NOT COMPLETED|Overall Study||0
9793953|NCT00571493|10901510|FG002|NOT COMPLETED|Overall Study||0
9793954|NCT00571493|10901511|FG003|NOT COMPLETED|Overall Study||0
9793955|NCT00571493|10901512|FG004|NOT COMPLETED|Overall Study||0
9793956|NCT00571493|10901513|FG005|NOT COMPLETED|Overall Study||0
9793957|NCT00571493|10901514|FG006|NOT COMPLETED|Overall Study||0
9793958|NCT00571519|10901529|FG000|STARTED|Overall Study||3
9793959|NCT00571519|10901530|FG001|STARTED|Overall Study||9
9793960|NCT00571519|10901531|FG002|STARTED|Overall Study||12
9793961|NCT00571519|10901532|FG003|STARTED|Overall Study||27
9793962|NCT00571519|10901533|FG004|STARTED|Overall Study||9
9793963|NCT00571519|10901534|FG005|STARTED|Overall Study||10
9793964|NCT00571519|10901535|FG006|STARTED|Overall Study||24
9793965|NCT00571519|10901529|FG000|COMPLETED|Overall Study||0
9793966|NCT00571519|10901530|FG001|COMPLETED|Overall Study||0
9793967|NCT00571519|10901531|FG002|COMPLETED|Overall Study||0
9793968|NCT00571519|10901532|FG003|COMPLETED|Overall Study||0
9793969|NCT00571519|10901533|FG004|COMPLETED|Overall Study||0
9793970|NCT00571519|10901534|FG005|COMPLETED|Overall Study||0
9793971|NCT00571519|10901535|FG006|COMPLETED|Overall Study||0
9793972|NCT00571519|10901529|FG000|NOT COMPLETED|Overall Study||3
9793973|NCT00571519|10901530|FG001|NOT COMPLETED|Overall Study||9
9793974|NCT00571519|10901531|FG002|NOT COMPLETED|Overall Study||12
9793975|NCT00571519|10901532|FG003|NOT COMPLETED|Overall Study||27
10015574|NCT01806688|11138604|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
10015575|NCT01806688|11138605|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
10015576|NCT01806688|11138604|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
10019127|NCT01827930|11142264|FG002|STARTED|Overall Study||19
9793976|NCT00571519|10901533|FG004|NOT COMPLETED|Overall Study||9
9793977|NCT00571519|10901534|FG005|NOT COMPLETED|Overall Study||10
9793978|NCT00571519|10901535|FG006|NOT COMPLETED|Overall Study||24
9793979|NCT00571649|10901553|FG000|STARTED|Treatment Period||4050
9793980|NCT00571649|10901554|FG001|STARTED|Treatment Period||4051
9793981|NCT00571649|10901553|FG000|Participants Received Treatment|Treatment Period||3997
9793982|NCT00571649|10901554|FG001|Participants Received Treatment|Treatment Period||4001
9793983|NCT00571649|10901553|FG000|Day 10|Treatment Period||3454
9793984|NCT00571649|10901554|FG001|Day 10|Treatment Period||3499
9793985|NCT00571649|10901553|FG000|Day 35|Treatment Period||3033
9793986|NCT00571649|10901554|FG001|Day 35|Treatment Period||3115
9793987|NCT00571649|10901553|FG000|COMPLETED|Treatment Period||2958
9793988|NCT00571649|10901554|FG001|COMPLETED|Treatment Period||3047
9793989|NCT00571649|10901553|FG000|NOT COMPLETED|Treatment Period||1092
9793990|NCT00571649|10901554|FG001|NOT COMPLETED|Treatment Period||1004
9793991|NCT00571649|10901553|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
9793992|NCT00571649|10901554|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
9793993|NCT00571649|10901553|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
9793994|NCT00571649|10901554|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
9793995|NCT00571649|10901553|FG000|NOT COMPLETED|Follow-up Period||545
9793996|NCT00571649|10901554|FG001|NOT COMPLETED|Follow-up Period||528
9793997|NCT00571662|10901560|FG000|STARTED|Overall Study||76
9793998|NCT00571662|10901560|FG000|COMPLETED|Overall Study||68
9793999|NCT00571662|10901560|FG000|NOT COMPLETED|Overall Study||8
9794000|NCT00571688|10901568|FG000|STARTED|Overall Study||25
9794001|NCT00571688|10901569|FG001|STARTED|Overall Study||25
9794002|NCT00571688|10901568|FG000|COMPLETED|Overall Study||20
9794003|NCT00571688|10901569|FG001|COMPLETED|Overall Study||19
9794004|NCT00571688|10901568|FG000|NOT COMPLETED|Overall Study||5
9794005|NCT00571688|10901569|FG001|NOT COMPLETED|Overall Study||6
9794006|NCT00571701|10901577|FG000|STARTED|First Intervention 12 Months||19
9794007|NCT00571701|10901578|FG001|STARTED|First Intervention 12 Months||22
9794008|NCT00571701|10901577|FG000|COMPLETED|First Intervention 12 Months||16
9794009|NCT00571701|10901578|FG001|COMPLETED|First Intervention 12 Months||21
9794010|NCT00571701|10901577|FG000|NOT COMPLETED|First Intervention 12 Months||3
9794011|NCT00571701|10901578|FG001|NOT COMPLETED|First Intervention 12 Months||1
9794012|NCT00571701|10901577|FG000|STARTED|Second Intervention 12 Months||16
9794013|NCT00571701|10901578|FG001|STARTED|Second Intervention 12 Months||21
9794014|NCT00571701|10901577|FG000|COMPLETED|Second Intervention 12 Months||13
10015577|NCT01806688|11138605|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
10015578|NCT01806688|11138604|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
10015579|NCT01806688|11138605|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
9794015|NCT00571701|10901578|FG001|COMPLETED|Second Intervention 12 Months||20
9794016|NCT00571701|10901577|FG000|NOT COMPLETED|Second Intervention 12 Months||3
9794017|NCT00571701|10901578|FG001|NOT COMPLETED|Second Intervention 12 Months||1
9794018|NCT00571948|10901604|FG000|STARTED|Overall Study||66
9794019|NCT00571948|10901605|FG001|STARTED|Overall Study||66
9794020|NCT00571948|10901604|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
9794021|NCT00571948|10901605|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
9794022|NCT00571948|10901604|FG000|NOT COMPLETED|Overall Study||11
9794023|NCT00571948|10901605|FG001|NOT COMPLETED|Overall Study||14
9794024|NCT00571961|10901611|FG000|STARTED|Overall Study||12
9794025|NCT00571961|10901611|FG000|COMPLETED|Overall Study||12
9794026|NCT00571961|10901611|FG000|NOT COMPLETED|Overall Study||0
9794027|NCT00571974|10901617|FG000|STARTED|Phase I||9
9794028|NCT00571974|10901618|FG001|STARTED|Phase I||0
9794029|NCT00571974|10901617|FG000|COMPLETED|Phase I||9
9794030|NCT00571974|10901618|FG001|COMPLETED|Phase I||0
9794031|NCT00571974|10901617|FG000|NOT COMPLETED|Phase I||0
9794032|NCT00571974|10901618|FG001|NOT COMPLETED|Phase I||0
9794033|NCT00571974|10901617|FG000|STARTED|Phase II||0
9794034|NCT00571974|10901618|FG001|STARTED|Phase II|3 participants are from phase I|21
9794035|NCT00571974|10901617|FG000|COMPLETED|Phase II||0
9794036|NCT00571974|10901618|FG001|COMPLETED|Phase II||17
9794037|NCT00571974|10901617|FG000|NOT COMPLETED|Phase II||0
9794038|NCT00571974|10901618|FG001|NOT COMPLETED|Phase II||4
9794039|NCT00571987|10901624|FG000|STARTED|Overall Study||107
9794040|NCT00571987|10901624|FG000|COMPLETED|Overall Study||100
9794041|NCT00571987|10901624|FG000|NOT COMPLETED|Overall Study||7
9794042|NCT00572039|10901631|FG000|STARTED|Overall Study||121
9794043|NCT00572039|10901632|FG001|STARTED|Overall Study||120
9794044|NCT00572039|10901631|FG000|COMPLETED|Overall Study||105
9794045|NCT00572039|10901632|FG001|COMPLETED|Overall Study||110
9794046|NCT00572039|10901631|FG000|NOT COMPLETED|Overall Study||16
9794047|NCT00572039|10901632|FG001|NOT COMPLETED|Overall Study||10
9794048|NCT00572117|10901642|FG000|STARTED|Overall Study||5
9794049|NCT00572117|10901643|FG001|STARTED|Overall Study||7
9794050|NCT00572117|10901642|FG000|COMPLETED|Overall Study||3
9794051|NCT00572117|10901643|FG001|COMPLETED|Overall Study||5
9794052|NCT00572117|10901642|FG000|NOT COMPLETED|Overall Study||2
9794053|NCT00572117|10901643|FG001|NOT COMPLETED|Overall Study||2
9794054|NCT00572156|10901655|FG000|STARTED|Overall Study||26
9794055|NCT00572156|10901656|FG001|STARTED|Overall Study||27
9794056|NCT00572156|10901657|FG002|STARTED|Overall Study||27
9794057|NCT00572156|10901658|FG003|STARTED|Overall Study||26
9794058|NCT00572156|10901655|FG000|COMPLETED|Overall Study||0
9794059|NCT00572156|10901656|FG001|COMPLETED|Overall Study||1
9794060|NCT00572156|10901657|FG002|COMPLETED|Overall Study||0
9794061|NCT00572156|10901658|FG003|COMPLETED|Overall Study||1
9794062|NCT00572156|10901655|FG000|NOT COMPLETED|Overall Study||26
9794063|NCT00572156|10901656|FG001|NOT COMPLETED|Overall Study||26
9794064|NCT00572156|10901657|FG002|NOT COMPLETED|Overall Study||27
9794065|NCT00572156|10901658|FG003|NOT COMPLETED|Overall Study||25
9794066|NCT00572195|10901668|FG000|STARTED|Overall Study||230
9794067|NCT00572195|10901668|FG000|COMPLETED|Overall Study||162
9794068|NCT00572195|10901668|FG000|NOT COMPLETED|Overall Study||68
9794069|NCT00572234|10901674|FG000|STARTED|Overall Study||19
9794070|NCT00572234|10901675|FG001|STARTED|Overall Study||21
9794071|NCT00572234|10901674|FG000|COMPLETED|Overall Study||18
9794072|NCT00572234|10901675|FG001|COMPLETED|Overall Study||16
9794073|NCT00572234|10901674|FG000|NOT COMPLETED|Overall Study||1
9794074|NCT00572234|10901675|FG001|NOT COMPLETED|Overall Study||5
9794075|NCT00572455|10901695|FG000|STARTED|Stage I (14 Days)||9
9794076|NCT00572455|10901696|FG001|STARTED|Stage I (14 Days)||9
9794077|NCT00572455|10901697|FG002|STARTED|Stage I (14 Days)||9
9794078|NCT00572455|10901698|FG003|STARTED|Stage I (14 Days)||10
9794079|NCT00572455|10901699|FG004|STARTED|Stage I (14 Days)||9
9794080|NCT00572455|10901700|FG005|STARTED|Stage I (14 Days)||9
9794081|NCT00572455|10901701|FG006|STARTED|Stage I (14 Days)||12
9794082|NCT00572455|10901702|FG007|STARTED|Stage I (14 Days)||0
9794083|NCT00572455|10901703|FG008|STARTED|Stage I (14 Days)||0
9794084|NCT00572455|10901704|FG009|STARTED|Stage I (14 Days)||0
9794085|NCT00572455|10901705|FG010|STARTED|Stage I (14 Days)||0
9794086|NCT00572455|10901706|FG011|STARTED|Stage I (14 Days)||0
9794087|NCT00572455|10901707|FG012|STARTED|Stage I (14 Days)||0
9794088|NCT00572455|10901708|FG013|STARTED|Stage I (14 Days)||0
9794089|NCT00572455|10901695|FG000|COMPLETED|Stage I (14 Days)||9
9794090|NCT00572455|10901696|FG001|COMPLETED|Stage I (14 Days)||9
9794091|NCT00572455|10901697|FG002|COMPLETED|Stage I (14 Days)||9
9794092|NCT00572455|10901698|FG003|COMPLETED|Stage I (14 Days)||10
9794093|NCT00572455|10901699|FG004|COMPLETED|Stage I (14 Days)||8
9794094|NCT00572455|10901700|FG005|COMPLETED|Stage I (14 Days)||6
9794095|NCT00572455|10901701|FG006|COMPLETED|Stage I (14 Days)||12
9794096|NCT00572455|10901702|FG007|COMPLETED|Stage I (14 Days)||0
9794097|NCT00572455|10901703|FG008|COMPLETED|Stage I (14 Days)||0
9794098|NCT00572455|10901704|FG009|COMPLETED|Stage I (14 Days)||0
9794099|NCT00572455|10901705|FG010|COMPLETED|Stage I (14 Days)||0
9794100|NCT00572455|10901706|FG011|COMPLETED|Stage I (14 Days)||0
9794101|NCT00572455|10901707|FG012|COMPLETED|Stage I (14 Days)||0
9794102|NCT00572455|10901708|FG013|COMPLETED|Stage I (14 Days)||0
9794103|NCT00572455|10901695|FG000|NOT COMPLETED|Stage I (14 Days)||0
9794104|NCT00572455|10901696|FG001|NOT COMPLETED|Stage I (14 Days)||0
9794105|NCT00572455|10901697|FG002|NOT COMPLETED|Stage I (14 Days)||0
9794106|NCT00572455|10901698|FG003|NOT COMPLETED|Stage I (14 Days)||0
9794107|NCT00572455|10901699|FG004|NOT COMPLETED|Stage I (14 Days)||1
9794108|NCT00572455|10901700|FG005|NOT COMPLETED|Stage I (14 Days)||3
9794109|NCT00572455|10901701|FG006|NOT COMPLETED|Stage I (14 Days)||0
9794110|NCT00572455|10901702|FG007|NOT COMPLETED|Stage I (14 Days)||0
9794111|NCT00572455|10901703|FG008|NOT COMPLETED|Stage I (14 Days)||0
9794112|NCT00572455|10901704|FG009|NOT COMPLETED|Stage I (14 Days)||0
9794113|NCT00572455|10901705|FG010|NOT COMPLETED|Stage I (14 Days)||0
9794114|NCT00572455|10901706|FG011|NOT COMPLETED|Stage I (14 Days)||0
9794115|NCT00572455|10901707|FG012|NOT COMPLETED|Stage I (14 Days)||0
9794116|NCT00572455|10901708|FG013|NOT COMPLETED|Stage I (14 Days)||0
9794117|NCT00572455|10901695|FG000|STARTED|Stage II (28 Days)||0
9794118|NCT00572455|10901696|FG001|STARTED|Stage II (28 Days)||0
9794119|NCT00572455|10901697|FG002|STARTED|Stage II (28 Days)||0
10015580|NCT01806688|11138604|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
10019128|NCT01827930|11142262|FG000|COMPLETED|Overall Study||24
10019129|NCT01827930|11142263|FG001|COMPLETED|Overall Study||25
9794120|NCT00572455|10901698|FG003|STARTED|Stage II (28 Days)||0
9794121|NCT00572455|10901699|FG004|STARTED|Stage II (28 Days)||0
9794122|NCT00572455|10901700|FG005|STARTED|Stage II (28 Days)||0
9794123|NCT00572455|10901701|FG006|STARTED|Stage II (28 Days)||0
9794124|NCT00572455|10901702|FG007|STARTED|Stage II (28 Days)||35
9794125|NCT00572455|10901703|FG008|STARTED|Stage II (28 Days)||36
9794126|NCT00572455|10901704|FG009|STARTED|Stage II (28 Days)||36
9794127|NCT00572455|10901705|FG010|STARTED|Stage II (28 Days)||36
9794128|NCT00572455|10901706|FG011|STARTED|Stage II (28 Days)||36
9794129|NCT00572455|10901707|FG012|STARTED|Stage II (28 Days)||36
9794130|NCT00572455|10901708|FG013|STARTED|Stage II (28 Days)||36
9794131|NCT00572455|10901695|FG000|Treated|Stage II (28 Days)||0
9794132|NCT00572455|10901696|FG001|Treated|Stage II (28 Days)||0
9794133|NCT00572455|10901697|FG002|Treated|Stage II (28 Days)||0
9794134|NCT00572455|10901698|FG003|Treated|Stage II (28 Days)||0
9794135|NCT00572455|10901699|FG004|Treated|Stage II (28 Days)||0
9794136|NCT00572455|10901700|FG005|Treated|Stage II (28 Days)||0
9794137|NCT00572455|10901701|FG006|Treated|Stage II (28 Days)||0
9794138|NCT00572455|10901702|FG007|Treated|Stage II (28 Days)||35
9794139|NCT00572455|10901703|FG008|Treated|Stage II (28 Days)||36
9794140|NCT00572455|10901704|FG009|Treated|Stage II (28 Days)||36
9794141|NCT00572455|10901705|FG010|Treated|Stage II (28 Days)||36
9794142|NCT00572455|10901706|FG011|Treated|Stage II (28 Days)||36
9794143|NCT00572455|10901707|FG012|Treated|Stage II (28 Days)||36
9794144|NCT00572455|10901708|FG013|Treated|Stage II (28 Days)||35
9794145|NCT00572455|10901695|FG000|COMPLETED|Stage II (28 Days)||0
9794146|NCT00572455|10901696|FG001|COMPLETED|Stage II (28 Days)||0
9794147|NCT00572455|10901697|FG002|COMPLETED|Stage II (28 Days)||0
9794148|NCT00572455|10901698|FG003|COMPLETED|Stage II (28 Days)||0
9794149|NCT00572455|10901699|FG004|COMPLETED|Stage II (28 Days)||0
9794150|NCT00572455|10901700|FG005|COMPLETED|Stage II (28 Days)||0
9794151|NCT00572455|10901701|FG006|COMPLETED|Stage II (28 Days)||0
9794152|NCT00572455|10901702|FG007|COMPLETED|Stage II (28 Days)||34
9794153|NCT00572455|10901703|FG008|COMPLETED|Stage II (28 Days)||33
9794154|NCT00572455|10901704|FG009|COMPLETED|Stage II (28 Days)||33
9794155|NCT00572455|10901705|FG010|COMPLETED|Stage II (28 Days)||31
9794156|NCT00572455|10901706|FG011|COMPLETED|Stage II (28 Days)||32
9794157|NCT00572455|10901707|FG012|COMPLETED|Stage II (28 Days)||31
9794158|NCT00572455|10901708|FG013|COMPLETED|Stage II (28 Days)||34
9794159|NCT00572455|10901695|FG000|NOT COMPLETED|Stage II (28 Days)||0
9794160|NCT00572455|10901696|FG001|NOT COMPLETED|Stage II (28 Days)||0
9794161|NCT00572455|10901697|FG002|NOT COMPLETED|Stage II (28 Days)||0
9794162|NCT00572455|10901698|FG003|NOT COMPLETED|Stage II (28 Days)||0
9794163|NCT00572455|10901699|FG004|NOT COMPLETED|Stage II (28 Days)||0
9794164|NCT00572455|10901700|FG005|NOT COMPLETED|Stage II (28 Days)||0
9794165|NCT00572455|10901701|FG006|NOT COMPLETED|Stage II (28 Days)||0
9794166|NCT00572455|10901702|FG007|NOT COMPLETED|Stage II (28 Days)||1
9794167|NCT00572455|10901703|FG008|NOT COMPLETED|Stage II (28 Days)||3
9794168|NCT00572455|10901704|FG009|NOT COMPLETED|Stage II (28 Days)||3
9794169|NCT00572455|10901705|FG010|NOT COMPLETED|Stage II (28 Days)||5
9794170|NCT00572455|10901706|FG011|NOT COMPLETED|Stage II (28 Days)||4
9794171|NCT00572455|10901707|FG012|NOT COMPLETED|Stage II (28 Days)||5
9794172|NCT00572455|10901708|FG013|NOT COMPLETED|Stage II (28 Days)||2
9794173|NCT00572468|10901740|FG000|STARTED|Overall Study||22
9794174|NCT00572468|10901741|FG001|STARTED|Overall Study||20
9794175|NCT00572468|10901740|FG000|COMPLETED|Overall Study||20
9794176|NCT00572468|10901741|FG001|COMPLETED|Overall Study||16
9794177|NCT00572468|10901740|FG000|NOT COMPLETED|Overall Study||2
9794178|NCT00572468|10901741|FG001|NOT COMPLETED|Overall Study||4
9794179|NCT00572533|10901749|FG000|STARTED|Overall Study||31
9794180|NCT00572533|10901750|FG001|STARTED|Overall Study||31
9794181|NCT00572533|10901749|FG000|COMPLETED|Overall Study||24
9794182|NCT00572533|10901750|FG001|COMPLETED|Overall Study||28
9794183|NCT00572533|10901749|FG000|NOT COMPLETED|Overall Study||7
9794184|NCT00572533|10901750|FG001|NOT COMPLETED|Overall Study||3
9794185|NCT00572572|10901758|FG000|STARTED|Overall Study||35
9794186|NCT00572572|10901759|FG001|STARTED|Overall Study||34
9794187|NCT00572572|10901758|FG000|COMPLETED|Overall Study||32
9794188|NCT00572572|10901759|FG001|COMPLETED|Overall Study||28
9794189|NCT00572572|10901758|FG000|NOT COMPLETED|Overall Study||3
9794190|NCT00572572|10901759|FG001|NOT COMPLETED|Overall Study||6
9794191|NCT00572624|10901767|FG000|STARTED|Overall Study||37
9794192|NCT00572624|10901768|FG001|STARTED|Overall Study||14
9794193|NCT00572624|10901767|FG000|COMPLETED|Overall Study||20
9794194|NCT00572624|10901768|FG001|COMPLETED|Overall Study||10
9794195|NCT00572624|10901767|FG000|NOT COMPLETED|Overall Study||17
9794196|NCT00572624|10901768|FG001|NOT COMPLETED|Overall Study||4
9794197|NCT00572728|10901774|FG000|STARTED|Overall Study|Registered|90
9794198|NCT00572728|10901774|FG000|Eligible|Overall Study||87
9794199|NCT00572728|10901774|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82
9794200|NCT00572728|10901774|FG000|Did Not Withdraw|Overall Study||72
9794201|NCT00572728|10901774|FG000|On Study|Overall Study||71
9794202|NCT00572728|10901774|FG000|Completed FLT1 Scan|Overall Study||67
9794203|NCT00572728|10901774|FG000|First Therapy Initiated|Overall Study||65
9794204|NCT00572728|10901774|FG000|Completed FLT2 Scan|Overall Study||60
9794205|NCT00572728|10901774|FG000|Second Chemotherapy Initiated|Overall Study||59
9794206|NCT00572728|10901774|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52
9794207|NCT00572728|10901774|FG000|Pathology Complete|Overall Study||51
9794208|NCT00572728|10901774|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
9794209|NCT00572728|10901774|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
9794210|NCT00572728|10901774|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
9794211|NCT00572728|10901774|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
9794212|NCT00572728|10901774|FG000|NOT COMPLETED|Overall Study||39
9794213|NCT00572832|10901782|FG000|STARTED|Overall Study||100
9794214|NCT00572832|10901783|FG001|STARTED|Overall Study||100
9794215|NCT00572832|10901782|FG000|COMPLETED|Overall Study||100
9794216|NCT00572832|10901783|FG001|COMPLETED|Overall Study||88
9794217|NCT00572832|10901782|FG000|NOT COMPLETED|Overall Study||0
9794218|NCT00572832|10901783|FG001|NOT COMPLETED|Overall Study||12
9794219|NCT00572897|10901791|FG000|STARTED|Overall Study||32
9794220|NCT00572897|10901792|FG001|STARTED|Overall Study||34
9794221|NCT00572897|10901791|FG000|COMPLETED|Overall Study||32
9794222|NCT00572897|10901792|FG001|COMPLETED|Overall Study||34
9794223|NCT00572897|10901791|FG000|NOT COMPLETED|Overall Study||0
9794224|NCT00572897|10901792|FG001|NOT COMPLETED|Overall Study||0
9794225|NCT00572910|10901804|FG000|STARTED|Overall Study||19
9794226|NCT00572910|10901805|FG001|STARTED|Overall Study||18
9794227|NCT00572910|10901806|FG002|STARTED|Overall Study||19
9794228|NCT00572910|10901807|FG003|STARTED|Overall Study||18
9794229|NCT00572910|10901808|FG004|STARTED|Overall Study||19
9794230|NCT00572910|10901809|FG005|STARTED|Overall Study||19
9794231|NCT00572910|10901810|FG006|STARTED|Overall Study||19
9794232|NCT00572910|10901811|FG007|STARTED|Overall Study||19
9794233|NCT00572910|10901812|FG008|STARTED|Overall Study||19
9794234|NCT00572910|10901813|FG009|STARTED|Overall Study||19
9794235|NCT00572910|10901814|FG010|STARTED|Overall Study||18
9794236|NCT00572910|10901804|FG000|COMPLETED|Overall Study||15
9794237|NCT00572910|10901805|FG001|COMPLETED|Overall Study||15
9794238|NCT00572910|10901806|FG002|COMPLETED|Overall Study||17
9794239|NCT00572910|10901807|FG003|COMPLETED|Overall Study||14
9794240|NCT00572910|10901808|FG004|COMPLETED|Overall Study||17
9794241|NCT00572910|10901809|FG005|COMPLETED|Overall Study||16
9794242|NCT00572910|10901810|FG006|COMPLETED|Overall Study||15
9794243|NCT00572910|10901811|FG007|COMPLETED|Overall Study||15
9794244|NCT00572910|10901812|FG008|COMPLETED|Overall Study||16
9794245|NCT00572910|10901813|FG009|COMPLETED|Overall Study||13
9794246|NCT00572910|10901814|FG010|COMPLETED|Overall Study||15
9794247|NCT00572910|10901804|FG000|NOT COMPLETED|Overall Study||4
9794248|NCT00572910|10901805|FG001|NOT COMPLETED|Overall Study||3
9794249|NCT00572910|10901806|FG002|NOT COMPLETED|Overall Study||2
9794250|NCT00572910|10901807|FG003|NOT COMPLETED|Overall Study||4
9794251|NCT00572910|10901808|FG004|NOT COMPLETED|Overall Study||2
9794252|NCT00572910|10901809|FG005|NOT COMPLETED|Overall Study||3
9794253|NCT00572910|10901810|FG006|NOT COMPLETED|Overall Study||4
9794254|NCT00572910|10901811|FG007|NOT COMPLETED|Overall Study||4
9794255|NCT00572910|10901812|FG008|NOT COMPLETED|Overall Study||3
9794256|NCT00572910|10901813|FG009|NOT COMPLETED|Overall Study||6
9794257|NCT00572910|10901814|FG010|NOT COMPLETED|Overall Study||3
9794258|NCT00572936|10901849|FG000|STARTED|First Intervention||4
9794259|NCT00572936|10901850|FG001|STARTED|First Intervention||4
9794260|NCT00572936|10901851|FG002|STARTED|First Intervention||5
9794261|NCT00572936|10901852|FG003|STARTED|First Intervention||5
9794262|NCT00572936|10901853|FG004|STARTED|First Intervention||5
9794263|NCT00572936|10901854|FG005|STARTED|First Intervention||5
9794264|NCT00572936|10901849|FG000|COMPLETED|First Intervention||4
9794265|NCT00572936|10901850|FG001|COMPLETED|First Intervention||4
9794266|NCT00572936|10901851|FG002|COMPLETED|First Intervention||5
9794267|NCT00572936|10901852|FG003|COMPLETED|First Intervention||5
9794268|NCT00572936|10901853|FG004|COMPLETED|First Intervention||5
9794269|NCT00572936|10901854|FG005|COMPLETED|First Intervention||5
9794270|NCT00572936|10901849|FG000|NOT COMPLETED|First Intervention||0
9794271|NCT00572936|10901850|FG001|NOT COMPLETED|First Intervention||0
9794272|NCT00572936|10901851|FG002|NOT COMPLETED|First Intervention||0
9794273|NCT00572936|10901852|FG003|NOT COMPLETED|First Intervention||0
9794274|NCT00572936|10901853|FG004|NOT COMPLETED|First Intervention||0
9794275|NCT00572936|10901854|FG005|NOT COMPLETED|First Intervention||0
9794276|NCT00572936|10901849|FG000|STARTED|Second Intervention||4
9794277|NCT00572936|10901850|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
9794278|NCT00572936|10901851|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
9794279|NCT00572936|10901852|FG003|STARTED|Second Intervention||5
9794280|NCT00572936|10901853|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
9794281|NCT00572936|10901854|FG005|STARTED|Second Intervention||5
9794282|NCT00572936|10901849|FG000|COMPLETED|Second Intervention||4
9794283|NCT00572936|10901850|FG001|COMPLETED|Second Intervention||3
9794284|NCT00572936|10901851|FG002|COMPLETED|Second Intervention||4
9794285|NCT00572936|10901852|FG003|COMPLETED|Second Intervention||5
9794286|NCT00572936|10901853|FG004|COMPLETED|Second Intervention||4
10015581|NCT01806688|11138605|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
10112136|NCT02501902|11243239|FG003|STARTED|Overall Study||11
10112137|NCT02501902|11243240|FG004|STARTED|Overall Study||11
9794287|NCT00572936|10901854|FG005|COMPLETED|Second Intervention||5
9794288|NCT00572936|10901849|FG000|NOT COMPLETED|Second Intervention||0
9794289|NCT00572936|10901850|FG001|NOT COMPLETED|Second Intervention||0
9794290|NCT00572936|10901851|FG002|NOT COMPLETED|Second Intervention||0
9794291|NCT00572936|10901852|FG003|NOT COMPLETED|Second Intervention||0
9794292|NCT00572936|10901853|FG004|NOT COMPLETED|Second Intervention||0
9794293|NCT00572936|10901854|FG005|NOT COMPLETED|Second Intervention||0
9794294|NCT00572936|10901849|FG000|STARTED|Third Intervention||4
9794295|NCT00572936|10901850|FG001|STARTED|Third Intervention||3
9794296|NCT00572936|10901851|FG002|STARTED|Third Intervention||4
9794297|NCT00572936|10901852|FG003|STARTED|Third Intervention||5
9794298|NCT00572936|10901853|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
9794299|NCT00572936|10901854|FG005|STARTED|Third Intervention||5
9794300|NCT00572936|10901849|FG000|COMPLETED|Third Intervention||4
9794301|NCT00572936|10901850|FG001|COMPLETED|Third Intervention||3
9794302|NCT00572936|10901851|FG002|COMPLETED|Third Intervention||4
10015582|NCT01806688|11138604|FG000|COMPLETED|First Intervention Pita Study||0
10015583|NCT01806688|11138605|FG001|COMPLETED|First Intervention Pita Study||38
9794303|NCT00572936|10901852|FG003|COMPLETED|Third Intervention||5
9794304|NCT00572936|10901853|FG004|COMPLETED|Third Intervention||3
9794305|NCT00572936|10901854|FG005|COMPLETED|Third Intervention||5
9794306|NCT00572936|10901849|FG000|NOT COMPLETED|Third Intervention||0
9794307|NCT00572936|10901850|FG001|NOT COMPLETED|Third Intervention||0
9794308|NCT00572936|10901851|FG002|NOT COMPLETED|Third Intervention||0
9794309|NCT00572936|10901852|FG003|NOT COMPLETED|Third Intervention||0
9794310|NCT00572936|10901853|FG004|NOT COMPLETED|Third Intervention||0
9794311|NCT00572936|10901854|FG005|NOT COMPLETED|Third Intervention||0
9794312|NCT00573066|10901862|FG000|STARTED|Overall Study||56
9794313|NCT00573066|10901862|FG000|COMPLETED|Overall Study||36
9794314|NCT00573066|10901862|FG000|NOT COMPLETED|Overall Study||20
9794315|NCT00573144|10901868|FG000|STARTED|Overall Study||30
9794316|NCT00573144|10901869|FG001|STARTED|Overall Study||28
9794317|NCT00573144|10901868|FG000|COMPLETED|Overall Study||28
9794318|NCT00573144|10901869|FG001|COMPLETED|Overall Study||25
9794319|NCT00573144|10901868|FG000|NOT COMPLETED|Overall Study||2
9794320|NCT00573144|10901869|FG001|NOT COMPLETED|Overall Study||3
10015584|NCT01806688|11138604|FG000|NOT COMPLETED|First Intervention Pita Study||0
10015585|NCT01806688|11138605|FG001|NOT COMPLETED|First Intervention Pita Study||0
10019130|NCT01827930|11142264|FG002|COMPLETED|Overall Study||19
10019131|NCT01827930|11142262|FG000|NOT COMPLETED|Overall Study||0
9794321|NCT00573170|10901875|FG000|STARTED|First Treatment Period||64
9794322|NCT00573170|10901876|FG001|STARTED|First Treatment Period||60
9794323|NCT00573170|10901877|FG002|STARTED|First Treatment Period||60
9794324|NCT00573170|10901878|FG003|STARTED|First Treatment Period||66
9794325|NCT00573170|10901879|FG004|STARTED|First Treatment Period||63
9794326|NCT00573170|10901880|FG005|STARTED|First Treatment Period||62
9794327|NCT00573170|10901875|FG000|COMPLETED|First Treatment Period||64
9794328|NCT00573170|10901876|FG001|COMPLETED|First Treatment Period||60
9794329|NCT00573170|10901877|FG002|COMPLETED|First Treatment Period||60
9794330|NCT00573170|10901878|FG003|COMPLETED|First Treatment Period||66
9794331|NCT00573170|10901879|FG004|COMPLETED|First Treatment Period||62
9794332|NCT00573170|10901880|FG005|COMPLETED|First Treatment Period||62
9794333|NCT00573170|10901875|FG000|NOT COMPLETED|First Treatment Period||0
9794334|NCT00573170|10901876|FG001|NOT COMPLETED|First Treatment Period||0
9794335|NCT00573170|10901877|FG002|NOT COMPLETED|First Treatment Period||0
9794336|NCT00573170|10901878|FG003|NOT COMPLETED|First Treatment Period||0
9794337|NCT00573170|10901879|FG004|NOT COMPLETED|First Treatment Period||1
9794338|NCT00573170|10901880|FG005|NOT COMPLETED|First Treatment Period||0
9794339|NCT00573170|10901875|FG000|STARTED|First Washout Period||64
9794340|NCT00573170|10901876|FG001|STARTED|First Washout Period||60
9794341|NCT00573170|10901877|FG002|STARTED|First Washout Period||60
9794342|NCT00573170|10901878|FG003|STARTED|First Washout Period||66
9794343|NCT00573170|10901879|FG004|STARTED|First Washout Period||62
9794344|NCT00573170|10901880|FG005|STARTED|First Washout Period||62
9794345|NCT00573170|10901875|FG000|COMPLETED|First Washout Period||56
9794346|NCT00573170|10901876|FG001|COMPLETED|First Washout Period||58
9794347|NCT00573170|10901877|FG002|COMPLETED|First Washout Period||59
9794348|NCT00573170|10901878|FG003|COMPLETED|First Washout Period||61
9794349|NCT00573170|10901879|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
9794350|NCT00573170|10901880|FG005|COMPLETED|First Washout Period||55
9794351|NCT00573170|10901875|FG000|NOT COMPLETED|First Washout Period||8
9794352|NCT00573170|10901876|FG001|NOT COMPLETED|First Washout Period||2
9794353|NCT00573170|10901877|FG002|NOT COMPLETED|First Washout Period||1
9794354|NCT00573170|10901878|FG003|NOT COMPLETED|First Washout Period||5
9794355|NCT00573170|10901879|FG004|NOT COMPLETED|First Washout Period||3
9794356|NCT00573170|10901880|FG005|NOT COMPLETED|First Washout Period||7
9794357|NCT00573170|10901875|FG000|STARTED|Second Treatment Period||56
9794358|NCT00573170|10901876|FG001|STARTED|Second Treatment Period||58
9794359|NCT00573170|10901877|FG002|STARTED|Second Treatment Period||59
9794360|NCT00573170|10901878|FG003|STARTED|Second Treatment Period||61
9794361|NCT00573170|10901879|FG004|STARTED|Second Treatment Period||59
9794362|NCT00573170|10901880|FG005|STARTED|Second Treatment Period||55
9794363|NCT00573170|10901875|FG000|COMPLETED|Second Treatment Period||56
9794364|NCT00573170|10901876|FG001|COMPLETED|Second Treatment Period||58
9794365|NCT00573170|10901877|FG002|COMPLETED|Second Treatment Period||59
9794366|NCT00573170|10901878|FG003|COMPLETED|Second Treatment Period||61
9794367|NCT00573170|10901879|FG004|COMPLETED|Second Treatment Period||59
9794368|NCT00573170|10901880|FG005|COMPLETED|Second Treatment Period||55
9794369|NCT00573170|10901875|FG000|NOT COMPLETED|Second Treatment Period||0
9794370|NCT00573170|10901876|FG001|NOT COMPLETED|Second Treatment Period||0
9794371|NCT00573170|10901877|FG002|NOT COMPLETED|Second Treatment Period||0
9794372|NCT00573170|10901878|FG003|NOT COMPLETED|Second Treatment Period||0
9794373|NCT00573170|10901879|FG004|NOT COMPLETED|Second Treatment Period||0
9794374|NCT00573170|10901880|FG005|NOT COMPLETED|Second Treatment Period||0
9794375|NCT00573170|10901875|FG000|STARTED|Second Washout Period||56
9794376|NCT00573170|10901876|FG001|STARTED|Second Washout Period||58
9794377|NCT00573170|10901877|FG002|STARTED|Second Washout Period||59
9794378|NCT00573170|10901878|FG003|STARTED|Second Washout Period||61
9794379|NCT00573170|10901879|FG004|STARTED|Second Washout Period||59
9794380|NCT00573170|10901880|FG005|STARTED|Second Washout Period||55
9794381|NCT00573170|10901875|FG000|COMPLETED|Second Washout Period||51
9794382|NCT00573170|10901876|FG001|COMPLETED|Second Washout Period||54
9794383|NCT00573170|10901877|FG002|COMPLETED|Second Washout Period||55
9794384|NCT00573170|10901878|FG003|COMPLETED|Second Washout Period||56
9794385|NCT00573170|10901879|FG004|COMPLETED|Second Washout Period||51
9794386|NCT00573170|10901880|FG005|COMPLETED|Second Washout Period||53
9794387|NCT00573170|10901875|FG000|NOT COMPLETED|Second Washout Period||5
9794388|NCT00573170|10901876|FG001|NOT COMPLETED|Second Washout Period||4
9794389|NCT00573170|10901877|FG002|NOT COMPLETED|Second Washout Period||4
9794390|NCT00573170|10901878|FG003|NOT COMPLETED|Second Washout Period||5
9794391|NCT00573170|10901879|FG004|NOT COMPLETED|Second Washout Period||8
10019132|NCT01827930|11142263|FG001|NOT COMPLETED|Overall Study||0
9794392|NCT00573170|10901880|FG005|NOT COMPLETED|Second Washout Period||2
9794393|NCT00573170|10901875|FG000|STARTED|Third Treatment Period||51
9794394|NCT00573170|10901876|FG001|STARTED|Third Treatment Period||54
9794395|NCT00573170|10901877|FG002|STARTED|Third Treatment Period||55
9794396|NCT00573170|10901878|FG003|STARTED|Third Treatment Period||56
9794397|NCT00573170|10901879|FG004|STARTED|Third Treatment Period||51
9794398|NCT00573170|10901880|FG005|STARTED|Third Treatment Period||53
9794399|NCT00573170|10901875|FG000|COMPLETED|Third Treatment Period||50
9794400|NCT00573170|10901876|FG001|COMPLETED|Third Treatment Period||54
9794401|NCT00573170|10901877|FG002|COMPLETED|Third Treatment Period||55
9794402|NCT00573170|10901878|FG003|COMPLETED|Third Treatment Period||56
9794403|NCT00573170|10901879|FG004|COMPLETED|Third Treatment Period||51
9794404|NCT00573170|10901880|FG005|COMPLETED|Third Treatment Period||51
9794405|NCT00573170|10901875|FG000|NOT COMPLETED|Third Treatment Period||1
9794406|NCT00573170|10901876|FG001|NOT COMPLETED|Third Treatment Period||0
9794407|NCT00573170|10901877|FG002|NOT COMPLETED|Third Treatment Period||0
9794408|NCT00573170|10901878|FG003|NOT COMPLETED|Third Treatment Period||0
9794409|NCT00573170|10901879|FG004|NOT COMPLETED|Third Treatment Period||0
9794410|NCT00573170|10901880|FG005|NOT COMPLETED|Third Treatment Period||2
9794411|NCT00573183|10901899|FG000|STARTED|Overall Study||234
9794412|NCT00573183|10901900|FG001|STARTED|Overall Study||237
9794413|NCT00573183|10901899|FG000|COMPLETED|Overall Study||162
9794414|NCT00573183|10901900|FG001|COMPLETED|Overall Study||174
9794415|NCT00573183|10901899|FG000|NOT COMPLETED|Overall Study||72
9794416|NCT00573183|10901900|FG001|NOT COMPLETED|Overall Study||63
9794417|NCT00573248|10901910|FG000|STARTED|Overall Study||40
9794418|NCT00573248|10901911|FG001|STARTED|Overall Study||38
9794419|NCT00573248|10901910|FG000|Nicotine Patches and Placebo Patches|Overall Study||25
9794420|NCT00573248|10901911|FG001|Nicotine Patches and Placebo Patches|Overall Study||27
9794421|NCT00573248|10901910|FG000|COMPLETED|Overall Study||25
9794422|NCT00573248|10901911|FG001|COMPLETED|Overall Study||27
9794423|NCT00573248|10901910|FG000|NOT COMPLETED|Overall Study||15
10015586|NCT01806688|11138604|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
10015587|NCT01806688|11138605|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
10019133|NCT01827930|11142264|FG002|NOT COMPLETED|Overall Study||0
9794424|NCT00573248|10901911|FG001|NOT COMPLETED|Overall Study||11
9794425|NCT00573261|10901919|FG000|STARTED|Overall Study||20
9794426|NCT00573261|10901920|FG001|STARTED|Overall Study||20
9794427|NCT00573261|10901919|FG000|COMPLETED|Overall Study||14
9794428|NCT00573261|10901920|FG001|COMPLETED|Overall Study||15
9794429|NCT00573261|10901919|FG000|NOT COMPLETED|Overall Study||6
10019134|NCT01827943|11142272|FG000|STARTED|Overall Study||54
9794430|NCT00573261|10901920|FG001|NOT COMPLETED|Overall Study||5
9794431|NCT00573287|10901930|FG000|STARTED|Overall Study||7
9794432|NCT00573287|10901931|FG001|STARTED|Overall Study||7
9794433|NCT00573287|10901930|FG000|COMPLETED|Overall Study||3
9794434|NCT00573287|10901931|FG001|COMPLETED|Overall Study||4
9794435|NCT00573287|10901930|FG000|NOT COMPLETED|Overall Study||4
9794436|NCT00573287|10901931|FG001|NOT COMPLETED|Overall Study||3
9794437|NCT00573313|10901941|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18
9794438|NCT00573313|10901942|FG001|STARTED|Overall Study||28
9794439|NCT00573313|10901943|FG002|STARTED|Overall Study|Nineteen recruited to start.|19
9794440|NCT00573313|10901944|FG003|STARTED|Overall Study||26
9794441|NCT00573313|10901941|FG000|COMPLETED|Overall Study||13
9794442|NCT00573313|10901942|FG001|COMPLETED|Overall Study||28
9794443|NCT00573313|10901943|FG002|COMPLETED|Overall Study||13
9794444|NCT00573313|10901944|FG003|COMPLETED|Overall Study||26
9794445|NCT00573313|10901941|FG000|NOT COMPLETED|Overall Study||5
9794446|NCT00573313|10901942|FG001|NOT COMPLETED|Overall Study||0
9794447|NCT00573313|10901943|FG002|NOT COMPLETED|Overall Study||6
9794448|NCT00573313|10901944|FG003|NOT COMPLETED|Overall Study||0
9794449|NCT00573430|10901954|FG000|STARTED|Overall Study|randomized|40
9794450|NCT00573430|10901955|FG001|STARTED|Overall Study|randomized|45
9794451|NCT00573430|10901956|FG002|STARTED|Overall Study|randomized|43
9794452|NCT00573430|10901954|FG000|COMPLETED|Overall Study||39
9794453|NCT00573430|10901955|FG001|COMPLETED|Overall Study||40
9794454|NCT00573430|10901956|FG002|COMPLETED|Overall Study||33
9794455|NCT00573430|10901954|FG000|NOT COMPLETED|Overall Study||1
9794456|NCT00573430|10901955|FG001|NOT COMPLETED|Overall Study||5
9794457|NCT00573430|10901956|FG002|NOT COMPLETED|Overall Study||10
9794458|NCT00573443|10901967|FG000|STARTED|Double-Blind Phase||110
9794459|NCT00573443|10901968|FG001|STARTED|Double-Blind Phase||107
9794460|NCT00573443|10901969|FG002|STARTED|Double-Blind Phase||109
9794461|NCT00573443|10901967|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
9794462|NCT00573443|10901968|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
9794463|NCT00573443|10901969|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
9794464|NCT00573443|10901967|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45
9794465|NCT00573443|10901968|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39
9794466|NCT00573443|10901969|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45
9794467|NCT00573443|10901967|FG000|COMPLETED|Double-Blind Phase||101
9794468|NCT00573443|10901968|FG001|COMPLETED|Double-Blind Phase||88
9794469|NCT00573443|10901969|FG002|COMPLETED|Double-Blind Phase||94
9794470|NCT00573443|10901967|FG000|NOT COMPLETED|Double-Blind Phase||9
9794471|NCT00573443|10901968|FG001|NOT COMPLETED|Double-Blind Phase||19
9794472|NCT00573443|10901969|FG002|NOT COMPLETED|Double-Blind Phase||15
9794473|NCT00573443|10901967|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
9794474|NCT00573443|10901968|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794475|NCT00573443|10901969|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794476|NCT00573443|10901967|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
9794477|NCT00573443|10901968|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794478|NCT00573443|10901969|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794479|NCT00573443|10901967|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
9794480|NCT00573443|10901968|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794481|NCT00573443|10901969|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794482|NCT00573443|10901967|FG000|COMPLETED|Open-Label Extension Phase||235
9794483|NCT00573443|10901968|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794484|NCT00573443|10901969|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
9794485|NCT00573443|10901967|FG000|NOT COMPLETED|Open-Label Extension Phase||18
9794486|NCT00573443|10901968|FG001|NOT COMPLETED|Open-Label Extension Phase||0
9794487|NCT00573443|10901969|FG002|NOT COMPLETED|Open-Label Extension Phase||0
9794488|NCT00573469|10901981|FG000|STARTED|Overall Study||26
9794489|NCT00573469|10901982|FG001|STARTED|Overall Study||25
9794490|NCT00573469|10901983|FG002|STARTED|Overall Study||26
9794491|NCT00573469|10901981|FG000|COMPLETED|Overall Study||20
9794492|NCT00573469|10901982|FG001|COMPLETED|Overall Study||21
9794493|NCT00573469|10901983|FG002|COMPLETED|Overall Study||22
9794494|NCT00573469|10901981|FG000|NOT COMPLETED|Overall Study||6
9794495|NCT00573469|10901982|FG001|NOT COMPLETED|Overall Study||4
9794496|NCT00573469|10901983|FG002|NOT COMPLETED|Overall Study||4
9794497|NCT00573508|10901993|FG000|STARTED|Overall Study||382
9794498|NCT00573508|10901994|FG001|STARTED|Overall Study||386
9794499|NCT00573508|10901993|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
9794500|NCT00573508|10901994|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
9794501|NCT00573508|10901993|FG000|COMPLETED|Overall Study||318
9794502|NCT00573508|10901994|FG001|COMPLETED|Overall Study||345
9794503|NCT00573508|10901993|FG000|NOT COMPLETED|Overall Study||64
9794504|NCT00573508|10901994|FG001|NOT COMPLETED|Overall Study||41
9794505|NCT00573534|10902000|FG000|STARTED|Overall Study||8
9794506|NCT00573534|10902000|FG000|COMPLETED|Overall Study||5
9794507|NCT00573534|10902000|FG000|NOT COMPLETED|Overall Study||3
9794508|NCT00573755|10902007|FG000|STARTED|Overall Study||2
9794509|NCT00573755|10902008|FG001|STARTED|Overall Study||2
9794510|NCT00573755|10902007|FG000|COMPLETED|Overall Study||1
9794511|NCT00573755|10902008|FG001|COMPLETED|Overall Study||2
9794512|NCT00573755|10902007|FG000|NOT COMPLETED|Overall Study||1
9794513|NCT00573755|10902008|FG001|NOT COMPLETED|Overall Study||0
9794514|NCT00573768|10902017|FG000|STARTED|Overall Study||89
9794515|NCT00573768|10902018|FG001|STARTED|Overall Study||91
9794516|NCT00573768|10902019|FG002|STARTED|Overall Study||91
9794517|NCT00573768|10902017|FG000|COMPLETED|Overall Study||87
9794518|NCT00573768|10902018|FG001|COMPLETED|Overall Study||89
9794519|NCT00573768|10902019|FG002|COMPLETED|Overall Study||87
9794520|NCT00573768|10902017|FG000|NOT COMPLETED|Overall Study||2
9794521|NCT00573768|10902018|FG001|NOT COMPLETED|Overall Study||2
9794522|NCT00573768|10902019|FG002|NOT COMPLETED|Overall Study||4
9794523|NCT00573794|10902027|FG000|STARTED|Overall Study||585
9794524|NCT00573794|10902027|FG000|COMPLETED|Overall Study||255
9794525|NCT00573794|10902027|FG000|NOT COMPLETED|Overall Study||330
9794526|NCT00573833|10902031|FG000|STARTED|Overall Study||23
9794527|NCT00573833|10902031|FG000|COMPLETED|Overall Study||21
9794528|NCT00573833|10902031|FG000|NOT COMPLETED|Overall Study||2
9794529|NCT00573859|10902035|FG000|STARTED|Medication Versus Placebo||27
9952502|NCT01422538|11071483|FG001|NOT COMPLETED|Overall Study||2
9952503|NCT01422538|11071484|FG002|NOT COMPLETED|Overall Study||2
9952504|NCT01422720|11071493|FG000|STARTED|Overall Study||72
9952505|NCT01422720|11071493|FG000|Safety Set|Overall Study||72
9952506|NCT01422720|11071493|FG000|Full Analysis Set (FAS)|Overall Study||71
9952507|NCT01422720|11071493|FG000|Per-Protocol Set (PPS)|Overall Study||55
9952508|NCT01422720|11071493|FG000|COMPLETED|Overall Study||50
9952509|NCT01422720|11071493|FG000|NOT COMPLETED|Overall Study||22
9952510|NCT01422824|11071501|FG000|STARTED|Overall Study||185
9952511|NCT01422824|11071501|FG000|Treated|Overall Study||184
9952512|NCT01422824|11071501|FG000|COMPLETED|Overall Study||147
9794530|NCT00573859|10902035|FG000|COMPLETED|Medication Versus Placebo||15
9794531|NCT00573859|10902035|FG000|NOT COMPLETED|Medication Versus Placebo||12
9794532|NCT00573859|10902035|FG000|STARTED|Smoking Versus Abstinence||27
9794533|NCT00573859|10902035|FG000|COMPLETED|Smoking Versus Abstinence||15
9794534|NCT00573859|10902035|FG000|NOT COMPLETED|Smoking Versus Abstinence||12
9794535|NCT00573872|10902039|FG000|STARTED|Overall Study|# of patients that signed consent|43
9794536|NCT00573872|10902039|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32
9794537|NCT00573872|10902039|FG000|NOT COMPLETED|Overall Study||11
9794538|NCT00573989|10902043|FG000|STARTED|Erlotinib Phase I||4
9794539|NCT00573989|10902044|FG001|STARTED|Erlotinib Phase I||6
9794540|NCT00573989|10902045|FG002|STARTED|Erlotinib Phase I||5
9794541|NCT00573989|10902046|FG003|STARTED|Erlotinib Phase I||0
9794542|NCT00573989|10902043|FG000|COMPLETED|Erlotinib Phase I||4
9794543|NCT00573989|10902044|FG001|COMPLETED|Erlotinib Phase I||6
9794544|NCT00573989|10902045|FG002|COMPLETED|Erlotinib Phase I||5
9794545|NCT00573989|10902046|FG003|COMPLETED|Erlotinib Phase I||0
9794546|NCT00573989|10902043|FG000|NOT COMPLETED|Erlotinib Phase I||0
9794547|NCT00573989|10902044|FG001|NOT COMPLETED|Erlotinib Phase I||0
9794548|NCT00573989|10902045|FG002|NOT COMPLETED|Erlotinib Phase I||0
9794549|NCT00573989|10902046|FG003|NOT COMPLETED|Erlotinib Phase I||0
9794550|NCT00573989|10902043|FG000|STARTED|Erlotinib 125mg- Phase II||0
9794551|NCT00573989|10902044|FG001|STARTED|Erlotinib 125mg- Phase II||0
9794552|NCT00573989|10902045|FG002|STARTED|Erlotinib 125mg- Phase II||0
9794553|NCT00573989|10902046|FG003|STARTED|Erlotinib 125mg- Phase II||12
9794554|NCT00573989|10902043|FG000|COMPLETED|Erlotinib 125mg- Phase II||0
9794555|NCT00573989|10902044|FG001|COMPLETED|Erlotinib 125mg- Phase II||0
9794556|NCT00573989|10902045|FG002|COMPLETED|Erlotinib 125mg- Phase II||0
9794557|NCT00573989|10902046|FG003|COMPLETED|Erlotinib 125mg- Phase II||12
9794558|NCT00573989|10902043|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0
9794559|NCT00573989|10902044|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0
9794560|NCT00573989|10902045|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0
9794561|NCT00573989|10902046|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0
9794562|NCT00574067|10902057|FG000|STARTED|Overall Study||53
9794563|NCT00574067|10902058|FG001|STARTED|Overall Study||53
9794564|NCT00574067|10902059|FG002|STARTED|Overall Study||54
9794565|NCT00574067|10902060|FG003|STARTED|Overall Study||53
9794566|NCT00574067|10902057|FG000|COMPLETED|Overall Study||52
9794567|NCT00574067|10902058|FG001|COMPLETED|Overall Study||52
9794568|NCT00574067|10902059|FG002|COMPLETED|Overall Study||54
9794569|NCT00574067|10902060|FG003|COMPLETED|Overall Study||53
9794570|NCT00574067|10902057|FG000|NOT COMPLETED|Overall Study||1
9794571|NCT00574067|10902058|FG001|NOT COMPLETED|Overall Study||1
9794572|NCT00574067|10902059|FG002|NOT COMPLETED|Overall Study||0
9794573|NCT00574067|10902060|FG003|NOT COMPLETED|Overall Study||0
9794574|NCT00574119|10902074|FG000|STARTED|Overall Study||16
9794575|NCT00574119|10902074|FG000|COMPLETED|Overall Study||12
9794576|NCT00574119|10902074|FG000|NOT COMPLETED|Overall Study||4
9794577|NCT00574145|10902080|FG000|STARTED|Overall Study||22
9794578|NCT00574145|10902081|FG001|STARTED|Overall Study||22
9794579|NCT00574145|10902080|FG000|COMPLETED|Overall Study||20
9794580|NCT00574145|10902081|FG001|COMPLETED|Overall Study||21
9794581|NCT00574145|10902080|FG000|NOT COMPLETED|Overall Study||2
9794582|NCT00574145|10902081|FG001|NOT COMPLETED|Overall Study||1
9794583|NCT00574171|10902087|FG000|STARTED|Overall Study||29
9794584|NCT00574171|10902087|FG000|COMPLETED|Overall Study||29
9794585|NCT00574171|10902087|FG000|NOT COMPLETED|Overall Study||0
9794586|NCT00574197|10902091|FG000|STARTED|Overall Study||11
9794587|NCT00574197|10902091|FG000|COMPLETED|Overall Study||6
9794588|NCT00574197|10902091|FG000|NOT COMPLETED|Overall Study||5
9794589|NCT00574236|10902095|FG000|STARTED|Overall Study||4
9794590|NCT00574236|10902095|FG000|COMPLETED|Overall Study||4
9794591|NCT00574236|10902095|FG000|NOT COMPLETED|Overall Study||0
9794592|NCT00574249|10902101|FG000|STARTED|Overall Study||364
9794593|NCT00574249|10902102|FG001|STARTED|Overall Study||366
9794594|NCT00574249|10902101|FG000|COMPLETED|Overall Study||338
9794595|NCT00574249|10902102|FG001|COMPLETED|Overall Study||338
9794596|NCT00574249|10902101|FG000|NOT COMPLETED|Overall Study||26
9794597|NCT00574249|10902102|FG001|NOT COMPLETED|Overall Study||28
9794598|NCT00574275|10902110|FG000|STARTED|Overall Study||275
9794599|NCT00574275|10902111|FG001|STARTED|Overall Study||271
9794600|NCT00574275|10902110|FG000|TREATED|Overall Study||273
9794601|NCT00574275|10902111|FG001|TREATED|Overall Study||268
9794602|NCT00574275|10902110|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
9794603|NCT00574275|10902111|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
9794604|NCT00574275|10902110|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
9794605|NCT00574275|10902111|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
9794606|NCT00574275|10902110|FG000|NOT COMPLETED|Overall Study||275
9794607|NCT00574275|10902111|FG001|NOT COMPLETED|Overall Study||271
9794608|NCT00574288|10902124|FG000|STARTED|Overall Study||20
9794609|NCT00574288|10902125|FG001|STARTED|Overall Study||3
9794610|NCT00574288|10902126|FG002|STARTED|Overall Study||3
9794611|NCT00574288|10902127|FG003|STARTED|Overall Study||3
9794612|NCT00574288|10902128|FG004|STARTED|Overall Study||3
9794613|NCT00574288|10902129|FG005|STARTED|Overall Study||30
9794614|NCT00574288|10902130|FG006|STARTED|Overall Study||42
9794615|NCT00574288|10902124|FG000|COMPLETED|Overall Study||0
9794616|NCT00574288|10902125|FG001|COMPLETED|Overall Study||0
9794617|NCT00574288|10902126|FG002|COMPLETED|Overall Study||0
9794618|NCT00574288|10902127|FG003|COMPLETED|Overall Study||1
9794619|NCT00574288|10902128|FG004|COMPLETED|Overall Study||1
9794620|NCT00574288|10902129|FG005|COMPLETED|Overall Study||4
9794621|NCT00574288|10902130|FG006|COMPLETED|Overall Study||14
9794622|NCT00574288|10902124|FG000|NOT COMPLETED|Overall Study||20
9794623|NCT00574288|10902125|FG001|NOT COMPLETED|Overall Study||3
9794624|NCT00574288|10902126|FG002|NOT COMPLETED|Overall Study||3
9794625|NCT00574288|10902127|FG003|NOT COMPLETED|Overall Study||2
9794626|NCT00574288|10902128|FG004|NOT COMPLETED|Overall Study||2
9794627|NCT00574288|10902129|FG005|NOT COMPLETED|Overall Study||26
9794628|NCT00574288|10902130|FG006|NOT COMPLETED|Overall Study||28
9794629|NCT00574340|10902156|FG000|STARTED|Study 1 (2 Days)||10
9794630|NCT00574340|10902157|FG001|STARTED|Study 1 (2 Days)||10
9794631|NCT00574340|10902156|FG000|COMPLETED|Study 1 (2 Days)||10
9794632|NCT00574340|10902157|FG001|COMPLETED|Study 1 (2 Days)||10
9794633|NCT00574340|10902156|FG000|NOT COMPLETED|Study 1 (2 Days)||0
9794634|NCT00574340|10902157|FG001|NOT COMPLETED|Study 1 (2 Days)||0
9794635|NCT00574340|10902156|FG000|STARTED|Study 2 (2 Days)||6
9794636|NCT00574340|10902157|FG001|STARTED|Study 2 (2 Days)||6
9794637|NCT00574340|10902156|FG000|COMPLETED|Study 2 (2 Days)||6
9794638|NCT00574340|10902157|FG001|COMPLETED|Study 2 (2 Days)||6
9794639|NCT00574340|10902156|FG000|NOT COMPLETED|Study 2 (2 Days)||0
9794640|NCT00574340|10902157|FG001|NOT COMPLETED|Study 2 (2 Days)||0
9794641|NCT00574405|10902165|FG000|STARTED|Overall Study||12
9794642|NCT00574405|10902166|FG001|STARTED|Overall Study||12
9794643|NCT00574405|10902165|FG000|COMPLETED|Overall Study||9
9794644|NCT00574405|10902166|FG001|COMPLETED|Overall Study||10
9794645|NCT00574405|10902165|FG000|NOT COMPLETED|Overall Study||3
9794646|NCT00574405|10902166|FG001|NOT COMPLETED|Overall Study||2
9794647|NCT00574548|10902174|FG000|STARTED|Overall Study||482
9794648|NCT00574548|10902175|FG001|STARTED|Overall Study||238
9794649|NCT00574548|10902174|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478
10015588|NCT01806688|11138604|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
10015589|NCT01806688|11138605|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
9794650|NCT00574548|10902175|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237
9794651|NCT00574548|10902174|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468
9794652|NCT00574548|10902175|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234
9794653|NCT00574548|10902174|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
9794654|NCT00574548|10902175|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
9794655|NCT00574548|10902174|FG000|Withdrawn Before Vax 2|Overall Study||41
9794656|NCT00574548|10902175|FG001|Withdrawn Before Vax 2|Overall Study||11
9794657|NCT00574548|10902174|FG000|Received Vax 2|Overall Study||427
9794658|NCT00574548|10902175|FG001|Received Vax 2|Overall Study||223
9794659|NCT00574548|10902174|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421
9794660|NCT00574548|10902175|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222
9794661|NCT00574548|10902174|FG000|COMPLETED|Overall Study||421
9794662|NCT00574548|10902175|FG001|COMPLETED|Overall Study||222
9794663|NCT00574548|10902174|FG000|NOT COMPLETED|Overall Study||61
9794664|NCT00574548|10902175|FG001|NOT COMPLETED|Overall Study||16
9794665|NCT00574587|10902203|FG000|STARTED|Overall Study||3
9794666|NCT00574587|10902204|FG001|STARTED|Overall Study||23
9794667|NCT00574587|10902205|FG002|STARTED|Overall Study||16
9794668|NCT00574587|10902206|FG003|STARTED|Overall Study||13
9794669|NCT00574587|10902203|FG000|COMPLETED|Overall Study||3
9794670|NCT00574587|10902204|FG001|COMPLETED|Overall Study||23
9794671|NCT00574587|10902205|FG002|COMPLETED|Overall Study||16
9794672|NCT00574587|10902206|FG003|COMPLETED|Overall Study||13
9794673|NCT00574587|10902203|FG000|NOT COMPLETED|Overall Study||0
9794674|NCT00574587|10902204|FG001|NOT COMPLETED|Overall Study||0
9794675|NCT00574587|10902205|FG002|NOT COMPLETED|Overall Study||0
9794676|NCT00574587|10902206|FG003|NOT COMPLETED|Overall Study||0
9794677|NCT00574704|10902221|FG000|STARTED|Overall Study||10
9794678|NCT00574704|10902222|FG001|STARTED|Overall Study||10
9794679|NCT00574704|10902223|FG002|STARTED|Overall Study||10
9794680|NCT00574704|10902224|FG003|STARTED|Overall Study||10
9794681|NCT00574704|10902221|FG000|COMPLETED|Overall Study||10
9794682|NCT00574704|10902222|FG001|COMPLETED|Overall Study||10
9794683|NCT00574704|10902223|FG002|COMPLETED|Overall Study||9
9794684|NCT00574704|10902224|FG003|COMPLETED|Overall Study||10
9794685|NCT00574704|10902221|FG000|NOT COMPLETED|Overall Study||0
9794686|NCT00574704|10902222|FG001|NOT COMPLETED|Overall Study||0
9794687|NCT00574704|10902223|FG002|NOT COMPLETED|Overall Study||1
9794688|NCT00574704|10902224|FG003|NOT COMPLETED|Overall Study||0
9794689|NCT00574795|10902234|FG000|STARTED|Infant Series||193
9794690|NCT00574795|10902234|FG000|Vaccinated Dose 1|Infant Series||193
9794691|NCT00574795|10902234|FG000|Vaccinated Dose 2|Infant Series||190
9794692|NCT00574795|10902234|FG000|Vaccinated Dose 3|Infant Series||190
9794693|NCT00574795|10902234|FG000|COMPLETED|Infant Series||188
9794694|NCT00574795|10902234|FG000|NOT COMPLETED|Infant Series||5
9794695|NCT00574795|10902234|FG000|STARTED|After Infant Series||188
9794696|NCT00574795|10902234|FG000|COMPLETED|After Infant Series||185
9794697|NCT00574795|10902234|FG000|NOT COMPLETED|After Infant Series||3
9794698|NCT00574795|10902234|FG000|STARTED|Toddler Dose||185
9794699|NCT00574795|10902234|FG000|COMPLETED|Toddler Dose||184
9794700|NCT00574795|10902234|FG000|NOT COMPLETED|Toddler Dose||1
9794701|NCT00574834|10902252|FG000|STARTED|Overall Study||9
9794702|NCT00574834|10902253|FG001|STARTED|Overall Study||4
9794703|NCT00574834|10902254|FG002|STARTED|Overall Study||4
9794704|NCT00574834|10902252|FG000|COMPLETED|Overall Study||9
9794705|NCT00574834|10902253|FG001|COMPLETED|Overall Study||4
9794706|NCT00574834|10902254|FG002|COMPLETED|Overall Study||4
9794707|NCT00574834|10902252|FG000|NOT COMPLETED|Overall Study||0
9794708|NCT00574834|10902253|FG001|NOT COMPLETED|Overall Study||0
9794709|NCT00574834|10902254|FG002|NOT COMPLETED|Overall Study||0
9794710|NCT00574847|10902264|FG000|STARTED|Overall Study||64
9794711|NCT00574847|10902265|FG001|STARTED|Overall Study||63
9794712|NCT00574847|10902264|FG000|COMPLETED|Overall Study||56
9794713|NCT00574847|10902265|FG001|COMPLETED|Overall Study||56
9794714|NCT00574847|10902264|FG000|NOT COMPLETED|Overall Study||8
9794715|NCT00574847|10902265|FG001|NOT COMPLETED|Overall Study||7
9794716|NCT00574873|10902273|FG000|STARTED|Overall Study||250
9794717|NCT00574873|10902274|FG001|STARTED|Overall Study||252
9794718|NCT00574873|10902273|FG000|Treated|Overall Study||248
9794719|NCT00574873|10902274|FG001|Treated|Overall Study||251
9794720|NCT00574873|10902273|FG000|COMPLETED|Overall Study||12
9794721|NCT00574873|10902274|FG001|COMPLETED|Overall Study||1
9794722|NCT00574873|10902273|FG000|NOT COMPLETED|Overall Study||238
9794723|NCT00574873|10902274|FG001|NOT COMPLETED|Overall Study||251
9794724|NCT00574912|10902280|FG000|STARTED|Overall Study||20
9794725|NCT00574912|10902280|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12
9794726|NCT00574912|10902280|FG000|Completed 0.5|Overall Study||12
9794727|NCT00574912|10902280|FG000|Completed 1.0|Overall Study||12
9794728|NCT00574912|10902280|FG000|Completed 1.5|Overall Study||12
9794729|NCT00574912|10902280|FG000|Completed 2.0|Overall Study||12
9794730|NCT00574912|10902280|FG000|COMPLETED|Overall Study||12
9794731|NCT00574912|10902280|FG000|NOT COMPLETED|Overall Study||8
9794732|NCT00574951|10902292|FG000|STARTED|Overall Study||23
9794733|NCT00574951|10902292|FG000|COMPLETED|Overall Study||22
9794734|NCT00574951|10902292|FG000|NOT COMPLETED|Overall Study||1
9794735|NCT00574990|10902299|FG000|STARTED|Overall Study||12
9794736|NCT00574990|10902300|FG001|STARTED|Overall Study||19
9794737|NCT00574990|10902301|FG002|STARTED|Overall Study||8
9794738|NCT00574990|10902299|FG000|COMPLETED|Overall Study||12
9794739|NCT00574990|10902300|FG001|COMPLETED|Overall Study||19
9794740|NCT00574990|10902301|FG002|COMPLETED|Overall Study||8
9794741|NCT00574990|10902299|FG000|NOT COMPLETED|Overall Study||0
9794742|NCT00574990|10902300|FG001|NOT COMPLETED|Overall Study||0
9794743|NCT00574990|10902301|FG002|NOT COMPLETED|Overall Study||0
9794744|NCT00575016|10902316|FG000|STARTED|Treatment Cycle 1||17
9794745|NCT00575016|10902317|FG001|STARTED|Treatment Cycle 1||21
9794746|NCT00575016|10902318|FG002|STARTED|Treatment Cycle 1||19
9794747|NCT00575016|10902319|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
9794748|NCT00575016|10902316|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
9794749|NCT00575016|10902317|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
9794750|NCT00575016|10902318|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
9794751|NCT00575016|10902319|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
9794752|NCT00575016|10902316|FG000|NOT COMPLETED|Treatment Cycle 1||9
9794753|NCT00575016|10902317|FG001|NOT COMPLETED|Treatment Cycle 1||5
9794754|NCT00575016|10902318|FG002|NOT COMPLETED|Treatment Cycle 1||4
9794755|NCT00575016|10902319|FG003|NOT COMPLETED|Treatment Cycle 1||5
9794756|NCT00575016|10902316|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
9794757|NCT00575016|10902317|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
9794758|NCT00575016|10902318|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
9794759|NCT00575016|10902319|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
9794760|NCT00575016|10902316|FG000|COMPLETED|Treatment Cycle 2||30
9794761|NCT00575016|10902317|FG001|COMPLETED|Treatment Cycle 2||0
9794762|NCT00575016|10902318|FG002|COMPLETED|Treatment Cycle 2||0
9794763|NCT00575016|10902319|FG003|COMPLETED|Treatment Cycle 2||0
9794764|NCT00575016|10902316|FG000|NOT COMPLETED|Treatment Cycle 2||1
9794765|NCT00575016|10902317|FG001|NOT COMPLETED|Treatment Cycle 2||0
9794766|NCT00575016|10902318|FG002|NOT COMPLETED|Treatment Cycle 2||0
9794767|NCT00575016|10902319|FG003|NOT COMPLETED|Treatment Cycle 2||0
9794768|NCT00575029|10902329|FG000|STARTED|Overall Study||7
9794769|NCT00575029|10902329|FG000|COMPLETED|Overall Study||7
9794770|NCT00575029|10902329|FG000|NOT COMPLETED|Overall Study||0
9794771|NCT00575042|10902333|FG000|STARTED|Overall Study||20
9794772|NCT00575042|10902333|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
9794773|NCT00575042|10902333|FG000|NOT COMPLETED|Overall Study||3
9794774|NCT00575094|10902338|FG000|STARTED|Overall Study||9
9794775|NCT00575094|10902338|FG000|COMPLETED|Overall Study||6
9794776|NCT00575094|10902338|FG000|NOT COMPLETED|Overall Study||3
9794777|NCT00575146|10902342|FG000|STARTED|Overall Study||20
9794778|NCT00575146|10902342|FG000|COMPLETED|Overall Study||17
9794779|NCT00575146|10902342|FG000|NOT COMPLETED|Overall Study||3
9794780|NCT00575159|10902346|FG000|STARTED|Overall Study||10
9794781|NCT00575159|10902346|FG000|COMPLETED|Overall Study||10
9794782|NCT00575159|10902346|FG000|NOT COMPLETED|Overall Study||0
9794783|NCT00575185|10902364|FG000|STARTED|Overall Study||12
9794784|NCT00575185|10902365|FG001|STARTED|Overall Study||11
9794785|NCT00575185|10902364|FG000|COMPLETED|Overall Study||12
9794786|NCT00575185|10902365|FG001|COMPLETED|Overall Study||11
9794787|NCT00575185|10902364|FG000|NOT COMPLETED|Overall Study||0
9794788|NCT00575185|10902365|FG001|NOT COMPLETED|Overall Study||0
9794789|NCT00575328|10902375|FG000|STARTED|Overall Study||4
9794790|NCT00575328|10902376|FG001|STARTED|Overall Study||4
9794791|NCT00575328|10902375|FG000|COMPLETED|Overall Study||1
9794792|NCT00575328|10902376|FG001|COMPLETED|Overall Study||2
9794793|NCT00575328|10902375|FG000|NOT COMPLETED|Overall Study||3
9794794|NCT00575328|10902376|FG001|NOT COMPLETED|Overall Study||2
9794795|NCT00575367|10902384|FG000|STARTED|Overall Study||19
9794796|NCT00575367|10902385|FG001|STARTED|Overall Study||18
9794797|NCT00575367|10902384|FG000|COMPLETED|Overall Study||19
9794798|NCT00575367|10902385|FG001|COMPLETED|Overall Study||18
9794799|NCT00575367|10902384|FG000|NOT COMPLETED|Overall Study||0
9794800|NCT00575367|10902385|FG001|NOT COMPLETED|Overall Study||0
9794801|NCT00575380|10902393|FG000|STARTED|Overall Study||58
9794802|NCT00575380|10902394|FG001|STARTED|Overall Study||58
9794803|NCT00575380|10902393|FG000|COMPLETED|Overall Study||57
9794804|NCT00575380|10902394|FG001|COMPLETED|Overall Study||55
9794805|NCT00575380|10902393|FG000|NOT COMPLETED|Overall Study||1
9794806|NCT00575380|10902394|FG001|NOT COMPLETED|Overall Study||3
9794807|NCT00575510|10902403|FG000|STARTED|Overall Study||114
9794808|NCT00575510|10902404|FG001|STARTED|Overall Study||114
9794809|NCT00575510|10902405|FG002|STARTED|Overall Study||113
9794810|NCT00575510|10902403|FG000|COMPLETED|Overall Study||102
9794811|NCT00575510|10902404|FG001|COMPLETED|Overall Study||101
9794812|NCT00575510|10902405|FG002|COMPLETED|Overall Study||96
9794813|NCT00575510|10902403|FG000|NOT COMPLETED|Overall Study||12
9794814|NCT00575510|10902404|FG001|NOT COMPLETED|Overall Study||13
9794815|NCT00575510|10902405|FG002|NOT COMPLETED|Overall Study||17
9794816|NCT00575588|10902416|FG000|STARTED|Overall Study|Randomized and treated|428
9794817|NCT00575588|10902417|FG001|STARTED|Overall Study|Randomized and treated|430
9794818|NCT00575588|10902416|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
9794819|NCT00575588|10902417|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
9794820|NCT00575588|10902416|FG000|NOT COMPLETED|Overall Study||263
9794821|NCT00575588|10902417|FG001|NOT COMPLETED|Overall Study||283
9794822|NCT00575666|10902425|FG000|STARTED|Overall Study||21
9794823|NCT00575666|10902426|FG001|STARTED|Overall Study||24
9794824|NCT00575666|10902425|FG000|COMPLETED|Overall Study||17
9794825|NCT00575666|10902426|FG001|COMPLETED|Overall Study||21
9794826|NCT00575666|10902425|FG000|NOT COMPLETED|Overall Study||4
9794827|NCT00575666|10902426|FG001|NOT COMPLETED|Overall Study||3
9794828|NCT00575887|10902432|FG000|STARTED|Overall Study||25
9794829|NCT00575887|10902432|FG000|COMPLETED|Overall Study||25
9794830|NCT00575887|10902432|FG000|NOT COMPLETED|Overall Study||0
9794831|NCT00575965|10902436|FG000|STARTED|Overall Study||18
9794832|NCT00575965|10902436|FG000|COMPLETED|Overall Study||18
9794833|NCT00575965|10902436|FG000|NOT COMPLETED|Overall Study||0
9794834|NCT00576056|10902440|FG000|STARTED|Overall Study||19
9794835|NCT00576056|10902440|FG000|COMPLETED|Overall Study||5
9794836|NCT00576056|10902440|FG000|NOT COMPLETED|Overall Study||14
9794837|NCT00576147|10902444|FG000|STARTED|Overall Study||431
9794838|NCT00576147|10902444|FG000|COMPLETED|Overall Study||431
9794839|NCT00576147|10902444|FG000|NOT COMPLETED|Overall Study||0
9794840|NCT00576199|10902448|FG000|STARTED|Overall Study||30
9794841|NCT00576199|10902448|FG000|COMPLETED|Overall Study||0
9794842|NCT00576199|10902448|FG000|NOT COMPLETED|Overall Study||30
9794843|NCT00576251|10902454|FG000|STARTED|Overall Study||109
9794844|NCT00576251|10902455|FG001|STARTED|Overall Study||112
9794845|NCT00576251|10902454|FG000|COMPLETED|Overall Study||108
9794846|NCT00576251|10902455|FG001|COMPLETED|Overall Study||111
9794847|NCT00576251|10902454|FG000|NOT COMPLETED|Overall Study||1
9794848|NCT00576251|10902455|FG001|NOT COMPLETED|Overall Study||1
9794849|NCT00576303|10902461|FG000|STARTED|Dose Titration Period||200
9794850|NCT00576303|10902461|FG000|COMPLETED|Dose Titration Period||183
9794851|NCT00576303|10902461|FG000|NOT COMPLETED|Dose Titration Period||17
9794852|NCT00576303|10902461|FG000|STARTED|Efficacy Evaluation Period||183
9794853|NCT00576303|10902461|FG000|COMPLETED|Efficacy Evaluation Period||178
9794854|NCT00576303|10902461|FG000|NOT COMPLETED|Efficacy Evaluation Period||5
9794855|NCT00576303|10902461|FG000|STARTED|Long Term Safety Period||178
9794856|NCT00576303|10902461|FG000|COMPLETED|Long Term Safety Period||162
9794857|NCT00576303|10902461|FG000|NOT COMPLETED|Long Term Safety Period||16
9794858|NCT00576316|10902465|FG000|STARTED|Overall Study|Number of patients recruited|201
10015590|NCT01806688|11138604|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
10015591|NCT01806688|11138605|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
9794859|NCT00576316|10902465|FG000|COMPLETED|Overall Study|Number of patients who completed study|181
9794860|NCT00576316|10902465|FG000|NOT COMPLETED|Overall Study||20
9794861|NCT00576381|10902469|FG000|STARTED|Overall Study||30
9794862|NCT00576381|10902469|FG000|COMPLETED|Overall Study||23
9794863|NCT00576381|10902469|FG000|NOT COMPLETED|Overall Study||7
9794864|NCT00576420|10902476|FG000|STARTED|Overall Study||26
9794865|NCT00576420|10902477|FG001|STARTED|Overall Study||24
9794866|NCT00576420|10902478|FG002|STARTED|Overall Study||23
9794867|NCT00576420|10902476|FG000|COMPLETED|Overall Study||26
9794868|NCT00576420|10902477|FG001|COMPLETED|Overall Study||24
9794869|NCT00576420|10902478|FG002|COMPLETED|Overall Study||22
9794870|NCT00576420|10902476|FG000|NOT COMPLETED|Overall Study||0
9794871|NCT00576420|10902477|FG001|NOT COMPLETED|Overall Study||0
10015592|NCT01806688|11138604|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
10015593|NCT01806688|11138605|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
9794872|NCT00576420|10902478|FG002|NOT COMPLETED|Overall Study||1
9830916|NCT00766090|10941717|FG011|COMPLETED|Treatment Period 1 (28 Days)||7
9830917|NCT00766090|10941706|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3
9830918|NCT00766090|10941707|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830919|NCT00766090|10941708|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830920|NCT00766090|10941709|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1
9830921|NCT00766090|10941710|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830922|NCT00766090|10941711|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830923|NCT00766090|10941712|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830924|NCT00766090|10941713|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830925|NCT00766090|10941714|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1
9830926|NCT00766090|10941715|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830927|NCT00766090|10941716|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830928|NCT00766090|10941717|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
9830929|NCT00766090|10941706|FG000|STARTED|Washout Period 1 (14 Days)||22
9830930|NCT00766090|10941707|FG001|STARTED|Washout Period 1 (14 Days)||27
9830931|NCT00766090|10941708|FG002|STARTED|Washout Period 1 (14 Days)||23
9830932|NCT00766090|10941709|FG003|STARTED|Washout Period 1 (14 Days)||25
9830933|NCT00766090|10941710|FG004|STARTED|Washout Period 1 (14 Days)||23
9830934|NCT00766090|10941711|FG005|STARTED|Washout Period 1 (14 Days)||23
9830935|NCT00766090|10941712|FG006|STARTED|Washout Period 1 (14 Days)||6
9830936|NCT00766090|10941713|FG007|STARTED|Washout Period 1 (14 Days)||8
9830937|NCT00766090|10941714|FG008|STARTED|Washout Period 1 (14 Days)||6
9830938|NCT00766090|10941715|FG009|STARTED|Washout Period 1 (14 Days)||8
9830939|NCT00766090|10941716|FG010|STARTED|Washout Period 1 (14 Days)||7
9830940|NCT00766090|10941717|FG011|STARTED|Washout Period 1 (14 Days)||7
9830941|NCT00766090|10941706|FG000|COMPLETED|Washout Period 1 (14 Days)||22
9830942|NCT00766090|10941707|FG001|COMPLETED|Washout Period 1 (14 Days)||27
9830943|NCT00766090|10941708|FG002|COMPLETED|Washout Period 1 (14 Days)||22
9830944|NCT00766090|10941709|FG003|COMPLETED|Washout Period 1 (14 Days)||25
9830945|NCT00766090|10941710|FG004|COMPLETED|Washout Period 1 (14 Days)||23
9830946|NCT00766090|10941711|FG005|COMPLETED|Washout Period 1 (14 Days)||23
9830947|NCT00766090|10941712|FG006|COMPLETED|Washout Period 1 (14 Days)||6
9830948|NCT00766090|10941713|FG007|COMPLETED|Washout Period 1 (14 Days)||8
9830949|NCT00766090|10941714|FG008|COMPLETED|Washout Period 1 (14 Days)||6
9830950|NCT00766090|10941715|FG009|COMPLETED|Washout Period 1 (14 Days)||8
9830951|NCT00766090|10941716|FG010|COMPLETED|Washout Period 1 (14 Days)||7
9830952|NCT00766090|10941717|FG011|COMPLETED|Washout Period 1 (14 Days)||7
9830953|NCT00766090|10941706|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830954|NCT00766090|10941707|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830955|NCT00766090|10941708|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1
9830956|NCT00766090|10941709|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830957|NCT00766090|10941710|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830958|NCT00766090|10941711|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830959|NCT00766090|10941712|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830960|NCT00766090|10941713|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830961|NCT00766090|10941714|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830962|NCT00766090|10941715|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830963|NCT00766090|10941716|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830964|NCT00766090|10941717|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
9830965|NCT00766090|10941706|FG000|STARTED|Treatment Period 2 (28 Days)||22
9830966|NCT00766090|10941707|FG001|STARTED|Treatment Period 2 (28 Days)||27
9830967|NCT00766090|10941708|FG002|STARTED|Treatment Period 2 (28 Days)||22
9830968|NCT00766090|10941709|FG003|STARTED|Treatment Period 2 (28 Days)||25
9830969|NCT00766090|10941710|FG004|STARTED|Treatment Period 2 (28 Days)||23
9830970|NCT00766090|10941711|FG005|STARTED|Treatment Period 2 (28 Days)||23
9830971|NCT00766090|10941712|FG006|STARTED|Treatment Period 2 (28 Days)||6
9830972|NCT00766090|10941713|FG007|STARTED|Treatment Period 2 (28 Days)||8
9830973|NCT00766090|10941714|FG008|STARTED|Treatment Period 2 (28 Days)||6
9830974|NCT00766090|10941715|FG009|STARTED|Treatment Period 2 (28 Days)||8
9830975|NCT00766090|10941716|FG010|STARTED|Treatment Period 2 (28 Days)||7
9830976|NCT00766090|10941717|FG011|STARTED|Treatment Period 2 (28 Days)||7
9830977|NCT00766090|10941706|FG000|COMPLETED|Treatment Period 2 (28 Days)||22
9830978|NCT00766090|10941707|FG001|COMPLETED|Treatment Period 2 (28 Days)||27
9830979|NCT00766090|10941708|FG002|COMPLETED|Treatment Period 2 (28 Days)||21
9830980|NCT00766090|10941709|FG003|COMPLETED|Treatment Period 2 (28 Days)||25
9830981|NCT00766090|10941710|FG004|COMPLETED|Treatment Period 2 (28 Days)||21
9830982|NCT00766090|10941711|FG005|COMPLETED|Treatment Period 2 (28 Days)||23
9830983|NCT00766090|10941712|FG006|COMPLETED|Treatment Period 2 (28 Days)||6
9830984|NCT00766090|10941713|FG007|COMPLETED|Treatment Period 2 (28 Days)||8
9830985|NCT00766090|10941714|FG008|COMPLETED|Treatment Period 2 (28 Days)||6
9830986|NCT00766090|10941715|FG009|COMPLETED|Treatment Period 2 (28 Days)||8
9830987|NCT00766090|10941716|FG010|COMPLETED|Treatment Period 2 (28 Days)||7
9830988|NCT00766090|10941717|FG011|COMPLETED|Treatment Period 2 (28 Days)||7
9830989|NCT00766090|10941706|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9794873|NCT00576472|10902542|FG000|STARTED|Initial Screening||230
9794874|NCT00576472|10902543|FG001|STARTED|Initial Screening||40
9794875|NCT00576472|10902544|FG002|STARTED|Initial Screening||199
9794876|NCT00576472|10902545|FG003|STARTED|Initial Screening||0
9794877|NCT00576472|10902546|FG004|STARTED|Initial Screening||0
9794878|NCT00576472|10902547|FG005|STARTED|Initial Screening||0
9794879|NCT00576472|10902548|FG006|STARTED|Initial Screening||0
9794880|NCT00576472|10902549|FG007|STARTED|Initial Screening||0
9794881|NCT00576472|10902550|FG008|STARTED|Initial Screening||0
9794882|NCT00576472|10902551|FG009|STARTED|Initial Screening||0
9794883|NCT00576472|10902552|FG010|STARTED|Initial Screening||0
9794884|NCT00576472|10902553|FG011|STARTED|Initial Screening||0
9794885|NCT00576472|10902554|FG012|STARTED|Initial Screening||0
9794886|NCT00576472|10902555|FG013|STARTED|Initial Screening||0
9794887|NCT00576472|10902556|FG014|STARTED|Initial Screening||0
9794888|NCT00576472|10902542|FG000|COMPLETED|Initial Screening||230
9794889|NCT00576472|10902543|FG001|COMPLETED|Initial Screening||40
9794890|NCT00576472|10902544|FG002|COMPLETED|Initial Screening||199
9794891|NCT00576472|10902545|FG003|COMPLETED|Initial Screening||0
9794892|NCT00576472|10902546|FG004|COMPLETED|Initial Screening||0
9794893|NCT00576472|10902547|FG005|COMPLETED|Initial Screening||0
9794894|NCT00576472|10902548|FG006|COMPLETED|Initial Screening||0
9794895|NCT00576472|10902549|FG007|COMPLETED|Initial Screening||0
9794896|NCT00576472|10902550|FG008|COMPLETED|Initial Screening||0
9794897|NCT00576472|10902551|FG009|COMPLETED|Initial Screening||0
9794898|NCT00576472|10902552|FG010|COMPLETED|Initial Screening||0
9794899|NCT00576472|10902553|FG011|COMPLETED|Initial Screening||0
9794900|NCT00576472|10902554|FG012|COMPLETED|Initial Screening||0
9794901|NCT00576472|10902555|FG013|COMPLETED|Initial Screening||0
9794902|NCT00576472|10902556|FG014|COMPLETED|Initial Screening||0
9794903|NCT00576472|10902542|FG000|NOT COMPLETED|Initial Screening||0
9794904|NCT00576472|10902543|FG001|NOT COMPLETED|Initial Screening||0
9794905|NCT00576472|10902544|FG002|NOT COMPLETED|Initial Screening||0
9794906|NCT00576472|10902545|FG003|NOT COMPLETED|Initial Screening||0
9794907|NCT00576472|10902546|FG004|NOT COMPLETED|Initial Screening||0
9794908|NCT00576472|10902547|FG005|NOT COMPLETED|Initial Screening||0
9794909|NCT00576472|10902548|FG006|NOT COMPLETED|Initial Screening||0
9794910|NCT00576472|10902549|FG007|NOT COMPLETED|Initial Screening||0
9794911|NCT00576472|10902550|FG008|NOT COMPLETED|Initial Screening||0
9794912|NCT00576472|10902551|FG009|NOT COMPLETED|Initial Screening||0
9794913|NCT00576472|10902552|FG010|NOT COMPLETED|Initial Screening||0
9794914|NCT00576472|10902553|FG011|NOT COMPLETED|Initial Screening||0
9794915|NCT00576472|10902554|FG012|NOT COMPLETED|Initial Screening||0
9794916|NCT00576472|10902555|FG013|NOT COMPLETED|Initial Screening||0
9794917|NCT00576472|10902556|FG014|NOT COMPLETED|Initial Screening||0
9794918|NCT00576472|10902542|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
9794919|NCT00576472|10902543|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
9794920|NCT00576472|10902544|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
9794921|NCT00576472|10902545|FG003|STARTED|MPH In-Lab Phase||335
9794922|NCT00576472|10902546|FG004|STARTED|MPH In-Lab Phase||67
9794923|NCT00576472|10902547|FG005|STARTED|MPH In-Lab Phase||67
9794924|NCT00576472|10902548|FG006|STARTED|MPH In-Lab Phase||0
9794925|NCT00576472|10902549|FG007|STARTED|MPH In-Lab Phase||0
9794926|NCT00576472|10902550|FG008|STARTED|MPH In-Lab Phase||0
9794927|NCT00576472|10902551|FG009|STARTED|MPH In-Lab Phase||0
9794928|NCT00576472|10902552|FG010|STARTED|MPH In-Lab Phase||0
9794929|NCT00576472|10902553|FG011|STARTED|MPH In-Lab Phase||0
10015594|NCT01806688|11138604|FG000|COMPLETED|Second Intervention Pita Study||0
10015595|NCT01806688|11138605|FG001|COMPLETED|Second Intervention Pita Study||38
10015596|NCT01806688|11138604|FG000|NOT COMPLETED|Second Intervention Pita Study||0
9794930|NCT00576472|10902554|FG012|STARTED|MPH In-Lab Phase||0
9794931|NCT00576472|10902555|FG013|STARTED|MPH In-Lab Phase||0
9794932|NCT00576472|10902556|FG014|STARTED|MPH In-Lab Phase||0
9794933|NCT00576472|10902542|FG000|COMPLETED|MPH In-Lab Phase||0
9794934|NCT00576472|10902543|FG001|COMPLETED|MPH In-Lab Phase||0
9794935|NCT00576472|10902544|FG002|COMPLETED|MPH In-Lab Phase||0
9794936|NCT00576472|10902545|FG003|COMPLETED|MPH In-Lab Phase||0
9794937|NCT00576472|10902546|FG004|COMPLETED|MPH In-Lab Phase||67
9794938|NCT00576472|10902547|FG005|COMPLETED|MPH In-Lab Phase||67
9794939|NCT00576472|10902548|FG006|COMPLETED|MPH In-Lab Phase||0
9794940|NCT00576472|10902549|FG007|COMPLETED|MPH In-Lab Phase||0
10015597|NCT01806688|11138605|FG001|NOT COMPLETED|Second Intervention Pita Study||0
10015598|NCT01806688|11138604|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
10015599|NCT01806688|11138605|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
9794941|NCT00576472|10902550|FG008|COMPLETED|MPH In-Lab Phase||0
9794942|NCT00576472|10902551|FG009|COMPLETED|MPH In-Lab Phase||0
9794943|NCT00576472|10902552|FG010|COMPLETED|MPH In-Lab Phase||0
9794944|NCT00576472|10902553|FG011|COMPLETED|MPH In-Lab Phase||0
9794945|NCT00576472|10902554|FG012|COMPLETED|MPH In-Lab Phase||0
9794946|NCT00576472|10902555|FG013|COMPLETED|MPH In-Lab Phase||0
9794947|NCT00576472|10902556|FG014|COMPLETED|MPH In-Lab Phase||0
9794948|NCT00576472|10902542|FG000|NOT COMPLETED|MPH In-Lab Phase||0
9794949|NCT00576472|10902543|FG001|NOT COMPLETED|MPH In-Lab Phase||0
9794950|NCT00576472|10902544|FG002|NOT COMPLETED|MPH In-Lab Phase||0
9794951|NCT00576472|10902545|FG003|NOT COMPLETED|MPH In-Lab Phase||335
9794952|NCT00576472|10902546|FG004|NOT COMPLETED|MPH In-Lab Phase||0
9794953|NCT00576472|10902547|FG005|NOT COMPLETED|MPH In-Lab Phase||0
9794954|NCT00576472|10902548|FG006|NOT COMPLETED|MPH In-Lab Phase||0
9794955|NCT00576472|10902549|FG007|NOT COMPLETED|MPH In-Lab Phase||0
9794956|NCT00576472|10902550|FG008|NOT COMPLETED|MPH In-Lab Phase||0
9794957|NCT00576472|10902551|FG009|NOT COMPLETED|MPH In-Lab Phase||0
9794958|NCT00576472|10902552|FG010|NOT COMPLETED|MPH In-Lab Phase||0
9794959|NCT00576472|10902553|FG011|NOT COMPLETED|MPH In-Lab Phase||0
9794960|NCT00576472|10902554|FG012|NOT COMPLETED|MPH In-Lab Phase||0
9794961|NCT00576472|10902555|FG013|NOT COMPLETED|MPH In-Lab Phase||0
9794962|NCT00576472|10902556|FG014|NOT COMPLETED|MPH In-Lab Phase||0
9794963|NCT00576472|10902542|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
9794964|NCT00576472|10902543|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
9794965|NCT00576472|10902544|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
9794966|NCT00576472|10902545|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
9794967|NCT00576472|10902546|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
9794968|NCT00576472|10902547|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
9794969|NCT00576472|10902548|FG006|STARTED|MPH Cross Over Phase||12
9794970|NCT00576472|10902549|FG007|STARTED|MPH Cross Over Phase||20
9794971|NCT00576472|10902550|FG008|STARTED|MPH Cross Over Phase||18
9794972|NCT00576472|10902551|FG009|STARTED|MPH Cross Over Phase||22
9794973|NCT00576472|10902552|FG010|STARTED|MPH Cross Over Phase||23
9794974|NCT00576472|10902553|FG011|STARTED|MPH Cross Over Phase||18
9794975|NCT00576472|10902554|FG012|STARTED|MPH Cross Over Phase||21
9794976|NCT00576472|10902555|FG013|STARTED|MPH Cross Over Phase||0
9794977|NCT00576472|10902556|FG014|STARTED|MPH Cross Over Phase||0
9794978|NCT00576472|10902542|FG000|COMPLETED|MPH Cross Over Phase||0
9794979|NCT00576472|10902543|FG001|COMPLETED|MPH Cross Over Phase||0
9794980|NCT00576472|10902544|FG002|COMPLETED|MPH Cross Over Phase||0
9794981|NCT00576472|10902545|FG003|COMPLETED|MPH Cross Over Phase||0
9794982|NCT00576472|10902546|FG004|COMPLETED|MPH Cross Over Phase||0
9794983|NCT00576472|10902547|FG005|COMPLETED|MPH Cross Over Phase||0
9794984|NCT00576472|10902548|FG006|COMPLETED|MPH Cross Over Phase||0
9794985|NCT00576472|10902549|FG007|COMPLETED|MPH Cross Over Phase||20
9794986|NCT00576472|10902550|FG008|COMPLETED|MPH Cross Over Phase||16
9794987|NCT00576472|10902551|FG009|COMPLETED|MPH Cross Over Phase||22
9794988|NCT00576472|10902552|FG010|COMPLETED|MPH Cross Over Phase||22
9794989|NCT00576472|10902553|FG011|COMPLETED|MPH Cross Over Phase||17
9794990|NCT00576472|10902554|FG012|COMPLETED|MPH Cross Over Phase||21
9794991|NCT00576472|10902555|FG013|COMPLETED|MPH Cross Over Phase||0
9794992|NCT00576472|10902556|FG014|COMPLETED|MPH Cross Over Phase||0
9794993|NCT00576472|10902542|FG000|NOT COMPLETED|MPH Cross Over Phase||0
9794994|NCT00576472|10902543|FG001|NOT COMPLETED|MPH Cross Over Phase||0
9794995|NCT00576472|10902544|FG002|NOT COMPLETED|MPH Cross Over Phase||0
9794996|NCT00576472|10902545|FG003|NOT COMPLETED|MPH Cross Over Phase||0
9794997|NCT00576472|10902546|FG004|NOT COMPLETED|MPH Cross Over Phase||0
9794998|NCT00576472|10902547|FG005|NOT COMPLETED|MPH Cross Over Phase||0
9794999|NCT00576472|10902548|FG006|NOT COMPLETED|MPH Cross Over Phase||12
9795000|NCT00576472|10902549|FG007|NOT COMPLETED|MPH Cross Over Phase||0
9795001|NCT00576472|10902550|FG008|NOT COMPLETED|MPH Cross Over Phase||2
9795002|NCT00576472|10902551|FG009|NOT COMPLETED|MPH Cross Over Phase||0
9795003|NCT00576472|10902552|FG010|NOT COMPLETED|MPH Cross Over Phase||1
9795004|NCT00576472|10902553|FG011|NOT COMPLETED|MPH Cross Over Phase||1
9795005|NCT00576472|10902554|FG012|NOT COMPLETED|MPH Cross Over Phase||0
9795006|NCT00576472|10902555|FG013|NOT COMPLETED|MPH Cross Over Phase||0
9795007|NCT00576472|10902556|FG014|NOT COMPLETED|MPH Cross Over Phase||0
9795008|NCT00576472|10902542|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795009|NCT00576472|10902543|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795010|NCT00576472|10902544|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795011|NCT00576472|10902545|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795012|NCT00576472|10902546|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795013|NCT00576472|10902547|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795014|NCT00576472|10902548|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795015|NCT00576472|10902549|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795016|NCT00576472|10902550|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795017|NCT00576472|10902551|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795018|NCT00576472|10902552|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795019|NCT00576472|10902553|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795020|NCT00576472|10902554|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9795021|NCT00576472|10902555|FG013|STARTED|MPH Home Maintenance Phase||27
9795022|NCT00576472|10902556|FG014|STARTED|MPH Home Maintenance Phase||91
9795023|NCT00576472|10902542|FG000|COMPLETED|MPH Home Maintenance Phase||0
9795024|NCT00576472|10902543|FG001|COMPLETED|MPH Home Maintenance Phase||0
9795025|NCT00576472|10902544|FG002|COMPLETED|MPH Home Maintenance Phase||0
9795026|NCT00576472|10902545|FG003|COMPLETED|MPH Home Maintenance Phase||0
9795027|NCT00576472|10902546|FG004|COMPLETED|MPH Home Maintenance Phase||0
9795028|NCT00576472|10902547|FG005|COMPLETED|MPH Home Maintenance Phase||0
9795029|NCT00576472|10902548|FG006|COMPLETED|MPH Home Maintenance Phase||0
9795030|NCT00576472|10902549|FG007|COMPLETED|MPH Home Maintenance Phase||0
9795031|NCT00576472|10902550|FG008|COMPLETED|MPH Home Maintenance Phase||0
9795032|NCT00576472|10902551|FG009|COMPLETED|MPH Home Maintenance Phase||0
9795033|NCT00576472|10902552|FG010|COMPLETED|MPH Home Maintenance Phase||0
9795034|NCT00576472|10902553|FG011|COMPLETED|MPH Home Maintenance Phase||0
9795035|NCT00576472|10902554|FG012|COMPLETED|MPH Home Maintenance Phase||0
9795036|NCT00576472|10902555|FG013|COMPLETED|MPH Home Maintenance Phase||0
9795037|NCT00576472|10902556|FG014|COMPLETED|MPH Home Maintenance Phase||68
9795038|NCT00576472|10902542|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0
9795039|NCT00576472|10902543|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0
9795040|NCT00576472|10902544|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0
9795041|NCT00576472|10902545|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0
9795042|NCT00576472|10902546|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0
9795043|NCT00576472|10902547|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0
9795044|NCT00576472|10902548|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0
9795045|NCT00576472|10902549|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0
9795046|NCT00576472|10902550|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0
9795047|NCT00576472|10902551|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0
9795048|NCT00576472|10902552|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0
9795049|NCT00576472|10902553|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0
9795050|NCT00576472|10902554|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0
9795051|NCT00576472|10902555|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27
9795052|NCT00576472|10902556|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23
9795053|NCT00576576|10902587|FG000|STARTED|Overall Study||27
9795054|NCT00576576|10902587|FG000|COMPLETED|Overall Study||20
9795055|NCT00576576|10902587|FG000|NOT COMPLETED|Overall Study||7
9795056|NCT00576628|10902591|FG000|STARTED|Overall Study||125
9795057|NCT00576628|10902591|FG000|COMPLETED|Overall Study||82
9795058|NCT00576628|10902591|FG000|NOT COMPLETED|Overall Study||43
9795059|NCT00576680|10902596|FG000|STARTED|Overall Study||43
9795060|NCT00576680|10902596|FG000|COMPLETED|Overall Study||43
9795061|NCT00576680|10902596|FG000|NOT COMPLETED|Overall Study||0
9795062|NCT00576693|10902602|FG000|STARTED|Overall Study||224
9795063|NCT00576693|10902603|FG001|STARTED|Overall Study||227
9795064|NCT00576693|10902602|FG000|COMPLETED|Overall Study||214
9795065|NCT00576693|10902603|FG001|COMPLETED|Overall Study||203
9795066|NCT00576693|10902602|FG000|NOT COMPLETED|Overall Study||10
9795067|NCT00576693|10902603|FG001|NOT COMPLETED|Overall Study||24
9795068|NCT00576732|10902612|FG000|STARTED|DOUBLE BLIND||35
9795069|NCT00576732|10902613|FG001|STARTED|DOUBLE BLIND||30
9795070|NCT00576732|10902614|FG002|STARTED|DOUBLE BLIND||31
9795071|NCT00576732|10902615|FG003|STARTED|DOUBLE BLIND||0
9795072|NCT00576732|10902616|FG004|STARTED|DOUBLE BLIND||0
9795073|NCT00576732|10902617|FG005|STARTED|DOUBLE BLIND||0
9795074|NCT00576732|10902612|FG000|COMPLETED|DOUBLE BLIND||27
9795075|NCT00576732|10902613|FG001|COMPLETED|DOUBLE BLIND||25
9795076|NCT00576732|10902614|FG002|COMPLETED|DOUBLE BLIND||25
9795077|NCT00576732|10902615|FG003|COMPLETED|DOUBLE BLIND||0
9795078|NCT00576732|10902616|FG004|COMPLETED|DOUBLE BLIND||0
9795079|NCT00576732|10902617|FG005|COMPLETED|DOUBLE BLIND||0
9795080|NCT00576732|10902612|FG000|NOT COMPLETED|DOUBLE BLIND||8
9795081|NCT00576732|10902613|FG001|NOT COMPLETED|DOUBLE BLIND||5
9795082|NCT00576732|10902614|FG002|NOT COMPLETED|DOUBLE BLIND||6
9795083|NCT00576732|10902615|FG003|NOT COMPLETED|DOUBLE BLIND||0
9795084|NCT00576732|10902616|FG004|NOT COMPLETED|DOUBLE BLIND||0
9795085|NCT00576732|10902617|FG005|NOT COMPLETED|DOUBLE BLIND||0
9795086|NCT00576732|10902612|FG000|STARTED|OPEN LABEL||0
9795087|NCT00576732|10902613|FG001|STARTED|OPEN LABEL||0
9795088|NCT00576732|10902614|FG002|STARTED|OPEN LABEL||0
9795089|NCT00576732|10902615|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
9795090|NCT00576732|10902616|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
9795091|NCT00576732|10902617|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
9795092|NCT00576732|10902612|FG000|COMPLETED|OPEN LABEL||0
9795093|NCT00576732|10902613|FG001|COMPLETED|OPEN LABEL||0
9795094|NCT00576732|10902614|FG002|COMPLETED|OPEN LABEL||0
9795095|NCT00576732|10902615|FG003|COMPLETED|OPEN LABEL||19
9795096|NCT00576732|10902616|FG004|COMPLETED|OPEN LABEL||20
9795097|NCT00576732|10902617|FG005|COMPLETED|OPEN LABEL||17
9795098|NCT00576732|10902612|FG000|NOT COMPLETED|OPEN LABEL||0
9795099|NCT00576732|10902613|FG001|NOT COMPLETED|OPEN LABEL||0
9795100|NCT00576732|10902614|FG002|NOT COMPLETED|OPEN LABEL||0
9795101|NCT00576732|10902615|FG003|NOT COMPLETED|OPEN LABEL||11
9795102|NCT00576732|10902616|FG004|NOT COMPLETED|OPEN LABEL||4
9795103|NCT00576732|10902617|FG005|NOT COMPLETED|OPEN LABEL||8
9795104|NCT00576758|10902631|FG000|STARTED|Induction Treatment Period||87
9795105|NCT00576758|10902632|FG001|STARTED|Induction Treatment Period||88
9795106|NCT00576758|10902631|FG000|Received Treatment|Induction Treatment Period||86
9795107|NCT00576758|10902632|FG001|Received Treatment|Induction Treatment Period||87
9795108|NCT00576758|10902631|FG000|COMPLETED|Induction Treatment Period||79
9795109|NCT00576758|10902632|FG001|COMPLETED|Induction Treatment Period||83
9795110|NCT00576758|10902631|FG000|NOT COMPLETED|Induction Treatment Period||8
9795111|NCT00576758|10902632|FG001|NOT COMPLETED|Induction Treatment Period||5
9795112|NCT00576758|10902631|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
9795113|NCT00576758|10902632|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
9795114|NCT00576758|10902631|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
9795115|NCT00576758|10902632|FG001|COMPLETED|Extension Treatment Period||30
9795116|NCT00576758|10902631|FG000|NOT COMPLETED|Extension Treatment Period||42
9795117|NCT00576758|10902632|FG001|NOT COMPLETED|Extension Treatment Period||43
9795118|NCT00576758|10902631|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
9795119|NCT00576758|10902632|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
9795120|NCT00576758|10902631|FG000|COMPLETED|Follow-up Period||28
9795121|NCT00576758|10902632|FG001|COMPLETED|Follow-up Period||34
9795122|NCT00576758|10902631|FG000|NOT COMPLETED|Follow-up Period||27
9795123|NCT00576758|10902632|FG001|NOT COMPLETED|Follow-up Period||17
9795124|NCT00576823|10902642|FG000|STARTED|12-week Efficacy Phase||12
9795125|NCT00576823|10902643|FG001|STARTED|12-week Efficacy Phase||6
9795126|NCT00576823|10902644|FG002|STARTED|12-week Efficacy Phase||7
9795127|NCT00576823|10902642|FG000|COMPLETED|12-week Efficacy Phase||11
9795128|NCT00576823|10902643|FG001|COMPLETED|12-week Efficacy Phase||6
9795129|NCT00576823|10902644|FG002|COMPLETED|12-week Efficacy Phase||7
9795130|NCT00576823|10902642|FG000|NOT COMPLETED|12-week Efficacy Phase||1
9795131|NCT00576823|10902643|FG001|NOT COMPLETED|12-week Efficacy Phase||0
9795132|NCT00576823|10902644|FG002|NOT COMPLETED|12-week Efficacy Phase||0
9795133|NCT00576823|10902642|FG000|STARTED|40-week Safety Extension Phase||11
9795134|NCT00576823|10902643|FG001|STARTED|40-week Safety Extension Phase||6
9795135|NCT00576823|10902644|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
9795136|NCT00576823|10902642|FG000|COMPLETED|40-week Safety Extension Phase||10
9795137|NCT00576823|10902643|FG001|COMPLETED|40-week Safety Extension Phase||6
9795138|NCT00576823|10902644|FG002|COMPLETED|40-week Safety Extension Phase||6
9795139|NCT00576823|10902642|FG000|NOT COMPLETED|40-week Safety Extension Phase||1
9795140|NCT00576823|10902643|FG001|NOT COMPLETED|40-week Safety Extension Phase||0
9795141|NCT00576823|10902644|FG002|NOT COMPLETED|40-week Safety Extension Phase||0
9795142|NCT00576901|10902655|FG000|STARTED|Overall Study||23
9795143|NCT00576901|10902655|FG000|COMPLETED|Overall Study||20
9795144|NCT00576901|10902655|FG000|NOT COMPLETED|Overall Study||3
9795145|NCT00576927|10902661|FG000|STARTED|Clinical Assessment||79
9795146|NCT00576927|10902661|FG000|COMPLETED|Clinical Assessment||43
9795147|NCT00576927|10902661|FG000|NOT COMPLETED|Clinical Assessment||36
9795148|NCT00576927|10902661|FG000|STARTED|Baseline||43
9795149|NCT00576927|10902661|FG000|COMPLETED|Baseline||30
9795150|NCT00576927|10902661|FG000|NOT COMPLETED|Baseline||13
9795151|NCT00576927|10902661|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30
9795152|NCT00576927|10902661|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23
9795153|NCT00576927|10902661|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
9795154|NCT00576927|10902661|FG000|STARTED|Sleep Hygiene With the Placebo||23
9795155|NCT00576927|10902661|FG000|COMPLETED|Sleep Hygiene With the Placebo||22
9795156|NCT00576927|10902661|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1
9795157|NCT00576927|10902661|FG000|STARTED|Sleep Hygiene With Study Drug||22
9795158|NCT00576927|10902661|FG000|COMPLETED|Sleep Hygiene With Study Drug||22
9795159|NCT00576927|10902661|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0
9795160|NCT00576927|10902661|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22
9795161|NCT00576927|10902661|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
9795162|NCT00576927|10902661|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
9795163|NCT00577005|10902669|FG000|STARTED|Overall Study||16
9795164|NCT00577005|10902670|FG001|STARTED|Overall Study||12
9795165|NCT00577005|10902669|FG000|COMPLETED|Overall Study||11
9795166|NCT00577005|10902670|FG001|COMPLETED|Overall Study||9
9795167|NCT00577005|10902669|FG000|NOT COMPLETED|Overall Study||5
9795168|NCT00577005|10902670|FG001|NOT COMPLETED|Overall Study||3
9795169|NCT00577031|10902679|FG000|STARTED|Overall Study||205
9795170|NCT00577031|10902679|FG000|COMPLETED|Overall Study||0
9795171|NCT00577031|10902679|FG000|NOT COMPLETED|Overall Study||205
9795172|NCT00577083|10902688|FG000|STARTED|First Intervention (14 Days)||48
9795173|NCT00577083|10902689|FG001|STARTED|First Intervention (14 Days)||52
9795174|NCT00577083|10902688|FG000|COMPLETED|First Intervention (14 Days)||48
9795175|NCT00577083|10902689|FG001|COMPLETED|First Intervention (14 Days)||52
9795176|NCT00577083|10902688|FG000|NOT COMPLETED|First Intervention (14 Days)||0
9795177|NCT00577083|10902689|FG001|NOT COMPLETED|First Intervention (14 Days)||0
9795178|NCT00577083|10902688|FG000|STARTED|Washout (14 Days)||48
9795179|NCT00577083|10902689|FG001|STARTED|Washout (14 Days)||52
9795180|NCT00577083|10902688|FG000|COMPLETED|Washout (14 Days)||48
9795181|NCT00577083|10902689|FG001|COMPLETED|Washout (14 Days)||52
9795182|NCT00577083|10902688|FG000|NOT COMPLETED|Washout (14 Days)||0
9795183|NCT00577083|10902689|FG001|NOT COMPLETED|Washout (14 Days)||0
9795184|NCT00577083|10902688|FG000|STARTED|Second Intervention (14days)||48
9795185|NCT00577083|10902689|FG001|STARTED|Second Intervention (14days)||52
9795186|NCT00577083|10902688|FG000|COMPLETED|Second Intervention (14days)||48
9795187|NCT00577083|10902689|FG001|COMPLETED|Second Intervention (14days)||52
9795188|NCT00577083|10902688|FG000|NOT COMPLETED|Second Intervention (14days)||0
9795189|NCT00577083|10902689|FG001|NOT COMPLETED|Second Intervention (14days)||0
9795190|NCT00577096|10902703|FG000|STARTED|Short Term Participation||69
9795191|NCT00577096|10902704|FG001|STARTED|Short Term Participation||66
9795192|NCT00577096|10902703|FG000|COMPLETED|Short Term Participation||62
9795193|NCT00577096|10902704|FG001|COMPLETED|Short Term Participation||58
9795194|NCT00577096|10902703|FG000|NOT COMPLETED|Short Term Participation||7
9795195|NCT00577096|10902704|FG001|NOT COMPLETED|Short Term Participation||8
9795196|NCT00577096|10902703|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
9795197|NCT00577096|10902704|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
9795198|NCT00577096|10902703|FG000|COMPLETED|Long Term Participation||34
9795199|NCT00577096|10902704|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
9795200|NCT00577096|10902703|FG000|NOT COMPLETED|Long Term Participation||0
9795201|NCT00577096|10902704|FG001|NOT COMPLETED|Long Term Participation||0
9795202|NCT00577122|10902712|FG000|STARTED|Overall Study||14
9795203|NCT00577122|10902713|FG001|STARTED|Overall Study||16
9795204|NCT00577122|10902712|FG000|COMPLETED|Overall Study||0
9795205|NCT00577122|10902713|FG001|COMPLETED|Overall Study||0
9795206|NCT00577122|10902712|FG000|NOT COMPLETED|Overall Study||14
9795207|NCT00577122|10902713|FG001|NOT COMPLETED|Overall Study||16
9795208|NCT00577135|10902724|FG000|STARTED|Overall Study||74
9795209|NCT00577135|10902725|FG001|STARTED|Overall Study||82
9795210|NCT00577135|10902726|FG002|STARTED|Overall Study||77
9795211|NCT00577135|10902727|FG003|STARTED|Overall Study||75
9795212|NCT00577135|10902724|FG000|COMPLETED|Overall Study||74
9795213|NCT00577135|10902725|FG001|COMPLETED|Overall Study||82
9795214|NCT00577135|10902726|FG002|COMPLETED|Overall Study||77
9795215|NCT00577135|10902727|FG003|COMPLETED|Overall Study||75
9795216|NCT00577135|10902724|FG000|NOT COMPLETED|Overall Study||0
9795217|NCT00577135|10902725|FG001|NOT COMPLETED|Overall Study||0
9795218|NCT00577135|10902726|FG002|NOT COMPLETED|Overall Study||0
9795219|NCT00577135|10902727|FG003|NOT COMPLETED|Overall Study||0
9795220|NCT00577382|10902739|FG000|STARTED|Overall Study||21
9795221|NCT00577382|10902740|FG001|STARTED|Overall Study||31
9795222|NCT00577382|10902739|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
9795223|NCT00577382|10902740|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
9795224|NCT00577382|10902739|FG000|NOT COMPLETED|Overall Study||21
9795225|NCT00577382|10902740|FG001|NOT COMPLETED|Overall Study||31
9795226|NCT00577408|10902748|FG000|STARTED|Overall Study||28
9795227|NCT00577408|10902749|FG001|STARTED|Overall Study||32
9795228|NCT00577408|10902748|FG000|COMPLETED|Overall Study||16
9795229|NCT00577408|10902749|FG001|COMPLETED|Overall Study||9
9795230|NCT00577408|10902748|FG000|NOT COMPLETED|Overall Study||12
9795231|NCT00577408|10902749|FG001|NOT COMPLETED|Overall Study||23
9795232|NCT00577460|10902758|FG000|STARTED|Overall Study||129
9795233|NCT00577460|10902759|FG001|STARTED|Overall Study||123
9795234|NCT00577460|10902760|FG002|STARTED|Overall Study||139
9795235|NCT00577460|10902758|FG000|COMPLETED|Overall Study||113
9795236|NCT00577460|10902759|FG001|COMPLETED|Overall Study||104
9795237|NCT00577460|10902760|FG002|COMPLETED|Overall Study||112
9795238|NCT00577460|10902758|FG000|NOT COMPLETED|Overall Study||16
9795239|NCT00577460|10902759|FG001|NOT COMPLETED|Overall Study||19
9795240|NCT00577460|10902760|FG002|NOT COMPLETED|Overall Study||27
9795241|NCT00577473|10902777|FG000|STARTED|Overall Study||154
9795242|NCT00577473|10902778|FG001|STARTED|Overall Study||147
9795243|NCT00577473|10902777|FG000|ITT Population|Overall Study||150
9795244|NCT00577473|10902778|FG001|ITT Population|Overall Study||136
9795245|NCT00577473|10902777|FG000|COMPLETED|Overall Study||133
9795246|NCT00577473|10902778|FG001|COMPLETED|Overall Study||123
9795247|NCT00577473|10902777|FG000|NOT COMPLETED|Overall Study||21
9795248|NCT00577473|10902778|FG001|NOT COMPLETED|Overall Study||24
9795249|NCT00577512|10902784|FG000|STARTED|Overall Study||4
9795250|NCT00577512|10902784|FG000|COMPLETED|Overall Study||0
9795251|NCT00577512|10902784|FG000|NOT COMPLETED|Overall Study||4
9795252|NCT00577590|10902791|FG000|STARTED|Overall Study||28
9795253|NCT00577590|10902792|FG001|STARTED|Overall Study||27
9795254|NCT00577590|10902793|FG002|STARTED|Overall Study||23
9795255|NCT00577590|10902791|FG000|COMPLETED|Overall Study||28
9795256|NCT00577590|10902792|FG001|COMPLETED|Overall Study||27
9795257|NCT00577590|10902793|FG002|COMPLETED|Overall Study||23
9795258|NCT00577590|10902791|FG000|NOT COMPLETED|Overall Study||0
9795259|NCT00577590|10902792|FG001|NOT COMPLETED|Overall Study||0
9795260|NCT00577590|10902793|FG002|NOT COMPLETED|Overall Study||0
9795261|NCT00577629|10902801|FG000|STARTED|Treatment Period||39
9795262|NCT00577629|10902801|FG000|COMPLETED|Treatment Period||38
9795263|NCT00577629|10902801|FG000|NOT COMPLETED|Treatment Period||1
9795264|NCT00577629|10902801|FG000|STARTED|Long Term Follow-Up||38
9795265|NCT00577629|10902801|FG000|COMPLETED|Long Term Follow-Up||13
9795266|NCT00577629|10902801|FG000|NOT COMPLETED|Long Term Follow-Up||25
9795267|NCT00577642|10902807|FG000|STARTED|Overall Study||29
9795268|NCT00577642|10902807|FG000|COMPLETED|Overall Study||28
9795269|NCT00577642|10902807|FG000|NOT COMPLETED|Overall Study||1
9795270|NCT00577655|10902813|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52
9795271|NCT00577655|10902814|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51
9795272|NCT00577655|10902813|FG000|COMPLETED|Overall Study||51
9795273|NCT00577655|10902814|FG001|COMPLETED|Overall Study||47
9795274|NCT00577655|10902813|FG000|NOT COMPLETED|Overall Study||1
9795275|NCT00577655|10902814|FG001|NOT COMPLETED|Overall Study||4
9795276|NCT00577707|10902821|FG000|STARTED|Overall Study||9
9795277|NCT00577707|10902821|FG000|COMPLETED|Overall Study||6
9795278|NCT00577707|10902821|FG000|NOT COMPLETED|Overall Study||3
9795279|NCT00577720|10902829|FG000|STARTED|Overall Study||37
9795280|NCT00577720|10902830|FG001|STARTED|Overall Study||36
9795281|NCT00577720|10902831|FG002|STARTED|Overall Study||36
9795282|NCT00577720|10902832|FG003|STARTED|Overall Study||72
9795283|NCT00577720|10902829|FG000|ITT (Intent to Treat) Population|Overall Study||34
9795284|NCT00577720|10902830|FG001|ITT (Intent to Treat) Population|Overall Study||35
9795285|NCT00577720|10902831|FG002|ITT (Intent to Treat) Population|Overall Study||35
9795286|NCT00577720|10902832|FG003|ITT (Intent to Treat) Population|Overall Study||65
9795287|NCT00577720|10902829|FG000|COMPLETED|Overall Study||33
9795288|NCT00577720|10902830|FG001|COMPLETED|Overall Study||35
9795289|NCT00577720|10902831|FG002|COMPLETED|Overall Study||35
9795290|NCT00577720|10902832|FG003|COMPLETED|Overall Study||65
9795291|NCT00577720|10902829|FG000|NOT COMPLETED|Overall Study||4
9795292|NCT00577720|10902830|FG001|NOT COMPLETED|Overall Study||1
9795293|NCT00577720|10902831|FG002|NOT COMPLETED|Overall Study||1
9795294|NCT00577720|10902832|FG003|NOT COMPLETED|Overall Study||7
9795295|NCT00577824|10902845|FG000|STARTED|Overall Study|Started=Randomized|72
9795296|NCT00577824|10902846|FG001|STARTED|Overall Study||73
9795297|NCT00577824|10902847|FG002|STARTED|Overall Study||36
9795298|NCT00577824|10902845|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
9795299|NCT00577824|10902846|FG001|Full Analysis Set|Overall Study||72
9795300|NCT00577824|10902847|FG002|Full Analysis Set|Overall Study||35
9795301|NCT00577824|10902845|FG000|COMPLETED|Overall Study||65
9795302|NCT00577824|10902846|FG001|COMPLETED|Overall Study||53
9795303|NCT00577824|10902847|FG002|COMPLETED|Overall Study||34
9795304|NCT00577824|10902845|FG000|NOT COMPLETED|Overall Study||7
9795305|NCT00577824|10902846|FG001|NOT COMPLETED|Overall Study||20
9795306|NCT00577824|10902847|FG002|NOT COMPLETED|Overall Study||2
9795307|NCT00577863|10902857|FG000|STARTED|Overall Study||92
9795308|NCT00577863|10902858|FG001|STARTED|Overall Study||108
9795309|NCT00577863|10902857|FG000|Received at Least One Injection|Overall Study||92
9795310|NCT00577863|10902858|FG001|Received at Least One Injection|Overall Study||107
9795311|NCT00577863|10902857|FG000|COMPLETED|Overall Study||82
9795312|NCT00577863|10902858|FG001|COMPLETED|Overall Study||94
9795313|NCT00577863|10902857|FG000|NOT COMPLETED|Overall Study||10
9795314|NCT00577863|10902858|FG001|NOT COMPLETED|Overall Study||14
9795315|NCT00577889|10902867|FG000|STARTED|Overall Study||9
9795316|NCT00577889|10902868|FG001|STARTED|Overall Study||6
9795317|NCT00577889|10902869|FG002|STARTED|Overall Study||6
9795318|NCT00577889|10902867|FG000|COMPLETED|Overall Study||8
9795319|NCT00577889|10902868|FG001|COMPLETED|Overall Study||6
9795320|NCT00577889|10902869|FG002|COMPLETED|Overall Study||6
9795321|NCT00577889|10902867|FG000|NOT COMPLETED|Overall Study||1
9795322|NCT00577889|10902868|FG001|NOT COMPLETED|Overall Study||0
9795323|NCT00577889|10902869|FG002|NOT COMPLETED|Overall Study||0
9795324|NCT00577993|10902880|FG000|STARTED|Overall Study||85
9795325|NCT00577993|10902881|FG001|STARTED|Overall Study||90
9795326|NCT00577993|10902882|FG002|STARTED|Overall Study||35
9795327|NCT00577993|10902880|FG000|COMPLETED|Overall Study||78
9795328|NCT00577993|10902881|FG001|COMPLETED|Overall Study||80
9795329|NCT00577993|10902882|FG002|COMPLETED|Overall Study||32
9795330|NCT00577993|10902880|FG000|NOT COMPLETED|Overall Study||7
9795331|NCT00577993|10902881|FG001|NOT COMPLETED|Overall Study||10
9795332|NCT00577993|10902882|FG002|NOT COMPLETED|Overall Study||3
9795333|NCT00578071|10902888|FG000|STARTED|Overall Study||29
9795334|NCT00578071|10902888|FG000|COMPLETED|Overall Study||29
9795335|NCT00578071|10902888|FG000|NOT COMPLETED|Overall Study||0
9795336|NCT00578136|10902895|FG000|STARTED|Overall Study||27
9795337|NCT00578136|10902896|FG001|STARTED|Overall Study||27
9795338|NCT00578136|10902895|FG000|COMPLETED|Overall Study||26
9795339|NCT00578136|10902896|FG001|COMPLETED|Overall Study||26
9795340|NCT00578136|10902895|FG000|NOT COMPLETED|Overall Study||1
9795341|NCT00578136|10902896|FG001|NOT COMPLETED|Overall Study||1
9795342|NCT00578175|10902905|FG000|STARTED|Overall Study||705
9795343|NCT00578175|10902906|FG001|STARTED|Overall Study||689
9795344|NCT00578175|10902907|FG002|STARTED|Overall Study||389
9795345|NCT00578175|10902905|FG000|COMPLETED|Overall Study||635
9795346|NCT00578175|10902906|FG001|COMPLETED|Overall Study||646
9795347|NCT00578175|10902907|FG002|COMPLETED|Overall Study||365
9795348|NCT00578175|10902905|FG000|NOT COMPLETED|Overall Study||70
9795349|NCT00578175|10902906|FG001|NOT COMPLETED|Overall Study||43
9795350|NCT00578175|10902907|FG002|NOT COMPLETED|Overall Study||24
9795351|NCT00578214|10902920|FG000|STARTED|Overall Study||22
9795352|NCT00578214|10902921|FG001|STARTED|Overall Study||22
9795353|NCT00578214|10902922|FG002|STARTED|Overall Study||31
9795354|NCT00578214|10902920|FG000|COMPLETED|Overall Study||22
9795355|NCT00578214|10902921|FG001|COMPLETED|Overall Study||22
9795356|NCT00578214|10902922|FG002|COMPLETED|Overall Study||31
9795357|NCT00578214|10902920|FG000|NOT COMPLETED|Overall Study||0
9795358|NCT00578214|10902921|FG001|NOT COMPLETED|Overall Study||0
9795359|NCT00578214|10902922|FG002|NOT COMPLETED|Overall Study||0
9795360|NCT00578227|10902933|FG000|STARTED|Overall Study||272
9795361|NCT00578227|10902934|FG001|STARTED|Overall Study||270
9795362|NCT00578227|10902935|FG002|STARTED|Overall Study||271
9795363|NCT00578227|10902933|FG000|COMPLETED|Overall Study||267
9795364|NCT00578227|10902934|FG001|COMPLETED|Overall Study||268
9795365|NCT00578227|10902935|FG002|COMPLETED|Overall Study||267
9795366|NCT00578227|10902933|FG000|NOT COMPLETED|Overall Study||5
9795367|NCT00578227|10902934|FG001|NOT COMPLETED|Overall Study||2
9795368|NCT00578227|10902935|FG002|NOT COMPLETED|Overall Study||4
9795369|NCT00578279|10902947|FG000|STARTED|Overall Study||10
9795370|NCT00578279|10902948|FG001|STARTED|Overall Study||10
9795371|NCT00578279|10902947|FG000|COMPLETED|Overall Study||10
9795372|NCT00578279|10902948|FG001|COMPLETED|Overall Study||10
9795373|NCT00578279|10902947|FG000|NOT COMPLETED|Overall Study||0
9795374|NCT00578279|10902948|FG001|NOT COMPLETED|Overall Study||0
9795375|NCT00578292|10902954|FG000|STARTED|Overall Study||10
9795376|NCT00578292|10902954|FG000|COMPLETED|Overall Study||7
9795377|NCT00578292|10902954|FG000|NOT COMPLETED|Overall Study||3
9795378|NCT00578305|10902961|FG000|STARTED|Double-blind Treatment Phase||62
9795379|NCT00578305|10902962|FG001|STARTED|Double-blind Treatment Phase||60
9795380|NCT00578305|10902963|FG002|STARTED|Double-blind Treatment Phase||63
9795381|NCT00578305|10902961|FG000|Treated|Double-blind Treatment Phase||62
9795382|NCT00578305|10902962|FG001|Treated|Double-blind Treatment Phase||60
9795383|NCT00578305|10902963|FG002|Treated|Double-blind Treatment Phase||63
9795384|NCT00578305|10902961|FG000|COMPLETED|Double-blind Treatment Phase||59
9795385|NCT00578305|10902962|FG001|COMPLETED|Double-blind Treatment Phase||56
9795386|NCT00578305|10902963|FG002|COMPLETED|Double-blind Treatment Phase||49
9795387|NCT00578305|10902961|FG000|NOT COMPLETED|Double-blind Treatment Phase||3
9795388|NCT00578305|10902962|FG001|NOT COMPLETED|Double-blind Treatment Phase||4
9795389|NCT00578305|10902963|FG002|NOT COMPLETED|Double-blind Treatment Phase||14
9795390|NCT00578305|10902961|FG000|STARTED|Extension Phase||53
9795391|NCT00578305|10902962|FG001|STARTED|Extension Phase||50
9795392|NCT00578305|10902963|FG002|STARTED|Extension Phase||43
9795393|NCT00578305|10902961|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
9795394|NCT00578305|10902962|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
9795395|NCT00578305|10902963|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
9795396|NCT00578305|10902961|FG000|NOT COMPLETED|Extension Phase||4
9795397|NCT00578305|10902962|FG001|NOT COMPLETED|Extension Phase||1
9795398|NCT00578305|10902963|FG002|NOT COMPLETED|Extension Phase||3
9795399|NCT00578305|10902961|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
9795400|NCT00578305|10902962|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
9795401|NCT00578305|10902963|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
9795402|NCT00578305|10902961|FG000|COMPLETED|Safety Follow-up Phase||11
9795403|NCT00578305|10902962|FG001|COMPLETED|Safety Follow-up Phase||9
9795404|NCT00578305|10902963|FG002|COMPLETED|Safety Follow-up Phase||8
9795405|NCT00578305|10902961|FG000|NOT COMPLETED|Safety Follow-up Phase||46
9795406|NCT00578305|10902962|FG001|NOT COMPLETED|Safety Follow-up Phase||45
9795407|NCT00578305|10902963|FG002|NOT COMPLETED|Safety Follow-up Phase||46
9795408|NCT00578318|10902979|FG000|STARTED|Overall Study||8
9795409|NCT00578318|10902980|FG001|STARTED|Overall Study||8
9795410|NCT00578318|10902979|FG000|COMPLETED|Overall Study||5
9795411|NCT00578318|10902980|FG001|COMPLETED|Overall Study||8
9795412|NCT00578318|10902979|FG000|NOT COMPLETED|Overall Study||3
9795413|NCT00578318|10902980|FG001|NOT COMPLETED|Overall Study||0
9795414|NCT00578331|10902988|FG000|STARTED|Overall Study||445
9795415|NCT00578331|10902989|FG001|STARTED|Overall Study||445
9795416|NCT00578331|10902988|FG000|COMPLETED|Overall Study||329
9795417|NCT00578331|10902989|FG001|COMPLETED|Overall Study||320
9795418|NCT00578331|10902988|FG000|NOT COMPLETED|Overall Study||116
9795419|NCT00578331|10902989|FG001|NOT COMPLETED|Overall Study||125
9795420|NCT00578344|10902995|FG000|STARTED|Overall Study||8
9795421|NCT00578344|10902995|FG000|COMPLETED|Overall Study||6
9795422|NCT00578344|10902995|FG000|NOT COMPLETED|Overall Study||2
9795423|NCT00578383|10903003|FG000|STARTED|Overall Study||37
9795424|NCT00578383|10903004|FG001|STARTED|Overall Study||36
9795425|NCT00578383|10903005|FG002|STARTED|Overall Study||19
9795426|NCT00578383|10903006|FG003|STARTED|Overall Study||15
9795427|NCT00578383|10903003|FG000|COMPLETED|Overall Study||21
9795428|NCT00578383|10903004|FG001|COMPLETED|Overall Study||20
9795429|NCT00578383|10903005|FG002|COMPLETED|Overall Study||13
9795430|NCT00578383|10903006|FG003|COMPLETED|Overall Study||9
9795431|NCT00578383|10903003|FG000|NOT COMPLETED|Overall Study||16
9795432|NCT00578383|10903004|FG001|NOT COMPLETED|Overall Study||16
9795433|NCT00578383|10903005|FG002|NOT COMPLETED|Overall Study||6
9795434|NCT00578383|10903006|FG003|NOT COMPLETED|Overall Study||6
9795435|NCT00578448|10903020|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12
9795436|NCT00578448|10903020|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9
9795437|NCT00578448|10903020|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
9795438|NCT00578448|10903020|FG000|STARTED|1 Year Long Term Extension (LTE)||9
9795439|NCT00578448|10903020|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8
9795440|NCT00578448|10903020|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
9795441|NCT00578461|10903026|FG000|STARTED|Overall Study||26
9795442|NCT00578461|10903026|FG000|COMPLETED|Overall Study||26
9795443|NCT00578461|10903026|FG000|NOT COMPLETED|Overall Study||0
9795444|NCT00578539|10903030|FG000|STARTED|Overall Study||24
9795445|NCT00578539|10903030|FG000|COMPLETED|Overall Study||24
9795446|NCT00578539|10903030|FG000|NOT COMPLETED|Overall Study||0
9795447|NCT00578552|10903037|FG000|STARTED|Overall Study||27
9795448|NCT00578552|10903038|FG001|STARTED|Overall Study||27
9795449|NCT00578552|10903039|FG002|STARTED|Overall Study||26
9795450|NCT00578552|10903037|FG000|COMPLETED|Overall Study||12
9795451|NCT00578552|10903038|FG001|COMPLETED|Overall Study||13
9795452|NCT00578552|10903039|FG002|COMPLETED|Overall Study||11
9795453|NCT00578552|10903037|FG000|NOT COMPLETED|Overall Study||15
9795454|NCT00578552|10903038|FG001|NOT COMPLETED|Overall Study||14
9795455|NCT00578552|10903039|FG002|NOT COMPLETED|Overall Study||15
9795456|NCT00578565|10903047|FG000|STARTED|Overall Study||10
9795457|NCT00578565|10903047|FG000|COMPLETED|Overall Study||7
9795458|NCT00578565|10903047|FG000|NOT COMPLETED|Overall Study||3
9795459|NCT00578617|10903054|FG000|STARTED|Overall Study||31
9795460|NCT00578617|10903055|FG001|STARTED|Overall Study||29
9795461|NCT00578617|10903054|FG000|COMPLETED|Overall Study||31
9795462|NCT00578617|10903055|FG001|COMPLETED|Overall Study||29
9795463|NCT00578617|10903054|FG000|NOT COMPLETED|Overall Study||0
9795464|NCT00578617|10903055|FG001|NOT COMPLETED|Overall Study||0
9795465|NCT00578643|10903061|FG000|STARTED|Overall Study||15
9795466|NCT00578643|10903061|FG000|COMPLETED|Overall Study||13
9795467|NCT00578643|10903061|FG000|NOT COMPLETED|Overall Study||2
9795468|NCT00578669|10903067|FG000|STARTED|Overall Study||107
9795469|NCT00578669|10903068|FG001|STARTED|Overall Study||99
9795470|NCT00578669|10903067|FG000|COMPLETED|Overall Study||107
9795471|NCT00578669|10903068|FG001|COMPLETED|Overall Study||99
9795472|NCT00578669|10903067|FG000|NOT COMPLETED|Overall Study||0
9795473|NCT00578669|10903068|FG001|NOT COMPLETED|Overall Study||0
9795474|NCT00578734|10903076|FG000|STARTED|Overall Study||84
9795475|NCT00578734|10903077|FG001|STARTED|Overall Study||81
9795476|NCT00578734|10903076|FG000|COMPLETED|Overall Study||84
9795477|NCT00578734|10903077|FG001|COMPLETED|Overall Study||81
9795478|NCT00578734|10903076|FG000|NOT COMPLETED|Overall Study||0
9795479|NCT00578734|10903077|FG001|NOT COMPLETED|Overall Study||0
9795480|NCT00578786|10903086|FG000|STARTED|Overall Study||96
9795481|NCT00578786|10903087|FG001|STARTED|Overall Study||190
9795482|NCT00578786|10903088|FG002|STARTED|Overall Study||97
9795483|NCT00578786|10903086|FG000|COMPLETED|Overall Study||57
9795484|NCT00578786|10903087|FG001|COMPLETED|Overall Study||124
9795485|NCT00578786|10903088|FG002|COMPLETED|Overall Study||67
9795486|NCT00578786|10903086|FG000|NOT COMPLETED|Overall Study||39
9795487|NCT00578786|10903087|FG001|NOT COMPLETED|Overall Study||66
9795488|NCT00578786|10903088|FG002|NOT COMPLETED|Overall Study||30
9795489|NCT00578812|10903108|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
9795490|NCT00578812|10903109|FG001|STARTED|Overall Study||192
9795491|NCT00578812|10903108|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
9795492|NCT00578812|10903109|FG001|COMPLETED|Overall Study||185
9795493|NCT00578812|10903108|FG000|NOT COMPLETED|Overall Study||6
9795494|NCT00578812|10903109|FG001|NOT COMPLETED|Overall Study||7
9795495|NCT00578864|10903118|FG000|STARTED|Overall Study||7
9795496|NCT00578864|10903119|FG001|STARTED|Overall Study||6
9795497|NCT00578864|10903118|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
9795498|NCT00578864|10903119|FG001|COMPLETED|Overall Study||6
9795499|NCT00578864|10903118|FG000|NOT COMPLETED|Overall Study||1
9795500|NCT00578864|10903119|FG001|NOT COMPLETED|Overall Study||0
9795501|NCT00578877|10903127|FG000|STARTED|Overall Study||150
9795502|NCT00578877|10903128|FG001|STARTED|Overall Study||300
9795503|NCT00578877|10903127|FG000|COMPLETED|Overall Study||69
9795504|NCT00578877|10903128|FG001|COMPLETED|Overall Study||172
9795505|NCT00578877|10903127|FG000|NOT COMPLETED|Overall Study||81
9795506|NCT00578877|10903128|FG001|NOT COMPLETED|Overall Study||128
9795507|NCT00578903|10903134|FG000|STARTED|Overall Study||22
9795508|NCT00578903|10903134|FG000|COMPLETED|Overall Study||22
9795509|NCT00578903|10903134|FG000|NOT COMPLETED|Overall Study||0
9795510|NCT00578929|10903142|FG000|STARTED|Vehicle Run-In Period||0
9795511|NCT00578929|10903143|FG001|STARTED|Vehicle Run-In Period||2388
9795512|NCT00578929|10903144|FG002|STARTED|Vehicle Run-In Period||0
9795513|NCT00578929|10903145|FG003|STARTED|Vehicle Run-In Period||0
9795514|NCT00578929|10903142|FG000|COMPLETED|Vehicle Run-In Period||0
9795515|NCT00578929|10903143|FG001|COMPLETED|Vehicle Run-In Period||2388
9795516|NCT00578929|10903144|FG002|COMPLETED|Vehicle Run-In Period||0
9795517|NCT00578929|10903145|FG003|COMPLETED|Vehicle Run-In Period||0
9795518|NCT00578929|10903142|FG000|NOT COMPLETED|Vehicle Run-In Period||0
9795519|NCT00578929|10903143|FG001|NOT COMPLETED|Vehicle Run-In Period||0
9795520|NCT00578929|10903144|FG002|NOT COMPLETED|Vehicle Run-In Period||0
9795521|NCT00578929|10903145|FG003|NOT COMPLETED|Vehicle Run-In Period||0
9795522|NCT00578929|10903142|FG000|STARTED|Randomized Period||298
9795523|NCT00578929|10903143|FG001|STARTED|Randomized Period||297
9795524|NCT00578929|10903144|FG002|STARTED|Randomized Period||296
9795525|NCT00578929|10903145|FG003|STARTED|Randomized Period||297
9795526|NCT00578929|10903142|FG000|COMPLETED|Randomized Period||281
9795527|NCT00578929|10903143|FG001|COMPLETED|Randomized Period||283
9795528|NCT00578929|10903144|FG002|COMPLETED|Randomized Period||288
9795529|NCT00578929|10903145|FG003|COMPLETED|Randomized Period||283
9795530|NCT00578929|10903142|FG000|NOT COMPLETED|Randomized Period||17
9795531|NCT00578929|10903143|FG001|NOT COMPLETED|Randomized Period||14
9795532|NCT00578929|10903144|FG002|NOT COMPLETED|Randomized Period||8
10112138|NCT02501902|11243241|FG005|STARTED|Overall Study||11
10112139|NCT02501902|11243242|FG006|STARTED|Overall Study||9
10112140|NCT02501902|11243243|FG007|STARTED|Overall Study||20
10112141|NCT02501902|11243236|FG000|COMPLETED|Overall Study||0
10112142|NCT02501902|11243237|FG001|COMPLETED|Overall Study||0
10112143|NCT02501902|11243238|FG002|COMPLETED|Overall Study||0
10112144|NCT02501902|11243239|FG003|COMPLETED|Overall Study||0
10112145|NCT02501902|11243240|FG004|COMPLETED|Overall Study||0
10112146|NCT02501902|11243241|FG005|COMPLETED|Overall Study||0
10112147|NCT02501902|11243242|FG006|COMPLETED|Overall Study||0
10112148|NCT02501902|11243243|FG007|COMPLETED|Overall Study||0
10112149|NCT02501902|11243236|FG000|NOT COMPLETED|Overall Study||3
10112150|NCT02501902|11243237|FG001|NOT COMPLETED|Overall Study||7
10112151|NCT02501902|11243238|FG002|NOT COMPLETED|Overall Study||4
10112152|NCT02501902|11243239|FG003|NOT COMPLETED|Overall Study||11
10112153|NCT02501902|11243240|FG004|NOT COMPLETED|Overall Study||11
10112154|NCT02501902|11243241|FG005|NOT COMPLETED|Overall Study||11
10112155|NCT02501902|11243242|FG006|NOT COMPLETED|Overall Study||9
9795533|NCT00578929|10903145|FG003|NOT COMPLETED|Randomized Period||14
9795534|NCT00578942|10903156|FG000|STARTED|Overall Study||48
9795535|NCT00578942|10903156|FG000|COMPLETED|Overall Study||47
9795536|NCT00578942|10903156|FG000|NOT COMPLETED|Overall Study||1
9795537|NCT00578968|10903163|FG000|STARTED|Baseline (Prior to Intervention)||12
9795538|NCT00578968|10903164|FG001|STARTED|Baseline (Prior to Intervention)||12
9795539|NCT00578968|10903165|FG002|STARTED|Baseline (Prior to Intervention)||12
9795540|NCT00578968|10903163|FG000|COMPLETED|Baseline (Prior to Intervention)||12
9795541|NCT00578968|10903164|FG001|COMPLETED|Baseline (Prior to Intervention)||12
9795542|NCT00578968|10903165|FG002|COMPLETED|Baseline (Prior to Intervention)||12
9795543|NCT00578968|10903163|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0
9795544|NCT00578968|10903164|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0
9795545|NCT00578968|10903165|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0
9795546|NCT00578968|10903163|FG000|STARTED|Intervention||12
9795547|NCT00578968|10903164|FG001|STARTED|Intervention||12
9795548|NCT00578968|10903165|FG002|STARTED|Intervention||0
9795549|NCT00578968|10903163|FG000|COMPLETED|Intervention||12
9795550|NCT00578968|10903164|FG001|COMPLETED|Intervention||12
9795551|NCT00578968|10903165|FG002|COMPLETED|Intervention||0
9795552|NCT00578968|10903163|FG000|NOT COMPLETED|Intervention||0
9795553|NCT00578968|10903164|FG001|NOT COMPLETED|Intervention||0
9795554|NCT00578968|10903165|FG002|NOT COMPLETED|Intervention||0
9795555|NCT00579059|10903176|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
9795556|NCT00579059|10903177|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
9795557|NCT00579059|10903176|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
9795558|NCT00579059|10903177|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
9795559|NCT00579059|10903176|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
9795560|NCT00579059|10903177|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4
9795561|NCT00579059|10903176|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8
9795562|NCT00579059|10903177|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3
9795563|NCT00579059|10903176|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
9795564|NCT00579059|10903177|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
9795565|NCT00579059|10903176|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
9795566|NCT00579059|10903177|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
9795567|NCT00579059|10903176|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
9795568|NCT00579059|10903177|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
9795569|NCT00579059|10903176|FG000|NOT COMPLETED|Overall Study||21
9795570|NCT00579059|10903177|FG001|NOT COMPLETED|Overall Study||10
9795571|NCT00579098|10903185|FG000|STARTED|Overall Study||62
9795572|NCT00579098|10903186|FG001|STARTED|Overall Study||63
9795573|NCT00579098|10903185|FG000|COMPLETED|Overall Study||53
9795574|NCT00579098|10903186|FG001|COMPLETED|Overall Study||55
9795575|NCT00579098|10903185|FG000|NOT COMPLETED|Overall Study||9
9795576|NCT00579098|10903186|FG001|NOT COMPLETED|Overall Study||8
9795577|NCT00579111|10903194|FG000|STARTED|Overall Study||3
9795578|NCT00579111|10903195|FG001|STARTED|Overall Study||1
9795579|NCT00579111|10903194|FG000|COMPLETED|Overall Study||1
9795580|NCT00579111|10903195|FG001|COMPLETED|Overall Study||0
9795581|NCT00579111|10903194|FG000|NOT COMPLETED|Overall Study||2
9795582|NCT00579111|10903195|FG001|NOT COMPLETED|Overall Study||1
9795583|NCT00579137|10903201|FG000|STARTED|Overall Study||3
9795584|NCT00579137|10903201|FG000|COMPLETED|Overall Study||3
9795585|NCT00579137|10903201|FG000|NOT COMPLETED|Overall Study||0
9795586|NCT00579280|10903208|FG000|STARTED|Overall Study||49
9795587|NCT00579280|10903209|FG001|STARTED|Overall Study||49
10112156|NCT02501902|11243243|FG007|NOT COMPLETED|Overall Study||20
10112157|NCT02501928|11243269|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
9795588|NCT00579280|10903210|FG002|STARTED|Overall Study||51
9795589|NCT00579280|10903208|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47
9795590|NCT00579280|10903209|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46
9795591|NCT00579280|10903210|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51
9795592|NCT00579280|10903208|FG000|NOT COMPLETED|Overall Study||2
9795593|NCT00579280|10903209|FG001|NOT COMPLETED|Overall Study||3
9795594|NCT00579280|10903210|FG002|NOT COMPLETED|Overall Study||0
9795595|NCT00579345|10903226|FG000|STARTED|Overall Study||549
9795596|NCT00579345|10903227|FG001|STARTED|Overall Study||169
9952513|NCT01422824|11071501|FG000|NOT COMPLETED|Overall Study||38
9952514|NCT01422850|11071505|FG000|STARTED|Overall Study||21
9952515|NCT01422850|11071505|FG000|Week 4 - First Treatment|Overall Study||21
9952516|NCT01422850|11071505|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
9952517|NCT01422850|11071505|FG000|Week 9 - Second Treatment|Overall Study||20
9952518|NCT01422850|11071505|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
9952519|NCT01422850|11071505|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
9952520|NCT01422850|11071505|FG000|COMPLETED|Overall Study||18
9952521|NCT01422850|11071505|FG000|NOT COMPLETED|Overall Study||3
9795597|NCT00579345|10903228|FG002|STARTED|Overall Study||391
9795598|NCT00579345|10903229|FG003|STARTED|Overall Study||144
9795599|NCT00579345|10903230|FG004|STARTED|Overall Study||90
9795600|NCT00579345|10903231|FG005|STARTED|Overall Study||78
9795601|NCT00579345|10903232|FG006|STARTED|Overall Study||57
9795602|NCT00579345|10903233|FG007|STARTED|Overall Study||44
9795603|NCT00579345|10903226|FG000|COMPLETED|Overall Study||544
9795604|NCT00579345|10903227|FG001|COMPLETED|Overall Study||168
9795605|NCT00579345|10903228|FG002|COMPLETED|Overall Study||389
9795606|NCT00579345|10903229|FG003|COMPLETED|Overall Study||143
9795607|NCT00579345|10903230|FG004|COMPLETED|Overall Study||90
9795608|NCT00579345|10903231|FG005|COMPLETED|Overall Study||78
9795609|NCT00579345|10903232|FG006|COMPLETED|Overall Study||57
9795610|NCT00579345|10903233|FG007|COMPLETED|Overall Study||42
9795611|NCT00579345|10903226|FG000|NOT COMPLETED|Overall Study||5
9795612|NCT00579345|10903227|FG001|NOT COMPLETED|Overall Study||1
9795613|NCT00579345|10903228|FG002|NOT COMPLETED|Overall Study||2
9795614|NCT00579345|10903229|FG003|NOT COMPLETED|Overall Study||1
9795615|NCT00579345|10903230|FG004|NOT COMPLETED|Overall Study||0
9795616|NCT00579345|10903231|FG005|NOT COMPLETED|Overall Study||0
9795617|NCT00579345|10903232|FG006|NOT COMPLETED|Overall Study||0
9795618|NCT00579345|10903233|FG007|NOT COMPLETED|Overall Study||2
9795619|NCT00579436|10903263|FG000|STARTED|Overall Study||19
9795620|NCT00579436|10903264|FG001|STARTED|Overall Study||14
9795621|NCT00579436|10903263|FG000|COMPLETED|Overall Study||19
9795622|NCT00579436|10903264|FG001|COMPLETED|Overall Study||14
9795623|NCT00579436|10903263|FG000|NOT COMPLETED|Overall Study||0
9795624|NCT00579436|10903264|FG001|NOT COMPLETED|Overall Study||0
9795625|NCT00579501|10903270|FG000|STARTED|Overall Study||29
9795626|NCT00579501|10903270|FG000|COMPLETED|Overall Study||0
9795627|NCT00579501|10903270|FG000|NOT COMPLETED|Overall Study||29
9795628|NCT00579553|10903276|FG000|STARTED|Overall Study||82
9795629|NCT00579553|10903277|FG001|STARTED|Overall Study||92
9795630|NCT00579553|10903276|FG000|COMPLETED|Overall Study||66
9795631|NCT00579553|10903277|FG001|COMPLETED|Overall Study||79
9795632|NCT00579553|10903276|FG000|NOT COMPLETED|Overall Study||16
9795633|NCT00579553|10903277|FG001|NOT COMPLETED|Overall Study||13
9795634|NCT00579670|10903288|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
9795635|NCT00579670|10903289|FG001|STARTED|Overall Study||57
9795636|NCT00579670|10903290|FG002|STARTED|Overall Study||88
9795637|NCT00579670|10903291|FG003|STARTED|Overall Study||285
9795638|NCT00579670|10903292|FG004|STARTED|Overall Study||5
9795639|NCT00579670|10903288|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
9795640|NCT00579670|10903289|FG001|Population: Within SmPC (Started)|Overall Study||56
9795641|NCT00579670|10903290|FG002|Population: Within SmPC (Started)|Overall Study||83
9795642|NCT00579670|10903291|FG003|Population: Within SmPC (Started)|Overall Study||159
9795643|NCT00579670|10903292|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
9795644|NCT00579670|10903288|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
9795645|NCT00579670|10903289|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
9795646|NCT00579670|10903290|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
9795647|NCT00579670|10903291|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
9795648|NCT00579670|10903292|FG004|Population: Within SmPC (Completed)|Overall Study||0
9795649|NCT00579670|10903288|FG000|COMPLETED|Overall Study||13
9795650|NCT00579670|10903289|FG001|COMPLETED|Overall Study||56
9795651|NCT00579670|10903290|FG002|COMPLETED|Overall Study||84
9795652|NCT00579670|10903291|FG003|COMPLETED|Overall Study||263
9795653|NCT00579670|10903292|FG004|COMPLETED|Overall Study||5
9795654|NCT00579670|10903288|FG000|NOT COMPLETED|Overall Study||2
9795655|NCT00579670|10903289|FG001|NOT COMPLETED|Overall Study||1
9795656|NCT00579670|10903290|FG002|NOT COMPLETED|Overall Study||4
9795657|NCT00579670|10903291|FG003|NOT COMPLETED|Overall Study||22
9795658|NCT00579670|10903292|FG004|NOT COMPLETED|Overall Study||0
9795659|NCT00579813|10903318|FG000|STARTED|Overall Study||60
9795660|NCT00579813|10903319|FG001|STARTED|Overall Study||10
9795661|NCT00579813|10903318|FG000|COMPLETED|Overall Study||60
9795662|NCT00579813|10903319|FG001|COMPLETED|Overall Study||10
9795663|NCT00579813|10903318|FG000|NOT COMPLETED|Overall Study||0
9795664|NCT00579813|10903319|FG001|NOT COMPLETED|Overall Study||0
9795665|NCT00579878|10903329|FG000|STARTED|Overall Study||22
9795666|NCT00579878|10903330|FG001|STARTED|Overall Study||23
9795667|NCT00579878|10903331|FG002|STARTED|Overall Study||24
9795668|NCT00579878|10903329|FG000|COMPLETED|Overall Study||15
9795669|NCT00579878|10903330|FG001|COMPLETED|Overall Study||20
9795670|NCT00579878|10903331|FG002|COMPLETED|Overall Study||14
9795671|NCT00579878|10903329|FG000|NOT COMPLETED|Overall Study||7
9795672|NCT00579878|10903330|FG001|NOT COMPLETED|Overall Study||3
9795673|NCT00579878|10903331|FG002|NOT COMPLETED|Overall Study||10
9795674|NCT00579982|10903339|FG000|STARTED|Overall Study||97
9795675|NCT00579982|10903339|FG000|COMPLETED|Overall Study||89
9795676|NCT00579982|10903339|FG000|NOT COMPLETED|Overall Study||8
9795677|NCT00580034|10903343|FG000|STARTED|Overall Study||88
9795678|NCT00580034|10903344|FG001|STARTED|Overall Study||88
9795679|NCT00580034|10903343|FG000|COMPLETED|Overall Study||78
9795680|NCT00580034|10903344|FG001|COMPLETED|Overall Study||88
9795681|NCT00580034|10903343|FG000|NOT COMPLETED|Overall Study||10
9795682|NCT00580034|10903344|FG001|NOT COMPLETED|Overall Study||0
9795683|NCT00580047|10903351|FG000|STARTED|Overall Study||24
9795684|NCT00580047|10903352|FG001|STARTED|Overall Study||23
9795685|NCT00580047|10903353|FG002|STARTED|Overall Study||12
9795686|NCT00580047|10903351|FG000|COMPLETED|Overall Study||21
9795687|NCT00580047|10903352|FG001|COMPLETED|Overall Study||21
9795688|NCT00580047|10903353|FG002|COMPLETED|Overall Study||10
9795689|NCT00580047|10903351|FG000|NOT COMPLETED|Overall Study||3
9795690|NCT00580047|10903352|FG001|NOT COMPLETED|Overall Study||2
9795691|NCT00580047|10903353|FG002|NOT COMPLETED|Overall Study||2
9795692|NCT00580073|10903364|FG000|STARTED|Overall Study||6
9795693|NCT00580073|10903364|FG000|COMPLETED|Overall Study||6
9795694|NCT00580073|10903364|FG000|NOT COMPLETED|Overall Study||0
9795695|NCT00580138|10903368|FG000|STARTED|Overall Study||30
9795696|NCT00580138|10903368|FG000|COMPLETED|Overall Study||30
9795697|NCT00580138|10903368|FG000|NOT COMPLETED|Overall Study||0
9795698|NCT00580151|10903374|FG000|STARTED|Overall Study||9
9795699|NCT00580151|10903375|FG001|STARTED|Overall Study||0
9795700|NCT00580151|10903374|FG000|COMPLETED|Overall Study||9
9795701|NCT00580151|10903375|FG001|COMPLETED|Overall Study||0
9795702|NCT00580151|10903374|FG000|NOT COMPLETED|Overall Study||0
9795703|NCT00580151|10903375|FG001|NOT COMPLETED|Overall Study||0
9795704|NCT00580229|10903381|FG000|STARTED|Overall Study||50
9795705|NCT00580229|10903381|FG000|COMPLETED|Overall Study||50
9795706|NCT00580229|10903381|FG000|NOT COMPLETED|Overall Study||0
9795707|NCT00580294|10903385|FG000|STARTED|Overall Study||12
9795708|NCT00580294|10903385|FG000|COMPLETED|Overall Study||12
9795709|NCT00580294|10903385|FG000|NOT COMPLETED|Overall Study||0
9795710|NCT00580333|10903389|FG000|STARTED|Overall Study||51
9795711|NCT00580333|10903389|FG000|COMPLETED|Overall Study||51
9795712|NCT00580333|10903389|FG000|NOT COMPLETED|Overall Study||0
9795713|NCT00580372|10903394|FG000|STARTED|Overall Study||231
9795714|NCT00580372|10903394|FG000|COMPLETED|Overall Study||231
9795715|NCT00580372|10903394|FG000|NOT COMPLETED|Overall Study||0
9795716|NCT00580398|10903400|FG000|STARTED|Overall Study||17
9795717|NCT00580398|10903401|FG001|STARTED|Overall Study||32
9795718|NCT00580398|10903400|FG000|COMPLETED|Overall Study||17
9795719|NCT00580398|10903401|FG001|COMPLETED|Overall Study||32
9795720|NCT00580398|10903400|FG000|NOT COMPLETED|Overall Study||0
9795721|NCT00580398|10903401|FG001|NOT COMPLETED|Overall Study||0
9795722|NCT00580502|10903407|FG000|STARTED|Overall Study||50
9795723|NCT00580502|10903407|FG000|COMPLETED|Overall Study||50
9795724|NCT00580502|10903407|FG000|NOT COMPLETED|Overall Study||0
9795725|NCT00580606|10903413|FG000|STARTED|Double Blind (DB)||20
9795726|NCT00580606|10903414|FG001|STARTED|Double Blind (DB)||20
9795727|NCT00580606|10903413|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
9795728|NCT00580606|10903414|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
9795729|NCT00580606|10903413|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
9795730|NCT00580606|10903414|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
9795731|NCT00580606|10903413|FG000|NOT COMPLETED|Double Blind (DB)||0
9795732|NCT00580606|10903414|FG001|NOT COMPLETED|Double Blind (DB)||0
9795733|NCT00580606|10903413|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
9795734|NCT00580606|10903414|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
9795735|NCT00580606|10903413|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
9795736|NCT00580606|10903414|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
9795737|NCT00580606|10903413|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15
9795738|NCT00580606|10903414|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12
9795739|NCT00580606|10903413|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13
9795740|NCT00580606|10903414|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6
9795741|NCT00580606|10903413|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9
9795742|NCT00580606|10903414|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5
9795743|NCT00580606|10903413|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2
9795744|NCT00580606|10903414|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2
9795745|NCT00580606|10903413|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
9795746|NCT00580606|10903414|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
9795747|NCT00580606|10903413|FG000|NOT COMPLETED|Open Label (OL)||9
9795748|NCT00580606|10903414|FG001|NOT COMPLETED|Open Label (OL)||12
9795749|NCT00580645|10903431|FG000|STARTED|Overall Study||20
9795750|NCT00580645|10903432|FG001|STARTED|Overall Study||20
9795751|NCT00580645|10903433|FG002|STARTED|Overall Study||20
9795752|NCT00580645|10903431|FG000|COMPLETED|Overall Study||20
9795753|NCT00580645|10903432|FG001|COMPLETED|Overall Study||20
9795754|NCT00580645|10903433|FG002|COMPLETED|Overall Study||20
9795755|NCT00580645|10903431|FG000|NOT COMPLETED|Overall Study||0
9795756|NCT00580645|10903432|FG001|NOT COMPLETED|Overall Study||0
9795757|NCT00580645|10903433|FG002|NOT COMPLETED|Overall Study||0
9795758|NCT00580671|10903444|FG000|STARTED|Overall Study||51
9795759|NCT00580671|10903445|FG001|STARTED|Overall Study||51
9795760|NCT00580671|10903446|FG002|STARTED|Overall Study||51
9795761|NCT00580671|10903444|FG000|COMPLETED|Overall Study||35
9795762|NCT00580671|10903445|FG001|COMPLETED|Overall Study||35
9795763|NCT00580671|10903446|FG002|COMPLETED|Overall Study||34
9795764|NCT00580671|10903444|FG000|NOT COMPLETED|Overall Study||16
9795765|NCT00580671|10903445|FG001|NOT COMPLETED|Overall Study||16
9795766|NCT00580671|10903446|FG002|NOT COMPLETED|Overall Study||17
9795767|NCT00580723|10903454|FG000|STARTED|Overall Study||24
9795768|NCT00580723|10903454|FG000|COMPLETED|Overall Study||16
9795769|NCT00580723|10903454|FG000|NOT COMPLETED|Overall Study||8
9795770|NCT00580788|10903462|FG000|STARTED|Overall Study||3
9795771|NCT00580788|10903463|FG001|STARTED|Overall Study||6
9795772|NCT00580788|10903464|FG002|STARTED|Overall Study||3
9795773|NCT00580788|10903465|FG003|STARTED|Overall Study||2
9795774|NCT00580788|10903462|FG000|COMPLETED|Overall Study||3
9795775|NCT00580788|10903463|FG001|COMPLETED|Overall Study||6
9795776|NCT00580788|10903464|FG002|COMPLETED|Overall Study||3
9795777|NCT00580788|10903465|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
9795778|NCT00580788|10903462|FG000|NOT COMPLETED|Overall Study||0
9795779|NCT00580788|10903463|FG001|NOT COMPLETED|Overall Study||0
9795780|NCT00580788|10903464|FG002|NOT COMPLETED|Overall Study||0
9795781|NCT00580788|10903465|FG003|NOT COMPLETED|Overall Study||1
9795782|NCT00580801|10903485|FG000|STARTED|Overall Study||8
9795783|NCT00580801|10903486|FG001|STARTED|Overall Study||8
9795784|NCT00580801|10903487|FG002|STARTED|Overall Study||8
9795785|NCT00580801|10903485|FG000|COMPLETED|Overall Study||2
9795786|NCT00580801|10903486|FG001|COMPLETED|Overall Study||7
9795787|NCT00580801|10903487|FG002|COMPLETED|Overall Study||5
9795788|NCT00580801|10903485|FG000|NOT COMPLETED|Overall Study||6
9795789|NCT00580801|10903486|FG001|NOT COMPLETED|Overall Study||1
9795790|NCT00580801|10903487|FG002|NOT COMPLETED|Overall Study||3
9795791|NCT00580840|10903495|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
9795792|NCT00580840|10903496|FG001|STARTED|Run-in||0
9795793|NCT00580840|10903497|FG002|STARTED|Run-in||0
9795794|NCT00580840|10903498|FG003|STARTED|Run-in||0
9795795|NCT00580840|10903495|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
9795796|NCT00580840|10903496|FG001|COMPLETED|Run-in||0
9795797|NCT00580840|10903497|FG002|COMPLETED|Run-in||0
9795798|NCT00580840|10903498|FG003|COMPLETED|Run-in||0
9795799|NCT00580840|10903495|FG000|NOT COMPLETED|Run-in||124
9795800|NCT00580840|10903496|FG001|NOT COMPLETED|Run-in||0
9795801|NCT00580840|10903497|FG002|NOT COMPLETED|Run-in||0
9795802|NCT00580840|10903498|FG003|NOT COMPLETED|Run-in||0
9795803|NCT00580840|10903495|FG000|STARTED|Double-Blind||0
9795804|NCT00580840|10903496|FG001|STARTED|Double-Blind||70
9795805|NCT00580840|10903497|FG002|STARTED|Double-Blind||70
9795806|NCT00580840|10903498|FG003|STARTED|Double-Blind||69
9795807|NCT00580840|10903495|FG000|COMPLETED|Double-Blind||0
9795808|NCT00580840|10903496|FG001|COMPLETED|Double-Blind||63
9795809|NCT00580840|10903497|FG002|COMPLETED|Double-Blind||61
9795810|NCT00580840|10903498|FG003|COMPLETED|Double-Blind||54
9795811|NCT00580840|10903495|FG000|NOT COMPLETED|Double-Blind||0
9795812|NCT00580840|10903496|FG001|NOT COMPLETED|Double-Blind||7
9795813|NCT00580840|10903497|FG002|NOT COMPLETED|Double-Blind||9
9795814|NCT00580840|10903498|FG003|NOT COMPLETED|Double-Blind||15
9795815|NCT00580853|10903511|FG000|STARTED|Overall Study||20
10015600|NCT01806688|11138604|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
10019135|NCT01827943|11142272|FG000|Safety Population|Overall Study||53
10019136|NCT01827943|11142272|FG000|COMPLETED|Overall Study||45
9795816|NCT00580853|10903512|FG001|STARTED|Overall Study||21
9795817|NCT00580853|10903513|FG002|STARTED|Overall Study||21
9795818|NCT00580853|10903511|FG000|COMPLETED|Overall Study||20
9795819|NCT00580853|10903512|FG001|COMPLETED|Overall Study||21
9795820|NCT00580853|10903513|FG002|COMPLETED|Overall Study||21
9795821|NCT00580853|10903511|FG000|NOT COMPLETED|Overall Study||0
9795822|NCT00580853|10903512|FG001|NOT COMPLETED|Overall Study||0
9795823|NCT00580853|10903513|FG002|NOT COMPLETED|Overall Study||0
9795824|NCT00580866|10903523|FG000|STARTED|Overall Study||10
9795825|NCT00580866|10903524|FG001|STARTED|Overall Study||7
9795826|NCT00580866|10903523|FG000|COMPLETED|Overall Study||8
9795827|NCT00580866|10903524|FG001|COMPLETED|Overall Study||5
9795828|NCT00580866|10903523|FG000|NOT COMPLETED|Overall Study||2
9795829|NCT00580866|10903524|FG001|NOT COMPLETED|Overall Study||2
9795830|NCT00580957|10903532|FG000|STARTED|Overall Study||28
9795831|NCT00580957|10903533|FG001|STARTED|Overall Study||28
10015601|NCT01806688|11138605|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
10015602|NCT01806688|11138604|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
10015603|NCT01806688|11138605|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
10015604|NCT01806688|11138604|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
10015605|NCT01806688|11138605|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
9795832|NCT00580957|10903532|FG000|COMPLETED|Overall Study||21
9795833|NCT00580957|10903533|FG001|COMPLETED|Overall Study||21
9795834|NCT00580957|10903532|FG000|NOT COMPLETED|Overall Study||7
9795835|NCT00580957|10903533|FG001|NOT COMPLETED|Overall Study||7
9795836|NCT00580970|10903541|FG000|STARTED|Pre-treatment||73
9795837|NCT00580970|10903541|FG000|COMPLETED|Pre-treatment||72
9795838|NCT00580970|10903541|FG000|NOT COMPLETED|Pre-treatment||1
9795839|NCT00580970|10903541|FG000|STARTED|Treatment (Lovastatin)||72
9795840|NCT00580970|10903541|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
9795841|NCT00580970|10903541|FG000|COMPLETED|Treatment (Lovastatin)||53
9795842|NCT00580970|10903541|FG000|NOT COMPLETED|Treatment (Lovastatin)||19
9795843|NCT00580983|10903545|FG000|STARTED|Overall Study||80
9795844|NCT00580983|10903545|FG000|COMPLETED|Overall Study||73
9795845|NCT00580983|10903545|FG000|NOT COMPLETED|Overall Study||7
9795846|NCT00581048|10903549|FG000|STARTED|Overall Study||33
9795847|NCT00581048|10903549|FG000|COMPLETED|Overall Study||33
9795848|NCT00581048|10903549|FG000|NOT COMPLETED|Overall Study||0
9795849|NCT00581061|10903554|FG000|STARTED|Overall Study||13
9795850|NCT00581061|10903554|FG000|COMPLETED|Overall Study||13
9795851|NCT00581061|10903554|FG000|NOT COMPLETED|Overall Study||0
9795852|NCT00581100|10903562|FG000|STARTED|Overall Study||38
9795853|NCT00581100|10903563|FG001|STARTED|Overall Study||34
9795854|NCT00581100|10903562|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
9795855|NCT00581100|10903563|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
9795856|NCT00581100|10903562|FG000|COMPLETED|Overall Study||31
9795857|NCT00581100|10903563|FG001|COMPLETED|Overall Study||29
9795858|NCT00581100|10903562|FG000|NOT COMPLETED|Overall Study||7
9795859|NCT00581100|10903563|FG001|NOT COMPLETED|Overall Study||5
9795860|NCT00581230|10903569|FG000|STARTED|Overall Study||51
9795861|NCT00581230|10903569|FG000|Laryngoscopy Without RAMP|Overall Study||51
9795862|NCT00581230|10903569|FG000|Laryngoscopy With RAMP|Overall Study||51
9795863|NCT00581230|10903569|FG000|COMPLETED|Overall Study||51
9795864|NCT00581230|10903569|FG000|NOT COMPLETED|Overall Study||0
9830990|NCT00766090|10941707|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9830991|NCT00766090|10941708|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
9830992|NCT00766090|10941709|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9830993|NCT00766090|10941710|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2
9830994|NCT00766090|10941711|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9830995|NCT00766090|10941712|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9830996|NCT00766090|10941713|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9830997|NCT00766090|10941714|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9830998|NCT00766090|10941715|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9830999|NCT00766090|10941716|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9831000|NCT00766090|10941717|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
9831001|NCT00766090|10941706|FG000|STARTED|Washout Period 2 (14 Days)||22
9831002|NCT00766090|10941707|FG001|STARTED|Washout Period 2 (14 Days)||27
9831003|NCT00766090|10941708|FG002|STARTED|Washout Period 2 (14 Days)||21
9831004|NCT00766090|10941709|FG003|STARTED|Washout Period 2 (14 Days)||25
9831005|NCT00766090|10941710|FG004|STARTED|Washout Period 2 (14 Days)||21
9831006|NCT00766090|10941711|FG005|STARTED|Washout Period 2 (14 Days)||23
9831007|NCT00766090|10941712|FG006|STARTED|Washout Period 2 (14 Days)||6
9831008|NCT00766090|10941713|FG007|STARTED|Washout Period 2 (14 Days)||8
9831009|NCT00766090|10941714|FG008|STARTED|Washout Period 2 (14 Days)||6
9831010|NCT00766090|10941715|FG009|STARTED|Washout Period 2 (14 Days)||8
9831011|NCT00766090|10941716|FG010|STARTED|Washout Period 2 (14 Days)||7
9831012|NCT00766090|10941717|FG011|STARTED|Washout Period 2 (14 Days)||7
9831013|NCT00766090|10941706|FG000|COMPLETED|Washout Period 2 (14 Days)||22
9831014|NCT00766090|10941707|FG001|COMPLETED|Washout Period 2 (14 Days)||27
9831015|NCT00766090|10941708|FG002|COMPLETED|Washout Period 2 (14 Days)||20
10015606|NCT01806688|11138604|FG000|COMPLETED|Third Intervention Pita Study||0
10015607|NCT01806688|11138605|FG001|COMPLETED|Third Intervention Pita Study||38
10019137|NCT01827943|11142272|FG000|NOT COMPLETED|Overall Study||9
9831016|NCT00766090|10941709|FG003|COMPLETED|Washout Period 2 (14 Days)||25
9831017|NCT00766090|10941710|FG004|COMPLETED|Washout Period 2 (14 Days)||21
9831018|NCT00766090|10941711|FG005|COMPLETED|Washout Period 2 (14 Days)||23
9831019|NCT00766090|10941712|FG006|COMPLETED|Washout Period 2 (14 Days)||6
9831020|NCT00766090|10941713|FG007|COMPLETED|Washout Period 2 (14 Days)||8
9831021|NCT00766090|10941714|FG008|COMPLETED|Washout Period 2 (14 Days)||6
9831022|NCT00766090|10941715|FG009|COMPLETED|Washout Period 2 (14 Days)||8
9831023|NCT00766090|10941716|FG010|COMPLETED|Washout Period 2 (14 Days)||7
9795865|NCT00581256|10903578|FG000|STARTED|Overall Study||28
9795866|NCT00581256|10903579|FG001|STARTED|Overall Study||26
9795867|NCT00581256|10903578|FG000|COMPLETED|Overall Study||28
9795868|NCT00581256|10903579|FG001|COMPLETED|Overall Study||26
9795869|NCT00581256|10903578|FG000|NOT COMPLETED|Overall Study||0
9795870|NCT00581256|10903579|FG001|NOT COMPLETED|Overall Study||0
9795871|NCT00581308|10903585|FG000|STARTED|Pre Discharge||215
9795872|NCT00581308|10903585|FG000|COMPLETED|Pre Discharge||213
9795873|NCT00581308|10903585|FG000|NOT COMPLETED|Pre Discharge||2
9795874|NCT00581308|10903585|FG000|STARTED|Month 1||213
9795875|NCT00581308|10903585|FG000|COMPLETED|Month 1||205
9795876|NCT00581308|10903585|FG000|NOT COMPLETED|Month 1||8
9795877|NCT00581308|10903585|FG000|STARTED|Month 6||205
9795878|NCT00581308|10903585|FG000|COMPLETED|Month 6||202
9795879|NCT00581308|10903585|FG000|NOT COMPLETED|Month 6||3
9795880|NCT00581308|10903585|FG000|STARTED|Month 12||202
9795881|NCT00581308|10903585|FG000|COMPLETED|Month 12||182
9795882|NCT00581308|10903585|FG000|NOT COMPLETED|Month 12||20
9795883|NCT00581308|10903585|FG000|STARTED|24 Months||182
9795884|NCT00581308|10903585|FG000|COMPLETED|24 Months||176
9795885|NCT00581308|10903585|FG000|NOT COMPLETED|24 Months||6
9795886|NCT00581308|10903585|FG000|STARTED|36 Months||176
9795887|NCT00581308|10903585|FG000|COMPLETED|36 Months||170
9795888|NCT00581308|10903585|FG000|NOT COMPLETED|36 Months||6
9795889|NCT00581308|10903585|FG000|STARTED|48 Months||170
9795890|NCT00581308|10903585|FG000|COMPLETED|48 Months||161
9795891|NCT00581308|10903585|FG000|NOT COMPLETED|48 Months||9
9795892|NCT00581308|10903585|FG000|STARTED|60 Months||161
9795893|NCT00581308|10903585|FG000|COMPLETED|60 Months||158
9795894|NCT00581308|10903585|FG000|NOT COMPLETED|60 Months||3
9795895|NCT00581347|10903594|FG000|STARTED|Overall Study||3839
9795896|NCT00581347|10903595|FG001|STARTED|Overall Study||3707
9795897|NCT00581347|10903594|FG000|COMPLETED|Overall Study||3839
9795898|NCT00581347|10903595|FG001|COMPLETED|Overall Study||3707
9795899|NCT00581347|10903594|FG000|NOT COMPLETED|Overall Study||0
9795900|NCT00581347|10903595|FG001|NOT COMPLETED|Overall Study||0
9795901|NCT00581360|10903601|FG000|STARTED|Overall Study||10
9795902|NCT00581360|10903601|FG000|COMPLETED|Overall Study||9
9795903|NCT00581360|10903601|FG000|NOT COMPLETED|Overall Study||1
9795904|NCT00581386|10903608|FG000|STARTED|Overall Study|05/30/2007|73
9795905|NCT00581386|10903609|FG001|STARTED|Overall Study|05/30/2007|73
9795906|NCT00581386|10903610|FG002|STARTED|Overall Study|05/30/2007|72
9795907|NCT00581386|10903608|FG000|COMPLETED|Overall Study|04/15/2009|73
9795908|NCT00581386|10903609|FG001|COMPLETED|Overall Study|04/15/2009|73
9795909|NCT00581386|10903610|FG002|COMPLETED|Overall Study|04/15/2009|72
9795910|NCT00581386|10903608|FG000|NOT COMPLETED|Overall Study||0
9795911|NCT00581386|10903609|FG001|NOT COMPLETED|Overall Study||0
9795912|NCT00581386|10903610|FG002|NOT COMPLETED|Overall Study||0
9795913|NCT00581399|10903620|FG000|STARTED|Overall Study||46
9795914|NCT00581399|10903621|FG001|STARTED|Overall Study||48
9795915|NCT00581399|10903620|FG000|COMPLETED|Overall Study||46
9795916|NCT00581399|10903621|FG001|COMPLETED|Overall Study||48
9795917|NCT00581399|10903620|FG000|NOT COMPLETED|Overall Study||0
9795918|NCT00581399|10903621|FG001|NOT COMPLETED|Overall Study||0
9795919|NCT00581529|10903627|FG000|STARTED|Overall Study||34
9795920|NCT00581529|10903627|FG000|COMPLETED|Overall Study||34
9795921|NCT00581529|10903627|FG000|NOT COMPLETED|Overall Study||0
9795922|NCT00581542|10903633|FG000|STARTED|Overall Study||62
9795923|NCT00581542|10903634|FG001|STARTED|Overall Study||62
9795924|NCT00581542|10903633|FG000|COMPLETED|Overall Study||51
9795925|NCT00581542|10903634|FG001|COMPLETED|Overall Study||39
9795926|NCT00581542|10903633|FG000|NOT COMPLETED|Overall Study||11
9795927|NCT00581542|10903634|FG001|NOT COMPLETED|Overall Study||23
9795928|NCT00581555|10903644|FG000|STARTED|Overall Study||62
9795929|NCT00581555|10903645|FG001|STARTED|Overall Study||58
9795930|NCT00581555|10903644|FG000|COMPLETED|Overall Study||19
9795931|NCT00581555|10903645|FG001|COMPLETED|Overall Study||38
9795932|NCT00581555|10903644|FG000|NOT COMPLETED|Overall Study||43
9795933|NCT00581555|10903645|FG001|NOT COMPLETED|Overall Study||20
9795934|NCT00581581|10903653|FG000|STARTED|Overall Study||32
9795935|NCT00581581|10903654|FG001|STARTED|Overall Study||30
9795936|NCT00581581|10903653|FG000|COMPLETED|Overall Study||32
9795937|NCT00581581|10903654|FG001|COMPLETED|Overall Study||30
9795938|NCT00581581|10903653|FG000|NOT COMPLETED|Overall Study||0
9795939|NCT00581581|10903654|FG001|NOT COMPLETED|Overall Study||0
9795940|NCT00581776|10903660|FG000|STARTED|Overall Study||30
9795941|NCT00581776|10903660|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
9795942|NCT00581776|10903660|FG000|NOT COMPLETED|Overall Study||3
9795943|NCT00581828|10903664|FG000|STARTED|Overall Study||19
9795944|NCT00581828|10903664|FG000|COMPLETED|Overall Study||18
9795945|NCT00581828|10903664|FG000|NOT COMPLETED|Overall Study||1
9795946|NCT00581854|10903668|FG000|STARTED|Overall Study||22
9795947|NCT00581854|10903668|FG000|COMPLETED|Overall Study||22
9795948|NCT00581854|10903668|FG000|NOT COMPLETED|Overall Study||0
9795949|NCT00581867|10903672|FG000|STARTED|First Intervention||16
9795950|NCT00581867|10903673|FG001|STARTED|First Intervention||15
9795951|NCT00581867|10903672|FG000|COMPLETED|First Intervention||16
9795952|NCT00581867|10903673|FG001|COMPLETED|First Intervention||15
9795953|NCT00581867|10903672|FG000|NOT COMPLETED|First Intervention||0
9795954|NCT00581867|10903673|FG001|NOT COMPLETED|First Intervention||0
9795955|NCT00581867|10903672|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
9831024|NCT00766090|10941717|FG011|COMPLETED|Washout Period 2 (14 Days)||7
9795956|NCT00581867|10903673|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
9795957|NCT00581867|10903672|FG000|COMPLETED|Second Intervention||15
9795958|NCT00581867|10903673|FG001|COMPLETED|Second Intervention||14
9795959|NCT00581867|10903672|FG000|NOT COMPLETED|Second Intervention||0
9795960|NCT00581867|10903673|FG001|NOT COMPLETED|Second Intervention||0
9795961|NCT00581893|10903679|FG000|STARTED|First Intervention (1 Month)||10
9795962|NCT00581893|10903680|FG001|STARTED|First Intervention (1 Month)||10
9795963|NCT00581893|10903679|FG000|COMPLETED|First Intervention (1 Month)||10
9795964|NCT00581893|10903680|FG001|COMPLETED|First Intervention (1 Month)||10
9795965|NCT00581893|10903679|FG000|NOT COMPLETED|First Intervention (1 Month)||0
9795966|NCT00581893|10903680|FG001|NOT COMPLETED|First Intervention (1 Month)||0
9795967|NCT00581893|10903679|FG000|STARTED|Washout (14 Days)||10
9795968|NCT00581893|10903680|FG001|STARTED|Washout (14 Days)||10
9795969|NCT00581893|10903679|FG000|COMPLETED|Washout (14 Days)||10
9795970|NCT00581893|10903680|FG001|COMPLETED|Washout (14 Days)||10
9795971|NCT00581893|10903679|FG000|NOT COMPLETED|Washout (14 Days)||0
9795972|NCT00581893|10903680|FG001|NOT COMPLETED|Washout (14 Days)||0
9795973|NCT00581893|10903679|FG000|STARTED|Second Intervention (1 Month)||10
9795974|NCT00581893|10903680|FG001|STARTED|Second Intervention (1 Month)||10
9795975|NCT00581893|10903679|FG000|COMPLETED|Second Intervention (1 Month)||7
9795976|NCT00581893|10903680|FG001|COMPLETED|Second Intervention (1 Month)||8
9795977|NCT00581893|10903679|FG000|NOT COMPLETED|Second Intervention (1 Month)||3
9795978|NCT00581893|10903680|FG001|NOT COMPLETED|Second Intervention (1 Month)||2
9795979|NCT00581919|10903686|FG000|STARTED|Overall Study||32
9795980|NCT00581919|10903686|FG000|COMPLETED|Overall Study||8
9795981|NCT00581919|10903686|FG000|NOT COMPLETED|Overall Study||24
9795982|NCT00581945|10903693|FG000|STARTED|Overall Study||74
9795983|NCT00581945|10903694|FG001|STARTED|Overall Study||73
9795984|NCT00581945|10903693|FG000|COMPLETED|Overall Study||65
9795985|NCT00581945|10903694|FG001|COMPLETED|Overall Study||63
9795986|NCT00581945|10903693|FG000|NOT COMPLETED|Overall Study||9
9795987|NCT00581945|10903694|FG001|NOT COMPLETED|Overall Study||10
9795988|NCT00581971|10903700|FG000|STARTED|Overall Study||30
9795989|NCT00581971|10903700|FG000|COMPLETED|Overall Study||30
9795990|NCT00581971|10903700|FG000|NOT COMPLETED|Overall Study||0
9795991|NCT00582010|10903707|FG000|STARTED|Overall Study||40
9795992|NCT00582010|10903708|FG001|STARTED|Overall Study||40
9795993|NCT00582010|10903707|FG000|COMPLETED|Overall Study||40
9795994|NCT00582010|10903708|FG001|COMPLETED|Overall Study||39
9795995|NCT00582010|10903707|FG000|NOT COMPLETED|Overall Study||0
9795996|NCT00582010|10903708|FG001|NOT COMPLETED|Overall Study||1
9795997|NCT00582075|10903714|FG000|STARTED|Overall Study||25
9795998|NCT00582075|10903714|FG000|COMPLETED|Overall Study||25
9795999|NCT00582075|10903714|FG000|NOT COMPLETED|Overall Study||0
9796000|NCT00582114|10903720|FG000|STARTED|Overall Study||100
9796001|NCT00582114|10903721|FG001|STARTED|Overall Study||100
9796002|NCT00582114|10903720|FG000|COMPLETED|Overall Study||58
9796003|NCT00582114|10903721|FG001|COMPLETED|Overall Study||46
9796004|NCT00582114|10903720|FG000|NOT COMPLETED|Overall Study||42
9796005|NCT00582114|10903721|FG001|NOT COMPLETED|Overall Study||54
9796006|NCT00582166|10903727|FG000|STARTED|Overall Study||18
9796007|NCT00582166|10903727|FG000|COMPLETED|Overall Study||16
9796008|NCT00582166|10903727|FG000|NOT COMPLETED|Overall Study||2
9796009|NCT00582205|10903731|FG000|STARTED|Overall Study||21
9796010|NCT00582205|10903731|FG000|COMPLETED|Overall Study||11
9796011|NCT00582205|10903731|FG000|NOT COMPLETED|Overall Study||10
9796012|NCT00582309|10903738|FG000|STARTED|Overall Study||56
9796013|NCT00582309|10903739|FG001|STARTED|Overall Study||49
9796014|NCT00582309|10903740|FG002|STARTED|Overall Study||46
9796015|NCT00582309|10903738|FG000|COMPLETED|Overall Study||56
9796016|NCT00582309|10903739|FG001|COMPLETED|Overall Study||49
9796017|NCT00582309|10903740|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
9796018|NCT00582309|10903738|FG000|NOT COMPLETED|Overall Study||0
9796019|NCT00582309|10903739|FG001|NOT COMPLETED|Overall Study||0
9796020|NCT00582309|10903740|FG002|NOT COMPLETED|Overall Study||2
9796021|NCT00582361|10903750|FG000|STARTED|Overall Study||25
9796022|NCT00582361|10903751|FG001|STARTED|Overall Study||38
9796023|NCT00582361|10903750|FG000|COMPLETED|Overall Study||25
9796024|NCT00582361|10903751|FG001|COMPLETED|Overall Study||38
9796025|NCT00582361|10903750|FG000|NOT COMPLETED|Overall Study||0
9796026|NCT00582361|10903751|FG001|NOT COMPLETED|Overall Study||0
9796027|NCT00582400|10903757|FG000|STARTED|Overall Study||9
9796028|NCT00582400|10903757|FG000|COMPLETED|Overall Study||6
9796029|NCT00582400|10903757|FG000|NOT COMPLETED|Overall Study||3
9796030|NCT00582426|10903763|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
9796031|NCT00582426|10903764|FG001|STARTED|Overall Study||71
9796032|NCT00582426|10903763|FG000|COMPLETED|Overall Study||48
9796033|NCT00582426|10903764|FG001|COMPLETED|Overall Study||58
9796034|NCT00582426|10903763|FG000|NOT COMPLETED|Overall Study||20
9796035|NCT00582426|10903764|FG001|NOT COMPLETED|Overall Study||13
9796036|NCT00582491|10903772|FG000|STARTED|Overall Study||11
9796037|NCT00582491|10903773|FG001|STARTED|Overall Study||10
9796038|NCT00582491|10903772|FG000|COMPLETED|Overall Study||10
9796039|NCT00582491|10903773|FG001|COMPLETED|Overall Study||10
9796040|NCT00582491|10903772|FG000|NOT COMPLETED|Overall Study||1
9796041|NCT00582491|10903773|FG001|NOT COMPLETED|Overall Study||0
9796042|NCT00582517|10903781|FG000|STARTED|Overall Study||45
9796043|NCT00582517|10903782|FG001|STARTED|Overall Study||55
9796044|NCT00582517|10903781|FG000|COMPLETED|Overall Study||45
9796045|NCT00582517|10903782|FG001|COMPLETED|Overall Study||55
9796046|NCT00582517|10903781|FG000|NOT COMPLETED|Overall Study||0
9796047|NCT00582517|10903782|FG001|NOT COMPLETED|Overall Study||0
9796048|NCT00582556|10903791|FG000|STARTED|Overall Study||14
9796049|NCT00582556|10903792|FG001|STARTED|Overall Study||15
9796050|NCT00582556|10903793|FG002|STARTED|Overall Study||14
9796051|NCT00582556|10903791|FG000|COMPLETED|Overall Study||14
9796052|NCT00582556|10903792|FG001|COMPLETED|Overall Study||14
9796053|NCT00582556|10903793|FG002|COMPLETED|Overall Study||12
9796054|NCT00582556|10903791|FG000|NOT COMPLETED|Overall Study||0
9796055|NCT00582556|10903792|FG001|NOT COMPLETED|Overall Study||1
9796056|NCT00582556|10903793|FG002|NOT COMPLETED|Overall Study||2
9796057|NCT00582608|10903802|FG000|STARTED|Overall Study||12
9796058|NCT00582608|10903802|FG000|COMPLETED|Overall Study||0
9796059|NCT00582608|10903802|FG000|NOT COMPLETED|Overall Study||12
9796060|NCT00582660|10903808|FG000|STARTED|Overall Study||20
9796061|NCT00582660|10903809|FG001|STARTED|Overall Study||20
9796062|NCT00582660|10903808|FG000|COMPLETED|Overall Study||20
9796063|NCT00582660|10903809|FG001|COMPLETED|Overall Study||20
9796064|NCT00582660|10903808|FG000|NOT COMPLETED|Overall Study||0
9796065|NCT00582660|10903809|FG001|NOT COMPLETED|Overall Study||0
9796066|NCT00582738|10903817|FG000|STARTED|Overall Study||21
9796067|NCT00582738|10903818|FG001|STARTED|Overall Study||22
9796068|NCT00582738|10903817|FG000|COMPLETED|Overall Study||12
9796069|NCT00582738|10903818|FG001|COMPLETED|Overall Study||4
9796070|NCT00582738|10903817|FG000|NOT COMPLETED|Overall Study||9
9796071|NCT00582738|10903818|FG001|NOT COMPLETED|Overall Study||18
9796072|NCT00582790|10903830|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
9796073|NCT00582790|10903830|FG000|COMPLETED|Overall Study||11
9796074|NCT00582790|10903830|FG000|NOT COMPLETED|Overall Study||1
9796075|NCT00582816|10903835|FG000|STARTED|Overall Study||9
9796076|NCT00582816|10903835|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
9796077|NCT00582816|10903835|FG000|NOT COMPLETED|Overall Study||3
9796078|NCT00582894|10903839|FG000|STARTED|Overall Study||17
9796079|NCT00582894|10903839|FG000|Day 100 Post Transplant|Overall Study||17
9796080|NCT00582894|10903839|FG000|COMPLETED|Overall Study||17
9796081|NCT00582894|10903839|FG000|NOT COMPLETED|Overall Study||0
9796082|NCT00582907|10903843|FG000|STARTED|1st Course||4
9796083|NCT00582907|10903844|FG001|STARTED|1st Course||3
9796084|NCT00582907|10903845|FG002|STARTED|1st Course||3
9796085|NCT00582907|10903846|FG003|STARTED|1st Course||4
9796086|NCT00582907|10903843|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
9796087|NCT00582907|10903844|FG001|COMPLETED|1st Course||3
9796088|NCT00582907|10903845|FG002|COMPLETED|1st Course||3
9796089|NCT00582907|10903846|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
9796090|NCT00582907|10903843|FG000|NOT COMPLETED|1st Course||1
9796091|NCT00582907|10903844|FG001|NOT COMPLETED|1st Course||0
10015608|NCT01806688|11138604|FG000|NOT COMPLETED|Third Intervention Pita Study||0
10015609|NCT01806688|11138605|FG001|NOT COMPLETED|Third Intervention Pita Study||0
10015610|NCT01806714|11138616|FG000|STARTED|Overall Study||2093
10015611|NCT01806714|11138617|FG001|STARTED|Overall Study||2089
10015612|NCT01806714|11138616|FG000|COMPLETED|Overall Study||1893
10015613|NCT01806714|11138617|FG001|COMPLETED|Overall Study||1919
10015614|NCT01806714|11138616|FG000|NOT COMPLETED|Overall Study||200
10015615|NCT01806714|11138617|FG001|NOT COMPLETED|Overall Study||170
10015616|NCT01806740|11138623|FG000|STARTED|Overall Study||37
10015617|NCT01806740|11138623|FG000|COMPLETED|Overall Study||31
10015618|NCT01806740|11138623|FG000|NOT COMPLETED|Overall Study||6
10015619|NCT01806779|11138632|FG000|STARTED|Overall Study||90
10015620|NCT01806779|11138633|FG001|STARTED|Overall Study||84
10015621|NCT01806779|11138634|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
10015622|NCT01806779|11138632|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
10015623|NCT01806779|11138633|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
10015624|NCT01806779|11138634|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
10015625|NCT01806779|11138632|FG000|Randomized at Visit 2|Overall Study||90
10015626|NCT01806779|11138633|FG001|Randomized at Visit 2|Overall Study||84
10015627|NCT01806779|11138634|FG002|Randomized at Visit 2|Overall Study||0
10015628|NCT01806779|11138632|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
10015629|NCT01806779|11138633|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
10015630|NCT01806779|11138634|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
10015631|NCT01806779|11138632|FG000|COMPLETED|Overall Study||48
10015632|NCT01806779|11138633|FG001|COMPLETED|Overall Study||40
10015633|NCT01806779|11138634|FG002|COMPLETED|Overall Study||0
10015634|NCT01806779|11138632|FG000|NOT COMPLETED|Overall Study||42
9796092|NCT00582907|10903845|FG002|NOT COMPLETED|1st Course||0
9796093|NCT00582907|10903846|FG003|NOT COMPLETED|1st Course||1
9796094|NCT00582907|10903843|FG000|STARTED|2nd Course||3
9796095|NCT00582907|10903844|FG001|STARTED|2nd Course||3
9796096|NCT00582907|10903845|FG002|STARTED|2nd Course||3
9796097|NCT00582907|10903846|FG003|STARTED|2nd Course||3
9796098|NCT00582907|10903843|FG000|COMPLETED|2nd Course||2
9796099|NCT00582907|10903844|FG001|COMPLETED|2nd Course||3
9796100|NCT00582907|10903845|FG002|COMPLETED|2nd Course||3
10015635|NCT01806779|11138633|FG001|NOT COMPLETED|Overall Study||44
10015636|NCT01806779|11138634|FG002|NOT COMPLETED|Overall Study||23
10015637|NCT01806857|11138641|FG000|STARTED|Overall Study||31
10015638|NCT01806857|11138642|FG001|STARTED|Overall Study||29
10015639|NCT01806857|11138641|FG000|COMPLETED|Overall Study||30
10015640|NCT01806857|11138642|FG001|COMPLETED|Overall Study||29
9796101|NCT00582907|10903846|FG003|COMPLETED|2nd Course||3
9796102|NCT00582907|10903843|FG000|NOT COMPLETED|2nd Course||1
9796103|NCT00582907|10903844|FG001|NOT COMPLETED|2nd Course||0
9796104|NCT00582907|10903845|FG002|NOT COMPLETED|2nd Course||0
9796105|NCT00582907|10903846|FG003|NOT COMPLETED|2nd Course||0
9796106|NCT00582907|10903843|FG000|STARTED|3rd Course||2
9796107|NCT00582907|10903844|FG001|STARTED|3rd Course||3
9796108|NCT00582907|10903845|FG002|STARTED|3rd Course||3
9796109|NCT00582907|10903846|FG003|STARTED|3rd Course||3
9796110|NCT00582907|10903843|FG000|COMPLETED|3rd Course||2
9796111|NCT00582907|10903844|FG001|COMPLETED|3rd Course||3
9796112|NCT00582907|10903845|FG002|COMPLETED|3rd Course||3
9796113|NCT00582907|10903846|FG003|COMPLETED|3rd Course||3
9796114|NCT00582907|10903843|FG000|NOT COMPLETED|3rd Course||0
9796115|NCT00582907|10903844|FG001|NOT COMPLETED|3rd Course||0
9796116|NCT00582907|10903845|FG002|NOT COMPLETED|3rd Course||0
9796117|NCT00582907|10903846|FG003|NOT COMPLETED|3rd Course||0
9796118|NCT00582907|10903843|FG000|STARTED|4th Course||2
9796119|NCT00582907|10903844|FG001|STARTED|4th Course||3
9796120|NCT00582907|10903845|FG002|STARTED|4th Course||3
9796121|NCT00582907|10903846|FG003|STARTED|4th Course||3
9796122|NCT00582907|10903843|FG000|COMPLETED|4th Course||2
9796123|NCT00582907|10903844|FG001|COMPLETED|4th Course||3
9796124|NCT00582907|10903845|FG002|COMPLETED|4th Course||3
9796125|NCT00582907|10903846|FG003|COMPLETED|4th Course||3
9796126|NCT00582907|10903843|FG000|NOT COMPLETED|4th Course||0
9796127|NCT00582907|10903844|FG001|NOT COMPLETED|4th Course||0
9796128|NCT00582907|10903845|FG002|NOT COMPLETED|4th Course||0
9796129|NCT00582907|10903846|FG003|NOT COMPLETED|4th Course||0
9796130|NCT00582933|10903852|FG000|STARTED|Overall Study||95
9796131|NCT00582933|10903852|FG000|COMPLETED|Overall Study||92
9796132|NCT00582933|10903852|FG000|NOT COMPLETED|Overall Study||3
9796133|NCT00582946|10903856|FG000|STARTED|Overall Study||16
9796134|NCT00582946|10903856|FG000|COMPLETED|Overall Study||16
9796135|NCT00582946|10903856|FG000|NOT COMPLETED|Overall Study||0
9796136|NCT00582972|10903860|FG000|STARTED|Overall Study||23
9796137|NCT00582972|10903860|FG000|COMPLETED|Overall Study||21
9796138|NCT00582972|10903860|FG000|NOT COMPLETED|Overall Study||2
9796139|NCT00582998|10903867|FG000|STARTED|Overall Study||119
9796140|NCT00582998|10903868|FG001|STARTED|Overall Study||130
9796141|NCT00582998|10903867|FG000|COMPLETED|Overall Study||119
9796142|NCT00582998|10903868|FG001|COMPLETED|Overall Study||130
9796143|NCT00582998|10903867|FG000|NOT COMPLETED|Overall Study||0
9796144|NCT00582998|10903868|FG001|NOT COMPLETED|Overall Study||0
9796145|NCT00583011|10903876|FG000|STARTED|Overall Study||36
9796146|NCT00583011|10903877|FG001|STARTED|Overall Study||40
9796147|NCT00583011|10903876|FG000|COMPLETED|Overall Study||36
9796148|NCT00583011|10903877|FG001|COMPLETED|Overall Study||40
9796149|NCT00583011|10903876|FG000|NOT COMPLETED|Overall Study||0
9796150|NCT00583011|10903877|FG001|NOT COMPLETED|Overall Study||0
9796151|NCT00583050|10903884|FG000|STARTED|Overall Study||1366
9796152|NCT00583050|10903884|FG000|COMPLETED|Overall Study||1366
9796153|NCT00583050|10903884|FG000|NOT COMPLETED|Overall Study||0
9796154|NCT00583102|10903888|FG000|STARTED|Overall Study||23
9796155|NCT00583102|10903888|FG000|COMPLETED|Overall Study||20
9796156|NCT00583102|10903888|FG000|NOT COMPLETED|Overall Study||3
9796157|NCT00583219|10903892|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
9796158|NCT00583219|10903892|FG000|COMPLETED|Phase 1||9
9796159|NCT00583219|10903892|FG000|NOT COMPLETED|Phase 1||0
9796160|NCT00583219|10903892|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
9796161|NCT00583219|10903892|FG000|COMPLETED|Phase 2||21
9796162|NCT00583219|10903892|FG000|NOT COMPLETED|Phase 2||1
9796163|NCT00583362|10903896|FG000|STARTED|Overall Study||298
9796164|NCT00583362|10903896|FG000|COMPLETED|Overall Study||96
9796165|NCT00583362|10903896|FG000|NOT COMPLETED|Overall Study||202
10015641|NCT01806857|11138641|FG000|NOT COMPLETED|Overall Study||1
10015642|NCT01806857|11138642|FG001|NOT COMPLETED|Overall Study||0
9796166|NCT00583375|10903902|FG000|STARTED|Overall Study||142
9796167|NCT00583375|10903903|FG001|STARTED|Overall Study||272
9796168|NCT00583375|10903902|FG000|COMPLETED|Overall Study||142
9796169|NCT00583375|10903903|FG001|COMPLETED|Overall Study||272
9796170|NCT00583375|10903902|FG000|NOT COMPLETED|Overall Study||0
9796171|NCT00583375|10903903|FG001|NOT COMPLETED|Overall Study||0
9796172|NCT00583414|10903909|FG000|STARTED|Overall Study||401
9796173|NCT00583414|10903909|FG000|COMPLETED|Overall Study||401
9796174|NCT00583414|10903909|FG000|NOT COMPLETED|Overall Study||0
9796175|NCT00583453|10903915|FG000|STARTED|Overall Study||9
9796176|NCT00583453|10903916|FG001|STARTED|Overall Study||8
9796177|NCT00583453|10903915|FG000|COMPLETED|Overall Study||9
9796178|NCT00583453|10903916|FG001|COMPLETED|Overall Study||6
9796179|NCT00583453|10903915|FG000|NOT COMPLETED|Overall Study||0
9796180|NCT00583453|10903916|FG001|NOT COMPLETED|Overall Study||2
9796181|NCT00583492|10903926|FG000|STARTED|Overall Study||21
9796182|NCT00583492|10903927|FG001|STARTED|Overall Study||23
9796183|NCT00583492|10903926|FG000|COMPLETED|Overall Study||21
10015643|NCT01806896|11138651|FG000|STARTED|Overall Study||20
10015644|NCT01806896|11138652|FG001|STARTED|Overall Study||17
9796184|NCT00583492|10903927|FG001|COMPLETED|Overall Study||23
9796185|NCT00583492|10903926|FG000|NOT COMPLETED|Overall Study||0
9796186|NCT00583492|10903927|FG001|NOT COMPLETED|Overall Study||0
9796187|NCT00583557|10903933|FG000|STARTED|Overall Study||155
9796188|NCT00583557|10903933|FG000|Received at Least 1 Dose Belimumab|Overall Study||153
9796189|NCT00583557|10903933|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
9796190|NCT00583557|10903933|FG000|NOT COMPLETED|Overall Study||70
9796191|NCT00583596|10903937|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
9796192|NCT00583596|10903937|FG000|COMPLETED|Overall Study||152
9796193|NCT00583596|10903937|FG000|NOT COMPLETED|Overall Study||284
9796194|NCT00583622|10903942|FG000|STARTED|Overall Study||12
9796195|NCT00583622|10903942|FG000|COMPLETED|Overall Study||12
9796196|NCT00583622|10903942|FG000|NOT COMPLETED|Overall Study||0
9796197|NCT00583661|10903946|FG000|STARTED|Overall Study||48
9796198|NCT00583661|10903946|FG000|COMPLETED|Overall Study||48
9796199|NCT00583661|10903946|FG000|NOT COMPLETED|Overall Study||0
9796200|NCT00583700|10903953|FG000|STARTED|Overall Study||27
9796201|NCT00583700|10903954|FG001|STARTED|Overall Study||27
9796202|NCT00583700|10903953|FG000|COMPLETED|Overall Study||24
9796203|NCT00583700|10903954|FG001|COMPLETED|Overall Study||23
9796204|NCT00583700|10903953|FG000|NOT COMPLETED|Overall Study||3
9796205|NCT00583700|10903954|FG001|NOT COMPLETED|Overall Study||4
9796206|NCT00583713|10903963|FG000|STARTED|Overall Study||6
9796207|NCT00583713|10903964|FG001|STARTED|Overall Study||6
9796208|NCT00583713|10903965|FG002|STARTED|Overall Study||6
9796209|NCT00583713|10903963|FG000|COMPLETED|Overall Study||6
9796210|NCT00583713|10903964|FG001|COMPLETED|Overall Study||6
9796211|NCT00583713|10903965|FG002|COMPLETED|Overall Study||6
9796212|NCT00583713|10903963|FG000|NOT COMPLETED|Overall Study||0
9796213|NCT00583713|10903964|FG001|NOT COMPLETED|Overall Study||0
9796214|NCT00583713|10903965|FG002|NOT COMPLETED|Overall Study||0
9796215|NCT00583791|10903973|FG000|STARTED|Overall Study||91
9796216|NCT00583791|10903973|FG000|COMPLETED|Overall Study||18
9796217|NCT00583791|10903973|FG000|NOT COMPLETED|Overall Study||73
9796218|NCT00583908|10903977|FG000|STARTED|Period 1 - First Intervention||1
9796219|NCT00583908|10903978|FG001|STARTED|Period 1 - First Intervention||2
9796220|NCT00583908|10903979|FG002|STARTED|Period 1 - First Intervention||1
9796221|NCT00583908|10903980|FG003|STARTED|Period 1 - First Intervention||1
9796222|NCT00583908|10903981|FG004|STARTED|Period 1 - First Intervention||2
9796223|NCT00583908|10903982|FG005|STARTED|Period 1 - First Intervention||1
9796224|NCT00583908|10903983|FG006|STARTED|Period 1 - First Intervention||1
9796225|NCT00583908|10903984|FG007|STARTED|Period 1 - First Intervention||1
9796226|NCT00583908|10903985|FG008|STARTED|Period 1 - First Intervention||1
9796227|NCT00583908|10903986|FG009|STARTED|Period 1 - First Intervention||1
9796228|NCT00583908|10903987|FG010|STARTED|Period 1 - First Intervention||1
9796229|NCT00583908|10903988|FG011|STARTED|Period 1 - First Intervention||1
9796230|NCT00583908|10903977|FG000|COMPLETED|Period 1 - First Intervention||1
9796231|NCT00583908|10903978|FG001|COMPLETED|Period 1 - First Intervention||2
9796232|NCT00583908|10903979|FG002|COMPLETED|Period 1 - First Intervention||1
9796233|NCT00583908|10903980|FG003|COMPLETED|Period 1 - First Intervention||1
9796234|NCT00583908|10903981|FG004|COMPLETED|Period 1 - First Intervention||2
9796235|NCT00583908|10903982|FG005|COMPLETED|Period 1 - First Intervention||1
9796236|NCT00583908|10903983|FG006|COMPLETED|Period 1 - First Intervention||1
9796237|NCT00583908|10903984|FG007|COMPLETED|Period 1 - First Intervention||1
9796238|NCT00583908|10903985|FG008|COMPLETED|Period 1 - First Intervention||1
9796239|NCT00583908|10903986|FG009|COMPLETED|Period 1 - First Intervention||1
9796240|NCT00583908|10903987|FG010|COMPLETED|Period 1 - First Intervention||1
9796241|NCT00583908|10903988|FG011|COMPLETED|Period 1 - First Intervention||1
9796242|NCT00583908|10903977|FG000|NOT COMPLETED|Period 1 - First Intervention||0
9796243|NCT00583908|10903978|FG001|NOT COMPLETED|Period 1 - First Intervention||0
9796244|NCT00583908|10903979|FG002|NOT COMPLETED|Period 1 - First Intervention||0
9796245|NCT00583908|10903980|FG003|NOT COMPLETED|Period 1 - First Intervention||0
9796246|NCT00583908|10903981|FG004|NOT COMPLETED|Period 1 - First Intervention||0
9796247|NCT00583908|10903982|FG005|NOT COMPLETED|Period 1 - First Intervention||0
9796248|NCT00583908|10903983|FG006|NOT COMPLETED|Period 1 - First Intervention||0
9796249|NCT00583908|10903984|FG007|NOT COMPLETED|Period 1 - First Intervention||0
9796250|NCT00583908|10903985|FG008|NOT COMPLETED|Period 1 - First Intervention||0
9796251|NCT00583908|10903986|FG009|NOT COMPLETED|Period 1 - First Intervention||0
9796252|NCT00583908|10903987|FG010|NOT COMPLETED|Period 1 - First Intervention||0
9796253|NCT00583908|10903988|FG011|NOT COMPLETED|Period 1 - First Intervention||0
9796254|NCT00583908|10903977|FG000|STARTED|Period 2 - Second Intervention||1
9796255|NCT00583908|10903978|FG001|STARTED|Period 2 - Second Intervention||2
9796256|NCT00583908|10903979|FG002|STARTED|Period 2 - Second Intervention||1
9796257|NCT00583908|10903980|FG003|STARTED|Period 2 - Second Intervention||1
9796258|NCT00583908|10903981|FG004|STARTED|Period 2 - Second Intervention||2
9796259|NCT00583908|10903982|FG005|STARTED|Period 2 - Second Intervention||1
9796260|NCT00583908|10903983|FG006|STARTED|Period 2 - Second Intervention||1
9796261|NCT00583908|10903984|FG007|STARTED|Period 2 - Second Intervention||1
9796262|NCT00583908|10903985|FG008|STARTED|Period 2 - Second Intervention||1
9796263|NCT00583908|10903986|FG009|STARTED|Period 2 - Second Intervention||1
9796264|NCT00583908|10903987|FG010|STARTED|Period 2 - Second Intervention||1
9796265|NCT00583908|10903988|FG011|STARTED|Period 2 - Second Intervention||1
9796266|NCT00583908|10903977|FG000|COMPLETED|Period 2 - Second Intervention||1
9796267|NCT00583908|10903978|FG001|COMPLETED|Period 2 - Second Intervention||2
9796268|NCT00583908|10903979|FG002|COMPLETED|Period 2 - Second Intervention||1
9796269|NCT00583908|10903980|FG003|COMPLETED|Period 2 - Second Intervention||1
9796270|NCT00583908|10903981|FG004|COMPLETED|Period 2 - Second Intervention||2
9796271|NCT00583908|10903982|FG005|COMPLETED|Period 2 - Second Intervention||1
9796272|NCT00583908|10903983|FG006|COMPLETED|Period 2 - Second Intervention||1
9796273|NCT00583908|10903984|FG007|COMPLETED|Period 2 - Second Intervention||1
9796274|NCT00583908|10903985|FG008|COMPLETED|Period 2 - Second Intervention||1
9796275|NCT00583908|10903986|FG009|COMPLETED|Period 2 - Second Intervention||1
9796276|NCT00583908|10903987|FG010|COMPLETED|Period 2 - Second Intervention||1
9796277|NCT00583908|10903988|FG011|COMPLETED|Period 2 - Second Intervention||1
9796278|NCT00583908|10903977|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
9796279|NCT00583908|10903978|FG001|NOT COMPLETED|Period 2 - Second Intervention||0
9796280|NCT00583908|10903979|FG002|NOT COMPLETED|Period 2 - Second Intervention||0
9796281|NCT00583908|10903980|FG003|NOT COMPLETED|Period 2 - Second Intervention||0
9796282|NCT00583908|10903981|FG004|NOT COMPLETED|Period 2 - Second Intervention||0
9796283|NCT00583908|10903982|FG005|NOT COMPLETED|Period 2 - Second Intervention||0
9796284|NCT00583908|10903983|FG006|NOT COMPLETED|Period 2 - Second Intervention||0
9796285|NCT00583908|10903984|FG007|NOT COMPLETED|Period 2 - Second Intervention||0
9796286|NCT00583908|10903985|FG008|NOT COMPLETED|Period 2 - Second Intervention||0
9796287|NCT00583908|10903986|FG009|NOT COMPLETED|Period 2 - Second Intervention||0
9796288|NCT00583908|10903987|FG010|NOT COMPLETED|Period 2 - Second Intervention||0
9796289|NCT00583908|10903988|FG011|NOT COMPLETED|Period 2 - Second Intervention||0
9796290|NCT00583908|10903977|FG000|STARTED|Period 3 - Third Intervention||1
9796291|NCT00583908|10903978|FG001|STARTED|Period 3 - Third Intervention||2
9796292|NCT00583908|10903979|FG002|STARTED|Period 3 - Third Intervention||1
10015645|NCT01806896|11138651|FG000|Received Treatment|Overall Study||19
10015646|NCT01806896|11138652|FG001|Received Treatment|Overall Study||17
10015647|NCT01806896|11138651|FG000|COMPLETED|Overall Study||17
10015648|NCT01806896|11138652|FG001|COMPLETED|Overall Study||17
10015649|NCT01806896|11138651|FG000|NOT COMPLETED|Overall Study||3
10015650|NCT01806896|11138652|FG001|NOT COMPLETED|Overall Study||0
10015651|NCT01807000|11138658|FG000|STARTED|Overall Study||6
10015652|NCT01807000|11138658|FG000|COMPLETED|Overall Study||6
10015653|NCT01807000|11138658|FG000|NOT COMPLETED|Overall Study||0
10015654|NCT01807026|11138668|FG000|STARTED|Overall Study||10
10015655|NCT01807026|11138669|FG001|STARTED|Overall Study||2
10015656|NCT01807026|11138670|FG002|STARTED|Overall Study||10
10015657|NCT01807026|11138671|FG003|STARTED|Overall Study||2
10015658|NCT01807026|11138672|FG004|STARTED|Overall Study||9
10015659|NCT01807026|11138673|FG005|STARTED|Overall Study||3
10015660|NCT01807026|11138668|FG000|Received at Least One Dose of Study Drug|Overall Study||10
10015661|NCT01807026|11138669|FG001|Received at Least One Dose of Study Drug|Overall Study||2
10015662|NCT01807026|11138670|FG002|Received at Least One Dose of Study Drug|Overall Study||10
9796293|NCT00583908|10903980|FG003|STARTED|Period 3 - Third Intervention||1
9796294|NCT00583908|10903981|FG004|STARTED|Period 3 - Third Intervention||2
9796295|NCT00583908|10903982|FG005|STARTED|Period 3 - Third Intervention||1
9796296|NCT00583908|10903983|FG006|STARTED|Period 3 - Third Intervention||1
9796297|NCT00583908|10903984|FG007|STARTED|Period 3 - Third Intervention||1
9796298|NCT00583908|10903985|FG008|STARTED|Period 3 - Third Intervention||1
9796299|NCT00583908|10903986|FG009|STARTED|Period 3 - Third Intervention||1
9796300|NCT00583908|10903987|FG010|STARTED|Period 3 - Third Intervention||1
9796301|NCT00583908|10903988|FG011|STARTED|Period 3 - Third Intervention||1
9796302|NCT00583908|10903977|FG000|COMPLETED|Period 3 - Third Intervention||1
9796303|NCT00583908|10903978|FG001|COMPLETED|Period 3 - Third Intervention||2
9796304|NCT00583908|10903979|FG002|COMPLETED|Period 3 - Third Intervention||1
9796305|NCT00583908|10903980|FG003|COMPLETED|Period 3 - Third Intervention||1
9796306|NCT00583908|10903981|FG004|COMPLETED|Period 3 - Third Intervention||2
9796307|NCT00583908|10903982|FG005|COMPLETED|Period 3 - Third Intervention||1
9796308|NCT00583908|10903983|FG006|COMPLETED|Period 3 - Third Intervention||1
9796309|NCT00583908|10903984|FG007|COMPLETED|Period 3 - Third Intervention||1
9796310|NCT00583908|10903985|FG008|COMPLETED|Period 3 - Third Intervention||1
9796311|NCT00583908|10903986|FG009|COMPLETED|Period 3 - Third Intervention||1
9796312|NCT00583908|10903987|FG010|COMPLETED|Period 3 - Third Intervention||1
9796313|NCT00583908|10903988|FG011|COMPLETED|Period 3 - Third Intervention||1
9796314|NCT00583908|10903977|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
9796315|NCT00583908|10903978|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
9796316|NCT00583908|10903979|FG002|NOT COMPLETED|Period 3 - Third Intervention||0
9796317|NCT00583908|10903980|FG003|NOT COMPLETED|Period 3 - Third Intervention||0
9796318|NCT00583908|10903981|FG004|NOT COMPLETED|Period 3 - Third Intervention||0
9796319|NCT00583908|10903982|FG005|NOT COMPLETED|Period 3 - Third Intervention||0
9796320|NCT00583908|10903983|FG006|NOT COMPLETED|Period 3 - Third Intervention||0
9796321|NCT00583908|10903984|FG007|NOT COMPLETED|Period 3 - Third Intervention||0
9796322|NCT00583908|10903985|FG008|NOT COMPLETED|Period 3 - Third Intervention||0
9796323|NCT00583908|10903986|FG009|NOT COMPLETED|Period 3 - Third Intervention||0
10015663|NCT01807026|11138671|FG003|Received at Least One Dose of Study Drug|Overall Study||2
10015664|NCT01807026|11138672|FG004|Received at Least One Dose of Study Drug|Overall Study||9
10015665|NCT01807026|11138673|FG005|Received at Least One Dose of Study Drug|Overall Study||3
10015666|NCT01807026|11138668|FG000|COMPLETED|Overall Study||10
9796324|NCT00583908|10903987|FG010|NOT COMPLETED|Period 3 - Third Intervention||0
9796325|NCT00583908|10903988|FG011|NOT COMPLETED|Period 3 - Third Intervention||0
9796326|NCT00583908|10903977|FG000|STARTED|Period 4 - Fourth Intervention||1
9796327|NCT00583908|10903978|FG001|STARTED|Period 4 - Fourth Intervention||2
9796328|NCT00583908|10903979|FG002|STARTED|Period 4 - Fourth Intervention||1
9796329|NCT00583908|10903980|FG003|STARTED|Period 4 - Fourth Intervention||1
9796330|NCT00583908|10903981|FG004|STARTED|Period 4 - Fourth Intervention||2
9796331|NCT00583908|10903982|FG005|STARTED|Period 4 - Fourth Intervention||1
9796332|NCT00583908|10903983|FG006|STARTED|Period 4 - Fourth Intervention||1
9796333|NCT00583908|10903984|FG007|STARTED|Period 4 - Fourth Intervention||1
9796334|NCT00583908|10903985|FG008|STARTED|Period 4 - Fourth Intervention||1
9796335|NCT00583908|10903986|FG009|STARTED|Period 4 - Fourth Intervention||1
9796336|NCT00583908|10903987|FG010|STARTED|Period 4 - Fourth Intervention||1
9796337|NCT00583908|10903988|FG011|STARTED|Period 4 - Fourth Intervention||1
9796338|NCT00583908|10903977|FG000|COMPLETED|Period 4 - Fourth Intervention||1
9796339|NCT00583908|10903978|FG001|COMPLETED|Period 4 - Fourth Intervention||2
9796340|NCT00583908|10903979|FG002|COMPLETED|Period 4 - Fourth Intervention||1
9796341|NCT00583908|10903980|FG003|COMPLETED|Period 4 - Fourth Intervention||1
9796342|NCT00583908|10903981|FG004|COMPLETED|Period 4 - Fourth Intervention||2
9796343|NCT00583908|10903982|FG005|COMPLETED|Period 4 - Fourth Intervention||1
9796344|NCT00583908|10903983|FG006|COMPLETED|Period 4 - Fourth Intervention||1
9796345|NCT00583908|10903984|FG007|COMPLETED|Period 4 - Fourth Intervention||1
9796346|NCT00583908|10903985|FG008|COMPLETED|Period 4 - Fourth Intervention||1
9796347|NCT00583908|10903986|FG009|COMPLETED|Period 4 - Fourth Intervention||1
9796348|NCT00583908|10903987|FG010|COMPLETED|Period 4 - Fourth Intervention||1
9796349|NCT00583908|10903988|FG011|COMPLETED|Period 4 - Fourth Intervention||1
9796350|NCT00583908|10903977|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796351|NCT00583908|10903978|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796352|NCT00583908|10903979|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796353|NCT00583908|10903980|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796354|NCT00583908|10903981|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796355|NCT00583908|10903982|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796356|NCT00583908|10903983|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796357|NCT00583908|10903984|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796358|NCT00583908|10903985|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796359|NCT00583908|10903986|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796360|NCT00583908|10903987|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796361|NCT00583908|10903988|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0
9796362|NCT00583947|10904008|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
9796363|NCT00583947|10904009|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
9796364|NCT00583947|10904008|FG000|COMPLETED|Cross-over Period||22
9796365|NCT00583947|10904009|FG001|COMPLETED|Cross-over Period||24
9796366|NCT00583947|10904008|FG000|NOT COMPLETED|Cross-over Period||5
9796367|NCT00583947|10904009|FG001|NOT COMPLETED|Cross-over Period||2
9796368|NCT00583947|10904008|FG000|STARTED|Washout||22
9796369|NCT00583947|10904009|FG001|STARTED|Washout||24
9796370|NCT00583947|10904008|FG000|COMPLETED|Washout||22
9796371|NCT00583947|10904009|FG001|COMPLETED|Washout||24
9796372|NCT00583947|10904008|FG000|NOT COMPLETED|Washout||0
9796373|NCT00583947|10904009|FG001|NOT COMPLETED|Washout||0
9796374|NCT00583947|10904008|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
9796375|NCT00583947|10904009|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
9796376|NCT00583947|10904008|FG000|COMPLETED|Open Label Period||22
9796377|NCT00583947|10904009|FG001|COMPLETED|Open Label Period||24
9796378|NCT00583947|10904008|FG000|NOT COMPLETED|Open Label Period||0
9796379|NCT00583947|10904009|FG001|NOT COMPLETED|Open Label Period||0
9796380|NCT00584077|10904017|FG000|STARTED|Overall Study||15
9796381|NCT00584077|10904017|FG000|COMPLETED|Overall Study||15
9796382|NCT00584077|10904017|FG000|NOT COMPLETED|Overall Study||0
9796383|NCT00584194|10904022|FG000|STARTED|Overall Study||278
9796384|NCT00584194|10904022|FG000|COMPLETED|Overall Study||143
9796385|NCT00584194|10904022|FG000|NOT COMPLETED|Overall Study||135
9796386|NCT00584220|10904026|FG000|STARTED|First Period||48
9796387|NCT00584220|10904027|FG001|STARTED|First Period||39
9796388|NCT00584220|10904026|FG000|COMPLETED|First Period||48
9796389|NCT00584220|10904027|FG001|COMPLETED|First Period||39
9796390|NCT00584220|10904026|FG000|NOT COMPLETED|First Period||0
9796391|NCT00584220|10904027|FG001|NOT COMPLETED|First Period||0
9796392|NCT00584220|10904026|FG000|STARTED|Second Period||48
9796393|NCT00584220|10904027|FG001|STARTED|Second Period||39
9796394|NCT00584220|10904026|FG000|COMPLETED|Second Period||48
9796395|NCT00584220|10904027|FG001|COMPLETED|Second Period||39
9796396|NCT00584220|10904026|FG000|NOT COMPLETED|Second Period||0
9796397|NCT00584220|10904027|FG001|NOT COMPLETED|Second Period||0
9796398|NCT00584285|10904033|FG000|STARTED|Overall Study||18
9796399|NCT00584285|10904033|FG000|COMPLETED|Overall Study||18
9796400|NCT00584285|10904033|FG000|NOT COMPLETED|Overall Study||0
9796401|NCT00584402|10904037|FG000|STARTED|Overall Study||8
9796402|NCT00584402|10904037|FG000|COMPLETED|Overall Study||8
9796403|NCT00584402|10904037|FG000|NOT COMPLETED|Overall Study||0
9796404|NCT00584415|10904041|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
9796405|NCT00584415|10904041|FG000|COMPLETED|Overall Study||112
9796406|NCT00584415|10904041|FG000|NOT COMPLETED|Overall Study||7
9796407|NCT00584454|10904046|FG000|STARTED|Overall Study||10
9796408|NCT00584454|10904046|FG000|COMPLETED|Overall Study||6
9796409|NCT00584454|10904046|FG000|NOT COMPLETED|Overall Study||4
9796410|NCT00584480|10904050|FG000|STARTED|First 8 Weeks (40 Treatments)||10
9796411|NCT00584480|10904050|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10
9796412|NCT00584480|10904050|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
9796413|NCT00584480|10904050|FG000|STARTED|4-Week Break From Treatment||10
9796414|NCT00584480|10904050|FG000|COMPLETED|4-Week Break From Treatment||10
9796415|NCT00584480|10904050|FG000|NOT COMPLETED|4-Week Break From Treatment||0
9796416|NCT00584480|10904050|FG000|STARTED|Second 8 Weeks (40 Treatments)||10
9796417|NCT00584480|10904050|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10
9796418|NCT00584480|10904050|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
9796419|NCT00584558|10904054|FG000|STARTED|Overall Study||2420
9796420|NCT00584558|10904054|FG000|COMPLETED|Overall Study||2420
9796421|NCT00584558|10904054|FG000|NOT COMPLETED|Overall Study||0
9796422|NCT00584701|10904059|FG000|STARTED|Active Risperidone||49
9796423|NCT00584701|10904059|FG000|COMPLETED|Active Risperidone||46
9796424|NCT00584701|10904059|FG000|NOT COMPLETED|Active Risperidone||3
9796425|NCT00584701|10904059|FG000|STARTED|Follow-up||46
9796426|NCT00584701|10904059|FG000|COMPLETED|Follow-up||34
9796427|NCT00584701|10904059|FG000|NOT COMPLETED|Follow-up||12
9796428|NCT00584727|10904064|FG000|STARTED|First Intervention||17
9796429|NCT00584727|10904065|FG001|STARTED|First Intervention||17
9796430|NCT00584727|10904066|FG002|STARTED|First Intervention||16
9796431|NCT00584727|10904067|FG003|STARTED|First Intervention||14
9796432|NCT00584727|10904068|FG004|STARTED|First Intervention||16
9796433|NCT00584727|10904069|FG005|STARTED|First Intervention||16
9796434|NCT00584727|10904064|FG000|COMPLETED|First Intervention||17
9796435|NCT00584727|10904065|FG001|COMPLETED|First Intervention||17
9796436|NCT00584727|10904066|FG002|COMPLETED|First Intervention||15
9796437|NCT00584727|10904067|FG003|COMPLETED|First Intervention||14
9796438|NCT00584727|10904068|FG004|COMPLETED|First Intervention||16
9796439|NCT00584727|10904069|FG005|COMPLETED|First Intervention||16
9796440|NCT00584727|10904064|FG000|NOT COMPLETED|First Intervention||0
9796441|NCT00584727|10904065|FG001|NOT COMPLETED|First Intervention||0
9796442|NCT00584727|10904066|FG002|NOT COMPLETED|First Intervention||1
9796443|NCT00584727|10904067|FG003|NOT COMPLETED|First Intervention||0
9796444|NCT00584727|10904068|FG004|NOT COMPLETED|First Intervention||0
9796445|NCT00584727|10904069|FG005|NOT COMPLETED|First Intervention||0
9796446|NCT00584727|10904064|FG000|STARTED|Second Intervention||17
9796447|NCT00584727|10904065|FG001|STARTED|Second Intervention||17
9796448|NCT00584727|10904066|FG002|STARTED|Second Intervention||15
9796449|NCT00584727|10904067|FG003|STARTED|Second Intervention||14
9796450|NCT00584727|10904068|FG004|STARTED|Second Intervention||16
9796451|NCT00584727|10904069|FG005|STARTED|Second Intervention||16
9796452|NCT00584727|10904064|FG000|COMPLETED|Second Intervention||17
9796453|NCT00584727|10904065|FG001|COMPLETED|Second Intervention||17
9796454|NCT00584727|10904066|FG002|COMPLETED|Second Intervention||15
9796455|NCT00584727|10904067|FG003|COMPLETED|Second Intervention||14
9796456|NCT00584727|10904068|FG004|COMPLETED|Second Intervention||16
9796457|NCT00584727|10904069|FG005|COMPLETED|Second Intervention||16
9796458|NCT00584727|10904064|FG000|NOT COMPLETED|Second Intervention||0
9796459|NCT00584727|10904065|FG001|NOT COMPLETED|Second Intervention||0
9796460|NCT00584727|10904066|FG002|NOT COMPLETED|Second Intervention||0
9796461|NCT00584727|10904067|FG003|NOT COMPLETED|Second Intervention||0
9796462|NCT00584727|10904068|FG004|NOT COMPLETED|Second Intervention||0
9796463|NCT00584727|10904069|FG005|NOT COMPLETED|Second Intervention||0
9796464|NCT00584727|10904064|FG000|STARTED|Third Intervention||17
9796465|NCT00584727|10904065|FG001|STARTED|Third Intervention||17
9796466|NCT00584727|10904066|FG002|STARTED|Third Intervention||15
9796467|NCT00584727|10904067|FG003|STARTED|Third Intervention||14
9796468|NCT00584727|10904068|FG004|STARTED|Third Intervention||16
9796469|NCT00584727|10904069|FG005|STARTED|Third Intervention||16
9796470|NCT00584727|10904064|FG000|COMPLETED|Third Intervention||17
9796471|NCT00584727|10904065|FG001|COMPLETED|Third Intervention||17
9796472|NCT00584727|10904066|FG002|COMPLETED|Third Intervention||14
9796473|NCT00584727|10904067|FG003|COMPLETED|Third Intervention||14
9796474|NCT00584727|10904068|FG004|COMPLETED|Third Intervention||12
9796475|NCT00584727|10904069|FG005|COMPLETED|Third Intervention||14
9796476|NCT00584727|10904064|FG000|NOT COMPLETED|Third Intervention||0
9796477|NCT00584727|10904065|FG001|NOT COMPLETED|Third Intervention||0
9796478|NCT00584727|10904066|FG002|NOT COMPLETED|Third Intervention||1
9952522|NCT01422876|11071521|FG000|STARTED|Week 24||137
9796479|NCT00584727|10904067|FG003|NOT COMPLETED|Third Intervention||0
9796480|NCT00584727|10904068|FG004|NOT COMPLETED|Third Intervention||4
9796481|NCT00584727|10904069|FG005|NOT COMPLETED|Third Intervention||2
9796482|NCT00584740|10904082|FG000|STARTED|Overall Study||39
9796483|NCT00584740|10904083|FG001|STARTED|Overall Study||20
9796484|NCT00584740|10904082|FG000|COMPLETED|Overall Study||27
9796485|NCT00584740|10904083|FG001|COMPLETED|Overall Study||14
9796486|NCT00584740|10904082|FG000|NOT COMPLETED|Overall Study||12
9796487|NCT00584740|10904083|FG001|NOT COMPLETED|Overall Study||6
9796488|NCT00584805|10904089|FG000|STARTED|Overall Study||138
9796489|NCT00584805|10904089|FG000|COMPLETED|Overall Study||39
9796490|NCT00584805|10904089|FG000|NOT COMPLETED|Overall Study||99
9796491|NCT00584831|10904095|FG000|STARTED|Intervention 1||1
9796492|NCT00584831|10904096|FG001|STARTED|Intervention 1||3
9952523|NCT01422876|11071522|FG001|STARTED|Week 24||136
9796493|NCT00584831|10904097|FG002|STARTED|Intervention 1||2
9796494|NCT00584831|10904098|FG003|STARTED|Intervention 1||1
9796495|NCT00584831|10904099|FG004|STARTED|Intervention 1||2
9796496|NCT00584831|10904100|FG005|STARTED|Intervention 1||1
10112158|NCT02501928|11243270|FG001|STARTED|Overall Study||2
10112159|NCT02501928|11243271|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
10112160|NCT02501928|11243272|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
10112161|NCT02501928|11243273|FG004|STARTED|Overall Study||7
10112162|NCT02501928|11243274|FG005|STARTED|Overall Study||3
10112163|NCT02501928|11243269|FG000|COMPLETED|Overall Study||0
10112164|NCT02501928|11243270|FG001|COMPLETED|Overall Study||2
10112165|NCT02501928|11243271|FG002|COMPLETED|Overall Study||0
10112166|NCT02501928|11243272|FG003|COMPLETED|Overall Study||0
10112167|NCT02501928|11243273|FG004|COMPLETED|Overall Study||6
10112168|NCT02501928|11243274|FG005|COMPLETED|Overall Study||3
10112169|NCT02501928|11243269|FG000|NOT COMPLETED|Overall Study||0
10112170|NCT02501928|11243270|FG001|NOT COMPLETED|Overall Study||0
10112171|NCT02501928|11243271|FG002|NOT COMPLETED|Overall Study||0
10112172|NCT02501928|11243272|FG003|NOT COMPLETED|Overall Study||0
10112173|NCT02501928|11243273|FG004|NOT COMPLETED|Overall Study||1
10112174|NCT02501928|11243274|FG005|NOT COMPLETED|Overall Study||0
10112175|NCT02502019|11243291|FG000|STARTED|Overall Study||27
10112176|NCT02502019|11243291|FG000|COMPLETED|Overall Study||27
10112177|NCT02502019|11243291|FG000|NOT COMPLETED|Overall Study||0
10112178|NCT02502097|11243299|FG000|STARTED|Period 1||4
10112179|NCT02502097|11243300|FG001|STARTED|Period 1||3
10112180|NCT02502097|11243301|FG002|STARTED|Period 1||22
10112181|NCT02502097|11243302|FG003|STARTED|Period 1||22
10112182|NCT02502097|11243299|FG000|COMPLETED|Period 1||4
10112183|NCT02502097|11243300|FG001|COMPLETED|Period 1||3
10112184|NCT02502097|11243301|FG002|COMPLETED|Period 1||21
9796497|NCT00584831|10904101|FG006|STARTED|Intervention 1||6
9796498|NCT00584831|10904102|FG007|STARTED|Intervention 1||2
9796499|NCT00584831|10904103|FG008|STARTED|Intervention 1||4
9796500|NCT00584831|10904104|FG009|STARTED|Intervention 1||2
9796501|NCT00584831|10904105|FG010|STARTED|Intervention 1||2
9796502|NCT00584831|10904106|FG011|STARTED|Intervention 1||1
9796503|NCT00584831|10904107|FG012|STARTED|Intervention 1||2
9796504|NCT00584831|10904108|FG013|STARTED|Intervention 1||1
9796505|NCT00584831|10904109|FG014|STARTED|Intervention 1||3
9796506|NCT00584831|10904110|FG015|STARTED|Intervention 1||1
9796507|NCT00584831|10904111|FG016|STARTED|Intervention 1||4
9796508|NCT00584831|10904112|FG017|STARTED|Intervention 1||1
9796509|NCT00584831|10904113|FG018|STARTED|Intervention 1||1
9796510|NCT00584831|10904095|FG000|COMPLETED|Intervention 1||1
9796511|NCT00584831|10904096|FG001|COMPLETED|Intervention 1||3
9796512|NCT00584831|10904097|FG002|COMPLETED|Intervention 1||2
10015667|NCT01807026|11138669|FG001|COMPLETED|Overall Study||2
10015668|NCT01807026|11138670|FG002|COMPLETED|Overall Study||10
10015669|NCT01807026|11138671|FG003|COMPLETED|Overall Study||2
9796513|NCT00584831|10904098|FG003|COMPLETED|Intervention 1||1
9796514|NCT00584831|10904099|FG004|COMPLETED|Intervention 1||2
9796515|NCT00584831|10904100|FG005|COMPLETED|Intervention 1||1
9796516|NCT00584831|10904101|FG006|COMPLETED|Intervention 1||6
10015670|NCT01807026|11138672|FG004|COMPLETED|Overall Study||9
10015671|NCT01807026|11138673|FG005|COMPLETED|Overall Study||3
10015672|NCT01807026|11138668|FG000|NOT COMPLETED|Overall Study||0
10015673|NCT01807026|11138669|FG001|NOT COMPLETED|Overall Study||0
10015674|NCT01807026|11138670|FG002|NOT COMPLETED|Overall Study||0
10015675|NCT01807026|11138671|FG003|NOT COMPLETED|Overall Study||0
10015676|NCT01807026|11138672|FG004|NOT COMPLETED|Overall Study||0
10015677|NCT01807026|11138673|FG005|NOT COMPLETED|Overall Study||0
10015678|NCT01807065|11138694|FG000|STARTED|Overall Study||25
10015679|NCT01807065|11138695|FG001|STARTED|Overall Study||26
10015680|NCT01807065|11138694|FG000|COMPLETED|Overall Study||24
10015681|NCT01807065|11138695|FG001|COMPLETED|Overall Study||25
10015682|NCT01807065|11138694|FG000|NOT COMPLETED|Overall Study||1
10015683|NCT01807065|11138695|FG001|NOT COMPLETED|Overall Study||1
10112185|NCT02502097|11243302|FG003|COMPLETED|Period 1||22
10112186|NCT02502097|11243299|FG000|NOT COMPLETED|Period 1||0
10112187|NCT02502097|11243300|FG001|NOT COMPLETED|Period 1||0
10112188|NCT02502097|11243301|FG002|NOT COMPLETED|Period 1||1
10112189|NCT02502097|11243302|FG003|NOT COMPLETED|Period 1||0
10112190|NCT02502097|11243299|FG000|STARTED|Wash Out Period||4
9796517|NCT00584831|10904102|FG007|COMPLETED|Intervention 1||2
9796518|NCT00584831|10904103|FG008|COMPLETED|Intervention 1||4
9796519|NCT00584831|10904104|FG009|COMPLETED|Intervention 1||2
9796520|NCT00584831|10904105|FG010|COMPLETED|Intervention 1||2
9796521|NCT00584831|10904106|FG011|COMPLETED|Intervention 1||1
9796522|NCT00584831|10904107|FG012|COMPLETED|Intervention 1||2
9796523|NCT00584831|10904108|FG013|COMPLETED|Intervention 1||1
9796524|NCT00584831|10904109|FG014|COMPLETED|Intervention 1||3
10015684|NCT01807091|11138701|FG000|STARTED|Overall Study||17
10015685|NCT01807091|11138701|FG000|COMPLETED|Overall Study||17
10015686|NCT01807091|11138701|FG000|NOT COMPLETED|Overall Study||0
10019138|NCT01828034|11142280|FG000|STARTED|Overall Study||3
10019139|NCT01828034|11142281|FG001|STARTED|Overall Study||6
10019140|NCT01828034|11142282|FG002|STARTED|Overall Study||3
10112191|NCT02502097|11243300|FG001|STARTED|Wash Out Period||3
10112192|NCT02502097|11243301|FG002|STARTED|Wash Out Period||21
9796525|NCT00584831|10904110|FG015|COMPLETED|Intervention 1||1
10019141|NCT01828034|11142283|FG003|STARTED|Overall Study||30
10019142|NCT01828034|11142280|FG000|COMPLETED|Overall Study||3
10019143|NCT01828034|11142281|FG001|COMPLETED|Overall Study||6
9796526|NCT00584831|10904111|FG016|COMPLETED|Intervention 1||4
9796527|NCT00584831|10904112|FG017|COMPLETED|Intervention 1||1
9796528|NCT00584831|10904113|FG018|COMPLETED|Intervention 1||1
9796529|NCT00584831|10904095|FG000|NOT COMPLETED|Intervention 1||0
9796530|NCT00584831|10904096|FG001|NOT COMPLETED|Intervention 1||0
9796531|NCT00584831|10904097|FG002|NOT COMPLETED|Intervention 1||0
9796532|NCT00584831|10904098|FG003|NOT COMPLETED|Intervention 1||0
9796533|NCT00584831|10904099|FG004|NOT COMPLETED|Intervention 1||0
9796534|NCT00584831|10904100|FG005|NOT COMPLETED|Intervention 1||0
9796535|NCT00584831|10904101|FG006|NOT COMPLETED|Intervention 1||0
9796536|NCT00584831|10904102|FG007|NOT COMPLETED|Intervention 1||0
9796537|NCT00584831|10904103|FG008|NOT COMPLETED|Intervention 1||0
9796538|NCT00584831|10904104|FG009|NOT COMPLETED|Intervention 1||0
9796539|NCT00584831|10904105|FG010|NOT COMPLETED|Intervention 1||0
9796540|NCT00584831|10904106|FG011|NOT COMPLETED|Intervention 1||0
9796541|NCT00584831|10904107|FG012|NOT COMPLETED|Intervention 1||0
9796542|NCT00584831|10904108|FG013|NOT COMPLETED|Intervention 1||0
9796543|NCT00584831|10904109|FG014|NOT COMPLETED|Intervention 1||0
9796544|NCT00584831|10904110|FG015|NOT COMPLETED|Intervention 1||0
9796545|NCT00584831|10904111|FG016|NOT COMPLETED|Intervention 1||0
10015687|NCT01807104|11138707|FG000|STARTED|Overall Study||43
10015688|NCT01807104|11138708|FG001|STARTED|Overall Study||44
10015689|NCT01807104|11138707|FG000|COMPLETED|Overall Study||39
10015690|NCT01807104|11138708|FG001|COMPLETED|Overall Study||40
10015691|NCT01807104|11138707|FG000|NOT COMPLETED|Overall Study||4
10015692|NCT01807104|11138708|FG001|NOT COMPLETED|Overall Study||4
10015693|NCT01807156|11138714|FG000|STARTED|Overall Study||7
10015694|NCT01807156|11138714|FG000|COMPLETED|Overall Study||6
10015695|NCT01807156|11138714|FG000|NOT COMPLETED|Overall Study||1
10015696|NCT01807221|11138724|FG000|STARTED|Overall Study||224
10015697|NCT01807221|11138725|FG001|STARTED|Overall Study||173
10015698|NCT01807221|11138726|FG002|STARTED|Overall Study||165
10015699|NCT01807221|11138727|FG003|STARTED|Overall Study||169
10015700|NCT01807221|11138728|FG004|STARTED|Overall Study||170
10015701|NCT01807221|11138729|FG005|STARTED|Overall Study||165
10015702|NCT01807221|11138724|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
10015703|NCT01807221|11138725|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
10015704|NCT01807221|11138726|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
10015705|NCT01807221|11138727|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
10015706|NCT01807221|11138728|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
10015707|NCT01807221|11138729|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
10015708|NCT01807221|11138724|FG000|COMPLETED|Overall Study||144
10015709|NCT01807221|11138725|FG001|COMPLETED|Overall Study||121
10015710|NCT01807221|11138726|FG002|COMPLETED|Overall Study||122
10015711|NCT01807221|11138727|FG003|COMPLETED|Overall Study||123
9796546|NCT00584831|10904112|FG017|NOT COMPLETED|Intervention 1||0
9796547|NCT00584831|10904113|FG018|NOT COMPLETED|Intervention 1||0
9796548|NCT00584831|10904095|FG000|STARTED|Intervention 2||1
9796549|NCT00584831|10904096|FG001|STARTED|Intervention 2||3
9796550|NCT00584831|10904097|FG002|STARTED|Intervention 2||2
9796551|NCT00584831|10904098|FG003|STARTED|Intervention 2||1
9796552|NCT00584831|10904099|FG004|STARTED|Intervention 2||2
9796553|NCT00584831|10904100|FG005|STARTED|Intervention 2||1
9796554|NCT00584831|10904101|FG006|STARTED|Intervention 2||6
9796555|NCT00584831|10904102|FG007|STARTED|Intervention 2||2
9796556|NCT00584831|10904103|FG008|STARTED|Intervention 2||4
9796557|NCT00584831|10904104|FG009|STARTED|Intervention 2||2
9796558|NCT00584831|10904105|FG010|STARTED|Intervention 2||2
9796559|NCT00584831|10904106|FG011|STARTED|Intervention 2||1
9796560|NCT00584831|10904107|FG012|STARTED|Intervention 2||2
9796561|NCT00584831|10904108|FG013|STARTED|Intervention 2||1
9796562|NCT00584831|10904109|FG014|STARTED|Intervention 2||3
9796563|NCT00584831|10904110|FG015|STARTED|Intervention 2||1
9796564|NCT00584831|10904111|FG016|STARTED|Intervention 2||4
9796565|NCT00584831|10904112|FG017|STARTED|Intervention 2||1
9796566|NCT00584831|10904113|FG018|STARTED|Intervention 2||1
9796567|NCT00584831|10904095|FG000|COMPLETED|Intervention 2||1
9796568|NCT00584831|10904096|FG001|COMPLETED|Intervention 2||3
9796569|NCT00584831|10904097|FG002|COMPLETED|Intervention 2||2
9796570|NCT00584831|10904098|FG003|COMPLETED|Intervention 2||1
9796571|NCT00584831|10904099|FG004|COMPLETED|Intervention 2||2
9796572|NCT00584831|10904100|FG005|COMPLETED|Intervention 2||1
9796573|NCT00584831|10904101|FG006|COMPLETED|Intervention 2||6
9796574|NCT00584831|10904102|FG007|COMPLETED|Intervention 2||2
9796575|NCT00584831|10904103|FG008|COMPLETED|Intervention 2||4
9796576|NCT00584831|10904104|FG009|COMPLETED|Intervention 2||2
9796577|NCT00584831|10904105|FG010|COMPLETED|Intervention 2||2
9796578|NCT00584831|10904106|FG011|COMPLETED|Intervention 2||1
9796579|NCT00584831|10904107|FG012|COMPLETED|Intervention 2||2
9796580|NCT00584831|10904108|FG013|COMPLETED|Intervention 2||1
9796581|NCT00584831|10904109|FG014|COMPLETED|Intervention 2||3
9796582|NCT00584831|10904110|FG015|COMPLETED|Intervention 2||1
9796583|NCT00584831|10904111|FG016|COMPLETED|Intervention 2||4
9796584|NCT00584831|10904112|FG017|COMPLETED|Intervention 2||1
9796585|NCT00584831|10904113|FG018|COMPLETED|Intervention 2||1
9796586|NCT00584831|10904095|FG000|NOT COMPLETED|Intervention 2||0
9796587|NCT00584831|10904096|FG001|NOT COMPLETED|Intervention 2||0
9796588|NCT00584831|10904097|FG002|NOT COMPLETED|Intervention 2||0
9796589|NCT00584831|10904098|FG003|NOT COMPLETED|Intervention 2||0
9796590|NCT00584831|10904099|FG004|NOT COMPLETED|Intervention 2||0
9796591|NCT00584831|10904100|FG005|NOT COMPLETED|Intervention 2||0
9796592|NCT00584831|10904101|FG006|NOT COMPLETED|Intervention 2||0
9796593|NCT00584831|10904102|FG007|NOT COMPLETED|Intervention 2||0
9796594|NCT00584831|10904103|FG008|NOT COMPLETED|Intervention 2||0
9796595|NCT00584831|10904104|FG009|NOT COMPLETED|Intervention 2||0
9796596|NCT00584831|10904105|FG010|NOT COMPLETED|Intervention 2||0
9796597|NCT00584831|10904106|FG011|NOT COMPLETED|Intervention 2||0
9796598|NCT00584831|10904107|FG012|NOT COMPLETED|Intervention 2||0
9796599|NCT00584831|10904108|FG013|NOT COMPLETED|Intervention 2||0
9796600|NCT00584831|10904109|FG014|NOT COMPLETED|Intervention 2||0
9796601|NCT00584831|10904110|FG015|NOT COMPLETED|Intervention 2||0
9796602|NCT00584831|10904111|FG016|NOT COMPLETED|Intervention 2||0
9796603|NCT00584831|10904112|FG017|NOT COMPLETED|Intervention 2||0
9796604|NCT00584831|10904113|FG018|NOT COMPLETED|Intervention 2||0
9796605|NCT00584831|10904095|FG000|STARTED|Intervention 3||1
9796606|NCT00584831|10904096|FG001|STARTED|Intervention 3||3
9796607|NCT00584831|10904097|FG002|STARTED|Intervention 3||2
9796608|NCT00584831|10904098|FG003|STARTED|Intervention 3||1
9796609|NCT00584831|10904099|FG004|STARTED|Intervention 3||2
9796610|NCT00584831|10904100|FG005|STARTED|Intervention 3||1
9796611|NCT00584831|10904101|FG006|STARTED|Intervention 3||6
9796612|NCT00584831|10904102|FG007|STARTED|Intervention 3||2
9796613|NCT00584831|10904103|FG008|STARTED|Intervention 3||4
9796614|NCT00584831|10904104|FG009|STARTED|Intervention 3||2
9796615|NCT00584831|10904105|FG010|STARTED|Intervention 3||2
9796616|NCT00584831|10904106|FG011|STARTED|Intervention 3||1
9796617|NCT00584831|10904107|FG012|STARTED|Intervention 3||2
9796618|NCT00584831|10904108|FG013|STARTED|Intervention 3||1
9796619|NCT00584831|10904109|FG014|STARTED|Intervention 3||3
9796620|NCT00584831|10904110|FG015|STARTED|Intervention 3||1
9796621|NCT00584831|10904111|FG016|STARTED|Intervention 3||4
9796622|NCT00584831|10904112|FG017|STARTED|Intervention 3||1
9796623|NCT00584831|10904113|FG018|STARTED|Intervention 3||1
9796624|NCT00584831|10904095|FG000|COMPLETED|Intervention 3||1
9796625|NCT00584831|10904096|FG001|COMPLETED|Intervention 3||3
9796626|NCT00584831|10904097|FG002|COMPLETED|Intervention 3||2
9796627|NCT00584831|10904098|FG003|COMPLETED|Intervention 3||1
9796628|NCT00584831|10904099|FG004|COMPLETED|Intervention 3||2
9796629|NCT00584831|10904100|FG005|COMPLETED|Intervention 3||1
9796630|NCT00584831|10904101|FG006|COMPLETED|Intervention 3||6
9796631|NCT00584831|10904102|FG007|COMPLETED|Intervention 3||2
9796632|NCT00584831|10904103|FG008|COMPLETED|Intervention 3||4
9796633|NCT00584831|10904104|FG009|COMPLETED|Intervention 3||2
9796634|NCT00584831|10904105|FG010|COMPLETED|Intervention 3||2
9796635|NCT00584831|10904106|FG011|COMPLETED|Intervention 3||1
9796636|NCT00584831|10904107|FG012|COMPLETED|Intervention 3||2
9796637|NCT00584831|10904108|FG013|COMPLETED|Intervention 3||1
9796638|NCT00584831|10904109|FG014|COMPLETED|Intervention 3||3
9796639|NCT00584831|10904110|FG015|COMPLETED|Intervention 3||1
9796640|NCT00584831|10904111|FG016|COMPLETED|Intervention 3||4
9796641|NCT00584831|10904112|FG017|COMPLETED|Intervention 3||1
9796642|NCT00584831|10904113|FG018|COMPLETED|Intervention 3||1
9796643|NCT00584831|10904095|FG000|NOT COMPLETED|Intervention 3||0
9796644|NCT00584831|10904096|FG001|NOT COMPLETED|Intervention 3||0
9796645|NCT00584831|10904097|FG002|NOT COMPLETED|Intervention 3||0
9796646|NCT00584831|10904098|FG003|NOT COMPLETED|Intervention 3||0
9796647|NCT00584831|10904099|FG004|NOT COMPLETED|Intervention 3||0
9796648|NCT00584831|10904100|FG005|NOT COMPLETED|Intervention 3||0
9796649|NCT00584831|10904101|FG006|NOT COMPLETED|Intervention 3||0
9796650|NCT00584831|10904102|FG007|NOT COMPLETED|Intervention 3||0
9796651|NCT00584831|10904103|FG008|NOT COMPLETED|Intervention 3||0
9796652|NCT00584831|10904104|FG009|NOT COMPLETED|Intervention 3||0
9796653|NCT00584831|10904105|FG010|NOT COMPLETED|Intervention 3||0
9796654|NCT00584831|10904106|FG011|NOT COMPLETED|Intervention 3||0
9796655|NCT00584831|10904107|FG012|NOT COMPLETED|Intervention 3||0
9796656|NCT00584831|10904108|FG013|NOT COMPLETED|Intervention 3||0
9796657|NCT00584831|10904109|FG014|NOT COMPLETED|Intervention 3||0
9796658|NCT00584831|10904110|FG015|NOT COMPLETED|Intervention 3||0
9796659|NCT00584831|10904111|FG016|NOT COMPLETED|Intervention 3||0
9796660|NCT00584831|10904112|FG017|NOT COMPLETED|Intervention 3||0
10015712|NCT01807221|11138728|FG004|COMPLETED|Overall Study||134
10015713|NCT01807221|11138729|FG005|COMPLETED|Overall Study||124
10015714|NCT01807221|11138724|FG000|NOT COMPLETED|Overall Study||80
10015715|NCT01807221|11138725|FG001|NOT COMPLETED|Overall Study||52
10015716|NCT01807221|11138726|FG002|NOT COMPLETED|Overall Study||43
9796661|NCT00584831|10904113|FG018|NOT COMPLETED|Intervention 3||0
9796662|NCT00584831|10904095|FG000|STARTED|Intervention 4||1
9796663|NCT00584831|10904096|FG001|STARTED|Intervention 4||3
9796664|NCT00584831|10904097|FG002|STARTED|Intervention 4||2
9796665|NCT00584831|10904098|FG003|STARTED|Intervention 4||1
9796666|NCT00584831|10904099|FG004|STARTED|Intervention 4||2
9796667|NCT00584831|10904100|FG005|STARTED|Intervention 4||1
9796668|NCT00584831|10904101|FG006|STARTED|Intervention 4||6
9796669|NCT00584831|10904102|FG007|STARTED|Intervention 4||2
9796670|NCT00584831|10904103|FG008|STARTED|Intervention 4||3
9796671|NCT00584831|10904104|FG009|STARTED|Intervention 4||2
9796672|NCT00584831|10904105|FG010|STARTED|Intervention 4||2
10015717|NCT01807221|11138727|FG003|NOT COMPLETED|Overall Study||46
10015718|NCT01807221|11138728|FG004|NOT COMPLETED|Overall Study||36
9796673|NCT00584831|10904106|FG011|STARTED|Intervention 4||1
9796674|NCT00584831|10904107|FG012|STARTED|Intervention 4||2
9796675|NCT00584831|10904108|FG013|STARTED|Intervention 4||1
9796676|NCT00584831|10904109|FG014|STARTED|Intervention 4||2
9796677|NCT00584831|10904110|FG015|STARTED|Intervention 4||1
9796678|NCT00584831|10904111|FG016|STARTED|Intervention 4||4
9796679|NCT00584831|10904112|FG017|STARTED|Intervention 4||1
9796680|NCT00584831|10904113|FG018|STARTED|Intervention 4||1
9796681|NCT00584831|10904095|FG000|COMPLETED|Intervention 4||1
9796682|NCT00584831|10904096|FG001|COMPLETED|Intervention 4||3
9796683|NCT00584831|10904097|FG002|COMPLETED|Intervention 4||2
9796684|NCT00584831|10904098|FG003|COMPLETED|Intervention 4||1
9796685|NCT00584831|10904099|FG004|COMPLETED|Intervention 4||2
9796686|NCT00584831|10904100|FG005|COMPLETED|Intervention 4||1
9796687|NCT00584831|10904101|FG006|COMPLETED|Intervention 4||6
9796688|NCT00584831|10904102|FG007|COMPLETED|Intervention 4||2
9796689|NCT00584831|10904103|FG008|COMPLETED|Intervention 4||3
9796690|NCT00584831|10904104|FG009|COMPLETED|Intervention 4||2
9796691|NCT00584831|10904105|FG010|COMPLETED|Intervention 4||2
10015719|NCT01807221|11138729|FG005|NOT COMPLETED|Overall Study||41
10015720|NCT01807234|11138749|FG000|STARTED|Overall Study||12
10015721|NCT01807234|11138750|FG001|STARTED|Overall Study||12
10015722|NCT01807234|11138751|FG002|STARTED|Overall Study||12
10015723|NCT01807234|11138752|FG003|STARTED|Overall Study||12
10015724|NCT01807234|11138753|FG004|STARTED|Overall Study||12
9796692|NCT00584831|10904106|FG011|COMPLETED|Intervention 4||1
9796693|NCT00584831|10904107|FG012|COMPLETED|Intervention 4||2
9796694|NCT00584831|10904108|FG013|COMPLETED|Intervention 4||1
9796695|NCT00584831|10904109|FG014|COMPLETED|Intervention 4||2
9796696|NCT00584831|10904110|FG015|COMPLETED|Intervention 4||1
9796697|NCT00584831|10904111|FG016|COMPLETED|Intervention 4||4
9796698|NCT00584831|10904112|FG017|COMPLETED|Intervention 4||1
9796699|NCT00584831|10904113|FG018|COMPLETED|Intervention 4||1
9796700|NCT00584831|10904095|FG000|NOT COMPLETED|Intervention 4||0
9796701|NCT00584831|10904096|FG001|NOT COMPLETED|Intervention 4||0
9796702|NCT00584831|10904097|FG002|NOT COMPLETED|Intervention 4||0
9796703|NCT00584831|10904098|FG003|NOT COMPLETED|Intervention 4||0
9796704|NCT00584831|10904099|FG004|NOT COMPLETED|Intervention 4||0
9796705|NCT00584831|10904100|FG005|NOT COMPLETED|Intervention 4||0
9796706|NCT00584831|10904101|FG006|NOT COMPLETED|Intervention 4||0
9796707|NCT00584831|10904102|FG007|NOT COMPLETED|Intervention 4||0
9796708|NCT00584831|10904103|FG008|NOT COMPLETED|Intervention 4||0
9796709|NCT00584831|10904104|FG009|NOT COMPLETED|Intervention 4||0
9796710|NCT00584831|10904105|FG010|NOT COMPLETED|Intervention 4||0
9796711|NCT00584831|10904106|FG011|NOT COMPLETED|Intervention 4||0
9796712|NCT00584831|10904107|FG012|NOT COMPLETED|Intervention 4||0
9796713|NCT00584831|10904108|FG013|NOT COMPLETED|Intervention 4||0
9796714|NCT00584831|10904109|FG014|NOT COMPLETED|Intervention 4||0
9796715|NCT00584831|10904110|FG015|NOT COMPLETED|Intervention 4||0
9796716|NCT00584831|10904111|FG016|NOT COMPLETED|Intervention 4||0
9796717|NCT00584831|10904112|FG017|NOT COMPLETED|Intervention 4||0
9796718|NCT00584831|10904113|FG018|NOT COMPLETED|Intervention 4||0
9796719|NCT00584844|10904123|FG000|STARTED|Overall Study||484
9796720|NCT00584844|10904123|FG000|COMPLETED|Overall Study||405
9796721|NCT00584844|10904123|FG000|NOT COMPLETED|Overall Study||79
9796722|NCT00584857|10904131|FG000|STARTED|Overall Study||30
9796723|NCT00584857|10904131|FG000|COMPLETED|Overall Study||30
9796724|NCT00584857|10904131|FG000|NOT COMPLETED|Overall Study||0
9796725|NCT00584870|10904138|FG000|STARTED|Overall Study||88
9796726|NCT00584870|10904139|FG001|STARTED|Overall Study||89
9796727|NCT00584870|10904140|FG002|STARTED|Overall Study||43
9796728|NCT00584870|10904138|FG000|Treated|Overall Study||88
9796729|NCT00584870|10904139|FG001|Treated|Overall Study||88
9796730|NCT00584870|10904140|FG002|Treated|Overall Study||41
9796731|NCT00584870|10904138|FG000|COMPLETED|Overall Study||59
9796732|NCT00584870|10904139|FG001|COMPLETED|Overall Study||64
9796733|NCT00584870|10904140|FG002|COMPLETED|Overall Study||25
9796734|NCT00584870|10904138|FG000|NOT COMPLETED|Overall Study||29
9796735|NCT00584870|10904139|FG001|NOT COMPLETED|Overall Study||25
9796736|NCT00584870|10904140|FG002|NOT COMPLETED|Overall Study||18
9796737|NCT00584909|10904148|FG000|STARTED|Overall Study||13
9796738|NCT00584909|10904148|FG000|COMPLETED|Overall Study||9
9796739|NCT00584909|10904148|FG000|NOT COMPLETED|Overall Study||4
9796740|NCT00584922|10904152|FG000|STARTED|Overall Study||175
9796741|NCT00584922|10904152|FG000|COMPLETED|Overall Study||175
9796742|NCT00584922|10904152|FG000|NOT COMPLETED|Overall Study||0
9796743|NCT00584948|10904158|FG000|STARTED|Overall Study||47
9796744|NCT00584948|10904159|FG001|STARTED|Overall Study||47
9796745|NCT00584948|10904158|FG000|COMPLETED|Overall Study||34
9796746|NCT00584948|10904159|FG001|COMPLETED|Overall Study||36
9796747|NCT00584948|10904158|FG000|NOT COMPLETED|Overall Study||13
9796748|NCT00584948|10904159|FG001|NOT COMPLETED|Overall Study||11
9796749|NCT00584987|10904169|FG000|STARTED|Overall Study||15
9796750|NCT00584987|10904170|FG001|STARTED|Overall Study||16
9796751|NCT00584987|10904171|FG002|STARTED|Overall Study||17
9796752|NCT00584987|10904172|FG003|STARTED|Overall Study||16
9796753|NCT00584987|10904169|FG000|COMPLETED|Overall Study||14
9796754|NCT00584987|10904170|FG001|COMPLETED|Overall Study||15
9796755|NCT00584987|10904171|FG002|COMPLETED|Overall Study||16
9796756|NCT00584987|10904172|FG003|COMPLETED|Overall Study||15
9796757|NCT00584987|10904169|FG000|NOT COMPLETED|Overall Study||1
9796758|NCT00584987|10904170|FG001|NOT COMPLETED|Overall Study||1
9796759|NCT00584987|10904171|FG002|NOT COMPLETED|Overall Study||1
9796760|NCT00584987|10904172|FG003|NOT COMPLETED|Overall Study||1
9796761|NCT00585013|10904184|FG000|STARTED|Overall Study||8
10015725|NCT01807234|11138754|FG005|STARTED|Overall Study||12
9796762|NCT00585013|10904185|FG001|STARTED|Overall Study||8
9796763|NCT00585013|10904184|FG000|COMPLETED|Overall Study||8
9796764|NCT00585013|10904185|FG001|COMPLETED|Overall Study||8
9796765|NCT00585013|10904184|FG000|NOT COMPLETED|Overall Study||0
9796766|NCT00585013|10904185|FG001|NOT COMPLETED|Overall Study||0
9796767|NCT00585039|10904195|FG000|STARTED|Overall Study||57
9796768|NCT00585039|10904196|FG001|STARTED|Overall Study||44
9796769|NCT00585039|10904195|FG000|COMPLETED|Overall Study||55
9796770|NCT00585039|10904196|FG001|COMPLETED|Overall Study||44
9796771|NCT00585039|10904195|FG000|NOT COMPLETED|Overall Study||2
9796772|NCT00585039|10904196|FG001|NOT COMPLETED|Overall Study||0
9796773|NCT00585052|10904204|FG000|STARTED|Overall Study||11
9796774|NCT00585052|10904204|FG000|COMPLETED|Overall Study||10
9796775|NCT00585052|10904204|FG000|NOT COMPLETED|Overall Study||1
9796776|NCT00585078|10904208|FG000|STARTED|Overall Study||40
9796777|NCT00585078|10904208|FG000|Treated|Overall Study||37
9796778|NCT00585078|10904208|FG000|Toxicity Evaluable|Overall Study||36
9796779|NCT00585078|10904208|FG000|Response Evaluable|Overall Study||24
9796780|NCT00585078|10904208|FG000|COMPLETED|Overall Study||0
9796781|NCT00585078|10904208|FG000|NOT COMPLETED|Overall Study||40
9796782|NCT00585104|10904212|FG000|STARTED|Overall Study||10
9796783|NCT00585104|10904212|FG000|COMPLETED|Overall Study||6
9796784|NCT00585104|10904212|FG000|NOT COMPLETED|Overall Study||4
9796785|NCT00585169|10904216|FG000|STARTED|Overall Study||29
9796786|NCT00585169|10904216|FG000|COMPLETED|Overall Study||28
9796787|NCT00585169|10904216|FG000|NOT COMPLETED|Overall Study||1
9796788|NCT00585182|10904222|FG000|STARTED|Overall Study||28
9796789|NCT00585182|10904222|FG000|COMPLETED|Overall Study||28
9796790|NCT00585182|10904222|FG000|NOT COMPLETED|Overall Study||0
9796791|NCT00585247|10904228|FG000|STARTED|Overall Study||14
9796792|NCT00585247|10904229|FG001|STARTED|Overall Study||13
9796793|NCT00585247|10904228|FG000|COMPLETED|Overall Study||14
9796794|NCT00585247|10904229|FG001|COMPLETED|Overall Study||13
9796795|NCT00585247|10904228|FG000|NOT COMPLETED|Overall Study||0
9796796|NCT00585247|10904229|FG001|NOT COMPLETED|Overall Study||0
9796797|NCT00585286|10904235|FG000|STARTED|Overall Study||15
9796798|NCT00585286|10904235|FG000|COMPLETED|Overall Study||14
9796799|NCT00585286|10904235|FG000|NOT COMPLETED|Overall Study||1
9796800|NCT00585312|10904241|FG000|STARTED|Overall Study|STARTED=Randomized|55
9796801|NCT00585312|10904242|FG001|STARTED|Overall Study|STARTED=Randomized|51
9796802|NCT00585312|10904241|FG000|Treated|Overall Study||53
9796803|NCT00585312|10904242|FG001|Treated|Overall Study||48
9796804|NCT00585312|10904241|FG000|COMPLETED|Overall Study||4
9796805|NCT00585312|10904242|FG001|COMPLETED|Overall Study||7
9796806|NCT00585312|10904241|FG000|NOT COMPLETED|Overall Study||51
9796807|NCT00585312|10904242|FG001|NOT COMPLETED|Overall Study||44
9796808|NCT00585325|10904250|FG000|STARTED|Overall Study||10
9796809|NCT00585325|10904251|FG001|STARTED|Overall Study||13
9796810|NCT00585325|10904250|FG000|COMPLETED|Overall Study||9
9796811|NCT00585325|10904251|FG001|COMPLETED|Overall Study||12
9796812|NCT00585325|10904250|FG000|NOT COMPLETED|Overall Study||1
9796813|NCT00585325|10904251|FG001|NOT COMPLETED|Overall Study||1
9796814|NCT00585351|10904263|FG000|STARTED|Notification Period (Informed Consent)||50
9796815|NCT00585351|10904264|FG001|STARTED|Notification Period (Informed Consent)||50
9796816|NCT00585351|10904265|FG002|STARTED|Notification Period (Informed Consent)||0
9796817|NCT00585351|10904266|FG003|STARTED|Notification Period (Informed Consent)||0
9796818|NCT00585351|10904267|FG004|STARTED|Notification Period (Informed Consent)||0
9796819|NCT00585351|10904268|FG005|STARTED|Notification Period (Informed Consent)||0
9796820|NCT00585351|10904269|FG006|STARTED|Notification Period (Informed Consent)||0
9796821|NCT00585351|10904270|FG007|STARTED|Notification Period (Informed Consent)||0
9796822|NCT00585351|10904263|FG000|COMPLETED|Notification Period (Informed Consent)||27
9796823|NCT00585351|10904264|FG001|COMPLETED|Notification Period (Informed Consent)||25
9796824|NCT00585351|10904265|FG002|COMPLETED|Notification Period (Informed Consent)||0
9796825|NCT00585351|10904266|FG003|COMPLETED|Notification Period (Informed Consent)||0
9796826|NCT00585351|10904267|FG004|COMPLETED|Notification Period (Informed Consent)||0
9796827|NCT00585351|10904268|FG005|COMPLETED|Notification Period (Informed Consent)||0
9796828|NCT00585351|10904269|FG006|COMPLETED|Notification Period (Informed Consent)||0
9796829|NCT00585351|10904270|FG007|COMPLETED|Notification Period (Informed Consent)||0
9796830|NCT00585351|10904263|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23
9796831|NCT00585351|10904264|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25
9796832|NCT00585351|10904265|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0
9796833|NCT00585351|10904266|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0
9796834|NCT00585351|10904267|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0
9796835|NCT00585351|10904268|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0
9796836|NCT00585351|10904269|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0
9796837|NCT00585351|10904270|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0
9796838|NCT00585351|10904263|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
9796839|NCT00585351|10904264|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
9796840|NCT00585351|10904265|FG002|STARTED|Enrollment Period (Intervention)||15
9796841|NCT00585351|10904266|FG003|STARTED|Enrollment Period (Intervention)||15
9796842|NCT00585351|10904267|FG004|STARTED|Enrollment Period (Intervention)||5
9796843|NCT00585351|10904268|FG005|STARTED|Enrollment Period (Intervention)||7
9796844|NCT00585351|10904269|FG006|STARTED|Enrollment Period (Intervention)||7
9796845|NCT00585351|10904270|FG007|STARTED|Enrollment Period (Intervention)||3
9796846|NCT00585351|10904263|FG000|COMPLETED|Enrollment Period (Intervention)||0
9796847|NCT00585351|10904264|FG001|COMPLETED|Enrollment Period (Intervention)||0
9796848|NCT00585351|10904265|FG002|COMPLETED|Enrollment Period (Intervention)||15
9796849|NCT00585351|10904266|FG003|COMPLETED|Enrollment Period (Intervention)||15
9796850|NCT00585351|10904267|FG004|COMPLETED|Enrollment Period (Intervention)||3
9796851|NCT00585351|10904268|FG005|COMPLETED|Enrollment Period (Intervention)||5
9796852|NCT00585351|10904269|FG006|COMPLETED|Enrollment Period (Intervention)||5
9796853|NCT00585351|10904270|FG007|COMPLETED|Enrollment Period (Intervention)||2
9796854|NCT00585351|10904263|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0
9796855|NCT00585351|10904264|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0
9796856|NCT00585351|10904265|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0
9796857|NCT00585351|10904266|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0
9796858|NCT00585351|10904267|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2
9796859|NCT00585351|10904268|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2
9796860|NCT00585351|10904269|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2
9796861|NCT00585351|10904270|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1
9796862|NCT00585377|10904284|FG000|STARTED|Overall Study||50
9796863|NCT00585377|10904284|FG000|COMPLETED|Overall Study||50
9796864|NCT00585377|10904284|FG000|NOT COMPLETED|Overall Study||0
9796865|NCT00585468|10904288|FG000|STARTED|First Intervention||10
9796866|NCT00585468|10904289|FG001|STARTED|First Intervention||11
9796867|NCT00585468|10904288|FG000|COMPLETED|First Intervention||9
9796868|NCT00585468|10904289|FG001|COMPLETED|First Intervention||10
9796869|NCT00585468|10904288|FG000|NOT COMPLETED|First Intervention||1
9796870|NCT00585468|10904289|FG001|NOT COMPLETED|First Intervention||1
9796871|NCT00585468|10904288|FG000|STARTED|Second Intervention||9
9796872|NCT00585468|10904289|FG001|STARTED|Second Intervention||10
9796873|NCT00585468|10904288|FG000|COMPLETED|Second Intervention||9
9796874|NCT00585468|10904289|FG001|COMPLETED|Second Intervention||10
9796875|NCT00585468|10904288|FG000|NOT COMPLETED|Second Intervention||0
9796876|NCT00585468|10904289|FG001|NOT COMPLETED|Second Intervention||0
9796877|NCT00585494|10904297|FG000|STARTED|Overall Study||300
9796878|NCT00585494|10904297|FG000|COMPLETED|Overall Study||244
9796879|NCT00585494|10904297|FG000|NOT COMPLETED|Overall Study||56
9796880|NCT00585533|10904301|FG000|STARTED|Overall Study||40
9796881|NCT00585533|10904301|FG000|COMPLETED|Overall Study||31
9796882|NCT00585533|10904301|FG000|NOT COMPLETED|Overall Study||9
9796883|NCT00585546|10904305|FG000|STARTED|LVAD Implantation Required for 4 Months||18
9796884|NCT00585546|10904305|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13
9796885|NCT00585546|10904305|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
9796886|NCT00585546|10904305|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13
9796887|NCT00585546|10904305|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
9796888|NCT00585546|10904305|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
9796889|NCT00585637|10904313|FG000|STARTED|Baseline||81
9796890|NCT00585637|10904314|FG001|STARTED|Baseline||81
9796891|NCT00585637|10904315|FG002|STARTED|Baseline||83
9796892|NCT00585637|10904316|FG003|STARTED|Baseline||83
9796893|NCT00585637|10904313|FG000|COMPLETED|Baseline||81
9796894|NCT00585637|10904314|FG001|COMPLETED|Baseline||81
9796895|NCT00585637|10904315|FG002|COMPLETED|Baseline||83
10015726|NCT01807234|11138749|FG000|Randomized, But Did Not Take Drug|Overall Study||3
10015727|NCT01807234|11138750|FG001|Randomized, But Did Not Take Drug|Overall Study||5
10015728|NCT01807234|11138751|FG002|Randomized, But Did Not Take Drug|Overall Study||2
9796896|NCT00585637|10904316|FG003|COMPLETED|Baseline||83
9796897|NCT00585637|10904313|FG000|NOT COMPLETED|Baseline||0
9796898|NCT00585637|10904314|FG001|NOT COMPLETED|Baseline||0
9796899|NCT00585637|10904315|FG002|NOT COMPLETED|Baseline||0
10015729|NCT01807234|11138752|FG003|Randomized, But Did Not Take Drug|Overall Study||1
10015730|NCT01807234|11138753|FG004|Randomized, But Did Not Take Drug|Overall Study||4
10015731|NCT01807234|11138754|FG005|Randomized, But Did Not Take Drug|Overall Study||3
10015732|NCT01807234|11138749|FG000|Completed Only 1 Attack|Overall Study||2
10015733|NCT01807234|11138750|FG001|Completed Only 1 Attack|Overall Study||1
10015734|NCT01807234|11138751|FG002|Completed Only 1 Attack|Overall Study||0
9796900|NCT00585637|10904316|FG003|NOT COMPLETED|Baseline||0
9796901|NCT00585637|10904313|FG000|STARTED|3-month Time Point||81
9796902|NCT00585637|10904314|FG001|STARTED|3-month Time Point||81
9796903|NCT00585637|10904315|FG002|STARTED|3-month Time Point||83
9796904|NCT00585637|10904316|FG003|STARTED|3-month Time Point||83
9796905|NCT00585637|10904313|FG000|COMPLETED|3-month Time Point||71
9796906|NCT00585637|10904314|FG001|COMPLETED|3-month Time Point||67
9796907|NCT00585637|10904315|FG002|COMPLETED|3-month Time Point||76
9796908|NCT00585637|10904316|FG003|COMPLETED|3-month Time Point||78
9796909|NCT00585637|10904313|FG000|NOT COMPLETED|3-month Time Point||10
9796910|NCT00585637|10904314|FG001|NOT COMPLETED|3-month Time Point||14
9796911|NCT00585637|10904315|FG002|NOT COMPLETED|3-month Time Point||7
9796912|NCT00585637|10904316|FG003|NOT COMPLETED|3-month Time Point||5
10015735|NCT01807234|11138752|FG003|Completed Only 1 Attack|Overall Study||1
9796913|NCT00585637|10904313|FG000|STARTED|6-month Time Point||81
9796914|NCT00585637|10904314|FG001|STARTED|6-month Time Point||81
9796915|NCT00585637|10904315|FG002|STARTED|6-month Time Point||83
9796916|NCT00585637|10904316|FG003|STARTED|6-month Time Point||83
9796917|NCT00585637|10904313|FG000|COMPLETED|6-month Time Point||75
9796918|NCT00585637|10904314|FG001|COMPLETED|6-month Time Point||68
9796919|NCT00585637|10904315|FG002|COMPLETED|6-month Time Point||72
9796920|NCT00585637|10904316|FG003|COMPLETED|6-month Time Point||77
9796921|NCT00585637|10904313|FG000|NOT COMPLETED|6-month Time Point||6
9796922|NCT00585637|10904314|FG001|NOT COMPLETED|6-month Time Point||13
9796923|NCT00585637|10904315|FG002|NOT COMPLETED|6-month Time Point||11
9796924|NCT00585637|10904316|FG003|NOT COMPLETED|6-month Time Point||6
9796925|NCT00585650|10904328|FG000|STARTED|Overall Study||8
9796926|NCT00585650|10904329|FG001|STARTED|Overall Study||12
9796927|NCT00585650|10904328|FG000|COMPLETED|Overall Study||8
9796928|NCT00585650|10904329|FG001|COMPLETED|Overall Study||12
9796929|NCT00585650|10904328|FG000|NOT COMPLETED|Overall Study||0
9796930|NCT00585650|10904329|FG001|NOT COMPLETED|Overall Study||0
9796931|NCT00585689|10904335|FG000|STARTED|Overall Study||29
9796932|NCT00585689|10904335|FG000|COMPLETED|Overall Study||22
9796933|NCT00585689|10904335|FG000|NOT COMPLETED|Overall Study||7
9831025|NCT00766090|10941706|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831026|NCT00766090|10941707|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831027|NCT00766090|10941708|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1
9831028|NCT00766090|10941709|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831029|NCT00766090|10941710|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831030|NCT00766090|10941711|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831031|NCT00766090|10941712|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831032|NCT00766090|10941713|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831033|NCT00766090|10941714|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831034|NCT00766090|10941715|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831035|NCT00766090|10941716|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831036|NCT00766090|10941717|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
9831037|NCT00766090|10941706|FG000|STARTED|Treatment Period 3 (28 Days)||22
9831038|NCT00766090|10941707|FG001|STARTED|Treatment Period 3 (28 Days)||27
9831039|NCT00766090|10941708|FG002|STARTED|Treatment Period 3 (28 Days)||20
9831040|NCT00766090|10941709|FG003|STARTED|Treatment Period 3 (28 Days)||25
9831041|NCT00766090|10941710|FG004|STARTED|Treatment Period 3 (28 Days)||21
9831042|NCT00766090|10941711|FG005|STARTED|Treatment Period 3 (28 Days)||23
9831043|NCT00766090|10941712|FG006|STARTED|Treatment Period 3 (28 Days)||6
9831044|NCT00766090|10941713|FG007|STARTED|Treatment Period 3 (28 Days)||8
9831045|NCT00766090|10941714|FG008|STARTED|Treatment Period 3 (28 Days)||6
9831046|NCT00766090|10941715|FG009|STARTED|Treatment Period 3 (28 Days)||8
9831047|NCT00766090|10941716|FG010|STARTED|Treatment Period 3 (28 Days)||7
9831048|NCT00766090|10941717|FG011|STARTED|Treatment Period 3 (28 Days)||7
9831049|NCT00766090|10941706|FG000|COMPLETED|Treatment Period 3 (28 Days)||22
9831050|NCT00766090|10941707|FG001|COMPLETED|Treatment Period 3 (28 Days)||26
9831051|NCT00766090|10941708|FG002|COMPLETED|Treatment Period 3 (28 Days)||20
9831052|NCT00766090|10941709|FG003|COMPLETED|Treatment Period 3 (28 Days)||24
9831053|NCT00766090|10941710|FG004|COMPLETED|Treatment Period 3 (28 Days)||20
9831054|NCT00766090|10941711|FG005|COMPLETED|Treatment Period 3 (28 Days)||22
9831055|NCT00766090|10941712|FG006|COMPLETED|Treatment Period 3 (28 Days)||6
9831056|NCT00766090|10941713|FG007|COMPLETED|Treatment Period 3 (28 Days)||8
9831057|NCT00766090|10941714|FG008|COMPLETED|Treatment Period 3 (28 Days)||6
9831058|NCT00766090|10941715|FG009|COMPLETED|Treatment Period 3 (28 Days)||8
9831059|NCT00766090|10941716|FG010|COMPLETED|Treatment Period 3 (28 Days)||7
9831060|NCT00766090|10941717|FG011|COMPLETED|Treatment Period 3 (28 Days)||6
9831061|NCT00766090|10941706|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9831062|NCT00766090|10941707|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1
9831063|NCT00766090|10941708|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9831064|NCT00766090|10941709|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1
9831065|NCT00766090|10941710|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1
9831066|NCT00766090|10941711|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1
9831067|NCT00766090|10941712|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9831068|NCT00766090|10941713|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9831069|NCT00766090|10941714|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9831070|NCT00766090|10941715|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9831071|NCT00766090|10941716|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
9831072|NCT00766090|10941717|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1
9831073|NCT00766116|10941731|FG000|STARTED|Overall Study||50
9831074|NCT00766116|10941731|FG000|COMPLETED|Overall Study||50
9831075|NCT00766116|10941731|FG000|NOT COMPLETED|Overall Study||0
9831076|NCT00766142|10941738|FG000|STARTED|Overall Study||18
9831077|NCT00766142|10941738|FG000|COMPLETED|Overall Study||14
9831078|NCT00766142|10941738|FG000|NOT COMPLETED|Overall Study||4
9831079|NCT00766363|10941746|FG000|STARTED|Overall Study||12
9831080|NCT00766363|10941747|FG001|STARTED|Overall Study||13
9831081|NCT00766363|10941748|FG002|STARTED|Overall Study|Number randomized.|12
9831082|NCT00766363|10941749|FG003|STARTED|Overall Study|Number randomized.|12
9831083|NCT00766363|10941746|FG000|SAFETY POPULATION|Overall Study||12
9831084|NCT00766363|10941747|FG001|SAFETY POPULATION|Overall Study||13
9831085|NCT00766363|10941748|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
9831086|NCT00766363|10941749|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
9831087|NCT00766363|10941746|FG000|PK POPULATION|Overall Study||12
9831088|NCT00766363|10941747|FG001|PK POPULATION|Overall Study||13
9831089|NCT00766363|10941748|FG002|PK POPULATION|Overall Study||10
9831090|NCT00766363|10941749|FG003|PK POPULATION|Overall Study||13
9796934|NCT00585715|10904341|FG000|STARTED|Overall Study||11
9796935|NCT00585715|10904342|FG001|STARTED|Overall Study||11
9796936|NCT00585715|10904341|FG000|COMPLETED|Overall Study||8
9796937|NCT00585715|10904342|FG001|COMPLETED|Overall Study||11
9796938|NCT00585715|10904341|FG000|NOT COMPLETED|Overall Study||3
9796939|NCT00585715|10904342|FG001|NOT COMPLETED|Overall Study||0
9796940|NCT00585780|10904352|FG000|STARTED|Overall Study||21
9796941|NCT00585780|10904353|FG001|STARTED|Overall Study||23
9796942|NCT00585780|10904354|FG002|STARTED|Overall Study||34
9796943|NCT00585780|10904355|FG003|STARTED|Overall Study||22
9796944|NCT00585780|10904352|FG000|COMPLETED|Overall Study||13
9796945|NCT00585780|10904353|FG001|COMPLETED|Overall Study||14
9796946|NCT00585780|10904354|FG002|COMPLETED|Overall Study||21
9796947|NCT00585780|10904355|FG003|COMPLETED|Overall Study||14
9796948|NCT00585780|10904352|FG000|NOT COMPLETED|Overall Study||8
9796949|NCT00585780|10904353|FG001|NOT COMPLETED|Overall Study||9
9796950|NCT00585780|10904354|FG002|NOT COMPLETED|Overall Study||13
9796951|NCT00585780|10904355|FG003|NOT COMPLETED|Overall Study||8
9796952|NCT00585910|10904369|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
9796953|NCT00585910|10904369|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
9796954|NCT00585910|10904369|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
9796955|NCT00585910|10904369|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
9796956|NCT00585910|10904369|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
9796957|NCT00585910|10904369|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
9796958|NCT00585923|10904376|FG000|STARTED|Overall Study||56
9796959|NCT00585923|10904377|FG001|STARTED|Overall Study||59
9796960|NCT00585923|10904376|FG000|COMPLETED|Overall Study||25
9796961|NCT00585923|10904377|FG001|COMPLETED|Overall Study||26
9796962|NCT00585923|10904376|FG000|NOT COMPLETED|Overall Study||31
9796963|NCT00585923|10904377|FG001|NOT COMPLETED|Overall Study||33
9796964|NCT00585975|10904385|FG000|STARTED|Overall Study||277
9796965|NCT00585975|10904386|FG001|STARTED|Overall Study||291
9796966|NCT00585975|10904385|FG000|COMPLETED|Overall Study||262
9796967|NCT00585975|10904386|FG001|COMPLETED|Overall Study||278
9796968|NCT00585975|10904385|FG000|NOT COMPLETED|Overall Study||15
9796969|NCT00585975|10904386|FG001|NOT COMPLETED|Overall Study||13
9796970|NCT00586001|10904394|FG000|STARTED|Overall Study||26
9796971|NCT00586001|10904395|FG001|STARTED|Overall Study||11
9796972|NCT00586001|10904394|FG000|COMPLETED|Overall Study||22
9796973|NCT00586001|10904395|FG001|COMPLETED|Overall Study||10
9796974|NCT00586001|10904394|FG000|NOT COMPLETED|Overall Study||4
9796975|NCT00586001|10904395|FG001|NOT COMPLETED|Overall Study||1
9796976|NCT00586066|10904404|FG000|STARTED|Overall Study||48
9796977|NCT00586066|10904405|FG001|STARTED|Overall Study||24
9796978|NCT00586066|10904404|FG000|COMPLETED|Overall Study||30
9796979|NCT00586066|10904405|FG001|COMPLETED|Overall Study||14
9796980|NCT00586066|10904404|FG000|NOT COMPLETED|Overall Study||18
9796981|NCT00586066|10904405|FG001|NOT COMPLETED|Overall Study||10
9796982|NCT00586105|10904411|FG000|STARTED|Overall Study||39
9796983|NCT00586105|10904411|FG000|COMPLETED|Overall Study||0
9796984|NCT00586105|10904411|FG000|NOT COMPLETED|Overall Study||39
9796985|NCT00586157|10904415|FG000|STARTED|First Intervention||15
9796986|NCT00586157|10904416|FG001|STARTED|First Intervention||15
9796987|NCT00586157|10904415|FG000|COMPLETED|First Intervention||14
9796988|NCT00586157|10904416|FG001|COMPLETED|First Intervention||15
9796989|NCT00586157|10904415|FG000|NOT COMPLETED|First Intervention||1
9796990|NCT00586157|10904416|FG001|NOT COMPLETED|First Intervention||0
9796991|NCT00586157|10904415|FG000|STARTED|Second Intervention||14
9796992|NCT00586157|10904416|FG001|STARTED|Second Intervention||15
9796993|NCT00586157|10904415|FG000|COMPLETED|Second Intervention||12
9796994|NCT00586157|10904416|FG001|COMPLETED|Second Intervention||14
9796995|NCT00586157|10904415|FG000|NOT COMPLETED|Second Intervention||2
9796996|NCT00586157|10904416|FG001|NOT COMPLETED|Second Intervention||1
9796997|NCT00586170|10904424|FG000|STARTED|Overall Study||5
9796998|NCT00586170|10904425|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
9796999|NCT00586170|10904424|FG000|COMPLETED|Overall Study||5
9797000|NCT00586170|10904425|FG001|COMPLETED|Overall Study||3
9797001|NCT00586170|10904424|FG000|NOT COMPLETED|Overall Study||0
9797002|NCT00586170|10904425|FG001|NOT COMPLETED|Overall Study||0
9797003|NCT00586196|10904433|FG000|STARTED|Overall Study||7
9797004|NCT00586196|10904434|FG001|STARTED|Overall Study||9
9797005|NCT00586196|10904433|FG000|COMPLETED|Overall Study||7
9797006|NCT00586196|10904434|FG001|COMPLETED|Overall Study||9
9797007|NCT00586196|10904433|FG000|NOT COMPLETED|Overall Study||0
9797008|NCT00586196|10904434|FG001|NOT COMPLETED|Overall Study||0
9797009|NCT00586261|10904442|FG000|STARTED|Overall Study||17
9797010|NCT00586261|10904443|FG001|STARTED|Overall Study||19
9797011|NCT00586261|10904442|FG000|COMPLETED|Overall Study||17
9797012|NCT00586261|10904443|FG001|COMPLETED|Overall Study||19
9797013|NCT00586261|10904442|FG000|NOT COMPLETED|Overall Study||0
9797014|NCT00586261|10904443|FG001|NOT COMPLETED|Overall Study||0
9797015|NCT00586313|10904449|FG000|STARTED|Overall Study||21
9797016|NCT00586313|10904449|FG000|COMPLETED|Overall Study||19
9797017|NCT00586313|10904449|FG000|NOT COMPLETED|Overall Study||2
9797018|NCT00586326|10904453|FG000|STARTED|Enrollment to Device Placement-Enrolled||133
9797019|NCT00586326|10904453|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118
9831091|NCT00766363|10941746|FG000|COMPLETED|Overall Study||11
9797020|NCT00586326|10904453|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
9797021|NCT00586326|10904453|FG000|STARTED|Device Placed toTreatment-ITT||118
9797022|NCT00586326|10904453|FG000|COMPLETED|Device Placed toTreatment-ITT||100
9797023|NCT00586326|10904453|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18
9797024|NCT00586326|10904453|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100
9797025|NCT00586326|10904453|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
9797026|NCT00586326|10904453|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
9797027|NCT00586339|10904464|FG000|STARTED|Overall Study||61
9797028|NCT00586339|10904465|FG001|STARTED|Overall Study||59
9797029|NCT00586339|10904466|FG002|STARTED|Overall Study||30
9797030|NCT00586339|10904464|FG000|COMPLETED|Overall Study||54
9797031|NCT00586339|10904465|FG001|COMPLETED|Overall Study||52
9797032|NCT00586339|10904466|FG002|COMPLETED|Overall Study||24
9797033|NCT00586339|10904464|FG000|NOT COMPLETED|Overall Study||7
9797034|NCT00586339|10904465|FG001|NOT COMPLETED|Overall Study||7
9797035|NCT00586339|10904466|FG002|NOT COMPLETED|Overall Study||6
9797036|NCT00586469|10904476|FG000|STARTED|Overall Study||500
9797037|NCT00586469|10904477|FG001|STARTED|Overall Study||500
9797038|NCT00586469|10904476|FG000|COMPLETED|Overall Study||500
9797039|NCT00586469|10904477|FG001|COMPLETED|Overall Study||499
9797040|NCT00586469|10904476|FG000|NOT COMPLETED|Overall Study||0
9797041|NCT00586469|10904477|FG001|NOT COMPLETED|Overall Study||1
9797042|NCT00586482|10904485|FG000|STARTED|Overall Study||22
9797043|NCT00586482|10904486|FG001|STARTED|Overall Study||24
9797044|NCT00586482|10904485|FG000|COMPLETED|Overall Study||22
9797045|NCT00586482|10904486|FG001|COMPLETED|Overall Study||24
10015736|NCT01807234|11138753|FG004|Completed Only 1 Attack|Overall Study||0
10015737|NCT01807234|11138754|FG005|Completed Only 1 Attack|Overall Study||1
10015738|NCT01807234|11138749|FG000|COMPLETED|Overall Study||7
10015739|NCT01807234|11138750|FG001|COMPLETED|Overall Study||6
9797046|NCT00586482|10904485|FG000|NOT COMPLETED|Overall Study||0
9797047|NCT00586482|10904486|FG001|NOT COMPLETED|Overall Study||0
9797048|NCT00586495|10904492|FG000|STARTED|Treatment Period||95
9797049|NCT00586495|10904492|FG000|COMPLETED|Treatment Period||0
9797050|NCT00586495|10904492|FG000|NOT COMPLETED|Treatment Period||95
9797051|NCT00586495|10904492|FG000|STARTED|Follow-up||92
9797052|NCT00586495|10904492|FG000|COMPLETED|Follow-up||0
9797053|NCT00586495|10904492|FG000|NOT COMPLETED|Follow-up||92
9797054|NCT00586508|10904498|FG000|STARTED|Overall Study||68
9797055|NCT00586508|10904499|FG001|STARTED|Overall Study||13
9797056|NCT00586508|10904498|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
9797057|NCT00586508|10904499|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10235245|NCT01219673|11365496|FG005|COMPLETED|Overall Study||0
10235246|NCT01219673|11365497|FG006|COMPLETED|Overall Study||0
10235247|NCT01219673|11365498|FG007|COMPLETED|Overall Study||0
10235248|NCT01219673|11365491|FG000|NOT COMPLETED|Overall Study||0
10235249|NCT01219673|11365492|FG001|NOT COMPLETED|Overall Study||0
10235250|NCT01219673|11365493|FG002|NOT COMPLETED|Overall Study||0
10235251|NCT01219673|11365494|FG003|NOT COMPLETED|Overall Study||0
10235252|NCT01219673|11365495|FG004|NOT COMPLETED|Overall Study||0
10235253|NCT01219673|11365496|FG005|NOT COMPLETED|Overall Study||0
10235254|NCT01219673|11365497|FG006|NOT COMPLETED|Overall Study||0
10235255|NCT01219673|11365498|FG007|NOT COMPLETED|Overall Study||0
10235256|NCT01223001|11365518|FG000|STARTED|Overall Study||4
10235257|NCT01223001|11365519|FG001|STARTED|Overall Study||4
10235258|NCT01223001|11365518|FG000|COMPLETED|Overall Study||0
10235259|NCT01223001|11365519|FG001|COMPLETED|Overall Study||0
10235260|NCT01223001|11365518|FG000|NOT COMPLETED|Overall Study||4
10235261|NCT01223001|11365519|FG001|NOT COMPLETED|Overall Study||4
10235262|NCT01217060|11365525|FG000|STARTED|Overall Study||4
9797058|NCT00586508|10904498|FG000|COMPLETED|Overall Study||0
9797059|NCT00586508|10904499|FG001|COMPLETED|Overall Study||0
9797060|NCT00586508|10904498|FG000|NOT COMPLETED|Overall Study||68
9797061|NCT00586508|10904499|FG001|NOT COMPLETED|Overall Study||13
9797062|NCT00586521|10904505|FG000|STARTED|On Demand Treatment (Months 1-6)||20
9797063|NCT00586521|10904505|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19
9797064|NCT00586521|10904505|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
9797065|NCT00586521|10904505|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19
10015740|NCT01807234|11138751|FG002|COMPLETED|Overall Study||10
9797066|NCT00586521|10904505|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19
9797067|NCT00586521|10904505|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
9797068|NCT00586573|10904509|FG000|STARTED|Overall Study||34
9797069|NCT00586573|10904509|FG000|COMPLETED|Overall Study||28
9797070|NCT00586573|10904509|FG000|NOT COMPLETED|Overall Study||6
9797071|NCT00586612|10904515|FG000|STARTED|Primary Phase||163
10015741|NCT01807234|11138752|FG003|COMPLETED|Overall Study||10
10235263|NCT01217060|11365525|FG000|COMPLETED|Overall Study||3
10235264|NCT01217060|11365525|FG000|NOT COMPLETED|Overall Study||1
10235265|NCT01217047|11365533|FG000|STARTED|Overall Study||3
9797072|NCT00586612|10904516|FG001|STARTED|Primary Phase||150
9797073|NCT00586612|10904515|FG000|COMPLETED|Primary Phase||162
9797074|NCT00586612|10904516|FG001|COMPLETED|Primary Phase||147
9797075|NCT00586612|10904515|FG000|NOT COMPLETED|Primary Phase||1
9797076|NCT00586612|10904516|FG001|NOT COMPLETED|Primary Phase||3
9797077|NCT00586612|10904515|FG000|STARTED|Booster Phase||154
9797078|NCT00586612|10904516|FG001|STARTED|Booster Phase||144
10235266|NCT01217047|11365534|FG001|STARTED|Overall Study||4
10235267|NCT01217047|11365535|FG002|STARTED|Overall Study||3
10235268|NCT01217047|11365533|FG000|COMPLETED|Overall Study||3
9797079|NCT00586612|10904515|FG000|COMPLETED|Booster Phase||151
9797080|NCT00586612|10904516|FG001|COMPLETED|Booster Phase||143
9797081|NCT00586612|10904515|FG000|NOT COMPLETED|Booster Phase||3
9797082|NCT00586612|10904516|FG001|NOT COMPLETED|Booster Phase||1
9952524|NCT01422876|11071523|FG002|STARTED|Week 24||141
9952525|NCT01422876|11071524|FG003|STARTED|Week 24||140
9952526|NCT01422876|11071525|FG004|STARTED|Week 24||132
9952527|NCT01422876|11071526|FG005|STARTED|Week 24||137
9952528|NCT01422876|11071527|FG006|STARTED|Week 24||136
9797083|NCT00586625|10904524|FG000|STARTED|Overall Study||575
9797084|NCT00586625|10904525|FG001|STARTED|Overall Study||286
9797085|NCT00586625|10904524|FG000|COMPLETED|Overall Study||532
9797086|NCT00586625|10904525|FG001|COMPLETED|Overall Study||269
9797087|NCT00586625|10904524|FG000|NOT COMPLETED|Overall Study||43
9797088|NCT00586625|10904525|FG001|NOT COMPLETED|Overall Study||17
9797089|NCT00586664|10904534|FG000|STARTED|Overall Study||43
9797090|NCT00586664|10904535|FG001|STARTED|Overall Study||43
9797091|NCT00586664|10904536|FG002|STARTED|Overall Study||44
9797092|NCT00586664|10904534|FG000|COMPLETED|Overall Study||38
9797093|NCT00586664|10904535|FG001|COMPLETED|Overall Study||36
9797094|NCT00586664|10904536|FG002|COMPLETED|Overall Study||43
9797095|NCT00586664|10904534|FG000|NOT COMPLETED|Overall Study||5
9797096|NCT00586664|10904535|FG001|NOT COMPLETED|Overall Study||7
9797097|NCT00586664|10904536|FG002|NOT COMPLETED|Overall Study||1
9797098|NCT00586690|10904546|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21
9797099|NCT00586690|10904547|FG001|STARTED|Overall Study||22
9797100|NCT00586690|10904546|FG000|COMPLETED|Overall Study||5
9797101|NCT00586690|10904547|FG001|COMPLETED|Overall Study||22
9797102|NCT00586690|10904546|FG000|NOT COMPLETED|Overall Study||16
9797103|NCT00586690|10904547|FG001|NOT COMPLETED|Overall Study||0
9797104|NCT00586703|10904552|FG000|STARTED|Overall Study||16
9797105|NCT00586703|10904552|FG000|COMPLETED|Overall Study||4
9797106|NCT00586703|10904552|FG000|NOT COMPLETED|Overall Study||12
9797107|NCT00586729|10904558|FG000|STARTED|Overall Study||14
9797108|NCT00586729|10904559|FG001|STARTED|Overall Study||9
9797109|NCT00586729|10904558|FG000|COMPLETED|Overall Study||11
9797110|NCT00586729|10904559|FG001|COMPLETED|Overall Study||8
9797111|NCT00586729|10904558|FG000|NOT COMPLETED|Overall Study||3
9797112|NCT00586729|10904559|FG001|NOT COMPLETED|Overall Study||1
9797113|NCT00586820|10904567|FG000|STARTED|Overall Study||12
9797114|NCT00586820|10904568|FG001|STARTED|Overall Study||11
9797115|NCT00586820|10904567|FG000|COMPLETED|Overall Study||11
9797116|NCT00586820|10904568|FG001|COMPLETED|Overall Study||11
9797117|NCT00586820|10904567|FG000|NOT COMPLETED|Overall Study||1
9797118|NCT00586820|10904568|FG001|NOT COMPLETED|Overall Study||0
9797119|NCT00586846|10904574|FG000|STARTED|Overall Study||40
9797120|NCT00586846|10904574|FG000|COMPLETED|Overall Study||34
9797121|NCT00586846|10904574|FG000|NOT COMPLETED|Overall Study||6
9797122|NCT00586898|10904578|FG000|STARTED|Overall Study||36
9797123|NCT00586898|10904578|FG000|COMPLETED|Overall Study||29
9797124|NCT00586898|10904578|FG000|NOT COMPLETED|Overall Study||7
9797125|NCT00587041|10904585|FG000|STARTED|Overall Study||12
9797126|NCT00587041|10904586|FG001|STARTED|Overall Study||14
9797127|NCT00587041|10904587|FG002|STARTED|Overall Study||14
9797128|NCT00587041|10904585|FG000|COMPLETED|Overall Study||12
9797129|NCT00587041|10904586|FG001|COMPLETED|Overall Study||14
9797130|NCT00587041|10904587|FG002|COMPLETED|Overall Study||14
9797131|NCT00587041|10904585|FG000|NOT COMPLETED|Overall Study||0
9797132|NCT00587041|10904586|FG001|NOT COMPLETED|Overall Study||0
9797133|NCT00587041|10904587|FG002|NOT COMPLETED|Overall Study||0
9797134|NCT00587054|10904595|FG000|STARTED|Overall Study||129
9797135|NCT00587054|10904595|FG000|COMPLETED|Overall Study||120
9797136|NCT00587054|10904595|FG000|NOT COMPLETED|Overall Study||9
9797137|NCT00587067|10904599|FG000|STARTED|Overall Study||34
9797138|NCT00587067|10904599|FG000|COMPLETED|Overall Study||34
9797139|NCT00587067|10904599|FG000|NOT COMPLETED|Overall Study||0
9797140|NCT00587132|10904607|FG000|STARTED|Overall Study||4
9797141|NCT00587132|10904608|FG001|STARTED|Overall Study||0
9797142|NCT00587132|10904609|FG002|STARTED|Overall Study||0
9797143|NCT00587132|10904610|FG003|STARTED|Overall Study||0
9797144|NCT00587132|10904607|FG000|COMPLETED|Overall Study||4
9797145|NCT00587132|10904608|FG001|COMPLETED|Overall Study||0
9797146|NCT00587132|10904609|FG002|COMPLETED|Overall Study||0
9797147|NCT00587132|10904610|FG003|COMPLETED|Overall Study||0
9797148|NCT00587132|10904607|FG000|NOT COMPLETED|Overall Study||0
9797149|NCT00587132|10904608|FG001|NOT COMPLETED|Overall Study||0
9797150|NCT00587132|10904609|FG002|NOT COMPLETED|Overall Study||0
9797151|NCT00587132|10904610|FG003|NOT COMPLETED|Overall Study||0
9797152|NCT00587158|10904622|FG000|STARTED|Overall Study||49
9797153|NCT00587158|10904623|FG001|STARTED|Overall Study||51
9797154|NCT00587158|10904622|FG000|Continued in Study|Overall Study||45
9797155|NCT00587158|10904623|FG001|Continued in Study|Overall Study||46
9797156|NCT00587158|10904622|FG000|COMPLETED|Overall Study||44
9797157|NCT00587158|10904623|FG001|COMPLETED|Overall Study||43
9797158|NCT00587158|10904622|FG000|NOT COMPLETED|Overall Study||5
9797159|NCT00587158|10904623|FG001|NOT COMPLETED|Overall Study||8
9797160|NCT00587171|10904631|FG000|STARTED|Overall Study||9
9797161|NCT00587171|10904632|FG001|STARTED|Overall Study||10
9797162|NCT00587171|10904631|FG000|COMPLETED|Overall Study||8
9797163|NCT00587171|10904632|FG001|COMPLETED|Overall Study||9
9797164|NCT00587171|10904631|FG000|NOT COMPLETED|Overall Study||1
9797165|NCT00587171|10904632|FG001|NOT COMPLETED|Overall Study||1
9952529|NCT01422876|11071528|FG007|STARTED|Week 24||135
9952530|NCT01422876|11071529|FG008|STARTED|Week 24||134
9797166|NCT00587288|10904640|FG000|STARTED|Overall Study||53
9797167|NCT00587288|10904641|FG001|STARTED|Overall Study||53
9797168|NCT00587288|10904640|FG000|COMPLETED|Overall Study||50
9797169|NCT00587288|10904641|FG001|COMPLETED|Overall Study||44
9797170|NCT00587288|10904640|FG000|NOT COMPLETED|Overall Study||3
9797171|NCT00587288|10904641|FG001|NOT COMPLETED|Overall Study||9
9797172|NCT00587431|10904651|FG000|STARTED|Overall Study||63
9797173|NCT00587431|10904652|FG001|STARTED|Overall Study||39
9797174|NCT00587431|10904651|FG000|COMPLETED|Overall Study||62
9797175|NCT00587431|10904652|FG001|COMPLETED|Overall Study||38
9797176|NCT00587431|10904651|FG000|NOT COMPLETED|Overall Study||1
9797177|NCT00587431|10904652|FG001|NOT COMPLETED|Overall Study||1
9797178|NCT00587457|10904664|FG000|STARTED|Overall Study||3
9797179|NCT00587457|10904665|FG001|STARTED|Overall Study||3
9797180|NCT00587457|10904666|FG002|STARTED|Overall Study||5
9797181|NCT00587457|10904664|FG000|COMPLETED|Overall Study||0
9797182|NCT00587457|10904665|FG001|COMPLETED|Overall Study||0
9797183|NCT00587457|10904666|FG002|COMPLETED|Overall Study||0
9797184|NCT00587457|10904664|FG000|NOT COMPLETED|Overall Study||3
9797185|NCT00587457|10904665|FG001|NOT COMPLETED|Overall Study||3
9797186|NCT00587457|10904666|FG002|NOT COMPLETED|Overall Study||5
9797187|NCT00587483|10904677|FG000|STARTED|Overall Study||115
9797188|NCT00587483|10904678|FG001|STARTED|Overall Study||115
9797189|NCT00587483|10904679|FG002|STARTED|Overall Study||112
9797190|NCT00587483|10904677|FG000|COMPLETED|Overall Study||115
9797191|NCT00587483|10904678|FG001|COMPLETED|Overall Study||115
9797192|NCT00587483|10904679|FG002|COMPLETED|Overall Study||112
9797193|NCT00587483|10904677|FG000|NOT COMPLETED|Overall Study||0
9797194|NCT00587483|10904678|FG001|NOT COMPLETED|Overall Study||0
9797195|NCT00587483|10904679|FG002|NOT COMPLETED|Overall Study||0
9797196|NCT00587587|10904689|FG000|STARTED|Overall Study||17
9797197|NCT00587587|10904690|FG001|STARTED|Overall Study||13
9797198|NCT00587587|10904689|FG000|COMPLETED|Overall Study||11
9797199|NCT00587587|10904690|FG001|COMPLETED|Overall Study||12
9797200|NCT00587587|10904689|FG000|NOT COMPLETED|Overall Study||6
9797201|NCT00587587|10904690|FG001|NOT COMPLETED|Overall Study||1
9797202|NCT00587639|10904698|FG000|STARTED|Overall Study||8
9797203|NCT00587639|10904698|FG000|COMPLETED|Overall Study||7
9797204|NCT00587639|10904698|FG000|NOT COMPLETED|Overall Study||1
9797205|NCT00587678|10904705|FG000|STARTED|Overall Study||22
9797206|NCT00587678|10904706|FG001|STARTED|Overall Study||22
9797207|NCT00587678|10904707|FG002|STARTED|Overall Study||41
9797208|NCT00587678|10904705|FG000|COMPLETED|Overall Study||16
9797209|NCT00587678|10904706|FG001|COMPLETED|Overall Study||18
9797210|NCT00587678|10904707|FG002|COMPLETED|Overall Study||33
9797211|NCT00587678|10904705|FG000|NOT COMPLETED|Overall Study||6
9797212|NCT00587678|10904706|FG001|NOT COMPLETED|Overall Study||4
9797213|NCT00587678|10904707|FG002|NOT COMPLETED|Overall Study||8
9797214|NCT00587769|10904715|FG000|STARTED|Overall Study||38
9797215|NCT00587769|10904715|FG000|COMPLETED|Overall Study||38
9797216|NCT00587769|10904715|FG000|NOT COMPLETED|Overall Study||0
9797217|NCT00587834|10904719|FG000|STARTED|Overall Study||96
9797218|NCT00587834|10904719|FG000|COMPLETED|Overall Study||96
9797219|NCT00587834|10904719|FG000|NOT COMPLETED|Overall Study||0
9797220|NCT00587847|10904734|FG000|STARTED|Overall Study||12
9797221|NCT00587847|10904734|FG000|COMPLETED|Overall Study||5
9797222|NCT00587847|10904734|FG000|NOT COMPLETED|Overall Study||7
9831092|NCT00766363|10941747|FG001|COMPLETED|Overall Study||12
9831093|NCT00766363|10941748|FG002|COMPLETED|Overall Study||12
9831094|NCT00766363|10941749|FG003|COMPLETED|Overall Study||12
9831095|NCT00766363|10941746|FG000|NOT COMPLETED|Overall Study||1
9831096|NCT00766363|10941747|FG001|NOT COMPLETED|Overall Study||1
9831097|NCT00766363|10941748|FG002|NOT COMPLETED|Overall Study||0
9831098|NCT00766363|10941749|FG003|NOT COMPLETED|Overall Study||0
9831099|NCT00766376|10941760|FG000|STARTED|Overall Study||151
9831100|NCT00766376|10941760|FG000|COMPLETED|Overall Study||124
9831101|NCT00766376|10941760|FG000|NOT COMPLETED|Overall Study||27
9831102|NCT00766415|10941766|FG000|STARTED|Overall Study||25
9831103|NCT00766415|10941767|FG001|STARTED|Overall Study||27
9831104|NCT00766415|10941766|FG000|COMPLETED|Overall Study||25
9831105|NCT00766415|10941767|FG001|COMPLETED|Overall Study||26
9831106|NCT00766415|10941766|FG000|NOT COMPLETED|Overall Study||0
9831107|NCT00766415|10941767|FG001|NOT COMPLETED|Overall Study||1
9831108|NCT00766467|10941775|FG000|STARTED|Overall Study||42
9831109|NCT00766467|10941776|FG001|STARTED|Overall Study||39
9831110|NCT00766467|10941775|FG000|Initiated Treatment|Overall Study||39
9831111|NCT00766467|10941776|FG001|Initiated Treatment|Overall Study||38
9831112|NCT00766467|10941775|FG000|COMPLETED|Overall Study||31
9831113|NCT00766467|10941776|FG001|COMPLETED|Overall Study||31
9831114|NCT00766467|10941775|FG000|NOT COMPLETED|Overall Study||11
9831115|NCT00766467|10941776|FG001|NOT COMPLETED|Overall Study||8
9831116|NCT00766493|10941782|FG000|STARTED|Pre-Discharge||250
9831117|NCT00766493|10941782|FG000|COMPLETED|Pre-Discharge||250
9831118|NCT00766493|10941782|FG000|NOT COMPLETED|Pre-Discharge||0
9831119|NCT00766493|10941782|FG000|STARTED|30 Days Post-Procedure||250
9831120|NCT00766493|10941782|FG000|COMPLETED|30 Days Post-Procedure||238
9831121|NCT00766493|10941782|FG000|NOT COMPLETED|30 Days Post-Procedure||12
9831122|NCT00766506|10941788|FG000|STARTED|Overall Study||58
9831123|NCT00766506|10941789|FG001|STARTED|Overall Study||50
9831124|NCT00766506|10941788|FG000|COMPLETED|Overall Study||53
9831125|NCT00766506|10941789|FG001|COMPLETED|Overall Study||48
9831126|NCT00766506|10941788|FG000|NOT COMPLETED|Overall Study||5
9831127|NCT00766506|10941789|FG001|NOT COMPLETED|Overall Study||2
9797223|NCT04545008|10904739|FG000|STARTED|Overall Study||2
9797224|NCT04545008|10904739|FG000|COMPLETED|Overall Study||2
9797225|NCT04545008|10904739|FG000|NOT COMPLETED|Overall Study||0
9797226|NCT04411680|10904745|FG000|STARTED|Treatment Period||78
9797227|NCT04411680|10904746|FG001|STARTED|Treatment Period||44
9797228|NCT04411680|10904745|FG000|COMPLETED|Treatment Period||49
9797229|NCT04411680|10904746|FG001|COMPLETED|Treatment Period||36
9797230|NCT04411680|10904745|FG000|NOT COMPLETED|Treatment Period||29
9797231|NCT04411680|10904746|FG001|NOT COMPLETED|Treatment Period||8
9797232|NCT04411680|10904745|FG000|STARTED|Follow up Period||78
9797233|NCT04411680|10904746|FG001|STARTED|Follow up Period||44
9797234|NCT04411680|10904745|FG000|COMPLETED|Follow up Period||60
9797235|NCT04411680|10904746|FG001|COMPLETED|Follow up Period||30
9797236|NCT04411680|10904745|FG000|NOT COMPLETED|Follow up Period||18
9797237|NCT04411680|10904746|FG001|NOT COMPLETED|Follow up Period||14
9797238|NCT04364984|10904755|FG000|STARTED|Overall Study||37
9797239|NCT04364984|10904756|FG001|STARTED|Overall Study||44
9797240|NCT04364984|10904757|FG002|STARTED|Overall Study||31
9797241|NCT04364984|10904755|FG000|COMPLETED|Overall Study||35
9797242|NCT04364984|10904756|FG001|COMPLETED|Overall Study||42
9797243|NCT04364984|10904757|FG002|COMPLETED|Overall Study||31
9797244|NCT04364984|10904755|FG000|NOT COMPLETED|Overall Study||2
9797245|NCT04364984|10904756|FG001|NOT COMPLETED|Overall Study||2
9797246|NCT04364984|10904757|FG002|NOT COMPLETED|Overall Study||0
9797247|NCT04363437|10904767|FG000|STARTED|Overall Study||10
9797248|NCT04363437|10904768|FG001|STARTED|Overall Study||11
9797249|NCT04363437|10904767|FG000|COMPLETED|Overall Study||10
9797250|NCT04363437|10904768|FG001|COMPLETED|Overall Study||11
9797251|NCT04363437|10904767|FG000|NOT COMPLETED|Overall Study||0
9797252|NCT04363437|10904768|FG001|NOT COMPLETED|Overall Study||0
9797253|NCT04346537|10904774|FG000|STARTED|Overall Study||109
9797254|NCT04346537|10904774|FG000|Implanted With INGEVITY+ Lead|Overall Study||101
9797255|NCT04346537|10904774|FG000|COMPLETED|Overall Study||99
9797256|NCT04346537|10904774|FG000|NOT COMPLETED|Overall Study||10
9797257|NCT04033991|10904778|FG000|STARTED|Overall Study||684
9797258|NCT04033991|10904778|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622
9797259|NCT04033991|10904778|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121
9797260|NCT04033991|10904778|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59
9797261|NCT04033991|10904778|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62
9797262|NCT04033991|10904778|FG000|COMPLETED|Overall Study||684
9797263|NCT04033991|10904778|FG000|NOT COMPLETED|Overall Study||0
9797264|NCT03930849|10904787|FG000|STARTED|Overall Study||17
9797265|NCT03930849|10904788|FG001|STARTED|Overall Study||18
9797266|NCT03930849|10904789|FG002|STARTED|Overall Study||18
9797267|NCT03930849|10904787|FG000|COMPLETED|Overall Study||13
9797268|NCT03930849|10904788|FG001|COMPLETED|Overall Study||18
9797269|NCT03930849|10904789|FG002|COMPLETED|Overall Study||14
9797270|NCT03930849|10904787|FG000|NOT COMPLETED|Overall Study||4
9797271|NCT03930849|10904788|FG001|NOT COMPLETED|Overall Study||0
9797272|NCT03930849|10904789|FG002|NOT COMPLETED|Overall Study||4
9797273|NCT03793439|10904797|FG000|STARTED|Overall Study||5
9797274|NCT03793439|10904797|FG000|COMPLETED|Overall Study||3
9797275|NCT03793439|10904797|FG000|NOT COMPLETED|Overall Study||2
9797276|NCT03711266|10904801|FG000|STARTED|Overall Study||30
9797277|NCT03711266|10904801|FG000|COMPLETED|Overall Study||20
9797278|NCT03711266|10904801|FG000|NOT COMPLETED|Overall Study||10
9797279|NCT03630393|10904807|FG000|STARTED|Overall Study||68
9797280|NCT03630393|10904808|FG001|STARTED|Overall Study||71
9797281|NCT03630393|10904807|FG000|COMPLETED|Overall Study||67
9797282|NCT03630393|10904808|FG001|COMPLETED|Overall Study||71
9797283|NCT03630393|10904807|FG000|NOT COMPLETED|Overall Study||1
9797284|NCT03630393|10904808|FG001|NOT COMPLETED|Overall Study||0
9797285|NCT03531788|10904816|FG000|STARTED|Overall Study||12
9797286|NCT03531788|10904817|FG001|STARTED|Overall Study||6
9797287|NCT03531788|10904816|FG000|COMPLETED|Overall Study||11
9797288|NCT03531788|10904817|FG001|COMPLETED|Overall Study||6
9797289|NCT03531788|10904816|FG000|NOT COMPLETED|Overall Study||1
9797290|NCT03531788|10904817|FG001|NOT COMPLETED|Overall Study||0
9797291|NCT03359811|10904825|FG000|STARTED|Overall Study||35
9797292|NCT03359811|10904826|FG001|STARTED|Overall Study||35
9797293|NCT03359811|10904825|FG000|COMPLETED|Overall Study||33
9797294|NCT03359811|10904826|FG001|COMPLETED|Overall Study||35
9797295|NCT03359811|10904825|FG000|NOT COMPLETED|Overall Study||2
9797296|NCT03359811|10904826|FG001|NOT COMPLETED|Overall Study||0
9797297|NCT03241589|10904835|FG000|STARTED|Overall Study||109
9797298|NCT03241589|10904836|FG001|STARTED|Overall Study||357
9797299|NCT03241589|10904835|FG000|COMPLETED|Overall Study||109
9797300|NCT03241589|10904836|FG001|COMPLETED|Overall Study||357
9797301|NCT03241589|10904835|FG000|NOT COMPLETED|Overall Study||0
9797302|NCT03241589|10904836|FG001|NOT COMPLETED|Overall Study||0
9797303|NCT02959775|10904847|FG000|STARTED|Overall Study||160
9797304|NCT02959775|10904848|FG001|STARTED|Overall Study||160
9797305|NCT02959775|10904849|FG002|STARTED|Overall Study||160
9797306|NCT02959775|10904847|FG000|COMPLETED|Overall Study||133
9797307|NCT02959775|10904848|FG001|COMPLETED|Overall Study||133
9797308|NCT02959775|10904849|FG002|COMPLETED|Overall Study||124
9797309|NCT02959775|10904847|FG000|NOT COMPLETED|Overall Study||27
9797310|NCT02959775|10904848|FG001|NOT COMPLETED|Overall Study||27
9797311|NCT02959775|10904849|FG002|NOT COMPLETED|Overall Study||36
9797312|NCT02954406|10904868|FG000|STARTED|Overall Study||3
9797313|NCT02954406|10904869|FG001|STARTED|Overall Study||6
9797314|NCT02954406|10904870|FG002|STARTED|Overall Study||6
9797315|NCT02954406|10904871|FG003|STARTED|Overall Study||6
9797316|NCT02954406|10904872|FG004|STARTED|Overall Study||7
9797317|NCT02954406|10904873|FG005|STARTED|Overall Study||3
9797318|NCT02954406|10904874|FG006|STARTED|Overall Study||3
9797319|NCT02954406|10904875|FG007|STARTED|Overall Study||2
9797320|NCT02954406|10904876|FG008|STARTED|Overall Study||4
9797321|NCT02954406|10904877|FG009|STARTED|Overall Study||3
9797322|NCT02954406|10904878|FG010|STARTED|Overall Study||0
9797323|NCT02954406|10904868|FG000|COMPLETED|Overall Study||0
9797324|NCT02954406|10904869|FG001|COMPLETED|Overall Study||0
9797325|NCT02954406|10904870|FG002|COMPLETED|Overall Study||0
9797326|NCT02954406|10904871|FG003|COMPLETED|Overall Study||0
9797327|NCT02954406|10904872|FG004|COMPLETED|Overall Study||0
9797328|NCT02954406|10904873|FG005|COMPLETED|Overall Study||0
9797329|NCT02954406|10904874|FG006|COMPLETED|Overall Study||0
9797330|NCT02954406|10904875|FG007|COMPLETED|Overall Study||0
9797331|NCT02954406|10904876|FG008|COMPLETED|Overall Study||0
9797332|NCT02954406|10904877|FG009|COMPLETED|Overall Study||0
9797333|NCT02954406|10904878|FG010|COMPLETED|Overall Study||0
9797334|NCT02954406|10904868|FG000|NOT COMPLETED|Overall Study||3
9797335|NCT02954406|10904869|FG001|NOT COMPLETED|Overall Study||6
9797336|NCT02954406|10904870|FG002|NOT COMPLETED|Overall Study||6
9797337|NCT02954406|10904871|FG003|NOT COMPLETED|Overall Study||6
9797338|NCT02954406|10904872|FG004|NOT COMPLETED|Overall Study||7
9797339|NCT02954406|10904873|FG005|NOT COMPLETED|Overall Study||3
9797340|NCT02954406|10904874|FG006|NOT COMPLETED|Overall Study||3
9797341|NCT02954406|10904875|FG007|NOT COMPLETED|Overall Study||2
9797342|NCT02954406|10904876|FG008|NOT COMPLETED|Overall Study||4
9797343|NCT02954406|10904877|FG009|NOT COMPLETED|Overall Study||3
9797344|NCT02954406|10904878|FG010|NOT COMPLETED|Overall Study||0
9797345|NCT02927145|10904913|FG000|STARTED|Initial Recruitment||12
9797346|NCT02927145|10904914|FG001|STARTED|Initial Recruitment||12
9797347|NCT02927145|10904915|FG002|STARTED|Initial Recruitment||12
9797348|NCT02927145|10904916|FG003|STARTED|Initial Recruitment||14
9797349|NCT02927145|10904917|FG004|STARTED|Initial Recruitment||17
9797350|NCT02927145|10904918|FG005|STARTED|Initial Recruitment||15
9797351|NCT02927145|10904919|FG006|STARTED|Initial Recruitment||0
9797352|NCT02927145|10904920|FG007|STARTED|Initial Recruitment||0
9797353|NCT02927145|10904921|FG008|STARTED|Initial Recruitment||6
9797354|NCT02927145|10904913|FG000|COMPLETED|Initial Recruitment||12
9797355|NCT02927145|10904914|FG001|COMPLETED|Initial Recruitment||11
9797356|NCT02927145|10904915|FG002|COMPLETED|Initial Recruitment||11
9797357|NCT02927145|10904916|FG003|COMPLETED|Initial Recruitment||10
9797358|NCT02927145|10904917|FG004|COMPLETED|Initial Recruitment||14
9797359|NCT02927145|10904918|FG005|COMPLETED|Initial Recruitment||14
9797360|NCT02927145|10904919|FG006|COMPLETED|Initial Recruitment||0
9797361|NCT02927145|10904920|FG007|COMPLETED|Initial Recruitment||0
9797362|NCT02927145|10904921|FG008|COMPLETED|Initial Recruitment||4
9797363|NCT02927145|10904913|FG000|NOT COMPLETED|Initial Recruitment||0
9797364|NCT02927145|10904914|FG001|NOT COMPLETED|Initial Recruitment||1
9797365|NCT02927145|10904915|FG002|NOT COMPLETED|Initial Recruitment||1
9797366|NCT02927145|10904916|FG003|NOT COMPLETED|Initial Recruitment||4
9797367|NCT02927145|10904917|FG004|NOT COMPLETED|Initial Recruitment||3
9797368|NCT02927145|10904918|FG005|NOT COMPLETED|Initial Recruitment||1
9797369|NCT02927145|10904919|FG006|NOT COMPLETED|Initial Recruitment||0
9797370|NCT02927145|10904920|FG007|NOT COMPLETED|Initial Recruitment||0
9797371|NCT02927145|10904921|FG008|NOT COMPLETED|Initial Recruitment||2
9797372|NCT02927145|10904913|FG000|STARTED|Invitation for Additional Challenge||0
9797373|NCT02927145|10904914|FG001|STARTED|Invitation for Additional Challenge||0
9797374|NCT02927145|10904915|FG002|STARTED|Invitation for Additional Challenge||0
9797375|NCT02927145|10904916|FG003|STARTED|Invitation for Additional Challenge||0
9797376|NCT02927145|10904917|FG004|STARTED|Invitation for Additional Challenge||0
9797377|NCT02927145|10904918|FG005|STARTED|Invitation for Additional Challenge||0
9797378|NCT02927145|10904919|FG006|STARTED|Invitation for Additional Challenge||9
9797379|NCT02927145|10904920|FG007|STARTED|Invitation for Additional Challenge||8
9797380|NCT02927145|10904921|FG008|STARTED|Invitation for Additional Challenge||0
9797381|NCT02927145|10904913|FG000|COMPLETED|Invitation for Additional Challenge||0
9797382|NCT02927145|10904914|FG001|COMPLETED|Invitation for Additional Challenge||0
9797383|NCT02927145|10904915|FG002|COMPLETED|Invitation for Additional Challenge||0
9797384|NCT02927145|10904916|FG003|COMPLETED|Invitation for Additional Challenge||0
9797385|NCT02927145|10904917|FG004|COMPLETED|Invitation for Additional Challenge||0
9797386|NCT02927145|10904918|FG005|COMPLETED|Invitation for Additional Challenge||0
9797387|NCT02927145|10904919|FG006|COMPLETED|Invitation for Additional Challenge||8
9797388|NCT02927145|10904920|FG007|COMPLETED|Invitation for Additional Challenge||8
9797389|NCT02927145|10904921|FG008|COMPLETED|Invitation for Additional Challenge||0
9797390|NCT02927145|10904913|FG000|NOT COMPLETED|Invitation for Additional Challenge||0
9797391|NCT02927145|10904914|FG001|NOT COMPLETED|Invitation for Additional Challenge||0
9797392|NCT02927145|10904915|FG002|NOT COMPLETED|Invitation for Additional Challenge||0
9797393|NCT02927145|10904916|FG003|NOT COMPLETED|Invitation for Additional Challenge||0
9797394|NCT02927145|10904917|FG004|NOT COMPLETED|Invitation for Additional Challenge||0
9797395|NCT02927145|10904918|FG005|NOT COMPLETED|Invitation for Additional Challenge||0
9797396|NCT02927145|10904919|FG006|NOT COMPLETED|Invitation for Additional Challenge||1
9797397|NCT02927145|10904920|FG007|NOT COMPLETED|Invitation for Additional Challenge||0
9797398|NCT02927145|10904921|FG008|NOT COMPLETED|Invitation for Additional Challenge||0
9797399|NCT02910583|10904944|FG000|STARTED|Overall Study||159
9797400|NCT02910583|10904945|FG001|STARTED|Overall Study||164
9797401|NCT02910583|10904944|FG000|MRD Cohort/ Not Randomized|Overall Study|Not applicable to this cohort.|0
9797402|NCT02910583|10904945|FG001|MRD Cohort/ Not Randomized|Overall Study||15
9797403|NCT02910583|10904944|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study|Not applicable to this cohort.|0
9797404|NCT02910583|10904945|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43
9797405|NCT02910583|10904944|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study|Not applicable to this cohort.|0
9797406|NCT02910583|10904945|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43
9797407|NCT02910583|10904944|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study|Not applicable to this cohort.|0
9797408|NCT02910583|10904945|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31
9797409|NCT02910583|10904944|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study|Not applicable to this cohort.|0
9797410|NCT02910583|10904945|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32
9797411|NCT02910583|10904944|FG000|COMPLETED|Overall Study||152
9797412|NCT02910583|10904945|FG001|COMPLETED|Overall Study||157
9797413|NCT02910583|10904944|FG000|NOT COMPLETED|Overall Study||7
9797414|NCT02910583|10904945|FG001|NOT COMPLETED|Overall Study||7
9797415|NCT02699060|10904982|FG000|STARTED|Overall Study||68
9797416|NCT02699060|10904982|FG000|COMPLETED|Overall Study||68
9797417|NCT02699060|10904982|FG000|NOT COMPLETED|Overall Study||0
9797418|NCT02598388|10905002|FG000|STARTED|Overall Study||40
9797419|NCT02598388|10905003|FG001|STARTED|Overall Study||10
9797420|NCT02598388|10905004|FG002|STARTED|Overall Study||20
9797421|NCT02598388|10905005|FG003|STARTED|Overall Study||5
9797422|NCT02598388|10905006|FG004|STARTED|Overall Study||161
9797423|NCT02598388|10905007|FG005|STARTED|Overall Study||39
9797424|NCT02598388|10905008|FG006|STARTED|Overall Study||161
9797425|NCT02598388|10905009|FG007|STARTED|Overall Study||39
9797426|NCT02598388|10905010|FG008|STARTED|Overall Study||39
9797427|NCT02598388|10905011|FG009|STARTED|Overall Study||10
9797428|NCT02598388|10905012|FG010|STARTED|Overall Study||40
9797429|NCT02598388|10905013|FG011|STARTED|Overall Study||10
9797430|NCT02598388|10905002|FG000|COMPLETED|Overall Study||39
9797431|NCT02598388|10905003|FG001|COMPLETED|Overall Study||10
9797432|NCT02598388|10905004|FG002|COMPLETED|Overall Study||18
9797433|NCT02598388|10905005|FG003|COMPLETED|Overall Study||5
9797434|NCT02598388|10905006|FG004|COMPLETED|Overall Study||151
9797435|NCT02598388|10905007|FG005|COMPLETED|Overall Study||38
9797436|NCT02598388|10905008|FG006|COMPLETED|Overall Study||156
9797437|NCT02598388|10905009|FG007|COMPLETED|Overall Study||38
9797438|NCT02598388|10905010|FG008|COMPLETED|Overall Study||39
9797439|NCT02598388|10905011|FG009|COMPLETED|Overall Study||9
9797440|NCT02598388|10905012|FG010|COMPLETED|Overall Study||39
9797441|NCT02598388|10905013|FG011|COMPLETED|Overall Study||10
9797442|NCT02598388|10905002|FG000|NOT COMPLETED|Overall Study||1
9797443|NCT02598388|10905003|FG001|NOT COMPLETED|Overall Study||0
9797444|NCT02598388|10905004|FG002|NOT COMPLETED|Overall Study||2
9797445|NCT02598388|10905005|FG003|NOT COMPLETED|Overall Study||0
9797446|NCT02598388|10905006|FG004|NOT COMPLETED|Overall Study||10
9797447|NCT02598388|10905007|FG005|NOT COMPLETED|Overall Study||1
9797448|NCT02598388|10905008|FG006|NOT COMPLETED|Overall Study||5
9797449|NCT02598388|10905009|FG007|NOT COMPLETED|Overall Study||1
9797450|NCT02598388|10905010|FG008|NOT COMPLETED|Overall Study||0
9797451|NCT02598388|10905011|FG009|NOT COMPLETED|Overall Study||1
9797452|NCT02598388|10905012|FG010|NOT COMPLETED|Overall Study||1
9797453|NCT02598388|10905013|FG011|NOT COMPLETED|Overall Study||0
9797454|NCT02493751|10905046|FG000|STARTED|Overall Study||16
9797455|NCT02493751|10905047|FG001|STARTED|Overall Study||39
9797456|NCT02493751|10905046|FG000|COMPLETED|Overall Study||0
9797457|NCT02493751|10905047|FG001|COMPLETED|Overall Study||0
9797458|NCT02493751|10905046|FG000|NOT COMPLETED|Overall Study||16
9797459|NCT02493751|10905047|FG001|NOT COMPLETED|Overall Study||39
9797460|NCT02285166|10905054|FG000|STARTED|Overall Study||15330
9797461|NCT02285166|10905054|FG000|COMPLETED|Overall Study||14364
9797462|NCT02285166|10905054|FG000|NOT COMPLETED|Overall Study||966
9797463|NCT02075593|10905060|FG000|STARTED|Overall Study||4
9952531|NCT01422876|11071530|FG009|STARTED|Week 24||135
9952532|NCT01422876|11071521|FG000|COMPLETED|Week 24||131
9952533|NCT01422876|11071522|FG001|COMPLETED|Week 24||133
9952534|NCT01422876|11071523|FG002|COMPLETED|Week 24||136
9952535|NCT01422876|11071524|FG003|COMPLETED|Week 24||132
9952536|NCT01422876|11071525|FG004|COMPLETED|Week 24||125
9952537|NCT01422876|11071526|FG005|COMPLETED|Week 24||131
9952538|NCT01422876|11071527|FG006|COMPLETED|Week 24||130
9797464|NCT02075593|10905060|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4
9797465|NCT02075593|10905060|FG000|COMPLETED|Overall Study||1
9797466|NCT02075593|10905060|FG000|NOT COMPLETED|Overall Study||3
9797467|NCT00587860|10905068|FG000|STARTED|Overall Study||35
9797468|NCT00587860|10905069|FG001|STARTED|Overall Study||35
9797469|NCT00587860|10905068|FG000|COMPLETED|Overall Study||30
9797470|NCT00587860|10905069|FG001|COMPLETED|Overall Study||30
9797471|NCT00587860|10905068|FG000|NOT COMPLETED|Overall Study||5
9797472|NCT00587860|10905069|FG001|NOT COMPLETED|Overall Study||5
9831128|NCT00766532|10941795|FG000|STARTED|Overall Study||12
9831129|NCT00766532|10941795|FG000|COMPLETED|Overall Study||10
9952539|NCT01422876|11071528|FG007|COMPLETED|Week 24||128
9797473|NCT00587964|10905075|FG000|STARTED|Overall Study||51
9797474|NCT00587964|10905075|FG000|COMPLETED|Overall Study||39
9797475|NCT00587964|10905075|FG000|NOT COMPLETED|Overall Study||12
9797476|NCT00587990|10905082|FG000|STARTED|Overall Study||2
9797477|NCT00587990|10905083|FG001|STARTED|Overall Study||4
9797478|NCT00587990|10905084|FG002|STARTED|Overall Study||3
9797479|NCT00587990|10905082|FG000|COMPLETED|Overall Study||2
9797480|NCT00587990|10905083|FG001|COMPLETED|Overall Study||4
9797481|NCT00587990|10905084|FG002|COMPLETED|Overall Study||2
9797482|NCT00587990|10905082|FG000|NOT COMPLETED|Overall Study||0
9797483|NCT00587990|10905083|FG001|NOT COMPLETED|Overall Study||0
9797484|NCT00587990|10905084|FG002|NOT COMPLETED|Overall Study||1
9797485|NCT00588094|10905092|FG000|STARTED|Overall Study||20
9797486|NCT00588094|10905092|FG000|COMPLETED|Overall Study||15
9797487|NCT00588094|10905092|FG000|NOT COMPLETED|Overall Study||5
9797488|NCT00588159|10905098|FG000|STARTED|Overall Study||72
9797489|NCT00588159|10905099|FG001|STARTED|Overall Study||74
9797490|NCT00588159|10905098|FG000|COMPLETED|Overall Study||57
9797491|NCT00588159|10905099|FG001|COMPLETED|Overall Study||63
9797492|NCT00588159|10905098|FG000|NOT COMPLETED|Overall Study||15
9797493|NCT00588159|10905099|FG001|NOT COMPLETED|Overall Study||11
9797494|NCT00588237|10905105|FG000|STARTED|Overall Study||42
9797495|NCT00588237|10905105|FG000|COMPLETED|Overall Study||38
9797496|NCT00588237|10905105|FG000|NOT COMPLETED|Overall Study||4
9797497|NCT00588341|10905109|FG000|STARTED|Overall Study||24
9797498|NCT00588341|10905109|FG000|COMPLETED|Overall Study||19
9797499|NCT00588341|10905109|FG000|NOT COMPLETED|Overall Study||5
9797500|NCT00588354|10905115|FG000|STARTED|Baseline to 2 Weeks||11
9797501|NCT00588354|10905116|FG001|STARTED|Baseline to 2 Weeks||15
9797502|NCT00588354|10905115|FG000|COMPLETED|Baseline to 2 Weeks||9
9797503|NCT00588354|10905116|FG001|COMPLETED|Baseline to 2 Weeks||15
9797504|NCT00588354|10905115|FG000|NOT COMPLETED|Baseline to 2 Weeks||2
9797505|NCT00588354|10905116|FG001|NOT COMPLETED|Baseline to 2 Weeks||0
9797506|NCT00588354|10905115|FG000|STARTED|Baseline to 4 Weeks||9
9797507|NCT00588354|10905116|FG001|STARTED|Baseline to 4 Weeks||15
9797508|NCT00588354|10905115|FG000|COMPLETED|Baseline to 4 Weeks||9
9797509|NCT00588354|10905116|FG001|COMPLETED|Baseline to 4 Weeks||14
9797510|NCT00588354|10905115|FG000|NOT COMPLETED|Baseline to 4 Weeks||0
9797511|NCT00588354|10905116|FG001|NOT COMPLETED|Baseline to 4 Weeks||1
9797512|NCT00588380|10905123|FG000|STARTED|Overall Study||88
9797513|NCT00588380|10905123|FG000|COMPLETED|Overall Study||88
9797514|NCT00588380|10905123|FG000|NOT COMPLETED|Overall Study||0
9797515|NCT00588406|10905130|FG000|STARTED|Overall Study||46
9797516|NCT00588406|10905131|FG001|STARTED|Overall Study||49
9797517|NCT00588406|10905130|FG000|COMPLETED|Overall Study||46
9797518|NCT00588406|10905131|FG001|COMPLETED|Overall Study||49
9797519|NCT00588406|10905130|FG000|NOT COMPLETED|Overall Study||0
9797520|NCT00588406|10905131|FG001|NOT COMPLETED|Overall Study||0
9797521|NCT00588445|10905137|FG000|STARTED|Overall Study||65
9797522|NCT00588445|10905137|FG000|COMPLETED|Overall Study||50
9797523|NCT00588445|10905137|FG000|NOT COMPLETED|Overall Study||15
9797524|NCT00588536|10905143|FG000|STARTED|Overall Study||5
9797525|NCT00588536|10905143|FG000|COMPLETED|Overall Study||5
9797526|NCT00588536|10905143|FG000|NOT COMPLETED|Overall Study||0
9797527|NCT00588640|10905147|FG000|STARTED|Overall Study||10
9797528|NCT00588640|10905147|FG000|COMPLETED|Overall Study||8
10235269|NCT01217047|11365534|FG001|COMPLETED|Overall Study||3
9797529|NCT00588640|10905147|FG000|NOT COMPLETED|Overall Study||2
9797530|NCT00588666|10905151|FG000|STARTED|Overall Study||51
9797531|NCT00588666|10905151|FG000|COMPLETED|Overall Study||47
9797532|NCT00588666|10905151|FG000|NOT COMPLETED|Overall Study||4
9797533|NCT00588692|10905157|FG000|STARTED|Overall Study||30
9797534|NCT00588692|10905158|FG001|STARTED|Overall Study||30
9797535|NCT00588692|10905157|FG000|COMPLETED|Overall Study||23
9797536|NCT00588692|10905158|FG001|COMPLETED|Overall Study||27
9797537|NCT00588692|10905157|FG000|NOT COMPLETED|Overall Study||7
9797538|NCT00588692|10905158|FG001|NOT COMPLETED|Overall Study||3
10112193|NCT02502097|11243302|FG003|STARTED|Wash Out Period||22
10112194|NCT02502097|11243299|FG000|COMPLETED|Wash Out Period||4
10112195|NCT02502097|11243300|FG001|COMPLETED|Wash Out Period||2
10112196|NCT02502097|11243301|FG002|COMPLETED|Wash Out Period||20
10112197|NCT02502097|11243302|FG003|COMPLETED|Wash Out Period||21
10112198|NCT02502097|11243299|FG000|NOT COMPLETED|Wash Out Period||0
10112199|NCT02502097|11243300|FG001|NOT COMPLETED|Wash Out Period||1
10112200|NCT02502097|11243301|FG002|NOT COMPLETED|Wash Out Period||1
10112201|NCT02502097|11243302|FG003|NOT COMPLETED|Wash Out Period||1
10112202|NCT02502097|11243299|FG000|STARTED|Period 2||4
10112203|NCT02502097|11243300|FG001|STARTED|Period 2||2
9797539|NCT00588731|10905168|FG000|STARTED|Overall Study||21
9797540|NCT00588731|10905169|FG001|STARTED|Overall Study||20
9797541|NCT00588731|10905168|FG000|COMPLETED|Overall Study||18
9797542|NCT00588731|10905169|FG001|COMPLETED|Overall Study||18
9797543|NCT00588731|10905168|FG000|NOT COMPLETED|Overall Study||3
9797544|NCT00588731|10905169|FG001|NOT COMPLETED|Overall Study||2
9797545|NCT00588809|10905175|FG000|STARTED|Overall Study||47
9797546|NCT00588809|10905175|FG000|COMPLETED|Overall Study||47
9797547|NCT00588809|10905175|FG000|NOT COMPLETED|Overall Study||0
9797548|NCT00588822|10905179|FG000|STARTED|Overall Study||21
9797549|NCT00588822|10905179|FG000|COMPLETED|Overall Study||13
9797550|NCT00588822|10905179|FG000|NOT COMPLETED|Overall Study||8
9797551|NCT00588848|10905185|FG000|STARTED|Overall Study||3
9797552|NCT00588848|10905186|FG001|STARTED|Overall Study||8
9797553|NCT00588848|10905185|FG000|COMPLETED|Overall Study||3
9797554|NCT00588848|10905186|FG001|COMPLETED|Overall Study||5
9797555|NCT00588848|10905185|FG000|NOT COMPLETED|Overall Study||0
9797556|NCT00588848|10905186|FG001|NOT COMPLETED|Overall Study||3
9797557|NCT00588900|10905194|FG000|STARTED|Overall Study||5
9797558|NCT00588900|10905194|FG000|COMPLETED|Overall Study||5
9797559|NCT00588900|10905194|FG000|NOT COMPLETED|Overall Study||0
9797560|NCT00588952|10905200|FG000|STARTED|Overall Study||29
9797561|NCT00588952|10905201|FG001|STARTED|Overall Study||70
9797562|NCT00588952|10905200|FG000|COMPLETED|Overall Study||26
9797563|NCT00588952|10905201|FG001|COMPLETED|Overall Study||63
9797564|NCT00588952|10905200|FG000|NOT COMPLETED|Overall Study||3
9797565|NCT00588952|10905201|FG001|NOT COMPLETED|Overall Study||7
9797566|NCT00588965|10905207|FG000|STARTED|Overall Study||35
9797567|NCT00588965|10905207|FG000|COMPLETED|Overall Study||35
9797568|NCT00588965|10905207|FG000|NOT COMPLETED|Overall Study||0
9797569|NCT00589056|10905213|FG000|STARTED|Overall Study||55
9797570|NCT00589056|10905213|FG000|COMPLETED|Overall Study||52
9797571|NCT00589056|10905213|FG000|NOT COMPLETED|Overall Study||3
9797572|NCT00589108|10905220|FG000|STARTED|Overall Study||80
9797573|NCT00589108|10905221|FG001|STARTED|Overall Study||80
9797574|NCT00589108|10905222|FG002|STARTED|Overall Study||80
9797575|NCT00589108|10905220|FG000|COMPLETED|Overall Study||76
9797576|NCT00589108|10905221|FG001|COMPLETED|Overall Study||76
9797577|NCT00589108|10905222|FG002|COMPLETED|Overall Study||75
9797578|NCT00589108|10905220|FG000|NOT COMPLETED|Overall Study||4
9797579|NCT00589108|10905221|FG001|NOT COMPLETED|Overall Study||4
9797580|NCT00589108|10905222|FG002|NOT COMPLETED|Overall Study||5
9797581|NCT00589121|10905232|FG000|STARTED|Overall Study||12
9797582|NCT00589121|10905233|FG001|STARTED|Overall Study||86
9797583|NCT00589121|10905232|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
9797584|NCT00589121|10905233|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
9797585|NCT00589121|10905232|FG000|NOT COMPLETED|Overall Study||2
9797586|NCT00589121|10905233|FG001|NOT COMPLETED|Overall Study||7
9797587|NCT00589277|10905244|FG000|STARTED|Overall Study||1222
9797588|NCT00589277|10905245|FG001|STARTED|Overall Study||810
9797589|NCT00589277|10905244|FG000|Completed 2 Week Follow Up|Overall Study||603
9797590|NCT00589277|10905245|FG001|Completed 2 Week Follow Up|Overall Study||424
9797591|NCT00589277|10905244|FG000|Completed 3 Month Follow Up|Overall Study||762
9797592|NCT00589277|10905245|FG001|Completed 3 Month Follow Up|Overall Study||524
9797593|NCT00589277|10905244|FG000|COMPLETED|Overall Study||762
9797594|NCT00589277|10905245|FG001|COMPLETED|Overall Study||524
9797595|NCT00589277|10905244|FG000|NOT COMPLETED|Overall Study||460
9797596|NCT00589277|10905245|FG001|NOT COMPLETED|Overall Study||286
9797597|NCT00589290|10905251|FG000|STARTED|Overall Study||41
9797598|NCT00589290|10905251|FG000|COMPLETED|Overall Study||40
9797599|NCT00589290|10905251|FG000|NOT COMPLETED|Overall Study||1
9797600|NCT00589303|10905259|FG000|STARTED|Overall Study||14
9797601|NCT00589303|10905260|FG001|STARTED|Overall Study||13
9797602|NCT00589303|10905259|FG000|COMPLETED|Overall Study||12
9797603|NCT00589303|10905260|FG001|COMPLETED|Overall Study||12
9797604|NCT00589303|10905259|FG000|NOT COMPLETED|Overall Study||2
9797605|NCT00589303|10905260|FG001|NOT COMPLETED|Overall Study||1
9797606|NCT00589329|10905268|FG000|STARTED|Overall Study||10
9797607|NCT00589329|10905269|FG001|STARTED|Overall Study||10
9797608|NCT00589329|10905268|FG000|COMPLETED|Overall Study||10
9797609|NCT00589329|10905269|FG001|COMPLETED|Overall Study||10
10015742|NCT01807234|11138753|FG004|COMPLETED|Overall Study||8
10015743|NCT01807234|11138754|FG005|COMPLETED|Overall Study||8
10015744|NCT01807234|11138749|FG000|NOT COMPLETED|Overall Study||5
10015745|NCT01807234|11138750|FG001|NOT COMPLETED|Overall Study||6
10015746|NCT01807234|11138751|FG002|NOT COMPLETED|Overall Study||2
9797610|NCT00589329|10905268|FG000|NOT COMPLETED|Overall Study||0
9797611|NCT00589329|10905269|FG001|NOT COMPLETED|Overall Study||0
9797612|NCT00589472|10905276|FG000|STARTED|Overall Study||19
9797613|NCT00589472|10905276|FG000|COMPLETED|Overall Study||18
9797614|NCT00589472|10905276|FG000|NOT COMPLETED|Overall Study||1
9797615|NCT00589563|10905280|FG000|STARTED|Overall Study||32
9797616|NCT00589563|10905280|FG000|COMPLETED|Overall Study||32
9797617|NCT00589563|10905280|FG000|NOT COMPLETED|Overall Study||0
9797618|NCT00589602|10905284|FG000|STARTED|Overall Study||13
9797619|NCT00589602|10905284|FG000|COMPLETED|Overall Study||12
9797620|NCT00589602|10905284|FG000|NOT COMPLETED|Overall Study||1
9797621|NCT00589628|10905292|FG000|STARTED|Overall Study||7
9797622|NCT00589628|10905293|FG001|STARTED|Overall Study||6
9797623|NCT00589628|10905292|FG000|COMPLETED|Overall Study||7
9797624|NCT00589628|10905293|FG001|COMPLETED|Overall Study||5
9797625|NCT00589628|10905292|FG000|NOT COMPLETED|Overall Study||0
9797626|NCT00589628|10905293|FG001|NOT COMPLETED|Overall Study||1
9797627|NCT00589667|10905299|FG000|STARTED|Overall Study||26
9797628|NCT00589667|10905299|FG000|COMPLETED|Overall Study||23
10015747|NCT01807234|11138752|FG003|NOT COMPLETED|Overall Study||2
10015748|NCT01807234|11138753|FG004|NOT COMPLETED|Overall Study||4
9797629|NCT00589667|10905299|FG000|NOT COMPLETED|Overall Study||3
9797630|NCT00589693|10905305|FG000|STARTED|Overall Study||115
9797631|NCT00589693|10905306|FG001|STARTED|Overall Study||112
9797632|NCT00589693|10905305|FG000|COMPLETED|Overall Study||71
9797633|NCT00589693|10905306|FG001|COMPLETED|Overall Study||83
9797634|NCT00589693|10905305|FG000|NOT COMPLETED|Overall Study||44
9797635|NCT00589693|10905306|FG001|NOT COMPLETED|Overall Study||29
10015749|NCT01807234|11138754|FG005|NOT COMPLETED|Overall Study||4
9797636|NCT00589784|10905314|FG000|STARTED|Overall Study||36
9797637|NCT00589784|10905315|FG001|STARTED|Overall Study||14
9797638|NCT00589784|10905314|FG000|COMPLETED|Overall Study||35
9797639|NCT00589784|10905315|FG001|COMPLETED|Overall Study||4
9797640|NCT00589784|10905314|FG000|NOT COMPLETED|Overall Study||1
9797641|NCT00589784|10905315|FG001|NOT COMPLETED|Overall Study||10
9797642|NCT00589797|10905322|FG000|STARTED|Overall Study||264
9797643|NCT00589797|10905323|FG001|STARTED|Overall Study||112
9797644|NCT00589797|10905322|FG000|Baseline|Overall Study||218
9797645|NCT00589797|10905323|FG001|Baseline|Overall Study||106
9797646|NCT00589797|10905322|FG000|24 Months|Overall Study||191
9797647|NCT00589797|10905323|FG001|24 Months|Overall Study||89
9797648|NCT00589797|10905322|FG000|COMPLETED|Overall Study||191
9797649|NCT00589797|10905323|FG001|COMPLETED|Overall Study||89
9797650|NCT00589797|10905322|FG000|NOT COMPLETED|Overall Study||73
9797651|NCT00589797|10905323|FG001|NOT COMPLETED|Overall Study||23
9797652|NCT00589836|10905329|FG000|STARTED|Overall Study||20
9797653|NCT00589836|10905329|FG000|COMPLETED|Overall Study||20
9797654|NCT00589836|10905329|FG000|NOT COMPLETED|Overall Study||0
9797655|NCT00589849|10905333|FG000|STARTED|Overall Study||32
9797656|NCT00589849|10905333|FG000|COMPLETED|Overall Study||32
9797657|NCT00589849|10905333|FG000|NOT COMPLETED|Overall Study||0
9797658|NCT00589888|10905337|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
9797659|NCT00589888|10905338|FG001|STARTED|Normal Saline @ 40cc/Hour||0
9797660|NCT00589888|10905339|FG002|STARTED|Normal Saline @ 40cc/Hour||0
9797661|NCT00589888|10905340|FG003|STARTED|Normal Saline @ 40cc/Hour||0
9797662|NCT00589888|10905341|FG004|STARTED|Normal Saline @ 40cc/Hour||0
9797663|NCT00589888|10905337|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13
9797664|NCT00589888|10905338|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0
9797665|NCT00589888|10905339|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0
9797666|NCT00589888|10905340|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0
9797667|NCT00589888|10905341|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0
9797668|NCT00589888|10905337|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
9797669|NCT00589888|10905338|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
9797670|NCT00589888|10905339|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
9797671|NCT00589888|10905340|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
9797672|NCT00589888|10905341|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
9797673|NCT00589888|10905337|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
9797674|NCT00589888|10905338|FG001|STARTED|Intralipid 20% @ 20cc/hr||13
9797675|NCT00589888|10905339|FG002|STARTED|Intralipid 20% @ 20cc/hr||0
9797676|NCT00589888|10905340|FG003|STARTED|Intralipid 20% @ 20cc/hr||0
9797677|NCT00589888|10905341|FG004|STARTED|Intralipid 20% @ 20cc/hr||0
9797678|NCT00589888|10905337|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0
9797679|NCT00589888|10905338|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13
9797680|NCT00589888|10905339|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0
9797681|NCT00589888|10905340|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0
9797682|NCT00589888|10905341|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0
9797683|NCT00589888|10905337|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
9797684|NCT00589888|10905338|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
9797685|NCT00589888|10905339|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
9797686|NCT00589888|10905340|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
9797687|NCT00589888|10905341|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
9797688|NCT00589888|10905337|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0
9797689|NCT00589888|10905338|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
10235270|NCT01217047|11365535|FG002|COMPLETED|Overall Study||3
9797690|NCT00589888|10905339|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
9797691|NCT00589888|10905340|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0
9797692|NCT00589888|10905341|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0
9797693|NCT00589888|10905337|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797694|NCT00589888|10905338|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797695|NCT00589888|10905339|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13
9797696|NCT00589888|10905340|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797697|NCT00589888|10905341|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797698|NCT00589888|10905337|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797699|NCT00589888|10905338|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797700|NCT00589888|10905339|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797701|NCT00589888|10905340|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797702|NCT00589888|10905341|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9797703|NCT00589888|10905337|FG000|STARTED|32-gram Oral Fat Load||0
9797704|NCT00589888|10905338|FG001|STARTED|32-gram Oral Fat Load||0
9797705|NCT00589888|10905339|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
9797706|NCT00589888|10905340|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
9797707|NCT00589888|10905341|FG004|STARTED|32-gram Oral Fat Load||0
10235271|NCT01217047|11365533|FG000|NOT COMPLETED|Overall Study||0
10235272|NCT01217047|11365534|FG001|NOT COMPLETED|Overall Study||1
9797708|NCT00589888|10905337|FG000|COMPLETED|32-gram Oral Fat Load||0
9797709|NCT00589888|10905338|FG001|COMPLETED|32-gram Oral Fat Load||0
9797710|NCT00589888|10905339|FG002|COMPLETED|32-gram Oral Fat Load||0
9797711|NCT00589888|10905340|FG003|COMPLETED|32-gram Oral Fat Load||13
9797712|NCT00589888|10905341|FG004|COMPLETED|32-gram Oral Fat Load||0
9797713|NCT00589888|10905337|FG000|NOT COMPLETED|32-gram Oral Fat Load||0
10235273|NCT01217047|11365535|FG002|NOT COMPLETED|Overall Study||0
9952540|NCT01422876|11071529|FG008|COMPLETED|Week 24||128
9952541|NCT01422876|11071530|FG009|COMPLETED|Week 24||125
9952542|NCT01422876|11071521|FG000|NOT COMPLETED|Week 24||6
9952543|NCT01422876|11071522|FG001|NOT COMPLETED|Week 24||3
9952544|NCT01422876|11071523|FG002|NOT COMPLETED|Week 24||5
9952545|NCT01422876|11071524|FG003|NOT COMPLETED|Week 24||8
9797714|NCT00589888|10905338|FG001|NOT COMPLETED|32-gram Oral Fat Load||0
9797715|NCT00589888|10905339|FG002|NOT COMPLETED|32-gram Oral Fat Load||0
9797716|NCT00589888|10905340|FG003|NOT COMPLETED|32-gram Oral Fat Load||0
9797717|NCT00589888|10905341|FG004|NOT COMPLETED|32-gram Oral Fat Load||0
9797718|NCT00589888|10905337|FG000|STARTED|64-gram Oral Fat Load||0
9797719|NCT00589888|10905338|FG001|STARTED|64-gram Oral Fat Load||0
9797720|NCT00589888|10905339|FG002|STARTED|64-gram Oral Fat Load||0
9797721|NCT00589888|10905340|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
9797722|NCT00589888|10905341|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
9797723|NCT00589888|10905337|FG000|COMPLETED|64-gram Oral Fat Load||0
9797724|NCT00589888|10905338|FG001|COMPLETED|64-gram Oral Fat Load||0
9797725|NCT00589888|10905339|FG002|COMPLETED|64-gram Oral Fat Load||0
9797726|NCT00589888|10905340|FG003|COMPLETED|64-gram Oral Fat Load||0
9797727|NCT00589888|10905341|FG004|COMPLETED|64-gram Oral Fat Load||13
9797728|NCT00589888|10905337|FG000|NOT COMPLETED|64-gram Oral Fat Load||0
9797729|NCT00589888|10905338|FG001|NOT COMPLETED|64-gram Oral Fat Load||0
9797730|NCT00589888|10905339|FG002|NOT COMPLETED|64-gram Oral Fat Load||0
9797731|NCT00589888|10905340|FG003|NOT COMPLETED|64-gram Oral Fat Load||0
9797732|NCT00589888|10905341|FG004|NOT COMPLETED|64-gram Oral Fat Load||0
9797733|NCT00589914|10905360|FG000|STARTED|Overall Study||606
9797734|NCT00589914|10905361|FG001|STARTED|Overall Study||608
9797735|NCT00589914|10905360|FG000|COMPLETED|Overall Study||456
9797736|NCT00589914|10905361|FG001|COMPLETED|Overall Study||471
9797737|NCT00589914|10905360|FG000|NOT COMPLETED|Overall Study||150
9797738|NCT00589914|10905361|FG001|NOT COMPLETED|Overall Study||137
9797739|NCT00589979|10905369|FG000|STARTED|Run-In Period||169
9797740|NCT00589979|10905370|FG001|STARTED|Run-In Period||0
9797741|NCT00589979|10905371|FG002|STARTED|Run-In Period||0
9797742|NCT00589979|10905369|FG000|COMPLETED|Run-In Period||93
9797743|NCT00589979|10905370|FG001|COMPLETED|Run-In Period||0
9797744|NCT00589979|10905371|FG002|COMPLETED|Run-In Period||0
9797745|NCT00589979|10905369|FG000|NOT COMPLETED|Run-In Period||76
9797746|NCT00589979|10905370|FG001|NOT COMPLETED|Run-In Period||0
9797747|NCT00589979|10905371|FG002|NOT COMPLETED|Run-In Period||0
9797748|NCT00589979|10905369|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
9797749|NCT00589979|10905370|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
9797750|NCT00589979|10905371|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
9797751|NCT00589979|10905369|FG000|COMPLETED|Double-Blind Treatment Period 1||0
9797752|NCT00589979|10905370|FG001|COMPLETED|Double-Blind Treatment Period 1||48
9797753|NCT00589979|10905371|FG002|COMPLETED|Double-Blind Treatment Period 1||41
9797754|NCT00589979|10905369|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0
9797755|NCT00589979|10905370|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2
9797756|NCT00589979|10905371|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2
9797757|NCT00589979|10905369|FG000|STARTED|Double-Blind Treatment Period 2||0
9797758|NCT00589979|10905370|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
9797759|NCT00589979|10905371|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
9797760|NCT00589979|10905369|FG000|COMPLETED|Double-Blind Treatment Period 2||0
9797761|NCT00589979|10905370|FG001|COMPLETED|Double-Blind Treatment Period 2||47
9797762|NCT00589979|10905371|FG002|COMPLETED|Double-Blind Treatment Period 2||39
9797763|NCT00589979|10905369|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0
9797764|NCT00589979|10905370|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1
9797765|NCT00589979|10905371|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2
9797766|NCT00589979|10905369|FG000|STARTED|Double-Blind Treatment Period 3||0
9797767|NCT00589979|10905370|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
9797768|NCT00589979|10905371|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
9797769|NCT00589979|10905369|FG000|COMPLETED|Double-Blind Treatment Period 3||0
9797770|NCT00589979|10905370|FG001|COMPLETED|Double-Blind Treatment Period 3||46
9797771|NCT00589979|10905371|FG002|COMPLETED|Double-Blind Treatment Period 3||38
9797772|NCT00589979|10905369|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0
9797773|NCT00589979|10905370|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1
9797774|NCT00589979|10905371|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1
9797775|NCT00590005|10905383|FG000|STARTED|Overall Study||106
9797776|NCT00590005|10905384|FG001|STARTED|Overall Study||119
9797777|NCT00590005|10905383|FG000|COMPLETED|Overall Study||106
9797778|NCT00590005|10905384|FG001|COMPLETED|Overall Study||119
9797779|NCT00590005|10905383|FG000|NOT COMPLETED|Overall Study||0
9797780|NCT00590005|10905384|FG001|NOT COMPLETED|Overall Study||0
9797781|NCT00590018|10905392|FG000|STARTED|Overall Study||9
9952546|NCT01422876|11071525|FG004|NOT COMPLETED|Week 24||7
9952547|NCT01422876|11071526|FG005|NOT COMPLETED|Week 24||6
9952548|NCT01422876|11071527|FG006|NOT COMPLETED|Week 24||6
9797782|NCT00590018|10905393|FG001|STARTED|Overall Study||9
9797783|NCT00590018|10905392|FG000|COMPLETED|Overall Study||9
9797784|NCT00590018|10905393|FG001|COMPLETED|Overall Study||9
9797785|NCT00590018|10905392|FG000|NOT COMPLETED|Overall Study||0
9797786|NCT00590018|10905393|FG001|NOT COMPLETED|Overall Study||0
9797787|NCT00590031|10905399|FG000|STARTED|Overall Study||61
9797788|NCT00590031|10905399|FG000|COMPLETED|Overall Study||55
9797789|NCT00590031|10905399|FG000|NOT COMPLETED|Overall Study||6
9797790|NCT00590044|10905405|FG000|STARTED|Overall Study||38
9797791|NCT00590044|10905406|FG001|STARTED|Overall Study||36
9797792|NCT00590044|10905405|FG000|COMPLETED|Overall Study||34
9797793|NCT00590044|10905406|FG001|COMPLETED|Overall Study||34
9797794|NCT00590044|10905405|FG000|NOT COMPLETED|Overall Study||4
9797795|NCT00590044|10905406|FG001|NOT COMPLETED|Overall Study||2
9797796|NCT00590161|10905417|FG000|STARTED|Overall Study||26
9797797|NCT00590161|10905418|FG001|STARTED|Overall Study||29
9797798|NCT00590161|10905417|FG000|COMPLETED|Overall Study||23
9797799|NCT00590161|10905418|FG001|COMPLETED|Overall Study||26
9797800|NCT00590161|10905417|FG000|NOT COMPLETED|Overall Study||3
9797801|NCT00590161|10905418|FG001|NOT COMPLETED|Overall Study||3
9797802|NCT00590226|10905426|FG000|STARTED|Overall Study||67
9797803|NCT00590226|10905427|FG001|STARTED|Overall Study||63
9797804|NCT00590226|10905426|FG000|COMPLETED|Overall Study||67
9797805|NCT00590226|10905427|FG001|COMPLETED|Overall Study||63
9797806|NCT00590226|10905426|FG000|NOT COMPLETED|Overall Study||0
9797807|NCT00590226|10905427|FG001|NOT COMPLETED|Overall Study||0
9797808|NCT00590317|10905435|FG000|STARTED|Overall Study||32
9797809|NCT00590317|10905436|FG001|STARTED|Overall Study||32
9797810|NCT00590317|10905435|FG000|COMPLETED|Overall Study||31
9797811|NCT00590317|10905436|FG001|COMPLETED|Overall Study||27
9797812|NCT00590317|10905435|FG000|NOT COMPLETED|Overall Study||1
9797813|NCT00590317|10905436|FG001|NOT COMPLETED|Overall Study||5
9797814|NCT00590369|10905445|FG000|STARTED|Overall Study||6
9797815|NCT00590369|10905446|FG001|STARTED|Overall Study||5
9797816|NCT00590369|10905445|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
9797817|NCT00590369|10905446|FG001|COMPLETED|Overall Study||5
9797818|NCT00590369|10905445|FG000|NOT COMPLETED|Overall Study||0
9797819|NCT00590369|10905446|FG001|NOT COMPLETED|Overall Study||0
9797820|NCT00590395|10905452|FG000|STARTED|Overall Study||19
9797821|NCT00590395|10905452|FG000|COMPLETED|Overall Study||19
9797822|NCT00590395|10905452|FG000|NOT COMPLETED|Overall Study||0
9797823|NCT00590460|10905456|FG000|STARTED|Overall Study||5
9797824|NCT00590460|10905456|FG000|COMPLETED|Overall Study||5
9797825|NCT00590460|10905456|FG000|NOT COMPLETED|Overall Study||0
9797826|NCT00590564|10905464|FG000|STARTED|Overall Study||42
9797827|NCT00590564|10905464|FG000|COMPLETED|Overall Study||24
9797828|NCT00590564|10905464|FG000|NOT COMPLETED|Overall Study||18
9797829|NCT00590577|10905472|FG000|STARTED|Overall Study||160
9797830|NCT00590577|10905473|FG001|STARTED|Overall Study||165
9797831|NCT00590577|10905474|FG002|STARTED|Overall Study||163
9797832|NCT00590577|10905475|FG003|STARTED|Overall Study||164
9797833|NCT00590577|10905472|FG000|COMPLETED|Overall Study||83
9797834|NCT00590577|10905473|FG001|COMPLETED|Overall Study||89
9797835|NCT00590577|10905474|FG002|COMPLETED|Overall Study||90
9797836|NCT00590577|10905475|FG003|COMPLETED|Overall Study||71
9797837|NCT00590577|10905472|FG000|NOT COMPLETED|Overall Study||77
9797838|NCT00590577|10905473|FG001|NOT COMPLETED|Overall Study||76
9797839|NCT00590577|10905474|FG002|NOT COMPLETED|Overall Study||73
9797840|NCT00590577|10905475|FG003|NOT COMPLETED|Overall Study||93
9797841|NCT00590590|10905488|FG000|STARTED|Overall Study||39
9797842|NCT00590590|10905489|FG001|STARTED|Overall Study||39
9797843|NCT00590590|10905490|FG002|STARTED|Overall Study||27
9797844|NCT00590590|10905488|FG000|COMPLETED|Overall Study||32
9797845|NCT00590590|10905489|FG001|COMPLETED|Overall Study||33
9797846|NCT00590590|10905490|FG002|COMPLETED|Overall Study||21
9797847|NCT00590590|10905488|FG000|NOT COMPLETED|Overall Study||7
9797848|NCT00590590|10905489|FG001|NOT COMPLETED|Overall Study||6
9797849|NCT00590590|10905490|FG002|NOT COMPLETED|Overall Study||6
9797850|NCT00590681|10905498|FG000|STARTED|Overall Study||62
9797851|NCT00590681|10905498|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
9797852|NCT00590681|10905498|FG000|NOT COMPLETED|Overall Study||20
9797853|NCT00590707|10905504|FG000|STARTED|Overall Study||100
9797854|NCT00590707|10905505|FG001|STARTED|Overall Study||100
9797855|NCT00590707|10905504|FG000|COMPLETED|Overall Study||100
9797856|NCT00590707|10905505|FG001|COMPLETED|Overall Study||100
9797857|NCT00590707|10905504|FG000|NOT COMPLETED|Overall Study||0
9797858|NCT00590707|10905505|FG001|NOT COMPLETED|Overall Study||0
9797859|NCT00590720|10905513|FG000|STARTED|Overall Study||4
9797860|NCT00590720|10905514|FG001|STARTED|Overall Study||7
9797861|NCT00590720|10905513|FG000|COMPLETED|Overall Study||3
9797862|NCT00590720|10905514|FG001|COMPLETED|Overall Study||6
9797863|NCT00590720|10905513|FG000|NOT COMPLETED|Overall Study||1
9797864|NCT00590720|10905514|FG001|NOT COMPLETED|Overall Study||1
9797865|NCT00590759|10905520|FG000|STARTED|Overall Study||150
9797866|NCT00590759|10905520|FG000|COMPLETED|Overall Study||70
9797867|NCT00590759|10905520|FG000|NOT COMPLETED|Overall Study||80
9797868|NCT00590772|10905524|FG000|STARTED|Overall Study||31
9797869|NCT00590772|10905524|FG000|COMPLETED|Overall Study||31
9797870|NCT00590772|10905524|FG000|NOT COMPLETED|Overall Study||0
9797871|NCT00590824|10905534|FG000|STARTED|Overall Study||11
9797872|NCT00590824|10905535|FG001|STARTED|Overall Study||9
9797873|NCT00590824|10905536|FG002|STARTED|Overall Study||2
9797874|NCT00590824|10905537|FG003|STARTED|Overall Study||1
9797875|NCT00590824|10905534|FG000|COMPLETED|Overall Study||11
9797876|NCT00590824|10905535|FG001|COMPLETED|Overall Study||7
9797877|NCT00590824|10905536|FG002|COMPLETED|Overall Study||1
9797878|NCT00590824|10905537|FG003|COMPLETED|Overall Study||0
9797879|NCT00590824|10905534|FG000|NOT COMPLETED|Overall Study||0
9797880|NCT00590824|10905535|FG001|NOT COMPLETED|Overall Study||2
9797881|NCT00590824|10905536|FG002|NOT COMPLETED|Overall Study||1
9797882|NCT00590824|10905537|FG003|NOT COMPLETED|Overall Study||1
9797883|NCT00590863|10905550|FG000|STARTED|Overall Study||221
9797884|NCT00590863|10905551|FG001|STARTED|Overall Study||220
9797885|NCT00590863|10905552|FG002|STARTED|Overall Study||224
9797886|NCT00590863|10905550|FG000|COMPLETED|Overall Study||137
9797887|NCT00590863|10905551|FG001|COMPLETED|Overall Study||138
9797888|NCT00590863|10905552|FG002|COMPLETED|Overall Study||146
9797889|NCT00590863|10905550|FG000|NOT COMPLETED|Overall Study||84
9797890|NCT00590863|10905551|FG001|NOT COMPLETED|Overall Study||82
9797891|NCT00590863|10905552|FG002|NOT COMPLETED|Overall Study||78
9797892|NCT00590889|10905563|FG000|STARTED|Overall Study||404
9797893|NCT00590889|10905564|FG001|STARTED|Overall Study||403
9797894|NCT00590889|10905563|FG000|COMPLETED|Overall Study||118
9797895|NCT00590889|10905564|FG001|COMPLETED|Overall Study||104
9797896|NCT00590889|10905563|FG000|NOT COMPLETED|Overall Study||286
9797897|NCT00590889|10905564|FG001|NOT COMPLETED|Overall Study||299
9797898|NCT00590902|10905570|FG000|STARTED|Overall Study||81
9797899|NCT00590902|10905570|FG000|COMPLETED|Overall Study||80
9797900|NCT00590902|10905570|FG000|NOT COMPLETED|Overall Study||1
9797901|NCT00590954|10905574|FG000|STARTED|Overall Study||32
9797902|NCT00590954|10905574|FG000|COMPLETED|Overall Study||30
9797903|NCT00590954|10905574|FG000|NOT COMPLETED|Overall Study||2
9797904|NCT00590967|10905582|FG000|STARTED|Overall Study||44
9797905|NCT00590967|10905583|FG001|STARTED|Overall Study||25
9797906|NCT00590967|10905582|FG000|COMPLETED|Overall Study||41
9797907|NCT00590967|10905583|FG001|COMPLETED|Overall Study||20
9797908|NCT00590967|10905582|FG000|NOT COMPLETED|Overall Study||3
9797909|NCT00590967|10905583|FG001|NOT COMPLETED|Overall Study||5
9797910|NCT00590980|10905589|FG000|STARTED|Overall Study||82
9797911|NCT00590980|10905589|FG000|COMPLETED|Overall Study||72
9797912|NCT00590980|10905589|FG000|NOT COMPLETED|Overall Study||10
9797913|NCT00591006|10905593|FG000|STARTED|Overall Study||1
9797914|NCT00591006|10905594|FG001|STARTED|Overall Study||0
9797915|NCT00591006|10905595|FG002|STARTED|Overall Study||1
9797916|NCT00591006|10905596|FG003|STARTED|Overall Study||1
9797917|NCT00591006|10905597|FG004|STARTED|Overall Study||1
9797918|NCT00591006|10905598|FG005|STARTED|Overall Study||0
9797919|NCT00591006|10905599|FG006|STARTED|Overall Study||1
9797920|NCT00591006|10905600|FG007|STARTED|Overall Study||0
9797921|NCT00591006|10905601|FG008|STARTED|Overall Study||1
9797922|NCT00591006|10905602|FG009|STARTED|Overall Study||1
9797923|NCT00591006|10905603|FG010|STARTED|Overall Study||0
9797924|NCT00591006|10905604|FG011|STARTED|Overall Study||1
9797925|NCT00591006|10905605|FG012|STARTED|Overall Study||1
9797926|NCT00591006|10905606|FG013|STARTED|Overall Study||2
9797927|NCT00591006|10905607|FG014|STARTED|Overall Study||0
9797928|NCT00591006|10905608|FG015|STARTED|Overall Study||1
9797929|NCT00591006|10905609|FG016|STARTED|Overall Study||0
9797930|NCT00591006|10905610|FG017|STARTED|Overall Study||1
9797931|NCT00591006|10905611|FG018|STARTED|Overall Study||0
9797932|NCT00591006|10905612|FG019|STARTED|Overall Study||1
9797933|NCT00591006|10905613|FG020|STARTED|Overall Study||0
9797934|NCT00591006|10905614|FG021|STARTED|Overall Study||1
9797935|NCT00591006|10905615|FG022|STARTED|Overall Study||1
9797936|NCT00591006|10905616|FG023|STARTED|Overall Study||1
9797937|NCT00591006|10905593|FG000|Treatment #2|Overall Study||1
9797938|NCT00591006|10905594|FG001|Treatment #2|Overall Study||0
9797939|NCT00591006|10905595|FG002|Treatment #2|Overall Study||1
9797940|NCT00591006|10905596|FG003|Treatment #2|Overall Study||1
9797941|NCT00591006|10905597|FG004|Treatment #2|Overall Study||1
9797942|NCT00591006|10905598|FG005|Treatment #2|Overall Study||0
9797943|NCT00591006|10905599|FG006|Treatment #2|Overall Study||1
9797944|NCT00591006|10905600|FG007|Treatment #2|Overall Study||0
9797945|NCT00591006|10905601|FG008|Treatment #2|Overall Study||1
9797946|NCT00591006|10905602|FG009|Treatment #2|Overall Study||1
9797947|NCT00591006|10905603|FG010|Treatment #2|Overall Study||0
9797948|NCT00591006|10905604|FG011|Treatment #2|Overall Study||1
9797949|NCT00591006|10905605|FG012|Treatment #2|Overall Study||1
9797950|NCT00591006|10905606|FG013|Treatment #2|Overall Study||2
9797951|NCT00591006|10905607|FG014|Treatment #2|Overall Study||0
9797952|NCT00591006|10905608|FG015|Treatment #2|Overall Study||0
9797953|NCT00591006|10905609|FG016|Treatment #2|Overall Study||0
9797954|NCT00591006|10905610|FG017|Treatment #2|Overall Study||1
9797955|NCT00591006|10905611|FG018|Treatment #2|Overall Study||0
9797956|NCT00591006|10905612|FG019|Treatment #2|Overall Study||1
9797957|NCT00591006|10905613|FG020|Treatment #2|Overall Study||0
9797958|NCT00591006|10905614|FG021|Treatment #2|Overall Study||1
9797959|NCT00591006|10905615|FG022|Treatment #2|Overall Study||1
9797960|NCT00591006|10905616|FG023|Treatment #2|Overall Study||1
9797961|NCT00591006|10905593|FG000|Treatment #3|Overall Study||1
9797962|NCT00591006|10905594|FG001|Treatment #3|Overall Study||0
9797963|NCT00591006|10905595|FG002|Treatment #3|Overall Study||1
9797964|NCT00591006|10905596|FG003|Treatment #3|Overall Study||1
9797965|NCT00591006|10905597|FG004|Treatment #3|Overall Study||1
9797966|NCT00591006|10905598|FG005|Treatment #3|Overall Study||0
9797967|NCT00591006|10905599|FG006|Treatment #3|Overall Study||1
9797968|NCT00591006|10905600|FG007|Treatment #3|Overall Study||0
9797969|NCT00591006|10905601|FG008|Treatment #3|Overall Study||1
9797970|NCT00591006|10905602|FG009|Treatment #3|Overall Study||1
9797971|NCT00591006|10905603|FG010|Treatment #3|Overall Study||0
9797972|NCT00591006|10905604|FG011|Treatment #3|Overall Study||1
9797973|NCT00591006|10905605|FG012|Treatment #3|Overall Study||1
9797974|NCT00591006|10905606|FG013|Treatment #3|Overall Study||2
9797975|NCT00591006|10905607|FG014|Treatment #3|Overall Study||0
9797976|NCT00591006|10905608|FG015|Treatment #3|Overall Study||0
9797977|NCT00591006|10905609|FG016|Treatment #3|Overall Study||0
9797978|NCT00591006|10905610|FG017|Treatment #3|Overall Study||1
9797979|NCT00591006|10905611|FG018|Treatment #3|Overall Study||0
9797980|NCT00591006|10905612|FG019|Treatment #3|Overall Study||1
9797981|NCT00591006|10905613|FG020|Treatment #3|Overall Study||0
9797982|NCT00591006|10905614|FG021|Treatment #3|Overall Study||1
9797983|NCT00591006|10905615|FG022|Treatment #3|Overall Study||1
9797984|NCT00591006|10905616|FG023|Treatment #3|Overall Study||1
9797985|NCT00591006|10905593|FG000|Treatment #4|Overall Study||1
9797986|NCT00591006|10905594|FG001|Treatment #4|Overall Study||0
9797987|NCT00591006|10905595|FG002|Treatment #4|Overall Study||1
9797988|NCT00591006|10905596|FG003|Treatment #4|Overall Study||1
9797989|NCT00591006|10905597|FG004|Treatment #4|Overall Study||1
9797990|NCT00591006|10905598|FG005|Treatment #4|Overall Study||0
9797991|NCT00591006|10905599|FG006|Treatment #4|Overall Study||1
9797992|NCT00591006|10905600|FG007|Treatment #4|Overall Study||0
9797993|NCT00591006|10905601|FG008|Treatment #4|Overall Study||1
9797994|NCT00591006|10905602|FG009|Treatment #4|Overall Study||1
9797995|NCT00591006|10905603|FG010|Treatment #4|Overall Study||0
9797996|NCT00591006|10905604|FG011|Treatment #4|Overall Study||1
9797997|NCT00591006|10905605|FG012|Treatment #4|Overall Study||1
9797998|NCT00591006|10905606|FG013|Treatment #4|Overall Study||2
9797999|NCT00591006|10905607|FG014|Treatment #4|Overall Study||0
9798000|NCT00591006|10905608|FG015|Treatment #4|Overall Study||0
9798001|NCT00591006|10905609|FG016|Treatment #4|Overall Study||0
9798002|NCT00591006|10905610|FG017|Treatment #4|Overall Study||1
9798003|NCT00591006|10905611|FG018|Treatment #4|Overall Study||0
9798004|NCT00591006|10905612|FG019|Treatment #4|Overall Study||1
9798005|NCT00591006|10905613|FG020|Treatment #4|Overall Study||0
9798006|NCT00591006|10905614|FG021|Treatment #4|Overall Study||1
9798007|NCT00591006|10905615|FG022|Treatment #4|Overall Study||0
9798008|NCT00591006|10905616|FG023|Treatment #4|Overall Study||0
9798009|NCT00591006|10905593|FG000|COMPLETED|Overall Study||1
9798010|NCT00591006|10905594|FG001|COMPLETED|Overall Study||0
9798011|NCT00591006|10905595|FG002|COMPLETED|Overall Study||1
9798012|NCT00591006|10905596|FG003|COMPLETED|Overall Study||1
9798013|NCT00591006|10905597|FG004|COMPLETED|Overall Study||1
9798014|NCT00591006|10905598|FG005|COMPLETED|Overall Study||0
9798015|NCT00591006|10905599|FG006|COMPLETED|Overall Study||1
9798016|NCT00591006|10905600|FG007|COMPLETED|Overall Study||0
9798017|NCT00591006|10905601|FG008|COMPLETED|Overall Study||1
9798018|NCT00591006|10905602|FG009|COMPLETED|Overall Study||1
9798019|NCT00591006|10905603|FG010|COMPLETED|Overall Study||0
9798020|NCT00591006|10905604|FG011|COMPLETED|Overall Study||1
9798021|NCT00591006|10905605|FG012|COMPLETED|Overall Study||1
9798022|NCT00591006|10905606|FG013|COMPLETED|Overall Study||2
9798023|NCT00591006|10905607|FG014|COMPLETED|Overall Study||0
9798024|NCT00591006|10905608|FG015|COMPLETED|Overall Study||0
9798025|NCT00591006|10905609|FG016|COMPLETED|Overall Study||0
9798026|NCT00591006|10905610|FG017|COMPLETED|Overall Study||1
9798027|NCT00591006|10905611|FG018|COMPLETED|Overall Study||0
9798028|NCT00591006|10905612|FG019|COMPLETED|Overall Study||1
9798029|NCT00591006|10905613|FG020|COMPLETED|Overall Study||0
9798030|NCT00591006|10905614|FG021|COMPLETED|Overall Study||1
9798031|NCT00591006|10905615|FG022|COMPLETED|Overall Study||0
9798032|NCT00591006|10905616|FG023|COMPLETED|Overall Study||0
9798033|NCT00591006|10905593|FG000|NOT COMPLETED|Overall Study||0
9798034|NCT00591006|10905594|FG001|NOT COMPLETED|Overall Study||0
9798035|NCT00591006|10905595|FG002|NOT COMPLETED|Overall Study||0
9798036|NCT00591006|10905596|FG003|NOT COMPLETED|Overall Study||0
9798037|NCT00591006|10905597|FG004|NOT COMPLETED|Overall Study||0
9798038|NCT00591006|10905598|FG005|NOT COMPLETED|Overall Study||0
9798039|NCT00591006|10905599|FG006|NOT COMPLETED|Overall Study||0
9798040|NCT00591006|10905600|FG007|NOT COMPLETED|Overall Study||0
9798041|NCT00591006|10905601|FG008|NOT COMPLETED|Overall Study||0
9798042|NCT00591006|10905602|FG009|NOT COMPLETED|Overall Study||0
9798043|NCT00591006|10905603|FG010|NOT COMPLETED|Overall Study||0
9798044|NCT00591006|10905604|FG011|NOT COMPLETED|Overall Study||0
9798045|NCT00591006|10905605|FG012|NOT COMPLETED|Overall Study||0
9798046|NCT00591006|10905606|FG013|NOT COMPLETED|Overall Study||0
9798047|NCT00591006|10905607|FG014|NOT COMPLETED|Overall Study||0
9798048|NCT00591006|10905608|FG015|NOT COMPLETED|Overall Study||1
9798049|NCT00591006|10905609|FG016|NOT COMPLETED|Overall Study||0
9798050|NCT00591006|10905610|FG017|NOT COMPLETED|Overall Study||0
9798051|NCT00591006|10905611|FG018|NOT COMPLETED|Overall Study||0
9798052|NCT00591006|10905612|FG019|NOT COMPLETED|Overall Study||0
9798053|NCT00591006|10905613|FG020|NOT COMPLETED|Overall Study||0
9798054|NCT00591006|10905614|FG021|NOT COMPLETED|Overall Study||0
9798055|NCT00591006|10905615|FG022|NOT COMPLETED|Overall Study||1
9798056|NCT00591006|10905616|FG023|NOT COMPLETED|Overall Study||1
9798057|NCT00591019|10905633|FG000|STARTED|Baseline (1 Day)||3
9798058|NCT00591019|10905634|FG001|STARTED|Baseline (1 Day)||4
9798059|NCT00591019|10905633|FG000|COMPLETED|Baseline (1 Day)||3
9798060|NCT00591019|10905634|FG001|COMPLETED|Baseline (1 Day)||4
9798061|NCT00591019|10905633|FG000|NOT COMPLETED|Baseline (1 Day)||0
9798062|NCT00591019|10905634|FG001|NOT COMPLETED|Baseline (1 Day)||0
9798063|NCT00591019|10905633|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
9798064|NCT00591019|10905634|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
9798065|NCT00591019|10905633|FG000|COMPLETED|Intervention 1 (14 Days)||2
9798066|NCT00591019|10905634|FG001|COMPLETED|Intervention 1 (14 Days)||3
9798067|NCT00591019|10905633|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0
9798068|NCT00591019|10905634|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0
9798069|NCT00591019|10905633|FG000|STARTED|Intevention 2 (14 Days)||2
9798070|NCT00591019|10905634|FG001|STARTED|Intevention 2 (14 Days)||3
9798071|NCT00591019|10905633|FG000|COMPLETED|Intevention 2 (14 Days)||2
9798072|NCT00591019|10905634|FG001|COMPLETED|Intevention 2 (14 Days)||3
9798073|NCT00591019|10905633|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0
9798074|NCT00591019|10905634|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0
9798075|NCT00591123|10905642|FG000|STARTED|Overall Study||38
9798076|NCT00591123|10905642|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38
9798077|NCT00591123|10905642|FG000|NOT COMPLETED|Overall Study||0
9798078|NCT00591149|10905646|FG000|STARTED|Overall Study||16
9798079|NCT00591149|10905646|FG000|COMPLETED|Overall Study||11
9798080|NCT00591149|10905646|FG000|NOT COMPLETED|Overall Study||5
9798081|NCT00591214|10905650|FG000|STARTED|Overall Study||10
9798082|NCT00591214|10905650|FG000|COMPLETED|Overall Study||2
9798083|NCT00591214|10905650|FG000|NOT COMPLETED|Overall Study||8
9798084|NCT00591240|10905656|FG000|STARTED|Overall Study||116
9798085|NCT00591240|10905657|FG001|STARTED|Overall Study||222
9798086|NCT00591240|10905656|FG000|COMPLETED|Overall Study||116
9798087|NCT00591240|10905657|FG001|COMPLETED|Overall Study||222
9798088|NCT00591240|10905656|FG000|NOT COMPLETED|Overall Study||0
9798089|NCT00591240|10905657|FG001|NOT COMPLETED|Overall Study||0
9798090|NCT00591253|10905666|FG000|STARTED|Overall Study|Randomized or Treated|140
9798091|NCT00591253|10905667|FG001|STARTED|Overall Study|Randomized or Treated|137
9798092|NCT00591253|10905668|FG002|STARTED|Overall Study|Randomized or Treated|138
9798093|NCT00591253|10905666|FG000|COMPLETED|Overall Study||126
9798094|NCT00591253|10905667|FG001|COMPLETED|Overall Study||116
9798095|NCT00591253|10905668|FG002|COMPLETED|Overall Study||123
9798096|NCT00591253|10905666|FG000|NOT COMPLETED|Overall Study||14
9798097|NCT00591253|10905667|FG001|NOT COMPLETED|Overall Study||21
9798098|NCT00591253|10905668|FG002|NOT COMPLETED|Overall Study||15
9798099|NCT00591266|10905679|FG000|STARTED|Overall Study|Randomized only|189
9798100|NCT00591266|10905680|FG001|STARTED|Overall Study|Randomized only|188
9798101|NCT00591266|10905681|FG002|STARTED|Overall Study|Randomized only|189
9798102|NCT00591266|10905679|FG000|COMPLETED|Overall Study||180
9798103|NCT00591266|10905680|FG001|COMPLETED|Overall Study||177
9798104|NCT00591266|10905681|FG002|COMPLETED|Overall Study||175
9798105|NCT00591266|10905679|FG000|NOT COMPLETED|Overall Study||9
9798106|NCT00591266|10905680|FG001|NOT COMPLETED|Overall Study||11
9798107|NCT00591266|10905681|FG002|NOT COMPLETED|Overall Study||14
9798108|NCT00591305|10905691|FG000|STARTED|Overall Study||1
9798109|NCT00591305|10905692|FG001|STARTED|Overall Study||0
9798110|NCT00591305|10905691|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1
9798111|NCT00591305|10905692|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0
9798112|NCT00591305|10905691|FG000|COMPLETED|Overall Study||1
9798113|NCT00591305|10905692|FG001|COMPLETED|Overall Study||0
9798114|NCT00591305|10905691|FG000|NOT COMPLETED|Overall Study||0
9798115|NCT00591305|10905692|FG001|NOT COMPLETED|Overall Study||0
9798116|NCT00591344|10905701|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
9798117|NCT00591344|10905702|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
9798118|NCT00591344|10905701|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
9798119|NCT00591344|10905702|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
9798120|NCT00591344|10905701|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
9798121|NCT00591344|10905702|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
9798122|NCT00591344|10905701|FG000|NOT COMPLETED|Overall Study||5
9798123|NCT00591344|10905702|FG001|NOT COMPLETED|Overall Study||8
9798124|NCT00591370|10905712|FG000|STARTED|Overall Study||51
9798125|NCT00591370|10905712|FG000|COMPLETED|Overall Study||49
9798126|NCT00591370|10905712|FG000|NOT COMPLETED|Overall Study||2
9798127|NCT00591409|10905726|FG000|STARTED|Overall Study||10
9798128|NCT00591409|10905727|FG001|STARTED|Overall Study||10
9798129|NCT00591409|10905728|FG002|STARTED|Overall Study||10
9798130|NCT00591409|10905729|FG003|STARTED|Overall Study||10
9798131|NCT00591409|10905730|FG004|STARTED|Overall Study||10
9798132|NCT00591409|10905731|FG005|STARTED|Overall Study||10
9798133|NCT00591409|10905732|FG006|STARTED|Overall Study||10
9798134|NCT00591409|10905733|FG007|STARTED|Overall Study||10
9798135|NCT00591409|10905734|FG008|STARTED|Overall Study||9
9798136|NCT00591409|10905735|FG009|STARTED|Overall Study||11
9798137|NCT00591409|10905726|FG000|Treated|Overall Study||10
9798138|NCT00591409|10905727|FG001|Treated|Overall Study||10
9798139|NCT00591409|10905728|FG002|Treated|Overall Study||10
9798140|NCT00591409|10905729|FG003|Treated|Overall Study||10
9798141|NCT00591409|10905730|FG004|Treated|Overall Study||9
9798142|NCT00591409|10905731|FG005|Treated|Overall Study||10
9798143|NCT00591409|10905732|FG006|Treated|Overall Study||10
9798144|NCT00591409|10905733|FG007|Treated|Overall Study||10
9798145|NCT00591409|10905734|FG008|Treated|Overall Study||9
9798146|NCT00591409|10905735|FG009|Treated|Overall Study||10
9798147|NCT00591409|10905726|FG000|COMPLETED|Overall Study||10
9798148|NCT00591409|10905727|FG001|COMPLETED|Overall Study||10
9798149|NCT00591409|10905728|FG002|COMPLETED|Overall Study||10
9798150|NCT00591409|10905729|FG003|COMPLETED|Overall Study||10
9798151|NCT00591409|10905730|FG004|COMPLETED|Overall Study||9
9798152|NCT00591409|10905731|FG005|COMPLETED|Overall Study||10
9798153|NCT00591409|10905732|FG006|COMPLETED|Overall Study||10
9798154|NCT00591409|10905733|FG007|COMPLETED|Overall Study||10
10235274|NCT01206101|11365546|FG000|STARTED|Overall Study||2
10235275|NCT01206101|11365547|FG001|STARTED|Overall Study||1
10235276|NCT01206101|11365546|FG000|COMPLETED|Overall Study||0
10235277|NCT01206101|11365547|FG001|COMPLETED|Overall Study||0
9798155|NCT00591409|10905734|FG008|COMPLETED|Overall Study||9
9798156|NCT00591409|10905735|FG009|COMPLETED|Overall Study||10
9798157|NCT00591409|10905726|FG000|NOT COMPLETED|Overall Study||0
9798158|NCT00591409|10905727|FG001|NOT COMPLETED|Overall Study||0
9798159|NCT00591409|10905728|FG002|NOT COMPLETED|Overall Study||0
9798160|NCT00591409|10905729|FG003|NOT COMPLETED|Overall Study||0
9798161|NCT00591409|10905730|FG004|NOT COMPLETED|Overall Study||1
9798162|NCT00591409|10905731|FG005|NOT COMPLETED|Overall Study||0
9798163|NCT00591409|10905732|FG006|NOT COMPLETED|Overall Study||0
9798164|NCT00591409|10905733|FG007|NOT COMPLETED|Overall Study||0
9798165|NCT00591409|10905734|FG008|NOT COMPLETED|Overall Study||0
9798166|NCT00591409|10905735|FG009|NOT COMPLETED|Overall Study||1
9798167|NCT00591565|10905757|FG000|STARTED|Overall Study||13
9798168|NCT00591565|10905757|FG000|COMPLETED|Overall Study||8
9798169|NCT00591565|10905757|FG000|NOT COMPLETED|Overall Study||5
9798170|NCT00591578|10905764|FG000|STARTED|Double-Blind Treatment Phase||327
9798171|NCT00591578|10905765|FG001|STARTED|Double-Blind Treatment Phase||329
9798172|NCT00591578|10905766|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
9798173|NCT00591578|10905764|FG000|COMPLETED|Double-Blind Treatment Phase||249
9798174|NCT00591578|10905765|FG001|COMPLETED|Double-Blind Treatment Phase||249
9798175|NCT00591578|10905766|FG002|COMPLETED|Double-Blind Treatment Phase||244
9798176|NCT00591578|10905764|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78
9798177|NCT00591578|10905765|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80
9798178|NCT00591578|10905766|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84
9798179|NCT00591578|10905764|FG000|STARTED|Open-Label Extension Phase||55
9798180|NCT00591578|10905765|FG001|STARTED|Open-Label Extension Phase||115
9798181|NCT00591578|10905766|FG002|STARTED|Open-Label Extension Phase||0
9798182|NCT00591578|10905764|FG000|COMPLETED|Open-Label Extension Phase||49
9798183|NCT00591578|10905765|FG001|COMPLETED|Open-Label Extension Phase||105
9798184|NCT00591578|10905766|FG002|COMPLETED|Open-Label Extension Phase||0
9798185|NCT00591578|10905764|FG000|NOT COMPLETED|Open-Label Extension Phase||6
9798186|NCT00591578|10905765|FG001|NOT COMPLETED|Open-Label Extension Phase||10
9798187|NCT00591578|10905766|FG002|NOT COMPLETED|Open-Label Extension Phase||0
9798188|NCT00591591|10905777|FG000|STARTED|Overall Study||176
9798189|NCT00591591|10905778|FG001|STARTED|Overall Study||133
9798190|NCT00591591|10905777|FG000|COMPLETED|Overall Study||165
9798191|NCT00591591|10905778|FG001|COMPLETED|Overall Study||94
9798192|NCT00591591|10905777|FG000|NOT COMPLETED|Overall Study||11
9798193|NCT00591591|10905778|FG001|NOT COMPLETED|Overall Study||39
9798194|NCT00591630|10905788|FG000|STARTED|Overall Study||6
9798195|NCT00591630|10905789|FG001|STARTED|Overall Study||8
9798196|NCT00591630|10905790|FG002|STARTED|Overall Study||10
9798197|NCT00591630|10905791|FG003|STARTED|Overall Study||6
9798198|NCT00591630|10905788|FG000|COMPLETED|Overall Study||6
9798199|NCT00591630|10905789|FG001|COMPLETED|Overall Study||8
9798200|NCT00591630|10905790|FG002|COMPLETED|Overall Study||9
9798201|NCT00591630|10905791|FG003|COMPLETED|Overall Study||6
9798202|NCT00591630|10905788|FG000|NOT COMPLETED|Overall Study||0
9798203|NCT00591630|10905789|FG001|NOT COMPLETED|Overall Study||0
10235278|NCT01206101|11365546|FG000|NOT COMPLETED|Overall Study||2
9798204|NCT00591630|10905790|FG002|NOT COMPLETED|Overall Study||1
9798205|NCT00591630|10905791|FG003|NOT COMPLETED|Overall Study||0
9798206|NCT00591721|10905803|FG000|STARTED|Overall Study||89
10235279|NCT01206101|11365547|FG001|NOT COMPLETED|Overall Study||1
10235280|NCT01216631|11365556|FG000|STARTED|Overall Study||0
9798207|NCT00591721|10905804|FG001|STARTED|Overall Study||92
9798208|NCT00591721|10905803|FG000|COMPLETED|Overall Study||68
9798209|NCT00591721|10905804|FG001|COMPLETED|Overall Study||70
9798210|NCT00591721|10905803|FG000|NOT COMPLETED|Overall Study||21
9798211|NCT00591721|10905804|FG001|NOT COMPLETED|Overall Study||22
9798212|NCT00591734|10905810|FG000|STARTED|Overall Study||57
9798213|NCT00591734|10905810|FG000|COMPLETED|Overall Study||4
9798214|NCT00591734|10905810|FG000|NOT COMPLETED|Overall Study||53
9798215|NCT00591760|10905816|FG000|STARTED|Overall Study||28
9798216|NCT00591760|10905817|FG001|STARTED|Overall Study||28
9798217|NCT00591760|10905816|FG000|COMPLETED|Overall Study||28
9798218|NCT00591760|10905817|FG001|COMPLETED|Overall Study||28
9798219|NCT00591760|10905816|FG000|NOT COMPLETED|Overall Study||0
9798220|NCT00591760|10905817|FG001|NOT COMPLETED|Overall Study||0
10235281|NCT01216631|11365557|FG001|STARTED|Overall Study||0
10235282|NCT01216631|11365558|FG002|STARTED|Overall Study||1
9798221|NCT00591773|10905826|FG000|STARTED|Overall Study||185
9798222|NCT00591773|10905827|FG001|STARTED|Overall Study||182
9798223|NCT00591773|10905828|FG002|STARTED|Overall Study||184
9798224|NCT00591773|10905826|FG000|COMPLETED|Overall Study||169
9798225|NCT00591773|10905827|FG001|COMPLETED|Overall Study||158
9798226|NCT00591773|10905828|FG002|COMPLETED|Overall Study||168
9798227|NCT00591773|10905826|FG000|NOT COMPLETED|Overall Study||16
9798228|NCT00591773|10905827|FG001|NOT COMPLETED|Overall Study||24
9798229|NCT00591773|10905828|FG002|NOT COMPLETED|Overall Study||16
9798230|NCT00591786|10905846|FG000|STARTED|Overall Study||9
9798231|NCT00591786|10905847|FG001|STARTED|Overall Study||9
9798232|NCT00591786|10905848|FG002|STARTED|Overall Study||11
9798233|NCT00591786|10905849|FG003|STARTED|Overall Study||11
9798234|NCT00591786|10905850|FG004|STARTED|Overall Study||10
9798235|NCT00591786|10905851|FG005|STARTED|Overall Study||10
9798236|NCT00591786|10905852|FG006|STARTED|Overall Study||10
9798237|NCT00591786|10905853|FG007|STARTED|Overall Study||10
9798238|NCT00591786|10905854|FG008|STARTED|Overall Study||10
9798239|NCT00591786|10905855|FG009|STARTED|Overall Study||10
9798240|NCT00591786|10905846|FG000|Treated Participants|Overall Study||9
9798241|NCT00591786|10905847|FG001|Treated Participants|Overall Study||9
9798242|NCT00591786|10905848|FG002|Treated Participants|Overall Study||10
9798243|NCT00591786|10905849|FG003|Treated Participants|Overall Study||11
9798244|NCT00591786|10905850|FG004|Treated Participants|Overall Study||10
9798245|NCT00591786|10905851|FG005|Treated Participants|Overall Study||10
9798246|NCT00591786|10905852|FG006|Treated Participants|Overall Study||10
9798247|NCT00591786|10905853|FG007|Treated Participants|Overall Study||10
9798248|NCT00591786|10905854|FG008|Treated Participants|Overall Study||10
9798249|NCT00591786|10905855|FG009|Treated Participants|Overall Study||10
9798250|NCT00591786|10905846|FG000|COMPLETED|Overall Study||9
9798251|NCT00591786|10905847|FG001|COMPLETED|Overall Study||9
9798252|NCT00591786|10905848|FG002|COMPLETED|Overall Study||10
9798253|NCT00591786|10905849|FG003|COMPLETED|Overall Study||11
9798254|NCT00591786|10905850|FG004|COMPLETED|Overall Study||10
9798255|NCT00591786|10905851|FG005|COMPLETED|Overall Study||10
9798256|NCT00591786|10905852|FG006|COMPLETED|Overall Study||10
9798257|NCT00591786|10905853|FG007|COMPLETED|Overall Study||10
9798258|NCT00591786|10905854|FG008|COMPLETED|Overall Study||10
9798259|NCT00591786|10905855|FG009|COMPLETED|Overall Study||10
9798260|NCT00591786|10905846|FG000|NOT COMPLETED|Overall Study||0
9798261|NCT00591786|10905847|FG001|NOT COMPLETED|Overall Study||0
9798262|NCT00591786|10905848|FG002|NOT COMPLETED|Overall Study||1
9798263|NCT00591786|10905849|FG003|NOT COMPLETED|Overall Study||0
9798264|NCT00591786|10905850|FG004|NOT COMPLETED|Overall Study||0
9798265|NCT00591786|10905851|FG005|NOT COMPLETED|Overall Study||0
9798266|NCT00591786|10905852|FG006|NOT COMPLETED|Overall Study||0
9798267|NCT00591786|10905853|FG007|NOT COMPLETED|Overall Study||0
9798268|NCT00591786|10905854|FG008|NOT COMPLETED|Overall Study||0
9798269|NCT00591786|10905855|FG009|NOT COMPLETED|Overall Study||0
9798270|NCT00591825|10905881|FG000|STARTED|Overall Study||14
9798271|NCT00591825|10905882|FG001|STARTED|Overall Study||13
9798272|NCT00591825|10905883|FG002|STARTED|Overall Study||13
9798273|NCT00591825|10905884|FG003|STARTED|Overall Study||14
9798274|NCT00591825|10905881|FG000|COMPLETED|Overall Study||14
9798275|NCT00591825|10905882|FG001|COMPLETED|Overall Study||13
9798276|NCT00591825|10905883|FG002|COMPLETED|Overall Study||13
9798277|NCT00591825|10905884|FG003|COMPLETED|Overall Study||14
9798278|NCT00591825|10905881|FG000|NOT COMPLETED|Overall Study||0
9798279|NCT00591825|10905882|FG001|NOT COMPLETED|Overall Study||0
9798280|NCT00591825|10905883|FG002|NOT COMPLETED|Overall Study||0
9798281|NCT00591825|10905884|FG003|NOT COMPLETED|Overall Study||0
9798282|NCT00591838|10905909|FG000|STARTED|Overall Study||5
9798283|NCT00591838|10905910|FG001|STARTED|Overall Study||6
9798284|NCT00591838|10905911|FG002|STARTED|Overall Study||6
9798285|NCT00591838|10905912|FG003|STARTED|Overall Study||6
9798286|NCT00591838|10905913|FG004|STARTED|Overall Study||51
9798287|NCT00591838|10905909|FG000|COMPLETED|Overall Study||5
9798288|NCT00591838|10905910|FG001|COMPLETED|Overall Study||6
9798289|NCT00591838|10905911|FG002|COMPLETED|Overall Study||6
9798290|NCT00591838|10905912|FG003|COMPLETED|Overall Study||5
9798291|NCT00591838|10905913|FG004|COMPLETED|Overall Study||51
9798292|NCT00591838|10905909|FG000|NOT COMPLETED|Overall Study||0
9798293|NCT00591838|10905910|FG001|NOT COMPLETED|Overall Study||0
9952549|NCT01422876|11071528|FG007|NOT COMPLETED|Week 24||7
9952550|NCT01422876|11071529|FG008|NOT COMPLETED|Week 24||6
9952551|NCT01422876|11071530|FG009|NOT COMPLETED|Week 24||10
9952552|NCT01422876|11071521|FG000|STARTED|Week 52||137
9952553|NCT01422876|11071522|FG001|STARTED|Week 52||136
9798294|NCT00591838|10905911|FG002|NOT COMPLETED|Overall Study||0
9798295|NCT00591838|10905912|FG003|NOT COMPLETED|Overall Study||1
9798296|NCT00591838|10905913|FG004|NOT COMPLETED|Overall Study||0
9798297|NCT00591851|10905926|FG000|STARTED|Overall Study||70
9798298|NCT00591851|10905926|FG000|COMPLETED|Overall Study||64
9798299|NCT00591851|10905926|FG000|NOT COMPLETED|Overall Study||6
9952554|NCT01422876|11071523|FG002|STARTED|Week 52||141
9798300|NCT00591864|10905930|FG000|STARTED|Overall Study||89
9798301|NCT00591864|10905930|FG000|COMPLETED|Overall Study||84
9798302|NCT00591864|10905930|FG000|NOT COMPLETED|Overall Study||5
9798303|NCT00591942|10905935|FG000|STARTED|Overall Study||36
9798304|NCT00591942|10905936|FG001|STARTED|Overall Study||36
9798305|NCT00591942|10905935|FG000|COMPLETED|Overall Study||36
9798306|NCT00591942|10905936|FG001|COMPLETED|Overall Study||36
9952555|NCT01422876|11071524|FG003|STARTED|Week 52||140
9798307|NCT00591942|10905935|FG000|NOT COMPLETED|Overall Study||0
9798308|NCT00591942|10905936|FG001|NOT COMPLETED|Overall Study||0
9798309|NCT00592072|10905942|FG000|STARTED|First Sequence||6
9798310|NCT00592072|10905943|FG001|STARTED|First Sequence||6
9798311|NCT00592072|10905942|FG000|COMPLETED|First Sequence||6
9798312|NCT00592072|10905943|FG001|COMPLETED|First Sequence||6
9798313|NCT00592072|10905942|FG000|NOT COMPLETED|First Sequence||0
9798314|NCT00592072|10905943|FG001|NOT COMPLETED|First Sequence||0
9798315|NCT00592072|10905942|FG000|STARTED|Wash Out Period||6
9798316|NCT00592072|10905943|FG001|STARTED|Wash Out Period||6
9798317|NCT00592072|10905942|FG000|COMPLETED|Wash Out Period||5
9798318|NCT00592072|10905943|FG001|COMPLETED|Wash Out Period||5
9798319|NCT00592072|10905942|FG000|NOT COMPLETED|Wash Out Period||1
9798320|NCT00592072|10905943|FG001|NOT COMPLETED|Wash Out Period||1
9798321|NCT00592072|10905942|FG000|STARTED|Second Sequence||5
9798322|NCT00592072|10905943|FG001|STARTED|Second Sequence||5
9798323|NCT00592072|10905942|FG000|COMPLETED|Second Sequence||5
9798324|NCT00592072|10905943|FG001|COMPLETED|Second Sequence||5
9798325|NCT00592072|10905942|FG000|NOT COMPLETED|Second Sequence||0
9798326|NCT00592072|10905943|FG001|NOT COMPLETED|Second Sequence||0
9798327|NCT00592124|10905955|FG000|STARTED|Overall Study||28
9798328|NCT00592124|10905956|FG001|STARTED|Overall Study||29
9798329|NCT00592124|10905957|FG002|STARTED|Overall Study||30
9798330|NCT00592124|10905958|FG003|STARTED|Overall Study||27
9798331|NCT00592124|10905959|FG004|STARTED|Overall Study||27
9798332|NCT00592124|10905960|FG005|STARTED|Overall Study||27
9798333|NCT00592124|10905955|FG000|COMPLETED|Overall Study||24
9798334|NCT00592124|10905956|FG001|COMPLETED|Overall Study||24
9798335|NCT00592124|10905957|FG002|COMPLETED|Overall Study||24
9798336|NCT00592124|10905958|FG003|COMPLETED|Overall Study||24
9798337|NCT00592124|10905959|FG004|COMPLETED|Overall Study||24
9798338|NCT00592124|10905960|FG005|COMPLETED|Overall Study||24
9798339|NCT00592124|10905955|FG000|NOT COMPLETED|Overall Study||4
9798340|NCT00592124|10905956|FG001|NOT COMPLETED|Overall Study||5
9798341|NCT00592124|10905957|FG002|NOT COMPLETED|Overall Study||6
9798342|NCT00592124|10905958|FG003|NOT COMPLETED|Overall Study||3
9798343|NCT00592124|10905959|FG004|NOT COMPLETED|Overall Study||3
9798344|NCT00592124|10905960|FG005|NOT COMPLETED|Overall Study||3
9831130|NCT00766532|10941795|FG000|NOT COMPLETED|Overall Study||2
9831131|NCT00766597|10941799|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
9831132|NCT00766597|10941799|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
9831133|NCT00766597|10941799|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
9831134|NCT00766597|10941799|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
9831135|NCT00766597|10941799|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
9831136|NCT00766597|10941799|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
9831137|NCT00766597|10941799|FG000|NOT COMPLETED|Overall Study||9
9831138|NCT00766649|10941805|FG000|STARTED|Overall Study||11
9831139|NCT00766649|10941805|FG000|COMPLETED|Overall Study||1
9831140|NCT00766649|10941805|FG000|NOT COMPLETED|Overall Study||10
9831141|NCT00766675|10941809|FG000|STARTED|Overall Study||80
9831142|NCT00766675|10941809|FG000|COMPLETED|Overall Study||40
9831143|NCT00766675|10941809|FG000|NOT COMPLETED|Overall Study||40
9831144|NCT00766727|10941813|FG000|STARTED|Overall Study||12
9831145|NCT00766727|10941813|FG000|COMPLETED|Overall Study||9
9831146|NCT00766727|10941813|FG000|NOT COMPLETED|Overall Study||3
9831147|NCT00766753|10941821|FG000|STARTED|Overall Study||11
9831148|NCT00766753|10941822|FG001|STARTED|Overall Study||11
9831149|NCT00766753|10941821|FG000|Received at Least One Vaccine|Overall Study||11
9831150|NCT00766753|10941822|FG001|Received at Least One Vaccine|Overall Study||11
9831151|NCT00766753|10941821|FG000|Completed at Least Four Vaccines|Overall Study||10
9831152|NCT00766753|10941822|FG001|Completed at Least Four Vaccines|Overall Study||9
9831153|NCT00766753|10941821|FG000|COMPLETED|Overall Study||11
9831154|NCT00766753|10941822|FG001|COMPLETED|Overall Study||11
9831155|NCT00766753|10941821|FG000|NOT COMPLETED|Overall Study||0
9831156|NCT00766753|10941822|FG001|NOT COMPLETED|Overall Study||0
9831157|NCT00766831|10941829|FG000|STARTED|Overall Study||190
9831158|NCT00766831|10941829|FG000|COMPLETED|Overall Study||75
9831159|NCT00766831|10941829|FG000|NOT COMPLETED|Overall Study||115
9831160|NCT00767000|10941838|FG000|STARTED|54-week Study||119
9831161|NCT00767000|10941839|FG001|STARTED|54-week Study||117
9831162|NCT00767000|10941840|FG002|STARTED|54-week Study||117
9831163|NCT00767000|10941841|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
9831164|NCT00767000|10941842|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
9831165|NCT00767000|10941838|FG000|COMPLETED|54-week Study||11
9831166|NCT00767000|10941839|FG001|COMPLETED|54-week Study||4
9831167|NCT00767000|10941840|FG002|COMPLETED|54-week Study||8
9831168|NCT00767000|10941841|FG003|COMPLETED|54-week Study||4
9831169|NCT00767000|10941842|FG004|COMPLETED|54-week Study||7
9831170|NCT00767000|10941838|FG000|NOT COMPLETED|54-week Study||108
9831171|NCT00767000|10941839|FG001|NOT COMPLETED|54-week Study||113
9831172|NCT00767000|10941840|FG002|NOT COMPLETED|54-week Study||109
9831173|NCT00767000|10941841|FG003|NOT COMPLETED|54-week Study||225
9831174|NCT00767000|10941842|FG004|NOT COMPLETED|54-week Study||224
9831175|NCT00767000|10941838|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
9798345|NCT00592176|10905970|FG000|STARTED|Overall Study||5
9798346|NCT00592176|10905970|FG000|COMPLETED|Overall Study||5
9798347|NCT00592176|10905970|FG000|NOT COMPLETED|Overall Study||0
9798348|NCT00592319|10905976|FG000|STARTED|Overall Study||2
9798349|NCT00592319|10905977|FG001|STARTED|Overall Study||8
9798350|NCT00592319|10905976|FG000|COMPLETED|Overall Study||2
9798351|NCT00592319|10905977|FG001|COMPLETED|Overall Study||5
9798352|NCT00592319|10905976|FG000|NOT COMPLETED|Overall Study||0
9798353|NCT00592319|10905977|FG001|NOT COMPLETED|Overall Study||3
9798354|NCT00592358|10905985|FG000|STARTED|Overall Study||17
9798355|NCT00592358|10905985|FG000|COMPLETED|Overall Study||11
9798356|NCT00592358|10905985|FG000|NOT COMPLETED|Overall Study||6
9952556|NCT01422876|11071525|FG004|STARTED|Week 52||132
9952557|NCT01422876|11071526|FG005|STARTED|Week 52||137
9952558|NCT01422876|11071527|FG006|STARTED|Week 52||136
9952559|NCT01422876|11071528|FG007|STARTED|Week 52||135
9952560|NCT01422876|11071529|FG008|STARTED|Week 52||134
9952561|NCT01422876|11071530|FG009|STARTED|Week 52||135
9952562|NCT01422876|11071521|FG000|COMPLETED|Week 52||125
9952563|NCT01422876|11071522|FG001|COMPLETED|Week 52||126
9952564|NCT01422876|11071523|FG002|COMPLETED|Week 52||128
9952565|NCT01422876|11071524|FG003|COMPLETED|Week 52||122
9952566|NCT01422876|11071525|FG004|COMPLETED|Week 52||117
9952567|NCT01422876|11071526|FG005|COMPLETED|Week 52||120
9952568|NCT01422876|11071527|FG006|COMPLETED|Week 52||120
9952569|NCT01422876|11071528|FG007|COMPLETED|Week 52||112
9952570|NCT01422876|11071529|FG008|COMPLETED|Week 52||113
9952571|NCT01422876|11071530|FG009|COMPLETED|Week 52||118
9952572|NCT01422876|11071521|FG000|NOT COMPLETED|Week 52||12
9952573|NCT01422876|11071522|FG001|NOT COMPLETED|Week 52||10
9952574|NCT01422876|11071523|FG002|NOT COMPLETED|Week 52||13
9952575|NCT01422876|11071524|FG003|NOT COMPLETED|Week 52||18
9952576|NCT01422876|11071525|FG004|NOT COMPLETED|Week 52||15
9952577|NCT01422876|11071526|FG005|NOT COMPLETED|Week 52||17
9952578|NCT01422876|11071527|FG006|NOT COMPLETED|Week 52||16
9952579|NCT01422876|11071528|FG007|NOT COMPLETED|Week 52||23
9952580|NCT01422876|11071529|FG008|NOT COMPLETED|Week 52||21
9952581|NCT01422876|11071530|FG009|NOT COMPLETED|Week 52||17
9952582|NCT01422889|11071548|FG000|STARTED|Overall Study||1120
9952583|NCT01422889|11071548|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
9952584|NCT01422889|11071548|FG000|NOT COMPLETED|Overall Study||9
9952585|NCT01422915|11071552|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
9952586|NCT01422915|11071552|FG000|COMPLETED|Overall Study||3
9952587|NCT01422915|11071552|FG000|NOT COMPLETED|Overall Study||1
9952588|NCT01423084|11071559|FG000|STARTED|Overall Study||170
9952589|NCT01423084|11071560|FG001|STARTED|Overall Study||174
9952590|NCT01423084|11071559|FG000|COMPLETED|Overall Study||168
9952591|NCT01423084|11071560|FG001|COMPLETED|Overall Study||170
9952592|NCT01423084|11071559|FG000|NOT COMPLETED|Overall Study||2
9952593|NCT01423084|11071560|FG001|NOT COMPLETED|Overall Study||4
9952594|NCT01423162|11071569|FG000|STARTED|Overall Study||11
9952595|NCT01423162|11071570|FG001|STARTED|Overall Study||9
9952596|NCT01423162|11071569|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
9952597|NCT01423162|11071570|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
9952598|NCT01423162|11071569|FG000|NOT COMPLETED|Overall Study||0
9952599|NCT01423162|11071570|FG001|NOT COMPLETED|Overall Study||0
9952600|NCT01423253|11071576|FG000|STARTED|Overall Study||48
9952601|NCT01423253|11071576|FG000|COMPLETED|Overall Study||39
9952602|NCT01423253|11071576|FG000|NOT COMPLETED|Overall Study||9
9952603|NCT01423604|11071583|FG000|STARTED|Safety Run-In||9
9952604|NCT01423604|11071584|FG001|STARTED|Safety Run-In||0
9952605|NCT01423604|11071583|FG000|COMPLETED|Safety Run-In||0
9952606|NCT01423604|11071584|FG001|COMPLETED|Safety Run-In||0
9952607|NCT01423604|11071583|FG000|NOT COMPLETED|Safety Run-In||9
9952608|NCT01423604|11071584|FG001|NOT COMPLETED|Safety Run-In||0
9798357|NCT00592384|10905991|FG000|STARTED|Overall Study||64
9798358|NCT00592384|10905992|FG001|STARTED|Overall Study||69
9798359|NCT00592384|10905991|FG000|COMPLETED|Overall Study||59
9798360|NCT00592384|10905992|FG001|COMPLETED|Overall Study||63
9798361|NCT00592384|10905991|FG000|NOT COMPLETED|Overall Study||5
9798362|NCT00592384|10905992|FG001|NOT COMPLETED|Overall Study||6
9798363|NCT00592475|10906001|FG000|STARTED|Overall Study||6
9798364|NCT00592475|10906002|FG001|STARTED|Overall Study||9
9798365|NCT00592475|10906003|FG002|STARTED|Overall Study||5
9798366|NCT00592475|10906001|FG000|COMPLETED|Overall Study||6
9798367|NCT00592475|10906002|FG001|COMPLETED|Overall Study||9
9798368|NCT00592475|10906003|FG002|COMPLETED|Overall Study||5
9798369|NCT00592475|10906001|FG000|NOT COMPLETED|Overall Study||0
9798370|NCT00592475|10906002|FG001|NOT COMPLETED|Overall Study||0
9798371|NCT00592475|10906003|FG002|NOT COMPLETED|Overall Study||0
9798372|NCT00592488|10906013|FG000|STARTED|Overall Study||6
9798373|NCT00592488|10906014|FG001|STARTED|Overall Study||7
9798374|NCT00592488|10906013|FG000|COMPLETED|Overall Study||6
9798375|NCT00592488|10906014|FG001|COMPLETED|Overall Study||7
9798376|NCT00592488|10906013|FG000|NOT COMPLETED|Overall Study||0
9798377|NCT00592488|10906014|FG001|NOT COMPLETED|Overall Study||0
9798378|NCT00592501|10906022|FG000|STARTED|Overall Study||25
9798379|NCT00592501|10906022|FG000|COMPLETED|Overall Study||23
9798380|NCT00592501|10906022|FG000|NOT COMPLETED|Overall Study||2
9798381|NCT00592553|10906029|FG000|STARTED|Overall Study||60
9798382|NCT00592553|10906030|FG001|STARTED|Overall Study||57
9798383|NCT00592553|10906031|FG002|STARTED|Overall Study||57
9798384|NCT00592553|10906029|FG000|As-treated Population|Overall Study||60
9798385|NCT00592553|10906030|FG001|As-treated Population|Overall Study||57
9798386|NCT00592553|10906031|FG002|As-treated Population|Overall Study||57
9798387|NCT00592553|10906029|FG000|ITT Population|Overall Study||60
9798388|NCT00592553|10906030|FG001|ITT Population|Overall Study||57
9798389|NCT00592553|10906031|FG002|ITT Population|Overall Study||57
9798390|NCT00592553|10906029|FG000|COMPLETED|Overall Study||59
9798391|NCT00592553|10906030|FG001|COMPLETED|Overall Study||57
9798392|NCT00592553|10906031|FG002|COMPLETED|Overall Study||57
9798393|NCT00592553|10906029|FG000|NOT COMPLETED|Overall Study||1
9798394|NCT00592553|10906030|FG001|NOT COMPLETED|Overall Study||0
9798395|NCT00592553|10906031|FG002|NOT COMPLETED|Overall Study||0
9798396|NCT00592631|10906041|FG000|STARTED|Overall Study||16
9798397|NCT00592631|10906042|FG001|STARTED|Overall Study||11
9798398|NCT00592631|10906041|FG000|COMPLETED|Overall Study||16
9798399|NCT00592631|10906042|FG001|COMPLETED|Overall Study||9
9798400|NCT00592631|10906041|FG000|NOT COMPLETED|Overall Study||0
9798401|NCT00592631|10906042|FG001|NOT COMPLETED|Overall Study||2
9798402|NCT00592683|10906050|FG000|STARTED|Overall Study||10
9798403|NCT00592683|10906051|FG001|STARTED|Overall Study||10
9798404|NCT00592683|10906050|FG000|COMPLETED|Overall Study||6
9798405|NCT00592683|10906051|FG001|COMPLETED|Overall Study||6
9798406|NCT00592683|10906050|FG000|NOT COMPLETED|Overall Study||4
9798407|NCT00592683|10906051|FG001|NOT COMPLETED|Overall Study||4
9798408|NCT00592761|10906057|FG000|STARTED|First Intervention (2 Weeks)||9
9798409|NCT00592761|10906058|FG001|STARTED|First Intervention (2 Weeks)||9
9798410|NCT00592761|10906057|FG000|COMPLETED|First Intervention (2 Weeks)||9
9798411|NCT00592761|10906058|FG001|COMPLETED|First Intervention (2 Weeks)||9
9798412|NCT00592761|10906057|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
9798413|NCT00592761|10906058|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
9798414|NCT00592761|10906057|FG000|STARTED|Second Intervention (2 Weeks)||9
9798415|NCT00592761|10906058|FG001|STARTED|Second Intervention (2 Weeks)||9
9798416|NCT00592761|10906057|FG000|COMPLETED|Second Intervention (2 Weeks)||9
9798417|NCT00592761|10906058|FG001|COMPLETED|Second Intervention (2 Weeks)||9
9798418|NCT00592761|10906057|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
9798419|NCT00592761|10906058|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
9798420|NCT00592774|10906069|FG000|STARTED|Overall Study||26
9798421|NCT00592774|10906070|FG001|STARTED|Overall Study||53
9798422|NCT00592774|10906071|FG002|STARTED|Overall Study||22
9798423|NCT00592774|10906072|FG003|STARTED|Overall Study||22
9798424|NCT00592774|10906073|FG004|STARTED|Overall Study||23
9798425|NCT00592774|10906069|FG000|COMPLETED|Overall Study||15
9798426|NCT00592774|10906070|FG001|COMPLETED|Overall Study||21
9798427|NCT00592774|10906071|FG002|COMPLETED|Overall Study||18
9798428|NCT00592774|10906072|FG003|COMPLETED|Overall Study||8
9798429|NCT00592774|10906073|FG004|COMPLETED|Overall Study||9
9798430|NCT00592774|10906069|FG000|NOT COMPLETED|Overall Study||11
9798431|NCT00592774|10906070|FG001|NOT COMPLETED|Overall Study||32
9798432|NCT00592774|10906071|FG002|NOT COMPLETED|Overall Study||4
9798433|NCT00592774|10906072|FG003|NOT COMPLETED|Overall Study||14
9798434|NCT00592774|10906073|FG004|NOT COMPLETED|Overall Study||14
9798435|NCT00592839|10906088|FG000|STARTED|Overall Study||53
9798436|NCT00592839|10906089|FG001|STARTED|Overall Study||52
9798437|NCT00592839|10906090|FG002|STARTED|Overall Study||52
9798438|NCT00592839|10906088|FG000|COMPLETED|Overall Study||51
9798439|NCT00592839|10906089|FG001|COMPLETED|Overall Study||48
9798440|NCT00592839|10906090|FG002|COMPLETED|Overall Study||46
9798441|NCT00592839|10906088|FG000|NOT COMPLETED|Overall Study||2
9798442|NCT00592839|10906089|FG001|NOT COMPLETED|Overall Study||4
9798443|NCT00592839|10906090|FG002|NOT COMPLETED|Overall Study||6
9798444|NCT00592852|10906098|FG000|STARTED|Overall Study||13
9798445|NCT00592852|10906098|FG000|COMPLETED|Overall Study||7
9798446|NCT00592852|10906098|FG000|NOT COMPLETED|Overall Study||6
9798447|NCT00592904|10906106|FG000|STARTED|Overall Study||57
10015750|NCT01807299|11138768|FG000|STARTED|Overall Study||14
10015751|NCT01807299|11138769|FG001|STARTED|Overall Study||14
10015752|NCT01807299|11138770|FG002|STARTED|Overall Study||12
9798448|NCT00592904|10906107|FG001|STARTED|Overall Study||148
10015753|NCT01807299|11138771|FG003|STARTED|Overall Study||13
9798449|NCT00592904|10906108|FG002|STARTED|Overall Study||27
9798450|NCT00592904|10906109|FG003|STARTED|Overall Study||30
9798451|NCT00592904|10906106|FG000|COMPLETED|Overall Study||32
9798452|NCT00592904|10906107|FG001|COMPLETED|Overall Study||93
9798453|NCT00592904|10906108|FG002|COMPLETED|Overall Study||10
9798454|NCT00592904|10906109|FG003|COMPLETED|Overall Study||19
9798455|NCT00592904|10906106|FG000|NOT COMPLETED|Overall Study||25
9798456|NCT00592904|10906107|FG001|NOT COMPLETED|Overall Study||55
9798457|NCT00592904|10906108|FG002|NOT COMPLETED|Overall Study||17
9798458|NCT00592904|10906109|FG003|NOT COMPLETED|Overall Study||11
9798459|NCT00592943|10906121|FG000|STARTED|Overall Study||6
9952609|NCT01423604|11071583|FG000|STARTED|Randomized||64
9952610|NCT01423604|11071584|FG001|STARTED|Randomized||63
9952611|NCT01423604|11071583|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
9952612|NCT01423604|11071584|FG001|COMPLETED|Randomized||0
9952613|NCT01423604|11071583|FG000|NOT COMPLETED|Randomized||63
9952614|NCT01423604|11071584|FG001|NOT COMPLETED|Randomized||63
9952615|NCT01423617|11071593|FG000|STARTED|Overall Study||46
9952616|NCT01423617|11071594|FG001|STARTED|Overall Study||46
10015754|NCT01807299|11138768|FG000|COMPLETED|Overall Study||11
10015755|NCT01807299|11138769|FG001|COMPLETED|Overall Study||13
10015756|NCT01807299|11138770|FG002|COMPLETED|Overall Study||12
9952617|NCT01423617|11071593|FG000|COMPLETED|Overall Study||46
9952618|NCT01423617|11071594|FG001|COMPLETED|Overall Study||45
9952619|NCT01423617|11071593|FG000|NOT COMPLETED|Overall Study||0
9952620|NCT01423617|11071594|FG001|NOT COMPLETED|Overall Study||1
9952621|NCT01423760|11071602|FG000|STARTED|Overall Study||14
9952622|NCT01423760|11071603|FG001|STARTED|Overall Study||13
9952623|NCT01423760|11071602|FG000|Number of Tecemotide Subjects|Overall Study||12
9952624|NCT01423760|11071603|FG001|Number of Tecemotide Subjects|Overall Study||8
9952625|NCT01423760|11071602|FG000|Number of Non-treatment Subjects|Overall Study||2
9952626|NCT01423760|11071603|FG001|Number of Non-treatment Subjects|Overall Study||5
9952627|NCT01423760|11071602|FG000|Safety Analysis Set|Overall Study||12
9952628|NCT01423760|11071603|FG001|Safety Analysis Set|Overall Study||8
9952629|NCT01423760|11071602|FG000|COMPLETED|Overall Study||14
9952630|NCT01423760|11071603|FG001|COMPLETED|Overall Study||13
9952631|NCT01423760|11071602|FG000|NOT COMPLETED|Overall Study||0
9952632|NCT01423760|11071603|FG001|NOT COMPLETED|Overall Study||0
9952633|NCT01423773|11071609|FG000|STARTED|Period One, 2 Days||10
9952634|NCT01423773|11071610|FG001|STARTED|Period One, 2 Days||10
9952635|NCT01423773|11071609|FG000|COMPLETED|Period One, 2 Days||10
9952636|NCT01423773|11071610|FG001|COMPLETED|Period One, 2 Days||10
9952637|NCT01423773|11071609|FG000|NOT COMPLETED|Period One, 2 Days||0
9952638|NCT01423773|11071610|FG001|NOT COMPLETED|Period One, 2 Days||0
9952639|NCT01423773|11071609|FG000|STARTED|Period 2, 2 Days||10
9952640|NCT01423773|11071610|FG001|STARTED|Period 2, 2 Days||10
9952641|NCT01423773|11071609|FG000|COMPLETED|Period 2, 2 Days||10
9952642|NCT01423773|11071610|FG001|COMPLETED|Period 2, 2 Days||10
9952643|NCT01423773|11071609|FG000|NOT COMPLETED|Period 2, 2 Days||0
9952644|NCT01423773|11071610|FG001|NOT COMPLETED|Period 2, 2 Days||0
9952645|NCT01423812|11071618|FG000|STARTED|Overall Study||30
9952646|NCT01423812|11071619|FG001|STARTED|Overall Study||30
9952647|NCT01423812|11071618|FG000|COMPLETED|Overall Study||27
9952648|NCT01423812|11071619|FG001|COMPLETED|Overall Study||26
9952649|NCT01423812|11071618|FG000|NOT COMPLETED|Overall Study||3
9952650|NCT01423812|11071619|FG001|NOT COMPLETED|Overall Study||4
9952651|NCT01423916|11071630|FG000|STARTED|Overall Study||74
9952652|NCT01423916|11071631|FG001|STARTED|Overall Study||73
9952653|NCT01423916|11071632|FG002|STARTED|Overall Study||71
9952654|NCT01423916|11071630|FG000|COMPLETED|Overall Study||63
9952655|NCT01423916|11071631|FG001|COMPLETED|Overall Study||53
9952656|NCT01423916|11071632|FG002|COMPLETED|Overall Study||64
9952657|NCT01423916|11071630|FG000|NOT COMPLETED|Overall Study||11
9952658|NCT01423916|11071631|FG001|NOT COMPLETED|Overall Study||20
9952659|NCT01423916|11071632|FG002|NOT COMPLETED|Overall Study||7
9952660|NCT01424033|11071651|FG000|STARTED|Overall Study||5
9952661|NCT01424033|11071651|FG000|COMPLETED|Overall Study||0
9952662|NCT01424033|11071651|FG000|NOT COMPLETED|Overall Study||5
9952663|NCT01424072|11071658|FG000|STARTED|Overall Study||27
9952664|NCT01424072|11071659|FG001|STARTED|Overall Study||26
9952665|NCT01424072|11071660|FG002|STARTED|Overall Study||22
9952666|NCT01424072|11071658|FG000|COMPLETED|Overall Study||27
9952667|NCT01424072|11071659|FG001|COMPLETED|Overall Study||26
9952668|NCT01424072|11071660|FG002|COMPLETED|Overall Study||22
9952669|NCT01424072|11071658|FG000|NOT COMPLETED|Overall Study||0
9952670|NCT01424072|11071659|FG001|NOT COMPLETED|Overall Study||0
9952671|NCT01424072|11071660|FG002|NOT COMPLETED|Overall Study||0
9952672|NCT01424189|11071670|FG000|STARTED|Overall Study||386
9952673|NCT01424189|11071671|FG001|STARTED|Overall Study||188
9952674|NCT01424189|11071670|FG000|COMPLETED|Overall Study||373
9952675|NCT01424189|11071671|FG001|COMPLETED|Overall Study||182
9952676|NCT01424189|11071670|FG000|NOT COMPLETED|Overall Study||13
9952677|NCT01424189|11071671|FG001|NOT COMPLETED|Overall Study||6
9952678|NCT01424215|11071679|FG000|STARTED|Overall Study||50
9952679|NCT01424215|11071680|FG001|STARTED|Overall Study||50
9952680|NCT01424215|11071679|FG000|COMPLETED|Overall Study||50
9952681|NCT01424215|11071680|FG001|COMPLETED|Overall Study||50
9952682|NCT01424215|11071679|FG000|NOT COMPLETED|Overall Study||0
9952683|NCT01424215|11071680|FG001|NOT COMPLETED|Overall Study||0
9952684|NCT01424228|11071688|FG000|STARTED|Overall Study||182
9952685|NCT01424228|11071689|FG001|STARTED|Overall Study||182
9952686|NCT01424228|11071688|FG000|COMPLETED|Overall Study||126
9952687|NCT01424228|11071689|FG001|COMPLETED|Overall Study||135
9952688|NCT01424228|11071688|FG000|NOT COMPLETED|Overall Study||56
9952689|NCT01424228|11071689|FG001|NOT COMPLETED|Overall Study||47
9952690|NCT01424293|11071695|FG000|STARTED|Overall Study||7
9952691|NCT01424293|11071695|FG000|COMPLETED|Overall Study||7
9952692|NCT01424293|11071695|FG000|NOT COMPLETED|Overall Study||0
9952693|NCT01424306|11071699|FG000|STARTED|Overall Study||4
9952694|NCT01424306|11071700|FG001|STARTED|Overall Study||4
9952695|NCT01424306|11071701|FG002|STARTED|Overall Study||3
9952696|NCT01424306|11071702|FG003|STARTED|Overall Study||3
9952697|NCT01424306|11071703|FG004|STARTED|Overall Study||5
9952698|NCT01424306|11071704|FG005|STARTED|Overall Study||6
9952699|NCT01424306|11071699|FG000|COMPLETED|Overall Study||4
9952700|NCT01424306|11071700|FG001|COMPLETED|Overall Study||4
9952701|NCT01424306|11071701|FG002|COMPLETED|Overall Study||3
9952702|NCT01424306|11071702|FG003|COMPLETED|Overall Study||3
9952703|NCT01424306|11071703|FG004|COMPLETED|Overall Study||4
9952704|NCT01424306|11071704|FG005|COMPLETED|Overall Study||6
9952705|NCT01424306|11071699|FG000|NOT COMPLETED|Overall Study||0
9952706|NCT01424306|11071700|FG001|NOT COMPLETED|Overall Study||0
9952707|NCT01424306|11071701|FG002|NOT COMPLETED|Overall Study||0
9952708|NCT01424306|11071702|FG003|NOT COMPLETED|Overall Study||0
9952709|NCT01424306|11071703|FG004|NOT COMPLETED|Overall Study||1
9952710|NCT01424306|11071704|FG005|NOT COMPLETED|Overall Study||0
9952711|NCT01424397|11071748|FG000|STARTED|Period-1 (8 Days)||7
9952712|NCT01424397|11071749|FG001|STARTED|Period-1 (8 Days)||8
9952713|NCT01424397|11071750|FG002|STARTED|Period-1 (8 Days)||8
9952714|NCT01424397|11071751|FG003|STARTED|Period-1 (8 Days)||8
9952715|NCT01424397|11071752|FG004|STARTED|Period-1 (8 Days)||8
9952716|NCT01424397|11071753|FG005|STARTED|Period-1 (8 Days)||8
9952717|NCT01424397|11071754|FG006|STARTED|Period-1 (8 Days)||4
9952718|NCT01424397|11071755|FG007|STARTED|Period-1 (8 Days)||4
9952719|NCT01424397|11071756|FG008|STARTED|Period-1 (8 Days)||4
9952720|NCT01424397|11071757|FG009|STARTED|Period-1 (8 Days)||3
9952721|NCT01424397|11071758|FG010|STARTED|Period-1 (8 Days)||4
9952722|NCT01424397|11071759|FG011|STARTED|Period-1 (8 Days)||4
9952723|NCT01424397|11071748|FG000|COMPLETED|Period-1 (8 Days)||7
9952724|NCT01424397|11071749|FG001|COMPLETED|Period-1 (8 Days)||8
9952725|NCT01424397|11071750|FG002|COMPLETED|Period-1 (8 Days)||8
9952726|NCT01424397|11071751|FG003|COMPLETED|Period-1 (8 Days)||8
9952727|NCT01424397|11071752|FG004|COMPLETED|Period-1 (8 Days)||8
9952728|NCT01424397|11071753|FG005|COMPLETED|Period-1 (8 Days)||8
9952729|NCT01424397|11071754|FG006|COMPLETED|Period-1 (8 Days)||4
9952730|NCT01424397|11071755|FG007|COMPLETED|Period-1 (8 Days)||4
9952731|NCT01424397|11071756|FG008|COMPLETED|Period-1 (8 Days)||4
9952732|NCT01424397|11071757|FG009|COMPLETED|Period-1 (8 Days)||3
9952733|NCT01424397|11071758|FG010|COMPLETED|Period-1 (8 Days)||4
9952734|NCT01424397|11071759|FG011|COMPLETED|Period-1 (8 Days)||4
9952735|NCT01424397|11071748|FG000|NOT COMPLETED|Period-1 (8 Days)||0
9952736|NCT01424397|11071749|FG001|NOT COMPLETED|Period-1 (8 Days)||0
9952737|NCT01424397|11071750|FG002|NOT COMPLETED|Period-1 (8 Days)||0
9952738|NCT01424397|11071751|FG003|NOT COMPLETED|Period-1 (8 Days)||0
9952739|NCT01424397|11071752|FG004|NOT COMPLETED|Period-1 (8 Days)||0
9952740|NCT01424397|11071753|FG005|NOT COMPLETED|Period-1 (8 Days)||0
9952741|NCT01424397|11071754|FG006|NOT COMPLETED|Period-1 (8 Days)||0
9952742|NCT01424397|11071755|FG007|NOT COMPLETED|Period-1 (8 Days)||0
9952743|NCT01424397|11071756|FG008|NOT COMPLETED|Period-1 (8 Days)||0
9952744|NCT01424397|11071757|FG009|NOT COMPLETED|Period-1 (8 Days)||0
9952745|NCT01424397|11071758|FG010|NOT COMPLETED|Period-1 (8 Days)||0
9952746|NCT01424397|11071759|FG011|NOT COMPLETED|Period-1 (8 Days)||0
9952747|NCT01424397|11071748|FG000|STARTED|Washout Period-1 (14-20 Days)||7
9952748|NCT01424397|11071749|FG001|STARTED|Washout Period-1 (14-20 Days)||8
9952749|NCT01424397|11071750|FG002|STARTED|Washout Period-1 (14-20 Days)||8
9952750|NCT01424397|11071751|FG003|STARTED|Washout Period-1 (14-20 Days)||8
9952751|NCT01424397|11071752|FG004|STARTED|Washout Period-1 (14-20 Days)||8
9952752|NCT01424397|11071753|FG005|STARTED|Washout Period-1 (14-20 Days)||8
9952753|NCT01424397|11071754|FG006|STARTED|Washout Period-1 (14-20 Days)||4
9952754|NCT01424397|11071755|FG007|STARTED|Washout Period-1 (14-20 Days)||4
9952755|NCT01424397|11071756|FG008|STARTED|Washout Period-1 (14-20 Days)||4
9952756|NCT01424397|11071757|FG009|STARTED|Washout Period-1 (14-20 Days)||3
9952757|NCT01424397|11071758|FG010|STARTED|Washout Period-1 (14-20 Days)||4
9952758|NCT01424397|11071759|FG011|STARTED|Washout Period-1 (14-20 Days)||4
9952759|NCT01424397|11071748|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7
9952760|NCT01424397|11071749|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8
9952761|NCT01424397|11071750|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8
9952762|NCT01424397|11071751|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8
9952763|NCT01424397|11071752|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8
9952764|NCT01424397|11071753|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8
9952765|NCT01424397|11071754|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4
9952766|NCT01424397|11071755|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4
9952767|NCT01424397|11071756|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4
9952768|NCT01424397|11071757|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3
9952769|NCT01424397|11071758|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4
9952770|NCT01424397|11071759|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4
9952771|NCT01424397|11071748|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952772|NCT01424397|11071749|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952773|NCT01424397|11071750|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952774|NCT01424397|11071751|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952775|NCT01424397|11071752|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952776|NCT01424397|11071753|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952777|NCT01424397|11071754|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952778|NCT01424397|11071755|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952779|NCT01424397|11071756|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952780|NCT01424397|11071757|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952781|NCT01424397|11071758|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952782|NCT01424397|11071759|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
9952783|NCT01424397|11071748|FG000|STARTED|Period-2 (8 Days)||7
9952784|NCT01424397|11071749|FG001|STARTED|Period-2 (8 Days)||8
9952785|NCT01424397|11071750|FG002|STARTED|Period-2 (8 Days)||8
9952786|NCT01424397|11071751|FG003|STARTED|Period-2 (8 Days)||8
9952787|NCT01424397|11071752|FG004|STARTED|Period-2 (8 Days)||8
9952788|NCT01424397|11071753|FG005|STARTED|Period-2 (8 Days)||8
9952789|NCT01424397|11071754|FG006|STARTED|Period-2 (8 Days)||4
9952790|NCT01424397|11071755|FG007|STARTED|Period-2 (8 Days)||4
9952791|NCT01424397|11071756|FG008|STARTED|Period-2 (8 Days)||4
9952792|NCT01424397|11071757|FG009|STARTED|Period-2 (8 Days)||3
9952793|NCT01424397|11071758|FG010|STARTED|Period-2 (8 Days)||4
9952794|NCT01424397|11071759|FG011|STARTED|Period-2 (8 Days)||4
9952795|NCT01424397|11071748|FG000|COMPLETED|Period-2 (8 Days)||7
9952796|NCT01424397|11071749|FG001|COMPLETED|Period-2 (8 Days)||8
9952797|NCT01424397|11071750|FG002|COMPLETED|Period-2 (8 Days)||7
9952798|NCT01424397|11071751|FG003|COMPLETED|Period-2 (8 Days)||8
9952799|NCT01424397|11071752|FG004|COMPLETED|Period-2 (8 Days)||8
9952800|NCT01424397|11071753|FG005|COMPLETED|Period-2 (8 Days)||8
9952801|NCT01424397|11071754|FG006|COMPLETED|Period-2 (8 Days)||4
9952802|NCT01424397|11071755|FG007|COMPLETED|Period-2 (8 Days)||4
9952803|NCT01424397|11071756|FG008|COMPLETED|Period-2 (8 Days)||4
9952804|NCT01424397|11071757|FG009|COMPLETED|Period-2 (8 Days)||3
9952805|NCT01424397|11071758|FG010|COMPLETED|Period-2 (8 Days)||4
9952806|NCT01424397|11071759|FG011|COMPLETED|Period-2 (8 Days)||4
9952807|NCT01424397|11071748|FG000|NOT COMPLETED|Period-2 (8 Days)||0
9952808|NCT01424397|11071749|FG001|NOT COMPLETED|Period-2 (8 Days)||0
9952809|NCT01424397|11071750|FG002|NOT COMPLETED|Period-2 (8 Days)||1
9952810|NCT01424397|11071751|FG003|NOT COMPLETED|Period-2 (8 Days)||0
9952811|NCT01424397|11071752|FG004|NOT COMPLETED|Period-2 (8 Days)||0
9952812|NCT01424397|11071753|FG005|NOT COMPLETED|Period-2 (8 Days)||0
9952813|NCT01424397|11071754|FG006|NOT COMPLETED|Period-2 (8 Days)||0
9952814|NCT01424397|11071755|FG007|NOT COMPLETED|Period-2 (8 Days)||0
9952815|NCT01424397|11071756|FG008|NOT COMPLETED|Period-2 (8 Days)||0
9952816|NCT01424397|11071757|FG009|NOT COMPLETED|Period-2 (8 Days)||0
9952817|NCT01424397|11071758|FG010|NOT COMPLETED|Period-2 (8 Days)||0
9952818|NCT01424397|11071759|FG011|NOT COMPLETED|Period-2 (8 Days)||0
9952819|NCT01424397|11071748|FG000|STARTED|Washout Period-2 (14-20 Days)||7
9952820|NCT01424397|11071749|FG001|STARTED|Washout Period-2 (14-20 Days)||8
9952821|NCT01424397|11071750|FG002|STARTED|Washout Period-2 (14-20 Days)||7
10015757|NCT01807299|11138771|FG003|COMPLETED|Overall Study||11
10015758|NCT01807299|11138768|FG000|NOT COMPLETED|Overall Study||3
10015759|NCT01807299|11138769|FG001|NOT COMPLETED|Overall Study||1
10015760|NCT01807299|11138770|FG002|NOT COMPLETED|Overall Study||0
10015761|NCT01807299|11138771|FG003|NOT COMPLETED|Overall Study||2
10015762|NCT01807455|11138781|FG000|STARTED|Overall Study||12
10015763|NCT01807455|11138781|FG000|COMPLETED|Overall Study||12
10015764|NCT01807455|11138781|FG000|NOT COMPLETED|Overall Study||0
9798460|NCT00592943|10906122|FG001|STARTED|Overall Study||6
9798461|NCT00592943|10906121|FG000|COMPLETED|Overall Study||6
9798462|NCT00592943|10906122|FG001|COMPLETED|Overall Study||6
9798463|NCT00592943|10906121|FG000|NOT COMPLETED|Overall Study||0
9798464|NCT00592943|10906122|FG001|NOT COMPLETED|Overall Study||0
9798465|NCT00593112|10906130|FG000|STARTED|Overall Study||27
9798466|NCT00593112|10906131|FG001|STARTED|Overall Study||12
9798467|NCT00593112|10906130|FG000|COMPLETED|Overall Study||17
9798468|NCT00593112|10906131|FG001|COMPLETED|Overall Study||12
9798469|NCT00593112|10906130|FG000|NOT COMPLETED|Overall Study||10
9798470|NCT00593112|10906131|FG001|NOT COMPLETED|Overall Study||0
9798471|NCT00593333|10906139|FG000|STARTED|Overall Study||54
9798472|NCT00593333|10906140|FG001|STARTED|Overall Study||56
9798473|NCT00593333|10906139|FG000|COMPLETED|Overall Study||44
9798474|NCT00593333|10906140|FG001|COMPLETED|Overall Study||45
9798475|NCT00593333|10906139|FG000|NOT COMPLETED|Overall Study||10
9798476|NCT00593333|10906140|FG001|NOT COMPLETED|Overall Study||11
9798477|NCT00593346|10906146|FG000|STARTED|Overall Study||151
9798478|NCT00593346|10906146|FG000|COMPLETED|Overall Study||151
9798479|NCT00593346|10906146|FG000|NOT COMPLETED|Overall Study||0
9798480|NCT00593372|10906153|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
9798481|NCT00593372|10906154|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
9798482|NCT00593372|10906153|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
9798483|NCT00593372|10906154|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
9798484|NCT00593372|10906153|FG000|NOT COMPLETED|Overall Study||0
9798485|NCT00593372|10906154|FG001|NOT COMPLETED|Overall Study||0
9798486|NCT00593385|10906160|FG000|STARTED|Overall Study||165
9798487|NCT00593385|10906160|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
9798488|NCT00593385|10906160|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
9798489|NCT00593385|10906160|FG000|NOT COMPLETED|Overall Study||40
9798490|NCT00593450|10906170|FG000|STARTED|Overall Study||301
9798491|NCT00593450|10906171|FG001|STARTED|Overall Study||286
9798492|NCT00593450|10906172|FG002|STARTED|Overall Study||298
9798493|NCT00593450|10906173|FG003|STARTED|Overall Study||300
9798494|NCT00593450|10906170|FG000|COMPLETED|Overall Study||284
9798495|NCT00593450|10906171|FG001|COMPLETED|Overall Study||265
9798496|NCT00593450|10906172|FG002|COMPLETED|Overall Study||285
9798497|NCT00593450|10906173|FG003|COMPLETED|Overall Study||271
9798498|NCT00593450|10906170|FG000|NOT COMPLETED|Overall Study||17
9952822|NCT01424397|11071751|FG003|STARTED|Washout Period-2 (14-20 Days)||8
9952823|NCT01424397|11071752|FG004|STARTED|Washout Period-2 (14-20 Days)||8
9952824|NCT01424397|11071753|FG005|STARTED|Washout Period-2 (14-20 Days)||8
9952825|NCT01424397|11071754|FG006|STARTED|Washout Period-2 (14-20 Days)||4
9952826|NCT01424397|11071755|FG007|STARTED|Washout Period-2 (14-20 Days)||4
9952827|NCT01424397|11071756|FG008|STARTED|Washout Period-2 (14-20 Days)||4
9952828|NCT01424397|11071757|FG009|STARTED|Washout Period-2 (14-20 Days)||3
9952829|NCT01424397|11071758|FG010|STARTED|Washout Period-2 (14-20 Days)||4
9952830|NCT01424397|11071759|FG011|STARTED|Washout Period-2 (14-20 Days)||4
10015765|NCT01807520|11138788|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67
10015766|NCT01807520|11138789|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66
9798499|NCT00593450|10906171|FG001|NOT COMPLETED|Overall Study||21
9798500|NCT00593450|10906172|FG002|NOT COMPLETED|Overall Study||13
9798501|NCT00593450|10906173|FG003|NOT COMPLETED|Overall Study||29
9798502|NCT00593489|10906185|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75
9798503|NCT00593489|10906186|FG001|STARTED|Allocation|allocated to usual care group|79
9798504|NCT00593489|10906185|FG000|COMPLETED|Allocation||73
9798505|NCT00593489|10906186|FG001|COMPLETED|Allocation||78
9798506|NCT00593489|10906185|FG000|NOT COMPLETED|Allocation||2
9798507|NCT00593489|10906186|FG001|NOT COMPLETED|Allocation||1
9798508|NCT00593489|10906185|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
9798509|NCT00593489|10906186|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
9798510|NCT00593489|10906185|FG000|COMPLETED|Analysis||73
9798511|NCT00593489|10906186|FG001|COMPLETED|Analysis||78
9798512|NCT00593489|10906185|FG000|NOT COMPLETED|Analysis||0
9798513|NCT00593489|10906186|FG001|NOT COMPLETED|Analysis||0
9798514|NCT00593554|10906196|FG000|STARTED|Overall Study||3
9798515|NCT00593554|10906197|FG001|STARTED|Overall Study||5
9798516|NCT00593554|10906196|FG000|COMPLETED|Overall Study||0
9798517|NCT00593554|10906197|FG001|COMPLETED|Overall Study||0
9798518|NCT00593554|10906196|FG000|NOT COMPLETED|Overall Study||3
9798519|NCT00593554|10906197|FG001|NOT COMPLETED|Overall Study||5
9798520|NCT00593606|10906203|FG000|STARTED|Overall Study||124
9798521|NCT00593606|10906203|FG000|Start of Treatment - Safety Set|Overall Study||116
9798522|NCT00593606|10906203|FG000|Full Analysis Set|Overall Study||114
9798523|NCT00593606|10906203|FG000|Treatment Period Completed|Overall Study||99
9798524|NCT00593606|10906203|FG000|COMPLETED|Overall Study||97
9798525|NCT00593606|10906203|FG000|NOT COMPLETED|Overall Study||27
9798526|NCT00593645|10906207|FG000|STARTED|Overall Study||7
9798527|NCT00593645|10906207|FG000|COMPLETED|Overall Study||7
9798528|NCT00593645|10906207|FG000|NOT COMPLETED|Overall Study||0
9798529|NCT00593684|10906213|FG000|STARTED|Overall Study||25
9798530|NCT00593684|10906214|FG001|STARTED|Overall Study||25
9798531|NCT00593684|10906213|FG000|COMPLETED|Overall Study||23
9798532|NCT00593684|10906214|FG001|COMPLETED|Overall Study||24
9798533|NCT00593684|10906213|FG000|NOT COMPLETED|Overall Study||2
9798534|NCT00593684|10906214|FG001|NOT COMPLETED|Overall Study||1
9798535|NCT00593736|10906224|FG000|STARTED|Screening Period and Placebo Run-in||0
9798536|NCT00593736|10906225|FG001|STARTED|Screening Period and Placebo Run-in||0
9798537|NCT00593736|10906226|FG002|STARTED|Screening Period and Placebo Run-in||0
9798538|NCT00593736|10906227|FG003|STARTED|Screening Period and Placebo Run-in||549
9798539|NCT00593736|10906224|FG000|COMPLETED|Screening Period and Placebo Run-in||0
9798540|NCT00593736|10906225|FG001|COMPLETED|Screening Period and Placebo Run-in||0
9798541|NCT00593736|10906226|FG002|COMPLETED|Screening Period and Placebo Run-in||0
9798542|NCT00593736|10906227|FG003|COMPLETED|Screening Period and Placebo Run-in||132
9798543|NCT00593736|10906224|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0
9798544|NCT00593736|10906225|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0
9798545|NCT00593736|10906226|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0
9798546|NCT00593736|10906227|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417
9798547|NCT00593736|10906224|FG000|STARTED|Treatment Period and Placebo Run-out||32
9798548|NCT00593736|10906225|FG001|STARTED|Treatment Period and Placebo Run-out||33
9798549|NCT00593736|10906226|FG002|STARTED|Treatment Period and Placebo Run-out||35
9798550|NCT00593736|10906227|FG003|STARTED|Treatment Period and Placebo Run-out||32
9798551|NCT00593736|10906224|FG000|COMPLETED|Treatment Period and Placebo Run-out||29
9798552|NCT00593736|10906225|FG001|COMPLETED|Treatment Period and Placebo Run-out||31
9798553|NCT00593736|10906226|FG002|COMPLETED|Treatment Period and Placebo Run-out||30
9798554|NCT00593736|10906227|FG003|COMPLETED|Treatment Period and Placebo Run-out||28
9798555|NCT00593736|10906224|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3
9798556|NCT00593736|10906225|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2
9798557|NCT00593736|10906226|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5
9798558|NCT00593736|10906227|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4
9798559|NCT00593814|10906239|FG000|STARTED|Overall Study||139
9798560|NCT00593814|10906240|FG001|STARTED|Overall Study||120
9798561|NCT00593814|10906239|FG000|COMPLETED|Overall Study||115
9798562|NCT00593814|10906240|FG001|COMPLETED|Overall Study||120
9798563|NCT00593814|10906239|FG000|NOT COMPLETED|Overall Study||24
9798564|NCT00593814|10906240|FG001|NOT COMPLETED|Overall Study||0
9798565|NCT00593827|10906248|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
9798566|NCT00593827|10906249|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
9798567|NCT00593827|10906248|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
9798568|NCT00593827|10906249|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
9798569|NCT00593827|10906248|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
9798570|NCT00593827|10906249|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
9798571|NCT00593827|10906248|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
9798572|NCT00593827|10906249|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
9798573|NCT00593827|10906248|FG000|NOT COMPLETED|Overall Study||0
9798574|NCT00593827|10906249|FG001|NOT COMPLETED|Overall Study||2
9798578|NCT00593866|10906259|FG000|STARTED|Overall Study||50
9798579|NCT00593866|10906259|FG000|COMPLETED|Overall Study||50
9798580|NCT00593866|10906259|FG000|NOT COMPLETED|Overall Study||0
9798581|NCT00593918|10906265|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
9798582|NCT00593918|10906266|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
9798583|NCT00593918|10906265|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
9798584|NCT00593918|10906266|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
9798585|NCT00593918|10906265|FG000|NOT COMPLETED|Overall Study||5
9798586|NCT00593918|10906266|FG001|NOT COMPLETED|Overall Study||24
9798587|NCT00593957|10906275|FG000|STARTED|Overall Study||13
9798588|NCT00593957|10906276|FG001|STARTED|Overall Study||13
9798589|NCT00593957|10906277|FG002|STARTED|Overall Study||12
9798590|NCT00593957|10906275|FG000|COMPLETED|Overall Study||13
9798591|NCT00593957|10906276|FG001|COMPLETED|Overall Study||12
9798592|NCT00593957|10906277|FG002|COMPLETED|Overall Study||10
9798593|NCT00593957|10906275|FG000|NOT COMPLETED|Overall Study||0
9798594|NCT00593957|10906276|FG001|NOT COMPLETED|Overall Study||1
9798595|NCT00593957|10906277|FG002|NOT COMPLETED|Overall Study||2
9798596|NCT00594009|10906299|FG000|STARTED|Overall Study||1
9798597|NCT00594009|10906299|FG000|COMPLETED|Overall Study||1
9798598|NCT00594009|10906299|FG000|NOT COMPLETED|Overall Study||0
9798599|NCT00594022|10906305|FG000|STARTED|Overall Study||176
9798600|NCT00594022|10906306|FG001|STARTED|Overall Study||173
9798601|NCT00594022|10906305|FG000|COMPLETED|Overall Study||176
9798602|NCT00594022|10906306|FG001|COMPLETED|Overall Study||173
9798603|NCT00594022|10906305|FG000|NOT COMPLETED|Overall Study||0
9798604|NCT00594022|10906306|FG001|NOT COMPLETED|Overall Study||0
10015767|NCT01807520|11138790|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65
10015768|NCT01807520|11138791|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0
10015769|NCT01807520|11138792|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0
10015770|NCT01807520|11138793|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0
10015771|NCT01807520|11138794|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0
10015772|NCT01807520|11138788|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
10015773|NCT01807520|11138789|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
10015774|NCT01807520|11138790|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
10015775|NCT01807520|11138791|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10112204|NCT02502097|11243301|FG002|STARTED|Period 2||20
10112205|NCT02502097|11243302|FG003|STARTED|Period 2||21
10112206|NCT02502097|11243299|FG000|COMPLETED|Period 2||4
10112207|NCT02502097|11243300|FG001|COMPLETED|Period 2||2
10112208|NCT02502097|11243301|FG002|COMPLETED|Period 2||19
10112209|NCT02502097|11243302|FG003|COMPLETED|Period 2||21
10112210|NCT02502097|11243299|FG000|NOT COMPLETED|Period 2||0
10112211|NCT02502097|11243300|FG001|NOT COMPLETED|Period 2||0
10112212|NCT02502097|11243301|FG002|NOT COMPLETED|Period 2||1
10112213|NCT02502097|11243302|FG003|NOT COMPLETED|Period 2||0
10112214|NCT02502149|11243309|FG000|STARTED|PK1 Assessment Period||24
10112215|NCT02502149|11243310|FG001|STARTED|PK1 Assessment Period||0
10112216|NCT02502149|11243311|FG002|STARTED|PK1 Assessment Period||0
10112217|NCT02502149|11243312|FG003|STARTED|PK1 Assessment Period||0
10112218|NCT02502149|11243313|FG004|STARTED|PK1 Assessment Period||0
9798605|NCT00594035|10906314|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
9798606|NCT00594035|10906315|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
9798607|NCT00594035|10906314|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
9798608|NCT00594035|10906315|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
9798609|NCT00594035|10906314|FG000|NOT COMPLETED|Overall Study||2
9798610|NCT00594035|10906315|FG001|NOT COMPLETED|Overall Study||3
9798611|NCT00594061|10906321|FG000|STARTED|Overall Study||9
9798612|NCT00594061|10906321|FG000|COMPLETED|Overall Study||9
9798613|NCT00594061|10906321|FG000|NOT COMPLETED|Overall Study||0
9798614|NCT00594100|10906325|FG000|STARTED|Procedure||245
10015776|NCT01807520|11138792|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10015777|NCT01807520|11138793|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10015778|NCT01807520|11138794|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10015779|NCT01807520|11138788|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67
10015780|NCT01807520|11138789|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65
10112219|NCT02502149|11243309|FG000|COMPLETED|PK1 Assessment Period||24
10112220|NCT02502149|11243310|FG001|COMPLETED|PK1 Assessment Period||0
10112221|NCT02502149|11243311|FG002|COMPLETED|PK1 Assessment Period||0
10112222|NCT02502149|11243312|FG003|COMPLETED|PK1 Assessment Period||0
10112223|NCT02502149|11243313|FG004|COMPLETED|PK1 Assessment Period||0
10112224|NCT02502149|11243309|FG000|NOT COMPLETED|PK1 Assessment Period||0
10112225|NCT02502149|11243310|FG001|NOT COMPLETED|PK1 Assessment Period||0
10112226|NCT02502149|11243311|FG002|NOT COMPLETED|PK1 Assessment Period||0
10112227|NCT02502149|11243312|FG003|NOT COMPLETED|PK1 Assessment Period||0
10112228|NCT02502149|11243313|FG004|NOT COMPLETED|PK1 Assessment Period||0
10112229|NCT02502149|11243309|FG000|STARTED|Intermediate||24
10112230|NCT02502149|11243310|FG001|STARTED|Intermediate||0
10112231|NCT02502149|11243311|FG002|STARTED|Intermediate||0
10112232|NCT02502149|11243312|FG003|STARTED|Intermediate||0
10112233|NCT02502149|11243313|FG004|STARTED|Intermediate||0
10112234|NCT02502149|11243309|FG000|COMPLETED|Intermediate||23
10112235|NCT02502149|11243310|FG001|COMPLETED|Intermediate||0
10112236|NCT02502149|11243311|FG002|COMPLETED|Intermediate||0
10112237|NCT02502149|11243312|FG003|COMPLETED|Intermediate||0
10112238|NCT02502149|11243313|FG004|COMPLETED|Intermediate||0
10112239|NCT02502149|11243309|FG000|NOT COMPLETED|Intermediate||1
10112240|NCT02502149|11243310|FG001|NOT COMPLETED|Intermediate||0
10112241|NCT02502149|11243311|FG002|NOT COMPLETED|Intermediate||0
10112242|NCT02502149|11243312|FG003|NOT COMPLETED|Intermediate||0
10112243|NCT02502149|11243313|FG004|NOT COMPLETED|Intermediate||0
10112244|NCT02502149|11243309|FG000|STARTED|PK2 Assessment Period||0
10112245|NCT02502149|11243310|FG001|STARTED|PK2 Assessment Period||11
10112246|NCT02502149|11243311|FG002|STARTED|PK2 Assessment Period||12
10112247|NCT02502149|11243312|FG003|STARTED|PK2 Assessment Period||0
10112248|NCT02502149|11243313|FG004|STARTED|PK2 Assessment Period||0
10112249|NCT02502149|11243309|FG000|COMPLETED|PK2 Assessment Period||0
9798615|NCT00594100|10906325|FG000|COMPLETED|Procedure||236
9798616|NCT00594100|10906325|FG000|NOT COMPLETED|Procedure||9
9798617|NCT00594100|10906325|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236
9798618|NCT00594100|10906325|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224
9798619|NCT00594100|10906325|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
9798620|NCT00594165|10906329|FG000|STARTED|Overall Study||217
9798621|NCT00594165|10906329|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
9798622|NCT00594165|10906329|FG000|NOT COMPLETED|Overall Study||217
9798623|NCT00594178|10906333|FG000|STARTED|Overall Study||17
9798624|NCT00594178|10906333|FG000|COMPLETED|Overall Study||12
9798625|NCT00594178|10906333|FG000|NOT COMPLETED|Overall Study||5
9798626|NCT00594204|10906339|FG000|STARTED|Overall Study||394
9798627|NCT00594204|10906340|FG001|STARTED|Overall Study||199
9798628|NCT00594204|10906339|FG000|Received Treatment|Overall Study||390
9798629|NCT00594204|10906340|FG001|Received Treatment|Overall Study||198
9798630|NCT00594204|10906339|FG000|COMPLETED|Overall Study||336
9798631|NCT00594204|10906340|FG001|COMPLETED|Overall Study||154
9798632|NCT00594204|10906339|FG000|NOT COMPLETED|Overall Study||58
9798633|NCT00594204|10906340|FG001|NOT COMPLETED|Overall Study||45
9798634|NCT00594230|10906348|FG000|STARTED|Overall Study||16
9798635|NCT00594230|10906349|FG001|STARTED|Overall Study||10
9798636|NCT00594230|10906348|FG000|COMPLETED|Overall Study||1
9798637|NCT00594230|10906349|FG001|COMPLETED|Overall Study||1
9798638|NCT00594230|10906348|FG000|NOT COMPLETED|Overall Study||15
9798639|NCT00594230|10906349|FG001|NOT COMPLETED|Overall Study||9
9798640|NCT00594256|10906355|FG000|STARTED|Overall Study||8
9798641|NCT00594256|10906355|FG000|COMPLETED|Overall Study||8
9798642|NCT00594256|10906355|FG000|NOT COMPLETED|Overall Study||0
9798643|NCT00594308|10906360|FG000|STARTED|Overall Study||10
9798644|NCT00594308|10906360|FG000|COMPLETED|Overall Study||10
9798645|NCT00594308|10906360|FG000|NOT COMPLETED|Overall Study||0
9798646|NCT00594399|10906366|FG000|STARTED|Initial 3 Month Counseling||180
9798647|NCT00594399|10906367|FG001|STARTED|Initial 3 Month Counseling||122
9798648|NCT00594399|10906368|FG002|STARTED|Initial 3 Month Counseling||0
9798649|NCT00594399|10906366|FG000|COMPLETED|Initial 3 Month Counseling||163
9798650|NCT00594399|10906367|FG001|COMPLETED|Initial 3 Month Counseling||118
9798651|NCT00594399|10906368|FG002|COMPLETED|Initial 3 Month Counseling||0
9798652|NCT00594399|10906366|FG000|NOT COMPLETED|Initial 3 Month Counseling||17
9798653|NCT00594399|10906367|FG001|NOT COMPLETED|Initial 3 Month Counseling||4
9798654|NCT00594399|10906368|FG002|NOT COMPLETED|Initial 3 Month Counseling||0
9798655|NCT00594399|10906366|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
9798656|NCT00594399|10906367|FG001|STARTED|Rerandomization Arm 1 Only||118
9798657|NCT00594399|10906368|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
9798658|NCT00594399|10906366|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
9798659|NCT00594399|10906367|FG001|Rerandomization|Rerandomization Arm 1 Only||114
10112250|NCT02502149|11243310|FG001|COMPLETED|PK2 Assessment Period||11
10112251|NCT02502149|11243311|FG002|COMPLETED|PK2 Assessment Period||12
10112252|NCT02502149|11243312|FG003|COMPLETED|PK2 Assessment Period||0
10112253|NCT02502149|11243313|FG004|COMPLETED|PK2 Assessment Period||0
10112254|NCT02502149|11243309|FG000|NOT COMPLETED|PK2 Assessment Period||0
10112255|NCT02502149|11243310|FG001|NOT COMPLETED|PK2 Assessment Period||0
10112256|NCT02502149|11243311|FG002|NOT COMPLETED|PK2 Assessment Period||0
10112257|NCT02502149|11243312|FG003|NOT COMPLETED|PK2 Assessment Period||0
9798660|NCT00594399|10906368|FG002|Rerandomization|Rerandomization Arm 1 Only||82
9798661|NCT00594399|10906366|FG000|COMPLETED|Rerandomization Arm 1 Only||79
9798662|NCT00594399|10906367|FG001|COMPLETED|Rerandomization Arm 1 Only||114
9798663|NCT00594399|10906368|FG002|COMPLETED|Rerandomization Arm 1 Only||82
9798664|NCT00594399|10906366|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2
9798665|NCT00594399|10906367|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4
9798666|NCT00594399|10906368|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0
9798667|NCT00594425|10906377|FG000|STARTED|Overall Study||50
9798668|NCT00594425|10906378|FG001|STARTED|Overall Study||48
9798669|NCT00594425|10906379|FG002|STARTED|Overall Study||52
9798670|NCT00594425|10906377|FG000|COMPLETED|Overall Study||43
9798671|NCT00594425|10906378|FG001|COMPLETED|Overall Study||34
9798672|NCT00594425|10906379|FG002|COMPLETED|Overall Study||42
9798673|NCT00594425|10906377|FG000|NOT COMPLETED|Overall Study||7
9798674|NCT00594425|10906378|FG001|NOT COMPLETED|Overall Study||14
9798675|NCT00594425|10906379|FG002|NOT COMPLETED|Overall Study||10
9798676|NCT00594464|10906387|FG000|STARTED|Overall Study||14
9798677|NCT00594464|10906387|FG000|COMPLETED|Overall Study||11
9798678|NCT00594464|10906387|FG000|NOT COMPLETED|Overall Study||3
9798679|NCT00594516|10906397|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
9798680|NCT00594516|10906398|FG001|STARTED|Open Label (OL): Tapentadol IR||0
9798681|NCT00594516|10906399|FG002|STARTED|Open Label (OL): Tapentadol IR||0
9798682|NCT00594516|10906397|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87
9798683|NCT00594516|10906398|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0
9798684|NCT00594516|10906399|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0
9798685|NCT00594516|10906397|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
9798686|NCT00594516|10906398|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
9798687|NCT00594516|10906399|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
9798688|NCT00594516|10906397|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0
9798689|NCT00594516|10906398|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44
9798690|NCT00594516|10906399|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43
9798691|NCT00594516|10906397|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
9798692|NCT00594516|10906398|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
9798693|NCT00594516|10906399|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
9798694|NCT00594516|10906397|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
9798695|NCT00594516|10906398|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
9798696|NCT00594516|10906399|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
9798697|NCT00594568|10906406|FG000|STARTED|Initial Treatment||501
9798698|NCT00594568|10906407|FG001|STARTED|Initial Treatment||507
9798699|NCT00594568|10906408|FG002|STARTED|Initial Treatment||529
9798700|NCT00594568|10906406|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
9798701|NCT00594568|10906407|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
10015781|NCT01807520|11138790|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65
10015782|NCT01807520|11138791|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0
10015783|NCT01807520|11138792|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0
9798702|NCT00594568|10906408|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
9798703|NCT00594568|10906406|FG000|COMPLETED|Initial Treatment||189
9798704|NCT00594568|10906407|FG001|COMPLETED|Initial Treatment||153
9798705|NCT00594568|10906408|FG002|COMPLETED|Initial Treatment||121
9798706|NCT00594568|10906406|FG000|NOT COMPLETED|Initial Treatment||312
9798707|NCT00594568|10906407|FG001|NOT COMPLETED|Initial Treatment||354
9798708|NCT00594568|10906408|FG002|NOT COMPLETED|Initial Treatment||408
9798709|NCT00594568|10906406|FG000|STARTED|Delayed Start||189
9798710|NCT00594568|10906407|FG001|STARTED|Delayed Start||153
9798711|NCT00594568|10906408|FG002|STARTED|Delayed Start||121
9798712|NCT00594568|10906406|FG000|COMPLETED|Delayed Start||91
9798713|NCT00594568|10906407|FG001|COMPLETED|Delayed Start||76
9798714|NCT00594568|10906408|FG002|COMPLETED|Delayed Start||55
9798715|NCT00594568|10906406|FG000|NOT COMPLETED|Delayed Start||98
9798716|NCT00594568|10906407|FG001|NOT COMPLETED|Delayed Start||77
9798717|NCT00594568|10906408|FG002|NOT COMPLETED|Delayed Start||66
9798718|NCT00594568|10906406|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
9798719|NCT00594568|10906407|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
9798720|NCT00594568|10906408|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
9798721|NCT00594568|10906406|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229
9798722|NCT00594568|10906407|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168
9798723|NCT00594568|10906408|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172
9798724|NCT00594568|10906406|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
9798725|NCT00594568|10906407|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
9798726|NCT00594568|10906408|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
9798727|NCT00594646|10906424|FG000|STARTED|Overall Study||100
9798728|NCT00594646|10906424|FG000|COMPLETED|Overall Study||84
9798729|NCT00594646|10906424|FG000|NOT COMPLETED|Overall Study||16
10015784|NCT01807520|11138793|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0
10015785|NCT01807520|11138794|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0
10015786|NCT01807520|11138788|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
10015787|NCT01807520|11138789|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
10015788|NCT01807520|11138790|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
10015789|NCT01807520|11138791|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10015790|NCT01807520|11138792|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
9798730|NCT00594659|10906432|FG000|STARTED|Overall Study||29
9798731|NCT00594659|10906433|FG001|STARTED|Overall Study||30
9798732|NCT00594659|10906434|FG002|STARTED|Overall Study||16
9798733|NCT00594659|10906432|FG000|COMPLETED|Overall Study||16
9798734|NCT00594659|10906433|FG001|COMPLETED|Overall Study||21
9798735|NCT00594659|10906434|FG002|COMPLETED|Overall Study||9
9798736|NCT00594659|10906432|FG000|NOT COMPLETED|Overall Study||13
9798737|NCT00594659|10906433|FG001|NOT COMPLETED|Overall Study||9
9798738|NCT00594659|10906434|FG002|NOT COMPLETED|Overall Study||7
10015791|NCT01807520|11138793|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10015792|NCT01807520|11138794|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10015793|NCT01807520|11138788|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
9798739|NCT00594685|10906442|FG000|STARTED|Overall Study||10
9798740|NCT00594685|10906442|FG000|COMPLETED|Overall Study||10
9798741|NCT00594685|10906442|FG000|NOT COMPLETED|Overall Study||0
9798742|NCT00594815|10906446|FG000|STARTED|Overall Study||52
9798743|NCT00594815|10906446|FG000|COMPLETED|Overall Study||43
9798744|NCT00594815|10906446|FG000|NOT COMPLETED|Overall Study||9
9798745|NCT00594854|10906452|FG000|STARTED|Overall Study||9
9798746|NCT00594854|10906453|FG001|STARTED|Overall Study||11
9798747|NCT00594854|10906452|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
9798748|NCT00594854|10906453|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
9798749|NCT00594854|10906452|FG000|NOT COMPLETED|Overall Study||7
9798750|NCT00594854|10906453|FG001|NOT COMPLETED|Overall Study||10
9798751|NCT00594880|10906461|FG000|STARTED|Overall Study||12
10015794|NCT01807520|11138789|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
10015795|NCT01807520|11138790|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
10015796|NCT01807520|11138791|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10015797|NCT01807520|11138792|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
9798752|NCT00594880|10906462|FG001|STARTED|Overall Study||11
9798753|NCT00594880|10906461|FG000|COMPLETED|Overall Study||10
9798754|NCT00594880|10906462|FG001|COMPLETED|Overall Study||10
9798755|NCT00594880|10906461|FG000|NOT COMPLETED|Overall Study||2
9798756|NCT00594880|10906462|FG001|NOT COMPLETED|Overall Study||1
9798757|NCT00594906|10906474|FG000|STARTED|Overall Study||7
9798758|NCT00594906|10906475|FG001|STARTED|Overall Study||3
9798759|NCT00594906|10906474|FG000|COMPLETED|Overall Study||6
9798760|NCT00594906|10906475|FG001|COMPLETED|Overall Study||1
9798761|NCT00594906|10906474|FG000|NOT COMPLETED|Overall Study||1
9798762|NCT00594906|10906475|FG001|NOT COMPLETED|Overall Study||2
9798763|NCT00594932|10906483|FG000|STARTED|First 3 Months||13
9798764|NCT00594932|10906484|FG001|STARTED|First 3 Months||14
9798765|NCT00594932|10906483|FG000|COMPLETED|First 3 Months||12
9798766|NCT00594932|10906484|FG001|COMPLETED|First 3 Months||11
9798767|NCT00594932|10906483|FG000|NOT COMPLETED|First 3 Months||1
9798768|NCT00594932|10906484|FG001|NOT COMPLETED|First 3 Months||3
9798769|NCT00594932|10906483|FG000|STARTED|Final 3 Months||12
9798770|NCT00594932|10906484|FG001|STARTED|Final 3 Months||11
9798771|NCT00594932|10906483|FG000|COMPLETED|Final 3 Months||8
9798772|NCT00594932|10906484|FG001|COMPLETED|Final 3 Months||8
9798773|NCT00594932|10906483|FG000|NOT COMPLETED|Final 3 Months||4
9798774|NCT00594932|10906484|FG001|NOT COMPLETED|Final 3 Months||3
9798775|NCT00594945|10906493|FG000|STARTED|Cohort 1 / Treatment Period 1||4
9798776|NCT00594945|10906494|FG001|STARTED|Cohort 1 / Treatment Period 1||0
9798777|NCT00594945|10906495|FG002|STARTED|Cohort 1 / Treatment Period 1||2
9798778|NCT00594945|10906493|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4
9798779|NCT00594945|10906494|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0
9798780|NCT00594945|10906495|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2
9798781|NCT00594945|10906493|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
9798782|NCT00594945|10906494|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
9798783|NCT00594945|10906495|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
9798784|NCT00594945|10906493|FG000|STARTED|Cohort 2 / Treatment Period 2||0
9798785|NCT00594945|10906494|FG001|STARTED|Cohort 2 / Treatment Period 2||3
9798786|NCT00594945|10906495|FG002|STARTED|Cohort 2 / Treatment Period 2||2
9798787|NCT00594945|10906493|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0
9798788|NCT00594945|10906494|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3
9798789|NCT00594945|10906495|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2
9798790|NCT00594945|10906493|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
9798791|NCT00594945|10906494|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
9798792|NCT00594945|10906495|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
9798793|NCT00594958|10906504|FG000|STARTED|Overall Study||214
9798794|NCT00594958|10906505|FG001|STARTED|Overall Study||213
9798795|NCT00594958|10906506|FG002|STARTED|Overall Study||212
9798796|NCT00594958|10906504|FG000|Randomized and at Least 1 Vaccination|Overall Study||212
9798797|NCT00594958|10906505|FG001|Randomized and at Least 1 Vaccination|Overall Study||213
9798798|NCT00594958|10906506|FG002|Randomized and at Least 1 Vaccination|Overall Study||211
9798799|NCT00594958|10906504|FG000|COMPLETED|Overall Study||200
10015798|NCT01807520|11138793|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10015799|NCT01807520|11138794|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10015800|NCT01807520|11138788|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63
9798800|NCT00594958|10906505|FG001|COMPLETED|Overall Study||210
9798801|NCT00594958|10906506|FG002|COMPLETED|Overall Study||202
9798802|NCT00594958|10906504|FG000|NOT COMPLETED|Overall Study||14
9798803|NCT00594958|10906505|FG001|NOT COMPLETED|Overall Study||3
9798804|NCT00594958|10906506|FG002|NOT COMPLETED|Overall Study||10
9798805|NCT00594997|10906516|FG000|STARTED|Overall Study||1562
9798806|NCT00594997|10906517|FG001|STARTED|Overall Study||2008
9798807|NCT00594997|10906516|FG000|COMPLETED|Overall Study||1562
9798808|NCT00594997|10906517|FG001|COMPLETED|Overall Study||2008
9798809|NCT00594997|10906516|FG000|NOT COMPLETED|Overall Study||0
9798810|NCT00594997|10906517|FG001|NOT COMPLETED|Overall Study||0
9798811|NCT00595075|10906527|FG000|STARTED|Overall Study||6
9798812|NCT00595075|10906528|FG001|STARTED|Overall Study||5
9798813|NCT00595075|10906527|FG000|COMPLETED|Overall Study||5
9798814|NCT00595075|10906528|FG001|COMPLETED|Overall Study||5
9798815|NCT00595075|10906527|FG000|NOT COMPLETED|Overall Study||1
9798816|NCT00595075|10906528|FG001|NOT COMPLETED|Overall Study||0
9798817|NCT00595088|10906534|FG000|STARTED|Overall Study||47
9798818|NCT00595088|10906534|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
9798819|NCT00595088|10906534|FG000|NOT COMPLETED|Overall Study||40
9798820|NCT00595101|10906542|FG000|STARTED|Overall Study||29
9798821|NCT00595101|10906543|FG001|STARTED|Overall Study||29
9798822|NCT00595101|10906544|FG002|STARTED|Overall Study||29
9798823|NCT00595101|10906545|FG003|STARTED|Overall Study||30
9798824|NCT00595101|10906542|FG000|COMPLETED|Overall Study||29
9798825|NCT00595101|10906543|FG001|COMPLETED|Overall Study||28
9798826|NCT00595101|10906544|FG002|COMPLETED|Overall Study||29
9798827|NCT00595101|10906545|FG003|COMPLETED|Overall Study||30
9798828|NCT00595101|10906542|FG000|NOT COMPLETED|Overall Study||0
9798829|NCT00595101|10906543|FG001|NOT COMPLETED|Overall Study||1
9798830|NCT00595101|10906544|FG002|NOT COMPLETED|Overall Study||0
9798831|NCT00595101|10906545|FG003|NOT COMPLETED|Overall Study||0
9798832|NCT00595114|10906557|FG000|STARTED|Overall Study||24
9798833|NCT00595114|10906558|FG001|STARTED|Overall Study||19
9798834|NCT00595114|10906557|FG000|COMPLETED|Overall Study||24
9798835|NCT00595114|10906558|FG001|COMPLETED|Overall Study||19
9798836|NCT00595114|10906557|FG000|NOT COMPLETED|Overall Study||0
9798837|NCT00595114|10906558|FG001|NOT COMPLETED|Overall Study||0
9798838|NCT00595127|10906564|FG000|STARTED|Overall Study||21
9798839|NCT00595127|10906564|FG000|COMPLETED|Overall Study||11
9798840|NCT00595127|10906564|FG000|NOT COMPLETED|Overall Study||10
9798841|NCT00595153|10906571|FG000|STARTED|Overall Study||24
9798842|NCT00595153|10906572|FG001|STARTED|Overall Study||42
9798843|NCT00595153|10906573|FG002|STARTED|Overall Study||61
9798844|NCT00595153|10906571|FG000|COMPLETED|Overall Study||20
9798845|NCT00595153|10906572|FG001|COMPLETED|Overall Study||26
9798846|NCT00595153|10906573|FG002|COMPLETED|Overall Study||36
9798847|NCT00595153|10906571|FG000|NOT COMPLETED|Overall Study||4
9798848|NCT00595153|10906572|FG001|NOT COMPLETED|Overall Study||16
9798849|NCT00595153|10906573|FG002|NOT COMPLETED|Overall Study||25
9798850|NCT00595231|10906583|FG000|STARTED|Overall Study||120
9798851|NCT00595231|10906584|FG001|STARTED|Overall Study||119
9798852|NCT00595231|10906583|FG000|COMPLETED|Overall Study||115
9798853|NCT00595231|10906584|FG001|COMPLETED|Overall Study||114
9798854|NCT00595231|10906583|FG000|NOT COMPLETED|Overall Study||5
9798855|NCT00595231|10906584|FG001|NOT COMPLETED|Overall Study||5
9798856|NCT00595270|10906593|FG000|STARTED|Overall Study||116
9798857|NCT00595270|10906594|FG001|STARTED|Overall Study||117
9798858|NCT00595270|10906595|FG002|STARTED|Overall Study||116
9798859|NCT00595270|10906593|FG000|COMPLETED|Overall Study||110
9798860|NCT00595270|10906594|FG001|COMPLETED|Overall Study||107
9798861|NCT00595270|10906595|FG002|COMPLETED|Overall Study||108
9798862|NCT00595270|10906593|FG000|NOT COMPLETED|Overall Study||6
9798863|NCT00595270|10906594|FG001|NOT COMPLETED|Overall Study||10
9798864|NCT00595270|10906595|FG002|NOT COMPLETED|Overall Study||8
9798865|NCT00595309|10906603|FG000|STARTED|Overall Study||198
9798866|NCT00595309|10906603|FG000|COMPLETED|Overall Study||194
9798867|NCT00595309|10906603|FG000|NOT COMPLETED|Overall Study||4
9798868|NCT00595335|10906609|FG000|STARTED|Baseline to Six Months||13
9798869|NCT00595335|10906610|FG001|STARTED|Baseline to Six Months||12
9798870|NCT00595335|10906609|FG000|COMPLETED|Baseline to Six Months||11
9798871|NCT00595335|10906610|FG001|COMPLETED|Baseline to Six Months||10
9798872|NCT00595335|10906609|FG000|NOT COMPLETED|Baseline to Six Months||2
9798873|NCT00595335|10906610|FG001|NOT COMPLETED|Baseline to Six Months||2
9798874|NCT00595335|10906609|FG000|STARTED|Six Months to Twelve Months||11
9798875|NCT00595335|10906610|FG001|STARTED|Six Months to Twelve Months||10
9798876|NCT00595335|10906609|FG000|COMPLETED|Six Months to Twelve Months||10
9798877|NCT00595335|10906610|FG001|COMPLETED|Six Months to Twelve Months||9
9798878|NCT00595335|10906609|FG000|NOT COMPLETED|Six Months to Twelve Months||1
9798879|NCT00595335|10906610|FG001|NOT COMPLETED|Six Months to Twelve Months||1
9798880|NCT00595361|10906622|FG000|STARTED|Overall Study||12
9798881|NCT00595361|10906623|FG001|STARTED|Overall Study||18
9798882|NCT00595361|10906622|FG000|COMPLETED|Overall Study||12
9798883|NCT00595361|10906623|FG001|COMPLETED|Overall Study||18
9798884|NCT00595361|10906622|FG000|NOT COMPLETED|Overall Study||0
9798885|NCT00595361|10906623|FG001|NOT COMPLETED|Overall Study||0
9798886|NCT00595413|10906633|FG000|STARTED|Overall Study||76
9798887|NCT00595413|10906634|FG001|STARTED|Overall Study||78
9798888|NCT00595413|10906635|FG002|STARTED|Overall Study||78
9798889|NCT00595413|10906636|FG003|STARTED|Overall Study||79
9798890|NCT00595413|10906633|FG000|COMPLETED|Overall Study||69
9798891|NCT00595413|10906634|FG001|COMPLETED|Overall Study||73
9798892|NCT00595413|10906635|FG002|COMPLETED|Overall Study||70
9798893|NCT00595413|10906636|FG003|COMPLETED|Overall Study||75
9798894|NCT00595413|10906633|FG000|NOT COMPLETED|Overall Study||7
9798895|NCT00595413|10906634|FG001|NOT COMPLETED|Overall Study||5
9798896|NCT00595413|10906635|FG002|NOT COMPLETED|Overall Study||8
9798897|NCT00595413|10906636|FG003|NOT COMPLETED|Overall Study||4
9798898|NCT00595465|10906649|FG000|STARTED|Overall Study||130
9798899|NCT00595465|10906650|FG001|STARTED|Overall Study||129
9798900|NCT00595465|10906651|FG002|STARTED|Overall Study||128
9798901|NCT00595465|10906649|FG000|COMPLETED|Overall Study||124
9798902|NCT00595465|10906650|FG001|COMPLETED|Overall Study||125
9798903|NCT00595465|10906651|FG002|COMPLETED|Overall Study||121
9798904|NCT00595465|10906649|FG000|NOT COMPLETED|Overall Study||6
9798905|NCT00595465|10906650|FG001|NOT COMPLETED|Overall Study||4
9798906|NCT00595465|10906651|FG002|NOT COMPLETED|Overall Study||7
9798907|NCT00595478|10906661|FG000|STARTED|Treatment||37
9798908|NCT00595478|10906662|FG001|STARTED|Treatment||38
9798909|NCT00595478|10906661|FG000|COMPLETED|Treatment||37
9798910|NCT00595478|10906662|FG001|COMPLETED|Treatment||38
9798911|NCT00595478|10906661|FG000|NOT COMPLETED|Treatment||0
9798912|NCT00595478|10906662|FG001|NOT COMPLETED|Treatment||0
9798913|NCT00595478|10906661|FG000|STARTED|36-week Follow-up Period||37
9798914|NCT00595478|10906662|FG001|STARTED|36-week Follow-up Period||38
9798915|NCT00595478|10906661|FG000|COMPLETED|36-week Follow-up Period||28
9798916|NCT00595478|10906662|FG001|COMPLETED|36-week Follow-up Period||30
9798917|NCT00595478|10906661|FG000|NOT COMPLETED|36-week Follow-up Period||9
9798918|NCT00595478|10906662|FG001|NOT COMPLETED|36-week Follow-up Period||8
9798919|NCT00595504|10906670|FG000|STARTED|Overall Study||16
9798920|NCT00595504|10906671|FG001|STARTED|Overall Study||9
9798921|NCT00595504|10906670|FG000|COMPLETED|Overall Study||14
9798922|NCT00595504|10906671|FG001|COMPLETED|Overall Study||6
9798923|NCT00595504|10906670|FG000|NOT COMPLETED|Overall Study||2
9798924|NCT00595504|10906671|FG001|NOT COMPLETED|Overall Study||3
9798925|NCT00595517|10906677|FG000|STARTED|Overall Study||130
9798926|NCT00595517|10906677|FG000|COMPLETED|Overall Study||111
9798927|NCT00595517|10906677|FG000|NOT COMPLETED|Overall Study||19
9798928|NCT00595530|10906681|FG000|STARTED|Overall Study||3
9798929|NCT00595530|10906681|FG000|COMPLETED|Overall Study||3
9798930|NCT00595530|10906681|FG000|NOT COMPLETED|Overall Study||0
9798931|NCT00595556|10906688|FG000|STARTED|Overall Study||20
9798932|NCT00595556|10906689|FG001|STARTED|Overall Study||20
9798933|NCT00595556|10906688|FG000|COMPLETED|Overall Study||17
9798934|NCT00595556|10906689|FG001|COMPLETED|Overall Study||19
9798935|NCT00595556|10906688|FG000|NOT COMPLETED|Overall Study||3
9798936|NCT00595556|10906689|FG001|NOT COMPLETED|Overall Study||1
9798937|NCT00595621|10906697|FG000|STARTED|Open Label Run in||22
9798938|NCT00595621|10906698|FG001|STARTED|Open Label Run in||0
9798939|NCT00595621|10906697|FG000|COMPLETED|Open Label Run in||19
9798940|NCT00595621|10906698|FG001|COMPLETED|Open Label Run in||0
9798941|NCT00595621|10906697|FG000|NOT COMPLETED|Open Label Run in||3
9798942|NCT00595621|10906698|FG001|NOT COMPLETED|Open Label Run in||0
9798943|NCT00595621|10906697|FG000|STARTED|Randomization and Study||10
9798944|NCT00595621|10906698|FG001|STARTED|Randomization and Study||9
9798945|NCT00595621|10906697|FG000|COMPLETED|Randomization and Study||8
9798946|NCT00595621|10906698|FG001|COMPLETED|Randomization and Study||8
9798947|NCT00595621|10906697|FG000|NOT COMPLETED|Randomization and Study||2
9798948|NCT00595621|10906698|FG001|NOT COMPLETED|Randomization and Study||1
9798949|NCT00595764|10906707|FG000|STARTED|Overall Study||71
9798950|NCT00595764|10906708|FG001|STARTED|Overall Study||70
9798951|NCT00595764|10906707|FG000|COMPLETED|Overall Study||32
9798952|NCT00595764|10906708|FG001|COMPLETED|Overall Study||27
9798953|NCT00595764|10906707|FG000|NOT COMPLETED|Overall Study||39
9798954|NCT00595764|10906708|FG001|NOT COMPLETED|Overall Study||43
9798955|NCT00595790|10906717|FG000|STARTED|Overall Study||125
9798956|NCT00595790|10906718|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
9798957|NCT00595790|10906719|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
9798958|NCT00595790|10906717|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
9798959|NCT00595790|10906718|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
9798960|NCT00595790|10906719|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
9798961|NCT00595790|10906717|FG000|NOT COMPLETED|Overall Study||2
9798962|NCT00595790|10906718|FG001|NOT COMPLETED|Overall Study||1
9798963|NCT00595790|10906719|FG002|NOT COMPLETED|Overall Study||3
9798964|NCT00595868|10906729|FG000|STARTED|Overall Study||107
9798965|NCT00595868|10906730|FG001|STARTED|Overall Study||111
9798966|NCT00595868|10906729|FG000|COMPLETED|Overall Study||62
9798967|NCT00595868|10906730|FG001|COMPLETED|Overall Study||61
9798968|NCT00595868|10906729|FG000|NOT COMPLETED|Overall Study||45
9798969|NCT00595868|10906730|FG001|NOT COMPLETED|Overall Study||50
9798970|NCT00595881|10906736|FG000|STARTED|Overall Study||420
9798971|NCT00595881|10906736|FG000|COMPLETED|Overall Study||420
9798972|NCT00595881|10906736|FG000|NOT COMPLETED|Overall Study||0
9798973|NCT00595946|10906743|FG000|STARTED|Overall Study||218
9798974|NCT00595946|10906744|FG001|STARTED|Overall Study||221
9798975|NCT00595946|10906743|FG000|COMPLETED|Overall Study||154
9798976|NCT00595946|10906744|FG001|COMPLETED|Overall Study||152
9798977|NCT00595946|10906743|FG000|NOT COMPLETED|Overall Study||64
9798978|NCT00595946|10906744|FG001|NOT COMPLETED|Overall Study||69
9798979|NCT00595959|10906750|FG000|STARTED|Overall Study||65
9798980|NCT00595959|10906750|FG000|COMPLETED|Overall Study||63
9798981|NCT00595959|10906750|FG000|NOT COMPLETED|Overall Study||2
9798982|NCT00596011|10906756|FG000|STARTED|Overall Study||49
9798983|NCT00596011|10906757|FG001|STARTED|Overall Study||48
9798984|NCT00596011|10906756|FG000|COMPLETED|Overall Study||36
9798985|NCT00596011|10906757|FG001|COMPLETED|Overall Study||38
9798986|NCT00596011|10906756|FG000|NOT COMPLETED|Overall Study||13
9798987|NCT00596011|10906757|FG001|NOT COMPLETED|Overall Study||10
9798988|NCT00596102|10906766|FG000|STARTED|Up to Month 6||2283
9798989|NCT00596102|10906767|FG001|STARTED|Up to Month 6||338
9798990|NCT00596102|10906768|FG002|STARTED|Up to Month 6||637
9798991|NCT00596102|10906766|FG000|COMPLETED|Up to Month 6||2283
9798992|NCT00596102|10906767|FG001|COMPLETED|Up to Month 6||338
9798993|NCT00596102|10906768|FG002|COMPLETED|Up to Month 6||637
9798994|NCT00596102|10906766|FG000|NOT COMPLETED|Up to Month 6||0
9798995|NCT00596102|10906767|FG001|NOT COMPLETED|Up to Month 6||0
9798996|NCT00596102|10906768|FG002|NOT COMPLETED|Up to Month 6||0
9798997|NCT00596102|10906766|FG000|STARTED|Up to Month 60||2283
9798998|NCT00596102|10906767|FG001|STARTED|Up to Month 60||338
9798999|NCT00596102|10906768|FG002|STARTED|Up to Month 60||637
9799000|NCT00596102|10906766|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
9799001|NCT00596102|10906767|FG001|COMPLETED|Up to Month 60||0
9799002|NCT00596102|10906768|FG002|COMPLETED|Up to Month 60||0
9799003|NCT00596102|10906766|FG000|NOT COMPLETED|Up to Month 60||2181
9799004|NCT00596102|10906767|FG001|NOT COMPLETED|Up to Month 60||338
9799005|NCT00596102|10906768|FG002|NOT COMPLETED|Up to Month 60||637
9799006|NCT00596167|10906775|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6
9799007|NCT00596167|10906775|FG000|COMPLETED|Overall Study||6
9799008|NCT00596167|10906775|FG000|NOT COMPLETED|Overall Study||0
9799009|NCT00596271|10906782|FG000|STARTED|Overall Study||65
9799010|NCT00596271|10906783|FG001|STARTED|Overall Study||65
9799011|NCT00596271|10906784|FG002|STARTED|Overall Study||62
9799012|NCT00596271|10906782|FG000|COMPLETED|Overall Study||60
9799013|NCT00596271|10906783|FG001|COMPLETED|Overall Study||59
9799014|NCT00596271|10906784|FG002|COMPLETED|Overall Study||61
9799015|NCT00596271|10906782|FG000|NOT COMPLETED|Overall Study||5
9799016|NCT00596271|10906783|FG001|NOT COMPLETED|Overall Study||6
9799017|NCT00596271|10906784|FG002|NOT COMPLETED|Overall Study||1
9799018|NCT00596362|10906793|FG000|STARTED|Overall Study||1
9799019|NCT00596362|10906793|FG000|COMPLETED|Overall Study||0
9799020|NCT00596362|10906793|FG000|NOT COMPLETED|Overall Study||1
9799021|NCT00596427|10906799|FG000|STARTED|Overall Study||30
9799022|NCT00596427|10906800|FG001|STARTED|Overall Study||30
9799023|NCT00596427|10906799|FG000|COMPLETED|Overall Study||26
9799024|NCT00596427|10906800|FG001|COMPLETED|Overall Study||28
9799025|NCT00596427|10906799|FG000|NOT COMPLETED|Overall Study||4
9799026|NCT00596427|10906800|FG001|NOT COMPLETED|Overall Study||2
9799027|NCT00596440|10906809|FG000|STARTED|Overall Study||113
9799028|NCT00596440|10906810|FG001|STARTED|Overall Study||121
9799029|NCT00596440|10906809|FG000|Showed to Eligibility Visit|Overall Study||85
9799030|NCT00596440|10906810|FG001|Showed to Eligibility Visit|Overall Study||72
9799031|NCT00596440|10906809|FG000|Showed to First Treatment Session|Overall Study||61
9799032|NCT00596440|10906810|FG001|Showed to First Treatment Session|Overall Study||52
9799033|NCT00596440|10906809|FG000|COMPLETED|Overall Study||48
9799034|NCT00596440|10906810|FG001|COMPLETED|Overall Study||41
9799035|NCT00596440|10906809|FG000|NOT COMPLETED|Overall Study||65
9799036|NCT00596440|10906810|FG001|NOT COMPLETED|Overall Study||80
9799037|NCT00596453|10906818|FG000|STARTED|Overall Study||13
9799038|NCT00596453|10906819|FG001|STARTED|Overall Study||15
9799039|NCT00596453|10906818|FG000|COMPLETED|Overall Study||12
9799040|NCT00596453|10906819|FG001|COMPLETED|Overall Study||12
9799041|NCT00596453|10906818|FG000|NOT COMPLETED|Overall Study||1
9799042|NCT00596453|10906819|FG001|NOT COMPLETED|Overall Study||3
9799043|NCT00596466|10906825|FG000|STARTED|Overall Study||75
9799044|NCT00596466|10906825|FG000|Enrolled, Treated|Overall Study||73
9799045|NCT00596466|10906825|FG000|COMPLETED|Overall Study||58
9799046|NCT00596466|10906825|FG000|NOT COMPLETED|Overall Study||17
9799047|NCT00596622|10906832|FG000|STARTED|Overall Study||46
9799048|NCT00596622|10906832|FG000|COMPLETED|Overall Study||33
9799049|NCT00596622|10906832|FG000|NOT COMPLETED|Overall Study||13
9799050|NCT00596635|10906844|FG000|STARTED|Overall Study||17
9799051|NCT00596635|10906845|FG001|STARTED|Overall Study||20
9799052|NCT00596635|10906846|FG002|STARTED|Overall Study||19
9799053|NCT00596635|10906844|FG000|COMPLETED|Overall Study||10
9799054|NCT00596635|10906845|FG001|COMPLETED|Overall Study||7
9799055|NCT00596635|10906846|FG002|COMPLETED|Overall Study||11
9799056|NCT00596635|10906844|FG000|NOT COMPLETED|Overall Study||7
9799057|NCT00596635|10906845|FG001|NOT COMPLETED|Overall Study||13
9799058|NCT00596635|10906846|FG002|NOT COMPLETED|Overall Study||8
9799059|NCT00596687|10906856|FG000|STARTED|Overall Study||118
9799060|NCT00596687|10906857|FG001|STARTED|Overall Study||116
9799061|NCT00596687|10906856|FG000|COMPLETED|Overall Study||104
9799062|NCT00596687|10906857|FG001|COMPLETED|Overall Study||107
9799063|NCT00596687|10906856|FG000|NOT COMPLETED|Overall Study||14
9799064|NCT00596687|10906857|FG001|NOT COMPLETED|Overall Study||9
9799065|NCT00596752|10906865|FG000|STARTED|Overall Study||415
9799066|NCT00596752|10906866|FG001|STARTED|Overall Study||425
9799067|NCT00596752|10906865|FG000|Randomized and Treated|Overall Study||415
9799068|NCT00596752|10906866|FG001|Randomized and Treated|Overall Study||424
9799069|NCT00596752|10906865|FG000|COMPLETED|Overall Study||289
9799070|NCT00596752|10906866|FG001|COMPLETED|Overall Study||282
9799071|NCT00596752|10906865|FG000|NOT COMPLETED|Overall Study||126
9799072|NCT00596752|10906866|FG001|NOT COMPLETED|Overall Study||143
9831176|NCT00767000|10941839|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
9831177|NCT00767000|10941840|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
9831178|NCT00767000|10941841|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
9831179|NCT00767000|10941842|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
9831180|NCT00767000|10941838|FG000|COMPLETED|Optional 104-week Extension||0
9831181|NCT00767000|10941839|FG001|COMPLETED|Optional 104-week Extension||0
9831182|NCT00767000|10941840|FG002|COMPLETED|Optional 104-week Extension||0
9831183|NCT00767000|10941841|FG003|COMPLETED|Optional 104-week Extension||0
9831184|NCT00767000|10941842|FG004|COMPLETED|Optional 104-week Extension||0
9831185|NCT00767000|10941838|FG000|NOT COMPLETED|Optional 104-week Extension||7
9831186|NCT00767000|10941839|FG001|NOT COMPLETED|Optional 104-week Extension||3
9831187|NCT00767000|10941840|FG002|NOT COMPLETED|Optional 104-week Extension||7
9831188|NCT00767000|10941841|FG003|NOT COMPLETED|Optional 104-week Extension||2
9831189|NCT00767000|10941842|FG004|NOT COMPLETED|Optional 104-week Extension||4
9831190|NCT00767039|10941856|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
9831191|NCT00767039|10941857|FG001|STARTED|Overall Study||25
9831192|NCT00767039|10941856|FG000|COMPLETED|Overall Study||22
9831193|NCT00767039|10941857|FG001|COMPLETED|Overall Study||23
9831194|NCT00767039|10941856|FG000|NOT COMPLETED|Overall Study||5
9831195|NCT00767039|10941857|FG001|NOT COMPLETED|Overall Study||2
9831196|NCT00767104|10941865|FG000|STARTED|Overall Study||20
9831197|NCT00767104|10941866|FG001|STARTED|Overall Study||20
9831198|NCT00767104|10941865|FG000|COMPLETED|Overall Study||19
9831199|NCT00767104|10941866|FG001|COMPLETED|Overall Study||18
9831200|NCT00767104|10941865|FG000|NOT COMPLETED|Overall Study||1
9831201|NCT00767104|10941866|FG001|NOT COMPLETED|Overall Study||2
9831202|NCT00767325|10941874|FG000|STARTED|Overall Study||104
9831203|NCT00767325|10941874|FG000|COMPLETED|Overall Study||89
9831204|NCT00767325|10941874|FG000|NOT COMPLETED|Overall Study||15
9831205|NCT00767338|10941882|FG000|STARTED|Overall Study||1
9831206|NCT00767338|10941883|FG001|STARTED|Overall Study||2
9831207|NCT00767338|10941884|FG002|STARTED|Overall Study||0
9831208|NCT00767338|10941885|FG003|STARTED|Overall Study||0
9831209|NCT00767338|10941882|FG000|COMPLETED|Overall Study||0
9831210|NCT00767338|10941883|FG001|COMPLETED|Overall Study||0
9831211|NCT00767338|10941884|FG002|COMPLETED|Overall Study||0
9831212|NCT00767338|10941885|FG003|COMPLETED|Overall Study||0
9831213|NCT00767338|10941882|FG000|NOT COMPLETED|Overall Study||1
9831214|NCT00767338|10941883|FG001|NOT COMPLETED|Overall Study||2
9831215|NCT00767338|10941884|FG002|NOT COMPLETED|Overall Study||0
9831216|NCT00767338|10941885|FG003|NOT COMPLETED|Overall Study||0
9831217|NCT00767364|10941897|FG000|STARTED|Overall Study||5
9831218|NCT00767364|10941898|FG001|STARTED|Overall Study||3
9831219|NCT00767364|10941897|FG000|COMPLETED|Overall Study||5
9831220|NCT00767364|10941898|FG001|COMPLETED|Overall Study||3
9831221|NCT00767364|10941897|FG000|NOT COMPLETED|Overall Study||0
9831222|NCT00767364|10941898|FG001|NOT COMPLETED|Overall Study||0
9831223|NCT00767455|10941904|FG000|STARTED|Overall Study||59
9831224|NCT00767455|10941904|FG000|COMPLETED|Overall Study||40
9831225|NCT00767455|10941904|FG000|NOT COMPLETED|Overall Study||19
9831226|NCT00767507|10941914|FG000|STARTED|Overall Study||5
9831227|NCT00767507|10941915|FG001|STARTED|Overall Study||6
9831228|NCT00767507|10941916|FG002|STARTED|Overall Study||106
9831229|NCT00767507|10941917|FG003|STARTED|Overall Study||104
9831230|NCT00767507|10941914|FG000|COMPLETED|Overall Study||5
9831231|NCT00767507|10941915|FG001|COMPLETED|Overall Study||6
9831232|NCT00767507|10941916|FG002|COMPLETED|Overall Study||106
9831233|NCT00767507|10941917|FG003|COMPLETED|Overall Study||101
9831234|NCT00767507|10941914|FG000|NOT COMPLETED|Overall Study||0
9831235|NCT00767507|10941915|FG001|NOT COMPLETED|Overall Study||0
9831236|NCT00767507|10941916|FG002|NOT COMPLETED|Overall Study||0
9831237|NCT00767507|10941917|FG003|NOT COMPLETED|Overall Study||3
9831238|NCT00767520|10941936|FG000|STARTED|Overall Study||79
9831239|NCT00767520|10941937|FG001|STARTED|Overall Study||78
9831240|NCT00767520|10941936|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
9831241|NCT00767520|10941937|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
9831242|NCT00767520|10941936|FG000|NOT COMPLETED|Overall Study||11
9831243|NCT00767520|10941937|FG001|NOT COMPLETED|Overall Study||17
9831244|NCT00767572|10941943|FG000|STARTED|First Intervention (12 Weeks)||12
9831245|NCT00767572|10941943|FG000|COMPLETED|First Intervention (12 Weeks)||12
9831246|NCT00767572|10941943|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
9831247|NCT00767572|10941943|FG000|STARTED|Washout (4 Weeks)||12
9831248|NCT00767572|10941943|FG000|COMPLETED|Washout (4 Weeks)||12
9831249|NCT00767572|10941943|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9831250|NCT00767572|10941943|FG000|STARTED|Second Intervention (12 Weeks)||12
9831251|NCT00767572|10941943|FG000|COMPLETED|Second Intervention (12 Weeks)||12
9831252|NCT00767572|10941943|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
9799073|NCT00594386|10906872|FG000|STARTED|Overall Study||258
9799074|NCT00594386|10906872|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
9799075|NCT00594386|10906872|FG000|NOT COMPLETED|Overall Study||258
9799076|NCT00596817|10906879|FG000|STARTED|Open-label Period||0
9799077|NCT00596817|10906880|FG001|STARTED|Open-label Period||639
9799078|NCT00596817|10906879|FG000|COMPLETED|Open-label Period||0
9799079|NCT00596817|10906880|FG001|COMPLETED|Open-label Period||492
9799080|NCT00596817|10906879|FG000|NOT COMPLETED|Open-label Period||0
9799081|NCT00596817|10906880|FG001|NOT COMPLETED|Open-label Period||147
9799082|NCT00596817|10906879|FG000|STARTED|Open-label Period to Double-blind Period||0
9799083|NCT00596817|10906880|FG001|STARTED|Open-label Period to Double-blind Period||492
9799084|NCT00596817|10906879|FG000|COMPLETED|Open-label Period to Double-blind Period||0
9799085|NCT00596817|10906880|FG001|COMPLETED|Open-label Period to Double-blind Period||400
9799086|NCT00596817|10906879|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0
9799087|NCT00596817|10906880|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92
9799088|NCT00596817|10906879|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
9799089|NCT00596817|10906880|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
9799090|NCT00596817|10906879|FG000|COMPLETED|Double-blind Period||104
9799091|NCT00596817|10906880|FG001|COMPLETED|Double-blind Period||125
9799092|NCT00596817|10906879|FG000|NOT COMPLETED|Double-blind Period||88
9799093|NCT00596817|10906880|FG001|NOT COMPLETED|Double-blind Period||79
9799094|NCT00596830|10906889|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
9799095|NCT00596830|10906890|FG001|STARTED|Overall Study||339
9799096|NCT00596830|10906889|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
9799097|NCT00596830|10906890|FG001|Treated|Overall Study||332
9799098|NCT00596830|10906889|FG000|COMPLETED|Overall Study||0
9799099|NCT00596830|10906890|FG001|COMPLETED|Overall Study||0
9799100|NCT00596830|10906889|FG000|NOT COMPLETED|Overall Study||342
9799101|NCT00596830|10906890|FG001|NOT COMPLETED|Overall Study||339
9799102|NCT00596934|10906896|FG000|STARTED|Overall Study||9
9799103|NCT00596934|10906896|FG000|COMPLETED|Overall Study||7
9799104|NCT00596934|10906896|FG000|NOT COMPLETED|Overall Study||2
9799105|NCT00596960|10906904|FG000|STARTED|Overall Study||70
9799106|NCT00596960|10906905|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
9799107|NCT00596960|10906904|FG000|COMPLETED|Overall Study||59
9799108|NCT00596960|10906905|FG001|COMPLETED|Overall Study||60
9799109|NCT00596960|10906904|FG000|NOT COMPLETED|Overall Study||11
9799110|NCT00596960|10906905|FG001|NOT COMPLETED|Overall Study||9
9799111|NCT00597012|10906913|FG000|STARTED|Overall Study||174
9799112|NCT00597012|10906914|FG001|STARTED|Overall Study||177
9799113|NCT00597012|10906913|FG000|COMPLETED|Overall Study||161
9799114|NCT00597012|10906914|FG001|COMPLETED|Overall Study||169
9799115|NCT00597012|10906913|FG000|NOT COMPLETED|Overall Study||13
9799116|NCT00597012|10906914|FG001|NOT COMPLETED|Overall Study||8
9799117|NCT00597038|10906924|FG000|STARTED|Overall Study||16
9799118|NCT00597038|10906925|FG001|STARTED|Overall Study||34
9799119|NCT00597038|10906924|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
9799120|NCT00597038|10906925|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
9799121|NCT00597038|10906924|FG000|NOT COMPLETED|Overall Study||2
9799122|NCT00597038|10906925|FG001|NOT COMPLETED|Overall Study||4
9799123|NCT00597116|10906935|FG000|STARTED|Overall Study||14
9799124|NCT00597116|10906936|FG001|STARTED|Overall Study||11
9799125|NCT00597116|10906935|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
9799126|NCT00597116|10906936|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
9799127|NCT00597116|10906935|FG000|NOT COMPLETED|Overall Study||14
9799128|NCT00597116|10906936|FG001|NOT COMPLETED|Overall Study||11
9799129|NCT00597207|10906944|FG000|STARTED|Overall Study||2099
9799130|NCT00597207|10906945|FG001|STARTED|Overall Study||2132
9799131|NCT00597207|10906944|FG000|COMPLETED|Overall Study||2094
9799132|NCT00597207|10906945|FG001|COMPLETED|Overall Study||2125
9799133|NCT00597207|10906944|FG000|NOT COMPLETED|Overall Study||5
9799134|NCT00597207|10906945|FG001|NOT COMPLETED|Overall Study||7
9799135|NCT00597246|10906951|FG000|STARTED|Overall Study||30
9799136|NCT00597246|10906951|FG000|COMPLETED|Overall Study||30
9799137|NCT00597246|10906951|FG000|NOT COMPLETED|Overall Study||0
9799138|NCT00597272|10906962|FG000|STARTED|Overall Study||1
9799139|NCT00597272|10906963|FG001|STARTED|Overall Study||1
9799140|NCT00597272|10906964|FG002|STARTED|Overall Study||10
10015801|NCT01807520|11138789|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65
9799141|NCT00597272|10906965|FG003|STARTED|Overall Study||1
9799142|NCT00597272|10906966|FG004|STARTED|Overall Study||1
9799143|NCT00597272|10906967|FG005|STARTED|Overall Study||10
9799144|NCT00597272|10906968|FG006|STARTED|Overall Study||10
9799145|NCT00597272|10906962|FG000|COMPLETED|Overall Study||1
9799146|NCT00597272|10906963|FG001|COMPLETED|Overall Study||1
9799147|NCT00597272|10906964|FG002|COMPLETED|Overall Study||10
9799148|NCT00597272|10906965|FG003|COMPLETED|Overall Study||1
9799149|NCT00597272|10906966|FG004|COMPLETED|Overall Study||1
9799150|NCT00597272|10906967|FG005|COMPLETED|Overall Study||10
9799151|NCT00597272|10906968|FG006|COMPLETED|Overall Study||10
9799152|NCT00597272|10906962|FG000|NOT COMPLETED|Overall Study||0
9799153|NCT00597272|10906963|FG001|NOT COMPLETED|Overall Study||0
9799154|NCT00597272|10906964|FG002|NOT COMPLETED|Overall Study||0
9799155|NCT00597272|10906965|FG003|NOT COMPLETED|Overall Study||0
9799156|NCT00597272|10906966|FG004|NOT COMPLETED|Overall Study||0
9799157|NCT00597272|10906967|FG005|NOT COMPLETED|Overall Study||0
9799158|NCT00597272|10906968|FG006|NOT COMPLETED|Overall Study||0
9799159|NCT00597376|10906986|FG000|STARTED|Overall Study||51
9799160|NCT00597376|10906987|FG001|STARTED|Overall Study||53
9799161|NCT00597376|10906986|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
9799162|NCT00597376|10906987|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
9799163|NCT00597376|10906986|FG000|NOT COMPLETED|Overall Study||8
9799164|NCT00597376|10906987|FG001|NOT COMPLETED|Overall Study||4
9799165|NCT00597402|10906993|FG000|STARTED|Overall Study||125
9799166|NCT00597402|10906993|FG000|COMPLETED|Overall Study||125
9799167|NCT00597402|10906993|FG000|NOT COMPLETED|Overall Study||0
9799168|NCT00597428|10906999|FG000|STARTED|Overall Study||214
9799169|NCT00597428|10907000|FG001|STARTED|Overall Study||223
9799170|NCT00597428|10906999|FG000|COMPLETED|Overall Study||153
9799171|NCT00597428|10907000|FG001|COMPLETED|Overall Study||152
9799172|NCT00597428|10906999|FG000|NOT COMPLETED|Overall Study||61
9799173|NCT00597428|10907000|FG001|NOT COMPLETED|Overall Study||71
9799174|NCT00597493|10907006|FG000|STARTED|Overall Study||32
9799175|NCT00597493|10907006|FG000|COMPLETED|Overall Study||32
9799176|NCT00597493|10907006|FG000|NOT COMPLETED|Overall Study||0
9799177|NCT00597506|10907014|FG000|STARTED|Overall Study||50
9799178|NCT00597506|10907014|FG000|COMPLETED|Overall Study||49
9799179|NCT00597506|10907014|FG000|NOT COMPLETED|Overall Study||1
9799180|NCT00597519|10907018|FG000|STARTED|Overall Study||28
9799181|NCT00597519|10907018|FG000|COMPLETED|Overall Study||27
9799182|NCT00597519|10907018|FG000|NOT COMPLETED|Overall Study||1
9799183|NCT00597545|10907024|FG000|STARTED|Overall Study||4
9799184|NCT00597545|10907025|FG001|STARTED|Overall Study||6
9799185|NCT00597545|10907024|FG000|COMPLETED|Overall Study||4
9799186|NCT00597545|10907025|FG001|COMPLETED|Overall Study||6
9799187|NCT00597545|10907024|FG000|NOT COMPLETED|Overall Study||0
9799188|NCT00597545|10907025|FG001|NOT COMPLETED|Overall Study||0
9799189|NCT00597558|10907031|FG000|STARTED|Overall Study||13
9799190|NCT00597558|10907031|FG000|COMPLETED|Overall Study||9
9799191|NCT00597558|10907031|FG000|NOT COMPLETED|Overall Study||4
9799192|NCT00597584|10907037|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
9799193|NCT00597584|10907038|FG001|STARTED|Overall Study||274
9799194|NCT00597584|10907037|FG000|COMPLETED|Overall Study||421
9799195|NCT00597584|10907038|FG001|COMPLETED|Overall Study||211
9799196|NCT00597584|10907037|FG000|NOT COMPLETED|Overall Study||128
9799197|NCT00597584|10907038|FG001|NOT COMPLETED|Overall Study||63
9799198|NCT00597675|10907046|FG000|STARTED|Blinded Phase||4
9799199|NCT00597675|10907047|FG001|STARTED|Blinded Phase||6
9799200|NCT00597675|10907046|FG000|COMPLETED|Blinded Phase||2
9799201|NCT00597675|10907047|FG001|COMPLETED|Blinded Phase||5
9799202|NCT00597675|10907046|FG000|NOT COMPLETED|Blinded Phase||2
9799203|NCT00597675|10907047|FG001|NOT COMPLETED|Blinded Phase||1
9799204|NCT00597675|10907046|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
9799205|NCT00597675|10907047|FG001|STARTED|Open Label Phase||5
9799206|NCT00597675|10907046|FG000|COMPLETED|Open Label Phase||2
9799207|NCT00597675|10907047|FG001|COMPLETED|Open Label Phase||5
9799208|NCT00597675|10907046|FG000|NOT COMPLETED|Open Label Phase||0
9799209|NCT00597675|10907047|FG001|NOT COMPLETED|Open Label Phase||0
9799210|NCT00597701|10907057|FG000|STARTED|Overall Study||25
9799211|NCT00597701|10907058|FG001|STARTED|Overall Study||21
9799212|NCT00597701|10907057|FG000|COMPLETED|Overall Study||18
9799213|NCT00597701|10907058|FG001|COMPLETED|Overall Study||13
9799214|NCT00597701|10907057|FG000|NOT COMPLETED|Overall Study||7
9799215|NCT00597701|10907058|FG001|NOT COMPLETED|Overall Study||8
9799216|NCT00597714|10907066|FG000|STARTED|Overall Study||80
9799217|NCT00597714|10907067|FG001|STARTED|Overall Study||57
9799218|NCT00597714|10907068|FG002|STARTED|Overall Study||94
9799219|NCT00597714|10907066|FG000|COMPLETED|Overall Study||24
9799220|NCT00597714|10907067|FG001|COMPLETED|Overall Study||11
9799221|NCT00597714|10907068|FG002|COMPLETED|Overall Study||84
9799222|NCT00597714|10907066|FG000|NOT COMPLETED|Overall Study||56
9799223|NCT00597714|10907067|FG001|NOT COMPLETED|Overall Study||46
9799224|NCT00597714|10907068|FG002|NOT COMPLETED|Overall Study||10
9799225|NCT00597727|10907081|FG000|STARTED|12 Month Blinded Phase||14
9799226|NCT00597727|10907082|FG001|STARTED|12 Month Blinded Phase||15
9799227|NCT00597727|10907083|FG002|STARTED|12 Month Blinded Phase||0
9799228|NCT00597727|10907084|FG003|STARTED|12 Month Blinded Phase||27
9799229|NCT00597727|10907085|FG004|STARTED|12 Month Blinded Phase||4
9799230|NCT00597727|10907081|FG000|COMPLETED|12 Month Blinded Phase||14
9799231|NCT00597727|10907082|FG001|COMPLETED|12 Month Blinded Phase||15
9799232|NCT00597727|10907083|FG002|COMPLETED|12 Month Blinded Phase||0
9799233|NCT00597727|10907084|FG003|COMPLETED|12 Month Blinded Phase||17
9799234|NCT00597727|10907085|FG004|COMPLETED|12 Month Blinded Phase||3
9799235|NCT00597727|10907081|FG000|NOT COMPLETED|12 Month Blinded Phase||0
9799236|NCT00597727|10907082|FG001|NOT COMPLETED|12 Month Blinded Phase||0
9799237|NCT00597727|10907083|FG002|NOT COMPLETED|12 Month Blinded Phase||0
9799238|NCT00597727|10907084|FG003|NOT COMPLETED|12 Month Blinded Phase||10
9799239|NCT00597727|10907085|FG004|NOT COMPLETED|12 Month Blinded Phase||1
9831253|NCT00767624|10941951|FG000|STARTED|Overall Study||75
9799240|NCT00597727|10907081|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
9799241|NCT00597727|10907082|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
9799242|NCT00597727|10907083|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
9799243|NCT00597727|10907084|FG003|STARTED|Open-label Extended Maintenance Phase||17
9799244|NCT00597727|10907085|FG004|STARTED|Open-label Extended Maintenance Phase||3
9799245|NCT00597727|10907081|FG000|COMPLETED|Open-label Extended Maintenance Phase||0
9799246|NCT00597727|10907082|FG001|COMPLETED|Open-label Extended Maintenance Phase||0
9799247|NCT00597727|10907083|FG002|COMPLETED|Open-label Extended Maintenance Phase||23
9799248|NCT00597727|10907084|FG003|COMPLETED|Open-label Extended Maintenance Phase||14
9799249|NCT00597727|10907085|FG004|COMPLETED|Open-label Extended Maintenance Phase||1
9799250|NCT00597727|10907081|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0
9799251|NCT00597727|10907082|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0
9799252|NCT00597727|10907083|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6
9799253|NCT00597727|10907084|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3
9799254|NCT00597727|10907085|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2
9799255|NCT00597753|10907101|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
9799256|NCT00597753|10907102|FG001|STARTED|Overall Study||271
9799257|NCT00597753|10907101|FG000|COMPLETED|Overall Study||366
9799258|NCT00597753|10907102|FG001|COMPLETED|Overall Study||202
9799259|NCT00597753|10907101|FG000|NOT COMPLETED|Overall Study||166
9799260|NCT00597753|10907102|FG001|NOT COMPLETED|Overall Study||69
9799261|NCT00597766|10907111|FG000|STARTED|Enrolled||9
9799262|NCT00597766|10907112|FG001|STARTED|Enrolled||9
9799263|NCT00597766|10907113|FG002|STARTED|Enrolled||10
9799264|NCT00597766|10907111|FG000|COMPLETED|Enrolled||9
9799265|NCT00597766|10907112|FG001|COMPLETED|Enrolled||9
9799266|NCT00597766|10907113|FG002|COMPLETED|Enrolled||10
9799267|NCT00597766|10907111|FG000|NOT COMPLETED|Enrolled||0
9799268|NCT00597766|10907112|FG001|NOT COMPLETED|Enrolled||0
9799269|NCT00597766|10907113|FG002|NOT COMPLETED|Enrolled||0
9799270|NCT00597766|10907111|FG000|STARTED|Follow-up 1, Week 4||9
9799271|NCT00597766|10907112|FG001|STARTED|Follow-up 1, Week 4||9
9799272|NCT00597766|10907113|FG002|STARTED|Follow-up 1, Week 4||10
9799273|NCT00597766|10907111|FG000|COMPLETED|Follow-up 1, Week 4||8
9799274|NCT00597766|10907112|FG001|COMPLETED|Follow-up 1, Week 4||9
9799275|NCT00597766|10907113|FG002|COMPLETED|Follow-up 1, Week 4||10
9799276|NCT00597766|10907111|FG000|NOT COMPLETED|Follow-up 1, Week 4||1
9799277|NCT00597766|10907112|FG001|NOT COMPLETED|Follow-up 1, Week 4||0
9799278|NCT00597766|10907113|FG002|NOT COMPLETED|Follow-up 1, Week 4||0
9799279|NCT00597766|10907111|FG000|STARTED|Follow-up 2, Week 8||8
9799280|NCT00597766|10907112|FG001|STARTED|Follow-up 2, Week 8||9
9799281|NCT00597766|10907113|FG002|STARTED|Follow-up 2, Week 8||10
9799282|NCT00597766|10907111|FG000|COMPLETED|Follow-up 2, Week 8||8
9799283|NCT00597766|10907112|FG001|COMPLETED|Follow-up 2, Week 8||9
9799284|NCT00597766|10907113|FG002|COMPLETED|Follow-up 2, Week 8||9
9799285|NCT00597766|10907111|FG000|NOT COMPLETED|Follow-up 2, Week 8||0
9799286|NCT00597766|10907112|FG001|NOT COMPLETED|Follow-up 2, Week 8||0
9799287|NCT00597766|10907113|FG002|NOT COMPLETED|Follow-up 2, Week 8||1
9799288|NCT00597766|10907111|FG000|STARTED|Follow-up 3, Week 12||8
9799289|NCT00597766|10907112|FG001|STARTED|Follow-up 3, Week 12||9
9799290|NCT00597766|10907113|FG002|STARTED|Follow-up 3, Week 12||9
9799291|NCT00597766|10907111|FG000|COMPLETED|Follow-up 3, Week 12||8
9799292|NCT00597766|10907112|FG001|COMPLETED|Follow-up 3, Week 12||9
9799293|NCT00597766|10907113|FG002|COMPLETED|Follow-up 3, Week 12||9
9799294|NCT00597766|10907111|FG000|NOT COMPLETED|Follow-up 3, Week 12||0
9799295|NCT00597766|10907112|FG001|NOT COMPLETED|Follow-up 3, Week 12||0
9799296|NCT00597766|10907113|FG002|NOT COMPLETED|Follow-up 3, Week 12||0
9799297|NCT00597818|10907125|FG000|STARTED|Overall Study||30
9799298|NCT00597818|10907126|FG001|STARTED|Overall Study||30
9799299|NCT00597818|10907127|FG002|STARTED|Overall Study||31
9799300|NCT00597818|10907128|FG003|STARTED|Overall Study||30
9799301|NCT00597818|10907125|FG000|COMPLETED|Overall Study||12
9799302|NCT00597818|10907126|FG001|COMPLETED|Overall Study||14
9799303|NCT00597818|10907127|FG002|COMPLETED|Overall Study||12
9799304|NCT00597818|10907128|FG003|COMPLETED|Overall Study||20
9799305|NCT00597818|10907125|FG000|NOT COMPLETED|Overall Study||18
9799306|NCT00597818|10907126|FG001|NOT COMPLETED|Overall Study||16
9799307|NCT00597818|10907127|FG002|NOT COMPLETED|Overall Study||19
9799308|NCT00597818|10907128|FG003|NOT COMPLETED|Overall Study||10
9799309|NCT00597896|10907140|FG000|STARTED|Overall Study||24
9799310|NCT00597896|10907141|FG001|STARTED|Overall Study||26
9799311|NCT00597896|10907140|FG000|COMPLETED|Overall Study||21
9799312|NCT00597896|10907141|FG001|COMPLETED|Overall Study||24
9799313|NCT00597896|10907140|FG000|NOT COMPLETED|Overall Study||3
9799314|NCT00597896|10907141|FG001|NOT COMPLETED|Overall Study||2
9799315|NCT00597935|10907152|FG000|STARTED|Randomized to Surgical and BPMT Arms||95
9799316|NCT00597935|10907153|FG001|STARTED|Randomized to Surgical and BPMT Arms||91
9799317|NCT00597935|10907154|FG002|STARTED|Randomized to Surgical and BPMT Arms||91
9799318|NCT00597935|10907155|FG003|STARTED|Randomized to Surgical and BPMT Arms||97
9799319|NCT00597935|10907152|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95
9799320|NCT00597935|10907153|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91
9799321|NCT00597935|10907154|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91
9799322|NCT00597935|10907155|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97
9799323|NCT00597935|10907152|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
9799324|NCT00597935|10907153|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
9799325|NCT00597935|10907154|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
9799326|NCT00597935|10907155|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
9799327|NCT00597935|10907152|FG000|STARTED|Baseline to 6-Months||95
9799328|NCT00597935|10907153|FG001|STARTED|Baseline to 6-Months||91
9799329|NCT00597935|10907154|FG002|STARTED|Baseline to 6-Months||91
9799330|NCT00597935|10907155|FG003|STARTED|Baseline to 6-Months||97
9799331|NCT00597935|10907152|FG000|COMPLETED|Baseline to 6-Months||93
9799332|NCT00597935|10907153|FG001|COMPLETED|Baseline to 6-Months||87
9799333|NCT00597935|10907154|FG002|COMPLETED|Baseline to 6-Months||87
9799334|NCT00597935|10907155|FG003|COMPLETED|Baseline to 6-Months||93
9799335|NCT00597935|10907152|FG000|NOT COMPLETED|Baseline to 6-Months||2
9799336|NCT00597935|10907153|FG001|NOT COMPLETED|Baseline to 6-Months||4
9799337|NCT00597935|10907154|FG002|NOT COMPLETED|Baseline to 6-Months||4
9799338|NCT00597935|10907155|FG003|NOT COMPLETED|Baseline to 6-Months||4
9799339|NCT00597935|10907152|FG000|STARTED|6-Months to 24-Months||93
9799340|NCT00597935|10907153|FG001|STARTED|6-Months to 24-Months||87
9799341|NCT00597935|10907154|FG002|STARTED|6-Months to 24-Months||87
9799342|NCT00597935|10907155|FG003|STARTED|6-Months to 24-Months||93
9799343|NCT00597935|10907152|FG000|COMPLETED|6-Months to 24-Months||76
9799344|NCT00597935|10907153|FG001|COMPLETED|6-Months to 24-Months||79
9799345|NCT00597935|10907154|FG002|COMPLETED|6-Months to 24-Months||77
9799346|NCT00597935|10907155|FG003|COMPLETED|6-Months to 24-Months||85
9799347|NCT00597935|10907152|FG000|NOT COMPLETED|6-Months to 24-Months||17
9799348|NCT00597935|10907153|FG001|NOT COMPLETED|6-Months to 24-Months||8
9799349|NCT00597935|10907154|FG002|NOT COMPLETED|6-Months to 24-Months||10
9799350|NCT00597935|10907155|FG003|NOT COMPLETED|6-Months to 24-Months||8
9799351|NCT00598078|10907165|FG000|STARTED|Period 1 (Day 1)||10
9799352|NCT00598078|10907166|FG001|STARTED|Period 1 (Day 1)||10
9799353|NCT00598078|10907165|FG000|COMPLETED|Period 1 (Day 1)||10
9799354|NCT00598078|10907166|FG001|COMPLETED|Period 1 (Day 1)||10
9799355|NCT00598078|10907165|FG000|NOT COMPLETED|Period 1 (Day 1)||0
9799356|NCT00598078|10907166|FG001|NOT COMPLETED|Period 1 (Day 1)||0
9799357|NCT00598078|10907165|FG000|STARTED|Period 2 (Day 2)||10
9799358|NCT00598078|10907166|FG001|STARTED|Period 2 (Day 2)||10
9799359|NCT00598078|10907165|FG000|COMPLETED|Period 2 (Day 2)||9
9799360|NCT00598078|10907166|FG001|COMPLETED|Period 2 (Day 2)||10
9799361|NCT00598078|10907165|FG000|NOT COMPLETED|Period 2 (Day 2)||1
9799362|NCT00598078|10907166|FG001|NOT COMPLETED|Period 2 (Day 2)||0
9799363|NCT00598078|10907165|FG000|STARTED|Period 3 (Day 3)||9
9799364|NCT00598078|10907166|FG001|STARTED|Period 3 (Day 3)||10
9799365|NCT00598078|10907165|FG000|COMPLETED|Period 3 (Day 3)||9
9799366|NCT00598078|10907166|FG001|COMPLETED|Period 3 (Day 3)||10
9799367|NCT00598078|10907165|FG000|NOT COMPLETED|Period 3 (Day 3)||0
9799368|NCT00598078|10907166|FG001|NOT COMPLETED|Period 3 (Day 3)||0
9799369|NCT00598273|10907177|FG000|STARTED|Overall Study||161
9799370|NCT00598273|10907178|FG001|STARTED|Overall Study||165
9799371|NCT00598273|10907179|FG002|STARTED|Overall Study||164
9799372|NCT00598273|10907177|FG000|COMPLETED|Overall Study||120
9799373|NCT00598273|10907178|FG001|COMPLETED|Overall Study||127
9799374|NCT00598273|10907179|FG002|COMPLETED|Overall Study||125
9799375|NCT00598273|10907177|FG000|NOT COMPLETED|Overall Study||41
9799376|NCT00598273|10907178|FG001|NOT COMPLETED|Overall Study||38
9799377|NCT00598273|10907179|FG002|NOT COMPLETED|Overall Study||39
9799378|NCT00598442|10907190|FG000|STARTED|Overall Study||167
10015802|NCT01807520|11138790|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0
10015803|NCT01807520|11138791|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29
10015804|NCT01807520|11138792|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29
10015805|NCT01807520|11138793|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0
10015806|NCT01807520|11138794|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0
10015807|NCT01807520|11138788|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63
10015808|NCT01807520|11138789|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65
9799379|NCT00598442|10907191|FG001|STARTED|Overall Study||163
9799380|NCT00598442|10907192|FG002|STARTED|Overall Study||163
9799381|NCT00598442|10907190|FG000|COMPLETED|Overall Study||124
9799382|NCT00598442|10907191|FG001|COMPLETED|Overall Study||124
9799383|NCT00598442|10907192|FG002|COMPLETED|Overall Study||139
9799384|NCT00598442|10907190|FG000|NOT COMPLETED|Overall Study||43
9799385|NCT00598442|10907191|FG001|NOT COMPLETED|Overall Study||39
9799386|NCT00598442|10907192|FG002|NOT COMPLETED|Overall Study||24
9799387|NCT00598481|10907200|FG000|STARTED|Baseline||12
9799388|NCT00598481|10907200|FG000|COMPLETED|Baseline||12
9799389|NCT00598481|10907200|FG000|NOT COMPLETED|Baseline||0
9799390|NCT00598481|10907200|FG000|STARTED|Treatment||12
9799391|NCT00598481|10907200|FG000|COMPLETED|Treatment||11
9799392|NCT00598481|10907200|FG000|NOT COMPLETED|Treatment||1
9799393|NCT00598507|10907207|FG000|STARTED|Overall Study||35
9799394|NCT00598507|10907207|FG000|COMPLETED|Overall Study||35
9799395|NCT00598507|10907207|FG000|NOT COMPLETED|Overall Study||0
9799396|NCT00598559|10907214|FG000|STARTED|Overall Study||92
9799397|NCT00598559|10907215|FG001|STARTED|Overall Study||91
9799398|NCT00598559|10907216|FG002|STARTED|Overall Study||30
9831254|NCT00767624|10941952|FG001|STARTED|Overall Study||75
10015809|NCT01807520|11138790|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0
10015810|NCT01807520|11138791|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29
10019144|NCT01828034|11142282|FG002|COMPLETED|Overall Study||3
9799399|NCT00598559|10907214|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
9799400|NCT00598559|10907215|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
9799401|NCT00598559|10907216|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
9799402|NCT00598559|10907214|FG000|NOT COMPLETED|Overall Study||27
9799403|NCT00598559|10907215|FG001|NOT COMPLETED|Overall Study||28
9799404|NCT00598559|10907216|FG002|NOT COMPLETED|Overall Study||3
9799405|NCT00598585|10907226|FG000|STARTED|Overall Study||6
9799406|NCT00598585|10907227|FG001|STARTED|Overall Study||6
9799407|NCT00598585|10907226|FG000|COMPLETED|Overall Study||5
9799408|NCT00598585|10907227|FG001|COMPLETED|Overall Study||6
9799409|NCT00598585|10907226|FG000|NOT COMPLETED|Overall Study||1
9799410|NCT00598585|10907227|FG001|NOT COMPLETED|Overall Study||0
9799411|NCT00598650|10907233|FG000|STARTED|Overall Study||108
9799412|NCT00598650|10907233|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
9799413|NCT00598650|10907233|FG000|NOT COMPLETED|Overall Study||27
9799414|NCT00598663|10907240|FG000|STARTED|First Intervention (6 Months)||76
9799415|NCT00598663|10907241|FG001|STARTED|First Intervention (6 Months)||77
9799416|NCT00598663|10907240|FG000|COMPLETED|First Intervention (6 Months)||73
9799417|NCT00598663|10907241|FG001|COMPLETED|First Intervention (6 Months)||71
9799418|NCT00598663|10907240|FG000|NOT COMPLETED|First Intervention (6 Months)||3
9799419|NCT00598663|10907241|FG001|NOT COMPLETED|First Intervention (6 Months)||6
9799420|NCT00598663|10907240|FG000|STARTED|Washout (4 Months)||73
9799421|NCT00598663|10907241|FG001|STARTED|Washout (4 Months)||71
9799422|NCT00598663|10907240|FG000|COMPLETED|Washout (4 Months)||73
9799423|NCT00598663|10907241|FG001|COMPLETED|Washout (4 Months)||70
9799424|NCT00598663|10907240|FG000|NOT COMPLETED|Washout (4 Months)||0
9799425|NCT00598663|10907241|FG001|NOT COMPLETED|Washout (4 Months)||1
9799426|NCT00598663|10907240|FG000|STARTED|Second Intervention (6 Months)||73
9799427|NCT00598663|10907241|FG001|STARTED|Second Intervention (6 Months)||70
9799428|NCT00598663|10907240|FG000|COMPLETED|Second Intervention (6 Months)||69
9799429|NCT00598663|10907241|FG001|COMPLETED|Second Intervention (6 Months)||69
9799430|NCT00598663|10907240|FG000|NOT COMPLETED|Second Intervention (6 Months)||4
9799431|NCT00598663|10907241|FG001|NOT COMPLETED|Second Intervention (6 Months)||1
9799432|NCT00598689|10907252|FG000|STARTED|Overall Study||40
9799433|NCT00598689|10907253|FG001|STARTED|Overall Study||40
9799434|NCT00598689|10907252|FG000|COMPLETED|Overall Study||40
9799435|NCT00598689|10907253|FG001|COMPLETED|Overall Study||40
9799436|NCT00598689|10907252|FG000|NOT COMPLETED|Overall Study||0
9799437|NCT00598689|10907253|FG001|NOT COMPLETED|Overall Study||0
9799438|NCT00598702|10907267|FG000|STARTED|Overall Study||1
9799439|NCT00598702|10907268|FG001|STARTED|Overall Study||3
9799440|NCT00598702|10907269|FG002|STARTED|Overall Study||7
9799441|NCT00598702|10907270|FG003|STARTED|Overall Study||33
9799442|NCT00598702|10907271|FG004|STARTED|Overall Study||9
9799443|NCT00598702|10907272|FG005|STARTED|Overall Study||42
9799444|NCT00598702|10907273|FG006|STARTED|Overall Study||1
9799445|NCT00598702|10907274|FG007|STARTED|Overall Study||4
9799446|NCT00598702|10907267|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
9799447|NCT00598702|10907268|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
9799448|NCT00598702|10907269|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
9799449|NCT00598702|10907270|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
9799450|NCT00598702|10907271|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
9799451|NCT00598702|10907272|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
9799452|NCT00598702|10907273|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
9799453|NCT00598702|10907274|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
9799454|NCT00598702|10907267|FG000|NOT COMPLETED|Overall Study||0
9799455|NCT00598702|10907268|FG001|NOT COMPLETED|Overall Study||2
9799456|NCT00598702|10907269|FG002|NOT COMPLETED|Overall Study||2
9799457|NCT00598702|10907270|FG003|NOT COMPLETED|Overall Study||8
9799458|NCT00598702|10907271|FG004|NOT COMPLETED|Overall Study||3
9799459|NCT00598702|10907272|FG005|NOT COMPLETED|Overall Study||12
9799460|NCT00598702|10907273|FG006|NOT COMPLETED|Overall Study||1
9799461|NCT00598702|10907274|FG007|NOT COMPLETED|Overall Study||0
9799462|NCT00598806|10907294|FG000|STARTED|Overall Study||402
9799463|NCT00598806|10907295|FG001|STARTED|Overall Study||410
9799464|NCT00598806|10907294|FG000|COMPLETED|Overall Study||329
9799465|NCT00598806|10907295|FG001|COMPLETED|Overall Study||346
9799466|NCT00598806|10907294|FG000|NOT COMPLETED|Overall Study||73
9799467|NCT00598806|10907295|FG001|NOT COMPLETED|Overall Study||64
9799468|NCT00598819|10907301|FG000|STARTED|Overall Study||14
9799469|NCT00598819|10907301|FG000|COMPLETED|Overall Study||14
9799470|NCT00598819|10907301|FG000|NOT COMPLETED|Overall Study||0
9799471|NCT00598832|10907307|FG000|STARTED|Overall Study||533
9799472|NCT00598832|10907308|FG001|STARTED|Overall Study||542
9799473|NCT00598832|10907307|FG000|COMPLETED|Overall Study||471
9799474|NCT00598832|10907308|FG001|COMPLETED|Overall Study||460
9799475|NCT00598832|10907307|FG000|NOT COMPLETED|Overall Study||62
9799476|NCT00598832|10907308|FG001|NOT COMPLETED|Overall Study||82
9799477|NCT00598871|10907316|FG000|STARTED|Overall Study||3
9799478|NCT00598871|10907317|FG001|STARTED|Overall Study||9
9799479|NCT00598871|10907316|FG000|COMPLETED|Overall Study||3
9799480|NCT00598871|10907317|FG001|COMPLETED|Overall Study||8
9799481|NCT00598871|10907316|FG000|NOT COMPLETED|Overall Study||0
9799482|NCT00598871|10907317|FG001|NOT COMPLETED|Overall Study||1
9799483|NCT00598975|10907325|FG000|STARTED|Overall Study||12
9799484|NCT00598975|10907326|FG001|STARTED|Overall Study||6
9799485|NCT00598975|10907325|FG000|Completed Cycle 1|Overall Study||12
9799486|NCT00598975|10907326|FG001|Completed Cycle 1|Overall Study||6
9799487|NCT00598975|10907325|FG000|COMPLETED|Overall Study||0
9799488|NCT00598975|10907326|FG001|COMPLETED|Overall Study||0
9799489|NCT00598975|10907325|FG000|NOT COMPLETED|Overall Study||12
9799490|NCT00598975|10907326|FG001|NOT COMPLETED|Overall Study||6
9799491|NCT00599014|10907334|FG000|STARTED|Overall Study||335
9799492|NCT00599014|10907334|FG000|COMPLETED|Overall Study||335
9799493|NCT00599014|10907334|FG000|NOT COMPLETED|Overall Study||0
9799494|NCT00599053|10907340|FG000|STARTED|Overall Study||5
9799495|NCT00599053|10907341|FG001|STARTED|Overall Study||2
9799496|NCT00599053|10907340|FG000|COMPLETED|Overall Study||5
9799497|NCT00599053|10907341|FG001|COMPLETED|Overall Study||2
9799498|NCT00599053|10907340|FG000|NOT COMPLETED|Overall Study||0
9799499|NCT00599053|10907341|FG001|NOT COMPLETED|Overall Study||0
9799500|NCT00599196|10907347|FG000|STARTED|Overall Study||381
9799501|NCT00599196|10907347|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
9799502|NCT00599196|10907347|FG000|NOT COMPLETED|Overall Study||381
9799503|NCT00599248|10907353|FG000|STARTED|Overall Study||3
9799504|NCT00599248|10907354|FG001|STARTED|Overall Study||3
9799505|NCT00599248|10907355|FG002|STARTED|Overall Study||3
9799506|NCT00599248|10907356|FG003|STARTED|Overall Study||3
9799507|NCT00599248|10907353|FG000|COMPLETED|Overall Study||3
9799508|NCT00599248|10907354|FG001|COMPLETED|Overall Study||3
9799509|NCT00599248|10907355|FG002|COMPLETED|Overall Study||3
9799510|NCT00599248|10907356|FG003|COMPLETED|Overall Study||3
9799511|NCT00599248|10907353|FG000|NOT COMPLETED|Overall Study||0
9799512|NCT00599248|10907354|FG001|NOT COMPLETED|Overall Study||0
9799513|NCT00599248|10907355|FG002|NOT COMPLETED|Overall Study||0
9799514|NCT00599248|10907356|FG003|NOT COMPLETED|Overall Study||0
9799515|NCT00599313|10907365|FG000|STARTED|Overall Study||36
9799516|NCT00599313|10907365|FG000|COMPLETED|Overall Study||0
9799517|NCT00599313|10907365|FG000|NOT COMPLETED|Overall Study||36
9799518|NCT00599326|10907369|FG000|STARTED|Overall Study||10
9799519|NCT00599326|10907369|FG000|COMPLETED|Overall Study||8
9799520|NCT00599326|10907369|FG000|NOT COMPLETED|Overall Study||2
9799521|NCT00599339|10907373|FG000|STARTED|Overall Study||2195
9799522|NCT00599339|10907373|FG000|Safety Set|Overall Study||2179
9799523|NCT00599339|10907373|FG000|COMPLETED|Overall Study||1531
9799524|NCT00599339|10907373|FG000|NOT COMPLETED|Overall Study||664
9799525|NCT00599521|10907397|FG000|STARTED|Overall Study||535
9799526|NCT00599521|10907398|FG001|STARTED|Overall Study||531
9799527|NCT00599521|10907397|FG000|COMPLETED|Overall Study||475
9799528|NCT00599521|10907398|FG001|COMPLETED|Overall Study||462
9799529|NCT00599521|10907397|FG000|NOT COMPLETED|Overall Study||60
9799530|NCT00599521|10907398|FG001|NOT COMPLETED|Overall Study||69
9799531|NCT00599638|10907408|FG000|STARTED|First Intervention Period (2 Weeks)||16
9799532|NCT00599638|10907409|FG001|STARTED|First Intervention Period (2 Weeks)||14
9799533|NCT00599638|10907410|FG002|STARTED|First Intervention Period (2 Weeks)||20
9799534|NCT00599638|10907411|FG003|STARTED|First Intervention Period (2 Weeks)||22
9799535|NCT00599638|10907408|FG000|Treated|First Intervention Period (2 Weeks)||16
9799536|NCT00599638|10907409|FG001|Treated|First Intervention Period (2 Weeks)||13
9799537|NCT00599638|10907410|FG002|Treated|First Intervention Period (2 Weeks)||20
9799538|NCT00599638|10907411|FG003|Treated|First Intervention Period (2 Weeks)||21
9799539|NCT00599638|10907408|FG000|COMPLETED|First Intervention Period (2 Weeks)||14
9799540|NCT00599638|10907409|FG001|COMPLETED|First Intervention Period (2 Weeks)||12
9799541|NCT00599638|10907410|FG002|COMPLETED|First Intervention Period (2 Weeks)||17
9799542|NCT00599638|10907411|FG003|COMPLETED|First Intervention Period (2 Weeks)||17
9799543|NCT00599638|10907408|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2
9799544|NCT00599638|10907409|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2
9799545|NCT00599638|10907410|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3
9799546|NCT00599638|10907411|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5
9799547|NCT00599638|10907408|FG000|STARTED|Washout Period (2 Weeks)||14
9799548|NCT00599638|10907409|FG001|STARTED|Washout Period (2 Weeks)||12
9799549|NCT00599638|10907410|FG002|STARTED|Washout Period (2 Weeks)||17
9799550|NCT00599638|10907411|FG003|STARTED|Washout Period (2 Weeks)||17
9799551|NCT00599638|10907408|FG000|COMPLETED|Washout Period (2 Weeks)||13
9799552|NCT00599638|10907409|FG001|COMPLETED|Washout Period (2 Weeks)||11
9799553|NCT00599638|10907410|FG002|COMPLETED|Washout Period (2 Weeks)||17
9799554|NCT00599638|10907411|FG003|COMPLETED|Washout Period (2 Weeks)||14
9799555|NCT00599638|10907408|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
9799556|NCT00599638|10907409|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
9799557|NCT00599638|10907410|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
9799558|NCT00599638|10907411|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3
9799559|NCT00599638|10907408|FG000|STARTED|Second Intervention Period (2 Weeks)||13
9799560|NCT00599638|10907409|FG001|STARTED|Second Intervention Period (2 Weeks)||11
9799561|NCT00599638|10907410|FG002|STARTED|Second Intervention Period (2 Weeks)||17
9799562|NCT00599638|10907411|FG003|STARTED|Second Intervention Period (2 Weeks)||14
9799563|NCT00599638|10907408|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12
9799564|NCT00599638|10907409|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11
9799565|NCT00599638|10907410|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17
9799566|NCT00599638|10907411|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14
9799567|NCT00599638|10907408|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
10015811|NCT01807520|11138792|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29
10015812|NCT01807520|11138793|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0
10015813|NCT01807520|11138794|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0
10015814|NCT01807520|11138788|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
10015815|NCT01807520|11138789|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
10015816|NCT01807520|11138790|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
9799568|NCT00599638|10907409|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
9799569|NCT00599638|10907410|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
9799570|NCT00599638|10907411|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
9799571|NCT00599755|10907419|FG000|STARTED|Overall Study||68
9799572|NCT00599755|10907419|FG000|COMPLETED|Overall Study||49
9799573|NCT00599755|10907419|FG000|NOT COMPLETED|Overall Study||19
9799574|NCT00599872|10907425|FG000|STARTED|Overall Study||216
9799575|NCT00599872|10907426|FG001|STARTED|Overall Study||214
9799576|NCT00599872|10907425|FG000|COMPLETED|Overall Study||167
9799577|NCT00599872|10907426|FG001|COMPLETED|Overall Study||181
9799578|NCT00599872|10907425|FG000|NOT COMPLETED|Overall Study||49
9799579|NCT00599872|10907426|FG001|NOT COMPLETED|Overall Study||33
9799580|NCT00599924|10907443|FG000|STARTED|Overall Study||4
9799581|NCT00599924|10907444|FG001|STARTED|Overall Study||9
9799582|NCT00599924|10907445|FG002|STARTED|Overall Study||5
9799583|NCT00599924|10907446|FG003|STARTED|Overall Study||12
9799584|NCT00599924|10907447|FG004|STARTED|Overall Study||9
9799585|NCT00599924|10907448|FG005|STARTED|Overall Study||6
9799586|NCT00599924|10907449|FG006|STARTED|Overall Study||8
9799587|NCT00599924|10907443|FG000|COMPLETED|Overall Study||1
9799588|NCT00599924|10907444|FG001|COMPLETED|Overall Study||4
9799589|NCT00599924|10907445|FG002|COMPLETED|Overall Study||3
9799590|NCT00599924|10907446|FG003|COMPLETED|Overall Study||4
9799591|NCT00599924|10907447|FG004|COMPLETED|Overall Study||3
9799592|NCT00599924|10907448|FG005|COMPLETED|Overall Study||2
9799593|NCT00599924|10907449|FG006|COMPLETED|Overall Study||3
9799594|NCT00599924|10907443|FG000|NOT COMPLETED|Overall Study||3
9799595|NCT00599924|10907444|FG001|NOT COMPLETED|Overall Study||5
9799596|NCT00599924|10907445|FG002|NOT COMPLETED|Overall Study||2
9799597|NCT00599924|10907446|FG003|NOT COMPLETED|Overall Study||8
9799598|NCT00599924|10907447|FG004|NOT COMPLETED|Overall Study||6
9799599|NCT00599924|10907448|FG005|NOT COMPLETED|Overall Study||4
9799600|NCT00599924|10907449|FG006|NOT COMPLETED|Overall Study||5
9799601|NCT00600028|10907472|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
9799602|NCT00600028|10907473|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
9799603|NCT00600028|10907472|FG000|COMPLETED|First Intervention (12 Weeks)||12
9799604|NCT00600028|10907473|FG001|COMPLETED|First Intervention (12 Weeks)||10
9799605|NCT00600028|10907472|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
9799606|NCT00600028|10907473|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
9799607|NCT00600028|10907472|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
9799608|NCT00600028|10907473|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
9799609|NCT00600028|10907472|FG000|COMPLETED|Second Intervention (12 Weeks)||12
9799610|NCT00600028|10907473|FG001|COMPLETED|Second Intervention (12 Weeks)||8
9799611|NCT00600028|10907472|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
9799612|NCT00600028|10907473|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2
10019145|NCT01828034|11142283|FG003|COMPLETED|Overall Study||29
9799613|NCT00600067|10907484|FG000|STARTED|Overall Study||55
9799614|NCT00600067|10907485|FG001|STARTED|Overall Study||75
9799615|NCT00600067|10907484|FG000|COMPLETED|Overall Study||52
9799616|NCT00600067|10907485|FG001|COMPLETED|Overall Study||68
9799617|NCT00600067|10907484|FG000|NOT COMPLETED|Overall Study||3
9799618|NCT00600067|10907485|FG001|NOT COMPLETED|Overall Study||7
9799619|NCT00600080|10907492|FG000|STARTED|Period 1: Baseline to One-week||28
9799620|NCT00600080|10907493|FG001|STARTED|Period 1: Baseline to One-week||32
9799621|NCT00600080|10907492|FG000|COMPLETED|Period 1: Baseline to One-week||28
9799622|NCT00600080|10907493|FG001|COMPLETED|Period 1: Baseline to One-week||32
9799623|NCT00600080|10907492|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0
9799624|NCT00600080|10907493|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0
9799625|NCT00600080|10907492|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
9799626|NCT00600080|10907493|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
9799627|NCT00600080|10907492|FG000|COMPLETED|Period 2: One-week to Two-weeks||28
9799628|NCT00600080|10907493|FG001|COMPLETED|Period 2: One-week to Two-weeks||32
9799629|NCT00600080|10907492|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0
9799630|NCT00600080|10907493|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0
9799631|NCT00600106|10907501|FG000|STARTED|Overall Study||18
9799632|NCT00600106|10907502|FG001|STARTED|Overall Study||19
9799633|NCT00600106|10907501|FG000|COMPLETED|Overall Study||17
9799634|NCT00600106|10907502|FG001|COMPLETED|Overall Study||18
9799635|NCT00600106|10907501|FG000|NOT COMPLETED|Overall Study||1
9799636|NCT00600106|10907502|FG001|NOT COMPLETED|Overall Study||1
9799637|NCT00600119|10907514|FG000|STARTED|Single-blind Placebo run-in Period||36
9799638|NCT00600119|10907515|FG001|STARTED|Single-blind Placebo run-in Period||35
9799639|NCT00600119|10907516|FG002|STARTED|Single-blind Placebo run-in Period||29
9799640|NCT00600119|10907517|FG003|STARTED|Single-blind Placebo run-in Period||31
9799641|NCT00600119|10907518|FG004|STARTED|Single-blind Placebo run-in Period||39
9799642|NCT00600119|10907519|FG005|STARTED|Single-blind Placebo run-in Period||37
9799643|NCT00600119|10907514|FG000|COMPLETED|Single-blind Placebo run-in Period||32
9799644|NCT00600119|10907515|FG001|COMPLETED|Single-blind Placebo run-in Period||33
9799645|NCT00600119|10907516|FG002|COMPLETED|Single-blind Placebo run-in Period||27
9799646|NCT00600119|10907517|FG003|COMPLETED|Single-blind Placebo run-in Period||30
9799647|NCT00600119|10907518|FG004|COMPLETED|Single-blind Placebo run-in Period||37
9799648|NCT00600119|10907519|FG005|COMPLETED|Single-blind Placebo run-in Period||35
9799649|NCT00600119|10907514|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4
9799650|NCT00600119|10907515|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2
9799651|NCT00600119|10907516|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2
9799652|NCT00600119|10907517|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1
9799653|NCT00600119|10907518|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2
9799654|NCT00600119|10907519|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2
9799655|NCT00600119|10907514|FG000|STARTED|Double-blind Treatment Period||32
9799656|NCT00600119|10907515|FG001|STARTED|Double-blind Treatment Period||33
9799657|NCT00600119|10907516|FG002|STARTED|Double-blind Treatment Period||27
9799658|NCT00600119|10907517|FG003|STARTED|Double-blind Treatment Period||30
9799659|NCT00600119|10907518|FG004|STARTED|Double-blind Treatment Period||37
9799660|NCT00600119|10907519|FG005|STARTED|Double-blind Treatment Period||35
10015817|NCT01807520|11138791|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
10015818|NCT01807520|11138792|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
10015819|NCT01807520|11138793|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
10015820|NCT01807520|11138794|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
10015821|NCT01807520|11138788|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
10015822|NCT01807520|11138789|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
9799661|NCT00600119|10907514|FG000|COMPLETED|Double-blind Treatment Period||27
9799662|NCT00600119|10907515|FG001|COMPLETED|Double-blind Treatment Period||28
9799663|NCT00600119|10907516|FG002|COMPLETED|Double-blind Treatment Period||27
9799664|NCT00600119|10907517|FG003|COMPLETED|Double-blind Treatment Period||28
9799665|NCT00600119|10907518|FG004|COMPLETED|Double-blind Treatment Period||31
9799666|NCT00600119|10907519|FG005|COMPLETED|Double-blind Treatment Period||21
9799667|NCT00600119|10907514|FG000|NOT COMPLETED|Double-blind Treatment Period||5
9799668|NCT00600119|10907515|FG001|NOT COMPLETED|Double-blind Treatment Period||5
9799669|NCT00600119|10907516|FG002|NOT COMPLETED|Double-blind Treatment Period||0
9799670|NCT00600119|10907517|FG003|NOT COMPLETED|Double-blind Treatment Period||2
9799671|NCT00600119|10907518|FG004|NOT COMPLETED|Double-blind Treatment Period||6
9799672|NCT00600119|10907519|FG005|NOT COMPLETED|Double-blind Treatment Period||14
9799673|NCT00600119|10907514|FG000|STARTED|Follow-up Period||27
9799674|NCT00600119|10907515|FG001|STARTED|Follow-up Period||28
9799675|NCT00600119|10907516|FG002|STARTED|Follow-up Period||27
9799676|NCT00600119|10907517|FG003|STARTED|Follow-up Period||28
9799677|NCT00600119|10907518|FG004|STARTED|Follow-up Period||31
9799678|NCT00600119|10907519|FG005|STARTED|Follow-up Period||21
9799679|NCT00600119|10907514|FG000|COMPLETED|Follow-up Period||26
9799680|NCT00600119|10907515|FG001|COMPLETED|Follow-up Period||28
9799681|NCT00600119|10907516|FG002|COMPLETED|Follow-up Period||27
9799682|NCT00600119|10907517|FG003|COMPLETED|Follow-up Period||28
9799683|NCT00600119|10907518|FG004|COMPLETED|Follow-up Period||31
9799684|NCT00600119|10907519|FG005|COMPLETED|Follow-up Period||20
9799685|NCT00600119|10907514|FG000|NOT COMPLETED|Follow-up Period||1
9799686|NCT00600119|10907515|FG001|NOT COMPLETED|Follow-up Period||0
9799687|NCT00600119|10907516|FG002|NOT COMPLETED|Follow-up Period||0
9799688|NCT00600119|10907517|FG003|NOT COMPLETED|Follow-up Period||0
9799689|NCT00600119|10907518|FG004|NOT COMPLETED|Follow-up Period||0
9799690|NCT00600119|10907519|FG005|NOT COMPLETED|Follow-up Period||1
9799691|NCT00600171|10907539|FG000|STARTED|Overall Study||102
9799692|NCT00600171|10907540|FG001|STARTED|Overall Study||101
9799693|NCT00600171|10907541|FG002|STARTED|Overall Study||101
9799694|NCT00600171|10907542|FG003|STARTED|Overall Study||100
9799695|NCT00600171|10907543|FG004|STARTED|Overall Study||101
9799696|NCT00600171|10907544|FG005|STARTED|Overall Study||102
9799697|NCT00600171|10907539|FG000|COMPLETED|Overall Study||86
9799698|NCT00600171|10907540|FG001|COMPLETED|Overall Study||84
9799699|NCT00600171|10907541|FG002|COMPLETED|Overall Study||91
9799700|NCT00600171|10907542|FG003|COMPLETED|Overall Study||88
9799701|NCT00600171|10907543|FG004|COMPLETED|Overall Study||93
9799702|NCT00600171|10907544|FG005|COMPLETED|Overall Study||97
9799703|NCT00600171|10907539|FG000|NOT COMPLETED|Overall Study||16
9799704|NCT00600171|10907540|FG001|NOT COMPLETED|Overall Study||17
9799705|NCT00600171|10907541|FG002|NOT COMPLETED|Overall Study||10
9799706|NCT00600171|10907542|FG003|NOT COMPLETED|Overall Study||12
9799707|NCT00600171|10907543|FG004|NOT COMPLETED|Overall Study||8
9799708|NCT00600171|10907544|FG005|NOT COMPLETED|Overall Study||5
9799709|NCT00600340|10907562|FG000|STARTED|Overall Study||285
9799710|NCT00600340|10907563|FG001|STARTED|Overall Study||279
9799711|NCT00600340|10907562|FG000|COMPLETED|Overall Study||285
9799712|NCT00600340|10907563|FG001|COMPLETED|Overall Study||279
10015823|NCT01807520|11138790|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
9799713|NCT00600340|10907562|FG000|NOT COMPLETED|Overall Study||0
9799714|NCT00600340|10907563|FG001|NOT COMPLETED|Overall Study||0
9799715|NCT00600353|10907571|FG000|STARTED|Overall Study||10
9799716|NCT00600353|10907572|FG001|STARTED|Overall Study||10
9799717|NCT00600353|10907571|FG000|COMPLETED|Overall Study||9
9799718|NCT00600353|10907572|FG001|COMPLETED|Overall Study||9
9799719|NCT00600353|10907571|FG000|NOT COMPLETED|Overall Study||1
9799720|NCT00600353|10907572|FG001|NOT COMPLETED|Overall Study||1
9799721|NCT00600613|10907578|FG000|STARTED|Overall Study||6
9799722|NCT00600613|10907578|FG000|COMPLETED|Overall Study||5
9799723|NCT00600613|10907578|FG000|NOT COMPLETED|Overall Study||1
9799724|NCT00600704|10907584|FG000|STARTED|Overall Study||100
9799725|NCT00600704|10907585|FG001|STARTED|Overall Study||92
9799726|NCT00600704|10907584|FG000|COMPLETED|Overall Study||100
9799727|NCT00600704|10907585|FG001|COMPLETED|Overall Study||92
9799728|NCT00600704|10907584|FG000|NOT COMPLETED|Overall Study||0
9799729|NCT00600704|10907585|FG001|NOT COMPLETED|Overall Study||0
9799730|NCT00600743|10907595|FG000|STARTED|Overall Study||4
9799731|NCT00600743|10907596|FG001|STARTED|Overall Study||4
9799732|NCT00600743|10907597|FG002|STARTED|Overall Study||8
9799733|NCT00600743|10907598|FG003|STARTED|Overall Study||7
9799734|NCT00600743|10907595|FG000|COMPLETED|Overall Study||4
9799735|NCT00600743|10907596|FG001|COMPLETED|Overall Study||4
9799736|NCT00600743|10907597|FG002|COMPLETED|Overall Study||8
9799737|NCT00600743|10907598|FG003|COMPLETED|Overall Study||7
9799738|NCT00600743|10907595|FG000|NOT COMPLETED|Overall Study||0
9799739|NCT00600743|10907596|FG001|NOT COMPLETED|Overall Study||0
9799740|NCT00600743|10907597|FG002|NOT COMPLETED|Overall Study||0
9799741|NCT00600743|10907598|FG003|NOT COMPLETED|Overall Study||0
9799742|NCT00600756|10907619|FG000|STARTED|Analysis After 6 Months||395
9799743|NCT00600756|10907620|FG001|STARTED|Analysis After 6 Months||403
9799744|NCT00600756|10907619|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
9799745|NCT00600756|10907620|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
9799746|NCT00600756|10907619|FG000|NOT COMPLETED|Analysis After 6 Months||131
9799747|NCT00600756|10907620|FG001|NOT COMPLETED|Analysis After 6 Months||120
9799748|NCT00600756|10907619|FG000|STARTED|Overall Study Analysis After 12 Months||395
9799749|NCT00600756|10907620|FG001|STARTED|Overall Study Analysis After 12 Months||403
9799750|NCT00600756|10907619|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395
9799751|NCT00600756|10907620|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403
9799752|NCT00600756|10907619|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391
9799753|NCT00600756|10907620|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402
9799754|NCT00600756|10907619|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379
9799755|NCT00600756|10907620|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392
9799756|NCT00600756|10907619|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
9799757|NCT00600756|10907620|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
9799758|NCT00600756|10907619|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183
9799759|NCT00600756|10907620|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176
10015824|NCT01807520|11138791|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
10015825|NCT01807520|11138792|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
10015826|NCT01807520|11138793|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
9799760|NCT00600821|10907628|FG000|STARTED|Overall Study||58
9799761|NCT00600821|10907629|FG001|STARTED|Overall Study||60
9799762|NCT00600821|10907628|FG000|Treated|Overall Study||58
9799763|NCT00600821|10907629|FG001|Treated|Overall Study||59
9799764|NCT00600821|10907628|FG000|COMPLETED|Overall Study||0
9799765|NCT00600821|10907629|FG001|COMPLETED|Overall Study||0
9799766|NCT00600821|10907628|FG000|NOT COMPLETED|Overall Study||58
9799767|NCT00600821|10907629|FG001|NOT COMPLETED|Overall Study||60
9799768|NCT00600886|10907639|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176
9799769|NCT00600886|10907640|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182
9799770|NCT00600886|10907639|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
9799771|NCT00600886|10907640|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
9799772|NCT00600886|10907639|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
9799773|NCT00600886|10907640|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
9799774|NCT00600886|10907639|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
9799775|NCT00600886|10907640|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
9799776|NCT00600886|10907639|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
9799777|NCT00600886|10907640|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
9799778|NCT00600886|10907639|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
9799779|NCT00600886|10907640|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
9799780|NCT00600886|10907639|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
9799781|NCT00600886|10907640|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
9831255|NCT00767624|10941951|FG000|COMPLETED|Overall Study||51
9831256|NCT00767624|10941952|FG001|COMPLETED|Overall Study||58
9799782|NCT00600886|10907639|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
9799783|NCT00600886|10907640|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
9799784|NCT00600886|10907639|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
9799785|NCT00600886|10907640|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
9799786|NCT00600886|10907639|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
9799787|NCT00600886|10907640|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
9799788|NCT00600886|10907639|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
9799789|NCT00600886|10907640|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
9799790|NCT00600886|10907639|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
9799791|NCT00600886|10907640|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
9799792|NCT00600886|10907639|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46
9799793|NCT00600886|10907640|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11
9799794|NCT00600886|10907639|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
9799795|NCT00600886|10907640|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
9799796|NCT00600886|10907639|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
9799797|NCT00600886|10907640|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
9799798|NCT00600886|10907639|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
9799799|NCT00600886|10907640|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
9799800|NCT00600886|10907639|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
9799801|NCT00600886|10907640|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
9799802|NCT00600886|10907639|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31
9799803|NCT00600886|10907640|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
9799804|NCT00600886|10907639|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
9799805|NCT00600886|10907640|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
9799806|NCT00600886|10907639|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62
9799807|NCT00600886|10907640|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13
9799808|NCT00600925|10907662|FG000|STARTED|Overall Study||300
10235283|NCT01216631|11365556|FG000|COMPLETED|Overall Study||0
10235284|NCT01216631|11365557|FG001|COMPLETED|Overall Study||0
9799809|NCT00600925|10907663|FG001|STARTED|Overall Study||302
9799810|NCT00600925|10907662|FG000|COMPLETED|Overall Study||300
9799811|NCT00600925|10907663|FG001|COMPLETED|Overall Study||302
9799812|NCT00600925|10907662|FG000|NOT COMPLETED|Overall Study||0
9799813|NCT00600925|10907663|FG001|NOT COMPLETED|Overall Study||0
9799814|NCT00600938|10907671|FG000|STARTED|Core Study||98
9799815|NCT00600938|10907672|FG001|STARTED|Core Study||99
9799816|NCT00600938|10907673|FG002|STARTED|Core Study||0
9799817|NCT00600938|10907674|FG003|STARTED|Core Study||0
9799818|NCT00600938|10907671|FG000|Core Safety Set|Core Study||96
9799819|NCT00600938|10907672|FG001|Core Safety Set|Core Study||91
9799820|NCT00600938|10907673|FG002|Core Safety Set|Core Study||0
9799821|NCT00600938|10907674|FG003|Core Safety Set|Core Study||0
10015827|NCT01807520|11138794|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10235285|NCT01216631|11365558|FG002|COMPLETED|Overall Study||1
9799822|NCT00600938|10907671|FG000|Per Protocol Set (PPS)|Core Study||91
9799823|NCT00600938|10907672|FG001|Per Protocol Set (PPS)|Core Study||81
9799824|NCT00600938|10907673|FG002|Per Protocol Set (PPS)|Core Study||0
9799825|NCT00600938|10907674|FG003|Per Protocol Set (PPS)|Core Study||0
9799826|NCT00600938|10907671|FG000|COMPLETED|Core Study||82
9799827|NCT00600938|10907672|FG001|COMPLETED|Core Study||78
9799828|NCT00600938|10907673|FG002|COMPLETED|Core Study||0
9799829|NCT00600938|10907674|FG003|COMPLETED|Core Study||0
9799830|NCT00600938|10907671|FG000|NOT COMPLETED|Core Study||16
9799831|NCT00600938|10907672|FG001|NOT COMPLETED|Core Study||21
9799832|NCT00600938|10907673|FG002|NOT COMPLETED|Core Study||0
9799833|NCT00600938|10907674|FG003|NOT COMPLETED|Core Study||0
9799834|NCT00600938|10907671|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
9799835|NCT00600938|10907672|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
9799836|NCT00600938|10907673|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
9799837|NCT00600938|10907674|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
9831257|NCT00767624|10941951|FG000|NOT COMPLETED|Overall Study||24
10235286|NCT01216631|11365556|FG000|NOT COMPLETED|Overall Study||0
10235287|NCT01216631|11365557|FG001|NOT COMPLETED|Overall Study||0
9799838|NCT00600938|10907671|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
9799839|NCT00600938|10907672|FG001|Extension Safety Set|Extension Study||29
9799840|NCT00600938|10907673|FG002|Extension Safety Set|Extension Study||42
9799841|NCT00600938|10907674|FG003|Extension Safety Set|Extension Study||1
9799842|NCT00600938|10907671|FG000|COMPLETED|Extension Study||65
9799843|NCT00600938|10907672|FG001|COMPLETED|Extension Study||24
9799844|NCT00600938|10907673|FG002|COMPLETED|Extension Study||33
9799845|NCT00600938|10907674|FG003|COMPLETED|Extension Study||0
9799846|NCT00600938|10907671|FG000|NOT COMPLETED|Extension Study||9
9799847|NCT00600938|10907672|FG001|NOT COMPLETED|Extension Study||5
9799848|NCT00600938|10907673|FG002|NOT COMPLETED|Extension Study||9
9799849|NCT00600938|10907674|FG003|NOT COMPLETED|Extension Study||1
9799850|NCT00601107|10907703|FG000|STARTED|Overall Study|Randomized.|27
9799851|NCT00601107|10907704|FG001|STARTED|Overall Study||31
9799852|NCT00601107|10907705|FG002|STARTED|Overall Study||28
9799853|NCT00601107|10907706|FG003|STARTED|Overall Study||25
9799854|NCT00601107|10907703|FG000|Treated|Overall Study||27
9799855|NCT00601107|10907704|FG001|Treated|Overall Study||31
9799856|NCT00601107|10907705|FG002|Treated|Overall Study||28
9799857|NCT00601107|10907706|FG003|Treated|Overall Study||25
9799858|NCT00601107|10907703|FG000|COMPLETED|Overall Study||14
9799859|NCT00601107|10907704|FG001|COMPLETED|Overall Study||22
9799860|NCT00601107|10907705|FG002|COMPLETED|Overall Study||16
9799861|NCT00601107|10907706|FG003|COMPLETED|Overall Study||13
9799862|NCT00601107|10907703|FG000|NOT COMPLETED|Overall Study||13
9799863|NCT00601107|10907704|FG001|NOT COMPLETED|Overall Study||9
9799864|NCT00601107|10907705|FG002|NOT COMPLETED|Overall Study||12
9799865|NCT00601107|10907706|FG003|NOT COMPLETED|Overall Study||12
9799866|NCT00601146|10907716|FG000|STARTED|Overall Study||39
9799867|NCT00601146|10907716|FG000|COMPLETED|Overall Study||39
9799868|NCT00601146|10907716|FG000|NOT COMPLETED|Overall Study||0
9799869|NCT00601172|10907722|FG000|STARTED|Overall Study||355
9799870|NCT00601172|10907723|FG001|STARTED|Overall Study||355
9799871|NCT00601172|10907722|FG000|COMPLETED|Overall Study||214
9799872|NCT00601172|10907723|FG001|COMPLETED|Overall Study||228
9799873|NCT00601172|10907722|FG000|NOT COMPLETED|Overall Study||141
9799874|NCT00601172|10907723|FG001|NOT COMPLETED|Overall Study||127
9799875|NCT00601250|10907732|FG000|STARTED|Overall Study|number who started treatment|177
9799876|NCT00601250|10907733|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
9799877|NCT00601250|10907732|FG000|COMPLETED|Overall Study|number who completed treatment|163
9799878|NCT00601250|10907733|FG001|COMPLETED|Overall Study|number who completed treatment|484
9799879|NCT00601250|10907732|FG000|NOT COMPLETED|Overall Study||14
9799880|NCT00601250|10907733|FG001|NOT COMPLETED|Overall Study||39
9799881|NCT00601354|10907741|FG000|STARTED|Overall Study||8
9799882|NCT00601354|10907742|FG001|STARTED|Overall Study||9
9799883|NCT00601354|10907741|FG000|COMPLETED|Overall Study||4
9799884|NCT00601354|10907742|FG001|COMPLETED|Overall Study||4
9799885|NCT00601354|10907741|FG000|NOT COMPLETED|Overall Study||4
9799886|NCT00601354|10907742|FG001|NOT COMPLETED|Overall Study||5
9799887|NCT00601367|10907748|FG000|STARTED|Overall Study||480
9799888|NCT00601367|10907748|FG000|COMPLETED|Overall Study||293
9799889|NCT00601367|10907748|FG000|NOT COMPLETED|Overall Study||187
9799890|NCT00601419|10907752|FG000|STARTED|Overall Study||230
9799891|NCT00601419|10907752|FG000|COMPLETED|Overall Study||226
9799892|NCT00601419|10907752|FG000|NOT COMPLETED|Overall Study||4
9799893|NCT00601458|10907775|FG000|STARTED|Overall Study||36
9799894|NCT00601458|10907776|FG001|STARTED|Overall Study||34
9799895|NCT00601458|10907777|FG002|STARTED|Overall Study||30
9799896|NCT00601458|10907775|FG000|COMPLETED|Overall Study||32
9799897|NCT00601458|10907776|FG001|COMPLETED|Overall Study||29
9799898|NCT00601458|10907777|FG002|COMPLETED|Overall Study||28
9799899|NCT00601458|10907775|FG000|NOT COMPLETED|Overall Study||4
9799900|NCT00601458|10907776|FG001|NOT COMPLETED|Overall Study||5
9799901|NCT00601458|10907777|FG002|NOT COMPLETED|Overall Study||2
9799902|NCT00601484|10907787|FG000|STARTED|Overall Study||34
9799903|NCT00601484|10907788|FG001|STARTED|Overall Study||31
9799904|NCT00601484|10907787|FG000|Treated|Overall Study||34
9799905|NCT00601484|10907788|FG001|Treated|Overall Study||30
9799906|NCT00601484|10907787|FG000|COMPLETED|Overall Study||29
9799907|NCT00601484|10907788|FG001|COMPLETED|Overall Study||23
9799908|NCT00601484|10907787|FG000|NOT COMPLETED|Overall Study||5
9799909|NCT00601484|10907788|FG001|NOT COMPLETED|Overall Study||8
9799910|NCT00601523|10907796|FG000|STARTED|Overall Study||368
9799911|NCT00601523|10907797|FG001|STARTED|Overall Study||143
9799912|NCT00601523|10907796|FG000|COMPLETED|Overall Study||291
10015828|NCT01807520|11138788|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
9799913|NCT00601523|10907797|FG001|COMPLETED|Overall Study||117
9799914|NCT00601523|10907796|FG000|NOT COMPLETED|Overall Study||77
9799915|NCT00601523|10907797|FG001|NOT COMPLETED|Overall Study||26
9799916|NCT00601627|10907803|FG000|STARTED|Overall Study||51
9799917|NCT00601627|10907803|FG000|COMPLETED|Overall Study||51
9799918|NCT00601627|10907803|FG000|NOT COMPLETED|Overall Study||0
9799919|NCT00601640|10907810|FG000|STARTED|Overall Study||52
9799920|NCT00601640|10907811|FG001|STARTED|Overall Study||52
9799921|NCT00601640|10907812|FG002|STARTED|Overall Study||52
9799922|NCT00601640|10907810|FG000|COMPLETED|Overall Study||47
9799923|NCT00601640|10907811|FG001|COMPLETED|Overall Study||47
9799924|NCT00601640|10907812|FG002|COMPLETED|Overall Study||42
9799925|NCT00601640|10907810|FG000|NOT COMPLETED|Overall Study||5
9799926|NCT00601640|10907811|FG001|NOT COMPLETED|Overall Study||5
9799927|NCT00601640|10907812|FG002|NOT COMPLETED|Overall Study||10
9799928|NCT00601705|10907822|FG000|STARTED|Overall Study||61
9799929|NCT00601705|10907822|FG000|COMPLETED|Overall Study||60
9799930|NCT00601705|10907822|FG000|NOT COMPLETED|Overall Study||1
9799931|NCT00601718|10907827|FG000|STARTED|Overall Study||29
9799932|NCT00601718|10907827|FG000|COMPLETED|Overall Study||29
9799933|NCT00601718|10907827|FG000|NOT COMPLETED|Overall Study||0
9799934|NCT00601731|10907843|FG000|STARTED|Overall Study||143
9799935|NCT00601731|10907844|FG001|STARTED|Overall Study||43
9799936|NCT00601731|10907845|FG002|STARTED|Overall Study||166
9799937|NCT00601731|10907846|FG003|STARTED|Overall Study||30
9799938|NCT00601731|10907843|FG000|COMPLETED|Overall Study||120
9799939|NCT00601731|10907844|FG001|COMPLETED|Overall Study||43
9799940|NCT00601731|10907845|FG002|COMPLETED|Overall Study||151
9799941|NCT00601731|10907846|FG003|COMPLETED|Overall Study||29
9799942|NCT00601731|10907843|FG000|NOT COMPLETED|Overall Study||23
9799943|NCT00601731|10907844|FG001|NOT COMPLETED|Overall Study||0
9799944|NCT00601731|10907845|FG002|NOT COMPLETED|Overall Study||15
9799945|NCT00601731|10907846|FG003|NOT COMPLETED|Overall Study||1
9799946|NCT00601796|10907872|FG000|STARTED|Overall Study||24
9799947|NCT00601796|10907872|FG000|COMPLETED|Overall Study||24
9799948|NCT00601796|10907872|FG000|NOT COMPLETED|Overall Study||0
9799949|NCT00601835|10907878|FG000|STARTED|Overall Study||2950
9799950|NCT00601835|10907879|FG001|STARTED|Overall Study||700
9799951|NCT00601835|10907878|FG000|COMPLETED|Overall Study||2890
9799952|NCT00601835|10907879|FG001|COMPLETED|Overall Study||686
9799953|NCT00601835|10907878|FG000|NOT COMPLETED|Overall Study||60
9799954|NCT00601835|10907879|FG001|NOT COMPLETED|Overall Study||14
9799955|NCT00601926|10907885|FG000|STARTED|Overall Study||5
9799956|NCT00601926|10907885|FG000|COMPLETED|Overall Study||5
9799957|NCT00601926|10907885|FG000|NOT COMPLETED|Overall Study||0
9799958|NCT00601952|10907891|FG000|STARTED|Overall Study||14
9799959|NCT00601952|10907892|FG001|STARTED|Overall Study||17
9799960|NCT00601952|10907891|FG000|COMPLETED|Overall Study||12
9799961|NCT00601952|10907892|FG001|COMPLETED|Overall Study||17
9799962|NCT00601952|10907891|FG000|NOT COMPLETED|Overall Study||2
9799963|NCT00601952|10907892|FG001|NOT COMPLETED|Overall Study||0
9799964|NCT00601965|10907902|FG000|STARTED|Overall Study||18
9799965|NCT00601965|10907903|FG001|STARTED|Overall Study||18
9799966|NCT00601965|10907904|FG002|STARTED|Overall Study||19
9799967|NCT00601965|10907905|FG003|STARTED|Overall Study||18
9799968|NCT00601965|10907902|FG000|COMPLETED|Overall Study||18
9799969|NCT00601965|10907903|FG001|COMPLETED|Overall Study||16
9799970|NCT00601965|10907904|FG002|COMPLETED|Overall Study||19
9799971|NCT00601965|10907905|FG003|COMPLETED|Overall Study||17
9799972|NCT00601965|10907902|FG000|NOT COMPLETED|Overall Study||0
9799973|NCT00601965|10907903|FG001|NOT COMPLETED|Overall Study||2
9799974|NCT00601965|10907904|FG002|NOT COMPLETED|Overall Study||0
9799975|NCT00601965|10907905|FG003|NOT COMPLETED|Overall Study||1
9799976|NCT00602043|10907915|FG000|STARTED|Overall Study||20
9799977|NCT00602043|10907915|FG000|COMPLETED|Overall Study||15
9799978|NCT00602043|10907915|FG000|NOT COMPLETED|Overall Study||5
9799979|NCT00602225|10907922|FG000|STARTED|Overall Study||50
9799980|NCT00602225|10907922|FG000|COMPLETED|Overall Study||50
9799981|NCT00602225|10907922|FG000|NOT COMPLETED|Overall Study||0
9799982|NCT00602290|10907930|FG000|STARTED|Overall Study||48
9799983|NCT00602290|10907931|FG001|STARTED|Overall Study||48
9799984|NCT00602290|10907932|FG002|STARTED|Overall Study||47
9799985|NCT00602290|10907930|FG000|COMPLETED|Overall Study||46
9799986|NCT00602290|10907931|FG001|COMPLETED|Overall Study||46
9799987|NCT00602290|10907932|FG002|COMPLETED|Overall Study||46
9799988|NCT00602290|10907930|FG000|NOT COMPLETED|Overall Study||2
9799989|NCT00602290|10907931|FG001|NOT COMPLETED|Overall Study||2
9799990|NCT00602290|10907932|FG002|NOT COMPLETED|Overall Study||1
9799991|NCT00602355|10907943|FG000|STARTED|Overall Study||53
9799992|NCT00602355|10907944|FG001|STARTED|Overall Study||56
9799993|NCT00602355|10907945|FG002|STARTED|Overall Study||53
9799994|NCT00602355|10907943|FG000|COMPLETED|Overall Study||44
9799995|NCT00602355|10907944|FG001|COMPLETED|Overall Study||38
9799996|NCT00602355|10907945|FG002|COMPLETED|Overall Study||43
9799997|NCT00602355|10907943|FG000|NOT COMPLETED|Overall Study||9
9799998|NCT00602355|10907944|FG001|NOT COMPLETED|Overall Study||18
9799999|NCT00602355|10907945|FG002|NOT COMPLETED|Overall Study||10
9800000|NCT00602420|10907955|FG000|STARTED|Overall Study||257
9800001|NCT00602420|10907956|FG001|STARTED|Overall Study||253
9800002|NCT00602420|10907955|FG000|COMPLETED|Overall Study||232
9800003|NCT00602420|10907956|FG001|COMPLETED|Overall Study||229
9800004|NCT00602420|10907955|FG000|NOT COMPLETED|Overall Study||25
9800005|NCT00602420|10907956|FG001|NOT COMPLETED|Overall Study||24
9800006|NCT00602446|10907962|FG000|STARTED|Overall Study||3
9800007|NCT00602446|10907962|FG000|COMPLETED|Overall Study||3
9800008|NCT00602446|10907962|FG000|NOT COMPLETED|Overall Study||0
9800009|NCT00602472|10907968|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263
9800010|NCT00602472|10907969|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792
9800011|NCT00602472|10907968|FG000|COMPLETED|Overall Study|number who completed treatment|242
9800012|NCT00602472|10907969|FG001|COMPLETED|Overall Study|number who completed treatment|734
9800013|NCT00602472|10907968|FG000|NOT COMPLETED|Overall Study||21
9800014|NCT00602472|10907969|FG001|NOT COMPLETED|Overall Study||58
9831258|NCT00767624|10941952|FG001|NOT COMPLETED|Overall Study||17
9831259|NCT00767676|10941958|FG000|STARTED|Overall Study||259
9831260|NCT00767676|10941958|FG000|COMPLETED|Overall Study||205
9800015|NCT00602537|10907977|FG000|STARTED|12 Week Double Blind Comparison||65
9800016|NCT00602537|10907978|FG001|STARTED|12 Week Double Blind Comparison||64
9800017|NCT00602537|10907977|FG000|Responded|12 Week Double Blind Comparison||44
9800018|NCT00602537|10907978|FG001|Responded|12 Week Double Blind Comparison||22
9800019|NCT00602537|10907977|FG000|COMPLETED|12 Week Double Blind Comparison||42
9800020|NCT00602537|10907978|FG001|COMPLETED|12 Week Double Blind Comparison||17
9800021|NCT00602537|10907977|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23
9800022|NCT00602537|10907978|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47
9800023|NCT00602537|10907977|FG000|STARTED|Follow Up Study Comparison||42
9800024|NCT00602537|10907978|FG001|STARTED|Follow Up Study Comparison||17
9800025|NCT00602537|10907977|FG000|COMPLETED|Follow Up Study Comparison||31
9800026|NCT00602537|10907978|FG001|COMPLETED|Follow Up Study Comparison||14
9800027|NCT00602537|10907977|FG000|NOT COMPLETED|Follow Up Study Comparison||11
9800028|NCT00602537|10907978|FG001|NOT COMPLETED|Follow Up Study Comparison||3
9800029|NCT00602771|10907986|FG000|STARTED|Overall Study||63
9800030|NCT00602771|10907987|FG001|STARTED|Overall Study||21
9800031|NCT00602771|10907986|FG000|COMPLETED|Overall Study||62
9800032|NCT00602771|10907987|FG001|COMPLETED|Overall Study||21
9800033|NCT00602771|10907986|FG000|NOT COMPLETED|Overall Study||1
9800034|NCT00602771|10907987|FG001|NOT COMPLETED|Overall Study||0
9800035|NCT00602797|10907993|FG000|STARTED|Overall Study||20
9800036|NCT00602797|10907993|FG000|COMPLETED|Overall Study||19
9800037|NCT00602797|10907993|FG000|NOT COMPLETED|Overall Study||1
9800038|NCT00602836|10907998|FG000|STARTED|Overall Study||44
9800039|NCT00602836|10907998|FG000|COMPLETED|Overall Study||39
9800040|NCT00602836|10907998|FG000|NOT COMPLETED|Overall Study||5
9800041|NCT00602927|10908004|FG000|STARTED|Period 1: 13 Days||19
9800042|NCT00602927|10908005|FG001|STARTED|Period 1: 13 Days||19
9800043|NCT00602927|10908004|FG000|COMPLETED|Period 1: 13 Days||15
9800044|NCT00602927|10908005|FG001|COMPLETED|Period 1: 13 Days||14
9800045|NCT00602927|10908004|FG000|NOT COMPLETED|Period 1: 13 Days||4
9800046|NCT00602927|10908005|FG001|NOT COMPLETED|Period 1: 13 Days||5
9800047|NCT00602927|10908004|FG000|STARTED|Period 2: 14 Days||15
9800048|NCT00602927|10908005|FG001|STARTED|Period 2: 14 Days||14
9800049|NCT00602927|10908004|FG000|COMPLETED|Period 2: 14 Days||15
9800050|NCT00602927|10908005|FG001|COMPLETED|Period 2: 14 Days||12
9800051|NCT00602927|10908004|FG000|NOT COMPLETED|Period 2: 14 Days||0
9800052|NCT00602927|10908005|FG001|NOT COMPLETED|Period 2: 14 Days||2
9800053|NCT00602927|10908004|FG000|STARTED|Period 3: 13 Days||15
9800054|NCT00602927|10908005|FG001|STARTED|Period 3: 13 Days||12
9800055|NCT00602927|10908004|FG000|COMPLETED|Period 3: 13 Days||13
9800056|NCT00602927|10908005|FG001|COMPLETED|Period 3: 13 Days||9
9800057|NCT00602927|10908004|FG000|NOT COMPLETED|Period 3: 13 Days||2
9800058|NCT00602927|10908005|FG001|NOT COMPLETED|Period 3: 13 Days||3
9800059|NCT00602953|10908016|FG000|STARTED|Overall Study||15
9800060|NCT00602953|10908017|FG001|STARTED|Overall Study||26
9800061|NCT00602953|10908018|FG002|STARTED|Overall Study||47
9800062|NCT00602953|10908019|FG003|STARTED|Overall Study||13
9800063|NCT00602953|10908020|FG004|STARTED|Overall Study||0
9800064|NCT00602953|10908016|FG000|COMPLETED|Overall Study||15
9800065|NCT00602953|10908017|FG001|COMPLETED|Overall Study||26
9800066|NCT00602953|10908018|FG002|COMPLETED|Overall Study||47
9800067|NCT00602953|10908019|FG003|COMPLETED|Overall Study||13
9800068|NCT00602953|10908020|FG004|COMPLETED|Overall Study||0
9800069|NCT00602953|10908016|FG000|NOT COMPLETED|Overall Study||0
9800070|NCT00602953|10908017|FG001|NOT COMPLETED|Overall Study||0
9800071|NCT00602953|10908018|FG002|NOT COMPLETED|Overall Study||0
9800072|NCT00602953|10908019|FG003|NOT COMPLETED|Overall Study||0
9800073|NCT00602953|10908020|FG004|NOT COMPLETED|Overall Study||0
9800074|NCT00602979|10908037|FG000|STARTED|Overall Study||48
9800075|NCT00602979|10908038|FG001|STARTED|Overall Study||48
9800076|NCT00602979|10908039|FG002|STARTED|Overall Study||48
9800077|NCT00602979|10908040|FG003|STARTED|Overall Study||48
9800078|NCT00602979|10908041|FG004|STARTED|Overall Study||48
9800079|NCT00602979|10908037|FG000|COMPLETED|Overall Study||45
9800080|NCT00602979|10908038|FG001|COMPLETED|Overall Study||45
9800081|NCT00602979|10908039|FG002|COMPLETED|Overall Study||45
9800082|NCT00602979|10908040|FG003|COMPLETED|Overall Study||45
9800083|NCT00602979|10908041|FG004|COMPLETED|Overall Study||45
9800084|NCT00602979|10908037|FG000|NOT COMPLETED|Overall Study||3
9800085|NCT00602979|10908038|FG001|NOT COMPLETED|Overall Study||3
9800086|NCT00602979|10908039|FG002|NOT COMPLETED|Overall Study||3
9800087|NCT00602979|10908040|FG003|NOT COMPLETED|Overall Study||3
9800088|NCT00602979|10908041|FG004|NOT COMPLETED|Overall Study||3
9800089|NCT00603018|10908053|FG000|STARTED|Overall Study||23
9800090|NCT00603018|10908053|FG000|COMPLETED|Overall Study||23
9800091|NCT00603018|10908053|FG000|NOT COMPLETED|Overall Study||0
9800092|NCT00603044|10908060|FG000|STARTED|Overall Study||11
9800093|NCT00603044|10908061|FG001|STARTED|Overall Study||13
9800094|NCT00603044|10908060|FG000|COMPLETED|Overall Study||11
9800095|NCT00603044|10908061|FG001|COMPLETED|Overall Study||13
9800096|NCT00603044|10908060|FG000|NOT COMPLETED|Overall Study||0
9800097|NCT00603044|10908061|FG001|NOT COMPLETED|Overall Study||0
9800098|NCT00603187|10908067|FG000|STARTED|Overall Study||4
9800099|NCT00603187|10908067|FG000|COMPLETED|Overall Study||4
9800100|NCT00603187|10908067|FG000|NOT COMPLETED|Overall Study||0
9800101|NCT00603239|10908073|FG000|STARTED|Overall Study||111
9800102|NCT00603239|10908074|FG001|STARTED|Overall Study||54
9800103|NCT00603239|10908073|FG000|COMPLETED|Overall Study||96
9800104|NCT00603239|10908074|FG001|COMPLETED|Overall Study||50
9800105|NCT00603239|10908073|FG000|NOT COMPLETED|Overall Study||15
9800106|NCT00603239|10908074|FG001|NOT COMPLETED|Overall Study||4
9800107|NCT00603265|10908083|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
9800108|NCT00603265|10908084|FG001|STARTED|Overall Study||78
9800109|NCT00603265|10908085|FG002|STARTED|Overall Study||72
9800110|NCT00603265|10908083|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
9800111|NCT00603265|10908084|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
9800112|NCT00603265|10908085|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
9800113|NCT00603265|10908083|FG000|COMPLETED|Overall Study||69
9800114|NCT00603265|10908084|FG001|COMPLETED|Overall Study||62
9800115|NCT00603265|10908085|FG002|COMPLETED|Overall Study||67
9800116|NCT00603265|10908083|FG000|NOT COMPLETED|Overall Study||7
9800117|NCT00603265|10908084|FG001|NOT COMPLETED|Overall Study||16
9800118|NCT00603265|10908085|FG002|NOT COMPLETED|Overall Study||5
9800119|NCT00603278|10908099|FG000|STARTED|Overall Study||107
9800120|NCT00603278|10908100|FG001|STARTED|Overall Study||105
9800121|NCT00603278|10908101|FG002|STARTED|Overall Study||101
9800122|NCT00603278|10908102|FG003|STARTED|Overall Study||103
9800123|NCT00603278|10908103|FG004|STARTED|Overall Study||99
9800124|NCT00603278|10908104|FG005|STARTED|Overall Study||100
9800125|NCT00603278|10908099|FG000|COMPLETED|Overall Study||66
9800126|NCT00603278|10908100|FG001|COMPLETED|Overall Study||88
9800127|NCT00603278|10908101|FG002|COMPLETED|Overall Study||87
9800128|NCT00603278|10908102|FG003|COMPLETED|Overall Study||92
9800129|NCT00603278|10908103|FG004|COMPLETED|Overall Study||86
9800130|NCT00603278|10908104|FG005|COMPLETED|Overall Study||81
9800131|NCT00603278|10908099|FG000|NOT COMPLETED|Overall Study||41
9800132|NCT00603278|10908100|FG001|NOT COMPLETED|Overall Study||17
9800133|NCT00603278|10908101|FG002|NOT COMPLETED|Overall Study||14
9800134|NCT00603278|10908102|FG003|NOT COMPLETED|Overall Study||11
9800135|NCT00603278|10908103|FG004|NOT COMPLETED|Overall Study||13
9800136|NCT00603278|10908104|FG005|NOT COMPLETED|Overall Study||19
9800137|NCT00603291|10908121|FG000|STARTED|Overall Study||95
9800138|NCT00603291|10908122|FG001|STARTED|Overall Study||256
9800139|NCT00603291|10908123|FG002|STARTED|Overall Study||253
9800140|NCT00603291|10908121|FG000|COMPLETED|Overall Study||75
9800141|NCT00603291|10908122|FG001|COMPLETED|Overall Study||169
9800142|NCT00603291|10908123|FG002|COMPLETED|Overall Study||157
9800143|NCT00603291|10908121|FG000|NOT COMPLETED|Overall Study||20
9800144|NCT00603291|10908122|FG001|NOT COMPLETED|Overall Study||87
9800145|NCT00603291|10908123|FG002|NOT COMPLETED|Overall Study||96
9800146|NCT00603304|10908133|FG000|STARTED|Overall Study||183
9800147|NCT00603304|10908134|FG001|STARTED|Overall Study||186
9800148|NCT00603304|10908133|FG000|COMPLETED|Overall Study||151
9800149|NCT00603304|10908134|FG001|COMPLETED|Overall Study||155
9800150|NCT00603304|10908133|FG000|NOT COMPLETED|Overall Study||32
9800151|NCT00603304|10908134|FG001|NOT COMPLETED|Overall Study||31
9800152|NCT00603382|10908148|FG000|STARTED|Overall Study||94
9800153|NCT00603382|10908149|FG001|STARTED|Overall Study||97
9800154|NCT00603382|10908150|FG002|STARTED|Overall Study||100
9800155|NCT00603382|10908151|FG003|STARTED|Overall Study||110
9800156|NCT00603382|10908152|FG004|STARTED|Overall Study||95
9800157|NCT00603382|10908153|FG005|STARTED|Overall Study||102
9800158|NCT00603382|10908148|FG000|COMPLETED|Overall Study||76
9800159|NCT00603382|10908149|FG001|COMPLETED|Overall Study||83
9800160|NCT00603382|10908150|FG002|COMPLETED|Overall Study||91
9800161|NCT00603382|10908151|FG003|COMPLETED|Overall Study||98
9800162|NCT00603382|10908152|FG004|COMPLETED|Overall Study||86
9800163|NCT00603382|10908153|FG005|COMPLETED|Overall Study||84
9800164|NCT00603382|10908148|FG000|NOT COMPLETED|Overall Study||18
9800165|NCT00603382|10908149|FG001|NOT COMPLETED|Overall Study||14
9800166|NCT00603382|10908150|FG002|NOT COMPLETED|Overall Study||9
9800167|NCT00603382|10908151|FG003|NOT COMPLETED|Overall Study||12
9800168|NCT00603382|10908152|FG004|NOT COMPLETED|Overall Study||9
9800169|NCT00603382|10908153|FG005|NOT COMPLETED|Overall Study||18
9800170|NCT00603408|10908167|FG000|STARTED|Overall Study||5
9800171|NCT00603408|10908167|FG000|COMPLETED|Overall Study||5
9800172|NCT00603408|10908167|FG000|NOT COMPLETED|Overall Study||0
9800173|NCT00603447|10908179|FG000|STARTED|Overall Study||6
9800174|NCT00603447|10908180|FG001|STARTED|Overall Study||6
9800175|NCT00603447|10908181|FG002|STARTED|Overall Study||8
9800176|NCT00603447|10908182|FG003|STARTED|Overall Study||6
9800177|NCT00603447|10908183|FG004|STARTED|Overall Study||6
9800178|NCT00603447|10908184|FG005|STARTED|Overall Study||8
9800179|NCT00603447|10908185|FG006|STARTED|Overall Study||44
9800180|NCT00603447|10908179|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
9800181|NCT00603447|10908180|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
9800182|NCT00603447|10908181|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
9800183|NCT00603447|10908182|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
9800184|NCT00603447|10908183|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
9800185|NCT00603447|10908184|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
9800186|NCT00603447|10908185|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
9800187|NCT00603447|10908179|FG000|NOT COMPLETED|Overall Study||0
9800188|NCT00603447|10908180|FG001|NOT COMPLETED|Overall Study||3
9800189|NCT00603447|10908181|FG002|NOT COMPLETED|Overall Study||2
9800190|NCT00603447|10908182|FG003|NOT COMPLETED|Overall Study||2
9800191|NCT00603447|10908183|FG004|NOT COMPLETED|Overall Study||5
9800192|NCT00603447|10908184|FG005|NOT COMPLETED|Overall Study||2
9800193|NCT00603447|10908185|FG006|NOT COMPLETED|Overall Study||24
9800194|NCT00603473|10908201|FG000|STARTED|Overall Study||89
9800195|NCT00603473|10908201|FG000|COMPLETED|Overall Study||80
9800196|NCT00603473|10908201|FG000|NOT COMPLETED|Overall Study||9
9800197|NCT00603512|10908210|FG000|STARTED|Overall Study||28
9800198|NCT00603512|10908211|FG001|STARTED|Overall Study||28
9800199|NCT00603512|10908212|FG002|STARTED|Overall Study||28
9800200|NCT00603512|10908213|FG003|STARTED|Overall Study||28
9800201|NCT00603512|10908214|FG004|STARTED|Overall Study||28
9800202|NCT00603512|10908210|FG000|Treated|Overall Study||28
9800203|NCT00603512|10908211|FG001|Treated|Overall Study||27
9800204|NCT00603512|10908212|FG002|Treated|Overall Study||27
9800205|NCT00603512|10908213|FG003|Treated|Overall Study||26
9800206|NCT00603512|10908214|FG004|Treated|Overall Study||28
9800207|NCT00603512|10908210|FG000|COMPLETED|Overall Study||26
9800208|NCT00603512|10908211|FG001|COMPLETED|Overall Study||23
9800209|NCT00603512|10908212|FG002|COMPLETED|Overall Study||23
9800210|NCT00603512|10908213|FG003|COMPLETED|Overall Study||21
9800211|NCT00603512|10908214|FG004|COMPLETED|Overall Study||23
9800212|NCT00603512|10908210|FG000|NOT COMPLETED|Overall Study||2
9800213|NCT00603512|10908211|FG001|NOT COMPLETED|Overall Study||5
9800214|NCT00603512|10908212|FG002|NOT COMPLETED|Overall Study||5
9800215|NCT00603512|10908213|FG003|NOT COMPLETED|Overall Study||7
9800216|NCT00603512|10908214|FG004|NOT COMPLETED|Overall Study||5
9800217|NCT00603525|10908228|FG000|STARTED|DB Treatment Period (24 Weeks)||84
9800218|NCT00603525|10908229|FG001|STARTED|DB Treatment Period (24 Weeks)||85
9800219|NCT00603525|10908230|FG002|STARTED|DB Treatment Period (24 Weeks)||0
9800220|NCT00603525|10908228|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67
9800221|NCT00603525|10908229|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63
9800222|NCT00603525|10908230|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
9800223|NCT00603525|10908228|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
9800224|NCT00603525|10908229|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
9800225|NCT00603525|10908230|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
9800226|NCT00603525|10908228|FG000|STARTED|OL Treatment Period (120 Weeks)||0
9800227|NCT00603525|10908229|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
9800228|NCT00603525|10908230|FG002|STARTED|OL Treatment Period (120 Weeks)||0
9800229|NCT00603525|10908228|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
9800230|NCT00603525|10908229|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13
9800231|NCT00603525|10908230|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
9800232|NCT00603525|10908228|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
9800233|NCT00603525|10908229|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
9800234|NCT00603525|10908230|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
9800235|NCT00603525|10908228|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
9800236|NCT00603525|10908229|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
9800237|NCT00603525|10908230|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
9800238|NCT00603525|10908228|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
9800239|NCT00603525|10908229|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
9800240|NCT00603525|10908230|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
9800241|NCT00603525|10908228|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
9800242|NCT00603525|10908229|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
9800243|NCT00603525|10908230|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13
9800244|NCT00603525|10908228|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
9800245|NCT00603525|10908229|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
9800246|NCT00603525|10908230|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
9800247|NCT00603538|10908244|FG000|STARTED|Overall Study||6
9800248|NCT00603538|10908245|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
9800249|NCT00603538|10908246|FG002|STARTED|Overall Study||6
9800250|NCT00603538|10908244|FG000|COMPLETED|Overall Study||3
9800251|NCT00603538|10908245|FG001|COMPLETED|Overall Study||3
9800252|NCT00603538|10908246|FG002|COMPLETED|Overall Study||4
9800253|NCT00603538|10908244|FG000|NOT COMPLETED|Overall Study||3
9800254|NCT00603538|10908245|FG001|NOT COMPLETED|Overall Study||4
9800255|NCT00603538|10908246|FG002|NOT COMPLETED|Overall Study||2
9800256|NCT00603564|10908259|FG000|STARTED|Overall Study|January 2006|20
9800257|NCT00603564|10908260|FG001|STARTED|Overall Study|January 2006|27
9800258|NCT00603564|10908259|FG000|COMPLETED|Overall Study|February 2008|20
9800259|NCT00603564|10908260|FG001|COMPLETED|Overall Study|February 2008|27
9800260|NCT00603564|10908259|FG000|NOT COMPLETED|Overall Study||0
9800261|NCT00603564|10908260|FG001|NOT COMPLETED|Overall Study||0
9800262|NCT00603590|10908268|FG000|STARTED|Overall Study||241
9800263|NCT00603590|10908269|FG001|STARTED|Overall Study||234
9800264|NCT00603590|10908268|FG000|One Month|Overall Study||204
9800265|NCT00603590|10908269|FG001|One Month|Overall Study||212
9800266|NCT00603590|10908268|FG000|Four Months|Overall Study||187
9800267|NCT00603590|10908269|FG001|Four Months|Overall Study||200
9800268|NCT00603590|10908268|FG000|Eight Months|Overall Study||178
9800269|NCT00603590|10908269|FG001|Eight Months|Overall Study||194
9800270|NCT00603590|10908268|FG000|COMPLETED|Overall Study||165
9800271|NCT00603590|10908269|FG001|COMPLETED|Overall Study||183
9800272|NCT00603590|10908268|FG000|NOT COMPLETED|Overall Study||76
9800273|NCT00603590|10908269|FG001|NOT COMPLETED|Overall Study||51
9800274|NCT00603642|10908277|FG000|STARTED|Overall Study||12
9800275|NCT00603642|10908278|FG001|STARTED|Overall Study||22
9800276|NCT00603642|10908277|FG000|COMPLETED|Overall Study||12
9800277|NCT00603642|10908278|FG001|COMPLETED|Overall Study||22
9800278|NCT00603642|10908277|FG000|NOT COMPLETED|Overall Study||0
9800279|NCT00603642|10908278|FG001|NOT COMPLETED|Overall Study||0
9800280|NCT00603720|10908289|FG000|STARTED|Overall Study||10
9800281|NCT00603720|10908290|FG001|STARTED|Overall Study||10
9800282|NCT00603720|10908291|FG002|STARTED|Overall Study||12
9800283|NCT00603720|10908292|FG003|STARTED|Overall Study||10
9800284|NCT00603720|10908293|FG004|STARTED|Overall Study||12
9800285|NCT00603720|10908289|FG000|COMPLETED|Overall Study||10
9800286|NCT00603720|10908290|FG001|COMPLETED|Overall Study||10
9800287|NCT00603720|10908291|FG002|COMPLETED|Overall Study||12
9800288|NCT00603720|10908292|FG003|COMPLETED|Overall Study||10
9800289|NCT00603720|10908293|FG004|COMPLETED|Overall Study||12
9800290|NCT00603720|10908289|FG000|NOT COMPLETED|Overall Study||0
9800291|NCT00603720|10908290|FG001|NOT COMPLETED|Overall Study||0
9800292|NCT00603720|10908291|FG002|NOT COMPLETED|Overall Study||0
9800293|NCT00603720|10908292|FG003|NOT COMPLETED|Overall Study||0
9800294|NCT00603720|10908293|FG004|NOT COMPLETED|Overall Study||0
9800295|NCT00603733|10908307|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
9800296|NCT00603733|10908308|FG001|STARTED|Active Phase ITT||95
9800297|NCT00603733|10908307|FG000|COMPLETED|Active Phase ITT||84
9800298|NCT00603733|10908308|FG001|COMPLETED|Active Phase ITT||78
9800299|NCT00603733|10908307|FG000|NOT COMPLETED|Active Phase ITT||11
9800300|NCT00603733|10908308|FG001|NOT COMPLETED|Active Phase ITT||17
9800301|NCT00603733|10908307|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
9800302|NCT00603733|10908308|FG001|STARTED|Run-In Phase - 4 Weeks||49
9800303|NCT00603733|10908307|FG000|COMPLETED|Run-In Phase - 4 Weeks||35
9800304|NCT00603733|10908308|FG001|COMPLETED|Run-In Phase - 4 Weeks||36
9800305|NCT00603733|10908307|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14
9800306|NCT00603733|10908308|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13
9800307|NCT00603733|10908307|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
9800308|NCT00603733|10908308|FG001|STARTED|Maintenance Phase ITT||82
9800309|NCT00603733|10908307|FG000|COMPLETED|Maintenance Phase ITT||61
9800310|NCT00603733|10908308|FG001|COMPLETED|Maintenance Phase ITT||66
9800311|NCT00603733|10908307|FG000|NOT COMPLETED|Maintenance Phase ITT||10
9800312|NCT00603733|10908308|FG001|NOT COMPLETED|Maintenance Phase ITT||16
9800313|NCT00603746|10908320|FG000|STARTED|Overall Study||103
9800314|NCT00603746|10908321|FG001|STARTED|Overall Study||99
9800315|NCT00603746|10908322|FG002|STARTED|Overall Study||101
9800316|NCT00603746|10908323|FG003|STARTED|Overall Study||107
9800317|NCT00603746|10908324|FG004|STARTED|Overall Study||102
9800318|NCT00603746|10908325|FG005|STARTED|Overall Study||110
9800319|NCT00603746|10908320|FG000|COMPLETED|Overall Study||65
9800320|NCT00603746|10908321|FG001|COMPLETED|Overall Study||81
9800321|NCT00603746|10908322|FG002|COMPLETED|Overall Study||93
9800322|NCT00603746|10908323|FG003|COMPLETED|Overall Study||94
9800323|NCT00603746|10908324|FG004|COMPLETED|Overall Study||85
9800324|NCT00603746|10908325|FG005|COMPLETED|Overall Study||97
9800325|NCT00603746|10908320|FG000|NOT COMPLETED|Overall Study||38
9800326|NCT00603746|10908321|FG001|NOT COMPLETED|Overall Study||18
9800327|NCT00603746|10908322|FG002|NOT COMPLETED|Overall Study||8
10235288|NCT01216631|11365558|FG002|NOT COMPLETED|Overall Study||0
10235289|NCT01211756|11365566|FG000|STARTED|Overall Study||1
10235290|NCT01211756|11365566|FG000|COMPLETED|Overall Study||1
10235291|NCT01211756|11365566|FG000|NOT COMPLETED|Overall Study||0
10235292|NCT01209520|11365570|FG000|STARTED|Overall Study||6
10235293|NCT01209520|11365570|FG000|COMPLETED|Overall Study||3
10235294|NCT01209520|11365570|FG000|NOT COMPLETED|Overall Study||3
10235295|NCT01207726|11365576|FG000|STARTED|Overall Study||7
9800328|NCT00603746|10908323|FG003|NOT COMPLETED|Overall Study||13
9800329|NCT00603746|10908324|FG004|NOT COMPLETED|Overall Study||17
9800330|NCT00603746|10908325|FG005|NOT COMPLETED|Overall Study||13
9800331|NCT00603798|10908342|FG000|STARTED|Overall Study||162
9800332|NCT00603798|10908343|FG001|STARTED|Overall Study||164
9800333|NCT00603798|10908344|FG002|STARTED|Overall Study||164
9800334|NCT00603798|10908342|FG000|COMPLETED|Overall Study||152
9800335|NCT00603798|10908343|FG001|COMPLETED|Overall Study||157
9800336|NCT00603798|10908344|FG002|COMPLETED|Overall Study||154
9800337|NCT00603798|10908342|FG000|NOT COMPLETED|Overall Study||10
9800338|NCT00603798|10908343|FG001|NOT COMPLETED|Overall Study||7
9800339|NCT00603798|10908344|FG002|NOT COMPLETED|Overall Study||10
9800340|NCT00603837|10908354|FG000|STARTED|Overall Study||20
9800341|NCT00603837|10908355|FG001|STARTED|Overall Study||19
9800342|NCT00603837|10908354|FG000|COMPLETED|Overall Study||17
9800343|NCT00603837|10908355|FG001|COMPLETED|Overall Study||19
9800344|NCT00603837|10908354|FG000|NOT COMPLETED|Overall Study||3
9800345|NCT00603837|10908355|FG001|NOT COMPLETED|Overall Study||0
9800346|NCT00603889|10908361|FG000|STARTED|Overall Study||12
10235296|NCT01207726|11365577|FG001|STARTED|Overall Study||6
10235297|NCT01207726|11365576|FG000|COMPLETED|Overall Study||7
10235298|NCT01207726|11365577|FG001|COMPLETED|Overall Study||6
9800347|NCT00603889|10908361|FG000|COMPLETED|Overall Study||12
9800348|NCT00603889|10908361|FG000|NOT COMPLETED|Overall Study||0
9800349|NCT00603902|10908368|FG000|STARTED|Overall Study||802
9800350|NCT00603902|10908369|FG001|STARTED|Overall Study||1603
9800351|NCT00603902|10908370|FG002|STARTED|Overall Study||1603
9800352|NCT00603902|10908368|FG000|COMPLETED|Overall Study||473
9800353|NCT00603902|10908369|FG001|COMPLETED|Overall Study||917
9800354|NCT00603902|10908370|FG002|COMPLETED|Overall Study||834
9800355|NCT00603902|10908368|FG000|NOT COMPLETED|Overall Study||329
9800356|NCT00603902|10908369|FG001|NOT COMPLETED|Overall Study||686
9800357|NCT00603902|10908370|FG002|NOT COMPLETED|Overall Study||769
9800358|NCT00603915|10908378|FG000|STARTED|Overall Study||20
9800359|NCT00603915|10908378|FG000|COMPLETED|Overall Study||19
9800360|NCT00603915|10908378|FG000|NOT COMPLETED|Overall Study||1
9800361|NCT00603941|10908385|FG000|STARTED|Overall Study||7
9800362|NCT00603941|10908386|FG001|STARTED|Overall Study||10
9800363|NCT00603941|10908387|FG002|STARTED|Overall Study||2
9800364|NCT00603941|10908385|FG000|COMPLETED|Overall Study||0
9800365|NCT00603941|10908386|FG001|COMPLETED|Overall Study||0
9800366|NCT00603941|10908387|FG002|COMPLETED|Overall Study||0
9800367|NCT00603941|10908385|FG000|NOT COMPLETED|Overall Study||7
9800368|NCT00603941|10908386|FG001|NOT COMPLETED|Overall Study||10
9800369|NCT00603941|10908387|FG002|NOT COMPLETED|Overall Study||2
9800370|NCT00603980|10908396|FG000|STARTED|Study Qualification||31
9800371|NCT00603980|10908396|FG000|COMPLETED|Study Qualification||15
9800372|NCT00603980|10908396|FG000|NOT COMPLETED|Study Qualification||16
9800373|NCT00603980|10908396|FG000|STARTED|Main Study||15
9800374|NCT00603980|10908396|FG000|COMPLETED|Main Study||14
9800375|NCT00603980|10908396|FG000|NOT COMPLETED|Main Study||1
9800376|NCT00603993|10908416|FG000|STARTED|Overall Study||88
9800377|NCT00603993|10908416|FG000|COMPLETED|Overall Study||68
9800378|NCT00603993|10908416|FG000|NOT COMPLETED|Overall Study||20
9800379|NCT00604019|10908422|FG000|STARTED|Overall Study||134
9800380|NCT00604019|10908423|FG001|STARTED|Overall Study||118
9800381|NCT00604019|10908422|FG000|COMPLETED|Overall Study||134
9800382|NCT00604019|10908423|FG001|COMPLETED|Overall Study||118
9800383|NCT00604019|10908422|FG000|NOT COMPLETED|Overall Study||0
9800384|NCT00604019|10908423|FG001|NOT COMPLETED|Overall Study||0
9800385|NCT00604045|10908431|FG000|STARTED|Overall Study||15
9800386|NCT00604045|10908432|FG001|STARTED|Overall Study||10
9800387|NCT00604045|10908431|FG000|COMPLETED|Overall Study||14
9800388|NCT00604045|10908432|FG001|COMPLETED|Overall Study||9
9800389|NCT00604045|10908431|FG000|NOT COMPLETED|Overall Study||1
9800390|NCT00604045|10908432|FG001|NOT COMPLETED|Overall Study||1
9800391|NCT00604162|10908438|FG000|STARTED|Overall Study||332
9800392|NCT00604162|10908438|FG000|COMPLETED|Overall Study||328
9800393|NCT00604162|10908438|FG000|NOT COMPLETED|Overall Study||4
9800394|NCT00604175|10908448|FG000|STARTED|Entry Through Week 28||130
9800395|NCT00604175|10908449|FG001|STARTED|Entry Through Week 28||95
9800396|NCT00604175|10908450|FG002|STARTED|Entry Through Week 28||94
9800397|NCT00604175|10908448|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
9800398|NCT00604175|10908449|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
9800399|NCT00604175|10908450|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
9800400|NCT00604175|10908448|FG000|NOT COMPLETED|Entry Through Week 28||10
9800401|NCT00604175|10908449|FG001|NOT COMPLETED|Entry Through Week 28||3
9800402|NCT00604175|10908450|FG002|NOT COMPLETED|Entry Through Week 28||1
9800403|NCT00604175|10908448|FG000|STARTED|Week 29 Through Week 72||120
9800404|NCT00604175|10908449|FG001|STARTED|Week 29 Through Week 72||92
9800405|NCT00604175|10908450|FG002|STARTED|Week 29 Through Week 72||93
9800406|NCT00604175|10908448|FG000|COMPLETED|Week 29 Through Week 72||108
9800407|NCT00604175|10908449|FG001|COMPLETED|Week 29 Through Week 72||85
9800408|NCT00604175|10908450|FG002|COMPLETED|Week 29 Through Week 72||89
9800409|NCT00604175|10908448|FG000|NOT COMPLETED|Week 29 Through Week 72||12
9800410|NCT00604175|10908449|FG001|NOT COMPLETED|Week 29 Through Week 72||7
9800411|NCT00604175|10908450|FG002|NOT COMPLETED|Week 29 Through Week 72||4
9800412|NCT00604188|10908484|FG000|STARTED|Overall Study||93
9800413|NCT00604188|10908485|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
9800414|NCT00604188|10908484|FG000|COMPLETED|Overall Study||66
9800415|NCT00604188|10908485|FG001|COMPLETED|Overall Study||70
9800416|NCT00604188|10908484|FG000|NOT COMPLETED|Overall Study||27
9800417|NCT00604188|10908485|FG001|NOT COMPLETED|Overall Study||25
9800418|NCT00604214|10908493|FG000|STARTED|Baseline to Day 28||851
9800419|NCT00604214|10908494|FG001|STARTED|Baseline to Day 28||845
9800420|NCT00604214|10908493|FG000|Received Study Drug|Baseline to Day 28||833
9800421|NCT00604214|10908494|FG001|Received Study Drug|Baseline to Day 28||833
9800422|NCT00604214|10908493|FG000|COMPLETED|Baseline to Day 28||623
9800423|NCT00604214|10908494|FG001|COMPLETED|Baseline to Day 28||632
9800424|NCT00604214|10908493|FG000|NOT COMPLETED|Baseline to Day 28||228
9800425|NCT00604214|10908494|FG001|NOT COMPLETED|Baseline to Day 28||213
9800426|NCT00604214|10908493|FG000|STARTED|Day 29 to Day 90||623
9800427|NCT00604214|10908494|FG001|STARTED|Day 29 to Day 90||632
9800428|NCT00604214|10908493|FG000|COMPLETED|Day 29 to Day 90||555
9800429|NCT00604214|10908494|FG001|COMPLETED|Day 29 to Day 90||553
9800430|NCT00604214|10908493|FG000|NOT COMPLETED|Day 29 to Day 90||68
9800431|NCT00604214|10908494|FG001|NOT COMPLETED|Day 29 to Day 90||79
9800432|NCT00604214|10908493|FG000|STARTED|Day 91 to Day 180||555
9800433|NCT00604214|10908494|FG001|STARTED|Day 91 to Day 180||553
9800434|NCT00604214|10908493|FG000|COMPLETED|Day 91 to Day 180||529
9800435|NCT00604214|10908494|FG001|COMPLETED|Day 91 to Day 180||521
9800436|NCT00604214|10908493|FG000|NOT COMPLETED|Day 91 to Day 180||26
9800437|NCT00604214|10908494|FG001|NOT COMPLETED|Day 91 to Day 180||32
9800438|NCT00604279|10908502|FG000|STARTED|Overall Study||229
9800439|NCT00604279|10908503|FG001|STARTED|Overall Study||223
9800440|NCT00604279|10908502|FG000|COMPLETED|Overall Study||165
9800441|NCT00604279|10908503|FG001|COMPLETED|Overall Study||185
9800442|NCT00604279|10908502|FG000|NOT COMPLETED|Overall Study||64
9800443|NCT00604279|10908503|FG001|NOT COMPLETED|Overall Study||38
9800444|NCT00604383|10908511|FG000|STARTED|Overall Study||345
9800445|NCT00604383|10908512|FG001|STARTED|Overall Study||340
9800446|NCT00604383|10908511|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345
9800447|NCT00604383|10908512|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340
9800448|NCT00604383|10908511|FG000|Received Extended Treatment|Overall Study||136
9800449|NCT00604383|10908512|FG001|Received Extended Treatment|Overall Study||141
9800450|NCT00604383|10908511|FG000|COMPLETED|Overall Study||258
9800451|NCT00604383|10908512|FG001|COMPLETED|Overall Study||256
9800452|NCT00604383|10908511|FG000|NOT COMPLETED|Overall Study||87
9800453|NCT00604383|10908512|FG001|NOT COMPLETED|Overall Study||84
9800454|NCT00604461|10908518|FG000|STARTED|Overall Study||13
9800455|NCT00604461|10908518|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
9800456|NCT00604461|10908518|FG000|NOT COMPLETED|Overall Study||1
9800457|NCT00604552|10908524|FG000|STARTED|Overall Study||189
9800458|NCT00604552|10908525|FG001|STARTED|Overall Study||160
9800459|NCT00604552|10908524|FG000|COMPLETED|Overall Study||189
9800460|NCT00604552|10908525|FG001|COMPLETED|Overall Study||160
9800461|NCT00604552|10908524|FG000|NOT COMPLETED|Overall Study||0
9800462|NCT00604552|10908525|FG001|NOT COMPLETED|Overall Study||0
9800463|NCT00604565|10908535|FG000|STARTED|Overall Study||4
9800464|NCT00604565|10908536|FG001|STARTED|Overall Study||7
9800465|NCT00604565|10908535|FG000|COMPLETED|Overall Study||4
9800466|NCT00604565|10908536|FG001|COMPLETED|Overall Study||4
9800467|NCT00604565|10908535|FG000|NOT COMPLETED|Overall Study||0
9800468|NCT00604565|10908536|FG001|NOT COMPLETED|Overall Study||3
9800469|NCT00604669|10908542|FG000|STARTED|Overall Study||170
9800470|NCT00604669|10908542|FG000|COMPLETED|Overall Study||163
9800471|NCT00604669|10908542|FG000|NOT COMPLETED|Overall Study||7
9800472|NCT00604695|10908548|FG000|STARTED|Overall Study||20
9800473|NCT00604695|10908549|FG001|STARTED|Overall Study||20
9800474|NCT00604695|10908548|FG000|COMPLETED|Overall Study||20
9800475|NCT00604695|10908549|FG001|COMPLETED|Overall Study||16
9800476|NCT00604695|10908548|FG000|NOT COMPLETED|Overall Study||0
9800477|NCT00604695|10908549|FG001|NOT COMPLETED|Overall Study||4
9800478|NCT00604708|10908557|FG000|STARTED|Overall Study||430
9800479|NCT00604708|10908558|FG001|STARTED|Overall Study||437
9800480|NCT00604708|10908557|FG000|COMPLETED|Overall Study||399
9800481|NCT00604708|10908558|FG001|COMPLETED|Overall Study||397
9800482|NCT00604708|10908557|FG000|NOT COMPLETED|Overall Study||31
9800483|NCT00604708|10908558|FG001|NOT COMPLETED|Overall Study||40
9800484|NCT00604721|10908564|FG000|STARTED|Overall Study||19
9800485|NCT00604721|10908564|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
9800486|NCT00604721|10908564|FG000|NOT COMPLETED|Overall Study||2
9800487|NCT00604786|10908571|FG000|STARTED|Overall Study||14
9800488|NCT00604786|10908572|FG001|STARTED|Overall Study||4
10235299|NCT01207726|11365576|FG000|NOT COMPLETED|Overall Study||0
10235300|NCT01207726|11365577|FG001|NOT COMPLETED|Overall Study||0
10235301|NCT01206296|11365587|FG000|STARTED|Overall Study||0
9800489|NCT00604786|10908571|FG000|COMPLETED|Overall Study||12
9800490|NCT00604786|10908572|FG001|COMPLETED|Overall Study||4
9800491|NCT00604786|10908571|FG000|NOT COMPLETED|Overall Study||2
9800492|NCT00604786|10908572|FG001|NOT COMPLETED|Overall Study||0
9800493|NCT00604825|10908582|FG000|STARTED|Overall Study||90
9800494|NCT00604825|10908583|FG001|STARTED|Overall Study||87
9800495|NCT00604825|10908584|FG002|STARTED|Overall Study||89
9800496|NCT00604825|10908585|FG003|STARTED|Overall Study||90
9800497|NCT00604825|10908582|FG000|COMPLETED|Overall Study||81
9800498|NCT00604825|10908583|FG001|COMPLETED|Overall Study||72
9800499|NCT00604825|10908584|FG002|COMPLETED|Overall Study||73
9800500|NCT00604825|10908585|FG003|COMPLETED|Overall Study||79
9800501|NCT00604825|10908582|FG000|NOT COMPLETED|Overall Study||9
9800502|NCT00604825|10908583|FG001|NOT COMPLETED|Overall Study||15
9800503|NCT00604825|10908584|FG002|NOT COMPLETED|Overall Study||16
9800504|NCT00604825|10908585|FG003|NOT COMPLETED|Overall Study||11
9800505|NCT00604890|10908599|FG000|STARTED|Overall Study||47
9800506|NCT00604890|10908600|FG001|STARTED|Overall Study||45
9800507|NCT00604890|10908601|FG002|STARTED|Overall Study||48
9800508|NCT00604890|10908602|FG003|STARTED|Overall Study||46
9800509|NCT00604890|10908599|FG000|COMPLETED|Overall Study||44
9800510|NCT00604890|10908600|FG001|COMPLETED|Overall Study||45
9800511|NCT00604890|10908601|FG002|COMPLETED|Overall Study||47
9800512|NCT00604890|10908602|FG003|COMPLETED|Overall Study||42
9800513|NCT00604890|10908599|FG000|NOT COMPLETED|Overall Study||3
9800514|NCT00604890|10908600|FG001|NOT COMPLETED|Overall Study||0
9800515|NCT00604890|10908601|FG002|NOT COMPLETED|Overall Study||1
9800516|NCT00604890|10908602|FG003|NOT COMPLETED|Overall Study||4
9800517|NCT00604968|10908613|FG000|STARTED|Overall Study||25
9800518|NCT00604968|10908613|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
9800519|NCT00604968|10908613|FG000|NOT COMPLETED|Overall Study||0
9800520|NCT00605033|10908619|FG000|STARTED|Overall Study||143
10235302|NCT01206296|11365587|FG000|COMPLETED|Overall Study||0
10019146|NCT01828034|11142280|FG000|NOT COMPLETED|Overall Study||0
9800521|NCT00605033|10908620|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
9800522|NCT00605033|10908619|FG000|COMPLETED|Overall Study||136
9800523|NCT00605033|10908620|FG001|COMPLETED|Overall Study||90
9800524|NCT00605033|10908619|FG000|NOT COMPLETED|Overall Study||7
9800525|NCT00605033|10908620|FG001|NOT COMPLETED|Overall Study||8
9952831|NCT01424397|11071748|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7
9952832|NCT01424397|11071749|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8
9952833|NCT01424397|11071750|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7
9952834|NCT01424397|11071751|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8
9952835|NCT01424397|11071752|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8
9952836|NCT01424397|11071753|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8
9952837|NCT01424397|11071754|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4
9952838|NCT01424397|11071755|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4
9800526|NCT00605072|10908629|FG000|STARTED|Overall Study||18
9800527|NCT00605072|10908630|FG001|STARTED|Overall Study||20
9800528|NCT00605072|10908631|FG002|STARTED|Overall Study||15
9800529|NCT00605072|10908629|FG000|COMPLETED|Overall Study||11
9800530|NCT00605072|10908630|FG001|COMPLETED|Overall Study||9
9800531|NCT00605072|10908631|FG002|COMPLETED|Overall Study||11
9800532|NCT00605072|10908629|FG000|NOT COMPLETED|Overall Study||7
9800533|NCT00605072|10908630|FG001|NOT COMPLETED|Overall Study||11
9800534|NCT00605072|10908631|FG002|NOT COMPLETED|Overall Study||4
9800535|NCT00605085|10908641|FG000|STARTED|Overall Study||2012
9800536|NCT00605085|10908642|FG001|STARTED|Overall Study||663
9800537|NCT00605085|10908641|FG000|COMPLETED|Overall Study||1962
9800538|NCT00605085|10908642|FG001|COMPLETED|Overall Study||638
9800539|NCT00605085|10908641|FG000|NOT COMPLETED|Overall Study||50
9800540|NCT00605085|10908642|FG001|NOT COMPLETED|Overall Study||25
9800541|NCT00605176|10908651|FG000|STARTED|Overall Study||160
9800542|NCT00605176|10908652|FG001|STARTED|Overall Study||160
9800543|NCT00605176|10908653|FG002|STARTED|Overall Study||159
9800544|NCT00605176|10908651|FG000|COMPLETED|Overall Study||149
9800545|NCT00605176|10908652|FG001|COMPLETED|Overall Study||154
9800546|NCT00605176|10908653|FG002|COMPLETED|Overall Study||150
9800547|NCT00605176|10908651|FG000|NOT COMPLETED|Overall Study||11
9800548|NCT00605176|10908652|FG001|NOT COMPLETED|Overall Study||6
9800549|NCT00605176|10908653|FG002|NOT COMPLETED|Overall Study||9
9800550|NCT00605189|10908664|FG000|STARTED|Overall Study||20
9800551|NCT00605189|10908665|FG001|STARTED|Overall Study||21
9800552|NCT00605189|10908666|FG002|STARTED|Overall Study||9
9800553|NCT00605189|10908664|FG000|COMPLETED|Overall Study||17
9800554|NCT00605189|10908665|FG001|COMPLETED|Overall Study||19
9800555|NCT00605189|10908666|FG002|COMPLETED|Overall Study||9
9800556|NCT00605189|10908664|FG000|NOT COMPLETED|Overall Study||3
9800557|NCT00605189|10908665|FG001|NOT COMPLETED|Overall Study||2
9800558|NCT00605189|10908666|FG002|NOT COMPLETED|Overall Study||0
9800559|NCT00605202|10908674|FG000|STARTED|First Intervention||5
9800560|NCT00605202|10908675|FG001|STARTED|First Intervention||5
9800561|NCT00605202|10908674|FG000|COMPLETED|First Intervention||5
9800562|NCT00605202|10908675|FG001|COMPLETED|First Intervention||5
9800563|NCT00605202|10908674|FG000|NOT COMPLETED|First Intervention||0
9800564|NCT00605202|10908675|FG001|NOT COMPLETED|First Intervention||0
9800565|NCT00605202|10908674|FG000|STARTED|Washout Period of 3 Weeks||5
9800566|NCT00605202|10908675|FG001|STARTED|Washout Period of 3 Weeks||5
9800567|NCT00605202|10908674|FG000|COMPLETED|Washout Period of 3 Weeks||5
9800568|NCT00605202|10908675|FG001|COMPLETED|Washout Period of 3 Weeks||5
9800569|NCT00605202|10908674|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0
9800570|NCT00605202|10908675|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0
9800571|NCT00605202|10908674|FG000|STARTED|Second Intervention||5
9800572|NCT00605202|10908675|FG001|STARTED|Second Intervention||5
9800573|NCT00605202|10908674|FG000|COMPLETED|Second Intervention||5
9800574|NCT00605202|10908675|FG001|COMPLETED|Second Intervention||5
9800575|NCT00605202|10908674|FG000|NOT COMPLETED|Second Intervention||0
9800576|NCT00605202|10908675|FG001|NOT COMPLETED|Second Intervention||0
9800577|NCT00605267|10908683|FG000|STARTED|Overall Study||98
9800578|NCT00605267|10908684|FG001|STARTED|Overall Study||99
9800579|NCT00605267|10908683|FG000|COMPLETED|Overall Study|Breast surgery performed|95
9800580|NCT00605267|10908684|FG001|COMPLETED|Overall Study|Breast surgery performed|90
9800581|NCT00605267|10908683|FG000|NOT COMPLETED|Overall Study||3
9800582|NCT00605267|10908684|FG001|NOT COMPLETED|Overall Study||9
9800583|NCT00605280|10908694|FG000|STARTED|Year 1||145
9800584|NCT00605280|10908695|FG001|STARTED|Year 1||22
9800585|NCT00605280|10908696|FG002|STARTED|Year 1||7
9800586|NCT00605280|10908697|FG003|STARTED|Year 1||143
9800587|NCT00605280|10908694|FG000|Received 0.3 mg Treatment|Year 1||144
9800588|NCT00605280|10908695|FG001|Received 0.3 mg Treatment|Year 1||13
9800589|NCT00605280|10908696|FG002|Received 0.3 mg Treatment|Year 1||3
9800590|NCT00605280|10908697|FG003|Received 0.3 mg Treatment|Year 1||0
9800591|NCT00605280|10908694|FG000|COMPLETED|Year 1||126
9800592|NCT00605280|10908695|FG001|COMPLETED|Year 1||11
9800593|NCT00605280|10908696|FG002|COMPLETED|Year 1||6
9800594|NCT00605280|10908697|FG003|COMPLETED|Year 1||124
9800595|NCT00605280|10908694|FG000|NOT COMPLETED|Year 1||19
9800596|NCT00605280|10908695|FG001|NOT COMPLETED|Year 1||11
9800597|NCT00605280|10908696|FG002|NOT COMPLETED|Year 1||1
9800598|NCT00605280|10908697|FG003|NOT COMPLETED|Year 1||19
9800599|NCT00605280|10908694|FG000|STARTED|Year 2||126
9800600|NCT00605280|10908695|FG001|STARTED|Year 2||11
9952839|NCT01424397|11071756|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4
9800601|NCT00605280|10908696|FG002|STARTED|Year 2||6
9800602|NCT00605280|10908697|FG003|STARTED|Year 2||124
9800603|NCT00605280|10908694|FG000|Received 0.3 mg Treatment|Year 2||126
9800604|NCT00605280|10908695|FG001|Received 0.3 mg Treatment|Year 2||3
9800605|NCT00605280|10908696|FG002|Received 0.3 mg Treatment|Year 2||2
9800606|NCT00605280|10908697|FG003|Received 0.3 mg Treatment|Year 2||0
9800607|NCT00605280|10908694|FG000|COMPLETED|Year 2||102
9800608|NCT00605280|10908695|FG001|COMPLETED|Year 2||5
9800609|NCT00605280|10908696|FG002|COMPLETED|Year 2||0
9800610|NCT00605280|10908697|FG003|COMPLETED|Year 2||102
9800611|NCT00605280|10908694|FG000|NOT COMPLETED|Year 2||24
9800612|NCT00605280|10908695|FG001|NOT COMPLETED|Year 2||6
9800613|NCT00605280|10908696|FG002|NOT COMPLETED|Year 2||6
9800614|NCT00605280|10908697|FG003|NOT COMPLETED|Year 2||22
9800615|NCT00605280|10908694|FG000|STARTED|Year 3 Extension||46
9800616|NCT00605280|10908695|FG001|STARTED|Year 3 Extension||0
9800617|NCT00605280|10908696|FG002|STARTED|Year 3 Extension||0
9800618|NCT00605280|10908697|FG003|STARTED|Year 3 Extension||54
9800619|NCT00605280|10908694|FG000|Received 0.3 mg Treatment|Year 3 Extension||46
9800620|NCT00605280|10908695|FG001|Received 0.3 mg Treatment|Year 3 Extension||0
9800621|NCT00605280|10908696|FG002|Received 0.3 mg Treatment|Year 3 Extension||0
9800622|NCT00605280|10908697|FG003|Received 0.3 mg Treatment|Year 3 Extension||54
9800623|NCT00605280|10908694|FG000|COMPLETED|Year 3 Extension||38
9800624|NCT00605280|10908695|FG001|COMPLETED|Year 3 Extension||0
9800625|NCT00605280|10908696|FG002|COMPLETED|Year 3 Extension||0
9800626|NCT00605280|10908697|FG003|COMPLETED|Year 3 Extension||45
9800627|NCT00605280|10908694|FG000|NOT COMPLETED|Year 3 Extension||8
9800628|NCT00605280|10908695|FG001|NOT COMPLETED|Year 3 Extension||0
9800629|NCT00605280|10908696|FG002|NOT COMPLETED|Year 3 Extension||0
9800630|NCT00605280|10908697|FG003|NOT COMPLETED|Year 3 Extension||9
9800631|NCT00605293|10908709|FG000|STARTED|Overall Study||65
9800632|NCT00605293|10908710|FG001|STARTED|Overall Study||36
9800633|NCT00605293|10908709|FG000|COMPLETED|Overall Study||48
9800634|NCT00605293|10908710|FG001|COMPLETED|Overall Study||31
9800635|NCT00605293|10908709|FG000|NOT COMPLETED|Overall Study||17
9800636|NCT00605293|10908710|FG001|NOT COMPLETED|Overall Study||5
9800637|NCT00605306|10908718|FG000|STARTED|Overall Study||14
9800638|NCT00605306|10908719|FG001|STARTED|Overall Study||14
9800639|NCT00605306|10908718|FG000|COMPLETED|Overall Study||14
9800640|NCT00605306|10908719|FG001|COMPLETED|Overall Study||13
9800641|NCT00605306|10908718|FG000|NOT COMPLETED|Overall Study||0
9800642|NCT00605306|10908719|FG001|NOT COMPLETED|Overall Study||1
9800643|NCT00605319|10908725|FG000|STARTED|Overall Study||17
9800644|NCT00605319|10908725|FG000|COMPLETED|Overall Study||11
9800645|NCT00605319|10908725|FG000|NOT COMPLETED|Overall Study||6
9800646|NCT00605345|10908737|FG000|STARTED|Overall Study||46
9800647|NCT00605345|10908738|FG001|STARTED|Overall Study||25
9800648|NCT00605345|10908737|FG000|COMPLETED|Overall Study||45
9800649|NCT00605345|10908738|FG001|COMPLETED|Overall Study||22
9800650|NCT00605345|10908737|FG000|NOT COMPLETED|Overall Study||1
9800651|NCT00605345|10908738|FG001|NOT COMPLETED|Overall Study||3
9800652|NCT00605358|10908746|FG000|STARTED|Overall Study||81
9800653|NCT00605358|10908747|FG001|STARTED|Overall Study||80
9800654|NCT00605358|10908746|FG000|COMPLETED|Overall Study||81
9800655|NCT00605358|10908747|FG001|COMPLETED|Overall Study||80
9800656|NCT00605358|10908746|FG000|NOT COMPLETED|Overall Study||0
9800657|NCT00605358|10908747|FG001|NOT COMPLETED|Overall Study||0
9800658|NCT00605384|10908755|FG000|STARTED|Overall Study||1
9800659|NCT00605384|10908756|FG001|STARTED|Overall Study||1
9800660|NCT00605384|10908755|FG000|COMPLETED|Overall Study|study terminated early|0
9800661|NCT00605384|10908756|FG001|COMPLETED|Overall Study|study terminated early|0
9800662|NCT00605384|10908755|FG000|NOT COMPLETED|Overall Study||1
9800663|NCT00605384|10908756|FG001|NOT COMPLETED|Overall Study||1
9800664|NCT00605423|10908764|FG000|STARTED|Overall Study||4
9800665|NCT00605423|10908765|FG001|STARTED|Overall Study||2
9800666|NCT00605423|10908764|FG000|COMPLETED|Overall Study||4
9800667|NCT00605423|10908765|FG001|COMPLETED|Overall Study||2
9800668|NCT00605423|10908764|FG000|NOT COMPLETED|Overall Study||0
9800669|NCT00605423|10908765|FG001|NOT COMPLETED|Overall Study||0
9800670|NCT00605475|10908781|FG000|STARTED|Overall Study||10
9800671|NCT00605475|10908782|FG001|STARTED|Overall Study||5
9800672|NCT00605475|10908783|FG002|STARTED|Overall Study||45
9800673|NCT00605475|10908784|FG003|STARTED|Overall Study||45
9800674|NCT00605475|10908785|FG004|STARTED|Overall Study||25
9800675|NCT00605475|10908786|FG005|STARTED|Overall Study||24
9800676|NCT00605475|10908787|FG006|STARTED|Overall Study||23
9800677|NCT00605475|10908788|FG007|STARTED|Overall Study||24
9800678|NCT00605475|10908789|FG008|STARTED|Overall Study||20
9800679|NCT00605475|10908790|FG009|STARTED|Overall Study||10
9800680|NCT00605475|10908781|FG000|COMPLETED|Overall Study||10
9800681|NCT00605475|10908782|FG001|COMPLETED|Overall Study||5
9800682|NCT00605475|10908783|FG002|COMPLETED|Overall Study||45
9800683|NCT00605475|10908784|FG003|COMPLETED|Overall Study||45
9800684|NCT00605475|10908785|FG004|COMPLETED|Overall Study||24
9800685|NCT00605475|10908786|FG005|COMPLETED|Overall Study||22
9800686|NCT00605475|10908787|FG006|COMPLETED|Overall Study||22
9800687|NCT00605475|10908788|FG007|COMPLETED|Overall Study||24
9800688|NCT00605475|10908789|FG008|COMPLETED|Overall Study||18
9800689|NCT00605475|10908790|FG009|COMPLETED|Overall Study||8
9800690|NCT00605475|10908781|FG000|NOT COMPLETED|Overall Study||0
9800691|NCT00605475|10908782|FG001|NOT COMPLETED|Overall Study||0
9800692|NCT00605475|10908783|FG002|NOT COMPLETED|Overall Study||0
9800693|NCT00605475|10908784|FG003|NOT COMPLETED|Overall Study||0
9800694|NCT00605475|10908785|FG004|NOT COMPLETED|Overall Study||1
9800695|NCT00605475|10908786|FG005|NOT COMPLETED|Overall Study||2
9800696|NCT00605475|10908787|FG006|NOT COMPLETED|Overall Study||1
9800697|NCT00605475|10908788|FG007|NOT COMPLETED|Overall Study||0
9800698|NCT00605475|10908789|FG008|NOT COMPLETED|Overall Study||2
9800699|NCT00605475|10908790|FG009|NOT COMPLETED|Overall Study||2
9800700|NCT00605540|10908833|FG000|STARTED|Overall Study||133
9800701|NCT00605540|10908833|FG000|COMPLETED|Overall Study||95
9800702|NCT00605540|10908833|FG000|NOT COMPLETED|Overall Study||38
9800703|NCT00605566|10908837|FG000|STARTED|Overall Study||22
9800704|NCT00605566|10908837|FG000|COMPLETED|Overall Study||19
9800705|NCT00605566|10908837|FG000|NOT COMPLETED|Overall Study||3
9800706|NCT00605644|10908846|FG000|STARTED|Overall Study||29
9800707|NCT00605644|10908847|FG001|STARTED|Overall Study||19
9800708|NCT00605644|10908848|FG002|STARTED|Overall Study||20
9800709|NCT00605644|10908849|FG003|STARTED|Overall Study||30
9800710|NCT00605644|10908850|FG004|STARTED|Overall Study||30
9800711|NCT00605644|10908846|FG000|COMPLETED|Overall Study||28
9800712|NCT00605644|10908847|FG001|COMPLETED|Overall Study||18
9800713|NCT00605644|10908848|FG002|COMPLETED|Overall Study||18
9800714|NCT00605644|10908849|FG003|COMPLETED|Overall Study||25
9800715|NCT00605644|10908850|FG004|COMPLETED|Overall Study||22
9800716|NCT00605644|10908846|FG000|NOT COMPLETED|Overall Study||1
9800717|NCT00605644|10908847|FG001|NOT COMPLETED|Overall Study||1
9800718|NCT00605644|10908848|FG002|NOT COMPLETED|Overall Study||2
9800719|NCT00605644|10908849|FG003|NOT COMPLETED|Overall Study||5
9800720|NCT00605644|10908850|FG004|NOT COMPLETED|Overall Study||8
9800721|NCT00605657|10908862|FG000|STARTED|Overall Study||5
9800722|NCT00605657|10908862|FG000|COMPLETED|Overall Study||3
9800723|NCT00605657|10908862|FG000|NOT COMPLETED|Overall Study||2
9800724|NCT00605696|10908868|FG000|STARTED|Overall Study||7
9800725|NCT00605696|10908869|FG001|STARTED|Overall Study||11
9800726|NCT00605696|10908868|FG000|COMPLETED|Overall Study||7
9800727|NCT00605696|10908869|FG001|COMPLETED|Overall Study||11
9800728|NCT00605696|10908868|FG000|NOT COMPLETED|Overall Study||0
9800729|NCT00605696|10908869|FG001|NOT COMPLETED|Overall Study||0
9800730|NCT00605722|10908875|FG000|STARTED|Overall Study||51
9800731|NCT00605722|10908875|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0
9800732|NCT00605722|10908875|FG000|NOT COMPLETED|Overall Study||51
9800733|NCT00605813|10908879|FG000|STARTED|Overall Study||542
9800734|NCT00605813|10908879|FG000|COMPLETED|Overall Study||517
9800735|NCT00605813|10908879|FG000|NOT COMPLETED|Overall Study||25
9800736|NCT00605826|10908894|FG000|STARTED|Overall Study||136
9800737|NCT00605826|10908895|FG001|STARTED|Overall Study||70
9800738|NCT00605826|10908894|FG000|COMPLETED|Overall Study||129
9800739|NCT00605826|10908895|FG001|COMPLETED|Overall Study||60
9800740|NCT00605826|10908894|FG000|NOT COMPLETED|Overall Study||7
9800741|NCT00605826|10908895|FG001|NOT COMPLETED|Overall Study||10
9800742|NCT00605839|10908904|FG000|STARTED|Overall Study||40
9800743|NCT00605839|10908905|FG001|STARTED|Overall Study||37
9800744|NCT00605839|10908906|FG002|STARTED|Overall Study||28
9800745|NCT00605839|10908904|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
9800746|NCT00605839|10908905|FG001|COMPLETED|Overall Study||37
9800747|NCT00605839|10908906|FG002|COMPLETED|Overall Study||28
9800748|NCT00605839|10908904|FG000|NOT COMPLETED|Overall Study||1
9800749|NCT00605839|10908905|FG001|NOT COMPLETED|Overall Study||0
9800750|NCT00605839|10908906|FG002|NOT COMPLETED|Overall Study||0
9800751|NCT00605865|10908914|FG000|STARTED|Overall Study||2272
9800752|NCT00605865|10908914|FG000|COMPLETED|Overall Study||2157
9800753|NCT00605865|10908914|FG000|NOT COMPLETED|Overall Study||115
9800754|NCT00605904|10908948|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
9800755|NCT00605904|10908949|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
9800756|NCT00605904|10908948|FG000|COMPLETED|Baseline Data Collection and Dosing||13
9800757|NCT00605904|10908949|FG001|COMPLETED|Baseline Data Collection and Dosing||16
9800758|NCT00605904|10908948|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0
9800759|NCT00605904|10908949|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5
9800760|NCT00605904|10908948|FG000|STARTED|Infusion Sessions||13
9800761|NCT00605904|10908949|FG001|STARTED|Infusion Sessions||16
9800762|NCT00605904|10908948|FG000|Saline Infusion|Infusion Sessions||13
9800763|NCT00605904|10908949|FG001|Saline Infusion|Infusion Sessions||14
9800764|NCT00605904|10908948|FG000|mCPP Infusion|Infusion Sessions||12
9800765|NCT00605904|10908949|FG001|mCPP Infusion|Infusion Sessions||13
9800766|NCT00605904|10908948|FG000|Yohimbine Infusion|Infusion Sessions||12
9800767|NCT00605904|10908949|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
9800768|NCT00605904|10908948|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
9800769|NCT00605904|10908949|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
9800770|NCT00605904|10908948|FG000|NOT COMPLETED|Infusion Sessions||1
9800771|NCT00605904|10908949|FG001|NOT COMPLETED|Infusion Sessions||3
9800772|NCT00605917|10908955|FG000|STARTED|Overall Study||987
9800773|NCT00605917|10908955|FG000|COMPLETED|Overall Study||908
9800774|NCT00605917|10908955|FG000|NOT COMPLETED|Overall Study||79
9800775|NCT00606008|10908990|FG000|STARTED|Overall Study||30
9800776|NCT00606008|10908990|FG000|COMPLETED|Overall Study||25
9800777|NCT00606008|10908990|FG000|NOT COMPLETED|Overall Study||5
9800778|NCT00606021|10909000|FG000|STARTED|Induction Phase||106
9800779|NCT00606021|10909001|FG001|STARTED|Induction Phase||0
9800780|NCT00606021|10909002|FG002|STARTED|Induction Phase||0
9800781|NCT00606021|10909000|FG000|COMPLETED|Induction Phase||19
9800782|NCT00606021|10909001|FG001|COMPLETED|Induction Phase||0
9800783|NCT00606021|10909002|FG002|COMPLETED|Induction Phase||0
9800784|NCT00606021|10909000|FG000|NOT COMPLETED|Induction Phase||87
9800785|NCT00606021|10909001|FG001|NOT COMPLETED|Induction Phase||0
9800786|NCT00606021|10909002|FG002|NOT COMPLETED|Induction Phase||0
9800787|NCT00606021|10909000|FG000|STARTED|Maintenance Phase||0
9800788|NCT00606021|10909001|FG001|STARTED|Maintenance Phase||28
9800789|NCT00606021|10909002|FG002|STARTED|Maintenance Phase||27
9800790|NCT00606021|10909000|FG000|COMPLETED|Maintenance Phase||0
9800791|NCT00606021|10909001|FG001|COMPLETED|Maintenance Phase||5
9800792|NCT00606021|10909002|FG002|COMPLETED|Maintenance Phase||10
9800793|NCT00606021|10909000|FG000|NOT COMPLETED|Maintenance Phase||0
9800794|NCT00606021|10909001|FG001|NOT COMPLETED|Maintenance Phase||23
9800795|NCT00606021|10909002|FG002|NOT COMPLETED|Maintenance Phase||17
9800796|NCT00606034|10909010|FG000|STARTED|Overall Study||21
9800797|NCT00606034|10909010|FG000|COMPLETED|Overall Study||20
9800798|NCT00606034|10909010|FG000|NOT COMPLETED|Overall Study||1
9800799|NCT00606047|10909016|FG000|STARTED|Overall Study||200
9800800|NCT00606047|10909016|FG000|COMPLETED|Overall Study||200
9800801|NCT00606047|10909016|FG000|NOT COMPLETED|Overall Study||0
9800802|NCT00606086|10909022|FG000|STARTED|Overall Study||72
9800803|NCT00606086|10909023|FG001|STARTED|Overall Study||68
9800804|NCT00606086|10909022|FG000|COMPLETED|Overall Study||60
9800805|NCT00606086|10909023|FG001|COMPLETED|Overall Study||53
9800806|NCT00606086|10909022|FG000|NOT COMPLETED|Overall Study||12
9800807|NCT00606086|10909023|FG001|NOT COMPLETED|Overall Study||15
9800808|NCT00606138|10909031|FG000|STARTED|Overall Study||6
9800809|NCT00606138|10909032|FG001|STARTED|Overall Study||2
9800810|NCT00606138|10909031|FG000|COMPLETED|Overall Study||6
9800811|NCT00606138|10909032|FG001|COMPLETED|Overall Study||2
9800812|NCT00606138|10909031|FG000|NOT COMPLETED|Overall Study||0
9800813|NCT00606138|10909032|FG001|NOT COMPLETED|Overall Study||0
9800814|NCT00606177|10909040|FG000|STARTED|Overall Study||55
9800815|NCT00606177|10909041|FG001|STARTED|Overall Study||44
9800816|NCT00606177|10909040|FG000|COMPLETED|Overall Study||28
9800817|NCT00606177|10909041|FG001|COMPLETED|Overall Study||19
9800818|NCT00606177|10909040|FG000|NOT COMPLETED|Overall Study||27
9800819|NCT00606177|10909041|FG001|NOT COMPLETED|Overall Study||25
9800820|NCT00606229|10909047|FG000|STARTED|Overall Study||41
9800821|NCT00606229|10909047|FG000|COMPLETED|Overall Study||19
9800822|NCT00606229|10909047|FG000|NOT COMPLETED|Overall Study||22
9800823|NCT00606281|10909053|FG000|STARTED|Overall Study||128
9800824|NCT00606281|10909054|FG001|STARTED|Overall Study||130
9800825|NCT00606281|10909053|FG000|COMPLETED|Overall Study||72
9800826|NCT00606281|10909054|FG001|COMPLETED|Overall Study||64
9800827|NCT00606281|10909053|FG000|NOT COMPLETED|Overall Study||56
9800828|NCT00606281|10909054|FG001|NOT COMPLETED|Overall Study||66
9800829|NCT00606294|10909062|FG000|STARTED|Overall Study||197
9800830|NCT00606294|10909063|FG001|STARTED|Overall Study||19
9800831|NCT00606294|10909062|FG000|COMPLETED|Overall Study||161
9800832|NCT00606294|10909063|FG001|COMPLETED|Overall Study||19
9800833|NCT00606294|10909062|FG000|NOT COMPLETED|Overall Study||36
9800834|NCT00606294|10909063|FG001|NOT COMPLETED|Overall Study||0
9800835|NCT00606307|10909069|FG000|STARTED|Overall Study||29
9800836|NCT00606307|10909069|FG000|COMPLETED|Overall Study||18
9800837|NCT00606307|10909069|FG000|NOT COMPLETED|Overall Study||11
9800838|NCT00606320|10909073|FG000|STARTED|Overall Study||59
9800839|NCT00606320|10909073|FG000|COMPLETED|Overall Study||22
9800840|NCT00606320|10909073|FG000|NOT COMPLETED|Overall Study||37
9800841|NCT00606489|10909079|FG000|STARTED|Overall Study||21
9800842|NCT00606489|10909080|FG001|STARTED|Overall Study||40
9800843|NCT00606489|10909079|FG000|COMPLETED|Overall Study||21
9800844|NCT00606489|10909080|FG001|COMPLETED|Overall Study||40
9800845|NCT00606489|10909079|FG000|NOT COMPLETED|Overall Study||0
9800846|NCT00606489|10909080|FG001|NOT COMPLETED|Overall Study||0
9800847|NCT00606502|10909088|FG000|STARTED|Randomization||100
9800848|NCT00606502|10909089|FG001|STARTED|Randomization||101
9800849|NCT00606502|10909088|FG000|COMPLETED|Randomization||97
9800850|NCT00606502|10909089|FG001|COMPLETED|Randomization||101
9800851|NCT00606502|10909088|FG000|NOT COMPLETED|Randomization||3
9800852|NCT00606502|10909089|FG001|NOT COMPLETED|Randomization||0
9800853|NCT00606502|10909088|FG000|STARTED|Treatment||97
9800854|NCT00606502|10909089|FG001|STARTED|Treatment||101
9800855|NCT00606502|10909088|FG000|COMPLETED|Treatment||97
9800856|NCT00606502|10909089|FG001|COMPLETED|Treatment||98
9800857|NCT00606502|10909088|FG000|NOT COMPLETED|Treatment||0
9800858|NCT00606502|10909089|FG001|NOT COMPLETED|Treatment||3
9800859|NCT00606554|10909097|FG000|STARTED|Overall Study||15
9800860|NCT00606554|10909098|FG001|STARTED|Overall Study||18
9800861|NCT00606554|10909097|FG000|COMPLETED|Overall Study||15
9800862|NCT00606554|10909098|FG001|COMPLETED|Overall Study||18
9800863|NCT00606554|10909097|FG000|NOT COMPLETED|Overall Study||0
9800864|NCT00606554|10909098|FG001|NOT COMPLETED|Overall Study||0
9800865|NCT00606580|10909111|FG000|STARTED|Overall Study||125
9800866|NCT00606580|10909112|FG001|STARTED|Overall Study||125
9800867|NCT00606580|10909113|FG002|STARTED|Overall Study||125
9800868|NCT00606580|10909111|FG000|COMPLETED|Overall Study||123
9800869|NCT00606580|10909112|FG001|COMPLETED|Overall Study||122
9800870|NCT00606580|10909113|FG002|COMPLETED|Overall Study||103
9800871|NCT00606580|10909111|FG000|NOT COMPLETED|Overall Study||2
9800872|NCT00606580|10909112|FG001|NOT COMPLETED|Overall Study||3
9800873|NCT00606580|10909113|FG002|NOT COMPLETED|Overall Study||22
9800874|NCT00606593|10909121|FG000|STARTED|Overall Study|Randomized participants|11
9800875|NCT00606593|10909122|FG001|STARTED|Overall Study|Randomized participants|11
9800876|NCT00606593|10909123|FG002|STARTED|Overall Study|Randomized participants|11
9800877|NCT00606593|10909124|FG003|STARTED|Overall Study|Randomized participants|11
9800878|NCT00606593|10909125|FG004|STARTED|Overall Study|Randomized participants|12
9800879|NCT00606593|10909126|FG005|STARTED|Overall Study|Randomized participants|11
9800880|NCT00606593|10909127|FG006|STARTED|Overall Study|Randomized participants|11
9800881|NCT00606593|10909128|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
9800882|NCT00606593|10909129|FG008|STARTED|Overall Study|Randomized participants|12
9800883|NCT00606593|10909130|FG009|STARTED|Overall Study|Randomized participants|11
9800884|NCT00606593|10909121|FG000|1st Double-blind Treatment|Overall Study||11
9800885|NCT00606593|10909122|FG001|1st Double-blind Treatment|Overall Study||11
9800886|NCT00606593|10909123|FG002|1st Double-blind Treatment|Overall Study||11
9800887|NCT00606593|10909124|FG003|1st Double-blind Treatment|Overall Study||11
9800888|NCT00606593|10909125|FG004|1st Double-blind Treatment|Overall Study||12
9800889|NCT00606593|10909126|FG005|1st Double-blind Treatment|Overall Study||11
9800890|NCT00606593|10909127|FG006|1st Double-blind Treatment|Overall Study||11
9800891|NCT00606593|10909128|FG007|1st Double-blind Treatment|Overall Study||11
9800892|NCT00606593|10909129|FG008|1st Double-blind Treatment|Overall Study||12
9800893|NCT00606593|10909130|FG009|1st Double-blind Treatment|Overall Study||11
9800894|NCT00606593|10909121|FG000|2nd Double-blind Treatment|Overall Study||11
9800895|NCT00606593|10909122|FG001|2nd Double-blind Treatment|Overall Study||11
9800896|NCT00606593|10909123|FG002|2nd Double-blind Treatment|Overall Study||11
9800897|NCT00606593|10909124|FG003|2nd Double-blind Treatment|Overall Study||10
9800898|NCT00606593|10909125|FG004|2nd Double-blind Treatment|Overall Study||12
9800899|NCT00606593|10909126|FG005|2nd Double-blind Treatment|Overall Study||11
9800900|NCT00606593|10909127|FG006|2nd Double-blind Treatment|Overall Study||10
9800901|NCT00606593|10909128|FG007|2nd Double-blind Treatment|Overall Study||9
9800902|NCT00606593|10909129|FG008|2nd Double-blind Treatment|Overall Study||12
9800903|NCT00606593|10909130|FG009|2nd Double-blind Treatment|Overall Study||11
9800904|NCT00606593|10909121|FG000|3rd Double-blind Treatment|Overall Study||11
9800905|NCT00606593|10909122|FG001|3rd Double-blind Treatment|Overall Study||11
9800906|NCT00606593|10909123|FG002|3rd Double-blind Treatment|Overall Study||10
9800907|NCT00606593|10909124|FG003|3rd Double-blind Treatment|Overall Study||10
9800908|NCT00606593|10909125|FG004|3rd Double-blind Treatment|Overall Study||11
9800909|NCT00606593|10909126|FG005|3rd Double-blind Treatment|Overall Study||11
9800910|NCT00606593|10909127|FG006|3rd Double-blind Treatment|Overall Study||10
9800911|NCT00606593|10909128|FG007|3rd Double-blind Treatment|Overall Study||9
9800912|NCT00606593|10909129|FG008|3rd Double-blind Treatment|Overall Study||12
9800913|NCT00606593|10909130|FG009|3rd Double-blind Treatment|Overall Study||11
9800914|NCT00606593|10909121|FG000|4th Double-blind Treatment|Overall Study||10
9800915|NCT00606593|10909122|FG001|4th Double-blind Treatment|Overall Study||11
9800916|NCT00606593|10909123|FG002|4th Double-blind Treatment|Overall Study||10
9800917|NCT00606593|10909124|FG003|4th Double-blind Treatment|Overall Study||10
9800918|NCT00606593|10909125|FG004|4th Double-blind Treatment|Overall Study||11
9800919|NCT00606593|10909126|FG005|4th Double-blind Treatment|Overall Study||11
9800920|NCT00606593|10909127|FG006|4th Double-blind Treatment|Overall Study||10
9800921|NCT00606593|10909128|FG007|4th Double-blind Treatment|Overall Study||9
9800922|NCT00606593|10909129|FG008|4th Double-blind Treatment|Overall Study||11
9800923|NCT00606593|10909130|FG009|4th Double-blind Treatment|Overall Study||11
9800924|NCT00606593|10909121|FG000|5th Double-blind Treatment|Overall Study||10
9800925|NCT00606593|10909122|FG001|5th Double-blind Treatment|Overall Study||11
9800926|NCT00606593|10909123|FG002|5th Double-blind Treatment|Overall Study||9
9800927|NCT00606593|10909124|FG003|5th Double-blind Treatment|Overall Study||10
9800928|NCT00606593|10909125|FG004|5th Double-blind Treatment|Overall Study||11
9800929|NCT00606593|10909126|FG005|5th Double-blind Treatment|Overall Study||11
9800930|NCT00606593|10909127|FG006|5th Double-blind Treatment|Overall Study||10
9800931|NCT00606593|10909128|FG007|5th Double-blind Treatment|Overall Study||9
9800932|NCT00606593|10909129|FG008|5th Double-blind Treatment|Overall Study||11
9800933|NCT00606593|10909130|FG009|5th Double-blind Treatment|Overall Study||11
9800934|NCT00606593|10909121|FG000|COMPLETED|Overall Study||10
9800935|NCT00606593|10909122|FG001|COMPLETED|Overall Study||11
9800936|NCT00606593|10909123|FG002|COMPLETED|Overall Study||9
9800937|NCT00606593|10909124|FG003|COMPLETED|Overall Study||10
9800938|NCT00606593|10909125|FG004|COMPLETED|Overall Study||11
9800939|NCT00606593|10909126|FG005|COMPLETED|Overall Study||11
9800940|NCT00606593|10909127|FG006|COMPLETED|Overall Study||10
9800941|NCT00606593|10909128|FG007|COMPLETED|Overall Study||9
9800942|NCT00606593|10909129|FG008|COMPLETED|Overall Study||11
9800943|NCT00606593|10909130|FG009|COMPLETED|Overall Study||11
9800944|NCT00606593|10909121|FG000|NOT COMPLETED|Overall Study||1
9800945|NCT00606593|10909122|FG001|NOT COMPLETED|Overall Study||0
9800946|NCT00606593|10909123|FG002|NOT COMPLETED|Overall Study||2
9800947|NCT00606593|10909124|FG003|NOT COMPLETED|Overall Study||1
9800948|NCT00606593|10909125|FG004|NOT COMPLETED|Overall Study||1
9800949|NCT00606593|10909126|FG005|NOT COMPLETED|Overall Study||0
9800950|NCT00606593|10909127|FG006|NOT COMPLETED|Overall Study||1
9800951|NCT00606593|10909128|FG007|NOT COMPLETED|Overall Study||2
9800952|NCT00606593|10909129|FG008|NOT COMPLETED|Overall Study||1
9800953|NCT00606593|10909130|FG009|NOT COMPLETED|Overall Study||0
9800954|NCT00606632|10909143|FG000|STARTED|Overall Study||226
9800955|NCT00606632|10909143|FG000|COMPLETED|Overall Study||204
9800956|NCT00606632|10909143|FG000|NOT COMPLETED|Overall Study||22
9800957|NCT00606684|10909158|FG000|STARTED|2-week Single-Blind Run-in Period||851
9800958|NCT00606684|10909159|FG001|STARTED|2-week Single-Blind Run-in Period||0
9800959|NCT00606684|10909160|FG002|STARTED|2-week Single-Blind Run-in Period||0
9800960|NCT00606684|10909161|FG003|STARTED|2-week Single-Blind Run-in Period||0
9800961|NCT00606684|10909162|FG004|STARTED|2-week Single-Blind Run-in Period||0
9800962|NCT00606684|10909163|FG005|STARTED|2-week Single-Blind Run-in Period||0
9800963|NCT00606684|10909164|FG006|STARTED|2-week Single-Blind Run-in Period||0
9800964|NCT00606684|10909158|FG000|COMPLETED|2-week Single-Blind Run-in Period||605
9800965|NCT00606684|10909159|FG001|COMPLETED|2-week Single-Blind Run-in Period||0
9800966|NCT00606684|10909160|FG002|COMPLETED|2-week Single-Blind Run-in Period||0
9800967|NCT00606684|10909161|FG003|COMPLETED|2-week Single-Blind Run-in Period||0
9800968|NCT00606684|10909162|FG004|COMPLETED|2-week Single-Blind Run-in Period||0
9800969|NCT00606684|10909163|FG005|COMPLETED|2-week Single-Blind Run-in Period||0
9800970|NCT00606684|10909164|FG006|COMPLETED|2-week Single-Blind Run-in Period||0
9800971|NCT00606684|10909158|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246
9800972|NCT00606684|10909159|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0
9800973|NCT00606684|10909160|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0
9800974|NCT00606684|10909161|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0
9800975|NCT00606684|10909162|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0
9800976|NCT00606684|10909163|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0
9800977|NCT00606684|10909164|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0
9800978|NCT00606684|10909158|FG000|STARTED|Double-Blind Treatment Period||0
9800979|NCT00606684|10909159|FG001|STARTED|Double-Blind Treatment Period||101
9800980|NCT00606684|10909160|FG002|STARTED|Double-Blind Treatment Period||99
9800981|NCT00606684|10909161|FG003|STARTED|Double-Blind Treatment Period||101
9800982|NCT00606684|10909162|FG004|STARTED|Double-Blind Treatment Period||101
10015829|NCT01807520|11138789|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
10235303|NCT01206296|11365587|FG000|NOT COMPLETED|Overall Study||0
10235304|NCT01207102|11365591|FG000|STARTED|Overall Study||10
9800983|NCT00606684|10909163|FG005|STARTED|Double-Blind Treatment Period||101
9800984|NCT00606684|10909164|FG006|STARTED|Double-Blind Treatment Period||99
9800985|NCT00606684|10909158|FG000|COMPLETED|Double-Blind Treatment Period||0
9800986|NCT00606684|10909159|FG001|COMPLETED|Double-Blind Treatment Period||85
9800987|NCT00606684|10909160|FG002|COMPLETED|Double-Blind Treatment Period||88
9800988|NCT00606684|10909161|FG003|COMPLETED|Double-Blind Treatment Period||91
9800989|NCT00606684|10909162|FG004|COMPLETED|Double-Blind Treatment Period||92
9800990|NCT00606684|10909163|FG005|COMPLETED|Double-Blind Treatment Period||92
9800991|NCT00606684|10909164|FG006|COMPLETED|Double-Blind Treatment Period||91
9800992|NCT00606684|10909158|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
9800993|NCT00606684|10909159|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
9800994|NCT00606684|10909160|FG002|NOT COMPLETED|Double-Blind Treatment Period||11
9800995|NCT00606684|10909161|FG003|NOT COMPLETED|Double-Blind Treatment Period||10
9800996|NCT00606684|10909162|FG004|NOT COMPLETED|Double-Blind Treatment Period||9
9800997|NCT00606684|10909163|FG005|NOT COMPLETED|Double-Blind Treatment Period||9
9800998|NCT00606684|10909164|FG006|NOT COMPLETED|Double-Blind Treatment Period||8
9800999|NCT00606801|10909180|FG000|STARTED|Adaptation||17
9801000|NCT00606801|10909181|FG001|STARTED|Adaptation||17
9801001|NCT00606801|10909180|FG000|COMPLETED|Adaptation||17
9801002|NCT00606801|10909181|FG001|COMPLETED|Adaptation||17
9801003|NCT00606801|10909180|FG000|NOT COMPLETED|Adaptation||0
9801004|NCT00606801|10909181|FG001|NOT COMPLETED|Adaptation||0
9801005|NCT00606801|10909180|FG000|STARTED|Intervention||17
9801006|NCT00606801|10909181|FG001|STARTED|Intervention||17
9801007|NCT00606801|10909180|FG000|COMPLETED|Intervention||14
9801008|NCT00606801|10909181|FG001|COMPLETED|Intervention||14
9801009|NCT00606801|10909180|FG000|NOT COMPLETED|Intervention||3
9801010|NCT00606801|10909181|FG001|NOT COMPLETED|Intervention||3
9801011|NCT00606892|10909191|FG000|STARTED|Adaptation||9
9801012|NCT00606892|10909192|FG001|STARTED|Adaptation||8
9801013|NCT00606892|10909191|FG000|COMPLETED|Adaptation||9
9801014|NCT00606892|10909192|FG001|COMPLETED|Adaptation||8
9801015|NCT00606892|10909191|FG000|NOT COMPLETED|Adaptation||0
9801016|NCT00606892|10909192|FG001|NOT COMPLETED|Adaptation||0
9801017|NCT00606892|10909191|FG000|STARTED|First Intervention||9
10235305|NCT01207102|11365591|FG000|COMPLETED|Overall Study||0
10235306|NCT01207102|11365591|FG000|NOT COMPLETED|Overall Study||10
10235307|NCT01213329|11365597|FG000|STARTED|Screening||25
10235308|NCT01213329|11365598|FG001|STARTED|Screening||25
10235309|NCT01213329|11365597|FG000|COMPLETED|Screening||25
10235310|NCT01213329|11365598|FG001|COMPLETED|Screening||25
10235311|NCT01213329|11365597|FG000|NOT COMPLETED|Screening||0
10235312|NCT01213329|11365598|FG001|NOT COMPLETED|Screening||0
10235313|NCT01213329|11365597|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
9801018|NCT00606892|10909192|FG001|STARTED|First Intervention||8
9801019|NCT00606892|10909191|FG000|COMPLETED|First Intervention||8
9801020|NCT00606892|10909192|FG001|COMPLETED|First Intervention||4
9801021|NCT00606892|10909191|FG000|NOT COMPLETED|First Intervention||1
9801022|NCT00606892|10909192|FG001|NOT COMPLETED|First Intervention||4
10235314|NCT01213329|11365598|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
10235315|NCT01213329|11365597|FG000|COMPLETED|Phase 2||0
9801023|NCT00606892|10909191|FG000|STARTED|Washout Period||8
9801024|NCT00606892|10909192|FG001|STARTED|Washout Period||4
9801025|NCT00606892|10909191|FG000|COMPLETED|Washout Period||8
9801026|NCT00606892|10909192|FG001|COMPLETED|Washout Period||4
9801027|NCT00606892|10909191|FG000|NOT COMPLETED|Washout Period||0
9801028|NCT00606892|10909192|FG001|NOT COMPLETED|Washout Period||0
9801029|NCT00606892|10909191|FG000|STARTED|Second Intervention||8
9801030|NCT00606892|10909192|FG001|STARTED|Second Intervention||4
9801031|NCT00606892|10909191|FG000|COMPLETED|Second Intervention||8
9801032|NCT00606892|10909192|FG001|COMPLETED|Second Intervention||4
9801033|NCT00606892|10909191|FG000|NOT COMPLETED|Second Intervention||0
9801034|NCT00606892|10909192|FG001|NOT COMPLETED|Second Intervention||0
9801035|NCT00606905|10909226|FG000|STARTED|Overall Study||38
9801036|NCT00606905|10909227|FG001|STARTED|Overall Study||39
9801037|NCT00606905|10909226|FG000|Pregnancy|Overall Study||29
9801038|NCT00606905|10909227|FG001|Pregnancy|Overall Study||33
9801039|NCT00606905|10909226|FG000|COMPLETED|Overall Study||23
9801040|NCT00606905|10909227|FG001|COMPLETED|Overall Study||24
9801041|NCT00606905|10909226|FG000|NOT COMPLETED|Overall Study||15
9801042|NCT00606905|10909227|FG001|NOT COMPLETED|Overall Study||15
9801043|NCT00606931|10909233|FG000|STARTED|Overall Study||22
9801044|NCT00606931|10909233|FG000|COMPLETED|Overall Study||19
9801045|NCT00606931|10909233|FG000|NOT COMPLETED|Overall Study||3
9801046|NCT00606944|10909239|FG000|STARTED|Overall Study||98
9801047|NCT00606944|10909240|FG001|STARTED|Overall Study||100
9801048|NCT00606944|10909239|FG000|COMPLETED|Overall Study||98
9801049|NCT00606944|10909240|FG001|COMPLETED|Overall Study||100
9801050|NCT00606944|10909239|FG000|NOT COMPLETED|Overall Study||0
9801051|NCT00606944|10909240|FG001|NOT COMPLETED|Overall Study||0
9801052|NCT00607022|10909249|FG000|STARTED|Overall Study||7
9801053|NCT00607022|10909250|FG001|STARTED|Overall Study||15
9801054|NCT00607022|10909251|FG002|STARTED|Overall Study||19
9801055|NCT00607022|10909249|FG000|COMPLETED|Overall Study||6
9801056|NCT00607022|10909250|FG001|COMPLETED|Overall Study||15
9801057|NCT00607022|10909251|FG002|COMPLETED|Overall Study||19
9801058|NCT00607022|10909249|FG000|NOT COMPLETED|Overall Study||1
9801059|NCT00607022|10909250|FG001|NOT COMPLETED|Overall Study||0
9801060|NCT00607022|10909251|FG002|NOT COMPLETED|Overall Study||0
9801061|NCT00607048|10909261|FG000|STARTED|Overall Study||3
9801062|NCT00607048|10909262|FG001|STARTED|Overall Study||6
9801063|NCT00607048|10909263|FG002|STARTED|Overall Study||7
9801064|NCT00607048|10909264|FG003|STARTED|Overall Study||3
9801065|NCT00607048|10909265|FG004|STARTED|Overall Study||6
9801066|NCT00607048|10909266|FG005|STARTED|Overall Study||7
9801067|NCT00607048|10909261|FG000|COMPLETED|Overall Study||0
9801068|NCT00607048|10909262|FG001|COMPLETED|Overall Study||2
9801069|NCT00607048|10909263|FG002|COMPLETED|Overall Study||3
9801070|NCT00607048|10909264|FG003|COMPLETED|Overall Study||0
9801071|NCT00607048|10909265|FG004|COMPLETED|Overall Study||0
9801072|NCT00607048|10909266|FG005|COMPLETED|Overall Study||2
9801073|NCT00607048|10909261|FG000|NOT COMPLETED|Overall Study||3
9801074|NCT00607048|10909262|FG001|NOT COMPLETED|Overall Study||4
9801075|NCT00607048|10909263|FG002|NOT COMPLETED|Overall Study||4
9801076|NCT00607048|10909264|FG003|NOT COMPLETED|Overall Study||3
9801077|NCT00607048|10909265|FG004|NOT COMPLETED|Overall Study||6
9801078|NCT00607048|10909266|FG005|NOT COMPLETED|Overall Study||5
9801079|NCT00607087|10909285|FG000|STARTED|Overall Study||99
9801080|NCT00607087|10909286|FG001|STARTED|Overall Study||95
9801081|NCT00607087|10909287|FG002|STARTED|Overall Study||94
9801082|NCT00607087|10909285|FG000|COMPLETED|Overall Study||84
9801083|NCT00607087|10909286|FG001|COMPLETED|Overall Study||84
9801084|NCT00607087|10909287|FG002|COMPLETED|Overall Study||84
9801085|NCT00607087|10909285|FG000|NOT COMPLETED|Overall Study||15
9801086|NCT00607087|10909286|FG001|NOT COMPLETED|Overall Study||11
9801087|NCT00607087|10909287|FG002|NOT COMPLETED|Overall Study||10
9801088|NCT00607087|10909285|FG000|STARTED|Period 1||99
9801089|NCT00607087|10909286|FG001|STARTED|Period 1||95
9801090|NCT00607087|10909287|FG002|STARTED|Period 1||94
9801091|NCT00607087|10909285|FG000|COMPLETED|Period 1||87
9801092|NCT00607087|10909286|FG001|COMPLETED|Period 1||89
9801093|NCT00607087|10909287|FG002|COMPLETED|Period 1||89
9801094|NCT00607087|10909285|FG000|NOT COMPLETED|Period 1||12
9801095|NCT00607087|10909286|FG001|NOT COMPLETED|Period 1||6
9801096|NCT00607087|10909287|FG002|NOT COMPLETED|Period 1||5
9801097|NCT00607087|10909285|FG000|STARTED|Period 2||87
9801098|NCT00607087|10909286|FG001|STARTED|Period 2||89
9801099|NCT00607087|10909287|FG002|STARTED|Period 2||89
9801100|NCT00607087|10909285|FG000|COMPLETED|Period 2||86
9801101|NCT00607087|10909286|FG001|COMPLETED|Period 2||86
9801102|NCT00607087|10909287|FG002|COMPLETED|Period 2||84
9801103|NCT00607087|10909285|FG000|NOT COMPLETED|Period 2||1
9801104|NCT00607087|10909286|FG001|NOT COMPLETED|Period 2||3
9801105|NCT00607087|10909287|FG002|NOT COMPLETED|Period 2||5
9801106|NCT00607087|10909285|FG000|STARTED|Period 3||86
9801107|NCT00607087|10909286|FG001|STARTED|Period 3||86
9801108|NCT00607087|10909287|FG002|STARTED|Period 3||84
9801109|NCT00607087|10909285|FG000|COMPLETED|Period 3||84
9801110|NCT00607087|10909286|FG001|COMPLETED|Period 3||84
9801111|NCT00607087|10909287|FG002|COMPLETED|Period 3||84
9801112|NCT00607087|10909285|FG000|NOT COMPLETED|Period 3||2
9801113|NCT00607087|10909286|FG001|NOT COMPLETED|Period 3||2
9801114|NCT00607087|10909287|FG002|NOT COMPLETED|Period 3||0
9801115|NCT00607113|10909297|FG000|STARTED|Overall Study||19
9801116|NCT00607113|10909298|FG001|STARTED|Overall Study||20
9801117|NCT00607113|10909297|FG000|COMPLETED|Overall Study||19
9801118|NCT00607113|10909298|FG001|COMPLETED|Overall Study||20
9801119|NCT00607113|10909297|FG000|NOT COMPLETED|Overall Study||0
9801120|NCT00607113|10909298|FG001|NOT COMPLETED|Overall Study||0
9801121|NCT00607126|10909305|FG000|STARTED|Overall Study||17
9801122|NCT00607126|10909306|FG001|STARTED|Overall Study||19
9801123|NCT00607126|10909305|FG000|COMPLETED|Overall Study||17
9801124|NCT00607126|10909306|FG001|COMPLETED|Overall Study||19
9801125|NCT00607126|10909305|FG000|NOT COMPLETED|Overall Study||0
9801126|NCT00607126|10909306|FG001|NOT COMPLETED|Overall Study||0
9801127|NCT00607243|10909314|FG000|STARTED|Initial Post-vaccination Period||82
9801128|NCT00607243|10909315|FG001|STARTED|Initial Post-vaccination Period||41
9801129|NCT00607243|10909314|FG000|COMPLETED|Initial Post-vaccination Period||82
9801130|NCT00607243|10909315|FG001|COMPLETED|Initial Post-vaccination Period||41
9801131|NCT00607243|10909314|FG000|NOT COMPLETED|Initial Post-vaccination Period||0
9801132|NCT00607243|10909315|FG001|NOT COMPLETED|Initial Post-vaccination Period||0
9801133|NCT00607243|10909314|FG000|STARTED|Telephone Safety Assessment Period||82
9801134|NCT00607243|10909315|FG001|STARTED|Telephone Safety Assessment Period||41
9801135|NCT00607243|10909314|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
9801136|NCT00607243|10909315|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
9801137|NCT00607243|10909314|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5
9801138|NCT00607243|10909315|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2
9801139|NCT00607269|10909323|FG000|STARTED|Overall Study||67
9801140|NCT00607269|10909324|FG001|STARTED|Overall Study||64
9801141|NCT00607269|10909323|FG000|COMPLETED|Overall Study||67
9801142|NCT00607269|10909324|FG001|COMPLETED|Overall Study||64
9801143|NCT00607269|10909323|FG000|NOT COMPLETED|Overall Study||0
9801144|NCT00607269|10909324|FG001|NOT COMPLETED|Overall Study||0
9801145|NCT00607321|10909330|FG000|STARTED|Overall Study||60
9801146|NCT00607321|10909330|FG000|COMPLETED|Overall Study||60
9801147|NCT00607321|10909330|FG000|NOT COMPLETED|Overall Study||0
9801148|NCT00607373|10909338|FG000|STARTED|Treatment Period||17
9801149|NCT00607373|10909339|FG001|STARTED|Treatment Period||34
9801150|NCT00607373|10909338|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
9801151|NCT00607373|10909339|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
9801152|NCT00607373|10909338|FG000|NOT COMPLETED|Treatment Period||0
9801153|NCT00607373|10909339|FG001|NOT COMPLETED|Treatment Period||6
9801154|NCT00607373|10909338|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
9801155|NCT00607373|10909339|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
9801156|NCT00607373|10909338|FG000|COMPLETED|Follow-up Period||0
9801157|NCT00607373|10909339|FG001|COMPLETED|Follow-up Period||6
9801158|NCT00607373|10909338|FG000|NOT COMPLETED|Follow-up Period||1
9801159|NCT00607373|10909339|FG001|NOT COMPLETED|Follow-up Period||5
9801160|NCT00607386|10909345|FG000|STARTED|Overall Study||28
9801161|NCT00607386|10909345|FG000|COMPLETED|Overall Study||27
9801162|NCT00607386|10909345|FG000|NOT COMPLETED|Overall Study||1
9801163|NCT00607594|10909349|FG000|STARTED|Overall Study||21
9801164|NCT00607594|10909349|FG000|COMPLETED|Overall Study||21
9801165|NCT00607594|10909349|FG000|NOT COMPLETED|Overall Study||0
9801166|NCT00607620|10909357|FG000|STARTED|Overall Study||409
9801167|NCT00607620|10909358|FG001|STARTED|Overall Study||469
9801168|NCT00607620|10909357|FG000|COMPLETED|Overall Study||409
9801169|NCT00607620|10909358|FG001|COMPLETED|Overall Study||469
9801170|NCT00607620|10909357|FG000|NOT COMPLETED|Overall Study||0
9801171|NCT00607620|10909358|FG001|NOT COMPLETED|Overall Study||0
9801172|NCT00607672|10909367|FG000|STARTED|Overall Study||32
9801173|NCT00607672|10909368|FG001|STARTED|Overall Study||27
9801174|NCT00607672|10909369|FG002|STARTED|Overall Study||27
9801175|NCT00607672|10909367|FG000|COMPLETED|Overall Study||28
9801176|NCT00607672|10909368|FG001|COMPLETED|Overall Study||24
9801177|NCT00607672|10909369|FG002|COMPLETED|Overall Study||22
9801178|NCT00607672|10909367|FG000|NOT COMPLETED|Overall Study||4
9801179|NCT00607672|10909368|FG001|NOT COMPLETED|Overall Study||3
9801180|NCT00607672|10909369|FG002|NOT COMPLETED|Overall Study||5
9801181|NCT00607724|10909387|FG000|STARTED|Stage 1: Dose Escalation||7
9801182|NCT00607724|10909388|FG001|STARTED|Stage 1: Dose Escalation||9
9801183|NCT00607724|10909389|FG002|STARTED|Stage 1: Dose Escalation||4
9801184|NCT00607724|10909390|FG003|STARTED|Stage 1: Dose Escalation||0
9801185|NCT00607724|10909391|FG004|STARTED|Stage 1: Dose Escalation||0
9801186|NCT00607724|10909392|FG005|STARTED|Stage 1: Dose Escalation||0
9801187|NCT00607724|10909393|FG006|STARTED|Stage 1: Dose Escalation||0
9801188|NCT00607724|10909387|FG000|COMPLETED|Stage 1: Dose Escalation||0
9801189|NCT00607724|10909388|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
9801190|NCT00607724|10909389|FG002|COMPLETED|Stage 1: Dose Escalation||0
9801191|NCT00607724|10909390|FG003|COMPLETED|Stage 1: Dose Escalation||0
9801192|NCT00607724|10909391|FG004|COMPLETED|Stage 1: Dose Escalation||0
9801193|NCT00607724|10909392|FG005|COMPLETED|Stage 1: Dose Escalation||0
9801194|NCT00607724|10909393|FG006|COMPLETED|Stage 1: Dose Escalation||0
9801195|NCT00607724|10909387|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7
9801196|NCT00607724|10909388|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8
10015830|NCT01807520|11138790|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10015831|NCT01807520|11138791|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
9801197|NCT00607724|10909389|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4
10015832|NCT01807520|11138792|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
10015833|NCT01807520|11138793|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
9801198|NCT00607724|10909390|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0
9801199|NCT00607724|10909391|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0
9801200|NCT00607724|10909392|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0
9801201|NCT00607724|10909393|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
9801202|NCT00607724|10909387|FG000|STARTED|Stage 2: Expanded Cohort||0
9801203|NCT00607724|10909388|FG001|STARTED|Stage 2: Expanded Cohort||0
9801204|NCT00607724|10909389|FG002|STARTED|Stage 2: Expanded Cohort||0
9801205|NCT00607724|10909390|FG003|STARTED|Stage 2: Expanded Cohort||6
9801206|NCT00607724|10909391|FG004|STARTED|Stage 2: Expanded Cohort||14
9801207|NCT00607724|10909392|FG005|STARTED|Stage 2: Expanded Cohort||12
9801208|NCT00607724|10909393|FG006|STARTED|Stage 2: Expanded Cohort||16
9801209|NCT00607724|10909387|FG000|COMPLETED|Stage 2: Expanded Cohort||0
9801210|NCT00607724|10909388|FG001|COMPLETED|Stage 2: Expanded Cohort||0
9801211|NCT00607724|10909389|FG002|COMPLETED|Stage 2: Expanded Cohort||0
9801212|NCT00607724|10909390|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
9801213|NCT00607724|10909391|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
9801214|NCT00607724|10909392|FG005|COMPLETED|Stage 2: Expanded Cohort||0
9801215|NCT00607724|10909393|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
9801216|NCT00607724|10909387|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
9801217|NCT00607724|10909388|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
9801218|NCT00607724|10909389|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
9801219|NCT00607724|10909390|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5
9801220|NCT00607724|10909391|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9
9801221|NCT00607724|10909392|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12
9801222|NCT00607724|10909393|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11
9801223|NCT00607789|10909419|FG000|STARTED|Overall Study|20 participants were randomized in each group|20
9801224|NCT00607789|10909420|FG001|STARTED|Overall Study||20
9801225|NCT00607789|10909419|FG000|COMPLETED|Overall Study||13
9801226|NCT00607789|10909420|FG001|COMPLETED|Overall Study||14
9801227|NCT00607789|10909419|FG000|NOT COMPLETED|Overall Study||7
9801228|NCT00607789|10909420|FG001|NOT COMPLETED|Overall Study||6
9801229|NCT00607815|10909428|FG000|STARTED|Overall Study||43
9801230|NCT00607815|10909429|FG001|STARTED|Overall Study||36
9801231|NCT00607815|10909428|FG000|COMPLETED|Overall Study||20
9801232|NCT00607815|10909429|FG001|COMPLETED|Overall Study||25
9801233|NCT00607815|10909428|FG000|NOT COMPLETED|Overall Study||23
9801234|NCT00607815|10909429|FG001|NOT COMPLETED|Overall Study||11
9801235|NCT00607867|10909439|FG000|STARTED|Overall Study||7
9801236|NCT00607867|10909440|FG001|STARTED|Overall Study||7
9801237|NCT00607867|10909439|FG000|COMPLETED|Overall Study||7
9801238|NCT00607867|10909440|FG001|COMPLETED|Overall Study||7
9801239|NCT00607867|10909439|FG000|NOT COMPLETED|Overall Study||0
9801240|NCT00607867|10909440|FG001|NOT COMPLETED|Overall Study||0
9801241|NCT00607880|10909448|FG000|STARTED|Overall Study||50
9801242|NCT00607880|10909449|FG001|STARTED|Overall Study||50
9801243|NCT00607880|10909448|FG000|COMPLETED|Overall Study||49
9801244|NCT00607880|10909449|FG001|COMPLETED|Overall Study||50
9801245|NCT00607880|10909448|FG000|NOT COMPLETED|Overall Study||1
9801246|NCT00607880|10909449|FG001|NOT COMPLETED|Overall Study||0
9801247|NCT00607893|10909457|FG000|STARTED|Overall Study||77
9801248|NCT00607893|10909458|FG001|STARTED|Overall Study||76
9801249|NCT00607893|10909457|FG000|Completed Baseline Visit|Overall Study||74
9801250|NCT00607893|10909458|FG001|Completed Baseline Visit|Overall Study||75
9801251|NCT00607893|10909457|FG000|Completed 8 Week Visit|Overall Study||71
9801252|NCT00607893|10909458|FG001|Completed 8 Week Visit|Overall Study||72
9801253|NCT00607893|10909457|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
9801254|NCT00607893|10909458|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
9801255|NCT00607893|10909457|FG000|COMPLETED|Overall Study||71
9801256|NCT00607893|10909458|FG001|COMPLETED|Overall Study||72
9801257|NCT00607893|10909457|FG000|NOT COMPLETED|Overall Study||6
9801258|NCT00607893|10909458|FG001|NOT COMPLETED|Overall Study||4
9801259|NCT00607919|10909468|FG000|STARTED|Acute Phase||120
9801260|NCT00607919|10909469|FG001|STARTED|Acute Phase||89
9801261|NCT00607919|10909468|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
9801262|NCT00607919|10909469|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
9801263|NCT00607919|10909468|FG000|NOT COMPLETED|Acute Phase||34
9801264|NCT00607919|10909469|FG001|NOT COMPLETED|Acute Phase||16
9801265|NCT00607919|10909468|FG000|STARTED|Open-Label Phase||84
9801266|NCT00607919|10909469|FG001|STARTED|Open-Label Phase||71
9801267|NCT00607919|10909468|FG000|COMPLETED|Open-Label Phase||74
9801268|NCT00607919|10909469|FG001|COMPLETED|Open-Label Phase||59
9801269|NCT00607919|10909468|FG000|NOT COMPLETED|Open-Label Phase||10
9801270|NCT00607919|10909469|FG001|NOT COMPLETED|Open-Label Phase||12
9801271|NCT00607997|10909481|FG000|STARTED|Overall Study||29
9801272|NCT00607997|10909482|FG001|STARTED|Overall Study||35
9801273|NCT00607997|10909483|FG002|STARTED|Overall Study||29
9801274|NCT00607997|10909484|FG003|STARTED|Overall Study||20
9801275|NCT00607997|10909481|FG000|COMPLETED|Overall Study||2
9801276|NCT00607997|10909482|FG001|COMPLETED|Overall Study||8
9801277|NCT00607997|10909483|FG002|COMPLETED|Overall Study||5
9801278|NCT00607997|10909484|FG003|COMPLETED|Overall Study||4
9801279|NCT00607997|10909481|FG000|NOT COMPLETED|Overall Study||27
9801280|NCT00607997|10909482|FG001|NOT COMPLETED|Overall Study||27
9801281|NCT00607997|10909483|FG002|NOT COMPLETED|Overall Study||24
9801282|NCT00607997|10909484|FG003|NOT COMPLETED|Overall Study||16
9801283|NCT00608062|10909505|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
9801284|NCT00608062|10909506|FG001|STARTED|Overall Study||12
9801285|NCT00608062|10909507|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
9801286|NCT00608062|10909508|FG003|STARTED|Overall Study||21
9801287|NCT00608062|10909509|FG004|STARTED|Overall Study||13
10015834|NCT01807520|11138794|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10015835|NCT01807520|11138788|FG000|STARTED|Follow-up Period (132-140 Weeks)||0
10015836|NCT01807520|11138789|FG001|STARTED|Follow-up Period (132-140 Weeks)||0
10015837|NCT01807520|11138790|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
10015838|NCT01807520|11138791|FG003|STARTED|Follow-up Period (132-140 Weeks)||0
10015839|NCT01807520|11138792|FG004|STARTED|Follow-up Period (132-140 Weeks)||0
10015840|NCT01807520|11138793|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
9801288|NCT00608062|10909510|FG005|STARTED|Overall Study||15
9801289|NCT00608062|10909505|FG000|COMPLETED|Overall Study||12
9801290|NCT00608062|10909506|FG001|COMPLETED|Overall Study||12
9801291|NCT00608062|10909507|FG002|COMPLETED|Overall Study||19
9801292|NCT00608062|10909508|FG003|COMPLETED|Overall Study||21
9801293|NCT00608062|10909509|FG004|COMPLETED|Overall Study||13
9801294|NCT00608062|10909510|FG005|COMPLETED|Overall Study||15
9801295|NCT00608062|10909505|FG000|NOT COMPLETED|Overall Study||0
9801296|NCT00608062|10909506|FG001|NOT COMPLETED|Overall Study||0
9801297|NCT00608062|10909507|FG002|NOT COMPLETED|Overall Study||0
9801298|NCT00608062|10909508|FG003|NOT COMPLETED|Overall Study||0
9801299|NCT00608062|10909509|FG004|NOT COMPLETED|Overall Study||0
9801300|NCT00608062|10909510|FG005|NOT COMPLETED|Overall Study||0
9801301|NCT00608140|10909528|FG000|STARTED|Overall Study||1
9801302|NCT00608140|10909529|FG001|STARTED|Overall Study||1
9801303|NCT00608140|10909528|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0
9801304|NCT00608140|10909529|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0
9801305|NCT00608140|10909528|FG000|NOT COMPLETED|Overall Study||1
9801306|NCT00608140|10909529|FG001|NOT COMPLETED|Overall Study||1
9801307|NCT00608205|10909546|FG000|STARTED|Overall Study||35
9801308|NCT00608205|10909547|FG001|STARTED|Overall Study||34
9801309|NCT00608205|10909546|FG000|COMPLETED|Overall Study||32
9801310|NCT00608205|10909547|FG001|COMPLETED|Overall Study||31
9801311|NCT00608205|10909546|FG000|NOT COMPLETED|Overall Study||3
9801312|NCT00608205|10909547|FG001|NOT COMPLETED|Overall Study||3
9801313|NCT00608244|10909555|FG000|STARTED|Overall Study||59
9801314|NCT00608244|10909555|FG000|COMPLETED|Overall Study||57
9801315|NCT00608244|10909555|FG000|NOT COMPLETED|Overall Study||2
9801316|NCT00608322|10909563|FG000|STARTED|Overall Study||26
9801317|NCT00608322|10909564|FG001|STARTED|Overall Study||23
9801318|NCT00608322|10909563|FG000|COMPLETED|Overall Study||24
9801319|NCT00608322|10909564|FG001|COMPLETED|Overall Study||22
9801320|NCT00608322|10909563|FG000|NOT COMPLETED|Overall Study||2
9801321|NCT00608322|10909564|FG001|NOT COMPLETED|Overall Study||1
9801322|NCT00608426|10909572|FG000|STARTED|Overall Study||2604
9801323|NCT00608426|10909573|FG001|STARTED|Overall Study||2519
9801324|NCT00608426|10909572|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
9801325|NCT00608426|10909573|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
9801326|NCT00608426|10909572|FG000|NOT COMPLETED|Overall Study||836
9801327|NCT00608426|10909573|FG001|NOT COMPLETED|Overall Study||905
9801328|NCT00608491|10909581|FG000|STARTED|Overall Study||94
9801329|NCT00608491|10909582|FG001|STARTED|Overall Study||94
9801330|NCT00608491|10909581|FG000|COMPLETED|Overall Study||73
9801331|NCT00608491|10909582|FG001|COMPLETED|Overall Study||72
9801332|NCT00608491|10909581|FG000|NOT COMPLETED|Overall Study||21
9801333|NCT00608491|10909582|FG001|NOT COMPLETED|Overall Study||22
9801334|NCT00608517|10909591|FG000|STARTED|Overall Study||2
9801335|NCT00608517|10909592|FG001|STARTED|Overall Study||3
9801336|NCT00608517|10909593|FG002|STARTED|Overall Study||1
9801337|NCT00608517|10909591|FG000|COMPLETED|Overall Study||1
9801338|NCT00608517|10909592|FG001|COMPLETED|Overall Study||3
9801339|NCT00608517|10909593|FG002|COMPLETED|Overall Study||1
9801340|NCT00608517|10909591|FG000|NOT COMPLETED|Overall Study||1
9801341|NCT00608517|10909592|FG001|NOT COMPLETED|Overall Study||0
9801342|NCT00608517|10909593|FG002|NOT COMPLETED|Overall Study||0
9801343|NCT00608530|10909606|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
9801344|NCT00608530|10909607|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
9801345|NCT00608530|10909608|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0
9801346|NCT00608530|10909609|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0
9801347|NCT00608530|10909606|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
9801348|NCT00608530|10909607|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
9801349|NCT00608530|10909608|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
9801350|NCT00608530|10909609|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
9801351|NCT00608530|10909606|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22
9831261|NCT00767676|10941958|FG000|NOT COMPLETED|Overall Study||54
9801352|NCT00608530|10909607|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28
9801353|NCT00608530|10909608|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0
9801354|NCT00608530|10909609|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0
9801355|NCT00608530|10909606|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
9801356|NCT00608530|10909607|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
9801357|NCT00608530|10909608|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
9801358|NCT00608530|10909609|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
9801359|NCT00608530|10909606|FG000|STARTED|Study 2 Nurse-delivered Treatments||0
9801360|NCT00608530|10909607|FG001|STARTED|Study 2 Nurse-delivered Treatments||0
9801361|NCT00608530|10909608|FG002|STARTED|Study 2 Nurse-delivered Treatments||33
9801362|NCT00608530|10909609|FG003|STARTED|Study 2 Nurse-delivered Treatments||34
9801363|NCT00608530|10909606|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
9801364|NCT00608530|10909607|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
9801365|NCT00608530|10909608|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
9801366|NCT00608530|10909609|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
9801367|NCT00608530|10909606|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0
9801368|NCT00608530|10909607|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0
9801369|NCT00608530|10909608|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21
9801370|NCT00608530|10909609|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27
9801371|NCT00608530|10909606|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
9801372|NCT00608530|10909607|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
9801373|NCT00608530|10909608|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
9801374|NCT00608530|10909609|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
9801375|NCT00608543|10909624|FG000|STARTED|Overall Study||17
9801376|NCT00608543|10909624|FG000|COMPLETED|Overall Study||13
9801377|NCT00608543|10909624|FG000|NOT COMPLETED|Overall Study||4
9801378|NCT00608569|10909631|FG000|STARTED|Overall Study||129
9801379|NCT00608569|10909632|FG001|STARTED|Overall Study||128
9801380|NCT00608569|10909631|FG000|COMPLETED|Overall Study||119
9801381|NCT00608569|10909632|FG001|COMPLETED|Overall Study||119
9801382|NCT00608569|10909631|FG000|NOT COMPLETED|Overall Study||10
9801383|NCT00608569|10909632|FG001|NOT COMPLETED|Overall Study||9
9801384|NCT00608582|10909640|FG000|STARTED|Overall Study||14
9801385|NCT00608582|10909641|FG001|STARTED|Overall Study||11
9801386|NCT00608582|10909640|FG000|COMPLETED|Overall Study||10
9801387|NCT00608582|10909641|FG001|COMPLETED|Overall Study||7
9801388|NCT00608582|10909640|FG000|NOT COMPLETED|Overall Study||4
9801389|NCT00608582|10909641|FG001|NOT COMPLETED|Overall Study||4
9801390|NCT00608634|10909652|FG000|STARTED|Overall Study||28
9801391|NCT00608634|10909653|FG001|STARTED|Overall Study||27
9801392|NCT00608634|10909654|FG002|STARTED|Overall Study||28
9801393|NCT00608634|10909652|FG000|COMPLETED|Overall Study||26
9801394|NCT00608634|10909653|FG001|COMPLETED|Overall Study||26
9801395|NCT00608634|10909654|FG002|COMPLETED|Overall Study||27
9801396|NCT00608634|10909652|FG000|NOT COMPLETED|Overall Study||2
9801397|NCT00608634|10909653|FG001|NOT COMPLETED|Overall Study||1
9801398|NCT00608634|10909654|FG002|NOT COMPLETED|Overall Study||1
9801399|NCT00608829|10909664|FG000|STARTED|Overall Study||23
9801400|NCT00608829|10909664|FG000|COMPLETED|Overall Study||8
9801401|NCT00608829|10909664|FG000|NOT COMPLETED|Overall Study||15
9801402|NCT00608842|10909672|FG000|STARTED|Overall Study||15
9801403|NCT00608842|10909673|FG001|STARTED|Overall Study||15
10235316|NCT01213329|11365598|FG001|COMPLETED|Phase 2||0
10235317|NCT01213329|11365597|FG000|NOT COMPLETED|Phase 2||0
10235318|NCT01213329|11365598|FG001|NOT COMPLETED|Phase 2||0
10235319|NCT01202110|11365604|FG000|STARTED|Overall Study||10
10235320|NCT01202110|11365605|FG001|STARTED|Overall Study||0
10235321|NCT01202110|11365604|FG000|COMPLETED|Overall Study||10
10235322|NCT01202110|11365605|FG001|COMPLETED|Overall Study||0
9801404|NCT00608842|10909674|FG002|STARTED|Overall Study||15
9801405|NCT00608842|10909675|FG003|STARTED|Overall Study||17
9801406|NCT00608842|10909672|FG000|COMPLETED|Overall Study||14
9801407|NCT00608842|10909673|FG001|COMPLETED|Overall Study||14
9801408|NCT00608842|10909674|FG002|COMPLETED|Overall Study||13
9801409|NCT00608842|10909675|FG003|COMPLETED|Overall Study||16
9801410|NCT00608842|10909672|FG000|NOT COMPLETED|Overall Study||1
9801411|NCT00608842|10909673|FG001|NOT COMPLETED|Overall Study||1
9801412|NCT00608842|10909674|FG002|NOT COMPLETED|Overall Study||2
9801413|NCT00608842|10909675|FG003|NOT COMPLETED|Overall Study||1
9801414|NCT00608868|10909685|FG000|STARTED|Overall Study||156
9801415|NCT00608868|10909685|FG000|Enrolled|Overall Study||156
9801416|NCT00608868|10909685|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
9801417|NCT00608868|10909685|FG000|Treatment Completed|Overall Study||141
9801418|NCT00608868|10909685|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
9801419|NCT00608868|10909685|FG000|Per Protocol (PP) Population|Overall Study||121
9801420|NCT00608868|10909685|FG000|COMPLETED|Overall Study||141
9801421|NCT00608868|10909685|FG000|NOT COMPLETED|Overall Study||15
10235323|NCT01202110|11365604|FG000|NOT COMPLETED|Overall Study||0
10235324|NCT01202110|11365605|FG001|NOT COMPLETED|Overall Study||0
9801422|NCT00608881|10909691|FG000|STARTED|Overall Study||303
9801423|NCT00608881|10909692|FG001|STARTED|Overall Study||306
10235325|NCT01206439|11365609|FG000|STARTED|Overall Study||2
10235326|NCT01206439|11365609|FG000|COMPLETED|Overall Study||1
10235327|NCT01206439|11365609|FG000|NOT COMPLETED|Overall Study||1
9801424|NCT00608881|10909691|FG000|COMPLETED|Overall Study||224
9801425|NCT00608881|10909692|FG001|COMPLETED|Overall Study||240
9801426|NCT00608881|10909691|FG000|NOT COMPLETED|Overall Study||79
9801427|NCT00608881|10909692|FG001|NOT COMPLETED|Overall Study||66
9801428|NCT00608894|10909700|FG000|STARTED|Overall Study||7
9801429|NCT00608894|10909701|FG001|STARTED|Overall Study||6
9801430|NCT00608894|10909700|FG000|COMPLETED|Overall Study||7
9801431|NCT00608894|10909701|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
9801432|NCT00608894|10909700|FG000|NOT COMPLETED|Overall Study||0
9801433|NCT00608894|10909701|FG001|NOT COMPLETED|Overall Study||2
9801434|NCT00608907|10909712|FG000|STARTED|Overall Study||30
9801435|NCT00608907|10909713|FG001|STARTED|Overall Study||13
9801436|NCT00608907|10909714|FG002|STARTED|Overall Study||18
9801437|NCT00608907|10909712|FG000|COMPLETED|Overall Study||18
9801438|NCT00608907|10909713|FG001|COMPLETED|Overall Study||13
9801439|NCT00608907|10909714|FG002|COMPLETED|Overall Study||17
9801440|NCT00608907|10909712|FG000|NOT COMPLETED|Overall Study||12
9801441|NCT00608907|10909713|FG001|NOT COMPLETED|Overall Study||0
9801442|NCT00608907|10909714|FG002|NOT COMPLETED|Overall Study||1
9801443|NCT00608959|10909724|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
9801444|NCT00608959|10909724|FG000|COMPLETED|Part 1||24
9801445|NCT00608959|10909724|FG000|NOT COMPLETED|Part 1||1
9801446|NCT00608959|10909724|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
9801447|NCT00608959|10909724|FG000|COMPLETED|Part 2||25
9801448|NCT00608959|10909724|FG000|NOT COMPLETED|Part 2||0
9801449|NCT00608985|10909738|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177
9801450|NCT00608985|10909739|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186
9801451|NCT00608985|10909740|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176
9801452|NCT00608985|10909741|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168
9801453|NCT00608985|10909738|FG000|Completed Double-blind Treatment|Overall Study||163
9801454|NCT00608985|10909739|FG001|Completed Double-blind Treatment|Overall Study||174
9801455|NCT00608985|10909740|FG002|Completed Double-blind Treatment|Overall Study||171
9801456|NCT00608985|10909741|FG003|Completed Double-blind Treatment|Overall Study||161
9801457|NCT00608985|10909738|FG000|COMPLETED|Overall Study|Completed follow-up|161
9801458|NCT00608985|10909739|FG001|COMPLETED|Overall Study|Completed follow-up|173
9801459|NCT00608985|10909740|FG002|COMPLETED|Overall Study|Completed follow-up|170
9801460|NCT00608985|10909741|FG003|COMPLETED|Overall Study|Completed follow-up|159
9801461|NCT00608985|10909738|FG000|NOT COMPLETED|Overall Study||16
9801462|NCT00608985|10909739|FG001|NOT COMPLETED|Overall Study||13
9801463|NCT00608985|10909740|FG002|NOT COMPLETED|Overall Study||6
9801464|NCT00608985|10909741|FG003|NOT COMPLETED|Overall Study||9
9801465|NCT00609128|10909751|FG000|STARTED|Overall Study||21
9801466|NCT00609128|10909751|FG000|COMPLETED|Overall Study||21
9801467|NCT00609128|10909751|FG000|NOT COMPLETED|Overall Study||0
9801468|NCT00609167|10909758|FG000|STARTED|Overall Study||33
9801469|NCT00609167|10909759|FG001|STARTED|Overall Study||30
9801470|NCT00609167|10909758|FG000|COMPLETED|Overall Study||25
9801471|NCT00609167|10909759|FG001|COMPLETED|Overall Study||23
9801472|NCT00609167|10909758|FG000|NOT COMPLETED|Overall Study||8
9801473|NCT00609167|10909759|FG001|NOT COMPLETED|Overall Study||7
9801474|NCT00609245|10909765|FG000|STARTED|Overall Study||13
9801475|NCT00609245|10909765|FG000|COMPLETED|Overall Study||12
9801476|NCT00609245|10909765|FG000|NOT COMPLETED|Overall Study||1
9801477|NCT00609271|10909773|FG000|STARTED|Overall Study||75
9801478|NCT00609271|10909774|FG001|STARTED|Overall Study||73
9801479|NCT00609271|10909773|FG000|COMPLETED|Overall Study||59
9801480|NCT00609271|10909774|FG001|COMPLETED|Overall Study||60
9801481|NCT00609271|10909773|FG000|NOT COMPLETED|Overall Study||16
10015841|NCT01807520|11138794|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
10015842|NCT01807520|11138788|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0
10015843|NCT01807520|11138789|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0
10015844|NCT01807520|11138790|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2
9801482|NCT00609271|10909774|FG001|NOT COMPLETED|Overall Study||13
9801483|NCT00609336|10909780|FG000|STARTED|Overall Study||35
9801484|NCT00609336|10909780|FG000|Surgery|Overall Study||22
9801485|NCT00609336|10909780|FG000|COMPLETED|Overall Study||22
9801486|NCT00609336|10909780|FG000|NOT COMPLETED|Overall Study||13
9801487|NCT00609362|10909787|FG000|STARTED|Overall Study||29
9801488|NCT00609362|10909788|FG001|STARTED|Overall Study||28
9801489|NCT00609362|10909787|FG000|COMPLETED|Overall Study||26
9801490|NCT00609362|10909788|FG001|COMPLETED|Overall Study||27
9801491|NCT00609362|10909787|FG000|NOT COMPLETED|Overall Study||3
9801492|NCT00609362|10909788|FG001|NOT COMPLETED|Overall Study||1
9801493|NCT00609466|10909797|FG000|STARTED|Overall Study||96
9801494|NCT00609466|10909798|FG001|STARTED|Overall Study||96
9801495|NCT00609466|10909799|FG002|STARTED|Overall Study||99
9801496|NCT00609466|10909797|FG000|COMPLETED|Overall Study||94
9801497|NCT00609466|10909798|FG001|COMPLETED|Overall Study||90
9801498|NCT00609466|10909799|FG002|COMPLETED|Overall Study||95
9801499|NCT00609466|10909797|FG000|NOT COMPLETED|Overall Study||2
9801500|NCT00609466|10909798|FG001|NOT COMPLETED|Overall Study||6
9801501|NCT00609466|10909799|FG002|NOT COMPLETED|Overall Study||4
9801502|NCT00609492|10909810|FG000|STARTED|Overall Study||44
9801503|NCT00609492|10909811|FG001|STARTED|Overall Study||72
9801504|NCT00609492|10909812|FG002|STARTED|Overall Study||129
9801505|NCT00609492|10909810|FG000|COMPLETED|Overall Study||43
9801506|NCT00609492|10909811|FG001|COMPLETED|Overall Study||69
9801507|NCT00609492|10909812|FG002|COMPLETED|Overall Study||122
9801508|NCT00609492|10909810|FG000|NOT COMPLETED|Overall Study||1
9801509|NCT00609492|10909811|FG001|NOT COMPLETED|Overall Study||3
9801510|NCT00609492|10909812|FG002|NOT COMPLETED|Overall Study||7
9801511|NCT00609518|10909824|FG000|STARTED|Overall Study||54
9801512|NCT00609518|10909825|FG001|STARTED|Overall Study||57
9801513|NCT00609518|10909824|FG000|Completed 6 Treatment Cycles|Overall Study||19
9801514|NCT00609518|10909825|FG001|Completed 6 Treatment Cycles|Overall Study||22
9801515|NCT00609518|10909824|FG000|COMPLETED|Overall Study||11
9801516|NCT00609518|10909825|FG001|COMPLETED|Overall Study||17
9801517|NCT00609518|10909824|FG000|NOT COMPLETED|Overall Study||43
9801518|NCT00609518|10909825|FG001|NOT COMPLETED|Overall Study||40
9801519|NCT00609609|10909833|FG000|STARTED|Overall Study||30
9801520|NCT00609609|10909834|FG001|STARTED|Overall Study||51
9801521|NCT00609609|10909833|FG000|COMPLETED|Overall Study||24
9801522|NCT00609609|10909834|FG001|COMPLETED|Overall Study||49
9801523|NCT00609609|10909833|FG000|NOT COMPLETED|Overall Study||6
9801524|NCT00609609|10909834|FG001|NOT COMPLETED|Overall Study||2
9801525|NCT00609622|10909842|FG000|STARTED|Overall Study||96
9801526|NCT00609622|10909843|FG001|STARTED|Overall Study||95
9801527|NCT00609622|10909842|FG000|COMPLETED|Overall Study||0
9801528|NCT00609622|10909843|FG001|COMPLETED|Overall Study||0
9801529|NCT00609622|10909842|FG000|NOT COMPLETED|Overall Study||96
9801530|NCT00609622|10909843|FG001|NOT COMPLETED|Overall Study||95
9801531|NCT00609674|10909851|FG000|STARTED|Overall Study||155
9801532|NCT00609674|10909852|FG001|STARTED|Overall Study||160
9801533|NCT00609674|10909851|FG000|COMPLETED|Overall Study||148
9801534|NCT00609674|10909852|FG001|COMPLETED|Overall Study||153
9801535|NCT00609674|10909851|FG000|NOT COMPLETED|Overall Study||7
9801536|NCT00609674|10909852|FG001|NOT COMPLETED|Overall Study||7
9801537|NCT00609739|10909858|FG000|STARTED|Overall Study||1
9801538|NCT00609739|10909858|FG000|COMPLETED|Overall Study||1
9801539|NCT00609739|10909858|FG000|NOT COMPLETED|Overall Study||0
9801540|NCT00609804|10909864|FG000|STARTED|Overall Study||25
9801541|NCT00609804|10909865|FG001|STARTED|Overall Study||28
9801542|NCT00609804|10909864|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
9801543|NCT00609804|10909865|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
9801544|NCT00609804|10909864|FG000|NOT COMPLETED|Overall Study||25
9801545|NCT00609804|10909865|FG001|NOT COMPLETED|Overall Study||28
9801546|NCT00609869|10909874|FG000|STARTED|Overall Study||29
9801547|NCT00609869|10909874|FG000|COMPLETED|Overall Study||18
9801548|NCT00609869|10909874|FG000|NOT COMPLETED|Overall Study||11
9801549|NCT00609947|10909878|FG000|STARTED|Overall Study||241
9801550|NCT00609947|10909878|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240
9801551|NCT00609947|10909878|FG000|NOT COMPLETED|Overall Study||1
9801552|NCT00609973|10909885|FG000|STARTED|Overall Study||17
9801553|NCT00609973|10909886|FG001|STARTED|Overall Study||16
9801554|NCT00609973|10909885|FG000|COMPLETED|Overall Study||9
9801555|NCT00609973|10909886|FG001|COMPLETED|Overall Study||10
9801556|NCT00609973|10909885|FG000|NOT COMPLETED|Overall Study||8
9801557|NCT00609973|10909886|FG001|NOT COMPLETED|Overall Study||6
9801558|NCT00609986|10909894|FG000|STARTED|Overall Study||52
9801559|NCT00609986|10909895|FG001|STARTED|Overall Study||52
9801560|NCT00609986|10909894|FG000|Received Transplant|Overall Study||44
9801561|NCT00609986|10909895|FG001|Received Transplant|Overall Study||49
9801562|NCT00609986|10909894|FG000|COMPLETED|Overall Study||44
9801563|NCT00609986|10909895|FG001|COMPLETED|Overall Study||49
9801564|NCT00609986|10909894|FG000|NOT COMPLETED|Overall Study||8
9801565|NCT00609986|10909895|FG001|NOT COMPLETED|Overall Study||3
9801566|NCT00610116|10909901|FG000|STARTED|Overall Study||305
9801567|NCT00610116|10909901|FG000|COMPLETED|Overall Study|Number of analyzable patients|292
9801568|NCT00610116|10909901|FG000|NOT COMPLETED|Overall Study||13
9801569|NCT00610129|10909905|FG000|STARTED|Overall Study||28
9801570|NCT00610129|10909905|FG000|COMPLETED|Overall Study||25
9801571|NCT00610129|10909905|FG000|NOT COMPLETED|Overall Study||3
9801572|NCT00610155|10909909|FG000|STARTED|Period 1||4
9801573|NCT00610155|10909910|FG001|STARTED|Period 1||3
9801574|NCT00610155|10909911|FG002|STARTED|Period 1||4
9801575|NCT00610155|10909912|FG003|STARTED|Period 1||3
9801576|NCT00610155|10909913|FG004|STARTED|Period 1||3
9801577|NCT00610155|10909914|FG005|STARTED|Period 1||1
9801578|NCT00610155|10909909|FG000|COMPLETED|Period 1||4
9801579|NCT00610155|10909910|FG001|COMPLETED|Period 1||3
9801580|NCT00610155|10909911|FG002|COMPLETED|Period 1||3
9801581|NCT00610155|10909912|FG003|COMPLETED|Period 1||3
9801582|NCT00610155|10909913|FG004|COMPLETED|Period 1||3
9801583|NCT00610155|10909914|FG005|COMPLETED|Period 1||1
9801584|NCT00610155|10909909|FG000|NOT COMPLETED|Period 1||0
9801585|NCT00610155|10909910|FG001|NOT COMPLETED|Period 1||0
9801586|NCT00610155|10909911|FG002|NOT COMPLETED|Period 1||1
9801587|NCT00610155|10909912|FG003|NOT COMPLETED|Period 1||0
9801588|NCT00610155|10909913|FG004|NOT COMPLETED|Period 1||0
9801589|NCT00610155|10909914|FG005|NOT COMPLETED|Period 1||0
9801590|NCT00610155|10909909|FG000|STARTED|Washout Period 1 (7 Days)||4
9801591|NCT00610155|10909910|FG001|STARTED|Washout Period 1 (7 Days)||3
9801592|NCT00610155|10909911|FG002|STARTED|Washout Period 1 (7 Days)||3
9801593|NCT00610155|10909912|FG003|STARTED|Washout Period 1 (7 Days)||3
9801594|NCT00610155|10909913|FG004|STARTED|Washout Period 1 (7 Days)||3
9801595|NCT00610155|10909914|FG005|STARTED|Washout Period 1 (7 Days)||1
9801596|NCT00610155|10909909|FG000|COMPLETED|Washout Period 1 (7 Days)||4
9801597|NCT00610155|10909910|FG001|COMPLETED|Washout Period 1 (7 Days)||3
9801598|NCT00610155|10909911|FG002|COMPLETED|Washout Period 1 (7 Days)||3
9801599|NCT00610155|10909912|FG003|COMPLETED|Washout Period 1 (7 Days)||3
9801600|NCT00610155|10909913|FG004|COMPLETED|Washout Period 1 (7 Days)||3
9801601|NCT00610155|10909914|FG005|COMPLETED|Washout Period 1 (7 Days)||1
9801602|NCT00610155|10909909|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9801603|NCT00610155|10909910|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9801604|NCT00610155|10909911|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9801605|NCT00610155|10909912|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
9801606|NCT00610155|10909913|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
9801607|NCT00610155|10909914|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
9801608|NCT00610155|10909909|FG000|STARTED|Period 2||4
9801609|NCT00610155|10909910|FG001|STARTED|Period 2||3
9801610|NCT00610155|10909911|FG002|STARTED|Period 2||3
9801611|NCT00610155|10909912|FG003|STARTED|Period 2||3
9801612|NCT00610155|10909913|FG004|STARTED|Period 2||3
9801613|NCT00610155|10909914|FG005|STARTED|Period 2||1
9801614|NCT00610155|10909909|FG000|COMPLETED|Period 2||4
9801615|NCT00610155|10909910|FG001|COMPLETED|Period 2||3
9801616|NCT00610155|10909911|FG002|COMPLETED|Period 2||3
9801617|NCT00610155|10909912|FG003|COMPLETED|Period 2||3
9801618|NCT00610155|10909913|FG004|COMPLETED|Period 2||3
9801619|NCT00610155|10909914|FG005|COMPLETED|Period 2||1
9801620|NCT00610155|10909909|FG000|NOT COMPLETED|Period 2||0
9801621|NCT00610155|10909910|FG001|NOT COMPLETED|Period 2||0
9801622|NCT00610155|10909911|FG002|NOT COMPLETED|Period 2||0
9801623|NCT00610155|10909912|FG003|NOT COMPLETED|Period 2||0
9801624|NCT00610155|10909913|FG004|NOT COMPLETED|Period 2||0
9801625|NCT00610155|10909914|FG005|NOT COMPLETED|Period 2||0
9801626|NCT00610155|10909909|FG000|STARTED|Washout Period 2 (7 Days)||4
9801627|NCT00610155|10909910|FG001|STARTED|Washout Period 2 (7 Days)||3
9801628|NCT00610155|10909911|FG002|STARTED|Washout Period 2 (7 Days)||3
9801629|NCT00610155|10909912|FG003|STARTED|Washout Period 2 (7 Days)||3
9801630|NCT00610155|10909913|FG004|STARTED|Washout Period 2 (7 Days)||3
10015845|NCT01807520|11138791|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0
10015846|NCT01807520|11138792|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0
10015847|NCT01807520|11138793|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77
9801631|NCT00610155|10909914|FG005|STARTED|Washout Period 2 (7 Days)||1
9801632|NCT00610155|10909909|FG000|COMPLETED|Washout Period 2 (7 Days)||4
9801633|NCT00610155|10909910|FG001|COMPLETED|Washout Period 2 (7 Days)||3
9801634|NCT00610155|10909911|FG002|COMPLETED|Washout Period 2 (7 Days)||3
9801635|NCT00610155|10909912|FG003|COMPLETED|Washout Period 2 (7 Days)||3
9801636|NCT00610155|10909913|FG004|COMPLETED|Washout Period 2 (7 Days)||3
9801637|NCT00610155|10909914|FG005|COMPLETED|Washout Period 2 (7 Days)||1
9801638|NCT00610155|10909909|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9801639|NCT00610155|10909910|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9801640|NCT00610155|10909911|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9801641|NCT00610155|10909912|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9801642|NCT00610155|10909913|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
9801643|NCT00610155|10909914|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
9801644|NCT00610155|10909909|FG000|STARTED|Period 3||4
9801645|NCT00610155|10909910|FG001|STARTED|Period 3||3
9801646|NCT00610155|10909911|FG002|STARTED|Period 3||3
9801647|NCT00610155|10909912|FG003|STARTED|Period 3||3
9801648|NCT00610155|10909913|FG004|STARTED|Period 3||3
9801649|NCT00610155|10909914|FG005|STARTED|Period 3||1
9801650|NCT00610155|10909909|FG000|COMPLETED|Period 3||3
9801651|NCT00610155|10909910|FG001|COMPLETED|Period 3||3
9801652|NCT00610155|10909911|FG002|COMPLETED|Period 3||3
9801653|NCT00610155|10909912|FG003|COMPLETED|Period 3||3
9801654|NCT00610155|10909913|FG004|COMPLETED|Period 3||3
9801655|NCT00610155|10909914|FG005|COMPLETED|Period 3||1
9801656|NCT00610155|10909909|FG000|NOT COMPLETED|Period 3||1
9801657|NCT00610155|10909910|FG001|NOT COMPLETED|Period 3||0
9801658|NCT00610155|10909911|FG002|NOT COMPLETED|Period 3||0
9801659|NCT00610155|10909912|FG003|NOT COMPLETED|Period 3||0
9801660|NCT00610155|10909913|FG004|NOT COMPLETED|Period 3||0
9801661|NCT00610155|10909914|FG005|NOT COMPLETED|Period 3||0
9801662|NCT00610168|10909924|FG000|STARTED|Overall Study||75
9801663|NCT00610168|10909925|FG001|STARTED|Overall Study||7
9801664|NCT00610168|10909924|FG000|COMPLETED|Overall Study||73
9801665|NCT00610168|10909925|FG001|COMPLETED|Overall Study||7
9801666|NCT00610168|10909924|FG000|NOT COMPLETED|Overall Study||2
9801667|NCT00610168|10909925|FG001|NOT COMPLETED|Overall Study||0
9801668|NCT00610207|10909931|FG000|STARTED|Overall Study||21
9801669|NCT00610207|10909931|FG000|COMPLETED|Overall Study||18
9801670|NCT00610207|10909931|FG000|NOT COMPLETED|Overall Study||3
9801671|NCT00610311|10909935|FG000|STARTED|Overall Study||3
9801672|NCT00610311|10909935|FG000|COMPLETED|Overall Study||3
9801673|NCT00610311|10909935|FG000|NOT COMPLETED|Overall Study||0
10015848|NCT01807520|11138794|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75
9801674|NCT00610363|10909941|FG000|STARTED|Overall Study||42
9801675|NCT00610363|10909942|FG001|STARTED|Overall Study||41
9801676|NCT00610363|10909941|FG000|COMPLETED|Overall Study||31
9801677|NCT00610363|10909942|FG001|COMPLETED|Overall Study||38
9801678|NCT00610363|10909941|FG000|NOT COMPLETED|Overall Study||11
9801679|NCT00610363|10909942|FG001|NOT COMPLETED|Overall Study||3
9801680|NCT00610428|10909952|FG000|STARTED|Overall Study||24
9801681|NCT00610428|10909953|FG001|STARTED|Overall Study||24
9801682|NCT00610428|10909954|FG002|STARTED|Overall Study||27
9801683|NCT00610428|10909952|FG000|COMPLETED|Overall Study||24
9801684|NCT00610428|10909953|FG001|COMPLETED|Overall Study||23
9801685|NCT00610428|10909954|FG002|COMPLETED|Overall Study||25
9801686|NCT00610428|10909952|FG000|NOT COMPLETED|Overall Study||0
9801687|NCT00610428|10909953|FG001|NOT COMPLETED|Overall Study||1
9801688|NCT00610428|10909954|FG002|NOT COMPLETED|Overall Study||2
9801689|NCT00610441|10909966|FG000|STARTED|Treatment Period 1 - 3 Weeks||15
9801690|NCT00610441|10909967|FG001|STARTED|Treatment Period 1 - 3 Weeks||16
9801691|NCT00610441|10909968|FG002|STARTED|Treatment Period 1 - 3 Weeks||18
9801692|NCT00610441|10909969|FG003|STARTED|Treatment Period 1 - 3 Weeks||18
9801693|NCT00610441|10909966|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12
9801694|NCT00610441|10909967|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14
9801695|NCT00610441|10909968|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11
9801696|NCT00610441|10909969|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16
9801697|NCT00610441|10909966|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
9801698|NCT00610441|10909967|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
9801699|NCT00610441|10909968|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
9801700|NCT00610441|10909969|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
9801701|NCT00610441|10909966|FG000|STARTED|Placebo Washout Period - 2 Weeks||12
9801702|NCT00610441|10909967|FG001|STARTED|Placebo Washout Period - 2 Weeks||14
9801703|NCT00610441|10909968|FG002|STARTED|Placebo Washout Period - 2 Weeks||11
9801704|NCT00610441|10909969|FG003|STARTED|Placebo Washout Period - 2 Weeks||16
9801705|NCT00610441|10909966|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12
9801706|NCT00610441|10909967|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13
9801707|NCT00610441|10909968|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9
9801708|NCT00610441|10909969|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16
9801709|NCT00610441|10909966|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
9801710|NCT00610441|10909967|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
9801711|NCT00610441|10909968|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
9801712|NCT00610441|10909969|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
9801713|NCT00610441|10909966|FG000|STARTED|Treatment Period 2 - 3 Weeks||12
9801714|NCT00610441|10909967|FG001|STARTED|Treatment Period 2 - 3 Weeks||13
9801715|NCT00610441|10909968|FG002|STARTED|Treatment Period 2 - 3 Weeks||9
9801716|NCT00610441|10909969|FG003|STARTED|Treatment Period 2 - 3 Weeks||16
9801717|NCT00610441|10909966|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10
9801718|NCT00610441|10909967|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12
9801719|NCT00610441|10909968|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9
9801720|NCT00610441|10909969|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14
9801721|NCT00610441|10909966|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
9801722|NCT00610441|10909967|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
9801723|NCT00610441|10909968|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
9801724|NCT00610441|10909969|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
9801725|NCT00610480|10909983|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
9801726|NCT00610480|10909984|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
9801727|NCT00610480|10909983|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
9801728|NCT00610480|10909984|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
9801729|NCT00610480|10909983|FG000|NOT COMPLETED|Overall Study||0
9801730|NCT00610480|10909984|FG001|NOT COMPLETED|Overall Study||0
9801731|NCT00610649|10910001|FG000|STARTED|Overall Study||4
9801732|NCT00610649|10910002|FG001|STARTED|Overall Study||2
9801733|NCT00610649|10910003|FG002|STARTED|Overall Study||4
9801734|NCT00610649|10910004|FG003|STARTED|Overall Study||2
9801735|NCT00610649|10910005|FG004|STARTED|Overall Study||4
9801736|NCT00610649|10910006|FG005|STARTED|Overall Study||2
9801737|NCT00610649|10910007|FG006|STARTED|Overall Study||4
9801738|NCT00610649|10910008|FG007|STARTED|Overall Study||2
9801739|NCT00610649|10910009|FG008|STARTED|Overall Study||10
9801740|NCT00610649|10910010|FG009|STARTED|Overall Study||10
9801741|NCT00610649|10910011|FG010|STARTED|Overall Study||10
9801742|NCT00610649|10910001|FG000|COMPLETED|Overall Study||3
9801743|NCT00610649|10910002|FG001|COMPLETED|Overall Study||1
9801744|NCT00610649|10910003|FG002|COMPLETED|Overall Study||4
9801745|NCT00610649|10910004|FG003|COMPLETED|Overall Study||2
9801746|NCT00610649|10910005|FG004|COMPLETED|Overall Study||4
9801747|NCT00610649|10910006|FG005|COMPLETED|Overall Study||2
9801748|NCT00610649|10910007|FG006|COMPLETED|Overall Study||4
9801749|NCT00610649|10910008|FG007|COMPLETED|Overall Study||2
9801750|NCT00610649|10910009|FG008|COMPLETED|Overall Study||10
9801751|NCT00610649|10910010|FG009|COMPLETED|Overall Study||9
9801752|NCT00610649|10910011|FG010|COMPLETED|Overall Study||9
9801753|NCT00610649|10910001|FG000|NOT COMPLETED|Overall Study||1
9801754|NCT00610649|10910002|FG001|NOT COMPLETED|Overall Study||1
9801755|NCT00610649|10910003|FG002|NOT COMPLETED|Overall Study||0
9801756|NCT00610649|10910004|FG003|NOT COMPLETED|Overall Study||0
9801757|NCT00610649|10910005|FG004|NOT COMPLETED|Overall Study||0
9801758|NCT00610649|10910006|FG005|NOT COMPLETED|Overall Study||0
9801759|NCT00610649|10910007|FG006|NOT COMPLETED|Overall Study||0
9801760|NCT00610649|10910008|FG007|NOT COMPLETED|Overall Study||0
9801761|NCT00610649|10910009|FG008|NOT COMPLETED|Overall Study||0
9801762|NCT00610649|10910010|FG009|NOT COMPLETED|Overall Study||1
9801763|NCT00610649|10910011|FG010|NOT COMPLETED|Overall Study||1
9801764|NCT00610675|10910035|FG000|STARTED|Overall Study||346
9801765|NCT00610675|10910035|FG000|Treated|Overall Study||342
9801766|NCT00610675|10910035|FG000|COMPLETED|Overall Study||126
9801767|NCT00610675|10910035|FG000|NOT COMPLETED|Overall Study||220
9801768|NCT00610688|10910042|FG000|STARTED|Overall Study||64
9801769|NCT00610688|10910043|FG001|STARTED|Overall Study||65
9801770|NCT00610688|10910044|FG002|STARTED|Overall Study||63
9801771|NCT00610688|10910042|FG000|COMPLETED|Overall Study||55
9801772|NCT00610688|10910043|FG001|COMPLETED|Overall Study||52
9801773|NCT00610688|10910044|FG002|COMPLETED|Overall Study||55
9801774|NCT00610688|10910042|FG000|NOT COMPLETED|Overall Study||9
9801775|NCT00610688|10910043|FG001|NOT COMPLETED|Overall Study||13
9801776|NCT00610688|10910044|FG002|NOT COMPLETED|Overall Study||8
9801777|NCT00610701|10910054|FG000|STARTED|Overall Study||15
9801778|NCT00610701|10910055|FG001|STARTED|Overall Study||20
9801779|NCT00610701|10910054|FG000|COMPLETED|Overall Study||5
9801780|NCT00610701|10910055|FG001|COMPLETED|Overall Study||9
9801781|NCT00610701|10910054|FG000|NOT COMPLETED|Overall Study||10
9801782|NCT00610701|10910055|FG001|NOT COMPLETED|Overall Study||11
9801783|NCT00610714|10910063|FG000|STARTED|Overall Study||105
9801784|NCT00610714|10910064|FG001|STARTED|Overall Study||106
9801785|NCT00610714|10910063|FG000|COMPLETED|Overall Study||79
9801786|NCT00610714|10910064|FG001|COMPLETED|Overall Study||82
9801787|NCT00610714|10910063|FG000|NOT COMPLETED|Overall Study||26
9801788|NCT00610714|10910064|FG001|NOT COMPLETED|Overall Study||24
9801789|NCT00610727|10910076|FG000|STARTED|Overall Study||14
9801790|NCT00610727|10910077|FG001|STARTED|Overall Study||8
9801791|NCT00610727|10910078|FG002|STARTED|Overall Study||8
9801792|NCT00610727|10910079|FG003|STARTED|Overall Study||8
9801793|NCT00610727|10910080|FG004|STARTED|Overall Study||8
9801794|NCT00610727|10910081|FG005|STARTED|Overall Study||8
9801795|NCT00610727|10910076|FG000|COMPLETED|Overall Study||14
9801796|NCT00610727|10910077|FG001|COMPLETED|Overall Study||8
9801797|NCT00610727|10910078|FG002|COMPLETED|Overall Study||8
9801798|NCT00610727|10910079|FG003|COMPLETED|Overall Study||8
9801799|NCT00610727|10910080|FG004|COMPLETED|Overall Study||8
9801800|NCT00610727|10910081|FG005|COMPLETED|Overall Study||8
9801801|NCT00610727|10910076|FG000|NOT COMPLETED|Overall Study||0
9801802|NCT00610727|10910077|FG001|NOT COMPLETED|Overall Study||0
9801803|NCT00610727|10910078|FG002|NOT COMPLETED|Overall Study||0
9801804|NCT00610727|10910079|FG003|NOT COMPLETED|Overall Study||0
9801805|NCT00610727|10910080|FG004|NOT COMPLETED|Overall Study||0
9801806|NCT00610727|10910081|FG005|NOT COMPLETED|Overall Study||0
9801807|NCT00610740|10910099|FG000|STARTED|Overall Study||18
9801808|NCT00610740|10910099|FG000|COMPLETED|Overall Study||18
9801809|NCT00610740|10910099|FG000|NOT COMPLETED|Overall Study||0
9801810|NCT00610857|10910103|FG000|STARTED|Overall Study||37
9801811|NCT00610857|10910103|FG000|COMPLETED|Overall Study||35
9801812|NCT00610857|10910103|FG000|NOT COMPLETED|Overall Study||2
9801813|NCT00610883|10910107|FG000|STARTED|Overall Study||17
9801814|NCT00610883|10910107|FG000|COMPLETED|Overall Study||17
9801815|NCT00610883|10910107|FG000|NOT COMPLETED|Overall Study||0
9801816|NCT00610935|10910113|FG000|STARTED|Overall Study||25
9801817|NCT00610935|10910114|FG001|STARTED|Overall Study||57
9801818|NCT00610935|10910113|FG000|ITTI Population|Overall Study||25
9801819|NCT00610935|10910114|FG001|ITTI Population|Overall Study||55
9801820|NCT00610935|10910113|FG000|ITT Population|Overall Study||25
9801821|NCT00610935|10910114|FG001|ITT Population|Overall Study||57
9801822|NCT00610935|10910113|FG000|COMPLETED|Overall Study||24
9801823|NCT00610935|10910114|FG001|COMPLETED|Overall Study||54
9801824|NCT00610935|10910113|FG000|NOT COMPLETED|Overall Study||1
9801825|NCT00610935|10910114|FG001|NOT COMPLETED|Overall Study||3
9801826|NCT00610987|10910122|FG000|STARTED|Overall Study||75
9801827|NCT00610987|10910123|FG001|STARTED|Overall Study||71
9801828|NCT00610987|10910122|FG000|COMPLETED|Overall Study||75
9801829|NCT00610987|10910123|FG001|COMPLETED|Overall Study||71
9801830|NCT00610987|10910122|FG000|NOT COMPLETED|Overall Study||0
9801831|NCT00610987|10910123|FG001|NOT COMPLETED|Overall Study||0
9801832|NCT00611026|10910132|FG000|STARTED|Randomized to Double-blind Treatment||480
9801833|NCT00611026|10910133|FG001|STARTED|Randomized to Double-blind Treatment||974
9801834|NCT00611026|10910134|FG002|STARTED|Randomized to Double-blind Treatment||963
9801835|NCT00611026|10910132|FG000|COMPLETED|Randomized to Double-blind Treatment||478
9801836|NCT00611026|10910133|FG001|COMPLETED|Randomized to Double-blind Treatment||973
9801837|NCT00611026|10910134|FG002|COMPLETED|Randomized to Double-blind Treatment||960
9801838|NCT00611026|10910132|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2
9801839|NCT00611026|10910133|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
9801840|NCT00611026|10910134|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3
9801841|NCT00611026|10910132|FG000|STARTED|Double-blind Treatment Period||478
9801842|NCT00611026|10910133|FG001|STARTED|Double-blind Treatment Period||973
9801843|NCT00611026|10910134|FG002|STARTED|Double-blind Treatment Period||960
9801844|NCT00611026|10910132|FG000|COMPLETED|Double-blind Treatment Period||431
9801845|NCT00611026|10910133|FG001|COMPLETED|Double-blind Treatment Period||885
9801846|NCT00611026|10910134|FG002|COMPLETED|Double-blind Treatment Period||862
9801847|NCT00611026|10910132|FG000|NOT COMPLETED|Double-blind Treatment Period||47
9801848|NCT00611026|10910133|FG001|NOT COMPLETED|Double-blind Treatment Period||88
9801849|NCT00611026|10910134|FG002|NOT COMPLETED|Double-blind Treatment Period||98
9801850|NCT00611130|10910146|FG000|STARTED|Overall Study||92
9801851|NCT00611130|10910147|FG001|STARTED|Overall Study||94
9801852|NCT00611130|10910146|FG000|Completed 12 Week Treatment Phase|Overall Study||61
9801853|NCT00611130|10910147|FG001|Completed 12 Week Treatment Phase|Overall Study||64
9801854|NCT00611130|10910146|FG000|COMPLETED|Overall Study||43
9801855|NCT00611130|10910147|FG001|COMPLETED|Overall Study||47
9801856|NCT00611130|10910146|FG000|NOT COMPLETED|Overall Study||49
9801857|NCT00611130|10910147|FG001|NOT COMPLETED|Overall Study||47
9801858|NCT00611247|10910156|FG000|STARTED|Overall Study||5
9801859|NCT00611247|10910157|FG001|STARTED|Overall Study||31
9801860|NCT00611247|10910156|FG000|COMPLETED|Overall Study||3
9801861|NCT00611247|10910157|FG001|COMPLETED|Overall Study||10
9801862|NCT00611247|10910156|FG000|NOT COMPLETED|Overall Study||2
9801863|NCT00611247|10910157|FG001|NOT COMPLETED|Overall Study||21
9801864|NCT00611325|10910166|FG000|STARTED|Overall Study||28
9801865|NCT00611325|10910167|FG001|STARTED|Overall Study||28
9801866|NCT00611325|10910166|FG000|COMPLETED|Overall Study||28
9801867|NCT00611325|10910167|FG001|COMPLETED|Overall Study||28
9801868|NCT00611325|10910166|FG000|NOT COMPLETED|Overall Study||0
9801869|NCT00611325|10910167|FG001|NOT COMPLETED|Overall Study||0
9801870|NCT00611351|10910173|FG000|STARTED|Overall Study||5
9801871|NCT00611351|10910173|FG000|COMPLETED|Overall Study||3
9801872|NCT00611351|10910173|FG000|NOT COMPLETED|Overall Study||2
9801873|NCT00611403|10910179|FG000|STARTED|Treatment Phase||68
9801874|NCT00611403|10910180|FG001|STARTED|Treatment Phase||69
9801875|NCT00611403|10910179|FG000|COMPLETED|Treatment Phase||62
9801876|NCT00611403|10910180|FG001|COMPLETED|Treatment Phase||58
9801877|NCT00611403|10910179|FG000|NOT COMPLETED|Treatment Phase||6
9801878|NCT00611403|10910180|FG001|NOT COMPLETED|Treatment Phase||11
9801879|NCT00611403|10910179|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
9801880|NCT00611403|10910180|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
9801881|NCT00611403|10910179|FG000|COMPLETED|Post Treatment Extension Phase||22
9801882|NCT00611403|10910180|FG001|COMPLETED|Post Treatment Extension Phase||24
9801883|NCT00611403|10910179|FG000|NOT COMPLETED|Post Treatment Extension Phase||4
9801884|NCT00611403|10910180|FG001|NOT COMPLETED|Post Treatment Extension Phase||1
9801885|NCT00611442|10910188|FG000|STARTED|Overall Study||95
9801886|NCT00611442|10910189|FG001|STARTED|Overall Study||96
9801887|NCT00611442|10910188|FG000|COMPLETED|Overall Study||94
9801888|NCT00611442|10910189|FG001|COMPLETED|Overall Study||94
9801889|NCT00611442|10910188|FG000|NOT COMPLETED|Overall Study||1
9801890|NCT00611442|10910189|FG001|NOT COMPLETED|Overall Study||2
9801891|NCT00611455|10910197|FG000|STARTED|DB Treatment Period (24 Weeks)||134
9801892|NCT00611455|10910198|FG001|STARTED|DB Treatment Period (24 Weeks)||131
9801893|NCT00611455|10910199|FG002|STARTED|DB Treatment Period (24 Weeks)||0
9801894|NCT00611455|10910197|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121
9801895|NCT00611455|10910198|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117
9801896|NCT00611455|10910199|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
9801897|NCT00611455|10910197|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
9801898|NCT00611455|10910198|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
9801899|NCT00611455|10910199|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
9801900|NCT00611455|10910197|FG000|STARTED|OL Treatment Period (120 Weeks)||0
9801901|NCT00611455|10910198|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
9801902|NCT00611455|10910199|FG002|STARTED|OL Treatment Period (120 Weeks)||0
9801903|NCT00611455|10910197|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
9801904|NCT00611455|10910198|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52
9801905|NCT00611455|10910199|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
9801906|NCT00611455|10910197|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
9801907|NCT00611455|10910198|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
9801908|NCT00611455|10910199|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
9801909|NCT00611455|10910197|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
9801910|NCT00611455|10910198|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
9801911|NCT00611455|10910199|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
9801912|NCT00611455|10910197|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
9801913|NCT00611455|10910198|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
9801914|NCT00611455|10910199|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49
9801915|NCT00611455|10910197|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
9801916|NCT00611455|10910198|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
9801917|NCT00611455|10910199|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
9801918|NCT00611468|10910209|FG000|STARTED|Overall Study||3
9801919|NCT00611468|10910210|FG001|STARTED|Overall Study||7
9801920|NCT00611468|10910211|FG002|STARTED|Overall Study||6
9801921|NCT00611468|10910212|FG003|STARTED|Overall Study||13
9801922|NCT00611468|10910209|FG000|COMPLETED|Overall Study||3
9801923|NCT00611468|10910210|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
9801924|NCT00611468|10910211|FG002|COMPLETED|Overall Study||6
9801925|NCT00611468|10910212|FG003|COMPLETED|Overall Study||13
9801926|NCT00611468|10910209|FG000|NOT COMPLETED|Overall Study||0
9801927|NCT00611468|10910210|FG001|NOT COMPLETED|Overall Study||1
9801928|NCT00611468|10910211|FG002|NOT COMPLETED|Overall Study||0
9801929|NCT00611468|10910212|FG003|NOT COMPLETED|Overall Study||0
9801930|NCT00611533|10910216|FG000|STARTED|First Intervention (6 Weeks)||8
9801931|NCT00611533|10910217|FG001|STARTED|First Intervention (6 Weeks)||8
9801932|NCT00611533|10910216|FG000|COMPLETED|First Intervention (6 Weeks)||8
9801933|NCT00611533|10910217|FG001|COMPLETED|First Intervention (6 Weeks)||6
9801934|NCT00611533|10910216|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
9801935|NCT00611533|10910217|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2
9801936|NCT00611533|10910216|FG000|STARTED|Second Intervention (6 Weeks)||8
9801937|NCT00611533|10910217|FG001|STARTED|Second Intervention (6 Weeks)||6
9801938|NCT00611533|10910216|FG000|COMPLETED|Second Intervention (6 Weeks)||8
9801939|NCT00611533|10910217|FG001|COMPLETED|Second Intervention (6 Weeks)||4
9801940|NCT00611533|10910216|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9801941|NCT00611533|10910217|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2
9801942|NCT00611559|10910227|FG000|STARTED|Overall Study||111
9801943|NCT00611559|10910228|FG001|STARTED|Overall Study||115
9801944|NCT00611559|10910229|FG002|STARTED|Overall Study||57
9801945|NCT00611559|10910227|FG000|COMPLETED|Overall Study||110
9801946|NCT00611559|10910228|FG001|COMPLETED|Overall Study||114
9801947|NCT00611559|10910229|FG002|COMPLETED|Overall Study||56
9801948|NCT00611559|10910227|FG000|NOT COMPLETED|Overall Study||1
9801949|NCT00611559|10910228|FG001|NOT COMPLETED|Overall Study||1
9801950|NCT00611559|10910229|FG002|NOT COMPLETED|Overall Study||1
9801951|NCT00611624|10910237|FG000|STARTED|Overall Study||28
9801952|NCT00611624|10910237|FG000|COMPLETED|Overall Study||28
9801953|NCT00611624|10910237|FG000|NOT COMPLETED|Overall Study||0
9831262|NCT00767767|10941967|FG000|STARTED|Overall Study||21
9831263|NCT00767767|10941968|FG001|STARTED|Overall Study||20
9831264|NCT00767767|10941969|FG002|STARTED|Overall Study||20
9831265|NCT00767767|10941970|FG003|STARTED|Overall Study||3
9831266|NCT00767767|10941971|FG004|STARTED|Overall Study||3
10015849|NCT01807520|11138788|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10015850|NCT01807520|11138789|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10015851|NCT01807520|11138790|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10015852|NCT01807520|11138791|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10015853|NCT01807520|11138792|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10015854|NCT01807520|11138793|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
10015855|NCT01807520|11138794|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
10015856|NCT01807585|11138808|FG000|STARTED|Overall Study||20
10015857|NCT01807585|11138809|FG001|STARTED|Overall Study||108
10015858|NCT01807585|11138810|FG002|STARTED|Overall Study||114
10015859|NCT01807585|11138808|FG000|3 Mos|Overall Study||20
10015860|NCT01807585|11138809|FG001|3 Mos|Overall Study||108
10015861|NCT01807585|11138810|FG002|3 Mos|Overall Study||113
10015862|NCT01807585|11138808|FG000|COMPLETED|Overall Study||19
10015863|NCT01807585|11138809|FG001|COMPLETED|Overall Study||104
10015864|NCT01807585|11138810|FG002|COMPLETED|Overall Study||108
10015865|NCT01807585|11138808|FG000|NOT COMPLETED|Overall Study||1
10015866|NCT01807585|11138809|FG001|NOT COMPLETED|Overall Study||4
10015867|NCT01807585|11138810|FG002|NOT COMPLETED|Overall Study||6
10015868|NCT01807598|11138821|FG000|STARTED|Overall Study||10
10015869|NCT01807598|11138821|FG000|COMPLETED|Overall Study||4
10015870|NCT01807598|11138821|FG000|NOT COMPLETED|Overall Study||6
10015871|NCT01807624|11138825|FG000|STARTED|Overall Study||24
10015872|NCT01807624|11138825|FG000|COMPLETED|Overall Study||24
10015873|NCT01807624|11138825|FG000|NOT COMPLETED|Overall Study||0
10015874|NCT01807637|11138831|FG000|STARTED|Baseline||4
10015875|NCT01807637|11138832|FG001|STARTED|Baseline||2
10015876|NCT01807637|11138831|FG000|COMPLETED|Baseline||4
10015877|NCT01807637|11138832|FG001|COMPLETED|Baseline||2
10015878|NCT01807637|11138831|FG000|NOT COMPLETED|Baseline||0
10015879|NCT01807637|11138832|FG001|NOT COMPLETED|Baseline||0
10015880|NCT01807637|11138831|FG000|STARTED|One Week||4
10015881|NCT01807637|11138832|FG001|STARTED|One Week||2
10015882|NCT01807637|11138831|FG000|COMPLETED|One Week||4
9831267|NCT00767767|10941967|FG000|COMPLETED|Overall Study||21
9831268|NCT00767767|10941968|FG001|COMPLETED|Overall Study||20
9831269|NCT00767767|10941969|FG002|COMPLETED|Overall Study||20
9831270|NCT00767767|10941970|FG003|COMPLETED|Overall Study||3
9831271|NCT00767767|10941971|FG004|COMPLETED|Overall Study||3
9831272|NCT00767767|10941967|FG000|NOT COMPLETED|Overall Study||0
9831273|NCT00767767|10941968|FG001|NOT COMPLETED|Overall Study||0
9831274|NCT00767767|10941969|FG002|NOT COMPLETED|Overall Study||0
9831275|NCT00767767|10941970|FG003|NOT COMPLETED|Overall Study||0
9831276|NCT00767767|10941971|FG004|NOT COMPLETED|Overall Study||0
9831277|NCT00767806|10941985|FG000|STARTED|Overall Study||198
9831278|NCT00767806|10941986|FG001|STARTED|Overall Study||203
9831279|NCT00767806|10941985|FG000|COMPLETED|Overall Study||147
9831280|NCT00767806|10941986|FG001|COMPLETED|Overall Study||156
9831281|NCT00767806|10941985|FG000|NOT COMPLETED|Overall Study||51
9831282|NCT00767806|10941986|FG001|NOT COMPLETED|Overall Study||47
10015883|NCT01807637|11138832|FG001|COMPLETED|One Week||2
10015884|NCT01807637|11138831|FG000|NOT COMPLETED|One Week||0
10015885|NCT01807637|11138832|FG001|NOT COMPLETED|One Week||0
10015886|NCT01807637|11138831|FG000|STARTED|One Month||4
10015887|NCT01807637|11138832|FG001|STARTED|One Month||2
9831283|NCT00767819|10941995|FG000|STARTED|Overall Study||37
9831284|NCT00767819|10941996|FG001|STARTED|Overall Study||24
9831285|NCT00767819|10941997|FG002|STARTED|Overall Study||10
9831286|NCT00767819|10941995|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37
9831287|NCT00767819|10941996|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24
9831288|NCT00767819|10941997|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10
10015888|NCT01807637|11138831|FG000|COMPLETED|One Month||4
10015889|NCT01807637|11138832|FG001|COMPLETED|One Month||2
10015890|NCT01807637|11138831|FG000|NOT COMPLETED|One Month||0
10015891|NCT01807637|11138832|FG001|NOT COMPLETED|One Month||0
10015892|NCT01807650|11138840|FG000|STARTED|Overall Study||112
9801954|NCT00611715|10910244|FG000|STARTED|Overall Study||42
9801955|NCT00611715|10910245|FG001|STARTED|Overall Study||6
9801956|NCT00611715|10910244|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
9801957|NCT00611715|10910245|FG001|COMPLETED|Overall Study||0
9801958|NCT00611715|10910244|FG000|NOT COMPLETED|Overall Study||41
9801959|NCT00611715|10910245|FG001|NOT COMPLETED|Overall Study||6
9801960|NCT00611767|10910259|FG000|STARTED|Overall Study||49
9801961|NCT00611767|10910260|FG001|STARTED|Overall Study||24
9801962|NCT00611767|10910259|FG000|Thiopental Test Day|Overall Study||3
9801963|NCT00611767|10910260|FG001|Thiopental Test Day|Overall Study||1
9801964|NCT00611767|10910259|FG000|Placebo Test Day|Overall Study||6
9801965|NCT00611767|10910260|FG001|Placebo Test Day|Overall Study||1
9801966|NCT00611767|10910259|FG000|COMPLETED|Overall Study||40
9801967|NCT00611767|10910260|FG001|COMPLETED|Overall Study||22
9801968|NCT00611767|10910259|FG000|NOT COMPLETED|Overall Study||9
9801969|NCT00611767|10910260|FG001|NOT COMPLETED|Overall Study||2
9801970|NCT00611806|10910268|FG000|STARTED|Overall Study||94
9801971|NCT00611806|10910269|FG001|STARTED|Overall Study||46
9801972|NCT00611806|10910268|FG000|COMPLETED|Overall Study||78
9801973|NCT00611806|10910269|FG001|COMPLETED|Overall Study||43
9801974|NCT00611806|10910268|FG000|NOT COMPLETED|Overall Study||16
9801975|NCT00611806|10910269|FG001|NOT COMPLETED|Overall Study||3
9801976|NCT00611858|10910275|FG000|STARTED|Overall Study||13
9801977|NCT00611858|10910275|FG000|COMPLETED|Overall Study||9
10015893|NCT01807650|11138840|FG000|COMPLETED|Overall Study||92
10015894|NCT01807650|11138840|FG000|NOT COMPLETED|Overall Study||20
10015895|NCT01807871|11138883|FG000|STARTED|Overall Study||356
9801978|NCT00611858|10910275|FG000|NOT COMPLETED|Overall Study||4
9801979|NCT00611884|10910285|FG000|STARTED|Overall Study||61
9801980|NCT00611884|10910286|FG001|STARTED|Overall Study||60
9801981|NCT00611884|10910287|FG002|STARTED|Overall Study||62
9801982|NCT00611884|10910288|FG003|STARTED|Overall Study||62
9801983|NCT00611884|10910285|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
9801984|NCT00611884|10910286|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
9801985|NCT00611884|10910287|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
9801986|NCT00611884|10910288|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
9801987|NCT00611884|10910285|FG000|COMPLETED|Overall Study||52
9801988|NCT00611884|10910286|FG001|COMPLETED|Overall Study||51
9801989|NCT00611884|10910287|FG002|COMPLETED|Overall Study||58
9801990|NCT00611884|10910288|FG003|COMPLETED|Overall Study||56
9801991|NCT00611884|10910285|FG000|NOT COMPLETED|Overall Study||9
9801992|NCT00611884|10910286|FG001|NOT COMPLETED|Overall Study||9
9801993|NCT00611884|10910287|FG002|NOT COMPLETED|Overall Study||4
9801994|NCT00611884|10910288|FG003|NOT COMPLETED|Overall Study||6
9801995|NCT00611897|10910298|FG000|STARTED|Day 1: Initial Treatment||8
9801996|NCT00611897|10910299|FG001|STARTED|Day 1: Initial Treatment||8
9801997|NCT00611897|10910298|FG000|COMPLETED|Day 1: Initial Treatment||8
9801998|NCT00611897|10910299|FG001|COMPLETED|Day 1: Initial Treatment||8
9801999|NCT00611897|10910298|FG000|NOT COMPLETED|Day 1: Initial Treatment||0
9802000|NCT00611897|10910299|FG001|NOT COMPLETED|Day 1: Initial Treatment||0
9802001|NCT00611897|10910298|FG000|STARTED|Day 2: Crossover Treatment||8
9802002|NCT00611897|10910299|FG001|STARTED|Day 2: Crossover Treatment||8
9802003|NCT00611897|10910298|FG000|COMPLETED|Day 2: Crossover Treatment||8
9802004|NCT00611897|10910299|FG001|COMPLETED|Day 2: Crossover Treatment||8
9802005|NCT00611897|10910298|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0
9802006|NCT00611897|10910299|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0
9802007|NCT00611923|10910309|FG000|STARTED|Overall Study||12
9802008|NCT00611923|10910310|FG001|STARTED|Overall Study||13
9802009|NCT00611923|10910309|FG000|COMPLETED|Overall Study||10
9802010|NCT00611923|10910310|FG001|COMPLETED|Overall Study||11
9802011|NCT00611923|10910309|FG000|NOT COMPLETED|Overall Study||2
9802012|NCT00611923|10910310|FG001|NOT COMPLETED|Overall Study||2
9802013|NCT00611975|10910320|FG000|STARTED|Overall Study||45
9802014|NCT00611975|10910321|FG001|STARTED|Overall Study||38
9802015|NCT00611975|10910320|FG000|COMPLETED|Overall Study||40
9802016|NCT00611975|10910321|FG001|COMPLETED|Overall Study||30
9802017|NCT00611975|10910320|FG000|NOT COMPLETED|Overall Study||5
9802018|NCT00611975|10910321|FG001|NOT COMPLETED|Overall Study||8
10015896|NCT01807871|11138884|FG001|STARTED|Overall Study||345
10015897|NCT01807871|11138883|FG000|COMPLETED|Overall Study||178
10015898|NCT01807871|11138884|FG001|COMPLETED|Overall Study||127
9802019|NCT00612040|10910330|FG000|STARTED|Overall Study||60
9802020|NCT00612040|10910331|FG001|STARTED|Overall Study||59
9802021|NCT00612040|10910332|FG002|STARTED|Overall Study||59
9802022|NCT00612040|10910330|FG000|Exposed|Overall Study||60
9802023|NCT00612040|10910331|FG001|Exposed|Overall Study||59
9802024|NCT00612040|10910332|FG002|Exposed|Overall Study||59
9802025|NCT00612040|10910330|FG000|COMPLETED|Overall Study||55
9802026|NCT00612040|10910331|FG001|COMPLETED|Overall Study||52
9802027|NCT00612040|10910332|FG002|COMPLETED|Overall Study||52
9802028|NCT00612040|10910330|FG000|NOT COMPLETED|Overall Study||5
9802029|NCT00612040|10910331|FG001|NOT COMPLETED|Overall Study||7
9802030|NCT00612040|10910332|FG002|NOT COMPLETED|Overall Study||7
9802031|NCT00612066|10910340|FG000|STARTED|Overall Study||2
9802032|NCT00612066|10910340|FG000|COMPLETED|Overall Study||1
9802033|NCT00612066|10910340|FG000|NOT COMPLETED|Overall Study||1
9802034|NCT00612105|10910346|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125
10015899|NCT01807871|11138883|FG000|NOT COMPLETED|Overall Study||178
9802035|NCT00612105|10910347|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62
9802036|NCT00612105|10910346|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89
9802037|NCT00612105|10910347|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57
9802038|NCT00612105|10910346|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
9802039|NCT00612105|10910347|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
9802040|NCT00612105|10910346|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89
9802041|NCT00612105|10910347|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57
9802042|NCT00612105|10910346|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
9802043|NCT00612105|10910347|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
9802044|NCT00612105|10910346|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
9802045|NCT00612105|10910347|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
9802046|NCT00612105|10910346|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
9802047|NCT00612105|10910347|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
9802048|NCT00612105|10910346|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85
9802049|NCT00612105|10910347|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58
9802050|NCT00612105|10910346|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
9802051|NCT00612105|10910347|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
9802052|NCT00612222|10910353|FG000|STARTED|Overall Study||4
9802053|NCT00612222|10910353|FG000|COMPLETED|Overall Study||4
9802054|NCT00612222|10910353|FG000|NOT COMPLETED|Overall Study||0
9802055|NCT00612235|10910361|FG000|STARTED|Overall Study||20
9802056|NCT00612235|10910362|FG001|STARTED|Overall Study||20
9802057|NCT00612235|10910363|FG002|STARTED|Overall Study||20
9802058|NCT00612235|10910364|FG003|STARTED|Overall Study||20
9802059|NCT00612235|10910361|FG000|COMPLETED|Overall Study||20
9802060|NCT00612235|10910362|FG001|COMPLETED|Overall Study||20
9802061|NCT00612235|10910363|FG002|COMPLETED|Overall Study||20
9802062|NCT00612235|10910364|FG003|COMPLETED|Overall Study||20
9802063|NCT00612235|10910361|FG000|NOT COMPLETED|Overall Study||0
9802064|NCT00612235|10910362|FG001|NOT COMPLETED|Overall Study||0
9802065|NCT00612235|10910363|FG002|NOT COMPLETED|Overall Study||0
9802066|NCT00612235|10910364|FG003|NOT COMPLETED|Overall Study||0
9802067|NCT00612313|10910377|FG000|STARTED|Overall Study||69
9802068|NCT00612313|10910378|FG001|STARTED|Overall Study||75
9802069|NCT00612313|10910377|FG000|COMPLETED|Overall Study||52
9802070|NCT00612313|10910378|FG001|COMPLETED|Overall Study||62
9802071|NCT00612313|10910377|FG000|NOT COMPLETED|Overall Study||17
9802072|NCT00612313|10910378|FG001|NOT COMPLETED|Overall Study||13
9802073|NCT00612339|10910390|FG000|STARTED|Overall Study||41
9802074|NCT00612339|10910390|FG000|COMPLETED|Overall Study||41
9802075|NCT00612339|10910390|FG000|NOT COMPLETED|Overall Study||0
9802076|NCT00612352|10910396|FG000|STARTED|Overall Study||65
9802077|NCT00612352|10910397|FG001|STARTED|Overall Study||115
9802078|NCT00612352|10910396|FG000|40%mg & 100%mg|Overall Study||1
9802079|NCT00612352|10910397|FG001|40%mg & 100%mg|Overall Study||1
9802080|NCT00612352|10910396|FG000|Placebo & 100%mg|Overall Study||1
9802081|NCT00612352|10910397|FG001|Placebo & 100%mg|Overall Study||0
9802082|NCT00612352|10910396|FG000|100%mg|Overall Study||2
9802083|NCT00612352|10910397|FG001|100%mg|Overall Study||1
9802084|NCT00612352|10910396|FG000|40%mg|Overall Study||1
9802085|NCT00612352|10910397|FG001|40%mg|Overall Study||0
9802086|NCT00612352|10910396|FG000|Placebo|Overall Study||4
9802087|NCT00612352|10910397|FG001|Placebo|Overall Study||4
9802088|NCT00612352|10910396|FG000|COMPLETED|Overall Study||56
9802089|NCT00612352|10910397|FG001|COMPLETED|Overall Study||109
9802090|NCT00612352|10910396|FG000|NOT COMPLETED|Overall Study||9
9802091|NCT00612352|10910397|FG001|NOT COMPLETED|Overall Study||6
9802092|NCT00612430|10910405|FG000|STARTED|Overall Study||32
9802093|NCT00612430|10910406|FG001|STARTED|Overall Study||27
9802094|NCT00612430|10910405|FG000|COMPLETED|Overall Study||32
9802095|NCT00612430|10910406|FG001|COMPLETED|Overall Study||27
9802096|NCT00612430|10910405|FG000|NOT COMPLETED|Overall Study||0
9802097|NCT00612430|10910406|FG001|NOT COMPLETED|Overall Study||0
9802098|NCT00612456|10910417|FG000|STARTED|Overall Study||27
9802099|NCT00612456|10910418|FG001|STARTED|Overall Study||27
9802100|NCT00612456|10910419|FG002|STARTED|Overall Study||16
9802101|NCT00612456|10910417|FG000|COMPLETED|Overall Study||25
9802102|NCT00612456|10910418|FG001|COMPLETED|Overall Study||25
9802103|NCT00612456|10910419|FG002|COMPLETED|Overall Study||16
9802104|NCT00612456|10910417|FG000|NOT COMPLETED|Overall Study||2
9802105|NCT00612456|10910418|FG001|NOT COMPLETED|Overall Study||2
9802106|NCT00612456|10910419|FG002|NOT COMPLETED|Overall Study||0
9802107|NCT00612508|10910431|FG000|STARTED|Overall Study||7
9802108|NCT00612508|10910432|FG001|STARTED|Overall Study||7
9802109|NCT00612508|10910431|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
9802110|NCT00612508|10910432|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
9802111|NCT00612508|10910431|FG000|NOT COMPLETED|Overall Study||3
9802112|NCT00612508|10910432|FG001|NOT COMPLETED|Overall Study||4
9802113|NCT00612534|10910444|FG000|STARTED|Overall Study||24
9802114|NCT00612534|10910445|FG001|STARTED|Overall Study||26
9802115|NCT00612534|10910446|FG002|STARTED|Overall Study||20
9802116|NCT00612534|10910447|FG003|STARTED|Overall Study||24
9802117|NCT00612534|10910444|FG000|COMPLETED|Overall Study||11
9802118|NCT00612534|10910445|FG001|COMPLETED|Overall Study||9
9802119|NCT00612534|10910446|FG002|COMPLETED|Overall Study||13
9802120|NCT00612534|10910447|FG003|COMPLETED|Overall Study||7
9802121|NCT00612534|10910444|FG000|NOT COMPLETED|Overall Study||13
9802122|NCT00612534|10910445|FG001|NOT COMPLETED|Overall Study||17
9802123|NCT00612534|10910446|FG002|NOT COMPLETED|Overall Study||7
9802124|NCT00612534|10910447|FG003|NOT COMPLETED|Overall Study||17
9802125|NCT00612560|10910461|FG000|STARTED|Overall Study||7
9802126|NCT00612560|10910462|FG001|STARTED|Overall Study||7
9802127|NCT00612560|10910463|FG002|STARTED|Overall Study||8
9802128|NCT00612560|10910464|FG003|STARTED|Overall Study||6
9802129|NCT00612560|10910461|FG000|COMPLETED|Overall Study||7
9802130|NCT00612560|10910462|FG001|COMPLETED|Overall Study||7
9802131|NCT00612560|10910463|FG002|COMPLETED|Overall Study||8
9802132|NCT00612560|10910464|FG003|COMPLETED|Overall Study||6
9802133|NCT00612560|10910461|FG000|NOT COMPLETED|Overall Study||0
9802134|NCT00612560|10910462|FG001|NOT COMPLETED|Overall Study||0
9802135|NCT00612560|10910463|FG002|NOT COMPLETED|Overall Study||0
9802136|NCT00612560|10910464|FG003|NOT COMPLETED|Overall Study||0
9802137|NCT00612573|10910478|FG000|STARTED|Overall Study||64
9802138|NCT00612573|10910479|FG001|STARTED|Overall Study||65
9802139|NCT00612573|10910480|FG002|STARTED|Overall Study||61
9802140|NCT00612573|10910481|FG003|STARTED|Overall Study||67
9802141|NCT00612573|10910478|FG000|COMPLETED|Overall Study||52
9802142|NCT00612573|10910479|FG001|COMPLETED|Overall Study||51
9802143|NCT00612573|10910480|FG002|COMPLETED|Overall Study||52
9802144|NCT00612573|10910481|FG003|COMPLETED|Overall Study||54
9802145|NCT00612573|10910478|FG000|NOT COMPLETED|Overall Study||12
9802146|NCT00612573|10910479|FG001|NOT COMPLETED|Overall Study||14
9802147|NCT00612573|10910480|FG002|NOT COMPLETED|Overall Study||9
9802148|NCT00612573|10910481|FG003|NOT COMPLETED|Overall Study||13
9802149|NCT00612586|10910493|FG000|STARTED|Overall Study||58
9802150|NCT00612586|10910494|FG001|STARTED|Overall Study||59
9802151|NCT00612586|10910493|FG000|Received at Least 1 Dose|Overall Study||57
9802152|NCT00612586|10910494|FG001|Received at Least 1 Dose|Overall Study||58
9802153|NCT00612586|10910493|FG000|COMPLETED|Overall Study||15
9802154|NCT00612586|10910494|FG001|COMPLETED|Overall Study||18
9802155|NCT00612586|10910493|FG000|NOT COMPLETED|Overall Study||43
9802156|NCT00612586|10910494|FG001|NOT COMPLETED|Overall Study||41
9802157|NCT00612690|10910503|FG000|STARTED|Overall Study||275
9802158|NCT00612690|10910504|FG001|STARTED|Overall Study||207
9802159|NCT00612690|10910503|FG000|COMPLETED|Overall Study||160
9802160|NCT00612690|10910504|FG001|COMPLETED|Overall Study||89
9802161|NCT00612690|10910503|FG000|NOT COMPLETED|Overall Study||115
9802162|NCT00612690|10910504|FG001|NOT COMPLETED|Overall Study||118
9802163|NCT00612716|10910512|FG000|STARTED|Overall Study||6
9802164|NCT00612716|10910512|FG000|COMPLETED|Overall Study||6
9802165|NCT00612716|10910512|FG000|NOT COMPLETED|Overall Study||0
9802166|NCT00612768|10910516|FG000|STARTED|Overall Study||50
9802167|NCT00612768|10910516|FG000|COMPLETED|Overall Study||50
9802168|NCT00612768|10910516|FG000|NOT COMPLETED|Overall Study||0
9802169|NCT00612807|10910543|FG000|STARTED|Overall Study||14
9802170|NCT00612807|10910544|FG001|STARTED|Overall Study||28
9802171|NCT00612807|10910543|FG000|COMPLETED|Overall Study||12
10015900|NCT01807871|11138884|FG001|NOT COMPLETED|Overall Study||218
10015901|NCT01807923|11138893|FG000|STARTED|Overall Study||187
10015902|NCT01807923|11138894|FG001|STARTED|Overall Study||185
9802172|NCT00612807|10910544|FG001|COMPLETED|Overall Study||28
9802173|NCT00612807|10910543|FG000|NOT COMPLETED|Overall Study||2
9802174|NCT00612807|10910544|FG001|NOT COMPLETED|Overall Study||0
9802175|NCT00612924|10910552|FG000|STARTED|Overall Study||101
9802176|NCT00612924|10910553|FG001|STARTED|Overall Study||94
9802177|NCT00612924|10910552|FG000|COMPLETED|Overall Study||94
9802178|NCT00612924|10910553|FG001|COMPLETED|Overall Study||85
9802179|NCT00612924|10910552|FG000|NOT COMPLETED|Overall Study||7
9802180|NCT00612924|10910553|FG001|NOT COMPLETED|Overall Study||9
9802181|NCT00613015|10910566|FG000|STARTED|Overall Study||13
9802182|NCT00613015|10910567|FG001|STARTED|Overall Study||12
9802183|NCT00613015|10910568|FG002|STARTED|Overall Study||26
9802184|NCT00613015|10910569|FG003|STARTED|Overall Study||24
9802185|NCT00613015|10910570|FG004|STARTED|Overall Study||15
9802186|NCT00613015|10910571|FG005|STARTED|Overall Study||19
9802187|NCT00613015|10910566|FG000|COMPLETED|Overall Study||13
9802188|NCT00613015|10910567|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
9802189|NCT00613015|10910568|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
9802190|NCT00613015|10910569|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
9802191|NCT00613015|10910570|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
10015903|NCT01807923|11138895|FG002|STARTED|Overall Study||187
10015904|NCT01807923|11138893|FG000|COMPLETED|Overall Study||182
9802192|NCT00613015|10910571|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
9802193|NCT00613015|10910566|FG000|NOT COMPLETED|Overall Study||0
9802194|NCT00613015|10910567|FG001|NOT COMPLETED|Overall Study||1
9802195|NCT00613015|10910568|FG002|NOT COMPLETED|Overall Study||3
10015905|NCT01807923|11138894|FG001|COMPLETED|Overall Study||179
10015906|NCT01807923|11138895|FG002|COMPLETED|Overall Study||176
9802196|NCT00613015|10910569|FG003|NOT COMPLETED|Overall Study||3
10015907|NCT01807923|11138893|FG000|NOT COMPLETED|Overall Study||5
10015908|NCT01807923|11138894|FG001|NOT COMPLETED|Overall Study||6
9802197|NCT00613015|10910570|FG004|NOT COMPLETED|Overall Study||2
9802198|NCT00613015|10910571|FG005|NOT COMPLETED|Overall Study||3
9802199|NCT00613028|10910587|FG000|STARTED|Overall Study||10
9802200|NCT00613028|10910588|FG001|STARTED|Overall Study||13
9802201|NCT00613028|10910587|FG000|COMPLETED|Overall Study||10
9802202|NCT00613028|10910588|FG001|COMPLETED|Overall Study||12
9802203|NCT00613028|10910587|FG000|NOT COMPLETED|Overall Study||0
9802204|NCT00613028|10910588|FG001|NOT COMPLETED|Overall Study||1
9802205|NCT00613080|10910594|FG000|STARTED|Overall Study||79
9802206|NCT00613080|10910594|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
9802207|NCT00613080|10910594|FG000|NOT COMPLETED|Overall Study||11
9802208|NCT00613106|10910600|FG000|STARTED|Overall Study||132
9802209|NCT00613106|10910601|FG001|STARTED|Overall Study||47
9802210|NCT00613106|10910600|FG000|COMPLETED|Overall Study||112
9802211|NCT00613106|10910601|FG001|COMPLETED|Overall Study||38
9802212|NCT00613106|10910600|FG000|NOT COMPLETED|Overall Study||20
9802213|NCT00613106|10910601|FG001|NOT COMPLETED|Overall Study||9
9802214|NCT00613171|10910607|FG000|STARTED|Overall Study||27
9802215|NCT00613171|10910607|FG000|COMPLETED|Overall Study||13
9802216|NCT00613171|10910607|FG000|NOT COMPLETED|Overall Study||14
9802217|NCT00613301|10910612|FG000|STARTED|Overall Study||416
9802218|NCT00613301|10910612|FG000|COMPLETED|Overall Study||188
9802219|NCT00613301|10910612|FG000|NOT COMPLETED|Overall Study||228
9802220|NCT00613314|10910617|FG000|STARTED|Overall Study||15268
9802221|NCT00613314|10910617|FG000|COMPLETED|Overall Study||15113
9802222|NCT00613314|10910617|FG000|NOT COMPLETED|Overall Study||155
9802223|NCT00613327|10910621|FG000|STARTED|Overall Study||345
9802224|NCT00613327|10910621|FG000|COMPLETED|Overall Study||244
9802225|NCT00613327|10910621|FG000|NOT COMPLETED|Overall Study||101
9802226|NCT00613366|10910627|FG000|STARTED|Overall Study||20
9802227|NCT00613366|10910628|FG001|STARTED|Overall Study||20
9802228|NCT00613366|10910627|FG000|COMPLETED|Overall Study||17
9802229|NCT00613366|10910628|FG001|COMPLETED|Overall Study||18
9802230|NCT00613366|10910627|FG000|NOT COMPLETED|Overall Study||3
9802231|NCT00613366|10910628|FG001|NOT COMPLETED|Overall Study||2
9802232|NCT00613379|10910637|FG000|STARTED|Overall Study||10
9802233|NCT00613379|10910638|FG001|STARTED|Overall Study||10
9802234|NCT00613379|10910639|FG002|STARTED|Overall Study||11
9802235|NCT00613379|10910637|FG000|COMPLETED|Overall Study||10
9802236|NCT00613379|10910638|FG001|COMPLETED|Overall Study||10
9802237|NCT00613379|10910639|FG002|COMPLETED|Overall Study||11
9802238|NCT00613379|10910637|FG000|NOT COMPLETED|Overall Study||0
9802239|NCT00613379|10910638|FG001|NOT COMPLETED|Overall Study||0
9802240|NCT00613379|10910639|FG002|NOT COMPLETED|Overall Study||0
9802241|NCT00613405|10910649|FG000|STARTED|Overall Study||45
9802242|NCT00613405|10910650|FG001|STARTED|Overall Study||42
9802243|NCT00613405|10910649|FG000|COMPLETED|Overall Study||45
9802244|NCT00613405|10910650|FG001|COMPLETED|Overall Study||42
9802245|NCT00613405|10910649|FG000|NOT COMPLETED|Overall Study||0
9802246|NCT00613405|10910650|FG001|NOT COMPLETED|Overall Study||0
9802247|NCT00613509|10910658|FG000|STARTED|Cycle 1||11
9802248|NCT00613509|10910659|FG001|STARTED|Cycle 1||12
9802249|NCT00613509|10910658|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
9802250|NCT00613509|10910659|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
9802251|NCT00613509|10910658|FG000|NOT COMPLETED|Cycle 1||5
9802252|NCT00613509|10910659|FG001|NOT COMPLETED|Cycle 1||8
9802253|NCT00613509|10910658|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11
9802254|NCT00613509|10910659|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4
9802255|NCT00613509|10910658|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
9802256|NCT00613509|10910659|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
9802257|NCT00613509|10910658|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
9802258|NCT00613509|10910659|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
9802259|NCT00613574|10910665|FG000|STARTED|Overall Study||407
9802260|NCT00613574|10910665|FG000|COMPLETED|Overall Study||401
9802261|NCT00613574|10910665|FG000|NOT COMPLETED|Overall Study||6
9802262|NCT00613626|10910672|FG000|STARTED|Overall Study||33
9802263|NCT00613626|10910673|FG001|STARTED|Overall Study||34
9802264|NCT00613626|10910674|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
9802265|NCT00613626|10910672|FG000|1st Dose ZD6474|Overall Study||33
9802266|NCT00613626|10910673|FG001|1st Dose ZD6474|Overall Study||34
9802267|NCT00613626|10910674|FG002|1st Dose ZD6474|Overall Study||7
9802268|NCT00613626|10910672|FG000|COMPLETED|Overall Study||33
9802269|NCT00613626|10910673|FG001|COMPLETED|Overall Study||33
9802270|NCT00613626|10910674|FG002|COMPLETED|Overall Study||7
9802271|NCT00613626|10910672|FG000|NOT COMPLETED|Overall Study||0
9802272|NCT00613626|10910673|FG001|NOT COMPLETED|Overall Study||1
9802273|NCT00613626|10910674|FG002|NOT COMPLETED|Overall Study||0
9802274|NCT00613821|10910683|FG000|STARTED|Overall Study||40
9802275|NCT00613821|10910684|FG001|STARTED|Overall Study||40
9802276|NCT00613821|10910683|FG000|COMPLETED|Overall Study||38
9802277|NCT00613821|10910684|FG001|COMPLETED|Overall Study||39
9802278|NCT00613821|10910683|FG000|NOT COMPLETED|Overall Study||2
9802279|NCT00613821|10910684|FG001|NOT COMPLETED|Overall Study||1
9802280|NCT00613834|10910692|FG000|STARTED|Overall Study||29
9802281|NCT00613834|10910693|FG001|STARTED|Overall Study||29
9802282|NCT00613834|10910692|FG000|COMPLETED|Overall Study||29
9802283|NCT00613834|10910693|FG001|COMPLETED|Overall Study||26
9802284|NCT00613834|10910692|FG000|NOT COMPLETED|Overall Study||0
9802285|NCT00613834|10910693|FG001|NOT COMPLETED|Overall Study||3
9802286|NCT00613925|10910703|FG000|STARTED|Overall Study||37
9802287|NCT00613925|10910704|FG001|STARTED|Overall Study||33
9802288|NCT00613925|10910703|FG000|COMPLETED|Overall Study||37
9802289|NCT00613925|10910704|FG001|COMPLETED|Overall Study||32
9802290|NCT00613925|10910703|FG000|NOT COMPLETED|Overall Study||0
9802291|NCT00613925|10910704|FG001|NOT COMPLETED|Overall Study||1
9802292|NCT00613938|10910714|FG000|STARTED|Overall Study||69
9802293|NCT00613938|10910715|FG001|STARTED|Overall Study||275
9802294|NCT00613938|10910716|FG002|STARTED|Overall Study||278
9802295|NCT00613938|10910717|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
9802296|NCT00613938|10910714|FG000|COMPLETED|Overall Study||49
9802297|NCT00613938|10910715|FG001|COMPLETED|Overall Study||247
9802298|NCT00613938|10910716|FG002|COMPLETED|Overall Study||255
9802299|NCT00613938|10910717|FG003|COMPLETED|Overall Study||253
9802300|NCT00613938|10910714|FG000|NOT COMPLETED|Overall Study||20
9802301|NCT00613938|10910715|FG001|NOT COMPLETED|Overall Study||28
9802302|NCT00613938|10910716|FG002|NOT COMPLETED|Overall Study||23
10015909|NCT01807923|11138895|FG002|NOT COMPLETED|Overall Study||11
10015910|NCT01807949|11138908|FG000|STARTED|Overall Study||187
9802303|NCT00613938|10910717|FG003|NOT COMPLETED|Overall Study||26
9802304|NCT00613951|10910730|FG000|STARTED|Overall Study||61
9802305|NCT00613951|10910731|FG001|STARTED|Overall Study||59
9802306|NCT00613951|10910732|FG002|STARTED|Overall Study||62
9802307|NCT00613951|10910730|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
9802308|NCT00613951|10910731|FG001|Exposed|Overall Study||59
9802309|NCT00613951|10910732|FG002|Exposed|Overall Study||62
9802310|NCT00613951|10910730|FG000|COMPLETED|Overall Study||54
9802311|NCT00613951|10910731|FG001|COMPLETED|Overall Study||54
9802312|NCT00613951|10910732|FG002|COMPLETED|Overall Study||57
9802313|NCT00613951|10910730|FG000|NOT COMPLETED|Overall Study||7
9802314|NCT00613951|10910731|FG001|NOT COMPLETED|Overall Study||5
9802315|NCT00613951|10910732|FG002|NOT COMPLETED|Overall Study||5
9802316|NCT00614055|10910746|FG000|STARTED|Overall Study||59
9802317|NCT00614055|10910747|FG001|STARTED|Overall Study||59
9802318|NCT00614055|10910748|FG002|STARTED|Overall Study||60
9802319|NCT00614055|10910746|FG000|Exposed|Overall Study||59
9802320|NCT00614055|10910747|FG001|Exposed|Overall Study||59
9802321|NCT00614055|10910748|FG002|Exposed|Overall Study||60
9802322|NCT00614055|10910746|FG000|COMPLETED|Overall Study||55
9802323|NCT00614055|10910747|FG001|COMPLETED|Overall Study||53
9802324|NCT00614055|10910748|FG002|COMPLETED|Overall Study||55
9802325|NCT00614055|10910746|FG000|NOT COMPLETED|Overall Study||4
9802326|NCT00614055|10910747|FG001|NOT COMPLETED|Overall Study||6
9802327|NCT00614055|10910748|FG002|NOT COMPLETED|Overall Study||5
9802328|NCT00614120|10910763|FG000|STARTED|Overall Study|Randomised|231
9802329|NCT00614120|10910764|FG001|STARTED|Overall Study|Randomised|233
9802330|NCT00614120|10910765|FG002|STARTED|Overall Study|Randomised|234
9802331|NCT00614120|10910766|FG003|STARTED|Overall Study|Randomised|231
9802332|NCT00614120|10910763|FG000|Exposed to Study Drug|Overall Study||231
9802333|NCT00614120|10910764|FG001|Exposed to Study Drug|Overall Study||233
9802334|NCT00614120|10910765|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
9802335|NCT00614120|10910766|FG003|Exposed to Study Drug|Overall Study||231
9802336|NCT00614120|10910763|FG000|COMPLETED|Overall Study||202
9802337|NCT00614120|10910764|FG001|COMPLETED|Overall Study||187
9802338|NCT00614120|10910765|FG002|COMPLETED|Overall Study||175
9802339|NCT00614120|10910766|FG003|COMPLETED|Overall Study||215
9802340|NCT00614120|10910763|FG000|NOT COMPLETED|Overall Study||29
9802341|NCT00614120|10910764|FG001|NOT COMPLETED|Overall Study||46
9802342|NCT00614120|10910765|FG002|NOT COMPLETED|Overall Study||59
9802343|NCT00614120|10910766|FG003|NOT COMPLETED|Overall Study||16
9802344|NCT00614198|10910778|FG000|STARTED|Stage 1||38
9802345|NCT00614198|10910779|FG001|STARTED|Stage 1||34
9802346|NCT00614198|10910778|FG000|COMPLETED|Stage 1||26
9802347|NCT00614198|10910779|FG001|COMPLETED|Stage 1||29
9802348|NCT00614198|10910778|FG000|NOT COMPLETED|Stage 1||12
9802349|NCT00614198|10910779|FG001|NOT COMPLETED|Stage 1||5
9802350|NCT00614198|10910778|FG000|STARTED|Stage 2||26
9802351|NCT00614198|10910779|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
9802352|NCT00614198|10910778|FG000|COMPLETED|Stage 2||18
9802353|NCT00614198|10910779|FG001|COMPLETED|Stage 2||17
9802354|NCT00614198|10910778|FG000|NOT COMPLETED|Stage 2||8
9802355|NCT00614198|10910779|FG001|NOT COMPLETED|Stage 2||12
9802356|NCT00614315|10910785|FG000|STARTED|Overall Study||30
9802357|NCT00614315|10910785|FG000|COMPLETED|Overall Study||30
9802358|NCT00614315|10910785|FG000|NOT COMPLETED|Overall Study||0
9802359|NCT00614380|10910793|FG000|STARTED|Overall Study||564
9802360|NCT00614380|10910794|FG001|STARTED|Overall Study||206
9802361|NCT00614380|10910795|FG002|STARTED|Overall Study||25
9802362|NCT00614380|10910796|FG003|STARTED|Overall Study||181
9802363|NCT00614380|10910793|FG000|COMPLETED|Overall Study||529
9802364|NCT00614380|10910794|FG001|COMPLETED|Overall Study||198
9802365|NCT00614380|10910795|FG002|COMPLETED|Overall Study||24
10015911|NCT01807949|11138909|FG001|STARTED|Overall Study||187
9802366|NCT00614380|10910796|FG003|COMPLETED|Overall Study||179
9802367|NCT00614380|10910793|FG000|NOT COMPLETED|Overall Study||35
9802368|NCT00614380|10910794|FG001|NOT COMPLETED|Overall Study||8
9802369|NCT00614380|10910795|FG002|NOT COMPLETED|Overall Study||1
9802370|NCT00614380|10910796|FG003|NOT COMPLETED|Overall Study||2
9802371|NCT00614393|10910816|FG000|STARTED|Overall Study||180
9802372|NCT00614393|10910817|FG001|STARTED|Overall Study||8
9802373|NCT00614393|10910818|FG002|STARTED|Overall Study||10
9802374|NCT00614393|10910819|FG003|STARTED|Overall Study||180
9802375|NCT00614393|10910820|FG004|STARTED|Overall Study||180
9802376|NCT00614393|10910816|FG000|Treated|Overall Study||180
9802377|NCT00614393|10910817|FG001|Treated|Overall Study||8
9802378|NCT00614393|10910818|FG002|Treated|Overall Study||10
9802379|NCT00614393|10910819|FG003|Treated|Overall Study||180
9802380|NCT00614393|10910820|FG004|Treated|Overall Study||178
9802381|NCT00614393|10910816|FG000|COMPLETED|Overall Study||0
9802382|NCT00614393|10910817|FG001|COMPLETED|Overall Study||0
9802383|NCT00614393|10910818|FG002|COMPLETED|Overall Study||0
9802384|NCT00614393|10910819|FG003|COMPLETED|Overall Study||0
9802385|NCT00614393|10910820|FG004|COMPLETED|Overall Study||0
9802386|NCT00614393|10910816|FG000|NOT COMPLETED|Overall Study||180
9802387|NCT00614393|10910817|FG001|NOT COMPLETED|Overall Study||8
9802388|NCT00614393|10910818|FG002|NOT COMPLETED|Overall Study||10
9802389|NCT00614393|10910819|FG003|NOT COMPLETED|Overall Study||180
9802390|NCT00614393|10910820|FG004|NOT COMPLETED|Overall Study||180
9802391|NCT00614406|10910834|FG000|STARTED|Overall Study||7
9802392|NCT00614406|10910835|FG001|STARTED|Overall Study||4
9802393|NCT00614406|10910834|FG000|COMPLETED|Overall Study||7
9802394|NCT00614406|10910835|FG001|COMPLETED|Overall Study||4
9802395|NCT00614406|10910834|FG000|NOT COMPLETED|Overall Study||0
9802396|NCT00614406|10910835|FG001|NOT COMPLETED|Overall Study||0
9802397|NCT00614432|10910843|FG000|STARTED|Overall Study||4
9802398|NCT00614432|10910844|FG001|STARTED|Overall Study||6
9802399|NCT00614432|10910843|FG000|COMPLETED|Overall Study||4
9802400|NCT00614432|10910844|FG001|COMPLETED|Overall Study||6
9802401|NCT00614432|10910843|FG000|NOT COMPLETED|Overall Study||0
9802402|NCT00614432|10910844|FG001|NOT COMPLETED|Overall Study||0
9802403|NCT00614445|10910852|FG000|STARTED|Overall Study||140
9802404|NCT00614445|10910853|FG001|STARTED|Overall Study||140
9802405|NCT00614445|10910852|FG000|COMPLETED|Overall Study||112
9802406|NCT00614445|10910853|FG001|COMPLETED|Overall Study||91
9802407|NCT00614445|10910852|FG000|NOT COMPLETED|Overall Study||28
9802408|NCT00614445|10910853|FG001|NOT COMPLETED|Overall Study||49
9802409|NCT00614458|10910859|FG000|STARTED|Overall Study||6
9802410|NCT00614458|10910859|FG000|COMPLETED|Overall Study||6
9802411|NCT00614458|10910859|FG000|NOT COMPLETED|Overall Study||0
9802412|NCT00614484|10910863|FG000|STARTED|Overall Study||28
9802413|NCT00614484|10910863|FG000|COMPLETED|Overall Study||28
9802414|NCT00614484|10910863|FG000|NOT COMPLETED|Overall Study||0
9802415|NCT00614523|10910870|FG000|STARTED|Overall Study||83
9802416|NCT00614523|10910871|FG001|STARTED|Overall Study||167
9802417|NCT00614523|10910870|FG000|COMPLETED|Overall Study||20
9802418|NCT00614523|10910871|FG001|COMPLETED|Overall Study||36
9802419|NCT00614523|10910870|FG000|NOT COMPLETED|Overall Study||63
9802420|NCT00614523|10910871|FG001|NOT COMPLETED|Overall Study||131
9802421|NCT00614575|10910877|FG000|STARTED|Overall Study|The number of patients enrolled.|1089
9802422|NCT00614575|10910877|FG000|COMPLETED|Overall Study||861
9802423|NCT00614575|10910877|FG000|NOT COMPLETED|Overall Study||228
9802424|NCT00614614|10910883|FG000|STARTED|Primary Vaccination Phase||1272
9802425|NCT00614614|10910884|FG001|STARTED|Primary Vaccination Phase||282
9802426|NCT00614614|10910885|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
9802427|NCT00614614|10910886|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
9802428|NCT00614614|10910887|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
9802429|NCT00614614|10910883|FG000|COMPLETED|Primary Vaccination Phase||1182
9802430|NCT00614614|10910884|FG001|COMPLETED|Primary Vaccination Phase||265
9802431|NCT00614614|10910885|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
9802432|NCT00614614|10910886|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
9802433|NCT00614614|10910887|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
9802434|NCT00614614|10910883|FG000|NOT COMPLETED|Primary Vaccination Phase||90
9802435|NCT00614614|10910884|FG001|NOT COMPLETED|Primary Vaccination Phase||17
9802436|NCT00614614|10910885|FG002|NOT COMPLETED|Primary Vaccination Phase||0
9802437|NCT00614614|10910886|FG003|NOT COMPLETED|Primary Vaccination Phase||0
9802438|NCT00614614|10910887|FG004|NOT COMPLETED|Primary Vaccination Phase||0
9802439|NCT00614614|10910883|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
9802440|NCT00614614|10910884|FG001|STARTED|Booster Vaccination Phase||233
9802441|NCT00614614|10910885|FG002|STARTED|Booster Vaccination Phase||432
9802442|NCT00614614|10910886|FG003|STARTED|Booster Vaccination Phase||229
9802443|NCT00614614|10910887|FG004|STARTED|Booster Vaccination Phase||409
9802444|NCT00614614|10910883|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
9802445|NCT00614614|10910884|FG001|COMPLETED|Booster Vaccination Phase||227
9802446|NCT00614614|10910885|FG002|COMPLETED|Booster Vaccination Phase||405
9802447|NCT00614614|10910886|FG003|COMPLETED|Booster Vaccination Phase||210
9802448|NCT00614614|10910887|FG004|COMPLETED|Booster Vaccination Phase||396
9802449|NCT00614614|10910883|FG000|NOT COMPLETED|Booster Vaccination Phase||0
9802450|NCT00614614|10910884|FG001|NOT COMPLETED|Booster Vaccination Phase||6
9802451|NCT00614614|10910885|FG002|NOT COMPLETED|Booster Vaccination Phase||27
9802452|NCT00614614|10910886|FG003|NOT COMPLETED|Booster Vaccination Phase||19
9802453|NCT00614614|10910887|FG004|NOT COMPLETED|Booster Vaccination Phase||13
9802454|NCT00614744|10910904|FG000|STARTED|Overall Study||83
9802455|NCT00614744|10910905|FG001|STARTED|Overall Study||85
9802456|NCT00614744|10910904|FG000|COMPLETED|Overall Study||78
10015912|NCT01807949|11138910|FG002|STARTED|Overall Study||189
10015913|NCT01807949|11138908|FG000|COMPLETED|Overall Study||185
10015914|NCT01807949|11138909|FG001|COMPLETED|Overall Study||180
10015915|NCT01807949|11138910|FG002|COMPLETED|Overall Study||180
10015916|NCT01807949|11138908|FG000|NOT COMPLETED|Overall Study||2
10015917|NCT01807949|11138909|FG001|NOT COMPLETED|Overall Study||7
10015918|NCT01807949|11138910|FG002|NOT COMPLETED|Overall Study||9
10015919|NCT01808066|11138920|FG000|STARTED|Overall Study||21
10015920|NCT01808066|11138920|FG000|COMPLETED|Overall Study||6
10015921|NCT01808066|11138920|FG000|NOT COMPLETED|Overall Study||15
10015922|NCT01808092|11138927|FG000|STARTED|Overall Study||409
10015923|NCT01808092|11138928|FG001|STARTED|Overall Study||408
10015924|NCT01808092|11138927|FG000|COMPLETED|Overall Study||355
10015925|NCT01808092|11138928|FG001|COMPLETED|Overall Study||363
10015926|NCT01808092|11138927|FG000|NOT COMPLETED|Overall Study||54
10015927|NCT01808092|11138928|FG001|NOT COMPLETED|Overall Study||45
10015928|NCT01808118|11138934|FG000|STARTED|Period 1||673
10015929|NCT01808118|11138935|FG001|STARTED|Period 1||0
10015930|NCT01808118|11138936|FG002|STARTED|Period 1||0
10015931|NCT01808118|11138934|FG000|COMPLETED|Period 1||305
10015932|NCT01808118|11138935|FG001|COMPLETED|Period 1||0
10015933|NCT01808118|11138936|FG002|COMPLETED|Period 1||0
10015934|NCT01808118|11138934|FG000|NOT COMPLETED|Period 1||368
10015935|NCT01808118|11138935|FG001|NOT COMPLETED|Period 1||0
10015936|NCT01808118|11138936|FG002|NOT COMPLETED|Period 1||0
9802457|NCT00614744|10910905|FG001|COMPLETED|Overall Study||79
9802458|NCT00614744|10910904|FG000|NOT COMPLETED|Overall Study||5
9802459|NCT00614744|10910905|FG001|NOT COMPLETED|Overall Study||6
9802460|NCT00614822|10910911|FG000|STARTED|Overall Study||50
9802461|NCT00614822|10910911|FG000|COMPLETED|Overall Study||47
9802462|NCT00614822|10910911|FG000|NOT COMPLETED|Overall Study||3
9802463|NCT00614874|10910916|FG000|STARTED|Overall Study||16
9802464|NCT00614874|10910916|FG000|COMPLETED|Overall Study||14
9802465|NCT00614874|10910916|FG000|NOT COMPLETED|Overall Study||2
9802466|NCT00614913|10910920|FG000|STARTED|Overall Study||76
9802467|NCT00614913|10910920|FG000|COMPLETED|Overall Study||76
9802468|NCT00614913|10910920|FG000|NOT COMPLETED|Overall Study||0
9802469|NCT00614926|10910926|FG000|STARTED|Overall Study||25
9802470|NCT00614926|10910927|FG001|STARTED|Overall Study||7
9802471|NCT00614926|10910926|FG000|COMPLETED|Overall Study||21
9802472|NCT00614926|10910927|FG001|COMPLETED|Overall Study||7
9802473|NCT00614926|10910926|FG000|NOT COMPLETED|Overall Study||4
9802474|NCT00614926|10910927|FG001|NOT COMPLETED|Overall Study||0
9802475|NCT00614939|10910935|FG000|STARTED|Overall Study|Randomized and treated|85
9802476|NCT00614939|10910936|FG001|STARTED|Overall Study|Randomized and treated|85
9802477|NCT00614939|10910935|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
9802478|NCT00614939|10910936|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
9802479|NCT00614939|10910935|FG000|NOT COMPLETED|Overall Study||35
9802480|NCT00614939|10910936|FG001|NOT COMPLETED|Overall Study||43
9802481|NCT00614991|10910948|FG000|STARTED|Overall Study||8
9802482|NCT00614991|10910949|FG001|STARTED|Overall Study||9
9802483|NCT00614991|10910950|FG002|STARTED|Overall Study||7
9802484|NCT00614991|10910951|FG003|STARTED|Overall Study||7
9802485|NCT00614991|10910952|FG004|STARTED|Overall Study||7
9802486|NCT00614991|10910953|FG005|STARTED|Overall Study||6
9802487|NCT00614991|10910948|FG000|COMPLETED|Overall Study||5
9802488|NCT00614991|10910949|FG001|COMPLETED|Overall Study||6
9802489|NCT00614991|10910950|FG002|COMPLETED|Overall Study||7
9802490|NCT00614991|10910951|FG003|COMPLETED|Overall Study||7
9802491|NCT00614991|10910952|FG004|COMPLETED|Overall Study||6
9802492|NCT00614991|10910953|FG005|COMPLETED|Overall Study||6
9802493|NCT00614991|10910948|FG000|NOT COMPLETED|Overall Study||3
9802494|NCT00614991|10910949|FG001|NOT COMPLETED|Overall Study||3
9802495|NCT00614991|10910950|FG002|NOT COMPLETED|Overall Study||0
9802496|NCT00614991|10910951|FG003|NOT COMPLETED|Overall Study||0
9802497|NCT00614991|10910952|FG004|NOT COMPLETED|Overall Study||1
9802498|NCT00614991|10910953|FG005|NOT COMPLETED|Overall Study||0
9802499|NCT00615017|10910978|FG000|STARTED|Overall Study|Patients received treatment|8
9802500|NCT00615017|10910979|FG001|STARTED|Overall Study|Patients received treatment|9
9802501|NCT00615017|10910980|FG002|STARTED|Overall Study|Patients received treatment|12
9802502|NCT00615017|10910981|FG003|STARTED|Overall Study|Patients received treatment|10
9802503|NCT00615017|10910982|FG004|STARTED|Overall Study|Patients received treatment|8
9802504|NCT00615017|10910983|FG005|STARTED|Overall Study|Patients received treatment|23
9802505|NCT00615017|10910978|FG000|COMPLETED|Overall Study|Patient completed the study drug|8
9802506|NCT00615017|10910979|FG001|COMPLETED|Overall Study|Patient completed the study drug|8
9802507|NCT00615017|10910980|FG002|COMPLETED|Overall Study|Patient completed the study drug|7
9802508|NCT00615017|10910981|FG003|COMPLETED|Overall Study|Patient completed the study drug|9
9802509|NCT00615017|10910982|FG004|COMPLETED|Overall Study|Patient completed the study drug|7
10015937|NCT01808118|11138934|FG000|STARTED|Period 2||0
10015938|NCT01808118|11138935|FG001|STARTED|Period 2||153
10015939|NCT01808118|11138936|FG002|STARTED|Period 2||152
10015940|NCT01808118|11138934|FG000|COMPLETED|Period 2||0
10015941|NCT01808118|11138935|FG001|COMPLETED|Period 2||140
10015942|NCT01808118|11138936|FG002|COMPLETED|Period 2||144
10015943|NCT01808118|11138934|FG000|NOT COMPLETED|Period 2||0
10015944|NCT01808118|11138935|FG001|NOT COMPLETED|Period 2||13
10015945|NCT01808118|11138936|FG002|NOT COMPLETED|Period 2||8
10015946|NCT01808144|11138952|FG000|STARTED|Overall Study||97
10015947|NCT01808144|11138953|FG001|STARTED|Overall Study||99
10015948|NCT01808144|11138952|FG000|COMPLETED|Overall Study||57
9802510|NCT00615017|10910983|FG005|COMPLETED|Overall Study|Patient completed the study drug|20
9802511|NCT00615017|10910978|FG000|NOT COMPLETED|Overall Study||0
9802512|NCT00615017|10910979|FG001|NOT COMPLETED|Overall Study||1
9802513|NCT00615017|10910980|FG002|NOT COMPLETED|Overall Study||5
9802514|NCT00615017|10910981|FG003|NOT COMPLETED|Overall Study||1
9802515|NCT00615017|10910982|FG004|NOT COMPLETED|Overall Study||1
9802516|NCT00615017|10910983|FG005|NOT COMPLETED|Overall Study||3
9802517|NCT00615030|10910997|FG000|STARTED|Period I||9
9802518|NCT00615030|10910998|FG001|STARTED|Period I||8
9802519|NCT00615030|10910999|FG002|STARTED|Period I||9
9802520|NCT00615030|10911000|FG003|STARTED|Period I||8
9802521|NCT00615030|10911001|FG004|STARTED|Period I||9
9802522|NCT00615030|10911002|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
9802523|NCT00615030|10911003|FG006|STARTED|Period I||7
9802524|NCT00615030|10911004|FG007|STARTED|Period I||7
9802525|NCT00615030|10911005|FG008|STARTED|Period I||9
9802526|NCT00615030|10911006|FG009|STARTED|Period I||8
9802527|NCT00615030|10911007|FG010|STARTED|Period I||8
9802528|NCT00615030|10911008|FG011|STARTED|Period I||7
9802529|NCT00615030|10910997|FG000|COMPLETED|Period I||8
9802530|NCT00615030|10910998|FG001|COMPLETED|Period I||8
9802531|NCT00615030|10910999|FG002|COMPLETED|Period I||9
9802532|NCT00615030|10911000|FG003|COMPLETED|Period I||8
9802533|NCT00615030|10911001|FG004|COMPLETED|Period I||8
9802534|NCT00615030|10911002|FG005|COMPLETED|Period I||5
9802535|NCT00615030|10911003|FG006|COMPLETED|Period I||7
9802536|NCT00615030|10911004|FG007|COMPLETED|Period I||7
9802537|NCT00615030|10911005|FG008|COMPLETED|Period I||8
9802538|NCT00615030|10911006|FG009|COMPLETED|Period I||8
9802539|NCT00615030|10911007|FG010|COMPLETED|Period I||7
9802540|NCT00615030|10911008|FG011|COMPLETED|Period I||6
9802541|NCT00615030|10910997|FG000|NOT COMPLETED|Period I||1
9802542|NCT00615030|10910998|FG001|NOT COMPLETED|Period I||0
9802543|NCT00615030|10910999|FG002|NOT COMPLETED|Period I||0
9802544|NCT00615030|10911000|FG003|NOT COMPLETED|Period I||0
9802545|NCT00615030|10911001|FG004|NOT COMPLETED|Period I||1
9802546|NCT00615030|10911002|FG005|NOT COMPLETED|Period I||1
9802547|NCT00615030|10911003|FG006|NOT COMPLETED|Period I||0
9802548|NCT00615030|10911004|FG007|NOT COMPLETED|Period I||0
9802549|NCT00615030|10911005|FG008|NOT COMPLETED|Period I||1
9802550|NCT00615030|10911006|FG009|NOT COMPLETED|Period I||0
9802551|NCT00615030|10911007|FG010|NOT COMPLETED|Period I||1
9802552|NCT00615030|10911008|FG011|NOT COMPLETED|Period I||1
9802553|NCT00615030|10910997|FG000|STARTED|Period II||8
9802554|NCT00615030|10910998|FG001|STARTED|Period II||8
9802555|NCT00615030|10910999|FG002|STARTED|Period II||9
9802556|NCT00615030|10911000|FG003|STARTED|Period II||8
9802557|NCT00615030|10911001|FG004|STARTED|Period II||8
9802558|NCT00615030|10911002|FG005|STARTED|Period II||5
9802559|NCT00615030|10911003|FG006|STARTED|Period II||7
10015949|NCT01808144|11138953|FG001|COMPLETED|Overall Study||51
10015950|NCT01808144|11138952|FG000|NOT COMPLETED|Overall Study||40
10015951|NCT01808144|11138953|FG001|NOT COMPLETED|Overall Study||48
10015952|NCT01808196|11138959|FG000|STARTED|Overall Study||6
10015953|NCT01808196|11138959|FG000|COMPLETED|Overall Study||5
9802560|NCT00615030|10911004|FG007|STARTED|Period II||7
9802561|NCT00615030|10911005|FG008|STARTED|Period II||8
9802562|NCT00615030|10911006|FG009|STARTED|Period II||8
9802563|NCT00615030|10911007|FG010|STARTED|Period II||7
9802564|NCT00615030|10911008|FG011|STARTED|Period II||6
9802565|NCT00615030|10910997|FG000|COMPLETED|Period II||8
9802566|NCT00615030|10910998|FG001|COMPLETED|Period II||8
9802567|NCT00615030|10910999|FG002|COMPLETED|Period II||8
9802568|NCT00615030|10911000|FG003|COMPLETED|Period II||7
9802569|NCT00615030|10911001|FG004|COMPLETED|Period II||8
9802570|NCT00615030|10911002|FG005|COMPLETED|Period II||5
9802571|NCT00615030|10911003|FG006|COMPLETED|Period II||6
9802572|NCT00615030|10911004|FG007|COMPLETED|Period II||7
9802573|NCT00615030|10911005|FG008|COMPLETED|Period II||7
9802574|NCT00615030|10911006|FG009|COMPLETED|Period II||8
9802575|NCT00615030|10911007|FG010|COMPLETED|Period II||7
9802576|NCT00615030|10911008|FG011|COMPLETED|Period II||6
9802577|NCT00615030|10910997|FG000|NOT COMPLETED|Period II||0
9802578|NCT00615030|10910998|FG001|NOT COMPLETED|Period II||0
9802579|NCT00615030|10910999|FG002|NOT COMPLETED|Period II||1
9802580|NCT00615030|10911000|FG003|NOT COMPLETED|Period II||1
9802581|NCT00615030|10911001|FG004|NOT COMPLETED|Period II||0
9802582|NCT00615030|10911002|FG005|NOT COMPLETED|Period II||0
9802583|NCT00615030|10911003|FG006|NOT COMPLETED|Period II||1
9802584|NCT00615030|10911004|FG007|NOT COMPLETED|Period II||0
9802585|NCT00615030|10911005|FG008|NOT COMPLETED|Period II||1
9802586|NCT00615030|10911006|FG009|NOT COMPLETED|Period II||0
9802587|NCT00615030|10911007|FG010|NOT COMPLETED|Period II||0
10015954|NCT01808196|11138959|FG000|NOT COMPLETED|Overall Study||1
9802588|NCT00615030|10911008|FG011|NOT COMPLETED|Period II||0
9802589|NCT00615030|10910997|FG000|STARTED|Period III||8
9802590|NCT00615030|10910998|FG001|STARTED|Period III||8
9802591|NCT00615030|10910999|FG002|STARTED|Period III||8
9802592|NCT00615030|10911000|FG003|STARTED|Period III||7
9802593|NCT00615030|10911001|FG004|STARTED|Period III||8
9802594|NCT00615030|10911002|FG005|STARTED|Period III||5
9802595|NCT00615030|10911003|FG006|STARTED|Period III||6
9802596|NCT00615030|10911004|FG007|STARTED|Period III||7
9802597|NCT00615030|10911005|FG008|STARTED|Period III||7
9802598|NCT00615030|10911006|FG009|STARTED|Period III||8
9802599|NCT00615030|10911007|FG010|STARTED|Period III||7
9802600|NCT00615030|10911008|FG011|STARTED|Period III||6
9802601|NCT00615030|10910997|FG000|COMPLETED|Period III||7
9802602|NCT00615030|10910998|FG001|COMPLETED|Period III||8
9802603|NCT00615030|10910999|FG002|COMPLETED|Period III||8
9802604|NCT00615030|10911000|FG003|COMPLETED|Period III||6
9802605|NCT00615030|10911001|FG004|COMPLETED|Period III||8
9802606|NCT00615030|10911002|FG005|COMPLETED|Period III||5
9802607|NCT00615030|10911003|FG006|COMPLETED|Period III||6
9802608|NCT00615030|10911004|FG007|COMPLETED|Period III||7
9802609|NCT00615030|10911005|FG008|COMPLETED|Period III||7
9802610|NCT00615030|10911006|FG009|COMPLETED|Period III||8
9802611|NCT00615030|10911007|FG010|COMPLETED|Period III||7
9802612|NCT00615030|10911008|FG011|COMPLETED|Period III||6
9802613|NCT00615030|10910997|FG000|NOT COMPLETED|Period III||1
9802614|NCT00615030|10910998|FG001|NOT COMPLETED|Period III||0
9802615|NCT00615030|10910999|FG002|NOT COMPLETED|Period III||0
9802616|NCT00615030|10911000|FG003|NOT COMPLETED|Period III||1
9802617|NCT00615030|10911001|FG004|NOT COMPLETED|Period III||0
9802618|NCT00615030|10911002|FG005|NOT COMPLETED|Period III||0
9802619|NCT00615030|10911003|FG006|NOT COMPLETED|Period III||0
9802620|NCT00615030|10911004|FG007|NOT COMPLETED|Period III||0
9802621|NCT00615030|10911005|FG008|NOT COMPLETED|Period III||0
9802622|NCT00615030|10911006|FG009|NOT COMPLETED|Period III||0
9802623|NCT00615030|10911007|FG010|NOT COMPLETED|Period III||0
9802624|NCT00615030|10911008|FG011|NOT COMPLETED|Period III||0
9802625|NCT00615056|10911026|FG000|STARTED|Overall Study||49
9802626|NCT00615056|10911027|FG001|STARTED|Overall Study||51
9802627|NCT00615056|10911028|FG002|STARTED|Overall Study||36
9802628|NCT00615056|10911029|FG003|STARTED|Overall Study||35
9802629|NCT00615056|10911026|FG000|Treated|Overall Study||46
9802630|NCT00615056|10911027|FG001|Treated|Overall Study||51
9802631|NCT00615056|10911028|FG002|Treated|Overall Study||36
9802632|NCT00615056|10911029|FG003|Treated|Overall Study||35
9802633|NCT00615056|10911026|FG000|COMPLETED|Overall Study||0
9802634|NCT00615056|10911027|FG001|COMPLETED|Overall Study||0
9802635|NCT00615056|10911028|FG002|COMPLETED|Overall Study||0
9802636|NCT00615056|10911029|FG003|COMPLETED|Overall Study||0
9802637|NCT00615056|10911026|FG000|NOT COMPLETED|Overall Study||49
9802638|NCT00615056|10911027|FG001|NOT COMPLETED|Overall Study||51
9802639|NCT00615056|10911028|FG002|NOT COMPLETED|Overall Study||36
9802640|NCT00615056|10911029|FG003|NOT COMPLETED|Overall Study||35
9802641|NCT00615069|10911039|FG000|STARTED|Overall Study||35
9802642|NCT00615069|10911039|FG000|COMPLETED|Overall Study||19
9802643|NCT00615069|10911039|FG000|NOT COMPLETED|Overall Study||16
9802644|NCT00615108|10911043|FG000|STARTED|Overall Study||3148
9802645|NCT00615108|10911043|FG000|COMPLETED|Overall Study||2641
9802646|NCT00615108|10911043|FG000|NOT COMPLETED|Overall Study||507
9802647|NCT00615199|10911053|FG000|STARTED|Overall Study||34
9802648|NCT00615199|10911054|FG001|STARTED|Overall Study||36
9802649|NCT00615199|10911055|FG002|STARTED|Overall Study||34
9802650|NCT00615199|10911056|FG003|STARTED|Overall Study||35
9802651|NCT00615199|10911053|FG000|COMPLETED|Overall Study||26
9802652|NCT00615199|10911054|FG001|COMPLETED|Overall Study||34
9802653|NCT00615199|10911055|FG002|COMPLETED|Overall Study||33
9802654|NCT00615199|10911056|FG003|COMPLETED|Overall Study||33
9802655|NCT00615199|10911053|FG000|NOT COMPLETED|Overall Study||8
9802656|NCT00615199|10911054|FG001|NOT COMPLETED|Overall Study||2
9802657|NCT00615199|10911055|FG002|NOT COMPLETED|Overall Study||1
9802658|NCT00615199|10911056|FG003|NOT COMPLETED|Overall Study||2
9802659|NCT00615264|10911068|FG000|STARTED|Overall Study||225
9802660|NCT00615264|10911069|FG001|STARTED|Overall Study||232
9802661|NCT00615264|10911068|FG000|Received at Least One Dose (ITT)|Overall Study||225
9802662|NCT00615264|10911069|FG001|Received at Least One Dose (ITT)|Overall Study||231
9802663|NCT00615264|10911068|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
9802664|NCT00615264|10911069|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
9802665|NCT00615264|10911068|FG000|COMPLETED|Overall Study||175
9802666|NCT00615264|10911069|FG001|COMPLETED|Overall Study||180
9802667|NCT00615264|10911068|FG000|NOT COMPLETED|Overall Study||50
9802668|NCT00615264|10911069|FG001|NOT COMPLETED|Overall Study||52
9802669|NCT00615290|10911075|FG000|STARTED|Overall Study||42
9802670|NCT00615290|10911075|FG000|COMPLETED|Overall Study||34
9802671|NCT00615290|10911075|FG000|NOT COMPLETED|Overall Study||8
9802672|NCT00615420|10911081|FG000|STARTED|Overall Study||54
9802673|NCT00615420|10911082|FG001|STARTED|Overall Study||52
9802674|NCT00615420|10911081|FG000|COMPLETED|Overall Study||23
9802675|NCT00615420|10911082|FG001|COMPLETED|Overall Study||25
9802676|NCT00615420|10911081|FG000|NOT COMPLETED|Overall Study||31
9802677|NCT00615420|10911082|FG001|NOT COMPLETED|Overall Study||27
9802678|NCT00615433|10911092|FG000|STARTED|Overall Study||120
9802679|NCT00615433|10911093|FG001|STARTED|Overall Study||119
9802680|NCT00615433|10911094|FG002|STARTED|Overall Study||123
9802681|NCT00615433|10911095|FG003|STARTED|Overall Study||116
9802682|NCT00615433|10911092|FG000|COMPLETED|Overall Study||77
9802683|NCT00615433|10911093|FG001|COMPLETED|Overall Study||66
9802684|NCT00615433|10911094|FG002|COMPLETED|Overall Study||84
9802685|NCT00615433|10911095|FG003|COMPLETED|Overall Study||71
9802686|NCT00615433|10911092|FG000|NOT COMPLETED|Overall Study||43
9802687|NCT00615433|10911093|FG001|NOT COMPLETED|Overall Study||53
9802688|NCT00615433|10911094|FG002|NOT COMPLETED|Overall Study||39
9802689|NCT00615433|10911095|FG003|NOT COMPLETED|Overall Study||45
9802690|NCT00615459|10911106|FG000|STARTED|Period I||41
9802691|NCT00615459|10911107|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
9802692|NCT00615459|10911108|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
9802693|NCT00615459|10911109|FG003|STARTED|Period I||43
9802694|NCT00615459|10911106|FG000|COMPLETED|Period I||37
9802695|NCT00615459|10911107|FG001|COMPLETED|Period I||40
9802696|NCT00615459|10911108|FG002|COMPLETED|Period I||40
9802697|NCT00615459|10911109|FG003|COMPLETED|Period I||42
9802698|NCT00615459|10911106|FG000|NOT COMPLETED|Period I||4
9802699|NCT00615459|10911107|FG001|NOT COMPLETED|Period I||1
9802700|NCT00615459|10911108|FG002|NOT COMPLETED|Period I||2
9802701|NCT00615459|10911109|FG003|NOT COMPLETED|Period I||1
9802702|NCT00615459|10911106|FG000|STARTED|Period II||37
9802703|NCT00615459|10911107|FG001|STARTED|Period II||40
9802704|NCT00615459|10911108|FG002|STARTED|Period II||40
9802705|NCT00615459|10911109|FG003|STARTED|Period II||42
9802706|NCT00615459|10911106|FG000|COMPLETED|Period II||36
9802707|NCT00615459|10911107|FG001|COMPLETED|Period II||40
9802708|NCT00615459|10911108|FG002|COMPLETED|Period II||40
9802709|NCT00615459|10911109|FG003|COMPLETED|Period II||41
9802710|NCT00615459|10911106|FG000|NOT COMPLETED|Period II||1
9802711|NCT00615459|10911107|FG001|NOT COMPLETED|Period II||0
9802712|NCT00615459|10911108|FG002|NOT COMPLETED|Period II||0
9802713|NCT00615459|10911109|FG003|NOT COMPLETED|Period II||1
9802714|NCT00615459|10911106|FG000|STARTED|Period III||36
9802715|NCT00615459|10911107|FG001|STARTED|Period III||40
9802716|NCT00615459|10911108|FG002|STARTED|Period III||40
9802717|NCT00615459|10911109|FG003|STARTED|Period III||41
9802718|NCT00615459|10911106|FG000|COMPLETED|Period III||36
9802719|NCT00615459|10911107|FG001|COMPLETED|Period III||37
9802720|NCT00615459|10911108|FG002|COMPLETED|Period III||39
9802721|NCT00615459|10911109|FG003|COMPLETED|Period III||41
9802722|NCT00615459|10911106|FG000|NOT COMPLETED|Period III||0
9802723|NCT00615459|10911107|FG001|NOT COMPLETED|Period III||3
9802724|NCT00615459|10911108|FG002|NOT COMPLETED|Period III||1
9802725|NCT00615459|10911109|FG003|NOT COMPLETED|Period III||0
9802726|NCT00615472|10911121|FG000|STARTED|Overall Study||30
9802727|NCT00615472|10911122|FG001|STARTED|Overall Study||28
9802728|NCT00615472|10911121|FG000|COMPLETED|Overall Study||30
9802729|NCT00615472|10911122|FG001|COMPLETED|Overall Study||28
9802730|NCT00615472|10911121|FG000|NOT COMPLETED|Overall Study||0
9802731|NCT00615472|10911122|FG001|NOT COMPLETED|Overall Study||0
9802732|NCT00615550|10911130|FG000|STARTED|Overall Study||229
9802733|NCT00615550|10911131|FG001|STARTED|Overall Study||236
9802734|NCT00615550|10911130|FG000|COMPLETED|Overall Study||223
9802735|NCT00615550|10911131|FG001|COMPLETED|Overall Study||235
9802736|NCT00615550|10911130|FG000|NOT COMPLETED|Overall Study||6
9802737|NCT00615550|10911131|FG001|NOT COMPLETED|Overall Study||1
9802738|NCT00615589|10911137|FG000|STARTED|Overall Study||22
9802739|NCT00615589|10911137|FG000|COMPLETED|Overall Study||22
9802740|NCT00615589|10911137|FG000|NOT COMPLETED|Overall Study||0
9802741|NCT00615719|10911142|FG000|STARTED|Overall Study||35
9802742|NCT00615719|10911142|FG000|COMPLETED|Overall Study||30
9802743|NCT00615719|10911142|FG000|NOT COMPLETED|Overall Study||5
9802744|NCT00615784|10911146|FG000|STARTED|Overall Study||24
9802745|NCT00615784|10911146|FG000|COMPLETED|Overall Study||24
9802746|NCT00615784|10911146|FG000|NOT COMPLETED|Overall Study||0
9802747|NCT00615836|10911154|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163
9802748|NCT00615836|10911155|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158
9802749|NCT00615836|10911156|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158
9802750|NCT00615836|10911157|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160
9802751|NCT00615836|10911158|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160
9802752|NCT00615836|10911154|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
9802753|NCT00615836|10911155|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
9802754|NCT00615836|10911156|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
10015955|NCT01808209|11138965|FG000|STARTED|Overall Study||33
10015956|NCT01808209|11138966|FG001|STARTED|Overall Study||27
10015957|NCT01808209|11138965|FG000|COMPLETED|Overall Study||33
10015958|NCT01808209|11138966|FG001|COMPLETED|Overall Study||26
9802755|NCT00615836|10911157|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
9802756|NCT00615836|10911158|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
9802757|NCT00615836|10911154|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144
9802758|NCT00615836|10911155|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148
9802759|NCT00615836|10911156|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138
9802760|NCT00615836|10911157|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135
9802761|NCT00615836|10911158|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145
9802762|NCT00615836|10911154|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
9802763|NCT00615836|10911155|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
9802764|NCT00615836|10911156|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
9802765|NCT00615836|10911157|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
10015959|NCT01808209|11138965|FG000|NOT COMPLETED|Overall Study||0
9802766|NCT00615836|10911158|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
9802767|NCT00615836|10911154|FG000|STARTED|Extension Study (FE992026 CS31)||141
10015960|NCT01808209|11138966|FG001|NOT COMPLETED|Overall Study||1
9802768|NCT00615836|10911155|FG001|STARTED|Extension Study (FE992026 CS31)||144
9802769|NCT00615836|10911156|FG002|STARTED|Extension Study (FE992026 CS31)||132
9802770|NCT00615836|10911157|FG003|STARTED|Extension Study (FE992026 CS31)||137
9802771|NCT00615836|10911158|FG004|STARTED|Extension Study (FE992026 CS31)||0
9802772|NCT00615836|10911154|FG000|COMPLETED|Extension Study (FE992026 CS31)||0
9802773|NCT00615836|10911155|FG001|COMPLETED|Extension Study (FE992026 CS31)||58
9802774|NCT00615836|10911156|FG002|COMPLETED|Extension Study (FE992026 CS31)||59
9802775|NCT00615836|10911157|FG003|COMPLETED|Extension Study (FE992026 CS31)||53
9802776|NCT00615836|10911158|FG004|COMPLETED|Extension Study (FE992026 CS31)||0
9802777|NCT00615836|10911154|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141
9802778|NCT00615836|10911155|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86
9802779|NCT00615836|10911156|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73
9802780|NCT00615836|10911157|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84
9802781|NCT00615836|10911158|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0
9802782|NCT00615901|10911174|FG000|STARTED|Overall Study||38
9802783|NCT00615901|10911174|FG000|COMPLETED|Overall Study||29
9802784|NCT00615901|10911174|FG000|NOT COMPLETED|Overall Study||9
9802785|NCT00615914|10911178|FG000|STARTED|Overall Study|The number of patients enrolled|1645
9802786|NCT00615914|10911178|FG000|COMPLETED|Overall Study||1008
9802787|NCT00615914|10911178|FG000|NOT COMPLETED|Overall Study||637
9802788|NCT00615927|10911185|FG000|STARTED|Overall Study||32
9802789|NCT00615927|10911186|FG001|STARTED|Overall Study||32
9802790|NCT00615927|10911185|FG000|COMPLETED|Overall Study||32
9802791|NCT00615927|10911186|FG001|COMPLETED|Overall Study||32
9802792|NCT00615927|10911185|FG000|NOT COMPLETED|Overall Study||0
9802793|NCT00615927|10911186|FG001|NOT COMPLETED|Overall Study||0
9802794|NCT00615992|10911192|FG000|STARTED|Overall Study||754
9802795|NCT00615992|10911192|FG000|COMPLETED|Overall Study||687
9802796|NCT00615992|10911192|FG000|NOT COMPLETED|Overall Study||67
9802797|NCT00616018|10911196|FG000|STARTED|Overall Study||27
9802798|NCT00616018|10911196|FG000|COMPLETED|Overall Study||24
9802799|NCT00616018|10911196|FG000|NOT COMPLETED|Overall Study||3
9802800|NCT00616109|10911201|FG000|STARTED|Overall Study||16
9802801|NCT00616109|10911201|FG000|COMPLETED|Overall Study||16
9802802|NCT00616109|10911201|FG000|NOT COMPLETED|Overall Study||0
9802803|NCT00616122|10911206|FG000|STARTED|Overall Study||4
9802804|NCT00616122|10911207|FG001|STARTED|Overall Study||7
9802805|NCT00616122|10911208|FG002|STARTED|Overall Study||10
9802806|NCT00616122|10911209|FG003|STARTED|Overall Study||11
9802807|NCT00616122|10911206|FG000|COMPLETED|Overall Study||4
9802808|NCT00616122|10911207|FG001|COMPLETED|Overall Study||7
9802809|NCT00616122|10911208|FG002|COMPLETED|Overall Study||10
9802810|NCT00616122|10911209|FG003|COMPLETED|Overall Study||0
9802811|NCT00616122|10911206|FG000|NOT COMPLETED|Overall Study||0
9802812|NCT00616122|10911207|FG001|NOT COMPLETED|Overall Study||0
9802813|NCT00616122|10911208|FG002|NOT COMPLETED|Overall Study||0
9802814|NCT00616122|10911209|FG003|NOT COMPLETED|Overall Study||11
9802815|NCT00616200|10911216|FG000|STARTED|Two Week Standard Diet||17
9802816|NCT00616200|10911216|FG000|COMPLETED|Two Week Standard Diet||16
9802817|NCT00616200|10911216|FG000|NOT COMPLETED|Two Week Standard Diet||1
9802818|NCT00616200|10911216|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16
9802819|NCT00616200|10911216|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13
9802820|NCT00616200|10911216|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
9802821|NCT00616239|10911220|FG000|STARTED|Overall Study||20
9802822|NCT00616239|10911220|FG000|COMPLETED|Overall Study||18
9802823|NCT00616239|10911220|FG000|NOT COMPLETED|Overall Study||2
9802824|NCT00616421|10911227|FG000|STARTED|Overall Study||359
9802825|NCT00616421|10911228|FG001|STARTED|Overall Study||1278
9802826|NCT00616421|10911229|FG002|STARTED|Overall Study||1270
9802827|NCT00616421|10911227|FG000|COMPLETED|Overall Study||333
9802828|NCT00616421|10911228|FG001|COMPLETED|Overall Study||1240
9802829|NCT00616421|10911229|FG002|COMPLETED|Overall Study||1229
9802830|NCT00616421|10911227|FG000|NOT COMPLETED|Overall Study||26
9802831|NCT00616421|10911228|FG001|NOT COMPLETED|Overall Study||38
9802832|NCT00616421|10911229|FG002|NOT COMPLETED|Overall Study||41
9802833|NCT00616434|10911253|FG000|STARTED|Overall Study||62
9802834|NCT00616434|10911254|FG001|STARTED|Overall Study||61
9802835|NCT00616434|10911253|FG000|COMPLETED|Overall Study||56
9802836|NCT00616434|10911254|FG001|COMPLETED|Overall Study||53
9802837|NCT00616434|10911253|FG000|NOT COMPLETED|Overall Study||6
9802838|NCT00616434|10911254|FG001|NOT COMPLETED|Overall Study||8
9802839|NCT00616629|10911265|FG000|STARTED|Overall Study|Two patients never received study drug|13
9802840|NCT00616629|10911266|FG001|STARTED|Overall Study|Two patients never received study drug|14
9802841|NCT00616629|10911267|FG002|STARTED|Overall Study|One patient never received study drug|14
9802842|NCT00616629|10911268|FG003|STARTED|Overall Study||2
9802843|NCT00616629|10911269|FG004|STARTED|Overall Study||12
9802844|NCT00616629|10911265|FG000|COMPLETED|Overall Study||11
9802845|NCT00616629|10911266|FG001|COMPLETED|Overall Study||12
9802846|NCT00616629|10911267|FG002|COMPLETED|Overall Study||13
9802847|NCT00616629|10911268|FG003|COMPLETED|Overall Study||2
9802848|NCT00616629|10911269|FG004|COMPLETED|Overall Study||12
9802849|NCT00616629|10911265|FG000|NOT COMPLETED|Overall Study||2
9802850|NCT00616629|10911266|FG001|NOT COMPLETED|Overall Study||2
9802851|NCT00616629|10911267|FG002|NOT COMPLETED|Overall Study||1
9802852|NCT00616629|10911268|FG003|NOT COMPLETED|Overall Study||0
9802853|NCT00616629|10911269|FG004|NOT COMPLETED|Overall Study||0
9802854|NCT00616655|10911284|FG000|STARTED|Overall Study||152
9802855|NCT00616655|10911285|FG001|STARTED|Overall Study||153
9802856|NCT00616655|10911286|FG002|STARTED|Overall Study||151
9802857|NCT00616655|10911284|FG000|COMPLETED|Overall Study||117
9802858|NCT00616655|10911285|FG001|COMPLETED|Overall Study||112
9802859|NCT00616655|10911286|FG002|COMPLETED|Overall Study||103
9802860|NCT00616655|10911284|FG000|NOT COMPLETED|Overall Study||35
9802861|NCT00616655|10911285|FG001|NOT COMPLETED|Overall Study||41
9802862|NCT00616655|10911286|FG002|NOT COMPLETED|Overall Study||48
9802863|NCT00616772|10911296|FG000|STARTED|Overall Study||340
9802864|NCT00616772|10911297|FG001|STARTED|Overall Study||342
9802865|NCT00616772|10911296|FG000|Treated|Overall Study||337
9802866|NCT00616772|10911297|FG001|Treated|Overall Study||339
9802867|NCT00616772|10911296|FG000|COMPLETED|Overall Study||225
10015961|NCT01808222|11138976|FG000|STARTED|Overall Study||25
10015962|NCT01808222|11138976|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25
10015963|NCT01808222|11138976|FG000|Completed mpMR Scan|Overall Study||24
10015964|NCT01808222|11138976|FG000|COMPLETED|Overall Study||24
10015965|NCT01808222|11138976|FG000|NOT COMPLETED|Overall Study||1
10015966|NCT01808248|11138982|FG000|STARTED|Overall Study||47
9802868|NCT00616772|10911297|FG001|COMPLETED|Overall Study||240
9802869|NCT00616772|10911296|FG000|NOT COMPLETED|Overall Study||115
9802870|NCT00616772|10911297|FG001|NOT COMPLETED|Overall Study||102
9802871|NCT00616902|10911305|FG000|STARTED|Overall Study||6
9802872|NCT00616902|10911306|FG001|STARTED|Overall Study||6
9802873|NCT00616902|10911305|FG000|COMPLETED|Overall Study||0
9802874|NCT00616902|10911306|FG001|COMPLETED|Overall Study||0
9802875|NCT00616902|10911305|FG000|NOT COMPLETED|Overall Study||6
9802876|NCT00616902|10911306|FG001|NOT COMPLETED|Overall Study||6
9831289|NCT00767819|10941995|FG000|Safety Analysis Set (SAF)|Overall Study||37
9831290|NCT00767819|10941996|FG001|Safety Analysis Set (SAF)|Overall Study||24
9831291|NCT00767819|10941997|FG002|Safety Analysis Set (SAF)|Overall Study||10
9831292|NCT00767819|10941995|FG000|COMPLETED|Overall Study||12
9831293|NCT00767819|10941996|FG001|COMPLETED|Overall Study||5
9831294|NCT00767819|10941997|FG002|COMPLETED|Overall Study||10
9831295|NCT00767819|10941995|FG000|NOT COMPLETED|Overall Study||25
9831296|NCT00767819|10941996|FG001|NOT COMPLETED|Overall Study||19
9831297|NCT00767819|10941997|FG002|NOT COMPLETED|Overall Study||0
9831298|NCT00768053|10942005|FG000|STARTED|Overall Study||108
9831299|NCT00768053|10942005|FG000|COMPLETED|Overall Study||97
9831300|NCT00768053|10942005|FG000|NOT COMPLETED|Overall Study||11
9831301|NCT00768066|10942012|FG000|STARTED|Overall Study||22
9831302|NCT00768066|10942013|FG001|STARTED|Overall Study||22
9831303|NCT00768066|10942014|FG002|STARTED|Overall Study||21
9831304|NCT00768066|10942012|FG000|COMPLETED|Overall Study||19
9831305|NCT00768066|10942013|FG001|COMPLETED|Overall Study||19
9831306|NCT00768066|10942014|FG002|COMPLETED|Overall Study||21
9831307|NCT00768066|10942012|FG000|NOT COMPLETED|Overall Study||3
9831308|NCT00768066|10942013|FG001|NOT COMPLETED|Overall Study||3
9831309|NCT00768066|10942014|FG002|NOT COMPLETED|Overall Study||0
9831310|NCT00768079|10942025|FG000|STARTED|Overall Study||38
9831311|NCT00768079|10942026|FG001|STARTED|Overall Study||36
9831312|NCT00768079|10942027|FG002|STARTED|Overall Study||36
9831313|NCT00768079|10942025|FG000|COMPLETED|Overall Study||36
9831314|NCT00768079|10942026|FG001|COMPLETED|Overall Study||35
9831315|NCT00768079|10942027|FG002|COMPLETED|Overall Study||32
9831316|NCT00768079|10942025|FG000|NOT COMPLETED|Overall Study||2
9831317|NCT00768079|10942026|FG001|NOT COMPLETED|Overall Study||1
9831318|NCT00768079|10942027|FG002|NOT COMPLETED|Overall Study||4
9831319|NCT00768118|10942037|FG000|STARTED|Overall Study||11
9831320|NCT00768118|10942037|FG000|COMPLETED|Overall Study||11
9831321|NCT00768118|10942037|FG000|NOT COMPLETED|Overall Study||0
9831322|NCT00768144|10942041|FG000|STARTED|Overall Study||36
9831323|NCT00768144|10942041|FG000|COMPLETED|Overall Study||0
9831324|NCT00768144|10942041|FG000|NOT COMPLETED|Overall Study||36
9831325|NCT00768222|10942047|FG000|STARTED|Overall Study||50
9831326|NCT00768222|10942048|FG001|STARTED|Overall Study||51
9831327|NCT00768222|10942047|FG000|COMPLETED|Overall Study||46
9831328|NCT00768222|10942048|FG001|COMPLETED|Overall Study||47
9831329|NCT00768222|10942047|FG000|NOT COMPLETED|Overall Study||4
9831330|NCT00768222|10942048|FG001|NOT COMPLETED|Overall Study||4
9831331|NCT00768261|10942058|FG000|STARTED|Overall Study||14
9831332|NCT00768261|10942059|FG001|STARTED|Overall Study||18
9831333|NCT00768261|10942060|FG002|STARTED|Overall Study||39
9831334|NCT00768261|10942061|FG003|STARTED|Overall Study||56
9831335|NCT00768261|10942058|FG000|COMPLETED|Overall Study||14
9831336|NCT00768261|10942059|FG001|COMPLETED|Overall Study||18
9831337|NCT00768261|10942060|FG002|COMPLETED|Overall Study||14
9831338|NCT00768261|10942061|FG003|COMPLETED|Overall Study||56
9831339|NCT00768261|10942058|FG000|NOT COMPLETED|Overall Study||0
9831340|NCT00768261|10942059|FG001|NOT COMPLETED|Overall Study||0
9831341|NCT00768261|10942060|FG002|NOT COMPLETED|Overall Study||25
9831342|NCT00768261|10942061|FG003|NOT COMPLETED|Overall Study||0
9831343|NCT00768287|10942074|FG000|STARTED|Pharmacokinetic Study||16
9831344|NCT00768287|10942075|FG001|STARTED|Pharmacokinetic Study||16
9831345|NCT00768287|10942076|FG002|STARTED|Pharmacokinetic Study||0
9831346|NCT00768287|10942077|FG003|STARTED|Pharmacokinetic Study||0
9831347|NCT00768287|10942078|FG004|STARTED|Pharmacokinetic Study||0
9831348|NCT00768287|10942079|FG005|STARTED|Pharmacokinetic Study||0
9831349|NCT00768287|10942074|FG000|COMPLETED|Pharmacokinetic Study||16
10015967|NCT01808248|11138982|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45
9831350|NCT00768287|10942075|FG001|COMPLETED|Pharmacokinetic Study||16
9831351|NCT00768287|10942076|FG002|COMPLETED|Pharmacokinetic Study||0
9831352|NCT00768287|10942077|FG003|COMPLETED|Pharmacokinetic Study||0
9802877|NCT00616928|10911316|FG000|STARTED|Overall Study||2304
9802878|NCT00616928|10911317|FG001|STARTED|Overall Study||768
9802879|NCT00616928|10911318|FG002|STARTED|Overall Study||1118
9802880|NCT00616928|10911319|FG003|STARTED|Overall Study||371
9802881|NCT00616928|10911316|FG000|COMPLETED|Overall Study||2242
9802882|NCT00616928|10911317|FG001|COMPLETED|Overall Study||750
9802883|NCT00616928|10911318|FG002|COMPLETED|Overall Study||1101
9802884|NCT00616928|10911319|FG003|COMPLETED|Overall Study||364
9802885|NCT00616928|10911316|FG000|NOT COMPLETED|Overall Study||62
9952840|NCT01424397|11071757|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3
9952841|NCT01424397|11071758|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4
9952842|NCT01424397|11071759|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4
9952843|NCT01424397|11071748|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9802886|NCT00616928|10911317|FG001|NOT COMPLETED|Overall Study||18
9802887|NCT00616928|10911318|FG002|NOT COMPLETED|Overall Study||17
9802888|NCT00616928|10911319|FG003|NOT COMPLETED|Overall Study||7
9802889|NCT00616941|10911344|FG000|STARTED|Overall Study||4
9802890|NCT00616941|10911345|FG001|STARTED|Overall Study||13
9802891|NCT00616941|10911346|FG002|STARTED|Overall Study||11
9802892|NCT00616941|10911344|FG000|COMPLETED|Overall Study||3
9802893|NCT00616941|10911345|FG001|COMPLETED|Overall Study||8
9802894|NCT00616941|10911346|FG002|COMPLETED|Overall Study||5
9802895|NCT00616941|10911344|FG000|NOT COMPLETED|Overall Study||1
9802896|NCT00616941|10911345|FG001|NOT COMPLETED|Overall Study||5
9802897|NCT00616941|10911346|FG002|NOT COMPLETED|Overall Study||6
9802898|NCT00617058|10911357|FG000|STARTED|Overall Study||1
9802899|NCT00617058|10911358|FG001|STARTED|Overall Study||0
9802900|NCT00617058|10911359|FG002|STARTED|Overall Study||0
9802901|NCT00617058|10911357|FG000|COMPLETED|Overall Study||1
9802902|NCT00617058|10911358|FG001|COMPLETED|Overall Study||0
9802903|NCT00617058|10911359|FG002|COMPLETED|Overall Study||0
9802904|NCT00617058|10911357|FG000|NOT COMPLETED|Overall Study||0
9802905|NCT00617058|10911358|FG001|NOT COMPLETED|Overall Study||0
9802906|NCT00617058|10911359|FG002|NOT COMPLETED|Overall Study||0
9802907|NCT00617084|10911369|FG000|STARTED|Overall Study||1140
9802908|NCT00617084|10911370|FG001|STARTED|Overall Study||1152
9802909|NCT00617084|10911369|FG000|COMPLETED|Overall Study||1119
9802910|NCT00617084|10911370|FG001|COMPLETED|Overall Study||1126
9802911|NCT00617084|10911369|FG000|NOT COMPLETED|Overall Study||21
9802912|NCT00617084|10911370|FG001|NOT COMPLETED|Overall Study||26
9802913|NCT00617097|10911378|FG000|STARTED|Overall Study||25
9802914|NCT00617097|10911379|FG001|STARTED|Overall Study||25
9802915|NCT00617097|10911378|FG000|COMPLETED|Overall Study||25
9802916|NCT00617097|10911379|FG001|COMPLETED|Overall Study||25
9802917|NCT00617097|10911378|FG000|NOT COMPLETED|Overall Study||0
9802918|NCT00617097|10911379|FG001|NOT COMPLETED|Overall Study||0
9802919|NCT00617123|10911389|FG000|STARTED|Referral Screening Period||137
10015968|NCT01808248|11138982|FG000|COMPLETED|Overall Study||42
10015969|NCT01808248|11138982|FG000|NOT COMPLETED|Overall Study||5
10015970|NCT01808313|11138988|FG000|STARTED|Overall Study||133
10015971|NCT01808313|11138988|FG000|COMPLETED|Overall Study||123
10015972|NCT01808313|11138988|FG000|NOT COMPLETED|Overall Study||10
10015973|NCT01808326|11138992|FG000|STARTED|Overall Study||5
10015974|NCT01808326|11138992|FG000|COMPLETED|Overall Study||5
10015975|NCT01808326|11138992|FG000|NOT COMPLETED|Overall Study||0
9802920|NCT00617123|10911390|FG001|STARTED|Referral Screening Period||121
9802921|NCT00617123|10911389|FG000|COMPLETED|Referral Screening Period||98
9802922|NCT00617123|10911390|FG001|COMPLETED|Referral Screening Period||95
9802923|NCT00617123|10911389|FG000|NOT COMPLETED|Referral Screening Period||39
9802924|NCT00617123|10911390|FG001|NOT COMPLETED|Referral Screening Period||26
9802925|NCT00617123|10911389|FG000|STARTED|Study Treatment Period||98
9802926|NCT00617123|10911390|FG001|STARTED|Study Treatment Period||95
9802927|NCT00617123|10911389|FG000|Treated|Study Treatment Period|1 participant was not treated|97
9802928|NCT00617123|10911390|FG001|Treated|Study Treatment Period||95
9802929|NCT00617123|10911389|FG000|COMPLETED|Study Treatment Period||81
9802930|NCT00617123|10911390|FG001|COMPLETED|Study Treatment Period||79
9802931|NCT00617123|10911389|FG000|NOT COMPLETED|Study Treatment Period||17
9802932|NCT00617123|10911390|FG001|NOT COMPLETED|Study Treatment Period||16
9802933|NCT00617175|10911398|FG000|STARTED|Overall Study||954
9802934|NCT00617175|10911399|FG001|STARTED|Overall Study||948
9802935|NCT00617175|10911398|FG000|COMPLETED|Overall Study||954
9802936|NCT00617175|10911399|FG001|COMPLETED|Overall Study||948
9802937|NCT00617175|10911398|FG000|NOT COMPLETED|Overall Study||0
9802938|NCT00617175|10911399|FG001|NOT COMPLETED|Overall Study||0
9802939|NCT00617188|10911405|FG000|STARTED|Overall Study||26
9952844|NCT01424397|11071749|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952845|NCT01424397|11071750|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952846|NCT01424397|11071751|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9802940|NCT00617188|10911405|FG000|COMPLETED|Overall Study||26
9802941|NCT00617188|10911405|FG000|NOT COMPLETED|Overall Study||0
9802942|NCT00617201|10911411|FG000|STARTED|Overall Study||25
9802943|NCT00617201|10911412|FG001|STARTED|Overall Study||25
9802944|NCT00617201|10911411|FG000|COMPLETED|Overall Study||16
9802945|NCT00617201|10911412|FG001|COMPLETED|Overall Study||12
9802946|NCT00617201|10911411|FG000|NOT COMPLETED|Overall Study||9
9802947|NCT00617201|10911412|FG001|NOT COMPLETED|Overall Study||13
9802948|NCT00617240|10911422|FG000|STARTED|Overall Study||5
9802949|NCT00617240|10911423|FG001|STARTED|Overall Study||4
9802950|NCT00617240|10911422|FG000|COMPLETED|Overall Study||4
9952847|NCT01424397|11071752|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952848|NCT01424397|11071753|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952849|NCT01424397|11071754|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952850|NCT01424397|11071755|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952851|NCT01424397|11071756|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952852|NCT01424397|11071757|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952853|NCT01424397|11071758|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952854|NCT01424397|11071759|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
9952855|NCT01424397|11071748|FG000|STARTED|Period-3 (8 Days)||7
9952856|NCT01424397|11071749|FG001|STARTED|Period-3 (8 Days)||8
9952857|NCT01424397|11071750|FG002|STARTED|Period-3 (8 Days)||7
9952858|NCT01424397|11071751|FG003|STARTED|Period-3 (8 Days)||8
9952859|NCT01424397|11071752|FG004|STARTED|Period-3 (8 Days)||8
9952860|NCT01424397|11071753|FG005|STARTED|Period-3 (8 Days)||8
9952861|NCT01424397|11071754|FG006|STARTED|Period-3 (8 Days)||4
9952862|NCT01424397|11071755|FG007|STARTED|Period-3 (8 Days)||4
9952863|NCT01424397|11071756|FG008|STARTED|Period-3 (8 Days)||4
9952864|NCT01424397|11071757|FG009|STARTED|Period-3 (8 Days)||3
9802951|NCT00617240|10911423|FG001|COMPLETED|Overall Study||4
9802952|NCT00617240|10911422|FG000|NOT COMPLETED|Overall Study||1
9802953|NCT00617240|10911423|FG001|NOT COMPLETED|Overall Study||0
9802954|NCT00617279|10911431|FG000|STARTED|Overall Study||14
9802955|NCT00617279|10911432|FG001|STARTED|Overall Study||17
9802956|NCT00617279|10911431|FG000|COMPLETED|Overall Study||0
9802957|NCT00617279|10911432|FG001|COMPLETED|Overall Study||0
9802958|NCT00617279|10911431|FG000|NOT COMPLETED|Overall Study||14
9802959|NCT00617279|10911432|FG001|NOT COMPLETED|Overall Study||17
9802960|NCT00617305|10911441|FG000|STARTED|Overall Study||33
9802961|NCT00617305|10911442|FG001|STARTED|Overall Study||4
9802962|NCT00617305|10911443|FG002|STARTED|Overall Study||1
9952865|NCT01424397|11071758|FG010|STARTED|Period-3 (8 Days)||4
9952866|NCT01424397|11071759|FG011|STARTED|Period-3 (8 Days)||4
9952867|NCT01424397|11071748|FG000|COMPLETED|Period-3 (8 Days)||7
9952868|NCT01424397|11071749|FG001|COMPLETED|Period-3 (8 Days)||8
9952869|NCT01424397|11071750|FG002|COMPLETED|Period-3 (8 Days)||7
9952870|NCT01424397|11071751|FG003|COMPLETED|Period-3 (8 Days)||8
9802963|NCT00617305|10911441|FG000|Completed 24-week Primary Analysis|Overall Study||31
9802964|NCT00617305|10911442|FG001|Completed 24-week Primary Analysis|Overall Study||4
9802965|NCT00617305|10911443|FG002|Completed 24-week Primary Analysis|Overall Study||0
9802966|NCT00617305|10911441|FG000|COMPLETED|Overall Study||25
9802967|NCT00617305|10911442|FG001|COMPLETED|Overall Study||4
9802968|NCT00617305|10911443|FG002|COMPLETED|Overall Study||0
9802969|NCT00617305|10911441|FG000|NOT COMPLETED|Overall Study||8
9802970|NCT00617305|10911442|FG001|NOT COMPLETED|Overall Study||0
9802971|NCT00617305|10911443|FG002|NOT COMPLETED|Overall Study||1
9802972|NCT00617344|10911457|FG000|STARTED|Overall Study||104
9802973|NCT00617344|10911458|FG001|STARTED|Overall Study||103
9802974|NCT00617344|10911459|FG002|STARTED|Overall Study||53
9802975|NCT00617344|10911457|FG000|Received Vaccination 1|Overall Study||104
9802976|NCT00617344|10911458|FG001|Received Vaccination 1|Overall Study||103
9802977|NCT00617344|10911459|FG002|Received Vaccination 1|Overall Study||53
9802978|NCT00617344|10911457|FG000|Received Vaccination 2|Overall Study||86
9802979|NCT00617344|10911458|FG001|Received Vaccination 2|Overall Study||85
9802980|NCT00617344|10911459|FG002|Received Vaccination 2|Overall Study||46
9802981|NCT00617344|10911457|FG000|Received Vaccination 3|Overall Study||79
9802982|NCT00617344|10911458|FG001|Received Vaccination 3|Overall Study||81
9802983|NCT00617344|10911459|FG002|Received Vaccination 3|Overall Study||45
9802984|NCT00617344|10911457|FG000|COMPLETED|Overall Study||79
9802985|NCT00617344|10911458|FG001|COMPLETED|Overall Study||81
9802986|NCT00617344|10911459|FG002|COMPLETED|Overall Study||45
9802987|NCT00617344|10911457|FG000|NOT COMPLETED|Overall Study||25
9802988|NCT00617344|10911458|FG001|NOT COMPLETED|Overall Study||22
9802989|NCT00617344|10911459|FG002|NOT COMPLETED|Overall Study||8
9802990|NCT00617357|10911467|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
9802991|NCT00617357|10911467|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
9802992|NCT00617357|10911467|FG000|NOT COMPLETED|Overall Study||16
9802993|NCT00617396|10911472|FG000|STARTED|Overall Study||25
9802994|NCT00617396|10911472|FG000|COMPLETED|Overall Study||25
9802995|NCT00617396|10911472|FG000|NOT COMPLETED|Overall Study||0
9802996|NCT00617409|10911479|FG000|STARTED|Overall Study||18
9802997|NCT00617409|10911480|FG001|STARTED|Overall Study||20
9802998|NCT00617409|10911481|FG002|STARTED|Overall Study||31
9802999|NCT00617409|10911479|FG000|COMPLETED|Overall Study||2
9803000|NCT00617409|10911480|FG001|COMPLETED|Overall Study||2
9803001|NCT00617409|10911481|FG002|COMPLETED|Overall Study||4
9803002|NCT00617409|10911479|FG000|NOT COMPLETED|Overall Study||16
9803003|NCT00617409|10911480|FG001|NOT COMPLETED|Overall Study||18
9803004|NCT00617409|10911481|FG002|NOT COMPLETED|Overall Study||27
9803005|NCT00617461|10911490|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
9803006|NCT00617461|10911491|FG001|STARTED|First Treatment Intervention Period||44
9803007|NCT00617461|10911490|FG000|COMPLETED|First Treatment Intervention Period||42
9803008|NCT00617461|10911491|FG001|COMPLETED|First Treatment Intervention Period||41
9952871|NCT01424397|11071752|FG004|COMPLETED|Period-3 (8 Days)||8
9952872|NCT01424397|11071753|FG005|COMPLETED|Period-3 (8 Days)||8
9952873|NCT01424397|11071754|FG006|COMPLETED|Period-3 (8 Days)||4
9952874|NCT01424397|11071755|FG007|COMPLETED|Period-3 (8 Days)||4
9803009|NCT00617461|10911490|FG000|NOT COMPLETED|First Treatment Intervention Period||10
9803010|NCT00617461|10911491|FG001|NOT COMPLETED|First Treatment Intervention Period||3
9803011|NCT00617461|10911490|FG000|STARTED|4-Day Crossover Period||42
9803012|NCT00617461|10911491|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
9803013|NCT00617461|10911490|FG000|COMPLETED|4-Day Crossover Period||41
9803014|NCT00617461|10911491|FG001|COMPLETED|4-Day Crossover Period||40
9803015|NCT00617461|10911490|FG000|NOT COMPLETED|4-Day Crossover Period||1
9803016|NCT00617461|10911491|FG001|NOT COMPLETED|4-Day Crossover Period||0
9803017|NCT00617461|10911490|FG000|STARTED|Second Treatment Intervention Period||41
9803018|NCT00617461|10911491|FG001|STARTED|Second Treatment Intervention Period||41
9803019|NCT00617461|10911490|FG000|COMPLETED|Second Treatment Intervention Period||41
9803020|NCT00617461|10911491|FG001|COMPLETED|Second Treatment Intervention Period||37
9803021|NCT00617461|10911490|FG000|NOT COMPLETED|Second Treatment Intervention Period||0
9803022|NCT00617461|10911491|FG001|NOT COMPLETED|Second Treatment Intervention Period||4
9803023|NCT00617461|10911490|FG000|STARTED|6-Day Down-Titration Period||41
9803024|NCT00617461|10911491|FG001|STARTED|6-Day Down-Titration Period||37
9803025|NCT00617461|10911490|FG000|COMPLETED|6-Day Down-Titration Period||39
9803026|NCT00617461|10911491|FG001|COMPLETED|6-Day Down-Titration Period||35
9803027|NCT00617461|10911490|FG000|NOT COMPLETED|6-Day Down-Titration Period||2
9803028|NCT00617461|10911491|FG001|NOT COMPLETED|6-Day Down-Titration Period||2
9803029|NCT00617539|10911513|FG000|STARTED|Overall Study||30
9803030|NCT00617539|10911513|FG000|COMPLETED|Overall Study||30
9803031|NCT00617539|10911513|FG000|NOT COMPLETED|Overall Study||0
9803032|NCT00617591|10911518|FG000|STARTED|Overall Study||57
9803033|NCT00617591|10911518|FG000|COMPLETED|Overall Study||47
9803034|NCT00617591|10911518|FG000|NOT COMPLETED|Overall Study||10
9803035|NCT00617604|10911525|FG000|STARTED|Overall Study||110
9803036|NCT00617604|10911526|FG001|STARTED|Overall Study||108
9803037|NCT00617604|10911525|FG000|Received Treatment|Overall Study||107
9803038|NCT00617604|10911526|FG001|Received Treatment|Overall Study||105
9803039|NCT00617604|10911525|FG000|Completed 12 Weeks of Treatment|Overall Study||89
9803040|NCT00617604|10911526|FG001|Completed 12 Weeks of Treatment|Overall Study||83
9803041|NCT00617604|10911525|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92
9803042|NCT00617604|10911526|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88
9803043|NCT00617604|10911525|FG000|NOT COMPLETED|Overall Study||18
9803044|NCT00617604|10911526|FG001|NOT COMPLETED|Overall Study||20
9803045|NCT00617669|10911534|FG000|STARTED|Overall Study||524
9803046|NCT00617669|10911535|FG001|STARTED|Overall Study||528
9803047|NCT00617669|10911534|FG000|Patients Who Received IP|Overall Study||522
9803048|NCT00617669|10911535|FG001|Patients Who Received IP|Overall Study||525
9803049|NCT00617669|10911534|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
9803050|NCT00617669|10911535|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
9803051|NCT00617669|10911534|FG000|NOT COMPLETED|Overall Study||430
9803052|NCT00617669|10911535|FG001|NOT COMPLETED|Overall Study||451
9803053|NCT00617734|10911543|FG000|STARTED|Overall Study||49
9803054|NCT00617734|10911544|FG001|STARTED|Overall Study||48
9803055|NCT00617734|10911543|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47
9803056|NCT00617734|10911544|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44
9803057|NCT00617734|10911543|FG000|COMPLETED|Overall Study||41
9803058|NCT00617734|10911544|FG001|COMPLETED|Overall Study||42
9803059|NCT00617734|10911543|FG000|NOT COMPLETED|Overall Study||8
9803060|NCT00617734|10911544|FG001|NOT COMPLETED|Overall Study||6
9803061|NCT00617773|10911550|FG000|STARTED|Overall Study||31
9803062|NCT00617773|10911550|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
9803063|NCT00617773|10911550|FG000|NOT COMPLETED|Overall Study||24
9803064|NCT00617851|10911558|FG000|STARTED|Overall Study||430
9803065|NCT00617851|10911559|FG001|STARTED|Overall Study||431
9803066|NCT00617851|10911560|FG002|STARTED|Overall Study||429
9803067|NCT00617851|10911561|FG003|STARTED|Overall Study||217
9803068|NCT00617851|10911558|FG000|COMPLETED|Overall Study||383
9803069|NCT00617851|10911559|FG001|COMPLETED|Overall Study||391
9803070|NCT00617851|10911560|FG002|COMPLETED|Overall Study||384
9803071|NCT00617851|10911561|FG003|COMPLETED|Overall Study||192
9803072|NCT00617851|10911558|FG000|NOT COMPLETED|Overall Study||47
9803073|NCT00617851|10911559|FG001|NOT COMPLETED|Overall Study||40
9803074|NCT00617851|10911560|FG002|NOT COMPLETED|Overall Study||45
9803075|NCT00617851|10911561|FG003|NOT COMPLETED|Overall Study||25
9803076|NCT00617890|10911585|FG000|STARTED|Overall Study||35
9803077|NCT00617890|10911586|FG001|STARTED|Overall Study||33
9803078|NCT00617890|10911587|FG002|STARTED|Overall Study||35
9803079|NCT00617890|10911588|FG003|STARTED|Overall Study||116
9803080|NCT00617890|10911585|FG000|Received Treatment|Overall Study||34
9803081|NCT00617890|10911586|FG001|Received Treatment|Overall Study||33
9803082|NCT00617890|10911587|FG002|Received Treatment|Overall Study||34
9803083|NCT00617890|10911588|FG003|Received Treatment|Overall Study||115
9803084|NCT00617890|10911585|FG000|COMPLETED|Overall Study||4
9803085|NCT00617890|10911586|FG001|COMPLETED|Overall Study||5
9803086|NCT00617890|10911587|FG002|COMPLETED|Overall Study||0
9803087|NCT00617890|10911588|FG003|COMPLETED|Overall Study||1
9803088|NCT00617890|10911585|FG000|NOT COMPLETED|Overall Study||31
9803089|NCT00617890|10911586|FG001|NOT COMPLETED|Overall Study||28
9803090|NCT00617890|10911587|FG002|NOT COMPLETED|Overall Study||35
9803091|NCT00617890|10911588|FG003|NOT COMPLETED|Overall Study||115
9803092|NCT00617903|10911603|FG000|STARTED|Overall Study||41
9803093|NCT00617903|10911604|FG001|STARTED|Overall Study||42
9803094|NCT00617903|10911603|FG000|COMPLETED|Overall Study||38
9803095|NCT00617903|10911604|FG001|COMPLETED|Overall Study||35
9803096|NCT00617903|10911603|FG000|NOT COMPLETED|Overall Study||3
9803097|NCT00617903|10911604|FG001|NOT COMPLETED|Overall Study||7
9803098|NCT00617929|10911610|FG000|STARTED|Overall Study||12
9803099|NCT00617929|10911610|FG000|COMPLETED|Overall Study||11
9803100|NCT00617929|10911610|FG000|NOT COMPLETED|Overall Study||1
9803101|NCT00617942|10911616|FG000|STARTED|Overall Study||37
9803102|NCT00617942|10911617|FG001|STARTED|Overall Study||23
9803103|NCT00617942|10911616|FG000|COMPLETED|Overall Study||29
9803104|NCT00617942|10911617|FG001|COMPLETED|Overall Study||19
9803105|NCT00617942|10911616|FG000|NOT COMPLETED|Overall Study||8
9803106|NCT00617942|10911617|FG001|NOT COMPLETED|Overall Study||4
9803107|NCT00617981|10911631|FG000|STARTED|Overall Study||354
9803108|NCT00617981|10911632|FG001|STARTED|Overall Study||347
9803109|NCT00617981|10911631|FG000|COMPLETED|Overall Study||244
9803110|NCT00617981|10911632|FG001|COMPLETED|Overall Study||245
9803111|NCT00617981|10911631|FG000|NOT COMPLETED|Overall Study||110
9803112|NCT00617981|10911632|FG001|NOT COMPLETED|Overall Study||102
9803113|NCT00618072|10911641|FG000|STARTED|Overall Study||16
9803114|NCT00618072|10911642|FG001|STARTED|Overall Study||15
9803115|NCT00618072|10911643|FG002|STARTED|Overall Study||15
9803116|NCT00618072|10911641|FG000|COMPLETED|Overall Study||14
9803117|NCT00618072|10911642|FG001|COMPLETED|Overall Study||14
9803118|NCT00618072|10911643|FG002|COMPLETED|Overall Study||11
9803119|NCT00618072|10911641|FG000|NOT COMPLETED|Overall Study||2
9803120|NCT00618072|10911642|FG001|NOT COMPLETED|Overall Study||1
9803121|NCT00618072|10911643|FG002|NOT COMPLETED|Overall Study||4
9803122|NCT00618332|10911653|FG000|STARTED|Overall Study||20
9803123|NCT00618332|10911654|FG001|STARTED|Overall Study||20
9803124|NCT00618332|10911653|FG000|COMPLETED|Overall Study||20
9803125|NCT00618332|10911654|FG001|COMPLETED|Overall Study||20
9803126|NCT00618332|10911653|FG000|NOT COMPLETED|Overall Study||0
9803127|NCT00618332|10911654|FG001|NOT COMPLETED|Overall Study||0
9803128|NCT00618371|10911660|FG000|STARTED|Overall Study||12
9803129|NCT00618371|10911660|FG000|COMPLETED|Overall Study||10
9803130|NCT00618371|10911660|FG000|NOT COMPLETED|Overall Study||2
9803131|NCT00618410|10911665|FG000|STARTED|First Intervention||7
9803132|NCT00618410|10911666|FG001|STARTED|First Intervention||6
9803133|NCT00618410|10911665|FG000|COMPLETED|First Intervention||7
9803134|NCT00618410|10911666|FG001|COMPLETED|First Intervention||6
9803135|NCT00618410|10911665|FG000|NOT COMPLETED|First Intervention||0
9803136|NCT00618410|10911666|FG001|NOT COMPLETED|First Intervention||0
9803137|NCT00618410|10911665|FG000|STARTED|Washout Period (2 Weeks)||7
9803138|NCT00618410|10911666|FG001|STARTED|Washout Period (2 Weeks)||6
9803139|NCT00618410|10911665|FG000|COMPLETED|Washout Period (2 Weeks)||7
9803140|NCT00618410|10911666|FG001|COMPLETED|Washout Period (2 Weeks)||5
9803141|NCT00618410|10911665|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
9803142|NCT00618410|10911666|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
9803143|NCT00618410|10911665|FG000|STARTED|Second Intervention||7
9803144|NCT00618410|10911666|FG001|STARTED|Second Intervention||5
9803145|NCT00618410|10911665|FG000|COMPLETED|Second Intervention||7
9803146|NCT00618410|10911666|FG001|COMPLETED|Second Intervention||5
9803147|NCT00618410|10911665|FG000|NOT COMPLETED|Second Intervention||0
9803148|NCT00618410|10911666|FG001|NOT COMPLETED|Second Intervention||0
9803149|NCT00618436|10911674|FG000|STARTED|Overall Study||34
9803150|NCT00618436|10911675|FG001|STARTED|Overall Study||18
9803151|NCT00618436|10911674|FG000|COMPLETED|Overall Study||34
9803152|NCT00618436|10911675|FG001|COMPLETED|Overall Study||18
9803153|NCT00618436|10911674|FG000|NOT COMPLETED|Overall Study||0
9803154|NCT00618436|10911675|FG001|NOT COMPLETED|Overall Study||0
9803155|NCT00618449|10911683|FG000|STARTED|Overall Study||679
9803156|NCT00618449|10911684|FG001|STARTED|Overall Study||668
9803157|NCT00618449|10911683|FG000|1-month, Post-treatment|Overall Study||666
9803158|NCT00618449|10911684|FG001|1-month, Post-treatment|Overall Study||656
9803159|NCT00618449|10911683|FG000|1-year, Post-treatment|Overall Study||581
9803160|NCT00618449|10911684|FG001|1-year, Post-treatment|Overall Study||558
9803161|NCT00618449|10911683|FG000|COMPLETED|Overall Study||581
9803162|NCT00618449|10911684|FG001|COMPLETED|Overall Study||558
9803163|NCT00618449|10911683|FG000|NOT COMPLETED|Overall Study||98
9803164|NCT00618449|10911684|FG001|NOT COMPLETED|Overall Study||110
9803165|NCT00618514|10911692|FG000|STARTED|Overall Study||36
9803166|NCT00618514|10911693|FG001|STARTED|Overall Study||38
9803167|NCT00618514|10911694|FG002|STARTED|Overall Study||16
9803168|NCT00618514|10911692|FG000|COMPLETED|Overall Study||25
9803169|NCT00618514|10911693|FG001|COMPLETED|Overall Study||26
9803170|NCT00618514|10911694|FG002|COMPLETED|Overall Study||12
9803171|NCT00618514|10911692|FG000|NOT COMPLETED|Overall Study||11
9803172|NCT00618514|10911693|FG001|NOT COMPLETED|Overall Study||12
9803173|NCT00618514|10911694|FG002|NOT COMPLETED|Overall Study||4
9803174|NCT00618540|10911700|FG000|STARTED|Overall Study||1
9803175|NCT00618540|10911700|FG000|COMPLETED|Overall Study||1
9803176|NCT00618540|10911700|FG000|NOT COMPLETED|Overall Study||0
9803177|NCT00618618|10911709|FG000|STARTED|Overall Study||24
9803178|NCT00618618|10911710|FG001|STARTED|Overall Study||14
9803179|NCT00618618|10911711|FG002|STARTED|Overall Study||21
9803180|NCT00618618|10911712|FG003|STARTED|Overall Study||14
9803181|NCT00618618|10911709|FG000|Received Treatment|Overall Study||24
9803182|NCT00618618|10911710|FG001|Received Treatment|Overall Study||13
9803183|NCT00618618|10911711|FG002|Received Treatment|Overall Study||20
9803184|NCT00618618|10911712|FG003|Received Treatment|Overall Study||14
9803185|NCT00618618|10911709|FG000|COMPLETED|Overall Study||20
9803186|NCT00618618|10911710|FG001|COMPLETED|Overall Study||11
9803187|NCT00618618|10911711|FG002|COMPLETED|Overall Study||18
9803188|NCT00618618|10911712|FG003|COMPLETED|Overall Study||13
9803189|NCT00618618|10911709|FG000|NOT COMPLETED|Overall Study||4
9803190|NCT00618618|10911710|FG001|NOT COMPLETED|Overall Study||3
9803191|NCT00618618|10911711|FG002|NOT COMPLETED|Overall Study||3
9803192|NCT00618618|10911712|FG003|NOT COMPLETED|Overall Study||1
9803193|NCT00618722|10911727|FG000|STARTED|Overall Study||21
9803194|NCT00618722|10911728|FG001|STARTED|Overall Study||20
9803195|NCT00618722|10911729|FG002|STARTED|Overall Study||22
9803196|NCT00618722|10911730|FG003|STARTED|Overall Study||22
9803197|NCT00618722|10911727|FG000|Received Treatment|Overall Study||20
9803198|NCT00618722|10911728|FG001|Received Treatment|Overall Study||20
9803199|NCT00618722|10911729|FG002|Received Treatment|Overall Study||22
9803200|NCT00618722|10911730|FG003|Received Treatment|Overall Study||22
9803201|NCT00618722|10911727|FG000|COMPLETED|Overall Study||18
9803202|NCT00618722|10911728|FG001|COMPLETED|Overall Study||18
9803203|NCT00618722|10911729|FG002|COMPLETED|Overall Study||19
9803204|NCT00618722|10911730|FG003|COMPLETED|Overall Study||18
9803205|NCT00618722|10911727|FG000|NOT COMPLETED|Overall Study||3
9803206|NCT00618722|10911728|FG001|NOT COMPLETED|Overall Study||2
9803207|NCT00618722|10911729|FG002|NOT COMPLETED|Overall Study||3
9803208|NCT00618722|10911730|FG003|NOT COMPLETED|Overall Study||4
9803209|NCT00618748|10911743|FG000|STARTED|Overall Study||56
9803210|NCT00618748|10911744|FG001|STARTED|Overall Study||25
9803211|NCT00618748|10911745|FG002|STARTED|Overall Study||20
9803212|NCT00618748|10911743|FG000|COMPLETED|Overall Study||45
9803213|NCT00618748|10911744|FG001|COMPLETED|Overall Study||20
9803214|NCT00618748|10911745|FG002|COMPLETED|Overall Study||6
9803215|NCT00618748|10911743|FG000|NOT COMPLETED|Overall Study||11
9803216|NCT00618748|10911744|FG001|NOT COMPLETED|Overall Study||5
9803217|NCT00618748|10911745|FG002|NOT COMPLETED|Overall Study||14
9803218|NCT00618774|10911755|FG000|STARTED|Overall Study||211
9803219|NCT00618774|10911756|FG001|STARTED|Overall Study||48
9803220|NCT00618774|10911755|FG000|COMPLETED|Overall Study||205
9803221|NCT00618774|10911756|FG001|COMPLETED|Overall Study||45
9803222|NCT00618774|10911755|FG000|NOT COMPLETED|Overall Study||6
9803223|NCT00618774|10911756|FG001|NOT COMPLETED|Overall Study||3
9803224|NCT00618787|10911764|FG000|STARTED|Overall Study||22
9803225|NCT00618787|10911765|FG001|STARTED|Overall Study||23
9803226|NCT00618787|10911764|FG000|COMPLETED|Overall Study||19
9803227|NCT00618787|10911765|FG001|COMPLETED|Overall Study||21
9803228|NCT00618787|10911764|FG000|NOT COMPLETED|Overall Study||3
9803229|NCT00618787|10911765|FG001|NOT COMPLETED|Overall Study||2
9803230|NCT00618813|10911771|FG000|STARTED|Overall Study||35
9803231|NCT00618813|10911771|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
9803232|NCT00618813|10911771|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
9803233|NCT00618813|10911771|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
9803234|NCT00618813|10911771|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
9803235|NCT00618813|10911771|FG000|COMPLETED|Overall Study||31
9803236|NCT00618813|10911771|FG000|NOT COMPLETED|Overall Study||4
9803237|NCT00618826|10911775|FG000|STARTED|Overall Study||14
9803238|NCT00618826|10911775|FG000|COMPLETED|Overall Study||13
9803239|NCT00618826|10911775|FG000|NOT COMPLETED|Overall Study||1
9803240|NCT00618839|10911780|FG000|STARTED|Overall Study||15
9803241|NCT00618839|10911780|FG000|COMPLETED|Overall Study||15
9803242|NCT00618839|10911780|FG000|NOT COMPLETED|Overall Study||0
9803243|NCT00618917|10911790|FG000|STARTED|Overall Study||4
9803244|NCT00618917|10911791|FG001|STARTED|Overall Study||3
9803245|NCT00618917|10911792|FG002|STARTED|Overall Study||11
10015976|NCT01808339|11138996|FG000|STARTED|Treatment Period 1 (14 Days)||4
10015977|NCT01808339|11138997|FG001|STARTED|Treatment Period 1 (14 Days)||4
10015978|NCT01808339|11138998|FG002|STARTED|Treatment Period 1 (14 Days)||4
9803246|NCT00618917|10911790|FG000|COMPLETED|Overall Study||3
9803247|NCT00618917|10911791|FG001|COMPLETED|Overall Study||3
9803248|NCT00618917|10911792|FG002|COMPLETED|Overall Study||11
9803249|NCT00618917|10911790|FG000|NOT COMPLETED|Overall Study||1
9803250|NCT00618917|10911791|FG001|NOT COMPLETED|Overall Study||0
9803251|NCT00618917|10911792|FG002|NOT COMPLETED|Overall Study||0
9803252|NCT00618956|10911802|FG000|STARTED|Overall Study||111
9803253|NCT00618956|10911803|FG001|STARTED|Overall Study||210
9803254|NCT00618956|10911802|FG000|COMPLETED|Overall Study||86
9803255|NCT00618956|10911803|FG001|COMPLETED|Overall Study||160
10015979|NCT01808339|11138999|FG003|STARTED|Treatment Period 1 (14 Days)||4
9803256|NCT00618956|10911802|FG000|NOT COMPLETED|Overall Study||25
9803257|NCT00618956|10911803|FG001|NOT COMPLETED|Overall Study||50
9803258|NCT00618982|10911815|FG000|STARTED|Overall Study||83
9803259|NCT00618982|10911815|FG000|COMPLETED|Overall Study||33
9803260|NCT00618982|10911815|FG000|NOT COMPLETED|Overall Study||50
9803261|NCT00618995|10911822|FG000|STARTED|Period 1||6
9803262|NCT00618995|10911823|FG001|STARTED|Period 1||7
9803263|NCT00618995|10911824|FG002|STARTED|Period 1||7
9803264|NCT00618995|10911825|FG003|STARTED|Period 1||6
9803265|NCT00618995|10911822|FG000|COMPLETED|Period 1||6
9803266|NCT00618995|10911823|FG001|COMPLETED|Period 1||6
9803267|NCT00618995|10911824|FG002|COMPLETED|Period 1||5
9803268|NCT00618995|10911825|FG003|COMPLETED|Period 1||6
9803269|NCT00618995|10911822|FG000|NOT COMPLETED|Period 1||0
9803270|NCT00618995|10911823|FG001|NOT COMPLETED|Period 1||1
9803271|NCT00618995|10911824|FG002|NOT COMPLETED|Period 1||2
9803272|NCT00618995|10911825|FG003|NOT COMPLETED|Period 1||0
9803273|NCT00618995|10911822|FG000|STARTED|Period 2||6
9803274|NCT00618995|10911823|FG001|STARTED|Period 2||6
9803275|NCT00618995|10911824|FG002|STARTED|Period 2||5
9803276|NCT00618995|10911825|FG003|STARTED|Period 2||6
9803277|NCT00618995|10911822|FG000|COMPLETED|Period 2||6
9803278|NCT00618995|10911823|FG001|COMPLETED|Period 2||6
9803279|NCT00618995|10911824|FG002|COMPLETED|Period 2||4
9803280|NCT00618995|10911825|FG003|COMPLETED|Period 2||6
9803281|NCT00618995|10911822|FG000|NOT COMPLETED|Period 2||0
9803282|NCT00618995|10911823|FG001|NOT COMPLETED|Period 2||0
9803283|NCT00618995|10911824|FG002|NOT COMPLETED|Period 2||1
9803284|NCT00618995|10911825|FG003|NOT COMPLETED|Period 2||0
9803285|NCT00618995|10911822|FG000|STARTED|Period 3||6
9803286|NCT00618995|10911823|FG001|STARTED|Period 3||6
9803287|NCT00618995|10911824|FG002|STARTED|Period 3||4
9803288|NCT00618995|10911825|FG003|STARTED|Period 3||6
9803289|NCT00618995|10911822|FG000|COMPLETED|Period 3||6
9803290|NCT00618995|10911823|FG001|COMPLETED|Period 3||6
9803291|NCT00618995|10911824|FG002|COMPLETED|Period 3||4
9803292|NCT00618995|10911825|FG003|COMPLETED|Period 3||6
9803293|NCT00618995|10911822|FG000|NOT COMPLETED|Period 3||0
9803294|NCT00618995|10911823|FG001|NOT COMPLETED|Period 3||0
9803295|NCT00618995|10911824|FG002|NOT COMPLETED|Period 3||0
9803296|NCT00618995|10911825|FG003|NOT COMPLETED|Period 3||0
9803297|NCT00618995|10911822|FG000|STARTED|Period 4||6
9803298|NCT00618995|10911823|FG001|STARTED|Period 4||6
9803299|NCT00618995|10911824|FG002|STARTED|Period 4||4
9803300|NCT00618995|10911825|FG003|STARTED|Period 4||6
9803301|NCT00618995|10911822|FG000|COMPLETED|Period 4||5
9803302|NCT00618995|10911823|FG001|COMPLETED|Period 4||6
9803303|NCT00618995|10911824|FG002|COMPLETED|Period 4||4
9803304|NCT00618995|10911825|FG003|COMPLETED|Period 4||6
9803305|NCT00618995|10911822|FG000|NOT COMPLETED|Period 4||1
9803306|NCT00618995|10911823|FG001|NOT COMPLETED|Period 4||0
9803307|NCT00618995|10911824|FG002|NOT COMPLETED|Period 4||0
9803308|NCT00618995|10911825|FG003|NOT COMPLETED|Period 4||0
9803309|NCT00619060|10911835|FG000|STARTED|Overall Study||10
9803310|NCT00619060|10911836|FG001|STARTED|Overall Study||12
9803311|NCT00619060|10911835|FG000|COMPLETED|Overall Study||10
9803312|NCT00619060|10911836|FG001|COMPLETED|Overall Study||12
9803313|NCT00619060|10911835|FG000|NOT COMPLETED|Overall Study||0
9803314|NCT00619060|10911836|FG001|NOT COMPLETED|Overall Study||0
9803315|NCT00619073|10911844|FG000|STARTED|First Intervention - 60 Days||8
9803316|NCT00619073|10911845|FG001|STARTED|First Intervention - 60 Days||8
9803317|NCT00619073|10911844|FG000|COMPLETED|First Intervention - 60 Days||8
9803318|NCT00619073|10911845|FG001|COMPLETED|First Intervention - 60 Days||8
9803319|NCT00619073|10911844|FG000|NOT COMPLETED|First Intervention - 60 Days||0
9803320|NCT00619073|10911845|FG001|NOT COMPLETED|First Intervention - 60 Days||0
9803321|NCT00619073|10911844|FG000|STARTED|Washout Period (30 Days)||8
9803322|NCT00619073|10911845|FG001|STARTED|Washout Period (30 Days)||8
9803323|NCT00619073|10911844|FG000|COMPLETED|Washout Period (30 Days)||8
9803324|NCT00619073|10911845|FG001|COMPLETED|Washout Period (30 Days)||8
9803325|NCT00619073|10911844|FG000|NOT COMPLETED|Washout Period (30 Days)||0
9803326|NCT00619073|10911845|FG001|NOT COMPLETED|Washout Period (30 Days)||0
9803327|NCT00619073|10911844|FG000|STARTED|Second Intervention - 60 Days||8
9803328|NCT00619073|10911845|FG001|STARTED|Second Intervention - 60 Days||8
9803329|NCT00619073|10911844|FG000|COMPLETED|Second Intervention - 60 Days||8
9803330|NCT00619073|10911845|FG001|COMPLETED|Second Intervention - 60 Days||8
9803331|NCT00619073|10911844|FG000|NOT COMPLETED|Second Intervention - 60 Days||0
9803332|NCT00619073|10911845|FG001|NOT COMPLETED|Second Intervention - 60 Days||0
10015980|NCT01808339|11139000|FG004|STARTED|Treatment Period 1 (14 Days)||6
10015981|NCT01808339|11139001|FG005|STARTED|Treatment Period 1 (14 Days)||6
10015982|NCT01808339|11138996|FG000|COMPLETED|Treatment Period 1 (14 Days)||4
10015983|NCT01808339|11138997|FG001|COMPLETED|Treatment Period 1 (14 Days)||3
10015984|NCT01808339|11138998|FG002|COMPLETED|Treatment Period 1 (14 Days)||4
10015985|NCT01808339|11138999|FG003|COMPLETED|Treatment Period 1 (14 Days)||2
10015986|NCT01808339|11139000|FG004|COMPLETED|Treatment Period 1 (14 Days)||4
9803333|NCT00619099|10911853|FG000|STARTED|Overall Study|All randomized subjects|44
9803334|NCT00619099|10911854|FG001|STARTED|Overall Study|All randomized subjects|23
9803335|NCT00619099|10911853|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
9803336|NCT00619099|10911854|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
9803337|NCT00619099|10911853|FG000|COMPLETED|Overall Study||11
9803338|NCT00619099|10911854|FG001|COMPLETED|Overall Study||4
9803339|NCT00619099|10911853|FG000|NOT COMPLETED|Overall Study||33
9803340|NCT00619099|10911854|FG001|NOT COMPLETED|Overall Study||19
9803341|NCT00619112|10911862|FG000|STARTED|Overall Study||40
9803342|NCT00619112|10911863|FG001|STARTED|Overall Study||20
9803343|NCT00619112|10911862|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
9803344|NCT00619112|10911863|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
9803345|NCT00619112|10911862|FG000|NOT COMPLETED|Overall Study||1
10015987|NCT01808339|11139001|FG005|COMPLETED|Treatment Period 1 (14 Days)||5
10015988|NCT01808339|11138996|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10015989|NCT01808339|11138997|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10015990|NCT01808339|11138998|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10015991|NCT01808339|11138999|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10015992|NCT01808339|11139000|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2
9803346|NCT00619112|10911863|FG001|NOT COMPLETED|Overall Study||2
9803347|NCT00619177|10911872|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
9803348|NCT00619177|10911872|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
9803349|NCT00619177|10911872|FG000|NOT COMPLETED|Overall Study||508
9803350|NCT00619190|10911878|FG000|STARTED|Overall Study||21
9803351|NCT00619190|10911879|FG001|STARTED|Overall Study||9
9803352|NCT00619190|10911878|FG000|COMPLETED|Overall Study||20
9803353|NCT00619190|10911879|FG001|COMPLETED|Overall Study||9
9803354|NCT00619190|10911878|FG000|NOT COMPLETED|Overall Study||1
9803355|NCT00619190|10911879|FG001|NOT COMPLETED|Overall Study||0
9803356|NCT00619229|10911887|FG000|STARTED|Overall Study||18
9803357|NCT00619229|10911888|FG001|STARTED|Overall Study||18
9803358|NCT00619229|10911887|FG000|Full Analysis Set (FAS)|Overall Study||16
9803359|NCT00619229|10911888|FG001|Full Analysis Set (FAS)|Overall Study||17
9803360|NCT00619229|10911887|FG000|COMPLETED|Overall Study||14
9803361|NCT00619229|10911888|FG001|COMPLETED|Overall Study||16
9803362|NCT00619229|10911887|FG000|NOT COMPLETED|Overall Study||4
9803363|NCT00619229|10911888|FG001|NOT COMPLETED|Overall Study||2
9803364|NCT00619255|10911896|FG000|STARTED|Overall Study||59
9803365|NCT00619255|10911897|FG001|STARTED|Overall Study||61
9803366|NCT00619255|10911896|FG000|COMPLETED|Overall Study||57
9803367|NCT00619255|10911897|FG001|COMPLETED|Overall Study||61
9803368|NCT00619255|10911896|FG000|NOT COMPLETED|Overall Study||2
9803369|NCT00619255|10911897|FG001|NOT COMPLETED|Overall Study||0
9803370|NCT00619307|10911905|FG000|STARTED|Overall Study||60
9803371|NCT00619307|10911906|FG001|STARTED|Overall Study||57
9803372|NCT00619307|10911905|FG000|COMPLETED|Overall Study||56
9803373|NCT00619307|10911906|FG001|COMPLETED|Overall Study||53
9803374|NCT00619307|10911905|FG000|NOT COMPLETED|Overall Study||4
9803375|NCT00619307|10911906|FG001|NOT COMPLETED|Overall Study||4
9803376|NCT00619359|10911914|FG000|STARTED|Overall Study||1147
9803377|NCT00619359|10911915|FG001|STARTED|Overall Study||1175
9803378|NCT00619359|10911914|FG000|COMPLETED|Overall Study||1080
9803379|NCT00619359|10911915|FG001|COMPLETED|Overall Study||1094
9803380|NCT00619359|10911914|FG000|NOT COMPLETED|Overall Study||67
9803381|NCT00619359|10911915|FG001|NOT COMPLETED|Overall Study||81
9803382|NCT00619385|10911924|FG000|STARTED|Overall Study||7
9803383|NCT00619385|10911925|FG001|STARTED|Overall Study||8
9803384|NCT00619385|10911926|FG002|STARTED|Overall Study||10
9803385|NCT00619385|10911924|FG000|COMPLETED|Overall Study||6
9803386|NCT00619385|10911925|FG001|COMPLETED|Overall Study||6
9803387|NCT00619385|10911926|FG002|COMPLETED|Overall Study||6
9803388|NCT00619385|10911924|FG000|NOT COMPLETED|Overall Study||1
9803389|NCT00619385|10911925|FG001|NOT COMPLETED|Overall Study||2
9803390|NCT00619385|10911926|FG002|NOT COMPLETED|Overall Study||4
9803391|NCT00619476|10911941|FG000|STARTED|Overall Study||95
9803392|NCT00619476|10911942|FG001|STARTED|Overall Study||107
9803393|NCT00619476|10911943|FG002|STARTED|Overall Study||84
9803394|NCT00619476|10911944|FG003|STARTED|Overall Study||90
9803395|NCT00619476|10911941|FG000|Intent-to-Treat Population|Overall Study||95
9803396|NCT00619476|10911942|FG001|Intent-to-Treat Population|Overall Study||107
9803397|NCT00619476|10911943|FG002|Intent-to-Treat Population|Overall Study||82
9803398|NCT00619476|10911944|FG003|Intent-to-Treat Population|Overall Study||87
9803399|NCT00619476|10911941|FG000|Safety Population|Overall Study||95
9803400|NCT00619476|10911942|FG001|Safety Population|Overall Study||107
9803401|NCT00619476|10911943|FG002|Safety Population|Overall Study||82
9803402|NCT00619476|10911944|FG003|Safety Population|Overall Study||87
9803403|NCT00619476|10911941|FG000|COMPLETED|Overall Study||64
9803404|NCT00619476|10911942|FG001|COMPLETED|Overall Study||85
9803405|NCT00619476|10911943|FG002|COMPLETED|Overall Study||60
9803406|NCT00619476|10911944|FG003|COMPLETED|Overall Study||56
9803407|NCT00619476|10911941|FG000|NOT COMPLETED|Overall Study||31
9803408|NCT00619476|10911942|FG001|NOT COMPLETED|Overall Study||22
9803409|NCT00619476|10911943|FG002|NOT COMPLETED|Overall Study||24
9803410|NCT00619476|10911944|FG003|NOT COMPLETED|Overall Study||34
9803411|NCT00619489|10911956|FG000|STARTED|Overall Study||37
9803412|NCT00619489|10911957|FG001|STARTED|Overall Study||35
9803413|NCT00619489|10911956|FG000|COMPLETED|Overall Study||14
9803414|NCT00619489|10911957|FG001|COMPLETED|Overall Study||1
9803415|NCT00619489|10911956|FG000|NOT COMPLETED|Overall Study||23
9803416|NCT00619489|10911957|FG001|NOT COMPLETED|Overall Study||34
10015993|NCT01808339|11139001|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
9803417|NCT00619502|10911965|FG000|STARTED|Overall Study||130
9803418|NCT00619502|10911966|FG001|STARTED|Overall Study||124
9803419|NCT00619502|10911965|FG000|COMPLETED|Overall Study||122
9803420|NCT00619502|10911966|FG001|COMPLETED|Overall Study||114
9803421|NCT00619502|10911965|FG000|NOT COMPLETED|Overall Study||8
9803422|NCT00619502|10911966|FG001|NOT COMPLETED|Overall Study||10
9803423|NCT00619619|10911982|FG000|STARTED|Overall Study||6
9803424|NCT00619619|10911983|FG001|STARTED|Overall Study||7
9803425|NCT00619619|10911984|FG002|STARTED|Overall Study||9
9803426|NCT00619619|10911985|FG003|STARTED|Overall Study||7
9803427|NCT00619619|10911986|FG004|STARTED|Overall Study||7
9803428|NCT00619619|10911987|FG005|STARTED|Overall Study||7
9803429|NCT00619619|10911988|FG006|STARTED|Overall Study||8
9803430|NCT00619619|10911989|FG007|STARTED|Overall Study||8
9803431|NCT00619619|10911982|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
9803432|NCT00619619|10911983|FG001|Entered the Extension Study|Overall Study||5
9803433|NCT00619619|10911984|FG002|Entered the Extension Study|Overall Study||8
9803434|NCT00619619|10911985|FG003|Entered the Extension Study|Overall Study||3
9803435|NCT00619619|10911986|FG004|Entered the Extension Study|Overall Study||7
9803436|NCT00619619|10911987|FG005|Entered the Extension Study|Overall Study||6
9803437|NCT00619619|10911988|FG006|Entered the Extension Study|Overall Study||6
9803438|NCT00619619|10911989|FG007|Entered the Extension Study|Overall Study||7
9803439|NCT00619619|10911982|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
9803440|NCT00619619|10911983|FG001|COMPLETED|Overall Study||7
9803441|NCT00619619|10911984|FG002|COMPLETED|Overall Study||8
9803442|NCT00619619|10911985|FG003|COMPLETED|Overall Study||6
9803443|NCT00619619|10911986|FG004|COMPLETED|Overall Study||5
9803444|NCT00619619|10911987|FG005|COMPLETED|Overall Study||7
9803445|NCT00619619|10911988|FG006|COMPLETED|Overall Study||7
9803446|NCT00619619|10911989|FG007|COMPLETED|Overall Study||5
9803447|NCT00619619|10911982|FG000|NOT COMPLETED|Overall Study||0
9803448|NCT00619619|10911983|FG001|NOT COMPLETED|Overall Study||0
9803449|NCT00619619|10911984|FG002|NOT COMPLETED|Overall Study||1
9803450|NCT00619619|10911985|FG003|NOT COMPLETED|Overall Study||1
9803451|NCT00619619|10911986|FG004|NOT COMPLETED|Overall Study||2
9803452|NCT00619619|10911987|FG005|NOT COMPLETED|Overall Study||0
9803453|NCT00619619|10911988|FG006|NOT COMPLETED|Overall Study||1
9803454|NCT00619619|10911989|FG007|NOT COMPLETED|Overall Study||3
9803455|NCT00619645|10912010|FG000|STARTED|Overall Study||8
9803456|NCT00619645|10912010|FG000|COMPLETED|Overall Study||7
9803457|NCT00619645|10912010|FG000|NOT COMPLETED|Overall Study||1
9803458|NCT00619684|10912014|FG000|STARTED|Overall Study||18
9803459|NCT00619684|10912014|FG000|COMPLETED|Overall Study||18
9803460|NCT00619684|10912014|FG000|NOT COMPLETED|Overall Study||0
9803461|NCT00619723|10912020|FG000|STARTED|Overall Study||63
9803462|NCT00619723|10912021|FG001|STARTED|Overall Study||67
9803463|NCT00619723|10912020|FG000|COMPLETED|Overall Study||61
9803464|NCT00619723|10912021|FG001|COMPLETED|Overall Study||61
9803465|NCT00619723|10912020|FG000|NOT COMPLETED|Overall Study||2
9803466|NCT00619723|10912021|FG001|NOT COMPLETED|Overall Study||6
9803467|NCT00619762|10912027|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
9803468|NCT00619762|10912027|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
9803469|NCT00619762|10912027|FG000|NOT COMPLETED|Overall Study||3
9803470|NCT00619801|10912034|FG000|STARTED|Overall Study||59
9803471|NCT00619801|10912035|FG001|STARTED|Overall Study||114
9803472|NCT00619801|10912034|FG000|Safety Population|Overall Study||59
9803473|NCT00619801|10912035|FG001|Safety Population|Overall Study||114
9803474|NCT00619801|10912034|FG000|COMPLETED|Overall Study||58
9803475|NCT00619801|10912035|FG001|COMPLETED|Overall Study||111
9803476|NCT00619801|10912034|FG000|NOT COMPLETED|Overall Study||1
9803477|NCT00619801|10912035|FG001|NOT COMPLETED|Overall Study||3
9803478|NCT00619827|10912043|FG000|STARTED|Overall Study||45
9803479|NCT00619827|10912044|FG001|STARTED|Overall Study||44
9803480|NCT00619827|10912043|FG000|COMPLETED|Overall Study||42
9803481|NCT00619827|10912044|FG001|COMPLETED|Overall Study||40
9803482|NCT00619827|10912043|FG000|NOT COMPLETED|Overall Study||3
9803483|NCT00619827|10912044|FG001|NOT COMPLETED|Overall Study||4
9803484|NCT00619866|10912053|FG000|STARTED|Weeks 1 - 12||52
9803485|NCT00619866|10912054|FG001|STARTED|Weeks 1 - 12||51
9803486|NCT00619866|10912055|FG002|STARTED|Weeks 1 - 12||52
9803487|NCT00619866|10912056|FG003|STARTED|Weeks 1 - 12||0
9803488|NCT00619866|10912057|FG004|STARTED|Weeks 1 - 12||0
9803489|NCT00619866|10912053|FG000|COMPLETED|Weeks 1 - 12||38
9803490|NCT00619866|10912054|FG001|COMPLETED|Weeks 1 - 12||45
9803491|NCT00619866|10912055|FG002|COMPLETED|Weeks 1 - 12||42
9803492|NCT00619866|10912056|FG003|COMPLETED|Weeks 1 - 12||0
9803493|NCT00619866|10912057|FG004|COMPLETED|Weeks 1 - 12||0
9803494|NCT00619866|10912053|FG000|NOT COMPLETED|Weeks 1 - 12||14
9803495|NCT00619866|10912054|FG001|NOT COMPLETED|Weeks 1 - 12||6
9803496|NCT00619866|10912055|FG002|NOT COMPLETED|Weeks 1 - 12||10
9803497|NCT00619866|10912056|FG003|NOT COMPLETED|Weeks 1 - 12||0
9803498|NCT00619866|10912057|FG004|NOT COMPLETED|Weeks 1 - 12||0
9803499|NCT00619866|10912053|FG000|STARTED|Weeks 13 - 24||0
9803500|NCT00619866|10912054|FG001|STARTED|Weeks 13 - 24||45
9803501|NCT00619866|10912055|FG002|STARTED|Weeks 13 - 24||42
9803502|NCT00619866|10912056|FG003|STARTED|Weeks 13 - 24||18
9803503|NCT00619866|10912057|FG004|STARTED|Weeks 13 - 24||20
9803504|NCT00619866|10912053|FG000|COMPLETED|Weeks 13 - 24||0
9803505|NCT00619866|10912054|FG001|COMPLETED|Weeks 13 - 24||38
9803506|NCT00619866|10912055|FG002|COMPLETED|Weeks 13 - 24||37
9803507|NCT00619866|10912056|FG003|COMPLETED|Weeks 13 - 24||14
9803508|NCT00619866|10912057|FG004|COMPLETED|Weeks 13 - 24||18
9803509|NCT00619866|10912053|FG000|NOT COMPLETED|Weeks 13 - 24||0
9803510|NCT00619866|10912054|FG001|NOT COMPLETED|Weeks 13 - 24||7
9803511|NCT00619866|10912055|FG002|NOT COMPLETED|Weeks 13 - 24||5
9803512|NCT00619866|10912056|FG003|NOT COMPLETED|Weeks 13 - 24||4
9803513|NCT00619866|10912057|FG004|NOT COMPLETED|Weeks 13 - 24||2
9803514|NCT00619892|10912071|FG000|STARTED|Overall Study||13
9803515|NCT00619892|10912072|FG001|STARTED|Overall Study||13
9803516|NCT00619892|10912071|FG000|COMPLETED|Overall Study||10
9803517|NCT00619892|10912072|FG001|COMPLETED|Overall Study||11
9803518|NCT00619892|10912071|FG000|NOT COMPLETED|Overall Study||3
9803519|NCT00619892|10912072|FG001|NOT COMPLETED|Overall Study||2
9803520|NCT00619918|10912082|FG000|STARTED|Overall Study||230
9803521|NCT00619918|10912083|FG001|STARTED|Overall Study||217
9803522|NCT00619918|10912082|FG000|COMPLETED|Overall Study||210
9803523|NCT00619918|10912083|FG001|COMPLETED|Overall Study||195
9803524|NCT00619918|10912082|FG000|NOT COMPLETED|Overall Study||20
9803525|NCT00619918|10912083|FG001|NOT COMPLETED|Overall Study||22
9803526|NCT00619957|10912091|FG000|STARTED|Month 24 Double-Blind||93
9803527|NCT00619957|10912092|FG001|STARTED|Month 24 Double-Blind||192
9803528|NCT00619957|10912091|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
9803529|NCT00619957|10912092|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
9803530|NCT00619957|10912091|FG000|COMPLETED|Month 24 Double-Blind||75
9803531|NCT00619957|10912092|FG001|COMPLETED|Month 24 Double-Blind||175
9803532|NCT00619957|10912091|FG000|NOT COMPLETED|Month 24 Double-Blind||18
10015994|NCT01808339|11138996|FG000|STARTED|Washout Period 1 (14-21 Days)||4
10015995|NCT01808339|11138997|FG001|STARTED|Washout Period 1 (14-21 Days)||3
10015996|NCT01808339|11138998|FG002|STARTED|Washout Period 1 (14-21 Days)||4
10015997|NCT01808339|11138999|FG003|STARTED|Washout Period 1 (14-21 Days)||2
10015998|NCT01808339|11139000|FG004|STARTED|Washout Period 1 (14-21 Days)||4
10015999|NCT01808339|11139001|FG005|STARTED|Washout Period 1 (14-21 Days)||5
9803533|NCT00619957|10912092|FG001|NOT COMPLETED|Month 24 Double-Blind||17
9803534|NCT00619957|10912091|FG000|STARTED|Month 48 Open-Label||67
9803535|NCT00619957|10912092|FG001|STARTED|Month 48 Open-Label||151
9803536|NCT00619957|10912091|FG000|COMPLETED|Month 48 Open-Label||55
9803537|NCT00619957|10912092|FG001|COMPLETED|Month 48 Open-Label||134
9803538|NCT00619957|10912091|FG000|NOT COMPLETED|Month 48 Open-Label||12
9803539|NCT00619957|10912092|FG001|NOT COMPLETED|Month 48 Open-Label||17
9803540|NCT00619970|10912103|FG000|STARTED|Overall Study||40
9803541|NCT00619970|10912104|FG001|STARTED|Overall Study||49
9803542|NCT00619970|10912105|FG002|STARTED|Overall Study||26
9803543|NCT00619970|10912103|FG000|COMPLETED|Overall Study||40
9803544|NCT00619970|10912104|FG001|COMPLETED|Overall Study||46
9803545|NCT00619970|10912105|FG002|COMPLETED|Overall Study||24
9803546|NCT00619970|10912103|FG000|NOT COMPLETED|Overall Study||0
9803547|NCT00619970|10912104|FG001|NOT COMPLETED|Overall Study||3
9803548|NCT00619970|10912105|FG002|NOT COMPLETED|Overall Study||2
9803549|NCT00619983|10912119|FG000|STARTED|Test Drug Alone||5
9803550|NCT00619983|10912120|FG001|STARTED|Test Drug Alone||5
9803551|NCT00619983|10912121|FG002|STARTED|Test Drug Alone||6
9803552|NCT00619983|10912122|FG003|STARTED|Test Drug Alone||6
9803553|NCT00619983|10912119|FG000|COMPLETED|Test Drug Alone||3
10016000|NCT01808339|11138996|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4
10016001|NCT01808339|11138997|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3
10016002|NCT01808339|11138998|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4
10016003|NCT01808339|11138999|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2
10016004|NCT01808339|11139000|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4
10016005|NCT01808339|11139001|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5
9803554|NCT00619983|10912120|FG001|COMPLETED|Test Drug Alone||4
9803555|NCT00619983|10912121|FG002|COMPLETED|Test Drug Alone||4
9803556|NCT00619983|10912122|FG003|COMPLETED|Test Drug Alone||3
9803557|NCT00619983|10912119|FG000|NOT COMPLETED|Test Drug Alone||2
9803558|NCT00619983|10912120|FG001|NOT COMPLETED|Test Drug Alone||1
9803559|NCT00619983|10912121|FG002|NOT COMPLETED|Test Drug Alone||2
9803560|NCT00619983|10912122|FG003|NOT COMPLETED|Test Drug Alone||3
9803561|NCT00619983|10912119|FG000|STARTED|Test Drug Plus Gabapentin||3
9803562|NCT00619983|10912120|FG001|STARTED|Test Drug Plus Gabapentin||4
9803563|NCT00619983|10912121|FG002|STARTED|Test Drug Plus Gabapentin||4
9803564|NCT00619983|10912122|FG003|STARTED|Test Drug Plus Gabapentin||3
9803565|NCT00619983|10912119|FG000|COMPLETED|Test Drug Plus Gabapentin||3
9803566|NCT00619983|10912120|FG001|COMPLETED|Test Drug Plus Gabapentin||4
9803567|NCT00619983|10912121|FG002|COMPLETED|Test Drug Plus Gabapentin||4
9803568|NCT00619983|10912122|FG003|COMPLETED|Test Drug Plus Gabapentin||3
9803569|NCT00619983|10912119|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0
9803570|NCT00619983|10912120|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0
9803571|NCT00619983|10912121|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0
9803572|NCT00619983|10912122|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0
9803573|NCT00619983|10912119|FG000|STARTED|Gabapentin Alone||3
9803574|NCT00619983|10912120|FG001|STARTED|Gabapentin Alone||4
9803575|NCT00619983|10912121|FG002|STARTED|Gabapentin Alone||4
9803576|NCT00619983|10912122|FG003|STARTED|Gabapentin Alone||3
9803577|NCT00619983|10912119|FG000|COMPLETED|Gabapentin Alone||3
9803578|NCT00619983|10912120|FG001|COMPLETED|Gabapentin Alone||4
9803579|NCT00619983|10912121|FG002|COMPLETED|Gabapentin Alone||4
9803580|NCT00619983|10912122|FG003|COMPLETED|Gabapentin Alone||3
9803581|NCT00619983|10912119|FG000|NOT COMPLETED|Gabapentin Alone||0
9803582|NCT00619983|10912120|FG001|NOT COMPLETED|Gabapentin Alone||0
9803583|NCT00619983|10912121|FG002|NOT COMPLETED|Gabapentin Alone||0
9803584|NCT00619983|10912122|FG003|NOT COMPLETED|Gabapentin Alone||0
9803585|NCT00620022|10912132|FG000|STARTED|Treatment Period 1||46
10016006|NCT01808339|11138996|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
9803586|NCT00620022|10912133|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
9803587|NCT00620022|10912132|FG000|COMPLETED|Treatment Period 1||41
9803588|NCT00620022|10912133|FG001|COMPLETED|Treatment Period 1||37
9803589|NCT00620022|10912132|FG000|NOT COMPLETED|Treatment Period 1||5
9803590|NCT00620022|10912133|FG001|NOT COMPLETED|Treatment Period 1||6
9803591|NCT00620022|10912132|FG000|STARTED|Treatment Period 2||41
9803592|NCT00620022|10912133|FG001|STARTED|Treatment Period 2||37
9803593|NCT00620022|10912132|FG000|COMPLETED|Treatment Period 2||39
9803594|NCT00620022|10912133|FG001|COMPLETED|Treatment Period 2||35
9803595|NCT00620022|10912132|FG000|NOT COMPLETED|Treatment Period 2||2
9803596|NCT00620022|10912133|FG001|NOT COMPLETED|Treatment Period 2||2
9803597|NCT00620061|10912139|FG000|STARTED|Overall Study||439
9803598|NCT00620061|10912139|FG000|COMPLETED|Overall Study||286
9803599|NCT00620061|10912139|FG000|NOT COMPLETED|Overall Study||153
9803600|NCT00620074|10912144|FG000|STARTED|Overall Study||6
9803601|NCT00620074|10912144|FG000|COMPLETED|Overall Study||5
9803602|NCT00620074|10912144|FG000|NOT COMPLETED|Overall Study||1
9803603|NCT00620113|10912152|FG000|STARTED|Overall Study||73
9803604|NCT00620113|10912153|FG001|STARTED|Overall Study||74
9803605|NCT00620113|10912154|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
9803606|NCT00620113|10912155|FG003|STARTED|Overall Study||69
9803607|NCT00620113|10912152|FG000|Efficacy/Safety Population|Overall Study||73
9803608|NCT00620113|10912153|FG001|Efficacy/Safety Population|Overall Study||74
9803609|NCT00620113|10912154|FG002|Efficacy/Safety Population|Overall Study||70
9803610|NCT00620113|10912155|FG003|Efficacy/Safety Population|Overall Study||69
9803611|NCT00620113|10912152|FG000|COMPLETED|Overall Study||60
9803612|NCT00620113|10912153|FG001|COMPLETED|Overall Study||67
9803613|NCT00620113|10912154|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
9803614|NCT00620113|10912155|FG003|COMPLETED|Overall Study||59
9803615|NCT00620113|10912152|FG000|NOT COMPLETED|Overall Study||13
9803616|NCT00620113|10912153|FG001|NOT COMPLETED|Overall Study||7
9803617|NCT00620113|10912154|FG002|NOT COMPLETED|Overall Study||5
9803618|NCT00620113|10912155|FG003|NOT COMPLETED|Overall Study||10
9803619|NCT00620126|10912167|FG000|STARTED|Overall Study||25
9803620|NCT00620126|10912168|FG001|STARTED|Overall Study||22
9803621|NCT00620126|10912167|FG000|COMPLETED|Overall Study||14
9803622|NCT00620126|10912168|FG001|COMPLETED|Overall Study||17
9803623|NCT00620126|10912167|FG000|NOT COMPLETED|Overall Study||11
9803624|NCT00620126|10912168|FG001|NOT COMPLETED|Overall Study||5
9803625|NCT00620191|10912176|FG000|STARTED|Overall Study||40
9803626|NCT00620191|10912177|FG001|STARTED|Overall Study||40
9803627|NCT00620191|10912176|FG000|3 Month Follow-up|Overall Study||39
9803628|NCT00620191|10912177|FG001|3 Month Follow-up|Overall Study||39
9803629|NCT00620191|10912176|FG000|6 Month Follow-up|Overall Study||38
9803630|NCT00620191|10912177|FG001|6 Month Follow-up|Overall Study||36
9803631|NCT00620191|10912176|FG000|9 Month Follow-up|Overall Study||37
9803632|NCT00620191|10912177|FG001|9 Month Follow-up|Overall Study||34
9803633|NCT00620191|10912176|FG000|COMPLETED|Overall Study|12 month follow-up|33
9803634|NCT00620191|10912177|FG001|COMPLETED|Overall Study|12 month follow-up|32
9803635|NCT00620191|10912176|FG000|NOT COMPLETED|Overall Study||7
9803636|NCT00620191|10912177|FG001|NOT COMPLETED|Overall Study||8
9803637|NCT00620282|10912191|FG000|STARTED|Overall Study||16
9803638|NCT00620282|10912192|FG001|STARTED|Overall Study||16
9803639|NCT00620282|10912193|FG002|STARTED|Overall Study||17
9803640|NCT00620282|10912191|FG000|COMPLETED|Overall Study||16
9803641|NCT00620282|10912192|FG001|COMPLETED|Overall Study||14
9803642|NCT00620282|10912193|FG002|COMPLETED|Overall Study||16
9803643|NCT00620282|10912191|FG000|NOT COMPLETED|Overall Study||0
9803644|NCT00620282|10912192|FG001|NOT COMPLETED|Overall Study||2
9803645|NCT00620282|10912193|FG002|NOT COMPLETED|Overall Study||1
9803646|NCT00620321|10912203|FG000|STARTED|Overall Study||8
9803647|NCT00620321|10912204|FG001|STARTED|Overall Study||16
9803648|NCT00620321|10912203|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9803649|NCT00620321|10912204|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
9803650|NCT00620321|10912203|FG000|COMPLETED|Overall Study||0
9803651|NCT00620321|10912204|FG001|COMPLETED|Overall Study||0
9803652|NCT00620321|10912203|FG000|NOT COMPLETED|Overall Study||8
9803653|NCT00620321|10912204|FG001|NOT COMPLETED|Overall Study||16
10016007|NCT01808339|11138997|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10016008|NCT01808339|11138998|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10016009|NCT01808339|11138999|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10016010|NCT01808339|11139000|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10016011|NCT01808339|11139001|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10016012|NCT01808339|11138996|FG000|STARTED|Treatment Period 2 (14 Days)||4
10016013|NCT01808339|11138997|FG001|STARTED|Treatment Period 2 (14 Days)||3
10016014|NCT01808339|11138998|FG002|STARTED|Treatment Period 2 (14 Days)||4
10016015|NCT01808339|11138999|FG003|STARTED|Treatment Period 2 (14 Days)||2
10016016|NCT01808339|11139000|FG004|STARTED|Treatment Period 2 (14 Days)||4
9803654|NCT00620373|10912210|FG000|STARTED|Overall Study||969
9803655|NCT00620373|10912210|FG000|COMPLETED|Overall Study||936
9803656|NCT00620373|10912210|FG000|NOT COMPLETED|Overall Study||33
9803657|NCT00620425|10912217|FG000|STARTED|Overall Study||18
9803658|NCT00620425|10912217|FG000|COMPLETED|Overall Study||18
9803659|NCT00620425|10912217|FG000|NOT COMPLETED|Overall Study||0
9803660|NCT00620503|10912228|FG000|STARTED|Screening (up to 21 Days)||2
9803661|NCT00620503|10912229|FG001|STARTED|Screening (up to 21 Days)||2
9803662|NCT00620503|10912230|FG002|STARTED|Screening (up to 21 Days)||2
9803663|NCT00620503|10912231|FG003|STARTED|Screening (up to 21 Days)||2
9803664|NCT00620503|10912232|FG004|STARTED|Screening (up to 21 Days)||2
9803665|NCT00620503|10912233|FG005|STARTED|Screening (up to 21 Days)||2
9803666|NCT00620503|10912228|FG000|COMPLETED|Screening (up to 21 Days)||2
9803667|NCT00620503|10912229|FG001|COMPLETED|Screening (up to 21 Days)||2
9803668|NCT00620503|10912230|FG002|COMPLETED|Screening (up to 21 Days)||2
9803669|NCT00620503|10912231|FG003|COMPLETED|Screening (up to 21 Days)||2
9803670|NCT00620503|10912232|FG004|COMPLETED|Screening (up to 21 Days)||2
9803671|NCT00620503|10912233|FG005|COMPLETED|Screening (up to 21 Days)||2
9803672|NCT00620503|10912228|FG000|NOT COMPLETED|Screening (up to 21 Days)||0
9803673|NCT00620503|10912229|FG001|NOT COMPLETED|Screening (up to 21 Days)||0
9803674|NCT00620503|10912230|FG002|NOT COMPLETED|Screening (up to 21 Days)||0
9803675|NCT00620503|10912231|FG003|NOT COMPLETED|Screening (up to 21 Days)||0
9803676|NCT00620503|10912232|FG004|NOT COMPLETED|Screening (up to 21 Days)||0
9803677|NCT00620503|10912233|FG005|NOT COMPLETED|Screening (up to 21 Days)||0
9803678|NCT00620503|10912228|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2
9803679|NCT00620503|10912229|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2
9803680|NCT00620503|10912230|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2
9803681|NCT00620503|10912231|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2
9803682|NCT00620503|10912232|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2
9803683|NCT00620503|10912233|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2
9803684|NCT00620503|10912228|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2
9803685|NCT00620503|10912229|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2
9803686|NCT00620503|10912230|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2
9803687|NCT00620503|10912231|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2
9803688|NCT00620503|10912232|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2
9803689|NCT00620503|10912233|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2
9803690|NCT00620503|10912228|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
9803691|NCT00620503|10912229|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
9803692|NCT00620503|10912230|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
9803693|NCT00620503|10912231|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
9803694|NCT00620503|10912232|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
9803695|NCT00620503|10912233|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
9803696|NCT00620503|10912228|FG000|STARTED|Washout (at Least 1 Day)||2
9803697|NCT00620503|10912229|FG001|STARTED|Washout (at Least 1 Day)||2
9803698|NCT00620503|10912230|FG002|STARTED|Washout (at Least 1 Day)||2
9803699|NCT00620503|10912231|FG003|STARTED|Washout (at Least 1 Day)||2
9803700|NCT00620503|10912232|FG004|STARTED|Washout (at Least 1 Day)||2
9803701|NCT00620503|10912233|FG005|STARTED|Washout (at Least 1 Day)||2
9803702|NCT00620503|10912228|FG000|COMPLETED|Washout (at Least 1 Day)||2
9803703|NCT00620503|10912229|FG001|COMPLETED|Washout (at Least 1 Day)||2
9803704|NCT00620503|10912230|FG002|COMPLETED|Washout (at Least 1 Day)||2
9803705|NCT00620503|10912231|FG003|COMPLETED|Washout (at Least 1 Day)||2
9803706|NCT00620503|10912232|FG004|COMPLETED|Washout (at Least 1 Day)||2
9803707|NCT00620503|10912233|FG005|COMPLETED|Washout (at Least 1 Day)||2
9803708|NCT00620503|10912228|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
9803709|NCT00620503|10912229|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
9803710|NCT00620503|10912230|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
9803711|NCT00620503|10912231|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
9803712|NCT00620503|10912232|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
9803713|NCT00620503|10912233|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
9803714|NCT00620503|10912228|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2
9803715|NCT00620503|10912229|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2
9803716|NCT00620503|10912230|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2
9803717|NCT00620503|10912231|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2
9803718|NCT00620503|10912232|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2
9803719|NCT00620503|10912233|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2
9803720|NCT00620503|10912228|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2
9803721|NCT00620503|10912229|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2
9803722|NCT00620503|10912230|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2
9803723|NCT00620503|10912231|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2
9803724|NCT00620503|10912232|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10016017|NCT01808339|11139001|FG005|STARTED|Treatment Period 2 (14 Days)||5
10016018|NCT01808339|11138996|FG000|COMPLETED|Treatment Period 2 (14 Days)||4
10016019|NCT01808339|11138997|FG001|COMPLETED|Treatment Period 2 (14 Days)||3
10016020|NCT01808339|11138998|FG002|COMPLETED|Treatment Period 2 (14 Days)||4
10016021|NCT01808339|11138999|FG003|COMPLETED|Treatment Period 2 (14 Days)||2
9803725|NCT00620503|10912233|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2
9803726|NCT00620503|10912228|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
9803727|NCT00620503|10912229|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
9803728|NCT00620503|10912230|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
9803729|NCT00620503|10912231|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
9803730|NCT00620503|10912232|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
9803731|NCT00620503|10912233|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
9803732|NCT00620503|10912228|FG000|STARTED|Washout (at Least 1 Day)||2
9803733|NCT00620503|10912229|FG001|STARTED|Washout (at Least 1 Day)||2
9803734|NCT00620503|10912230|FG002|STARTED|Washout (at Least 1 Day)||2
9803735|NCT00620503|10912231|FG003|STARTED|Washout (at Least 1 Day)||2
9803736|NCT00620503|10912232|FG004|STARTED|Washout (at Least 1 Day)||2
9803737|NCT00620503|10912233|FG005|STARTED|Washout (at Least 1 Day)||2
9803738|NCT00620503|10912228|FG000|COMPLETED|Washout (at Least 1 Day)||2
9803739|NCT00620503|10912229|FG001|COMPLETED|Washout (at Least 1 Day)||2
9803740|NCT00620503|10912230|FG002|COMPLETED|Washout (at Least 1 Day)||2
10016022|NCT01808339|11139000|FG004|COMPLETED|Treatment Period 2 (14 Days)||4
10016023|NCT01808339|11139001|FG005|COMPLETED|Treatment Period 2 (14 Days)||5
9803741|NCT00620503|10912231|FG003|COMPLETED|Washout (at Least 1 Day)||2
9803742|NCT00620503|10912232|FG004|COMPLETED|Washout (at Least 1 Day)||2
9803743|NCT00620503|10912233|FG005|COMPLETED|Washout (at Least 1 Day)||2
9803744|NCT00620503|10912228|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
9803745|NCT00620503|10912229|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
9803746|NCT00620503|10912230|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
9803747|NCT00620503|10912231|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
9803748|NCT00620503|10912232|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
9803749|NCT00620503|10912233|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
9803750|NCT00620503|10912228|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2
9803751|NCT00620503|10912229|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2
9803752|NCT00620503|10912230|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2
9803753|NCT00620503|10912231|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2
9803754|NCT00620503|10912232|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2
9803755|NCT00620503|10912233|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2
9803756|NCT00620503|10912228|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
9803757|NCT00620503|10912229|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
9803758|NCT00620503|10912230|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
9803759|NCT00620503|10912231|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
9803760|NCT00620503|10912232|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
9803761|NCT00620503|10912233|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
9803762|NCT00620503|10912228|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
9803763|NCT00620503|10912229|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
9803764|NCT00620503|10912230|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
9803765|NCT00620503|10912231|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
9803766|NCT00620503|10912232|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
9803767|NCT00620503|10912233|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
9803768|NCT00620503|10912228|FG000|STARTED|Follow-up (up to 14 Days)||2
9803769|NCT00620503|10912229|FG001|STARTED|Follow-up (up to 14 Days)||2
9803770|NCT00620503|10912230|FG002|STARTED|Follow-up (up to 14 Days)||2
9803771|NCT00620503|10912231|FG003|STARTED|Follow-up (up to 14 Days)||2
9803772|NCT00620503|10912232|FG004|STARTED|Follow-up (up to 14 Days)||2
9803773|NCT00620503|10912233|FG005|STARTED|Follow-up (up to 14 Days)||2
9803774|NCT00620503|10912228|FG000|COMPLETED|Follow-up (up to 14 Days)||2
9803775|NCT00620503|10912229|FG001|COMPLETED|Follow-up (up to 14 Days)||2
9803776|NCT00620503|10912230|FG002|COMPLETED|Follow-up (up to 14 Days)||2
9803777|NCT00620503|10912231|FG003|COMPLETED|Follow-up (up to 14 Days)||2
9803778|NCT00620503|10912232|FG004|COMPLETED|Follow-up (up to 14 Days)||2
10235328|NCT01204788|11365615|FG000|STARTED|Overall Study||1
10235329|NCT01204788|11365616|FG001|STARTED|Overall Study||3
10235330|NCT01204788|11365615|FG000|COMPLETED|Overall Study||0
10235331|NCT01204788|11365616|FG001|COMPLETED|Overall Study||0
10235332|NCT01204788|11365615|FG000|NOT COMPLETED|Overall Study||1
10235333|NCT01204788|11365616|FG001|NOT COMPLETED|Overall Study||3
10235334|NCT01200602|11365624|FG000|STARTED|Overall Study||0
10235335|NCT01200602|11365625|FG001|STARTED|Overall Study||0
10235336|NCT01200602|11365624|FG000|COMPLETED|Overall Study||0
10235337|NCT01200602|11365625|FG001|COMPLETED|Overall Study||0
10235338|NCT01200602|11365624|FG000|NOT COMPLETED|Overall Study||0
10235339|NCT01200602|11365625|FG001|NOT COMPLETED|Overall Study||0
10235340|NCT01198548|11365631|FG000|STARTED|Overall Study||10
10235341|NCT01198548|11365631|FG000|COMPLETED|Overall Study||0
10235342|NCT01198548|11365631|FG000|NOT COMPLETED|Overall Study||10
10235343|NCT01194908|11365635|FG000|STARTED|Overall Study||5
9803779|NCT00620503|10912233|FG005|COMPLETED|Follow-up (up to 14 Days)||2
9803780|NCT00620503|10912228|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0
9803781|NCT00620503|10912229|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0
9803782|NCT00620503|10912230|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0
9803783|NCT00620503|10912231|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0
9803784|NCT00620503|10912232|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0
9803785|NCT00620503|10912233|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0
9803786|NCT00620542|10912243|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
9803787|NCT00620542|10912244|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
9803788|NCT00620542|10912245|FG002|STARTED|Part A (Run-in - 2 Weeks)||0
9803789|NCT00620542|10912246|FG003|STARTED|Part A (Run-in - 2 Weeks)||0
9803790|NCT00620542|10912243|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783
9803791|NCT00620542|10912244|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795
9803792|NCT00620542|10912245|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0
9803793|NCT00620542|10912246|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0
9803794|NCT00620542|10912243|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695
9803795|NCT00620542|10912244|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690
9803796|NCT00620542|10912245|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0
9803797|NCT00620542|10912246|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0
9803798|NCT00620542|10912243|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
9803799|NCT00620542|10912244|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
9803800|NCT00620542|10912245|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
9803801|NCT00620542|10912246|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
10235344|NCT01194908|11365635|FG000|COMPLETED|Overall Study||5
10235345|NCT01194908|11365635|FG000|NOT COMPLETED|Overall Study||0
10235346|NCT01194856|11365641|FG000|STARTED|Overall Study||1
10235347|NCT01194856|11365642|FG001|STARTED|Overall Study||0
10235348|NCT01194856|11365641|FG000|COMPLETED|Overall Study||0
9803802|NCT00620542|10912243|FG000|STARTED|Part B (2 Year Core Study)||0
9803803|NCT00620542|10912244|FG001|STARTED|Part B (2 Year Core Study)||0
9803804|NCT00620542|10912245|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
9803805|NCT00620542|10912246|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
9803806|NCT00620542|10912243|FG000|Received Treatment|Part B (2 Year Core Study)||0
9803807|NCT00620542|10912244|FG001|Received Treatment|Part B (2 Year Core Study)||0
9803808|NCT00620542|10912245|FG002|Received Treatment|Part B (2 Year Core Study)||691
9803809|NCT00620542|10912246|FG003|Received Treatment|Part B (2 Year Core Study)||689
9803810|NCT00620542|10912243|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0
9803811|NCT00620542|10912244|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0
9803812|NCT00620542|10912245|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
9803813|NCT00620542|10912246|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
9803814|NCT00620542|10912243|FG000|COMPLETED|Part B (2 Year Core Study)||0
9803815|NCT00620542|10912244|FG001|COMPLETED|Part B (2 Year Core Study)||0
9803816|NCT00620542|10912245|FG002|COMPLETED|Part B (2 Year Core Study)||546
9803817|NCT00620542|10912246|FG003|COMPLETED|Part B (2 Year Core Study)||547
9803818|NCT00620542|10912243|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0
9803819|NCT00620542|10912244|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0
9803820|NCT00620542|10912245|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148
9803821|NCT00620542|10912246|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144
9803822|NCT00620555|10912254|FG000|STARTED|Overall Study||65
9803823|NCT00620555|10912254|FG000|COMPLETED|Overall Study||44
9803824|NCT00620555|10912254|FG000|NOT COMPLETED|Overall Study||21
9803825|NCT00620659|10912258|FG000|STARTED|Treatment Period 1||21
9803826|NCT00620659|10912259|FG001|STARTED|Treatment Period 1||21
9803827|NCT00620659|10912260|FG002|STARTED|Treatment Period 1||21
9803828|NCT00620659|10912261|FG003|STARTED|Treatment Period 1||21
9803829|NCT00620659|10912262|FG004|STARTED|Treatment Period 1||21
9803830|NCT00620659|10912263|FG005|STARTED|Treatment Period 1||20
9803831|NCT00620659|10912258|FG000|COMPLETED|Treatment Period 1||18
9803832|NCT00620659|10912259|FG001|COMPLETED|Treatment Period 1||21
9803833|NCT00620659|10912260|FG002|COMPLETED|Treatment Period 1||20
9803834|NCT00620659|10912261|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
9803835|NCT00620659|10912262|FG004|COMPLETED|Treatment Period 1||20
9803836|NCT00620659|10912263|FG005|COMPLETED|Treatment Period 1||20
9803837|NCT00620659|10912258|FG000|NOT COMPLETED|Treatment Period 1||3
9803838|NCT00620659|10912259|FG001|NOT COMPLETED|Treatment Period 1||0
9803839|NCT00620659|10912260|FG002|NOT COMPLETED|Treatment Period 1||1
9803840|NCT00620659|10912261|FG003|NOT COMPLETED|Treatment Period 1||3
9803841|NCT00620659|10912262|FG004|NOT COMPLETED|Treatment Period 1||1
9803842|NCT00620659|10912263|FG005|NOT COMPLETED|Treatment Period 1||0
9803843|NCT00620659|10912258|FG000|STARTED|Placebo Washout Period 1||18
9803844|NCT00620659|10912259|FG001|STARTED|Placebo Washout Period 1||21
9803845|NCT00620659|10912260|FG002|STARTED|Placebo Washout Period 1||20
9803846|NCT00620659|10912261|FG003|STARTED|Placebo Washout Period 1||19
9803847|NCT00620659|10912262|FG004|STARTED|Placebo Washout Period 1||20
9803848|NCT00620659|10912263|FG005|STARTED|Placebo Washout Period 1||20
9803849|NCT00620659|10912258|FG000|COMPLETED|Placebo Washout Period 1||18
9803850|NCT00620659|10912259|FG001|COMPLETED|Placebo Washout Period 1||21
9803851|NCT00620659|10912260|FG002|COMPLETED|Placebo Washout Period 1||20
9803852|NCT00620659|10912261|FG003|COMPLETED|Placebo Washout Period 1||18
9803853|NCT00620659|10912262|FG004|COMPLETED|Placebo Washout Period 1||20
9803854|NCT00620659|10912263|FG005|COMPLETED|Placebo Washout Period 1||20
9803855|NCT00620659|10912258|FG000|NOT COMPLETED|Placebo Washout Period 1||0
9803856|NCT00620659|10912259|FG001|NOT COMPLETED|Placebo Washout Period 1||0
9803857|NCT00620659|10912260|FG002|NOT COMPLETED|Placebo Washout Period 1||0
9803858|NCT00620659|10912261|FG003|NOT COMPLETED|Placebo Washout Period 1||1
9803859|NCT00620659|10912262|FG004|NOT COMPLETED|Placebo Washout Period 1||0
9803860|NCT00620659|10912263|FG005|NOT COMPLETED|Placebo Washout Period 1||0
9803861|NCT00620659|10912258|FG000|STARTED|Treatment Period 2||18
9803862|NCT00620659|10912259|FG001|STARTED|Treatment Period 2||21
9803863|NCT00620659|10912260|FG002|STARTED|Treatment Period 2||20
9803864|NCT00620659|10912261|FG003|STARTED|Treatment Period 2||18
9803865|NCT00620659|10912262|FG004|STARTED|Treatment Period 2||20
9803866|NCT00620659|10912263|FG005|STARTED|Treatment Period 2||20
9803867|NCT00620659|10912258|FG000|COMPLETED|Treatment Period 2||18
9803868|NCT00620659|10912259|FG001|COMPLETED|Treatment Period 2||18
9803869|NCT00620659|10912260|FG002|COMPLETED|Treatment Period 2||19
9803870|NCT00620659|10912261|FG003|COMPLETED|Treatment Period 2||18
9803871|NCT00620659|10912262|FG004|COMPLETED|Treatment Period 2||15
9803872|NCT00620659|10912263|FG005|COMPLETED|Treatment Period 2||20
9803873|NCT00620659|10912258|FG000|NOT COMPLETED|Treatment Period 2||0
9803874|NCT00620659|10912259|FG001|NOT COMPLETED|Treatment Period 2||3
9803875|NCT00620659|10912260|FG002|NOT COMPLETED|Treatment Period 2||1
9803876|NCT00620659|10912261|FG003|NOT COMPLETED|Treatment Period 2||0
9803877|NCT00620659|10912262|FG004|NOT COMPLETED|Treatment Period 2||5
9803878|NCT00620659|10912263|FG005|NOT COMPLETED|Treatment Period 2||0
9803879|NCT00620659|10912258|FG000|STARTED|Placebo Washout Period 2||18
9803880|NCT00620659|10912259|FG001|STARTED|Placebo Washout Period 2||18
9803881|NCT00620659|10912260|FG002|STARTED|Placebo Washout Period 2||19
9803882|NCT00620659|10912261|FG003|STARTED|Placebo Washout Period 2||18
9803883|NCT00620659|10912262|FG004|STARTED|Placebo Washout Period 2||15
9803884|NCT00620659|10912263|FG005|STARTED|Placebo Washout Period 2||20
9803885|NCT00620659|10912258|FG000|COMPLETED|Placebo Washout Period 2||16
9803886|NCT00620659|10912259|FG001|COMPLETED|Placebo Washout Period 2||18
9803887|NCT00620659|10912260|FG002|COMPLETED|Placebo Washout Period 2||19
9803888|NCT00620659|10912261|FG003|COMPLETED|Placebo Washout Period 2||18
9803889|NCT00620659|10912262|FG004|COMPLETED|Placebo Washout Period 2||15
9803890|NCT00620659|10912263|FG005|COMPLETED|Placebo Washout Period 2||20
9803891|NCT00620659|10912258|FG000|NOT COMPLETED|Placebo Washout Period 2||2
9803892|NCT00620659|10912259|FG001|NOT COMPLETED|Placebo Washout Period 2||0
9803893|NCT00620659|10912260|FG002|NOT COMPLETED|Placebo Washout Period 2||0
9803894|NCT00620659|10912261|FG003|NOT COMPLETED|Placebo Washout Period 2||0
9803895|NCT00620659|10912262|FG004|NOT COMPLETED|Placebo Washout Period 2||0
9803896|NCT00620659|10912263|FG005|NOT COMPLETED|Placebo Washout Period 2||0
9803897|NCT00620659|10912258|FG000|STARTED|Treatment Period 3||16
9803898|NCT00620659|10912259|FG001|STARTED|Treatment Period 3||18
9803899|NCT00620659|10912260|FG002|STARTED|Treatment Period 3||19
9803900|NCT00620659|10912261|FG003|STARTED|Treatment Period 3||18
9803901|NCT00620659|10912262|FG004|STARTED|Treatment Period 3||15
9803902|NCT00620659|10912263|FG005|STARTED|Treatment Period 3||20
9803903|NCT00620659|10912258|FG000|COMPLETED|Treatment Period 3||16
9803904|NCT00620659|10912259|FG001|COMPLETED|Treatment Period 3||16
9803905|NCT00620659|10912260|FG002|COMPLETED|Treatment Period 3||19
9803906|NCT00620659|10912261|FG003|COMPLETED|Treatment Period 3||17
9803907|NCT00620659|10912262|FG004|COMPLETED|Treatment Period 3||15
9803908|NCT00620659|10912263|FG005|COMPLETED|Treatment Period 3||20
9803909|NCT00620659|10912258|FG000|NOT COMPLETED|Treatment Period 3||0
9803910|NCT00620659|10912259|FG001|NOT COMPLETED|Treatment Period 3||2
9803911|NCT00620659|10912260|FG002|NOT COMPLETED|Treatment Period 3||0
9803912|NCT00620659|10912261|FG003|NOT COMPLETED|Treatment Period 3||1
9803913|NCT00620659|10912262|FG004|NOT COMPLETED|Treatment Period 3||0
9803914|NCT00620659|10912263|FG005|NOT COMPLETED|Treatment Period 3||0
9803915|NCT00620698|10912276|FG000|STARTED|Overall Study||89
9803916|NCT00620698|10912276|FG000|COMPLETED|Overall Study||60
9803917|NCT00620698|10912276|FG000|NOT COMPLETED|Overall Study||29
9803918|NCT00620711|10912280|FG000|STARTED|Overall Study||4
9803919|NCT00620711|10912280|FG000|COMPLETED|Overall Study||4
9803920|NCT00620711|10912280|FG000|NOT COMPLETED|Overall Study||0
9803921|NCT00620750|10912284|FG000|STARTED|Overall Study||65
9803922|NCT00620750|10912284|FG000|COMPLETED|Overall Study||40
9803923|NCT00620750|10912284|FG000|NOT COMPLETED|Overall Study||25
9803924|NCT00620763|10912288|FG000|STARTED|Period: First Intervention||10
9803925|NCT00620763|10912289|FG001|STARTED|Period: First Intervention||12
9803926|NCT00620763|10912288|FG000|COMPLETED|Period: First Intervention||10
9803927|NCT00620763|10912289|FG001|COMPLETED|Period: First Intervention||7
9803928|NCT00620763|10912288|FG000|NOT COMPLETED|Period: First Intervention||0
9803929|NCT00620763|10912289|FG001|NOT COMPLETED|Period: First Intervention||5
9803930|NCT00620763|10912288|FG000|STARTED|Period: Washout Period of 1 Week||10
9803931|NCT00620763|10912289|FG001|STARTED|Period: Washout Period of 1 Week||7
9803932|NCT00620763|10912288|FG000|COMPLETED|Period: Washout Period of 1 Week||10
9803933|NCT00620763|10912289|FG001|COMPLETED|Period: Washout Period of 1 Week||7
9803934|NCT00620763|10912288|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0
9803935|NCT00620763|10912289|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0
9803936|NCT00620763|10912288|FG000|STARTED|Period: Second Intervention||10
9803937|NCT00620763|10912289|FG001|STARTED|Period: Second Intervention||7
9803938|NCT00620763|10912288|FG000|COMPLETED|Period: Second Intervention||9
9803939|NCT00620763|10912289|FG001|COMPLETED|Period: Second Intervention||7
9803940|NCT00620763|10912288|FG000|NOT COMPLETED|Period: Second Intervention||1
9803941|NCT00620763|10912289|FG001|NOT COMPLETED|Period: Second Intervention||0
9803942|NCT00620776|10912297|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
9803943|NCT00620776|10912298|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
9803944|NCT00620776|10912297|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
9803945|NCT00620776|10912298|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
9803946|NCT00620776|10912297|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
9803947|NCT00620776|10912298|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
9803948|NCT00620776|10912297|FG000|NOT COMPLETED|Overall Study||12
9803949|NCT00620776|10912298|FG001|NOT COMPLETED|Overall Study||16
9803950|NCT00620815|10912307|FG000|STARTED|Overall Study||199
9803951|NCT00620815|10912308|FG001|STARTED|Overall Study||203
9803952|NCT00620815|10912309|FG002|STARTED|Overall Study||199
9803953|NCT00620815|10912307|FG000|COMPLETED|Overall Study||195
9803954|NCT00620815|10912308|FG001|COMPLETED|Overall Study||192
9803955|NCT00620815|10912309|FG002|COMPLETED|Overall Study||192
9803956|NCT00620815|10912307|FG000|NOT COMPLETED|Overall Study||4
9803957|NCT00620815|10912308|FG001|NOT COMPLETED|Overall Study||11
9803958|NCT00620815|10912309|FG002|NOT COMPLETED|Overall Study||7
9803959|NCT00620828|10912335|FG000|STARTED|Overall Study||32
9803960|NCT00620828|10912336|FG001|STARTED|Overall Study||35
9803961|NCT00620828|10912335|FG000|Number of Subjects Enrolled = 67|Overall Study||32
9803962|NCT00620828|10912336|FG001|Number of Subjects Enrolled = 67|Overall Study||35
9803963|NCT00620828|10912335|FG000|COMPLETED|Overall Study||32
9803964|NCT00620828|10912336|FG001|COMPLETED|Overall Study||35
9803965|NCT00620828|10912335|FG000|NOT COMPLETED|Overall Study||0
9803966|NCT00620828|10912336|FG001|NOT COMPLETED|Overall Study||0
9803967|NCT00620854|10912348|FG000|STARTED|Period 1||4
9803968|NCT00620854|10912349|FG001|STARTED|Period 1||4
9803969|NCT00620854|10912350|FG002|STARTED|Period 1||4
9803970|NCT00620854|10912351|FG003|STARTED|Period 1||4
9803971|NCT00620854|10912352|FG004|STARTED|Period 1||4
9803972|NCT00620854|10912353|FG005|STARTED|Period 1||4
9803973|NCT00620854|10912348|FG000|COMPLETED|Period 1||4
9803974|NCT00620854|10912349|FG001|COMPLETED|Period 1||4
9803975|NCT00620854|10912350|FG002|COMPLETED|Period 1||4
9803976|NCT00620854|10912351|FG003|COMPLETED|Period 1||4
9803977|NCT00620854|10912352|FG004|COMPLETED|Period 1||4
9803978|NCT00620854|10912353|FG005|COMPLETED|Period 1||4
9803979|NCT00620854|10912348|FG000|NOT COMPLETED|Period 1||0
9803980|NCT00620854|10912349|FG001|NOT COMPLETED|Period 1||0
9803981|NCT00620854|10912350|FG002|NOT COMPLETED|Period 1||0
9803982|NCT00620854|10912351|FG003|NOT COMPLETED|Period 1||0
9803983|NCT00620854|10912352|FG004|NOT COMPLETED|Period 1||0
9803984|NCT00620854|10912353|FG005|NOT COMPLETED|Period 1||0
9803985|NCT00620854|10912348|FG000|STARTED|Washout 1||4
9803986|NCT00620854|10912349|FG001|STARTED|Washout 1||4
9803987|NCT00620854|10912350|FG002|STARTED|Washout 1||4
9803988|NCT00620854|10912351|FG003|STARTED|Washout 1||4
9803989|NCT00620854|10912352|FG004|STARTED|Washout 1||4
9803990|NCT00620854|10912353|FG005|STARTED|Washout 1||4
9803991|NCT00620854|10912348|FG000|COMPLETED|Washout 1||4
9803992|NCT00620854|10912349|FG001|COMPLETED|Washout 1||4
9803993|NCT00620854|10912350|FG002|COMPLETED|Washout 1||3
9803994|NCT00620854|10912351|FG003|COMPLETED|Washout 1||3
9803995|NCT00620854|10912352|FG004|COMPLETED|Washout 1||4
9803996|NCT00620854|10912353|FG005|COMPLETED|Washout 1||4
9803997|NCT00620854|10912348|FG000|NOT COMPLETED|Washout 1||0
9803998|NCT00620854|10912349|FG001|NOT COMPLETED|Washout 1||0
9803999|NCT00620854|10912350|FG002|NOT COMPLETED|Washout 1||1
9804000|NCT00620854|10912351|FG003|NOT COMPLETED|Washout 1||1
9804001|NCT00620854|10912352|FG004|NOT COMPLETED|Washout 1||0
9804002|NCT00620854|10912353|FG005|NOT COMPLETED|Washout 1||0
9804003|NCT00620854|10912348|FG000|STARTED|Period 2||4
9804004|NCT00620854|10912349|FG001|STARTED|Period 2||4
9804005|NCT00620854|10912350|FG002|STARTED|Period 2||3
9804006|NCT00620854|10912351|FG003|STARTED|Period 2||3
9804007|NCT00620854|10912352|FG004|STARTED|Period 2||4
9804008|NCT00620854|10912353|FG005|STARTED|Period 2||4
9804009|NCT00620854|10912348|FG000|COMPLETED|Period 2||4
9804010|NCT00620854|10912349|FG001|COMPLETED|Period 2||4
9804011|NCT00620854|10912350|FG002|COMPLETED|Period 2||3
9804012|NCT00620854|10912351|FG003|COMPLETED|Period 2||3
9804013|NCT00620854|10912352|FG004|COMPLETED|Period 2||4
9804014|NCT00620854|10912353|FG005|COMPLETED|Period 2||4
10016024|NCT01808339|11138996|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10016025|NCT01808339|11138997|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10016026|NCT01808339|11138998|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10016027|NCT01808339|11138999|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10016028|NCT01808339|11139000|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10016029|NCT01808339|11139001|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
9804015|NCT00620854|10912348|FG000|NOT COMPLETED|Period 2||0
9804016|NCT00620854|10912349|FG001|NOT COMPLETED|Period 2||0
9804017|NCT00620854|10912350|FG002|NOT COMPLETED|Period 2||0
9804018|NCT00620854|10912351|FG003|NOT COMPLETED|Period 2||0
9804019|NCT00620854|10912352|FG004|NOT COMPLETED|Period 2||0
9804020|NCT00620854|10912353|FG005|NOT COMPLETED|Period 2||0
9804021|NCT00620854|10912348|FG000|STARTED|Washout 2||4
9804022|NCT00620854|10912349|FG001|STARTED|Washout 2||4
9804023|NCT00620854|10912350|FG002|STARTED|Washout 2||3
9804024|NCT00620854|10912351|FG003|STARTED|Washout 2||3
9804025|NCT00620854|10912352|FG004|STARTED|Washout 2||4
9804026|NCT00620854|10912353|FG005|STARTED|Washout 2||4
9804027|NCT00620854|10912348|FG000|COMPLETED|Washout 2||4
10016030|NCT01808339|11138996|FG000|STARTED|Washout Period 2 (14-21 Days)||4
10112258|NCT02502149|11243313|FG004|NOT COMPLETED|PK2 Assessment Period||0
9804028|NCT00620854|10912349|FG001|COMPLETED|Washout 2||4
9804029|NCT00620854|10912350|FG002|COMPLETED|Washout 2||3
9804030|NCT00620854|10912351|FG003|COMPLETED|Washout 2||3
9804031|NCT00620854|10912352|FG004|COMPLETED|Washout 2||4
9804032|NCT00620854|10912353|FG005|COMPLETED|Washout 2||4
10112259|NCT02502149|11243309|FG000|STARTED|Treatment Period||0
10112260|NCT02502149|11243310|FG001|STARTED|Treatment Period||0
10112261|NCT02502149|11243311|FG002|STARTED|Treatment Period||0
9804033|NCT00620854|10912348|FG000|NOT COMPLETED|Washout 2||0
9804034|NCT00620854|10912349|FG001|NOT COMPLETED|Washout 2||0
9804035|NCT00620854|10912350|FG002|NOT COMPLETED|Washout 2||0
9804036|NCT00620854|10912351|FG003|NOT COMPLETED|Washout 2||0
10016031|NCT01808339|11138997|FG001|STARTED|Washout Period 2 (14-21 Days)||3
10016032|NCT01808339|11138998|FG002|STARTED|Washout Period 2 (14-21 Days)||4
9804037|NCT00620854|10912352|FG004|NOT COMPLETED|Washout 2||0
9804038|NCT00620854|10912353|FG005|NOT COMPLETED|Washout 2||0
9804039|NCT00620854|10912348|FG000|STARTED|Period 3||4
9804040|NCT00620854|10912349|FG001|STARTED|Period 3||4
9804041|NCT00620854|10912350|FG002|STARTED|Period 3||3
9804042|NCT00620854|10912351|FG003|STARTED|Period 3||3
9804043|NCT00620854|10912352|FG004|STARTED|Period 3||4
9804044|NCT00620854|10912353|FG005|STARTED|Period 3||4
9804045|NCT00620854|10912348|FG000|COMPLETED|Period 3||4
9804046|NCT00620854|10912349|FG001|COMPLETED|Period 3||4
9804047|NCT00620854|10912350|FG002|COMPLETED|Period 3||3
9804048|NCT00620854|10912351|FG003|COMPLETED|Period 3||3
9804049|NCT00620854|10912352|FG004|COMPLETED|Period 3||4
9804050|NCT00620854|10912353|FG005|COMPLETED|Period 3||4
9804051|NCT00620854|10912348|FG000|NOT COMPLETED|Period 3||0
9804052|NCT00620854|10912349|FG001|NOT COMPLETED|Period 3||0
9804053|NCT00620854|10912350|FG002|NOT COMPLETED|Period 3||0
9804054|NCT00620854|10912351|FG003|NOT COMPLETED|Period 3||0
9804055|NCT00620854|10912352|FG004|NOT COMPLETED|Period 3||0
9804056|NCT00620854|10912353|FG005|NOT COMPLETED|Period 3||0
9804057|NCT00620945|10912364|FG000|STARTED|Overall Study|Total number in the study|87
9804058|NCT00620945|10912364|FG000|COMPLETED|Overall Study||87
9804059|NCT00620945|10912364|FG000|NOT COMPLETED|Overall Study||0
9804060|NCT00621023|10912368|FG000|STARTED|Overall Study||6
9804061|NCT00621023|10912368|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
9804062|NCT00621023|10912368|FG000|NOT COMPLETED|Overall Study||6
9831353|NCT00768287|10942078|FG004|COMPLETED|Pharmacokinetic Study||0
9831354|NCT00768287|10942079|FG005|COMPLETED|Pharmacokinetic Study||0
9831355|NCT00768287|10942074|FG000|NOT COMPLETED|Pharmacokinetic Study||0
9831356|NCT00768287|10942075|FG001|NOT COMPLETED|Pharmacokinetic Study||0
9831357|NCT00768287|10942076|FG002|NOT COMPLETED|Pharmacokinetic Study||0
9831358|NCT00768287|10942077|FG003|NOT COMPLETED|Pharmacokinetic Study||0
9831359|NCT00768287|10942078|FG004|NOT COMPLETED|Pharmacokinetic Study||0
9831360|NCT00768287|10942079|FG005|NOT COMPLETED|Pharmacokinetic Study||0
9831361|NCT00768287|10942074|FG000|STARTED|Repeat Pharmacokinetic Study||0
9831362|NCT00768287|10942075|FG001|STARTED|Repeat Pharmacokinetic Study||0
9831363|NCT00768287|10942076|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
9831364|NCT00768287|10942077|FG003|STARTED|Repeat Pharmacokinetic Study||0
9831365|NCT00768287|10942078|FG004|STARTED|Repeat Pharmacokinetic Study||0
9831366|NCT00768287|10942079|FG005|STARTED|Repeat Pharmacokinetic Study||0
9831367|NCT00768287|10942074|FG000|COMPLETED|Repeat Pharmacokinetic Study||0
9831368|NCT00768287|10942075|FG001|COMPLETED|Repeat Pharmacokinetic Study||0
9831369|NCT00768287|10942076|FG002|COMPLETED|Repeat Pharmacokinetic Study||14
9831370|NCT00768287|10942077|FG003|COMPLETED|Repeat Pharmacokinetic Study||0
9831371|NCT00768287|10942078|FG004|COMPLETED|Repeat Pharmacokinetic Study||0
9831372|NCT00768287|10942079|FG005|COMPLETED|Repeat Pharmacokinetic Study||0
9831373|NCT00768287|10942074|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0
9831374|NCT00768287|10942075|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0
9831375|NCT00768287|10942076|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0
9831376|NCT00768287|10942077|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0
9831377|NCT00768287|10942078|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0
9831378|NCT00768287|10942079|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0
9831379|NCT00768287|10942074|FG000|STARTED|Treatment Study||0
9831380|NCT00768287|10942075|FG001|STARTED|Treatment Study||0
9831381|NCT00768287|10942076|FG002|STARTED|Treatment Study||0
9831382|NCT00768287|10942077|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
9831383|NCT00768287|10942078|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
9831384|NCT00768287|10942079|FG005|STARTED|Treatment Study||0
9831385|NCT00768287|10942074|FG000|Treated|Treatment Study||0
9831386|NCT00768287|10942075|FG001|Treated|Treatment Study||0
9831387|NCT00768287|10942076|FG002|Treated|Treatment Study||0
9831388|NCT00768287|10942077|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
9831389|NCT00768287|10942078|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
9831390|NCT00768287|10942079|FG005|Treated|Treatment Study||0
9831391|NCT00768287|10942074|FG000|COMPLETED|Treatment Study||0
9831392|NCT00768287|10942075|FG001|COMPLETED|Treatment Study||0
9831393|NCT00768287|10942076|FG002|COMPLETED|Treatment Study||0
9831394|NCT00768287|10942077|FG003|COMPLETED|Treatment Study||58
9831395|NCT00768287|10942078|FG004|COMPLETED|Treatment Study||9
9831396|NCT00768287|10942079|FG005|COMPLETED|Treatment Study||0
9831397|NCT00768287|10942074|FG000|NOT COMPLETED|Treatment Study||0
9831398|NCT00768287|10942075|FG001|NOT COMPLETED|Treatment Study||0
9831399|NCT00768287|10942076|FG002|NOT COMPLETED|Treatment Study||0
9831400|NCT00768287|10942077|FG003|NOT COMPLETED|Treatment Study||0
9831401|NCT00768287|10942078|FG004|NOT COMPLETED|Treatment Study||0
9831402|NCT00768287|10942079|FG005|NOT COMPLETED|Treatment Study||0
9831403|NCT00768287|10942074|FG000|STARTED|Surgical Sub-study||0
9831404|NCT00768287|10942075|FG001|STARTED|Surgical Sub-study||0
9831405|NCT00768287|10942076|FG002|STARTED|Surgical Sub-study||0
9831406|NCT00768287|10942077|FG003|STARTED|Surgical Sub-study||0
9831407|NCT00768287|10942078|FG004|STARTED|Surgical Sub-study||0
9831408|NCT00768287|10942079|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
9831409|NCT00768287|10942074|FG000|COMPLETED|Surgical Sub-study||0
9831410|NCT00768287|10942075|FG001|COMPLETED|Surgical Sub-study||0
9831411|NCT00768287|10942076|FG002|COMPLETED|Surgical Sub-study||0
9831412|NCT00768287|10942077|FG003|COMPLETED|Surgical Sub-study||0
9831413|NCT00768287|10942078|FG004|COMPLETED|Surgical Sub-study||0
9831414|NCT00768287|10942079|FG005|COMPLETED|Surgical Sub-study||17
9831415|NCT00768287|10942074|FG000|NOT COMPLETED|Surgical Sub-study||0
9831416|NCT00768287|10942075|FG001|NOT COMPLETED|Surgical Sub-study||0
9831417|NCT00768287|10942076|FG002|NOT COMPLETED|Surgical Sub-study||0
9804063|NCT00621049|10912374|FG000|STARTED|Adjuvant Treatment||55
9804064|NCT00621049|10912375|FG001|STARTED|Adjuvant Treatment||57
9804065|NCT00621049|10912374|FG000|COMPLETED|Adjuvant Treatment||52
9804066|NCT00621049|10912375|FG001|COMPLETED|Adjuvant Treatment||47
9804067|NCT00621049|10912374|FG000|NOT COMPLETED|Adjuvant Treatment||3
9804068|NCT00621049|10912375|FG001|NOT COMPLETED|Adjuvant Treatment||10
9804069|NCT00621049|10912374|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
9804070|NCT00621049|10912375|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
9804071|NCT00621049|10912374|FG000|COMPLETED|Maintenance Treatment||34
9804072|NCT00621049|10912375|FG001|COMPLETED|Maintenance Treatment||0
9804073|NCT00621049|10912374|FG000|NOT COMPLETED|Maintenance Treatment||15
9804074|NCT00621049|10912375|FG001|NOT COMPLETED|Maintenance Treatment||0
9804075|NCT00621140|10912383|FG000|STARTED|Overall Study|number who started treatment|167
9804076|NCT00621140|10912384|FG001|STARTED|Overall Study|number who started treatment|336
9804077|NCT00621140|10912383|FG000|COMPLETED|Overall Study|number who completed treatment|152
9804078|NCT00621140|10912384|FG001|COMPLETED|Overall Study|number who completed treatment|318
9804079|NCT00621140|10912383|FG000|NOT COMPLETED|Overall Study||15
9804080|NCT00621140|10912384|FG001|NOT COMPLETED|Overall Study||18
9804081|NCT00621153|10912392|FG000|STARTED|Overall Study|randomised|117
9804082|NCT00621153|10912393|FG001|STARTED|Overall Study|randomised|116
9804083|NCT00621153|10912392|FG000|Discontinued|Overall Study||20
9804084|NCT00621153|10912393|FG001|Discontinued|Overall Study||15
9804085|NCT00621153|10912392|FG000|COMPLETED|Overall Study|completed|97
9804086|NCT00621153|10912393|FG001|COMPLETED|Overall Study|completed|101
9804087|NCT00621153|10912392|FG000|NOT COMPLETED|Overall Study||20
9804088|NCT00621153|10912393|FG001|NOT COMPLETED|Overall Study||15
9804089|NCT00621179|10912403|FG000|STARTED|Overall Study||12
9804090|NCT00621179|10912404|FG001|STARTED|Overall Study||8
9804091|NCT00621179|10912405|FG002|STARTED|Overall Study||7
9804092|NCT00621179|10912406|FG003|STARTED|Overall Study||10
9804093|NCT00621179|10912403|FG000|COMPLETED|Overall Study||12
9804094|NCT00621179|10912404|FG001|COMPLETED|Overall Study||8
9804095|NCT00621179|10912405|FG002|COMPLETED|Overall Study||6
9804096|NCT00621179|10912406|FG003|COMPLETED|Overall Study||9
9804097|NCT00621179|10912403|FG000|NOT COMPLETED|Overall Study||0
9804098|NCT00621179|10912404|FG001|NOT COMPLETED|Overall Study||0
9804099|NCT00621179|10912405|FG002|NOT COMPLETED|Overall Study||1
9804100|NCT00621179|10912406|FG003|NOT COMPLETED|Overall Study||1
9804101|NCT00621192|10912420|FG000|STARTED|Overall Study||39
9804102|NCT00621192|10912421|FG001|STARTED|Overall Study||103
9804103|NCT00621192|10912422|FG002|STARTED|Overall Study||31
9804104|NCT00621192|10912423|FG003|STARTED|Overall Study||27
9804105|NCT00621192|10912420|FG000|Safety Population|Overall Study||39
9804106|NCT00621192|10912421|FG001|Safety Population|Overall Study||103
9804107|NCT00621192|10912422|FG002|Safety Population|Overall Study||31
9804108|NCT00621192|10912423|FG003|Safety Population|Overall Study||27
9804109|NCT00621192|10912420|FG000|Efficacy Population|Overall Study||39
9804110|NCT00621192|10912421|FG001|Efficacy Population|Overall Study||101
9804111|NCT00621192|10912422|FG002|Efficacy Population|Overall Study||28
9804112|NCT00621192|10912423|FG003|Efficacy Population|Overall Study||27
9804113|NCT00621192|10912420|FG000|COMPLETED|Overall Study||35
9804114|NCT00621192|10912421|FG001|COMPLETED|Overall Study||94
9804115|NCT00621192|10912422|FG002|COMPLETED|Overall Study||26
9804116|NCT00621192|10912423|FG003|COMPLETED|Overall Study||24
9804117|NCT00621192|10912420|FG000|NOT COMPLETED|Overall Study||4
9804118|NCT00621192|10912421|FG001|NOT COMPLETED|Overall Study||9
9804119|NCT00621192|10912422|FG002|NOT COMPLETED|Overall Study||5
9804120|NCT00621192|10912423|FG003|NOT COMPLETED|Overall Study||3
9804121|NCT00621244|10912437|FG000|STARTED|Overall Study||86
9804122|NCT00621244|10912438|FG001|STARTED|Overall Study||34
9804123|NCT00621244|10912439|FG002|STARTED|Overall Study||33
9804124|NCT00621244|10912440|FG003|STARTED|Overall Study||23
9804125|NCT00621244|10912437|FG000|COMPLETED|Overall Study||0
9804126|NCT00621244|10912438|FG001|COMPLETED|Overall Study||0
9804127|NCT00621244|10912439|FG002|COMPLETED|Overall Study||0
9804128|NCT00621244|10912440|FG003|COMPLETED|Overall Study||0
9804129|NCT00621244|10912437|FG000|NOT COMPLETED|Overall Study||86
9804130|NCT00621244|10912438|FG001|NOT COMPLETED|Overall Study||34
9804131|NCT00621244|10912439|FG002|NOT COMPLETED|Overall Study||33
9804132|NCT00621244|10912440|FG003|NOT COMPLETED|Overall Study||23
9804133|NCT00621257|10912519|FG000|STARTED|Overall Study||24
9804134|NCT00621257|10912520|FG001|STARTED|Overall Study||24
9804135|NCT00621257|10912521|FG002|STARTED|Overall Study||23
9804136|NCT00621257|10912522|FG003|STARTED|Overall Study||32
9804137|NCT00621257|10912523|FG004|STARTED|Overall Study||31
9804138|NCT00621257|10912519|FG000|COMPLETED|Overall Study||20
9804139|NCT00621257|10912520|FG001|COMPLETED|Overall Study||21
9804140|NCT00621257|10912521|FG002|COMPLETED|Overall Study||20
9804141|NCT00621257|10912522|FG003|COMPLETED|Overall Study||26
9804142|NCT00621257|10912523|FG004|COMPLETED|Overall Study||22
9804143|NCT00621257|10912519|FG000|NOT COMPLETED|Overall Study||4
9804144|NCT00621257|10912520|FG001|NOT COMPLETED|Overall Study||3
9804145|NCT00621257|10912521|FG002|NOT COMPLETED|Overall Study||3
9804146|NCT00621257|10912522|FG003|NOT COMPLETED|Overall Study||6
9804147|NCT00621257|10912523|FG004|NOT COMPLETED|Overall Study||9
9804148|NCT00621296|10912535|FG000|STARTED|Overall Study||15
9804149|NCT00621296|10912535|FG000|COMPLETED|Overall Study||1
9804150|NCT00621296|10912535|FG000|NOT COMPLETED|Overall Study||14
9804151|NCT00621309|10912539|FG000|STARTED|Overall Study||6
9804152|NCT00621309|10912540|FG001|STARTED|Overall Study||4
9804153|NCT00621309|10912541|FG002|STARTED|Overall Study||5
9804154|NCT00621309|10912542|FG003|STARTED|Overall Study||6
9804155|NCT00621309|10912543|FG004|STARTED|Overall Study||4
9804156|NCT00621309|10912544|FG005|STARTED|Overall Study||4
9804157|NCT00621309|10912539|FG000|COMPLETED|Overall Study||4
9804158|NCT00621309|10912540|FG001|COMPLETED|Overall Study||4
9804159|NCT00621309|10912541|FG002|COMPLETED|Overall Study||4
9804160|NCT00621309|10912542|FG003|COMPLETED|Overall Study||5
9804161|NCT00621309|10912543|FG004|COMPLETED|Overall Study||3
9804162|NCT00621309|10912544|FG005|COMPLETED|Overall Study||3
9804163|NCT00621309|10912539|FG000|NOT COMPLETED|Overall Study||2
9804164|NCT00621309|10912540|FG001|NOT COMPLETED|Overall Study||0
9804165|NCT00621309|10912541|FG002|NOT COMPLETED|Overall Study||1
9804166|NCT00621309|10912542|FG003|NOT COMPLETED|Overall Study||1
9804167|NCT00621309|10912543|FG004|NOT COMPLETED|Overall Study||1
9804168|NCT00621309|10912544|FG005|NOT COMPLETED|Overall Study||1
9804169|NCT00621322|10912556|FG000|STARTED|Overall Study||10
9804170|NCT00621322|10912557|FG001|STARTED|Overall Study||10
9804171|NCT00621322|10912558|FG002|STARTED|Overall Study||40
9804172|NCT00621322|10912559|FG003|STARTED|Overall Study||40
9804173|NCT00621322|10912560|FG004|STARTED|Overall Study||40
9804174|NCT00621322|10912561|FG005|STARTED|Overall Study||40
9804175|NCT00621322|10912556|FG000|COMPLETED|Overall Study||9
9804176|NCT00621322|10912557|FG001|COMPLETED|Overall Study||10
9804177|NCT00621322|10912558|FG002|COMPLETED|Overall Study||38
9804178|NCT00621322|10912559|FG003|COMPLETED|Overall Study||37
9804179|NCT00621322|10912560|FG004|COMPLETED|Overall Study||39
9804180|NCT00621322|10912561|FG005|COMPLETED|Overall Study||36
9804181|NCT00621322|10912556|FG000|NOT COMPLETED|Overall Study||1
9804182|NCT00621322|10912557|FG001|NOT COMPLETED|Overall Study||0
9804183|NCT00621322|10912558|FG002|NOT COMPLETED|Overall Study||2
9804184|NCT00621322|10912559|FG003|NOT COMPLETED|Overall Study||3
9804185|NCT00621322|10912560|FG004|NOT COMPLETED|Overall Study||1
9804186|NCT00621322|10912561|FG005|NOT COMPLETED|Overall Study||4
9804187|NCT00621348|10912578|FG000|STARTED|Overall Study||58
9804188|NCT00621348|10912579|FG001|STARTED|Overall Study||53
9804189|NCT00621348|10912580|FG002|STARTED|Overall Study||56
9804190|NCT00621348|10912578|FG000|COMPLETED|Overall Study||58
9804191|NCT00621348|10912579|FG001|COMPLETED|Overall Study||53
9804192|NCT00621348|10912580|FG002|COMPLETED|Overall Study||56
9804193|NCT00621348|10912578|FG000|NOT COMPLETED|Overall Study||0
9804194|NCT00621348|10912579|FG001|NOT COMPLETED|Overall Study||0
9804195|NCT00621348|10912580|FG002|NOT COMPLETED|Overall Study||0
9804196|NCT00621504|10912590|FG000|STARTED|Overall Study||299
9804197|NCT00621504|10912591|FG001|STARTED|Overall Study||307
9804198|NCT00621504|10912590|FG000|COMPLETED|Overall Study||273
9804199|NCT00621504|10912591|FG001|COMPLETED|Overall Study||282
9804200|NCT00621504|10912590|FG000|NOT COMPLETED|Overall Study||26
9804201|NCT00621504|10912591|FG001|NOT COMPLETED|Overall Study||25
9804202|NCT00621517|10912599|FG000|STARTED|Overall Study||29
9804203|NCT00621517|10912600|FG001|STARTED|Overall Study||31
9804204|NCT00621517|10912599|FG000|COMPLETED|Overall Study||22
9804205|NCT00621517|10912600|FG001|COMPLETED|Overall Study||24
9804206|NCT00621517|10912599|FG000|NOT COMPLETED|Overall Study||7
9804207|NCT00621517|10912600|FG001|NOT COMPLETED|Overall Study||7
9804208|NCT00621530|10912608|FG000|STARTED|Overall Study||30
9804209|NCT00621530|10912609|FG001|STARTED|Overall Study||32
9804210|NCT00621530|10912608|FG000|COMPLETED|Overall Study||28
9804211|NCT00621530|10912609|FG001|COMPLETED|Overall Study||29
9804212|NCT00621530|10912608|FG000|NOT COMPLETED|Overall Study||2
9804213|NCT00621530|10912609|FG001|NOT COMPLETED|Overall Study||3
9804214|NCT00621543|10912618|FG000|STARTED|Overall Study||120
9804215|NCT00621543|10912618|FG000|COMPLETED|Overall Study||97
9804216|NCT00621543|10912618|FG000|NOT COMPLETED|Overall Study||23
9804217|NCT00621582|10912622|FG000|STARTED|Overall Study||4918
9804218|NCT00621582|10912622|FG000|COMPLETED|Overall Study||4812
9804219|NCT00621582|10912622|FG000|NOT COMPLETED|Overall Study||106
9804220|NCT00621621|10912629|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
9804221|NCT00621621|10912630|FG001|STARTED|Overall Study||705
9804222|NCT00621621|10912629|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75
9804223|NCT00621621|10912630|FG001|COMPLETED|Overall Study||705
9804224|NCT00621621|10912629|FG000|NOT COMPLETED|Overall Study||30
9804225|NCT00621621|10912630|FG001|NOT COMPLETED|Overall Study||0
9804226|NCT00621686|10912640|FG000|STARTED|Overall Study||19
9804227|NCT00621686|10912641|FG001|STARTED|Overall Study||35
9804228|NCT00621686|10912640|FG000|COMPLETED|Overall Study||19
9804229|NCT00621686|10912641|FG001|COMPLETED|Overall Study||35
9804230|NCT00621686|10912640|FG000|NOT COMPLETED|Overall Study||0
9804231|NCT00621686|10912641|FG001|NOT COMPLETED|Overall Study||0
9804232|NCT00621764|10912652|FG000|STARTED|Overall Study||50
9804233|NCT00621764|10912653|FG001|STARTED|Overall Study||50
9804234|NCT00621764|10912654|FG002|STARTED|Overall Study||101
9804235|NCT00621764|10912655|FG003|STARTED|Overall Study||99
9804236|NCT00621764|10912652|FG000|COMPLETED|Overall Study||50
9804237|NCT00621764|10912653|FG001|COMPLETED|Overall Study||50
9804238|NCT00621764|10912654|FG002|COMPLETED|Overall Study||101
9804239|NCT00621764|10912655|FG003|COMPLETED|Overall Study||98
9804240|NCT00621764|10912652|FG000|NOT COMPLETED|Overall Study||0
9804241|NCT00621764|10912653|FG001|NOT COMPLETED|Overall Study||0
9804242|NCT00621764|10912654|FG002|NOT COMPLETED|Overall Study||0
9804243|NCT00621764|10912655|FG003|NOT COMPLETED|Overall Study||1
9804244|NCT00621777|10912668|FG000|STARTED|Open Phase||203
9804245|NCT00621777|10912669|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
9804246|NCT00621777|10912668|FG000|COMPLETED|Open Phase||87
9804247|NCT00621777|10912669|FG001|COMPLETED|Open Phase||0
9804248|NCT00621777|10912668|FG000|NOT COMPLETED|Open Phase||116
9804249|NCT00621777|10912669|FG001|NOT COMPLETED|Open Phase||0
9804250|NCT00621777|10912668|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
9804251|NCT00621777|10912669|FG001|STARTED|Randomized Phase||47
9804252|NCT00621777|10912668|FG000|COMPLETED|Randomized Phase||33
9804253|NCT00621777|10912669|FG001|COMPLETED|Randomized Phase||28
9804254|NCT00621777|10912668|FG000|NOT COMPLETED|Randomized Phase||7
9804255|NCT00621777|10912669|FG001|NOT COMPLETED|Randomized Phase||19
9804256|NCT00621842|10912677|FG000|STARTED|Overall Study||57
9804257|NCT00621842|10912677|FG000|COMPLETED|Overall Study||38
9804258|NCT00621842|10912677|FG000|NOT COMPLETED|Overall Study||19
9804259|NCT00621855|10912686|FG000|STARTED|Overall Study|Started means randomised to treatment|372
9804260|NCT00621855|10912687|FG001|STARTED|Overall Study|Started means randomised to treatment|371
9804261|NCT00621855|10912688|FG002|STARTED|Overall Study|Started means randomised to treatment|411
9804262|NCT00621855|10912689|FG003|STARTED|Overall Study|Started means randomised to treatment|351
9804263|NCT00621855|10912690|FG004|STARTED|Overall Study|Started means randomised to treatment|373
9804264|NCT00621855|10912686|FG000|COMPLETED|Overall Study|Completed means completed treatment|296
9804265|NCT00621855|10912687|FG001|COMPLETED|Overall Study|Completed means completed treatment|310
9804266|NCT00621855|10912688|FG002|COMPLETED|Overall Study|Completed means completed treatment|330
9804267|NCT00621855|10912689|FG003|COMPLETED|Overall Study|Completed means completed treatment|284
9804268|NCT00621855|10912690|FG004|COMPLETED|Overall Study|Completed means completed treatment|318
9804269|NCT00621855|10912686|FG000|NOT COMPLETED|Overall Study||76
9804270|NCT00621855|10912687|FG001|NOT COMPLETED|Overall Study||61
9804271|NCT00621855|10912688|FG002|NOT COMPLETED|Overall Study||81
9804272|NCT00621855|10912689|FG003|NOT COMPLETED|Overall Study||67
9804273|NCT00621855|10912690|FG004|NOT COMPLETED|Overall Study||55
10016033|NCT01808339|11138999|FG003|STARTED|Washout Period 2 (14-21 Days)||2
10016034|NCT01808339|11139000|FG004|STARTED|Washout Period 2 (14-21 Days)||4
10016035|NCT01808339|11139001|FG005|STARTED|Washout Period 2 (14-21 Days)||5
10016036|NCT01808339|11138996|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4
10016037|NCT01808339|11138997|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3
10016038|NCT01808339|11138998|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4
9804274|NCT00621933|10912702|FG000|STARTED|Overall Study||399
9804275|NCT00621933|10912702|FG000|COMPLETED|Overall Study||399
9804276|NCT00621933|10912702|FG000|NOT COMPLETED|Overall Study||0
9804277|NCT00621946|10912708|FG000|STARTED|Overall Study||13
9804278|NCT00621946|10912709|FG001|STARTED|Overall Study||13
9804279|NCT00621946|10912708|FG000|COMPLETED|Overall Study||13
9804280|NCT00621946|10912709|FG001|COMPLETED|Overall Study||12
9804281|NCT00621946|10912708|FG000|NOT COMPLETED|Overall Study||0
9804282|NCT00621946|10912709|FG001|NOT COMPLETED|Overall Study||1
9804283|NCT00621959|10912718|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
9804284|NCT00621959|10912719|FG001|STARTED|Overall Study||301
9804285|NCT00621959|10912718|FG000|COMPLETED|Overall Study||288
9804286|NCT00621959|10912719|FG001|COMPLETED|Overall Study||292
9804287|NCT00621959|10912718|FG000|NOT COMPLETED|Overall Study||7
9804288|NCT00621959|10912719|FG001|NOT COMPLETED|Overall Study||9
9804289|NCT00621985|10912725|FG000|STARTED|Hydrocortisone Admission||5
9804290|NCT00621985|10912725|FG000|COMPLETED|Hydrocortisone Admission||5
9804291|NCT00621985|10912725|FG000|NOT COMPLETED|Hydrocortisone Admission||0
9804292|NCT00621985|10912725|FG000|STARTED|Dexamethasone Admission||5
9804293|NCT00621985|10912725|FG000|COMPLETED|Dexamethasone Admission||4
9804294|NCT00621985|10912725|FG000|NOT COMPLETED|Dexamethasone Admission||1
9804295|NCT00622180|10912731|FG000|STARTED|Overall Study||6
9804296|NCT00622180|10912732|FG001|STARTED|Overall Study||7
9804297|NCT00622180|10912731|FG000|COMPLETED|Overall Study||5
9804298|NCT00622180|10912732|FG001|COMPLETED|Overall Study||5
9804299|NCT00622180|10912731|FG000|NOT COMPLETED|Overall Study||1
9804300|NCT00622180|10912732|FG001|NOT COMPLETED|Overall Study||2
9804301|NCT00622284|10912740|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
9804302|NCT00622284|10912741|FG001|STARTED|Overall Study|Number who started treatment.|775
9804303|NCT00622284|10912740|FG000|COMPLETED|Overall Study|Number who completed treatment.|587
9804304|NCT00622284|10912741|FG001|COMPLETED|Overall Study|Number who completed treatment.|604
9804305|NCT00622284|10912740|FG000|NOT COMPLETED|Overall Study||189
9804306|NCT00622284|10912741|FG001|NOT COMPLETED|Overall Study||171
9804307|NCT00622336|10912747|FG000|STARTED|Treatment Phase||330
9804308|NCT00622336|10912747|FG000|Safety Population|Treatment Phase||330
9804309|NCT00622336|10912747|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
9804310|NCT00622336|10912747|FG000|NOT COMPLETED|Treatment Phase||309
10016039|NCT01808339|11138999|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2
10016040|NCT01808339|11139000|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4
9804311|NCT00622336|10912747|FG000|STARTED|Extension Phase||21
9804312|NCT00622336|10912747|FG000|COMPLETED|Extension Phase||0
9804313|NCT00622336|10912747|FG000|NOT COMPLETED|Extension Phase||21
9804314|NCT00622388|10912753|FG000|STARTED|Overall Study||81
9804315|NCT00622388|10912753|FG000|COMPLETED|Overall Study||9
9804316|NCT00622388|10912753|FG000|NOT COMPLETED|Overall Study||72
9804317|NCT00622401|10912761|FG000|STARTED|Overall Study||6
9804318|NCT00622401|10912762|FG001|STARTED|Overall Study||2
9804319|NCT00622401|10912763|FG002|STARTED|Overall Study|Never Opened|0
9804320|NCT00622401|10912761|FG000|COMPLETED|Overall Study||3
9804321|NCT00622401|10912762|FG001|COMPLETED|Overall Study||0
9804322|NCT00622401|10912763|FG002|COMPLETED|Overall Study||0
9804323|NCT00622401|10912761|FG000|NOT COMPLETED|Overall Study||3
9804324|NCT00622401|10912762|FG001|NOT COMPLETED|Overall Study||2
9804325|NCT00622401|10912763|FG002|NOT COMPLETED|Overall Study||0
9804326|NCT00622427|10912772|FG000|STARTED|Overall Study||16
9804327|NCT00622427|10912773|FG001|STARTED|Overall Study||16
9804328|NCT00622427|10912772|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
9804329|NCT00622427|10912773|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
9804330|NCT00622427|10912772|FG000|NOT COMPLETED|Overall Study||0
9804331|NCT00622427|10912773|FG001|NOT COMPLETED|Overall Study||0
9804332|NCT00622440|10912783|FG000|STARTED|Baseline - Week 12 (Treatment)||35
9804333|NCT00622440|10912784|FG001|STARTED|Baseline - Week 12 (Treatment)||35
9804334|NCT00622440|10912783|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31
9804335|NCT00622440|10912784|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34
9804336|NCT00622440|10912783|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
9804337|NCT00622440|10912784|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
9804338|NCT00622440|10912783|FG000|STARTED|Week 12 - Week 48 (Treatment)||31
9804339|NCT00622440|10912784|FG001|STARTED|Week 12 - Week 48 (Treatment)||34
9804340|NCT00622440|10912783|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28
9804341|NCT00622440|10912784|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28
9804342|NCT00622440|10912783|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
9804343|NCT00622440|10912784|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
9804344|NCT00622440|10912783|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
9804345|NCT00622440|10912784|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
9804346|NCT00622440|10912783|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
9804347|NCT00622440|10912784|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
9804348|NCT00622440|10912783|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
9804349|NCT00622440|10912784|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
9804350|NCT00622466|10912790|FG000|STARTED|Overall Study||20
9804351|NCT00622466|10912790|FG000|COMPLETED|Overall Study||16
9804352|NCT00622466|10912790|FG000|NOT COMPLETED|Overall Study||4
9804353|NCT00622505|10912796|FG000|STARTED|Overall Study||79
9804354|NCT00622505|10912797|FG001|STARTED|Overall Study||42
9804355|NCT00622505|10912796|FG000|COMPLETED|Overall Study||50
9804356|NCT00622505|10912797|FG001|COMPLETED|Overall Study||19
9804357|NCT00622505|10912796|FG000|NOT COMPLETED|Overall Study||29
9804358|NCT00622505|10912797|FG001|NOT COMPLETED|Overall Study||23
9804359|NCT00622518|10912805|FG000|STARTED|Overall Study||59
9804360|NCT00622518|10912806|FG001|STARTED|Overall Study||60
9804361|NCT00622518|10912805|FG000|COMPLETED|Overall Study||59
9804362|NCT00622518|10912806|FG001|COMPLETED|Overall Study||60
9804363|NCT00622518|10912805|FG000|NOT COMPLETED|Overall Study||0
9804364|NCT00622518|10912806|FG001|NOT COMPLETED|Overall Study||0
9804365|NCT00622544|10912812|FG000|STARTED|Overall Study||44
9804366|NCT00622544|10912812|FG000|COMPLETED|Overall Study|35|35
9804367|NCT00622544|10912812|FG000|NOT COMPLETED|Overall Study||9
9804368|NCT00622635|10912816|FG000|STARTED|Treatment Period 1||13
9804369|NCT00622635|10912817|FG001|STARTED|Treatment Period 1||11
9804370|NCT00622635|10912818|FG002|STARTED|Treatment Period 1||11
9804371|NCT00622635|10912819|FG003|STARTED|Treatment Period 1||13
9804372|NCT00622635|10912820|FG004|STARTED|Treatment Period 1||10
9804373|NCT00622635|10912821|FG005|STARTED|Treatment Period 1||10
9804374|NCT00622635|10912816|FG000|COMPLETED|Treatment Period 1||13
9804375|NCT00622635|10912817|FG001|COMPLETED|Treatment Period 1||10
9804376|NCT00622635|10912818|FG002|COMPLETED|Treatment Period 1||10
9804377|NCT00622635|10912819|FG003|COMPLETED|Treatment Period 1||13
9804378|NCT00622635|10912820|FG004|COMPLETED|Treatment Period 1||9
9804379|NCT00622635|10912821|FG005|COMPLETED|Treatment Period 1||10
9804380|NCT00622635|10912816|FG000|NOT COMPLETED|Treatment Period 1||0
9804381|NCT00622635|10912817|FG001|NOT COMPLETED|Treatment Period 1||1
9804382|NCT00622635|10912818|FG002|NOT COMPLETED|Treatment Period 1||1
9804383|NCT00622635|10912819|FG003|NOT COMPLETED|Treatment Period 1||0
9804384|NCT00622635|10912820|FG004|NOT COMPLETED|Treatment Period 1||1
9804385|NCT00622635|10912821|FG005|NOT COMPLETED|Treatment Period 1||0
9804386|NCT00622635|10912816|FG000|STARTED|Treatment Period 2||13
9804387|NCT00622635|10912817|FG001|STARTED|Treatment Period 2||10
9804388|NCT00622635|10912818|FG002|STARTED|Treatment Period 2||10
9804389|NCT00622635|10912819|FG003|STARTED|Treatment Period 2||13
9804390|NCT00622635|10912820|FG004|STARTED|Treatment Period 2||9
9804391|NCT00622635|10912821|FG005|STARTED|Treatment Period 2||10
9804392|NCT00622635|10912816|FG000|COMPLETED|Treatment Period 2||12
9804393|NCT00622635|10912817|FG001|COMPLETED|Treatment Period 2||10
9804394|NCT00622635|10912818|FG002|COMPLETED|Treatment Period 2||10
9804395|NCT00622635|10912819|FG003|COMPLETED|Treatment Period 2||13
9804396|NCT00622635|10912820|FG004|COMPLETED|Treatment Period 2||9
9804397|NCT00622635|10912821|FG005|COMPLETED|Treatment Period 2||10
9804398|NCT00622635|10912816|FG000|NOT COMPLETED|Treatment Period 2||1
9804399|NCT00622635|10912817|FG001|NOT COMPLETED|Treatment Period 2||0
9804400|NCT00622635|10912818|FG002|NOT COMPLETED|Treatment Period 2||0
9804401|NCT00622635|10912819|FG003|NOT COMPLETED|Treatment Period 2||0
9804402|NCT00622635|10912820|FG004|NOT COMPLETED|Treatment Period 2||0
9804403|NCT00622635|10912821|FG005|NOT COMPLETED|Treatment Period 2||0
9804404|NCT00622635|10912816|FG000|STARTED|Treatment Period 3||12
9804405|NCT00622635|10912817|FG001|STARTED|Treatment Period 3||10
9804406|NCT00622635|10912818|FG002|STARTED|Treatment Period 3||10
9804407|NCT00622635|10912819|FG003|STARTED|Treatment Period 3||13
9804408|NCT00622635|10912820|FG004|STARTED|Treatment Period 3||9
9804409|NCT00622635|10912821|FG005|STARTED|Treatment Period 3||10
9804410|NCT00622635|10912816|FG000|COMPLETED|Treatment Period 3||12
9804411|NCT00622635|10912817|FG001|COMPLETED|Treatment Period 3||10
9804412|NCT00622635|10912818|FG002|COMPLETED|Treatment Period 3||10
9804413|NCT00622635|10912819|FG003|COMPLETED|Treatment Period 3||10
9804414|NCT00622635|10912820|FG004|COMPLETED|Treatment Period 3||9
9804415|NCT00622635|10912821|FG005|COMPLETED|Treatment Period 3||10
9804416|NCT00622635|10912816|FG000|NOT COMPLETED|Treatment Period 3||0
9804417|NCT00622635|10912817|FG001|NOT COMPLETED|Treatment Period 3||0
9804418|NCT00622635|10912818|FG002|NOT COMPLETED|Treatment Period 3||0
9804419|NCT00622635|10912819|FG003|NOT COMPLETED|Treatment Period 3||3
9804420|NCT00622635|10912820|FG004|NOT COMPLETED|Treatment Period 3||0
9804421|NCT00622635|10912821|FG005|NOT COMPLETED|Treatment Period 3||0
9804422|NCT00622700|10912832|FG000|STARTED|Core Treatment Period||197
9804423|NCT00622700|10912833|FG001|STARTED|Core Treatment Period||205
9804424|NCT00622700|10912834|FG002|STARTED|Core Treatment Period||216
9804425|NCT00622700|10912835|FG003|STARTED|Core Treatment Period||0
9804426|NCT00622700|10912836|FG004|STARTED|Core Treatment Period||0
9804427|NCT00622700|10912837|FG005|STARTED|Core Treatment Period||0
9804428|NCT00622700|10912838|FG006|STARTED|Core Treatment Period||0
9804429|NCT00622700|10912832|FG000|Treated|Core Treatment Period||197
9804430|NCT00622700|10912833|FG001|Treated|Core Treatment Period||203
9804431|NCT00622700|10912834|FG002|Treated|Core Treatment Period||214
9804432|NCT00622700|10912835|FG003|Treated|Core Treatment Period||0
9804433|NCT00622700|10912836|FG004|Treated|Core Treatment Period||0
9804434|NCT00622700|10912837|FG005|Treated|Core Treatment Period||0
9804435|NCT00622700|10912838|FG006|Treated|Core Treatment Period||0
9804436|NCT00622700|10912832|FG000|COMPLETED|Core Treatment Period||141
9804437|NCT00622700|10912833|FG001|COMPLETED|Core Treatment Period||150
9804438|NCT00622700|10912834|FG002|COMPLETED|Core Treatment Period||163
9804439|NCT00622700|10912835|FG003|COMPLETED|Core Treatment Period||0
9804440|NCT00622700|10912836|FG004|COMPLETED|Core Treatment Period||0
9804441|NCT00622700|10912837|FG005|COMPLETED|Core Treatment Period||0
9804442|NCT00622700|10912838|FG006|COMPLETED|Core Treatment Period||0
9804443|NCT00622700|10912832|FG000|NOT COMPLETED|Core Treatment Period||56
9804444|NCT00622700|10912833|FG001|NOT COMPLETED|Core Treatment Period||55
9804445|NCT00622700|10912834|FG002|NOT COMPLETED|Core Treatment Period||53
9804446|NCT00622700|10912835|FG003|NOT COMPLETED|Core Treatment Period||0
9804447|NCT00622700|10912836|FG004|NOT COMPLETED|Core Treatment Period||0
9804448|NCT00622700|10912837|FG005|NOT COMPLETED|Core Treatment Period||0
9804449|NCT00622700|10912838|FG006|NOT COMPLETED|Core Treatment Period||0
9804450|NCT00622700|10912832|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
9804451|NCT00622700|10912833|FG001|STARTED|Extension Treatment Period||0
9804452|NCT00622700|10912834|FG002|STARTED|Extension Treatment Period||0
9804453|NCT00622700|10912835|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
9804454|NCT00622700|10912836|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
9804455|NCT00622700|10912837|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
9804456|NCT00622700|10912838|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
9804457|NCT00622700|10912832|FG000|COMPLETED|Extension Treatment Period||0
9804458|NCT00622700|10912833|FG001|COMPLETED|Extension Treatment Period||0
9804459|NCT00622700|10912834|FG002|COMPLETED|Extension Treatment Period||0
9804460|NCT00622700|10912835|FG003|COMPLETED|Extension Treatment Period||43
9804461|NCT00622700|10912836|FG004|COMPLETED|Extension Treatment Period||103
9804462|NCT00622700|10912837|FG005|COMPLETED|Extension Treatment Period||50
9804463|NCT00622700|10912838|FG006|COMPLETED|Extension Treatment Period||120
9804464|NCT00622700|10912832|FG000|NOT COMPLETED|Extension Treatment Period||0
9804465|NCT00622700|10912833|FG001|NOT COMPLETED|Extension Treatment Period||0
9804466|NCT00622700|10912834|FG002|NOT COMPLETED|Extension Treatment Period||0
9804467|NCT00622700|10912835|FG003|NOT COMPLETED|Extension Treatment Period||21
9804468|NCT00622700|10912836|FG004|NOT COMPLETED|Extension Treatment Period||39
9804469|NCT00622700|10912837|FG005|NOT COMPLETED|Extension Treatment Period||17
9804470|NCT00622700|10912838|FG006|NOT COMPLETED|Extension Treatment Period||30
9804471|NCT00622713|10912855|FG000|STARTED|Overall Study||228
9804472|NCT00622713|10912855|FG000|Exposed to Study Drug|Overall Study||226
9804473|NCT00622713|10912855|FG000|Intent to Treat (ITT) Population|Overall Study||218
9804474|NCT00622713|10912855|FG000|COMPLETED|Overall Study||169
9804475|NCT00622713|10912855|FG000|NOT COMPLETED|Overall Study||59
9804476|NCT00622726|10912861|FG000|STARTED|March, 2008 to August, 2010||75
9804477|NCT00622726|10912862|FG001|STARTED|March, 2008 to August, 2010||75
9804478|NCT00622726|10912861|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
9804479|NCT00622726|10912862|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
9804480|NCT00622726|10912861|FG000|NOT COMPLETED|March, 2008 to August, 2010||5
9804481|NCT00622726|10912862|FG001|NOT COMPLETED|March, 2008 to August, 2010||2
9804482|NCT00622726|10912861|FG000|STARTED|August, 2010 to April, 2013||70
9804483|NCT00622726|10912862|FG001|STARTED|August, 2010 to April, 2013||73
9804484|NCT00622726|10912861|FG000|COMPLETED|August, 2010 to April, 2013||69
9804485|NCT00622726|10912862|FG001|COMPLETED|August, 2010 to April, 2013||68
9804486|NCT00622726|10912861|FG000|NOT COMPLETED|August, 2010 to April, 2013||1
9804487|NCT00622726|10912862|FG001|NOT COMPLETED|August, 2010 to April, 2013||5
9804488|NCT00622739|10912874|FG000|STARTED|Overall Study||13
9804489|NCT00622739|10912875|FG001|STARTED|Overall Study||15
9804490|NCT00622739|10912874|FG000|COMPLETED|Overall Study||11
9804491|NCT00622739|10912875|FG001|COMPLETED|Overall Study||9
9804492|NCT00622739|10912874|FG000|NOT COMPLETED|Overall Study||2
9804493|NCT00622739|10912875|FG001|NOT COMPLETED|Overall Study||6
9804494|NCT00622869|10912886|FG000|STARTED|Overall Study||245
9804495|NCT00622869|10912887|FG001|STARTED|Overall Study||231
9804496|NCT00622869|10912888|FG002|STARTED|Overall Study||243
9804497|NCT00622869|10912886|FG000|COMPLETED|Overall Study||202
9804498|NCT00622869|10912887|FG001|COMPLETED|Overall Study||174
9804499|NCT00622869|10912888|FG002|COMPLETED|Overall Study||204
9804500|NCT00622869|10912886|FG000|NOT COMPLETED|Overall Study||43
9804501|NCT00622869|10912887|FG001|NOT COMPLETED|Overall Study||57
9804502|NCT00622869|10912888|FG002|NOT COMPLETED|Overall Study||39
9804503|NCT00622895|10912896|FG000|STARTED|Overall Study||3
9804504|NCT00622895|10912896|FG000|COMPLETED|Overall Study||3
9804505|NCT00622895|10912896|FG000|NOT COMPLETED|Overall Study||0
9804506|NCT00622908|10912905|FG000|STARTED|Overall Study|Intent to treat population|137
9804507|NCT00622908|10912906|FG001|STARTED|Overall Study|Intent to treat population|132
9804508|NCT00622908|10912905|FG000|COMPLETED|Overall Study||134
9804509|NCT00622908|10912906|FG001|COMPLETED|Overall Study||122
9804510|NCT00622908|10912905|FG000|NOT COMPLETED|Overall Study||3
9804511|NCT00622908|10912906|FG001|NOT COMPLETED|Overall Study||10
9804512|NCT00623012|10912912|FG000|STARTED|Overall Study||2
9804513|NCT00623012|10912912|FG000|COMPLETED|Overall Study||2
9804514|NCT00623012|10912912|FG000|NOT COMPLETED|Overall Study||0
9804515|NCT00623103|10912918|FG000|STARTED|Overall Study||295
9804516|NCT00623103|10912919|FG001|STARTED|Overall Study||288
9804517|NCT00623103|10912918|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
9804518|NCT00623103|10912919|FG001|Safety Set: Received Study Drug|Overall Study||288
9804519|NCT00623103|10912918|FG000|COMPLETED|Overall Study||184
9804520|NCT00623103|10912919|FG001|COMPLETED|Overall Study||175
9804521|NCT00623103|10912918|FG000|NOT COMPLETED|Overall Study||111
9804522|NCT00623103|10912919|FG001|NOT COMPLETED|Overall Study||113
9804523|NCT00623181|10912927|FG000|STARTED|Overall Study||56
9804524|NCT00623181|10912928|FG001|STARTED|Overall Study||54
9804525|NCT00623181|10912927|FG000|COMPLETED|Overall Study||56
9804526|NCT00623181|10912928|FG001|COMPLETED|Overall Study||54
9804527|NCT00623181|10912927|FG000|NOT COMPLETED|Overall Study||0
9804528|NCT00623181|10912928|FG001|NOT COMPLETED|Overall Study||0
9804529|NCT00623194|10912938|FG000|STARTED|Overall Study||146
9804530|NCT00623194|10912938|FG000|COMPLETED|Overall Study||141
9804531|NCT00623194|10912938|FG000|NOT COMPLETED|Overall Study||5
9804532|NCT00623233|10912942|FG000|STARTED|Overall Study||52
9804533|NCT00623233|10912942|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
9804534|NCT00623233|10912942|FG000|NOT COMPLETED|Overall Study||24
9804535|NCT00623363|10912948|FG000|STARTED|Overall Study||7
9804536|NCT00623363|10912949|FG001|STARTED|Overall Study||20
9804537|NCT00623363|10912948|FG000|COMPLETED|Overall Study||5
9804538|NCT00623363|10912949|FG001|COMPLETED|Overall Study||18
9804539|NCT00623363|10912948|FG000|NOT COMPLETED|Overall Study||2
9804540|NCT00623363|10912949|FG001|NOT COMPLETED|Overall Study||2
9804541|NCT00623428|10912958|FG000|STARTED|Treatment Period||95
9804542|NCT00623428|10912959|FG001|STARTED|Treatment Period||93
9804543|NCT00623428|10912958|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
9804544|NCT00623428|10912959|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
9804545|NCT00623428|10912958|FG000|NOT COMPLETED|Treatment Period||0
9804546|NCT00623428|10912959|FG001|NOT COMPLETED|Treatment Period||27
9804547|NCT00623428|10912958|FG000|STARTED|Follow-up Period||95
9804548|NCT00623428|10912959|FG001|STARTED|Follow-up Period||93
9804549|NCT00623428|10912958|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
9804550|NCT00623428|10912959|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
9804551|NCT00623428|10912958|FG000|NOT COMPLETED|Follow-up Period||29
9804552|NCT00623428|10912959|FG001|NOT COMPLETED|Follow-up Period||15
9804553|NCT00623441|10912965|FG000|STARTED|Overall Study||8314
9804554|NCT00623441|10912965|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
9804555|NCT00623441|10912965|FG000|NOT COMPLETED|Overall Study||0
9804556|NCT00623467|10912969|FG000|STARTED|Overall Study||343
9804557|NCT00623467|10912969|FG000|COMPLETED|Overall Study||336
9804558|NCT00623467|10912969|FG000|NOT COMPLETED|Overall Study||7
9804559|NCT00623480|10912977|FG000|STARTED|Overall Study||42
9804560|NCT00623480|10912978|FG001|STARTED|Overall Study||42
9804561|NCT00623480|10912977|FG000|COMPLETED|Overall Study||35
9804562|NCT00623480|10912978|FG001|COMPLETED|Overall Study||35
9804563|NCT00623480|10912977|FG000|NOT COMPLETED|Overall Study||7
9804564|NCT00623480|10912978|FG001|NOT COMPLETED|Overall Study||7
9804565|NCT00623506|10912986|FG000|STARTED|Overall Study||15
9804566|NCT00623506|10912987|FG001|STARTED|Overall Study||15
9804567|NCT00623506|10912986|FG000|Week 4|Overall Study||11
9804568|NCT00623506|10912987|FG001|Week 4|Overall Study||11
9804569|NCT00623506|10912986|FG000|COMPLETED|Overall Study||11
9804570|NCT00623506|10912987|FG001|COMPLETED|Overall Study||11
9804571|NCT00623506|10912986|FG000|NOT COMPLETED|Overall Study||4
9804572|NCT00623506|10912987|FG001|NOT COMPLETED|Overall Study||4
9804573|NCT00623545|10912993|FG000|STARTED|Overall Study||28
9804574|NCT00623545|10912993|FG000|COMPLETED|Overall Study||18
9804575|NCT00623545|10912993|FG000|NOT COMPLETED|Overall Study||10
9804576|NCT00623597|10913000|FG000|STARTED|Overall Study||5
9804577|NCT00623597|10913001|FG001|STARTED|Overall Study||13
9804578|NCT00623597|10913000|FG000|COMPLETED|Overall Study||4
9804579|NCT00623597|10913001|FG001|COMPLETED|Overall Study||13
9804580|NCT00623597|10913000|FG000|NOT COMPLETED|Overall Study||1
9804581|NCT00623597|10913001|FG001|NOT COMPLETED|Overall Study||0
9804582|NCT00623623|10913011|FG000|STARTED|Overall Study||950
9804583|NCT00623623|10913012|FG001|STARTED|Overall Study||949
9804584|NCT00623623|10913011|FG000|COMPLETED|Overall Study||949
9804585|NCT00623623|10913012|FG001|COMPLETED|Overall Study||948
9804586|NCT00623623|10913011|FG000|NOT COMPLETED|Overall Study||1
9804587|NCT00623623|10913012|FG001|NOT COMPLETED|Overall Study||1
9804588|NCT00623636|10913020|FG000|STARTED|Double Blind||452
9804589|NCT00623636|10913021|FG001|STARTED|Double Blind||450
9804590|NCT00623636|10913020|FG000|COMPLETED|Double Blind||419
9804591|NCT00623636|10913021|FG001|COMPLETED|Double Blind||422
9804592|NCT00623636|10913020|FG000|NOT COMPLETED|Double Blind||33
9804593|NCT00623636|10913021|FG001|NOT COMPLETED|Double Blind||28
9804594|NCT00623636|10913020|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
9804595|NCT00623636|10913021|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
9804596|NCT00623636|10913020|FG000|COMPLETED|Open Label||0
9804597|NCT00623636|10913021|FG001|COMPLETED|Open Label||263
9804598|NCT00623636|10913020|FG000|NOT COMPLETED|Open Label||0
9804599|NCT00623636|10913021|FG001|NOT COMPLETED|Open Label||412
9804600|NCT00623714|10913028|FG000|STARTED|Period 1||6
9804601|NCT00623714|10913029|FG001|STARTED|Period 1||7
9804602|NCT00623714|10913028|FG000|COMPLETED|Period 1||6
9804603|NCT00623714|10913029|FG001|COMPLETED|Period 1||7
9804604|NCT00623714|10913028|FG000|NOT COMPLETED|Period 1||0
9804605|NCT00623714|10913029|FG001|NOT COMPLETED|Period 1||0
9804606|NCT00623714|10913028|FG000|STARTED|Period 2||6
9804607|NCT00623714|10913029|FG001|STARTED|Period 2||7
9804608|NCT00623714|10913028|FG000|COMPLETED|Period 2||6
9804609|NCT00623714|10913029|FG001|COMPLETED|Period 2||7
9804610|NCT00623714|10913028|FG000|NOT COMPLETED|Period 2||0
9804611|NCT00623714|10913029|FG001|NOT COMPLETED|Period 2||0
9804612|NCT00623727|10913037|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
9804613|NCT00623727|10913038|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
9804614|NCT00623727|10913037|FG000|Participants Received Treatment|Double Blind (DB)||67
9804615|NCT00623727|10913038|FG001|Participants Received Treatment|Double Blind (DB)||72
9804616|NCT00623727|10913037|FG000|COMPLETED|Double Blind (DB)||34
9804617|NCT00623727|10913038|FG001|COMPLETED|Double Blind (DB)||41
9804618|NCT00623727|10913037|FG000|NOT COMPLETED|Double Blind (DB)||36
9804619|NCT00623727|10913038|FG001|NOT COMPLETED|Double Blind (DB)||32
9804620|NCT00623727|10913037|FG000|STARTED|Open Label Follow-up||0
9804621|NCT00623727|10913038|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
9804622|NCT00623727|10913037|FG000|COMPLETED|Open Label Follow-up||0
9804623|NCT00623727|10913038|FG001|COMPLETED|Open Label Follow-up||18
9804624|NCT00623727|10913037|FG000|NOT COMPLETED|Open Label Follow-up||0
9804625|NCT00623727|10913038|FG001|NOT COMPLETED|Open Label Follow-up||8
9804626|NCT00623727|10913037|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
9804627|NCT00623727|10913038|FG001|STARTED|Open Label Extension Period||0
9804628|NCT00623727|10913037|FG000|COMPLETED|Open Label Extension Period||20
9804629|NCT00623727|10913038|FG001|COMPLETED|Open Label Extension Period||0
9804630|NCT00623727|10913037|FG000|NOT COMPLETED|Open Label Extension Period||0
9804631|NCT00623727|10913038|FG001|NOT COMPLETED|Open Label Extension Period||0
9804632|NCT00623766|10913048|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
9804633|NCT00623766|10913049|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
9804634|NCT00623766|10913048|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
9804635|NCT00623766|10913049|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
9804636|NCT00623766|10913048|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
9804637|NCT00623766|10913049|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
9804638|NCT00623766|10913048|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11
9804639|NCT00623766|10913049|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2
9804640|NCT00623766|10913048|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
9804641|NCT00623766|10913049|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
9804642|NCT00623766|10913048|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
9804643|NCT00623766|10913049|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
9804644|NCT00623779|10913062|FG000|STARTED|Overall Study||41
9804645|NCT00623779|10913063|FG001|STARTED|Overall Study||42
9804646|NCT00623779|10913064|FG002|STARTED|Overall Study||45
9804647|NCT00623779|10913062|FG000|COMPLETED|Overall Study||38
9804648|NCT00623779|10913063|FG001|COMPLETED|Overall Study||39
9804649|NCT00623779|10913064|FG002|COMPLETED|Overall Study||44
9804650|NCT00623779|10913062|FG000|NOT COMPLETED|Overall Study||3
9804651|NCT00623779|10913063|FG001|NOT COMPLETED|Overall Study||3
9804652|NCT00623779|10913064|FG002|NOT COMPLETED|Overall Study||1
9804653|NCT00623805|10913074|FG000|STARTED|Overall Study||62
9804654|NCT00623805|10913075|FG001|STARTED|Overall Study||61
9804655|NCT00623805|10913074|FG000|COMPLETED|Overall Study||42
9804656|NCT00623805|10913075|FG001|COMPLETED|Overall Study||39
9804657|NCT00623805|10913074|FG000|NOT COMPLETED|Overall Study||20
9804658|NCT00623805|10913075|FG001|NOT COMPLETED|Overall Study||22
9804659|NCT00623831|10913083|FG000|STARTED|Overall Study||13
9804660|NCT00623831|10913084|FG001|STARTED|Overall Study||4
9804661|NCT00623831|10913083|FG000|COMPLETED|Overall Study||12
9804662|NCT00623831|10913084|FG001|COMPLETED|Overall Study||3
9804663|NCT00623831|10913083|FG000|NOT COMPLETED|Overall Study||1
9804664|NCT00623831|10913084|FG001|NOT COMPLETED|Overall Study||1
9804665|NCT00623935|10913093|FG000|STARTED|Overall Study||56
9804666|NCT00623935|10913093|FG000|COMPLETED|Overall Study||54
9804667|NCT00623935|10913093|FG000|NOT COMPLETED|Overall Study||2
9804668|NCT00624013|10913099|FG000|STARTED|Overall Study||44
9804669|NCT00624013|10913100|FG001|STARTED|Overall Study||45
9804670|NCT00624013|10913099|FG000|COMPLETED|Overall Study||36
9804671|NCT00624013|10913100|FG001|COMPLETED|Overall Study||39
9804672|NCT00624013|10913099|FG000|NOT COMPLETED|Overall Study||8
9804673|NCT00624013|10913100|FG001|NOT COMPLETED|Overall Study||6
9804674|NCT00624052|10913112|FG000|STARTED|Overall Study||219
9804675|NCT00624052|10913113|FG001|STARTED|Overall Study||436
9804676|NCT00624052|10913114|FG002|STARTED|Overall Study||91
9804677|NCT00624052|10913115|FG003|STARTED|Overall Study||92
9804678|NCT00624052|10913112|FG000|COMPLETED|Overall Study||204
9804679|NCT00624052|10913113|FG001|COMPLETED|Overall Study||422
9804680|NCT00624052|10913114|FG002|COMPLETED|Overall Study||88
9804681|NCT00624052|10913115|FG003|COMPLETED|Overall Study||88
9804682|NCT00624052|10913112|FG000|NOT COMPLETED|Overall Study||15
9804683|NCT00624052|10913113|FG001|NOT COMPLETED|Overall Study||14
9804684|NCT00624052|10913114|FG002|NOT COMPLETED|Overall Study||3
9804685|NCT00624052|10913115|FG003|NOT COMPLETED|Overall Study||4
9804686|NCT00624065|10913131|FG000|STARTED|Overall Study||216
9804687|NCT00624065|10913132|FG001|STARTED|Overall Study||216
9804688|NCT00624065|10913131|FG000|COMPLETED|Overall Study||197
9804689|NCT00624065|10913132|FG001|COMPLETED|Overall Study||192
9804690|NCT00624065|10913131|FG000|NOT COMPLETED|Overall Study||19
9804691|NCT00624065|10913132|FG001|NOT COMPLETED|Overall Study||24
9804692|NCT00624195|10913140|FG000|STARTED|Overall Study||29
9804693|NCT00624195|10913141|FG001|STARTED|Overall Study||30
9804694|NCT00624195|10913140|FG000|COMPLETED|Overall Study||26
9804695|NCT00624195|10913141|FG001|COMPLETED|Overall Study||23
9804696|NCT00624195|10913140|FG000|NOT COMPLETED|Overall Study||3
9804697|NCT00624195|10913141|FG001|NOT COMPLETED|Overall Study||7
9804698|NCT00624221|10913149|FG000|STARTED|Overall Study||20
9804699|NCT00624221|10913150|FG001|STARTED|Overall Study||20
9804700|NCT00624221|10913149|FG000|COMPLETED|Overall Study||20
9804701|NCT00624221|10913150|FG001|COMPLETED|Overall Study||20
9804702|NCT00624221|10913149|FG000|NOT COMPLETED|Overall Study||0
9804703|NCT00624221|10913150|FG001|NOT COMPLETED|Overall Study||0
9804704|NCT00624286|10913158|FG000|STARTED|Overall Study||211
9804705|NCT00624286|10913159|FG001|STARTED|Overall Study||205
9804706|NCT00624286|10913158|FG000|COMPLETED|Overall Study||186
9804707|NCT00624286|10913159|FG001|COMPLETED|Overall Study||178
9804708|NCT00624286|10913158|FG000|NOT COMPLETED|Overall Study||25
9804709|NCT00624286|10913159|FG001|NOT COMPLETED|Overall Study||27
9804710|NCT00624338|10913168|FG000|STARTED|Overall Study||159
9804711|NCT00624338|10913169|FG001|STARTED|Overall Study||145
9804712|NCT00624338|10913170|FG002|STARTED|Overall Study||157
9804713|NCT00624338|10913168|FG000|Treated|Overall Study||157
9804714|NCT00624338|10913169|FG001|Treated|Overall Study||144
9804715|NCT00624338|10913170|FG002|Treated|Overall Study||154
9804716|NCT00624338|10913168|FG000|COMPLETED|Overall Study||112
9804717|NCT00624338|10913169|FG001|COMPLETED|Overall Study||62
9804718|NCT00624338|10913170|FG002|COMPLETED|Overall Study||111
9804719|NCT00624338|10913168|FG000|NOT COMPLETED|Overall Study||47
9804720|NCT00624338|10913169|FG001|NOT COMPLETED|Overall Study||83
9804721|NCT00624338|10913170|FG002|NOT COMPLETED|Overall Study||46
9804722|NCT00624377|10913178|FG000|STARTED|Overall Study||2031
9804723|NCT00624377|10913178|FG000|COMPLETED|Overall Study||1387
9804724|NCT00624377|10913178|FG000|NOT COMPLETED|Overall Study||644
9804725|NCT00624416|10913182|FG000|STARTED|Overall Study||10
9804726|NCT00624416|10913182|FG000|COMPLETED|Overall Study||10
9804727|NCT00624416|10913182|FG000|NOT COMPLETED|Overall Study||0
9804728|NCT00624442|10913191|FG000|STARTED|Overall Study||8
9804729|NCT00624442|10913192|FG001|STARTED|Overall Study||9
9804730|NCT00624442|10913193|FG002|STARTED|Overall Study||10
9804731|NCT00624442|10913194|FG003|STARTED|Overall Study||8
9804732|NCT00624442|10913195|FG004|STARTED|Overall Study||10
9804733|NCT00624442|10913191|FG000|COMPLETED|Overall Study||8
9804734|NCT00624442|10913192|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
9804735|NCT00624442|10913193|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
9804736|NCT00624442|10913194|FG003|COMPLETED|Overall Study||8
9804737|NCT00624442|10913195|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
9804738|NCT00624442|10913191|FG000|NOT COMPLETED|Overall Study||0
9804739|NCT00624442|10913192|FG001|NOT COMPLETED|Overall Study||1
9804740|NCT00624442|10913193|FG002|NOT COMPLETED|Overall Study||2
9804741|NCT00624442|10913194|FG003|NOT COMPLETED|Overall Study||0
9804742|NCT00624442|10913195|FG004|NOT COMPLETED|Overall Study||2
9804743|NCT00624468|10913230|FG000|STARTED|Double-blind Period||17
9804744|NCT00624468|10913231|FG001|STARTED|Double-blind Period||17
9804745|NCT00624468|10913232|FG002|STARTED|Double-blind Period||0
9804746|NCT00624468|10913233|FG003|STARTED|Double-blind Period||0
9804747|NCT00624468|10913230|FG000|COMPLETED|Double-blind Period||3
9804748|NCT00624468|10913231|FG001|COMPLETED|Double-blind Period||4
9804749|NCT00624468|10913232|FG002|COMPLETED|Double-blind Period||0
9804750|NCT00624468|10913233|FG003|COMPLETED|Double-blind Period||0
9804751|NCT00624468|10913230|FG000|NOT COMPLETED|Double-blind Period||14
9804752|NCT00624468|10913231|FG001|NOT COMPLETED|Double-blind Period||13
9804753|NCT00624468|10913232|FG002|NOT COMPLETED|Double-blind Period||0
9804754|NCT00624468|10913233|FG003|NOT COMPLETED|Double-blind Period||0
9804755|NCT00624468|10913230|FG000|STARTED|Safety Follow-up (SFU) Period||0
9804756|NCT00624468|10913231|FG001|STARTED|Safety Follow-up (SFU) Period||0
9804757|NCT00624468|10913232|FG002|STARTED|Safety Follow-up (SFU) Period||13
9804758|NCT00624468|10913233|FG003|STARTED|Safety Follow-up (SFU) Period||14
9804759|NCT00624468|10913230|FG000|COMPLETED|Safety Follow-up (SFU) Period||0
9804760|NCT00624468|10913231|FG001|COMPLETED|Safety Follow-up (SFU) Period||0
9804761|NCT00624468|10913232|FG002|COMPLETED|Safety Follow-up (SFU) Period||11
9804762|NCT00624468|10913233|FG003|COMPLETED|Safety Follow-up (SFU) Period||11
9804763|NCT00624468|10913230|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0
9804764|NCT00624468|10913231|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0
9804765|NCT00624468|10913232|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2
9804766|NCT00624468|10913233|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3
9804767|NCT00624520|10913243|FG000|STARTED|Overall Study||56
9804768|NCT00624520|10913244|FG001|STARTED|Overall Study||47
9804769|NCT00624520|10913243|FG000|COMPLETED|Overall Study||44
9804770|NCT00624520|10913244|FG001|COMPLETED|Overall Study||39
9804771|NCT00624520|10913243|FG000|NOT COMPLETED|Overall Study||12
9804772|NCT00624520|10913244|FG001|NOT COMPLETED|Overall Study||8
9804773|NCT00624559|10913254|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
9804774|NCT00624559|10913255|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
9804775|NCT00624559|10913256|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
9804776|NCT00624559|10913257|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
9804777|NCT00624559|10913254|FG000|COMPLETED|Overall Study||3
9804778|NCT00624559|10913255|FG001|COMPLETED|Overall Study||3
9804779|NCT00624559|10913256|FG002|COMPLETED|Overall Study||3
9804780|NCT00624559|10913257|FG003|COMPLETED|Overall Study||3
9804781|NCT00624559|10913254|FG000|NOT COMPLETED|Overall Study||0
9804782|NCT00624559|10913255|FG001|NOT COMPLETED|Overall Study||0
9804783|NCT00624559|10913256|FG002|NOT COMPLETED|Overall Study||0
9804784|NCT00624559|10913257|FG003|NOT COMPLETED|Overall Study||0
9804785|NCT00624585|10913267|FG000|STARTED|Overall Study||18
9804786|NCT00624585|10913267|FG000|COMPLETED|Overall Study||6
9804787|NCT00624585|10913267|FG000|NOT COMPLETED|Overall Study||12
9804788|NCT00624780|10913277|FG000|STARTED|Treatment Optimization (Up to Week 12)||154
9804789|NCT00624780|10913278|FG001|STARTED|Treatment Optimization (Up to Week 12)||52
9804790|NCT00624780|10913279|FG002|STARTED|Treatment Optimization (Up to Week 12)||154
9804791|NCT00624780|10913280|FG003|STARTED|Treatment Optimization (Up to Week 12)||52
9804792|NCT00624780|10913281|FG004|STARTED|Treatment Optimization (Up to Week 12)||153
9804793|NCT00624780|10913282|FG005|STARTED|Treatment Optimization (Up to Week 12)||50
9804794|NCT00624780|10913277|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121
9804795|NCT00624780|10913278|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39
9804796|NCT00624780|10913279|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112
9804797|NCT00624780|10913280|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38
9804798|NCT00624780|10913281|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114
9804799|NCT00624780|10913282|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39
9804800|NCT00624780|10913277|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
9804801|NCT00624780|10913278|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
9804802|NCT00624780|10913279|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
9804803|NCT00624780|10913280|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
9804804|NCT00624780|10913281|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
9804805|NCT00624780|10913282|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
9804806|NCT00624780|10913277|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121
9804807|NCT00624780|10913278|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39
9804808|NCT00624780|10913279|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112
9804809|NCT00624780|10913280|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38
9804810|NCT00624780|10913281|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114
9804811|NCT00624780|10913282|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39
9804812|NCT00624780|10913277|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
9804813|NCT00624780|10913278|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
9804814|NCT00624780|10913279|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
9804815|NCT00624780|10913280|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
9804816|NCT00624780|10913281|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
9804817|NCT00624780|10913282|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
9804818|NCT00624780|10913277|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
9804819|NCT00624780|10913278|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
9804820|NCT00624780|10913279|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
9804821|NCT00624780|10913280|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
9804822|NCT00624780|10913281|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
9804823|NCT00624780|10913282|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
9804824|NCT00624780|10913277|FG000|STARTED|Treatment Discontinuation (Week 25)||106
9804825|NCT00624780|10913278|FG001|STARTED|Treatment Discontinuation (Week 25)||28
9804826|NCT00624780|10913279|FG002|STARTED|Treatment Discontinuation (Week 25)||94
9804827|NCT00624780|10913280|FG003|STARTED|Treatment Discontinuation (Week 25)||27
9804828|NCT00624780|10913281|FG004|STARTED|Treatment Discontinuation (Week 25)||95
9804829|NCT00624780|10913282|FG005|STARTED|Treatment Discontinuation (Week 25)||30
9804830|NCT00624780|10913277|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104
9804831|NCT00624780|10913278|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28
9804832|NCT00624780|10913279|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91
9804833|NCT00624780|10913280|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26
9804834|NCT00624780|10913281|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95
9804835|NCT00624780|10913282|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29
9804836|NCT00624780|10913277|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
9804837|NCT00624780|10913278|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
9804838|NCT00624780|10913279|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
9804839|NCT00624780|10913280|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
9804840|NCT00624780|10913281|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
9804841|NCT00624780|10913282|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
9804842|NCT00624780|10913277|FG000|STARTED|Follow-up (Week 26)||104
9804843|NCT00624780|10913278|FG001|STARTED|Follow-up (Week 26)||28
9804844|NCT00624780|10913279|FG002|STARTED|Follow-up (Week 26)||91
9804845|NCT00624780|10913280|FG003|STARTED|Follow-up (Week 26)||26
9804846|NCT00624780|10913281|FG004|STARTED|Follow-up (Week 26)||95
9804847|NCT00624780|10913282|FG005|STARTED|Follow-up (Week 26)||29
9804848|NCT00624780|10913277|FG000|COMPLETED|Follow-up (Week 26)||102
9804849|NCT00624780|10913278|FG001|COMPLETED|Follow-up (Week 26)||27
9804850|NCT00624780|10913279|FG002|COMPLETED|Follow-up (Week 26)||89
9804851|NCT00624780|10913280|FG003|COMPLETED|Follow-up (Week 26)||26
9804852|NCT00624780|10913281|FG004|COMPLETED|Follow-up (Week 26)||93
9804853|NCT00624780|10913282|FG005|COMPLETED|Follow-up (Week 26)||29
9804854|NCT00624780|10913277|FG000|NOT COMPLETED|Follow-up (Week 26)||2
9804855|NCT00624780|10913278|FG001|NOT COMPLETED|Follow-up (Week 26)||1
9804856|NCT00624780|10913279|FG002|NOT COMPLETED|Follow-up (Week 26)||2
9804857|NCT00624780|10913280|FG003|NOT COMPLETED|Follow-up (Week 26)||0
9804858|NCT00624780|10913281|FG004|NOT COMPLETED|Follow-up (Week 26)||2
9804859|NCT00624780|10913282|FG005|NOT COMPLETED|Follow-up (Week 26)||0
9804860|NCT00624806|10913301|FG000|STARTED|Overall Study||10
9804861|NCT00624806|10913302|FG001|STARTED|Overall Study||8
9804862|NCT00624806|10913301|FG000|COMPLETED|Overall Study||10
9804863|NCT00624806|10913302|FG001|COMPLETED|Overall Study||8
9804864|NCT00624806|10913301|FG000|NOT COMPLETED|Overall Study||0
9804865|NCT00624806|10913302|FG001|NOT COMPLETED|Overall Study||0
9804866|NCT00624819|10913312|FG000|STARTED|Follow-up Period: Year 1||391
9804867|NCT00624819|10913313|FG001|STARTED|Follow-up Period: Year 1||31
9804868|NCT00624819|10913314|FG002|STARTED|Follow-up Period: Year 1||102
9804869|NCT00624819|10913315|FG003|STARTED|Follow-up Period: Year 1||0
9804870|NCT00624819|10913312|FG000|COMPLETED|Follow-up Period: Year 1||391
9804871|NCT00624819|10913313|FG001|COMPLETED|Follow-up Period: Year 1||31
9804872|NCT00624819|10913314|FG002|COMPLETED|Follow-up Period: Year 1||102
9804873|NCT00624819|10913315|FG003|COMPLETED|Follow-up Period: Year 1||0
9804874|NCT00624819|10913312|FG000|NOT COMPLETED|Follow-up Period: Year 1||0
9804875|NCT00624819|10913313|FG001|NOT COMPLETED|Follow-up Period: Year 1||0
9804876|NCT00624819|10913314|FG002|NOT COMPLETED|Follow-up Period: Year 1||0
9804877|NCT00624819|10913315|FG003|NOT COMPLETED|Follow-up Period: Year 1||0
9804878|NCT00624819|10913312|FG000|STARTED|Follow-up Period: Year 2||370
9804879|NCT00624819|10913313|FG001|STARTED|Follow-up Period: Year 2||31
9804880|NCT00624819|10913314|FG002|STARTED|Follow-up Period: Year 2||96
9804881|NCT00624819|10913315|FG003|STARTED|Follow-up Period: Year 2||0
9804882|NCT00624819|10913312|FG000|COMPLETED|Follow-up Period: Year 2||370
9804883|NCT00624819|10913313|FG001|COMPLETED|Follow-up Period: Year 2||31
9804884|NCT00624819|10913314|FG002|COMPLETED|Follow-up Period: Year 2||96
9804885|NCT00624819|10913315|FG003|COMPLETED|Follow-up Period: Year 2||0
9804886|NCT00624819|10913312|FG000|NOT COMPLETED|Follow-up Period: Year 2||0
9804887|NCT00624819|10913313|FG001|NOT COMPLETED|Follow-up Period: Year 2||0
9804888|NCT00624819|10913314|FG002|NOT COMPLETED|Follow-up Period: Year 2||0
9804889|NCT00624819|10913315|FG003|NOT COMPLETED|Follow-up Period: Year 2||0
9804890|NCT00624819|10913312|FG000|STARTED|Follow-up Period: Year 4||264
9804891|NCT00624819|10913313|FG001|STARTED|Follow-up Period: Year 4||20
9804892|NCT00624819|10913314|FG002|STARTED|Follow-up Period: Year 4||65
9804893|NCT00624819|10913315|FG003|STARTED|Follow-up Period: Year 4||100
9804894|NCT00624819|10913312|FG000|COMPLETED|Follow-up Period: Year 4||263
9804895|NCT00624819|10913313|FG001|COMPLETED|Follow-up Period: Year 4||19
9804896|NCT00624819|10913314|FG002|COMPLETED|Follow-up Period: Year 4||64
9804897|NCT00624819|10913315|FG003|COMPLETED|Follow-up Period: Year 4||100
9804898|NCT00624819|10913312|FG000|NOT COMPLETED|Follow-up Period: Year 4||1
9804899|NCT00624819|10913313|FG001|NOT COMPLETED|Follow-up Period: Year 4||1
9804900|NCT00624819|10913314|FG002|NOT COMPLETED|Follow-up Period: Year 4||1
9804901|NCT00624819|10913315|FG003|NOT COMPLETED|Follow-up Period: Year 4||0
9804902|NCT00624832|10913329|FG000|STARTED|Overall Study||18
9804903|NCT00624832|10913330|FG001|STARTED|Overall Study||16
9804904|NCT00624832|10913331|FG002|STARTED|Overall Study||10
9804905|NCT00624832|10913332|FG003|STARTED|Overall Study||16
9804906|NCT00624832|10913329|FG000|COMPLETED|Overall Study||16
9804907|NCT00624832|10913330|FG001|COMPLETED|Overall Study||15
9804908|NCT00624832|10913331|FG002|COMPLETED|Overall Study||10
9804909|NCT00624832|10913332|FG003|COMPLETED|Overall Study||15
9804910|NCT00624832|10913329|FG000|NOT COMPLETED|Overall Study||2
9804911|NCT00624832|10913330|FG001|NOT COMPLETED|Overall Study||1
9804912|NCT00624832|10913331|FG002|NOT COMPLETED|Overall Study||0
9804913|NCT00624832|10913332|FG003|NOT COMPLETED|Overall Study||1
9804914|NCT00624910|10913344|FG000|STARTED|Overall Study||28
9804915|NCT00624910|10913345|FG001|STARTED|Overall Study||15
9804916|NCT00624910|10913346|FG002|STARTED|Overall Study||11
9804917|NCT00624910|10913344|FG000|COMPLETED|Overall Study||28
9804918|NCT00624910|10913345|FG001|COMPLETED|Overall Study||15
9804919|NCT00624910|10913346|FG002|COMPLETED|Overall Study||11
9804920|NCT00624910|10913344|FG000|NOT COMPLETED|Overall Study||0
9804921|NCT00624910|10913345|FG001|NOT COMPLETED|Overall Study||0
9804922|NCT00624910|10913346|FG002|NOT COMPLETED|Overall Study||0
9804923|NCT00624923|10913356|FG000|STARTED|Overall Study||127
9804924|NCT00624923|10913357|FG001|STARTED|Overall Study||124
9804925|NCT00624923|10913356|FG000|COMPLETED|Overall Study||89
9804926|NCT00624923|10913357|FG001|COMPLETED|Overall Study||101
9804927|NCT00624923|10913356|FG000|NOT COMPLETED|Overall Study||38
9804928|NCT00624923|10913357|FG001|NOT COMPLETED|Overall Study||23
9804929|NCT00625131|10913367|FG000|STARTED|Overall Study||38
9804930|NCT00625131|10913368|FG001|STARTED|Overall Study||44
9804931|NCT00625131|10913369|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5
9804932|NCT00625131|10913367|FG000|COMPLETED|Overall Study||34
9804933|NCT00625131|10913368|FG001|COMPLETED|Overall Study||42
9804934|NCT00625131|10913369|FG002|COMPLETED|Overall Study||0
9804935|NCT00625131|10913367|FG000|NOT COMPLETED|Overall Study||4
9804936|NCT00625131|10913368|FG001|NOT COMPLETED|Overall Study||2
9804937|NCT00625131|10913369|FG002|NOT COMPLETED|Overall Study||5
9804938|NCT00625183|10913375|FG000|STARTED|Overall Study||5
9804939|NCT00625183|10913375|FG000|COMPLETED|Overall Study||4
9804940|NCT00625183|10913375|FG000|NOT COMPLETED|Overall Study||1
9804941|NCT00625365|10913381|FG000|STARTED|Overall Study||1060
9804942|NCT00625365|10913381|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
9804943|NCT00625365|10913381|FG000|NOT COMPLETED|Overall Study||7
9804944|NCT00625391|10913389|FG000|STARTED|Overall Study||44
9804945|NCT00625391|10913390|FG001|STARTED|Overall Study||47
9804946|NCT00625391|10913391|FG002|STARTED|Overall Study||42
9804947|NCT00625391|10913392|FG003|STARTED|Overall Study||38
9804948|NCT00625391|10913389|FG000|COMPLETED|Overall Study||37
9804949|NCT00625391|10913390|FG001|COMPLETED|Overall Study||39
9804950|NCT00625391|10913391|FG002|COMPLETED|Overall Study||37
9804951|NCT00625391|10913392|FG003|COMPLETED|Overall Study||37
9804952|NCT00625391|10913389|FG000|NOT COMPLETED|Overall Study||7
9804953|NCT00625391|10913390|FG001|NOT COMPLETED|Overall Study||8
9804954|NCT00625391|10913391|FG002|NOT COMPLETED|Overall Study||5
9804955|NCT00625391|10913392|FG003|NOT COMPLETED|Overall Study||1
9804956|NCT00625404|10913404|FG000|STARTED|Overall Study||1062
9804957|NCT00625404|10913405|FG001|STARTED|Overall Study||1058
9804958|NCT00625404|10913404|FG000|COMPLETED|Overall Study||855
9804959|NCT00625404|10913405|FG001|COMPLETED|Overall Study||885
9804960|NCT00625404|10913404|FG000|NOT COMPLETED|Overall Study||207
9804961|NCT00625404|10913405|FG001|NOT COMPLETED|Overall Study||173
9804962|NCT00625443|10913418|FG000|STARTED|Overall Study||12
9804963|NCT00625443|10913419|FG001|STARTED|Overall Study||26
9804964|NCT00625443|10913420|FG002|STARTED|Overall Study||15
9804965|NCT00625443|10913418|FG000|COMPLETED|Overall Study||10
9804966|NCT00625443|10913419|FG001|COMPLETED|Overall Study||15
9804967|NCT00625443|10913420|FG002|COMPLETED|Overall Study||10
9804968|NCT00625443|10913418|FG000|NOT COMPLETED|Overall Study||2
9804969|NCT00625443|10913419|FG001|NOT COMPLETED|Overall Study||11
9804970|NCT00625443|10913420|FG002|NOT COMPLETED|Overall Study||5
9804971|NCT00625729|10913431|FG000|STARTED|Overall Study||6
9804972|NCT00625729|10913431|FG000|COMPLETED|Overall Study||6
9804973|NCT00625729|10913431|FG000|NOT COMPLETED|Overall Study||0
9804974|NCT00625807|10913438|FG000|STARTED|Overall Study||22
9804975|NCT00625807|10913439|FG001|STARTED|Overall Study||28
9804976|NCT00625807|10913438|FG000|COMPLETED|Overall Study||20
9804977|NCT00625807|10913439|FG001|COMPLETED|Overall Study||20
9804978|NCT00625807|10913438|FG000|NOT COMPLETED|Overall Study||2
9804979|NCT00625807|10913439|FG001|NOT COMPLETED|Overall Study||8
9804980|NCT00625820|10913447|FG000|STARTED|Overall Study||17
9804981|NCT00625820|10913447|FG000|COMPLETED|Overall Study||16
9804982|NCT00625820|10913447|FG000|NOT COMPLETED|Overall Study||1
9804983|NCT00625846|10913456|FG000|STARTED|Overall Study||39
9804984|NCT00625846|10913457|FG001|STARTED|Overall Study||35
9804985|NCT00625846|10913458|FG002|STARTED|Overall Study||16
9804986|NCT00625846|10913459|FG003|STARTED|Overall Study||62
9804987|NCT00625846|10913456|FG000|COMPLETED|Overall Study||37
9804988|NCT00625846|10913457|FG001|COMPLETED|Overall Study||35
9804989|NCT00625846|10913458|FG002|COMPLETED|Overall Study||15
9804990|NCT00625846|10913459|FG003|COMPLETED|Overall Study||60
9804991|NCT00625846|10913456|FG000|NOT COMPLETED|Overall Study||2
9804992|NCT00625846|10913457|FG001|NOT COMPLETED|Overall Study||0
9804993|NCT00625846|10913458|FG002|NOT COMPLETED|Overall Study||1
9804994|NCT00625846|10913459|FG003|NOT COMPLETED|Overall Study||2
9804995|NCT00625872|10913475|FG000|STARTED|Overall Study||12
9804996|NCT00625872|10913476|FG001|STARTED|Overall Study||11
9804997|NCT00625872|10913475|FG000|Treated|Overall Study||12
9804998|NCT00625872|10913476|FG001|Treated|Overall Study||10
9804999|NCT00625872|10913475|FG000|COMPLETED|Overall Study||8
9805000|NCT00625872|10913476|FG001|COMPLETED|Overall Study||5
9805001|NCT00625872|10913475|FG000|NOT COMPLETED|Overall Study||4
9805002|NCT00625872|10913476|FG001|NOT COMPLETED|Overall Study||6
9805003|NCT00625989|10913482|FG000|STARTED|Overall Study||6
9805004|NCT00625989|10913483|FG001|STARTED|Overall Study||6
9805005|NCT00625989|10913482|FG000|COMPLETED|Overall Study||6
9805006|NCT00625989|10913483|FG001|COMPLETED|Overall Study||6
9805007|NCT00625989|10913482|FG000|NOT COMPLETED|Overall Study||0
9805008|NCT00625989|10913483|FG001|NOT COMPLETED|Overall Study||0
9805009|NCT00626028|10913490|FG000|STARTED|Overall Study||68
9805010|NCT00626028|10913491|FG001|STARTED|Overall Study||68
9805011|NCT00626028|10913490|FG000|COMPLETED|Overall Study||62
9805012|NCT00626028|10913491|FG001|COMPLETED|Overall Study||59
9805013|NCT00626028|10913490|FG000|NOT COMPLETED|Overall Study||6
9805014|NCT00626028|10913491|FG001|NOT COMPLETED|Overall Study||9
9831418|NCT00768287|10942077|FG003|NOT COMPLETED|Surgical Sub-study||0
9831419|NCT00768287|10942078|FG004|NOT COMPLETED|Surgical Sub-study||0
9831420|NCT00768287|10942079|FG005|NOT COMPLETED|Surgical Sub-study||0
9831421|NCT00768300|10942093|FG000|STARTED|Overall Study||330
9831422|NCT00768300|10942094|FG001|STARTED|Overall Study||164
9831423|NCT00768300|10942093|FG000|Randomized and Treated|Overall Study||329
9831424|NCT00768300|10942094|FG001|Randomized and Treated|Overall Study||163
9831425|NCT00768300|10942093|FG000|COMPLETED|Overall Study||1
9831426|NCT00768300|10942094|FG001|COMPLETED|Overall Study||1
9831427|NCT00768300|10942093|FG000|NOT COMPLETED|Overall Study||329
9831428|NCT00768300|10942094|FG001|NOT COMPLETED|Overall Study||163
9831429|NCT00768430|10942102|FG000|STARTED|24 Hour Endpoint||48
9831430|NCT00768430|10942103|FG001|STARTED|24 Hour Endpoint||25
9831431|NCT00768430|10942102|FG000|COMPLETED|24 Hour Endpoint||47
9831432|NCT00768430|10942103|FG001|COMPLETED|24 Hour Endpoint||25
9831433|NCT00768430|10942102|FG000|NOT COMPLETED|24 Hour Endpoint||1
9831434|NCT00768430|10942103|FG001|NOT COMPLETED|24 Hour Endpoint||0
9831435|NCT00768430|10942102|FG000|STARTED|7 Day Endpoint||47
9831436|NCT00768430|10942103|FG001|STARTED|7 Day Endpoint||25
9831437|NCT00768430|10942102|FG000|COMPLETED|7 Day Endpoint||45
9831438|NCT00768430|10942103|FG001|COMPLETED|7 Day Endpoint||22
9831439|NCT00768430|10942102|FG000|NOT COMPLETED|7 Day Endpoint||2
9831440|NCT00768430|10942103|FG001|NOT COMPLETED|7 Day Endpoint||3
9831441|NCT00768469|10942111|FG000|STARTED|Overall Study||3
9831442|NCT00768469|10942112|FG001|STARTED|Overall Study||7
9831443|NCT00768469|10942111|FG000|COMPLETED|Overall Study||0
9831444|NCT00768469|10942112|FG001|COMPLETED|Overall Study||0
9831445|NCT00768469|10942111|FG000|NOT COMPLETED|Overall Study||3
9831446|NCT00768469|10942112|FG001|NOT COMPLETED|Overall Study||7
9831447|NCT00768521|10942119|FG000|STARTED|Period 1||9
9831448|NCT00768521|10942120|FG001|STARTED|Period 1||11
9831449|NCT00768521|10942119|FG000|COMPLETED|Period 1||9
9831450|NCT00768521|10942120|FG001|COMPLETED|Period 1||11
9831451|NCT00768521|10942119|FG000|NOT COMPLETED|Period 1||0
9831452|NCT00768521|10942120|FG001|NOT COMPLETED|Period 1||0
9831453|NCT00768521|10942119|FG000|STARTED|Period 2||9
9831454|NCT00768521|10942120|FG001|STARTED|Period 2||11
9831455|NCT00768521|10942119|FG000|COMPLETED|Period 2||9
9831456|NCT00768521|10942120|FG001|COMPLETED|Period 2||11
9831457|NCT00768521|10942119|FG000|NOT COMPLETED|Period 2||0
9831458|NCT00768521|10942120|FG001|NOT COMPLETED|Period 2||0
9831459|NCT00768560|10942132|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5
9831460|NCT00768560|10942133|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6
9831461|NCT00768560|10942134|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6
9831462|NCT00768560|10942135|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6
9831463|NCT00768560|10942136|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6
9831464|NCT00768560|10942137|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6
9831465|NCT00768560|10942132|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
9831466|NCT00768560|10942133|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
9805015|NCT00626093|10913497|FG000|STARTED|Overall Study||77
9805016|NCT00626093|10913497|FG000|COMPLETED|Overall Study||54
9805017|NCT00626093|10913497|FG000|NOT COMPLETED|Overall Study||23
9805018|NCT00626197|10913504|FG000|STARTED|Overall Study||127
9805019|NCT00626197|10913505|FG001|STARTED|Overall Study||128
9805020|NCT00626197|10913506|FG002|STARTED|Overall Study||126
9805021|NCT00626197|10913504|FG000|COMPLETED|Overall Study||83
9805022|NCT00626197|10913505|FG001|COMPLETED|Overall Study||74
9805023|NCT00626197|10913506|FG002|COMPLETED|Overall Study||49
9805024|NCT00626197|10913504|FG000|NOT COMPLETED|Overall Study||44
9805025|NCT00626197|10913505|FG001|NOT COMPLETED|Overall Study||54
9805026|NCT00626197|10913506|FG002|NOT COMPLETED|Overall Study||77
9805027|NCT00626210|10913520|FG000|STARTED|Overall Study||2
9805028|NCT00626210|10913520|FG000|COMPLETED|Overall Study||2
9805029|NCT00626210|10913520|FG000|NOT COMPLETED|Overall Study||0
9805030|NCT00626275|10913524|FG000|STARTED|Part A - Treatment Period 1||7
9805031|NCT00626275|10913525|FG001|STARTED|Part A - Treatment Period 1||7
9805032|NCT00626275|10913526|FG002|STARTED|Part A - Treatment Period 1||7
9805033|NCT00626275|10913527|FG003|STARTED|Part A - Treatment Period 1||8
9805034|NCT00626275|10913528|FG004|STARTED|Part A - Treatment Period 1||9
9805035|NCT00626275|10913529|FG005|STARTED|Part A - Treatment Period 1||8
9805036|NCT00626275|10913530|FG006|STARTED|Part A - Treatment Period 1||0
9805037|NCT00626275|10913531|FG007|STARTED|Part A - Treatment Period 1||0
9805038|NCT00626275|10913524|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
9805039|NCT00626275|10913525|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
9805040|NCT00626275|10913526|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
9805041|NCT00626275|10913527|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
9805042|NCT00626275|10913528|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
9805043|NCT00626275|10913529|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
9805044|NCT00626275|10913530|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
9805045|NCT00626275|10913531|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
9805046|NCT00626275|10913524|FG000|COMPLETED|Part A - Treatment Period 1||6
9805047|NCT00626275|10913525|FG001|COMPLETED|Part A - Treatment Period 1||7
9805048|NCT00626275|10913526|FG002|COMPLETED|Part A - Treatment Period 1||6
9805049|NCT00626275|10913527|FG003|COMPLETED|Part A - Treatment Period 1||8
9805050|NCT00626275|10913528|FG004|COMPLETED|Part A - Treatment Period 1||9
9805051|NCT00626275|10913529|FG005|COMPLETED|Part A - Treatment Period 1||8
9805052|NCT00626275|10913530|FG006|COMPLETED|Part A - Treatment Period 1||0
9805053|NCT00626275|10913531|FG007|COMPLETED|Part A - Treatment Period 1||0
9805054|NCT00626275|10913524|FG000|NOT COMPLETED|Part A - Treatment Period 1||1
9805055|NCT00626275|10913525|FG001|NOT COMPLETED|Part A - Treatment Period 1||0
9805056|NCT00626275|10913526|FG002|NOT COMPLETED|Part A - Treatment Period 1||1
9805057|NCT00626275|10913527|FG003|NOT COMPLETED|Part A - Treatment Period 1||0
9805058|NCT00626275|10913528|FG004|NOT COMPLETED|Part A - Treatment Period 1||0
9805059|NCT00626275|10913529|FG005|NOT COMPLETED|Part A - Treatment Period 1||0
9805060|NCT00626275|10913530|FG006|NOT COMPLETED|Part A - Treatment Period 1||0
9805061|NCT00626275|10913531|FG007|NOT COMPLETED|Part A - Treatment Period 1||0
9805062|NCT00626275|10913524|FG000|STARTED|Part A - Washout Period 1||6
9805063|NCT00626275|10913525|FG001|STARTED|Part A - Washout Period 1||7
9805064|NCT00626275|10913526|FG002|STARTED|Part A - Washout Period 1||6
9805065|NCT00626275|10913527|FG003|STARTED|Part A - Washout Period 1||8
9805066|NCT00626275|10913528|FG004|STARTED|Part A - Washout Period 1||9
9805067|NCT00626275|10913529|FG005|STARTED|Part A - Washout Period 1||8
9805068|NCT00626275|10913530|FG006|STARTED|Part A - Washout Period 1||0
9805069|NCT00626275|10913531|FG007|STARTED|Part A - Washout Period 1||0
9805070|NCT00626275|10913524|FG000|COMPLETED|Part A - Washout Period 1||6
9805071|NCT00626275|10913525|FG001|COMPLETED|Part A - Washout Period 1||7
9805072|NCT00626275|10913526|FG002|COMPLETED|Part A - Washout Period 1||6
9805073|NCT00626275|10913527|FG003|COMPLETED|Part A - Washout Period 1||8
9805074|NCT00626275|10913528|FG004|COMPLETED|Part A - Washout Period 1||9
9805075|NCT00626275|10913529|FG005|COMPLETED|Part A - Washout Period 1||8
9805076|NCT00626275|10913530|FG006|COMPLETED|Part A - Washout Period 1||0
9805077|NCT00626275|10913531|FG007|COMPLETED|Part A - Washout Period 1||0
9805078|NCT00626275|10913524|FG000|NOT COMPLETED|Part A - Washout Period 1||0
9805079|NCT00626275|10913525|FG001|NOT COMPLETED|Part A - Washout Period 1||0
9805080|NCT00626275|10913526|FG002|NOT COMPLETED|Part A - Washout Period 1||0
9805081|NCT00626275|10913527|FG003|NOT COMPLETED|Part A - Washout Period 1||0
9805082|NCT00626275|10913528|FG004|NOT COMPLETED|Part A - Washout Period 1||0
9805083|NCT00626275|10913529|FG005|NOT COMPLETED|Part A - Washout Period 1||0
9805084|NCT00626275|10913530|FG006|NOT COMPLETED|Part A - Washout Period 1||0
9805085|NCT00626275|10913531|FG007|NOT COMPLETED|Part A - Washout Period 1||0
9805086|NCT00626275|10913524|FG000|STARTED|Part A - Treatment Period 2||6
9805087|NCT00626275|10913525|FG001|STARTED|Part A - Treatment Period 2||7
9805088|NCT00626275|10913526|FG002|STARTED|Part A - Treatment Period 2||6
9805089|NCT00626275|10913527|FG003|STARTED|Part A - Treatment Period 2||8
9805090|NCT00626275|10913528|FG004|STARTED|Part A - Treatment Period 2||9
9805091|NCT00626275|10913529|FG005|STARTED|Part A - Treatment Period 2||8
9805092|NCT00626275|10913530|FG006|STARTED|Part A - Treatment Period 2||0
9805093|NCT00626275|10913531|FG007|STARTED|Part A - Treatment Period 2||0
9805094|NCT00626275|10913524|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
9805095|NCT00626275|10913525|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
9805096|NCT00626275|10913526|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
9805097|NCT00626275|10913527|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
9805098|NCT00626275|10913528|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
9805099|NCT00626275|10913529|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
9805100|NCT00626275|10913530|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
9805101|NCT00626275|10913531|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
9805102|NCT00626275|10913524|FG000|COMPLETED|Part A - Treatment Period 2||6
9805103|NCT00626275|10913525|FG001|COMPLETED|Part A - Treatment Period 2||7
9805104|NCT00626275|10913526|FG002|COMPLETED|Part A - Treatment Period 2||6
9805105|NCT00626275|10913527|FG003|COMPLETED|Part A - Treatment Period 2||8
9805106|NCT00626275|10913528|FG004|COMPLETED|Part A - Treatment Period 2||9
9805107|NCT00626275|10913529|FG005|COMPLETED|Part A - Treatment Period 2||8
9805108|NCT00626275|10913530|FG006|COMPLETED|Part A - Treatment Period 2||0
9805109|NCT00626275|10913531|FG007|COMPLETED|Part A - Treatment Period 2||0
9805110|NCT00626275|10913524|FG000|NOT COMPLETED|Part A - Treatment Period 2||0
9805111|NCT00626275|10913525|FG001|NOT COMPLETED|Part A - Treatment Period 2||0
9805112|NCT00626275|10913526|FG002|NOT COMPLETED|Part A - Treatment Period 2||0
9805113|NCT00626275|10913527|FG003|NOT COMPLETED|Part A - Treatment Period 2||0
9805114|NCT00626275|10913528|FG004|NOT COMPLETED|Part A - Treatment Period 2||0
9805115|NCT00626275|10913529|FG005|NOT COMPLETED|Part A - Treatment Period 2||0
9805116|NCT00626275|10913530|FG006|NOT COMPLETED|Part A - Treatment Period 2||0
9805117|NCT00626275|10913531|FG007|NOT COMPLETED|Part A - Treatment Period 2||0
9805118|NCT00626275|10913524|FG000|STARTED|Part A - Washout Period 2||6
9805119|NCT00626275|10913525|FG001|STARTED|Part A - Washout Period 2||7
9805120|NCT00626275|10913526|FG002|STARTED|Part A - Washout Period 2||6
9805121|NCT00626275|10913527|FG003|STARTED|Part A - Washout Period 2||8
9805122|NCT00626275|10913528|FG004|STARTED|Part A - Washout Period 2||9
9805123|NCT00626275|10913529|FG005|STARTED|Part A - Washout Period 2||8
9805124|NCT00626275|10913530|FG006|STARTED|Part A - Washout Period 2||0
9805125|NCT00626275|10913531|FG007|STARTED|Part A - Washout Period 2||0
9805126|NCT00626275|10913524|FG000|COMPLETED|Part A - Washout Period 2||6
9805127|NCT00626275|10913525|FG001|COMPLETED|Part A - Washout Period 2||7
9805128|NCT00626275|10913526|FG002|COMPLETED|Part A - Washout Period 2||6
9805129|NCT00626275|10913527|FG003|COMPLETED|Part A - Washout Period 2||8
9805130|NCT00626275|10913528|FG004|COMPLETED|Part A - Washout Period 2||9
9805131|NCT00626275|10913529|FG005|COMPLETED|Part A - Washout Period 2||8
9805132|NCT00626275|10913530|FG006|COMPLETED|Part A - Washout Period 2||0
9805133|NCT00626275|10913531|FG007|COMPLETED|Part A - Washout Period 2||0
9805134|NCT00626275|10913524|FG000|NOT COMPLETED|Part A - Washout Period 2||0
9805135|NCT00626275|10913525|FG001|NOT COMPLETED|Part A - Washout Period 2||0
9805136|NCT00626275|10913526|FG002|NOT COMPLETED|Part A - Washout Period 2||0
9805137|NCT00626275|10913527|FG003|NOT COMPLETED|Part A - Washout Period 2||0
9805138|NCT00626275|10913528|FG004|NOT COMPLETED|Part A - Washout Period 2||0
9805139|NCT00626275|10913529|FG005|NOT COMPLETED|Part A - Washout Period 2||0
9805140|NCT00626275|10913530|FG006|NOT COMPLETED|Part A - Washout Period 2||0
9805141|NCT00626275|10913531|FG007|NOT COMPLETED|Part A - Washout Period 2||0
9805142|NCT00626275|10913524|FG000|STARTED|Part A - Treatment Period 3||6
9805143|NCT00626275|10913525|FG001|STARTED|Part A - Treatment Period 3||7
9805144|NCT00626275|10913526|FG002|STARTED|Part A - Treatment Period 3||6
9805145|NCT00626275|10913527|FG003|STARTED|Part A - Treatment Period 3||8
9805146|NCT00626275|10913528|FG004|STARTED|Part A - Treatment Period 3||9
9805147|NCT00626275|10913529|FG005|STARTED|Part A - Treatment Period 3||8
9805148|NCT00626275|10913530|FG006|STARTED|Part A - Treatment Period 3||0
9805149|NCT00626275|10913531|FG007|STARTED|Part A - Treatment Period 3||0
9805150|NCT00626275|10913524|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
9805151|NCT00626275|10913525|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
9805152|NCT00626275|10913526|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
9805153|NCT00626275|10913527|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
9805154|NCT00626275|10913528|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
9805155|NCT00626275|10913529|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
9805156|NCT00626275|10913530|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
9805157|NCT00626275|10913531|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
9805158|NCT00626275|10913524|FG000|COMPLETED|Part A - Treatment Period 3||6
9805159|NCT00626275|10913525|FG001|COMPLETED|Part A - Treatment Period 3||7
9805160|NCT00626275|10913526|FG002|COMPLETED|Part A - Treatment Period 3||6
9805161|NCT00626275|10913527|FG003|COMPLETED|Part A - Treatment Period 3||8
9805162|NCT00626275|10913528|FG004|COMPLETED|Part A - Treatment Period 3||9
9805163|NCT00626275|10913529|FG005|COMPLETED|Part A - Treatment Period 3||8
9805164|NCT00626275|10913530|FG006|COMPLETED|Part A - Treatment Period 3||0
9805165|NCT00626275|10913531|FG007|COMPLETED|Part A - Treatment Period 3||0
9805166|NCT00626275|10913524|FG000|NOT COMPLETED|Part A - Treatment Period 3||0
9805167|NCT00626275|10913525|FG001|NOT COMPLETED|Part A - Treatment Period 3||0
9805168|NCT00626275|10913526|FG002|NOT COMPLETED|Part A - Treatment Period 3||0
10016041|NCT01808339|11139001|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5
10016042|NCT01808339|11138996|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
9805169|NCT00626275|10913527|FG003|NOT COMPLETED|Part A - Treatment Period 3||0
9805170|NCT00626275|10913528|FG004|NOT COMPLETED|Part A - Treatment Period 3||0
9805171|NCT00626275|10913529|FG005|NOT COMPLETED|Part A - Treatment Period 3||0
9805172|NCT00626275|10913530|FG006|NOT COMPLETED|Part A - Treatment Period 3||0
9805173|NCT00626275|10913531|FG007|NOT COMPLETED|Part A - Treatment Period 3||0
9805174|NCT00626275|10913524|FG000|STARTED|Re-randomization Period for Part B||0
9805175|NCT00626275|10913525|FG001|STARTED|Re-randomization Period for Part B||0
9805176|NCT00626275|10913526|FG002|STARTED|Re-randomization Period for Part B||0
9805177|NCT00626275|10913527|FG003|STARTED|Re-randomization Period for Part B||0
9805178|NCT00626275|10913528|FG004|STARTED|Re-randomization Period for Part B||0
9805179|NCT00626275|10913529|FG005|STARTED|Re-randomization Period for Part B||0
9805180|NCT00626275|10913530|FG006|STARTED|Re-randomization Period for Part B||20
9805181|NCT00626275|10913531|FG007|STARTED|Re-randomization Period for Part B||24
9805182|NCT00626275|10913524|FG000|COMPLETED|Re-randomization Period for Part B||0
9805183|NCT00626275|10913525|FG001|COMPLETED|Re-randomization Period for Part B||0
9805184|NCT00626275|10913526|FG002|COMPLETED|Re-randomization Period for Part B||0
9805185|NCT00626275|10913527|FG003|COMPLETED|Re-randomization Period for Part B||0
9805186|NCT00626275|10913528|FG004|COMPLETED|Re-randomization Period for Part B||0
9805187|NCT00626275|10913529|FG005|COMPLETED|Re-randomization Period for Part B||0
9805188|NCT00626275|10913530|FG006|COMPLETED|Re-randomization Period for Part B||20
9805189|NCT00626275|10913531|FG007|COMPLETED|Re-randomization Period for Part B||24
9805190|NCT00626275|10913524|FG000|NOT COMPLETED|Re-randomization Period for Part B||0
9805191|NCT00626275|10913525|FG001|NOT COMPLETED|Re-randomization Period for Part B||0
9805192|NCT00626275|10913526|FG002|NOT COMPLETED|Re-randomization Period for Part B||0
9805193|NCT00626275|10913527|FG003|NOT COMPLETED|Re-randomization Period for Part B||0
9805194|NCT00626275|10913528|FG004|NOT COMPLETED|Re-randomization Period for Part B||0
9805195|NCT00626275|10913529|FG005|NOT COMPLETED|Re-randomization Period for Part B||0
9805196|NCT00626275|10913530|FG006|NOT COMPLETED|Re-randomization Period for Part B||0
9805197|NCT00626275|10913531|FG007|NOT COMPLETED|Re-randomization Period for Part B||0
9805198|NCT00626275|10913524|FG000|STARTED|Part B||0
9805199|NCT00626275|10913525|FG001|STARTED|Part B||0
9805200|NCT00626275|10913526|FG002|STARTED|Part B||0
9805201|NCT00626275|10913527|FG003|STARTED|Part B||0
9805202|NCT00626275|10913528|FG004|STARTED|Part B||0
9805203|NCT00626275|10913529|FG005|STARTED|Part B||0
9805204|NCT00626275|10913530|FG006|STARTED|Part B||20
9805205|NCT00626275|10913531|FG007|STARTED|Part B||24
9805206|NCT00626275|10913524|FG000|COMPLETED|Part B||0
9805207|NCT00626275|10913525|FG001|COMPLETED|Part B||0
9805208|NCT00626275|10913526|FG002|COMPLETED|Part B||0
9805209|NCT00626275|10913527|FG003|COMPLETED|Part B||0
9805210|NCT00626275|10913528|FG004|COMPLETED|Part B||0
9805211|NCT00626275|10913529|FG005|COMPLETED|Part B||0
9805212|NCT00626275|10913530|FG006|COMPLETED|Part B||19
9805213|NCT00626275|10913531|FG007|COMPLETED|Part B||23
9805214|NCT00626275|10913524|FG000|NOT COMPLETED|Part B||0
9805215|NCT00626275|10913525|FG001|NOT COMPLETED|Part B||0
9805216|NCT00626275|10913526|FG002|NOT COMPLETED|Part B||0
9805217|NCT00626275|10913527|FG003|NOT COMPLETED|Part B||0
9805218|NCT00626275|10913528|FG004|NOT COMPLETED|Part B||0
9805219|NCT00626275|10913529|FG005|NOT COMPLETED|Part B||0
9805220|NCT00626275|10913530|FG006|NOT COMPLETED|Part B||1
9805221|NCT00626275|10913531|FG007|NOT COMPLETED|Part B||1
9805222|NCT00626327|10913548|FG000|STARTED|Overall Study||504
9805223|NCT00626327|10913549|FG001|STARTED|Overall Study||616
9805224|NCT00626327|10913550|FG002|STARTED|Overall Study||510
9805225|NCT00626327|10913548|FG000|COMPLETED|Overall Study||426
9805226|NCT00626327|10913549|FG001|COMPLETED|Overall Study||557
9805227|NCT00626327|10913550|FG002|COMPLETED|Overall Study||422
9805228|NCT00626327|10913548|FG000|NOT COMPLETED|Overall Study||78
9805229|NCT00626327|10913549|FG001|NOT COMPLETED|Overall Study||59
9805230|NCT00626327|10913550|FG002|NOT COMPLETED|Overall Study||88
9805231|NCT00626340|10913566|FG000|STARTED|Overall Study||18
9805232|NCT00626340|10913566|FG000|COMPLETED|Overall Study||18
9805233|NCT00626340|10913566|FG000|NOT COMPLETED|Overall Study||0
9805234|NCT00626366|10913572|FG000|STARTED|Overall Study||9
9805235|NCT00626366|10913573|FG001|STARTED|Overall Study||9
9805236|NCT00626366|10913572|FG000|COMPLETED|Overall Study||9
9805237|NCT00626366|10913573|FG001|COMPLETED|Overall Study||9
9805238|NCT00626366|10913572|FG000|NOT COMPLETED|Overall Study||0
9805239|NCT00626366|10913573|FG001|NOT COMPLETED|Overall Study||0
9805240|NCT00626392|10913585|FG000|STARTED|Run-in Period||45
9805241|NCT00626392|10913586|FG001|STARTED|Run-in Period||44
9805242|NCT00626392|10913587|FG002|STARTED|Run-in Period||44
9805243|NCT00626392|10913588|FG003|STARTED|Run-in Period||44
9805244|NCT00626392|10913589|FG004|STARTED|Run-in Period||45
9805245|NCT00626392|10913590|FG005|STARTED|Run-in Period||45
9805246|NCT00626392|10913585|FG000|COMPLETED|Run-in Period||44
9805247|NCT00626392|10913586|FG001|COMPLETED|Run-in Period||43
9805248|NCT00626392|10913587|FG002|COMPLETED|Run-in Period||41
9805249|NCT00626392|10913588|FG003|COMPLETED|Run-in Period||43
9805250|NCT00626392|10913589|FG004|COMPLETED|Run-in Period||41
9805251|NCT00626392|10913590|FG005|COMPLETED|Run-in Period||44
9805252|NCT00626392|10913585|FG000|NOT COMPLETED|Run-in Period||1
9805253|NCT00626392|10913586|FG001|NOT COMPLETED|Run-in Period||1
9805254|NCT00626392|10913587|FG002|NOT COMPLETED|Run-in Period||3
9805255|NCT00626392|10913588|FG003|NOT COMPLETED|Run-in Period||1
9805256|NCT00626392|10913589|FG004|NOT COMPLETED|Run-in Period||4
9805257|NCT00626392|10913590|FG005|NOT COMPLETED|Run-in Period||1
9805258|NCT00626392|10913585|FG000|STARTED|Coadministration Period||44
9805259|NCT00626392|10913586|FG001|STARTED|Coadministration Period||43
9805260|NCT00626392|10913587|FG002|STARTED|Coadministration Period||41
9805261|NCT00626392|10913588|FG003|STARTED|Coadministration Period||43
9805262|NCT00626392|10913589|FG004|STARTED|Coadministration Period||41
9805263|NCT00626392|10913590|FG005|STARTED|Coadministration Period||44
9805264|NCT00626392|10913585|FG000|COMPLETED|Coadministration Period||40
9805265|NCT00626392|10913586|FG001|COMPLETED|Coadministration Period||38
9805266|NCT00626392|10913587|FG002|COMPLETED|Coadministration Period||31
9805267|NCT00626392|10913588|FG003|COMPLETED|Coadministration Period||36
9805268|NCT00626392|10913589|FG004|COMPLETED|Coadministration Period||36
9805269|NCT00626392|10913590|FG005|COMPLETED|Coadministration Period||38
9805270|NCT00626392|10913585|FG000|NOT COMPLETED|Coadministration Period||4
9805271|NCT00626392|10913586|FG001|NOT COMPLETED|Coadministration Period||5
9805272|NCT00626392|10913587|FG002|NOT COMPLETED|Coadministration Period||10
9805273|NCT00626392|10913588|FG003|NOT COMPLETED|Coadministration Period||7
9805274|NCT00626392|10913589|FG004|NOT COMPLETED|Coadministration Period||5
9805275|NCT00626392|10913590|FG005|NOT COMPLETED|Coadministration Period||6
9805276|NCT00626405|10913598|FG000|STARTED|Overall Study||43
9805277|NCT00626405|10913599|FG001|STARTED|Overall Study||52
9805278|NCT00626405|10913598|FG000|COMPLETED|Overall Study||42
9805279|NCT00626405|10913599|FG001|COMPLETED|Overall Study||51
9805280|NCT00626405|10913598|FG000|NOT COMPLETED|Overall Study||1
9805281|NCT00626405|10913599|FG001|NOT COMPLETED|Overall Study||1
9805282|NCT00626431|10913607|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
9805283|NCT00626431|10913608|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
9805284|NCT00626431|10913607|FG000|COMPLETED|Overall Study||134
9805285|NCT00626431|10913608|FG001|COMPLETED|Overall Study||114
9805286|NCT00626431|10913607|FG000|NOT COMPLETED|Overall Study||17
9805287|NCT00626431|10913608|FG001|NOT COMPLETED|Overall Study||45
9805288|NCT00626522|10913620|FG000|STARTED|Overall Study||121
9805289|NCT00626522|10913621|FG001|STARTED|Overall Study||120
9805290|NCT00626522|10913622|FG002|STARTED|Overall Study||125
9805291|NCT00626522|10913623|FG003|STARTED|Overall Study||76
9805292|NCT00626522|10913624|FG004|STARTED|Overall Study||65
9805293|NCT00626522|10913625|FG005|STARTED|Overall Study||59
9805294|NCT00626522|10913620|FG000|COMPLETED|Overall Study||115
9805295|NCT00626522|10913621|FG001|COMPLETED|Overall Study||113
9805296|NCT00626522|10913622|FG002|COMPLETED|Overall Study||117
9805297|NCT00626522|10913623|FG003|COMPLETED|Overall Study||74
9805298|NCT00626522|10913624|FG004|COMPLETED|Overall Study||58
9805299|NCT00626522|10913625|FG005|COMPLETED|Overall Study||57
9805300|NCT00626522|10913620|FG000|NOT COMPLETED|Overall Study||6
9805301|NCT00626522|10913621|FG001|NOT COMPLETED|Overall Study||7
9805302|NCT00626522|10913622|FG002|NOT COMPLETED|Overall Study||8
9805303|NCT00626522|10913623|FG003|NOT COMPLETED|Overall Study||2
9805304|NCT00626522|10913624|FG004|NOT COMPLETED|Overall Study||7
9805305|NCT00626522|10913625|FG005|NOT COMPLETED|Overall Study||2
9805306|NCT00626548|10913641|FG000|STARTED|Overall Study||705
9805307|NCT00626548|10913642|FG001|STARTED|Overall Study||716
9805308|NCT00626548|10913641|FG000|Patients Received Treatment|Overall Study||703
9805309|NCT00626548|10913642|FG001|Patients Received Treatment|Overall Study||712
9805310|NCT00626548|10913641|FG000|COMPLETED|Overall Study||0
9805311|NCT00626548|10913642|FG001|COMPLETED|Overall Study||0
9805312|NCT00626548|10913641|FG000|NOT COMPLETED|Overall Study||705
9805313|NCT00626548|10913642|FG001|NOT COMPLETED|Overall Study||716
9805314|NCT00626574|10913650|FG000|STARTED|Overall Study||2
9805315|NCT00626574|10913651|FG001|STARTED|Overall Study||1
9805316|NCT00626574|10913650|FG000|COMPLETED|Overall Study||2
9805317|NCT00626574|10913651|FG001|COMPLETED|Overall Study||1
9805318|NCT00626574|10913650|FG000|NOT COMPLETED|Overall Study||0
9805319|NCT00626574|10913651|FG001|NOT COMPLETED|Overall Study||0
9805320|NCT00626626|10913661|FG000|STARTED|Overall Study||5
9805321|NCT00626626|10913662|FG001|STARTED|Overall Study||3
9805322|NCT00626626|10913661|FG000|COMPLETED|Overall Study||5
9805323|NCT00626626|10913662|FG001|COMPLETED|Overall Study||3
9805324|NCT00626626|10913661|FG000|NOT COMPLETED|Overall Study||0
9805325|NCT00626626|10913662|FG001|NOT COMPLETED|Overall Study||0
9805326|NCT00626639|10913671|FG000|STARTED|Overall Study||2
9805327|NCT00626639|10913672|FG001|STARTED|Overall Study||3
9805328|NCT00626639|10913671|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
9805329|NCT00626639|10913672|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
9805330|NCT00626639|10913671|FG000|NOT COMPLETED|Overall Study||2
9805331|NCT00626639|10913672|FG001|NOT COMPLETED|Overall Study||2
9805332|NCT00626743|10913682|FG000|STARTED|Treatment Period 1||6
9805333|NCT00626743|10913683|FG001|STARTED|Treatment Period 1||7
9805334|NCT00626743|10913682|FG000|COMPLETED|Treatment Period 1||6
9805335|NCT00626743|10913683|FG001|COMPLETED|Treatment Period 1||6
9805336|NCT00626743|10913682|FG000|NOT COMPLETED|Treatment Period 1||0
9805337|NCT00626743|10913683|FG001|NOT COMPLETED|Treatment Period 1||1
9805338|NCT00626743|10913682|FG000|STARTED|Wash-out Period of 6 Days||6
9805339|NCT00626743|10913683|FG001|STARTED|Wash-out Period of 6 Days||6
9805340|NCT00626743|10913682|FG000|COMPLETED|Wash-out Period of 6 Days||6
9805341|NCT00626743|10913683|FG001|COMPLETED|Wash-out Period of 6 Days||6
9805342|NCT00626743|10913682|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0
9805343|NCT00626743|10913683|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0
9805344|NCT00626743|10913682|FG000|STARTED|Treatment Period 2||6
9805345|NCT00626743|10913683|FG001|STARTED|Treatment Period 2||6
9805346|NCT00626743|10913682|FG000|COMPLETED|Treatment Period 2||6
10016043|NCT01808339|11138997|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10016044|NCT01808339|11138998|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10016045|NCT01808339|11138999|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10016046|NCT01808339|11139000|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
9805347|NCT00626743|10913683|FG001|COMPLETED|Treatment Period 2||6
9805348|NCT00626743|10913682|FG000|NOT COMPLETED|Treatment Period 2||0
9805349|NCT00626743|10913683|FG001|NOT COMPLETED|Treatment Period 2||0
9805350|NCT00626782|10913691|FG000|STARTED|Overall Study||12
9805351|NCT00626782|10913692|FG001|STARTED|Overall Study||12
9805352|NCT00626782|10913691|FG000|COMPLETED|Overall Study||12
9805353|NCT00626782|10913692|FG001|COMPLETED|Overall Study||12
9805354|NCT00626782|10913691|FG000|NOT COMPLETED|Overall Study||0
9805355|NCT00626782|10913692|FG001|NOT COMPLETED|Overall Study||0
9805356|NCT00626795|10913703|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0
9805357|NCT00626795|10913704|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65
9805358|NCT00626795|10913705|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0
9805359|NCT00626795|10913703|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0
9805360|NCT00626795|10913704|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64
9805361|NCT00626795|10913705|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0
9805362|NCT00626795|10913703|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
9805363|NCT00626795|10913704|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
9805364|NCT00626795|10913705|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
9805365|NCT00626795|10913703|FG000|STARTED|Blinded Treatment||204
9805366|NCT00626795|10913704|FG001|STARTED|Blinded Treatment||205
9805367|NCT00626795|10913705|FG002|STARTED|Blinded Treatment||205
9805368|NCT00626795|10913703|FG000|COMPLETED|Blinded Treatment||194
9805369|NCT00626795|10913704|FG001|COMPLETED|Blinded Treatment||200
9805370|NCT00626795|10913705|FG002|COMPLETED|Blinded Treatment||196
9805371|NCT00626795|10913703|FG000|NOT COMPLETED|Blinded Treatment||10
9805372|NCT00626795|10913704|FG001|NOT COMPLETED|Blinded Treatment||5
9805373|NCT00626795|10913705|FG002|NOT COMPLETED|Blinded Treatment||9
9805374|NCT00626808|10913721|FG000|STARTED|Overall Study||254464
9805375|NCT00626808|10913722|FG001|STARTED|Overall Study||34316
9805376|NCT00626808|10913723|FG002|STARTED|Overall Study||30011
9805377|NCT00626808|10913724|FG003|STARTED|Overall Study||2906
9805378|NCT00626808|10913721|FG000|COMPLETED|Overall Study||254464
9805379|NCT00626808|10913722|FG001|COMPLETED|Overall Study||34316
9805380|NCT00626808|10913723|FG002|COMPLETED|Overall Study||30011
9805381|NCT00626808|10913724|FG003|COMPLETED|Overall Study||2906
9805382|NCT00626808|10913721|FG000|NOT COMPLETED|Overall Study||0
9805383|NCT00626808|10913722|FG001|NOT COMPLETED|Overall Study||0
9805384|NCT00626808|10913723|FG002|NOT COMPLETED|Overall Study||0
9805385|NCT00626808|10913724|FG003|NOT COMPLETED|Overall Study||0
9805386|NCT00626821|10913734|FG000|STARTED|Overall Study||3017
9805387|NCT00626821|10913734|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
9805388|NCT00626821|10913734|FG000|COMPLETED|Overall Study||2796
9805389|NCT00626821|10913734|FG000|NOT COMPLETED|Overall Study||221
9805390|NCT00626886|10913740|FG000|STARTED|Overall Study||24
9805391|NCT00626886|10913741|FG001|STARTED|Overall Study||29
9805392|NCT00626886|10913740|FG000|COMPLETED|Overall Study||24
9805393|NCT00626886|10913741|FG001|COMPLETED|Overall Study||29
9805394|NCT00626886|10913740|FG000|NOT COMPLETED|Overall Study||0
9805395|NCT00626886|10913741|FG001|NOT COMPLETED|Overall Study||0
9805396|NCT00626912|10913749|FG000|STARTED|Overall Study||222
9805397|NCT00626912|10913750|FG001|STARTED|Overall Study||225
9805398|NCT00626912|10913749|FG000|COMPLETED|Overall Study||220
9805399|NCT00626912|10913750|FG001|COMPLETED|Overall Study||215
9805400|NCT00626912|10913749|FG000|NOT COMPLETED|Overall Study||2
9805401|NCT00626912|10913750|FG001|NOT COMPLETED|Overall Study||10
9805402|NCT00626925|10913758|FG000|STARTED|Overall Study||67
9805403|NCT00626925|10913759|FG001|STARTED|Overall Study||71
9805404|NCT00626925|10913758|FG000|COMPLETED|Overall Study||55
9805405|NCT00626925|10913759|FG001|COMPLETED|Overall Study||62
9805406|NCT00626925|10913758|FG000|NOT COMPLETED|Overall Study||12
9805407|NCT00626925|10913759|FG001|NOT COMPLETED|Overall Study||9
9805408|NCT00627016|10913781|FG000|STARTED|Overall Study||153
9805409|NCT00627016|10913782|FG001|STARTED|Overall Study||152
9805410|NCT00627016|10913781|FG000|COMPLETED|Overall Study||147
9805411|NCT00627016|10913782|FG001|COMPLETED|Overall Study||146
9805412|NCT00627016|10913781|FG000|NOT COMPLETED|Overall Study||6
9805413|NCT00627016|10913782|FG001|NOT COMPLETED|Overall Study||6
9805414|NCT00627042|10913788|FG000|STARTED|Overall Study||42
9805415|NCT00627042|10913788|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
9805416|NCT00627042|10913788|FG000|COMPLETED|Overall Study||40
9805417|NCT00627042|10913788|FG000|NOT COMPLETED|Overall Study||2
9805418|NCT00627094|10913794|FG000|STARTED|Overall Study||60
9805419|NCT00627094|10913795|FG001|STARTED|Overall Study||60
9805420|NCT00627094|10913794|FG000|COMPLETED|Overall Study||48
9805421|NCT00627094|10913795|FG001|COMPLETED|Overall Study||45
9805422|NCT00627094|10913794|FG000|NOT COMPLETED|Overall Study||12
9805423|NCT00627094|10913795|FG001|NOT COMPLETED|Overall Study||15
9805424|NCT00627367|10913805|FG000|STARTED|Overall Study||112
9805425|NCT00627367|10913806|FG001|STARTED|Overall Study||112
9805426|NCT00627367|10913805|FG000|COMPLETED|Overall Study||112
9805427|NCT00627367|10913806|FG001|COMPLETED|Overall Study||112
9805428|NCT00627367|10913805|FG000|NOT COMPLETED|Overall Study||0
9805429|NCT00627367|10913806|FG001|NOT COMPLETED|Overall Study||0
9805430|NCT00627393|10913815|FG000|STARTED|Intention-To-Treat Analysis||58
9805431|NCT00627393|10913816|FG001|STARTED|Intention-To-Treat Analysis||56
9805432|NCT00627393|10913815|FG000|COMPLETED|Intention-To-Treat Analysis||49
9805433|NCT00627393|10913816|FG001|COMPLETED|Intention-To-Treat Analysis||48
9805434|NCT00627393|10913815|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9
9805435|NCT00627393|10913816|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8
9805436|NCT00627393|10913815|FG000|STARTED|Per-Protocol Analysis||49
9805437|NCT00627393|10913816|FG001|STARTED|Per-Protocol Analysis||48
9805438|NCT00627393|10913815|FG000|COMPLETED|Per-Protocol Analysis||39
9805439|NCT00627393|10913816|FG001|COMPLETED|Per-Protocol Analysis||35
9805440|NCT00627393|10913815|FG000|NOT COMPLETED|Per-Protocol Analysis||10
9805441|NCT00627393|10913816|FG001|NOT COMPLETED|Per-Protocol Analysis||13
9805442|NCT00627406|10913828|FG000|STARTED|Overall Study||60
9805443|NCT00627406|10913829|FG001|STARTED|Overall Study||58
9805444|NCT00627406|10913830|FG002|STARTED|Overall Study||125
9805445|NCT00627406|10913831|FG003|STARTED|Overall Study||141
9805446|NCT00627406|10913828|FG000|COMPLETED|Overall Study||60
9805447|NCT00627406|10913829|FG001|COMPLETED|Overall Study||58
9805448|NCT00627406|10913830|FG002|COMPLETED|Overall Study||125
9805449|NCT00627406|10913831|FG003|COMPLETED|Overall Study||141
9805450|NCT00627406|10913828|FG000|NOT COMPLETED|Overall Study||0
9805451|NCT00627406|10913829|FG001|NOT COMPLETED|Overall Study||0
9805452|NCT00627406|10913830|FG002|NOT COMPLETED|Overall Study||0
9805453|NCT00627406|10913831|FG003|NOT COMPLETED|Overall Study||0
9805454|NCT00627445|10913843|FG000|STARTED|Overall Study||219
9805455|NCT00627445|10913844|FG001|STARTED|Overall Study||222
9805456|NCT00627445|10913843|FG000|Exposed to Study Drug|Overall Study||219
9805457|NCT00627445|10913844|FG001|Exposed to Study Drug|Overall Study||222
9805458|NCT00627445|10913843|FG000|COMPLETED|Overall Study||210
9805459|NCT00627445|10913844|FG001|COMPLETED|Overall Study||210
9805460|NCT00627445|10913843|FG000|NOT COMPLETED|Overall Study||9
9805461|NCT00627445|10913844|FG001|NOT COMPLETED|Overall Study||12
9805462|NCT00627458|10913855|FG000|STARTED|Overall Study||127
9805463|NCT00627458|10913856|FG001|STARTED|Overall Study||137
9805464|NCT00627458|10913857|FG002|STARTED|Overall Study||139
9805465|NCT00627458|10913855|FG000|COMPLETED|Overall Study||123
9805466|NCT00627458|10913856|FG001|COMPLETED|Overall Study||130
9805467|NCT00627458|10913857|FG002|COMPLETED|Overall Study||133
9805468|NCT00627458|10913855|FG000|NOT COMPLETED|Overall Study||4
9805469|NCT00627458|10913856|FG001|NOT COMPLETED|Overall Study||7
9805470|NCT00627458|10913857|FG002|NOT COMPLETED|Overall Study||6
9805471|NCT00627497|10913870|FG000|STARTED|Overall Study||14
9805472|NCT00627497|10913871|FG001|STARTED|Overall Study||12
9805473|NCT00627497|10913872|FG002|STARTED|Overall Study||4
9805474|NCT00627497|10913873|FG003|STARTED|Overall Study||2
9805475|NCT00627497|10913870|FG000|COMPLETED|Overall Study||13
9805476|NCT00627497|10913871|FG001|COMPLETED|Overall Study||11
9805477|NCT00627497|10913872|FG002|COMPLETED|Overall Study||4
9805478|NCT00627497|10913873|FG003|COMPLETED|Overall Study||2
9805479|NCT00627497|10913870|FG000|NOT COMPLETED|Overall Study||1
9805480|NCT00627497|10913871|FG001|NOT COMPLETED|Overall Study||1
9805481|NCT00627497|10913872|FG002|NOT COMPLETED|Overall Study||0
9805482|NCT00627497|10913873|FG003|NOT COMPLETED|Overall Study||0
9805483|NCT00627523|10913885|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
9805484|NCT00627523|10913886|FG001|STARTED|Overall Study||22
9805485|NCT00627523|10913885|FG000|COMPLETED|Overall Study||19
9805486|NCT00627523|10913886|FG001|COMPLETED|Overall Study||20
9805487|NCT00627523|10913885|FG000|NOT COMPLETED|Overall Study||2
9805488|NCT00627523|10913886|FG001|NOT COMPLETED|Overall Study||2
9805489|NCT00627679|10913892|FG000|STARTED|Overall Study||4
9805490|NCT00627679|10913893|FG001|STARTED|Overall Study||4
9805491|NCT00627679|10913894|FG002|STARTED|Overall Study||4
9805492|NCT00627679|10913895|FG003|STARTED|Overall Study||4
9805493|NCT00627679|10913892|FG000|COMPLETED|Overall Study||4
9805494|NCT00627679|10913893|FG001|COMPLETED|Overall Study||4
9805495|NCT00627679|10913894|FG002|COMPLETED|Overall Study||4
9805496|NCT00627679|10913895|FG003|COMPLETED|Overall Study||4
9805497|NCT00627679|10913892|FG000|NOT COMPLETED|Overall Study||0
9805498|NCT00627679|10913893|FG001|NOT COMPLETED|Overall Study||0
9805499|NCT00627679|10913894|FG002|NOT COMPLETED|Overall Study||0
9805500|NCT00627679|10913895|FG003|NOT COMPLETED|Overall Study||0
9805501|NCT00627705|10913907|FG000|STARTED|Overall Study||15
9805502|NCT00627705|10913908|FG001|STARTED|Overall Study||18
9805503|NCT00627705|10913907|FG000|COMPLETED|Overall Study||13
9805504|NCT00627705|10913908|FG001|COMPLETED|Overall Study||12
9805505|NCT00627705|10913907|FG000|NOT COMPLETED|Overall Study||2
9805506|NCT00627705|10913908|FG001|NOT COMPLETED|Overall Study||6
9805507|NCT00627861|10913914|FG000|STARTED|Overall Study||1
9805508|NCT00627861|10913914|FG000|COMPLETED|Overall Study||1
9805509|NCT00627861|10913914|FG000|NOT COMPLETED|Overall Study||0
9805510|NCT00627926|10913923|FG000|STARTED|Overall Study||361
9805511|NCT00627926|10913924|FG001|STARTED|Overall Study||364
9805512|NCT00627926|10913925|FG002|STARTED|Overall Study||363
9805513|NCT00627926|10913923|FG000|COMPLETED|Overall Study||202
9805514|NCT00627926|10913924|FG001|COMPLETED|Overall Study||260
9805515|NCT00627926|10913925|FG002|COMPLETED|Overall Study||268
9805516|NCT00627926|10913923|FG000|NOT COMPLETED|Overall Study||159
9805517|NCT00627926|10913924|FG001|NOT COMPLETED|Overall Study||104
9805518|NCT00627926|10913925|FG002|NOT COMPLETED|Overall Study||95
9805519|NCT00627978|10913935|FG000|STARTED|Overall Study||10
9805520|NCT00627978|10913936|FG001|STARTED|Overall Study||5
9805521|NCT00627978|10913935|FG000|COMPLETED|Overall Study||10
9805522|NCT00627978|10913936|FG001|COMPLETED|Overall Study||5
9805523|NCT00627978|10913935|FG000|NOT COMPLETED|Overall Study||0
9805524|NCT00627978|10913936|FG001|NOT COMPLETED|Overall Study||0
9805525|NCT00628030|10913944|FG000|STARTED|Baseline to Post-Assessment||92
9805526|NCT00628030|10913945|FG001|STARTED|Baseline to Post-Assessment||92
9805527|NCT00628030|10913944|FG000|COMPLETED|Baseline to Post-Assessment||59
9805528|NCT00628030|10913945|FG001|COMPLETED|Baseline to Post-Assessment||63
9805529|NCT00628030|10913944|FG000|NOT COMPLETED|Baseline to Post-Assessment||33
9805530|NCT00628030|10913945|FG001|NOT COMPLETED|Baseline to Post-Assessment||29
9805531|NCT00628030|10913944|FG000|STARTED|Post to 6 Month Follow-up||59
9805532|NCT00628030|10913945|FG001|STARTED|Post to 6 Month Follow-up||63
9805533|NCT00628030|10913944|FG000|COMPLETED|Post to 6 Month Follow-up||27
9805534|NCT00628030|10913945|FG001|COMPLETED|Post to 6 Month Follow-up||33
9805535|NCT00628030|10913944|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32
9805536|NCT00628030|10913945|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30
9805537|NCT00628108|10913953|FG000|STARTED|Overall Study||23
9805538|NCT00628108|10913954|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
9805539|NCT00628108|10913953|FG000|Safety Population|Overall Study||24
9805540|NCT00628108|10913954|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
9805541|NCT00628108|10913953|FG000|COMPLETED|Overall Study||22
9805542|NCT00628108|10913954|FG001|COMPLETED|Overall Study||43
9805543|NCT00628108|10913953|FG000|NOT COMPLETED|Overall Study||1
9805544|NCT00628108|10913954|FG001|NOT COMPLETED|Overall Study||3
9805545|NCT00628134|10913960|FG000|STARTED|Overall Study||4
9805546|NCT00628134|10913961|FG001|STARTED|Overall Study||4
9805547|NCT00628134|10913960|FG000|COMPLETED|Overall Study||4
9805548|NCT00628134|10913961|FG001|COMPLETED|Overall Study||4
9805549|NCT00628134|10913960|FG000|NOT COMPLETED|Overall Study||0
9805550|NCT00628134|10913961|FG001|NOT COMPLETED|Overall Study||0
9805551|NCT00628147|10913969|FG000|STARTED|Overall Study||142
9805552|NCT00628147|10913970|FG001|STARTED|Overall Study||142
9805553|NCT00628147|10913969|FG000|COMPLETED|Overall Study||135
9805554|NCT00628147|10913970|FG001|COMPLETED|Overall Study||141
9805555|NCT00628147|10913969|FG000|NOT COMPLETED|Overall Study||7
9805556|NCT00628147|10913970|FG001|NOT COMPLETED|Overall Study||1
9805557|NCT00628212|10913980|FG000|STARTED|Overall Study||80
9805558|NCT00628212|10913981|FG001|STARTED|Overall Study||84
9805559|NCT00628212|10913982|FG002|STARTED|Overall Study||79
9805560|NCT00628212|10913983|FG003|STARTED|Overall Study||81
9805561|NCT00628212|10913980|FG000|COMPLETED|Overall Study||77
9805562|NCT00628212|10913981|FG001|COMPLETED|Overall Study||83
9805563|NCT00628212|10913982|FG002|COMPLETED|Overall Study||76
9805564|NCT00628212|10913983|FG003|COMPLETED|Overall Study||76
9805565|NCT00628212|10913980|FG000|NOT COMPLETED|Overall Study||3
9805566|NCT00628212|10913981|FG001|NOT COMPLETED|Overall Study||1
9805567|NCT00628212|10913982|FG002|NOT COMPLETED|Overall Study||3
9805568|NCT00628212|10913983|FG003|NOT COMPLETED|Overall Study||5
9805569|NCT00628251|10913996|FG000|STARTED|Randomised Part|Patients randomised|32
9805570|NCT00628251|10913997|FG001|STARTED|Randomised Part|Patients randomised|32
9805571|NCT00628251|10913998|FG002|STARTED|Randomised Part|Patients randomised|33
9805572|NCT00628251|10913996|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
9805573|NCT00628251|10913997|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
9805574|NCT00628251|10913998|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
9805575|NCT00628251|10913996|FG000|NOT COMPLETED|Randomised Part||0
9805576|NCT00628251|10913997|FG001|NOT COMPLETED|Randomised Part||0
9805577|NCT00628251|10913998|FG002|NOT COMPLETED|Randomised Part||1
9805578|NCT00628251|10913996|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
9805579|NCT00628251|10913997|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
9805580|NCT00628251|10913998|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
9805581|NCT00628251|10913996|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
9805582|NCT00628251|10913997|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
9805583|NCT00628251|10913998|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
9805584|NCT00628251|10913996|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
9805585|NCT00628251|10913997|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
9805586|NCT00628251|10913998|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
9805587|NCT00628251|10913996|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
9805588|NCT00628251|10913997|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
9805589|NCT00628251|10913998|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
9805590|NCT00628251|10913996|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
9805591|NCT00628251|10913997|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
9805592|NCT00628251|10913998|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
9805593|NCT00628251|10913996|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
9805594|NCT00628251|10913997|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
9832506|NCT00773370|10943265|FG000|COMPLETED|Overall Study||25
9805595|NCT00628251|10913998|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
9805596|NCT00628251|10913996|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
9805597|NCT00628251|10913997|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
9805598|NCT00628251|10913998|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
9805599|NCT00628355|10914010|FG000|STARTED|Overall Study||15
9805600|NCT00628355|10914011|FG001|STARTED|Overall Study||15
9805601|NCT00628355|10914010|FG000|COMPLETED|Overall Study||14
9805602|NCT00628355|10914011|FG001|COMPLETED|Overall Study||14
9805603|NCT00628355|10914010|FG000|NOT COMPLETED|Overall Study||1
9805604|NCT00628355|10914011|FG001|NOT COMPLETED|Overall Study||1
9805605|NCT00628394|10914022|FG000|STARTED|Overall Study||14
9805606|NCT00628394|10914023|FG001|STARTED|Overall Study||13
9805607|NCT00628394|10914024|FG002|STARTED|Overall Study||13
9805608|NCT00628394|10914025|FG003|STARTED|Overall Study||13
9805609|NCT00628394|10914022|FG000|COMPLETED|Overall Study||10
9805610|NCT00628394|10914023|FG001|COMPLETED|Overall Study||9
9805611|NCT00628394|10914024|FG002|COMPLETED|Overall Study||11
9805612|NCT00628394|10914025|FG003|COMPLETED|Overall Study||10
9805613|NCT00628394|10914022|FG000|NOT COMPLETED|Overall Study||4
9805614|NCT00628394|10914023|FG001|NOT COMPLETED|Overall Study||4
9805615|NCT00628394|10914024|FG002|NOT COMPLETED|Overall Study||2
9805616|NCT00628394|10914025|FG003|NOT COMPLETED|Overall Study||3
9805617|NCT00628407|10914035|FG000|STARTED|Overall Study||13
9805618|NCT00628407|10914035|FG000|COMPLETED|Overall Study||13
9805619|NCT00628407|10914035|FG000|NOT COMPLETED|Overall Study||0
9805620|NCT00628498|10914039|FG000|STARTED|Overall Study||1206
9805621|NCT00628498|10914039|FG000|COMPLETED|Overall Study||1154
9805622|NCT00628498|10914039|FG000|NOT COMPLETED|Overall Study||52
9805623|NCT00628589|10914046|FG000|STARTED|Overall Study||115
9805624|NCT00628589|10914047|FG001|STARTED|Overall Study||116
9805625|NCT00628589|10914048|FG002|STARTED|Overall Study||113
9805626|NCT00628589|10914046|FG000|COMPLETED|Overall Study||114
9805627|NCT00628589|10914047|FG001|COMPLETED|Overall Study||114
9805628|NCT00628589|10914048|FG002|COMPLETED|Overall Study||110
9805629|NCT00628589|10914046|FG000|NOT COMPLETED|Overall Study||1
9805630|NCT00628589|10914047|FG001|NOT COMPLETED|Overall Study||2
9805631|NCT00628589|10914048|FG002|NOT COMPLETED|Overall Study||3
9805632|NCT00628628|10914058|FG000|STARTED|Overall Study||40
9805633|NCT00628628|10914059|FG001|STARTED|Overall Study||40
9805634|NCT00628628|10914058|FG000|COMPLETED|Overall Study||40
9805635|NCT00628628|10914059|FG001|COMPLETED|Overall Study||40
9805636|NCT00628628|10914058|FG000|NOT COMPLETED|Overall Study||0
9805637|NCT00628628|10914059|FG001|NOT COMPLETED|Overall Study||0
9805638|NCT00628758|10914067|FG000|STARTED|Overall Study||209
9805639|NCT00628758|10914068|FG001|STARTED|Overall Study||221
9805640|NCT00628758|10914067|FG000|COMPLETED|Overall Study||165
9805641|NCT00628758|10914068|FG001|COMPLETED|Overall Study||179
9805642|NCT00628758|10914067|FG000|NOT COMPLETED|Overall Study||44
9805643|NCT00628758|10914068|FG001|NOT COMPLETED|Overall Study||42
9805644|NCT00628862|10914079|FG000|STARTED|Overall Study|randomised patients|206
9805645|NCT00628862|10914080|FG001|STARTED|Overall Study|randomised patients|199
9805646|NCT00628862|10914081|FG002|STARTED|Overall Study|randomised patients|208
9805647|NCT00628862|10914079|FG000|COMPLETED|Overall Study|randomised patients|195
9805648|NCT00628862|10914080|FG001|COMPLETED|Overall Study|randomised patients|182
9805649|NCT00628862|10914081|FG002|COMPLETED|Overall Study|randomised patients|186
9805650|NCT00628862|10914079|FG000|NOT COMPLETED|Overall Study||11
9805651|NCT00628862|10914080|FG001|NOT COMPLETED|Overall Study||17
9805652|NCT00628862|10914081|FG002|NOT COMPLETED|Overall Study||22
9805653|NCT00628901|10914091|FG000|STARTED|Overall Study||30
9805654|NCT00628901|10914092|FG001|STARTED|Overall Study||30
9805655|NCT00628901|10914091|FG000|COMPLETED|Overall Study||27
9805656|NCT00628901|10914092|FG001|COMPLETED|Overall Study||29
9805657|NCT00628901|10914091|FG000|NOT COMPLETED|Overall Study||3
9805658|NCT00628901|10914092|FG001|NOT COMPLETED|Overall Study||1
9805659|NCT00628927|10914100|FG000|STARTED|Overall Study||183
9805660|NCT00628927|10914101|FG001|STARTED|Overall Study||30
9805661|NCT00628927|10914100|FG000|COMPLETED|Overall Study||175
9805662|NCT00628927|10914101|FG001|COMPLETED|Overall Study||30
9805663|NCT00628927|10914100|FG000|NOT COMPLETED|Overall Study||8
9805664|NCT00628927|10914101|FG001|NOT COMPLETED|Overall Study||0
9805665|NCT00629018|10914114|FG000|STARTED|Overall Study||55
9805666|NCT00629018|10914115|FG001|STARTED|Overall Study||55
9805667|NCT00629018|10914114|FG000|COMPLETED|Overall Study||55
9805668|NCT00629018|10914115|FG001|COMPLETED|Overall Study||55
9805669|NCT00629018|10914114|FG000|NOT COMPLETED|Overall Study||0
9805670|NCT00629018|10914115|FG001|NOT COMPLETED|Overall Study||0
9805671|NCT00629083|10914123|FG000|STARTED|Overall Study||228
9805672|NCT00629083|10914124|FG001|STARTED|Overall Study||117
9805673|NCT00629083|10914123|FG000|COMPLETED|Overall Study||200
9805674|NCT00629083|10914124|FG001|COMPLETED|Overall Study||103
9805675|NCT00629083|10914123|FG000|NOT COMPLETED|Overall Study||28
9805676|NCT00629083|10914124|FG001|NOT COMPLETED|Overall Study||14
9805677|NCT00629122|10914134|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2
9805678|NCT00629122|10914135|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3
9805679|NCT00629122|10914134|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
9805680|NCT00629122|10914135|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
9805681|NCT00629122|10914134|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
9805682|NCT00629122|10914135|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
9805683|NCT00629122|10914134|FG000|STARTED|Second Period: Day 3-5 (Washout)||2
9805684|NCT00629122|10914135|FG001|STARTED|Second Period: Day 3-5 (Washout)||3
9805685|NCT00629122|10914134|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2
9805686|NCT00629122|10914135|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3
9805687|NCT00629122|10914134|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
9805688|NCT00629122|10914135|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
9805689|NCT00629122|10914134|FG000|STARTED|Third Period: Day 6-8 (Oral)||2
9805690|NCT00629122|10914135|FG001|STARTED|Third Period: Day 6-8 (Oral)||3
9805691|NCT00629122|10914134|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2
9805692|NCT00629122|10914135|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3
9805693|NCT00629122|10914134|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
9805694|NCT00629122|10914135|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
9805695|NCT00629239|10914143|FG000|STARTED|Overall Study||34
9805696|NCT00629239|10914144|FG001|STARTED|Overall Study||32
9805697|NCT00629239|10914143|FG000|COMPLETED|Overall Study||26
9805698|NCT00629239|10914144|FG001|COMPLETED|Overall Study||28
9805699|NCT00629239|10914143|FG000|NOT COMPLETED|Overall Study||8
9805700|NCT00629239|10914144|FG001|NOT COMPLETED|Overall Study||4
9805701|NCT00629265|10914152|FG000|STARTED|Overall Study||116
9805702|NCT00629265|10914153|FG001|STARTED|Overall Study||54
9805703|NCT00629265|10914152|FG000|COMPLETED|Overall Study||84
9805704|NCT00629265|10914153|FG001|COMPLETED|Overall Study||34
9805705|NCT00629265|10914152|FG000|NOT COMPLETED|Overall Study||32
9805706|NCT00629265|10914153|FG001|NOT COMPLETED|Overall Study||20
9805707|NCT00629499|10914159|FG000|STARTED|Overall Study||63
9805708|NCT00629499|10914159|FG000|COMPLETED|Overall Study||63
9805709|NCT00629499|10914159|FG000|NOT COMPLETED|Overall Study||0
9805710|NCT00629525|10914163|FG000|STARTED|Overall Study||35
9805711|NCT00629525|10914163|FG000|COMPLETED|Overall Study||32
9805712|NCT00629525|10914163|FG000|NOT COMPLETED|Overall Study||3
9805713|NCT00629707|10914169|FG000|STARTED|Overall Study||10
9805714|NCT00629707|10914170|FG001|STARTED|Overall Study||10
9805715|NCT00629707|10914169|FG000|COMPLETED|Overall Study||10
9805716|NCT00629707|10914170|FG001|COMPLETED|Overall Study||8
9805717|NCT00629707|10914169|FG000|NOT COMPLETED|Overall Study||0
9805718|NCT00629707|10914170|FG001|NOT COMPLETED|Overall Study||2
9805719|NCT00629772|10914178|FG000|STARTED|First Intervention - Day 0 - Week 14||12
9805720|NCT00629772|10914179|FG001|STARTED|First Intervention - Day 0 - Week 14||12
9805721|NCT00629772|10914178|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12
9805722|NCT00629772|10914179|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12
9805723|NCT00629772|10914178|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
9805724|NCT00629772|10914179|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
9805725|NCT00629772|10914178|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
9805726|NCT00629772|10914179|FG001|STARTED|Second Intervention Week 14 - Week 26||12
9805727|NCT00629772|10914178|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11
9805728|NCT00629772|10914179|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10
9805729|NCT00629772|10914178|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
9805730|NCT00629772|10914179|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
9805731|NCT00630032|10914188|FG000|STARTED|Overall Study||398
9805732|NCT00630032|10914189|FG001|STARTED|Overall Study||364
9805733|NCT00630032|10914188|FG000|COMPLETED|Overall Study||308
9805734|NCT00630032|10914189|FG001|COMPLETED|Overall Study||269
9805735|NCT00630032|10914188|FG000|NOT COMPLETED|Overall Study||90
9805736|NCT00630032|10914189|FG001|NOT COMPLETED|Overall Study||95
9805737|NCT00630058|10914197|FG000|STARTED|Overall Study||10
9805738|NCT00630058|10914198|FG001|STARTED|Overall Study||10
9805739|NCT00630058|10914197|FG000|COMPLETED|Overall Study||6
9805740|NCT00630058|10914198|FG001|COMPLETED|Overall Study||6
9805741|NCT00630058|10914197|FG000|NOT COMPLETED|Overall Study||4
9805742|NCT00630058|10914198|FG001|NOT COMPLETED|Overall Study||4
9805743|NCT00630253|10914207|FG000|STARTED|Overall Study||16
9805744|NCT00630253|10914208|FG001|STARTED|Overall Study||9
9805745|NCT00630253|10914209|FG002|STARTED|Overall Study||6
9805746|NCT00630253|10914207|FG000|COMPLETED|Overall Study||16
9805747|NCT00630253|10914208|FG001|COMPLETED|Overall Study||9
9805748|NCT00630253|10914209|FG002|COMPLETED|Overall Study||6
9805749|NCT00630253|10914207|FG000|NOT COMPLETED|Overall Study||0
9805750|NCT00630253|10914208|FG001|NOT COMPLETED|Overall Study||0
9805751|NCT00630253|10914209|FG002|NOT COMPLETED|Overall Study||0
9805752|NCT00630305|10914217|FG000|STARTED|Overall Study||37
9805753|NCT00630305|10914217|FG000|COMPLETED|Overall Study||35
9805754|NCT00630305|10914217|FG000|NOT COMPLETED|Overall Study||2
9805755|NCT00630331|10914233|FG000|STARTED|Overall Study||3828
9805756|NCT00630331|10914234|FG001|STARTED|Overall Study||3676
9805757|NCT00630331|10914235|FG002|STARTED|Overall Study||3900
9805758|NCT00630331|10914233|FG000|COMPLETED|Overall Study||3622
9805759|NCT00630331|10914234|FG001|COMPLETED|Overall Study||3510
9805760|NCT00630331|10914235|FG002|COMPLETED|Overall Study||3712
9805761|NCT00630331|10914233|FG000|NOT COMPLETED|Overall Study||206
9805762|NCT00630331|10914234|FG001|NOT COMPLETED|Overall Study||166
9805763|NCT00630331|10914235|FG002|NOT COMPLETED|Overall Study||188
9805764|NCT00630344|10914243|FG000|STARTED|Overall Study||36
9805765|NCT00630344|10914243|FG000|COMPLETED|Overall Study||0
9805766|NCT00630344|10914243|FG000|NOT COMPLETED|Overall Study||36
9805767|NCT00630396|10914248|FG000|STARTED|Overall Study||60
9805768|NCT00630396|10914248|FG000|COMPLETED|Overall Study||53
9805769|NCT00630396|10914248|FG000|NOT COMPLETED|Overall Study||7
9805770|NCT00630409|10914252|FG000|STARTED|Overall Study||5
9805771|NCT00630409|10914252|FG000|COMPLETED|Overall Study||4
9805772|NCT00630409|10914252|FG000|NOT COMPLETED|Overall Study||1
9805773|NCT00630539|10914261|FG000|STARTED|Overall Study||34
9805774|NCT00630539|10914262|FG001|STARTED|Overall Study||33
9805775|NCT00630539|10914263|FG002|STARTED|Overall Study||29
9805776|NCT00630539|10914264|FG003|STARTED|Overall Study||30
9805777|NCT00630539|10914261|FG000|COMPLETED|Overall Study||33
9805778|NCT00630539|10914262|FG001|COMPLETED|Overall Study||29
9805779|NCT00630539|10914263|FG002|COMPLETED|Overall Study||28
9805780|NCT00630539|10914264|FG003|COMPLETED|Overall Study||27
9805781|NCT00630539|10914261|FG000|NOT COMPLETED|Overall Study||1
9805782|NCT00630539|10914262|FG001|NOT COMPLETED|Overall Study||4
9805783|NCT00630539|10914263|FG002|NOT COMPLETED|Overall Study||1
9805784|NCT00630539|10914264|FG003|NOT COMPLETED|Overall Study||3
9805785|NCT00630734|10914284|FG000|STARTED|Overall Study||11
9805786|NCT00630734|10914285|FG001|STARTED|Overall Study||13
9805787|NCT00630734|10914286|FG002|STARTED|Overall Study||8
9805788|NCT00630734|10914284|FG000|COMPLETED|Overall Study||9
9805789|NCT00630734|10914285|FG001|COMPLETED|Overall Study||12
9805790|NCT00630734|10914286|FG002|COMPLETED|Overall Study||7
9805791|NCT00630734|10914284|FG000|NOT COMPLETED|Overall Study||2
9805792|NCT00630734|10914285|FG001|NOT COMPLETED|Overall Study||1
9805793|NCT00630734|10914286|FG002|NOT COMPLETED|Overall Study||1
9805794|NCT00630747|10914296|FG000|STARTED|Overall Study||94
9805795|NCT00630747|10914296|FG000|Participants Treated in Phase I of Study|Overall Study||94
9805796|NCT00630747|10914296|FG000|COMPLETED|Overall Study||85
9805797|NCT00630747|10914296|FG000|NOT COMPLETED|Overall Study||9
9805798|NCT00630786|10914303|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
9805799|NCT00630786|10914304|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
9805800|NCT00630786|10914305|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9
9805801|NCT00630786|10914303|FG000|Received Study Medication|Overall Study||19
9805802|NCT00630786|10914304|FG001|Received Study Medication|Overall Study||25
9805803|NCT00630786|10914305|FG002|Received Study Medication|Overall Study||8
10016047|NCT01808339|11139001|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10016048|NCT01808339|11138996|FG000|STARTED|Treatment Period 3 (14 Days)||4
10016049|NCT01808339|11138997|FG001|STARTED|Treatment Period 3 (14 Days)||3
10016050|NCT01808339|11138998|FG002|STARTED|Treatment Period 3 (14 Days)||4
9805804|NCT00630786|10914303|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18
9805805|NCT00630786|10914304|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23
9805806|NCT00630786|10914305|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7
9805807|NCT00630786|10914303|FG000|NOT COMPLETED|Overall Study||1
9805808|NCT00630786|10914304|FG001|NOT COMPLETED|Overall Study||2
9805809|NCT00630786|10914305|FG002|NOT COMPLETED|Overall Study||2
9805810|NCT00630812|10914313|FG000|STARTED|Randomisation to First Dose||192
9805811|NCT00630812|10914314|FG001|STARTED|Randomisation to First Dose||126
9805812|NCT00630812|10914313|FG000|COMPLETED|Randomisation to First Dose||184
9805813|NCT00630812|10914314|FG001|COMPLETED|Randomisation to First Dose||121
9805814|NCT00630812|10914313|FG000|NOT COMPLETED|Randomisation to First Dose||8
9805815|NCT00630812|10914314|FG001|NOT COMPLETED|Randomisation to First Dose||5
9805816|NCT00630812|10914313|FG000|STARTED|Double Blind Treatment Period||184
9805817|NCT00630812|10914314|FG001|STARTED|Double Blind Treatment Period||121
9805818|NCT00630812|10914313|FG000|COMPLETED|Double Blind Treatment Period||153
9805819|NCT00630812|10914314|FG001|COMPLETED|Double Blind Treatment Period||107
9805820|NCT00630812|10914313|FG000|NOT COMPLETED|Double Blind Treatment Period||31
9805821|NCT00630812|10914314|FG001|NOT COMPLETED|Double Blind Treatment Period||14
9805822|NCT00630825|10914324|FG000|STARTED|Overall Study||65
9805823|NCT00630825|10914325|FG001|STARTED|Overall Study||65
9805824|NCT00630825|10914326|FG002|STARTED|Overall Study||66
9805825|NCT00630825|10914327|FG003|STARTED|Overall Study||66
9805826|NCT00630825|10914324|FG000|Received at Least One Dose of Study Drug|Overall Study||65
9805827|NCT00630825|10914325|FG001|Received at Least One Dose of Study Drug|Overall Study||65
9805828|NCT00630825|10914326|FG002|Received at Least One Dose of Study Drug|Overall Study||66
9805829|NCT00630825|10914327|FG003|Received at Least One Dose of Study Drug|Overall Study||66
9805830|NCT00630825|10914324|FG000|COMPLETED|Overall Study||56
9805831|NCT00630825|10914325|FG001|COMPLETED|Overall Study||58
9805832|NCT00630825|10914326|FG002|COMPLETED|Overall Study||58
9805833|NCT00630825|10914327|FG003|COMPLETED|Overall Study||60
9805834|NCT00630825|10914324|FG000|NOT COMPLETED|Overall Study||9
9805835|NCT00630825|10914325|FG001|NOT COMPLETED|Overall Study||7
9805836|NCT00630825|10914326|FG002|NOT COMPLETED|Overall Study||8
9805837|NCT00630825|10914327|FG003|NOT COMPLETED|Overall Study||6
9805838|NCT00630838|10914339|FG000|STARTED|Overall Study||32
9805839|NCT00630838|10914340|FG001|STARTED|Overall Study||30
9805840|NCT00630838|10914339|FG000|COMPLETED|Overall Study||32
9805841|NCT00630838|10914340|FG001|COMPLETED|Overall Study||28
9805842|NCT00630838|10914339|FG000|NOT COMPLETED|Overall Study||0
9805843|NCT00630838|10914340|FG001|NOT COMPLETED|Overall Study||2
9805844|NCT00630864|10914348|FG000|STARTED|Part 1 (up to Week 6)||21
9805845|NCT00630864|10914348|FG000|COMPLETED|Part 1 (up to Week 6)||20
10016051|NCT01808339|11138999|FG003|STARTED|Treatment Period 3 (14 Days)||2
9805846|NCT00630864|10914348|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1
9805847|NCT00630864|10914348|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20
9805848|NCT00630864|10914348|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
9832507|NCT00773370|10943266|FG001|COMPLETED|Overall Study||23
9805849|NCT00630864|10914348|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
9805850|NCT00630877|10914355|FG000|STARTED|Overall Study|For all arms, started means treated.|91
9805851|NCT00630877|10914356|FG001|STARTED|Overall Study||90
9805852|NCT00630877|10914357|FG002|STARTED|Overall Study||90
9805853|NCT00630877|10914355|FG000|COMPLETED|Overall Study||72
9805854|NCT00630877|10914356|FG001|COMPLETED|Overall Study||75
9805855|NCT00630877|10914357|FG002|COMPLETED|Overall Study||80
9805856|NCT00630877|10914355|FG000|NOT COMPLETED|Overall Study||19
9805857|NCT00630877|10914356|FG001|NOT COMPLETED|Overall Study||15
9805858|NCT00630877|10914357|FG002|NOT COMPLETED|Overall Study||10
9805859|NCT00630916|10914369|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
9805860|NCT00630916|10914369|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
9805861|NCT00630916|10914369|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
9805862|NCT00630916|10914369|FG000|NOT COMPLETED|Overall Study||210
9805863|NCT00630955|10914376|FG000|STARTED|Overall Study||34
9805864|NCT00630955|10914377|FG001|STARTED|Overall Study||37
9805865|NCT00630955|10914378|FG002|STARTED|Overall Study||40
9805866|NCT00630955|10914376|FG000|COMPLETED|Overall Study||31
9805867|NCT00630955|10914377|FG001|COMPLETED|Overall Study||31
9805868|NCT00630955|10914378|FG002|COMPLETED|Overall Study||28
9952875|NCT01424397|11071756|FG008|COMPLETED|Period-3 (8 Days)||4
9952876|NCT01424397|11071757|FG009|COMPLETED|Period-3 (8 Days)||3
9952877|NCT01424397|11071758|FG010|COMPLETED|Period-3 (8 Days)||4
9952878|NCT01424397|11071759|FG011|COMPLETED|Period-3 (8 Days)||4
9952879|NCT01424397|11071748|FG000|NOT COMPLETED|Period-3 (8 Days)||0
9952880|NCT01424397|11071749|FG001|NOT COMPLETED|Period-3 (8 Days)||0
9952881|NCT01424397|11071750|FG002|NOT COMPLETED|Period-3 (8 Days)||0
9952882|NCT01424397|11071751|FG003|NOT COMPLETED|Period-3 (8 Days)||0
9952883|NCT01424397|11071752|FG004|NOT COMPLETED|Period-3 (8 Days)||0
9952884|NCT01424397|11071753|FG005|NOT COMPLETED|Period-3 (8 Days)||0
9952885|NCT01424397|11071754|FG006|NOT COMPLETED|Period-3 (8 Days)||0
9952886|NCT01424397|11071755|FG007|NOT COMPLETED|Period-3 (8 Days)||0
9952887|NCT01424397|11071756|FG008|NOT COMPLETED|Period-3 (8 Days)||0
9952888|NCT01424397|11071757|FG009|NOT COMPLETED|Period-3 (8 Days)||0
9805869|NCT00630955|10914376|FG000|NOT COMPLETED|Overall Study||3
9805870|NCT00630955|10914377|FG001|NOT COMPLETED|Overall Study||6
9805871|NCT00630955|10914378|FG002|NOT COMPLETED|Overall Study||12
9805872|NCT00630994|10914386|FG000|STARTED|Overall Study||4
9805873|NCT00630994|10914386|FG000|COMPLETED|Overall Study||0
9805874|NCT00630994|10914386|FG000|NOT COMPLETED|Overall Study||4
9805875|NCT00631007|10914396|FG000|STARTED|Overall Study||60
9805876|NCT00631007|10914397|FG001|STARTED|Overall Study||61
9805877|NCT00631007|10914398|FG002|STARTED|Overall Study||63
9805878|NCT00631007|10914399|FG003|STARTED|Overall Study||62
9805879|NCT00631007|10914400|FG004|STARTED|Overall Study||60
9805880|NCT00631007|10914401|FG005|STARTED|Overall Study||61
9805881|NCT00631007|10914396|FG000|COMPLETED|Overall Study||49
9805882|NCT00631007|10914397|FG001|COMPLETED|Overall Study||50
9805883|NCT00631007|10914398|FG002|COMPLETED|Overall Study||53
9805884|NCT00631007|10914399|FG003|COMPLETED|Overall Study||53
9805885|NCT00631007|10914400|FG004|COMPLETED|Overall Study||48
9805886|NCT00631007|10914401|FG005|COMPLETED|Overall Study||46
9805887|NCT00631007|10914396|FG000|NOT COMPLETED|Overall Study||11
9805888|NCT00631007|10914397|FG001|NOT COMPLETED|Overall Study||11
9805889|NCT00631007|10914398|FG002|NOT COMPLETED|Overall Study||10
9805890|NCT00631007|10914399|FG003|NOT COMPLETED|Overall Study||9
9805891|NCT00631007|10914400|FG004|NOT COMPLETED|Overall Study||12
9805892|NCT00631007|10914401|FG005|NOT COMPLETED|Overall Study||15
9805893|NCT00631020|10914415|FG000|STARTED|Overall Study||34
9805894|NCT00631020|10914415|FG000|COMPLETED|Overall Study||26
9805895|NCT00631020|10914415|FG000|NOT COMPLETED|Overall Study||8
9805896|NCT00631163|10914419|FG000|STARTED|Number of Participants in Year 1||102
9805897|NCT00631163|10914419|FG000|COMPLETED|Number of Participants in Year 1||68
9805898|NCT00631163|10914419|FG000|NOT COMPLETED|Number of Participants in Year 1||34
9805899|NCT00631163|10914419|FG000|STARTED|Number of Participants in Year 2||57
9805900|NCT00631163|10914419|FG000|COMPLETED|Number of Participants in Year 2||52
9805901|NCT00631163|10914419|FG000|NOT COMPLETED|Number of Participants in Year 2||5
9805902|NCT00631189|10914434|FG000|STARTED|Initial Phase||668
9805903|NCT00631189|10914435|FG001|STARTED|Initial Phase||0
9805904|NCT00631189|10914436|FG002|STARTED|Initial Phase||0
9805905|NCT00631189|10914437|FG003|STARTED|Initial Phase||0
9805906|NCT00631189|10914434|FG000|COMPLETED|Initial Phase||317
9805907|NCT00631189|10914435|FG001|COMPLETED|Initial Phase||0
9805908|NCT00631189|10914436|FG002|COMPLETED|Initial Phase||0
9805909|NCT00631189|10914437|FG003|COMPLETED|Initial Phase||0
9805910|NCT00631189|10914434|FG000|NOT COMPLETED|Initial Phase||351
9805911|NCT00631189|10914435|FG001|NOT COMPLETED|Initial Phase||0
9805912|NCT00631189|10914436|FG002|NOT COMPLETED|Initial Phase||0
9805913|NCT00631189|10914437|FG003|NOT COMPLETED|Initial Phase||0
9805914|NCT00631189|10914434|FG000|STARTED|Treatment Phase||0
9805915|NCT00631189|10914435|FG001|STARTED|Treatment Phase||104
9805916|NCT00631189|10914436|FG002|STARTED|Treatment Phase||103
9805917|NCT00631189|10914437|FG003|STARTED|Treatment Phase||110
9805918|NCT00631189|10914434|FG000|COMPLETED|Treatment Phase||0
9805919|NCT00631189|10914435|FG001|COMPLETED|Treatment Phase||97
9805920|NCT00631189|10914436|FG002|COMPLETED|Treatment Phase||92
9805921|NCT00631189|10914437|FG003|COMPLETED|Treatment Phase||103
9805922|NCT00631189|10914434|FG000|NOT COMPLETED|Treatment Phase||0
9805923|NCT00631189|10914435|FG001|NOT COMPLETED|Treatment Phase||7
9805924|NCT00631189|10914436|FG002|NOT COMPLETED|Treatment Phase||11
9805925|NCT00631189|10914437|FG003|NOT COMPLETED|Treatment Phase||7
9805926|NCT00631319|10914449|FG000|STARTED|Conversion and Titration Phase||343
9805927|NCT00631319|10914450|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
9805928|NCT00631319|10914449|FG000|COMPLETED|Conversion and Titration Phase||200
9805929|NCT00631319|10914450|FG001|COMPLETED|Conversion and Titration Phase||0
9805930|NCT00631319|10914449|FG000|NOT COMPLETED|Conversion and Titration Phase||143
9805931|NCT00631319|10914450|FG001|NOT COMPLETED|Conversion and Titration Phase||0
9805932|NCT00631319|10914449|FG000|STARTED|Double-blind Phase||100
9805933|NCT00631319|10914450|FG001|STARTED|Double-blind Phase||100
9805934|NCT00631319|10914449|FG000|COMPLETED|Double-blind Phase||60
9805935|NCT00631319|10914450|FG001|COMPLETED|Double-blind Phase||65
9805936|NCT00631319|10914449|FG000|NOT COMPLETED|Double-blind Phase||40
9805937|NCT00631319|10914450|FG001|NOT COMPLETED|Double-blind Phase||35
9805938|NCT00631358|10914459|FG000|STARTED|Overall Study||50
9805939|NCT00631358|10914460|FG001|STARTED|Overall Study||47
9805940|NCT00631358|10914459|FG000|COMPLETED|Overall Study||44
9805941|NCT00631358|10914460|FG001|COMPLETED|Overall Study||45
9805942|NCT00631358|10914459|FG000|NOT COMPLETED|Overall Study||6
9805943|NCT00631358|10914460|FG001|NOT COMPLETED|Overall Study||2
9805944|NCT00631371|10914468|FG000|STARTED|Overall Study||400
9805945|NCT00631371|10914469|FG001|STARTED|Overall Study||391
9805946|NCT00631371|10914468|FG000|Treated|Overall Study||393
9805947|NCT00631371|10914469|FG001|Treated|Overall Study||391
9805948|NCT00631371|10914468|FG000|COMPLETED|Overall Study||0
9805949|NCT00631371|10914469|FG001|COMPLETED|Overall Study||0
9805950|NCT00631371|10914468|FG000|NOT COMPLETED|Overall Study||400
9805951|NCT00631371|10914469|FG001|NOT COMPLETED|Overall Study||391
9805952|NCT00631410|10914477|FG000|STARTED|Overall Study||6
9805953|NCT00631410|10914478|FG001|STARTED|Overall Study||6
9805954|NCT00631410|10914477|FG000|COMPLETED|Overall Study||0
9805955|NCT00631410|10914478|FG001|COMPLETED|Overall Study||0
9805956|NCT00631410|10914477|FG000|NOT COMPLETED|Overall Study||6
9805957|NCT00631410|10914478|FG001|NOT COMPLETED|Overall Study||6
9805958|NCT00631449|10914489|FG000|STARTED|Overall Study||15
9805959|NCT00631449|10914490|FG001|STARTED|Overall Study||15
9805960|NCT00631449|10914489|FG000|COMPLETED|Overall Study||15
9805961|NCT00631449|10914490|FG001|COMPLETED|Overall Study||15
9805962|NCT00631449|10914489|FG000|NOT COMPLETED|Overall Study||0
9805963|NCT00631449|10914490|FG001|NOT COMPLETED|Overall Study||0
9805964|NCT00631475|10914498|FG000|STARTED|Overall Study||128
9805965|NCT00631475|10914498|FG000|COMPLETED|Overall Study||83
9805966|NCT00631475|10914498|FG000|NOT COMPLETED|Overall Study||45
9805967|NCT00631488|10914505|FG000|STARTED|Overall Study||48
9805968|NCT00631488|10914506|FG001|STARTED|Overall Study||49
9805969|NCT00631488|10914507|FG002|STARTED|Overall Study||49
9805970|NCT00631488|10914505|FG000|Completed Post-Treatment Period|Overall Study||44
9805971|NCT00631488|10914506|FG001|Completed Post-Treatment Period|Overall Study||47
9805972|NCT00631488|10914507|FG002|Completed Post-Treatment Period|Overall Study||47
9805973|NCT00631488|10914505|FG000|COMPLETED|Overall Study||44
9805974|NCT00631488|10914506|FG001|COMPLETED|Overall Study||47
9805975|NCT00631488|10914507|FG002|COMPLETED|Overall Study||47
9805976|NCT00631488|10914505|FG000|NOT COMPLETED|Overall Study||4
9805977|NCT00631488|10914506|FG001|NOT COMPLETED|Overall Study||2
9805978|NCT00631488|10914507|FG002|NOT COMPLETED|Overall Study||2
9805979|NCT00631540|10914515|FG000|STARTED|Overall Study||100
9805980|NCT00631540|10914515|FG000|COMPLETED|Overall Study||86
10016052|NCT01808339|11139000|FG004|STARTED|Treatment Period 3 (14 Days)||4
10016053|NCT01808339|11139001|FG005|STARTED|Treatment Period 3 (14 Days)||5
10016054|NCT01808339|11138996|FG000|COMPLETED|Treatment Period 3 (14 Days)||4
9805981|NCT00631540|10914515|FG000|NOT COMPLETED|Overall Study||14
9805982|NCT00631566|10914522|FG000|STARTED|Overall Study||21
9805983|NCT00631566|10914523|FG001|STARTED|Overall Study||28
9805984|NCT00631566|10914524|FG002|STARTED|Overall Study||501
9805985|NCT00631566|10914522|FG000|COMPLETED|Overall Study||19
9805986|NCT00631566|10914523|FG001|COMPLETED|Overall Study||24
9805987|NCT00631566|10914524|FG002|COMPLETED|Overall Study||501
9805988|NCT00631566|10914522|FG000|NOT COMPLETED|Overall Study||2
9805989|NCT00631566|10914523|FG001|NOT COMPLETED|Overall Study||4
9805990|NCT00631566|10914524|FG002|NOT COMPLETED|Overall Study||0
9805991|NCT00631657|10914534|FG000|STARTED|6-Month Treatment Period||344
9805992|NCT00631657|10914535|FG001|STARTED|6-Month Treatment Period||0
9805993|NCT00631657|10914536|FG002|STARTED|6-Month Treatment Period||116
9805994|NCT00631657|10914534|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
9805995|NCT00631657|10914535|FG001|Treated|6-Month Treatment Period||0
9805996|NCT00631657|10914536|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
9805997|NCT00631657|10914534|FG000|COMPLETED|6-Month Treatment Period||203
9805998|NCT00631657|10914535|FG001|COMPLETED|6-Month Treatment Period||0
9805999|NCT00631657|10914536|FG002|COMPLETED|6-Month Treatment Period||66
9806000|NCT00631657|10914534|FG000|NOT COMPLETED|6-Month Treatment Period||141
9806001|NCT00631657|10914535|FG001|NOT COMPLETED|6-Month Treatment Period||0
9806002|NCT00631657|10914536|FG002|NOT COMPLETED|6-Month Treatment Period||50
9806003|NCT00631657|10914534|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
9806004|NCT00631657|10914535|FG001|STARTED|7-Day Discontinuation Period||137
9806005|NCT00631657|10914536|FG002|STARTED|7-Day Discontinuation Period||66
9806006|NCT00631657|10914534|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
9806007|NCT00631657|10914535|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
9806008|NCT00631657|10914536|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
9806009|NCT00631657|10914534|FG000|COMPLETED|7-Day Discontinuation Period||65
9806010|NCT00631657|10914535|FG001|COMPLETED|7-Day Discontinuation Period||136
9806011|NCT00631657|10914536|FG002|COMPLETED|7-Day Discontinuation Period||65
9806012|NCT00631657|10914534|FG000|NOT COMPLETED|7-Day Discontinuation Period||2
9806013|NCT00631657|10914535|FG001|NOT COMPLETED|7-Day Discontinuation Period||1
9806014|NCT00631657|10914536|FG002|NOT COMPLETED|7-Day Discontinuation Period||1
9806015|NCT00631670|10914549|FG000|STARTED|Overall Study||21
9806016|NCT00631670|10914550|FG001|STARTED|Overall Study||0
9806017|NCT00631670|10914549|FG000|COMPLETED|Overall Study||21
9806018|NCT00631670|10914550|FG001|COMPLETED|Overall Study||0
9806019|NCT00631670|10914549|FG000|NOT COMPLETED|Overall Study||0
9806020|NCT00631670|10914550|FG001|NOT COMPLETED|Overall Study||0
9806021|NCT00631696|10914562|FG000|STARTED|Overall Study||112
9806022|NCT00631696|10914563|FG001|STARTED|Overall Study||110
9806023|NCT00631696|10914562|FG000|Received Study Treatment (Tx)|Overall Study||111
9806024|NCT00631696|10914563|FG001|Received Study Treatment (Tx)|Overall Study||109
9806025|NCT00631696|10914562|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
9806026|NCT00631696|10914563|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0
9806027|NCT00631696|10914562|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
9806028|NCT00631696|10914563|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
9806029|NCT00631696|10914562|FG000|NOT COMPLETED|Overall Study||37
9806030|NCT00631696|10914563|FG001|NOT COMPLETED|Overall Study||40
9806031|NCT00631748|10914571|FG000|STARTED|Overall Study||29
9806032|NCT00631748|10914572|FG001|STARTED|Overall Study||31
9806033|NCT00631748|10914571|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
9806034|NCT00631748|10914572|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
9806035|NCT00631748|10914571|FG000|NOT COMPLETED|Overall Study||18
9806036|NCT00631748|10914572|FG001|NOT COMPLETED|Overall Study||22
9831467|NCT00768560|10942134|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
9831468|NCT00768560|10942135|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
9831469|NCT00768560|10942136|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
9831470|NCT00768560|10942137|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
9831471|NCT00768560|10942132|FG000|COMPLETED|Intervention Set 1||5
9831472|NCT00768560|10942133|FG001|COMPLETED|Intervention Set 1||5
9831473|NCT00768560|10942134|FG002|COMPLETED|Intervention Set 1||6
9831474|NCT00768560|10942135|FG003|COMPLETED|Intervention Set 1||6
9831475|NCT00768560|10942136|FG004|COMPLETED|Intervention Set 1||6
9831476|NCT00768560|10942137|FG005|COMPLETED|Intervention Set 1||6
9831477|NCT00768560|10942132|FG000|NOT COMPLETED|Intervention Set 1||0
9831478|NCT00768560|10942133|FG001|NOT COMPLETED|Intervention Set 1||1
9831479|NCT00768560|10942134|FG002|NOT COMPLETED|Intervention Set 1||0
9831480|NCT00768560|10942135|FG003|NOT COMPLETED|Intervention Set 1||0
9831481|NCT00768560|10942136|FG004|NOT COMPLETED|Intervention Set 1||0
9831482|NCT00768560|10942137|FG005|NOT COMPLETED|Intervention Set 1||0
9831483|NCT00768560|10942132|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
9831484|NCT00768560|10942133|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
9831485|NCT00768560|10942134|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
9831486|NCT00768560|10942135|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
9831487|NCT00768560|10942136|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
9831488|NCT00768560|10942137|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
9831489|NCT00768560|10942132|FG000|COMPLETED|Intervention Set 2||5
9831490|NCT00768560|10942133|FG001|COMPLETED|Intervention Set 2||5
9831491|NCT00768560|10942134|FG002|COMPLETED|Intervention Set 2||6
9831492|NCT00768560|10942135|FG003|COMPLETED|Intervention Set 2||6
9831493|NCT00768560|10942136|FG004|COMPLETED|Intervention Set 2||6
9831494|NCT00768560|10942137|FG005|COMPLETED|Intervention Set 2||6
9831495|NCT00768560|10942132|FG000|NOT COMPLETED|Intervention Set 2||0
9831496|NCT00768560|10942133|FG001|NOT COMPLETED|Intervention Set 2||0
9831497|NCT00768560|10942134|FG002|NOT COMPLETED|Intervention Set 2||0
9831498|NCT00768560|10942135|FG003|NOT COMPLETED|Intervention Set 2||0
9831499|NCT00768560|10942136|FG004|NOT COMPLETED|Intervention Set 2||0
9831500|NCT00768560|10942137|FG005|NOT COMPLETED|Intervention Set 2||0
9831501|NCT00768560|10942132|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
9831502|NCT00768560|10942133|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
9831503|NCT00768560|10942134|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
9831504|NCT00768560|10942135|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
9831505|NCT00768560|10942136|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
9831506|NCT00768560|10942137|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
9831507|NCT00768560|10942132|FG000|COMPLETED|Intervention Set 3||5
9831508|NCT00768560|10942133|FG001|COMPLETED|Intervention Set 3||5
9831509|NCT00768560|10942134|FG002|COMPLETED|Intervention Set 3||6
9831510|NCT00768560|10942135|FG003|COMPLETED|Intervention Set 3||6
9806037|NCT00631852|10914579|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16
9806038|NCT00631852|10914579|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16
9806039|NCT00631852|10914579|FG000|NOT COMPLETED|Overall Study||0
9806040|NCT00631917|10914585|FG000|STARTED|Overall Study||375
9806041|NCT00631917|10914586|FG001|STARTED|Overall Study||399
9806042|NCT00631917|10914585|FG000|COMPLETED|Overall Study||287
9806043|NCT00631917|10914586|FG001|COMPLETED|Overall Study||291
9806044|NCT00631917|10914585|FG000|NOT COMPLETED|Overall Study||88
9806045|NCT00631917|10914586|FG001|NOT COMPLETED|Overall Study||108
9806046|NCT00631969|10914594|FG000|STARTED|Overall Study||186
9806047|NCT00631969|10914595|FG001|STARTED|Overall Study||176
9806048|NCT00631969|10914594|FG000|Received Treatment|Overall Study|safety population|184
9806049|NCT00631969|10914595|FG001|Received Treatment|Overall Study|safety population|174
9806050|NCT00631969|10914594|FG000|COMPLETED|Overall Study||171
9806051|NCT00631969|10914595|FG001|COMPLETED|Overall Study||155
9806052|NCT00631969|10914594|FG000|NOT COMPLETED|Overall Study||15
9806053|NCT00631969|10914595|FG001|NOT COMPLETED|Overall Study||21
9806054|NCT00632021|10914605|FG000|STARTED|Overall Study||432
9806055|NCT00632021|10914606|FG001|STARTED|Overall Study||430
9806056|NCT00632021|10914605|FG000|COMPLETED|Overall Study||428
9806057|NCT00632021|10914606|FG001|COMPLETED|Overall Study||423
9806058|NCT00632021|10914605|FG000|NOT COMPLETED|Overall Study||4
9806059|NCT00632021|10914606|FG001|NOT COMPLETED|Overall Study||7
9806060|NCT00632099|10914615|FG000|STARTED|Overall Study||10
9806061|NCT00632099|10914616|FG001|STARTED|Overall Study||11
9806062|NCT00632099|10914615|FG000|COMPLETED|Overall Study||7
9806063|NCT00632099|10914616|FG001|COMPLETED|Overall Study||8
9806064|NCT00632099|10914615|FG000|NOT COMPLETED|Overall Study||3
9806065|NCT00632099|10914616|FG001|NOT COMPLETED|Overall Study||3
9806066|NCT00632125|10914622|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
9806067|NCT00632125|10914622|FG000|COMPLETED|Overall Study||1393
9806068|NCT00632125|10914622|FG000|NOT COMPLETED|Overall Study||302
9806069|NCT00632203|10914628|FG000|STARTED|Overall Study||26
9806070|NCT00632203|10914629|FG001|STARTED|Overall Study||27
9806071|NCT00632203|10914628|FG000|COMPLETED|Overall Study||25
9806072|NCT00632203|10914629|FG001|COMPLETED|Overall Study||27
9806073|NCT00632203|10914628|FG000|NOT COMPLETED|Overall Study||1
9806074|NCT00632203|10914629|FG001|NOT COMPLETED|Overall Study||0
9806075|NCT00632229|10914637|FG000|STARTED|Overall Study||17
9806076|NCT00632229|10914638|FG001|STARTED|Overall Study||17
9806077|NCT00632229|10914637|FG000|COMPLETED|Overall Study||11
9806078|NCT00632229|10914638|FG001|COMPLETED|Overall Study||11
9806079|NCT00632229|10914637|FG000|NOT COMPLETED|Overall Study||6
9806080|NCT00632229|10914638|FG001|NOT COMPLETED|Overall Study||6
9806081|NCT00632281|10914644|FG000|STARTED|Overall Study||38
9806082|NCT00632281|10914644|FG000|COMPLETED|Overall Study||38
9806083|NCT00632281|10914644|FG000|NOT COMPLETED|Overall Study||0
9806084|NCT00632359|10914648|FG000|STARTED|Overall Study||33
9806085|NCT00632359|10914648|FG000|COMPLETED|Overall Study||31
9806086|NCT00632359|10914648|FG000|NOT COMPLETED|Overall Study||2
9806087|NCT00632411|10914655|FG000|STARTED|Overall Study||649
9806088|NCT00632411|10914656|FG001|STARTED|Overall Study||649
9806089|NCT00632411|10914655|FG000|COMPLETED|Overall Study||489
9806090|NCT00632411|10914656|FG001|COMPLETED|Overall Study||473
9806091|NCT00632411|10914655|FG000|NOT COMPLETED|Overall Study||160
9806092|NCT00632411|10914656|FG001|NOT COMPLETED|Overall Study||176
9806093|NCT00632424|10914665|FG000|STARTED|Overall Study||18
9806094|NCT00632424|10914665|FG000|COMPLETED|Overall Study||0
9806095|NCT00632424|10914665|FG000|NOT COMPLETED|Overall Study||18
9806096|NCT00632463|10914682|FG000|STARTED|Overall Study||7
9806097|NCT00632463|10914683|FG001|STARTED|Overall Study||7
9806098|NCT00632463|10914684|FG002|STARTED|Overall Study||7
9806099|NCT00632463|10914682|FG000|COMPLETED|Overall Study||7
9806100|NCT00632463|10914683|FG001|COMPLETED|Overall Study||6
9806101|NCT00632463|10914684|FG002|COMPLETED|Overall Study||7
9806102|NCT00632463|10914682|FG000|NOT COMPLETED|Overall Study||0
9806103|NCT00632463|10914683|FG001|NOT COMPLETED|Overall Study||1
9806104|NCT00632463|10914684|FG002|NOT COMPLETED|Overall Study||0
9806105|NCT00632489|10914695|FG000|STARTED|Overall Study||15
9806106|NCT00632489|10914696|FG001|STARTED|Overall Study||5
9806107|NCT00632489|10914697|FG002|STARTED|Overall Study||0
9806108|NCT00632489|10914695|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
9806109|NCT00632489|10914696|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
9806110|NCT00632489|10914697|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
9806111|NCT00632489|10914695|FG000|NOT COMPLETED|Overall Study||15
9806112|NCT00632489|10914696|FG001|NOT COMPLETED|Overall Study||5
9952889|NCT01424397|11071758|FG010|NOT COMPLETED|Period-3 (8 Days)||0
9806113|NCT00632489|10914697|FG002|NOT COMPLETED|Overall Study||0
9806114|NCT00632502|10914707|FG000|STARTED|Overall Study||25
9806115|NCT00632502|10914708|FG001|STARTED|Overall Study||12
9806116|NCT00632502|10914707|FG000|Treated|Overall Study||22
9806117|NCT00632502|10914708|FG001|Treated|Overall Study||12
9806118|NCT00632502|10914707|FG000|Completed Treatment|Overall Study||19
9806119|NCT00632502|10914708|FG001|Completed Treatment|Overall Study||9
9806120|NCT00632502|10914707|FG000|COMPLETED|Overall Study||22
9806121|NCT00632502|10914708|FG001|COMPLETED|Overall Study||11
9806122|NCT00632502|10914707|FG000|NOT COMPLETED|Overall Study||3
9806123|NCT00632502|10914708|FG001|NOT COMPLETED|Overall Study||1
9806124|NCT00632541|10914715|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18
9806125|NCT00632541|10914715|FG000|COMPLETED|Overall Study||11
9806126|NCT00632541|10914715|FG000|NOT COMPLETED|Overall Study||7
9806127|NCT00632619|10914721|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
9806128|NCT00632619|10914722|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
9806129|NCT00632619|10914721|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
9806130|NCT00632619|10914722|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
9806131|NCT00632619|10914721|FG000|NOT COMPLETED|Overall Study||8
9806132|NCT00632619|10914722|FG001|NOT COMPLETED|Overall Study||4
9806133|NCT00632632|10914730|FG000|STARTED|Overall Study||13
9806134|NCT00632632|10914731|FG001|STARTED|Overall Study||12
9806135|NCT00632632|10914730|FG000|COMPLETED|Overall Study||13
9806136|NCT00632632|10914731|FG001|COMPLETED|Overall Study||9
9806137|NCT00632632|10914730|FG000|NOT COMPLETED|Overall Study||0
9806138|NCT00632632|10914731|FG001|NOT COMPLETED|Overall Study||3
9806139|NCT00632736|10914737|FG000|STARTED|Overall Study||419
9806140|NCT00632736|10914737|FG000|COMPLETED|Overall Study||151
9806141|NCT00632736|10914737|FG000|NOT COMPLETED|Overall Study||268
9806142|NCT00632749|10914755|FG000|STARTED|Overall Study||4
9806143|NCT00632749|10914756|FG001|STARTED|Overall Study||5
9806144|NCT00632749|10914757|FG002|STARTED|Overall Study||3
9806145|NCT00632749|10914758|FG003|STARTED|Overall Study||4
9806146|NCT00632749|10914759|FG004|STARTED|Overall Study||7
9806147|NCT00632749|10914760|FG005|STARTED|Overall Study||8
9806148|NCT00632749|10914761|FG006|STARTED|Overall Study||5
9806149|NCT00632749|10914762|FG007|STARTED|Overall Study||4
9806150|NCT00632749|10914763|FG008|STARTED|Overall Study||5
9806151|NCT00632749|10914764|FG009|STARTED|Overall Study||3
9806152|NCT00632749|10914765|FG010|STARTED|Overall Study||7
9806153|NCT00632749|10914766|FG011|STARTED|Overall Study||4
9806154|NCT00632749|10914767|FG012|STARTED|Overall Study||3
9806155|NCT00632749|10914768|FG013|STARTED|Overall Study||6
9806156|NCT00632749|10914755|FG000|Treated|Overall Study||4
9806157|NCT00632749|10914756|FG001|Treated|Overall Study||3
9806158|NCT00632749|10914757|FG002|Treated|Overall Study||3
9806159|NCT00632749|10914758|FG003|Treated|Overall Study||4
9806160|NCT00632749|10914759|FG004|Treated|Overall Study||7
9806161|NCT00632749|10914760|FG005|Treated|Overall Study||7
9806162|NCT00632749|10914761|FG006|Treated|Overall Study||4
9806163|NCT00632749|10914762|FG007|Treated|Overall Study||4
9806164|NCT00632749|10914763|FG008|Treated|Overall Study||5
9806165|NCT00632749|10914764|FG009|Treated|Overall Study||3
9806166|NCT00632749|10914765|FG010|Treated|Overall Study||7
9806167|NCT00632749|10914766|FG011|Treated|Overall Study||4
9806168|NCT00632749|10914767|FG012|Treated|Overall Study||3
9806169|NCT00632749|10914768|FG013|Treated|Overall Study||6
9806170|NCT00632749|10914755|FG000|Not Treated|Overall Study||0
9806171|NCT00632749|10914756|FG001|Not Treated|Overall Study||2
9806172|NCT00632749|10914757|FG002|Not Treated|Overall Study||0
9806173|NCT00632749|10914758|FG003|Not Treated|Overall Study||0
9806174|NCT00632749|10914759|FG004|Not Treated|Overall Study||0
9806175|NCT00632749|10914760|FG005|Not Treated|Overall Study||1
9806176|NCT00632749|10914761|FG006|Not Treated|Overall Study||1
9806177|NCT00632749|10914762|FG007|Not Treated|Overall Study||0
9806178|NCT00632749|10914763|FG008|Not Treated|Overall Study||0
9806179|NCT00632749|10914764|FG009|Not Treated|Overall Study||0
9806180|NCT00632749|10914765|FG010|Not Treated|Overall Study||0
9806181|NCT00632749|10914766|FG011|Not Treated|Overall Study||0
9806182|NCT00632749|10914767|FG012|Not Treated|Overall Study||0
9806183|NCT00632749|10914768|FG013|Not Treated|Overall Study||0
9806184|NCT00632749|10914755|FG000|COMPLETED|Overall Study||0
9806185|NCT00632749|10914756|FG001|COMPLETED|Overall Study||0
9806186|NCT00632749|10914757|FG002|COMPLETED|Overall Study||0
9806187|NCT00632749|10914758|FG003|COMPLETED|Overall Study||0
9806188|NCT00632749|10914759|FG004|COMPLETED|Overall Study||0
9806189|NCT00632749|10914760|FG005|COMPLETED|Overall Study||0
9806190|NCT00632749|10914761|FG006|COMPLETED|Overall Study||0
9806191|NCT00632749|10914762|FG007|COMPLETED|Overall Study||0
9806192|NCT00632749|10914763|FG008|COMPLETED|Overall Study||0
9806193|NCT00632749|10914764|FG009|COMPLETED|Overall Study||0
9806194|NCT00632749|10914765|FG010|COMPLETED|Overall Study||0
9806195|NCT00632749|10914766|FG011|COMPLETED|Overall Study||0
9806196|NCT00632749|10914767|FG012|COMPLETED|Overall Study||0
9806197|NCT00632749|10914768|FG013|COMPLETED|Overall Study||0
9806198|NCT00632749|10914755|FG000|NOT COMPLETED|Overall Study||4
9806199|NCT00632749|10914756|FG001|NOT COMPLETED|Overall Study||5
9806200|NCT00632749|10914757|FG002|NOT COMPLETED|Overall Study||3
9806201|NCT00632749|10914758|FG003|NOT COMPLETED|Overall Study||4
9806202|NCT00632749|10914759|FG004|NOT COMPLETED|Overall Study||7
9806203|NCT00632749|10914760|FG005|NOT COMPLETED|Overall Study||8
9806204|NCT00632749|10914761|FG006|NOT COMPLETED|Overall Study||5
9806205|NCT00632749|10914762|FG007|NOT COMPLETED|Overall Study||4
9806206|NCT00632749|10914763|FG008|NOT COMPLETED|Overall Study||5
9806207|NCT00632749|10914764|FG009|NOT COMPLETED|Overall Study||3
9806208|NCT00632749|10914765|FG010|NOT COMPLETED|Overall Study||7
9806209|NCT00632749|10914766|FG011|NOT COMPLETED|Overall Study||4
9806210|NCT00632749|10914767|FG012|NOT COMPLETED|Overall Study||3
9806211|NCT00632749|10914768|FG013|NOT COMPLETED|Overall Study||6
9806212|NCT00632814|10914807|FG000|STARTED|Overall Study||11
9806213|NCT00632814|10914808|FG001|STARTED|Overall Study||13
9806214|NCT00632814|10914809|FG002|STARTED|Overall Study||8
9806215|NCT00632814|10914807|FG000|COMPLETED|Overall Study||11
9806216|NCT00632814|10914808|FG001|COMPLETED|Overall Study||13
9806217|NCT00632814|10914809|FG002|COMPLETED|Overall Study||8
9806218|NCT00632814|10914807|FG000|NOT COMPLETED|Overall Study||0
9806219|NCT00632814|10914808|FG001|NOT COMPLETED|Overall Study||0
9806220|NCT00632814|10914809|FG002|NOT COMPLETED|Overall Study||0
9806221|NCT00632827|10914817|FG000|STARTED|Overall Study||21
9806222|NCT00632827|10914817|FG000|Received GVD|Overall Study||21
9806223|NCT00632827|10914817|FG000|Received M-CHOP|Overall Study||18
9806224|NCT00632827|10914817|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16
9806225|NCT00632827|10914817|FG000|COMPLETED|Overall Study||11
9806226|NCT00632827|10914817|FG000|NOT COMPLETED|Overall Study||10
9806227|NCT00632931|10914822|FG000|STARTED|Part 1, Period 1||13
9806228|NCT00632931|10914823|FG001|STARTED|Part 1, Period 1||12
9806229|NCT00632931|10914824|FG002|STARTED|Part 1, Period 1||0
9806230|NCT00632931|10914822|FG000|COMPLETED|Part 1, Period 1||11
9806231|NCT00632931|10914823|FG001|COMPLETED|Part 1, Period 1||12
9806232|NCT00632931|10914824|FG002|COMPLETED|Part 1, Period 1||0
9806233|NCT00632931|10914822|FG000|NOT COMPLETED|Part 1, Period 1||2
9806234|NCT00632931|10914823|FG001|NOT COMPLETED|Part 1, Period 1||0
9806235|NCT00632931|10914824|FG002|NOT COMPLETED|Part 1, Period 1||0
9806236|NCT00632931|10914822|FG000|STARTED|Part 1, Washout||11
9806237|NCT00632931|10914823|FG001|STARTED|Part 1, Washout||12
9806238|NCT00632931|10914824|FG002|STARTED|Part 1, Washout||0
9806239|NCT00632931|10914822|FG000|COMPLETED|Part 1, Washout||11
10235349|NCT01194856|11365642|FG001|COMPLETED|Overall Study||0
9806240|NCT00632931|10914823|FG001|COMPLETED|Part 1, Washout||12
9806241|NCT00632931|10914824|FG002|COMPLETED|Part 1, Washout||0
9806242|NCT00632931|10914822|FG000|NOT COMPLETED|Part 1, Washout||0
9806243|NCT00632931|10914823|FG001|NOT COMPLETED|Part 1, Washout||0
9806244|NCT00632931|10914824|FG002|NOT COMPLETED|Part 1, Washout||0
9806245|NCT00632931|10914822|FG000|STARTED|Part 1, Period 2||11
9806246|NCT00632931|10914823|FG001|STARTED|Part 1, Period 2||12
9806247|NCT00632931|10914824|FG002|STARTED|Part 1, Period 2||0
9806248|NCT00632931|10914822|FG000|COMPLETED|Part 1, Period 2||11
9806249|NCT00632931|10914823|FG001|COMPLETED|Part 1, Period 2||12
9806250|NCT00632931|10914824|FG002|COMPLETED|Part 1, Period 2||0
9806251|NCT00632931|10914822|FG000|NOT COMPLETED|Part 1, Period 2||0
9806252|NCT00632931|10914823|FG001|NOT COMPLETED|Part 1, Period 2||0
9806253|NCT00632931|10914824|FG002|NOT COMPLETED|Part 1, Period 2||0
9806254|NCT00632931|10914822|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
9806255|NCT00632931|10914823|FG001|STARTED|Post-Part 1 Washout||12
9806256|NCT00632931|10914824|FG002|STARTED|Post-Part 1 Washout||0
9806257|NCT00632931|10914822|FG000|COMPLETED|Post-Part 1 Washout||12
9806258|NCT00632931|10914823|FG001|COMPLETED|Post-Part 1 Washout||12
9806259|NCT00632931|10914824|FG002|COMPLETED|Post-Part 1 Washout||0
9806260|NCT00632931|10914822|FG000|NOT COMPLETED|Post-Part 1 Washout||0
9806261|NCT00632931|10914823|FG001|NOT COMPLETED|Post-Part 1 Washout||0
9806262|NCT00632931|10914824|FG002|NOT COMPLETED|Post-Part 1 Washout||0
9806263|NCT00632931|10914822|FG000|STARTED|Part 2||0
9806264|NCT00632931|10914823|FG001|STARTED|Part 2||0
9806265|NCT00632931|10914824|FG002|STARTED|Part 2||24
9806266|NCT00632931|10914822|FG000|COMPLETED|Part 2||0
9806267|NCT00632931|10914823|FG001|COMPLETED|Part 2||0
9806268|NCT00632931|10914824|FG002|COMPLETED|Part 2||0
9806269|NCT00632931|10914822|FG000|NOT COMPLETED|Part 2||0
9806270|NCT00632931|10914823|FG001|NOT COMPLETED|Part 2||0
9806271|NCT00632931|10914824|FG002|NOT COMPLETED|Part 2||24
9806272|NCT00632970|10914831|FG000|STARTED|Overall Study||3
9806273|NCT00632970|10914832|FG001|STARTED|Overall Study||3
9806274|NCT00632970|10914831|FG000|COMPLETED|Overall Study||3
9806275|NCT00632970|10914832|FG001|COMPLETED|Overall Study||3
9806276|NCT00632970|10914831|FG000|NOT COMPLETED|Overall Study||0
9806277|NCT00632970|10914832|FG001|NOT COMPLETED|Overall Study||0
9806278|NCT00633009|10914841|FG000|STARTED|Overall Study||12
9806279|NCT00633009|10914842|FG001|STARTED|Overall Study||27
9806280|NCT00633009|10914843|FG002|STARTED|Overall Study||11
9806281|NCT00633009|10914841|FG000|COMPLETED|Overall Study||8
9806282|NCT00633009|10914842|FG001|COMPLETED|Overall Study||23
9806283|NCT00633009|10914843|FG002|COMPLETED|Overall Study||10
9806284|NCT00633009|10914841|FG000|NOT COMPLETED|Overall Study||4
9806285|NCT00633009|10914842|FG001|NOT COMPLETED|Overall Study||4
9806286|NCT00633009|10914843|FG002|NOT COMPLETED|Overall Study||1
9806287|NCT00633022|10914857|FG000|STARTED|Overall Study||34
9806288|NCT00633022|10914858|FG001|STARTED|Overall Study||33
9806289|NCT00633022|10914859|FG002|STARTED|Overall Study||32
9806290|NCT00633022|10914857|FG000|COMPLETED|Overall Study||33
9806291|NCT00633022|10914858|FG001|COMPLETED|Overall Study||32
9806292|NCT00633022|10914859|FG002|COMPLETED|Overall Study||27
9806293|NCT00633022|10914857|FG000|NOT COMPLETED|Overall Study||1
9806294|NCT00633022|10914858|FG001|NOT COMPLETED|Overall Study||1
9806295|NCT00633022|10914859|FG002|NOT COMPLETED|Overall Study||5
9806296|NCT00633074|10914869|FG000|STARTED|Overall Study||360
9806297|NCT00633074|10914870|FG001|STARTED|Overall Study||360
9806298|NCT00633074|10914869|FG000|COMPLETED|Overall Study||359
9806299|NCT00633074|10914870|FG001|COMPLETED|Overall Study||360
9806300|NCT00633074|10914869|FG000|NOT COMPLETED|Overall Study||1
9806301|NCT00633074|10914870|FG001|NOT COMPLETED|Overall Study||0
9806302|NCT00633126|10914876|FG000|STARTED|Overall Study||9
9806303|NCT00633126|10914876|FG000|COMPLETED|Overall Study||8
9806304|NCT00633126|10914876|FG000|NOT COMPLETED|Overall Study||1
9806305|NCT00633139|10914883|FG000|STARTED|Overall Study||4
9806306|NCT00633139|10914884|FG001|STARTED|Overall Study||5
9806307|NCT00633139|10914885|FG002|STARTED|Overall Study||4
9806308|NCT00633139|10914883|FG000|COMPLETED|Overall Study||4
9806309|NCT00633139|10914884|FG001|COMPLETED|Overall Study||4
9806310|NCT00633139|10914885|FG002|COMPLETED|Overall Study||3
9806311|NCT00633139|10914883|FG000|NOT COMPLETED|Overall Study||0
9806312|NCT00633139|10914884|FG001|NOT COMPLETED|Overall Study||1
9806313|NCT00633139|10914885|FG002|NOT COMPLETED|Overall Study||1
9806314|NCT00633152|10914895|FG000|STARTED|Overall Study||103
9806315|NCT00633152|10914896|FG001|STARTED|Overall Study||47
9806316|NCT00633152|10914895|FG000|MITT and Safety Population|Overall Study||98
9806317|NCT00633152|10914896|FG001|MITT and Safety Population|Overall Study||45
9806318|NCT00633152|10914895|FG000|Clinically Evaluable Population|Overall Study||86
9806319|NCT00633152|10914896|FG001|Clinically Evaluable Population|Overall Study||39
9806320|NCT00633152|10914895|FG000|COMPLETED|Overall Study||89
9806321|NCT00633152|10914896|FG001|COMPLETED|Overall Study||41
9806322|NCT00633152|10914895|FG000|NOT COMPLETED|Overall Study||14
9806323|NCT00633152|10914896|FG001|NOT COMPLETED|Overall Study||6
9806324|NCT00633217|10914906|FG000|STARTED|Overall Study||121
9806325|NCT00633217|10914907|FG001|STARTED|Overall Study||126
9806326|NCT00633217|10914906|FG000|COMPLETED|Overall Study||106
9806327|NCT00633217|10914907|FG001|COMPLETED|Overall Study||103
9806328|NCT00633217|10914906|FG000|NOT COMPLETED|Overall Study||15
9806329|NCT00633217|10914907|FG001|NOT COMPLETED|Overall Study||23
9806330|NCT00633243|10914915|FG000|STARTED|Overall Study||12
9806331|NCT00633243|10914916|FG001|STARTED|Overall Study||9
9806332|NCT00633243|10914915|FG000|COMPLETED|Overall Study||11
9806333|NCT00633243|10914916|FG001|COMPLETED|Overall Study||2
9806334|NCT00633243|10914915|FG000|NOT COMPLETED|Overall Study||1
9806335|NCT00633243|10914916|FG001|NOT COMPLETED|Overall Study||7
9806336|NCT00633256|10914924|FG000|STARTED|Overall Study||12
9806337|NCT00633256|10914925|FG001|STARTED|Overall Study||13
9806338|NCT00633256|10914924|FG000|COMPLETED|Overall Study||8
9806339|NCT00633256|10914925|FG001|COMPLETED|Overall Study||10
9806340|NCT00633256|10914924|FG000|NOT COMPLETED|Overall Study||4
9806341|NCT00633256|10914925|FG001|NOT COMPLETED|Overall Study||3
9806342|NCT00633360|10914933|FG000|STARTED|Overall Study||16
9806343|NCT00633360|10914934|FG001|STARTED|Overall Study||16
9806344|NCT00633360|10914933|FG000|COMPLETED|Overall Study||12
9806345|NCT00633360|10914934|FG001|COMPLETED|Overall Study||13
9806346|NCT00633360|10914933|FG000|NOT COMPLETED|Overall Study||4
9806347|NCT00633360|10914934|FG001|NOT COMPLETED|Overall Study||3
9806348|NCT00633399|10914944|FG000|STARTED|Overall Study||71
9806349|NCT00633399|10914945|FG001|STARTED|Overall Study||68
9806350|NCT00633399|10914944|FG000|COMPLETED|Overall Study||49
9806351|NCT00633399|10914945|FG001|COMPLETED|Overall Study||53
9806352|NCT00633399|10914944|FG000|NOT COMPLETED|Overall Study||22
9806353|NCT00633399|10914945|FG001|NOT COMPLETED|Overall Study||15
9806354|NCT00633464|10914953|FG000|STARTED|Overall Study||40
9806355|NCT00633464|10914954|FG001|STARTED|Overall Study||39
9806356|NCT00633464|10914953|FG000|Treated|Overall Study||40
9806357|NCT00633464|10914954|FG001|Treated|Overall Study||37
9806358|NCT00633464|10914953|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
9806359|NCT00633464|10914954|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
9806360|NCT00633464|10914953|FG000|NOT COMPLETED|Overall Study||0
9806361|NCT00633464|10914954|FG001|NOT COMPLETED|Overall Study||2
9806362|NCT00633477|10914962|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
9806363|NCT00633477|10914963|FG001|STARTED|Overall Study||11
9806364|NCT00633477|10914962|FG000|Randomized But Not Treated|Overall Study||1
9806365|NCT00633477|10914963|FG001|Randomized But Not Treated|Overall Study||0
9806366|NCT00633477|10914962|FG000|Prematurely Discontinued Study Drug|Overall Study||1
9806367|NCT00633477|10914963|FG001|Prematurely Discontinued Study Drug|Overall Study||0
9806368|NCT00633477|10914962|FG000|Completed Study Through Day 28|Overall Study||4
9806369|NCT00633477|10914963|FG001|Completed Study Through Day 28|Overall Study||8
9806370|NCT00633477|10914962|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
9806371|NCT00633477|10914963|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
9806372|NCT00633477|10914962|FG000|NOT COMPLETED|Overall Study||2
9806373|NCT00633477|10914963|FG001|NOT COMPLETED|Overall Study||0
9806374|NCT00633594|10914972|FG000|STARTED|Overall Study||5
9806375|NCT00633594|10914973|FG001|STARTED|Overall Study||8
9806376|NCT00633594|10914974|FG002|STARTED|Overall Study||26
9806377|NCT00633594|10914972|FG000|COMPLETED|Overall Study||5
9806378|NCT00633594|10914973|FG001|COMPLETED|Overall Study||3
9806379|NCT00633594|10914974|FG002|COMPLETED|Overall Study||16
9806380|NCT00633594|10914972|FG000|NOT COMPLETED|Overall Study||0
9806381|NCT00633594|10914973|FG001|NOT COMPLETED|Overall Study||5
9806382|NCT00633594|10914974|FG002|NOT COMPLETED|Overall Study||10
9806383|NCT00633750|10914985|FG000|STARTED|Overall Study||47
9806384|NCT00633750|10914985|FG000|COMPLETED|Overall Study||42
9806385|NCT00633750|10914985|FG000|NOT COMPLETED|Overall Study||5
9806386|NCT00633867|10914993|FG000|STARTED|Overall Study||60
9806387|NCT00633867|10914994|FG001|STARTED|Overall Study||60
9806388|NCT00633867|10914993|FG000|COMPLETED|Overall Study||60
9806389|NCT00633867|10914994|FG001|COMPLETED|Overall Study||60
9806390|NCT00633867|10914993|FG000|NOT COMPLETED|Overall Study||0
9806391|NCT00633867|10914994|FG001|NOT COMPLETED|Overall Study||0
9806392|NCT00633880|10915003|FG000|STARTED|Open Label Titration||181
9806393|NCT00633880|10915004|FG001|STARTED|Open Label Titration||0
9806394|NCT00633880|10915005|FG002|STARTED|Open Label Titration||0
9806395|NCT00633880|10915003|FG000|COMPLETED|Open Label Titration||101
9806396|NCT00633880|10915004|FG001|COMPLETED|Open Label Titration||0
9806397|NCT00633880|10915005|FG002|COMPLETED|Open Label Titration||0
9806398|NCT00633880|10915003|FG000|NOT COMPLETED|Open Label Titration||80
9806399|NCT00633880|10915004|FG001|NOT COMPLETED|Open Label Titration||0
9806400|NCT00633880|10915005|FG002|NOT COMPLETED|Open Label Titration||0
9806401|NCT00633880|10915003|FG000|STARTED|Randomized Double Blind||0
9806402|NCT00633880|10915004|FG001|STARTED|Randomized Double Blind||50
9806403|NCT00633880|10915005|FG002|STARTED|Randomized Double Blind||51
9806404|NCT00633880|10915003|FG000|COMPLETED|Randomized Double Blind||0
9806405|NCT00633880|10915004|FG001|COMPLETED|Randomized Double Blind||50
9806406|NCT00633880|10915005|FG002|COMPLETED|Randomized Double Blind||51
9806407|NCT00633880|10915003|FG000|NOT COMPLETED|Randomized Double Blind||0
9806408|NCT00633880|10915004|FG001|NOT COMPLETED|Randomized Double Blind||0
9806409|NCT00633880|10915005|FG002|NOT COMPLETED|Randomized Double Blind||0
9806410|NCT00633893|10915015|FG000|STARTED|Overall Study||840
9806411|NCT00633893|10915016|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
9806412|NCT00633893|10915017|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
9806413|NCT00633893|10915015|FG000|COMPLETED|Overall Study||726
10235350|NCT01194856|11365641|FG000|NOT COMPLETED|Overall Study||1
10235351|NCT01194856|11365642|FG001|NOT COMPLETED|Overall Study||0
10235352|NCT01194427|11365648|FG000|STARTED|Overall Study||2
10235353|NCT01194427|11365648|FG000|COMPLETED|Overall Study||2
10235354|NCT01194427|11365648|FG000|NOT COMPLETED|Overall Study||0
10235355|NCT01193556|11365654|FG000|STARTED|Overall Study||26
9806414|NCT00633893|10915016|FG001|COMPLETED|Overall Study||684
9806415|NCT00633893|10915017|FG002|COMPLETED|Overall Study||641
9806416|NCT00633893|10915015|FG000|NOT COMPLETED|Overall Study||114
9806417|NCT00633893|10915016|FG001|NOT COMPLETED|Overall Study||129
9806418|NCT00633893|10915017|FG002|NOT COMPLETED|Overall Study||188
9806419|NCT00633919|10915027|FG000|STARTED|Overall Study||63
9806420|NCT00633919|10915028|FG001|STARTED|Overall Study||61
9806421|NCT00633919|10915027|FG000|COMPLETED|Overall Study||36
9806422|NCT00633919|10915028|FG001|COMPLETED|Overall Study||39
9806423|NCT00633919|10915027|FG000|NOT COMPLETED|Overall Study||27
9806424|NCT00633919|10915028|FG001|NOT COMPLETED|Overall Study||22
9806425|NCT00633932|10915037|FG000|STARTED|Overall Study|Randomised|191
9806426|NCT00633932|10915038|FG001|STARTED|Overall Study|Randomised|190
9806427|NCT00633932|10915039|FG002|STARTED|Overall Study|Randomised|191
9806428|NCT00633932|10915037|FG000|COMPLETED|Overall Study||179
9806429|NCT00633932|10915038|FG001|COMPLETED|Overall Study||176
9806430|NCT00633932|10915039|FG002|COMPLETED|Overall Study||180
9806431|NCT00633932|10915037|FG000|NOT COMPLETED|Overall Study||12
9806432|NCT00633932|10915038|FG001|NOT COMPLETED|Overall Study||14
9806433|NCT00633932|10915039|FG002|NOT COMPLETED|Overall Study||11
9806434|NCT00633945|10915047|FG000|STARTED|Overall Study||5
9806435|NCT00633945|10915047|FG000|COMPLETED|Overall Study||3
9806436|NCT00633945|10915047|FG000|NOT COMPLETED|Overall Study||2
9806437|NCT00633984|10915055|FG000|STARTED|Overall Study||87
9806438|NCT00633984|10915056|FG001|STARTED|Overall Study||82
9806439|NCT00633984|10915055|FG000|COMPLETED|Overall Study||78
9806440|NCT00633984|10915056|FG001|COMPLETED|Overall Study||69
9806441|NCT00633984|10915055|FG000|NOT COMPLETED|Overall Study||9
9806442|NCT00633984|10915056|FG001|NOT COMPLETED|Overall Study||13
9806443|NCT00634036|10915064|FG000|STARTED|Overall Study||12
9806444|NCT00634036|10915065|FG001|STARTED|Overall Study||11
9806445|NCT00634036|10915064|FG000|COMPLETED|Overall Study||10
9806446|NCT00634036|10915065|FG001|COMPLETED|Overall Study||9
9806447|NCT00634036|10915064|FG000|NOT COMPLETED|Overall Study||2
9806448|NCT00634036|10915065|FG001|NOT COMPLETED|Overall Study||2
9806449|NCT00634049|10915071|FG000|STARTED|Overall Study||149
9806450|NCT00634049|10915071|FG000|COMPLETED|Overall Study||146
9806451|NCT00634049|10915071|FG000|NOT COMPLETED|Overall Study||3
9806452|NCT00634088|10915108|FG000|STARTED|Time Period 1: Dose Level 1||6
9806453|NCT00634088|10915109|FG001|STARTED|Time Period 1: Dose Level 1||0
9806454|NCT00634088|10915110|FG002|STARTED|Time Period 1: Dose Level 1||0
10016055|NCT01808339|11138997|FG001|COMPLETED|Treatment Period 3 (14 Days)||3
10016056|NCT01808339|11138998|FG002|COMPLETED|Treatment Period 3 (14 Days)||3
10235356|NCT01193556|11365655|FG001|STARTED|Overall Study||25
10235357|NCT01193556|11365654|FG000|COMPLETED|Overall Study||0
9806455|NCT00634088|10915111|FG003|STARTED|Time Period 1: Dose Level 1||0
9806456|NCT00634088|10915108|FG000|COMPLETED|Time Period 1: Dose Level 1||0
9806457|NCT00634088|10915109|FG001|COMPLETED|Time Period 1: Dose Level 1||0
9806458|NCT00634088|10915110|FG002|COMPLETED|Time Period 1: Dose Level 1||0
9806459|NCT00634088|10915111|FG003|COMPLETED|Time Period 1: Dose Level 1||0
10235358|NCT01193556|11365655|FG001|COMPLETED|Overall Study||0
9806460|NCT00634088|10915108|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6
9806461|NCT00634088|10915109|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0
9806462|NCT00634088|10915110|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0
9806463|NCT00634088|10915111|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0
9806464|NCT00634088|10915108|FG000|STARTED|Time Period 2: Dose Level 2||0
10235359|NCT01193556|11365654|FG000|NOT COMPLETED|Overall Study||26
9806465|NCT00634088|10915109|FG001|STARTED|Time Period 2: Dose Level 2||3
9806466|NCT00634088|10915110|FG002|STARTED|Time Period 2: Dose Level 2||0
9806467|NCT00634088|10915111|FG003|STARTED|Time Period 2: Dose Level 2||0
9806468|NCT00634088|10915108|FG000|COMPLETED|Time Period 2: Dose Level 2||0
9806469|NCT00634088|10915109|FG001|COMPLETED|Time Period 2: Dose Level 2||0
9806470|NCT00634088|10915110|FG002|COMPLETED|Time Period 2: Dose Level 2||0
9806471|NCT00634088|10915111|FG003|COMPLETED|Time Period 2: Dose Level 2||0
9806472|NCT00634088|10915108|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0
9806473|NCT00634088|10915109|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3
9806474|NCT00634088|10915110|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0
9806475|NCT00634088|10915111|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0
9806476|NCT00634088|10915108|FG000|STARTED|Time Period 3: Dose Level 3||0
9806477|NCT00634088|10915109|FG001|STARTED|Time Period 3: Dose Level 3||0
9806478|NCT00634088|10915110|FG002|STARTED|Time Period 3: Dose Level 3||1
9806479|NCT00634088|10915111|FG003|STARTED|Time Period 3: Dose Level 3||0
9806480|NCT00634088|10915108|FG000|COMPLETED|Time Period 3: Dose Level 3||0
9806481|NCT00634088|10915109|FG001|COMPLETED|Time Period 3: Dose Level 3||0
9806482|NCT00634088|10915110|FG002|COMPLETED|Time Period 3: Dose Level 3||0
9806483|NCT00634088|10915111|FG003|COMPLETED|Time Period 3: Dose Level 3||0
9806484|NCT00634088|10915108|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0
9806485|NCT00634088|10915109|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0
9806486|NCT00634088|10915110|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1
9806487|NCT00634088|10915111|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0
9806488|NCT00634088|10915108|FG000|STARTED|Time Period 4: Triplet Combination||0
9806489|NCT00634088|10915109|FG001|STARTED|Time Period 4: Triplet Combination||0
9806490|NCT00634088|10915110|FG002|STARTED|Time Period 4: Triplet Combination||0
9806491|NCT00634088|10915111|FG003|STARTED|Time Period 4: Triplet Combination||0
9806492|NCT00634088|10915108|FG000|COMPLETED|Time Period 4: Triplet Combination||0
9806493|NCT00634088|10915109|FG001|COMPLETED|Time Period 4: Triplet Combination||0
9806494|NCT00634088|10915110|FG002|COMPLETED|Time Period 4: Triplet Combination||0
9806495|NCT00634088|10915111|FG003|COMPLETED|Time Period 4: Triplet Combination||0
9806496|NCT00634088|10915108|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0
9806497|NCT00634088|10915109|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0
9806498|NCT00634088|10915110|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0
9806499|NCT00634088|10915111|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0
9806500|NCT00634101|10915123|FG000|STARTED|Overall Study||66
9806501|NCT00634101|10915124|FG001|STARTED|Overall Study||59
9806502|NCT00634101|10915123|FG000|COMPLETED|Overall Study||61
9806503|NCT00634101|10915124|FG001|COMPLETED|Overall Study||56
9806504|NCT00634101|10915123|FG000|NOT COMPLETED|Overall Study||5
9806505|NCT00634101|10915124|FG001|NOT COMPLETED|Overall Study||3
9806506|NCT00634114|10915133|FG000|STARTED|Overall Study|Randomised|188
9806507|NCT00634114|10915134|FG001|STARTED|Overall Study|Randomised|189
9806508|NCT00634114|10915135|FG002|STARTED|Overall Study|Randomised|187
9806509|NCT00634114|10915133|FG000|COMPLETED|Overall Study|Completed|160
9806510|NCT00634114|10915134|FG001|COMPLETED|Overall Study|Completed|154
9806511|NCT00634114|10915135|FG002|COMPLETED|Overall Study|Completed|148
9806512|NCT00634114|10915133|FG000|NOT COMPLETED|Overall Study||28
9806513|NCT00634114|10915134|FG001|NOT COMPLETED|Overall Study||35
9806514|NCT00634114|10915135|FG002|NOT COMPLETED|Overall Study||39
9806515|NCT00634166|10915145|FG000|STARTED|Overall Study||82
9806516|NCT00634166|10915146|FG001|STARTED|Overall Study||138
9806517|NCT00634166|10915145|FG000|COMPLETED|Overall Study||22
9806518|NCT00634166|10915146|FG001|COMPLETED|Overall Study||78
9806519|NCT00634166|10915145|FG000|NOT COMPLETED|Overall Study||60
9806520|NCT00634166|10915146|FG001|NOT COMPLETED|Overall Study||60
9806521|NCT00634179|10915152|FG000|STARTED|Phase I: Induction||19
9806522|NCT00634179|10915152|FG000|COMPLETED|Phase I: Induction||19
9806523|NCT00634179|10915152|FG000|NOT COMPLETED|Phase I: Induction||0
9806524|NCT00634179|10915152|FG000|STARTED|Phase II: Maintenance||30
9806525|NCT00634179|10915152|FG000|COMPLETED|Phase II: Maintenance||29
9806526|NCT00634179|10915152|FG000|NOT COMPLETED|Phase II: Maintenance||1
9806527|NCT00634244|10915162|FG000|STARTED|Overall Study||35
9806528|NCT00634244|10915163|FG001|STARTED|Overall Study||37
9806529|NCT00634244|10915164|FG002|STARTED|Overall Study||20
9806530|NCT00634244|10915162|FG000|Eligible and Treated|Overall Study||35
9806531|NCT00634244|10915163|FG001|Eligible and Treated|Overall Study||36
9806532|NCT00634244|10915164|FG002|Eligible and Treated|Overall Study||20
9806533|NCT00634244|10915162|FG000|COMPLETED|Overall Study||34
9806534|NCT00634244|10915163|FG001|COMPLETED|Overall Study||24
9806535|NCT00634244|10915164|FG002|COMPLETED|Overall Study||20
9806536|NCT00634244|10915162|FG000|NOT COMPLETED|Overall Study||1
9806537|NCT00634244|10915163|FG001|NOT COMPLETED|Overall Study||13
9806538|NCT00634244|10915164|FG002|NOT COMPLETED|Overall Study||0
9806539|NCT00634270|10915174|FG000|STARTED|Overall Study|February 12, 2008|49
9806540|NCT00634270|10915175|FG001|STARTED|Overall Study||13
9806541|NCT00634270|10915174|FG000|COMPLETED|Overall Study||46
9806542|NCT00634270|10915175|FG001|COMPLETED|Overall Study||12
9806543|NCT00634270|10915174|FG000|NOT COMPLETED|Overall Study||3
9806544|NCT00634270|10915175|FG001|NOT COMPLETED|Overall Study||1
9806545|NCT00634283|10915187|FG000|STARTED|Overall Study||6
9806546|NCT00634283|10915187|FG000|COMPLETED|Overall Study||6
9806547|NCT00634283|10915187|FG000|NOT COMPLETED|Overall Study||0
9806548|NCT00634543|10915195|FG000|STARTED|Overall Study||78
9806549|NCT00634543|10915196|FG001|STARTED|Overall Study||84
9806550|NCT00634543|10915195|FG000|Treated|Overall Study||76
9806551|NCT00634543|10915196|FG001|Treated|Overall Study||80
9806552|NCT00634543|10915195|FG000|COMPLETED|Overall Study||59
9806553|NCT00634543|10915196|FG001|COMPLETED|Overall Study||63
9806554|NCT00634543|10915195|FG000|NOT COMPLETED|Overall Study||19
9806555|NCT00634543|10915196|FG001|NOT COMPLETED|Overall Study||21
9806556|NCT00634569|10915204|FG000|STARTED|Overall Study||14
9806557|NCT00634569|10915205|FG001|STARTED|Overall Study||10
9806558|NCT00634569|10915204|FG000|COMPLETED|Overall Study||14
9806559|NCT00634569|10915205|FG001|COMPLETED|Overall Study||5
9806560|NCT00634569|10915204|FG000|NOT COMPLETED|Overall Study||0
9806561|NCT00634569|10915205|FG001|NOT COMPLETED|Overall Study||5
9806562|NCT00634621|10915211|FG000|STARTED|Overall Study||283
9806563|NCT00634621|10915211|FG000|COMPLETED|Overall Study||283
9806564|NCT00634621|10915211|FG000|NOT COMPLETED|Overall Study||0
9806565|NCT00634647|10915219|FG000|STARTED|Overall Study||24
9806566|NCT00634647|10915219|FG000|COMPLETED|Overall Study||17
9806567|NCT00634647|10915219|FG000|NOT COMPLETED|Overall Study||7
9806568|NCT00634751|10915227|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9
9806569|NCT00634751|10915228|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0
9806570|NCT00634751|10915229|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0
9806571|NCT00634751|10915230|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0
9806572|NCT00634751|10915227|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
9806573|NCT00634751|10915228|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
9806574|NCT00634751|10915229|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
9806575|NCT00634751|10915230|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
9806576|NCT00634751|10915227|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
9806577|NCT00634751|10915228|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
9806578|NCT00634751|10915229|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
9806579|NCT00634751|10915230|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
9806580|NCT00634751|10915227|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
9806581|NCT00634751|10915228|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
9806582|NCT00634751|10915229|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
9806583|NCT00634751|10915230|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
9806584|NCT00634751|10915227|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
9806585|NCT00634751|10915228|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
9806586|NCT00634751|10915229|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
9806587|NCT00634751|10915230|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
9806588|NCT00634751|10915227|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
9806589|NCT00634751|10915228|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
9806590|NCT00634751|10915229|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
9806591|NCT00634751|10915230|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
9806592|NCT00634751|10915227|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0
9806593|NCT00634751|10915228|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0
9806594|NCT00634751|10915229|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24
9806595|NCT00634751|10915230|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8
9806596|NCT00634751|10915227|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0
9806597|NCT00634751|10915228|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0
9806598|NCT00634751|10915229|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23
9806599|NCT00634751|10915230|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7
9806600|NCT00634751|10915227|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
9806601|NCT00634751|10915228|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
9806602|NCT00634751|10915229|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
9806603|NCT00634751|10915230|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
9806604|NCT00634803|10915243|FG000|STARTED|Overall Study||30
9806605|NCT00634803|10915244|FG001|STARTED|Overall Study||30
9806606|NCT00634803|10915245|FG002|STARTED|Overall Study||30
9806607|NCT00634803|10915243|FG000|Month 1|Overall Study||29
9806608|NCT00634803|10915244|FG001|Month 1|Overall Study||29
9806609|NCT00634803|10915245|FG002|Month 1|Overall Study||29
9806610|NCT00634803|10915243|FG000|Month 2|Overall Study||26
9806611|NCT00634803|10915244|FG001|Month 2|Overall Study||26
9806612|NCT00634803|10915245|FG002|Month 2|Overall Study||28
9806613|NCT00634803|10915243|FG000|Month 3|Overall Study||25
9806614|NCT00634803|10915244|FG001|Month 3|Overall Study||23
9806615|NCT00634803|10915245|FG002|Month 3|Overall Study||26
9806616|NCT00634803|10915243|FG000|COMPLETED|Overall Study||24
9806617|NCT00634803|10915244|FG001|COMPLETED|Overall Study||23
9806618|NCT00634803|10915245|FG002|COMPLETED|Overall Study||23
9806619|NCT00634803|10915243|FG000|NOT COMPLETED|Overall Study||6
9806620|NCT00634803|10915244|FG001|NOT COMPLETED|Overall Study||7
9806621|NCT00634803|10915245|FG002|NOT COMPLETED|Overall Study||7
9806622|NCT00634842|10915255|FG000|STARTED|Overall Study||122
9806623|NCT00634842|10915256|FG001|STARTED|Overall Study||122
9806624|NCT00634842|10915255|FG000|COMPLETED|Overall Study||107
9806625|NCT00634842|10915256|FG001|COMPLETED|Overall Study||104
9806626|NCT00634842|10915255|FG000|NOT COMPLETED|Overall Study||15
9806627|NCT00634842|10915256|FG001|NOT COMPLETED|Overall Study||18
9806628|NCT00634907|10915264|FG000|STARTED|Overall Study||131
9806629|NCT00634907|10915265|FG001|STARTED|Overall Study||132
9806630|NCT00634907|10915264|FG000|COMPLETED|Overall Study||114
9806631|NCT00634907|10915265|FG001|COMPLETED|Overall Study||115
9806632|NCT00634907|10915264|FG000|NOT COMPLETED|Overall Study||17
9806633|NCT00634907|10915265|FG001|NOT COMPLETED|Overall Study||17
9806634|NCT00634920|10915274|FG000|STARTED|Period 1 - Pre-Randomization||0
9806635|NCT00634920|10915275|FG001|STARTED|Period 1 - Pre-Randomization||0
9806636|NCT00634920|10915276|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
9806637|NCT00634920|10915274|FG000|COMPLETED|Period 1 - Pre-Randomization||0
9806638|NCT00634920|10915275|FG001|COMPLETED|Period 1 - Pre-Randomization||0
9806639|NCT00634920|10915276|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
9806640|NCT00634920|10915274|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0
9806641|NCT00634920|10915275|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0
9806642|NCT00634920|10915276|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137
9806643|NCT00634920|10915274|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
9806644|NCT00634920|10915275|FG001|STARTED|Period 2 - Post-Randomization||100
9806645|NCT00634920|10915276|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
9806646|NCT00634920|10915274|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
9806647|NCT00634920|10915275|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
9806648|NCT00634920|10915276|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
9806649|NCT00634920|10915274|FG000|COMPLETED|Period 2 - Post-Randomization||43
9806650|NCT00634920|10915275|FG001|COMPLETED|Period 2 - Post-Randomization||68
9806651|NCT00634920|10915276|FG002|COMPLETED|Period 2 - Post-Randomization||0
9806652|NCT00634920|10915274|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61
9806653|NCT00634920|10915275|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32
9806654|NCT00634920|10915276|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0
9806655|NCT00634933|10915285|FG000|STARTED|Part A: Baseline to Week 24||74
9806656|NCT00634933|10915286|FG001|STARTED|Part A: Baseline to Week 24||75
9806657|NCT00634933|10915287|FG002|STARTED|Part A: Baseline to Week 24||73
9806658|NCT00634933|10915288|FG003|STARTED|Part A: Baseline to Week 24||0
9806659|NCT00634933|10915289|FG004|STARTED|Part A: Baseline to Week 24||0
9806660|NCT00634933|10915285|FG000|COMPLETED|Part A: Baseline to Week 24||63
9806661|NCT00634933|10915286|FG001|COMPLETED|Part A: Baseline to Week 24||57
9806662|NCT00634933|10915287|FG002|COMPLETED|Part A: Baseline to Week 24||55
9806663|NCT00634933|10915288|FG003|COMPLETED|Part A: Baseline to Week 24||0
9806664|NCT00634933|10915289|FG004|COMPLETED|Part A: Baseline to Week 24||0
9806665|NCT00634933|10915285|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11
9806666|NCT00634933|10915286|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18
9806667|NCT00634933|10915287|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18
9806668|NCT00634933|10915288|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0
9806669|NCT00634933|10915289|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0
9806670|NCT00634933|10915285|FG000|STARTED|Between Part A and Part B||0
9806671|NCT00634933|10915286|FG001|STARTED|Between Part A and Part B||57
10016057|NCT01808339|11138999|FG003|COMPLETED|Treatment Period 3 (14 Days)||2
10016058|NCT01808339|11139000|FG004|COMPLETED|Treatment Period 3 (14 Days)||4
10016059|NCT01808339|11139001|FG005|COMPLETED|Treatment Period 3 (14 Days)||5
10016060|NCT01808339|11138996|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10016061|NCT01808339|11138997|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10016062|NCT01808339|11138998|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10016063|NCT01808339|11138999|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10016064|NCT01808339|11139000|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10016065|NCT01808339|11139001|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10016066|NCT01808508|11139012|FG000|STARTED|Overall Study||11
9806672|NCT00634933|10915287|FG002|STARTED|Between Part A and Part B||55
9806673|NCT00634933|10915288|FG003|STARTED|Between Part A and Part B||31
9806674|NCT00634933|10915289|FG004|STARTED|Between Part A and Part B||32
9806675|NCT00634933|10915285|FG000|COMPLETED|Between Part A and Part B||0
9806676|NCT00634933|10915286|FG001|COMPLETED|Between Part A and Part B||56
9806677|NCT00634933|10915287|FG002|COMPLETED|Between Part A and Part B||55
9806678|NCT00634933|10915288|FG003|COMPLETED|Between Part A and Part B||31
9806679|NCT00634933|10915289|FG004|COMPLETED|Between Part A and Part B||32
9806680|NCT00634933|10915285|FG000|NOT COMPLETED|Between Part A and Part B||0
9806681|NCT00634933|10915286|FG001|NOT COMPLETED|Between Part A and Part B||1
9806682|NCT00634933|10915287|FG002|NOT COMPLETED|Between Part A and Part B||0
9806683|NCT00634933|10915288|FG003|NOT COMPLETED|Between Part A and Part B||0
9806684|NCT00634933|10915289|FG004|NOT COMPLETED|Between Part A and Part B||0
9806685|NCT00634933|10915285|FG000|STARTED|Part B: Week 24 to Week 52||0
9806686|NCT00634933|10915286|FG001|STARTED|Part B: Week 24 to Week 52||56
9806687|NCT00634933|10915287|FG002|STARTED|Part B: Week 24 to Week 52||55
9806688|NCT00634933|10915288|FG003|STARTED|Part B: Week 24 to Week 52||31
9806689|NCT00634933|10915289|FG004|STARTED|Part B: Week 24 to Week 52||32
9806690|NCT00634933|10915285|FG000|COMPLETED|Part B: Week 24 to Week 52||0
9806691|NCT00634933|10915286|FG001|COMPLETED|Part B: Week 24 to Week 52||42
9806692|NCT00634933|10915287|FG002|COMPLETED|Part B: Week 24 to Week 52||33
9806693|NCT00634933|10915288|FG003|COMPLETED|Part B: Week 24 to Week 52||25
9806694|NCT00634933|10915289|FG004|COMPLETED|Part B: Week 24 to Week 52||22
9806695|NCT00634933|10915285|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0
9806696|NCT00634933|10915286|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14
9806697|NCT00634933|10915287|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22
9806698|NCT00634933|10915288|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6
9806699|NCT00634933|10915289|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10
9806700|NCT00635024|10915301|FG000|STARTED|Overall Study||1
10016067|NCT01808508|11139013|FG001|STARTED|Overall Study||9
9806701|NCT00635024|10915301|FG000|COMPLETED|Overall Study||0
9806702|NCT00635024|10915301|FG000|NOT COMPLETED|Overall Study||1
9806703|NCT00635050|10915305|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
9806704|NCT00635050|10915305|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31
9806705|NCT00635050|10915305|FG000|NOT COMPLETED|Overall Study||1
9806706|NCT00635089|10915312|FG000|STARTED|Overall Study||190
9806707|NCT00635089|10915312|FG000|Completed >/= 16 Weeks of Study|Overall Study||181
9806708|NCT00635089|10915312|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
9806709|NCT00635089|10915312|FG000|NOT COMPLETED|Overall Study||78
9806710|NCT00635102|10915331|FG000|STARTED|Overall Study||27
9806711|NCT00635102|10915332|FG001|STARTED|Overall Study||30
9806712|NCT00635102|10915331|FG000|COMPLETED|Overall Study||20
9806713|NCT00635102|10915332|FG001|COMPLETED|Overall Study||22
9806714|NCT00635102|10915331|FG000|NOT COMPLETED|Overall Study||7
9806715|NCT00635102|10915332|FG001|NOT COMPLETED|Overall Study||8
9806716|NCT00635128|10915340|FG000|STARTED|Overall Study||351
9806717|NCT00635128|10915341|FG001|STARTED|Overall Study||64
9806718|NCT00635128|10915340|FG000|COMPLETED|Overall Study||351
9806719|NCT00635128|10915341|FG001|COMPLETED|Overall Study||64
9806720|NCT00635128|10915340|FG000|NOT COMPLETED|Overall Study||0
9806721|NCT00635128|10915341|FG001|NOT COMPLETED|Overall Study||0
9806722|NCT00635154|10915349|FG000|STARTED|Overall Study||54
9806723|NCT00635154|10915349|FG000|COMPLETED|Overall Study||21
9806724|NCT00635154|10915349|FG000|NOT COMPLETED|Overall Study||33
9806725|NCT00635219|10915360|FG000|STARTED|Overall Study||148
9806726|NCT00635219|10915361|FG001|STARTED|Overall Study||155
9806727|NCT00635219|10915362|FG002|STARTED|Overall Study||157
9806728|NCT00635219|10915363|FG003|STARTED|Overall Study||151
9806729|NCT00635219|10915364|FG004|STARTED|Overall Study||155
9806730|NCT00635219|10915360|FG000|COMPLETED|Overall Study||123
9806731|NCT00635219|10915361|FG001|COMPLETED|Overall Study||130
9806732|NCT00635219|10915362|FG002|COMPLETED|Overall Study||122
9806733|NCT00635219|10915363|FG003|COMPLETED|Overall Study||117
9806734|NCT00635219|10915364|FG004|COMPLETED|Overall Study||113
9806735|NCT00635219|10915360|FG000|NOT COMPLETED|Overall Study||25
9806736|NCT00635219|10915361|FG001|NOT COMPLETED|Overall Study||25
9806737|NCT00635219|10915362|FG002|NOT COMPLETED|Overall Study||35
9806738|NCT00635219|10915363|FG003|NOT COMPLETED|Overall Study||34
9806739|NCT00635219|10915364|FG004|NOT COMPLETED|Overall Study||42
9806740|NCT00635232|10915381|FG000|STARTED|Overall Study||58
9806741|NCT00635232|10915382|FG001|STARTED|Overall Study||59
9806742|NCT00635232|10915383|FG002|STARTED|Overall Study||58
9806743|NCT00635232|10915384|FG003|STARTED|Overall Study||58
9806744|NCT00635232|10915385|FG004|STARTED|Overall Study||28
9806745|NCT00635232|10915381|FG000|COMPLETED|Overall Study||44
9806746|NCT00635232|10915382|FG001|COMPLETED|Overall Study||39
9806747|NCT00635232|10915383|FG002|COMPLETED|Overall Study||55
9806748|NCT00635232|10915384|FG003|COMPLETED|Overall Study||48
9806749|NCT00635232|10915385|FG004|COMPLETED|Overall Study||20
9806750|NCT00635232|10915381|FG000|NOT COMPLETED|Overall Study||14
9806751|NCT00635232|10915382|FG001|NOT COMPLETED|Overall Study||20
9806752|NCT00635232|10915383|FG002|NOT COMPLETED|Overall Study||3
9806753|NCT00635232|10915384|FG003|NOT COMPLETED|Overall Study||10
9806754|NCT00635232|10915385|FG004|NOT COMPLETED|Overall Study||8
9806755|NCT00635349|10915399|FG000|STARTED|Overall Study||73
9806756|NCT00635349|10915400|FG001|STARTED|Overall Study||67
9806757|NCT00635349|10915399|FG000|COMPLETED|Overall Study||29
9806758|NCT00635349|10915400|FG001|COMPLETED|Overall Study||19
10016068|NCT01808508|11139014|FG002|STARTED|Overall Study||3
10016069|NCT01808508|11139012|FG000|COMPLETED|Overall Study||10
9806759|NCT00635349|10915399|FG000|NOT COMPLETED|Overall Study||44
9806760|NCT00635349|10915400|FG001|NOT COMPLETED|Overall Study||48
9806761|NCT00635362|10915408|FG000|STARTED|Overall Study||22
9806762|NCT00635362|10915409|FG001|STARTED|Overall Study||20
9806763|NCT00635362|10915408|FG000|COMPLETED|Overall Study||9
9806764|NCT00635362|10915409|FG001|COMPLETED|Overall Study||12
9806765|NCT00635362|10915408|FG000|NOT COMPLETED|Overall Study||13
9806766|NCT00635362|10915409|FG001|NOT COMPLETED|Overall Study||8
9806767|NCT00635427|10915420|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
9806768|NCT00635427|10915421|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
9806769|NCT00635427|10915422|FG002|STARTED|Overall Study||16
9806770|NCT00635427|10915423|FG003|STARTED|Overall Study||16
9806771|NCT00635427|10915424|FG004|STARTED|Overall Study||38
9806772|NCT00635427|10915420|FG000|COMPLETED|Overall Study||1
9806773|NCT00635427|10915421|FG001|COMPLETED|Overall Study||6
9806774|NCT00635427|10915422|FG002|COMPLETED|Overall Study||5
9806775|NCT00635427|10915423|FG003|COMPLETED|Overall Study||7
9806776|NCT00635427|10915424|FG004|COMPLETED|Overall Study||30
9806777|NCT00635427|10915420|FG000|NOT COMPLETED|Overall Study||12
9806778|NCT00635427|10915421|FG001|NOT COMPLETED|Overall Study||6
9806779|NCT00635427|10915422|FG002|NOT COMPLETED|Overall Study||11
9806780|NCT00635427|10915423|FG003|NOT COMPLETED|Overall Study||9
9806781|NCT00635427|10915424|FG004|NOT COMPLETED|Overall Study||8
9806782|NCT00635453|10915436|FG000|STARTED|Overall Study||360
9806783|NCT00635453|10915437|FG001|STARTED|Overall Study||355
9806784|NCT00635453|10915436|FG000|6 Months Assessment|Overall Study||322
9806785|NCT00635453|10915437|FG001|6 Months Assessment|Overall Study||311
10016070|NCT01808508|11139013|FG001|COMPLETED|Overall Study||9
10016071|NCT01808508|11139014|FG002|COMPLETED|Overall Study||3
9806786|NCT00635453|10915436|FG000|12 Months Assessment|Overall Study||285
9806787|NCT00635453|10915437|FG001|12 Months Assessment|Overall Study||260
9806788|NCT00635453|10915436|FG000|3 Years Assessment|Overall Study||246
9806789|NCT00635453|10915437|FG001|3 Years Assessment|Overall Study||204
9806790|NCT00635453|10915436|FG000|COMPLETED|Overall Study||206
9806791|NCT00635453|10915437|FG001|COMPLETED|Overall Study||181
9806792|NCT00635453|10915436|FG000|NOT COMPLETED|Overall Study||154
9806793|NCT00635453|10915437|FG001|NOT COMPLETED|Overall Study||174
9806794|NCT00635479|10915445|FG000|STARTED|Overall Study||55
9806795|NCT00635479|10915446|FG001|STARTED|Overall Study||60
9806796|NCT00635479|10915445|FG000|COMPLETED|Overall Study||49
9806797|NCT00635479|10915446|FG001|COMPLETED|Overall Study||42
9806798|NCT00635479|10915445|FG000|NOT COMPLETED|Overall Study||6
9806799|NCT00635479|10915446|FG001|NOT COMPLETED|Overall Study||18
9806800|NCT00635492|10915454|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114
9806801|NCT00635492|10915455|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274
9806802|NCT00635492|10915454|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
9806803|NCT00635492|10915455|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
9806804|NCT00635492|10915454|FG000|NOT COMPLETED|Overall Study||279
9806805|NCT00635492|10915455|FG001|NOT COMPLETED|Overall Study||282
9806806|NCT00635570|10915467|FG000|STARTED|Overall Study||136
9806807|NCT00635570|10915468|FG001|STARTED|Overall Study||137
9806808|NCT00635570|10915467|FG000|COMPLETED|Overall Study||121
9806809|NCT00635570|10915468|FG001|COMPLETED|Overall Study||126
9806810|NCT00635570|10915467|FG000|NOT COMPLETED|Overall Study||15
9806811|NCT00635570|10915468|FG001|NOT COMPLETED|Overall Study||11
9806812|NCT00635609|10915476|FG000|STARTED|Overall Study||48
9806813|NCT00635609|10915477|FG001|STARTED|Overall Study||45
9806814|NCT00635609|10915476|FG000|COMPLETED|Overall Study||41
9806815|NCT00635609|10915477|FG001|COMPLETED|Overall Study||42
9806816|NCT00635609|10915476|FG000|NOT COMPLETED|Overall Study||7
9806817|NCT00635609|10915477|FG001|NOT COMPLETED|Overall Study||3
9806818|NCT00635648|10915483|FG000|STARTED|Overall Study||63
9806819|NCT00635648|10915483|FG000|COMPLETED|Overall Study||26
9806820|NCT00635648|10915483|FG000|NOT COMPLETED|Overall Study||37
9806821|NCT00635661|10915487|FG000|STARTED|Overall Study||34
9806822|NCT00635661|10915487|FG000|COMPLETED|Overall Study||30
9806823|NCT00635661|10915487|FG000|NOT COMPLETED|Overall Study||4
9806824|NCT00635700|10915493|FG000|STARTED|Overall Study||24
9806825|NCT00635700|10915494|FG001|STARTED|Overall Study||27
9806826|NCT00635700|10915493|FG000|COMPLETED|Overall Study||9
9806827|NCT00635700|10915494|FG001|COMPLETED|Overall Study||13
9806828|NCT00635700|10915493|FG000|NOT COMPLETED|Overall Study||15
9806829|NCT00635700|10915494|FG001|NOT COMPLETED|Overall Study||14
9806830|NCT00635739|10915502|FG000|STARTED|Overall Study||42
9806831|NCT00635739|10915503|FG001|STARTED|Overall Study||38
9806832|NCT00635739|10915502|FG000|COMPLETED|Overall Study||39
9806833|NCT00635739|10915503|FG001|COMPLETED|Overall Study||36
9806834|NCT00635739|10915502|FG000|NOT COMPLETED|Overall Study||3
9806835|NCT00635739|10915503|FG001|NOT COMPLETED|Overall Study||2
9806836|NCT00635778|10915516|FG000|STARTED|Overall Study||1
9806837|NCT00635778|10915517|FG001|STARTED|Overall Study||3
9806838|NCT00635778|10915518|FG002|STARTED|Overall Study||3
9806839|NCT00635778|10915519|FG003|STARTED|Overall Study||8
9806840|NCT00635778|10915520|FG004|STARTED|Overall Study||8
9806841|NCT00635778|10915521|FG005|STARTED|Overall Study||21
9806842|NCT00635778|10915522|FG006|STARTED|Overall Study||6
9806843|NCT00635778|10915516|FG000|COMPLETED|Overall Study||0
9806844|NCT00635778|10915517|FG001|COMPLETED|Overall Study||0
9806845|NCT00635778|10915518|FG002|COMPLETED|Overall Study||0
9806846|NCT00635778|10915519|FG003|COMPLETED|Overall Study||0
10016072|NCT01808508|11139012|FG000|NOT COMPLETED|Overall Study||1
10016073|NCT01808508|11139013|FG001|NOT COMPLETED|Overall Study||0
10016074|NCT01808508|11139014|FG002|NOT COMPLETED|Overall Study||0
10016075|NCT01808534|11139022|FG000|STARTED|Overall Study||5
9806847|NCT00635778|10915520|FG004|COMPLETED|Overall Study||0
9806848|NCT00635778|10915521|FG005|COMPLETED|Overall Study||0
9806849|NCT00635778|10915522|FG006|COMPLETED|Overall Study||0
9806850|NCT00635778|10915516|FG000|NOT COMPLETED|Overall Study||1
9806851|NCT00635778|10915517|FG001|NOT COMPLETED|Overall Study||3
10016076|NCT01808534|11139022|FG000|COMPLETED|Overall Study||1
9806852|NCT00635778|10915518|FG002|NOT COMPLETED|Overall Study||3
9806853|NCT00635778|10915519|FG003|NOT COMPLETED|Overall Study||8
9806854|NCT00635778|10915520|FG004|NOT COMPLETED|Overall Study||8
9806855|NCT00635778|10915521|FG005|NOT COMPLETED|Overall Study||21
9806856|NCT00635778|10915522|FG006|NOT COMPLETED|Overall Study||6
9806857|NCT00635804|10915547|FG000|STARTED|Overall Study||7
9806858|NCT00635804|10915548|FG001|STARTED|Overall Study||6
9806859|NCT00635804|10915549|FG002|STARTED|Overall Study||6
9806860|NCT00635804|10915550|FG003|STARTED|Overall Study||6
9806861|NCT00635804|10915551|FG004|STARTED|Overall Study||6
9806862|NCT00635804|10915552|FG005|STARTED|Overall Study||12
9806863|NCT00635804|10915553|FG006|STARTED|Overall Study||3
9806864|NCT00635804|10915554|FG007|STARTED|Overall Study||14
9806865|NCT00635804|10915547|FG000|COMPLETED|Overall Study||6
9806866|NCT00635804|10915548|FG001|COMPLETED|Overall Study||6
9806867|NCT00635804|10915549|FG002|COMPLETED|Overall Study||6
9806868|NCT00635804|10915550|FG003|COMPLETED|Overall Study||6
9806869|NCT00635804|10915551|FG004|COMPLETED|Overall Study||6
9806870|NCT00635804|10915552|FG005|COMPLETED|Overall Study||11
9806871|NCT00635804|10915553|FG006|COMPLETED|Overall Study||3
9806872|NCT00635804|10915554|FG007|COMPLETED|Overall Study||14
9806873|NCT00635804|10915547|FG000|NOT COMPLETED|Overall Study||1
9806874|NCT00635804|10915548|FG001|NOT COMPLETED|Overall Study||0
9806875|NCT00635804|10915549|FG002|NOT COMPLETED|Overall Study||0
9806876|NCT00635804|10915550|FG003|NOT COMPLETED|Overall Study||0
9806877|NCT00635804|10915551|FG004|NOT COMPLETED|Overall Study||0
9806878|NCT00635804|10915552|FG005|NOT COMPLETED|Overall Study||1
9806879|NCT00635804|10915553|FG006|NOT COMPLETED|Overall Study||0
9806880|NCT00635804|10915554|FG007|NOT COMPLETED|Overall Study||0
9806881|NCT00635817|10915579|FG000|STARTED|Overall Study||21
9806882|NCT00635817|10915580|FG001|STARTED|Overall Study||21
9806883|NCT00635817|10915581|FG002|STARTED|Overall Study||21
9806884|NCT00635817|10915582|FG003|STARTED|Overall Study||21
9806885|NCT00635817|10915579|FG000|COMPLETED|Overall Study||15
9806886|NCT00635817|10915580|FG001|COMPLETED|Overall Study||19
9806887|NCT00635817|10915581|FG002|COMPLETED|Overall Study||19
9806888|NCT00635817|10915582|FG003|COMPLETED|Overall Study||21
9806889|NCT00635817|10915579|FG000|NOT COMPLETED|Overall Study||6
9806890|NCT00635817|10915580|FG001|NOT COMPLETED|Overall Study||2
10016077|NCT01808534|11139022|FG000|NOT COMPLETED|Overall Study||4
10016078|NCT01808547|11139028|FG000|STARTED|Overall Study||174
10016079|NCT01808547|11139029|FG001|STARTED|Overall Study||94
9806891|NCT00635817|10915581|FG002|NOT COMPLETED|Overall Study||2
9806892|NCT00635817|10915582|FG003|NOT COMPLETED|Overall Study||0
9806893|NCT00635830|10915596|FG000|STARTED|Overall Study||20
9806894|NCT00635830|10915597|FG001|STARTED|Overall Study||20
9806895|NCT00635830|10915596|FG000|COMPLETED|Overall Study||20
9806896|NCT00635830|10915597|FG001|COMPLETED|Overall Study||20
9806897|NCT00635830|10915596|FG000|NOT COMPLETED|Overall Study||0
9806898|NCT00635830|10915597|FG001|NOT COMPLETED|Overall Study||0
9806899|NCT00635999|10915606|FG000|STARTED|Overall Study||27
9806900|NCT00635999|10915607|FG001|STARTED|Overall Study||25
9806901|NCT00635999|10915608|FG002|STARTED|Overall Study||24
9806902|NCT00635999|10915606|FG000|COMPLETED|Overall Study||23
9806903|NCT00635999|10915607|FG001|COMPLETED|Overall Study||23
9806904|NCT00635999|10915608|FG002|COMPLETED|Overall Study||23
9806905|NCT00635999|10915606|FG000|NOT COMPLETED|Overall Study||4
9806906|NCT00635999|10915607|FG001|NOT COMPLETED|Overall Study||2
9806907|NCT00635999|10915608|FG002|NOT COMPLETED|Overall Study||1
9806908|NCT00636077|10915616|FG000|STARTED|Week 1||3
9806909|NCT00636077|10915617|FG001|STARTED|Week 1||3
9806910|NCT00636077|10915618|FG002|STARTED|Week 1||3
9806911|NCT00636077|10915619|FG003|STARTED|Week 1||3
9806912|NCT00636077|10915616|FG000|COMPLETED|Week 1||3
9806913|NCT00636077|10915617|FG001|COMPLETED|Week 1||3
9806914|NCT00636077|10915618|FG002|COMPLETED|Week 1||3
9806915|NCT00636077|10915619|FG003|COMPLETED|Week 1||3
9806916|NCT00636077|10915616|FG000|NOT COMPLETED|Week 1||0
9806917|NCT00636077|10915617|FG001|NOT COMPLETED|Week 1||0
9806918|NCT00636077|10915618|FG002|NOT COMPLETED|Week 1||0
9806919|NCT00636077|10915619|FG003|NOT COMPLETED|Week 1||0
9806920|NCT00636077|10915616|FG000|STARTED|Week 2||3
9806921|NCT00636077|10915617|FG001|STARTED|Week 2||3
9806922|NCT00636077|10915618|FG002|STARTED|Week 2||3
9806923|NCT00636077|10915619|FG003|STARTED|Week 2||3
9806924|NCT00636077|10915616|FG000|COMPLETED|Week 2||3
9806925|NCT00636077|10915617|FG001|COMPLETED|Week 2||3
9806926|NCT00636077|10915618|FG002|COMPLETED|Week 2||3
9806927|NCT00636077|10915619|FG003|COMPLETED|Week 2||3
9806928|NCT00636077|10915616|FG000|NOT COMPLETED|Week 2||0
9806929|NCT00636077|10915617|FG001|NOT COMPLETED|Week 2||0
9806930|NCT00636077|10915618|FG002|NOT COMPLETED|Week 2||0
9806931|NCT00636077|10915619|FG003|NOT COMPLETED|Week 2||0
9806932|NCT00636077|10915616|FG000|STARTED|Week 3||3
9806933|NCT00636077|10915617|FG001|STARTED|Week 3||3
9806934|NCT00636077|10915618|FG002|STARTED|Week 3||3
9806935|NCT00636077|10915619|FG003|STARTED|Week 3||3
9806936|NCT00636077|10915616|FG000|COMPLETED|Week 3||3
9806937|NCT00636077|10915617|FG001|COMPLETED|Week 3||3
9806938|NCT00636077|10915618|FG002|COMPLETED|Week 3||3
9806939|NCT00636077|10915619|FG003|COMPLETED|Week 3||3
9806940|NCT00636077|10915616|FG000|NOT COMPLETED|Week 3||0
9806941|NCT00636077|10915617|FG001|NOT COMPLETED|Week 3||0
9806942|NCT00636077|10915618|FG002|NOT COMPLETED|Week 3||0
9806943|NCT00636077|10915619|FG003|NOT COMPLETED|Week 3||0
9806944|NCT00636077|10915616|FG000|STARTED|Week 4||3
9806945|NCT00636077|10915617|FG001|STARTED|Week 4||3
9806946|NCT00636077|10915618|FG002|STARTED|Week 4||3
9806947|NCT00636077|10915619|FG003|STARTED|Week 4||3
9806948|NCT00636077|10915616|FG000|COMPLETED|Week 4||3
9806949|NCT00636077|10915617|FG001|COMPLETED|Week 4||3
9806950|NCT00636077|10915618|FG002|COMPLETED|Week 4||3
9806951|NCT00636077|10915619|FG003|COMPLETED|Week 4||3
9806952|NCT00636077|10915616|FG000|NOT COMPLETED|Week 4||0
9806953|NCT00636077|10915617|FG001|NOT COMPLETED|Week 4||0
10016080|NCT01808547|11139028|FG000|Safety Population|Overall Study||170
9806954|NCT00636077|10915618|FG002|NOT COMPLETED|Week 4||0
9806955|NCT00636077|10915619|FG003|NOT COMPLETED|Week 4||0
9806956|NCT00636155|10915629|FG000|STARTED|Overall Study||20
9806957|NCT00636155|10915629|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
9806958|NCT00636155|10915629|FG000|NOT COMPLETED|Overall Study||18
9806959|NCT00636168|10915635|FG000|STARTED|Randomized to Study Drug||475
9806960|NCT00636168|10915636|FG001|STARTED|Randomized to Study Drug||476
9806961|NCT00636168|10915635|FG000|COMPLETED|Randomized to Study Drug||471
9806962|NCT00636168|10915636|FG001|COMPLETED|Randomized to Study Drug||474
9806963|NCT00636168|10915635|FG000|NOT COMPLETED|Randomized to Study Drug||4
9806964|NCT00636168|10915636|FG001|NOT COMPLETED|Randomized to Study Drug||2
9806965|NCT00636168|10915635|FG000|STARTED|Treated With Study Drug||471
9806966|NCT00636168|10915636|FG001|STARTED|Treated With Study Drug||474
9806967|NCT00636168|10915635|FG000|COMPLETED|Treated With Study Drug||63
9806968|NCT00636168|10915636|FG001|COMPLETED|Treated With Study Drug||143
9806969|NCT00636168|10915635|FG000|NOT COMPLETED|Treated With Study Drug||408
9806970|NCT00636168|10915636|FG001|NOT COMPLETED|Treated With Study Drug||331
9806971|NCT00636168|10915635|FG000|STARTED|Long Term Follow-Up||141
9806972|NCT00636168|10915636|FG001|STARTED|Long Term Follow-Up||143
9806973|NCT00636168|10915635|FG000|COMPLETED|Long Term Follow-Up||130
9806974|NCT00636168|10915636|FG001|COMPLETED|Long Term Follow-Up||129
9806975|NCT00636168|10915635|FG000|NOT COMPLETED|Long Term Follow-Up||11
9806976|NCT00636168|10915636|FG001|NOT COMPLETED|Long Term Follow-Up||14
9806977|NCT00636181|10915645|FG000|STARTED|Overall Study||54
9806978|NCT00636181|10915646|FG001|STARTED|Overall Study||53
9806979|NCT00636181|10915647|FG002|STARTED|Overall Study||57
9806980|NCT00636181|10915645|FG000|COMPLETED|Overall Study||46
9806981|NCT00636181|10915646|FG001|COMPLETED|Overall Study||47
9806982|NCT00636181|10915647|FG002|COMPLETED|Overall Study||47
9806983|NCT00636181|10915645|FG000|NOT COMPLETED|Overall Study||8
9806984|NCT00636181|10915646|FG001|NOT COMPLETED|Overall Study||6
9806985|NCT00636181|10915647|FG002|NOT COMPLETED|Overall Study||10
9806986|NCT00636194|10915657|FG000|STARTED|Overall Study||175
9806987|NCT00636194|10915658|FG001|STARTED|Overall Study||175
9806988|NCT00636194|10915657|FG000|COMPLETED|Overall Study||172
9806989|NCT00636194|10915658|FG001|COMPLETED|Overall Study||175
9806990|NCT00636194|10915657|FG000|NOT COMPLETED|Overall Study||3
9806991|NCT00636194|10915658|FG001|NOT COMPLETED|Overall Study||0
9806992|NCT00636207|10915667|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
9806993|NCT00636207|10915668|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
9806994|NCT00636207|10915669|FG002|STARTED|Overall Study||18
9806995|NCT00636207|10915670|FG003|STARTED|Overall Study||6
9806996|NCT00636207|10915671|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
9806997|NCT00636207|10915672|FG005|STARTED|Overall Study||1
9806998|NCT00636207|10915673|FG006|STARTED|Overall Study||3
9806999|NCT00636207|10915667|FG000|COMPLETED|Overall Study||0
9807000|NCT00636207|10915668|FG001|COMPLETED|Overall Study||7
9807001|NCT00636207|10915669|FG002|COMPLETED|Overall Study||18
9807002|NCT00636207|10915670|FG003|COMPLETED|Overall Study||6
9807003|NCT00636207|10915671|FG004|COMPLETED|Overall Study||8
9807004|NCT00636207|10915672|FG005|COMPLETED|Overall Study||1
9807005|NCT00636207|10915673|FG006|COMPLETED|Overall Study||3
9807006|NCT00636207|10915667|FG000|NOT COMPLETED|Overall Study||1
9807007|NCT00636207|10915668|FG001|NOT COMPLETED|Overall Study||1
9807008|NCT00636207|10915669|FG002|NOT COMPLETED|Overall Study||0
9807009|NCT00636207|10915670|FG003|NOT COMPLETED|Overall Study||0
9807010|NCT00636207|10915671|FG004|NOT COMPLETED|Overall Study||1
9807011|NCT00636207|10915672|FG005|NOT COMPLETED|Overall Study||0
9807012|NCT00636207|10915673|FG006|NOT COMPLETED|Overall Study||0
9807013|NCT00636220|10915694|FG000|STARTED|Overall Study||101
9807014|NCT00636220|10915694|FG000|COMPLETED|Overall Study||101
9807015|NCT00636220|10915694|FG000|NOT COMPLETED|Overall Study||0
9807016|NCT00636363|10915701|FG000|STARTED|Overall Study||178
9807017|NCT00636363|10915702|FG001|STARTED|Overall Study||176
9807018|NCT00636363|10915703|FG002|STARTED|Overall Study||181
9807019|NCT00636363|10915701|FG000|COMPLETED|Overall Study||165
9807020|NCT00636363|10915702|FG001|COMPLETED|Overall Study||156
9807021|NCT00636363|10915703|FG002|COMPLETED|Overall Study||163
9807022|NCT00636363|10915701|FG000|NOT COMPLETED|Overall Study||13
9807023|NCT00636363|10915702|FG001|NOT COMPLETED|Overall Study||20
9807024|NCT00636363|10915703|FG002|NOT COMPLETED|Overall Study||18
9807025|NCT00636389|10915711|FG000|STARTED|Period 1 - 1 Week||7
9807026|NCT00636389|10915712|FG001|STARTED|Period 1 - 1 Week||5
9807027|NCT00636389|10915711|FG000|COMPLETED|Period 1 - 1 Week||7
9807028|NCT00636389|10915712|FG001|COMPLETED|Period 1 - 1 Week||5
9807029|NCT00636389|10915711|FG000|NOT COMPLETED|Period 1 - 1 Week||0
9807030|NCT00636389|10915712|FG001|NOT COMPLETED|Period 1 - 1 Week||0
9807031|NCT00636389|10915711|FG000|STARTED|Period 2 - 1 Week||7
9807032|NCT00636389|10915712|FG001|STARTED|Period 2 - 1 Week||5
9807033|NCT00636389|10915711|FG000|COMPLETED|Period 2 - 1 Week||7
9807034|NCT00636389|10915712|FG001|COMPLETED|Period 2 - 1 Week||5
9807035|NCT00636389|10915711|FG000|NOT COMPLETED|Period 2 - 1 Week||0
9807036|NCT00636389|10915712|FG001|NOT COMPLETED|Period 2 - 1 Week||0
9831511|NCT00768560|10942136|FG004|COMPLETED|Intervention Set 3||6
9831512|NCT00768560|10942137|FG005|COMPLETED|Intervention Set 3||6
9831513|NCT00768560|10942132|FG000|NOT COMPLETED|Intervention Set 3||0
9831514|NCT00768560|10942133|FG001|NOT COMPLETED|Intervention Set 3||0
9831515|NCT00768560|10942134|FG002|NOT COMPLETED|Intervention Set 3||0
9831516|NCT00768560|10942135|FG003|NOT COMPLETED|Intervention Set 3||0
9831517|NCT00768560|10942136|FG004|NOT COMPLETED|Intervention Set 3||0
9831518|NCT00768560|10942137|FG005|NOT COMPLETED|Intervention Set 3||0
9832508|NCT00773370|10943265|FG000|NOT COMPLETED|Overall Study||18
9832509|NCT00773370|10943266|FG001|NOT COMPLETED|Overall Study||10
9832510|NCT00773383|10943272|FG000|STARTED|Overall Study||35
9832511|NCT00773383|10943272|FG000|Received Study Drug|Overall Study||34
9832512|NCT00773383|10943272|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
9832513|NCT00773383|10943272|FG000|NOT COMPLETED|Overall Study||31
9832514|NCT00773422|10943283|FG000|STARTED|Overall Study||11
9807037|NCT00636441|10915725|FG000|STARTED|Overall Study||6
9807038|NCT00636441|10915726|FG001|STARTED|Overall Study||7
9807039|NCT00636441|10915727|FG002|STARTED|Overall Study||6
9807040|NCT00636441|10915728|FG003|STARTED|Overall Study||6
9807041|NCT00636441|10915729|FG004|STARTED|Overall Study||6
9807042|NCT00636441|10915730|FG005|STARTED|Overall Study||7
9807043|NCT00636441|10915731|FG006|STARTED|Overall Study||18
9807044|NCT00636441|10915725|FG000|Assigned Treatment|Overall Study||6
9807045|NCT00636441|10915726|FG001|Assigned Treatment|Overall Study||7
9807046|NCT00636441|10915727|FG002|Assigned Treatment|Overall Study||6
9807047|NCT00636441|10915728|FG003|Assigned Treatment|Overall Study||6
9807048|NCT00636441|10915729|FG004|Assigned Treatment|Overall Study||6
9807049|NCT00636441|10915730|FG005|Assigned Treatment|Overall Study||7
9807050|NCT00636441|10915731|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
9807051|NCT00636441|10915725|FG000|COMPLETED|Overall Study||6
9807052|NCT00636441|10915726|FG001|COMPLETED|Overall Study||6
9807053|NCT00636441|10915727|FG002|COMPLETED|Overall Study||5
9807054|NCT00636441|10915728|FG003|COMPLETED|Overall Study||6
9807055|NCT00636441|10915729|FG004|COMPLETED|Overall Study||6
9807056|NCT00636441|10915730|FG005|COMPLETED|Overall Study||6
9807057|NCT00636441|10915731|FG006|COMPLETED|Overall Study||0
9807058|NCT00636441|10915725|FG000|NOT COMPLETED|Overall Study||0
9807059|NCT00636441|10915726|FG001|NOT COMPLETED|Overall Study||1
9807060|NCT00636441|10915727|FG002|NOT COMPLETED|Overall Study||1
9807061|NCT00636441|10915728|FG003|NOT COMPLETED|Overall Study||0
9807062|NCT00636441|10915729|FG004|NOT COMPLETED|Overall Study||0
9807063|NCT00636441|10915730|FG005|NOT COMPLETED|Overall Study||1
9807064|NCT00636441|10915731|FG006|NOT COMPLETED|Overall Study||18
9807065|NCT00636506|10915742|FG000|STARTED|Overall Study||76
9807066|NCT00636506|10915742|FG000|COMPLETED|Overall Study||60
9807067|NCT00636506|10915742|FG000|NOT COMPLETED|Overall Study||16
9807068|NCT00636610|10915766|FG000|STARTED|Overall Study||98
9807069|NCT00636610|10915767|FG001|STARTED|Overall Study||101
9807070|NCT00636610|10915766|FG000|COMPLETED|Overall Study||6
9807071|NCT00636610|10915767|FG001|COMPLETED|Overall Study||18
9807072|NCT00636610|10915766|FG000|NOT COMPLETED|Overall Study||92
9807073|NCT00636610|10915767|FG001|NOT COMPLETED|Overall Study||83
9807074|NCT00636636|10915777|FG000|STARTED|Overall Study||221
9807075|NCT00636636|10915778|FG001|STARTED|Overall Study||231
9807076|NCT00636636|10915777|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186
9807077|NCT00636636|10915778|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
9807078|NCT00636636|10915777|FG000|379|Overall Study||186
9807079|NCT00636636|10915778|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
9807080|NCT00636636|10915777|FG000|COMPLETED|Overall Study||185
9807081|NCT00636636|10915778|FG001|COMPLETED|Overall Study||192
9807082|NCT00636636|10915777|FG000|NOT COMPLETED|Overall Study||36
9807083|NCT00636636|10915778|FG001|NOT COMPLETED|Overall Study||39
9807084|NCT00636649|10915786|FG000|STARTED|Overall Study||20
9807085|NCT00636649|10915787|FG001|STARTED|Overall Study||20
9807086|NCT00636649|10915786|FG000|COMPLETED|Overall Study||20
9807087|NCT00636649|10915787|FG001|COMPLETED|Overall Study||20
9807088|NCT00636649|10915786|FG000|NOT COMPLETED|Overall Study||0
9807089|NCT00636649|10915787|FG001|NOT COMPLETED|Overall Study||0
9807090|NCT00636675|10915799|FG000|STARTED|Overall Study||951
9807091|NCT00636675|10915800|FG001|STARTED|Overall Study||775
9807092|NCT00636675|10915799|FG000|COMPLETED|Overall Study||811
9807093|NCT00636675|10915800|FG001|COMPLETED|Overall Study||734
9807094|NCT00636675|10915799|FG000|NOT COMPLETED|Overall Study||140
9807095|NCT00636675|10915800|FG001|NOT COMPLETED|Overall Study||41
9807096|NCT00636701|10915808|FG000|STARTED|Overall Study||2
9807097|NCT00636701|10915809|FG001|STARTED|Overall Study||2
9807098|NCT00636701|10915808|FG000|COMPLETED|Overall Study||2
9807099|NCT00636701|10915809|FG001|COMPLETED|Overall Study||2
9807100|NCT00636701|10915808|FG000|NOT COMPLETED|Overall Study||0
9807101|NCT00636701|10915809|FG001|NOT COMPLETED|Overall Study||0
9807102|NCT00636792|10915815|FG000|STARTED|Overall Study||73
9807103|NCT00636792|10915815|FG000|COMPLETED|Overall Study||40
9807104|NCT00636792|10915815|FG000|NOT COMPLETED|Overall Study||33
9807105|NCT00636805|10915819|FG000|STARTED|Overall Study||63
9807106|NCT00636805|10915819|FG000|COMPLETED|Overall Study||63
9807107|NCT00636805|10915819|FG000|NOT COMPLETED|Overall Study||0
9807108|NCT00636818|10915823|FG000|STARTED|Overall Study||45
9807109|NCT00636818|10915823|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
9807110|NCT00636818|10915823|FG000|COMPLETED|Overall Study||34
9807111|NCT00636818|10915823|FG000|NOT COMPLETED|Overall Study||11
9807112|NCT00636961|10915829|FG000|STARTED|Period 1||14
9807113|NCT00636961|10915830|FG001|STARTED|Period 1||13
9807114|NCT00636961|10915829|FG000|COMPLETED|Period 1||13
9807115|NCT00636961|10915830|FG001|COMPLETED|Period 1||12
9807116|NCT00636961|10915829|FG000|NOT COMPLETED|Period 1||1
9807117|NCT00636961|10915830|FG001|NOT COMPLETED|Period 1||1
9807118|NCT00636961|10915829|FG000|STARTED|Period 2||13
9807119|NCT00636961|10915830|FG001|STARTED|Period 2||12
9807120|NCT00636961|10915829|FG000|COMPLETED|Period 2||12
9807121|NCT00636961|10915830|FG001|COMPLETED|Period 2||12
9807122|NCT00636961|10915829|FG000|NOT COMPLETED|Period 2||1
9807123|NCT00636961|10915830|FG001|NOT COMPLETED|Period 2||0
9807124|NCT00636987|10915836|FG000|STARTED|Overall Study||297
9807125|NCT00636987|10915836|FG000|COMPLETED|Overall Study||108
9807126|NCT00636987|10915836|FG000|NOT COMPLETED|Overall Study||189
9807127|NCT00637000|10915846|FG000|STARTED|Overall Study|Randomized and treated|20
9807128|NCT00637000|10915847|FG001|STARTED|Overall Study|Randomized and treated|18
9807129|NCT00637000|10915846|FG000|Evaluable|Overall Study||18
9807130|NCT00637000|10915847|FG001|Evaluable|Overall Study||16
9807131|NCT00637000|10915846|FG000|COMPLETED|Overall Study||16
9807132|NCT00637000|10915847|FG001|COMPLETED|Overall Study||15
9807133|NCT00637000|10915846|FG000|NOT COMPLETED|Overall Study||4
9807134|NCT00637000|10915847|FG001|NOT COMPLETED|Overall Study||3
9807135|NCT00637156|10915855|FG000|STARTED|Overall Study||209
9807136|NCT00637156|10915856|FG001|STARTED|Overall Study||188
9807137|NCT00637156|10915855|FG000|COMPLETED|Overall Study||199
9807138|NCT00637156|10915856|FG001|COMPLETED|Overall Study||164
9807139|NCT00637156|10915855|FG000|NOT COMPLETED|Overall Study||10
9807140|NCT00637156|10915856|FG001|NOT COMPLETED|Overall Study||24
9807141|NCT00637195|10915864|FG000|STARTED|Overall Study||76
9807142|NCT00637195|10915865|FG001|STARTED|Overall Study||76
9807143|NCT00637195|10915864|FG000|COMPLETED|Overall Study||73
9807144|NCT00637195|10915865|FG001|COMPLETED|Overall Study||75
9807145|NCT00637195|10915864|FG000|NOT COMPLETED|Overall Study||3
9807146|NCT00637195|10915865|FG001|NOT COMPLETED|Overall Study||1
9807147|NCT00637247|10915873|FG000|STARTED|Overall Study||72
9807148|NCT00637247|10915874|FG001|STARTED|Overall Study||70
9807149|NCT00637247|10915873|FG000|COMPLETED|Overall Study||72
9807150|NCT00637247|10915874|FG001|COMPLETED|Overall Study||70
9807151|NCT00637247|10915873|FG000|NOT COMPLETED|Overall Study||0
9807152|NCT00637247|10915874|FG001|NOT COMPLETED|Overall Study||0
9807153|NCT00637273|10915885|FG000|STARTED|Overall Study||170
9807154|NCT00637273|10915886|FG001|STARTED|Overall Study||172
9807155|NCT00637273|10915887|FG002|STARTED|Overall Study||172
9807156|NCT00637273|10915885|FG000|Intent to Treat (ITT)|Overall Study||160
9807157|NCT00637273|10915886|FG001|Intent to Treat (ITT)|Overall Study||166
9807158|NCT00637273|10915887|FG002|Intent to Treat (ITT)|Overall Study||165
9807159|NCT00637273|10915885|FG000|COMPLETED|Overall Study||127
9807160|NCT00637273|10915886|FG001|COMPLETED|Overall Study||144
9807161|NCT00637273|10915887|FG002|COMPLETED|Overall Study||131
9807162|NCT00637273|10915885|FG000|NOT COMPLETED|Overall Study||43
9807163|NCT00637273|10915886|FG001|NOT COMPLETED|Overall Study||28
9807164|NCT00637273|10915887|FG002|NOT COMPLETED|Overall Study||41
9807165|NCT00637299|10915897|FG000|STARTED|Overall Study||10
9807166|NCT00637299|10915898|FG001|STARTED|Overall Study||10
9807167|NCT00637299|10915897|FG000|COMPLETED|Overall Study||10
9807168|NCT00637299|10915898|FG001|COMPLETED|Overall Study||10
9807169|NCT00637299|10915897|FG000|NOT COMPLETED|Overall Study||0
9807170|NCT00637299|10915898|FG001|NOT COMPLETED|Overall Study||0
9807171|NCT00637377|10915908|FG000|STARTED|Overall Study||303
9807172|NCT00637377|10915909|FG001|STARTED|Overall Study||313
9807173|NCT00637377|10915910|FG002|STARTED|Overall Study||311
9807174|NCT00637377|10915911|FG003|STARTED|Overall Study||313
9807175|NCT00637377|10915908|FG000|Participants Received Treatment|Overall Study|safety population|291
9807176|NCT00637377|10915909|FG001|Participants Received Treatment|Overall Study|safety population|309
9807177|NCT00637377|10915910|FG002|Participants Received Treatment|Overall Study|safety population|297
9807178|NCT00637377|10915911|FG003|Participants Received Treatment|Overall Study|safety population|307
9807179|NCT00637377|10915908|FG000|Participants Treated (FAS)|Overall Study||291
9807180|NCT00637377|10915909|FG001|Participants Treated (FAS)|Overall Study||309
9807181|NCT00637377|10915910|FG002|Participants Treated (FAS)|Overall Study||296
9807182|NCT00637377|10915911|FG003|Participants Treated (FAS)|Overall Study||306
9807183|NCT00637377|10915908|FG000|COMPLETED|Overall Study||276
9807184|NCT00637377|10915909|FG001|COMPLETED|Overall Study||281
9807185|NCT00637377|10915910|FG002|COMPLETED|Overall Study||274
9807186|NCT00637377|10915911|FG003|COMPLETED|Overall Study||284
9807187|NCT00637377|10915908|FG000|NOT COMPLETED|Overall Study||27
9807188|NCT00637377|10915909|FG001|NOT COMPLETED|Overall Study||32
9807189|NCT00637377|10915910|FG002|NOT COMPLETED|Overall Study||37
9807190|NCT00637377|10915911|FG003|NOT COMPLETED|Overall Study||29
9807191|NCT00637494|10915923|FG000|STARTED|Overall Study||141
9807192|NCT00637494|10915924|FG001|STARTED|Overall Study||151
9807193|NCT00637494|10915923|FG000|COMPLETED|Overall Study||109
9807194|NCT00637494|10915924|FG001|COMPLETED|Overall Study||108
9807195|NCT00637494|10915923|FG000|NOT COMPLETED|Overall Study||32
9807196|NCT00637494|10915924|FG001|NOT COMPLETED|Overall Study||43
9807197|NCT00637572|10915932|FG000|STARTED|Overall Study||32
9807198|NCT00637572|10915933|FG001|STARTED|Overall Study||31
9807199|NCT00637572|10915932|FG000|COMPLETED|Overall Study||29
9807200|NCT00637572|10915933|FG001|COMPLETED|Overall Study||24
9807201|NCT00637572|10915932|FG000|NOT COMPLETED|Overall Study||3
9807202|NCT00637572|10915933|FG001|NOT COMPLETED|Overall Study||7
9807203|NCT00637780|10915939|FG000|STARTED|Overall Study||2
9807204|NCT00637780|10915939|FG000|COMPLETED|Overall Study||2
9807205|NCT00637780|10915939|FG000|NOT COMPLETED|Overall Study||0
9807206|NCT00637923|10915945|FG000|STARTED|Overall Study||75
9807207|NCT00637923|10915946|FG001|STARTED|Overall Study||37
9807208|NCT00637923|10915945|FG000|COMPLETED|Overall Study||45
9807209|NCT00637923|10915946|FG001|COMPLETED|Overall Study||18
9807210|NCT00637923|10915945|FG000|NOT COMPLETED|Overall Study||30
9807211|NCT00637923|10915946|FG001|NOT COMPLETED|Overall Study||19
9807212|NCT00638014|10915954|FG000|STARTED|Overall Study||23
9807213|NCT00638014|10915955|FG001|STARTED|Overall Study||28
9807214|NCT00638014|10915954|FG000|COMPLETED|Overall Study||23
9807215|NCT00638014|10915955|FG001|COMPLETED|Overall Study||28
9807216|NCT00638014|10915954|FG000|NOT COMPLETED|Overall Study||0
9807217|NCT00638014|10915955|FG001|NOT COMPLETED|Overall Study||0
9807218|NCT00638027|10915963|FG000|STARTED|Overall Study||11
9807219|NCT00638027|10915964|FG001|STARTED|Overall Study||10
9807220|NCT00638027|10915963|FG000|COMPLETED|Overall Study||11
9807221|NCT00638027|10915964|FG001|COMPLETED|Overall Study|all 10 included in analyses|8
9807222|NCT00638027|10915963|FG000|NOT COMPLETED|Overall Study||0
9807223|NCT00638027|10915964|FG001|NOT COMPLETED|Overall Study||2
9807224|NCT00638157|10915972|FG000|STARTED|Overall Study||12
9807225|NCT00638157|10915973|FG001|STARTED|Overall Study||12
9807226|NCT00638157|10915972|FG000|Treated|Overall Study||10
9807227|NCT00638157|10915973|FG001|Treated|Overall Study||12
9807228|NCT00638157|10915972|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
9807229|NCT00638157|10915973|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
9807230|NCT00638157|10915972|FG000|NOT COMPLETED|Overall Study||7
9807231|NCT00638157|10915973|FG001|NOT COMPLETED|Overall Study||4
9807232|NCT00638183|10915980|FG000|STARTED|Overall Study||385
9807233|NCT00638183|10915980|FG000|COMPLETED|Overall Study||266
9807234|NCT00638183|10915980|FG000|NOT COMPLETED|Overall Study||119
9807235|NCT00638235|10915993|FG000|STARTED|Overall Study||141
9807236|NCT00638235|10915994|FG001|STARTED|Overall Study||26
9807237|NCT00638235|10915995|FG002|STARTED|Overall Study||81
9807238|NCT00638235|10915996|FG003|STARTED|Overall Study||56
9807239|NCT00638235|10915997|FG004|STARTED|Overall Study||55
9807240|NCT00638235|10915998|FG005|STARTED|Overall Study||139
9807241|NCT00638235|10915999|FG006|STARTED|Overall Study||23
9807242|NCT00638235|10916000|FG007|STARTED|Overall Study||35
9807243|NCT00638235|10916001|FG008|STARTED|Overall Study||142
10016081|NCT01808547|11139029|FG001|Safety Population|Overall Study||85
10016082|NCT01808547|11139028|FG000|mITT Population|Overall Study||168
9807244|NCT00638235|10915993|FG000|COMPLETED|Overall Study||110
9807245|NCT00638235|10915994|FG001|COMPLETED|Overall Study||23
9807246|NCT00638235|10915995|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
9807247|NCT00638235|10915996|FG003|COMPLETED|Overall Study||46
9807248|NCT00638235|10915997|FG004|COMPLETED|Overall Study||42
9807249|NCT00638235|10915998|FG005|COMPLETED|Overall Study||113
9807250|NCT00638235|10915999|FG006|COMPLETED|Overall Study||23
9807251|NCT00638235|10916000|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
9807252|NCT00638235|10916001|FG008|COMPLETED|Overall Study||124
9807253|NCT00638235|10915993|FG000|NOT COMPLETED|Overall Study||31
9807254|NCT00638235|10915994|FG001|NOT COMPLETED|Overall Study||3
9807255|NCT00638235|10915995|FG002|NOT COMPLETED|Overall Study||18
9807256|NCT00638235|10915996|FG003|NOT COMPLETED|Overall Study||10
9807257|NCT00638235|10915997|FG004|NOT COMPLETED|Overall Study||13
9807258|NCT00638235|10915998|FG005|NOT COMPLETED|Overall Study||26
9807259|NCT00638235|10915999|FG006|NOT COMPLETED|Overall Study||0
9807260|NCT00638235|10916000|FG007|NOT COMPLETED|Overall Study||1
9807261|NCT00638235|10916001|FG008|NOT COMPLETED|Overall Study||18
9807262|NCT00638274|10916030|FG000|STARTED|Overall Study||179
9807263|NCT00638274|10916031|FG001|STARTED|Overall Study||177
9807264|NCT00638274|10916030|FG000|COMPLETED|Overall Study||173
9807265|NCT00638274|10916031|FG001|COMPLETED|Overall Study||172
9807266|NCT00638274|10916030|FG000|NOT COMPLETED|Overall Study||6
9807267|NCT00638274|10916031|FG001|NOT COMPLETED|Overall Study||5
9807268|NCT00638365|10916040|FG000|STARTED|Overall Study||9
9807269|NCT00638365|10916041|FG001|STARTED|Overall Study||10
9807270|NCT00638365|10916042|FG002|STARTED|Overall Study||8
9807271|NCT00638365|10916040|FG000|COMPLETED|Overall Study||9
9807272|NCT00638365|10916041|FG001|COMPLETED|Overall Study||10
9807273|NCT00638365|10916042|FG002|COMPLETED|Overall Study||8
9807274|NCT00638365|10916040|FG000|NOT COMPLETED|Overall Study||0
9807275|NCT00638365|10916041|FG001|NOT COMPLETED|Overall Study||0
9807276|NCT00638365|10916042|FG002|NOT COMPLETED|Overall Study||0
9807277|NCT00638378|10916050|FG000|STARTED|Overall Study||22
9807278|NCT00638378|10916050|FG000|COMPLETED|Overall Study||0
9807279|NCT00638378|10916050|FG000|NOT COMPLETED|Overall Study||22
9807280|NCT00638404|10916056|FG000|STARTED|Overall Study||200
9807281|NCT00638404|10916057|FG001|STARTED|Overall Study||100
9807282|NCT00638404|10916056|FG000|COMPLETED|Overall Study||192
9807283|NCT00638404|10916057|FG001|COMPLETED|Overall Study||100
9807284|NCT00638404|10916056|FG000|NOT COMPLETED|Overall Study||8
9807285|NCT00638404|10916057|FG001|NOT COMPLETED|Overall Study||0
9807286|NCT00638443|10916067|FG000|STARTED|First Intervention||14
9807287|NCT00638443|10916068|FG001|STARTED|First Intervention||15
9807288|NCT00638443|10916067|FG000|COMPLETED|First Intervention||12
9807289|NCT00638443|10916068|FG001|COMPLETED|First Intervention||14
9807290|NCT00638443|10916067|FG000|NOT COMPLETED|First Intervention||2
9807291|NCT00638443|10916068|FG001|NOT COMPLETED|First Intervention||1
9807292|NCT00638443|10916067|FG000|STARTED|Washout||12
9807293|NCT00638443|10916068|FG001|STARTED|Washout||14
9807294|NCT00638443|10916067|FG000|COMPLETED|Washout||12
9807295|NCT00638443|10916068|FG001|COMPLETED|Washout||14
9807296|NCT00638443|10916067|FG000|NOT COMPLETED|Washout||0
9807297|NCT00638443|10916068|FG001|NOT COMPLETED|Washout||0
9807298|NCT00638443|10916067|FG000|STARTED|Second Intervention||12
9807299|NCT00638443|10916068|FG001|STARTED|Second Intervention||14
9807300|NCT00638443|10916067|FG000|COMPLETED|Second Intervention||12
9807301|NCT00638443|10916068|FG001|COMPLETED|Second Intervention||14
9807302|NCT00638443|10916067|FG000|NOT COMPLETED|Second Intervention||0
10016083|NCT01808547|11139029|FG001|mITT Population|Overall Study||85
9807303|NCT00638443|10916068|FG001|NOT COMPLETED|Second Intervention||0
9807304|NCT00638456|10916078|FG000|STARTED|Overall Study||21
9807305|NCT00638456|10916079|FG001|STARTED|Overall Study||11
9807306|NCT00638456|10916078|FG000|COMPLETED|Overall Study||15
9807307|NCT00638456|10916079|FG001|COMPLETED|Overall Study||9
9807308|NCT00638456|10916078|FG000|NOT COMPLETED|Overall Study||6
9807309|NCT00638456|10916079|FG001|NOT COMPLETED|Overall Study||2
9807310|NCT00638508|10916087|FG000|STARTED|Overall Study||35
9807311|NCT00638508|10916088|FG001|STARTED|Overall Study||32
9807312|NCT00638508|10916087|FG000|COMPLETED|Overall Study||30
9807313|NCT00638508|10916088|FG001|COMPLETED|Overall Study||30
9807314|NCT00638508|10916087|FG000|NOT COMPLETED|Overall Study||5
9807315|NCT00638508|10916088|FG001|NOT COMPLETED|Overall Study||2
9807316|NCT00638651|10916098|FG000|STARTED|Overall Study||3
9807317|NCT00638651|10916098|FG000|COMPLETED|Overall Study||3
9807318|NCT00638651|10916098|FG000|NOT COMPLETED|Overall Study||0
9807319|NCT00638690|10916105|FG000|STARTED|Overall Study||797
9807320|NCT00638690|10916106|FG001|STARTED|Overall Study||398
9807321|NCT00638690|10916105|FG000|COMPLETED|Overall Study||116
9807322|NCT00638690|10916106|FG001|COMPLETED|Overall Study||56
9807323|NCT00638690|10916105|FG000|NOT COMPLETED|Overall Study||681
9807324|NCT00638690|10916106|FG001|NOT COMPLETED|Overall Study||342
9807325|NCT00638716|10916116|FG000|STARTED|Overall Study||50
9807326|NCT00638716|10916117|FG001|STARTED|Overall Study||52
9807327|NCT00638716|10916118|FG002|STARTED|Overall Study||58
9807328|NCT00638716|10916116|FG000|COMPLETED|Overall Study||43
9807329|NCT00638716|10916117|FG001|COMPLETED|Overall Study||37
9807330|NCT00638716|10916118|FG002|COMPLETED|Overall Study||46
9807331|NCT00638716|10916116|FG000|NOT COMPLETED|Overall Study||7
9807332|NCT00638716|10916117|FG001|NOT COMPLETED|Overall Study||15
9807333|NCT00638716|10916118|FG002|NOT COMPLETED|Overall Study||12
9807334|NCT00638820|10916126|FG000|STARTED|Overall Study||3
9807335|NCT00638820|10916126|FG000|COMPLETED|Overall Study||3
9807336|NCT00638820|10916126|FG000|NOT COMPLETED|Overall Study||0
9807337|NCT00638846|10916132|FG000|STARTED|Overall Study||137
9807338|NCT00638846|10916133|FG001|STARTED|Overall Study||139
9807339|NCT00638846|10916132|FG000|COMPLETED|Overall Study||133
9807340|NCT00638846|10916133|FG001|COMPLETED|Overall Study||133
9807341|NCT00638846|10916132|FG000|NOT COMPLETED|Overall Study||4
9807342|NCT00638846|10916133|FG001|NOT COMPLETED|Overall Study||6
9807343|NCT00638885|10916139|FG000|STARTED|Overall Study||142
9807344|NCT00638885|10916139|FG000|COMPLETED|Overall Study||142
9807345|NCT00638885|10916139|FG000|NOT COMPLETED|Overall Study||0
9807346|NCT00638924|10916143|FG000|STARTED|Overall Study||40
9807347|NCT00638924|10916143|FG000|2 Months|Overall Study||40
9807348|NCT00638924|10916143|FG000|COMPLETED|Overall Study||40
9807349|NCT00638924|10916143|FG000|NOT COMPLETED|Overall Study||0
9807350|NCT00638937|10916147|FG000|STARTED|Overall Study||37
9807351|NCT00638937|10916147|FG000|COMPLETED|Overall Study||37
9807352|NCT00638937|10916147|FG000|NOT COMPLETED|Overall Study||0
9807353|NCT00638963|10916155|FG000|STARTED|Overall Study|Received randomized treatment assignment|3
9807354|NCT00638963|10916156|FG001|STARTED|Overall Study|Received randomized treatment assignment|3
9807355|NCT00638963|10916155|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
9807356|NCT00638963|10916156|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
9807357|NCT00638963|10916155|FG000|NOT COMPLETED|Overall Study||1
9807358|NCT00638963|10916156|FG001|NOT COMPLETED|Overall Study||0
9807359|NCT00638989|10916165|FG000|STARTED|Overall Study||10
9807360|NCT00638989|10916166|FG001|STARTED|Overall Study||10
9807361|NCT00638989|10916167|FG002|STARTED|Overall Study||10
9807362|NCT00638989|10916165|FG000|COMPLETED|Overall Study||10
9807363|NCT00638989|10916166|FG001|COMPLETED|Overall Study||10
9807364|NCT00638989|10916167|FG002|COMPLETED|Overall Study||9
9807365|NCT00638989|10916165|FG000|NOT COMPLETED|Overall Study||0
9807366|NCT00638989|10916166|FG001|NOT COMPLETED|Overall Study||0
9807367|NCT00638989|10916167|FG002|NOT COMPLETED|Overall Study||1
9807368|NCT00639002|10916177|FG000|STARTED|Overall Study||13
9807369|NCT00639002|10916177|FG000|Received Ruxolitinib|Overall Study||13
9807370|NCT00639002|10916177|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7
9807371|NCT00639002|10916177|FG000|COMPLETED|Overall Study||0
9807372|NCT00639002|10916177|FG000|NOT COMPLETED|Overall Study||13
9807373|NCT00639093|10916184|FG000|STARTED|Overall Study|45|45
9807374|NCT00639093|10916185|FG001|STARTED|Overall Study|46|46
9807375|NCT00639093|10916184|FG000|COMPLETED|Overall Study|45|45
9807376|NCT00639093|10916185|FG001|COMPLETED|Overall Study|46|46
9807377|NCT00639093|10916184|FG000|NOT COMPLETED|Overall Study||0
9807378|NCT00639093|10916185|FG001|NOT COMPLETED|Overall Study||0
9807379|NCT00639158|10916193|FG000|STARTED|Overall Study|All randomized subjects were treated.|272
9807380|NCT00639158|10916194|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
9807381|NCT00639158|10916193|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
9807382|NCT00639158|10916194|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
9807383|NCT00639158|10916193|FG000|NOT COMPLETED|Overall Study||26
9807384|NCT00639158|10916194|FG001|NOT COMPLETED|Overall Study||30
9807385|NCT00639223|10916202|FG000|STARTED|Overall Study||22
9807386|NCT00639223|10916203|FG001|STARTED|Overall Study||21
9807387|NCT00639223|10916202|FG000|COMPLETED|Overall Study||22
9807388|NCT00639223|10916203|FG001|COMPLETED|Overall Study||19
9807389|NCT00639223|10916202|FG000|NOT COMPLETED|Overall Study||0
9807390|NCT00639223|10916203|FG001|NOT COMPLETED|Overall Study||2
9807391|NCT00639379|10916209|FG000|STARTED|Period 1 - 2 Weeks||44
9807392|NCT00639379|10916210|FG001|STARTED|Period 1 - 2 Weeks||45
9807393|NCT00639379|10916209|FG000|COMPLETED|Period 1 - 2 Weeks||39
9807394|NCT00639379|10916210|FG001|COMPLETED|Period 1 - 2 Weeks||45
9807395|NCT00639379|10916209|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5
9807396|NCT00639379|10916210|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0
9807397|NCT00639379|10916209|FG000|STARTED|Period 2 - 2 Weeks||39
9807398|NCT00639379|10916210|FG001|STARTED|Period 2 - 2 Weeks||45
9807399|NCT00639379|10916209|FG000|COMPLETED|Period 2 - 2 Weeks||39
9807400|NCT00639379|10916210|FG001|COMPLETED|Period 2 - 2 Weeks||45
9807401|NCT00639379|10916209|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0
9807402|NCT00639379|10916210|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0
9807403|NCT00639418|10916220|FG000|STARTED|Overall Study||28101
9807404|NCT00639418|10916221|FG001|STARTED|Overall Study||35967
9807405|NCT00639418|10916222|FG002|STARTED|Overall Study||36496
9807406|NCT00639418|10916223|FG003|STARTED|Overall Study||46930
9807407|NCT00639418|10916220|FG000|COMPLETED|Overall Study||28101
9807408|NCT00639418|10916221|FG001|COMPLETED|Overall Study||35967
9807409|NCT00639418|10916222|FG002|COMPLETED|Overall Study||36496
9807410|NCT00639418|10916223|FG003|COMPLETED|Overall Study||46930
9807411|NCT00639418|10916220|FG000|NOT COMPLETED|Overall Study||0
9807412|NCT00639418|10916221|FG001|NOT COMPLETED|Overall Study||0
9807413|NCT00639418|10916222|FG002|NOT COMPLETED|Overall Study||0
9807414|NCT00639418|10916223|FG003|NOT COMPLETED|Overall Study||0
9807415|NCT00639457|10916239|FG000|STARTED|Overall Study||22
9807416|NCT00639457|10916240|FG001|STARTED|Overall Study||22
9807417|NCT00639457|10916239|FG000|COMPLETED|Overall Study||20
9807418|NCT00639457|10916240|FG001|COMPLETED|Overall Study||19
9807419|NCT00639457|10916239|FG000|NOT COMPLETED|Overall Study||2
9807420|NCT00639457|10916240|FG001|NOT COMPLETED|Overall Study||3
9807421|NCT00639509|10916246|FG000|STARTED|Overall Study||24
9807422|NCT00639509|10916246|FG000|COMPLETED|Overall Study||23
9807423|NCT00639509|10916246|FG000|NOT COMPLETED|Overall Study||1
9807424|NCT00639678|10916254|FG000|STARTED|Overall Study||74
9807425|NCT00639678|10916255|FG001|STARTED|Overall Study||6
9807426|NCT00639678|10916256|FG002|STARTED|Overall Study||217
9807427|NCT00639678|10916257|FG003|STARTED|Overall Study||23
9807428|NCT00639678|10916254|FG000|COMPLETED|Overall Study||70
9807429|NCT00639678|10916255|FG001|COMPLETED|Overall Study||5
9807430|NCT00639678|10916256|FG002|COMPLETED|Overall Study||206
10016084|NCT01808547|11139028|FG000|COMPLETED|Overall Study||137
10016085|NCT01808547|11139029|FG001|COMPLETED|Overall Study||48
9807431|NCT00639678|10916257|FG003|COMPLETED|Overall Study||23
9807432|NCT00639678|10916254|FG000|NOT COMPLETED|Overall Study||4
9807433|NCT00639678|10916255|FG001|NOT COMPLETED|Overall Study||1
9807434|NCT00639678|10916256|FG002|NOT COMPLETED|Overall Study||11
9807435|NCT00639678|10916257|FG003|NOT COMPLETED|Overall Study||0
9807436|NCT00639717|10916269|FG000|STARTED|Overall Study||48
9807437|NCT00639717|10916269|FG000|COMPLETED|Overall Study||48
9807438|NCT00639717|10916269|FG000|NOT COMPLETED|Overall Study||0
9807439|NCT00639769|10916273|FG000|STARTED|Overall Study||40
9807440|NCT00639769|10916273|FG000|COMPLETED|Overall Study||0
9807441|NCT00639769|10916273|FG000|NOT COMPLETED|Overall Study||40
9807442|NCT00639860|10916277|FG000|STARTED|Overall Study||10
9807443|NCT00639860|10916277|FG000|COMPLETED|Overall Study||10
9807444|NCT00639860|10916277|FG000|NOT COMPLETED|Overall Study||0
9807445|NCT00640016|10916285|FG000|STARTED|Overall Study||3
9807446|NCT00640016|10916286|FG001|STARTED|Overall Study||3
9807447|NCT00640016|10916287|FG002|STARTED|Overall Study||4
9807448|NCT00640016|10916288|FG003|STARTED|Overall Study||4
9807449|NCT00640016|10916285|FG000|Treated|Overall Study||3
9807450|NCT00640016|10916286|FG001|Treated|Overall Study||2
9807451|NCT00640016|10916287|FG002|Treated|Overall Study||4
9807452|NCT00640016|10916288|FG003|Treated|Overall Study||4
9807453|NCT00640016|10916285|FG000|COMPLETED|Overall Study||1
9807454|NCT00640016|10916286|FG001|COMPLETED|Overall Study||1
10016086|NCT01808547|11139028|FG000|NOT COMPLETED|Overall Study||37
10016087|NCT01808547|11139029|FG001|NOT COMPLETED|Overall Study||46
9807455|NCT00640016|10916287|FG002|COMPLETED|Overall Study||1
9807456|NCT00640016|10916288|FG003|COMPLETED|Overall Study||1
9807457|NCT00640016|10916285|FG000|NOT COMPLETED|Overall Study||2
9807458|NCT00640016|10916286|FG001|NOT COMPLETED|Overall Study||2
9807459|NCT00640016|10916287|FG002|NOT COMPLETED|Overall Study||3
9807460|NCT00640016|10916288|FG003|NOT COMPLETED|Overall Study||3
9807461|NCT00640042|10916305|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
9807462|NCT00640042|10916305|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
9807463|NCT00640042|10916305|FG000|NOT COMPLETED|Enrollment||83
9807464|NCT00640042|10916305|FG000|STARTED|Treatment||1487
9807465|NCT00640042|10916305|FG000|COMPLETED|Treatment||561
9807466|NCT00640042|10916305|FG000|NOT COMPLETED|Treatment||926
9807467|NCT00640146|10916311|FG000|STARTED|Overall Study||19
9807468|NCT00640146|10916312|FG001|STARTED|Overall Study||18
9807469|NCT00640146|10916311|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
9807470|NCT00640146|10916312|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
10016088|NCT01808560|11139038|FG000|STARTED|Randomization and Treatment Allocation||18
9807471|NCT00640146|10916311|FG000|COMPLETED|Overall Study||15
9807472|NCT00640146|10916312|FG001|COMPLETED|Overall Study||12
9807473|NCT00640146|10916311|FG000|NOT COMPLETED|Overall Study||4
9807474|NCT00640146|10916312|FG001|NOT COMPLETED|Overall Study||6
10016089|NCT01808560|11139039|FG001|STARTED|Randomization and Treatment Allocation||16
9807475|NCT00640224|10916322|FG000|STARTED|Overall Study||23
9807476|NCT00640224|10916323|FG001|STARTED|Overall Study||23
9807477|NCT00640224|10916324|FG002|STARTED|Overall Study||0
9807478|NCT00640224|10916325|FG003|STARTED|Overall Study||0
9807479|NCT00640224|10916322|FG000|COMPLETED|Overall Study||17
9807480|NCT00640224|10916323|FG001|COMPLETED|Overall Study||20
9807481|NCT00640224|10916324|FG002|COMPLETED|Overall Study||0
9807482|NCT00640224|10916325|FG003|COMPLETED|Overall Study||0
9807483|NCT00640224|10916322|FG000|NOT COMPLETED|Overall Study||6
9807484|NCT00640224|10916323|FG001|NOT COMPLETED|Overall Study||3
9807485|NCT00640224|10916324|FG002|NOT COMPLETED|Overall Study||0
9807486|NCT00640224|10916325|FG003|NOT COMPLETED|Overall Study||0
9807487|NCT00640250|10916335|FG000|STARTED|Overall Study||48
9807488|NCT00640250|10916335|FG000|COMPLETED|Overall Study||48
9807489|NCT00640250|10916335|FG000|NOT COMPLETED|Overall Study||0
9807490|NCT00640289|10916438|FG000|STARTED|Overall Study||72
9807491|NCT00640289|10916438|FG000|COMPLETED|Overall Study||59
9807492|NCT00640289|10916438|FG000|NOT COMPLETED|Overall Study||13
9807493|NCT00640315|10916444|FG000|STARTED|Overall Study||10
9807494|NCT00640315|10916445|FG001|STARTED|Overall Study||13
9807495|NCT00640315|10916444|FG000|Participants Received Treatment|Overall Study||10
9807496|NCT00640315|10916445|FG001|Participants Received Treatment|Overall Study||13
9807497|NCT00640315|10916444|FG000|COMPLETED|Overall Study||10
9807498|NCT00640315|10916445|FG001|COMPLETED|Overall Study||12
9807499|NCT00640315|10916444|FG000|NOT COMPLETED|Overall Study||0
9807500|NCT00640315|10916445|FG001|NOT COMPLETED|Overall Study||1
9807501|NCT00640328|10916457|FG000|STARTED|First Treatment Period (Weeks 0-24)||8
9807502|NCT00640328|10916458|FG001|STARTED|First Treatment Period (Weeks 0-24)||11
9807503|NCT00640328|10916459|FG002|STARTED|First Treatment Period (Weeks 0-24)||7
9807504|NCT00640328|10916460|FG003|STARTED|First Treatment Period (Weeks 0-24)||4
9807505|NCT00640328|10916461|FG004|STARTED|First Treatment Period (Weeks 0-24)||4
9807506|NCT00640328|10916462|FG005|STARTED|First Treatment Period (Weeks 0-24)||4
9807507|NCT00640328|10916457|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8
9807508|NCT00640328|10916458|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10
9807509|NCT00640328|10916459|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7
9807510|NCT00640328|10916460|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4
9807511|NCT00640328|10916461|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4
9807512|NCT00640328|10916462|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4
9807513|NCT00640328|10916457|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
9807514|NCT00640328|10916458|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
9807515|NCT00640328|10916459|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
9807516|NCT00640328|10916460|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
9807517|NCT00640328|10916461|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
9807518|NCT00640328|10916462|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
9807519|NCT00640328|10916457|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8
9807520|NCT00640328|10916458|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10
9807521|NCT00640328|10916459|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7
9807522|NCT00640328|10916460|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4
9807523|NCT00640328|10916461|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4
9807524|NCT00640328|10916462|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4
9807525|NCT00640328|10916457|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8
9807526|NCT00640328|10916458|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10
9807527|NCT00640328|10916459|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7
9807528|NCT00640328|10916460|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4
9807529|NCT00640328|10916461|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3
9807530|NCT00640328|10916462|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4
9807531|NCT00640328|10916457|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
9807532|NCT00640328|10916458|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
9807533|NCT00640328|10916459|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
9807534|NCT00640328|10916460|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
9807535|NCT00640328|10916461|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
9807536|NCT00640328|10916462|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
9807537|NCT00640328|10916457|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8
9807538|NCT00640328|10916458|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11
9807539|NCT00640328|10916459|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7
9807540|NCT00640328|10916460|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4
9807541|NCT00640328|10916461|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4
9807542|NCT00640328|10916462|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4
9807543|NCT00640328|10916457|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8
9807544|NCT00640328|10916458|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10
9807545|NCT00640328|10916459|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6
9807546|NCT00640328|10916460|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3
9807547|NCT00640328|10916461|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4
9807548|NCT00640328|10916462|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4
9807549|NCT00640328|10916457|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
9807550|NCT00640328|10916458|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
9807551|NCT00640328|10916459|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
9807552|NCT00640328|10916460|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
9807553|NCT00640328|10916461|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
9807554|NCT00640328|10916462|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
9807555|NCT00640341|10916486|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170
9807556|NCT00640341|10916487|FG001|STARTED|Overall Study||170
9807557|NCT00640341|10916488|FG002|STARTED|Overall Study||170
9807558|NCT00640341|10916486|FG000|Eligible Participants at Baseline|Overall Study||165
9807559|NCT00640341|10916487|FG001|Eligible Participants at Baseline|Overall Study||167
9807560|NCT00640341|10916488|FG002|Eligible Participants at Baseline|Overall Study||168
9807561|NCT00640341|10916486|FG000|COMPLETED|Overall Study||149
9807562|NCT00640341|10916487|FG001|COMPLETED|Overall Study||165
9807563|NCT00640341|10916488|FG002|COMPLETED|Overall Study||163
9807564|NCT00640341|10916486|FG000|NOT COMPLETED|Overall Study||21
9807565|NCT00640341|10916487|FG001|NOT COMPLETED|Overall Study||5
9807566|NCT00640341|10916488|FG002|NOT COMPLETED|Overall Study||7
9807567|NCT00640393|10916496|FG000|STARTED|Part 1||99
9807568|NCT00640393|10916497|FG001|STARTED|Part 1||0
9807569|NCT00640393|10916498|FG002|STARTED|Part 1||0
9807570|NCT00640393|10916496|FG000|COMPLETED|Part 1||94
9807571|NCT00640393|10916497|FG001|COMPLETED|Part 1||0
9807572|NCT00640393|10916498|FG002|COMPLETED|Part 1||0
9807573|NCT00640393|10916496|FG000|NOT COMPLETED|Part 1||5
9807574|NCT00640393|10916497|FG001|NOT COMPLETED|Part 1||0
9807575|NCT00640393|10916498|FG002|NOT COMPLETED|Part 1||0
9807576|NCT00640393|10916496|FG000|STARTED|Randomization||94
9807577|NCT00640393|10916497|FG001|STARTED|Randomization||0
9807578|NCT00640393|10916498|FG002|STARTED|Randomization||0
9807579|NCT00640393|10916496|FG000|COMPLETED|Randomization||75
9807580|NCT00640393|10916497|FG001|COMPLETED|Randomization||0
9807581|NCT00640393|10916498|FG002|COMPLETED|Randomization||0
9807582|NCT00640393|10916496|FG000|NOT COMPLETED|Randomization||19
9807583|NCT00640393|10916497|FG001|NOT COMPLETED|Randomization||0
9807584|NCT00640393|10916498|FG002|NOT COMPLETED|Randomization||0
9807585|NCT00640393|10916496|FG000|STARTED|Part 2||0
9807586|NCT00640393|10916497|FG001|STARTED|Part 2||37
9807587|NCT00640393|10916498|FG002|STARTED|Part 2||38
9807588|NCT00640393|10916496|FG000|COMPLETED|Part 2||0
9807589|NCT00640393|10916497|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
9807590|NCT00640393|10916498|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
9807591|NCT00640393|10916496|FG000|NOT COMPLETED|Part 2||0
9807592|NCT00640393|10916497|FG001|NOT COMPLETED|Part 2||10
9807593|NCT00640393|10916498|FG002|NOT COMPLETED|Part 2||3
9807594|NCT00640510|10916508|FG000|STARTED|Overall Study||17
9807595|NCT00640510|10916509|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
9807596|NCT00640510|10916508|FG000|COMPLETED|Overall Study||16
9807597|NCT00640510|10916509|FG001|COMPLETED|Overall Study||15
9807598|NCT00640510|10916508|FG000|NOT COMPLETED|Overall Study||1
9807599|NCT00640510|10916509|FG001|NOT COMPLETED|Overall Study||2
9807600|NCT00640562|10916517|FG000|STARTED|Overall Study||109
9807601|NCT00640562|10916518|FG001|STARTED|Overall Study||107
9807602|NCT00640562|10916517|FG000|COMPLETED|Overall Study||91
9807603|NCT00640562|10916518|FG001|COMPLETED|Overall Study||81
9807604|NCT00640562|10916517|FG000|NOT COMPLETED|Overall Study||18
9807605|NCT00640562|10916518|FG001|NOT COMPLETED|Overall Study||26
10016090|NCT01808560|11139040|FG002|STARTED|Randomization and Treatment Allocation||0
10016091|NCT01808560|11139038|FG000|COMPLETED|Randomization and Treatment Allocation||18
10016092|NCT01808560|11139039|FG001|COMPLETED|Randomization and Treatment Allocation||16
10016093|NCT01808560|11139040|FG002|COMPLETED|Randomization and Treatment Allocation||0
10016094|NCT01808560|11139038|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0
9807606|NCT00640601|10916524|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
9807607|NCT00640601|10916524|FG000|COMPLETED|Overall Study||183
9807608|NCT00640601|10916524|FG000|NOT COMPLETED|Overall Study||112
9807609|NCT00640614|10916530|FG000|STARTED|Overall Study||125
9807610|NCT00640614|10916531|FG001|STARTED|Overall Study||110
9807611|NCT00640614|10916530|FG000|COMPLETED|Overall Study||124
9807612|NCT00640614|10916531|FG001|COMPLETED|Overall Study||110
9807613|NCT00640614|10916530|FG000|NOT COMPLETED|Overall Study||1
9807614|NCT00640614|10916531|FG001|NOT COMPLETED|Overall Study||0
9807615|NCT00640653|10916565|FG000|STARTED|Overall Study||131
9807616|NCT00640653|10916566|FG001|STARTED|Overall Study||134
9807617|NCT00640653|10916567|FG002|STARTED|Overall Study||129
9807618|NCT00640653|10916568|FG003|STARTED|Overall Study||134
9807619|NCT00640653|10916569|FG004|STARTED|Overall Study||134
9807620|NCT00640653|10916565|FG000|Followed-up at 3 mo|Overall Study||126
9807621|NCT00640653|10916566|FG001|Followed-up at 3 mo|Overall Study||127
9807622|NCT00640653|10916567|FG002|Followed-up at 3 mo|Overall Study||125
9807623|NCT00640653|10916568|FG003|Followed-up at 3 mo|Overall Study||129
9807624|NCT00640653|10916569|FG004|Followed-up at 3 mo|Overall Study||126
9807625|NCT00640653|10916565|FG000|Followed-up at 6 mo|Overall Study||127
9807626|NCT00640653|10916566|FG001|Followed-up at 6 mo|Overall Study||130
9807627|NCT00640653|10916567|FG002|Followed-up at 6 mo|Overall Study||124
9807628|NCT00640653|10916568|FG003|Followed-up at 6 mo|Overall Study||130
9807629|NCT00640653|10916569|FG004|Followed-up at 6 mo|Overall Study||125
9807630|NCT00640653|10916565|FG000|Followed-up at 12 mo|Overall Study||124
9807631|NCT00640653|10916566|FG001|Followed-up at 12 mo|Overall Study||121
9807632|NCT00640653|10916567|FG002|Followed-up at 12 mo|Overall Study||115
9807633|NCT00640653|10916568|FG003|Followed-up at 12 mo|Overall Study||122
9807634|NCT00640653|10916569|FG004|Followed-up at 12 mo|Overall Study||116
9807635|NCT00640653|10916565|FG000|Followed-up at 18 mo|Overall Study||118
9807636|NCT00640653|10916566|FG001|Followed-up at 18 mo|Overall Study||112
9807637|NCT00640653|10916567|FG002|Followed-up at 18 mo|Overall Study||113
9807638|NCT00640653|10916568|FG003|Followed-up at 18 mo|Overall Study||117
9807639|NCT00640653|10916569|FG004|Followed-up at 18 mo|Overall Study||117
9807640|NCT00640653|10916565|FG000|Followed-up at 24 mo|Overall Study||114
9807641|NCT00640653|10916566|FG001|Followed-up at 24 mo|Overall Study||116
9807642|NCT00640653|10916567|FG002|Followed-up at 24 mo|Overall Study||105
9807643|NCT00640653|10916568|FG003|Followed-up at 24 mo|Overall Study||112
9807644|NCT00640653|10916569|FG004|Followed-up at 24 mo|Overall Study||112
9807645|NCT00640653|10916565|FG000|COMPLETED|Overall Study||128
9807646|NCT00640653|10916566|FG001|COMPLETED|Overall Study||131
9807647|NCT00640653|10916567|FG002|COMPLETED|Overall Study||129
9807648|NCT00640653|10916568|FG003|COMPLETED|Overall Study||132
9807649|NCT00640653|10916569|FG004|COMPLETED|Overall Study||129
9807650|NCT00640653|10916565|FG000|NOT COMPLETED|Overall Study||3
9807651|NCT00640653|10916566|FG001|NOT COMPLETED|Overall Study||3
9807652|NCT00640653|10916567|FG002|NOT COMPLETED|Overall Study||0
9807653|NCT00640653|10916568|FG003|NOT COMPLETED|Overall Study||2
9807654|NCT00640653|10916569|FG004|NOT COMPLETED|Overall Study||5
9807655|NCT00640822|10916584|FG000|STARTED|Overall Study||322
9807656|NCT00640822|10916585|FG001|STARTED|Overall Study||317
9807657|NCT00640822|10916586|FG002|STARTED|Overall Study||102
9807658|NCT00640822|10916584|FG000|COMPLETED|Overall Study||279
9807659|NCT00640822|10916585|FG001|COMPLETED|Overall Study||258
9807660|NCT00640822|10916586|FG002|COMPLETED|Overall Study||77
9807661|NCT00640822|10916584|FG000|NOT COMPLETED|Overall Study||43
9807662|NCT00640822|10916585|FG001|NOT COMPLETED|Overall Study||59
9807663|NCT00640822|10916586|FG002|NOT COMPLETED|Overall Study||25
9807664|NCT00640835|10916596|FG000|STARTED|Overall Study||194
9807665|NCT00640835|10916597|FG001|STARTED|Overall Study||188
9807666|NCT00640835|10916596|FG000|COMPLETED|Overall Study||118
9807667|NCT00640835|10916597|FG001|COMPLETED|Overall Study||131
9807668|NCT00640835|10916596|FG000|NOT COMPLETED|Overall Study||76
9807669|NCT00640835|10916597|FG001|NOT COMPLETED|Overall Study||57
9807670|NCT00640926|10916606|FG000|STARTED|Overall Study||53
9807671|NCT00640926|10916607|FG001|STARTED|Overall Study||52
9807672|NCT00640926|10916608|FG002|STARTED|Overall Study||53
9807673|NCT00640926|10916606|FG000|COMPLETED|Overall Study||45
9807674|NCT00640926|10916607|FG001|COMPLETED|Overall Study||46
9807675|NCT00640926|10916608|FG002|COMPLETED|Overall Study||45
9807676|NCT00640926|10916606|FG000|NOT COMPLETED|Overall Study||8
9807677|NCT00640926|10916607|FG001|NOT COMPLETED|Overall Study||6
9807678|NCT00640926|10916608|FG002|NOT COMPLETED|Overall Study||8
9807679|NCT00640978|10916616|FG000|STARTED|Overall Study||15
9807680|NCT00640978|10916616|FG000|COMPLETED|Overall Study||15
9807681|NCT00640978|10916616|FG000|NOT COMPLETED|Overall Study||0
9807682|NCT00641043|10916622|FG000|STARTED|Overall Study|number who started treatment|130
9807683|NCT00641043|10916623|FG001|STARTED|Overall Study|number who started treatment|259
9807684|NCT00641043|10916622|FG000|COMPLETED|Overall Study|number who completed treatment|111
9807685|NCT00641043|10916623|FG001|COMPLETED|Overall Study|number who completed treatment|244
9807686|NCT00641043|10916622|FG000|NOT COMPLETED|Overall Study||19
9807687|NCT00641043|10916623|FG001|NOT COMPLETED|Overall Study||15
9807688|NCT00641056|10916631|FG000|STARTED|Overall Study||233
9807689|NCT00641056|10916632|FG001|STARTED|Overall Study||234
9807690|NCT00641056|10916631|FG000|Intent to Treat (ITT)|Overall Study||233
9807691|NCT00641056|10916632|FG001|Intent to Treat (ITT)|Overall Study||223
9807692|NCT00641056|10916631|FG000|COMPLETED|Overall Study||204
9807693|NCT00641056|10916632|FG001|COMPLETED|Overall Study||209
9807694|NCT00641056|10916631|FG000|NOT COMPLETED|Overall Study||29
9807695|NCT00641056|10916632|FG001|NOT COMPLETED|Overall Study||25
9807696|NCT00641147|10916644|FG000|STARTED|Completed 4 Months.||21
9807697|NCT00641147|10916645|FG001|STARTED|Completed 4 Months.||23
9807698|NCT00641147|10916644|FG000|COMPLETED|Completed 4 Months.||19
9807699|NCT00641147|10916645|FG001|COMPLETED|Completed 4 Months.||23
9807700|NCT00641147|10916644|FG000|NOT COMPLETED|Completed 4 Months.||2
9807701|NCT00641147|10916645|FG001|NOT COMPLETED|Completed 4 Months.||0
9807702|NCT00641147|10916644|FG000|STARTED|Completed 8 Months.||19
9807703|NCT00641147|10916645|FG001|STARTED|Completed 8 Months.||23
9807704|NCT00641147|10916644|FG000|COMPLETED|Completed 8 Months.||16
9807705|NCT00641147|10916645|FG001|COMPLETED|Completed 8 Months.||21
9807706|NCT00641147|10916644|FG000|NOT COMPLETED|Completed 8 Months.||3
9807707|NCT00641147|10916645|FG001|NOT COMPLETED|Completed 8 Months.||2
9807708|NCT00641147|10916644|FG000|STARTED|Completed 12 Months.||16
9807709|NCT00641147|10916645|FG001|STARTED|Completed 12 Months.||21
9807710|NCT00641147|10916644|FG000|COMPLETED|Completed 12 Months.||15
9807711|NCT00641147|10916645|FG001|COMPLETED|Completed 12 Months.||19
9807712|NCT00641147|10916644|FG000|NOT COMPLETED|Completed 12 Months.||1
9807713|NCT00641147|10916645|FG001|NOT COMPLETED|Completed 12 Months.||2
9807714|NCT00641147|10916644|FG000|STARTED|Completed 16 Months.||15
9807715|NCT00641147|10916645|FG001|STARTED|Completed 16 Months.||19
9807716|NCT00641147|10916644|FG000|COMPLETED|Completed 16 Months.||13
9807717|NCT00641147|10916645|FG001|COMPLETED|Completed 16 Months.||19
9807718|NCT00641147|10916644|FG000|NOT COMPLETED|Completed 16 Months.||2
9807719|NCT00641147|10916645|FG001|NOT COMPLETED|Completed 16 Months.||0
9807720|NCT00641563|10916655|FG000|STARTED|Infusion 1||5
9807721|NCT00641563|10916656|FG001|STARTED|Infusion 1||5
9807722|NCT00641563|10916655|FG000|COMPLETED|Infusion 1||5
9807723|NCT00641563|10916656|FG001|COMPLETED|Infusion 1||5
9807724|NCT00641563|10916655|FG000|NOT COMPLETED|Infusion 1||0
9807725|NCT00641563|10916656|FG001|NOT COMPLETED|Infusion 1||0
9807726|NCT00641563|10916655|FG000|STARTED|Infusion 2||5
9807727|NCT00641563|10916656|FG001|STARTED|Infusion 2||5
9807728|NCT00641563|10916655|FG000|COMPLETED|Infusion 2||5
9807729|NCT00641563|10916656|FG001|COMPLETED|Infusion 2||5
9807730|NCT00641563|10916655|FG000|NOT COMPLETED|Infusion 2||0
9807731|NCT00641563|10916656|FG001|NOT COMPLETED|Infusion 2||0
9807732|NCT00641641|10916662|FG000|STARTED|Overall Study||16
9807733|NCT00641641|10916662|FG000|COMPLETED|Overall Study||16
9807734|NCT00641641|10916662|FG000|NOT COMPLETED|Overall Study||0
9807735|NCT00641667|10916666|FG000|STARTED|Overall Study||66
9807736|NCT00641667|10916666|FG000|COMPLETED|Overall Study||60
9807737|NCT00641667|10916666|FG000|NOT COMPLETED|Overall Study||6
9807738|NCT00641706|10916672|FG000|STARTED|Overall Study||37
9807739|NCT00641706|10916673|FG001|STARTED|Overall Study||7
9807740|NCT00641706|10916672|FG000|COMPLETED|Overall Study||28
9807741|NCT00641706|10916673|FG001|COMPLETED|Overall Study||4
9807742|NCT00641706|10916672|FG000|NOT COMPLETED|Overall Study||9
9807743|NCT00641706|10916673|FG001|NOT COMPLETED|Overall Study||3
9807744|NCT00641719|10916681|FG000|STARTED|Overall Study||129
9807745|NCT00641719|10916682|FG001|STARTED|Overall Study||129
9807746|NCT00641719|10916681|FG000|COMPLETED|Overall Study||99
9807747|NCT00641719|10916682|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
9807748|NCT00641719|10916681|FG000|NOT COMPLETED|Overall Study||30
9807749|NCT00641719|10916682|FG001|NOT COMPLETED|Overall Study||37
9807750|NCT00641745|10916690|FG000|STARTED|Overall Study||427
9807751|NCT00641745|10916691|FG001|STARTED|Overall Study||202
9807752|NCT00641745|10916690|FG000|COMPLETED|Overall Study||147
9807753|NCT00641745|10916691|FG001|COMPLETED|Overall Study||89
9807754|NCT00641745|10916690|FG000|NOT COMPLETED|Overall Study||280
9807755|NCT00641745|10916691|FG001|NOT COMPLETED|Overall Study||113
9807756|NCT00641797|10916699|FG000|STARTED|Overall Study||11
9807757|NCT00641797|10916700|FG001|STARTED|Overall Study||15
9807758|NCT00641797|10916699|FG000|COMPLETED|Overall Study||11
9807759|NCT00641797|10916700|FG001|COMPLETED|Overall Study||15
9807760|NCT00641797|10916699|FG000|NOT COMPLETED|Overall Study||0
9807761|NCT00641797|10916700|FG001|NOT COMPLETED|Overall Study||0
9807762|NCT00641862|10916708|FG000|STARTED|Overall Study||183
9807763|NCT00641862|10916709|FG001|STARTED|Overall Study||183
9807764|NCT00641862|10916708|FG000|COMPLETED|Overall Study||139
9807765|NCT00641862|10916709|FG001|COMPLETED|Overall Study||145
9807766|NCT00641862|10916708|FG000|NOT COMPLETED|Overall Study||44
9807767|NCT00641862|10916709|FG001|NOT COMPLETED|Overall Study||38
9807768|NCT00642018|10916717|FG000|STARTED|Overall Study||52
9807769|NCT00642018|10916718|FG001|STARTED|Overall Study||102
9807770|NCT00642018|10916717|FG000|Received at Least One Dose of Study Drug|Overall Study||51
9807771|NCT00642018|10916718|FG001|Received at Least One Dose of Study Drug|Overall Study||98
9807772|NCT00642018|10916717|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
9807773|NCT00642018|10916718|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
9807774|NCT00642018|10916717|FG000|NOT COMPLETED|Overall Study||28
9807775|NCT00642018|10916718|FG001|NOT COMPLETED|Overall Study||79
9807776|NCT00642174|10916727|FG000|STARTED|Period 1 - Initial Drug||18
9807777|NCT00642174|10916728|FG001|STARTED|Period 1 - Initial Drug||17
9807778|NCT00642174|10916727|FG000|COMPLETED|Period 1 - Initial Drug||18
9807779|NCT00642174|10916728|FG001|COMPLETED|Period 1 - Initial Drug||16
9807780|NCT00642174|10916727|FG000|NOT COMPLETED|Period 1 - Initial Drug||0
9807781|NCT00642174|10916728|FG001|NOT COMPLETED|Period 1 - Initial Drug||1
9807782|NCT00642174|10916727|FG000|STARTED|Period 2 - Crossover Drug||18
9807783|NCT00642174|10916728|FG001|STARTED|Period 2 - Crossover Drug||16
9807784|NCT00642174|10916727|FG000|COMPLETED|Period 2 - Crossover Drug||18
9807785|NCT00642174|10916728|FG001|COMPLETED|Period 2 - Crossover Drug||16
9807786|NCT00642174|10916727|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0
9807787|NCT00642174|10916728|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0
9807788|NCT00642278|10916741|FG000|STARTED|Overall Study||65
9807789|NCT00642278|10916742|FG001|STARTED|Overall Study||64
9807790|NCT00642278|10916743|FG002|STARTED|Overall Study||64
9807791|NCT00642278|10916744|FG003|STARTED|Overall Study||65
9807792|NCT00642278|10916745|FG004|STARTED|Overall Study||64
9807793|NCT00642278|10916746|FG005|STARTED|Overall Study||64
9807794|NCT00642278|10916747|FG006|STARTED|Overall Study||65
9807795|NCT00642278|10916741|FG000|COMPLETED|Overall Study||55
9807796|NCT00642278|10916742|FG001|COMPLETED|Overall Study||59
9807797|NCT00642278|10916743|FG002|COMPLETED|Overall Study||59
9807798|NCT00642278|10916744|FG003|COMPLETED|Overall Study||56
9807799|NCT00642278|10916745|FG004|COMPLETED|Overall Study||56
9807800|NCT00642278|10916746|FG005|COMPLETED|Overall Study||57
9807801|NCT00642278|10916747|FG006|COMPLETED|Overall Study||60
9807802|NCT00642278|10916741|FG000|NOT COMPLETED|Overall Study||10
9807803|NCT00642278|10916742|FG001|NOT COMPLETED|Overall Study||5
9807804|NCT00642278|10916743|FG002|NOT COMPLETED|Overall Study||5
9807805|NCT00642278|10916744|FG003|NOT COMPLETED|Overall Study||9
9807806|NCT00642278|10916745|FG004|NOT COMPLETED|Overall Study||8
9807807|NCT00642278|10916746|FG005|NOT COMPLETED|Overall Study||7
9807808|NCT00642278|10916747|FG006|NOT COMPLETED|Overall Study||5
9807809|NCT00642304|10916763|FG000|STARTED|Overall Study||20
9807810|NCT00642304|10916763|FG000|COMPLETED|Overall Study||14
9807811|NCT00642304|10916763|FG000|NOT COMPLETED|Overall Study||6
9807812|NCT00642356|10916769|FG000|STARTED|Overall Study||7
9807813|NCT00642356|10916770|FG001|STARTED|Overall Study||7
9807814|NCT00642356|10916769|FG000|COMPLETED|Overall Study||5
9807815|NCT00642356|10916770|FG001|COMPLETED|Overall Study||4
9807816|NCT00642356|10916769|FG000|NOT COMPLETED|Overall Study||2
9807817|NCT00642356|10916770|FG001|NOT COMPLETED|Overall Study||3
9807818|NCT00642369|10916778|FG000|STARTED|Overall Study||30
9807819|NCT00642369|10916779|FG001|STARTED|Overall Study||30
9807820|NCT00642369|10916778|FG000|COMPLETED|Overall Study||25
9807821|NCT00642369|10916779|FG001|COMPLETED|Overall Study||24
9807822|NCT00642369|10916778|FG000|NOT COMPLETED|Overall Study||5
9807823|NCT00642369|10916779|FG001|NOT COMPLETED|Overall Study||6
9807824|NCT00642460|10916789|FG000|STARTED|Part I: 12 Week Double-Blind||37
9807825|NCT00642460|10916790|FG001|STARTED|Part I: 12 Week Double-Blind||38
9807826|NCT00642460|10916791|FG002|STARTED|Part I: 12 Week Double-Blind||37
9807827|NCT00642460|10916792|FG003|STARTED|Part I: 12 Week Double-Blind||0
9807828|NCT00642460|10916793|FG004|STARTED|Part I: 12 Week Double-Blind||0
9807829|NCT00642460|10916794|FG005|STARTED|Part I: 12 Week Double-Blind||0
9807830|NCT00642460|10916789|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
9807831|NCT00642460|10916790|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
9807832|NCT00642460|10916791|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
9807833|NCT00642460|10916792|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
9807834|NCT00642460|10916793|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
9807835|NCT00642460|10916794|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
9807836|NCT00642460|10916789|FG000|COMPLETED|Part I: 12 Week Double-Blind||36
9807837|NCT00642460|10916790|FG001|COMPLETED|Part I: 12 Week Double-Blind||37
9807838|NCT00642460|10916791|FG002|COMPLETED|Part I: 12 Week Double-Blind||36
9807839|NCT00642460|10916792|FG003|COMPLETED|Part I: 12 Week Double-Blind||0
9807840|NCT00642460|10916793|FG004|COMPLETED|Part I: 12 Week Double-Blind||0
9807841|NCT00642460|10916794|FG005|COMPLETED|Part I: 12 Week Double-Blind||0
9807842|NCT00642460|10916789|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1
9807843|NCT00642460|10916790|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1
9807844|NCT00642460|10916791|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1
9807845|NCT00642460|10916792|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0
9807846|NCT00642460|10916793|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0
9807847|NCT00642460|10916794|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0
9807848|NCT00642460|10916789|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
9807849|NCT00642460|10916790|FG001|STARTED|Part II: Open-Label Up to Week 92||40
9807850|NCT00642460|10916791|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
9807851|NCT00642460|10916792|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
9807852|NCT00642460|10916793|FG004|STARTED|Part II: Open-Label Up to Week 92||0
9807853|NCT00642460|10916794|FG005|STARTED|Part II: Open-Label Up to Week 92||0
9807854|NCT00642460|10916789|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
9807855|NCT00642460|10916790|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
9807856|NCT00642460|10916791|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
9807857|NCT00642460|10916792|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
9807858|NCT00642460|10916793|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
9807859|NCT00642460|10916794|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
9807860|NCT00642460|10916789|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43
9807861|NCT00642460|10916790|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32
9807862|NCT00642460|10916791|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0
9807863|NCT00642460|10916792|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17
9807864|NCT00642460|10916793|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0
9807865|NCT00642460|10916794|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0
9807866|NCT00642460|10916789|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
9807867|NCT00642460|10916790|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
9807868|NCT00642460|10916791|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
9807869|NCT00642460|10916792|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
9807870|NCT00642460|10916793|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
9807871|NCT00642460|10916794|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
9807872|NCT00642460|10916789|FG000|STARTED|Part III: Open-Label Up to Week 260||0
9807873|NCT00642460|10916790|FG001|STARTED|Part III: Open-Label Up to Week 260||0
9807874|NCT00642460|10916791|FG002|STARTED|Part III: Open-Label Up to Week 260||0
9807875|NCT00642460|10916792|FG003|STARTED|Part III: Open-Label Up to Week 260||0
9807876|NCT00642460|10916793|FG004|STARTED|Part III: Open-Label Up to Week 260||53
9807877|NCT00642460|10916794|FG005|STARTED|Part III: Open-Label Up to Week 260||59
9807878|NCT00642460|10916789|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0
9807879|NCT00642460|10916790|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0
9807880|NCT00642460|10916791|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0
9807881|NCT00642460|10916792|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0
9807882|NCT00642460|10916793|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28
9807883|NCT00642460|10916794|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38
9807884|NCT00642460|10916789|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
9807885|NCT00642460|10916790|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
9807886|NCT00642460|10916791|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
9807887|NCT00642460|10916792|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
9807888|NCT00642460|10916793|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
9807889|NCT00642460|10916794|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
9807890|NCT00642473|10916806|FG000|STARTED|Overall Study||18
9807891|NCT00642473|10916807|FG001|STARTED|Overall Study||16
9807892|NCT00642473|10916806|FG000|COMPLETED|Overall Study||14
9807893|NCT00642473|10916807|FG001|COMPLETED|Overall Study||5
9807894|NCT00642473|10916806|FG000|NOT COMPLETED|Overall Study||4
9807895|NCT00642473|10916807|FG001|NOT COMPLETED|Overall Study||11
9807896|NCT00642616|10916820|FG000|STARTED|Overall Study||9
9807897|NCT00642616|10916821|FG001|STARTED|Overall Study||8
9807898|NCT00642616|10916822|FG002|STARTED|Overall Study||9
9807899|NCT00642616|10916823|FG003|STARTED|Overall Study||8
9807900|NCT00642616|10916820|FG000|COMPLETED|Overall Study||0
9807901|NCT00642616|10916821|FG001|COMPLETED|Overall Study||1
9807902|NCT00642616|10916822|FG002|COMPLETED|Overall Study||0
9807903|NCT00642616|10916823|FG003|COMPLETED|Overall Study||1
9807904|NCT00642616|10916820|FG000|NOT COMPLETED|Overall Study||9
9807905|NCT00642616|10916821|FG001|NOT COMPLETED|Overall Study||7
9807906|NCT00642616|10916822|FG002|NOT COMPLETED|Overall Study||9
9807907|NCT00642616|10916823|FG003|NOT COMPLETED|Overall Study||7
9807908|NCT00642642|10916835|FG000|STARTED|Biopsy & Product Manufacture||122
9807909|NCT00642642|10916835|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
9807910|NCT00642642|10916835|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13
9807911|NCT00642642|10916835|FG000|STARTED|Treatment & Follow Up||109
9807912|NCT00642642|10916835|FG000|COMPLETED|Treatment & Follow Up||92
9807913|NCT00642642|10916835|FG000|NOT COMPLETED|Treatment & Follow Up||17
9807914|NCT00642668|10916845|FG000|STARTED|Overall Study||35
9807915|NCT00642668|10916845|FG000|COMPLETED|Overall Study||21
9807916|NCT00642668|10916845|FG000|NOT COMPLETED|Overall Study||14
9807917|NCT00642694|10916851|FG000|STARTED|Overall Study||14
9807918|NCT00642694|10916852|FG001|STARTED|Overall Study||15
9807919|NCT00642694|10916851|FG000|COMPLETED|Overall Study||8
9807920|NCT00642694|10916852|FG001|COMPLETED|Overall Study||11
9807921|NCT00642694|10916851|FG000|NOT COMPLETED|Overall Study||6
9807922|NCT00642694|10916852|FG001|NOT COMPLETED|Overall Study||4
9807923|NCT00642707|10916862|FG000|STARTED|Overall Study||11
9807924|NCT00642707|10916863|FG001|STARTED|Overall Study||11
9807925|NCT00642707|10916864|FG002|STARTED|Overall Study||12
9807926|NCT00642707|10916865|FG003|STARTED|Overall Study||10
9807927|NCT00642707|10916862|FG000|COMPLETED|Overall Study||10
9807928|NCT00642707|10916863|FG001|COMPLETED|Overall Study||11
9807929|NCT00642707|10916864|FG002|COMPLETED|Overall Study||12
9807930|NCT00642707|10916865|FG003|COMPLETED|Overall Study||8
9807931|NCT00642707|10916862|FG000|NOT COMPLETED|Overall Study||1
9807932|NCT00642707|10916863|FG001|NOT COMPLETED|Overall Study||0
9807933|NCT00642707|10916864|FG002|NOT COMPLETED|Overall Study||0
9807934|NCT00642707|10916865|FG003|NOT COMPLETED|Overall Study||2
9831519|NCT00768599|10942148|FG000|STARTED|Overall Study||45
9831520|NCT00768599|10942149|FG001|STARTED|Overall Study||43
9831521|NCT00768599|10942150|FG002|STARTED|Overall Study||47
9831522|NCT00768599|10942148|FG000|COMPLETED|Overall Study||34
9831523|NCT00768599|10942149|FG001|COMPLETED|Overall Study||27
9831524|NCT00768599|10942150|FG002|COMPLETED|Overall Study||35
9831525|NCT00768599|10942148|FG000|NOT COMPLETED|Overall Study||11
9831526|NCT00768599|10942149|FG001|NOT COMPLETED|Overall Study||16
9831527|NCT00768599|10942150|FG002|NOT COMPLETED|Overall Study||12
9831528|NCT00768651|10942158|FG000|STARTED|Overall Study||8
9831529|NCT00768651|10942158|FG000|COMPLETED|Overall Study||7
9831530|NCT00768651|10942158|FG000|NOT COMPLETED|Overall Study||1
9831531|NCT00768664|10942163|FG000|STARTED|Overall Study||69
9831532|NCT00768664|10942163|FG000|COMPLETED|Overall Study||0
9831533|NCT00768664|10942163|FG000|NOT COMPLETED|Overall Study||69
9831534|NCT00768716|10942169|FG000|STARTED|Overall Study||54
9831535|NCT00768716|10942170|FG001|STARTED|Overall Study||41
9831536|NCT00768716|10942169|FG000|COMPLETED|Overall Study||54
9831537|NCT00768716|10942170|FG001|COMPLETED|Overall Study||41
9831538|NCT00768716|10942169|FG000|NOT COMPLETED|Overall Study||0
9831539|NCT00768716|10942170|FG001|NOT COMPLETED|Overall Study||0
9831540|NCT00768755|10942183|FG000|STARTED|Phase 1||10
9831541|NCT00768755|10942184|FG001|STARTED|Phase 1||0
9831542|NCT00768755|10942185|FG002|STARTED|Phase 1||0
9831543|NCT00768755|10942186|FG003|STARTED|Phase 1||0
9831544|NCT00768755|10942183|FG000|COMPLETED|Phase 1||0
9831545|NCT00768755|10942184|FG001|COMPLETED|Phase 1||0
9831546|NCT00768755|10942185|FG002|COMPLETED|Phase 1||0
9831547|NCT00768755|10942186|FG003|COMPLETED|Phase 1||0
9831548|NCT00768755|10942183|FG000|NOT COMPLETED|Phase 1||10
9831549|NCT00768755|10942184|FG001|NOT COMPLETED|Phase 1||0
9831550|NCT00768755|10942185|FG002|NOT COMPLETED|Phase 1||0
9831551|NCT00768755|10942186|FG003|NOT COMPLETED|Phase 1||0
9831552|NCT00768755|10942183|FG000|STARTED|Phase 2||0
9831553|NCT00768755|10942184|FG001|STARTED|Phase 2||55
9831554|NCT00768755|10942185|FG002|STARTED|Phase 2||58
9831555|NCT00768755|10942186|FG003|STARTED|Phase 2||57
9831556|NCT00768755|10942183|FG000|Treated|Phase 2||0
9831557|NCT00768755|10942184|FG001|Treated|Phase 2||55
9831558|NCT00768755|10942185|FG002|Treated|Phase 2||58
9831559|NCT00768755|10942186|FG003|Treated|Phase 2||55
9831560|NCT00768755|10942183|FG000|COMPLETED|Phase 2||0
9831561|NCT00768755|10942184|FG001|COMPLETED|Phase 2||0
9831562|NCT00768755|10942185|FG002|COMPLETED|Phase 2||0
9831563|NCT00768755|10942186|FG003|COMPLETED|Phase 2||0
9831564|NCT00768755|10942183|FG000|NOT COMPLETED|Phase 2||0
9831565|NCT00768755|10942184|FG001|NOT COMPLETED|Phase 2||55
9807935|NCT00642746|10916877|FG000|STARTED|Overall Study||10
9807936|NCT00642746|10916878|FG001|STARTED|Overall Study||1
9807937|NCT00642746|10916877|FG000|COMPLETED|Overall Study||9
9807938|NCT00642746|10916878|FG001|COMPLETED|Overall Study||1
9807939|NCT00642746|10916877|FG000|NOT COMPLETED|Overall Study||1
9807940|NCT00642746|10916878|FG001|NOT COMPLETED|Overall Study||0
9807941|NCT00642759|10916884|FG000|STARTED|Overall Study||36
9807942|NCT00642759|10916884|FG000|COMPLETED|Overall Study||35
9807943|NCT00642759|10916884|FG000|NOT COMPLETED|Overall Study||1
9807944|NCT00642772|10916889|FG000|STARTED|Overall Study||24
9807945|NCT00642772|10916889|FG000|COMPLETED|Overall Study||14
9807946|NCT00642772|10916889|FG000|NOT COMPLETED|Overall Study||10
9807947|NCT00642811|10916899|FG000|STARTED|Overall Study||20
9807948|NCT00642811|10916900|FG001|STARTED|Overall Study||21
9807949|NCT00642811|10916901|FG002|STARTED|Overall Study||13
9807950|NCT00642811|10916902|FG003|STARTED|Overall Study||16
9807951|NCT00642811|10916903|FG004|STARTED|Overall Study||14
9807952|NCT00642811|10916904|FG005|STARTED|Overall Study||14
9807953|NCT00642811|10916899|FG000|COMPLETED|Overall Study||17
9807954|NCT00642811|10916900|FG001|COMPLETED|Overall Study||17
9807955|NCT00642811|10916901|FG002|COMPLETED|Overall Study||13
9807956|NCT00642811|10916902|FG003|COMPLETED|Overall Study||15
9807957|NCT00642811|10916903|FG004|COMPLETED|Overall Study||13
9807958|NCT00642811|10916904|FG005|COMPLETED|Overall Study||13
9807959|NCT00642811|10916899|FG000|NOT COMPLETED|Overall Study||3
9807960|NCT00642811|10916900|FG001|NOT COMPLETED|Overall Study||4
9807961|NCT00642811|10916901|FG002|NOT COMPLETED|Overall Study||0
9807962|NCT00642811|10916902|FG003|NOT COMPLETED|Overall Study||1
9807963|NCT00642811|10916903|FG004|NOT COMPLETED|Overall Study||1
9807964|NCT00642811|10916904|FG005|NOT COMPLETED|Overall Study||1
9807965|NCT00642850|10916918|FG000|STARTED|Overall Study||188
9807966|NCT00642850|10916918|FG000|COMPLETED|Overall Study||155
9807967|NCT00642850|10916918|FG000|NOT COMPLETED|Overall Study||33
9807968|NCT00642902|10916926|FG000|STARTED|Overall Study||63
9807969|NCT00642902|10916927|FG001|STARTED|Overall Study||63
9807970|NCT00642902|10916928|FG002|STARTED|Overall Study||64
9807971|NCT00642902|10916929|FG003|STARTED|Overall Study||65
9807972|NCT00642902|10916926|FG000|Treated|Overall Study||63
9807973|NCT00642902|10916927|FG001|Treated|Overall Study||63
9807974|NCT00642902|10916928|FG002|Treated|Overall Study||63
9807975|NCT00642902|10916929|FG003|Treated|Overall Study||65
9807976|NCT00642902|10916926|FG000|COMPLETED|Overall Study||23
9807977|NCT00642902|10916927|FG001|COMPLETED|Overall Study||21
9807978|NCT00642902|10916928|FG002|COMPLETED|Overall Study||21
9807979|NCT00642902|10916929|FG003|COMPLETED|Overall Study||25
9807980|NCT00642902|10916926|FG000|NOT COMPLETED|Overall Study||40
9807981|NCT00642902|10916927|FG001|NOT COMPLETED|Overall Study||42
9807982|NCT00642902|10916928|FG002|NOT COMPLETED|Overall Study||43
9807983|NCT00642902|10916929|FG003|NOT COMPLETED|Overall Study||40
9807984|NCT00642941|10916951|FG000|STARTED|Overall Study||70
9807985|NCT00642941|10916952|FG001|STARTED|Overall Study||54
9807986|NCT00642941|10916953|FG002|STARTED|Overall Study||7
9807987|NCT00642941|10916954|FG003|STARTED|Overall Study||40
9807988|NCT00642941|10916955|FG004|STARTED|Overall Study||25
9807989|NCT00642941|10916956|FG005|STARTED|Overall Study||41
9807990|NCT00642941|10916957|FG006|STARTED|Overall Study||23
9807991|NCT00642941|10916958|FG007|STARTED|Overall Study||14
9807992|NCT00642941|10916959|FG008|STARTED|Overall Study||11
9807993|NCT00642941|10916960|FG009|STARTED|Overall Study||9
9807994|NCT00642941|10916961|FG010|STARTED|Overall Study||12
9807995|NCT00642941|10916962|FG011|STARTED|Overall Study||11
9807996|NCT00642941|10916951|FG000|COMPLETED|Overall Study||0
9807997|NCT00642941|10916952|FG001|COMPLETED|Overall Study||0
9807998|NCT00642941|10916953|FG002|COMPLETED|Overall Study||0
9807999|NCT00642941|10916954|FG003|COMPLETED|Overall Study||0
9808000|NCT00642941|10916955|FG004|COMPLETED|Overall Study||0
9808001|NCT00642941|10916956|FG005|COMPLETED|Overall Study||0
9808002|NCT00642941|10916957|FG006|COMPLETED|Overall Study||0
9808003|NCT00642941|10916958|FG007|COMPLETED|Overall Study||0
9808004|NCT00642941|10916959|FG008|COMPLETED|Overall Study||0
9808005|NCT00642941|10916960|FG009|COMPLETED|Overall Study||0
9808006|NCT00642941|10916961|FG010|COMPLETED|Overall Study||0
9808007|NCT00642941|10916962|FG011|COMPLETED|Overall Study||0
9808008|NCT00642941|10916951|FG000|NOT COMPLETED|Overall Study||70
9808009|NCT00642941|10916952|FG001|NOT COMPLETED|Overall Study||54
9808010|NCT00642941|10916953|FG002|NOT COMPLETED|Overall Study||7
9808011|NCT00642941|10916954|FG003|NOT COMPLETED|Overall Study||40
9808012|NCT00642941|10916955|FG004|NOT COMPLETED|Overall Study||25
9808013|NCT00642941|10916956|FG005|NOT COMPLETED|Overall Study||41
9808014|NCT00642941|10916957|FG006|NOT COMPLETED|Overall Study||23
9808015|NCT00642941|10916958|FG007|NOT COMPLETED|Overall Study||14
9808016|NCT00642941|10916959|FG008|NOT COMPLETED|Overall Study||11
9808017|NCT00642941|10916960|FG009|NOT COMPLETED|Overall Study||9
9808018|NCT00642941|10916961|FG010|NOT COMPLETED|Overall Study||12
9808019|NCT00642941|10916962|FG011|NOT COMPLETED|Overall Study||11
9808020|NCT00642954|10917014|FG000|STARTED|Overall Study||4
9808021|NCT00642954|10917015|FG001|STARTED|Overall Study||4
9808022|NCT00642954|10917016|FG002|STARTED|Overall Study||3
9808023|NCT00642954|10917017|FG003|STARTED|Overall Study||3
9808024|NCT00642954|10917018|FG004|STARTED|Overall Study||17
9808025|NCT00642954|10917014|FG000|COMPLETED|Overall Study||0
9808026|NCT00642954|10917015|FG001|COMPLETED|Overall Study||0
9808027|NCT00642954|10917016|FG002|COMPLETED|Overall Study||0
9808028|NCT00642954|10917017|FG003|COMPLETED|Overall Study||0
9808029|NCT00642954|10917018|FG004|COMPLETED|Overall Study||1
9808030|NCT00642954|10917014|FG000|NOT COMPLETED|Overall Study||4
9808031|NCT00642954|10917015|FG001|NOT COMPLETED|Overall Study||4
9808032|NCT00642954|10917016|FG002|NOT COMPLETED|Overall Study||3
9808033|NCT00642954|10917017|FG003|NOT COMPLETED|Overall Study||3
9808034|NCT00642954|10917018|FG004|NOT COMPLETED|Overall Study||16
9808035|NCT00642993|10917032|FG000|STARTED|Overall Study||267
9808036|NCT00642993|10917033|FG001|STARTED|Overall Study||134
9808037|NCT00642993|10917032|FG000|COMPLETED|Overall Study||161
9808038|NCT00642993|10917033|FG001|COMPLETED|Overall Study||118
9808039|NCT00642993|10917032|FG000|NOT COMPLETED|Overall Study||106
9808040|NCT00642993|10917033|FG001|NOT COMPLETED|Overall Study||16
9808041|NCT00643006|10917041|FG000|STARTED|Overall Study||34
10016095|NCT01808560|11139039|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0
10016096|NCT01808560|11139040|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0
10016097|NCT01808560|11139038|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
10016098|NCT01808560|11139039|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
10016099|NCT01808560|11139040|FG002|STARTED|1-Month After Cataract Surgery||0
10016100|NCT01808560|11139038|FG000|COMPLETED|1-Month After Cataract Surgery||16
10016101|NCT01808560|11139039|FG001|COMPLETED|1-Month After Cataract Surgery||13
10016102|NCT01808560|11139040|FG002|COMPLETED|1-Month After Cataract Surgery||0
10016103|NCT01808560|11139038|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0
10016104|NCT01808560|11139039|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0
10016105|NCT01808560|11139040|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0
10016106|NCT01808560|11139038|FG000|STARTED|3-Month After Cataract Surgery||17
10016107|NCT01808560|11139039|FG001|STARTED|3-Month After Cataract Surgery||13
10016108|NCT01808560|11139040|FG002|STARTED|3-Month After Cataract Surgery||0
10016109|NCT01808560|11139038|FG000|COMPLETED|3-Month After Cataract Surgery||17
10016110|NCT01808560|11139039|FG001|COMPLETED|3-Month After Cataract Surgery||13
10016111|NCT01808560|11139040|FG002|COMPLETED|3-Month After Cataract Surgery||0
10016112|NCT01808560|11139038|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0
10016113|NCT01808560|11139039|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0
10016114|NCT01808560|11139040|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0
10016115|NCT01808560|11139038|FG000|STARTED|Crossover Treatment||0
10016116|NCT01808560|11139039|FG001|STARTED|Crossover Treatment||0
10016117|NCT01808560|11139040|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
10016118|NCT01808560|11139038|FG000|COMPLETED|Crossover Treatment||0
10016119|NCT01808560|11139039|FG001|COMPLETED|Crossover Treatment||0
10016120|NCT01808560|11139040|FG002|COMPLETED|Crossover Treatment||13
10016121|NCT01808560|11139038|FG000|NOT COMPLETED|Crossover Treatment||0
10016122|NCT01808560|11139039|FG001|NOT COMPLETED|Crossover Treatment||0
10016123|NCT01808560|11139040|FG002|NOT COMPLETED|Crossover Treatment||0
10016124|NCT01808560|11139038|FG000|STARTED|4-Month After Cataract Surgery||0
10016125|NCT01808560|11139039|FG001|STARTED|4-Month After Cataract Surgery||0
10016126|NCT01808560|11139040|FG002|STARTED|4-Month After Cataract Surgery||13
10016127|NCT01808560|11139038|FG000|COMPLETED|4-Month After Cataract Surgery||0
10016128|NCT01808560|11139039|FG001|COMPLETED|4-Month After Cataract Surgery||0
10016129|NCT01808560|11139040|FG002|COMPLETED|4-Month After Cataract Surgery||13
10016130|NCT01808560|11139038|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0
10016131|NCT01808560|11139039|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0
10016132|NCT01808560|11139040|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0
10016133|NCT01808573|11139050|FG000|STARTED|Overall Study||307
10016134|NCT01808573|11139051|FG001|STARTED|Overall Study||314
10016135|NCT01808573|11139050|FG000|Received Treatment|Overall Study||303
10016136|NCT01808573|11139051|FG001|Received Treatment|Overall Study||311
10016137|NCT01808573|11139050|FG000|COMPLETED|Overall Study||0
10016138|NCT01808573|11139051|FG001|COMPLETED|Overall Study||0
10016139|NCT01808573|11139050|FG000|NOT COMPLETED|Overall Study||307
10016140|NCT01808573|11139051|FG001|NOT COMPLETED|Overall Study||314
10016141|NCT01808612|11139060|FG000|STARTED|Treatment Period||169
10016142|NCT01808612|11139061|FG001|STARTED|Treatment Period||84
9808042|NCT00643006|10917042|FG001|STARTED|Overall Study||33
9808043|NCT00643006|10917041|FG000|COMPLETED|Overall Study||29
9808044|NCT00643006|10917042|FG001|COMPLETED|Overall Study||29
9808045|NCT00643006|10917041|FG000|NOT COMPLETED|Overall Study||5
9808046|NCT00643006|10917042|FG001|NOT COMPLETED|Overall Study||4
10016143|NCT01808612|11139062|FG002|STARTED|Treatment Period||260
10016144|NCT01808612|11139060|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
10016145|NCT01808612|11139061|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
10016146|NCT01808612|11139062|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
10016147|NCT01808612|11139060|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
10016148|NCT01808612|11139061|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
10016149|NCT01808612|11139062|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
10016150|NCT01808612|11139060|FG000|NOT COMPLETED|Treatment Period||15
10016151|NCT01808612|11139061|FG001|NOT COMPLETED|Treatment Period||7
10016152|NCT01808612|11139062|FG002|NOT COMPLETED|Treatment Period||14
10016153|NCT01808612|11139060|FG000|STARTED|Discontinuation Period||87
10016154|NCT01808612|11139061|FG001|STARTED|Discontinuation Period||38
10016155|NCT01808612|11139062|FG002|STARTED|Discontinuation Period||145
10016156|NCT01808612|11139060|FG000|COMPLETED|Discontinuation Period||85
10016157|NCT01808612|11139061|FG001|COMPLETED|Discontinuation Period||37
10016158|NCT01808612|11139062|FG002|COMPLETED|Discontinuation Period||145
10016159|NCT01808612|11139060|FG000|NOT COMPLETED|Discontinuation Period||2
10016160|NCT01808612|11139061|FG001|NOT COMPLETED|Discontinuation Period||1
10016161|NCT01808612|11139062|FG002|NOT COMPLETED|Discontinuation Period||0
10016162|NCT01808651|11139076|FG000|STARTED|Study Period 1||99
10016163|NCT01808651|11139077|FG001|STARTED|Study Period 1||65
10016164|NCT01808651|11139078|FG002|STARTED|Study Period 1||36
10016165|NCT01808651|11139076|FG000|Received at Least One Dose of Study Drug|Study Period 1||98
10016166|NCT01808651|11139077|FG001|Received at Least One Dose of Study Drug|Study Period 1||65
10016167|NCT01808651|11139078|FG002|Received at Least One Dose of Study Drug|Study Period 1||36
10016168|NCT01808651|11139076|FG000|COMPLETED|Study Period 1||73
10016169|NCT01808651|11139077|FG001|COMPLETED|Study Period 1||48
10016170|NCT01808651|11139078|FG002|COMPLETED|Study Period 1||31
10016171|NCT01808651|11139076|FG000|NOT COMPLETED|Study Period 1||26
10016172|NCT01808651|11139077|FG001|NOT COMPLETED|Study Period 1||17
10016173|NCT01808651|11139078|FG002|NOT COMPLETED|Study Period 1||5
10016174|NCT01808651|11139076|FG000|STARTED|Study Period 2||77
10016175|NCT01808651|11139077|FG001|STARTED|Study Period 2||52
10016176|NCT01808651|11139078|FG002|STARTED|Study Period 2||33
10016177|NCT01808651|11139076|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
10016178|NCT01808651|11139077|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
10016179|NCT01808651|11139078|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
10016180|NCT01808651|11139076|FG000|NOT COMPLETED|Study Period 2||0
10016181|NCT01808651|11139077|FG001|NOT COMPLETED|Study Period 2||0
10016182|NCT01808651|11139078|FG002|NOT COMPLETED|Study Period 2||0
10016183|NCT01808690|11139091|FG000|STARTED|Overall Study||25
10016184|NCT01808690|11139092|FG001|STARTED|Overall Study||23
10016185|NCT01808690|11139091|FG000|COMPLETED|Overall Study||24
10016186|NCT01808690|11139092|FG001|COMPLETED|Overall Study||21
10016187|NCT01808690|11139091|FG000|NOT COMPLETED|Overall Study||1
10016188|NCT01808690|11139092|FG001|NOT COMPLETED|Overall Study||2
10016189|NCT01808755|11139098|FG000|STARTED|Overall Study||30
10016190|NCT01808755|11139099|FG001|STARTED|Overall Study||30
10016191|NCT01808755|11139098|FG000|COMPLETED|Overall Study||30
10016192|NCT01808755|11139099|FG001|COMPLETED|Overall Study||30
10016193|NCT01808755|11139098|FG000|NOT COMPLETED|Overall Study||0
10016194|NCT01808755|11139099|FG001|NOT COMPLETED|Overall Study||0
10016195|NCT01808963|11139104|FG000|STARTED|Overall Study||13
9808047|NCT00643097|10917053|FG000|STARTED|Overall Study||18
9808048|NCT00643097|10917054|FG001|STARTED|Overall Study||12
9808049|NCT00643097|10917055|FG002|STARTED|Overall Study||10
9808050|NCT00643097|10917053|FG000|COMPLETED|Overall Study||18
9808051|NCT00643097|10917054|FG001|COMPLETED|Overall Study||12
9808052|NCT00643097|10917055|FG002|COMPLETED|Overall Study||10
9808053|NCT00643097|10917053|FG000|NOT COMPLETED|Overall Study||0
9808054|NCT00643097|10917054|FG001|NOT COMPLETED|Overall Study||0
9808055|NCT00643097|10917055|FG002|NOT COMPLETED|Overall Study||0
9808056|NCT00643123|10917065|FG000|STARTED|Overall Study||15
9808057|NCT00643123|10917066|FG001|STARTED|Overall Study||12
9808058|NCT00643123|10917065|FG000|COMPLETED|Overall Study||10
9808059|NCT00643123|10917066|FG001|COMPLETED|Overall Study||11
10016196|NCT01808963|11139104|FG000|COMPLETED|Overall Study||13
10016197|NCT01808963|11139104|FG000|NOT COMPLETED|Overall Study||0
10016198|NCT01809054|11139110|FG000|STARTED|Overall Study||27
10016199|NCT01809054|11139111|FG001|STARTED|Overall Study||22
10016200|NCT01809054|11139110|FG000|COMPLETED|Overall Study||27
10016201|NCT01809054|11139111|FG001|COMPLETED|Overall Study||22
9808060|NCT00643123|10917065|FG000|NOT COMPLETED|Overall Study||5
9808061|NCT00643123|10917066|FG001|NOT COMPLETED|Overall Study||1
9808062|NCT00643162|10917074|FG000|STARTED|Overall Study||7
9808063|NCT00643162|10917075|FG001|STARTED|Overall Study||5
9808064|NCT00643162|10917074|FG000|COMPLETED|Overall Study||6
9808065|NCT00643162|10917075|FG001|COMPLETED|Overall Study||4
9808066|NCT00643162|10917074|FG000|NOT COMPLETED|Overall Study||1
9808067|NCT00643162|10917075|FG001|NOT COMPLETED|Overall Study||1
9808068|NCT00643201|10917083|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
9808069|NCT00643201|10917084|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
9808070|NCT00643201|10917083|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314
9808071|NCT00643201|10917084|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291
9808072|NCT00643201|10917083|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
9808073|NCT00643201|10917084|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
9808074|NCT00643201|10917083|FG000|STARTED|Completed Study Follow Up||2617
10016202|NCT01809054|11139110|FG000|NOT COMPLETED|Overall Study||0
10016203|NCT01809054|11139111|FG001|NOT COMPLETED|Overall Study||0
10016204|NCT01809106|11139121|FG000|STARTED|Overall Study||130
9808075|NCT00643201|10917084|FG001|STARTED|Completed Study Follow Up||2639
10016205|NCT01809106|11139122|FG001|STARTED|Overall Study||130
10016206|NCT01809106|11139123|FG002|STARTED|Overall Study||130
10016207|NCT01809106|11139124|FG003|STARTED|Overall Study||128
10016208|NCT01809106|11139121|FG000|COMPLETED|Overall Study||122
9808076|NCT00643201|10917083|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
9808077|NCT00643201|10917084|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
9808078|NCT00643201|10917083|FG000|NOT COMPLETED|Completed Study Follow Up||70
9808079|NCT00643201|10917084|FG001|NOT COMPLETED|Completed Study Follow Up||79
9808080|NCT00643279|10917094|FG000|STARTED|Overall Study||134
9808081|NCT00643279|10917095|FG001|STARTED|Overall Study||140
9808082|NCT00643279|10917094|FG000|COMPLETED|Overall Study||118
9808083|NCT00643279|10917095|FG001|COMPLETED|Overall Study||127
9808084|NCT00643279|10917094|FG000|NOT COMPLETED|Overall Study||16
9808085|NCT00643279|10917095|FG001|NOT COMPLETED|Overall Study||13
9808086|NCT00643448|10917106|FG000|STARTED|Overall Study||21
9808087|NCT00643448|10917107|FG001|STARTED|Overall Study||22
9808088|NCT00643448|10917108|FG002|STARTED|Overall Study||22
9808089|NCT00643448|10917106|FG000|COMPLETED|Overall Study||17
9808090|NCT00643448|10917107|FG001|COMPLETED|Overall Study||17
9808091|NCT00643448|10917108|FG002|COMPLETED|Overall Study||16
9808092|NCT00643448|10917106|FG000|NOT COMPLETED|Overall Study||4
9808093|NCT00643448|10917107|FG001|NOT COMPLETED|Overall Study||5
9808094|NCT00643448|10917108|FG002|NOT COMPLETED|Overall Study||6
9808095|NCT00643487|10917118|FG000|STARTED|Overall Study||8
9808096|NCT00643487|10917118|FG000|COMPLETED|Overall Study||5
9808097|NCT00643487|10917118|FG000|NOT COMPLETED|Overall Study||3
9808098|NCT00643565|10917124|FG000|STARTED|Overall Study||80
9808099|NCT00643565|10917125|FG001|STARTED|Overall Study||74
9808100|NCT00643565|10917124|FG000|COMPLETED|Overall Study||7
9808101|NCT00643565|10917125|FG001|COMPLETED|Overall Study||7
9808102|NCT00643565|10917124|FG000|NOT COMPLETED|Overall Study||73
9808103|NCT00643565|10917125|FG001|NOT COMPLETED|Overall Study||67
9808104|NCT00643578|10917132|FG000|STARTED|Overall Study||6
9808105|NCT00643578|10917133|FG001|STARTED|Overall Study||6
9808106|NCT00643578|10917132|FG000|COMPLETED|Overall Study||4
9808107|NCT00643578|10917133|FG001|COMPLETED|Overall Study||6
9808108|NCT00643578|10917132|FG000|NOT COMPLETED|Overall Study||2
9808109|NCT00643578|10917133|FG001|NOT COMPLETED|Overall Study||0
9808110|NCT00643604|10917141|FG000|STARTED|Overall Study||7
9808111|NCT00643604|10917141|FG000|COMPLETED|Overall Study||6
9808112|NCT00643604|10917141|FG000|NOT COMPLETED|Overall Study||1
9808113|NCT00643682|10917147|FG000|STARTED|Overall Study||999
9808114|NCT00643682|10917148|FG001|STARTED|Overall Study||1001
9808115|NCT00643682|10917147|FG000|COMPLETED|Overall Study||477
9808116|NCT00643682|10917148|FG001|COMPLETED|Overall Study||492
9808117|NCT00643682|10917147|FG000|NOT COMPLETED|Overall Study||522
9808118|NCT00643682|10917148|FG001|NOT COMPLETED|Overall Study||509
9808119|NCT00643760|10917159|FG000|STARTED|Overall Study||120
9808120|NCT00643760|10917160|FG001|STARTED|Overall Study||62
9808121|NCT00643760|10917161|FG002|STARTED|Overall Study||56
9808122|NCT00643760|10917162|FG003|STARTED|Overall Study||117
9808123|NCT00643760|10917163|FG004|STARTED|Overall Study||66
9808124|NCT00643760|10917159|FG000|Safety Population/Treated With Drug|Overall Study||120
9808125|NCT00643760|10917160|FG001|Safety Population/Treated With Drug|Overall Study||62
9808126|NCT00643760|10917161|FG002|Safety Population/Treated With Drug|Overall Study||56
9808127|NCT00643760|10917162|FG003|Safety Population/Treated With Drug|Overall Study||116
9808128|NCT00643760|10917163|FG004|Safety Population/Treated With Drug|Overall Study||66
9808129|NCT00643760|10917159|FG000|ITT Population|Overall Study||120
9808130|NCT00643760|10917160|FG001|ITT Population|Overall Study||62
9808131|NCT00643760|10917161|FG002|ITT Population|Overall Study||56
9808132|NCT00643760|10917162|FG003|ITT Population|Overall Study||116
9808133|NCT00643760|10917163|FG004|ITT Population|Overall Study||66
9808134|NCT00643760|10917159|FG000|COMPLETED|Overall Study||90
9808135|NCT00643760|10917160|FG001|COMPLETED|Overall Study||47
9808136|NCT00643760|10917161|FG002|COMPLETED|Overall Study||37
9808137|NCT00643760|10917162|FG003|COMPLETED|Overall Study||79
9808138|NCT00643760|10917163|FG004|COMPLETED|Overall Study||47
9808139|NCT00643760|10917159|FG000|NOT COMPLETED|Overall Study||30
9808140|NCT00643760|10917160|FG001|NOT COMPLETED|Overall Study||15
9808141|NCT00643760|10917161|FG002|NOT COMPLETED|Overall Study||19
9808142|NCT00643760|10917162|FG003|NOT COMPLETED|Overall Study||38
9808143|NCT00643760|10917163|FG004|NOT COMPLETED|Overall Study||19
9808144|NCT00643851|10917178|FG000|STARTED|Overall Study||194
9808145|NCT00643851|10917179|FG001|STARTED|Overall Study||203
9808146|NCT00643851|10917180|FG002|STARTED|Overall Study||201
9808147|NCT00643851|10917178|FG000|COMPLETED|Overall Study||177
9808148|NCT00643851|10917179|FG001|COMPLETED|Overall Study||170
9808149|NCT00643851|10917180|FG002|COMPLETED|Overall Study||171
9808150|NCT00643851|10917178|FG000|NOT COMPLETED|Overall Study||17
9808151|NCT00643851|10917179|FG001|NOT COMPLETED|Overall Study||33
9808152|NCT00643851|10917180|FG002|NOT COMPLETED|Overall Study||30
10235360|NCT01193556|11365655|FG001|NOT COMPLETED|Overall Study||25
10235361|NCT01189435|11365661|FG000|STARTED|Overall Study||2
10235362|NCT01189435|11365661|FG000|COMPLETED|Overall Study||0
10235363|NCT01189435|11365661|FG000|NOT COMPLETED|Overall Study||2
9808153|NCT00643916|10917194|FG000|STARTED|Overall Study||55
9808154|NCT00643916|10917195|FG001|STARTED|Overall Study||67
9808155|NCT00643916|10917196|FG002|STARTED|Overall Study||68
9808156|NCT00643916|10917197|FG003|STARTED|Overall Study||62
9808157|NCT00643916|10917198|FG004|STARTED|Overall Study||59
9808158|NCT00643916|10917199|FG005|STARTED|Overall Study||67
9808159|NCT00643916|10917194|FG000|COMPLETED|Overall Study||51
9808160|NCT00643916|10917195|FG001|COMPLETED|Overall Study||61
9808161|NCT00643916|10917196|FG002|COMPLETED|Overall Study||62
9808162|NCT00643916|10917197|FG003|COMPLETED|Overall Study||60
9808163|NCT00643916|10917198|FG004|COMPLETED|Overall Study||57
9808164|NCT00643916|10917199|FG005|COMPLETED|Overall Study||66
9808165|NCT00643916|10917194|FG000|NOT COMPLETED|Overall Study||4
9808166|NCT00643916|10917195|FG001|NOT COMPLETED|Overall Study||6
9808167|NCT00643916|10917196|FG002|NOT COMPLETED|Overall Study||6
9808168|NCT00643916|10917197|FG003|NOT COMPLETED|Overall Study||2
9808169|NCT00643916|10917198|FG004|NOT COMPLETED|Overall Study||2
9808170|NCT00643916|10917199|FG005|NOT COMPLETED|Overall Study||1
9808171|NCT00644059|10917216|FG000|STARTED|Overall Study||2019
9808172|NCT00644059|10917217|FG001|STARTED|Overall Study||1849
9808173|NCT00644059|10917218|FG002|STARTED|Overall Study||1034
9808174|NCT00644059|10917216|FG000|COMPLETED|Overall Study||1895
9808175|NCT00644059|10917217|FG001|COMPLETED|Overall Study||1726
9808176|NCT00644059|10917218|FG002|COMPLETED|Overall Study||969
10016209|NCT01809106|11139122|FG001|COMPLETED|Overall Study||125
10016210|NCT01809106|11139123|FG002|COMPLETED|Overall Study||127
10016211|NCT01809106|11139124|FG003|COMPLETED|Overall Study||124
9808177|NCT00644059|10917216|FG000|NOT COMPLETED|Overall Study||124
9808178|NCT00644059|10917217|FG001|NOT COMPLETED|Overall Study||123
9808179|NCT00644059|10917218|FG002|NOT COMPLETED|Overall Study||65
9808180|NCT00644189|10917267|FG000|STARTED|Phase I||3
9808181|NCT00644189|10917268|FG001|STARTED|Phase I||3
9808182|NCT00644189|10917269|FG002|STARTED|Phase I||6
9808183|NCT00644189|10917270|FG003|STARTED|Phase I||18
9808184|NCT00644189|10917267|FG000|COMPLETED|Phase I||3
9808185|NCT00644189|10917268|FG001|COMPLETED|Phase I||3
9808186|NCT00644189|10917269|FG002|COMPLETED|Phase I||6
9808187|NCT00644189|10917270|FG003|COMPLETED|Phase I||18
9808188|NCT00644189|10917267|FG000|NOT COMPLETED|Phase I||0
9808189|NCT00644189|10917268|FG001|NOT COMPLETED|Phase I||0
9808190|NCT00644189|10917269|FG002|NOT COMPLETED|Phase I||0
9808191|NCT00644189|10917270|FG003|NOT COMPLETED|Phase I||0
9808192|NCT00644189|10917267|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
9808193|NCT00644189|10917268|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
9808194|NCT00644189|10917269|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
10016212|NCT01809106|11139121|FG000|NOT COMPLETED|Overall Study||8
9808195|NCT00644189|10917270|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
9808196|NCT00644189|10917267|FG000|Completed All 6 Cycles of Treatment|Phase II||0
9808197|NCT00644189|10917268|FG001|Completed All 6 Cycles of Treatment|Phase II||0
9808198|NCT00644189|10917269|FG002|Completed All 6 Cycles of Treatment|Phase II||0
9808199|NCT00644189|10917270|FG003|Completed All 6 Cycles of Treatment|Phase II||19
9808200|NCT00644189|10917267|FG000|COMPLETED|Phase II||0
9808201|NCT00644189|10917268|FG001|COMPLETED|Phase II||0
9808202|NCT00644189|10917269|FG002|COMPLETED|Phase II||0
9808203|NCT00644189|10917270|FG003|COMPLETED|Phase II||50
9808204|NCT00644189|10917267|FG000|NOT COMPLETED|Phase II||0
9808205|NCT00644189|10917268|FG001|NOT COMPLETED|Phase II||0
9808206|NCT00644189|10917269|FG002|NOT COMPLETED|Phase II||0
9808207|NCT00644189|10917270|FG003|NOT COMPLETED|Phase II||0
9808208|NCT00644280|10917278|FG000|STARTED|Overall Study||6
9808209|NCT00644280|10917279|FG001|STARTED|Overall Study||5
9808210|NCT00644280|10917278|FG000|COMPLETED|Overall Study||6
9808211|NCT00644280|10917279|FG001|COMPLETED|Overall Study||5
9808212|NCT00644280|10917278|FG000|NOT COMPLETED|Overall Study||0
9808213|NCT00644280|10917279|FG001|NOT COMPLETED|Overall Study||0
9808214|NCT00644332|10917285|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
9808215|NCT00644332|10917285|FG000|COMPLETED|Overall Study||150
9808216|NCT00644332|10917285|FG000|NOT COMPLETED|Overall Study||21
9808217|NCT00644358|10917289|FG000|STARTED|Overall Study||616
9808218|NCT00644358|10917289|FG000|COMPLETED|Overall Study||254
9808219|NCT00644358|10917289|FG000|NOT COMPLETED|Overall Study||362
9808220|NCT00644423|10917295|FG000|STARTED|Overall Study||6
9808221|NCT00644423|10917296|FG001|STARTED|Overall Study||5
9808222|NCT00644423|10917295|FG000|COMPLETED|Overall Study||5
9808223|NCT00644423|10917296|FG001|COMPLETED|Overall Study||4
9808224|NCT00644423|10917295|FG000|NOT COMPLETED|Overall Study||1
9808225|NCT00644423|10917296|FG001|NOT COMPLETED|Overall Study||1
9808226|NCT00644592|10917304|FG000|STARTED|Overall Study||5
9808227|NCT00644592|10917305|FG001|STARTED|Overall Study||6
9808228|NCT00644592|10917304|FG000|COMPLETED|Overall Study||5
9808229|NCT00644592|10917305|FG001|COMPLETED|Overall Study||6
9808230|NCT00644592|10917304|FG000|NOT COMPLETED|Overall Study||0
9808231|NCT00644592|10917305|FG001|NOT COMPLETED|Overall Study||0
9808232|NCT00644657|10917311|FG000|STARTED|Overall Study||27
9808233|NCT00644657|10917311|FG000|COMPLETED|Overall Study||27
9808234|NCT00644657|10917311|FG000|NOT COMPLETED|Overall Study||0
10016213|NCT01809106|11139122|FG001|NOT COMPLETED|Overall Study||5
9808235|NCT00644787|10917315|FG000|STARTED|Period 1: Titration Phase||156
9808236|NCT00644787|10917316|FG001|STARTED|Period 1: Titration Phase||0
9808237|NCT00644787|10917317|FG002|STARTED|Period 1: Titration Phase||0
9808238|NCT00644787|10917315|FG000|COMPLETED|Period 1: Titration Phase||129
9808239|NCT00644787|10917316|FG001|COMPLETED|Period 1: Titration Phase||0
10016214|NCT01809106|11139123|FG002|NOT COMPLETED|Overall Study||3
9808240|NCT00644787|10917317|FG002|COMPLETED|Period 1: Titration Phase||0
9808241|NCT00644787|10917315|FG000|NOT COMPLETED|Period 1: Titration Phase||27
9808242|NCT00644787|10917316|FG001|NOT COMPLETED|Period 1: Titration Phase||0
9808243|NCT00644787|10917317|FG002|NOT COMPLETED|Period 1: Titration Phase||0
9808244|NCT00644787|10917315|FG000|STARTED|Period 2: Double Blind Phase||0
9808245|NCT00644787|10917316|FG001|STARTED|Period 2: Double Blind Phase||58
9808246|NCT00644787|10917317|FG002|STARTED|Period 2: Double Blind Phase||62
9808247|NCT00644787|10917315|FG000|COMPLETED|Period 2: Double Blind Phase||0
9808248|NCT00644787|10917316|FG001|COMPLETED|Period 2: Double Blind Phase||49
9808249|NCT00644787|10917317|FG002|COMPLETED|Period 2: Double Blind Phase||55
9808250|NCT00644787|10917315|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0
9808251|NCT00644787|10917316|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9
9808252|NCT00644787|10917317|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7
9808253|NCT00644878|10917325|FG000|STARTED|Overall Study||18
9808254|NCT00644878|10917325|FG000|COMPLETED|Overall Study||0
9808255|NCT00644878|10917325|FG000|NOT COMPLETED|Overall Study||18
9808256|NCT00644917|10917329|FG000|STARTED|Overall Study||38
9808257|NCT00644917|10917329|FG000|COMPLETED|Overall Study||36
9808258|NCT00644917|10917329|FG000|NOT COMPLETED|Overall Study||2
9808259|NCT00644969|10917339|FG000|STARTED|Treatment Phase||85
9808260|NCT00644969|10917340|FG001|STARTED|Treatment Phase||43
9808261|NCT00644969|10917339|FG000|COMPLETED|Treatment Phase||71
9808262|NCT00644969|10917340|FG001|COMPLETED|Treatment Phase||40
9808263|NCT00644969|10917339|FG000|NOT COMPLETED|Treatment Phase||14
9808264|NCT00644969|10917340|FG001|NOT COMPLETED|Treatment Phase||3
9808265|NCT00644969|10917339|FG000|STARTED|Post Treatment Phase||71
9808266|NCT00644969|10917340|FG001|STARTED|Post Treatment Phase||40
9808267|NCT00644969|10917339|FG000|COMPLETED|Post Treatment Phase||61
9808268|NCT00644969|10917340|FG001|COMPLETED|Post Treatment Phase||37
9808269|NCT00644969|10917339|FG000|NOT COMPLETED|Post Treatment Phase||10
9808270|NCT00644969|10917340|FG001|NOT COMPLETED|Post Treatment Phase||3
9808271|NCT00644995|10917348|FG000|STARTED|Overall Study||25
9808272|NCT00644995|10917349|FG001|STARTED|Overall Study||27
9808273|NCT00644995|10917348|FG000|Completed 4 Month Assessment|Overall Study||23
9808274|NCT00644995|10917349|FG001|Completed 4 Month Assessment|Overall Study||24
9808275|NCT00644995|10917348|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23
9808276|NCT00644995|10917349|FG001|COMPLETED|Overall Study||23
9808277|NCT00644995|10917348|FG000|NOT COMPLETED|Overall Study||2
9808278|NCT00644995|10917349|FG001|NOT COMPLETED|Overall Study||4
9808279|NCT00645047|10917359|FG000|STARTED|Overall Study||103
9808280|NCT00645047|10917360|FG001|STARTED|Overall Study||104
9808281|NCT00645047|10917359|FG000|Post|Overall Study||74
9808282|NCT00645047|10917360|FG001|Post|Overall Study||80
9808283|NCT00645047|10917359|FG000|COMPLETED|Overall Study|6 month follow up|60
9808284|NCT00645047|10917360|FG001|COMPLETED|Overall Study||65
9808285|NCT00645047|10917359|FG000|NOT COMPLETED|Overall Study||43
9808286|NCT00645047|10917360|FG001|NOT COMPLETED|Overall Study||39
9808287|NCT00645099|10917368|FG000|STARTED|Overall Study||239
9808288|NCT00645099|10917369|FG001|STARTED|Overall Study||220
9808289|NCT00645099|10917368|FG000|COMPLETED|Overall Study||168
9808290|NCT00645099|10917369|FG001|COMPLETED|Overall Study||178
9808291|NCT00645099|10917368|FG000|NOT COMPLETED|Overall Study||71
9808292|NCT00645099|10917369|FG001|NOT COMPLETED|Overall Study||42
9808293|NCT00645164|10917375|FG000|STARTED|Overall Study||59
9808294|NCT00645164|10917375|FG000|COMPLETED|Overall Study||52
9808295|NCT00645164|10917375|FG000|NOT COMPLETED|Overall Study||7
9808296|NCT00645333|10917379|FG000|STARTED|Overall Study||30
9808297|NCT00645333|10917379|FG000|COMPLETED|Overall Study||30
9808298|NCT00645333|10917379|FG000|NOT COMPLETED|Overall Study||0
9808299|NCT00645411|10917387|FG000|STARTED|Overall Study||656
9808300|NCT00645411|10917388|FG001|STARTED|Overall Study||318
9808301|NCT00645411|10917389|FG002|STARTED|Overall Study||1608
9808302|NCT00645411|10917390|FG003|STARTED|Overall Study||1022
9808303|NCT00645411|10917387|FG000|COMPLETED|Overall Study||643
9808304|NCT00645411|10917388|FG001|COMPLETED|Overall Study||312
9808305|NCT00645411|10917389|FG002|COMPLETED|Overall Study||1457
9808306|NCT00645411|10917390|FG003|COMPLETED|Overall Study||919
9808307|NCT00645411|10917387|FG000|NOT COMPLETED|Overall Study||13
9808308|NCT00645411|10917388|FG001|NOT COMPLETED|Overall Study||6
9808309|NCT00645411|10917389|FG002|NOT COMPLETED|Overall Study||151
9808310|NCT00645411|10917390|FG003|NOT COMPLETED|Overall Study||103
9808311|NCT00645450|10917409|FG000|STARTED|Overall Study||5
9808312|NCT00645450|10917410|FG001|STARTED|Overall Study||4
9808313|NCT00645450|10917409|FG000|COMPLETED|Overall Study||5
9808314|NCT00645450|10917410|FG001|COMPLETED|Overall Study||4
9808315|NCT00645450|10917409|FG000|NOT COMPLETED|Overall Study||0
9808316|NCT00645450|10917410|FG001|NOT COMPLETED|Overall Study||0
9808317|NCT00645528|10917416|FG000|STARTED|Overall Study||39
9808318|NCT00645528|10917416|FG000|COMPLETED|Overall Study||32
9808319|NCT00645528|10917416|FG000|NOT COMPLETED|Overall Study||7
9808320|NCT00645593|10917422|FG000|STARTED|Overall Study||29
9808321|NCT00645593|10917423|FG001|STARTED|Overall Study||60
9808322|NCT00645593|10917422|FG000|COMPLETED|Overall Study||28
9808323|NCT00645593|10917423|FG001|COMPLETED|Overall Study||60
9808324|NCT00645593|10917422|FG000|NOT COMPLETED|Overall Study||1
9808325|NCT00645593|10917423|FG001|NOT COMPLETED|Overall Study||0
9808326|NCT00645671|10917431|FG000|STARTED|Overall Study||201
9808327|NCT00645671|10917432|FG001|STARTED|Overall Study||199
9808328|NCT00645671|10917431|FG000|COMPLETED|Overall Study||200
9808329|NCT00645671|10917432|FG001|COMPLETED|Overall Study||193
9808330|NCT00645671|10917431|FG000|NOT COMPLETED|Overall Study||1
9808331|NCT00645671|10917432|FG001|NOT COMPLETED|Overall Study||6
9808332|NCT00645710|10917441|FG000|STARTED|Overall Study||3
9808333|NCT00645710|10917442|FG001|STARTED|Overall Study||3
9808334|NCT00645710|10917443|FG002|STARTED|Overall Study||10
9808335|NCT00645710|10917441|FG000|COMPLETED|Overall Study||3
9808336|NCT00645710|10917442|FG001|COMPLETED|Overall Study||3
9808337|NCT00645710|10917443|FG002|COMPLETED|Overall Study||10
9808338|NCT00645710|10917441|FG000|NOT COMPLETED|Overall Study||0
9808339|NCT00645710|10917442|FG001|NOT COMPLETED|Overall Study||0
9808340|NCT00645710|10917443|FG002|NOT COMPLETED|Overall Study||0
10016215|NCT01809106|11139124|FG003|NOT COMPLETED|Overall Study||4
10016216|NCT01809132|11139137|FG000|STARTED|Overall Study||53
10016217|NCT01809132|11139138|FG001|STARTED|Overall Study||50
10016218|NCT01809132|11139139|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
10016219|NCT01809132|11139137|FG000|COMPLETED|Overall Study||53
10016220|NCT01809132|11139138|FG001|COMPLETED|Overall Study||50
10016221|NCT01809132|11139139|FG002|COMPLETED|Overall Study||0
10016222|NCT01809132|11139137|FG000|NOT COMPLETED|Overall Study||0
10016223|NCT01809132|11139138|FG001|NOT COMPLETED|Overall Study||0
10016224|NCT01809132|11139139|FG002|NOT COMPLETED|Overall Study||1
10016225|NCT01809197|11139149|FG000|STARTED|Overall Study||187
10016226|NCT01809197|11139150|FG001|STARTED|Overall Study||185
10016227|NCT01809197|11139149|FG000|COMPLETED|Overall Study||177
10016228|NCT01809197|11139150|FG001|COMPLETED|Overall Study||177
10016229|NCT01809197|11139149|FG000|NOT COMPLETED|Overall Study||10
9808341|NCT00645762|10917452|FG000|STARTED|Overall Study||71
9808342|NCT00645762|10917452|FG000|COMPLETED|Overall Study||67
9808343|NCT00645762|10917452|FG000|NOT COMPLETED|Overall Study||4
9808344|NCT00645788|10917462|FG000|STARTED|Overall Study||94
9808345|NCT00645788|10917463|FG001|STARTED|Overall Study||94
9808346|NCT00645788|10917464|FG002|STARTED|Overall Study||65
9808347|NCT00645788|10917465|FG003|STARTED|Overall Study||35
9808348|NCT00645788|10917462|FG000|Participants Receive Treatment|Overall Study||93
9808349|NCT00645788|10917463|FG001|Participants Receive Treatment|Overall Study||93
9808350|NCT00645788|10917464|FG002|Participants Receive Treatment|Overall Study||65
9808351|NCT00645788|10917465|FG003|Participants Receive Treatment|Overall Study||35
9808352|NCT00645788|10917462|FG000|COMPLETED|Overall Study||74
9808353|NCT00645788|10917463|FG001|COMPLETED|Overall Study||67
9808354|NCT00645788|10917464|FG002|COMPLETED|Overall Study||47
9808355|NCT00645788|10917465|FG003|COMPLETED|Overall Study||21
9808356|NCT00645788|10917462|FG000|NOT COMPLETED|Overall Study||20
9808357|NCT00645788|10917463|FG001|NOT COMPLETED|Overall Study||27
9808358|NCT00645788|10917464|FG002|NOT COMPLETED|Overall Study||18
9808359|NCT00645788|10917465|FG003|NOT COMPLETED|Overall Study||14
9808360|NCT00645827|10917477|FG000|STARTED|Overall Study||14
9808361|NCT00645827|10917478|FG001|STARTED|Overall Study||17
9808362|NCT00645827|10917477|FG000|COMPLETED|Overall Study||14
9808363|NCT00645827|10917478|FG001|COMPLETED|Overall Study||17
9808364|NCT00645827|10917477|FG000|NOT COMPLETED|Overall Study||0
9808365|NCT00645827|10917478|FG001|NOT COMPLETED|Overall Study||0
9808366|NCT00645840|10917484|FG000|STARTED|Overall Study||15
9808367|NCT00645840|10917484|FG000|COMPLETED|Overall Study||12
9808368|NCT00645840|10917484|FG000|NOT COMPLETED|Overall Study||3
9808369|NCT00645853|10917490|FG000|STARTED|Overall Study||288
9808370|NCT00645853|10917491|FG001|STARTED|Overall Study||235
9808371|NCT00645853|10917490|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
9808372|NCT00645853|10917491|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
9808373|NCT00645853|10917490|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
9808374|NCT00645853|10917491|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
9808375|NCT00645853|10917490|FG000|AZ Study Closure in Hungary|Overall Study||60
9808376|NCT00645853|10917491|FG001|AZ Study Closure in Hungary|Overall Study||40
9808377|NCT00645853|10917490|FG000|COMPLETED|Overall Study||196
9808378|NCT00645853|10917491|FG001|COMPLETED|Overall Study||178
9808379|NCT00645853|10917490|FG000|NOT COMPLETED|Overall Study||92
9808380|NCT00645853|10917491|FG001|NOT COMPLETED|Overall Study||57
9808381|NCT00645944|10917499|FG000|STARTED|Randomized||20
9808382|NCT00645944|10917500|FG001|STARTED|Randomized||19
9808383|NCT00645944|10917499|FG000|COMPLETED|Randomized||19
9808384|NCT00645944|10917500|FG001|COMPLETED|Randomized||17
9808385|NCT00645944|10917499|FG000|NOT COMPLETED|Randomized||1
9808386|NCT00645944|10917500|FG001|NOT COMPLETED|Randomized||2
9808387|NCT00645944|10917499|FG000|STARTED|Received Medication||19
9808388|NCT00645944|10917500|FG001|STARTED|Received Medication||17
9808389|NCT00645944|10917499|FG000|COMPLETED|Received Medication||13
9808390|NCT00645944|10917500|FG001|COMPLETED|Received Medication||14
9808391|NCT00645944|10917499|FG000|NOT COMPLETED|Received Medication||6
9808392|NCT00645944|10917500|FG001|NOT COMPLETED|Received Medication||3
10016230|NCT01809197|11139150|FG001|NOT COMPLETED|Overall Study||8
10016231|NCT01809210|11139163|FG000|STARTED|Overall Study||3
10016232|NCT01809210|11139164|FG001|STARTED|Overall Study||9
10016233|NCT01809210|11139165|FG002|STARTED|Overall Study||7
10016234|NCT01809210|11139166|FG003|STARTED|Overall Study||3
9808393|NCT00645970|10917508|FG000|STARTED|Overall Study||141
9808394|NCT00645970|10917509|FG001|STARTED|Overall Study||218
9808395|NCT00645970|10917508|FG000|6 Months|Overall Study||58
9808396|NCT00645970|10917509|FG001|6 Months|Overall Study||97
9808397|NCT00645970|10917508|FG000|1 Year|Overall Study||37
9808398|NCT00645970|10917509|FG001|1 Year|Overall Study||42
9808399|NCT00645970|10917508|FG000|COMPLETED|Overall Study||32
9808400|NCT00645970|10917509|FG001|COMPLETED|Overall Study||32
9808401|NCT00645970|10917508|FG000|NOT COMPLETED|Overall Study||109
9808402|NCT00645970|10917509|FG001|NOT COMPLETED|Overall Study||186
9808403|NCT00646048|10917515|FG000|STARTED|Overall Study||43
9808404|NCT00646048|10917515|FG000|COMPLETED|Overall Study||27
9808405|NCT00646048|10917515|FG000|NOT COMPLETED|Overall Study||16
9808406|NCT00646113|10917519|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
9808407|NCT00646113|10917519|FG000|COMPLETED|Overall Study||61
9808408|NCT00646113|10917519|FG000|NOT COMPLETED|Overall Study||8
9808409|NCT00646399|10917525|FG000|STARTED|Overall Study||792
9808410|NCT00646399|10917526|FG001|STARTED|Overall Study||787
9808411|NCT00646399|10917525|FG000|COMPLETED|Overall Study||709
9808412|NCT00646399|10917526|FG001|COMPLETED|Overall Study||713
9808413|NCT00646399|10917525|FG000|NOT COMPLETED|Overall Study||83
9808414|NCT00646399|10917526|FG001|NOT COMPLETED|Overall Study||74
9808415|NCT00646451|10917532|FG000|STARTED|Overall Study||10
9808416|NCT00646451|10917533|FG001|STARTED|Overall Study||10
9808417|NCT00646451|10917532|FG000|COMPLETED|Overall Study||6
9808418|NCT00646451|10917533|FG001|COMPLETED|Overall Study||10
9808419|NCT00646451|10917532|FG000|NOT COMPLETED|Overall Study||4
9808420|NCT00646451|10917533|FG001|NOT COMPLETED|Overall Study||0
9808421|NCT00646581|10917543|FG000|STARTED|Overall Study||15
9808422|NCT00646581|10917544|FG001|STARTED|Overall Study||15
9808423|NCT00646581|10917543|FG000|COMPLETED|Overall Study||15
9808424|NCT00646581|10917544|FG001|COMPLETED|Overall Study||15
9808425|NCT00646581|10917543|FG000|NOT COMPLETED|Overall Study||0
9808426|NCT00646581|10917544|FG001|NOT COMPLETED|Overall Study||0
9808427|NCT00646646|10917554|FG000|STARTED|Overall Study||15
9808428|NCT00646646|10917555|FG001|STARTED|Overall Study||15
9808429|NCT00646646|10917556|FG002|STARTED|Overall Study||15
9808430|NCT00646646|10917557|FG003|STARTED|Overall Study||20
9808431|NCT00646646|10917554|FG000|COMPLETED|Overall Study||15
9808432|NCT00646646|10917555|FG001|COMPLETED|Overall Study||15
9808433|NCT00646646|10917556|FG002|COMPLETED|Overall Study||15
9808434|NCT00646646|10917557|FG003|COMPLETED|Overall Study||20
9808435|NCT00646646|10917554|FG000|NOT COMPLETED|Overall Study||0
9808436|NCT00646646|10917555|FG001|NOT COMPLETED|Overall Study||0
9808437|NCT00646646|10917556|FG002|NOT COMPLETED|Overall Study||0
9808438|NCT00646646|10917557|FG003|NOT COMPLETED|Overall Study||0
9808439|NCT00646763|10917569|FG000|STARTED|Overall Study||18
9808440|NCT00646763|10917570|FG001|STARTED|Overall Study||17
9808441|NCT00646763|10917569|FG000|COMPLETED|Overall Study||18
9808442|NCT00646763|10917570|FG001|COMPLETED|Overall Study||17
9808443|NCT00646763|10917569|FG000|NOT COMPLETED|Overall Study||0
9808444|NCT00646763|10917570|FG001|NOT COMPLETED|Overall Study||0
9808445|NCT00646776|10917578|FG000|STARTED|Overall Study|Treated on Day 1|15
9808446|NCT00646776|10917579|FG001|STARTED|Overall Study|Treated on Day 1|18
9808447|NCT00646776|10917578|FG000|COMPLETED|Overall Study||14
9808448|NCT00646776|10917579|FG001|COMPLETED|Overall Study||5
9808449|NCT00646776|10917578|FG000|NOT COMPLETED|Overall Study||1
9808450|NCT00646776|10917579|FG001|NOT COMPLETED|Overall Study||13
9808451|NCT00646906|10917592|FG000|STARTED|Crossover Period 1||9
9808452|NCT00646906|10917593|FG001|STARTED|Crossover Period 1||9
9808453|NCT00646906|10917594|FG002|STARTED|Crossover Period 1||10
9808454|NCT00646906|10917595|FG003|STARTED|Crossover Period 1||9
9808455|NCT00646906|10917596|FG004|STARTED|Crossover Period 1||8
9808456|NCT00646906|10917597|FG005|STARTED|Crossover Period 1||5
9808457|NCT00646906|10917598|FG006|STARTED|Crossover Period 1||5
10016235|NCT01809210|11139167|FG004|STARTED|Overall Study||6
10016236|NCT01809210|11139168|FG005|STARTED|Overall Study||15
10016237|NCT01809210|11139169|FG006|STARTED|Overall Study||12
10016238|NCT01809210|11139163|FG000|COMPLETED|Overall Study||2
10016239|NCT01809210|11139164|FG001|COMPLETED|Overall Study||8
10016240|NCT01809210|11139165|FG002|COMPLETED|Overall Study||4
10016241|NCT01809210|11139166|FG003|COMPLETED|Overall Study||2
10016242|NCT01809210|11139167|FG004|COMPLETED|Overall Study||4
10016243|NCT01809210|11139168|FG005|COMPLETED|Overall Study||12
10016244|NCT01809210|11139169|FG006|COMPLETED|Overall Study||7
9808458|NCT00646906|10917592|FG000|COMPLETED|Crossover Period 1||8
9808459|NCT00646906|10917593|FG001|COMPLETED|Crossover Period 1||9
9808460|NCT00646906|10917594|FG002|COMPLETED|Crossover Period 1||10
9808461|NCT00646906|10917595|FG003|COMPLETED|Crossover Period 1||9
9808462|NCT00646906|10917596|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
9808463|NCT00646906|10917597|FG005|COMPLETED|Crossover Period 1||4
9808464|NCT00646906|10917598|FG006|COMPLETED|Crossover Period 1||5
9808465|NCT00646906|10917592|FG000|NOT COMPLETED|Crossover Period 1||1
9808466|NCT00646906|10917593|FG001|NOT COMPLETED|Crossover Period 1||0
10016245|NCT01809210|11139163|FG000|NOT COMPLETED|Overall Study||1
10016246|NCT01809210|11139164|FG001|NOT COMPLETED|Overall Study||1
9808467|NCT00646906|10917594|FG002|NOT COMPLETED|Crossover Period 1||0
9808468|NCT00646906|10917595|FG003|NOT COMPLETED|Crossover Period 1||0
9808469|NCT00646906|10917596|FG004|NOT COMPLETED|Crossover Period 1||0
9808470|NCT00646906|10917597|FG005|NOT COMPLETED|Crossover Period 1||1
9808471|NCT00646906|10917598|FG006|NOT COMPLETED|Crossover Period 1||0
9808472|NCT00646906|10917592|FG000|STARTED|Washout (>/= 14 Days)||8
9808473|NCT00646906|10917593|FG001|STARTED|Washout (>/= 14 Days)||9
9808474|NCT00646906|10917594|FG002|STARTED|Washout (>/= 14 Days)||10
9808475|NCT00646906|10917595|FG003|STARTED|Washout (>/= 14 Days)||9
10016247|NCT01809210|11139165|FG002|NOT COMPLETED|Overall Study||3
9808476|NCT00646906|10917596|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
9808477|NCT00646906|10917597|FG005|STARTED|Washout (>/= 14 Days)||4
9808478|NCT00646906|10917598|FG006|STARTED|Washout (>/= 14 Days)||5
9808479|NCT00646906|10917592|FG000|COMPLETED|Washout (>/= 14 Days)||8
9808480|NCT00646906|10917593|FG001|COMPLETED|Washout (>/= 14 Days)||9
9808481|NCT00646906|10917594|FG002|COMPLETED|Washout (>/= 14 Days)||10
9808482|NCT00646906|10917595|FG003|COMPLETED|Washout (>/= 14 Days)||9
9808483|NCT00646906|10917596|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
9808484|NCT00646906|10917597|FG005|COMPLETED|Washout (>/= 14 Days)||4
9808485|NCT00646906|10917598|FG006|COMPLETED|Washout (>/= 14 Days)||5
9808486|NCT00646906|10917592|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0
9808487|NCT00646906|10917593|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0
9808488|NCT00646906|10917594|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0
9808489|NCT00646906|10917595|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0
9808490|NCT00646906|10917596|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0
9808491|NCT00646906|10917597|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0
9808492|NCT00646906|10917598|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0
9808493|NCT00646906|10917592|FG000|STARTED|Crossover Period 2||8
9808494|NCT00646906|10917593|FG001|STARTED|Crossover Period 2||9
9808495|NCT00646906|10917594|FG002|STARTED|Crossover Period 2||10
9808496|NCT00646906|10917595|FG003|STARTED|Crossover Period 2||9
9808497|NCT00646906|10917596|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
9808498|NCT00646906|10917597|FG005|STARTED|Crossover Period 2||4
9808499|NCT00646906|10917598|FG006|STARTED|Crossover Period 2||5
9808500|NCT00646906|10917592|FG000|COMPLETED|Crossover Period 2||8
9808501|NCT00646906|10917593|FG001|COMPLETED|Crossover Period 2||8
9808502|NCT00646906|10917594|FG002|COMPLETED|Crossover Period 2||8
9808503|NCT00646906|10917595|FG003|COMPLETED|Crossover Period 2||8
9808504|NCT00646906|10917596|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
9808505|NCT00646906|10917597|FG005|COMPLETED|Crossover Period 2||4
9808506|NCT00646906|10917598|FG006|COMPLETED|Crossover Period 2||4
9808507|NCT00646906|10917592|FG000|NOT COMPLETED|Crossover Period 2||0
9808508|NCT00646906|10917593|FG001|NOT COMPLETED|Crossover Period 2||1
9808509|NCT00646906|10917594|FG002|NOT COMPLETED|Crossover Period 2||2
9808510|NCT00646906|10917595|FG003|NOT COMPLETED|Crossover Period 2||1
9808511|NCT00646906|10917596|FG004|NOT COMPLETED|Crossover Period 2||0
9808512|NCT00646906|10917597|FG005|NOT COMPLETED|Crossover Period 2||0
9808513|NCT00646906|10917598|FG006|NOT COMPLETED|Crossover Period 2||1
9808514|NCT00646958|10917614|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51
9808515|NCT00646958|10917615|FG001|STARTED|Overall Study|No. Participants Randomized|50
9808516|NCT00646958|10917616|FG002|STARTED|Overall Study|No. Participants Randomized|49
9808517|NCT00646958|10917614|FG000|COMPLETED|Overall Study||40
9808518|NCT00646958|10917615|FG001|COMPLETED|Overall Study||41
9808519|NCT00646958|10917616|FG002|COMPLETED|Overall Study||40
9808520|NCT00646958|10917614|FG000|NOT COMPLETED|Overall Study||11
9808521|NCT00646958|10917615|FG001|NOT COMPLETED|Overall Study||9
9808522|NCT00646958|10917616|FG002|NOT COMPLETED|Overall Study||9
9808523|NCT00647270|10917627|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
9808524|NCT00647270|10917628|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159
9808525|NCT00647270|10917629|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205
9808526|NCT00647270|10917627|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
9808527|NCT00647270|10917628|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
9808528|NCT00647270|10917629|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
9808529|NCT00647270|10917627|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
9808530|NCT00647270|10917628|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
9808531|NCT00647270|10917629|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
9808532|NCT00647270|10917627|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
9808533|NCT00647270|10917628|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146
9808534|NCT00647270|10917629|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182
9808535|NCT00647270|10917627|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
9808536|NCT00647270|10917628|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
9808537|NCT00647270|10917629|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
9808538|NCT00647270|10917627|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
9808539|NCT00647270|10917628|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
9808540|NCT00647270|10917629|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
9808541|NCT00647296|10917644|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27
9808542|NCT00647296|10917645|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23
9808543|NCT00647296|10917646|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26
9808544|NCT00647296|10917647|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26
9808545|NCT00647296|10917644|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
9808546|NCT00647296|10917645|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
9808547|NCT00647296|10917646|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
9808548|NCT00647296|10917647|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
9808549|NCT00647296|10917644|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
9808550|NCT00647296|10917645|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
9808551|NCT00647296|10917646|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
9808552|NCT00647296|10917647|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
9808553|NCT00647296|10917644|FG000|STARTED|Part 2: 4-week Placebo Washout||97
9808554|NCT00647296|10917645|FG001|STARTED|Part 2: 4-week Placebo Washout||0
9808555|NCT00647296|10917646|FG002|STARTED|Part 2: 4-week Placebo Washout||0
9808556|NCT00647296|10917647|FG003|STARTED|Part 2: 4-week Placebo Washout||0
9808557|NCT00647296|10917644|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92
9808558|NCT00647296|10917645|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0
9808559|NCT00647296|10917646|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0
9808560|NCT00647296|10917647|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0
9808561|NCT00647296|10917644|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
9808562|NCT00647296|10917645|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
9808563|NCT00647296|10917646|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
9808564|NCT00647296|10917647|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
9808565|NCT00647296|10917644|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0
9808566|NCT00647296|10917645|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48
9808567|NCT00647296|10917646|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0
9808568|NCT00647296|10917647|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44
9808569|NCT00647296|10917644|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
9808570|NCT00647296|10917645|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
9808571|NCT00647296|10917646|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
9808572|NCT00647296|10917647|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
9808573|NCT00647296|10917644|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
9808574|NCT00647296|10917645|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
9808575|NCT00647296|10917646|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
9808576|NCT00647296|10917647|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
9808577|NCT00647348|10917671|FG000|STARTED|Overall Study||70
9808578|NCT00647348|10917672|FG001|STARTED|Overall Study||70
9808579|NCT00647348|10917671|FG000|COMPLETED|Overall Study||67
9808580|NCT00647348|10917672|FG001|COMPLETED|Overall Study||64
9808581|NCT00647348|10917671|FG000|NOT COMPLETED|Overall Study||3
9808582|NCT00647348|10917672|FG001|NOT COMPLETED|Overall Study||6
9808583|NCT00647400|10917680|FG000|STARTED|Overall Study||89
9808584|NCT00647400|10917681|FG001|STARTED|Overall Study||58
9808585|NCT00647400|10917680|FG000|COMPLETED|Overall Study||67
9808586|NCT00647400|10917681|FG001|COMPLETED|Overall Study||45
9808587|NCT00647400|10917680|FG000|NOT COMPLETED|Overall Study||22
9808588|NCT00647400|10917681|FG001|NOT COMPLETED|Overall Study||13
9808589|NCT00647556|10917689|FG000|STARTED|Overall Study||15
9808590|NCT00647556|10917690|FG001|STARTED|Overall Study||15
9808591|NCT00647556|10917689|FG000|COMPLETED|Overall Study||12
9808592|NCT00647556|10917690|FG001|COMPLETED|Overall Study||13
9808593|NCT00647556|10917689|FG000|NOT COMPLETED|Overall Study||3
9808594|NCT00647556|10917690|FG001|NOT COMPLETED|Overall Study||2
9808595|NCT00647699|10917698|FG000|STARTED|Overall Study||73
9808596|NCT00647699|10917699|FG001|STARTED|Overall Study||74
9808597|NCT00647699|10917698|FG000|COMPLETED|Overall Study||65
9808598|NCT00647699|10917699|FG001|COMPLETED|Overall Study||62
9808599|NCT00647699|10917698|FG000|NOT COMPLETED|Overall Study||8
9808600|NCT00647699|10917699|FG001|NOT COMPLETED|Overall Study||12
9808601|NCT00647998|10917707|FG000|STARTED|Overall Study||9
9808602|NCT00647998|10917708|FG001|STARTED|Overall Study||9
9808603|NCT00647998|10917707|FG000|COMPLETED|Overall Study||9
9808604|NCT00647998|10917708|FG001|COMPLETED|Overall Study||9
9808605|NCT00647998|10917707|FG000|NOT COMPLETED|Overall Study||0
9808606|NCT00647998|10917708|FG001|NOT COMPLETED|Overall Study||0
9808607|NCT00648037|10917716|FG000|STARTED|Overall Study||26
9808608|NCT00648037|10917716|FG000|COMPLETED|Overall Study||10
9808609|NCT00648037|10917716|FG000|NOT COMPLETED|Overall Study||16
9808610|NCT00648115|10917723|FG000|STARTED|Overall Study||42
9808611|NCT00648115|10917724|FG001|STARTED|Overall Study||42
9808612|NCT00648115|10917725|FG002|STARTED|Overall Study||27
9808613|NCT00648115|10917723|FG000|COMPLETED|Overall Study||42
9808614|NCT00648115|10917724|FG001|COMPLETED|Overall Study||42
9808615|NCT00648115|10917725|FG002|COMPLETED|Overall Study||27
9808616|NCT00648115|10917723|FG000|NOT COMPLETED|Overall Study||0
9808617|NCT00648115|10917724|FG001|NOT COMPLETED|Overall Study||0
9808618|NCT00648115|10917725|FG002|NOT COMPLETED|Overall Study||0
9808619|NCT00648167|10917733|FG000|STARTED|Overall Study||55
9808620|NCT00648167|10917733|FG000|Start Dose 4.5 g/Day|Overall Study||34
9808621|NCT00648167|10917733|FG000|Start Dose 6 g/Day|Overall Study||21
9808622|NCT00648167|10917733|FG000|COMPLETED|Overall Study||48
9808623|NCT00648167|10917733|FG000|NOT COMPLETED|Overall Study||7
9808624|NCT00648375|10917739|FG000|STARTED|Overall Study||1
9808625|NCT00648375|10917740|FG001|STARTED|Overall Study||2
9808626|NCT00648375|10917739|FG000|COMPLETED|Overall Study||1
9808627|NCT00648375|10917740|FG001|COMPLETED|Overall Study||2
9808628|NCT00648375|10917739|FG000|NOT COMPLETED|Overall Study||0
9808629|NCT00648375|10917740|FG001|NOT COMPLETED|Overall Study||0
9808630|NCT00648648|10917774|FG000|STARTED|Overall Study||3
9808631|NCT00648648|10917775|FG001|STARTED|Overall Study||3
9808632|NCT00648648|10917776|FG002|STARTED|Overall Study||3
9808633|NCT00648648|10917777|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
9808634|NCT00648648|10917778|FG004|STARTED|Overall Study||9
9808635|NCT00648648|10917779|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
9808636|NCT00648648|10917780|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
9808637|NCT00648648|10917781|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
9808638|NCT00648648|10917782|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
9808639|NCT00648648|10917783|FG009|STARTED|Overall Study||10
9808640|NCT00648648|10917784|FG010|STARTED|Overall Study||6
9808641|NCT00648648|10917785|FG011|STARTED|Overall Study||13
9808642|NCT00648648|10917786|FG012|STARTED|Overall Study||6
9808643|NCT00648648|10917787|FG013|STARTED|Overall Study||5
9808644|NCT00648648|10917788|FG014|STARTED|Overall Study||4
9808645|NCT00648648|10917789|FG015|STARTED|Overall Study||11
9808646|NCT00648648|10917790|FG016|STARTED|Overall Study||16
9808647|NCT00648648|10917791|FG017|STARTED|Overall Study||6
9808648|NCT00648648|10917792|FG018|STARTED|Overall Study||5
9808649|NCT00648648|10917793|FG019|STARTED|Overall Study||7
9808650|NCT00648648|10917794|FG020|STARTED|Overall Study||6
9808651|NCT00648648|10917795|FG021|STARTED|Overall Study||10
9808652|NCT00648648|10917796|FG022|STARTED|Overall Study||14
9808653|NCT00648648|10917797|FG023|STARTED|Overall Study||4
9808654|NCT00648648|10917798|FG024|STARTED|Overall Study||4
9808655|NCT00648648|10917799|FG025|STARTED|Overall Study||4
9808656|NCT00648648|10917800|FG026|STARTED|Overall Study||26
9808657|NCT00648648|10917801|FG027|STARTED|Overall Study||12
9808658|NCT00648648|10917774|FG000|Treated|Overall Study||3
9808659|NCT00648648|10917775|FG001|Treated|Overall Study||3
9808660|NCT00648648|10917776|FG002|Treated|Overall Study||3
9808661|NCT00648648|10917777|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
9808662|NCT00648648|10917778|FG004|Treated|Overall Study||8
9808663|NCT00648648|10917779|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
9808664|NCT00648648|10917780|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
9808665|NCT00648648|10917781|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
9808666|NCT00648648|10917782|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
9808667|NCT00648648|10917783|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
9808668|NCT00648648|10917784|FG010|Treated|Overall Study||6
9808669|NCT00648648|10917785|FG011|Treated|Overall Study||13
9808670|NCT00648648|10917786|FG012|Treated|Overall Study||6
9808671|NCT00648648|10917787|FG013|Treated|Overall Study||5
9808672|NCT00648648|10917788|FG014|Treated|Overall Study||4
9808673|NCT00648648|10917789|FG015|Treated|Overall Study||11
9808674|NCT00648648|10917790|FG016|Treated|Overall Study||16
9808675|NCT00648648|10917791|FG017|Treated|Overall Study||6
9808676|NCT00648648|10917792|FG018|Treated|Overall Study||4
9808677|NCT00648648|10917793|FG019|Treated|Overall Study||7
9808678|NCT00648648|10917794|FG020|Treated|Overall Study||6
9808679|NCT00648648|10917795|FG021|Treated|Overall Study||10
9808680|NCT00648648|10917796|FG022|Treated|Overall Study||14
9808681|NCT00648648|10917797|FG023|Treated|Overall Study||4
9808682|NCT00648648|10917798|FG024|Treated|Overall Study||4
9808683|NCT00648648|10917799|FG025|Treated|Overall Study||4
9808684|NCT00648648|10917800|FG026|Treated|Overall Study||26
9808685|NCT00648648|10917801|FG027|Treated|Overall Study||12
9808686|NCT00648648|10917774|FG000|COMPLETED|Overall Study||3
9808687|NCT00648648|10917775|FG001|COMPLETED|Overall Study||3
9808688|NCT00648648|10917776|FG002|COMPLETED|Overall Study||3
9808689|NCT00648648|10917777|FG003|COMPLETED|Overall Study||0
9808690|NCT00648648|10917778|FG004|COMPLETED|Overall Study||0
9808691|NCT00648648|10917779|FG005|COMPLETED|Overall Study||0
9808692|NCT00648648|10917780|FG006|COMPLETED|Overall Study||0
9808693|NCT00648648|10917781|FG007|COMPLETED|Overall Study||0
9808694|NCT00648648|10917782|FG008|COMPLETED|Overall Study||0
9808695|NCT00648648|10917783|FG009|COMPLETED|Overall Study||0
9808696|NCT00648648|10917784|FG010|COMPLETED|Overall Study||0
9808697|NCT00648648|10917785|FG011|COMPLETED|Overall Study||0
9808698|NCT00648648|10917786|FG012|COMPLETED|Overall Study||0
9808699|NCT00648648|10917787|FG013|COMPLETED|Overall Study||0
9808700|NCT00648648|10917788|FG014|COMPLETED|Overall Study||0
9808701|NCT00648648|10917789|FG015|COMPLETED|Overall Study||0
9808702|NCT00648648|10917790|FG016|COMPLETED|Overall Study||2
9808703|NCT00648648|10917791|FG017|COMPLETED|Overall Study||0
9808704|NCT00648648|10917792|FG018|COMPLETED|Overall Study||0
9808705|NCT00648648|10917793|FG019|COMPLETED|Overall Study||0
9808706|NCT00648648|10917794|FG020|COMPLETED|Overall Study||0
9808707|NCT00648648|10917795|FG021|COMPLETED|Overall Study||0
9808708|NCT00648648|10917796|FG022|COMPLETED|Overall Study||0
9808709|NCT00648648|10917797|FG023|COMPLETED|Overall Study||0
9808710|NCT00648648|10917798|FG024|COMPLETED|Overall Study||0
9808711|NCT00648648|10917799|FG025|COMPLETED|Overall Study||0
9808712|NCT00648648|10917800|FG026|COMPLETED|Overall Study||0
9808713|NCT00648648|10917801|FG027|COMPLETED|Overall Study||0
9808714|NCT00648648|10917774|FG000|NOT COMPLETED|Overall Study||0
9808715|NCT00648648|10917775|FG001|NOT COMPLETED|Overall Study||0
9808716|NCT00648648|10917776|FG002|NOT COMPLETED|Overall Study||0
9808717|NCT00648648|10917777|FG003|NOT COMPLETED|Overall Study||4
9808718|NCT00648648|10917778|FG004|NOT COMPLETED|Overall Study||9
9808719|NCT00648648|10917779|FG005|NOT COMPLETED|Overall Study||1
9808720|NCT00648648|10917780|FG006|NOT COMPLETED|Overall Study||10
9808721|NCT00648648|10917781|FG007|NOT COMPLETED|Overall Study||1
9808722|NCT00648648|10917782|FG008|NOT COMPLETED|Overall Study||3
9808723|NCT00648648|10917783|FG009|NOT COMPLETED|Overall Study||10
9808724|NCT00648648|10917784|FG010|NOT COMPLETED|Overall Study||6
9808725|NCT00648648|10917785|FG011|NOT COMPLETED|Overall Study||13
9808726|NCT00648648|10917786|FG012|NOT COMPLETED|Overall Study||6
9808727|NCT00648648|10917787|FG013|NOT COMPLETED|Overall Study||5
9808728|NCT00648648|10917788|FG014|NOT COMPLETED|Overall Study||4
9808729|NCT00648648|10917789|FG015|NOT COMPLETED|Overall Study||11
9808730|NCT00648648|10917790|FG016|NOT COMPLETED|Overall Study||14
9808731|NCT00648648|10917791|FG017|NOT COMPLETED|Overall Study||6
9808732|NCT00648648|10917792|FG018|NOT COMPLETED|Overall Study||5
9808733|NCT00648648|10917793|FG019|NOT COMPLETED|Overall Study||7
9808734|NCT00648648|10917794|FG020|NOT COMPLETED|Overall Study||6
9808735|NCT00648648|10917795|FG021|NOT COMPLETED|Overall Study||10
9808736|NCT00648648|10917796|FG022|NOT COMPLETED|Overall Study||14
9808737|NCT00648648|10917797|FG023|NOT COMPLETED|Overall Study||4
9808738|NCT00648648|10917798|FG024|NOT COMPLETED|Overall Study||4
9808739|NCT00648648|10917799|FG025|NOT COMPLETED|Overall Study||4
9808740|NCT00648648|10917800|FG026|NOT COMPLETED|Overall Study||26
9808741|NCT00648648|10917801|FG027|NOT COMPLETED|Overall Study||12
9808742|NCT00648739|10917859|FG000|STARTED|Overall Study||4
9808743|NCT00648739|10917860|FG001|STARTED|Overall Study||5
9808744|NCT00648739|10917861|FG002|STARTED|Overall Study||3
9808745|NCT00648739|10917862|FG003|STARTED|Overall Study||3
9808746|NCT00648739|10917863|FG004|STARTED|Overall Study||3
9808747|NCT00648739|10917864|FG005|STARTED|Overall Study||7
9808748|NCT00648739|10917865|FG006|STARTED|Overall Study||1
9808749|NCT00648739|10917859|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
9808750|NCT00648739|10917860|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
9808751|NCT00648739|10917861|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9808752|NCT00648739|10917862|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
9808753|NCT00648739|10917863|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10016248|NCT01809210|11139166|FG003|NOT COMPLETED|Overall Study||1
10016249|NCT01809210|11139167|FG004|NOT COMPLETED|Overall Study||2
10016250|NCT01809210|11139168|FG005|NOT COMPLETED|Overall Study||3
10016251|NCT01809210|11139169|FG006|NOT COMPLETED|Overall Study||5
10016252|NCT01809262|11139185|FG000|STARTED|Period 1 (First Dose + Washout)||4
10016253|NCT01809262|11139186|FG001|STARTED|Period 1 (First Dose + Washout)||4
10016254|NCT01809262|11139187|FG002|STARTED|Period 1 (First Dose + Washout)||4
10016255|NCT01809262|11139188|FG003|STARTED|Period 1 (First Dose + Washout)||3
9808754|NCT00648739|10917864|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
9808755|NCT00648739|10917865|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
9808756|NCT00648739|10917859|FG000|COMPLETED|Overall Study||2
9808757|NCT00648739|10917860|FG001|COMPLETED|Overall Study||3
9808758|NCT00648739|10917861|FG002|COMPLETED|Overall Study||0
9808759|NCT00648739|10917862|FG003|COMPLETED|Overall Study||1
9808760|NCT00648739|10917863|FG004|COMPLETED|Overall Study||1
9808761|NCT00648739|10917864|FG005|COMPLETED|Overall Study||2
9808762|NCT00648739|10917865|FG006|COMPLETED|Overall Study||0
9808763|NCT00648739|10917859|FG000|NOT COMPLETED|Overall Study||2
9808764|NCT00648739|10917860|FG001|NOT COMPLETED|Overall Study||2
9808765|NCT00648739|10917861|FG002|NOT COMPLETED|Overall Study||3
9808766|NCT00648739|10917862|FG003|NOT COMPLETED|Overall Study||2
10016256|NCT01809262|11139189|FG004|STARTED|Period 1 (First Dose + Washout)||4
10016257|NCT01809262|11139190|FG005|STARTED|Period 1 (First Dose + Washout)||3
10016258|NCT01809262|11139191|FG006|STARTED|Period 1 (First Dose + Washout)||3
10016259|NCT01809262|11139192|FG007|STARTED|Period 1 (First Dose + Washout)||4
10016260|NCT01809262|11139193|FG008|STARTED|Period 1 (First Dose + Washout)||3
10016261|NCT01809262|11139194|FG009|STARTED|Period 1 (First Dose + Washout)||4
10016262|NCT01809262|11139185|FG000|COMPLETED|Period 1 (First Dose + Washout)||4
10016263|NCT01809262|11139186|FG001|COMPLETED|Period 1 (First Dose + Washout)||4
10235364|NCT01193530|11365667|FG000|STARTED|Overall Study||4
10235365|NCT01193530|11365668|FG001|STARTED|Overall Study||8
9808767|NCT00648739|10917863|FG004|NOT COMPLETED|Overall Study||2
9808768|NCT00648739|10917864|FG005|NOT COMPLETED|Overall Study||5
9808769|NCT00648739|10917865|FG006|NOT COMPLETED|Overall Study||1
9808770|NCT00648908|10917886|FG000|STARTED|Overall Study||269
9808771|NCT00648908|10917886|FG000|COMPLETED|Overall Study||154
9808772|NCT00648908|10917886|FG000|NOT COMPLETED|Overall Study||115
9808773|NCT00649220|10917891|FG000|STARTED|Overall Study||19
9808774|NCT00649220|10917891|FG000|COMPLETED|Overall Study||16
9808775|NCT00649220|10917891|FG000|NOT COMPLETED|Overall Study||3
9808776|NCT00649389|10917899|FG000|STARTED|Overall Study||628
9808777|NCT00649389|10917900|FG001|STARTED|Overall Study||637
9808778|NCT00649389|10917901|FG002|STARTED|Overall Study||600
9808779|NCT00649389|10917902|FG003|STARTED|Overall Study||627
9808780|NCT00649389|10917899|FG000|COMPLETED|Overall Study||557
9808781|NCT00649389|10917900|FG001|COMPLETED|Overall Study||531
9808782|NCT00649389|10917901|FG002|COMPLETED|Overall Study||512
9808783|NCT00649389|10917902|FG003|COMPLETED|Overall Study||516
9808784|NCT00649389|10917899|FG000|NOT COMPLETED|Overall Study||71
10016264|NCT01809262|11139187|FG002|COMPLETED|Period 1 (First Dose + Washout)||4
10235366|NCT01193530|11365667|FG000|COMPLETED|Overall Study||1
9808785|NCT00649389|10917900|FG001|NOT COMPLETED|Overall Study||106
9808786|NCT00649389|10917901|FG002|NOT COMPLETED|Overall Study||88
9808787|NCT00649389|10917902|FG003|NOT COMPLETED|Overall Study||111
9808788|NCT00649428|10917914|FG000|STARTED|Overall Study||100
9808789|NCT00649428|10917915|FG001|STARTED|Overall Study||103
9808790|NCT00649428|10917914|FG000|COMPLETED|Overall Study||80
9808791|NCT00649428|10917915|FG001|COMPLETED|Overall Study||88
10016265|NCT01809262|11139188|FG003|COMPLETED|Period 1 (First Dose + Washout)||3
9808792|NCT00649428|10917914|FG000|NOT COMPLETED|Overall Study||20
9808793|NCT00649428|10917915|FG001|NOT COMPLETED|Overall Study||15
9808794|NCT00649792|10917922|FG000|STARTED|Overall Study||214
9808795|NCT00649792|10917922|FG000|COMPLETED|Overall Study||146
9808796|NCT00649792|10917922|FG000|NOT COMPLETED|Overall Study||68
9808797|NCT00649961|10917926|FG000|STARTED|Overall Study||18
9808798|NCT00649961|10917926|FG000|COMPLETED|Overall Study||18
9808799|NCT00649961|10917926|FG000|NOT COMPLETED|Overall Study||0
9808800|NCT00650078|10917932|FG000|STARTED|Overall Study||231
9808801|NCT00650078|10917933|FG001|STARTED|Overall Study||119
9808802|NCT00650078|10917932|FG000|COMPLETED|Overall Study||217
9808803|NCT00650078|10917933|FG001|COMPLETED|Overall Study||106
9808804|NCT00650078|10917932|FG000|NOT COMPLETED|Overall Study||14
9808805|NCT00650078|10917933|FG001|NOT COMPLETED|Overall Study||13
9808806|NCT00650091|10917941|FG000|STARTED|Initial Study Design - Interim Analysis||81
9808807|NCT00650091|10917942|FG001|STARTED|Initial Study Design - Interim Analysis||78
9808808|NCT00650091|10917943|FG002|STARTED|Initial Study Design - Interim Analysis||77
9808809|NCT00650091|10917941|FG000|COMPLETED|Initial Study Design - Interim Analysis||81
9808810|NCT00650091|10917942|FG001|COMPLETED|Initial Study Design - Interim Analysis||78
9808811|NCT00650091|10917943|FG002|COMPLETED|Initial Study Design - Interim Analysis||77
9808812|NCT00650091|10917941|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0
9808813|NCT00650091|10917942|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0
9808814|NCT00650091|10917943|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0
9808815|NCT00650091|10917941|FG000|STARTED|Amended Study Design||133
9808816|NCT00650091|10917942|FG001|STARTED|Amended Study Design||131
9808817|NCT00650091|10917943|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
9808818|NCT00650091|10917941|FG000|COMPLETED|Amended Study Design||110
9808819|NCT00650091|10917942|FG001|COMPLETED|Amended Study Design||111
9808820|NCT00650091|10917943|FG002|COMPLETED|Amended Study Design||0
9808821|NCT00650091|10917941|FG000|NOT COMPLETED|Amended Study Design||23
9808822|NCT00650091|10917942|FG001|NOT COMPLETED|Amended Study Design||20
9808823|NCT00650091|10917943|FG002|NOT COMPLETED|Amended Study Design||0
9808824|NCT00650104|10917951|FG000|STARTED|Overall Study||83
9808825|NCT00650104|10917951|FG000|COMPLETED|Overall Study||42
9808826|NCT00650104|10917951|FG000|NOT COMPLETED|Overall Study||41
9808827|NCT00650260|10917957|FG000|STARTED|Overall Study||21
9808828|NCT00650260|10917958|FG001|STARTED|Overall Study||21
9808829|NCT00650260|10917957|FG000|COMPLETED|Overall Study||21
9808830|NCT00650260|10917958|FG001|COMPLETED|Overall Study||21
9808831|NCT00650260|10917957|FG000|NOT COMPLETED|Overall Study||0
9808832|NCT00650260|10917958|FG001|NOT COMPLETED|Overall Study||0
9808833|NCT00650546|10917964|FG000|STARTED|Overall Study||8
9808834|NCT00650546|10917964|FG000|COMPLETED|Overall Study||8
9808835|NCT00650546|10917964|FG000|NOT COMPLETED|Overall Study||0
9808836|NCT00650585|10917971|FG000|STARTED|Overall Study||4348
9808837|NCT00650585|10917972|FG001|STARTED|Overall Study||3990
9808838|NCT00650585|10917971|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
9808839|NCT00650585|10917972|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
9808840|NCT00650585|10917971|FG000|NOT COMPLETED|Overall Study||1797
9808841|NCT00650585|10917972|FG001|NOT COMPLETED|Overall Study||1477
9808842|NCT00650767|10917982|FG000|STARTED|Overall Study||51
9808843|NCT00650767|10917983|FG001|STARTED|Overall Study||50
9808844|NCT00650767|10917984|FG002|STARTED|Overall Study||50
9808845|NCT00650767|10917985|FG003|STARTED|Overall Study||50
9808846|NCT00650767|10917982|FG000|COMPLETED|Overall Study||46
9808847|NCT00650767|10917983|FG001|COMPLETED|Overall Study||41
9808848|NCT00650767|10917984|FG002|COMPLETED|Overall Study||36
9808849|NCT00650767|10917985|FG003|COMPLETED|Overall Study||39
9808850|NCT00650767|10917982|FG000|NOT COMPLETED|Overall Study||5
9808851|NCT00650767|10917983|FG001|NOT COMPLETED|Overall Study||9
9808852|NCT00650767|10917984|FG002|NOT COMPLETED|Overall Study||14
9808853|NCT00650767|10917985|FG003|NOT COMPLETED|Overall Study||11
9808854|NCT00650806|10917999|FG000|STARTED|Overall Study||89
9808855|NCT00650806|10918000|FG001|STARTED|Overall Study||98
9808856|NCT00650806|10918001|FG002|STARTED|Overall Study||93
9808857|NCT00650806|10918002|FG003|STARTED|Overall Study||96
9808858|NCT00650806|10917999|FG000|COMPLETED|Overall Study||71
9808859|NCT00650806|10918000|FG001|COMPLETED|Overall Study||77
9808860|NCT00650806|10918001|FG002|COMPLETED|Overall Study||64
9808861|NCT00650806|10918002|FG003|COMPLETED|Overall Study||70
9808862|NCT00650806|10917999|FG000|NOT COMPLETED|Overall Study||18
9808863|NCT00650806|10918000|FG001|NOT COMPLETED|Overall Study||21
9808864|NCT00650806|10918001|FG002|NOT COMPLETED|Overall Study||29
9808865|NCT00650806|10918002|FG003|NOT COMPLETED|Overall Study||26
9808866|NCT00650845|10918016|FG000|STARTED|Overall Study||75
9808867|NCT00650845|10918017|FG001|STARTED|Overall Study||57
9808868|NCT00650845|10918016|FG000|COMPLETED|Overall Study||70
9808869|NCT00650845|10918017|FG001|COMPLETED|Overall Study||44
9808870|NCT00650845|10918016|FG000|NOT COMPLETED|Overall Study||5
9808871|NCT00650845|10918017|FG001|NOT COMPLETED|Overall Study||13
9808872|NCT00650858|10918027|FG000|STARTED|Overall Study||8
9808873|NCT00650858|10918028|FG001|STARTED|Overall Study||8
9808874|NCT00650858|10918029|FG002|STARTED|Overall Study||36
9808875|NCT00650858|10918027|FG000|COMPLETED|Overall Study||8
9808876|NCT00650858|10918028|FG001|COMPLETED|Overall Study||8
9808877|NCT00650858|10918029|FG002|COMPLETED|Overall Study||36
9808878|NCT00650858|10918027|FG000|NOT COMPLETED|Overall Study||0
9808879|NCT00650858|10918028|FG001|NOT COMPLETED|Overall Study||0
9808880|NCT00650858|10918029|FG002|NOT COMPLETED|Overall Study||0
9808881|NCT00650936|10918037|FG000|STARTED|Overall Study||1000
9808882|NCT00650936|10918037|FG000|COMPLETED|Overall Study||930
9808883|NCT00650936|10918037|FG000|NOT COMPLETED|Overall Study||70
9808884|NCT00651040|10918043|FG000|STARTED|Overall Study||16
9808885|NCT00651040|10918044|FG001|STARTED|Overall Study||15
9808886|NCT00651040|10918043|FG000|COMPLETED|Overall Study||13
9808887|NCT00651040|10918044|FG001|COMPLETED|Overall Study||14
9808888|NCT00651040|10918043|FG000|NOT COMPLETED|Overall Study||3
9808889|NCT00651040|10918044|FG001|NOT COMPLETED|Overall Study||1
9808890|NCT00651118|10918054|FG000|STARTED|Overall Study||207
9808891|NCT00651118|10918055|FG001|STARTED|Overall Study||207
9808892|NCT00651118|10918056|FG002|STARTED|Overall Study||208
9808893|NCT00651118|10918057|FG003|STARTED|Overall Study||210
9808894|NCT00651118|10918054|FG000|COMPLETED|Overall Study||198
9808895|NCT00651118|10918055|FG001|COMPLETED|Overall Study||200
9808896|NCT00651118|10918056|FG002|COMPLETED|Overall Study||197
9808897|NCT00651118|10918057|FG003|COMPLETED|Overall Study||203
9808898|NCT00651118|10918054|FG000|NOT COMPLETED|Overall Study||9
9808899|NCT00651118|10918055|FG001|NOT COMPLETED|Overall Study||7
9808900|NCT00651118|10918056|FG002|NOT COMPLETED|Overall Study||11
9808901|NCT00651118|10918057|FG003|NOT COMPLETED|Overall Study||7
9808902|NCT00651157|10918070|FG000|STARTED|Overall Study||23
9808903|NCT00651157|10918070|FG000|COMPLETED|Overall Study||21
9808904|NCT00651157|10918070|FG000|NOT COMPLETED|Overall Study||2
9808905|NCT00651183|10918076|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
9808906|NCT00651183|10918077|FG001|STARTED|Overall Study||97
9808907|NCT00651183|10918076|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
9808908|NCT00651183|10918077|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
9808909|NCT00651183|10918076|FG000|NOT COMPLETED|Overall Study||20
9808910|NCT00651183|10918077|FG001|NOT COMPLETED|Overall Study||10
9808911|NCT00651261|10918085|FG000|STARTED|Overall Study||360
9808912|NCT00651261|10918086|FG001|STARTED|Overall Study||357
9808913|NCT00651261|10918085|FG000|COMPLETED|Overall Study||69
9808914|NCT00651261|10918086|FG001|COMPLETED|Overall Study||51
9808915|NCT00651261|10918085|FG000|NOT COMPLETED|Overall Study||291
9808916|NCT00651261|10918086|FG001|NOT COMPLETED|Overall Study||306
9808917|NCT00651313|10918094|FG000|STARTED|Overall Study||41
9808918|NCT00651313|10918095|FG001|STARTED|Overall Study||43
9808919|NCT00651313|10918094|FG000|COMPLETED|Overall Study||35
9808920|NCT00651313|10918095|FG001|COMPLETED|Overall Study||37
9808921|NCT00651313|10918094|FG000|NOT COMPLETED|Overall Study||6
9808922|NCT00651313|10918095|FG001|NOT COMPLETED|Overall Study||6
9831566|NCT00768755|10942185|FG002|NOT COMPLETED|Phase 2||58
9831567|NCT00768755|10942186|FG003|NOT COMPLETED|Phase 2||57
9831568|NCT00768898|10942195|FG000|STARTED|Overall Study||30
9831569|NCT00768898|10942195|FG000|COMPLETED|Overall Study||28
9831570|NCT00768898|10942195|FG000|NOT COMPLETED|Overall Study||2
9831571|NCT00768989|10942206|FG000|STARTED|Prior to Week 24||63
9831572|NCT00768989|10942207|FG001|STARTED|Prior to Week 24||30
9831573|NCT00768989|10942206|FG000|COMPLETED|Prior to Week 24||59
9831574|NCT00768989|10942207|FG001|COMPLETED|Prior to Week 24||27
9831575|NCT00768989|10942206|FG000|NOT COMPLETED|Prior to Week 24||4
9831576|NCT00768989|10942207|FG001|NOT COMPLETED|Prior to Week 24||3
9831577|NCT00768989|10942206|FG000|STARTED|Week 24 to Prior to Week 36||59
9831578|NCT00768989|10942207|FG001|STARTED|Week 24 to Prior to Week 36||27
9831579|NCT00768989|10942206|FG000|COMPLETED|Week 24 to Prior to Week 36||51
9831580|NCT00768989|10942207|FG001|COMPLETED|Week 24 to Prior to Week 36||27
9831581|NCT00768989|10942206|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8
9831582|NCT00768989|10942207|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0
9831583|NCT00768989|10942206|FG000|STARTED|On or After Week 36||51
9831584|NCT00768989|10942207|FG001|STARTED|On or After Week 36||27
9831585|NCT00768989|10942206|FG000|COMPLETED|On or After Week 36||0
9831586|NCT00768989|10942207|FG001|COMPLETED|On or After Week 36||0
9831587|NCT00768989|10942206|FG000|NOT COMPLETED|On or After Week 36||51
9831588|NCT00768989|10942207|FG001|NOT COMPLETED|On or After Week 36||27
9831589|NCT00769015|10942217|FG000|STARTED|Overall Study||96
9831590|NCT00769015|10942218|FG001|STARTED|Overall Study||92
9831591|NCT00769015|10942217|FG000|COMPLETED|Overall Study||87
9831592|NCT00769015|10942218|FG001|COMPLETED|Overall Study||76
9831593|NCT00769015|10942217|FG000|NOT COMPLETED|Overall Study||9
9831594|NCT00769015|10942218|FG001|NOT COMPLETED|Overall Study||16
9831595|NCT00769067|10942226|FG000|STARTED|Overall Study||94
9831596|NCT00769067|10942227|FG001|STARTED|Overall Study||94
9831597|NCT00769067|10942226|FG000|Treated|Overall Study||94
9831598|NCT00769067|10942227|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
9831599|NCT00769067|10942226|FG000|COMPLETED|Overall Study||0
9831600|NCT00769067|10942227|FG001|COMPLETED|Overall Study||0
9831601|NCT00769067|10942226|FG000|NOT COMPLETED|Overall Study||94
9831602|NCT00769067|10942227|FG001|NOT COMPLETED|Overall Study||94
9831603|NCT00769119|10942236|FG000|STARTED|Overall Study||22
9831604|NCT00769119|10942237|FG001|STARTED|Overall Study||16
9831605|NCT00769119|10942236|FG000|COMPLETED|Overall Study||20
9831606|NCT00769119|10942237|FG001|COMPLETED|Overall Study||13
9831607|NCT00769119|10942236|FG000|NOT COMPLETED|Overall Study||2
9831608|NCT00769119|10942237|FG001|NOT COMPLETED|Overall Study||3
9831609|NCT00769132|10942243|FG000|STARTED|Period 1||7
9808923|NCT00651482|10918101|FG000|STARTED|Overall Study||10
9808924|NCT00651482|10918101|FG000|COMPLETED|Overall Study||10
9808925|NCT00651482|10918101|FG000|NOT COMPLETED|Overall Study||0
9808926|NCT00651573|10918108|FG000|STARTED|Overall Study||365
9808927|NCT00651573|10918109|FG001|STARTED|Overall Study||357
9808928|NCT00651573|10918108|FG000|COMPLETED|Overall Study||363
9808929|NCT00651573|10918109|FG001|COMPLETED|Overall Study||354
9808930|NCT00651573|10918108|FG000|NOT COMPLETED|Overall Study||2
9808931|NCT00651573|10918109|FG001|NOT COMPLETED|Overall Study||3
9808932|NCT00651625|10918117|FG000|STARTED|Overall Study||219
9808933|NCT00651625|10918118|FG001|STARTED|Overall Study||218
9808934|NCT00651625|10918117|FG000|COMPLETED|Overall Study||219
9808935|NCT00651625|10918118|FG001|COMPLETED|Overall Study||218
9808936|NCT00651625|10918117|FG000|NOT COMPLETED|Overall Study||0
9808937|NCT00651625|10918118|FG001|NOT COMPLETED|Overall Study||0
9808938|NCT00651664|10918134|FG000|STARTED|Overall Study||3
9808939|NCT00651664|10918135|FG001|STARTED|Overall Study||3
9808940|NCT00651664|10918136|FG002|STARTED|Overall Study||3
9808941|NCT00651664|10918137|FG003|STARTED|Overall Study||14
9808942|NCT00651664|10918138|FG004|STARTED|Overall Study||6
9808943|NCT00651664|10918139|FG005|STARTED|Overall Study||3
9808944|NCT00651664|10918140|FG006|STARTED|Overall Study||6
9808945|NCT00651664|10918141|FG007|STARTED|Overall Study||7
9808946|NCT00651664|10918142|FG008|STARTED|Overall Study||7
9808947|NCT00651664|10918143|FG009|STARTED|Overall Study||7
9808948|NCT00651664|10918134|FG000|COMPLETED|Overall Study||0
9808949|NCT00651664|10918135|FG001|COMPLETED|Overall Study||0
9808950|NCT00651664|10918136|FG002|COMPLETED|Overall Study||0
9808951|NCT00651664|10918137|FG003|COMPLETED|Overall Study||0
9808952|NCT00651664|10918138|FG004|COMPLETED|Overall Study||0
9808953|NCT00651664|10918139|FG005|COMPLETED|Overall Study||0
9808954|NCT00651664|10918140|FG006|COMPLETED|Overall Study||0
9808955|NCT00651664|10918141|FG007|COMPLETED|Overall Study||0
9808956|NCT00651664|10918142|FG008|COMPLETED|Overall Study||0
9808957|NCT00651664|10918143|FG009|COMPLETED|Overall Study||0
9808958|NCT00651664|10918134|FG000|NOT COMPLETED|Overall Study||3
9808959|NCT00651664|10918135|FG001|NOT COMPLETED|Overall Study||3
9808960|NCT00651664|10918136|FG002|NOT COMPLETED|Overall Study||3
9808961|NCT00651664|10918137|FG003|NOT COMPLETED|Overall Study||14
9808962|NCT00651664|10918138|FG004|NOT COMPLETED|Overall Study||6
9808963|NCT00651664|10918139|FG005|NOT COMPLETED|Overall Study||3
9808964|NCT00651664|10918140|FG006|NOT COMPLETED|Overall Study||6
9808965|NCT00651664|10918141|FG007|NOT COMPLETED|Overall Study||7
9808966|NCT00651664|10918142|FG008|NOT COMPLETED|Overall Study||7
9808967|NCT00651664|10918143|FG009|NOT COMPLETED|Overall Study||7
9808968|NCT00651755|10918169|FG000|STARTED|Cycle 1 (First 21 Days)||11
9808969|NCT00651755|10918170|FG001|STARTED|Cycle 1 (First 21 Days)||9
9808970|NCT00651755|10918169|FG000|COMPLETED|Cycle 1 (First 21 Days)||10
9808971|NCT00651755|10918170|FG001|COMPLETED|Cycle 1 (First 21 Days)||9
9808972|NCT00651755|10918169|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1
9808973|NCT00651755|10918170|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0
9808974|NCT00651755|10918169|FG000|STARTED|Cycle 2 (Second 21 Days)||10
9808975|NCT00651755|10918170|FG001|STARTED|Cycle 2 (Second 21 Days)||9
9808976|NCT00651755|10918169|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10
9808977|NCT00651755|10918170|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8
9808978|NCT00651755|10918169|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
9808979|NCT00651755|10918170|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
9808980|NCT00651794|10918180|FG000|STARTED|Overall Study||36
9808981|NCT00651794|10918181|FG001|STARTED|Overall Study||31
9808982|NCT00651794|10918182|FG002|STARTED|Overall Study||31
9808983|NCT00651794|10918180|FG000|COMPLETED|Overall Study||15
9808984|NCT00651794|10918181|FG001|COMPLETED|Overall Study||9
9808985|NCT00651794|10918182|FG002|COMPLETED|Overall Study||10
9808986|NCT00651794|10918180|FG000|NOT COMPLETED|Overall Study||21
9808987|NCT00651794|10918181|FG001|NOT COMPLETED|Overall Study||22
9808988|NCT00651794|10918182|FG002|NOT COMPLETED|Overall Study||21
9808989|NCT00651820|10918190|FG000|STARTED|Overall Study||28
9808990|NCT00651820|10918190|FG000|COMPLETED|Overall Study||26
9808991|NCT00651820|10918190|FG000|NOT COMPLETED|Overall Study||2
9808992|NCT00651924|10918198|FG000|STARTED|Overall Study||18
9808993|NCT00651924|10918199|FG001|STARTED|Overall Study||9
9808994|NCT00651924|10918198|FG000|COMPLETED|Overall Study||18
9808995|NCT00651924|10918199|FG001|COMPLETED|Overall Study||2
9808996|NCT00651924|10918198|FG000|NOT COMPLETED|Overall Study||0
9808997|NCT00651924|10918199|FG001|NOT COMPLETED|Overall Study||7
9808998|NCT00651937|10918207|FG000|STARTED|Overall Study||39
9808999|NCT00651937|10918208|FG001|STARTED|Overall Study||41
9809000|NCT00651937|10918207|FG000|COMPLETED|Overall Study||35
9809001|NCT00651937|10918208|FG001|COMPLETED|Overall Study||40
9809002|NCT00651937|10918207|FG000|NOT COMPLETED|Overall Study||4
9809003|NCT00651937|10918208|FG001|NOT COMPLETED|Overall Study||1
9809004|NCT00652028|10918218|FG000|STARTED|Overall Study||16
9809005|NCT00652028|10918219|FG001|STARTED|Overall Study||14
9809006|NCT00652028|10918220|FG002|STARTED|Overall Study||15
9809007|NCT00652028|10918221|FG003|STARTED|Overall Study||14
9809008|NCT00652028|10918218|FG000|COMPLETED|Overall Study||15
9809009|NCT00652028|10918219|FG001|COMPLETED|Overall Study||13
9809010|NCT00652028|10918220|FG002|COMPLETED|Overall Study||14
9809011|NCT00652028|10918221|FG003|COMPLETED|Overall Study||14
9809012|NCT00652028|10918218|FG000|NOT COMPLETED|Overall Study||1
9809013|NCT00652028|10918219|FG001|NOT COMPLETED|Overall Study||1
9809014|NCT00652028|10918220|FG002|NOT COMPLETED|Overall Study||1
9809015|NCT00652028|10918221|FG003|NOT COMPLETED|Overall Study||0
9809016|NCT00652080|10918231|FG000|STARTED|Overall Study||35
9809017|NCT00652080|10918231|FG000|COMPLETED|Overall Study||31
9809018|NCT00652080|10918231|FG000|NOT COMPLETED|Overall Study||4
9809019|NCT00652093|10918243|FG000|STARTED|Overall Study||4
9809020|NCT00652093|10918244|FG001|STARTED|Overall Study||4
9809021|NCT00652093|10918245|FG002|STARTED|Overall Study||4
9809022|NCT00652093|10918246|FG003|STARTED|Overall Study||4
9809023|NCT00652093|10918247|FG004|STARTED|Overall Study||4
9809024|NCT00652093|10918248|FG005|STARTED|Overall Study||4
9809025|NCT00652093|10918243|FG000|COMPLETED|Overall Study||4
9809026|NCT00652093|10918244|FG001|COMPLETED|Overall Study||4
9809027|NCT00652093|10918245|FG002|COMPLETED|Overall Study||3
9809028|NCT00652093|10918246|FG003|COMPLETED|Overall Study||4
9809029|NCT00652093|10918247|FG004|COMPLETED|Overall Study||2
9809030|NCT00652093|10918248|FG005|COMPLETED|Overall Study||4
9809031|NCT00652093|10918243|FG000|NOT COMPLETED|Overall Study||0
9809032|NCT00652093|10918244|FG001|NOT COMPLETED|Overall Study||0
9809033|NCT00652093|10918245|FG002|NOT COMPLETED|Overall Study||1
9809034|NCT00652093|10918246|FG003|NOT COMPLETED|Overall Study||0
9809035|NCT00652093|10918247|FG004|NOT COMPLETED|Overall Study||2
9809036|NCT00652093|10918248|FG005|NOT COMPLETED|Overall Study||0
9809037|NCT00652145|10918264|FG000|STARTED|Overall Study||26
9809038|NCT00652145|10918265|FG001|STARTED|Overall Study||26
9809039|NCT00652145|10918264|FG000|COMPLETED|Overall Study||26
9809040|NCT00652145|10918265|FG001|COMPLETED|Overall Study||26
9809041|NCT00652145|10918264|FG000|NOT COMPLETED|Overall Study||0
9809042|NCT00652145|10918265|FG001|NOT COMPLETED|Overall Study||0
9809043|NCT00652314|10918275|FG000|STARTED|Overall Study||62
9809044|NCT00652314|10918276|FG001|STARTED|Overall Study||35
9809045|NCT00652314|10918275|FG000|COMPLETED|Overall Study||53
9809046|NCT00652314|10918276|FG001|COMPLETED|Overall Study||26
9809047|NCT00652314|10918275|FG000|NOT COMPLETED|Overall Study||9
9809048|NCT00652314|10918276|FG001|NOT COMPLETED|Overall Study||9
9809049|NCT00652340|10918284|FG000|STARTED|Overall Study||78
9809050|NCT00652340|10918285|FG001|STARTED|Overall Study||42
9809051|NCT00652340|10918284|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
9809052|NCT00652340|10918285|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
9809053|NCT00652340|10918284|FG000|NOT COMPLETED|Overall Study||4
9809054|NCT00652340|10918285|FG001|NOT COMPLETED|Overall Study||3
9809055|NCT00652366|10918296|FG000|STARTED|Overall Study||106
9809056|NCT00652366|10918297|FG001|STARTED|Overall Study||75
9809057|NCT00652366|10918298|FG002|STARTED|Overall Study||71
9809058|NCT00652366|10918299|FG003|STARTED|Overall Study||179
9809059|NCT00652366|10918300|FG004|STARTED|Overall Study||36
9809060|NCT00652366|10918296|FG000|COMPLETED|Overall Study||0
9809061|NCT00652366|10918297|FG001|COMPLETED|Overall Study||0
9809062|NCT00652366|10918298|FG002|COMPLETED|Overall Study||0
9809063|NCT00652366|10918299|FG003|COMPLETED|Overall Study||0
9809064|NCT00652366|10918300|FG004|COMPLETED|Overall Study||0
9809065|NCT00652366|10918296|FG000|NOT COMPLETED|Overall Study||106
9809066|NCT00652366|10918297|FG001|NOT COMPLETED|Overall Study||75
9809067|NCT00652366|10918298|FG002|NOT COMPLETED|Overall Study||71
9809068|NCT00652366|10918299|FG003|NOT COMPLETED|Overall Study||179
9809069|NCT00652366|10918300|FG004|NOT COMPLETED|Overall Study||36
9809070|NCT00652626|10918321|FG000|STARTED|Initial Treatment Phase||5
9809071|NCT00652626|10918322|FG001|STARTED|Initial Treatment Phase||5
9809072|NCT00652626|10918323|FG002|STARTED|Initial Treatment Phase||7
9809073|NCT00652626|10918324|FG003|STARTED|Initial Treatment Phase||6
9809074|NCT00652626|10918325|FG004|STARTED|Initial Treatment Phase||8
9809075|NCT00652626|10918326|FG005|STARTED|Initial Treatment Phase||0
9809076|NCT00652626|10918327|FG006|STARTED|Initial Treatment Phase||0
9809077|NCT00652626|10918321|FG000|Received Study Drug|Initial Treatment Phase||5
9809078|NCT00652626|10918322|FG001|Received Study Drug|Initial Treatment Phase||5
9809079|NCT00652626|10918323|FG002|Received Study Drug|Initial Treatment Phase||6
9809080|NCT00652626|10918324|FG003|Received Study Drug|Initial Treatment Phase||5
9809081|NCT00652626|10918325|FG004|Received Study Drug|Initial Treatment Phase||6
9809082|NCT00652626|10918326|FG005|Received Study Drug|Initial Treatment Phase||0
9809083|NCT00652626|10918327|FG006|Received Study Drug|Initial Treatment Phase||0
9809084|NCT00652626|10918321|FG000|COMPLETED|Initial Treatment Phase||5
9809085|NCT00652626|10918322|FG001|COMPLETED|Initial Treatment Phase||5
9809086|NCT00652626|10918323|FG002|COMPLETED|Initial Treatment Phase||6
9809087|NCT00652626|10918324|FG003|COMPLETED|Initial Treatment Phase||5
9809088|NCT00652626|10918325|FG004|COMPLETED|Initial Treatment Phase||5
9809089|NCT00652626|10918326|FG005|COMPLETED|Initial Treatment Phase||0
9809090|NCT00652626|10918327|FG006|COMPLETED|Initial Treatment Phase||0
9809091|NCT00652626|10918321|FG000|NOT COMPLETED|Initial Treatment Phase||0
9809092|NCT00652626|10918322|FG001|NOT COMPLETED|Initial Treatment Phase||0
9809093|NCT00652626|10918323|FG002|NOT COMPLETED|Initial Treatment Phase||1
9809094|NCT00652626|10918324|FG003|NOT COMPLETED|Initial Treatment Phase||1
9809095|NCT00652626|10918325|FG004|NOT COMPLETED|Initial Treatment Phase||3
9809096|NCT00652626|10918326|FG005|NOT COMPLETED|Initial Treatment Phase||0
9809097|NCT00652626|10918327|FG006|NOT COMPLETED|Initial Treatment Phase||0
9809098|NCT00652626|10918321|FG000|STARTED|Extension Phase||0
9809099|NCT00652626|10918322|FG001|STARTED|Extension Phase||0
9809100|NCT00652626|10918323|FG002|STARTED|Extension Phase||0
9809101|NCT00652626|10918324|FG003|STARTED|Extension Phase||0
9809102|NCT00652626|10918325|FG004|STARTED|Extension Phase||0
9809103|NCT00652626|10918326|FG005|STARTED|Extension Phase||14
9809104|NCT00652626|10918327|FG006|STARTED|Extension Phase||4
9809105|NCT00652626|10918321|FG000|COMPLETED|Extension Phase||0
9809106|NCT00652626|10918322|FG001|COMPLETED|Extension Phase||0
9809107|NCT00652626|10918323|FG002|COMPLETED|Extension Phase||0
9809108|NCT00652626|10918324|FG003|COMPLETED|Extension Phase||0
9809109|NCT00652626|10918325|FG004|COMPLETED|Extension Phase||0
9809110|NCT00652626|10918326|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
9809111|NCT00652626|10918327|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
9809112|NCT00652626|10918321|FG000|NOT COMPLETED|Extension Phase||0
9809113|NCT00652626|10918322|FG001|NOT COMPLETED|Extension Phase||0
9809114|NCT00652626|10918323|FG002|NOT COMPLETED|Extension Phase||0
9809115|NCT00652626|10918324|FG003|NOT COMPLETED|Extension Phase||0
9809116|NCT00652626|10918325|FG004|NOT COMPLETED|Extension Phase||0
9809117|NCT00652626|10918326|FG005|NOT COMPLETED|Extension Phase||12
9809118|NCT00652626|10918327|FG006|NOT COMPLETED|Extension Phase||3
9809119|NCT00652743|10918348|FG000|STARTED|Months 12-18||219
9809120|NCT00652743|10918349|FG001|STARTED|Months 12-18||188
9809121|NCT00652743|10918350|FG002|STARTED|Months 12-18||437
9809122|NCT00652743|10918348|FG000|COMPLETED|Months 12-18||218
9809123|NCT00652743|10918349|FG001|COMPLETED|Months 12-18||186
9809124|NCT00652743|10918350|FG002|COMPLETED|Months 12-18||430
9809125|NCT00652743|10918348|FG000|NOT COMPLETED|Months 12-18||1
9809126|NCT00652743|10918349|FG001|NOT COMPLETED|Months 12-18||2
9809127|NCT00652743|10918350|FG002|NOT COMPLETED|Months 12-18||7
9809128|NCT00652743|10918348|FG000|STARTED|Months 24-30||212
9809129|NCT00652743|10918349|FG001|STARTED|Months 24-30||186
9809130|NCT00652743|10918350|FG002|STARTED|Months 24-30||433
9809131|NCT00652743|10918348|FG000|COMPLETED|Months 24-30||207
9809132|NCT00652743|10918349|FG001|COMPLETED|Months 24-30||185
9809133|NCT00652743|10918350|FG002|COMPLETED|Months 24-30||422
9809134|NCT00652743|10918348|FG000|NOT COMPLETED|Months 24-30||5
9809135|NCT00652743|10918349|FG001|NOT COMPLETED|Months 24-30||1
9809136|NCT00652743|10918350|FG002|NOT COMPLETED|Months 24-30||11
9809137|NCT00652743|10918348|FG000|STARTED|Months 36-42||216
9809138|NCT00652743|10918349|FG001|STARTED|Months 36-42||185
9809139|NCT00652743|10918350|FG002|STARTED|Months 36-42||390
9809140|NCT00652743|10918348|FG000|COMPLETED|Months 36-42||210
9809141|NCT00652743|10918349|FG001|COMPLETED|Months 36-42||180
9809142|NCT00652743|10918350|FG002|COMPLETED|Months 36-42||381
9809143|NCT00652743|10918348|FG000|NOT COMPLETED|Months 36-42||6
9809144|NCT00652743|10918349|FG001|NOT COMPLETED|Months 36-42||5
9809145|NCT00652743|10918350|FG002|NOT COMPLETED|Months 36-42||9
9809146|NCT00652743|10918348|FG000|STARTED|Months 42-48||196
9809147|NCT00652743|10918349|FG001|STARTED|Months 42-48||170
9809148|NCT00652743|10918350|FG002|STARTED|Months 42-48||367
9809149|NCT00652743|10918348|FG000|COMPLETED|Months 42-48||196
9809150|NCT00652743|10918349|FG001|COMPLETED|Months 42-48||170
9809151|NCT00652743|10918350|FG002|COMPLETED|Months 42-48||367
9809152|NCT00652743|10918348|FG000|NOT COMPLETED|Months 42-48||0
9809153|NCT00652743|10918349|FG001|NOT COMPLETED|Months 42-48||0
9809154|NCT00652743|10918350|FG002|NOT COMPLETED|Months 42-48||0
9809155|NCT00652834|10918361|FG000|STARTED|Overall Study||23
9809156|NCT00652834|10918361|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
9809157|NCT00652834|10918361|FG000|NOT COMPLETED|Overall Study||5
9809158|NCT00652899|10918365|FG000|STARTED|Overall Study||14
9809159|NCT00652899|10918365|FG000|COMPLETED|Overall Study||12
9809160|NCT00652899|10918365|FG000|NOT COMPLETED|Overall Study||2
9809161|NCT00652938|10918376|FG000|STARTED|Overall Study||247
9809162|NCT00652938|10918377|FG001|STARTED|Overall Study||247
9809163|NCT00652938|10918378|FG002|STARTED|Overall Study||247
9809164|NCT00652938|10918376|FG000|COMPLETED|Overall Study||246
9809165|NCT00652938|10918377|FG001|COMPLETED|Overall Study||240
9809166|NCT00652938|10918378|FG002|COMPLETED|Overall Study||242
9809167|NCT00652938|10918376|FG000|NOT COMPLETED|Overall Study||1
9809168|NCT00652938|10918377|FG001|NOT COMPLETED|Overall Study||7
9809169|NCT00652938|10918378|FG002|NOT COMPLETED|Overall Study||5
9809170|NCT00652951|10918389|FG000|STARTED|Primary Phase||260
9809171|NCT00652951|10918390|FG001|STARTED|Primary Phase||260
9809172|NCT00652951|10918391|FG002|STARTED|Primary Phase||260
9809173|NCT00652951|10918389|FG000|COMPLETED|Primary Phase||260
9809174|NCT00652951|10918390|FG001|COMPLETED|Primary Phase||260
9809175|NCT00652951|10918391|FG002|COMPLETED|Primary Phase||260
9809176|NCT00652951|10918389|FG000|NOT COMPLETED|Primary Phase||0
9809177|NCT00652951|10918390|FG001|NOT COMPLETED|Primary Phase||0
9809178|NCT00652951|10918391|FG002|NOT COMPLETED|Primary Phase||0
9809179|NCT00652951|10918389|FG000|STARTED|Booster Phase||257
9809180|NCT00652951|10918390|FG001|STARTED|Booster Phase||259
9809181|NCT00652951|10918391|FG002|STARTED|Booster Phase||258
9809182|NCT00652951|10918389|FG000|COMPLETED|Booster Phase||256
9809183|NCT00652951|10918390|FG001|COMPLETED|Booster Phase||258
9809184|NCT00652951|10918391|FG002|COMPLETED|Booster Phase||258
9809185|NCT00652951|10918389|FG000|NOT COMPLETED|Booster Phase||1
9809186|NCT00652951|10918390|FG001|NOT COMPLETED|Booster Phase||1
9809187|NCT00652951|10918391|FG002|NOT COMPLETED|Booster Phase||0
9809188|NCT00653133|10918401|FG000|STARTED|Overall Study||1324
9809189|NCT00653133|10918402|FG001|STARTED|Overall Study||497
9809190|NCT00653133|10918401|FG000|COMPLETED|Overall Study||1324
9809191|NCT00653133|10918402|FG001|COMPLETED|Overall Study||497
9809192|NCT00653133|10918401|FG000|NOT COMPLETED|Overall Study||0
9809193|NCT00653133|10918402|FG001|NOT COMPLETED|Overall Study||0
9809194|NCT00653159|10918410|FG000|STARTED|Overall Study||11
9809195|NCT00653159|10918411|FG001|STARTED|Overall Study||12
9809196|NCT00653159|10918410|FG000|COMPLETED|Overall Study||6
9809197|NCT00653159|10918411|FG001|COMPLETED|Overall Study||9
9809198|NCT00653159|10918410|FG000|NOT COMPLETED|Overall Study||5
9809199|NCT00653159|10918411|FG001|NOT COMPLETED|Overall Study||3
9809200|NCT00653224|10918419|FG000|STARTED|Overall Study||293
9809201|NCT00653224|10918420|FG001|STARTED|Overall Study||287
9809202|NCT00653224|10918419|FG000|COMPLETED|Overall Study||286
9809203|NCT00653224|10918420|FG001|COMPLETED|Overall Study||280
9809204|NCT00653224|10918419|FG000|NOT COMPLETED|Overall Study||7
9809205|NCT00653224|10918420|FG001|NOT COMPLETED|Overall Study||7
9809206|NCT00653263|10918426|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
9809207|NCT00653263|10918426|FG000|COMPLETED|Overall Study||6
9809208|NCT00653263|10918426|FG000|NOT COMPLETED|Overall Study||2
9809209|NCT00653328|10918430|FG000|STARTED|Overall Study||15
9809210|NCT00653328|10918430|FG000|COMPLETED|Overall Study||0
9809211|NCT00653328|10918430|FG000|NOT COMPLETED|Overall Study||15
9809212|NCT00653432|10918436|FG000|STARTED|Overall Study||184
9809213|NCT00653432|10918437|FG001|STARTED|Overall Study||185
9809214|NCT00653432|10918436|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
9809215|NCT00653432|10918437|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
9809216|NCT00653432|10918436|FG000|COMPLETED|Overall Study||162
9809217|NCT00653432|10918437|FG001|COMPLETED|Overall Study||169
9809218|NCT00653432|10918436|FG000|NOT COMPLETED|Overall Study||22
9809219|NCT00653432|10918437|FG001|NOT COMPLETED|Overall Study||16
9809220|NCT00653861|10918443|FG000|STARTED|Overall Study||72
9809221|NCT00653861|10918443|FG000|COMPLETED|Overall Study||72
9809222|NCT00653861|10918443|FG000|NOT COMPLETED|Overall Study||0
9809223|NCT00653939|10918454|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
9809224|NCT00653939|10918455|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
9809225|NCT00653939|10918454|FG000|COMPLETED|Overall Study||19
9809226|NCT00653939|10918455|FG001|COMPLETED|Overall Study||17
9809227|NCT00653939|10918454|FG000|NOT COMPLETED|Overall Study||12
9809228|NCT00653939|10918455|FG001|NOT COMPLETED|Overall Study||15
9809229|NCT00653991|10918465|FG000|STARTED|3 Month Follow-up||444
9809230|NCT00653991|10918466|FG001|STARTED|3 Month Follow-up||491
9809231|NCT00653991|10918465|FG000|COMPLETED|3 Month Follow-up||294
9809232|NCT00653991|10918466|FG001|COMPLETED|3 Month Follow-up||334
9809233|NCT00653991|10918465|FG000|NOT COMPLETED|3 Month Follow-up||150
9809234|NCT00653991|10918466|FG001|NOT COMPLETED|3 Month Follow-up||157
9809235|NCT00653991|10918465|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
9809236|NCT00653991|10918466|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
9809237|NCT00653991|10918465|FG000|COMPLETED|6 Month Follow-up||311
9809238|NCT00653991|10918466|FG001|COMPLETED|6 Month Follow-up||350
9809239|NCT00653991|10918465|FG000|NOT COMPLETED|6 Month Follow-up||133
9809240|NCT00653991|10918466|FG001|NOT COMPLETED|6 Month Follow-up||141
9809241|NCT00654004|10918476|FG000|STARTED|Overall Study||14
9809242|NCT00654004|10918477|FG001|STARTED|Overall Study||12
9809243|NCT00654004|10918476|FG000|COMPLETED|Overall Study||13
9809244|NCT00654004|10918477|FG001|COMPLETED|Overall Study||12
9809245|NCT00654004|10918476|FG000|NOT COMPLETED|Overall Study||1
9809246|NCT00654004|10918477|FG001|NOT COMPLETED|Overall Study||0
9809247|NCT00654030|10918483|FG000|STARTED|Overall Study||12
9809248|NCT00654030|10918483|FG000|COMPLETED|Overall Study||11
9809249|NCT00654030|10918483|FG000|NOT COMPLETED|Overall Study||1
9809250|NCT00654069|10918490|FG000|STARTED|Overall Study||136
9809251|NCT00654069|10918491|FG001|STARTED|Overall Study||135
9809252|NCT00654069|10918492|FG002|STARTED|Overall Study||134
9809253|NCT00654069|10918490|FG000|COMPLETED|Overall Study||119
9809254|NCT00654069|10918491|FG001|COMPLETED|Overall Study||124
9809255|NCT00654069|10918492|FG002|COMPLETED|Overall Study||116
9809256|NCT00654069|10918490|FG000|NOT COMPLETED|Overall Study||17
9809257|NCT00654069|10918491|FG001|NOT COMPLETED|Overall Study||11
9809258|NCT00654069|10918492|FG002|NOT COMPLETED|Overall Study||18
9809259|NCT00654147|10918502|FG000|STARTED|Overall Study||21
9809260|NCT00654147|10918503|FG001|STARTED|Overall Study||23
9809261|NCT00654147|10918502|FG000|COMPLETED|Overall Study||19
9809262|NCT00654147|10918503|FG001|COMPLETED|Overall Study||19
9809263|NCT00654147|10918502|FG000|NOT COMPLETED|Overall Study||2
9809264|NCT00654147|10918503|FG001|NOT COMPLETED|Overall Study||4
9809265|NCT00654186|10918509|FG000|STARTED|Overall Study||32
9809266|NCT00654186|10918509|FG000|COMPLETED|Overall Study||27
9809267|NCT00654186|10918509|FG000|NOT COMPLETED|Overall Study||5
9809268|NCT00654238|10918513|FG000|STARTED|Overall Study||59
9809269|NCT00654238|10918513|FG000|COMPLETED|Overall Study||55
9809270|NCT00654238|10918513|FG000|NOT COMPLETED|Overall Study||4
9809271|NCT00654329|10918522|FG000|STARTED|Overall Study||23
9809272|NCT00654329|10918523|FG001|STARTED|Overall Study||28
9809273|NCT00654329|10918524|FG002|STARTED|Overall Study||23
9809274|NCT00654329|10918525|FG003|STARTED|Overall Study||27
9809275|NCT00654329|10918522|FG000|COMPLETED|Overall Study||23
9809276|NCT00654329|10918523|FG001|COMPLETED|Overall Study||28
9809277|NCT00654329|10918524|FG002|COMPLETED|Overall Study||23
9809278|NCT00654329|10918525|FG003|COMPLETED|Overall Study||27
9809279|NCT00654329|10918522|FG000|NOT COMPLETED|Overall Study||0
9809280|NCT00654329|10918523|FG001|NOT COMPLETED|Overall Study||0
9809281|NCT00654329|10918524|FG002|NOT COMPLETED|Overall Study||0
9809282|NCT00654329|10918525|FG003|NOT COMPLETED|Overall Study||0
9809283|NCT00654355|10918537|FG000|STARTED|Overall Study||15
9809284|NCT00654355|10918538|FG001|STARTED|Overall Study||15
9809285|NCT00654355|10918537|FG000|COMPLETED|Overall Study||13
9809286|NCT00654355|10918538|FG001|COMPLETED|Overall Study||13
9809287|NCT00654355|10918537|FG000|NOT COMPLETED|Overall Study||2
9809288|NCT00654355|10918538|FG001|NOT COMPLETED|Overall Study||2
9809289|NCT00654368|10918547|FG000|STARTED|Overall Study||53
9809290|NCT00654368|10918548|FG001|STARTED|Overall Study||98
9809291|NCT00654368|10918549|FG002|STARTED|Overall Study||107
9809292|NCT00654368|10918547|FG000|COMPLETED|Overall Study||0
9809293|NCT00654368|10918548|FG001|COMPLETED|Overall Study||50
9809294|NCT00654368|10918549|FG002|COMPLETED|Overall Study||75
9809295|NCT00654368|10918547|FG000|NOT COMPLETED|Overall Study||53
9809296|NCT00654368|10918548|FG001|NOT COMPLETED|Overall Study||48
9809297|NCT00654368|10918549|FG002|NOT COMPLETED|Overall Study||32
9809298|NCT00654381|10918560|FG000|STARTED|1st Stage||39
9809299|NCT00654381|10918561|FG001|STARTED|1st Stage||41
9809300|NCT00654381|10918562|FG002|STARTED|1st Stage||159
9809301|NCT00654381|10918563|FG003|STARTED|1st Stage||160
9809302|NCT00654381|10918564|FG004|STARTED|1st Stage||81
9809303|NCT00654381|10918565|FG005|STARTED|1st Stage||81
9809304|NCT00654381|10918560|FG000|COMPLETED|1st Stage||36
9809305|NCT00654381|10918561|FG001|COMPLETED|1st Stage||38
9809306|NCT00654381|10918562|FG002|COMPLETED|1st Stage||156
9809307|NCT00654381|10918563|FG003|COMPLETED|1st Stage||155
9809308|NCT00654381|10918564|FG004|COMPLETED|1st Stage||79
9809309|NCT00654381|10918565|FG005|COMPLETED|1st Stage||79
9809310|NCT00654381|10918560|FG000|NOT COMPLETED|1st Stage||3
9809311|NCT00654381|10918561|FG001|NOT COMPLETED|1st Stage||3
9809312|NCT00654381|10918562|FG002|NOT COMPLETED|1st Stage||3
9809313|NCT00654381|10918563|FG003|NOT COMPLETED|1st Stage||5
9809314|NCT00654381|10918564|FG004|NOT COMPLETED|1st Stage||2
9809315|NCT00654381|10918565|FG005|NOT COMPLETED|1st Stage||2
9809316|NCT00654381|10918560|FG000|STARTED|2nd Stage||36
9809317|NCT00654381|10918561|FG001|STARTED|2nd Stage||38
9809318|NCT00654381|10918562|FG002|STARTED|2nd Stage||156
9809319|NCT00654381|10918563|FG003|STARTED|2nd Stage||155
9809320|NCT00654381|10918564|FG004|STARTED|2nd Stage||79
9809321|NCT00654381|10918565|FG005|STARTED|2nd Stage||79
9809322|NCT00654381|10918560|FG000|COMPLETED|2nd Stage||34
9809323|NCT00654381|10918561|FG001|COMPLETED|2nd Stage||38
9809324|NCT00654381|10918562|FG002|COMPLETED|2nd Stage||153
9809325|NCT00654381|10918563|FG003|COMPLETED|2nd Stage||151
9809326|NCT00654381|10918564|FG004|COMPLETED|2nd Stage||71
9809327|NCT00654381|10918565|FG005|COMPLETED|2nd Stage||76
9809328|NCT00654381|10918560|FG000|NOT COMPLETED|2nd Stage||2
9809329|NCT00654381|10918561|FG001|NOT COMPLETED|2nd Stage||0
9809330|NCT00654381|10918562|FG002|NOT COMPLETED|2nd Stage||3
9809331|NCT00654381|10918563|FG003|NOT COMPLETED|2nd Stage||4
9809332|NCT00654381|10918564|FG004|NOT COMPLETED|2nd Stage||8
9809333|NCT00654381|10918565|FG005|NOT COMPLETED|2nd Stage||3
9809334|NCT00654381|10918560|FG000|STARTED|Extension Stage||34
9809335|NCT00654381|10918561|FG001|STARTED|Extension Stage||38
9809336|NCT00654381|10918562|FG002|STARTED|Extension Stage||153
9809337|NCT00654381|10918563|FG003|STARTED|Extension Stage||151
9809338|NCT00654381|10918564|FG004|STARTED|Extension Stage||71
9809339|NCT00654381|10918565|FG005|STARTED|Extension Stage||76
9809340|NCT00654381|10918560|FG000|COMPLETED|Extension Stage||33
9809341|NCT00654381|10918561|FG001|COMPLETED|Extension Stage||36
9809342|NCT00654381|10918562|FG002|COMPLETED|Extension Stage||142
9809343|NCT00654381|10918563|FG003|COMPLETED|Extension Stage||142
9809344|NCT00654381|10918564|FG004|COMPLETED|Extension Stage||68
9809345|NCT00654381|10918565|FG005|COMPLETED|Extension Stage||73
9809346|NCT00654381|10918560|FG000|NOT COMPLETED|Extension Stage||1
9809347|NCT00654381|10918561|FG001|NOT COMPLETED|Extension Stage||2
9809348|NCT00654381|10918562|FG002|NOT COMPLETED|Extension Stage||11
9809349|NCT00654381|10918563|FG003|NOT COMPLETED|Extension Stage||9
9809350|NCT00654381|10918564|FG004|NOT COMPLETED|Extension Stage||3
9809351|NCT00654381|10918565|FG005|NOT COMPLETED|Extension Stage||3
9809352|NCT00654420|10918586|FG000|STARTED|Phase I (Dose Escalation)||4
9809353|NCT00654420|10918587|FG001|STARTED|Phase I (Dose Escalation)||16
9809354|NCT00654420|10918588|FG002|STARTED|Phase I (Dose Escalation)||0
9809355|NCT00654420|10918589|FG003|STARTED|Phase I (Dose Escalation)||0
9809356|NCT00654420|10918586|FG000|COMPLETED|Phase I (Dose Escalation)||0
9809357|NCT00654420|10918587|FG001|COMPLETED|Phase I (Dose Escalation)||0
9809358|NCT00654420|10918588|FG002|COMPLETED|Phase I (Dose Escalation)||0
9809359|NCT00654420|10918589|FG003|COMPLETED|Phase I (Dose Escalation)||0
9809360|NCT00654420|10918586|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4
9809361|NCT00654420|10918587|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16
9809362|NCT00654420|10918588|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0
9809363|NCT00654420|10918589|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0
9809364|NCT00654420|10918586|FG000|STARTED|Phase II||0
9809365|NCT00654420|10918587|FG001|STARTED|Phase II||0
9809366|NCT00654420|10918588|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
9809367|NCT00654420|10918589|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
9809368|NCT00654420|10918586|FG000|COMPLETED|Phase II||0
9809369|NCT00654420|10918587|FG001|COMPLETED|Phase II||0
9809370|NCT00654420|10918588|FG002|COMPLETED|Phase II||0
9809371|NCT00654420|10918589|FG003|COMPLETED|Phase II||0
9809372|NCT00654420|10918586|FG000|NOT COMPLETED|Phase II||0
9809373|NCT00654420|10918587|FG001|NOT COMPLETED|Phase II||0
9809374|NCT00654420|10918588|FG002|NOT COMPLETED|Phase II||37
9809375|NCT00654420|10918589|FG003|NOT COMPLETED|Phase II||38
9809376|NCT00654498|10918601|FG000|STARTED|Overall Study||203
9809377|NCT00654498|10918602|FG001|STARTED|Overall Study||103
9809378|NCT00654498|10918601|FG000|COMPLETED|Overall Study||189
9809379|NCT00654498|10918602|FG001|COMPLETED|Overall Study||91
9809380|NCT00654498|10918601|FG000|NOT COMPLETED|Overall Study||14
9809381|NCT00654498|10918602|FG001|NOT COMPLETED|Overall Study||12
9809382|NCT00654511|10918612|FG000|STARTED|Overall Study||26
9809383|NCT00654511|10918613|FG001|STARTED|Overall Study||25
9809384|NCT00654511|10918614|FG002|STARTED|Overall Study||25
9809385|NCT00654511|10918615|FG003|STARTED|Overall Study||25
9809386|NCT00654511|10918612|FG000|COMPLETED|Overall Study||26
9809387|NCT00654511|10918613|FG001|COMPLETED|Overall Study||25
9809388|NCT00654511|10918614|FG002|COMPLETED|Overall Study||25
9809389|NCT00654511|10918615|FG003|COMPLETED|Overall Study||25
9809390|NCT00654511|10918612|FG000|NOT COMPLETED|Overall Study||0
9809391|NCT00654511|10918613|FG001|NOT COMPLETED|Overall Study||0
9809392|NCT00654511|10918614|FG002|NOT COMPLETED|Overall Study||0
9809393|NCT00654511|10918615|FG003|NOT COMPLETED|Overall Study||0
9809394|NCT00654615|10918631|FG000|STARTED|Overall Study||30
9809395|NCT00654615|10918632|FG001|STARTED|Overall Study||30
9809396|NCT00654615|10918631|FG000|COMPLETED|Overall Study||22
9809397|NCT00654615|10918632|FG001|COMPLETED|Overall Study||23
9809398|NCT00654615|10918631|FG000|NOT COMPLETED|Overall Study||8
9809399|NCT00654615|10918632|FG001|NOT COMPLETED|Overall Study||7
9809400|NCT00654641|10918640|FG000|STARTED|Overall Study||28
9809401|NCT00654641|10918641|FG001|STARTED|Overall Study||26
9809402|NCT00654641|10918640|FG000|COMPLETED|Overall Study||26
9809403|NCT00654641|10918641|FG001|COMPLETED|Overall Study||23
9809404|NCT00654641|10918640|FG000|NOT COMPLETED|Overall Study||2
9809405|NCT00654641|10918641|FG001|NOT COMPLETED|Overall Study||3
10016266|NCT01809262|11139189|FG004|COMPLETED|Period 1 (First Dose + Washout)||3
10016267|NCT01809262|11139190|FG005|COMPLETED|Period 1 (First Dose + Washout)||3
10016268|NCT01809262|11139191|FG006|COMPLETED|Period 1 (First Dose + Washout)||3
10016269|NCT01809262|11139192|FG007|COMPLETED|Period 1 (First Dose + Washout)||4
10016270|NCT01809262|11139193|FG008|COMPLETED|Period 1 (First Dose + Washout)||3
9809406|NCT00654654|10918647|FG000|STARTED|Overall Study||50
9809407|NCT00654654|10918647|FG000|COMPLETED|Overall Study||43
9809408|NCT00654654|10918647|FG000|NOT COMPLETED|Overall Study||7
9809409|NCT00654732|10918653|FG000|STARTED|Overall Study||26
9809410|NCT00654732|10918654|FG001|STARTED|Overall Study||32
9809411|NCT00654732|10918653|FG000|COMPLETED|Overall Study||22
9809412|NCT00654732|10918654|FG001|COMPLETED|Overall Study||26
9809413|NCT00654732|10918653|FG000|NOT COMPLETED|Overall Study||4
9809414|NCT00654732|10918654|FG001|NOT COMPLETED|Overall Study||6
9809415|NCT00654745|10918660|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
9809416|NCT00654745|10918660|FG000|COMPLETED|Overall Study||164
9809417|NCT00654745|10918660|FG000|NOT COMPLETED|Overall Study||43
9809418|NCT00654784|10918672|FG000|STARTED|Overall Study||13
9809419|NCT00654784|10918673|FG001|STARTED|Overall Study||8
9809420|NCT00654784|10918672|FG000|COMPLETED|Overall Study||13
9809421|NCT00654784|10918673|FG001|COMPLETED|Overall Study||8
9809422|NCT00654784|10918672|FG000|NOT COMPLETED|Overall Study||0
9809423|NCT00654784|10918673|FG001|NOT COMPLETED|Overall Study||0
9809424|NCT00654836|10918679|FG000|STARTED|Overall Study||32
9809425|NCT00654836|10918679|FG000|COMPLETED|Overall Study||32
9809426|NCT00654836|10918679|FG000|NOT COMPLETED|Overall Study||0
9809427|NCT00654875|10918685|FG000|STARTED|Overall Study||164
9809428|NCT00654875|10918686|FG001|STARTED|Overall Study||164
9809429|NCT00654875|10918685|FG000|COMPLETED|Overall Study||147
9809430|NCT00654875|10918686|FG001|COMPLETED|Overall Study||147
9809431|NCT00654875|10918685|FG000|NOT COMPLETED|Overall Study||17
9809432|NCT00654875|10918686|FG001|NOT COMPLETED|Overall Study||17
9809433|NCT00654901|10918696|FG000|STARTED|Overall Study||254
9809434|NCT00654901|10918697|FG001|STARTED|Overall Study||262
9809435|NCT00654901|10918698|FG002|STARTED|Overall Study||252
9809436|NCT00654901|10918699|FG003|STARTED|Overall Study||113
9809437|NCT00654901|10918696|FG000|COMPLETED|Overall Study||250
9809438|NCT00654901|10918697|FG001|COMPLETED|Overall Study||262
9809439|NCT00654901|10918698|FG002|COMPLETED|Overall Study||250
9809440|NCT00654901|10918699|FG003|COMPLETED|Overall Study||113
9809441|NCT00654901|10918696|FG000|NOT COMPLETED|Overall Study||4
9809442|NCT00654901|10918697|FG001|NOT COMPLETED|Overall Study||0
9809443|NCT00654901|10918698|FG002|NOT COMPLETED|Overall Study||2
9809444|NCT00654901|10918699|FG003|NOT COMPLETED|Overall Study||0
9809445|NCT00654927|10918709|FG000|STARTED|Overall Study||177
9809446|NCT00654927|10918709|FG000|COMPLETED|Overall Study||70
9809447|NCT00654927|10918709|FG000|NOT COMPLETED|Overall Study||107
9809448|NCT00654940|10918715|FG000|STARTED|Period 1|Assigned to study treatment.|13
9809449|NCT00654940|10918716|FG001|STARTED|Period 1|Assigned to study treatment.|12
10016271|NCT01809262|11139194|FG009|COMPLETED|Period 1 (First Dose + Washout)||4
9809450|NCT00654940|10918715|FG000|Received Study Treatment|Period 1||12
9809451|NCT00654940|10918716|FG001|Received Study Treatment|Period 1||12
9809452|NCT00654940|10918715|FG000|COMPLETED|Period 1||12
9809453|NCT00654940|10918716|FG001|COMPLETED|Period 1||11
9809454|NCT00654940|10918715|FG000|NOT COMPLETED|Period 1||1
9809455|NCT00654940|10918716|FG001|NOT COMPLETED|Period 1||1
10016272|NCT01809262|11139185|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0
9809456|NCT00654940|10918715|FG000|STARTED|Washout Period of 2 Weeks||12
9809457|NCT00654940|10918716|FG001|STARTED|Washout Period of 2 Weeks||11
9809458|NCT00654940|10918715|FG000|COMPLETED|Washout Period of 2 Weeks||12
9809459|NCT00654940|10918716|FG001|COMPLETED|Washout Period of 2 Weeks||11
9809460|NCT00654940|10918715|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9809461|NCT00654940|10918716|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9809462|NCT00654940|10918715|FG000|STARTED|Period 2||12
9809463|NCT00654940|10918716|FG001|STARTED|Period 2||11
9809464|NCT00654940|10918715|FG000|COMPLETED|Period 2||12
9809465|NCT00654940|10918716|FG001|COMPLETED|Period 2||11
9809466|NCT00654940|10918715|FG000|NOT COMPLETED|Period 2||0
9809467|NCT00654940|10918716|FG001|NOT COMPLETED|Period 2||0
9809468|NCT00654953|10918731|FG000|STARTED|Overall Study||36
9809469|NCT00654953|10918732|FG001|STARTED|Overall Study||36
9809470|NCT00654953|10918733|FG002|STARTED|Overall Study||30
9809471|NCT00654953|10918731|FG000|COMPLETED|Overall Study||6
9809472|NCT00654953|10918732|FG001|COMPLETED|Overall Study||8
9809473|NCT00654953|10918733|FG002|COMPLETED|Overall Study||8
9809474|NCT00654953|10918731|FG000|NOT COMPLETED|Overall Study||30
9809475|NCT00654953|10918732|FG001|NOT COMPLETED|Overall Study||28
9809476|NCT00654953|10918733|FG002|NOT COMPLETED|Overall Study||22
9809477|NCT00655083|10918743|FG000|STARTED|Overall Study||12
9809478|NCT00655083|10918744|FG001|STARTED|Overall Study||8
9809479|NCT00655083|10918743|FG000|COMPLETED|Overall Study||12
9809480|NCT00655083|10918744|FG001|COMPLETED|Overall Study||8
9809481|NCT00655083|10918743|FG000|NOT COMPLETED|Overall Study||0
9809482|NCT00655083|10918744|FG001|NOT COMPLETED|Overall Study||0
9809483|NCT00655356|10918752|FG000|STARTED|Overall Study||110
9809484|NCT00655356|10918753|FG001|STARTED|Overall Study||108
9809485|NCT00655356|10918752|FG000|COMPLETED|Overall Study||93
9809486|NCT00655356|10918753|FG001|COMPLETED|Overall Study||98
9809487|NCT00655356|10918752|FG000|NOT COMPLETED|Overall Study||17
9809488|NCT00655356|10918753|FG001|NOT COMPLETED|Overall Study||10
9809489|NCT00655473|10918761|FG000|STARTED|Overall Study||64
9809490|NCT00655473|10918762|FG001|STARTED|Overall Study||66
9809491|NCT00655473|10918761|FG000|COMPLETED|Overall Study||53
9809492|NCT00655473|10918762|FG001|COMPLETED|Overall Study||51
9809493|NCT00655473|10918761|FG000|NOT COMPLETED|Overall Study||11
9809494|NCT00655473|10918762|FG001|NOT COMPLETED|Overall Study||15
9809495|NCT00655486|10918768|FG000|STARTED|Overall Study||97
9809496|NCT00655486|10918768|FG000|COMPLETED|Overall Study||69
9809497|NCT00655486|10918768|FG000|NOT COMPLETED|Overall Study||28
9809498|NCT00655499|10918772|FG000|STARTED|Overall Study||69
9809499|NCT00655499|10918772|FG000|COMPLETED|Overall Study||65
9809500|NCT00655499|10918772|FG000|NOT COMPLETED|Overall Study||4
9809501|NCT00655538|10918779|FG000|STARTED|Overall Study||238
9809502|NCT00655538|10918780|FG001|STARTED|Overall Study||238
9809503|NCT00655538|10918779|FG000|COMPLETED|Overall Study||214
9809504|NCT00655538|10918780|FG001|COMPLETED|Overall Study||211
9809505|NCT00655538|10918779|FG000|NOT COMPLETED|Overall Study||24
9809506|NCT00655538|10918780|FG001|NOT COMPLETED|Overall Study||27
9809507|NCT00655551|10918789|FG000|STARTED|All Periods Combined||25
9809508|NCT00655551|10918790|FG001|STARTED|All Periods Combined||50
9809509|NCT00655551|10918791|FG002|STARTED|All Periods Combined||25
9809510|NCT00655551|10918789|FG000|COMPLETED|All Periods Combined||25
9809511|NCT00655551|10918790|FG001|COMPLETED|All Periods Combined||47
9809512|NCT00655551|10918791|FG002|COMPLETED|All Periods Combined||21
9809513|NCT00655551|10918789|FG000|NOT COMPLETED|All Periods Combined||0
9809514|NCT00655551|10918790|FG001|NOT COMPLETED|All Periods Combined||3
9809515|NCT00655551|10918791|FG002|NOT COMPLETED|All Periods Combined||4
9809516|NCT00655551|10918789|FG000|STARTED|Period 1 (up to 7 Days)||25
9809517|NCT00655551|10918790|FG001|STARTED|Period 1 (up to 7 Days)||0
9809518|NCT00655551|10918791|FG002|STARTED|Period 1 (up to 7 Days)||0
9809519|NCT00655551|10918789|FG000|COMPLETED|Period 1 (up to 7 Days)||25
9809520|NCT00655551|10918790|FG001|COMPLETED|Period 1 (up to 7 Days)||0
9809521|NCT00655551|10918791|FG002|COMPLETED|Period 1 (up to 7 Days)||0
9809522|NCT00655551|10918789|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0
9809523|NCT00655551|10918790|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0
9809524|NCT00655551|10918791|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0
9809525|NCT00655551|10918789|FG000|STARTED|Period 2 (up to 7 Days)||0
9809526|NCT00655551|10918790|FG001|STARTED|Period 2 (up to 7 Days)||25
9809527|NCT00655551|10918791|FG002|STARTED|Period 2 (up to 7 Days)||0
9809528|NCT00655551|10918789|FG000|COMPLETED|Period 2 (up to 7 Days)||0
9809529|NCT00655551|10918790|FG001|COMPLETED|Period 2 (up to 7 Days)||24
9809530|NCT00655551|10918791|FG002|COMPLETED|Period 2 (up to 7 Days)||0
9809531|NCT00655551|10918789|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0
9809532|NCT00655551|10918790|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1
9809533|NCT00655551|10918791|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0
9809534|NCT00655551|10918789|FG000|STARTED|Period 3 (up to 7 Days)||0
9809535|NCT00655551|10918790|FG001|STARTED|Period 3 (up to 7 Days)||0
9809536|NCT00655551|10918791|FG002|STARTED|Period 3 (up to 7 Days)||25
9809537|NCT00655551|10918789|FG000|COMPLETED|Period 3 (up to 7 Days)||0
9809538|NCT00655551|10918790|FG001|COMPLETED|Period 3 (up to 7 Days)||0
9809539|NCT00655551|10918791|FG002|COMPLETED|Period 3 (up to 7 Days)||21
9809540|NCT00655551|10918789|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0
9809541|NCT00655551|10918790|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0
9809542|NCT00655551|10918791|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4
9809543|NCT00655551|10918789|FG000|STARTED|Period 4 (up to 7 Days)||0
9809544|NCT00655551|10918790|FG001|STARTED|Period 4 (up to 7 Days)||25
9809545|NCT00655551|10918791|FG002|STARTED|Period 4 (up to 7 Days)||0
9809546|NCT00655551|10918789|FG000|COMPLETED|Period 4 (up to 7 Days)||0
9809547|NCT00655551|10918790|FG001|COMPLETED|Period 4 (up to 7 Days)||23
9809548|NCT00655551|10918791|FG002|COMPLETED|Period 4 (up to 7 Days)||0
9809549|NCT00655551|10918789|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0
9809550|NCT00655551|10918790|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2
9809551|NCT00655551|10918791|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0
9809552|NCT00655564|10918799|FG000|STARTED|Overall Study||15
9809553|NCT00655564|10918799|FG000|COMPLETED|Overall Study||12
9809554|NCT00655564|10918799|FG000|NOT COMPLETED|Overall Study||3
9809555|NCT00655629|10918806|FG000|STARTED|Overall Study||172
9809556|NCT00655629|10918807|FG001|STARTED|Overall Study||167
9809557|NCT00655629|10918806|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
9809558|NCT00655629|10918807|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
9809559|NCT00655629|10918806|FG000|COMPLETED|Overall Study||151
9809560|NCT00655629|10918807|FG001|COMPLETED|Overall Study||144
9809561|NCT00655629|10918806|FG000|NOT COMPLETED|Overall Study||21
9809562|NCT00655629|10918807|FG001|NOT COMPLETED|Overall Study||23
9809563|NCT00655642|10918817|FG000|STARTED|Overall Study||42
9809564|NCT00655642|10918818|FG001|STARTED|Overall Study||43
9809565|NCT00655642|10918819|FG002|STARTED|Overall Study||45
9809566|NCT00655642|10918820|FG003|STARTED|Overall Study||41
9809567|NCT00655642|10918817|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
9809568|NCT00655642|10918818|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
9809569|NCT00655642|10918819|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
9809570|NCT00655642|10918820|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
9809571|NCT00655642|10918817|FG000|NOT COMPLETED|Overall Study||1
9809572|NCT00655642|10918818|FG001|NOT COMPLETED|Overall Study||3
9809573|NCT00655642|10918819|FG002|NOT COMPLETED|Overall Study||2
9809574|NCT00655642|10918820|FG003|NOT COMPLETED|Overall Study||2
9809575|NCT00655668|10918830|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54
9809576|NCT00655668|10918830|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
9809577|NCT00655668|10918830|FG000|NOT COMPLETED|Overall Study||54
9809578|NCT00655707|10918834|FG000|STARTED|Overall Study||5
9809579|NCT00655707|10918834|FG000|COMPLETED|Overall Study||5
9809580|NCT00655707|10918834|FG000|NOT COMPLETED|Overall Study||0
9809581|NCT00655733|10918841|FG000|STARTED|Overall Study||51
9809582|NCT00655733|10918842|FG001|STARTED|Overall Study||50
9809583|NCT00655733|10918841|FG000|COMPLETED|Overall Study||44
9809584|NCT00655733|10918842|FG001|COMPLETED|Overall Study||42
9809585|NCT00655733|10918841|FG000|NOT COMPLETED|Overall Study||7
9809586|NCT00655733|10918842|FG001|NOT COMPLETED|Overall Study||8
9809587|NCT00655746|10918850|FG000|STARTED|Overall Study||14
9809588|NCT00655746|10918850|FG000|COMPLETED|Overall Study||13
9809589|NCT00655746|10918850|FG000|NOT COMPLETED|Overall Study||1
9809590|NCT00655811|10918858|FG000|STARTED|Overall Study||40
9809591|NCT00655811|10918858|FG000|COMPLETED|Overall Study||40
9809592|NCT00655811|10918858|FG000|NOT COMPLETED|Overall Study||0
9809593|NCT00655850|10918868|FG000|STARTED|Overall Study||39
9809594|NCT00655850|10918868|FG000|COMPLETED|Overall Study||36
9809595|NCT00655850|10918868|FG000|NOT COMPLETED|Overall Study||3
9809596|NCT00655863|10918877|FG000|STARTED|Overall Study||24
9809597|NCT00655863|10918878|FG001|STARTED|Overall Study||25
9809598|NCT00655863|10918879|FG002|STARTED|Overall Study||22
9809599|NCT00655863|10918877|FG000|COMPLETED|Overall Study||24
9809600|NCT00655863|10918878|FG001|COMPLETED|Overall Study||25
9809601|NCT00655863|10918879|FG002|COMPLETED|Overall Study||21
9809602|NCT00655863|10918877|FG000|NOT COMPLETED|Overall Study||0
9809603|NCT00655863|10918878|FG001|NOT COMPLETED|Overall Study||0
9809604|NCT00655863|10918879|FG002|NOT COMPLETED|Overall Study||1
9809605|NCT00655889|10918887|FG000|STARTED|Overall Study||13
9809606|NCT00655889|10918887|FG000|COMPLETED|Overall Study||11
9809607|NCT00655889|10918887|FG000|NOT COMPLETED|Overall Study||2
9809608|NCT00655928|10918893|FG000|STARTED|Overall Study||26
9809609|NCT00655928|10918894|FG001|STARTED|Overall Study||26
9809610|NCT00655928|10918893|FG000|COMPLETED|Overall Study||23
9809611|NCT00655928|10918894|FG001|COMPLETED|Overall Study||24
9809612|NCT00655928|10918893|FG000|NOT COMPLETED|Overall Study||3
9809613|NCT00655928|10918894|FG001|NOT COMPLETED|Overall Study||2
9809614|NCT00655980|10918903|FG000|STARTED|Overall Study||276
9809615|NCT00655980|10918904|FG001|STARTED|Overall Study||281
9809616|NCT00655980|10918905|FG002|STARTED|Overall Study||130
9809617|NCT00655980|10918903|FG000|COMPLETED|Overall Study||250
9809618|NCT00655980|10918904|FG001|COMPLETED|Overall Study||250
9809619|NCT00655980|10918905|FG002|COMPLETED|Overall Study||125
9809620|NCT00655980|10918903|FG000|NOT COMPLETED|Overall Study||26
9809621|NCT00655980|10918904|FG001|NOT COMPLETED|Overall Study||31
9809622|NCT00655980|10918905|FG002|NOT COMPLETED|Overall Study||5
9809623|NCT00656019|10918920|FG000|STARTED|Overall Study||29
9809624|NCT00656019|10918921|FG001|STARTED|Overall Study||19
9809625|NCT00656019|10918922|FG002|STARTED|Overall Study||11
9809626|NCT00656019|10918923|FG003|STARTED|Overall Study||4
9809627|NCT00656019|10918920|FG000|COMPLETED|Overall Study||15
9809628|NCT00656019|10918921|FG001|COMPLETED|Overall Study||18
9809629|NCT00656019|10918922|FG002|COMPLETED|Overall Study||11
9809630|NCT00656019|10918923|FG003|COMPLETED|Overall Study||4
9809631|NCT00656019|10918920|FG000|NOT COMPLETED|Overall Study||14
9809632|NCT00656019|10918921|FG001|NOT COMPLETED|Overall Study||1
9809633|NCT00656019|10918922|FG002|NOT COMPLETED|Overall Study||0
9809634|NCT00656019|10918923|FG003|NOT COMPLETED|Overall Study||0
9809635|NCT00656058|10918933|FG000|STARTED|Overall Study||25
9809636|NCT00656058|10918933|FG000|COMPLETED|Overall Study||19
9809637|NCT00656058|10918933|FG000|NOT COMPLETED|Overall Study||6
9809638|NCT00656084|10918937|FG000|STARTED|Overall Study||16
9809639|NCT00656084|10918937|FG000|COMPLETED|Overall Study||9
9809640|NCT00656084|10918937|FG000|NOT COMPLETED|Overall Study||7
9809641|NCT00656136|10918943|FG000|STARTED|Overall Study|Randomised patients.|195
9809642|NCT00656136|10918944|FG001|STARTED|Overall Study|Randomised patients.|390
9809643|NCT00656136|10918943|FG000|COMPLETED|Overall Study||0
9809644|NCT00656136|10918944|FG001|COMPLETED|Overall Study||0
9809645|NCT00656136|10918943|FG000|NOT COMPLETED|Overall Study||195
9809646|NCT00656136|10918944|FG001|NOT COMPLETED|Overall Study||390
9809647|NCT00656175|10918952|FG000|STARTED|Overall Study||18
9809648|NCT00656175|10918953|FG001|STARTED|Overall Study||21
9809649|NCT00656175|10918952|FG000|COMPLETED|Overall Study||17
9809650|NCT00656175|10918953|FG001|COMPLETED|Overall Study||20
9809651|NCT00656175|10918952|FG000|NOT COMPLETED|Overall Study||1
9809652|NCT00656175|10918953|FG001|NOT COMPLETED|Overall Study||1
9809653|NCT00656201|10918961|FG000|STARTED|Overall Study||235
9809654|NCT00656201|10918962|FG001|STARTED|Overall Study||233
9809655|NCT00656201|10918961|FG000|COMPLETED|Overall Study||206
9809656|NCT00656201|10918962|FG001|COMPLETED|Overall Study||201
9809657|NCT00656201|10918961|FG000|NOT COMPLETED|Overall Study||29
9809658|NCT00656201|10918962|FG001|NOT COMPLETED|Overall Study||32
9809659|NCT00656292|10918970|FG000|STARTED|Overall Study||32
9809660|NCT00656292|10918971|FG001|STARTED|Overall Study||29
9809661|NCT00656292|10918970|FG000|COMPLETED|Overall Study||29
9809662|NCT00656292|10918971|FG001|COMPLETED|Overall Study||24
9809663|NCT00656292|10918970|FG000|NOT COMPLETED|Overall Study||3
9809664|NCT00656292|10918971|FG001|NOT COMPLETED|Overall Study||5
9809665|NCT00656305|10918979|FG000|STARTED|Overall Study||87
9809666|NCT00656305|10918980|FG001|STARTED|Overall Study||28
9809667|NCT00656305|10918979|FG000|COMPLETED|Overall Study||65
9809668|NCT00656305|10918980|FG001|COMPLETED|Overall Study||21
9809669|NCT00656305|10918979|FG000|NOT COMPLETED|Overall Study||22
9809670|NCT00656305|10918980|FG001|NOT COMPLETED|Overall Study||7
9809671|NCT00656370|10918986|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
9809672|NCT00656370|10918986|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
9809673|NCT00656370|10918986|FG000|NOT COMPLETED|Overall Study||10
9809674|NCT00656448|10918994|FG000|STARTED|Overall Study||25
9809675|NCT00656448|10918995|FG001|STARTED|Overall Study||25
9809676|NCT00656448|10918994|FG000|COMPLETED|Overall Study||25
9809677|NCT00656448|10918995|FG001|COMPLETED|Overall Study||25
9809678|NCT00656448|10918994|FG000|NOT COMPLETED|Overall Study||0
9809679|NCT00656448|10918995|FG001|NOT COMPLETED|Overall Study||0
9809680|NCT00656474|10919002|FG000|STARTED|Overall Study||12
9809681|NCT00656474|10919002|FG000|COMPLETED|Overall Study||11
9809682|NCT00656474|10919002|FG000|NOT COMPLETED|Overall Study||1
9809683|NCT00656487|10919010|FG000|STARTED|Overall Study||23
9809684|NCT00656487|10919011|FG001|STARTED|Overall Study||23
9809685|NCT00656487|10919012|FG002|STARTED|Overall Study||20
9809686|NCT00656487|10919010|FG000|COMPLETED|Overall Study||21
9809687|NCT00656487|10919011|FG001|COMPLETED|Overall Study||19
9809688|NCT00656487|10919012|FG002|COMPLETED|Overall Study||20
9809689|NCT00656487|10919010|FG000|NOT COMPLETED|Overall Study||2
9809690|NCT00656487|10919011|FG001|NOT COMPLETED|Overall Study||4
9809691|NCT00656487|10919012|FG002|NOT COMPLETED|Overall Study||0
9809692|NCT00656513|10919023|FG000|STARTED|Overall Study||48
9809693|NCT00656513|10919024|FG001|STARTED|Overall Study||73
9809694|NCT00656513|10919025|FG002|STARTED|Overall Study||75
9809695|NCT00656513|10919023|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
9809696|NCT00656513|10919024|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
9809697|NCT00656513|10919025|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
9809698|NCT00656513|10919023|FG000|NOT COMPLETED|Overall Study||4
9809699|NCT00656513|10919024|FG001|NOT COMPLETED|Overall Study||30
9809700|NCT00656513|10919025|FG002|NOT COMPLETED|Overall Study||22
9809701|NCT00656617|10919033|FG000|STARTED|Overall Study||106
9809702|NCT00656617|10919033|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
9809703|NCT00656617|10919033|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
9809704|NCT00656617|10919033|FG000|COMPLETED|Overall Study||99
9809705|NCT00656617|10919033|FG000|NOT COMPLETED|Overall Study||7
9809706|NCT00656630|10919041|FG000|STARTED|Overall Study||22
9809707|NCT00656630|10919042|FG001|STARTED|Overall Study||27
9809708|NCT00656630|10919043|FG002|STARTED|Overall Study||19
9809709|NCT00656630|10919041|FG000|COMPLETED|Overall Study||20
9809710|NCT00656630|10919042|FG001|COMPLETED|Overall Study||25
9809711|NCT00656630|10919043|FG002|COMPLETED|Overall Study||17
9809712|NCT00656630|10919041|FG000|NOT COMPLETED|Overall Study||2
9809713|NCT00656630|10919042|FG001|NOT COMPLETED|Overall Study||2
9809714|NCT00656630|10919043|FG002|NOT COMPLETED|Overall Study||2
9809715|NCT00656656|10919051|FG000|STARTED|Overall Study||23
9809716|NCT00656656|10919051|FG000|COMPLETED|Overall Study||23
9809717|NCT00656656|10919051|FG000|NOT COMPLETED|Overall Study||0
9809718|NCT00656669|10919055|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23
9809719|NCT00656669|10919055|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
9809720|NCT00656669|10919055|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
9809721|NCT00656669|10919055|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
9809722|NCT00656669|10919055|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
9809723|NCT00656669|10919055|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
9809724|NCT00656669|10919055|FG000|STARTED|AC (Cycles 6-9)||17
9809725|NCT00656669|10919055|FG000|COMPLETED|AC (Cycles 6-9)||15
9809726|NCT00656669|10919055|FG000|NOT COMPLETED|AC (Cycles 6-9)||2
9809727|NCT00656799|10919064|FG000|STARTED|Overall Study||6
9809728|NCT00656799|10919064|FG000|COMPLETED|Overall Study||4
9809729|NCT00656799|10919064|FG000|NOT COMPLETED|Overall Study||2
9809730|NCT00656851|10919070|FG000|STARTED|Overall Study||12
9809731|NCT00656851|10919071|FG001|STARTED|Overall Study||12
9809732|NCT00656851|10919070|FG000|COMPLETED|Overall Study||12
9809733|NCT00656851|10919071|FG001|COMPLETED|Overall Study||8
9809734|NCT00656851|10919070|FG000|NOT COMPLETED|Overall Study||0
9809735|NCT00656851|10919071|FG001|NOT COMPLETED|Overall Study||4
9809736|NCT00656968|10919079|FG000|STARTED|Overall Study||115
9809737|NCT00656968|10919080|FG001|STARTED|Overall Study||117
9809738|NCT00656968|10919079|FG000|COMPLETED|Overall Study||115
9809739|NCT00656968|10919080|FG001|COMPLETED|Overall Study||117
9809740|NCT00656968|10919079|FG000|NOT COMPLETED|Overall Study||0
9809741|NCT00656968|10919080|FG001|NOT COMPLETED|Overall Study||0
9809742|NCT00657020|10919086|FG000|STARTED|PERIOD 1||11
9809743|NCT00657020|10919087|FG001|STARTED|PERIOD 1||12
9809744|NCT00657020|10919086|FG000|COMPLETED|PERIOD 1||11
9809745|NCT00657020|10919087|FG001|COMPLETED|PERIOD 1||11
9809746|NCT00657020|10919086|FG000|NOT COMPLETED|PERIOD 1||0
9809747|NCT00657020|10919087|FG001|NOT COMPLETED|PERIOD 1||1
9809748|NCT00657020|10919086|FG000|STARTED|PERIOD 2||11
9809749|NCT00657020|10919087|FG001|STARTED|PERIOD 2||11
9809750|NCT00657020|10919086|FG000|COMPLETED|PERIOD 2||11
9809751|NCT00657020|10919087|FG001|COMPLETED|PERIOD 2||11
9809752|NCT00657020|10919086|FG000|NOT COMPLETED|PERIOD 2||0
9809753|NCT00657020|10919087|FG001|NOT COMPLETED|PERIOD 2||0
9809754|NCT00657046|10919102|FG000|STARTED|Overall Study||30
9809755|NCT00657046|10919103|FG001|STARTED|Overall Study||32
9809756|NCT00657046|10919104|FG002|STARTED|Overall Study||23
9809757|NCT00657046|10919102|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30
9809758|NCT00657046|10919103|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31
9809759|NCT00657046|10919104|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23
9809760|NCT00657046|10919102|FG000|Had Visits up to Visit 18|Overall Study||28
9809761|NCT00657046|10919103|FG001|Had Visits up to Visit 18|Overall Study||30
9809762|NCT00657046|10919104|FG002|Had Visits up to Visit 18|Overall Study||23
9809763|NCT00657046|10919102|FG000|COMPLETED|Overall Study||26
9809764|NCT00657046|10919103|FG001|COMPLETED|Overall Study||29
9809765|NCT00657046|10919104|FG002|COMPLETED|Overall Study||21
9809766|NCT00657046|10919102|FG000|NOT COMPLETED|Overall Study||4
9809767|NCT00657046|10919103|FG001|NOT COMPLETED|Overall Study||3
9809768|NCT00657046|10919104|FG002|NOT COMPLETED|Overall Study||2
9809769|NCT00657150|10919114|FG000|STARTED|Overall Study||1010
9809770|NCT00657150|10919115|FG001|STARTED|Overall Study||1003
9809771|NCT00657150|10919114|FG000|COMPLETED|Overall Study||895
9809772|NCT00657150|10919115|FG001|COMPLETED|Overall Study||910
9809773|NCT00657150|10919114|FG000|NOT COMPLETED|Overall Study||115
9809774|NCT00657150|10919115|FG001|NOT COMPLETED|Overall Study||93
9809775|NCT00657150|10919114|FG000|STARTED|Treatment||1010
9809776|NCT00657150|10919115|FG001|STARTED|Treatment||1003
9809777|NCT00657150|10919114|FG000|COMPLETED|Treatment||903
9809778|NCT00657150|10919115|FG001|COMPLETED|Treatment||906
9809779|NCT00657150|10919114|FG000|NOT COMPLETED|Treatment||107
9809780|NCT00657150|10919115|FG001|NOT COMPLETED|Treatment||97
9809781|NCT00657267|10919121|FG000|STARTED|Overall Study||58
9809782|NCT00657267|10919121|FG000|COMPLETED|Overall Study||4
9809783|NCT00657267|10919121|FG000|NOT COMPLETED|Overall Study||54
9831610|NCT00769132|10942244|FG001|STARTED|Period 1||6
9831611|NCT00769132|10942245|FG002|STARTED|Period 1||6
9831612|NCT00769132|10942246|FG003|STARTED|Period 1||7
9831613|NCT00769132|10942243|FG000|COMPLETED|Period 1||6
9831614|NCT00769132|10942244|FG001|COMPLETED|Period 1||6
9831615|NCT00769132|10942245|FG002|COMPLETED|Period 1||6
9831616|NCT00769132|10942246|FG003|COMPLETED|Period 1||6
9831617|NCT00769132|10942243|FG000|NOT COMPLETED|Period 1||1
9831618|NCT00769132|10942244|FG001|NOT COMPLETED|Period 1||0
9831619|NCT00769132|10942245|FG002|NOT COMPLETED|Period 1||0
9831620|NCT00769132|10942246|FG003|NOT COMPLETED|Period 1||1
9831621|NCT00769132|10942243|FG000|STARTED|Period 2||6
9831622|NCT00769132|10942244|FG001|STARTED|Period 2||6
9831623|NCT00769132|10942245|FG002|STARTED|Period 2||6
9831624|NCT00769132|10942246|FG003|STARTED|Period 2||6
9831625|NCT00769132|10942243|FG000|COMPLETED|Period 2||6
9831626|NCT00769132|10942244|FG001|COMPLETED|Period 2||6
9831627|NCT00769132|10942245|FG002|COMPLETED|Period 2||6
9831628|NCT00769132|10942246|FG003|COMPLETED|Period 2||5
9831629|NCT00769132|10942243|FG000|NOT COMPLETED|Period 2||0
9831630|NCT00769132|10942244|FG001|NOT COMPLETED|Period 2||0
9831631|NCT00769132|10942245|FG002|NOT COMPLETED|Period 2||0
9831632|NCT00769132|10942246|FG003|NOT COMPLETED|Period 2||1
9831633|NCT00769132|10942243|FG000|STARTED|Period 3||6
9831634|NCT00769132|10942244|FG001|STARTED|Period 3||6
9831635|NCT00769132|10942245|FG002|STARTED|Period 3||6
9809784|NCT00657280|10919127|FG000|STARTED|Overall Study||16
9809785|NCT00657280|10919127|FG000|COMPLETED|Overall Study||16
9809786|NCT00657280|10919127|FG000|NOT COMPLETED|Overall Study||0
9809787|NCT00657358|10919131|FG000|STARTED|Overall Study||22
9809788|NCT00657358|10919131|FG000|COMPLETED|Overall Study||16
9809789|NCT00657358|10919131|FG000|NOT COMPLETED|Overall Study||6
9809790|NCT00657371|10919136|FG000|STARTED|Overall Study||288
9809791|NCT00657371|10919136|FG000|COMPLETED|Overall Study||249
9809792|NCT00657371|10919136|FG000|NOT COMPLETED|Overall Study||39
9809793|NCT00657540|10919142|FG000|STARTED|Overall Study||29
9809794|NCT00657540|10919143|FG001|STARTED|Overall Study||31
9809795|NCT00657540|10919142|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
9809796|NCT00657540|10919143|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
9809797|NCT00657540|10919142|FG000|NOT COMPLETED|Overall Study||1
9809798|NCT00657540|10919143|FG001|NOT COMPLETED|Overall Study||4
9809799|NCT00657605|10919149|FG000|STARTED|Overall Study||3
9809800|NCT00657605|10919149|FG000|COMPLETED|Overall Study||3
9809801|NCT00657605|10919149|FG000|NOT COMPLETED|Overall Study||0
9809802|NCT00657618|10919153|FG000|STARTED|Overall Study||77
9809803|NCT00657618|10919153|FG000|COMPLETED|Overall Study||34
9809804|NCT00657618|10919153|FG000|NOT COMPLETED|Overall Study||43
9809805|NCT00657657|10919157|FG000|STARTED|Overall Study||29
9809806|NCT00657657|10919157|FG000|COMPLETED|Overall Study||29
9809807|NCT00657657|10919157|FG000|NOT COMPLETED|Overall Study||0
9809808|NCT00657709|10919166|FG000|STARTED|Overall Study||833
9809809|NCT00657709|10919167|FG001|STARTED|Overall Study||828
9809810|NCT00657709|10919168|FG002|STARTED|Overall Study||820
9809811|NCT00657709|10919169|FG003|STARTED|Overall Study||659
9809812|NCT00657709|10919170|FG004|STARTED|Overall Study||490
9809813|NCT00657709|10919166|FG000|COMPLETED|Overall Study||810
9809814|NCT00657709|10919167|FG001|COMPLETED|Overall Study||795
9809815|NCT00657709|10919168|FG002|COMPLETED|Overall Study||792
9809816|NCT00657709|10919169|FG003|COMPLETED|Overall Study||645
9809817|NCT00657709|10919170|FG004|COMPLETED|Overall Study||457
9809818|NCT00657709|10919166|FG000|NOT COMPLETED|Overall Study||23
9809819|NCT00657709|10919167|FG001|NOT COMPLETED|Overall Study||33
9809820|NCT00657709|10919168|FG002|NOT COMPLETED|Overall Study||28
9809821|NCT00657709|10919169|FG003|NOT COMPLETED|Overall Study||14
9809822|NCT00657709|10919170|FG004|NOT COMPLETED|Overall Study||33
9809823|NCT00657917|10919192|FG000|STARTED|Overall Study||1
9809824|NCT00657917|10919192|FG000|COMPLETED|Overall Study||1
9809825|NCT00657917|10919192|FG000|NOT COMPLETED|Overall Study||0
9809826|NCT00658021|10919199|FG000|STARTED|28-Week Treatment Period||42
9809827|NCT00658021|10919200|FG001|STARTED|28-Week Treatment Period||38
9809828|NCT00658021|10919201|FG002|STARTED|28-Week Treatment Period||42
9809829|NCT00658021|10919199|FG000|Received Treatment|28-Week Treatment Period||40
9809830|NCT00658021|10919200|FG001|Received Treatment|28-Week Treatment Period||38
9809831|NCT00658021|10919201|FG002|Received Treatment|28-Week Treatment Period||42
9809832|NCT00658021|10919199|FG000|COMPLETED|28-Week Treatment Period||31
9809833|NCT00658021|10919200|FG001|COMPLETED|28-Week Treatment Period||25
10016273|NCT01809262|11139186|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10016274|NCT01809262|11139187|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10016275|NCT01809262|11139188|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0
9809834|NCT00658021|10919201|FG002|COMPLETED|28-Week Treatment Period||25
9809835|NCT00658021|10919199|FG000|NOT COMPLETED|28-Week Treatment Period||11
9809836|NCT00658021|10919200|FG001|NOT COMPLETED|28-Week Treatment Period||13
9809837|NCT00658021|10919201|FG002|NOT COMPLETED|28-Week Treatment Period||17
9809838|NCT00658021|10919199|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
9809839|NCT00658021|10919200|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
9809840|NCT00658021|10919201|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
9809841|NCT00658021|10919199|FG000|COMPLETED|Long-term Safety Follow-up Period||7
9809842|NCT00658021|10919200|FG001|COMPLETED|Long-term Safety Follow-up Period||2
9809843|NCT00658021|10919201|FG002|COMPLETED|Long-term Safety Follow-up Period||7
9809844|NCT00658021|10919199|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0
9809845|NCT00658021|10919200|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3
10016276|NCT01809262|11139189|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1
9809846|NCT00658021|10919201|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0
9809847|NCT00658112|10919211|FG000|STARTED|Overall Study||20
9809848|NCT00658112|10919211|FG000|COMPLETED|Overall Study||11
9809849|NCT00658112|10919211|FG000|NOT COMPLETED|Overall Study||9
9809850|NCT00658138|10919215|FG000|STARTED|Overall Study||61
9809851|NCT00658138|10919215|FG000|COMPLETED|Overall Study||40
10016277|NCT01809262|11139190|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10016278|NCT01809262|11139191|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10016279|NCT01809262|11139192|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10016280|NCT01809262|11139193|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0
9809852|NCT00658138|10919215|FG000|NOT COMPLETED|Overall Study||21
9809853|NCT00658320|10919222|FG000|STARTED|Core Study: 12 Months||61
9809854|NCT00658320|10919223|FG001|STARTED|Core Study: 12 Months||61
9809855|NCT00658320|10919222|FG000|COMPLETED|Core Study: 12 Months||56
9809856|NCT00658320|10919223|FG001|COMPLETED|Core Study: 12 Months||58
9809857|NCT00658320|10919222|FG000|NOT COMPLETED|Core Study: 12 Months||5
9809858|NCT00658320|10919223|FG001|NOT COMPLETED|Core Study: 12 Months||3
9809859|NCT00658320|10919222|FG000|STARTED|Extension Study: Month 12 to Month 24||53
9809860|NCT00658320|10919223|FG001|STARTED|Extension Study: Month 12 to Month 24||57
9809861|NCT00658320|10919222|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
9809862|NCT00658320|10919223|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
9809863|NCT00658320|10919222|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47
9809864|NCT00658320|10919223|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50
9809865|NCT00658320|10919222|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
9809866|NCT00658320|10919223|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
9809867|NCT00658320|10919222|FG000|STARTED|Extension Study: After Month 24||44
9809868|NCT00658320|10919223|FG001|STARTED|Extension Study: After Month 24||0
9809869|NCT00658320|10919222|FG000|COMPLETED|Extension Study: After Month 24||42
9809870|NCT00658320|10919223|FG001|COMPLETED|Extension Study: After Month 24||0
9809871|NCT00658320|10919222|FG000|NOT COMPLETED|Extension Study: After Month 24||2
9809872|NCT00658320|10919223|FG001|NOT COMPLETED|Extension Study: After Month 24||0
9809873|NCT00658333|10919233|FG000|STARTED|Overall Study||15
9809874|NCT00658333|10919234|FG001|STARTED|Overall Study||15
9809875|NCT00658333|10919233|FG000|COMPLETED|Overall Study||13
9809876|NCT00658333|10919234|FG001|COMPLETED|Overall Study||14
9809877|NCT00658333|10919233|FG000|NOT COMPLETED|Overall Study||2
9809878|NCT00658333|10919234|FG001|NOT COMPLETED|Overall Study||1
9809879|NCT00658359|10919243|FG000|STARTED|Overall Study||64
9809880|NCT00658359|10919244|FG001|STARTED|Overall Study||60
9809881|NCT00658359|10919245|FG002|STARTED|Overall Study||54
9809882|NCT00658359|10919243|FG000|COMPLETED|Overall Study||36
9809883|NCT00658359|10919244|FG001|COMPLETED|Overall Study||15
9809884|NCT00658359|10919245|FG002|COMPLETED|Overall Study||8
9809885|NCT00658359|10919243|FG000|NOT COMPLETED|Overall Study||28
9809886|NCT00658359|10919244|FG001|NOT COMPLETED|Overall Study||45
9809887|NCT00658359|10919245|FG002|NOT COMPLETED|Overall Study||46
9809888|NCT00658385|10919255|FG000|STARTED|Overall Study||5
9809889|NCT00658385|10919255|FG000|COMPLETED|Overall Study||5
9809890|NCT00658385|10919255|FG000|NOT COMPLETED|Overall Study||0
9809891|NCT00658411|10919259|FG000|STARTED|Overall Study||5
9809892|NCT00658411|10919259|FG000|COMPLETED|Overall Study||5
9809893|NCT00658411|10919259|FG000|NOT COMPLETED|Overall Study||0
9809894|NCT00658515|10919269|FG000|STARTED|Overall Study||7938
9809895|NCT00658515|10919270|FG001|STARTED|Overall Study||7933
9809896|NCT00658515|10919269|FG000|COMPLETED|Overall Study||7626
9809897|NCT00658515|10919270|FG001|COMPLETED|Overall Study||7668
9809898|NCT00658515|10919269|FG000|NOT COMPLETED|Overall Study||312
9809899|NCT00658515|10919270|FG001|NOT COMPLETED|Overall Study||265
9809900|NCT00658528|10919278|FG000|STARTED|Overall Study|Treated|531
9809901|NCT00658528|10919279|FG001|STARTED|Overall Study|Treated|524
9809902|NCT00658528|10919278|FG000|COMPLETED|Overall Study||491
9809903|NCT00658528|10919279|FG001|COMPLETED|Overall Study||479
9809904|NCT00658528|10919278|FG000|NOT COMPLETED|Overall Study||40
9809905|NCT00658528|10919279|FG001|NOT COMPLETED|Overall Study||45
9809906|NCT00658541|10919285|FG000|STARTED|First Intervention||19
9809907|NCT00658541|10919286|FG001|STARTED|First Intervention||19
9809908|NCT00658541|10919285|FG000|COMPLETED|First Intervention||19
9809909|NCT00658541|10919286|FG001|COMPLETED|First Intervention||19
9809910|NCT00658541|10919285|FG000|NOT COMPLETED|First Intervention||0
9809911|NCT00658541|10919286|FG001|NOT COMPLETED|First Intervention||0
9809912|NCT00658541|10919285|FG000|STARTED|Washout Period of 7 Days||19
9809913|NCT00658541|10919286|FG001|STARTED|Washout Period of 7 Days||19
9809914|NCT00658541|10919285|FG000|COMPLETED|Washout Period of 7 Days||18
9809915|NCT00658541|10919286|FG001|COMPLETED|Washout Period of 7 Days||17
9809916|NCT00658541|10919285|FG000|NOT COMPLETED|Washout Period of 7 Days||1
9809917|NCT00658541|10919286|FG001|NOT COMPLETED|Washout Period of 7 Days||2
9809918|NCT00658541|10919285|FG000|STARTED|Second Intervention||18
9809919|NCT00658541|10919286|FG001|STARTED|Second Intervention||17
9809920|NCT00658541|10919285|FG000|COMPLETED|Second Intervention||18
9809921|NCT00658541|10919286|FG001|COMPLETED|Second Intervention||17
9809922|NCT00658541|10919285|FG000|NOT COMPLETED|Second Intervention||0
9809923|NCT00658541|10919286|FG001|NOT COMPLETED|Second Intervention||0
9809924|NCT00658567|10919295|FG000|STARTED|Overall Study||40
9809925|NCT00658567|10919296|FG001|STARTED|Overall Study||42
9809926|NCT00658567|10919297|FG002|STARTED|Overall Study||41
9809927|NCT00658567|10919295|FG000|COMPLETED|Overall Study||32
9809928|NCT00658567|10919296|FG001|COMPLETED|Overall Study||38
9809929|NCT00658567|10919297|FG002|COMPLETED|Overall Study||35
9809930|NCT00658567|10919295|FG000|NOT COMPLETED|Overall Study||8
9809931|NCT00658567|10919296|FG001|NOT COMPLETED|Overall Study||4
9809932|NCT00658567|10919297|FG002|NOT COMPLETED|Overall Study||6
9809933|NCT00658606|10919307|FG000|STARTED|Overall Study||49
9809934|NCT00658606|10919308|FG001|STARTED|Overall Study||49
9809935|NCT00658606|10919307|FG000|Completed Treatment|Overall Study||42
9809936|NCT00658606|10919308|FG001|Completed Treatment|Overall Study||44
9809937|NCT00658606|10919307|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33
9809938|NCT00658606|10919308|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26
9809939|NCT00658606|10919307|FG000|NOT COMPLETED|Overall Study||16
9809940|NCT00658606|10919308|FG001|NOT COMPLETED|Overall Study||23
9809941|NCT00658619|10919319|FG000|STARTED|Overall Study||3
9809942|NCT00658619|10919320|FG001|STARTED|Overall Study||3
9809943|NCT00658619|10919321|FG002|STARTED|Overall Study||41
9809944|NCT00658619|10919322|FG003|STARTED|Overall Study||49
9809945|NCT00658619|10919323|FG004|STARTED|Overall Study||23
9809946|NCT00658619|10919319|FG000|COMPLETED|Overall Study||3
9809947|NCT00658619|10919320|FG001|COMPLETED|Overall Study||2
9809948|NCT00658619|10919321|FG002|COMPLETED|Overall Study||31
9809949|NCT00658619|10919322|FG003|COMPLETED|Overall Study||37
9809950|NCT00658619|10919323|FG004|COMPLETED|Overall Study||21
9809951|NCT00658619|10919319|FG000|NOT COMPLETED|Overall Study||0
9809952|NCT00658619|10919320|FG001|NOT COMPLETED|Overall Study||1
9809953|NCT00658619|10919321|FG002|NOT COMPLETED|Overall Study||10
9809954|NCT00658619|10919322|FG003|NOT COMPLETED|Overall Study||12
9809955|NCT00658619|10919323|FG004|NOT COMPLETED|Overall Study||2
9809956|NCT00658632|10919334|FG000|STARTED|Overall Study|Treated|682
9809957|NCT00658632|10919335|FG001|STARTED|Overall Study|Treated|698
9809958|NCT00658632|10919334|FG000|COMPLETED|Overall Study||618
9809959|NCT00658632|10919335|FG001|COMPLETED|Overall Study||633
9809960|NCT00658632|10919334|FG000|NOT COMPLETED|Overall Study||64
9809961|NCT00658632|10919335|FG001|NOT COMPLETED|Overall Study||65
9809962|NCT00658658|10919346|FG000|STARTED|Overall Study||6
9809963|NCT00658658|10919347|FG001|STARTED|Overall Study||7
9809964|NCT00658658|10919348|FG002|STARTED|Overall Study||4
9809965|NCT00658658|10919349|FG003|STARTED|Overall Study||6
9809966|NCT00658658|10919350|FG004|STARTED|Overall Study||8
9809967|NCT00658658|10919346|FG000|COMPLETED|Overall Study||1
9809968|NCT00658658|10919347|FG001|COMPLETED|Overall Study||5
9809969|NCT00658658|10919348|FG002|COMPLETED|Overall Study||4
9809970|NCT00658658|10919349|FG003|COMPLETED|Overall Study||4
9809971|NCT00658658|10919350|FG004|COMPLETED|Overall Study||3
9809972|NCT00658658|10919346|FG000|NOT COMPLETED|Overall Study||5
9809973|NCT00658658|10919347|FG001|NOT COMPLETED|Overall Study||2
9809974|NCT00658658|10919348|FG002|NOT COMPLETED|Overall Study||0
9809975|NCT00658658|10919349|FG003|NOT COMPLETED|Overall Study||2
9809976|NCT00658658|10919350|FG004|NOT COMPLETED|Overall Study||5
9809977|NCT00658684|10919365|FG000|STARTED|Overall Study||152
9809978|NCT00658684|10919366|FG001|STARTED|Overall Study||99
9809979|NCT00658684|10919367|FG002|STARTED|Overall Study||25
9809980|NCT00658684|10919368|FG003|STARTED|Overall Study||28
9809981|NCT00658684|10919365|FG000|COMPLETED|Overall Study||133
9809982|NCT00658684|10919366|FG001|COMPLETED|Overall Study||84
9809983|NCT00658684|10919367|FG002|COMPLETED|Overall Study||22
9809984|NCT00658684|10919368|FG003|COMPLETED|Overall Study||27
9809985|NCT00658684|10919365|FG000|NOT COMPLETED|Overall Study||19
9809986|NCT00658684|10919366|FG001|NOT COMPLETED|Overall Study||15
9809987|NCT00658684|10919367|FG002|NOT COMPLETED|Overall Study||3
9809988|NCT00658684|10919368|FG003|NOT COMPLETED|Overall Study||1
9809989|NCT00658697|10919378|FG000|STARTED|Overall Study||41
9809990|NCT00658697|10919378|FG000|COMPLETED|Overall Study||41
9809991|NCT00658697|10919378|FG000|NOT COMPLETED|Overall Study||0
9809992|NCT00658723|10919386|FG000|STARTED|Overall Study||60
9809993|NCT00658723|10919387|FG001|STARTED|Overall Study||30
9809994|NCT00658723|10919388|FG002|STARTED|Overall Study||51
9809995|NCT00658723|10919386|FG000|COMPLETED|Overall Study||56
9809996|NCT00658723|10919387|FG001|COMPLETED|Overall Study||26
9809997|NCT00658723|10919388|FG002|COMPLETED|Overall Study||44
9809998|NCT00658723|10919386|FG000|NOT COMPLETED|Overall Study||4
9809999|NCT00658723|10919387|FG001|NOT COMPLETED|Overall Study||4
9810000|NCT00658723|10919388|FG002|NOT COMPLETED|Overall Study||7
9810001|NCT00658736|10919401|FG000|STARTED|Overall Study||19
9810002|NCT00658736|10919402|FG001|STARTED|Overall Study||21
9810003|NCT00658736|10919401|FG000|COMPLETED|Overall Study||13
9810004|NCT00658736|10919402|FG001|COMPLETED|Overall Study||19
9810005|NCT00658736|10919401|FG000|NOT COMPLETED|Overall Study||6
9810006|NCT00658736|10919402|FG001|NOT COMPLETED|Overall Study||2
9810007|NCT00658775|10919410|FG000|STARTED|Overall Study|Treated|537
9810008|NCT00658775|10919411|FG001|STARTED|Overall Study|Treated|528
9810009|NCT00658775|10919410|FG000|COMPLETED|Overall Study||495
9810010|NCT00658775|10919411|FG001|COMPLETED|Overall Study||485
9810011|NCT00658775|10919410|FG000|NOT COMPLETED|Overall Study||42
9810012|NCT00658775|10919411|FG001|NOT COMPLETED|Overall Study||43
9810013|NCT00658788|10919417|FG000|STARTED|Overall Study||305
9810014|NCT00658788|10919417|FG000|COMPLETED|Overall Study||231
9810015|NCT00658788|10919417|FG000|NOT COMPLETED|Overall Study||74
9810016|NCT00658879|10919430|FG000|STARTED|Overall Study||251
9810017|NCT00658879|10919430|FG000|COMPLETED|Overall Study||250
9810018|NCT00658879|10919430|FG000|NOT COMPLETED|Overall Study||1
9810019|NCT00658996|10919434|FG000|STARTED|First Intervention||109
9810020|NCT00658996|10919435|FG001|STARTED|First Intervention||107
9810021|NCT00658996|10919434|FG000|COMPLETED|First Intervention||108
9810022|NCT00658996|10919435|FG001|COMPLETED|First Intervention||106
9810023|NCT00658996|10919434|FG000|NOT COMPLETED|First Intervention||1
9810024|NCT00658996|10919435|FG001|NOT COMPLETED|First Intervention||1
9810025|NCT00658996|10919434|FG000|STARTED|Crossover Period||108
9810026|NCT00658996|10919435|FG001|STARTED|Crossover Period||106
9810027|NCT00658996|10919434|FG000|COMPLETED|Crossover Period||106
9810028|NCT00658996|10919435|FG001|COMPLETED|Crossover Period||105
9810029|NCT00658996|10919434|FG000|NOT COMPLETED|Crossover Period||2
9810030|NCT00658996|10919435|FG001|NOT COMPLETED|Crossover Period||1
9810031|NCT00658996|10919434|FG000|STARTED|Second Intervention||106
9810032|NCT00658996|10919435|FG001|STARTED|Second Intervention||105
9810033|NCT00658996|10919434|FG000|COMPLETED|Second Intervention||105
9810034|NCT00658996|10919435|FG001|COMPLETED|Second Intervention||104
9810035|NCT00658996|10919434|FG000|NOT COMPLETED|Second Intervention||1
9810036|NCT00658996|10919435|FG001|NOT COMPLETED|Second Intervention||1
9810037|NCT00659165|10919443|FG000|STARTED|Overall Study||5
10016281|NCT01809262|11139194|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10016282|NCT01809262|11139185|FG000|STARTED|Period 2 (Second Dose + Washout)||4
10016283|NCT01809262|11139186|FG001|STARTED|Period 2 (Second Dose + Washout)||4
10016284|NCT01809262|11139187|FG002|STARTED|Period 2 (Second Dose + Washout)||4
10016285|NCT01809262|11139188|FG003|STARTED|Period 2 (Second Dose + Washout)||3
10016286|NCT01809262|11139189|FG004|STARTED|Period 2 (Second Dose + Washout)||3
10016287|NCT01809262|11139190|FG005|STARTED|Period 2 (Second Dose + Washout)||3
9810038|NCT00659165|10919444|FG001|STARTED|Overall Study||5
9810039|NCT00659165|10919443|FG000|COMPLETED|Overall Study||5
9810040|NCT00659165|10919444|FG001|COMPLETED|Overall Study||5
9810041|NCT00659165|10919443|FG000|NOT COMPLETED|Overall Study||0
9810042|NCT00659165|10919444|FG001|NOT COMPLETED|Overall Study||0
9810043|NCT00659230|10919452|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
9810044|NCT00659230|10919453|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
9810045|NCT00659230|10919452|FG000|COMPLETED|Overall Study||42
9810046|NCT00659230|10919453|FG001|COMPLETED|Overall Study||37
9810047|NCT00659230|10919452|FG000|NOT COMPLETED|Overall Study||9
9810048|NCT00659230|10919453|FG001|NOT COMPLETED|Overall Study||12
9810049|NCT00659269|10919461|FG000|STARTED|Overall Study||157
9810050|NCT00659269|10919462|FG001|STARTED|Overall Study||162
9810051|NCT00659269|10919461|FG000|Group 1 (Heavy Metals)|Overall Study||52
9810052|NCT00659269|10919462|FG001|Group 1 (Heavy Metals)|Overall Study||52
9810053|NCT00659269|10919461|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12
9810054|NCT00659269|10919462|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12
9810055|NCT00659269|10919461|FG000|Group 3 (Taxanes)|Overall Study||92
9810056|NCT00659269|10919462|FG001|Group 3 (Taxanes)|Overall Study||97
9810057|NCT00659269|10919461|FG000|COMPLETED|Overall Study||156
9810058|NCT00659269|10919462|FG001|COMPLETED|Overall Study||161
9810059|NCT00659269|10919461|FG000|NOT COMPLETED|Overall Study||1
9810060|NCT00659269|10919462|FG001|NOT COMPLETED|Overall Study||1
9810061|NCT00659295|10919479|FG000|STARTED|Overall Study||13529
9810062|NCT00659295|10919480|FG001|STARTED|Overall Study||37641
9810063|NCT00659295|10919479|FG000|COMPLETED|Overall Study||10821
9810064|NCT00659295|10919480|FG001|COMPLETED|Overall Study||32038
9810065|NCT00659295|10919479|FG000|NOT COMPLETED|Overall Study||2708
9810066|NCT00659295|10919480|FG001|NOT COMPLETED|Overall Study||5603
9831636|NCT00769132|10942246|FG003|STARTED|Period 3||5
9831637|NCT00769132|10942243|FG000|COMPLETED|Period 3||5
9831638|NCT00769132|10942244|FG001|COMPLETED|Period 3||6
9831639|NCT00769132|10942245|FG002|COMPLETED|Period 3||6
9831640|NCT00769132|10942246|FG003|COMPLETED|Period 3||5
9831641|NCT00769132|10942243|FG000|NOT COMPLETED|Period 3||1
9831642|NCT00769132|10942244|FG001|NOT COMPLETED|Period 3||0
9831643|NCT00769132|10942245|FG002|NOT COMPLETED|Period 3||0
9831644|NCT00769132|10942246|FG003|NOT COMPLETED|Period 3||0
9831645|NCT00769132|10942243|FG000|STARTED|Period 4||5
9831646|NCT00769132|10942244|FG001|STARTED|Period 4||6
9831647|NCT00769132|10942245|FG002|STARTED|Period 4||6
9831648|NCT00769132|10942246|FG003|STARTED|Period 4||5
9831649|NCT00769132|10942243|FG000|COMPLETED|Period 4||5
9831650|NCT00769132|10942244|FG001|COMPLETED|Period 4||5
9831651|NCT00769132|10942245|FG002|COMPLETED|Period 4||6
9831652|NCT00769132|10942246|FG003|COMPLETED|Period 4||5
9831653|NCT00769132|10942243|FG000|NOT COMPLETED|Period 4||0
9831654|NCT00769132|10942244|FG001|NOT COMPLETED|Period 4||1
9831655|NCT00769132|10942245|FG002|NOT COMPLETED|Period 4||0
9831656|NCT00769132|10942246|FG003|NOT COMPLETED|Period 4||0
9831657|NCT00769184|10942256|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
9831658|NCT00769184|10942257|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
9831659|NCT00769184|10942256|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
9831660|NCT00769184|10942257|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
9831661|NCT00769184|10942256|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
9831662|NCT00769184|10942257|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
9831663|NCT00769184|10942256|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6
10016288|NCT01809262|11139191|FG006|STARTED|Period 2 (Second Dose + Washout)||3
10016289|NCT01809262|11139192|FG007|STARTED|Period 2 (Second Dose + Washout)||4
10016290|NCT01809262|11139193|FG008|STARTED|Period 2 (Second Dose + Washout)||3
10016291|NCT01809262|11139194|FG009|STARTED|Period 2 (Second Dose + Washout)||4
10016292|NCT01809262|11139185|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4
10016293|NCT01809262|11139186|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4
10016294|NCT01809262|11139187|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4
10016295|NCT01809262|11139188|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3
9831664|NCT00769184|10942257|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7
9831665|NCT00769184|10942256|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
9831666|NCT00769184|10942257|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
9831667|NCT00769184|10942256|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
9831668|NCT00769184|10942257|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
9831669|NCT00769184|10942256|FG000|STARTED|No Treatment (6 Weeks)||6
9831670|NCT00769184|10942257|FG001|STARTED|No Treatment (6 Weeks)||7
9831671|NCT00769184|10942256|FG000|COMPLETED|No Treatment (6 Weeks)||5
9831672|NCT00769184|10942257|FG001|COMPLETED|No Treatment (6 Weeks)||6
9831673|NCT00769184|10942256|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1
9831674|NCT00769184|10942257|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1
9831675|NCT00769314|10942267|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
10016296|NCT01809262|11139189|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3
10016297|NCT01809262|11139190|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3
10016298|NCT01809262|11139191|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3
10016299|NCT01809262|11139192|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4
10016300|NCT01809262|11139193|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3
10016301|NCT01809262|11139194|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4
10016302|NCT01809262|11139185|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10235367|NCT01193530|11365668|FG001|COMPLETED|Overall Study||3
10235368|NCT01193530|11365667|FG000|NOT COMPLETED|Overall Study||3
9810067|NCT00659334|10919493|FG000|STARTED|Overall Study||46
9810068|NCT00659334|10919494|FG001|STARTED|Overall Study||41
9810069|NCT00659334|10919495|FG002|STARTED|Overall Study||5
9810070|NCT00659334|10919496|FG003|STARTED|Overall Study||2
9810071|NCT00659334|10919497|FG004|STARTED|Overall Study||1
9810072|NCT00659334|10919498|FG005|STARTED|Overall Study||0
9810073|NCT00659334|10919499|FG006|STARTED|Overall Study||21
9810074|NCT00659334|10919493|FG000|COMPLETED|Overall Study|8 Screen failures|38
9810075|NCT00659334|10919494|FG001|COMPLETED|Overall Study|5 Screen failures|36
10235369|NCT01193530|11365668|FG001|NOT COMPLETED|Overall Study||5
10235370|NCT01182610|11365674|FG000|STARTED|Overall Study||1
10235371|NCT01182610|11365674|FG000|COMPLETED|Overall Study||1
9810076|NCT00659334|10919495|FG002|COMPLETED|Overall Study||5
9810077|NCT00659334|10919496|FG003|COMPLETED|Overall Study||2
9810078|NCT00659334|10919497|FG004|COMPLETED|Overall Study||1
9810079|NCT00659334|10919498|FG005|COMPLETED|Overall Study||0
9810080|NCT00659334|10919499|FG006|COMPLETED|Overall Study|1 screen failure|20
9810081|NCT00659334|10919493|FG000|NOT COMPLETED|Overall Study||8
9810082|NCT00659334|10919494|FG001|NOT COMPLETED|Overall Study||5
9810083|NCT00659334|10919495|FG002|NOT COMPLETED|Overall Study||0
9810084|NCT00659334|10919496|FG003|NOT COMPLETED|Overall Study||0
9810085|NCT00659334|10919497|FG004|NOT COMPLETED|Overall Study||0
9810086|NCT00659334|10919498|FG005|NOT COMPLETED|Overall Study||0
9810087|NCT00659334|10919499|FG006|NOT COMPLETED|Overall Study||1
9810088|NCT00659360|10919515|FG000|STARTED|Overall Study||17
9810089|NCT00659360|10919515|FG000|COMPLETED|Overall Study||17
9810090|NCT00659360|10919515|FG000|NOT COMPLETED|Overall Study||0
9810091|NCT00659373|10919523|FG000|STARTED|Overall Study||25
9810092|NCT00659373|10919524|FG001|STARTED|Overall Study||61
9810093|NCT00659373|10919523|FG000|COMPLETED|Overall Study||20
9810094|NCT00659373|10919524|FG001|COMPLETED|Overall Study||54
9810095|NCT00659373|10919523|FG000|NOT COMPLETED|Overall Study||5
9810096|NCT00659373|10919524|FG001|NOT COMPLETED|Overall Study||7
9810097|NCT00659425|10919540|FG000|STARTED|Overall Study||1
9810098|NCT00659425|10919541|FG001|STARTED|Overall Study||1
9810099|NCT00659425|10919542|FG002|STARTED|Overall Study||1
9810100|NCT00659425|10919543|FG003|STARTED|Overall Study||4
9810101|NCT00659425|10919544|FG004|STARTED|Overall Study||4
9810102|NCT00659425|10919545|FG005|STARTED|Overall Study||5
9810103|NCT00659425|10919546|FG006|STARTED|Overall Study||8
9810104|NCT00659425|10919547|FG007|STARTED|Overall Study||11
9810105|NCT00659425|10919548|FG008|STARTED|Overall Study||6
9810106|NCT00659425|10919549|FG009|STARTED|Overall Study||14
9810107|NCT00659425|10919540|FG000|COMPLETED|Overall Study||0
9810108|NCT00659425|10919541|FG001|COMPLETED|Overall Study||0
9810109|NCT00659425|10919542|FG002|COMPLETED|Overall Study||0
9810110|NCT00659425|10919543|FG003|COMPLETED|Overall Study||0
9810111|NCT00659425|10919544|FG004|COMPLETED|Overall Study||0
9810112|NCT00659425|10919545|FG005|COMPLETED|Overall Study||1
9810113|NCT00659425|10919546|FG006|COMPLETED|Overall Study||0
9810114|NCT00659425|10919547|FG007|COMPLETED|Overall Study||0
9810115|NCT00659425|10919548|FG008|COMPLETED|Overall Study||0
9810116|NCT00659425|10919549|FG009|COMPLETED|Overall Study||1
9810117|NCT00659425|10919540|FG000|NOT COMPLETED|Overall Study||1
9810118|NCT00659425|10919541|FG001|NOT COMPLETED|Overall Study||1
9810119|NCT00659425|10919542|FG002|NOT COMPLETED|Overall Study||1
9810120|NCT00659425|10919543|FG003|NOT COMPLETED|Overall Study||4
9810121|NCT00659425|10919544|FG004|NOT COMPLETED|Overall Study||4
9810122|NCT00659425|10919545|FG005|NOT COMPLETED|Overall Study||4
9810123|NCT00659425|10919546|FG006|NOT COMPLETED|Overall Study||8
9810124|NCT00659425|10919547|FG007|NOT COMPLETED|Overall Study||11
9810125|NCT00659425|10919548|FG008|NOT COMPLETED|Overall Study||6
9810126|NCT00659425|10919549|FG009|NOT COMPLETED|Overall Study||13
9810127|NCT00659438|10919586|FG000|STARTED|Overall Study||47
9810128|NCT00659438|10919587|FG001|STARTED|Overall Study||48
9810129|NCT00659438|10919586|FG000|Assessable Set : Primary Analysis|Overall Study||44
9810130|NCT00659438|10919587|FG001|Assessable Set : Primary Analysis|Overall Study||45
9810131|NCT00659438|10919586|FG000|Secondary Analysis Set|Overall Study||47
9810132|NCT00659438|10919587|FG001|Secondary Analysis Set|Overall Study||48
9810133|NCT00659438|10919586|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
9810134|NCT00659438|10919587|FG001|Safety Analysis Set|Overall Study||47
9810135|NCT00659438|10919586|FG000|COMPLETED|Overall Study||33
9810136|NCT00659438|10919587|FG001|COMPLETED|Overall Study||40
9810137|NCT00659438|10919586|FG000|NOT COMPLETED|Overall Study||14
9810138|NCT00659438|10919587|FG001|NOT COMPLETED|Overall Study||8
9810139|NCT00659490|10919596|FG000|STARTED|Overall Study||61
9810140|NCT00659490|10919597|FG001|STARTED|Overall Study||59
10016303|NCT01809262|11139186|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10016304|NCT01809262|11139187|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
9810141|NCT00659490|10919598|FG002|STARTED|Overall Study||31
9810142|NCT00659490|10919596|FG000|COMPLETED|Overall Study||59
9810143|NCT00659490|10919597|FG001|COMPLETED|Overall Study||59
9810144|NCT00659490|10919598|FG002|COMPLETED|Overall Study||30
9810145|NCT00659490|10919596|FG000|NOT COMPLETED|Overall Study||2
9810146|NCT00659490|10919597|FG001|NOT COMPLETED|Overall Study||0
9810147|NCT00659490|10919598|FG002|NOT COMPLETED|Overall Study||1
9810148|NCT00659529|10919606|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
9810149|NCT00659529|10919606|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
9810150|NCT00659529|10919606|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
9810151|NCT00659529|10919606|FG000|NOT COMPLETED|Overall Study||16
9810152|NCT00659581|10919610|FG000|STARTED|Overall Study||20994
9810153|NCT00659581|10919610|FG000|COMPLETED|Overall Study||12412
9810154|NCT00659581|10919610|FG000|NOT COMPLETED|Overall Study||8582
9810155|NCT00659607|10919614|FG000|STARTED|Overall Study||3932
9810156|NCT00659607|10919614|FG000|COMPLETED|Overall Study||3616
9810157|NCT00659607|10919614|FG000|NOT COMPLETED|Overall Study||316
9810158|NCT00659633|10919620|FG000|STARTED|Overall Study||10
9810159|NCT00659633|10919620|FG000|COMPLETED|Overall Study||10
9810160|NCT00659633|10919620|FG000|NOT COMPLETED|Overall Study||0
9810161|NCT00659724|10919624|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
9810162|NCT00659724|10919624|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
9810163|NCT00659724|10919624|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
9810164|NCT00659724|10919624|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
9810165|NCT00659724|10919624|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
9810166|NCT00659724|10919624|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
9810167|NCT00659737|10919632|FG000|STARTED|Overall Study||57
9810168|NCT00659737|10919633|FG001|STARTED|Overall Study||58
9810169|NCT00659737|10919632|FG000|COMPLETED|Overall Study||57
9810170|NCT00659737|10919633|FG001|COMPLETED|Overall Study||58
9810171|NCT00659737|10919632|FG000|NOT COMPLETED|Overall Study||0
9810172|NCT00659737|10919633|FG001|NOT COMPLETED|Overall Study||0
9810173|NCT00659789|10919641|FG000|STARTED|Overall Study||93
9810174|NCT00659789|10919642|FG001|STARTED|Overall Study||43
9810175|NCT00659789|10919641|FG000|COMPLETED|Overall Study||86
9810176|NCT00659789|10919642|FG001|COMPLETED|Overall Study||36
9810177|NCT00659789|10919641|FG000|NOT COMPLETED|Overall Study||7
9810178|NCT00659789|10919642|FG001|NOT COMPLETED|Overall Study||7
9810179|NCT00659802|10919651|FG000|STARTED|Overall Study||74
9810180|NCT00659802|10919652|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
9810181|NCT00659802|10919653|FG002|STARTED|Overall Study||75
9810182|NCT00659802|10919651|FG000|COMPLETED|Overall Study||59
9810183|NCT00659802|10919652|FG001|COMPLETED|Overall Study||57
9810184|NCT00659802|10919653|FG002|COMPLETED|Overall Study||64
9810185|NCT00659802|10919651|FG000|NOT COMPLETED|Overall Study||15
9810186|NCT00659802|10919652|FG001|NOT COMPLETED|Overall Study||18
9810187|NCT00659802|10919653|FG002|NOT COMPLETED|Overall Study||11
9810188|NCT00659815|10919663|FG000|STARTED|Overall Study||157
9810189|NCT00659815|10919664|FG001|STARTED|Overall Study||151
9810190|NCT00659815|10919663|FG000|COMPLETED|Overall Study||153
9810191|NCT00659815|10919664|FG001|COMPLETED|Overall Study||147
9810192|NCT00659815|10919663|FG000|NOT COMPLETED|Overall Study||4
9810193|NCT00659815|10919664|FG001|NOT COMPLETED|Overall Study||4
9810194|NCT00659828|10919670|FG000|STARTED|Overall Study||1
9810195|NCT00659828|10919670|FG000|COMPLETED|Overall Study||1
9810196|NCT00659828|10919670|FG000|NOT COMPLETED|Overall Study||0
9810197|NCT00659880|10919674|FG000|STARTED|Overall Study||9
9810198|NCT00659880|10919674|FG000|6 Weeks|Overall Study||9
9810199|NCT00659880|10919674|FG000|6 Months|Overall Study||9
9810200|NCT00659880|10919674|FG000|12 Months|Overall Study||7
9810201|NCT00659880|10919674|FG000|24 Months|Overall Study||6
9810202|NCT00659880|10919674|FG000|COMPLETED|Overall Study|60 months|4
9810203|NCT00659880|10919674|FG000|NOT COMPLETED|Overall Study||5
9810204|NCT00659945|10919681|FG000|STARTED|Overall Study||75
9810205|NCT00659945|10919682|FG001|STARTED|Overall Study||75
9810206|NCT00659945|10919681|FG000|COMPLETED|Overall Study||75
9810207|NCT00659945|10919682|FG001|COMPLETED|Overall Study||75
9810208|NCT00659945|10919681|FG000|NOT COMPLETED|Overall Study||0
9810209|NCT00659945|10919682|FG001|NOT COMPLETED|Overall Study||0
9810210|NCT00659984|10919688|FG000|STARTED|Overall Study||15
9810211|NCT00659984|10919688|FG000|COMPLETED|Overall Study||14
9810212|NCT00659984|10919688|FG000|NOT COMPLETED|Overall Study||1
9810213|NCT00660010|10919698|FG000|STARTED|Overall Study||55
9810214|NCT00660010|10919698|FG000|COMPLETED|Overall Study||46
9810215|NCT00660010|10919698|FG000|NOT COMPLETED|Overall Study||9
9810216|NCT00660023|10919702|FG000|STARTED|Overall Study||124
9810217|NCT00660023|10919702|FG000|Treated|Overall Study||114
9810218|NCT00660023|10919702|FG000|COMPLETED|Overall Study||95
9810219|NCT00660023|10919702|FG000|NOT COMPLETED|Overall Study||29
9810220|NCT00660049|10919706|FG000|STARTED|Overall Study||12
9810221|NCT00660049|10919706|FG000|COMPLETED|Overall Study||6
9810222|NCT00660049|10919706|FG000|NOT COMPLETED|Overall Study||6
9810223|NCT00660075|10919712|FG000|STARTED|First Intervention (Week 1 to Week 6)||18
9810224|NCT00660075|10919713|FG001|STARTED|First Intervention (Week 1 to Week 6)||18
9810225|NCT00660075|10919712|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18
9810226|NCT00660075|10919713|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18
9810227|NCT00660075|10919712|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
9810228|NCT00660075|10919713|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
9810229|NCT00660075|10919712|FG000|STARTED|Washout Period (Week 7 to Week 10)||18
9810230|NCT00660075|10919713|FG001|STARTED|Washout Period (Week 7 to Week 10)||18
9810231|NCT00660075|10919712|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18
9810232|NCT00660075|10919713|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18
9810233|NCT00660075|10919712|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
9810234|NCT00660075|10919713|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
9810235|NCT00660075|10919712|FG000|STARTED|Second Intervention (Week 11 to Week 16||18
9810236|NCT00660075|10919713|FG001|STARTED|Second Intervention (Week 11 to Week 16||18
9810237|NCT00660075|10919712|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18
9810238|NCT00660075|10919713|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18
9810239|NCT00660075|10919712|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
9810240|NCT00660075|10919713|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
9810241|NCT00660179|10919722|FG000|STARTED|Overall Study||250
9810242|NCT00660179|10919723|FG001|STARTED|Overall Study||250
9810243|NCT00660179|10919724|FG002|STARTED|Overall Study||242
9810244|NCT00660179|10919722|FG000|COMPLETED|Overall Study||194
9810245|NCT00660179|10919723|FG001|COMPLETED|Overall Study||192
9810246|NCT00660179|10919724|FG002|COMPLETED|Overall Study||201
9810247|NCT00660179|10919722|FG000|NOT COMPLETED|Overall Study||56
9810248|NCT00660179|10919723|FG001|NOT COMPLETED|Overall Study||58
9810249|NCT00660179|10919724|FG002|NOT COMPLETED|Overall Study||41
9810250|NCT00660192|10919734|FG000|STARTED|Overall Study||12
9810251|NCT00660192|10919735|FG001|STARTED|Overall Study||13
9810252|NCT00660192|10919734|FG000|COMPLETED|Overall Study||10
9810253|NCT00660192|10919735|FG001|COMPLETED|Overall Study||10
9810254|NCT00660192|10919734|FG000|NOT COMPLETED|Overall Study||2
9810255|NCT00660192|10919735|FG001|NOT COMPLETED|Overall Study||3
9810256|NCT00660309|10919743|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
9810257|NCT00660309|10919744|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
9810258|NCT00660309|10919743|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22
9810259|NCT00660309|10919744|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21
9810260|NCT00660309|10919743|FG000|Pharmacodynamic Analysis Set|Overall Study||22
9810261|NCT00660309|10919744|FG001|Pharmacodynamic Analysis Set|Overall Study||20
9810262|NCT00660309|10919743|FG000|COMPLETED|Overall Study||21
9810263|NCT00660309|10919744|FG001|COMPLETED|Overall Study||19
9810264|NCT00660309|10919743|FG000|NOT COMPLETED|Overall Study||2
9810265|NCT00660309|10919744|FG001|NOT COMPLETED|Overall Study||3
9810266|NCT00660387|10919753|FG000|STARTED|Overall Study||37
9810267|NCT00660387|10919754|FG001|STARTED|Overall Study||34
9810268|NCT00660387|10919753|FG000|COMPLETED|Overall Study||35
9810269|NCT00660387|10919754|FG001|COMPLETED|Overall Study||31
9810270|NCT00660387|10919753|FG000|NOT COMPLETED|Overall Study||2
9810271|NCT00660387|10919754|FG001|NOT COMPLETED|Overall Study||3
9810272|NCT00660400|10919760|FG000|STARTED|Overall Study||25
10016305|NCT01809262|11139188|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
9810273|NCT00660400|10919760|FG000|COMPLETED|Overall Study||21
9810274|NCT00660400|10919760|FG000|NOT COMPLETED|Overall Study||4
9810275|NCT00660504|10919766|FG000|STARTED|Overall Study||149
9810276|NCT00660504|10919767|FG001|STARTED|Overall Study||151
9810277|NCT00660504|10919766|FG000|COMPLETED|Overall Study||149
9810278|NCT00660504|10919767|FG001|COMPLETED|Overall Study||150
9810279|NCT00660504|10919766|FG000|NOT COMPLETED|Overall Study||0
9810280|NCT00660504|10919767|FG001|NOT COMPLETED|Overall Study||1
9810281|NCT00660517|10919777|FG000|STARTED|Overall Study||153
9810282|NCT00660517|10919778|FG001|STARTED|Overall Study||152
9810283|NCT00660517|10919779|FG002|STARTED|Overall Study||151
9810284|NCT00660517|10919780|FG003|STARTED|Overall Study||151
9810285|NCT00660517|10919777|FG000|COMPLETED|Overall Study||145
9810286|NCT00660517|10919778|FG001|COMPLETED|Overall Study||144
9810287|NCT00660517|10919779|FG002|COMPLETED|Overall Study||144
9810288|NCT00660517|10919780|FG003|COMPLETED|Overall Study||144
9810289|NCT00660517|10919777|FG000|NOT COMPLETED|Overall Study||8
9810290|NCT00660517|10919778|FG001|NOT COMPLETED|Overall Study||8
9810291|NCT00660517|10919779|FG002|NOT COMPLETED|Overall Study||7
9810292|NCT00660517|10919780|FG003|NOT COMPLETED|Overall Study||7
9810293|NCT00660530|10919791|FG000|STARTED|Overall Study||11
9810294|NCT00660530|10919791|FG000|COMPLETED|Overall Study||11
9810295|NCT00660530|10919791|FG000|NOT COMPLETED|Overall Study||0
9810296|NCT00660543|10919797|FG000|STARTED|Overall Study||14
9810297|NCT00660543|10919797|FG000|COMPLETED|Overall Study||14
9810298|NCT00660543|10919797|FG000|NOT COMPLETED|Overall Study||0
9810299|NCT00660660|10919808|FG000|STARTED|Overall Study|Randomized|143
9810300|NCT00660660|10919809|FG001|STARTED|Overall Study|Randomized|133
9810301|NCT00660660|10919808|FG000|Met Criteria for MITT Population|Overall Study||137
9810302|NCT00660660|10919809|FG001|Met Criteria for MITT Population|Overall Study||125
9810303|NCT00660660|10919808|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
9810304|NCT00660660|10919809|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
9810305|NCT00660660|10919808|FG000|NOT COMPLETED|Overall Study||5
9810306|NCT00660660|10919809|FG001|NOT COMPLETED|Overall Study||9
9810307|NCT00660699|10919815|FG000|STARTED|Overall Study||50
9810308|NCT00660699|10919815|FG000|COMPLETED|Overall Study||48
9810309|NCT00660699|10919815|FG000|NOT COMPLETED|Overall Study||2
9810310|NCT00660790|10919819|FG000|STARTED|Baseline to 3 Months||97
9810311|NCT00660790|10919819|FG000|COMPLETED|Baseline to 3 Months||94
9810312|NCT00660790|10919819|FG000|NOT COMPLETED|Baseline to 3 Months||3
9810313|NCT00660790|10919819|FG000|STARTED|3 Months to 2 Years||94
9810314|NCT00660790|10919819|FG000|COMPLETED|3 Months to 2 Years||77
9810315|NCT00660790|10919819|FG000|NOT COMPLETED|3 Months to 2 Years||17
9810316|NCT00660816|10919825|FG000|STARTED|Overall Study||24
9810317|NCT00660816|10919826|FG001|STARTED|Overall Study||22
9810318|NCT00660816|10919825|FG000|COMPLETED|Overall Study||4
9810319|NCT00660816|10919826|FG001|COMPLETED|Overall Study||3
9810320|NCT00660816|10919825|FG000|NOT COMPLETED|Overall Study||20
9810321|NCT00660816|10919826|FG001|NOT COMPLETED|Overall Study||19
9810322|NCT00660829|10919834|FG000|STARTED|Overall Study|2 subjects were randomized in error|268
9810323|NCT00660829|10919835|FG001|STARTED|Overall Study|2 subjects were randomized in error|268
9810324|NCT00660829|10919834|FG000|COMPLETED|Overall Study||250
9810325|NCT00660829|10919835|FG001|COMPLETED|Overall Study||249
9810326|NCT00660829|10919834|FG000|NOT COMPLETED|Overall Study||18
9810327|NCT00660829|10919835|FG001|NOT COMPLETED|Overall Study||19
9810328|NCT00660907|10919843|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
10016306|NCT01809262|11139189|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10016307|NCT01809262|11139190|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10016308|NCT01809262|11139191|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10016309|NCT01809262|11139192|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10016310|NCT01809262|11139193|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10016311|NCT01809262|11139194|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10016312|NCT01809262|11139185|FG000|STARTED|Period 3 (Third Dose + Washout)||4
10016313|NCT01809262|11139186|FG001|STARTED|Period 3 (Third Dose + Washout)||4
9810329|NCT00660907|10919844|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
9810330|NCT00660907|10919843|FG000|COMPLETED|Overall Study||322
9810331|NCT00660907|10919844|FG001|COMPLETED|Overall Study||314
9810332|NCT00660907|10919843|FG000|NOT COMPLETED|Overall Study||84
9810333|NCT00660907|10919844|FG001|NOT COMPLETED|Overall Study||94
9810334|NCT00660985|10919852|FG000|STARTED|Overall Study||26
9810335|NCT00660985|10919853|FG001|STARTED|Overall Study||25
9810336|NCT00660985|10919852|FG000|COMPLETED|Overall Study||25
9810337|NCT00660985|10919853|FG001|COMPLETED|Overall Study||25
9810338|NCT00660985|10919852|FG000|NOT COMPLETED|Overall Study||1
9810339|NCT00660985|10919853|FG001|NOT COMPLETED|Overall Study||0
9810340|NCT00661037|10919861|FG000|STARTED|Overall Study||836
9810341|NCT00661037|10919862|FG001|STARTED|Overall Study||1284
9810342|NCT00661037|10919861|FG000|Witdrawn|Overall Study||47
9810343|NCT00661037|10919862|FG001|Witdrawn|Overall Study||68
9810344|NCT00661037|10919861|FG000|Deaths|Overall Study||108
9810345|NCT00661037|10919862|FG001|Deaths|Overall Study||188
9810346|NCT00661037|10919861|FG000|COMPLETED|Overall Study||682
9810347|NCT00661037|10919862|FG001|COMPLETED|Overall Study||1027
9810348|NCT00661037|10919861|FG000|NOT COMPLETED|Overall Study||154
9810349|NCT00661037|10919862|FG001|NOT COMPLETED|Overall Study||257
9810350|NCT00661089|10919872|FG000|STARTED|Overall Study||10
9810351|NCT00661089|10919873|FG001|STARTED|Overall Study||11
9810352|NCT00661089|10919872|FG000|COMPLETED|Overall Study||10
9810353|NCT00661089|10919873|FG001|COMPLETED|Overall Study||9
9810354|NCT00661089|10919872|FG000|NOT COMPLETED|Overall Study||0
9810355|NCT00661089|10919873|FG001|NOT COMPLETED|Overall Study||2
9810356|NCT00661141|10919883|FG000|STARTED|Overall Study||8
9810357|NCT00661141|10919884|FG001|STARTED|Overall Study||8
9810358|NCT00661141|10919885|FG002|STARTED|Overall Study||4
9810359|NCT00661141|10919886|FG003|STARTED|Overall Study||4
9810360|NCT00661141|10919887|FG004|STARTED|Overall Study||4
9810361|NCT00661141|10919888|FG005|STARTED|Overall Study||4
9810362|NCT00661141|10919883|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6
9810363|NCT00661141|10919884|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6
9810364|NCT00661141|10919885|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2
9810365|NCT00661141|10919886|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2
9810366|NCT00661141|10919887|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4
9810367|NCT00661141|10919888|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4
9810368|NCT00661141|10919883|FG000|Administered 30 Minutes After Ethanol|Overall Study||2
9810369|NCT00661141|10919884|FG001|Administered 30 Minutes After Ethanol|Overall Study||2
9810370|NCT00661141|10919885|FG002|Administered 30 Minutes After Ethanol|Overall Study||2
9810371|NCT00661141|10919886|FG003|Administered 30 Minutes After Ethanol|Overall Study||2
9810372|NCT00661141|10919887|FG004|Administered 30 Minutes After Ethanol|Overall Study||0
9810373|NCT00661141|10919888|FG005|Administered 30 Minutes After Ethanol|Overall Study||0
9810374|NCT00661141|10919883|FG000|COMPLETED|Overall Study||8
9810375|NCT00661141|10919884|FG001|COMPLETED|Overall Study||8
9810376|NCT00661141|10919885|FG002|COMPLETED|Overall Study||4
9810377|NCT00661141|10919886|FG003|COMPLETED|Overall Study||4
9810378|NCT00661141|10919887|FG004|COMPLETED|Overall Study||4
9810379|NCT00661141|10919888|FG005|COMPLETED|Overall Study||4
9810380|NCT00661141|10919883|FG000|NOT COMPLETED|Overall Study||0
9810381|NCT00661141|10919884|FG001|NOT COMPLETED|Overall Study||0
9810382|NCT00661141|10919885|FG002|NOT COMPLETED|Overall Study||0
9810383|NCT00661141|10919886|FG003|NOT COMPLETED|Overall Study||0
9810384|NCT00661141|10919887|FG004|NOT COMPLETED|Overall Study||0
9810385|NCT00661141|10919888|FG005|NOT COMPLETED|Overall Study||0
10016314|NCT01809262|11139187|FG002|STARTED|Period 3 (Third Dose + Washout)||4
10016315|NCT01809262|11139188|FG003|STARTED|Period 3 (Third Dose + Washout)||3
10016316|NCT01809262|11139189|FG004|STARTED|Period 3 (Third Dose + Washout)||3
10016317|NCT01809262|11139190|FG005|STARTED|Period 3 (Third Dose + Washout)||3
10016318|NCT01809262|11139191|FG006|STARTED|Period 3 (Third Dose + Washout)||3
10016319|NCT01809262|11139192|FG007|STARTED|Period 3 (Third Dose + Washout)||4
9810386|NCT00661193|10919909|FG000|STARTED|Overall Study||33
9810387|NCT00661193|10919910|FG001|STARTED|Overall Study||26
9810388|NCT00661193|10919909|FG000|COMPLETED|Overall Study||0
9810389|NCT00661193|10919910|FG001|COMPLETED|Overall Study||0
9810390|NCT00661193|10919909|FG000|NOT COMPLETED|Overall Study||33
9810391|NCT00661193|10919910|FG001|NOT COMPLETED|Overall Study||26
9810392|NCT00661258|10919918|FG000|STARTED|Overall Study||34
9810393|NCT00661258|10919919|FG001|STARTED|Overall Study||34
9810394|NCT00661258|10919918|FG000|COMPLETED|Overall Study||31
9810395|NCT00661258|10919919|FG001|COMPLETED|Overall Study||33
9810396|NCT00661258|10919918|FG000|NOT COMPLETED|Overall Study||3
9810397|NCT00661258|10919919|FG001|NOT COMPLETED|Overall Study||1
9810398|NCT00661271|10919927|FG000|STARTED|Overall Study||48
9810399|NCT00661271|10919928|FG001|STARTED|Overall Study||45
9810400|NCT00661271|10919927|FG000|COMPLETED|Overall Study||20
9810401|NCT00661271|10919928|FG001|COMPLETED|Overall Study||20
9810402|NCT00661271|10919927|FG000|NOT COMPLETED|Overall Study||28
9810403|NCT00661271|10919928|FG001|NOT COMPLETED|Overall Study||25
9810404|NCT00661362|10919936|FG000|STARTED|Overall Study|Randomized and treated|283
9810405|NCT00661362|10919937|FG001|STARTED|Overall Study|Randomized and treated|287
9810406|NCT00661362|10919936|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
9810407|NCT00661362|10919937|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
9810408|NCT00661362|10919936|FG000|NOT COMPLETED|Overall Study||29
9810409|NCT00661362|10919937|FG001|NOT COMPLETED|Overall Study||40
9810410|NCT00661388|10919943|FG000|STARTED|Overall Study||75
9810411|NCT00661388|10919943|FG000|COMPLETED|Overall Study||51
9810412|NCT00661388|10919943|FG000|NOT COMPLETED|Overall Study||24
9810413|NCT00661427|10919949|FG000|STARTED|Overall Study||35
9810414|NCT00661427|10919950|FG001|STARTED|Overall Study||26
9810415|NCT00661427|10919949|FG000|COMPLETED|Overall Study||30
9810416|NCT00661427|10919950|FG001|COMPLETED|Overall Study||19
9810417|NCT00661427|10919949|FG000|NOT COMPLETED|Overall Study||5
9810418|NCT00661427|10919950|FG001|NOT COMPLETED|Overall Study||7
9810419|NCT00661453|10919956|FG000|STARTED|Overall Study||38
9810420|NCT00661453|10919956|FG000|COMPLETED|Overall Study||25
9810421|NCT00661453|10919956|FG000|NOT COMPLETED|Overall Study||13
9810422|NCT00661479|10919964|FG000|STARTED|Overall Study||12
9810423|NCT00661479|10919965|FG001|STARTED|Overall Study||3
9810424|NCT00661479|10919966|FG002|STARTED|Overall Study||3
9810425|NCT00661479|10919967|FG003|STARTED|Overall Study||3
9810426|NCT00661479|10919964|FG000|COMPLETED|Overall Study||12
9810427|NCT00661479|10919965|FG001|COMPLETED|Overall Study||3
9810428|NCT00661479|10919966|FG002|COMPLETED|Overall Study||3
9810429|NCT00661479|10919967|FG003|COMPLETED|Overall Study||3
9810430|NCT00661479|10919964|FG000|NOT COMPLETED|Overall Study||0
9810431|NCT00661479|10919965|FG001|NOT COMPLETED|Overall Study||0
9810432|NCT00661479|10919966|FG002|NOT COMPLETED|Overall Study||0
9810433|NCT00661479|10919967|FG003|NOT COMPLETED|Overall Study||0
9810434|NCT00661492|10919978|FG000|STARTED|Overall Study||75
9810435|NCT00661492|10919979|FG001|STARTED|Overall Study||40
9810436|NCT00661492|10919978|FG000|COMPLETED|Overall Study||7
9810437|NCT00661492|10919979|FG001|COMPLETED|Overall Study||11
9810438|NCT00661492|10919978|FG000|NOT COMPLETED|Overall Study||68
9810439|NCT00661492|10919979|FG001|NOT COMPLETED|Overall Study||29
9810440|NCT00661505|10919985|FG000|STARTED|Overall Study||132
9810441|NCT00661505|10919985|FG000|COMPLETED|Overall Study||102
9810442|NCT00661505|10919985|FG000|NOT COMPLETED|Overall Study||30
9810443|NCT00661531|10919990|FG000|STARTED|Overall Study||11
9810444|NCT00661531|10919990|FG000|COMPLETED|Overall Study||8
9810445|NCT00661531|10919990|FG000|NOT COMPLETED|Overall Study||3
9810446|NCT00661544|10919994|FG000|STARTED|Overall Study||48
9810447|NCT00661544|10919994|FG000|COMPLETED|Overall Study||48
9810448|NCT00661544|10919994|FG000|NOT COMPLETED|Overall Study||0
9810449|NCT00661557|10920000|FG000|STARTED|Overall Study||192
9810450|NCT00661557|10920001|FG001|STARTED|Overall Study||79
9810451|NCT00661557|10920000|FG000|COMPLETED|Overall Study||183
9810452|NCT00661557|10920001|FG001|COMPLETED|Overall Study||79
9810453|NCT00661557|10920000|FG000|NOT COMPLETED|Overall Study||9
9810454|NCT00661557|10920001|FG001|NOT COMPLETED|Overall Study||0
9810455|NCT00661570|10920007|FG000|STARTED|Overall Study||26
9810456|NCT00661570|10920007|FG000|COMPLETED|Overall Study||26
9810457|NCT00661570|10920007|FG000|NOT COMPLETED|Overall Study||0
9810458|NCT00661583|10920014|FG000|STARTED|Overall Study||10
9810459|NCT00661583|10920015|FG001|STARTED|Overall Study||10
9810460|NCT00661583|10920016|FG002|STARTED|Overall Study||10
9810461|NCT00661583|10920014|FG000|COMPLETED|Overall Study||10
9810462|NCT00661583|10920015|FG001|COMPLETED|Overall Study||10
9810463|NCT00661583|10920016|FG002|COMPLETED|Overall Study||10
10016320|NCT01809262|11139193|FG008|STARTED|Period 3 (Third Dose + Washout)||3
10016321|NCT01809262|11139194|FG009|STARTED|Period 3 (Third Dose + Washout)||4
10016322|NCT01809262|11139185|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4
9810464|NCT00661583|10920014|FG000|NOT COMPLETED|Overall Study||0
9810465|NCT00661583|10920015|FG001|NOT COMPLETED|Overall Study||0
9810466|NCT00661583|10920016|FG002|NOT COMPLETED|Overall Study||0
9810467|NCT00661609|10920024|FG000|STARTED|Overall Study|All dosed patients|41
9832515|NCT00773422|10943284|FG001|STARTED|Overall Study||9
9810468|NCT00661609|10920024|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
9810469|NCT00661609|10920024|FG000|NOT COMPLETED|Overall Study||41
9810470|NCT00661622|10920030|FG000|STARTED|Overall Study||26
9810471|NCT00661622|10920031|FG001|STARTED|Overall Study||27
9810472|NCT00661622|10920030|FG000|COMPLETED|Overall Study||25
9810473|NCT00661622|10920031|FG001|COMPLETED|Overall Study||27
9810474|NCT00661622|10920030|FG000|NOT COMPLETED|Overall Study||1
9810475|NCT00661622|10920031|FG001|NOT COMPLETED|Overall Study||0
9810476|NCT00661661|10920040|FG000|STARTED|Overall Study||382
9810477|NCT00661661|10920041|FG001|STARTED|Overall Study||105
9810478|NCT00661661|10920040|FG000|COMPLETED|Overall Study||242
9810479|NCT00661661|10920041|FG001|COMPLETED|Overall Study||66
9810480|NCT00661661|10920040|FG000|NOT COMPLETED|Overall Study||140
9810481|NCT00661661|10920041|FG001|NOT COMPLETED|Overall Study||39
9810482|NCT00661674|10920049|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
9810483|NCT00661674|10920050|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
10016323|NCT01809262|11139186|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3
10016324|NCT01809262|11139187|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4
10016325|NCT01809262|11139188|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3
10016326|NCT01809262|11139189|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3
10016327|NCT01809262|11139190|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3
9810484|NCT00661674|10920051|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
9810485|NCT00661674|10920052|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
9810486|NCT00661674|10920053|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
9810487|NCT00661674|10920054|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
9810488|NCT00661674|10920049|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
9810489|NCT00661674|10920050|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
9810490|NCT00661674|10920051|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
9810491|NCT00661674|10920052|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
9810492|NCT00661674|10920053|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
9810493|NCT00661674|10920054|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
9810494|NCT00661674|10920049|FG000|NOT COMPLETED|Overall Study||0
9810495|NCT00661674|10920050|FG001|NOT COMPLETED|Overall Study||0
9810496|NCT00661674|10920051|FG002|NOT COMPLETED|Overall Study||0
9810497|NCT00661674|10920052|FG003|NOT COMPLETED|Overall Study||0
9810498|NCT00661674|10920053|FG004|NOT COMPLETED|Overall Study||0
9810499|NCT00661674|10920054|FG005|NOT COMPLETED|Overall Study||0
9810500|NCT00661687|10920062|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
9810501|NCT00661687|10920062|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
9810502|NCT00661687|10920062|FG000|NOT COMPLETED|Overall Study||15
9810503|NCT00661713|10920076|FG000|STARTED|Overall Study||128
9810504|NCT00661713|10920077|FG001|STARTED|Overall Study||247
9810505|NCT00661713|10920078|FG002|STARTED|Overall Study||128
9810506|NCT00661713|10920079|FG003|STARTED|Overall Study||247
9810507|NCT00661713|10920080|FG004|STARTED|Overall Study||127
9810508|NCT00661713|10920081|FG005|STARTED|Overall Study||253
9810509|NCT00661713|10920082|FG006|STARTED|Overall Study||373
9810510|NCT00661713|10920083|FG007|STARTED|Overall Study||128
9810511|NCT00661713|10920076|FG000|COMPLETED|Overall Study||112
9810512|NCT00661713|10920077|FG001|COMPLETED|Overall Study||208
9810513|NCT00661713|10920078|FG002|COMPLETED|Overall Study||111
9810514|NCT00661713|10920079|FG003|COMPLETED|Overall Study||219
9810515|NCT00661713|10920080|FG004|COMPLETED|Overall Study||107
9810516|NCT00661713|10920081|FG005|COMPLETED|Overall Study||216
10016328|NCT01809262|11139191|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3
10016329|NCT01809262|11139192|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4
10016330|NCT01809262|11139193|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3
10016331|NCT01809262|11139194|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4
10016332|NCT01809262|11139185|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016333|NCT01809262|11139186|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
10016334|NCT01809262|11139187|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016335|NCT01809262|11139188|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016336|NCT01809262|11139189|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016337|NCT01809262|11139190|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016338|NCT01809262|11139191|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016339|NCT01809262|11139192|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016340|NCT01809262|11139193|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016341|NCT01809262|11139194|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10016342|NCT01809262|11139185|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4
10016343|NCT01809262|11139186|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3
10016344|NCT01809262|11139187|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4
10016345|NCT01809262|11139188|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3
10016346|NCT01809262|11139189|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3
10016347|NCT01809262|11139190|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3
10016348|NCT01809262|11139191|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3
10016349|NCT01809262|11139192|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4
10016350|NCT01809262|11139193|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3
10016351|NCT01809262|11139194|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4
10016352|NCT01809262|11139185|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4
9810517|NCT00661713|10920082|FG006|COMPLETED|Overall Study||309
9810518|NCT00661713|10920083|FG007|COMPLETED|Overall Study||117
9810519|NCT00661713|10920076|FG000|NOT COMPLETED|Overall Study||16
9810520|NCT00661713|10920077|FG001|NOT COMPLETED|Overall Study||39
9810521|NCT00661713|10920078|FG002|NOT COMPLETED|Overall Study||17
9810522|NCT00661713|10920079|FG003|NOT COMPLETED|Overall Study||28
9810523|NCT00661713|10920080|FG004|NOT COMPLETED|Overall Study||20
9810524|NCT00661713|10920081|FG005|NOT COMPLETED|Overall Study||37
9810525|NCT00661713|10920082|FG006|NOT COMPLETED|Overall Study||64
9810526|NCT00661713|10920083|FG007|NOT COMPLETED|Overall Study||11
9831676|NCT00769314|10942268|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
9831677|NCT00769314|10942267|FG000|COMPLETED|Overall Study||361
9831678|NCT00769314|10942268|FG001|COMPLETED|Overall Study||384
9831679|NCT00769314|10942267|FG000|NOT COMPLETED|Overall Study||17
9831680|NCT00769314|10942268|FG001|NOT COMPLETED|Overall Study||13
9831681|NCT00769392|10942274|FG000|STARTED|Overall Study||28
9831682|NCT00769392|10942274|FG000|COMPLETED|Overall Study||24
9831683|NCT00769392|10942274|FG000|NOT COMPLETED|Overall Study||4
9831684|NCT00769483|10942284|FG000|STARTED|Overall Study||9
9831685|NCT00769483|10942285|FG001|STARTED|Overall Study||13
9831686|NCT00769483|10942286|FG002|STARTED|Overall Study||15
9831687|NCT00769483|10942287|FG003|STARTED|Overall Study||15
9831688|NCT00769483|10942288|FG004|STARTED|Overall Study||16
9831689|NCT00769483|10942289|FG005|STARTED|Overall Study||9
9831690|NCT00769483|10942284|FG000|COMPLETED|Overall Study||9
9831691|NCT00769483|10942285|FG001|COMPLETED|Overall Study||12
9831692|NCT00769483|10942286|FG002|COMPLETED|Overall Study||15
9831693|NCT00769483|10942287|FG003|COMPLETED|Overall Study||15
9831694|NCT00769483|10942288|FG004|COMPLETED|Overall Study||15
9831695|NCT00769483|10942289|FG005|COMPLETED|Overall Study||9
9831696|NCT00769483|10942284|FG000|NOT COMPLETED|Overall Study||0
9831697|NCT00769483|10942285|FG001|NOT COMPLETED|Overall Study||1
9831698|NCT00769483|10942286|FG002|NOT COMPLETED|Overall Study||0
9831699|NCT00769483|10942287|FG003|NOT COMPLETED|Overall Study||0
9831700|NCT00769483|10942288|FG004|NOT COMPLETED|Overall Study||1
9831701|NCT00769483|10942289|FG005|NOT COMPLETED|Overall Study||0
9831702|NCT00769561|10942307|FG000|STARTED|Overall Study||29
9831703|NCT00769561|10942308|FG001|STARTED|Overall Study||29
9831704|NCT00769561|10942307|FG000|COMPLETED|Overall Study||26
9831705|NCT00769561|10942308|FG001|COMPLETED|Overall Study||24
9831706|NCT00769561|10942307|FG000|NOT COMPLETED|Overall Study||3
9831707|NCT00769561|10942308|FG001|NOT COMPLETED|Overall Study||5
9831708|NCT00769600|10942316|FG000|STARTED|Overall Study||15
9831709|NCT00769600|10942317|FG001|STARTED|Overall Study||8
9831710|NCT00769600|10942316|FG000|COMPLETED|Overall Study||15
9831711|NCT00769600|10942317|FG001|COMPLETED|Overall Study||8
9831712|NCT00769600|10942316|FG000|NOT COMPLETED|Overall Study||0
9831713|NCT00769600|10942317|FG001|NOT COMPLETED|Overall Study||0
9831714|NCT00769704|10942328|FG000|STARTED|Overall Study||141
9831715|NCT00769704|10942329|FG001|STARTED|Overall Study||296
9831716|NCT00769704|10942328|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
9831717|NCT00769704|10942329|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
9831718|NCT00769704|10942328|FG000|Received Treatment|Overall Study||127
9831719|NCT00769704|10942329|FG001|Received Treatment|Overall Study||292
9831720|NCT00769704|10942328|FG000|COMPLETED|Overall Study||30
9831721|NCT00769704|10942329|FG001|COMPLETED|Overall Study||97
9831722|NCT00769704|10942328|FG000|NOT COMPLETED|Overall Study||111
9831723|NCT00769704|10942329|FG001|NOT COMPLETED|Overall Study||199
9831724|NCT00769808|10942336|FG000|STARTED|Overall Study||72
9831725|NCT00769808|10942336|FG000|COMPLETED|Overall Study||64
9831726|NCT00769808|10942336|FG000|NOT COMPLETED|Overall Study||8
9831727|NCT00769860|10942342|FG000|STARTED|Overall Study||16
9831728|NCT00769860|10942343|FG001|STARTED|Overall Study||8
9831729|NCT00769860|10942342|FG000|Month 4|Overall Study||16
9831730|NCT00769860|10942343|FG001|Month 4|Overall Study||8
9831731|NCT00769860|10942342|FG000|Month 8|Overall Study||14
9831732|NCT00769860|10942343|FG001|Month 8|Overall Study||8
9831733|NCT00769860|10942342|FG000|COMPLETED|Overall Study||14
9831734|NCT00769860|10942343|FG001|COMPLETED|Overall Study||8
9831735|NCT00769860|10942342|FG000|NOT COMPLETED|Overall Study||2
9831736|NCT00769860|10942343|FG001|NOT COMPLETED|Overall Study||0
9831737|NCT00769886|10942353|FG000|STARTED|Overall Study||36
9831738|NCT00769886|10942354|FG001|STARTED|Overall Study||36
9831739|NCT00769886|10942355|FG002|STARTED|Overall Study||35
9831740|NCT00769886|10942356|FG003|STARTED|Overall Study||37
9831741|NCT00769886|10942353|FG000|COMPLETED|Overall Study||31
9831742|NCT00769886|10942354|FG001|COMPLETED|Overall Study||32
9831743|NCT00769886|10942355|FG002|COMPLETED|Overall Study||34
9831744|NCT00769886|10942356|FG003|COMPLETED|Overall Study||35
9831745|NCT00769886|10942353|FG000|NOT COMPLETED|Overall Study||5
9831746|NCT00769886|10942354|FG001|NOT COMPLETED|Overall Study||4
9831747|NCT00769886|10942355|FG002|NOT COMPLETED|Overall Study||1
9831748|NCT00769886|10942356|FG003|NOT COMPLETED|Overall Study||2
9831749|NCT00770029|10942368|FG000|STARTED|Overall Study||184
9831750|NCT00770029|10942369|FG001|STARTED|Overall Study||92
9831751|NCT00770029|10942368|FG000|COMPLETED|Overall Study||178
9831752|NCT00770029|10942369|FG001|COMPLETED|Overall Study||89
9831753|NCT00770029|10942368|FG000|NOT COMPLETED|Overall Study||6
9831754|NCT00770029|10942369|FG001|NOT COMPLETED|Overall Study||3
9831755|NCT00770120|10942375|FG000|STARTED|Overall Study||61
9810527|NCT00661726|10920103|FG000|STARTED|Overall Study||6
9810528|NCT00661726|10920103|FG000|COMPLETED|Overall Study||5
9810529|NCT00661726|10920103|FG000|NOT COMPLETED|Overall Study||1
9810530|NCT00661778|10920107|FG000|STARTED|Overall Study||50
9810531|NCT00661778|10920107|FG000|COMPLETED|Overall Study||0
9810532|NCT00661778|10920107|FG000|NOT COMPLETED|Overall Study||50
9810533|NCT00661830|10920113|FG000|STARTED|Overall Study||49
9810534|NCT00661830|10920114|FG001|STARTED|Overall Study||48
9810535|NCT00661830|10920113|FG000|COMPLETED|Overall Study||9
9810536|NCT00661830|10920114|FG001|COMPLETED|Overall Study||6
9810537|NCT00661830|10920113|FG000|NOT COMPLETED|Overall Study||40
9810538|NCT00661830|10920114|FG001|NOT COMPLETED|Overall Study||42
9810539|NCT00661895|10920122|FG000|STARTED|Overall Study||49
9810540|NCT00661895|10920123|FG001|STARTED|Overall Study||50
9810541|NCT00661895|10920122|FG000|COMPLETED|Overall Study||49
9810542|NCT00661895|10920123|FG001|COMPLETED|Overall Study||50
9810543|NCT00661895|10920122|FG000|NOT COMPLETED|Overall Study||0
9810544|NCT00661895|10920123|FG001|NOT COMPLETED|Overall Study||0
9810545|NCT00661960|10920132|FG000|STARTED|Overall Study||5
9810546|NCT00661960|10920133|FG001|STARTED|Overall Study||10
9810547|NCT00661960|10920134|FG002|STARTED|Overall Study||10
9810548|NCT00661960|10920132|FG000|COMPLETED|Overall Study||5
9810549|NCT00661960|10920133|FG001|COMPLETED|Overall Study||7
10016353|NCT01809262|11139186|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10016354|NCT01809262|11139187|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4
10016355|NCT01809262|11139188|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10016356|NCT01809262|11139189|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10112262|NCT02502149|11243312|FG003|STARTED|Treatment Period||11
10112263|NCT02502149|11243313|FG004|STARTED|Treatment Period||12
10112264|NCT02502149|11243309|FG000|COMPLETED|Treatment Period||0
10112265|NCT02502149|11243310|FG001|COMPLETED|Treatment Period||0
10112266|NCT02502149|11243311|FG002|COMPLETED|Treatment Period||0
9810550|NCT00661960|10920134|FG002|COMPLETED|Overall Study||9
9810551|NCT00661960|10920132|FG000|NOT COMPLETED|Overall Study||0
9810552|NCT00661960|10920133|FG001|NOT COMPLETED|Overall Study||3
9810553|NCT00661960|10920134|FG002|NOT COMPLETED|Overall Study||1
9810554|NCT00661999|10920145|FG000|STARTED|Overall Study||164
9810555|NCT00661999|10920146|FG001|STARTED|Overall Study||163
9810556|NCT00661999|10920147|FG002|STARTED|Overall Study||163
9810557|NCT00661999|10920145|FG000|COMPLETED|Overall Study||105
9810558|NCT00661999|10920146|FG001|COMPLETED|Overall Study||113
9810559|NCT00661999|10920147|FG002|COMPLETED|Overall Study||106
9810560|NCT00661999|10920145|FG000|NOT COMPLETED|Overall Study||59
9810561|NCT00661999|10920146|FG001|NOT COMPLETED|Overall Study||50
9810562|NCT00661999|10920147|FG002|NOT COMPLETED|Overall Study||57
9810563|NCT00662012|10920155|FG000|STARTED|Overall Study||414
9810564|NCT00662012|10920155|FG000|COMPLETED|Overall Study||327
9810565|NCT00662012|10920155|FG000|NOT COMPLETED|Overall Study||87
9810566|NCT00662025|10920159|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
9810567|NCT00662025|10920159|FG000|COMPLETED|Overall Study||0
9810568|NCT00662025|10920159|FG000|NOT COMPLETED|Overall Study||63
9810569|NCT00662038|10920163|FG000|STARTED|Overall Study||1058
9810570|NCT00662038|10920163|FG000|COMPLETED|Overall Study||427
9810571|NCT00662038|10920163|FG000|NOT COMPLETED|Overall Study||631
9810572|NCT00662129|10920167|FG000|STARTED|Overall Study||50
9810573|NCT00662129|10920167|FG000|COMPLETED|Overall Study||47
9810574|NCT00662129|10920167|FG000|NOT COMPLETED|Overall Study||3
9810575|NCT00662155|10920175|FG000|STARTED|Overall Study||16
9810576|NCT00662155|10920176|FG001|STARTED|Overall Study||20
9810577|NCT00662155|10920177|FG002|STARTED|Overall Study||20
9810578|NCT00662155|10920178|FG003|STARTED|Overall Study||18
9810579|NCT00662155|10920175|FG000|COMPLETED|Overall Study||13
9810580|NCT00662155|10920176|FG001|COMPLETED|Overall Study||15
9810581|NCT00662155|10920177|FG002|COMPLETED|Overall Study||13
9810582|NCT00662155|10920178|FG003|COMPLETED|Overall Study||14
9810583|NCT00662155|10920175|FG000|NOT COMPLETED|Overall Study||3
9810584|NCT00662155|10920176|FG001|NOT COMPLETED|Overall Study||5
9810585|NCT00662155|10920177|FG002|NOT COMPLETED|Overall Study||7
9810586|NCT00662155|10920178|FG003|NOT COMPLETED|Overall Study||4
9810587|NCT00662207|10920188|FG000|STARTED|Overall Study||3
9810588|NCT00662207|10920188|FG000|COMPLETED|Overall Study||3
9810589|NCT00662207|10920188|FG000|NOT COMPLETED|Overall Study||0
9810590|NCT00662259|10920194|FG000|STARTED|Overall Study||21
9810591|NCT00662259|10920195|FG001|STARTED|Overall Study||11
9810592|NCT00662259|10920194|FG000|COMPLETED|Overall Study||19
9810593|NCT00662259|10920195|FG001|COMPLETED|Overall Study||11
9810594|NCT00662259|10920194|FG000|NOT COMPLETED|Overall Study||2
9810595|NCT00662259|10920195|FG001|NOT COMPLETED|Overall Study||0
9810596|NCT00662298|10920201|FG000|STARTED|Overall Study||5
9810597|NCT00662298|10920201|FG000|COMPLETED|Overall Study||5
9810598|NCT00662298|10920201|FG000|NOT COMPLETED|Overall Study||0
9810599|NCT00662311|10920208|FG000|STARTED|Overall Study||5
9810600|NCT00662311|10920209|FG001|STARTED|Overall Study||0
9810601|NCT00662311|10920210|FG002|STARTED|Overall Study||0
9810602|NCT00662311|10920208|FG000|COMPLETED|Overall Study||4
9810603|NCT00662311|10920209|FG001|COMPLETED|Overall Study||0
10016357|NCT01809262|11139190|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10016358|NCT01809262|11139191|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10016359|NCT01809262|11139192|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4
10016360|NCT01809262|11139193|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10016361|NCT01809262|11139194|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4
9810604|NCT00662311|10920210|FG002|COMPLETED|Overall Study||0
9810605|NCT00662311|10920208|FG000|NOT COMPLETED|Overall Study||1
9810606|NCT00662311|10920209|FG001|NOT COMPLETED|Overall Study||0
9810607|NCT00662311|10920210|FG002|NOT COMPLETED|Overall Study||0
9810608|NCT00662363|10920220|FG000|STARTED|Overall Study||32
9810609|NCT00662363|10920221|FG001|STARTED|Overall Study||32
9810610|NCT00662363|10920220|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
9810611|NCT00662363|10920221|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
9810612|NCT00662363|10920220|FG000|NOT COMPLETED|Overall Study||11
9810613|NCT00662363|10920221|FG001|NOT COMPLETED|Overall Study||10
9810614|NCT00662532|10920231|FG000|STARTED|Overall Study||22
9810615|NCT00662532|10920232|FG001|STARTED|Overall Study||22
9810616|NCT00662532|10920231|FG000|COMPLETED|Overall Study||22
9810617|NCT00662532|10920232|FG001|COMPLETED|Overall Study||20
9810618|NCT00662532|10920231|FG000|NOT COMPLETED|Overall Study||0
9810619|NCT00662532|10920232|FG001|NOT COMPLETED|Overall Study||2
9810620|NCT00662545|10920240|FG000|STARTED|Overall Study||5
9810621|NCT00662545|10920241|FG001|STARTED|Overall Study||5
9810622|NCT00662545|10920240|FG000|COMPLETED|Overall Study||5
9810623|NCT00662545|10920241|FG001|COMPLETED|Overall Study||5
9810624|NCT00662545|10920240|FG000|NOT COMPLETED|Overall Study||0
9810625|NCT00662545|10920241|FG001|NOT COMPLETED|Overall Study||0
9810626|NCT00662558|10920249|FG000|STARTED|Overall Study||398
9810627|NCT00662558|10920250|FG001|STARTED|Overall Study||404
9810628|NCT00662558|10920249|FG000|Received Treatment|Overall Study||396
9810629|NCT00662558|10920250|FG001|Received Treatment|Overall Study||396
9810630|NCT00662558|10920249|FG000|COMPLETED|Overall Study||342
9810631|NCT00662558|10920250|FG001|COMPLETED|Overall Study||294
9810632|NCT00662558|10920249|FG000|NOT COMPLETED|Overall Study||56
9810633|NCT00662558|10920250|FG001|NOT COMPLETED|Overall Study||110
9810634|NCT00662649|10920260|FG000|STARTED|Core Study (24 Months)||429
9810635|NCT00662649|10920261|FG001|STARTED|Core Study (24 Months)||425
9810636|NCT00662649|10920262|FG002|STARTED|Core Study (24 Months)||418
9810637|NCT00662649|10920263|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
9810638|NCT00662649|10920264|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
9810639|NCT00662649|10920260|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429
9810640|NCT00662649|10920261|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425
9810641|NCT00662649|10920262|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418
9810642|NCT00662649|10920263|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0
9810643|NCT00662649|10920264|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0
9810644|NCT00662649|10920260|FG000|COMPLETED|Core Study (24 Months)||332
9810645|NCT00662649|10920261|FG001|COMPLETED|Core Study (24 Months)||369
9810646|NCT00662649|10920262|FG002|COMPLETED|Core Study (24 Months)||332
9810647|NCT00662649|10920263|FG003|COMPLETED|Core Study (24 Months)||0
9810648|NCT00662649|10920264|FG004|COMPLETED|Core Study (24 Months)||0
9810649|NCT00662649|10920260|FG000|NOT COMPLETED|Core Study (24 Months)||97
9810650|NCT00662649|10920261|FG001|NOT COMPLETED|Core Study (24 Months)||56
9810651|NCT00662649|10920262|FG002|NOT COMPLETED|Core Study (24 Months)||86
9810652|NCT00662649|10920263|FG003|NOT COMPLETED|Core Study (24 Months)||0
9810653|NCT00662649|10920264|FG004|NOT COMPLETED|Core Study (24 Months)||0
9810654|NCT00662649|10920260|FG000|STARTED|Extension Study (Month 24 to 60)||289
9810655|NCT00662649|10920261|FG001|STARTED|Extension Study (Month 24 to 60)||331
9810656|NCT00662649|10920262|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
9810657|NCT00662649|10920263|FG003|STARTED|Extension Study (Month 24 to 60)||145
9810658|NCT00662649|10920264|FG004|STARTED|Extension Study (Month 24 to 60)||155
9810659|NCT00662649|10920260|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
9810660|NCT00662649|10920261|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
9810661|NCT00662649|10920262|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
9810662|NCT00662649|10920263|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
9810663|NCT00662649|10920264|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
9810664|NCT00662649|10920260|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
9810665|NCT00662649|10920261|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
9810666|NCT00662649|10920262|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
9810667|NCT00662649|10920263|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
9810668|NCT00662649|10920264|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
9810669|NCT00662649|10920260|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
9810670|NCT00662649|10920261|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
9810671|NCT00662649|10920262|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
10016362|NCT01809262|11139185|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016363|NCT01809262|11139186|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016364|NCT01809262|11139187|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016365|NCT01809262|11139188|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016366|NCT01809262|11139189|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016367|NCT01809262|11139190|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016368|NCT01809262|11139191|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016369|NCT01809262|11139192|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10019147|NCT01828034|11142281|FG001|NOT COMPLETED|Overall Study||0
9810672|NCT00662649|10920263|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
9810673|NCT00662649|10920264|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
9810674|NCT00662649|10920260|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
9810675|NCT00662649|10920261|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
9810676|NCT00662649|10920262|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
9810677|NCT00662649|10920263|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
9810678|NCT00662649|10920264|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
9810679|NCT00662649|10920260|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
9810680|NCT00662649|10920261|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
9810681|NCT00662649|10920262|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
9810682|NCT00662649|10920263|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
9810683|NCT00662649|10920264|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
9810684|NCT00662649|10920260|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
10016370|NCT01809262|11139193|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016371|NCT01809262|11139194|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10016372|NCT01809262|11139185|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4
10016373|NCT01809262|11139186|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3
9810685|NCT00662649|10920261|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
9810686|NCT00662649|10920262|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
9810687|NCT00662649|10920263|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
9810688|NCT00662649|10920264|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
9810689|NCT00662649|10920260|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
9810690|NCT00662649|10920261|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
9810691|NCT00662649|10920262|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
9810692|NCT00662649|10920263|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
9810693|NCT00662649|10920264|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
9810694|NCT00662649|10920260|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
9810695|NCT00662649|10920261|FG001|COMPLETED|Extension Study (Month 24 to 60)||290
9810696|NCT00662649|10920262|FG002|COMPLETED|Extension Study (Month 24 to 60)||0
9810697|NCT00662649|10920263|FG003|COMPLETED|Extension Study (Month 24 to 60)||112
9810698|NCT00662649|10920264|FG004|COMPLETED|Extension Study (Month 24 to 60)||126
9810699|NCT00662649|10920260|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44
9810700|NCT00662649|10920261|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41
9810701|NCT00662649|10920262|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0
9810702|NCT00662649|10920263|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33
9810703|NCT00662649|10920264|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29
9810704|NCT00662675|10920280|FG000|STARTED|Overall Study||20
9810705|NCT00662675|10920281|FG001|STARTED|Overall Study||20
9810706|NCT00662675|10920280|FG000|COMPLETED|Overall Study||20
9810707|NCT00662675|10920281|FG001|COMPLETED|Overall Study||20
9810708|NCT00662675|10920280|FG000|NOT COMPLETED|Overall Study||0
9810709|NCT00662675|10920281|FG001|NOT COMPLETED|Overall Study||0
9810710|NCT00662818|10920289|FG000|STARTED|Period 1 (6 Weeks)||84
9810711|NCT00662818|10920290|FG001|STARTED|Period 1 (6 Weeks)||81
9810712|NCT00662818|10920289|FG000|Treated|Period 1 (6 Weeks)||56
9810713|NCT00662818|10920290|FG001|Treated|Period 1 (6 Weeks)||58
9810714|NCT00662818|10920289|FG000|COMPLETED|Period 1 (6 Weeks)||56
9810715|NCT00662818|10920290|FG001|COMPLETED|Period 1 (6 Weeks)||58
9810716|NCT00662818|10920289|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28
9810717|NCT00662818|10920290|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23
9810718|NCT00662818|10920289|FG000|STARTED|Wash-Out (14 Days)||56
9810719|NCT00662818|10920290|FG001|STARTED|Wash-Out (14 Days)||58
9810720|NCT00662818|10920289|FG000|COMPLETED|Wash-Out (14 Days)||51
9810721|NCT00662818|10920290|FG001|COMPLETED|Wash-Out (14 Days)||53
9810722|NCT00662818|10920289|FG000|NOT COMPLETED|Wash-Out (14 Days)||5
9810723|NCT00662818|10920290|FG001|NOT COMPLETED|Wash-Out (14 Days)||5
9810724|NCT00662818|10920289|FG000|STARTED|Period 2 (6 Weeks)||51
9810725|NCT00662818|10920290|FG001|STARTED|Period 2 (6 Weeks)||53
9810726|NCT00662818|10920289|FG000|COMPLETED|Period 2 (6 Weeks)||38
9810727|NCT00662818|10920290|FG001|COMPLETED|Period 2 (6 Weeks)||41
9810728|NCT00662818|10920289|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13
9810729|NCT00662818|10920290|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12
9810730|NCT00662831|10920300|FG000|STARTED|Overall Study||184
9810731|NCT00662831|10920301|FG001|STARTED|Overall Study||92
9810732|NCT00662831|10920300|FG000|COMPLETED|Overall Study||78
9810733|NCT00662831|10920301|FG001|COMPLETED|Overall Study||33
9810734|NCT00662831|10920300|FG000|NOT COMPLETED|Overall Study||106
9810735|NCT00662831|10920301|FG001|NOT COMPLETED|Overall Study||59
9810736|NCT00662857|10920307|FG000|STARTED|TI Dosing Period 1 (1 Day)||13
9810737|NCT00662857|10920308|FG001|STARTED|TI Dosing Period 1 (1 Day)||16
9810738|NCT00662857|10920307|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13
9810739|NCT00662857|10920308|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16
9810740|NCT00662857|10920307|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
9810741|NCT00662857|10920308|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
9810742|NCT00662857|10920307|FG000|STARTED|Washout 1 (3 - 14 Days)||13
10235372|NCT01182610|11365674|FG000|NOT COMPLETED|Overall Study||0
10235373|NCT01189071|11365680|FG000|STARTED|Overall Study||0
10235374|NCT01189071|11365681|FG001|STARTED|Overall Study||0
10235375|NCT01189071|11365680|FG000|COMPLETED|Overall Study||0
10235376|NCT01189071|11365681|FG001|COMPLETED|Overall Study||0
10235377|NCT01189071|11365680|FG000|NOT COMPLETED|Overall Study||0
10235378|NCT01189071|11365681|FG001|NOT COMPLETED|Overall Study||0
10235379|NCT01183416|11365687|FG000|STARTED|Overall Study||4
10235380|NCT01183416|11365687|FG000|COMPLETED|Overall Study||4
10235381|NCT01183416|11365687|FG000|NOT COMPLETED|Overall Study||0
10235382|NCT01184456|11365693|FG000|STARTED|Overall Study||0
10235383|NCT01184456|11365694|FG001|STARTED|Overall Study||0
10235384|NCT01184456|11365693|FG000|COMPLETED|Overall Study||0
10235385|NCT01184456|11365694|FG001|COMPLETED|Overall Study||0
10235386|NCT01184456|11365693|FG000|NOT COMPLETED|Overall Study||0
10235387|NCT01184456|11365694|FG001|NOT COMPLETED|Overall Study||0
10235388|NCT01183221|11365702|FG000|STARTED|First Dose||15
10235389|NCT01183221|11365703|FG001|STARTED|First Dose||15
10235390|NCT01183221|11365702|FG000|COMPLETED|First Dose||15
10235391|NCT01183221|11365703|FG001|COMPLETED|First Dose||15
10235392|NCT01183221|11365702|FG000|NOT COMPLETED|First Dose||0
10235393|NCT01183221|11365703|FG001|NOT COMPLETED|First Dose||0
10235394|NCT01183221|11365702|FG000|STARTED|3 Weeks Wash Out||15
10235395|NCT01183221|11365703|FG001|STARTED|3 Weeks Wash Out||15
10235396|NCT01183221|11365702|FG000|COMPLETED|3 Weeks Wash Out||14
10235397|NCT01183221|11365703|FG001|COMPLETED|3 Weeks Wash Out||14
10235398|NCT01183221|11365702|FG000|NOT COMPLETED|3 Weeks Wash Out||1
10235399|NCT01183221|11365703|FG001|NOT COMPLETED|3 Weeks Wash Out||1
10235400|NCT01183221|11365702|FG000|STARTED|Second Dose||14
10235401|NCT01183221|11365703|FG001|STARTED|Second Dose||14
10235402|NCT01183221|11365702|FG000|COMPLETED|Second Dose||14
10235403|NCT01183221|11365703|FG001|COMPLETED|Second Dose||14
10235404|NCT01183221|11365702|FG000|NOT COMPLETED|Second Dose||0
10235405|NCT01183221|11365703|FG001|NOT COMPLETED|Second Dose||0
10235406|NCT01189227|11365711|FG000|STARTED|Overall Study||6
10235407|NCT01189227|11365712|FG001|STARTED|Overall Study||3
10235408|NCT01189227|11365711|FG000|COMPLETED|Overall Study||0
10235409|NCT01189227|11365712|FG001|COMPLETED|Overall Study||0
10235410|NCT01189227|11365711|FG000|NOT COMPLETED|Overall Study||6
10235411|NCT01189227|11365712|FG001|NOT COMPLETED|Overall Study||3
10235412|NCT01190306|11365720|FG000|STARTED|Overall Study||61
10235413|NCT01190306|11365721|FG001|STARTED|Overall Study||66
10235414|NCT01190306|11365720|FG000|COMPLETED|Overall Study||61
10235415|NCT01190306|11365721|FG001|COMPLETED|Overall Study||66
10235416|NCT01190306|11365720|FG000|NOT COMPLETED|Overall Study||0
9810743|NCT00662857|10920308|FG001|STARTED|Washout 1 (3 - 14 Days)||16
9810744|NCT00662857|10920307|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13
9810745|NCT00662857|10920308|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14
9810746|NCT00662857|10920307|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
9810747|NCT00662857|10920308|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
9810748|NCT00662857|10920307|FG000|STARTED|TI Dosing Period 2 (1 Day)||13
9810749|NCT00662857|10920308|FG001|STARTED|TI Dosing Period 2 (1 Day)||14
9810750|NCT00662857|10920307|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13
9810751|NCT00662857|10920308|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14
9810752|NCT00662857|10920307|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
9810753|NCT00662857|10920308|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
9810754|NCT00662857|10920307|FG000|STARTED|Washout 2 (3 - 14 Days)||13
9810755|NCT00662857|10920308|FG001|STARTED|Washout 2 (3 - 14 Days)||14
9810756|NCT00662857|10920307|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12
10235417|NCT01190306|11365721|FG001|NOT COMPLETED|Overall Study||0
10235418|NCT01179737|11365731|FG000|STARTED|Cohort 1 & Cohort 2||12
10235419|NCT01179737|11365732|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
10235420|NCT01179737|11365733|FG002|STARTED|Cohort 1 & Cohort 2||4
10235421|NCT01179737|11365734|FG003|STARTED|Cohort 1 & Cohort 2||4
10235422|NCT01179737|11365731|FG000|COMPLETED|Cohort 1 & Cohort 2||7
10235423|NCT01179737|11365732|FG001|COMPLETED|Cohort 1 & Cohort 2||1
10235424|NCT01179737|11365733|FG002|COMPLETED|Cohort 1 & Cohort 2||0
10235425|NCT01179737|11365734|FG003|COMPLETED|Cohort 1 & Cohort 2||0
10235426|NCT01179737|11365731|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5
10235427|NCT01179737|11365732|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2
10235428|NCT01179737|11365733|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4
10235429|NCT01179737|11365734|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4
10235430|NCT01179737|11365731|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
10235431|NCT01179737|11365732|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1
10235432|NCT01179737|11365733|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0
10235433|NCT01179737|11365734|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0
10235434|NCT01179737|11365731|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
10235435|NCT01179737|11365732|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
9810757|NCT00662857|10920308|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14
10235436|NCT01179737|11365733|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10235437|NCT01179737|11365734|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10235438|NCT01179737|11365731|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
10235439|NCT01179737|11365732|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10235440|NCT01179737|11365733|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10235441|NCT01179737|11365734|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10235442|NCT01179737|11365731|FG000|STARTED|Extension|Two patients did not enrol in the extension|3
10235443|NCT01179737|11365732|FG001|STARTED|Extension|One patient did not enrol in the extension|0
9810758|NCT00662857|10920307|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
9810759|NCT00662857|10920308|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
9810760|NCT00662857|10920307|FG000|STARTED|Lispro Dosing Period (1 Day)||12
9810761|NCT00662857|10920308|FG001|STARTED|Lispro Dosing Period (1 Day)||14
9810762|NCT00662857|10920307|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12
9810763|NCT00662857|10920308|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14
9810764|NCT00662857|10920307|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
9810765|NCT00662857|10920308|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
9810766|NCT00662909|10920320|FG000|STARTED|Overall Study||454
9810767|NCT00662909|10920321|FG001|STARTED|Overall Study||442
9810768|NCT00662909|10920322|FG002|STARTED|Overall Study||433
9810769|NCT00662909|10920320|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
9810770|NCT00662909|10920321|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
9810771|NCT00662909|10920322|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
9810772|NCT00662909|10920320|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
9810773|NCT00662909|10920321|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
9810774|NCT00662909|10920322|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
9810775|NCT00662909|10920320|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
9810776|NCT00662909|10920321|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
9810777|NCT00662909|10920322|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
9810778|NCT00662909|10920320|FG000|COMPLETED|Overall Study||385
9810779|NCT00662909|10920321|FG001|COMPLETED|Overall Study||383
9810780|NCT00662909|10920322|FG002|COMPLETED|Overall Study||380
10016374|NCT01809262|11139187|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4
10016375|NCT01809262|11139188|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3
10016376|NCT01809262|11139189|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3
10016377|NCT01809262|11139190|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3
10016378|NCT01809262|11139191|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3
10016379|NCT01809262|11139192|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4
10016380|NCT01809262|11139193|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3
10016381|NCT01809262|11139194|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4
10016382|NCT01809262|11139185|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10016383|NCT01809262|11139186|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10016384|NCT01809262|11139187|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10016385|NCT01809262|11139188|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10016386|NCT01809262|11139189|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10016387|NCT01809262|11139190|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10016388|NCT01809262|11139191|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10016389|NCT01809262|11139192|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10016390|NCT01809262|11139193|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10016391|NCT01809262|11139194|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10016392|NCT01809262|11139185|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016393|NCT01809262|11139186|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016394|NCT01809262|11139187|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016395|NCT01809262|11139188|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016396|NCT01809262|11139189|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016397|NCT01809262|11139190|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016398|NCT01809262|11139191|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016399|NCT01809262|11139192|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016400|NCT01809262|11139193|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016401|NCT01809262|11139194|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10016402|NCT01809314|11139206|FG000|STARTED|Overall Study||1167
10016403|NCT01809314|11139206|FG000|COMPLETED|Overall Study||422
10112267|NCT02502149|11243312|FG003|COMPLETED|Treatment Period||11
10112268|NCT02502149|11243313|FG004|COMPLETED|Treatment Period||12
10112269|NCT02502149|11243309|FG000|NOT COMPLETED|Treatment Period||0
10112270|NCT02502149|11243310|FG001|NOT COMPLETED|Treatment Period||0
10112271|NCT02502149|11243311|FG002|NOT COMPLETED|Treatment Period||0
10112272|NCT02502149|11243312|FG003|NOT COMPLETED|Treatment Period||0
10112273|NCT02502149|11243313|FG004|NOT COMPLETED|Treatment Period||0
10112274|NCT02502461|11243332|FG000|STARTED|Overall Study||46
10016404|NCT01809314|11139206|FG000|NOT COMPLETED|Overall Study||745
10016405|NCT01809327|11139215|FG000|STARTED|Overall Study||237
10016406|NCT01809327|11139216|FG001|STARTED|Overall Study||237
10016407|NCT01809327|11139217|FG002|STARTED|Overall Study||238
10016408|NCT01809327|11139218|FG003|STARTED|Overall Study||237
10016409|NCT01809327|11139219|FG004|STARTED|Overall Study||237
10016410|NCT01809327|11139215|FG000|COMPLETED|Overall Study||205
10016411|NCT01809327|11139216|FG001|COMPLETED|Overall Study||211
10016412|NCT01809327|11139217|FG002|COMPLETED|Overall Study||216
10016413|NCT01809327|11139218|FG003|COMPLETED|Overall Study||225
10112275|NCT02502461|11243333|FG001|STARTED|Overall Study||44
10112276|NCT02502461|11243332|FG000|COMPLETED|Overall Study||46
10016414|NCT01809327|11139219|FG004|COMPLETED|Overall Study||212
10016415|NCT01809327|11139215|FG000|NOT COMPLETED|Overall Study||32
10016416|NCT01809327|11139216|FG001|NOT COMPLETED|Overall Study||26
10016417|NCT01809327|11139217|FG002|NOT COMPLETED|Overall Study||22
10016418|NCT01809327|11139218|FG003|NOT COMPLETED|Overall Study||12
10016419|NCT01809327|11139219|FG004|NOT COMPLETED|Overall Study||25
10016420|NCT01809639|11139233|FG000|STARTED|Overall Study||18
10016421|NCT01809639|11139234|FG001|STARTED|Overall Study||7
10016422|NCT01809639|11139233|FG000|COMPLETED|Overall Study||18
10016423|NCT01809639|11139234|FG001|COMPLETED|Overall Study||7
10016424|NCT01809639|11139233|FG000|NOT COMPLETED|Overall Study||0
10016425|NCT01809639|11139234|FG001|NOT COMPLETED|Overall Study||0
10016426|NCT01809834|11139240|FG000|STARTED|Overall Study||44
10016427|NCT01809834|11139240|FG000|COMPLETED|Overall Study||44
10016428|NCT01809834|11139240|FG000|NOT COMPLETED|Overall Study||0
10112277|NCT02502461|11243333|FG001|COMPLETED|Overall Study||44
10112278|NCT02502461|11243332|FG000|NOT COMPLETED|Overall Study||0
10112279|NCT02502461|11243333|FG001|NOT COMPLETED|Overall Study||0
10112280|NCT02502487|11243342|FG000|STARTED|Overall Study||86
10112281|NCT02502487|11243343|FG001|STARTED|Overall Study||86
10112282|NCT02502487|11243344|FG002|STARTED|Overall Study||86
9810781|NCT00662909|10920320|FG000|NOT COMPLETED|Overall Study||69
9810782|NCT00662909|10920321|FG001|NOT COMPLETED|Overall Study||59
9810783|NCT00662909|10920322|FG002|NOT COMPLETED|Overall Study||53
9810784|NCT00663026|10920333|FG000|STARTED|Overall Study||19
9810785|NCT00663026|10920334|FG001|STARTED|Overall Study||29
9810786|NCT00663026|10920335|FG002|STARTED|Overall Study||31
9810787|NCT00663026|10920333|FG000|COMPLETED|Overall Study||17
9810788|NCT00663026|10920334|FG001|COMPLETED|Overall Study||23
9810789|NCT00663026|10920335|FG002|COMPLETED|Overall Study||27
9810790|NCT00663026|10920333|FG000|NOT COMPLETED|Overall Study||2
9810791|NCT00663026|10920334|FG001|NOT COMPLETED|Overall Study||6
9810792|NCT00663026|10920335|FG002|NOT COMPLETED|Overall Study||4
9810793|NCT00663039|10920345|FG000|STARTED|Overall Study||14
9810794|NCT00663039|10920346|FG001|STARTED|Overall Study||13
9810795|NCT00663039|10920345|FG000|COMPLETED|Overall Study||10
9810796|NCT00663039|10920346|FG001|COMPLETED|Overall Study||9
9810797|NCT00663039|10920345|FG000|NOT COMPLETED|Overall Study||4
9810798|NCT00663039|10920346|FG001|NOT COMPLETED|Overall Study||4
9810799|NCT00663117|10920354|FG000|STARTED|Overall Study||20
9810800|NCT00663117|10920355|FG001|STARTED|Overall Study||20
9810801|NCT00663117|10920354|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
9810802|NCT00663117|10920355|FG001|COMPLETED|Overall Study||20
9810803|NCT00663117|10920354|FG000|NOT COMPLETED|Overall Study||1
9810804|NCT00663117|10920355|FG001|NOT COMPLETED|Overall Study||0
9810805|NCT00663169|10920369|FG000|STARTED|Overall Study||3
9810806|NCT00663169|10920370|FG001|STARTED|Overall Study||3
9810807|NCT00663169|10920369|FG000|COMPLETED|Overall Study||3
9810808|NCT00663169|10920370|FG001|COMPLETED|Overall Study||3
9810809|NCT00663169|10920369|FG000|NOT COMPLETED|Overall Study||0
9810810|NCT00663169|10920370|FG001|NOT COMPLETED|Overall Study||0
9810811|NCT00663208|10920383|FG000|STARTED|Treatment Period||4
9810812|NCT00663208|10920384|FG001|STARTED|Treatment Period||4
9810813|NCT00663208|10920385|FG002|STARTED|Treatment Period||4
9810814|NCT00663208|10920386|FG003|STARTED|Treatment Period||4
9810815|NCT00663208|10920387|FG004|STARTED|Treatment Period||4
9810816|NCT00663208|10920388|FG005|STARTED|Treatment Period||4
9810817|NCT00663208|10920389|FG006|STARTED|Treatment Period||6
9810818|NCT00663208|10920383|FG000|COMPLETED|Treatment Period||4
9810819|NCT00663208|10920384|FG001|COMPLETED|Treatment Period||3
9810820|NCT00663208|10920385|FG002|COMPLETED|Treatment Period||4
9810821|NCT00663208|10920386|FG003|COMPLETED|Treatment Period||4
9810822|NCT00663208|10920387|FG004|COMPLETED|Treatment Period||4
9810823|NCT00663208|10920388|FG005|COMPLETED|Treatment Period||4
9810824|NCT00663208|10920389|FG006|COMPLETED|Treatment Period||6
9810825|NCT00663208|10920383|FG000|NOT COMPLETED|Treatment Period||0
9810826|NCT00663208|10920384|FG001|NOT COMPLETED|Treatment Period||1
9810827|NCT00663208|10920385|FG002|NOT COMPLETED|Treatment Period||0
9810828|NCT00663208|10920386|FG003|NOT COMPLETED|Treatment Period||0
10112283|NCT02502487|11243342|FG000|COMPLETED|Overall Study||86
10112284|NCT02502487|11243343|FG001|COMPLETED|Overall Study||86
10112285|NCT02502487|11243344|FG002|COMPLETED|Overall Study||86
10112286|NCT02502487|11243342|FG000|NOT COMPLETED|Overall Study||0
9810829|NCT00663208|10920387|FG004|NOT COMPLETED|Treatment Period||0
9810830|NCT00663208|10920388|FG005|NOT COMPLETED|Treatment Period||0
9810831|NCT00663208|10920389|FG006|NOT COMPLETED|Treatment Period||0
9810832|NCT00663208|10920383|FG000|STARTED|Follow-up Period||4
9810833|NCT00663208|10920384|FG001|STARTED|Follow-up Period||3
9810834|NCT00663208|10920385|FG002|STARTED|Follow-up Period||4
9810835|NCT00663208|10920386|FG003|STARTED|Follow-up Period||4
9810836|NCT00663208|10920387|FG004|STARTED|Follow-up Period||4
9810837|NCT00663208|10920388|FG005|STARTED|Follow-up Period||4
9810838|NCT00663208|10920389|FG006|STARTED|Follow-up Period||6
9810839|NCT00663208|10920383|FG000|COMPLETED|Follow-up Period||1
9810840|NCT00663208|10920384|FG001|COMPLETED|Follow-up Period||3
9810841|NCT00663208|10920385|FG002|COMPLETED|Follow-up Period||1
10112287|NCT02502487|11243343|FG001|NOT COMPLETED|Overall Study||0
9810842|NCT00663208|10920386|FG003|COMPLETED|Follow-up Period||2
10016429|NCT01809938|11139246|FG000|STARTED|First Intervention (170 Minutes)||5
10016430|NCT01809938|11139247|FG001|STARTED|First Intervention (170 Minutes)||5
10112288|NCT02502487|11243344|FG002|NOT COMPLETED|Overall Study||0
9810843|NCT00663208|10920387|FG004|COMPLETED|Follow-up Period||4
10016431|NCT01809938|11139246|FG000|COMPLETED|First Intervention (170 Minutes)||5
10112289|NCT02502526|11243355|FG000|STARTED|Overall Study||62
9810844|NCT00663208|10920388|FG005|COMPLETED|Follow-up Period||4
9810845|NCT00663208|10920389|FG006|COMPLETED|Follow-up Period||5
9810846|NCT00663208|10920383|FG000|NOT COMPLETED|Follow-up Period||3
9810847|NCT00663208|10920384|FG001|NOT COMPLETED|Follow-up Period||0
9810848|NCT00663208|10920385|FG002|NOT COMPLETED|Follow-up Period||3
9810849|NCT00663208|10920386|FG003|NOT COMPLETED|Follow-up Period||2
9810850|NCT00663208|10920387|FG004|NOT COMPLETED|Follow-up Period||0
9810851|NCT00663208|10920388|FG005|NOT COMPLETED|Follow-up Period||0
9810852|NCT00663208|10920389|FG006|NOT COMPLETED|Follow-up Period||1
9810853|NCT00663234|10920407|FG000|STARTED|Overall Study||28
9810854|NCT00663234|10920407|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10
9810855|NCT00663234|10920407|FG000|COMPLETED|Overall Study||27
9810856|NCT00663234|10920407|FG000|NOT COMPLETED|Overall Study||1
9810857|NCT00663260|10920418|FG000|STARTED|Overall Study||84
9810858|NCT00663260|10920419|FG001|STARTED|Overall Study||83
9810859|NCT00663260|10920420|FG002|STARTED|Overall Study||85
9810860|NCT00663260|10920418|FG000|COMPLETED|Overall Study||63
9810861|NCT00663260|10920419|FG001|COMPLETED|Overall Study||72
9810862|NCT00663260|10920420|FG002|COMPLETED|Overall Study||69
9810863|NCT00663260|10920418|FG000|NOT COMPLETED|Overall Study||21
9810864|NCT00663260|10920419|FG001|NOT COMPLETED|Overall Study||11
9810865|NCT00663260|10920420|FG002|NOT COMPLETED|Overall Study||16
9810866|NCT00663403|10920428|FG000|STARTED|Overall Study||8
9810867|NCT00663403|10920428|FG000|COMPLETED|Overall Study||8
10016432|NCT01809938|11139247|FG001|COMPLETED|First Intervention (170 Minutes)||5
10016433|NCT01809938|11139246|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0
10016434|NCT01809938|11139247|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0
10016435|NCT01809938|11139246|FG000|STARTED|Washout (Not Less Than 24 Hours)||5
10016436|NCT01809938|11139247|FG001|STARTED|Washout (Not Less Than 24 Hours)||5
10016437|NCT01809938|11139246|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5
9810868|NCT00663403|10920428|FG000|NOT COMPLETED|Overall Study||0
9810869|NCT00663702|10920434|FG000|STARTED|Overall Study||52
9810870|NCT00663702|10920435|FG001|STARTED|Overall Study||71
9810871|NCT00663702|10920434|FG000|COMPLETED|Overall Study||34
9810872|NCT00663702|10920435|FG001|COMPLETED|Overall Study||61
9810873|NCT00663702|10920434|FG000|NOT COMPLETED|Overall Study||18
9810874|NCT00663702|10920435|FG001|NOT COMPLETED|Overall Study||10
9810875|NCT00663793|10920443|FG000|STARTED|Overall Study||8
9810876|NCT00663793|10920444|FG001|STARTED|Overall Study||8
9810877|NCT00663793|10920443|FG000|COMPLETED|Overall Study||8
9810878|NCT00663793|10920444|FG001|COMPLETED|Overall Study||8
10016438|NCT01809938|11139247|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5
10016439|NCT01809938|11139246|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
10016440|NCT01809938|11139247|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
10016441|NCT01809938|11139246|FG000|STARTED|Second Intervention (170 Minutes)||5
10016442|NCT01809938|11139247|FG001|STARTED|Second Intervention (170 Minutes)||5
10016443|NCT01809938|11139246|FG000|COMPLETED|Second Intervention (170 Minutes)||5
10016444|NCT01809938|11139247|FG001|COMPLETED|Second Intervention (170 Minutes)||5
10016445|NCT01809938|11139246|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0
10016446|NCT01809938|11139247|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0
10016447|NCT01810016|11139255|FG000|STARTED|Overall Study||5
9810879|NCT00663793|10920443|FG000|NOT COMPLETED|Overall Study||0
9810880|NCT00663793|10920444|FG001|NOT COMPLETED|Overall Study||0
9810881|NCT00663819|10920452|FG000|STARTED|Overall Study||123
9810882|NCT00663819|10920453|FG001|STARTED|Overall Study||135
9810883|NCT00663819|10920452|FG000|COMPLETED|Overall Study||123
9810884|NCT00663819|10920453|FG001|COMPLETED|Overall Study||135
9810885|NCT00663819|10920452|FG000|NOT COMPLETED|Overall Study||0
9810886|NCT00663819|10920453|FG001|NOT COMPLETED|Overall Study||0
9810887|NCT00663858|10920464|FG000|STARTED|Overall Study||212
9810888|NCT00663858|10920465|FG001|STARTED|Overall Study||106
9810889|NCT00663858|10920466|FG002|STARTED|Overall Study||102
9810890|NCT00663858|10920464|FG000|COMPLETED|Overall Study||178
9810891|NCT00663858|10920465|FG001|COMPLETED|Overall Study||96
9810892|NCT00663858|10920466|FG002|COMPLETED|Overall Study||82
9810893|NCT00663858|10920464|FG000|NOT COMPLETED|Overall Study||34
9810894|NCT00663858|10920465|FG001|NOT COMPLETED|Overall Study||10
9810895|NCT00663858|10920466|FG002|NOT COMPLETED|Overall Study||20
9810896|NCT00663871|10920476|FG000|STARTED|Overall Study||134
9810897|NCT00663871|10920477|FG001|STARTED|Overall Study||138
9810898|NCT00663871|10920476|FG000|COMPLETED|Overall Study||124
9810899|NCT00663871|10920477|FG001|COMPLETED|Overall Study||131
9810900|NCT00663871|10920476|FG000|NOT COMPLETED|Overall Study||10
10016448|NCT01810016|11139256|FG001|STARTED|Overall Study||2
10016449|NCT01810016|11139257|FG002|STARTED|Overall Study||1
10016450|NCT01810016|11139255|FG000|COMPLETED|Overall Study||4
10016451|NCT01810016|11139256|FG001|COMPLETED|Overall Study||1
9810901|NCT00663871|10920477|FG001|NOT COMPLETED|Overall Study||7
9810902|NCT00663923|10920485|FG000|STARTED|Overall Study||50
9810903|NCT00663923|10920485|FG000|COMPLETED|Overall Study||48
9810904|NCT00663923|10920485|FG000|NOT COMPLETED|Overall Study||2
9810905|NCT00663962|10920493|FG000|STARTED|Overall Study||7
9810906|NCT00663962|10920494|FG001|STARTED|Overall Study||8
9810907|NCT00663962|10920493|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
9810908|NCT00663962|10920494|FG001|COMPLETED|Overall Study||8
9810909|NCT00663962|10920493|FG000|NOT COMPLETED|Overall Study||1
9810910|NCT00663962|10920494|FG001|NOT COMPLETED|Overall Study||0
9810911|NCT00664105|10920500|FG000|STARTED|Overall Study||63
9810912|NCT00664105|10920500|FG000|COMPLETED|Overall Study||39
9810913|NCT00664105|10920500|FG000|NOT COMPLETED|Overall Study||24
9810914|NCT00664209|10920505|FG000|STARTED|Motor Fluctuations Screen||13
9810915|NCT00664209|10920505|FG000|COMPLETED|Motor Fluctuations Screen||6
9810916|NCT00664209|10920505|FG000|NOT COMPLETED|Motor Fluctuations Screen||7
9810917|NCT00664209|10920505|FG000|STARTED|Study Treatment Period||6
9810918|NCT00664209|10920505|FG000|COMPLETED|Study Treatment Period||0
9810919|NCT00664209|10920505|FG000|NOT COMPLETED|Study Treatment Period||6
9810920|NCT00664326|10920510|FG000|STARTED|Overall Study||49
9810921|NCT00664326|10920510|FG000|COMPLETED|Overall Study|transitioned to rollover study|1
9810922|NCT00664326|10920510|FG000|NOT COMPLETED|Overall Study||48
9810923|NCT00664430|10920514|FG000|STARTED|Overall Study||13
9810924|NCT00664430|10920514|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
9810925|NCT00664430|10920514|FG000|NOT COMPLETED|Overall Study||13
9952890|NCT01424397|11071759|FG011|NOT COMPLETED|Period-3 (8 Days)||0
9952891|NCT01424501|11071779|FG000|STARTED|Overall Study||7
9952892|NCT01424501|11071780|FG001|STARTED|Overall Study||6
9952893|NCT01424501|11071781|FG002|STARTED|Overall Study||24
9952894|NCT01424501|11071782|FG003|STARTED|Overall Study||25
9952895|NCT01424501|11071783|FG004|STARTED|Overall Study||40
9952896|NCT01424501|11071784|FG005|STARTED|Overall Study||40
9952897|NCT01424501|11071779|FG000|COMPLETED|Overall Study||6
9952898|NCT01424501|11071780|FG001|COMPLETED|Overall Study||5
9952899|NCT01424501|11071781|FG002|COMPLETED|Overall Study||22
9952900|NCT01424501|11071782|FG003|COMPLETED|Overall Study||25
9810926|NCT00664521|10920520|FG000|STARTED|Overall Study||18
9810927|NCT00664521|10920521|FG001|STARTED|Overall Study||9
9810928|NCT00664521|10920520|FG000|COMPLETED|Overall Study||12
9810929|NCT00664521|10920521|FG001|COMPLETED|Overall Study||8
9810930|NCT00664521|10920520|FG000|NOT COMPLETED|Overall Study||6
9810931|NCT00664521|10920521|FG001|NOT COMPLETED|Overall Study||1
9810932|NCT00664534|10920529|FG000|STARTED|Overall Study||173
9810933|NCT00664534|10920530|FG001|STARTED|Overall Study||171
9810934|NCT00664534|10920529|FG000|COMPLETED|Overall Study||132
9810935|NCT00664534|10920530|FG001|COMPLETED|Overall Study||138
9810936|NCT00664534|10920529|FG000|NOT COMPLETED|Overall Study||41
9810937|NCT00664534|10920530|FG001|NOT COMPLETED|Overall Study||33
9810938|NCT00664560|10920539|FG000|STARTED|Overall Study|Safety Population|247
9810939|NCT00664560|10920540|FG001|STARTED|Overall Study|Safety Population|243
9810940|NCT00664560|10920541|FG002|STARTED|Overall Study|Safety Population|124
9810941|NCT00664560|10920539|FG000|COMPLETED|Overall Study||208
9810942|NCT00664560|10920540|FG001|COMPLETED|Overall Study||208
9810943|NCT00664560|10920541|FG002|COMPLETED|Overall Study||105
9810944|NCT00664560|10920539|FG000|NOT COMPLETED|Overall Study||39
9810945|NCT00664560|10920540|FG001|NOT COMPLETED|Overall Study||35
9810946|NCT00664560|10920541|FG002|NOT COMPLETED|Overall Study||19
9810947|NCT00664742|10920549|FG000|STARTED|Overall Study||607
9810948|NCT00664742|10920549|FG000|COMPLETED|Overall Study||481
9810949|NCT00664742|10920549|FG000|NOT COMPLETED|Overall Study||126
9810950|NCT00664755|10920555|FG000|STARTED|Overall Study||67
9810951|NCT00664755|10920556|FG001|STARTED|Overall Study||73
9810952|NCT00664755|10920555|FG000|COMPLETED|Overall Study||67
9810953|NCT00664755|10920556|FG001|COMPLETED|Overall Study||73
9810954|NCT00664755|10920555|FG000|NOT COMPLETED|Overall Study||0
9810955|NCT00664755|10920556|FG001|NOT COMPLETED|Overall Study||0
9810956|NCT00664859|10920565|FG000|STARTED|Overall Study||51
9810957|NCT00664859|10920566|FG001|STARTED|Overall Study||45
9810958|NCT00664859|10920567|FG002|STARTED|Overall Study||44
9810959|NCT00664859|10920565|FG000|COMPLETED|Overall Study||34
9810960|NCT00664859|10920566|FG001|COMPLETED|Overall Study||35
9810961|NCT00664859|10920567|FG002|COMPLETED|Overall Study||23
9810962|NCT00664859|10920565|FG000|NOT COMPLETED|Overall Study||17
9810963|NCT00664859|10920566|FG001|NOT COMPLETED|Overall Study||10
9810964|NCT00664859|10920567|FG002|NOT COMPLETED|Overall Study||21
9810965|NCT00665002|10920575|FG000|STARTED|Overall Study||16
9810966|NCT00665002|10920575|FG000|COMPLETED|Overall Study||4
9810967|NCT00665002|10920575|FG000|NOT COMPLETED|Overall Study||12
9810968|NCT00665132|10920579|FG000|STARTED|Overall Study||10
9810969|NCT00665132|10920579|FG000|COMPLETED|Overall Study||10
9810970|NCT00665132|10920579|FG000|NOT COMPLETED|Overall Study||0
9810971|NCT00665353|10920583|FG000|STARTED|Study Step 1||19
9810972|NCT00665353|10920583|FG000|COMPLETED|Study Step 1||16
9810973|NCT00665353|10920583|FG000|NOT COMPLETED|Study Step 1||3
9810974|NCT00665353|10920583|FG000|STARTED|Study Step 2||16
9810975|NCT00665353|10920583|FG000|COMPLETED|Study Step 2||2
9810976|NCT00665353|10920583|FG000|NOT COMPLETED|Study Step 2||14
9810977|NCT00665366|10920589|FG000|STARTED|Overall Study|Participants randomized|189
9810978|NCT00665366|10920590|FG001|STARTED|Overall Study|Participants randomized|181
9810979|NCT00665366|10920589|FG000|COMPLETED|Overall Study||131
9810980|NCT00665366|10920590|FG001|COMPLETED|Overall Study||122
9810981|NCT00665366|10920589|FG000|NOT COMPLETED|Overall Study||58
9810982|NCT00665366|10920590|FG001|NOT COMPLETED|Overall Study||59
9952901|NCT01424501|11071783|FG004|COMPLETED|Overall Study||40
9952902|NCT01424501|11071784|FG005|COMPLETED|Overall Study||40
9952903|NCT01424501|11071779|FG000|NOT COMPLETED|Overall Study||1
9952904|NCT01424501|11071780|FG001|NOT COMPLETED|Overall Study||1
9810983|NCT00665392|10920596|FG000|STARTED|Overall Study||42
9810984|NCT00665392|10920596|FG000|COMPLETED|Overall Study||41
9810985|NCT00665392|10920596|FG000|NOT COMPLETED|Overall Study||1
9810986|NCT00665431|10920604|FG000|STARTED|Overall Study|Safety population|243
9810987|NCT00665431|10920605|FG001|STARTED|Overall Study|Safety population|245
9952905|NCT01424501|11071781|FG002|NOT COMPLETED|Overall Study||2
9810988|NCT00665431|10920606|FG002|STARTED|Overall Study|Safety population|122
9810989|NCT00665431|10920604|FG000|COMPLETED|Overall Study||203
9810990|NCT00665431|10920605|FG001|COMPLETED|Overall Study||188
9810991|NCT00665431|10920606|FG002|COMPLETED|Overall Study||98
9810992|NCT00665431|10920604|FG000|NOT COMPLETED|Overall Study||40
9810993|NCT00665431|10920605|FG001|NOT COMPLETED|Overall Study||57
9810994|NCT00665431|10920606|FG002|NOT COMPLETED|Overall Study||24
9810995|NCT00665457|10920614|FG000|STARTED|Overall Study||3
9810996|NCT00665457|10920614|FG000|COMPLETED|Overall Study||3
9810997|NCT00665457|10920614|FG000|NOT COMPLETED|Overall Study||0
9810998|NCT00665470|10920620|FG000|STARTED|Overall Study||10
9810999|NCT00665470|10920621|FG001|STARTED|Overall Study||0
9811000|NCT00665470|10920620|FG000|COMPLETED|Overall Study||10
9811001|NCT00665470|10920621|FG001|COMPLETED|Overall Study||0
9811002|NCT00665470|10920620|FG000|NOT COMPLETED|Overall Study||0
9811003|NCT00665470|10920621|FG001|NOT COMPLETED|Overall Study||0
9811004|NCT00665561|10920629|FG000|STARTED|Overall Study||1316
9811005|NCT00665561|10920630|FG001|STARTED|Overall Study||1130
9811006|NCT00665561|10920629|FG000|COMPLETED|Overall Study||814
9811007|NCT00665561|10920630|FG001|COMPLETED|Overall Study||596
9811008|NCT00665561|10920629|FG000|NOT COMPLETED|Overall Study||502
9811009|NCT00665561|10920630|FG001|NOT COMPLETED|Overall Study||534
9811010|NCT00665626|10920638|FG000|STARTED|Overall Study|Participants randomized|73
9811011|NCT00665626|10920639|FG001|STARTED|Overall Study|Participants randomized|146
9811012|NCT00665626|10920638|FG000|COMPLETED|Overall Study|Participants completed the study|63
9811013|NCT00665626|10920639|FG001|COMPLETED|Overall Study|Participants completed the study|124
9811014|NCT00665626|10920638|FG000|NOT COMPLETED|Overall Study||10
9811015|NCT00665626|10920639|FG001|NOT COMPLETED|Overall Study||22
9811016|NCT00665652|10920645|FG000|STARTED|Overall Study||8
9811017|NCT00665652|10920645|FG000|COMPLETED|Overall Study||2
9811018|NCT00665652|10920645|FG000|NOT COMPLETED|Overall Study||6
9811019|NCT00665704|10920649|FG000|STARTED|Overall Study||9
9811020|NCT00665704|10920649|FG000|COMPLETED|Overall Study||9
9811021|NCT00665704|10920649|FG000|NOT COMPLETED|Overall Study||0
9811022|NCT00665847|10920653|FG000|STARTED|Overall Study||101
9811023|NCT00665847|10920653|FG000|COMPLETED|Overall Study||76
9811024|NCT00665847|10920653|FG000|NOT COMPLETED|Overall Study||25
9811025|NCT00665925|10920661|FG000|STARTED|Overall Study|Participants randomized|77
9811026|NCT00665925|10920662|FG001|STARTED|Overall Study|Participants randomized|76
9811027|NCT00665925|10920663|FG002|STARTED|Overall Study|Participants randomized|152
9811028|NCT00665925|10920664|FG003|STARTED|Overall Study|Participants randomized|152
9811029|NCT00665925|10920661|FG000|COMPLETED|Overall Study|Participants completed the study|62
9811030|NCT00665925|10920662|FG001|COMPLETED|Overall Study|Participants completed the study|59
9811031|NCT00665925|10920663|FG002|COMPLETED|Overall Study|Participants completed the study|126
9811032|NCT00665925|10920664|FG003|COMPLETED|Overall Study|Participants completed the study|131
9811033|NCT00665925|10920661|FG000|NOT COMPLETED|Overall Study||15
9811034|NCT00665925|10920662|FG001|NOT COMPLETED|Overall Study||17
9811035|NCT00665925|10920663|FG002|NOT COMPLETED|Overall Study||26
9811036|NCT00665925|10920664|FG003|NOT COMPLETED|Overall Study||21
9811037|NCT00666029|10920677|FG000|STARTED|Overall Study||20
9811038|NCT00666029|10920678|FG001|STARTED|Overall Study||20
9811039|NCT00666029|10920677|FG000|COMPLETED|Overall Study||19
9811040|NCT00666029|10920678|FG001|COMPLETED|Overall Study||20
9811041|NCT00666029|10920677|FG000|NOT COMPLETED|Overall Study||1
9811042|NCT00666029|10920678|FG001|NOT COMPLETED|Overall Study||0
9811043|NCT00666198|10920685|FG000|STARTED|Overall Study||3337
9811044|NCT00666198|10920685|FG000|COMPLETED|Overall Study||3304
9811045|NCT00666198|10920685|FG000|NOT COMPLETED|Overall Study||33
9811046|NCT00666211|10920691|FG000|STARTED|Overall Study||42
9811047|NCT00666211|10920692|FG001|STARTED|Overall Study||56
9811048|NCT00666211|10920691|FG000|COMPLETED|Overall Study||22
9811049|NCT00666211|10920692|FG001|COMPLETED|Overall Study||18
9811050|NCT00666211|10920691|FG000|NOT COMPLETED|Overall Study||20
9811051|NCT00666211|10920692|FG001|NOT COMPLETED|Overall Study||38
9811052|NCT00666224|10920700|FG000|STARTED|Double-Blind||243
9811053|NCT00666224|10920701|FG001|STARTED|Double-Blind||238
9811054|NCT00666224|10920700|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
9811055|NCT00666224|10920701|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
9811056|NCT00666224|10920700|FG000|NOT COMPLETED|Double-Blind||45
9811057|NCT00666224|10920701|FG001|NOT COMPLETED|Double-Blind||27
9811058|NCT00666224|10920700|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
9811059|NCT00666224|10920701|FG001|STARTED|Open-Label||211
9811060|NCT00666224|10920700|FG000|COMPLETED|Open-Label||163
9811061|NCT00666224|10920701|FG001|COMPLETED|Open-Label||126
9811062|NCT00666224|10920700|FG000|NOT COMPLETED|Open-Label||35
9811063|NCT00666224|10920701|FG001|NOT COMPLETED|Open-Label||85
9811064|NCT00666263|10920708|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22
9811065|NCT00666263|10920709|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22
9811066|NCT00666263|10920708|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
9811067|NCT00666263|10920709|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
9811068|NCT00666263|10920708|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
9811069|NCT00666263|10920709|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
9811070|NCT00666263|10920708|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22
9811071|NCT00666263|10920709|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21
9811072|NCT00666263|10920708|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22
9811073|NCT00666263|10920709|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21
9811074|NCT00666263|10920708|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
9811075|NCT00666263|10920709|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
9811076|NCT00666263|10920708|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22
10016452|NCT01810016|11139257|FG002|COMPLETED|Overall Study||0
10016453|NCT01810016|11139255|FG000|NOT COMPLETED|Overall Study||1
9811077|NCT00666263|10920709|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21
9811078|NCT00666263|10920708|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
9811079|NCT00666263|10920709|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
9811080|NCT00666263|10920708|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
9811081|NCT00666263|10920709|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
9811082|NCT00666263|10920708|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22
9811083|NCT00666263|10920709|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21
9811084|NCT00666263|10920708|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21
9811085|NCT00666263|10920709|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21
9811086|NCT00666263|10920708|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
9811087|NCT00666263|10920709|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
9811088|NCT00666263|10920708|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21
9811089|NCT00666263|10920709|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21
9811090|NCT00666263|10920708|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
9811091|NCT00666263|10920709|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
9811092|NCT00666263|10920708|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
9811093|NCT00666263|10920709|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
9811094|NCT00666263|10920708|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
9811095|NCT00666263|10920709|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
9811096|NCT00666263|10920708|FG000|COMPLETED|End of Study Visit||22
9811097|NCT00666263|10920709|FG001|COMPLETED|End of Study Visit||22
9811098|NCT00666263|10920708|FG000|NOT COMPLETED|End of Study Visit||0
9811099|NCT00666263|10920709|FG001|NOT COMPLETED|End of Study Visit||0
9811100|NCT00666276|10920754|FG000|STARTED|Overall Study||1004
9811101|NCT00666276|10920754|FG000|COMPLETED|Overall Study||970
9811102|NCT00666276|10920754|FG000|NOT COMPLETED|Overall Study||34
9811103|NCT00666328|10920777|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
9811104|NCT00666328|10920777|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
9811105|NCT00666328|10920777|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
9811106|NCT00666328|10920777|FG000|NOT COMPLETED|Overall Study||5
9811107|NCT00666406|10920783|FG000|STARTED|First PK Infusion||6
9811108|NCT00666406|10920784|FG001|STARTED|First PK Infusion||3
9811109|NCT00666406|10920783|FG000|COMPLETED|First PK Infusion||6
9811110|NCT00666406|10920784|FG001|COMPLETED|First PK Infusion||3
9811111|NCT00666406|10920783|FG000|NOT COMPLETED|First PK Infusion||0
9811112|NCT00666406|10920784|FG001|NOT COMPLETED|First PK Infusion||0
9811113|NCT00666406|10920783|FG000|STARTED|Second PK Infusion||6
9811114|NCT00666406|10920784|FG001|STARTED|Second PK Infusion||3
9811115|NCT00666406|10920783|FG000|COMPLETED|Second PK Infusion||6
9811116|NCT00666406|10920784|FG001|COMPLETED|Second PK Infusion||3
9811117|NCT00666406|10920783|FG000|NOT COMPLETED|Second PK Infusion||0
9811118|NCT00666406|10920784|FG001|NOT COMPLETED|Second PK Infusion||0
9811119|NCT00666458|10920791|FG000|STARTED|Overall Study|Randomized and treated|403
9811120|NCT00666458|10920792|FG001|STARTED|Overall Study|Randomized and treated|398
9811121|NCT00666458|10920791|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
9811122|NCT00666458|10920792|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
9811123|NCT00666458|10920791|FG000|NOT COMPLETED|Overall Study||38
9811124|NCT00666458|10920792|FG001|NOT COMPLETED|Overall Study||24
9811125|NCT00666536|10920800|FG000|STARTED|Overall Study||369
9811126|NCT00666536|10920801|FG001|STARTED|Overall Study||359
9811127|NCT00666536|10920800|FG000|COMPLETED|Overall Study||336
9811128|NCT00666536|10920801|FG001|COMPLETED|Overall Study||322
9811129|NCT00666536|10920800|FG000|NOT COMPLETED|Overall Study||33
9811130|NCT00666536|10920801|FG001|NOT COMPLETED|Overall Study||37
9811131|NCT00666562|10920810|FG000|STARTED|Overall Study||11
9811132|NCT00666562|10920811|FG001|STARTED|Overall Study||10
9811133|NCT00666562|10920812|FG002|STARTED|Overall Study||10
9811134|NCT00666562|10920810|FG000|COMPLETED|Overall Study||11
9811135|NCT00666562|10920811|FG001|COMPLETED|Overall Study||8
9811136|NCT00666562|10920812|FG002|COMPLETED|Overall Study||10
9811137|NCT00666562|10920810|FG000|NOT COMPLETED|Overall Study||0
9811138|NCT00666562|10920811|FG001|NOT COMPLETED|Overall Study||2
9811139|NCT00666562|10920812|FG002|NOT COMPLETED|Overall Study||0
9811140|NCT00666588|10920831|FG000|STARTED|Overall Study||18
9811141|NCT00666588|10920832|FG001|STARTED|Overall Study||6
10016454|NCT01810016|11139256|FG001|NOT COMPLETED|Overall Study||1
9811142|NCT00666588|10920833|FG002|STARTED|Overall Study||6
9811143|NCT00666588|10920834|FG003|STARTED|Overall Study||22
9811144|NCT00666588|10920831|FG000|COMPLETED|Overall Study||14
9811145|NCT00666588|10920832|FG001|COMPLETED|Overall Study||6
9811146|NCT00666588|10920833|FG002|COMPLETED|Overall Study||6
10016455|NCT01810016|11139257|FG002|NOT COMPLETED|Overall Study||1
10016456|NCT01810042|11139265|FG000|STARTED|Overall Study||49
9811147|NCT00666588|10920834|FG003|COMPLETED|Overall Study||20
9811148|NCT00666588|10920831|FG000|NOT COMPLETED|Overall Study||4
9811149|NCT00666588|10920832|FG001|NOT COMPLETED|Overall Study||0
9811150|NCT00666588|10920833|FG002|NOT COMPLETED|Overall Study||0
9811151|NCT00666588|10920834|FG003|NOT COMPLETED|Overall Study||2
9811152|NCT00666666|10920844|FG000|STARTED|Overall Study||55
9811153|NCT00666666|10920844|FG000|COMPLETED|Overall Study||55
9811154|NCT00666666|10920844|FG000|NOT COMPLETED|Overall Study||0
9811155|NCT00666679|10920850|FG000|STARTED|First Intervention||66
9811156|NCT00666679|10920851|FG001|STARTED|First Intervention||68
9811157|NCT00666679|10920850|FG000|COMPLETED|First Intervention||62
9811158|NCT00666679|10920851|FG001|COMPLETED|First Intervention||67
9811159|NCT00666679|10920850|FG000|NOT COMPLETED|First Intervention||4
9811160|NCT00666679|10920851|FG001|NOT COMPLETED|First Intervention||1
9811161|NCT00666679|10920850|FG000|STARTED|Washout Period of 1 Week||62
9811162|NCT00666679|10920851|FG001|STARTED|Washout Period of 1 Week||67
9811163|NCT00666679|10920850|FG000|COMPLETED|Washout Period of 1 Week||62
9811164|NCT00666679|10920851|FG001|COMPLETED|Washout Period of 1 Week||65
9811165|NCT00666679|10920850|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9811166|NCT00666679|10920851|FG001|NOT COMPLETED|Washout Period of 1 Week||2
9811167|NCT00666679|10920850|FG000|STARTED|Second Intervention||62
9811168|NCT00666679|10920851|FG001|STARTED|Second Intervention||65
9811169|NCT00666679|10920850|FG000|COMPLETED|Second Intervention||61
9811170|NCT00666679|10920851|FG001|COMPLETED|Second Intervention||64
9811171|NCT00666679|10920850|FG000|NOT COMPLETED|Second Intervention||1
9811172|NCT00666679|10920851|FG001|NOT COMPLETED|Second Intervention||1
9811173|NCT00666705|10920857|FG000|STARTED|Overall Study||18
9811174|NCT00666705|10920857|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
9811175|NCT00666705|10920857|FG000|Washout (Days 4 - 5)|Overall Study||18
9811176|NCT00666705|10920857|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
10016457|NCT01810042|11139265|FG000|COMPLETED|Overall Study||39
10016458|NCT01810042|11139265|FG000|NOT COMPLETED|Overall Study||10
10016459|NCT01810263|11139271|FG000|STARTED|Overall Study||16
10016460|NCT01810263|11139272|FG001|STARTED|Overall Study||18
10016461|NCT01810263|11139271|FG000|COMPLETED|Overall Study|2014 July|8
10016462|NCT01810263|11139272|FG001|COMPLETED|Overall Study||11
10016463|NCT01810263|11139271|FG000|NOT COMPLETED|Overall Study||8
10016464|NCT01810263|11139272|FG001|NOT COMPLETED|Overall Study||7
10016465|NCT01810289|11139280|FG000|STARTED|Overall Study||7277
10016466|NCT01810289|11139281|FG001|STARTED|Overall Study||4747
10016467|NCT01810289|11139280|FG000|COMPLETED|Overall Study||7277
10016468|NCT01810289|11139281|FG001|COMPLETED|Overall Study||4747
10016469|NCT01810289|11139280|FG000|NOT COMPLETED|Overall Study||0
10016470|NCT01810289|11139281|FG001|NOT COMPLETED|Overall Study||0
10016471|NCT01810380|11139290|FG000|STARTED|Overall Study||163
9811177|NCT00666705|10920857|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
9811178|NCT00666705|10920857|FG000|COMPLETED|Overall Study||17
9811179|NCT00666705|10920857|FG000|NOT COMPLETED|Overall Study||1
9811180|NCT00666718|10920868|FG000|STARTED|Overall Study||187
9811181|NCT00666718|10920869|FG001|STARTED|Overall Study||187
9811182|NCT00666718|10920868|FG000|COMPLETED|Overall Study||175
9811183|NCT00666718|10920869|FG001|COMPLETED|Overall Study||169
9811184|NCT00666718|10920868|FG000|NOT COMPLETED|Overall Study||12
9811185|NCT00666718|10920869|FG001|NOT COMPLETED|Overall Study||18
9811186|NCT00666757|10920877|FG000|STARTED|Overall Study||372
9811187|NCT00666757|10920878|FG001|STARTED|Overall Study||378
9811188|NCT00666757|10920877|FG000|COMPLETED|Overall Study||272
9811189|NCT00666757|10920878|FG001|COMPLETED|Overall Study||281
9811190|NCT00666757|10920877|FG000|NOT COMPLETED|Overall Study||100
9811191|NCT00666757|10920878|FG001|NOT COMPLETED|Overall Study||97
9811192|NCT00666835|10920889|FG000|STARTED|Overall Study||314
9811193|NCT00666835|10920890|FG001|STARTED|Overall Study||164
9811194|NCT00666835|10920889|FG000|COMPLETED|Overall Study||261
9811195|NCT00666835|10920890|FG001|COMPLETED|Overall Study||142
9811196|NCT00666835|10920889|FG000|NOT COMPLETED|Overall Study||53
9811197|NCT00666835|10920890|FG001|NOT COMPLETED|Overall Study||22
9811198|NCT00666848|10920900|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
9811199|NCT00666848|10920901|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
9811200|NCT00666848|10920902|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
9811201|NCT00666848|10920900|FG000|COMPLETED|Overall Study|finished Aim 2|8
9811202|NCT00666848|10920901|FG001|COMPLETED|Overall Study|finished Aim 1|9
9811203|NCT00666848|10920902|FG002|COMPLETED|Overall Study|finished Aim 3|7
9811204|NCT00666848|10920900|FG000|NOT COMPLETED|Overall Study||0
9811205|NCT00666848|10920901|FG001|NOT COMPLETED|Overall Study||0
9811206|NCT00666848|10920902|FG002|NOT COMPLETED|Overall Study||0
9811207|NCT00666926|10920910|FG000|STARTED|Overall Study||2
9811208|NCT00666926|10920911|FG001|STARTED|Overall Study||4
9811209|NCT00666926|10920912|FG002|STARTED|Overall Study||3
9811210|NCT00666926|10920913|FG003|STARTED|Overall Study||4
9811211|NCT00666926|10920914|FG004|STARTED|Overall Study||3
9811212|NCT00666926|10920915|FG005|STARTED|Overall Study||4
10016472|NCT01810380|11139291|FG001|STARTED|Overall Study||151
10016473|NCT01810380|11139292|FG002|STARTED|Overall Study||154
10016474|NCT01810380|11139290|FG000|Treated|Overall Study||161
10016475|NCT01810380|11139291|FG001|Treated|Overall Study||150
9811213|NCT00666926|10920916|FG006|STARTED|Overall Study||4
9811214|NCT00666926|10920917|FG007|STARTED|Overall Study||1
9811215|NCT00666926|10920918|FG008|STARTED|Overall Study||3
9811216|NCT00666926|10920919|FG009|STARTED|Overall Study||10
9811217|NCT00666926|10920920|FG010|STARTED|Overall Study||6
9811218|NCT00666926|10920921|FG011|STARTED|Overall Study||33
9811219|NCT00666926|10920922|FG012|STARTED|Overall Study||3
9811220|NCT00666926|10920923|FG013|STARTED|Overall Study||4
9811221|NCT00666926|10920924|FG014|STARTED|Overall Study||7
9811222|NCT00666926|10920925|FG015|STARTED|Overall Study||8
9811223|NCT00666926|10920910|FG000|COMPLETED|Overall Study||0
9811224|NCT00666926|10920911|FG001|COMPLETED|Overall Study||0
9811225|NCT00666926|10920912|FG002|COMPLETED|Overall Study||0
9811226|NCT00666926|10920913|FG003|COMPLETED|Overall Study||0
9811227|NCT00666926|10920914|FG004|COMPLETED|Overall Study||0
9811228|NCT00666926|10920915|FG005|COMPLETED|Overall Study||0
9811229|NCT00666926|10920916|FG006|COMPLETED|Overall Study||0
9811230|NCT00666926|10920917|FG007|COMPLETED|Overall Study||0
9811231|NCT00666926|10920918|FG008|COMPLETED|Overall Study||0
9811232|NCT00666926|10920919|FG009|COMPLETED|Overall Study||0
9811233|NCT00666926|10920920|FG010|COMPLETED|Overall Study||0
9811234|NCT00666926|10920921|FG011|COMPLETED|Overall Study||0
9811235|NCT00666926|10920922|FG012|COMPLETED|Overall Study||0
9811236|NCT00666926|10920923|FG013|COMPLETED|Overall Study||0
9811237|NCT00666926|10920924|FG014|COMPLETED|Overall Study||0
9811238|NCT00666926|10920925|FG015|COMPLETED|Overall Study||0
9811239|NCT00666926|10920910|FG000|NOT COMPLETED|Overall Study||2
9811240|NCT00666926|10920911|FG001|NOT COMPLETED|Overall Study||4
9811241|NCT00666926|10920912|FG002|NOT COMPLETED|Overall Study||3
9811242|NCT00666926|10920913|FG003|NOT COMPLETED|Overall Study||4
9811243|NCT00666926|10920914|FG004|NOT COMPLETED|Overall Study||3
9811244|NCT00666926|10920915|FG005|NOT COMPLETED|Overall Study||4
9811245|NCT00666926|10920916|FG006|NOT COMPLETED|Overall Study||4
9811246|NCT00666926|10920917|FG007|NOT COMPLETED|Overall Study||1
9811247|NCT00666926|10920918|FG008|NOT COMPLETED|Overall Study||3
9811248|NCT00666926|10920919|FG009|NOT COMPLETED|Overall Study||10
9811249|NCT00666926|10920920|FG010|NOT COMPLETED|Overall Study||6
9811250|NCT00666926|10920921|FG011|NOT COMPLETED|Overall Study||33
9811251|NCT00666926|10920922|FG012|NOT COMPLETED|Overall Study||3
9811252|NCT00666926|10920923|FG013|NOT COMPLETED|Overall Study||4
9811253|NCT00666926|10920924|FG014|NOT COMPLETED|Overall Study||7
9811254|NCT00666926|10920925|FG015|NOT COMPLETED|Overall Study||8
9811255|NCT00666965|10920980|FG000|STARTED|Overall Study||58
9811256|NCT00666965|10920981|FG001|STARTED|Overall Study||57
9811257|NCT00666965|10920982|FG002|STARTED|Overall Study||58
9811258|NCT00666965|10920983|FG003|STARTED|Overall Study||57
9811259|NCT00666965|10920980|FG000|COMPLETED|Overall Study||55
9811260|NCT00666965|10920981|FG001|COMPLETED|Overall Study||53
9811261|NCT00666965|10920982|FG002|COMPLETED|Overall Study||56
9811262|NCT00666965|10920983|FG003|COMPLETED|Overall Study||42
9811263|NCT00666965|10920980|FG000|NOT COMPLETED|Overall Study||3
9811264|NCT00666965|10920981|FG001|NOT COMPLETED|Overall Study||4
9811265|NCT00666965|10920982|FG002|NOT COMPLETED|Overall Study||2
9811266|NCT00666965|10920983|FG003|NOT COMPLETED|Overall Study||15
9811267|NCT00666978|10920995|FG000|STARTED|Overall Study||270
9811268|NCT00666978|10920996|FG001|STARTED|Overall Study||270
9811269|NCT00666978|10920995|FG000|COMPLETED|Overall Study||192
9811270|NCT00666978|10920996|FG001|COMPLETED|Overall Study||187
9811271|NCT00666978|10920995|FG000|NOT COMPLETED|Overall Study||78
9811272|NCT00666978|10920996|FG001|NOT COMPLETED|Overall Study||83
9811273|NCT00667004|10921006|FG000|STARTED|Overall Study||95
9811274|NCT00667004|10921007|FG001|STARTED|Overall Study||88
9811275|NCT00667004|10921006|FG000|COMPLETED|Overall Study||93
9811276|NCT00667004|10921007|FG001|COMPLETED|Overall Study||85
9811277|NCT00667004|10921006|FG000|NOT COMPLETED|Overall Study||2
9811278|NCT00667004|10921007|FG001|NOT COMPLETED|Overall Study||3
9811279|NCT00667095|10921015|FG000|STARTED|Overall Study||11
9811280|NCT00667095|10921016|FG001|STARTED|Overall Study||10
9811281|NCT00667095|10921015|FG000|COMPLETED|Overall Study||11
9811282|NCT00667095|10921016|FG001|COMPLETED|Overall Study||9
9811283|NCT00667095|10921015|FG000|NOT COMPLETED|Overall Study||0
9811284|NCT00667095|10921016|FG001|NOT COMPLETED|Overall Study||1
9811285|NCT00667186|10921024|FG000|STARTED|Overall Study||4692
9811286|NCT00667186|10921025|FG001|STARTED|Overall Study||4880
9811287|NCT00667186|10921024|FG000|COMPLETED|Overall Study||4692
9811288|NCT00667186|10921025|FG001|COMPLETED|Overall Study||4880
9811289|NCT00667186|10921024|FG000|NOT COMPLETED|Overall Study||0
9811290|NCT00667186|10921025|FG001|NOT COMPLETED|Overall Study||0
9811291|NCT00667225|10921033|FG000|STARTED|Overall Study||16
9811292|NCT00667225|10921034|FG001|STARTED|Overall Study||13
9811293|NCT00667225|10921033|FG000|COMPLETED|Overall Study||15
9811294|NCT00667225|10921034|FG001|COMPLETED|Overall Study||12
9811295|NCT00667225|10921033|FG000|NOT COMPLETED|Overall Study||1
9811296|NCT00667225|10921034|FG001|NOT COMPLETED|Overall Study||1
9811297|NCT00667277|10921040|FG000|STARTED|Overall Study||13
9811298|NCT00667277|10921040|FG000|COMPLETED|Overall Study||11
9811299|NCT00667277|10921040|FG000|NOT COMPLETED|Overall Study||2
9811300|NCT00667342|10921047|FG000|STARTED|Overall Study||31
9811301|NCT00667342|10921048|FG001|STARTED|Overall Study||0
9811302|NCT00667342|10921049|FG002|STARTED|Overall Study||12
9811303|NCT00667342|10921047|FG000|COMPLETED|Overall Study||17
9811304|NCT00667342|10921048|FG001|COMPLETED|Overall Study||0
9811305|NCT00667342|10921049|FG002|COMPLETED|Overall Study||3
9811306|NCT00667342|10921047|FG000|NOT COMPLETED|Overall Study||14
9811307|NCT00667342|10921048|FG001|NOT COMPLETED|Overall Study||0
9811308|NCT00667342|10921049|FG002|NOT COMPLETED|Overall Study||9
9811309|NCT00667355|10921063|FG000|STARTED|Overall Study||41
9811310|NCT00667355|10921063|FG000|COMPLETED|Overall Study||30
10016476|NCT01810380|11139292|FG002|Treated|Overall Study||153
10235444|NCT01179737|11365733|FG002|STARTED|Extension||0
10235445|NCT01179737|11365734|FG003|STARTED|Extension||0
10235446|NCT01179737|11365731|FG000|COMPLETED|Extension||0
10235447|NCT01179737|11365732|FG001|COMPLETED|Extension||0
10235448|NCT01179737|11365733|FG002|COMPLETED|Extension||0
9811311|NCT00667355|10921063|FG000|NOT COMPLETED|Overall Study||11
9811312|NCT00667368|10921069|FG000|STARTED|Overall Study||682
9811313|NCT00667368|10921070|FG001|STARTED|Overall Study||683
9811314|NCT00667368|10921069|FG000|COMPLETED|Overall Study||482
9811315|NCT00667368|10921070|FG001|COMPLETED|Overall Study||511
9811316|NCT00667368|10921069|FG000|NOT COMPLETED|Overall Study||200
9811317|NCT00667368|10921070|FG001|NOT COMPLETED|Overall Study||172
9811318|NCT00667381|10921078|FG000|STARTED|Overall Study||501
9811319|NCT00667381|10921079|FG001|STARTED|Overall Study||503
9811320|NCT00667381|10921078|FG000|COMPLETED|Overall Study||501
9811321|NCT00667381|10921079|FG001|COMPLETED|Overall Study||503
9811322|NCT00667381|10921078|FG000|NOT COMPLETED|Overall Study||0
9811323|NCT00667381|10921079|FG001|NOT COMPLETED|Overall Study||0
9811324|NCT00667394|10921087|FG000|STARTED|Overall Study||41
9811325|NCT00667394|10921088|FG001|STARTED|Overall Study||1
9811326|NCT00667394|10921087|FG000|COMPLETED|Overall Study||37
9811327|NCT00667394|10921088|FG001|COMPLETED|Overall Study||1
9811328|NCT00667394|10921087|FG000|NOT COMPLETED|Overall Study||4
9811329|NCT00667394|10921088|FG001|NOT COMPLETED|Overall Study||0
9811330|NCT00667420|10921094|FG000|STARTED|Overall Study||17
9811331|NCT00667420|10921094|FG000|Completion of Pre-operative EOX-P|Overall Study||15
9811332|NCT00667420|10921094|FG000|Completion of Surgery/Re-staging|Overall Study||11
9811333|NCT00667420|10921094|FG000|COMPLETED|Overall Study||7
9811334|NCT00667420|10921094|FG000|NOT COMPLETED|Overall Study||10
9811335|NCT00667446|10921101|FG000|STARTED|Treatment Period (36 Months)||34
9811336|NCT00667446|10921102|FG001|STARTED|Treatment Period (36 Months)||38
9811337|NCT00667446|10921101|FG000|COMPLETED|Treatment Period (36 Months)||11
9811338|NCT00667446|10921102|FG001|COMPLETED|Treatment Period (36 Months)||13
9811339|NCT00667446|10921101|FG000|NOT COMPLETED|Treatment Period (36 Months)||23
9811340|NCT00667446|10921102|FG001|NOT COMPLETED|Treatment Period (36 Months)||25
9811341|NCT00667446|10921101|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28
9811342|NCT00667446|10921102|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26
9811343|NCT00667446|10921101|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28
9811344|NCT00667446|10921102|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25
9811345|NCT00667446|10921101|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
9811346|NCT00667446|10921102|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
9811347|NCT00667459|10921110|FG000|STARTED|Overall Study||280
9811348|NCT00667459|10921111|FG001|STARTED|Overall Study||265
9811349|NCT00667459|10921110|FG000|COMPLETED|Overall Study||272
9811350|NCT00667459|10921111|FG001|COMPLETED|Overall Study||220
9811351|NCT00667459|10921110|FG000|NOT COMPLETED|Overall Study||8
9811352|NCT00667459|10921111|FG001|NOT COMPLETED|Overall Study||45
9811353|NCT00667511|10921117|FG000|STARTED|Intervention 1: Home DHD||58
10235449|NCT01179737|11365734|FG003|COMPLETED|Extension||0
10235450|NCT01179737|11365731|FG000|NOT COMPLETED|Extension||3
10235451|NCT01179737|11365732|FG001|NOT COMPLETED|Extension||0
10235452|NCT01179737|11365733|FG002|NOT COMPLETED|Extension||0
10235453|NCT01179737|11365734|FG003|NOT COMPLETED|Extension||0
10235454|NCT01183468|11365747|FG000|STARTED|Overall Study||8
10235455|NCT01183468|11365748|FG001|STARTED|Overall Study||9
9811354|NCT00667511|10921117|FG000|COMPLETED|Intervention 1: Home DHD||51
9811355|NCT00667511|10921117|FG000|NOT COMPLETED|Intervention 1: Home DHD||7
9811356|NCT00667511|10921117|FG000|STARTED|Training/Transition Period||51
9811357|NCT00667511|10921117|FG000|COMPLETED|Training/Transition Period||43
9811358|NCT00667511|10921117|FG000|NOT COMPLETED|Training/Transition Period||8
9811359|NCT00667511|10921117|FG000|STARTED|Intervention 2: Home NHD||43
9811360|NCT00667511|10921117|FG000|COMPLETED|Intervention 2: Home NHD||39
9811361|NCT00667511|10921117|FG000|NOT COMPLETED|Intervention 2: Home NHD||4
9831756|NCT00770120|10942375|FG000|Eligible|Overall Study||60
9831757|NCT00770120|10942375|FG000|Not Analyzable|Overall Study||1
9831758|NCT00770120|10942375|FG000|COMPLETED|Overall Study||0
9831759|NCT00770120|10942375|FG000|NOT COMPLETED|Overall Study||61
9831760|NCT00770133|10942384|FG000|STARTED|Overall Study||35
9831761|NCT00770133|10942385|FG001|STARTED|Overall Study||36
9831762|NCT00770133|10942386|FG002|STARTED|Overall Study||35
9831763|NCT00770133|10942387|FG003|STARTED|Overall Study||35
9831764|NCT00770133|10942384|FG000|COMPLETED|Overall Study||32
9831765|NCT00770133|10942385|FG001|COMPLETED|Overall Study||35
9831766|NCT00770133|10942386|FG002|COMPLETED|Overall Study||32
10235456|NCT01183468|11365749|FG002|STARTED|Overall Study||0
9831767|NCT00770133|10942387|FG003|COMPLETED|Overall Study||32
9831768|NCT00770133|10942384|FG000|NOT COMPLETED|Overall Study||3
9831769|NCT00770133|10942385|FG001|NOT COMPLETED|Overall Study||1
9831770|NCT00770133|10942386|FG002|NOT COMPLETED|Overall Study||3
10235457|NCT01183468|11365750|FG003|STARTED|Overall Study||0
10235458|NCT01183468|11365747|FG000|COMPLETED|Overall Study||5
10235459|NCT01183468|11365748|FG001|COMPLETED|Overall Study||7
10235460|NCT01183468|11365749|FG002|COMPLETED|Overall Study||0
10235461|NCT01183468|11365750|FG003|COMPLETED|Overall Study||0
9811362|NCT00667563|10921123|FG000|STARTED|Overall Study||150
9811363|NCT00667563|10921123|FG000|COMPLETED|Overall Study||126
9811364|NCT00667563|10921123|FG000|NOT COMPLETED|Overall Study||24
9811365|NCT00667576|10921132|FG000|STARTED|Overall Study||30
9811366|NCT00667576|10921133|FG001|STARTED|Overall Study||31
9811367|NCT00667576|10921134|FG002|STARTED|Overall Study||31
10235462|NCT01183468|11365747|FG000|NOT COMPLETED|Overall Study||3
10235463|NCT01183468|11365748|FG001|NOT COMPLETED|Overall Study||2
10235464|NCT01183468|11365749|FG002|NOT COMPLETED|Overall Study||0
10235465|NCT01183468|11365750|FG003|NOT COMPLETED|Overall Study||0
10235466|NCT01181921|11365758|FG000|STARTED|Overall Study||1
9811368|NCT00667576|10921135|FG003|STARTED|Overall Study||31
9811369|NCT00667576|10921136|FG004|STARTED|Overall Study||30
9811370|NCT00667576|10921132|FG000|COMPLETED|Overall Study||28
9811371|NCT00667576|10921133|FG001|COMPLETED|Overall Study||30
9811372|NCT00667576|10921134|FG002|COMPLETED|Overall Study||29
9811373|NCT00667576|10921135|FG003|COMPLETED|Overall Study||27
9811374|NCT00667576|10921136|FG004|COMPLETED|Overall Study||29
9811375|NCT00667576|10921132|FG000|NOT COMPLETED|Overall Study||2
9811376|NCT00667576|10921133|FG001|NOT COMPLETED|Overall Study||1
9811377|NCT00667576|10921134|FG002|NOT COMPLETED|Overall Study||2
9811378|NCT00667576|10921135|FG003|NOT COMPLETED|Overall Study||4
9811379|NCT00667576|10921136|FG004|NOT COMPLETED|Overall Study||1
9811380|NCT00667589|10921152|FG000|STARTED|Overall Study||1
9811381|NCT00667589|10921153|FG001|STARTED|Overall Study||0
9811382|NCT00667589|10921154|FG002|STARTED|Overall Study||3
9811383|NCT00667589|10921155|FG003|STARTED|Overall Study||2
9811384|NCT00667589|10921152|FG000|COMPLETED|Overall Study||0
9811385|NCT00667589|10921153|FG001|COMPLETED|Overall Study||0
9811386|NCT00667589|10921154|FG002|COMPLETED|Overall Study||0
9811387|NCT00667589|10921155|FG003|COMPLETED|Overall Study||1
9811388|NCT00667589|10921152|FG000|NOT COMPLETED|Overall Study||1
9811389|NCT00667589|10921153|FG001|NOT COMPLETED|Overall Study||0
9811390|NCT00667589|10921154|FG002|NOT COMPLETED|Overall Study||3
9811391|NCT00667589|10921155|FG003|NOT COMPLETED|Overall Study||1
9811392|NCT00667602|10921168|FG000|STARTED|Overall Study||219
9811393|NCT00667602|10921169|FG001|STARTED|Overall Study||228
9811394|NCT00667602|10921170|FG002|STARTED|Overall Study||215
9811395|NCT00667602|10921168|FG000|COMPLETED|Overall Study||211
9811396|NCT00667602|10921169|FG001|COMPLETED|Overall Study||213
9811397|NCT00667602|10921170|FG002|COMPLETED|Overall Study||197
9811398|NCT00667602|10921168|FG000|NOT COMPLETED|Overall Study||8
9811399|NCT00667602|10921169|FG001|NOT COMPLETED|Overall Study||15
9811400|NCT00667602|10921170|FG002|NOT COMPLETED|Overall Study||18
9811401|NCT00667615|10921183|FG000|STARTED|Overall Study||30
9811402|NCT00667615|10921183|FG000|COMPLETED|Overall Study||30
9811403|NCT00667615|10921183|FG000|NOT COMPLETED|Overall Study||0
9811404|NCT00667693|10921189|FG000|STARTED|Overall Study||49
9811405|NCT00667693|10921190|FG001|STARTED|Overall Study||52
9811406|NCT00667693|10921189|FG000|COMPLETED|Overall Study||49
9811407|NCT00667693|10921190|FG001|COMPLETED|Overall Study||50
9811408|NCT00667693|10921189|FG000|NOT COMPLETED|Overall Study||0
9811409|NCT00667693|10921190|FG001|NOT COMPLETED|Overall Study||2
9811410|NCT00667719|10921196|FG000|STARTED|Overall Study||564
9811411|NCT00667719|10921196|FG000|COMPLETED|Overall Study||493
9811412|NCT00667719|10921196|FG000|NOT COMPLETED|Overall Study||71
9811413|NCT00667732|10921207|FG000|STARTED|Run -In (8 Weeks)||41
9811414|NCT00667732|10921208|FG001|STARTED|Run -In (8 Weeks)||0
9811415|NCT00667732|10921209|FG002|STARTED|Run -In (8 Weeks)||0
9811416|NCT00667732|10921207|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
9811417|NCT00667732|10921208|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
9811418|NCT00667732|10921209|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
9811419|NCT00667732|10921207|FG000|COMPLETED|Run -In (8 Weeks)||34
9811420|NCT00667732|10921208|FG001|COMPLETED|Run -In (8 Weeks)||0
9811421|NCT00667732|10921209|FG002|COMPLETED|Run -In (8 Weeks)||0
9811422|NCT00667732|10921207|FG000|NOT COMPLETED|Run -In (8 Weeks)||7
9811423|NCT00667732|10921208|FG001|NOT COMPLETED|Run -In (8 Weeks)||0
9811424|NCT00667732|10921209|FG002|NOT COMPLETED|Run -In (8 Weeks)||0
9811425|NCT00667732|10921207|FG000|STARTED|Randomization (24 Weeks)||0
9811426|NCT00667732|10921208|FG001|STARTED|Randomization (24 Weeks)||17
9811427|NCT00667732|10921209|FG002|STARTED|Randomization (24 Weeks)||17
9811428|NCT00667732|10921207|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
9811429|NCT00667732|10921208|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
9811430|NCT00667732|10921209|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
9811431|NCT00667732|10921207|FG000|COMPLETED|Randomization (24 Weeks)||0
9811432|NCT00667732|10921208|FG001|COMPLETED|Randomization (24 Weeks)||16
9811433|NCT00667732|10921209|FG002|COMPLETED|Randomization (24 Weeks)||17
9811434|NCT00667732|10921207|FG000|NOT COMPLETED|Randomization (24 Weeks)||0
9811435|NCT00667732|10921208|FG001|NOT COMPLETED|Randomization (24 Weeks)||1
9811436|NCT00667732|10921209|FG002|NOT COMPLETED|Randomization (24 Weeks)||0
9811437|NCT00667732|10921207|FG000|STARTED|Extension (26 Weeks)||0
10235467|NCT01181921|11365758|FG000|COMPLETED|Overall Study||0
10235468|NCT01181921|11365758|FG000|NOT COMPLETED|Overall Study||1
9811438|NCT00667732|10921208|FG001|STARTED|Extension (26 Weeks)||14
10235469|NCT01188798|11365764|FG000|STARTED|Overall Study||2
10235470|NCT01188798|11365765|FG001|STARTED|Overall Study||4
9811439|NCT00667732|10921209|FG002|STARTED|Extension (26 Weeks)||17
9811440|NCT00667732|10921207|FG000|COMPLETED|Extension (26 Weeks)||0
9811441|NCT00667732|10921208|FG001|COMPLETED|Extension (26 Weeks)||14
9811442|NCT00667732|10921209|FG002|COMPLETED|Extension (26 Weeks)||17
9811443|NCT00667732|10921207|FG000|NOT COMPLETED|Extension (26 Weeks)||0
9811444|NCT00667732|10921208|FG001|NOT COMPLETED|Extension (26 Weeks)||0
9811445|NCT00667732|10921209|FG002|NOT COMPLETED|Extension (26 Weeks)||0
9811446|NCT00667745|10921221|FG000|STARTED|Overall Study||141
9811447|NCT00667745|10921222|FG001|STARTED|Overall Study||142
9811448|NCT00667745|10921221|FG000|COMPLETED|Overall Study||116
9811449|NCT00667745|10921222|FG001|COMPLETED|Overall Study||121
9811450|NCT00667745|10921221|FG000|NOT COMPLETED|Overall Study||25
9811451|NCT00667745|10921222|FG001|NOT COMPLETED|Overall Study||21
9811452|NCT00667810|10921233|FG000|STARTED|Overall Study||269
9811453|NCT00667810|10921234|FG001|STARTED|Overall Study||264
9811454|NCT00667810|10921235|FG002|STARTED|Overall Study||346
9811455|NCT00667810|10921236|FG003|STARTED|Overall Study||11
9811456|NCT00667810|10921233|FG000|Treated|Overall Study||267
9811457|NCT00667810|10921234|FG001|Treated|Overall Study||263
9811458|NCT00667810|10921235|FG002|Treated|Overall Study||344
9811459|NCT00667810|10921236|FG003|Treated|Overall Study||11
9811460|NCT00667810|10921233|FG000|COMPLETED|Overall Study||102
9811461|NCT00667810|10921234|FG001|COMPLETED|Overall Study||94
9811462|NCT00667810|10921235|FG002|COMPLETED|Overall Study||124
9811463|NCT00667810|10921236|FG003|COMPLETED|Overall Study||9
9811464|NCT00667810|10921233|FG000|NOT COMPLETED|Overall Study||167
9811465|NCT00667810|10921234|FG001|NOT COMPLETED|Overall Study||170
9811466|NCT00667810|10921235|FG002|NOT COMPLETED|Overall Study||222
9811467|NCT00667810|10921236|FG003|NOT COMPLETED|Overall Study||2
9811468|NCT00667849|10921253|FG000|STARTED|Overall Study||250
9811469|NCT00667849|10921254|FG001|STARTED|Overall Study||251
9811470|NCT00667849|10921253|FG000|COMPLETED|Overall Study||142
9811471|NCT00667849|10921254|FG001|COMPLETED|Overall Study||130
9811472|NCT00667849|10921253|FG000|NOT COMPLETED|Overall Study||108
9811473|NCT00667849|10921254|FG001|NOT COMPLETED|Overall Study||121
9811474|NCT00667862|10921263|FG000|STARTED|Overall Study||35
9811475|NCT00667862|10921263|FG000|COMPLETED|Overall Study||0
9811476|NCT00667862|10921263|FG000|NOT COMPLETED|Overall Study||35
9811477|NCT00667875|10921270|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
9811478|NCT00667875|10921271|FG001|STARTED|Overall Study||21
9811479|NCT00667875|10921272|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
9811480|NCT00667875|10921270|FG000|Subjects Included in Analysisd|Overall Study||20
9811481|NCT00667875|10921271|FG001|Subjects Included in Analysisd|Overall Study||21
9811482|NCT00667875|10921272|FG002|Subjects Included in Analysisd|Overall Study||19
9811483|NCT00667875|10921270|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
9811484|NCT00667875|10921271|FG001|COMPLETED|Overall Study||10
9811485|NCT00667875|10921272|FG002|COMPLETED|Overall Study||8
9811486|NCT00667875|10921270|FG000|NOT COMPLETED|Overall Study||10
9811487|NCT00667875|10921271|FG001|NOT COMPLETED|Overall Study||11
9811488|NCT00667875|10921272|FG002|NOT COMPLETED|Overall Study||13
9811489|NCT00667888|10921288|FG000|STARTED|Overall Study||111
9811490|NCT00667888|10921289|FG001|STARTED|Overall Study||111
9811491|NCT00667888|10921288|FG000|COMPLETED|Overall Study||101
9811492|NCT00667888|10921289|FG001|COMPLETED|Overall Study||102
9811493|NCT00667888|10921288|FG000|NOT COMPLETED|Overall Study||10
9811494|NCT00667888|10921289|FG001|NOT COMPLETED|Overall Study||9
9811495|NCT00667992|10921297|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49
9811496|NCT00667992|10921298|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50
9811497|NCT00667992|10921297|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44
9811498|NCT00667992|10921298|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45
9811499|NCT00667992|10921297|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
9811500|NCT00667992|10921298|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
9811501|NCT00667992|10921297|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44
9811502|NCT00667992|10921298|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45
9811503|NCT00667992|10921297|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
10016477|NCT01810380|11139290|FG000|COMPLETED|Overall Study||108
10016478|NCT01810380|11139291|FG001|COMPLETED|Overall Study||113
10016479|NCT01810380|11139292|FG002|COMPLETED|Overall Study||122
10016480|NCT01810380|11139290|FG000|NOT COMPLETED|Overall Study||55
10016481|NCT01810380|11139291|FG001|NOT COMPLETED|Overall Study||38
10016482|NCT01810380|11139292|FG002|NOT COMPLETED|Overall Study||32
10016483|NCT01810432|11139300|FG000|STARTED|Period 1||20
10016484|NCT01810432|11139301|FG001|STARTED|Period 1||20
10016485|NCT01810432|11139300|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
9811504|NCT00667992|10921298|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
9811505|NCT00667992|10921297|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
9811506|NCT00667992|10921298|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
9811507|NCT00667992|10921297|FG000|STARTED|Wash-out||41
9811508|NCT00667992|10921298|FG001|STARTED|Wash-out||41
9811509|NCT00667992|10921297|FG000|COMPLETED|Wash-out||34
9811510|NCT00667992|10921298|FG001|COMPLETED|Wash-out||36
10016486|NCT01810432|11139301|FG001|Received at Least 1 Dose of Study Drug|Period 1||20
10016487|NCT01810432|11139300|FG000|COMPLETED|Period 1||20
10016488|NCT01810432|11139301|FG001|COMPLETED|Period 1||20
10016489|NCT01810432|11139300|FG000|NOT COMPLETED|Period 1||0
9811511|NCT00667992|10921297|FG000|NOT COMPLETED|Wash-out||7
9811512|NCT00667992|10921298|FG001|NOT COMPLETED|Wash-out||5
9811513|NCT00667992|10921297|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34
9811514|NCT00667992|10921298|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36
9811515|NCT00667992|10921297|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
9811516|NCT00667992|10921298|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
9811517|NCT00667992|10921297|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
9811518|NCT00667992|10921298|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
9811519|NCT00667992|10921297|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33
9811520|NCT00667992|10921298|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35
9811521|NCT00667992|10921297|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
9811522|NCT00667992|10921298|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
9811523|NCT00667992|10921297|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
9811524|NCT00667992|10921298|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
9811525|NCT00668148|10921314|FG000|STARTED|Overall Study||113
9811526|NCT00668148|10921314|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111
9811527|NCT00668148|10921314|FG000|COMPLETED|Overall Study||103
9811528|NCT00668148|10921314|FG000|NOT COMPLETED|Overall Study||10
9811529|NCT00668200|10921329|FG000|STARTED|Overall Study||80
9811530|NCT00668200|10921329|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
9811531|NCT00668200|10921329|FG000|Intent to Treat (ITT)|Overall Study||80
9811532|NCT00668200|10921329|FG000|COMPLETED|Overall Study||77
9811533|NCT00668200|10921329|FG000|NOT COMPLETED|Overall Study||3
9811534|NCT00668317|10921333|FG000|STARTED|Overall Study||5
9811535|NCT00668317|10921333|FG000|COMPLETED|Overall Study||3
9811536|NCT00668317|10921333|FG000|NOT COMPLETED|Overall Study||2
9811537|NCT00668382|10921337|FG000|STARTED|Overall Study|beginning of trial|11
9811538|NCT00668382|10921337|FG000|COMPLETED|Overall Study||11
9811539|NCT00668382|10921337|FG000|NOT COMPLETED|Overall Study||0
9811540|NCT00668395|10921344|FG000|STARTED|Overall Study||45
9811541|NCT00668395|10921345|FG001|STARTED|Overall Study||22
9811542|NCT00668395|10921346|FG002|STARTED|Overall Study||6
9811543|NCT00668395|10921344|FG000|COMPLETED|Overall Study||39
9811544|NCT00668395|10921345|FG001|COMPLETED|Overall Study||16
9811545|NCT00668395|10921346|FG002|COMPLETED|Overall Study||5
9811546|NCT00668395|10921344|FG000|NOT COMPLETED|Overall Study||6
9811547|NCT00668395|10921345|FG001|NOT COMPLETED|Overall Study||6
9811548|NCT00668395|10921346|FG002|NOT COMPLETED|Overall Study||1
9811549|NCT00668434|10921356|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
9811550|NCT00668434|10921357|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
9811551|NCT00668434|10921356|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
9811552|NCT00668434|10921357|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
9811553|NCT00668434|10921356|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
9811554|NCT00668434|10921357|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
9811555|NCT00668434|10921356|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
9811556|NCT00668434|10921357|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
9811557|NCT00668434|10921356|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
9811558|NCT00668434|10921357|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
9811559|NCT00668434|10921356|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
9811560|NCT00668434|10921357|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
9811561|NCT00668525|10921366|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
9811562|NCT00668525|10921367|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
9811563|NCT00668525|10921368|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
9811564|NCT00668525|10921366|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
9811565|NCT00668525|10921367|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
9811566|NCT00668525|10921368|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
9811567|NCT00668525|10921366|FG000|NOT COMPLETED|Overall Study||77
9811568|NCT00668525|10921367|FG001|NOT COMPLETED|Overall Study||93
9811569|NCT00668525|10921368|FG002|NOT COMPLETED|Overall Study||53
9811570|NCT00668564|10921376|FG000|STARTED|Overall Study||18
9811571|NCT00668564|10921376|FG000|COMPLETED|Overall Study||18
9811572|NCT00668564|10921376|FG000|NOT COMPLETED|Overall Study||0
9811573|NCT00668707|10921382|FG000|STARTED|Overall Study||356
9811574|NCT00668707|10921383|FG001|STARTED|Overall Study||353
9811575|NCT00668707|10921382|FG000|COMPLETED|Overall Study||157
9811576|NCT00668707|10921383|FG001|COMPLETED|Overall Study||173
9811577|NCT00668707|10921382|FG000|NOT COMPLETED|Overall Study||199
9811578|NCT00668707|10921383|FG001|NOT COMPLETED|Overall Study||180
9811579|NCT00668733|10921396|FG000|STARTED|Overall Study||89
9811580|NCT00668733|10921397|FG001|STARTED|Overall Study||90
9811581|NCT00668733|10921396|FG000|COMPLETED|Overall Study||87
9811582|NCT00668733|10921397|FG001|COMPLETED|Overall Study||83
9811583|NCT00668733|10921396|FG000|NOT COMPLETED|Overall Study||2
9811584|NCT00668733|10921397|FG001|NOT COMPLETED|Overall Study||7
9811585|NCT00668746|10921405|FG000|STARTED|Overall Study||23
9811586|NCT00668746|10921406|FG001|STARTED|Overall Study||12
9811587|NCT00668746|10921405|FG000|COMPLETED|Overall Study||21
9811588|NCT00668746|10921406|FG001|COMPLETED|Overall Study||11
9811589|NCT00668746|10921405|FG000|NOT COMPLETED|Overall Study||2
9811590|NCT00668746|10921406|FG001|NOT COMPLETED|Overall Study||1
9811591|NCT00668811|10921422|FG000|STARTED|Overall Study||23
9811592|NCT00668811|10921422|FG000|COMPLETED|Overall Study||23
9811593|NCT00668811|10921422|FG000|NOT COMPLETED|Overall Study||0
9811594|NCT00668863|10921426|FG000|STARTED|Overall Study||71
9811595|NCT00668863|10921426|FG000|COMPLETED|Overall Study||0
9811596|NCT00668863|10921426|FG000|NOT COMPLETED|Overall Study||71
9811597|NCT00668902|10921433|FG000|STARTED|Overall Study||10
9811598|NCT00668902|10921434|FG001|STARTED|Overall Study||10
9811599|NCT00668902|10921435|FG002|STARTED|Overall Study||5
9811600|NCT00668902|10921433|FG000|COMPLETED|Overall Study||10
9811601|NCT00668902|10921434|FG001|COMPLETED|Overall Study||10
9811602|NCT00668902|10921435|FG002|COMPLETED|Overall Study||5
9811603|NCT00668902|10921433|FG000|NOT COMPLETED|Overall Study||0
10016490|NCT01810432|11139301|FG001|NOT COMPLETED|Period 1||0
10016491|NCT01810432|11139300|FG000|STARTED|Washout||20
10016492|NCT01810432|11139301|FG001|STARTED|Washout||20
10016493|NCT01810432|11139300|FG000|COMPLETED|Washout||19
10016494|NCT01810432|11139301|FG001|COMPLETED|Washout||19
10016495|NCT01810432|11139300|FG000|NOT COMPLETED|Washout||1
9811604|NCT00668902|10921434|FG001|NOT COMPLETED|Overall Study||0
9811605|NCT00668902|10921435|FG002|NOT COMPLETED|Overall Study||0
9811606|NCT00669019|10921443|FG000|STARTED|Overall Study||23
9811607|NCT00669019|10921443|FG000|COMPLETED|Overall Study||23
9811608|NCT00669019|10921443|FG000|NOT COMPLETED|Overall Study||0
9811609|NCT00669032|10921449|FG000|STARTED|Overall Study||153
9811610|NCT00669032|10921450|FG001|STARTED|Overall Study||153
9811611|NCT00669032|10921449|FG000|COMPLETED|Overall Study||109
9811612|NCT00669032|10921450|FG001|COMPLETED|Overall Study||94
9811613|NCT00669032|10921449|FG000|NOT COMPLETED|Overall Study||44
9811614|NCT00669032|10921450|FG001|NOT COMPLETED|Overall Study||59
9811615|NCT00669071|10921456|FG000|STARTED|Overall Study||56
9811616|NCT00669071|10921456|FG000|COMPLETED|Overall Study||52
9811617|NCT00669071|10921456|FG000|NOT COMPLETED|Overall Study||4
9811618|NCT00669110|10921464|FG000|STARTED|Overall Study||20
9811619|NCT00669110|10921465|FG001|STARTED|Overall Study||20
9811620|NCT00669110|10921464|FG000|COMPLETED|Overall Study||12
9811621|NCT00669110|10921465|FG001|COMPLETED|Overall Study||7
9811622|NCT00669110|10921464|FG000|NOT COMPLETED|Overall Study||8
9811623|NCT00669110|10921465|FG001|NOT COMPLETED|Overall Study||13
9811624|NCT00669162|10921471|FG000|STARTED|Overall Study||27
9811625|NCT00669162|10921471|FG000|COMPLETED|Overall Study||26
9811626|NCT00669162|10921471|FG000|NOT COMPLETED|Overall Study||1
9811627|NCT00669214|10921477|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27
9811628|NCT00669214|10921478|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62
9811629|NCT00669214|10921477|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22
9811630|NCT00669214|10921478|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55
9811631|NCT00669214|10921477|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
9811632|NCT00669214|10921478|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
9811633|NCT00669214|10921477|FG000|STARTED|Open-Label Treatment Period (Week 24)||22
9811634|NCT00669214|10921478|FG001|STARTED|Open-Label Treatment Period (Week 24)||55
9811635|NCT00669214|10921477|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18
9811636|NCT00669214|10921478|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46
9811637|NCT00669214|10921477|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
9811638|NCT00669214|10921478|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
9811639|NCT00669240|10921488|FG000|STARTED|Overall Study||567
9811640|NCT00669240|10921488|FG000|Assigned to Treatment|Overall Study||566
9811641|NCT00669240|10921488|FG000|Received Treatment|Overall Study||551
9811642|NCT00669240|10921488|FG000|COMPLETED|Overall Study||402
9811643|NCT00669240|10921488|FG000|NOT COMPLETED|Overall Study||165
9811644|NCT00669279|10921494|FG000|STARTED|Overall Study||22
9811645|NCT00669279|10921495|FG001|STARTED|Overall Study||19
9811646|NCT00669279|10921494|FG000|COMPLETED|Overall Study||22
9811647|NCT00669279|10921495|FG001|COMPLETED|Overall Study||19
9811648|NCT00669279|10921494|FG000|NOT COMPLETED|Overall Study||0
9811649|NCT00669279|10921495|FG001|NOT COMPLETED|Overall Study||0
9811650|NCT00669318|10921501|FG000|STARTED|Overall Study||41
9811651|NCT00669318|10921501|FG000|COMPLETED|Overall Study||39
10016496|NCT01810432|11139301|FG001|NOT COMPLETED|Washout||1
10016497|NCT01810432|11139300|FG000|STARTED|Period 2||19
10016498|NCT01810432|11139301|FG001|STARTED|Period 2||19
9811652|NCT00669318|10921501|FG000|NOT COMPLETED|Overall Study||2
9811653|NCT00669331|10921507|FG000|STARTED|Randomisation to First Dose||244
9811654|NCT00669331|10921508|FG001|STARTED|Randomisation to First Dose||241
9811655|NCT00669331|10921507|FG000|COMPLETED|Randomisation to First Dose||233
9811656|NCT00669331|10921508|FG001|COMPLETED|Randomisation to First Dose||228
9811657|NCT00669331|10921507|FG000|NOT COMPLETED|Randomisation to First Dose||11
9811658|NCT00669331|10921508|FG001|NOT COMPLETED|Randomisation to First Dose||13
9811659|NCT00669331|10921507|FG000|STARTED|Blinded Treatment Period||233
9811660|NCT00669331|10921508|FG001|STARTED|Blinded Treatment Period||228
9811661|NCT00669331|10921507|FG000|COMPLETED|Blinded Treatment Period||191
9811662|NCT00669331|10921508|FG001|COMPLETED|Blinded Treatment Period||189
9811663|NCT00669331|10921507|FG000|NOT COMPLETED|Blinded Treatment Period||42
9811664|NCT00669331|10921508|FG001|NOT COMPLETED|Blinded Treatment Period||39
9811665|NCT00669383|10921518|FG000|STARTED|Overall Study||44
9811666|NCT00669383|10921519|FG001|STARTED|Overall Study||41
9811667|NCT00669383|10921518|FG000|COMPLETED|Overall Study||44
9811668|NCT00669383|10921519|FG001|COMPLETED|Overall Study||41
9811669|NCT00669383|10921518|FG000|NOT COMPLETED|Overall Study||0
9811670|NCT00669383|10921519|FG001|NOT COMPLETED|Overall Study||0
10016499|NCT01810432|11139300|FG000|Received at Least 1 Dose of Study Drug|Period 2||19
10016500|NCT01810432|11139301|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
10016501|NCT01810432|11139300|FG000|COMPLETED|Period 2||15
10016502|NCT01810432|11139301|FG001|COMPLETED|Period 2||17
9811671|NCT00669396|10921527|FG000|STARTED|Overall Study||23
9811672|NCT00669396|10921528|FG001|STARTED|Overall Study||34
9811673|NCT00669396|10921527|FG000|COMPLETED|Overall Study||13
9811674|NCT00669396|10921528|FG001|COMPLETED|Overall Study||22
9811675|NCT00669396|10921527|FG000|NOT COMPLETED|Overall Study||10
9811676|NCT00669396|10921528|FG001|NOT COMPLETED|Overall Study||12
9811677|NCT00669409|10921540|FG000|STARTED|Part 1||6
9811678|NCT00669409|10921541|FG001|STARTED|Part 1||6
9811679|NCT00669409|10921542|FG002|STARTED|Part 1||6
9811680|NCT00669409|10921543|FG003|STARTED|Part 1||6
9811681|NCT00669409|10921544|FG004|STARTED|Part 1||6
9811682|NCT00669409|10921545|FG005|STARTED|Part 1||12
9811683|NCT00669409|10921546|FG006|STARTED|Part 1||0
9811684|NCT00669409|10921547|FG007|STARTED|Part 1||0
9811685|NCT00669409|10921548|FG008|STARTED|Part 1||0
9811686|NCT00669409|10921549|FG009|STARTED|Part 1||0
9811687|NCT00669409|10921550|FG010|STARTED|Part 1||0
9811688|NCT00669409|10921540|FG000|COMPLETED|Part 1||6
9811689|NCT00669409|10921541|FG001|COMPLETED|Part 1||6
9811690|NCT00669409|10921542|FG002|COMPLETED|Part 1||6
9811691|NCT00669409|10921543|FG003|COMPLETED|Part 1||6
9811692|NCT00669409|10921544|FG004|COMPLETED|Part 1||6
9811693|NCT00669409|10921545|FG005|COMPLETED|Part 1||12
9811694|NCT00669409|10921546|FG006|COMPLETED|Part 1||0
9811695|NCT00669409|10921547|FG007|COMPLETED|Part 1||0
9811696|NCT00669409|10921548|FG008|COMPLETED|Part 1||0
9811697|NCT00669409|10921549|FG009|COMPLETED|Part 1||0
9811698|NCT00669409|10921550|FG010|COMPLETED|Part 1||0
9811699|NCT00669409|10921540|FG000|NOT COMPLETED|Part 1||0
9811700|NCT00669409|10921541|FG001|NOT COMPLETED|Part 1||0
9811701|NCT00669409|10921542|FG002|NOT COMPLETED|Part 1||0
9811702|NCT00669409|10921543|FG003|NOT COMPLETED|Part 1||0
9811703|NCT00669409|10921544|FG004|NOT COMPLETED|Part 1||0
9811704|NCT00669409|10921545|FG005|NOT COMPLETED|Part 1||0
9811705|NCT00669409|10921546|FG006|NOT COMPLETED|Part 1||0
9811706|NCT00669409|10921547|FG007|NOT COMPLETED|Part 1||0
9811707|NCT00669409|10921548|FG008|NOT COMPLETED|Part 1||0
9811708|NCT00669409|10921549|FG009|NOT COMPLETED|Part 1||0
9811709|NCT00669409|10921550|FG010|NOT COMPLETED|Part 1||0
9811710|NCT00669409|10921540|FG000|STARTED|Part 2||0
9811711|NCT00669409|10921541|FG001|STARTED|Part 2||0
9811712|NCT00669409|10921542|FG002|STARTED|Part 2||0
9811713|NCT00669409|10921543|FG003|STARTED|Part 2||0
9811714|NCT00669409|10921544|FG004|STARTED|Part 2||0
9811715|NCT00669409|10921545|FG005|STARTED|Part 2||0
9811716|NCT00669409|10921546|FG006|STARTED|Part 2||9
9811717|NCT00669409|10921547|FG007|STARTED|Part 2||9
9811718|NCT00669409|10921548|FG008|STARTED|Part 2||9
9811719|NCT00669409|10921549|FG009|STARTED|Part 2||10
9811720|NCT00669409|10921550|FG010|STARTED|Part 2||4
9811721|NCT00669409|10921540|FG000|COMPLETED|Part 2||0
9811722|NCT00669409|10921541|FG001|COMPLETED|Part 2||0
9811723|NCT00669409|10921542|FG002|COMPLETED|Part 2||0
9811724|NCT00669409|10921543|FG003|COMPLETED|Part 2||0
9811725|NCT00669409|10921544|FG004|COMPLETED|Part 2||0
9811726|NCT00669409|10921545|FG005|COMPLETED|Part 2||0
9811727|NCT00669409|10921546|FG006|COMPLETED|Part 2||9
9811728|NCT00669409|10921547|FG007|COMPLETED|Part 2||9
9811729|NCT00669409|10921548|FG008|COMPLETED|Part 2||9
9811730|NCT00669409|10921549|FG009|COMPLETED|Part 2||9
9811731|NCT00669409|10921550|FG010|COMPLETED|Part 2||4
9811732|NCT00669409|10921540|FG000|NOT COMPLETED|Part 2||0
9811733|NCT00669409|10921541|FG001|NOT COMPLETED|Part 2||0
9811734|NCT00669409|10921542|FG002|NOT COMPLETED|Part 2||0
9811735|NCT00669409|10921543|FG003|NOT COMPLETED|Part 2||0
9811736|NCT00669409|10921544|FG004|NOT COMPLETED|Part 2||0
9811737|NCT00669409|10921545|FG005|NOT COMPLETED|Part 2||0
9811738|NCT00669409|10921546|FG006|NOT COMPLETED|Part 2||0
9811739|NCT00669409|10921547|FG007|NOT COMPLETED|Part 2||0
9811740|NCT00669409|10921548|FG008|NOT COMPLETED|Part 2||0
9811741|NCT00669409|10921549|FG009|NOT COMPLETED|Part 2||1
9811742|NCT00669409|10921550|FG010|NOT COMPLETED|Part 2||0
9811743|NCT00669539|10921579|FG000|STARTED|Overall Study||94
9811744|NCT00669539|10921580|FG001|STARTED|Overall Study||52
9811745|NCT00669539|10921579|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
9811746|NCT00669539|10921580|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
9811747|NCT00669539|10921579|FG000|NOT COMPLETED|Overall Study||8
9811748|NCT00669539|10921580|FG001|NOT COMPLETED|Overall Study||9
9811749|NCT00669552|10921586|FG000|STARTED|Overall Study||11
9811750|NCT00669552|10921586|FG000|COMPLETED|Overall Study||11
9811751|NCT00669552|10921586|FG000|NOT COMPLETED|Overall Study||0
9811752|NCT00669578|10921592|FG000|STARTED|Overall Study||12
9811753|NCT00669578|10921593|FG001|STARTED|Overall Study||65
9811754|NCT00669578|10921592|FG000|COMPLETED|Overall Study||12
9811755|NCT00669578|10921593|FG001|COMPLETED|Overall Study||65
9811756|NCT00669578|10921592|FG000|NOT COMPLETED|Overall Study||0
9811757|NCT00669578|10921593|FG001|NOT COMPLETED|Overall Study||0
9811758|NCT00669617|10921600|FG000|STARTED|Period 1||18
9811759|NCT00669617|10921601|FG001|STARTED|Period 1||17
9811760|NCT00669617|10921602|FG002|STARTED|Period 1||18
9811761|NCT00669617|10921603|FG003|STARTED|Period 1||18
9811762|NCT00669617|10921604|FG004|STARTED|Period 1||18
9811763|NCT00669617|10921600|FG000|COMPLETED|Period 1||18
9811764|NCT00669617|10921601|FG001|COMPLETED|Period 1||17
9811765|NCT00669617|10921602|FG002|COMPLETED|Period 1||17
9811766|NCT00669617|10921603|FG003|COMPLETED|Period 1||18
9811767|NCT00669617|10921604|FG004|COMPLETED|Period 1||17
9811768|NCT00669617|10921600|FG000|NOT COMPLETED|Period 1||0
9811769|NCT00669617|10921601|FG001|NOT COMPLETED|Period 1||0
9811770|NCT00669617|10921602|FG002|NOT COMPLETED|Period 1||1
9811771|NCT00669617|10921603|FG003|NOT COMPLETED|Period 1||0
9811772|NCT00669617|10921604|FG004|NOT COMPLETED|Period 1||1
9811773|NCT00669617|10921600|FG000|STARTED|Period 2||18
9811774|NCT00669617|10921601|FG001|STARTED|Period 2||17
9811775|NCT00669617|10921602|FG002|STARTED|Period 2||17
9811776|NCT00669617|10921603|FG003|STARTED|Period 2||18
9811777|NCT00669617|10921604|FG004|STARTED|Period 2||17
9811778|NCT00669617|10921600|FG000|COMPLETED|Period 2||18
9811779|NCT00669617|10921601|FG001|COMPLETED|Period 2||17
9811780|NCT00669617|10921602|FG002|COMPLETED|Period 2||17
9811781|NCT00669617|10921603|FG003|COMPLETED|Period 2||18
9811782|NCT00669617|10921604|FG004|COMPLETED|Period 2||17
9811783|NCT00669617|10921600|FG000|NOT COMPLETED|Period 2||0
9811784|NCT00669617|10921601|FG001|NOT COMPLETED|Period 2||0
9811785|NCT00669617|10921602|FG002|NOT COMPLETED|Period 2||0
9811786|NCT00669617|10921603|FG003|NOT COMPLETED|Period 2||0
9811787|NCT00669617|10921604|FG004|NOT COMPLETED|Period 2||0
9811788|NCT00669617|10921600|FG000|STARTED|Period 3||18
9811789|NCT00669617|10921601|FG001|STARTED|Period 3||17
9811790|NCT00669617|10921602|FG002|STARTED|Period 3||17
9811791|NCT00669617|10921603|FG003|STARTED|Period 3||18
9811792|NCT00669617|10921604|FG004|STARTED|Period 3||17
9811793|NCT00669617|10921600|FG000|COMPLETED|Period 3||17
9811794|NCT00669617|10921601|FG001|COMPLETED|Period 3||17
9811795|NCT00669617|10921602|FG002|COMPLETED|Period 3||17
9811796|NCT00669617|10921603|FG003|COMPLETED|Period 3||18
9811797|NCT00669617|10921604|FG004|COMPLETED|Period 3||17
9811798|NCT00669617|10921600|FG000|NOT COMPLETED|Period 3||1
9811799|NCT00669617|10921601|FG001|NOT COMPLETED|Period 3||0
9811800|NCT00669617|10921602|FG002|NOT COMPLETED|Period 3||0
9811801|NCT00669617|10921603|FG003|NOT COMPLETED|Period 3||0
9811802|NCT00669617|10921604|FG004|NOT COMPLETED|Period 3||0
9811803|NCT00669617|10921600|FG000|STARTED|Period 4||17
9811804|NCT00669617|10921601|FG001|STARTED|Period 4||17
9811805|NCT00669617|10921602|FG002|STARTED|Period 4||17
9811806|NCT00669617|10921603|FG003|STARTED|Period 4||18
9811807|NCT00669617|10921604|FG004|STARTED|Period 4||17
9811808|NCT00669617|10921600|FG000|COMPLETED|Period 4||17
9811809|NCT00669617|10921601|FG001|COMPLETED|Period 4||17
9811810|NCT00669617|10921602|FG002|COMPLETED|Period 4||17
9811811|NCT00669617|10921603|FG003|COMPLETED|Period 4||18
9811812|NCT00669617|10921604|FG004|COMPLETED|Period 4||17
9811813|NCT00669617|10921600|FG000|NOT COMPLETED|Period 4||0
10235471|NCT01188798|11365764|FG000|COMPLETED|Overall Study||0
10235472|NCT01188798|11365765|FG001|COMPLETED|Overall Study||1
10235473|NCT01188798|11365764|FG000|NOT COMPLETED|Overall Study||2
10235474|NCT01188798|11365765|FG001|NOT COMPLETED|Overall Study||3
10235475|NCT01174368|11365772|FG000|STARTED|Overall Study||1
10235476|NCT01174368|11365772|FG000|COMPLETED|Overall Study||0
10235477|NCT01174368|11365772|FG000|NOT COMPLETED|Overall Study||1
10235478|NCT01183897|11365776|FG000|STARTED|Overall Study||31
9811814|NCT00669617|10921601|FG001|NOT COMPLETED|Period 4||0
9811815|NCT00669617|10921602|FG002|NOT COMPLETED|Period 4||0
9811816|NCT00669617|10921603|FG003|NOT COMPLETED|Period 4||0
9811817|NCT00669617|10921604|FG004|NOT COMPLETED|Period 4||0
9811818|NCT00669617|10921600|FG000|STARTED|Period 5||17
9811819|NCT00669617|10921601|FG001|STARTED|Period 5||17
9811820|NCT00669617|10921602|FG002|STARTED|Period 5||17
9811821|NCT00669617|10921603|FG003|STARTED|Period 5||18
9811822|NCT00669617|10921604|FG004|STARTED|Period 5||17
9811823|NCT00669617|10921600|FG000|COMPLETED|Period 5||17
9811824|NCT00669617|10921601|FG001|COMPLETED|Period 5||17
9811825|NCT00669617|10921602|FG002|COMPLETED|Period 5||17
9811826|NCT00669617|10921603|FG003|COMPLETED|Period 5||18
9811827|NCT00669617|10921604|FG004|COMPLETED|Period 5||17
9811828|NCT00669617|10921600|FG000|NOT COMPLETED|Period 5||0
9811829|NCT00669617|10921601|FG001|NOT COMPLETED|Period 5||0
9811830|NCT00669617|10921602|FG002|NOT COMPLETED|Period 5||0
9811831|NCT00669617|10921603|FG003|NOT COMPLETED|Period 5||0
9811832|NCT00669617|10921604|FG004|NOT COMPLETED|Period 5||0
9811833|NCT00669682|10921616|FG000|STARTED|Overall Study||9
9811834|NCT00669682|10921616|FG000|COMPLETED|Overall Study||9
9811835|NCT00669682|10921616|FG000|NOT COMPLETED|Overall Study||0
9811836|NCT00669864|10921621|FG000|STARTED|Overall Study||293
9811837|NCT00669864|10921621|FG000|COMPLETED|Overall Study||284
9811838|NCT00669864|10921621|FG000|NOT COMPLETED|Overall Study||9
9811839|NCT00669877|10921625|FG000|STARTED|Overall Study||56
9811840|NCT00669877|10921625|FG000|COMPLETED|Overall Study||52
9811841|NCT00669877|10921625|FG000|NOT COMPLETED|Overall Study||4
9811842|NCT00669903|10921633|FG000|STARTED|Overall Study||23
9811843|NCT00669903|10921634|FG001|STARTED|Overall Study||37
9811844|NCT00669903|10921635|FG002|STARTED|Overall Study||18
9811845|NCT00669903|10921636|FG003|STARTED|Overall Study||22
9811846|NCT00669903|10921633|FG000|Completed Treatment Period|Overall Study||23
9811847|NCT00669903|10921634|FG001|Completed Treatment Period|Overall Study||33
10235479|NCT01183897|11365776|FG000|COMPLETED|Overall Study||31
9811848|NCT00669903|10921635|FG002|Completed Treatment Period|Overall Study||13
9811849|NCT00669903|10921636|FG003|Completed Treatment Period|Overall Study||19
9811850|NCT00669903|10921633|FG000|COMPLETED|Overall Study||22
9811851|NCT00669903|10921634|FG001|COMPLETED|Overall Study||32
9811852|NCT00669903|10921635|FG002|COMPLETED|Overall Study||13
9811853|NCT00669903|10921636|FG003|COMPLETED|Overall Study||18
9811854|NCT00669903|10921633|FG000|NOT COMPLETED|Overall Study||1
9811855|NCT00669903|10921634|FG001|NOT COMPLETED|Overall Study||5
9811856|NCT00669903|10921635|FG002|NOT COMPLETED|Overall Study||5
9811857|NCT00669903|10921636|FG003|NOT COMPLETED|Overall Study||4
9811858|NCT00669916|10921648|FG000|STARTED|Overall Study||18
9811859|NCT00669916|10921649|FG001|STARTED|Overall Study||18
9811860|NCT00669916|10921648|FG000|COMPLETED|Overall Study||18
9811861|NCT00669916|10921649|FG001|COMPLETED|Overall Study||18
9811862|NCT00669916|10921648|FG000|NOT COMPLETED|Overall Study||0
9811863|NCT00669916|10921649|FG001|NOT COMPLETED|Overall Study||0
9811864|NCT00669942|10921667|FG000|STARTED|Part 1||6
9811865|NCT00669942|10921668|FG001|STARTED|Part 1||6
9811866|NCT00669942|10921669|FG002|STARTED|Part 1||6
9811867|NCT00669942|10921670|FG003|STARTED|Part 1||6
9811868|NCT00669942|10921671|FG004|STARTED|Part 1||8
9811869|NCT00669942|10921672|FG005|STARTED|Part 1||0
9811870|NCT00669942|10921673|FG006|STARTED|Part 1||0
9811871|NCT00669942|10921674|FG007|STARTED|Part 1||0
9811872|NCT00669942|10921675|FG008|STARTED|Part 1||0
9811873|NCT00669942|10921676|FG009|STARTED|Part 1||0
9811874|NCT00669942|10921677|FG010|STARTED|Part 1||0
9811875|NCT00669942|10921678|FG011|STARTED|Part 1||0
9811876|NCT00669942|10921667|FG000|COMPLETED|Part 1||6
9811877|NCT00669942|10921668|FG001|COMPLETED|Part 1||6
9811878|NCT00669942|10921669|FG002|COMPLETED|Part 1||6
9811879|NCT00669942|10921670|FG003|COMPLETED|Part 1||6
9811880|NCT00669942|10921671|FG004|COMPLETED|Part 1||8
9811881|NCT00669942|10921672|FG005|COMPLETED|Part 1||0
9811882|NCT00669942|10921673|FG006|COMPLETED|Part 1||0
9811883|NCT00669942|10921674|FG007|COMPLETED|Part 1||0
10235480|NCT01183897|11365776|FG000|NOT COMPLETED|Overall Study||0
10235481|NCT01183884|11365780|FG000|STARTED|Overall Study||46
9811884|NCT00669942|10921675|FG008|COMPLETED|Part 1||0
9811885|NCT00669942|10921676|FG009|COMPLETED|Part 1||0
9811886|NCT00669942|10921677|FG010|COMPLETED|Part 1||0
9811887|NCT00669942|10921678|FG011|COMPLETED|Part 1||0
9811888|NCT00669942|10921667|FG000|NOT COMPLETED|Part 1||0
9811889|NCT00669942|10921668|FG001|NOT COMPLETED|Part 1||0
9811890|NCT00669942|10921669|FG002|NOT COMPLETED|Part 1||0
9811891|NCT00669942|10921670|FG003|NOT COMPLETED|Part 1||0
9811892|NCT00669942|10921671|FG004|NOT COMPLETED|Part 1||0
9811893|NCT00669942|10921672|FG005|NOT COMPLETED|Part 1||0
9811894|NCT00669942|10921673|FG006|NOT COMPLETED|Part 1||0
9811895|NCT00669942|10921674|FG007|NOT COMPLETED|Part 1||0
9811896|NCT00669942|10921675|FG008|NOT COMPLETED|Part 1||0
9811897|NCT00669942|10921676|FG009|NOT COMPLETED|Part 1||0
9811898|NCT00669942|10921677|FG010|NOT COMPLETED|Part 1||0
9811899|NCT00669942|10921678|FG011|NOT COMPLETED|Part 1||0
9811900|NCT00669942|10921667|FG000|STARTED|Parts 2 and 3||0
9811901|NCT00669942|10921668|FG001|STARTED|Parts 2 and 3||0
9811902|NCT00669942|10921669|FG002|STARTED|Parts 2 and 3||0
9811903|NCT00669942|10921670|FG003|STARTED|Parts 2 and 3||0
9811904|NCT00669942|10921671|FG004|STARTED|Parts 2 and 3||0
9811905|NCT00669942|10921672|FG005|STARTED|Parts 2 and 3||6
9811906|NCT00669942|10921673|FG006|STARTED|Parts 2 and 3||6
9811907|NCT00669942|10921674|FG007|STARTED|Parts 2 and 3||26
9811908|NCT00669942|10921675|FG008|STARTED|Parts 2 and 3||26
9811909|NCT00669942|10921676|FG009|STARTED|Parts 2 and 3||0
9811910|NCT00669942|10921677|FG010|STARTED|Parts 2 and 3||0
9811911|NCT00669942|10921678|FG011|STARTED|Parts 2 and 3||0
9811912|NCT00669942|10921667|FG000|COMPLETED|Parts 2 and 3||0
9811913|NCT00669942|10921668|FG001|COMPLETED|Parts 2 and 3||0
9811914|NCT00669942|10921669|FG002|COMPLETED|Parts 2 and 3||0
9811915|NCT00669942|10921670|FG003|COMPLETED|Parts 2 and 3||0
9811916|NCT00669942|10921671|FG004|COMPLETED|Parts 2 and 3||0
9811917|NCT00669942|10921672|FG005|COMPLETED|Parts 2 and 3||4
9811918|NCT00669942|10921673|FG006|COMPLETED|Parts 2 and 3||6
9811919|NCT00669942|10921674|FG007|COMPLETED|Parts 2 and 3||24
9811920|NCT00669942|10921675|FG008|COMPLETED|Parts 2 and 3||23
9811921|NCT00669942|10921676|FG009|COMPLETED|Parts 2 and 3||0
9811922|NCT00669942|10921677|FG010|COMPLETED|Parts 2 and 3||0
9811923|NCT00669942|10921678|FG011|COMPLETED|Parts 2 and 3||0
9811924|NCT00669942|10921667|FG000|NOT COMPLETED|Parts 2 and 3||0
9811925|NCT00669942|10921668|FG001|NOT COMPLETED|Parts 2 and 3||0
9811926|NCT00669942|10921669|FG002|NOT COMPLETED|Parts 2 and 3||0
9811927|NCT00669942|10921670|FG003|NOT COMPLETED|Parts 2 and 3||0
9811928|NCT00669942|10921671|FG004|NOT COMPLETED|Parts 2 and 3||0
9811929|NCT00669942|10921672|FG005|NOT COMPLETED|Parts 2 and 3||2
9811930|NCT00669942|10921673|FG006|NOT COMPLETED|Parts 2 and 3||0
9811931|NCT00669942|10921674|FG007|NOT COMPLETED|Parts 2 and 3||2
9811932|NCT00669942|10921675|FG008|NOT COMPLETED|Parts 2 and 3||3
9811933|NCT00669942|10921676|FG009|NOT COMPLETED|Parts 2 and 3||0
9811934|NCT00669942|10921677|FG010|NOT COMPLETED|Parts 2 and 3||0
9811935|NCT00669942|10921678|FG011|NOT COMPLETED|Parts 2 and 3||0
9811936|NCT00669942|10921667|FG000|STARTED|Healthy Volunteers||0
9811937|NCT00669942|10921668|FG001|STARTED|Healthy Volunteers||0
9811938|NCT00669942|10921669|FG002|STARTED|Healthy Volunteers||0
10235482|NCT01183884|11365780|FG000|COMPLETED|Overall Study||8
9811939|NCT00669942|10921670|FG003|STARTED|Healthy Volunteers||0
9811940|NCT00669942|10921671|FG004|STARTED|Healthy Volunteers||0
9811941|NCT00669942|10921672|FG005|STARTED|Healthy Volunteers||0
9811942|NCT00669942|10921673|FG006|STARTED|Healthy Volunteers||0
9811943|NCT00669942|10921674|FG007|STARTED|Healthy Volunteers||0
9811944|NCT00669942|10921675|FG008|STARTED|Healthy Volunteers||0
9811945|NCT00669942|10921676|FG009|STARTED|Healthy Volunteers||3
9811946|NCT00669942|10921677|FG010|STARTED|Healthy Volunteers||3
9811947|NCT00669942|10921678|FG011|STARTED|Healthy Volunteers||2
9811948|NCT00669942|10921667|FG000|COMPLETED|Healthy Volunteers||0
9811949|NCT00669942|10921668|FG001|COMPLETED|Healthy Volunteers||0
9811950|NCT00669942|10921669|FG002|COMPLETED|Healthy Volunteers||0
9811951|NCT00669942|10921670|FG003|COMPLETED|Healthy Volunteers||0
9811952|NCT00669942|10921671|FG004|COMPLETED|Healthy Volunteers||0
9811953|NCT00669942|10921672|FG005|COMPLETED|Healthy Volunteers||0
9811954|NCT00669942|10921673|FG006|COMPLETED|Healthy Volunteers||0
9811955|NCT00669942|10921674|FG007|COMPLETED|Healthy Volunteers||0
9811956|NCT00669942|10921675|FG008|COMPLETED|Healthy Volunteers||0
9811957|NCT00669942|10921676|FG009|COMPLETED|Healthy Volunteers||3
9811958|NCT00669942|10921677|FG010|COMPLETED|Healthy Volunteers||2
9811959|NCT00669942|10921678|FG011|COMPLETED|Healthy Volunteers||2
9811960|NCT00669942|10921667|FG000|NOT COMPLETED|Healthy Volunteers||0
9811961|NCT00669942|10921668|FG001|NOT COMPLETED|Healthy Volunteers||0
9811962|NCT00669942|10921669|FG002|NOT COMPLETED|Healthy Volunteers||0
9811963|NCT00669942|10921670|FG003|NOT COMPLETED|Healthy Volunteers||0
9811964|NCT00669942|10921671|FG004|NOT COMPLETED|Healthy Volunteers||0
9811965|NCT00669942|10921672|FG005|NOT COMPLETED|Healthy Volunteers||0
9811966|NCT00669942|10921673|FG006|NOT COMPLETED|Healthy Volunteers||0
9811967|NCT00669942|10921674|FG007|NOT COMPLETED|Healthy Volunteers||0
9811968|NCT00669942|10921675|FG008|NOT COMPLETED|Healthy Volunteers||0
9811969|NCT00669942|10921676|FG009|NOT COMPLETED|Healthy Volunteers||0
9811970|NCT00669942|10921677|FG010|NOT COMPLETED|Healthy Volunteers||1
9811971|NCT00669942|10921678|FG011|NOT COMPLETED|Healthy Volunteers||0
9811972|NCT00669955|10921703|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
9811973|NCT00669955|10921704|FG001|STARTED|Overall Study||222
9811974|NCT00669955|10921703|FG000|COMPLETED|Overall Study||204
9811975|NCT00669955|10921704|FG001|COMPLETED|Overall Study||195
9811976|NCT00669955|10921703|FG000|NOT COMPLETED|Overall Study||14
9811977|NCT00669955|10921704|FG001|NOT COMPLETED|Overall Study||27
9811978|NCT00670007|10921710|FG000|STARTED|Overall Study||140
9811979|NCT00670007|10921710|FG000|COMPLETED|Overall Study||131
9811980|NCT00670007|10921710|FG000|NOT COMPLETED|Overall Study||9
9811981|NCT00670046|10921717|FG000|STARTED|Overall Study||7
9811982|NCT00670046|10921718|FG001|STARTED|Overall Study||8
9811983|NCT00670046|10921717|FG000|COMPLETED|Overall Study||6
9811984|NCT00670046|10921718|FG001|COMPLETED|Overall Study||6
9811985|NCT00670046|10921717|FG000|NOT COMPLETED|Overall Study||1
9811986|NCT00670046|10921718|FG001|NOT COMPLETED|Overall Study||2
9811987|NCT00670111|10921727|FG000|STARTED|Enrollment to One Month||5
9811988|NCT00670111|10921728|FG001|STARTED|Enrollment to One Month||8
9811989|NCT00670111|10921729|FG002|STARTED|Enrollment to One Month||19
9811990|NCT00670111|10921727|FG000|COMPLETED|Enrollment to One Month||4
9811991|NCT00670111|10921728|FG001|COMPLETED|Enrollment to One Month||8
9811992|NCT00670111|10921729|FG002|COMPLETED|Enrollment to One Month||0
9811993|NCT00670111|10921727|FG000|NOT COMPLETED|Enrollment to One Month||1
9811994|NCT00670111|10921728|FG001|NOT COMPLETED|Enrollment to One Month||0
9811995|NCT00670111|10921729|FG002|NOT COMPLETED|Enrollment to One Month||19
9811996|NCT00670111|10921727|FG000|STARTED|One Month Period A||4
9811997|NCT00670111|10921728|FG001|STARTED|One Month Period A||8
9811998|NCT00670111|10921729|FG002|STARTED|One Month Period A||0
9811999|NCT00670111|10921727|FG000|COMPLETED|One Month Period A||4
9812000|NCT00670111|10921728|FG001|COMPLETED|One Month Period A||8
9812001|NCT00670111|10921729|FG002|COMPLETED|One Month Period A||0
9812002|NCT00670111|10921727|FG000|NOT COMPLETED|One Month Period A||0
9812003|NCT00670111|10921728|FG001|NOT COMPLETED|One Month Period A||0
9812004|NCT00670111|10921729|FG002|NOT COMPLETED|One Month Period A||0
9812005|NCT00670111|10921727|FG000|STARTED|One Month Period B||4
9812006|NCT00670111|10921728|FG001|STARTED|One Month Period B||8
9812007|NCT00670111|10921729|FG002|STARTED|One Month Period B||0
9812008|NCT00670111|10921727|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
9812009|NCT00670111|10921728|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
9812010|NCT00670111|10921729|FG002|COMPLETED|One Month Period B||0
9812011|NCT00670111|10921727|FG000|NOT COMPLETED|One Month Period B||0
9812012|NCT00670111|10921728|FG001|NOT COMPLETED|One Month Period B||0
9812013|NCT00670111|10921729|FG002|NOT COMPLETED|One Month Period B||0
9812014|NCT00670111|10921727|FG000|STARTED|One Month to Six Months||4
9812015|NCT00670111|10921728|FG001|STARTED|One Month to Six Months||8
9812016|NCT00670111|10921729|FG002|STARTED|One Month to Six Months||0
9812017|NCT00670111|10921727|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
9812018|NCT00670111|10921728|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
9812019|NCT00670111|10921729|FG002|COMPLETED|One Month to Six Months||0
9812020|NCT00670111|10921727|FG000|NOT COMPLETED|One Month to Six Months||0
9812021|NCT00670111|10921728|FG001|NOT COMPLETED|One Month to Six Months||0
9812022|NCT00670111|10921729|FG002|NOT COMPLETED|One Month to Six Months||0
9812023|NCT00670111|10921727|FG000|STARTED|Six Months to Twelve Months||4
9812024|NCT00670111|10921728|FG001|STARTED|Six Months to Twelve Months||8
9812025|NCT00670111|10921729|FG002|STARTED|Six Months to Twelve Months||0
9812026|NCT00670111|10921727|FG000|COMPLETED|Six Months to Twelve Months||4
9812027|NCT00670111|10921728|FG001|COMPLETED|Six Months to Twelve Months||8
9812028|NCT00670111|10921729|FG002|COMPLETED|Six Months to Twelve Months||0
9812029|NCT00670111|10921727|FG000|NOT COMPLETED|Six Months to Twelve Months||0
9812030|NCT00670111|10921728|FG001|NOT COMPLETED|Six Months to Twelve Months||0
9812031|NCT00670111|10921729|FG002|NOT COMPLETED|Six Months to Twelve Months||0
9831771|NCT00770133|10942387|FG003|NOT COMPLETED|Overall Study||3
9812032|NCT00670202|10921739|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
9812033|NCT00670202|10921740|FG001|STARTED|Overall Study||0
9812034|NCT00670202|10921739|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
9812035|NCT00670202|10921740|FG001|COMPLETED|Overall Study||0
9812036|NCT00670202|10921739|FG000|NOT COMPLETED|Overall Study||0
9812037|NCT00670202|10921740|FG001|NOT COMPLETED|Overall Study||0
9812038|NCT00670228|10921748|FG000|STARTED|Overall Study||18
9812039|NCT00670228|10921749|FG001|STARTED|Overall Study||15
9812040|NCT00670228|10921748|FG000|COMPLETED|Overall Study||13
9812041|NCT00670228|10921749|FG001|COMPLETED|Overall Study||12
9812042|NCT00670228|10921748|FG000|NOT COMPLETED|Overall Study||5
9812043|NCT00670228|10921749|FG001|NOT COMPLETED|Overall Study||3
9812044|NCT00670241|10921758|FG000|STARTED|Overall Study||183
9812045|NCT00670241|10921759|FG001|STARTED|Overall Study||184
9812046|NCT00670241|10921760|FG002|STARTED|Overall Study||91
9812047|NCT00670241|10921758|FG000|COMPLETED|Overall Study||171
9812048|NCT00670241|10921759|FG001|COMPLETED|Overall Study||163
9812049|NCT00670241|10921760|FG002|COMPLETED|Overall Study||64
9812050|NCT00670241|10921758|FG000|NOT COMPLETED|Overall Study||12
9812051|NCT00670241|10921759|FG001|NOT COMPLETED|Overall Study||21
9812052|NCT00670241|10921760|FG002|NOT COMPLETED|Overall Study||27
9812053|NCT00670267|10921768|FG000|STARTED|Overall Study||10
9812054|NCT00670267|10921768|FG000|COMPLETED|Overall Study||9
9812055|NCT00670267|10921768|FG000|NOT COMPLETED|Overall Study||1
9812056|NCT00670306|10921774|FG000|STARTED|Overall Study||528
9812057|NCT00670306|10921774|FG000|COMPLETED|Overall Study||473
9812058|NCT00670306|10921774|FG000|NOT COMPLETED|Overall Study||55
9812059|NCT00670449|10921782|FG000|STARTED|Overall Study||47
9812060|NCT00670449|10921783|FG001|STARTED|Overall Study||46
9812061|NCT00670449|10921784|FG002|STARTED|Overall Study||27
9812062|NCT00670449|10921785|FG003|STARTED|Overall Study||23
9812063|NCT00670449|10921782|FG000|Switched to 0.5mg (Open Label)|Overall Study||45
9812064|NCT00670449|10921783|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
9812065|NCT00670449|10921784|FG002|Switched to 0.5mg (Open Label)|Overall Study||23
9812066|NCT00670449|10921785|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
9812067|NCT00670449|10921782|FG000|COMPLETED|Overall Study||38
9812068|NCT00670449|10921783|FG001|COMPLETED|Overall Study||36
9812069|NCT00670449|10921784|FG002|COMPLETED|Overall Study||18
9812070|NCT00670449|10921785|FG003|COMPLETED|Overall Study||15
9812071|NCT00670449|10921782|FG000|NOT COMPLETED|Overall Study||9
9812072|NCT00670449|10921783|FG001|NOT COMPLETED|Overall Study||10
9812073|NCT00670449|10921784|FG002|NOT COMPLETED|Overall Study||9
10235483|NCT01183884|11365780|FG000|NOT COMPLETED|Overall Study||38
9812074|NCT00670449|10921785|FG003|NOT COMPLETED|Overall Study||8
9812075|NCT00670462|10921796|FG000|STARTED|Overall Study||106
9812076|NCT00670462|10921797|FG001|STARTED|Overall Study||107
9812077|NCT00670462|10921796|FG000|COMPLETED|Overall Study||76
9812078|NCT00670462|10921797|FG001|COMPLETED|Overall Study||76
9812079|NCT00670462|10921796|FG000|NOT COMPLETED|Overall Study||30
9812080|NCT00670462|10921797|FG001|NOT COMPLETED|Overall Study||31
9812081|NCT00670488|10921815|FG000|STARTED|Overall Study||3
9812082|NCT00670488|10921816|FG001|STARTED|Overall Study||58
9812083|NCT00670488|10921817|FG002|STARTED|Overall Study||3
9812084|NCT00670488|10921818|FG003|STARTED|Overall Study||7
9812085|NCT00670488|10921819|FG004|STARTED|Overall Study||3
9812086|NCT00670488|10921820|FG005|STARTED|Overall Study||5
9812087|NCT00670488|10921821|FG006|STARTED|Overall Study||17
9812088|NCT00670488|10921822|FG007|STARTED|Overall Study||3
9812089|NCT00670488|10921823|FG008|STARTED|Overall Study||3
9812090|NCT00670488|10921824|FG009|STARTED|Overall Study||2
9812091|NCT00670488|10921815|FG000|COMPLETED|Overall Study||0
9812092|NCT00670488|10921816|FG001|COMPLETED|Overall Study||0
9812093|NCT00670488|10921817|FG002|COMPLETED|Overall Study||0
9812094|NCT00670488|10921818|FG003|COMPLETED|Overall Study||0
9812095|NCT00670488|10921819|FG004|COMPLETED|Overall Study||0
9812096|NCT00670488|10921820|FG005|COMPLETED|Overall Study||0
9812097|NCT00670488|10921821|FG006|COMPLETED|Overall Study||0
9812098|NCT00670488|10921822|FG007|COMPLETED|Overall Study||0
9812099|NCT00670488|10921823|FG008|COMPLETED|Overall Study||0
9812100|NCT00670488|10921824|FG009|COMPLETED|Overall Study||0
9812101|NCT00670488|10921815|FG000|NOT COMPLETED|Overall Study||3
9812102|NCT00670488|10921816|FG001|NOT COMPLETED|Overall Study||58
9812103|NCT00670488|10921817|FG002|NOT COMPLETED|Overall Study||3
9812104|NCT00670488|10921818|FG003|NOT COMPLETED|Overall Study||7
9812105|NCT00670488|10921819|FG004|NOT COMPLETED|Overall Study||3
9812106|NCT00670488|10921820|FG005|NOT COMPLETED|Overall Study||5
9812107|NCT00670488|10921821|FG006|NOT COMPLETED|Overall Study||17
9812108|NCT00670488|10921822|FG007|NOT COMPLETED|Overall Study||3
9812109|NCT00670488|10921823|FG008|NOT COMPLETED|Overall Study||3
9812110|NCT00670488|10921824|FG009|NOT COMPLETED|Overall Study||2
9812111|NCT00670540|10921846|FG000|STARTED|Overall Study||8256
9812112|NCT00670540|10921846|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931
9812113|NCT00670540|10921846|FG000|NOT COMPLETED|Overall Study||3325
9812114|NCT00670709|10921852|FG000|STARTED|Overall Study||27
9812115|NCT00670709|10921853|FG001|STARTED|Overall Study||15
9812116|NCT00670709|10921852|FG000|COMPLETED|Overall Study||27
10235484|NCT01183429|11365784|FG000|STARTED|Overall Study||39
10235485|NCT01183429|11365784|FG000|COMPLETED|Overall Study||39
9812117|NCT00670709|10921853|FG001|COMPLETED|Overall Study||15
9812118|NCT00670709|10921852|FG000|NOT COMPLETED|Overall Study||0
9812119|NCT00670709|10921853|FG001|NOT COMPLETED|Overall Study||0
9812120|NCT00670748|10921863|FG000|STARTED|Overall Study||17
9812121|NCT00670748|10921864|FG001|STARTED|Overall Study||16
9812122|NCT00670748|10921865|FG002|STARTED|Overall Study||7
9812123|NCT00670748|10921866|FG003|STARTED|Overall Study||5
9812124|NCT00670748|10921863|FG000|COMPLETED|Overall Study||14
9812125|NCT00670748|10921864|FG001|COMPLETED|Overall Study||14
9812126|NCT00670748|10921865|FG002|COMPLETED|Overall Study||5
9812127|NCT00670748|10921866|FG003|COMPLETED|Overall Study||4
9812128|NCT00670748|10921863|FG000|NOT COMPLETED|Overall Study||3
9812129|NCT00670748|10921864|FG001|NOT COMPLETED|Overall Study||2
9812130|NCT00670748|10921865|FG002|NOT COMPLETED|Overall Study||2
9812131|NCT00670748|10921866|FG003|NOT COMPLETED|Overall Study||1
9812132|NCT00670774|10921876|FG000|STARTED|Overall Study||26
9812133|NCT00670774|10921876|FG000|COMPLETED|Overall Study||26
9812134|NCT00670774|10921876|FG000|NOT COMPLETED|Overall Study||0
10016503|NCT01810432|11139300|FG000|NOT COMPLETED|Period 2||4
10016504|NCT01810432|11139301|FG001|NOT COMPLETED|Period 2||2
10016505|NCT01810666|11139307|FG000|STARTED|Overall Study||30
9812135|NCT00670800|10921882|FG000|STARTED|Overall Study||7
9812136|NCT00670800|10921883|FG001|STARTED|Overall Study||7
9812137|NCT00670800|10921882|FG000|COMPLETED|Overall Study||7
9812138|NCT00670800|10921883|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
9812139|NCT00670800|10921882|FG000|NOT COMPLETED|Overall Study||0
9812140|NCT00670800|10921883|FG001|NOT COMPLETED|Overall Study||2
9812141|NCT00670930|10921893|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
9812142|NCT00670930|10921894|FG001|STARTED|Overall Study||13
9812143|NCT00670930|10921893|FG000|Intent to Treat (ITT) Population|Overall Study||23
9812144|NCT00670930|10921894|FG001|Intent to Treat (ITT) Population|Overall Study||12
9812145|NCT00670930|10921893|FG000|COMPLETED|Overall Study||22
9812146|NCT00670930|10921894|FG001|COMPLETED|Overall Study||12
9812147|NCT00670930|10921893|FG000|NOT COMPLETED|Overall Study||1
9812148|NCT00670930|10921894|FG001|NOT COMPLETED|Overall Study||1
9812149|NCT00670956|10921900|FG000|STARTED|Overall Study||1
9812150|NCT00670956|10921900|FG000|COMPLETED|Overall Study||1
9812151|NCT00670956|10921900|FG000|NOT COMPLETED|Overall Study||0
9812152|NCT00670982|10921906|FG000|STARTED|Overall Study||22
9812153|NCT00670982|10921907|FG001|STARTED|Overall Study||7
9812154|NCT00670982|10921906|FG000|COMPLETED|Overall Study||22
9812155|NCT00670982|10921907|FG001|COMPLETED|Overall Study||7
9812156|NCT00670982|10921906|FG000|NOT COMPLETED|Overall Study||0
9812157|NCT00670982|10921907|FG001|NOT COMPLETED|Overall Study||0
9812158|NCT00671034|10921915|FG000|STARTED|Overall Study||69
9812159|NCT00671034|10921916|FG001|STARTED|Overall Study||42
9812160|NCT00671034|10921917|FG002|STARTED|Overall Study||55
9812161|NCT00671034|10921915|FG000|COMPLETED|Overall Study||30
9812162|NCT00671034|10921916|FG001|COMPLETED|Overall Study||22
9812163|NCT00671034|10921917|FG002|COMPLETED|Overall Study||31
9812164|NCT00671034|10921915|FG000|NOT COMPLETED|Overall Study||39
9812165|NCT00671034|10921916|FG001|NOT COMPLETED|Overall Study||20
9812166|NCT00671034|10921917|FG002|NOT COMPLETED|Overall Study||24
9812167|NCT00671060|10921928|FG000|STARTED|Overall Study||77
9812168|NCT00671060|10921929|FG001|STARTED|Overall Study||76
9812169|NCT00671060|10921928|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
9812170|NCT00671060|10921929|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
9812171|NCT00671060|10921928|FG000|NOT COMPLETED|Overall Study||1
9812172|NCT00671060|10921929|FG001|NOT COMPLETED|Overall Study||1
9812173|NCT00671177|10921937|FG000|STARTED|Overall Study||114
9812174|NCT00671177|10921938|FG001|STARTED|Overall Study||115
9812175|NCT00671177|10921937|FG000|COMPLETED|Overall Study||112
9812176|NCT00671177|10921938|FG001|COMPLETED|Overall Study||114
9812177|NCT00671177|10921937|FG000|NOT COMPLETED|Overall Study||2
10016506|NCT01810666|11139307|FG000|COMPLETED|Overall Study||30
9812178|NCT00671177|10921938|FG001|NOT COMPLETED|Overall Study||1
9812179|NCT00671437|10921944|FG000|STARTED|Overall Study||42
9812180|NCT00671437|10921944|FG000|COMPLETED|Overall Study||27
9812181|NCT00671437|10921944|FG000|NOT COMPLETED|Overall Study||15
9812182|NCT00671502|10921959|FG000|STARTED|Overall Study||281
9812183|NCT00671502|10921960|FG001|STARTED|Overall Study||280
9812184|NCT00671502|10921961|FG002|STARTED|Overall Study||279
9812185|NCT00671502|10921959|FG000|COMPLETED|Overall Study||242
9812186|NCT00671502|10921960|FG001|COMPLETED|Overall Study||241
9812187|NCT00671502|10921961|FG002|COMPLETED|Overall Study||252
9812188|NCT00671502|10921959|FG000|NOT COMPLETED|Overall Study||39
9812189|NCT00671502|10921960|FG001|NOT COMPLETED|Overall Study||39
9812190|NCT00671502|10921961|FG002|NOT COMPLETED|Overall Study||27
9812191|NCT00671515|10921969|FG000|STARTED|Phase 1||23
9812192|NCT00671515|10921969|FG000|COMPLETED|Phase 1||20
9812193|NCT00671515|10921969|FG000|NOT COMPLETED|Phase 1||3
9812194|NCT00671515|10921969|FG000|STARTED|Phase 2||13
9812195|NCT00671515|10921969|FG000|COMPLETED|Phase 2||9
9812196|NCT00671515|10921969|FG000|NOT COMPLETED|Phase 2||4
9812197|NCT00671554|10921973|FG000|STARTED|Overall Study||3
9812198|NCT00671554|10921973|FG000|COMPLETED|Overall Study||0
9812199|NCT00671554|10921973|FG000|NOT COMPLETED|Overall Study||3
9812200|NCT00671658|10921978|FG000|STARTED|Overall Study||220
9812201|NCT00671658|10921978|FG000|COMPLETED|Overall Study||215
9812202|NCT00671658|10921978|FG000|NOT COMPLETED|Overall Study||5
9812203|NCT00671671|10921984|FG000|STARTED|Overall Study||10
9812204|NCT00671671|10921985|FG001|STARTED|Overall Study||10
9812205|NCT00671671|10921984|FG000|COMPLETED|Overall Study||10
9812206|NCT00671671|10921985|FG001|COMPLETED|Overall Study||10
9812207|NCT00671671|10921984|FG000|NOT COMPLETED|Overall Study||0
9812208|NCT00671671|10921985|FG001|NOT COMPLETED|Overall Study||0
9812209|NCT00671723|10921995|FG000|STARTED|Overall Study||11
9812210|NCT00671723|10921996|FG001|STARTED|Overall Study||11
9812211|NCT00671723|10921997|FG002|STARTED|Overall Study||11
9812212|NCT00671723|10921995|FG000|COMPLETED|Overall Study||11
9812213|NCT00671723|10921996|FG001|COMPLETED|Overall Study||11
9812214|NCT00671723|10921997|FG002|COMPLETED|Overall Study||11
9812215|NCT00671723|10921995|FG000|NOT COMPLETED|Overall Study||0
9812216|NCT00671723|10921996|FG001|NOT COMPLETED|Overall Study||0
9812217|NCT00671723|10921997|FG002|NOT COMPLETED|Overall Study||0
9812218|NCT00671749|10922005|FG000|STARTED|Overall Study||100
9812219|NCT00671749|10922005|FG000|COMPLETED|Overall Study||92
9812220|NCT00671749|10922005|FG000|NOT COMPLETED|Overall Study||8
9812221|NCT00671788|10922009|FG000|STARTED|Overall Study||35
9812222|NCT00671788|10922009|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
9812223|NCT00671788|10922009|FG000|NOT COMPLETED|Overall Study||14
9812224|NCT00671853|10922015|FG000|STARTED|Overall Study||46
9812225|NCT00671853|10922016|FG001|STARTED|Overall Study||45
9812226|NCT00671853|10922015|FG000|COMPLETED|Overall Study||26
9812227|NCT00671853|10922016|FG001|COMPLETED|Overall Study||18
9812228|NCT00671853|10922015|FG000|NOT COMPLETED|Overall Study||20
9812229|NCT00671853|10922016|FG001|NOT COMPLETED|Overall Study||27
9812230|NCT00671879|10922027|FG000|STARTED|Overall Study||281
9812231|NCT00671879|10922028|FG001|STARTED|Overall Study||279
9812232|NCT00671879|10922029|FG002|STARTED|Overall Study||280
9812233|NCT00671879|10922027|FG000|COMPLETED|Overall Study||281
9812234|NCT00671879|10922028|FG001|COMPLETED|Overall Study||275
9812235|NCT00671879|10922029|FG002|COMPLETED|Overall Study||274
9812236|NCT00671879|10922027|FG000|NOT COMPLETED|Overall Study||0
9812237|NCT00671879|10922028|FG001|NOT COMPLETED|Overall Study||4
9812238|NCT00671879|10922029|FG002|NOT COMPLETED|Overall Study||6
9812239|NCT00671918|10922038|FG000|STARTED|Overall Study||186
9812240|NCT00671918|10922038|FG000|COMPLETED|Overall Study||169
9812241|NCT00671918|10922038|FG000|NOT COMPLETED|Overall Study||17
9812242|NCT00671931|10922048|FG000|STARTED|Overall Study||9
9812243|NCT00671931|10922049|FG001|STARTED|Overall Study||8
9812244|NCT00671931|10922050|FG002|STARTED|Overall Study||9
9812245|NCT00671931|10922051|FG003|STARTED|Overall Study||10
9812246|NCT00671931|10922052|FG004|STARTED|Overall Study||8
9812247|NCT00671931|10922048|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
9812248|NCT00671931|10922049|FG001|COMPLETED|Overall Study|All completed|8
9812249|NCT00671931|10922050|FG002|COMPLETED|Overall Study|all completed|9
9812250|NCT00671931|10922051|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
9812251|NCT00671931|10922052|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7
9812252|NCT00671931|10922048|FG000|NOT COMPLETED|Overall Study||1
9812253|NCT00671931|10922049|FG001|NOT COMPLETED|Overall Study||0
9812254|NCT00671931|10922050|FG002|NOT COMPLETED|Overall Study||0
9812255|NCT00671931|10922051|FG003|NOT COMPLETED|Overall Study||2
9812256|NCT00671931|10922052|FG004|NOT COMPLETED|Overall Study||1
9812257|NCT00671970|10922066|FG000|STARTED|Overall Study||32
9812258|NCT00671970|10922067|FG001|STARTED|Overall Study||25
9812259|NCT00671970|10922066|FG000|COMPLETED|Overall Study||32
9812260|NCT00671970|10922067|FG001|COMPLETED|Overall Study||25
9812261|NCT00671970|10922066|FG000|NOT COMPLETED|Overall Study||0
9812262|NCT00671970|10922067|FG001|NOT COMPLETED|Overall Study||0
9812263|NCT00672100|10922088|FG000|STARTED|Overall Study||12
9812264|NCT00672100|10922089|FG001|STARTED|Overall Study||12
9812265|NCT00672100|10922090|FG002|STARTED|Overall Study||12
9812266|NCT00672100|10922088|FG000|PACU (Within 8 Hours)|Overall Study||12
9812267|NCT00672100|10922089|FG001|PACU (Within 8 Hours)|Overall Study||12
9812268|NCT00672100|10922090|FG002|PACU (Within 8 Hours)|Overall Study||12
9812269|NCT00672100|10922088|FG000|COMPLETED|Overall Study||12
9812270|NCT00672100|10922089|FG001|COMPLETED|Overall Study||12
9812271|NCT00672100|10922090|FG002|COMPLETED|Overall Study||12
9812272|NCT00672100|10922088|FG000|NOT COMPLETED|Overall Study||0
9812273|NCT00672100|10922089|FG001|NOT COMPLETED|Overall Study||0
9812274|NCT00672100|10922090|FG002|NOT COMPLETED|Overall Study||0
9812275|NCT00672139|10922104|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
9812276|NCT00672139|10922105|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
9812277|NCT00672139|10922104|FG000|COMPLETED|Overall Study||27
9812278|NCT00672139|10922105|FG001|COMPLETED|Overall Study||47
9812279|NCT00672139|10922104|FG000|NOT COMPLETED|Overall Study||30
9812280|NCT00672139|10922105|FG001|NOT COMPLETED|Overall Study||45
9812281|NCT00672204|10922111|FG000|STARTED|Overall Study||23
9812282|NCT00672204|10922111|FG000|COMPLETED|Overall Study||3
9812283|NCT00672204|10922111|FG000|NOT COMPLETED|Overall Study||20
9812284|NCT00672243|10922115|FG000|STARTED|Overall Study||32
9812285|NCT00672243|10922115|FG000|COMPLETED|Overall Study||32
9812286|NCT00672243|10922115|FG000|NOT COMPLETED|Overall Study||0
9812287|NCT00672256|10922120|FG000|STARTED|Overall Study|January 2007|62
9812288|NCT00672256|10922120|FG000|COMPLETED|Overall Study||18
9812289|NCT00672256|10922120|FG000|NOT COMPLETED|Overall Study||44
9812290|NCT00672438|10922126|FG000|STARTED|Infusion 1||119
9812291|NCT00672438|10922127|FG001|STARTED|Infusion 1||118
9812292|NCT00672438|10922126|FG000|COMPLETED|Infusion 1||119
9812293|NCT00672438|10922127|FG001|COMPLETED|Infusion 1||118
9812294|NCT00672438|10922126|FG000|NOT COMPLETED|Infusion 1||0
9812295|NCT00672438|10922127|FG001|NOT COMPLETED|Infusion 1||0
9812296|NCT00672438|10922126|FG000|STARTED|Washout||119
9812297|NCT00672438|10922127|FG001|STARTED|Washout||118
9812298|NCT00672438|10922126|FG000|COMPLETED|Washout||119
9812299|NCT00672438|10922127|FG001|COMPLETED|Washout||118
9812300|NCT00672438|10922126|FG000|NOT COMPLETED|Washout||0
9812301|NCT00672438|10922127|FG001|NOT COMPLETED|Washout||0
9812302|NCT00672438|10922126|FG000|STARTED|Infusion 2||119
9812303|NCT00672438|10922127|FG001|STARTED|Infusion 2||118
9812304|NCT00672438|10922126|FG000|COMPLETED|Infusion 2||119
9812305|NCT00672438|10922127|FG001|COMPLETED|Infusion 2||118
9812306|NCT00672438|10922126|FG000|NOT COMPLETED|Infusion 2||0
9812307|NCT00672438|10922127|FG001|NOT COMPLETED|Infusion 2||0
9812308|NCT00672451|10922135|FG000|STARTED|Overall Study||1
9812309|NCT00672451|10922136|FG001|STARTED|Overall Study||2
9812310|NCT00672451|10922135|FG000|COMPLETED|Overall Study||1
9812311|NCT00672451|10922136|FG001|COMPLETED|Overall Study||2
9812312|NCT00672451|10922135|FG000|NOT COMPLETED|Overall Study||0
9812313|NCT00672451|10922136|FG001|NOT COMPLETED|Overall Study||0
9812314|NCT00672477|10922144|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
9812315|NCT00672477|10922145|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
9812316|NCT00672477|10922144|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
9812317|NCT00672477|10922145|FG001|COMPLETED|Overall Study||88
9812318|NCT00672477|10922144|FG000|NOT COMPLETED|Overall Study||27
9812319|NCT00672477|10922145|FG001|NOT COMPLETED|Overall Study||26
9812320|NCT00672490|10922153|FG000|STARTED|Overall Study||187
9812321|NCT00672490|10922154|FG001|STARTED|Overall Study||189
9812322|NCT00672490|10922153|FG000|COMPLETED|Overall Study||163
9812323|NCT00672490|10922154|FG001|COMPLETED|Overall Study||157
9812324|NCT00672490|10922153|FG000|NOT COMPLETED|Overall Study||24
9812325|NCT00672490|10922154|FG001|NOT COMPLETED|Overall Study||32
9812326|NCT00672555|10922160|FG000|STARTED|Overall Study||70
9812327|NCT00672555|10922160|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
9812328|NCT00672555|10922160|FG000|NOT COMPLETED|Overall Study||6
9812329|NCT00672594|10922164|FG000|STARTED|Overall Study||30
9812330|NCT00672594|10922164|FG000|COMPLETED|Overall Study||27
9812331|NCT00672594|10922164|FG000|NOT COMPLETED|Overall Study||3
9831772|NCT00770146|10942399|FG000|STARTED|Treatment Period||53
9831773|NCT00770146|10942400|FG001|STARTED|Treatment Period||105
9831774|NCT00770146|10942399|FG000|Treated|Treatment Period||52
9831775|NCT00770146|10942400|FG001|Treated|Treatment Period||105
9831776|NCT00770146|10942399|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
9831777|NCT00770146|10942400|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
9831778|NCT00770146|10942399|FG000|COMPLETED|Treatment Period||44
9831779|NCT00770146|10942400|FG001|COMPLETED|Treatment Period||60
9831780|NCT00770146|10942399|FG000|NOT COMPLETED|Treatment Period||9
9831781|NCT00770146|10942400|FG001|NOT COMPLETED|Treatment Period||45
9831782|NCT00770146|10942399|FG000|STARTED|Follow-up Period||53
9831783|NCT00770146|10942400|FG001|STARTED|Follow-up Period||105
9831784|NCT00770146|10942399|FG000|COMPLETED|Follow-up Period||42
9831785|NCT00770146|10942400|FG001|COMPLETED|Follow-up Period||85
9831786|NCT00770146|10942399|FG000|NOT COMPLETED|Follow-up Period||11
9831787|NCT00770146|10942400|FG001|NOT COMPLETED|Follow-up Period||20
9831788|NCT00770211|10942408|FG000|STARTED|Overall Study||182
9831789|NCT00770211|10942409|FG001|STARTED|Overall Study||89
9831790|NCT00770211|10942408|FG000|COMPLETED|Overall Study||181
9831791|NCT00770211|10942409|FG001|COMPLETED|Overall Study||87
9831792|NCT00770211|10942408|FG000|NOT COMPLETED|Overall Study||1
9831793|NCT00770211|10942409|FG001|NOT COMPLETED|Overall Study||2
9831794|NCT00770224|10942415|FG000|STARTED|Step 1: Induction||87
9831795|NCT00770224|10942416|FG001|STARTED|Step 1: Induction||0
9831796|NCT00770224|10942415|FG000|Eligible and Evaluable|Step 1: Induction||84
9831797|NCT00770224|10942416|FG001|Eligible and Evaluable|Step 1: Induction||0
9831798|NCT00770224|10942415|FG000|COMPLETED|Step 1: Induction||73
9831799|NCT00770224|10942416|FG001|COMPLETED|Step 1: Induction||0
9831800|NCT00770224|10942415|FG000|NOT COMPLETED|Step 1: Induction||14
9831801|NCT00770224|10942416|FG001|NOT COMPLETED|Step 1: Induction||0
9831802|NCT00770224|10942415|FG000|STARTED|Step 2: Maintenance||0
9831803|NCT00770224|10942416|FG001|STARTED|Step 2: Maintenance||71
9831804|NCT00770224|10942415|FG000|Eligible and Evaluable|Step 2: Maintenance||0
9831805|NCT00770224|10942416|FG001|Eligible and Evaluable|Step 2: Maintenance||69
9831806|NCT00770224|10942415|FG000|COMPLETED|Step 2: Maintenance||0
9831807|NCT00770224|10942416|FG001|COMPLETED|Step 2: Maintenance||41
9831808|NCT00770224|10942415|FG000|NOT COMPLETED|Step 2: Maintenance||0
9831809|NCT00770224|10942416|FG001|NOT COMPLETED|Step 2: Maintenance||30
9831810|NCT00770289|10942423|FG000|STARTED|Overall Study||851
9831811|NCT00770289|10942423|FG000|COMPLETED|Overall Study||845
9831812|NCT00770289|10942423|FG000|NOT COMPLETED|Overall Study||6
9831813|NCT00770315|10942436|FG000|STARTED|Overall Study||197
9831814|NCT00770315|10942437|FG001|STARTED|Overall Study||195
9831815|NCT00770315|10942438|FG002|STARTED|Overall Study||194
9831816|NCT00770315|10942439|FG003|STARTED|Overall Study||198
9812332|NCT00672620|10922172|FG000|STARTED|Overall Study||153
9812333|NCT00672620|10922173|FG001|STARTED|Overall Study||153
9812334|NCT00672620|10922174|FG002|STARTED|Overall Study||153
9812335|NCT00672620|10922175|FG003|STARTED|Overall Study||152
9812336|NCT00672620|10922172|FG000|Treated|Overall Study||151
9812337|NCT00672620|10922173|FG001|Treated|Overall Study||149
10235486|NCT01183429|11365784|FG000|NOT COMPLETED|Overall Study||0
10235487|NCT01166178|11365790|FG000|STARTED|Overall Study||21
10235488|NCT01166178|11365791|FG001|STARTED|Overall Study||8
9812338|NCT00672620|10922174|FG002|Treated|Overall Study||153
9812339|NCT00672620|10922175|FG003|Treated|Overall Study||150
9812340|NCT00672620|10922172|FG000|COMPLETED|Overall Study||120
9812341|NCT00672620|10922173|FG001|COMPLETED|Overall Study||99
9812342|NCT00672620|10922174|FG002|COMPLETED|Overall Study||122
9812343|NCT00672620|10922175|FG003|COMPLETED|Overall Study||110
9812344|NCT00672620|10922172|FG000|NOT COMPLETED|Overall Study||33
9812345|NCT00672620|10922173|FG001|NOT COMPLETED|Overall Study||54
9812346|NCT00672620|10922174|FG002|NOT COMPLETED|Overall Study||31
9812347|NCT00672620|10922175|FG003|NOT COMPLETED|Overall Study||42
9812348|NCT00672633|10922187|FG000|STARTED|Overall Study||12
9812349|NCT00672633|10922188|FG001|STARTED|Overall Study||13
9812350|NCT00672633|10922187|FG000|COMPLETED|Overall Study||12
9812351|NCT00672633|10922188|FG001|COMPLETED|Overall Study||12
9812352|NCT00672633|10922187|FG000|NOT COMPLETED|Overall Study||0
9812353|NCT00672633|10922188|FG001|NOT COMPLETED|Overall Study||1
9812354|NCT00672646|10922197|FG000|STARTED|Overall Study||40
9812355|NCT00672646|10922198|FG001|STARTED|Overall Study||23
9812356|NCT00672646|10922199|FG002|STARTED|Overall Study||40
9812357|NCT00672646|10922197|FG000|COMPLETED|Overall Study||40
9812358|NCT00672646|10922198|FG001|COMPLETED|Overall Study||22
9812359|NCT00672646|10922199|FG002|COMPLETED|Overall Study||37
9812360|NCT00672646|10922197|FG000|NOT COMPLETED|Overall Study||0
9812361|NCT00672646|10922198|FG001|NOT COMPLETED|Overall Study||1
10016507|NCT01810666|11139307|FG000|NOT COMPLETED|Overall Study||0
10016508|NCT01810692|11139313|FG000|STARTED|Overall Study||77
10016509|NCT01810692|11139314|FG001|STARTED|Overall Study||77
10016510|NCT01810692|11139313|FG000|COMPLETED|Overall Study||77
10235489|NCT01166178|11365790|FG000|COMPLETED|Overall Study||0
9812362|NCT00672646|10922199|FG002|NOT COMPLETED|Overall Study||3
9812363|NCT00672737|10922207|FG000|STARTED|Overall Study||56
9812364|NCT00672737|10922207|FG000|COMPLETED|Overall Study||48
9812365|NCT00672737|10922207|FG000|NOT COMPLETED|Overall Study||8
9812366|NCT00672841|10922214|FG000|STARTED|Overall Study||17
9812367|NCT00672841|10922215|FG001|STARTED|Overall Study||47
9812368|NCT00672841|10922214|FG000|COMPLETED|Overall Study||16
9812369|NCT00672841|10922215|FG001|COMPLETED|Overall Study||32
9812370|NCT00672841|10922214|FG000|NOT COMPLETED|Overall Study||1
9812371|NCT00672841|10922215|FG001|NOT COMPLETED|Overall Study||15
9812372|NCT00672854|10922226|FG000|STARTED|Overall Study||49
9812373|NCT00672854|10922227|FG001|STARTED|Overall Study||51
9812374|NCT00672854|10922226|FG000|COMPLETED|Overall Study||49
9812375|NCT00672854|10922227|FG001|COMPLETED|Overall Study||51
9812376|NCT00672854|10922226|FG000|NOT COMPLETED|Overall Study||0
9812377|NCT00672854|10922227|FG001|NOT COMPLETED|Overall Study||0
9812378|NCT00672932|10922237|FG000|STARTED|Overall Study||9
9812379|NCT00672932|10922238|FG001|STARTED|Overall Study||9
9812380|NCT00672932|10922237|FG000|Completed Initial 12-week Assignment|Overall Study||9
9812381|NCT00672932|10922238|FG001|Completed Initial 12-week Assignment|Overall Study||9
9812382|NCT00672932|10922237|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
9812383|NCT00672932|10922238|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9
9812384|NCT00672932|10922237|FG000|Rolled Over to Raltegravir|Overall Study||0
9812385|NCT00672932|10922238|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
9812386|NCT00672932|10922237|FG000|COMPLETED|Overall Study||9
9812387|NCT00672932|10922238|FG001|COMPLETED|Overall Study||9
9812388|NCT00672932|10922237|FG000|NOT COMPLETED|Overall Study||0
9812389|NCT00672932|10922238|FG001|NOT COMPLETED|Overall Study||0
9812390|NCT00672958|10922246|FG000|STARTED|Overall Study||300
9812391|NCT00672958|10922247|FG001|STARTED|Overall Study||300
9812392|NCT00672958|10922246|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
9812393|NCT00672958|10922247|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
9812394|NCT00672958|10922246|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
9812395|NCT00672958|10922247|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
9812396|NCT00672958|10922246|FG000|COMPLETED|Overall Study||236
9812397|NCT00672958|10922247|FG001|COMPLETED|Overall Study||244
9812398|NCT00672958|10922246|FG000|NOT COMPLETED|Overall Study||64
9812399|NCT00672958|10922247|FG001|NOT COMPLETED|Overall Study||56
9812400|NCT00672984|10922256|FG000|STARTED|First Intervention||31
9812401|NCT00672984|10922257|FG001|STARTED|First Intervention||25
9812402|NCT00672984|10922258|FG002|STARTED|First Intervention||27
9812403|NCT00672984|10922256|FG000|COMPLETED|First Intervention||22
9812404|NCT00672984|10922257|FG001|COMPLETED|First Intervention||23
9812405|NCT00672984|10922258|FG002|COMPLETED|First Intervention||25
9812406|NCT00672984|10922256|FG000|NOT COMPLETED|First Intervention||9
9812407|NCT00672984|10922257|FG001|NOT COMPLETED|First Intervention||2
10016511|NCT01810692|11139314|FG001|COMPLETED|Overall Study||77
9812408|NCT00672984|10922258|FG002|NOT COMPLETED|First Intervention||2
9812409|NCT00672984|10922256|FG000|STARTED|Second Intervention||22
9812410|NCT00672984|10922257|FG001|STARTED|Second Intervention||23
9812411|NCT00672984|10922258|FG002|STARTED|Second Intervention||25
9812412|NCT00672984|10922256|FG000|COMPLETED|Second Intervention||22
9812413|NCT00672984|10922257|FG001|COMPLETED|Second Intervention||17
9812414|NCT00672984|10922258|FG002|COMPLETED|Second Intervention||24
9812415|NCT00672984|10922256|FG000|NOT COMPLETED|Second Intervention||0
9812416|NCT00672984|10922257|FG001|NOT COMPLETED|Second Intervention||6
9812417|NCT00672984|10922258|FG002|NOT COMPLETED|Second Intervention||1
9812418|NCT00672984|10922256|FG000|STARTED|Third Intervention||22
9812419|NCT00672984|10922257|FG001|STARTED|Third Intervention||17
9812420|NCT00672984|10922258|FG002|STARTED|Third Intervention||24
9812421|NCT00672984|10922256|FG000|COMPLETED|Third Intervention||21
9812422|NCT00672984|10922257|FG001|COMPLETED|Third Intervention||17
9812423|NCT00672984|10922258|FG002|COMPLETED|Third Intervention||23
9812424|NCT00672984|10922256|FG000|NOT COMPLETED|Third Intervention||1
9812425|NCT00672984|10922257|FG001|NOT COMPLETED|Third Intervention||0
9812426|NCT00672984|10922258|FG002|NOT COMPLETED|Third Intervention||1
9812427|NCT00673049|10922270|FG000|STARTED|Before Progression on Erlotinib||292
9812428|NCT00673049|10922271|FG001|STARTED|Before Progression on Erlotinib||290
9812429|NCT00673049|10922272|FG002|STARTED|Before Progression on Erlotinib||1
9812430|NCT00673049|10922273|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
9812431|NCT00673049|10922270|FG000|Treated|Before Progression on Erlotinib||289
9812432|NCT00673049|10922271|FG001|Treated|Before Progression on Erlotinib||289
9812433|NCT00673049|10922272|FG002|Treated|Before Progression on Erlotinib||1
9812434|NCT00673049|10922273|FG003|Treated|Before Progression on Erlotinib||0
9812435|NCT00673049|10922270|FG000|COMPLETED|Before Progression on Erlotinib||0
9812436|NCT00673049|10922271|FG001|COMPLETED|Before Progression on Erlotinib||0
9812437|NCT00673049|10922272|FG002|COMPLETED|Before Progression on Erlotinib||0
9812438|NCT00673049|10922273|FG003|COMPLETED|Before Progression on Erlotinib||0
9812439|NCT00673049|10922270|FG000|NOT COMPLETED|Before Progression on Erlotinib||292
9812440|NCT00673049|10922271|FG001|NOT COMPLETED|Before Progression on Erlotinib||290
9812441|NCT00673049|10922272|FG002|NOT COMPLETED|Before Progression on Erlotinib||1
9812442|NCT00673049|10922273|FG003|NOT COMPLETED|Before Progression on Erlotinib||0
9812443|NCT00673049|10922270|FG000|STARTED|After Progression on Erlotinib||0
9812444|NCT00673049|10922271|FG001|STARTED|After Progression on Erlotinib||0
9812445|NCT00673049|10922272|FG002|STARTED|After Progression on Erlotinib||0
9812446|NCT00673049|10922273|FG003|STARTED|After Progression on Erlotinib||83
9812447|NCT00673049|10922270|FG000|COMPLETED|After Progression on Erlotinib||0
9812448|NCT00673049|10922271|FG001|COMPLETED|After Progression on Erlotinib||0
9812449|NCT00673049|10922272|FG002|COMPLETED|After Progression on Erlotinib||0
9812450|NCT00673049|10922273|FG003|COMPLETED|After Progression on Erlotinib||0
9812451|NCT00673049|10922270|FG000|NOT COMPLETED|After Progression on Erlotinib||0
9812452|NCT00673049|10922271|FG001|NOT COMPLETED|After Progression on Erlotinib||0
9812453|NCT00673049|10922272|FG002|NOT COMPLETED|After Progression on Erlotinib||0
9812454|NCT00673049|10922273|FG003|NOT COMPLETED|After Progression on Erlotinib||83
9812455|NCT00673075|10922283|FG000|STARTED|Overall Study||21
9812456|NCT00673075|10922284|FG001|STARTED|Overall Study||18
9812457|NCT00673075|10922283|FG000|COMPLETED|Overall Study||12
9812458|NCT00673075|10922284|FG001|COMPLETED|Overall Study||11
9812459|NCT00673075|10922283|FG000|NOT COMPLETED|Overall Study||9
9812460|NCT00673075|10922284|FG001|NOT COMPLETED|Overall Study||7
9812461|NCT00673114|10922292|FG000|STARTED|Overall Study||3
9812462|NCT00673114|10922292|FG000|COMPLETED|Overall Study||3
9812463|NCT00673114|10922292|FG000|NOT COMPLETED|Overall Study||0
9812464|NCT00673127|10922296|FG000|STARTED|Overall Study||57
9812465|NCT00673127|10922296|FG000|COMPLETED|Overall Study||57
9812466|NCT00673127|10922296|FG000|NOT COMPLETED|Overall Study||0
9812467|NCT00673153|10922301|FG000|STARTED|Overall Study||31
9812468|NCT00673153|10922301|FG000|COMPLETED|Overall Study||30
9812469|NCT00673153|10922301|FG000|NOT COMPLETED|Overall Study||1
9812470|NCT00673231|10922309|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
9812471|NCT00673231|10922310|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202
9812472|NCT00673231|10922311|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
9812473|NCT00673231|10922312|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
9812474|NCT00673231|10922309|FG000|COMPLETED|Overall Study||168
9812475|NCT00673231|10922310|FG001|COMPLETED|Overall Study||180
9812476|NCT00673231|10922311|FG002|COMPLETED|Overall Study||186
9812477|NCT00673231|10922312|FG003|COMPLETED|Overall Study||178
9812478|NCT00673231|10922309|FG000|NOT COMPLETED|Overall Study||29
9812479|NCT00673231|10922310|FG001|NOT COMPLETED|Overall Study||22
9812480|NCT00673231|10922311|FG002|NOT COMPLETED|Overall Study||26
9812481|NCT00673231|10922312|FG003|NOT COMPLETED|Overall Study||18
9812482|NCT00673244|10922324|FG000|STARTED|Overall Study||52
9812483|NCT00673244|10922325|FG001|STARTED|Overall Study||25
9812484|NCT00673244|10922324|FG000|COMPLETED|Overall Study||52
9812485|NCT00673244|10922325|FG001|COMPLETED|Overall Study||25
9812486|NCT00673244|10922324|FG000|NOT COMPLETED|Overall Study||0
9812487|NCT00673244|10922325|FG001|NOT COMPLETED|Overall Study||0
9812488|NCT00673257|10922331|FG000|STARTED|Overall Study||107
9812489|NCT00673257|10922331|FG000|COMPLETED|Overall Study||102
10016512|NCT01810692|11139313|FG000|NOT COMPLETED|Overall Study||0
10016513|NCT01810692|11139314|FG001|NOT COMPLETED|Overall Study||0
10016514|NCT01810783|11139320|FG000|STARTED|Overall Study||210
9812490|NCT00673257|10922331|FG000|NOT COMPLETED|Overall Study||5
9812491|NCT00673387|10922343|FG000|STARTED|Overall Study||75
9812492|NCT00673387|10922344|FG001|STARTED|Overall Study||77
9812493|NCT00673387|10922345|FG002|STARTED|Overall Study||72
9812494|NCT00673387|10922346|FG003|STARTED|Overall Study||75
9812495|NCT00673387|10922347|FG004|STARTED|Overall Study||78
9812496|NCT00673387|10922348|FG005|STARTED|Overall Study||78
9812497|NCT00673387|10922349|FG006|STARTED|Overall Study||78
9812498|NCT00673387|10922350|FG007|STARTED|Overall Study||75
9812499|NCT00673387|10922343|FG000|COMPLETED|Overall Study||46
9812500|NCT00673387|10922344|FG001|COMPLETED|Overall Study||54
9812501|NCT00673387|10922345|FG002|COMPLETED|Overall Study||41
9812502|NCT00673387|10922346|FG003|COMPLETED|Overall Study||49
9812503|NCT00673387|10922347|FG004|COMPLETED|Overall Study||48
9812504|NCT00673387|10922348|FG005|COMPLETED|Overall Study||44
10016515|NCT01810783|11139320|FG000|COMPLETED|Overall Study||101
10016516|NCT01810783|11139320|FG000|NOT COMPLETED|Overall Study||109
10016517|NCT01810939|11139324|FG000|STARTED|Part A Treatment Period||243
10016518|NCT01810939|11139325|FG001|STARTED|Part A Treatment Period||0
10235490|NCT01166178|11365791|FG001|COMPLETED|Overall Study||0
10235491|NCT01166178|11365790|FG000|NOT COMPLETED|Overall Study||21
9812505|NCT00673387|10922349|FG006|COMPLETED|Overall Study||48
9812506|NCT00673387|10922350|FG007|COMPLETED|Overall Study||40
9812507|NCT00673387|10922343|FG000|NOT COMPLETED|Overall Study||29
9812508|NCT00673387|10922344|FG001|NOT COMPLETED|Overall Study||23
9812509|NCT00673387|10922345|FG002|NOT COMPLETED|Overall Study||31
9812510|NCT00673387|10922346|FG003|NOT COMPLETED|Overall Study||26
9812511|NCT00673387|10922347|FG004|NOT COMPLETED|Overall Study||30
9812512|NCT00673387|10922348|FG005|NOT COMPLETED|Overall Study||34
9812513|NCT00673387|10922349|FG006|NOT COMPLETED|Overall Study||30
9812514|NCT00673387|10922350|FG007|NOT COMPLETED|Overall Study||35
9812515|NCT00673400|10922378|FG000|STARTED|Overall Study||52
9812516|NCT00673400|10922378|FG000|COMPLETED|Overall Study||52
9812517|NCT00673400|10922378|FG000|NOT COMPLETED|Overall Study||0
9812518|NCT00673439|10922388|FG000|STARTED|Overall Study||3
9812519|NCT00673439|10922388|FG000|COMPLETED|Overall Study||3
9812520|NCT00673439|10922388|FG000|NOT COMPLETED|Overall Study||0
9812521|NCT00673452|10922395|FG000|STARTED|Acute Double-Blind Phase||263
9812522|NCT00673452|10922396|FG001|STARTED|Acute Double-Blind Phase||267
9812523|NCT00673452|10922395|FG000|COMPLETED|Acute Double-Blind Phase||176
9812524|NCT00673452|10922396|FG001|COMPLETED|Acute Double-Blind Phase||187
9812525|NCT00673452|10922395|FG000|NOT COMPLETED|Acute Double-Blind Phase||87
9812526|NCT00673452|10922396|FG001|NOT COMPLETED|Acute Double-Blind Phase||80
9812527|NCT00673452|10922395|FG000|STARTED|Continuation Double-Blind Phase||176
9812528|NCT00673452|10922396|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
9812529|NCT00673452|10922395|FG000|COMPLETED|Continuation Double-Blind Phase||151
9812530|NCT00673452|10922396|FG001|COMPLETED|Continuation Double-Blind Phase||153
9812531|NCT00673452|10922395|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25
9812532|NCT00673452|10922396|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34
9812533|NCT00673465|10922402|FG000|STARTED|Part 1/Period 1 (United States)||3
9812534|NCT00673465|10922403|FG001|STARTED|Part 1/Period 1 (United States)||3
9812535|NCT00673465|10922404|FG002|STARTED|Part 1/Period 1 (United States)||3
9812536|NCT00673465|10922405|FG003|STARTED|Part 1/Period 1 (United States)||3
9812537|NCT00673465|10922406|FG004|STARTED|Part 1/Period 1 (United States)||3
9812538|NCT00673465|10922407|FG005|STARTED|Part 1/Period 1 (United States)||2
9812539|NCT00673465|10922408|FG006|STARTED|Part 1/Period 1 (United States)||0
9812540|NCT00673465|10922409|FG007|STARTED|Part 1/Period 1 (United States)||0
9812541|NCT00673465|10922410|FG008|STARTED|Part 1/Period 1 (United States)||0
9812542|NCT00673465|10922411|FG009|STARTED|Part 1/Period 1 (United States)||0
9812543|NCT00673465|10922412|FG010|STARTED|Part 1/Period 1 (United States)||0
9812544|NCT00673465|10922413|FG011|STARTED|Part 1/Period 1 (United States)||0
9812545|NCT00673465|10922402|FG000|COMPLETED|Part 1/Period 1 (United States)||3
9812546|NCT00673465|10922403|FG001|COMPLETED|Part 1/Period 1 (United States)||3
9812547|NCT00673465|10922404|FG002|COMPLETED|Part 1/Period 1 (United States)||3
9812548|NCT00673465|10922405|FG003|COMPLETED|Part 1/Period 1 (United States)||3
9812549|NCT00673465|10922406|FG004|COMPLETED|Part 1/Period 1 (United States)||2
9812550|NCT00673465|10922407|FG005|COMPLETED|Part 1/Period 1 (United States)||1
9812551|NCT00673465|10922408|FG006|COMPLETED|Part 1/Period 1 (United States)||0
10235492|NCT01166178|11365791|FG001|NOT COMPLETED|Overall Study||8
10235493|NCT01176513|11365797|FG000|STARTED|Overall Study||25
10235494|NCT01176513|11365797|FG000|COMPLETED|Overall Study||22
10235495|NCT01176513|11365797|FG000|NOT COMPLETED|Overall Study||3
9812552|NCT00673465|10922409|FG007|COMPLETED|Part 1/Period 1 (United States)||0
9812553|NCT00673465|10922410|FG008|COMPLETED|Part 1/Period 1 (United States)||0
9812554|NCT00673465|10922411|FG009|COMPLETED|Part 1/Period 1 (United States)||0
9812555|NCT00673465|10922412|FG010|COMPLETED|Part 1/Period 1 (United States)||0
9812556|NCT00673465|10922413|FG011|COMPLETED|Part 1/Period 1 (United States)||0
9812557|NCT00673465|10922402|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812558|NCT00673465|10922403|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0
10016519|NCT01810939|11139326|FG002|STARTED|Part A Treatment Period||0
10016520|NCT01810939|11139324|FG000|COMPLETED|Part A Treatment Period||219
10235496|NCT01165450|11365801|FG000|STARTED|Overall Study||2
10235497|NCT01165450|11365801|FG000|COMPLETED|Overall Study||2
9812559|NCT00673465|10922404|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812560|NCT00673465|10922405|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812561|NCT00673465|10922406|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1
9812562|NCT00673465|10922407|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1
9812563|NCT00673465|10922408|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812564|NCT00673465|10922409|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812565|NCT00673465|10922410|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812566|NCT00673465|10922411|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812567|NCT00673465|10922412|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812568|NCT00673465|10922413|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0
9812569|NCT00673465|10922402|FG000|STARTED|Part 1/Period 2 (United States)||3
9812570|NCT00673465|10922403|FG001|STARTED|Part 1/Period 2 (United States)||3
9812571|NCT00673465|10922404|FG002|STARTED|Part 1/Period 2 (United States)||3
9812572|NCT00673465|10922405|FG003|STARTED|Part 1/Period 2 (United States)||3
9812573|NCT00673465|10922406|FG004|STARTED|Part 1/Period 2 (United States)||2
9812574|NCT00673465|10922407|FG005|STARTED|Part 1/Period 2 (United States)||1
9812575|NCT00673465|10922408|FG006|STARTED|Part 1/Period 2 (United States)||0
9812576|NCT00673465|10922409|FG007|STARTED|Part 1/Period 2 (United States)||0
9812577|NCT00673465|10922410|FG008|STARTED|Part 1/Period 2 (United States)||0
9812578|NCT00673465|10922411|FG009|STARTED|Part 1/Period 2 (United States)||0
9812579|NCT00673465|10922412|FG010|STARTED|Part 1/Period 2 (United States)||0
9812580|NCT00673465|10922413|FG011|STARTED|Part 1/Period 2 (United States)||0
9812581|NCT00673465|10922402|FG000|COMPLETED|Part 1/Period 2 (United States)||3
9812582|NCT00673465|10922403|FG001|COMPLETED|Part 1/Period 2 (United States)||3
9812583|NCT00673465|10922404|FG002|COMPLETED|Part 1/Period 2 (United States)||3
9812584|NCT00673465|10922405|FG003|COMPLETED|Part 1/Period 2 (United States)||3
9812585|NCT00673465|10922406|FG004|COMPLETED|Part 1/Period 2 (United States)||1
9812586|NCT00673465|10922407|FG005|COMPLETED|Part 1/Period 2 (United States)||1
9812587|NCT00673465|10922408|FG006|COMPLETED|Part 1/Period 2 (United States)||0
9812588|NCT00673465|10922409|FG007|COMPLETED|Part 1/Period 2 (United States)||0
9812589|NCT00673465|10922410|FG008|COMPLETED|Part 1/Period 2 (United States)||0
9812590|NCT00673465|10922411|FG009|COMPLETED|Part 1/Period 2 (United States)||0
9812591|NCT00673465|10922412|FG010|COMPLETED|Part 1/Period 2 (United States)||0
9812592|NCT00673465|10922413|FG011|COMPLETED|Part 1/Period 2 (United States)||0
9812593|NCT00673465|10922402|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812594|NCT00673465|10922403|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812595|NCT00673465|10922404|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812596|NCT00673465|10922405|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812597|NCT00673465|10922406|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1
9812598|NCT00673465|10922407|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812599|NCT00673465|10922408|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812600|NCT00673465|10922409|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812601|NCT00673465|10922410|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812602|NCT00673465|10922411|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812603|NCT00673465|10922412|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812604|NCT00673465|10922413|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0
9812605|NCT00673465|10922402|FG000|STARTED|Part 1/Period 3 (United States)||3
9812606|NCT00673465|10922403|FG001|STARTED|Part 1/Period 3 (United States)||3
9812607|NCT00673465|10922404|FG002|STARTED|Part 1/Period 3 (United States)||3
9812608|NCT00673465|10922405|FG003|STARTED|Part 1/Period 3 (United States)||3
9812609|NCT00673465|10922406|FG004|STARTED|Part 1/Period 3 (United States)||1
9812610|NCT00673465|10922407|FG005|STARTED|Part 1/Period 3 (United States)||1
9812611|NCT00673465|10922408|FG006|STARTED|Part 1/Period 3 (United States)||0
9812612|NCT00673465|10922409|FG007|STARTED|Part 1/Period 3 (United States)||0
9812613|NCT00673465|10922410|FG008|STARTED|Part 1/Period 3 (United States)||0
9812614|NCT00673465|10922411|FG009|STARTED|Part 1/Period 3 (United States)||0
9812615|NCT00673465|10922412|FG010|STARTED|Part 1/Period 3 (United States)||0
9812616|NCT00673465|10922413|FG011|STARTED|Part 1/Period 3 (United States)||0
9812617|NCT00673465|10922402|FG000|COMPLETED|Part 1/Period 3 (United States)||3
9812618|NCT00673465|10922403|FG001|COMPLETED|Part 1/Period 3 (United States)||3
9812619|NCT00673465|10922404|FG002|COMPLETED|Part 1/Period 3 (United States)||3
9812620|NCT00673465|10922405|FG003|COMPLETED|Part 1/Period 3 (United States)||3
9812621|NCT00673465|10922406|FG004|COMPLETED|Part 1/Period 3 (United States)||1
9812622|NCT00673465|10922407|FG005|COMPLETED|Part 1/Period 3 (United States)||1
9812623|NCT00673465|10922408|FG006|COMPLETED|Part 1/Period 3 (United States)||0
9812624|NCT00673465|10922409|FG007|COMPLETED|Part 1/Period 3 (United States)||0
9812625|NCT00673465|10922410|FG008|COMPLETED|Part 1/Period 3 (United States)||0
9812626|NCT00673465|10922411|FG009|COMPLETED|Part 1/Period 3 (United States)||0
9812627|NCT00673465|10922412|FG010|COMPLETED|Part 1/Period 3 (United States)||0
9812628|NCT00673465|10922413|FG011|COMPLETED|Part 1/Period 3 (United States)||0
9812629|NCT00673465|10922402|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812630|NCT00673465|10922403|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812631|NCT00673465|10922404|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812632|NCT00673465|10922405|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812633|NCT00673465|10922406|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812634|NCT00673465|10922407|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812635|NCT00673465|10922408|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812636|NCT00673465|10922409|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0
10016521|NCT01810939|11139325|FG001|COMPLETED|Part A Treatment Period||0
10016522|NCT01810939|11139326|FG002|COMPLETED|Part A Treatment Period||0
10016523|NCT01810939|11139324|FG000|NOT COMPLETED|Part A Treatment Period||24
9812637|NCT00673465|10922410|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812638|NCT00673465|10922411|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812639|NCT00673465|10922412|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812640|NCT00673465|10922413|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0
9812641|NCT00673465|10922402|FG000|STARTED|Part 2 (India)||0
9812642|NCT00673465|10922403|FG001|STARTED|Part 2 (India)||0
10016524|NCT01810939|11139325|FG001|NOT COMPLETED|Part A Treatment Period||0
10016525|NCT01810939|11139326|FG002|NOT COMPLETED|Part A Treatment Period||0
10016526|NCT01810939|11139324|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0
10016527|NCT01810939|11139325|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
10019148|NCT01828034|11142282|FG002|NOT COMPLETED|Overall Study||0
10019149|NCT01828034|11142283|FG003|NOT COMPLETED|Overall Study||1
9812643|NCT00673465|10922404|FG002|STARTED|Part 2 (India)||0
9812644|NCT00673465|10922405|FG003|STARTED|Part 2 (India)||0
9812645|NCT00673465|10922406|FG004|STARTED|Part 2 (India)||0
9812646|NCT00673465|10922407|FG005|STARTED|Part 2 (India)||0
9812647|NCT00673465|10922408|FG006|STARTED|Part 2 (India)||0
9812648|NCT00673465|10922409|FG007|STARTED|Part 2 (India)||0
9812649|NCT00673465|10922410|FG008|STARTED|Part 2 (India)||0
9812650|NCT00673465|10922411|FG009|STARTED|Part 2 (India)||0
9812651|NCT00673465|10922412|FG010|STARTED|Part 2 (India)||0
9812652|NCT00673465|10922413|FG011|STARTED|Part 2 (India)||0
9812653|NCT00673465|10922402|FG000|COMPLETED|Part 2 (India)||0
9812654|NCT00673465|10922403|FG001|COMPLETED|Part 2 (India)||0
9812655|NCT00673465|10922404|FG002|COMPLETED|Part 2 (India)||0
9812656|NCT00673465|10922405|FG003|COMPLETED|Part 2 (India)||0
9812657|NCT00673465|10922406|FG004|COMPLETED|Part 2 (India)||0
9812658|NCT00673465|10922407|FG005|COMPLETED|Part 2 (India)||0
9812659|NCT00673465|10922408|FG006|COMPLETED|Part 2 (India)||0
9812660|NCT00673465|10922409|FG007|COMPLETED|Part 2 (India)||0
9812661|NCT00673465|10922410|FG008|COMPLETED|Part 2 (India)||0
9812662|NCT00673465|10922411|FG009|COMPLETED|Part 2 (India)||0
9812663|NCT00673465|10922412|FG010|COMPLETED|Part 2 (India)||0
9812664|NCT00673465|10922413|FG011|COMPLETED|Part 2 (India)||0
9812665|NCT00673465|10922402|FG000|NOT COMPLETED|Part 2 (India)||0
9812666|NCT00673465|10922403|FG001|NOT COMPLETED|Part 2 (India)||0
9812667|NCT00673465|10922404|FG002|NOT COMPLETED|Part 2 (India)||0
9812668|NCT00673465|10922405|FG003|NOT COMPLETED|Part 2 (India)||0
9812669|NCT00673465|10922406|FG004|NOT COMPLETED|Part 2 (India)||0
9812670|NCT00673465|10922407|FG005|NOT COMPLETED|Part 2 (India)||0
9812671|NCT00673465|10922408|FG006|NOT COMPLETED|Part 2 (India)||0
9812672|NCT00673465|10922409|FG007|NOT COMPLETED|Part 2 (India)||0
9812673|NCT00673465|10922410|FG008|NOT COMPLETED|Part 2 (India)||0
9812674|NCT00673465|10922411|FG009|NOT COMPLETED|Part 2 (India)||0
9812675|NCT00673465|10922412|FG010|NOT COMPLETED|Part 2 (India)||0
9812676|NCT00673465|10922413|FG011|NOT COMPLETED|Part 2 (India)||0
9812677|NCT00673660|10922421|FG000|STARTED|Overall Study||375
9812678|NCT00673660|10922421|FG000|COMPLETED|Overall Study||268
9812679|NCT00673660|10922421|FG000|NOT COMPLETED|Overall Study||107
9812680|NCT00673673|10922430|FG000|STARTED|Overall Study||39
9812681|NCT00673673|10922430|FG000|COMPLETED|Overall Study||3
9812682|NCT00673673|10922430|FG000|NOT COMPLETED|Overall Study||36
9812683|NCT00673712|10922436|FG000|STARTED|Overall Study||321
9812684|NCT00673712|10922437|FG001|STARTED|Overall Study||326
9812685|NCT00673712|10922436|FG000|COMPLETED|Overall Study||321
9812686|NCT00673712|10922437|FG001|COMPLETED|Overall Study||326
9812687|NCT00673712|10922436|FG000|NOT COMPLETED|Overall Study||0
9812688|NCT00673712|10922437|FG001|NOT COMPLETED|Overall Study||0
9812689|NCT00673738|10922443|FG000|STARTED|Overall Study||27
9812690|NCT00673738|10922443|FG000|COMPLETED|Overall Study||27
9812691|NCT00673738|10922443|FG000|NOT COMPLETED|Overall Study||0
9812692|NCT00673764|10922447|FG000|STARTED|Overall Study||24
9812693|NCT00673764|10922448|FG001|STARTED|Overall Study||24
9812694|NCT00673764|10922447|FG000|COMPLETED|Overall Study||24
9812695|NCT00673764|10922448|FG001|COMPLETED|Overall Study||24
9812696|NCT00673764|10922447|FG000|NOT COMPLETED|Overall Study||0
9812697|NCT00673764|10922448|FG001|NOT COMPLETED|Overall Study||0
9812698|NCT00673790|10922457|FG000|STARTED|Overall Study||223
9812699|NCT00673790|10922458|FG001|STARTED|Overall Study||212
9812700|NCT00673790|10922459|FG002|STARTED|Overall Study||102
9812701|NCT00673790|10922457|FG000|COMPLETED|Overall Study||178
9812702|NCT00673790|10922458|FG001|COMPLETED|Overall Study||174
9812703|NCT00673790|10922459|FG002|COMPLETED|Overall Study||90
9812704|NCT00673790|10922457|FG000|NOT COMPLETED|Overall Study||45
9812705|NCT00673790|10922458|FG001|NOT COMPLETED|Overall Study||38
9812706|NCT00673790|10922459|FG002|NOT COMPLETED|Overall Study||12
9812707|NCT00673816|10922468|FG000|STARTED|Overall Study||2
9812708|NCT00673816|10922468|FG000|COMPLETED|Overall Study||0
9812709|NCT00673816|10922468|FG000|NOT COMPLETED|Overall Study||2
9812710|NCT00673855|10922473|FG000|STARTED|First Intervention||10
9812711|NCT00673855|10922474|FG001|STARTED|First Intervention||10
9812712|NCT00673855|10922473|FG000|COMPLETED|First Intervention||10
9812713|NCT00673855|10922474|FG001|COMPLETED|First Intervention||10
9812714|NCT00673855|10922473|FG000|NOT COMPLETED|First Intervention||0
9812715|NCT00673855|10922474|FG001|NOT COMPLETED|First Intervention||0
9812716|NCT00673855|10922473|FG000|STARTED|Second Intervention||10
9812717|NCT00673855|10922474|FG001|STARTED|Second Intervention||10
9812718|NCT00673855|10922473|FG000|COMPLETED|Second Intervention||10
9812719|NCT00673855|10922474|FG001|COMPLETED|Second Intervention||10
9812720|NCT00673855|10922473|FG000|NOT COMPLETED|Second Intervention||0
9812721|NCT00673855|10922474|FG001|NOT COMPLETED|Second Intervention||0
9812722|NCT00673881|10922480|FG000|STARTED|Overall Study||25
9812723|NCT00673881|10922480|FG000|COMPLETED|Overall Study||24
9812724|NCT00673881|10922480|FG000|NOT COMPLETED|Overall Study||1
9812725|NCT00673894|10922486|FG000|STARTED|First Intervention 4 Weeks||8
9812726|NCT00673894|10922487|FG001|STARTED|First Intervention 4 Weeks||7
9812727|NCT00673894|10922486|FG000|COMPLETED|First Intervention 4 Weeks||6
9812728|NCT00673894|10922487|FG001|COMPLETED|First Intervention 4 Weeks||7
9812729|NCT00673894|10922486|FG000|NOT COMPLETED|First Intervention 4 Weeks||2
9812730|NCT00673894|10922487|FG001|NOT COMPLETED|First Intervention 4 Weeks||0
9812731|NCT00673894|10922486|FG000|STARTED|Washout 4-6 Weeks||6
9812732|NCT00673894|10922487|FG001|STARTED|Washout 4-6 Weeks||7
9812733|NCT00673894|10922486|FG000|COMPLETED|Washout 4-6 Weeks||6
9812734|NCT00673894|10922487|FG001|COMPLETED|Washout 4-6 Weeks||7
9812735|NCT00673894|10922486|FG000|NOT COMPLETED|Washout 4-6 Weeks||0
9812736|NCT00673894|10922487|FG001|NOT COMPLETED|Washout 4-6 Weeks||0
9812737|NCT00673894|10922486|FG000|STARTED|Second Intervention 4 Weeks||6
9812738|NCT00673894|10922487|FG001|STARTED|Second Intervention 4 Weeks||7
9812739|NCT00673894|10922486|FG000|COMPLETED|Second Intervention 4 Weeks||6
9812740|NCT00673894|10922487|FG001|COMPLETED|Second Intervention 4 Weeks||7
9812741|NCT00673894|10922486|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0
9812742|NCT00673894|10922487|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0
9812743|NCT00673920|10922501|FG000|STARTED|Baseline up to Week 48||64
9812744|NCT00673920|10922502|FG001|STARTED|Baseline up to Week 48||117
9812745|NCT00673920|10922503|FG002|STARTED|Baseline up to Week 48||133
9812746|NCT00673920|10922504|FG003|STARTED|Baseline up to Week 48||0
9812747|NCT00673920|10922505|FG004|STARTED|Baseline up to Week 48||0
9812748|NCT00673920|10922506|FG005|STARTED|Baseline up to Week 48||0
9812749|NCT00673920|10922507|FG006|STARTED|Baseline up to Week 48||0
9812750|NCT00673920|10922508|FG007|STARTED|Baseline up to Week 48||0
9812751|NCT00673920|10922501|FG000|COMPLETED|Baseline up to Week 48||60
9812752|NCT00673920|10922502|FG001|COMPLETED|Baseline up to Week 48||114
9812753|NCT00673920|10922503|FG002|COMPLETED|Baseline up to Week 48||126
9812754|NCT00673920|10922504|FG003|COMPLETED|Baseline up to Week 48||0
9812755|NCT00673920|10922505|FG004|COMPLETED|Baseline up to Week 48||0
9812756|NCT00673920|10922506|FG005|COMPLETED|Baseline up to Week 48||0
9812757|NCT00673920|10922507|FG006|COMPLETED|Baseline up to Week 48||0
9812758|NCT00673920|10922508|FG007|COMPLETED|Baseline up to Week 48||0
9812759|NCT00673920|10922501|FG000|NOT COMPLETED|Baseline up to Week 48||4
9812760|NCT00673920|10922502|FG001|NOT COMPLETED|Baseline up to Week 48||3
9812761|NCT00673920|10922503|FG002|NOT COMPLETED|Baseline up to Week 48||7
9812762|NCT00673920|10922504|FG003|NOT COMPLETED|Baseline up to Week 48||0
9812763|NCT00673920|10922505|FG004|NOT COMPLETED|Baseline up to Week 48||0
9812764|NCT00673920|10922506|FG005|NOT COMPLETED|Baseline up to Week 48||0
9812765|NCT00673920|10922507|FG006|NOT COMPLETED|Baseline up to Week 48||0
9812766|NCT00673920|10922508|FG007|NOT COMPLETED|Baseline up to Week 48||0
9812767|NCT00673920|10922501|FG000|STARTED|Week 24 to Week 48||0
9812768|NCT00673920|10922502|FG001|STARTED|Week 24 to Week 48||0
9812769|NCT00673920|10922503|FG002|STARTED|Week 24 to Week 48||0
9812770|NCT00673920|10922504|FG003|STARTED|Week 24 to Week 48||61
9812771|NCT00673920|10922505|FG004|STARTED|Week 24 to Week 48||61
9812772|NCT00673920|10922506|FG005|STARTED|Week 24 to Week 48||109
9812773|NCT00673920|10922507|FG006|STARTED|Week 24 to Week 48||29
9812774|NCT00673920|10922508|FG007|STARTED|Week 24 to Week 48||28
9812775|NCT00673920|10922501|FG000|COMPLETED|Week 24 to Week 48||0
9812776|NCT00673920|10922502|FG001|COMPLETED|Week 24 to Week 48||0
9812777|NCT00673920|10922503|FG002|COMPLETED|Week 24 to Week 48||0
9812778|NCT00673920|10922504|FG003|COMPLETED|Week 24 to Week 48||60
9812779|NCT00673920|10922505|FG004|COMPLETED|Week 24 to Week 48||61
9812780|NCT00673920|10922506|FG005|COMPLETED|Week 24 to Week 48||106
9812781|NCT00673920|10922507|FG006|COMPLETED|Week 24 to Week 48||28
9812782|NCT00673920|10922508|FG007|COMPLETED|Week 24 to Week 48||28
9812783|NCT00673920|10922501|FG000|NOT COMPLETED|Week 24 to Week 48||0
9812784|NCT00673920|10922502|FG001|NOT COMPLETED|Week 24 to Week 48||0
9812785|NCT00673920|10922503|FG002|NOT COMPLETED|Week 24 to Week 48||0
9812786|NCT00673920|10922504|FG003|NOT COMPLETED|Week 24 to Week 48||1
9812787|NCT00673920|10922505|FG004|NOT COMPLETED|Week 24 to Week 48||0
9812788|NCT00673920|10922506|FG005|NOT COMPLETED|Week 24 to Week 48||3
9812789|NCT00673920|10922507|FG006|NOT COMPLETED|Week 24 to Week 48||1
9812790|NCT00673920|10922508|FG007|NOT COMPLETED|Week 24 to Week 48||0
9812791|NCT00673933|10922530|FG000|STARTED|Overall Study||20
9812792|NCT00673933|10922530|FG000|COMPLETED|Overall Study||17
9812793|NCT00673933|10922530|FG000|NOT COMPLETED|Overall Study||3
9812794|NCT00673959|10922536|FG000|STARTED|Overall Study||10
9812795|NCT00673959|10922537|FG001|STARTED|Overall Study||10
9812796|NCT00673959|10922536|FG000|COMPLETED|Overall Study||10
9812797|NCT00673959|10922537|FG001|COMPLETED|Overall Study||10
9812798|NCT00673959|10922536|FG000|NOT COMPLETED|Overall Study||0
9812799|NCT00673959|10922537|FG001|NOT COMPLETED|Overall Study||0
9812800|NCT00674115|10922543|FG000|STARTED|First Intervention||14
9812801|NCT00674115|10922544|FG001|STARTED|First Intervention||16
9812802|NCT00674115|10922545|FG002|STARTED|First Intervention||14
9812803|NCT00674115|10922546|FG003|STARTED|First Intervention||16
9812804|NCT00674115|10922543|FG000|COMPLETED|First Intervention||14
9812805|NCT00674115|10922544|FG001|COMPLETED|First Intervention||16
9812806|NCT00674115|10922545|FG002|COMPLETED|First Intervention||14
9812807|NCT00674115|10922546|FG003|COMPLETED|First Intervention||16
9812808|NCT00674115|10922543|FG000|NOT COMPLETED|First Intervention||0
9812809|NCT00674115|10922544|FG001|NOT COMPLETED|First Intervention||0
9812810|NCT00674115|10922545|FG002|NOT COMPLETED|First Intervention||0
9812811|NCT00674115|10922546|FG003|NOT COMPLETED|First Intervention||0
9812812|NCT00674115|10922543|FG000|STARTED|Washout Period of 2 Weeks||14
9812813|NCT00674115|10922544|FG001|STARTED|Washout Period of 2 Weeks||16
9812814|NCT00674115|10922545|FG002|STARTED|Washout Period of 2 Weeks||14
9812815|NCT00674115|10922546|FG003|STARTED|Washout Period of 2 Weeks||16
9812816|NCT00674115|10922543|FG000|COMPLETED|Washout Period of 2 Weeks||14
9812817|NCT00674115|10922544|FG001|COMPLETED|Washout Period of 2 Weeks||16
9812818|NCT00674115|10922545|FG002|COMPLETED|Washout Period of 2 Weeks||14
9812819|NCT00674115|10922546|FG003|COMPLETED|Washout Period of 2 Weeks||16
9812820|NCT00674115|10922543|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9812821|NCT00674115|10922544|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9812822|NCT00674115|10922545|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
9812823|NCT00674115|10922546|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
9812824|NCT00674115|10922543|FG000|STARTED|Second Intervention||14
9812825|NCT00674115|10922544|FG001|STARTED|Second Intervention||16
9812826|NCT00674115|10922545|FG002|STARTED|Second Intervention||14
9812827|NCT00674115|10922546|FG003|STARTED|Second Intervention||16
9812828|NCT00674115|10922543|FG000|COMPLETED|Second Intervention||14
9812829|NCT00674115|10922544|FG001|COMPLETED|Second Intervention||16
9812830|NCT00674115|10922545|FG002|COMPLETED|Second Intervention||14
9812831|NCT00674115|10922546|FG003|COMPLETED|Second Intervention||16
9812832|NCT00674115|10922543|FG000|NOT COMPLETED|Second Intervention||0
9812833|NCT00674115|10922544|FG001|NOT COMPLETED|Second Intervention||0
9812834|NCT00674115|10922545|FG002|NOT COMPLETED|Second Intervention||0
9812835|NCT00674115|10922546|FG003|NOT COMPLETED|Second Intervention||0
9812836|NCT00674115|10922543|FG000|STARTED|Washout Period of 2 Weeks||14
9812837|NCT00674115|10922544|FG001|STARTED|Washout Period of 2 Weeks||16
9812838|NCT00674115|10922545|FG002|STARTED|Washout Period of 2 Weeks||0
9812839|NCT00674115|10922546|FG003|STARTED|Washout Period of 2 Weeks||0
9812840|NCT00674115|10922543|FG000|COMPLETED|Washout Period of 2 Weeks||14
9812841|NCT00674115|10922544|FG001|COMPLETED|Washout Period of 2 Weeks||16
9812842|NCT00674115|10922545|FG002|COMPLETED|Washout Period of 2 Weeks||0
9812843|NCT00674115|10922546|FG003|COMPLETED|Washout Period of 2 Weeks||0
9812844|NCT00674115|10922543|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9812845|NCT00674115|10922544|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9812846|NCT00674115|10922545|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
9812847|NCT00674115|10922546|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
9812848|NCT00674115|10922543|FG000|STARTED|Third Intervention||14
9812849|NCT00674115|10922544|FG001|STARTED|Third Intervention||16
9812850|NCT00674115|10922545|FG002|STARTED|Third Intervention||0
9812851|NCT00674115|10922546|FG003|STARTED|Third Intervention||0
9812852|NCT00674115|10922543|FG000|COMPLETED|Third Intervention||14
9812853|NCT00674115|10922544|FG001|COMPLETED|Third Intervention||16
9812854|NCT00674115|10922545|FG002|COMPLETED|Third Intervention||0
9812855|NCT00674115|10922546|FG003|COMPLETED|Third Intervention||0
9812856|NCT00674115|10922543|FG000|NOT COMPLETED|Third Intervention||0
9812857|NCT00674115|10922544|FG001|NOT COMPLETED|Third Intervention||0
9812858|NCT00674115|10922545|FG002|NOT COMPLETED|Third Intervention||0
9812859|NCT00674115|10922546|FG003|NOT COMPLETED|Third Intervention||0
9812860|NCT00674128|10922557|FG000|STARTED|Overall Study||50
9812861|NCT00674128|10922558|FG001|STARTED|Overall Study||44
9812862|NCT00674128|10922557|FG000|COMPLETED|Overall Study||25
9812863|NCT00674128|10922558|FG001|COMPLETED|Overall Study||21
9812864|NCT00674128|10922557|FG000|NOT COMPLETED|Overall Study||25
9812865|NCT00674128|10922558|FG001|NOT COMPLETED|Overall Study||23
9812866|NCT00674154|10922566|FG000|STARTED|Overall Study||23
9812867|NCT00674154|10922567|FG001|STARTED|Overall Study||23
9812868|NCT00674154|10922566|FG000|COMPLETED|Overall Study||20
9812869|NCT00674154|10922567|FG001|COMPLETED|Overall Study||20
9812870|NCT00674154|10922566|FG000|NOT COMPLETED|Overall Study||3
9812871|NCT00674154|10922567|FG001|NOT COMPLETED|Overall Study||3
9812872|NCT00674206|10922573|FG000|STARTED|Overall Study||6
9812873|NCT00674206|10922573|FG000|COMPLETED|Overall Study||6
9812874|NCT00674206|10922573|FG000|NOT COMPLETED|Overall Study||0
9812875|NCT00674219|10922579|FG000|STARTED|Overall Study||10
9812876|NCT00674219|10922580|FG001|STARTED|Overall Study||7
9812877|NCT00674219|10922579|FG000|COMPLETED|Overall Study||10
9812878|NCT00674219|10922580|FG001|COMPLETED|Overall Study||7
9812879|NCT00674219|10922579|FG000|NOT COMPLETED|Overall Study||0
9812880|NCT00674219|10922580|FG001|NOT COMPLETED|Overall Study||0
9812881|NCT00674297|10922586|FG000|STARTED|Overall Study||18
9812882|NCT00674297|10922587|FG001|STARTED|Overall Study||7
9812883|NCT00674297|10922588|FG002|STARTED|Overall Study||9
9812884|NCT00674297|10922589|FG003|STARTED|Overall Study||7
9812885|NCT00674297|10922586|FG000|COMPLETED|Overall Study||8
9812886|NCT00674297|10922587|FG001|COMPLETED|Overall Study||7
9812887|NCT00674297|10922588|FG002|COMPLETED|Overall Study||5
9812888|NCT00674297|10922589|FG003|COMPLETED|Overall Study||4
9812889|NCT00674297|10922586|FG000|NOT COMPLETED|Overall Study||10
9812890|NCT00674297|10922587|FG001|NOT COMPLETED|Overall Study||0
9812891|NCT00674297|10922588|FG002|NOT COMPLETED|Overall Study||4
9812892|NCT00674297|10922589|FG003|NOT COMPLETED|Overall Study||3
9812893|NCT00674323|10922599|FG000|STARTED|Overall Study||19
9812894|NCT00674323|10922600|FG001|STARTED|Overall Study||21
9812895|NCT00674323|10922601|FG002|STARTED|Overall Study||21
9812896|NCT00674323|10922599|FG000|COMPLETED|Overall Study||18
9812897|NCT00674323|10922600|FG001|COMPLETED|Overall Study||20
9812898|NCT00674323|10922601|FG002|COMPLETED|Overall Study||21
9812899|NCT00674323|10922599|FG000|NOT COMPLETED|Overall Study||1
9812900|NCT00674323|10922600|FG001|NOT COMPLETED|Overall Study||1
9812901|NCT00674323|10922601|FG002|NOT COMPLETED|Overall Study||0
9812902|NCT00674362|10922611|FG000|STARTED|Double Blind||96
9812903|NCT00674362|10922612|FG001|STARTED|Double Blind||98
9812904|NCT00674362|10922611|FG000|COMPLETED|Double Blind||84
9812905|NCT00674362|10922612|FG001|COMPLETED|Double Blind||80
9812906|NCT00674362|10922611|FG000|NOT COMPLETED|Double Blind||12
9812907|NCT00674362|10922612|FG001|NOT COMPLETED|Double Blind||18
9812908|NCT00674362|10922611|FG000|STARTED|Open Label||20
9812909|NCT00674362|10922612|FG001|STARTED|Open Label||7
9812910|NCT00674362|10922611|FG000|COMPLETED|Open Label||18
9812911|NCT00674362|10922612|FG001|COMPLETED|Open Label||7
9812912|NCT00674362|10922611|FG000|NOT COMPLETED|Open Label||2
9812913|NCT00674362|10922612|FG001|NOT COMPLETED|Open Label||0
9812914|NCT00674466|10922622|FG000|STARTED|Overall Study||30
9812915|NCT00674466|10922623|FG001|STARTED|Overall Study||30
9812916|NCT00674466|10922624|FG002|STARTED|Overall Study||30
9812917|NCT00674466|10922622|FG000|COMPLETED|Overall Study||23
9812918|NCT00674466|10922623|FG001|COMPLETED|Overall Study||22
9812919|NCT00674466|10922624|FG002|COMPLETED|Overall Study||21
9812920|NCT00674466|10922622|FG000|NOT COMPLETED|Overall Study||7
9812921|NCT00674466|10922623|FG001|NOT COMPLETED|Overall Study||8
9812922|NCT00674466|10922624|FG002|NOT COMPLETED|Overall Study||9
9812923|NCT00674479|10922632|FG000|STARTED|Overall Study||51
9812924|NCT00674479|10922632|FG000|COMPLETED|Overall Study||51
9812925|NCT00674479|10922632|FG000|NOT COMPLETED|Overall Study||0
9812926|NCT00674492|10922636|FG000|STARTED|Overall Study||21
9812927|NCT00674492|10922636|FG000|COMPLETED|Overall Study||21
9812928|NCT00674492|10922636|FG000|NOT COMPLETED|Overall Study||0
9812929|NCT00674570|10922643|FG000|STARTED|Overall Study||37
9812930|NCT00674570|10922644|FG001|STARTED|Overall Study||34
9812931|NCT00674570|10922645|FG002|STARTED|Overall Study||35
9812932|NCT00674570|10922643|FG000|COMPLETED|Overall Study||37
9812933|NCT00674570|10922644|FG001|COMPLETED|Overall Study||32
9812934|NCT00674570|10922645|FG002|COMPLETED|Overall Study||35
9812935|NCT00674570|10922643|FG000|NOT COMPLETED|Overall Study||0
9812936|NCT00674570|10922644|FG001|NOT COMPLETED|Overall Study||2
9812937|NCT00674570|10922645|FG002|NOT COMPLETED|Overall Study||0
9812938|NCT00674583|10922655|FG000|STARTED|Overall Study||311
9812939|NCT00674583|10922656|FG001|STARTED|Overall Study||103
9812940|NCT00674583|10922655|FG000|COMPLETED|Overall Study||311
9812941|NCT00674583|10922656|FG001|COMPLETED|Overall Study||103
9812942|NCT00674583|10922655|FG000|NOT COMPLETED|Overall Study||0
9812943|NCT00674583|10922656|FG001|NOT COMPLETED|Overall Study||0
9812944|NCT00674609|10922669|FG000|STARTED|Overall Study||60
9812945|NCT00674609|10922670|FG001|STARTED|Overall Study||58
9812946|NCT00674609|10922671|FG002|STARTED|Overall Study||59
9812947|NCT00674609|10922669|FG000|COMPLETED|Overall Study||48
9812948|NCT00674609|10922670|FG001|COMPLETED|Overall Study||45
9812949|NCT00674609|10922671|FG002|COMPLETED|Overall Study||51
9812950|NCT00674609|10922669|FG000|NOT COMPLETED|Overall Study||12
9812951|NCT00674609|10922670|FG001|NOT COMPLETED|Overall Study||13
9812952|NCT00674609|10922671|FG002|NOT COMPLETED|Overall Study||8
9812953|NCT00674622|10922682|FG000|STARTED|Overall Study||22
9812954|NCT00674622|10922683|FG001|STARTED|Overall Study||22
9812955|NCT00674622|10922684|FG002|STARTED|Overall Study||22
9812956|NCT00674622|10922682|FG000|COMPLETED|Overall Study||21
9812957|NCT00674622|10922683|FG001|COMPLETED|Overall Study||18
9812958|NCT00674622|10922684|FG002|COMPLETED|Overall Study||22
9812959|NCT00674622|10922682|FG000|NOT COMPLETED|Overall Study||1
9812960|NCT00674622|10922683|FG001|NOT COMPLETED|Overall Study||4
9812961|NCT00674622|10922684|FG002|NOT COMPLETED|Overall Study||0
9812962|NCT00674661|10922694|FG000|STARTED|Overall Study||67
9812963|NCT00674661|10922695|FG001|STARTED|Overall Study||63
9812964|NCT00674661|10922694|FG000|COMPLETED|Overall Study||56
9812965|NCT00674661|10922695|FG001|COMPLETED|Overall Study||48
9812966|NCT00674661|10922694|FG000|NOT COMPLETED|Overall Study||11
9812967|NCT00674661|10922695|FG001|NOT COMPLETED|Overall Study||15
9812968|NCT00674700|10922704|FG000|STARTED|Year 1||170
9812969|NCT00674700|10922705|FG001|STARTED|Year 1||169
9812970|NCT00674700|10922706|FG002|STARTED|Year 1||170
9812971|NCT00674700|10922704|FG000|COMPLETED|Year 1||139
9812972|NCT00674700|10922705|FG001|COMPLETED|Year 1||135
9812973|NCT00674700|10922706|FG002|COMPLETED|Year 1||153
9812974|NCT00674700|10922704|FG000|NOT COMPLETED|Year 1||31
9812975|NCT00674700|10922705|FG001|NOT COMPLETED|Year 1||34
9812976|NCT00674700|10922706|FG002|NOT COMPLETED|Year 1||17
9812977|NCT00674700|10922704|FG000|STARTED|Year 2 Follow-up Without Treatment||139
9812978|NCT00674700|10922705|FG001|STARTED|Year 2 Follow-up Without Treatment||135
9812979|NCT00674700|10922706|FG002|STARTED|Year 2 Follow-up Without Treatment||153
9812980|NCT00674700|10922704|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133
9812981|NCT00674700|10922705|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123
9812982|NCT00674700|10922706|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141
9812983|NCT00674700|10922704|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
9812984|NCT00674700|10922705|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
9812985|NCT00674700|10922706|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
9812986|NCT00674739|10922717|FG000|STARTED|Overall Study||178
9812987|NCT00674739|10922718|FG001|STARTED|Overall Study||195
9812988|NCT00674739|10922719|FG002|STARTED|Overall Study||97
9812989|NCT00674739|10922717|FG000|COMPLETED|Overall Study||121
9812990|NCT00674739|10922718|FG001|COMPLETED|Overall Study||136
9812991|NCT00674739|10922719|FG002|COMPLETED|Overall Study||65
9812992|NCT00674739|10922717|FG000|NOT COMPLETED|Overall Study||57
9812993|NCT00674739|10922718|FG001|NOT COMPLETED|Overall Study||59
9812994|NCT00674739|10922719|FG002|NOT COMPLETED|Overall Study||32
9812995|NCT00674765|10922729|FG000|STARTED|Overall Study||81
9812996|NCT00674765|10922730|FG001|STARTED|Overall Study||75
9812997|NCT00674765|10922729|FG000|COMPLETED|Overall Study||45
9812998|NCT00674765|10922730|FG001|COMPLETED|Overall Study||46
9812999|NCT00674765|10922729|FG000|NOT COMPLETED|Overall Study||36
9813000|NCT00674765|10922730|FG001|NOT COMPLETED|Overall Study||29
9813001|NCT00674817|10922736|FG000|STARTED|Period 1||44
9813002|NCT00674817|10922736|FG000|COMPLETED|Period 1||41
9813003|NCT00674817|10922736|FG000|NOT COMPLETED|Period 1||3
9813004|NCT00674817|10922736|FG000|STARTED|Period 2||41
9813005|NCT00674817|10922736|FG000|COMPLETED|Period 2||41
9813006|NCT00674817|10922736|FG000|NOT COMPLETED|Period 2||0
9813007|NCT00674817|10922736|FG000|STARTED|Period 3||41
9813008|NCT00674817|10922736|FG000|COMPLETED|Period 3||39
9813009|NCT00674817|10922736|FG000|NOT COMPLETED|Period 3||2
9813010|NCT00674817|10922736|FG000|STARTED|Period 4||39
9813011|NCT00674817|10922736|FG000|COMPLETED|Period 4||38
9813012|NCT00674817|10922736|FG000|NOT COMPLETED|Period 4||1
9813013|NCT00674817|10922736|FG000|STARTED|Period 5||38
9813014|NCT00674817|10922736|FG000|COMPLETED|Period 5||38
9813015|NCT00674817|10922736|FG000|NOT COMPLETED|Period 5||0
9813016|NCT00674817|10922736|FG000|STARTED|Period 6||38
9813017|NCT00674817|10922736|FG000|COMPLETED|Period 6||38
9813018|NCT00674817|10922736|FG000|NOT COMPLETED|Period 6||0
9813019|NCT00674973|10922752|FG000|STARTED|Overall Study||103
9813020|NCT00674973|10922753|FG001|STARTED|Overall Study||104
9813021|NCT00674973|10922752|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
9813022|NCT00674973|10922753|FG001|Switch to Open-Label Erlotinib|Overall Study||0
9813023|NCT00674973|10922752|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3
9813024|NCT00674973|10922753|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2
9813025|NCT00674973|10922752|FG000|NOT COMPLETED|Overall Study||100
9813026|NCT00674973|10922753|FG001|NOT COMPLETED|Overall Study||102
9813027|NCT00674986|10922761|FG000|STARTED|Overall Study||230
9813028|NCT00674986|10922762|FG001|STARTED|Overall Study||269
9813029|NCT00674986|10922761|FG000|Intent to Treat Population|Overall Study||227
9813030|NCT00674986|10922762|FG001|Intent to Treat Population|Overall Study||256
9813031|NCT00674986|10922761|FG000|COMPLETED|Overall Study||187
9813032|NCT00674986|10922762|FG001|COMPLETED|Overall Study||188
9813033|NCT00674986|10922761|FG000|NOT COMPLETED|Overall Study||43
9813034|NCT00674986|10922762|FG001|NOT COMPLETED|Overall Study||81
9813035|NCT00675025|10922771|FG000|STARTED|Overall Study||54
9813036|NCT00675025|10922772|FG001|STARTED|Overall Study||63
9813037|NCT00675025|10922771|FG000|COMPLETED|Overall Study||0
9813038|NCT00675025|10922772|FG001|COMPLETED|Overall Study||0
9813039|NCT00675025|10922771|FG000|NOT COMPLETED|Overall Study||54
9813040|NCT00675025|10922772|FG001|NOT COMPLETED|Overall Study||63
9813041|NCT00675103|10922778|FG000|STARTED|Overall Study||7
9813042|NCT00675103|10922778|FG000|COMPLETED|Overall Study||4
9813043|NCT00675103|10922778|FG000|NOT COMPLETED|Overall Study||3
9813044|NCT00675259|10922782|FG000|STARTED|Overall Study||33
9813045|NCT00675259|10922782|FG000|COMPLETED|Overall Study||19
9813046|NCT00675259|10922782|FG000|NOT COMPLETED|Overall Study||14
9813047|NCT00675415|10922792|FG000|STARTED|Overall Study||132
9813048|NCT00675415|10922793|FG001|STARTED|Overall Study||131
9813049|NCT00675415|10922792|FG000|COMPLETED|Overall Study||124
9813050|NCT00675415|10922793|FG001|COMPLETED|Overall Study||123
9813051|NCT00675415|10922792|FG000|NOT COMPLETED|Overall Study||8
9813052|NCT00675415|10922793|FG001|NOT COMPLETED|Overall Study||8
9813053|NCT00675428|10922801|FG000|STARTED|Overall Study||3
9813054|NCT00675428|10922802|FG001|STARTED|Overall Study||3
9813055|NCT00675428|10922801|FG000|COMPLETED|Overall Study||0
9813056|NCT00675428|10922802|FG001|COMPLETED|Overall Study||0
9813057|NCT00675428|10922801|FG000|NOT COMPLETED|Overall Study||3
9813058|NCT00675428|10922802|FG001|NOT COMPLETED|Overall Study||3
9813059|NCT00675441|10922808|FG000|STARTED|Overall Study||5
9813060|NCT00675441|10922808|FG000|COMPLETED|Overall Study||2
9813061|NCT00675441|10922808|FG000|NOT COMPLETED|Overall Study||3
9813062|NCT00675506|10922814|FG000|STARTED|Overall Study||31
9813063|NCT00675506|10922815|FG001|STARTED|Overall Study||29
9813064|NCT00675506|10922814|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
9813065|NCT00675506|10922815|FG001|Received Intervention|Overall Study||29
9813066|NCT00675506|10922814|FG000|COMPLETED|Overall Study||19
9813067|NCT00675506|10922815|FG001|COMPLETED|Overall Study||17
9813068|NCT00675506|10922814|FG000|NOT COMPLETED|Overall Study||12
9813069|NCT00675506|10922815|FG001|NOT COMPLETED|Overall Study||12
9813070|NCT00675558|10922825|FG000|STARTED|Surgery||10
9813071|NCT00675558|10922826|FG001|STARTED|Surgery||10
9813072|NCT00675558|10922827|FG002|STARTED|Surgery||30
9813073|NCT00675558|10922825|FG000|COMPLETED|Surgery||10
9813074|NCT00675558|10922826|FG001|COMPLETED|Surgery||10
9813075|NCT00675558|10922827|FG002|COMPLETED|Surgery||30
9813076|NCT00675558|10922825|FG000|NOT COMPLETED|Surgery||0
9813077|NCT00675558|10922826|FG001|NOT COMPLETED|Surgery||0
9813078|NCT00675558|10922827|FG002|NOT COMPLETED|Surgery||0
9813079|NCT00675558|10922825|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
9813080|NCT00675558|10922826|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
9813081|NCT00675558|10922827|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
9813082|NCT00675558|10922825|FG000|COMPLETED|Second Operation||0
9813083|NCT00675558|10922826|FG001|COMPLETED|Second Operation||0
9813084|NCT00675558|10922827|FG002|COMPLETED|Second Operation||10
9813085|NCT00675558|10922825|FG000|NOT COMPLETED|Second Operation||0
9813086|NCT00675558|10922826|FG001|NOT COMPLETED|Second Operation||0
9813087|NCT00675558|10922827|FG002|NOT COMPLETED|Second Operation||0
9813088|NCT00675584|10922837|FG000|STARTED|Overall Study||139
9813089|NCT00675584|10922838|FG001|STARTED|Overall Study||139
9813090|NCT00675584|10922837|FG000|COMPLETED|Overall Study||100
9813091|NCT00675584|10922838|FG001|COMPLETED|Overall Study||113
9813092|NCT00675584|10922837|FG000|NOT COMPLETED|Overall Study||39
9813093|NCT00675584|10922838|FG001|NOT COMPLETED|Overall Study||26
9813094|NCT00675597|10922844|FG000|STARTED|Overall Study||26
9813095|NCT00675597|10922844|FG000|COMPLETED|Overall Study||23
9813096|NCT00675597|10922844|FG000|NOT COMPLETED|Overall Study||3
9813097|NCT00675766|10922852|FG000|STARTED|Overall Study||106
9813098|NCT00675766|10922853|FG001|STARTED|Overall Study||30
9813099|NCT00675766|10922854|FG002|STARTED|Overall Study||50
9813100|NCT00675766|10922855|FG003|STARTED|Overall Study||37
9813101|NCT00675766|10922852|FG000|Year 2|Overall Study||105
9813102|NCT00675766|10922853|FG001|Year 2|Overall Study||28
9813103|NCT00675766|10922854|FG002|Year 2|Overall Study||34
9813104|NCT00675766|10922855|FG003|Year 2|Overall Study||20
9813105|NCT00675766|10922852|FG000|Year 3|Overall Study||100
9813106|NCT00675766|10922853|FG001|Year 3|Overall Study||25
9813107|NCT00675766|10922854|FG002|Year 3|Overall Study||29
9813108|NCT00675766|10922855|FG003|Year 3|Overall Study||11
9813109|NCT00675766|10922852|FG000|COMPLETED|Overall Study||100
9813110|NCT00675766|10922853|FG001|COMPLETED|Overall Study||25
9813111|NCT00675766|10922854|FG002|COMPLETED|Overall Study||29
9813112|NCT00675766|10922855|FG003|COMPLETED|Overall Study||11
9813113|NCT00675766|10922852|FG000|NOT COMPLETED|Overall Study||6
9813114|NCT00675766|10922853|FG001|NOT COMPLETED|Overall Study||5
9813115|NCT00675766|10922854|FG002|NOT COMPLETED|Overall Study||21
9813116|NCT00675766|10922855|FG003|NOT COMPLETED|Overall Study||26
9813117|NCT00675792|10922867|FG000|STARTED|Overall Study||51
9813118|NCT00675792|10922868|FG001|STARTED|Overall Study||49
10016528|NCT01810939|11139326|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
10016529|NCT01810939|11139324|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0
10016530|NCT01810939|11139325|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45
10016531|NCT01810939|11139326|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30
10016532|NCT01810939|11139324|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
9813119|NCT00675792|10922867|FG000|COMPLETED|Overall Study||51
9813120|NCT00675792|10922868|FG001|COMPLETED|Overall Study||49
9813121|NCT00675792|10922867|FG000|NOT COMPLETED|Overall Study||0
9813122|NCT00675792|10922868|FG001|NOT COMPLETED|Overall Study||0
9813123|NCT00675909|10922877|FG000|STARTED|Overall Study||60
9813124|NCT00675909|10922878|FG001|STARTED|Overall Study||60
9813125|NCT00675909|10922879|FG002|STARTED|Overall Study||60
9813126|NCT00675909|10922877|FG000|COMPLETED|Overall Study||60
9813127|NCT00675909|10922878|FG001|COMPLETED|Overall Study||60
9813128|NCT00675909|10922879|FG002|COMPLETED|Overall Study||60
9813129|NCT00675909|10922877|FG000|NOT COMPLETED|Overall Study||0
9813130|NCT00675909|10922878|FG001|NOT COMPLETED|Overall Study||0
9813131|NCT00675909|10922879|FG002|NOT COMPLETED|Overall Study||0
9813132|NCT00675922|10922887|FG000|STARTED|Overall Study||98
9813133|NCT00675922|10922887|FG000|COMPLETED|Overall Study||98
9813134|NCT00675922|10922887|FG000|NOT COMPLETED|Overall Study||0
9813135|NCT00675948|10922894|FG000|STARTED|Overall Study||39
9813136|NCT00675948|10922895|FG001|STARTED|Overall Study||4
9813137|NCT00675948|10922894|FG000|COMPLETED|Overall Study||0
9813138|NCT00675948|10922895|FG001|COMPLETED|Overall Study||1
9813139|NCT00675948|10922894|FG000|NOT COMPLETED|Overall Study||39
9813140|NCT00675948|10922895|FG001|NOT COMPLETED|Overall Study||3
9813141|NCT00675987|10922904|FG000|STARTED|Overall Study||26
9813142|NCT00675987|10922905|FG001|STARTED|Overall Study||27
9813143|NCT00675987|10922904|FG000|COMPLETED|Overall Study||26
9813144|NCT00675987|10922905|FG001|COMPLETED|Overall Study||27
9813145|NCT00675987|10922904|FG000|NOT COMPLETED|Overall Study||0
9813146|NCT00675987|10922905|FG001|NOT COMPLETED|Overall Study||0
9813147|NCT00676013|10922913|FG000|STARTED|Overall Study||158
9813148|NCT00676013|10922913|FG000|COMPLETED|Overall Study||157
9813149|NCT00676013|10922913|FG000|NOT COMPLETED|Overall Study||1
9813150|NCT00676052|10922926|FG000|STARTED|Overall Study||96
9813151|NCT00676052|10922927|FG001|STARTED|Overall Study||95
9813152|NCT00676052|10922928|FG002|STARTED|Overall Study||96
9813153|NCT00676052|10922929|FG003|STARTED|Overall Study||97
9813154|NCT00676052|10922930|FG004|STARTED|Overall Study||95
9813155|NCT00676052|10922931|FG005|STARTED|Overall Study||97
9813156|NCT00676052|10922926|FG000|COMPLETED|Overall Study||87
9813157|NCT00676052|10922927|FG001|COMPLETED|Overall Study||88
9813158|NCT00676052|10922928|FG002|COMPLETED|Overall Study||90
9813159|NCT00676052|10922929|FG003|COMPLETED|Overall Study||92
9813160|NCT00676052|10922930|FG004|COMPLETED|Overall Study||89
9813161|NCT00676052|10922931|FG005|COMPLETED|Overall Study||91
9813162|NCT00676052|10922926|FG000|NOT COMPLETED|Overall Study||9
9813163|NCT00676052|10922927|FG001|NOT COMPLETED|Overall Study||7
9813164|NCT00676052|10922928|FG002|NOT COMPLETED|Overall Study||6
9813165|NCT00676052|10922929|FG003|NOT COMPLETED|Overall Study||5
9813166|NCT00676052|10922930|FG004|NOT COMPLETED|Overall Study||6
9813167|NCT00676052|10922931|FG005|NOT COMPLETED|Overall Study||6
9813168|NCT00676065|10922948|FG000|STARTED|Overall Study||16534
9813169|NCT00676065|10922949|FG001|STARTED|Overall Study||15428
9813170|NCT00676065|10922950|FG002|STARTED|Overall Study||26341
9813171|NCT00676065|10922948|FG000|COMPLETED|Overall Study||16534
9813172|NCT00676065|10922949|FG001|COMPLETED|Overall Study||15428
9813173|NCT00676065|10922950|FG002|COMPLETED|Overall Study||26341
9813174|NCT00676065|10922948|FG000|NOT COMPLETED|Overall Study||0
9813175|NCT00676065|10922949|FG001|NOT COMPLETED|Overall Study||0
9813176|NCT00676065|10922950|FG002|NOT COMPLETED|Overall Study||0
9813177|NCT00676091|10922960|FG000|STARTED|Infant Series||177
9813178|NCT00676091|10922961|FG001|STARTED|Infant Series||177
9813179|NCT00676091|10922960|FG000|Vaccinated Dose 1|Infant Series||163
9813180|NCT00676091|10922961|FG001|Vaccinated Dose 1|Infant Series||162
9813181|NCT00676091|10922960|FG000|Vaccinated Dose 2|Infant Series||159
9813182|NCT00676091|10922961|FG001|Vaccinated Dose 2|Infant Series||162
9813183|NCT00676091|10922960|FG000|Vaccinated Dose 3|Infant Series||158
9813184|NCT00676091|10922961|FG001|Vaccinated Dose 3|Infant Series||161
9813185|NCT00676091|10922960|FG000|COMPLETED|Infant Series||157
9813186|NCT00676091|10922961|FG001|COMPLETED|Infant Series||159
9813187|NCT00676091|10922960|FG000|NOT COMPLETED|Infant Series||20
9813188|NCT00676091|10922961|FG001|NOT COMPLETED|Infant Series||18
9813189|NCT00676091|10922960|FG000|STARTED|After Infant Series||157
9813190|NCT00676091|10922961|FG001|STARTED|After Infant Series||159
9813191|NCT00676091|10922960|FG000|COMPLETED|After Infant Series||156
9813192|NCT00676091|10922961|FG001|COMPLETED|After Infant Series||156
9813193|NCT00676091|10922960|FG000|NOT COMPLETED|After Infant Series||1
9813194|NCT00676091|10922961|FG001|NOT COMPLETED|After Infant Series||3
9813195|NCT00676091|10922960|FG000|STARTED|Toddler Dose||156
9813196|NCT00676091|10922961|FG001|STARTED|Toddler Dose||156
9813197|NCT00676091|10922960|FG000|COMPLETED|Toddler Dose||153
9813198|NCT00676091|10922961|FG001|COMPLETED|Toddler Dose||156
9813199|NCT00676091|10922960|FG000|NOT COMPLETED|Toddler Dose||3
9813200|NCT00676091|10922961|FG001|NOT COMPLETED|Toddler Dose||0
9813201|NCT00676130|10922973|FG000|STARTED|Overall Study||76
9813202|NCT00676130|10922974|FG001|STARTED|Overall Study||77
9813203|NCT00676130|10922973|FG000|COMPLETED|Overall Study||73
9813204|NCT00676130|10922974|FG001|COMPLETED|Overall Study||73
9813205|NCT00676130|10922973|FG000|NOT COMPLETED|Overall Study||3
9813206|NCT00676130|10922974|FG001|NOT COMPLETED|Overall Study||4
9813207|NCT00676143|10922982|FG000|STARTED|Overall Study||441
9813208|NCT00676143|10922983|FG001|STARTED|Overall Study||658
9813209|NCT00676143|10922982|FG000|Treated|Overall Study||439
9813210|NCT00676143|10922983|FG001|Treated|Overall Study||654
9813211|NCT00676143|10922982|FG000|COMPLETED|Overall Study||285
9813212|NCT00676143|10922983|FG001|COMPLETED|Overall Study||398
9813213|NCT00676143|10922982|FG000|NOT COMPLETED|Overall Study||156
9813214|NCT00676143|10922983|FG001|NOT COMPLETED|Overall Study||260
9813215|NCT00676182|10922992|FG000|STARTED|Overall Study||75
9813216|NCT00676182|10922992|FG000|COMPLETED|Overall Study||75
9813217|NCT00676182|10922992|FG000|NOT COMPLETED|Overall Study||0
9813218|NCT00676195|10923002|FG000|STARTED|Overall Study||24
9813219|NCT00676195|10923002|FG000|COMPLETED|Overall Study||21
9813220|NCT00676195|10923002|FG000|NOT COMPLETED|Overall Study||3
9813221|NCT00676208|10923009|FG000|STARTED|Overall Study||14
9813222|NCT00676208|10923010|FG001|STARTED|Overall Study||19
9813223|NCT00676208|10923009|FG000|COMPLETED|Overall Study||12
9813224|NCT00676208|10923010|FG001|COMPLETED|Overall Study||13
10235498|NCT01165450|11365801|FG000|NOT COMPLETED|Overall Study||0
10235499|NCT01179399|11365805|FG000|STARTED|Overall Study||32
10235500|NCT01179399|11365805|FG000|COMPLETED|Overall Study||0
10235501|NCT01179399|11365805|FG000|NOT COMPLETED|Overall Study||32
10235502|NCT01169753|11365811|FG000|STARTED|Overall Study||0
10235503|NCT01169753|11365812|FG001|STARTED|Overall Study||1
10235504|NCT01169753|11365811|FG000|COMPLETED|Overall Study||0
10235505|NCT01169753|11365812|FG001|COMPLETED|Overall Study||0
10235506|NCT01169753|11365811|FG000|NOT COMPLETED|Overall Study||0
10235507|NCT01169753|11365812|FG001|NOT COMPLETED|Overall Study||1
10235508|NCT01171534|11365820|FG000|STARTED|Overall Study|retrospective arm never performed on study|0
10235509|NCT01171534|11365821|FG001|STARTED|Overall Study||7
10235510|NCT01171534|11365820|FG000|COMPLETED|Overall Study||0
10235511|NCT01171534|11365821|FG001|COMPLETED|Overall Study||4
10235512|NCT01171534|11365820|FG000|NOT COMPLETED|Overall Study||0
9813225|NCT00676208|10923009|FG000|NOT COMPLETED|Overall Study||2
9813226|NCT00676208|10923010|FG001|NOT COMPLETED|Overall Study||6
9813227|NCT00676338|10923022|FG000|STARTED|Overall Study||248
9813228|NCT00676338|10923023|FG001|STARTED|Overall Study||246
9813229|NCT00676338|10923024|FG002|STARTED|Overall Study||163
9813230|NCT00676338|10923025|FG003|STARTED|Overall Study||163
10235513|NCT01171534|11365821|FG001|NOT COMPLETED|Overall Study||3
9813231|NCT00676338|10923022|FG000|COMPLETED|Overall Study||210
9813232|NCT00676338|10923023|FG001|COMPLETED|Overall Study||213
9813233|NCT00676338|10923024|FG002|COMPLETED|Overall Study||133
9813234|NCT00676338|10923025|FG003|COMPLETED|Overall Study||140
9813235|NCT00676338|10923022|FG000|NOT COMPLETED|Overall Study||38
9813236|NCT00676338|10923023|FG001|NOT COMPLETED|Overall Study||33
9813237|NCT00676338|10923024|FG002|NOT COMPLETED|Overall Study||30
9813238|NCT00676338|10923025|FG003|NOT COMPLETED|Overall Study||23
9813239|NCT00676364|10923037|FG000|STARTED|Overall Study||57
9813240|NCT00676364|10923038|FG001|STARTED|Overall Study||57
9813241|NCT00676364|10923037|FG000|COMPLETED|Overall Study||57
9813242|NCT00676364|10923038|FG001|COMPLETED|Overall Study||57
9813243|NCT00676364|10923037|FG000|NOT COMPLETED|Overall Study||0
9813244|NCT00676364|10923038|FG001|NOT COMPLETED|Overall Study||0
9813245|NCT00676403|10923052|FG000|STARTED|Overall Study||23
9813246|NCT00676403|10923053|FG001|STARTED|Overall Study||22
9813247|NCT00676403|10923054|FG002|STARTED|Overall Study||23
9813248|NCT00676403|10923055|FG003|STARTED|Overall Study||22
9813249|NCT00676403|10923056|FG004|STARTED|Overall Study||24
9813250|NCT00676403|10923057|FG005|STARTED|Overall Study||23
9813251|NCT00676403|10923052|FG000|COMPLETED|Overall Study||21
9813252|NCT00676403|10923053|FG001|COMPLETED|Overall Study||20
9813253|NCT00676403|10923054|FG002|COMPLETED|Overall Study||22
9813254|NCT00676403|10923055|FG003|COMPLETED|Overall Study||17
9813255|NCT00676403|10923056|FG004|COMPLETED|Overall Study||23
9813256|NCT00676403|10923057|FG005|COMPLETED|Overall Study||18
9813257|NCT00676403|10923052|FG000|NOT COMPLETED|Overall Study||2
9813258|NCT00676403|10923053|FG001|NOT COMPLETED|Overall Study||2
9813259|NCT00676403|10923054|FG002|NOT COMPLETED|Overall Study||1
9813260|NCT00676403|10923055|FG003|NOT COMPLETED|Overall Study||5
9813261|NCT00676403|10923056|FG004|NOT COMPLETED|Overall Study||1
9813262|NCT00676403|10923057|FG005|NOT COMPLETED|Overall Study||5
9813263|NCT00676520|10923077|FG000|STARTED|Overall Study||8040
9813264|NCT00676520|10923077|FG000|COMPLETED|Overall Study||7309
9813265|NCT00676520|10923077|FG000|NOT COMPLETED|Overall Study||731
9813266|NCT00676572|10923088|FG000|STARTED|Overall Study||6
10235514|NCT01169610|11365827|FG000|STARTED|Overall Study||1
10235515|NCT01169610|11365827|FG000|COMPLETED|Overall Study||1
10235516|NCT01169610|11365827|FG000|NOT COMPLETED|Overall Study||0
10235517|NCT01163084|11365833|FG000|STARTED|Overall Study||4
10235518|NCT01163084|11365834|FG001|STARTED|Overall Study||5
10235519|NCT01163084|11365833|FG000|COMPLETED|Overall Study||4
10235520|NCT01163084|11365834|FG001|COMPLETED|Overall Study||5
10235521|NCT01163084|11365833|FG000|NOT COMPLETED|Overall Study||0
10235522|NCT01163084|11365834|FG001|NOT COMPLETED|Overall Study||0
10235523|NCT01166724|11365842|FG000|STARTED|Overall Study||7
10235524|NCT01166724|11365843|FG001|STARTED|Overall Study||5
10235525|NCT01166724|11365842|FG000|COMPLETED|Overall Study||0
10235526|NCT01166724|11365843|FG001|COMPLETED|Overall Study||0
10235527|NCT01166724|11365842|FG000|NOT COMPLETED|Overall Study||7
10235528|NCT01166724|11365843|FG001|NOT COMPLETED|Overall Study||5
10235529|NCT01162382|11365849|FG000|STARTED|Overall Study||0
10235530|NCT01162382|11365849|FG000|COMPLETED|Overall Study||0
10235531|NCT01162382|11365849|FG000|NOT COMPLETED|Overall Study||0
10235532|NCT01157533|11365853|FG000|STARTED|Overall Study||1
10235533|NCT01157533|11365853|FG000|COMPLETED|Overall Study||1
10235534|NCT01157533|11365853|FG000|NOT COMPLETED|Overall Study||0
10235535|NCT01162304|11365857|FG000|STARTED|Overall Study||18
10235536|NCT01162304|11365857|FG000|COMPLETED|Overall Study||7
10235537|NCT01162304|11365857|FG000|NOT COMPLETED|Overall Study||11
10235538|NCT01151904|11365863|FG000|STARTED|Overall Study||17
10235539|NCT01151904|11365863|FG000|COMPLETED|Overall Study||17
10235540|NCT01151904|11365863|FG000|NOT COMPLETED|Overall Study||0
10235541|NCT01155518|11365873|FG000|STARTED|Overall Study||1
10235542|NCT01155518|11365874|FG001|STARTED|Overall Study||1
10235543|NCT01155518|11365875|FG002|STARTED|Overall Study||0
10235544|NCT01155518|11365876|FG003|STARTED|Overall Study||0
10235545|NCT01155518|11365877|FG004|STARTED|Overall Study||1
10235546|NCT01155518|11365878|FG005|STARTED|Overall Study||2
10235547|NCT01155518|11365873|FG000|COMPLETED|Overall Study||1
10235548|NCT01155518|11365874|FG001|COMPLETED|Overall Study|never started the study|0
10235549|NCT01155518|11365875|FG002|COMPLETED|Overall Study||0
10235550|NCT01155518|11365876|FG003|COMPLETED|Overall Study||0
10235551|NCT01155518|11365877|FG004|COMPLETED|Overall Study||1
10235552|NCT01155518|11365878|FG005|COMPLETED|Overall Study||2
10235553|NCT01155518|11365873|FG000|NOT COMPLETED|Overall Study||0
10235554|NCT01155518|11365874|FG001|NOT COMPLETED|Overall Study||1
10235555|NCT01155518|11365875|FG002|NOT COMPLETED|Overall Study||0
10235556|NCT01155518|11365876|FG003|NOT COMPLETED|Overall Study||0
10235557|NCT01155518|11365877|FG004|NOT COMPLETED|Overall Study||0
10235558|NCT01155518|11365878|FG005|NOT COMPLETED|Overall Study||0
10235559|NCT01150409|11365894|FG000|STARTED|Overall Study||11
10235560|NCT01150409|11365895|FG001|STARTED|Overall Study||0
9813267|NCT00676572|10923089|FG001|STARTED|Overall Study||6
9813268|NCT00676572|10923088|FG000|COMPLETED|Overall Study||6
9813269|NCT00676572|10923089|FG001|COMPLETED|Overall Study||6
10235561|NCT01150409|11365894|FG000|COMPLETED|Overall Study||11
10235562|NCT01150409|11365895|FG001|COMPLETED|Overall Study||0
10235563|NCT01150409|11365894|FG000|NOT COMPLETED|Overall Study||0
10235564|NCT01150409|11365895|FG001|NOT COMPLETED|Overall Study||0
10235565|NCT01151553|11365901|FG000|STARTED|Overall Study||5
10235566|NCT01151553|11365901|FG000|COMPLETED|Overall Study||5
9813270|NCT00676572|10923088|FG000|NOT COMPLETED|Overall Study||0
9813271|NCT00676572|10923089|FG001|NOT COMPLETED|Overall Study||0
9813272|NCT00676585|10923097|FG000|STARTED|Overall Study||25
9813273|NCT00676585|10923098|FG001|STARTED|Overall Study||25
9813274|NCT00676585|10923097|FG000|COMPLETED|Overall Study||25
9813275|NCT00676585|10923098|FG001|COMPLETED|Overall Study||25
9813276|NCT00676585|10923097|FG000|NOT COMPLETED|Overall Study||0
9813277|NCT00676585|10923098|FG001|NOT COMPLETED|Overall Study||0
9813278|NCT00676650|10923106|FG000|STARTED|Overall Study||584
9813279|NCT00676650|10923107|FG001|STARTED|Overall Study||289
9813280|NCT00676650|10923106|FG000|Treated|Overall Study||581
9813281|NCT00676650|10923107|FG001|Treated|Overall Study||285
9813282|NCT00676650|10923106|FG000|COMPLETED|Overall Study||0
9813283|NCT00676650|10923107|FG001|COMPLETED|Overall Study||0
9813284|NCT00676650|10923106|FG000|NOT COMPLETED|Overall Study||584
9813285|NCT00676650|10923107|FG001|NOT COMPLETED|Overall Study||289
9813286|NCT00676676|10923113|FG000|STARTED|Overall Study||9
9813287|NCT00676676|10923113|FG000|COMPLETED|Overall Study||9
10016533|NCT01810939|11139325|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
10016534|NCT01810939|11139326|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
10016535|NCT01810952|11139337|FG000|STARTED|Overall Study||20
9813288|NCT00676676|10923113|FG000|NOT COMPLETED|Overall Study||0
9813289|NCT00676689|10923117|FG000|STARTED|Overall Study||81
9813290|NCT00676689|10923117|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
9813291|NCT00676689|10923117|FG000|30 Day Follow-up|Overall Study||78
9813292|NCT00676689|10923117|FG000|1 Year Follow-up|Overall Study||64
9813293|NCT00676689|10923117|FG000|COMPLETED|Overall Study||20
9813294|NCT00676689|10923117|FG000|NOT COMPLETED|Overall Study||61
9813295|NCT00676780|10923121|FG000|STARTED|Overall Study||33
9813296|NCT00676780|10923121|FG000|COMPLETED|Overall Study||26
9813297|NCT00676780|10923121|FG000|NOT COMPLETED|Overall Study||7
9813298|NCT00676793|10923127|FG000|STARTED|Overall Study||32
9813299|NCT00676793|10923127|FG000|COMPLETED|Overall Study||19
9813300|NCT00676793|10923127|FG000|NOT COMPLETED|Overall Study||13
9813301|NCT00676806|10923134|FG000|STARTED|Overall Study||3
9813302|NCT00676806|10923135|FG001|STARTED|Overall Study||3
9813303|NCT00676806|10923134|FG000|COMPLETED|Overall Study||3
9813304|NCT00676806|10923135|FG001|COMPLETED|Overall Study||3
9813305|NCT00676806|10923134|FG000|NOT COMPLETED|Overall Study||0
9813306|NCT00676806|10923135|FG001|NOT COMPLETED|Overall Study||0
9813307|NCT00676897|10923147|FG000|STARTED|Overall Study||8
9813308|NCT00676897|10923148|FG001|STARTED|Overall Study||10
9813309|NCT00676897|10923147|FG000|COMPLETED|Overall Study||8
9813310|NCT00676897|10923148|FG001|COMPLETED|Overall Study||10
9813311|NCT00676897|10923147|FG000|NOT COMPLETED|Overall Study||0
9813312|NCT00676897|10923148|FG001|NOT COMPLETED|Overall Study||0
9813313|NCT00677014|10923157|FG000|STARTED|Overall Study||325
9813314|NCT00677014|10923158|FG001|STARTED|Overall Study||323
9813315|NCT00677014|10923159|FG002|STARTED|Overall Study||332
9813316|NCT00677014|10923157|FG000|COMPLETED|Overall Study||281
9813317|NCT00677014|10923158|FG001|COMPLETED|Overall Study||282
9813318|NCT00677014|10923159|FG002|COMPLETED|Overall Study||283
9813319|NCT00677014|10923157|FG000|NOT COMPLETED|Overall Study||44
9813320|NCT00677014|10923158|FG001|NOT COMPLETED|Overall Study||41
9813321|NCT00677014|10923159|FG002|NOT COMPLETED|Overall Study||49
9813322|NCT00677040|10923167|FG000|STARTED|Overall Study||20
9813323|NCT00677040|10923167|FG000|COMPLETED|Overall Study||20
9813324|NCT00677040|10923167|FG000|NOT COMPLETED|Overall Study||0
9813325|NCT00677092|10923172|FG000|STARTED|Overall Study||12
9813326|NCT00677092|10923172|FG000|Received Study Treatment|Overall Study||11
9813327|NCT00677092|10923172|FG000|COMPLETED|Overall Study||6
9813328|NCT00677092|10923172|FG000|NOT COMPLETED|Overall Study||6
9813329|NCT00677235|10923179|FG000|STARTED|Overall Study||138
9813330|NCT00677235|10923180|FG001|STARTED|Overall Study||132
9813331|NCT00677235|10923179|FG000|COMPLETED|Overall Study||97
9813332|NCT00677235|10923180|FG001|COMPLETED|Overall Study||94
9813333|NCT00677235|10923179|FG000|NOT COMPLETED|Overall Study||41
9813334|NCT00677235|10923180|FG001|NOT COMPLETED|Overall Study||38
9813335|NCT00677352|10923188|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
9813336|NCT00677352|10923189|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
10235567|NCT01151553|11365901|FG000|NOT COMPLETED|Overall Study||0
10235568|NCT01148056|11365905|FG000|STARTED|Overall Study||2
9813337|NCT00677352|10923188|FG000|COMPLETED|Treatment Phase||132
9813338|NCT00677352|10923189|FG001|COMPLETED|Treatment Phase||122
10016536|NCT01810952|11139338|FG001|STARTED|Overall Study||17
10016537|NCT01810952|11139337|FG000|COMPLETED|Overall Study||20
9813339|NCT00677352|10923188|FG000|NOT COMPLETED|Treatment Phase||25
9813340|NCT00677352|10923189|FG001|NOT COMPLETED|Treatment Phase||42
9813341|NCT00677352|10923188|FG000|STARTED|Tapering Phase||132
9813342|NCT00677352|10923189|FG001|STARTED|Tapering Phase||122
9813343|NCT00677352|10923188|FG000|COMPLETED|Tapering Phase||126
9813344|NCT00677352|10923189|FG001|COMPLETED|Tapering Phase||112
9813345|NCT00677352|10923188|FG000|NOT COMPLETED|Tapering Phase||6
9813346|NCT00677352|10923189|FG001|NOT COMPLETED|Tapering Phase||10
9831817|NCT00770315|10942436|FG000|COMPLETED|Overall Study||157
9831818|NCT00770315|10942437|FG001|COMPLETED|Overall Study||152
9831819|NCT00770315|10942438|FG002|COMPLETED|Overall Study||137
9831820|NCT00770315|10942439|FG003|COMPLETED|Overall Study||160
9831821|NCT00770315|10942436|FG000|NOT COMPLETED|Overall Study||40
9831822|NCT00770315|10942437|FG001|NOT COMPLETED|Overall Study||43
9831823|NCT00770315|10942438|FG002|NOT COMPLETED|Overall Study||57
9831824|NCT00770315|10942439|FG003|NOT COMPLETED|Overall Study||38
9831825|NCT00770328|10942451|FG000|STARTED|Overall Study||22
9831826|NCT00770328|10942452|FG001|STARTED|Overall Study||15
9831827|NCT00770328|10942451|FG000|COMPLETED|Overall Study||9
9831828|NCT00770328|10942452|FG001|COMPLETED|Overall Study||11
9813347|NCT00677365|10923199|FG000|STARTED|Overall Study||37
9813348|NCT00677365|10923200|FG001|STARTED|Overall Study||38
9813349|NCT00677365|10923201|FG002|STARTED|Overall Study||37
9813350|NCT00677365|10923202|FG003|STARTED|Overall Study||39
9813351|NCT00677365|10923199|FG000|COMPLETED|Overall Study||35
9813352|NCT00677365|10923200|FG001|COMPLETED|Overall Study||37
9813353|NCT00677365|10923201|FG002|COMPLETED|Overall Study||35
9813354|NCT00677365|10923202|FG003|COMPLETED|Overall Study||36
9813355|NCT00677365|10923199|FG000|NOT COMPLETED|Overall Study||2
9813356|NCT00677365|10923200|FG001|NOT COMPLETED|Overall Study||1
9813357|NCT00677365|10923201|FG002|NOT COMPLETED|Overall Study||2
9813358|NCT00677365|10923202|FG003|NOT COMPLETED|Overall Study||3
9813359|NCT00677534|10923212|FG000|STARTED|Washout (Weeks 1-4)||10
9813360|NCT00677534|10923212|FG000|COMPLETED|Washout (Weeks 1-4)||7
9813361|NCT00677534|10923212|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3
9813362|NCT00677534|10923212|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7
9813363|NCT00677534|10923212|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7
9813364|NCT00677534|10923212|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
9813365|NCT00677534|10923212|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
9813366|NCT00677534|10923212|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
9813367|NCT00677534|10923212|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
9813368|NCT00677690|10923218|FG000|STARTED|Overall Study||42
9813369|NCT00677690|10923219|FG001|STARTED|Overall Study||41
9813370|NCT00677690|10923218|FG000|COMPLETED|Overall Study||42
9813371|NCT00677690|10923219|FG001|COMPLETED|Overall Study||41
9813372|NCT00677690|10923218|FG000|NOT COMPLETED|Overall Study||0
10016538|NCT01810952|11139338|FG001|COMPLETED|Overall Study||17
10016539|NCT01810952|11139337|FG000|NOT COMPLETED|Overall Study||0
10016540|NCT01810952|11139338|FG001|NOT COMPLETED|Overall Study||0
10016541|NCT01810991|11139350|FG000|STARTED|Overall Study||19
9813373|NCT00677690|10923219|FG001|NOT COMPLETED|Overall Study||0
9813374|NCT00677807|10923228|FG000|STARTED|Overall Study||144
9813375|NCT00677807|10923229|FG001|STARTED|Overall Study||146
9813376|NCT00677807|10923230|FG002|STARTED|Overall Study||125
9813377|NCT00677807|10923228|FG000|Safety/ITT: Received Study Drug|Overall Study||144
9813378|NCT00677807|10923229|FG001|Safety/ITT: Received Study Drug|Overall Study||146
9813379|NCT00677807|10923230|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
9813380|NCT00677807|10923228|FG000|COMPLETED|Overall Study||126
9813381|NCT00677807|10923229|FG001|COMPLETED|Overall Study||135
9813382|NCT00677807|10923230|FG002|COMPLETED|Overall Study||105
9813383|NCT00677807|10923228|FG000|NOT COMPLETED|Overall Study||18
9813384|NCT00677807|10923229|FG001|NOT COMPLETED|Overall Study||11
9813385|NCT00677807|10923230|FG002|NOT COMPLETED|Overall Study||20
9813386|NCT00677820|10923240|FG000|STARTED|Overall Study||240
9813387|NCT00677820|10923241|FG001|STARTED|Overall Study||60
9813388|NCT00677820|10923240|FG000|COMPLETED|Overall Study||239
9813389|NCT00677820|10923241|FG001|COMPLETED|Overall Study||60
9813390|NCT00677820|10923240|FG000|NOT COMPLETED|Overall Study||1
9813391|NCT00677820|10923241|FG001|NOT COMPLETED|Overall Study||0
9813392|NCT00677833|10923251|FG000|STARTED|Overall Study||55
9813393|NCT00677833|10923252|FG001|STARTED|Overall Study||51
9813394|NCT00677833|10923253|FG002|STARTED|Overall Study||124
9813395|NCT00677833|10923254|FG003|STARTED|Overall Study||131
9813396|NCT00677833|10923251|FG000|COMPLETED|Overall Study||51
9813397|NCT00677833|10923252|FG001|COMPLETED|Overall Study||51
9813398|NCT00677833|10923253|FG002|COMPLETED|Overall Study||122
9813399|NCT00677833|10923254|FG003|COMPLETED|Overall Study||128
9813400|NCT00677833|10923251|FG000|NOT COMPLETED|Overall Study||4
9813401|NCT00677833|10923252|FG001|NOT COMPLETED|Overall Study||0
9813402|NCT00677833|10923253|FG002|NOT COMPLETED|Overall Study||2
9813403|NCT00677833|10923254|FG003|NOT COMPLETED|Overall Study||3
9813404|NCT00677898|10923264|FG000|STARTED|Overall Study||119
9813405|NCT00677898|10923265|FG001|STARTED|Overall Study||120
9813406|NCT00677898|10923264|FG000|COMPLETED|Overall Study||99
9813407|NCT00677898|10923265|FG001|COMPLETED|Overall Study||102
9813408|NCT00677898|10923264|FG000|NOT COMPLETED|Overall Study||20
9813409|NCT00677898|10923265|FG001|NOT COMPLETED|Overall Study||18
9813410|NCT00677924|10923273|FG000|STARTED|Overall Study||3
9813411|NCT00677924|10923274|FG001|STARTED|Overall Study||6
9813412|NCT00677924|10923273|FG000|COMPLETED|Overall Study||3
9813413|NCT00677924|10923274|FG001|COMPLETED|Overall Study||6
9813414|NCT00677924|10923273|FG000|NOT COMPLETED|Overall Study||0
9813415|NCT00677924|10923274|FG001|NOT COMPLETED|Overall Study||0
9813416|NCT00678015|10923280|FG000|STARTED|Overall Study||12
9813417|NCT00678015|10923280|FG000|COMPLETED|Overall Study||12
9813418|NCT00678015|10923280|FG000|NOT COMPLETED|Overall Study||0
9813419|NCT00678080|10923286|FG000|STARTED|Overall Study||11
9813420|NCT00678080|10923287|FG001|STARTED|Overall Study||14
9813421|NCT00678080|10923286|FG000|COMPLETED|Overall Study||8
9813422|NCT00678080|10923287|FG001|COMPLETED|Overall Study||13
9813423|NCT00678080|10923286|FG000|NOT COMPLETED|Overall Study||3
9813424|NCT00678080|10923287|FG001|NOT COMPLETED|Overall Study||1
9813425|NCT00678210|10923297|FG000|STARTED|Overall Study||49
9813426|NCT00678210|10923298|FG001|STARTED|Overall Study||49
9813427|NCT00678210|10923299|FG002|STARTED|Overall Study||49
9813428|NCT00678210|10923300|FG003|STARTED|Overall Study||50
9813429|NCT00678210|10923297|FG000|COMPLETED|Overall Study||38
9813430|NCT00678210|10923298|FG001|COMPLETED|Overall Study||38
9813431|NCT00678210|10923299|FG002|COMPLETED|Overall Study||43
9813432|NCT00678210|10923300|FG003|COMPLETED|Overall Study||30
9813433|NCT00678210|10923297|FG000|NOT COMPLETED|Overall Study||11
9813434|NCT00678210|10923298|FG001|NOT COMPLETED|Overall Study||11
9813435|NCT00678210|10923299|FG002|NOT COMPLETED|Overall Study||6
9813436|NCT00678210|10923300|FG003|NOT COMPLETED|Overall Study||20
9813437|NCT00678249|10923313|FG000|STARTED|Overall Study||97
9813438|NCT00678249|10923314|FG001|STARTED|Overall Study||93
9813439|NCT00678249|10923315|FG002|STARTED|Overall Study||37
9813440|NCT00678249|10923313|FG000|COMPLETED|Overall Study||97
9813441|NCT00678249|10923314|FG001|COMPLETED|Overall Study||93
9813442|NCT00678249|10923315|FG002|COMPLETED|Overall Study||37
9813443|NCT00678249|10923313|FG000|NOT COMPLETED|Overall Study||0
9813444|NCT00678249|10923314|FG001|NOT COMPLETED|Overall Study||0
9813445|NCT00678249|10923315|FG002|NOT COMPLETED|Overall Study||0
9813446|NCT00678301|10923325|FG000|STARTED|Overall Study||239
9813447|NCT00678301|10923326|FG001|STARTED|Overall Study||118
9813448|NCT00678301|10923325|FG000|COMPLETED|Overall Study||231
9813449|NCT00678301|10923326|FG001|COMPLETED|Overall Study||116
9813450|NCT00678301|10923325|FG000|NOT COMPLETED|Overall Study||8
9813451|NCT00678301|10923326|FG001|NOT COMPLETED|Overall Study||2
9813452|NCT00678379|10923335|FG000|STARTED|Overall Study||40
9813453|NCT00678379|10923336|FG001|STARTED|Overall Study||40
9813454|NCT00678379|10923337|FG002|STARTED|Overall Study||40
9813455|NCT00678379|10923335|FG000|COMPLETED|Overall Study||34
9813456|NCT00678379|10923336|FG001|COMPLETED|Overall Study||37
9813457|NCT00678379|10923337|FG002|COMPLETED|Overall Study||36
9813458|NCT00678379|10923335|FG000|NOT COMPLETED|Overall Study||6
9813459|NCT00678379|10923336|FG001|NOT COMPLETED|Overall Study||3
9813460|NCT00678379|10923337|FG002|NOT COMPLETED|Overall Study||4
9813461|NCT00678392|10923347|FG000|STARTED|Overall Study||361
9813462|NCT00678392|10923348|FG001|STARTED|Overall Study||362
9813463|NCT00678392|10923347|FG000|Treated|Overall Study||359
9813464|NCT00678392|10923348|FG001|Treated|Overall Study||355
9813465|NCT00678392|10923347|FG000|COMPLETED|Overall Study||0
9813466|NCT00678392|10923348|FG001|COMPLETED|Overall Study||0
9813467|NCT00678392|10923347|FG000|NOT COMPLETED|Overall Study||361
9813468|NCT00678392|10923348|FG001|NOT COMPLETED|Overall Study||362
9813469|NCT00678418|10923356|FG000|STARTED|Part A (Double Blind)||126
9813470|NCT00678418|10923357|FG001|STARTED|Part A (Double Blind)||124
9813471|NCT00678418|10923356|FG000|COMPLETED|Part A (Double Blind)||67
9813472|NCT00678418|10923357|FG001|COMPLETED|Part A (Double Blind)||47
9813473|NCT00678418|10923356|FG000|NOT COMPLETED|Part A (Double Blind)||59
9813474|NCT00678418|10923357|FG001|NOT COMPLETED|Part A (Double Blind)||77
9813475|NCT00678418|10923356|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
9813476|NCT00678418|10923357|FG001|STARTED|Part B (Open Label)||0
9813477|NCT00678418|10923356|FG000|COMPLETED|Part B (Open Label)||71
10016542|NCT01810991|11139350|FG000|COMPLETED|Overall Study||17
10016543|NCT01810991|11139350|FG000|NOT COMPLETED|Overall Study||2
10016544|NCT01811004|11139356|FG000|STARTED|Overall Study||9
10016545|NCT01811004|11139357|FG001|STARTED|Overall Study||8
10016546|NCT01811004|11139356|FG000|COMPLETED|Overall Study||8
10016547|NCT01811004|11139357|FG001|COMPLETED|Overall Study||5
10016548|NCT01811004|11139356|FG000|NOT COMPLETED|Overall Study||1
10016549|NCT01811004|11139357|FG001|NOT COMPLETED|Overall Study||3
10016550|NCT01811030|11139365|FG000|STARTED|Overall Study||33
10016551|NCT01811030|11139365|FG000|COMPLETED|Overall Study||20
10016552|NCT01811030|11139365|FG000|NOT COMPLETED|Overall Study||13
10016553|NCT01811147|11139373|FG000|STARTED|Overall Study||51
10016554|NCT01811147|11139374|FG001|STARTED|Overall Study||56
10016555|NCT01811147|11139375|FG002|STARTED|Overall Study||49
10016556|NCT01811147|11139376|FG003|STARTED|Overall Study||33
9813478|NCT00678418|10923357|FG001|COMPLETED|Part B (Open Label)||0
9813479|NCT00678418|10923356|FG000|NOT COMPLETED|Part B (Open Label)||43
9813480|NCT00678418|10923357|FG001|NOT COMPLETED|Part B (Open Label)||0
9813481|NCT00678444|10923365|FG000|STARTED|Overall Study||100
9813482|NCT00678444|10923366|FG001|STARTED|Overall Study||99
9813483|NCT00678444|10923365|FG000|COMPLETED|Overall Study||100
9813484|NCT00678444|10923366|FG001|COMPLETED|Overall Study||99
9813485|NCT00678444|10923365|FG000|NOT COMPLETED|Overall Study||0
9813486|NCT00678444|10923366|FG001|NOT COMPLETED|Overall Study||0
9813487|NCT00678470|10923372|FG000|STARTED|Overall Study||18
9813488|NCT00678470|10923372|FG000|COMPLETED|Overall Study||14
9813489|NCT00678470|10923372|FG000|NOT COMPLETED|Overall Study||4
9813490|NCT00678496|10923378|FG000|STARTED|Overall Study||12
10016557|NCT01811147|11139373|FG000|COMPLETED|Overall Study||15
10016558|NCT01811147|11139374|FG001|COMPLETED|Overall Study||11
10016559|NCT01811147|11139375|FG002|COMPLETED|Overall Study||6
10016560|NCT01811147|11139376|FG003|COMPLETED|Overall Study||4
9813491|NCT00678496|10923379|FG001|STARTED|Overall Study||12
9813492|NCT00678496|10923378|FG000|Completed 8 Weeks Follow-up|Overall Study||9
9813493|NCT00678496|10923379|FG001|Completed 8 Weeks Follow-up|Overall Study||12
9813494|NCT00678496|10923378|FG000|COMPLETED|Overall Study||10
9813495|NCT00678496|10923379|FG001|COMPLETED|Overall Study||8
9813496|NCT00678496|10923378|FG000|NOT COMPLETED|Overall Study||2
9813497|NCT00678496|10923379|FG001|NOT COMPLETED|Overall Study||4
9813498|NCT00678535|10923389|FG000|STARTED|Overall Study|ITT population|455
9813499|NCT00678535|10923390|FG001|STARTED|Overall Study|ITT population|449
9813500|NCT00678535|10923389|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
9813501|NCT00678535|10923390|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
9813502|NCT00678535|10923389|FG000|NOT COMPLETED|Overall Study||93
9813503|NCT00678535|10923390|FG001|NOT COMPLETED|Overall Study||98
10016561|NCT01811147|11139373|FG000|NOT COMPLETED|Overall Study||36
9813504|NCT00678561|10923404|FG000|STARTED|Overall Study||6
9813505|NCT00678561|10923405|FG001|STARTED|Overall Study||6
9813506|NCT00678561|10923406|FG002|STARTED|Overall Study||8
9813507|NCT00678561|10923407|FG003|STARTED|Overall Study||4
9813508|NCT00678561|10923408|FG004|STARTED|Overall Study||17
9813509|NCT00678561|10923409|FG005|STARTED|Overall Study||17
9813510|NCT00678561|10923410|FG006|STARTED|Overall Study||15
9813511|NCT00678561|10923411|FG007|STARTED|Overall Study||8
9813512|NCT00678561|10923404|FG000|COMPLETED|Overall Study||6
9813513|NCT00678561|10923405|FG001|COMPLETED|Overall Study||5
9813514|NCT00678561|10923406|FG002|COMPLETED|Overall Study||7
9813515|NCT00678561|10923407|FG003|COMPLETED|Overall Study||4
9813516|NCT00678561|10923408|FG004|COMPLETED|Overall Study||15
9813517|NCT00678561|10923409|FG005|COMPLETED|Overall Study||16
9813518|NCT00678561|10923410|FG006|COMPLETED|Overall Study||15
9813519|NCT00678561|10923411|FG007|COMPLETED|Overall Study||7
9813520|NCT00678561|10923404|FG000|NOT COMPLETED|Overall Study||0
9813521|NCT00678561|10923405|FG001|NOT COMPLETED|Overall Study||1
9813522|NCT00678561|10923406|FG002|NOT COMPLETED|Overall Study||1
9813523|NCT00678561|10923407|FG003|NOT COMPLETED|Overall Study||0
9813524|NCT00678561|10923408|FG004|NOT COMPLETED|Overall Study||2
9813525|NCT00678561|10923409|FG005|NOT COMPLETED|Overall Study||1
9813526|NCT00678561|10923410|FG006|NOT COMPLETED|Overall Study||0
9813527|NCT00678561|10923411|FG007|NOT COMPLETED|Overall Study||1
9813528|NCT00678587|10923438|FG000|STARTED|Overall Study||147
9813529|NCT00678587|10923439|FG001|STARTED|Overall Study||145
9813530|NCT00678587|10923438|FG000|COMPLETED|Overall Study||127
9813531|NCT00678587|10923439|FG001|COMPLETED|Overall Study||127
9813532|NCT00678587|10923438|FG000|NOT COMPLETED|Overall Study||20
9813533|NCT00678587|10923439|FG001|NOT COMPLETED|Overall Study||18
9813534|NCT00678639|10923448|FG000|STARTED|Overall Study||53
9813535|NCT00678639|10923449|FG001|STARTED|Overall Study||57
9813536|NCT00678639|10923448|FG000|Hospital Discharge|Overall Study||53
9813537|NCT00678639|10923449|FG001|Hospital Discharge|Overall Study||57
9813538|NCT00678639|10923448|FG000|COMPLETED|Overall Study||51
9813539|NCT00678639|10923449|FG001|COMPLETED|Overall Study||57
9813540|NCT00678639|10923448|FG000|NOT COMPLETED|Overall Study||2
9813541|NCT00678639|10923449|FG001|NOT COMPLETED|Overall Study||0
9813542|NCT00678652|10923460|FG000|STARTED|Overall Study||9
9813543|NCT00678652|10923461|FG001|STARTED|Overall Study||9
9813544|NCT00678652|10923462|FG002|STARTED|Overall Study||9
9813545|NCT00678652|10923463|FG003|STARTED|Overall Study||9
9813546|NCT00678652|10923460|FG000|COMPLETED|Overall Study||6
9813547|NCT00678652|10923461|FG001|COMPLETED|Overall Study||9
9813548|NCT00678652|10923462|FG002|COMPLETED|Overall Study||8
9813549|NCT00678652|10923463|FG003|COMPLETED|Overall Study||9
9813550|NCT00678652|10923460|FG000|NOT COMPLETED|Overall Study||3
9813551|NCT00678652|10923461|FG001|NOT COMPLETED|Overall Study||0
9813552|NCT00678652|10923462|FG002|NOT COMPLETED|Overall Study||1
9813553|NCT00678652|10923463|FG003|NOT COMPLETED|Overall Study||0
9813554|NCT00678691|10923475|FG000|STARTED|Overall Study||27
9813555|NCT00678691|10923476|FG001|STARTED|Overall Study||28
9813556|NCT00678691|10923475|FG000|COMPLETED|Overall Study||21
9813557|NCT00678691|10923476|FG001|COMPLETED|Overall Study||24
9813558|NCT00678691|10923475|FG000|NOT COMPLETED|Overall Study||6
9813559|NCT00678691|10923476|FG001|NOT COMPLETED|Overall Study||4
9813560|NCT00678795|10923484|FG000|STARTED|Overall Study||67
9813561|NCT00678795|10923485|FG001|STARTED|Overall Study||68
9813562|NCT00678795|10923484|FG000|COMPLETED|Overall Study||56
9813563|NCT00678795|10923485|FG001|COMPLETED|Overall Study||62
9813564|NCT00678795|10923484|FG000|NOT COMPLETED|Overall Study||11
9813565|NCT00678795|10923485|FG001|NOT COMPLETED|Overall Study||6
9813566|NCT00678834|10923494|FG000|STARTED|Overall Study||40
9813567|NCT00678834|10923495|FG001|STARTED|Overall Study||15
9813568|NCT00678834|10923496|FG002|STARTED|Overall Study||25
9813569|NCT00678834|10923494|FG000|COMPLETED|Overall Study||24
9813570|NCT00678834|10923495|FG001|COMPLETED|Overall Study||15
9813571|NCT00678834|10923496|FG002|COMPLETED|Overall Study||16
9813572|NCT00678834|10923494|FG000|NOT COMPLETED|Overall Study||16
9813573|NCT00678834|10923495|FG001|NOT COMPLETED|Overall Study||0
9813574|NCT00678834|10923496|FG002|NOT COMPLETED|Overall Study||9
9813575|NCT00678886|10923516|FG000|STARTED|Overall Study||10
9813576|NCT00678886|10923517|FG001|STARTED|Overall Study||19
9813577|NCT00678886|10923518|FG002|STARTED|Overall Study||81
9813578|NCT00678886|10923519|FG003|STARTED|Overall Study||162
9813579|NCT00678886|10923516|FG000|COMPLETED|Overall Study||10
9813580|NCT00678886|10923517|FG001|COMPLETED|Overall Study||19
9813581|NCT00678886|10923518|FG002|COMPLETED|Overall Study||72
9813582|NCT00678886|10923519|FG003|COMPLETED|Overall Study||153
9813583|NCT00678886|10923516|FG000|NOT COMPLETED|Overall Study||0
9813584|NCT00678886|10923517|FG001|NOT COMPLETED|Overall Study||0
9813585|NCT00678886|10923518|FG002|NOT COMPLETED|Overall Study||9
9813586|NCT00678886|10923519|FG003|NOT COMPLETED|Overall Study||9
9813587|NCT00678899|10923528|FG000|STARTED|Overall Study||50
9813588|NCT00678899|10923528|FG000|COMPLETED|Overall Study||49
9813589|NCT00678899|10923528|FG000|NOT COMPLETED|Overall Study||1
9813590|NCT00679029|10923533|FG000|STARTED|Overall Study||15
9813591|NCT00679029|10923533|FG000|COMPLETED|Overall Study||10
9813592|NCT00679029|10923533|FG000|NOT COMPLETED|Overall Study||5
9813593|NCT00679042|10923537|FG000|STARTED|Transplant + 1 Year Follow Up||21
9813594|NCT00679042|10923537|FG000|COMPLETED|Transplant + 1 Year Follow Up||19
9813595|NCT00679042|10923537|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2
9813596|NCT00679042|10923537|FG000|STARTED|5-Year Follow Up||19
9813597|NCT00679042|10923537|FG000|COMPLETED|5-Year Follow Up||5
9813598|NCT00679042|10923537|FG000|NOT COMPLETED|5-Year Follow Up||14
9813599|NCT00679042|10923537|FG000|STARTED|10-Year Follow Up||5
9813600|NCT00679042|10923537|FG000|COMPLETED|10-Year Follow Up||0
9813601|NCT00679042|10923537|FG000|NOT COMPLETED|10-Year Follow Up||5
9813602|NCT00679055|10923543|FG000|STARTED|Overall Study||8
9813603|NCT00679055|10923544|FG001|STARTED|Overall Study||6
9813604|NCT00679055|10923543|FG000|COMPLETED|Overall Study||6
9813605|NCT00679055|10923544|FG001|COMPLETED|Overall Study||1
9813606|NCT00679055|10923543|FG000|NOT COMPLETED|Overall Study||2
9813607|NCT00679055|10923544|FG001|NOT COMPLETED|Overall Study||5
9813608|NCT00679081|10923550|FG000|STARTED|Overall Study|Study design was within-subject control.|15
9813609|NCT00679081|10923550|FG000|COMPLETED|Overall Study||14
9813610|NCT00679081|10923550|FG000|NOT COMPLETED|Overall Study||1
9813611|NCT00679172|10923563|FG000|STARTED|Overall Study||37
9813612|NCT00679172|10923564|FG001|STARTED|Overall Study||38
9813613|NCT00679172|10923565|FG002|STARTED|Overall Study||36
9813614|NCT00679172|10923566|FG003|STARTED|Overall Study||39
9813615|NCT00679172|10923567|FG004|STARTED|Overall Study||37
9813616|NCT00679172|10923563|FG000|COMPLETED|Overall Study||36
9813617|NCT00679172|10923564|FG001|COMPLETED|Overall Study||37
9813618|NCT00679172|10923565|FG002|COMPLETED|Overall Study||35
9813619|NCT00679172|10923566|FG003|COMPLETED|Overall Study||38
9813620|NCT00679172|10923567|FG004|COMPLETED|Overall Study||37
9813621|NCT00679172|10923563|FG000|NOT COMPLETED|Overall Study||1
9813622|NCT00679172|10923564|FG001|NOT COMPLETED|Overall Study||1
9813623|NCT00679172|10923565|FG002|NOT COMPLETED|Overall Study||1
9813624|NCT00679172|10923566|FG003|NOT COMPLETED|Overall Study||1
9813625|NCT00679172|10923567|FG004|NOT COMPLETED|Overall Study||0
9813626|NCT00679211|10923582|FG000|STARTED|Overall Study||110
9813627|NCT00679211|10923582|FG000|COMPLETED|Overall Study||0
9813628|NCT00679211|10923582|FG000|NOT COMPLETED|Overall Study||110
9813629|NCT00679263|10923591|FG000|STARTED|Visit 3/Dose 2||10
9813630|NCT00679263|10923592|FG001|STARTED|Visit 3/Dose 2||11
9813631|NCT00679263|10923593|FG002|STARTED|Visit 3/Dose 2||11
9813632|NCT00679263|10923591|FG000|COMPLETED|Visit 3/Dose 2||9
9813633|NCT00679263|10923592|FG001|COMPLETED|Visit 3/Dose 2||6
9813634|NCT00679263|10923593|FG002|COMPLETED|Visit 3/Dose 2||11
9813635|NCT00679263|10923591|FG000|NOT COMPLETED|Visit 3/Dose 2||1
9813636|NCT00679263|10923592|FG001|NOT COMPLETED|Visit 3/Dose 2||5
9813637|NCT00679263|10923593|FG002|NOT COMPLETED|Visit 3/Dose 2||0
10235569|NCT01148056|11365905|FG000|COMPLETED|Overall Study||2
10235570|NCT01148056|11365905|FG000|NOT COMPLETED|Overall Study||0
10235571|NCT01147393|11365909|FG000|STARTED|Dose Level 1||3
10235572|NCT01147393|11365909|FG000|COMPLETED|Dose Level 1||1
10235573|NCT01147393|11365909|FG000|NOT COMPLETED|Dose Level 1||2
10235574|NCT01147393|11365909|FG000|STARTED|Dose Level -1||1
10235575|NCT01147393|11365909|FG000|COMPLETED|Dose Level -1||0
10235576|NCT01147393|11365909|FG000|NOT COMPLETED|Dose Level -1||1
10235577|NCT01147042|11365916|FG000|STARTED|Overall Study||2
10235578|NCT01147042|11365917|FG001|STARTED|Overall Study||0
10235579|NCT01147042|11365916|FG000|COMPLETED|Overall Study||2
10235580|NCT01147042|11365917|FG001|COMPLETED|Overall Study||0
10235581|NCT01147042|11365916|FG000|NOT COMPLETED|Overall Study||0
10235582|NCT01147042|11365917|FG001|NOT COMPLETED|Overall Study||0
10239708|NCT00058188|11371394|FG000|COMPLETED|Overall Study||0
10239709|NCT00058188|11371395|FG001|COMPLETED|Overall Study||0
10239710|NCT00058188|11371394|FG000|NOT COMPLETED|Overall Study||0
10239711|NCT00058188|11371395|FG001|NOT COMPLETED|Overall Study||0
10239712|NCT00014560|11371401|FG000|STARTED|Overall Study||3
10239713|NCT00014560|11371401|FG000|COMPLETED|Overall Study||0
10239714|NCT00014560|11371401|FG000|NOT COMPLETED|Overall Study||3
10239715|NCT00038142|11371407|FG000|STARTED|Overall Study||32
10239716|NCT00038142|11371408|FG001|STARTED|Overall Study||14
10239717|NCT00038142|11371407|FG000|COMPLETED|Overall Study||10
10239718|NCT00038142|11371408|FG001|COMPLETED|Overall Study||7
10239719|NCT00038142|11371407|FG000|NOT COMPLETED|Overall Study||22
10239720|NCT00038142|11371408|FG001|NOT COMPLETED|Overall Study||7
10239721|NCT00020722|11371414|FG000|STARTED|Overall Study||7
9813638|NCT00679263|10923591|FG000|STARTED|Visit 2/Dose 1||11
9813639|NCT00679263|10923592|FG001|STARTED|Visit 2/Dose 1||6
9813640|NCT00679263|10923593|FG002|STARTED|Visit 2/Dose 1||11
9813641|NCT00679263|10923591|FG000|COMPLETED|Visit 2/Dose 1||9
9813642|NCT00679263|10923592|FG001|COMPLETED|Visit 2/Dose 1||5
9813643|NCT00679263|10923593|FG002|COMPLETED|Visit 2/Dose 1||11
9813644|NCT00679263|10923591|FG000|NOT COMPLETED|Visit 2/Dose 1||2
9813645|NCT00679263|10923592|FG001|NOT COMPLETED|Visit 2/Dose 1||1
9813646|NCT00679263|10923593|FG002|NOT COMPLETED|Visit 2/Dose 1||0
9813647|NCT00679289|10923604|FG000|STARTED|Overall Study||6
9813648|NCT00679289|10923605|FG001|STARTED|Overall Study||6
9813649|NCT00679289|10923606|FG002|STARTED|Overall Study||24
9813650|NCT00679289|10923604|FG000|COMPLETED|Overall Study||1
9813651|NCT00679289|10923605|FG001|COMPLETED|Overall Study||0
9813652|NCT00679289|10923606|FG002|COMPLETED|Overall Study||1
9813653|NCT00679289|10923604|FG000|NOT COMPLETED|Overall Study||5
9813654|NCT00679289|10923605|FG001|NOT COMPLETED|Overall Study||6
9813655|NCT00679289|10923606|FG002|NOT COMPLETED|Overall Study||23
9813656|NCT00679302|10923618|FG000|STARTED|Overall Study||84
9813657|NCT00679302|10923619|FG001|STARTED|Overall Study||77
10239722|NCT00020722|11371414|FG000|COMPLETED|Overall Study||7
10239723|NCT00020722|11371414|FG000|NOT COMPLETED|Overall Study||0
10239724|NCT00002975|11371419|FG000|STARTED|Overall Study||180
10239725|NCT00002975|11371419|FG000|Treated With Study Therapy|Overall Study||175
9813658|NCT00679302|10923618|FG000|COMPLETED|Overall Study||76
9813659|NCT00679302|10923619|FG001|COMPLETED|Overall Study||73
9813660|NCT00679302|10923618|FG000|NOT COMPLETED|Overall Study||8
9813661|NCT00679302|10923619|FG001|NOT COMPLETED|Overall Study||4
9813662|NCT00679341|10923627|FG000|STARTED|Overall Study||67
9813663|NCT00679341|10923628|FG001|STARTED|Overall Study||70
9813664|NCT00679341|10923627|FG000|COMPLETED|Overall Study||14
9813665|NCT00679341|10923628|FG001|COMPLETED|Overall Study||19
9813666|NCT00679341|10923627|FG000|NOT COMPLETED|Overall Study||53
9813667|NCT00679341|10923628|FG001|NOT COMPLETED|Overall Study||51
9813668|NCT00679354|10923635|FG000|STARTED|Overall Study||30
9813669|NCT00679354|10923635|FG000|COMPLETED|Overall Study||0
9813670|NCT00679354|10923635|FG000|NOT COMPLETED|Overall Study||30
9813671|NCT00679367|10923640|FG000|STARTED|Overall Study||16
9813672|NCT00679367|10923640|FG000|COMPLETED|Overall Study||4
9813673|NCT00679367|10923640|FG000|NOT COMPLETED|Overall Study||12
9813674|NCT00679380|10923649|FG000|STARTED|Overall Study||109
9813675|NCT00679380|10923650|FG001|STARTED|Overall Study||109
9813676|NCT00679380|10923651|FG002|STARTED|Overall Study||103
9813677|NCT00679380|10923652|FG003|STARTED|Overall Study||89
9813678|NCT00679380|10923649|FG000|COMPLETED|Overall Study||67
9813679|NCT00679380|10923650|FG001|COMPLETED|Overall Study||76
9813680|NCT00679380|10923651|FG002|COMPLETED|Overall Study||68
9813681|NCT00679380|10923652|FG003|COMPLETED|Overall Study||61
9813682|NCT00679380|10923649|FG000|NOT COMPLETED|Overall Study||42
9813683|NCT00679380|10923650|FG001|NOT COMPLETED|Overall Study||33
9813684|NCT00679380|10923651|FG002|NOT COMPLETED|Overall Study||35
9813685|NCT00679380|10923652|FG003|NOT COMPLETED|Overall Study||28
9813686|NCT00679432|10923666|FG000|STARTED|Overall Study||126
9813687|NCT00679432|10923667|FG001|STARTED|Overall Study||127
9813688|NCT00679432|10923668|FG002|STARTED|Overall Study||129
9813689|NCT00679432|10923669|FG003|STARTED|Overall Study||127
9813690|NCT00679432|10923666|FG000|COMPLETED|Overall Study||89
9813691|NCT00679432|10923667|FG001|COMPLETED|Overall Study||89
9813692|NCT00679432|10923668|FG002|COMPLETED|Overall Study||76
9813693|NCT00679432|10923669|FG003|COMPLETED|Overall Study||95
9813694|NCT00679432|10923666|FG000|NOT COMPLETED|Overall Study||37
9813695|NCT00679432|10923667|FG001|NOT COMPLETED|Overall Study||38
9813696|NCT00679432|10923668|FG002|NOT COMPLETED|Overall Study||53
9813697|NCT00679432|10923669|FG003|NOT COMPLETED|Overall Study||32
9813698|NCT00679549|10923681|FG000|STARTED|Overall Study||75
9813699|NCT00679549|10923682|FG001|STARTED|Overall Study||75
9813700|NCT00679549|10923681|FG000|COMPLETED|Overall Study||69
9813701|NCT00679549|10923682|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
9813702|NCT00679549|10923681|FG000|NOT COMPLETED|Overall Study||6
9813703|NCT00679549|10923682|FG001|NOT COMPLETED|Overall Study||9
9813704|NCT00679627|10923690|FG000|STARTED|Overall Study||1021
9813705|NCT00679627|10923691|FG001|STARTED|Overall Study||1024
9813706|NCT00679627|10923690|FG000|COMPLETED|Overall Study||322
9813707|NCT00679627|10923691|FG001|COMPLETED|Overall Study||339
9813708|NCT00679627|10923690|FG000|NOT COMPLETED|Overall Study||699
9813709|NCT00679627|10923691|FG001|NOT COMPLETED|Overall Study||685
9813710|NCT00679913|10923699|FG000|STARTED|Overall Study||101
9813711|NCT00679913|10923700|FG001|STARTED|Overall Study||99
9813712|NCT00679913|10923699|FG000|COMPLETED|Overall Study||83
9813713|NCT00679913|10923700|FG001|COMPLETED|Overall Study||86
9813714|NCT00679913|10923699|FG000|NOT COMPLETED|Overall Study||18
9813715|NCT00679913|10923700|FG001|NOT COMPLETED|Overall Study||13
9813716|NCT00679939|10923709|FG000|STARTED|52-Week Double-Blind (DB) Period||114
9813717|NCT00679939|10923710|FG001|STARTED|52-Week Double-Blind (DB) Period||112
9813718|NCT00679939|10923709|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77
9813719|NCT00679939|10923710|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85
9813720|NCT00679939|10923709|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
9813721|NCT00679939|10923710|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
9813722|NCT00679939|10923709|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
9813723|NCT00679939|10923710|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
9813724|NCT00679939|10923709|FG000|COMPLETED|24-Week Open-Label (OL) Period||69
9813725|NCT00679939|10923710|FG001|COMPLETED|24-Week Open-Label (OL) Period||80
9813726|NCT00679939|10923709|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7
9813727|NCT00679939|10923710|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4
9813728|NCT00679952|10923722|FG000|STARTED|Overall Study||86
9813729|NCT00679952|10923723|FG001|STARTED|Overall Study||82
9813730|NCT00679952|10923722|FG000|COMPLETED|Overall Study||86
9813731|NCT00679952|10923723|FG001|COMPLETED|Overall Study||82
9813732|NCT00679952|10923722|FG000|NOT COMPLETED|Overall Study||0
9813733|NCT00679952|10923723|FG001|NOT COMPLETED|Overall Study||0
9813734|NCT00680017|10923731|FG000|STARTED|Overall Study||140
9813735|NCT00680017|10923732|FG001|STARTED|Overall Study||140
9813736|NCT00680017|10923731|FG000|COMPLETED|Overall Study||123
9813737|NCT00680017|10923732|FG001|COMPLETED|Overall Study||128
9813738|NCT00680017|10923731|FG000|NOT COMPLETED|Overall Study||17
9813739|NCT00680017|10923732|FG001|NOT COMPLETED|Overall Study||12
9813740|NCT00680043|10923741|FG000|STARTED|Overall Study||39
9813741|NCT00680043|10923742|FG001|STARTED|Overall Study||37
9813742|NCT00680043|10923743|FG002|STARTED|Overall Study||38
9813743|NCT00680043|10923741|FG000|COMPLETED|Overall Study||37
9813744|NCT00680043|10923742|FG001|COMPLETED|Overall Study||36
9813745|NCT00680043|10923743|FG002|COMPLETED|Overall Study||34
9813746|NCT00680043|10923741|FG000|NOT COMPLETED|Overall Study||2
9813747|NCT00680043|10923742|FG001|NOT COMPLETED|Overall Study||1
9813748|NCT00680043|10923743|FG002|NOT COMPLETED|Overall Study||4
9813749|NCT00680056|10923753|FG000|STARTED|First Intervention||16
9813750|NCT00680056|10923754|FG001|STARTED|First Intervention||17
9813751|NCT00680056|10923753|FG000|COMPLETED|First Intervention||15
9813752|NCT00680056|10923754|FG001|COMPLETED|First Intervention||15
9813753|NCT00680056|10923753|FG000|NOT COMPLETED|First Intervention||1
9813754|NCT00680056|10923754|FG001|NOT COMPLETED|First Intervention||2
9813755|NCT00680056|10923753|FG000|STARTED|Washout Period of One Week||15
9813756|NCT00680056|10923754|FG001|STARTED|Washout Period of One Week||15
9813757|NCT00680056|10923753|FG000|COMPLETED|Washout Period of One Week||15
9813758|NCT00680056|10923754|FG001|COMPLETED|Washout Period of One Week||15
9813759|NCT00680056|10923753|FG000|NOT COMPLETED|Washout Period of One Week||0
9813760|NCT00680056|10923754|FG001|NOT COMPLETED|Washout Period of One Week||0
9813761|NCT00680056|10923753|FG000|STARTED|Second Intervention||15
9813762|NCT00680056|10923754|FG001|STARTED|Second Intervention||15
9813763|NCT00680056|10923753|FG000|COMPLETED|Second Intervention||12
9813764|NCT00680056|10923754|FG001|COMPLETED|Second Intervention||14
9813765|NCT00680056|10923753|FG000|NOT COMPLETED|Second Intervention||3
9813766|NCT00680056|10923754|FG001|NOT COMPLETED|Second Intervention||1
9813767|NCT00680121|10923763|FG000|STARTED|Overall Study||60
9813768|NCT00680121|10923764|FG001|STARTED|Overall Study||60
9813769|NCT00680121|10923763|FG000|COMPLETED|Overall Study||33
9813770|NCT00680121|10923764|FG001|COMPLETED|Overall Study||37
9813771|NCT00680121|10923763|FG000|NOT COMPLETED|Overall Study||27
9813772|NCT00680121|10923764|FG001|NOT COMPLETED|Overall Study||23
9813773|NCT00680186|10923772|FG000|STARTED|Overall Study|Started treatment.|1280
9813774|NCT00680186|10923773|FG001|STARTED|Overall Study|Started treatment.|1288
9813775|NCT00680186|10923772|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155
9813776|NCT00680186|10923773|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172
9813777|NCT00680186|10923772|FG000|NOT COMPLETED|Overall Study||125
9813778|NCT00680186|10923773|FG001|NOT COMPLETED|Overall Study||116
9813779|NCT00680225|10923779|FG000|STARTED|Overall Study||10
9813780|NCT00680225|10923779|FG000|COMPLETED|Overall Study||8
9813781|NCT00680225|10923779|FG000|NOT COMPLETED|Overall Study||2
9813782|NCT00680368|10923783|FG000|STARTED|Overall Study||112
9813783|NCT00680368|10923783|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
9813784|NCT00680368|10923783|FG000|NOT COMPLETED|Overall Study||15
9813785|NCT00680407|10923792|FG000|STARTED|Overall Study||26
9813786|NCT00680407|10923793|FG001|STARTED|Overall Study||27
9813787|NCT00680407|10923794|FG002|STARTED|Overall Study||25
9813788|NCT00680407|10923792|FG000|COMPLETED|Overall Study||18
9813789|NCT00680407|10923793|FG001|COMPLETED|Overall Study||22
9813790|NCT00680407|10923794|FG002|COMPLETED|Overall Study||22
9813791|NCT00680407|10923792|FG000|NOT COMPLETED|Overall Study||8
9813792|NCT00680407|10923793|FG001|NOT COMPLETED|Overall Study||5
9813793|NCT00680407|10923794|FG002|NOT COMPLETED|Overall Study||3
9813794|NCT00680459|10923804|FG000|STARTED|Overall Study||7
9813795|NCT00680459|10923805|FG001|STARTED|Overall Study||6
9813796|NCT00680459|10923804|FG000|COMPLETED|Overall Study||7
10235583|NCT01147536|11365922|FG000|STARTED|Overall Study||12
10235584|NCT01147536|11365922|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10235585|NCT01147536|11365922|FG000|COMPLETED|Overall Study||9
10235586|NCT01147536|11365922|FG000|NOT COMPLETED|Overall Study||3
10235587|NCT01139996|11365928|FG000|STARTED|Overall Study||11
10235588|NCT01139996|11365929|FG001|STARTED|Overall Study||11
10235589|NCT01139996|11365928|FG000|COMPLETED|Overall Study||11
10235590|NCT01139996|11365929|FG001|COMPLETED|Overall Study||11
10235591|NCT01139996|11365928|FG000|NOT COMPLETED|Overall Study||0
10235592|NCT01139996|11365929|FG001|NOT COMPLETED|Overall Study||0
10235593|NCT01133288|11365935|FG000|STARTED|Eligibility Assessment||7
10235594|NCT01133288|11365935|FG000|COMPLETED|Eligibility Assessment||2
10235595|NCT01133288|11365935|FG000|NOT COMPLETED|Eligibility Assessment||5
10235596|NCT01133288|11365935|FG000|STARTED|Intervention Allocation||2
10235597|NCT01133288|11365935|FG000|COMPLETED|Intervention Allocation||0
10235598|NCT01133288|11365935|FG000|NOT COMPLETED|Intervention Allocation||2
10235599|NCT01142128|11365943|FG000|STARTED|Overall Study||8
10235600|NCT01142128|11365943|FG000|Nexium Alone|Overall Study||3
10235601|NCT01142128|11365943|FG000|Placebo to Nexium, Alone|Overall Study||3
10235602|NCT01142128|11365943|FG000|Viokase 16 Plus Nexium|Overall Study||2
10235603|NCT01142128|11365943|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0
10235604|NCT01142128|11365943|FG000|COMPLETED|Overall Study||4
10235605|NCT01142128|11365943|FG000|NOT COMPLETED|Overall Study||4
10235606|NCT01131884|11365955|FG000|STARTED|Overall Study||1
10235607|NCT01131884|11365956|FG001|STARTED|Overall Study||0
10235608|NCT01131884|11365955|FG000|COMPLETED|Overall Study||1
9813797|NCT00680459|10923805|FG001|COMPLETED|Overall Study||6
9813798|NCT00680459|10923804|FG000|NOT COMPLETED|Overall Study||0
9813799|NCT00680459|10923805|FG001|NOT COMPLETED|Overall Study||0
9813800|NCT00680524|10923811|FG000|STARTED|Overall Study||20
9813801|NCT00680524|10923811|FG000|COMPLETED|Overall Study||17
9813802|NCT00680524|10923811|FG000|NOT COMPLETED|Overall Study||3
9813803|NCT00680628|10923817|FG000|STARTED|Overall Study||43
9813804|NCT00680628|10923818|FG001|STARTED|Overall Study||40
9813805|NCT00680628|10923817|FG000|COMPLETED|Overall Study||43
9813806|NCT00680628|10923818|FG001|COMPLETED|Overall Study||40
9813807|NCT00680628|10923817|FG000|NOT COMPLETED|Overall Study||0
9813808|NCT00680628|10923818|FG001|NOT COMPLETED|Overall Study||0
9813809|NCT00680706|10923826|FG000|STARTED|Overall Study||70
9813810|NCT00680706|10923827|FG001|STARTED|Overall Study||60
9813811|NCT00680706|10923826|FG000|COMPLETED|Overall Study||63
9813812|NCT00680706|10923827|FG001|COMPLETED|Overall Study||55
9813813|NCT00680706|10923826|FG000|NOT COMPLETED|Overall Study||7
9813814|NCT00680706|10923827|FG001|NOT COMPLETED|Overall Study||5
9813815|NCT00680745|10923837|FG000|STARTED|Overall Study|Safety Analysis Set|154
9813816|NCT00680745|10923838|FG001|STARTED|Overall Study|Safety Analysis Set|145
9813817|NCT00680745|10923839|FG002|STARTED|Overall Study|Safety Analysis Set|151
9813818|NCT00680745|10923840|FG003|STARTED|Overall Study|Safety Analysis Set|146
9813819|NCT00680745|10923837|FG000|COMPLETED|Overall Study||140
9813820|NCT00680745|10923838|FG001|COMPLETED|Overall Study||132
9813821|NCT00680745|10923839|FG002|COMPLETED|Overall Study||141
9813822|NCT00680745|10923840|FG003|COMPLETED|Overall Study||133
9813823|NCT00680745|10923837|FG000|NOT COMPLETED|Overall Study||14
9813824|NCT00680745|10923838|FG001|NOT COMPLETED|Overall Study||13
9813825|NCT00680745|10923839|FG002|NOT COMPLETED|Overall Study||10
9813826|NCT00680745|10923840|FG003|NOT COMPLETED|Overall Study||13
9813827|NCT00680771|10923853|FG000|STARTED|Overall Study||15
9813828|NCT00680771|10923854|FG001|STARTED|Overall Study||13
9813829|NCT00680771|10923853|FG000|COMPLETED|Overall Study||9
9813830|NCT00680771|10923854|FG001|COMPLETED|Overall Study||11
9813831|NCT00680771|10923853|FG000|NOT COMPLETED|Overall Study||6
9813832|NCT00680771|10923854|FG001|NOT COMPLETED|Overall Study||2
9813833|NCT00680797|10923864|FG000|STARTED|Overall Study||9
9813834|NCT00680797|10923865|FG001|STARTED|Overall Study||8
9813835|NCT00680797|10923866|FG002|STARTED|Overall Study||8
9813836|NCT00680797|10923867|FG003|STARTED|Overall Study||8
9813837|NCT00680797|10923864|FG000|COMPLETED|Overall Study||9
9813838|NCT00680797|10923865|FG001|COMPLETED|Overall Study||8
9813839|NCT00680797|10923866|FG002|COMPLETED|Overall Study||8
9813840|NCT00680797|10923867|FG003|COMPLETED|Overall Study||8
9813841|NCT00680797|10923864|FG000|NOT COMPLETED|Overall Study||0
9813842|NCT00680797|10923865|FG001|NOT COMPLETED|Overall Study||0
9813843|NCT00680797|10923866|FG002|NOT COMPLETED|Overall Study||0
9813844|NCT00680797|10923867|FG003|NOT COMPLETED|Overall Study||0
9813845|NCT00680823|10923880|FG000|STARTED|Overall Study||50
9813846|NCT00680823|10923881|FG001|STARTED|Overall Study||50
9813847|NCT00680823|10923882|FG002|STARTED|Overall Study||50
9813848|NCT00680823|10923880|FG000|COMPLETED|Overall Study||50
9813849|NCT00680823|10923881|FG001|COMPLETED|Overall Study||50
9813850|NCT00680823|10923882|FG002|COMPLETED|Overall Study||50
9813851|NCT00680823|10923880|FG000|NOT COMPLETED|Overall Study||0
9813852|NCT00680823|10923881|FG001|NOT COMPLETED|Overall Study||0
9813853|NCT00680823|10923882|FG002|NOT COMPLETED|Overall Study||0
9813854|NCT00680836|10923892|FG000|STARTED|Overall Study||27
9813855|NCT00680836|10923893|FG001|STARTED|Overall Study||27
9813856|NCT00680836|10923892|FG000|COMPLETED|Overall Study||19
9813857|NCT00680836|10923893|FG001|COMPLETED|Overall Study||25
9813858|NCT00680836|10923892|FG000|NOT COMPLETED|Overall Study||8
9813859|NCT00680836|10923893|FG001|NOT COMPLETED|Overall Study||2
9813860|NCT00680862|10923900|FG000|STARTED|Overall Study||25
9813861|NCT00680862|10923900|FG000|COMPLETED|Overall Study||25
9813862|NCT00680862|10923900|FG000|NOT COMPLETED|Overall Study||0
9813863|NCT00680914|10923906|FG000|STARTED|Overall Study||374
9813864|NCT00680914|10923907|FG001|STARTED|Overall Study||129
9813865|NCT00680914|10923906|FG000|COMPLETED|Overall Study||364
9813866|NCT00680914|10923907|FG001|COMPLETED|Overall Study||125
9813867|NCT00680914|10923906|FG000|NOT COMPLETED|Overall Study||10
9813868|NCT00680914|10923907|FG001|NOT COMPLETED|Overall Study||4
9813869|NCT00680953|10923916|FG000|STARTED|Overall Study||500
9813870|NCT00680953|10923917|FG001|STARTED|Overall Study||511
9813871|NCT00680953|10923918|FG002|STARTED|Overall Study||251
9813872|NCT00680953|10923916|FG000|COMPLETED|Overall Study||414
9813873|NCT00680953|10923917|FG001|COMPLETED|Overall Study||416
9813874|NCT00680953|10923918|FG002|COMPLETED|Overall Study||204
9813875|NCT00680953|10923916|FG000|NOT COMPLETED|Overall Study||86
9813876|NCT00680953|10923917|FG001|NOT COMPLETED|Overall Study||95
9813877|NCT00680953|10923918|FG002|NOT COMPLETED|Overall Study||47
9813878|NCT00680992|10923929|FG000|STARTED|Overall Study||268
9813879|NCT00680992|10923930|FG001|STARTED|Overall Study||252
9813880|NCT00680992|10923931|FG002|STARTED|Overall Study||12
9813881|NCT00680992|10923929|FG000|Safety Analysis Set|Overall Study||265
9813882|NCT00680992|10923930|FG001|Safety Analysis Set|Overall Study||249
9813883|NCT00680992|10923931|FG002|Safety Analysis Set|Overall Study||12
9813884|NCT00680992|10923929|FG000|Efficacy Analysis Set|Overall Study||260
9813885|NCT00680992|10923930|FG001|Efficacy Analysis Set|Overall Study||242
9813886|NCT00680992|10923931|FG002|Efficacy Analysis Set|Overall Study||11
9813887|NCT00680992|10923929|FG000|COMPLETED|Overall Study||0
9813888|NCT00680992|10923930|FG001|COMPLETED|Overall Study||0
9813889|NCT00680992|10923931|FG002|COMPLETED|Overall Study||0
9813890|NCT00680992|10923929|FG000|NOT COMPLETED|Overall Study||268
9813891|NCT00680992|10923930|FG001|NOT COMPLETED|Overall Study||252
9813892|NCT00680992|10923931|FG002|NOT COMPLETED|Overall Study||12
9813893|NCT00681031|10923940|FG000|STARTED|Overall Study||96
9813894|NCT00681031|10923940|FG000|COMPLETED|Overall Study||96
9813895|NCT00681031|10923940|FG000|NOT COMPLETED|Overall Study||0
9813896|NCT00681083|10923944|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
9813897|NCT00681083|10923945|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
10235609|NCT01131884|11365956|FG001|COMPLETED|Overall Study||0
10235610|NCT01131884|11365955|FG000|NOT COMPLETED|Overall Study||0
10235611|NCT01131884|11365956|FG001|NOT COMPLETED|Overall Study||0
10235612|NCT01128114|11365962|FG000|STARTED|Overall Study||32
10235613|NCT01128114|11365962|FG000|COMPLETED|Overall Study||24
10235614|NCT01128114|11365962|FG000|NOT COMPLETED|Overall Study||8
10235615|NCT01126879|11365968|FG000|STARTED|Overall Study||8
10235616|NCT01126879|11365969|FG001|STARTED|Overall Study||4
10235617|NCT01126879|11365968|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8
10235618|NCT01126879|11365969|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4
10235619|NCT01126879|11365968|FG000|Prostatectomy or Radiation|Overall Study||8
10235620|NCT01126879|11365969|FG001|Prostatectomy or Radiation|Overall Study||4
10235621|NCT01126879|11365968|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4
9813898|NCT00681083|10923944|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
9813899|NCT00681083|10923945|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
9813900|NCT00681083|10923944|FG000|NOT COMPLETED|Night 1||3
9813901|NCT00681083|10923945|FG001|NOT COMPLETED|Night 1||3
9813902|NCT00681083|10923944|FG000|STARTED|Night 2 (Crossover of Night 1)||10
9813903|NCT00681083|10923945|FG001|STARTED|Night 2 (Crossover of Night 1)||10
9813904|NCT00681083|10923944|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10
9813905|NCT00681083|10923945|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10
9813906|NCT00681083|10923944|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
9813907|NCT00681083|10923945|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
9813908|NCT00681109|10923954|FG000|STARTED|Overall Study||30
9813909|NCT00681109|10923955|FG001|STARTED|Overall Study||30
9813910|NCT00681109|10923956|FG002|STARTED|Overall Study||15
9813911|NCT00681109|10923954|FG000|COMPLETED|Overall Study||28
9813912|NCT00681109|10923955|FG001|COMPLETED|Overall Study||24
9813913|NCT00681109|10923956|FG002|COMPLETED|Overall Study||15
9813914|NCT00681109|10923954|FG000|NOT COMPLETED|Overall Study||2
9813915|NCT00681109|10923955|FG001|NOT COMPLETED|Overall Study||6
9813916|NCT00681109|10923956|FG002|NOT COMPLETED|Overall Study||0
9813917|NCT00681187|10923969|FG000|STARTED|Overall Study||11
9813918|NCT00681187|10923970|FG001|STARTED|Overall Study||15
9813919|NCT00681187|10923969|FG000|COMPLETED|Overall Study||10
9813920|NCT00681187|10923970|FG001|COMPLETED|Overall Study||13
9813921|NCT00681187|10923969|FG000|NOT COMPLETED|Overall Study||1
9813922|NCT00681187|10923970|FG001|NOT COMPLETED|Overall Study||2
9813923|NCT00681265|10923989|FG000|STARTED|Overall Study||16
9813924|NCT00681265|10923989|FG000|COMPLETED|Overall Study||16
9813925|NCT00681265|10923989|FG000|NOT COMPLETED|Overall Study||0
9813926|NCT00681291|10923997|FG000|STARTED|Overall Study||88
9813927|NCT00681291|10923998|FG001|STARTED|Overall Study||84
9813928|NCT00681291|10923997|FG000|COMPLETED|Overall Study||75
9813929|NCT00681291|10923998|FG001|COMPLETED|Overall Study||57
10235622|NCT01126879|11365969|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2
10235623|NCT01126879|11365968|FG000|COMPLETED|Overall Study||3
10235624|NCT01126879|11365969|FG001|COMPLETED|Overall Study||2
10235625|NCT01126879|11365968|FG000|NOT COMPLETED|Overall Study||5
10235626|NCT01126879|11365969|FG001|NOT COMPLETED|Overall Study||2
10235627|NCT01136811|11365975|FG000|STARTED|Overall Study||11
10235628|NCT01136811|11365975|FG000|COMPLETED|Overall Study||0
10235629|NCT01136811|11365975|FG000|NOT COMPLETED|Overall Study||11
10235630|NCT01139294|11365981|FG000|STARTED|Overall Study||0
10235631|NCT01139294|11365982|FG001|STARTED|Overall Study||0
10235632|NCT01139294|11365981|FG000|COMPLETED|Overall Study||0
10235633|NCT01139294|11365982|FG001|COMPLETED|Overall Study||0
10235634|NCT01139294|11365981|FG000|NOT COMPLETED|Overall Study||0
10235635|NCT01139294|11365982|FG001|NOT COMPLETED|Overall Study||0
10235636|NCT01139125|11365988|FG000|STARTED|Overall Study||3
10235637|NCT01139125|11365988|FG000|COMPLETED|Overall Study||2
10235638|NCT01139125|11365988|FG000|NOT COMPLETED|Overall Study||1
10235639|NCT01136668|11365994|FG000|STARTED|Overall Study||7
10235640|NCT01136668|11365995|FG001|STARTED|Overall Study||6
10235641|NCT01136668|11365994|FG000|COMPLETED|Overall Study||7
10235642|NCT01136668|11365995|FG001|COMPLETED|Overall Study||6
10235643|NCT01136668|11365994|FG000|NOT COMPLETED|Overall Study||0
10235644|NCT01136668|11365995|FG001|NOT COMPLETED|Overall Study||0
9813930|NCT00681291|10923997|FG000|NOT COMPLETED|Overall Study||13
9813931|NCT00681291|10923998|FG001|NOT COMPLETED|Overall Study||27
9813932|NCT00681473|10924004|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
9813933|NCT00681473|10924004|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
9813934|NCT00681473|10924004|FG000|NOT COMPLETED|Overall Study||0
9813935|NCT00681538|10924010|FG000|STARTED|Phase A- 4 Weeks Single Blind||572
9813936|NCT00681538|10924011|FG001|STARTED|Phase A- 4 Weeks Single Blind||0
9813937|NCT00681538|10924010|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538
10235645|NCT01133639|11366003|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
10235646|NCT01133639|11366004|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
10235647|NCT01133639|11366003|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
10235648|NCT01133639|11366004|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
9813938|NCT00681538|10924011|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0
9831829|NCT00770328|10942451|FG000|NOT COMPLETED|Overall Study||13
9813939|NCT00681538|10924010|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
9813940|NCT00681538|10924011|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
9813941|NCT00681538|10924010|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124
9813942|NCT00681538|10924011|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117
9813943|NCT00681538|10924010|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109
9813944|NCT00681538|10924011|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115
9813945|NCT00681538|10924010|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
9813946|NCT00681538|10924011|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
9813947|NCT00681564|10924019|FG000|STARTED|Overall Study||47
9813948|NCT00681564|10924020|FG001|STARTED|Overall Study||55
9813949|NCT00681564|10924019|FG000|COMPLETED|Overall Study||41
9813950|NCT00681564|10924020|FG001|COMPLETED|Overall Study||47
9813951|NCT00681564|10924019|FG000|NOT COMPLETED|Overall Study||6
9813952|NCT00681564|10924020|FG001|NOT COMPLETED|Overall Study||8
9813953|NCT00681590|10924028|FG000|STARTED|Overall Study||34
9813954|NCT00681590|10924029|FG001|STARTED|Overall Study||71
9813955|NCT00681590|10924028|FG000|COMPLETED|Overall Study||32
9813956|NCT00681590|10924029|FG001|COMPLETED|Overall Study||59
9813957|NCT00681590|10924028|FG000|NOT COMPLETED|Overall Study||2
9813958|NCT00681590|10924029|FG001|NOT COMPLETED|Overall Study||12
9813959|NCT00681668|10924035|FG000|STARTED|Overall Study||5
9813960|NCT00681668|10924035|FG000|COMPLETED|Overall Study||3
9813961|NCT00681668|10924035|FG000|NOT COMPLETED|Overall Study||2
9813962|NCT00681811|10924041|FG000|STARTED|Overall Study||6
9813963|NCT00681811|10924042|FG001|STARTED|Overall Study||5
9813964|NCT00681811|10924041|FG000|COMPLETED|Overall Study||3
9813965|NCT00681811|10924042|FG001|COMPLETED|Overall Study||1
9813966|NCT00681811|10924041|FG000|NOT COMPLETED|Overall Study||3
9813967|NCT00681811|10924042|FG001|NOT COMPLETED|Overall Study||4
9813968|NCT00681824|10924062|FG000|STARTED|Overall Study||28
9813969|NCT00681824|10924063|FG001|STARTED|Overall Study||13
9813970|NCT00681824|10924064|FG002|STARTED|Overall Study||34
9813971|NCT00681824|10924062|FG000|COMPLETED|Overall Study||27
9813972|NCT00681824|10924063|FG001|COMPLETED|Overall Study||12
9813973|NCT00681824|10924064|FG002|COMPLETED|Overall Study||33
9813974|NCT00681824|10924062|FG000|NOT COMPLETED|Overall Study||1
9813975|NCT00681824|10924063|FG001|NOT COMPLETED|Overall Study||1
9813976|NCT00681824|10924064|FG002|NOT COMPLETED|Overall Study||1
9813977|NCT00681863|10924072|FG000|STARTED|Overall Study||45
9813978|NCT00681863|10924072|FG000|COMPLETED|Overall Study||22
9813979|NCT00681863|10924072|FG000|NOT COMPLETED|Overall Study||23
9813980|NCT00681889|10924076|FG000|STARTED|Overall Study||9
9813981|NCT00681889|10924076|FG000|COMPLETED|Overall Study||9
9813982|NCT00681889|10924076|FG000|NOT COMPLETED|Overall Study||0
9813983|NCT00682357|10924083|FG000|STARTED|Overall Study||10
9813984|NCT00682357|10924084|FG001|STARTED|Overall Study||10
9813985|NCT00682357|10924085|FG002|STARTED|Overall Study||5
9813986|NCT00682357|10924083|FG000|COMPLETED|Overall Study||10
9813987|NCT00682357|10924084|FG001|COMPLETED|Overall Study||10
9813988|NCT00682357|10924085|FG002|COMPLETED|Overall Study||5
9813989|NCT00682357|10924083|FG000|NOT COMPLETED|Overall Study||0
9813990|NCT00682357|10924084|FG001|NOT COMPLETED|Overall Study||0
9813991|NCT00682357|10924085|FG002|NOT COMPLETED|Overall Study||0
9813992|NCT00682435|10924093|FG000|STARTED|Overall Study||230
9813993|NCT00682435|10924093|FG000|Ensured Enrolled Only Once|Overall Study||228
9813994|NCT00682435|10924093|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223
9813995|NCT00682435|10924093|FG000|COMPLETED|Overall Study||223
9813996|NCT00682435|10924093|FG000|NOT COMPLETED|Overall Study||7
9813997|NCT00682448|10924099|FG000|STARTED|Overall Study||12
9813998|NCT00682448|10924100|FG001|STARTED|Overall Study||13
9813999|NCT00682448|10924099|FG000|COMPLETED|Overall Study||7
9814000|NCT00682448|10924100|FG001|COMPLETED|Overall Study||7
9814001|NCT00682448|10924099|FG000|NOT COMPLETED|Overall Study||5
9814002|NCT00682448|10924100|FG001|NOT COMPLETED|Overall Study||6
9814003|NCT00682539|10924109|FG000|STARTED|Bevacizumab vs Triamcinolone||18
9814004|NCT00682539|10924110|FG001|STARTED|Bevacizumab vs Triamcinolone||16
9814005|NCT00682539|10924111|FG002|STARTED|Bevacizumab vs Triamcinolone||0
9814006|NCT00682539|10924109|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15
9814007|NCT00682539|10924110|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15
9814008|NCT00682539|10924111|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0
9814009|NCT00682539|10924109|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
9814010|NCT00682539|10924110|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
9814011|NCT00682539|10924111|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
9814012|NCT00682539|10924109|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
9814013|NCT00682539|10924110|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
9814014|NCT00682539|10924111|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
9814015|NCT00682539|10924109|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0
9814016|NCT00682539|10924110|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15
9814017|NCT00682539|10924111|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10
9814018|NCT00682539|10924109|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
9814019|NCT00682539|10924110|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
9814020|NCT00682539|10924111|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
9814021|NCT00682565|10924122|FG000|STARTED|Overall Study||31
9814022|NCT00682565|10924123|FG001|STARTED|Overall Study||35
9814023|NCT00682565|10924124|FG002|STARTED|Overall Study||29
9814024|NCT00682565|10924122|FG000|COMPLETED|Overall Study||30
9814025|NCT00682565|10924123|FG001|COMPLETED|Overall Study||32
9814026|NCT00682565|10924124|FG002|COMPLETED|Overall Study||29
9814027|NCT00682565|10924122|FG000|NOT COMPLETED|Overall Study||1
9814028|NCT00682565|10924123|FG001|NOT COMPLETED|Overall Study||3
9814029|NCT00682565|10924124|FG002|NOT COMPLETED|Overall Study||0
9814030|NCT00682461|10924135|FG000|STARTED|Overall Study||100
9814031|NCT00682461|10924136|FG001|STARTED|Overall Study||100
9814032|NCT00682461|10924135|FG000|COMPLETED|Overall Study||75
9814033|NCT00682461|10924136|FG001|COMPLETED|Overall Study||69
9814034|NCT00682461|10924135|FG000|NOT COMPLETED|Overall Study||25
9814035|NCT00682461|10924136|FG001|NOT COMPLETED|Overall Study||31
9814036|NCT00682617|10924145|FG000|STARTED|Overall Study||13
9814037|NCT00682617|10924146|FG001|STARTED|Overall Study||28
9814038|NCT00682617|10924145|FG000|COMPLETED|Overall Study||10
9814039|NCT00682617|10924146|FG001|COMPLETED|Overall Study||21
9814040|NCT00682617|10924145|FG000|NOT COMPLETED|Overall Study||3
9814041|NCT00682617|10924146|FG001|NOT COMPLETED|Overall Study||7
9814042|NCT00682643|10924154|FG000|STARTED|Overall Study||182
9814043|NCT00682643|10924155|FG001|STARTED|Overall Study||368
9814044|NCT00682643|10924154|FG000|COMPLETED|Overall Study||104
9814045|NCT00682643|10924155|FG001|COMPLETED|Overall Study||199
9814046|NCT00682643|10924154|FG000|NOT COMPLETED|Overall Study||78
9814047|NCT00682643|10924155|FG001|NOT COMPLETED|Overall Study||169
9814048|NCT00682734|10924165|FG000|STARTED|Emergency Department Portion||113
9814049|NCT00682734|10924166|FG001|STARTED|Emergency Department Portion||118
9814050|NCT00682734|10924167|FG002|STARTED|Emergency Department Portion||118
9814051|NCT00682734|10924165|FG000|COMPLETED|Emergency Department Portion||113
9814052|NCT00682734|10924166|FG001|COMPLETED|Emergency Department Portion||117
9814053|NCT00682734|10924167|FG002|COMPLETED|Emergency Department Portion||117
9814054|NCT00682734|10924165|FG000|NOT COMPLETED|Emergency Department Portion||0
10235649|NCT01133639|11366003|FG000|NOT COMPLETED|Overall Study||0
10235650|NCT01133639|11366004|FG001|NOT COMPLETED|Overall Study||0
10235651|NCT01131455|11366012|FG000|STARTED|Overall Study||6
10235652|NCT01131455|11366013|FG001|STARTED|Overall Study||4
10235653|NCT01131455|11366014|FG002|STARTED|Overall Study||0
10235654|NCT01131455|11366012|FG000|COMPLETED|Overall Study||0
9814055|NCT00682734|10924166|FG001|NOT COMPLETED|Emergency Department Portion||1
9814056|NCT00682734|10924167|FG002|NOT COMPLETED|Emergency Department Portion||1
9814057|NCT00682734|10924165|FG000|STARTED|48 Hour Follow-up||113
9814058|NCT00682734|10924166|FG001|STARTED|48 Hour Follow-up||117
9814059|NCT00682734|10924167|FG002|STARTED|48 Hour Follow-up||117
9814060|NCT00682734|10924165|FG000|COMPLETED|48 Hour Follow-up||107
9814061|NCT00682734|10924166|FG001|COMPLETED|48 Hour Follow-up||111
9814062|NCT00682734|10924167|FG002|COMPLETED|48 Hour Follow-up||106
9814063|NCT00682734|10924165|FG000|NOT COMPLETED|48 Hour Follow-up||6
9814064|NCT00682734|10924166|FG001|NOT COMPLETED|48 Hour Follow-up||6
9814065|NCT00682734|10924167|FG002|NOT COMPLETED|48 Hour Follow-up||11
9814066|NCT00682786|10924177|FG000|STARTED|Overall Study||98
9814067|NCT00682786|10924178|FG001|STARTED|Overall Study||37
9814068|NCT00682786|10924177|FG000|COMPLETED|Overall Study||96
9814069|NCT00682786|10924178|FG001|COMPLETED|Overall Study||34
9814070|NCT00682786|10924177|FG000|NOT COMPLETED|Overall Study||2
9814071|NCT00682786|10924178|FG001|NOT COMPLETED|Overall Study||3
9814072|NCT00682838|10924194|FG000|STARTED|Overall Study||65
9814073|NCT00682838|10924195|FG001|STARTED|Overall Study||67
9814074|NCT00682838|10924196|FG002|STARTED|Overall Study||75
9814075|NCT00682838|10924197|FG003|STARTED|Overall Study||73
9814076|NCT00682838|10924194|FG000|COMPLETED|Overall Study||65
9814077|NCT00682838|10924195|FG001|COMPLETED|Overall Study||67
9814078|NCT00682838|10924196|FG002|COMPLETED|Overall Study||75
10235655|NCT01131455|11366013|FG001|COMPLETED|Overall Study||0
10235656|NCT01131455|11366014|FG002|COMPLETED|Overall Study||0
10235657|NCT01131455|11366012|FG000|NOT COMPLETED|Overall Study||6
10235658|NCT01131455|11366013|FG001|NOT COMPLETED|Overall Study||4
10235659|NCT01131455|11366014|FG002|NOT COMPLETED|Overall Study||0
10235660|NCT01126801|11366024|FG000|STARTED|Overall Study||1
10235661|NCT01126801|11366025|FG001|STARTED|Overall Study||1
10235662|NCT01126801|11366024|FG000|COMPLETED|Overall Study||1
10235663|NCT01126801|11366025|FG001|COMPLETED|Overall Study||1
10235664|NCT01126801|11366024|FG000|NOT COMPLETED|Overall Study||0
10235665|NCT01126801|11366025|FG001|NOT COMPLETED|Overall Study||0
10235666|NCT01123850|11366031|FG000|STARTED|Overall Study||45
10235667|NCT01123850|11366031|FG000|COMPLETED|Overall Study||0
10235668|NCT01123850|11366031|FG000|NOT COMPLETED|Overall Study||45
10235669|NCT01126957|11366035|FG000|STARTED|Overall Study||103
10235670|NCT01126957|11366035|FG000|COMPLETED|Overall Study||103
10235671|NCT01126957|11366035|FG000|NOT COMPLETED|Overall Study||0
10235672|NCT01127503|11366042|FG000|STARTED|Overall Study||1
10235673|NCT01127503|11366043|FG001|STARTED|Overall Study||1
9814079|NCT00682838|10924197|FG003|COMPLETED|Overall Study||73
9814080|NCT00682838|10924194|FG000|NOT COMPLETED|Overall Study||0
9814081|NCT00682838|10924195|FG001|NOT COMPLETED|Overall Study||0
9814082|NCT00682838|10924196|FG002|NOT COMPLETED|Overall Study||0
9814083|NCT00682838|10924197|FG003|NOT COMPLETED|Overall Study||0
9814084|NCT00682851|10924209|FG000|STARTED|Overall Study||251
9814085|NCT00682851|10924210|FG001|STARTED|Overall Study||268
9814086|NCT00682851|10924209|FG000|COMPLETED|Overall Study||251
10235674|NCT01127503|11366042|FG000|COMPLETED|Overall Study||1
10235675|NCT01127503|11366043|FG001|COMPLETED|Overall Study||1
10235676|NCT01127503|11366042|FG000|NOT COMPLETED|Overall Study||0
10235677|NCT01127503|11366043|FG001|NOT COMPLETED|Overall Study||0
10235678|NCT01122511|11366051|FG000|STARTED|Overall Study||2
9814087|NCT00682851|10924210|FG001|COMPLETED|Overall Study||268
9814088|NCT00682851|10924209|FG000|NOT COMPLETED|Overall Study||0
9814089|NCT00682851|10924210|FG001|NOT COMPLETED|Overall Study||0
9814090|NCT00682890|10924218|FG000|STARTED|Overall Study||12
9814091|NCT00682890|10924219|FG001|STARTED|Overall Study||11
10016562|NCT01811147|11139374|FG001|NOT COMPLETED|Overall Study||45
10016563|NCT01811147|11139375|FG002|NOT COMPLETED|Overall Study||43
10016564|NCT01811147|11139376|FG003|NOT COMPLETED|Overall Study||29
10016565|NCT01811186|11139388|FG000|STARTED|Overall Study||132
10235679|NCT01122511|11366052|FG001|STARTED|Overall Study||2
10235680|NCT01122511|11366051|FG000|COMPLETED|Overall Study||0
9814092|NCT00682890|10924218|FG000|COMPLETED|Overall Study||10
9814093|NCT00682890|10924219|FG001|COMPLETED|Overall Study||9
9814094|NCT00682890|10924218|FG000|NOT COMPLETED|Overall Study||2
9814095|NCT00682890|10924219|FG001|NOT COMPLETED|Overall Study||2
9814096|NCT00682929|10924228|FG000|STARTED|Overall Study||13
9814097|NCT00682929|10924229|FG001|STARTED|Overall Study||14
9814098|NCT00682929|10924230|FG002|STARTED|Overall Study||14
9814099|NCT00682929|10924228|FG000|COMPLETED|Overall Study||7
9814100|NCT00682929|10924229|FG001|COMPLETED|Overall Study||9
9814101|NCT00682929|10924230|FG002|COMPLETED|Overall Study||12
9814102|NCT00682929|10924228|FG000|NOT COMPLETED|Overall Study||6
9814103|NCT00682929|10924229|FG001|NOT COMPLETED|Overall Study||5
9814104|NCT00682929|10924230|FG002|NOT COMPLETED|Overall Study||2
9814105|NCT00683020|10924240|FG000|STARTED|Overall Study||182
9814106|NCT00683020|10924241|FG001|STARTED|Overall Study||180
9814107|NCT00683020|10924240|FG000|COMPLETED|Overall Study||127
9814108|NCT00683020|10924241|FG001|COMPLETED|Overall Study||125
9814109|NCT00683020|10924240|FG000|NOT COMPLETED|Overall Study||55
9814110|NCT00683020|10924241|FG001|NOT COMPLETED|Overall Study||55
9814111|NCT00683046|10924247|FG000|STARTED|Overall Study||204
9814112|NCT00683046|10924247|FG000|COMPLETED|Overall Study||204
9814113|NCT00683046|10924247|FG000|NOT COMPLETED|Overall Study||0
9831830|NCT00770328|10942452|FG001|NOT COMPLETED|Overall Study||4
9831831|NCT00770341|10942461|FG000|STARTED|Overall Study|Number randomized|89
9831832|NCT00770341|10942462|FG001|STARTED|Overall Study|Number randomized|22
9831833|NCT00770341|10942463|FG002|STARTED|Overall Study|Number randomized|11
9831834|NCT00770341|10942461|FG000|COMPLETED|Overall Study||77
9831835|NCT00770341|10942462|FG001|COMPLETED|Overall Study||17
9831836|NCT00770341|10942463|FG002|COMPLETED|Overall Study||8
9831837|NCT00770341|10942461|FG000|NOT COMPLETED|Overall Study||12
9831838|NCT00770341|10942462|FG001|NOT COMPLETED|Overall Study||5
9831839|NCT00770341|10942463|FG002|NOT COMPLETED|Overall Study||3
9831840|NCT00770367|10942474|FG000|STARTED|First Intervention||18
9831841|NCT00770367|10942475|FG001|STARTED|First Intervention||18
9831842|NCT00770367|10942474|FG000|COMPLETED|First Intervention||18
9831843|NCT00770367|10942475|FG001|COMPLETED|First Intervention||16
9831844|NCT00770367|10942474|FG000|NOT COMPLETED|First Intervention||0
9831845|NCT00770367|10942475|FG001|NOT COMPLETED|First Intervention||2
9831846|NCT00770367|10942474|FG000|STARTED|Washout Period of 4 Weeks||18
9831847|NCT00770367|10942475|FG001|STARTED|Washout Period of 4 Weeks||16
9831848|NCT00770367|10942474|FG000|COMPLETED|Washout Period of 4 Weeks||18
9831849|NCT00770367|10942475|FG001|COMPLETED|Washout Period of 4 Weeks||15
9831850|NCT00770367|10942474|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
9831851|NCT00770367|10942475|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
10235681|NCT01122511|11366052|FG001|COMPLETED|Overall Study||0
10235682|NCT01122511|11366051|FG000|NOT COMPLETED|Overall Study||2
10235683|NCT01122511|11366052|FG001|NOT COMPLETED|Overall Study||2
10235684|NCT01118013|11366058|FG000|STARTED|Overall Study||6
10235685|NCT01118013|11366058|FG000|COMPLETED|Overall Study||6
10235686|NCT01118013|11366058|FG000|NOT COMPLETED|Overall Study||0
10235687|NCT01122381|11366064|FG000|STARTED|Overall Study||1
10235688|NCT01122381|11366065|FG001|STARTED|Overall Study||1
10235689|NCT01122381|11366064|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
10235690|NCT01122381|11366065|FG001|COMPLETED|Overall Study||0
10235691|NCT01122381|11366064|FG000|NOT COMPLETED|Overall Study||0
10235692|NCT01122381|11366065|FG001|NOT COMPLETED|Overall Study||1
10235693|NCT01116232|11366071|FG000|STARTED|Overall Study||4
10235694|NCT01116232|11366071|FG000|COMPLETED|Overall Study||0
10235695|NCT01116232|11366071|FG000|NOT COMPLETED|Overall Study||4
10235696|NCT01110174|11366078|FG000|STARTED|Overall Study||8
10235697|NCT01110174|11366078|FG000|COMPLETED|Overall Study||8
10235698|NCT01110174|11366078|FG000|NOT COMPLETED|Overall Study||0
10235699|NCT01115699|11366082|FG000|STARTED|Overall Study||2
9831852|NCT00770367|10942474|FG000|STARTED|Second Intervention||18
9831853|NCT00770367|10942475|FG001|STARTED|Second Intervention||15
9831854|NCT00770367|10942474|FG000|COMPLETED|Second Intervention||16
9831855|NCT00770367|10942475|FG001|COMPLETED|Second Intervention||15
9831856|NCT00770367|10942474|FG000|NOT COMPLETED|Second Intervention||2
9831857|NCT00770367|10942475|FG001|NOT COMPLETED|Second Intervention||0
9831858|NCT00770432|10942485|FG000|STARTED|Overall Study||102
9831859|NCT00770432|10942486|FG001|STARTED|Overall Study||101
10016566|NCT01811186|11139389|FG001|STARTED|Overall Study||126
9831860|NCT00770432|10942485|FG000|COMPLETED|Overall Study||98
9831861|NCT00770432|10942486|FG001|COMPLETED|Overall Study||94
9831862|NCT00770432|10942485|FG000|NOT COMPLETED|Overall Study||4
9831863|NCT00770432|10942486|FG001|NOT COMPLETED|Overall Study||7
10235700|NCT01115699|11366082|FG000|COMPLETED|Overall Study||2
10235701|NCT01115699|11366082|FG000|NOT COMPLETED|Overall Study||0
10239726|NCT00002975|11371419|FG000|COMPLETED|Overall Study||175
9814114|NCT00683085|10924251|FG000|STARTED|Overall Study||2
9814115|NCT00683085|10924251|FG000|COMPLETED|Overall Study||2
9814116|NCT00683085|10924251|FG000|NOT COMPLETED|Overall Study||0
9814117|NCT00683163|10924257|FG000|STARTED|Overall Study||22
9814118|NCT00683163|10924258|FG001|STARTED|Overall Study||22
9814119|NCT00683163|10924257|FG000|COMPLETED|Overall Study||22
9814120|NCT00683163|10924258|FG001|COMPLETED|Overall Study||22
9814121|NCT00683163|10924257|FG000|NOT COMPLETED|Overall Study||0
9814122|NCT00683163|10924258|FG001|NOT COMPLETED|Overall Study||0
9814123|NCT00683293|10924266|FG000|STARTED|Overall Study||50
9814124|NCT00683293|10924267|FG001|STARTED|Overall Study||50
9814125|NCT00683293|10924266|FG000|COMPLETED|Overall Study||48
9814126|NCT00683293|10924267|FG001|COMPLETED|Overall Study||47
9814127|NCT00683293|10924266|FG000|NOT COMPLETED|Overall Study||2
9814128|NCT00683293|10924267|FG001|NOT COMPLETED|Overall Study||3
9814129|NCT00683332|10924273|FG000|STARTED|Overall Study||621
9814130|NCT00683332|10924273|FG000|COMPLETED|Overall Study||621
9814131|NCT00683332|10924273|FG000|NOT COMPLETED|Overall Study||0
9814132|NCT00683384|10924277|FG000|STARTED|Overall Study||93
9814133|NCT00683384|10924277|FG000|COMPLETED|Overall Study||91
9814134|NCT00683384|10924277|FG000|NOT COMPLETED|Overall Study||2
9814135|NCT00683410|10924281|FG000|STARTED|Overall Study||3366
9814136|NCT00683410|10924281|FG000|Vaccinated Dose 1|Overall Study||3240
9814137|NCT00683410|10924281|FG000|Vaccinated Dose 2|Overall Study||1623
9814138|NCT00683410|10924281|FG000|Vaccinated Dose 3|Overall Study||817
9814139|NCT00683410|10924281|FG000|Vaccinated Dose 4|Overall Study||175
9814140|NCT00683410|10924281|FG000|COMPLETED|Overall Study||3366
9814141|NCT00683410|10924281|FG000|NOT COMPLETED|Overall Study||0
9814142|NCT00683449|10924290|FG000|STARTED|Overall Study||5
9814143|NCT00683449|10924291|FG001|STARTED|Overall Study||13
9814144|NCT00683449|10924292|FG002|STARTED|Overall Study||3
9814145|NCT00683449|10924293|FG003|STARTED|Overall Study||6
9814146|NCT00683449|10924294|FG004|STARTED|Overall Study||2
9814147|NCT00683449|10924290|FG000|COMPLETED|Overall Study||5
9814148|NCT00683449|10924291|FG001|COMPLETED|Overall Study||12
9814149|NCT00683449|10924292|FG002|COMPLETED|Overall Study||3
9814150|NCT00683449|10924293|FG003|COMPLETED|Overall Study||6
9814151|NCT00683449|10924294|FG004|COMPLETED|Overall Study||2
9814152|NCT00683449|10924290|FG000|NOT COMPLETED|Overall Study||0
9814153|NCT00683449|10924291|FG001|NOT COMPLETED|Overall Study||1
9814154|NCT00683449|10924292|FG002|NOT COMPLETED|Overall Study||0
9814155|NCT00683449|10924293|FG003|NOT COMPLETED|Overall Study||0
9814156|NCT00683449|10924294|FG004|NOT COMPLETED|Overall Study||0
9814157|NCT00683475|10924313|FG000|STARTED|Overall Study||69
9814158|NCT00683475|10924314|FG001|STARTED|Overall Study||69
9814159|NCT00683475|10924313|FG000|Received Any Quantity of Study Drug|Overall Study||66
9814160|NCT00683475|10924314|FG001|Received Any Quantity of Study Drug|Overall Study||66
9814161|NCT00683475|10924313|FG000|COMPLETED|Overall Study||65
9814162|NCT00683475|10924314|FG001|COMPLETED|Overall Study||66
9814163|NCT00683475|10924313|FG000|NOT COMPLETED|Overall Study||4
9814164|NCT00683475|10924314|FG001|NOT COMPLETED|Overall Study||3
9814165|NCT00683592|10924323|FG000|STARTED|Overall Study||240
9814166|NCT00683592|10924324|FG001|STARTED|Overall Study||241
9814167|NCT00683592|10924323|FG000|Intent to Treat Population|Overall Study||231
9814168|NCT00683592|10924324|FG001|Intent to Treat Population|Overall Study||232
10235702|NCT01108666|11366086|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
10235703|NCT01108666|11366086|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
10235704|NCT01108666|11366086|FG000|NOT COMPLETED|Overall Study||0
10235705|NCT01115244|11366092|FG000|STARTED|Overall Study||0
10235706|NCT01115244|11366093|FG001|STARTED|Overall Study||0
10235707|NCT01115244|11366092|FG000|COMPLETED|Overall Study||0
10235708|NCT01115244|11366093|FG001|COMPLETED|Overall Study||0
10235709|NCT01115244|11366092|FG000|NOT COMPLETED|Overall Study||0
10235710|NCT01115244|11366093|FG001|NOT COMPLETED|Overall Study||0
10235711|NCT01108523|11366099|FG000|STARTED|Overall Study||7
10235712|NCT01108523|11366099|FG000|COMPLETED|Overall Study||3
10235713|NCT01108523|11366099|FG000|NOT COMPLETED|Overall Study||4
10235714|NCT01107795|11366103|FG000|STARTED|Overall Study||41
10235715|NCT01107795|11366103|FG000|COMPLETED|Overall Study||41
9814169|NCT00683592|10924323|FG000|Safety Population|Overall Study||235
9814170|NCT00683592|10924324|FG001|Safety Population|Overall Study||233
9814171|NCT00683592|10924323|FG000|COMPLETED|Overall Study||193
9814172|NCT00683592|10924324|FG001|COMPLETED|Overall Study||195
9814173|NCT00683592|10924323|FG000|NOT COMPLETED|Overall Study||47
9814174|NCT00683592|10924324|FG001|NOT COMPLETED|Overall Study||46
9814175|NCT00683618|10924333|FG000|STARTED|Randomised Treatment Period||145
9814176|NCT00683618|10924334|FG001|STARTED|Randomised Treatment Period||145
9814177|NCT00683618|10924335|FG002|STARTED|Randomised Treatment Period||146
9814178|NCT00683618|10924333|FG000|COMPLETED|Randomised Treatment Period||139
9814179|NCT00683618|10924334|FG001|COMPLETED|Randomised Treatment Period||143
10235716|NCT01107795|11366103|FG000|NOT COMPLETED|Overall Study||0
10235717|NCT01106534|11366107|FG000|STARTED|Overall Study||2997
10235718|NCT01106534|11366107|FG000|COMPLETED|Overall Study||2960
10235719|NCT01106534|11366107|FG000|NOT COMPLETED|Overall Study||37
10235720|NCT01104116|11366112|FG000|STARTED|Overall Study||1
9814180|NCT00683618|10924335|FG002|COMPLETED|Randomised Treatment Period||140
9814181|NCT00683618|10924333|FG000|NOT COMPLETED|Randomised Treatment Period||6
9814182|NCT00683618|10924334|FG001|NOT COMPLETED|Randomised Treatment Period||2
10235721|NCT01104116|11366112|FG000|COMPLETED|Overall Study||1
10016567|NCT01811186|11139388|FG000|COMPLETED|Overall Study||61
10016568|NCT01811186|11139389|FG001|COMPLETED|Overall Study||64
10016569|NCT01811186|11139388|FG000|NOT COMPLETED|Overall Study||71
10016570|NCT01811186|11139389|FG001|NOT COMPLETED|Overall Study||62
10016571|NCT01811212|11139399|FG000|STARTED|Overall Study||25
10016572|NCT01811212|11139399|FG000|COMPLETED|Overall Study||25
10016573|NCT01811212|11139399|FG000|NOT COMPLETED|Overall Study||0
10016574|NCT01811225|11139403|FG000|STARTED|Treatment Period 1||49
10016575|NCT01811225|11139404|FG001|STARTED|Treatment Period 1||46
10016576|NCT01811225|11139403|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
10016577|NCT01811225|11139404|FG001|COMPLETED|Treatment Period 1||29
10016578|NCT01811225|11139403|FG000|NOT COMPLETED|Treatment Period 1||25
10016579|NCT01811225|11139404|FG001|NOT COMPLETED|Treatment Period 1||17
10016580|NCT01811225|11139403|FG000|STARTED|Treatment Period 2||24
10016581|NCT01811225|11139404|FG001|STARTED|Treatment Period 2||29
10235722|NCT01104116|11366112|FG000|NOT COMPLETED|Overall Study||0
10235723|NCT01100658|11366116|FG000|STARTED|Overall Study||1
9814183|NCT00683618|10924335|FG002|NOT COMPLETED|Randomised Treatment Period||6
9814184|NCT00683618|10924333|FG000|STARTED|Extension Treatment Period||36
9814185|NCT00683618|10924334|FG001|STARTED|Extension Treatment Period||23
9814186|NCT00683618|10924335|FG002|STARTED|Extension Treatment Period||0
9814187|NCT00683618|10924333|FG000|COMPLETED|Extension Treatment Period||33
9814188|NCT00683618|10924334|FG001|COMPLETED|Extension Treatment Period||23
9814189|NCT00683618|10924335|FG002|COMPLETED|Extension Treatment Period||0
9814190|NCT00683618|10924333|FG000|NOT COMPLETED|Extension Treatment Period||3
9814191|NCT00683618|10924334|FG001|NOT COMPLETED|Extension Treatment Period||0
9814192|NCT00683618|10924335|FG002|NOT COMPLETED|Extension Treatment Period||0
9814193|NCT00683644|10924347|FG000|STARTED|Overall Study||58
9814194|NCT00683644|10924348|FG001|STARTED|Overall Study||58
9814195|NCT00683644|10924347|FG000|COMPLETED|Overall Study||45
9814196|NCT00683644|10924348|FG001|COMPLETED|Overall Study||44
9814197|NCT00683644|10924347|FG000|NOT COMPLETED|Overall Study||13
9814198|NCT00683644|10924348|FG001|NOT COMPLETED|Overall Study||14
9814199|NCT00683657|10924360|FG000|STARTED|Overall Study||46
9814200|NCT00683657|10924361|FG001|STARTED|Overall Study||47
9814201|NCT00683657|10924360|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
9814202|NCT00683657|10924361|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
9814203|NCT00683657|10924360|FG000|COMPLETED|Overall Study||45
9814204|NCT00683657|10924361|FG001|COMPLETED|Overall Study||46
9814205|NCT00683657|10924360|FG000|NOT COMPLETED|Overall Study||1
9814206|NCT00683657|10924361|FG001|NOT COMPLETED|Overall Study||1
9814207|NCT00683696|10924369|FG000|STARTED|Overall Study||404
9814208|NCT00683696|10924370|FG001|STARTED|Overall Study||405
9814209|NCT00683696|10924369|FG000|COMPLETED|Overall Study||0
9814210|NCT00683696|10924370|FG001|COMPLETED|Overall Study||0
9814211|NCT00683696|10924369|FG000|NOT COMPLETED|Overall Study||404
9814212|NCT00683696|10924370|FG001|NOT COMPLETED|Overall Study||405
9814213|NCT00683774|10924379|FG000|STARTED|Overall Study||11
9814214|NCT00683774|10924380|FG001|STARTED|Overall Study||10
9814215|NCT00683774|10924379|FG000|COMPLETED|Overall Study||8
9814216|NCT00683774|10924380|FG001|COMPLETED|Overall Study||9
9814217|NCT00683774|10924379|FG000|NOT COMPLETED|Overall Study||3
10235724|NCT01100658|11366116|FG000|COMPLETED|Overall Study||0
10235725|NCT01100658|11366116|FG000|NOT COMPLETED|Overall Study||1
10235726|NCT01103180|11366122|FG000|STARTED|Overall Study||35
10235727|NCT01103180|11366123|FG001|STARTED|Overall Study||35
10235728|NCT01103180|11366122|FG000|COMPLETED|Overall Study||13
10235729|NCT01103180|11366123|FG001|COMPLETED|Overall Study||14
10235730|NCT01103180|11366122|FG000|NOT COMPLETED|Overall Study||22
10235731|NCT01103180|11366123|FG001|NOT COMPLETED|Overall Study||21
10235732|NCT01090141|11366131|FG000|STARTED|Overall Study||0
10235733|NCT01090141|11366132|FG001|STARTED|Overall Study||0
10235734|NCT01090141|11366131|FG000|COMPLETED|Overall Study||0
10235735|NCT01090141|11366132|FG001|COMPLETED|Overall Study||0
10235736|NCT01090141|11366131|FG000|NOT COMPLETED|Overall Study||0
10235737|NCT01090141|11366132|FG001|NOT COMPLETED|Overall Study||0
10235738|NCT01102140|11366140|FG000|STARTED|Overall Study||13
10235739|NCT01102140|11366141|FG001|STARTED|Overall Study||7
10235740|NCT01102140|11366140|FG000|COMPLETED|Overall Study||10
10235741|NCT01102140|11366141|FG001|COMPLETED|Overall Study||5
9814218|NCT00683774|10924380|FG001|NOT COMPLETED|Overall Study||1
9814219|NCT00683800|10924388|FG000|STARTED|Overall Study||1101
10016582|NCT01811225|11139403|FG000|COMPLETED|Treatment Period 2||20
10235742|NCT01102140|11366140|FG000|NOT COMPLETED|Overall Study||3
10235743|NCT01102140|11366141|FG001|NOT COMPLETED|Overall Study||2
10235744|NCT01095250|11366153|FG000|STARTED|Overall Study||8
10235745|NCT01095250|11366154|FG001|STARTED|Overall Study||10
10235746|NCT01095250|11366155|FG002|STARTED|Overall Study||8
9814220|NCT00683800|10924389|FG001|STARTED|Overall Study||1085
9814221|NCT00683800|10924388|FG000|Treated|Overall Study||1066
9814222|NCT00683800|10924389|FG001|Treated|Overall Study||1052
9814223|NCT00683800|10924388|FG000|COMPLETED|Overall Study||669
9814224|NCT00683800|10924389|FG001|COMPLETED|Overall Study||719
9814225|NCT00683800|10924388|FG000|NOT COMPLETED|Overall Study||432
10016583|NCT01811225|11139404|FG001|COMPLETED|Treatment Period 2||23
10235747|NCT01095250|11366156|FG003|STARTED|Overall Study||5
10235748|NCT01095250|11366153|FG000|COMPLETED|Overall Study||0
10235749|NCT01095250|11366154|FG001|COMPLETED|Overall Study||0
9814226|NCT00683800|10924389|FG001|NOT COMPLETED|Overall Study||366
9814227|NCT00683826|10924398|FG000|STARTED|Overall Study||8
9814228|NCT00683826|10924398|FG000|0g Leucine|Overall Study||8
9814229|NCT00683826|10924398|FG000|8g Leucine|Overall Study||8
9814230|NCT00683826|10924398|FG000|4g Leucine|Overall Study||7
9814231|NCT00683826|10924398|FG000|COMPLETED|Overall Study||7
9814232|NCT00683826|10924398|FG000|NOT COMPLETED|Overall Study||1
9814233|NCT00683852|10924408|FG000|STARTED|30-Day Phase 1 Period||56
9814234|NCT00683852|10924409|FG001|STARTED|30-Day Phase 1 Period||84
9814235|NCT00683852|10924410|FG002|STARTED|30-Day Phase 1 Period||85
9814236|NCT00683852|10924408|FG000|COMPLETED|30-Day Phase 1 Period||54
9814237|NCT00683852|10924409|FG001|COMPLETED|30-Day Phase 1 Period||83
9814238|NCT00683852|10924410|FG002|COMPLETED|30-Day Phase 1 Period||84
9814239|NCT00683852|10924408|FG000|NOT COMPLETED|30-Day Phase 1 Period||2
9814240|NCT00683852|10924409|FG001|NOT COMPLETED|30-Day Phase 1 Period||1
9814241|NCT00683852|10924410|FG002|NOT COMPLETED|30-Day Phase 1 Period||1
9814242|NCT00683852|10924408|FG000|STARTED|30-Day Phase 2 Period||54
9814243|NCT00683852|10924409|FG001|STARTED|30-Day Phase 2 Period||83
9814244|NCT00683852|10924410|FG002|STARTED|30-Day Phase 2 Period||84
9814245|NCT00683852|10924408|FG000|COMPLETED|30-Day Phase 2 Period||48
9814246|NCT00683852|10924409|FG001|COMPLETED|30-Day Phase 2 Period||78
9814247|NCT00683852|10924410|FG002|COMPLETED|30-Day Phase 2 Period||75
9814248|NCT00683852|10924408|FG000|NOT COMPLETED|30-Day Phase 2 Period||6
9814249|NCT00683852|10924409|FG001|NOT COMPLETED|30-Day Phase 2 Period||5
9814250|NCT00683852|10924410|FG002|NOT COMPLETED|30-Day Phase 2 Period||9
9814251|NCT00683878|10924428|FG000|STARTED|Overall Study||139
9814252|NCT00683878|10924429|FG001|STARTED|Overall Study||141
9814253|NCT00683878|10924430|FG002|STARTED|Overall Study||140
9814254|NCT00683878|10924428|FG000|COMPLETED|Overall Study||116
9814255|NCT00683878|10924429|FG001|COMPLETED|Overall Study||125
9814256|NCT00683878|10924430|FG002|COMPLETED|Overall Study||126
9814257|NCT00683878|10924428|FG000|NOT COMPLETED|Overall Study||23
9814258|NCT00683878|10924429|FG001|NOT COMPLETED|Overall Study||16
9814259|NCT00683878|10924430|FG002|NOT COMPLETED|Overall Study||14
9814260|NCT00683904|10924440|FG000|STARTED|Dose Level 1||6
9814261|NCT00683904|10924441|FG001|STARTED|Dose Level 1||0
9814262|NCT00683904|10924440|FG000|COMPLETED|Dose Level 1||3
9814263|NCT00683904|10924441|FG001|COMPLETED|Dose Level 1||0
9814264|NCT00683904|10924440|FG000|NOT COMPLETED|Dose Level 1||3
9814265|NCT00683904|10924441|FG001|NOT COMPLETED|Dose Level 1||0
9814266|NCT00683904|10924440|FG000|STARTED|Dose Level 2||0
9814267|NCT00683904|10924441|FG001|STARTED|Dose Level 2||6
9814268|NCT00683904|10924440|FG000|COMPLETED|Dose Level 2||0
9814269|NCT00683904|10924441|FG001|COMPLETED|Dose Level 2||4
9814270|NCT00683904|10924440|FG000|NOT COMPLETED|Dose Level 2||0
9814271|NCT00683904|10924441|FG001|NOT COMPLETED|Dose Level 2||2
9814272|NCT00683930|10924456|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
9814273|NCT00683930|10924457|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
9814274|NCT00683930|10924458|FG002|STARTED|Overall Study||37
9814275|NCT00683930|10924456|FG000|COMPLETED|Overall Study||29
10235750|NCT01095250|11366155|FG002|COMPLETED|Overall Study||0
10235751|NCT01095250|11366156|FG003|COMPLETED|Overall Study||0
10235752|NCT01095250|11366153|FG000|NOT COMPLETED|Overall Study||8
10235753|NCT01095250|11366154|FG001|NOT COMPLETED|Overall Study||10
10235754|NCT01095250|11366155|FG002|NOT COMPLETED|Overall Study||8
10235755|NCT01095250|11366156|FG003|NOT COMPLETED|Overall Study||5
10235756|NCT01094561|11366166|FG000|STARTED|Overall Study||23
10235757|NCT01094561|11366166|FG000|COMPLETED|Overall Study||17
10235758|NCT01094561|11366166|FG000|NOT COMPLETED|Overall Study||6
10235759|NCT01093846|11366173|FG000|STARTED|Overall Study||19
10235760|NCT01093846|11366174|FG001|STARTED|Overall Study||18
10235761|NCT01093846|11366175|FG002|STARTED|Overall Study||22
10235762|NCT01093846|11366173|FG000|COMPLETED|Overall Study||0
10235763|NCT01093846|11366174|FG001|COMPLETED|Overall Study||0
10235764|NCT01093846|11366175|FG002|COMPLETED|Overall Study||1
10235765|NCT01093846|11366173|FG000|NOT COMPLETED|Overall Study||19
10235766|NCT01093846|11366174|FG001|NOT COMPLETED|Overall Study||18
10235767|NCT01093846|11366175|FG002|NOT COMPLETED|Overall Study||21
10235768|NCT01078844|11366181|FG000|STARTED|Overall Study||4
10235769|NCT01078844|11366181|FG000|COMPLETED|Overall Study||0
10235770|NCT01078844|11366181|FG000|NOT COMPLETED|Overall Study||4
10235771|NCT01081886|11366188|FG000|STARTED|Overall Study||11
10235772|NCT01081886|11366189|FG001|STARTED|Overall Study||13
10235773|NCT01081886|11366188|FG000|COMPLETED|Overall Study||0
10235774|NCT01081886|11366189|FG001|COMPLETED|Overall Study||0
9814276|NCT00683930|10924457|FG001|COMPLETED|Overall Study||18
9814277|NCT00683930|10924458|FG002|COMPLETED|Overall Study||28
9814278|NCT00683930|10924456|FG000|NOT COMPLETED|Overall Study||7
9814279|NCT00683930|10924457|FG001|NOT COMPLETED|Overall Study||3
9814280|NCT00683930|10924458|FG002|NOT COMPLETED|Overall Study||9
9814281|NCT00684021|10924471|FG000|STARTED|Overall Study||43
9814282|NCT00684021|10924472|FG001|STARTED|Overall Study||24
9814283|NCT00684021|10924473|FG002|STARTED|Overall Study||36
10235775|NCT01081886|11366188|FG000|NOT COMPLETED|Overall Study||11
9814284|NCT00684021|10924474|FG003|STARTED|Overall Study||17
9814285|NCT00684021|10924471|FG000|COMPLETED|Overall Study||41
9814286|NCT00684021|10924472|FG001|COMPLETED|Overall Study||22
9814287|NCT00684021|10924473|FG002|COMPLETED|Overall Study||34
10235776|NCT01081886|11366189|FG001|NOT COMPLETED|Overall Study||13
10235777|NCT01085643|11366195|FG000|STARTED|Overall Study||4
10235778|NCT01085643|11366195|FG000|COMPLETED|Overall Study||4
9814288|NCT00684021|10924474|FG003|COMPLETED|Overall Study||15
9814289|NCT00684021|10924471|FG000|NOT COMPLETED|Overall Study||2
9814290|NCT00684021|10924472|FG001|NOT COMPLETED|Overall Study||2
9814291|NCT00684021|10924473|FG002|NOT COMPLETED|Overall Study||2
9814292|NCT00684021|10924474|FG003|NOT COMPLETED|Overall Study||2
9814293|NCT00684047|10924487|FG000|STARTED|Overall Study||72
9814294|NCT00684047|10924488|FG001|STARTED|Overall Study||110
9814295|NCT00684047|10924489|FG002|STARTED|Overall Study||57
9814296|NCT00684047|10924487|FG000|COMPLETED|Overall Study||59
9814297|NCT00684047|10924488|FG001|COMPLETED|Overall Study||94
9814298|NCT00684047|10924489|FG002|COMPLETED|Overall Study||52
9814299|NCT00684047|10924487|FG000|NOT COMPLETED|Overall Study||13
9814300|NCT00684047|10924488|FG001|NOT COMPLETED|Overall Study||16
9814301|NCT00684047|10924489|FG002|NOT COMPLETED|Overall Study||5
9814302|NCT00684060|10924499|FG000|STARTED|Overall Study||58
9814303|NCT00684060|10924500|FG001|STARTED|Overall Study||29
9814304|NCT00684060|10924499|FG000|COMPLETED|Overall Study||55
9814305|NCT00684060|10924500|FG001|COMPLETED|Overall Study||26
9814306|NCT00684060|10924499|FG000|NOT COMPLETED|Overall Study||3
9814307|NCT00684060|10924500|FG001|NOT COMPLETED|Overall Study||3
9814308|NCT00684073|10924506|FG000|STARTED|Selection||60
9814309|NCT00684073|10924506|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
9814310|NCT00684073|10924506|FG000|NOT COMPLETED|Selection||7
9814311|NCT00684073|10924506|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
9814312|NCT00684073|10924506|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
9814313|NCT00684073|10924506|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1
9814314|NCT00684138|10924516|FG000|STARTED|Overall Study||141
9814315|NCT00684138|10924517|FG001|STARTED|Overall Study||139
9814316|NCT00684138|10924516|FG000|COMPLETED|Overall Study||138
9814317|NCT00684138|10924517|FG001|COMPLETED|Overall Study||131
9814318|NCT00684138|10924516|FG000|NOT COMPLETED|Overall Study||3
9814319|NCT00684138|10924517|FG001|NOT COMPLETED|Overall Study||8
9814320|NCT00684177|10924527|FG000|STARTED|Overall Study||343
9814321|NCT00684177|10924528|FG001|STARTED|Overall Study||164
9814322|NCT00684177|10924527|FG000|COMPLETED|Overall Study||322
9814323|NCT00684177|10924528|FG001|COMPLETED|Overall Study||141
9814324|NCT00684177|10924527|FG000|NOT COMPLETED|Overall Study||21
9814325|NCT00684177|10924528|FG001|NOT COMPLETED|Overall Study||23
9814326|NCT00684203|10924540|FG000|STARTED|Overall Study||40
9814327|NCT00684203|10924541|FG001|STARTED|Overall Study||31
9814328|NCT00684203|10924542|FG002|STARTED|Overall Study||21
9814329|NCT00684203|10924543|FG003|STARTED|Overall Study||6
9814330|NCT00684203|10924544|FG004|STARTED|Overall Study||17
9814331|NCT00684203|10924545|FG005|STARTED|Overall Study||2
9814332|NCT00684203|10924540|FG000|COMPLETED|Overall Study||31
10235779|NCT01085643|11366195|FG000|NOT COMPLETED|Overall Study||0
10235780|NCT01083472|11366201|FG000|STARTED|Overall Study||18
10235781|NCT01083472|11366202|FG001|STARTED|Overall Study||19
10235782|NCT01083472|11366201|FG000|COMPLETED|Overall Study||18
10235783|NCT01083472|11366202|FG001|COMPLETED|Overall Study||19
10235784|NCT01083472|11366201|FG000|NOT COMPLETED|Overall Study||0
10235785|NCT01083472|11366202|FG001|NOT COMPLETED|Overall Study||0
10235786|NCT01080768|11366210|FG000|STARTED|Overall Study||14
10235787|NCT01080768|11366211|FG001|STARTED|Overall Study||17
10235788|NCT01080768|11366210|FG000|COMPLETED|Overall Study||12
10235789|NCT01080768|11366211|FG001|COMPLETED|Overall Study||16
10235790|NCT01080768|11366210|FG000|NOT COMPLETED|Overall Study||2
10235791|NCT01080768|11366211|FG001|NOT COMPLETED|Overall Study||1
10235792|NCT01079598|11366217|FG000|STARTED|Overall Study||8
10235793|NCT01079598|11366217|FG000|COMPLETED|Overall Study||8
10235794|NCT01079598|11366217|FG000|NOT COMPLETED|Overall Study||0
10235795|NCT01074502|11366221|FG000|STARTED|Overall Study||3
10235796|NCT01074502|11366221|FG000|COMPLETED|Overall Study||2
10235797|NCT01074502|11366221|FG000|NOT COMPLETED|Overall Study||1
10235798|NCT01074437|11366227|FG000|STARTED|Overall Study||4
10235799|NCT01074437|11366228|FG001|STARTED|Overall Study||5
10235800|NCT01074437|11366227|FG000|COMPLETED|Overall Study||4
9814333|NCT00684203|10924541|FG001|COMPLETED|Overall Study||23
9814334|NCT00684203|10924542|FG002|COMPLETED|Overall Study||12
9814335|NCT00684203|10924543|FG003|COMPLETED|Overall Study||6
9814336|NCT00684203|10924544|FG004|COMPLETED|Overall Study||17
9814337|NCT00684203|10924545|FG005|COMPLETED|Overall Study||2
10235801|NCT01074437|11366228|FG001|COMPLETED|Overall Study||5
10235802|NCT01074437|11366227|FG000|NOT COMPLETED|Overall Study||0
10235803|NCT01074437|11366228|FG001|NOT COMPLETED|Overall Study||0
10235804|NCT01069861|11366234|FG000|STARTED|Overall Study||4
10235805|NCT01069861|11366234|FG000|COMPLETED|Overall Study||1
9814338|NCT00684203|10924540|FG000|NOT COMPLETED|Overall Study||9
9814339|NCT00684203|10924541|FG001|NOT COMPLETED|Overall Study||8
9814340|NCT00684203|10924542|FG002|NOT COMPLETED|Overall Study||9
9814341|NCT00684203|10924543|FG003|NOT COMPLETED|Overall Study||0
9814342|NCT00684203|10924544|FG004|NOT COMPLETED|Overall Study||0
9814343|NCT00684203|10924545|FG005|NOT COMPLETED|Overall Study||0
9814344|NCT00684242|10924566|FG000|STARTED|Overall Study||3
9814345|NCT00684242|10924566|FG000|COMPLETED|Overall Study||3
9814346|NCT00684242|10924566|FG000|NOT COMPLETED|Overall Study||0
9814347|NCT00684307|10924575|FG000|STARTED|Overall Study|Patients who received treatment|164
9814348|NCT00684307|10924576|FG001|STARTED|Overall Study||151
10235806|NCT01069861|11366234|FG000|NOT COMPLETED|Overall Study||3
10235807|NCT01072526|11366238|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
9814349|NCT00684307|10924577|FG002|STARTED|Overall Study||156
9814350|NCT00684307|10924578|FG003|STARTED|Overall Study||160
9814351|NCT00684307|10924579|FG004|STARTED|Overall Study||318
9814352|NCT00684307|10924575|FG000|On Treatment Period Started|Overall Study||164
9814353|NCT00684307|10924576|FG001|On Treatment Period Started|Overall Study||151
9814354|NCT00684307|10924577|FG002|On Treatment Period Started|Overall Study||156
9814355|NCT00684307|10924578|FG003|On Treatment Period Started|Overall Study||160
9814356|NCT00684307|10924579|FG004|On Treatment Period Started|Overall Study||318
9814357|NCT00684307|10924575|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
9814358|NCT00684307|10924576|FG001|On Treatment Period Completed|Overall Study||129
9814359|NCT00684307|10924577|FG002|On Treatment Period Completed|Overall Study||128
9814360|NCT00684307|10924578|FG003|On Treatment Period Completed|Overall Study||128
9814361|NCT00684307|10924579|FG004|On Treatment Period Completed|Overall Study||293
9814362|NCT00684307|10924575|FG000|COMPLETED|Overall Study||140
9814363|NCT00684307|10924576|FG001|COMPLETED|Overall Study||129
9814364|NCT00684307|10924577|FG002|COMPLETED|Overall Study||128
9814365|NCT00684307|10924578|FG003|COMPLETED|Overall Study||128
9814366|NCT00684307|10924579|FG004|COMPLETED|Overall Study||293
9814367|NCT00684307|10924575|FG000|NOT COMPLETED|Overall Study||24
9814368|NCT00684307|10924576|FG001|NOT COMPLETED|Overall Study||22
9814369|NCT00684307|10924577|FG002|NOT COMPLETED|Overall Study||28
9814370|NCT00684307|10924578|FG003|NOT COMPLETED|Overall Study||32
9814371|NCT00684307|10924579|FG004|NOT COMPLETED|Overall Study||25
9814372|NCT00684320|10924593|FG000|STARTED|Overall Study||26
9814373|NCT00684320|10924594|FG001|STARTED|Overall Study||22
9814374|NCT00684320|10924593|FG000|COMPLETED|Overall Study||22
9814375|NCT00684320|10924594|FG001|COMPLETED|Overall Study||22
9814376|NCT00684320|10924593|FG000|NOT COMPLETED|Overall Study||4
9814377|NCT00684320|10924594|FG001|NOT COMPLETED|Overall Study||0
9814378|NCT00684411|10924600|FG000|STARTED|Overall Study||12
9814379|NCT00684411|10924600|FG000|Disease Evaluable|Overall Study||11
9814380|NCT00684411|10924600|FG000|COMPLETED|Overall Study||0
9814381|NCT00684411|10924600|FG000|NOT COMPLETED|Overall Study||12
9814382|NCT00684424|10924604|FG000|STARTED|Overall Study||199
9814383|NCT00684424|10924604|FG000|COMPLETED|Overall Study||194
9814384|NCT00684424|10924604|FG000|NOT COMPLETED|Overall Study||5
9814385|NCT00684515|10924612|FG000|STARTED|Overall Study||33
9814386|NCT00684515|10924613|FG001|STARTED|Overall Study||29
9814387|NCT00684515|10924614|FG002|STARTED|Overall Study||28
9814388|NCT00684515|10924612|FG000|COMPLETED|Overall Study||29
9814389|NCT00684515|10924613|FG001|COMPLETED|Overall Study||26
9814390|NCT00684515|10924614|FG002|COMPLETED|Overall Study||27
9814391|NCT00684515|10924612|FG000|NOT COMPLETED|Overall Study||4
9814392|NCT00684515|10924613|FG001|NOT COMPLETED|Overall Study||3
9814393|NCT00684515|10924614|FG002|NOT COMPLETED|Overall Study||1
9814394|NCT00684541|10924624|FG000|STARTED|Overall Study||23
9814395|NCT00684541|10924625|FG001|STARTED|Overall Study||26
9814396|NCT00684541|10924624|FG000|COMPLETED|Overall Study||20
9814397|NCT00684541|10924625|FG001|COMPLETED|Overall Study||23
9814398|NCT00684541|10924624|FG000|NOT COMPLETED|Overall Study||3
9814399|NCT00684541|10924625|FG001|NOT COMPLETED|Overall Study||3
9814400|NCT00684554|10924634|FG000|STARTED|Overall Study||10
9814401|NCT00684554|10924635|FG001|STARTED|Overall Study||10
9814402|NCT00684554|10924634|FG000|COMPLETED|Overall Study||10
9814403|NCT00684554|10924635|FG001|COMPLETED|Overall Study||10
9814404|NCT00684554|10924634|FG000|NOT COMPLETED|Overall Study||0
9814405|NCT00684554|10924635|FG001|NOT COMPLETED|Overall Study||0
9814406|NCT00684567|10924641|FG000|STARTED|Concomitant Radiotherapy Period||30
9814407|NCT00684567|10924641|FG000|COMPLETED|Concomitant Radiotherapy Period||28
9814408|NCT00684567|10924641|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2
9814409|NCT00684567|10924641|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
10235808|NCT01072526|11366239|FG001|STARTED|Overall Study||0
10235809|NCT01072526|11366238|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
10235810|NCT01072526|11366239|FG001|COMPLETED|Overall Study||0
10235811|NCT01072526|11366238|FG000|NOT COMPLETED|Overall Study||0
10235812|NCT01072526|11366239|FG001|NOT COMPLETED|Overall Study||0
10235813|NCT01071993|11366249|FG000|STARTED|Overall Study||0
10235814|NCT01071993|11366250|FG001|STARTED|Overall Study||0
10235815|NCT01071993|11366249|FG000|COMPLETED|Overall Study||0
10235816|NCT01071993|11366250|FG001|COMPLETED|Overall Study||0
10235817|NCT01071993|11366249|FG000|NOT COMPLETED|Overall Study||0
10235818|NCT01071993|11366250|FG001|NOT COMPLETED|Overall Study||0
10235819|NCT01065051|11366258|FG000|STARTED|Overall Study||1
10235820|NCT01065051|11366259|FG001|STARTED|Overall Study||0
10235821|NCT01065051|11366258|FG000|COMPLETED|Overall Study||1
9814410|NCT00684567|10924641|FG000|COMPLETED|Monotherapy Period||9
9814411|NCT00684567|10924641|FG000|NOT COMPLETED|Monotherapy Period||14
9814412|NCT00684593|10924647|FG000|STARTED|Overall Study||21
9814413|NCT00684593|10924648|FG001|STARTED|Overall Study||10
9814414|NCT00684593|10924647|FG000|COMPLETED|Overall Study||21
9814415|NCT00684593|10924648|FG001|COMPLETED|Overall Study||8
9814416|NCT00684593|10924647|FG000|NOT COMPLETED|Overall Study||0
9814417|NCT00684593|10924648|FG001|NOT COMPLETED|Overall Study||2
9814418|NCT00684645|10924654|FG000|STARTED|Overall Study||186
9814419|NCT00684645|10924654|FG000|COMPLETED|Overall Study||72
9814420|NCT00684645|10924654|FG000|NOT COMPLETED|Overall Study||114
9814421|NCT00684671|10924661|FG000|STARTED|Overall Study||172
10235822|NCT01065051|11366259|FG001|COMPLETED|Overall Study||0
9814422|NCT00684671|10924662|FG001|STARTED|Overall Study||170
9814423|NCT00684671|10924663|FG002|STARTED|Overall Study||164
9814424|NCT00684671|10924661|FG000|COMPLETED|Overall Study||169
9814425|NCT00684671|10924662|FG001|COMPLETED|Overall Study||170
9814426|NCT00684671|10924663|FG002|COMPLETED|Overall Study||164
9814427|NCT00684671|10924661|FG000|NOT COMPLETED|Overall Study||3
9814428|NCT00684671|10924662|FG001|NOT COMPLETED|Overall Study||0
9814429|NCT00684671|10924663|FG002|NOT COMPLETED|Overall Study||0
9814430|NCT00684723|10924671|FG000|STARTED|First Intervention||27
9814431|NCT00684723|10924672|FG001|STARTED|First Intervention||27
9814432|NCT00684723|10924671|FG000|COMPLETED|First Intervention||27
9814433|NCT00684723|10924672|FG001|COMPLETED|First Intervention||27
9814434|NCT00684723|10924671|FG000|NOT COMPLETED|First Intervention||0
9814435|NCT00684723|10924672|FG001|NOT COMPLETED|First Intervention||0
9814436|NCT00684723|10924671|FG000|STARTED|Washout Period of 7 Days||27
9814437|NCT00684723|10924672|FG001|STARTED|Washout Period of 7 Days||27
9814438|NCT00684723|10924671|FG000|COMPLETED|Washout Period of 7 Days||27
9814439|NCT00684723|10924672|FG001|COMPLETED|Washout Period of 7 Days||27
9814440|NCT00684723|10924671|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9814441|NCT00684723|10924672|FG001|NOT COMPLETED|Washout Period of 7 Days||0
9814442|NCT00684723|10924671|FG000|STARTED|Second Intervention||27
9814443|NCT00684723|10924672|FG001|STARTED|Second Intervention||27
9814444|NCT00684723|10924671|FG000|COMPLETED|Second Intervention||27
9814445|NCT00684723|10924672|FG001|COMPLETED|Second Intervention||27
9814446|NCT00684723|10924671|FG000|NOT COMPLETED|Second Intervention||0
9814447|NCT00684723|10924672|FG001|NOT COMPLETED|Second Intervention||0
9814448|NCT00684749|10924678|FG000|STARTED|Overall Study||142
9814449|NCT00684749|10924678|FG000|COMPLETED|Overall Study||142
9814450|NCT00684749|10924678|FG000|NOT COMPLETED|Overall Study||0
9814451|NCT00684762|10924682|FG000|STARTED|First Intervention||16
9814452|NCT00684762|10924683|FG001|STARTED|First Intervention||16
9814453|NCT00684762|10924682|FG000|COMPLETED|First Intervention||16
9814454|NCT00684762|10924683|FG001|COMPLETED|First Intervention||16
9814455|NCT00684762|10924682|FG000|NOT COMPLETED|First Intervention||0
9814456|NCT00684762|10924683|FG001|NOT COMPLETED|First Intervention||0
9814457|NCT00684762|10924682|FG000|STARTED|Washout Period of 7 Days||16
9814458|NCT00684762|10924683|FG001|STARTED|Washout Period of 7 Days||16
9814459|NCT00684762|10924682|FG000|COMPLETED|Washout Period of 7 Days||14
9814460|NCT00684762|10924683|FG001|COMPLETED|Washout Period of 7 Days||14
9814461|NCT00684762|10924682|FG000|NOT COMPLETED|Washout Period of 7 Days||2
9814462|NCT00684762|10924683|FG001|NOT COMPLETED|Washout Period of 7 Days||2
9814463|NCT00684762|10924682|FG000|STARTED|Second Intervention||14
9814464|NCT00684762|10924683|FG001|STARTED|Second Intervention||14
9814465|NCT00684762|10924682|FG000|COMPLETED|Second Intervention||14
9814466|NCT00684762|10924683|FG001|COMPLETED|Second Intervention||14
9814467|NCT00684762|10924682|FG000|NOT COMPLETED|Second Intervention||0
9814468|NCT00684762|10924683|FG001|NOT COMPLETED|Second Intervention||0
9814469|NCT00684775|10924691|FG000|STARTED|Overall Study||19
9814470|NCT00684775|10924692|FG001|STARTED|Overall Study||19
9814471|NCT00684775|10924691|FG000|COMPLETED|Overall Study||19
9814472|NCT00684775|10924692|FG001|COMPLETED|Overall Study||19
9814473|NCT00684775|10924691|FG000|NOT COMPLETED|Overall Study||0
9814474|NCT00684775|10924692|FG001|NOT COMPLETED|Overall Study||0
9814475|NCT00684788|10924708|FG000|STARTED|Overall Study||17
9814476|NCT00684788|10924709|FG001|STARTED|Overall Study||18
9814477|NCT00684788|10924708|FG000|COMPLETED|Overall Study||17
10016584|NCT01811225|11139403|FG000|NOT COMPLETED|Treatment Period 2||4
10016585|NCT01811225|11139404|FG001|NOT COMPLETED|Treatment Period 2||6
10016586|NCT01811238|11139410|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
10016587|NCT01811238|11139410|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
9814478|NCT00684788|10924709|FG001|COMPLETED|Overall Study||18
9814479|NCT00684788|10924708|FG000|NOT COMPLETED|Overall Study||0
9814480|NCT00684788|10924709|FG001|NOT COMPLETED|Overall Study||0
9814481|NCT00684814|10924721|FG000|STARTED|First Intervention||19
9814482|NCT00684814|10924722|FG001|STARTED|First Intervention||19
9814483|NCT00684814|10924721|FG000|COMPLETED|First Intervention||19
9814484|NCT00684814|10924722|FG001|COMPLETED|First Intervention||19
9814485|NCT00684814|10924721|FG000|NOT COMPLETED|First Intervention||0
9814486|NCT00684814|10924722|FG001|NOT COMPLETED|First Intervention||0
9814487|NCT00684814|10924721|FG000|STARTED|Washout Period of 7 Days||19
9814488|NCT00684814|10924722|FG001|STARTED|Washout Period of 7 Days||19
9814489|NCT00684814|10924721|FG000|COMPLETED|Washout Period of 7 Days||17
9814490|NCT00684814|10924722|FG001|COMPLETED|Washout Period of 7 Days||15
9814491|NCT00684814|10924721|FG000|NOT COMPLETED|Washout Period of 7 Days||2
9814492|NCT00684814|10924722|FG001|NOT COMPLETED|Washout Period of 7 Days||4
9814493|NCT00684814|10924721|FG000|STARTED|Second Intervention||17
9814494|NCT00684814|10924722|FG001|STARTED|Second Intervention||15
9814495|NCT00684814|10924721|FG000|COMPLETED|Second Intervention||16
9814496|NCT00684814|10924722|FG001|COMPLETED|Second Intervention||15
9814497|NCT00684814|10924721|FG000|NOT COMPLETED|Second Intervention||1
9814498|NCT00684814|10924722|FG001|NOT COMPLETED|Second Intervention||0
9814499|NCT00684983|10924730|FG000|STARTED|Overall Study||19
9814500|NCT00684983|10924731|FG001|STARTED|Overall Study||45
9814501|NCT00684983|10924730|FG000|COMPLETED|Overall Study||19
9814502|NCT00684983|10924731|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
10019150|NCT01828073|11142292|FG000|STARTED|Overall Study||22
10019151|NCT01828073|11142293|FG001|STARTED|Overall Study||18
9814503|NCT00684983|10924730|FG000|NOT COMPLETED|Overall Study||0
9814504|NCT00684983|10924731|FG001|NOT COMPLETED|Overall Study||0
9814505|NCT00684996|10924739|FG000|STARTED|Overall Study||5
9814506|NCT00684996|10924739|FG000|Eligible|Overall Study||5
9814507|NCT00684996|10924739|FG000|COMPLETED|Overall Study||0
9814508|NCT00684996|10924739|FG000|NOT COMPLETED|Overall Study||5
9814509|NCT00685035|10924746|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9
9814510|NCT00685035|10924747|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8
9814511|NCT00685035|10924746|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8
9814512|NCT00685035|10924747|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8
9814513|NCT00685035|10924746|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
9814514|NCT00685035|10924747|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
9814515|NCT00685035|10924746|FG000|STARTED|Period 2: 2-day Washout||8
9814516|NCT00685035|10924747|FG001|STARTED|Period 2: 2-day Washout||8
9814517|NCT00685035|10924746|FG000|COMPLETED|Period 2: 2-day Washout||8
9814518|NCT00685035|10924747|FG001|COMPLETED|Period 2: 2-day Washout||8
9814519|NCT00685035|10924746|FG000|NOT COMPLETED|Period 2: 2-day Washout||0
9814520|NCT00685035|10924747|FG001|NOT COMPLETED|Period 2: 2-day Washout||0
9814521|NCT00685035|10924746|FG000|STARTED|Period 3: 2nd Intervention||8
9814522|NCT00685035|10924747|FG001|STARTED|Period 3: 2nd Intervention||8
9814523|NCT00685035|10924746|FG000|COMPLETED|Period 3: 2nd Intervention||8
9814524|NCT00685035|10924747|FG001|COMPLETED|Period 3: 2nd Intervention||8
9814525|NCT00685035|10924746|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0
9814526|NCT00685035|10924747|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0
9814527|NCT00685139|10924771|FG000|STARTED|First Intervention||17
9814528|NCT00685139|10924772|FG001|STARTED|First Intervention||17
9814529|NCT00685139|10924771|FG000|COMPLETED|First Intervention||17
9814530|NCT00685139|10924772|FG001|COMPLETED|First Intervention||17
9814531|NCT00685139|10924771|FG000|NOT COMPLETED|First Intervention||0
9814532|NCT00685139|10924772|FG001|NOT COMPLETED|First Intervention||0
9814533|NCT00685139|10924771|FG000|STARTED|Washout Period of 28 Days||17
9814534|NCT00685139|10924772|FG001|STARTED|Washout Period of 28 Days||17
9814535|NCT00685139|10924771|FG000|COMPLETED|Washout Period of 28 Days||17
9814536|NCT00685139|10924772|FG001|COMPLETED|Washout Period of 28 Days||17
9814537|NCT00685139|10924771|FG000|NOT COMPLETED|Washout Period of 28 Days||0
9814538|NCT00685139|10924772|FG001|NOT COMPLETED|Washout Period of 28 Days||0
9814539|NCT00685139|10924771|FG000|STARTED|Second Intervention||17
9814540|NCT00685139|10924772|FG001|STARTED|Second Intervention||17
9814541|NCT00685139|10924771|FG000|COMPLETED|Second Intervention||17
9814542|NCT00685139|10924772|FG001|COMPLETED|Second Intervention||17
9814543|NCT00685139|10924771|FG000|NOT COMPLETED|Second Intervention||0
9814544|NCT00685139|10924772|FG001|NOT COMPLETED|Second Intervention||0
9814545|NCT00685165|10924778|FG000|STARTED|First Intervention||11
9814546|NCT00685165|10924779|FG001|STARTED|First Intervention||11
9814547|NCT00685165|10924778|FG000|COMPLETED|First Intervention||11
9814548|NCT00685165|10924779|FG001|COMPLETED|First Intervention||11
9814549|NCT00685165|10924778|FG000|NOT COMPLETED|First Intervention||0
9814550|NCT00685165|10924779|FG001|NOT COMPLETED|First Intervention||0
9814551|NCT00685165|10924778|FG000|STARTED|Washout Period of 14 Days||11
9814552|NCT00685165|10924779|FG001|STARTED|Washout Period of 14 Days||11
9814553|NCT00685165|10924778|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
9814554|NCT00685165|10924779|FG001|COMPLETED|Washout Period of 14 Days||11
9814555|NCT00685165|10924778|FG000|NOT COMPLETED|Washout Period of 14 Days||1
9814556|NCT00685165|10924779|FG001|NOT COMPLETED|Washout Period of 14 Days||0
9814557|NCT00685165|10924778|FG000|STARTED|Second Intervention||10
9814558|NCT00685165|10924779|FG001|STARTED|Second Intervention||11
9814559|NCT00685165|10924778|FG000|COMPLETED|Second Intervention||10
9814560|NCT00685165|10924779|FG001|COMPLETED|Second Intervention||11
9814561|NCT00685165|10924778|FG000|NOT COMPLETED|Second Intervention||0
9814562|NCT00685165|10924779|FG001|NOT COMPLETED|Second Intervention||0
9814563|NCT00685178|10924789|FG000|STARTED|Overall Study||40
9814564|NCT00685178|10924790|FG001|STARTED|Overall Study||45
9814565|NCT00685178|10924791|FG002|STARTED|Overall Study||39
9814566|NCT00685178|10924792|FG003|STARTED|Overall Study||47
9814567|NCT00685178|10924789|FG000|COMPLETED|Overall Study||27
9814568|NCT00685178|10924790|FG001|COMPLETED|Overall Study||26
9814569|NCT00685178|10924791|FG002|COMPLETED|Overall Study||27
9814570|NCT00685178|10924792|FG003|COMPLETED|Overall Study||33
9814571|NCT00685178|10924789|FG000|NOT COMPLETED|Overall Study||13
9814572|NCT00685178|10924790|FG001|NOT COMPLETED|Overall Study||19
9814573|NCT00685178|10924791|FG002|NOT COMPLETED|Overall Study||12
9814574|NCT00685178|10924792|FG003|NOT COMPLETED|Overall Study||14
9814575|NCT00685295|10924804|FG000|STARTED|Overall Study||30
9814576|NCT00685295|10924805|FG001|STARTED|Overall Study||30
9814577|NCT00685295|10924804|FG000|COMPLETED|Overall Study||30
9952906|NCT01424501|11071782|FG003|NOT COMPLETED|Overall Study||0
9814578|NCT00685295|10924805|FG001|COMPLETED|Overall Study||30
9814579|NCT00685295|10924804|FG000|NOT COMPLETED|Overall Study||0
9814580|NCT00685295|10924805|FG001|NOT COMPLETED|Overall Study||0
9814581|NCT00685334|10924815|FG000|STARTED|Overall Study||12
9814582|NCT00685334|10924816|FG001|STARTED|Overall Study||10
9814583|NCT00685334|10924815|FG000|COMPLETED|Overall Study||2
9814584|NCT00685334|10924816|FG001|COMPLETED|Overall Study||3
9814585|NCT00685334|10924815|FG000|NOT COMPLETED|Overall Study||10
9814586|NCT00685334|10924816|FG001|NOT COMPLETED|Overall Study||7
9814587|NCT00685373|10924822|FG000|STARTED|Overall Study||166
9814588|NCT00685373|10924822|FG000|COMPLETED|Overall Study||151
9814589|NCT00685373|10924822|FG000|NOT COMPLETED|Overall Study||15
9814590|NCT00685399|10924833|FG000|STARTED|Treatment Period 1||16
9814591|NCT00685399|10924834|FG001|STARTED|Treatment Period 1||0
9814592|NCT00685399|10924835|FG002|STARTED|Treatment Period 1||0
9814593|NCT00685399|10924836|FG003|STARTED|Treatment Period 1||0
9814594|NCT00685399|10924837|FG004|STARTED|Treatment Period 1||0
9814595|NCT00685399|10924838|FG005|STARTED|Treatment Period 1||0
9814596|NCT00685399|10924839|FG006|STARTED|Treatment Period 1||0
9814597|NCT00685399|10924840|FG007|STARTED|Treatment Period 1||0
9814598|NCT00685399|10924833|FG000|COMPLETED|Treatment Period 1||10
9814599|NCT00685399|10924834|FG001|COMPLETED|Treatment Period 1||0
9814600|NCT00685399|10924835|FG002|COMPLETED|Treatment Period 1||0
9814601|NCT00685399|10924836|FG003|COMPLETED|Treatment Period 1||0
9814602|NCT00685399|10924837|FG004|COMPLETED|Treatment Period 1||0
9814603|NCT00685399|10924838|FG005|COMPLETED|Treatment Period 1||0
9814604|NCT00685399|10924839|FG006|COMPLETED|Treatment Period 1||0
9814605|NCT00685399|10924840|FG007|COMPLETED|Treatment Period 1||0
9814606|NCT00685399|10924833|FG000|NOT COMPLETED|Treatment Period 1||6
9814607|NCT00685399|10924834|FG001|NOT COMPLETED|Treatment Period 1||0
9814608|NCT00685399|10924835|FG002|NOT COMPLETED|Treatment Period 1||0
9814609|NCT00685399|10924836|FG003|NOT COMPLETED|Treatment Period 1||0
10016588|NCT01811238|11139410|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
10016589|NCT01811238|11139410|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
10235823|NCT01065051|11366258|FG000|NOT COMPLETED|Overall Study||0
10235824|NCT01065051|11366259|FG001|NOT COMPLETED|Overall Study||0
10235825|NCT01069120|11366267|FG000|STARTED|Overall Study||27
10235826|NCT01069120|11366267|FG000|COMPLETED|Overall Study||0
10235827|NCT01069120|11366267|FG000|NOT COMPLETED|Overall Study||27
10235828|NCT01066637|11366275|FG000|STARTED|Overall Study||16
10235829|NCT01066637|11366276|FG001|STARTED|Overall Study||10
10235830|NCT01066637|11366275|FG000|COMPLETED|Overall Study||16
10235831|NCT01066637|11366276|FG001|COMPLETED|Overall Study||10
10235832|NCT01066637|11366275|FG000|NOT COMPLETED|Overall Study||0
10235833|NCT01066637|11366276|FG001|NOT COMPLETED|Overall Study||0
10235834|NCT01058642|11366286|FG000|STARTED|Treatment Period 1||9
10235835|NCT01058642|11366287|FG001|STARTED|Treatment Period 1||12
10235836|NCT01058642|11366288|FG002|STARTED|Treatment Period 1||11
10235837|NCT01058642|11366289|FG003|STARTED|Treatment Period 1||9
10235838|NCT01058642|11366286|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
10235839|NCT01058642|11366287|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
10235840|NCT01058642|11366288|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
10235841|NCT01058642|11366289|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
10235842|NCT01058642|11366286|FG000|COMPLETED|Treatment Period 1||7
10235843|NCT01058642|11366287|FG001|COMPLETED|Treatment Period 1||11
10235844|NCT01058642|11366288|FG002|COMPLETED|Treatment Period 1||9
10235845|NCT01058642|11366289|FG003|COMPLETED|Treatment Period 1||7
10235846|NCT01058642|11366286|FG000|NOT COMPLETED|Treatment Period 1||2
10235847|NCT01058642|11366287|FG001|NOT COMPLETED|Treatment Period 1||1
10235848|NCT01058642|11366288|FG002|NOT COMPLETED|Treatment Period 1||2
10235849|NCT01058642|11366289|FG003|NOT COMPLETED|Treatment Period 1||2
10235850|NCT01058642|11366286|FG000|STARTED|Washout Period||7
10235851|NCT01058642|11366287|FG001|STARTED|Washout Period||11
10235852|NCT01058642|11366288|FG002|STARTED|Washout Period||9
10235853|NCT01058642|11366289|FG003|STARTED|Washout Period||7
10235854|NCT01058642|11366286|FG000|COMPLETED|Washout Period||7
10235855|NCT01058642|11366287|FG001|COMPLETED|Washout Period||11
10235856|NCT01058642|11366288|FG002|COMPLETED|Washout Period||9
10235857|NCT01058642|11366289|FG003|COMPLETED|Washout Period||7
10235858|NCT01058642|11366286|FG000|NOT COMPLETED|Washout Period||0
10235859|NCT01058642|11366287|FG001|NOT COMPLETED|Washout Period||0
10235860|NCT01058642|11366288|FG002|NOT COMPLETED|Washout Period||0
10235861|NCT01058642|11366289|FG003|NOT COMPLETED|Washout Period||0
10235862|NCT01058642|11366286|FG000|STARTED|Treatment Period 2||7
10235863|NCT01058642|11366287|FG001|STARTED|Treatment Period 2||11
10235864|NCT01058642|11366288|FG002|STARTED|Treatment Period 2||9
10235865|NCT01058642|11366289|FG003|STARTED|Treatment Period 2||7
10235866|NCT01058642|11366286|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
10235867|NCT01058642|11366287|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
9814610|NCT00685399|10924837|FG004|NOT COMPLETED|Treatment Period 1||0
9814611|NCT00685399|10924838|FG005|NOT COMPLETED|Treatment Period 1||0
9814612|NCT00685399|10924839|FG006|NOT COMPLETED|Treatment Period 1||0
9814613|NCT00685399|10924840|FG007|NOT COMPLETED|Treatment Period 1||0
9814614|NCT00685399|10924833|FG000|STARTED|Treatment Period 2||0
10235868|NCT01058642|11366288|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
10235869|NCT01058642|11366289|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
10235870|NCT01058642|11366286|FG000|COMPLETED|Treatment Period 2||7
10235871|NCT01058642|11366287|FG001|COMPLETED|Treatment Period 2||11
9814615|NCT00685399|10924834|FG001|STARTED|Treatment Period 2||14
9814616|NCT00685399|10924835|FG002|STARTED|Treatment Period 2||5
9814617|NCT00685399|10924836|FG003|STARTED|Treatment Period 2|in extension period only|0
10235872|NCT01058642|11366288|FG002|COMPLETED|Treatment Period 2||9
10235873|NCT01058642|11366289|FG003|COMPLETED|Treatment Period 2||7
10235874|NCT01058642|11366286|FG000|NOT COMPLETED|Treatment Period 2||0
10235875|NCT01058642|11366287|FG001|NOT COMPLETED|Treatment Period 2||0
9814618|NCT00685399|10924837|FG004|STARTED|Treatment Period 2||4
9814619|NCT00685399|10924838|FG005|STARTED|Treatment Period 2||12
9814620|NCT00685399|10924839|FG006|STARTED|Treatment Period 2||13
9814621|NCT00685399|10924840|FG007|STARTED|Treatment Period 2||12
10016590|NCT01811238|11139410|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
10016591|NCT01811238|11139410|FG000|NOT COMPLETED|Overall Study||81
10016592|NCT01811303|11139415|FG000|STARTED|First Intervention (1 Day)||4
10016593|NCT01811303|11139416|FG001|STARTED|First Intervention (1 Day)||4
10016594|NCT01811303|11139417|FG002|STARTED|First Intervention (1 Day)||4
10235876|NCT01058642|11366288|FG002|NOT COMPLETED|Treatment Period 2||0
9814622|NCT00685399|10924833|FG000|COMPLETED|Treatment Period 2||0
9814623|NCT00685399|10924834|FG001|COMPLETED|Treatment Period 2||2
9814624|NCT00685399|10924835|FG002|COMPLETED|Treatment Period 2||2
9814625|NCT00685399|10924836|FG003|COMPLETED|Treatment Period 2|in extension period only|0
9814626|NCT00685399|10924837|FG004|COMPLETED|Treatment Period 2||4
9814627|NCT00685399|10924838|FG005|COMPLETED|Treatment Period 2||10
9814628|NCT00685399|10924839|FG006|COMPLETED|Treatment Period 2||13
9814629|NCT00685399|10924840|FG007|COMPLETED|Treatment Period 2||10
9814630|NCT00685399|10924833|FG000|NOT COMPLETED|Treatment Period 2||0
9814631|NCT00685399|10924834|FG001|NOT COMPLETED|Treatment Period 2||12
9814632|NCT00685399|10924835|FG002|NOT COMPLETED|Treatment Period 2||3
9814633|NCT00685399|10924836|FG003|NOT COMPLETED|Treatment Period 2||0
9814634|NCT00685399|10924837|FG004|NOT COMPLETED|Treatment Period 2||0
9814635|NCT00685399|10924838|FG005|NOT COMPLETED|Treatment Period 2||2
9814636|NCT00685399|10924839|FG006|NOT COMPLETED|Treatment Period 2||0
9814637|NCT00685399|10924840|FG007|NOT COMPLETED|Treatment Period 2||2
9814638|NCT00685399|10924833|FG000|STARTED|Extension||0
9814639|NCT00685399|10924834|FG001|STARTED|Extension||0
9814640|NCT00685399|10924835|FG002|STARTED|Extension||0
9814641|NCT00685399|10924836|FG003|STARTED|Extension||28
9814642|NCT00685399|10924837|FG004|STARTED|Extension||0
9814643|NCT00685399|10924838|FG005|STARTED|Extension||0
9814644|NCT00685399|10924839|FG006|STARTED|Extension||0
9814645|NCT00685399|10924840|FG007|STARTED|Extension||0
9814646|NCT00685399|10924833|FG000|COMPLETED|Extension||0
9814647|NCT00685399|10924834|FG001|COMPLETED|Extension||0
10016595|NCT01811303|11139418|FG003|STARTED|First Intervention (1 Day)||2
10235877|NCT01058642|11366289|FG003|NOT COMPLETED|Treatment Period 2||0
10235878|NCT01065818|11366297|FG000|STARTED|Overall Study||6
10235879|NCT01065818|11366297|FG000|COMPLETED|Overall Study||4
10235880|NCT01065818|11366297|FG000|NOT COMPLETED|Overall Study||2
10235881|NCT01051921|11366301|FG000|STARTED|Overall Study||67
10235882|NCT01051921|11366301|FG000|COMPLETED|Overall Study||37
10235883|NCT01051921|11366301|FG000|NOT COMPLETED|Overall Study||30
10235884|NCT01048125|11366307|FG000|STARTED|Overall Study||0
10235885|NCT01048125|11366308|FG001|STARTED|Overall Study||0
10235886|NCT01048125|11366307|FG000|COMPLETED|Overall Study||0
10235887|NCT01048125|11366308|FG001|COMPLETED|Overall Study||0
10235888|NCT01048125|11366307|FG000|NOT COMPLETED|Overall Study||0
10235889|NCT01048125|11366308|FG001|NOT COMPLETED|Overall Study||0
10235890|NCT01056315|11366316|FG000|STARTED|Overall Study||27
10235891|NCT01056315|11366317|FG001|STARTED|Overall Study||23
10235892|NCT01056315|11366316|FG000|COMPLETED|Overall Study||13
10235893|NCT01056315|11366317|FG001|COMPLETED|Overall Study||12
10235894|NCT01056315|11366316|FG000|NOT COMPLETED|Overall Study||14
10235895|NCT01056315|11366317|FG001|NOT COMPLETED|Overall Study||11
10235896|NCT01058369|11366323|FG000|STARTED|Overall Study||2
10235897|NCT01058369|11366323|FG000|COMPLETED|Overall Study||0
10235898|NCT01058369|11366323|FG000|NOT COMPLETED|Overall Study||2
10235899|NCT01048723|11366327|FG000|STARTED|Overall Study||2
10235900|NCT01048723|11366327|FG000|COMPLETED|Overall Study||2
10235901|NCT01048723|11366327|FG000|NOT COMPLETED|Overall Study||0
10235902|NCT01053221|11366333|FG000|STARTED|Overall Study||5
10235903|NCT01053221|11366334|FG001|STARTED|Overall Study||9
10235904|NCT01053221|11366333|FG000|COMPLETED|Overall Study||0
10235905|NCT01053221|11366334|FG001|COMPLETED|Overall Study||0
10235906|NCT01053221|11366333|FG000|NOT COMPLETED|Overall Study||5
10235907|NCT01053221|11366334|FG001|NOT COMPLETED|Overall Study||9
10235908|NCT01038752|11366342|FG000|STARTED|Overall Study||8
10235909|NCT01038752|11366343|FG001|STARTED|Overall Study||6
10235910|NCT01038752|11366342|FG000|COMPLETED|Overall Study||3
10235911|NCT01038752|11366343|FG001|COMPLETED|Overall Study||1
10235912|NCT01038752|11366342|FG000|NOT COMPLETED|Overall Study||5
10235913|NCT01038752|11366343|FG001|NOT COMPLETED|Overall Study||5
10235914|NCT01050218|11366349|FG000|STARTED|Overall Study||237
10235915|NCT01050218|11366349|FG000|COMPLETED|Overall Study||142
10235916|NCT01050218|11366349|FG000|NOT COMPLETED|Overall Study||95
10235917|NCT01045694|11366353|FG000|STARTED|Overall Study||8
10235918|NCT01045694|11366353|FG000|COMPLETED|Overall Study||6
10235919|NCT01045694|11366353|FG000|NOT COMPLETED|Overall Study||2
10235920|NCT01035944|11366361|FG000|STARTED|Overall Study||14
10235921|NCT01035944|11366362|FG001|STARTED|Overall Study||14
10235922|NCT01035944|11366363|FG002|STARTED|Overall Study||5
10235923|NCT01035944|11366364|FG003|STARTED|Overall Study||4
9814648|NCT00685399|10924835|FG002|COMPLETED|Extension||0
9814649|NCT00685399|10924836|FG003|COMPLETED|Extension||21
10016596|NCT01811303|11139415|FG000|COMPLETED|First Intervention (1 Day)||4
10235924|NCT01035944|11366361|FG000|COMPLETED|Overall Study||11
10235925|NCT01035944|11366362|FG001|COMPLETED|Overall Study||13
10235926|NCT01035944|11366363|FG002|COMPLETED|Overall Study||4
10235927|NCT01035944|11366364|FG003|COMPLETED|Overall Study||4
9814650|NCT00685399|10924837|FG004|COMPLETED|Extension||0
9814651|NCT00685399|10924838|FG005|COMPLETED|Extension||0
9814652|NCT00685399|10924839|FG006|COMPLETED|Extension||0
9814653|NCT00685399|10924840|FG007|COMPLETED|Extension||0
9814654|NCT00685399|10924833|FG000|NOT COMPLETED|Extension||0
9814655|NCT00685399|10924834|FG001|NOT COMPLETED|Extension||0
9814656|NCT00685399|10924835|FG002|NOT COMPLETED|Extension||0
9814657|NCT00685399|10924836|FG003|NOT COMPLETED|Extension||7
9814658|NCT00685399|10924837|FG004|NOT COMPLETED|Extension||0
10016597|NCT01811303|11139416|FG001|COMPLETED|First Intervention (1 Day)||4
10016598|NCT01811303|11139417|FG002|COMPLETED|First Intervention (1 Day)||4
10235928|NCT01035944|11366361|FG000|NOT COMPLETED|Overall Study||3
10235929|NCT01035944|11366362|FG001|NOT COMPLETED|Overall Study||1
10235930|NCT01035944|11366363|FG002|NOT COMPLETED|Overall Study||1
10235931|NCT01035944|11366364|FG003|NOT COMPLETED|Overall Study||0
9814659|NCT00685399|10924838|FG005|NOT COMPLETED|Extension||0
9814660|NCT00685399|10924839|FG006|NOT COMPLETED|Extension||0
9814661|NCT00685399|10924840|FG007|NOT COMPLETED|Extension||0
9814662|NCT00685477|10924867|FG000|STARTED|Overall Study||10
9814663|NCT00685477|10924868|FG001|STARTED|Overall Study||10
9814664|NCT00685477|10924869|FG002|STARTED|Overall Study||10
9814665|NCT00685477|10924870|FG003|STARTED|Overall Study||10
9814666|NCT00685477|10924871|FG004|STARTED|Overall Study||10
9814667|NCT00685477|10924872|FG005|STARTED|Overall Study||10
9814668|NCT00685477|10924867|FG000|COMPLETED|Overall Study||10
9814669|NCT00685477|10924868|FG001|COMPLETED|Overall Study||10
9814670|NCT00685477|10924869|FG002|COMPLETED|Overall Study||10
9814671|NCT00685477|10924870|FG003|COMPLETED|Overall Study||10
10235932|NCT01031628|11366378|FG000|STARTED|Overall Study||0
10235933|NCT01031628|11366379|FG001|STARTED|Overall Study||1
10235934|NCT01031628|11366380|FG002|STARTED|Overall Study||3
10235935|NCT01031628|11366381|FG003|STARTED|Overall Study||0
10235936|NCT01031628|11366378|FG000|COMPLETED|Overall Study||0
10235937|NCT01031628|11366379|FG001|COMPLETED|Overall Study||0
10235938|NCT01031628|11366380|FG002|COMPLETED|Overall Study||0
10235939|NCT01031628|11366381|FG003|COMPLETED|Overall Study||0
10235940|NCT01031628|11366378|FG000|NOT COMPLETED|Overall Study||0
10235941|NCT01031628|11366379|FG001|NOT COMPLETED|Overall Study||1
10235942|NCT01031628|11366380|FG002|NOT COMPLETED|Overall Study||3
10235943|NCT01031628|11366381|FG003|NOT COMPLETED|Overall Study||0
10235944|NCT01030757|11366391|FG000|STARTED|Overall Study||2
10235945|NCT01030757|11366391|FG000|COMPLETED|Overall Study||2
10235946|NCT01030757|11366391|FG000|NOT COMPLETED|Overall Study||0
10235947|NCT01035073|11366395|FG000|STARTED|Overall Study||0
10235948|NCT01035073|11366395|FG000|COMPLETED|Overall Study||0
10235949|NCT01035073|11366395|FG000|NOT COMPLETED|Overall Study||0
10235950|NCT01031550|11366401|FG000|STARTED|Overall Study||5
10235951|NCT01031550|11366402|FG001|STARTED|Overall Study||3
10235952|NCT01031550|11366401|FG000|COMPLETED|Overall Study||5
10235953|NCT01031550|11366402|FG001|COMPLETED|Overall Study||3
10235954|NCT01031550|11366401|FG000|NOT COMPLETED|Overall Study||0
10235955|NCT01031550|11366402|FG001|NOT COMPLETED|Overall Study||0
10235956|NCT01030198|11366412|FG000|STARTED|Overall Study|None recruited|0
10235957|NCT01030198|11366413|FG001|STARTED|Overall Study||7
10235958|NCT01030198|11366412|FG000|COMPLETED|Overall Study|None recruited|0
10235959|NCT01030198|11366413|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
10235960|NCT01030198|11366412|FG000|NOT COMPLETED|Overall Study||0
10235961|NCT01030198|11366413|FG001|NOT COMPLETED|Overall Study||7
10235962|NCT01028300|11366419|FG000|STARTED|Overall Study||4
10235963|NCT01028300|11366419|FG000|COMPLETED|Overall Study||0
10235964|NCT01028300|11366419|FG000|NOT COMPLETED|Overall Study||4
10235965|NCT01025271|11366423|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
10235966|NCT01025271|11366423|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
10235967|NCT01025271|11366423|FG000|NOT COMPLETED|Overall Study||0
10235968|NCT01022398|11366430|FG000|STARTED|Overall Study||2
10235969|NCT01022398|11366431|FG001|STARTED|Overall Study||2
10235970|NCT01022398|11366430|FG000|COMPLETED|Overall Study||0
10235971|NCT01022398|11366431|FG001|COMPLETED|Overall Study||0
10235972|NCT01022398|11366430|FG000|NOT COMPLETED|Overall Study||2
10235973|NCT01022398|11366431|FG001|NOT COMPLETED|Overall Study||2
10235974|NCT01019980|11366438|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
10016599|NCT01811303|11139418|FG003|COMPLETED|First Intervention (1 Day)||2
10016600|NCT01811303|11139415|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10016601|NCT01811303|11139416|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10235975|NCT01019980|11366439|FG001|STARTED|Overall Study||0
10235976|NCT01019980|11366438|FG000|Discontinued|Overall Study||2
10235977|NCT01019980|11366439|FG001|Discontinued|Overall Study||0
10235978|NCT01019980|11366438|FG000|COMPLETED|Overall Study||0
10235979|NCT01019980|11366439|FG001|COMPLETED|Overall Study||0
10235980|NCT01019980|11366438|FG000|NOT COMPLETED|Overall Study||2
10235981|NCT01019980|11366439|FG001|NOT COMPLETED|Overall Study||0
10235982|NCT01025492|11366445|FG000|STARTED|Overall Study||24
10235983|NCT01025492|11366445|FG000|COMPLETED|Overall Study||24
10235984|NCT01025492|11366445|FG000|NOT COMPLETED|Overall Study||0
10235985|NCT01017263|11366449|FG000|STARTED|Overall Study||14
9814672|NCT00685477|10924871|FG004|COMPLETED|Overall Study||10
9814673|NCT00685477|10924872|FG005|COMPLETED|Overall Study||10
9814674|NCT00685477|10924867|FG000|NOT COMPLETED|Overall Study||0
9814675|NCT00685477|10924868|FG001|NOT COMPLETED|Overall Study||0
9814676|NCT00685477|10924869|FG002|NOT COMPLETED|Overall Study||0
9814677|NCT00685477|10924870|FG003|NOT COMPLETED|Overall Study||0
9814678|NCT00685477|10924871|FG004|NOT COMPLETED|Overall Study||0
9814679|NCT00685477|10924872|FG005|NOT COMPLETED|Overall Study||0
9814680|NCT00685516|10924884|FG000|STARTED|Overall Study||42
9814681|NCT00685516|10924885|FG001|STARTED|Overall Study||38
9814682|NCT00685516|10924886|FG002|STARTED|Overall Study||33
9814683|NCT00685516|10924884|FG000|COMPLETED|Overall Study||34
9814684|NCT00685516|10924885|FG001|COMPLETED|Overall Study||33
9814685|NCT00685516|10924886|FG002|COMPLETED|Overall Study||26
9814686|NCT00685516|10924884|FG000|NOT COMPLETED|Overall Study||8
10016602|NCT01811303|11139417|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10016603|NCT01811303|11139418|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10235986|NCT01017263|11366449|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
10235987|NCT01017263|11366449|FG000|NOT COMPLETED|Overall Study||12
10235988|NCT01020903|11366455|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
10235989|NCT01020903|11366456|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
9814687|NCT00685516|10924885|FG001|NOT COMPLETED|Overall Study||5
9814688|NCT00685516|10924886|FG002|NOT COMPLETED|Overall Study||7
9814689|NCT00685659|10924900|FG000|STARTED|Overall Study||108
9814690|NCT00685659|10924901|FG001|STARTED|Overall Study||106
9814691|NCT00685659|10924902|FG002|STARTED|Overall Study||107
9814692|NCT00685659|10924900|FG000|COMPLETED|Overall Study||77
9814693|NCT00685659|10924901|FG001|COMPLETED|Overall Study||81
9814694|NCT00685659|10924902|FG002|COMPLETED|Overall Study||92
9814695|NCT00685659|10924900|FG000|NOT COMPLETED|Overall Study||31
9814696|NCT00685659|10924901|FG001|NOT COMPLETED|Overall Study||25
9814697|NCT00685659|10924902|FG002|NOT COMPLETED|Overall Study||15
9814698|NCT00685685|10924910|FG000|STARTED|First Intervention||27
9814699|NCT00685685|10924911|FG001|STARTED|First Intervention||27
9814700|NCT00685685|10924910|FG000|COMPLETED|First Intervention||27
9814701|NCT00685685|10924911|FG001|COMPLETED|First Intervention||27
9814702|NCT00685685|10924910|FG000|NOT COMPLETED|First Intervention||0
9814703|NCT00685685|10924911|FG001|NOT COMPLETED|First Intervention||0
9814704|NCT00685685|10924910|FG000|STARTED|Washout Period of 7 Days||27
9814705|NCT00685685|10924911|FG001|STARTED|Washout Period of 7 Days||27
9814706|NCT00685685|10924910|FG000|COMPLETED|Washout Period of 7 Days||25
9814707|NCT00685685|10924911|FG001|COMPLETED|Washout Period of 7 Days||26
10235990|NCT01020903|11366455|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
10235991|NCT01020903|11366456|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
10235992|NCT01020903|11366455|FG000|NOT COMPLETED|Overall Study||0
10235993|NCT01020903|11366456|FG001|NOT COMPLETED|Overall Study||0
9814708|NCT00685685|10924910|FG000|NOT COMPLETED|Washout Period of 7 Days||2
9814709|NCT00685685|10924911|FG001|NOT COMPLETED|Washout Period of 7 Days||1
9814710|NCT00685685|10924910|FG000|STARTED|Second Intervention||25
9814711|NCT00685685|10924911|FG001|STARTED|Second Intervention||26
9814712|NCT00685685|10924910|FG000|COMPLETED|Second Intervention||25
9814713|NCT00685685|10924911|FG001|COMPLETED|Second Intervention||26
10235994|NCT01023620|11366464|FG000|STARTED|Overall Study||0
10235995|NCT01023620|11366465|FG001|STARTED|Overall Study||0
10235996|NCT01023620|11366464|FG000|COMPLETED|Overall Study||0
10235997|NCT01023620|11366465|FG001|COMPLETED|Overall Study||0
10235998|NCT01023620|11366464|FG000|NOT COMPLETED|Overall Study||0
10235999|NCT01023620|11366465|FG001|NOT COMPLETED|Overall Study||0
10236000|NCT01018810|11366476|FG000|STARTED|Overall Study||4
10236001|NCT01018810|11366477|FG001|STARTED|Overall Study||1
10236002|NCT01018810|11366478|FG002|STARTED|Overall Study||1
10236003|NCT01018810|11366479|FG003|STARTED|Overall Study||1
10236004|NCT01018810|11366480|FG004|STARTED|Overall Study||1
10236005|NCT01018810|11366476|FG000|COMPLETED|Overall Study||2
10236006|NCT01018810|11366477|FG001|COMPLETED|Overall Study||0
10236007|NCT01018810|11366478|FG002|COMPLETED|Overall Study||0
10236008|NCT01018810|11366479|FG003|COMPLETED|Overall Study||0
10236009|NCT01018810|11366480|FG004|COMPLETED|Overall Study||0
10236010|NCT01018810|11366476|FG000|NOT COMPLETED|Overall Study||2
10236011|NCT01018810|11366477|FG001|NOT COMPLETED|Overall Study||1
10236012|NCT01018810|11366478|FG002|NOT COMPLETED|Overall Study||1
10236013|NCT01018810|11366479|FG003|NOT COMPLETED|Overall Study||1
10236014|NCT01018810|11366480|FG004|NOT COMPLETED|Overall Study||1
10236015|NCT01016561|11366492|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
10236016|NCT01016561|11366492|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
9814714|NCT00685685|10924910|FG000|NOT COMPLETED|Second Intervention||0
9814715|NCT00685685|10924911|FG001|NOT COMPLETED|Second Intervention||0
9814716|NCT00685698|10924917|FG000|STARTED|Overall Study||38
9814717|NCT00685698|10924917|FG000|COMPLETED|Overall Study||25
9814718|NCT00685698|10924917|FG000|NOT COMPLETED|Overall Study||13
10016604|NCT01811303|11139415|FG000|STARTED|Washout (2 Days or More)||4
10016605|NCT01811303|11139416|FG001|STARTED|Washout (2 Days or More)||4
10016606|NCT01811303|11139417|FG002|STARTED|Washout (2 Days or More)||4
9814719|NCT00685750|10924940|FG000|STARTED|Overall Study||17
9814720|NCT00685750|10924941|FG001|STARTED|Overall Study||3
9814721|NCT00685750|10924942|FG002|STARTED|Overall Study||21
9814722|NCT00685750|10924943|FG003|STARTED|Overall Study||2
9814723|NCT00685750|10924944|FG004|STARTED|Overall Study||15
9814724|NCT00685750|10924945|FG005|STARTED|Overall Study||20
9814725|NCT00685750|10924946|FG006|STARTED|Overall Study||10
9814726|NCT00685750|10924940|FG000|COMPLETED|Overall Study||17
9814727|NCT00685750|10924941|FG001|COMPLETED|Overall Study||3
9814728|NCT00685750|10924942|FG002|COMPLETED|Overall Study||19
9814729|NCT00685750|10924943|FG003|COMPLETED|Overall Study||2
9814730|NCT00685750|10924944|FG004|COMPLETED|Overall Study||15
9814731|NCT00685750|10924945|FG005|COMPLETED|Overall Study||20
9814732|NCT00685750|10924946|FG006|COMPLETED|Overall Study||9
9814733|NCT00685750|10924940|FG000|NOT COMPLETED|Overall Study||0
9814734|NCT00685750|10924941|FG001|NOT COMPLETED|Overall Study||0
9814735|NCT00685750|10924942|FG002|NOT COMPLETED|Overall Study||2
9814736|NCT00685750|10924943|FG003|NOT COMPLETED|Overall Study||0
9814737|NCT00685750|10924944|FG004|NOT COMPLETED|Overall Study||0
9814738|NCT00685750|10924945|FG005|NOT COMPLETED|Overall Study||0
9814739|NCT00685750|10924946|FG006|NOT COMPLETED|Overall Study||1
9814740|NCT00685763|10924966|FG000|STARTED|Overall Study||13
10236017|NCT01016561|11366492|FG000|NOT COMPLETED|Overall Study||0
10236018|NCT01016847|11366498|FG000|STARTED|Overall Study||1
10236019|NCT01016847|11366499|FG001|STARTED|Overall Study||2
10236020|NCT01016847|11366498|FG000|COMPLETED|Overall Study||1
10236021|NCT01016847|11366499|FG001|COMPLETED|Overall Study||2
10236022|NCT01016847|11366498|FG000|NOT COMPLETED|Overall Study||0
10236023|NCT01016847|11366499|FG001|NOT COMPLETED|Overall Study||0
10236024|NCT01014767|11366509|FG000|STARTED|Overall Study||12
10236025|NCT01014767|11366510|FG001|STARTED|Overall Study||1
10236026|NCT01014767|11366511|FG002|STARTED|Overall Study||4
10236027|NCT01014767|11366512|FG003|STARTED|Overall Study||1
10236028|NCT01014767|11366509|FG000|COMPLETED|Overall Study||0
10236029|NCT01014767|11366510|FG001|COMPLETED|Overall Study||0
10236030|NCT01014767|11366511|FG002|COMPLETED|Overall Study||0
10236031|NCT01014767|11366512|FG003|COMPLETED|Overall Study||0
10236032|NCT01014767|11366509|FG000|NOT COMPLETED|Overall Study||12
10236033|NCT01014767|11366510|FG001|NOT COMPLETED|Overall Study||1
10236034|NCT01014767|11366511|FG002|NOT COMPLETED|Overall Study||4
10236035|NCT01014767|11366512|FG003|NOT COMPLETED|Overall Study||1
10236036|NCT01013701|11366522|FG000|STARTED|Overall Study||7
10236037|NCT01013701|11366522|FG000|COMPLETED|Overall Study||0
10236038|NCT01013701|11366522|FG000|NOT COMPLETED|Overall Study||7
10236039|NCT01012414|11366527|FG000|STARTED|Overall Study||10
10236040|NCT01012414|11366527|FG000|COMPLETED|Overall Study|No subjects completed the study.|0
10236041|NCT01012414|11366527|FG000|NOT COMPLETED|Overall Study||10
10236042|NCT01011634|11366535|FG000|STARTED|Overall Study||9
10236043|NCT01011634|11366536|FG001|STARTED|Overall Study||9
10236044|NCT01011634|11366535|FG000|COMPLETED|Overall Study||9
10236045|NCT01011634|11366536|FG001|COMPLETED|Overall Study||8
10236046|NCT01011634|11366535|FG000|NOT COMPLETED|Overall Study||0
10236047|NCT01011634|11366536|FG001|NOT COMPLETED|Overall Study||1
10236048|NCT01009931|11366542|FG000|STARTED|Overall Study||1
10236049|NCT01009931|11366542|FG000|COMPLETED|Overall Study||0
10236050|NCT01009931|11366542|FG000|NOT COMPLETED|Overall Study||1
10236051|NCT01001390|11366546|FG000|STARTED|Overall Study||2
10236052|NCT01001390|11366547|FG001|STARTED|Overall Study||0
10236053|NCT01001390|11366546|FG000|COMPLETED|Overall Study||0
10236054|NCT01001390|11366547|FG001|COMPLETED|Overall Study||0
10236055|NCT01001390|11366546|FG000|NOT COMPLETED|Overall Study||2
10236056|NCT01001390|11366547|FG001|NOT COMPLETED|Overall Study||0
10236057|NCT01006018|11366555|FG000|STARTED|Overall Study||0
10236058|NCT01006018|11366556|FG001|STARTED|Overall Study||0
10236059|NCT01006018|11366557|FG002|STARTED|Overall Study||0
10236060|NCT01006018|11366555|FG000|COMPLETED|Overall Study||0
10236061|NCT01006018|11366556|FG001|COMPLETED|Overall Study||0
10236062|NCT01006018|11366557|FG002|COMPLETED|Overall Study||0
10236063|NCT01006018|11366555|FG000|NOT COMPLETED|Overall Study||0
10236064|NCT01006018|11366556|FG001|NOT COMPLETED|Overall Study||0
10236065|NCT01006018|11366557|FG002|NOT COMPLETED|Overall Study||0
10236066|NCT01004510|11366565|FG000|STARTED|Overall Study||3
10236067|NCT01004510|11366565|FG000|COMPLETED|Overall Study||2
10236068|NCT01004510|11366565|FG000|NOT COMPLETED|Overall Study||1
10236069|NCT01005914|11366569|FG000|STARTED|Overall Study||11
10236070|NCT01005914|11366569|FG000|COMPLETED|Overall Study||1
10236071|NCT01005914|11366569|FG000|NOT COMPLETED|Overall Study||10
10236072|NCT00996333|11366573|FG000|STARTED|Overall Study||46
10236073|NCT00996333|11366573|FG000|COMPLETED|Overall Study||33
10236074|NCT00996333|11366573|FG000|NOT COMPLETED|Overall Study||13
10236075|NCT00998738|11366577|FG000|STARTED|Overall Study||1
10236076|NCT00998738|11366577|FG000|COMPLETED|Overall Study||0
10236077|NCT00998738|11366577|FG000|NOT COMPLETED|Overall Study||1
9814741|NCT00685763|10924966|FG000|COMPLETED|Overall Study||11
9814742|NCT00685763|10924966|FG000|NOT COMPLETED|Overall Study||2
9814743|NCT00685802|10924970|FG000|STARTED|First Intervention||16
9814744|NCT00685802|10924971|FG001|STARTED|First Intervention||16
9814745|NCT00685802|10924970|FG000|COMPLETED|First Intervention||16
10236078|NCT00996502|11366581|FG000|STARTED|Overall Study||4
10236079|NCT00996502|11366581|FG000|COMPLETED|Overall Study||4
10236080|NCT00996502|11366581|FG000|NOT COMPLETED|Overall Study||0
10236081|NCT00997386|11366585|FG000|STARTED|Overall Study||16
10236082|NCT00997386|11366585|FG000|COMPLETED|Overall Study||9
9814746|NCT00685802|10924971|FG001|COMPLETED|First Intervention||16
10236083|NCT00997386|11366585|FG000|NOT COMPLETED|Overall Study||7
9814747|NCT00685802|10924970|FG000|NOT COMPLETED|First Intervention||0
10236084|NCT00985738|11366591|FG000|STARTED|Overall Study||8
9814748|NCT00685802|10924971|FG001|NOT COMPLETED|First Intervention||0
10236085|NCT00985738|11366592|FG001|STARTED|Overall Study||8
9814749|NCT00685802|10924970|FG000|STARTED|Washout Period of 7 Days||16
9814750|NCT00685802|10924971|FG001|STARTED|Washout Period of 7 Days||16
9814751|NCT00685802|10924970|FG000|COMPLETED|Washout Period of 7 Days||14
9814752|NCT00685802|10924971|FG001|COMPLETED|Washout Period of 7 Days||15
9814753|NCT00685802|10924970|FG000|NOT COMPLETED|Washout Period of 7 Days||2
9814754|NCT00685802|10924971|FG001|NOT COMPLETED|Washout Period of 7 Days||1
9814755|NCT00685802|10924970|FG000|STARTED|Second Intervention||14
9814756|NCT00685802|10924971|FG001|STARTED|Second Intervention||15
9814757|NCT00685802|10924970|FG000|COMPLETED|Second Intervention||14
9814758|NCT00685802|10924971|FG001|COMPLETED|Second Intervention||15
9814759|NCT00685802|10924970|FG000|NOT COMPLETED|Second Intervention||0
9814760|NCT00685802|10924971|FG001|NOT COMPLETED|Second Intervention||0
9814761|NCT00685932|10924979|FG000|STARTED|Overall Study||76
9814762|NCT00685932|10924980|FG001|STARTED|Overall Study||78
9814763|NCT00685932|10924979|FG000|COMPLETED|Overall Study||55
9814764|NCT00685932|10924980|FG001|COMPLETED|Overall Study||58
9814765|NCT00685932|10924979|FG000|NOT COMPLETED|Overall Study||21
9814766|NCT00685932|10924980|FG001|NOT COMPLETED|Overall Study||20
9814767|NCT00685945|10924986|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
9814768|NCT00685945|10924986|FG000|COMPLETED|Control (Bradykinin Infusion)||24
9814769|NCT00685945|10924986|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0
9814770|NCT00685945|10924986|FG000|STARTED|L-NMMA + Bradykinin||24
9814771|NCT00685945|10924986|FG000|COMPLETED|L-NMMA + Bradykinin||23
9814772|NCT00685945|10924986|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1
9814773|NCT00685945|10924986|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11
9814774|NCT00685945|10924986|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
9814775|NCT00685945|10924986|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
9814776|NCT00685945|10924986|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12
9814777|NCT00685945|10924986|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
9814778|NCT00685945|10924986|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
9814779|NCT00686075|10925006|FG000|STARTED|Overall Study||79
9814780|NCT00686075|10925007|FG001|STARTED|Overall Study||81
10236086|NCT00985738|11366591|FG000|COMPLETED|Overall Study||0
10236087|NCT00985738|11366592|FG001|COMPLETED|Overall Study||0
10236088|NCT00985738|11366591|FG000|NOT COMPLETED|Overall Study||8
10236089|NCT00985738|11366592|FG001|NOT COMPLETED|Overall Study||8
10236090|NCT00986999|11366598|FG000|STARTED|Overall Study||7
10236091|NCT00986999|11366598|FG000|COMPLETED|Overall Study||6
10236092|NCT00986999|11366598|FG000|NOT COMPLETED|Overall Study||1
10236093|NCT00989937|11366602|FG000|STARTED|Overall Study||0
10236094|NCT00989937|11366602|FG000|COMPLETED|Overall Study||0
10236095|NCT00989937|11366602|FG000|NOT COMPLETED|Overall Study||0
10236096|NCT00986947|11366606|FG000|STARTED|Overall Study||20
10236097|NCT00986947|11366606|FG000|COMPLETED|Overall Study||0
10236098|NCT00986947|11366606|FG000|NOT COMPLETED|Overall Study||20
10236099|NCT00982995|11366610|FG000|STARTED|Overall Study||3
10236100|NCT00982995|11366610|FG000|COMPLETED|Overall Study||3
10236101|NCT00982995|11366610|FG000|NOT COMPLETED|Overall Study||0
10236102|NCT00984490|11366614|FG000|STARTED|Overall Study||5
10236103|NCT00984490|11366614|FG000|COMPLETED|Overall Study||5
10236104|NCT00984490|11366614|FG000|NOT COMPLETED|Overall Study||0
10236105|NCT00986310|11366621|FG000|STARTED|Overall Study||0
10236106|NCT00986310|11366622|FG001|STARTED|Overall Study||0
10236107|NCT00986310|11366621|FG000|COMPLETED|Overall Study||0
10236108|NCT00986310|11366622|FG001|COMPLETED|Overall Study||0
10236109|NCT00986310|11366621|FG000|NOT COMPLETED|Overall Study||0
10236110|NCT00986310|11366622|FG001|NOT COMPLETED|Overall Study||0
10236111|NCT00978874|11366628|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
10236112|NCT00978874|11366628|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
10236113|NCT00978874|11366628|FG000|NOT COMPLETED|Overall Study||0
10236114|NCT00983645|11366634|FG000|STARTED|Overall Study||8
10236115|NCT00983645|11366635|FG001|STARTED|Overall Study||7
10236116|NCT00983645|11366634|FG000|COMPLETED|Overall Study||8
10236117|NCT00983645|11366635|FG001|COMPLETED|Overall Study||7
10236118|NCT00983645|11366634|FG000|NOT COMPLETED|Overall Study||0
10236119|NCT00983645|11366635|FG001|NOT COMPLETED|Overall Study||0
10239727|NCT00002975|11371419|FG000|NOT COMPLETED|Overall Study||5
10239728|NCT00006478|11371423|FG000|STARTED|Overall Study||19
10239729|NCT00006478|11371423|FG000|COMPLETED|Overall Study||12
10239730|NCT00006478|11371423|FG000|NOT COMPLETED|Overall Study||7
10239731|NCT00019747|11371429|FG000|STARTED|Overall Study||23
10239732|NCT00019747|11371430|FG001|STARTED|Overall Study||16
10239733|NCT00019747|11371429|FG000|COMPLETED|Overall Study||23
10239734|NCT00019747|11371430|FG001|COMPLETED|Overall Study||16
10239735|NCT00019747|11371429|FG000|NOT COMPLETED|Overall Study||0
10239736|NCT00019747|11371430|FG001|NOT COMPLETED|Overall Study||0
10239737|NCT00006916|11371436|FG000|STARTED|Overall Study||19
10239738|NCT00006916|11371436|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
10239739|NCT00006916|11371436|FG000|NOT COMPLETED|Overall Study||5
10239740|NCT00003726|11371440|FG000|STARTED|Overall Study||1
9814781|NCT00686075|10925008|FG002|STARTED|Overall Study||80
9814782|NCT00686075|10925009|FG003|STARTED|Overall Study||80
9814783|NCT00686075|10925010|FG004|STARTED|Overall Study||40
9814784|NCT00686075|10925011|FG005|STARTED|Overall Study||40
10239741|NCT00003726|11371440|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
9814785|NCT00686075|10925012|FG006|STARTED|Overall Study||82
9814786|NCT00686075|10925013|FG007|STARTED|Overall Study||78
9814787|NCT00686075|10925014|FG008|STARTED|Overall Study||81
9814788|NCT00686075|10925015|FG009|STARTED|Overall Study||79
9814789|NCT00686075|10925006|FG000|Treated|Overall Study||78
9814790|NCT00686075|10925007|FG001|Treated|Overall Study||79
9814791|NCT00686075|10925008|FG002|Treated|Overall Study||80
9814792|NCT00686075|10925009|FG003|Treated|Overall Study||80
9814793|NCT00686075|10925010|FG004|Treated|Overall Study||40
9814794|NCT00686075|10925011|FG005|Treated|Overall Study||40
9814795|NCT00686075|10925012|FG006|Treated|Overall Study||82
9814796|NCT00686075|10925013|FG007|Treated|Overall Study||77
9814797|NCT00686075|10925014|FG008|Treated|Overall Study||80
9814798|NCT00686075|10925015|FG009|Treated|Overall Study||78
9814799|NCT00686075|10925006|FG000|COMPLETED|Overall Study||71
9814800|NCT00686075|10925007|FG001|COMPLETED|Overall Study||71
9814801|NCT00686075|10925008|FG002|COMPLETED|Overall Study||74
9814802|NCT00686075|10925009|FG003|COMPLETED|Overall Study||71
9814803|NCT00686075|10925010|FG004|COMPLETED|Overall Study||36
9814804|NCT00686075|10925011|FG005|COMPLETED|Overall Study||37
9814805|NCT00686075|10925012|FG006|COMPLETED|Overall Study||82
9814806|NCT00686075|10925013|FG007|COMPLETED|Overall Study||76
9814807|NCT00686075|10925014|FG008|COMPLETED|Overall Study||75
9814808|NCT00686075|10925015|FG009|COMPLETED|Overall Study||69
9814809|NCT00686075|10925006|FG000|NOT COMPLETED|Overall Study||8
9814810|NCT00686075|10925007|FG001|NOT COMPLETED|Overall Study||10
9814811|NCT00686075|10925008|FG002|NOT COMPLETED|Overall Study||6
9814812|NCT00686075|10925009|FG003|NOT COMPLETED|Overall Study||9
9814813|NCT00686075|10925010|FG004|NOT COMPLETED|Overall Study||4
9814814|NCT00686075|10925011|FG005|NOT COMPLETED|Overall Study||3
9814815|NCT00686075|10925012|FG006|NOT COMPLETED|Overall Study||0
10236120|NCT00979147|11366643|FG000|STARTED|Overall Study||0
10236121|NCT00979147|11366644|FG001|STARTED|Overall Study||0
10236122|NCT00979147|11366643|FG000|COMPLETED|Overall Study||0
10236123|NCT00979147|11366644|FG001|COMPLETED|Overall Study||0
10236124|NCT00979147|11366643|FG000|NOT COMPLETED|Overall Study||0
10236125|NCT00979147|11366644|FG001|NOT COMPLETED|Overall Study||0
10236126|NCT00967447|11366650|FG000|STARTED|Overall Study|there are no collected data in CRF|2
10236127|NCT00967447|11366650|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2
10236128|NCT00967447|11366650|FG000|NOT COMPLETED|Overall Study||0
10236129|NCT00970606|11366656|FG000|STARTED|Overall Study||4
10236130|NCT00970606|11366657|FG001|STARTED|Overall Study||3
10236131|NCT00970606|11366656|FG000|COMPLETED|Overall Study||4
10236132|NCT00970606|11366657|FG001|COMPLETED|Overall Study||3
10236133|NCT00970606|11366656|FG000|NOT COMPLETED|Overall Study||0
10236134|NCT00970606|11366657|FG001|NOT COMPLETED|Overall Study||0
10236135|NCT00979550|11366665|FG000|STARTED|Overall Study||4
10236136|NCT00979550|11366666|FG001|STARTED|Overall Study||3
10236137|NCT00979550|11366665|FG000|COMPLETED|Overall Study||4
10236138|NCT00979550|11366666|FG001|COMPLETED|Overall Study||3
10236139|NCT00979550|11366665|FG000|NOT COMPLETED|Overall Study||0
10236140|NCT00979550|11366666|FG001|NOT COMPLETED|Overall Study||0
10236141|NCT00966992|11366674|FG000|STARTED|Overall Study||3
10236142|NCT00966992|11366675|FG001|STARTED|Overall Study||0
10236143|NCT00966992|11366674|FG000|COMPLETED|Overall Study||3
10236144|NCT00966992|11366675|FG001|COMPLETED|Overall Study||0
10236145|NCT00966992|11366674|FG000|NOT COMPLETED|Overall Study||0
10236146|NCT00966992|11366675|FG001|NOT COMPLETED|Overall Study||0
10236147|NCT00981370|11366681|FG000|STARTED|Overall Study||0
10236148|NCT00981370|11366681|FG000|COMPLETED|Overall Study||0
10236149|NCT00981370|11366681|FG000|NOT COMPLETED|Overall Study||0
10236150|NCT00975611|11366685|FG000|STARTED|Overall Study||22
10236151|NCT00975611|11366685|FG000|COMPLETED|Overall Study||5
10236152|NCT00975611|11366685|FG000|NOT COMPLETED|Overall Study||17
10236153|NCT00978419|11366691|FG000|STARTED|Overall Study||0
10236154|NCT00978419|11366692|FG001|STARTED|Overall Study||0
10236155|NCT00978419|11366691|FG000|COMPLETED|Overall Study||0
10236156|NCT00978419|11366692|FG001|COMPLETED|Overall Study||0
10236157|NCT00978419|11366691|FG000|NOT COMPLETED|Overall Study||0
10236158|NCT00978419|11366692|FG001|NOT COMPLETED|Overall Study||0
10236159|NCT00973856|11366700|FG000|STARTED|Overall Study||3
10236160|NCT00973856|11366701|FG001|STARTED|Overall Study||2
10236161|NCT00973856|11366700|FG000|COMPLETED|Overall Study||3
10236162|NCT00973856|11366701|FG001|COMPLETED|Overall Study||2
10236163|NCT00973856|11366700|FG000|NOT COMPLETED|Overall Study||0
10236164|NCT00973856|11366701|FG001|NOT COMPLETED|Overall Study||0
10236165|NCT00979810|11366706|FG000|STARTED|Overall Study||11
10236166|NCT00979810|11366706|FG000|COMPLETED|Overall Study||11
9814816|NCT00686075|10925013|FG007|NOT COMPLETED|Overall Study||2
9814817|NCT00686075|10925014|FG008|NOT COMPLETED|Overall Study||6
9814818|NCT00686075|10925015|FG009|NOT COMPLETED|Overall Study||10
10236167|NCT00979810|11366706|FG000|NOT COMPLETED|Overall Study||0
10236168|NCT00974922|11366710|FG000|STARTED|Overall Study||40
10236169|NCT00974922|11366710|FG000|COMPLETED|Overall Study||16
9814819|NCT00686127|10925039|FG000|STARTED|Overall Study||14
9814820|NCT00686127|10925040|FG001|STARTED|Overall Study||7
9814821|NCT00686127|10925039|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
9814822|NCT00686127|10925040|FG001|COMPLETED|Overall Study||1
9814823|NCT00686127|10925039|FG000|NOT COMPLETED|Overall Study||14
9814824|NCT00686127|10925040|FG001|NOT COMPLETED|Overall Study||6
9814825|NCT00686166|10925046|FG000|STARTED|Overall Study||83
10236170|NCT00974922|11366710|FG000|NOT COMPLETED|Overall Study||24
10236171|NCT00976339|11366716|FG000|STARTED|Overall Study||10
9814826|NCT00686166|10925046|FG000|Eligible|Overall Study||78
9814827|NCT00686166|10925046|FG000|Eligible and Began Protocol Therapy|Overall Study||74
9814828|NCT00686166|10925046|FG000|COMPLETED|Overall Study||63
9814829|NCT00686166|10925046|FG000|NOT COMPLETED|Overall Study||20
9814830|NCT00686205|10925057|FG000|STARTED|Overall Study||21606
9814831|NCT00686205|10925058|FG001|STARTED|Overall Study||2505
9814832|NCT00686205|10925057|FG000|COMPLETED|Overall Study||15599
9814833|NCT00686205|10925058|FG001|COMPLETED|Overall Study||1524
9814834|NCT00686205|10925057|FG000|NOT COMPLETED|Overall Study||6007
9814835|NCT00686205|10925058|FG001|NOT COMPLETED|Overall Study||981
9814836|NCT00686231|10925064|FG000|STARTED|Dose Test - Visit 1||12
9814837|NCT00686231|10925065|FG001|STARTED|Dose Test - Visit 1||7
9814838|NCT00686231|10925066|FG002|STARTED|Dose Test - Visit 1||0
9814839|NCT00686231|10925067|FG003|STARTED|Dose Test - Visit 1||0
9814840|NCT00686231|10925064|FG000|COMPLETED|Dose Test - Visit 1||12
9814841|NCT00686231|10925065|FG001|COMPLETED|Dose Test - Visit 1||7
9814842|NCT00686231|10925066|FG002|COMPLETED|Dose Test - Visit 1||0
9814843|NCT00686231|10925067|FG003|COMPLETED|Dose Test - Visit 1||0
9814844|NCT00686231|10925064|FG000|NOT COMPLETED|Dose Test - Visit 1||0
10236172|NCT00976339|11366717|FG001|STARTED|Overall Study||10
10236173|NCT00976339|11366716|FG000|COMPLETED|Overall Study||10
10236174|NCT00976339|11366717|FG001|COMPLETED|Overall Study||10
10236175|NCT00976339|11366716|FG000|NOT COMPLETED|Overall Study||0
10236176|NCT00976339|11366717|FG001|NOT COMPLETED|Overall Study||0
10236177|NCT00965146|11366725|FG000|STARTED|Overall Study||210
10236178|NCT00965146|11366725|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
10236179|NCT00965146|11366725|FG000|NOT COMPLETED|Overall Study||210
10236180|NCT00972023|11366729|FG000|STARTED|Overall Study||1
10236181|NCT00972023|11366729|FG000|COMPLETED|Overall Study||0
10236182|NCT00972023|11366729|FG000|NOT COMPLETED|Overall Study||1
10236183|NCT00970736|11366735|FG000|STARTED|Overall Study||20
10236184|NCT00970736|11366735|FG000|COMPLETED|Overall Study||18
10236185|NCT00970736|11366735|FG000|NOT COMPLETED|Overall Study||2
10236186|NCT00957827|11366741|FG000|STARTED|Overall Study||2
10236187|NCT00957827|11366742|FG001|STARTED|Overall Study||2
10236188|NCT00957827|11366741|FG000|COMPLETED|Overall Study||2
10236189|NCT00957827|11366742|FG001|COMPLETED|Overall Study||2
10236190|NCT00957827|11366741|FG000|NOT COMPLETED|Overall Study||0
10236191|NCT00957827|11366742|FG001|NOT COMPLETED|Overall Study||0
10236192|NCT00953329|11366748|FG000|STARTED|Overall Study||1
10236193|NCT00953329|11366748|FG000|COMPLETED|Overall Study||0
10236194|NCT00953329|11366748|FG000|NOT COMPLETED|Overall Study||1
10236195|NCT00965055|11366752|FG000|STARTED|Overall Study||2
10236196|NCT00965055|11366752|FG000|COMPLETED|Overall Study||2
10236197|NCT00965055|11366752|FG000|NOT COMPLETED|Overall Study||0
10236198|NCT00962429|11366758|FG000|STARTED|Overall Study||0
10236199|NCT00962429|11366759|FG001|STARTED|Overall Study||0
10236200|NCT00962429|11366758|FG000|COMPLETED|Overall Study||0
10236201|NCT00962429|11366759|FG001|COMPLETED|Overall Study||0
10236202|NCT00962429|11366758|FG000|NOT COMPLETED|Overall Study||0
10236203|NCT00962429|11366759|FG001|NOT COMPLETED|Overall Study||0
10236204|NCT00958893|11366765|FG000|STARTED|Overall Study||4
10236205|NCT00958893|11366765|FG000|COMPLETED|Overall Study||0
10236206|NCT00958893|11366765|FG000|NOT COMPLETED|Overall Study||4
10236207|NCT00966654|11366769|FG000|STARTED|Overall Study||12
10236208|NCT00966654|11366769|FG000|COMPLETED|Overall Study||0
10236209|NCT00966654|11366769|FG000|NOT COMPLETED|Overall Study||12
10236210|NCT00960154|11366777|FG000|STARTED|Overall Study||25
10236211|NCT00960154|11366778|FG001|STARTED|Overall Study||25
10236212|NCT00960154|11366777|FG000|COMPLETED|Overall Study||0
10236213|NCT00960154|11366778|FG001|COMPLETED|Overall Study||0
10236214|NCT00960154|11366777|FG000|NOT COMPLETED|Overall Study||25
10236215|NCT00960154|11366778|FG001|NOT COMPLETED|Overall Study||25
10236216|NCT00960752|11366787|FG000|STARTED|Overall Study||13
10236217|NCT00960752|11366788|FG001|STARTED|Overall Study||13
10236218|NCT00960752|11366789|FG002|STARTED|Overall Study||19
10236219|NCT00960752|11366787|FG000|COMPLETED|Overall Study||13
10236220|NCT00960752|11366788|FG001|COMPLETED|Overall Study||13
10236221|NCT00960752|11366789|FG002|COMPLETED|Overall Study||17
10236222|NCT00960752|11366787|FG000|NOT COMPLETED|Overall Study||0
10236223|NCT00960752|11366788|FG001|NOT COMPLETED|Overall Study||0
10236224|NCT00960752|11366789|FG002|NOT COMPLETED|Overall Study||2
10236225|NCT00958347|11366797|FG000|STARTED|Overall Study||226
10236226|NCT00958347|11366797|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
10236227|NCT00958347|11366797|FG000|NOT COMPLETED|Overall Study||226
10236228|NCT00954187|11366803|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
10236229|NCT00954187|11366804|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
10236230|NCT00954187|11366803|FG000|COMPLETED|Overall Study||0
9814845|NCT00686231|10925065|FG001|NOT COMPLETED|Dose Test - Visit 1||0
9814846|NCT00686231|10925066|FG002|NOT COMPLETED|Dose Test - Visit 1||0
9814847|NCT00686231|10925067|FG003|NOT COMPLETED|Dose Test - Visit 1||0
9814848|NCT00686231|10925064|FG000|STARTED|Combination Test - Visit 2||0
10236231|NCT00954187|11366804|FG001|COMPLETED|Overall Study||0
10236232|NCT00954187|11366803|FG000|NOT COMPLETED|Overall Study||0
10236233|NCT00954187|11366804|FG001|NOT COMPLETED|Overall Study||0
10236234|NCT00953615|11366810|FG000|STARTED|Overall Study||1
10236235|NCT00953615|11366810|FG000|COMPLETED|Overall Study||0
10236236|NCT00953615|11366810|FG000|NOT COMPLETED|Overall Study||1
10236237|NCT00947284|11366814|FG000|STARTED|Overall Study||0
9814849|NCT00686231|10925065|FG001|STARTED|Combination Test - Visit 2||0
9814850|NCT00686231|10925066|FG002|STARTED|Combination Test - Visit 2||10
9814851|NCT00686231|10925067|FG003|STARTED|Combination Test - Visit 2||9
9814852|NCT00686231|10925064|FG000|COMPLETED|Combination Test - Visit 2||0
9814853|NCT00686231|10925065|FG001|COMPLETED|Combination Test - Visit 2||0
9814854|NCT00686231|10925066|FG002|COMPLETED|Combination Test - Visit 2||10
9814855|NCT00686231|10925067|FG003|COMPLETED|Combination Test - Visit 2||9
9814856|NCT00686231|10925064|FG000|NOT COMPLETED|Combination Test - Visit 2||0
9814857|NCT00686231|10925065|FG001|NOT COMPLETED|Combination Test - Visit 2||0
9814858|NCT00686231|10925066|FG002|NOT COMPLETED|Combination Test - Visit 2||0
9814859|NCT00686231|10925067|FG003|NOT COMPLETED|Combination Test - Visit 2||0
9814860|NCT00686257|10925079|FG000|STARTED|Overall Study||29
9814861|NCT00686257|10925080|FG001|STARTED|Overall Study||31
9814862|NCT00686257|10925079|FG000|COMPLETED|Overall Study||29
9814863|NCT00686257|10925080|FG001|COMPLETED|Overall Study||31
9814864|NCT00686257|10925079|FG000|NOT COMPLETED|Overall Study||0
9814865|NCT00686257|10925080|FG001|NOT COMPLETED|Overall Study||0
9814866|NCT00686335|10925088|FG000|STARTED|Run-in Period||12
9814867|NCT00686335|10925088|FG000|COMPLETED|Run-in Period||7
9814868|NCT00686335|10925088|FG000|NOT COMPLETED|Run-in Period||5
9814869|NCT00686335|10925088|FG000|STARTED|Treatment Period||7
9814870|NCT00686335|10925088|FG000|COMPLETED|Treatment Period||7
9814871|NCT00686335|10925088|FG000|NOT COMPLETED|Treatment Period||0
10016607|NCT01811303|11139418|FG003|STARTED|Washout (2 Days or More)||2
10016608|NCT01811303|11139415|FG000|COMPLETED|Washout (2 Days or More)||4
10016609|NCT01811303|11139416|FG001|COMPLETED|Washout (2 Days or More)||4
10016610|NCT01811303|11139417|FG002|COMPLETED|Washout (2 Days or More)||4
10016611|NCT01811303|11139418|FG003|COMPLETED|Washout (2 Days or More)||2
10236238|NCT00947284|11366815|FG001|STARTED|Overall Study||3
10236239|NCT00947284|11366814|FG000|COMPLETED|Overall Study||0
10236240|NCT00947284|11366815|FG001|COMPLETED|Overall Study||0
10236241|NCT00947284|11366814|FG000|NOT COMPLETED|Overall Study||0
10236242|NCT00947284|11366815|FG001|NOT COMPLETED|Overall Study||3
10236243|NCT00957034|11366822|FG000|STARTED|Overall Study||6
10236244|NCT00957034|11366823|FG001|STARTED|Overall Study||4
10236245|NCT00957034|11366824|FG002|STARTED|Overall Study||7
10236246|NCT00957034|11366822|FG000|COMPLETED|Overall Study||0
10236247|NCT00957034|11366823|FG001|COMPLETED|Overall Study||0
10236248|NCT00957034|11366824|FG002|COMPLETED|Overall Study||1
10236249|NCT00957034|11366822|FG000|NOT COMPLETED|Overall Study||6
10236250|NCT00957034|11366823|FG001|NOT COMPLETED|Overall Study||4
10236251|NCT00957034|11366824|FG002|NOT COMPLETED|Overall Study||6
10236252|NCT00949988|11366832|FG000|STARTED|Overall Study||3
10236253|NCT00949988|11366832|FG000|COMPLETED|Overall Study||0
10236254|NCT00949988|11366832|FG000|NOT COMPLETED|Overall Study||3
10236255|NCT00948194|11366838|FG000|STARTED|Overall Study||6
10236256|NCT00948194|11366839|FG001|STARTED|Overall Study||7
10236257|NCT00948194|11366838|FG000|COMPLETED|Overall Study||5
10236258|NCT00948194|11366839|FG001|COMPLETED|Overall Study||7
10236259|NCT00948194|11366838|FG000|NOT COMPLETED|Overall Study||1
10236260|NCT00948194|11366839|FG001|NOT COMPLETED|Overall Study||0
10236261|NCT00946985|11366845|FG000|STARTED|Stabilization Phase (25 Weeks)||162
10236262|NCT00946985|11366845|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2
10236263|NCT00946985|11366845|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
10236264|NCT00946985|11366845|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
10236265|NCT00946985|11366845|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0
10236266|NCT00946985|11366845|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
10236267|NCT00950183|11366849|FG000|STARTED|Overall Study||36
10236268|NCT00950183|11366849|FG000|COMPLETED|Overall Study||0
10236269|NCT00950183|11366849|FG000|NOT COMPLETED|Overall Study||36
10236270|NCT00950690|11366853|FG000|STARTED|Overall Study||1349
10236271|NCT00950690|11366853|FG000|COMPLETED|Overall Study||1105
10236272|NCT00950690|11366853|FG000|NOT COMPLETED|Overall Study||244
10236273|NCT00944229|11366857|FG000|STARTED|Overall Study||58
10236274|NCT00944229|11366857|FG000|COMPLETED|Overall Study||33
10236275|NCT00944229|11366857|FG000|NOT COMPLETED|Overall Study||25
10236276|NCT00941928|11366861|FG000|STARTED|Overall Study||2
10236277|NCT00941928|11366861|FG000|COMPLETED|Overall Study||0
10236278|NCT00941928|11366861|FG000|NOT COMPLETED|Overall Study||2
10236279|NCT00949403|11366865|FG000|STARTED|Overall Study||9
10236280|NCT00949403|11366865|FG000|COMPLETED|Overall Study||9
10236281|NCT00949403|11366865|FG000|NOT COMPLETED|Overall Study||0
10236282|NCT00947791|11366871|FG000|STARTED|Overall Study||0
10236283|NCT00947791|11366872|FG001|STARTED|Overall Study||1
10236284|NCT00947791|11366871|FG000|COMPLETED|Overall Study||0
10236285|NCT00947791|11366872|FG001|COMPLETED|Overall Study||1
10236286|NCT00947791|11366871|FG000|NOT COMPLETED|Overall Study||0
10236287|NCT00947791|11366872|FG001|NOT COMPLETED|Overall Study||0
9814872|NCT00686517|10925097|FG000|STARTED|Treatment||44
9814873|NCT00686517|10925098|FG001|STARTED|Treatment||43
10016612|NCT01811303|11139415|FG000|NOT COMPLETED|Washout (2 Days or More)||0
10236288|NCT00947011|11366878|FG000|STARTED|Overall Study||12
10236289|NCT00947011|11366878|FG000|COMPLETED|Overall Study||0
10236290|NCT00947011|11366878|FG000|NOT COMPLETED|Overall Study||12
10236291|NCT00943605|11366886|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
10236292|NCT00943605|11366887|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
9814874|NCT00686517|10925099|FG002|STARTED|Treatment||43
10016613|NCT01811303|11139416|FG001|NOT COMPLETED|Washout (2 Days or More)||0
10236293|NCT00943605|11366886|FG000|COMPLETED|Overall Study||0
9814875|NCT00686517|10925097|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
9814876|NCT00686517|10925098|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
9814877|NCT00686517|10925099|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
9814878|NCT00686517|10925097|FG000|COMPLETED|Treatment||38
9814879|NCT00686517|10925098|FG001|COMPLETED|Treatment||40
9814880|NCT00686517|10925099|FG002|COMPLETED|Treatment||42
9814881|NCT00686517|10925097|FG000|NOT COMPLETED|Treatment||6
9814882|NCT00686517|10925098|FG001|NOT COMPLETED|Treatment||3
9814883|NCT00686517|10925099|FG002|NOT COMPLETED|Treatment||1
9814884|NCT00686517|10925097|FG000|STARTED|Follow-up||37
9814885|NCT00686517|10925098|FG001|STARTED|Follow-up||38
9814886|NCT00686517|10925099|FG002|STARTED|Follow-up||39
9814887|NCT00686517|10925097|FG000|COMPLETED|Follow-up||29
9814888|NCT00686517|10925098|FG001|COMPLETED|Follow-up||28
9814889|NCT00686517|10925099|FG002|COMPLETED|Follow-up||29
9814890|NCT00686517|10925097|FG000|NOT COMPLETED|Follow-up||8
9814891|NCT00686517|10925098|FG001|NOT COMPLETED|Follow-up||10
9814892|NCT00686517|10925099|FG002|NOT COMPLETED|Follow-up||10
9814893|NCT00686543|10925111|FG000|STARTED|Overall Study||14
9814894|NCT00686543|10925112|FG001|STARTED|Overall Study||21
9814895|NCT00686543|10925113|FG002|STARTED|Overall Study||20
9814896|NCT00686543|10925114|FG003|STARTED|Overall Study||20
9814897|NCT00686543|10925111|FG000|COMPLETED|Overall Study||0
9814898|NCT00686543|10925112|FG001|COMPLETED|Overall Study||20
9814899|NCT00686543|10925113|FG002|COMPLETED|Overall Study||15
9814900|NCT00686543|10925114|FG003|COMPLETED|Overall Study||17
9814901|NCT00686543|10925111|FG000|NOT COMPLETED|Overall Study||14
9814902|NCT00686543|10925112|FG001|NOT COMPLETED|Overall Study||1
9814903|NCT00686543|10925113|FG002|NOT COMPLETED|Overall Study||5
9814904|NCT00686543|10925114|FG003|NOT COMPLETED|Overall Study||3
9814905|NCT00686582|10925127|FG000|STARTED|Overall Study||92
9814906|NCT00686582|10925128|FG001|STARTED|Overall Study||91
9814907|NCT00686582|10925129|FG002|STARTED|Overall Study||121
9814908|NCT00686582|10925127|FG000|Booster Vaccination|Overall Study||75
9814909|NCT00686582|10925128|FG001|Booster Vaccination|Overall Study||77
9814910|NCT00686582|10925129|FG002|Booster Vaccination|Overall Study||0
9814911|NCT00686582|10925127|FG000|COMPLETED|Overall Study||74
9814912|NCT00686582|10925128|FG001|COMPLETED|Overall Study||77
9814913|NCT00686582|10925129|FG002|COMPLETED|Overall Study||121
9814914|NCT00686582|10925127|FG000|NOT COMPLETED|Overall Study||18
9814915|NCT00686582|10925128|FG001|NOT COMPLETED|Overall Study||14
9814916|NCT00686582|10925129|FG002|NOT COMPLETED|Overall Study||0
9814917|NCT00686595|10925135|FG000|STARTED|Overall Study||38
9814918|NCT00686595|10925135|FG000|COMPLETED|Overall Study||31
9814919|NCT00686595|10925135|FG000|NOT COMPLETED|Overall Study||7
9814920|NCT00686634|10925139|FG000|STARTED|Overall Study||108
9814921|NCT00686634|10925139|FG000|COMPLETED|Overall Study||102
9814922|NCT00686634|10925139|FG000|NOT COMPLETED|Overall Study||6
9814923|NCT00686647|10925144|FG000|STARTED|Overall Study||93
9814924|NCT00686647|10925144|FG000|COMPLETED|Overall Study||91
10016614|NCT01811303|11139417|FG002|NOT COMPLETED|Washout (2 Days or More)||0
10236294|NCT00943605|11366887|FG001|COMPLETED|Overall Study||0
10236295|NCT00943605|11366886|FG000|NOT COMPLETED|Overall Study||30
10236296|NCT00943605|11366887|FG001|NOT COMPLETED|Overall Study||30
10236297|NCT00942409|11366893|FG000|STARTED|Overall Study||5
10236298|NCT00942409|11366893|FG000|COMPLETED|Overall Study||2
10236299|NCT00942409|11366893|FG000|NOT COMPLETED|Overall Study||3
10236300|NCT00936585|11366897|FG000|STARTED|Overall Study||2
10236301|NCT00936585|11366897|FG000|COMPLETED|Overall Study||2
10236302|NCT00936585|11366897|FG000|NOT COMPLETED|Overall Study||0
10236303|NCT00936598|11366903|FG000|STARTED|Overall Study||4
10236304|NCT00936598|11366904|FG001|STARTED|Overall Study||1
10236305|NCT00936598|11366903|FG000|COMPLETED|Overall Study||2
10236306|NCT00936598|11366904|FG001|COMPLETED|Overall Study||1
10236307|NCT00936598|11366903|FG000|NOT COMPLETED|Overall Study||2
10236308|NCT00936598|11366904|FG001|NOT COMPLETED|Overall Study||0
10236309|NCT00920309|11366912|FG000|STARTED|Overall Study||14
10236310|NCT00920309|11366913|FG001|STARTED|Overall Study||7
10236311|NCT00920309|11366912|FG000|COMPLETED|Overall Study||14
10236312|NCT00920309|11366913|FG001|COMPLETED|Overall Study||7
10236313|NCT00920309|11366912|FG000|NOT COMPLETED|Overall Study||0
10236314|NCT00920309|11366913|FG001|NOT COMPLETED|Overall Study||0
10236315|NCT00935649|11366920|FG000|STARTED|Overall Study||139
10236316|NCT00935649|11366920|FG000|COMPLETED|Overall Study||134
10236317|NCT00935649|11366920|FG000|NOT COMPLETED|Overall Study||5
10236318|NCT00934791|11366928|FG000|STARTED|Overall Study||1
10236319|NCT00934791|11366929|FG001|STARTED|Overall Study||0
10236320|NCT00934791|11366928|FG000|COMPLETED|Overall Study||0
9814925|NCT00686647|10925144|FG000|NOT COMPLETED|Overall Study||2
9814926|NCT00686686|10925149|FG000|STARTED|Overall Study||23
9814927|NCT00686686|10925149|FG000|COMPLETED|Overall Study||17
9814928|NCT00686686|10925149|FG000|NOT COMPLETED|Overall Study||6
10236321|NCT00934791|11366929|FG001|COMPLETED|Overall Study||0
10236322|NCT00934791|11366928|FG000|NOT COMPLETED|Overall Study||1
10236323|NCT00934791|11366929|FG001|NOT COMPLETED|Overall Study||0
10236324|NCT00932152|11366937|FG000|STARTED|Overall Study||1
9814929|NCT00686699|10925155|FG000|STARTED|Treatment Period 1||4
10236325|NCT00932152|11366938|FG001|STARTED|Overall Study||2
9814930|NCT00686699|10925156|FG001|STARTED|Treatment Period 1||7
9814931|NCT00686699|10925155|FG000|COMPLETED|Treatment Period 1||4
9814932|NCT00686699|10925156|FG001|COMPLETED|Treatment Period 1||5
9814933|NCT00686699|10925155|FG000|NOT COMPLETED|Treatment Period 1||0
9814934|NCT00686699|10925156|FG001|NOT COMPLETED|Treatment Period 1||2
9814935|NCT00686699|10925155|FG000|STARTED|Treatment Period 2||4
9814936|NCT00686699|10925156|FG001|STARTED|Treatment Period 2||5
9952907|NCT01424501|11071783|FG004|NOT COMPLETED|Overall Study||0
10236326|NCT00932152|11366937|FG000|COMPLETED|Overall Study||0
10236327|NCT00932152|11366938|FG001|COMPLETED|Overall Study||0
10236328|NCT00932152|11366937|FG000|NOT COMPLETED|Overall Study||1
10236329|NCT00932152|11366938|FG001|NOT COMPLETED|Overall Study||2
10236330|NCT00928499|11366946|FG000|STARTED|Overall Study||18
10236331|NCT00928499|11366947|FG001|STARTED|Overall Study||14
10236332|NCT00928499|11366946|FG000|COMPLETED|Overall Study||18
10236333|NCT00928499|11366947|FG001|COMPLETED|Overall Study||14
10236334|NCT00928499|11366946|FG000|NOT COMPLETED|Overall Study||0
10236335|NCT00928499|11366947|FG001|NOT COMPLETED|Overall Study||0
10236336|NCT00924807|11366953|FG000|STARTED|Overall Study||4
10236337|NCT00924807|11366953|FG000|COMPLETED|Overall Study||4
10236338|NCT00924807|11366953|FG000|NOT COMPLETED|Overall Study||0
10236339|NCT00930787|11366959|FG000|STARTED|Overall Study||14
10236340|NCT00930787|11366960|FG001|STARTED|Overall Study||9
10236341|NCT00930787|11366959|FG000|COMPLETED|Overall Study||14
10236342|NCT00930787|11366960|FG001|COMPLETED|Overall Study||9
10236343|NCT00930787|11366959|FG000|NOT COMPLETED|Overall Study||0
10236344|NCT00930787|11366960|FG001|NOT COMPLETED|Overall Study||0
10236345|NCT00929474|11366968|FG000|STARTED|Overall Study||8
10236346|NCT00929474|11366969|FG001|STARTED|Overall Study||9
10236347|NCT00929474|11366968|FG000|COMPLETED|Overall Study||0
10236348|NCT00929474|11366969|FG001|COMPLETED|Overall Study||0
10236349|NCT00929474|11366968|FG000|NOT COMPLETED|Overall Study||8
10236350|NCT00929474|11366969|FG001|NOT COMPLETED|Overall Study||9
10236351|NCT00925548|11366977|FG000|STARTED|Overall Study||11
10236352|NCT00925548|11366978|FG001|STARTED|Overall Study||5
10236353|NCT00925548|11366977|FG000|COMPLETED|Overall Study||1
10236354|NCT00925548|11366978|FG001|COMPLETED|Overall Study||0
10236355|NCT00925548|11366977|FG000|NOT COMPLETED|Overall Study||10
10236356|NCT00925548|11366978|FG001|NOT COMPLETED|Overall Study||5
10236357|NCT00926575|11366987|FG000|STARTED|Overall Study||70
10236358|NCT00926575|11366988|FG001|STARTED|Overall Study||70
10236359|NCT00926575|11366987|FG000|COMPLETED|Overall Study||54
10236360|NCT00926575|11366988|FG001|COMPLETED|Overall Study||53
10236361|NCT00926575|11366987|FG000|NOT COMPLETED|Overall Study||16
10236362|NCT00926575|11366988|FG001|NOT COMPLETED|Overall Study||17
10236363|NCT00911053|11366999|FG000|STARTED|Overall Study||0
10236364|NCT00911053|11367000|FG001|STARTED|Overall Study||0
10236365|NCT00911053|11367001|FG002|STARTED|Overall Study||0
10236366|NCT00911053|11367002|FG003|STARTED|Overall Study||0
10236367|NCT00911053|11367003|FG004|STARTED|Overall Study||0
10236368|NCT00911053|11366999|FG000|COMPLETED|Overall Study||0
10236369|NCT00911053|11367000|FG001|COMPLETED|Overall Study||0
10236370|NCT00911053|11367001|FG002|COMPLETED|Overall Study||0
10236371|NCT00911053|11367002|FG003|COMPLETED|Overall Study||0
10236372|NCT00911053|11367003|FG004|COMPLETED|Overall Study||0
10236373|NCT00911053|11366999|FG000|NOT COMPLETED|Overall Study||0
10236374|NCT00911053|11367000|FG001|NOT COMPLETED|Overall Study||0
10236375|NCT00911053|11367001|FG002|NOT COMPLETED|Overall Study||0
10236376|NCT00911053|11367002|FG003|NOT COMPLETED|Overall Study||0
10236377|NCT00911053|11367003|FG004|NOT COMPLETED|Overall Study||0
10236378|NCT00918463|11367015|FG000|STARTED|Overall Study||2
10236379|NCT00918463|11367015|FG000|COMPLETED|Overall Study||0
10236380|NCT00918463|11367015|FG000|NOT COMPLETED|Overall Study||2
10236381|NCT00913692|11367019|FG000|STARTED|Screening (4 Months)||11
10236382|NCT00913692|11367019|FG000|COMPLETED|Screening (4 Months)||2
10236383|NCT00913692|11367019|FG000|NOT COMPLETED|Screening (4 Months)||9
10236384|NCT00913692|11367019|FG000|STARTED|Treatment Phase 1 (5 Months)||2
10236385|NCT00913692|11367019|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1
10236386|NCT00913692|11367019|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
10236387|NCT00913692|11367019|FG000|STARTED|Washout (2 Weeks)||1
10236388|NCT00913692|11367019|FG000|COMPLETED|Washout (2 Weeks)||1
10236389|NCT00913692|11367019|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10236390|NCT00913692|11367019|FG000|STARTED|Treatment Phase 2 (5 Months)||1
10236391|NCT00913692|11367019|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1
10236392|NCT00913692|11367019|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
10236393|NCT00918645|11367026|FG000|STARTED|Overall Study||13
10236394|NCT00918645|11367026|FG000|COMPLETED|Overall Study||12
9814937|NCT00686699|10925155|FG000|COMPLETED|Treatment Period 2||4
9814938|NCT00686699|10925156|FG001|COMPLETED|Treatment Period 2||5
9952908|NCT01424501|11071784|FG005|NOT COMPLETED|Overall Study||0
10236395|NCT00918645|11367026|FG000|NOT COMPLETED|Overall Study||1
10236396|NCT00907218|11367030|FG000|STARTED|Overall Study||2
9814939|NCT00686699|10925155|FG000|NOT COMPLETED|Treatment Period 2||0
10236397|NCT00907218|11367030|FG000|COMPLETED|Overall Study||2
10236398|NCT00907218|11367030|FG000|NOT COMPLETED|Overall Study||0
10236399|NCT00895284|11367036|FG000|STARTED|Overall Study||3
10236400|NCT00895284|11367037|FG001|STARTED|Overall Study||0
10236401|NCT00895284|11367036|FG000|COMPLETED|Overall Study||3
10236402|NCT00895284|11367037|FG001|COMPLETED|Overall Study||0
10236403|NCT00895284|11367036|FG000|NOT COMPLETED|Overall Study||0
10236404|NCT00895284|11367037|FG001|NOT COMPLETED|Overall Study||0
9814940|NCT00686699|10925156|FG001|NOT COMPLETED|Treatment Period 2||0
9814941|NCT00686712|10925165|FG000|STARTED|Overall Study||30
10236405|NCT00897910|11367043|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
10236406|NCT00897910|11367043|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
10236407|NCT00897910|11367043|FG000|NOT COMPLETED|Overall Study||0
10236408|NCT00901303|11367049|FG000|STARTED|Overall Study||5
10236409|NCT00901303|11367050|FG001|STARTED|Overall Study||1
10236410|NCT00901303|11367049|FG000|COMPLETED|Overall Study||5
10236411|NCT00901303|11367050|FG001|COMPLETED|Overall Study||1
10236412|NCT00901303|11367049|FG000|NOT COMPLETED|Overall Study||0
10236413|NCT00901303|11367050|FG001|NOT COMPLETED|Overall Study||0
10236414|NCT00906035|11367059|FG000|STARTED|Overall Study||8
10236415|NCT00906035|11367060|FG001|STARTED|Overall Study||9
10236416|NCT00906035|11367061|FG002|STARTED|Overall Study||8
10236417|NCT00906035|11367059|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
10236418|NCT00906035|11367060|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
10236419|NCT00906035|11367061|FG002|COMPLETED|Overall Study||8
10236420|NCT00906035|11367059|FG000|NOT COMPLETED|Overall Study||2
10236421|NCT00906035|11367060|FG001|NOT COMPLETED|Overall Study||3
10236422|NCT00906035|11367061|FG002|NOT COMPLETED|Overall Study||0
10236423|NCT00904423|11367069|FG000|STARTED|Overall Study||8
10236424|NCT00904423|11367069|FG000|COMPLETED|Overall Study||8
10236425|NCT00904423|11367069|FG000|NOT COMPLETED|Overall Study||0
10236426|NCT00903396|11367077|FG000|STARTED|Overall Study||2
10236427|NCT00903396|11367078|FG001|STARTED|Overall Study||1
10236428|NCT00903396|11367079|FG002|STARTED|Overall Study||3
10236429|NCT00903396|11367080|FG003|STARTED|Overall Study||1
10236430|NCT00903396|11367077|FG000|COMPLETED|Overall Study||2
10236431|NCT00903396|11367078|FG001|COMPLETED|Overall Study||1
10236432|NCT00903396|11367079|FG002|COMPLETED|Overall Study||3
10236433|NCT00903396|11367080|FG003|COMPLETED|Overall Study||1
10236434|NCT00903396|11367077|FG000|NOT COMPLETED|Overall Study||0
10236435|NCT00903396|11367078|FG001|NOT COMPLETED|Overall Study||0
10236436|NCT00903396|11367079|FG002|NOT COMPLETED|Overall Study||0
10236437|NCT00903396|11367080|FG003|NOT COMPLETED|Overall Study||0
10236438|NCT00894790|11367092|FG000|STARTED|Overall Study||4
10236439|NCT00894790|11367093|FG001|STARTED|Overall Study||4
10236440|NCT00894790|11367092|FG000|COMPLETED|Overall Study||3
10236441|NCT00894790|11367093|FG001|COMPLETED|Overall Study||2
10236442|NCT00894790|11367092|FG000|NOT COMPLETED|Overall Study||1
10236443|NCT00894790|11367093|FG001|NOT COMPLETED|Overall Study||2
10236444|NCT00902668|11367099|FG000|STARTED|Overall Study||3
10236445|NCT00902668|11367099|FG000|COMPLETED|Overall Study||0
10236446|NCT00902668|11367099|FG000|NOT COMPLETED|Overall Study||3
10236447|NCT00881205|11367105|FG000|STARTED|Overall Study||45
10236448|NCT00881205|11367106|FG001|STARTED|Overall Study||41
10236449|NCT00881205|11367105|FG000|COMPLETED|Overall Study||34
10236450|NCT00881205|11367106|FG001|COMPLETED|Overall Study||34
10236451|NCT00881205|11367105|FG000|NOT COMPLETED|Overall Study||11
10236452|NCT00881205|11367106|FG001|NOT COMPLETED|Overall Study||7
10236453|NCT00896025|11367113|FG000|STARTED|Overall Study||8
10236454|NCT00896025|11367113|FG000|COMPLETED|Overall Study||8
10236455|NCT00896025|11367113|FG000|NOT COMPLETED|Overall Study||0
10236456|NCT00903006|11367123|FG000|STARTED|Overall Study||2
10236457|NCT00903006|11367124|FG001|STARTED|Overall Study||3
10236458|NCT00903006|11367125|FG002|STARTED|Overall Study||1
10236459|NCT00903006|11367126|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
10236460|NCT00903006|11367123|FG000|COMPLETED|Overall Study||0
10236461|NCT00903006|11367124|FG001|COMPLETED|Overall Study||0
10236462|NCT00903006|11367125|FG002|COMPLETED|Overall Study||0
10236463|NCT00903006|11367126|FG003|COMPLETED|Overall Study||0
10236464|NCT00903006|11367123|FG000|NOT COMPLETED|Overall Study||2
10236465|NCT00903006|11367124|FG001|NOT COMPLETED|Overall Study||3
10236466|NCT00903006|11367125|FG002|NOT COMPLETED|Overall Study||1
10236467|NCT00903006|11367126|FG003|NOT COMPLETED|Overall Study||0
10236468|NCT00904189|11367136|FG000|STARTED|Overall Study||2
10236469|NCT00904189|11367136|FG000|COMPLETED|Overall Study||2
10236470|NCT00904189|11367136|FG000|NOT COMPLETED|Overall Study||0
10236471|NCT00887315|11367143|FG000|STARTED|Overall Study||7
10236472|NCT00887315|11367144|FG001|STARTED|Overall Study||4
10236473|NCT00887315|11367143|FG000|COMPLETED|Overall Study||0
10236474|NCT00887315|11367144|FG001|COMPLETED|Overall Study||0
10236475|NCT00887315|11367143|FG000|NOT COMPLETED|Overall Study||7
10236476|NCT00887315|11367144|FG001|NOT COMPLETED|Overall Study||4
10236477|NCT00891904|11367150|FG000|STARTED|Overall Study||2
10236478|NCT00891904|11367150|FG000|COMPLETED|Overall Study||0
10236479|NCT00891904|11367150|FG000|NOT COMPLETED|Overall Study||2
10236480|NCT00881608|11367159|FG000|STARTED|Overall Study||11
10236481|NCT00881608|11367159|FG000|COMPLETED|Overall Study||0
10236482|NCT00881608|11367159|FG000|NOT COMPLETED|Overall Study||11
10236483|NCT00889421|11367171|FG000|STARTED|Overall Study||3
10236484|NCT00889421|11367171|FG000|COMPLETED|Overall Study||0
10236485|NCT00889421|11367171|FG000|NOT COMPLETED|Overall Study||3
10236486|NCT00875394|11367178|FG000|STARTED|Overall Study||36
10236487|NCT00875394|11367179|FG001|STARTED|Overall Study||23
10236488|NCT00875394|11367180|FG002|STARTED|Overall Study||9
10236489|NCT00875394|11367178|FG000|COMPLETED|Overall Study||36
10236490|NCT00875394|11367179|FG001|COMPLETED|Overall Study||23
10236491|NCT00875394|11367180|FG002|COMPLETED|Overall Study||9
9814942|NCT00686712|10925166|FG001|STARTED|Overall Study||25
9814943|NCT00686712|10925167|FG002|STARTED|Overall Study||30
9814944|NCT00686712|10925165|FG000|COMPLETED|Overall Study||20
9814945|NCT00686712|10925166|FG001|COMPLETED|Overall Study||14
9814946|NCT00686712|10925167|FG002|COMPLETED|Overall Study||17
9814947|NCT00686712|10925165|FG000|NOT COMPLETED|Overall Study||10
9814948|NCT00686712|10925166|FG001|NOT COMPLETED|Overall Study||11
9814949|NCT00686712|10925167|FG002|NOT COMPLETED|Overall Study||13
9814950|NCT00686725|10925180|FG000|STARTED|Overall Study||47
9814951|NCT00686725|10925181|FG001|STARTED|Overall Study||52
9814952|NCT00686725|10925180|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
9814953|NCT00686725|10925181|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
9814954|NCT00686725|10925180|FG000|NOT COMPLETED|Overall Study||46
9814955|NCT00686725|10925181|FG001|NOT COMPLETED|Overall Study||42
9814956|NCT00686777|10925187|FG000|STARTED|Overall Study||75
9814957|NCT00686777|10925187|FG000|Completed 24 Weeks of Treatment|Overall Study||69
9814958|NCT00686777|10925187|FG000|Completed 48 Weeks of Treatment|Overall Study||65
9814959|NCT00686777|10925187|FG000|Included in Follow-up (All Treated)|Overall Study||75
9814960|NCT00686777|10925187|FG000|Completed 24 Weeks of Follow-up|Overall Study||70
9814961|NCT00686777|10925187|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
9814962|NCT00686777|10925187|FG000|NOT COMPLETED|Overall Study||10
9814963|NCT00686790|10925191|FG000|STARTED|Overall Study||48
9814964|NCT00686790|10925191|FG000|COMPLETED|Overall Study||32
9814965|NCT00686790|10925191|FG000|NOT COMPLETED|Overall Study||16
9814966|NCT00686803|10925198|FG000|STARTED|Overall Study||6
9814967|NCT00686803|10925199|FG001|STARTED|Overall Study||12
9814968|NCT00686803|10925200|FG002|STARTED|Overall Study||3
9814969|NCT00686803|10925198|FG000|COMPLETED|Overall Study||6
9814970|NCT00686803|10925199|FG001|COMPLETED|Overall Study||12
9814971|NCT00686803|10925200|FG002|COMPLETED|Overall Study||3
9814972|NCT00686803|10925198|FG000|NOT COMPLETED|Overall Study||0
9814973|NCT00686803|10925199|FG001|NOT COMPLETED|Overall Study||0
9814974|NCT00686803|10925200|FG002|NOT COMPLETED|Overall Study||0
9814975|NCT00686829|10925208|FG000|STARTED|Overall Study||79
9814976|NCT00686829|10925208|FG000|COMPLETED|Overall Study||0
9814977|NCT00686829|10925208|FG000|NOT COMPLETED|Overall Study||79
9814978|NCT00686842|10925212|FG000|STARTED|Overall Study||17
9814979|NCT00686842|10925212|FG000|COMPLETED|Overall Study||17
9814980|NCT00686842|10925212|FG000|NOT COMPLETED|Overall Study||0
9814981|NCT00686855|10925218|FG000|STARTED|Overall Study||28
9814982|NCT00686855|10925219|FG001|STARTED|Overall Study||18
9814983|NCT00686855|10925218|FG000|COMPLETED|Overall Study||27
9814984|NCT00686855|10925219|FG001|COMPLETED|Overall Study||17
9814985|NCT00686855|10925218|FG000|NOT COMPLETED|Overall Study||1
9814986|NCT00686855|10925219|FG001|NOT COMPLETED|Overall Study||1
9814987|NCT00686881|10925227|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
9814988|NCT00686881|10925228|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
9814989|NCT00686881|10925227|FG000|COMPLETED|Overall Study||45
9814990|NCT00686881|10925228|FG001|COMPLETED|Overall Study||53
9814991|NCT00686881|10925227|FG000|NOT COMPLETED|Overall Study||82
10236492|NCT00875394|11367178|FG000|NOT COMPLETED|Overall Study||0
10236493|NCT00875394|11367179|FG001|NOT COMPLETED|Overall Study||0
10236494|NCT00875394|11367180|FG002|NOT COMPLETED|Overall Study||0
10236495|NCT00882310|11367188|FG000|STARTED|Overall Study||37
10236496|NCT00882310|11367188|FG000|COMPLETED|Overall Study||15
10236497|NCT00882310|11367188|FG000|NOT COMPLETED|Overall Study||22
10236498|NCT00880542|11367192|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
10236499|NCT00880542|11367192|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
10236500|NCT00880542|11367192|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
10236501|NCT00880542|11367192|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4
10236502|NCT00880542|11367192|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4
10236503|NCT00880542|11367192|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
9814992|NCT00686881|10925228|FG001|NOT COMPLETED|Overall Study||81
10016615|NCT01811303|11139418|FG003|NOT COMPLETED|Washout (2 Days or More)||0
10016616|NCT01811303|11139415|FG000|STARTED|Second Intervention (1 Day)||4
10016617|NCT01811303|11139416|FG001|STARTED|Second Intervention (1 Day)||4
10016618|NCT01811303|11139417|FG002|STARTED|Second Intervention (1 Day)||4
9814993|NCT00686894|10925236|FG000|STARTED|Overall Study||7
9814994|NCT00686894|10925236|FG000|COMPLETED|Overall Study||1
9814995|NCT00686894|10925236|FG000|NOT COMPLETED|Overall Study||6
9814996|NCT00686920|10925242|FG000|STARTED|Overall Study||252
9814997|NCT00686920|10925243|FG001|STARTED|Overall Study||70
9814998|NCT00686920|10925242|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252
9814999|NCT00686920|10925243|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70
9815000|NCT00686920|10925242|FG000|COMPLETED|Overall Study||120
9815001|NCT00686920|10925243|FG001|COMPLETED|Overall Study||34
10236504|NCT00880542|11367192|FG000|STARTED|REP: Surgical Resection||4
10236505|NCT00880542|11367192|FG000|COMPLETED|REP: Surgical Resection||3
10236506|NCT00880542|11367192|FG000|NOT COMPLETED|REP: Surgical Resection||1
9815002|NCT00686920|10925242|FG000|NOT COMPLETED|Overall Study||132
9815003|NCT00686920|10925243|FG001|NOT COMPLETED|Overall Study||36
9815004|NCT00686959|10925251|FG000|STARTED|Overall Study||301
9815005|NCT00686959|10925252|FG001|STARTED|Overall Study||297
9815006|NCT00686959|10925251|FG000|Received at Least One Dose of Study Drug|Overall Study||283
9815007|NCT00686959|10925252|FG001|Received at Least One Dose of Study Drug|Overall Study||272
10236507|NCT00880542|11367192|FG000|STARTED|Post Surgical Evaluation||3
10236508|NCT00880542|11367192|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
10236509|NCT00880542|11367192|FG000|NOT COMPLETED|Post Surgical Evaluation||0
10236510|NCT00880542|11367192|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
10236511|NCT00880542|11367192|FG000|COMPLETED|Continued Treatment Period||0
10236512|NCT00880542|11367192|FG000|NOT COMPLETED|Continued Treatment Period||0
10236513|NCT00880542|11367192|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
10236514|NCT00880542|11367192|FG000|COMPLETED|Follow-up Period||7
10236515|NCT00880542|11367192|FG000|NOT COMPLETED|Follow-up Period||0
10236516|NCT00879619|11367196|FG000|STARTED|Overall Study||4
10236517|NCT00879619|11367196|FG000|COMPLETED|Overall Study||4
10236518|NCT00879619|11367196|FG000|NOT COMPLETED|Overall Study||0
10236519|NCT00874939|11367200|FG000|STARTED|Overall Study||4
10236520|NCT00874939|11367200|FG000|Treated|Overall Study||0
10236521|NCT00874939|11367200|FG000|COMPLETED|Overall Study||0
10236522|NCT00874939|11367200|FG000|NOT COMPLETED|Overall Study||4
10236523|NCT00878605|11367214|FG000|STARTED|Overall Study||10
10236524|NCT00878605|11367215|FG001|STARTED|Overall Study||10
10236525|NCT00878605|11367216|FG002|STARTED|Overall Study||9
10236526|NCT00878605|11367217|FG003|STARTED|Overall Study||9
10236527|NCT00878605|11367214|FG000|COMPLETED|Overall Study||7
10236528|NCT00878605|11367215|FG001|COMPLETED|Overall Study||7
10236529|NCT00878605|11367216|FG002|COMPLETED|Overall Study||8
10236530|NCT00878605|11367217|FG003|COMPLETED|Overall Study||6
10236531|NCT00878605|11367214|FG000|NOT COMPLETED|Overall Study||3
10236532|NCT00878605|11367215|FG001|NOT COMPLETED|Overall Study||3
10236533|NCT00878605|11367216|FG002|NOT COMPLETED|Overall Study||1
10236534|NCT00878605|11367217|FG003|NOT COMPLETED|Overall Study||3
10236535|NCT00877071|11367227|FG000|STARTED|Overall Study||2
10236536|NCT00877071|11367227|FG000|COMPLETED|Overall Study||0
10236537|NCT00877071|11367227|FG000|NOT COMPLETED|Overall Study||2
10236538|NCT00878969|11367234|FG000|STARTED|Overall Study||25
10236539|NCT00878969|11367235|FG001|STARTED|Overall Study||27
10236540|NCT00878969|11367236|FG002|STARTED|Overall Study||26
10236541|NCT00878969|11367234|FG000|COMPLETED|Overall Study||10
10236542|NCT00878969|11367235|FG001|COMPLETED|Overall Study||12
10236543|NCT00878969|11367236|FG002|COMPLETED|Overall Study||15
10236544|NCT00878969|11367234|FG000|NOT COMPLETED|Overall Study||15
10236545|NCT00878969|11367235|FG001|NOT COMPLETED|Overall Study||15
10236546|NCT00878969|11367236|FG002|NOT COMPLETED|Overall Study||11
10236547|NCT00865514|11367244|FG000|STARTED|Overall Study||2
10236548|NCT00865514|11367244|FG000|COMPLETED|Overall Study||0
10236549|NCT00865514|11367244|FG000|NOT COMPLETED|Overall Study||2
10236550|NCT00869414|11367249|FG000|STARTED|Overall Study||0
10236551|NCT00869414|11367250|FG001|STARTED|Overall Study||0
10236552|NCT00869414|11367251|FG002|STARTED|Overall Study||0
10236553|NCT00869414|11367249|FG000|COMPLETED|Overall Study||0
10236554|NCT00869414|11367250|FG001|COMPLETED|Overall Study||0
10236555|NCT00869414|11367251|FG002|COMPLETED|Overall Study||0
10236556|NCT00869414|11367249|FG000|NOT COMPLETED|Overall Study||0
10236557|NCT00869414|11367250|FG001|NOT COMPLETED|Overall Study||0
10236558|NCT00869414|11367251|FG002|NOT COMPLETED|Overall Study||0
10236559|NCT00863512|11367261|FG000|STARTED|Overall Study||17
10236560|NCT00863512|11367262|FG001|STARTED|Overall Study||17
10236561|NCT00863512|11367261|FG000|COMPLETED|Overall Study||3
10236562|NCT00863512|11367262|FG001|COMPLETED|Overall Study||17
10236563|NCT00863512|11367261|FG000|NOT COMPLETED|Overall Study||14
10236564|NCT00863512|11367262|FG001|NOT COMPLETED|Overall Study||0
10236565|NCT00868998|11367268|FG000|STARTED|Overall Study||5
10236566|NCT00868998|11367268|FG000|COMPLETED|Overall Study||0
10236567|NCT00868998|11367268|FG000|NOT COMPLETED|Overall Study||5
10236568|NCT00869258|11367272|FG000|STARTED|Overall Study||32
10236569|NCT00869258|11367272|FG000|COMPLETED|Overall Study||31
10236570|NCT00869258|11367272|FG000|NOT COMPLETED|Overall Study||1
10236571|NCT00863330|11367276|FG000|STARTED|Overall Study||6
10236572|NCT00863330|11367276|FG000|COMPLETED|Overall Study||0
10236573|NCT00863330|11367276|FG000|NOT COMPLETED|Overall Study||6
10236574|NCT00853229|11367282|FG000|STARTED|Phase 1: Initial Intervention||8
10236575|NCT00853229|11367283|FG001|STARTED|Phase 1: Initial Intervention||8
10236576|NCT00853229|11367282|FG000|COMPLETED|Phase 1: Initial Intervention||0
10236577|NCT00853229|11367283|FG001|COMPLETED|Phase 1: Initial Intervention||0
10236578|NCT00853229|11367282|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
10236579|NCT00853229|11367283|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8
10236580|NCT00853229|11367282|FG000|STARTED|Phase 2: Cross Over||0
10236581|NCT00853229|11367283|FG001|STARTED|Phase 2: Cross Over||0
10236582|NCT00853229|11367282|FG000|COMPLETED|Phase 2: Cross Over||0
10236583|NCT00853229|11367283|FG001|COMPLETED|Phase 2: Cross Over||0
10236584|NCT00853229|11367282|FG000|NOT COMPLETED|Phase 2: Cross Over||0
10236585|NCT00853229|11367283|FG001|NOT COMPLETED|Phase 2: Cross Over||0
10236586|NCT00860249|11367294|FG000|STARTED|Overall Study||21
10236587|NCT00860249|11367295|FG001|STARTED|Overall Study||18
10236588|NCT00860249|11367296|FG002|STARTED|Overall Study||21
10236589|NCT00860249|11367294|FG000|COMPLETED|Overall Study||0
10236590|NCT00860249|11367295|FG001|COMPLETED|Overall Study||0
10236591|NCT00860249|11367296|FG002|COMPLETED|Overall Study||0
10236592|NCT00860249|11367294|FG000|NOT COMPLETED|Overall Study||21
10236593|NCT00860249|11367295|FG001|NOT COMPLETED|Overall Study||18
9815008|NCT00686959|10925251|FG000|Entered Consolidation Phase|Overall Study||229
9815009|NCT00686959|10925252|FG001|Entered Consolidation Phase|Overall Study||202
9815010|NCT00686959|10925251|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177
10016619|NCT01811303|11139418|FG003|STARTED|Second Intervention (1 Day)||2
10016620|NCT01811303|11139415|FG000|COMPLETED|Second Intervention (1 Day)||4
10016621|NCT01811303|11139416|FG001|COMPLETED|Second Intervention (1 Day)||4
10236594|NCT00860249|11367296|FG002|NOT COMPLETED|Overall Study||21
10236595|NCT00860158|11367304|FG000|STARTED|Overall Study||1
10236596|NCT00860158|11367304|FG000|COMPLETED|Overall Study||0
10236597|NCT00860158|11367304|FG000|NOT COMPLETED|Overall Study||1
10236598|NCT00853567|11367311|FG000|STARTED|Overall Study||71
10236599|NCT00853567|11367311|FG000|COMPLETED|Overall Study||0
10236600|NCT00853567|11367311|FG000|NOT COMPLETED|Overall Study||71
10236601|NCT00849524|11367319|FG000|STARTED|Overall Study||6
10236602|NCT00849524|11367319|FG000|COMPLETED|Overall Study||3
10236603|NCT00849524|11367319|FG000|NOT COMPLETED|Overall Study||3
10236604|NCT00843986|11367325|FG000|STARTED|Overall Study||3
10236605|NCT00843986|11367326|FG001|STARTED|Overall Study||6
10236606|NCT00843986|11367325|FG000|Completed Treatment (Infusion)|Overall Study||2
10236607|NCT00843986|11367326|FG001|Completed Treatment (Infusion)|Overall Study||6
10236608|NCT00843986|11367325|FG000|COMPLETED|Overall Study||2
10236609|NCT00843986|11367326|FG001|COMPLETED|Overall Study||5
10236610|NCT00843986|11367325|FG000|NOT COMPLETED|Overall Study||1
10236611|NCT00843986|11367326|FG001|NOT COMPLETED|Overall Study||1
10236612|NCT00851682|11367334|FG000|STARTED|Overall Study||60
10236613|NCT00851682|11367335|FG001|STARTED|Overall Study||5
10236614|NCT00851682|11367334|FG000|COMPLETED|Overall Study||55
10236615|NCT00851682|11367335|FG001|COMPLETED|Overall Study||5
10236616|NCT00851682|11367334|FG000|NOT COMPLETED|Overall Study||5
10236617|NCT00851682|11367335|FG001|NOT COMPLETED|Overall Study||0
10236618|NCT00852124|11367343|FG000|STARTED|Overall Study||3
10236619|NCT00852124|11367344|FG001|STARTED|Overall Study||0
10236620|NCT00852124|11367343|FG000|COMPLETED|Overall Study||3
10236621|NCT00852124|11367344|FG001|COMPLETED|Overall Study||0
10236622|NCT00852124|11367343|FG000|NOT COMPLETED|Overall Study||0
10236623|NCT00852124|11367344|FG001|NOT COMPLETED|Overall Study||0
10236624|NCT00850421|11367349|FG000|STARTED|Overall Study||35
10236625|NCT00850421|11367349|FG000|COMPLETED|Overall Study||18
10236626|NCT00850421|11367349|FG000|NOT COMPLETED|Overall Study||17
10236627|NCT00851747|11367357|FG000|STARTED|Overall Study||6
10236628|NCT00851747|11367358|FG001|STARTED|Overall Study||6
10236629|NCT00851747|11367359|FG002|STARTED|Overall Study||6
10236630|NCT00851747|11367357|FG000|COMPLETED|Overall Study||0
10236631|NCT00851747|11367358|FG001|COMPLETED|Overall Study||0
10236632|NCT00851747|11367359|FG002|COMPLETED|Overall Study||0
10236633|NCT00851747|11367357|FG000|NOT COMPLETED|Overall Study||6
10236634|NCT00851747|11367358|FG001|NOT COMPLETED|Overall Study||6
10236635|NCT00851747|11367359|FG002|NOT COMPLETED|Overall Study||6
10236636|NCT00852241|11367366|FG000|STARTED|Overall Study||18
10236637|NCT00852241|11367366|FG000|COMPLETED|Overall Study||0
10236638|NCT00852241|11367366|FG000|NOT COMPLETED|Overall Study||18
10236639|NCT00851552|11367370|FG000|STARTED|Overall Study||9
10236640|NCT00851552|11367370|FG000|COMPLETED|Overall Study||2
10236641|NCT00851552|11367370|FG000|NOT COMPLETED|Overall Study||7
10236642|NCT00850720|11367374|FG000|STARTED|Overall Study||0
10236643|NCT00850720|11367374|FG000|COMPLETED|Overall Study||0
10236644|NCT00850720|11367374|FG000|NOT COMPLETED|Overall Study||0
10239742|NCT00003726|11371440|FG000|NOT COMPLETED|Overall Study||1
10239743|NCT04051996|11371446|FG000|STARTED|Overall Study||1
10239744|NCT04051996|11371447|FG001|STARTED|Overall Study||0
10239745|NCT04051996|11371446|FG000|COMPLETED|Overall Study||1
10239746|NCT04051996|11371447|FG001|COMPLETED|Overall Study||0
10239747|NCT04051996|11371446|FG000|NOT COMPLETED|Overall Study||0
10016622|NCT01811303|11139417|FG002|COMPLETED|Second Intervention (1 Day)||4
10016623|NCT01811303|11139418|FG003|COMPLETED|Second Intervention (1 Day)||2
10016624|NCT01811303|11139415|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10016625|NCT01811303|11139416|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10239748|NCT04051996|11371447|FG001|NOT COMPLETED|Overall Study||0
10239749|NCT02970799|11371455|FG000|STARTED|Overall Study||0
10239750|NCT02970799|11371456|FG001|STARTED|Overall Study||0
10239751|NCT02970799|11371455|FG000|COMPLETED|Overall Study||0
10239752|NCT02970799|11371456|FG001|COMPLETED|Overall Study||0
9815011|NCT00686959|10925252|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
10016626|NCT01811303|11139417|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10016627|NCT01811303|11139418|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10016628|NCT01811303|11139415|FG000|STARTED|Washout (2 Days or More)||4
10016629|NCT01811303|11139416|FG001|STARTED|Washout (2 Days or More)||4
10016630|NCT01811303|11139417|FG002|STARTED|Washout (2 Days or More)||4
10239753|NCT02970799|11371455|FG000|NOT COMPLETED|Overall Study||0
10239754|NCT02970799|11371456|FG001|NOT COMPLETED|Overall Study||0
10239755|NCT02385292|11371464|FG000|STARTED|Overall Study||0
10239756|NCT02385292|11371465|FG001|STARTED|Overall Study||0
10239757|NCT02385292|11371464|FG000|COMPLETED|Overall Study||0
10239758|NCT02385292|11371465|FG001|COMPLETED|Overall Study||0
10239759|NCT02385292|11371464|FG000|NOT COMPLETED|Overall Study||0
10239760|NCT02385292|11371465|FG001|NOT COMPLETED|Overall Study||0
10239761|NCT02126878|11371474|FG000|STARTED|Overall Study||0
10239762|NCT02126878|11371475|FG001|STARTED|Overall Study||0
10239763|NCT02126878|11371476|FG002|STARTED|Overall Study||0
10239764|NCT02126878|11371474|FG000|COMPLETED|Overall Study||0
9815012|NCT00686959|10925251|FG000|NOT COMPLETED|Overall Study||124
9815013|NCT00686959|10925252|FG001|NOT COMPLETED|Overall Study||117
9815014|NCT00686998|10925261|FG000|STARTED|Overall Study|Randomized & received study medication|43
9815015|NCT00686998|10925262|FG001|STARTED|Overall Study|Randomized & received study medication|41
9815016|NCT00686998|10925263|FG002|STARTED|Overall Study|Randomized & received study medication|22
9815017|NCT00686998|10925261|FG000|Randomized|Overall Study||43
9815018|NCT00686998|10925262|FG001|Randomized|Overall Study||41
9815019|NCT00686998|10925263|FG002|Randomized|Overall Study||22
9815020|NCT00686998|10925261|FG000|Received Treatment|Overall Study||43
9815021|NCT00686998|10925262|FG001|Received Treatment|Overall Study||41
9815022|NCT00686998|10925263|FG002|Received Treatment|Overall Study||22
9815023|NCT00686998|10925261|FG000|Eligible for Efficacy Analysis|Overall Study||42
9815024|NCT00686998|10925262|FG001|Eligible for Efficacy Analysis|Overall Study||39
9815025|NCT00686998|10925263|FG002|Eligible for Efficacy Analysis|Overall Study||21
10016631|NCT01811303|11139418|FG003|STARTED|Washout (2 Days or More)||2
10016632|NCT01811303|11139415|FG000|COMPLETED|Washout (2 Days or More)||4
10112290|NCT02502526|11243356|FG001|STARTED|Overall Study||59
10112291|NCT02502526|11243357|FG002|STARTED|Overall Study||61
10112292|NCT02502526|11243355|FG000|Intent-to-Treat (ITT)|Overall Study||57
10112293|NCT02502526|11243356|FG001|Intent-to-Treat (ITT)|Overall Study||57
10112294|NCT02502526|11243357|FG002|Intent-to-Treat (ITT)|Overall Study||59
10112295|NCT02502526|11243355|FG000|COMPLETED|Overall Study||56
10112296|NCT02502526|11243356|FG001|COMPLETED|Overall Study||55
10112297|NCT02502526|11243357|FG002|COMPLETED|Overall Study||55
10112298|NCT02502526|11243355|FG000|NOT COMPLETED|Overall Study||6
10112299|NCT02502526|11243356|FG001|NOT COMPLETED|Overall Study||4
10112300|NCT02502526|11243357|FG002|NOT COMPLETED|Overall Study||6
10112301|NCT02502734|11243366|FG000|STARTED|Double-blind Treatment Period 1||30
10112302|NCT02502734|11243367|FG001|STARTED|Double-blind Treatment Period 1||30
10112303|NCT02502734|11243366|FG000|COMPLETED|Double-blind Treatment Period 1||29
10016633|NCT01811303|11139416|FG001|COMPLETED|Washout (2 Days or More)||4
10016634|NCT01811303|11139417|FG002|COMPLETED|Washout (2 Days or More)||4
10016635|NCT01811303|11139418|FG003|COMPLETED|Washout (2 Days or More)||2
10016636|NCT01811303|11139415|FG000|NOT COMPLETED|Washout (2 Days or More)||0
10016637|NCT01811303|11139416|FG001|NOT COMPLETED|Washout (2 Days or More)||0
10016638|NCT01811303|11139417|FG002|NOT COMPLETED|Washout (2 Days or More)||0
10016639|NCT01811303|11139418|FG003|NOT COMPLETED|Washout (2 Days or More)||0
10016640|NCT01811303|11139415|FG000|STARTED|Third Intervention (1 Day)||4
10016641|NCT01811303|11139416|FG001|STARTED|Third Intervention (1 Day)||4
10112304|NCT02502734|11243367|FG001|COMPLETED|Double-blind Treatment Period 1||30
10112305|NCT02502734|11243366|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
10112306|NCT02502734|11243367|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0
10112307|NCT02502734|11243366|FG000|STARTED|Washout Period||29
10112308|NCT02502734|11243367|FG001|STARTED|Washout Period||30
10112309|NCT02502734|11243366|FG000|COMPLETED|Washout Period||28
10112310|NCT02502734|11243367|FG001|COMPLETED|Washout Period||30
10112311|NCT02502734|11243366|FG000|NOT COMPLETED|Washout Period||1
10112312|NCT02502734|11243367|FG001|NOT COMPLETED|Washout Period||0
10112313|NCT02502734|11243366|FG000|STARTED|Double-blind Treatment Period 2||28
10112314|NCT02502734|11243367|FG001|STARTED|Double-blind Treatment Period 2||30
10112315|NCT02502734|11243366|FG000|COMPLETED|Double-blind Treatment Period 2||28
10016642|NCT01811303|11139417|FG002|STARTED|Third Intervention (1 Day)||4
10016643|NCT01811303|11139418|FG003|STARTED|Third Intervention (1 Day)||2
10016644|NCT01811303|11139415|FG000|COMPLETED|Third Intervention (1 Day)||4
10016645|NCT01811303|11139416|FG001|COMPLETED|Third Intervention (1 Day)||4
10016646|NCT01811303|11139417|FG002|COMPLETED|Third Intervention (1 Day)||4
10016647|NCT01811303|11139418|FG003|COMPLETED|Third Intervention (1 Day)||2
10016648|NCT01811303|11139415|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10016649|NCT01811303|11139416|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10236645|NCT00845845|11367380|FG000|STARTED|Overall Study||3
10236646|NCT00845845|11367381|FG001|STARTED|Overall Study||6
10236647|NCT00845845|11367380|FG000|COMPLETED|Overall Study||3
10236648|NCT00845845|11367381|FG001|COMPLETED|Overall Study||2
10236649|NCT00845845|11367380|FG000|NOT COMPLETED|Overall Study||0
10236650|NCT00845845|11367381|FG001|NOT COMPLETED|Overall Study||4
10236651|NCT00851591|11367389|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2
10236652|NCT00851591|11367390|FG001|STARTED|Overall Study|One received treatment.|1
10236653|NCT00851591|11367389|FG000|COMPLETED|Overall Study||0
10236654|NCT00851591|11367390|FG001|COMPLETED|Overall Study||1
10236655|NCT00851591|11367389|FG000|NOT COMPLETED|Overall Study||2
10236656|NCT00851591|11367390|FG001|NOT COMPLETED|Overall Study||0
10236657|NCT00847509|11367396|FG000|STARTED|Overall Study||49
10236658|NCT00847509|11367396|FG000|COMPLETED|Overall Study||38
10236659|NCT00847509|11367396|FG000|NOT COMPLETED|Overall Study||11
10236660|NCT00843310|11367400|FG000|STARTED|Overall Study||8
10236661|NCT00843310|11367400|FG000|COMPLETED|Overall Study||1
9815026|NCT00686998|10925261|FG000|Completed Scheduled Treatment|Overall Study||30
9815027|NCT00686998|10925262|FG001|Completed Scheduled Treatment|Overall Study||33
9815028|NCT00686998|10925263|FG002|Completed Scheduled Treatment|Overall Study||18
9815029|NCT00686998|10925261|FG000|COMPLETED|Overall Study||30
9815030|NCT00686998|10925262|FG001|COMPLETED|Overall Study||33
10112316|NCT02502734|11243367|FG001|COMPLETED|Double-blind Treatment Period 2||30
10112317|NCT02502734|11243366|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0
10112318|NCT02502734|11243367|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0
9815031|NCT00686998|10925263|FG002|COMPLETED|Overall Study||18
9815032|NCT00686998|10925261|FG000|NOT COMPLETED|Overall Study||13
9815033|NCT00686998|10925262|FG001|NOT COMPLETED|Overall Study||8
9815034|NCT00686998|10925263|FG002|NOT COMPLETED|Overall Study||4
10236662|NCT00843310|11367400|FG000|NOT COMPLETED|Overall Study||7
10236663|NCT00847002|11367406|FG000|STARTED|Overall Study||4
10236664|NCT00847002|11367407|FG001|STARTED|Overall Study||4
10236665|NCT00847002|11367406|FG000|COMPLETED|Overall Study||4
10236666|NCT00847002|11367407|FG001|COMPLETED|Overall Study||4
10236667|NCT00847002|11367406|FG000|NOT COMPLETED|Overall Study||0
10236668|NCT00847002|11367407|FG001|NOT COMPLETED|Overall Study||0
10236669|NCT00845702|11367413|FG000|STARTED|TOF MRA||33
10236670|NCT00845702|11367413|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
10236671|NCT00845702|11367413|FG000|NOT COMPLETED|TOF MRA||1
10236672|NCT00845702|11367413|FG000|STARTED|Dotarem MRA||32
10236673|NCT00845702|11367413|FG000|COMPLETED|Dotarem MRA||32
10236674|NCT00845702|11367413|FG000|NOT COMPLETED|Dotarem MRA||0
10236675|NCT00843830|11367419|FG000|STARTED|Overall Study||4
10236676|NCT00843830|11367419|FG000|COMPLETED|Overall Study||4
10236677|NCT00843830|11367419|FG000|NOT COMPLETED|Overall Study||0
10236678|NCT00835679|11367427|FG000|STARTED|Overall Study||9
10236679|NCT00835679|11367428|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
10236680|NCT00835679|11367429|FG002|STARTED|Overall Study||0
10236681|NCT00835679|11367430|FG003|STARTED|Overall Study||0
10236682|NCT00835679|11367427|FG000|COMPLETED|Overall Study||8
10236683|NCT00835679|11367428|FG001|COMPLETED|Overall Study||0
10236684|NCT00835679|11367429|FG002|COMPLETED|Overall Study||0
10236685|NCT00835679|11367430|FG003|COMPLETED|Overall Study||0
10236686|NCT00835679|11367427|FG000|NOT COMPLETED|Overall Study||1
10236687|NCT00835679|11367428|FG001|NOT COMPLETED|Overall Study||0
10236688|NCT00835679|11367429|FG002|NOT COMPLETED|Overall Study||0
10236689|NCT00835679|11367430|FG003|NOT COMPLETED|Overall Study||0
10236690|NCT00841035|11367444|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
10236691|NCT00841035|11367444|FG000|COMPLETED|Phase 1 Overall Study||6
10236692|NCT00841035|11367444|FG000|NOT COMPLETED|Phase 1 Overall Study||13
10236693|NCT00841035|11367444|FG000|STARTED|Phase 2 of Overall Study||6
10236694|NCT00841035|11367444|FG000|COMPLETED|Phase 2 of Overall Study||6
10236695|NCT00841035|11367444|FG000|NOT COMPLETED|Phase 2 of Overall Study||0
10236696|NCT00832520|11367449|FG000|STARTED|Overall Study||13
10236697|NCT00832520|11367449|FG000|COMPLETED|Overall Study||13
10236698|NCT00832520|11367449|FG000|NOT COMPLETED|Overall Study||0
10236699|NCT00833859|11367453|FG000|STARTED|Overall Study||2
10236700|NCT00833859|11367453|FG000|COMPLETED|Overall Study||2
10236701|NCT00833859|11367453|FG000|NOT COMPLETED|Overall Study||0
10236702|NCT00843050|11367457|FG000|STARTED|Overall Study||13
10236703|NCT00843050|11367457|FG000|COMPLETED|Overall Study||0
10236704|NCT00843050|11367457|FG000|NOT COMPLETED|Overall Study||13
10236705|NCT00840827|11367462|FG000|STARTED|Overall Study||6
10236706|NCT00840827|11367462|FG000|COMPLETED|Overall Study||0
10236707|NCT00840827|11367462|FG000|NOT COMPLETED|Overall Study||6
10236708|NCT00835328|11367470|FG000|STARTED|Cohort 1: Dose Level 1||5
10236709|NCT00835328|11367471|FG001|STARTED|Cohort 1: Dose Level 1||0
10236710|NCT00835328|11367472|FG002|STARTED|Cohort 1: Dose Level 1||0
10236711|NCT00835328|11367473|FG003|STARTED|Cohort 1: Dose Level 1||0
10236712|NCT00835328|11367470|FG000|COMPLETED|Cohort 1: Dose Level 1||5
10236713|NCT00835328|11367471|FG001|COMPLETED|Cohort 1: Dose Level 1||0
10236714|NCT00835328|11367472|FG002|COMPLETED|Cohort 1: Dose Level 1||0
10236715|NCT00835328|11367473|FG003|COMPLETED|Cohort 1: Dose Level 1||0
10236716|NCT00835328|11367470|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
10236717|NCT00835328|11367471|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
10236718|NCT00835328|11367472|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
10236719|NCT00835328|11367473|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
10236720|NCT00835328|11367470|FG000|STARTED|Cohort 2: Dose Level 2||0
10236721|NCT00835328|11367471|FG001|STARTED|Cohort 2: Dose Level 2||2
10236722|NCT00835328|11367472|FG002|STARTED|Cohort 2: Dose Level 2||0
10236723|NCT00835328|11367473|FG003|STARTED|Cohort 2: Dose Level 2||0
10236724|NCT00835328|11367470|FG000|COMPLETED|Cohort 2: Dose Level 2||0
10236725|NCT00835328|11367471|FG001|COMPLETED|Cohort 2: Dose Level 2||2
10236726|NCT00835328|11367472|FG002|COMPLETED|Cohort 2: Dose Level 2||0
10236727|NCT00835328|11367473|FG003|COMPLETED|Cohort 2: Dose Level 2||0
10236728|NCT00835328|11367470|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
10236729|NCT00835328|11367471|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
10236730|NCT00835328|11367472|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
10236731|NCT00835328|11367473|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0
10236732|NCT00835328|11367470|FG000|STARTED|Cohort 3: Dose Level 3||0
10236733|NCT00835328|11367471|FG001|STARTED|Cohort 3: Dose Level 3||0
10236734|NCT00835328|11367472|FG002|STARTED|Cohort 3: Dose Level 3||2
10236735|NCT00835328|11367473|FG003|STARTED|Cohort 3: Dose Level 3||0
10236736|NCT00835328|11367470|FG000|COMPLETED|Cohort 3: Dose Level 3||0
10236737|NCT00835328|11367471|FG001|COMPLETED|Cohort 3: Dose Level 3||0
10236738|NCT00835328|11367472|FG002|COMPLETED|Cohort 3: Dose Level 3||2
10236739|NCT00835328|11367473|FG003|COMPLETED|Cohort 3: Dose Level 3||0
10236740|NCT00835328|11367470|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
10236741|NCT00835328|11367471|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
10236742|NCT00835328|11367472|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
10236743|NCT00835328|11367473|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
10239765|NCT02126878|11371475|FG001|COMPLETED|Overall Study||0
9815035|NCT00687076|10925273|FG000|STARTED|Overall Study||51
9815036|NCT00687076|10925274|FG001|STARTED|Overall Study||51
9815037|NCT00687076|10925273|FG000|COMPLETED|Overall Study||19
9815038|NCT00687076|10925274|FG001|COMPLETED|Overall Study||21
9815039|NCT00687076|10925273|FG000|NOT COMPLETED|Overall Study||32
9815040|NCT00687076|10925274|FG001|NOT COMPLETED|Overall Study||30
9815041|NCT00687102|10925282|FG000|STARTED|Overall Study||733
9815042|NCT00687102|10925283|FG001|STARTED|Overall Study||765
9815043|NCT00687102|10925282|FG000|COMPLETED|Overall Study||733
9815044|NCT00687102|10925283|FG001|COMPLETED|Overall Study||765
9815045|NCT00687102|10925282|FG000|NOT COMPLETED|Overall Study||0
9815046|NCT00687102|10925283|FG001|NOT COMPLETED|Overall Study||0
9815047|NCT00687167|10925289|FG000|STARTED|First Intervention||17
9815048|NCT00687167|10925290|FG001|STARTED|First Intervention||17
9815049|NCT00687167|10925289|FG000|COMPLETED|First Intervention||17
9815050|NCT00687167|10925290|FG001|COMPLETED|First Intervention||17
9815051|NCT00687167|10925289|FG000|NOT COMPLETED|First Intervention||0
9815052|NCT00687167|10925290|FG001|NOT COMPLETED|First Intervention||0
9815053|NCT00687167|10925289|FG000|STARTED|Washout Period of 28 Days||17
9815054|NCT00687167|10925290|FG001|STARTED|Washout Period of 28 Days||17
9815055|NCT00687167|10925289|FG000|COMPLETED|Washout Period of 28 Days||17
9815056|NCT00687167|10925290|FG001|COMPLETED|Washout Period of 28 Days||17
9815057|NCT00687167|10925289|FG000|NOT COMPLETED|Washout Period of 28 Days||0
9815058|NCT00687167|10925290|FG001|NOT COMPLETED|Washout Period of 28 Days||0
9815059|NCT00687167|10925289|FG000|STARTED|Second Intervention||17
9815060|NCT00687167|10925290|FG001|STARTED|Second Intervention||17
9815061|NCT00687167|10925289|FG000|COMPLETED|Second Intervention||17
9815062|NCT00687167|10925290|FG001|COMPLETED|Second Intervention||17
9815063|NCT00687167|10925289|FG000|NOT COMPLETED|Second Intervention||0
9815064|NCT00687167|10925290|FG001|NOT COMPLETED|Second Intervention||0
9815065|NCT00687193|10925302|FG000|STARTED|Overall Study||53
9815066|NCT00687193|10925303|FG001|STARTED|Overall Study||53
9815067|NCT00687193|10925304|FG002|STARTED|Overall Study||52
9815068|NCT00687193|10925305|FG003|STARTED|Overall Study||53
9815069|NCT00687193|10925306|FG004|STARTED|Overall Study||54
9815070|NCT00687193|10925307|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
9815071|NCT00687193|10925302|FG000|COMPLETED|Overall Study||51
9815072|NCT00687193|10925303|FG001|COMPLETED|Overall Study||49
9815073|NCT00687193|10925304|FG002|COMPLETED|Overall Study||50
9815074|NCT00687193|10925305|FG003|COMPLETED|Overall Study||49
9815075|NCT00687193|10925306|FG004|COMPLETED|Overall Study||52
9815076|NCT00687193|10925307|FG005|COMPLETED|Overall Study||48
9815077|NCT00687193|10925302|FG000|NOT COMPLETED|Overall Study||2
9815078|NCT00687193|10925303|FG001|NOT COMPLETED|Overall Study||4
9815079|NCT00687193|10925304|FG002|NOT COMPLETED|Overall Study||2
9815080|NCT00687193|10925305|FG003|NOT COMPLETED|Overall Study||4
9815081|NCT00687193|10925306|FG004|NOT COMPLETED|Overall Study||2
9815082|NCT00687193|10925307|FG005|NOT COMPLETED|Overall Study||4
9815083|NCT00687219|10925324|FG000|STARTED|Overall Study||102
9815084|NCT00687219|10925324|FG000|COMPLETED|Overall Study||51
9815085|NCT00687219|10925324|FG000|NOT COMPLETED|Overall Study||51
9815086|NCT00687271|10925332|FG000|STARTED|Overall Study||94
9815087|NCT00687271|10925333|FG001|STARTED|Overall Study||96
9815088|NCT00687271|10925334|FG002|STARTED|Overall Study||96
9815089|NCT00687271|10925335|FG003|STARTED|Overall Study||48
9815090|NCT00687271|10925332|FG000|Treated|Overall Study||94
9815091|NCT00687271|10925333|FG001|Treated|Overall Study||95
9815092|NCT00687271|10925334|FG002|Treated|Overall Study||96
9815093|NCT00687271|10925335|FG003|Treated|Overall Study||48
10236744|NCT00835328|11367470|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
10236745|NCT00835328|11367471|FG001|STARTED|Cohort 4: Dose Level 4||0
10236746|NCT00835328|11367472|FG002|STARTED|Cohort 4: Dose Level 4||0
10236747|NCT00835328|11367473|FG003|STARTED|Cohort 4: Dose Level 4||4
10236748|NCT00835328|11367470|FG000|COMPLETED|Cohort 4: Dose Level 4||0
10236749|NCT00835328|11367471|FG001|COMPLETED|Cohort 4: Dose Level 4||0
9815094|NCT00687271|10925332|FG000|COMPLETED|Overall Study||91
9815095|NCT00687271|10925333|FG001|COMPLETED|Overall Study||90
9815096|NCT00687271|10925334|FG002|COMPLETED|Overall Study||91
9815097|NCT00687271|10925335|FG003|COMPLETED|Overall Study||48
9815098|NCT00687271|10925332|FG000|NOT COMPLETED|Overall Study||3
9815099|NCT00687271|10925333|FG001|NOT COMPLETED|Overall Study||6
9815100|NCT00687271|10925334|FG002|NOT COMPLETED|Overall Study||5
9815101|NCT00687271|10925335|FG003|NOT COMPLETED|Overall Study||0
9815102|NCT00687297|10925347|FG000|STARTED|Randomization||80
9815103|NCT00687297|10925348|FG001|STARTED|Randomization||82
9815104|NCT00687297|10925347|FG000|COMPLETED|Randomization||77
9815105|NCT00687297|10925348|FG001|COMPLETED|Randomization||81
9815106|NCT00687297|10925347|FG000|NOT COMPLETED|Randomization||3
9815107|NCT00687297|10925348|FG001|NOT COMPLETED|Randomization||1
9815108|NCT00687297|10925347|FG000|STARTED|Induction||77
9815109|NCT00687297|10925348|FG001|STARTED|Induction||81
9815110|NCT00687297|10925347|FG000|COMPLETED|Induction||32
9815111|NCT00687297|10925348|FG001|COMPLETED|Induction||26
9815112|NCT00687297|10925347|FG000|NOT COMPLETED|Induction||45
9815113|NCT00687297|10925348|FG001|NOT COMPLETED|Induction||55
9815114|NCT00687297|10925347|FG000|STARTED|Maintenance||32
10236750|NCT00835328|11367472|FG002|COMPLETED|Cohort 4: Dose Level 4||0
10236751|NCT00835328|11367473|FG003|COMPLETED|Cohort 4: Dose Level 4||4
10236752|NCT00835328|11367470|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0
10236753|NCT00835328|11367471|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0
9815115|NCT00687297|10925348|FG001|STARTED|Maintenance||26
9815116|NCT00687297|10925347|FG000|COMPLETED|Maintenance||29
9815117|NCT00687297|10925348|FG001|COMPLETED|Maintenance||25
9815118|NCT00687297|10925347|FG000|NOT COMPLETED|Maintenance||3
9815119|NCT00687297|10925348|FG001|NOT COMPLETED|Maintenance||1
9831864|NCT00770484|10942494|FG000|STARTED|Overall Study||8
9831865|NCT00770484|10942495|FG001|STARTED|Overall Study||4
9831866|NCT00770484|10942494|FG000|COMPLETED|Overall Study||7
9831867|NCT00770484|10942495|FG001|COMPLETED|Overall Study||4
9831868|NCT00770484|10942494|FG000|NOT COMPLETED|Overall Study||1
9831869|NCT00770484|10942495|FG001|NOT COMPLETED|Overall Study||0
9831870|NCT00770510|10942501|FG000|STARTED|Overall Study||72
9831871|NCT00770510|10942501|FG000|COMPLETED|Overall Study||67
9831872|NCT00770510|10942501|FG000|NOT COMPLETED|Overall Study||5
9831873|NCT00770562|10942515|FG000|STARTED|Overall Study||53
9831874|NCT00770562|10942516|FG001|STARTED|Overall Study||50
9831875|NCT00770562|10942515|FG000|COMPLETED|Overall Study||52
9831876|NCT00770562|10942516|FG001|COMPLETED|Overall Study||49
9831877|NCT00770562|10942515|FG000|NOT COMPLETED|Overall Study||1
9831878|NCT00770562|10942516|FG001|NOT COMPLETED|Overall Study||1
9831879|NCT00770588|10942525|FG000|STARTED|Overall Study||148
9831880|NCT00770588|10942526|FG001|STARTED|Overall Study||148
9831881|NCT00770588|10942525|FG000|COMPLETED|Overall Study||67
9831882|NCT00770588|10942526|FG001|COMPLETED|Overall Study||53
9831883|NCT00770588|10942525|FG000|NOT COMPLETED|Overall Study||81
9831884|NCT00770588|10942526|FG001|NOT COMPLETED|Overall Study||95
9831885|NCT00770601|10942533|FG000|STARTED|Overall Study||7
9831886|NCT00770601|10942533|FG000|COMPLETED|Overall Study||6
9831887|NCT00770601|10942533|FG000|NOT COMPLETED|Overall Study||1
9831888|NCT00770653|10942539|FG000|STARTED|Overall Study||155
9831889|NCT00770653|10942540|FG001|STARTED|Overall Study||150
9831890|NCT00770653|10942539|FG000|COMPLETED|Overall Study||123
10112319|NCT02502864|11243375|FG000|STARTED|Overall Study||9
10112320|NCT02502864|11243375|FG000|COMPLETED|Overall Study||8
10112321|NCT02502864|11243375|FG000|NOT COMPLETED|Overall Study||1
10112322|NCT02503085|11243379|FG000|STARTED|Period 1||7
10112323|NCT02503085|11243380|FG001|STARTED|Period 1||7
10112324|NCT02503085|11243381|FG002|STARTED|Period 1||7
10112325|NCT02503085|11243382|FG003|STARTED|Period 1||7
10112326|NCT02503085|11243379|FG000|COMPLETED|Period 1||7
10112327|NCT02503085|11243380|FG001|COMPLETED|Period 1||7
10112328|NCT02503085|11243381|FG002|COMPLETED|Period 1||7
10112329|NCT02503085|11243382|FG003|COMPLETED|Period 1||7
10112330|NCT02503085|11243379|FG000|NOT COMPLETED|Period 1||0
10112331|NCT02503085|11243380|FG001|NOT COMPLETED|Period 1||0
10112332|NCT02503085|11243381|FG002|NOT COMPLETED|Period 1||0
10112333|NCT02503085|11243382|FG003|NOT COMPLETED|Period 1||0
10112334|NCT02503085|11243379|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7
10112335|NCT02503085|11243380|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7
10112336|NCT02503085|11243381|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7
10112337|NCT02503085|11243382|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7
10112338|NCT02503085|11243379|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10112339|NCT02503085|11243380|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10112340|NCT02503085|11243381|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10112341|NCT02503085|11243382|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10112342|NCT02503085|11243379|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10112343|NCT02503085|11243380|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10112344|NCT02503085|11243381|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10112345|NCT02503085|11243382|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10112346|NCT02503085|11243379|FG000|STARTED|Period 2||7
9831891|NCT00770653|10942540|FG001|COMPLETED|Overall Study||121
9831892|NCT00770653|10942539|FG000|NOT COMPLETED|Overall Study||32
9831893|NCT00770653|10942540|FG001|NOT COMPLETED|Overall Study||29
9831894|NCT00770679|10942546|FG000|STARTED|Overall Study||16
9831895|NCT00770679|10942546|FG000|COMPLETED|Overall Study||10
9831896|NCT00770679|10942546|FG000|NOT COMPLETED|Overall Study||6
9831897|NCT00770692|10942554|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
9831898|NCT00770692|10942555|FG001|STARTED|Overall Study||83
9831899|NCT00770692|10942556|FG002|STARTED|Overall Study||84
9831900|NCT00770692|10942557|FG003|STARTED|Overall Study||77
9831901|NCT00770692|10942554|FG000|COMPLETED|Overall Study||69
9831902|NCT00770692|10942555|FG001|COMPLETED|Overall Study||74
9831903|NCT00770692|10942556|FG002|COMPLETED|Overall Study||70
9831904|NCT00770692|10942557|FG003|COMPLETED|Overall Study||66
9831905|NCT00770692|10942554|FG000|NOT COMPLETED|Overall Study||12
9831906|NCT00770692|10942555|FG001|NOT COMPLETED|Overall Study||9
9831907|NCT00770692|10942556|FG002|NOT COMPLETED|Overall Study||14
9831908|NCT00770692|10942557|FG003|NOT COMPLETED|Overall Study||11
9831909|NCT00770757|10942567|FG000|STARTED|Overall Study||13
9831910|NCT00770757|10942567|FG000|COMPLETED|Overall Study||13
9831911|NCT00770757|10942567|FG000|NOT COMPLETED|Overall Study||0
9831912|NCT00770770|10942573|FG000|STARTED|Overall Study||14
9831913|NCT00770770|10942574|FG001|STARTED|Overall Study||6
10112347|NCT02503085|11243380|FG001|STARTED|Period 2||7
10112348|NCT02503085|11243381|FG002|STARTED|Period 2||7
10112349|NCT02503085|11243382|FG003|STARTED|Period 2||7
10112350|NCT02503085|11243379|FG000|COMPLETED|Period 2||7
10112351|NCT02503085|11243380|FG001|COMPLETED|Period 2||7
10112352|NCT02503085|11243381|FG002|COMPLETED|Period 2||7
9831914|NCT00770770|10942573|FG000|COMPLETED|Overall Study||4
9831915|NCT00770770|10942574|FG001|COMPLETED|Overall Study||5
10112353|NCT02503085|11243382|FG003|COMPLETED|Period 2||7
9815120|NCT00687323|10925356|FG000|STARTED|Overall Study|Number of screened participants|195
9815121|NCT00687323|10925356|FG000|Received Treatment|Overall Study||47
9815122|NCT00687323|10925356|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15
9815123|NCT00687323|10925356|FG000|NOT COMPLETED|Overall Study||180
9815124|NCT00687362|10925360|FG000|STARTED|Overall Study||22
9815125|NCT00687362|10925360|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19
9815126|NCT00687362|10925360|FG000|NOT COMPLETED|Overall Study||3
9815127|NCT00687401|10925364|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
9815128|NCT00687401|10925364|FG000|COMPLETED|Overall Study||129
9815129|NCT00687401|10925364|FG000|NOT COMPLETED|Overall Study||30
9815130|NCT00687440|10925369|FG000|STARTED|Overall Study|Number of screened participants|27
9815131|NCT00687440|10925369|FG000|COMPLETED|Overall Study||15
9815132|NCT00687440|10925369|FG000|NOT COMPLETED|Overall Study||12
9815133|NCT00687453|10925375|FG000|STARTED|Overall Study||11
9815134|NCT00687453|10925376|FG001|STARTED|Overall Study||13
9815135|NCT00687453|10925375|FG000|COMPLETED|Overall Study||8
9815136|NCT00687453|10925376|FG001|COMPLETED|Overall Study||7
9815137|NCT00687453|10925375|FG000|NOT COMPLETED|Overall Study||3
9815138|NCT00687453|10925376|FG001|NOT COMPLETED|Overall Study||6
9815139|NCT00687544|10925382|FG000|STARTED|Overall Study||11
9815140|NCT00687544|10925382|FG000|COMPLETED|Overall Study||0
9815141|NCT00687544|10925382|FG000|NOT COMPLETED|Overall Study||11
9815142|NCT00687609|10925386|FG000|STARTED|Overall Study||7
9815143|NCT00687609|10925386|FG000|COMPLETED|Overall Study||4
9815144|NCT00687609|10925386|FG000|NOT COMPLETED|Overall Study||3
9815145|NCT00687674|10925390|FG000|STARTED|Overall Study||13
9815146|NCT00687674|10925390|FG000|COMPLETED|Overall Study||11
9815147|NCT00687674|10925390|FG000|NOT COMPLETED|Overall Study||2
9815148|NCT00687713|10925396|FG000|STARTED|Overall Study||100
9815149|NCT00687713|10925397|FG001|STARTED|Overall Study||104
9815150|NCT00687713|10925396|FG000|COMPLETED|Overall Study||68
9815151|NCT00687713|10925397|FG001|COMPLETED|Overall Study||64
9815152|NCT00687713|10925396|FG000|NOT COMPLETED|Overall Study||32
9815153|NCT00687713|10925397|FG001|NOT COMPLETED|Overall Study||40
9815154|NCT00687739|10925409|FG000|STARTED|Overall Study||25
9815155|NCT00687739|10925410|FG001|STARTED|Overall Study||15
9815156|NCT00687739|10925411|FG002|STARTED|Overall Study||25
9815157|NCT00687739|10925412|FG003|STARTED|Overall Study||14
9815158|NCT00687739|10925409|FG000|COMPLETED|Overall Study||23
9815159|NCT00687739|10925410|FG001|COMPLETED|Overall Study||12
9815160|NCT00687739|10925411|FG002|COMPLETED|Overall Study||23
9815161|NCT00687739|10925412|FG003|COMPLETED|Overall Study||12
9815162|NCT00687739|10925409|FG000|NOT COMPLETED|Overall Study||2
9815163|NCT00687739|10925410|FG001|NOT COMPLETED|Overall Study||3
9815164|NCT00687739|10925411|FG002|NOT COMPLETED|Overall Study||2
9815165|NCT00687739|10925412|FG003|NOT COMPLETED|Overall Study||2
9815166|NCT00687804|10925427|FG000|STARTED|Core Study||116
9815167|NCT00687804|10925428|FG001|STARTED|Core Study||118
9815168|NCT00687804|10925429|FG002|STARTED|Core Study||111
9815169|NCT00687804|10925427|FG000|COMPLETED|Core Study||102
9815170|NCT00687804|10925428|FG001|COMPLETED|Core Study||103
9815171|NCT00687804|10925429|FG002|COMPLETED|Core Study||98
9815172|NCT00687804|10925427|FG000|NOT COMPLETED|Core Study||14
9815173|NCT00687804|10925428|FG001|NOT COMPLETED|Core Study||15
9815174|NCT00687804|10925429|FG002|NOT COMPLETED|Core Study||13
9815175|NCT00687804|10925427|FG000|STARTED|Open-Label Extension Study||83
9815176|NCT00687804|10925428|FG001|STARTED|Open-Label Extension Study||83
9815177|NCT00687804|10925429|FG002|STARTED|Open-Label Extension Study||74
9815178|NCT00687804|10925427|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
9815179|NCT00687804|10925428|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
9815180|NCT00687804|10925429|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
9815181|NCT00687804|10925427|FG000|COMPLETED|Open-Label Extension Study||73
9815182|NCT00687804|10925428|FG001|COMPLETED|Open-Label Extension Study||72
9815183|NCT00687804|10925429|FG002|COMPLETED|Open-Label Extension Study||63
9815184|NCT00687804|10925427|FG000|NOT COMPLETED|Open-Label Extension Study||10
9815185|NCT00687804|10925428|FG001|NOT COMPLETED|Open-Label Extension Study||11
9815186|NCT00687804|10925429|FG002|NOT COMPLETED|Open-Label Extension Study||11
9815187|NCT00687830|10925445|FG000|STARTED|Overall Study||68
9815188|NCT00687830|10925446|FG001|STARTED|Overall Study||68
9815189|NCT00687830|10925445|FG000|COMPLETED|Overall Study||68
9815190|NCT00687830|10925446|FG001|COMPLETED|Overall Study||68
9815191|NCT00687830|10925445|FG000|NOT COMPLETED|Overall Study||0
9815192|NCT00687830|10925446|FG001|NOT COMPLETED|Overall Study||0
9815193|NCT00687856|10925452|FG000|STARTED|Overall Study||211
9815194|NCT00687856|10925452|FG000|COMPLETED|Overall Study||211
9815195|NCT00687856|10925452|FG000|NOT COMPLETED|Overall Study||0
9815196|NCT00687908|10925458|FG000|STARTED|Overall Study||123
9815197|NCT00687908|10925459|FG001|STARTED|Overall Study||120
9815198|NCT00687908|10925458|FG000|COMPLETED|Overall Study||105
9815199|NCT00687908|10925459|FG001|COMPLETED|Overall Study||78
9815200|NCT00687908|10925458|FG000|NOT COMPLETED|Overall Study||18
9815201|NCT00687908|10925459|FG001|NOT COMPLETED|Overall Study||42
9815202|NCT00687973|10925467|FG000|STARTED|Overall Study||193
9815203|NCT00687973|10925468|FG001|STARTED|Overall Study||200
9815204|NCT00687973|10925467|FG000|COMPLETED|Overall Study||169
9815205|NCT00687973|10925468|FG001|COMPLETED|Overall Study||162
9815206|NCT00687973|10925467|FG000|NOT COMPLETED|Overall Study||24
9815207|NCT00687973|10925468|FG001|NOT COMPLETED|Overall Study||38
9815208|NCT00688064|10925477|FG000|STARTED|Overall Study||232
9815209|NCT00688064|10925478|FG001|STARTED|Overall Study||227
9815210|NCT00688064|10925477|FG000|COMPLETED|Overall Study||211
9815211|NCT00688064|10925478|FG001|COMPLETED|Overall Study||201
9815212|NCT00688064|10925477|FG000|NOT COMPLETED|Overall Study||21
9815213|NCT00688064|10925478|FG001|NOT COMPLETED|Overall Study||26
9815214|NCT00688103|10925486|FG000|STARTED|Overall Study||74
9815215|NCT00688103|10925487|FG001|STARTED|Overall Study||77
9815216|NCT00688103|10925486|FG000|Actually Treated|Overall Study||71
9815217|NCT00688103|10925487|FG001|Actually Treated|Overall Study||76
9815218|NCT00688103|10925486|FG000|COMPLETED|Overall Study||44
9815219|NCT00688103|10925487|FG001|COMPLETED|Overall Study||64
9815220|NCT00688103|10925486|FG000|NOT COMPLETED|Overall Study||30
9815221|NCT00688103|10925487|FG001|NOT COMPLETED|Overall Study||13
9815222|NCT00688155|10925499|FG000|STARTED|Overall Study||18
9815223|NCT00688155|10925500|FG001|STARTED|Overall Study||18
9815224|NCT00688155|10925501|FG002|STARTED|Overall Study||19
9815225|NCT00688155|10925502|FG003|STARTED|Overall Study||18
9815226|NCT00688155|10925499|FG000|COMPLETED|Overall Study||16
9815227|NCT00688155|10925500|FG001|COMPLETED|Overall Study||16
9815228|NCT00688155|10925501|FG002|COMPLETED|Overall Study||18
9815229|NCT00688155|10925502|FG003|COMPLETED|Overall Study||17
9815230|NCT00688155|10925499|FG000|NOT COMPLETED|Overall Study||2
9815231|NCT00688155|10925500|FG001|NOT COMPLETED|Overall Study||2
9815232|NCT00688155|10925501|FG002|NOT COMPLETED|Overall Study||1
9815233|NCT00688155|10925502|FG003|NOT COMPLETED|Overall Study||1
9815234|NCT00688181|10925512|FG000|STARTED|Overall Study||36
9815235|NCT00688181|10925512|FG000|COMPLETED|Overall Study||13
9815236|NCT00688181|10925512|FG000|NOT COMPLETED|Overall Study||23
9815237|NCT00688259|10925520|FG000|STARTED|Overall Study||44
9815238|NCT00688259|10925521|FG001|STARTED|Overall Study||44
9815239|NCT00688259|10925520|FG000|End to Active Treatment,|Overall Study||37
9815240|NCT00688259|10925521|FG001|End to Active Treatment,|Overall Study||37
9815241|NCT00688259|10925520|FG000|COMPLETED|Overall Study||37
9815242|NCT00688259|10925521|FG001|COMPLETED|Overall Study||36
9815243|NCT00688259|10925520|FG000|NOT COMPLETED|Overall Study||7
9815244|NCT00688259|10925521|FG001|NOT COMPLETED|Overall Study||8
9815245|NCT00688324|10925527|FG000|STARTED|Overall Study||36
9815246|NCT00688324|10925527|FG000|COMPLETED|Overall Study||28
9815247|NCT00688324|10925527|FG000|NOT COMPLETED|Overall Study||8
10016650|NCT01811303|11139417|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10016651|NCT01811303|11139418|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10016652|NCT01811303|11139415|FG000|STARTED|Washout (2 Days or More)||4
10016653|NCT01811303|11139416|FG001|STARTED|Washout (2 Days or More)||4
10016654|NCT01811303|11139417|FG002|STARTED|Washout (2 Days or More)||4
10016655|NCT01811303|11139418|FG003|STARTED|Washout (2 Days or More)||2
10016656|NCT01811303|11139415|FG000|COMPLETED|Washout (2 Days or More)||4
10016657|NCT01811303|11139416|FG001|COMPLETED|Washout (2 Days or More)||4
10016658|NCT01811303|11139417|FG002|COMPLETED|Washout (2 Days or More)||4
9815248|NCT00688467|10925534|FG000|STARTED|Treatment Period 1||9
9815249|NCT00688467|10925535|FG001|STARTED|Treatment Period 1||10
9815250|NCT00688467|10925534|FG000|COMPLETED|Treatment Period 1||7
9815251|NCT00688467|10925535|FG001|COMPLETED|Treatment Period 1||8
9815252|NCT00688467|10925534|FG000|NOT COMPLETED|Treatment Period 1||2
9815253|NCT00688467|10925535|FG001|NOT COMPLETED|Treatment Period 1||2
9815254|NCT00688467|10925534|FG000|STARTED|Treatment Period 2||7
9815255|NCT00688467|10925535|FG001|STARTED|Treatment Period 2||8
9815256|NCT00688467|10925534|FG000|COMPLETED|Treatment Period 2||7
9815257|NCT00688467|10925535|FG001|COMPLETED|Treatment Period 2||6
9815258|NCT00688467|10925534|FG000|NOT COMPLETED|Treatment Period 2||0
9815259|NCT00688467|10925535|FG001|NOT COMPLETED|Treatment Period 2||2
9815260|NCT00688519|10925543|FG000|STARTED|Overall Study||223
9815261|NCT00688519|10925544|FG001|STARTED|Overall Study||113
9815262|NCT00688519|10925543|FG000|COMPLETED|Overall Study||204
9815263|NCT00688519|10925544|FG001|COMPLETED|Overall Study||98
9815264|NCT00688519|10925543|FG000|NOT COMPLETED|Overall Study||19
9815265|NCT00688519|10925544|FG001|NOT COMPLETED|Overall Study||15
9815266|NCT00688545|10925552|FG000|STARTED|Overall Study||55
9815267|NCT00688545|10925553|FG001|STARTED|Overall Study||219
9815268|NCT00688545|10925552|FG000|Switched Treatment at Least Once|Overall Study||6
9815269|NCT00688545|10925553|FG001|Switched Treatment at Least Once|Overall Study||13
9815270|NCT00688545|10925552|FG000|COMPLETED|Overall Study||50
9815271|NCT00688545|10925553|FG001|COMPLETED|Overall Study||204
9815272|NCT00688545|10925552|FG000|NOT COMPLETED|Overall Study||5
9815273|NCT00688545|10925553|FG001|NOT COMPLETED|Overall Study||15
9815274|NCT00688597|10925564|FG000|STARTED|Overall Study||3
9815275|NCT00688597|10925565|FG001|STARTED|Overall Study||0
9815276|NCT00688597|10925566|FG002|STARTED|Overall Study||0
9815277|NCT00688597|10925564|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9815278|NCT00688597|10925565|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0
10016659|NCT01811303|11139418|FG003|COMPLETED|Washout (2 Days or More)||2
9815279|NCT00688597|10925566|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0
9815280|NCT00688597|10925564|FG000|COMPLETED|Overall Study||0
9815281|NCT00688597|10925565|FG001|COMPLETED|Overall Study||0
9815282|NCT00688597|10925566|FG002|COMPLETED|Overall Study||0
9815283|NCT00688597|10925564|FG000|NOT COMPLETED|Overall Study||3
9815284|NCT00688597|10925565|FG001|NOT COMPLETED|Overall Study||0
9815285|NCT00688597|10925566|FG002|NOT COMPLETED|Overall Study||0
9815286|NCT00688623|10925574|FG000|STARTED|Overall Study|Intent to treat (ITT)|73
9815287|NCT00688623|10925574|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
9815288|NCT00688623|10925574|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
9815289|NCT00688623|10925574|FG000|COMPLETED|Overall Study||18
9815290|NCT00688623|10925574|FG000|NOT COMPLETED|Overall Study||55
9815291|NCT00688636|10925580|FG000|STARTED|Overall Study||11
9815292|NCT00688636|10925581|FG001|STARTED|Overall Study||13
9815293|NCT00688636|10925580|FG000|COMPLETED|Overall Study||9
9815294|NCT00688636|10925581|FG001|COMPLETED|Overall Study||12
9815295|NCT00688636|10925580|FG000|NOT COMPLETED|Overall Study||2
9815296|NCT00688636|10925581|FG001|NOT COMPLETED|Overall Study||1
9815297|NCT00688662|10925589|FG000|STARTED|Overall Study||141
9815298|NCT00688662|10925590|FG001|STARTED|Overall Study||73
9815299|NCT00688662|10925589|FG000|COMPLETED|Overall Study||118
9815300|NCT00688662|10925590|FG001|COMPLETED|Overall Study||55
9815301|NCT00688662|10925589|FG000|NOT COMPLETED|Overall Study||23
9815302|NCT00688662|10925590|FG001|NOT COMPLETED|Overall Study||18
9815303|NCT00688688|10925600|FG000|STARTED|Overall Study||815
9815304|NCT00688688|10925601|FG001|STARTED|Overall Study||824
9815305|NCT00688688|10925602|FG002|STARTED|Overall Study||813
9815306|NCT00688688|10925600|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
9815307|NCT00688688|10925601|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
9815308|NCT00688688|10925602|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
9815309|NCT00688688|10925600|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
9815310|NCT00688688|10925601|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
9815311|NCT00688688|10925602|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
9815312|NCT00688688|10925600|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
9815313|NCT00688688|10925601|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
9815314|NCT00688688|10925602|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
9815315|NCT00688688|10925600|FG000|COMPLETED|Overall Study||629
9815316|NCT00688688|10925601|FG001|COMPLETED|Overall Study||645
9815317|NCT00688688|10925602|FG002|COMPLETED|Overall Study||621
9815318|NCT00688688|10925600|FG000|NOT COMPLETED|Overall Study||186
9815319|NCT00688688|10925601|FG001|NOT COMPLETED|Overall Study||179
9815320|NCT00688688|10925602|FG002|NOT COMPLETED|Overall Study||192
9815321|NCT00688701|10925613|FG000|STARTED|Overall Study|Randomized|61
9815322|NCT00688701|10925614|FG001|STARTED|Overall Study||61
9815323|NCT00688701|10925615|FG002|STARTED|Overall Study||120
9815324|NCT00688701|10925616|FG003|STARTED|Overall Study||119
9815325|NCT00688701|10925613|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
9815326|NCT00688701|10925614|FG001|Treated/Safety Population|Overall Study||61
9815327|NCT00688701|10925615|FG002|Treated/Safety Population|Overall Study||120
9815328|NCT00688701|10925616|FG003|Treated/Safety Population|Overall Study||119
9815329|NCT00688701|10925613|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
9815330|NCT00688701|10925614|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60
9815331|NCT00688701|10925615|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120
9815332|NCT00688701|10925616|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118
9815333|NCT00688701|10925613|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
9815334|NCT00688701|10925614|FG001|Subgroup for Standardized Meal Test|Overall Study||35
9815335|NCT00688701|10925615|FG002|Subgroup for Standardized Meal Test|Overall Study||60
9815336|NCT00688701|10925616|FG003|Subgroup for Standardized Meal Test|Overall Study||65
9815337|NCT00688701|10925613|FG000|COMPLETED|Overall Study||57
9815338|NCT00688701|10925614|FG001|COMPLETED|Overall Study||56
9815339|NCT00688701|10925615|FG002|COMPLETED|Overall Study||110
9815340|NCT00688701|10925616|FG003|COMPLETED|Overall Study||108
9815341|NCT00688701|10925613|FG000|NOT COMPLETED|Overall Study||4
9815342|NCT00688701|10925614|FG001|NOT COMPLETED|Overall Study||5
9815343|NCT00688701|10925615|FG002|NOT COMPLETED|Overall Study||10
9815344|NCT00688701|10925616|FG003|NOT COMPLETED|Overall Study||11
9815345|NCT00688740|10925629|FG000|STARTED|Overall Study||745
9815346|NCT00688740|10925630|FG001|STARTED|Overall Study||746
9815347|NCT00688740|10925629|FG000|COMPLETED|Overall Study||679
9815348|NCT00688740|10925630|FG001|COMPLETED|Overall Study||711
9815349|NCT00688740|10925629|FG000|NOT COMPLETED|Overall Study||66
9815350|NCT00688740|10925630|FG001|NOT COMPLETED|Overall Study||35
9815351|NCT00688753|10925636|FG000|STARTED|Overall Study||92
9815352|NCT00688753|10925636|FG000|COMPLETED|Overall Study||0
9815353|NCT00688753|10925636|FG000|NOT COMPLETED|Overall Study||92
9815354|NCT00688844|10925640|FG000|STARTED|Overall Study||58
9815355|NCT00688844|10925640|FG000|COMPLETED|Overall Study||48
9815356|NCT00688844|10925640|FG000|NOT COMPLETED|Overall Study||10
9815357|NCT00688870|10925646|FG000|STARTED|Infant Series||84
9815358|NCT00688870|10925647|FG001|STARTED|Infant Series||84
9815359|NCT00688870|10925646|FG000|Vaccinated Dose 1|Infant Series||83
9815360|NCT00688870|10925647|FG001|Vaccinated Dose 1|Infant Series||84
9815361|NCT00688870|10925646|FG000|Vaccinated Dose 2|Infant Series||80
9815362|NCT00688870|10925647|FG001|Vaccinated Dose 2|Infant Series||84
9815363|NCT00688870|10925646|FG000|Vaccinated Dose 3|Infant Series||80
9815364|NCT00688870|10925647|FG001|Vaccinated Dose 3|Infant Series||84
9815365|NCT00688870|10925646|FG000|COMPLETED|Infant Series||80
9815366|NCT00688870|10925647|FG001|COMPLETED|Infant Series||84
9815367|NCT00688870|10925646|FG000|NOT COMPLETED|Infant Series||4
9815368|NCT00688870|10925647|FG001|NOT COMPLETED|Infant Series||0
9815369|NCT00688870|10925646|FG000|STARTED|After Infant Series||80
9815370|NCT00688870|10925647|FG001|STARTED|After Infant Series||84
9815371|NCT00688870|10925646|FG000|COMPLETED|After Infant Series||80
9815372|NCT00688870|10925647|FG001|COMPLETED|After Infant Series||84
9815373|NCT00688870|10925646|FG000|NOT COMPLETED|After Infant Series||0
9815374|NCT00688870|10925647|FG001|NOT COMPLETED|After Infant Series||0
9815375|NCT00688870|10925646|FG000|STARTED|Toddler Dose||80
9815376|NCT00688870|10925647|FG001|STARTED|Toddler Dose||84
9815377|NCT00688870|10925646|FG000|COMPLETED|Toddler Dose||80
9815378|NCT00688870|10925647|FG001|COMPLETED|Toddler Dose||84
9815379|NCT00688870|10925646|FG000|NOT COMPLETED|Toddler Dose||0
9815380|NCT00688870|10925647|FG001|NOT COMPLETED|Toddler Dose||0
9815381|NCT00688909|10925657|FG000|STARTED|Overall Study||261
10016660|NCT01811303|11139415|FG000|NOT COMPLETED|Washout (2 Days or More)||0
10016661|NCT01811303|11139416|FG001|NOT COMPLETED|Washout (2 Days or More)||0
9815382|NCT00688909|10925657|FG000|COMPLETED|Overall Study||228
9815383|NCT00688909|10925657|FG000|NOT COMPLETED|Overall Study||33
9815384|NCT00689026|10925664|FG000|STARTED|Overall Study||30
9815385|NCT00689026|10925665|FG001|STARTED|Overall Study||30
9815386|NCT00689026|10925664|FG000|COMPLETED|Overall Study||17
9815387|NCT00689026|10925665|FG001|COMPLETED|Overall Study||24
9815388|NCT00689026|10925664|FG000|NOT COMPLETED|Overall Study||13
9815389|NCT00689026|10925665|FG001|NOT COMPLETED|Overall Study||6
9815390|NCT00689078|10925675|FG000|STARTED|Overall Study||9
9815391|NCT00689078|10925676|FG001|STARTED|Overall Study||9
9815392|NCT00689078|10925677|FG002|STARTED|Overall Study||9
9815393|NCT00689078|10925678|FG003|STARTED|Overall Study||9
9815394|NCT00689078|10925675|FG000|Intent to Treat|Overall Study||9
9815395|NCT00689078|10925676|FG001|Intent to Treat|Overall Study||7
9815396|NCT00689078|10925677|FG002|Intent to Treat|Overall Study||8
9815397|NCT00689078|10925678|FG003|Intent to Treat|Overall Study||8
9815398|NCT00689078|10925675|FG000|COMPLETED|Overall Study||9
9815399|NCT00689078|10925676|FG001|COMPLETED|Overall Study||7
9815400|NCT00689078|10925677|FG002|COMPLETED|Overall Study||8
9815401|NCT00689078|10925678|FG003|COMPLETED|Overall Study||8
9815402|NCT00689078|10925675|FG000|NOT COMPLETED|Overall Study||0
9815403|NCT00689078|10925676|FG001|NOT COMPLETED|Overall Study||2
9815404|NCT00689078|10925677|FG002|NOT COMPLETED|Overall Study||1
9815405|NCT00689078|10925678|FG003|NOT COMPLETED|Overall Study||1
9815406|NCT00689091|10925690|FG000|STARTED|Overall Study||10831
9815407|NCT00689091|10925691|FG001|STARTED|Overall Study||10770
9815408|NCT00689091|10925690|FG000|COMPLETED|Overall Study||9460
9815409|NCT00689091|10925691|FG001|COMPLETED|Overall Study||9376
9815410|NCT00689091|10925690|FG000|NOT COMPLETED|Overall Study||1371
9815411|NCT00689091|10925691|FG001|NOT COMPLETED|Overall Study||1394
9815412|NCT00689104|10925705|FG000|STARTED|Overall Study||497
9815413|NCT00689104|10925706|FG001|STARTED|Overall Study||497
9815414|NCT00689104|10925707|FG002|STARTED|Overall Study||498
9815415|NCT00689104|10925708|FG003|STARTED|Overall Study||495
9815416|NCT00689104|10925705|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
9815417|NCT00689104|10925706|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
9815418|NCT00689104|10925707|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
9815419|NCT00689104|10925708|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
9815420|NCT00689104|10925705|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
9815421|NCT00689104|10925706|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
9815422|NCT00689104|10925707|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
10016662|NCT01811303|11139417|FG002|NOT COMPLETED|Washout (2 Days or More)||0
9815423|NCT00689104|10925708|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
9815424|NCT00689104|10925705|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
9815425|NCT00689104|10925706|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
9815426|NCT00689104|10925707|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
9815427|NCT00689104|10925708|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
9815428|NCT00689104|10925705|FG000|COMPLETED|Overall Study||453
9815429|NCT00689104|10925706|FG001|COMPLETED|Overall Study||440
9815430|NCT00689104|10925707|FG002|COMPLETED|Overall Study||453
9815431|NCT00689104|10925708|FG003|COMPLETED|Overall Study||445
9815432|NCT00689104|10925705|FG000|NOT COMPLETED|Overall Study||44
9815433|NCT00689104|10925706|FG001|NOT COMPLETED|Overall Study||57
9815434|NCT00689104|10925707|FG002|NOT COMPLETED|Overall Study||45
9815435|NCT00689104|10925708|FG003|NOT COMPLETED|Overall Study||50
9815436|NCT00689117|10925722|FG000|STARTED|Overall Study||476
9815437|NCT00689117|10925723|FG001|STARTED|Overall Study||467
9815438|NCT00689117|10925724|FG002|STARTED|Overall Study||464
9815439|NCT00689117|10925725|FG003|STARTED|Overall Study||242
9815440|NCT00689117|10925722|FG000|COMPLETED|Overall Study||414
9815441|NCT00689117|10925723|FG001|COMPLETED|Overall Study||416
9815442|NCT00689117|10925724|FG002|COMPLETED|Overall Study||405
9815443|NCT00689117|10925725|FG003|COMPLETED|Overall Study||211
9815444|NCT00689117|10925722|FG000|NOT COMPLETED|Overall Study||62
9815445|NCT00689117|10925723|FG001|NOT COMPLETED|Overall Study||51
9815446|NCT00689117|10925724|FG002|NOT COMPLETED|Overall Study||59
9815447|NCT00689117|10925725|FG003|NOT COMPLETED|Overall Study||31
9815448|NCT00689221|10925737|FG000|STARTED|Overall Study||272
9815449|NCT00689221|10925738|FG001|STARTED|Overall Study||273
10016663|NCT01811303|11139418|FG003|NOT COMPLETED|Washout (2 Days or More)||0
10016664|NCT01811303|11139415|FG000|STARTED|Fourth Intervention (1 Day)||4
9815450|NCT00689221|10925737|FG000|COMPLETED|Overall Study||233
9815451|NCT00689221|10925738|FG001|COMPLETED|Overall Study||237
9815452|NCT00689221|10925737|FG000|NOT COMPLETED|Overall Study||39
9815453|NCT00689221|10925738|FG001|NOT COMPLETED|Overall Study||36
9815454|NCT00689260|10925746|FG000|STARTED|Overall Study||21
9815455|NCT00689260|10925747|FG001|STARTED|Overall Study||21
9815456|NCT00689260|10925746|FG000|COMPLETED|Overall Study||19
9815457|NCT00689260|10925747|FG001|COMPLETED|Overall Study||21
9815458|NCT00689260|10925746|FG000|NOT COMPLETED|Overall Study||2
9815459|NCT00689260|10925747|FG001|NOT COMPLETED|Overall Study||0
9815460|NCT00689273|10925758|FG000|STARTED|Overall Study||79
9815461|NCT00689273|10925759|FG001|STARTED|Overall Study||78
9815462|NCT00689273|10925758|FG000|Treated|Overall Study||78
9815463|NCT00689273|10925759|FG001|Treated|Overall Study||78
9815464|NCT00689273|10925758|FG000|COMPLETED|Overall Study||66
9815465|NCT00689273|10925759|FG001|COMPLETED|Overall Study||73
9815466|NCT00689273|10925758|FG000|NOT COMPLETED|Overall Study||13
9815467|NCT00689273|10925759|FG001|NOT COMPLETED|Overall Study||5
9815468|NCT00689299|10925768|FG000|STARTED|Overall Study||58
9815469|NCT00689299|10925769|FG001|STARTED|Overall Study||57
9815470|NCT00689299|10925770|FG002|STARTED|Overall Study||54
9815471|NCT00689299|10925768|FG000|COMPLETED|Overall Study||51
9815472|NCT00689299|10925769|FG001|COMPLETED|Overall Study||54
9815473|NCT00689299|10925770|FG002|COMPLETED|Overall Study||49
9815474|NCT00689299|10925768|FG000|NOT COMPLETED|Overall Study||7
9815475|NCT00689299|10925769|FG001|NOT COMPLETED|Overall Study||3
9815476|NCT00689299|10925770|FG002|NOT COMPLETED|Overall Study||5
9815477|NCT00689338|10925778|FG000|STARTED|Overall Study||216
9815478|NCT00689338|10925778|FG000|COMPLETED|Overall Study||73
9815479|NCT00689338|10925778|FG000|NOT COMPLETED|Overall Study||143
9815480|NCT00689351|10925784|FG000|STARTED|Infant Series of Dosing||91
9815481|NCT00689351|10925785|FG001|STARTED|Infant Series of Dosing||89
9815482|NCT00689351|10925784|FG000|Vaccinated Dose 1|Infant Series of Dosing||88
9815483|NCT00689351|10925785|FG001|Vaccinated Dose 1|Infant Series of Dosing||89
9815484|NCT00689351|10925784|FG000|Vaccinated Dose 2|Infant Series of Dosing||86
9815485|NCT00689351|10925785|FG001|Vaccinated Dose 2|Infant Series of Dosing||88
9815486|NCT00689351|10925784|FG000|Vaccinated Dose 3|Infant Series of Dosing||85
9815487|NCT00689351|10925785|FG001|Vaccinated Dose 3|Infant Series of Dosing||88
9815488|NCT00689351|10925784|FG000|COMPLETED|Infant Series of Dosing||85
9815489|NCT00689351|10925785|FG001|COMPLETED|Infant Series of Dosing||88
9815490|NCT00689351|10925784|FG000|NOT COMPLETED|Infant Series of Dosing||6
9815491|NCT00689351|10925785|FG001|NOT COMPLETED|Infant Series of Dosing||1
9815492|NCT00689351|10925784|FG000|STARTED|After Infant Series||85
9815493|NCT00689351|10925785|FG001|STARTED|After Infant Series||88
9815494|NCT00689351|10925784|FG000|COMPLETED|After Infant Series||84
9815495|NCT00689351|10925785|FG001|COMPLETED|After Infant Series||88
9815496|NCT00689351|10925784|FG000|NOT COMPLETED|After Infant Series||1
9815497|NCT00689351|10925785|FG001|NOT COMPLETED|After Infant Series||0
9815498|NCT00689351|10925784|FG000|STARTED|Toddler Dose||84
9815499|NCT00689351|10925785|FG001|STARTED|Toddler Dose||88
9815500|NCT00689351|10925784|FG000|COMPLETED|Toddler Dose||84
9815501|NCT00689351|10925785|FG001|COMPLETED|Toddler Dose||88
9815502|NCT00689351|10925784|FG000|NOT COMPLETED|Toddler Dose||0
9815503|NCT00689351|10925785|FG001|NOT COMPLETED|Toddler Dose||0
9815504|NCT00689390|10925797|FG000|STARTED|Overall Study||1907
9815505|NCT00689390|10925798|FG001|STARTED|Overall Study||47
9815506|NCT00689390|10925797|FG000|COMPLETED|Overall Study||1481
9815507|NCT00689390|10925798|FG001|COMPLETED|Overall Study||37
9815508|NCT00689390|10925797|FG000|NOT COMPLETED|Overall Study||426
9815509|NCT00689390|10925798|FG001|NOT COMPLETED|Overall Study||10
9815510|NCT00689481|10925811|FG000|STARTED|Overall Study||214
9815511|NCT00689481|10925812|FG001|STARTED|Overall Study||109
9815512|NCT00689481|10925811|FG000|COMPLETED|Overall Study||190
9815513|NCT00689481|10925812|FG001|COMPLETED|Overall Study||95
9815514|NCT00689481|10925811|FG000|NOT COMPLETED|Overall Study||24
10016665|NCT01811303|11139416|FG001|STARTED|Fourth Intervention (1 Day)||4
9815515|NCT00689481|10925812|FG001|NOT COMPLETED|Overall Study||14
9815516|NCT00689572|10925820|FG000|STARTED|Overall Study||53
9815517|NCT00689572|10925821|FG001|STARTED|Overall Study||55
9815518|NCT00689572|10925820|FG000|COMPLETED|Overall Study||39
9815519|NCT00689572|10925821|FG001|COMPLETED|Overall Study||34
9815520|NCT00689572|10925820|FG000|NOT COMPLETED|Overall Study||14
9815521|NCT00689572|10925821|FG001|NOT COMPLETED|Overall Study||21
9815522|NCT00689611|10925829|FG000|STARTED|Overall Study||200
9815523|NCT00689611|10925830|FG001|STARTED|Overall Study||192
9815524|NCT00689611|10925829|FG000|COMPLETED|Overall Study||159
9815525|NCT00689611|10925830|FG001|COMPLETED|Overall Study||146
9815526|NCT00689611|10925829|FG000|NOT COMPLETED|Overall Study||41
9815527|NCT00689611|10925830|FG001|NOT COMPLETED|Overall Study||46
9815528|NCT00689728|10925839|FG000|STARTED|Double-Blind Treatment||35
9815529|NCT00689728|10925840|FG001|STARTED|Double-Blind Treatment||30
9815530|NCT00689728|10925841|FG002|STARTED|Double-Blind Treatment||35
9815531|NCT00689728|10925839|FG000|COMPLETED|Double-Blind Treatment||31
10016666|NCT01811303|11139417|FG002|STARTED|Fourth Intervention (1 Day)||4
10016667|NCT01811303|11139418|FG003|STARTED|Fourth Intervention (1 Day)||2
10016668|NCT01811303|11139415|FG000|COMPLETED|Fourth Intervention (1 Day)||4
9815532|NCT00689728|10925840|FG001|COMPLETED|Double-Blind Treatment||26
9815533|NCT00689728|10925841|FG002|COMPLETED|Double-Blind Treatment||30
9815534|NCT00689728|10925839|FG000|NOT COMPLETED|Double-Blind Treatment||4
9815535|NCT00689728|10925840|FG001|NOT COMPLETED|Double-Blind Treatment||4
9815536|NCT00689728|10925841|FG002|NOT COMPLETED|Double-Blind Treatment||5
9815537|NCT00689728|10925839|FG000|STARTED|Rescue||31
9815538|NCT00689728|10925840|FG001|STARTED|Rescue||26
9815539|NCT00689728|10925841|FG002|STARTED|Rescue||30
9815540|NCT00689728|10925839|FG000|COMPLETED|Rescue||30
9815541|NCT00689728|10925840|FG001|COMPLETED|Rescue||24
9815542|NCT00689728|10925841|FG002|COMPLETED|Rescue||29
9815543|NCT00689728|10925839|FG000|NOT COMPLETED|Rescue||1
9815544|NCT00689728|10925840|FG001|NOT COMPLETED|Rescue||2
9815545|NCT00689728|10925841|FG002|NOT COMPLETED|Rescue||1
9815546|NCT00689728|10925839|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
9815547|NCT00689728|10925840|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
9815548|NCT00689728|10925841|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
9815549|NCT00689728|10925839|FG000|COMPLETED|Optional Follow-Up||6
9815550|NCT00689728|10925840|FG001|COMPLETED|Optional Follow-Up||5
9815551|NCT00689728|10925841|FG002|COMPLETED|Optional Follow-Up||4
9815552|NCT00689728|10925839|FG000|NOT COMPLETED|Optional Follow-Up||3
9815553|NCT00689728|10925840|FG001|NOT COMPLETED|Optional Follow-Up||6
9815554|NCT00689728|10925841|FG002|NOT COMPLETED|Optional Follow-Up||6
9815555|NCT00689793|10925872|FG000|STARTED|Overall Study||78
9815556|NCT00689793|10925873|FG001|STARTED|Overall Study||76
9815557|NCT00689793|10925872|FG000|COMPLETED|Overall Study||74
9815558|NCT00689793|10925873|FG001|COMPLETED|Overall Study||71
9815559|NCT00689793|10925872|FG000|NOT COMPLETED|Overall Study||4
9815560|NCT00689793|10925873|FG001|NOT COMPLETED|Overall Study||5
9815561|NCT00689819|10925883|FG000|STARTED|Overall Study||65
9815562|NCT00689819|10925884|FG001|STARTED|Overall Study||58
9815563|NCT00689819|10925883|FG000|COMPLETED|Overall Study||45
9815564|NCT00689819|10925884|FG001|COMPLETED|Overall Study||43
9815565|NCT00689819|10925883|FG000|NOT COMPLETED|Overall Study||20
9815566|NCT00689819|10925884|FG001|NOT COMPLETED|Overall Study||15
9815567|NCT00689871|10925894|FG000|STARTED|Overall Study|908 Implants|455
9815568|NCT00689871|10925895|FG001|STARTED|Overall Study|127 Implants|98
9815569|NCT00689871|10925896|FG002|STARTED|Overall Study|288 Implants|147
9815570|NCT00689871|10925897|FG003|STARTED|Overall Study|25 Implants|15
9815571|NCT00689871|10925894|FG000|COMPLETED|Overall Study|35 Patients discontinued|280
9815572|NCT00689871|10925895|FG001|COMPLETED|Overall Study|35 Patients discontinued|46
9815573|NCT00689871|10925896|FG002|COMPLETED|Overall Study|28 Patients discontinued|74
9815574|NCT00689871|10925897|FG003|COMPLETED|Overall Study|4 Patients discontinued|8
9815575|NCT00689871|10925894|FG000|NOT COMPLETED|Overall Study||175
9815576|NCT00689871|10925895|FG001|NOT COMPLETED|Overall Study||52
9815577|NCT00689871|10925896|FG002|NOT COMPLETED|Overall Study||73
9815578|NCT00689871|10925897|FG003|NOT COMPLETED|Overall Study||7
9815579|NCT00689936|10925910|FG000|STARTED|Active Treatment Phase||535
9815580|NCT00689936|10925911|FG001|STARTED|Active Treatment Phase||541
9815581|NCT00689936|10925912|FG002|STARTED|Active Treatment Phase||547
9815582|NCT00689936|10925910|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
9815583|NCT00689936|10925911|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
9815584|NCT00689936|10925912|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
9815585|NCT00689936|10925910|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
9815586|NCT00689936|10925911|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
9815587|NCT00689936|10925912|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
9815588|NCT00689936|10925910|FG000|COMPLETED|Active Treatment Phase||0
10016669|NCT01811303|11139416|FG001|COMPLETED|Fourth Intervention (1 Day)||4
9815589|NCT00689936|10925911|FG001|COMPLETED|Active Treatment Phase||0
9815590|NCT00689936|10925912|FG002|COMPLETED|Active Treatment Phase||0
9815591|NCT00689936|10925910|FG000|NOT COMPLETED|Active Treatment Phase||535
9815592|NCT00689936|10925911|FG001|NOT COMPLETED|Active Treatment Phase||541
9815593|NCT00689936|10925912|FG002|NOT COMPLETED|Active Treatment Phase||547
9815594|NCT00689936|10925910|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
9831916|NCT00770770|10942573|FG000|NOT COMPLETED|Overall Study||10
10016670|NCT01811303|11139417|FG002|COMPLETED|Fourth Intervention (1 Day)||4
9815595|NCT00689936|10925911|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
9815596|NCT00689936|10925912|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
9815597|NCT00689936|10925910|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
9815598|NCT00689936|10925911|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
9815599|NCT00689936|10925912|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
9815600|NCT00689936|10925910|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
9815601|NCT00689936|10925911|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
9815602|NCT00689936|10925912|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
9815603|NCT00689936|10925910|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
9815604|NCT00689936|10925911|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
9815605|NCT00689936|10925912|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
9815606|NCT00689936|10925910|FG000|COMPLETED|Long-Term Follow Up Phase||255
9815607|NCT00689936|10925911|FG001|COMPLETED|Long-Term Follow Up Phase||275
9815608|NCT00689936|10925912|FG002|COMPLETED|Long-Term Follow Up Phase||315
9815609|NCT00689936|10925910|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127
9815610|NCT00689936|10925911|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188
9815611|NCT00689936|10925912|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144
9815612|NCT00690040|10925922|FG000|STARTED|Overall Study||145
9815613|NCT00690040|10925923|FG001|STARTED|Overall Study||148
9815614|NCT00690040|10925922|FG000|COMPLETED|Overall Study||145
9815615|NCT00690040|10925923|FG001|COMPLETED|Overall Study||148
9815616|NCT00690040|10925922|FG000|NOT COMPLETED|Overall Study||0
9815617|NCT00690040|10925923|FG001|NOT COMPLETED|Overall Study||0
9815618|NCT00690235|10925931|FG000|STARTED|Overall Study||17
9815619|NCT00690235|10925932|FG001|STARTED|Overall Study||16
9815620|NCT00690235|10925931|FG000|COMPLETED|Overall Study||12
9815621|NCT00690235|10925932|FG001|COMPLETED|Overall Study||12
9815622|NCT00690235|10925931|FG000|NOT COMPLETED|Overall Study||5
9815623|NCT00690235|10925932|FG001|NOT COMPLETED|Overall Study||4
9815624|NCT00690274|10925940|FG000|STARTED|Overall Study||29
10016671|NCT01811303|11139418|FG003|COMPLETED|Fourth Intervention (1 Day)||2
10016672|NCT01811303|11139415|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10016673|NCT01811303|11139416|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10016674|NCT01811303|11139417|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
10016675|NCT01811303|11139418|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
10016676|NCT01811316|11139429|FG000|STARTED|Overall Study||21
10016677|NCT01811316|11139430|FG001|STARTED|Overall Study||22
10016678|NCT01811316|11139431|FG002|STARTED|Overall Study||19
10016679|NCT01811316|11139429|FG000|Visit 4 Weeks|Overall Study||19
10016680|NCT01811316|11139430|FG001|Visit 4 Weeks|Overall Study||22
10016681|NCT01811316|11139431|FG002|Visit 4 Weeks|Overall Study||19
10016682|NCT01811316|11139429|FG000|Visit 12 Weeks|Overall Study||18
10016683|NCT01811316|11139430|FG001|Visit 12 Weeks|Overall Study||22
10016684|NCT01811316|11139431|FG002|Visit 12 Weeks|Overall Study||19
10016685|NCT01811316|11139429|FG000|COMPLETED|Overall Study||18
10016686|NCT01811316|11139430|FG001|COMPLETED|Overall Study||22
10016687|NCT01811316|11139431|FG002|COMPLETED|Overall Study||19
10016688|NCT01811316|11139429|FG000|NOT COMPLETED|Overall Study||3
10016689|NCT01811316|11139430|FG001|NOT COMPLETED|Overall Study||0
10016690|NCT01811316|11139431|FG002|NOT COMPLETED|Overall Study||0
10016691|NCT01811355|11139439|FG000|STARTED|First Dose||11
10016692|NCT01811355|11139440|FG001|STARTED|First Dose||12
10016693|NCT01811355|11139439|FG000|COMPLETED|First Dose||9
10016694|NCT01811355|11139440|FG001|COMPLETED|First Dose||12
10016695|NCT01811355|11139439|FG000|NOT COMPLETED|First Dose||2
10016696|NCT01811355|11139440|FG001|NOT COMPLETED|First Dose||0
10016697|NCT01811355|11139439|FG000|STARTED|Washout||9
10016698|NCT01811355|11139440|FG001|STARTED|Washout||12
10016699|NCT01811355|11139439|FG000|COMPLETED|Washout||9
10016700|NCT01811355|11139440|FG001|COMPLETED|Washout||12
10016701|NCT01811355|11139439|FG000|NOT COMPLETED|Washout||0
10016702|NCT01811355|11139440|FG001|NOT COMPLETED|Washout||0
10016703|NCT01811355|11139439|FG000|STARTED|Second Dose||9
10016704|NCT01811355|11139440|FG001|STARTED|Second Dose||12
10016705|NCT01811355|11139439|FG000|COMPLETED|Second Dose||9
10016706|NCT01811355|11139440|FG001|COMPLETED|Second Dose||12
10016707|NCT01811355|11139439|FG000|NOT COMPLETED|Second Dose||0
10016708|NCT01811355|11139440|FG001|NOT COMPLETED|Second Dose||0
10016709|NCT01811472|11139451|FG000|STARTED|Overall Study||20
10016710|NCT01811472|11139452|FG001|STARTED|Overall Study||11
10016711|NCT01811472|11139453|FG002|STARTED|Overall Study||21
10016712|NCT01811472|11139451|FG000|COMPLETED|Overall Study||18
10016713|NCT01811472|11139452|FG001|COMPLETED|Overall Study||11
10016714|NCT01811472|11139453|FG002|COMPLETED|Overall Study||16
9815625|NCT00690274|10925941|FG001|STARTED|Overall Study||23
9815626|NCT00690274|10925940|FG000|COMPLETED|Overall Study||23
9815627|NCT00690274|10925941|FG001|COMPLETED|Overall Study||15
9815628|NCT00690274|10925940|FG000|NOT COMPLETED|Overall Study||6
10016715|NCT01811472|11139451|FG000|NOT COMPLETED|Overall Study||2
10016716|NCT01811472|11139452|FG001|NOT COMPLETED|Overall Study||0
10016717|NCT01811472|11139453|FG002|NOT COMPLETED|Overall Study||5
10016718|NCT01811485|11139465|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56
10016719|NCT01811485|11139466|FG001|STARTED|Overall Study||59
10016720|NCT01811485|11139467|FG002|STARTED|Overall Study||56
10016721|NCT01811485|11139465|FG000|COMPLETED|Overall Study||54
10016722|NCT01811485|11139466|FG001|COMPLETED|Overall Study||55
10016723|NCT01811485|11139467|FG002|COMPLETED|Overall Study||51
10016724|NCT01811485|11139465|FG000|NOT COMPLETED|Overall Study||2
10016725|NCT01811485|11139466|FG001|NOT COMPLETED|Overall Study||4
10016726|NCT01811485|11139467|FG002|NOT COMPLETED|Overall Study||5
10016727|NCT01811563|11139480|FG000|STARTED|Overall Study||25
10016728|NCT01811563|11139481|FG001|STARTED|Overall Study||23
10016729|NCT01811563|11139480|FG000|COMPLETED|Overall Study||20
10016730|NCT01811563|11139481|FG001|COMPLETED|Overall Study||20
10112354|NCT02503085|11243379|FG000|NOT COMPLETED|Period 2||0
10112355|NCT02503085|11243380|FG001|NOT COMPLETED|Period 2||0
10112356|NCT02503085|11243381|FG002|NOT COMPLETED|Period 2||0
10112357|NCT02503085|11243382|FG003|NOT COMPLETED|Period 2||0
10016731|NCT01811563|11139480|FG000|NOT COMPLETED|Overall Study||5
10016732|NCT01811563|11139481|FG001|NOT COMPLETED|Overall Study||3
10016733|NCT01811654|11139489|FG000|STARTED|Overall Study||14
10016734|NCT01811654|11139490|FG001|STARTED|Overall Study||16
10016735|NCT01811654|11139489|FG000|COMPLETED|Overall Study||14
10016736|NCT01811654|11139490|FG001|COMPLETED|Overall Study||16
10016737|NCT01811654|11139489|FG000|NOT COMPLETED|Overall Study||0
10016738|NCT01811654|11139490|FG001|NOT COMPLETED|Overall Study||0
10112358|NCT02503085|11243379|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7
10112359|NCT02503085|11243380|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7
10112360|NCT02503085|11243381|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7
10112361|NCT02503085|11243382|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7
10112362|NCT02503085|11243379|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10112363|NCT02503085|11243380|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7
10016739|NCT01811680|11139496|FG000|STARTED|Overall Study||10
10016740|NCT01811680|11139496|FG000|COMPLETED|Overall Study||10
10016741|NCT01811680|11139496|FG000|NOT COMPLETED|Overall Study||0
10016742|NCT01811693|11139504|FG000|STARTED|Overall Study||4
10016743|NCT01811693|11139505|FG001|STARTED|Overall Study||0
10016744|NCT01811693|11139506|FG002|STARTED|Overall Study||0
10016745|NCT01811693|11139504|FG000|COMPLETED|Overall Study||4
10016746|NCT01811693|11139505|FG001|COMPLETED|Overall Study||0
10016747|NCT01811693|11139506|FG002|COMPLETED|Overall Study||0
10016748|NCT01811693|11139504|FG000|NOT COMPLETED|Overall Study||0
10016749|NCT01811693|11139505|FG001|NOT COMPLETED|Overall Study||0
10016750|NCT01811693|11139506|FG002|NOT COMPLETED|Overall Study||0
10016751|NCT01811706|11139510|FG000|STARTED|First Intervention ( 4 Weeks)||10
10016752|NCT01811706|11139511|FG001|STARTED|First Intervention ( 4 Weeks)||10
10016753|NCT01811706|11139510|FG000|COMPLETED|First Intervention ( 4 Weeks)||9
10016754|NCT01811706|11139511|FG001|COMPLETED|First Intervention ( 4 Weeks)||10
10016755|NCT01811706|11139510|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1
10016756|NCT01811706|11139511|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0
10016757|NCT01811706|11139510|FG000|STARTED|Washout ( 2 Weeks)||9
10112364|NCT02503085|11243381|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10112365|NCT02503085|11243382|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7
10112366|NCT02503085|11243379|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
10112367|NCT02503085|11243380|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10112368|NCT02503085|11243381|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
10112369|NCT02503085|11243382|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10112370|NCT02503085|11243379|FG000|STARTED|Period 3||6
10112371|NCT02503085|11243380|FG001|STARTED|Period 3||7
10112372|NCT02503085|11243381|FG002|STARTED|Period 3||6
10112373|NCT02503085|11243382|FG003|STARTED|Period 3||7
10112374|NCT02503085|11243379|FG000|COMPLETED|Period 3||6
10112375|NCT02503085|11243380|FG001|COMPLETED|Period 3||7
10112376|NCT02503085|11243381|FG002|COMPLETED|Period 3||6
10112377|NCT02503085|11243382|FG003|COMPLETED|Period 3||7
10112378|NCT02503085|11243379|FG000|NOT COMPLETED|Period 3||0
10112379|NCT02503085|11243380|FG001|NOT COMPLETED|Period 3||0
10112380|NCT02503085|11243381|FG002|NOT COMPLETED|Period 3||0
10112381|NCT02503085|11243382|FG003|NOT COMPLETED|Period 3||0
10236754|NCT00835328|11367472|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0
10236755|NCT00835328|11367473|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0
9815629|NCT00690274|10925941|FG001|NOT COMPLETED|Overall Study||8
9815630|NCT00690339|10925951|FG000|STARTED|Overall Study||492
9815631|NCT00690339|10925952|FG001|STARTED|Overall Study||225
9815632|NCT00690339|10925953|FG002|STARTED|Overall Study||156
10112382|NCT02503085|11243379|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
10112383|NCT02503085|11243380|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7
10112384|NCT02503085|11243381|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
10112385|NCT02503085|11243382|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7
10236756|NCT00832572|11367487|FG000|STARTED|Period 1||3
9815633|NCT00690339|10925954|FG003|STARTED|Overall Study||68
10016758|NCT01811706|11139511|FG001|STARTED|Washout ( 2 Weeks)||10
10016759|NCT01811706|11139510|FG000|COMPLETED|Washout ( 2 Weeks)||9
10016760|NCT01811706|11139511|FG001|COMPLETED|Washout ( 2 Weeks)||10
10016761|NCT01811706|11139510|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0
10016762|NCT01811706|11139511|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0
10016763|NCT01811706|11139510|FG000|STARTED|Second Intervention (4 Weeks)||9
10016764|NCT01811706|11139511|FG001|STARTED|Second Intervention (4 Weeks)||10
10016765|NCT01811706|11139510|FG000|COMPLETED|Second Intervention (4 Weeks)||9
10016766|NCT01811706|11139511|FG001|COMPLETED|Second Intervention (4 Weeks)||10
10016767|NCT01811706|11139510|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10016768|NCT01811706|11139511|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10112386|NCT02503085|11243379|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10236757|NCT00832572|11367488|FG001|STARTED|Period 1||2
9815634|NCT00690339|10925951|FG000|COMPLETED|Overall Study||375
9815635|NCT00690339|10925952|FG001|COMPLETED|Overall Study||144
9815636|NCT00690339|10925953|FG002|COMPLETED|Overall Study||99
9815637|NCT00690339|10925954|FG003|COMPLETED|Overall Study||43
9815638|NCT00690339|10925951|FG000|NOT COMPLETED|Overall Study||117
9815639|NCT00690339|10925952|FG001|NOT COMPLETED|Overall Study||81
9815640|NCT00690339|10925953|FG002|NOT COMPLETED|Overall Study||57
9815641|NCT00690339|10925954|FG003|NOT COMPLETED|Overall Study||25
9815642|NCT00690378|10925966|FG000|STARTED|Overall Study|Randomized|69
9815643|NCT00690378|10925967|FG001|STARTED|Overall Study|Randomized|68
9815644|NCT00690378|10925966|FG000|Treated|Overall Study||68
9815645|NCT00690378|10925967|FG001|Treated|Overall Study||67
9815646|NCT00690378|10925966|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
9815647|NCT00690378|10925967|FG001|COMPLETED|Overall Study|Up to LFU visit|54
9815648|NCT00690378|10925966|FG000|NOT COMPLETED|Overall Study||20
9815649|NCT00690378|10925967|FG001|NOT COMPLETED|Overall Study||14
9815650|NCT00690430|10925975|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
9815651|NCT00690430|10925976|FG001|STARTED|Core Phase||57
9815652|NCT00690430|10925977|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0
9815653|NCT00690430|10925975|FG000|COMPLETED|Core Phase||35
9815654|NCT00690430|10925976|FG001|COMPLETED|Core Phase||34
9815655|NCT00690430|10925977|FG002|COMPLETED|Core Phase||0
9815656|NCT00690430|10925975|FG000|NOT COMPLETED|Core Phase||18
9815657|NCT00690430|10925976|FG001|NOT COMPLETED|Core Phase||23
9815658|NCT00690430|10925977|FG002|NOT COMPLETED|Core Phase||0
9815659|NCT00690430|10925975|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
9815660|NCT00690430|10925976|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
9815661|NCT00690430|10925977|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
9815662|NCT00690430|10925975|FG000|COMPLETED|Extension Phase||2
9815663|NCT00690430|10925976|FG001|COMPLETED|Extension Phase||1
9815664|NCT00690430|10925977|FG002|COMPLETED|Extension Phase||2
9815665|NCT00690430|10925975|FG000|NOT COMPLETED|Extension Phase||18
9815666|NCT00690430|10925976|FG001|NOT COMPLETED|Extension Phase||5
9815667|NCT00690430|10925977|FG002|NOT COMPLETED|Extension Phase||13
9815668|NCT00690443|10925988|FG000|STARTED|Overall Study||23
9815669|NCT00690443|10925989|FG001|STARTED|Overall Study||21
9815670|NCT00690443|10925988|FG000|COMPLETED|Overall Study||22
9815671|NCT00690443|10925989|FG001|COMPLETED|Overall Study||19
9815672|NCT00690443|10925988|FG000|NOT COMPLETED|Overall Study||1
9815673|NCT00690443|10925989|FG001|NOT COMPLETED|Overall Study||2
9815674|NCT00690482|10925997|FG000|STARTED|Overall Study||61
9815675|NCT00690482|10925998|FG001|STARTED|Overall Study||57
9815676|NCT00690482|10925997|FG000|COMPLETED|Overall Study||57
9815677|NCT00690482|10925998|FG001|COMPLETED|Overall Study||54
9815678|NCT00690482|10925997|FG000|NOT COMPLETED|Overall Study||4
9815679|NCT00690482|10925998|FG001|NOT COMPLETED|Overall Study||3
9815680|NCT00690495|10926006|FG000|STARTED|Overall Study||50
9815681|NCT00690495|10926007|FG001|STARTED|Overall Study||50
9815682|NCT00690495|10926006|FG000|Primary Endpoint|Overall Study||50
9815683|NCT00690495|10926007|FG001|Primary Endpoint|Overall Study||50
9815684|NCT00690495|10926006|FG000|COMPLETED|Overall Study||50
9815685|NCT00690495|10926007|FG001|COMPLETED|Overall Study||50
9815686|NCT00690495|10926006|FG000|NOT COMPLETED|Overall Study||0
9815687|NCT00690495|10926007|FG001|NOT COMPLETED|Overall Study||0
9815688|NCT00690573|10926013|FG000|STARTED|Overall Study||25
9815689|NCT00690573|10926013|FG000|COMPLETED|Overall Study||16
9815690|NCT00690573|10926013|FG000|NOT COMPLETED|Overall Study||9
9815691|NCT00690612|10926017|FG000|STARTED|Overall Study||35
9815692|NCT00690612|10926017|FG000|COMPLETED|Overall Study||32
9815693|NCT00690612|10926017|FG000|NOT COMPLETED|Overall Study||3
9815694|NCT00690755|10926028|FG000|STARTED|Overall Study||30
9815695|NCT00690755|10926029|FG001|STARTED|Overall Study||0
9815696|NCT00690755|10926030|FG002|STARTED|Overall Study||97
9815697|NCT00690755|10926031|FG003|STARTED|Overall Study||20
9815698|NCT00690755|10926032|FG004|STARTED|Overall Study||0
9815699|NCT00690755|10926033|FG005|STARTED|Overall Study||10
9815700|NCT00690755|10926034|FG006|STARTED|Overall Study||0
9815701|NCT00690755|10926028|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
9815702|NCT00690755|10926029|FG001|COMPLETED|Overall Study||0
9815703|NCT00690755|10926030|FG002|COMPLETED|Overall Study||51
9815704|NCT00690755|10926031|FG003|COMPLETED|Overall Study||15
9815705|NCT00690755|10926032|FG004|COMPLETED|Overall Study||0
9815706|NCT00690755|10926033|FG005|COMPLETED|Overall Study||6
9815707|NCT00690755|10926034|FG006|COMPLETED|Overall Study||0
9815708|NCT00690755|10926028|FG000|NOT COMPLETED|Overall Study||2
9815709|NCT00690755|10926029|FG001|NOT COMPLETED|Overall Study||0
9815710|NCT00690755|10926030|FG002|NOT COMPLETED|Overall Study||46
9815711|NCT00690755|10926031|FG003|NOT COMPLETED|Overall Study||5
9815712|NCT00690755|10926032|FG004|NOT COMPLETED|Overall Study||0
9815713|NCT00690755|10926033|FG005|NOT COMPLETED|Overall Study||4
9815714|NCT00690755|10926034|FG006|NOT COMPLETED|Overall Study||0
9815715|NCT00690794|10926052|FG000|STARTED|Overall Study||363
10236758|NCT00832572|11367487|FG000|COMPLETED|Period 1||3
9815716|NCT00690794|10926053|FG001|STARTED|Overall Study||363
9815717|NCT00690794|10926052|FG000|COMPLETED|Overall Study||342
9815718|NCT00690794|10926053|FG001|COMPLETED|Overall Study||328
10236759|NCT00832572|11367488|FG001|COMPLETED|Period 1||2
9815719|NCT00690794|10926052|FG000|NOT COMPLETED|Overall Study||21
9815720|NCT00690794|10926053|FG001|NOT COMPLETED|Overall Study||35
9815721|NCT00690820|10926061|FG000|STARTED|Period 1||8
9815722|NCT00690820|10926062|FG001|STARTED|Period 1||9
9815723|NCT00690820|10926061|FG000|COMPLETED|Period 1||8
9815724|NCT00690820|10926062|FG001|COMPLETED|Period 1||8
9815725|NCT00690820|10926061|FG000|NOT COMPLETED|Period 1||0
9815726|NCT00690820|10926062|FG001|NOT COMPLETED|Period 1||1
9815727|NCT00690820|10926061|FG000|STARTED|Period 2||8
9815728|NCT00690820|10926062|FG001|STARTED|Period 2||8
9815729|NCT00690820|10926061|FG000|COMPLETED|Period 2||8
9815730|NCT00690820|10926062|FG001|COMPLETED|Period 2||8
9815731|NCT00690820|10926061|FG000|NOT COMPLETED|Period 2||0
9815732|NCT00690820|10926062|FG001|NOT COMPLETED|Period 2||0
9815733|NCT00690833|10926068|FG000|STARTED|Overall Study||41
9815734|NCT00690833|10926068|FG000|COMPLETED|Overall Study||39
9815735|NCT00690833|10926068|FG000|NOT COMPLETED|Overall Study||2
9815736|NCT00690898|10926072|FG000|STARTED|SCREENING|Total of patients screened for the study.|108
9815737|NCT00690898|10926072|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90
9815738|NCT00690898|10926072|FG000|NOT COMPLETED|SCREENING||18
9815739|NCT00690898|10926072|FG000|STARTED|TREATMENT|Total number of patients treated.|90
9815740|NCT00690898|10926072|FG000|COMPLETED|TREATMENT||64
9815741|NCT00690898|10926072|FG000|NOT COMPLETED|TREATMENT||26
9815742|NCT00690924|10926076|FG000|STARTED|Overall Study||16
9815743|NCT00690924|10926076|FG000|COMPLETED|Overall Study||16
9815744|NCT00690924|10926076|FG000|NOT COMPLETED|Overall Study||0
9815745|NCT00691002|10926084|FG000|STARTED|8-week, Double-blind, 4-arm||353
9815746|NCT00691002|10926085|FG001|STARTED|8-week, Double-blind, 4-arm||342
9815747|NCT00691002|10926086|FG002|STARTED|8-week, Double-blind, 4-arm||363
9815748|NCT00691002|10926087|FG003|STARTED|8-week, Double-blind, 4-arm||181
9815749|NCT00691002|10926088|FG004|STARTED|8-week, Double-blind, 4-arm||0
9815750|NCT00691002|10926084|FG000|COMPLETED|8-week, Double-blind, 4-arm||325
9815751|NCT00691002|10926085|FG001|COMPLETED|8-week, Double-blind, 4-arm||308
9815752|NCT00691002|10926086|FG002|COMPLETED|8-week, Double-blind, 4-arm||340
9815753|NCT00691002|10926087|FG003|COMPLETED|8-week, Double-blind, 4-arm||169
9815754|NCT00691002|10926088|FG004|COMPLETED|8-week, Double-blind, 4-arm||0
9815755|NCT00691002|10926084|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28
9815756|NCT00691002|10926085|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34
9815757|NCT00691002|10926086|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23
9815758|NCT00691002|10926087|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12
9815759|NCT00691002|10926088|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0
9815760|NCT00691002|10926084|FG000|STARTED|52-week, Open-label, Single Arm||454
9815761|NCT00691002|10926085|FG001|STARTED|52-week, Open-label, Single Arm||0
9815762|NCT00691002|10926086|FG002|STARTED|52-week, Open-label, Single Arm||0
9815763|NCT00691002|10926087|FG003|STARTED|52-week, Open-label, Single Arm||0
9815764|NCT00691002|10926088|FG004|STARTED|52-week, Open-label, Single Arm||0
9815765|NCT00691002|10926084|FG000|COMPLETED|52-week, Open-label, Single Arm||403
9815766|NCT00691002|10926085|FG001|COMPLETED|52-week, Open-label, Single Arm||0
9815767|NCT00691002|10926086|FG002|COMPLETED|52-week, Open-label, Single Arm||0
9815768|NCT00691002|10926087|FG003|COMPLETED|52-week, Open-label, Single Arm||0
9815769|NCT00691002|10926088|FG004|COMPLETED|52-week, Open-label, Single Arm||0
9815770|NCT00691002|10926084|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51
9815771|NCT00691002|10926085|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0
9815772|NCT00691002|10926086|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0
9815773|NCT00691002|10926087|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0
9815774|NCT00691002|10926088|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0
9815775|NCT00691015|10926099|FG000|STARTED|Overall Study||48
9815776|NCT00691015|10926099|FG000|COMPLETED|Overall Study||47
9815777|NCT00691015|10926099|FG000|NOT COMPLETED|Overall Study||1
9815778|NCT00691028|10926106|FG000|STARTED|Open-label Period||0
9815779|NCT00691028|10926107|FG001|STARTED|Open-label Period||0
9815780|NCT00691028|10926108|FG002|STARTED|Open-label Period||0
9815781|NCT00691028|10926109|FG003|STARTED|Open-label Period||327
9815782|NCT00691028|10926106|FG000|COMPLETED|Open-label Period||0
9815783|NCT00691028|10926107|FG001|COMPLETED|Open-label Period||0
9815784|NCT00691028|10926108|FG002|COMPLETED|Open-label Period||0
9815785|NCT00691028|10926109|FG003|COMPLETED|Open-label Period||307
9815786|NCT00691028|10926106|FG000|NOT COMPLETED|Open-label Period||0
9815787|NCT00691028|10926107|FG001|NOT COMPLETED|Open-label Period||0
9815788|NCT00691028|10926108|FG002|NOT COMPLETED|Open-label Period||0
9815789|NCT00691028|10926109|FG003|NOT COMPLETED|Open-label Period||20
9815790|NCT00691028|10926106|FG000|STARTED|Double-blind Period||99
9815791|NCT00691028|10926107|FG001|STARTED|Double-blind Period||104
9815792|NCT00691028|10926108|FG002|STARTED|Double-blind Period||104
9815793|NCT00691028|10926109|FG003|STARTED|Double-blind Period||0
9815794|NCT00691028|10926106|FG000|COMPLETED|Double-blind Period||86
9815795|NCT00691028|10926107|FG001|COMPLETED|Double-blind Period||91
9815796|NCT00691028|10926108|FG002|COMPLETED|Double-blind Period||95
9815797|NCT00691028|10926109|FG003|COMPLETED|Double-blind Period||0
9815798|NCT00691028|10926106|FG000|NOT COMPLETED|Double-blind Period||13
9815799|NCT00691028|10926107|FG001|NOT COMPLETED|Double-blind Period||13
9815800|NCT00691028|10926108|FG002|NOT COMPLETED|Double-blind Period||9
9815801|NCT00691028|10926109|FG003|NOT COMPLETED|Double-blind Period||0
9815802|NCT00691054|10926121|FG000|STARTED|Overall Study||20
9815803|NCT00691054|10926121|FG000|COMPLETED|Overall Study||19
9815804|NCT00691054|10926121|FG000|NOT COMPLETED|Overall Study||1
9815805|NCT00691093|10926127|FG000|STARTED|Overall Study||823
9815806|NCT00691093|10926127|FG000|COMPLETED|Overall Study||816
9815807|NCT00691093|10926127|FG000|NOT COMPLETED|Overall Study||7
9815808|NCT00691132|10926138|FG000|STARTED|Overall Study||53
9815809|NCT00691132|10926139|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
9815810|NCT00691132|10926138|FG000|COMPLETED|Overall Study||41
9815811|NCT00691132|10926139|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
9815812|NCT00691132|10926138|FG000|NOT COMPLETED|Overall Study||12
9815813|NCT00691132|10926139|FG001|NOT COMPLETED|Overall Study||13
9815814|NCT00691197|10926157|FG000|STARTED|Overall Study||166
9815815|NCT00691197|10926158|FG001|STARTED|Overall Study||80
9815816|NCT00691197|10926157|FG000|COMPLETED|Overall Study||155
9815817|NCT00691197|10926158|FG001|COMPLETED|Overall Study||75
9815818|NCT00691197|10926157|FG000|NOT COMPLETED|Overall Study||11
9815819|NCT00691197|10926158|FG001|NOT COMPLETED|Overall Study||5
9815820|NCT00691210|10926172|FG000|STARTED|Overall Study||3
9815821|NCT00691210|10926173|FG001|STARTED|Overall Study||5
9815822|NCT00691210|10926174|FG002|STARTED|Overall Study||3
9815823|NCT00691210|10926175|FG003|STARTED|Overall Study||9
9815824|NCT00691210|10926176|FG004|STARTED|Overall Study||5
9815825|NCT00691210|10926177|FG005|STARTED|Overall Study||7
9815826|NCT00691210|10926178|FG006|STARTED|Overall Study||6
9815827|NCT00691210|10926179|FG007|STARTED|Overall Study||0
9815828|NCT00691210|10926172|FG000|COMPLETED|Overall Study||3
9815829|NCT00691210|10926173|FG001|COMPLETED|Overall Study||5
9815830|NCT00691210|10926174|FG002|COMPLETED|Overall Study||3
9815831|NCT00691210|10926175|FG003|COMPLETED|Overall Study||6
9815832|NCT00691210|10926176|FG004|COMPLETED|Overall Study||5
9815833|NCT00691210|10926177|FG005|COMPLETED|Overall Study||6
9815834|NCT00691210|10926178|FG006|COMPLETED|Overall Study||6
9815835|NCT00691210|10926179|FG007|COMPLETED|Overall Study||0
9815836|NCT00691210|10926172|FG000|NOT COMPLETED|Overall Study||0
9815837|NCT00691210|10926173|FG001|NOT COMPLETED|Overall Study||0
9815838|NCT00691210|10926174|FG002|NOT COMPLETED|Overall Study||0
9815839|NCT00691210|10926175|FG003|NOT COMPLETED|Overall Study||3
9815840|NCT00691210|10926176|FG004|NOT COMPLETED|Overall Study||0
9815841|NCT00691210|10926177|FG005|NOT COMPLETED|Overall Study||1
9815842|NCT00691210|10926178|FG006|NOT COMPLETED|Overall Study||0
9815843|NCT00691210|10926179|FG007|NOT COMPLETED|Overall Study||0
9815844|NCT00691301|10926197|FG000|STARTED|Overall Study||55
9815845|NCT00691301|10926197|FG000|COMPLETED|Overall Study||1
9815846|NCT00691301|10926197|FG000|NOT COMPLETED|Overall Study||54
9815847|NCT00691327|10926209|FG000|STARTED|Overall Study||45055
9815848|NCT00691327|10926210|FG001|STARTED|Overall Study||39274
9815849|NCT00691327|10926209|FG000|COMPLETED|Overall Study||42214
9815850|NCT00691327|10926210|FG001|COMPLETED|Overall Study||36766
9815851|NCT00691327|10926209|FG000|NOT COMPLETED|Overall Study||2841
9815852|NCT00691327|10926210|FG001|NOT COMPLETED|Overall Study||2508
9815853|NCT00691483|10926218|FG000|STARTED|Overall Study||493
9815854|NCT00691483|10926219|FG001|STARTED|Overall Study||166
9815855|NCT00691483|10926218|FG000|Received Treatment|Overall Study||486
9815856|NCT00691483|10926219|FG001|Received Treatment|Overall Study||165
9815857|NCT00691483|10926218|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425
9815858|NCT00691483|10926219|FG001|COMPLETED|Overall Study||141
9815859|NCT00691483|10926218|FG000|NOT COMPLETED|Overall Study||68
9815860|NCT00691483|10926219|FG001|NOT COMPLETED|Overall Study||25
9815861|NCT00691600|10926227|FG000|STARTED|Overall Study||12
9815862|NCT00691600|10926228|FG001|STARTED|Overall Study||11
9815863|NCT00691600|10926227|FG000|COMPLETED|Overall Study||12
9815864|NCT00691600|10926228|FG001|COMPLETED|Overall Study||11
9815865|NCT00691600|10926227|FG000|NOT COMPLETED|Overall Study||0
9815866|NCT00691600|10926228|FG001|NOT COMPLETED|Overall Study||0
9815867|NCT00691665|10926236|FG000|STARTED|Overall Study||65
9815868|NCT00691665|10926237|FG001|STARTED|Overall Study||65
9815869|NCT00691665|10926236|FG000|COMPLETED|Overall Study||65
9815870|NCT00691665|10926237|FG001|COMPLETED|Overall Study||65
9815871|NCT00691665|10926236|FG000|NOT COMPLETED|Overall Study||0
10016769|NCT01811732|11139521|FG000|STARTED|Overall Study||331
10016770|NCT01811732|11139522|FG001|STARTED|Overall Study||329
10016771|NCT01811732|11139521|FG000|COMPLETED|Overall Study||276
10016772|NCT01811732|11139522|FG001|COMPLETED|Overall Study||271
10016773|NCT01811732|11139521|FG000|NOT COMPLETED|Overall Study||55
10112387|NCT02503085|11243380|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7
9815872|NCT00691665|10926237|FG001|NOT COMPLETED|Overall Study||0
9815873|NCT00691704|10926243|FG000|STARTED|Induction Therapy||18
9815874|NCT00691704|10926243|FG000|COMPLETED|Induction Therapy||16
9815875|NCT00691704|10926243|FG000|NOT COMPLETED|Induction Therapy||2
9815876|NCT00691704|10926243|FG000|STARTED|Two Years of Maintenance Therapy||16
9815877|NCT00691704|10926243|FG000|COMPLETED|Two Years of Maintenance Therapy||3
9815878|NCT00691704|10926243|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13
9815879|NCT00691808|10926250|FG000|STARTED|Overall Study||35
9815880|NCT00691808|10926251|FG001|STARTED|Overall Study||36
9815881|NCT00691808|10926252|FG002|STARTED|Overall Study||32
9815882|NCT00691808|10926250|FG000|COMPLETED|Overall Study||35
9815883|NCT00691808|10926251|FG001|COMPLETED|Overall Study||35
9815884|NCT00691808|10926252|FG002|COMPLETED|Overall Study||32
9815885|NCT00691808|10926250|FG000|NOT COMPLETED|Overall Study||0
10016774|NCT01811732|11139522|FG001|NOT COMPLETED|Overall Study||58
9815886|NCT00691808|10926251|FG001|NOT COMPLETED|Overall Study||1
10016775|NCT01811875|11139529|FG000|STARTED|Overall Study||7
10016776|NCT01811875|11139529|FG000|COMPLETED|Overall Study||5
9815887|NCT00691808|10926252|FG002|NOT COMPLETED|Overall Study||0
9815888|NCT00691938|10926267|FG000|STARTED|Overall Study||5
9815889|NCT00691938|10926268|FG001|STARTED|Overall Study||3
9815890|NCT00691938|10926269|FG002|STARTED|Overall Study||6
9815891|NCT00691938|10926270|FG003|STARTED|Overall Study||8
9815892|NCT00691938|10926271|FG004|STARTED|Overall Study||10
9815893|NCT00691938|10926272|FG005|STARTED|Overall Study||6
9815894|NCT00691938|10926273|FG006|STARTED|Overall Study||14
9815895|NCT00691938|10926267|FG000|COMPLETED|Overall Study||4
9815896|NCT00691938|10926268|FG001|COMPLETED|Overall Study||3
9815897|NCT00691938|10926269|FG002|COMPLETED|Overall Study||6
9815898|NCT00691938|10926270|FG003|COMPLETED|Overall Study||8
9815899|NCT00691938|10926271|FG004|COMPLETED|Overall Study||10
9815900|NCT00691938|10926272|FG005|COMPLETED|Overall Study||6
9815901|NCT00691938|10926273|FG006|COMPLETED|Overall Study||14
10112388|NCT02503085|11243381|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10112389|NCT02503085|11243382|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7
9815902|NCT00691938|10926267|FG000|NOT COMPLETED|Overall Study||1
10016777|NCT01811875|11139529|FG000|NOT COMPLETED|Overall Study||2
9815903|NCT00691938|10926268|FG001|NOT COMPLETED|Overall Study||0
9815904|NCT00691938|10926269|FG002|NOT COMPLETED|Overall Study||0
9815905|NCT00691938|10926270|FG003|NOT COMPLETED|Overall Study||0
9815906|NCT00691938|10926271|FG004|NOT COMPLETED|Overall Study||0
9815907|NCT00691938|10926272|FG005|NOT COMPLETED|Overall Study||0
9815908|NCT00691938|10926273|FG006|NOT COMPLETED|Overall Study||0
9815909|NCT00692185|10926286|FG000|STARTED|Overall Study||11
9815910|NCT00692185|10926287|FG001|STARTED|Overall Study||12
9815911|NCT00692185|10926286|FG000|COMPLETED|Overall Study||8
9815912|NCT00692185|10926287|FG001|COMPLETED|Overall Study||9
9815913|NCT00692185|10926286|FG000|NOT COMPLETED|Overall Study||3
9815914|NCT00692185|10926287|FG001|NOT COMPLETED|Overall Study||3
9815915|NCT00692198|10926297|FG000|STARTED|Overall Study||368
9815916|NCT00692198|10926298|FG001|STARTED|Overall Study||370
9815917|NCT00692198|10926297|FG000|COMPLETED|Overall Study||368
9815918|NCT00692198|10926298|FG001|COMPLETED|Overall Study||370
9815919|NCT00692198|10926297|FG000|NOT COMPLETED|Overall Study||0
9815920|NCT00692198|10926298|FG001|NOT COMPLETED|Overall Study||0
9815921|NCT00692211|10926307|FG000|STARTED|Overall Study||202
9815922|NCT00692211|10926308|FG001|STARTED|Overall Study||202
9815923|NCT00692211|10926307|FG000|COMPLETED|Overall Study||202
9815924|NCT00692211|10926308|FG001|COMPLETED|Overall Study||202
9815925|NCT00692211|10926307|FG000|NOT COMPLETED|Overall Study||0
9815926|NCT00692211|10926308|FG001|NOT COMPLETED|Overall Study||0
9815927|NCT00692237|10926316|FG000|STARTED|Overall Study||30
9815928|NCT00692237|10926317|FG001|STARTED|Overall Study||29
9815929|NCT00692237|10926316|FG000|COMPLETED|Overall Study||29
9815930|NCT00692237|10926317|FG001|COMPLETED|Overall Study||25
9815931|NCT00692237|10926316|FG000|NOT COMPLETED|Overall Study||1
9815932|NCT00692237|10926317|FG001|NOT COMPLETED|Overall Study||4
9815933|NCT00692276|10926325|FG000|STARTED|Randomized Population||190
9815934|NCT00692276|10926326|FG001|STARTED|Randomized Population||201
9815935|NCT00692276|10926325|FG000|COMPLETED|Randomized Population||190
9815936|NCT00692276|10926326|FG001|COMPLETED|Randomized Population||201
9815937|NCT00692276|10926325|FG000|NOT COMPLETED|Randomized Population||0
9815938|NCT00692276|10926326|FG001|NOT COMPLETED|Randomized Population||0
9815939|NCT00692276|10926325|FG000|STARTED|Completed 24 Months||190
9815940|NCT00692276|10926326|FG001|STARTED|Completed 24 Months||201
9815941|NCT00692276|10926325|FG000|COMPLETED|Completed 24 Months||183
9815942|NCT00692276|10926326|FG001|COMPLETED|Completed 24 Months||187
9815943|NCT00692276|10926325|FG000|NOT COMPLETED|Completed 24 Months||7
9815944|NCT00692276|10926326|FG001|NOT COMPLETED|Completed 24 Months||14
9815945|NCT00692341|10926335|FG000|STARTED|Overall Study||8
9815946|NCT00692341|10926336|FG001|STARTED|Overall Study||8
9815947|NCT00692341|10926337|FG002|STARTED|Overall Study||8
9815948|NCT00692341|10926335|FG000|COMPLETED|Overall Study||8
9815949|NCT00692341|10926336|FG001|COMPLETED|Overall Study||8
9815950|NCT00692341|10926337|FG002|COMPLETED|Overall Study||8
9815951|NCT00692341|10926335|FG000|NOT COMPLETED|Overall Study||0
9815952|NCT00692341|10926336|FG001|NOT COMPLETED|Overall Study||0
9815953|NCT00692341|10926337|FG002|NOT COMPLETED|Overall Study||0
9815954|NCT00692406|10926345|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
9815955|NCT00692406|10926345|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
9815956|NCT00692406|10926345|FG000|NOT COMPLETED|Overall Study||57
9815957|NCT00692419|10926351|FG000|STARTED|Overall Study||100
9815958|NCT00692419|10926352|FG001|STARTED|Overall Study||120
9815959|NCT00692419|10926351|FG000|COMPLETED|Overall Study||84
9815960|NCT00692419|10926352|FG001|COMPLETED|Overall Study||102
9815961|NCT00692419|10926351|FG000|NOT COMPLETED|Overall Study||16
9815962|NCT00692419|10926352|FG001|NOT COMPLETED|Overall Study||18
9815963|NCT00692692|10926362|FG000|STARTED|Overall Study||20
10016778|NCT01811940|11139535|FG000|STARTED|Overall Study||64
9815964|NCT00692692|10926363|FG001|STARTED|Overall Study||16
9815965|NCT00692692|10926362|FG000|COMPLETED|Overall Study||20
9815966|NCT00692692|10926363|FG001|COMPLETED|Overall Study||16
9815967|NCT00692692|10926362|FG000|NOT COMPLETED|Overall Study||0
9815968|NCT00692692|10926363|FG001|NOT COMPLETED|Overall Study||0
9815969|NCT00692770|10926371|FG000|STARTED|Overall Study||556
9815970|NCT00692770|10926372|FG001|STARTED|Overall Study||558
9815971|NCT00692770|10926371|FG000|Participants Received Treatment|Overall Study||553
9815972|NCT00692770|10926372|FG001|Participants Received Treatment|Overall Study||554
9815973|NCT00692770|10926371|FG000|COMPLETED|Overall Study||0
9815974|NCT00692770|10926372|FG001|COMPLETED|Overall Study||0
9815975|NCT00692770|10926371|FG000|NOT COMPLETED|Overall Study||556
9815976|NCT00692770|10926372|FG001|NOT COMPLETED|Overall Study||558
9815977|NCT00692978|10926386|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15
9815978|NCT00692978|10926387|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15
9815979|NCT00692978|10926386|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15
9815980|NCT00692978|10926387|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15
9815981|NCT00692978|10926386|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
9815982|NCT00692978|10926387|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
9815983|NCT00692978|10926386|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15
9815984|NCT00692978|10926387|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15
9815985|NCT00692978|10926386|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
9815986|NCT00692978|10926387|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
9815987|NCT00692978|10926386|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
9815988|NCT00692978|10926387|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
9815989|NCT00692978|10926386|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15
9815990|NCT00692978|10926387|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15
9815991|NCT00692978|10926386|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
9815992|NCT00692978|10926387|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
9815993|NCT00692978|10926386|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
9815994|NCT00692978|10926387|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
9815995|NCT00692978|10926386|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15
9815996|NCT00692978|10926387|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15
9815997|NCT00692978|10926386|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
9815998|NCT00692978|10926387|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
9815999|NCT00692978|10926386|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
9816000|NCT00692978|10926387|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
9816001|NCT00693160|10926407|FG000|STARTED|Overall Study||14
9816002|NCT00693160|10926408|FG001|STARTED|Overall Study||16
9816003|NCT00693160|10926407|FG000|COMPLETED|Overall Study||14
9816004|NCT00693160|10926408|FG001|COMPLETED|Overall Study||16
9816005|NCT00693160|10926407|FG000|NOT COMPLETED|Overall Study||0
9816006|NCT00693160|10926408|FG001|NOT COMPLETED|Overall Study||0
9831917|NCT00770770|10942574|FG001|NOT COMPLETED|Overall Study||1
9831918|NCT00770861|10942582|FG000|STARTED|Overall Study||141
9831919|NCT00770861|10942583|FG001|STARTED|Overall Study||136
9831920|NCT00770861|10942582|FG000|COMPLETED|Overall Study||131
9831921|NCT00770861|10942583|FG001|COMPLETED|Overall Study||120
9831922|NCT00770861|10942582|FG000|NOT COMPLETED|Overall Study||10
9831923|NCT00770861|10942583|FG001|NOT COMPLETED|Overall Study||16
9831924|NCT00770874|10942591|FG000|STARTED|Overall Study||188
9831925|NCT00770874|10942592|FG001|STARTED|Overall Study||176
9831926|NCT00770874|10942591|FG000|COMPLETED|Overall Study||188
9831927|NCT00770874|10942592|FG001|COMPLETED|Overall Study||176
9831928|NCT00770874|10942591|FG000|NOT COMPLETED|Overall Study||0
9831929|NCT00770874|10942592|FG001|NOT COMPLETED|Overall Study||0
9831930|NCT00770913|10942601|FG000|STARTED|Overall Study||113
9831931|NCT00770913|10942602|FG001|STARTED|Overall Study||111
9831932|NCT00770913|10942603|FG002|STARTED|Overall Study||113
9831933|NCT00770913|10942601|FG000|COMPLETED|Overall Study||102
9831934|NCT00770913|10942602|FG001|COMPLETED|Overall Study||103
9831935|NCT00770913|10942603|FG002|COMPLETED|Overall Study||100
9831936|NCT00770913|10942601|FG000|NOT COMPLETED|Overall Study||11
9831937|NCT00770913|10942602|FG001|NOT COMPLETED|Overall Study||8
9831938|NCT00770913|10942603|FG002|NOT COMPLETED|Overall Study||13
9831939|NCT00770991|10942613|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
9831940|NCT00770991|10942614|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
9831941|NCT00770991|10942613|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
9831942|NCT00770991|10942614|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
9831943|NCT00770991|10942613|FG000|NOT COMPLETED|Overall Study||5
9831944|NCT00770991|10942614|FG001|NOT COMPLETED|Overall Study||5
9831945|NCT00771030|10942632|FG000|STARTED|Overall Study||6
9831946|NCT00771030|10942633|FG001|STARTED|Overall Study||4
9831947|NCT00771030|10942634|FG002|STARTED|Overall Study||6
9831948|NCT00771030|10942635|FG003|STARTED|Overall Study||6
9831949|NCT00771030|10942636|FG004|STARTED|Overall Study||6
9831950|NCT00771030|10942637|FG005|STARTED|Overall Study||6
9831951|NCT00771030|10942638|FG006|STARTED|Overall Study||6
9831952|NCT00771030|10942632|FG000|Received Study Drug|Overall Study||6
9831953|NCT00771030|10942633|FG001|Received Study Drug|Overall Study||4
9831954|NCT00771030|10942634|FG002|Received Study Drug|Overall Study||6
9831955|NCT00771030|10942635|FG003|Received Study Drug|Overall Study||6
9831956|NCT00771030|10942636|FG004|Received Study Drug|Overall Study||6
9831957|NCT00771030|10942637|FG005|Received Study Drug|Overall Study||6
9831958|NCT00771030|10942638|FG006|Received Study Drug|Overall Study||6
9831959|NCT00771030|10942632|FG000|COMPLETED|Overall Study||6
9831960|NCT00771030|10942633|FG001|COMPLETED|Overall Study||3
9831961|NCT00771030|10942634|FG002|COMPLETED|Overall Study||6
9831962|NCT00771030|10942635|FG003|COMPLETED|Overall Study||6
9831963|NCT00771030|10942636|FG004|COMPLETED|Overall Study||6
9831964|NCT00771030|10942637|FG005|COMPLETED|Overall Study||6
9831965|NCT00771030|10942638|FG006|COMPLETED|Overall Study||6
9831966|NCT00771030|10942632|FG000|NOT COMPLETED|Overall Study||0
9816007|NCT00693225|10926416|FG000|STARTED|Overall Study||43
9816008|NCT00693225|10926417|FG001|STARTED|Overall Study||48
9816009|NCT00693225|10926416|FG000|COMPLETED|Overall Study||41
9816010|NCT00693225|10926417|FG001|COMPLETED|Overall Study||43
9816011|NCT00693225|10926416|FG000|NOT COMPLETED|Overall Study||2
9816012|NCT00693225|10926417|FG001|NOT COMPLETED|Overall Study||5
9816013|NCT00693303|10926423|FG000|STARTED|Overall Study||21
9816014|NCT00693303|10926423|FG000|COMPLETED|Overall Study||21
9816015|NCT00693303|10926423|FG000|NOT COMPLETED|Overall Study||0
9816016|NCT00693420|10926429|FG000|STARTED|Overall Study||137
9816017|NCT00693420|10926430|FG001|STARTED|Overall Study||141
9816018|NCT00693420|10926429|FG000|COMPLETED|Overall Study||131
9816019|NCT00693420|10926430|FG001|COMPLETED|Overall Study||126
9816020|NCT00693420|10926429|FG000|NOT COMPLETED|Overall Study||6
9816021|NCT00693420|10926430|FG001|NOT COMPLETED|Overall Study||15
9816022|NCT00693472|10926440|FG000|STARTED|Part 1||19
9816023|NCT00693472|10926441|FG001|STARTED|Part 1||13
9816024|NCT00693472|10926442|FG002|STARTED|Part 1||0
9816025|NCT00693472|10926443|FG003|STARTED|Part 1||0
9816026|NCT00693472|10926440|FG000|COMPLETED|Part 1||13
9816027|NCT00693472|10926441|FG001|COMPLETED|Part 1||9
9816028|NCT00693472|10926442|FG002|COMPLETED|Part 1||0
9816029|NCT00693472|10926443|FG003|COMPLETED|Part 1||0
9816030|NCT00693472|10926440|FG000|NOT COMPLETED|Part 1||6
9816031|NCT00693472|10926441|FG001|NOT COMPLETED|Part 1||4
9816032|NCT00693472|10926442|FG002|NOT COMPLETED|Part 1||0
9816033|NCT00693472|10926443|FG003|NOT COMPLETED|Part 1||0
9816034|NCT00693472|10926440|FG000|STARTED|Part 2||0
9816035|NCT00693472|10926441|FG001|STARTED|Part 2||0
9816036|NCT00693472|10926442|FG002|STARTED|Part 2||8
9816037|NCT00693472|10926443|FG003|STARTED|Part 2||6
9816038|NCT00693472|10926440|FG000|COMPLETED|Part 2||0
9816039|NCT00693472|10926441|FG001|COMPLETED|Part 2||0
9816040|NCT00693472|10926442|FG002|COMPLETED|Part 2||6
9816041|NCT00693472|10926443|FG003|COMPLETED|Part 2||4
9816042|NCT00693472|10926440|FG000|NOT COMPLETED|Part 2||0
9816043|NCT00693472|10926441|FG001|NOT COMPLETED|Part 2||0
9816044|NCT00693472|10926442|FG002|NOT COMPLETED|Part 2||2
9816045|NCT00693472|10926443|FG003|NOT COMPLETED|Part 2||2
9816046|NCT00693485|10926456|FG000|STARTED|Overall Study||25
9816047|NCT00693485|10926457|FG001|STARTED|Overall Study||21
9816048|NCT00693485|10926458|FG002|STARTED|Overall Study||24
9816049|NCT00693485|10926456|FG000|COMPLETED|Overall Study||25
9816050|NCT00693485|10926457|FG001|COMPLETED|Overall Study||19
9816051|NCT00693485|10926458|FG002|COMPLETED|Overall Study||24
9816052|NCT00693485|10926456|FG000|NOT COMPLETED|Overall Study||0
9816053|NCT00693485|10926457|FG001|NOT COMPLETED|Overall Study||2
9816054|NCT00693485|10926458|FG002|NOT COMPLETED|Overall Study||0
9816055|NCT00693498|10926468|FG000|STARTED|Overall Study||81
9816056|NCT00693498|10926469|FG001|STARTED|Overall Study||81
9816057|NCT00693498|10926468|FG000|COMPLETED|Overall Study||81
9816058|NCT00693498|10926469|FG001|COMPLETED|Overall Study||81
9816059|NCT00693498|10926468|FG000|NOT COMPLETED|Overall Study||0
9816060|NCT00693498|10926469|FG001|NOT COMPLETED|Overall Study||0
9816061|NCT00693654|10926477|FG000|STARTED|Overall Study||14
9816062|NCT00693654|10926478|FG001|STARTED|Overall Study||14
9816063|NCT00693654|10926477|FG000|COMPLETED|Overall Study||14
9816064|NCT00693654|10926478|FG001|COMPLETED|Overall Study||14
9816065|NCT00693654|10926477|FG000|NOT COMPLETED|Overall Study||0
9816066|NCT00693654|10926478|FG001|NOT COMPLETED|Overall Study||0
9816067|NCT00693693|10926488|FG000|STARTED|Overall Study||7
9816068|NCT00693693|10926489|FG001|STARTED|Overall Study||9
9816069|NCT00693693|10926490|FG002|STARTED|Overall Study||9
9816070|NCT00693693|10926488|FG000|COMPLETED|Overall Study||6
9816071|NCT00693693|10926489|FG001|COMPLETED|Overall Study||8
9816072|NCT00693693|10926490|FG002|COMPLETED|Overall Study||7
9816073|NCT00693693|10926488|FG000|NOT COMPLETED|Overall Study||1
9816074|NCT00693693|10926489|FG001|NOT COMPLETED|Overall Study||1
9816075|NCT00693693|10926490|FG002|NOT COMPLETED|Overall Study||2
9816076|NCT00693706|10926500|FG000|STARTED|Overall Study||101
9816077|NCT00693706|10926501|FG001|STARTED|Overall Study||99
9816078|NCT00693706|10926500|FG000|COMPLETED|Overall Study||101
9816079|NCT00693706|10926501|FG001|COMPLETED|Overall Study||98
9816080|NCT00693706|10926500|FG000|NOT COMPLETED|Overall Study||0
9816081|NCT00693706|10926501|FG001|NOT COMPLETED|Overall Study||1
9816082|NCT00693719|10926507|FG000|STARTED|Overall Study||31
9816083|NCT00693719|10926507|FG000|COMPLETED|Overall Study||31
9816084|NCT00693719|10926507|FG000|NOT COMPLETED|Overall Study||0
9816085|NCT00693784|10926511|FG000|STARTED|Overall Study||15
9816086|NCT00693784|10926511|FG000|26-Week Primary Endpoint|Overall Study||15
9816087|NCT00693784|10926511|FG000|52-week Extended Follow-up|Overall Study||13
9816088|NCT00693784|10926511|FG000|104-week Extended Follow-up|Overall Study||11
9816089|NCT00693784|10926511|FG000|COMPLETED|Overall Study||11
9816090|NCT00693784|10926511|FG000|NOT COMPLETED|Overall Study||4
9816091|NCT00693992|10926517|FG000|STARTED|Overall Study||106
9816092|NCT00693992|10926518|FG001|STARTED|Overall Study||104
9816093|NCT00693992|10926517|FG000|COMPLETED|Overall Study||106
9816094|NCT00693992|10926518|FG001|COMPLETED|Overall Study||104
9816095|NCT00693992|10926517|FG000|NOT COMPLETED|Overall Study||0
9816096|NCT00693992|10926518|FG001|NOT COMPLETED|Overall Study||0
9816097|NCT00694018|10926526|FG000|STARTED|Overall Study||118
9816098|NCT00694018|10926527|FG001|STARTED|Overall Study||111
9816099|NCT00694018|10926526|FG000|6 Months|Overall Study||106
9816100|NCT00694018|10926527|FG001|6 Months|Overall Study||101
9816101|NCT00694018|10926526|FG000|COMPLETED|Overall Study||105
9816102|NCT00694018|10926527|FG001|COMPLETED|Overall Study||102
9816103|NCT00694018|10926526|FG000|NOT COMPLETED|Overall Study||13
9816104|NCT00694018|10926527|FG001|NOT COMPLETED|Overall Study||9
9816105|NCT00694070|10926533|FG000|STARTED|Overall Study||51
9816106|NCT00694070|10926533|FG000|COMPLETED|Overall Study||51
9816107|NCT00694070|10926533|FG000|NOT COMPLETED|Overall Study||0
9816108|NCT00694096|10926537|FG000|STARTED|Overall Study||25
9816109|NCT00694096|10926537|FG000|COMPLETED|Overall Study||20
9816110|NCT00694096|10926537|FG000|NOT COMPLETED|Overall Study||5
9816111|NCT00694109|10926541|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
10016779|NCT01811940|11139536|FG001|STARTED|Overall Study||63
10016780|NCT01811940|11139535|FG000|COMPLETED|Overall Study||42
10016781|NCT01811940|11139536|FG001|COMPLETED|Overall Study||37
9816112|NCT00694109|10926541|FG000|Treated|Overall Study||141
9816113|NCT00694109|10926541|FG000|Consented 2 Years Additional Treatment|Overall Study||42
9816114|NCT00694109|10926541|FG000|Completed Consented Length of Treatment|Overall Study||60
9816115|NCT00694109|10926541|FG000|COMPLETED|Overall Study||25
9816116|NCT00694109|10926541|FG000|NOT COMPLETED|Overall Study||117
9816117|NCT00694122|10926546|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
9816118|NCT00694122|10926547|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
9816119|NCT00694122|10926546|FG000|COMPLETED|First Intervention (3-4 Weeks)||10
9816120|NCT00694122|10926547|FG001|COMPLETED|First Intervention (3-4 Weeks)||5
9816121|NCT00694122|10926546|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10
9816122|NCT00694122|10926547|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2
9816123|NCT00694122|10926546|FG000|STARTED|Washout (1 Day)||10
9816124|NCT00694122|10926547|FG001|STARTED|Washout (1 Day)||5
9816125|NCT00694122|10926546|FG000|COMPLETED|Washout (1 Day)||10
9816126|NCT00694122|10926547|FG001|COMPLETED|Washout (1 Day)||5
9816127|NCT00694122|10926546|FG000|NOT COMPLETED|Washout (1 Day)||0
9816128|NCT00694122|10926547|FG001|NOT COMPLETED|Washout (1 Day)||0
9816129|NCT00694122|10926546|FG000|STARTED|Second Intervention (3-4 Weeks)||10
9816130|NCT00694122|10926547|FG001|STARTED|Second Intervention (3-4 Weeks)||5
9816131|NCT00694122|10926546|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10
9816132|NCT00694122|10926547|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5
9816133|NCT00694122|10926546|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
9816134|NCT00694122|10926547|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
9816135|NCT00694161|10926558|FG000|STARTED|Part 1 (up to Week 6)||35
9816136|NCT00694161|10926558|FG000|COMPLETED|Part 1 (up to Week 6)||35
9816137|NCT00694161|10926558|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0
9816138|NCT00694161|10926558|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35
9816139|NCT00694161|10926558|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
9816140|NCT00694161|10926558|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
9816141|NCT00694304|10926562|FG000|STARTED|Overall Study||535
9816142|NCT00694304|10926562|FG000|COMPLETED|Overall Study||328
9816143|NCT00694304|10926562|FG000|NOT COMPLETED|Overall Study||207
9816144|NCT00694356|10926569|FG000|STARTED|Overall Study||3
9816145|NCT00694356|10926570|FG001|STARTED|Overall Study||6
9816146|NCT00694356|10926571|FG002|STARTED|Overall Study||6
9816147|NCT00694356|10926569|FG000|COMPLETED|Overall Study||0
9816148|NCT00694356|10926570|FG001|COMPLETED|Overall Study||0
9816149|NCT00694356|10926571|FG002|COMPLETED|Overall Study||0
9816150|NCT00694356|10926569|FG000|NOT COMPLETED|Overall Study||3
9816151|NCT00694356|10926570|FG001|NOT COMPLETED|Overall Study||6
9816152|NCT00694356|10926571|FG002|NOT COMPLETED|Overall Study||6
9816153|NCT00694473|10926579|FG000|STARTED|Overall Study|Aug 2008|76
9816154|NCT00694473|10926579|FG000|COMPLETED|Overall Study|Dec 2010|69
9816155|NCT00694473|10926579|FG000|NOT COMPLETED|Overall Study||7
9816156|NCT00694551|10926586|FG000|STARTED|Overall Study||10
9816157|NCT00694551|10926587|FG001|STARTED|Overall Study||10
10016782|NCT01811940|11139535|FG000|NOT COMPLETED|Overall Study||22
10016783|NCT01811940|11139536|FG001|NOT COMPLETED|Overall Study||26
10016784|NCT01811953|11139548|FG000|STARTED|Overall Study||6
10016785|NCT01811953|11139549|FG001|STARTED|Overall Study||6
10016786|NCT01811953|11139550|FG002|STARTED|Overall Study||6
10016787|NCT01811953|11139551|FG003|STARTED|Overall Study||6
10016788|NCT01811953|11139552|FG004|STARTED|Overall Study||12
10016789|NCT01811953|11139553|FG005|STARTED|Overall Study||12
9816158|NCT00694551|10926588|FG002|STARTED|Overall Study||9
9816159|NCT00694551|10926586|FG000|COMPLETED|Overall Study||9
9816160|NCT00694551|10926587|FG001|COMPLETED|Overall Study||10
9816161|NCT00694551|10926588|FG002|COMPLETED|Overall Study||8
9816162|NCT00694551|10926586|FG000|NOT COMPLETED|Overall Study||1
9816163|NCT00694551|10926587|FG001|NOT COMPLETED|Overall Study||0
9816164|NCT00694551|10926588|FG002|NOT COMPLETED|Overall Study||1
9816165|NCT00694564|10926597|FG000|STARTED|Overall Study||8
9816166|NCT00694564|10926597|FG000|COMPLETED|Overall Study||6
9816167|NCT00694564|10926597|FG000|NOT COMPLETED|Overall Study||2
9816168|NCT00694603|10926601|FG000|STARTED|Overall Study||18
9816169|NCT00694603|10926601|FG000|COMPLETED|Overall Study||18
10016790|NCT01811953|11139548|FG000|COMPLETED|Overall Study||6
9816170|NCT00694603|10926601|FG000|NOT COMPLETED|Overall Study||0
9816171|NCT00694707|10926610|FG000|STARTED|Overall Study||151
9816172|NCT00694707|10926611|FG001|STARTED|Overall Study||145
9816173|NCT00694707|10926612|FG002|STARTED|Overall Study||147
9816174|NCT00694707|10926613|FG003|STARTED|Overall Study||148
9816175|NCT00694707|10926614|FG004|STARTED|Overall Study||141
10016791|NCT01811953|11139549|FG001|COMPLETED|Overall Study||6
10016792|NCT01811953|11139550|FG002|COMPLETED|Overall Study||6
10016793|NCT01811953|11139551|FG003|COMPLETED|Overall Study||5
9816176|NCT00694707|10926610|FG000|COMPLETED|Overall Study||79
9816177|NCT00694707|10926611|FG001|COMPLETED|Overall Study||90
9816178|NCT00694707|10926612|FG002|COMPLETED|Overall Study||96
9816179|NCT00694707|10926613|FG003|COMPLETED|Overall Study||98
9816180|NCT00694707|10926614|FG004|COMPLETED|Overall Study||101
9816181|NCT00694707|10926610|FG000|NOT COMPLETED|Overall Study||72
9816182|NCT00694707|10926611|FG001|NOT COMPLETED|Overall Study||55
9816183|NCT00694707|10926612|FG002|NOT COMPLETED|Overall Study||51
9816184|NCT00694707|10926613|FG003|NOT COMPLETED|Overall Study||50
9816185|NCT00694707|10926614|FG004|NOT COMPLETED|Overall Study||40
9816186|NCT00695019|10926629|FG000|STARTED|Overall Study||59
9816187|NCT00695019|10926630|FG001|STARTED|Overall Study||53
9816188|NCT00695019|10926631|FG002|STARTED|Overall Study||57
9816189|NCT00695019|10926629|FG000|COMPLETED|Overall Study||46
9816190|NCT00695019|10926630|FG001|COMPLETED|Overall Study||39
9816191|NCT00695019|10926631|FG002|COMPLETED|Overall Study||47
9816192|NCT00695019|10926629|FG000|NOT COMPLETED|Overall Study||13
9816193|NCT00695019|10926630|FG001|NOT COMPLETED|Overall Study||14
9816194|NCT00695019|10926631|FG002|NOT COMPLETED|Overall Study||10
9816195|NCT00695097|10926641|FG000|STARTED|Overall Study||10
9816196|NCT00695097|10926642|FG001|STARTED|Overall Study||5
9816197|NCT00695097|10926641|FG000|COMPLETED|Overall Study||9
9816198|NCT00695097|10926642|FG001|COMPLETED|Overall Study||5
9816199|NCT00695097|10926641|FG000|NOT COMPLETED|Overall Study||1
9816200|NCT00695097|10926642|FG001|NOT COMPLETED|Overall Study||0
9816201|NCT00695110|10926648|FG000|STARTED|Treatment Period 1||29
9816202|NCT00695110|10926648|FG000|COMPLETED|Treatment Period 1||26
9816203|NCT00695110|10926648|FG000|NOT COMPLETED|Treatment Period 1||3
9816204|NCT00695110|10926648|FG000|STARTED|Treatment Period 2||26
9816205|NCT00695110|10926648|FG000|COMPLETED|Treatment Period 2||26
9816206|NCT00695110|10926648|FG000|NOT COMPLETED|Treatment Period 2||0
9816207|NCT00695110|10926648|FG000|STARTED|Treatment Period 3||26
9816208|NCT00695110|10926648|FG000|COMPLETED|Treatment Period 3||25
9816209|NCT00695110|10926648|FG000|NOT COMPLETED|Treatment Period 3||1
9816210|NCT00695110|10926648|FG000|STARTED|Treatment Period 4||25
9816211|NCT00695110|10926648|FG000|COMPLETED|Treatment Period 4||24
9816212|NCT00695110|10926648|FG000|NOT COMPLETED|Treatment Period 4||1
9816213|NCT00695136|10926655|FG000|STARTED|Overall Study|7|7
10016794|NCT01811953|11139552|FG004|COMPLETED|Overall Study||11
10016795|NCT01811953|11139553|FG005|COMPLETED|Overall Study||11
10016796|NCT01811953|11139548|FG000|NOT COMPLETED|Overall Study||0
10016797|NCT01811953|11139549|FG001|NOT COMPLETED|Overall Study||0
10016798|NCT01811953|11139550|FG002|NOT COMPLETED|Overall Study||0
10016799|NCT01811953|11139551|FG003|NOT COMPLETED|Overall Study||1
9816214|NCT00695136|10926655|FG000|COMPLETED|Overall Study||5
9816215|NCT00695136|10926655|FG000|NOT COMPLETED|Overall Study||2
9816216|NCT00695188|10926661|FG000|STARTED|Overall Study||10
9816217|NCT00695188|10926662|FG001|STARTED|Overall Study||9
9816218|NCT00695188|10926661|FG000|COMPLETED|Overall Study||10
9816219|NCT00695188|10926662|FG001|COMPLETED|Overall Study||9
9816220|NCT00695188|10926661|FG000|NOT COMPLETED|Overall Study||0
9816221|NCT00695188|10926662|FG001|NOT COMPLETED|Overall Study||0
9816222|NCT00695253|10926668|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49
9816223|NCT00695253|10926668|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18
9816224|NCT00695253|10926668|FG000|NOT COMPLETED|Overall Study||31
9816225|NCT00695292|10926673|FG000|STARTED|Overall Study||37
9816226|NCT00695292|10926673|FG000|COMPLETED|Overall Study||37
9816227|NCT00695292|10926673|FG000|NOT COMPLETED|Overall Study||0
9816228|NCT00695318|10926679|FG000|STARTED|Overall Study||10
9816229|NCT00695318|10926680|FG001|STARTED|Overall Study||7
9816230|NCT00695318|10926679|FG000|COMPLETED|Overall Study||5
9816231|NCT00695318|10926680|FG001|COMPLETED|Overall Study||6
10016800|NCT01811953|11139552|FG004|NOT COMPLETED|Overall Study||1
10016801|NCT01811953|11139553|FG005|NOT COMPLETED|Overall Study||1
10016802|NCT01812005|11139569|FG000|STARTED|Overall Study||1
9816232|NCT00695318|10926679|FG000|NOT COMPLETED|Overall Study||5
9816233|NCT00695318|10926680|FG001|NOT COMPLETED|Overall Study||1
9816234|NCT00695396|10926694|FG000|STARTED|Overall Study||8
9816235|NCT00695396|10926695|FG001|STARTED|Overall Study||8
9816236|NCT00695396|10926696|FG002|STARTED|Overall Study||9
9816237|NCT00695396|10926694|FG000|COMPLETED|Overall Study||1
9816238|NCT00695396|10926695|FG001|COMPLETED|Overall Study||0
9816239|NCT00695396|10926696|FG002|COMPLETED|Overall Study||1
9816240|NCT00695396|10926694|FG000|NOT COMPLETED|Overall Study||7
10016803|NCT01812005|11139570|FG001|STARTED|Overall Study||13
10016804|NCT01812005|11139569|FG000|COMPLETED|Overall Study||1
10016805|NCT01812005|11139570|FG001|COMPLETED|Overall Study||13
10016806|NCT01812005|11139569|FG000|NOT COMPLETED|Overall Study||0
9816241|NCT00695396|10926695|FG001|NOT COMPLETED|Overall Study||8
9816242|NCT00695396|10926696|FG002|NOT COMPLETED|Overall Study||8
9816243|NCT00695409|10926704|FG000|STARTED|Overall Study||122
9816244|NCT00695409|10926704|FG000|COMPLETED|Overall Study||122
9816245|NCT00695409|10926704|FG000|NOT COMPLETED|Overall Study||0
9816246|NCT00695435|10926709|FG000|STARTED|Overall Study||7
9816247|NCT00695435|10926710|FG001|STARTED|Overall Study||7
9816248|NCT00695435|10926711|FG002|STARTED|Overall Study||7
9816249|NCT00695435|10926709|FG000|COMPLETED|Overall Study||7
9816250|NCT00695435|10926710|FG001|COMPLETED|Overall Study||7
10016807|NCT01812005|11139570|FG001|NOT COMPLETED|Overall Study||0
10016808|NCT01812044|11139579|FG000|STARTED|Overall Study||17
10016809|NCT01812044|11139580|FG001|STARTED|Overall Study||17
9816251|NCT00695435|10926711|FG002|COMPLETED|Overall Study||7
9816252|NCT00695435|10926709|FG000|NOT COMPLETED|Overall Study||0
9816253|NCT00695435|10926710|FG001|NOT COMPLETED|Overall Study||0
9816254|NCT00695435|10926711|FG002|NOT COMPLETED|Overall Study||0
9816255|NCT00695500|10926721|FG000|STARTED|Overall Study||24
9816256|NCT00695500|10926722|FG001|STARTED|Overall Study||22
9816257|NCT00695500|10926721|FG000|COMPLETED|Overall Study||21
9816258|NCT00695500|10926722|FG001|COMPLETED|Overall Study||17
9816259|NCT00695500|10926721|FG000|NOT COMPLETED|Overall Study||3
9816260|NCT00695500|10926722|FG001|NOT COMPLETED|Overall Study||5
9816261|NCT00695565|10926730|FG000|STARTED|Overall Study||90
9816262|NCT00695565|10926731|FG001|STARTED|Overall Study||90
9816263|NCT00695565|10926730|FG000|COMPLETED|Overall Study||77
9816264|NCT00695565|10926731|FG001|COMPLETED|Overall Study||81
9816265|NCT00695565|10926730|FG000|NOT COMPLETED|Overall Study||13
9816266|NCT00695565|10926731|FG001|NOT COMPLETED|Overall Study||9
9816267|NCT00695578|10926739|FG000|STARTED|Overall Study||10
9816268|NCT00695578|10926740|FG001|STARTED|Overall Study||10
9816269|NCT00695578|10926739|FG000|COMPLETED|Overall Study||10
9816270|NCT00695578|10926740|FG001|COMPLETED|Overall Study||10
9816271|NCT00695578|10926739|FG000|NOT COMPLETED|Overall Study||0
9816272|NCT00695578|10926740|FG001|NOT COMPLETED|Overall Study||0
9816273|NCT00695669|10926750|FG000|STARTED|Overall Study||78
9816274|NCT00695669|10926751|FG001|STARTED|Overall Study||78
9816275|NCT00695669|10926752|FG002|STARTED|Overall Study||78
9816276|NCT00695669|10926753|FG003|STARTED|Overall Study||78
9816277|NCT00695669|10926750|FG000|COMPLETED|Overall Study||74
9816278|NCT00695669|10926751|FG001|COMPLETED|Overall Study||74
9816279|NCT00695669|10926752|FG002|COMPLETED|Overall Study||75
9816280|NCT00695669|10926753|FG003|COMPLETED|Overall Study||74
9816281|NCT00695669|10926750|FG000|NOT COMPLETED|Overall Study||4
9816282|NCT00695669|10926751|FG001|NOT COMPLETED|Overall Study||4
9816283|NCT00695669|10926752|FG002|NOT COMPLETED|Overall Study||3
9816284|NCT00695669|10926753|FG003|NOT COMPLETED|Overall Study||4
9816285|NCT00695786|10926770|FG000|STARTED|Overall Study||2
9816286|NCT00695786|10926771|FG001|STARTED|Overall Study||79
9816287|NCT00695786|10926772|FG002|STARTED|Overall Study||31
9816288|NCT00695786|10926773|FG003|STARTED|Overall Study||44
9816289|NCT00695786|10926770|FG000|COMPLETED|Overall Study||1
9816290|NCT00695786|10926771|FG001|COMPLETED|Overall Study||67
9816291|NCT00695786|10926772|FG002|COMPLETED|Overall Study||23
9816292|NCT00695786|10926773|FG003|COMPLETED|Overall Study||36
9816293|NCT00695786|10926770|FG000|NOT COMPLETED|Overall Study||1
9816294|NCT00695786|10926771|FG001|NOT COMPLETED|Overall Study||12
9816295|NCT00695786|10926772|FG002|NOT COMPLETED|Overall Study||8
9816296|NCT00695786|10926773|FG003|NOT COMPLETED|Overall Study||8
9816297|NCT00695864|10926783|FG000|STARTED|Placebo||14
9816298|NCT00695864|10926783|FG000|COMPLETED|Placebo||9
9816299|NCT00695864|10926783|FG000|NOT COMPLETED|Placebo||5
9816300|NCT00695864|10926783|FG000|STARTED|Ondansetron||14
9816301|NCT00695864|10926783|FG000|COMPLETED|Ondansetron||9
9816302|NCT00695864|10926783|FG000|NOT COMPLETED|Ondansetron||5
9816303|NCT00695903|10926791|FG000|STARTED|Had End of Therapy (EOT) Assessment||19
9816304|NCT00695903|10926792|FG001|STARTED|Had End of Therapy (EOT) Assessment||19
9816305|NCT00695903|10926791|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
9816306|NCT00695903|10926792|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
9816307|NCT00695903|10926791|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7
9816308|NCT00695903|10926792|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4
9816309|NCT00695903|10926791|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
9816310|NCT00695903|10926792|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
9816311|NCT00695903|10926791|FG000|STARTED|Had Test of Cure (TOC) Assessment||7
9816312|NCT00695903|10926792|FG001|STARTED|Had Test of Cure (TOC) Assessment||4
9816313|NCT00695903|10926791|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5
9816314|NCT00695903|10926792|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3
9816315|NCT00695903|10926791|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
9816316|NCT00695903|10926792|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
9816317|NCT00695955|10926798|FG000|STARTED|Cohort 1||362
9816318|NCT00695955|10926798|FG000|COMPLETED|Cohort 1||260
9816319|NCT00695955|10926798|FG000|NOT COMPLETED|Cohort 1||102
9816320|NCT00695955|10926798|FG000|STARTED|Cohort 2||307
9816321|NCT00695955|10926798|FG000|COMPLETED|Cohort 2||203
9816322|NCT00695955|10926798|FG000|NOT COMPLETED|Cohort 2||104
9816323|NCT00696020|10926808|FG000|STARTED|Overall Study||90
9816324|NCT00696020|10926809|FG001|STARTED|Overall Study||89
9816325|NCT00696020|10926810|FG002|STARTED|Overall Study||93
9816326|NCT00696020|10926811|FG003|STARTED|Overall Study||88
9816327|NCT00696020|10926808|FG000|COMPLETED|Overall Study||86
9816328|NCT00696020|10926809|FG001|COMPLETED|Overall Study||87
9816329|NCT00696020|10926810|FG002|COMPLETED|Overall Study||90
9816330|NCT00696020|10926811|FG003|COMPLETED|Overall Study||84
9816331|NCT00696020|10926808|FG000|NOT COMPLETED|Overall Study||4
9816332|NCT00696020|10926809|FG001|NOT COMPLETED|Overall Study||2
9816333|NCT00696020|10926810|FG002|NOT COMPLETED|Overall Study||3
9816334|NCT00696020|10926811|FG003|NOT COMPLETED|Overall Study||4
9816335|NCT00696072|10926825|FG000|STARTED|Overall Study||57
9816336|NCT00696072|10926826|FG001|STARTED|Overall Study||63
9816337|NCT00696072|10926825|FG000|COMPLETED|Overall Study||0
9816338|NCT00696072|10926826|FG001|COMPLETED|Overall Study||0
9816339|NCT00696072|10926825|FG000|NOT COMPLETED|Overall Study||57
9816340|NCT00696072|10926826|FG001|NOT COMPLETED|Overall Study||63
9816341|NCT00696137|10926833|FG000|STARTED|Overall Study||5
9816342|NCT00696137|10926833|FG000|COMPLETED|Overall Study||3
9816343|NCT00696137|10926833|FG000|NOT COMPLETED|Overall Study||2
9816344|NCT00696241|10926842|FG000|STARTED|Overall Study||283
9816345|NCT00696241|10926843|FG001|STARTED|Overall Study||283
9816346|NCT00696241|10926844|FG002|STARTED|Overall Study||285
9816347|NCT00696241|10926845|FG003|STARTED|Overall Study||282
9816348|NCT00696241|10926846|FG004|STARTED|Overall Study||142
9816349|NCT00696241|10926842|FG000|COMPLETED|Overall Study||259
9816350|NCT00696241|10926843|FG001|COMPLETED|Overall Study||261
9816351|NCT00696241|10926844|FG002|COMPLETED|Overall Study||261
9816352|NCT00696241|10926845|FG003|COMPLETED|Overall Study||268
9816353|NCT00696241|10926846|FG004|COMPLETED|Overall Study||130
9816354|NCT00696241|10926842|FG000|NOT COMPLETED|Overall Study||24
9816355|NCT00696241|10926843|FG001|NOT COMPLETED|Overall Study||22
9816356|NCT00696241|10926844|FG002|NOT COMPLETED|Overall Study||24
9816357|NCT00696241|10926845|FG003|NOT COMPLETED|Overall Study||14
9816358|NCT00696241|10926846|FG004|NOT COMPLETED|Overall Study||12
9816359|NCT00696293|10926858|FG000|STARTED|Overall Study||30
9816360|NCT00696293|10926858|FG000|COMPLETED|Overall Study||28
9816361|NCT00696293|10926858|FG000|NOT COMPLETED|Overall Study||2
9816362|NCT00696384|10926863|FG000|STARTED|Open Label Phase||418
9816363|NCT00696384|10926864|FG001|STARTED|Open Label Phase||0
9816364|NCT00696384|10926865|FG002|STARTED|Open Label Phase||0
9816365|NCT00696384|10926863|FG000|COMPLETED|Open Label Phase||299
9816366|NCT00696384|10926864|FG001|COMPLETED|Open Label Phase||0
9816367|NCT00696384|10926865|FG002|COMPLETED|Open Label Phase||0
9816368|NCT00696384|10926863|FG000|NOT COMPLETED|Open Label Phase||119
9816369|NCT00696384|10926864|FG001|NOT COMPLETED|Open Label Phase||0
9816370|NCT00696384|10926865|FG002|NOT COMPLETED|Open Label Phase||0
9816371|NCT00696384|10926863|FG000|STARTED|Double Blind Phase||0
9816372|NCT00696384|10926864|FG001|STARTED|Double Blind Phase||148
9816373|NCT00696384|10926865|FG002|STARTED|Double Blind Phase||151
9816374|NCT00696384|10926863|FG000|COMPLETED|Double Blind Phase||0
9816375|NCT00696384|10926864|FG001|COMPLETED|Double Blind Phase||137
9816376|NCT00696384|10926865|FG002|COMPLETED|Double Blind Phase||145
9816377|NCT00696384|10926863|FG000|NOT COMPLETED|Double Blind Phase||0
9816378|NCT00696384|10926864|FG001|NOT COMPLETED|Double Blind Phase||11
9816379|NCT00696384|10926865|FG002|NOT COMPLETED|Double Blind Phase||6
9816380|NCT00696410|10926876|FG000|STARTED|Overall Study||38
9816381|NCT00696410|10926877|FG001|STARTED|Overall Study||10
9816382|NCT00696410|10926876|FG000|COMPLETED|Overall Study||25
9816383|NCT00696410|10926877|FG001|COMPLETED|Overall Study||10
9816384|NCT00696410|10926876|FG000|NOT COMPLETED|Overall Study||13
9816385|NCT00696410|10926877|FG001|NOT COMPLETED|Overall Study||0
9816386|NCT00696423|10926890|FG000|STARTED|Overall Study||244
9816387|NCT00696423|10926891|FG001|STARTED|Overall Study||223
9816388|NCT00696423|10926890|FG000|COMPLETED|Overall Study||244
9816389|NCT00696423|10926891|FG001|COMPLETED|Overall Study||218
9816390|NCT00696423|10926890|FG000|NOT COMPLETED|Overall Study||0
9816391|NCT00696423|10926891|FG001|NOT COMPLETED|Overall Study||5
9816392|NCT00696436|10926902|FG000|STARTED|Overall Study|Randomized participants only.|280
9816393|NCT00696436|10926903|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
9816394|NCT00696436|10926904|FG002|STARTED|Overall Study|Randomized participants only.|282
9816395|NCT00696436|10926905|FG003|STARTED|Overall Study|Randomized participants only.|290
9816396|NCT00696436|10926906|FG004|STARTED|Overall Study|Randomized participants only.|154
9816397|NCT00696436|10926902|FG000|COMPLETED|Overall Study||257
9816398|NCT00696436|10926903|FG001|COMPLETED|Overall Study||255
9816399|NCT00696436|10926904|FG002|COMPLETED|Overall Study||254
9816400|NCT00696436|10926905|FG003|COMPLETED|Overall Study||268
9816401|NCT00696436|10926906|FG004|COMPLETED|Overall Study||141
9816402|NCT00696436|10926902|FG000|NOT COMPLETED|Overall Study||23
9816403|NCT00696436|10926903|FG001|NOT COMPLETED|Overall Study||30
9816404|NCT00696436|10926904|FG002|NOT COMPLETED|Overall Study||28
9816405|NCT00696436|10926905|FG003|NOT COMPLETED|Overall Study||22
9816406|NCT00696436|10926906|FG004|NOT COMPLETED|Overall Study||13
9816407|NCT00696449|10926922|FG000|STARTED|Overall Study||15
9816408|NCT00696449|10926923|FG001|STARTED|Overall Study||15
9816409|NCT00696449|10926924|FG002|STARTED|Overall Study||15
9816410|NCT00696449|10926925|FG003|STARTED|Overall Study||16
9816411|NCT00696449|10926922|FG000|COMPLETED|Overall Study||12
9816412|NCT00696449|10926923|FG001|COMPLETED|Overall Study||9
9816413|NCT00696449|10926924|FG002|COMPLETED|Overall Study||14
9816414|NCT00696449|10926925|FG003|COMPLETED|Overall Study||13
9816415|NCT00696449|10926922|FG000|NOT COMPLETED|Overall Study||3
9816416|NCT00696449|10926923|FG001|NOT COMPLETED|Overall Study||6
9816417|NCT00696449|10926924|FG002|NOT COMPLETED|Overall Study||1
9816418|NCT00696449|10926925|FG003|NOT COMPLETED|Overall Study||3
9816419|NCT00696488|10926935|FG000|STARTED|Overall Study||20
9816420|NCT00696488|10926935|FG000|COMPLETED|Overall Study||20
9816421|NCT00696488|10926935|FG000|NOT COMPLETED|Overall Study||0
9816422|NCT00696618|10926942|FG000|STARTED|Overall Study||3
9816423|NCT00696618|10926943|FG001|STARTED|Overall Study||3
9816424|NCT00696618|10926944|FG002|STARTED|Overall Study||3
9816425|NCT00696618|10926942|FG000|COMPLETED|Overall Study||3
9816426|NCT00696618|10926943|FG001|COMPLETED|Overall Study||3
9816427|NCT00696618|10926944|FG002|COMPLETED|Overall Study||3
9816428|NCT00696618|10926942|FG000|NOT COMPLETED|Overall Study||0
9816429|NCT00696618|10926943|FG001|NOT COMPLETED|Overall Study||0
9816430|NCT00696618|10926944|FG002|NOT COMPLETED|Overall Study||0
9816431|NCT00696657|10926961|FG000|STARTED|Overall Study||46
9816432|NCT00696657|10926962|FG001|STARTED|Overall Study||47
9816433|NCT00696657|10926963|FG002|STARTED|Overall Study||44
9816434|NCT00696657|10926964|FG003|STARTED|Overall Study||49
9816435|NCT00696657|10926965|FG004|STARTED|Overall Study||44
9816436|NCT00696657|10926966|FG005|STARTED|Overall Study||45
9816437|NCT00696657|10926967|FG006|STARTED|Overall Study||45
9816438|NCT00696657|10926968|FG007|STARTED|Overall Study||45
9816439|NCT00696657|10926969|FG008|STARTED|Overall Study||50
9816440|NCT00696657|10926961|FG000|EXPOSED|Overall Study||46
9816441|NCT00696657|10926962|FG001|EXPOSED|Overall Study||47
9816442|NCT00696657|10926963|FG002|EXPOSED|Overall Study||43
9816443|NCT00696657|10926964|FG003|EXPOSED|Overall Study||48
9816444|NCT00696657|10926965|FG004|EXPOSED|Overall Study||44
9816445|NCT00696657|10926966|FG005|EXPOSED|Overall Study||43
9816446|NCT00696657|10926967|FG006|EXPOSED|Overall Study||45
9816447|NCT00696657|10926968|FG007|EXPOSED|Overall Study||45
9816448|NCT00696657|10926969|FG008|EXPOSED|Overall Study||50
9816449|NCT00696657|10926961|FG000|COMPLETED|Overall Study||45
9816450|NCT00696657|10926962|FG001|COMPLETED|Overall Study||42
9816451|NCT00696657|10926963|FG002|COMPLETED|Overall Study||36
9816452|NCT00696657|10926964|FG003|COMPLETED|Overall Study||38
9816453|NCT00696657|10926965|FG004|COMPLETED|Overall Study||34
9816454|NCT00696657|10926966|FG005|COMPLETED|Overall Study||33
9816455|NCT00696657|10926967|FG006|COMPLETED|Overall Study||30
9816456|NCT00696657|10926968|FG007|COMPLETED|Overall Study||42
9816457|NCT00696657|10926969|FG008|COMPLETED|Overall Study||41
9816458|NCT00696657|10926961|FG000|NOT COMPLETED|Overall Study||1
9816459|NCT00696657|10926962|FG001|NOT COMPLETED|Overall Study||5
9816460|NCT00696657|10926963|FG002|NOT COMPLETED|Overall Study||8
9816461|NCT00696657|10926964|FG003|NOT COMPLETED|Overall Study||11
9816462|NCT00696657|10926965|FG004|NOT COMPLETED|Overall Study||10
9816463|NCT00696657|10926966|FG005|NOT COMPLETED|Overall Study||12
9816464|NCT00696657|10926967|FG006|NOT COMPLETED|Overall Study||15
9816465|NCT00696657|10926968|FG007|NOT COMPLETED|Overall Study||3
9816466|NCT00696657|10926969|FG008|NOT COMPLETED|Overall Study||9
9816467|NCT00696696|10926989|FG000|STARTED|Overall Study||44
9816468|NCT00696696|10926989|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
9816469|NCT00696696|10926989|FG000|NOT COMPLETED|Overall Study||18
9816470|NCT00696709|10926998|FG000|STARTED|Overall Study||65
9816471|NCT00696709|10926999|FG001|STARTED|Overall Study||63
9816472|NCT00696709|10927000|FG002|STARTED|Overall Study||33
9816473|NCT00696709|10927001|FG003|STARTED|Overall Study||64
9816474|NCT00696709|10927002|FG004|STARTED|Overall Study||65
9816475|NCT00696709|10926998|FG000|Vaccination 1 (Day 1)|Overall Study||65
9816476|NCT00696709|10926999|FG001|Vaccination 1 (Day 1)|Overall Study||63
9816477|NCT00696709|10927000|FG002|Vaccination 1 (Day 1)|Overall Study||32
9816478|NCT00696709|10927001|FG003|Vaccination 1 (Day 1)|Overall Study||64
9816479|NCT00696709|10927002|FG004|Vaccination 1 (Day 1)|Overall Study||65
9816480|NCT00696709|10926998|FG000|Vaccination 2 (~Day 30)|Overall Study||64
9816481|NCT00696709|10926999|FG001|Vaccination 2 (~Day 30)|Overall Study||60
9816482|NCT00696709|10927000|FG002|Vaccination 2 (~Day 30)|Overall Study||32
9816483|NCT00696709|10927001|FG003|Vaccination 2 (~Day 30)|Overall Study||61
9816484|NCT00696709|10927002|FG004|Vaccination 2 (~Day 30)|Overall Study||64
9816485|NCT00696709|10926998|FG000|Vaccination 3 (~Day 60)|Overall Study||64
9816486|NCT00696709|10926999|FG001|Vaccination 3 (~Day 60)|Overall Study||60
9816487|NCT00696709|10927000|FG002|Vaccination 3 (~Day 60)|Overall Study||32
9816488|NCT00696709|10927001|FG003|Vaccination 3 (~Day 60)|Overall Study||59
9816489|NCT00696709|10927002|FG004|Vaccination 3 (~Day 60)|Overall Study||63
9816490|NCT00696709|10926998|FG000|Vaccination 4 (~Day 90)|Overall Study||62
9816491|NCT00696709|10926999|FG001|Vaccination 4 (~Day 90)|Overall Study||60
9816492|NCT00696709|10927000|FG002|Vaccination 4 (~Day 90)|Overall Study||32
9816493|NCT00696709|10927001|FG003|Vaccination 4 (~Day 90)|Overall Study||59
9816494|NCT00696709|10927002|FG004|Vaccination 4 (~Day 90)|Overall Study||63
9816495|NCT00696709|10926998|FG000|COMPLETED|Overall Study||62
9816496|NCT00696709|10926999|FG001|COMPLETED|Overall Study||60
9816497|NCT00696709|10927000|FG002|COMPLETED|Overall Study||32
9816498|NCT00696709|10927001|FG003|COMPLETED|Overall Study||59
9816499|NCT00696709|10927002|FG004|COMPLETED|Overall Study||62
9816500|NCT00696709|10926998|FG000|NOT COMPLETED|Overall Study||3
9816501|NCT00696709|10926999|FG001|NOT COMPLETED|Overall Study||3
9816502|NCT00696709|10927000|FG002|NOT COMPLETED|Overall Study||1
9816503|NCT00696709|10927001|FG003|NOT COMPLETED|Overall Study||5
9816504|NCT00696709|10927002|FG004|NOT COMPLETED|Overall Study||3
9816505|NCT00696761|10927022|FG000|STARTED|Overall Study||61
9816506|NCT00696761|10927023|FG001|STARTED|Overall Study||76
9816507|NCT00696761|10927024|FG002|STARTED|Overall Study||41
9816508|NCT00696761|10927025|FG003|STARTED|Overall Study||54
9816509|NCT00696761|10927022|FG000|COMPLETED|Overall Study||41
9816510|NCT00696761|10927023|FG001|COMPLETED|Overall Study||50
9816511|NCT00696761|10927024|FG002|COMPLETED|Overall Study||30
9816512|NCT00696761|10927025|FG003|COMPLETED|Overall Study||44
9816513|NCT00696761|10927022|FG000|NOT COMPLETED|Overall Study||20
9816514|NCT00696761|10927023|FG001|NOT COMPLETED|Overall Study||26
9816515|NCT00696761|10927024|FG002|NOT COMPLETED|Overall Study||11
9816516|NCT00696761|10927025|FG003|NOT COMPLETED|Overall Study||10
9816517|NCT00696774|10927046|FG000|STARTED|Period II||115
9816518|NCT00696774|10927047|FG001|STARTED|Period II||91
9816519|NCT00696774|10927048|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
9816520|NCT00696774|10927046|FG000|COMPLETED|Period II||115
9816521|NCT00696774|10927047|FG001|COMPLETED|Period II||91
9816522|NCT00696774|10927048|FG002|COMPLETED|Period II||0
9816523|NCT00696774|10927046|FG000|NOT COMPLETED|Period II||0
9816524|NCT00696774|10927047|FG001|NOT COMPLETED|Period II||0
9816525|NCT00696774|10927048|FG002|NOT COMPLETED|Period II||36
9816526|NCT00696774|10927046|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
9816527|NCT00696774|10927047|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
9816528|NCT00696774|10927048|FG002|STARTED|Period III||0
9816529|NCT00696774|10927046|FG000|COMPLETED|Period III||106
9816530|NCT00696774|10927047|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
9816531|NCT00696774|10927048|FG002|COMPLETED|Period III||0
9816532|NCT00696774|10927046|FG000|NOT COMPLETED|Period III||7
9816533|NCT00696774|10927047|FG001|NOT COMPLETED|Period III||7
9816534|NCT00696774|10927048|FG002|NOT COMPLETED|Period III||0
9816535|NCT00696787|10927059|FG000|STARTED|Overall Study||40
9816536|NCT00696787|10927060|FG001|STARTED|Overall Study||42
9816537|NCT00696787|10927061|FG002|STARTED|Overall Study||43
9816538|NCT00696787|10927059|FG000|COMPLETED|Overall Study||25
9816539|NCT00696787|10927060|FG001|COMPLETED|Overall Study||22
9816540|NCT00696787|10927061|FG002|COMPLETED|Overall Study||17
9816541|NCT00696787|10927059|FG000|NOT COMPLETED|Overall Study||15
9816542|NCT00696787|10927060|FG001|NOT COMPLETED|Overall Study||20
9816543|NCT00696787|10927061|FG002|NOT COMPLETED|Overall Study||26
9816544|NCT00697073|10927069|FG000|STARTED|Overall Study||68
9816545|NCT00697073|10927069|FG000|COMPLETED|Overall Study||59
9816546|NCT00697073|10927069|FG000|NOT COMPLETED|Overall Study||9
9816547|NCT00697112|10927073|FG000|STARTED|Overall Study||53
9816548|NCT00697112|10927073|FG000|Met the Inclusion Criteria|Overall Study||52
9816549|NCT00697112|10927073|FG000|COMPLETED|Overall Study||43
9816550|NCT00697112|10927073|FG000|NOT COMPLETED|Overall Study||10
9816551|NCT00697190|10927077|FG000|STARTED|First Intervention||19
9816552|NCT00697190|10927078|FG001|STARTED|First Intervention||20
9816553|NCT00697190|10927077|FG000|COMPLETED|First Intervention||19
9816554|NCT00697190|10927078|FG001|COMPLETED|First Intervention||20
9816555|NCT00697190|10927077|FG000|NOT COMPLETED|First Intervention||0
9816556|NCT00697190|10927078|FG001|NOT COMPLETED|First Intervention||0
9816557|NCT00697190|10927077|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
9816558|NCT00697190|10927078|FG001|STARTED|Second Intervention||20
9816559|NCT00697190|10927077|FG000|COMPLETED|Second Intervention||18
9816560|NCT00697190|10927078|FG001|COMPLETED|Second Intervention||20
9816561|NCT00697190|10927077|FG000|NOT COMPLETED|Second Intervention||0
9816562|NCT00697190|10927078|FG001|NOT COMPLETED|Second Intervention||0
9816563|NCT00697203|10927092|FG000|STARTED|Overall Study||76
9816564|NCT00697203|10927093|FG001|STARTED|Overall Study||68
9816565|NCT00697203|10927094|FG002|STARTED|Overall Study||74
9816566|NCT00697203|10927095|FG003|STARTED|Overall Study||74
9816567|NCT00697203|10927092|FG000|COMPLETED|Overall Study||67
9816568|NCT00697203|10927093|FG001|COMPLETED|Overall Study||62
9816569|NCT00697203|10927094|FG002|COMPLETED|Overall Study||66
9816570|NCT00697203|10927095|FG003|COMPLETED|Overall Study||67
9816571|NCT00697203|10927092|FG000|NOT COMPLETED|Overall Study||9
9816572|NCT00697203|10927093|FG001|NOT COMPLETED|Overall Study||6
9816573|NCT00697203|10927094|FG002|NOT COMPLETED|Overall Study||8
9816574|NCT00697203|10927095|FG003|NOT COMPLETED|Overall Study||7
9816575|NCT00697346|10927108|FG000|STARTED|Overall Study||28
9816576|NCT00697346|10927109|FG001|STARTED|Overall Study||28
9816577|NCT00697346|10927110|FG002|STARTED|Overall Study||2
9816578|NCT00697346|10927108|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
9816579|NCT00697346|10927109|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
9816580|NCT00697346|10927110|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
9816581|NCT00697346|10927108|FG000|NOT COMPLETED|Overall Study||28
9816582|NCT00697346|10927109|FG001|NOT COMPLETED|Overall Study||26
9816583|NCT00697346|10927110|FG002|NOT COMPLETED|Overall Study||1
9816584|NCT00697463|10927137|FG000|STARTED|Overall Study||22
9816585|NCT00697463|10927137|FG000|COMPLETED|Overall Study||21
9816586|NCT00697463|10927137|FG000|NOT COMPLETED|Overall Study||1
9816587|NCT00697515|10927141|FG000|STARTED|Dose Optimization Period||142
9816588|NCT00697515|10927142|FG001|STARTED|Dose Optimization Period||0
9816589|NCT00697515|10927141|FG000|COMPLETED|Dose Optimization Period||127
9816590|NCT00697515|10927142|FG001|COMPLETED|Dose Optimization Period||0
9816591|NCT00697515|10927141|FG000|NOT COMPLETED|Dose Optimization Period||15
9816592|NCT00697515|10927142|FG001|NOT COMPLETED|Dose Optimization Period||0
9816593|NCT00697515|10927141|FG000|STARTED|First Intervention (Crossover Period)||63
9816594|NCT00697515|10927142|FG001|STARTED|First Intervention (Crossover Period)||64
9816595|NCT00697515|10927141|FG000|COMPLETED|First Intervention (Crossover Period)||53
9816596|NCT00697515|10927142|FG001|COMPLETED|First Intervention (Crossover Period)||52
9816597|NCT00697515|10927141|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10
9816598|NCT00697515|10927142|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12
9816599|NCT00697515|10927141|FG000|STARTED|Second Intervention (Crossover Period)||53
9816600|NCT00697515|10927142|FG001|STARTED|Second Intervention (Crossover Period)||52
9816601|NCT00697515|10927141|FG000|COMPLETED|Second Intervention (Crossover Period)||52
9816602|NCT00697515|10927142|FG001|COMPLETED|Second Intervention (Crossover Period)||51
9816603|NCT00697515|10927141|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1
9816604|NCT00697515|10927142|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1
9816605|NCT00697541|10927150|FG000|STARTED|Overall Study||10
9816606|NCT00697541|10927151|FG001|STARTED|Overall Study||10
9816607|NCT00697541|10927150|FG000|COMPLETED|Overall Study||8
9816608|NCT00697541|10927151|FG001|COMPLETED|Overall Study||9
9816609|NCT00697541|10927150|FG000|NOT COMPLETED|Overall Study||2
9816610|NCT00697541|10927151|FG001|NOT COMPLETED|Overall Study||1
9816611|NCT00697593|10927158|FG000|STARTED|Overall Study||70
9816612|NCT00697593|10927158|FG000|COMPLETED|Overall Study||51
9816613|NCT00697593|10927158|FG000|NOT COMPLETED|Overall Study||19
9816614|NCT00697619|10927164|FG000|STARTED|Overall Study||30
9816615|NCT00697619|10927165|FG001|STARTED|Overall Study||30
9816616|NCT00697619|10927164|FG000|COMPLETED|Overall Study||24
9816617|NCT00697619|10927165|FG001|COMPLETED|Overall Study||22
9816618|NCT00697619|10927164|FG000|NOT COMPLETED|Overall Study||6
9816619|NCT00697619|10927165|FG001|NOT COMPLETED|Overall Study||8
9816620|NCT00697697|10927173|FG000|STARTED|Overall Study||94
9816621|NCT00697697|10927174|FG001|STARTED|Overall Study||98
9816622|NCT00697697|10927173|FG000|COMPLETED|Overall Study||45
9816623|NCT00697697|10927174|FG001|COMPLETED|Overall Study||44
9816624|NCT00697697|10927173|FG000|NOT COMPLETED|Overall Study||49
9816625|NCT00697697|10927174|FG001|NOT COMPLETED|Overall Study||54
9816626|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
9816627|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
9816628|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
9816629|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
9816630|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
9816631|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
9816632|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
9816633|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
9816634|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
9816635|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816636|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816637|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816638|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816639|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816640|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816641|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816642|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816643|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816644|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816645|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816646|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816647|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816648|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816649|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
9816650|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816651|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
9816652|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816653|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816654|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816655|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816656|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816657|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816658|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816659|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
9816660|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816661|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816662|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816663|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816664|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816665|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816666|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816667|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
9816668|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816669|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816670|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816671|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816672|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816673|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
9816674|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816675|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816676|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
9816677|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816678|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816679|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816680|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816681|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816682|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816683|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816684|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
9816685|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816686|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816687|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816688|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816689|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816690|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816691|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816692|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816693|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816694|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816695|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816696|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816697|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
9816698|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816699|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816700|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816701|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
9816702|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816703|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816704|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816705|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816706|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816707|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816708|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816709|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
9816710|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816711|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816712|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816713|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816714|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816715|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816716|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816717|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816718|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816719|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816720|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816721|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
9816722|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816723|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816724|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816725|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816726|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
9816727|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816728|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816729|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816730|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816731|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816732|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816733|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816734|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
9816735|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816736|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816737|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816738|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816739|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816740|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816741|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816742|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
9816743|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10016810|NCT01812044|11139581|FG002|STARTED|Overall Study||16
9816744|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816745|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
9816746|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816747|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816748|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816749|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816750|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816751|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
9816752|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816753|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816754|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816755|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816756|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816757|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816758|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816759|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
9816760|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816761|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816762|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816763|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816764|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816765|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816766|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816767|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816768|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816769|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
9816770|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816771|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816772|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816773|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816774|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816775|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816776|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
9816777|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816778|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816779|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816780|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816781|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816782|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816783|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816784|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
9816785|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816786|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816787|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816788|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816789|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816790|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816791|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816792|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816793|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
9816794|NCT00697788|10927180|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816795|NCT00697788|10927181|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816796|NCT00697788|10927182|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816797|NCT00697788|10927183|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816798|NCT00697788|10927184|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816799|NCT00697788|10927185|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816800|NCT00697788|10927186|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816801|NCT00697788|10927187|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
9816802|NCT00697788|10927180|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816803|NCT00697788|10927181|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816804|NCT00697788|10927182|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816805|NCT00697788|10927183|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816806|NCT00697788|10927184|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816807|NCT00697788|10927185|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816808|NCT00697788|10927186|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816809|NCT00697788|10927187|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
9816810|NCT00697788|10927180|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816811|NCT00697788|10927181|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816812|NCT00697788|10927182|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816813|NCT00697788|10927183|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816814|NCT00697788|10927184|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816815|NCT00697788|10927185|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816816|NCT00697788|10927186|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816817|NCT00697788|10927187|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
9816818|NCT00697801|10927217|FG000|STARTED|Overall Study||69
9816819|NCT00697801|10927218|FG001|STARTED|Overall Study||70
9816820|NCT00697801|10927219|FG002|STARTED|Overall Study||69
9816821|NCT00697801|10927217|FG000|COMPLETED|Overall Study||57
9816822|NCT00697801|10927218|FG001|COMPLETED|Overall Study||58
9816823|NCT00697801|10927219|FG002|COMPLETED|Overall Study||45
9816824|NCT00697801|10927217|FG000|NOT COMPLETED|Overall Study||12
9816825|NCT00697801|10927218|FG001|NOT COMPLETED|Overall Study||12
9816826|NCT00697801|10927219|FG002|NOT COMPLETED|Overall Study||24
9816827|NCT00697827|10927229|FG000|STARTED|Overall Study||28
9816828|NCT00697827|10927230|FG001|STARTED|Overall Study||16
9816829|NCT00697827|10927229|FG000|COMPLETED|Overall Study||26
9816830|NCT00697827|10927230|FG001|COMPLETED|Overall Study||15
9816831|NCT00697827|10927229|FG000|NOT COMPLETED|Overall Study||2
9816832|NCT00697827|10927230|FG001|NOT COMPLETED|Overall Study||1
9816833|NCT00698035|10927238|FG000|STARTED|Overall Study||39
9816834|NCT00698035|10927239|FG001|STARTED|Overall Study||36
9816835|NCT00698035|10927238|FG000|COMPLETED|Overall Study||35
9816836|NCT00698035|10927239|FG001|COMPLETED|Overall Study||34
9816837|NCT00698035|10927238|FG000|NOT COMPLETED|Overall Study||4
9816838|NCT00698035|10927239|FG001|NOT COMPLETED|Overall Study||2
9816839|NCT00698139|10927251|FG000|STARTED|Overall Study||1
9816840|NCT00698139|10927252|FG001|STARTED|Overall Study||1
9816841|NCT00698139|10927253|FG002|STARTED|Overall Study||1
9816842|NCT00698139|10927251|FG000|2nd Visit|Overall Study||1
9816843|NCT00698139|10927252|FG001|2nd Visit|Overall Study||1
9816844|NCT00698139|10927253|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
9816845|NCT00698139|10927251|FG000|COMPLETED|Overall Study||1
9816846|NCT00698139|10927252|FG001|COMPLETED|Overall Study||1
9816847|NCT00698139|10927253|FG002|COMPLETED|Overall Study||1
9816848|NCT00698139|10927251|FG000|NOT COMPLETED|Overall Study||0
9816849|NCT00698139|10927252|FG001|NOT COMPLETED|Overall Study||0
9816850|NCT00698139|10927253|FG002|NOT COMPLETED|Overall Study||0
9816851|NCT00698204|10927263|FG000|STARTED|Overall Study||20
9816852|NCT00698204|10927264|FG001|STARTED|Overall Study||20
9816853|NCT00698204|10927263|FG000|COMPLETED|Overall Study||19
9816854|NCT00698204|10927264|FG001|COMPLETED|Overall Study||20
9816855|NCT00698204|10927263|FG000|NOT COMPLETED|Overall Study||1
9816856|NCT00698204|10927264|FG001|NOT COMPLETED|Overall Study||0
9816857|NCT00698451|10927272|FG000|STARTED|Overall Study||54
9816858|NCT00698451|10927272|FG000|COMPLETED|Overall Study||15
9816859|NCT00698451|10927272|FG000|NOT COMPLETED|Overall Study||39
9816860|NCT00698516|10927276|FG000|STARTED|Overall Study||50
9816861|NCT00698516|10927276|FG000|COMPLETED|Overall Study||45
9816862|NCT00698516|10927276|FG000|NOT COMPLETED|Overall Study||5
9816863|NCT00698581|10927286|FG000|STARTED|Overall Study||68
9816864|NCT00698581|10927287|FG001|STARTED|Overall Study||20
9816865|NCT00698581|10927286|FG000|COMPLETED|Overall Study||23
9816866|NCT00698581|10927287|FG001|COMPLETED|Overall Study||8
9816867|NCT00698581|10927286|FG000|NOT COMPLETED|Overall Study||45
9816868|NCT00698581|10927287|FG001|NOT COMPLETED|Overall Study||12
9816869|NCT00698646|10927297|FG000|STARTED|Overall Study||128
9816870|NCT00698646|10927298|FG001|STARTED|Overall Study||128
9816871|NCT00698646|10927299|FG002|STARTED|Overall Study||128
9816872|NCT00698646|10927297|FG000|COMPLETED|Overall Study||92
9816873|NCT00698646|10927298|FG001|COMPLETED|Overall Study||97
9816874|NCT00698646|10927299|FG002|COMPLETED|Overall Study||99
9816875|NCT00698646|10927297|FG000|NOT COMPLETED|Overall Study||36
9816876|NCT00698646|10927298|FG001|NOT COMPLETED|Overall Study||31
9816877|NCT00698646|10927299|FG002|NOT COMPLETED|Overall Study||29
9816878|NCT00698685|10927307|FG000|STARTED|Overall Study||14
9816879|NCT00698685|10927307|FG000|COMPLETED|Overall Study||12
9816880|NCT00698685|10927307|FG000|NOT COMPLETED|Overall Study||2
9816881|NCT00698841|10927311|FG000|STARTED|Overall Study||51
9816882|NCT00698841|10927311|FG000|COMPLETED|Overall Study||33
9816883|NCT00698841|10927311|FG000|NOT COMPLETED|Overall Study||18
9816884|NCT00698867|10927315|FG000|STARTED|Overall Study||118
9816885|NCT00698867|10927315|FG000|Subjects With 1 Year Data|Overall Study||68
9816886|NCT00698867|10927315|FG000|Subjects With 2 Year Data|Overall Study||55
9816887|NCT00698867|10927315|FG000|Subjects With 3 Year Data|Overall Study||35
9816888|NCT00698867|10927315|FG000|Subjects With 4 Year Data|Overall Study||34
9816889|NCT00698867|10927315|FG000|COMPLETED|Overall Study||27
9816890|NCT00698867|10927315|FG000|NOT COMPLETED|Overall Study||91
9816891|NCT00698932|10927321|FG000|STARTED|Overall Study|Randomized and treated|284
9816892|NCT00698932|10927322|FG001|STARTED|Overall Study|Randomized and treated|284
9816893|NCT00698932|10927321|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
9816894|NCT00698932|10927322|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
9816895|NCT00698932|10927321|FG000|NOT COMPLETED|Overall Study||22
9816896|NCT00698932|10927322|FG001|NOT COMPLETED|Overall Study||36
9816897|NCT00698997|10927330|FG000|STARTED|Overall Study|1 enrollment|55
9816898|NCT00698997|10927331|FG001|STARTED|Overall Study|1 enrollment|63
9816899|NCT00698997|10927330|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45
9816900|NCT00698997|10927331|FG001|COMPLETED|Overall Study|36 - final assessment completed|36
9816901|NCT00698997|10927330|FG000|NOT COMPLETED|Overall Study||10
9816902|NCT00698997|10927331|FG001|NOT COMPLETED|Overall Study||27
9816903|NCT00699010|10927340|FG000|STARTED|Overall Study||15
9816904|NCT00699010|10927341|FG001|STARTED|Overall Study||15
9816905|NCT00699010|10927340|FG000|COMPLETED|Overall Study||15
9816906|NCT00699010|10927341|FG001|COMPLETED|Overall Study||15
9816907|NCT00699010|10927340|FG000|NOT COMPLETED|Overall Study||0
9816908|NCT00699010|10927341|FG001|NOT COMPLETED|Overall Study||0
9816909|NCT00699140|10927347|FG000|STARTED|Overall Study||18
9816910|NCT00699140|10927347|FG000|COMPLETED|Overall Study||18
9816911|NCT00699140|10927347|FG000|NOT COMPLETED|Overall Study||0
9816912|NCT00699153|10927357|FG000|STARTED|Overall Study|Intent to treat population|203
9816913|NCT00699153|10927358|FG001|STARTED|Overall Study|Intent to treat population|202
10016811|NCT01812044|11139579|FG000|COMPLETED|Overall Study||17
10016812|NCT01812044|11139580|FG001|COMPLETED|Overall Study||17
10016813|NCT01812044|11139581|FG002|COMPLETED|Overall Study||16
9816914|NCT00699153|10927357|FG000|COMPLETED|Overall Study||200
9816915|NCT00699153|10927358|FG001|COMPLETED|Overall Study||200
9816916|NCT00699153|10927357|FG000|NOT COMPLETED|Overall Study||3
9816917|NCT00699153|10927358|FG001|NOT COMPLETED|Overall Study||2
9816918|NCT00699192|10927367|FG000|STARTED|Overall Study||275
9816919|NCT00699192|10927368|FG001|STARTED|Overall Study||272
9816920|NCT00699192|10927369|FG002|STARTED|Overall Study||272
9816921|NCT00699192|10927367|FG000|COMPLETED|Overall Study||259
9816922|NCT00699192|10927368|FG001|COMPLETED|Overall Study||260
9816923|NCT00699192|10927369|FG002|COMPLETED|Overall Study||261
9816924|NCT00699192|10927367|FG000|NOT COMPLETED|Overall Study||16
9816925|NCT00699192|10927368|FG001|NOT COMPLETED|Overall Study||12
9816926|NCT00699192|10927369|FG002|NOT COMPLETED|Overall Study||11
9816927|NCT00699218|10927377|FG000|STARTED|Overall Study||15
9816928|NCT00699218|10927377|FG000|COMPLETED|Overall Study||15
9816929|NCT00699218|10927377|FG000|NOT COMPLETED|Overall Study||0
9816930|NCT00699283|10927383|FG000|STARTED|Overall Study||47
9816931|NCT00699283|10927384|FG001|STARTED|Overall Study||15
9816932|NCT00699283|10927383|FG000|COMPLETED|Overall Study||14
9816933|NCT00699283|10927384|FG001|COMPLETED|Overall Study||7
9816934|NCT00699283|10927383|FG000|NOT COMPLETED|Overall Study||33
9816935|NCT00699283|10927384|FG001|NOT COMPLETED|Overall Study||8
9816936|NCT00699335|10927389|FG000|STARTED|Overall Study||5308
9816937|NCT00699335|10927389|FG000|COMPLETED|Overall Study||5080
9816938|NCT00699335|10927389|FG000|NOT COMPLETED|Overall Study||228
9816939|NCT00699348|10927396|FG000|STARTED|Overall Study||351
9816940|NCT00699348|10927396|FG000|COMPLETED|Overall Study||261
9816941|NCT00699348|10927396|FG000|NOT COMPLETED|Overall Study||90
9816942|NCT00699374|10927402|FG000|STARTED|Overall Study||530
9816943|NCT00699374|10927403|FG001|STARTED|Overall Study||544
9816944|NCT00699374|10927402|FG000|Treated|Overall Study||526
9816945|NCT00699374|10927403|FG001|Treated|Overall Study||542
9816946|NCT00699374|10927402|FG000|COMPLETED|Overall Study||0
9816947|NCT00699374|10927403|FG001|COMPLETED|Overall Study||0
9816948|NCT00699374|10927402|FG000|NOT COMPLETED|Overall Study||530
9816949|NCT00699374|10927403|FG001|NOT COMPLETED|Overall Study||544
9816950|NCT00699400|10927412|FG000|STARTED|Overall Study||42
9816951|NCT00699400|10927413|FG001|STARTED|Overall Study||3
9816952|NCT00699400|10927414|FG002|STARTED|Overall Study||138
9816953|NCT00699400|10927415|FG003|STARTED|Overall Study||6
9816954|NCT00699400|10927416|FG004|STARTED|Overall Study||4
9816955|NCT00699400|10927417|FG005|STARTED|Overall Study||11
9816956|NCT00699400|10927412|FG000|COMPLETED|Overall Study||42
9816957|NCT00699400|10927413|FG001|COMPLETED|Overall Study||3
9816958|NCT00699400|10927414|FG002|COMPLETED|Overall Study||138
9816959|NCT00699400|10927415|FG003|COMPLETED|Overall Study||6
9816960|NCT00699400|10927416|FG004|COMPLETED|Overall Study||4
9816961|NCT00699400|10927417|FG005|COMPLETED|Overall Study||0
9816962|NCT00699400|10927412|FG000|NOT COMPLETED|Overall Study||0
9816963|NCT00699400|10927413|FG001|NOT COMPLETED|Overall Study||0
9816964|NCT00699400|10927414|FG002|NOT COMPLETED|Overall Study||0
9816965|NCT00699400|10927415|FG003|NOT COMPLETED|Overall Study||0
9816966|NCT00699400|10927416|FG004|NOT COMPLETED|Overall Study||0
9816967|NCT00699400|10927417|FG005|NOT COMPLETED|Overall Study||11
9816968|NCT00699491|10927431|FG000|STARTED|Overall Study||3
9816969|NCT00699491|10927432|FG001|STARTED|Overall Study||2
9816970|NCT00699491|10927433|FG002|STARTED|Overall Study||7
9816971|NCT00699491|10927434|FG003|STARTED|Overall Study||6
9816972|NCT00699491|10927435|FG004|STARTED|Overall Study||8
9816973|NCT00699491|10927436|FG005|STARTED|Overall Study||22
9816974|NCT00699491|10927431|FG000|COMPLETED|Overall Study||3
9816975|NCT00699491|10927432|FG001|COMPLETED|Overall Study||2
9816976|NCT00699491|10927433|FG002|COMPLETED|Overall Study||7
9816977|NCT00699491|10927434|FG003|COMPLETED|Overall Study||6
9816978|NCT00699491|10927435|FG004|COMPLETED|Overall Study||8
9816979|NCT00699491|10927436|FG005|COMPLETED|Overall Study||22
9816980|NCT00699491|10927431|FG000|NOT COMPLETED|Overall Study||0
9816981|NCT00699491|10927432|FG001|NOT COMPLETED|Overall Study||0
9816982|NCT00699491|10927433|FG002|NOT COMPLETED|Overall Study||0
9816983|NCT00699491|10927434|FG003|NOT COMPLETED|Overall Study||0
9816984|NCT00699491|10927435|FG004|NOT COMPLETED|Overall Study||0
9816985|NCT00699491|10927436|FG005|NOT COMPLETED|Overall Study||0
9816986|NCT00699556|10927450|FG000|STARTED|First Intervention (1 Day)||11
9816987|NCT00699556|10927451|FG001|STARTED|First Intervention (1 Day)||11
9816988|NCT00699556|10927450|FG000|COMPLETED|First Intervention (1 Day)||11
9816989|NCT00699556|10927451|FG001|COMPLETED|First Intervention (1 Day)||11
9816990|NCT00699556|10927450|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9816991|NCT00699556|10927451|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9816992|NCT00699556|10927450|FG000|STARTED|Second Intervention (1 Day)||11
9816993|NCT00699556|10927451|FG001|STARTED|Second Intervention (1 Day)||11
9816994|NCT00699556|10927450|FG000|COMPLETED|Second Intervention (1 Day)||11
9816995|NCT00699556|10927451|FG001|COMPLETED|Second Intervention (1 Day)||11
9816996|NCT00699556|10927450|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9816997|NCT00699556|10927451|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9831967|NCT00771030|10942633|FG001|NOT COMPLETED|Overall Study||1
9831968|NCT00771030|10942634|FG002|NOT COMPLETED|Overall Study||0
10016814|NCT01812044|11139579|FG000|NOT COMPLETED|Overall Study||0
9831969|NCT00771030|10942635|FG003|NOT COMPLETED|Overall Study||0
9816998|NCT00699582|10927461|FG000|STARTED|Overall Study||138
9816999|NCT00699582|10927462|FG001|STARTED|Overall Study||130
9817000|NCT00699582|10927463|FG002|STARTED|Overall Study||121
9817001|NCT00699582|10927461|FG000|COMPLETED|Overall Study||120
9817002|NCT00699582|10927462|FG001|COMPLETED|Overall Study||108
9817003|NCT00699582|10927463|FG002|COMPLETED|Overall Study||93
9817004|NCT00699582|10927461|FG000|NOT COMPLETED|Overall Study||18
9817005|NCT00699582|10927462|FG001|NOT COMPLETED|Overall Study||22
9817006|NCT00699582|10927463|FG002|NOT COMPLETED|Overall Study||28
9817007|NCT00699608|10927471|FG000|STARTED|First Intervention||16
9817008|NCT00699608|10927472|FG001|STARTED|First Intervention||15
9817009|NCT00699608|10927473|FG002|STARTED|First Intervention||15
9817010|NCT00699608|10927474|FG003|STARTED|First Intervention||15
9817011|NCT00699608|10927475|FG004|STARTED|First Intervention||15
9817012|NCT00699608|10927476|FG005|STARTED|First Intervention||15
9817013|NCT00699608|10927471|FG000|COMPLETED|First Intervention||16
9817014|NCT00699608|10927472|FG001|COMPLETED|First Intervention||15
10236760|NCT00832572|11367487|FG000|NOT COMPLETED|Period 1||0
10236761|NCT00832572|11367488|FG001|NOT COMPLETED|Period 1||0
10236762|NCT00832572|11367487|FG000|STARTED|Period 2||3
10236763|NCT00832572|11367488|FG001|STARTED|Period 2||2
10236764|NCT00832572|11367487|FG000|COMPLETED|Period 2||3
9817015|NCT00699608|10927473|FG002|COMPLETED|First Intervention||14
10016815|NCT01812044|11139580|FG001|NOT COMPLETED|Overall Study||0
10016816|NCT01812044|11139581|FG002|NOT COMPLETED|Overall Study||0
10016817|NCT01812057|11139591|FG000|STARTED|Overall Study||25
10016818|NCT01812057|11139592|FG001|STARTED|Overall Study||24
10016819|NCT01812057|11139591|FG000|COMPLETED|Overall Study||23
10016820|NCT01812057|11139592|FG001|COMPLETED|Overall Study||24
9817016|NCT00699608|10927474|FG003|COMPLETED|First Intervention||15
9817017|NCT00699608|10927475|FG004|COMPLETED|First Intervention||14
9817018|NCT00699608|10927476|FG005|COMPLETED|First Intervention||15
9817019|NCT00699608|10927471|FG000|NOT COMPLETED|First Intervention||0
9817020|NCT00699608|10927472|FG001|NOT COMPLETED|First Intervention||0
9817021|NCT00699608|10927473|FG002|NOT COMPLETED|First Intervention||1
10112390|NCT02503085|11243379|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10112391|NCT02503085|11243380|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10112392|NCT02503085|11243381|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10112393|NCT02503085|11243382|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10236765|NCT00832572|11367488|FG001|COMPLETED|Period 2||2
10236766|NCT00832572|11367487|FG000|NOT COMPLETED|Period 2||0
9817022|NCT00699608|10927474|FG003|NOT COMPLETED|First Intervention||0
9817023|NCT00699608|10927475|FG004|NOT COMPLETED|First Intervention||1
9817024|NCT00699608|10927476|FG005|NOT COMPLETED|First Intervention||0
9817025|NCT00699608|10927471|FG000|STARTED|First 4-14 Day Washout Period||16
9817026|NCT00699608|10927472|FG001|STARTED|First 4-14 Day Washout Period||15
9817027|NCT00699608|10927473|FG002|STARTED|First 4-14 Day Washout Period||14
9817028|NCT00699608|10927474|FG003|STARTED|First 4-14 Day Washout Period||15
9817029|NCT00699608|10927475|FG004|STARTED|First 4-14 Day Washout Period||14
9817030|NCT00699608|10927476|FG005|STARTED|First 4-14 Day Washout Period||15
9817031|NCT00699608|10927471|FG000|COMPLETED|First 4-14 Day Washout Period||16
9817032|NCT00699608|10927472|FG001|COMPLETED|First 4-14 Day Washout Period||15
9817033|NCT00699608|10927473|FG002|COMPLETED|First 4-14 Day Washout Period||14
9817034|NCT00699608|10927474|FG003|COMPLETED|First 4-14 Day Washout Period||15
9817035|NCT00699608|10927475|FG004|COMPLETED|First 4-14 Day Washout Period||14
9817036|NCT00699608|10927476|FG005|COMPLETED|First 4-14 Day Washout Period||15
9817037|NCT00699608|10927471|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0
9817038|NCT00699608|10927472|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0
9817039|NCT00699608|10927473|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0
9817040|NCT00699608|10927474|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0
9817041|NCT00699608|10927475|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0
9817042|NCT00699608|10927476|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0
9817043|NCT00699608|10927471|FG000|STARTED|Second Intervention||16
9817044|NCT00699608|10927472|FG001|STARTED|Second Intervention||15
9817045|NCT00699608|10927473|FG002|STARTED|Second Intervention||14
9817046|NCT00699608|10927474|FG003|STARTED|Second Intervention||15
9817047|NCT00699608|10927475|FG004|STARTED|Second Intervention||14
9817048|NCT00699608|10927476|FG005|STARTED|Second Intervention||15
9817049|NCT00699608|10927471|FG000|COMPLETED|Second Intervention||16
9817050|NCT00699608|10927472|FG001|COMPLETED|Second Intervention||15
9817051|NCT00699608|10927473|FG002|COMPLETED|Second Intervention||13
9817052|NCT00699608|10927474|FG003|COMPLETED|Second Intervention||14
9817053|NCT00699608|10927475|FG004|COMPLETED|Second Intervention||14
9817054|NCT00699608|10927476|FG005|COMPLETED|Second Intervention||15
9817055|NCT00699608|10927471|FG000|NOT COMPLETED|Second Intervention||0
9817056|NCT00699608|10927472|FG001|NOT COMPLETED|Second Intervention||0
10016821|NCT01812057|11139591|FG000|NOT COMPLETED|Overall Study||2
9817057|NCT00699608|10927473|FG002|NOT COMPLETED|Second Intervention||1
9817058|NCT00699608|10927474|FG003|NOT COMPLETED|Second Intervention||1
9817059|NCT00699608|10927475|FG004|NOT COMPLETED|Second Intervention||0
9817060|NCT00699608|10927476|FG005|NOT COMPLETED|Second Intervention||0
10112394|NCT02503085|11243379|FG000|STARTED|Period 4||6
10236767|NCT00832572|11367488|FG001|NOT COMPLETED|Period 2||0
9817061|NCT00699608|10927471|FG000|STARTED|Second 4-14 Day Washout Period||16
10016822|NCT01812057|11139592|FG001|NOT COMPLETED|Overall Study||0
10016823|NCT01812109|11139602|FG000|STARTED|Overall Study||154
10016824|NCT01812109|11139602|FG000|With Torsion|Overall Study||36
9817062|NCT00699608|10927472|FG001|STARTED|Second 4-14 Day Washout Period||15
9817063|NCT00699608|10927473|FG002|STARTED|Second 4-14 Day Washout Period||13
9817064|NCT00699608|10927474|FG003|STARTED|Second 4-14 Day Washout Period||14
9817065|NCT00699608|10927475|FG004|STARTED|Second 4-14 Day Washout Period||14
9817066|NCT00699608|10927476|FG005|STARTED|Second 4-14 Day Washout Period||15
9817067|NCT00699608|10927471|FG000|COMPLETED|Second 4-14 Day Washout Period||16
9817068|NCT00699608|10927472|FG001|COMPLETED|Second 4-14 Day Washout Period||15
9817069|NCT00699608|10927473|FG002|COMPLETED|Second 4-14 Day Washout Period||13
9817070|NCT00699608|10927474|FG003|COMPLETED|Second 4-14 Day Washout Period||14
9817071|NCT00699608|10927475|FG004|COMPLETED|Second 4-14 Day Washout Period||14
9817072|NCT00699608|10927476|FG005|COMPLETED|Second 4-14 Day Washout Period||15
9817073|NCT00699608|10927471|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0
9817074|NCT00699608|10927472|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0
9817075|NCT00699608|10927473|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0
9817076|NCT00699608|10927474|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0
9817077|NCT00699608|10927475|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0
9817078|NCT00699608|10927476|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0
9817079|NCT00699608|10927471|FG000|STARTED|Third Intervention||16
9817080|NCT00699608|10927472|FG001|STARTED|Third Intervention||15
9817081|NCT00699608|10927473|FG002|STARTED|Third Intervention||13
9817082|NCT00699608|10927474|FG003|STARTED|Third Intervention||14
9817083|NCT00699608|10927475|FG004|STARTED|Third Intervention||14
9817084|NCT00699608|10927476|FG005|STARTED|Third Intervention||15
9817085|NCT00699608|10927471|FG000|COMPLETED|Third Intervention||16
9817086|NCT00699608|10927472|FG001|COMPLETED|Third Intervention||15
9817087|NCT00699608|10927473|FG002|COMPLETED|Third Intervention||13
9817088|NCT00699608|10927474|FG003|COMPLETED|Third Intervention||14
9817089|NCT00699608|10927475|FG004|COMPLETED|Third Intervention||14
9817090|NCT00699608|10927476|FG005|COMPLETED|Third Intervention||15
9817091|NCT00699608|10927471|FG000|NOT COMPLETED|Third Intervention||0
9817092|NCT00699608|10927472|FG001|NOT COMPLETED|Third Intervention||0
9817093|NCT00699608|10927473|FG002|NOT COMPLETED|Third Intervention||0
9817094|NCT00699608|10927474|FG003|NOT COMPLETED|Third Intervention||0
9817095|NCT00699608|10927475|FG004|NOT COMPLETED|Third Intervention||0
9817096|NCT00699608|10927476|FG005|NOT COMPLETED|Third Intervention||0
9817097|NCT00699660|10927486|FG000|STARTED|Overall Study||190
9817098|NCT00699660|10927487|FG001|STARTED|Overall Study||216
9817099|NCT00699660|10927486|FG000|COMPLETED|Overall Study||176
9817100|NCT00699660|10927487|FG001|COMPLETED|Overall Study||208
9817101|NCT00699660|10927486|FG000|NOT COMPLETED|Overall Study||14
9817102|NCT00699660|10927487|FG001|NOT COMPLETED|Overall Study||8
9817103|NCT00699699|10927493|FG000|STARTED|Overall Study||1280
9817104|NCT00699699|10927493|FG000|COMPLETED|Overall Study||1223
9817105|NCT00699699|10927493|FG000|NOT COMPLETED|Overall Study||57
9817106|NCT00699751|10927499|FG000|STARTED|Period 1: Without/Before Drug Switch||614
9817107|NCT00699751|10927500|FG001|STARTED|Period 1: Without/Before Drug Switch||307
9817108|NCT00699751|10927499|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
9817109|NCT00699751|10927500|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
9817110|NCT00699751|10927499|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
9817111|NCT00699751|10927500|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
9817112|NCT00699751|10927499|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
9817113|NCT00699751|10927500|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
9817114|NCT00699751|10927499|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
9817115|NCT00699751|10927500|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
9817116|NCT00699751|10927499|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
9817117|NCT00699751|10927500|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
9817118|NCT00699751|10927499|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0
9817119|NCT00699751|10927500|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
9817120|NCT00699751|10927499|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
9817121|NCT00699751|10927500|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
9817122|NCT00699751|10927499|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
9817123|NCT00699751|10927500|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
9817124|NCT00699751|10927499|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
9817125|NCT00699751|10927500|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
9817126|NCT00699751|10927499|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
9817127|NCT00699751|10927500|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
9817128|NCT00699751|10927499|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
9817129|NCT00699751|10927500|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
9817130|NCT00699803|10927509|FG000|STARTED|Overall Study||32
9817131|NCT00699803|10927510|FG001|STARTED|Overall Study||32
9817132|NCT00699803|10927509|FG000|COMPLETED|Overall Study||30
9817133|NCT00699803|10927510|FG001|COMPLETED|Overall Study||26
9817134|NCT00699803|10927509|FG000|NOT COMPLETED|Overall Study||2
9817135|NCT00699803|10927510|FG001|NOT COMPLETED|Overall Study||6
9817136|NCT00699816|10927518|FG000|STARTED|Overall Study||115
9817137|NCT00699816|10927519|FG001|STARTED|Overall Study||115
9817138|NCT00699816|10927518|FG000|COMPLETED|Overall Study||114
9817139|NCT00699816|10927519|FG001|COMPLETED|Overall Study||112
9817140|NCT00699816|10927518|FG000|NOT COMPLETED|Overall Study||1
9817141|NCT00699816|10927519|FG001|NOT COMPLETED|Overall Study||3
9817142|NCT00699907|10927528|FG000|STARTED|Overall Study||14
9817143|NCT00699907|10927529|FG001|STARTED|Overall Study||57
9817144|NCT00699907|10927530|FG002|STARTED|Overall Study||56
9817145|NCT00699907|10927528|FG000|COMPLETED|Overall Study||12
9817146|NCT00699907|10927529|FG001|COMPLETED|Overall Study||47
9817147|NCT00699907|10927530|FG002|COMPLETED|Overall Study||48
9817148|NCT00699907|10927528|FG000|NOT COMPLETED|Overall Study||2
9817149|NCT00699907|10927529|FG001|NOT COMPLETED|Overall Study||10
9817150|NCT00699907|10927530|FG002|NOT COMPLETED|Overall Study||8
9817151|NCT00699972|10927541|FG000|STARTED|Overall Study||122
9817152|NCT00699972|10927542|FG001|STARTED|Overall Study||133
9817153|NCT00699972|10927543|FG002|STARTED|Overall Study||135
9817154|NCT00699972|10927541|FG000|COMPLETED|Overall Study||106
9817155|NCT00699972|10927542|FG001|COMPLETED|Overall Study||114
9817156|NCT00699972|10927543|FG002|COMPLETED|Overall Study||100
9817157|NCT00699972|10927541|FG000|NOT COMPLETED|Overall Study||16
9817158|NCT00699972|10927542|FG001|NOT COMPLETED|Overall Study||19
9817159|NCT00699972|10927543|FG002|NOT COMPLETED|Overall Study||35
9817160|NCT00699998|10927555|FG000|STARTED|Overall Study||3620
9817161|NCT00699998|10927556|FG001|STARTED|Overall Study||1043
9817162|NCT00699998|10927557|FG002|STARTED|Overall Study||3623
9817163|NCT00699998|10927558|FG003|STARTED|Overall Study||1040
9817164|NCT00699998|10927555|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590
9817165|NCT00699998|10927556|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033
9817166|NCT00699998|10927557|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590
9817167|NCT00699998|10927558|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027
9817168|NCT00699998|10927555|FG000|COMPLETED|Overall Study||3421
9817169|NCT00699998|10927556|FG001|COMPLETED|Overall Study||957
9817170|NCT00699998|10927557|FG002|COMPLETED|Overall Study||3417
9817171|NCT00699998|10927558|FG003|COMPLETED|Overall Study||958
9817172|NCT00699998|10927555|FG000|NOT COMPLETED|Overall Study||199
9817173|NCT00699998|10927556|FG001|NOT COMPLETED|Overall Study||86
9817174|NCT00699998|10927557|FG002|NOT COMPLETED|Overall Study||206
9817175|NCT00699998|10927558|FG003|NOT COMPLETED|Overall Study||82
9817176|NCT00700011|10927575|FG000|STARTED|Overall Study||8
9817177|NCT00700011|10927576|FG001|STARTED|Overall Study||2
9817178|NCT00700011|10927575|FG000|COMPLETED|Overall Study||8
9817179|NCT00700011|10927576|FG001|COMPLETED|Overall Study||1
9817180|NCT00700011|10927575|FG000|NOT COMPLETED|Overall Study||0
9817181|NCT00700011|10927576|FG001|NOT COMPLETED|Overall Study||1
9817182|NCT00700063|10927590|FG000|STARTED|Overall Study||33
9817183|NCT00700063|10927591|FG001|STARTED|Overall Study||34
9817184|NCT00700063|10927592|FG002|STARTED|Overall Study||33
9817185|NCT00700063|10927593|FG003|STARTED|Overall Study||33
9817186|NCT00700063|10927594|FG004|STARTED|Overall Study||33
9817187|NCT00700063|10927595|FG005|STARTED|Overall Study||34
9817188|NCT00700063|10927596|FG006|STARTED|Overall Study||32
9817189|NCT00700063|10927597|FG007|STARTED|Overall Study||33
9817190|NCT00700063|10927590|FG000|COMPLETED|Overall Study||32
9817191|NCT00700063|10927591|FG001|COMPLETED|Overall Study||34
9817192|NCT00700063|10927592|FG002|COMPLETED|Overall Study||33
9817193|NCT00700063|10927593|FG003|COMPLETED|Overall Study||31
9817194|NCT00700063|10927594|FG004|COMPLETED|Overall Study||31
9817195|NCT00700063|10927595|FG005|COMPLETED|Overall Study||34
9817196|NCT00700063|10927596|FG006|COMPLETED|Overall Study||32
9817197|NCT00700063|10927597|FG007|COMPLETED|Overall Study||33
9817198|NCT00700063|10927590|FG000|NOT COMPLETED|Overall Study||1
9817199|NCT00700063|10927591|FG001|NOT COMPLETED|Overall Study||0
9817200|NCT00700063|10927592|FG002|NOT COMPLETED|Overall Study||0
9817201|NCT00700063|10927593|FG003|NOT COMPLETED|Overall Study||2
9817202|NCT00700063|10927594|FG004|NOT COMPLETED|Overall Study||2
9817203|NCT00700063|10927595|FG005|NOT COMPLETED|Overall Study||0
9817204|NCT00700063|10927596|FG006|NOT COMPLETED|Overall Study||0
9817205|NCT00700063|10927597|FG007|NOT COMPLETED|Overall Study||0
9817206|NCT00700102|10927617|FG000|STARTED|Overall Study||411
9817207|NCT00700102|10927618|FG001|STARTED|Overall Study||409
9817208|NCT00700102|10927617|FG000|Intention to Treat|Overall Study||410
9817209|NCT00700102|10927618|FG001|Intention to Treat|Overall Study||409
9817210|NCT00700102|10927617|FG000|Received at Least One Dose|Overall Study||407
9817211|NCT00700102|10927618|FG001|Received at Least One Dose|Overall Study||403
9817212|NCT00700102|10927617|FG000|COMPLETED|Overall Study||9
9817213|NCT00700102|10927618|FG001|COMPLETED|Overall Study||14
9817214|NCT00700102|10927617|FG000|NOT COMPLETED|Overall Study||402
9817215|NCT00700102|10927618|FG001|NOT COMPLETED|Overall Study||395
9817216|NCT00700115|10927626|FG000|STARTED|Overall Study||40
9817217|NCT00700115|10927627|FG001|STARTED|Overall Study||20
9817218|NCT00700115|10927626|FG000|COMPLETED|Overall Study||39
9817219|NCT00700115|10927627|FG001|COMPLETED|Overall Study||19
9817220|NCT00700115|10927626|FG000|NOT COMPLETED|Overall Study||1
9817221|NCT00700115|10927627|FG001|NOT COMPLETED|Overall Study||1
9817222|NCT00700141|10927633|FG000|STARTED|Overall Study||482
9817223|NCT00700141|10927633|FG000|COMPLETED|Overall Study||482
9817224|NCT00700141|10927633|FG000|NOT COMPLETED|Overall Study||0
9817225|NCT00700180|10927639|FG000|STARTED|Overall Study||154
9817226|NCT00700180|10927640|FG001|STARTED|Overall Study||149
9817227|NCT00700180|10927639|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
9817228|NCT00700180|10927640|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
9817229|NCT00700180|10927639|FG000|NOT COMPLETED|Overall Study||154
9817230|NCT00700180|10927640|FG001|NOT COMPLETED|Overall Study||149
9817231|NCT00700271|10927648|FG000|STARTED|Overall Study||278
9817232|NCT00700271|10927649|FG001|STARTED|Overall Study||268
9817233|NCT00700271|10927648|FG000|COMPLETED|Overall Study||264
9817234|NCT00700271|10927649|FG001|COMPLETED|Overall Study||256
9817235|NCT00700271|10927648|FG000|NOT COMPLETED|Overall Study||14
9817236|NCT00700271|10927649|FG001|NOT COMPLETED|Overall Study||12
9817237|NCT00700310|10927659|FG000|STARTED|Overall Study||187
9817238|NCT00700310|10927660|FG001|STARTED|Overall Study||180
9817239|NCT00700310|10927661|FG002|STARTED|Overall Study||174
9817240|NCT00700310|10927662|FG003|STARTED|Overall Study||171
9817241|NCT00700310|10927659|FG000|COMPLETED|Overall Study||166
9817242|NCT00700310|10927660|FG001|COMPLETED|Overall Study||154
9817243|NCT00700310|10927661|FG002|COMPLETED|Overall Study||158
9817244|NCT00700310|10927662|FG003|COMPLETED|Overall Study||145
9817245|NCT00700310|10927659|FG000|NOT COMPLETED|Overall Study||21
9817246|NCT00700310|10927660|FG001|NOT COMPLETED|Overall Study||26
9817247|NCT00700310|10927661|FG002|NOT COMPLETED|Overall Study||16
9817248|NCT00700310|10927662|FG003|NOT COMPLETED|Overall Study||26
9817249|NCT00700336|10927675|FG000|STARTED|Overall Study||40
9817250|NCT00700336|10927676|FG001|STARTED|Overall Study||23
9817251|NCT00700336|10927677|FG002|STARTED|Overall Study||6
9817252|NCT00700336|10927675|FG000|COMPLETED|Overall Study||40
9817253|NCT00700336|10927676|FG001|COMPLETED|Overall Study||23
10236768|NCT00832624|11367496|FG000|STARTED|Overall Study||10
10236769|NCT00832624|11367496|FG000|COMPLETED|Overall Study||0
10236770|NCT00832624|11367496|FG000|NOT COMPLETED|Overall Study||10
10236771|NCT00832299|11367500|FG000|STARTED|Overall Study||2
10236772|NCT00832299|11367500|FG000|COMPLETED|Overall Study||2
9817254|NCT00700336|10927677|FG002|COMPLETED|Overall Study||6
9817255|NCT00700336|10927675|FG000|NOT COMPLETED|Overall Study||0
9817256|NCT00700336|10927676|FG001|NOT COMPLETED|Overall Study||0
9817257|NCT00700336|10927677|FG002|NOT COMPLETED|Overall Study||0
9817258|NCT00700375|10927686|FG000|STARTED|Overall Study||30
9817259|NCT00700375|10927687|FG001|STARTED|Overall Study||29
9817260|NCT00700375|10927686|FG000|2 Days After Creatinine Mesurement|Overall Study||30
9817261|NCT00700375|10927687|FG001|2 Days After Creatinine Mesurement|Overall Study||29
9817262|NCT00700375|10927686|FG000|COMPLETED|Overall Study||30
9817263|NCT00700375|10927687|FG001|COMPLETED|Overall Study||29
9817264|NCT00700375|10927686|FG000|NOT COMPLETED|Overall Study||0
9817265|NCT00700375|10927687|FG001|NOT COMPLETED|Overall Study||0
9817266|NCT00700401|10927693|FG000|STARTED|Overall Study||262
9817267|NCT00700401|10927693|FG000|COMPLETED|Overall Study||168
9817268|NCT00700401|10927693|FG000|NOT COMPLETED|Overall Study||94
9817269|NCT00700427|10927697|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
9817270|NCT00700427|10927698|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0
9817271|NCT00700427|10927699|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0
9817272|NCT00700427|10927700|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0
9817273|NCT00700427|10927701|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0
9817274|NCT00700427|10927697|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
10112395|NCT02503085|11243380|FG001|STARTED|Period 4||7
10112396|NCT02503085|11243381|FG002|STARTED|Period 4||6
9817275|NCT00700427|10927698|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
9817276|NCT00700427|10927699|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
9817277|NCT00700427|10927700|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
9817278|NCT00700427|10927701|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
9817279|NCT00700427|10927697|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
9817280|NCT00700427|10927698|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817281|NCT00700427|10927699|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817282|NCT00700427|10927700|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817283|NCT00700427|10927701|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817284|NCT00700427|10927697|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
9817285|NCT00700427|10927698|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817286|NCT00700427|10927699|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817287|NCT00700427|10927700|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817288|NCT00700427|10927701|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
9817289|NCT00700427|10927697|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0
9817290|NCT00700427|10927698|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005
9817291|NCT00700427|10927699|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0
9817292|NCT00700427|10927700|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0
9817293|NCT00700427|10927701|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0
9817294|NCT00700427|10927697|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0
9817295|NCT00700427|10927698|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524
9817296|NCT00700427|10927699|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0
9817297|NCT00700427|10927700|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0
10112397|NCT02503085|11243382|FG003|STARTED|Period 4||7
10112398|NCT02503085|11243379|FG000|COMPLETED|Period 4||6
10236773|NCT00832299|11367500|FG000|NOT COMPLETED|Overall Study||0
10236774|NCT00836355|11367508|FG000|STARTED|Overall Study||0
10236775|NCT00836355|11367509|FG001|STARTED|Overall Study||4
9817298|NCT00700427|10927701|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0
9817299|NCT00700427|10927697|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
9817300|NCT00700427|10927698|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
9817301|NCT00700427|10927699|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
9817302|NCT00700427|10927700|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
9817303|NCT00700427|10927701|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
9817304|NCT00700427|10927697|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0
9817305|NCT00700427|10927698|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0
9817306|NCT00700427|10927699|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266
9817307|NCT00700427|10927700|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258
9817308|NCT00700427|10927701|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0
9817309|NCT00700427|10927697|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
9817310|NCT00700427|10927698|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
9817311|NCT00700427|10927699|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
9817312|NCT00700427|10927700|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
9817313|NCT00700427|10927701|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
9817314|NCT00700427|10927697|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
9817315|NCT00700427|10927698|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
9817316|NCT00700427|10927699|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
9817317|NCT00700427|10927700|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
9817318|NCT00700427|10927701|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
9817319|NCT00700427|10927697|FG000|STARTED|Study Period 4 (Open-Label Extension)||0
9817320|NCT00700427|10927698|FG001|STARTED|Study Period 4 (Open-Label Extension)||0
9817321|NCT00700427|10927699|FG002|STARTED|Study Period 4 (Open-Label Extension)||0
9817322|NCT00700427|10927700|FG003|STARTED|Study Period 4 (Open-Label Extension)||0
9817323|NCT00700427|10927701|FG004|STARTED|Study Period 4 (Open-Label Extension)||180
10112399|NCT02503085|11243380|FG001|COMPLETED|Period 4||7
10112400|NCT02503085|11243381|FG002|COMPLETED|Period 4||6
10016825|NCT01812109|11139602|FG000|Without Torsion|Overall Study||85
9817324|NCT00700427|10927697|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0
9817325|NCT00700427|10927698|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0
9817326|NCT00700427|10927699|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0
9817327|NCT00700427|10927700|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0
9817328|NCT00700427|10927701|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96
9817329|NCT00700427|10927697|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
9817330|NCT00700427|10927698|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
9817331|NCT00700427|10927699|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
9817332|NCT00700427|10927700|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
9817333|NCT00700427|10927701|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
9817334|NCT00700440|10927709|FG000|STARTED|Overall Study||100
9817335|NCT00700440|10927709|FG000|COMPLETED|Overall Study||100
9817336|NCT00700440|10927709|FG000|NOT COMPLETED|Overall Study||0
9817337|NCT00700570|10927715|FG000|STARTED|Overall Study||19
9817338|NCT00700570|10927716|FG001|STARTED|Overall Study||26
9817339|NCT00700570|10927715|FG000|COMPLETED|Overall Study||8
9817340|NCT00700570|10927716|FG001|COMPLETED|Overall Study||0
9817341|NCT00700570|10927715|FG000|NOT COMPLETED|Overall Study||11
9817342|NCT00700570|10927716|FG001|NOT COMPLETED|Overall Study||26
9817343|NCT00700622|10927724|FG000|STARTED|Overall Study||65
9817344|NCT00700622|10927725|FG001|STARTED|Overall Study||65
9817345|NCT00700622|10927724|FG000|COMPLETED|Overall Study||52
9817346|NCT00700622|10927725|FG001|COMPLETED|Overall Study||60
9817347|NCT00700622|10927724|FG000|NOT COMPLETED|Overall Study||13
9817348|NCT00700622|10927725|FG001|NOT COMPLETED|Overall Study||5
9817349|NCT00700635|10927734|FG000|STARTED|Overall Study||111
9817350|NCT00700635|10927735|FG001|STARTED|Overall Study||111
9817351|NCT00700635|10927736|FG002|STARTED|Overall Study||111
9817352|NCT00700635|10927734|FG000|COMPLETED|Overall Study||100
9817353|NCT00700635|10927735|FG001|COMPLETED|Overall Study||103
9817354|NCT00700635|10927736|FG002|COMPLETED|Overall Study||110
9817355|NCT00700635|10927734|FG000|NOT COMPLETED|Overall Study||11
9817356|NCT00700635|10927735|FG001|NOT COMPLETED|Overall Study||8
9817357|NCT00700635|10927736|FG002|NOT COMPLETED|Overall Study||1
9817358|NCT00700713|10927747|FG000|STARTED|Overall Study||48
9817359|NCT00700713|10927748|FG001|STARTED|Overall Study||66
9817360|NCT00700713|10927749|FG002|STARTED|Overall Study||67
10016826|NCT01812109|11139602|FG000|COMPLETED|Overall Study||121
10016827|NCT01812109|11139602|FG000|NOT COMPLETED|Overall Study||33
10016828|NCT01812473|11139608|FG000|STARTED|Overall Study||22
9817361|NCT00700713|10927747|FG000|COMPLETED|Overall Study||47
9817362|NCT00700713|10927748|FG001|COMPLETED|Overall Study||66
9817363|NCT00700713|10927749|FG002|COMPLETED|Overall Study||65
9817364|NCT00700713|10927747|FG000|NOT COMPLETED|Overall Study||1
9817365|NCT00700713|10927748|FG001|NOT COMPLETED|Overall Study||0
9817366|NCT00700713|10927749|FG002|NOT COMPLETED|Overall Study||2
9817367|NCT00700739|10927759|FG000|STARTED|Overall Study||22
9817368|NCT00700739|10927760|FG001|STARTED|Overall Study||16
9817369|NCT00700739|10927759|FG000|COMPLETED|Overall Study||18
9817370|NCT00700739|10927760|FG001|COMPLETED|Overall Study||12
9817371|NCT00700739|10927759|FG000|NOT COMPLETED|Overall Study||4
10016829|NCT01812473|11139609|FG001|STARTED|Overall Study||13
10016830|NCT01812473|11139608|FG000|COMPLETED|Overall Study||22
10016831|NCT01812473|11139609|FG001|COMPLETED|Overall Study||13
9817372|NCT00700739|10927760|FG001|NOT COMPLETED|Overall Study||4
9817373|NCT00700752|10927767|FG000|STARTED|First Intervention||20
9817374|NCT00700752|10927768|FG001|STARTED|First Intervention||20
9817375|NCT00700752|10927767|FG000|COMPLETED|First Intervention||20
9817376|NCT00700752|10927768|FG001|COMPLETED|First Intervention||18
9817377|NCT00700752|10927767|FG000|NOT COMPLETED|First Intervention||0
9817378|NCT00700752|10927768|FG001|NOT COMPLETED|First Intervention||2
9817379|NCT00700752|10927767|FG000|STARTED|Second Intervention||20
9817380|NCT00700752|10927768|FG001|STARTED|Second Intervention||18
9817381|NCT00700752|10927767|FG000|COMPLETED|Second Intervention||20
9817382|NCT00700752|10927768|FG001|COMPLETED|Second Intervention||18
9817383|NCT00700752|10927767|FG000|NOT COMPLETED|Second Intervention||0
9817384|NCT00700752|10927768|FG001|NOT COMPLETED|Second Intervention||0
9817385|NCT00700804|10927776|FG000|STARTED|Overall Study||17
9817386|NCT00700804|10927777|FG001|STARTED|Overall Study||17
9817387|NCT00700804|10927776|FG000|COMPLETED|Overall Study||14
9817388|NCT00700804|10927777|FG001|COMPLETED|Overall Study||13
9817389|NCT00700804|10927776|FG000|NOT COMPLETED|Overall Study||3
9817390|NCT00700804|10927777|FG001|NOT COMPLETED|Overall Study||4
9817391|NCT00700817|10927788|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225
9817392|NCT00700817|10927789|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221
9817393|NCT00700817|10927790|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219
9817394|NCT00700817|10927791|FG003|STARTED|Week 0-26 (Main Period)||0
9817395|NCT00700817|10927792|FG004|STARTED|Week 0-26 (Main Period)||0
9817396|NCT00700817|10927788|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
9817397|NCT00700817|10927789|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
9817398|NCT00700817|10927790|FG002|Exposed|Week 0-26 (Main Period)||219
9817399|NCT00700817|10927791|FG003|Exposed|Week 0-26 (Main Period)||0
9817400|NCT00700817|10927792|FG004|Exposed|Week 0-26 (Main Period)||0
9817401|NCT00700817|10927788|FG000|COMPLETED|Week 0-26 (Main Period)||169
9817402|NCT00700817|10927789|FG001|COMPLETED|Week 0-26 (Main Period)||191
9817403|NCT00700817|10927790|FG002|COMPLETED|Week 0-26 (Main Period)||194
9817404|NCT00700817|10927791|FG003|COMPLETED|Week 0-26 (Main Period)||0
9817405|NCT00700817|10927792|FG004|COMPLETED|Week 0-26 (Main Period)||0
9817406|NCT00700817|10927788|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56
9817407|NCT00700817|10927789|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30
9817408|NCT00700817|10927790|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25
9817409|NCT00700817|10927791|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0
9817410|NCT00700817|10927792|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0
9817411|NCT00700817|10927788|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
9817412|NCT00700817|10927789|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
9817413|NCT00700817|10927790|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
9817414|NCT00700817|10927791|FG003|STARTED|Week 26-52 (Extension Period 1)||0
9817415|NCT00700817|10927792|FG004|STARTED|Week 26-52 (Extension Period 1)||0
9817416|NCT00700817|10927788|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135
9817417|NCT00700817|10927789|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150
9817418|NCT00700817|10927790|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151
9817419|NCT00700817|10927791|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0
9817420|NCT00700817|10927792|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0
9817421|NCT00700817|10927788|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
9817422|NCT00700817|10927789|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
9817423|NCT00700817|10927790|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
9817424|NCT00700817|10927791|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
9817425|NCT00700817|10927792|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
9817426|NCT00700817|10927788|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
9817427|NCT00700817|10927789|FG001|STARTED|Week 52-78 (Extension Period 2)||150
9817428|NCT00700817|10927790|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
9817429|NCT00700817|10927791|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
9817430|NCT00700817|10927792|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
9817431|NCT00700817|10927788|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124
9817432|NCT00700817|10927789|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135
9817433|NCT00700817|10927790|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0
9817434|NCT00700817|10927791|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59
9817435|NCT00700817|10927792|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63
9817436|NCT00700817|10927788|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
9817437|NCT00700817|10927789|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
9817438|NCT00700817|10927790|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
9817439|NCT00700817|10927791|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
9817440|NCT00700817|10927792|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
9817447|NCT00700973|10927808|FG000|STARTED|Overall Study||71
9817448|NCT00700973|10927809|FG001|STARTED|Overall Study||70
9817449|NCT00700973|10927808|FG000|COMPLETED|Overall Study||63
9817450|NCT00700973|10927809|FG001|COMPLETED|Overall Study||63
9817451|NCT00700973|10927808|FG000|NOT COMPLETED|Overall Study||8
9817452|NCT00700973|10927809|FG001|NOT COMPLETED|Overall Study||7
9817453|NCT00700999|10927817|FG000|STARTED|Overall Study||36
9817454|NCT00700999|10927818|FG001|STARTED|Overall Study||29
9817455|NCT00700999|10927817|FG000|First MRI Scan|Overall Study||29
9817456|NCT00700999|10927818|FG001|First MRI Scan|Overall Study||22
9817457|NCT00700999|10927817|FG000|Second MRI Scan|Overall Study||19
9817458|NCT00700999|10927818|FG001|Second MRI Scan|Overall Study||18
9817459|NCT00700999|10927817|FG000|COMPLETED|Overall Study||21
9817460|NCT00700999|10927818|FG001|COMPLETED|Overall Study||20
9817461|NCT00700999|10927817|FG000|NOT COMPLETED|Overall Study||15
9817462|NCT00700999|10927818|FG001|NOT COMPLETED|Overall Study||9
9817463|NCT00701038|10927826|FG000|STARTED|Overall Study||27
9817464|NCT00701038|10927827|FG001|STARTED|Overall Study||27
9817465|NCT00701038|10927826|FG000|COMPLETED|Overall Study||23
9817466|NCT00701038|10927827|FG001|COMPLETED|Overall Study||23
9817467|NCT00701038|10927826|FG000|NOT COMPLETED|Overall Study||4
9817468|NCT00701038|10927827|FG001|NOT COMPLETED|Overall Study||4
9817469|NCT00701051|10927835|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
9817470|NCT00701051|10927836|FG001|STARTED|Screening||0
9817471|NCT00701051|10927837|FG002|STARTED|Screening||0
9817472|NCT00701051|10927835|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
9817473|NCT00701051|10927836|FG001|COMPLETED|Screening||0
9817474|NCT00701051|10927837|FG002|COMPLETED|Screening||0
9817475|NCT00701051|10927835|FG000|NOT COMPLETED|Screening||59
9817476|NCT00701051|10927836|FG001|NOT COMPLETED|Screening||0
9817477|NCT00701051|10927837|FG002|NOT COMPLETED|Screening||0
9817478|NCT00701051|10927835|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
9817479|NCT00701051|10927836|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
9817480|NCT00701051|10927837|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
9817481|NCT00701051|10927835|FG000|COMPLETED|Exercise Intervention||0
9817482|NCT00701051|10927836|FG001|COMPLETED|Exercise Intervention||14
9817483|NCT00701051|10927837|FG002|COMPLETED|Exercise Intervention||9
9817484|NCT00701051|10927835|FG000|NOT COMPLETED|Exercise Intervention||0
9817485|NCT00701051|10927836|FG001|NOT COMPLETED|Exercise Intervention||5
9817486|NCT00701051|10927837|FG002|NOT COMPLETED|Exercise Intervention||3
9817487|NCT00701051|10927835|FG000|STARTED|Detraining Intervention (Optional)||0
9817488|NCT00701051|10927836|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
9817489|NCT00701051|10927837|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
9817490|NCT00701051|10927835|FG000|COMPLETED|Detraining Intervention (Optional)||0
9817491|NCT00701051|10927836|FG001|COMPLETED|Detraining Intervention (Optional)||6
9817492|NCT00701051|10927837|FG002|COMPLETED|Detraining Intervention (Optional)||6
9817493|NCT00701051|10927835|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0
9817494|NCT00701051|10927836|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0
9817495|NCT00701051|10927837|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0
9817496|NCT00701064|10927845|FG000|STARTED|Overall Study||35
9817497|NCT00701064|10927846|FG001|STARTED|Overall Study||36
9817498|NCT00701064|10927845|FG000|COMPLETED|Overall Study||31
9817499|NCT00701064|10927846|FG001|COMPLETED|Overall Study||32
9817500|NCT00701064|10927845|FG000|NOT COMPLETED|Overall Study||4
9817501|NCT00701064|10927846|FG001|NOT COMPLETED|Overall Study||4
9817502|NCT00701090|10927854|FG000|STARTED|Overall Study||516
9817503|NCT00701090|10927855|FG001|STARTED|Overall Study||519
9817504|NCT00701090|10927854|FG000|COMPLETED|Overall Study||468
9817505|NCT00701090|10927855|FG001|COMPLETED|Overall Study||468
9817506|NCT00701090|10927854|FG000|NOT COMPLETED|Overall Study||48
9817507|NCT00701090|10927855|FG001|NOT COMPLETED|Overall Study||51
9817508|NCT00701103|10927872|FG000|STARTED|Overall Study||5
9817509|NCT00701103|10927873|FG001|STARTED|Overall Study||3
9817510|NCT00701103|10927874|FG002|STARTED|Overall Study||8
9817511|NCT00701103|10927875|FG003|STARTED|Overall Study||6
9817512|NCT00701103|10927876|FG004|STARTED|Overall Study||6
9817513|NCT00701103|10927877|FG005|STARTED|Overall Study||6
9817514|NCT00701103|10927878|FG006|STARTED|Overall Study||8
9817515|NCT00701103|10927879|FG007|STARTED|Overall Study||7
9817516|NCT00701103|10927880|FG008|STARTED|Overall Study||9
9817517|NCT00701103|10927881|FG009|STARTED|Overall Study||11
9817518|NCT00701103|10927882|FG010|STARTED|Overall Study||11
9817519|NCT00701103|10927872|FG000|COMPLETED|Overall Study||0
9817520|NCT00701103|10927873|FG001|COMPLETED|Overall Study||0
9817521|NCT00701103|10927874|FG002|COMPLETED|Overall Study||0
9817522|NCT00701103|10927875|FG003|COMPLETED|Overall Study||0
9817523|NCT00701103|10927876|FG004|COMPLETED|Overall Study||0
9817524|NCT00701103|10927877|FG005|COMPLETED|Overall Study||0
9817525|NCT00701103|10927878|FG006|COMPLETED|Overall Study||0
9817526|NCT00701103|10927879|FG007|COMPLETED|Overall Study||0
9817527|NCT00701103|10927880|FG008|COMPLETED|Overall Study||0
9817528|NCT00701103|10927881|FG009|COMPLETED|Overall Study||0
9817529|NCT00701103|10927882|FG010|COMPLETED|Overall Study||0
9817530|NCT00701103|10927872|FG000|NOT COMPLETED|Overall Study||5
9817531|NCT00701103|10927873|FG001|NOT COMPLETED|Overall Study||3
9817532|NCT00701103|10927874|FG002|NOT COMPLETED|Overall Study||8
9817533|NCT00701103|10927875|FG003|NOT COMPLETED|Overall Study||6
9817534|NCT00701103|10927876|FG004|NOT COMPLETED|Overall Study||6
9817535|NCT00701103|10927877|FG005|NOT COMPLETED|Overall Study||6
9817536|NCT00701103|10927878|FG006|NOT COMPLETED|Overall Study||8
9817537|NCT00701103|10927879|FG007|NOT COMPLETED|Overall Study||7
9817538|NCT00701103|10927880|FG008|NOT COMPLETED|Overall Study||9
9817539|NCT00701103|10927881|FG009|NOT COMPLETED|Overall Study||11
9817540|NCT00701103|10927882|FG010|NOT COMPLETED|Overall Study||11
9817541|NCT00701129|10927910|FG000|STARTED|Overall Study||4
9817542|NCT00701129|10927910|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
9817543|NCT00701129|10927910|FG000|COMPLETED|Overall Study||2
9817544|NCT00701129|10927910|FG000|NOT COMPLETED|Overall Study||2
9817545|NCT00701311|10927914|FG000|STARTED|Overall Study||17
9817546|NCT00701311|10927914|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
9817547|NCT00701311|10927914|FG000|NOT COMPLETED|Overall Study||8
9817548|NCT00701363|10927922|FG000|STARTED|Screening (Pre-assignment) Phase||128
9817549|NCT00701363|10927923|FG001|STARTED|Screening (Pre-assignment) Phase||0
9817550|NCT00701363|10927924|FG002|STARTED|Screening (Pre-assignment) Phase||0
9817551|NCT00701363|10927925|FG003|STARTED|Screening (Pre-assignment) Phase||0
9817552|NCT00701363|10927922|FG000|COMPLETED|Screening (Pre-assignment) Phase||124
9817553|NCT00701363|10927923|FG001|COMPLETED|Screening (Pre-assignment) Phase||0
9817554|NCT00701363|10927924|FG002|COMPLETED|Screening (Pre-assignment) Phase||0
9817555|NCT00701363|10927925|FG003|COMPLETED|Screening (Pre-assignment) Phase||0
9817556|NCT00701363|10927922|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4
9817557|NCT00701363|10927923|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0
9817558|NCT00701363|10927924|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0
9817559|NCT00701363|10927925|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0
9817560|NCT00701363|10927922|FG000|STARTED|Treatment Phase 1||124
9817561|NCT00701363|10927923|FG001|STARTED|Treatment Phase 1||0
9817562|NCT00701363|10927924|FG002|STARTED|Treatment Phase 1||0
9817563|NCT00701363|10927925|FG003|STARTED|Treatment Phase 1||0
9817564|NCT00701363|10927922|FG000|COMPLETED|Treatment Phase 1||109
9817565|NCT00701363|10927923|FG001|COMPLETED|Treatment Phase 1||0
9817566|NCT00701363|10927924|FG002|COMPLETED|Treatment Phase 1||0
9817567|NCT00701363|10927925|FG003|COMPLETED|Treatment Phase 1||0
9817568|NCT00701363|10927922|FG000|NOT COMPLETED|Treatment Phase 1||15
9817569|NCT00701363|10927923|FG001|NOT COMPLETED|Treatment Phase 1||0
9817570|NCT00701363|10927924|FG002|NOT COMPLETED|Treatment Phase 1||0
9817571|NCT00701363|10927925|FG003|NOT COMPLETED|Treatment Phase 1||0
9817572|NCT00701363|10927922|FG000|STARTED|Treatment Phase 2||0
9817573|NCT00701363|10927923|FG001|STARTED|Treatment Phase 2||13
9817574|NCT00701363|10927924|FG002|STARTED|Treatment Phase 2||70
9817575|NCT00701363|10927925|FG003|STARTED|Treatment Phase 2||26
9817576|NCT00701363|10927922|FG000|COMPLETED|Treatment Phase 2||0
9817577|NCT00701363|10927923|FG001|COMPLETED|Treatment Phase 2||13
9817578|NCT00701363|10927924|FG002|COMPLETED|Treatment Phase 2||68
9817579|NCT00701363|10927925|FG003|COMPLETED|Treatment Phase 2||26
9817580|NCT00701363|10927922|FG000|NOT COMPLETED|Treatment Phase 2||0
9817581|NCT00701363|10927923|FG001|NOT COMPLETED|Treatment Phase 2||0
9817582|NCT00701363|10927924|FG002|NOT COMPLETED|Treatment Phase 2||2
9817583|NCT00701363|10927925|FG003|NOT COMPLETED|Treatment Phase 2||0
9817584|NCT00701376|10927945|FG000|STARTED|Overall Study||106
9817585|NCT00701376|10927945|FG000|COMPLETED|Overall Study||105
9817586|NCT00701376|10927945|FG000|NOT COMPLETED|Overall Study||1
9817587|NCT00701389|10927950|FG000|STARTED|Period 1||6
9817588|NCT00701389|10927951|FG001|STARTED|Period 1||6
9817589|NCT00701389|10927952|FG002|STARTED|Period 1||6
9817590|NCT00701389|10927953|FG003|STARTED|Period 1||6
9817591|NCT00701389|10927950|FG000|COMPLETED|Period 1||6
9817592|NCT00701389|10927951|FG001|COMPLETED|Period 1||6
9817593|NCT00701389|10927952|FG002|COMPLETED|Period 1||6
9817594|NCT00701389|10927953|FG003|COMPLETED|Period 1||6
9817595|NCT00701389|10927950|FG000|NOT COMPLETED|Period 1||0
9817596|NCT00701389|10927951|FG001|NOT COMPLETED|Period 1||0
9817597|NCT00701389|10927952|FG002|NOT COMPLETED|Period 1||0
9817598|NCT00701389|10927953|FG003|NOT COMPLETED|Period 1||0
9817599|NCT00701389|10927950|FG000|STARTED|Period 2||6
9817600|NCT00701389|10927951|FG001|STARTED|Period 2||6
9817601|NCT00701389|10927952|FG002|STARTED|Period 2||6
9817602|NCT00701389|10927953|FG003|STARTED|Period 2||6
9817603|NCT00701389|10927950|FG000|COMPLETED|Period 2||6
9817604|NCT00701389|10927951|FG001|COMPLETED|Period 2||6
9817605|NCT00701389|10927952|FG002|COMPLETED|Period 2||6
9817606|NCT00701389|10927953|FG003|COMPLETED|Period 2||6
9817607|NCT00701389|10927950|FG000|NOT COMPLETED|Period 2||0
9817608|NCT00701389|10927951|FG001|NOT COMPLETED|Period 2||0
9817609|NCT00701389|10927952|FG002|NOT COMPLETED|Period 2||0
9817610|NCT00701389|10927953|FG003|NOT COMPLETED|Period 2||0
9817611|NCT00701389|10927950|FG000|STARTED|Period 3||6
9817612|NCT00701389|10927951|FG001|STARTED|Period 3||6
9817613|NCT00701389|10927952|FG002|STARTED|Period 3||6
9817614|NCT00701389|10927953|FG003|STARTED|Period 3||6
9817615|NCT00701389|10927950|FG000|COMPLETED|Period 3||6
9817616|NCT00701389|10927951|FG001|COMPLETED|Period 3||6
9817617|NCT00701389|10927952|FG002|COMPLETED|Period 3||6
9817618|NCT00701389|10927953|FG003|COMPLETED|Period 3||6
9817619|NCT00701389|10927950|FG000|NOT COMPLETED|Period 3||0
9817620|NCT00701389|10927951|FG001|NOT COMPLETED|Period 3||0
9817621|NCT00701389|10927952|FG002|NOT COMPLETED|Period 3||0
9817622|NCT00701389|10927953|FG003|NOT COMPLETED|Period 3||0
9817623|NCT00701389|10927950|FG000|STARTED|Period 4||6
9817624|NCT00701389|10927951|FG001|STARTED|Period 4||6
9817625|NCT00701389|10927952|FG002|STARTED|Period 4||6
9817626|NCT00701389|10927953|FG003|STARTED|Period 4||6
9817627|NCT00701389|10927950|FG000|COMPLETED|Period 4||6
9817628|NCT00701389|10927951|FG001|COMPLETED|Period 4||6
9817629|NCT00701389|10927952|FG002|COMPLETED|Period 4||6
9817630|NCT00701389|10927953|FG003|COMPLETED|Period 4||6
9817631|NCT00701389|10927950|FG000|NOT COMPLETED|Period 4||0
9817632|NCT00701389|10927951|FG001|NOT COMPLETED|Period 4||0
9817633|NCT00701389|10927952|FG002|NOT COMPLETED|Period 4||0
9817634|NCT00701389|10927953|FG003|NOT COMPLETED|Period 4||0
9817635|NCT00701415|10927969|FG000|STARTED|Overall Study||16
9817636|NCT00701415|10927970|FG001|STARTED|Overall Study||15
9817637|NCT00701415|10927969|FG000|COMPLETED|Overall Study||15
9817638|NCT00701415|10927970|FG001|COMPLETED|Overall Study||14
9817639|NCT00701415|10927969|FG000|NOT COMPLETED|Overall Study||1
9817640|NCT00701415|10927970|FG001|NOT COMPLETED|Overall Study||1
9817641|NCT00701441|10927978|FG000|STARTED|Overall Study||9
9817642|NCT00701441|10927979|FG001|STARTED|Overall Study||16
9817643|NCT00701441|10927978|FG000|COMPLETED|Overall Study||9
9817644|NCT00701441|10927979|FG001|COMPLETED|Overall Study||12
9817645|NCT00701441|10927978|FG000|NOT COMPLETED|Overall Study||0
9817646|NCT00701441|10927979|FG001|NOT COMPLETED|Overall Study||4
9817647|NCT00701558|10927989|FG000|STARTED|Overall Study||19
9817648|NCT00701558|10927989|FG000|COMPLETED|Overall Study||4
9817649|NCT00701558|10927989|FG000|NOT COMPLETED|Overall Study||15
9817650|NCT00701636|10927995|FG000|STARTED|Overall Study||15
9817651|NCT00701636|10927996|FG001|STARTED|Overall Study||15
9817652|NCT00701636|10927995|FG000|COMPLETED|Overall Study||15
9817653|NCT00701636|10927996|FG001|COMPLETED|Overall Study||15
9817654|NCT00701636|10927995|FG000|NOT COMPLETED|Overall Study||0
9817655|NCT00701636|10927996|FG001|NOT COMPLETED|Overall Study||0
9817656|NCT00701662|10928001|FG000|STARTED|Overall Study||8
9817657|NCT00701662|10928001|FG000|COMPLETED|Overall Study||7
9817658|NCT00701662|10928001|FG000|NOT COMPLETED|Overall Study||1
9817659|NCT00701675|10928008|FG000|STARTED|Overall Study||14
9817660|NCT00701675|10928009|FG001|STARTED|Overall Study||14
9817661|NCT00701675|10928010|FG002|STARTED|Overall Study||14
9817662|NCT00701675|10928008|FG000|COMPLETED|Overall Study||10
9817663|NCT00701675|10928009|FG001|COMPLETED|Overall Study||6
9817664|NCT00701675|10928010|FG002|COMPLETED|Overall Study||7
9817665|NCT00701675|10928008|FG000|NOT COMPLETED|Overall Study||4
9817666|NCT00701675|10928009|FG001|NOT COMPLETED|Overall Study||8
9817667|NCT00701675|10928010|FG002|NOT COMPLETED|Overall Study||7
9817668|NCT00701701|10928020|FG000|STARTED|Overall Study||1
9817669|NCT00701701|10928021|FG001|STARTED|Overall Study||3
9817670|NCT00701701|10928020|FG000|COMPLETED|Overall Study||1
9817671|NCT00701701|10928021|FG001|COMPLETED|Overall Study||1
9817672|NCT00701701|10928020|FG000|NOT COMPLETED|Overall Study||0
9817673|NCT00701701|10928021|FG001|NOT COMPLETED|Overall Study||2
9817674|NCT00701714|10928030|FG000|STARTED|Treatment Period (up to 1 Year)||174
9817675|NCT00701714|10928031|FG001|STARTED|Treatment Period (up to 1 Year)||163
9817676|NCT00701714|10928030|FG000|COMPLETED|Treatment Period (up to 1 Year)||37
9817677|NCT00701714|10928031|FG001|COMPLETED|Treatment Period (up to 1 Year)||29
9817678|NCT00701714|10928030|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137
9817679|NCT00701714|10928031|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134
9817680|NCT00701714|10928030|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
9817681|NCT00701714|10928031|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
9817682|NCT00701714|10928030|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144
9817683|NCT00701714|10928031|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112
9817684|NCT00701714|10928030|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
9817685|NCT00701714|10928031|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
9817686|NCT00701727|10928041|FG000|STARTED|First Treatment Period||16
9817687|NCT00701727|10928042|FG001|STARTED|First Treatment Period||15
9817688|NCT00701727|10928041|FG000|COMPLETED|First Treatment Period||15
9817689|NCT00701727|10928042|FG001|COMPLETED|First Treatment Period||13
9817690|NCT00701727|10928041|FG000|NOT COMPLETED|First Treatment Period||1
9817691|NCT00701727|10928042|FG001|NOT COMPLETED|First Treatment Period||2
9817692|NCT00701727|10928041|FG000|STARTED|Second Treatment Period||15
9817693|NCT00701727|10928042|FG001|STARTED|Second Treatment Period||13
9817694|NCT00701727|10928041|FG000|COMPLETED|Second Treatment Period||13
9817695|NCT00701727|10928042|FG001|COMPLETED|Second Treatment Period||13
9817696|NCT00701727|10928041|FG000|NOT COMPLETED|Second Treatment Period||2
9817697|NCT00701727|10928042|FG001|NOT COMPLETED|Second Treatment Period||0
9817698|NCT00701779|10928048|FG000|STARTED|Overall Study||63
9817699|NCT00701779|10928048|FG000|3 Month|Overall Study||60
9817700|NCT00701779|10928048|FG000|6 Month|Overall Study||58
9817701|NCT00701779|10928048|FG000|9 Month|Overall Study||56
9817702|NCT00701779|10928048|FG000|12 Month|Overall Study||54
9817703|NCT00701779|10928048|FG000|COMPLETED|Overall Study||54
9817704|NCT00701779|10928048|FG000|NOT COMPLETED|Overall Study||9
9817705|NCT00701805|10928056|FG000|STARTED|Overall Study||26
9817706|NCT00701805|10928057|FG001|STARTED|Overall Study||29
9817707|NCT00701805|10928058|FG002|STARTED|Overall Study||23
9817708|NCT00701805|10928059|FG003|STARTED|Overall Study||26
9817709|NCT00701805|10928056|FG000|COMPLETED|Overall Study||23
9817710|NCT00701805|10928057|FG001|COMPLETED|Overall Study||25
9817711|NCT00701805|10928058|FG002|COMPLETED|Overall Study||16
9817712|NCT00701805|10928059|FG003|COMPLETED|Overall Study||22
9817713|NCT00701805|10928056|FG000|NOT COMPLETED|Overall Study||3
9817714|NCT00701805|10928057|FG001|NOT COMPLETED|Overall Study||4
9817715|NCT00701805|10928058|FG002|NOT COMPLETED|Overall Study||7
9817716|NCT00701805|10928059|FG003|NOT COMPLETED|Overall Study||4
9817717|NCT00701896|10928071|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143
9817718|NCT00701896|10928072|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151
9817719|NCT00701896|10928071|FG000|COMPLETED|Overall Study||110
9817720|NCT00701896|10928072|FG001|COMPLETED|Overall Study||118
9817721|NCT00701896|10928071|FG000|NOT COMPLETED|Overall Study||33
9817722|NCT00701896|10928072|FG001|NOT COMPLETED|Overall Study||33
9817723|NCT00701935|10928080|FG000|STARTED|Overall Study||43
9817724|NCT00701935|10928081|FG001|STARTED|Overall Study||37
9817725|NCT00701935|10928080|FG000|COMPLETED|Overall Study||27
9817726|NCT00701935|10928081|FG001|COMPLETED|Overall Study||26
9817727|NCT00701935|10928080|FG000|NOT COMPLETED|Overall Study||16
9817728|NCT00701935|10928081|FG001|NOT COMPLETED|Overall Study||11
9817729|NCT00702052|10928087|FG000|STARTED|Overall Study||58
9817730|NCT00702052|10928087|FG000|COMPLETED|Overall Study||0
9817731|NCT00702052|10928087|FG000|NOT COMPLETED|Overall Study||58
9817732|NCT00702143|10928094|FG000|STARTED|Overall Study||45
9817733|NCT00702143|10928095|FG001|STARTED|Overall Study||60
9817734|NCT00702143|10928096|FG002|STARTED|Overall Study||79
9817735|NCT00702143|10928094|FG000|COMPLETED|Overall Study||45
9817736|NCT00702143|10928095|FG001|COMPLETED|Overall Study||60
9817737|NCT00702143|10928096|FG002|COMPLETED|Overall Study||78
9817738|NCT00702143|10928094|FG000|NOT COMPLETED|Overall Study||0
9817739|NCT00702143|10928095|FG001|NOT COMPLETED|Overall Study||0
9817740|NCT00702143|10928096|FG002|NOT COMPLETED|Overall Study||1
9817741|NCT00702208|10928102|FG000|STARTED|Overall Study||198
9817742|NCT00702208|10928102|FG000|COMPLETED|Overall Study||167
9817743|NCT00702208|10928102|FG000|NOT COMPLETED|Overall Study||31
9817744|NCT00702221|10928109|FG000|STARTED|Overall Study||10
9817745|NCT00702221|10928110|FG001|STARTED|Overall Study||10
9817746|NCT00702221|10928109|FG000|COMPLETED|Overall Study||6
9817747|NCT00702221|10928110|FG001|COMPLETED|Overall Study||7
9817748|NCT00702221|10928109|FG000|NOT COMPLETED|Overall Study||4
9817749|NCT00702221|10928110|FG001|NOT COMPLETED|Overall Study||3
9817750|NCT00702299|10928116|FG000|STARTED|Overall Study||15
9817751|NCT00702299|10928116|FG000|COMPLETED|Overall Study||15
9817752|NCT00702299|10928116|FG000|NOT COMPLETED|Overall Study||0
9817753|NCT00702325|10928125|FG000|STARTED|Overall Study|Randomized|156
9817754|NCT00702325|10928126|FG001|STARTED|Overall Study|Randomized|155
9817755|NCT00702325|10928125|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
9817756|NCT00702325|10928126|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
9817757|NCT00702325|10928125|FG000|NOT COMPLETED|Overall Study||38
9817758|NCT00702325|10928126|FG001|NOT COMPLETED|Overall Study||53
9817759|NCT00702364|10928134|FG000|STARTED|Overall Study||26
9817760|NCT00702364|10928135|FG001|STARTED|Overall Study||29
9817761|NCT00702364|10928134|FG000|COMPLETED|Overall Study||24
9817762|NCT00702364|10928135|FG001|COMPLETED|Overall Study||25
9817763|NCT00702364|10928134|FG000|NOT COMPLETED|Overall Study||2
9817764|NCT00702364|10928135|FG001|NOT COMPLETED|Overall Study||4
9817765|NCT00702377|10928143|FG000|STARTED|Overall Study||53
9817766|NCT00702377|10928144|FG001|STARTED|Overall Study||56
9817767|NCT00702377|10928143|FG000|COMPLETED|Overall Study||52
9817768|NCT00702377|10928144|FG001|COMPLETED|Overall Study||53
9817769|NCT00702377|10928143|FG000|NOT COMPLETED|Overall Study||1
9817770|NCT00702377|10928144|FG001|NOT COMPLETED|Overall Study||3
9817771|NCT00702403|10928150|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
9817772|NCT00702403|10928150|FG000|Ineligible for Study Drug|From Consent to Engraftment||17
9817773|NCT00702403|10928150|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
9817774|NCT00702403|10928150|FG000|NOT COMPLETED|From Consent to Engraftment||17
9817775|NCT00702403|10928150|FG000|STARTED|From Engraftment to Study Completion||40
9817776|NCT00702403|10928150|FG000|Patient Drop-outs|From Engraftment to Study Completion||27
9817777|NCT00702403|10928150|FG000|COMPLETED|From Engraftment to Study Completion||13
9817778|NCT00702403|10928150|FG000|NOT COMPLETED|From Engraftment to Study Completion||27
9817779|NCT00702468|10928159|FG000|STARTED|Overall Study||18
9817780|NCT00702468|10928160|FG001|STARTED|Overall Study||18
9817781|NCT00702468|10928159|FG000|COMPLETED|Overall Study||15
9817782|NCT00702468|10928160|FG001|COMPLETED|Overall Study||2
9817783|NCT00702468|10928159|FG000|NOT COMPLETED|Overall Study||3
9817784|NCT00702468|10928160|FG001|NOT COMPLETED|Overall Study||16
9817785|NCT00702507|10928166|FG000|STARTED|Initial Treatment Phase||200
9817786|NCT00702507|10928166|FG000|COMPLETED|Initial Treatment Phase||159
9817787|NCT00702507|10928166|FG000|NOT COMPLETED|Initial Treatment Phase||41
9817788|NCT00702507|10928166|FG000|STARTED|Follow-up Phase||159
9817789|NCT00702507|10928166|FG000|COMPLETED|Follow-up Phase||132
9817790|NCT00702507|10928166|FG000|NOT COMPLETED|Follow-up Phase||27
9817791|NCT00702650|10928171|FG000|STARTED|Overall Study||155
9817792|NCT00702650|10928171|FG000|COMPLETED|Overall Study||135
9817793|NCT00702650|10928171|FG000|NOT COMPLETED|Overall Study||20
9817794|NCT00702689|10928175|FG000|STARTED|Overall Study||20
9817795|NCT00702689|10928175|FG000|COMPLETED|Overall Study||14
9817796|NCT00702689|10928175|FG000|NOT COMPLETED|Overall Study||6
9817797|NCT00702715|10928181|FG000|STARTED|Overall Study||35
9817798|NCT00702715|10928182|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33
9817799|NCT00702715|10928181|FG000|COMPLETED|Overall Study||34
9817800|NCT00702715|10928182|FG001|COMPLETED|Overall Study||33
9817801|NCT00702715|10928181|FG000|NOT COMPLETED|Overall Study||1
9817802|NCT00702715|10928182|FG001|NOT COMPLETED|Overall Study||0
9817803|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
9817804|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
9817805|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
9817806|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
9817807|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
9817808|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
9817809|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
9817810|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
9817811|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
9817812|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
9817813|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
9817814|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
9817815|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
9817816|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
9817817|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
9817818|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
9817819|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
9817820|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
9817821|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
9817822|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
9817823|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
9817824|NCT00702754|10928188|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
9817825|NCT00702754|10928188|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
9817826|NCT00702754|10928188|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
9817827|NCT00702780|10928194|FG000|STARTED|Overall Study||37
9817828|NCT00702780|10928195|FG001|STARTED|Overall Study||37
9817829|NCT00702780|10928194|FG000|COMPLETED|Overall Study||28
9817830|NCT00702780|10928195|FG001|COMPLETED|Overall Study||29
9817831|NCT00702780|10928194|FG000|NOT COMPLETED|Overall Study||9
9817832|NCT00702780|10928195|FG001|NOT COMPLETED|Overall Study||8
9817833|NCT00702884|10928201|FG000|STARTED|Overall Study||25
9817834|NCT00702884|10928201|FG000|COMPLETED|Overall Study||25
9817835|NCT00702884|10928201|FG000|NOT COMPLETED|Overall Study||0
9817836|NCT00702923|10928208|FG000|STARTED|Overall Study||12
9817837|NCT00702923|10928208|FG000|COMPLETED|Overall Study||11
9817838|NCT00702923|10928208|FG000|NOT COMPLETED|Overall Study||1
9817839|NCT00702949|10928216|FG000|STARTED|Overall Study||63
9817840|NCT00702949|10928217|FG001|STARTED|Overall Study||66
9817841|NCT00702949|10928218|FG002|STARTED|Overall Study||62
9817842|NCT00702949|10928216|FG000|Evaluable for Primary Endpoint|Overall Study||56
9817843|NCT00702949|10928217|FG001|Evaluable for Primary Endpoint|Overall Study||56
9817844|NCT00702949|10928218|FG002|Evaluable for Primary Endpoint|Overall Study||51
9817845|NCT00702949|10928216|FG000|COMPLETED|Overall Study||58
9817846|NCT00702949|10928217|FG001|COMPLETED|Overall Study||57
9817847|NCT00702949|10928218|FG002|COMPLETED|Overall Study||54
9817848|NCT00702949|10928216|FG000|NOT COMPLETED|Overall Study||5
9817849|NCT00702949|10928217|FG001|NOT COMPLETED|Overall Study||9
9817850|NCT00702949|10928218|FG002|NOT COMPLETED|Overall Study||8
9817851|NCT00703053|10928237|FG000|STARTED|Overall Study||27
9817852|NCT00703053|10928238|FG001|STARTED|Overall Study||26
9817853|NCT00703053|10928239|FG002|STARTED|Overall Study||51
9817854|NCT00703053|10928240|FG003|STARTED|Overall Study||49
9817855|NCT00703053|10928241|FG004|STARTED|Overall Study||51
9817856|NCT00703053|10928242|FG005|STARTED|Overall Study||49
9817857|NCT00703053|10928243|FG006|STARTED|Overall Study||52
9817858|NCT00703053|10928244|FG007|STARTED|Overall Study||97
9817859|NCT00703053|10928245|FG008|STARTED|Overall Study||103
9817860|NCT00703053|10928237|FG000|COMPLETED|Overall Study||26
9817861|NCT00703053|10928238|FG001|COMPLETED|Overall Study||24
9817862|NCT00703053|10928239|FG002|COMPLETED|Overall Study||48
9817863|NCT00703053|10928240|FG003|COMPLETED|Overall Study||46
9817864|NCT00703053|10928241|FG004|COMPLETED|Overall Study||50
9817865|NCT00703053|10928242|FG005|COMPLETED|Overall Study||43
9817866|NCT00703053|10928243|FG006|COMPLETED|Overall Study||45
9817867|NCT00703053|10928244|FG007|COMPLETED|Overall Study||91
9817868|NCT00703053|10928245|FG008|COMPLETED|Overall Study||102
9817869|NCT00703053|10928237|FG000|NOT COMPLETED|Overall Study||1
9817870|NCT00703053|10928238|FG001|NOT COMPLETED|Overall Study||2
9817871|NCT00703053|10928239|FG002|NOT COMPLETED|Overall Study||3
9817872|NCT00703053|10928240|FG003|NOT COMPLETED|Overall Study||3
9817873|NCT00703053|10928241|FG004|NOT COMPLETED|Overall Study||1
9817874|NCT00703053|10928242|FG005|NOT COMPLETED|Overall Study||6
9817875|NCT00703053|10928243|FG006|NOT COMPLETED|Overall Study||7
9817876|NCT00703053|10928244|FG007|NOT COMPLETED|Overall Study||6
9817877|NCT00703053|10928245|FG008|NOT COMPLETED|Overall Study||1
9817878|NCT00703118|10928270|FG000|STARTED|Overall Study||266
9817879|NCT00703118|10928271|FG001|STARTED|Overall Study||264
9817880|NCT00703118|10928272|FG002|STARTED|Overall Study||132
9817881|NCT00703118|10928270|FG000|COMPLETED|Overall Study||245
9817882|NCT00703118|10928271|FG001|COMPLETED|Overall Study||248
9817883|NCT00703118|10928272|FG002|COMPLETED|Overall Study||110
9817884|NCT00703118|10928270|FG000|NOT COMPLETED|Overall Study||21
9817885|NCT00703118|10928271|FG001|NOT COMPLETED|Overall Study||16
9817886|NCT00703118|10928272|FG002|NOT COMPLETED|Overall Study||22
9817887|NCT00703157|10928285|FG000|STARTED|Overall Study||26
9817888|NCT00703157|10928286|FG001|STARTED|Overall Study||26
9817889|NCT00703157|10928285|FG000|6 Months FU|Overall Study||25
9817890|NCT00703157|10928286|FG001|6 Months FU|Overall Study||25
9817891|NCT00703157|10928285|FG000|24 Months FU|Overall Study||22
9817892|NCT00703157|10928286|FG001|24 Months FU|Overall Study||24
9817893|NCT00703157|10928285|FG000|COMPLETED|Overall Study||22
9817894|NCT00703157|10928286|FG001|COMPLETED|Overall Study||24
9817895|NCT00703157|10928285|FG000|NOT COMPLETED|Overall Study||4
9817896|NCT00703157|10928286|FG001|NOT COMPLETED|Overall Study||2
9817897|NCT00703261|10928296|FG000|STARTED|Overall Study||42
9817898|NCT00703261|10928297|FG001|STARTED|Overall Study||41
9817899|NCT00703261|10928296|FG000|COMPLETED|Overall Study||36
9817900|NCT00703261|10928297|FG001|COMPLETED|Overall Study||35
9817901|NCT00703261|10928296|FG000|NOT COMPLETED|Overall Study||6
9817902|NCT00703261|10928297|FG001|NOT COMPLETED|Overall Study||6
9817903|NCT00703391|10928306|FG000|STARTED|Overall Study||12
9817904|NCT00703391|10928307|FG001|STARTED|Overall Study||6
9817905|NCT00703391|10928306|FG000|COMPLETED|Overall Study||12
9817906|NCT00703391|10928307|FG001|COMPLETED|Overall Study||6
9817907|NCT00703391|10928306|FG000|NOT COMPLETED|Overall Study||0
9817908|NCT00703391|10928307|FG001|NOT COMPLETED|Overall Study||0
9817909|NCT00703508|10928313|FG000|STARTED|Overall Study||26
9817910|NCT00703508|10928313|FG000|COMPLETED|Overall Study||26
9817911|NCT00703508|10928313|FG000|NOT COMPLETED|Overall Study||0
9817912|NCT00703664|10928322|FG000|STARTED|Overall Study||22
9817913|NCT00703664|10928323|FG001|STARTED|Overall Study||4
9817914|NCT00703664|10928324|FG002|STARTED|Overall Study||39
9817915|NCT00703664|10928322|FG000|COMPLETED|Overall Study||22
9817916|NCT00703664|10928323|FG001|COMPLETED|Overall Study||4
9817917|NCT00703664|10928324|FG002|COMPLETED|Overall Study||39
9817918|NCT00703664|10928322|FG000|NOT COMPLETED|Overall Study||0
9817919|NCT00703664|10928323|FG001|NOT COMPLETED|Overall Study||0
9817920|NCT00703664|10928324|FG002|NOT COMPLETED|Overall Study||0
9817921|NCT00703677|10928332|FG000|STARTED|Overall Study||17
9817922|NCT00703677|10928332|FG000|COMPLETED|Overall Study||14
9817923|NCT00703677|10928332|FG000|NOT COMPLETED|Overall Study||3
9817924|NCT00703729|10928338|FG000|STARTED|Overall Study||25
9817925|NCT00703729|10928339|FG001|STARTED|Overall Study||24
9817926|NCT00703729|10928338|FG000|COMPLETED|Overall Study||25
9817927|NCT00703729|10928339|FG001|COMPLETED|Overall Study||21
9817928|NCT00703729|10928338|FG000|NOT COMPLETED|Overall Study||0
9817929|NCT00703729|10928339|FG001|NOT COMPLETED|Overall Study||3
9817930|NCT00703781|10928347|FG000|STARTED|Overall Study||63
9817931|NCT00703781|10928348|FG001|STARTED|Overall Study||63
9817932|NCT00703781|10928347|FG000|COMPLETED|Overall Study||61
9817933|NCT00703781|10928348|FG001|COMPLETED|Overall Study||61
9817934|NCT00703781|10928347|FG000|NOT COMPLETED|Overall Study||2
9817935|NCT00703781|10928348|FG001|NOT COMPLETED|Overall Study||2
9817936|NCT00703820|10928356|FG000|STARTED|Overall Study||133
9817937|NCT00703820|10928357|FG001|STARTED|Overall Study||129
9817938|NCT00703820|10928356|FG000|COMPLETED|Overall Study||98
9817939|NCT00703820|10928357|FG001|COMPLETED|Overall Study||95
9817940|NCT00703820|10928356|FG000|NOT COMPLETED|Overall Study||35
9817941|NCT00703820|10928357|FG001|NOT COMPLETED|Overall Study||34
9817942|NCT00703846|10928365|FG000|STARTED|Overall Study||500
9817943|NCT00703846|10928365|FG000|COMPLETED|Overall Study||363
9817944|NCT00703846|10928365|FG000|NOT COMPLETED|Overall Study||137
9817945|NCT00703911|10928369|FG000|STARTED|Overall Study||102
9817946|NCT00703911|10928369|FG000|COMPLETED|Overall Study||92
9817947|NCT00703911|10928369|FG000|NOT COMPLETED|Overall Study||10
9817948|NCT00703924|10928375|FG000|STARTED|Overall Study||50
9817949|NCT00703924|10928376|FG001|STARTED|Overall Study||42
9817950|NCT00703924|10928375|FG000|COMPLETED|Overall Study||49
9817951|NCT00703924|10928376|FG001|COMPLETED|Overall Study||41
9817952|NCT00703924|10928375|FG000|NOT COMPLETED|Overall Study||1
9817953|NCT00703924|10928376|FG001|NOT COMPLETED|Overall Study||1
9817954|NCT00703937|10928388|FG000|STARTED|Overall Study||343
9817955|NCT00703937|10928389|FG001|STARTED|Overall Study||360
9817956|NCT00703937|10928388|FG000|COMPLETED|Overall Study||278
9817957|NCT00703937|10928389|FG001|COMPLETED|Overall Study||267
9817958|NCT00703937|10928388|FG000|NOT COMPLETED|Overall Study||65
9817959|NCT00703937|10928389|FG001|NOT COMPLETED|Overall Study||93
9817960|NCT00703963|10928397|FG000|STARTED|Overall Study||100
9817961|NCT00703963|10928398|FG001|STARTED|Overall Study||100
9817962|NCT00703963|10928397|FG000|COMPLETED|Overall Study||93
9817963|NCT00703963|10928398|FG001|COMPLETED|Overall Study||86
9817964|NCT00703963|10928397|FG000|NOT COMPLETED|Overall Study||7
9817965|NCT00703963|10928398|FG001|NOT COMPLETED|Overall Study||14
9817966|NCT00703976|10928406|FG000|STARTED|Overall Study||37
9817967|NCT00703976|10928407|FG001|STARTED|Overall Study||41
9817968|NCT00703976|10928406|FG000|COMPLETED|Overall Study||37
9817969|NCT00703976|10928407|FG001|COMPLETED|Overall Study||41
9817970|NCT00703976|10928406|FG000|NOT COMPLETED|Overall Study||0
9817971|NCT00703976|10928407|FG001|NOT COMPLETED|Overall Study||0
9817972|NCT00704028|10928417|FG000|STARTED|Overall Study||82
9831970|NCT00771030|10942636|FG004|NOT COMPLETED|Overall Study||0
9817973|NCT00704028|10928418|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
9817974|NCT00704028|10928417|FG000|COMPLETED|Overall Study||70
9817975|NCT00704028|10928418|FG001|COMPLETED|Overall Study||57
9817976|NCT00704028|10928417|FG000|NOT COMPLETED|Overall Study||12
9817977|NCT00704028|10928418|FG001|NOT COMPLETED|Overall Study||21
9817978|NCT00704132|10928426|FG000|STARTED|Overall Study||26
9817979|NCT00704132|10928427|FG001|STARTED|Overall Study||24
9817980|NCT00704132|10928426|FG000|COMPLETED|Overall Study||25
9817981|NCT00704132|10928427|FG001|COMPLETED|Overall Study||22
9817982|NCT00704132|10928426|FG000|NOT COMPLETED|Overall Study||1
9817983|NCT00704132|10928427|FG001|NOT COMPLETED|Overall Study||2
9817984|NCT00704171|10928435|FG000|STARTED|Overall Study||62
9817985|NCT00704171|10928436|FG001|STARTED|Overall Study||59
9817986|NCT00704171|10928435|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
9817987|NCT00704171|10928436|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59
9817988|NCT00704171|10928435|FG000|NOT COMPLETED|Overall Study||1
9817989|NCT00704171|10928436|FG001|NOT COMPLETED|Overall Study||0
9817990|NCT00704184|10928447|FG000|STARTED|Double-Blind Treatment||20
9817991|NCT00704184|10928448|FG001|STARTED|Double-Blind Treatment||18
9817992|NCT00704184|10928449|FG002|STARTED|Double-Blind Treatment||20
9817993|NCT00704184|10928450|FG003|STARTED|Double-Blind Treatment||18
9817994|NCT00704184|10928451|FG004|STARTED|Double-Blind Treatment||19
9817995|NCT00704184|10928447|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
9817996|NCT00704184|10928448|FG001|Treated|Double-Blind Treatment||18
9817997|NCT00704184|10928449|FG002|Treated|Double-Blind Treatment||20
9817998|NCT00704184|10928450|FG003|Treated|Double-Blind Treatment||18
9817999|NCT00704184|10928451|FG004|Treated|Double-Blind Treatment||19
9818000|NCT00704184|10928447|FG000|COMPLETED|Double-Blind Treatment||19
9818001|NCT00704184|10928448|FG001|COMPLETED|Double-Blind Treatment||18
9818002|NCT00704184|10928449|FG002|COMPLETED|Double-Blind Treatment||20
9818003|NCT00704184|10928450|FG003|COMPLETED|Double-Blind Treatment||18
9818004|NCT00704184|10928451|FG004|COMPLETED|Double-Blind Treatment||19
9818005|NCT00704184|10928447|FG000|NOT COMPLETED|Double-Blind Treatment||1
9818006|NCT00704184|10928448|FG001|NOT COMPLETED|Double-Blind Treatment||0
9818007|NCT00704184|10928449|FG002|NOT COMPLETED|Double-Blind Treatment||0
9818008|NCT00704184|10928450|FG003|NOT COMPLETED|Double-Blind Treatment||0
9818009|NCT00704184|10928451|FG004|NOT COMPLETED|Double-Blind Treatment||0
9818010|NCT00704184|10928447|FG000|STARTED|Open-Label Treatment||19
9818011|NCT00704184|10928448|FG001|STARTED|Open-Label Treatment||18
9818012|NCT00704184|10928449|FG002|STARTED|Open-Label Treatment||20
9818013|NCT00704184|10928450|FG003|STARTED|Open-Label Treatment||18
9818014|NCT00704184|10928451|FG004|STARTED|Open-Label Treatment||19
9818015|NCT00704184|10928447|FG000|COMPLETED|Open-Label Treatment||18
9818016|NCT00704184|10928448|FG001|COMPLETED|Open-Label Treatment||16
9818017|NCT00704184|10928449|FG002|COMPLETED|Open-Label Treatment||16
9818018|NCT00704184|10928450|FG003|COMPLETED|Open-Label Treatment||13
9818019|NCT00704184|10928451|FG004|COMPLETED|Open-Label Treatment||16
9818020|NCT00704184|10928447|FG000|NOT COMPLETED|Open-Label Treatment||1
9818021|NCT00704184|10928448|FG001|NOT COMPLETED|Open-Label Treatment||2
9818022|NCT00704184|10928449|FG002|NOT COMPLETED|Open-Label Treatment||4
9818023|NCT00704184|10928450|FG003|NOT COMPLETED|Open-Label Treatment||5
9818024|NCT00704184|10928451|FG004|NOT COMPLETED|Open-Label Treatment||3
9818025|NCT00704262|10928463|FG000|STARTED|Overall Study||33
9818026|NCT00704262|10928463|FG000|COMPLETED|Overall Study||31
9818027|NCT00704262|10928463|FG000|NOT COMPLETED|Overall Study||2
9818028|NCT00704340|10928469|FG000|STARTED|Overall Study||120
9818029|NCT00704340|10928470|FG001|STARTED|Overall Study||117
9818030|NCT00704340|10928469|FG000|COMPLETED|Overall Study||118
9818031|NCT00704340|10928470|FG001|COMPLETED|Overall Study||115
9818032|NCT00704340|10928469|FG000|NOT COMPLETED|Overall Study||2
9818033|NCT00704340|10928470|FG001|NOT COMPLETED|Overall Study||2
9818034|NCT00704353|10928478|FG000|STARTED|Overall Study||366
9818035|NCT00704353|10928479|FG001|STARTED|Overall Study||369
9818036|NCT00704353|10928478|FG000|COMPLETED|Overall Study||268
9818037|NCT00704353|10928479|FG001|COMPLETED|Overall Study||255
9818038|NCT00704353|10928478|FG000|NOT COMPLETED|Overall Study||98
9818039|NCT00704353|10928479|FG001|NOT COMPLETED|Overall Study||114
9831971|NCT00771030|10942637|FG005|NOT COMPLETED|Overall Study||0
9831972|NCT00771030|10942638|FG006|NOT COMPLETED|Overall Study||0
9831973|NCT00771056|10942659|FG000|STARTED|Overall Study||23
10016832|NCT01812473|11139608|FG000|NOT COMPLETED|Overall Study||0
10016833|NCT01812473|11139609|FG001|NOT COMPLETED|Overall Study||0
9831974|NCT00771056|10942659|FG000|COMPLETED|Overall Study||18
9831975|NCT00771056|10942659|FG000|NOT COMPLETED|Overall Study||5
9831976|NCT00771173|10942665|FG000|STARTED|Overall Study||129
9831977|NCT00771173|10942666|FG001|STARTED|Overall Study||129
9831978|NCT00771173|10942665|FG000|COMPLETED|Overall Study||107
9831979|NCT00771173|10942666|FG001|COMPLETED|Overall Study||112
9831980|NCT00771173|10942665|FG000|NOT COMPLETED|Overall Study||22
9831981|NCT00771173|10942666|FG001|NOT COMPLETED|Overall Study||17
9831982|NCT00771238|10942674|FG000|STARTED|Overall Study||31
9831983|NCT00771238|10942675|FG001|STARTED|Overall Study||21
9831984|NCT00771238|10942674|FG000|COMPLETED|Overall Study||31
9831985|NCT00771238|10942675|FG001|COMPLETED|Overall Study||21
9831986|NCT00771238|10942674|FG000|NOT COMPLETED|Overall Study||0
9831987|NCT00771238|10942675|FG001|NOT COMPLETED|Overall Study||0
9818040|NCT00704379|10928487|FG000|STARTED|Overall Study||46
9818041|NCT00704379|10928488|FG001|STARTED|Overall Study||48
9818042|NCT00704379|10928487|FG000|COMPLETED|Overall Study||39
9818043|NCT00704379|10928488|FG001|COMPLETED|Overall Study||41
9818044|NCT00704379|10928487|FG000|NOT COMPLETED|Overall Study||7
9818045|NCT00704379|10928488|FG001|NOT COMPLETED|Overall Study||7
9818046|NCT00704405|10928501|FG000|STARTED|Overall Study (NC Population)||42
9818047|NCT00704405|10928502|FG001|STARTED|Overall Study (NC Population)||44
9818048|NCT00704405|10928503|FG002|STARTED|Overall Study (NC Population)||41
9818049|NCT00704405|10928504|FG003|STARTED|Overall Study (NC Population)||42
9818050|NCT00704405|10928505|FG004|STARTED|Overall Study (NC Population)||42
9818051|NCT00704405|10928501|FG000|COMPLETED|Overall Study (NC Population)||37
9818052|NCT00704405|10928502|FG001|COMPLETED|Overall Study (NC Population)||40
9818053|NCT00704405|10928503|FG002|COMPLETED|Overall Study (NC Population)||38
9818054|NCT00704405|10928504|FG003|COMPLETED|Overall Study (NC Population)||38
9818055|NCT00704405|10928505|FG004|COMPLETED|Overall Study (NC Population)||37
9818056|NCT00704405|10928501|FG000|NOT COMPLETED|Overall Study (NC Population)||5
9818057|NCT00704405|10928502|FG001|NOT COMPLETED|Overall Study (NC Population)||4
9818058|NCT00704405|10928503|FG002|NOT COMPLETED|Overall Study (NC Population)||3
9818059|NCT00704405|10928504|FG003|NOT COMPLETED|Overall Study (NC Population)||4
9818060|NCT00704405|10928505|FG004|NOT COMPLETED|Overall Study (NC Population)||5
9818061|NCT00704405|10928501|FG000|STARTED|Overall Study (C Population)||16
9818062|NCT00704405|10928502|FG001|STARTED|Overall Study (C Population)||14
9818063|NCT00704405|10928503|FG002|STARTED|Overall Study (C Population)||15
9818064|NCT00704405|10928504|FG003|STARTED|Overall Study (C Population)||15
9818065|NCT00704405|10928505|FG004|STARTED|Overall Study (C Population)||14
9818066|NCT00704405|10928501|FG000|COMPLETED|Overall Study (C Population)||15
9818067|NCT00704405|10928502|FG001|COMPLETED|Overall Study (C Population)||11
9818068|NCT00704405|10928503|FG002|COMPLETED|Overall Study (C Population)||14
9818069|NCT00704405|10928504|FG003|COMPLETED|Overall Study (C Population)||14
9818070|NCT00704405|10928505|FG004|COMPLETED|Overall Study (C Population)||14
9818071|NCT00704405|10928501|FG000|NOT COMPLETED|Overall Study (C Population)||1
9818072|NCT00704405|10928502|FG001|NOT COMPLETED|Overall Study (C Population)||3
9818073|NCT00704405|10928503|FG002|NOT COMPLETED|Overall Study (C Population)||1
9818074|NCT00704405|10928504|FG003|NOT COMPLETED|Overall Study (C Population)||1
9818075|NCT00704405|10928505|FG004|NOT COMPLETED|Overall Study (C Population)||0
9818076|NCT00704418|10928525|FG000|STARTED|Overall Study||78
9818077|NCT00704418|10928526|FG001|STARTED|Overall Study||78
9818078|NCT00704418|10928525|FG000|COMPLETED|Overall Study||73
9818079|NCT00704418|10928526|FG001|COMPLETED|Overall Study||72
9818080|NCT00704418|10928525|FG000|NOT COMPLETED|Overall Study||5
9818081|NCT00704418|10928526|FG001|NOT COMPLETED|Overall Study||6
9818082|NCT00704522|10928534|FG000|STARTED|Overall Study||481
9818083|NCT00704522|10928535|FG001|STARTED|Overall Study||120
9818084|NCT00704522|10928534|FG000|COMPLETED|Overall Study||298
9818085|NCT00704522|10928535|FG001|COMPLETED|Overall Study||75
9818086|NCT00704522|10928534|FG000|NOT COMPLETED|Overall Study||183
9818087|NCT00704522|10928535|FG001|NOT COMPLETED|Overall Study||45
9818088|NCT00704717|10928540|FG000|STARTED|Overall Study||185
9818089|NCT00704717|10928540|FG000|COMPLETED|Overall Study||185
9818090|NCT00704717|10928540|FG000|NOT COMPLETED|Overall Study||0
9818091|NCT00704730|10928546|FG000|STARTED|Overall Study|Randomized|219
9818092|NCT00704730|10928547|FG001|STARTED|Overall Study|Randomized|111
9818093|NCT00704730|10928546|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
9818094|NCT00704730|10928547|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
9818095|NCT00704730|10928546|FG000|NOT COMPLETED|Overall Study||121
9818096|NCT00704730|10928547|FG001|NOT COMPLETED|Overall Study||96
9818097|NCT00704808|10928554|FG000|STARTED|Overall Study||180
9818098|NCT00704808|10928554|FG000|COMPLETED|Overall Study||49
9818099|NCT00704808|10928554|FG000|NOT COMPLETED|Overall Study||131
9818100|NCT00704847|10928560|FG000|STARTED|Overall Study||521
9818101|NCT00704847|10928561|FG001|STARTED|Overall Study||509
9818102|NCT00704847|10928560|FG000|COMPLETED|Overall Study||300
9818103|NCT00704847|10928561|FG001|COMPLETED|Overall Study||339
9818104|NCT00704847|10928560|FG000|NOT COMPLETED|Overall Study||221
9818105|NCT00704847|10928561|FG001|NOT COMPLETED|Overall Study||170
9818106|NCT00704912|10928570|FG000|STARTED|Overall Study||50
9818107|NCT00704912|10928571|FG001|STARTED|Overall Study||49
9818108|NCT00704912|10928572|FG002|STARTED|Overall Study||50
9818109|NCT00704912|10928570|FG000|COMPLETED|Overall Study||44
9818110|NCT00704912|10928571|FG001|COMPLETED|Overall Study||45
9818111|NCT00704912|10928572|FG002|COMPLETED|Overall Study||43
9818112|NCT00704912|10928570|FG000|NOT COMPLETED|Overall Study||6
9818113|NCT00704912|10928571|FG001|NOT COMPLETED|Overall Study||4
9818114|NCT00704912|10928572|FG002|NOT COMPLETED|Overall Study||7
9818115|NCT00704938|10928582|FG000|STARTED|Overall Study||2
9818116|NCT00704938|10928583|FG001|STARTED|Overall Study||1
9818117|NCT00704938|10928582|FG000|COMPLETED|Overall Study||2
9818118|NCT00704938|10928583|FG001|COMPLETED|Overall Study||1
9818119|NCT00704938|10928582|FG000|NOT COMPLETED|Overall Study||0
9818120|NCT00704938|10928583|FG001|NOT COMPLETED|Overall Study||0
9818121|NCT00704964|10928589|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
9818122|NCT00704964|10928589|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
9818123|NCT00704964|10928589|FG000|NOT COMPLETED|Overall Study||328
9818124|NCT00705003|10928596|FG000|STARTED|Enrolled||71
9818125|NCT00705003|10928597|FG001|STARTED|Enrolled||37
9818126|NCT00705003|10928598|FG002|STARTED|Enrolled||34
9818127|NCT00705003|10928596|FG000|COMPLETED|Enrolled||67
9818128|NCT00705003|10928597|FG001|COMPLETED|Enrolled||34
9818129|NCT00705003|10928598|FG002|COMPLETED|Enrolled||33
9818130|NCT00705003|10928596|FG000|NOT COMPLETED|Enrolled||4
9818131|NCT00705003|10928597|FG001|NOT COMPLETED|Enrolled||3
9818132|NCT00705003|10928598|FG002|NOT COMPLETED|Enrolled||1
9818133|NCT00705003|10928596|FG000|STARTED|Treated||67
9818134|NCT00705003|10928597|FG001|STARTED|Treated||34
9818135|NCT00705003|10928598|FG002|STARTED|Treated||33
9818136|NCT00705003|10928596|FG000|COMPLETED|Treated||54
9818137|NCT00705003|10928597|FG001|COMPLETED|Treated||28
9818138|NCT00705003|10928598|FG002|COMPLETED|Treated||30
9818139|NCT00705003|10928596|FG000|NOT COMPLETED|Treated||13
9818140|NCT00705003|10928597|FG001|NOT COMPLETED|Treated||6
9818141|NCT00705003|10928598|FG002|NOT COMPLETED|Treated||3
9818142|NCT00705016|10928610|FG000|STARTED|Overall Study||62
9818143|NCT00705016|10928611|FG001|STARTED|Overall Study||60
9818144|NCT00705016|10928612|FG002|STARTED|Overall Study||62
9818145|NCT00705016|10928610|FG000|COMPLETED|Overall Study||2
9818146|NCT00705016|10928611|FG001|COMPLETED|Overall Study||2
9818147|NCT00705016|10928612|FG002|COMPLETED|Overall Study||4
9818148|NCT00705016|10928610|FG000|NOT COMPLETED|Overall Study||60
9818149|NCT00705016|10928611|FG001|NOT COMPLETED|Overall Study||58
9818150|NCT00705016|10928612|FG002|NOT COMPLETED|Overall Study||58
9818151|NCT00705107|10928620|FG000|STARTED|Overall Study||267
9818152|NCT00705107|10928620|FG000|COMPLETED|Overall Study||218
9818153|NCT00705107|10928620|FG000|NOT COMPLETED|Overall Study||49
9818154|NCT00705133|10928624|FG000|STARTED|Overall Study||15
9818155|NCT00705133|10928624|FG000|COMPLETED|Overall Study||15
9818156|NCT00705133|10928624|FG000|NOT COMPLETED|Overall Study||0
9818157|NCT00705146|10928630|FG000|STARTED|Overall Study||32
9818158|NCT00705146|10928631|FG001|STARTED|Overall Study||24
9818159|NCT00705146|10928630|FG000|COMPLETED|Overall Study||31
9818160|NCT00705146|10928631|FG001|COMPLETED|Overall Study||23
9818161|NCT00705146|10928630|FG000|NOT COMPLETED|Overall Study||1
9818162|NCT00705146|10928631|FG001|NOT COMPLETED|Overall Study||1
9818163|NCT00705159|10928641|FG000|STARTED|Overall Study||34
9818164|NCT00705159|10928642|FG001|STARTED|Overall Study||35
9818165|NCT00705159|10928643|FG002|STARTED|Overall Study||34
9818166|NCT00705159|10928644|FG003|STARTED|Overall Study||34
9818167|NCT00705159|10928641|FG000|COMPLETED|Overall Study||34
9818168|NCT00705159|10928642|FG001|COMPLETED|Overall Study||33
9818169|NCT00705159|10928643|FG002|COMPLETED|Overall Study||29
9818170|NCT00705159|10928644|FG003|COMPLETED|Overall Study||30
9818171|NCT00705159|10928641|FG000|NOT COMPLETED|Overall Study||0
9818172|NCT00705159|10928642|FG001|NOT COMPLETED|Overall Study||2
9818173|NCT00705159|10928643|FG002|NOT COMPLETED|Overall Study||5
9818174|NCT00705159|10928644|FG003|NOT COMPLETED|Overall Study||4
9818175|NCT00705224|10928654|FG000|STARTED|Overall Study||250
9818176|NCT00705224|10928654|FG000|COMPLETED|Overall Study||239
9818177|NCT00705224|10928654|FG000|NOT COMPLETED|Overall Study||11
9818178|NCT00705250|10928661|FG000|STARTED|Overall Study||36
9818179|NCT00705250|10928661|FG000|COMPLETED|Overall Study||34
9818180|NCT00705250|10928661|FG000|NOT COMPLETED|Overall Study||2
9818181|NCT00705263|10928665|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
9818182|NCT00705263|10928665|FG000|COMPLETED|Overall Study||108
9818183|NCT00705263|10928665|FG000|NOT COMPLETED|Overall Study||2
9818184|NCT00705289|10928669|FG000|STARTED|Overall Study||728
9818185|NCT00705289|10928669|FG000|COMPLETED|Overall Study||597
9818186|NCT00705289|10928669|FG000|NOT COMPLETED|Overall Study||131
9818187|NCT00705341|10928692|FG000|STARTED|Phase 1:Control Challenge||126
9818188|NCT00705341|10928693|FG001|STARTED|Phase 1:Control Challenge||93
9818189|NCT00705341|10928694|FG002|STARTED|Phase 1:Control Challenge||0
9818190|NCT00705341|10928695|FG003|STARTED|Phase 1:Control Challenge||0
9818191|NCT00705341|10928692|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
9818192|NCT00705341|10928693|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
9818193|NCT00705341|10928694|FG002|COMPLETED|Phase 1:Control Challenge||0
9818194|NCT00705341|10928695|FG003|COMPLETED|Phase 1:Control Challenge||0
9818195|NCT00705341|10928692|FG000|NOT COMPLETED|Phase 1:Control Challenge||0
9818196|NCT00705341|10928693|FG001|NOT COMPLETED|Phase 1:Control Challenge||0
9818197|NCT00705341|10928694|FG002|NOT COMPLETED|Phase 1:Control Challenge||0
9818198|NCT00705341|10928695|FG003|NOT COMPLETED|Phase 1:Control Challenge||0
9818199|NCT00705341|10928692|FG000|STARTED|Phase 2: Trial||0
9818200|NCT00705341|10928693|FG001|STARTED|Phase 2: Trial||0
9818201|NCT00705341|10928694|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
9818202|NCT00705341|10928695|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
9818203|NCT00705341|10928692|FG000|COMPLETED|Phase 2: Trial||0
9818204|NCT00705341|10928693|FG001|COMPLETED|Phase 2: Trial||0
9818205|NCT00705341|10928694|FG002|COMPLETED|Phase 2: Trial||23
9818206|NCT00705341|10928695|FG003|COMPLETED|Phase 2: Trial||28
9818207|NCT00705341|10928692|FG000|NOT COMPLETED|Phase 2: Trial||0
9818208|NCT00705341|10928693|FG001|NOT COMPLETED|Phase 2: Trial||0
9818209|NCT00705341|10928694|FG002|NOT COMPLETED|Phase 2: Trial||7
9818210|NCT00705341|10928695|FG003|NOT COMPLETED|Phase 2: Trial||4
9818211|NCT00705367|10928705|FG000|STARTED|Short-term Period||6
9818212|NCT00705367|10928706|FG001|STARTED|Short-term Period||3
9818213|NCT00705367|10928705|FG000|COMPLETED|Short-term Period||6
9818214|NCT00705367|10928706|FG001|COMPLETED|Short-term Period||3
9818215|NCT00705367|10928705|FG000|NOT COMPLETED|Short-term Period||0
9818216|NCT00705367|10928706|FG001|NOT COMPLETED|Short-term Period||0
9818217|NCT00705367|10928705|FG000|STARTED|Long-term Extension Period||9
9818218|NCT00705367|10928706|FG001|STARTED|Long-term Extension Period||0
9818219|NCT00705367|10928705|FG000|COMPLETED|Long-term Extension Period||0
9818220|NCT00705367|10928706|FG001|COMPLETED|Long-term Extension Period||0
9818221|NCT00705367|10928705|FG000|NOT COMPLETED|Long-term Extension Period||9
9818222|NCT00705367|10928706|FG001|NOT COMPLETED|Long-term Extension Period||0
9818223|NCT00705406|10928716|FG000|STARTED|Overall Study||203
9818224|NCT00705406|10928717|FG001|STARTED|Overall Study||202
9818225|NCT00705406|10928716|FG000|COMPLETED|Overall Study||199
9818226|NCT00705406|10928717|FG001|COMPLETED|Overall Study||197
9818227|NCT00705406|10928716|FG000|NOT COMPLETED|Overall Study||4
9818228|NCT00705406|10928717|FG001|NOT COMPLETED|Overall Study||5
9818229|NCT00705432|10928730|FG000|STARTED|Treatment Period||311
9818230|NCT00705432|10928731|FG001|STARTED|Treatment Period||316
9818231|NCT00705432|10928732|FG002|STARTED|Treatment Period||311
9818232|NCT00705432|10928733|FG003|STARTED|Treatment Period||52
9818233|NCT00705432|10928734|FG004|STARTED|Treatment Period||52
9818234|NCT00705432|10928735|FG005|STARTED|Treatment Period||55
9818235|NCT00705432|10928730|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
9818236|NCT00705432|10928731|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
9818237|NCT00705432|10928732|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
9818238|NCT00705432|10928733|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
9818239|NCT00705432|10928734|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
9818240|NCT00705432|10928735|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
9818241|NCT00705432|10928730|FG000|COMPLETED|Treatment Period||148
9818242|NCT00705432|10928731|FG001|COMPLETED|Treatment Period||205
9818243|NCT00705432|10928732|FG002|COMPLETED|Treatment Period||190
9818244|NCT00705432|10928733|FG003|COMPLETED|Treatment Period||11
9818245|NCT00705432|10928734|FG004|COMPLETED|Treatment Period||24
9818246|NCT00705432|10928735|FG005|COMPLETED|Treatment Period||25
9818247|NCT00705432|10928730|FG000|NOT COMPLETED|Treatment Period||163
9818248|NCT00705432|10928731|FG001|NOT COMPLETED|Treatment Period||111
9818249|NCT00705432|10928732|FG002|NOT COMPLETED|Treatment Period||121
9818250|NCT00705432|10928733|FG003|NOT COMPLETED|Treatment Period||41
9818251|NCT00705432|10928734|FG004|NOT COMPLETED|Treatment Period||28
9818252|NCT00705432|10928735|FG005|NOT COMPLETED|Treatment Period||30
9818253|NCT00705432|10928730|FG000|STARTED|Follow-up Period (Upto Week 72)||278
9818254|NCT00705432|10928731|FG001|STARTED|Follow-up Period (Upto Week 72)||295
9818255|NCT00705432|10928732|FG002|STARTED|Follow-up Period (Upto Week 72)||291
9818256|NCT00705432|10928733|FG003|STARTED|Follow-up Period (Upto Week 72)||42
9818257|NCT00705432|10928734|FG004|STARTED|Follow-up Period (Upto Week 72)||44
9818258|NCT00705432|10928735|FG005|STARTED|Follow-up Period (Upto Week 72)||53
9818259|NCT00705432|10928730|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207
9818260|NCT00705432|10928731|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252
9818261|NCT00705432|10928732|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266
9818262|NCT00705432|10928733|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28
9818263|NCT00705432|10928734|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38
9818264|NCT00705432|10928735|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46
9818265|NCT00705432|10928730|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
9818266|NCT00705432|10928731|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
9818267|NCT00705432|10928732|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
9818268|NCT00705432|10928733|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
9818269|NCT00705432|10928734|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
9818270|NCT00705432|10928735|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
9818271|NCT00705484|10928748|FG000|STARTED|Overall Study|Number Enrolled|1059
9818272|NCT00705484|10928749|FG001|STARTED|Overall Study|Number Enrolled|1180
9818273|NCT00705484|10928748|FG000|Follow-up Period|Overall Study||1059
9818274|NCT00705484|10928749|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
9818275|NCT00705484|10928748|FG000|COMPLETED|Overall Study||677
9818276|NCT00705484|10928749|FG001|COMPLETED|Overall Study||772
9818277|NCT00705484|10928748|FG000|NOT COMPLETED|Overall Study||382
9818278|NCT00705484|10928749|FG001|NOT COMPLETED|Overall Study||408
9818279|NCT00705523|10928759|FG000|STARTED|Overall Study||19
9818280|NCT00705523|10928760|FG001|STARTED|Overall Study||21
9818281|NCT00705523|10928759|FG000|COMPLETED|Overall Study||17
9818282|NCT00705523|10928760|FG001|COMPLETED|Overall Study||18
9818283|NCT00705523|10928759|FG000|NOT COMPLETED|Overall Study||2
9818284|NCT00705523|10928760|FG001|NOT COMPLETED|Overall Study||3
9818285|NCT00705536|10928768|FG000|STARTED|Start Period 1||6
9818286|NCT00705536|10928769|FG001|STARTED|Start Period 1||6
9818287|NCT00705536|10928770|FG002|STARTED|Start Period 1||7
9818288|NCT00705536|10928771|FG003|STARTED|Start Period 1||7
9818289|NCT00705536|10928768|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6
9818290|NCT00705536|10928769|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6
9818291|NCT00705536|10928770|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7
9818292|NCT00705536|10928771|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7
9818293|NCT00705536|10928768|FG000|COMPLETED|Start Period 1||6
9818294|NCT00705536|10928769|FG001|COMPLETED|Start Period 1||6
9818295|NCT00705536|10928770|FG002|COMPLETED|Start Period 1||7
9818296|NCT00705536|10928771|FG003|COMPLETED|Start Period 1||6
9818297|NCT00705536|10928768|FG000|NOT COMPLETED|Start Period 1||0
9818298|NCT00705536|10928769|FG001|NOT COMPLETED|Start Period 1||0
9818299|NCT00705536|10928770|FG002|NOT COMPLETED|Start Period 1||0
9818300|NCT00705536|10928771|FG003|NOT COMPLETED|Start Period 1||1
9818301|NCT00705536|10928768|FG000|STARTED|Washout Period of at Least 6 Days||6
9818302|NCT00705536|10928769|FG001|STARTED|Washout Period of at Least 6 Days||6
9818303|NCT00705536|10928770|FG002|STARTED|Washout Period of at Least 6 Days||7
9818304|NCT00705536|10928771|FG003|STARTED|Washout Period of at Least 6 Days||6
9818305|NCT00705536|10928768|FG000|COMPLETED|Washout Period of at Least 6 Days||6
9818306|NCT00705536|10928769|FG001|COMPLETED|Washout Period of at Least 6 Days||6
9818307|NCT00705536|10928770|FG002|COMPLETED|Washout Period of at Least 6 Days||7
9818308|NCT00705536|10928771|FG003|COMPLETED|Washout Period of at Least 6 Days||6
9818309|NCT00705536|10928768|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0
9818310|NCT00705536|10928769|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0
9818311|NCT00705536|10928770|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0
9818312|NCT00705536|10928771|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0
9818313|NCT00705536|10928768|FG000|STARTED|Start Period 2||6
9818314|NCT00705536|10928769|FG001|STARTED|Start Period 2||6
9818315|NCT00705536|10928770|FG002|STARTED|Start Period 2||7
9818316|NCT00705536|10928771|FG003|STARTED|Start Period 2||6
9818317|NCT00705536|10928768|FG000|COMPLETED|Start Period 2||6
9818318|NCT00705536|10928769|FG001|COMPLETED|Start Period 2||6
9818319|NCT00705536|10928770|FG002|COMPLETED|Start Period 2||7
9818320|NCT00705536|10928771|FG003|COMPLETED|Start Period 2||6
9818321|NCT00705536|10928768|FG000|NOT COMPLETED|Start Period 2||0
9818322|NCT00705536|10928769|FG001|NOT COMPLETED|Start Period 2||0
9818323|NCT00705536|10928770|FG002|NOT COMPLETED|Start Period 2||0
9818324|NCT00705536|10928771|FG003|NOT COMPLETED|Start Period 2||0
9818325|NCT00705536|10928768|FG000|STARTED|Completed Study||6
9818326|NCT00705536|10928769|FG001|STARTED|Completed Study||6
9818327|NCT00705536|10928770|FG002|STARTED|Completed Study||7
9818328|NCT00705536|10928771|FG003|STARTED|Completed Study||6
9818329|NCT00705536|10928768|FG000|COMPLETED|Completed Study||6
9818330|NCT00705536|10928769|FG001|COMPLETED|Completed Study||6
9818331|NCT00705536|10928770|FG002|COMPLETED|Completed Study||7
9818332|NCT00705536|10928771|FG003|COMPLETED|Completed Study||6
9818333|NCT00705536|10928768|FG000|NOT COMPLETED|Completed Study||0
9818334|NCT00705536|10928769|FG001|NOT COMPLETED|Completed Study||0
9818335|NCT00705536|10928770|FG002|NOT COMPLETED|Completed Study||0
9818336|NCT00705536|10928771|FG003|NOT COMPLETED|Completed Study||0
9818337|NCT00705575|10928792|FG000|STARTED|Overall Study||349
9818338|NCT00705575|10928793|FG001|STARTED|Overall Study||339
9818339|NCT00705575|10928792|FG000|COMPLETED|Overall Study||326
9818340|NCT00705575|10928793|FG001|COMPLETED|Overall Study||293
9818341|NCT00705575|10928792|FG000|NOT COMPLETED|Overall Study||23
9818342|NCT00705575|10928793|FG001|NOT COMPLETED|Overall Study||46
9818343|NCT00705614|10928801|FG000|STARTED|Initial Intervention||1541
9818344|NCT00705614|10928802|FG001|STARTED|Initial Intervention||1121
9818345|NCT00705614|10928801|FG000|COMPLETED|Initial Intervention||1023
9818346|NCT00705614|10928802|FG001|COMPLETED|Initial Intervention||800
9818347|NCT00705614|10928801|FG000|NOT COMPLETED|Initial Intervention||518
9818348|NCT00705614|10928802|FG001|NOT COMPLETED|Initial Intervention||321
9818349|NCT00705614|10928801|FG000|STARTED|Switch to Remicade||0
9818350|NCT00705614|10928802|FG001|STARTED|Switch to Remicade||298
9818351|NCT00705614|10928801|FG000|COMPLETED|Switch to Remicade||0
9818352|NCT00705614|10928802|FG001|COMPLETED|Switch to Remicade||249
9818353|NCT00705614|10928801|FG000|NOT COMPLETED|Switch to Remicade||0
9818354|NCT00705614|10928802|FG001|NOT COMPLETED|Switch to Remicade||49
9818355|NCT00705653|10928810|FG000|STARTED|Overall Study||46
9818356|NCT00705653|10928810|FG000|COMPLETED|Overall Study||46
9818357|NCT00705653|10928810|FG000|NOT COMPLETED|Overall Study||0
9818358|NCT00705666|10928814|FG000|STARTED|Overall Study||789
9818359|NCT00705666|10928814|FG000|COMPLETED|Overall Study||450
9818360|NCT00705666|10928814|FG000|NOT COMPLETED|Overall Study||339
9818361|NCT00705679|10928823|FG000|STARTED|Overall Study||1007
9818362|NCT00705679|10928824|FG001|STARTED|Overall Study||1003
9818363|NCT00705679|10928825|FG002|STARTED|Overall Study||1009
9818364|NCT00705679|10928826|FG003|STARTED|Overall Study||1007
9818365|NCT00705679|10928827|FG004|STARTED|Overall Study||1003
9818366|NCT00705679|10928823|FG000|COMPLETED|Overall Study||942
9818367|NCT00705679|10928824|FG001|COMPLETED|Overall Study||864
9818368|NCT00705679|10928825|FG002|COMPLETED|Overall Study||894
9818369|NCT00705679|10928826|FG003|COMPLETED|Overall Study||927
9818370|NCT00705679|10928827|FG004|COMPLETED|Overall Study||934
9818371|NCT00705679|10928823|FG000|NOT COMPLETED|Overall Study||65
9818372|NCT00705679|10928824|FG001|NOT COMPLETED|Overall Study||139
9818373|NCT00705679|10928825|FG002|NOT COMPLETED|Overall Study||115
9818374|NCT00705679|10928826|FG003|NOT COMPLETED|Overall Study||80
9818375|NCT00705679|10928827|FG004|NOT COMPLETED|Overall Study||69
9818376|NCT00705718|10928846|FG000|STARTED|Overall Study||44
9818377|NCT00705718|10928847|FG001|STARTED|Overall Study||150
9818378|NCT00705718|10928846|FG000|1 Month Follow up|Overall Study|1 Death|43
9818379|NCT00705718|10928847|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
9818380|NCT00705718|10928846|FG000|6 Month Follow up|Overall Study|3 Deaths|40
9818381|NCT00705718|10928847|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
9818382|NCT00705718|10928846|FG000|12 Month Follow up|Overall Study|2 Deaths|37
9818383|NCT00705718|10928847|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
9818384|NCT00705718|10928846|FG000|COMPLETED|Overall Study||37
9818385|NCT00705718|10928847|FG001|COMPLETED|Overall Study||128
9818386|NCT00705718|10928846|FG000|NOT COMPLETED|Overall Study||7
9818387|NCT00705718|10928847|FG001|NOT COMPLETED|Overall Study||22
9818388|NCT00705757|10928856|FG000|STARTED|Overall Study||32
9818389|NCT00705757|10928857|FG001|STARTED|Overall Study||29
9818390|NCT00705757|10928858|FG002|STARTED|Overall Study||28
9818391|NCT00705757|10928856|FG000|COMPLETED|Overall Study||19
9818392|NCT00705757|10928857|FG001|COMPLETED|Overall Study||21
9818393|NCT00705757|10928858|FG002|COMPLETED|Overall Study||17
9818394|NCT00705757|10928856|FG000|NOT COMPLETED|Overall Study||13
9818395|NCT00705757|10928857|FG001|NOT COMPLETED|Overall Study||8
9818396|NCT00705757|10928858|FG002|NOT COMPLETED|Overall Study||11
9818397|NCT00705783|10928868|FG000|STARTED|Conversion Phase||633
9818398|NCT00705783|10928869|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
9818399|NCT00705783|10928870|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
9818400|NCT00705783|10928868|FG000|Received Study Medication|Conversion Phase||632
9818401|NCT00705783|10928869|FG001|Received Study Medication|Conversion Phase||0
9818402|NCT00705783|10928870|FG002|Received Study Medication|Conversion Phase||0
9818403|NCT00705783|10928868|FG000|COMPLETED|Conversion Phase||500
9818404|NCT00705783|10928869|FG001|COMPLETED|Conversion Phase||0
9818405|NCT00705783|10928870|FG002|COMPLETED|Conversion Phase||0
9818406|NCT00705783|10928868|FG000|NOT COMPLETED|Conversion Phase||133
9818407|NCT00705783|10928869|FG001|NOT COMPLETED|Conversion Phase||0
9818408|NCT00705783|10928870|FG002|NOT COMPLETED|Conversion Phase||0
9818409|NCT00705783|10928868|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
9818410|NCT00705783|10928869|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
9818411|NCT00705783|10928870|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
9818412|NCT00705783|10928868|FG000|Received Study Medication|Oral Stabilization Phase||709
9818413|NCT00705783|10928869|FG001|Received Study Medication|Oral Stabilization Phase||0
9818414|NCT00705783|10928870|FG002|Received Study Medication|Oral Stabilization Phase||0
9818415|NCT00705783|10928868|FG000|COMPLETED|Oral Stabilization Phase||576
9818416|NCT00705783|10928869|FG001|COMPLETED|Oral Stabilization Phase||0
9818417|NCT00705783|10928870|FG002|COMPLETED|Oral Stabilization Phase||0
9818418|NCT00705783|10928868|FG000|NOT COMPLETED|Oral Stabilization Phase||134
9818419|NCT00705783|10928869|FG001|NOT COMPLETED|Oral Stabilization Phase||0
9818420|NCT00705783|10928870|FG002|NOT COMPLETED|Oral Stabilization Phase||0
9818421|NCT00705783|10928868|FG000|STARTED|Depot Stabilization Phase||576
9818422|NCT00705783|10928869|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
9818423|NCT00705783|10928870|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
9818424|NCT00705783|10928868|FG000|COMPLETED|Depot Stabilization Phase||403
9818425|NCT00705783|10928869|FG001|COMPLETED|Depot Stabilization Phase||0
9818426|NCT00705783|10928870|FG002|COMPLETED|Depot Stabilization Phase||0
9818427|NCT00705783|10928868|FG000|NOT COMPLETED|Depot Stabilization Phase||173
9818428|NCT00705783|10928869|FG001|NOT COMPLETED|Depot Stabilization Phase||0
9818429|NCT00705783|10928870|FG002|NOT COMPLETED|Depot Stabilization Phase||0
9818430|NCT00705783|10928868|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
9818431|NCT00705783|10928869|FG001|STARTED|Depot Maintenance Phase||269
9818432|NCT00705783|10928870|FG002|STARTED|Depot Maintenance Phase||134
9818433|NCT00705783|10928868|FG000|COMPLETED|Depot Maintenance Phase||0
9818434|NCT00705783|10928869|FG001|COMPLETED|Depot Maintenance Phase||23
9818435|NCT00705783|10928870|FG002|COMPLETED|Depot Maintenance Phase||3
9818436|NCT00705783|10928868|FG000|NOT COMPLETED|Depot Maintenance Phase||0
9818437|NCT00705783|10928869|FG001|NOT COMPLETED|Depot Maintenance Phase||246
9818438|NCT00705783|10928870|FG002|NOT COMPLETED|Depot Maintenance Phase||131
9818439|NCT00705874|10928886|FG000|STARTED|Overall Study||12
9818440|NCT00705874|10928887|FG001|STARTED|Overall Study||9
9818441|NCT00705874|10928888|FG002|STARTED|Overall Study||34
9818442|NCT00705874|10928889|FG003|STARTED|Overall Study||34
9818443|NCT00705874|10928890|FG004|STARTED|Overall Study||48
9818444|NCT00705874|10928891|FG005|STARTED|Overall Study||32
9818445|NCT00705874|10928892|FG006|STARTED|Overall Study||3
9818446|NCT00705874|10928886|FG000|COMPLETED|Overall Study||10
9818447|NCT00705874|10928887|FG001|COMPLETED|Overall Study||8
9818448|NCT00705874|10928888|FG002|COMPLETED|Overall Study||32
9818449|NCT00705874|10928889|FG003|COMPLETED|Overall Study||33
9818450|NCT00705874|10928890|FG004|COMPLETED|Overall Study||36
9818451|NCT00705874|10928891|FG005|COMPLETED|Overall Study||28
9818452|NCT00705874|10928892|FG006|COMPLETED|Overall Study||3
9818453|NCT00705874|10928886|FG000|NOT COMPLETED|Overall Study||2
9818454|NCT00705874|10928887|FG001|NOT COMPLETED|Overall Study||1
9818455|NCT00705874|10928888|FG002|NOT COMPLETED|Overall Study||2
9818456|NCT00705874|10928889|FG003|NOT COMPLETED|Overall Study||1
9818457|NCT00705874|10928890|FG004|NOT COMPLETED|Overall Study||12
9818458|NCT00705874|10928891|FG005|NOT COMPLETED|Overall Study||4
9818459|NCT00705874|10928892|FG006|NOT COMPLETED|Overall Study||0
9818460|NCT00705939|10928911|FG000|STARTED|Overall Study||12
9818461|NCT00705939|10928912|FG001|STARTED|Overall Study||14
9818462|NCT00705939|10928913|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
9818463|NCT00705939|10928911|FG000|COMPLETED|Overall Study||12
9818464|NCT00705939|10928912|FG001|COMPLETED|Overall Study||12
9818465|NCT00705939|10928913|FG002|COMPLETED|Overall Study||14
9818466|NCT00705939|10928911|FG000|NOT COMPLETED|Overall Study||0
9818467|NCT00705939|10928912|FG001|NOT COMPLETED|Overall Study||2
9818468|NCT00705939|10928913|FG002|NOT COMPLETED|Overall Study||4
9818469|NCT00706004|10928922|FG000|STARTED|Overall Study||9
9818470|NCT00706004|10928922|FG000|COMPLETED|Overall Study||7
9818471|NCT00706004|10928922|FG000|NOT COMPLETED|Overall Study||2
9818472|NCT00706030|10928931|FG000|STARTED|Overall Study||6
9818473|NCT00706030|10928932|FG001|STARTED|Overall Study||6
9818474|NCT00706030|10928933|FG002|STARTED|Overall Study||64
10016834|NCT01812655|11139618|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
10016835|NCT01812655|11139619|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
10016836|NCT01812655|11139620|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
10016837|NCT01812655|11139618|FG000|COMPLETED|Overall Study||8
10016838|NCT01812655|11139619|FG001|COMPLETED|Overall Study||10
10016839|NCT01812655|11139620|FG002|COMPLETED|Overall Study||10
10016840|NCT01812655|11139618|FG000|NOT COMPLETED|Overall Study||1
10016841|NCT01812655|11139619|FG001|NOT COMPLETED|Overall Study||1
10016842|NCT01812655|11139620|FG002|NOT COMPLETED|Overall Study||0
10016843|NCT01812668|11139631|FG000|STARTED|Overall Study||20
10016844|NCT01812668|11139631|FG000|COMPLETED|Overall Study||20
10016845|NCT01812668|11139631|FG000|NOT COMPLETED|Overall Study||0
10016846|NCT01812681|11139637|FG000|STARTED|Overall Study||60
10016847|NCT01812681|11139638|FG001|STARTED|Overall Study||24
10016848|NCT01812681|11139637|FG000|COMPLETED|Overall Study||57
10016849|NCT01812681|11139638|FG001|COMPLETED|Overall Study||24
10016850|NCT01812681|11139637|FG000|NOT COMPLETED|Overall Study||3
10016851|NCT01812681|11139638|FG001|NOT COMPLETED|Overall Study||0
10016852|NCT01812707|11139648|FG000|STARTED|Overall Study||25
10016853|NCT01812707|11139649|FG001|STARTED|Overall Study||25
10016854|NCT01812707|11139650|FG002|STARTED|Overall Study||25
10016855|NCT01812707|11139651|FG003|STARTED|Overall Study||25
10016856|NCT01812707|11139648|FG000|Treated|Overall Study||25
10016857|NCT01812707|11139649|FG001|Treated|Overall Study||25
10016858|NCT01812707|11139650|FG002|Treated|Overall Study||25
10016859|NCT01812707|11139651|FG003|Treated|Overall Study||25
10016860|NCT01812707|11139648|FG000|COMPLETED|Overall Study||23
10016861|NCT01812707|11139649|FG001|COMPLETED|Overall Study||25
10016862|NCT01812707|11139650|FG002|COMPLETED|Overall Study||25
10016863|NCT01812707|11139651|FG003|COMPLETED|Overall Study||23
10016864|NCT01812707|11139648|FG000|NOT COMPLETED|Overall Study||2
10016865|NCT01812707|11139649|FG001|NOT COMPLETED|Overall Study||0
10016866|NCT01812707|11139650|FG002|NOT COMPLETED|Overall Study||0
10016867|NCT01812707|11139651|FG003|NOT COMPLETED|Overall Study||2
10016868|NCT01812759|11139665|FG000|STARTED|Overall Study||1
10016869|NCT01812759|11139666|FG001|STARTED|Overall Study||1
10016870|NCT01812759|11139667|FG002|STARTED|Overall Study||1
10016871|NCT01812759|11139665|FG000|COMPLETED|Overall Study||1
10016872|NCT01812759|11139666|FG001|COMPLETED|Overall Study||1
10016873|NCT01812759|11139667|FG002|COMPLETED|Overall Study||0
10016874|NCT01812759|11139665|FG000|NOT COMPLETED|Overall Study||0
10016875|NCT01812759|11139666|FG001|NOT COMPLETED|Overall Study||0
10016876|NCT01812759|11139667|FG002|NOT COMPLETED|Overall Study||1
10016877|NCT01812837|11139678|FG000|STARTED|Overall Study||17
10016878|NCT01812837|11139679|FG001|STARTED|Overall Study||17
10016879|NCT01812837|11139680|FG002|STARTED|Overall Study||17
10016880|NCT01812837|11139678|FG000|COMPLETED|Overall Study||15
10016881|NCT01812837|11139679|FG001|COMPLETED|Overall Study||16
10016882|NCT01812837|11139680|FG002|COMPLETED|Overall Study||17
10016883|NCT01812837|11139678|FG000|NOT COMPLETED|Overall Study||2
10016884|NCT01812837|11139679|FG001|NOT COMPLETED|Overall Study||1
10016885|NCT01812837|11139680|FG002|NOT COMPLETED|Overall Study||0
10016886|NCT01813019|11139690|FG000|STARTED|Overall Study||24
10016887|NCT01813019|11139691|FG001|STARTED|Overall Study||26
10016888|NCT01813019|11139690|FG000|COMPLETED|Overall Study||17
10016889|NCT01813019|11139691|FG001|COMPLETED|Overall Study||20
10016890|NCT01813019|11139690|FG000|NOT COMPLETED|Overall Study||7
10016891|NCT01813019|11139691|FG001|NOT COMPLETED|Overall Study||6
10016892|NCT01813058|11139699|FG000|STARTED|Overall Study||60
10016893|NCT01813058|11139700|FG001|STARTED|Overall Study||60
10016894|NCT01813058|11139699|FG000|COMPLETED|Overall Study||55
10016895|NCT01813058|11139700|FG001|COMPLETED|Overall Study||56
10016896|NCT01813058|11139699|FG000|NOT COMPLETED|Overall Study||5
10016897|NCT01813058|11139700|FG001|NOT COMPLETED|Overall Study||4
10016898|NCT01813071|11139715|FG000|STARTED|Overall Study||10
10016899|NCT01813071|11139716|FG001|STARTED|Overall Study||10
10016900|NCT01813071|11139717|FG002|STARTED|Overall Study||10
10016901|NCT01813071|11139718|FG003|STARTED|Overall Study||9
10016902|NCT01813071|11139719|FG004|STARTED|Overall Study||12
10016903|NCT01813071|11139720|FG005|STARTED|Overall Study||12
10016904|NCT01813071|11139721|FG006|STARTED|Overall Study||12
10016905|NCT01813071|11139722|FG007|STARTED|Overall Study||12
10016906|NCT01813071|11139723|FG008|STARTED|Overall Study||16
10016907|NCT01813071|11139715|FG000|COMPLETED|Overall Study||10
10016908|NCT01813071|11139716|FG001|COMPLETED|Overall Study||10
9818475|NCT00706030|10928934|FG003|STARTED|Overall Study||16
9818476|NCT00706030|10928931|FG000|Treated|Overall Study||6
10016909|NCT01813071|11139717|FG002|COMPLETED|Overall Study||10
10016910|NCT01813071|11139718|FG003|COMPLETED|Overall Study||9
10016911|NCT01813071|11139719|FG004|COMPLETED|Overall Study||11
10016912|NCT01813071|11139720|FG005|COMPLETED|Overall Study||5
10016913|NCT01813071|11139721|FG006|COMPLETED|Overall Study||9
10016914|NCT01813071|11139722|FG007|COMPLETED|Overall Study||7
10016915|NCT01813071|11139723|FG008|COMPLETED|Overall Study||13
10016916|NCT01813071|11139715|FG000|NOT COMPLETED|Overall Study||0
10016917|NCT01813071|11139716|FG001|NOT COMPLETED|Overall Study||0
10016918|NCT01813071|11139717|FG002|NOT COMPLETED|Overall Study||0
10016919|NCT01813071|11139718|FG003|NOT COMPLETED|Overall Study||0
10112401|NCT02503085|11243382|FG003|COMPLETED|Period 4||7
10112402|NCT02503085|11243379|FG000|NOT COMPLETED|Period 4||0
10112403|NCT02503085|11243380|FG001|NOT COMPLETED|Period 4||0
10112404|NCT02503085|11243381|FG002|NOT COMPLETED|Period 4||0
9818477|NCT00706030|10928932|FG001|Treated|Overall Study||6
9818478|NCT00706030|10928933|FG002|Treated|Overall Study||64
9818479|NCT00706030|10928934|FG003|Treated|Overall Study||15
9818480|NCT00706030|10928931|FG000|COMPLETED|Overall Study||0
9818481|NCT00706030|10928932|FG001|COMPLETED|Overall Study||0
9818482|NCT00706030|10928933|FG002|COMPLETED|Overall Study||4
9818483|NCT00706030|10928934|FG003|COMPLETED|Overall Study||0
9818484|NCT00706030|10928931|FG000|NOT COMPLETED|Overall Study||6
9818485|NCT00706030|10928932|FG001|NOT COMPLETED|Overall Study||6
9818486|NCT00706030|10928933|FG002|NOT COMPLETED|Overall Study||60
9818487|NCT00706030|10928934|FG003|NOT COMPLETED|Overall Study||16
9818488|NCT00706095|10928948|FG000|STARTED|Overall Study||6
9818489|NCT00706095|10928949|FG001|STARTED|Overall Study||7
9818490|NCT00706095|10928950|FG002|STARTED|Overall Study||5
9818491|NCT00706095|10928948|FG000|COMPLETED|Overall Study||0
9818492|NCT00706095|10928949|FG001|COMPLETED|Overall Study||0
9818493|NCT00706095|10928950|FG002|COMPLETED|Overall Study||0
9818494|NCT00706095|10928948|FG000|NOT COMPLETED|Overall Study||6
9818495|NCT00706095|10928949|FG001|NOT COMPLETED|Overall Study||7
9818496|NCT00706095|10928950|FG002|NOT COMPLETED|Overall Study||5
9818497|NCT00706121|10928962|FG000|STARTED|Overall Study||2039
9818498|NCT00706121|10928963|FG001|STARTED|Overall Study||2096
9818499|NCT00706121|10928964|FG002|STARTED|Overall Study||2030
9818500|NCT00706121|10928965|FG003|STARTED|Overall Study||1929
9818501|NCT00706121|10928962|FG000|COMPLETED|Overall Study||1643
9818502|NCT00706121|10928963|FG001|COMPLETED|Overall Study||1700
9818503|NCT00706121|10928964|FG002|COMPLETED|Overall Study||1626
9818504|NCT00706121|10928965|FG003|COMPLETED|Overall Study||1577
9818505|NCT00706121|10928962|FG000|NOT COMPLETED|Overall Study||396
9818506|NCT00706121|10928963|FG001|NOT COMPLETED|Overall Study||396
9818507|NCT00706121|10928964|FG002|NOT COMPLETED|Overall Study||404
9818508|NCT00706121|10928965|FG003|NOT COMPLETED|Overall Study||352
9818509|NCT00706134|10928987|FG000|STARTED|Overall Study||189
9818510|NCT00706134|10928988|FG001|STARTED|Overall Study||192
9818511|NCT00706134|10928989|FG002|STARTED|Overall Study||189
9818512|NCT00706134|10928990|FG003|STARTED|Overall Study||186
9818513|NCT00706134|10928987|FG000|Entered Double-blind Period|Overall Study||187
9818514|NCT00706134|10928988|FG001|Entered Double-blind Period|Overall Study||192
9818515|NCT00706134|10928989|FG002|Entered Double-blind Period|Overall Study||189
9818516|NCT00706134|10928990|FG003|Entered Double-blind Period|Overall Study||186
9818517|NCT00706134|10928987|FG000|COMPLETED|Overall Study||169
9818518|NCT00706134|10928988|FG001|COMPLETED|Overall Study||173
9818519|NCT00706134|10928989|FG002|COMPLETED|Overall Study||183
9818520|NCT00706134|10928990|FG003|COMPLETED|Overall Study||175
9818521|NCT00706134|10928987|FG000|NOT COMPLETED|Overall Study||20
9818522|NCT00706134|10928988|FG001|NOT COMPLETED|Overall Study||19
9818523|NCT00706134|10928989|FG002|NOT COMPLETED|Overall Study||6
9818524|NCT00706134|10928990|FG003|NOT COMPLETED|Overall Study||11
9818525|NCT00706238|10929000|FG000|STARTED|Overall Study||5
9818526|NCT00706238|10929000|FG000|COMPLETED|Overall Study||0
9818527|NCT00706238|10929000|FG000|NOT COMPLETED|Overall Study||5
9818528|NCT00706264|10929006|FG000|STARTED|Overall Study||193
9818529|NCT00706264|10929007|FG001|STARTED|Overall Study||192
9818530|NCT00706264|10929006|FG000|COMPLETED|Overall Study||190
9818531|NCT00706264|10929007|FG001|COMPLETED|Overall Study||190
10112405|NCT02503085|11243382|FG003|NOT COMPLETED|Period 4||0
10112406|NCT02503202|11243394|FG000|STARTED|Base Study: Up to Month 6||266
10112407|NCT02503202|11243395|FG001|STARTED|Base Study: Up to Month 6||265
10112408|NCT02503202|11243396|FG002|STARTED|Base Study: Up to Month 6||267
10112409|NCT02503202|11243397|FG003|STARTED|Base Study: Up to Month 6||266
10112410|NCT02503202|11243398|FG004|STARTED|Base Study: Up to Month 6||133
10112411|NCT02503202|11243394|FG000|Vaccinated|Base Study: Up to Month 6||266
10112412|NCT02503202|11243395|FG001|Vaccinated|Base Study: Up to Month 6||265
10112413|NCT02503202|11243396|FG002|Vaccinated|Base Study: Up to Month 6||266
10112414|NCT02503202|11243397|FG003|Vaccinated|Base Study: Up to Month 6||264
10112415|NCT02503202|11243398|FG004|Vaccinated|Base Study: Up to Month 6||133
10016920|NCT01813071|11139719|FG004|NOT COMPLETED|Overall Study||1
10016921|NCT01813071|11139720|FG005|NOT COMPLETED|Overall Study||7
9818532|NCT00706264|10929006|FG000|NOT COMPLETED|Overall Study||3
9818533|NCT00706264|10929007|FG001|NOT COMPLETED|Overall Study||2
9818534|NCT00706342|10929015|FG000|STARTED|Overall Study||18
10016922|NCT01813071|11139721|FG006|NOT COMPLETED|Overall Study||3
10016923|NCT01813071|11139722|FG007|NOT COMPLETED|Overall Study||5
10016924|NCT01813071|11139723|FG008|NOT COMPLETED|Overall Study||3
10016925|NCT01813110|11139757|FG000|STARTED|Overall Study||10
10112416|NCT02503202|11243394|FG000|COMPLETED|Base Study: Up to Month 6||248
9818535|NCT00706342|10929015|FG000|COMPLETED|Overall Study||0
9818536|NCT00706342|10929015|FG000|NOT COMPLETED|Overall Study||18
9818537|NCT00706355|10929023|FG000|STARTED|Period 1: PF-04217903 50 mg||3
9818538|NCT00706355|10929024|FG001|STARTED|Period 1: PF-04217903 50 mg||0
9818539|NCT00706355|10929025|FG002|STARTED|Period 1: PF-04217903 50 mg||0
10236776|NCT00836355|11367510|FG002|STARTED|Overall Study||0
10236777|NCT00836355|11367511|FG003|STARTED|Overall Study||2
10236778|NCT00836355|11367508|FG000|COMPLETED|Overall Study||0
10236779|NCT00836355|11367509|FG001|COMPLETED|Overall Study||4
10236780|NCT00836355|11367510|FG002|COMPLETED|Overall Study||0
10236781|NCT00836355|11367511|FG003|COMPLETED|Overall Study||2
10236782|NCT00836355|11367508|FG000|NOT COMPLETED|Overall Study||0
10236783|NCT00836355|11367509|FG001|NOT COMPLETED|Overall Study||0
9818540|NCT00706355|10929026|FG003|STARTED|Period 1: PF-04217903 50 mg||0
9818541|NCT00706355|10929023|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0
10016926|NCT01813110|11139758|FG001|STARTED|Overall Study||11
10016927|NCT01813110|11139757|FG000|COMPLETED|Overall Study||10
10016928|NCT01813110|11139758|FG001|COMPLETED|Overall Study||10
10016929|NCT01813110|11139757|FG000|NOT COMPLETED|Overall Study||0
10016930|NCT01813110|11139758|FG001|NOT COMPLETED|Overall Study||1
10016931|NCT01813149|11139767|FG000|STARTED|Overall Study||90
10016932|NCT01813149|11139768|FG001|STARTED|Overall Study||38
9818542|NCT00706355|10929024|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0
9818543|NCT00706355|10929025|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0
9818544|NCT00706355|10929026|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0
9818545|NCT00706355|10929023|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
9818546|NCT00706355|10929024|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
9818547|NCT00706355|10929025|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
9818548|NCT00706355|10929026|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
9818549|NCT00706355|10929023|FG000|STARTED|Period 2: PF-04217903 100 mg||0
9818550|NCT00706355|10929024|FG001|STARTED|Period 2: PF-04217903 100 mg||7
9818551|NCT00706355|10929025|FG002|STARTED|Period 2: PF-04217903 100 mg||0
9818552|NCT00706355|10929026|FG003|STARTED|Period 2: PF-04217903 100 mg||0
9818553|NCT00706355|10929023|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0
9818554|NCT00706355|10929024|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0
9818555|NCT00706355|10929025|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0
9818556|NCT00706355|10929026|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0
9818557|NCT00706355|10929023|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
9818558|NCT00706355|10929024|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
9818559|NCT00706355|10929025|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
9818560|NCT00706355|10929026|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
9818561|NCT00706355|10929023|FG000|STARTED|Period 3: PF-04217903 200 mg||0
9818562|NCT00706355|10929024|FG001|STARTED|Period 3: PF-04217903 200 mg||0
9818563|NCT00706355|10929025|FG002|STARTED|Period 3: PF-04217903 200 mg||2
9818564|NCT00706355|10929026|FG003|STARTED|Period 3: PF-04217903 200 mg||0
9818565|NCT00706355|10929023|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0
9818566|NCT00706355|10929024|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0
9818567|NCT00706355|10929025|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0
9818568|NCT00706355|10929026|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0
9818569|NCT00706355|10929023|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
9818570|NCT00706355|10929024|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
9818571|NCT00706355|10929025|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
9818572|NCT00706355|10929026|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
9818573|NCT00706355|10929023|FG000|STARTED|Period 4: PF-04217903 150 mg||0
9818574|NCT00706355|10929024|FG001|STARTED|Period 4: PF-04217903 150 mg||0
9818575|NCT00706355|10929025|FG002|STARTED|Period 4: PF-04217903 150 mg||0
9818576|NCT00706355|10929026|FG003|STARTED|Period 4: PF-04217903 150 mg||4
9818577|NCT00706355|10929023|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0
9818578|NCT00706355|10929024|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0
9818579|NCT00706355|10929025|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0
9818580|NCT00706355|10929026|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0
9818581|NCT00706355|10929023|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
9818582|NCT00706355|10929024|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
9818583|NCT00706355|10929025|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
9818584|NCT00706355|10929026|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
9818585|NCT00706381|10929042|FG000|STARTED|Overall Study||10
9818586|NCT00706381|10929043|FG001|STARTED|Overall Study||6
9818587|NCT00706381|10929044|FG002|STARTED|Overall Study||6
9818588|NCT00706381|10929045|FG003|STARTED|Overall Study||9
9818589|NCT00706381|10929042|FG000|Intervention 1 (1 Day)|Overall Study||10
9818590|NCT00706381|10929043|FG001|Intervention 1 (1 Day)|Overall Study||6
9818591|NCT00706381|10929044|FG002|Intervention 1 (1 Day)|Overall Study||6
9818592|NCT00706381|10929045|FG003|Intervention 1 (1 Day)|Overall Study||9
9818593|NCT00706381|10929042|FG000|Intervention 2 (1 Day)|Overall Study||10
9818594|NCT00706381|10929043|FG001|Intervention 2 (1 Day)|Overall Study||6
9818595|NCT00706381|10929044|FG002|Intervention 2 (1 Day)|Overall Study||6
9818596|NCT00706381|10929045|FG003|Intervention 2 (1 Day)|Overall Study||9
10236784|NCT00836355|11367510|FG002|NOT COMPLETED|Overall Study||0
10236785|NCT00836355|11367511|FG003|NOT COMPLETED|Overall Study||0
9818597|NCT00706381|10929042|FG000|Intervention 3 (1 Day)|Overall Study||10
9818598|NCT00706381|10929043|FG001|Intervention 3 (1 Day)|Overall Study||6
9818599|NCT00706381|10929044|FG002|Intervention 3 (1 Day)|Overall Study||6
9818600|NCT00706381|10929045|FG003|Intervention 3 (1 Day)|Overall Study||9
9818601|NCT00706381|10929042|FG000|Intervention 4 (1 Day)|Overall Study||10
9818602|NCT00706381|10929043|FG001|Intervention 4 (1 Day)|Overall Study||5
9818603|NCT00706381|10929044|FG002|Intervention 4 (1 Day)|Overall Study||6
10016933|NCT01813149|11139767|FG000|COMPLETED|Overall Study||90
10016934|NCT01813149|11139768|FG001|COMPLETED|Overall Study||38
9818604|NCT00706381|10929045|FG003|Intervention 4 (1 Day)|Overall Study||9
9818605|NCT00706381|10929042|FG000|Intervention 5 (1 Day)|Overall Study||10
9818606|NCT00706381|10929043|FG001|Intervention 5 (1 Day)|Overall Study||5
9818607|NCT00706381|10929044|FG002|Intervention 5 (1 Day)|Overall Study||5
9818608|NCT00706381|10929045|FG003|Intervention 5 (1 Day)|Overall Study||9
9818609|NCT00706381|10929042|FG000|COMPLETED|Overall Study||10
9818610|NCT00706381|10929043|FG001|COMPLETED|Overall Study||5
9818611|NCT00706381|10929044|FG002|COMPLETED|Overall Study||5
9818612|NCT00706381|10929045|FG003|COMPLETED|Overall Study||9
9818613|NCT00706381|10929042|FG000|NOT COMPLETED|Overall Study||0
9818614|NCT00706381|10929043|FG001|NOT COMPLETED|Overall Study||1
9818615|NCT00706381|10929044|FG002|NOT COMPLETED|Overall Study||1
9818616|NCT00706381|10929045|FG003|NOT COMPLETED|Overall Study||0
9818617|NCT00706394|10929058|FG000|STARTED|Overall Study||19
9818618|NCT00706394|10929058|FG000|COMPLETED|Overall Study||8
9818619|NCT00706394|10929058|FG000|NOT COMPLETED|Overall Study||11
9818620|NCT00706407|10929064|FG000|STARTED|Overall Study||42
9818621|NCT00706407|10929064|FG000|COMPLETED|Overall Study||33
9818622|NCT00706407|10929064|FG000|NOT COMPLETED|Overall Study||9
9818623|NCT00706433|10929075|FG000|STARTED|Overall Study||68
9818624|NCT00706433|10929076|FG001|STARTED|Overall Study||65
9818625|NCT00706433|10929077|FG002|STARTED|Overall Study||67
9818626|NCT00706433|10929078|FG003|STARTED|Overall Study||66
9818627|NCT00706433|10929075|FG000|COMPLETED|Overall Study||63
9818628|NCT00706433|10929076|FG001|COMPLETED|Overall Study||62
9818629|NCT00706433|10929077|FG002|COMPLETED|Overall Study||57
9818630|NCT00706433|10929078|FG003|COMPLETED|Overall Study||64
9818631|NCT00706433|10929075|FG000|NOT COMPLETED|Overall Study||5
9818632|NCT00706433|10929076|FG001|NOT COMPLETED|Overall Study||3
9818633|NCT00706433|10929077|FG002|NOT COMPLETED|Overall Study||10
9818634|NCT00706433|10929078|FG003|NOT COMPLETED|Overall Study||2
9818635|NCT00706446|10929094|FG000|STARTED|Overall Study||29
10016935|NCT01813149|11139767|FG000|NOT COMPLETED|Overall Study||0
10016936|NCT01813149|11139768|FG001|NOT COMPLETED|Overall Study||0
10016937|NCT01813214|11139781|FG000|STARTED|Overall Study||3
10016938|NCT01813214|11139782|FG001|STARTED|Overall Study||2
10016939|NCT01813214|11139781|FG000|COMPLETED|Overall Study||3
10112417|NCT02503202|11243395|FG001|COMPLETED|Base Study: Up to Month 6||253
10112418|NCT02503202|11243396|FG002|COMPLETED|Base Study: Up to Month 6||252
10112419|NCT02503202|11243397|FG003|COMPLETED|Base Study: Up to Month 6||255
10016940|NCT01813214|11139782|FG001|COMPLETED|Overall Study||2
10016941|NCT01813214|11139781|FG000|NOT COMPLETED|Overall Study||0
10016942|NCT01813214|11139782|FG001|NOT COMPLETED|Overall Study||0
10016943|NCT01813357|11139790|FG000|STARTED|Overall Study||40
10016944|NCT01813357|11139791|FG001|STARTED|Overall Study||44
10016945|NCT01813357|11139790|FG000|COMPLETED|Overall Study||35
10016946|NCT01813357|11139791|FG001|COMPLETED|Overall Study||38
10016947|NCT01813357|11139790|FG000|NOT COMPLETED|Overall Study||5
10016948|NCT01813357|11139791|FG001|NOT COMPLETED|Overall Study||6
10016949|NCT01813422|11139799|FG000|STARTED|Overall Study||486
10112420|NCT02503202|11243398|FG004|COMPLETED|Base Study: Up to Month 6||130
10112421|NCT02503202|11243394|FG000|NOT COMPLETED|Base Study: Up to Month 6||18
10112422|NCT02503202|11243395|FG001|NOT COMPLETED|Base Study: Up to Month 6||12
10112423|NCT02503202|11243396|FG002|NOT COMPLETED|Base Study: Up to Month 6||15
10112424|NCT02503202|11243397|FG003|NOT COMPLETED|Base Study: Up to Month 6||11
10112425|NCT02503202|11243398|FG004|NOT COMPLETED|Base Study: Up to Month 6||3
10112426|NCT02503202|11243394|FG000|STARTED|Extension: Month 6 to 24||119
10112427|NCT02503202|11243395|FG001|STARTED|Extension: Month 6 to 24||130
10112428|NCT02503202|11243396|FG002|STARTED|Extension: Month 6 to 24||112
10112429|NCT02503202|11243397|FG003|STARTED|Extension: Month 6 to 24||137
9818636|NCT00706446|10929095|FG001|STARTED|Overall Study||57
9818637|NCT00706446|10929096|FG002|STARTED|Overall Study||44
9818638|NCT00706446|10929097|FG003|STARTED|Overall Study||26
9818639|NCT00706446|10929098|FG004|STARTED|Overall Study||54
9818640|NCT00706446|10929099|FG005|STARTED|Overall Study||45
9818641|NCT00706446|10929094|FG000|COMPLETED|Overall Study||3
9818642|NCT00706446|10929095|FG001|COMPLETED|Overall Study||8
9818643|NCT00706446|10929096|FG002|COMPLETED|Overall Study||7
9818644|NCT00706446|10929097|FG003|COMPLETED|Overall Study||4
9818645|NCT00706446|10929098|FG004|COMPLETED|Overall Study||10
9818646|NCT00706446|10929099|FG005|COMPLETED|Overall Study||7
9818647|NCT00706446|10929094|FG000|NOT COMPLETED|Overall Study||26
9818648|NCT00706446|10929095|FG001|NOT COMPLETED|Overall Study||49
9818649|NCT00706446|10929096|FG002|NOT COMPLETED|Overall Study||37
9818650|NCT00706446|10929097|FG003|NOT COMPLETED|Overall Study||22
9818651|NCT00706446|10929098|FG004|NOT COMPLETED|Overall Study||44
9818652|NCT00706446|10929099|FG005|NOT COMPLETED|Overall Study||38
9818653|NCT00706485|10929113|FG000|STARTED|Overall Study||5
9818654|NCT00706485|10929113|FG000|COMPLETED|Overall Study||5
9818655|NCT00706485|10929113|FG000|NOT COMPLETED|Overall Study||0
9818656|NCT00706511|10929121|FG000|STARTED|Overall Study||10
9818657|NCT00706511|10929122|FG001|STARTED|Overall Study||4
9818658|NCT00706511|10929123|FG002|STARTED|Overall Study||3
9818659|NCT00706511|10929124|FG003|STARTED|Overall Study||10
9818660|NCT00706511|10929121|FG000|COMPLETED|Overall Study||9
9818661|NCT00706511|10929122|FG001|COMPLETED|Overall Study||4
10016950|NCT01813422|11139800|FG001|STARTED|Overall Study||484
10016951|NCT01813422|11139799|FG000|Received Treatment|Overall Study||484
10016952|NCT01813422|11139800|FG001|Received Treatment|Overall Study||484
10016953|NCT01813422|11139799|FG000|COMPLETED|Overall Study||466
10016954|NCT01813422|11139800|FG001|COMPLETED|Overall Study||468
9818662|NCT00706511|10929123|FG002|COMPLETED|Overall Study||3
9818663|NCT00706511|10929124|FG003|COMPLETED|Overall Study||10
9818664|NCT00706511|10929121|FG000|NOT COMPLETED|Overall Study||1
9818665|NCT00706511|10929122|FG001|NOT COMPLETED|Overall Study||0
9818666|NCT00706511|10929123|FG002|NOT COMPLETED|Overall Study||0
9818667|NCT00706511|10929124|FG003|NOT COMPLETED|Overall Study||0
9818668|NCT00706550|10929134|FG000|STARTED|Overall Study||43
9818669|NCT00706550|10929135|FG001|STARTED|Overall Study||64
9818670|NCT00706550|10929134|FG000|COMPLETED|Overall Study||36
9818671|NCT00706550|10929135|FG001|COMPLETED|Overall Study||36
9818672|NCT00706550|10929134|FG000|NOT COMPLETED|Overall Study||7
9818673|NCT00706550|10929135|FG001|NOT COMPLETED|Overall Study||28
9818674|NCT00706563|10929144|FG000|STARTED|Overall Study||61
9818675|NCT00706563|10929145|FG001|STARTED|Overall Study||59
9818676|NCT00706563|10929144|FG000|COMPLETED|Overall Study||61
9818677|NCT00706563|10929145|FG001|COMPLETED|Overall Study||59
9818678|NCT00706563|10929144|FG000|NOT COMPLETED|Overall Study||0
9818679|NCT00706563|10929145|FG001|NOT COMPLETED|Overall Study||0
9818680|NCT00706589|10929153|FG000|STARTED|Overall Study||32
9818681|NCT00706589|10929154|FG001|STARTED|Overall Study||29
9818682|NCT00706589|10929153|FG000|COMPLETED|Overall Study||29
9818683|NCT00706589|10929154|FG001|COMPLETED|Overall Study||25
9818684|NCT00706589|10929153|FG000|NOT COMPLETED|Overall Study||3
9818685|NCT00706589|10929154|FG001|NOT COMPLETED|Overall Study||4
9818686|NCT00706628|10929164|FG000|STARTED|Overall Study||47
9818687|NCT00706628|10929165|FG001|STARTED|Overall Study||21
9818688|NCT00706628|10929166|FG002|STARTED|Overall Study||16
9818689|NCT00706628|10929167|FG003|STARTED|Overall Study||3
9818690|NCT00706628|10929164|FG000|COMPLETED|Overall Study||0
9818691|NCT00706628|10929165|FG001|COMPLETED|Overall Study||0
9818692|NCT00706628|10929166|FG002|COMPLETED|Overall Study||0
9818693|NCT00706628|10929167|FG003|COMPLETED|Overall Study||0
9818694|NCT00706628|10929164|FG000|NOT COMPLETED|Overall Study||47
9818695|NCT00706628|10929165|FG001|NOT COMPLETED|Overall Study||21
9818696|NCT00706628|10929166|FG002|NOT COMPLETED|Overall Study||16
9818697|NCT00706628|10929167|FG003|NOT COMPLETED|Overall Study||3
9818698|NCT00706641|10929180|FG000|STARTED|Dasatinib Administration||25
9818699|NCT00706641|10929180|FG000|Toxicity Evaluation|Dasatinib Administration||24
9818700|NCT00706641|10929180|FG000|COMPLETED|Dasatinib Administration||23
9818701|NCT00706641|10929180|FG000|NOT COMPLETED|Dasatinib Administration||2
9818702|NCT00706641|10929180|FG000|STARTED|Radical Cystectomy||23
9818703|NCT00706641|10929180|FG000|COMPLETED|Radical Cystectomy||22
9818704|NCT00706641|10929180|FG000|NOT COMPLETED|Radical Cystectomy||1
9818705|NCT00706654|10929187|FG000|STARTED|Conversion Phase||709
9818706|NCT00706654|10929188|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
9818707|NCT00706654|10929189|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
9818708|NCT00706654|10929190|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
9818709|NCT00706654|10929187|FG000|COMPLETED|Conversion Phase||614
9818710|NCT00706654|10929188|FG001|COMPLETED|Conversion Phase||0
9818711|NCT00706654|10929189|FG002|COMPLETED|Conversion Phase||0
9818712|NCT00706654|10929190|FG003|COMPLETED|Conversion Phase||0
9818713|NCT00706654|10929187|FG000|NOT COMPLETED|Conversion Phase||95
9818714|NCT00706654|10929188|FG001|NOT COMPLETED|Conversion Phase||0
9818715|NCT00706654|10929189|FG002|NOT COMPLETED|Conversion Phase||0
9818716|NCT00706654|10929190|FG003|NOT COMPLETED|Conversion Phase||0
9818717|NCT00706654|10929187|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
9818718|NCT00706654|10929188|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
9818719|NCT00706654|10929189|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
9818720|NCT00706654|10929190|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
9818721|NCT00706654|10929187|FG000|COMPLETED|Oral Stabilization Phase||662
9818722|NCT00706654|10929188|FG001|COMPLETED|Oral Stabilization Phase||0
10236786|NCT00832598|11367521|FG000|STARTED|Overall Study||13
10236787|NCT00832598|11367521|FG000|COMPLETED|Overall Study||13
10236788|NCT00832598|11367521|FG000|NOT COMPLETED|Overall Study||0
10236789|NCT00816777|11367527|FG000|STARTED|Overall Study||2
9818723|NCT00706654|10929189|FG002|COMPLETED|Oral Stabilization Phase||0
9818724|NCT00706654|10929190|FG003|COMPLETED|Oral Stabilization Phase||0
9818725|NCT00706654|10929187|FG000|NOT COMPLETED|Oral Stabilization Phase||180
9818726|NCT00706654|10929188|FG001|NOT COMPLETED|Oral Stabilization Phase||0
9818727|NCT00706654|10929189|FG002|NOT COMPLETED|Oral Stabilization Phase||0
9818728|NCT00706654|10929190|FG003|NOT COMPLETED|Oral Stabilization Phase||0
9818729|NCT00706654|10929187|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
9818730|NCT00706654|10929188|FG001|STARTED|Depot Maintenance Phase||265
9818731|NCT00706654|10929189|FG002|STARTED|Depot Maintenance Phase||266
9818732|NCT00706654|10929190|FG003|STARTED|Depot Maintenance Phase||131
9818733|NCT00706654|10929187|FG000|COMPLETED|Depot Maintenance Phase||0
9818734|NCT00706654|10929188|FG001|COMPLETED|Depot Maintenance Phase||196
9818735|NCT00706654|10929189|FG002|COMPLETED|Depot Maintenance Phase||178
9818736|NCT00706654|10929190|FG003|COMPLETED|Depot Maintenance Phase||61
9818737|NCT00706654|10929187|FG000|NOT COMPLETED|Depot Maintenance Phase||0
9818738|NCT00706654|10929188|FG001|NOT COMPLETED|Depot Maintenance Phase||69
10236790|NCT00816777|11367528|FG001|STARTED|Overall Study||2
9818739|NCT00706654|10929189|FG002|NOT COMPLETED|Depot Maintenance Phase||88
9818740|NCT00706654|10929190|FG003|NOT COMPLETED|Depot Maintenance Phase||70
9818741|NCT00706706|10929200|FG000|STARTED|Overall Study||105
9818742|NCT00706706|10929200|FG000|COMPLETED|Overall Study||0
9818743|NCT00706706|10929200|FG000|NOT COMPLETED|Overall Study||105
9818744|NCT00706719|10929207|FG000|STARTED|Overall Study||5
9818745|NCT00706719|10929208|FG001|STARTED|Overall Study||7
9818746|NCT00706719|10929209|FG002|STARTED|Overall Study||5
9818747|NCT00706719|10929207|FG000|COMPLETED|Overall Study||5
9818748|NCT00706719|10929208|FG001|COMPLETED|Overall Study||6
9818749|NCT00706719|10929209|FG002|COMPLETED|Overall Study||1
9818750|NCT00706719|10929207|FG000|NOT COMPLETED|Overall Study||0
9818751|NCT00706719|10929208|FG001|NOT COMPLETED|Overall Study||1
9818752|NCT00706719|10929209|FG002|NOT COMPLETED|Overall Study||4
9818753|NCT00706784|10929218|FG000|STARTED|Overall Study||3
9818754|NCT00706784|10929219|FG001|STARTED|Overall Study||3
9818755|NCT00706784|10929218|FG000|COMPLETED|Overall Study||3
9818756|NCT00706784|10929219|FG001|COMPLETED|Overall Study||3
9818757|NCT00706784|10929218|FG000|NOT COMPLETED|Overall Study||0
9818758|NCT00706784|10929219|FG001|NOT COMPLETED|Overall Study||0
9818759|NCT00706810|10929225|FG000|STARTED|Overall Study||8
9818760|NCT00706810|10929225|FG000|COMPLETED|Overall Study||7
9818761|NCT00706810|10929225|FG000|NOT COMPLETED|Overall Study||1
9818762|NCT00706823|10929232|FG000|STARTED|Overall Study||25
9818763|NCT00706823|10929233|FG001|STARTED|Overall Study||25
9818764|NCT00706823|10929232|FG000|COMPLETED|Overall Study||25
9818765|NCT00706823|10929233|FG001|COMPLETED|Overall Study||25
9818766|NCT00706823|10929232|FG000|NOT COMPLETED|Overall Study||0
9818767|NCT00706823|10929233|FG001|NOT COMPLETED|Overall Study||0
9818768|NCT00706836|10929239|FG000|STARTED|Overall Study||16
9818769|NCT00706836|10929239|FG000|COMPLETED|Overall Study||16
9818770|NCT00706836|10929239|FG000|NOT COMPLETED|Overall Study||0
9818771|NCT00706849|10929249|FG000|STARTED|Treatment Period||41
9818772|NCT00706849|10929250|FG001|STARTED|Treatment Period||83
9818773|NCT00706849|10929249|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
9818774|NCT00706849|10929250|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
9818775|NCT00706849|10929249|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
9818776|NCT00706849|10929250|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
9818777|NCT00706849|10929249|FG000|NOT COMPLETED|Treatment Period||0
9818778|NCT00706849|10929250|FG001|NOT COMPLETED|Treatment Period||10
9818779|NCT00706849|10929249|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
9818780|NCT00706849|10929250|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
9818781|NCT00706849|10929249|FG000|COMPLETED|Follow-up Period||3
9818782|NCT00706849|10929250|FG001|COMPLETED|Follow-up Period||25
10016955|NCT01813422|11139799|FG000|NOT COMPLETED|Overall Study||20
10016956|NCT01813422|11139800|FG001|NOT COMPLETED|Overall Study||16
10016957|NCT01813474|11139809|FG000|STARTED|Overall Study||4
9818783|NCT00706849|10929249|FG000|NOT COMPLETED|Follow-up Period||0
9818784|NCT00706849|10929250|FG001|NOT COMPLETED|Follow-up Period||3
9818785|NCT00706901|10929259|FG000|STARTED|Overall Study||59
9818786|NCT00706901|10929260|FG001|STARTED|Overall Study||62
9818787|NCT00706901|10929261|FG002|STARTED|Overall Study||59
9818788|NCT00706901|10929259|FG000|COMPLETED|Overall Study||51
9818789|NCT00706901|10929260|FG001|COMPLETED|Overall Study||57
9818790|NCT00706901|10929261|FG002|COMPLETED|Overall Study||51
9818791|NCT00706901|10929259|FG000|NOT COMPLETED|Overall Study||8
9818792|NCT00706901|10929260|FG001|NOT COMPLETED|Overall Study||5
9818793|NCT00706901|10929261|FG002|NOT COMPLETED|Overall Study||8
9818794|NCT00706914|10929273|FG000|STARTED|Overall Study||63
9818795|NCT00706914|10929274|FG001|STARTED|Overall Study||62
9818796|NCT00706914|10929275|FG002|STARTED|Overall Study||31
9818797|NCT00706914|10929273|FG000|COMPLETED|Overall Study||57
9818798|NCT00706914|10929274|FG001|COMPLETED|Overall Study||58
9818799|NCT00706914|10929275|FG002|COMPLETED|Overall Study||30
9818800|NCT00706914|10929273|FG000|NOT COMPLETED|Overall Study||6
9818801|NCT00706914|10929274|FG001|NOT COMPLETED|Overall Study||4
9818802|NCT00706914|10929275|FG002|NOT COMPLETED|Overall Study||1
9818803|NCT00706966|10929283|FG000|STARTED|Overall Study||10
9818804|NCT00706966|10929283|FG000|COMPLETED|Overall Study||9
9818805|NCT00706966|10929283|FG000|NOT COMPLETED|Overall Study||1
9818806|NCT00706979|10929317|FG000|STARTED|Overall Study||426
9818807|NCT00706979|10929318|FG001|STARTED|Overall Study||423
9818808|NCT00706979|10929317|FG000|COMPLETED|Overall Study||426
9818809|NCT00706979|10929318|FG001|COMPLETED|Overall Study||423
9818810|NCT00706979|10929317|FG000|NOT COMPLETED|Overall Study||0
9818811|NCT00706979|10929318|FG001|NOT COMPLETED|Overall Study||0
9818812|NCT00706992|10929331|FG000|STARTED|Overall Study||8
9818813|NCT00706992|10929332|FG001|STARTED|Overall Study||8
9818814|NCT00706992|10929333|FG002|STARTED|Overall Study||9
9818815|NCT00706992|10929334|FG003|STARTED|Overall Study||8
9818816|NCT00706992|10929335|FG004|STARTED|Overall Study||6
9818817|NCT00706992|10929336|FG005|STARTED|Overall Study||5
9818818|NCT00706992|10929337|FG006|STARTED|Overall Study||6
9818819|NCT00706992|10929331|FG000|COMPLETED|Overall Study||3
9818820|NCT00706992|10929332|FG001|COMPLETED|Overall Study||3
10016958|NCT01813474|11139810|FG001|STARTED|Overall Study||7
10016959|NCT01813474|11139811|FG002|STARTED|Overall Study||12
9818821|NCT00706992|10929333|FG002|COMPLETED|Overall Study||3
9818822|NCT00706992|10929334|FG003|COMPLETED|Overall Study||6
9818823|NCT00706992|10929335|FG004|COMPLETED|Overall Study||2
9818824|NCT00706992|10929336|FG005|COMPLETED|Overall Study||3
9818825|NCT00706992|10929337|FG006|COMPLETED|Overall Study||3
9818826|NCT00706992|10929331|FG000|NOT COMPLETED|Overall Study||5
9818827|NCT00706992|10929332|FG001|NOT COMPLETED|Overall Study||5
9818828|NCT00706992|10929333|FG002|NOT COMPLETED|Overall Study||6
9818829|NCT00706992|10929334|FG003|NOT COMPLETED|Overall Study||2
9818830|NCT00706992|10929335|FG004|NOT COMPLETED|Overall Study||4
9818831|NCT00706992|10929336|FG005|NOT COMPLETED|Overall Study||2
9818832|NCT00706992|10929337|FG006|NOT COMPLETED|Overall Study||3
9818833|NCT00707031|10929356|FG000|STARTED|Overall Study|Randomized|320
9818834|NCT00707031|10929357|FG001|STARTED|Overall Study||319
9818835|NCT00707031|10929356|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
9818836|NCT00707031|10929357|FG001|Treated/Safety Population|Overall Study||316
9818837|NCT00707031|10929356|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
9818838|NCT00707031|10929357|FG001|Modified Intent-to-Treat Population|Overall Study||315
9818839|NCT00707031|10929356|FG000|COMPLETED|Overall Study||216
9818840|NCT00707031|10929357|FG001|COMPLETED|Overall Study||220
9818841|NCT00707031|10929356|FG000|NOT COMPLETED|Overall Study||104
9818842|NCT00707031|10929357|FG001|NOT COMPLETED|Overall Study||99
9818843|NCT00707057|10929366|FG000|STARTED|Overall Study||169
9818844|NCT00707057|10929367|FG001|STARTED|Overall Study||87
9818845|NCT00707057|10929366|FG000|COMPLETED|Overall Study||161
9818846|NCT00707057|10929367|FG001|COMPLETED|Overall Study||83
9818847|NCT00707057|10929366|FG000|NOT COMPLETED|Overall Study||8
9818848|NCT00707057|10929367|FG001|NOT COMPLETED|Overall Study||4
9818849|NCT00707174|10929375|FG000|STARTED|Overall Study||46
9818850|NCT00707174|10929376|FG001|STARTED|Overall Study||44
9818851|NCT00707174|10929375|FG000|COMPLETED|Overall Study||41
9818852|NCT00707174|10929376|FG001|COMPLETED|Overall Study||37
9818853|NCT00707174|10929375|FG000|NOT COMPLETED|Overall Study||5
9818854|NCT00707174|10929376|FG001|NOT COMPLETED|Overall Study||7
9818855|NCT00707239|10929385|FG000|STARTED|Overall Study||37
9818856|NCT00707239|10929386|FG001|STARTED|Overall Study||36
9818857|NCT00707239|10929387|FG002|STARTED|Overall Study||35
9818858|NCT00707239|10929385|FG000|Treated|Overall Study||36
9818859|NCT00707239|10929386|FG001|Treated|Overall Study||35
9818860|NCT00707239|10929387|FG002|Treated|Overall Study||34
9818861|NCT00707239|10929385|FG000|COMPLETED|Overall Study||18
9818862|NCT00707239|10929386|FG001|COMPLETED|Overall Study||25
9818863|NCT00707239|10929387|FG002|COMPLETED|Overall Study||21
9818864|NCT00707239|10929385|FG000|NOT COMPLETED|Overall Study||19
9818865|NCT00707239|10929386|FG001|NOT COMPLETED|Overall Study||11
9818866|NCT00707239|10929387|FG002|NOT COMPLETED|Overall Study||14
9818867|NCT00707343|10929398|FG000|STARTED|Overall Study||15
9818868|NCT00707343|10929398|FG000|COMPLETED|Overall Study||15
9818869|NCT00707343|10929398|FG000|NOT COMPLETED|Overall Study||0
9818870|NCT00707447|10929404|FG000|STARTED|Overall Study||89
9818871|NCT00707447|10929405|FG001|STARTED|Overall Study||93
9818872|NCT00707447|10929404|FG000|COMPLETED|Overall Study||81
9818873|NCT00707447|10929405|FG001|COMPLETED|Overall Study||85
9818874|NCT00707447|10929404|FG000|NOT COMPLETED|Overall Study||8
9818875|NCT00707447|10929405|FG001|NOT COMPLETED|Overall Study||8
9818876|NCT00707486|10929411|FG000|STARTED|Overall Study||72
9818877|NCT00707486|10929411|FG000|COMPLETED|Overall Study||71
9818878|NCT00707486|10929411|FG000|NOT COMPLETED|Overall Study||1
9818879|NCT00707577|10929419|FG000|STARTED|Overall Study||174
9818880|NCT00707577|10929420|FG001|STARTED|Overall Study||156
9818881|NCT00707577|10929419|FG000|COMPLETED|Overall Study||120
9818882|NCT00707577|10929420|FG001|COMPLETED|Overall Study||118
9818883|NCT00707577|10929419|FG000|NOT COMPLETED|Overall Study||54
9818884|NCT00707577|10929420|FG001|NOT COMPLETED|Overall Study||38
9818885|NCT00707655|10929428|FG000|STARTED|Overall Study||3
9818886|NCT00707655|10929429|FG001|STARTED|Overall Study||5
9818887|NCT00707655|10929428|FG000|COMPLETED|Overall Study||3
9818888|NCT00707655|10929429|FG001|COMPLETED|Overall Study||3
9818889|NCT00707655|10929428|FG000|NOT COMPLETED|Overall Study||0
9818890|NCT00707655|10929429|FG001|NOT COMPLETED|Overall Study||2
9818891|NCT00707746|10929439|FG000|STARTED|Treatment Period||12
9818892|NCT00707746|10929440|FG001|STARTED|Treatment Period||22
9818893|NCT00707746|10929439|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
9818894|NCT00707746|10929440|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
9818895|NCT00707746|10929439|FG000|COMPLETED|Treatment Period||10
9818896|NCT00707746|10929440|FG001|COMPLETED|Treatment Period||17
9818897|NCT00707746|10929439|FG000|NOT COMPLETED|Treatment Period||2
9818898|NCT00707746|10929440|FG001|NOT COMPLETED|Treatment Period||5
9818899|NCT00707746|10929439|FG000|STARTED|Follow-up Period||12
9818900|NCT00707746|10929440|FG001|STARTED|Follow-up Period||21
9818901|NCT00707746|10929439|FG000|COMPLETED|Follow-up Period||12
9818902|NCT00707746|10929440|FG001|COMPLETED|Follow-up Period||21
9818903|NCT00707746|10929439|FG000|NOT COMPLETED|Follow-up Period||0
9818904|NCT00707746|10929440|FG001|NOT COMPLETED|Follow-up Period||0
9818905|NCT00707759|10929448|FG000|STARTED|Overall Study||14
9818906|NCT00707759|10929449|FG001|STARTED|Overall Study||14
9818907|NCT00707759|10929448|FG000|COMPLETED|Overall Study||12
9818908|NCT00707759|10929449|FG001|COMPLETED|Overall Study||12
9818909|NCT00707759|10929448|FG000|NOT COMPLETED|Overall Study||2
9818910|NCT00707759|10929449|FG001|NOT COMPLETED|Overall Study||2
9818911|NCT00707863|10929457|FG000|STARTED|Overall Study||6
9818912|NCT00707863|10929458|FG001|STARTED|Overall Study||11
9818913|NCT00707863|10929457|FG000|COMPLETED|Overall Study||6
9818914|NCT00707863|10929458|FG001|COMPLETED|Overall Study||8
9818915|NCT00707863|10929457|FG000|NOT COMPLETED|Overall Study||0
9818916|NCT00707863|10929458|FG001|NOT COMPLETED|Overall Study||3
9818917|NCT00707915|10929464|FG000|STARTED|Overall Study||30
9818918|NCT00707915|10929464|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30
9818919|NCT00707915|10929464|FG000|COMPLETED|Overall Study||30
9818920|NCT00707915|10929464|FG000|NOT COMPLETED|Overall Study||0
9818921|NCT00707954|10929473|FG000|STARTED|Overall Study||12
9818922|NCT00707954|10929474|FG001|STARTED|Overall Study||12
9818923|NCT00707954|10929475|FG002|STARTED|Overall Study||14
9818924|NCT00707954|10929476|FG003|STARTED|Overall Study||13
9818925|NCT00707954|10929477|FG004|STARTED|Overall Study||10
9818926|NCT00707954|10929473|FG000|COMPLETED|Overall Study||12
9818927|NCT00707954|10929474|FG001|COMPLETED|Overall Study||12
9818928|NCT00707954|10929475|FG002|COMPLETED|Overall Study||14
9818929|NCT00707954|10929476|FG003|COMPLETED|Overall Study||13
9818930|NCT00707954|10929477|FG004|COMPLETED|Overall Study||9
9818931|NCT00707954|10929473|FG000|NOT COMPLETED|Overall Study||0
9818932|NCT00707954|10929474|FG001|NOT COMPLETED|Overall Study||0
9818933|NCT00707954|10929475|FG002|NOT COMPLETED|Overall Study||0
9818934|NCT00707954|10929476|FG003|NOT COMPLETED|Overall Study||0
9818935|NCT00707954|10929477|FG004|NOT COMPLETED|Overall Study||1
9818936|NCT00707967|10929492|FG000|STARTED|Overall Study||22
9818937|NCT00707967|10929493|FG001|STARTED|Overall Study||8
9818938|NCT00707967|10929494|FG002|STARTED|Overall Study||7
9818939|NCT00707967|10929492|FG000|COMPLETED|Overall Study||22
9818940|NCT00707967|10929493|FG001|COMPLETED|Overall Study||8
9818941|NCT00707967|10929494|FG002|COMPLETED|Overall Study||7
9818942|NCT00707967|10929492|FG000|NOT COMPLETED|Overall Study||0
9818943|NCT00707967|10929493|FG001|NOT COMPLETED|Overall Study||0
9818944|NCT00707967|10929494|FG002|NOT COMPLETED|Overall Study||0
9818945|NCT00707980|10929502|FG000|STARTED|Overall Study||836
9818946|NCT00707980|10929502|FG000|Received Treatment|Overall Study||834
9818947|NCT00707980|10929502|FG000|COMPLETED|Overall Study||526
9818948|NCT00707980|10929502|FG000|NOT COMPLETED|Overall Study||310
9818949|NCT00707993|10929508|FG000|STARTED|Overall Study||222
9818950|NCT00707993|10929509|FG001|STARTED|Overall Study||219
9818951|NCT00707993|10929508|FG000|COMPLETED|Overall Study||133
9818952|NCT00707993|10929509|FG001|COMPLETED|Overall Study||125
9818953|NCT00707993|10929508|FG000|NOT COMPLETED|Overall Study||89
9818954|NCT00707993|10929509|FG001|NOT COMPLETED|Overall Study||94
9818955|NCT00708019|10929517|FG000|STARTED|Overall Study||92
9818956|NCT00708019|10929518|FG001|STARTED|Overall Study||93
9818957|NCT00708019|10929517|FG000|COMPLETED|Overall Study||77
9818958|NCT00708019|10929518|FG001|COMPLETED|Overall Study||78
9818959|NCT00708019|10929517|FG000|NOT COMPLETED|Overall Study||15
9818960|NCT00708019|10929518|FG001|NOT COMPLETED|Overall Study||15
9818961|NCT00708032|10929526|FG000|STARTED|Overall Study||36
9818962|NCT00708032|10929527|FG001|STARTED|Overall Study||38
9818963|NCT00708032|10929526|FG000|COMPLETED|Overall Study||26
9818964|NCT00708032|10929527|FG001|COMPLETED|Overall Study||22
9818965|NCT00708032|10929526|FG000|NOT COMPLETED|Overall Study||10
9818966|NCT00708032|10929527|FG001|NOT COMPLETED|Overall Study||16
9818967|NCT00708071|10929533|FG000|STARTED|Overall Study|Randomized and treated|45
9818968|NCT00708071|10929533|FG000|COMPLETED|Overall Study||45
10016960|NCT01813474|11139809|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1
10016961|NCT01813474|11139810|FG001|COMPLETED|Overall Study||0
10016962|NCT01813474|11139811|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1
10016963|NCT01813474|11139809|FG000|NOT COMPLETED|Overall Study||3
10016964|NCT01813474|11139810|FG001|NOT COMPLETED|Overall Study||7
10016965|NCT01813474|11139811|FG002|NOT COMPLETED|Overall Study||11
9818969|NCT00708071|10929533|FG000|NOT COMPLETED|Overall Study||0
9818970|NCT00708097|10929567|FG000|STARTED|Period 1||11
9818971|NCT00708097|10929568|FG001|STARTED|Period 1||12
9818972|NCT00708097|10929569|FG002|STARTED|Period 1||12
9818973|NCT00708097|10929570|FG003|STARTED|Period 1||11
9818974|NCT00708097|10929571|FG004|STARTED|Period 1||11
10019152|NCT01828073|11142292|FG000|COMPLETED|Overall Study||21
9818975|NCT00708097|10929567|FG000|COMPLETED|Period 1||11
9818976|NCT00708097|10929568|FG001|COMPLETED|Period 1||11
9818977|NCT00708097|10929569|FG002|COMPLETED|Period 1||12
9818978|NCT00708097|10929570|FG003|COMPLETED|Period 1||9
9818979|NCT00708097|10929571|FG004|COMPLETED|Period 1||10
9818980|NCT00708097|10929567|FG000|NOT COMPLETED|Period 1||0
9818981|NCT00708097|10929568|FG001|NOT COMPLETED|Period 1||1
9818982|NCT00708097|10929569|FG002|NOT COMPLETED|Period 1||0
9818983|NCT00708097|10929570|FG003|NOT COMPLETED|Period 1||2
9818984|NCT00708097|10929571|FG004|NOT COMPLETED|Period 1||1
9818985|NCT00708097|10929567|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
9818986|NCT00708097|10929568|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
9818987|NCT00708097|10929569|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
9831988|NCT00771264|10942683|FG000|STARTED|Overall Study||110
10019153|NCT01828073|11142293|FG001|COMPLETED|Overall Study||16
9818988|NCT00708097|10929570|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
9818989|NCT00708097|10929571|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
9818990|NCT00708097|10929567|FG000|COMPLETED|Period 2||10
9818991|NCT00708097|10929568|FG001|COMPLETED|Period 2||11
9818992|NCT00708097|10929569|FG002|COMPLETED|Period 2||9
9818993|NCT00708097|10929570|FG003|COMPLETED|Period 2||10
9818994|NCT00708097|10929571|FG004|COMPLETED|Period 2||10
9818995|NCT00708097|10929567|FG000|NOT COMPLETED|Period 2||0
9818996|NCT00708097|10929568|FG001|NOT COMPLETED|Period 2||1
9818997|NCT00708097|10929569|FG002|NOT COMPLETED|Period 2||1
9818998|NCT00708097|10929570|FG003|NOT COMPLETED|Period 2||1
9818999|NCT00708097|10929571|FG004|NOT COMPLETED|Period 2||0
9819000|NCT00708097|10929567|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
9819001|NCT00708097|10929568|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
9819002|NCT00708097|10929569|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
9819003|NCT00708097|10929570|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
9819004|NCT00708097|10929571|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
9819005|NCT00708097|10929567|FG000|COMPLETED|Period 3||9
9819006|NCT00708097|10929568|FG001|COMPLETED|Period 3||11
9819007|NCT00708097|10929569|FG002|COMPLETED|Period 3||10
9819008|NCT00708097|10929570|FG003|COMPLETED|Period 3||10
9819009|NCT00708097|10929571|FG004|COMPLETED|Period 3||10
9819010|NCT00708097|10929567|FG000|NOT COMPLETED|Period 3||0
9819011|NCT00708097|10929568|FG001|NOT COMPLETED|Period 3||0
9819012|NCT00708097|10929569|FG002|NOT COMPLETED|Period 3||0
9819013|NCT00708097|10929570|FG003|NOT COMPLETED|Period 3||0
9819014|NCT00708097|10929571|FG004|NOT COMPLETED|Period 3||0
9819015|NCT00708097|10929567|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
9819016|NCT00708097|10929568|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
9819017|NCT00708097|10929569|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
9819018|NCT00708097|10929570|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
9819019|NCT00708097|10929571|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
9819020|NCT00708097|10929567|FG000|COMPLETED|Period 4||12
9819021|NCT00708097|10929568|FG001|COMPLETED|Period 4||9
9819022|NCT00708097|10929569|FG002|COMPLETED|Period 4||10
9819023|NCT00708097|10929570|FG003|COMPLETED|Period 4||11
9819024|NCT00708097|10929571|FG004|COMPLETED|Period 4||8
9819025|NCT00708097|10929567|FG000|NOT COMPLETED|Period 4||0
9819026|NCT00708097|10929568|FG001|NOT COMPLETED|Period 4||0
9819027|NCT00708097|10929569|FG002|NOT COMPLETED|Period 4||0
9819028|NCT00708097|10929570|FG003|NOT COMPLETED|Period 4||0
9819029|NCT00708097|10929571|FG004|NOT COMPLETED|Period 4||0
9819030|NCT00708097|10929567|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
9819031|NCT00708097|10929568|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
9819032|NCT00708097|10929569|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
9819033|NCT00708097|10929570|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
9819034|NCT00708097|10929571|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
9819035|NCT00708097|10929567|FG000|COMPLETED|Period 5||8
9819036|NCT00708097|10929568|FG001|COMPLETED|Period 5||9
9819037|NCT00708097|10929569|FG002|COMPLETED|Period 5||11
9819038|NCT00708097|10929570|FG003|COMPLETED|Period 5||10
9819039|NCT00708097|10929571|FG004|COMPLETED|Period 5||12
9819040|NCT00708097|10929567|FG000|NOT COMPLETED|Period 5||0
9819041|NCT00708097|10929568|FG001|NOT COMPLETED|Period 5||0
9819042|NCT00708097|10929569|FG002|NOT COMPLETED|Period 5||0
9819043|NCT00708097|10929570|FG003|NOT COMPLETED|Period 5||0
9819044|NCT00708097|10929571|FG004|NOT COMPLETED|Period 5||0
9819045|NCT00708110|10929592|FG000|STARTED|Overall Study||7
9819046|NCT00708110|10929593|FG001|STARTED|Overall Study||9
9819047|NCT00708110|10929594|FG002|STARTED|Overall Study||9
9819048|NCT00708110|10929595|FG003|STARTED|Overall Study||10
9819049|NCT00708110|10929592|FG000|COMPLETED|Overall Study||7
9819050|NCT00708110|10929593|FG001|COMPLETED|Overall Study||9
9819051|NCT00708110|10929594|FG002|COMPLETED|Overall Study||9
9819052|NCT00708110|10929595|FG003|COMPLETED|Overall Study||10
9819053|NCT00708110|10929592|FG000|NOT COMPLETED|Overall Study||0
9819054|NCT00708110|10929593|FG001|NOT COMPLETED|Overall Study||0
9819055|NCT00708110|10929594|FG002|NOT COMPLETED|Overall Study||0
9819056|NCT00708110|10929595|FG003|NOT COMPLETED|Overall Study||0
9819057|NCT00708123|10929605|FG000|STARTED|Period 1||12
9819058|NCT00708123|10929606|FG001|STARTED|Period 1||12
9819059|NCT00708123|10929607|FG002|STARTED|Period 1||12
9819060|NCT00708123|10929608|FG003|STARTED|Period 1||12
9819061|NCT00708123|10929609|FG004|STARTED|Period 1||12
9819062|NCT00708123|10929605|FG000|COMPLETED|Period 1||12
9819063|NCT00708123|10929606|FG001|COMPLETED|Period 1||11
9819064|NCT00708123|10929607|FG002|COMPLETED|Period 1||11
9819065|NCT00708123|10929608|FG003|COMPLETED|Period 1||11
9819066|NCT00708123|10929609|FG004|COMPLETED|Period 1||12
9819067|NCT00708123|10929605|FG000|NOT COMPLETED|Period 1||0
9819068|NCT00708123|10929606|FG001|NOT COMPLETED|Period 1||1
9819069|NCT00708123|10929607|FG002|NOT COMPLETED|Period 1||1
9819070|NCT00708123|10929608|FG003|NOT COMPLETED|Period 1||1
9819071|NCT00708123|10929609|FG004|NOT COMPLETED|Period 1||0
9819072|NCT00708123|10929605|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
9819073|NCT00708123|10929606|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
9819074|NCT00708123|10929607|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
9819075|NCT00708123|10929608|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
9819076|NCT00708123|10929609|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
9819077|NCT00708123|10929605|FG000|COMPLETED|Period 2||10
9819078|NCT00708123|10929606|FG001|COMPLETED|Period 2||12
9819079|NCT00708123|10929607|FG002|COMPLETED|Period 2||12
9819080|NCT00708123|10929608|FG003|COMPLETED|Period 2||10
9819081|NCT00708123|10929609|FG004|COMPLETED|Period 2||11
9819082|NCT00708123|10929605|FG000|NOT COMPLETED|Period 2||1
9819083|NCT00708123|10929606|FG001|NOT COMPLETED|Period 2||0
9819084|NCT00708123|10929607|FG002|NOT COMPLETED|Period 2||0
9819085|NCT00708123|10929608|FG003|NOT COMPLETED|Period 2||1
9819086|NCT00708123|10929609|FG004|NOT COMPLETED|Period 2||0
9819087|NCT00708123|10929605|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
9819088|NCT00708123|10929606|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
9819089|NCT00708123|10929607|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
9819090|NCT00708123|10929608|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
9819091|NCT00708123|10929609|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
9819092|NCT00708123|10929605|FG000|COMPLETED|Period 3||12
9819093|NCT00708123|10929606|FG001|COMPLETED|Period 3||10
9819094|NCT00708123|10929607|FG002|COMPLETED|Period 3||10
9819095|NCT00708123|10929608|FG003|COMPLETED|Period 3||11
9819096|NCT00708123|10929609|FG004|COMPLETED|Period 3||10
9819097|NCT00708123|10929605|FG000|NOT COMPLETED|Period 3||0
9819098|NCT00708123|10929606|FG001|NOT COMPLETED|Period 3||0
10016966|NCT01813721|11139820|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007
10016967|NCT01813721|11139820|FG000|COMPLETED|Overall Study||943
10016968|NCT01813721|11139820|FG000|NOT COMPLETED|Overall Study||64
10016969|NCT01813734|11139842|FG000|STARTED|Overall Study||9
9819099|NCT00708123|10929607|FG002|NOT COMPLETED|Period 3||1
9819100|NCT00708123|10929608|FG003|NOT COMPLETED|Period 3||1
9819101|NCT00708123|10929609|FG004|NOT COMPLETED|Period 3||0
9819102|NCT00708123|10929605|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
9819103|NCT00708123|10929606|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
9819104|NCT00708123|10929607|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
9819105|NCT00708123|10929608|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
9819106|NCT00708123|10929609|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
9819107|NCT00708123|10929605|FG000|COMPLETED|Period 4||10
9819108|NCT00708123|10929606|FG001|COMPLETED|Period 4||11
9819109|NCT00708123|10929607|FG002|COMPLETED|Period 4||10
9819110|NCT00708123|10929608|FG003|COMPLETED|Period 4||10
9819111|NCT00708123|10929609|FG004|COMPLETED|Period 4||11
9819112|NCT00708123|10929605|FG000|NOT COMPLETED|Period 4||0
9819113|NCT00708123|10929606|FG001|NOT COMPLETED|Period 4||1
9819114|NCT00708123|10929607|FG002|NOT COMPLETED|Period 4||0
9819115|NCT00708123|10929608|FG003|NOT COMPLETED|Period 4||0
9819116|NCT00708123|10929609|FG004|NOT COMPLETED|Period 4||0
9819117|NCT00708123|10929605|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
9819118|NCT00708123|10929606|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
9819119|NCT00708123|10929607|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
9819120|NCT00708123|10929608|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
9819121|NCT00708123|10929609|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
9819122|NCT00708123|10929605|FG000|COMPLETED|Period 5||10
9819123|NCT00708123|10929606|FG001|COMPLETED|Period 5||10
9819124|NCT00708123|10929607|FG002|COMPLETED|Period 5||11
9819125|NCT00708123|10929608|FG003|COMPLETED|Period 5||11
9819126|NCT00708123|10929609|FG004|COMPLETED|Period 5||10
9819127|NCT00708123|10929605|FG000|NOT COMPLETED|Period 5||0
9819128|NCT00708123|10929606|FG001|NOT COMPLETED|Period 5||0
9819129|NCT00708123|10929607|FG002|NOT COMPLETED|Period 5||0
10016970|NCT01813734|11139842|FG000|COMPLETED|Overall Study||9
9819130|NCT00708123|10929608|FG003|NOT COMPLETED|Period 5||0
9819131|NCT00708123|10929609|FG004|NOT COMPLETED|Period 5||0
9819132|NCT00708162|10929627|FG000|STARTED|Randomized Phase||361
9819133|NCT00708162|10929628|FG001|STARTED|Randomized Phase||363
9819134|NCT00708162|10929627|FG000|Randomized and Treated|Randomized Phase||354
9819135|NCT00708162|10929628|FG001|Randomized and Treated|Randomized Phase||358
9819136|NCT00708162|10929627|FG000|COMPLETED|Randomized Phase||205
9819137|NCT00708162|10929628|FG001|COMPLETED|Randomized Phase||209
9819138|NCT00708162|10929627|FG000|NOT COMPLETED|Randomized Phase||156
9819139|NCT00708162|10929628|FG001|NOT COMPLETED|Randomized Phase||154
9819140|NCT00708162|10929627|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
9819141|NCT00708162|10929628|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
9819142|NCT00708162|10929627|FG000|COMPLETED|Open-Label Phase||152
9819143|NCT00708162|10929628|FG001|COMPLETED|Open-Label Phase||121
9819144|NCT00708162|10929627|FG000|NOT COMPLETED|Open-Label Phase||44
9819145|NCT00708162|10929628|FG001|NOT COMPLETED|Open-Label Phase||30
9819146|NCT00708175|10929637|FG000|STARTED|Overall Study||78
9819147|NCT00708175|10929638|FG001|STARTED|Overall Study||78
9819148|NCT00708175|10929637|FG000|COMPLETED|Overall Study||60
9819149|NCT00708175|10929638|FG001|COMPLETED|Overall Study||57
9819150|NCT00708175|10929637|FG000|NOT COMPLETED|Overall Study||18
9819151|NCT00708175|10929638|FG001|NOT COMPLETED|Overall Study||21
9819152|NCT00708201|10929646|FG000|STARTED|Overall Study||137
9819153|NCT00708201|10929647|FG001|STARTED|Overall Study||143
9819154|NCT00708201|10929646|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130
9819155|NCT00708201|10929647|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137
9819156|NCT00708201|10929646|FG000|COMPLETED|Overall Study||130
9819157|NCT00708201|10929647|FG001|COMPLETED|Overall Study||137
9819158|NCT00708201|10929646|FG000|NOT COMPLETED|Overall Study||7
9819159|NCT00708201|10929647|FG001|NOT COMPLETED|Overall Study||6
9819160|NCT00708214|10929656|FG000|STARTED|Overall Study||7
9819161|NCT00708214|10929657|FG001|STARTED|Overall Study||13
9819162|NCT00708214|10929658|FG002|STARTED|Overall Study||8
9819163|NCT00708214|10929656|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
9819164|NCT00708214|10929657|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
9819165|NCT00708214|10929658|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
9819166|NCT00708214|10929656|FG000|NOT COMPLETED|Overall Study||7
9819167|NCT00708214|10929657|FG001|NOT COMPLETED|Overall Study||13
9819168|NCT00708214|10929658|FG002|NOT COMPLETED|Overall Study||8
9819169|NCT00708227|10929675|FG000|STARTED|Overall Study||19
9819170|NCT00708227|10929676|FG001|STARTED|Overall Study||26
9819171|NCT00708227|10929677|FG002|STARTED|Overall Study||18
9819172|NCT00708227|10929678|FG003|STARTED|Overall Study||25
9819173|NCT00708227|10929675|FG000|COMPLETED|Overall Study||18
9819174|NCT00708227|10929676|FG001|COMPLETED|Overall Study||21
9819175|NCT00708227|10929677|FG002|COMPLETED|Overall Study||17
9819176|NCT00708227|10929678|FG003|COMPLETED|Overall Study||22
9819177|NCT00708227|10929675|FG000|NOT COMPLETED|Overall Study||1
9819178|NCT00708227|10929676|FG001|NOT COMPLETED|Overall Study||5
9819179|NCT00708227|10929677|FG002|NOT COMPLETED|Overall Study||1
9819180|NCT00708227|10929678|FG003|NOT COMPLETED|Overall Study||3
9831989|NCT00771264|10942684|FG001|STARTED|Overall Study||110
9831990|NCT00771264|10942683|FG000|COMPLETED|Overall Study||103
9831991|NCT00771264|10942684|FG001|COMPLETED|Overall Study||105
9831992|NCT00771264|10942683|FG000|NOT COMPLETED|Overall Study||7
9831993|NCT00771264|10942684|FG001|NOT COMPLETED|Overall Study||5
9831994|NCT00771277|10942690|FG000|STARTED|Overall Study||6
9831995|NCT00771277|10942690|FG000|COMPLETED|Overall Study||6
9831996|NCT00771277|10942690|FG000|NOT COMPLETED|Overall Study||0
9831997|NCT00771407|10942696|FG000|STARTED|Overall Study||60
9831998|NCT00771407|10942697|FG001|STARTED|Overall Study||60
9831999|NCT00771407|10942696|FG000|COMPLETED|Overall Study||40
9832000|NCT00771407|10942697|FG001|COMPLETED|Overall Study||35
9832001|NCT00771407|10942696|FG000|NOT COMPLETED|Overall Study||20
9832002|NCT00771407|10942697|FG001|NOT COMPLETED|Overall Study||25
9832003|NCT00771472|10942703|FG000|STARTED|Overall Study||6
9832004|NCT00771472|10942704|FG001|STARTED|Overall Study||4
9832005|NCT00771472|10942703|FG000|COMPLETED|Overall Study||0
9832006|NCT00771472|10942704|FG001|COMPLETED|Overall Study||0
9832007|NCT00771472|10942703|FG000|NOT COMPLETED|Overall Study||6
9832008|NCT00771472|10942704|FG001|NOT COMPLETED|Overall Study||4
9832009|NCT00771537|10942725|FG000|STARTED|Overall Study||135
9832010|NCT00771537|10942726|FG001|STARTED|Overall Study||124
9832011|NCT00771537|10942727|FG002|STARTED|Overall Study||151
9832012|NCT00771537|10942728|FG003|STARTED|Overall Study||114
9832013|NCT00771537|10942729|FG004|STARTED|Overall Study||127
9832014|NCT00771537|10942730|FG005|STARTED|Overall Study||118
9832015|NCT00771537|10942731|FG006|STARTED|Overall Study||128
9832016|NCT00771537|10942732|FG007|STARTED|Overall Study||132
9832017|NCT00771537|10942733|FG008|STARTED|Overall Study||115
9832018|NCT00771537|10942734|FG009|STARTED|Overall Study||119
9832019|NCT00771537|10942735|FG010|STARTED|Overall Study||133
9832020|NCT00771537|10942736|FG011|STARTED|Overall Study||137
9832021|NCT00771537|10942737|FG012|STARTED|Overall Study||128
9832022|NCT00771537|10942738|FG013|STARTED|Overall Study||124
9832023|NCT00771537|10942739|FG014|STARTED|Overall Study||124
9832024|NCT00771537|10942740|FG015|STARTED|Overall Study||122
9832025|NCT00771537|10942725|FG000|COMPLETED|Overall Study||135
9832026|NCT00771537|10942726|FG001|COMPLETED|Overall Study||124
9832027|NCT00771537|10942727|FG002|COMPLETED|Overall Study||151
9819181|NCT00708305|10929708|FG000|STARTED|Period 1||16
9819182|NCT00708305|10929709|FG001|STARTED|Period 1||16
9819183|NCT00708305|10929710|FG002|STARTED|Period 1||17
9819184|NCT00708305|10929711|FG003|STARTED|Period 1||16
9819185|NCT00708305|10929708|FG000|COMPLETED|Period 1||15
9819186|NCT00708305|10929709|FG001|COMPLETED|Period 1||16
9819187|NCT00708305|10929710|FG002|COMPLETED|Period 1||16
9819188|NCT00708305|10929711|FG003|COMPLETED|Period 1||14
9819189|NCT00708305|10929708|FG000|NOT COMPLETED|Period 1||1
9819190|NCT00708305|10929709|FG001|NOT COMPLETED|Period 1||0
9819191|NCT00708305|10929710|FG002|NOT COMPLETED|Period 1||1
9819192|NCT00708305|10929711|FG003|NOT COMPLETED|Period 1||2
9819193|NCT00708305|10929708|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
9819194|NCT00708305|10929709|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
9819195|NCT00708305|10929710|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
9819196|NCT00708305|10929711|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
9819197|NCT00708305|10929708|FG000|COMPLETED|Period 2||14
9819198|NCT00708305|10929709|FG001|COMPLETED|Period 2||13
9819199|NCT00708305|10929710|FG002|COMPLETED|Period 2||16
9819200|NCT00708305|10929711|FG003|COMPLETED|Period 2||14
9819201|NCT00708305|10929708|FG000|NOT COMPLETED|Period 2||1
9819202|NCT00708305|10929709|FG001|NOT COMPLETED|Period 2||2
9819203|NCT00708305|10929710|FG002|NOT COMPLETED|Period 2||0
9819204|NCT00708305|10929711|FG003|NOT COMPLETED|Period 2||1
9819205|NCT00708305|10929708|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
9819206|NCT00708305|10929709|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
9819207|NCT00708305|10929710|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
9819208|NCT00708305|10929711|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
9819209|NCT00708305|10929708|FG000|COMPLETED|Period 3||14
9819210|NCT00708305|10929709|FG001|COMPLETED|Period 3||12
9819211|NCT00708305|10929710|FG002|COMPLETED|Period 3||14
9819212|NCT00708305|10929711|FG003|COMPLETED|Period 3||14
9819213|NCT00708305|10929708|FG000|NOT COMPLETED|Period 3||1
9819214|NCT00708305|10929709|FG001|NOT COMPLETED|Period 3||2
9819215|NCT00708305|10929710|FG002|NOT COMPLETED|Period 3||0
9819216|NCT00708305|10929711|FG003|NOT COMPLETED|Period 3||0
9819217|NCT00708305|10929708|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
9819218|NCT00708305|10929709|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
9819219|NCT00708305|10929710|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
9819220|NCT00708305|10929711|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
9819221|NCT00708305|10929708|FG000|COMPLETED|Period 4||12
9819222|NCT00708305|10929709|FG001|COMPLETED|Period 4||14
9819223|NCT00708305|10929710|FG002|COMPLETED|Period 4||14
9819224|NCT00708305|10929711|FG003|COMPLETED|Period 4||14
9819225|NCT00708305|10929708|FG000|NOT COMPLETED|Period 4||0
9819226|NCT00708305|10929709|FG001|NOT COMPLETED|Period 4||0
9819227|NCT00708305|10929710|FG002|NOT COMPLETED|Period 4||0
9819228|NCT00708305|10929711|FG003|NOT COMPLETED|Period 4||0
10016971|NCT01813734|11139842|FG000|NOT COMPLETED|Overall Study||0
10016972|NCT01813890|11139849|FG000|STARTED|Overall Study||20
10016973|NCT01813890|11139850|FG001|STARTED|Overall Study||21
9819229|NCT00708422|10929726|FG000|STARTED|Overall Study||116
9819230|NCT00708422|10929727|FG001|STARTED|Overall Study||115
9819231|NCT00708422|10929726|FG000|COMPLETED|Overall Study||112
9819232|NCT00708422|10929727|FG001|COMPLETED|Overall Study||114
9819233|NCT00708422|10929726|FG000|NOT COMPLETED|Overall Study||4
9819234|NCT00708422|10929727|FG001|NOT COMPLETED|Overall Study||1
9819235|NCT00708435|10929735|FG000|STARTED|Overall Study||107
9819236|NCT00708435|10929736|FG001|STARTED|Overall Study||109
9819237|NCT00708435|10929735|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
9819238|NCT00708435|10929736|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
9819239|NCT00708435|10929735|FG000|NOT COMPLETED|Overall Study||25
9819240|NCT00708435|10929736|FG001|NOT COMPLETED|Overall Study||17
9819241|NCT00708461|10929746|FG000|STARTED|Overall Study||752
9819242|NCT00708461|10929747|FG001|STARTED|Overall Study||995
9819243|NCT00708461|10929746|FG000|COMPLETED|Overall Study||611
9819244|NCT00708461|10929747|FG001|COMPLETED|Overall Study||795
9819245|NCT00708461|10929746|FG000|NOT COMPLETED|Overall Study||141
9819246|NCT00708461|10929747|FG001|NOT COMPLETED|Overall Study||200
9819247|NCT00708500|10929756|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
9819248|NCT00708500|10929757|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
9819249|NCT00708500|10929758|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
9819250|NCT00708500|10929756|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
9819251|NCT00708500|10929757|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
10016974|NCT01813890|11139851|FG002|STARTED|Overall Study||19
9819252|NCT00708500|10929758|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
9819253|NCT00708500|10929756|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
9819254|NCT00708500|10929757|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
9819255|NCT00708500|10929758|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
9819256|NCT00708500|10929756|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
9819257|NCT00708500|10929757|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
9819258|NCT00708500|10929758|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
9819259|NCT00708500|10929756|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
9819260|NCT00708500|10929757|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
9819261|NCT00708500|10929758|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
9819262|NCT00708500|10929756|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
9819263|NCT00708500|10929757|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
9819264|NCT00708500|10929758|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
9819265|NCT00708500|10929756|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
9819266|NCT00708500|10929757|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
9819267|NCT00708500|10929758|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
9819268|NCT00708500|10929756|FG000|STARTED|FOLLOWUP||77
10016975|NCT01813890|11139849|FG000|COMPLETED|Overall Study||11
10016976|NCT01813890|11139850|FG001|COMPLETED|Overall Study||17
10016977|NCT01813890|11139851|FG002|COMPLETED|Overall Study||13
10016978|NCT01813890|11139849|FG000|NOT COMPLETED|Overall Study||9
10016979|NCT01813890|11139850|FG001|NOT COMPLETED|Overall Study||4
10016980|NCT01813890|11139851|FG002|NOT COMPLETED|Overall Study||6
10016981|NCT01814007|11139859|FG000|STARTED|Overall Study||35
10016982|NCT01814007|11139859|FG000|COMPLETED|Overall Study||34
9819269|NCT00708500|10929757|FG001|STARTED|FOLLOWUP||151
9819270|NCT00708500|10929758|FG002|STARTED|FOLLOWUP||158
9819271|NCT00708500|10929756|FG000|COMPLETED|FOLLOWUP||37
9819272|NCT00708500|10929757|FG001|COMPLETED|FOLLOWUP||136
9819273|NCT00708500|10929758|FG002|COMPLETED|FOLLOWUP||143
9819274|NCT00708500|10929756|FG000|NOT COMPLETED|FOLLOWUP||40
10016983|NCT01814007|11139859|FG000|NOT COMPLETED|Overall Study||1
10016984|NCT01814046|11139866|FG000|STARTED|Drug Administration||22
10016985|NCT01814046|11139867|FG001|STARTED|Drug Administration||2
10016986|NCT01814046|11139868|FG002|STARTED|Drug Administration||0
10016987|NCT01814046|11139866|FG000|COMPLETED|Drug Administration||21
10016988|NCT01814046|11139867|FG001|COMPLETED|Drug Administration||2
9819275|NCT00708500|10929757|FG001|NOT COMPLETED|FOLLOWUP||15
9819276|NCT00708500|10929758|FG002|NOT COMPLETED|FOLLOWUP||15
9819277|NCT00708526|10929768|FG000|STARTED|Wake up After Anesthesia||11
9819278|NCT00708526|10929769|FG001|STARTED|Wake up After Anesthesia||11
9819279|NCT00708526|10929768|FG000|COMPLETED|Wake up After Anesthesia||11
9819280|NCT00708526|10929769|FG001|COMPLETED|Wake up After Anesthesia||11
9819281|NCT00708526|10929768|FG000|NOT COMPLETED|Wake up After Anesthesia||0
9819282|NCT00708526|10929769|FG001|NOT COMPLETED|Wake up After Anesthesia||0
9819283|NCT00708526|10929768|FG000|STARTED|Return of Cognitive Function||11
9819284|NCT00708526|10929769|FG001|STARTED|Return of Cognitive Function||11
9819285|NCT00708526|10929768|FG000|COMPLETED|Return of Cognitive Function||11
9819286|NCT00708526|10929769|FG001|COMPLETED|Return of Cognitive Function||11
9819287|NCT00708526|10929768|FG000|NOT COMPLETED|Return of Cognitive Function||0
9819288|NCT00708526|10929769|FG001|NOT COMPLETED|Return of Cognitive Function||0
9819289|NCT00708552|10929779|FG000|STARTED|Overall Study||145
9819290|NCT00708552|10929780|FG001|STARTED|Overall Study||145
9819291|NCT00708552|10929781|FG002|STARTED|Overall Study||133
9819292|NCT00708552|10929782|FG003|STARTED|Overall Study||151
9819293|NCT00708552|10929779|FG000|COMPLETED|Overall Study||118
9819294|NCT00708552|10929780|FG001|COMPLETED|Overall Study||127
9819295|NCT00708552|10929781|FG002|COMPLETED|Overall Study||118
9819296|NCT00708552|10929782|FG003|COMPLETED|Overall Study||130
9819297|NCT00708552|10929779|FG000|NOT COMPLETED|Overall Study||27
9819298|NCT00708552|10929780|FG001|NOT COMPLETED|Overall Study||18
9819299|NCT00708552|10929781|FG002|NOT COMPLETED|Overall Study||15
9819300|NCT00708552|10929782|FG003|NOT COMPLETED|Overall Study||21
9819301|NCT00708643|10929798|FG000|STARTED|Overall Study||40
9819302|NCT00708643|10929799|FG001|STARTED|Overall Study||40
9819303|NCT00708643|10929798|FG000|COMPLETED|Overall Study||40
9819304|NCT00708643|10929799|FG001|COMPLETED|Overall Study||39
9819305|NCT00708643|10929798|FG000|NOT COMPLETED|Overall Study||0
9819306|NCT00708643|10929799|FG001|NOT COMPLETED|Overall Study||1
9819307|NCT00708682|10929805|FG000|STARTED|Infant Series||225
9819308|NCT00708682|10929805|FG000|Vaccinated Dose 1|Infant Series||223
9819309|NCT00708682|10929805|FG000|Vaccinated Dose 2|Infant Series||214
9819310|NCT00708682|10929805|FG000|Vaccinated Dose 3|Infant Series||194
9819311|NCT00708682|10929805|FG000|COMPLETED|Infant Series||192
9819312|NCT00708682|10929805|FG000|NOT COMPLETED|Infant Series||33
10016989|NCT01814046|11139868|FG002|COMPLETED|Drug Administration||0
10016990|NCT01814046|11139866|FG000|NOT COMPLETED|Drug Administration||1
10016991|NCT01814046|11139867|FG001|NOT COMPLETED|Drug Administration||0
10016992|NCT01814046|11139868|FG002|NOT COMPLETED|Drug Administration||0
10016993|NCT01814046|11139866|FG000|STARTED|Retreatment||0
10016994|NCT01814046|11139867|FG001|STARTED|Retreatment||0
10016995|NCT01814046|11139868|FG002|STARTED|Retreatment||3
10016996|NCT01814046|11139866|FG000|COMPLETED|Retreatment||0
9819313|NCT00708682|10929805|FG000|STARTED|After Infant Series||192
9819314|NCT00708682|10929805|FG000|COMPLETED|After Infant Series||191
9819315|NCT00708682|10929805|FG000|NOT COMPLETED|After Infant Series||1
9819316|NCT00708682|10929805|FG000|STARTED|Toddler Dose||191
9819317|NCT00708682|10929805|FG000|COMPLETED|Toddler Dose||183
9819318|NCT00708682|10929805|FG000|NOT COMPLETED|Toddler Dose||8
9819319|NCT00708708|10929811|FG000|STARTED|Overall Study||955
9819320|NCT00708708|10929811|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
9819321|NCT00708708|10929811|FG000|NOT COMPLETED|Overall Study||742
9819322|NCT00708721|10929818|FG000|STARTED|Overall Study||2
9819323|NCT00708721|10929819|FG001|STARTED|Overall Study||4
9819324|NCT00708721|10929820|FG002|STARTED|Overall Study||3
9819325|NCT00708721|10929821|FG003|STARTED|Overall Study||2
9819326|NCT00708721|10929818|FG000|COMPLETED|Overall Study||2
9819327|NCT00708721|10929819|FG001|COMPLETED|Overall Study||4
9819328|NCT00708721|10929820|FG002|COMPLETED|Overall Study||3
9819329|NCT00708721|10929821|FG003|COMPLETED|Overall Study||2
9819330|NCT00708721|10929818|FG000|NOT COMPLETED|Overall Study||0
9819331|NCT00708721|10929819|FG001|NOT COMPLETED|Overall Study||0
9819332|NCT00708721|10929820|FG002|NOT COMPLETED|Overall Study||0
9819333|NCT00708721|10929821|FG003|NOT COMPLETED|Overall Study||0
9819334|NCT00708851|10929832|FG000|STARTED|Overall Study||12
9819335|NCT00708851|10929832|FG000|COMPLETED|Overall Study||12
9819336|NCT00708851|10929832|FG000|NOT COMPLETED|Overall Study||0
9819337|NCT00708877|10929838|FG000|STARTED|Overall Study||5
9819338|NCT00708877|10929838|FG000|COMPLETED|Overall Study||5
9819339|NCT00708877|10929838|FG000|NOT COMPLETED|Overall Study||0
9819340|NCT00708942|10929847|FG000|STARTED|Overall Study||47
9819341|NCT00708942|10929848|FG001|STARTED|Overall Study||12
9819342|NCT00708942|10929849|FG002|STARTED|Overall Study||11
9819343|NCT00708942|10929850|FG003|STARTED|Overall Study||10
9819344|NCT00708942|10929851|FG004|STARTED|Overall Study||3
9819345|NCT00708942|10929847|FG000|COMPLETED|Overall Study||40
9819346|NCT00708942|10929848|FG001|COMPLETED|Overall Study||11
9819347|NCT00708942|10929849|FG002|COMPLETED|Overall Study||9
9819348|NCT00708942|10929850|FG003|COMPLETED|Overall Study||10
9819349|NCT00708942|10929851|FG004|COMPLETED|Overall Study||2
9819350|NCT00708942|10929847|FG000|NOT COMPLETED|Overall Study||7
9819351|NCT00708942|10929848|FG001|NOT COMPLETED|Overall Study||1
9819352|NCT00708942|10929849|FG002|NOT COMPLETED|Overall Study||2
9819353|NCT00708942|10929850|FG003|NOT COMPLETED|Overall Study||0
9819354|NCT00708942|10929851|FG004|NOT COMPLETED|Overall Study||1
9819355|NCT00709059|10929863|FG000|STARTED|Overall Study||538
9819356|NCT00709059|10929863|FG000|COMPLETED|Overall Study||444
9819357|NCT00709059|10929863|FG000|NOT COMPLETED|Overall Study||94
9819358|NCT00709098|10929870|FG000|STARTED|Double-blind Period||25
9819359|NCT00709098|10929871|FG001|STARTED|Double-blind Period||24
9819360|NCT00709098|10929872|FG002|STARTED|Double-blind Period||0
9819361|NCT00709098|10929870|FG000|COMPLETED|Double-blind Period||19
9819362|NCT00709098|10929871|FG001|COMPLETED|Double-blind Period||16
9819363|NCT00709098|10929872|FG002|COMPLETED|Double-blind Period||0
9819364|NCT00709098|10929870|FG000|NOT COMPLETED|Double-blind Period||6
9819365|NCT00709098|10929871|FG001|NOT COMPLETED|Double-blind Period||8
9819366|NCT00709098|10929872|FG002|NOT COMPLETED|Double-blind Period||0
9819367|NCT00709098|10929870|FG000|STARTED|Open-label Period||0
9819368|NCT00709098|10929871|FG001|STARTED|Open-label Period||0
9819369|NCT00709098|10929872|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
9819370|NCT00709098|10929870|FG000|COMPLETED|Open-label Period||0
9819371|NCT00709098|10929871|FG001|COMPLETED|Open-label Period||0
9819372|NCT00709098|10929872|FG002|COMPLETED|Open-label Period||18
9819373|NCT00709098|10929870|FG000|NOT COMPLETED|Open-label Period||0
9819374|NCT00709098|10929871|FG001|NOT COMPLETED|Open-label Period||0
9819375|NCT00709098|10929872|FG002|NOT COMPLETED|Open-label Period||14
9819376|NCT00709111|10929881|FG000|STARTED|Overall Study||34
9819377|NCT00709111|10929881|FG000|Week 22/24|Overall Study||33
9819378|NCT00709111|10929881|FG000|COMPLETED|Overall Study||32
9819379|NCT00709111|10929881|FG000|NOT COMPLETED|Overall Study||2
9819380|NCT00709124|10929887|FG000|STARTED|Overall Study||16
9819381|NCT00709124|10929888|FG001|STARTED|Overall Study||18
9819382|NCT00709124|10929887|FG000|COMPLETED|Overall Study||12
9819383|NCT00709124|10929888|FG001|COMPLETED|Overall Study||17
9819384|NCT00709124|10929887|FG000|NOT COMPLETED|Overall Study||4
9819385|NCT00709124|10929888|FG001|NOT COMPLETED|Overall Study||1
9819386|NCT00709202|10929900|FG000|STARTED|Overall Study||19
9819387|NCT00709202|10929901|FG001|STARTED|Overall Study||21
9819388|NCT00709202|10929900|FG000|COMPLETED|Overall Study||13
9819389|NCT00709202|10929901|FG001|COMPLETED|Overall Study||15
9819390|NCT00709202|10929900|FG000|NOT COMPLETED|Overall Study||6
9819391|NCT00709202|10929901|FG001|NOT COMPLETED|Overall Study||6
9819392|NCT00709228|10929908|FG000|STARTED|Overall Study||496
9819393|NCT00709228|10929908|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
9819394|NCT00709228|10929908|FG000|NOT COMPLETED|Overall Study||332
9819395|NCT00709306|10929916|FG000|STARTED|Overall Study||48
9819396|NCT00709306|10929917|FG001|STARTED|Overall Study||44
9819397|NCT00709306|10929918|FG002|STARTED|Overall Study||58
9819398|NCT00709306|10929919|FG003|STARTED|Overall Study||47
9819399|NCT00709306|10929916|FG000|COMPLETED|Overall Study||39
9819400|NCT00709306|10929917|FG001|COMPLETED|Overall Study||30
9819401|NCT00709306|10929918|FG002|COMPLETED|Overall Study||48
9819402|NCT00709306|10929919|FG003|COMPLETED|Overall Study||37
9819403|NCT00709306|10929916|FG000|NOT COMPLETED|Overall Study||9
9819404|NCT00709306|10929917|FG001|NOT COMPLETED|Overall Study||14
9819405|NCT00709306|10929918|FG002|NOT COMPLETED|Overall Study||10
9819406|NCT00709306|10929919|FG003|NOT COMPLETED|Overall Study||10
9819407|NCT00709319|10929929|FG000|STARTED|Overall Study||87
9819408|NCT00709319|10929929|FG000|COMPLETED|Overall Study||81
9819409|NCT00709319|10929929|FG000|NOT COMPLETED|Overall Study||6
9819410|NCT00709592|10929935|FG000|STARTED|Overall Study||19
9819411|NCT00709592|10929936|FG001|STARTED|Overall Study||23
9819412|NCT00709592|10929935|FG000|COMPLETED|Overall Study||19
9819413|NCT00709592|10929936|FG001|COMPLETED|Overall Study||22
9819414|NCT00709592|10929935|FG000|NOT COMPLETED|Overall Study||0
9819415|NCT00709592|10929936|FG001|NOT COMPLETED|Overall Study||1
9819416|NCT00709618|10929942|FG000|STARTED|Overall Study||44
9819417|NCT00709618|10929942|FG000|COMPLETED|Overall Study||14
9819418|NCT00709618|10929942|FG000|NOT COMPLETED|Overall Study||30
9819419|NCT00709696|10929948|FG000|STARTED|Overall Study||4
9819420|NCT00709696|10929949|FG001|STARTED|Overall Study||3
9819421|NCT00709696|10929948|FG000|COMPLETED|Overall Study||4
9819422|NCT00709696|10929949|FG001|COMPLETED|Overall Study||3
9819423|NCT00709696|10929948|FG000|NOT COMPLETED|Overall Study||0
9819424|NCT00709696|10929949|FG001|NOT COMPLETED|Overall Study||0
9819425|NCT00709722|10929955|FG000|STARTED|Overall Study||21
9819426|NCT00709722|10929955|FG000|COMPLETED|Overall Study||20
9819427|NCT00709722|10929955|FG000|NOT COMPLETED|Overall Study||1
9819428|NCT00709735|10929961|FG000|STARTED|Overall Study||11
9819429|NCT00709735|10929962|FG001|STARTED|Overall Study||12
9819430|NCT00709735|10929961|FG000|COMPLETED|Overall Study||8
9819431|NCT00709735|10929962|FG001|COMPLETED|Overall Study||10
9819432|NCT00709735|10929961|FG000|NOT COMPLETED|Overall Study||3
9819433|NCT00709735|10929962|FG001|NOT COMPLETED|Overall Study||2
9819434|NCT00709761|10929968|FG000|STARTED|Overall Study||60
9819435|NCT00709761|10929968|FG000|COMPLETED|Overall Study||33
9819436|NCT00709761|10929968|FG000|NOT COMPLETED|Overall Study||27
9819437|NCT00709826|10929974|FG000|STARTED|Overall Study||70
9819438|NCT00709826|10929975|FG001|STARTED|Overall Study||39
9819439|NCT00709826|10929974|FG000|COMPLETED|Overall Study||68
9819440|NCT00709826|10929975|FG001|COMPLETED|Overall Study||38
9819441|NCT00709826|10929974|FG000|NOT COMPLETED|Overall Study||2
9819442|NCT00709826|10929975|FG001|NOT COMPLETED|Overall Study||1
9819443|NCT00709852|10929981|FG000|STARTED|Period 1||228
9819444|NCT00709852|10929982|FG001|STARTED|Period 1||174
9819445|NCT00709852|10929981|FG000|COMPLETED|Period 1||220
9819446|NCT00709852|10929982|FG001|COMPLETED|Period 1||171
9819447|NCT00709852|10929981|FG000|NOT COMPLETED|Period 1||8
9819448|NCT00709852|10929982|FG001|NOT COMPLETED|Period 1||3
9819449|NCT00709852|10929981|FG000|STARTED|Period 2||220
9819450|NCT00709852|10929982|FG001|STARTED|Period 2||171
9819451|NCT00709852|10929981|FG000|COMPLETED|Period 2||211
9819452|NCT00709852|10929982|FG001|COMPLETED|Period 2||169
9819453|NCT00709852|10929981|FG000|NOT COMPLETED|Period 2||9
9819454|NCT00709852|10929982|FG001|NOT COMPLETED|Period 2||2
9819455|NCT00709878|10930001|FG000|STARTED|Overall Study||8
9819456|NCT00709878|10930002|FG001|STARTED|Overall Study||8
9819457|NCT00709878|10930003|FG002|STARTED|Overall Study||8
9819458|NCT00709878|10930004|FG003|STARTED|Overall Study||8
9819459|NCT00709878|10930001|FG000|COMPLETED|Overall Study||8
9819460|NCT00709878|10930002|FG001|COMPLETED|Overall Study||8
9819461|NCT00709878|10930003|FG002|COMPLETED|Overall Study||8
9819462|NCT00709878|10930004|FG003|COMPLETED|Overall Study||8
9819463|NCT00709878|10930001|FG000|NOT COMPLETED|Overall Study||0
9819464|NCT00709878|10930002|FG001|NOT COMPLETED|Overall Study||0
9819465|NCT00709878|10930003|FG002|NOT COMPLETED|Overall Study||0
9819466|NCT00709878|10930004|FG003|NOT COMPLETED|Overall Study||0
9819467|NCT00709891|10930014|FG000|STARTED|Baseline, Cross-sectional Phase||47208
9819468|NCT00709891|10930014|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758
9819469|NCT00709891|10930014|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
9819470|NCT00709891|10930014|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
9819471|NCT00709891|10930014|FG000|COMPLETED|Longitudinal Follow-up Phase||5020
9819472|NCT00709891|10930014|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982
9819473|NCT00709956|10930020|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
9819474|NCT00709956|10930021|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
9819475|NCT00709956|10930020|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
9819476|NCT00709956|10930021|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
9819477|NCT00709956|10930020|FG000|COMPLETED|Overall Study||30
9819478|NCT00709956|10930021|FG001|COMPLETED|Overall Study||33
9819479|NCT00709956|10930020|FG000|NOT COMPLETED|Overall Study||3
9819480|NCT00709956|10930021|FG001|NOT COMPLETED|Overall Study||4
9819481|NCT00709995|10930031|FG000|STARTED|Overall Study||11
9819482|NCT00709995|10930032|FG001|STARTED|Overall Study||6
9819483|NCT00709995|10930031|FG000|Progressive Disease|Overall Study||6
9819484|NCT00709995|10930032|FG001|Progressive Disease|Overall Study||1
9819485|NCT00709995|10930031|FG000|COMPLETED|Overall Study||6
9819486|NCT00709995|10930032|FG001|COMPLETED|Overall Study||1
9819487|NCT00709995|10930031|FG000|NOT COMPLETED|Overall Study||5
9819488|NCT00709995|10930032|FG001|NOT COMPLETED|Overall Study||5
9819489|NCT00710021|10930044|FG000|STARTED|Overall Study||19
9819490|NCT00710021|10930045|FG001|STARTED|Overall Study||19
9819491|NCT00710021|10930046|FG002|STARTED|Overall Study||19
9819492|NCT00710021|10930044|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19
9819493|NCT00710021|10930045|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
9819494|NCT00710021|10930046|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
9819495|NCT00710021|10930044|FG000|COMPLETED|Overall Study||18
9819496|NCT00710021|10930045|FG001|COMPLETED|Overall Study||16
9819497|NCT00710021|10930046|FG002|COMPLETED|Overall Study||18
9819498|NCT00710021|10930044|FG000|NOT COMPLETED|Overall Study||1
9819499|NCT00710021|10930045|FG001|NOT COMPLETED|Overall Study||3
9819500|NCT00710021|10930046|FG002|NOT COMPLETED|Overall Study||1
9819501|NCT00710034|10930057|FG000|STARTED|Completed 6 Weeks of Treatment||195
9819502|NCT00710034|10930058|FG001|STARTED|Completed 6 Weeks of Treatment||196
9819503|NCT00710034|10930057|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
9819504|NCT00710034|10930058|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
9819505|NCT00710034|10930057|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41
9819506|NCT00710034|10930058|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47
9819507|NCT00710034|10930057|FG000|STARTED|Completed 12 Weeks of Treatment||154
9819508|NCT00710034|10930058|FG001|STARTED|Completed 12 Weeks of Treatment||149
9819509|NCT00710034|10930057|FG000|COMPLETED|Completed 12 Weeks of Treatment||141
9819510|NCT00710034|10930058|FG001|COMPLETED|Completed 12 Weeks of Treatment||138
9819511|NCT00710034|10930057|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13
9819512|NCT00710034|10930058|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11
9819513|NCT00710203|10930064|FG000|STARTED|Overall Study||10
9819514|NCT00710203|10930064|FG000|COMPLETED|Overall Study||10
9819515|NCT00710203|10930064|FG000|NOT COMPLETED|Overall Study||0
9819516|NCT00710385|10930074|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
9819517|NCT00710385|10930074|FG000|COMPLETED|Overall Study||12
9819518|NCT00710385|10930074|FG000|NOT COMPLETED|Overall Study||5
9819519|NCT00710424|10930086|FG000|STARTED|Overall Study||149
9819520|NCT00710424|10930087|FG001|STARTED|Overall Study||148
9819521|NCT00710424|10930086|FG000|COMPLETED|Overall Study||105
9819522|NCT00710424|10930087|FG001|COMPLETED|Overall Study||125
9819523|NCT00710424|10930086|FG000|NOT COMPLETED|Overall Study||44
9819524|NCT00710424|10930087|FG001|NOT COMPLETED|Overall Study||23
9819525|NCT00710554|10930095|FG000|STARTED|Overall Study||128
9819526|NCT00710554|10930096|FG001|STARTED|Overall Study||118
9819527|NCT00710554|10930095|FG000|COMPLETED|Overall Study||79
9819528|NCT00710554|10930096|FG001|COMPLETED|Overall Study||94
9819529|NCT00710554|10930095|FG000|NOT COMPLETED|Overall Study||49
9819530|NCT00710554|10930096|FG001|NOT COMPLETED|Overall Study||24
9819531|NCT00710593|10930104|FG000|STARTED|Overall Study||69
9819532|NCT00710593|10930105|FG001|STARTED|Overall Study||30
9819533|NCT00710593|10930104|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
9819534|NCT00710593|10930105|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
9819535|NCT00710593|10930104|FG000|NOT COMPLETED|Overall Study||15
9819536|NCT00710593|10930105|FG001|NOT COMPLETED|Overall Study||5
9819537|NCT00710606|10930129|FG000|STARTED|Overall Study||20
9819538|NCT00710606|10930130|FG001|STARTED|Overall Study||20
9819539|NCT00710606|10930129|FG000|COMPLETED|Overall Study||20
9819540|NCT00710606|10930130|FG001|COMPLETED|Overall Study||18
9819541|NCT00710606|10930129|FG000|NOT COMPLETED|Overall Study||0
9819542|NCT00710606|10930130|FG001|NOT COMPLETED|Overall Study||2
9819543|NCT00710684|10930141|FG000|STARTED|Overall Study||225
9819544|NCT00710684|10930142|FG001|STARTED|Overall Study||221
9819545|NCT00710684|10930143|FG002|STARTED|Overall Study||236
9819546|NCT00710684|10930141|FG000|COMPLETED|Overall Study||151
9819547|NCT00710684|10930142|FG001|COMPLETED|Overall Study||147
9819548|NCT00710684|10930143|FG002|COMPLETED|Overall Study||172
9819549|NCT00710684|10930141|FG000|NOT COMPLETED|Overall Study||74
9819550|NCT00710684|10930142|FG001|NOT COMPLETED|Overall Study||74
9819551|NCT00710684|10930143|FG002|NOT COMPLETED|Overall Study||64
9819552|NCT00710749|10930157|FG000|STARTED|Clinic Baseline Recording||30
9819553|NCT00710749|10930158|FG001|STARTED|Clinic Baseline Recording||30
9819554|NCT00710749|10930157|FG000|COMPLETED|Clinic Baseline Recording||30
9819555|NCT00710749|10930158|FG001|COMPLETED|Clinic Baseline Recording||30
9819556|NCT00710749|10930157|FG000|NOT COMPLETED|Clinic Baseline Recording||0
9819557|NCT00710749|10930158|FG001|NOT COMPLETED|Clinic Baseline Recording||0
9819558|NCT00710749|10930157|FG000|STARTED|First Intervention||30
9819559|NCT00710749|10930158|FG001|STARTED|First Intervention||30
9819560|NCT00710749|10930157|FG000|COMPLETED|First Intervention||29
9819561|NCT00710749|10930158|FG001|COMPLETED|First Intervention||30
9819562|NCT00710749|10930157|FG000|NOT COMPLETED|First Intervention||1
9819563|NCT00710749|10930158|FG001|NOT COMPLETED|First Intervention||0
9819564|NCT00710749|10930157|FG000|STARTED|Second Intervention||29
9819565|NCT00710749|10930158|FG001|STARTED|Second Intervention||30
9819566|NCT00710749|10930157|FG000|COMPLETED|Second Intervention||29
9819567|NCT00710749|10930158|FG001|COMPLETED|Second Intervention||30
9819568|NCT00710749|10930157|FG000|NOT COMPLETED|Second Intervention||0
9819569|NCT00710749|10930158|FG001|NOT COMPLETED|Second Intervention||0
9819570|NCT00710762|10930168|FG000|STARTED|Overall Study||44
9819571|NCT00710762|10930169|FG001|STARTED|Overall Study||40
9819572|NCT00710762|10930168|FG000|COMPLETED|Overall Study||5
9819573|NCT00710762|10930169|FG001|COMPLETED|Overall Study||0
9819574|NCT00710762|10930168|FG000|NOT COMPLETED|Overall Study||39
9819575|NCT00710762|10930169|FG001|NOT COMPLETED|Overall Study||40
9819576|NCT00710814|10930177|FG000|STARTED|Overall Study||15
9819577|NCT00710814|10930178|FG001|STARTED|Overall Study||16
9819578|NCT00710814|10930177|FG000|COMPLETED|Overall Study||14
9819579|NCT00710814|10930178|FG001|COMPLETED|Overall Study||13
9819580|NCT00710814|10930177|FG000|NOT COMPLETED|Overall Study||1
9819581|NCT00710814|10930178|FG001|NOT COMPLETED|Overall Study||3
9819582|NCT00710840|10930186|FG000|STARTED|Overall Study||22
9819583|NCT00710840|10930187|FG001|STARTED|Overall Study||22
9819584|NCT00710840|10930186|FG000|COMPLETED|Overall Study||22
9819585|NCT00710840|10930187|FG001|COMPLETED|Overall Study||19
9819586|NCT00710840|10930186|FG000|NOT COMPLETED|Overall Study||0
9819587|NCT00710840|10930187|FG001|NOT COMPLETED|Overall Study||3
9819588|NCT00710866|10930195|FG000|STARTED|Overall Study||133
9819589|NCT00710866|10930196|FG001|STARTED|Overall Study||134
9819590|NCT00710866|10930195|FG000|COMPLETED|Overall Study||124
9819591|NCT00710866|10930196|FG001|COMPLETED|Overall Study||128
9819592|NCT00710866|10930195|FG000|NOT COMPLETED|Overall Study||9
9819593|NCT00710866|10930196|FG001|NOT COMPLETED|Overall Study||6
9819594|NCT00710879|10930204|FG000|STARTED|Overall Study||60
9819595|NCT00710879|10930205|FG001|STARTED|Overall Study||117
9819596|NCT00710879|10930204|FG000|COMPLETED|Overall Study||58
9819597|NCT00710879|10930205|FG001|COMPLETED|Overall Study||113
9819598|NCT00710879|10930204|FG000|NOT COMPLETED|Overall Study||2
9819599|NCT00710879|10930205|FG001|NOT COMPLETED|Overall Study||4
9819600|NCT00710905|10930211|FG000|STARTED|Overall Study||50
9819601|NCT00710905|10930211|FG000|COMPLETED|Overall Study||34
9819602|NCT00710905|10930211|FG000|NOT COMPLETED|Overall Study||16
9819603|NCT00710931|10930215|FG000|STARTED|Overall Study||34
9819604|NCT00710931|10930215|FG000|COMPLETED|Overall Study||29
9819605|NCT00710931|10930215|FG000|NOT COMPLETED|Overall Study||5
9819606|NCT00710944|10930222|FG000|STARTED|Overall Study||55
9819607|NCT00710944|10930223|FG001|STARTED|Overall Study||58
9819608|NCT00710944|10930224|FG002|STARTED|Overall Study||19
9819609|NCT00710944|10930222|FG000|COMPLETED|Overall Study||45
9819610|NCT00710944|10930223|FG001|COMPLETED|Overall Study||49
9819611|NCT00710944|10930224|FG002|COMPLETED|Overall Study||17
9819612|NCT00710944|10930222|FG000|NOT COMPLETED|Overall Study||10
9819613|NCT00710944|10930223|FG001|NOT COMPLETED|Overall Study||9
9819614|NCT00710944|10930224|FG002|NOT COMPLETED|Overall Study||2
9819615|NCT00710996|10930235|FG000|STARTED|Overall Study||17
9819616|NCT00710996|10930236|FG001|STARTED|Overall Study||20
9819617|NCT00710996|10930237|FG002|STARTED|Overall Study||21
9819618|NCT00710996|10930235|FG000|COMPLETED|Overall Study||16
9819619|NCT00710996|10930236|FG001|COMPLETED|Overall Study||16
9819620|NCT00710996|10930237|FG002|COMPLETED|Overall Study||21
9819621|NCT00710996|10930235|FG000|NOT COMPLETED|Overall Study||1
9819622|NCT00710996|10930236|FG001|NOT COMPLETED|Overall Study||4
9819623|NCT00710996|10930237|FG002|NOT COMPLETED|Overall Study||0
9819624|NCT00711009|10930247|FG000|STARTED|Overall Study||105
9819625|NCT00711009|10930248|FG001|STARTED|Overall Study||101
9819626|NCT00711009|10930247|FG000|COMPLETED|Overall Study||90
9819627|NCT00711009|10930248|FG001|COMPLETED|Overall Study||82
9819628|NCT00711009|10930247|FG000|NOT COMPLETED|Overall Study||15
9819629|NCT00711009|10930248|FG001|NOT COMPLETED|Overall Study||19
9819630|NCT00711022|10930254|FG000|STARTED|Overall Study||51
9819631|NCT00711022|10930254|FG000|COMPLETED|Overall Study||40
9819632|NCT00711022|10930254|FG000|NOT COMPLETED|Overall Study||11
9819633|NCT00711100|10930258|FG000|STARTED|Overall Study||104
9819634|NCT00711100|10930258|FG000|COMPLETED|Overall Study||91
9819635|NCT00711100|10930258|FG000|NOT COMPLETED|Overall Study||13
9819636|NCT00711113|10930274|FG000|STARTED|Overall Study||47
9819637|NCT00711113|10930274|FG000|COMPLETED|Overall Study||36
9819638|NCT00711113|10930274|FG000|NOT COMPLETED|Overall Study||11
9819639|NCT00711191|10930281|FG000|STARTED|Overall Study||3
9819640|NCT00711191|10930282|FG001|STARTED|Overall Study||6
9819641|NCT00711191|10930283|FG002|STARTED|Overall Study||13
9819642|NCT00711191|10930281|FG000|COMPLETED|Overall Study||0
9819643|NCT00711191|10930282|FG001|COMPLETED|Overall Study||1
9819644|NCT00711191|10930283|FG002|COMPLETED|Overall Study||1
9819645|NCT00711191|10930281|FG000|NOT COMPLETED|Overall Study||3
9819646|NCT00711191|10930282|FG001|NOT COMPLETED|Overall Study||5
9819647|NCT00711191|10930283|FG002|NOT COMPLETED|Overall Study||12
9819648|NCT00711243|10930300|FG000|STARTED|Registed and Started Treatment||3
9819649|NCT00711243|10930301|FG001|STARTED|Registed and Started Treatment||3
9819650|NCT00711243|10930302|FG002|STARTED|Registed and Started Treatment||3
9819651|NCT00711243|10930303|FG003|STARTED|Registed and Started Treatment||3
9819652|NCT00711243|10930304|FG004|STARTED|Registed and Started Treatment||3
9819653|NCT00711243|10930305|FG005|STARTED|Registed and Started Treatment||44
9819654|NCT00711243|10930300|FG000|Registered to Study|Registed and Started Treatment||3
9819655|NCT00711243|10930301|FG001|Registered to Study|Registed and Started Treatment||3
9819656|NCT00711243|10930302|FG002|Registered to Study|Registed and Started Treatment||3
9819657|NCT00711243|10930303|FG003|Registered to Study|Registed and Started Treatment||3
9819658|NCT00711243|10930304|FG004|Registered to Study|Registed and Started Treatment||3
9819659|NCT00711243|10930305|FG005|Registered to Study|Registed and Started Treatment||44
9819660|NCT00711243|10930300|FG000|Started Treatment|Registed and Started Treatment||3
9819661|NCT00711243|10930301|FG001|Started Treatment|Registed and Started Treatment||3
9819662|NCT00711243|10930302|FG002|Started Treatment|Registed and Started Treatment||3
9819663|NCT00711243|10930303|FG003|Started Treatment|Registed and Started Treatment||3
9819664|NCT00711243|10930304|FG004|Started Treatment|Registed and Started Treatment||3
9819665|NCT00711243|10930305|FG005|Started Treatment|Registed and Started Treatment||43
9819666|NCT00711243|10930300|FG000|COMPLETED|Registed and Started Treatment||3
9819667|NCT00711243|10930301|FG001|COMPLETED|Registed and Started Treatment||3
9819668|NCT00711243|10930302|FG002|COMPLETED|Registed and Started Treatment||3
9819669|NCT00711243|10930303|FG003|COMPLETED|Registed and Started Treatment||3
9819670|NCT00711243|10930304|FG004|COMPLETED|Registed and Started Treatment||3
9819671|NCT00711243|10930305|FG005|COMPLETED|Registed and Started Treatment||43
9819672|NCT00711243|10930300|FG000|NOT COMPLETED|Registed and Started Treatment||0
9819673|NCT00711243|10930301|FG001|NOT COMPLETED|Registed and Started Treatment||0
9819674|NCT00711243|10930302|FG002|NOT COMPLETED|Registed and Started Treatment||0
9819675|NCT00711243|10930303|FG003|NOT COMPLETED|Registed and Started Treatment||0
9819676|NCT00711243|10930304|FG004|NOT COMPLETED|Registed and Started Treatment||0
9819677|NCT00711243|10930305|FG005|NOT COMPLETED|Registed and Started Treatment||1
9819678|NCT00711243|10930300|FG000|STARTED|Reached First Response/4 Cycles||3
9819679|NCT00711243|10930301|FG001|STARTED|Reached First Response/4 Cycles||3
9819680|NCT00711243|10930302|FG002|STARTED|Reached First Response/4 Cycles||3
9819681|NCT00711243|10930303|FG003|STARTED|Reached First Response/4 Cycles||3
9819682|NCT00711243|10930304|FG004|STARTED|Reached First Response/4 Cycles||3
9819683|NCT00711243|10930305|FG005|STARTED|Reached First Response/4 Cycles||43
9819684|NCT00711243|10930300|FG000|COMPLETED|Reached First Response/4 Cycles||3
9819685|NCT00711243|10930301|FG001|COMPLETED|Reached First Response/4 Cycles||3
9819686|NCT00711243|10930302|FG002|COMPLETED|Reached First Response/4 Cycles||3
9819687|NCT00711243|10930303|FG003|COMPLETED|Reached First Response/4 Cycles||2
9819688|NCT00711243|10930304|FG004|COMPLETED|Reached First Response/4 Cycles||3
9819689|NCT00711243|10930305|FG005|COMPLETED|Reached First Response/4 Cycles||41
9819690|NCT00711243|10930300|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0
9819691|NCT00711243|10930301|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0
9819692|NCT00711243|10930302|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0
9819693|NCT00711243|10930303|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1
9819694|NCT00711243|10930304|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0
9819695|NCT00711243|10930305|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2
9819696|NCT00711243|10930300|FG000|STARTED|Treated Cycle 5 After First Response||3
9819697|NCT00711243|10930301|FG001|STARTED|Treated Cycle 5 After First Response||3
9819698|NCT00711243|10930302|FG002|STARTED|Treated Cycle 5 After First Response||3
9819699|NCT00711243|10930303|FG003|STARTED|Treated Cycle 5 After First Response||2
9819700|NCT00711243|10930304|FG004|STARTED|Treated Cycle 5 After First Response||3
9819701|NCT00711243|10930305|FG005|STARTED|Treated Cycle 5 After First Response||41
9819702|NCT00711243|10930300|FG000|COMPLETED|Treated Cycle 5 After First Response||2
9819703|NCT00711243|10930301|FG001|COMPLETED|Treated Cycle 5 After First Response||1
9819704|NCT00711243|10930302|FG002|COMPLETED|Treated Cycle 5 After First Response||3
9819705|NCT00711243|10930303|FG003|COMPLETED|Treated Cycle 5 After First Response||2
9819706|NCT00711243|10930304|FG004|COMPLETED|Treated Cycle 5 After First Response||2
9819707|NCT00711243|10930305|FG005|COMPLETED|Treated Cycle 5 After First Response||37
9819708|NCT00711243|10930300|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1
9819709|NCT00711243|10930301|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2
9819710|NCT00711243|10930302|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0
9819711|NCT00711243|10930303|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0
9819712|NCT00711243|10930304|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1
9819713|NCT00711243|10930305|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4
9819714|NCT00711243|10930300|FG000|STARTED|Follow up Every 3 Months Until Death||3
9819715|NCT00711243|10930301|FG001|STARTED|Follow up Every 3 Months Until Death||3
9819716|NCT00711243|10930302|FG002|STARTED|Follow up Every 3 Months Until Death||3
9819717|NCT00711243|10930303|FG003|STARTED|Follow up Every 3 Months Until Death||3
9819718|NCT00711243|10930304|FG004|STARTED|Follow up Every 3 Months Until Death||3
9819719|NCT00711243|10930305|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
9819720|NCT00711243|10930300|FG000|COMPLETED|Follow up Every 3 Months Until Death||3
9819721|NCT00711243|10930301|FG001|COMPLETED|Follow up Every 3 Months Until Death||3
9819722|NCT00711243|10930302|FG002|COMPLETED|Follow up Every 3 Months Until Death||3
9819723|NCT00711243|10930303|FG003|COMPLETED|Follow up Every 3 Months Until Death||3
9819724|NCT00711243|10930304|FG004|COMPLETED|Follow up Every 3 Months Until Death||3
9819725|NCT00711243|10930305|FG005|COMPLETED|Follow up Every 3 Months Until Death||37
9819726|NCT00711243|10930300|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0
9819727|NCT00711243|10930301|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0
9819728|NCT00711243|10930302|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0
9819729|NCT00711243|10930303|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0
9819730|NCT00711243|10930304|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0
9819731|NCT00711243|10930305|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2
9819732|NCT00711347|10930323|FG000|STARTED|Overall Study||14
9819733|NCT00711347|10930324|FG001|STARTED|Overall Study||14
9819734|NCT00711347|10930323|FG000|COMPLETED|Overall Study||14
9819735|NCT00711347|10930324|FG001|COMPLETED|Overall Study||14
9819736|NCT00711347|10930323|FG000|NOT COMPLETED|Overall Study||0
9819737|NCT00711347|10930324|FG001|NOT COMPLETED|Overall Study||0
9819738|NCT00711412|10930330|FG000|STARTED|Induction Treatment||44
9819739|NCT00711412|10930330|FG000|Registered to Study|Induction Treatment||44
9819740|NCT00711412|10930330|FG000|Started Induction Treatment|Induction Treatment||43
9819741|NCT00711412|10930330|FG000|COMPLETED|Induction Treatment||40
9819742|NCT00711412|10930330|FG000|NOT COMPLETED|Induction Treatment||4
9819743|NCT00711412|10930330|FG000|STARTED|Evaluated for Combination Treatment||40
9819744|NCT00711412|10930330|FG000|COMPLETED|Evaluated for Combination Treatment||34
9819745|NCT00711412|10930330|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6
9819746|NCT00711412|10930330|FG000|STARTED|Combination Treatment||34
9819747|NCT00711412|10930330|FG000|COMPLETED|Combination Treatment||33
9819748|NCT00711412|10930330|FG000|NOT COMPLETED|Combination Treatment||1
9819749|NCT00711412|10930330|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
9819750|NCT00711412|10930330|FG000|COMPLETED|Evaluation for Response and Surgery||28
9819751|NCT00711412|10930330|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6
9819752|NCT00711412|10930330|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
9819753|NCT00711412|10930330|FG000|COMPLETED|Survival Follow up Until Death||26
9819754|NCT00711412|10930330|FG000|NOT COMPLETED|Survival Follow up Until Death||12
9819755|NCT00711425|10930335|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
9819756|NCT00711425|10930335|FG000|COMPLETED|Overall Study||41
9819757|NCT00711425|10930335|FG000|NOT COMPLETED|Overall Study||4
9819758|NCT00711464|10930339|FG000|STARTED|Overall Study||29
9819759|NCT00711464|10930339|FG000|COMPLETED|Overall Study||29
9819760|NCT00711464|10930339|FG000|NOT COMPLETED|Overall Study||0
9819761|NCT00711477|10930351|FG000|STARTED|Overall Study||23
9819762|NCT00711477|10930352|FG001|STARTED|Overall Study||23
9819763|NCT00711477|10930351|FG000|COMPLETED|Overall Study||20
9819764|NCT00711477|10930352|FG001|COMPLETED|Overall Study||20
9819765|NCT00711477|10930351|FG000|NOT COMPLETED|Overall Study||3
9819766|NCT00711477|10930352|FG001|NOT COMPLETED|Overall Study||3
9819767|NCT00711490|10930360|FG000|STARTED|Overall Study||5
9819768|NCT00711490|10930360|FG000|COMPLETED|Overall Study||5
9819769|NCT00711490|10930360|FG000|NOT COMPLETED|Overall Study||0
9819770|NCT00711516|10930367|FG000|STARTED|Overall Study||21
9819771|NCT00711516|10930368|FG001|STARTED|Overall Study||19
9819772|NCT00711516|10930367|FG000|COMPLETED|Overall Study||20
9819773|NCT00711516|10930368|FG001|COMPLETED|Overall Study||16
9819774|NCT00711516|10930367|FG000|NOT COMPLETED|Overall Study||1
9819775|NCT00711516|10930368|FG001|NOT COMPLETED|Overall Study||3
9819776|NCT00711529|10930376|FG000|STARTED|Overall Study||13
9819777|NCT00711529|10930377|FG001|STARTED|Overall Study||14
9819778|NCT00711529|10930376|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
9819779|NCT00711529|10930377|FG001|COMPLETED|Overall Study||8
9819780|NCT00711529|10930376|FG000|NOT COMPLETED|Overall Study||4
9819781|NCT00711529|10930377|FG001|NOT COMPLETED|Overall Study||6
9819782|NCT00711594|10930387|FG000|STARTED|Overall Study||3
9819783|NCT00711594|10930388|FG001|STARTED|Overall Study||3
9819784|NCT00711594|10930389|FG002|STARTED|Overall Study||6
9819785|NCT00711594|10930390|FG003|STARTED|Overall Study||62
9819786|NCT00711594|10930387|FG000|COMPLETED|Overall Study||0
9819787|NCT00711594|10930388|FG001|COMPLETED|Overall Study||0
9819788|NCT00711594|10930389|FG002|COMPLETED|Overall Study||0
9819789|NCT00711594|10930390|FG003|COMPLETED|Overall Study||0
9819790|NCT00711594|10930387|FG000|NOT COMPLETED|Overall Study||3
9819791|NCT00711594|10930388|FG001|NOT COMPLETED|Overall Study||3
9819792|NCT00711594|10930389|FG002|NOT COMPLETED|Overall Study||6
9819793|NCT00711594|10930390|FG003|NOT COMPLETED|Overall Study||62
9819794|NCT00711646|10930404|FG000|STARTED|Overall Study||124
9819795|NCT00711646|10930405|FG001|STARTED|Overall Study||65
9819796|NCT00711646|10930404|FG000|COMPLETED|Overall Study||112
9819797|NCT00711646|10930405|FG001|COMPLETED|Overall Study||62
9819798|NCT00711646|10930404|FG000|NOT COMPLETED|Overall Study||12
9819799|NCT00711646|10930405|FG001|NOT COMPLETED|Overall Study||3
9819800|NCT00711711|10930413|FG000|STARTED|Overall Study||30
9819801|NCT00711711|10930414|FG001|STARTED|Overall Study||30
9819802|NCT00711711|10930413|FG000|Second Postsurgical Day|Overall Study||30
9819803|NCT00711711|10930414|FG001|Second Postsurgical Day|Overall Study||30
9819804|NCT00711711|10930413|FG000|Seventh Postsurgical Day|Overall Study||29
9819805|NCT00711711|10930414|FG001|Seventh Postsurgical Day|Overall Study||27
9819806|NCT00711711|10930413|FG000|COMPLETED|Overall Study||29
9819807|NCT00711711|10930414|FG001|COMPLETED|Overall Study||24
9819808|NCT00711711|10930413|FG000|NOT COMPLETED|Overall Study||1
9819809|NCT00711711|10930414|FG001|NOT COMPLETED|Overall Study||6
9819810|NCT00711802|10930430|FG000|STARTED|Overall Study||75
9819811|NCT00711802|10930431|FG001|STARTED|Overall Study||38
9819812|NCT00711802|10930432|FG002|STARTED|Overall Study||75
9819813|NCT00711802|10930433|FG003|STARTED|Overall Study||38
9819814|NCT00711802|10930434|FG004|STARTED|Overall Study||83
9819815|NCT00711802|10930435|FG005|STARTED|Overall Study||42
9819816|NCT00711802|10930436|FG006|STARTED|Overall Study||30
9819817|NCT00711802|10930437|FG007|STARTED|Overall Study||15
9819818|NCT00711802|10930430|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
9819819|NCT00711802|10930431|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37
9819820|NCT00711802|10930432|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73
9819821|NCT00711802|10930433|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
9819822|NCT00711802|10930434|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81
9819823|NCT00711802|10930435|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42
9819824|NCT00711802|10930436|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30
9819825|NCT00711802|10930437|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15
9819826|NCT00711802|10930430|FG000|COMPLETED|Overall Study||73
9819827|NCT00711802|10930431|FG001|COMPLETED|Overall Study||32
9819828|NCT00711802|10930432|FG002|COMPLETED|Overall Study||69
9819829|NCT00711802|10930433|FG003|COMPLETED|Overall Study||35
9819830|NCT00711802|10930434|FG004|COMPLETED|Overall Study||69
9819831|NCT00711802|10930435|FG005|COMPLETED|Overall Study||34
9819832|NCT00711802|10930436|FG006|COMPLETED|Overall Study||25
9819833|NCT00711802|10930437|FG007|COMPLETED|Overall Study||13
9819834|NCT00711802|10930430|FG000|NOT COMPLETED|Overall Study||2
9819835|NCT00711802|10930431|FG001|NOT COMPLETED|Overall Study||6
9819836|NCT00711802|10930432|FG002|NOT COMPLETED|Overall Study||6
9819837|NCT00711802|10930433|FG003|NOT COMPLETED|Overall Study||3
9819838|NCT00711802|10930434|FG004|NOT COMPLETED|Overall Study||14
9819839|NCT00711802|10930435|FG005|NOT COMPLETED|Overall Study||8
9819840|NCT00711802|10930436|FG006|NOT COMPLETED|Overall Study||5
9819841|NCT00711802|10930437|FG007|NOT COMPLETED|Overall Study||2
9819842|NCT00711828|10930458|FG000|STARTED|Overall Study||21
9819843|NCT00711828|10930458|FG000|COMPLETED|Overall Study||21
9819844|NCT00711828|10930458|FG000|NOT COMPLETED|Overall Study||0
9819845|NCT00711867|10930464|FG000|STARTED|Overall Study||30
9819846|NCT00711867|10930465|FG001|STARTED|Overall Study||25
9819847|NCT00711867|10930464|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
9819848|NCT00711867|10930465|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
9819849|NCT00711867|10930464|FG000|NOT COMPLETED|Overall Study||5
9819850|NCT00711867|10930465|FG001|NOT COMPLETED|Overall Study||4
9819851|NCT00711880|10930473|FG000|STARTED|Overall Study||63
9819852|NCT00711880|10930474|FG001|STARTED|Overall Study||62
9819853|NCT00711880|10930473|FG000|COMPLETED|Overall Study||50
9819854|NCT00711880|10930474|FG001|COMPLETED|Overall Study||55
9819855|NCT00711880|10930473|FG000|NOT COMPLETED|Overall Study||13
9819856|NCT00711880|10930474|FG001|NOT COMPLETED|Overall Study||7
9819857|NCT00711958|10930482|FG000|STARTED|Overall Study||74
9819858|NCT00711958|10930483|FG001|STARTED|Overall Study||40
9819859|NCT00711958|10930482|FG000|COMPLETED|Overall Study||41
9819860|NCT00711958|10930483|FG001|COMPLETED|Overall Study||17
9819861|NCT00711958|10930482|FG000|NOT COMPLETED|Overall Study||33
9819862|NCT00711958|10930483|FG001|NOT COMPLETED|Overall Study||23
9819863|NCT00711971|10930492|FG000|STARTED|Overall Study||42
9819864|NCT00711971|10930493|FG001|STARTED|Overall Study||42
9819865|NCT00711971|10930494|FG002|STARTED|Overall Study||42
9819866|NCT00711971|10930492|FG000|COMPLETED|Overall Study||39
9819867|NCT00711971|10930493|FG001|COMPLETED|Overall Study||38
9819868|NCT00711971|10930494|FG002|COMPLETED|Overall Study||41
9819869|NCT00711971|10930492|FG000|NOT COMPLETED|Overall Study||3
9819870|NCT00711971|10930493|FG001|NOT COMPLETED|Overall Study||4
9819871|NCT00711971|10930494|FG002|NOT COMPLETED|Overall Study||1
9819872|NCT00711997|10930508|FG000|STARTED|Overall Study||3
9819873|NCT00711997|10930509|FG001|STARTED|Overall Study||6
9819874|NCT00711997|10930508|FG000|COMPLETED|Overall Study||3
9819875|NCT00711997|10930509|FG001|COMPLETED|Overall Study||6
9819876|NCT00711997|10930508|FG000|NOT COMPLETED|Overall Study||0
9819877|NCT00711997|10930509|FG001|NOT COMPLETED|Overall Study||0
9819878|NCT00712010|10930517|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
9819879|NCT00712010|10930517|FG000|COMPLETED|1st Protein Testing (1 Day)||24
9819880|NCT00712010|10930517|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0
9819881|NCT00712010|10930517|FG000|STARTED|Washout (7 Days)||24
9819882|NCT00712010|10930517|FG000|COMPLETED|Washout (7 Days)||24
9819883|NCT00712010|10930517|FG000|NOT COMPLETED|Washout (7 Days)||0
9819884|NCT00712010|10930517|FG000|STARTED|2nd Protein Testing (1 Day)||24
9819885|NCT00712010|10930517|FG000|COMPLETED|2nd Protein Testing (1 Day)||24
9819886|NCT00712010|10930517|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0
9819887|NCT00712010|10930517|FG000|STARTED|Washout (7 Days)||24
9819888|NCT00712010|10930517|FG000|COMPLETED|Washout (7 Days)||24
9819889|NCT00712010|10930517|FG000|NOT COMPLETED|Washout (7 Days)||0
9819890|NCT00712010|10930517|FG000|STARTED|3rd Protein Testing (1 Day)||24
9819891|NCT00712010|10930517|FG000|COMPLETED|3rd Protein Testing (1 Day)||24
9819892|NCT00712010|10930517|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0
9819893|NCT00712010|10930517|FG000|STARTED|Washout (7 Days)||24
9819894|NCT00712010|10930517|FG000|COMPLETED|Washout (7 Days)||24
9819895|NCT00712010|10930517|FG000|NOT COMPLETED|Washout (7 Days)||0
9819896|NCT00712010|10930517|FG000|STARTED|4th Protein Testing (1 Day)||24
9819897|NCT00712010|10930517|FG000|COMPLETED|4th Protein Testing (1 Day)||24
9819898|NCT00712010|10930517|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0
9819899|NCT00712010|10930517|FG000|STARTED|Washout (7 Days)||24
9819900|NCT00712010|10930517|FG000|COMPLETED|Washout (7 Days)||23
9819901|NCT00712010|10930517|FG000|NOT COMPLETED|Washout (7 Days)||1
9819902|NCT00712010|10930517|FG000|STARTED|5th Protein Testing (1 Day)||23
9819903|NCT00712010|10930517|FG000|COMPLETED|5th Protein Testing (1 Day)||23
9819904|NCT00712010|10930517|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0
9819905|NCT00712010|10930517|FG000|STARTED|Washout (7 Days)||23
9819906|NCT00712010|10930517|FG000|COMPLETED|Washout (7 Days)||23
9819907|NCT00712010|10930517|FG000|NOT COMPLETED|Washout (7 Days)||0
9819908|NCT00712010|10930517|FG000|STARTED|6th Protein Testing (1 Day)||23
9819909|NCT00712010|10930517|FG000|COMPLETED|6th Protein Testing (1 Day)||23
9819910|NCT00712010|10930517|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0
9819911|NCT00712010|10930517|FG000|STARTED|Washout (7 Days)||23
9819912|NCT00712010|10930517|FG000|COMPLETED|Washout (7 Days)||23
9819913|NCT00712010|10930517|FG000|NOT COMPLETED|Washout (7 Days)||0
9819914|NCT00712010|10930517|FG000|STARTED|7th and Last Protein Testing (1 Day)||23
9819915|NCT00712010|10930517|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23
9819916|NCT00712010|10930517|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
9819917|NCT00712075|10930536|FG000|STARTED|Overall Study||22
9819918|NCT00712075|10930537|FG001|STARTED|Overall Study||30
9819919|NCT00712075|10930538|FG002|STARTED|Overall Study||25
9819920|NCT00712075|10930536|FG000|COMPLETED|Overall Study||17
9819921|NCT00712075|10930537|FG001|COMPLETED|Overall Study||26
9819922|NCT00712075|10930538|FG002|COMPLETED|Overall Study||14
9819923|NCT00712075|10930536|FG000|NOT COMPLETED|Overall Study||5
9819924|NCT00712075|10930537|FG001|NOT COMPLETED|Overall Study||4
9819925|NCT00712075|10930538|FG002|NOT COMPLETED|Overall Study||11
9819926|NCT00712166|10930548|FG000|STARTED|Overall Study||81
9819927|NCT00712166|10930549|FG001|STARTED|Overall Study||76
9819928|NCT00712166|10930548|FG000|COMPLETED|Overall Study||81
9819929|NCT00712166|10930549|FG001|COMPLETED|Overall Study||75
9819930|NCT00712166|10930548|FG000|NOT COMPLETED|Overall Study||0
9819931|NCT00712166|10930549|FG001|NOT COMPLETED|Overall Study||1
9819932|NCT00712179|10930557|FG000|STARTED|Overall Study||49
9819933|NCT00712179|10930557|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
9819934|NCT00712179|10930557|FG000|NOT COMPLETED|Overall Study||12
9819935|NCT00712244|10930565|FG000|STARTED|Overall Study||29
9819936|NCT00712244|10930566|FG001|STARTED|Overall Study||29
9819937|NCT00712244|10930567|FG002|STARTED|Overall Study||27
9819938|NCT00712244|10930568|FG003|STARTED|Overall Study||27
9819939|NCT00712244|10930565|FG000|COMPLETED|Overall Study||25
9819940|NCT00712244|10930566|FG001|COMPLETED|Overall Study||28
9819941|NCT00712244|10930567|FG002|COMPLETED|Overall Study||25
10236791|NCT00816777|11367527|FG000|COMPLETED|Overall Study||2
10236792|NCT00816777|11367528|FG001|COMPLETED|Overall Study||2
10236793|NCT00816777|11367527|FG000|NOT COMPLETED|Overall Study||0
10236794|NCT00816777|11367528|FG001|NOT COMPLETED|Overall Study||0
9819942|NCT00712244|10930568|FG003|COMPLETED|Overall Study||26
9819943|NCT00712244|10930565|FG000|NOT COMPLETED|Overall Study||4
9819944|NCT00712244|10930566|FG001|NOT COMPLETED|Overall Study||1
9819945|NCT00712244|10930567|FG002|NOT COMPLETED|Overall Study||2
9819946|NCT00712244|10930568|FG003|NOT COMPLETED|Overall Study||1
9819947|NCT00712270|10930581|FG000|STARTED|Overall Study||21
9819948|NCT00712270|10930581|FG000|COMPLETED|Overall Study||7
9819949|NCT00712270|10930581|FG000|NOT COMPLETED|Overall Study||14
9819950|NCT00712296|10930595|FG000|STARTED|Phase I ( 1 Week)||12
9819951|NCT00712296|10930596|FG001|STARTED|Phase I ( 1 Week)||8
9819952|NCT00712296|10930597|FG002|STARTED|Phase I ( 1 Week)||0
9819953|NCT00712296|10930598|FG003|STARTED|Phase I ( 1 Week)||0
9819954|NCT00712296|10930599|FG004|STARTED|Phase I ( 1 Week)||0
9819955|NCT00712296|10930595|FG000|COMPLETED|Phase I ( 1 Week)||12
9819956|NCT00712296|10930596|FG001|COMPLETED|Phase I ( 1 Week)||8
9819957|NCT00712296|10930597|FG002|COMPLETED|Phase I ( 1 Week)||0
9819958|NCT00712296|10930598|FG003|COMPLETED|Phase I ( 1 Week)||0
9819959|NCT00712296|10930599|FG004|COMPLETED|Phase I ( 1 Week)||0
9819960|NCT00712296|10930595|FG000|NOT COMPLETED|Phase I ( 1 Week)||0
9819961|NCT00712296|10930596|FG001|NOT COMPLETED|Phase I ( 1 Week)||0
9819962|NCT00712296|10930597|FG002|NOT COMPLETED|Phase I ( 1 Week)||0
9819963|NCT00712296|10930598|FG003|NOT COMPLETED|Phase I ( 1 Week)||0
9819964|NCT00712296|10930599|FG004|NOT COMPLETED|Phase I ( 1 Week)||0
9819965|NCT00712296|10930595|FG000|STARTED|Phase II (28 Weeks)||0
9819966|NCT00712296|10930596|FG001|STARTED|Phase II (28 Weeks)||0
9819967|NCT00712296|10930597|FG002|STARTED|Phase II (28 Weeks)||15
9819968|NCT00712296|10930598|FG003|STARTED|Phase II (28 Weeks)||16
9819969|NCT00712296|10930599|FG004|STARTED|Phase II (28 Weeks)||15
9819970|NCT00712296|10930595|FG000|COMPLETED|Phase II (28 Weeks)||0
9819971|NCT00712296|10930596|FG001|COMPLETED|Phase II (28 Weeks)||0
9819972|NCT00712296|10930597|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
9819973|NCT00712296|10930598|FG003|COMPLETED|Phase II (28 Weeks)||1
9819974|NCT00712296|10930599|FG004|COMPLETED|Phase II (28 Weeks)||3
9819975|NCT00712296|10930595|FG000|NOT COMPLETED|Phase II (28 Weeks)||0
9819976|NCT00712296|10930596|FG001|NOT COMPLETED|Phase II (28 Weeks)||0
9819977|NCT00712296|10930597|FG002|NOT COMPLETED|Phase II (28 Weeks)||13
9819978|NCT00712296|10930598|FG003|NOT COMPLETED|Phase II (28 Weeks)||15
9819979|NCT00712296|10930599|FG004|NOT COMPLETED|Phase II (28 Weeks)||12
9819980|NCT00712335|10930635|FG000|STARTED|Overall Study||8
9819981|NCT00712335|10930636|FG001|STARTED|Overall Study||32
9819982|NCT00712335|10930637|FG002|STARTED|Overall Study||11
9819983|NCT00712335|10930638|FG003|STARTED|Overall Study||24
9819984|NCT00712335|10930639|FG004|STARTED|Overall Study||30
10236795|NCT00823095|11367534|FG000|STARTED|Overall Study||7
10236796|NCT00823095|11367534|FG000|COMPLETED|Overall Study||7
10236797|NCT00823095|11367534|FG000|NOT COMPLETED|Overall Study||0
9819985|NCT00712335|10930635|FG000|COMPLETED|Overall Study||5
9819986|NCT00712335|10930636|FG001|COMPLETED|Overall Study||15
9819987|NCT00712335|10930637|FG002|COMPLETED|Overall Study||6
9819988|NCT00712335|10930638|FG003|COMPLETED|Overall Study||19
9819989|NCT00712335|10930639|FG004|COMPLETED|Overall Study||30
9819990|NCT00712335|10930635|FG000|NOT COMPLETED|Overall Study||3
9819991|NCT00712335|10930636|FG001|NOT COMPLETED|Overall Study||17
9819992|NCT00712335|10930637|FG002|NOT COMPLETED|Overall Study||5
9819993|NCT00712335|10930638|FG003|NOT COMPLETED|Overall Study||5
9819994|NCT00712335|10930639|FG004|NOT COMPLETED|Overall Study||0
9819995|NCT00712348|10930651|FG000|STARTED|Overall Study||31
9819996|NCT00712348|10930651|FG000|COMPLETED|Overall Study||30
9819997|NCT00712348|10930651|FG000|NOT COMPLETED|Overall Study||1
9819998|NCT00712530|10930658|FG000|STARTED|Overall Study||3
9819999|NCT00712530|10930659|FG001|STARTED|Overall Study||3
9832028|NCT00771537|10942728|FG003|COMPLETED|Overall Study||114
9820000|NCT00712530|10930660|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
9820001|NCT00712530|10930658|FG000|COMPLETED|Overall Study||3
9820002|NCT00712530|10930659|FG001|COMPLETED|Overall Study||3
9820003|NCT00712530|10930660|FG002|COMPLETED|Overall Study||3
9820004|NCT00712530|10930658|FG000|NOT COMPLETED|Overall Study||0
9820005|NCT00712530|10930659|FG001|NOT COMPLETED|Overall Study||0
9820006|NCT00712530|10930660|FG002|NOT COMPLETED|Overall Study||0
9820007|NCT00712543|10930670|FG000|STARTED|Day 1-7||23
9820008|NCT00712543|10930671|FG001|STARTED|Day 1-7||27
9820009|NCT00712543|10930670|FG000|COMPLETED|Day 1-7||23
9820010|NCT00712543|10930671|FG001|COMPLETED|Day 1-7||27
9820011|NCT00712543|10930670|FG000|NOT COMPLETED|Day 1-7||0
9820012|NCT00712543|10930671|FG001|NOT COMPLETED|Day 1-7||0
9820013|NCT00712543|10930670|FG000|STARTED|Day 8-14||23
9820014|NCT00712543|10930671|FG001|STARTED|Day 8-14||27
9820015|NCT00712543|10930670|FG000|COMPLETED|Day 8-14||23
9820016|NCT00712543|10930671|FG001|COMPLETED|Day 8-14||25
9820017|NCT00712543|10930670|FG000|NOT COMPLETED|Day 8-14||0
9820018|NCT00712543|10930671|FG001|NOT COMPLETED|Day 8-14||2
9820019|NCT00712673|10930680|FG000|STARTED|Overall Study|Randomized.|85
9820020|NCT00712673|10930681|FG001|STARTED|Overall Study||85
9820021|NCT00712673|10930682|FG002|STARTED|Overall Study||255
9820022|NCT00712673|10930683|FG003|STARTED|Overall Study||255
9820023|NCT00712673|10930680|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
9820024|NCT00712673|10930681|FG001|Safety Population|Overall Study||85
9820025|NCT00712673|10930682|FG002|Safety Population|Overall Study||255
9820026|NCT00712673|10930683|FG003|Safety Population|Overall Study||255
9820027|NCT00712673|10930680|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
9820028|NCT00712673|10930681|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85
9820029|NCT00712673|10930682|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255
9820030|NCT00712673|10930683|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255
9820031|NCT00712673|10930680|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
9820032|NCT00712673|10930681|FG001|Subgroup for Standardized Meal Test|Overall Study||0
9820033|NCT00712673|10930682|FG002|Subgroup for Standardized Meal Test|Overall Study||255
9820034|NCT00712673|10930683|FG003|Subgroup for Standardized Meal Test|Overall Study||0
9820035|NCT00712673|10930680|FG000|COMPLETED|Overall Study||64
9820036|NCT00712673|10930681|FG001|COMPLETED|Overall Study||64
9820037|NCT00712673|10930682|FG002|COMPLETED|Overall Study||198
9820038|NCT00712673|10930683|FG003|COMPLETED|Overall Study||185
9820039|NCT00712673|10930680|FG000|NOT COMPLETED|Overall Study||21
9820040|NCT00712673|10930681|FG001|NOT COMPLETED|Overall Study||21
9820041|NCT00712673|10930682|FG002|NOT COMPLETED|Overall Study||57
9820042|NCT00712673|10930683|FG003|NOT COMPLETED|Overall Study||70
9820043|NCT00712712|10930702|FG000|STARTED|Overall Study||78
9820044|NCT00712712|10930702|FG000|COMPLETED|Overall Study||55
9820045|NCT00712712|10930702|FG000|NOT COMPLETED|Overall Study||23
9820046|NCT00712725|10930714|FG000|STARTED|Overall Study||169
9820047|NCT00712725|10930715|FG001|STARTED|Overall Study||39
9820048|NCT00712725|10930716|FG002|STARTED|Overall Study||57
9820049|NCT00712725|10930717|FG003|STARTED|Overall Study||84
9820050|NCT00712725|10930718|FG004|STARTED|Overall Study||86
9820051|NCT00712725|10930719|FG005|STARTED|Overall Study||84
9820052|NCT00712725|10930720|FG006|STARTED|Overall Study||83
9820053|NCT00712725|10930721|FG007|STARTED|Overall Study||74
9820054|NCT00712725|10930714|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
9820055|NCT00712725|10930715|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
9820056|NCT00712725|10930716|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
9820057|NCT00712725|10930717|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
9820058|NCT00712725|10930718|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
9820059|NCT00712725|10930719|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
9820060|NCT00712725|10930720|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
9820061|NCT00712725|10930721|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
9820062|NCT00712725|10930714|FG000|NOT COMPLETED|Overall Study||29
9820063|NCT00712725|10930715|FG001|NOT COMPLETED|Overall Study||6
9820064|NCT00712725|10930716|FG002|NOT COMPLETED|Overall Study||10
9820065|NCT00712725|10930717|FG003|NOT COMPLETED|Overall Study||17
9820066|NCT00712725|10930718|FG004|NOT COMPLETED|Overall Study||19
9820067|NCT00712725|10930719|FG005|NOT COMPLETED|Overall Study||16
9820068|NCT00712725|10930720|FG006|NOT COMPLETED|Overall Study||22
9820069|NCT00712725|10930721|FG007|NOT COMPLETED|Overall Study||11
9820070|NCT00712920|10930742|FG000|STARTED|Overall Study||192
9820071|NCT00712920|10930743|FG001|STARTED|Overall Study|3 subjects were randomized in error|197
9820072|NCT00712920|10930744|FG002|STARTED|Overall Study||192
9820073|NCT00712920|10930742|FG000|COMPLETED|Overall Study||175
9820074|NCT00712920|10930743|FG001|COMPLETED|Overall Study||180
9820075|NCT00712920|10930744|FG002|COMPLETED|Overall Study||180
9820076|NCT00712920|10930742|FG000|NOT COMPLETED|Overall Study||17
9820077|NCT00712920|10930743|FG001|NOT COMPLETED|Overall Study||17
9820078|NCT00712920|10930744|FG002|NOT COMPLETED|Overall Study||12
9820079|NCT00712959|10930754|FG000|STARTED|Overall Study||361
9820080|NCT00712959|10930755|FG001|STARTED|Overall Study||407
9820081|NCT00712959|10930754|FG000|COMPLETED|Overall Study||342
9820082|NCT00712959|10930755|FG001|COMPLETED|Overall Study||404
9820083|NCT00712959|10930754|FG000|NOT COMPLETED|Overall Study||19
9820084|NCT00712959|10930755|FG001|NOT COMPLETED|Overall Study||3
9820085|NCT00712985|10930761|FG000|STARTED|Overall Study||18
9820086|NCT00712985|10930761|FG000|COMPLETED|Overall Study||13
9820087|NCT00712985|10930761|FG000|NOT COMPLETED|Overall Study||5
9820088|NCT00713219|10930765|FG000|STARTED|Overall Study||14
9820089|NCT00713219|10930765|FG000|COMPLETED|Overall Study||12
9820090|NCT00713219|10930765|FG000|NOT COMPLETED|Overall Study||2
9820091|NCT00713284|10930769|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
9820092|NCT00713284|10930769|FG000|COMPLETED|Overall Study||13
9820093|NCT00713284|10930769|FG000|NOT COMPLETED|Overall Study||16
9820094|NCT00713310|10930775|FG000|STARTED|Overall Study||41
9820095|NCT00713310|10930776|FG001|STARTED|Overall Study||42
9820096|NCT00713310|10930775|FG000|mITT Population|Overall Study||41
9820097|NCT00713310|10930776|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
9820098|NCT00713310|10930775|FG000|COMPLETED|Overall Study||36
9820099|NCT00713310|10930776|FG001|COMPLETED|Overall Study||36
9820100|NCT00713310|10930775|FG000|NOT COMPLETED|Overall Study||5
9820101|NCT00713310|10930776|FG001|NOT COMPLETED|Overall Study||6
9820102|NCT00713323|10930782|FG000|STARTED|Overall Study||380
9820103|NCT00713323|10930782|FG000|COMPLETED|Overall Study||234
9820104|NCT00713323|10930782|FG000|NOT COMPLETED|Overall Study||146
9820105|NCT00713349|10930786|FG000|STARTED|Overall Study||25
9820106|NCT00713349|10930786|FG000|COMPLETED|Overall Study||24
9820107|NCT00713349|10930786|FG000|NOT COMPLETED|Overall Study||1
9820108|NCT00713427|10930792|FG000|STARTED|Overall Study||70
9820109|NCT00713427|10930792|FG000|COMPLETED|Overall Study||66
9820110|NCT00713427|10930792|FG000|NOT COMPLETED|Overall Study||4
9832029|NCT00771537|10942729|FG004|COMPLETED|Overall Study||127
9832030|NCT00771537|10942730|FG005|COMPLETED|Overall Study||118
9832031|NCT00771537|10942731|FG006|COMPLETED|Overall Study||128
9832032|NCT00771537|10942732|FG007|COMPLETED|Overall Study||132
9832033|NCT00771537|10942733|FG008|COMPLETED|Overall Study||115
9832034|NCT00771537|10942734|FG009|COMPLETED|Overall Study||119
9832035|NCT00771537|10942735|FG010|COMPLETED|Overall Study||133
9832036|NCT00771537|10942736|FG011|COMPLETED|Overall Study||137
9832037|NCT00771537|10942737|FG012|COMPLETED|Overall Study||128
9832038|NCT00771537|10942738|FG013|COMPLETED|Overall Study||124
9832039|NCT00771537|10942739|FG014|COMPLETED|Overall Study||124
9832040|NCT00771537|10942740|FG015|COMPLETED|Overall Study||122
9832041|NCT00771537|10942725|FG000|NOT COMPLETED|Overall Study||0
9832042|NCT00771537|10942726|FG001|NOT COMPLETED|Overall Study||0
9832043|NCT00771537|10942727|FG002|NOT COMPLETED|Overall Study||0
9832044|NCT00771537|10942728|FG003|NOT COMPLETED|Overall Study||0
9832045|NCT00771537|10942729|FG004|NOT COMPLETED|Overall Study||0
9832046|NCT00771537|10942730|FG005|NOT COMPLETED|Overall Study||0
9832047|NCT00771537|10942731|FG006|NOT COMPLETED|Overall Study||0
9832048|NCT00771537|10942732|FG007|NOT COMPLETED|Overall Study||0
9832049|NCT00771537|10942733|FG008|NOT COMPLETED|Overall Study||0
9832050|NCT00771537|10942734|FG009|NOT COMPLETED|Overall Study||0
9832051|NCT00771537|10942735|FG010|NOT COMPLETED|Overall Study||0
9832052|NCT00771537|10942736|FG011|NOT COMPLETED|Overall Study||0
9832053|NCT00771537|10942737|FG012|NOT COMPLETED|Overall Study||0
9832054|NCT00771537|10942738|FG013|NOT COMPLETED|Overall Study||0
9832055|NCT00771537|10942739|FG014|NOT COMPLETED|Overall Study||0
9832056|NCT00771537|10942740|FG015|NOT COMPLETED|Overall Study||0
9832057|NCT00771615|10942775|FG000|STARTED|Overall Study||49
9832058|NCT00771615|10942776|FG001|STARTED|Overall Study||72
9832059|NCT00771615|10942777|FG002|STARTED|Overall Study||41
9832060|NCT00771615|10942778|FG003|STARTED|Overall Study||60
9832061|NCT00771615|10942779|FG004|STARTED|Overall Study||40
9832062|NCT00771615|10942780|FG005|STARTED|Overall Study||61
9832063|NCT00771615|10942781|FG006|STARTED|Overall Study||46
9832064|NCT00771615|10942782|FG007|STARTED|Overall Study||59
9832065|NCT00771615|10942783|FG008|STARTED|Overall Study||41
9832066|NCT00771615|10942775|FG000|COMPLETED|Overall Study|Up to Day 364|48
9832067|NCT00771615|10942776|FG001|COMPLETED|Overall Study|Up to Day 364|70
9832068|NCT00771615|10942777|FG002|COMPLETED|Overall Study|Up to Day 364|40
10016997|NCT01814046|11139867|FG001|COMPLETED|Retreatment||0
9832069|NCT00771615|10942778|FG003|COMPLETED|Overall Study|Up to Day 364|59
9832070|NCT00771615|10942779|FG004|COMPLETED|Overall Study|Up to Day 364|40
9832071|NCT00771615|10942780|FG005|COMPLETED|Overall Study|Up to Day 364|60
9832072|NCT00771615|10942781|FG006|COMPLETED|Overall Study|Up to Day 364|45
9832073|NCT00771615|10942782|FG007|COMPLETED|Overall Study|Up to Day 364|58
9832074|NCT00771615|10942783|FG008|COMPLETED|Overall Study|Up to Day 364|41
9832075|NCT00771615|10942775|FG000|NOT COMPLETED|Overall Study||1
9832076|NCT00771615|10942776|FG001|NOT COMPLETED|Overall Study||2
9832077|NCT00771615|10942777|FG002|NOT COMPLETED|Overall Study||1
9832078|NCT00771615|10942778|FG003|NOT COMPLETED|Overall Study||1
9832079|NCT00771615|10942779|FG004|NOT COMPLETED|Overall Study||0
10016998|NCT01814046|11139868|FG002|COMPLETED|Retreatment||3
9832080|NCT00771615|10942780|FG005|NOT COMPLETED|Overall Study||1
9832081|NCT00771615|10942781|FG006|NOT COMPLETED|Overall Study||1
10016999|NCT01814046|11139866|FG000|NOT COMPLETED|Retreatment||0
9820111|NCT00713479|10930796|FG000|STARTED|First Medication Condition||6
9820112|NCT00713479|10930797|FG001|STARTED|First Medication Condition||6
9820113|NCT00713479|10930796|FG000|COMPLETED|First Medication Condition||2
9820114|NCT00713479|10930797|FG001|COMPLETED|First Medication Condition||6
9820115|NCT00713479|10930796|FG000|NOT COMPLETED|First Medication Condition||4
9820116|NCT00713479|10930797|FG001|NOT COMPLETED|First Medication Condition||0
9820117|NCT00713479|10930796|FG000|STARTED|Washout||2
9820118|NCT00713479|10930797|FG001|STARTED|Washout||6
9820119|NCT00713479|10930796|FG000|COMPLETED|Washout||2
9820120|NCT00713479|10930797|FG001|COMPLETED|Washout||6
9820121|NCT00713479|10930796|FG000|NOT COMPLETED|Washout||0
9820122|NCT00713479|10930797|FG001|NOT COMPLETED|Washout||0
9820123|NCT00713479|10930796|FG000|STARTED|Next Medication Condition||2
9820124|NCT00713479|10930797|FG001|STARTED|Next Medication Condition||6
9820125|NCT00713479|10930796|FG000|COMPLETED|Next Medication Condition||2
9820126|NCT00713479|10930797|FG001|COMPLETED|Next Medication Condition||6
9820127|NCT00713479|10930796|FG000|NOT COMPLETED|Next Medication Condition||0
9820128|NCT00713479|10930797|FG001|NOT COMPLETED|Next Medication Condition||0
9820129|NCT00713544|10930811|FG000|STARTED|Overall Study||52
9820130|NCT00713544|10930812|FG001|STARTED|Overall Study||52
9820131|NCT00713544|10930813|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
9820132|NCT00713544|10930814|FG003|STARTED|Overall Study||76
9820133|NCT00713544|10930815|FG004|STARTED|Overall Study||65
9820134|NCT00713544|10930816|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
9820135|NCT00713544|10930811|FG000|COMPLETED|Overall Study||45
9820136|NCT00713544|10930812|FG001|COMPLETED|Overall Study||46
9820137|NCT00713544|10930813|FG002|COMPLETED|Overall Study||41
9820138|NCT00713544|10930814|FG003|COMPLETED|Overall Study||66
9820139|NCT00713544|10930815|FG004|COMPLETED|Overall Study||57
9820140|NCT00713544|10930816|FG005|COMPLETED|Overall Study||67
9820141|NCT00713544|10930811|FG000|NOT COMPLETED|Overall Study||7
9820142|NCT00713544|10930812|FG001|NOT COMPLETED|Overall Study||6
9820143|NCT00713544|10930813|FG002|NOT COMPLETED|Overall Study||11
9820144|NCT00713544|10930814|FG003|NOT COMPLETED|Overall Study||10
9820145|NCT00713544|10930815|FG004|NOT COMPLETED|Overall Study||8
9820146|NCT00713544|10930816|FG005|NOT COMPLETED|Overall Study||9
9820147|NCT00713583|10930832|FG000|STARTED|Overall Study||45
9820148|NCT00713583|10930833|FG001|STARTED|Overall Study||40
9820149|NCT00713583|10930832|FG000|COMPLETED|Overall Study||45
9820150|NCT00713583|10930833|FG001|COMPLETED|Overall Study||40
9820151|NCT00713583|10930832|FG000|NOT COMPLETED|Overall Study||0
9820152|NCT00713583|10930833|FG001|NOT COMPLETED|Overall Study||0
9820153|NCT00713609|10930845|FG000|STARTED|Overall Study||106
9952909|NCT01424514|11071799|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20
9952910|NCT01424514|11071800|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20
9952911|NCT01424514|11071799|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
10112430|NCT02503202|11243398|FG004|STARTED|Extension: Month 6 to 24||68
10112431|NCT02503202|11243394|FG000|COMPLETED|Extension: Month 6 to 24||108
10112432|NCT02503202|11243395|FG001|COMPLETED|Extension: Month 6 to 24||114
10112433|NCT02503202|11243396|FG002|COMPLETED|Extension: Month 6 to 24||103
10112434|NCT02503202|11243397|FG003|COMPLETED|Extension: Month 6 to 24||119
10112435|NCT02503202|11243398|FG004|COMPLETED|Extension: Month 6 to 24||67
10112436|NCT02503202|11243394|FG000|NOT COMPLETED|Extension: Month 6 to 24||11
10112437|NCT02503202|11243395|FG001|NOT COMPLETED|Extension: Month 6 to 24||16
10112438|NCT02503202|11243396|FG002|NOT COMPLETED|Extension: Month 6 to 24||9
10112439|NCT02503202|11243397|FG003|NOT COMPLETED|Extension: Month 6 to 24||18
10112440|NCT02503202|11243398|FG004|NOT COMPLETED|Extension: Month 6 to 24||1
10112441|NCT02503215|11243410|FG000|STARTED|Overall Study||17
10112442|NCT02503215|11243410|FG000|COMPLETED|Overall Study||14
10112443|NCT02503215|11243410|FG000|NOT COMPLETED|Overall Study||3
10112444|NCT02503254|11243416|FG000|STARTED|Overall Study||41
10112445|NCT02503254|11243417|FG001|STARTED|Overall Study||39
10112446|NCT02503254|11243416|FG000|COMPLETED|Overall Study||41
10112447|NCT02503254|11243417|FG001|COMPLETED|Overall Study||39
9820154|NCT00713609|10930846|FG001|STARTED|Overall Study||105
9820155|NCT00713609|10930847|FG002|STARTED|Overall Study||107
9820156|NCT00713609|10930848|FG003|STARTED|Overall Study||108
9820157|NCT00713609|10930849|FG004|STARTED|Overall Study||106
9820158|NCT00713609|10930850|FG005|STARTED|Overall Study||55
9820159|NCT00713609|10930845|FG000|COMPLETED|Overall Study||85
9952912|NCT01424514|11071800|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
9952913|NCT01424514|11071799|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
9952914|NCT01424514|11071800|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
9952915|NCT01424514|11071799|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19
9952916|NCT01424514|11071800|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19
9952917|NCT01424514|11071799|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19
9952918|NCT01424514|11071800|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19
9952919|NCT01424514|11071799|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
9952920|NCT01424514|11071800|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
9952921|NCT01424514|11071799|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19
9952922|NCT01424514|11071800|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19
9820160|NCT00713609|10930846|FG001|COMPLETED|Overall Study||90
9952923|NCT01424514|11071799|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
9952924|NCT01424514|11071800|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
9952925|NCT01424514|11071799|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
9952926|NCT01424514|11071800|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
9952927|NCT01424566|11071811|FG000|STARTED|Single-blind Treatment||406
9952928|NCT01424566|11071812|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
9952929|NCT01424566|11071813|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
9952930|NCT01424566|11071811|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
9952931|NCT01424566|11071812|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
9952932|NCT01424566|11071813|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
9952933|NCT01424566|11071811|FG000|Single-blind Safety Population|Single-blind Treatment||404
10017000|NCT01814046|11139867|FG001|NOT COMPLETED|Retreatment||0
10017001|NCT01814046|11139868|FG002|NOT COMPLETED|Retreatment||0
10017002|NCT01814072|11139907|FG000|STARTED|Overall Study||18
9952934|NCT01424566|11071812|FG001|Single-blind Safety Population|Single-blind Treatment||0
9952935|NCT01424566|11071813|FG002|Single-blind Safety Population|Single-blind Treatment||0
9952936|NCT01424566|11071811|FG000|Met Randomization Criteria|Single-blind Treatment||206
9957084|NCT01449370|11076259|FG024|COMPLETED|Overall Study||0
10017003|NCT01814072|11139908|FG001|STARTED|Overall Study||18
9820161|NCT00713609|10930847|FG002|COMPLETED|Overall Study||92
9820162|NCT00713609|10930848|FG003|COMPLETED|Overall Study||99
9820163|NCT00713609|10930849|FG004|COMPLETED|Overall Study||87
9820164|NCT00713609|10930850|FG005|COMPLETED|Overall Study||47
10017004|NCT01814072|11139909|FG002|STARTED|Overall Study||18
10017005|NCT01814072|11139910|FG003|STARTED|Overall Study||18
10017006|NCT01814072|11139911|FG004|STARTED|Overall Study||18
10017007|NCT01814072|11139912|FG005|STARTED|Overall Study||18
10017008|NCT01814072|11139913|FG006|STARTED|Overall Study||18
9820165|NCT00713609|10930845|FG000|NOT COMPLETED|Overall Study||21
9820166|NCT00713609|10930846|FG001|NOT COMPLETED|Overall Study||15
9820167|NCT00713609|10930847|FG002|NOT COMPLETED|Overall Study||15
9820168|NCT00713609|10930848|FG003|NOT COMPLETED|Overall Study||9
9820169|NCT00713609|10930849|FG004|NOT COMPLETED|Overall Study||19
9820170|NCT00713609|10930850|FG005|NOT COMPLETED|Overall Study||8
9820171|NCT00713648|10930864|FG000|STARTED|Overall Study||41
9820172|NCT00713648|10930864|FG000|COMPLETED|Overall Study||33
9820173|NCT00713648|10930864|FG000|NOT COMPLETED|Overall Study||8
9820174|NCT00713661|10930872|FG000|STARTED|Overall Study||7
9820175|NCT00713661|10930873|FG001|STARTED|Overall Study||9
9820176|NCT00713661|10930874|FG002|STARTED|Overall Study||4
9820177|NCT00713661|10930875|FG003|STARTED|Overall Study||5
9820178|NCT00713661|10930872|FG000|COMPLETED|Overall Study||7
9820179|NCT00713661|10930873|FG001|COMPLETED|Overall Study||9
9820180|NCT00713661|10930874|FG002|COMPLETED|Overall Study||4
9820181|NCT00713661|10930875|FG003|COMPLETED|Overall Study||5
9820182|NCT00713661|10930872|FG000|NOT COMPLETED|Overall Study||0
9820183|NCT00713661|10930873|FG001|NOT COMPLETED|Overall Study||0
9820184|NCT00713661|10930874|FG002|NOT COMPLETED|Overall Study||0
9820185|NCT00713661|10930875|FG003|NOT COMPLETED|Overall Study||0
9820186|NCT00713700|10930885|FG000|STARTED|Overall Study||192
9820187|NCT00713700|10930885|FG000|COMPLETED|Overall Study||188
9820188|NCT00713700|10930885|FG000|NOT COMPLETED|Overall Study||4
9820189|NCT00713817|10930891|FG000|STARTED|Overall Study||10
9820190|NCT00713817|10930892|FG001|STARTED|Overall Study||9
9820191|NCT00713817|10930891|FG000|COMPLETED|Overall Study||10
9820192|NCT00713817|10930892|FG001|COMPLETED|Overall Study||9
9820193|NCT00713817|10930891|FG000|NOT COMPLETED|Overall Study||0
9820194|NCT00713817|10930892|FG001|NOT COMPLETED|Overall Study||0
9820195|NCT00713830|10930900|FG000|STARTED|Overall Study|Randomized.|286
9820196|NCT00713830|10930901|FG001|STARTED|Overall Study||573
9820197|NCT00713830|10930900|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
9820198|NCT00713830|10930901|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570
9820199|NCT00713830|10930900|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
9820200|NCT00713830|10930901|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
9820201|NCT00713830|10930900|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
9820202|NCT00713830|10930901|FG001|Subgroup for Standardized Meal Test|Overall Study||313
9820203|NCT00713830|10930900|FG000|COMPLETED|Overall Study||204
9820204|NCT00713830|10930901|FG001|COMPLETED|Overall Study||396
9820205|NCT00713830|10930900|FG000|NOT COMPLETED|Overall Study||82
9820206|NCT00713830|10930901|FG001|NOT COMPLETED|Overall Study||177
9820207|NCT00714051|10930909|FG000|STARTED|Overall Study||27
9820208|NCT00714051|10930910|FG001|STARTED|Overall Study||28
9820209|NCT00714051|10930909|FG000|COMPLETED|Overall Study||26
9820210|NCT00714051|10930910|FG001|COMPLETED|Overall Study||27
9820211|NCT00714051|10930909|FG000|NOT COMPLETED|Overall Study||1
9820212|NCT00714051|10930910|FG001|NOT COMPLETED|Overall Study||1
9820213|NCT00714168|10930918|FG000|STARTED|Overall Study||165
9820214|NCT00714168|10930919|FG001|STARTED|Overall Study||198
9820215|NCT00714168|10930918|FG000|COMPLETED|Overall Study||121
9820216|NCT00714168|10930919|FG001|COMPLETED|Overall Study||139
9820217|NCT00714168|10930918|FG000|NOT COMPLETED|Overall Study||44
9820218|NCT00714168|10930919|FG001|NOT COMPLETED|Overall Study||59
9820219|NCT00714233|10930929|FG000|STARTED|Overall Study||10
9820220|NCT00714233|10930930|FG001|STARTED|Overall Study||11
9820221|NCT00714233|10930931|FG002|STARTED|Overall Study||11
9820222|NCT00714233|10930932|FG003|STARTED|Overall Study||10
9820223|NCT00714233|10930929|FG000|COMPLETED|Overall Study||6
9820224|NCT00714233|10930930|FG001|COMPLETED|Overall Study||10
9820225|NCT00714233|10930931|FG002|COMPLETED|Overall Study||10
9820226|NCT00714233|10930932|FG003|COMPLETED|Overall Study||6
9820227|NCT00714233|10930929|FG000|NOT COMPLETED|Overall Study||4
9820228|NCT00714233|10930930|FG001|NOT COMPLETED|Overall Study||1
9820229|NCT00714233|10930931|FG002|NOT COMPLETED|Overall Study||1
9820230|NCT00714233|10930932|FG003|NOT COMPLETED|Overall Study||4
9820231|NCT00714259|10930947|FG000|STARTED|Overall Study||5
9820232|NCT00714259|10930947|FG000|COMPLETED|Overall Study||3
9820233|NCT00714259|10930947|FG000|NOT COMPLETED|Overall Study||2
9820234|NCT00714272|10930953|FG000|STARTED|Overall Study||2
9820235|NCT00714272|10930954|FG001|STARTED|Overall Study||2
9820236|NCT00714272|10930953|FG000|COMPLETED|Overall Study||2
9820237|NCT00714272|10930954|FG001|COMPLETED|Overall Study||2
9820238|NCT00714272|10930953|FG000|NOT COMPLETED|Overall Study||0
9820239|NCT00714272|10930954|FG001|NOT COMPLETED|Overall Study||0
9820240|NCT00714285|10930964|FG000|STARTED|Overall Study||105
9820241|NCT00714285|10930965|FG001|STARTED|Overall Study||105
10017009|NCT01814072|11139914|FG007|STARTED|Overall Study||18
10017010|NCT01814072|11139915|FG008|STARTED|Overall Study||19
10017011|NCT01814072|11139916|FG009|STARTED|Overall Study||18
9820242|NCT00714285|10930966|FG002|STARTED|Overall Study||105
9820243|NCT00714285|10930967|FG003|STARTED|Overall Study||105
9820244|NCT00714285|10930964|FG000|COMPLETED|Overall Study|Completed upto Day 180|105
9820245|NCT00714285|10930965|FG001|COMPLETED|Overall Study|Completed upto Day 180|102
9820246|NCT00714285|10930966|FG002|COMPLETED|Overall Study|Completed upto Day 180|105
9820247|NCT00714285|10930967|FG003|COMPLETED|Overall Study|Completed upto Day 180|104
9820248|NCT00714285|10930964|FG000|NOT COMPLETED|Overall Study||0
9820249|NCT00714285|10930965|FG001|NOT COMPLETED|Overall Study||3
9820250|NCT00714285|10930966|FG002|NOT COMPLETED|Overall Study||0
9820251|NCT00714285|10930967|FG003|NOT COMPLETED|Overall Study||1
9820252|NCT00714311|10930981|FG000|STARTED|Overall Study||52
9820253|NCT00714311|10930982|FG001|STARTED|Overall Study||52
9820254|NCT00714311|10930981|FG000|COMPLETED|Overall Study||39
9820255|NCT00714311|10930982|FG001|COMPLETED|Overall Study||30
9820256|NCT00714311|10930981|FG000|NOT COMPLETED|Overall Study||13
9820257|NCT00714311|10930982|FG001|NOT COMPLETED|Overall Study||22
9820258|NCT00714389|10930988|FG000|STARTED|Overall Study||12
9820259|NCT00714389|10930988|FG000|COMPLETED|Overall Study||12
9820260|NCT00714389|10930988|FG000|NOT COMPLETED|Overall Study||0
9820261|NCT00714415|10930994|FG000|STARTED|Overall Study||25
9820262|NCT00714415|10930995|FG001|STARTED|Overall Study||55
9820263|NCT00714415|10930994|FG000|COMPLETED|Overall Study||23
9820264|NCT00714415|10930995|FG001|COMPLETED|Overall Study||55
9820265|NCT00714415|10930994|FG000|NOT COMPLETED|Overall Study||2
9820266|NCT00714415|10930995|FG001|NOT COMPLETED|Overall Study||0
9820267|NCT00714493|10931001|FG000|STARTED|Overall Study||203
9820268|NCT00714493|10931001|FG000|COMPLETED|Overall Study||154
9820269|NCT00714493|10931001|FG000|NOT COMPLETED|Overall Study||49
9820270|NCT00714571|10931011|FG000|STARTED|Stage 1||12
9820271|NCT00714571|10931012|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
9820272|NCT00714571|10931013|FG002|STARTED|Stage 1||11
9820273|NCT00714571|10931014|FG003|STARTED|Stage 1||14
9820274|NCT00714571|10931015|FG004|STARTED|Stage 1||0
9820275|NCT00714571|10931016|FG005|STARTED|Stage 1||0
9820276|NCT00714571|10931011|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
9820277|NCT00714571|10931012|FG001|COMPLETED|Stage 1||15
9820278|NCT00714571|10931013|FG002|COMPLETED|Stage 1||10
9820279|NCT00714571|10931014|FG003|COMPLETED|Stage 1||14
9820280|NCT00714571|10931015|FG004|COMPLETED|Stage 1||0
9820281|NCT00714571|10931016|FG005|COMPLETED|Stage 1||0
9820282|NCT00714571|10931011|FG000|NOT COMPLETED|Stage 1||0
9820283|NCT00714571|10931012|FG001|NOT COMPLETED|Stage 1||0
9820284|NCT00714571|10931013|FG002|NOT COMPLETED|Stage 1||1
9820285|NCT00714571|10931014|FG003|NOT COMPLETED|Stage 1||0
9820286|NCT00714571|10931015|FG004|NOT COMPLETED|Stage 1||0
9820287|NCT00714571|10931016|FG005|NOT COMPLETED|Stage 1||0
9820288|NCT00714571|10931011|FG000|STARTED|Stage 2||0
9820289|NCT00714571|10931012|FG001|STARTED|Stage 2||0
9820290|NCT00714571|10931013|FG002|STARTED|Stage 2||0
9820291|NCT00714571|10931014|FG003|STARTED|Stage 2||0
9820292|NCT00714571|10931015|FG004|STARTED|Stage 2||15
9820293|NCT00714571|10931016|FG005|STARTED|Stage 2||15
9820294|NCT00714571|10931011|FG000|COMPLETED|Stage 2||0
9820295|NCT00714571|10931012|FG001|COMPLETED|Stage 2||0
9820296|NCT00714571|10931013|FG002|COMPLETED|Stage 2||0
9820297|NCT00714571|10931014|FG003|COMPLETED|Stage 2||0
9820298|NCT00714571|10931015|FG004|COMPLETED|Stage 2||15
9820299|NCT00714571|10931016|FG005|COMPLETED|Stage 2||15
9820300|NCT00714571|10931011|FG000|NOT COMPLETED|Stage 2||0
9820301|NCT00714571|10931012|FG001|NOT COMPLETED|Stage 2||0
9820302|NCT00714571|10931013|FG002|NOT COMPLETED|Stage 2||0
10017012|NCT01814072|11139917|FG010|STARTED|Overall Study||18
9820303|NCT00714571|10931014|FG003|NOT COMPLETED|Stage 2||0
9820304|NCT00714571|10931015|FG004|NOT COMPLETED|Stage 2||0
9820305|NCT00714571|10931016|FG005|NOT COMPLETED|Stage 2||0
9820306|NCT00714688|10931033|FG000|STARTED|Overall Study||97
9820307|NCT00714688|10931034|FG001|STARTED|Overall Study||90
9820308|NCT00714688|10931035|FG002|STARTED|Overall Study||92
9820309|NCT00714688|10931033|FG000|COMPLETED|Overall Study||68
9820310|NCT00714688|10931034|FG001|COMPLETED|Overall Study||55
10017013|NCT01814072|11139918|FG011|STARTED|Overall Study||18
10017014|NCT01814072|11139919|FG012|STARTED|Overall Study||18
10017015|NCT01814072|11139920|FG013|STARTED|Overall Study||18
10017016|NCT01814072|11139921|FG014|STARTED|Overall Study||18
10017017|NCT01814072|11139922|FG015|STARTED|Overall Study||18
10017018|NCT01814072|11139923|FG016|STARTED|Overall Study||17
10017019|NCT01814072|11139924|FG017|STARTED|Overall Study||18
10017020|NCT01814072|11139925|FG018|STARTED|Overall Study||17
9820311|NCT00714688|10931035|FG002|COMPLETED|Overall Study||55
9820312|NCT00714688|10931033|FG000|NOT COMPLETED|Overall Study||29
9820313|NCT00714688|10931034|FG001|NOT COMPLETED|Overall Study||35
9820314|NCT00714688|10931035|FG002|NOT COMPLETED|Overall Study||37
9820315|NCT00714714|10931043|FG000|STARTED|Overall Study||25
9820316|NCT00714714|10931043|FG000|COMPLETED|Overall Study||24
9820317|NCT00714714|10931043|FG000|NOT COMPLETED|Overall Study||1
9820318|NCT00714753|10931049|FG000|STARTED|Overall Study||5
9820319|NCT00714753|10931049|FG000|HDR Brachytherapy|Overall Study||5
9820320|NCT00714753|10931049|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1
9820321|NCT00714753|10931049|FG000|COMPLETED|Overall Study||5
9820322|NCT00714753|10931049|FG000|NOT COMPLETED|Overall Study||0
9820323|NCT00714792|10931055|FG000|STARTED|Overall Study||10
9820324|NCT00714792|10931056|FG001|STARTED|Overall Study||8
9820325|NCT00714792|10931055|FG000|COMPLETED|Overall Study||10
9820326|NCT00714792|10931056|FG001|COMPLETED|Overall Study||8
9820327|NCT00714792|10931055|FG000|NOT COMPLETED|Overall Study||0
9820328|NCT00714792|10931056|FG001|NOT COMPLETED|Overall Study||0
9820329|NCT00714870|10931064|FG000|STARTED|Overall Study||49
9820330|NCT00714870|10931065|FG001|STARTED|Overall Study||27
9820331|NCT00714870|10931064|FG000|COMPLETED|Overall Study||22
9820332|NCT00714870|10931065|FG001|COMPLETED|Overall Study||22
9820333|NCT00714870|10931064|FG000|NOT COMPLETED|Overall Study||27
9820334|NCT00714870|10931065|FG001|NOT COMPLETED|Overall Study||5
9820335|NCT00715026|10931071|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
9820336|NCT00715026|10931071|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
9820337|NCT00715026|10931071|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
9820338|NCT00715026|10931071|FG000|NOT COMPLETED|Overall Study||10
9820339|NCT00715078|10931078|FG000|STARTED|Overall Study||41
9820340|NCT00715078|10931079|FG001|STARTED|Overall Study||40
9820341|NCT00715078|10931080|FG002|STARTED|Overall Study||41
9820342|NCT00715078|10931078|FG000|Received ≥ 1 Study Infusion|Overall Study||40
9820343|NCT00715078|10931079|FG001|Received ≥ 1 Study Infusion|Overall Study||40
9820344|NCT00715078|10931080|FG002|Received ≥ 1 Study Infusion|Overall Study||39
9820345|NCT00715078|10931078|FG000|Received ≥ 1 Leukapheresis|Overall Study||40
9820346|NCT00715078|10931079|FG001|Received ≥ 1 Leukapheresis|Overall Study||40
9820347|NCT00715078|10931080|FG002|Received ≥ 1 Leukapheresis|Overall Study||40
9820348|NCT00715078|10931078|FG000|COMPLETED|Overall Study||11
9820349|NCT00715078|10931079|FG001|COMPLETED|Overall Study||4
9820350|NCT00715078|10931080|FG002|COMPLETED|Overall Study||3
9820351|NCT00715078|10931078|FG000|NOT COMPLETED|Overall Study||30
9820352|NCT00715078|10931079|FG001|NOT COMPLETED|Overall Study||36
9820353|NCT00715078|10931080|FG002|NOT COMPLETED|Overall Study||38
9820354|NCT00715104|10931091|FG000|STARTED|Overall Study||18
9820355|NCT00715104|10931092|FG001|STARTED|Overall Study||16
9820356|NCT00715104|10931093|FG002|STARTED|Overall Study||8
9820357|NCT00715104|10931091|FG000|COMPLETED|Overall Study||18
9820358|NCT00715104|10931092|FG001|COMPLETED|Overall Study||16
9820359|NCT00715104|10931093|FG002|COMPLETED|Overall Study||8
9820360|NCT00715104|10931091|FG000|NOT COMPLETED|Overall Study||0
9820361|NCT00715104|10931092|FG001|NOT COMPLETED|Overall Study||0
9820362|NCT00715104|10931093|FG002|NOT COMPLETED|Overall Study||0
9820363|NCT00715117|10931137|FG000|STARTED|Overall Study||6
9820364|NCT00715117|10931138|FG001|STARTED|Overall Study||6
9820365|NCT00715117|10931137|FG000|Completion fo 8 Week Study|Overall Study||6
9820366|NCT00715117|10931138|FG001|Completion fo 8 Week Study|Overall Study||6
9820367|NCT00715117|10931137|FG000|COMPLETED|Overall Study||6
9820368|NCT00715117|10931138|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
9820369|NCT00715117|10931137|FG000|NOT COMPLETED|Overall Study||0
9820370|NCT00715117|10931138|FG001|NOT COMPLETED|Overall Study||1
9820371|NCT00715208|10931151|FG000|STARTED|Overall Study||7
9820372|NCT00715208|10931152|FG001|STARTED|Overall Study||48
9820373|NCT00715208|10931151|FG000|COMPLETED|Overall Study||6
10017021|NCT01814072|11139926|FG019|STARTED|Overall Study||16
10017022|NCT01814072|11139927|FG020|STARTED|Overall Study||16
10017023|NCT01814072|11139928|FG021|STARTED|Overall Study||17
10017024|NCT01814072|11139929|FG022|STARTED|Overall Study||17
10017025|NCT01814072|11139930|FG023|STARTED|Overall Study||18
9820374|NCT00715208|10931152|FG001|COMPLETED|Overall Study||39
10017026|NCT01814072|11139931|FG024|STARTED|Overall Study||17
10017027|NCT01814072|11139932|FG025|STARTED|Overall Study||16
10017028|NCT01814072|11139933|FG026|STARTED|Overall Study||18
9820375|NCT00715208|10931151|FG000|NOT COMPLETED|Overall Study||1
9820376|NCT00715208|10931152|FG001|NOT COMPLETED|Overall Study||9
10017029|NCT01814072|11139934|FG027|STARTED|Overall Study||17
9820377|NCT00715299|10931158|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
9820378|NCT00715299|10931158|FG000|COMPLETED|Overall Study||30
9820379|NCT00715299|10931158|FG000|NOT COMPLETED|Overall Study||6
9820380|NCT00715390|10931162|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
10017030|NCT01814072|11139935|FG028|STARTED|Overall Study||18
9820381|NCT00715390|10931162|FG000|Eligible|Overall Study||234
9820382|NCT00715390|10931162|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
9820383|NCT00715390|10931162|FG000|NOT COMPLETED|Overall Study||0
9820384|NCT00715403|10931173|FG000|STARTED|Overall Study||1
9820385|NCT00715403|10931174|FG001|STARTED|Overall Study||1
9820386|NCT00715403|10931175|FG002|STARTED|Overall Study||4
9820387|NCT00715403|10931176|FG003|STARTED|Overall Study||9
9820388|NCT00715403|10931177|FG004|STARTED|Overall Study||6
9820389|NCT00715403|10931178|FG005|STARTED|Overall Study||19
9820390|NCT00715403|10931179|FG006|STARTED|Overall Study||1
9820391|NCT00715403|10931173|FG000|COMPLETED|Overall Study||0
9820392|NCT00715403|10931174|FG001|COMPLETED|Overall Study||0
9820393|NCT00715403|10931175|FG002|COMPLETED|Overall Study||0
9820394|NCT00715403|10931176|FG003|COMPLETED|Overall Study||0
9820395|NCT00715403|10931177|FG004|COMPLETED|Overall Study||0
9820396|NCT00715403|10931178|FG005|COMPLETED|Overall Study||0
9820397|NCT00715403|10931179|FG006|COMPLETED|Overall Study||0
9820398|NCT00715403|10931173|FG000|NOT COMPLETED|Overall Study||1
9820399|NCT00715403|10931174|FG001|NOT COMPLETED|Overall Study||1
9820400|NCT00715403|10931175|FG002|NOT COMPLETED|Overall Study||4
9820401|NCT00715403|10931176|FG003|NOT COMPLETED|Overall Study||9
9820402|NCT00715403|10931177|FG004|NOT COMPLETED|Overall Study||6
9820403|NCT00715403|10931178|FG005|NOT COMPLETED|Overall Study||19
9820404|NCT00715403|10931179|FG006|NOT COMPLETED|Overall Study||1
9820405|NCT00715429|10931197|FG000|STARTED|Overall Study||7
9820406|NCT00715429|10931198|FG001|STARTED|Overall Study||7
9820407|NCT00715429|10931197|FG000|COMPLETED|Overall Study||7
9820408|NCT00715429|10931198|FG001|COMPLETED|Overall Study||6
9820409|NCT00715429|10931197|FG000|NOT COMPLETED|Overall Study||0
9820410|NCT00715429|10931198|FG001|NOT COMPLETED|Overall Study||1
9820411|NCT00715520|10931207|FG000|STARTED|Overall Study||20
9820412|NCT00715520|10931208|FG001|STARTED|Overall Study||10
9820413|NCT00715520|10931209|FG002|STARTED|Overall Study||3
9820414|NCT00715520|10931207|FG000|COMPLETED|Overall Study||10
9820415|NCT00715520|10931208|FG001|COMPLETED|Overall Study||9
9820416|NCT00715520|10931209|FG002|COMPLETED|Overall Study||1
9820417|NCT00715520|10931207|FG000|NOT COMPLETED|Overall Study||10
9820418|NCT00715520|10931208|FG001|NOT COMPLETED|Overall Study||1
9820419|NCT00715520|10931209|FG002|NOT COMPLETED|Overall Study||2
9820420|NCT00715559|10931217|FG000|STARTED|Overall Study||3
9820421|NCT00715559|10931217|FG000|COMPLETED|Overall Study||2
9820422|NCT00715559|10931217|FG000|NOT COMPLETED|Overall Study||1
9820423|NCT00715624|10931223|FG000|STARTED|Overall Study|Randomized|167
9820424|NCT00715624|10931224|FG001|STARTED|Overall Study||329
9820425|NCT00715624|10931223|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
9820426|NCT00715624|10931224|FG001|Treated/Safety Population|Overall Study||328
9820427|NCT00715624|10931223|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
9820428|NCT00715624|10931224|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327
9820429|NCT00715624|10931223|FG000|COMPLETED|Overall Study||115
9820430|NCT00715624|10931224|FG001|COMPLETED|Overall Study||213
9820431|NCT00715624|10931223|FG000|NOT COMPLETED|Overall Study||52
9820432|NCT00715624|10931224|FG001|NOT COMPLETED|Overall Study||116
9820433|NCT00715650|10931232|FG000|STARTED|Intervention||47
9820434|NCT00715650|10931233|FG001|STARTED|Intervention||45
9820435|NCT00715650|10931232|FG000|Received Any Session|Intervention||39
9820436|NCT00715650|10931233|FG001|Received Any Session|Intervention||38
9820437|NCT00715650|10931232|FG000|Attended ≥ 2 Sessions|Intervention||36
9820438|NCT00715650|10931233|FG001|Attended ≥ 2 Sessions|Intervention||33
9820439|NCT00715650|10931232|FG000|Attended ≥ 3 Sessions|Intervention||23
9820440|NCT00715650|10931233|FG001|Attended ≥ 3 Sessions|Intervention||17
9820441|NCT00715650|10931232|FG000|COMPLETED|Intervention||42
9820442|NCT00715650|10931233|FG001|COMPLETED|Intervention||42
9820443|NCT00715650|10931232|FG000|NOT COMPLETED|Intervention||5
9820444|NCT00715650|10931233|FG001|NOT COMPLETED|Intervention||3
9820445|NCT00715650|10931232|FG000|STARTED|Follow-up||42
9820446|NCT00715650|10931233|FG001|STARTED|Follow-up||42
9820447|NCT00715650|10931232|FG000|Completed Month 1 Follow-up|Follow-up||40
9820448|NCT00715650|10931233|FG001|Completed Month 1 Follow-up|Follow-up||38
9820449|NCT00715650|10931232|FG000|Completed Month 3 Follow-up|Follow-up||35
9820450|NCT00715650|10931233|FG001|Completed Month 3 Follow-up|Follow-up||40
9820451|NCT00715650|10931232|FG000|Completed Month 6 Follow-up|Follow-up||29
9820452|NCT00715650|10931233|FG001|Completed Month 6 Follow-up|Follow-up||37
9820453|NCT00715650|10931232|FG000|COMPLETED|Follow-up||29
9820454|NCT00715650|10931233|FG001|COMPLETED|Follow-up||37
9820455|NCT00715650|10931232|FG000|NOT COMPLETED|Follow-up||13
9820456|NCT00715650|10931233|FG001|NOT COMPLETED|Follow-up||5
9820457|NCT00715676|10931242|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
9820458|NCT00715676|10931243|FG001|STARTED|Overall Study||54
9820459|NCT00715676|10931244|FG002|STARTED|Overall Study||53
9820460|NCT00715676|10931242|FG000|COMPLETED|Overall Study||43
9820461|NCT00715676|10931243|FG001|COMPLETED|Overall Study||43
9820462|NCT00715676|10931244|FG002|COMPLETED|Overall Study||21
9820463|NCT00715676|10931242|FG000|NOT COMPLETED|Overall Study||6
9820464|NCT00715676|10931243|FG001|NOT COMPLETED|Overall Study||11
9820465|NCT00715676|10931244|FG002|NOT COMPLETED|Overall Study||32
9820466|NCT00715728|10931254|FG000|STARTED|Overall Study||14
9820467|NCT00715728|10931255|FG001|STARTED|Overall Study||14
9820468|NCT00715728|10931254|FG000|COMPLETED|Overall Study||14
9820469|NCT00715728|10931255|FG001|COMPLETED|Overall Study||14
9820470|NCT00715728|10931254|FG000|NOT COMPLETED|Overall Study||0
9820471|NCT00715728|10931255|FG001|NOT COMPLETED|Overall Study||0
9820472|NCT00715741|10931267|FG000|STARTED|Overall Study||25
9820473|NCT00715741|10931268|FG001|STARTED|Overall Study||25
9820474|NCT00715741|10931269|FG002|STARTED|Overall Study||25
9820475|NCT00715741|10931270|FG003|STARTED|Overall Study||25
9820476|NCT00715741|10931267|FG000|COMPLETED|Overall Study||25
9820477|NCT00715741|10931268|FG001|COMPLETED|Overall Study||25
9820478|NCT00715741|10931269|FG002|COMPLETED|Overall Study||25
9820479|NCT00715741|10931270|FG003|COMPLETED|Overall Study||25
9820480|NCT00715741|10931267|FG000|NOT COMPLETED|Overall Study||0
9820481|NCT00715741|10931268|FG001|NOT COMPLETED|Overall Study||0
9820482|NCT00715741|10931269|FG002|NOT COMPLETED|Overall Study||0
9820483|NCT00715741|10931270|FG003|NOT COMPLETED|Overall Study||0
9820484|NCT00715754|10931280|FG000|STARTED|Overall Study||47
9820485|NCT00715754|10931280|FG000|COMPLETED|Overall Study||47
9820486|NCT00715754|10931280|FG000|NOT COMPLETED|Overall Study||0
9820487|NCT00715793|10931284|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4
9820488|NCT00715793|10931285|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6
9820489|NCT00715793|10931284|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3
9820490|NCT00715793|10931285|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6
9820491|NCT00715793|10931284|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
9820492|NCT00715793|10931285|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
9820493|NCT00715793|10931284|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
9820494|NCT00715793|10931285|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
9820495|NCT00715793|10931284|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
9820496|NCT00715793|10931285|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
9820497|NCT00715793|10931284|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
9820498|NCT00715793|10931285|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
9820499|NCT00715884|10931294|FG000|STARTED|Overall Study||452
9820500|NCT00715884|10931295|FG001|STARTED|Overall Study||226
9820501|NCT00715884|10931294|FG000|COMPLETED|Overall Study||444
9820502|NCT00715884|10931295|FG001|COMPLETED|Overall Study||225
9820503|NCT00715884|10931294|FG000|NOT COMPLETED|Overall Study||8
9820504|NCT00715884|10931295|FG001|NOT COMPLETED|Overall Study||1
9820505|NCT00715910|10931305|FG000|STARTED|Year 1||433
9820506|NCT00715910|10931306|FG001|STARTED|Year 1||147
9820507|NCT00715910|10931307|FG002|STARTED|Year 1||68
9820508|NCT00715910|10931308|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
9820509|NCT00715910|10931309|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
9820510|NCT00715910|10931310|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
9820511|NCT00715910|10931305|FG000|COMPLETED|Year 1||433
9820512|NCT00715910|10931306|FG001|COMPLETED|Year 1||147
9820513|NCT00715910|10931307|FG002|COMPLETED|Year 1||68
9820514|NCT00715910|10931308|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
9820515|NCT00715910|10931309|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
9820516|NCT00715910|10931310|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
9820517|NCT00715910|10931305|FG000|NOT COMPLETED|Year 1||0
9820518|NCT00715910|10931306|FG001|NOT COMPLETED|Year 1||0
9820519|NCT00715910|10931307|FG002|NOT COMPLETED|Year 1||0
9820520|NCT00715910|10931308|FG003|NOT COMPLETED|Year 1||0
9820521|NCT00715910|10931309|FG004|NOT COMPLETED|Year 1||0
9820522|NCT00715910|10931310|FG005|NOT COMPLETED|Year 1||0
9820523|NCT00715910|10931305|FG000|STARTED|Year 3||345
9820524|NCT00715910|10931306|FG001|STARTED|Year 3||86
9820525|NCT00715910|10931307|FG002|STARTED|Year 3||56
9820526|NCT00715910|10931308|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
9820527|NCT00715910|10931309|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
9820528|NCT00715910|10931310|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
9820529|NCT00715910|10931305|FG000|COMPLETED|Year 3||345
9820530|NCT00715910|10931306|FG001|COMPLETED|Year 3||86
9820531|NCT00715910|10931307|FG002|COMPLETED|Year 3||56
9820532|NCT00715910|10931308|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
9820533|NCT00715910|10931309|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
9820534|NCT00715910|10931310|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
9820535|NCT00715910|10931305|FG000|NOT COMPLETED|Year 3||0
9820536|NCT00715910|10931306|FG001|NOT COMPLETED|Year 3||0
9820537|NCT00715910|10931307|FG002|NOT COMPLETED|Year 3||0
9820538|NCT00715910|10931308|FG003|NOT COMPLETED|Year 3||0
9820539|NCT00715910|10931309|FG004|NOT COMPLETED|Year 3||0
9820540|NCT00715910|10931310|FG005|NOT COMPLETED|Year 3||0
9820541|NCT00715910|10931305|FG000|STARTED|Year 5||218
9820542|NCT00715910|10931306|FG001|STARTED|Year 5||56
9820543|NCT00715910|10931307|FG002|STARTED|Year 5||38
9820544|NCT00715910|10931308|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
9820545|NCT00715910|10931309|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
9820546|NCT00715910|10931310|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
9820547|NCT00715910|10931305|FG000|COMPLETED|Year 5||218
9820548|NCT00715910|10931306|FG001|COMPLETED|Year 5||56
9820549|NCT00715910|10931307|FG002|COMPLETED|Year 5||38
9820550|NCT00715910|10931308|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
9820551|NCT00715910|10931309|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
9832082|NCT00771615|10942782|FG007|NOT COMPLETED|Overall Study||1
9820552|NCT00715910|10931310|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
9820553|NCT00715910|10931305|FG000|NOT COMPLETED|Year 5||0
9820554|NCT00715910|10931306|FG001|NOT COMPLETED|Year 5||0
9820555|NCT00715910|10931307|FG002|NOT COMPLETED|Year 5||0
9820556|NCT00715910|10931308|FG003|NOT COMPLETED|Year 5||0
9820557|NCT00715910|10931309|FG004|NOT COMPLETED|Year 5||0
9820558|NCT00715910|10931310|FG005|NOT COMPLETED|Year 5||0
9820559|NCT00715910|10931305|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
9820560|NCT00715910|10931306|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
9820561|NCT00715910|10931307|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
9820562|NCT00715910|10931308|FG003|STARTED|Booster and ESFU Phase||183
9820563|NCT00715910|10931309|FG004|STARTED|Booster and ESFU Phase||38
9820564|NCT00715910|10931310|FG005|STARTED|Booster and ESFU Phase||101
9820565|NCT00715910|10931305|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
9820566|NCT00715910|10931306|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
9820567|NCT00715910|10931307|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
9820568|NCT00715910|10931308|FG003|COMPLETED|Booster and ESFU Phase||172
9820569|NCT00715910|10931309|FG004|COMPLETED|Booster and ESFU Phase||36
9820570|NCT00715910|10931310|FG005|COMPLETED|Booster and ESFU Phase||88
9820571|NCT00715910|10931305|FG000|NOT COMPLETED|Booster and ESFU Phase||0
9820572|NCT00715910|10931306|FG001|NOT COMPLETED|Booster and ESFU Phase||0
9820573|NCT00715910|10931307|FG002|NOT COMPLETED|Booster and ESFU Phase||0
9820574|NCT00715910|10931308|FG003|NOT COMPLETED|Booster and ESFU Phase||11
9820575|NCT00715910|10931309|FG004|NOT COMPLETED|Booster and ESFU Phase||2
9820576|NCT00715910|10931310|FG005|NOT COMPLETED|Booster and ESFU Phase||13
9820577|NCT00715949|10931326|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120
9820578|NCT00715949|10931326|FG000|COMPLETED|Overall Study|116 patients completed first test|116
9820579|NCT00715949|10931326|FG000|NOT COMPLETED|Overall Study||4
9820580|NCT00715962|10931332|FG000|STARTED|Overall Study||50
9820581|NCT00715962|10931333|FG001|STARTED|Overall Study||50
9820582|NCT00715962|10931332|FG000|COMPLETED|Overall Study||44
9820583|NCT00715962|10931333|FG001|COMPLETED|Overall Study||48
9820584|NCT00715962|10931332|FG000|NOT COMPLETED|Overall Study||6
9820585|NCT00715962|10931333|FG001|NOT COMPLETED|Overall Study||2
9820586|NCT00716079|10931342|FG000|STARTED|Overall Study||1403
9820587|NCT00716079|10931343|FG001|STARTED|Overall Study||1436
9820588|NCT00716079|10931342|FG000|COMPLETED|Overall Study||1394
9820589|NCT00716079|10931343|FG001|COMPLETED|Overall Study||1421
9820590|NCT00716079|10931342|FG000|NOT COMPLETED|Overall Study||9
9820591|NCT00716079|10931343|FG001|NOT COMPLETED|Overall Study||15
9820592|NCT00716092|10931352|FG000|STARTED|Overall Study||40
9820593|NCT00716092|10931353|FG001|STARTED|Overall Study||40
9820594|NCT00716092|10931354|FG002|STARTED|Overall Study||41
9820595|NCT00716092|10931352|FG000|COMPLETED|Overall Study||38
9820596|NCT00716092|10931353|FG001|COMPLETED|Overall Study||39
9820597|NCT00716092|10931354|FG002|COMPLETED|Overall Study||41
9820598|NCT00716092|10931352|FG000|NOT COMPLETED|Overall Study||2
9820599|NCT00716092|10931353|FG001|NOT COMPLETED|Overall Study||1
9820600|NCT00716092|10931354|FG002|NOT COMPLETED|Overall Study||0
9820601|NCT00716144|10931366|FG000|STARTED|Overall Study||41
9820602|NCT00716144|10931367|FG001|STARTED|Overall Study||45
9820603|NCT00716144|10931368|FG002|STARTED|Overall Study||45
9820604|NCT00716144|10931369|FG003|STARTED|Overall Study||45
9820605|NCT00716144|10931366|FG000|COMPLETED|Overall Study||32
9820606|NCT00716144|10931367|FG001|COMPLETED|Overall Study||38
9820607|NCT00716144|10931368|FG002|COMPLETED|Overall Study||33
9820608|NCT00716144|10931369|FG003|COMPLETED|Overall Study||33
9820609|NCT00716144|10931366|FG000|NOT COMPLETED|Overall Study||9
9820610|NCT00716144|10931367|FG001|NOT COMPLETED|Overall Study||7
9820611|NCT00716144|10931368|FG002|NOT COMPLETED|Overall Study||12
9820612|NCT00716144|10931369|FG003|NOT COMPLETED|Overall Study||12
9820613|NCT00716274|10931382|FG000|STARTED|Study Period II (16-Weeks)||45
9820614|NCT00716274|10931383|FG001|STARTED|Study Period II (16-Weeks)||44
9820615|NCT00716274|10931384|FG002|STARTED|Study Period II (16-Weeks)||0
9820616|NCT00716274|10931385|FG003|STARTED|Study Period II (16-Weeks)||0
9820617|NCT00716274|10931386|FG004|STARTED|Study Period II (16-Weeks)||0
9820618|NCT00716274|10931387|FG005|STARTED|Study Period II (16-Weeks)||21
9820619|NCT00716274|10931382|FG000|COMPLETED|Study Period II (16-Weeks)||36
9820620|NCT00716274|10931383|FG001|COMPLETED|Study Period II (16-Weeks)||35
9820621|NCT00716274|10931384|FG002|COMPLETED|Study Period II (16-Weeks)||0
9820622|NCT00716274|10931385|FG003|COMPLETED|Study Period II (16-Weeks)||0
9820623|NCT00716274|10931386|FG004|COMPLETED|Study Period II (16-Weeks)||0
9820624|NCT00716274|10931387|FG005|COMPLETED|Study Period II (16-Weeks)||19
9820625|NCT00716274|10931382|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9
9820626|NCT00716274|10931383|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9
9820627|NCT00716274|10931384|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0
9820628|NCT00716274|10931385|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0
9820629|NCT00716274|10931386|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0
9820630|NCT00716274|10931387|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2
9820631|NCT00716274|10931382|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
9820632|NCT00716274|10931383|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
9820633|NCT00716274|10931384|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
9820634|NCT00716274|10931385|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
9820635|NCT00716274|10931386|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
9820636|NCT00716274|10931387|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
9820637|NCT00716274|10931382|FG000|COMPLETED|Study Period III (16-Weeks)||0
9820638|NCT00716274|10931383|FG001|COMPLETED|Study Period III (16-Weeks)||0
9820639|NCT00716274|10931384|FG002|COMPLETED|Study Period III (16-Weeks)||16
9820640|NCT00716274|10931385|FG003|COMPLETED|Study Period III (16-Weeks)||17
9820641|NCT00716274|10931386|FG004|COMPLETED|Study Period III (16-Weeks)||32
9820642|NCT00716274|10931387|FG005|COMPLETED|Study Period III (16-Weeks)||19
9820643|NCT00716274|10931382|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0
9820644|NCT00716274|10931383|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0
9820645|NCT00716274|10931384|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2
9820646|NCT00716274|10931385|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1
9820647|NCT00716274|10931386|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3
9820648|NCT00716274|10931387|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0
9820649|NCT00716417|10931414|FG000|STARTED|Overall Study||3
9820650|NCT00716417|10931415|FG001|STARTED|Overall Study||6
9820651|NCT00716417|10931416|FG002|STARTED|Overall Study||5
9820652|NCT00716417|10931417|FG003|STARTED|Overall Study||11
9820653|NCT00716417|10931418|FG004|STARTED|Overall Study||1
9820654|NCT00716417|10931419|FG005|STARTED|Overall Study||3
9820655|NCT00716417|10931420|FG006|STARTED|Overall Study||7
9820656|NCT00716417|10931421|FG007|STARTED|Overall Study||3
9820657|NCT00716417|10931422|FG008|STARTED|Overall Study||5
9820658|NCT00716417|10931423|FG009|STARTED|Overall Study||3
9820659|NCT00716417|10931414|FG000|COMPLETED|Overall Study||0
9820660|NCT00716417|10931415|FG001|COMPLETED|Overall Study||0
9820661|NCT00716417|10931416|FG002|COMPLETED|Overall Study||0
9820662|NCT00716417|10931417|FG003|COMPLETED|Overall Study||0
9820663|NCT00716417|10931418|FG004|COMPLETED|Overall Study||0
9820664|NCT00716417|10931419|FG005|COMPLETED|Overall Study||0
9820665|NCT00716417|10931420|FG006|COMPLETED|Overall Study||0
9820666|NCT00716417|10931421|FG007|COMPLETED|Overall Study||0
9820667|NCT00716417|10931422|FG008|COMPLETED|Overall Study||0
9820668|NCT00716417|10931423|FG009|COMPLETED|Overall Study||0
9820669|NCT00716417|10931414|FG000|NOT COMPLETED|Overall Study||3
9820670|NCT00716417|10931415|FG001|NOT COMPLETED|Overall Study||6
9820671|NCT00716417|10931416|FG002|NOT COMPLETED|Overall Study||5
9820672|NCT00716417|10931417|FG003|NOT COMPLETED|Overall Study||11
9820673|NCT00716417|10931418|FG004|NOT COMPLETED|Overall Study||1
9820674|NCT00716417|10931419|FG005|NOT COMPLETED|Overall Study||3
9820675|NCT00716417|10931420|FG006|NOT COMPLETED|Overall Study||7
9820676|NCT00716417|10931421|FG007|NOT COMPLETED|Overall Study||3
9820677|NCT00716417|10931422|FG008|NOT COMPLETED|Overall Study||5
9820678|NCT00716417|10931423|FG009|NOT COMPLETED|Overall Study||3
9820679|NCT00716443|10931447|FG000|STARTED|Overall Study||51
9820680|NCT00716443|10931447|FG000|COMPLETED|Overall Study||51
9820681|NCT00716443|10931447|FG000|NOT COMPLETED|Overall Study||0
9820682|NCT00716456|10931455|FG000|STARTED|Overall Study||3
9820683|NCT00716456|10931456|FG001|STARTED|Overall Study||5
9820684|NCT00716456|10931457|FG002|STARTED|Overall Study||13
9820685|NCT00716456|10931455|FG000|COMPLETED|Overall Study||3
9820686|NCT00716456|10931456|FG001|COMPLETED|Overall Study||3
9820687|NCT00716456|10931457|FG002|COMPLETED|Overall Study||13
10017031|NCT01814072|11139936|FG029|STARTED|Overall Study||17
10017032|NCT01814072|11139937|FG030|STARTED|Overall Study||17
10017033|NCT01814072|11139938|FG031|STARTED|Overall Study||17
10017034|NCT01814072|11139907|FG000|3-mo Visit|Overall Study||15
10017035|NCT01814072|11139908|FG001|3-mo Visit|Overall Study||18
10017036|NCT01814072|11139909|FG002|3-mo Visit|Overall Study||16
10017037|NCT01814072|11139910|FG003|3-mo Visit|Overall Study||18
10017038|NCT01814072|11139911|FG004|3-mo Visit|Overall Study||15
10017039|NCT01814072|11139912|FG005|3-mo Visit|Overall Study||15
10017040|NCT01814072|11139913|FG006|3-mo Visit|Overall Study||16
10017041|NCT01814072|11139914|FG007|3-mo Visit|Overall Study||18
10017042|NCT01814072|11139915|FG008|3-mo Visit|Overall Study||18
10017043|NCT01814072|11139916|FG009|3-mo Visit|Overall Study||15
10017044|NCT01814072|11139917|FG010|3-mo Visit|Overall Study||18
10017045|NCT01814072|11139918|FG011|3-mo Visit|Overall Study||17
10017046|NCT01814072|11139919|FG012|3-mo Visit|Overall Study||16
10017047|NCT01814072|11139920|FG013|3-mo Visit|Overall Study||16
10017048|NCT01814072|11139921|FG014|3-mo Visit|Overall Study||16
10017049|NCT01814072|11139922|FG015|3-mo Visit|Overall Study||16
9820688|NCT00716456|10931455|FG000|NOT COMPLETED|Overall Study||0
9820689|NCT00716456|10931456|FG001|NOT COMPLETED|Overall Study||2
9820690|NCT00716456|10931457|FG002|NOT COMPLETED|Overall Study||0
9820691|NCT00716482|10931465|FG000|STARTED|Overall Study||1681
9820692|NCT00716482|10931465|FG000|COMPLETED|Overall Study||1562
9820693|NCT00716482|10931465|FG000|NOT COMPLETED|Overall Study||119
9820694|NCT00716586|10931475|FG000|STARTED|Overall Study||44
9820695|NCT00716586|10931475|FG000|COMPLETED|Overall Study||44
10017050|NCT01814072|11139923|FG016|3-mo Visit|Overall Study||16
10017051|NCT01814072|11139924|FG017|3-mo Visit|Overall Study||16
10017052|NCT01814072|11139925|FG018|3-mo Visit|Overall Study||14
9820696|NCT00716586|10931475|FG000|NOT COMPLETED|Overall Study||0
9820697|NCT00716625|10931480|FG000|STARTED|Overall Study||1674
9820698|NCT00716625|10931480|FG000|COMPLETED|Overall Study||1673
9820699|NCT00716625|10931480|FG000|NOT COMPLETED|Overall Study||1
9820700|NCT00716742|10931501|FG000|STARTED|Baseline||364
9820701|NCT00716742|10931502|FG001|STARTED|Baseline||370
10017053|NCT01814072|11139926|FG019|3-mo Visit|Overall Study||13
10017054|NCT01814072|11139927|FG020|3-mo Visit|Overall Study||15
10017055|NCT01814072|11139928|FG021|3-mo Visit|Overall Study||17
9820702|NCT00716742|10931503|FG002|STARTED|Baseline||365
9820703|NCT00716742|10931501|FG000|COMPLETED|Baseline||347
9820704|NCT00716742|10931502|FG001|COMPLETED|Baseline||356
9820705|NCT00716742|10931503|FG002|COMPLETED|Baseline||352
9820706|NCT00716742|10931501|FG000|NOT COMPLETED|Baseline||17
9820707|NCT00716742|10931502|FG001|NOT COMPLETED|Baseline||14
9820708|NCT00716742|10931503|FG002|NOT COMPLETED|Baseline||13
9820709|NCT00716742|10931501|FG000|STARTED|1 Year Follow-up||347
9820710|NCT00716742|10931502|FG001|STARTED|1 Year Follow-up||356
9820711|NCT00716742|10931503|FG002|STARTED|1 Year Follow-up||352
9820712|NCT00716742|10931501|FG000|COMPLETED|1 Year Follow-up||160
9820713|NCT00716742|10931502|FG001|COMPLETED|1 Year Follow-up||163
9820714|NCT00716742|10931503|FG002|COMPLETED|1 Year Follow-up||152
9820715|NCT00716742|10931501|FG000|NOT COMPLETED|1 Year Follow-up||187
9820716|NCT00716742|10931502|FG001|NOT COMPLETED|1 Year Follow-up||193
9820717|NCT00716742|10931503|FG002|NOT COMPLETED|1 Year Follow-up||200
9820718|NCT00716742|10931501|FG000|STARTED|2 Year Follow-up||160
9820719|NCT00716742|10931502|FG001|STARTED|2 Year Follow-up||163
9820720|NCT00716742|10931503|FG002|STARTED|2 Year Follow-up||152
9820721|NCT00716742|10931501|FG000|COMPLETED|2 Year Follow-up||56
9820722|NCT00716742|10931502|FG001|COMPLETED|2 Year Follow-up||67
9820723|NCT00716742|10931503|FG002|COMPLETED|2 Year Follow-up||50
9820724|NCT00716742|10931501|FG000|NOT COMPLETED|2 Year Follow-up||104
9820725|NCT00716742|10931502|FG001|NOT COMPLETED|2 Year Follow-up||96
9820726|NCT00716742|10931503|FG002|NOT COMPLETED|2 Year Follow-up||102
9820727|NCT00716742|10931501|FG000|STARTED|3 Year Follow-up||56
9820728|NCT00716742|10931502|FG001|STARTED|3 Year Follow-up||67
9820729|NCT00716742|10931503|FG002|STARTED|3 Year Follow-up||50
9820730|NCT00716742|10931501|FG000|COMPLETED|3 Year Follow-up||26
9820731|NCT00716742|10931502|FG001|COMPLETED|3 Year Follow-up||35
9820732|NCT00716742|10931503|FG002|COMPLETED|3 Year Follow-up||29
9820733|NCT00716742|10931501|FG000|NOT COMPLETED|3 Year Follow-up||30
9820734|NCT00716742|10931502|FG001|NOT COMPLETED|3 Year Follow-up||32
9820735|NCT00716742|10931503|FG002|NOT COMPLETED|3 Year Follow-up||21
9820736|NCT00716820|10931511|FG000|STARTED|Overall Study||472
9820737|NCT00716820|10931511|FG000|COMPLETED|Overall Study||472
10017056|NCT01814072|11139929|FG022|3-mo Visit|Overall Study||15
10017057|NCT01814072|11139930|FG023|3-mo Visit|Overall Study||18
10017058|NCT01814072|11139931|FG024|3-mo Visit|Overall Study||13
10017059|NCT01814072|11139932|FG025|3-mo Visit|Overall Study||14
10017060|NCT01814072|11139933|FG026|3-mo Visit|Overall Study||17
9820738|NCT00716820|10931511|FG000|NOT COMPLETED|Overall Study||0
9820739|NCT00716859|10931538|FG000|STARTED|Overall Study||70
9820740|NCT00716859|10931539|FG001|STARTED|Overall Study||69
9820741|NCT00716859|10931538|FG000|Received Treatment|Overall Study||69
9820742|NCT00716859|10931539|FG001|Received Treatment|Overall Study||68
9820743|NCT00716859|10931538|FG000|COMPLETED|Overall Study||61
9820744|NCT00716859|10931539|FG001|COMPLETED|Overall Study||64
9820745|NCT00716859|10931538|FG000|NOT COMPLETED|Overall Study||9
9820746|NCT00716859|10931539|FG001|NOT COMPLETED|Overall Study||5
9820747|NCT00716963|10931545|FG000|STARTED|Overall Study||2
9820748|NCT00716963|10931546|FG001|STARTED|Overall Study||1
9820749|NCT00716963|10931547|FG002|STARTED|Overall Study||1
9820750|NCT00716963|10931548|FG003|STARTED|Overall Study||1
9820751|NCT00716963|10931549|FG004|STARTED|Overall Study||1
9820752|NCT00716963|10931550|FG005|STARTED|Overall Study||1
9820753|NCT00716963|10931545|FG000|COMPLETED|Overall Study||1
9820754|NCT00716963|10931546|FG001|COMPLETED|Overall Study||1
9820755|NCT00716963|10931547|FG002|COMPLETED|Overall Study||1
9820756|NCT00716963|10931548|FG003|COMPLETED|Overall Study||1
9820757|NCT00716963|10931549|FG004|COMPLETED|Overall Study||1
9820758|NCT00716963|10931550|FG005|COMPLETED|Overall Study||1
9820759|NCT00716963|10931545|FG000|NOT COMPLETED|Overall Study||1
9820760|NCT00716963|10931546|FG001|NOT COMPLETED|Overall Study||0
9820761|NCT00716963|10931547|FG002|NOT COMPLETED|Overall Study||0
9820762|NCT00716963|10931548|FG003|NOT COMPLETED|Overall Study||0
9820763|NCT00716963|10931549|FG004|NOT COMPLETED|Overall Study||0
9820764|NCT00716963|10931550|FG005|NOT COMPLETED|Overall Study||0
9820765|NCT00716976|10931560|FG000|STARTED|Overall Study||65
9820766|NCT00716976|10931561|FG001|STARTED|Overall Study||66
9820767|NCT00716976|10931560|FG000|COMPLETED|Overall Study||45
9820768|NCT00716976|10931561|FG001|COMPLETED|Overall Study||57
9820769|NCT00716976|10931560|FG000|NOT COMPLETED|Overall Study||20
9820770|NCT00716976|10931561|FG001|NOT COMPLETED|Overall Study||9
9820771|NCT00717041|10931569|FG000|STARTED|Overall Study||1206
9820772|NCT00717041|10931569|FG000|COMPLETED|Overall Study||1206
9820773|NCT00717041|10931569|FG000|NOT COMPLETED|Overall Study||0
9820774|NCT00717054|10931577|FG000|STARTED|Overall Study||58
9820775|NCT00717054|10931578|FG001|STARTED|Overall Study||57
9820776|NCT00717054|10931577|FG000|COMPLETED|Overall Study||58
9820777|NCT00717054|10931578|FG001|COMPLETED|Overall Study||57
10017061|NCT01814072|11139934|FG027|3-mo Visit|Overall Study||14
9820778|NCT00717054|10931577|FG000|NOT COMPLETED|Overall Study||0
9820779|NCT00717054|10931578|FG001|NOT COMPLETED|Overall Study||0
10017062|NCT01814072|11139935|FG028|3-mo Visit|Overall Study||15
9820780|NCT00717067|10931590|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6
9820781|NCT00717067|10931591|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6
9820782|NCT00717067|10931592|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6
9820783|NCT00717067|10931593|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0
9820784|NCT00717067|10931594|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0
9820785|NCT00717067|10931590|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
9820786|NCT00717067|10931591|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
9820787|NCT00717067|10931592|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
9820788|NCT00717067|10931593|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
9820789|NCT00717067|10931594|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
9820790|NCT00717067|10931590|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
9820791|NCT00717067|10931591|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
9820792|NCT00717067|10931592|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
9820793|NCT00717067|10931593|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
9820794|NCT00717067|10931594|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
9820795|NCT00717067|10931590|FG000|STARTED|Part 1b: Severe Renal Impairment||0
9820796|NCT00717067|10931591|FG001|STARTED|Part 1b: Severe Renal Impairment||0
9820797|NCT00717067|10931592|FG002|STARTED|Part 1b: Severe Renal Impairment||0
9820798|NCT00717067|10931593|FG003|STARTED|Part 1b: Severe Renal Impairment||6
9820799|NCT00717067|10931594|FG004|STARTED|Part 1b: Severe Renal Impairment||0
9820800|NCT00717067|10931590|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0
9820801|NCT00717067|10931591|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0
9820802|NCT00717067|10931592|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0
9820803|NCT00717067|10931593|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6
9820804|NCT00717067|10931594|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0
9820805|NCT00717067|10931590|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
9820806|NCT00717067|10931591|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
9820807|NCT00717067|10931592|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
9820808|NCT00717067|10931593|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
9820809|NCT00717067|10931594|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
9820810|NCT00717067|10931590|FG000|STARTED|Part 2: End Stage Renal Disease||0
9820811|NCT00717067|10931591|FG001|STARTED|Part 2: End Stage Renal Disease||0
9820812|NCT00717067|10931592|FG002|STARTED|Part 2: End Stage Renal Disease||0
9820813|NCT00717067|10931593|FG003|STARTED|Part 2: End Stage Renal Disease||0
9820814|NCT00717067|10931594|FG004|STARTED|Part 2: End Stage Renal Disease||6
9820815|NCT00717067|10931590|FG000|COMPLETED|Part 2: End Stage Renal Disease||0
9820816|NCT00717067|10931591|FG001|COMPLETED|Part 2: End Stage Renal Disease||0
9820817|NCT00717067|10931592|FG002|COMPLETED|Part 2: End Stage Renal Disease||0
9820818|NCT00717067|10931593|FG003|COMPLETED|Part 2: End Stage Renal Disease||0
9820819|NCT00717067|10931594|FG004|COMPLETED|Part 2: End Stage Renal Disease||6
9820820|NCT00717067|10931590|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0
9820821|NCT00717067|10931591|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0
9820822|NCT00717067|10931592|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0
9820823|NCT00717067|10931593|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0
9820824|NCT00717067|10931594|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0
9820825|NCT00717093|10931618|FG000|STARTED|Overall Study||214
9820826|NCT00717093|10931619|FG001|STARTED|Overall Study||218
9820827|NCT00717093|10931618|FG000|Received Treatment|Overall Study||213
9820828|NCT00717093|10931619|FG001|Received Treatment|Overall Study||218
9820829|NCT00717093|10931618|FG000|COMPLETED|Overall Study||170
9820830|NCT00717093|10931619|FG001|COMPLETED|Overall Study||170
9820831|NCT00717093|10931618|FG000|NOT COMPLETED|Overall Study||44
9820832|NCT00717093|10931619|FG001|NOT COMPLETED|Overall Study||48
9820833|NCT00717197|10931625|FG000|STARTED|Overall Study||30
9820834|NCT00717197|10931625|FG000|COMPLETED|Overall Study||23
9820835|NCT00717197|10931625|FG000|NOT COMPLETED|Overall Study||7
9820836|NCT00717236|10931631|FG000|STARTED|Double-Blind Period||851
9820837|NCT00717236|10931632|FG001|STARTED|Double-Blind Period||212
9820838|NCT00717236|10931631|FG000|COMPLETED|Double-Blind Period||771
9820839|NCT00717236|10931632|FG001|COMPLETED|Double-Blind Period||184
9820840|NCT00717236|10931631|FG000|NOT COMPLETED|Double-Blind Period||80
9820841|NCT00717236|10931632|FG001|NOT COMPLETED|Double-Blind Period||28
9820842|NCT00717236|10931631|FG000|STARTED|Open-Label Period||771
9820843|NCT00717236|10931632|FG001|STARTED|Open-Label Period||184
9820844|NCT00717236|10931631|FG000|COMPLETED|Open-Label Period||646
9820845|NCT00717236|10931632|FG001|COMPLETED|Open-Label Period||163
9820846|NCT00717236|10931631|FG000|NOT COMPLETED|Open-Label Period||125
9820847|NCT00717236|10931632|FG001|NOT COMPLETED|Open-Label Period||21
9820848|NCT00717249|10931642|FG000|STARTED|Overall Study||326
9820849|NCT00717249|10931643|FG001|STARTED|Overall Study||165
9820850|NCT00717249|10931642|FG000|COMPLETED|Overall Study||304
9820851|NCT00717249|10931643|FG001|COMPLETED|Overall Study||150
9820852|NCT00717249|10931642|FG000|NOT COMPLETED|Overall Study||22
9820853|NCT00717249|10931643|FG001|NOT COMPLETED|Overall Study||15
9820854|NCT00717288|10931652|FG000|STARTED|Overall Study||28
9820855|NCT00717288|10931653|FG001|STARTED|Overall Study||29
9820856|NCT00717288|10931654|FG002|STARTED|Overall Study||25
9820857|NCT00717288|10931652|FG000|COMPLETED|Overall Study||28
9820858|NCT00717288|10931653|FG001|COMPLETED|Overall Study||29
9820859|NCT00717288|10931654|FG002|COMPLETED|Overall Study||25
9820860|NCT00717288|10931652|FG000|NOT COMPLETED|Overall Study||0
9820861|NCT00717288|10931653|FG001|NOT COMPLETED|Overall Study||0
9820862|NCT00717288|10931654|FG002|NOT COMPLETED|Overall Study||0
10017063|NCT01814072|11139936|FG029|3-mo Visit|Overall Study||16
10017064|NCT01814072|11139937|FG030|3-mo Visit|Overall Study||16
10017065|NCT01814072|11139938|FG031|3-mo Visit|Overall Study||17
9820863|NCT00717314|10931670|FG000|STARTED|Overall Study||43
9820864|NCT00717314|10931671|FG001|STARTED|Overall Study||44
9820865|NCT00717314|10931670|FG000|COMPLETED|Overall Study||37
9820866|NCT00717314|10931671|FG001|COMPLETED|Overall Study||34
9820867|NCT00717314|10931670|FG000|NOT COMPLETED|Overall Study||6
9820868|NCT00717314|10931671|FG001|NOT COMPLETED|Overall Study||10
9820869|NCT00717366|10931679|FG000|STARTED|Core Study Period (20 Weeks)||16
9820870|NCT00717366|10931680|FG001|STARTED|Core Study Period (20 Weeks)||48
9820871|NCT00717366|10931679|FG000|COMPLETED|Core Study Period (20 Weeks)||12
9820872|NCT00717366|10931680|FG001|COMPLETED|Core Study Period (20 Weeks)||35
9820873|NCT00717366|10931679|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4
9820874|NCT00717366|10931680|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13
9820875|NCT00717366|10931679|FG000|STARTED|Extension Period (52 Weeks)||9
9820876|NCT00717366|10931680|FG001|STARTED|Extension Period (52 Weeks)||28
9820877|NCT00717366|10931679|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
9820878|NCT00717366|10931680|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
9820879|NCT00717366|10931679|FG000|COMPLETED|Extension Period (52 Weeks)||5
9820880|NCT00717366|10931680|FG001|COMPLETED|Extension Period (52 Weeks)||12
9820881|NCT00717366|10931679|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
9820882|NCT00717366|10931680|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16
9820883|NCT00717405|10931686|FG000|STARTED|Overall Study||52
9820884|NCT00717405|10931686|FG000|COMPLETED|Overall Study||52
9820885|NCT00717405|10931686|FG000|NOT COMPLETED|Overall Study||0
9820886|NCT00717418|10931694|FG000|STARTED|Baseline||180
9820887|NCT00717418|10931695|FG001|STARTED|Baseline||74
9820888|NCT00717418|10931696|FG002|STARTED|Baseline||508
9820889|NCT00717418|10931697|FG003|STARTED|Baseline||19
9820890|NCT00717418|10931694|FG000|COMPLETED|Baseline||180
9820891|NCT00717418|10931695|FG001|COMPLETED|Baseline||74
9820892|NCT00717418|10931696|FG002|COMPLETED|Baseline||508
9820893|NCT00717418|10931697|FG003|COMPLETED|Baseline||4
9820894|NCT00717418|10931694|FG000|NOT COMPLETED|Baseline||0
9820895|NCT00717418|10931695|FG001|NOT COMPLETED|Baseline||0
9820896|NCT00717418|10931696|FG002|NOT COMPLETED|Baseline||0
9820897|NCT00717418|10931697|FG003|NOT COMPLETED|Baseline||15
9820898|NCT00717418|10931694|FG000|STARTED|1-Year Follow-Up||180
9820899|NCT00717418|10931695|FG001|STARTED|1-Year Follow-Up||74
9820900|NCT00717418|10931696|FG002|STARTED|1-Year Follow-Up||508
9820901|NCT00717418|10931697|FG003|STARTED|1-Year Follow-Up||4
9820902|NCT00717418|10931694|FG000|COMPLETED|1-Year Follow-Up||33
9820903|NCT00717418|10931695|FG001|COMPLETED|1-Year Follow-Up||23
9820904|NCT00717418|10931696|FG002|COMPLETED|1-Year Follow-Up||74
9820905|NCT00717418|10931697|FG003|COMPLETED|1-Year Follow-Up||0
9820906|NCT00717418|10931694|FG000|NOT COMPLETED|1-Year Follow-Up||147
9820907|NCT00717418|10931695|FG001|NOT COMPLETED|1-Year Follow-Up||51
9820908|NCT00717418|10931696|FG002|NOT COMPLETED|1-Year Follow-Up||434
9820909|NCT00717418|10931697|FG003|NOT COMPLETED|1-Year Follow-Up||4
9820910|NCT00717522|10931701|FG000|STARTED|Overall Study||7
9820911|NCT00717522|10931701|FG000|COMPLETED|Overall Study||0
9820912|NCT00717522|10931701|FG000|NOT COMPLETED|Overall Study||7
9820913|NCT00717574|10931707|FG000|STARTED|Overall Study||16
9820914|NCT00717574|10931708|FG001|STARTED|Overall Study||16
9820915|NCT00717574|10931707|FG000|COMPLETED|Overall Study||14
9820916|NCT00717574|10931708|FG001|COMPLETED|Overall Study||14
9820917|NCT00717574|10931707|FG000|NOT COMPLETED|Overall Study||2
9820918|NCT00717574|10931708|FG001|NOT COMPLETED|Overall Study||2
9820919|NCT00717626|10931714|FG000|STARTED|Overall Study||14
9820920|NCT00717626|10931714|FG000|COMPLETED|Overall Study||14
9820921|NCT00717626|10931714|FG000|NOT COMPLETED|Overall Study||0
9820922|NCT00717756|10931718|FG000|STARTED|Overall Study||41
9820923|NCT00717756|10931718|FG000|COMPLETED|Overall Study||40
9820924|NCT00717756|10931718|FG000|NOT COMPLETED|Overall Study||1
9820925|NCT00717769|10931725|FG000|STARTED|Overall Study||120
9820926|NCT00717769|10931726|FG001|STARTED|Overall Study||120
9820927|NCT00717769|10931727|FG002|STARTED|Overall Study||30
9820928|NCT00717769|10931725|FG000|COMPLETED|Overall Study||104
9820929|NCT00717769|10931726|FG001|COMPLETED|Overall Study||102
9820930|NCT00717769|10931727|FG002|COMPLETED|Overall Study||19
9820931|NCT00717769|10931725|FG000|NOT COMPLETED|Overall Study||16
9820932|NCT00717769|10931726|FG001|NOT COMPLETED|Overall Study||18
9820933|NCT00717769|10931727|FG002|NOT COMPLETED|Overall Study||11
9820934|NCT00717860|10931739|FG000|STARTED|Overall Study||61
9820935|NCT00717860|10931740|FG001|STARTED|Overall Study||60
9820936|NCT00717860|10931739|FG000|COMPLETED|Overall Study||34
9820937|NCT00717860|10931740|FG001|COMPLETED|Overall Study||32
9820938|NCT00717860|10931739|FG000|NOT COMPLETED|Overall Study||27
10017066|NCT01814072|11139907|FG000|Intent to Treat|Overall Study||4
10017067|NCT01814072|11139908|FG001|Intent to Treat|Overall Study||2
9820939|NCT00717860|10931740|FG001|NOT COMPLETED|Overall Study||28
9820940|NCT00717873|10931748|FG000|STARTED|Overall Study||46
9820941|NCT00717873|10931749|FG001|STARTED|Overall Study||59
9820942|NCT00717873|10931748|FG000|COMPLETED|Overall Study||46
9820943|NCT00717873|10931749|FG001|COMPLETED|Overall Study||59
9820944|NCT00717873|10931748|FG000|NOT COMPLETED|Overall Study||0
9820945|NCT00717873|10931749|FG001|NOT COMPLETED|Overall Study||0
9820946|NCT00717886|10931755|FG000|STARTED|Overall Study||13
9820947|NCT00717886|10931755|FG000|COMPLETED|Overall Study||9
10017068|NCT01814072|11139909|FG002|Intent to Treat|Overall Study||3
9820948|NCT00717886|10931755|FG000|NOT COMPLETED|Overall Study||4
9820949|NCT00717912|10931759|FG000|STARTED|Overall Study||1
9820950|NCT00717912|10931760|FG001|STARTED|Overall Study||1
9820951|NCT00717912|10931761|FG002|STARTED|Overall Study||1
9820952|NCT00717912|10931762|FG003|STARTED|Overall Study||1
9820953|NCT00717912|10931763|FG004|STARTED|Overall Study||1
9820954|NCT00717912|10931764|FG005|STARTED|Overall Study||1
9820955|NCT00717912|10931759|FG000|COMPLETED|Overall Study||1
9820956|NCT00717912|10931760|FG001|COMPLETED|Overall Study||1
9820957|NCT00717912|10931761|FG002|COMPLETED|Overall Study||1
9820958|NCT00717912|10931762|FG003|COMPLETED|Overall Study||1
9820959|NCT00717912|10931763|FG004|COMPLETED|Overall Study||1
9820960|NCT00717912|10931764|FG005|COMPLETED|Overall Study||1
9820961|NCT00717912|10931759|FG000|NOT COMPLETED|Overall Study||0
9820962|NCT00717912|10931760|FG001|NOT COMPLETED|Overall Study||0
9820963|NCT00717912|10931761|FG002|NOT COMPLETED|Overall Study||0
9820964|NCT00717912|10931762|FG003|NOT COMPLETED|Overall Study||0
9820965|NCT00717912|10931763|FG004|NOT COMPLETED|Overall Study||0
9820966|NCT00717912|10931764|FG005|NOT COMPLETED|Overall Study||0
9820967|NCT00717977|10931773|FG000|STARTED|Overall Study||74
9820968|NCT00717977|10931773|FG000|COMPLETED|Overall Study||74
9820969|NCT00717977|10931773|FG000|NOT COMPLETED|Overall Study||0
9820970|NCT00718042|10931783|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313
9820971|NCT00718042|10931784|FG001|STARTED|ABBOTT PRISM Chagas Testing||289
9820972|NCT00718042|10931785|FG002|STARTED|ABBOTT PRISM Chagas Testing||525
9820973|NCT00718042|10931786|FG003|STARTED|ABBOTT PRISM Chagas Testing||110
9820974|NCT00718042|10931787|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549
9820975|NCT00718042|10931788|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
9820976|NCT00718042|10931783|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249
9820977|NCT00718042|10931784|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287
9820978|NCT00718042|10931785|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524
9820979|NCT00718042|10931786|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110
9820980|NCT00718042|10931787|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511
9820981|NCT00718042|10931788|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0
9820982|NCT00718042|10931783|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
9820983|NCT00718042|10931784|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
9820984|NCT00718042|10931785|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
9820985|NCT00718042|10931786|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
9820986|NCT00718042|10931787|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
9820987|NCT00718042|10931788|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
9820988|NCT00718042|10931783|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
9820989|NCT00718042|10931784|FG001|STARTED|ESA Chagas Testing||287
9820990|NCT00718042|10931785|FG002|STARTED|ESA Chagas Testing||524
9820991|NCT00718042|10931786|FG003|STARTED|ESA Chagas Testing||110
9820992|NCT00718042|10931787|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
9820993|NCT00718042|10931788|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
9820994|NCT00718042|10931783|FG000|COMPLETED|ESA Chagas Testing||36
9820995|NCT00718042|10931784|FG001|COMPLETED|ESA Chagas Testing||287
9820996|NCT00718042|10931785|FG002|COMPLETED|ESA Chagas Testing||524
9820997|NCT00718042|10931786|FG003|COMPLETED|ESA Chagas Testing||110
9820998|NCT00718042|10931787|FG004|COMPLETED|ESA Chagas Testing||43
9820999|NCT00718042|10931788|FG005|COMPLETED|ESA Chagas Testing||330
9821000|NCT00718042|10931783|FG000|NOT COMPLETED|ESA Chagas Testing||0
9821001|NCT00718042|10931784|FG001|NOT COMPLETED|ESA Chagas Testing||0
9821002|NCT00718042|10931785|FG002|NOT COMPLETED|ESA Chagas Testing||0
9821003|NCT00718042|10931786|FG003|NOT COMPLETED|ESA Chagas Testing||0
10017069|NCT01814072|11139910|FG003|Intent to Treat|Overall Study||0
10017070|NCT01814072|11139911|FG004|Intent to Treat|Overall Study||4
10017071|NCT01814072|11139912|FG005|Intent to Treat|Overall Study||6
9821004|NCT00718042|10931787|FG004|NOT COMPLETED|ESA Chagas Testing||0
9821005|NCT00718042|10931788|FG005|NOT COMPLETED|ESA Chagas Testing||0
9821006|NCT00718042|10931783|FG000|STARTED|Donor Follow-up||36
9821007|NCT00718042|10931784|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
9821008|NCT00718042|10931785|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
10017072|NCT01814072|11139913|FG006|Intent to Treat|Overall Study||4
9821009|NCT00718042|10931786|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
9821010|NCT00718042|10931787|FG004|STARTED|Donor Follow-up||43
9821011|NCT00718042|10931788|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
9821012|NCT00718042|10931783|FG000|COMPLETED|Donor Follow-up||23
9821013|NCT00718042|10931784|FG001|COMPLETED|Donor Follow-up||0
9821014|NCT00718042|10931785|FG002|COMPLETED|Donor Follow-up||0
9821015|NCT00718042|10931786|FG003|COMPLETED|Donor Follow-up||0
9821016|NCT00718042|10931787|FG004|COMPLETED|Donor Follow-up||24
9821017|NCT00718042|10931788|FG005|COMPLETED|Donor Follow-up||0
9821018|NCT00718042|10931783|FG000|NOT COMPLETED|Donor Follow-up||13
9821019|NCT00718042|10931784|FG001|NOT COMPLETED|Donor Follow-up||0
9821020|NCT00718042|10931785|FG002|NOT COMPLETED|Donor Follow-up||0
9821021|NCT00718042|10931786|FG003|NOT COMPLETED|Donor Follow-up||0
9821022|NCT00718042|10931787|FG004|NOT COMPLETED|Donor Follow-up||19
9821023|NCT00718042|10931788|FG005|NOT COMPLETED|Donor Follow-up||0
9821024|NCT00718081|10931803|FG000|STARTED|Overall Study||29
9821025|NCT00718081|10931804|FG001|STARTED|Overall Study||29
9821026|NCT00718081|10931805|FG002|STARTED|Overall Study||30
9821027|NCT00718081|10931803|FG000|COMPLETED|Overall Study||22
10017073|NCT01814072|11139914|FG007|Intent to Treat|Overall Study||1
10017074|NCT01814072|11139915|FG008|Intent to Treat|Overall Study||3
10017075|NCT01814072|11139916|FG009|Intent to Treat|Overall Study||5
10017076|NCT01814072|11139917|FG010|Intent to Treat|Overall Study||1
10017077|NCT01814072|11139918|FG011|Intent to Treat|Overall Study||2
10017078|NCT01814072|11139919|FG012|Intent to Treat|Overall Study||3
10017079|NCT01814072|11139920|FG013|Intent to Treat|Overall Study||2
9821028|NCT00718081|10931804|FG001|COMPLETED|Overall Study||25
9821029|NCT00718081|10931805|FG002|COMPLETED|Overall Study||9
9821030|NCT00718081|10931803|FG000|NOT COMPLETED|Overall Study||7
9821031|NCT00718081|10931804|FG001|NOT COMPLETED|Overall Study||4
9821032|NCT00718081|10931805|FG002|NOT COMPLETED|Overall Study||21
9821033|NCT00718094|10931815|FG000|STARTED|Overall Study||15
9821034|NCT00718094|10931816|FG001|STARTED|Overall Study||5
9821035|NCT00718094|10931815|FG000|COMPLETED|Overall Study||15
9821036|NCT00718094|10931816|FG001|COMPLETED|Overall Study||5
9821037|NCT00718094|10931815|FG000|NOT COMPLETED|Overall Study||0
9821038|NCT00718094|10931816|FG001|NOT COMPLETED|Overall Study||0
9821039|NCT00718120|10931824|FG000|STARTED|Overall Study||55
9821040|NCT00718120|10931825|FG001|STARTED|Overall Study||55
9821041|NCT00718120|10931824|FG000|COMPLETED|Overall Study||55
9821042|NCT00718120|10931825|FG001|COMPLETED|Overall Study||55
9821043|NCT00718120|10931824|FG000|NOT COMPLETED|Overall Study||0
9821044|NCT00718120|10931825|FG001|NOT COMPLETED|Overall Study||0
9821045|NCT00718159|10931838|FG000|STARTED|Overall Study||3
9821046|NCT00718159|10931839|FG001|STARTED|Overall Study||3
9821047|NCT00718159|10931840|FG002|STARTED|Overall Study||3
9821048|NCT00718159|10931841|FG003|STARTED|Overall Study||4
9821049|NCT00718159|10931842|FG004|STARTED|Overall Study||8
9821050|NCT00718159|10931843|FG005|STARTED|Overall Study||1
9821051|NCT00718159|10931844|FG006|STARTED|Overall Study||1
9821052|NCT00718159|10931838|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9821053|NCT00718159|10931839|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9821054|NCT00718159|10931840|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9821055|NCT00718159|10931841|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
9821056|NCT00718159|10931842|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
9821057|NCT00718159|10931843|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1
9821058|NCT00718159|10931844|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
9821059|NCT00718159|10931838|FG000|COMPLETED|Overall Study||0
9821060|NCT00718159|10931839|FG001|COMPLETED|Overall Study||0
9821061|NCT00718159|10931840|FG002|COMPLETED|Overall Study||0
9821062|NCT00718159|10931841|FG003|COMPLETED|Overall Study||0
9821063|NCT00718159|10931842|FG004|COMPLETED|Overall Study||0
9821064|NCT00718159|10931843|FG005|COMPLETED|Overall Study||0
9821065|NCT00718159|10931844|FG006|COMPLETED|Overall Study||0
9821066|NCT00718159|10931838|FG000|NOT COMPLETED|Overall Study||3
9821067|NCT00718159|10931839|FG001|NOT COMPLETED|Overall Study||3
9821068|NCT00718159|10931840|FG002|NOT COMPLETED|Overall Study||3
9821069|NCT00718159|10931841|FG003|NOT COMPLETED|Overall Study||4
9821070|NCT00718159|10931842|FG004|NOT COMPLETED|Overall Study||8
9821071|NCT00718159|10931843|FG005|NOT COMPLETED|Overall Study||1
9821072|NCT00718159|10931844|FG006|NOT COMPLETED|Overall Study||1
9821073|NCT00718237|10931862|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
9821074|NCT00718237|10931863|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
9821075|NCT00718237|10931862|FG000|Vaccinated at Visit 1|Overall Study||380
9821076|NCT00718237|10931863|FG001|Vaccinated at Visit 1|Overall Study||381
9821077|NCT00718237|10931862|FG000|Vaccinated at Visit 2|Overall Study||373
9821078|NCT00718237|10931863|FG001|Vaccinated at Visit 2|Overall Study||374
9821079|NCT00718237|10931862|FG000|Vaccinated at Visit 3|Overall Study||371
9821080|NCT00718237|10931863|FG001|Vaccinated at Visit 3|Overall Study||369
9821081|NCT00718237|10931862|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
9821082|NCT00718237|10931863|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
9821083|NCT00718237|10931862|FG000|NOT COMPLETED|Overall Study||13
9821084|NCT00718237|10931863|FG001|NOT COMPLETED|Overall Study||15
9821085|NCT00718302|10931873|FG000|STARTED|Overall Study||119
9821086|NCT00718302|10931874|FG001|STARTED|Overall Study||114
9821087|NCT00718302|10931873|FG000|COMPLETED|Overall Study||119
9821088|NCT00718302|10931874|FG001|COMPLETED|Overall Study||114
9821089|NCT00718302|10931873|FG000|NOT COMPLETED|Overall Study||0
9821090|NCT00718302|10931874|FG001|NOT COMPLETED|Overall Study||0
9821091|NCT00718315|10931885|FG000|STARTED|Overall Study||67
9821092|NCT00718315|10931886|FG001|STARTED|Overall Study||67
9821093|NCT00718315|10931887|FG002|STARTED|Overall Study||67
9821094|NCT00718315|10931885|FG000|COMPLETED|Overall Study||48
9821095|NCT00718315|10931886|FG001|COMPLETED|Overall Study||45
9821096|NCT00718315|10931887|FG002|COMPLETED|Overall Study||46
9821097|NCT00718315|10931885|FG000|NOT COMPLETED|Overall Study||19
9821098|NCT00718315|10931886|FG001|NOT COMPLETED|Overall Study||22
9821099|NCT00718315|10931887|FG002|NOT COMPLETED|Overall Study||21
9821100|NCT00718328|10931897|FG000|STARTED|Overall Study||1
9821101|NCT00718328|10931898|FG001|STARTED|Overall Study||0
10017080|NCT01814072|11139921|FG014|Intent to Treat|Overall Study||3
10017081|NCT01814072|11139922|FG015|Intent to Treat|Overall Study||2
10017082|NCT01814072|11139923|FG016|Intent to Treat|Overall Study||3
10017083|NCT01814072|11139924|FG017|Intent to Treat|Overall Study||1
9821102|NCT00718328|10931897|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
9821103|NCT00718328|10931898|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0
9821104|NCT00718328|10931897|FG000|NOT COMPLETED|Overall Study||1
9821105|NCT00718328|10931898|FG001|NOT COMPLETED|Overall Study||0
9821106|NCT00718419|10931906|FG000|STARTED|Overall Study||14
9821107|NCT00718419|10931907|FG001|STARTED|Overall Study||42
9821108|NCT00718419|10931906|FG000|Received at Least One Dose of Study Drug|Overall Study||14
9821109|NCT00718419|10931907|FG001|Received at Least One Dose of Study Drug|Overall Study||42
9821110|NCT00718419|10931906|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
9821111|NCT00718419|10931907|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
10017084|NCT01814072|11139925|FG018|Intent to Treat|Overall Study||3
9821112|NCT00718419|10931906|FG000|NOT COMPLETED|Overall Study||13
9821113|NCT00718419|10931907|FG001|NOT COMPLETED|Overall Study||39
9821114|NCT00718510|10931915|FG000|STARTED|First Intervention (3 Weeks)||7
9821115|NCT00718510|10931916|FG001|STARTED|First Intervention (3 Weeks)||8
9821116|NCT00718510|10931915|FG000|Received Intervention|First Intervention (3 Weeks)||7
9821117|NCT00718510|10931916|FG001|Received Intervention|First Intervention (3 Weeks)||7
9821118|NCT00718510|10931915|FG000|COMPLETED|First Intervention (3 Weeks)||7
9821119|NCT00718510|10931916|FG001|COMPLETED|First Intervention (3 Weeks)||7
9821120|NCT00718510|10931915|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
9821121|NCT00718510|10931916|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
9821122|NCT00718510|10931915|FG000|STARTED|Washout (5 Days)||7
9821123|NCT00718510|10931916|FG001|STARTED|Washout (5 Days)||7
9821124|NCT00718510|10931915|FG000|COMPLETED|Washout (5 Days)||7
9821125|NCT00718510|10931916|FG001|COMPLETED|Washout (5 Days)||7
9821126|NCT00718510|10931915|FG000|NOT COMPLETED|Washout (5 Days)||0
9821127|NCT00718510|10931916|FG001|NOT COMPLETED|Washout (5 Days)||0
9821128|NCT00718510|10931915|FG000|STARTED|Second Intervention (3 Weeks)||7
9821129|NCT00718510|10931916|FG001|STARTED|Second Intervention (3 Weeks)||7
9821130|NCT00718510|10931915|FG000|COMPLETED|Second Intervention (3 Weeks)||6
9821131|NCT00718510|10931916|FG001|COMPLETED|Second Intervention (3 Weeks)||7
9821132|NCT00718510|10931915|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
9821133|NCT00718510|10931916|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9821134|NCT00718523|10931924|FG000|STARTED|Overall Study||84
9821135|NCT00718523|10931925|FG001|STARTED|Overall Study||86
9821136|NCT00718523|10931924|FG000|COMPLETED|Overall Study||66
9821137|NCT00718523|10931925|FG001|COMPLETED|Overall Study||62
9821138|NCT00718523|10931924|FG000|NOT COMPLETED|Overall Study||18
9821139|NCT00718523|10931925|FG001|NOT COMPLETED|Overall Study||24
9821140|NCT00718549|10931931|FG000|STARTED|Induction Phase||128
9821141|NCT00718549|10931932|FG001|STARTED|Induction Phase||0
9821142|NCT00718549|10931933|FG002|STARTED|Induction Phase||0
9821143|NCT00718549|10931931|FG000|COMPLETED|Induction Phase||66
9821144|NCT00718549|10931932|FG001|COMPLETED|Induction Phase||0
9821145|NCT00718549|10931933|FG002|COMPLETED|Induction Phase||0
9821146|NCT00718549|10931931|FG000|NOT COMPLETED|Induction Phase||62
9821147|NCT00718549|10931932|FG001|NOT COMPLETED|Induction Phase||0
9821148|NCT00718549|10931933|FG002|NOT COMPLETED|Induction Phase||0
9821149|NCT00718549|10931931|FG000|STARTED|Maintenance/ Observation Phase||0
9821150|NCT00718549|10931932|FG001|STARTED|Maintenance/ Observation Phase||33
9821151|NCT00718549|10931933|FG002|STARTED|Maintenance/ Observation Phase||33
9821152|NCT00718549|10931931|FG000|COMPLETED|Maintenance/ Observation Phase||0
9821153|NCT00718549|10931932|FG001|COMPLETED|Maintenance/ Observation Phase||5
9821154|NCT00718549|10931933|FG002|COMPLETED|Maintenance/ Observation Phase||3
9821155|NCT00718549|10931931|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0
9821156|NCT00718549|10931932|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28
9821157|NCT00718549|10931933|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30
9821158|NCT00718666|10931949|FG000|STARTED|Persistence Phase Year 1||118
9821159|NCT00718666|10931950|FG001|STARTED|Persistence Phase Year 1||130
9821160|NCT00718666|10931951|FG002|STARTED|Persistence Phase Year 1||0
9821161|NCT00718666|10931949|FG000|COMPLETED|Persistence Phase Year 1||118
9821162|NCT00718666|10931950|FG001|COMPLETED|Persistence Phase Year 1||130
9821163|NCT00718666|10931951|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
9821164|NCT00718666|10931949|FG000|NOT COMPLETED|Persistence Phase Year 1||0
9821165|NCT00718666|10931950|FG001|NOT COMPLETED|Persistence Phase Year 1||0
9821166|NCT00718666|10931951|FG002|NOT COMPLETED|Persistence Phase Year 1||0
9821167|NCT00718666|10931949|FG000|STARTED|Persistence Phase Year 3||98
9821168|NCT00718666|10931950|FG001|STARTED|Persistence Phase Year 3||104
9821169|NCT00718666|10931951|FG002|STARTED|Persistence Phase Year 3||0
9821170|NCT00718666|10931949|FG000|COMPLETED|Persistence Phase Year 3||98
9821171|NCT00718666|10931950|FG001|COMPLETED|Persistence Phase Year 3||104
9821172|NCT00718666|10931951|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
9821173|NCT00718666|10931949|FG000|NOT COMPLETED|Persistence Phase Year 3||0
9821174|NCT00718666|10931950|FG001|NOT COMPLETED|Persistence Phase Year 3||0
9821175|NCT00718666|10931951|FG002|NOT COMPLETED|Persistence Phase Year 3||0
9821176|NCT00718666|10931949|FG000|STARTED|Persistence Phase Year 5||70
9821177|NCT00718666|10931950|FG001|STARTED|Persistence Phase Year 5||82
9821178|NCT00718666|10931951|FG002|STARTED|Persistence Phase Year 5||0
9821179|NCT00718666|10931949|FG000|COMPLETED|Persistence Phase Year 5||70
10017085|NCT01814072|11139926|FG019|Intent to Treat|Overall Study||5
10017086|NCT01814072|11139927|FG020|Intent to Treat|Overall Study||2
9821180|NCT00718666|10931950|FG001|COMPLETED|Persistence Phase Year 5||82
9821181|NCT00718666|10931951|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
9821182|NCT00718666|10931949|FG000|NOT COMPLETED|Persistence Phase Year 5||0
9821183|NCT00718666|10931950|FG001|NOT COMPLETED|Persistence Phase Year 5||0
9821184|NCT00718666|10931951|FG002|NOT COMPLETED|Persistence Phase Year 5||0
9821185|NCT00718666|10931949|FG000|STARTED|Booster Phase Year 5||38
9821186|NCT00718666|10931950|FG001|STARTED|Booster Phase Year 5||46
9821187|NCT00718666|10931951|FG002|STARTED|Booster Phase Year 5||100
9821188|NCT00718666|10931949|FG000|COMPLETED|Booster Phase Year 5||36
9821189|NCT00718666|10931950|FG001|COMPLETED|Booster Phase Year 5||46
9821190|NCT00718666|10931951|FG002|COMPLETED|Booster Phase Year 5||94
9821191|NCT00718666|10931949|FG000|NOT COMPLETED|Booster Phase Year 5||2
9821192|NCT00718666|10931950|FG001|NOT COMPLETED|Booster Phase Year 5||0
9821193|NCT00718666|10931951|FG002|NOT COMPLETED|Booster Phase Year 5||6
9821194|NCT00718718|10931976|FG000|STARTED|Prior to Week 12||19
9821195|NCT00718718|10931977|FG001|STARTED|Prior to Week 12||0
9821196|NCT00718718|10931978|FG002|STARTED|Prior to Week 12||17
9821197|NCT00718718|10931979|FG003|STARTED|Prior to Week 12||0
9821198|NCT00718718|10931980|FG004|STARTED|Prior to Week 12||30
9821199|NCT00718718|10931981|FG005|STARTED|Prior to Week 12||0
9821200|NCT00718718|10931982|FG006|STARTED|Prior to Week 12||30
9821201|NCT00718718|10931983|FG007|STARTED|Prior to Week 12||30
9821202|NCT00718718|10931984|FG008|STARTED|Prior to Week 12||30
9821203|NCT00718718|10931985|FG009|STARTED|Prior to Week 12||31
9821204|NCT00718718|10931976|FG000|COMPLETED|Prior to Week 12||18
9821205|NCT00718718|10931977|FG001|COMPLETED|Prior to Week 12||0
9821206|NCT00718718|10931978|FG002|COMPLETED|Prior to Week 12||16
9821207|NCT00718718|10931979|FG003|COMPLETED|Prior to Week 12||0
9821208|NCT00718718|10931980|FG004|COMPLETED|Prior to Week 12||27
9821209|NCT00718718|10931981|FG005|COMPLETED|Prior to Week 12||0
9821210|NCT00718718|10931982|FG006|COMPLETED|Prior to Week 12||29
9821211|NCT00718718|10931983|FG007|COMPLETED|Prior to Week 12||28
9821212|NCT00718718|10931984|FG008|COMPLETED|Prior to Week 12||28
9821213|NCT00718718|10931985|FG009|COMPLETED|Prior to Week 12||31
9821214|NCT00718718|10931976|FG000|NOT COMPLETED|Prior to Week 12||1
9821215|NCT00718718|10931977|FG001|NOT COMPLETED|Prior to Week 12||0
9821216|NCT00718718|10931978|FG002|NOT COMPLETED|Prior to Week 12||1
9821217|NCT00718718|10931979|FG003|NOT COMPLETED|Prior to Week 12||0
10017087|NCT01814072|11139928|FG021|Intent to Treat|Overall Study||1
10236798|NCT00827567|11367539|FG000|STARTED|Overall Study||4
10236799|NCT00827567|11367539|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
9821218|NCT00718718|10931980|FG004|NOT COMPLETED|Prior to Week 12||3
9821219|NCT00718718|10931981|FG005|NOT COMPLETED|Prior to Week 12||0
9821220|NCT00718718|10931982|FG006|NOT COMPLETED|Prior to Week 12||1
9821221|NCT00718718|10931983|FG007|NOT COMPLETED|Prior to Week 12||2
9821222|NCT00718718|10931984|FG008|NOT COMPLETED|Prior to Week 12||2
9821223|NCT00718718|10931985|FG009|NOT COMPLETED|Prior to Week 12||0
9821224|NCT00718718|10931976|FG000|STARTED|Week 12 to End of Study||0
9821225|NCT00718718|10931977|FG001|STARTED|Week 12 to End of Study||18
9821226|NCT00718718|10931978|FG002|STARTED|Week 12 to End of Study||0
9821227|NCT00718718|10931979|FG003|STARTED|Week 12 to End of Study||16
9821228|NCT00718718|10931980|FG004|STARTED|Week 12 to End of Study||0
9821229|NCT00718718|10931981|FG005|STARTED|Week 12 to End of Study||27
9821230|NCT00718718|10931982|FG006|STARTED|Week 12 to End of Study||29
9821231|NCT00718718|10931983|FG007|STARTED|Week 12 to End of Study||28
9821232|NCT00718718|10931984|FG008|STARTED|Week 12 to End of Study||28
10236800|NCT00827567|11367539|FG000|NOT COMPLETED|Overall Study||4
10236801|NCT00815633|11367543|FG000|STARTED|Overall Study||1
9821233|NCT00718718|10931985|FG009|STARTED|Week 12 to End of Study||31
9821234|NCT00718718|10931976|FG000|Treated|Week 12 to End of Study||0
9821235|NCT00718718|10931977|FG001|Treated|Week 12 to End of Study||18
9821236|NCT00718718|10931978|FG002|Treated|Week 12 to End of Study||0
9821237|NCT00718718|10931979|FG003|Treated|Week 12 to End of Study||16
9821238|NCT00718718|10931980|FG004|Treated|Week 12 to End of Study||0
9821239|NCT00718718|10931981|FG005|Treated|Week 12 to End of Study||26
9821240|NCT00718718|10931982|FG006|Treated|Week 12 to End of Study||29
9821241|NCT00718718|10931983|FG007|Treated|Week 12 to End of Study||28
9821242|NCT00718718|10931984|FG008|Treated|Week 12 to End of Study||28
9821243|NCT00718718|10931985|FG009|Treated|Week 12 to End of Study||31
9821244|NCT00718718|10931976|FG000|COMPLETED|Week 12 to End of Study||0
9821245|NCT00718718|10931977|FG001|COMPLETED|Week 12 to End of Study||17
9821246|NCT00718718|10931978|FG002|COMPLETED|Week 12 to End of Study||0
9821247|NCT00718718|10931979|FG003|COMPLETED|Week 12 to End of Study||15
9821248|NCT00718718|10931980|FG004|COMPLETED|Week 12 to End of Study||0
9821249|NCT00718718|10931981|FG005|COMPLETED|Week 12 to End of Study||24
9821250|NCT00718718|10931982|FG006|COMPLETED|Week 12 to End of Study||27
9821251|NCT00718718|10931983|FG007|COMPLETED|Week 12 to End of Study||27
10017088|NCT01814072|11139929|FG022|Intent to Treat|Overall Study||4
9821252|NCT00718718|10931984|FG008|COMPLETED|Week 12 to End of Study||27
9821253|NCT00718718|10931985|FG009|COMPLETED|Week 12 to End of Study||31
9821254|NCT00718718|10931976|FG000|NOT COMPLETED|Week 12 to End of Study||0
9821255|NCT00718718|10931977|FG001|NOT COMPLETED|Week 12 to End of Study||1
9821256|NCT00718718|10931978|FG002|NOT COMPLETED|Week 12 to End of Study||0
9821257|NCT00718718|10931979|FG003|NOT COMPLETED|Week 12 to End of Study||1
10017089|NCT01814072|11139930|FG023|Intent to Treat|Overall Study||1
10236802|NCT00815633|11367543|FG000|COMPLETED|Overall Study||0
9821258|NCT00718718|10931980|FG004|NOT COMPLETED|Week 12 to End of Study||0
9821259|NCT00718718|10931981|FG005|NOT COMPLETED|Week 12 to End of Study||3
9821260|NCT00718718|10931982|FG006|NOT COMPLETED|Week 12 to End of Study||2
9821261|NCT00718718|10931983|FG007|NOT COMPLETED|Week 12 to End of Study||1
9821262|NCT00718718|10931984|FG008|NOT COMPLETED|Week 12 to End of Study||1
9821263|NCT00718718|10931985|FG009|NOT COMPLETED|Week 12 to End of Study||0
9821264|NCT00718770|10932011|FG000|STARTED|Overall Study||10
10017090|NCT01814072|11139931|FG024|Intent to Treat|Overall Study||6
10017091|NCT01814072|11139932|FG025|Intent to Treat|Overall Study||2
9821265|NCT00718770|10932011|FG000|COMPLETED|Overall Study||2
9821266|NCT00718770|10932011|FG000|NOT COMPLETED|Overall Study||8
9832083|NCT00771615|10942783|FG008|NOT COMPLETED|Overall Study||0
9832084|NCT00771667|10942816|FG000|STARTED|Induction Phase||132
9832085|NCT00771667|10942817|FG001|STARTED|Induction Phase||131
9832086|NCT00771667|10942818|FG002|STARTED|Induction Phase||132
9832087|NCT00771667|10942819|FG003|STARTED|Induction Phase||131
9832088|NCT00771667|10942820|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
9832089|NCT00771667|10942821|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
9832090|NCT00771667|10942822|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
9832091|NCT00771667|10942823|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
9832092|NCT00771667|10942824|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
9832093|NCT00771667|10942825|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
9832094|NCT00771667|10942816|FG000|COMPLETED|Induction Phase||113
9832095|NCT00771667|10942817|FG001|COMPLETED|Induction Phase||121
9832096|NCT00771667|10942818|FG002|COMPLETED|Induction Phase||120
9832097|NCT00771667|10942819|FG003|COMPLETED|Induction Phase||123
9832098|NCT00771667|10942820|FG004|COMPLETED|Induction Phase||0
9832099|NCT00771667|10942821|FG005|COMPLETED|Induction Phase||0
9832100|NCT00771667|10942822|FG006|COMPLETED|Induction Phase||0
9832101|NCT00771667|10942823|FG007|COMPLETED|Induction Phase||0
9832102|NCT00771667|10942824|FG008|COMPLETED|Induction Phase||0
9832103|NCT00771667|10942825|FG009|COMPLETED|Induction Phase||0
9832104|NCT00771667|10942816|FG000|NOT COMPLETED|Induction Phase||19
9832105|NCT00771667|10942817|FG001|NOT COMPLETED|Induction Phase||10
9832106|NCT00771667|10942818|FG002|NOT COMPLETED|Induction Phase||12
9832107|NCT00771667|10942819|FG003|NOT COMPLETED|Induction Phase||8
9832108|NCT00771667|10942820|FG004|NOT COMPLETED|Induction Phase||0
9832109|NCT00771667|10942821|FG005|NOT COMPLETED|Induction Phase||0
9832110|NCT00771667|10942822|FG006|NOT COMPLETED|Induction Phase||0
9832111|NCT00771667|10942823|FG007|NOT COMPLETED|Induction Phase||0
9832112|NCT00771667|10942824|FG008|NOT COMPLETED|Induction Phase||0
9832113|NCT00771667|10942825|FG009|NOT COMPLETED|Induction Phase||0
9832114|NCT00771667|10942816|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
9832115|NCT00771667|10942817|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
9832116|NCT00771667|10942818|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
9832117|NCT00771667|10942819|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
9832118|NCT00771667|10942820|FG004|STARTED|Maintenance Phase||28
9832119|NCT00771667|10942821|FG005|STARTED|Maintenance Phase||85
9832120|NCT00771667|10942822|FG006|STARTED|Maintenance Phase||73
9832121|NCT00771667|10942823|FG007|STARTED|Maintenance Phase||72
9832122|NCT00771667|10942824|FG008|STARTED|Maintenance Phase||110
9832123|NCT00771667|10942825|FG009|STARTED|Maintenance Phase||109
9832124|NCT00771667|10942816|FG000|COMPLETED|Maintenance Phase||0
9832125|NCT00771667|10942817|FG001|COMPLETED|Maintenance Phase||0
9832126|NCT00771667|10942818|FG002|COMPLETED|Maintenance Phase||0
9832127|NCT00771667|10942819|FG003|COMPLETED|Maintenance Phase||0
9832128|NCT00771667|10942820|FG004|COMPLETED|Maintenance Phase||26
9832129|NCT00771667|10942821|FG005|COMPLETED|Maintenance Phase||78
9832130|NCT00771667|10942822|FG006|COMPLETED|Maintenance Phase||63
9832131|NCT00771667|10942823|FG007|COMPLETED|Maintenance Phase||67
9832132|NCT00771667|10942824|FG008|COMPLETED|Maintenance Phase||88
9832133|NCT00771667|10942825|FG009|COMPLETED|Maintenance Phase||92
9832134|NCT00771667|10942816|FG000|NOT COMPLETED|Maintenance Phase||0
9832135|NCT00771667|10942817|FG001|NOT COMPLETED|Maintenance Phase||0
9832136|NCT00771667|10942818|FG002|NOT COMPLETED|Maintenance Phase||0
9832137|NCT00771667|10942819|FG003|NOT COMPLETED|Maintenance Phase||0
9832138|NCT00771667|10942820|FG004|NOT COMPLETED|Maintenance Phase||2
9832139|NCT00771667|10942821|FG005|NOT COMPLETED|Maintenance Phase||7
9832140|NCT00771667|10942822|FG006|NOT COMPLETED|Maintenance Phase||10
9832141|NCT00771667|10942823|FG007|NOT COMPLETED|Maintenance Phase||5
9832142|NCT00771667|10942824|FG008|NOT COMPLETED|Maintenance Phase||22
9832143|NCT00771667|10942825|FG009|NOT COMPLETED|Maintenance Phase||17
9832144|NCT00771745|10942845|FG000|STARTED|Overall Study||6
9832145|NCT00771745|10942846|FG001|STARTED|Overall Study||5
9832146|NCT00771745|10942845|FG000|COMPLETED|Overall Study||6
9832147|NCT00771745|10942846|FG001|COMPLETED|Overall Study||5
9832148|NCT00771745|10942845|FG000|NOT COMPLETED|Overall Study||0
9832149|NCT00771745|10942846|FG001|NOT COMPLETED|Overall Study||0
9832150|NCT00771758|10942855|FG000|STARTED|Overall Study||44
9832151|NCT00771758|10942856|FG001|STARTED|Overall Study||43
9832152|NCT00771758|10942857|FG002|STARTED|Overall Study||21
9821267|NCT00718809|10932017|FG000|STARTED|Overall Study||12
9821268|NCT00718809|10932018|FG001|STARTED|Overall Study||9
9821269|NCT00718809|10932017|FG000|COMPLETED|Overall Study||0
9821270|NCT00718809|10932018|FG001|COMPLETED|Overall Study||0
9821271|NCT00718809|10932017|FG000|NOT COMPLETED|Overall Study||12
9821272|NCT00718809|10932018|FG001|NOT COMPLETED|Overall Study||9
9821273|NCT00718861|10932026|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
9821274|NCT00718861|10932027|FG001|STARTED|Overall Study||95
9821275|NCT00718861|10932026|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92
9821276|NCT00718861|10932027|FG001|Safety Set|Overall Study||95
9821277|NCT00718861|10932026|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
9821278|NCT00718861|10932027|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
9821279|NCT00718861|10932026|FG000|COMPLETED|Overall Study||74
9821280|NCT00718861|10932027|FG001|COMPLETED|Overall Study||77
9821281|NCT00718861|10932026|FG000|NOT COMPLETED|Overall Study||21
9821282|NCT00718861|10932027|FG001|NOT COMPLETED|Overall Study||18
9821283|NCT00718887|10932035|FG000|STARTED|Overall Study|Participants who received treatment.|89
9821284|NCT00718887|10932036|FG001|STARTED|Overall Study|Participants who received treatment.|77
9821285|NCT00718887|10932035|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84
9821286|NCT00718887|10932036|FG001|COMPLETED|Overall Study||68
9821287|NCT00718887|10932035|FG000|NOT COMPLETED|Overall Study||5
9821288|NCT00718887|10932036|FG001|NOT COMPLETED|Overall Study||9
9821289|NCT00719043|10932055|FG000|STARTED|Overall Study||120
9821290|NCT00719043|10932056|FG001|STARTED|Overall Study||121
9821291|NCT00719043|10932057|FG002|STARTED|Overall Study||119
9821292|NCT00719043|10932058|FG003|STARTED|Overall Study||119
9821293|NCT00719043|10932059|FG004|STARTED|Overall Study||122
9821294|NCT00719043|10932060|FG005|STARTED|Overall Study||120
9821295|NCT00719043|10932061|FG006|STARTED|Overall Study||120
9821296|NCT00719043|10932055|FG000|COMPLETED|Overall Study|Up to Day 909|88
9821297|NCT00719043|10932056|FG001|COMPLETED|Overall Study|Up to Day 909|96
9821298|NCT00719043|10932057|FG002|COMPLETED|Overall Study|Up to Day 909|99
9821299|NCT00719043|10932058|FG003|COMPLETED|Overall Study|Up to Day 909|96
9821300|NCT00719043|10932059|FG004|COMPLETED|Overall Study|Up to Day 909|95
9821301|NCT00719043|10932060|FG005|COMPLETED|Overall Study|Up to Day 909|86
9821302|NCT00719043|10932061|FG006|COMPLETED|Overall Study|Up to Day 909|92
9821303|NCT00719043|10932055|FG000|NOT COMPLETED|Overall Study||32
9821304|NCT00719043|10932056|FG001|NOT COMPLETED|Overall Study||25
9821305|NCT00719043|10932057|FG002|NOT COMPLETED|Overall Study||20
9821306|NCT00719043|10932058|FG003|NOT COMPLETED|Overall Study||23
9821307|NCT00719043|10932059|FG004|NOT COMPLETED|Overall Study||27
9821308|NCT00719043|10932060|FG005|NOT COMPLETED|Overall Study||34
9821309|NCT00719043|10932061|FG006|NOT COMPLETED|Overall Study||28
9821310|NCT00719134|10932089|FG000|STARTED|Overall Study||76
9821311|NCT00719134|10932089|FG000|COMPLETED|Overall Study||66
9821312|NCT00719134|10932089|FG000|NOT COMPLETED|Overall Study||10
9821313|NCT00719160|10932094|FG000|STARTED|Overall Study||6
9821314|NCT00719160|10932095|FG001|STARTED|Overall Study||6
9821315|NCT00719160|10932094|FG000|COMPLETED|Overall Study||6
9821316|NCT00719160|10932095|FG001|COMPLETED|Overall Study||6
9821317|NCT00719160|10932094|FG000|NOT COMPLETED|Overall Study||0
9821318|NCT00719160|10932095|FG001|NOT COMPLETED|Overall Study||0
9821319|NCT00719186|10932104|FG000|STARTED|Overall Study||376
9821320|NCT00719186|10932105|FG001|STARTED|Overall Study||374
9821321|NCT00719186|10932104|FG000|COMPLETED|Overall Study||376
9821322|NCT00719186|10932105|FG001|COMPLETED|Overall Study||374
9821323|NCT00719186|10932104|FG000|NOT COMPLETED|Overall Study||0
9821324|NCT00719186|10932105|FG001|NOT COMPLETED|Overall Study||0
9821325|NCT00719212|10932111|FG000|STARTED|Overall Study||61
9821326|NCT00719212|10932111|FG000|COMPLETED|Overall Study||17
9821327|NCT00719212|10932111|FG000|NOT COMPLETED|Overall Study||44
9821328|NCT00719264|10932117|FG000|STARTED|Overall Study||182
9821329|NCT00719264|10932118|FG001|STARTED|Overall Study||183
9821330|NCT00719264|10932117|FG000|Full Analysis Set|Overall Study||182
9821331|NCT00719264|10932118|FG001|Full Analysis Set|Overall Study||183
9821332|NCT00719264|10932117|FG000|Safety Set|Overall Study||180
9821333|NCT00719264|10932118|FG001|Safety Set|Overall Study||181
9821334|NCT00719264|10932117|FG000|COMPLETED|Overall Study||0
9821335|NCT00719264|10932118|FG001|COMPLETED|Overall Study||0
9821336|NCT00719264|10932117|FG000|NOT COMPLETED|Overall Study||182
10017092|NCT01814072|11139933|FG026|Intent to Treat|Overall Study||2
10017093|NCT01814072|11139934|FG027|Intent to Treat|Overall Study||4
9821337|NCT00719264|10932118|FG001|NOT COMPLETED|Overall Study||183
9821338|NCT00719329|10932127|FG000|STARTED|Overall Study||705
9821339|NCT00719329|10932128|FG001|STARTED|Overall Study||571
9821340|NCT00719329|10932129|FG002|STARTED|Overall Study||647
9821341|NCT00719329|10932127|FG000|Day 1 Swab|Overall Study||705
10017094|NCT01814072|11139935|FG028|Intent to Treat|Overall Study||4
9821342|NCT00719329|10932128|FG001|Day 1 Swab|Overall Study||569
9821343|NCT00719329|10932129|FG002|Day 1 Swab|Overall Study||646
9821344|NCT00719329|10932127|FG000|Day 3 Swab|Overall Study||614
9821345|NCT00719329|10932128|FG001|Day 3 Swab|Overall Study||501
9821346|NCT00719329|10932129|FG002|Day 3 Swab|Overall Study||578
9821347|NCT00719329|10932127|FG000|Day 7 Swab|Overall Study||593
9821348|NCT00719329|10932128|FG001|Day 7 Swab|Overall Study||467
9821349|NCT00719329|10932129|FG002|Day 7 Swab|Overall Study||561
9821350|NCT00719329|10932127|FG000|COMPLETED|Overall Study||705
9821351|NCT00719329|10932128|FG001|COMPLETED|Overall Study||569
9821352|NCT00719329|10932129|FG002|COMPLETED|Overall Study||646
9821353|NCT00719329|10932127|FG000|NOT COMPLETED|Overall Study||0
9821354|NCT00719329|10932128|FG001|NOT COMPLETED|Overall Study||2
9821355|NCT00719329|10932129|FG002|NOT COMPLETED|Overall Study||1
9821356|NCT00719355|10932142|FG000|STARTED|Overall Study||51
9821357|NCT00719355|10932143|FG001|STARTED|Overall Study||52
9821358|NCT00719355|10932142|FG000|Completed 6 Weeks|Overall Study||49
9821359|NCT00719355|10932143|FG001|Completed 6 Weeks|Overall Study||48
9821360|NCT00719355|10932142|FG000|Completed 12 Weeks|Overall Study||43
9821361|NCT00719355|10932143|FG001|Completed 12 Weeks|Overall Study||46
9821362|NCT00719355|10932142|FG000|Completed 24 Weeks|Overall Study||34
9821363|NCT00719355|10932143|FG001|Completed 24 Weeks|Overall Study||43
9821364|NCT00719355|10932142|FG000|Completed 32 Weeks|Overall Study||33
9821365|NCT00719355|10932143|FG001|Completed 32 Weeks|Overall Study||39
9821366|NCT00719355|10932142|FG000|COMPLETED|Overall Study||33
9821367|NCT00719355|10932143|FG001|COMPLETED|Overall Study||39
9821368|NCT00719355|10932142|FG000|NOT COMPLETED|Overall Study||18
9821369|NCT00719355|10932143|FG001|NOT COMPLETED|Overall Study||13
9821370|NCT00719472|10932149|FG000|STARTED|Enrolled in Study||451
9821371|NCT00719472|10932149|FG000|COMPLETED|Enrolled in Study||425
9821372|NCT00719472|10932149|FG000|NOT COMPLETED|Enrolled in Study||26
9821373|NCT00719472|10932149|FG000|STARTED|Received Cycle 1 Treatment||425
9821374|NCT00719472|10932149|FG000|COMPLETED|Received Cycle 1 Treatment||372
9821375|NCT00719472|10932149|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53
9821376|NCT00719472|10932149|FG000|STARTED|Received Cycle 2 Treatment||372
9821377|NCT00719472|10932149|FG000|COMPLETED|Received Cycle 2 Treatment||304
9821378|NCT00719472|10932149|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68
9821379|NCT00719537|10932155|FG000|STARTED|Overall Study||2
9821380|NCT00719537|10932156|FG001|STARTED|Overall Study||1
9821381|NCT00719537|10932155|FG000|COMPLETED|Overall Study||1
9821382|NCT00719537|10932156|FG001|COMPLETED|Overall Study||0
9821383|NCT00719537|10932155|FG000|NOT COMPLETED|Overall Study||1
9821384|NCT00719537|10932156|FG001|NOT COMPLETED|Overall Study||1
9821385|NCT00719563|10932164|FG000|STARTED|Overall Study||171
9821386|NCT00719563|10932165|FG001|STARTED|Overall Study||170
9821387|NCT00719563|10932164|FG000|COMPLETED|Overall Study||133
9821388|NCT00719563|10932165|FG001|COMPLETED|Overall Study||128
9821389|NCT00719563|10932164|FG000|NOT COMPLETED|Overall Study||38
9821390|NCT00719563|10932165|FG001|NOT COMPLETED|Overall Study||42
9821391|NCT00719576|10932174|FG000|STARTED|Overall Study||72
9821392|NCT00719576|10932175|FG001|STARTED|Overall Study||72
9821393|NCT00719576|10932174|FG000|COMPLETED|Overall Study||70
9821394|NCT00719576|10932175|FG001|COMPLETED|Overall Study||67
9821395|NCT00719576|10932174|FG000|NOT COMPLETED|Overall Study||2
9821396|NCT00719576|10932175|FG001|NOT COMPLETED|Overall Study||5
9821397|NCT00719615|10932186|FG000|STARTED|Overall Study||42
9821398|NCT00719615|10932187|FG001|STARTED|Overall Study||45
9821399|NCT00719615|10932188|FG002|STARTED|Overall Study||24
9821400|NCT00719615|10932186|FG000|COMPLETED|Overall Study||42
9821401|NCT00719615|10932187|FG001|COMPLETED|Overall Study||45
9821402|NCT00719615|10932188|FG002|COMPLETED|Overall Study||24
9821403|NCT00719615|10932186|FG000|NOT COMPLETED|Overall Study||0
9821404|NCT00719615|10932187|FG001|NOT COMPLETED|Overall Study||0
9821405|NCT00719615|10932188|FG002|NOT COMPLETED|Overall Study||0
9821406|NCT00719680|10932196|FG000|STARTED|Overall Study||21
9821407|NCT00719680|10932196|FG000|COMPLETED|Overall Study||16
9821408|NCT00719680|10932196|FG000|NOT COMPLETED|Overall Study||5
9821409|NCT00719706|10932202|FG000|STARTED|Overall Study||20
9821410|NCT00719706|10932203|FG001|STARTED|Overall Study||20
9821411|NCT00719706|10932202|FG000|COMPLETED|Overall Study||11
9821412|NCT00719706|10932203|FG001|COMPLETED|Overall Study||14
9821413|NCT00719706|10932202|FG000|NOT COMPLETED|Overall Study||9
9821414|NCT00719706|10932203|FG001|NOT COMPLETED|Overall Study||6
9821415|NCT00719732|10932209|FG000|STARTED|Overall Study||218
9821416|NCT00719732|10932209|FG000|COMPLETED|Overall Study||196
9821417|NCT00719732|10932209|FG000|NOT COMPLETED|Overall Study||22
9821418|NCT00719810|10932216|FG000|STARTED|Overall Study||49
9821419|NCT00719810|10932217|FG001|STARTED|Overall Study||51
9821420|NCT00719810|10932218|FG002|STARTED|Overall Study||50
9821421|NCT00719810|10932216|FG000|COMPLETED|Overall Study||46
9821422|NCT00719810|10932217|FG001|COMPLETED|Overall Study||47
9821423|NCT00719810|10932218|FG002|COMPLETED|Overall Study||42
9821424|NCT00719810|10932216|FG000|NOT COMPLETED|Overall Study||3
9821425|NCT00719810|10932217|FG001|NOT COMPLETED|Overall Study||4
9821426|NCT00719810|10932218|FG002|NOT COMPLETED|Overall Study||8
9821427|NCT00719849|10932228|FG000|STARTED|Overall Study||4
9821428|NCT00719849|10932229|FG001|STARTED|Overall Study||9
9821429|NCT00719849|10932228|FG000|COMPLETED|Overall Study||4
9821430|NCT00719849|10932229|FG001|COMPLETED|Overall Study||8
9821431|NCT00719849|10932228|FG000|NOT COMPLETED|Overall Study||0
9821432|NCT00719849|10932229|FG001|NOT COMPLETED|Overall Study||1
9821433|NCT00719862|10932237|FG000|STARTED|Overall Study||242
9821434|NCT00719862|10932238|FG001|STARTED|Overall Study|1 subject was randomized in error|239
9821435|NCT00719862|10932237|FG000|COMPLETED|Overall Study||234
9821436|NCT00719862|10932238|FG001|COMPLETED|Overall Study||233
9821437|NCT00719862|10932237|FG000|NOT COMPLETED|Overall Study||8
9821438|NCT00719862|10932238|FG001|NOT COMPLETED|Overall Study||6
9821439|NCT00719901|10932244|FG000|STARTED|Overall Study||11
9821440|NCT00719901|10932244|FG000|COMPLETED|Overall Study||0
9821441|NCT00719901|10932244|FG000|NOT COMPLETED|Overall Study||11
9821442|NCT00719953|10932248|FG000|STARTED|Overall Study||30
9821443|NCT00719953|10932248|FG000|COMPLETED|Overall Study||26
9821444|NCT00719953|10932248|FG000|NOT COMPLETED|Overall Study||4
9821445|NCT00720057|10932254|FG000|STARTED|Overall Study||153
9821446|NCT00720057|10932255|FG001|STARTED|Overall Study||159
9821447|NCT00720057|10932254|FG000|COMPLETED|Overall Study||152
9821448|NCT00720057|10932255|FG001|COMPLETED|Overall Study||156
9821449|NCT00720057|10932254|FG000|NOT COMPLETED|Overall Study||1
9821450|NCT00720057|10932255|FG001|NOT COMPLETED|Overall Study||3
9821451|NCT00720096|10932263|FG000|STARTED|Overall Study||2
9821452|NCT00720096|10932264|FG001|STARTED|Overall Study||2
9821453|NCT00720096|10932263|FG000|COMPLETED|Overall Study||2
9821454|NCT00720096|10932264|FG001|COMPLETED|Overall Study||0
9821455|NCT00720096|10932263|FG000|NOT COMPLETED|Overall Study||0
9821456|NCT00720096|10932264|FG001|NOT COMPLETED|Overall Study||2
9821457|NCT00720109|10932270|FG000|STARTED|Induction Period||63
9821458|NCT00720109|10932271|FG001|STARTED|Induction Period||0
9821459|NCT00720109|10932272|FG002|STARTED|Induction Period||0
9821460|NCT00720109|10932270|FG000|COMPLETED|Induction Period||57
9821461|NCT00720109|10932271|FG001|COMPLETED|Induction Period||0
9821462|NCT00720109|10932272|FG002|COMPLETED|Induction Period||0
9821463|NCT00720109|10932270|FG000|NOT COMPLETED|Induction Period||6
9821464|NCT00720109|10932271|FG001|NOT COMPLETED|Induction Period||0
9821465|NCT00720109|10932272|FG002|NOT COMPLETED|Induction Period||0
9821466|NCT00720109|10932270|FG000|STARTED|Risk Stratification Period||0
9821467|NCT00720109|10932271|FG001|STARTED|Risk Stratification Period||48
9821468|NCT00720109|10932272|FG002|STARTED|Risk Stratification Period||9
9821469|NCT00720109|10932270|FG000|COMPLETED|Risk Stratification Period||0
9821470|NCT00720109|10932271|FG001|COMPLETED|Risk Stratification Period||33
9821471|NCT00720109|10932272|FG002|COMPLETED|Risk Stratification Period||1
9821472|NCT00720109|10932270|FG000|NOT COMPLETED|Risk Stratification Period||0
9821473|NCT00720109|10932271|FG001|NOT COMPLETED|Risk Stratification Period||15
9821474|NCT00720109|10932272|FG002|NOT COMPLETED|Risk Stratification Period||8
9821475|NCT00720122|10932281|FG000|STARTED|Overall Study||28
9821476|NCT00720122|10932281|FG000|COMPLETED|Overall Study||19
9821477|NCT00720122|10932281|FG000|NOT COMPLETED|Overall Study||9
9821478|NCT00720213|10932285|FG000|STARTED|Screening Phase With Diagnostic PSG||44
9821479|NCT00720213|10932286|FG001|STARTED|Screening Phase With Diagnostic PSG||0
9821480|NCT00720213|10932287|FG002|STARTED|Screening Phase With Diagnostic PSG||0
9821481|NCT00720213|10932285|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37
9821482|NCT00720213|10932286|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0
9821483|NCT00720213|10932287|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0
9821484|NCT00720213|10932285|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
9821485|NCT00720213|10932286|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
9821486|NCT00720213|10932287|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
9821487|NCT00720213|10932285|FG000|STARTED|Treatment Period||0
9821488|NCT00720213|10932286|FG001|STARTED|Treatment Period||20
9821489|NCT00720213|10932287|FG002|STARTED|Treatment Period||17
9821490|NCT00720213|10932285|FG000|COMPLETED|Treatment Period||0
9821491|NCT00720213|10932286|FG001|COMPLETED|Treatment Period||20
9821492|NCT00720213|10932287|FG002|COMPLETED|Treatment Period||17
9821493|NCT00720213|10932285|FG000|NOT COMPLETED|Treatment Period||0
9821494|NCT00720213|10932286|FG001|NOT COMPLETED|Treatment Period||0
9821495|NCT00720213|10932287|FG002|NOT COMPLETED|Treatment Period||0
9821496|NCT00720226|10932297|FG000|STARTED|Overall Study||54
9821497|NCT00720226|10932298|FG001|STARTED|Overall Study||52
9821498|NCT00720226|10932297|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
9821499|NCT00720226|10932298|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
9821500|NCT00720226|10932297|FG000|NOT COMPLETED|Overall Study||7
9821501|NCT00720226|10932298|FG001|NOT COMPLETED|Overall Study||4
9821502|NCT00720278|10932307|FG000|STARTED|Overall Study|1 subject was randomized in error|178
10017095|NCT01814072|11139936|FG029|Intent to Treat|Overall Study||3
10017096|NCT01814072|11139937|FG030|Intent to Treat|Overall Study||2
10017097|NCT01814072|11139938|FG031|Intent to Treat|Overall Study||0
10017098|NCT01814072|11139907|FG000|COMPLETED|Overall Study||14
10112448|NCT02503254|11243416|FG000|NOT COMPLETED|Overall Study||0
10112449|NCT02503254|11243417|FG001|NOT COMPLETED|Overall Study||0
10112450|NCT02503332|11243427|FG000|STARTED|Overall Study||86
9821503|NCT00720278|10932308|FG001|STARTED|Overall Study|1 subject was randomized in error|170
9821504|NCT00720278|10932309|FG002|STARTED|Overall Study|1 subject was randomized in error|178
10017099|NCT01814072|11139908|FG001|COMPLETED|Overall Study||16
9821505|NCT00720278|10932307|FG000|COMPLETED|Overall Study||171
9821506|NCT00720278|10932308|FG001|COMPLETED|Overall Study||166
9821507|NCT00720278|10932309|FG002|COMPLETED|Overall Study||172
9821508|NCT00720278|10932307|FG000|NOT COMPLETED|Overall Study||7
9821509|NCT00720278|10932308|FG001|NOT COMPLETED|Overall Study||4
9821510|NCT00720278|10932309|FG002|NOT COMPLETED|Overall Study||6
9821511|NCT00720330|10932320|FG000|STARTED|Overall Study||5
9821512|NCT00720330|10932321|FG001|STARTED|Overall Study||4
9821513|NCT00720330|10932322|FG002|STARTED|Overall Study||3
9821514|NCT00720330|10932320|FG000|COMPLETED|Overall Study||5
9821515|NCT00720330|10932321|FG001|COMPLETED|Overall Study||4
9821516|NCT00720330|10932322|FG002|COMPLETED|Overall Study||3
10017100|NCT01814072|11139909|FG002|COMPLETED|Overall Study||15
10017101|NCT01814072|11139910|FG003|COMPLETED|Overall Study||18
10017102|NCT01814072|11139911|FG004|COMPLETED|Overall Study||14
9821517|NCT00720330|10932320|FG000|NOT COMPLETED|Overall Study||0
9821518|NCT00720330|10932321|FG001|NOT COMPLETED|Overall Study||0
9821519|NCT00720330|10932322|FG002|NOT COMPLETED|Overall Study||0
9821520|NCT00720356|10932330|FG000|STARTED|Registration to Study||115
9821521|NCT00720356|10932330|FG000|Completed Registration Step 1|Registration to Study||115
9821522|NCT00720356|10932330|FG000|Completed Registration Step 2|Registration to Study||48
9821523|NCT00720356|10932330|FG000|COMPLETED|Registration to Study||48
9821524|NCT00720356|10932330|FG000|NOT COMPLETED|Registration to Study||67
9821525|NCT00720356|10932330|FG000|STARTED|Reached 1st Response/2 Cycles||48
9821526|NCT00720356|10932330|FG000|COMPLETED|Reached 1st Response/2 Cycles||46
9821527|NCT00720356|10932330|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
9821528|NCT00720356|10932330|FG000|STARTED|Went on to be Treated Cycle 3||46
9821529|NCT00720356|10932330|FG000|COMPLETED|Went on to be Treated Cycle 3||44
9821530|NCT00720356|10932330|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2
9821531|NCT00720356|10932330|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
9821532|NCT00720356|10932330|FG000|COMPLETED|Follow up Until Death||43
9821533|NCT00720356|10932330|FG000|NOT COMPLETED|Follow up Until Death||5
9821534|NCT00720369|10932336|FG000|STARTED|Overall Study||11
9821535|NCT00720369|10932337|FG001|STARTED|Overall Study||8
9821536|NCT00720369|10932336|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
9821537|NCT00720369|10932337|FG001|COMPLETED|Overall Study||8
9821538|NCT00720369|10932336|FG000|NOT COMPLETED|Overall Study||1
9821539|NCT00720369|10932337|FG001|NOT COMPLETED|Overall Study||0
9821540|NCT00720382|10932347|FG000|STARTED|Overall Study||466
9821541|NCT00720382|10932348|FG001|STARTED|Overall Study||237
9821542|NCT00720382|10932347|FG000|COMPLETED|Overall Study||290
9821543|NCT00720382|10932348|FG001|COMPLETED|Overall Study||178
9821544|NCT00720382|10932347|FG000|NOT COMPLETED|Overall Study||176
9821545|NCT00720382|10932348|FG001|NOT COMPLETED|Overall Study||59
9821546|NCT00720434|10932358|FG000|STARTED|Double-Blind Period (Week 1-4)||10
9821547|NCT00720434|10932359|FG001|STARTED|Double-Blind Period (Week 1-4)||9
9821548|NCT00720434|10932360|FG002|STARTED|Double-Blind Period (Week 1-4)||8
9821549|NCT00720434|10932361|FG003|STARTED|Double-Blind Period (Week 1-4)||8
9821550|NCT00720434|10932358|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10
9821551|NCT00720434|10932359|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8
9821552|NCT00720434|10932360|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8
9821553|NCT00720434|10932361|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8
9821554|NCT00720434|10932358|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
9821555|NCT00720434|10932359|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
9821556|NCT00720434|10932360|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
9821557|NCT00720434|10932361|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
9821558|NCT00720434|10932358|FG000|STARTED|Open-Label Period (Week 5-72)||10
9821559|NCT00720434|10932359|FG001|STARTED|Open-Label Period (Week 5-72)||8
9821560|NCT00720434|10932360|FG002|STARTED|Open-Label Period (Week 5-72)||8
9821561|NCT00720434|10932361|FG003|STARTED|Open-Label Period (Week 5-72)||8
9821562|NCT00720434|10932358|FG000|COMPLETED|Open-Label Period (Week 5-72)||4
9821563|NCT00720434|10932359|FG001|COMPLETED|Open-Label Period (Week 5-72)||5
9821564|NCT00720434|10932360|FG002|COMPLETED|Open-Label Period (Week 5-72)||4
9821565|NCT00720434|10932361|FG003|COMPLETED|Open-Label Period (Week 5-72)||4
9821566|NCT00720434|10932358|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6
9821567|NCT00720434|10932359|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3
9821568|NCT00720434|10932360|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4
9821569|NCT00720434|10932361|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4
9821570|NCT00720473|10932373|FG000|STARTED|Overall Study||45
9821571|NCT00720473|10932374|FG001|STARTED|Overall Study||24
9821572|NCT00720473|10932373|FG000|COMPLETED|Overall Study||15
9821573|NCT00720473|10932374|FG001|COMPLETED|Overall Study||16
9821574|NCT00720473|10932373|FG000|NOT COMPLETED|Overall Study||30
9821575|NCT00720473|10932374|FG001|NOT COMPLETED|Overall Study||8
9821576|NCT00720499|10932381|FG000|STARTED|Treatment Period 1 (4 Weeks)||69
9821577|NCT00720499|10932382|FG001|STARTED|Treatment Period 1 (4 Weeks)||72
9821578|NCT00720499|10932381|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66
9821579|NCT00720499|10932382|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70
9821580|NCT00720499|10932381|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
9821581|NCT00720499|10932382|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
9821582|NCT00720499|10932381|FG000|STARTED|Washout Period (2 Weeks)||66
9821583|NCT00720499|10932382|FG001|STARTED|Washout Period (2 Weeks)||70
9821584|NCT00720499|10932381|FG000|COMPLETED|Washout Period (2 Weeks)||66
9821585|NCT00720499|10932382|FG001|COMPLETED|Washout Period (2 Weeks)||70
9821586|NCT00720499|10932381|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
9821587|NCT00720499|10932382|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
9821588|NCT00720499|10932381|FG000|STARTED|Treatment Period 2 (4 Weeks)||66
9821589|NCT00720499|10932382|FG001|STARTED|Treatment Period 2 (4 Weeks)||70
9821590|NCT00720499|10932381|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64
9821591|NCT00720499|10932382|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67
9821592|NCT00720499|10932381|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
9821593|NCT00720499|10932382|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
9821594|NCT00720629|10932389|FG000|STARTED|Overall Study||8
9821595|NCT00720629|10932389|FG000|COMPLETED|Overall Study||8
9821596|NCT00720629|10932389|FG000|NOT COMPLETED|Overall Study||0
9821597|NCT00720759|10932399|FG000|STARTED|Overall Study||6
9821598|NCT00720759|10932400|FG001|STARTED|Overall Study||6
9821599|NCT00720759|10932401|FG002|STARTED|Overall Study||6
9821600|NCT00720759|10932402|FG003|STARTED|Overall Study||6
9821601|NCT00720759|10932399|FG000|COMPLETED|Overall Study||6
9821602|NCT00720759|10932400|FG001|COMPLETED|Overall Study||5
9821603|NCT00720759|10932401|FG002|COMPLETED|Overall Study||5
9821604|NCT00720759|10932402|FG003|COMPLETED|Overall Study||6
9821605|NCT00720759|10932399|FG000|NOT COMPLETED|Overall Study||0
9821606|NCT00720759|10932400|FG001|NOT COMPLETED|Overall Study||1
9821607|NCT00720759|10932401|FG002|NOT COMPLETED|Overall Study||1
9821608|NCT00720759|10932402|FG003|NOT COMPLETED|Overall Study||0
9821609|NCT00720798|10932412|FG000|STARTED|Overall Study||2067
9821610|NCT00720798|10932412|FG000|COMPLETED|Overall Study||1311
9821611|NCT00720798|10932412|FG000|NOT COMPLETED|Overall Study||756
9821612|NCT00720876|10932416|FG000|STARTED|Overall Study||30
9821613|NCT00720876|10932416|FG000|COMPLETED|Overall Study||28
9821614|NCT00720876|10932416|FG000|NOT COMPLETED|Overall Study||2
9821615|NCT00720941|10932422|FG000|STARTED|Overall Study||557
9821616|NCT00720941|10932423|FG001|STARTED|Overall Study||553
9821617|NCT00720941|10932422|FG000|Ongoing|Overall Study||34
9821618|NCT00720941|10932423|FG001|Ongoing|Overall Study||23
9821619|NCT00720941|10932422|FG000|COMPLETED|Overall Study||144
9821620|NCT00720941|10932423|FG001|COMPLETED|Overall Study||138
9821621|NCT00720941|10932422|FG000|NOT COMPLETED|Overall Study||413
9821622|NCT00720941|10932423|FG001|NOT COMPLETED|Overall Study||415
9821623|NCT00721110|10932433|FG000|STARTED|Overall Study||16
9821624|NCT00721110|10932434|FG001|STARTED|Overall Study||16
9821625|NCT00721110|10932435|FG002|STARTED|Overall Study||16
9821626|NCT00721110|10932436|FG003|STARTED|Overall Study||16
9821627|NCT00721110|10932433|FG000|COMPLETED|Overall Study||15
9821628|NCT00721110|10932434|FG001|COMPLETED|Overall Study||16
9821629|NCT00721110|10932435|FG002|COMPLETED|Overall Study||15
9821630|NCT00721110|10932436|FG003|COMPLETED|Overall Study||16
9821631|NCT00721110|10932433|FG000|NOT COMPLETED|Overall Study||1
9821632|NCT00721110|10932434|FG001|NOT COMPLETED|Overall Study||0
9821633|NCT00721110|10932435|FG002|NOT COMPLETED|Overall Study||1
9821634|NCT00721110|10932436|FG003|NOT COMPLETED|Overall Study||0
9821635|NCT00721123|10932446|FG000|STARTED|Overall Study||538
9821636|NCT00721123|10932446|FG000|COMPLETED|Overall Study||355
9821637|NCT00721123|10932446|FG000|NOT COMPLETED|Overall Study||183
9821638|NCT00721136|10932470|FG000|STARTED|Overall Study||42
9821639|NCT00721136|10932471|FG001|STARTED|Overall Study||42
9821640|NCT00721136|10932472|FG002|STARTED|Overall Study||8
9821641|NCT00721136|10932473|FG003|STARTED|Overall Study||8
9821642|NCT00721136|10932470|FG000|COMPLETED|Overall Study||42
9821643|NCT00721136|10932471|FG001|COMPLETED|Overall Study||42
9821644|NCT00721136|10932472|FG002|COMPLETED|Overall Study||8
9821645|NCT00721136|10932473|FG003|COMPLETED|Overall Study||8
9821646|NCT00721136|10932470|FG000|NOT COMPLETED|Overall Study||0
9821647|NCT00721136|10932471|FG001|NOT COMPLETED|Overall Study||0
9821648|NCT00721136|10932472|FG002|NOT COMPLETED|Overall Study||0
9821649|NCT00721136|10932473|FG003|NOT COMPLETED|Overall Study||0
9821650|NCT00721149|10932487|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
9821651|NCT00721149|10932487|FG000|COMPLETED|Overall Study||9
9821652|NCT00721149|10932487|FG000|NOT COMPLETED|Overall Study||1
9821653|NCT00721162|10932491|FG000|STARTED|Overall Study||60
9821654|NCT00721162|10932491|FG000|Received Any Amount of Study Drug|Overall Study||60
9821655|NCT00721162|10932491|FG000|COMPLETED|Overall Study||60
9821656|NCT00721162|10932491|FG000|NOT COMPLETED|Overall Study||0
9821657|NCT00721175|10932497|FG000|STARTED|Overall Study||54
9821658|NCT00721175|10932498|FG001|STARTED|Overall Study||54
9821659|NCT00721175|10932497|FG000|COMPLETED|Overall Study||54
9821660|NCT00721175|10932498|FG001|COMPLETED|Overall Study||54
9821661|NCT00721175|10932497|FG000|NOT COMPLETED|Overall Study||0
9821662|NCT00721175|10932498|FG001|NOT COMPLETED|Overall Study||0
9821663|NCT00721188|10932504|FG000|STARTED|Overall Study||11
9821664|NCT00721188|10932504|FG000|COMPLETED|Overall Study||11
9821665|NCT00721188|10932504|FG000|NOT COMPLETED|Overall Study||0
9821666|NCT00721214|10932508|FG000|STARTED|Overall Study||16
9821667|NCT00721214|10932508|FG000|COMPLETED|Overall Study||12
9821668|NCT00721214|10932508|FG000|NOT COMPLETED|Overall Study||4
9821669|NCT00721227|10932514|FG000|STARTED|Overall Study||9
9821670|NCT00721227|10932515|FG001|STARTED|Overall Study||6
9821671|NCT00721227|10932514|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
9821672|NCT00721227|10932515|FG001|COMPLETED|Overall Study||6
9821673|NCT00721227|10932514|FG000|NOT COMPLETED|Overall Study||4
9821674|NCT00721227|10932515|FG001|NOT COMPLETED|Overall Study||0
9821675|NCT00721253|10932523|FG000|STARTED|Overall Study||20
9821676|NCT00721253|10932524|FG001|STARTED|Overall Study||22
9821677|NCT00721253|10932525|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
9821678|NCT00721253|10932523|FG000|COMPLETED|Overall Study||20
9821679|NCT00721253|10932524|FG001|COMPLETED|Overall Study||22
9821680|NCT00721253|10932525|FG002|COMPLETED|Overall Study||0
9821681|NCT00721253|10932523|FG000|NOT COMPLETED|Overall Study||0
9821682|NCT00721253|10932524|FG001|NOT COMPLETED|Overall Study||0
9821683|NCT00721253|10932525|FG002|NOT COMPLETED|Overall Study||0
9821684|NCT00721279|10932533|FG000|STARTED|Overall Study||452
9821685|NCT00721279|10932534|FG001|STARTED|Overall Study||97
9821686|NCT00721279|10932533|FG000|COMPLETED|Overall Study||416
9821687|NCT00721279|10932534|FG001|COMPLETED|Overall Study||73
9821688|NCT00721279|10932533|FG000|NOT COMPLETED|Overall Study||36
9821689|NCT00721279|10932534|FG001|NOT COMPLETED|Overall Study||24
9821690|NCT00721357|10932543|FG000|STARTED|Overall Study||15
9821691|NCT00721357|10932544|FG001|STARTED|Overall Study||15
9821692|NCT00721357|10932543|FG000|COMPLETED|Overall Study||15
9821693|NCT00721357|10932544|FG001|COMPLETED|Overall Study||15
9821694|NCT00721357|10932543|FG000|NOT COMPLETED|Overall Study||0
9821695|NCT00721357|10932544|FG001|NOT COMPLETED|Overall Study||0
9821696|NCT00721396|10932556|FG000|STARTED|Overall Study||627
9821697|NCT00721396|10932557|FG001|STARTED|Overall Study||628
9821698|NCT00721396|10932558|FG002|STARTED|Overall Study||318
9821699|NCT00721396|10932559|FG003|STARTED|Overall Study||312
9821700|NCT00721396|10932556|FG000|COMPLETED|Overall Study||597
9821701|NCT00721396|10932557|FG001|COMPLETED|Overall Study||592
9821702|NCT00721396|10932558|FG002|COMPLETED|Overall Study||308
9821703|NCT00721396|10932559|FG003|COMPLETED|Overall Study||302
9821704|NCT00721396|10932556|FG000|NOT COMPLETED|Overall Study||30
9821705|NCT00721396|10932557|FG001|NOT COMPLETED|Overall Study||36
9821706|NCT00721396|10932558|FG002|NOT COMPLETED|Overall Study||10
9821707|NCT00721396|10932559|FG003|NOT COMPLETED|Overall Study||10
9821708|NCT00721409|10932577|FG000|STARTED|Overall Study||12
9821709|NCT00721409|10932578|FG001|STARTED|Overall Study||84
9821710|NCT00721409|10932579|FG002|STARTED|Overall Study||81
9821711|NCT00721409|10932577|FG000|Treated|Overall Study||12
9821712|NCT00721409|10932578|FG001|Treated|Overall Study||83
9821713|NCT00721409|10932579|FG002|Treated|Overall Study||77
9821714|NCT00721409|10932577|FG000|COMPLETED|Overall Study||0
9821715|NCT00721409|10932578|FG001|COMPLETED|Overall Study||2
9821716|NCT00721409|10932579|FG002|COMPLETED|Overall Study||2
9821717|NCT00721409|10932577|FG000|NOT COMPLETED|Overall Study||12
9821718|NCT00721409|10932578|FG001|NOT COMPLETED|Overall Study||82
9821719|NCT00721409|10932579|FG002|NOT COMPLETED|Overall Study||79
9821720|NCT00721500|10932603|FG000|STARTED|Period One||6
9821721|NCT00721500|10932604|FG001|STARTED|Period One||7
9821722|NCT00721500|10932605|FG002|STARTED|Period One||6
9821723|NCT00721500|10932606|FG003|STARTED|Period One||6
9821724|NCT00721500|10932603|FG000|COMPLETED|Period One||6
9821725|NCT00721500|10932604|FG001|COMPLETED|Period One||7
9821726|NCT00721500|10932605|FG002|COMPLETED|Period One||6
9821727|NCT00721500|10932606|FG003|COMPLETED|Period One||6
9821728|NCT00721500|10932603|FG000|NOT COMPLETED|Period One||0
9821729|NCT00721500|10932604|FG001|NOT COMPLETED|Period One||0
9821730|NCT00721500|10932605|FG002|NOT COMPLETED|Period One||0
9821731|NCT00721500|10932606|FG003|NOT COMPLETED|Period One||0
9821732|NCT00721500|10932603|FG000|STARTED|Period Two||6
9821733|NCT00721500|10932604|FG001|STARTED|Period Two||7
9821734|NCT00721500|10932605|FG002|STARTED|Period Two||6
9821735|NCT00721500|10932606|FG003|STARTED|Period Two||6
9821736|NCT00721500|10932603|FG000|COMPLETED|Period Two||6
9821737|NCT00721500|10932604|FG001|COMPLETED|Period Two||7
9821738|NCT00721500|10932605|FG002|COMPLETED|Period Two||6
9821739|NCT00721500|10932606|FG003|COMPLETED|Period Two||6
9821740|NCT00721500|10932603|FG000|NOT COMPLETED|Period Two||0
9821741|NCT00721500|10932604|FG001|NOT COMPLETED|Period Two||0
9821742|NCT00721500|10932605|FG002|NOT COMPLETED|Period Two||0
9821743|NCT00721500|10932606|FG003|NOT COMPLETED|Period Two||0
9821744|NCT00721500|10932603|FG000|STARTED|Period Three||6
9821745|NCT00721500|10932604|FG001|STARTED|Period Three||7
9821746|NCT00721500|10932605|FG002|STARTED|Period Three||6
9821747|NCT00721500|10932606|FG003|STARTED|Period Three||6
9821748|NCT00721500|10932603|FG000|COMPLETED|Period Three||6
9821749|NCT00721500|10932604|FG001|COMPLETED|Period Three||7
9821750|NCT00721500|10932605|FG002|COMPLETED|Period Three||6
9821751|NCT00721500|10932606|FG003|COMPLETED|Period Three||6
9821752|NCT00721500|10932603|FG000|NOT COMPLETED|Period Three||0
9821753|NCT00721500|10932604|FG001|NOT COMPLETED|Period Three||0
9821754|NCT00721500|10932605|FG002|NOT COMPLETED|Period Three||0
9821755|NCT00721500|10932606|FG003|NOT COMPLETED|Period Three||0
9821756|NCT00721513|10932618|FG000|STARTED|Overall Study||20
9821757|NCT00721513|10932618|FG000|COMPLETED|Overall Study||20
9821758|NCT00721513|10932618|FG000|NOT COMPLETED|Overall Study||0
9821759|NCT00721539|10932622|FG000|STARTED|Overall Study||9
10017103|NCT01814072|11139912|FG005|COMPLETED|Overall Study||12
10017104|NCT01814072|11139913|FG006|COMPLETED|Overall Study||14
10017105|NCT01814072|11139914|FG007|COMPLETED|Overall Study||17
10017106|NCT01814072|11139915|FG008|COMPLETED|Overall Study||16
9821760|NCT00721539|10932622|FG000|COMPLETED|Overall Study||9
10017107|NCT01814072|11139916|FG009|COMPLETED|Overall Study||13
10017108|NCT01814072|11139917|FG010|COMPLETED|Overall Study||17
10017109|NCT01814072|11139918|FG011|COMPLETED|Overall Study||16
10017110|NCT01814072|11139919|FG012|COMPLETED|Overall Study||15
10017111|NCT01814072|11139920|FG013|COMPLETED|Overall Study||16
10017112|NCT01814072|11139921|FG014|COMPLETED|Overall Study||15
10017113|NCT01814072|11139922|FG015|COMPLETED|Overall Study||16
10017114|NCT01814072|11139923|FG016|COMPLETED|Overall Study||14
9821761|NCT00721539|10932622|FG000|NOT COMPLETED|Overall Study||0
9821762|NCT00721578|10932626|FG000|STARTED|Overall Study||12
9821763|NCT00721578|10932627|FG001|STARTED|Overall Study||11
9821764|NCT00721578|10932626|FG000|COMPLETED|Overall Study||10
9821765|NCT00721578|10932627|FG001|COMPLETED|Overall Study||9
9821766|NCT00721578|10932626|FG000|NOT COMPLETED|Overall Study||2
9821767|NCT00721578|10932627|FG001|NOT COMPLETED|Overall Study||2
9821768|NCT00721617|10932633|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
9821769|NCT00721617|10932633|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
9821770|NCT00721617|10932633|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
9821771|NCT00721617|10932633|FG000|STARTED|4 Hours Into Saline Infusion||12
9821772|NCT00721617|10932633|FG000|COMPLETED|4 Hours Into Saline Infusion||12
9821773|NCT00721617|10932633|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
9821774|NCT00721617|10932633|FG000|STARTED|8 Hours Into Saline Infusion||12
9821775|NCT00721617|10932633|FG000|COMPLETED|8 Hours Into Saline Infusion||12
9821776|NCT00721617|10932633|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0
9821777|NCT00721617|10932633|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
9821778|NCT00721617|10932633|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
9821779|NCT00721617|10932633|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
9821780|NCT00721617|10932633|FG000|STARTED|4 Hours Into Intralipid Infusion||12
9821781|NCT00721617|10932633|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
9821782|NCT00721617|10932633|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
9821783|NCT00721617|10932633|FG000|STARTED|8 Hours Into Intralipid Infusion||12
9821784|NCT00721617|10932633|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12
9821785|NCT00721617|10932633|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
9821786|NCT00721617|10932633|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
9821787|NCT00721617|10932633|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
9821788|NCT00721617|10932633|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
9821789|NCT00721617|10932633|FG000|STARTED|4 Hours Into Dextrose Infusion||12
9821790|NCT00721617|10932633|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
9821791|NCT00721617|10932633|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
9821792|NCT00721617|10932633|FG000|STARTED|8 Hours Into Dextrose Infusion||12
9821793|NCT00721617|10932633|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12
9821794|NCT00721617|10932633|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
9821795|NCT00721617|10932633|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
9821796|NCT00721617|10932633|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
9821797|NCT00721617|10932633|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
9821798|NCT00721617|10932633|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12
9821799|NCT00721617|10932633|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12
9821800|NCT00721617|10932633|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
9821801|NCT00721617|10932633|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12
9821802|NCT00721617|10932633|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12
9821803|NCT00721617|10932633|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
9821804|NCT00721630|10932638|FG000|STARTED|Overall Study||24
9821805|NCT00721630|10932638|FG000|COMPLETED|Overall Study||23
9821806|NCT00721630|10932638|FG000|NOT COMPLETED|Overall Study||1
9821807|NCT00721734|10932647|FG000|STARTED|Overall Study||12
9821808|NCT00721734|10932648|FG001|STARTED|Overall Study||12
9821809|NCT00721734|10932649|FG002|STARTED|Overall Study||10
9821810|NCT00721734|10932650|FG003|STARTED|Overall Study||8
9821811|NCT00721734|10932651|FG004|STARTED|Overall Study||8
9821812|NCT00721734|10932647|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
9821813|NCT00721734|10932648|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
9821814|NCT00721734|10932649|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
9821815|NCT00721734|10932650|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
9821816|NCT00721734|10932651|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
9821817|NCT00721734|10932647|FG000|NOT COMPLETED|Overall Study||8
9821818|NCT00721734|10932648|FG001|NOT COMPLETED|Overall Study||12
9821819|NCT00721734|10932649|FG002|NOT COMPLETED|Overall Study||8
9821820|NCT00721734|10932650|FG003|NOT COMPLETED|Overall Study||6
9821821|NCT00721734|10932651|FG004|NOT COMPLETED|Overall Study||6
9821822|NCT00721799|10932663|FG000|STARTED|Overall Study||33
9821823|NCT00721799|10932663|FG000|Recieved FLT PET Scan 1|Overall Study||26
9821824|NCT00721799|10932663|FG000|Received FLT PET Scan #2|Overall Study||25
9821825|NCT00721799|10932663|FG000|COMPLETED|Overall Study||25
9821826|NCT00721799|10932663|FG000|NOT COMPLETED|Overall Study||8
9821827|NCT00721955|10932670|FG000|STARTED|Overall Study||105
9821828|NCT00721955|10932671|FG001|STARTED|Overall Study||104
9821829|NCT00721955|10932672|FG002|STARTED|Overall Study||105
9821830|NCT00721955|10932670|FG000|COMPLETED|Overall Study||105
9821831|NCT00721955|10932671|FG001|COMPLETED|Overall Study||104
9821832|NCT00721955|10932672|FG002|COMPLETED|Overall Study||103
9821833|NCT00721955|10932670|FG000|NOT COMPLETED|Overall Study||0
9821834|NCT00721955|10932671|FG001|NOT COMPLETED|Overall Study||0
9821835|NCT00721955|10932672|FG002|NOT COMPLETED|Overall Study||2
9821836|NCT00721968|10932682|FG000|STARTED|Overall Study||27
9821837|NCT00721968|10932683|FG001|STARTED|Overall Study||17
9821838|NCT00721968|10932682|FG000|COMPLETED|Overall Study||25
9821839|NCT00721968|10932683|FG001|COMPLETED|Overall Study||17
9821840|NCT00721968|10932682|FG000|NOT COMPLETED|Overall Study||2
9821841|NCT00721968|10932683|FG001|NOT COMPLETED|Overall Study||0
9821842|NCT00722007|10932689|FG000|STARTED|Overall Study||147
9821843|NCT00722007|10932689|FG000|COMPLETED|Overall Study||117
9821844|NCT00722007|10932689|FG000|NOT COMPLETED|Overall Study||30
9821845|NCT00722020|10932696|FG000|STARTED|Overall Study||19
9821846|NCT00722020|10932697|FG001|STARTED|Overall Study||24
9821847|NCT00722020|10932696|FG000|COMPLETED|Overall Study||19
9821848|NCT00722020|10932697|FG001|COMPLETED|Overall Study||24
9821849|NCT00722020|10932696|FG000|NOT COMPLETED|Overall Study||0
9821850|NCT00722020|10932697|FG001|NOT COMPLETED|Overall Study||0
9821851|NCT00722072|10932705|FG000|STARTED|Overall Study||12
9821852|NCT00722072|10932705|FG000|COMPLETED|Overall Study||9
9821853|NCT00722072|10932705|FG000|NOT COMPLETED|Overall Study||3
9821854|NCT00722111|10932711|FG000|STARTED|Overall Study||11
9821855|NCT00722111|10932712|FG001|STARTED|Overall Study||72
9821856|NCT00722111|10932711|FG000|COMPLETED|Overall Study||11
9821857|NCT00722111|10932712|FG001|COMPLETED|Overall Study||72
9821858|NCT00722111|10932711|FG000|NOT COMPLETED|Overall Study||0
9821859|NCT00722111|10932712|FG001|NOT COMPLETED|Overall Study||0
9821860|NCT00722124|10932721|FG000|STARTED|Overall Study||40
9821861|NCT00722124|10932722|FG001|STARTED|Overall Study||40
9821862|NCT00722124|10932723|FG002|STARTED|Overall Study||40
9821863|NCT00722124|10932721|FG000|COMPLETED|Overall Study||23
9821864|NCT00722124|10932722|FG001|COMPLETED|Overall Study||26
9821865|NCT00722124|10932723|FG002|COMPLETED|Overall Study||20
9821866|NCT00722124|10932721|FG000|NOT COMPLETED|Overall Study||17
9821867|NCT00722124|10932722|FG001|NOT COMPLETED|Overall Study||14
9821868|NCT00722124|10932723|FG002|NOT COMPLETED|Overall Study||20
9821869|NCT00722137|10932733|FG000|STARTED|Overall Study||244
9821870|NCT00722137|10932734|FG001|STARTED|Overall Study||243
9821871|NCT00722137|10932733|FG000|COMPLETED|Overall Study||199
9821872|NCT00722137|10932734|FG001|COMPLETED|Overall Study||195
9821873|NCT00722137|10932733|FG000|NOT COMPLETED|Overall Study||45
9821874|NCT00722137|10932734|FG001|NOT COMPLETED|Overall Study||48
9821875|NCT00722371|10932747|FG000|STARTED|Overall Study||231
9821876|NCT00722371|10932748|FG001|STARTED|Overall Study||230
9821877|NCT00722371|10932749|FG002|STARTED|Overall Study||233
9821878|NCT00722371|10932750|FG003|STARTED|Overall Study||230
9821879|NCT00722371|10932751|FG004|STARTED|Overall Study||230
9821880|NCT00722371|10932752|FG005|STARTED|Overall Study||231
9821881|NCT00722371|10932753|FG006|STARTED|Overall Study||230
9821882|NCT00722371|10932747|FG000|COMPLETED|Overall Study||175
9821883|NCT00722371|10932748|FG001|COMPLETED|Overall Study||158
9821884|NCT00722371|10932749|FG002|COMPLETED|Overall Study||168
9821885|NCT00722371|10932750|FG003|COMPLETED|Overall Study||167
9821886|NCT00722371|10932751|FG004|COMPLETED|Overall Study||182
9821887|NCT00722371|10932752|FG005|COMPLETED|Overall Study||178
9821888|NCT00722371|10932753|FG006|COMPLETED|Overall Study||179
9821889|NCT00722371|10932747|FG000|NOT COMPLETED|Overall Study||56
9821890|NCT00722371|10932748|FG001|NOT COMPLETED|Overall Study||72
9821891|NCT00722371|10932749|FG002|NOT COMPLETED|Overall Study||65
9821892|NCT00722371|10932750|FG003|NOT COMPLETED|Overall Study||63
9821893|NCT00722371|10932751|FG004|NOT COMPLETED|Overall Study||48
9821894|NCT00722371|10932752|FG005|NOT COMPLETED|Overall Study||53
9821895|NCT00722371|10932753|FG006|NOT COMPLETED|Overall Study||51
9821896|NCT00722423|10932771|FG000|STARTED|Overall Study||182
9821897|NCT00722423|10932772|FG001|STARTED|Overall Study||182
9821898|NCT00722423|10932771|FG000|COMPLETED|Overall Study||182
9821899|NCT00722423|10932772|FG001|COMPLETED|Overall Study||181
9821900|NCT00722423|10932771|FG000|NOT COMPLETED|Overall Study||0
9821901|NCT00722423|10932772|FG001|NOT COMPLETED|Overall Study||1
9821902|NCT00722436|10932782|FG000|STARTED|Overall Study||9
9821903|NCT00722436|10932783|FG001|STARTED|Overall Study||11
9821904|NCT00722436|10932782|FG000|COMPLETED|Overall Study||9
9821905|NCT00722436|10932783|FG001|COMPLETED|Overall Study||11
9821906|NCT00722436|10932782|FG000|NOT COMPLETED|Overall Study||0
9821907|NCT00722436|10932783|FG001|NOT COMPLETED|Overall Study||0
9821908|NCT00722553|10932789|FG000|STARTED|Overall Study||30
9821909|NCT00722553|10932789|FG000|COMPLETED|Overall Study||30
9821910|NCT00722553|10932789|FG000|NOT COMPLETED|Overall Study||0
9821911|NCT00722566|10932797|FG000|STARTED|Overall Study|One patient randomized and not dosed|148
9821912|NCT00722566|10932798|FG001|STARTED|Overall Study||74
9821913|NCT00722566|10932797|FG000|COMPLETED|Overall Study|Completed 8 cycles|81
9821914|NCT00722566|10932798|FG001|COMPLETED|Overall Study|Completed 8 cycles|39
9821915|NCT00722566|10932797|FG000|NOT COMPLETED|Overall Study||67
9821916|NCT00722566|10932798|FG001|NOT COMPLETED|Overall Study||35
9821917|NCT00722722|10932809|FG000|STARTED|Overall Study||3
9821918|NCT00722722|10932810|FG001|STARTED|Overall Study||5
9821919|NCT00722722|10932811|FG002|STARTED|Overall Study||10
9821920|NCT00722722|10932809|FG000|COMPLETED|Overall Study||3
9821921|NCT00722722|10932810|FG001|COMPLETED|Overall Study||5
9821922|NCT00722722|10932811|FG002|COMPLETED|Overall Study||10
9821923|NCT00722722|10932809|FG000|NOT COMPLETED|Overall Study||0
9821924|NCT00722722|10932810|FG001|NOT COMPLETED|Overall Study||0
9821925|NCT00722722|10932811|FG002|NOT COMPLETED|Overall Study||0
9821926|NCT00722761|10932821|FG000|STARTED|Overall Study||16
9821927|NCT00722761|10932822|FG001|STARTED|Overall Study||14
9821928|NCT00722761|10932821|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
9821929|NCT00722761|10932822|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
9821930|NCT00722761|10932821|FG000|COMPLETED|Overall Study||10
9821931|NCT00722761|10932822|FG001|COMPLETED|Overall Study||8
9821932|NCT00722761|10932821|FG000|NOT COMPLETED|Overall Study||6
9821933|NCT00722761|10932822|FG001|NOT COMPLETED|Overall Study||6
9821934|NCT00722800|10932830|FG000|STARTED|Overall Study||2
9821935|NCT00722800|10932831|FG001|STARTED|Overall Study||2
9821936|NCT00722800|10932830|FG000|COMPLETED|Overall Study||0
9821937|NCT00722800|10932831|FG001|COMPLETED|Overall Study||2
9821938|NCT00722800|10932830|FG000|NOT COMPLETED|Overall Study||2
9821939|NCT00722800|10932831|FG001|NOT COMPLETED|Overall Study||0
9821940|NCT00722865|10932837|FG000|STARTED|Overall Study||25
9821941|NCT00722865|10932837|FG000|COMPLETED|Overall Study||23
9821942|NCT00722865|10932837|FG000|NOT COMPLETED|Overall Study||2
9821943|NCT00723008|10932843|FG000|STARTED|Enrollment||11
9821944|NCT00723008|10932844|FG001|STARTED|Enrollment||9
9821945|NCT00723008|10932843|FG000|COMPLETED|Enrollment||10
9821946|NCT00723008|10932844|FG001|COMPLETED|Enrollment||9
9821947|NCT00723008|10932843|FG000|NOT COMPLETED|Enrollment||1
9821948|NCT00723008|10932844|FG001|NOT COMPLETED|Enrollment||0
9821949|NCT00723008|10932843|FG000|STARTED|4-Week Double Blinded||10
9821950|NCT00723008|10932844|FG001|STARTED|4-Week Double Blinded||9
9821951|NCT00723008|10932843|FG000|COMPLETED|4-Week Double Blinded||5
9821952|NCT00723008|10932844|FG001|COMPLETED|4-Week Double Blinded||4
9821953|NCT00723008|10932843|FG000|NOT COMPLETED|4-Week Double Blinded||5
9821954|NCT00723008|10932844|FG001|NOT COMPLETED|4-Week Double Blinded||5
9821955|NCT00723008|10932843|FG000|STARTED|4-Week Unblinded Treatment||5
9821956|NCT00723008|10932844|FG001|STARTED|4-Week Unblinded Treatment||4
9821957|NCT00723008|10932843|FG000|COMPLETED|4-Week Unblinded Treatment||4
9821958|NCT00723008|10932844|FG001|COMPLETED|4-Week Unblinded Treatment||3
9821959|NCT00723008|10932843|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1
9821960|NCT00723008|10932844|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1
9821961|NCT00723021|10932858|FG000|STARTED|Intervention Period 1||3
9821962|NCT00723021|10932859|FG001|STARTED|Intervention Period 1||3
9821963|NCT00723021|10932860|FG002|STARTED|Intervention Period 1||3
9821964|NCT00723021|10932861|FG003|STARTED|Intervention Period 1||3
9821965|NCT00723021|10932862|FG004|STARTED|Intervention Period 1||3
9821966|NCT00723021|10932858|FG000|COMPLETED|Intervention Period 1||3
9821967|NCT00723021|10932859|FG001|COMPLETED|Intervention Period 1||3
9821968|NCT00723021|10932860|FG002|COMPLETED|Intervention Period 1||3
9821969|NCT00723021|10932861|FG003|COMPLETED|Intervention Period 1||3
9821970|NCT00723021|10932862|FG004|COMPLETED|Intervention Period 1||3
9821971|NCT00723021|10932858|FG000|NOT COMPLETED|Intervention Period 1||0
9821972|NCT00723021|10932859|FG001|NOT COMPLETED|Intervention Period 1||0
9821973|NCT00723021|10932860|FG002|NOT COMPLETED|Intervention Period 1||0
9821974|NCT00723021|10932861|FG003|NOT COMPLETED|Intervention Period 1||0
9821975|NCT00723021|10932862|FG004|NOT COMPLETED|Intervention Period 1||0
9821976|NCT00723021|10932858|FG000|STARTED|Intervention Period 2||3
9821977|NCT00723021|10932859|FG001|STARTED|Intervention Period 2||3
9821978|NCT00723021|10932860|FG002|STARTED|Intervention Period 2||3
9821979|NCT00723021|10932861|FG003|STARTED|Intervention Period 2||3
9821980|NCT00723021|10932862|FG004|STARTED|Intervention Period 2||3
9821981|NCT00723021|10932858|FG000|COMPLETED|Intervention Period 2||3
9821982|NCT00723021|10932859|FG001|COMPLETED|Intervention Period 2||3
9821983|NCT00723021|10932860|FG002|COMPLETED|Intervention Period 2||3
9821984|NCT00723021|10932861|FG003|COMPLETED|Intervention Period 2||3
9821985|NCT00723021|10932862|FG004|COMPLETED|Intervention Period 2||3
9821986|NCT00723021|10932858|FG000|NOT COMPLETED|Intervention Period 2||0
9821987|NCT00723021|10932859|FG001|NOT COMPLETED|Intervention Period 2||0
9821988|NCT00723021|10932860|FG002|NOT COMPLETED|Intervention Period 2||0
9821989|NCT00723021|10932861|FG003|NOT COMPLETED|Intervention Period 2||0
9821990|NCT00723021|10932862|FG004|NOT COMPLETED|Intervention Period 2||0
9821991|NCT00723021|10932858|FG000|STARTED|Intervention Period 3||3
9821992|NCT00723021|10932859|FG001|STARTED|Intervention Period 3||3
9821993|NCT00723021|10932860|FG002|STARTED|Intervention Period 3||3
9821994|NCT00723021|10932861|FG003|STARTED|Intervention Period 3||3
9821995|NCT00723021|10932862|FG004|STARTED|Intervention Period 3||3
9821996|NCT00723021|10932858|FG000|COMPLETED|Intervention Period 3||3
9821997|NCT00723021|10932859|FG001|COMPLETED|Intervention Period 3||3
9821998|NCT00723021|10932860|FG002|COMPLETED|Intervention Period 3||3
9821999|NCT00723021|10932861|FG003|COMPLETED|Intervention Period 3||3
9822000|NCT00723021|10932862|FG004|COMPLETED|Intervention Period 3||3
9822001|NCT00723021|10932858|FG000|NOT COMPLETED|Intervention Period 3||0
9822002|NCT00723021|10932859|FG001|NOT COMPLETED|Intervention Period 3||0
9822003|NCT00723021|10932860|FG002|NOT COMPLETED|Intervention Period 3||0
9822004|NCT00723021|10932861|FG003|NOT COMPLETED|Intervention Period 3||0
9822005|NCT00723021|10932862|FG004|NOT COMPLETED|Intervention Period 3||0
9822006|NCT00723021|10932858|FG000|STARTED|Intervention Period 4||3
9822007|NCT00723021|10932859|FG001|STARTED|Intervention Period 4||3
9822008|NCT00723021|10932860|FG002|STARTED|Intervention Period 4||3
9822009|NCT00723021|10932861|FG003|STARTED|Intervention Period 4||3
9822010|NCT00723021|10932862|FG004|STARTED|Intervention Period 4||3
9822011|NCT00723021|10932858|FG000|COMPLETED|Intervention Period 4||3
9822012|NCT00723021|10932859|FG001|COMPLETED|Intervention Period 4||3
9822013|NCT00723021|10932860|FG002|COMPLETED|Intervention Period 4||3
9822014|NCT00723021|10932861|FG003|COMPLETED|Intervention Period 4||3
9822015|NCT00723021|10932862|FG004|COMPLETED|Intervention Period 4||2
9822016|NCT00723021|10932858|FG000|NOT COMPLETED|Intervention Period 4||0
9822017|NCT00723021|10932859|FG001|NOT COMPLETED|Intervention Period 4||0
9822018|NCT00723021|10932860|FG002|NOT COMPLETED|Intervention Period 4||0
9822019|NCT00723021|10932861|FG003|NOT COMPLETED|Intervention Period 4||0
9822020|NCT00723021|10932862|FG004|NOT COMPLETED|Intervention Period 4||1
9822021|NCT00723021|10932858|FG000|STARTED|Intervention Period 5||3
9822022|NCT00723021|10932859|FG001|STARTED|Intervention Period 5||3
9822023|NCT00723021|10932860|FG002|STARTED|Intervention Period 5||3
9822024|NCT00723021|10932861|FG003|STARTED|Intervention Period 5||3
9822025|NCT00723021|10932862|FG004|STARTED|Intervention Period 5||2
9822026|NCT00723021|10932858|FG000|COMPLETED|Intervention Period 5||3
9822027|NCT00723021|10932859|FG001|COMPLETED|Intervention Period 5||3
9822028|NCT00723021|10932860|FG002|COMPLETED|Intervention Period 5||3
9822029|NCT00723021|10932861|FG003|COMPLETED|Intervention Period 5||3
9822030|NCT00723021|10932862|FG004|COMPLETED|Intervention Period 5||2
9822031|NCT00723021|10932858|FG000|NOT COMPLETED|Intervention Period 5||0
9822032|NCT00723021|10932859|FG001|NOT COMPLETED|Intervention Period 5||0
9822033|NCT00723021|10932860|FG002|NOT COMPLETED|Intervention Period 5||0
9822034|NCT00723021|10932861|FG003|NOT COMPLETED|Intervention Period 5||0
9822035|NCT00723021|10932862|FG004|NOT COMPLETED|Intervention Period 5||0
9822036|NCT00723073|10932883|FG000|STARTED|Overall Study||149
9822037|NCT00723073|10932884|FG001|STARTED|Overall Study||174
9822038|NCT00723073|10932883|FG000|COMPLETED|Overall Study||149
9822039|NCT00723073|10932884|FG001|COMPLETED|Overall Study||174
9822040|NCT00723073|10932883|FG000|NOT COMPLETED|Overall Study||0
9822041|NCT00723073|10932884|FG001|NOT COMPLETED|Overall Study||0
9822042|NCT00723099|10932890|FG000|STARTED|Overall Study||73
9822043|NCT00723099|10932890|FG000|COMPLETED|Overall Study||72
9822044|NCT00723099|10932890|FG000|NOT COMPLETED|Overall Study||1
9822045|NCT00723125|10932897|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
9822046|NCT00723125|10932898|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
9822047|NCT00723125|10932897|FG000|COMPLETED|Overall Study||15
9822048|NCT00723125|10932898|FG001|COMPLETED|Overall Study||21
9822049|NCT00723125|10932897|FG000|NOT COMPLETED|Overall Study||18
9822050|NCT00723125|10932898|FG001|NOT COMPLETED|Overall Study||6
9822051|NCT00723177|10932913|FG000|STARTED|Overall Study||15
9822052|NCT00723177|10932914|FG001|STARTED|Overall Study||14
9822053|NCT00723177|10932915|FG002|STARTED|Overall Study||15
9822054|NCT00723177|10932913|FG000|COMPLETED|Overall Study||10
9822055|NCT00723177|10932914|FG001|COMPLETED|Overall Study||10
9822056|NCT00723177|10932915|FG002|COMPLETED|Overall Study||10
9822057|NCT00723177|10932913|FG000|NOT COMPLETED|Overall Study||5
9822058|NCT00723177|10932914|FG001|NOT COMPLETED|Overall Study||4
9822059|NCT00723177|10932915|FG002|NOT COMPLETED|Overall Study||5
9822060|NCT00723190|10932923|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
9822061|NCT00723190|10932923|FG000|SAFETY POPULATION|Overall Study||301
9822062|NCT00723190|10932923|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
9822063|NCT00723190|10932923|FG000|NOT COMPLETED|Overall Study||142
9822064|NCT00723203|10932927|FG000|STARTED|Overall Study||16
9822065|NCT00723203|10932927|FG000|COMPLETED|Overall Study||13
9822066|NCT00723203|10932927|FG000|NOT COMPLETED|Overall Study||3
9822067|NCT00723229|10932933|FG000|STARTED|First Intervention||25
9822068|NCT00723229|10932934|FG001|STARTED|First Intervention||23
9822069|NCT00723229|10932933|FG000|COMPLETED|First Intervention||18
9822070|NCT00723229|10932934|FG001|COMPLETED|First Intervention||20
9822071|NCT00723229|10932933|FG000|NOT COMPLETED|First Intervention||7
9822072|NCT00723229|10932934|FG001|NOT COMPLETED|First Intervention||3
9822073|NCT00723229|10932933|FG000|STARTED|Second Intervention||18
9822074|NCT00723229|10932934|FG001|STARTED|Second Intervention||20
9822075|NCT00723229|10932933|FG000|COMPLETED|Second Intervention||18
9822076|NCT00723229|10932934|FG001|COMPLETED|Second Intervention||20
9822077|NCT00723229|10932933|FG000|NOT COMPLETED|Second Intervention||0
9822078|NCT00723229|10932934|FG001|NOT COMPLETED|Second Intervention||0
9822079|NCT00723255|10932940|FG000|STARTED|Overall Study||53
9822080|NCT00723255|10932940|FG000|COMPLETED|Overall Study|Eligible and treated patients|49
9822081|NCT00723255|10932940|FG000|NOT COMPLETED|Overall Study||4
9822082|NCT00723294|10932956|FG000|STARTED|Overall Study||99
9822083|NCT00723294|10932956|FG000|COMPLETED|Overall Study||86
9822084|NCT00723294|10932956|FG000|NOT COMPLETED|Overall Study||13
9822085|NCT00723398|10932965|FG000|STARTED|Overall Study||53
9822086|NCT00723398|10932966|FG001|STARTED|Overall Study||53
9822087|NCT00723398|10932967|FG002|STARTED|Overall Study||53
9822088|NCT00723398|10932968|FG003|STARTED|Overall Study||54
9822089|NCT00723398|10932969|FG004|STARTED|Overall Study||53
9822090|NCT00723398|10932965|FG000|COMPLETED|Overall Study||47
9822091|NCT00723398|10932966|FG001|COMPLETED|Overall Study||38
9822092|NCT00723398|10932967|FG002|COMPLETED|Overall Study||36
9822093|NCT00723398|10932968|FG003|COMPLETED|Overall Study||49
9822094|NCT00723398|10932969|FG004|COMPLETED|Overall Study||44
9822095|NCT00723398|10932965|FG000|NOT COMPLETED|Overall Study||6
9822096|NCT00723398|10932966|FG001|NOT COMPLETED|Overall Study||15
9822097|NCT00723398|10932967|FG002|NOT COMPLETED|Overall Study||17
9822098|NCT00723398|10932968|FG003|NOT COMPLETED|Overall Study||5
9822099|NCT00723398|10932969|FG004|NOT COMPLETED|Overall Study||9
9822100|NCT00723450|10932983|FG000|STARTED|Open-Label Phase||298
9822101|NCT00723450|10932984|FG001|STARTED|Open-Label Phase||0
9822102|NCT00723450|10932985|FG002|STARTED|Open-Label Phase||0
9822103|NCT00723450|10932983|FG000|COMPLETED|Open-Label Phase||173
9822104|NCT00723450|10932984|FG001|COMPLETED|Open-Label Phase||0
9822105|NCT00723450|10932985|FG002|COMPLETED|Open-Label Phase||0
9822106|NCT00723450|10932983|FG000|NOT COMPLETED|Open-Label Phase||125
9822107|NCT00723450|10932984|FG001|NOT COMPLETED|Open-Label Phase||0
9822108|NCT00723450|10932985|FG002|NOT COMPLETED|Open-Label Phase||0
9822109|NCT00723450|10932983|FG000|STARTED|Randomized Phase||0
9822110|NCT00723450|10932984|FG001|STARTED|Randomized Phase||86
9822111|NCT00723450|10932985|FG002|STARTED|Randomized Phase||87
9822112|NCT00723450|10932983|FG000|COMPLETED|Randomized Phase||0
9822113|NCT00723450|10932984|FG001|COMPLETED|Randomized Phase||21
9822114|NCT00723450|10932985|FG002|COMPLETED|Randomized Phase||20
9822115|NCT00723450|10932983|FG000|NOT COMPLETED|Randomized Phase||0
9822116|NCT00723450|10932984|FG001|NOT COMPLETED|Randomized Phase||65
9822117|NCT00723450|10932985|FG002|NOT COMPLETED|Randomized Phase||67
9822118|NCT00723489|10932998|FG000|STARTED|Overall Study||21
9822119|NCT00723489|10932999|FG001|STARTED|Overall Study||19
9822120|NCT00723489|10933000|FG002|STARTED|Overall Study||19
9822121|NCT00723489|10933001|FG003|STARTED|Overall Study||23
9822122|NCT00723489|10932998|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
9822123|NCT00723489|10932999|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
9822124|NCT00723489|10933000|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
9822125|NCT00723489|10933001|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
9822126|NCT00723489|10932998|FG000|NOT COMPLETED|Overall Study||1
9822127|NCT00723489|10932999|FG001|NOT COMPLETED|Overall Study||4
9822128|NCT00723489|10933000|FG002|NOT COMPLETED|Overall Study||0
9822129|NCT00723489|10933001|FG003|NOT COMPLETED|Overall Study||3
9822130|NCT00723528|10933014|FG000|STARTED|Period 1: Controlled Period (CP)||32
9822131|NCT00723528|10933015|FG001|STARTED|Period 1: Controlled Period (CP)||64
9822132|NCT00723528|10933016|FG002|STARTED|Period 1: Controlled Period (CP)||62
9822133|NCT00723528|10933017|FG003|STARTED|Period 1: Controlled Period (CP)||0
9822134|NCT00723528|10933018|FG004|STARTED|Period 1: Controlled Period (CP)||0
9822135|NCT00723528|10933019|FG005|STARTED|Period 1: Controlled Period (CP)||0
9822136|NCT00723528|10933020|FG006|STARTED|Period 1: Controlled Period (CP)||0
9822137|NCT00723528|10933014|FG000|COMPLETED|Period 1: Controlled Period (CP)||28
9822138|NCT00723528|10933015|FG001|COMPLETED|Period 1: Controlled Period (CP)||64
9822139|NCT00723528|10933016|FG002|COMPLETED|Period 1: Controlled Period (CP)||58
9822140|NCT00723528|10933017|FG003|COMPLETED|Period 1: Controlled Period (CP)||0
9822141|NCT00723528|10933018|FG004|COMPLETED|Period 1: Controlled Period (CP)||0
9822142|NCT00723528|10933019|FG005|COMPLETED|Period 1: Controlled Period (CP)||0
9822143|NCT00723528|10933020|FG006|COMPLETED|Period 1: Controlled Period (CP)||0
9822144|NCT00723528|10933014|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4
9822145|NCT00723528|10933015|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0
9822146|NCT00723528|10933016|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4
9822147|NCT00723528|10933017|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0
9822148|NCT00723528|10933018|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0
9822149|NCT00723528|10933019|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0
9822150|NCT00723528|10933020|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0
9822151|NCT00723528|10933014|FG000|STARTED|Period 2: After Controlled Period||0
9822152|NCT00723528|10933015|FG001|STARTED|Period 2: After Controlled Period||0
9822153|NCT00723528|10933016|FG002|STARTED|Period 2: After Controlled Period||0
9822154|NCT00723528|10933017|FG003|STARTED|Period 2: After Controlled Period||15
9822155|NCT00723528|10933018|FG004|STARTED|Period 2: After Controlled Period||13
9822156|NCT00723528|10933019|FG005|STARTED|Period 2: After Controlled Period||64
9822157|NCT00723528|10933020|FG006|STARTED|Period 2: After Controlled Period||58
9822158|NCT00723528|10933014|FG000|COMPLETED|Period 2: After Controlled Period||0
9822159|NCT00723528|10933015|FG001|COMPLETED|Period 2: After Controlled Period||0
9822160|NCT00723528|10933016|FG002|COMPLETED|Period 2: After Controlled Period||0
9822161|NCT00723528|10933017|FG003|COMPLETED|Period 2: After Controlled Period||14
9822162|NCT00723528|10933018|FG004|COMPLETED|Period 2: After Controlled Period||11
9822163|NCT00723528|10933019|FG005|COMPLETED|Period 2: After Controlled Period||58
9822164|NCT00723528|10933020|FG006|COMPLETED|Period 2: After Controlled Period||54
9822165|NCT00723528|10933014|FG000|NOT COMPLETED|Period 2: After Controlled Period||0
9822166|NCT00723528|10933015|FG001|NOT COMPLETED|Period 2: After Controlled Period||0
9822167|NCT00723528|10933016|FG002|NOT COMPLETED|Period 2: After Controlled Period||0
9822168|NCT00723528|10933017|FG003|NOT COMPLETED|Period 2: After Controlled Period||1
9822169|NCT00723528|10933018|FG004|NOT COMPLETED|Period 2: After Controlled Period||2
9822170|NCT00723528|10933019|FG005|NOT COMPLETED|Period 2: After Controlled Period||6
9822171|NCT00723528|10933020|FG006|NOT COMPLETED|Period 2: After Controlled Period||4
9822172|NCT00723554|10933036|FG000|STARTED|Overall Study||63
9822173|NCT00723554|10933036|FG000|COMPLETED|Overall Study||34
9822174|NCT00723554|10933036|FG000|NOT COMPLETED|Overall Study||29
9822175|NCT00723580|10933042|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
9822176|NCT00723580|10933042|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
9822177|NCT00723580|10933042|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1
9822178|NCT00723580|10933042|FG000|NOT COMPLETED|Overall Study||0
9822179|NCT00723606|10933048|FG000|STARTED|Overall Study||189
9822180|NCT00723606|10933049|FG001|STARTED|Overall Study||187
9822181|NCT00723606|10933048|FG000|COMPLETED|Overall Study||185
9822182|NCT00723606|10933049|FG001|COMPLETED|Overall Study||180
9822183|NCT00723606|10933048|FG000|NOT COMPLETED|Overall Study||4
9822184|NCT00723606|10933049|FG001|NOT COMPLETED|Overall Study||7
9832153|NCT00771758|10942855|FG000|COMPLETED|Overall Study||36
9832154|NCT00771758|10942856|FG001|COMPLETED|Overall Study||31
9832155|NCT00771758|10942857|FG002|COMPLETED|Overall Study||19
9832156|NCT00771758|10942855|FG000|NOT COMPLETED|Overall Study||8
9832157|NCT00771758|10942856|FG001|NOT COMPLETED|Overall Study||12
9832158|NCT00771758|10942857|FG002|NOT COMPLETED|Overall Study||2
9832159|NCT00771810|10942885|FG000|STARTED|Overall Study||10
9832160|NCT00771810|10942886|FG001|STARTED|Overall Study||11
9832161|NCT00771810|10942887|FG002|STARTED|Overall Study||13
9832162|NCT00771810|10942885|FG000|COMPLETED|Overall Study||5
9832163|NCT00771810|10942886|FG001|COMPLETED|Overall Study||6
9832164|NCT00771810|10942887|FG002|COMPLETED|Overall Study||6
9832165|NCT00771810|10942885|FG000|NOT COMPLETED|Overall Study||5
9832166|NCT00771810|10942886|FG001|NOT COMPLETED|Overall Study||5
9822185|NCT00723632|10933055|FG000|STARTED|Overall Study||901
9822186|NCT00723632|10933055|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
9822187|NCT00723632|10933055|FG000|NOT COMPLETED|Overall Study||203
9822188|NCT00723645|10933059|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
9822189|NCT00723645|10933059|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
9822190|NCT00723645|10933059|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
9822191|NCT00723645|10933059|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
9822192|NCT00723645|10933059|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
9822193|NCT00723645|10933059|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
9822194|NCT00723645|10933059|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
9822195|NCT00723645|10933059|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
9822196|NCT00723645|10933059|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
9822197|NCT00723697|10933063|FG000|STARTED|Overall Study||1307
9822198|NCT00723697|10933063|FG000|COMPLETED|Overall Study||1289
9822199|NCT00723697|10933063|FG000|NOT COMPLETED|Overall Study||18
9822200|NCT00723710|10933070|FG000|STARTED|Overall Study||294
9822201|NCT00723710|10933070|FG000|COMPLETED|Overall Study||120
9822202|NCT00723710|10933070|FG000|NOT COMPLETED|Overall Study||174
9822203|NCT00723749|10933074|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
9822204|NCT00723749|10933074|FG000|COMPLETED|Overall Study||182
9822205|NCT00723749|10933074|FG000|NOT COMPLETED|Overall Study||163
9822206|NCT00723788|10933078|FG000|STARTED|Overall Study||21
9822207|NCT00723788|10933078|FG000|COMPLETED|Overall Study||21
9822208|NCT00723788|10933078|FG000|NOT COMPLETED|Overall Study||0
9822209|NCT00723801|10933086|FG000|STARTED|Overall Study||20
9822210|NCT00723801|10933087|FG001|STARTED|Overall Study||20
9822211|NCT00723801|10933086|FG000|COMPLETED|Overall Study||17
9822212|NCT00723801|10933087|FG001|COMPLETED|Overall Study||17
9822213|NCT00723801|10933086|FG000|NOT COMPLETED|Overall Study||3
9822214|NCT00723801|10933087|FG001|NOT COMPLETED|Overall Study||3
9822215|NCT00723827|10933093|FG000|STARTED|Overall Study||682
9822216|NCT00723827|10933093|FG000|COMPLETED|Overall Study||682
9822217|NCT00723827|10933093|FG000|NOT COMPLETED|Overall Study||0
9822218|NCT00723840|10933097|FG000|STARTED|Overall Study||245
9822219|NCT00723840|10933097|FG000|COMPLETED|Overall Study||163
9822220|NCT00723840|10933097|FG000|NOT COMPLETED|Overall Study||82
9822221|NCT00723892|10933110|FG000|STARTED|Overall Study||313
9822222|NCT00723892|10933111|FG001|STARTED|Overall Study||255
9822223|NCT00723892|10933110|FG000|COMPLETED|Overall Study||206
9822224|NCT00723892|10933111|FG001|COMPLETED|Overall Study||168
9822225|NCT00723892|10933110|FG000|NOT COMPLETED|Overall Study||107
9822226|NCT00723892|10933111|FG001|NOT COMPLETED|Overall Study||87
9822227|NCT00723931|10933117|FG000|STARTED|Overall Study||1267
9822228|NCT00723931|10933117|FG000|COMPLETED|Overall Study||1267
9822229|NCT00723931|10933117|FG000|NOT COMPLETED|Overall Study||0
9822230|NCT00723957|10933123|FG000|STARTED|Overall Study|Randomized|98
9822231|NCT00723957|10933124|FG001|STARTED|Overall Study|Randomized|99
9822232|NCT00723957|10933123|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
9822233|NCT00723957|10933124|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
9822234|NCT00723957|10933123|FG000|NOT COMPLETED|Overall Study||51
9822235|NCT00723957|10933124|FG001|NOT COMPLETED|Overall Study||53
9822236|NCT00724009|10933130|FG000|STARTED|Overall Study||29
9822237|NCT00724009|10933130|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
9822238|NCT00724009|10933130|FG000|NOT COMPLETED|Overall Study||0
9822239|NCT00724061|10933134|FG000|STARTED|Dose Escalation Phase||7
9822240|NCT00724061|10933134|FG000|COMPLETED|Dose Escalation Phase||2
9822241|NCT00724061|10933134|FG000|NOT COMPLETED|Dose Escalation Phase||5
9822242|NCT00724061|10933134|FG000|STARTED|Maintenance Therapy||2
9822243|NCT00724061|10933134|FG000|COMPLETED|Maintenance Therapy||2
9822244|NCT00724061|10933134|FG000|NOT COMPLETED|Maintenance Therapy||0
9822245|NCT00724126|10933140|FG000|STARTED|Overall Study||321
9822246|NCT00724126|10933141|FG001|STARTED|Overall Study||316
9822247|NCT00724126|10933140|FG000|COMPLETED|Overall Study||302
9822248|NCT00724126|10933141|FG001|COMPLETED|Overall Study||301
9822249|NCT00724126|10933140|FG000|NOT COMPLETED|Overall Study||19
9822250|NCT00724126|10933141|FG001|NOT COMPLETED|Overall Study||15
9822251|NCT00724152|10933152|FG000|STARTED|Two-arm Study Period||14
9822252|NCT00724152|10933153|FG001|STARTED|Two-arm Study Period||11
9822253|NCT00724152|10933154|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
9822254|NCT00724152|10933152|FG000|COMPLETED|Two-arm Study Period||11
9822255|NCT00724152|10933153|FG001|COMPLETED|Two-arm Study Period||9
9822256|NCT00724152|10933154|FG002|COMPLETED|Two-arm Study Period||0
9822257|NCT00724152|10933152|FG000|NOT COMPLETED|Two-arm Study Period||3
9822258|NCT00724152|10933153|FG001|NOT COMPLETED|Two-arm Study Period||2
9822259|NCT00724152|10933154|FG002|NOT COMPLETED|Two-arm Study Period||0
9822260|NCT00724152|10933152|FG000|STARTED|Three-arm Study Period (+Standard Care)||4
9822261|NCT00724152|10933153|FG001|STARTED|Three-arm Study Period (+Standard Care)||2
9822262|NCT00724152|10933154|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
9822263|NCT00724152|10933152|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3
9822264|NCT00724152|10933153|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0
9822265|NCT00724152|10933154|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1
9822266|NCT00724152|10933152|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
9822267|NCT00724152|10933153|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
9822268|NCT00724152|10933154|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
9822269|NCT00724243|10933164|FG000|STARTED|Overall Study||33
9822270|NCT00724243|10933164|FG000|COMPLETED|Overall Study||18
9822271|NCT00724243|10933164|FG000|NOT COMPLETED|Overall Study||15
9822272|NCT00724308|10933170|FG000|STARTED|Overall Study||270
9822273|NCT00724308|10933171|FG001|STARTED|Overall Study||307
9822274|NCT00724308|10933170|FG000|COMPLETED|Overall Study||190
9822275|NCT00724308|10933171|FG001|COMPLETED|Overall Study||210
9822276|NCT00724308|10933170|FG000|NOT COMPLETED|Overall Study||80
9822277|NCT00724308|10933171|FG001|NOT COMPLETED|Overall Study||97
9822278|NCT00724347|10933177|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
9822279|NCT00724347|10933177|FG000|Baseline Testing|Overall Study||18
9822280|NCT00724347|10933177|FG000|COMPLETED|Overall Study||16
9822281|NCT00724347|10933177|FG000|NOT COMPLETED|Overall Study||2
9822282|NCT00724373|10933181|FG000|STARTED|Overall Study||442
9822283|NCT00724373|10933181|FG000|COMPLETED|Overall Study||271
9822284|NCT00724373|10933181|FG000|NOT COMPLETED|Overall Study||171
9822285|NCT00724451|10933185|FG000|STARTED|Overall Study||1128
9822286|NCT00724451|10933185|FG000|Received Antiviral Treatment|Overall Study||500
9822287|NCT00724451|10933185|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
9822288|NCT00724451|10933185|FG000|NOT COMPLETED|Overall Study||802
9822289|NCT00724464|10933189|FG000|STARTED|Overall Study||332
9822290|NCT00724464|10933189|FG000|COMPLETED|Overall Study||309
9822291|NCT00724464|10933189|FG000|NOT COMPLETED|Overall Study||23
9822292|NCT00724503|10933196|FG000|STARTED|Overall Study||267
9822293|NCT00724503|10933197|FG001|STARTED|Overall Study||263
9822294|NCT00724503|10933196|FG000|COMPLETED|Overall Study||57
9822295|NCT00724503|10933197|FG001|COMPLETED|Overall Study||43
9822296|NCT00724503|10933196|FG000|NOT COMPLETED|Overall Study||210
9822297|NCT00724503|10933197|FG001|NOT COMPLETED|Overall Study||220
9822298|NCT00724568|10933205|FG000|STARTED|Overall Study||42
9822299|NCT00724568|10933206|FG001|STARTED|Overall Study||32
9822300|NCT00724568|10933205|FG000|COMPLETED|Overall Study||42
9822301|NCT00724568|10933206|FG001|COMPLETED|Overall Study||32
9822302|NCT00724568|10933205|FG000|NOT COMPLETED|Overall Study||0
9822303|NCT00724568|10933206|FG001|NOT COMPLETED|Overall Study||0
9822304|NCT00724594|10933214|FG000|STARTED|Overall Study||12
9822305|NCT00724594|10933215|FG001|STARTED|Overall Study||12
9822306|NCT00724594|10933216|FG002|STARTED|Overall Study||11
9822307|NCT00724594|10933217|FG003|STARTED|Overall Study||11
9822308|NCT00724594|10933214|FG000|COMPLETED|Overall Study||12
9822309|NCT00724594|10933215|FG001|COMPLETED|Overall Study||12
9822310|NCT00724594|10933216|FG002|COMPLETED|Overall Study||11
9822311|NCT00724594|10933217|FG003|COMPLETED|Overall Study||10
9822312|NCT00724594|10933214|FG000|NOT COMPLETED|Overall Study||0
9822313|NCT00724594|10933215|FG001|NOT COMPLETED|Overall Study||0
9822314|NCT00724594|10933216|FG002|NOT COMPLETED|Overall Study||0
9822315|NCT00724594|10933217|FG003|NOT COMPLETED|Overall Study||1
9822316|NCT00724711|10933244|FG000|STARTED|Overall Study||155
9822317|NCT00724711|10933245|FG001|STARTED|Overall Study||156
9822318|NCT00724711|10933244|FG000|COMPLETED|Overall Study||138
9822319|NCT00724711|10933245|FG001|COMPLETED|Overall Study||139
9822320|NCT00724711|10933244|FG000|NOT COMPLETED|Overall Study||17
9822321|NCT00724711|10933245|FG001|NOT COMPLETED|Overall Study||17
9822322|NCT00724750|10933253|FG000|STARTED|Overall Study||45
9822323|NCT00724750|10933254|FG001|STARTED|Overall Study||42
9822324|NCT00724750|10933253|FG000|COMPLETED|Overall Study||45
9822325|NCT00724750|10933254|FG001|COMPLETED|Overall Study||42
9822326|NCT00724750|10933253|FG000|NOT COMPLETED|Overall Study||0
9822327|NCT00724750|10933254|FG001|NOT COMPLETED|Overall Study||0
9822328|NCT00724815|10933262|FG000|STARTED|Overall Study|subjects randomized|265
9822329|NCT00724815|10933263|FG001|STARTED|Overall Study|subjects randomized|265
9822330|NCT00724815|10933262|FG000|COMPLETED|Overall Study||222
9822331|NCT00724815|10933263|FG001|COMPLETED|Overall Study||226
9822332|NCT00724815|10933262|FG000|NOT COMPLETED|Overall Study||43
9822333|NCT00724815|10933263|FG001|NOT COMPLETED|Overall Study||39
9822334|NCT00724854|10933271|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
9822335|NCT00724854|10933272|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
9822336|NCT00724854|10933271|FG000|COMPLETED|Overall Study||607
9822337|NCT00724854|10933272|FG001|COMPLETED|Overall Study||41
9822338|NCT00724854|10933271|FG000|NOT COMPLETED|Overall Study||403
9822339|NCT00724854|10933272|FG001|NOT COMPLETED|Overall Study||31
9822340|NCT00724867|10933279|FG000|STARTED|Overall Study||268
9822341|NCT00724867|10933279|FG000|COMPLETED|Overall Study||140
9822342|NCT00724867|10933279|FG000|NOT COMPLETED|Overall Study||128
9822343|NCT00724893|10933288|FG000|STARTED|Overall Study||1302
9822344|NCT00724893|10933289|FG001|STARTED|Overall Study||1128
9822345|NCT00724893|10933288|FG000|COMPLETED|Overall Study||938
9822346|NCT00724893|10933289|FG001|COMPLETED|Overall Study||670
9822347|NCT00724893|10933288|FG000|NOT COMPLETED|Overall Study||364
9822348|NCT00724893|10933289|FG001|NOT COMPLETED|Overall Study||458
9822349|NCT00724932|10933312|FG000|STARTED|Overall Study||70
9822350|NCT00724932|10933313|FG001|STARTED|Overall Study||70
9822351|NCT00724932|10933312|FG000|COMPLETED|Overall Study||65
9822352|NCT00724932|10933313|FG001|COMPLETED|Overall Study||67
9822353|NCT00724932|10933312|FG000|NOT COMPLETED|Overall Study||5
9822354|NCT00724932|10933313|FG001|NOT COMPLETED|Overall Study||3
9822355|NCT00724945|10933321|FG000|STARTED|Period 1||58
9822356|NCT00724945|10933322|FG001|STARTED|Period 1||55
9822357|NCT00724945|10933321|FG000|COMPLETED|Period 1||55
9822358|NCT00724945|10933322|FG001|COMPLETED|Period 1||54
9822359|NCT00724945|10933321|FG000|NOT COMPLETED|Period 1||3
9822360|NCT00724945|10933322|FG001|NOT COMPLETED|Period 1||1
9822361|NCT00724945|10933321|FG000|STARTED|Period 2||55
9822362|NCT00724945|10933322|FG001|STARTED|Period 2||54
9822363|NCT00724945|10933321|FG000|COMPLETED|Period 2||51
9822364|NCT00724945|10933322|FG001|COMPLETED|Period 2||54
9822365|NCT00724945|10933321|FG000|NOT COMPLETED|Period 2||4
9822366|NCT00724945|10933322|FG001|NOT COMPLETED|Period 2||0
9822367|NCT00724958|10933328|FG000|STARTED|Overall Study||348
9822368|NCT00724958|10933328|FG000|COMPLETED|Overall Study||166
9822369|NCT00724958|10933328|FG000|NOT COMPLETED|Overall Study||182
9822370|NCT00724971|10933332|FG000|STARTED|Overall Study||10
9822371|NCT00724971|10933332|FG000|COMPLETED|Overall Study||4
9822372|NCT00724971|10933332|FG000|NOT COMPLETED|Overall Study||6
9822373|NCT00724984|10933342|FG000|STARTED|Overall Study||5
9822374|NCT00724984|10933343|FG001|STARTED|Overall Study||8
9822375|NCT00724984|10933344|FG002|STARTED|Overall Study||3
9822376|NCT00724984|10933345|FG003|STARTED|Overall Study||9
9822377|NCT00724984|10933346|FG004|STARTED|Overall Study||16
9822378|NCT00724984|10933347|FG005|STARTED|Overall Study||14
9822379|NCT00724984|10933342|FG000|COMPLETED|Overall Study||4
9822380|NCT00724984|10933343|FG001|COMPLETED|Overall Study||7
9822381|NCT00724984|10933344|FG002|COMPLETED|Overall Study||3
9822382|NCT00724984|10933345|FG003|COMPLETED|Overall Study||7
9822383|NCT00724984|10933346|FG004|COMPLETED|Overall Study||12
9822384|NCT00724984|10933347|FG005|COMPLETED|Overall Study||9
9822385|NCT00724984|10933342|FG000|NOT COMPLETED|Overall Study||1
9822386|NCT00724984|10933343|FG001|NOT COMPLETED|Overall Study||1
9822387|NCT00724984|10933344|FG002|NOT COMPLETED|Overall Study||0
9822388|NCT00724984|10933345|FG003|NOT COMPLETED|Overall Study||2
9822389|NCT00724984|10933346|FG004|NOT COMPLETED|Overall Study||4
9822390|NCT00724984|10933347|FG005|NOT COMPLETED|Overall Study||5
9822391|NCT00725010|10933361|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
9822392|NCT00725010|10933361|FG000|COMPLETED|Overall Study||25
9822393|NCT00725010|10933361|FG000|NOT COMPLETED|Overall Study||25
9822394|NCT00725075|10933370|FG000|STARTED|Overall Study||72
9822395|NCT00725075|10933371|FG001|STARTED|Overall Study||73
9822396|NCT00725075|10933372|FG002|STARTED|Overall Study||70
9822397|NCT00725075|10933370|FG000|Treated|Overall Study||71
9822398|NCT00725075|10933371|FG001|Treated|Overall Study||73
9822399|NCT00725075|10933372|FG002|Treated|Overall Study||70
9822400|NCT00725075|10933370|FG000|COMPLETED|Overall Study||61
9822401|NCT00725075|10933371|FG001|COMPLETED|Overall Study||65
9822402|NCT00725075|10933372|FG002|COMPLETED|Overall Study||61
9822403|NCT00725075|10933370|FG000|NOT COMPLETED|Overall Study||11
9822404|NCT00725075|10933371|FG001|NOT COMPLETED|Overall Study||8
9822405|NCT00725075|10933372|FG002|NOT COMPLETED|Overall Study||9
9822406|NCT00725101|10933380|FG000|STARTED|Overall Study||1700
9822407|NCT00725101|10933380|FG000|COMPLETED|Overall Study||1205
9822408|NCT00725101|10933380|FG000|NOT COMPLETED|Overall Study||495
9822409|NCT00725153|10933384|FG000|STARTED|Period One, 10 Hours of Wear||27
9822410|NCT00725153|10933385|FG001|STARTED|Period One, 10 Hours of Wear||28
9822411|NCT00725153|10933384|FG000|COMPLETED|Period One, 10 Hours of Wear||27
9822412|NCT00725153|10933385|FG001|COMPLETED|Period One, 10 Hours of Wear||28
9822413|NCT00725153|10933384|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0
9822414|NCT00725153|10933385|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0
9822415|NCT00725153|10933384|FG000|STARTED|Period Two, 10 Hours of Wear||27
9822416|NCT00725153|10933385|FG001|STARTED|Period Two, 10 Hours of Wear||28
9822417|NCT00725153|10933384|FG000|COMPLETED|Period Two, 10 Hours of Wear||27
9822418|NCT00725153|10933385|FG001|COMPLETED|Period Two, 10 Hours of Wear||28
9822419|NCT00725153|10933384|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0
9822420|NCT00725153|10933385|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0
9822421|NCT00725205|10933391|FG000|STARTED|Overall Study||294
9822422|NCT00725205|10933391|FG000|COMPLETED|Overall Study||207
9822423|NCT00725205|10933391|FG000|NOT COMPLETED|Overall Study||87
9822424|NCT00725270|10933397|FG000|STARTED|Overall Study||5
9822425|NCT00725270|10933398|FG001|STARTED|Overall Study||7
9822426|NCT00725270|10933397|FG000|COMPLETED|Overall Study||5
9822427|NCT00725270|10933398|FG001|COMPLETED|Overall Study||7
9822428|NCT00725270|10933397|FG000|NOT COMPLETED|Overall Study||0
9822429|NCT00725270|10933398|FG001|NOT COMPLETED|Overall Study||0
9822430|NCT00725283|10933404|FG000|STARTED|Overall Study||34
9822431|NCT00725283|10933404|FG000|COMPLETED|Overall Study||10
9822432|NCT00725283|10933404|FG000|NOT COMPLETED|Overall Study||24
9822433|NCT00725296|10933408|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
9822434|NCT00725296|10933408|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
9822435|NCT00725296|10933408|FG000|NOT COMPLETED|Overall Study||62
9822436|NCT00725322|10933415|FG000|STARTED|First Injection Visit||15
9822437|NCT00725322|10933416|FG001|STARTED|First Injection Visit||15
9822438|NCT00725322|10933415|FG000|COMPLETED|First Injection Visit||15
9822439|NCT00725322|10933416|FG001|COMPLETED|First Injection Visit||15
9822440|NCT00725322|10933415|FG000|NOT COMPLETED|First Injection Visit||0
9822441|NCT00725322|10933416|FG001|NOT COMPLETED|First Injection Visit||0
9822442|NCT00725322|10933415|FG000|STARTED|Washout (28 Days)||15
9822443|NCT00725322|10933416|FG001|STARTED|Washout (28 Days)||15
9822444|NCT00725322|10933415|FG000|COMPLETED|Washout (28 Days)||13
9822445|NCT00725322|10933416|FG001|COMPLETED|Washout (28 Days)||14
9822446|NCT00725322|10933415|FG000|NOT COMPLETED|Washout (28 Days)||2
9822447|NCT00725322|10933416|FG001|NOT COMPLETED|Washout (28 Days)||1
9822448|NCT00725322|10933415|FG000|STARTED|Second Injection Visit||13
9822449|NCT00725322|10933416|FG001|STARTED|Second Injection Visit||14
9822450|NCT00725322|10933415|FG000|COMPLETED|Second Injection Visit||13
9822451|NCT00725322|10933416|FG001|COMPLETED|Second Injection Visit||14
9822452|NCT00725322|10933415|FG000|NOT COMPLETED|Second Injection Visit||0
9822453|NCT00725322|10933416|FG001|NOT COMPLETED|Second Injection Visit||0
9822454|NCT00725361|10933422|FG000|STARTED|Overall Study||20
9822455|NCT00725361|10933422|FG000|COMPLETED|Overall Study||16
9822456|NCT00725361|10933422|FG000|NOT COMPLETED|Overall Study||4
9822457|NCT00725452|10933426|FG000|STARTED|Overall Study||26
9822458|NCT00725452|10933426|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
9822459|NCT00725452|10933426|FG000|NOT COMPLETED|Overall Study||11
9822460|NCT00725504|10933430|FG000|STARTED|Overall Study||71
9822461|NCT00725504|10933430|FG000|COMPLETED|Overall Study||71
9822462|NCT00725504|10933430|FG000|NOT COMPLETED|Overall Study||0
9822463|NCT00725530|10933437|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27
9822464|NCT00725530|10933438|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27
9822465|NCT00725530|10933437|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27
9822466|NCT00725530|10933438|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27
9822467|NCT00725530|10933437|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
9822468|NCT00725530|10933438|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
9822469|NCT00725530|10933437|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27
9822470|NCT00725530|10933438|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27
9822471|NCT00725530|10933437|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
9822472|NCT00725530|10933438|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
9822473|NCT00725530|10933437|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
9822474|NCT00725530|10933438|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
9822475|NCT00725543|10933444|FG000|STARTED|Overall Study||358
9822476|NCT00725543|10933444|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
9822477|NCT00725543|10933444|FG000|NOT COMPLETED|Overall Study||153
9822478|NCT00725608|10933448|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
9822479|NCT00725608|10933448|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
9822480|NCT00725608|10933448|FG000|NOT COMPLETED|Overall Study||167
9822481|NCT00725621|10933452|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
9822482|NCT00725621|10933452|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
9822483|NCT00725621|10933452|FG000|NOT COMPLETED|Overall Study||271
9822484|NCT00725712|10933462|FG000|STARTED|Overall Study||48
9822485|NCT00725712|10933463|FG001|STARTED|Overall Study||26
9822486|NCT00725712|10933462|FG000|COMPLETED|Overall Study||0
9822487|NCT00725712|10933463|FG001|COMPLETED|Overall Study||0
9822488|NCT00725712|10933462|FG000|NOT COMPLETED|Overall Study||48
9822489|NCT00725712|10933463|FG001|NOT COMPLETED|Overall Study||26
9822490|NCT00725725|10933476|FG000|STARTED|Overall Study||14
9822491|NCT00725725|10933477|FG001|STARTED|Overall Study||15
9822492|NCT00725725|10933478|FG002|STARTED|Overall Study||17
9822493|NCT00725725|10933476|FG000|Treated|Overall Study||11
9822494|NCT00725725|10933477|FG001|Treated|Overall Study||15
9822495|NCT00725725|10933478|FG002|Treated|Overall Study||14
9822496|NCT00725725|10933476|FG000|COMPLETED|Overall Study||10
9822497|NCT00725725|10933477|FG001|COMPLETED|Overall Study||11
9822498|NCT00725725|10933478|FG002|COMPLETED|Overall Study||12
9822499|NCT00725725|10933476|FG000|NOT COMPLETED|Overall Study||4
10017115|NCT01814072|11139924|FG017|COMPLETED|Overall Study||17
10017116|NCT01814072|11139925|FG018|COMPLETED|Overall Study||14
10017117|NCT01814072|11139926|FG019|COMPLETED|Overall Study||11
10017118|NCT01814072|11139927|FG020|COMPLETED|Overall Study||14
10017119|NCT01814072|11139928|FG021|COMPLETED|Overall Study||16
10017120|NCT01814072|11139929|FG022|COMPLETED|Overall Study||13
10017121|NCT01814072|11139930|FG023|COMPLETED|Overall Study||17
10017122|NCT01814072|11139931|FG024|COMPLETED|Overall Study||11
10017123|NCT01814072|11139932|FG025|COMPLETED|Overall Study||14
9822500|NCT00725725|10933477|FG001|NOT COMPLETED|Overall Study||4
9822501|NCT00725725|10933478|FG002|NOT COMPLETED|Overall Study||5
9822502|NCT00725751|10933488|FG000|STARTED|Overall Study||90
9822503|NCT00725751|10933489|FG001|STARTED|Overall Study||258
9822504|NCT00725751|10933488|FG000|COMPLETED|Overall Study||56
10017124|NCT01814072|11139933|FG026|COMPLETED|Overall Study||16
10017125|NCT01814072|11139934|FG027|COMPLETED|Overall Study||13
9822505|NCT00725751|10933489|FG001|COMPLETED|Overall Study||150
9822506|NCT00725751|10933488|FG000|NOT COMPLETED|Overall Study||34
9822507|NCT00725751|10933489|FG001|NOT COMPLETED|Overall Study||108
9822508|NCT00725764|10933496|FG000|STARTED|Overall Study||14
9822509|NCT00725764|10933496|FG000|COMPLETED|Overall Study||0
9822510|NCT00725764|10933496|FG000|NOT COMPLETED|Overall Study||14
10017126|NCT01814072|11139935|FG028|COMPLETED|Overall Study||14
10017127|NCT01814072|11139936|FG029|COMPLETED|Overall Study||14
10017128|NCT01814072|11139937|FG030|COMPLETED|Overall Study||15
9822511|NCT00725842|10933501|FG000|STARTED|Overall Study||97
9822512|NCT00725842|10933501|FG000|Participants Eligible for Analysis|Overall Study||90
9822513|NCT00725842|10933501|FG000|COMPLETED|Overall Study||57
9822514|NCT00725842|10933501|FG000|NOT COMPLETED|Overall Study||40
9822515|NCT00725920|10933507|FG000|STARTED|Overall Study||17
9822516|NCT00725920|10933508|FG001|STARTED|Overall Study||18
9822517|NCT00725920|10933507|FG000|COMPLETED|Overall Study||14
9822518|NCT00725920|10933508|FG001|COMPLETED|Overall Study||12
9822519|NCT00725920|10933507|FG000|NOT COMPLETED|Overall Study||3
9822520|NCT00725920|10933508|FG001|NOT COMPLETED|Overall Study||6
9822521|NCT00725959|10933516|FG000|STARTED|Overall Study||942
9822522|NCT00725959|10933517|FG001|STARTED|Overall Study||636
9822523|NCT00725959|10933516|FG000|COMPLETED|Overall Study||653
9822524|NCT00725959|10933517|FG001|COMPLETED|Overall Study||439
9822525|NCT00725959|10933516|FG000|NOT COMPLETED|Overall Study||289
9822526|NCT00725959|10933517|FG001|NOT COMPLETED|Overall Study||197
9822527|NCT00726232|10933529|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
9822528|NCT00726232|10933530|FG001|STARTED|Initial Phase (Dose-finding)||8
9822529|NCT00726232|10933531|FG002|STARTED|Initial Phase (Dose-finding)||7
9822530|NCT00726232|10933532|FG003|STARTED|Initial Phase (Dose-finding)||8
9822531|NCT00726232|10933533|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
9822532|NCT00726232|10933534|FG005|STARTED|Initial Phase (Dose-finding)||9
9822533|NCT00726232|10933535|FG006|STARTED|Initial Phase (Dose-finding)||0
9822534|NCT00726232|10933536|FG007|STARTED|Initial Phase (Dose-finding)||0
9822535|NCT00726232|10933529|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
9822536|NCT00726232|10933530|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
9822537|NCT00726232|10933531|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
9822538|NCT00726232|10933532|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
9822539|NCT00726232|10933533|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
9822540|NCT00726232|10933534|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
9822541|NCT00726232|10933535|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
9822542|NCT00726232|10933536|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
9822543|NCT00726232|10933529|FG000|ITT Participants|Initial Phase (Dose-finding)||19
9822544|NCT00726232|10933530|FG001|ITT Participants|Initial Phase (Dose-finding)||8
9822545|NCT00726232|10933531|FG002|ITT Participants|Initial Phase (Dose-finding)||7
9822546|NCT00726232|10933532|FG003|ITT Participants|Initial Phase (Dose-finding)||8
9822547|NCT00726232|10933533|FG004|ITT Participants|Initial Phase (Dose-finding)||22
9822548|NCT00726232|10933534|FG005|ITT Participants|Initial Phase (Dose-finding)||9
9822549|NCT00726232|10933535|FG006|ITT Participants|Initial Phase (Dose-finding)||0
9822550|NCT00726232|10933536|FG007|ITT Participants|Initial Phase (Dose-finding)||0
9822551|NCT00726232|10933529|FG000|COMPLETED|Initial Phase (Dose-finding)||6
9822552|NCT00726232|10933530|FG001|COMPLETED|Initial Phase (Dose-finding)||2
9822553|NCT00726232|10933531|FG002|COMPLETED|Initial Phase (Dose-finding)||2
9822554|NCT00726232|10933532|FG003|COMPLETED|Initial Phase (Dose-finding)||0
9822555|NCT00726232|10933533|FG004|COMPLETED|Initial Phase (Dose-finding)||1
9822556|NCT00726232|10933534|FG005|COMPLETED|Initial Phase (Dose-finding)||0
9822557|NCT00726232|10933535|FG006|COMPLETED|Initial Phase (Dose-finding)||0
9822558|NCT00726232|10933536|FG007|COMPLETED|Initial Phase (Dose-finding)||0
9822559|NCT00726232|10933529|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13
9822560|NCT00726232|10933530|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6
9822561|NCT00726232|10933531|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5
9822562|NCT00726232|10933532|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8
9822563|NCT00726232|10933533|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21
9822564|NCT00726232|10933534|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9
9822565|NCT00726232|10933535|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0
9822566|NCT00726232|10933536|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0
9822567|NCT00726232|10933529|FG000|STARTED|Expansion Phase||0
9822568|NCT00726232|10933530|FG001|STARTED|Expansion Phase||0
9822569|NCT00726232|10933531|FG002|STARTED|Expansion Phase||0
9822570|NCT00726232|10933532|FG003|STARTED|Expansion Phase||0
9822571|NCT00726232|10933533|FG004|STARTED|Expansion Phase||0
9822572|NCT00726232|10933534|FG005|STARTED|Expansion Phase||0
9822573|NCT00726232|10933535|FG006|STARTED|Expansion Phase||34
9822574|NCT00726232|10933536|FG007|STARTED|Expansion Phase||39
9822575|NCT00726232|10933529|FG000|Safety Evaluable Participants|Expansion Phase||0
9822576|NCT00726232|10933530|FG001|Safety Evaluable Participants|Expansion Phase||0
9822577|NCT00726232|10933531|FG002|Safety Evaluable Participants|Expansion Phase||0
9822578|NCT00726232|10933532|FG003|Safety Evaluable Participants|Expansion Phase||0
9822579|NCT00726232|10933533|FG004|Safety Evaluable Participants|Expansion Phase||0
9822580|NCT00726232|10933534|FG005|Safety Evaluable Participants|Expansion Phase||0
9822581|NCT00726232|10933535|FG006|Safety Evaluable Participants|Expansion Phase||34
9822582|NCT00726232|10933536|FG007|Safety Evaluable Participants|Expansion Phase||39
9822583|NCT00726232|10933529|FG000|ITT Participants|Expansion Phase||0
9822584|NCT00726232|10933530|FG001|ITT Participants|Expansion Phase||0
9822585|NCT00726232|10933531|FG002|ITT Participants|Expansion Phase||0
9822586|NCT00726232|10933532|FG003|ITT Participants|Expansion Phase||0
9822587|NCT00726232|10933533|FG004|ITT Participants|Expansion Phase||0
9822588|NCT00726232|10933534|FG005|ITT Participants|Expansion Phase||0
9822589|NCT00726232|10933535|FG006|ITT Participants|Expansion Phase||34
9822590|NCT00726232|10933536|FG007|ITT Participants|Expansion Phase||39
9822591|NCT00726232|10933529|FG000|COMPLETED|Expansion Phase||0
9822592|NCT00726232|10933530|FG001|COMPLETED|Expansion Phase||0
9822593|NCT00726232|10933531|FG002|COMPLETED|Expansion Phase||0
9822594|NCT00726232|10933532|FG003|COMPLETED|Expansion Phase||0
9822595|NCT00726232|10933533|FG004|COMPLETED|Expansion Phase||0
9822596|NCT00726232|10933534|FG005|COMPLETED|Expansion Phase||0
9822597|NCT00726232|10933535|FG006|COMPLETED|Expansion Phase||10
9822598|NCT00726232|10933536|FG007|COMPLETED|Expansion Phase||1
9822599|NCT00726232|10933529|FG000|NOT COMPLETED|Expansion Phase||0
9822600|NCT00726232|10933530|FG001|NOT COMPLETED|Expansion Phase||0
9822601|NCT00726232|10933531|FG002|NOT COMPLETED|Expansion Phase||0
9822602|NCT00726232|10933532|FG003|NOT COMPLETED|Expansion Phase||0
9822603|NCT00726232|10933533|FG004|NOT COMPLETED|Expansion Phase||0
9822604|NCT00726232|10933534|FG005|NOT COMPLETED|Expansion Phase||0
9822605|NCT00726232|10933535|FG006|NOT COMPLETED|Expansion Phase||24
9822606|NCT00726232|10933536|FG007|NOT COMPLETED|Expansion Phase||38
9822607|NCT00726323|10933557|FG000|STARTED|Overall Study||37
9822608|NCT00726323|10933558|FG001|STARTED|Overall Study||37
9822609|NCT00726323|10933557|FG000|COMPLETED|Overall Study||0
9822610|NCT00726323|10933558|FG001|COMPLETED|Overall Study||6
9822611|NCT00726323|10933557|FG000|NOT COMPLETED|Overall Study||37
9822612|NCT00726323|10933558|FG001|NOT COMPLETED|Overall Study||31
9822613|NCT00726375|10933564|FG000|STARTED|Overall Study||34
9822614|NCT00726375|10933564|FG000|COMPLETED|Overall Study||34
9822615|NCT00726375|10933564|FG000|NOT COMPLETED|Overall Study||0
9822616|NCT00726388|10933568|FG000|STARTED|Overall Study||1050
9822617|NCT00726388|10933568|FG000|Treated|Overall Study||971
9822618|NCT00726388|10933568|FG000|COMPLETED|Overall Study||943
9822619|NCT00726388|10933568|FG000|NOT COMPLETED|Overall Study||107
9822620|NCT00726414|10933572|FG000|STARTED|First Intervention||11
9822621|NCT00726414|10933573|FG001|STARTED|First Intervention||11
9822622|NCT00726414|10933572|FG000|COMPLETED|First Intervention||11
9822623|NCT00726414|10933573|FG001|COMPLETED|First Intervention||11
9822624|NCT00726414|10933572|FG000|NOT COMPLETED|First Intervention||0
9822625|NCT00726414|10933573|FG001|NOT COMPLETED|First Intervention||0
9822626|NCT00726414|10933572|FG000|STARTED|Washout Period of 7 Days||11
9822627|NCT00726414|10933573|FG001|STARTED|Washout Period of 7 Days||11
9822628|NCT00726414|10933572|FG000|COMPLETED|Washout Period of 7 Days||11
9822629|NCT00726414|10933573|FG001|COMPLETED|Washout Period of 7 Days||11
9822630|NCT00726414|10933572|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9822631|NCT00726414|10933573|FG001|NOT COMPLETED|Washout Period of 7 Days||0
9822632|NCT00726414|10933572|FG000|STARTED|Second Intervention||11
9822633|NCT00726414|10933573|FG001|STARTED|Second Intervention||11
9822634|NCT00726414|10933572|FG000|COMPLETED|Second Intervention||11
9822635|NCT00726414|10933573|FG001|COMPLETED|Second Intervention||11
9822636|NCT00726414|10933572|FG000|NOT COMPLETED|Second Intervention||0
9822637|NCT00726414|10933573|FG001|NOT COMPLETED|Second Intervention||0
9822638|NCT00726453|10933581|FG000|STARTED|Primary Enrollment Group||1402
9822639|NCT00726453|10933582|FG001|STARTED|Primary Enrollment Group||0
9822640|NCT00726453|10933581|FG000|COMPLETED|Primary Enrollment Group||1371
9822641|NCT00726453|10933582|FG001|COMPLETED|Primary Enrollment Group||0
9822642|NCT00726453|10933581|FG000|NOT COMPLETED|Primary Enrollment Group||31
9822643|NCT00726453|10933582|FG001|NOT COMPLETED|Primary Enrollment Group||0
9822644|NCT00726453|10933581|FG000|STARTED|38 mm Length Group||0
9822645|NCT00726453|10933582|FG001|STARTED|38 mm Length Group||114
9822646|NCT00726453|10933581|FG000|COMPLETED|38 mm Length Group||0
9822647|NCT00726453|10933582|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
9822648|NCT00726453|10933581|FG000|NOT COMPLETED|38 mm Length Group||0
9822649|NCT00726453|10933582|FG001|NOT COMPLETED|38 mm Length Group||3
9822650|NCT00726557|10933587|FG000|STARTED|Overall Study||246
9822651|NCT00726557|10933587|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
9822652|NCT00726557|10933587|FG000|NOT COMPLETED|Overall Study||128
9822653|NCT00726609|10933592|FG000|STARTED|Overall Study||214
9822654|NCT00726609|10933592|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
9822655|NCT00726609|10933592|FG000|NOT COMPLETED|Overall Study||98
9822656|NCT00726622|10933598|FG000|STARTED|Overall Study||243
9822657|NCT00726622|10933599|FG001|STARTED|Overall Study||243
9822658|NCT00726622|10933598|FG000|COMPLETED|Overall Study||225
9822659|NCT00726622|10933599|FG001|COMPLETED|Overall Study||240
9822660|NCT00726622|10933598|FG000|NOT COMPLETED|Overall Study||18
9822661|NCT00726622|10933599|FG001|NOT COMPLETED|Overall Study||3
9822662|NCT00726661|10933607|FG000|STARTED|Overall Study||832
9822663|NCT00726661|10933608|FG001|STARTED|Overall Study||435
9822664|NCT00726661|10933607|FG000|COMPLETED|Overall Study||18
9822665|NCT00726661|10933608|FG001|COMPLETED|Overall Study||17
9822666|NCT00726661|10933607|FG000|NOT COMPLETED|Overall Study||814
9822667|NCT00726661|10933608|FG001|NOT COMPLETED|Overall Study||418
9822668|NCT00726713|10933617|FG000|STARTED|Overall Study||106
9822669|NCT00726713|10933618|FG001|STARTED|Overall Study||108
9822670|NCT00726713|10933617|FG000|COMPLETED|Overall Study||99
9822671|NCT00726713|10933618|FG001|COMPLETED|Overall Study||101
9822672|NCT00726713|10933617|FG000|NOT COMPLETED|Overall Study||7
9822673|NCT00726713|10933618|FG001|NOT COMPLETED|Overall Study||7
9822674|NCT00726739|10933627|FG000|STARTED|Overall Study||11
9822675|NCT00726739|10933628|FG001|STARTED|Overall Study||10
9822676|NCT00726739|10933627|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
9822677|NCT00726739|10933628|FG001|COMPLETED|Overall Study||10
9822678|NCT00726739|10933627|FG000|NOT COMPLETED|Overall Study||1
9822679|NCT00726739|10933628|FG001|NOT COMPLETED|Overall Study||0
9822680|NCT00726752|10933635|FG000|STARTED|Overall Study||6
9822681|NCT00726752|10933635|FG000|COMPLETED|Overall Study||0
9822682|NCT00726752|10933635|FG000|NOT COMPLETED|Overall Study||6
9822683|NCT00726882|10933639|FG000|STARTED|Overall Study||35
9822684|NCT00726882|10933639|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
9822685|NCT00726882|10933639|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
9822686|NCT00726882|10933639|FG000|COMPLETED|Overall Study||13
9822687|NCT00726882|10933639|FG000|NOT COMPLETED|Overall Study||22
9822688|NCT00726895|10933645|FG000|STARTED|First Intervention||12
9822689|NCT00726895|10933646|FG001|STARTED|First Intervention||12
9822690|NCT00726895|10933645|FG000|COMPLETED|First Intervention||12
9822691|NCT00726895|10933646|FG001|COMPLETED|First Intervention||12
9822692|NCT00726895|10933645|FG000|NOT COMPLETED|First Intervention||0
9822693|NCT00726895|10933646|FG001|NOT COMPLETED|First Intervention||0
9822694|NCT00726895|10933645|FG000|STARTED|Washout Period of 7 Days||12
9822695|NCT00726895|10933646|FG001|STARTED|Washout Period of 7 Days||12
9822696|NCT00726895|10933645|FG000|COMPLETED|Washout Period of 7 Days||12
9822697|NCT00726895|10933646|FG001|COMPLETED|Washout Period of 7 Days||11
9822698|NCT00726895|10933645|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9822699|NCT00726895|10933646|FG001|NOT COMPLETED|Washout Period of 7 Days||1
9822700|NCT00726895|10933645|FG000|STARTED|Second Intervention||12
9822701|NCT00726895|10933646|FG001|STARTED|Second Intervention||11
9822702|NCT00726895|10933645|FG000|COMPLETED|Second Intervention||12
9822703|NCT00726895|10933646|FG001|COMPLETED|Second Intervention||11
9822704|NCT00726895|10933645|FG000|NOT COMPLETED|Second Intervention||0
9822705|NCT00726895|10933646|FG001|NOT COMPLETED|Second Intervention||0
9822706|NCT00726986|10933653|FG000|STARTED|Induction Phase||18
9822707|NCT00726986|10933653|FG000|Maintance|Induction Phase||3
9822708|NCT00726986|10933653|FG000|COMPLETED|Induction Phase||3
9822709|NCT00726986|10933653|FG000|NOT COMPLETED|Induction Phase||15
9822710|NCT00726986|10933653|FG000|STARTED|Maintenance Phase||3
9822711|NCT00726986|10933653|FG000|COMPLETED|Maintenance Phase||0
9822712|NCT00726986|10933653|FG000|NOT COMPLETED|Maintenance Phase||3
9822713|NCT00726999|10933659|FG000|STARTED|Overall Study||32
9822714|NCT00726999|10933660|FG001|STARTED|Overall Study||31
9822715|NCT00726999|10933659|FG000|COMPLETED|Overall Study||29
9822716|NCT00726999|10933660|FG001|COMPLETED|Overall Study||30
9822717|NCT00726999|10933659|FG000|NOT COMPLETED|Overall Study||3
9822718|NCT00726999|10933660|FG001|NOT COMPLETED|Overall Study||1
9822719|NCT00727025|10933668|FG000|STARTED|Overall Study||74
9822720|NCT00727025|10933668|FG000|COMPLETED|Overall Study||51
9822721|NCT00727025|10933668|FG000|NOT COMPLETED|Overall Study||23
9822722|NCT00727064|10933678|FG000|STARTED|Overall Study||7
9822723|NCT00727064|10933679|FG001|STARTED|Overall Study||7
9822724|NCT00727064|10933678|FG000|COMPLETED|Overall Study||7
9822725|NCT00727064|10933679|FG001|COMPLETED|Overall Study||7
9822726|NCT00727064|10933678|FG000|NOT COMPLETED|Overall Study||0
9822727|NCT00727064|10933679|FG001|NOT COMPLETED|Overall Study||0
9822728|NCT00727194|10933685|FG000|STARTED|Screening Period||7
9822729|NCT00727194|10933686|FG001|STARTED|Screening Period||7
9822730|NCT00727194|10933687|FG002|STARTED|Screening Period||16
9822731|NCT00727194|10933685|FG000|COMPLETED|Screening Period||7
9822732|NCT00727194|10933686|FG001|COMPLETED|Screening Period||7
9822733|NCT00727194|10933687|FG002|COMPLETED|Screening Period||0
9822734|NCT00727194|10933685|FG000|NOT COMPLETED|Screening Period||0
9822735|NCT00727194|10933686|FG001|NOT COMPLETED|Screening Period||0
9822736|NCT00727194|10933687|FG002|NOT COMPLETED|Screening Period||16
9822737|NCT00727194|10933685|FG000|STARTED|Treatment Period 1||7
9822738|NCT00727194|10933686|FG001|STARTED|Treatment Period 1||7
9822739|NCT00727194|10933687|FG002|STARTED|Treatment Period 1||0
9822740|NCT00727194|10933685|FG000|COMPLETED|Treatment Period 1||7
9822741|NCT00727194|10933686|FG001|COMPLETED|Treatment Period 1||7
9822742|NCT00727194|10933687|FG002|COMPLETED|Treatment Period 1||0
9822743|NCT00727194|10933685|FG000|NOT COMPLETED|Treatment Period 1||0
9822744|NCT00727194|10933686|FG001|NOT COMPLETED|Treatment Period 1||0
9822745|NCT00727194|10933687|FG002|NOT COMPLETED|Treatment Period 1||0
9822746|NCT00727194|10933685|FG000|STARTED|Washout Period||7
9822747|NCT00727194|10933686|FG001|STARTED|Washout Period||7
9822748|NCT00727194|10933687|FG002|STARTED|Washout Period||0
9822749|NCT00727194|10933685|FG000|COMPLETED|Washout Period||7
9822750|NCT00727194|10933686|FG001|COMPLETED|Washout Period||7
9822751|NCT00727194|10933687|FG002|COMPLETED|Washout Period||0
9822752|NCT00727194|10933685|FG000|NOT COMPLETED|Washout Period||0
9822753|NCT00727194|10933686|FG001|NOT COMPLETED|Washout Period||0
9822754|NCT00727194|10933687|FG002|NOT COMPLETED|Washout Period||0
9822755|NCT00727194|10933685|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
9822756|NCT00727194|10933686|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
9822757|NCT00727194|10933687|FG002|STARTED|Treatment Period 2||0
9822758|NCT00727194|10933685|FG000|COMPLETED|Treatment Period 2||6
9822759|NCT00727194|10933686|FG001|COMPLETED|Treatment Period 2||5
9822760|NCT00727194|10933687|FG002|COMPLETED|Treatment Period 2||0
9822761|NCT00727194|10933685|FG000|NOT COMPLETED|Treatment Period 2||0
9822762|NCT00727194|10933686|FG001|NOT COMPLETED|Treatment Period 2||1
9822763|NCT00727194|10933687|FG002|NOT COMPLETED|Treatment Period 2||0
9822764|NCT00727220|10933703|FG000|STARTED|Overall Study||21
9822765|NCT00727220|10933704|FG001|STARTED|Overall Study||21
9822766|NCT00727220|10933703|FG000|COMPLETED|Overall Study||20
9822767|NCT00727220|10933704|FG001|COMPLETED|Overall Study||17
9822768|NCT00727220|10933703|FG000|NOT COMPLETED|Overall Study||1
9822769|NCT00727220|10933704|FG001|NOT COMPLETED|Overall Study||4
9822770|NCT00727246|10933714|FG000|STARTED|Overall Study||3
9822771|NCT00727246|10933715|FG001|STARTED|Overall Study||3
9822772|NCT00727246|10933716|FG002|STARTED|Overall Study||8
9822773|NCT00727246|10933717|FG003|STARTED|Overall Study||5
9822774|NCT00727246|10933714|FG000|COMPLETED|Overall Study||3
9822775|NCT00727246|10933715|FG001|COMPLETED|Overall Study||2
9822776|NCT00727246|10933716|FG002|COMPLETED|Overall Study||7
9822777|NCT00727246|10933717|FG003|COMPLETED|Overall Study||3
9822778|NCT00727246|10933714|FG000|NOT COMPLETED|Overall Study||0
9822779|NCT00727246|10933715|FG001|NOT COMPLETED|Overall Study||1
9822780|NCT00727246|10933716|FG002|NOT COMPLETED|Overall Study||1
9822781|NCT00727246|10933717|FG003|NOT COMPLETED|Overall Study||2
9822782|NCT00727259|10933727|FG000|STARTED|Overall Study||1995
9822783|NCT00727259|10933727|FG000|COMPLETED|Overall Study||940
9822784|NCT00727259|10933727|FG000|NOT COMPLETED|Overall Study||1055
9822785|NCT00727272|10933732|FG000|STARTED|Period I||9
9822786|NCT00727272|10933733|FG001|STARTED|Period I||9
9822787|NCT00727272|10933734|FG002|STARTED|Period I||9
9822788|NCT00727272|10933732|FG000|COMPLETED|Period I||9
9822789|NCT00727272|10933733|FG001|COMPLETED|Period I||9
9822790|NCT00727272|10933734|FG002|COMPLETED|Period I||9
9822791|NCT00727272|10933732|FG000|NOT COMPLETED|Period I||0
9822792|NCT00727272|10933733|FG001|NOT COMPLETED|Period I||0
9822793|NCT00727272|10933734|FG002|NOT COMPLETED|Period I||0
9822794|NCT00727272|10933732|FG000|STARTED|Washout Period A||9
9822795|NCT00727272|10933733|FG001|STARTED|Washout Period A||9
9822796|NCT00727272|10933734|FG002|STARTED|Washout Period A||9
9822797|NCT00727272|10933732|FG000|COMPLETED|Washout Period A||9
9822798|NCT00727272|10933733|FG001|COMPLETED|Washout Period A||9
9822799|NCT00727272|10933734|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
9822800|NCT00727272|10933732|FG000|NOT COMPLETED|Washout Period A||0
9822801|NCT00727272|10933733|FG001|NOT COMPLETED|Washout Period A||0
9822802|NCT00727272|10933734|FG002|NOT COMPLETED|Washout Period A||1
9822803|NCT00727272|10933732|FG000|STARTED|Period II||9
9822804|NCT00727272|10933733|FG001|STARTED|Period II||9
9822805|NCT00727272|10933734|FG002|STARTED|Period II||8
9822806|NCT00727272|10933732|FG000|COMPLETED|Period II||9
9822807|NCT00727272|10933733|FG001|COMPLETED|Period II||9
9822808|NCT00727272|10933734|FG002|COMPLETED|Period II||8
9822809|NCT00727272|10933732|FG000|NOT COMPLETED|Period II||0
9822810|NCT00727272|10933733|FG001|NOT COMPLETED|Period II||0
9822811|NCT00727272|10933734|FG002|NOT COMPLETED|Period II||0
9822812|NCT00727272|10933732|FG000|STARTED|Washout Period B||9
9822813|NCT00727272|10933733|FG001|STARTED|Washout Period B||9
9822814|NCT00727272|10933734|FG002|STARTED|Washout Period B||8
9822815|NCT00727272|10933732|FG000|COMPLETED|Washout Period B||9
9822816|NCT00727272|10933733|FG001|COMPLETED|Washout Period B||9
9822817|NCT00727272|10933734|FG002|COMPLETED|Washout Period B|personal reasons|7
9822818|NCT00727272|10933732|FG000|NOT COMPLETED|Washout Period B||0
9822819|NCT00727272|10933733|FG001|NOT COMPLETED|Washout Period B||0
9822820|NCT00727272|10933734|FG002|NOT COMPLETED|Washout Period B||1
9822821|NCT00727272|10933732|FG000|STARTED|Period III||9
9822822|NCT00727272|10933733|FG001|STARTED|Period III||9
9822823|NCT00727272|10933734|FG002|STARTED|Period III||7
9822824|NCT00727272|10933732|FG000|COMPLETED|Period III||9
9822825|NCT00727272|10933733|FG001|COMPLETED|Period III||9
9822826|NCT00727272|10933734|FG002|COMPLETED|Period III||7
9822827|NCT00727272|10933732|FG000|NOT COMPLETED|Period III||0
9822828|NCT00727272|10933733|FG001|NOT COMPLETED|Period III||0
9822829|NCT00727272|10933734|FG002|NOT COMPLETED|Period III||0
9822830|NCT00727298|10933744|FG000|STARTED|Overall Study||4485
9822831|NCT00727298|10933744|FG000|COMPLETED|Overall Study||3228
9822832|NCT00727298|10933744|FG000|NOT COMPLETED|Overall Study||1257
9822833|NCT00727311|10933748|FG000|STARTED|Overall Study||2302
9822834|NCT00727311|10933748|FG000|COMPLETED|Overall Study||1195
9822835|NCT00727311|10933748|FG000|NOT COMPLETED|Overall Study||1107
9822836|NCT00727337|10933756|FG000|STARTED|Overall Study||68
9822837|NCT00727337|10933757|FG001|STARTED|Overall Study||65
9822838|NCT00727337|10933758|FG002|STARTED|Overall Study||73
9822839|NCT00727337|10933759|FG003|STARTED|Overall Study||73
9822840|NCT00727337|10933756|FG000|COMPLETED|Overall Study||61
9822841|NCT00727337|10933757|FG001|COMPLETED|Overall Study||55
9822842|NCT00727337|10933758|FG002|COMPLETED|Overall Study||63
9822843|NCT00727337|10933759|FG003|COMPLETED|Overall Study||64
9822844|NCT00727337|10933756|FG000|NOT COMPLETED|Overall Study||7
9822845|NCT00727337|10933757|FG001|NOT COMPLETED|Overall Study||10
9822846|NCT00727337|10933758|FG002|NOT COMPLETED|Overall Study||10
9822847|NCT00727337|10933759|FG003|NOT COMPLETED|Overall Study||9
9822848|NCT00727402|10933774|FG000|STARTED|Overall Study||205
9822849|NCT00727402|10933774|FG000|COMPLETED|Overall Study||89
9822850|NCT00727402|10933774|FG000|NOT COMPLETED|Overall Study||116
9822851|NCT00727415|10933778|FG000|STARTED|Phase I||9
9822852|NCT00727415|10933778|FG000|COMPLETED|Phase I||7
9822853|NCT00727415|10933778|FG000|NOT COMPLETED|Phase I||2
9822854|NCT00727415|10933778|FG000|STARTED|Phase II||33
9822855|NCT00727415|10933778|FG000|COMPLETED|Phase II||33
9822856|NCT00727415|10933778|FG000|NOT COMPLETED|Phase II||0
9822857|NCT00727441|10933785|FG000|STARTED|Overall Study||29
9822858|NCT00727441|10933786|FG001|STARTED|Overall Study||28
9822859|NCT00727441|10933787|FG002|STARTED|Overall Study||30
9822860|NCT00727441|10933785|FG000|COMPLETED|Overall Study||11
9822861|NCT00727441|10933786|FG001|COMPLETED|Overall Study||6
9822862|NCT00727441|10933787|FG002|COMPLETED|Overall Study||5
9822863|NCT00727441|10933785|FG000|NOT COMPLETED|Overall Study||18
9822864|NCT00727441|10933786|FG001|NOT COMPLETED|Overall Study||22
9822865|NCT00727441|10933787|FG002|NOT COMPLETED|Overall Study||25
9822866|NCT00727506|10933804|FG000|STARTED|Overall Study|Entered|6
9822867|NCT00727506|10933805|FG001|STARTED|Overall Study|Entered|8
9822868|NCT00727506|10933806|FG002|STARTED|Overall Study|Entered|18
9822869|NCT00727506|10933807|FG003|STARTED|Overall Study|Randomized|39
9822870|NCT00727506|10933808|FG004|STARTED|Overall Study|Randomized|41
9822871|NCT00727506|10933809|FG005|STARTED|Overall Study|Randomized|39
9822872|NCT00727506|10933804|FG000|COMPLETED|Overall Study||0
9822873|NCT00727506|10933805|FG001|COMPLETED|Overall Study||0
9822874|NCT00727506|10933806|FG002|COMPLETED|Overall Study||0
9822875|NCT00727506|10933807|FG003|COMPLETED|Overall Study||0
9822876|NCT00727506|10933808|FG004|COMPLETED|Overall Study||0
9822877|NCT00727506|10933809|FG005|COMPLETED|Overall Study||0
9822878|NCT00727506|10933804|FG000|NOT COMPLETED|Overall Study||6
9822879|NCT00727506|10933805|FG001|NOT COMPLETED|Overall Study||8
9822880|NCT00727506|10933806|FG002|NOT COMPLETED|Overall Study||18
9822881|NCT00727506|10933807|FG003|NOT COMPLETED|Overall Study||39
9822882|NCT00727506|10933808|FG004|NOT COMPLETED|Overall Study||41
9822883|NCT00727506|10933809|FG005|NOT COMPLETED|Overall Study||39
9822884|NCT00727532|10933829|FG000|STARTED|Overall Study||9
9822885|NCT00727532|10933829|FG000|COMPLETED|Overall Study||7
9822886|NCT00727532|10933829|FG000|NOT COMPLETED|Overall Study||2
9822887|NCT00727558|10933835|FG000|STARTED|Overall Study||127
9822888|NCT00727558|10933836|FG001|STARTED|Overall Study||121
9822889|NCT00727558|10933835|FG000|COMPLETED|Overall Study||125
9822890|NCT00727558|10933836|FG001|COMPLETED|Overall Study||118
9822891|NCT00727558|10933835|FG000|NOT COMPLETED|Overall Study||2
9822892|NCT00727558|10933836|FG001|NOT COMPLETED|Overall Study||3
9822893|NCT00727571|10933846|FG000|STARTED|Overall Study||232
9822894|NCT00727571|10933847|FG001|STARTED|Overall Study||228
9822895|NCT00727571|10933848|FG002|STARTED|Overall Study||165
9822896|NCT00727571|10933849|FG003|STARTED|Overall Study||169
9822897|NCT00727571|10933846|FG000|COMPLETED|Overall Study||231
9822898|NCT00727571|10933847|FG001|COMPLETED|Overall Study||173
9822899|NCT00727571|10933848|FG002|COMPLETED|Overall Study||135
9822900|NCT00727571|10933849|FG003|COMPLETED|Overall Study||163
9822901|NCT00727571|10933846|FG000|NOT COMPLETED|Overall Study||1
9822902|NCT00727571|10933847|FG001|NOT COMPLETED|Overall Study||55
9822903|NCT00727571|10933848|FG002|NOT COMPLETED|Overall Study||30
9822904|NCT00727571|10933849|FG003|NOT COMPLETED|Overall Study||6
9822905|NCT00727597|10933861|FG000|STARTED|Overall Study||51
9822906|NCT00727597|10933862|FG001|STARTED|Overall Study||50
9822907|NCT00727597|10933861|FG000|COMPLETED|Overall Study||51
9822908|NCT00727597|10933862|FG001|COMPLETED|Overall Study||50
9822909|NCT00727597|10933861|FG000|NOT COMPLETED|Overall Study||0
9822910|NCT00727597|10933862|FG001|NOT COMPLETED|Overall Study||0
9822911|NCT00727636|10933870|FG000|STARTED|Overall Study||37
9822912|NCT00727636|10933871|FG001|STARTED|Overall Study||15
9822913|NCT00727636|10933870|FG000|COMPLETED|Overall Study||33
9822914|NCT00727636|10933871|FG001|COMPLETED|Overall Study||15
9822915|NCT00727636|10933870|FG000|NOT COMPLETED|Overall Study||4
9822916|NCT00727636|10933871|FG001|NOT COMPLETED|Overall Study||0
9822917|NCT00727649|10933879|FG000|STARTED|First Intervention (4-weeks)||37
9822918|NCT00727649|10933880|FG001|STARTED|First Intervention (4-weeks)||43
9822919|NCT00727649|10933879|FG000|COMPLETED|First Intervention (4-weeks)||34
9822920|NCT00727649|10933880|FG001|COMPLETED|First Intervention (4-weeks)||40
9822921|NCT00727649|10933879|FG000|NOT COMPLETED|First Intervention (4-weeks)||3
9822922|NCT00727649|10933880|FG001|NOT COMPLETED|First Intervention (4-weeks)||3
9822923|NCT00727649|10933879|FG000|STARTED|Wash-out (2-weeks)||34
9822924|NCT00727649|10933880|FG001|STARTED|Wash-out (2-weeks)||40
9822925|NCT00727649|10933879|FG000|COMPLETED|Wash-out (2-weeks)||30
9822926|NCT00727649|10933880|FG001|COMPLETED|Wash-out (2-weeks)||37
9822927|NCT00727649|10933879|FG000|NOT COMPLETED|Wash-out (2-weeks)||4
9822928|NCT00727649|10933880|FG001|NOT COMPLETED|Wash-out (2-weeks)||3
9822929|NCT00727649|10933879|FG000|STARTED|Second Intervention (4-weeks)||30
9822930|NCT00727649|10933880|FG001|STARTED|Second Intervention (4-weeks)||37
9822931|NCT00727649|10933879|FG000|COMPLETED|Second Intervention (4-weeks)||29
9822932|NCT00727649|10933880|FG001|COMPLETED|Second Intervention (4-weeks)||34
9822933|NCT00727649|10933879|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1
9822934|NCT00727649|10933880|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3
9822935|NCT00727714|10933888|FG000|STARTED|Overall Study||95
9822936|NCT00727714|10933888|FG000|COMPLETED|Overall Study||93
9822937|NCT00727714|10933888|FG000|NOT COMPLETED|Overall Study||2
9822938|NCT00727740|10933894|FG000|STARTED|Overall Study||56
9822939|NCT00727740|10933895|FG001|STARTED|Overall Study||61
9822940|NCT00727740|10933894|FG000|COMPLETED|Overall Study||56
9822941|NCT00727740|10933895|FG001|COMPLETED|Overall Study||61
9822942|NCT00727740|10933894|FG000|NOT COMPLETED|Overall Study||0
9822943|NCT00727740|10933895|FG001|NOT COMPLETED|Overall Study||0
9822944|NCT00727844|10933903|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
9822945|NCT00727844|10933904|FG001|STARTED|Initial Randomization||20
9822946|NCT00727844|10933905|FG002|STARTED|Initial Randomization||0
9822947|NCT00727844|10933906|FG003|STARTED|Initial Randomization||0
9822948|NCT00727844|10933903|FG000|Included in MITT Analysis|Initial Randomization||19
9822949|NCT00727844|10933904|FG001|Included in MITT Analysis|Initial Randomization||20
9822950|NCT00727844|10933905|FG002|Included in MITT Analysis|Initial Randomization||0
9822951|NCT00727844|10933906|FG003|Included in MITT Analysis|Initial Randomization||0
9822952|NCT00727844|10933903|FG000|COMPLETED|Initial Randomization||19
9822953|NCT00727844|10933904|FG001|COMPLETED|Initial Randomization||20
9822954|NCT00727844|10933905|FG002|COMPLETED|Initial Randomization||0
9822955|NCT00727844|10933906|FG003|COMPLETED|Initial Randomization||0
9822956|NCT00727844|10933903|FG000|NOT COMPLETED|Initial Randomization||2
9822957|NCT00727844|10933904|FG001|NOT COMPLETED|Initial Randomization||0
9822958|NCT00727844|10933905|FG002|NOT COMPLETED|Initial Randomization||0
9822959|NCT00727844|10933906|FG003|NOT COMPLETED|Initial Randomization||0
9822960|NCT00727844|10933903|FG000|STARTED|Second Randomization||0
9822961|NCT00727844|10933904|FG001|STARTED|Second Randomization||0
9822962|NCT00727844|10933905|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
9822963|NCT00727844|10933906|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
9822964|NCT00727844|10933903|FG000|COMPLETED|Second Randomization||0
9822965|NCT00727844|10933904|FG001|COMPLETED|Second Randomization||0
9822966|NCT00727844|10933905|FG002|COMPLETED|Second Randomization||17
9822967|NCT00727844|10933906|FG003|COMPLETED|Second Randomization||16
9822968|NCT00727844|10933903|FG000|NOT COMPLETED|Second Randomization||0
9822969|NCT00727844|10933904|FG001|NOT COMPLETED|Second Randomization||0
9822970|NCT00727844|10933905|FG002|NOT COMPLETED|Second Randomization||0
9822971|NCT00727844|10933906|FG003|NOT COMPLETED|Second Randomization||0
9822972|NCT00727857|10933914|FG000|STARTED|Overall Study||201
9822973|NCT00727857|10933915|FG001|STARTED|Overall Study||189
9822974|NCT00727857|10933916|FG002|STARTED|Overall Study||210
9822975|NCT00727857|10933914|FG000|COMPLETED|Overall Study||157
9822976|NCT00727857|10933915|FG001|COMPLETED|Overall Study||125
9822977|NCT00727857|10933916|FG002|COMPLETED|Overall Study||142
9822978|NCT00727857|10933914|FG000|NOT COMPLETED|Overall Study||44
9822979|NCT00727857|10933915|FG001|NOT COMPLETED|Overall Study||64
9822980|NCT00727857|10933916|FG002|NOT COMPLETED|Overall Study||68
9832167|NCT00771810|10942887|FG002|NOT COMPLETED|Overall Study||7
9832168|NCT00771849|10942898|FG000|STARTED|Overall Study||52
9832169|NCT00771849|10942899|FG001|STARTED|Overall Study|One subject was not vaccinated|51
9832170|NCT00771849|10942898|FG000|COMPLETED|Overall Study||50
9832171|NCT00771849|10942899|FG001|COMPLETED|Overall Study||47
9832172|NCT00771849|10942898|FG000|NOT COMPLETED|Overall Study||2
9832173|NCT00771849|10942899|FG001|NOT COMPLETED|Overall Study||4
9832174|NCT00771875|10942908|FG000|STARTED|Overall Study||10
9832175|NCT00771875|10942909|FG001|STARTED|Overall Study||10
9832176|NCT00771875|10942910|FG002|STARTED|Overall Study||10
9832177|NCT00771875|10942908|FG000|COMPLETED|Overall Study||10
9832178|NCT00771875|10942909|FG001|COMPLETED|Overall Study||9
9832179|NCT00771875|10942910|FG002|COMPLETED|Overall Study||10
9832180|NCT00771875|10942908|FG000|NOT COMPLETED|Overall Study||0
9832181|NCT00771875|10942909|FG001|NOT COMPLETED|Overall Study||1
9832182|NCT00771875|10942910|FG002|NOT COMPLETED|Overall Study||0
9832183|NCT00771901|10942921|FG000|STARTED|Overall Study||10
9832184|NCT00771901|10942922|FG001|STARTED|Overall Study||10
9832185|NCT00771901|10942923|FG002|STARTED|Overall Study||10
9832186|NCT00771901|10942921|FG000|COMPLETED|Overall Study||10
9832187|NCT00771901|10942922|FG001|COMPLETED|Overall Study||10
9832188|NCT00771901|10942923|FG002|COMPLETED|Overall Study||6
9832189|NCT00771901|10942921|FG000|NOT COMPLETED|Overall Study||0
9832190|NCT00771901|10942922|FG001|NOT COMPLETED|Overall Study||0
9832191|NCT00771901|10942923|FG002|NOT COMPLETED|Overall Study||4
9832192|NCT00771914|10942935|FG000|STARTED|Overall Study||7
9832193|NCT00771914|10942936|FG001|STARTED|Overall Study||6
9832194|NCT00771914|10942937|FG002|STARTED|Overall Study||6
9832195|NCT00771914|10942938|FG003|STARTED|Overall Study||8
9832196|NCT00771914|10942935|FG000|COMPLETED|Overall Study||7
9832197|NCT00771914|10942936|FG001|COMPLETED|Overall Study||6
9832198|NCT00771914|10942937|FG002|COMPLETED|Overall Study||6
9832199|NCT00771914|10942938|FG003|COMPLETED|Overall Study||6
9832200|NCT00771914|10942935|FG000|NOT COMPLETED|Overall Study||0
9832201|NCT00771914|10942936|FG001|NOT COMPLETED|Overall Study||0
9832202|NCT00771914|10942937|FG002|NOT COMPLETED|Overall Study||0
9832203|NCT00771914|10942938|FG003|NOT COMPLETED|Overall Study||2
9832204|NCT00771927|10942950|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
9832205|NCT00771927|10942951|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
9832206|NCT00771927|10942950|FG000|COMPLETED|Overall Study||256
9832207|NCT00771927|10942951|FG001|COMPLETED|Overall Study||256
9832208|NCT00771927|10942950|FG000|NOT COMPLETED|Overall Study||255
9832209|NCT00771927|10942951|FG001|NOT COMPLETED|Overall Study||237
9832210|NCT00771953|10942959|FG000|STARTED|Overall Study||36
9832211|NCT00771953|10942960|FG001|STARTED|Overall Study||36
9832212|NCT00771953|10942959|FG000|COMPLETED|Overall Study||26
9832213|NCT00771953|10942960|FG001|COMPLETED|Overall Study||26
9832214|NCT00771953|10942959|FG000|NOT COMPLETED|Overall Study||10
9832215|NCT00771953|10942960|FG001|NOT COMPLETED|Overall Study||10
9822981|NCT00727909|10933925|FG000|STARTED|Overall Study||65
9822982|NCT00727909|10933926|FG001|STARTED|Overall Study||72
9822983|NCT00727909|10933927|FG002|STARTED|Overall Study||67
9822984|NCT00727909|10933928|FG003|STARTED|Overall Study||75
9822985|NCT00727909|10933925|FG000|COMPLETED|Overall Study||60
9822986|NCT00727909|10933926|FG001|COMPLETED|Overall Study||61
9822987|NCT00727909|10933927|FG002|COMPLETED|Overall Study||58
9822988|NCT00727909|10933928|FG003|COMPLETED|Overall Study||70
9822989|NCT00727909|10933925|FG000|NOT COMPLETED|Overall Study||5
9822990|NCT00727909|10933926|FG001|NOT COMPLETED|Overall Study||11
9822991|NCT00727909|10933927|FG002|NOT COMPLETED|Overall Study||9
9822992|NCT00727909|10933928|FG003|NOT COMPLETED|Overall Study||5
9822993|NCT00727961|10933932|FG000|STARTED|Overall Study||58
9822994|NCT00727961|10933932|FG000|COMPLETED|Overall Study||21
9822995|NCT00727961|10933932|FG000|NOT COMPLETED|Overall Study||37
9822996|NCT00728130|10933936|FG000|STARTED|Overall Study||22
9822997|NCT00728130|10933936|FG000|COMPLETED|Overall Study||19
9822998|NCT00728130|10933936|FG000|NOT COMPLETED|Overall Study||3
9822999|NCT00728182|10933942|FG000|STARTED|Overall Study||92
9823000|NCT00728182|10933943|FG001|STARTED|Overall Study||93
9823001|NCT00728182|10933942|FG000|COMPLETED|Overall Study||89
9823002|NCT00728182|10933943|FG001|COMPLETED|Overall Study||90
9823003|NCT00728182|10933942|FG000|NOT COMPLETED|Overall Study||3
9823004|NCT00728182|10933943|FG001|NOT COMPLETED|Overall Study||3
9823005|NCT00728260|10933951|FG000|STARTED|Overall Study||1421
9823006|NCT00728260|10933951|FG000|COMPLETED|Overall Study||1421
9823007|NCT00728260|10933951|FG000|NOT COMPLETED|Overall Study||0
9823008|NCT00728468|10933955|FG000|STARTED|Overall Study||16
9823009|NCT00728468|10933955|FG000|Treated|Overall Study||15
9823010|NCT00728468|10933955|FG000|COMPLETED|Overall Study||0
9823011|NCT00728468|10933955|FG000|NOT COMPLETED|Overall Study||16
9823012|NCT00728481|10933961|FG000|STARTED|Overall Study||19
9823013|NCT00728481|10933962|FG001|STARTED|Overall Study||32
9823014|NCT00728481|10933961|FG000|COMPLETED|Overall Study||18
9823015|NCT00728481|10933962|FG001|COMPLETED|Overall Study||28
9823016|NCT00728481|10933961|FG000|NOT COMPLETED|Overall Study||1
9823017|NCT00728481|10933962|FG001|NOT COMPLETED|Overall Study||4
9823018|NCT00728494|10933970|FG000|STARTED|Overall Study||60
9823019|NCT00728494|10933971|FG001|STARTED|Overall Study||39
9823020|NCT00728494|10933970|FG000|COMPLETED|Overall Study||51
9823021|NCT00728494|10933971|FG001|COMPLETED|Overall Study||32
9823022|NCT00728494|10933970|FG000|NOT COMPLETED|Overall Study||9
9823023|NCT00728494|10933971|FG001|NOT COMPLETED|Overall Study||7
9823024|NCT00728507|10933979|FG000|STARTED|Overall Study||62
9823025|NCT00728507|10933980|FG001|STARTED|Overall Study||59
9823026|NCT00728507|10933979|FG000|COMPLETED|Overall Study||60
9823027|NCT00728507|10933980|FG001|COMPLETED|Overall Study||51
9823028|NCT00728507|10933979|FG000|NOT COMPLETED|Overall Study||2
9823029|NCT00728507|10933980|FG001|NOT COMPLETED|Overall Study||8
9823030|NCT00728689|10933988|FG000|STARTED|First Intervention (Days 1 - 3)||6
9823031|NCT00728689|10933989|FG001|STARTED|First Intervention (Days 1 - 3)||6
9823032|NCT00728689|10933988|FG000|COMPLETED|First Intervention (Days 1 - 3)||6
9823033|NCT00728689|10933989|FG001|COMPLETED|First Intervention (Days 1 - 3)||6
9823034|NCT00728689|10933988|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0
9823035|NCT00728689|10933989|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0
9823036|NCT00728689|10933988|FG000|STARTED|Washout Period (Days 4 - 10)||6
9823037|NCT00728689|10933989|FG001|STARTED|Washout Period (Days 4 - 10)||6
9823038|NCT00728689|10933988|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
9823039|NCT00728689|10933989|FG001|COMPLETED|Washout Period (Days 4 - 10)||6
9823040|NCT00728689|10933988|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1
9823041|NCT00728689|10933989|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0
9823042|NCT00728689|10933988|FG000|STARTED|Second Intervention (Days 11 - 13)||5
9823043|NCT00728689|10933989|FG001|STARTED|Second Intervention (Days 11 - 13)||6
10017129|NCT01814072|11139938|FG031|COMPLETED|Overall Study||17
10017130|NCT01814072|11139907|FG000|NOT COMPLETED|Overall Study||4
10017131|NCT01814072|11139908|FG001|NOT COMPLETED|Overall Study||2
10236803|NCT00815633|11367543|FG000|NOT COMPLETED|Overall Study||1
10236804|NCT00814983|11367549|FG000|STARTED|Overall Study||15
9823044|NCT00728689|10933988|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5
9823045|NCT00728689|10933989|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6
9823046|NCT00728689|10933988|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
9823047|NCT00728689|10933989|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
9823048|NCT00728728|10933999|FG000|STARTED|Overall Study||42
9823049|NCT00728728|10934000|FG001|STARTED|Overall Study||46
9823050|NCT00728728|10933999|FG000|COMPLETED|Overall Study||38
9823051|NCT00728728|10934000|FG001|COMPLETED|Overall Study||34
9823052|NCT00728728|10933999|FG000|NOT COMPLETED|Overall Study||4
9823053|NCT00728728|10934000|FG001|NOT COMPLETED|Overall Study||12
9823054|NCT00728819|10934009|FG000|STARTED|Overall Study||171
10017132|NCT01814072|11139909|FG002|NOT COMPLETED|Overall Study||3
10017133|NCT01814072|11139910|FG003|NOT COMPLETED|Overall Study||0
9823055|NCT00728819|10934010|FG001|STARTED|Overall Study||168
9823056|NCT00728819|10934009|FG000|COMPLETED|Overall Study||135
9823057|NCT00728819|10934010|FG001|COMPLETED|Overall Study||139
9823058|NCT00728819|10934009|FG000|NOT COMPLETED|Overall Study||36
9823059|NCT00728819|10934010|FG001|NOT COMPLETED|Overall Study||29
9823060|NCT00728910|10934016|FG000|STARTED|Atorvastatin||25
9823061|NCT00728910|10934016|FG000|COMPLETED|Atorvastatin||22
9823062|NCT00728910|10934016|FG000|NOT COMPLETED|Atorvastatin||3
9823063|NCT00728910|10934016|FG000|STARTED|Atorvastatin+ABT335||22
9823064|NCT00728910|10934016|FG000|COMPLETED|Atorvastatin+ABT335||22
9823065|NCT00728910|10934016|FG000|NOT COMPLETED|Atorvastatin+ABT335||0
9823066|NCT00728910|10934016|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22
9823067|NCT00728910|10934016|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
9823068|NCT00728910|10934016|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
9823069|NCT00728923|10934025|FG000|STARTED|Overall Study||9
9823070|NCT00728923|10934025|FG000|COMPLETED|Overall Study||9
9823071|NCT00728923|10934025|FG000|NOT COMPLETED|Overall Study||0
9823072|NCT00728936|10934036|FG000|STARTED|Overall Study||10
9823073|NCT00728936|10934037|FG001|STARTED|Overall Study||8
9823074|NCT00728936|10934038|FG002|STARTED|Overall Study||9
9823075|NCT00728936|10934039|FG003|STARTED|Overall Study||8
9823076|NCT00728936|10934040|FG004|STARTED|Overall Study||8
9823077|NCT00728936|10934041|FG005|STARTED|Overall Study||8
9823078|NCT00728936|10934042|FG006|STARTED|Overall Study||7
9823079|NCT00728936|10934036|FG000|COMPLETED|Overall Study||10
9823080|NCT00728936|10934037|FG001|COMPLETED|Overall Study||8
9823081|NCT00728936|10934038|FG002|COMPLETED|Overall Study||9
9823082|NCT00728936|10934039|FG003|COMPLETED|Overall Study||8
9823083|NCT00728936|10934040|FG004|COMPLETED|Overall Study||8
9823084|NCT00728936|10934041|FG005|COMPLETED|Overall Study||7
9823085|NCT00728936|10934042|FG006|COMPLETED|Overall Study||7
9823086|NCT00728936|10934036|FG000|NOT COMPLETED|Overall Study||0
9823087|NCT00728936|10934037|FG001|NOT COMPLETED|Overall Study||0
9823088|NCT00728936|10934038|FG002|NOT COMPLETED|Overall Study||0
9823089|NCT00728936|10934039|FG003|NOT COMPLETED|Overall Study||0
9823090|NCT00728936|10934040|FG004|NOT COMPLETED|Overall Study||0
9823091|NCT00728936|10934041|FG005|NOT COMPLETED|Overall Study||1
9823092|NCT00728936|10934042|FG006|NOT COMPLETED|Overall Study||0
9823093|NCT00728949|10934060|FG000|STARTED|Overall Study||62
9823094|NCT00728949|10934061|FG001|STARTED|Overall Study||31
9823095|NCT00728949|10934060|FG000|COMPLETED|Overall Study||51
9823096|NCT00728949|10934061|FG001|COMPLETED|Overall Study||27
9823097|NCT00728949|10934060|FG000|NOT COMPLETED|Overall Study||11
9823098|NCT00728949|10934061|FG001|NOT COMPLETED|Overall Study||4
9823099|NCT00728988|10934069|FG000|STARTED|Overall Study||247
9823100|NCT00728988|10934070|FG001|STARTED|Overall Study||252
9823101|NCT00728988|10934069|FG000|Treated|Overall Study||245
9823102|NCT00728988|10934070|FG001|Treated|Overall Study||250
9823103|NCT00728988|10934069|FG000|Full Analysis Set|Overall Study||163
9823104|NCT00728988|10934070|FG001|Full Analysis Set|Overall Study||172
9823105|NCT00728988|10934069|FG000|COMPLETED|Overall Study||154
9823106|NCT00728988|10934070|FG001|COMPLETED|Overall Study||164
9823107|NCT00728988|10934069|FG000|NOT COMPLETED|Overall Study||93
9823108|NCT00728988|10934070|FG001|NOT COMPLETED|Overall Study||88
9823109|NCT00729053|10934081|FG000|STARTED|Overall Study||23
9823110|NCT00729053|10934082|FG001|STARTED|Overall Study||23
9823111|NCT00729053|10934083|FG002|STARTED|Overall Study||23
9823112|NCT00729053|10934084|FG003|STARTED|Overall Study||23
9823113|NCT00729053|10934081|FG000|COMPLETED|Overall Study||23
9823114|NCT00729053|10934082|FG001|COMPLETED|Overall Study||23
9823115|NCT00729053|10934083|FG002|COMPLETED|Overall Study||23
9823116|NCT00729053|10934084|FG003|COMPLETED|Overall Study||23
9823117|NCT00729053|10934081|FG000|NOT COMPLETED|Overall Study||0
9823118|NCT00729053|10934082|FG001|NOT COMPLETED|Overall Study||0
9823119|NCT00729053|10934083|FG002|NOT COMPLETED|Overall Study||0
9823120|NCT00729053|10934084|FG003|NOT COMPLETED|Overall Study||0
9823121|NCT00729157|10934094|FG000|STARTED|Overall Study||41
9823122|NCT00729157|10934094|FG000|COMPLETED|Overall Study||40
9823123|NCT00729157|10934094|FG000|NOT COMPLETED|Overall Study||1
9823124|NCT00729183|10934100|FG000|STARTED|Overall Study||109
9823125|NCT00729183|10934101|FG001|STARTED|Overall Study||105
9823126|NCT00729183|10934100|FG000|COMPLETED|Overall Study|Completed 24 month visit|84
9823127|NCT00729183|10934101|FG001|COMPLETED|Overall Study|Completed 24 month visit|90
9823128|NCT00729183|10934100|FG000|NOT COMPLETED|Overall Study||25
9823129|NCT00729183|10934101|FG001|NOT COMPLETED|Overall Study||15
9823130|NCT00729248|10934107|FG000|STARTED|Overall Study||12
10236805|NCT00814983|11367550|FG001|STARTED|Overall Study||0
10236806|NCT00814983|11367549|FG000|COMPLETED|Overall Study||12
10236807|NCT00814983|11367550|FG001|COMPLETED|Overall Study||0
10236808|NCT00814983|11367549|FG000|NOT COMPLETED|Overall Study||3
10236809|NCT00814983|11367550|FG001|NOT COMPLETED|Overall Study||0
10236810|NCT00825227|11367558|FG000|STARTED|Overall Study||6
9823131|NCT00729248|10934107|FG000|COMPLETED|Overall Study||10
9823132|NCT00729248|10934107|FG000|NOT COMPLETED|Overall Study||2
9823133|NCT00729326|10934114|FG000|STARTED|Overall Study||41
9823134|NCT00729326|10934115|FG001|STARTED|Overall Study||42
9823135|NCT00729326|10934114|FG000|COMPLETED|Overall Study||31
9823136|NCT00729326|10934115|FG001|COMPLETED|Overall Study||33
9823137|NCT00729326|10934114|FG000|NOT COMPLETED|Overall Study||10
9823138|NCT00729326|10934115|FG001|NOT COMPLETED|Overall Study||9
9823139|NCT00729378|10934123|FG000|STARTED|Baseline||430
9823140|NCT00729378|10934124|FG001|STARTED|Baseline||309
9823141|NCT00729378|10934123|FG000|COMPLETED|Baseline||292
9823142|NCT00729378|10934124|FG001|COMPLETED|Baseline||217
9823143|NCT00729378|10934123|FG000|NOT COMPLETED|Baseline||138
9823144|NCT00729378|10934124|FG001|NOT COMPLETED|Baseline||92
10236811|NCT00825227|11367559|FG001|STARTED|Overall Study||4
9823145|NCT00729378|10934123|FG000|STARTED|12-months||292
9823146|NCT00729378|10934124|FG001|STARTED|12-months||217
9823147|NCT00729378|10934123|FG000|COMPLETED|12-months||192
9823148|NCT00729378|10934124|FG001|COMPLETED|12-months||152
9823149|NCT00729378|10934123|FG000|NOT COMPLETED|12-months||100
9823150|NCT00729378|10934124|FG001|NOT COMPLETED|12-months||65
9823151|NCT00729378|10934123|FG000|STARTED|24-months||192
9823152|NCT00729378|10934124|FG001|STARTED|24-months||152
9823153|NCT00729378|10934123|FG000|COMPLETED|24-months||120
9823154|NCT00729378|10934124|FG001|COMPLETED|24-months||101
9823155|NCT00729378|10934123|FG000|NOT COMPLETED|24-months||72
9823156|NCT00729378|10934124|FG001|NOT COMPLETED|24-months||51
9823157|NCT00729378|10934123|FG000|STARTED|36-months||120
9823158|NCT00729378|10934124|FG001|STARTED|36-months||101
9823159|NCT00729378|10934123|FG000|COMPLETED|36-months||105
9823160|NCT00729378|10934124|FG001|COMPLETED|36-months||95
9823161|NCT00729378|10934123|FG000|NOT COMPLETED|36-months||15
9823162|NCT00729378|10934124|FG001|NOT COMPLETED|36-months||6
9823163|NCT00729430|10934135|FG000|STARTED|Overall Study||180
9823164|NCT00729430|10934136|FG001|STARTED|Overall Study||178
9823165|NCT00729430|10934135|FG000|COMPLETED|Overall Study||133
9823166|NCT00729430|10934136|FG001|COMPLETED|Overall Study||128
9823167|NCT00729430|10934135|FG000|NOT COMPLETED|Overall Study||47
9823168|NCT00729430|10934136|FG001|NOT COMPLETED|Overall Study||50
9823169|NCT00729469|10934145|FG000|STARTED|Overall Study||456
9823170|NCT00729469|10934146|FG001|STARTED|Overall Study||463
9823171|NCT00729469|10934145|FG000|COMPLETED|Overall Study||403
9823172|NCT00729469|10934146|FG001|COMPLETED|Overall Study||416
9823173|NCT00729469|10934145|FG000|NOT COMPLETED|Overall Study||53
9823174|NCT00729469|10934146|FG001|NOT COMPLETED|Overall Study||47
9823175|NCT00729482|10934152|FG000|STARTED|Overall Study||54
9823176|NCT00729482|10934152|FG000|COMPLETED|Overall Study||54
9823177|NCT00729482|10934152|FG000|NOT COMPLETED|Overall Study||0
9823178|NCT00729521|10934159|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
9823179|NCT00729521|10934160|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
9823180|NCT00729521|10934161|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
9823181|NCT00729521|10934159|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
9823182|NCT00729521|10934160|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
9823183|NCT00729521|10934161|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
9823184|NCT00729521|10934159|FG000|NOT COMPLETED|Overall Study||0
9823185|NCT00729521|10934160|FG001|NOT COMPLETED|Overall Study||0
9823186|NCT00729521|10934161|FG002|NOT COMPLETED|Overall Study||0
9823187|NCT00729586|10934171|FG000|STARTED|Overall Study||51
9823188|NCT00729586|10934172|FG001|STARTED|Overall Study||22
9823189|NCT00729586|10934171|FG000|COMPLETED|Overall Study|Eligible and treated patients|50
9823190|NCT00729586|10934172|FG001|COMPLETED|Overall Study|Eligible and treated patients|21
9823191|NCT00729586|10934171|FG000|NOT COMPLETED|Overall Study||1
9823192|NCT00729586|10934172|FG001|NOT COMPLETED|Overall Study||1
9823193|NCT00729612|10934179|FG000|STARTED|Overall Study||63
9823194|NCT00729612|10934179|FG000|Died Before Cycle 1|Overall Study||1
9823195|NCT00729612|10934179|FG000|Received Cycle 1|Overall Study||62
9823196|NCT00729612|10934179|FG000|Did Not Receive Cycle 2|Overall Study||7
9823197|NCT00729612|10934179|FG000|Received Cycle 2|Overall Study||54
9823198|NCT00729612|10934179|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1
9823199|NCT00729612|10934179|FG000|COMPLETED|Overall Study||53
9823200|NCT00729612|10934179|FG000|NOT COMPLETED|Overall Study||10
9823201|NCT00729677|10934183|FG000|STARTED|Overall Study||64
9823202|NCT00729677|10934183|FG000|COMPLETED|Overall Study||64
9823203|NCT00729677|10934183|FG000|NOT COMPLETED|Overall Study||0
9823204|NCT00729690|10934197|FG000|STARTED|Overall Study||16
10112451|NCT02503332|11243428|FG001|STARTED|Overall Study||79
10112452|NCT02503332|11243429|FG002|STARTED|Overall Study||41
10112453|NCT02503332|11243430|FG003|STARTED|Overall Study||40
10112454|NCT02503332|11243427|FG000|COMPLETED|Overall Study||52
10112455|NCT02503332|11243428|FG001|COMPLETED|Overall Study||60
10112456|NCT02503332|11243429|FG002|COMPLETED|Overall Study||33
10112457|NCT02503332|11243430|FG003|COMPLETED|Overall Study||36
9823205|NCT00729690|10934198|FG001|STARTED|Overall Study||16
9823206|NCT00729690|10934199|FG002|STARTED|Overall Study||16
9823207|NCT00729690|10934197|FG000|COMPLETED|Overall Study||16
9823208|NCT00729690|10934198|FG001|COMPLETED|Overall Study||14
9823209|NCT00729690|10934199|FG002|COMPLETED|Overall Study||14
9823210|NCT00729690|10934197|FG000|NOT COMPLETED|Overall Study||0
9823211|NCT00729690|10934198|FG001|NOT COMPLETED|Overall Study||2
9823212|NCT00729690|10934199|FG002|NOT COMPLETED|Overall Study||2
9823213|NCT00729781|10934207|FG000|STARTED|Original Study||45
9823214|NCT00729781|10934207|FG000|COMPLETED|Original Study||45
9823215|NCT00729781|10934207|FG000|NOT COMPLETED|Original Study||0
9823216|NCT00729781|10934207|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
9823217|NCT00729781|10934207|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
9823218|NCT00729781|10934207|FG000|NOT COMPLETED|Long-term Follow-up Study||0
9823219|NCT00729807|10934211|FG000|STARTED|Overall Study||6
9823220|NCT00729807|10934211|FG000|COMPLETED|Overall Study||6
9823221|NCT00729807|10934211|FG000|NOT COMPLETED|Overall Study||0
9823222|NCT00729833|10934215|FG000|STARTED|Overall Study||20
10112458|NCT02503332|11243427|FG000|NOT COMPLETED|Overall Study||34
9823223|NCT00729833|10934216|FG001|STARTED|Overall Study||7
9823224|NCT00729833|10934217|FG002|STARTED|Overall Study||12
10112459|NCT02503332|11243428|FG001|NOT COMPLETED|Overall Study||19
9823225|NCT00729833|10934218|FG003|STARTED|Overall Study||6
9823226|NCT00729833|10934215|FG000|COMPLETED|Overall Study||0
9823227|NCT00729833|10934216|FG001|COMPLETED|Overall Study||0
9823228|NCT00729833|10934217|FG002|COMPLETED|Overall Study||0
9823229|NCT00729833|10934218|FG003|COMPLETED|Overall Study||0
9823230|NCT00729833|10934215|FG000|NOT COMPLETED|Overall Study||20
9823231|NCT00729833|10934216|FG001|NOT COMPLETED|Overall Study||7
9823232|NCT00729833|10934217|FG002|NOT COMPLETED|Overall Study||12
9823233|NCT00729833|10934218|FG003|NOT COMPLETED|Overall Study||6
9823234|NCT00729846|10934231|FG000|STARTED|Overall Study||11
9823235|NCT00729846|10934232|FG001|STARTED|Overall Study||11
9823236|NCT00729846|10934231|FG000|COMPLETED|Overall Study||11
9823237|NCT00729846|10934232|FG001|COMPLETED|Overall Study||11
9823238|NCT00729846|10934231|FG000|NOT COMPLETED|Overall Study||0
9823239|NCT00729846|10934232|FG001|NOT COMPLETED|Overall Study||0
9823240|NCT00729859|10934241|FG000|STARTED|Overall Study||8
9823241|NCT00729859|10934242|FG001|STARTED|Overall Study||8
9823242|NCT00729859|10934243|FG002|STARTED|Overall Study||8
9823243|NCT00729859|10934241|FG000|COMPLETED|Overall Study||8
9823244|NCT00729859|10934242|FG001|COMPLETED|Overall Study||6
9823245|NCT00729859|10934243|FG002|COMPLETED|Overall Study||8
9823246|NCT00729859|10934241|FG000|NOT COMPLETED|Overall Study||0
9823247|NCT00729859|10934242|FG001|NOT COMPLETED|Overall Study||2
9823248|NCT00729859|10934243|FG002|NOT COMPLETED|Overall Study||0
9823249|NCT00729924|10934259|FG000|STARTED|Overall Study||40
9823250|NCT00729924|10934259|FG000|COMPLETED|Overall Study||40
9823251|NCT00729924|10934259|FG000|NOT COMPLETED|Overall Study||0
9823252|NCT00729937|10934272|FG000|STARTED|Overall Study||629
9823253|NCT00729937|10934273|FG001|STARTED|Overall Study||636
9823254|NCT00729937|10934274|FG002|STARTED|Overall Study||251
9823255|NCT00729937|10934275|FG003|STARTED|Overall Study||249
9823256|NCT00729937|10934276|FG004|STARTED|Overall Study||249
9823257|NCT00729937|10934277|FG005|STARTED|Overall Study||251
9823258|NCT00729937|10934272|FG000|COMPLETED|Overall Study||555
9823259|NCT00729937|10934273|FG001|COMPLETED|Overall Study||548
9823260|NCT00729937|10934274|FG002|COMPLETED|Overall Study||222
9823261|NCT00729937|10934275|FG003|COMPLETED|Overall Study||215
9823262|NCT00729937|10934276|FG004|COMPLETED|Overall Study||221
9823263|NCT00729937|10934277|FG005|COMPLETED|Overall Study||214
9823264|NCT00729937|10934272|FG000|NOT COMPLETED|Overall Study||74
9823265|NCT00729937|10934273|FG001|NOT COMPLETED|Overall Study||88
9823266|NCT00729937|10934274|FG002|NOT COMPLETED|Overall Study||29
9823267|NCT00729937|10934275|FG003|NOT COMPLETED|Overall Study||34
9823268|NCT00729937|10934276|FG004|NOT COMPLETED|Overall Study||28
9823269|NCT00729937|10934277|FG005|NOT COMPLETED|Overall Study||37
9823270|NCT00730015|10934294|FG000|STARTED|Overall Study||217
9823271|NCT00730015|10934295|FG001|STARTED|Overall Study||217
9823272|NCT00730015|10934296|FG002|STARTED|Overall Study||209
9823273|NCT00730015|10934294|FG000|COMPLETED|Overall Study||186
9823274|NCT00730015|10934295|FG001|COMPLETED|Overall Study||177
9823275|NCT00730015|10934296|FG002|COMPLETED|Overall Study||177
9823276|NCT00730015|10934294|FG000|NOT COMPLETED|Overall Study||31
9823277|NCT00730015|10934295|FG001|NOT COMPLETED|Overall Study||40
9823278|NCT00730015|10934296|FG002|NOT COMPLETED|Overall Study||32
9823279|NCT00730028|10934314|FG000|STARTED|Overall Study||264
9823280|NCT00730028|10934315|FG001|STARTED|Overall Study||260
9823281|NCT00730028|10934316|FG002|STARTED|Overall Study||266
9823282|NCT00730028|10934317|FG003|STARTED|Overall Study||263
9823283|NCT00730028|10934318|FG004|STARTED|Overall Study||257
10017134|NCT01814072|11139911|FG004|NOT COMPLETED|Overall Study||4
10017135|NCT01814072|11139912|FG005|NOT COMPLETED|Overall Study||6
10017136|NCT01814072|11139913|FG006|NOT COMPLETED|Overall Study||4
10017137|NCT01814072|11139914|FG007|NOT COMPLETED|Overall Study||1
10017138|NCT01814072|11139915|FG008|NOT COMPLETED|Overall Study||3
10017139|NCT01814072|11139916|FG009|NOT COMPLETED|Overall Study||5
10017140|NCT01814072|11139917|FG010|NOT COMPLETED|Overall Study||1
10017141|NCT01814072|11139918|FG011|NOT COMPLETED|Overall Study||2
10017142|NCT01814072|11139919|FG012|NOT COMPLETED|Overall Study||3
10017143|NCT01814072|11139920|FG013|NOT COMPLETED|Overall Study||2
9823284|NCT00730028|10934314|FG000|COMPLETED|Overall Study||204
9823285|NCT00730028|10934315|FG001|COMPLETED|Overall Study||194
9823286|NCT00730028|10934316|FG002|COMPLETED|Overall Study||221
9823287|NCT00730028|10934317|FG003|COMPLETED|Overall Study||207
9823288|NCT00730028|10934318|FG004|COMPLETED|Overall Study||175
9823289|NCT00730028|10934314|FG000|NOT COMPLETED|Overall Study||60
9823290|NCT00730028|10934315|FG001|NOT COMPLETED|Overall Study||66
9823291|NCT00730028|10934316|FG002|NOT COMPLETED|Overall Study||45
9823292|NCT00730028|10934317|FG003|NOT COMPLETED|Overall Study||56
9823293|NCT00730028|10934318|FG004|NOT COMPLETED|Overall Study||82
9823294|NCT00730041|10934332|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
9823295|NCT00730041|10934333|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
9823296|NCT00730041|10934332|FG000|COMPLETED|Overall Study||26
9823297|NCT00730041|10934333|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
9823298|NCT00730041|10934332|FG000|NOT COMPLETED|Overall Study||0
9823299|NCT00730041|10934333|FG001|NOT COMPLETED|Overall Study||2
9823300|NCT00730158|10934341|FG000|STARTED|Overall Study||17
9823301|NCT00730158|10934342|FG001|STARTED|Overall Study||16
9823302|NCT00730158|10934341|FG000|COMPLETED|Overall Study||16
9823303|NCT00730158|10934342|FG001|COMPLETED|Overall Study||15
10017144|NCT01814072|11139921|FG014|NOT COMPLETED|Overall Study||3
10017145|NCT01814072|11139922|FG015|NOT COMPLETED|Overall Study||2
9823304|NCT00730158|10934341|FG000|NOT COMPLETED|Overall Study||1
9823305|NCT00730158|10934342|FG001|NOT COMPLETED|Overall Study||1
9823306|NCT00730171|10934352|FG000|STARTED|Overall Study||1725
9823307|NCT00730171|10934352|FG000|CC Safety Population|Overall Study||607
9823308|NCT00730171|10934352|FG000|IBS-C Safety Population|Overall Study||1119
9823309|NCT00730171|10934352|FG000|COMPLETED|Overall Study||954
9823310|NCT00730171|10934352|FG000|NOT COMPLETED|Overall Study||771
9823311|NCT00730236|10934360|FG000|STARTED|Overall Study||29
9823312|NCT00730236|10934360|FG000|COMPLETED|Overall Study||23
9823313|NCT00730236|10934360|FG000|NOT COMPLETED|Overall Study||6
9823314|NCT00730275|10934368|FG000|STARTED|Overall Study||9
9823315|NCT00730275|10934369|FG001|STARTED|Overall Study||9
9823316|NCT00730275|10934370|FG002|STARTED|Overall Study||8
9823317|NCT00730275|10934371|FG003|STARTED|Overall Study||9
9823318|NCT00730275|10934368|FG000|COMPLETED|Overall Study||9
9823319|NCT00730275|10934369|FG001|COMPLETED|Overall Study||9
9823320|NCT00730275|10934370|FG002|COMPLETED|Overall Study||8
9823321|NCT00730275|10934371|FG003|COMPLETED|Overall Study||8
9823322|NCT00730275|10934368|FG000|NOT COMPLETED|Overall Study||0
9823323|NCT00730275|10934369|FG001|NOT COMPLETED|Overall Study||0
9823324|NCT00730275|10934370|FG002|NOT COMPLETED|Overall Study||0
9823325|NCT00730275|10934371|FG003|NOT COMPLETED|Overall Study||1
9823326|NCT00730327|10934384|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
9823327|NCT00730327|10934385|FG001|STARTED|Overall Study||130
9823328|NCT00730327|10934384|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
9823329|NCT00730327|10934385|FG001|Completed Week 26|Overall Study||99
9823330|NCT00730327|10934384|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
9823331|NCT00730327|10934385|FG001|COMPLETED|Overall Study||93
9823332|NCT00730327|10934384|FG000|NOT COMPLETED|Overall Study||27
9823333|NCT00730327|10934385|FG001|NOT COMPLETED|Overall Study||37
9823334|NCT00730353|10934391|FG000|STARTED|Overall Study||28
9823335|NCT00730353|10934391|FG000|COMPLETED|Overall Study||28
9823336|NCT00730353|10934391|FG000|NOT COMPLETED|Overall Study||0
9823337|NCT00730405|10934400|FG000|STARTED|Overall Study-Treatment Phase||116
9823338|NCT00730405|10934401|FG001|STARTED|Overall Study-Treatment Phase||117
9823339|NCT00730405|10934402|FG002|STARTED|Overall Study-Treatment Phase||117
10017146|NCT01814072|11139923|FG016|NOT COMPLETED|Overall Study||3
10017147|NCT01814072|11139924|FG017|NOT COMPLETED|Overall Study||1
10017148|NCT01814072|11139925|FG018|NOT COMPLETED|Overall Study||3
10017149|NCT01814072|11139926|FG019|NOT COMPLETED|Overall Study||5
10017150|NCT01814072|11139927|FG020|NOT COMPLETED|Overall Study||2
10017151|NCT01814072|11139928|FG021|NOT COMPLETED|Overall Study||1
9823340|NCT00730405|10934403|FG003|STARTED|Overall Study-Treatment Phase||117
9823341|NCT00730405|10934404|FG004|STARTED|Overall Study-Treatment Phase||115
9823342|NCT00730405|10934400|FG000|COMPLETED|Overall Study-Treatment Phase||97
9823343|NCT00730405|10934401|FG001|COMPLETED|Overall Study-Treatment Phase||96
9823344|NCT00730405|10934402|FG002|COMPLETED|Overall Study-Treatment Phase||96
9823345|NCT00730405|10934403|FG003|COMPLETED|Overall Study-Treatment Phase||98
9823346|NCT00730405|10934404|FG004|COMPLETED|Overall Study-Treatment Phase||95
9823347|NCT00730405|10934400|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19
9823348|NCT00730405|10934401|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21
9823349|NCT00730405|10934402|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21
9823350|NCT00730405|10934403|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19
9823351|NCT00730405|10934404|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20
9823352|NCT00730405|10934400|FG000|STARTED|Overall Study-follow-up Phase||116
9823353|NCT00730405|10934401|FG001|STARTED|Overall Study-follow-up Phase||117
9823354|NCT00730405|10934402|FG002|STARTED|Overall Study-follow-up Phase||117
9823355|NCT00730405|10934403|FG003|STARTED|Overall Study-follow-up Phase||117
9823356|NCT00730405|10934404|FG004|STARTED|Overall Study-follow-up Phase||115
9823357|NCT00730405|10934400|FG000|COMPLETED|Overall Study-follow-up Phase||95
9823358|NCT00730405|10934401|FG001|COMPLETED|Overall Study-follow-up Phase||96
9823359|NCT00730405|10934402|FG002|COMPLETED|Overall Study-follow-up Phase||94
10017152|NCT01814072|11139929|FG022|NOT COMPLETED|Overall Study||4
10017153|NCT01814072|11139930|FG023|NOT COMPLETED|Overall Study||1
10017154|NCT01814072|11139931|FG024|NOT COMPLETED|Overall Study||6
10017155|NCT01814072|11139932|FG025|NOT COMPLETED|Overall Study||2
9823360|NCT00730405|10934403|FG003|COMPLETED|Overall Study-follow-up Phase||100
9823361|NCT00730405|10934404|FG004|COMPLETED|Overall Study-follow-up Phase||93
9823362|NCT00730405|10934400|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21
9823363|NCT00730405|10934401|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21
9823364|NCT00730405|10934402|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23
9823365|NCT00730405|10934403|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17
9823366|NCT00730405|10934404|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22
9823367|NCT00730483|10934418|FG000|STARTED|Overall Study||13
9823368|NCT00730483|10934418|FG000|1 Month After First DEB-TACE|Overall Study||13
9823369|NCT00730483|10934418|FG000|6 Months After First DEB-TACE|Overall Study||10
9823370|NCT00730483|10934418|FG000|COMPLETED|Overall Study||6
9823371|NCT00730483|10934418|FG000|NOT COMPLETED|Overall Study||7
9823372|NCT00730522|10934425|FG000|STARTED|Overall Study||28
9823373|NCT00730522|10934426|FG001|STARTED|Overall Study||27
9823374|NCT00730522|10934425|FG000|COMPLETED|Overall Study||28
10017156|NCT01814072|11139933|FG026|NOT COMPLETED|Overall Study||2
9823375|NCT00730522|10934426|FG001|COMPLETED|Overall Study||27
9823376|NCT00730522|10934425|FG000|NOT COMPLETED|Overall Study||0
9823377|NCT00730522|10934426|FG001|NOT COMPLETED|Overall Study||0
9823378|NCT00730691|10934439|FG000|STARTED|Overall Study||157
9823379|NCT00730691|10934440|FG001|STARTED|Overall Study||156
9823380|NCT00730691|10934441|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
9823381|NCT00730691|10934442|FG003|STARTED|Overall Study||156
9823382|NCT00730691|10934443|FG004|STARTED|Overall Study||156
9823383|NCT00730691|10934439|FG000|COMPLETED|Overall Study||121
9823384|NCT00730691|10934440|FG001|COMPLETED|Overall Study||120
9823385|NCT00730691|10934441|FG002|COMPLETED|Overall Study||117
9823386|NCT00730691|10934442|FG003|COMPLETED|Overall Study||111
9823387|NCT00730691|10934443|FG004|COMPLETED|Overall Study||106
9823388|NCT00730691|10934439|FG000|NOT COMPLETED|Overall Study||36
9823389|NCT00730691|10934440|FG001|NOT COMPLETED|Overall Study||36
9823390|NCT00730691|10934441|FG002|NOT COMPLETED|Overall Study||39
9823391|NCT00730691|10934442|FG003|NOT COMPLETED|Overall Study||45
9823392|NCT00730691|10934443|FG004|NOT COMPLETED|Overall Study||50
9823393|NCT00730730|10934455|FG000|STARTED|Overall Study||50
9823394|NCT00730730|10934455|FG000|COMPLETED|Overall Study||50
9823395|NCT00730730|10934455|FG000|NOT COMPLETED|Overall Study||0
9823396|NCT00730756|10934461|FG000|STARTED|Overall Study||49
9823397|NCT00730756|10934462|FG001|STARTED|Overall Study||53
9823398|NCT00730756|10934461|FG000|COMPLETED|Overall Study||45
9823399|NCT00730756|10934462|FG001|COMPLETED|Overall Study||48
9823400|NCT00730756|10934461|FG000|NOT COMPLETED|Overall Study||4
9823401|NCT00730756|10934462|FG001|NOT COMPLETED|Overall Study||5
9823402|NCT00730847|10934468|FG000|STARTED|Overall Study||596
9823403|NCT00730847|10934468|FG000|COMPLETED|Overall Study||465
9823404|NCT00730847|10934468|FG000|NOT COMPLETED|Overall Study||131
9823405|NCT00730912|10934475|FG000|STARTED|Overall Study||53
9823406|NCT00730912|10934476|FG001|STARTED|Overall Study||104
9823407|NCT00730912|10934477|FG002|STARTED|Overall Study||104
9823408|NCT00730912|10934475|FG000|COMPLETED|Overall Study||53
9823409|NCT00730912|10934476|FG001|COMPLETED|Overall Study||104
9823410|NCT00730912|10934477|FG002|COMPLETED|Overall Study||103
9823411|NCT00730912|10934475|FG000|NOT COMPLETED|Overall Study||0
9823412|NCT00730912|10934476|FG001|NOT COMPLETED|Overall Study||0
9823413|NCT00730912|10934477|FG002|NOT COMPLETED|Overall Study||1
9823414|NCT00730925|10934485|FG000|STARTED|Overall Study||41
9823415|NCT00730925|10934485|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
9823416|NCT00730925|10934485|FG000|NOT COMPLETED|Overall Study||41
9823417|NCT00730964|10934489|FG000|STARTED|Overall Study||1039
9823418|NCT00730964|10934489|FG000|COMPLETED|Overall Study||1039
9823419|NCT00730964|10934489|FG000|NOT COMPLETED|Overall Study||0
9823420|NCT00731042|10934496|FG000|STARTED|First Intervention||16
9823421|NCT00731042|10934497|FG001|STARTED|First Intervention||17
9823422|NCT00731042|10934496|FG000|COMPLETED|First Intervention||16
9823423|NCT00731042|10934497|FG001|COMPLETED|First Intervention||17
9823424|NCT00731042|10934496|FG000|NOT COMPLETED|First Intervention||0
9823425|NCT00731042|10934497|FG001|NOT COMPLETED|First Intervention||0
9823426|NCT00731042|10934496|FG000|STARTED|Wash-out||16
9823427|NCT00731042|10934497|FG001|STARTED|Wash-out||17
9823428|NCT00731042|10934496|FG000|COMPLETED|Wash-out||16
9823429|NCT00731042|10934497|FG001|COMPLETED|Wash-out||17
9823430|NCT00731042|10934496|FG000|NOT COMPLETED|Wash-out||0
10017157|NCT01814072|11139934|FG027|NOT COMPLETED|Overall Study||4
10017158|NCT01814072|11139935|FG028|NOT COMPLETED|Overall Study||4
10017159|NCT01814072|11139936|FG029|NOT COMPLETED|Overall Study||3
10017160|NCT01814072|11139937|FG030|NOT COMPLETED|Overall Study||2
9823431|NCT00731042|10934497|FG001|NOT COMPLETED|Wash-out||0
9823432|NCT00731042|10934496|FG000|STARTED|Second Intervention||16
9823433|NCT00731042|10934497|FG001|STARTED|Second Intervention||17
9823434|NCT00731042|10934496|FG000|COMPLETED|Second Intervention||16
9823435|NCT00731042|10934497|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
9823436|NCT00731042|10934496|FG000|NOT COMPLETED|Second Intervention||0
9823437|NCT00731042|10934497|FG001|NOT COMPLETED|Second Intervention||2
9823438|NCT00731055|10934503|FG000|STARTED|Overall Study|This is a within-subjects study design.|16
9823439|NCT00731055|10934503|FG000|Received Placebo|Overall Study||16
9823440|NCT00731055|10934503|FG000|Received Varenicline 0.5 mg|Overall Study||16
9823441|NCT00731055|10934503|FG000|Received Varenicline 1.0 mg|Overall Study||16
9823442|NCT00731055|10934503|FG000|Received Varenicline 2.0 mg|Overall Study||16
9823443|NCT00731055|10934503|FG000|COMPLETED|Overall Study||16
9823444|NCT00731055|10934503|FG000|NOT COMPLETED|Overall Study||0
9823445|NCT00731094|10934512|FG000|STARTED|Overall Study||116
9823446|NCT00731094|10934513|FG001|STARTED|Overall Study||116
9823447|NCT00731094|10934512|FG000|Month 6|Overall Study||101
9823448|NCT00731094|10934513|FG001|Month 6|Overall Study||107
9823449|NCT00731094|10934512|FG000|COMPLETED|Overall Study||98
9823450|NCT00731094|10934513|FG001|COMPLETED|Overall Study||105
9823451|NCT00731094|10934512|FG000|NOT COMPLETED|Overall Study||18
9823452|NCT00731094|10934513|FG001|NOT COMPLETED|Overall Study||11
9823453|NCT00731120|10934522|FG000|STARTED|Overall Study||153
9823454|NCT00731120|10934523|FG001|STARTED|Overall Study||152
10017161|NCT01814072|11139938|FG031|NOT COMPLETED|Overall Study||0
10017162|NCT01814137|11139980|FG000|STARTED|Overall Study||20
10017163|NCT01814137|11139981|FG001|STARTED|Overall Study||20
9823455|NCT00731120|10934524|FG002|STARTED|Overall Study||152
9823456|NCT00731120|10934522|FG000|Treated|Overall Study||153
9823457|NCT00731120|10934523|FG001|Treated|Overall Study||151
9823458|NCT00731120|10934524|FG002|Treated|Overall Study||152
9823459|NCT00731120|10934522|FG000|COMPLETED|Overall Study||111
9823460|NCT00731120|10934523|FG001|COMPLETED|Overall Study||109
9823461|NCT00731120|10934524|FG002|COMPLETED|Overall Study||116
9823462|NCT00731120|10934522|FG000|NOT COMPLETED|Overall Study||42
9823463|NCT00731120|10934523|FG001|NOT COMPLETED|Overall Study||43
9823464|NCT00731120|10934524|FG002|NOT COMPLETED|Overall Study||36
9823465|NCT00731133|10934532|FG000|STARTED|Overall Study||15
9823466|NCT00731133|10934532|FG000|COMPLETED|Overall Study||5
9823467|NCT00731133|10934532|FG000|NOT COMPLETED|Overall Study||10
9823468|NCT00731198|10934538|FG000|STARTED|Overall Study||325
9823469|NCT00731198|10934539|FG001|STARTED|Overall Study||325
9823470|NCT00731198|10934538|FG000|COMPLETED|Overall Study||319
9823471|NCT00731198|10934539|FG001|COMPLETED|Overall Study||319
9823472|NCT00731198|10934538|FG000|NOT COMPLETED|Overall Study||6
9823473|NCT00731198|10934539|FG001|NOT COMPLETED|Overall Study||6
9823474|NCT00731211|10934545|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
9823475|NCT00731211|10934545|FG000|COMPLETED|Overall Study||55
9823476|NCT00731211|10934545|FG000|NOT COMPLETED|Overall Study||0
9823477|NCT00731341|10934549|FG000|STARTED|Overall Study||3
9823478|NCT00731341|10934549|FG000|COMPLETED|Overall Study||3
9823479|NCT00731341|10934549|FG000|NOT COMPLETED|Overall Study||0
9823480|NCT00731484|10934553|FG000|STARTED|Overall Study||233
9823481|NCT00731484|10934553|FG000|COMPLETED|Overall Study||233
9823482|NCT00731484|10934553|FG000|NOT COMPLETED|Overall Study||0
9823483|NCT00731549|10934557|FG000|STARTED|Overall Study||1081
9823484|NCT00731549|10934557|FG000|COMPLETED|Overall Study||858
9823485|NCT00731549|10934557|FG000|NOT COMPLETED|Overall Study||223
9823486|NCT00731588|10934563|FG000|STARTED|Overall Study||9
9823487|NCT00731588|10934564|FG001|STARTED|Overall Study||95
9823488|NCT00731588|10934563|FG000|COMPLETED|Overall Study||9
9823489|NCT00731588|10934564|FG001|COMPLETED|Overall Study||53
9823490|NCT00731588|10934563|FG000|NOT COMPLETED|Overall Study||0
9823491|NCT00731588|10934564|FG001|NOT COMPLETED|Overall Study||42
9823492|NCT00731614|10934573|FG000|STARTED|Overall Study||23
9823493|NCT00731614|10934574|FG001|STARTED|Overall Study||31
9823494|NCT00731614|10934573|FG000|End of Treatment|Overall Study||16
9823495|NCT00731614|10934574|FG001|End of Treatment|Overall Study||24
9823496|NCT00731614|10934573|FG000|12 Weeks Posttreatment|Overall Study||18
9823497|NCT00731614|10934574|FG001|12 Weeks Posttreatment|Overall Study||23
9823498|NCT00731614|10934573|FG000|COMPLETED|Overall Study||16
9823499|NCT00731614|10934574|FG001|COMPLETED|Overall Study||18
9823500|NCT00731614|10934573|FG000|NOT COMPLETED|Overall Study||7
9823501|NCT00731614|10934574|FG001|NOT COMPLETED|Overall Study||13
9823502|NCT00731640|10934582|FG000|STARTED|Overall Study||20
9823503|NCT00731640|10934583|FG001|STARTED|Overall Study||32
9823504|NCT00731640|10934582|FG000|COMPLETED|Overall Study||20
9823505|NCT00731640|10934583|FG001|COMPLETED|Overall Study||32
9823506|NCT00731640|10934582|FG000|NOT COMPLETED|Overall Study||0
9823507|NCT00731640|10934583|FG001|NOT COMPLETED|Overall Study||0
9823508|NCT00731653|10934589|FG000|STARTED|Overall Study||81
9823509|NCT00731653|10934589|FG000|COMPLETED|Overall Study||72
9823510|NCT00731653|10934589|FG000|NOT COMPLETED|Overall Study||9
9823511|NCT00731666|10934593|FG000|STARTED|Overall Study||40
9823512|NCT00731666|10934593|FG000|COMPLETED|Overall Study||28
9823513|NCT00731666|10934593|FG000|NOT COMPLETED|Overall Study||12
9823514|NCT00731679|10934599|FG000|STARTED|Overall Study||314
9823515|NCT00731679|10934600|FG001|STARTED|Overall Study||309
9823516|NCT00731679|10934599|FG000|COMPLETED|Overall Study||292
9823517|NCT00731679|10934600|FG001|COMPLETED|Overall Study||283
9823518|NCT00731679|10934599|FG000|NOT COMPLETED|Overall Study||22
9823519|NCT00731679|10934600|FG001|NOT COMPLETED|Overall Study||26
9823520|NCT00731692|10934609|FG000|STARTED|Core Study (36 Months)||147
9823521|NCT00731692|10934610|FG001|STARTED|Core Study (36 Months)||336
9823522|NCT00731692|10934611|FG002|STARTED|Core Study (36 Months)||487
9823523|NCT00731692|10934609|FG000|Safety Set (SAF)|Core Study (36 Months)||0
9823524|NCT00731692|10934610|FG001|Safety Set (SAF)|Core Study (36 Months)||336
9823525|NCT00731692|10934611|FG002|Safety Set (SAF)|Core Study (36 Months)||487
9823526|NCT00731692|10934609|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0
10017164|NCT01814137|11139980|FG000|COMPLETED|Overall Study||15
10017165|NCT01814137|11139981|FG001|COMPLETED|Overall Study||15
9823527|NCT00731692|10934610|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336
9823528|NCT00731692|10934611|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487
9823529|NCT00731692|10934609|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
9823530|NCT00731692|10934610|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
9823531|NCT00731692|10934611|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
9823532|NCT00731692|10934609|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
9823533|NCT00731692|10934610|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
9823534|NCT00731692|10934611|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
9823535|NCT00731692|10934609|FG000|COMPLETED|Core Study (36 Months)||79
9823536|NCT00731692|10934610|FG001|COMPLETED|Core Study (36 Months)||220
9823537|NCT00731692|10934611|FG002|COMPLETED|Core Study (36 Months)||317
9823538|NCT00731692|10934609|FG000|NOT COMPLETED|Core Study (36 Months)||68
10017166|NCT01814137|11139980|FG000|NOT COMPLETED|Overall Study||5
9823539|NCT00731692|10934610|FG001|NOT COMPLETED|Core Study (36 Months)||116
9823540|NCT00731692|10934611|FG002|NOT COMPLETED|Core Study (36 Months)||170
9823541|NCT00731692|10934609|FG000|STARTED|Extension Phase||74
9823542|NCT00731692|10934610|FG001|STARTED|Extension Phase||196
9823543|NCT00731692|10934611|FG002|STARTED|Extension Phase||301
9823544|NCT00731692|10934609|FG000|COMPLETED|Extension Phase||0
9823545|NCT00731692|10934610|FG001|COMPLETED|Extension Phase||0
9823546|NCT00731692|10934611|FG002|COMPLETED|Extension Phase||0
9823547|NCT00731692|10934609|FG000|NOT COMPLETED|Extension Phase||74
9823548|NCT00731692|10934610|FG001|NOT COMPLETED|Extension Phase||196
9823549|NCT00731692|10934611|FG002|NOT COMPLETED|Extension Phase||301
9823550|NCT00731783|10934629|FG000|STARTED|One Month Follow-Up Visit||92
10236812|NCT00825227|11367558|FG000|COMPLETED|Overall Study||6
10236813|NCT00825227|11367559|FG001|COMPLETED|Overall Study||4
10236814|NCT00825227|11367558|FG000|NOT COMPLETED|Overall Study||0
10236815|NCT00825227|11367559|FG001|NOT COMPLETED|Overall Study||0
10236816|NCT00819832|11367573|FG000|STARTED|Overall Study|No patient data analysis.|3
10236817|NCT00819832|11367574|FG001|STARTED|Overall Study||0
9823551|NCT00731783|10934630|FG001|STARTED|One Month Follow-Up Visit||91
9823552|NCT00731783|10934629|FG000|COMPLETED|One Month Follow-Up Visit||78
9823553|NCT00731783|10934630|FG001|COMPLETED|One Month Follow-Up Visit||69
9823554|NCT00731783|10934629|FG000|NOT COMPLETED|One Month Follow-Up Visit||14
9823555|NCT00731783|10934630|FG001|NOT COMPLETED|One Month Follow-Up Visit||22
9823556|NCT00731783|10934629|FG000|STARTED|Three Month Follow-Up Visit||79
9823557|NCT00731783|10934630|FG001|STARTED|Three Month Follow-Up Visit||73
9823558|NCT00731783|10934629|FG000|COMPLETED|Three Month Follow-Up Visit||72
9823559|NCT00731783|10934630|FG001|COMPLETED|Three Month Follow-Up Visit||57
9823560|NCT00731783|10934629|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7
9823561|NCT00731783|10934630|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16
9823562|NCT00731783|10934629|FG000|STARTED|Six Month Follow-Up Visit||77
9823563|NCT00731783|10934630|FG001|STARTED|Six Month Follow-Up Visit||67
9823564|NCT00731783|10934629|FG000|COMPLETED|Six Month Follow-Up Visit||71
9823565|NCT00731783|10934630|FG001|COMPLETED|Six Month Follow-Up Visit||64
9823566|NCT00731783|10934629|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6
9823567|NCT00731783|10934630|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3
9823568|NCT00731783|10934629|FG000|STARTED|12 Month Follow-Up Visit||74
9823569|NCT00731783|10934630|FG001|STARTED|12 Month Follow-Up Visit||65
9823570|NCT00731783|10934629|FG000|COMPLETED|12 Month Follow-Up Visit||68
9823571|NCT00731783|10934630|FG001|COMPLETED|12 Month Follow-Up Visit||58
9823572|NCT00731783|10934629|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6
9823573|NCT00731783|10934630|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7
9823574|NCT00731822|10934638|FG000|STARTED|Overall Study||20
9823575|NCT00731822|10934639|FG001|STARTED|Overall Study||40
9823576|NCT00731822|10934638|FG000|COMPLETED|Overall Study||16
9823577|NCT00731822|10934639|FG001|COMPLETED|Overall Study||39
9823578|NCT00731822|10934638|FG000|NOT COMPLETED|Overall Study||4
9823579|NCT00731822|10934639|FG001|NOT COMPLETED|Overall Study||1
9823580|NCT00731874|10934647|FG000|STARTED|Overall Study||10
9823581|NCT00731874|10934648|FG001|STARTED|Overall Study||13
9823582|NCT00731874|10934647|FG000|COMPLETED|Overall Study||10
9823583|NCT00731874|10934648|FG001|COMPLETED|Overall Study||13
9823584|NCT00731874|10934647|FG000|NOT COMPLETED|Overall Study||0
9823585|NCT00731874|10934648|FG001|NOT COMPLETED|Overall Study||0
9823586|NCT00731939|10934654|FG000|STARTED|Overall Study||124
9823587|NCT00731939|10934654|FG000|COMPLETED|Overall Study||90
9823588|NCT00731939|10934654|FG000|NOT COMPLETED|Overall Study||34
9823589|NCT00732030|10934658|FG000|STARTED|Overall Study||26
9823590|NCT00732030|10934658|FG000|COMPLETED|Overall Study||24
9823591|NCT00732030|10934658|FG000|NOT COMPLETED|Overall Study||2
9823592|NCT00732069|10934662|FG000|STARTED|First Study Drug||3
9823593|NCT00732069|10934663|FG001|STARTED|First Study Drug||3
9823594|NCT00732069|10934664|FG002|STARTED|First Study Drug||3
9823595|NCT00732069|10934665|FG003|STARTED|First Study Drug||2
9823596|NCT00732069|10934666|FG004|STARTED|First Study Drug||3
9823597|NCT00732069|10934667|FG005|STARTED|First Study Drug||2
9823598|NCT00732069|10934662|FG000|COMPLETED|First Study Drug||3
9823599|NCT00732069|10934663|FG001|COMPLETED|First Study Drug||3
9823600|NCT00732069|10934664|FG002|COMPLETED|First Study Drug||3
9823601|NCT00732069|10934665|FG003|COMPLETED|First Study Drug||2
9823602|NCT00732069|10934666|FG004|COMPLETED|First Study Drug||3
9823603|NCT00732069|10934667|FG005|COMPLETED|First Study Drug||2
9823604|NCT00732069|10934662|FG000|NOT COMPLETED|First Study Drug||0
9823605|NCT00732069|10934663|FG001|NOT COMPLETED|First Study Drug||0
9823606|NCT00732069|10934664|FG002|NOT COMPLETED|First Study Drug||0
9823607|NCT00732069|10934665|FG003|NOT COMPLETED|First Study Drug||0
9823608|NCT00732069|10934666|FG004|NOT COMPLETED|First Study Drug||0
9823609|NCT00732069|10934667|FG005|NOT COMPLETED|First Study Drug||0
9823610|NCT00732069|10934662|FG000|STARTED|Washout After First Study Drug||3
9823611|NCT00732069|10934663|FG001|STARTED|Washout After First Study Drug||3
9823612|NCT00732069|10934664|FG002|STARTED|Washout After First Study Drug||3
9823613|NCT00732069|10934665|FG003|STARTED|Washout After First Study Drug||2
9823614|NCT00732069|10934666|FG004|STARTED|Washout After First Study Drug||3
9823615|NCT00732069|10934667|FG005|STARTED|Washout After First Study Drug||2
9823616|NCT00732069|10934662|FG000|COMPLETED|Washout After First Study Drug||2
9823617|NCT00732069|10934663|FG001|COMPLETED|Washout After First Study Drug||3
9823618|NCT00732069|10934664|FG002|COMPLETED|Washout After First Study Drug||3
9823619|NCT00732069|10934665|FG003|COMPLETED|Washout After First Study Drug||2
9823620|NCT00732069|10934666|FG004|COMPLETED|Washout After First Study Drug||3
9823621|NCT00732069|10934667|FG005|COMPLETED|Washout After First Study Drug||2
10236818|NCT00819832|11367575|FG002|STARTED|Overall Study||0
10236819|NCT00819832|11367576|FG003|STARTED|Overall Study||0
9823622|NCT00732069|10934662|FG000|NOT COMPLETED|Washout After First Study Drug||1
9823623|NCT00732069|10934663|FG001|NOT COMPLETED|Washout After First Study Drug||0
9823624|NCT00732069|10934664|FG002|NOT COMPLETED|Washout After First Study Drug||0
9823625|NCT00732069|10934665|FG003|NOT COMPLETED|Washout After First Study Drug||0
9823626|NCT00732069|10934666|FG004|NOT COMPLETED|Washout After First Study Drug||0
9823627|NCT00732069|10934667|FG005|NOT COMPLETED|Washout After First Study Drug||0
9823628|NCT00732069|10934662|FG000|STARTED|Second Study Drug||2
9823629|NCT00732069|10934663|FG001|STARTED|Second Study Drug||3
9823630|NCT00732069|10934664|FG002|STARTED|Second Study Drug||3
9823631|NCT00732069|10934665|FG003|STARTED|Second Study Drug||2
9823632|NCT00732069|10934666|FG004|STARTED|Second Study Drug||3
9823633|NCT00732069|10934667|FG005|STARTED|Second Study Drug||2
9823634|NCT00732069|10934662|FG000|COMPLETED|Second Study Drug||2
9823635|NCT00732069|10934663|FG001|COMPLETED|Second Study Drug||3
9823636|NCT00732069|10934664|FG002|COMPLETED|Second Study Drug||3
9823637|NCT00732069|10934665|FG003|COMPLETED|Second Study Drug||2
9823638|NCT00732069|10934666|FG004|COMPLETED|Second Study Drug||3
9823639|NCT00732069|10934667|FG005|COMPLETED|Second Study Drug||2
9823640|NCT00732069|10934662|FG000|NOT COMPLETED|Second Study Drug||0
9823641|NCT00732069|10934663|FG001|NOT COMPLETED|Second Study Drug||0
9823642|NCT00732069|10934664|FG002|NOT COMPLETED|Second Study Drug||0
9823643|NCT00732069|10934665|FG003|NOT COMPLETED|Second Study Drug||0
9823644|NCT00732069|10934666|FG004|NOT COMPLETED|Second Study Drug||0
9823645|NCT00732069|10934667|FG005|NOT COMPLETED|Second Study Drug||0
9823646|NCT00732069|10934662|FG000|STARTED|Washout After Second Study Drug||2
9823647|NCT00732069|10934663|FG001|STARTED|Washout After Second Study Drug||3
9823648|NCT00732069|10934664|FG002|STARTED|Washout After Second Study Drug||3
9823649|NCT00732069|10934665|FG003|STARTED|Washout After Second Study Drug||2
9823650|NCT00732069|10934666|FG004|STARTED|Washout After Second Study Drug||3
9823651|NCT00732069|10934667|FG005|STARTED|Washout After Second Study Drug||2
9823652|NCT00732069|10934662|FG000|COMPLETED|Washout After Second Study Drug||2
9823653|NCT00732069|10934663|FG001|COMPLETED|Washout After Second Study Drug||3
9823654|NCT00732069|10934664|FG002|COMPLETED|Washout After Second Study Drug||3
9823655|NCT00732069|10934665|FG003|COMPLETED|Washout After Second Study Drug||2
9823656|NCT00732069|10934666|FG004|COMPLETED|Washout After Second Study Drug||3
9823657|NCT00732069|10934667|FG005|COMPLETED|Washout After Second Study Drug||2
9823658|NCT00732069|10934662|FG000|NOT COMPLETED|Washout After Second Study Drug||0
9823659|NCT00732069|10934663|FG001|NOT COMPLETED|Washout After Second Study Drug||0
9823660|NCT00732069|10934664|FG002|NOT COMPLETED|Washout After Second Study Drug||0
9823661|NCT00732069|10934665|FG003|NOT COMPLETED|Washout After Second Study Drug||0
10017167|NCT01814137|11139981|FG001|NOT COMPLETED|Overall Study||5
10017168|NCT01814241|11139987|FG000|STARTED|Overall Study||20
10017169|NCT01814241|11139987|FG000|COMPLETED|Overall Study||16
10017170|NCT01814241|11139987|FG000|NOT COMPLETED|Overall Study||4
9823662|NCT00732069|10934666|FG004|NOT COMPLETED|Washout After Second Study Drug||0
9823663|NCT00732069|10934667|FG005|NOT COMPLETED|Washout After Second Study Drug||0
9823664|NCT00732069|10934662|FG000|STARTED|Third Study Drug||2
9823665|NCT00732069|10934663|FG001|STARTED|Third Study Drug||3
9823666|NCT00732069|10934664|FG002|STARTED|Third Study Drug||3
9823667|NCT00732069|10934665|FG003|STARTED|Third Study Drug||2
9823668|NCT00732069|10934666|FG004|STARTED|Third Study Drug||3
9823669|NCT00732069|10934667|FG005|STARTED|Third Study Drug||2
9823670|NCT00732069|10934662|FG000|COMPLETED|Third Study Drug||2
9823671|NCT00732069|10934663|FG001|COMPLETED|Third Study Drug||3
9823672|NCT00732069|10934664|FG002|COMPLETED|Third Study Drug||3
9823673|NCT00732069|10934665|FG003|COMPLETED|Third Study Drug||2
9823674|NCT00732069|10934666|FG004|COMPLETED|Third Study Drug||3
9823675|NCT00732069|10934667|FG005|COMPLETED|Third Study Drug||2
9823676|NCT00732069|10934662|FG000|NOT COMPLETED|Third Study Drug||0
9823677|NCT00732069|10934663|FG001|NOT COMPLETED|Third Study Drug||0
9823678|NCT00732069|10934664|FG002|NOT COMPLETED|Third Study Drug||0
9823679|NCT00732069|10934665|FG003|NOT COMPLETED|Third Study Drug||0
9823680|NCT00732069|10934666|FG004|NOT COMPLETED|Third Study Drug||0
9823681|NCT00732069|10934667|FG005|NOT COMPLETED|Third Study Drug||0
9823682|NCT00732160|10934679|FG000|STARTED|Overall Study||7
9823683|NCT00732160|10934680|FG001|STARTED|Overall Study||5
9823684|NCT00732160|10934681|FG002|STARTED|Overall Study||6
9823685|NCT00732160|10934682|FG003|STARTED|Overall Study||5
9823686|NCT00732160|10934679|FG000|HS Vehicle|Overall Study||7
9823687|NCT00732160|10934680|FG001|HS Vehicle|Overall Study||5
9823688|NCT00732160|10934681|FG002|HS Vehicle|Overall Study||3
9823689|NCT00732160|10934682|FG003|HS Vehicle|Overall Study||3
9823690|NCT00732160|10934679|FG000|HS Aldosterone|Overall Study||7
9823691|NCT00732160|10934680|FG001|HS Aldosterone|Overall Study||5
9823692|NCT00732160|10934681|FG002|HS Aldosterone|Overall Study||3
9823693|NCT00732160|10934682|FG003|HS Aldosterone|Overall Study||3
9823694|NCT00732160|10934679|FG000|LS Vehicle|Overall Study||2
9823695|NCT00732160|10934680|FG001|LS Vehicle|Overall Study||1
9823696|NCT00732160|10934681|FG002|LS Vehicle|Overall Study||6
9823697|NCT00732160|10934682|FG003|LS Vehicle|Overall Study||5
9823698|NCT00732160|10934679|FG000|LS Aldosterone|Overall Study||2
9823699|NCT00732160|10934680|FG001|LS Aldosterone|Overall Study||1
9823700|NCT00732160|10934681|FG002|LS Aldosterone|Overall Study||6
10017171|NCT01814332|11139994|FG000|STARTED|Overall Study||63
10017172|NCT01814332|11139995|FG001|STARTED|Overall Study||65
9823701|NCT00732160|10934682|FG003|LS Aldosterone|Overall Study||5
9823702|NCT00732160|10934679|FG000|COMPLETED|Overall Study||2
9823703|NCT00732160|10934680|FG001|COMPLETED|Overall Study||1
9823704|NCT00732160|10934681|FG002|COMPLETED|Overall Study||3
9823705|NCT00732160|10934682|FG003|COMPLETED|Overall Study||3
9823706|NCT00732160|10934679|FG000|NOT COMPLETED|Overall Study||5
9823707|NCT00732160|10934680|FG001|NOT COMPLETED|Overall Study||4
9823708|NCT00732160|10934681|FG002|NOT COMPLETED|Overall Study||3
9823709|NCT00732160|10934682|FG003|NOT COMPLETED|Overall Study||2
9823710|NCT00732199|10934694|FG000|STARTED|Overall Study||50
9823711|NCT00732199|10934695|FG001|STARTED|Overall Study||42
9823712|NCT00732199|10934694|FG000|COMPLETED|Overall Study||16
9823713|NCT00732199|10934695|FG001|COMPLETED|Overall Study||16
9823714|NCT00732199|10934694|FG000|NOT COMPLETED|Overall Study||34
9823715|NCT00732199|10934695|FG001|NOT COMPLETED|Overall Study||26
9823716|NCT00732225|10934709|FG000|STARTED|Overall Study|76 eyes of 71 patients|71
9823717|NCT00732225|10934710|FG001|STARTED|Overall Study|41 eyes of 40 patients|40
9823718|NCT00732225|10934711|FG002|STARTED|Overall Study|26 eyes of 26 patients|26
9823719|NCT00732225|10934712|FG003|STARTED|Overall Study|33 eyes of 33 patients|33
9823720|NCT00732225|10934713|FG004|STARTED|Overall Study|55 eyes of 54 patients|54
9823721|NCT00732225|10934709|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60
9823722|NCT00732225|10934710|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32
9823723|NCT00732225|10934711|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23
9823724|NCT00732225|10934712|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29
9823725|NCT00732225|10934713|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48
9823726|NCT00732225|10934709|FG000|NOT COMPLETED|Overall Study||11
9823727|NCT00732225|10934710|FG001|NOT COMPLETED|Overall Study||8
9823728|NCT00732225|10934711|FG002|NOT COMPLETED|Overall Study||3
9823729|NCT00732225|10934712|FG003|NOT COMPLETED|Overall Study||4
9823730|NCT00732225|10934713|FG004|NOT COMPLETED|Overall Study||6
9823731|NCT00732238|10934727|FG000|STARTED|Overall Study||33
9823732|NCT00732238|10934728|FG001|STARTED|Overall Study||28
9823733|NCT00732238|10934727|FG000|COMPLETED|Overall Study||28
9823734|NCT00732238|10934728|FG001|COMPLETED|Overall Study||27
9823735|NCT00732238|10934727|FG000|NOT COMPLETED|Overall Study||5
9823736|NCT00732238|10934728|FG001|NOT COMPLETED|Overall Study||1
9823737|NCT00732251|10934736|FG000|STARTED|Overall Study||8
9823738|NCT00732251|10934736|FG000|COMPLETED|Overall Study||1
9823739|NCT00732251|10934736|FG000|NOT COMPLETED|Overall Study||7
9823740|NCT00732303|10934740|FG000|STARTED|Overall Study||8
9823741|NCT00732303|10934740|FG000|COMPLETED|Overall Study||6
9823742|NCT00732303|10934740|FG000|NOT COMPLETED|Overall Study||2
9823743|NCT00732472|10934748|FG000|STARTED|Overall Study||9
9823744|NCT00732472|10934749|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
9823745|NCT00732472|10934750|FG002|STARTED|Overall Study||10
9823746|NCT00732472|10934751|FG003|STARTED|Overall Study||9
9823747|NCT00732472|10934748|FG000|COMPLETED|Overall Study||9
9823748|NCT00732472|10934749|FG001|COMPLETED|Overall Study||7
9823749|NCT00732472|10934750|FG002|COMPLETED|Overall Study||9
9823750|NCT00732472|10934751|FG003|COMPLETED|Overall Study||6
9823751|NCT00732472|10934748|FG000|NOT COMPLETED|Overall Study||0
9823752|NCT00732472|10934749|FG001|NOT COMPLETED|Overall Study||3
9823753|NCT00732472|10934750|FG002|NOT COMPLETED|Overall Study||1
9823754|NCT00732472|10934751|FG003|NOT COMPLETED|Overall Study||3
9823755|NCT00732498|10934762|FG000|STARTED|Overall Study||28
9823756|NCT00732498|10934762|FG000|COMPLETED|Overall Study||22
9823757|NCT00732498|10934762|FG000|NOT COMPLETED|Overall Study||6
9823758|NCT00732615|10934768|FG000|STARTED|Overall Study||40
9823759|NCT00732615|10934769|FG001|STARTED|Overall Study||84
9823760|NCT00732615|10934768|FG000|COMPLETED|Overall Study||33
9823761|NCT00732615|10934769|FG001|COMPLETED|Overall Study||79
9823762|NCT00732615|10934768|FG000|NOT COMPLETED|Overall Study||7
9823763|NCT00732615|10934769|FG001|NOT COMPLETED|Overall Study||5
9823764|NCT00732641|10934778|FG000|STARTED|Overall Study||123
9823765|NCT00732641|10934779|FG001|STARTED|Overall Study||121
9823766|NCT00732641|10934778|FG000|COMPLETED|Overall Study||17
9823767|NCT00732641|10934779|FG001|COMPLETED|Overall Study||9
9823768|NCT00732641|10934778|FG000|NOT COMPLETED|Overall Study||106
9823769|NCT00732641|10934779|FG001|NOT COMPLETED|Overall Study||112
9823770|NCT00732654|10934788|FG000|STARTED|Overall Study||10
9823771|NCT00732654|10934789|FG001|STARTED|Overall Study||10
9823772|NCT00732654|10934790|FG002|STARTED|Overall Study||10
9823773|NCT00732654|10934788|FG000|COMPLETED|Overall Study||10
10017173|NCT01814332|11139994|FG000|COMPLETED|Overall Study||47
10017174|NCT01814332|11139995|FG001|COMPLETED|Overall Study||49
10017175|NCT01814332|11139994|FG000|NOT COMPLETED|Overall Study||16
10017176|NCT01814332|11139995|FG001|NOT COMPLETED|Overall Study||16
10017177|NCT01814371|11140003|FG000|STARTED|Overall Study||248
9823774|NCT00732654|10934789|FG001|COMPLETED|Overall Study||9
9823775|NCT00732654|10934790|FG002|COMPLETED|Overall Study||10
9823776|NCT00732654|10934788|FG000|NOT COMPLETED|Overall Study||0
9823777|NCT00732654|10934789|FG001|NOT COMPLETED|Overall Study||1
9823778|NCT00732654|10934790|FG002|NOT COMPLETED|Overall Study||0
9823779|NCT00732758|10934800|FG000|STARTED|Overall Study||78
9823780|NCT00732758|10934801|FG001|STARTED|Overall Study||79
9823781|NCT00732758|10934800|FG000|COMPLETED|Overall Study||70
9823782|NCT00732758|10934801|FG001|COMPLETED|Overall Study||63
10017178|NCT01814371|11140004|FG001|STARTED|Overall Study||226
9823783|NCT00732758|10934800|FG000|NOT COMPLETED|Overall Study||8
9823784|NCT00732758|10934801|FG001|NOT COMPLETED|Overall Study||16
9823785|NCT00732875|10934807|FG000|STARTED|Overall Study||92
9823786|NCT00732875|10934807|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
9823787|NCT00732875|10934807|FG000|NOT COMPLETED|Overall Study||35
9823788|NCT00732901|10934813|FG000|STARTED|Overall Study||11
9823789|NCT00732901|10934814|FG001|STARTED|Overall Study||12
9823790|NCT00732901|10934813|FG000|COMPLETED|Overall Study||11
9823791|NCT00732901|10934814|FG001|COMPLETED|Overall Study||12
9823792|NCT00732901|10934813|FG000|NOT COMPLETED|Overall Study||0
9823793|NCT00732901|10934814|FG001|NOT COMPLETED|Overall Study||0
9823794|NCT00732940|10934822|FG000|STARTED|Overall Study||28
9823795|NCT00732940|10934823|FG001|STARTED|Overall Study||28
9823796|NCT00732940|10934822|FG000|COMPLETED|Overall Study||26
9823797|NCT00732940|10934823|FG001|COMPLETED|Overall Study||25
9823798|NCT00732940|10934822|FG000|NOT COMPLETED|Overall Study||2
9823799|NCT00732940|10934823|FG001|NOT COMPLETED|Overall Study||3
9823800|NCT00732992|10934831|FG000|STARTED|Overall Study||6
9823801|NCT00732992|10934832|FG001|STARTED|Overall Study||6
9823802|NCT00732992|10934831|FG000|COMPLETED|Overall Study||0
9823803|NCT00732992|10934832|FG001|COMPLETED|Overall Study||0
9823804|NCT00732992|10934831|FG000|NOT COMPLETED|Overall Study||6
9823805|NCT00732992|10934832|FG001|NOT COMPLETED|Overall Study||6
9823806|NCT00733096|10934842|FG000|STARTED|Overall Study||28
9823807|NCT00733096|10934843|FG001|STARTED|Overall Study||26
9823808|NCT00733096|10934844|FG002|STARTED|Overall Study||30
9823809|NCT00733096|10934842|FG000|COMPLETED|Overall Study||28
9823810|NCT00733096|10934843|FG001|COMPLETED|Overall Study||26
9823811|NCT00733096|10934844|FG002|COMPLETED|Overall Study||30
9823812|NCT00733096|10934842|FG000|NOT COMPLETED|Overall Study||0
9823813|NCT00733096|10934843|FG001|NOT COMPLETED|Overall Study||0
9823814|NCT00733096|10934844|FG002|NOT COMPLETED|Overall Study||0
9823815|NCT00733135|10934852|FG000|STARTED|Overall Study||133
9823816|NCT00733135|10934852|FG000|COMPLETED|Overall Study||131
9823817|NCT00733135|10934852|FG000|NOT COMPLETED|Overall Study||2
9823818|NCT00733226|10934860|FG000|STARTED|Overall Study||40
9823819|NCT00733226|10934861|FG001|STARTED|Overall Study||40
9823820|NCT00733226|10934860|FG000|COMPLETED|Overall Study||35
9823821|NCT00733226|10934861|FG001|COMPLETED|Overall Study||40
9823822|NCT00733226|10934860|FG000|NOT COMPLETED|Overall Study||5
9823823|NCT00733226|10934861|FG001|NOT COMPLETED|Overall Study||0
9823824|NCT00733278|10934867|FG000|STARTED|Overall Study||7
9823825|NCT00733278|10934867|FG000|COMPLETED|Overall Study||7
9823826|NCT00733278|10934867|FG000|NOT COMPLETED|Overall Study||0
9832216|NCT00772005|10942972|FG000|STARTED|Overall Study||71
9832217|NCT00772005|10942973|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
9832218|NCT00772005|10942974|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
9832219|NCT00772005|10942975|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
9832220|NCT00772005|10942972|FG000|COMPLETED|Overall Study||46
9832221|NCT00772005|10942973|FG001|COMPLETED|Overall Study||40
9832222|NCT00772005|10942974|FG002|COMPLETED|Overall Study||44
10236820|NCT00819832|11367577|FG004|STARTED|Overall Study||0
10236821|NCT00819832|11367578|FG005|STARTED|Overall Study||0
10236822|NCT00819832|11367573|FG000|COMPLETED|Overall Study||0
10236823|NCT00819832|11367574|FG001|COMPLETED|Overall Study||0
10236824|NCT00819832|11367575|FG002|COMPLETED|Overall Study||0
10236825|NCT00819832|11367576|FG003|COMPLETED|Overall Study||0
10236826|NCT00819832|11367577|FG004|COMPLETED|Overall Study||0
10236827|NCT00819832|11367578|FG005|COMPLETED|Overall Study||0
9832223|NCT00772005|10942975|FG003|COMPLETED|Overall Study||46
9832224|NCT00772005|10942972|FG000|NOT COMPLETED|Overall Study||25
9832225|NCT00772005|10942973|FG001|NOT COMPLETED|Overall Study||30
9832226|NCT00772005|10942974|FG002|NOT COMPLETED|Overall Study||28
9832227|NCT00772005|10942975|FG003|NOT COMPLETED|Overall Study||26
9832228|NCT00772031|10942987|FG000|STARTED|Overall Study||96
9832229|NCT00772031|10942988|FG001|STARTED|Overall Study||95
9832230|NCT00772031|10942987|FG000|COMPLETED|Overall Study||64
9832231|NCT00772031|10942988|FG001|COMPLETED|Overall Study||52
9832232|NCT00772031|10942987|FG000|NOT COMPLETED|Overall Study||32
9832233|NCT00772031|10942988|FG001|NOT COMPLETED|Overall Study||43
9832234|NCT00772070|10943002|FG000|STARTED|Overall Study||102
9832235|NCT00772070|10943003|FG001|STARTED|Overall Study||71
9832236|NCT00772070|10943002|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
9832237|NCT00772070|10943003|FG001|COMPLETED|Overall Study||61
9832238|NCT00772070|10943002|FG000|NOT COMPLETED|Overall Study||2
9832239|NCT00772070|10943003|FG001|NOT COMPLETED|Overall Study||10
9832240|NCT00772109|10943013|FG000|STARTED|Overall Study||956
9832241|NCT00772109|10943014|FG001|STARTED|Overall Study||953
10236828|NCT00819832|11367573|FG000|NOT COMPLETED|Overall Study||3
10236829|NCT00819832|11367574|FG001|NOT COMPLETED|Overall Study||0
9832242|NCT00772109|10943015|FG002|STARTED|Overall Study||955
9832243|NCT00772109|10943016|FG003|STARTED|Overall Study||1428
9832244|NCT00772109|10943013|FG000|COMPLETED|Overall Study||935
9832245|NCT00772109|10943014|FG001|COMPLETED|Overall Study||934
9832246|NCT00772109|10943015|FG002|COMPLETED|Overall Study||936
9832247|NCT00772109|10943016|FG003|COMPLETED|Overall Study||1397
9832248|NCT00772109|10943013|FG000|NOT COMPLETED|Overall Study||21
10236830|NCT00819832|11367575|FG002|NOT COMPLETED|Overall Study||0
10236831|NCT00819832|11367576|FG003|NOT COMPLETED|Overall Study||0
9832249|NCT00772109|10943014|FG001|NOT COMPLETED|Overall Study||19
9832250|NCT00772109|10943015|FG002|NOT COMPLETED|Overall Study||19
9832251|NCT00772109|10943016|FG003|NOT COMPLETED|Overall Study||31
9832252|NCT00772148|10943028|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29
9823827|NCT00733291|10934874|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
9823828|NCT00733291|10934875|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
9823829|NCT00733291|10934876|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
9823830|NCT00733291|10934877|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
9823831|NCT00733291|10934874|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
9823832|NCT00733291|10934875|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
9823833|NCT00733291|10934876|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
9823834|NCT00733291|10934877|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
9823835|NCT00733291|10934874|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
9823836|NCT00733291|10934875|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
9823837|NCT00733291|10934876|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
9823838|NCT00733291|10934877|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
9823839|NCT00733291|10934874|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13
9823840|NCT00733291|10934875|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17
9823841|NCT00733291|10934876|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17
9823842|NCT00733291|10934877|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17
9823843|NCT00733291|10934874|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
9823844|NCT00733291|10934875|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
9823845|NCT00733291|10934876|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
9823846|NCT00733291|10934877|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
9823847|NCT00733291|10934874|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
9823848|NCT00733291|10934875|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
9823849|NCT00733291|10934876|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
9823850|NCT00733291|10934877|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
9823851|NCT00733291|10934874|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
9823852|NCT00733291|10934875|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
9823853|NCT00733291|10934876|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
9823854|NCT00733291|10934877|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
9823855|NCT00733291|10934874|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
9823856|NCT00733291|10934875|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
9823857|NCT00733291|10934876|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
9823858|NCT00733291|10934877|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
9823859|NCT00733291|10934874|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
9823860|NCT00733291|10934875|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
9823861|NCT00733291|10934876|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
9823862|NCT00733291|10934877|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
9823863|NCT00733304|10934891|FG000|STARTED|Overall Study||19
9823864|NCT00733304|10934892|FG001|STARTED|Overall Study||15
9823865|NCT00733304|10934893|FG002|STARTED|Overall Study||8
9823866|NCT00733304|10934891|FG000|COMPLETED|Overall Study||12
9823867|NCT00733304|10934892|FG001|COMPLETED|Overall Study||12
9823868|NCT00733304|10934893|FG002|COMPLETED|Overall Study||3
9823869|NCT00733304|10934891|FG000|NOT COMPLETED|Overall Study||7
9823870|NCT00733304|10934892|FG001|NOT COMPLETED|Overall Study||3
9823871|NCT00733304|10934893|FG002|NOT COMPLETED|Overall Study||5
9823872|NCT00733330|10934903|FG000|STARTED|Overall Study||32
9823873|NCT00733330|10934904|FG001|STARTED|Overall Study||52
9823874|NCT00733330|10934903|FG000|COMPLETED|Overall Study||30
9823875|NCT00733330|10934904|FG001|COMPLETED|Overall Study||48
9823876|NCT00733330|10934903|FG000|NOT COMPLETED|Overall Study||2
10017179|NCT01814371|11140003|FG000|COMPLETED|Overall Study||218
10017180|NCT01814371|11140004|FG001|COMPLETED|Overall Study||199
10017181|NCT01814371|11140003|FG000|NOT COMPLETED|Overall Study||30
10017182|NCT01814371|11140004|FG001|NOT COMPLETED|Overall Study||27
10017183|NCT01814397|11140013|FG000|STARTED|Overall Study||50
10017184|NCT01814397|11140013|FG000|3 Month Evaluation|Overall Study||43
9823877|NCT00733330|10934904|FG001|NOT COMPLETED|Overall Study||4
9823878|NCT00733343|10934914|FG000|STARTED|Overall Study||666
9823879|NCT00733343|10934915|FG001|STARTED|Overall Study||659
9823880|NCT00733343|10934914|FG000|COMPLETED|Overall Study||583
9823881|NCT00733343|10934915|FG001|COMPLETED|Overall Study||578
9823882|NCT00733343|10934914|FG000|NOT COMPLETED|Overall Study||83
9823883|NCT00733343|10934915|FG001|NOT COMPLETED|Overall Study||81
9823884|NCT00733356|10934922|FG000|STARTED|Vyvanse Dose Titration||28
9823885|NCT00733356|10934922|FG000|COMPLETED|Vyvanse Dose Titration||26
10017185|NCT01814397|11140013|FG000|COMPLETED|Overall Study||36
10017186|NCT01814397|11140013|FG000|NOT COMPLETED|Overall Study||14
10017187|NCT01814553|11140019|FG000|STARTED|Overall Study||18
10017188|NCT01814553|11140020|FG001|STARTED|Overall Study||22
10017189|NCT01814553|11140019|FG000|COMPLETED|Overall Study||0
10017190|NCT01814553|11140020|FG001|COMPLETED|Overall Study||0
9823886|NCT00733356|10934922|FG000|NOT COMPLETED|Vyvanse Dose Titration||2
9823887|NCT00733356|10934922|FG000|STARTED|Modified Lab School, Reading Evaluation||26
9823888|NCT00733356|10934922|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26
9823889|NCT00733356|10934922|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
9823890|NCT00733369|10934928|FG000|STARTED|Overall Study||50
9823891|NCT00733369|10934929|FG001|STARTED|Overall Study||56
9823892|NCT00733369|10934928|FG000|COMPLETED|Overall Study||40
10017191|NCT01814553|11140019|FG000|NOT COMPLETED|Overall Study||18
10017192|NCT01814553|11140020|FG001|NOT COMPLETED|Overall Study||22
9823893|NCT00733369|10934929|FG001|COMPLETED|Overall Study||47
9823894|NCT00733369|10934928|FG000|NOT COMPLETED|Overall Study||10
10017193|NCT01814670|11140026|FG000|STARTED|Overall Study||185
9823895|NCT00733369|10934929|FG001|NOT COMPLETED|Overall Study||9
9823896|NCT00733408|10934935|FG000|STARTED|Overall Study||59
9823897|NCT00733408|10934935|FG000|COMPLETED|Overall Study||55
9823898|NCT00733408|10934935|FG000|NOT COMPLETED|Overall Study||4
9823899|NCT00733421|10934941|FG000|STARTED|Overall Study|November 2008|50
9823900|NCT00733421|10934942|FG001|STARTED|Overall Study|November 2008|50
9823901|NCT00733421|10934941|FG000|COMPLETED|Overall Study|All but one randomsied patient|49
9823902|NCT00733421|10934942|FG001|COMPLETED|Overall Study|All but one randomised patient|49
9823903|NCT00733421|10934941|FG000|NOT COMPLETED|Overall Study||1
9823904|NCT00733421|10934942|FG001|NOT COMPLETED|Overall Study||1
9823905|NCT00733499|10934950|FG000|STARTED|Pre-operative||102
9823906|NCT00733499|10934951|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
9823907|NCT00733499|10934950|FG000|COMPLETED|Pre-operative||102
9823908|NCT00733499|10934951|FG001|COMPLETED|Pre-operative||102
9823909|NCT00733499|10934950|FG000|NOT COMPLETED|Pre-operative||0
9823910|NCT00733499|10934951|FG001|NOT COMPLETED|Pre-operative||1
9823911|NCT00733499|10934950|FG000|STARTED|3 Months Follow-up||102
9823912|NCT00733499|10934951|FG001|STARTED|3 Months Follow-up||102
9823913|NCT00733499|10934950|FG000|COMPLETED|3 Months Follow-up||101
9823914|NCT00733499|10934951|FG001|COMPLETED|3 Months Follow-up||100
9823915|NCT00733499|10934950|FG000|NOT COMPLETED|3 Months Follow-up||1
9823916|NCT00733499|10934951|FG001|NOT COMPLETED|3 Months Follow-up||2
9823917|NCT00733499|10934950|FG000|STARTED|6 Months Follow-up||101
9823918|NCT00733499|10934951|FG001|STARTED|6 Months Follow-up||100
9823919|NCT00733499|10934950|FG000|COMPLETED|6 Months Follow-up||101
9823920|NCT00733499|10934951|FG001|COMPLETED|6 Months Follow-up||97
9823921|NCT00733499|10934950|FG000|NOT COMPLETED|6 Months Follow-up||0
9823922|NCT00733499|10934951|FG001|NOT COMPLETED|6 Months Follow-up||3
9823923|NCT00733499|10934950|FG000|STARTED|12 Months Follow-up||101
9823924|NCT00733499|10934951|FG001|STARTED|12 Months Follow-up||97
9823925|NCT00733499|10934950|FG000|COMPLETED|12 Months Follow-up||99
9823926|NCT00733499|10934951|FG001|COMPLETED|12 Months Follow-up||96
9823927|NCT00733499|10934950|FG000|NOT COMPLETED|12 Months Follow-up||2
9823928|NCT00733499|10934951|FG001|NOT COMPLETED|12 Months Follow-up||1
9823929|NCT00733499|10934950|FG000|STARTED|24 Months Follow-up||99
9823930|NCT00733499|10934951|FG001|STARTED|24 Months Follow-up||96
9823931|NCT00733499|10934950|FG000|COMPLETED|24 Months Follow-up||99
9823932|NCT00733499|10934951|FG001|COMPLETED|24 Months Follow-up||95
9823933|NCT00733499|10934950|FG000|NOT COMPLETED|24 Months Follow-up||0
9823934|NCT00733499|10934951|FG001|NOT COMPLETED|24 Months Follow-up||1
9823935|NCT00733499|10934950|FG000|STARTED|5 Year Followup||91
9823936|NCT00733499|10934951|FG001|STARTED|5 Year Followup||78
9823937|NCT00733499|10934950|FG000|COMPLETED|5 Year Followup||70
9823938|NCT00733499|10934951|FG001|COMPLETED|5 Year Followup||53
9823939|NCT00733499|10934950|FG000|NOT COMPLETED|5 Year Followup||21
9823940|NCT00733499|10934951|FG001|NOT COMPLETED|5 Year Followup||25
9823941|NCT00733499|10934950|FG000|STARTED|10 Year Followup||46
9823942|NCT00733499|10934951|FG001|STARTED|10 Year Followup||32
9823943|NCT00733499|10934950|FG000|COMPLETED|10 Year Followup||26
9823944|NCT00733499|10934951|FG001|COMPLETED|10 Year Followup||13
9823945|NCT00733499|10934950|FG000|NOT COMPLETED|10 Year Followup||20
9823946|NCT00733499|10934951|FG001|NOT COMPLETED|10 Year Followup||19
9823947|NCT00733512|10934957|FG000|STARTED|Overall Study||146
9823948|NCT00733512|10934957|FG000|COMPLETED|Overall Study||146
9823949|NCT00733512|10934957|FG000|NOT COMPLETED|Overall Study||0
9823950|NCT00733746|10934961|FG000|STARTED|Overall Study||119
9823951|NCT00733746|10934961|FG000|COMPLETED|Overall Study||114
9823952|NCT00733746|10934961|FG000|NOT COMPLETED|Overall Study||5
9823953|NCT00733824|10934970|FG000|STARTED|Phase I||10
9823954|NCT00733824|10934971|FG001|STARTED|Phase I||3
9823955|NCT00733824|10934972|FG002|STARTED|Phase I||6
9823956|NCT00733824|10934973|FG003|STARTED|Phase I||6
9823957|NCT00733824|10934974|FG004|STARTED|Phase I||0
9823958|NCT00733824|10934970|FG000|COMPLETED|Phase I||9
9823959|NCT00733824|10934971|FG001|COMPLETED|Phase I||3
9823960|NCT00733824|10934972|FG002|COMPLETED|Phase I||6
9823961|NCT00733824|10934973|FG003|COMPLETED|Phase I||6
9823962|NCT00733824|10934974|FG004|COMPLETED|Phase I||0
9823963|NCT00733824|10934970|FG000|NOT COMPLETED|Phase I||1
9823964|NCT00733824|10934971|FG001|NOT COMPLETED|Phase I||0
9823965|NCT00733824|10934972|FG002|NOT COMPLETED|Phase I||0
9823966|NCT00733824|10934973|FG003|NOT COMPLETED|Phase I||0
9823967|NCT00733824|10934974|FG004|NOT COMPLETED|Phase I||0
9823968|NCT00733824|10934970|FG000|STARTED|Phase II||0
9823969|NCT00733824|10934971|FG001|STARTED|Phase II||0
9823970|NCT00733824|10934972|FG002|STARTED|Phase II||0
9823971|NCT00733824|10934973|FG003|STARTED|Phase II||0
9823972|NCT00733824|10934974|FG004|STARTED|Phase II||36
9823973|NCT00733824|10934970|FG000|COMPLETED|Phase II||0
9823974|NCT00733824|10934971|FG001|COMPLETED|Phase II||0
9823975|NCT00733824|10934972|FG002|COMPLETED|Phase II||0
9823976|NCT00733824|10934973|FG003|COMPLETED|Phase II||0
9823977|NCT00733824|10934974|FG004|COMPLETED|Phase II||36
9823978|NCT00733824|10934970|FG000|NOT COMPLETED|Phase II||0
9823979|NCT00733824|10934971|FG001|NOT COMPLETED|Phase II||0
9823980|NCT00733824|10934972|FG002|NOT COMPLETED|Phase II||0
9823981|NCT00733824|10934973|FG003|NOT COMPLETED|Phase II||0
9823982|NCT00733824|10934974|FG004|NOT COMPLETED|Phase II||0
9823983|NCT00733902|10934992|FG000|STARTED|Overall Study||174
9823984|NCT00733902|10934993|FG001|STARTED|Overall Study||174
9823985|NCT00733902|10934994|FG002|STARTED|Overall Study||174
9823986|NCT00733902|10934995|FG003|STARTED|Overall Study||175
9823987|NCT00733902|10934992|FG000|Treated|Overall Study||172
9823988|NCT00733902|10934993|FG001|Treated|Overall Study||172
9823989|NCT00733902|10934994|FG002|Treated|Overall Study||172
9823990|NCT00733902|10934995|FG003|Treated|Overall Study||174
9823991|NCT00733902|10934992|FG000|COMPLETED|Overall Study||10
9823992|NCT00733902|10934993|FG001|COMPLETED|Overall Study||12
9823993|NCT00733902|10934994|FG002|COMPLETED|Overall Study||13
9823994|NCT00733902|10934995|FG003|COMPLETED|Overall Study||11
10236832|NCT00819832|11367577|FG004|NOT COMPLETED|Overall Study||0
10236833|NCT00819832|11367578|FG005|NOT COMPLETED|Overall Study||0
10236834|NCT00822679|11367594|FG000|STARTED|Overall Study||0
10236835|NCT00822679|11367595|FG001|STARTED|Overall Study||0
9823995|NCT00733902|10934992|FG000|NOT COMPLETED|Overall Study||164
9823996|NCT00733902|10934993|FG001|NOT COMPLETED|Overall Study||162
9823997|NCT00733902|10934994|FG002|NOT COMPLETED|Overall Study||161
9823998|NCT00733902|10934995|FG003|NOT COMPLETED|Overall Study||164
9823999|NCT00733954|10935007|FG000|STARTED|Overall Study||124
9824000|NCT00733954|10935008|FG001|STARTED|Overall Study||125
9824001|NCT00733954|10935007|FG000|COMPLETED|Overall Study||116
9824002|NCT00733954|10935008|FG001|COMPLETED|Overall Study||123
9824003|NCT00733954|10935007|FG000|NOT COMPLETED|Overall Study||8
9824004|NCT00733954|10935008|FG001|NOT COMPLETED|Overall Study||2
9824005|NCT00733980|10935016|FG000|STARTED|Overall Study||74
9824006|NCT00733980|10935017|FG001|STARTED|Overall Study||76
9824007|NCT00733980|10935016|FG000|COMPLETED|Overall Study||52
9824008|NCT00733980|10935017|FG001|COMPLETED|Overall Study||55
9824009|NCT00733980|10935016|FG000|NOT COMPLETED|Overall Study||22
9824010|NCT00733980|10935017|FG001|NOT COMPLETED|Overall Study||21
9824011|NCT00733993|10935026|FG000|STARTED|Overall Study||13
9824012|NCT00733993|10935027|FG001|STARTED|Overall Study||10
9824013|NCT00733993|10935026|FG000|COMPLETED|Overall Study||13
9824014|NCT00733993|10935027|FG001|COMPLETED|Overall Study||10
9824015|NCT00733993|10935026|FG000|NOT COMPLETED|Overall Study||0
9824016|NCT00733993|10935027|FG001|NOT COMPLETED|Overall Study||0
9824017|NCT00734032|10935042|FG000|STARTED|Overall Study||25
9824018|NCT00734032|10935043|FG001|STARTED|Overall Study||28
9824019|NCT00734032|10935044|FG002|STARTED|Overall Study||28
9824020|NCT00734032|10935045|FG003|STARTED|Overall Study||26
9824021|NCT00734032|10935042|FG000|COMPLETED|Overall Study||25
9824022|NCT00734032|10935043|FG001|COMPLETED|Overall Study||27
9824023|NCT00734032|10935044|FG002|COMPLETED|Overall Study||28
9824024|NCT00734032|10935045|FG003|COMPLETED|Overall Study||26
9824025|NCT00734032|10935042|FG000|NOT COMPLETED|Overall Study||0
9824026|NCT00734032|10935043|FG001|NOT COMPLETED|Overall Study||1
9824027|NCT00734032|10935044|FG002|NOT COMPLETED|Overall Study||0
9824028|NCT00734032|10935045|FG003|NOT COMPLETED|Overall Study||0
9824029|NCT00734071|10935057|FG000|STARTED|Overall Study||152
9824030|NCT00734071|10935058|FG001|STARTED|Overall Study||152
9824031|NCT00734071|10935057|FG000|Treated|Overall Study||151
9824032|NCT00734071|10935058|FG001|Treated|Overall Study||148
9824033|NCT00734071|10935057|FG000|COMPLETED|Overall Study||114
9824034|NCT00734071|10935058|FG001|COMPLETED|Overall Study||125
9824035|NCT00734071|10935057|FG000|NOT COMPLETED|Overall Study||38
9824036|NCT00734071|10935058|FG001|NOT COMPLETED|Overall Study||27
9824037|NCT00734097|10935064|FG000|STARTED|Screening||337
9824038|NCT00734097|10935064|FG000|COMPLETED|Screening|20 participants were screening failure.|317
9824039|NCT00734097|10935064|FG000|NOT COMPLETED|Screening||20
9824040|NCT00734097|10935064|FG000|STARTED|Open Label|Full analysis performed in 311|317
9824041|NCT00734097|10935064|FG000|Safety Analysis|Open Label||317
9824042|NCT00734097|10935064|FG000|Full Analysis|Open Label||311
9824043|NCT00734097|10935064|FG000|Per Protocol|Open Label||301
9824044|NCT00734097|10935064|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301
9824045|NCT00734097|10935064|FG000|NOT COMPLETED|Open Label||16
9824046|NCT00734149|10935068|FG000|STARTED|Overall Study||45
9824047|NCT00734149|10935068|FG000|COMPLETED|Overall Study||44
9824048|NCT00734149|10935068|FG000|NOT COMPLETED|Overall Study||1
9824049|NCT00734162|10935078|FG000|STARTED|Randomized Phase (Through Week 72)||10
9824050|NCT00734162|10935079|FG001|STARTED|Randomized Phase (Through Week 72)||42
9824051|NCT00734162|10935080|FG002|STARTED|Randomized Phase (Through Week 72)||13
9824052|NCT00734162|10935081|FG003|STARTED|Randomized Phase (Through Week 72)||41
9824053|NCT00734162|10935078|FG000|COMPLETED|Randomized Phase (Through Week 72)||10
10236836|NCT00822679|11367594|FG000|COMPLETED|Overall Study||0
10236837|NCT00822679|11367595|FG001|COMPLETED|Overall Study||0
9824054|NCT00734162|10935079|FG001|COMPLETED|Randomized Phase (Through Week 72)||41
9824055|NCT00734162|10935080|FG002|COMPLETED|Randomized Phase (Through Week 72)||13
9824056|NCT00734162|10935081|FG003|COMPLETED|Randomized Phase (Through Week 72)||37
9824057|NCT00734162|10935078|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0
9824058|NCT00734162|10935079|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1
9824059|NCT00734162|10935080|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0
10236838|NCT00822679|11367594|FG000|NOT COMPLETED|Overall Study||0
10236839|NCT00822679|11367595|FG001|NOT COMPLETED|Overall Study||0
10236840|NCT00814892|11367601|FG000|STARTED|Overall Study||2
10236841|NCT00814892|11367601|FG000|COMPLETED|Overall Study||0
10236842|NCT00814892|11367601|FG000|NOT COMPLETED|Overall Study||2
9824060|NCT00734162|10935081|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4
9824061|NCT00734162|10935078|FG000|STARTED|Open-Label Phase||10
9824062|NCT00734162|10935079|FG001|STARTED|Open-Label Phase||41
9824063|NCT00734162|10935080|FG002|STARTED|Open-Label Phase||13
9824064|NCT00734162|10935081|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
9824065|NCT00734162|10935078|FG000|COMPLETED|Open-Label Phase||7
9824066|NCT00734162|10935079|FG001|COMPLETED|Open-Label Phase||39
9824067|NCT00734162|10935080|FG002|COMPLETED|Open-Label Phase||12
9824068|NCT00734162|10935081|FG003|COMPLETED|Open-Label Phase||36
9824069|NCT00734162|10935078|FG000|NOT COMPLETED|Open-Label Phase||3
9824070|NCT00734162|10935079|FG001|NOT COMPLETED|Open-Label Phase||2
9824071|NCT00734162|10935080|FG002|NOT COMPLETED|Open-Label Phase||1
9824072|NCT00734162|10935081|FG003|NOT COMPLETED|Open-Label Phase||3
9824073|NCT00734214|10935097|FG000|STARTED|Overall Study||128
9824074|NCT00734214|10935098|FG001|STARTED|Overall Study||130
9824075|NCT00734214|10935097|FG000|COMPLETED|Overall Study||124
9824076|NCT00734214|10935098|FG001|COMPLETED|Overall Study||126
9824077|NCT00734214|10935097|FG000|NOT COMPLETED|Overall Study||4
9824078|NCT00734214|10935098|FG001|NOT COMPLETED|Overall Study||4
9824079|NCT00734305|10935106|FG000|STARTED|Overall Study||7
9824080|NCT00734305|10935107|FG001|STARTED|Overall Study||3
9824081|NCT00734305|10935108|FG002|STARTED|Overall Study||4
9824082|NCT00734305|10935109|FG003|STARTED|Overall Study||3
9824083|NCT00734305|10935110|FG004|STARTED|Overall Study||5
9824084|NCT00734305|10935111|FG005|STARTED|Overall Study||4
9824085|NCT00734305|10935112|FG006|STARTED|Overall Study||18
9824086|NCT00734305|10935106|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
9824087|NCT00734305|10935107|FG001|COMPLETED|Overall Study||3
9824088|NCT00734305|10935108|FG002|COMPLETED|Overall Study||4
9824089|NCT00734305|10935109|FG003|COMPLETED|Overall Study||3
9824090|NCT00734305|10935110|FG004|COMPLETED|Overall Study||5
9824091|NCT00734305|10935111|FG005|COMPLETED|Overall Study||4
9824092|NCT00734305|10935112|FG006|COMPLETED|Overall Study||18
9824093|NCT00734305|10935106|FG000|NOT COMPLETED|Overall Study||1
9824094|NCT00734305|10935107|FG001|NOT COMPLETED|Overall Study||0
9824095|NCT00734305|10935108|FG002|NOT COMPLETED|Overall Study||0
9824096|NCT00734305|10935109|FG003|NOT COMPLETED|Overall Study||0
9824097|NCT00734305|10935110|FG004|NOT COMPLETED|Overall Study||0
9824098|NCT00734305|10935111|FG005|NOT COMPLETED|Overall Study||0
9824099|NCT00734305|10935112|FG006|NOT COMPLETED|Overall Study||0
9824100|NCT00734344|10935132|FG000|STARTED|Overall Study||9
9824101|NCT00734344|10935133|FG001|STARTED|Overall Study||9
9824102|NCT00734344|10935132|FG000|COMPLETED|Overall Study||9
9824103|NCT00734344|10935133|FG001|COMPLETED|Overall Study||9
9824104|NCT00734344|10935132|FG000|NOT COMPLETED|Overall Study||0
9824105|NCT00734344|10935133|FG001|NOT COMPLETED|Overall Study||0
9824106|NCT00734409|10935143|FG000|STARTED|Overall Study||155
9824107|NCT00734409|10935144|FG001|STARTED|Overall Study||145
9824108|NCT00734409|10935143|FG000|COMPLETED|Overall Study||155
9824109|NCT00734409|10935144|FG001|COMPLETED|Overall Study||145
9824110|NCT00734409|10935143|FG000|NOT COMPLETED|Overall Study||0
9824111|NCT00734409|10935144|FG001|NOT COMPLETED|Overall Study||0
9824112|NCT00734474|10935159|FG000|STARTED|Overall Study||15
9824113|NCT00734474|10935160|FG001|STARTED|Overall Study||30
9824114|NCT00734474|10935161|FG002|STARTED|Overall Study||304
9824115|NCT00734474|10935162|FG003|STARTED|Overall Study||10
9824116|NCT00734474|10935163|FG004|STARTED|Overall Study||302
9824117|NCT00734474|10935164|FG005|STARTED|Overall Study||25
9824118|NCT00734474|10935165|FG006|STARTED|Overall Study||24
9824119|NCT00734474|10935166|FG007|STARTED|Overall Study||315
9824120|NCT00734474|10935167|FG008|STARTED|Overall Study||177
9824121|NCT00734474|10935159|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
9824122|NCT00734474|10935160|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
9824123|NCT00734474|10935161|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304
9824124|NCT00734474|10935162|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
9824125|NCT00734474|10935163|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302
9824126|NCT00734474|10935164|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
9824127|NCT00734474|10935165|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24
9824128|NCT00734474|10935166|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315
9824129|NCT00734474|10935167|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177
9824130|NCT00734474|10935159|FG000|Entered Study Before Dose Decision Point|Overall Study||15
9824131|NCT00734474|10935160|FG001|Entered Study Before Dose Decision Point|Overall Study||30
9824132|NCT00734474|10935161|FG002|Entered Study Before Dose Decision Point|Overall Study||25
9824133|NCT00734474|10935162|FG003|Entered Study Before Dose Decision Point|Overall Study||10
9824134|NCT00734474|10935163|FG004|Entered Study Before Dose Decision Point|Overall Study||21
9824135|NCT00734474|10935164|FG005|Entered Study Before Dose Decision Point|Overall Study||25
9824136|NCT00734474|10935165|FG006|Entered Study Before Dose Decision Point|Overall Study||24
9824137|NCT00734474|10935166|FG007|Entered Study Before Dose Decision Point|Overall Study||42
9824138|NCT00734474|10935167|FG008|Entered Study Before Dose Decision Point|Overall Study||38
9824139|NCT00734474|10935159|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
9824140|NCT00734474|10935160|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
9832253|NCT00772148|10943029|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29
9824141|NCT00734474|10935161|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
9824142|NCT00734474|10935162|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
9824143|NCT00734474|10935163|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
9824144|NCT00734474|10935164|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
9824145|NCT00734474|10935165|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
9824146|NCT00734474|10935166|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
9824147|NCT00734474|10935167|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
9824148|NCT00734474|10935159|FG000|Entered Study After Dose Decision Point|Overall Study||0
9824149|NCT00734474|10935160|FG001|Entered Study After Dose Decision Point|Overall Study||0
9824150|NCT00734474|10935161|FG002|Entered Study After Dose Decision Point|Overall Study||279
9824151|NCT00734474|10935162|FG003|Entered Study After Dose Decision Point|Overall Study||0
9824152|NCT00734474|10935163|FG004|Entered Study After Dose Decision Point|Overall Study||281
9824153|NCT00734474|10935164|FG005|Entered Study After Dose Decision Point|Overall Study||0
9824154|NCT00734474|10935165|FG006|Entered Study After Dose Decision Point|Overall Study||0
9824155|NCT00734474|10935166|FG007|Entered Study After Dose Decision Point|Overall Study||273
9824156|NCT00734474|10935167|FG008|Entered Study After Dose Decision Point|Overall Study||139
9824157|NCT00734474|10935159|FG000|Completed 26-Week Visit|Overall Study||0
9824158|NCT00734474|10935160|FG001|Completed 26-Week Visit|Overall Study||0
9824159|NCT00734474|10935161|FG002|Completed 26-Week Visit|Overall Study||258
9824160|NCT00734474|10935162|FG003|Completed 26-Week Visit|Overall Study||2
9824161|NCT00734474|10935163|FG004|Completed 26-Week Visit|Overall Study||268
9824162|NCT00734474|10935164|FG005|Completed 26-Week Visit|Overall Study||2
9824163|NCT00734474|10935165|FG006|Completed 26-Week Visit|Overall Study||2
9824164|NCT00734474|10935166|FG007|Completed 26-Week Visit|Overall Study||270
9824165|NCT00734474|10935167|FG008|Completed 26-Week Visit|Overall Study||124
9824166|NCT00734474|10935159|FG000|Completed 52-Week Visit|Overall Study||0
9824167|NCT00734474|10935160|FG001|Completed 52-Week Visit|Overall Study||0
9824168|NCT00734474|10935161|FG002|Completed 52-Week Visit|Overall Study||238
9824169|NCT00734474|10935162|FG003|Completed 52-Week Visit|Overall Study||0
9824170|NCT00734474|10935163|FG004|Completed 52-Week Visit|Overall Study||243
9824171|NCT00734474|10935164|FG005|Completed 52-Week Visit|Overall Study||0
9824172|NCT00734474|10935165|FG006|Completed 52-Week Visit|Overall Study||0
9824173|NCT00734474|10935166|FG007|Completed 52-Week Visit|Overall Study||238
9824174|NCT00734474|10935167|FG008|Completed 52-Week Visit|Overall Study||112
9824175|NCT00734474|10935159|FG000|COMPLETED|Overall Study||0
9824176|NCT00734474|10935160|FG001|COMPLETED|Overall Study||0
9824177|NCT00734474|10935161|FG002|COMPLETED|Overall Study||192
9824178|NCT00734474|10935162|FG003|COMPLETED|Overall Study||0
9824179|NCT00734474|10935163|FG004|COMPLETED|Overall Study||184
9824180|NCT00734474|10935164|FG005|COMPLETED|Overall Study||0
9824181|NCT00734474|10935165|FG006|COMPLETED|Overall Study||0
9824182|NCT00734474|10935166|FG007|COMPLETED|Overall Study||186
9824183|NCT00734474|10935167|FG008|COMPLETED|Overall Study||95
9824184|NCT00734474|10935159|FG000|NOT COMPLETED|Overall Study||15
9824185|NCT00734474|10935160|FG001|NOT COMPLETED|Overall Study||30
9824186|NCT00734474|10935161|FG002|NOT COMPLETED|Overall Study||112
9824187|NCT00734474|10935162|FG003|NOT COMPLETED|Overall Study||10
9824188|NCT00734474|10935163|FG004|NOT COMPLETED|Overall Study||118
9824189|NCT00734474|10935164|FG005|NOT COMPLETED|Overall Study||25
9824190|NCT00734474|10935165|FG006|NOT COMPLETED|Overall Study||24
9824191|NCT00734474|10935166|FG007|NOT COMPLETED|Overall Study||129
9824192|NCT00734474|10935167|FG008|NOT COMPLETED|Overall Study||82
9824193|NCT00734500|10935193|FG000|STARTED|Overall Study||15
9824194|NCT00734500|10935193|FG000|COMPLETED|Overall Study||14
9824195|NCT00734500|10935193|FG000|NOT COMPLETED|Overall Study||1
9824196|NCT00734539|10935199|FG000|STARTED|Main Study||189
9824197|NCT00734539|10935200|FG001|STARTED|Main Study||173
9824198|NCT00734539|10935199|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
9824199|NCT00734539|10935200|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
9824200|NCT00734539|10935199|FG000|NOT COMPLETED|Main Study||37
9824201|NCT00734539|10935200|FG001|NOT COMPLETED|Main Study||35
9824202|NCT00734539|10935199|FG000|STARTED|Long Term Follow up||152
9824203|NCT00734539|10935200|FG001|STARTED|Long Term Follow up||138
9824204|NCT00734539|10935199|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
9824205|NCT00734539|10935200|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
9824206|NCT00734539|10935199|FG000|NOT COMPLETED|Long Term Follow up||34
9824207|NCT00734539|10935200|FG001|NOT COMPLETED|Long Term Follow up||31
9824208|NCT00734578|10935212|FG000|STARTED|Overall Study||154
9824209|NCT00734578|10935213|FG001|STARTED|Overall Study||153
9824210|NCT00734578|10935214|FG002|STARTED|Overall Study||154
9824211|NCT00734578|10935212|FG000|COMPLETED|Overall Study||121
9824212|NCT00734578|10935213|FG001|COMPLETED|Overall Study||128
9824213|NCT00734578|10935214|FG002|COMPLETED|Overall Study||129
9824214|NCT00734578|10935212|FG000|NOT COMPLETED|Overall Study||33
9824215|NCT00734578|10935213|FG001|NOT COMPLETED|Overall Study||25
9824216|NCT00734578|10935214|FG002|NOT COMPLETED|Overall Study||25
9824217|NCT00734591|10935224|FG000|STARTED|Retrospective Period||3875
9824218|NCT00734591|10935225|FG001|STARTED|Retrospective Period||3564
9824219|NCT00734591|10935224|FG000|COMPLETED|Retrospective Period||3875
9824220|NCT00734591|10935225|FG001|COMPLETED|Retrospective Period||3564
9824221|NCT00734591|10935224|FG000|NOT COMPLETED|Retrospective Period||0
9824222|NCT00734591|10935225|FG001|NOT COMPLETED|Retrospective Period||0
9824223|NCT00734591|10935224|FG000|STARTED|Screening for Prospective Period||3875
9824224|NCT00734591|10935225|FG001|STARTED|Screening for Prospective Period||3564
9824225|NCT00734591|10935224|FG000|COMPLETED|Screening for Prospective Period||1358
9824226|NCT00734591|10935225|FG001|COMPLETED|Screening for Prospective Period||1273
9824227|NCT00734591|10935224|FG000|NOT COMPLETED|Screening for Prospective Period||2517
9824228|NCT00734591|10935225|FG001|NOT COMPLETED|Screening for Prospective Period||2291
9824229|NCT00734591|10935224|FG000|STARTED|Prospective Period||1358
9824230|NCT00734591|10935225|FG001|STARTED|Prospective Period||1273
9824231|NCT00734591|10935224|FG000|COMPLETED|Prospective Period||1307
9824232|NCT00734591|10935225|FG001|COMPLETED|Prospective Period||1229
9824233|NCT00734591|10935224|FG000|NOT COMPLETED|Prospective Period||51
9824234|NCT00734591|10935225|FG001|NOT COMPLETED|Prospective Period||44
9824235|NCT00734604|10935237|FG000|STARTED|Overall Study||62
9824236|NCT00734604|10935238|FG001|STARTED|Overall Study||63
9824237|NCT00734604|10935239|FG002|STARTED|Overall Study||63
9824238|NCT00734604|10935240|FG003|STARTED|Overall Study||63
9824239|NCT00734604|10935241|FG004|STARTED|Overall Study||63
9824240|NCT00734604|10935242|FG005|STARTED|Overall Study||64
9824241|NCT00734604|10935237|FG000|COMPLETED|Overall Study||59
9824242|NCT00734604|10935238|FG001|COMPLETED|Overall Study||51
9824243|NCT00734604|10935239|FG002|COMPLETED|Overall Study||57
9824244|NCT00734604|10935240|FG003|COMPLETED|Overall Study||54
9824245|NCT00734604|10935241|FG004|COMPLETED|Overall Study||55
9824246|NCT00734604|10935242|FG005|COMPLETED|Overall Study||58
9824247|NCT00734604|10935237|FG000|NOT COMPLETED|Overall Study||3
9824248|NCT00734604|10935238|FG001|NOT COMPLETED|Overall Study||12
9824249|NCT00734604|10935239|FG002|NOT COMPLETED|Overall Study||6
9824250|NCT00734604|10935240|FG003|NOT COMPLETED|Overall Study||9
9824251|NCT00734604|10935241|FG004|NOT COMPLETED|Overall Study||8
9824252|NCT00734604|10935242|FG005|NOT COMPLETED|Overall Study||6
9824253|NCT00734617|10935255|FG000|STARTED|Overall Study||249
9824254|NCT00734617|10935256|FG001|STARTED|Overall Study||230
9824255|NCT00734617|10935255|FG000|COMPLETED|Overall Study||142
9824256|NCT00734617|10935256|FG001|COMPLETED|Overall Study||128
9824257|NCT00734617|10935255|FG000|NOT COMPLETED|Overall Study||107
9824258|NCT00734617|10935256|FG001|NOT COMPLETED|Overall Study||102
9824259|NCT00734630|10935264|FG000|STARTED|Overall Study||258
9824260|NCT00734630|10935265|FG001|STARTED|Overall Study||233
9824261|NCT00734630|10935264|FG000|COMPLETED|Overall Study||229
9824262|NCT00734630|10935265|FG001|COMPLETED|Overall Study||200
9824263|NCT00734630|10935264|FG000|NOT COMPLETED|Overall Study||29
9824264|NCT00734630|10935265|FG001|NOT COMPLETED|Overall Study||33
9824265|NCT00734656|10935271|FG000|STARTED|Lab Session 1||24
9824266|NCT00734656|10935272|FG001|STARTED|Lab Session 1||23
9824267|NCT00734656|10935273|FG002|STARTED|Lab Session 1||26
9824268|NCT00734656|10935274|FG003|STARTED|Lab Session 1||21
9824269|NCT00734656|10935271|FG000|COMPLETED|Lab Session 1||22
9824270|NCT00734656|10935272|FG001|COMPLETED|Lab Session 1||23
9824271|NCT00734656|10935273|FG002|COMPLETED|Lab Session 1||26
9824272|NCT00734656|10935274|FG003|COMPLETED|Lab Session 1||21
9824273|NCT00734656|10935271|FG000|NOT COMPLETED|Lab Session 1||2
9824274|NCT00734656|10935272|FG001|NOT COMPLETED|Lab Session 1||0
9824275|NCT00734656|10935273|FG002|NOT COMPLETED|Lab Session 1||0
9824276|NCT00734656|10935274|FG003|NOT COMPLETED|Lab Session 1||0
9824277|NCT00734656|10935271|FG000|STARTED|Washout 1||22
9824278|NCT00734656|10935272|FG001|STARTED|Washout 1||23
9824279|NCT00734656|10935273|FG002|STARTED|Washout 1||26
9824280|NCT00734656|10935274|FG003|STARTED|Washout 1||21
9824281|NCT00734656|10935271|FG000|COMPLETED|Washout 1||21
9824282|NCT00734656|10935272|FG001|COMPLETED|Washout 1||18
9824283|NCT00734656|10935273|FG002|COMPLETED|Washout 1||24
9824284|NCT00734656|10935274|FG003|COMPLETED|Washout 1||18
9824285|NCT00734656|10935271|FG000|NOT COMPLETED|Washout 1||1
9824286|NCT00734656|10935272|FG001|NOT COMPLETED|Washout 1||5
9824287|NCT00734656|10935273|FG002|NOT COMPLETED|Washout 1||2
9824288|NCT00734656|10935274|FG003|NOT COMPLETED|Washout 1||3
9824289|NCT00734656|10935271|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
9824290|NCT00734656|10935272|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
9824291|NCT00734656|10935273|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
9824292|NCT00734656|10935274|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
9824293|NCT00734656|10935271|FG000|COMPLETED|Lab Session 2||18
9824294|NCT00734656|10935272|FG001|COMPLETED|Lab Session 2||21
9824295|NCT00734656|10935273|FG002|COMPLETED|Lab Session 2||21
9824296|NCT00734656|10935274|FG003|COMPLETED|Lab Session 2||19
9824297|NCT00734656|10935271|FG000|NOT COMPLETED|Lab Session 2||1
9824298|NCT00734656|10935272|FG001|NOT COMPLETED|Lab Session 2||0
9824299|NCT00734656|10935273|FG002|NOT COMPLETED|Lab Session 2||0
9824300|NCT00734656|10935274|FG003|NOT COMPLETED|Lab Session 2||1
9824301|NCT00734656|10935271|FG000|STARTED|Washout 2||18
9824302|NCT00734656|10935272|FG001|STARTED|Washout 2||21
9824303|NCT00734656|10935273|FG002|STARTED|Washout 2||21
10017194|NCT01814670|11140026|FG000|COMPLETED|Overall Study||173
10017195|NCT01814670|11140026|FG000|NOT COMPLETED|Overall Study||12
10017196|NCT01814696|11140032|FG000|STARTED|Overall Study||15
9824304|NCT00734656|10935274|FG003|STARTED|Washout 2||19
9824305|NCT00734656|10935271|FG000|COMPLETED|Washout 2||17
9824306|NCT00734656|10935272|FG001|COMPLETED|Washout 2||20
9824307|NCT00734656|10935273|FG002|COMPLETED|Washout 2||20
9824308|NCT00734656|10935274|FG003|COMPLETED|Washout 2||19
9824309|NCT00734656|10935271|FG000|NOT COMPLETED|Washout 2||1
9824310|NCT00734656|10935272|FG001|NOT COMPLETED|Washout 2||1
9824311|NCT00734656|10935273|FG002|NOT COMPLETED|Washout 2||1
9824312|NCT00734656|10935274|FG003|NOT COMPLETED|Washout 2||0
9824313|NCT00734656|10935271|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
9824314|NCT00734656|10935272|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
9824315|NCT00734656|10935273|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
9824316|NCT00734656|10935274|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
9824317|NCT00734656|10935271|FG000|COMPLETED|Lab Session 3||18
9824318|NCT00734656|10935272|FG001|COMPLETED|Lab Session 3||19
9824319|NCT00734656|10935273|FG002|COMPLETED|Lab Session 3||20
9824320|NCT00734656|10935274|FG003|COMPLETED|Lab Session 3||19
9824321|NCT00734656|10935271|FG000|NOT COMPLETED|Lab Session 3||0
9824322|NCT00734656|10935272|FG001|NOT COMPLETED|Lab Session 3||0
9824323|NCT00734656|10935273|FG002|NOT COMPLETED|Lab Session 3||0
9824324|NCT00734656|10935274|FG003|NOT COMPLETED|Lab Session 3||0
9824325|NCT00734656|10935271|FG000|STARTED|Washout 3||18
9824326|NCT00734656|10935272|FG001|STARTED|Washout 3||19
9824327|NCT00734656|10935273|FG002|STARTED|Washout 3||20
9824328|NCT00734656|10935274|FG003|STARTED|Washout 3||19
9824329|NCT00734656|10935271|FG000|COMPLETED|Washout 3||17
9824330|NCT00734656|10935272|FG001|COMPLETED|Washout 3||19
9824331|NCT00734656|10935273|FG002|COMPLETED|Washout 3||20
9824332|NCT00734656|10935274|FG003|COMPLETED|Washout 3||18
10017197|NCT01814696|11140033|FG001|STARTED|Overall Study||11
9824333|NCT00734656|10935271|FG000|NOT COMPLETED|Washout 3||1
9824334|NCT00734656|10935272|FG001|NOT COMPLETED|Washout 3||0
9824335|NCT00734656|10935273|FG002|NOT COMPLETED|Washout 3||0
9824336|NCT00734656|10935274|FG003|NOT COMPLETED|Washout 3||1
9824337|NCT00734656|10935271|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
9824338|NCT00734656|10935272|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
9824339|NCT00734656|10935273|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
9824340|NCT00734656|10935274|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
9824341|NCT00734656|10935271|FG000|COMPLETED|Lab Session 4||20
9824342|NCT00734656|10935272|FG001|COMPLETED|Lab Session 4||18
9824343|NCT00734656|10935273|FG002|COMPLETED|Lab Session 4||16
9824344|NCT00734656|10935274|FG003|COMPLETED|Lab Session 4||19
9824345|NCT00734656|10935271|FG000|NOT COMPLETED|Lab Session 4||0
9824346|NCT00734656|10935272|FG001|NOT COMPLETED|Lab Session 4||0
9824347|NCT00734656|10935273|FG002|NOT COMPLETED|Lab Session 4||0
9824348|NCT00734656|10935274|FG003|NOT COMPLETED|Lab Session 4||1
9824349|NCT00734734|10935284|FG000|STARTED|Overall Study||64
9824350|NCT00734734|10935284|FG000|COMPLETED|Overall Study||64
9824351|NCT00734734|10935284|FG000|NOT COMPLETED|Overall Study||0
9824352|NCT00734747|10935289|FG000|STARTED|SRS Procedure||72
9824353|NCT00734747|10935289|FG000|COMPLETED|SRS Procedure||69
9824354|NCT00734747|10935289|FG000|NOT COMPLETED|SRS Procedure||3
9824355|NCT00734747|10935289|FG000|STARTED|6 Month Follow-up||69
9824356|NCT00734747|10935289|FG000|COMPLETED|6 Month Follow-up||66
9824357|NCT00734747|10935289|FG000|NOT COMPLETED|6 Month Follow-up||3
9824358|NCT00734799|10935295|FG000|STARTED|Overall Study||9
9824359|NCT00734799|10935296|FG001|STARTED|Overall Study||13
9824360|NCT00734799|10935295|FG000|COMPLETED|Overall Study||9
9824361|NCT00734799|10935296|FG001|COMPLETED|Overall Study||9
9824362|NCT00734799|10935295|FG000|NOT COMPLETED|Overall Study||0
9824363|NCT00734799|10935296|FG001|NOT COMPLETED|Overall Study||4
9824364|NCT00734851|10935302|FG000|STARTED|Overall Study||34
9824365|NCT00734851|10935302|FG000|COMPLETED|Overall Study||13
9824366|NCT00734851|10935302|FG000|NOT COMPLETED|Overall Study||21
9824367|NCT00734903|10935308|FG000|STARTED|Overall Study||33
9824368|NCT00734903|10935309|FG001|STARTED|Overall Study||33
9824369|NCT00734903|10935308|FG000|Completed End of Treatment Assessment|Overall Study||21
9824370|NCT00734903|10935309|FG001|Completed End of Treatment Assessment|Overall Study||23
9824371|NCT00734903|10935308|FG000|Completed 3-month Followup|Overall Study||14
9824372|NCT00734903|10935309|FG001|Completed 3-month Followup|Overall Study||15
9824373|NCT00734903|10935308|FG000|COMPLETED|Overall Study||30
9824374|NCT00734903|10935309|FG001|COMPLETED|Overall Study||32
9824375|NCT00734903|10935308|FG000|NOT COMPLETED|Overall Study||3
9824376|NCT00734903|10935309|FG001|NOT COMPLETED|Overall Study||1
9824377|NCT00734929|10935317|FG000|STARTED|Overall Study||57
9824378|NCT00734929|10935318|FG001|STARTED|Overall Study||58
9824379|NCT00734929|10935317|FG000|COMPLETED|Overall Study||51
9824380|NCT00734929|10935318|FG001|COMPLETED|Overall Study||53
9824381|NCT00734929|10935317|FG000|NOT COMPLETED|Overall Study||6
10017198|NCT01814696|11140032|FG000|COMPLETED|Overall Study||13
10017199|NCT01814696|11140033|FG001|COMPLETED|Overall Study||11
10017200|NCT01814696|11140032|FG000|NOT COMPLETED|Overall Study||2
9824382|NCT00734929|10935318|FG001|NOT COMPLETED|Overall Study||5
9824383|NCT00734968|10935328|FG000|STARTED|Overall Study||77
9824384|NCT00734968|10935329|FG001|STARTED|Overall Study||76
9824385|NCT00734968|10935328|FG000|COMPLETED|Overall Study||76
9824386|NCT00734968|10935329|FG001|COMPLETED|Overall Study||75
9824387|NCT00734968|10935328|FG000|NOT COMPLETED|Overall Study||1
9824388|NCT00734968|10935329|FG001|NOT COMPLETED|Overall Study||1
9824389|NCT00734994|10935335|FG000|STARTED|Overall Study||15
9824390|NCT00734994|10935335|FG000|COMPLETED|Overall Study||14
9824391|NCT00734994|10935335|FG000|NOT COMPLETED|Overall Study||1
9824392|NCT00735007|10935340|FG000|STARTED|Overall Study||106
9824393|NCT00735007|10935340|FG000|COMPLETED|Overall Study||101
9824394|NCT00735007|10935340|FG000|NOT COMPLETED|Overall Study||5
9824395|NCT00735072|10935346|FG000|STARTED|Overall Study||23
9824396|NCT00735072|10935347|FG001|STARTED|Overall Study||22
9824397|NCT00735072|10935346|FG000|COMPLETED|Overall Study||22
9824398|NCT00735072|10935347|FG001|COMPLETED|Overall Study||21
9824399|NCT00735072|10935346|FG000|NOT COMPLETED|Overall Study||1
9824400|NCT00735072|10935347|FG001|NOT COMPLETED|Overall Study||1
9824401|NCT00735306|10935355|FG000|STARTED|Overall Study||12
9824402|NCT00735306|10935355|FG000|COMPLETED|Overall Study||12
9824403|NCT00735306|10935355|FG000|NOT COMPLETED|Overall Study||0
9824404|NCT00735371|10935364|FG000|STARTED|Overall Study||78
9824405|NCT00735371|10935365|FG001|STARTED|Overall Study||79
9824406|NCT00735371|10935366|FG002|STARTED|Overall Study||78
9824407|NCT00735371|10935367|FG003|STARTED|Overall Study||79
9824408|NCT00735371|10935364|FG000|COMPLETED|Overall Study||63
9824409|NCT00735371|10935365|FG001|COMPLETED|Overall Study||66
9824410|NCT00735371|10935366|FG002|COMPLETED|Overall Study||67
9824411|NCT00735371|10935367|FG003|COMPLETED|Overall Study||69
9824412|NCT00735371|10935364|FG000|NOT COMPLETED|Overall Study||15
9824413|NCT00735371|10935365|FG001|NOT COMPLETED|Overall Study||13
9824414|NCT00735371|10935366|FG002|NOT COMPLETED|Overall Study||11
9824415|NCT00735371|10935367|FG003|NOT COMPLETED|Overall Study||10
9824416|NCT00735397|10935377|FG000|STARTED|Overall Study||1218
9824417|NCT00735397|10935377|FG000|COMPLETED|Overall Study||35
9824418|NCT00735397|10935377|FG000|NOT COMPLETED|Overall Study||1183
9824419|NCT00735436|10935384|FG000|STARTED|Overall Study||18
9824420|NCT00735436|10935384|FG000|COMPLETED|Overall Study||18
9824421|NCT00735436|10935384|FG000|NOT COMPLETED|Overall Study||0
9824422|NCT00735449|10935391|FG000|STARTED|Overall Study||102
9824423|NCT00735449|10935392|FG001|STARTED|Overall Study||102
9824424|NCT00735449|10935391|FG000|COMPLETED|Overall Study||95
9824425|NCT00735449|10935392|FG001|COMPLETED|Overall Study||96
9824426|NCT00735449|10935391|FG000|NOT COMPLETED|Overall Study||7
9824427|NCT00735449|10935392|FG001|NOT COMPLETED|Overall Study||6
9824428|NCT00735462|10935401|FG000|STARTED|Overall Study||202
9824429|NCT00735462|10935402|FG001|STARTED|Overall Study||204
9824430|NCT00735462|10935403|FG002|STARTED|Overall Study||105
9824431|NCT00735462|10935401|FG000|COMPLETED|Overall Study||139
9824432|NCT00735462|10935402|FG001|COMPLETED|Overall Study||149
9824433|NCT00735462|10935403|FG002|COMPLETED|Overall Study||77
9824434|NCT00735462|10935401|FG000|NOT COMPLETED|Overall Study||63
9824435|NCT00735462|10935402|FG001|NOT COMPLETED|Overall Study||55
9824436|NCT00735462|10935403|FG002|NOT COMPLETED|Overall Study||28
9824437|NCT00735475|10935413|FG000|STARTED|Overall Study||631
9824438|NCT00735475|10935414|FG001|STARTED|Overall Study||637
9824439|NCT00735475|10935413|FG000|COMPLETED|Overall Study||623
9824440|NCT00735475|10935414|FG001|COMPLETED|Overall Study||626
9824441|NCT00735475|10935413|FG000|NOT COMPLETED|Overall Study||8
9824442|NCT00735475|10935414|FG001|NOT COMPLETED|Overall Study||11
9824443|NCT00735618|10935420|FG000|STARTED|Overall Study||19
9824444|NCT00735618|10935420|FG000|COMPLETED|Overall Study||19
9824445|NCT00735618|10935420|FG000|NOT COMPLETED|Overall Study||0
9824446|NCT00735644|10935429|FG000|STARTED|Overall Study||303
9824447|NCT00735644|10935430|FG001|STARTED|Overall Study||300
9824448|NCT00735644|10935431|FG002|STARTED|Overall Study||296
9824449|NCT00735644|10935432|FG003|STARTED|Overall Study||199
9824450|NCT00735644|10935433|FG004|STARTED|Overall Study||102
9824451|NCT00735644|10935429|FG000|COMPLETED|Overall Study||303
9824452|NCT00735644|10935430|FG001|COMPLETED|Overall Study||298
9824453|NCT00735644|10935431|FG002|COMPLETED|Overall Study||295
9824454|NCT00735644|10935432|FG003|COMPLETED|Overall Study||198
9824455|NCT00735644|10935433|FG004|COMPLETED|Overall Study||102
9824456|NCT00735644|10935429|FG000|NOT COMPLETED|Overall Study||0
9824457|NCT00735644|10935430|FG001|NOT COMPLETED|Overall Study||2
9824458|NCT00735644|10935431|FG002|NOT COMPLETED|Overall Study||1
9824459|NCT00735644|10935432|FG003|NOT COMPLETED|Overall Study||1
9824460|NCT00735644|10935433|FG004|NOT COMPLETED|Overall Study||0
9824461|NCT00735670|10935454|FG000|STARTED|Overall Study||10
9824462|NCT00735670|10935455|FG001|STARTED|Overall Study||11
9824463|NCT00735670|10935454|FG000|COMPLETED|Overall Study||6
9824464|NCT00735670|10935455|FG001|COMPLETED|Overall Study||6
9824465|NCT00735670|10935454|FG000|NOT COMPLETED|Overall Study||4
9824466|NCT00735670|10935455|FG001|NOT COMPLETED|Overall Study||5
9824467|NCT00735696|10935461|FG000|STARTED|Overall Study||41
9824468|NCT00735696|10935461|FG000|Received Any Quantity of Study Drug|Overall Study||40
9824469|NCT00735696|10935461|FG000|COMPLETED|Overall Study||39
9824470|NCT00735696|10935461|FG000|NOT COMPLETED|Overall Study||2
9824471|NCT00735709|10935469|FG000|STARTED|Overall Study||140
9824472|NCT00735709|10935470|FG001|STARTED|Overall Study||140
9824473|NCT00735709|10935471|FG002|STARTED|Overall Study||140
9824474|NCT00735709|10935472|FG003|STARTED|Overall Study||140
9824475|NCT00735709|10935469|FG000|Treated|Overall Study||140
9824476|NCT00735709|10935470|FG001|Treated|Overall Study||140
9824477|NCT00735709|10935471|FG002|Treated|Overall Study||140
9824478|NCT00735709|10935472|FG003|Treated|Overall Study||139
9824479|NCT00735709|10935469|FG000|COMPLETED|Overall Study||127
9824480|NCT00735709|10935470|FG001|COMPLETED|Overall Study||127
9824481|NCT00735709|10935471|FG002|COMPLETED|Overall Study||129
9824482|NCT00735709|10935472|FG003|COMPLETED|Overall Study||122
9824483|NCT00735709|10935469|FG000|NOT COMPLETED|Overall Study||13
9824484|NCT00735709|10935470|FG001|NOT COMPLETED|Overall Study||13
9824485|NCT00735709|10935471|FG002|NOT COMPLETED|Overall Study||11
9824486|NCT00735709|10935472|FG003|NOT COMPLETED|Overall Study||18
9824487|NCT00735787|10935484|FG000|STARTED|Period 1||23
9824488|NCT00735787|10935485|FG001|STARTED|Period 1||49
9824489|NCT00735787|10935484|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
9824490|NCT00735787|10935485|FG001|COMPLETED|Period 1||41
9824491|NCT00735787|10935484|FG000|NOT COMPLETED|Period 1||6
9824492|NCT00735787|10935485|FG001|NOT COMPLETED|Period 1||8
9824493|NCT00735787|10935484|FG000|STARTED|Period 2||18
9824494|NCT00735787|10935485|FG001|STARTED|Period 2||41
9824495|NCT00735787|10935484|FG000|COMPLETED|Period 2||13
9824496|NCT00735787|10935485|FG001|COMPLETED|Period 2||40
9824497|NCT00735787|10935484|FG000|NOT COMPLETED|Period 2||5
9824498|NCT00735787|10935485|FG001|NOT COMPLETED|Period 2||1
9824499|NCT00735826|10935491|FG000|STARTED|Overall Study||10
9824500|NCT00735826|10935491|FG000|COMPLETED|Overall Study||10
9824501|NCT00735826|10935491|FG000|NOT COMPLETED|Overall Study||0
9824502|NCT00735839|10935499|FG000|STARTED|Overall Study||30
9824503|NCT00735839|10935500|FG001|STARTED|Overall Study||10
9824504|NCT00735839|10935499|FG000|COMPLETED|Overall Study||30
9824505|NCT00735839|10935500|FG001|COMPLETED|Overall Study||10
9824506|NCT00735839|10935499|FG000|NOT COMPLETED|Overall Study||0
9824507|NCT00735839|10935500|FG001|NOT COMPLETED|Overall Study||0
9824508|NCT00735878|10935509|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
9824509|NCT00735878|10935510|FG001|STARTED|Phase I- Dose Determination||7
9824510|NCT00735878|10935511|FG002|STARTED|Phase I- Dose Determination||5
9824511|NCT00735878|10935509|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
9824512|NCT00735878|10935510|FG001|COMPLETED|Phase I- Dose Determination||7
9824513|NCT00735878|10935511|FG002|COMPLETED|Phase I- Dose Determination||4
9824514|NCT00735878|10935509|FG000|NOT COMPLETED|Phase I- Dose Determination||0
9824515|NCT00735878|10935510|FG001|NOT COMPLETED|Phase I- Dose Determination||0
9824516|NCT00735878|10935511|FG002|NOT COMPLETED|Phase I- Dose Determination||1
9824517|NCT00735878|10935509|FG000|STARTED|Phase II- Determined Dose||0
9824518|NCT00735878|10935510|FG001|STARTED|Phase II- Determined Dose||7
9824519|NCT00735878|10935511|FG002|STARTED|Phase II- Determined Dose||0
9824520|NCT00735878|10935509|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
9824521|NCT00735878|10935510|FG001|COMPLETED|Phase II- Determined Dose||7
9824522|NCT00735878|10935511|FG002|COMPLETED|Phase II- Determined Dose||0
9824523|NCT00735878|10935509|FG000|NOT COMPLETED|Phase II- Determined Dose||0
9824524|NCT00735878|10935510|FG001|NOT COMPLETED|Phase II- Determined Dose||0
9824525|NCT00735878|10935511|FG002|NOT COMPLETED|Phase II- Determined Dose||0
9824526|NCT00735904|10935522|FG000|STARTED|Overall Study||38
9824527|NCT00735904|10935522|FG000|COMPLETED|Overall Study||0
9824528|NCT00735904|10935522|FG000|NOT COMPLETED|Overall Study||38
9824529|NCT00735917|10935526|FG000|STARTED|Overall Study||19
9824530|NCT00735917|10935526|FG000|COMPLETED|Overall Study||19
9824531|NCT00735917|10935526|FG000|NOT COMPLETED|Overall Study||0
9824532|NCT00735943|10935530|FG000|STARTED|Overall Study||22
9824533|NCT00735943|10935530|FG000|COMPLETED|Overall Study||20
9824534|NCT00735943|10935530|FG000|NOT COMPLETED|Overall Study||2
9824535|NCT00735969|10935534|FG000|STARTED|Overall Study||21
9824536|NCT00735969|10935534|FG000|COMPLETED|Overall Study||21
9824537|NCT00735969|10935534|FG000|NOT COMPLETED|Overall Study||0
9824538|NCT00736034|10935538|FG000|STARTED|Overall Study||18
9824539|NCT00736034|10935538|FG000|COMPLETED|Overall Study||16
9824540|NCT00736034|10935538|FG000|NOT COMPLETED|Overall Study||2
9824541|NCT00736073|10935544|FG000|STARTED|Overall Study||34
9824542|NCT00736073|10935545|FG001|STARTED|Overall Study||39
9824543|NCT00736073|10935544|FG000|COMPLETED|Overall Study||34
9824544|NCT00736073|10935545|FG001|COMPLETED|Overall Study||39
9824545|NCT00736073|10935544|FG000|NOT COMPLETED|Overall Study||0
9824546|NCT00736073|10935545|FG001|NOT COMPLETED|Overall Study||0
9824547|NCT00736099|10935554|FG000|STARTED|Overall Study|Number who started treatment.|1532
9824548|NCT00736099|10935555|FG001|STARTED|Overall Study|Number who started treatment.|589
9824549|NCT00736099|10935554|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349
9824550|NCT00736099|10935555|FG001|COMPLETED|Overall Study|Number who completed treatment.|531
9824551|NCT00736099|10935554|FG000|NOT COMPLETED|Overall Study||183
9824552|NCT00736099|10935555|FG001|NOT COMPLETED|Overall Study||58
9824553|NCT00736125|10935563|FG000|STARTED|Overall Study||10
9824554|NCT00736125|10935564|FG001|STARTED|Overall Study||10
9824555|NCT00736125|10935563|FG000|COMPLETED|Overall Study||9
9824556|NCT00736125|10935564|FG001|COMPLETED|Overall Study||8
9824557|NCT00736125|10935563|FG000|NOT COMPLETED|Overall Study||1
9824558|NCT00736125|10935564|FG001|NOT COMPLETED|Overall Study||2
9824559|NCT00736190|10935570|FG000|STARTED|Overall Study||90
9824560|NCT00736190|10935570|FG000|COMPLETED|Overall Study||87
9824561|NCT00736190|10935570|FG000|NOT COMPLETED|Overall Study||3
9824562|NCT00736229|10935577|FG000|STARTED|Overall Study|Actively Enrolled|40
9824563|NCT00736229|10935578|FG001|STARTED|Overall Study|Historic control|71
9824564|NCT00736229|10935579|FG002|STARTED|Overall Study|Historic Control|84
9824565|NCT00736229|10935577|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
9824566|NCT00736229|10935578|FG001|COMPLETED|Overall Study||71
9824567|NCT00736229|10935579|FG002|COMPLETED|Overall Study||84
9824568|NCT00736229|10935577|FG000|NOT COMPLETED|Overall Study||0
9824569|NCT00736229|10935578|FG001|NOT COMPLETED|Overall Study||0
9824570|NCT00736229|10935579|FG002|NOT COMPLETED|Overall Study||0
9824571|NCT00736242|10935588|FG000|STARTED|Overall Study||232
9824572|NCT00736242|10935588|FG000|Participants in Safety Analysis Set|Overall Study||229
9824573|NCT00736242|10935588|FG000|COMPLETED|Overall Study||107
9824574|NCT00736242|10935588|FG000|NOT COMPLETED|Overall Study||125
9824575|NCT00736255|10935594|FG000|STARTED|Overall Study||17
9824576|NCT00736255|10935595|FG001|STARTED|Overall Study||15
9824577|NCT00736255|10935594|FG000|COMPLETED|Overall Study||14
10017201|NCT01814696|11140033|FG001|NOT COMPLETED|Overall Study||0
10017202|NCT01814748|11140041|FG000|STARTED|Overall Study||102
10017203|NCT01814748|11140042|FG001|STARTED|Overall Study||101
10017204|NCT01814748|11140041|FG000|COMPLETED|Overall Study||94
10017205|NCT01814748|11140042|FG001|COMPLETED|Overall Study||94
10017206|NCT01814748|11140041|FG000|NOT COMPLETED|Overall Study||8
10017207|NCT01814748|11140042|FG001|NOT COMPLETED|Overall Study||7
10017208|NCT01814761|11140050|FG000|STARTED|Overall Study||42
10017209|NCT01814761|11140051|FG001|STARTED|Overall Study||270
10017210|NCT01814761|11140050|FG000|COMPLETED|Overall Study||34
10017211|NCT01814761|11140051|FG001|COMPLETED|Overall Study||240
10017212|NCT01814761|11140050|FG000|NOT COMPLETED|Overall Study||8
10017213|NCT01814761|11140051|FG001|NOT COMPLETED|Overall Study||30
10017214|NCT01814774|11140057|FG000|STARTED|Overall Study||48
10017215|NCT01814774|11140057|FG000|COMPLETED|Overall Study||48
10017216|NCT01814774|11140057|FG000|NOT COMPLETED|Overall Study||0
10017217|NCT01814787|11140065|FG000|STARTED|Overall Study||685
10017218|NCT01814787|11140066|FG001|STARTED|Overall Study||684
10017219|NCT01814787|11140065|FG000|COMPLETED|Overall Study||685
10017220|NCT01814787|11140066|FG001|COMPLETED|Overall Study||684
10017221|NCT01814787|11140065|FG000|NOT COMPLETED|Overall Study||0
10017222|NCT01814787|11140066|FG001|NOT COMPLETED|Overall Study||0
10017223|NCT01814800|11140072|FG000|STARTED|Overall Study||59
10017224|NCT01814800|11140072|FG000|COMPLETED|Overall Study||54
10017225|NCT01814800|11140072|FG000|NOT COMPLETED|Overall Study||5
10017226|NCT01814813|11140079|FG000|STARTED|Overall Study||29
9824578|NCT00736255|10935595|FG001|COMPLETED|Overall Study||14
9824579|NCT00736255|10935594|FG000|NOT COMPLETED|Overall Study||3
9824580|NCT00736255|10935595|FG001|NOT COMPLETED|Overall Study||1
9824581|NCT00736333|10935601|FG000|STARTED|Overall Study||167
9824582|NCT00736333|10935601|FG000|COMPLETED|Overall Study||56
9824583|NCT00736333|10935601|FG000|NOT COMPLETED|Overall Study||111
9824584|NCT00736450|10935605|FG000|STARTED|Overall Study||37
9824585|NCT00736450|10935605|FG000|COMPLETED|Overall Study||12
9824586|NCT00736450|10935605|FG000|NOT COMPLETED|Overall Study||25
9824587|NCT00736476|10935611|FG000|STARTED|Overall Study||36
9824588|NCT00736476|10935612|FG001|STARTED|Overall Study||27
9824589|NCT00736476|10935611|FG000|COMPLETED|Overall Study||35
9824590|NCT00736476|10935612|FG001|COMPLETED|Overall Study||27
9824591|NCT00736476|10935611|FG000|NOT COMPLETED|Overall Study||1
9824592|NCT00736476|10935612|FG001|NOT COMPLETED|Overall Study||0
9824593|NCT00736489|10935624|FG000|STARTED|Period 1|Cross-over study|6
9824594|NCT00736489|10935625|FG001|STARTED|Period 1||5
9824595|NCT00736489|10935626|FG002|STARTED|Period 1||6
9824596|NCT00736489|10935627|FG003|STARTED|Period 1||7
9824597|NCT00736489|10935628|FG004|STARTED|Period 1||7
9824598|NCT00736489|10935629|FG005|STARTED|Period 1||6
9824599|NCT00736489|10935624|FG000|COMPLETED|Period 1||5
9824600|NCT00736489|10935625|FG001|COMPLETED|Period 1||5
9824601|NCT00736489|10935626|FG002|COMPLETED|Period 1||6
9824602|NCT00736489|10935627|FG003|COMPLETED|Period 1||7
9824603|NCT00736489|10935628|FG004|COMPLETED|Period 1||7
9824604|NCT00736489|10935629|FG005|COMPLETED|Period 1||5
9824605|NCT00736489|10935624|FG000|NOT COMPLETED|Period 1||1
9824606|NCT00736489|10935625|FG001|NOT COMPLETED|Period 1||0
9824607|NCT00736489|10935626|FG002|NOT COMPLETED|Period 1||0
9824608|NCT00736489|10935627|FG003|NOT COMPLETED|Period 1||0
9824609|NCT00736489|10935628|FG004|NOT COMPLETED|Period 1||0
9824610|NCT00736489|10935629|FG005|NOT COMPLETED|Period 1||1
9824611|NCT00736489|10935624|FG000|STARTED|Period 2||5
9824612|NCT00736489|10935625|FG001|STARTED|Period 2||5
9824613|NCT00736489|10935626|FG002|STARTED|Period 2||6
9824614|NCT00736489|10935627|FG003|STARTED|Period 2||7
9824615|NCT00736489|10935628|FG004|STARTED|Period 2||7
9824616|NCT00736489|10935629|FG005|STARTED|Period 2||5
9824617|NCT00736489|10935624|FG000|COMPLETED|Period 2||5
9824618|NCT00736489|10935625|FG001|COMPLETED|Period 2||5
9824619|NCT00736489|10935626|FG002|COMPLETED|Period 2||6
9824620|NCT00736489|10935627|FG003|COMPLETED|Period 2||7
9824621|NCT00736489|10935628|FG004|COMPLETED|Period 2||7
9824622|NCT00736489|10935629|FG005|COMPLETED|Period 2||5
9824623|NCT00736489|10935624|FG000|NOT COMPLETED|Period 2||0
10017227|NCT01814813|11140080|FG001|STARTED|Overall Study||30
10017228|NCT01814813|11140081|FG002|STARTED|Overall Study||31
10017229|NCT01814813|11140079|FG000|COMPLETED|Overall Study||29
10017230|NCT01814813|11140080|FG001|COMPLETED|Overall Study||30
10017231|NCT01814813|11140081|FG002|COMPLETED|Overall Study||31
10017232|NCT01814813|11140079|FG000|NOT COMPLETED|Overall Study||0
9824624|NCT00736489|10935625|FG001|NOT COMPLETED|Period 2||0
9824625|NCT00736489|10935626|FG002|NOT COMPLETED|Period 2||0
9824626|NCT00736489|10935627|FG003|NOT COMPLETED|Period 2||0
9824627|NCT00736489|10935628|FG004|NOT COMPLETED|Period 2||0
9824628|NCT00736489|10935629|FG005|NOT COMPLETED|Period 2||0
9824629|NCT00736489|10935624|FG000|STARTED|Period 3||5
9824630|NCT00736489|10935625|FG001|STARTED|Period 3||5
9824631|NCT00736489|10935626|FG002|STARTED|Period 3||6
9824632|NCT00736489|10935627|FG003|STARTED|Period 3||7
9824633|NCT00736489|10935628|FG004|STARTED|Period 3||7
9824634|NCT00736489|10935629|FG005|STARTED|Period 3||5
9824635|NCT00736489|10935624|FG000|COMPLETED|Period 3||5
9824636|NCT00736489|10935625|FG001|COMPLETED|Period 3||5
9824637|NCT00736489|10935626|FG002|COMPLETED|Period 3||6
9824638|NCT00736489|10935627|FG003|COMPLETED|Period 3||7
9824639|NCT00736489|10935628|FG004|COMPLETED|Period 3||7
9824640|NCT00736489|10935629|FG005|COMPLETED|Period 3||5
9824641|NCT00736489|10935624|FG000|NOT COMPLETED|Period 3||0
9824642|NCT00736489|10935625|FG001|NOT COMPLETED|Period 3||0
9824643|NCT00736489|10935626|FG002|NOT COMPLETED|Period 3||0
9824644|NCT00736489|10935627|FG003|NOT COMPLETED|Period 3||0
9824645|NCT00736489|10935628|FG004|NOT COMPLETED|Period 3||0
9824646|NCT00736489|10935629|FG005|NOT COMPLETED|Period 3||0
9824647|NCT00736489|10935624|FG000|STARTED|Period 4||5
9824648|NCT00736489|10935625|FG001|STARTED|Period 4||5
9824649|NCT00736489|10935626|FG002|STARTED|Period 4||6
9824650|NCT00736489|10935627|FG003|STARTED|Period 4||7
9824651|NCT00736489|10935628|FG004|STARTED|Period 4||7
9824652|NCT00736489|10935629|FG005|STARTED|Period 4||5
9824653|NCT00736489|10935624|FG000|COMPLETED|Period 4||5
9824654|NCT00736489|10935625|FG001|COMPLETED|Period 4||5
9824655|NCT00736489|10935626|FG002|COMPLETED|Period 4||6
9824656|NCT00736489|10935627|FG003|COMPLETED|Period 4||7
9824657|NCT00736489|10935628|FG004|COMPLETED|Period 4||7
9824658|NCT00736489|10935629|FG005|COMPLETED|Period 4||5
9824659|NCT00736489|10935624|FG000|NOT COMPLETED|Period 4||0
9824660|NCT00736489|10935625|FG001|NOT COMPLETED|Period 4||0
9824661|NCT00736489|10935626|FG002|NOT COMPLETED|Period 4||0
9824662|NCT00736489|10935627|FG003|NOT COMPLETED|Period 4||0
9824663|NCT00736489|10935628|FG004|NOT COMPLETED|Period 4||0
9824664|NCT00736489|10935629|FG005|NOT COMPLETED|Period 4||0
9824665|NCT00736489|10935624|FG000|STARTED|Period 5||5
9824666|NCT00736489|10935625|FG001|STARTED|Period 5||5
9824667|NCT00736489|10935626|FG002|STARTED|Period 5||6
9824668|NCT00736489|10935627|FG003|STARTED|Period 5||7
9824669|NCT00736489|10935628|FG004|STARTED|Period 5||7
9824670|NCT00736489|10935629|FG005|STARTED|Period 5||5
9824671|NCT00736489|10935624|FG000|COMPLETED|Period 5||5
9824672|NCT00736489|10935625|FG001|COMPLETED|Period 5||5
9824673|NCT00736489|10935626|FG002|COMPLETED|Period 5||6
9824674|NCT00736489|10935627|FG003|COMPLETED|Period 5||7
9824675|NCT00736489|10935628|FG004|COMPLETED|Period 5||7
9824676|NCT00736489|10935629|FG005|COMPLETED|Period 5||5
9824677|NCT00736489|10935624|FG000|NOT COMPLETED|Period 5||0
9824678|NCT00736489|10935625|FG001|NOT COMPLETED|Period 5||0
9824679|NCT00736489|10935626|FG002|NOT COMPLETED|Period 5||0
9824680|NCT00736489|10935627|FG003|NOT COMPLETED|Period 5||0
9824681|NCT00736489|10935628|FG004|NOT COMPLETED|Period 5||0
9824682|NCT00736489|10935629|FG005|NOT COMPLETED|Period 5||0
9824683|NCT00736489|10935624|FG000|STARTED|Period 6||5
9824684|NCT00736489|10935625|FG001|STARTED|Period 6||5
9824685|NCT00736489|10935626|FG002|STARTED|Period 6||6
9824686|NCT00736489|10935627|FG003|STARTED|Period 6||7
9824687|NCT00736489|10935628|FG004|STARTED|Period 6||7
9824688|NCT00736489|10935629|FG005|STARTED|Period 6||5
9824689|NCT00736489|10935624|FG000|COMPLETED|Period 6||5
9824690|NCT00736489|10935625|FG001|COMPLETED|Period 6||5
9824691|NCT00736489|10935626|FG002|COMPLETED|Period 6||6
9824692|NCT00736489|10935627|FG003|COMPLETED|Period 6||7
9824693|NCT00736489|10935628|FG004|COMPLETED|Period 6||7
9824694|NCT00736489|10935629|FG005|COMPLETED|Period 6||5
9824695|NCT00736489|10935624|FG000|NOT COMPLETED|Period 6||0
9824696|NCT00736489|10935625|FG001|NOT COMPLETED|Period 6||0
9824697|NCT00736489|10935626|FG002|NOT COMPLETED|Period 6||0
9824698|NCT00736489|10935627|FG003|NOT COMPLETED|Period 6||0
9824699|NCT00736489|10935628|FG004|NOT COMPLETED|Period 6||0
9824700|NCT00736489|10935629|FG005|NOT COMPLETED|Period 6||0
9824701|NCT00736502|10935643|FG000|STARTED|Overall Study|Entered and treated.|278
9824702|NCT00736502|10935643|FG000|COMPLETED|Overall Study||213
9824703|NCT00736502|10935643|FG000|NOT COMPLETED|Overall Study||65
9824704|NCT00736580|10935649|FG000|STARTED|Overall Study||117
9824705|NCT00736580|10935650|FG001|STARTED|Overall Study||123
9824706|NCT00736580|10935649|FG000|COMPLETED|Overall Study||117
9824707|NCT00736580|10935650|FG001|COMPLETED|Overall Study||123
9824708|NCT00736580|10935649|FG000|NOT COMPLETED|Overall Study||0
9824709|NCT00736580|10935650|FG001|NOT COMPLETED|Overall Study||0
9824710|NCT00736632|10935659|FG000|STARTED|Overall Study||44
9824711|NCT00736632|10935660|FG001|STARTED|Overall Study||50
9824712|NCT00736632|10935661|FG002|STARTED|Overall Study||31
9824713|NCT00736632|10935659|FG000|COMPLETED|Overall Study||44
9824714|NCT00736632|10935660|FG001|COMPLETED|Overall Study||50
9824715|NCT00736632|10935661|FG002|COMPLETED|Overall Study||31
9824716|NCT00736632|10935659|FG000|NOT COMPLETED|Overall Study||0
9824717|NCT00736632|10935660|FG001|NOT COMPLETED|Overall Study||0
9824718|NCT00736632|10935661|FG002|NOT COMPLETED|Overall Study||0
9824719|NCT00736645|10935671|FG000|STARTED|Overall Study||13
9824720|NCT00736645|10935672|FG001|STARTED|Overall Study||15
9824721|NCT00736645|10935673|FG002|STARTED|Overall Study||14
9824722|NCT00736645|10935674|FG003|STARTED|Overall Study||13
9824723|NCT00736645|10935671|FG000|COMPLETED|Overall Study||13
9824724|NCT00736645|10935672|FG001|COMPLETED|Overall Study||13
9824725|NCT00736645|10935673|FG002|COMPLETED|Overall Study||14
9824726|NCT00736645|10935674|FG003|COMPLETED|Overall Study||13
9824727|NCT00736645|10935671|FG000|NOT COMPLETED|Overall Study||0
9824728|NCT00736645|10935672|FG001|NOT COMPLETED|Overall Study||2
9824729|NCT00736645|10935673|FG002|NOT COMPLETED|Overall Study||0
9824730|NCT00736645|10935674|FG003|NOT COMPLETED|Overall Study||0
9824731|NCT00736723|10935686|FG000|STARTED|Overall Study||30
9824732|NCT00736723|10935687|FG001|STARTED|Overall Study||21
9824733|NCT00736723|10935686|FG000|COMPLETED|Overall Study||26
9824734|NCT00736723|10935687|FG001|COMPLETED|Overall Study||18
9824735|NCT00736723|10935686|FG000|NOT COMPLETED|Overall Study||4
9824736|NCT00736723|10935687|FG001|NOT COMPLETED|Overall Study||3
9824737|NCT00736840|10935693|FG000|STARTED|Overall Study||414
9824738|NCT00736840|10935693|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
9824739|NCT00736840|10935693|FG000|NOT COMPLETED|Overall Study||13
9824740|NCT00736853|10935697|FG000|STARTED|Open-Label Period||319
9824741|NCT00736853|10935698|FG001|STARTED|Open-Label Period||0
9824742|NCT00736853|10935699|FG002|STARTED|Open-Label Period||0
9824743|NCT00736853|10935697|FG000|Treated|Open-Label Period||277
9824744|NCT00736853|10935698|FG001|Treated|Open-Label Period||0
9824745|NCT00736853|10935699|FG002|Treated|Open-Label Period||0
9824746|NCT00736853|10935697|FG000|COMPLETED|Open-Label Period||187
9824747|NCT00736853|10935698|FG001|COMPLETED|Open-Label Period||0
9824748|NCT00736853|10935699|FG002|COMPLETED|Open-Label Period||0
9824749|NCT00736853|10935697|FG000|NOT COMPLETED|Open-Label Period||132
9824750|NCT00736853|10935698|FG001|NOT COMPLETED|Open-Label Period||0
9824751|NCT00736853|10935699|FG002|NOT COMPLETED|Open-Label Period||0
9824752|NCT00736853|10935697|FG000|STARTED|Double-Blind Period||0
9824753|NCT00736853|10935698|FG001|STARTED|Double-Blind Period||94
9824754|NCT00736853|10935699|FG002|STARTED|Double-Blind Period||93
9824755|NCT00736853|10935697|FG000|COMPLETED|Double-Blind Period||0
9824756|NCT00736853|10935698|FG001|COMPLETED|Double-Blind Period||70
9824757|NCT00736853|10935699|FG002|COMPLETED|Double-Blind Period||45
9824758|NCT00736853|10935697|FG000|NOT COMPLETED|Double-Blind Period||0
9824759|NCT00736853|10935698|FG001|NOT COMPLETED|Double-Blind Period||24
9824760|NCT00736853|10935699|FG002|NOT COMPLETED|Double-Blind Period||48
9824761|NCT00736879|10935712|FG000|STARTED|Double Blind Treatment Period||68
9824762|NCT00736879|10935713|FG001|STARTED|Double Blind Treatment Period||72
9824763|NCT00736879|10935714|FG002|STARTED|Double Blind Treatment Period||74
9824764|NCT00736879|10935715|FG003|STARTED|Double Blind Treatment Period||68
9824765|NCT00736879|10935712|FG000|COMPLETED|Double Blind Treatment Period||65
9824766|NCT00736879|10935713|FG001|COMPLETED|Double Blind Treatment Period||68
9824767|NCT00736879|10935714|FG002|COMPLETED|Double Blind Treatment Period||67
9824768|NCT00736879|10935715|FG003|COMPLETED|Double Blind Treatment Period||63
9824769|NCT00736879|10935712|FG000|NOT COMPLETED|Double Blind Treatment Period||3
9824770|NCT00736879|10935713|FG001|NOT COMPLETED|Double Blind Treatment Period||4
9824771|NCT00736879|10935714|FG002|NOT COMPLETED|Double Blind Treatment Period||7
9824772|NCT00736879|10935715|FG003|NOT COMPLETED|Double Blind Treatment Period||5
9824773|NCT00736879|10935712|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
9824774|NCT00736879|10935713|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
9824775|NCT00736879|10935714|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
9824776|NCT00736879|10935715|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
9824777|NCT00736879|10935712|FG000|COMPLETED|Follow up Period - No Drug Treatment||65
9824778|NCT00736879|10935713|FG001|COMPLETED|Follow up Period - No Drug Treatment||67
9824779|NCT00736879|10935714|FG002|COMPLETED|Follow up Period - No Drug Treatment||66
9824780|NCT00736879|10935715|FG003|COMPLETED|Follow up Period - No Drug Treatment||62
9824781|NCT00736879|10935712|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1
9824782|NCT00736879|10935713|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3
9824783|NCT00736879|10935714|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0
9824784|NCT00736879|10935715|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0
10017233|NCT01814813|11140080|FG001|NOT COMPLETED|Overall Study||0
10017234|NCT01814813|11140081|FG002|NOT COMPLETED|Overall Study||0
10017235|NCT01814878|11140091|FG000|STARTED|Overall Study||162
10017236|NCT01814878|11140092|FG001|STARTED|Overall Study||158
10017237|NCT01814878|11140091|FG000|COMPLETED|Overall Study||116
10017238|NCT01814878|11140092|FG001|COMPLETED|Overall Study||128
10017239|NCT01814878|11140091|FG000|NOT COMPLETED|Overall Study||46
10017240|NCT01814878|11140092|FG001|NOT COMPLETED|Overall Study||30
10017241|NCT01815008|11140098|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19
10017242|NCT01815008|11140098|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
10017243|NCT01815008|11140098|FG000|NOT COMPLETED|Overall Study||4
9824785|NCT00736944|10935728|FG000|STARTED|Induction||30
9824786|NCT00736944|10935728|FG000|COMPLETED|Induction||29
9824787|NCT00736944|10935728|FG000|NOT COMPLETED|Induction||1
9824788|NCT00736944|10935728|FG000|STARTED|Definitive Treatment||29
9824789|NCT00736944|10935728|FG000|COMPLETED|Definitive Treatment||28
10017244|NCT01815099|11140104|FG000|STARTED|Overall Study||4
9824790|NCT00736944|10935728|FG000|NOT COMPLETED|Definitive Treatment||1
9824791|NCT00736957|10935735|FG000|STARTED|Overall Study||219
9824792|NCT00736957|10935735|FG000|Treated|Overall Study||190
9824793|NCT00736957|10935735|FG000|COMPLETED|Overall Study||97
9824794|NCT00736957|10935735|FG000|NOT COMPLETED|Overall Study||122
9824795|NCT00736996|10935742|FG000|STARTED|Overall Study||25
9824796|NCT00736996|10935743|FG001|STARTED|Overall Study||26
9824797|NCT00736996|10935744|FG002|STARTED|Overall Study||27
9824798|NCT00736996|10935742|FG000|COMPLETED|Overall Study||24
9824799|NCT00736996|10935743|FG001|COMPLETED|Overall Study||17
9824800|NCT00736996|10935744|FG002|COMPLETED|Overall Study||25
9824801|NCT00736996|10935742|FG000|NOT COMPLETED|Overall Study||1
10017245|NCT01815099|11140104|FG000|Began rTMS Treatment|Overall Study||3
10017246|NCT01815099|11140104|FG000|COMPLETED|Overall Study||2
10017247|NCT01815099|11140104|FG000|NOT COMPLETED|Overall Study||2
10017248|NCT01815138|11140111|FG000|STARTED|Overall Study||34
10017249|NCT01815138|11140112|FG001|STARTED|Overall Study||37
10017250|NCT01815138|11140111|FG000|COMPLETED|Overall Study||26
10017251|NCT01815138|11140112|FG001|COMPLETED|Overall Study||31
10017252|NCT01815138|11140111|FG000|NOT COMPLETED|Overall Study||8
10017253|NCT01815138|11140112|FG001|NOT COMPLETED|Overall Study||6
10017254|NCT01815229|11140121|FG000|STARTED|Overall Study||13
10017255|NCT01815229|11140122|FG001|STARTED|Overall Study||18
10017256|NCT01815229|11140123|FG002|STARTED|Overall Study||51
10017257|NCT01815229|11140121|FG000|COMPLETED|Overall Study||13
10017258|NCT01815229|11140122|FG001|COMPLETED|Overall Study||18
10017259|NCT01815229|11140123|FG002|COMPLETED|Overall Study||0
10017260|NCT01815229|11140121|FG000|NOT COMPLETED|Overall Study||0
10017261|NCT01815229|11140122|FG001|NOT COMPLETED|Overall Study||0
10017262|NCT01815229|11140123|FG002|NOT COMPLETED|Overall Study||51
9824802|NCT00736996|10935743|FG001|NOT COMPLETED|Overall Study||9
9824803|NCT00736996|10935744|FG002|NOT COMPLETED|Overall Study||2
9824804|NCT00737048|10935755|FG000|STARTED|Overall Study||132
9824805|NCT00737048|10935756|FG001|STARTED|Overall Study||66
9824806|NCT00737048|10935757|FG002|STARTED|Overall Study||130
9824807|NCT00737048|10935755|FG000|COMPLETED|Overall Study||129
9824808|NCT00737048|10935756|FG001|COMPLETED|Overall Study||60
9824809|NCT00737048|10935757|FG002|COMPLETED|Overall Study||126
9824810|NCT00737048|10935755|FG000|NOT COMPLETED|Overall Study||3
9824811|NCT00737048|10935756|FG001|NOT COMPLETED|Overall Study||6
9824812|NCT00737048|10935757|FG002|NOT COMPLETED|Overall Study||4
9824813|NCT00737061|10935765|FG000|STARTED|Waiting Period||645
9824814|NCT00737061|10935765|FG000|COMPLETED|Waiting Period||570
9824815|NCT00737061|10935765|FG000|NOT COMPLETED|Waiting Period||75
9824816|NCT00737061|10935765|FG000|STARTED|1 Year Wearing Period||570
9824817|NCT00737061|10935765|FG000|COMPLETED|1 Year Wearing Period||553
9824818|NCT00737061|10935765|FG000|NOT COMPLETED|1 Year Wearing Period||17
9824819|NCT00737100|10935772|FG000|STARTED|Overall Study||168
9824820|NCT00737100|10935773|FG001|STARTED|Overall Study||166
9824821|NCT00737100|10935774|FG002|STARTED|Overall Study||176
9824822|NCT00737100|10935772|FG000|COMPLETED|Overall Study||161
9824823|NCT00737100|10935773|FG001|COMPLETED|Overall Study||159
9824824|NCT00737100|10935774|FG002|COMPLETED|Overall Study||169
9824825|NCT00737100|10935772|FG000|NOT COMPLETED|Overall Study||7
9824826|NCT00737100|10935773|FG001|NOT COMPLETED|Overall Study||7
9824827|NCT00737100|10935774|FG002|NOT COMPLETED|Overall Study||7
9824828|NCT00737178|10935786|FG000|STARTED|Overall Study||71
9824829|NCT00737178|10935787|FG001|STARTED|Overall Study||85
9824830|NCT00737178|10935786|FG000|COMPLETED|Overall Study||66
9824831|NCT00737178|10935787|FG001|COMPLETED|Overall Study||76
9824832|NCT00737178|10935786|FG000|NOT COMPLETED|Overall Study||5
9824833|NCT00737178|10935787|FG001|NOT COMPLETED|Overall Study||9
9824834|NCT00737204|10935795|FG000|STARTED|Overall Study||36
9824835|NCT00737204|10935796|FG001|STARTED|Overall Study||34
9824836|NCT00737204|10935795|FG000|COMPLETED|Overall Study||36
9824837|NCT00737204|10935796|FG001|COMPLETED|Overall Study||28
9824838|NCT00737204|10935795|FG000|NOT COMPLETED|Overall Study||0
9824839|NCT00737204|10935796|FG001|NOT COMPLETED|Overall Study||6
9824840|NCT00737243|10935802|FG000|STARTED|Overall Study||289
9824841|NCT00737243|10935802|FG000|Successful Assay Performed|Overall Study||252
9824842|NCT00737243|10935802|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
9824843|NCT00737243|10935802|FG000|Treated|Overall Study||223
9824844|NCT00737243|10935802|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
9824845|NCT00737243|10935802|FG000|Site Specific Therapy More Responsive|Overall Study||115
9824846|NCT00737243|10935802|FG000|Site Specific Therapy Less Responsive|Overall Study||79
9824847|NCT00737243|10935802|FG000|Empiric CUP Therapy|Overall Study||29
9824848|NCT00737243|10935802|FG000|COMPLETED|Overall Study||194
9824849|NCT00737243|10935802|FG000|NOT COMPLETED|Overall Study||95
9824850|NCT00737360|10935808|FG000|STARTED|Overall Study||27
9824851|NCT00737360|10935808|FG000|COMPLETED|Overall Study||27
9824852|NCT00737360|10935808|FG000|NOT COMPLETED|Overall Study||0
9824853|NCT00737438|10935812|FG000|STARTED|Overall Study||23
9824854|NCT00737438|10935812|FG000|COMPLETED|Overall Study||20
9824855|NCT00737438|10935812|FG000|NOT COMPLETED|Overall Study||3
9824856|NCT00737464|10935816|FG000|STARTED|Overall Study||132
9824857|NCT00737464|10935816|FG000|COMPLETED|Overall Study||114
9824858|NCT00737464|10935816|FG000|NOT COMPLETED|Overall Study||18
10017263|NCT01815333|11140130|FG000|STARTED|Overall Study||10
10017264|NCT01815333|11140130|FG000|COMPLETED|Overall Study||10
10017265|NCT01815333|11140130|FG000|NOT COMPLETED|Overall Study||0
10017266|NCT01815424|11140137|FG000|STARTED|Week 0 to 16||90
9824859|NCT00737477|10935820|FG000|STARTED|Overall Study||96
9824860|NCT00737477|10935820|FG000|COMPLETED|Overall Study||62
9824861|NCT00737477|10935820|FG000|NOT COMPLETED|Overall Study||34
9824862|NCT00737529|10935824|FG000|STARTED|Overall Study||134
9824863|NCT00737529|10935824|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
9824864|NCT00737529|10935824|FG000|NOT COMPLETED|Overall Study||133
9824865|NCT00737568|10935830|FG000|STARTED|Treatment Period Through Week 240||141
9824866|NCT00737568|10935831|FG001|STARTED|Treatment Period Through Week 240||139
9824867|NCT00737568|10935830|FG000|COMPLETED|Treatment Period Through Week 240||121
9824868|NCT00737568|10935831|FG001|COMPLETED|Treatment Period Through Week 240||118
9824869|NCT00737568|10935830|FG000|NOT COMPLETED|Treatment Period Through Week 240||20
9824870|NCT00737568|10935831|FG001|NOT COMPLETED|Treatment Period Through Week 240||21
9824871|NCT00737568|10935830|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
9824872|NCT00737568|10935831|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
9824873|NCT00737568|10935830|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
9824874|NCT00737568|10935831|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
9824875|NCT00737568|10935830|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
9824876|NCT00737568|10935831|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
9824877|NCT00737633|10935839|FG000|STARTED|Overall Study||44
9824878|NCT00737633|10935840|FG001|STARTED|Overall Study||57
9824879|NCT00737633|10935839|FG000|COMPLETED|Overall Study||0
9824880|NCT00737633|10935840|FG001|COMPLETED|Overall Study||0
9824881|NCT00737633|10935839|FG000|NOT COMPLETED|Overall Study||44
9824882|NCT00737633|10935840|FG001|NOT COMPLETED|Overall Study||57
9832254|NCT00772148|10943028|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21
9832255|NCT00772148|10943029|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23
9832256|NCT00772148|10943028|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
9832257|NCT00772148|10943029|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
9832258|NCT00772148|10943028|FG000|STARTED|Maintenance Phase (Week 52)||21
9832259|NCT00772148|10943029|FG001|STARTED|Maintenance Phase (Week 52)||23
9832260|NCT00772148|10943028|FG000|COMPLETED|Maintenance Phase (Week 52)||17
9832261|NCT00772148|10943029|FG001|COMPLETED|Maintenance Phase (Week 52)||18
9832262|NCT00772148|10943028|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4
9832263|NCT00772148|10943029|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5
9832264|NCT00772304|10943035|FG000|STARTED|Overall Study||102
9832265|NCT00772304|10943035|FG000|COMPLETED|Overall Study||102
9832266|NCT00772304|10943035|FG000|NOT COMPLETED|Overall Study||0
9832267|NCT00772330|10943039|FG000|STARTED|Overall Study||23
9832268|NCT00772330|10943039|FG000|COMPLETED|Overall Study||20
9832269|NCT00772330|10943039|FG000|NOT COMPLETED|Overall Study||3
9832270|NCT00772369|10943046|FG000|STARTED|Overall Study||3214
9832271|NCT00772369|10943046|FG000|COMPLETED|Overall Study||3213
9832272|NCT00772369|10943046|FG000|NOT COMPLETED|Overall Study||1
9832273|NCT00772382|10943050|FG000|STARTED|Overall Study||116
10017267|NCT01815424|11140138|FG001|STARTED|Week 0 to 16||88
10017268|NCT01815424|11140139|FG002|STARTED|Week 0 to 16||88
10017269|NCT01815424|11140140|FG003|STARTED|Week 0 to 16||0
10017270|NCT01815424|11140141|FG004|STARTED|Week 0 to 16||0
10017271|NCT01815424|11140137|FG000|COMPLETED|Week 0 to 16||83
10017272|NCT01815424|11140138|FG001|COMPLETED|Week 0 to 16||84
10017273|NCT01815424|11140139|FG002|COMPLETED|Week 0 to 16||77
10017274|NCT01815424|11140140|FG003|COMPLETED|Week 0 to 16||0
10017275|NCT01815424|11140141|FG004|COMPLETED|Week 0 to 16||0
9832274|NCT00772382|10943050|FG000|COMPLETED|Overall Study||61
9832275|NCT00772382|10943050|FG000|NOT COMPLETED|Overall Study||55
9832276|NCT00772447|10943056|FG000|STARTED|Overall Study||131
9832277|NCT00772447|10943057|FG001|STARTED|Overall Study||134
9832278|NCT00772447|10943056|FG000|COMPLETED|Overall Study||111
9832279|NCT00772447|10943057|FG001|COMPLETED|Overall Study||110
9832280|NCT00772447|10943056|FG000|NOT COMPLETED|Overall Study||20
9832281|NCT00772447|10943057|FG001|NOT COMPLETED|Overall Study||24
9832282|NCT00772538|10943066|FG000|STARTED|Overall Study||222
9832283|NCT00772538|10943067|FG001|STARTED|Overall Study||237
9832284|NCT00772538|10943066|FG000|COMPLETED|Overall Study||202
9832285|NCT00772538|10943067|FG001|COMPLETED|Overall Study||211
9832286|NCT00772538|10943066|FG000|NOT COMPLETED|Overall Study||20
9832287|NCT00772538|10943067|FG001|NOT COMPLETED|Overall Study||26
9832288|NCT00772577|10943075|FG000|STARTED|Overall Study||193
9832289|NCT00772577|10943076|FG001|STARTED|Overall Study||193
9832290|NCT00772577|10943075|FG000|COMPLETED|Overall Study||170
9832291|NCT00772577|10943076|FG001|COMPLETED|Overall Study||170
10017276|NCT01815424|11140137|FG000|NOT COMPLETED|Week 0 to 16||7
9832292|NCT00772577|10943075|FG000|NOT COMPLETED|Overall Study||23
9832293|NCT00772577|10943076|FG001|NOT COMPLETED|Overall Study||23
9832294|NCT00772590|10943086|FG000|STARTED|Overall Study||19
9832295|NCT00772590|10943087|FG001|STARTED|Overall Study||19
9832296|NCT00772590|10943088|FG002|STARTED|Overall Study||18
9832297|NCT00772590|10943089|FG003|STARTED|Overall Study||17
9832298|NCT00772590|10943086|FG000|COMPLETED|Overall Study||19
9832299|NCT00772590|10943087|FG001|COMPLETED|Overall Study||19
9832300|NCT00772590|10943088|FG002|COMPLETED|Overall Study||18
9832301|NCT00772590|10943089|FG003|COMPLETED|Overall Study||17
10017277|NCT01815424|11140138|FG001|NOT COMPLETED|Week 0 to 16||4
10017278|NCT01815424|11140139|FG002|NOT COMPLETED|Week 0 to 16||11
10017279|NCT01815424|11140140|FG003|NOT COMPLETED|Week 0 to 16||0
10017280|NCT01815424|11140141|FG004|NOT COMPLETED|Week 0 to 16||0
9824883|NCT00737672|10935848|FG000|STARTED|Overall Study||145
9824884|NCT00737672|10935849|FG001|STARTED|Overall Study||148
9824885|NCT00737672|10935848|FG000|Exclusions Due to Protocol Deviations|Overall Study||14
9824886|NCT00737672|10935849|FG001|Exclusions Due to Protocol Deviations|Overall Study||10
9824887|NCT00737672|10935848|FG000|Per Protocol Population|Overall Study||131
9824888|NCT00737672|10935849|FG001|Per Protocol Population|Overall Study||138
10017281|NCT01815424|11140137|FG000|STARTED|Week 16 to 52||83
10017282|NCT01815424|11140138|FG001|STARTED|Week 16 to 52||84
9824889|NCT00737672|10935848|FG000|COMPLETED|Overall Study||65
9824890|NCT00737672|10935849|FG001|COMPLETED|Overall Study||65
9824891|NCT00737672|10935848|FG000|NOT COMPLETED|Overall Study||80
9824892|NCT00737672|10935849|FG001|NOT COMPLETED|Overall Study||83
9824893|NCT00737698|10935858|FG000|STARTED|Overall Study||23
9824894|NCT00737698|10935859|FG001|STARTED|Overall Study||42
9824895|NCT00737698|10935860|FG002|STARTED|Overall Study||21
9824896|NCT00737698|10935858|FG000|COMPLETED|Overall Study||17
9824897|NCT00737698|10935859|FG001|COMPLETED|Overall Study||37
9824898|NCT00737698|10935860|FG002|COMPLETED|Overall Study||17
9824899|NCT00737698|10935858|FG000|NOT COMPLETED|Overall Study||6
9824900|NCT00737698|10935859|FG001|NOT COMPLETED|Overall Study||5
9824901|NCT00737698|10935860|FG002|NOT COMPLETED|Overall Study||4
9824902|NCT00737711|10935868|FG000|STARTED|Overall Study||189
9824903|NCT00737711|10935868|FG000|COMPLETED|Overall Study||158
9824904|NCT00737711|10935868|FG000|NOT COMPLETED|Overall Study||31
9824905|NCT00737737|10935874|FG000|STARTED|Overall Study||2
9824906|NCT00737737|10935875|FG001|STARTED|Overall Study||2
9824907|NCT00737737|10935874|FG000|COMPLETED|Overall Study||2
9824908|NCT00737737|10935875|FG001|COMPLETED|Overall Study||2
9824909|NCT00737737|10935874|FG000|NOT COMPLETED|Overall Study||0
9824910|NCT00737737|10935875|FG001|NOT COMPLETED|Overall Study||0
9824911|NCT00737893|10935883|FG000|STARTED|Overall Study||29
9824912|NCT00737893|10935884|FG001|STARTED|Overall Study||27
9824913|NCT00737893|10935883|FG000|COMPLETED|Overall Study||29
9824914|NCT00737893|10935884|FG001|COMPLETED|Overall Study||27
9824915|NCT00737893|10935883|FG000|NOT COMPLETED|Overall Study||0
9824916|NCT00737893|10935884|FG001|NOT COMPLETED|Overall Study||0
9824917|NCT00738023|10935892|FG000|STARTED|Intralipid Infusion||19
9824918|NCT00738023|10935893|FG001|STARTED|Intralipid Infusion||13
9824919|NCT00738023|10935892|FG000|COMPLETED|Intralipid Infusion||19
9824920|NCT00738023|10935893|FG001|COMPLETED|Intralipid Infusion||13
9824921|NCT00738023|10935892|FG000|NOT COMPLETED|Intralipid Infusion||0
9824922|NCT00738023|10935893|FG001|NOT COMPLETED|Intralipid Infusion||0
9824923|NCT00738023|10935892|FG000|STARTED|Saline Infusion||19
9824924|NCT00738023|10935893|FG001|STARTED|Saline Infusion||0
9824925|NCT00738023|10935892|FG000|COMPLETED|Saline Infusion||19
9824926|NCT00738023|10935893|FG001|COMPLETED|Saline Infusion||0
9824927|NCT00738023|10935892|FG000|NOT COMPLETED|Saline Infusion||0
9824928|NCT00738023|10935893|FG001|NOT COMPLETED|Saline Infusion||0
9824929|NCT00738023|10935892|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
9824930|NCT00738023|10935893|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
9824931|NCT00738023|10935892|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
9824932|NCT00738023|10935893|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
9824933|NCT00738023|10935892|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
9824934|NCT00738023|10935893|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
9824935|NCT00738049|10935902|FG000|STARTED|1st Intervention(14 Days)||13
9824936|NCT00738049|10935903|FG001|STARTED|1st Intervention(14 Days)||7
9824937|NCT00738049|10935902|FG000|COMPLETED|1st Intervention(14 Days)||13
9824938|NCT00738049|10935903|FG001|COMPLETED|1st Intervention(14 Days)||7
9824939|NCT00738049|10935902|FG000|NOT COMPLETED|1st Intervention(14 Days)||0
9824940|NCT00738049|10935903|FG001|NOT COMPLETED|1st Intervention(14 Days)||0
9824941|NCT00738049|10935902|FG000|STARTED|2nd Intervention(14 Days)||13
9824942|NCT00738049|10935903|FG001|STARTED|2nd Intervention(14 Days)||7
9824943|NCT00738049|10935902|FG000|COMPLETED|2nd Intervention(14 Days)||13
9824944|NCT00738049|10935903|FG001|COMPLETED|2nd Intervention(14 Days)||7
9824945|NCT00738049|10935902|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0
9824946|NCT00738049|10935903|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0
9824947|NCT00738049|10935902|FG000|STARTED|Washout||13
9824948|NCT00738049|10935903|FG001|STARTED|Washout||7
9824949|NCT00738049|10935902|FG000|COMPLETED|Washout||13
9824950|NCT00738049|10935903|FG001|COMPLETED|Washout||7
9824951|NCT00738049|10935902|FG000|NOT COMPLETED|Washout||0
9824952|NCT00738049|10935903|FG001|NOT COMPLETED|Washout||0
9824953|NCT00738062|10935918|FG000|STARTED|Open Label Treatment||103
9824954|NCT00738062|10935919|FG001|STARTED|Open Label Treatment||0
9824955|NCT00738062|10935920|FG002|STARTED|Open Label Treatment||0
10017283|NCT01815424|11140139|FG002|STARTED|Week 16 to 52||0
9824956|NCT00738062|10935918|FG000|COMPLETED|Open Label Treatment||75
9824957|NCT00738062|10935919|FG001|COMPLETED|Open Label Treatment||0
9824958|NCT00738062|10935920|FG002|COMPLETED|Open Label Treatment||0
9824959|NCT00738062|10935918|FG000|NOT COMPLETED|Open Label Treatment||28
9824960|NCT00738062|10935919|FG001|NOT COMPLETED|Open Label Treatment||0
9824961|NCT00738062|10935920|FG002|NOT COMPLETED|Open Label Treatment||0
9824962|NCT00738062|10935918|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
9824963|NCT00738062|10935919|FG001|STARTED|2 Week Randomized Withdrawal||38
9824964|NCT00738062|10935920|FG002|STARTED|2 Week Randomized Withdrawal||37
9824965|NCT00738062|10935918|FG000|COMPLETED|2 Week Randomized Withdrawal||0
9824966|NCT00738062|10935919|FG001|COMPLETED|2 Week Randomized Withdrawal||38
9824967|NCT00738062|10935920|FG002|COMPLETED|2 Week Randomized Withdrawal||37
9824968|NCT00738062|10935918|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0
9824969|NCT00738062|10935919|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0
9824970|NCT00738062|10935920|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0
9824971|NCT00738062|10935918|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
9824972|NCT00738062|10935919|FG001|STARTED|Open-Label Extension||0
9824973|NCT00738062|10935920|FG002|STARTED|Open-Label Extension||0
9824974|NCT00738062|10935918|FG000|COMPLETED|Open-Label Extension||57
9824975|NCT00738062|10935919|FG001|COMPLETED|Open-Label Extension||0
9824976|NCT00738062|10935920|FG002|COMPLETED|Open-Label Extension||0
9824977|NCT00738062|10935918|FG000|NOT COMPLETED|Open-Label Extension||17
9824978|NCT00738062|10935919|FG001|NOT COMPLETED|Open-Label Extension||0
9824979|NCT00738062|10935920|FG002|NOT COMPLETED|Open-Label Extension||0
9824980|NCT00738101|10935929|FG000|STARTED|Overall Study||293
9824981|NCT00738101|10935929|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
9824982|NCT00738101|10935929|FG000|NOT COMPLETED|Overall Study||7
9824983|NCT00738283|10935933|FG000|STARTED|Overall Study||17
9824984|NCT00738283|10935933|FG000|COMPLETED|Overall Study||13
9824985|NCT00738283|10935933|FG000|NOT COMPLETED|Overall Study||4
9824986|NCT00738361|10935937|FG000|STARTED|Overall Study||4
9824987|NCT00738361|10935937|FG000|COMPLETED|Overall Study||4
9824988|NCT00738361|10935937|FG000|NOT COMPLETED|Overall Study||0
9824989|NCT00738374|10935945|FG000|STARTED|Induction Treatment Phase||97
9824990|NCT00738374|10935946|FG001|STARTED|Induction Treatment Phase||0
9824991|NCT00738374|10935947|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
9824992|NCT00738374|10935948|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
9824993|NCT00738374|10935945|FG000|COMPLETED|Induction Treatment Phase||73
9824994|NCT00738374|10935946|FG001|COMPLETED|Induction Treatment Phase||0
9824995|NCT00738374|10935947|FG002|COMPLETED|Induction Treatment Phase||0
9824996|NCT00738374|10935948|FG003|COMPLETED|Induction Treatment Phase||0
9824997|NCT00738374|10935945|FG000|NOT COMPLETED|Induction Treatment Phase||24
9824998|NCT00738374|10935946|FG001|NOT COMPLETED|Induction Treatment Phase||0
9824999|NCT00738374|10935947|FG002|NOT COMPLETED|Induction Treatment Phase||0
9825000|NCT00738374|10935948|FG003|NOT COMPLETED|Induction Treatment Phase||0
9825001|NCT00738374|10935945|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
9825002|NCT00738374|10935946|FG001|STARTED|Maintenance Treatment/Observation Phase||7
9825003|NCT00738374|10935947|FG002|STARTED|Maintenance Treatment/Observation Phase||34
9825004|NCT00738374|10935948|FG003|STARTED|Maintenance Treatment/Observation Phase||32
9825005|NCT00738374|10935945|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0
9825006|NCT00738374|10935946|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0
9825007|NCT00738374|10935947|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27
9825008|NCT00738374|10935948|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20
9825009|NCT00738374|10935945|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
9825010|NCT00738374|10935946|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
9825011|NCT00738374|10935947|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
9825012|NCT00738374|10935948|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
9825013|NCT00738400|10935959|FG000|STARTED|Overall Study||76
9825014|NCT00738400|10935960|FG001|STARTED|Overall Study||74
9825015|NCT00738400|10935959|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
9825016|NCT00738400|10935960|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
9825017|NCT00738400|10935959|FG000|ITT (Intent To Treatment) Population|Overall Study||75
9825018|NCT00738400|10935960|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
9825019|NCT00738400|10935959|FG000|COMPLETED|Overall Study||72
9825020|NCT00738400|10935960|FG001|COMPLETED|Overall Study||67
9825021|NCT00738400|10935959|FG000|NOT COMPLETED|Overall Study||4
9825022|NCT00738400|10935960|FG001|NOT COMPLETED|Overall Study||7
9825023|NCT00738426|10935968|FG000|STARTED|Overall Study||37
9825024|NCT00738426|10935969|FG001|STARTED|Overall Study||35
9825025|NCT00738426|10935968|FG000|COMPLETED|Overall Study||35
9825026|NCT00738426|10935969|FG001|COMPLETED|Overall Study||32
9825027|NCT00738426|10935968|FG000|NOT COMPLETED|Overall Study||2
9825028|NCT00738426|10935969|FG001|NOT COMPLETED|Overall Study||3
9825029|NCT00738530|10935977|FG000|STARTED|Overall Study||327
9825030|NCT00738530|10935978|FG001|STARTED|Overall Study||322
9825031|NCT00738530|10935977|FG000|Treated|Overall Study||325
9825032|NCT00738530|10935978|FG001|Treated|Overall Study||316
9825033|NCT00738530|10935977|FG000|COMPLETED|Overall Study||93
9825034|NCT00738530|10935978|FG001|COMPLETED|Overall Study||84
9825035|NCT00738530|10935977|FG000|NOT COMPLETED|Overall Study||234
9825036|NCT00738530|10935978|FG001|NOT COMPLETED|Overall Study||238
9825037|NCT00738543|10935984|FG000|STARTED|Povidone Iodine||48
9825038|NCT00738543|10935984|FG000|COMPLETED|Povidone Iodine||48
10017284|NCT01815424|11140140|FG003|STARTED|Week 16 to 52||38
10017285|NCT01815424|11140141|FG004|STARTED|Week 16 to 52||39
10017286|NCT01815424|11140137|FG000|COMPLETED|Week 16 to 52||81
10017287|NCT01815424|11140138|FG001|COMPLETED|Week 16 to 52||79
10017288|NCT01815424|11140139|FG002|COMPLETED|Week 16 to 52||0
9825039|NCT00738543|10935984|FG000|NOT COMPLETED|Povidone Iodine||0
9825040|NCT00738543|10935984|FG000|STARTED|Sodium Hypochlorite||48
9825041|NCT00738543|10935984|FG000|COMPLETED|Sodium Hypochlorite||48
9825042|NCT00738543|10935984|FG000|NOT COMPLETED|Sodium Hypochlorite||0
9825043|NCT00738543|10935984|FG000|STARTED|Control||48
9825044|NCT00738543|10935984|FG000|COMPLETED|Control||48
9825045|NCT00738543|10935984|FG000|NOT COMPLETED|Control||0
9825046|NCT00738673|10935990|FG000|STARTED|Overall Study||25
9825047|NCT00738673|10935991|FG001|STARTED|Overall Study||12
9825048|NCT00738673|10935990|FG000|Intent to Treat Population|Overall Study||24
9825049|NCT00738673|10935991|FG001|Intent to Treat Population|Overall Study||12
9825050|NCT00738673|10935990|FG000|COMPLETED|Overall Study||1
10017289|NCT01815424|11140140|FG003|COMPLETED|Week 16 to 52||35
10017290|NCT01815424|11140141|FG004|COMPLETED|Week 16 to 52||36
10017291|NCT01815424|11140137|FG000|NOT COMPLETED|Week 16 to 52||2
9825051|NCT00738673|10935991|FG001|COMPLETED|Overall Study||1
9825052|NCT00738673|10935990|FG000|NOT COMPLETED|Overall Study||24
9825053|NCT00738673|10935991|FG001|NOT COMPLETED|Overall Study||11
9825054|NCT00738699|10935999|FG000|STARTED|Overall Study||275
9825055|NCT00738699|10936000|FG001|STARTED|Overall Study||140
9825056|NCT00738699|10935999|FG000|Participants Not Treated|Overall Study||2
9825057|NCT00738699|10936000|FG001|Participants Not Treated|Overall Study||1
9825058|NCT00738699|10935999|FG000|Participants Treated|Overall Study||273
9825059|NCT00738699|10936000|FG001|Participants Treated|Overall Study||139
9825060|NCT00738699|10935999|FG000|COMPLETED|Overall Study||0
9825061|NCT00738699|10936000|FG001|COMPLETED|Overall Study||0
9825062|NCT00738699|10935999|FG000|NOT COMPLETED|Overall Study||275
9825063|NCT00738699|10936000|FG001|NOT COMPLETED|Overall Study||140
9825064|NCT00738881|10936008|FG000|STARTED|Overall Study||11
9825065|NCT00738881|10936009|FG001|STARTED|Overall Study||12
9825066|NCT00738881|10936008|FG000|COMPLETED|Overall Study||11
9825067|NCT00738881|10936009|FG001|COMPLETED|Overall Study||10
9825068|NCT00738881|10936008|FG000|NOT COMPLETED|Overall Study||0
9825069|NCT00738881|10936009|FG001|NOT COMPLETED|Overall Study||2
9825070|NCT00738894|10936017|FG000|STARTED|Overall Study||441
9825071|NCT00738894|10936018|FG001|STARTED|Overall Study||223
9825072|NCT00738894|10936017|FG000|COMPLETED|Overall Study||402
9825073|NCT00738894|10936018|FG001|COMPLETED|Overall Study||190
9825074|NCT00738894|10936017|FG000|NOT COMPLETED|Overall Study||39
9825075|NCT00738894|10936018|FG001|NOT COMPLETED|Overall Study||33
9825076|NCT00739102|10936024|FG000|STARTED|Overall Study||250
9825077|NCT00739102|10936024|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
9825078|NCT00739102|10936024|FG000|NOT COMPLETED|Overall Study||15
9825079|NCT00739297|10936028|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17
9825080|NCT00739297|10936029|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11
9825081|NCT00739297|10936030|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6
9825082|NCT00739297|10936031|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19
9825083|NCT00739297|10936032|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6
9825084|NCT00739297|10936033|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9
9825085|NCT00739297|10936034|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68
9825086|NCT00739297|10936028|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
9825087|NCT00739297|10936029|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
9825088|NCT00739297|10936030|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
9825089|NCT00739297|10936031|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
9825090|NCT00739297|10936032|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
9825091|NCT00739297|10936033|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
9825092|NCT00739297|10936034|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
9825093|NCT00739297|10936028|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
9825094|NCT00739297|10936029|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
9825095|NCT00739297|10936030|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
9825096|NCT00739297|10936031|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
9825097|NCT00739297|10936032|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
9825098|NCT00739297|10936033|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
9825099|NCT00739297|10936034|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
9825100|NCT00739297|10936028|FG000|STARTED|First Washout Period of 4-7 Days||17
9825101|NCT00739297|10936029|FG001|STARTED|First Washout Period of 4-7 Days||11
9825102|NCT00739297|10936030|FG002|STARTED|First Washout Period of 4-7 Days||6
9825103|NCT00739297|10936031|FG003|STARTED|First Washout Period of 4-7 Days||19
9825104|NCT00739297|10936032|FG004|STARTED|First Washout Period of 4-7 Days||6
9825105|NCT00739297|10936033|FG005|STARTED|First Washout Period of 4-7 Days||9
9825106|NCT00739297|10936034|FG006|STARTED|First Washout Period of 4-7 Days||68
9825107|NCT00739297|10936028|FG000|COMPLETED|First Washout Period of 4-7 Days||17
9825108|NCT00739297|10936029|FG001|COMPLETED|First Washout Period of 4-7 Days||11
9825109|NCT00739297|10936030|FG002|COMPLETED|First Washout Period of 4-7 Days||6
9825110|NCT00739297|10936031|FG003|COMPLETED|First Washout Period of 4-7 Days||17
9825111|NCT00739297|10936032|FG004|COMPLETED|First Washout Period of 4-7 Days||6
9825112|NCT00739297|10936033|FG005|COMPLETED|First Washout Period of 4-7 Days||9
9825113|NCT00739297|10936034|FG006|COMPLETED|First Washout Period of 4-7 Days||66
9825114|NCT00739297|10936028|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0
9825115|NCT00739297|10936029|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0
9832302|NCT00772590|10943086|FG000|NOT COMPLETED|Overall Study||0
10017292|NCT01815424|11140138|FG001|NOT COMPLETED|Week 16 to 52||5
10017293|NCT01815424|11140139|FG002|NOT COMPLETED|Week 16 to 52||0
9825116|NCT00739297|10936030|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0
9825117|NCT00739297|10936031|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2
9825118|NCT00739297|10936032|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0
9825119|NCT00739297|10936033|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0
9825120|NCT00739297|10936034|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2
9825121|NCT00739297|10936028|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18
9825122|NCT00739297|10936029|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8
9825123|NCT00739297|10936030|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10
9825124|NCT00739297|10936031|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14
9825125|NCT00739297|10936032|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6
9825126|NCT00739297|10936033|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10
9825127|NCT00739297|10936034|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66
9825128|NCT00739297|10936028|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
9825129|NCT00739297|10936029|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
9825130|NCT00739297|10936030|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
9825131|NCT00739297|10936031|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
9825132|NCT00739297|10936032|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
9825133|NCT00739297|10936033|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
9825134|NCT00739297|10936034|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
10112460|NCT02503332|11243429|FG002|NOT COMPLETED|Overall Study||8
10112461|NCT02503332|11243430|FG003|NOT COMPLETED|Overall Study||4
10112462|NCT02503410|11243446|FG000|STARTED|Overall Study||4
9825135|NCT00739297|10936028|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
9825136|NCT00739297|10936029|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
9825137|NCT00739297|10936030|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
9825138|NCT00739297|10936031|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
9825139|NCT00739297|10936032|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
9825140|NCT00739297|10936033|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
9825141|NCT00739297|10936034|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
9825142|NCT00739297|10936028|FG000|STARTED|Second Washout Period of 4-7 Days||18
9825143|NCT00739297|10936029|FG001|STARTED|Second Washout Period of 4-7 Days||8
9825144|NCT00739297|10936030|FG002|STARTED|Second Washout Period of 4-7 Days||10
9825145|NCT00739297|10936031|FG003|STARTED|Second Washout Period of 4-7 Days||14
9825146|NCT00739297|10936032|FG004|STARTED|Second Washout Period of 4-7 Days||6
9825147|NCT00739297|10936033|FG005|STARTED|Second Washout Period of 4-7 Days||10
9825148|NCT00739297|10936034|FG006|STARTED|Second Washout Period of 4-7 Days||66
9825149|NCT00739297|10936028|FG000|COMPLETED|Second Washout Period of 4-7 Days||18
9825150|NCT00739297|10936029|FG001|COMPLETED|Second Washout Period of 4-7 Days||8
9825151|NCT00739297|10936030|FG002|COMPLETED|Second Washout Period of 4-7 Days||10
9825152|NCT00739297|10936031|FG003|COMPLETED|Second Washout Period of 4-7 Days||14
9825153|NCT00739297|10936032|FG004|COMPLETED|Second Washout Period of 4-7 Days||6
9825154|NCT00739297|10936033|FG005|COMPLETED|Second Washout Period of 4-7 Days||10
9825155|NCT00739297|10936034|FG006|COMPLETED|Second Washout Period of 4-7 Days||66
9825156|NCT00739297|10936028|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0
9825157|NCT00739297|10936029|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0
9825158|NCT00739297|10936030|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10112463|NCT02503410|11243447|FG001|STARTED|Overall Study||3
10112464|NCT02503410|11243446|FG000|COMPLETED|Overall Study||4
10112465|NCT02503410|11243447|FG001|COMPLETED|Overall Study||3
10112466|NCT02503410|11243446|FG000|NOT COMPLETED|Overall Study||0
10112467|NCT02503410|11243447|FG001|NOT COMPLETED|Overall Study||0
10112468|NCT02503501|11243460|FG000|STARTED|Overall Study||19
10112469|NCT02503501|11243461|FG001|STARTED|Overall Study||16
10112470|NCT02503501|11243460|FG000|COMPLETED|Overall Study||18
10112471|NCT02503501|11243461|FG001|COMPLETED|Overall Study||13
10112472|NCT02503501|11243460|FG000|NOT COMPLETED|Overall Study||1
10112473|NCT02503501|11243461|FG001|NOT COMPLETED|Overall Study||3
10112474|NCT02503540|11243467|FG000|STARTED|Overall Study||31
10112475|NCT02503540|11243467|FG000|COMPLETED|Overall Study||28
10112476|NCT02503540|11243467|FG000|NOT COMPLETED|Overall Study||3
10112477|NCT02503735|11243471|FG000|STARTED|Overall Study||10
10112478|NCT02503735|11243471|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
10112479|NCT02503735|11243471|FG000|COMPLETED|Overall Study||10
10112480|NCT02503735|11243471|FG000|NOT COMPLETED|Overall Study||0
10112481|NCT02503787|11243481|FG000|STARTED|Enrollment||64
10112482|NCT02503787|11243481|FG000|COMPLETED|Enrollment||44
10112483|NCT02503787|11243481|FG000|NOT COMPLETED|Enrollment||20
10112484|NCT02503787|11243481|FG000|STARTED|Device Trial (HD Programming Trial)||44
10112485|NCT02503787|11243481|FG000|COMPLETED|Device Trial (HD Programming Trial)||37
10112486|NCT02503787|11243481|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7
9825159|NCT00739297|10936031|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0
9825160|NCT00739297|10936032|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0
9825161|NCT00739297|10936033|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0
9825162|NCT00739297|10936034|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0
9825163|NCT00739297|10936028|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16
9825164|NCT00739297|10936029|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12
9825165|NCT00739297|10936030|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6
9825166|NCT00739297|10936031|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18
9825167|NCT00739297|10936032|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6
9825168|NCT00739297|10936033|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8
9825169|NCT00739297|10936034|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66
9825170|NCT00739297|10936028|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
9825171|NCT00739297|10936029|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
9825172|NCT00739297|10936030|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
9825173|NCT00739297|10936031|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
9825174|NCT00739297|10936032|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
9825175|NCT00739297|10936033|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
9825176|NCT00739297|10936034|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
9825177|NCT00739297|10936028|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
9825178|NCT00739297|10936029|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
9825179|NCT00739297|10936030|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
9825180|NCT00739297|10936031|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
9825181|NCT00739297|10936032|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
9825182|NCT00739297|10936033|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
9825183|NCT00739297|10936034|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
9825184|NCT00739297|10936028|FG000|STARTED|Third Washout Period of 4-7 Days||16
9825185|NCT00739297|10936029|FG001|STARTED|Third Washout Period of 4-7 Days||12
9825186|NCT00739297|10936030|FG002|STARTED|Third Washout Period of 4-7 Days||6
9825187|NCT00739297|10936031|FG003|STARTED|Third Washout Period of 4-7 Days||18
9825188|NCT00739297|10936032|FG004|STARTED|Third Washout Period of 4-7 Days||6
9825189|NCT00739297|10936033|FG005|STARTED|Third Washout Period of 4-7 Days||8
9825190|NCT00739297|10936034|FG006|STARTED|Third Washout Period of 4-7 Days||66
9825191|NCT00739297|10936028|FG000|COMPLETED|Third Washout Period of 4-7 Days||16
9825192|NCT00739297|10936029|FG001|COMPLETED|Third Washout Period of 4-7 Days||12
9825193|NCT00739297|10936030|FG002|COMPLETED|Third Washout Period of 4-7 Days||6
9825194|NCT00739297|10936031|FG003|COMPLETED|Third Washout Period of 4-7 Days||18
9825195|NCT00739297|10936032|FG004|COMPLETED|Third Washout Period of 4-7 Days||6
9825196|NCT00739297|10936033|FG005|COMPLETED|Third Washout Period of 4-7 Days||8
9825197|NCT00739297|10936034|FG006|COMPLETED|Third Washout Period of 4-7 Days||66
9825198|NCT00739297|10936028|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0
9825199|NCT00739297|10936029|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0
9825200|NCT00739297|10936030|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0
9825201|NCT00739297|10936031|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0
9825202|NCT00739297|10936032|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0
9825203|NCT00739297|10936033|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0
9825204|NCT00739297|10936034|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0
9825205|NCT00739297|10936028|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
9825206|NCT00739297|10936029|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
9825207|NCT00739297|10936030|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
9825208|NCT00739297|10936031|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
9825209|NCT00739297|10936032|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
9825210|NCT00739297|10936033|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
9825211|NCT00739297|10936034|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
9825212|NCT00739297|10936028|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
9825213|NCT00739297|10936029|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
9825214|NCT00739297|10936030|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
9825215|NCT00739297|10936031|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
9825216|NCT00739297|10936032|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
9825217|NCT00739297|10936033|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
9825218|NCT00739297|10936034|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
9825219|NCT00739297|10936028|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
9825220|NCT00739297|10936029|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
9825221|NCT00739297|10936030|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
9825222|NCT00739297|10936031|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
9825223|NCT00739297|10936032|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
9825224|NCT00739297|10936033|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
9825225|NCT00739297|10936034|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
9825226|NCT00739310|10936050|FG000|STARTED|Overall Study||29
9825227|NCT00739310|10936050|FG000|COMPLETED|Overall Study||22
9825228|NCT00739310|10936050|FG000|NOT COMPLETED|Overall Study||7
9825229|NCT00739336|10936057|FG000|STARTED|Overall Study||21
9825230|NCT00739336|10936058|FG001|STARTED|Overall Study||24
9825231|NCT00739336|10936057|FG000|COMPLETED|Overall Study||17
9825232|NCT00739336|10936058|FG001|COMPLETED|Overall Study||24
9825233|NCT00739336|10936057|FG000|NOT COMPLETED|Overall Study||4
9825234|NCT00739336|10936058|FG001|NOT COMPLETED|Overall Study||0
9825235|NCT00739583|10936066|FG000|STARTED|Overall Study||10
9825236|NCT00739583|10936067|FG001|STARTED|Overall Study||10
9825237|NCT00739583|10936066|FG000|COMPLETED|Overall Study||10
9825238|NCT00739583|10936067|FG001|COMPLETED|Overall Study||10
9825239|NCT00739583|10936066|FG000|NOT COMPLETED|Overall Study||0
9825240|NCT00739583|10936067|FG001|NOT COMPLETED|Overall Study||0
9825241|NCT00739596|10936075|FG000|STARTED|Overall Study||166
9825242|NCT00739596|10936076|FG001|STARTED|Overall Study||166
9825243|NCT00739596|10936075|FG000|COMPLETED|Overall Study||141
9825244|NCT00739596|10936076|FG001|COMPLETED|Overall Study||149
9825245|NCT00739596|10936075|FG000|NOT COMPLETED|Overall Study||25
9825246|NCT00739596|10936076|FG001|NOT COMPLETED|Overall Study||17
9825247|NCT00739648|10936084|FG000|STARTED|Overall Study||108
9825248|NCT00739648|10936085|FG001|STARTED|Overall Study||214
9825249|NCT00739648|10936084|FG000|COMPLETED|Overall Study||82
9825250|NCT00739648|10936085|FG001|COMPLETED|Overall Study||161
9825251|NCT00739648|10936084|FG000|NOT COMPLETED|Overall Study||26
9825252|NCT00739648|10936085|FG001|NOT COMPLETED|Overall Study||53
9825253|NCT00739661|10936097|FG000|STARTED|Overall Study||52
9825254|NCT00739661|10936098|FG001|STARTED|Overall Study||52
9825255|NCT00739661|10936097|FG000|COMPLETED|Overall Study||6
9825256|NCT00739661|10936098|FG001|COMPLETED|Overall Study||10
10017294|NCT01815424|11140140|FG003|NOT COMPLETED|Week 16 to 52||3
10017295|NCT01815424|11140141|FG004|NOT COMPLETED|Week 16 to 52||3
10017296|NCT01815502|11140156|FG000|STARTED|Overall Study||10
9825257|NCT00739661|10936097|FG000|NOT COMPLETED|Overall Study||46
9825258|NCT00739661|10936098|FG001|NOT COMPLETED|Overall Study||42
9825259|NCT00739752|10936110|FG000|STARTED|Overall Study||299
9825260|NCT00739752|10936111|FG001|STARTED|Overall Study||284
9825261|NCT00739752|10936112|FG002|STARTED|Overall Study||292
9825262|NCT00739752|10936113|FG003|STARTED|Overall Study||288
9825263|NCT00739752|10936114|FG004|STARTED|Overall Study||291
9825264|NCT00739752|10936115|FG005|STARTED|Overall Study||293
9825265|NCT00739752|10936110|FG000|COMPLETED|Overall Study||299
9825266|NCT00739752|10936111|FG001|COMPLETED|Overall Study||284
9825267|NCT00739752|10936112|FG002|COMPLETED|Overall Study||292
9825268|NCT00739752|10936113|FG003|COMPLETED|Overall Study||288
9825269|NCT00739752|10936114|FG004|COMPLETED|Overall Study||291
9825270|NCT00739752|10936115|FG005|COMPLETED|Overall Study||293
9825271|NCT00739752|10936110|FG000|NOT COMPLETED|Overall Study||0
9825272|NCT00739752|10936111|FG001|NOT COMPLETED|Overall Study||0
9825273|NCT00739752|10936112|FG002|NOT COMPLETED|Overall Study||0
9825274|NCT00739752|10936113|FG003|NOT COMPLETED|Overall Study||0
9825275|NCT00739752|10936114|FG004|NOT COMPLETED|Overall Study||0
9825276|NCT00739752|10936115|FG005|NOT COMPLETED|Overall Study||0
9825277|NCT00739765|10936132|FG000|STARTED|Overall Study||40
9825278|NCT00739765|10936133|FG001|STARTED|Overall Study||38
9825279|NCT00739765|10936134|FG002|STARTED|Overall Study||32
9825280|NCT00739765|10936132|FG000|COMPLETED|Overall Study||34
9825281|NCT00739765|10936133|FG001|COMPLETED|Overall Study||27
9825282|NCT00739765|10936134|FG002|COMPLETED|Overall Study||21
9825283|NCT00739765|10936132|FG000|NOT COMPLETED|Overall Study||6
9825284|NCT00739765|10936133|FG001|NOT COMPLETED|Overall Study||11
9825285|NCT00739765|10936134|FG002|NOT COMPLETED|Overall Study||11
9825286|NCT00739908|10936144|FG000|STARTED|Overall Study||142
9825287|NCT00739908|10936145|FG001|STARTED|Overall Study||143
9825288|NCT00739908|10936144|FG000|COMPLETED|Overall Study||117
9825289|NCT00739908|10936145|FG001|COMPLETED|Overall Study||118
9825290|NCT00739908|10936144|FG000|NOT COMPLETED|Overall Study||25
9825291|NCT00739908|10936145|FG001|NOT COMPLETED|Overall Study||25
9825292|NCT00739934|10936153|FG000|STARTED|Voriconazole IV||40
9825293|NCT00739934|10936153|FG000|COMPLETED|Voriconazole IV||34
9825294|NCT00739934|10936153|FG000|NOT COMPLETED|Voriconazole IV||6
9825295|NCT00739934|10936153|FG000|STARTED|Voriconazole Oral||34
9825296|NCT00739934|10936153|FG000|COMPLETED|Voriconazole Oral||31
9825297|NCT00739934|10936153|FG000|NOT COMPLETED|Voriconazole Oral||3
9825298|NCT00739960|10936162|FG000|STARTED|Overall Study||1
9825299|NCT00739960|10936162|FG000|COMPLETED|Overall Study||1
9825300|NCT00739960|10936162|FG000|NOT COMPLETED|Overall Study||0
9825301|NCT00739973|10936175|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
9825302|NCT00739973|10936176|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0
9825303|NCT00739973|10936177|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0
9825304|NCT00739973|10936178|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0
10017297|NCT01815502|11140157|FG001|STARTED|Overall Study||10
10017298|NCT01815502|11140156|FG000|COMPLETED|Overall Study||10
10017299|NCT01815502|11140157|FG001|COMPLETED|Overall Study||10
10017300|NCT01815502|11140156|FG000|NOT COMPLETED|Overall Study||0
10017301|NCT01815502|11140157|FG001|NOT COMPLETED|Overall Study||0
10017302|NCT01815515|11140166|FG000|STARTED|Overall Study||17
10017303|NCT01815515|11140166|FG000|COMPLETED|Overall Study||17
10236843|NCT00809458|11367607|FG000|STARTED|Overall Study||9
9825305|NCT00739973|10936179|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0
10017304|NCT01815515|11140166|FG000|NOT COMPLETED|Overall Study||0
10236844|NCT00809458|11367608|FG001|STARTED|Overall Study||6
9825306|NCT00739973|10936180|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0
9825307|NCT00739973|10936181|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0
9825308|NCT00739973|10936182|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0
9825309|NCT00739973|10936183|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0
9825310|NCT00739973|10936175|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
9825311|NCT00739973|10936176|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825312|NCT00739973|10936177|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825313|NCT00739973|10936178|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825314|NCT00739973|10936179|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825315|NCT00739973|10936180|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10017305|NCT01815645|11140172|FG000|STARTED|Overall Study||32
10017306|NCT01815645|11140173|FG001|STARTED|Overall Study||33
10017307|NCT01815645|11140172|FG000|COMPLETED|Overall Study||32
10017308|NCT01815645|11140173|FG001|COMPLETED|Overall Study||33
10017309|NCT01815645|11140172|FG000|NOT COMPLETED|Overall Study||0
9825316|NCT00739973|10936181|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825317|NCT00739973|10936182|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825318|NCT00739973|10936183|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825319|NCT00739973|10936175|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
9825320|NCT00739973|10936176|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825321|NCT00739973|10936177|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825322|NCT00739973|10936178|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825323|NCT00739973|10936179|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825324|NCT00739973|10936180|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825325|NCT00739973|10936181|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825326|NCT00739973|10936182|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825327|NCT00739973|10936183|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
9825328|NCT00739973|10936175|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198
9825329|NCT00739973|10936176|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
9825330|NCT00739973|10936177|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203
9825331|NCT00739973|10936178|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185
9825332|NCT00739973|10936179|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181
9825333|NCT00739973|10936180|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181
9825334|NCT00739973|10936181|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
9825335|NCT00739973|10936182|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178
9825336|NCT00739973|10936183|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184
9825337|NCT00739973|10936175|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
9825338|NCT00739973|10936176|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
9825339|NCT00739973|10936177|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
9825340|NCT00739973|10936178|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
9825341|NCT00739973|10936179|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
9825342|NCT00739973|10936180|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
9825343|NCT00739973|10936181|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
9825344|NCT00739973|10936182|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
9825345|NCT00739973|10936183|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
9825346|NCT00739973|10936175|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
9825347|NCT00739973|10936176|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
9825348|NCT00739973|10936177|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
9825349|NCT00739973|10936178|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
9825350|NCT00739973|10936179|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
9825351|NCT00739973|10936180|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
9825352|NCT00739973|10936181|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
9825353|NCT00739973|10936182|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
9825354|NCT00739973|10936183|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
9825355|NCT00739999|10936213|FG000|STARTED|Overall Study||15
9825356|NCT00739999|10936214|FG001|STARTED|Overall Study||24
10017310|NCT01815645|11140173|FG001|NOT COMPLETED|Overall Study||0
10017311|NCT01815671|11140183|FG000|STARTED|Overall Study||88
10017312|NCT01815671|11140184|FG001|STARTED|Overall Study||85
10017313|NCT01815671|11140183|FG000|COMPLETED|Overall Study||88
10017314|NCT01815671|11140184|FG001|COMPLETED|Overall Study||85
9825357|NCT00739999|10936213|FG000|COMPLETED|Overall Study||15
9825358|NCT00739999|10936214|FG001|COMPLETED|Overall Study||24
9825359|NCT00739999|10936213|FG000|NOT COMPLETED|Overall Study||0
9825360|NCT00739999|10936214|FG001|NOT COMPLETED|Overall Study||0
9825361|NCT00740051|10936227|FG000|STARTED|Overall Study||76
9825362|NCT00740051|10936228|FG001|STARTED|Overall Study||151
9825363|NCT00740051|10936227|FG000|COMPLETED|Overall Study||58
9825364|NCT00740051|10936228|FG001|COMPLETED|Overall Study||119
9825365|NCT00740051|10936227|FG000|NOT COMPLETED|Overall Study||18
9825366|NCT00740051|10936228|FG001|NOT COMPLETED|Overall Study||32
9825367|NCT00740129|10936235|FG000|STARTED|Overall Study||6
9825368|NCT00740129|10936235|FG000|COMPLETED|Overall Study||6
9825369|NCT00740129|10936235|FG000|NOT COMPLETED|Overall Study||0
9825370|NCT00740207|10936242|FG000|STARTED|Overall Study||17
9825371|NCT00740207|10936243|FG001|STARTED|Overall Study||16
9825372|NCT00740207|10936242|FG000|COMPLETED|Overall Study||17
9825373|NCT00740207|10936243|FG001|COMPLETED|Overall Study||16
9825374|NCT00740207|10936242|FG000|NOT COMPLETED|Overall Study||0
9825375|NCT00740207|10936243|FG001|NOT COMPLETED|Overall Study||0
9825376|NCT00740220|10936253|FG000|STARTED|Overall Study||97
9825377|NCT00740220|10936253|FG000|COMPLETED|Overall Study||88
9825378|NCT00740220|10936253|FG000|NOT COMPLETED|Overall Study||9
9825379|NCT00740376|10936259|FG000|STARTED|Overall Study||22
10017315|NCT01815671|11140183|FG000|NOT COMPLETED|Overall Study||0
10017316|NCT01815671|11140184|FG001|NOT COMPLETED|Overall Study||0
10017317|NCT01815736|11140192|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963
9825380|NCT00740376|10936260|FG001|STARTED|Overall Study||15
9825381|NCT00740376|10936259|FG000|COMPLETED|Overall Study||19
9825382|NCT00740376|10936260|FG001|COMPLETED|Overall Study||12
9825383|NCT00740376|10936259|FG000|NOT COMPLETED|Overall Study||3
9825384|NCT00740376|10936260|FG001|NOT COMPLETED|Overall Study||3
10017318|NCT01815736|11140193|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480
10112487|NCT02503787|11243481|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37
10112488|NCT02503787|11243481|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32
10112489|NCT02503787|11243481|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
10112490|NCT02503787|11243481|FG000|STARTED|Implant to 3 Month Endpoint||32
10112491|NCT02503787|11243481|FG000|COMPLETED|Implant to 3 Month Endpoint||29
10112492|NCT02503787|11243481|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3
10112493|NCT02503852|11243489|FG000|STARTED|Overall Study||16
10112494|NCT02503852|11243490|FG001|STARTED|Overall Study||22
10112495|NCT02503852|11243491|FG002|STARTED|Overall Study||24
10112496|NCT02503852|11243492|FG003|STARTED|Overall Study||9
10017319|NCT01815736|11140192|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
10017320|NCT01815736|11140193|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
10017321|NCT01815736|11140192|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
10017322|NCT01815736|11140193|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
10017323|NCT01815736|11140192|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
10017324|NCT01815736|11140193|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
10017325|NCT01815736|11140192|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854
10017326|NCT01815736|11140193|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398
10017327|NCT01815736|11140192|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
10017328|NCT01815736|11140193|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
10017329|NCT01815840|11140203|FG000|STARTED|Overall Study||116
10017330|NCT01815840|11140204|FG001|STARTED|Overall Study||113
10017331|NCT01815840|11140203|FG000|COMPLETED|Overall Study||57
10017332|NCT01815840|11140204|FG001|COMPLETED|Overall Study||50
10017333|NCT01815840|11140203|FG000|NOT COMPLETED|Overall Study||59
10112497|NCT02503852|11243489|FG000|COMPLETED|Overall Study||12
10112498|NCT02503852|11243490|FG001|COMPLETED|Overall Study||19
10112499|NCT02503852|11243491|FG002|COMPLETED|Overall Study||21
10236845|NCT00809458|11367607|FG000|COMPLETED|Overall Study||8
10236846|NCT00809458|11367608|FG001|COMPLETED|Overall Study||5
10236847|NCT00809458|11367607|FG000|NOT COMPLETED|Overall Study||1
10112500|NCT02503852|11243492|FG003|COMPLETED|Overall Study||8
10112501|NCT02503852|11243489|FG000|NOT COMPLETED|Overall Study||4
10112502|NCT02503852|11243490|FG001|NOT COMPLETED|Overall Study||3
10112503|NCT02503852|11243491|FG002|NOT COMPLETED|Overall Study||3
10112504|NCT02503852|11243492|FG003|NOT COMPLETED|Overall Study||1
10112505|NCT02503865|11243505|FG000|STARTED|Overall Study||70
10112506|NCT02503865|11243506|FG001|STARTED|Overall Study||269
10112507|NCT02503865|11243507|FG002|STARTED|Overall Study||66
10112508|NCT02503865|11243505|FG000|COMPLETED|Overall Study||65
10112509|NCT02503865|11243506|FG001|COMPLETED|Overall Study||222
10112510|NCT02503865|11243507|FG002|COMPLETED|Overall Study||64
10112511|NCT02503865|11243505|FG000|NOT COMPLETED|Overall Study||5
10112512|NCT02503865|11243506|FG001|NOT COMPLETED|Overall Study||47
10112513|NCT02503865|11243507|FG002|NOT COMPLETED|Overall Study||2
10112514|NCT02503982|11243516|FG000|STARTED|Overall Study||13
10112515|NCT02503982|11243516|FG000|COMPLETED|Overall Study||13
10112516|NCT02503982|11243516|FG000|NOT COMPLETED|Overall Study||0
10112517|NCT02504073|11243520|FG000|STARTED|Overall Study||54
10112518|NCT02504073|11243520|FG000|COMPLETED|Overall Study||54
10112519|NCT02504073|11243520|FG000|NOT COMPLETED|Overall Study||0
10112520|NCT02504216|11243527|FG000|STARTED|Overall Study||3286
10112521|NCT02504216|11243528|FG001|STARTED|Overall Study||3278
10112522|NCT02504216|11243527|FG000|Received Treatment|Overall Study||3256
10236848|NCT00809458|11367608|FG001|NOT COMPLETED|Overall Study||1
10236849|NCT00802659|11367618|FG000|STARTED|Overall Study||0
10236850|NCT00802659|11367619|FG001|STARTED|Overall Study||2
10236851|NCT00802659|11367620|FG002|STARTED|Overall Study||0
10236852|NCT00802659|11367621|FG003|STARTED|Overall Study||0
10112523|NCT02504216|11243528|FG001|Received Treatment|Overall Study||3248
10112524|NCT02504216|11243527|FG000|COMPLETED|Overall Study||3275
10112525|NCT02504216|11243528|FG001|COMPLETED|Overall Study||3263
10112526|NCT02504216|11243527|FG000|NOT COMPLETED|Overall Study||11
10112527|NCT02504216|11243528|FG001|NOT COMPLETED|Overall Study||15
10112528|NCT02504268|11243537|FG000|STARTED|Overall Study||451
10112529|NCT02504268|11243538|FG001|STARTED|Overall Study||301
10112530|NCT02504268|11243539|FG002|STARTED|Overall Study||242
10112531|NCT02504268|11243540|FG003|STARTED|Overall Study||0
10112532|NCT02504268|11243541|FG004|STARTED|Overall Study||0
10112533|NCT02504268|11243542|FG005|STARTED|Overall Study||0
10112534|NCT02504268|11243543|FG006|STARTED|Overall Study||0
10112535|NCT02504268|11243544|FG007|STARTED|Overall Study||0
10112536|NCT02504268|11243545|FG008|STARTED|Overall Study||0
10112537|NCT02504268|11243537|FG000|Induction to Open Label|Overall Study||289
10112538|NCT02504268|11243538|FG001|Induction to Open Label|Overall Study||196
10112539|NCT02504268|11243539|FG002|Induction to Open Label|Overall Study||147
10112540|NCT02504268|11243540|FG003|Induction to Open Label|Overall Study||0
10112541|NCT02504268|11243541|FG004|Induction to Open Label|Overall Study||0
10112542|NCT02504268|11243542|FG005|Induction to Open Label|Overall Study||0
10112543|NCT02504268|11243543|FG006|Induction to Open Label|Overall Study||0
10236853|NCT00802659|11367618|FG000|COMPLETED|Overall Study||0
10236854|NCT00802659|11367619|FG001|COMPLETED|Overall Study||1
10236855|NCT00802659|11367620|FG002|COMPLETED|Overall Study||0
10236856|NCT00802659|11367621|FG003|COMPLETED|Overall Study||0
10236857|NCT00802659|11367618|FG000|NOT COMPLETED|Overall Study||0
10112544|NCT02504268|11243544|FG007|Induction to Open Label|Overall Study||0
10112545|NCT02504268|11243545|FG008|Induction to Open Label|Overall Study||0
10112546|NCT02504268|11243537|FG000|Early Escaped to Open Label|Overall Study||10
10112547|NCT02504268|11243538|FG001|Early Escaped to Open Label|Overall Study||21
10112548|NCT02504268|11243539|FG002|Early Escaped to Open Label|Overall Study||8
10112549|NCT02504268|11243540|FG003|Early Escaped to Open Label|Overall Study||0
10112550|NCT02504268|11243541|FG004|Early Escaped to Open Label|Overall Study||0
10112551|NCT02504268|11243542|FG005|Early Escaped to Open Label|Overall Study||0
10112552|NCT02504268|11243543|FG006|Early Escaped to Open Label|Overall Study||0
10112553|NCT02504268|11243544|FG007|Early Escaped to Open Label|Overall Study||0
10112554|NCT02504268|11243545|FG008|Early Escaped to Open Label|Overall Study||0
10112555|NCT02504268|11243537|FG000|Induction to De-Escalation|Overall Study||94
10112556|NCT02504268|11243538|FG001|Induction to De-Escalation|Overall Study||37
10112557|NCT02504268|11243539|FG002|Induction to De-Escalation|Overall Study||53
10112558|NCT02504268|11243540|FG003|Induction to De-Escalation|Overall Study||0
10112559|NCT02504268|11243541|FG004|Induction to De-Escalation|Overall Study||0
10112560|NCT02504268|11243542|FG005|Induction to De-Escalation|Overall Study||0
10112561|NCT02504268|11243543|FG006|Induction to De-Escalation|Overall Study||0
10112562|NCT02504268|11243544|FG007|Induction to De-Escalation|Overall Study||0
10112563|NCT02504268|11243545|FG008|Induction to De-Escalation|Overall Study||0
10112564|NCT02504268|11243537|FG000|Randomized in De-Escalation Period|Overall Study||0
10112565|NCT02504268|11243538|FG001|Randomized in De-Escalation Period|Overall Study||0
10112566|NCT02504268|11243539|FG002|Randomized in De-Escalation Period|Overall Study||0
10112567|NCT02504268|11243540|FG003|Randomized in De-Escalation Period|Overall Study||50
10112568|NCT02504268|11243541|FG004|Randomized in De-Escalation Period|Overall Study||50
10112569|NCT02504268|11243542|FG005|Randomized in De-Escalation Period|Overall Study||47
10112570|NCT02504268|11243543|FG006|Randomized in De-Escalation Period|Overall Study||37
10112571|NCT02504268|11243544|FG007|Randomized in De-Escalation Period|Overall Study||0
10112572|NCT02504268|11243545|FG008|Randomized in De-Escalation Period|Overall Study||0
10112573|NCT02504268|11243537|FG000|De-Escalation to Open Label Extension|Overall Study||0
10112574|NCT02504268|11243538|FG001|De-Escalation to Open Label Extension|Overall Study||0
10112575|NCT02504268|11243539|FG002|De-Escalation to Open Label Extension|Overall Study||0
10112576|NCT02504268|11243540|FG003|De-Escalation to Open Label Extension|Overall Study||36
10112577|NCT02504268|11243541|FG004|De-Escalation to Open Label Extension|Overall Study||30
10112578|NCT02504268|11243542|FG005|De-Escalation to Open Label Extension|Overall Study||32
10112579|NCT02504268|11243543|FG006|De-Escalation to Open Label Extension|Overall Study||22
10112580|NCT02504268|11243544|FG007|De-Escalation to Open Label Extension|Overall Study||0
10112581|NCT02504268|11243545|FG008|De-Escalation to Open Label Extension|Overall Study||0
10112582|NCT02504268|11243537|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10112583|NCT02504268|11243538|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10112584|NCT02504268|11243539|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10112585|NCT02504268|11243540|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2
10112586|NCT02504268|11243541|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5
10112587|NCT02504268|11243542|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4
10112588|NCT02504268|11243543|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3
10112589|NCT02504268|11243544|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10112590|NCT02504268|11243545|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10112591|NCT02504268|11243537|FG000|Open Label and Open Label Extension Period|Overall Study||0
10112592|NCT02504268|11243538|FG001|Open Label and Open Label Extension Period|Overall Study||0
10112593|NCT02504268|11243539|FG002|Open Label and Open Label Extension Period|Overall Study||0
10112594|NCT02504268|11243540|FG003|Open Label and Open Label Extension Period|Overall Study||0
10112595|NCT02504268|11243541|FG004|Open Label and Open Label Extension Period|Overall Study||0
10112596|NCT02504268|11243542|FG005|Open Label and Open Label Extension Period|Overall Study||0
10112597|NCT02504268|11243543|FG006|Open Label and Open Label Extension Period|Overall Study||0
10112598|NCT02504268|11243544|FG007|Open Label and Open Label Extension Period|Overall Study||685
10112599|NCT02504268|11243545|FG008|Open Label and Open Label Extension Period|Overall Study||120
10112600|NCT02504268|11243537|FG000|COMPLETED|Overall Study||388
10112601|NCT02504268|11243538|FG001|COMPLETED|Overall Study||233
10112602|NCT02504268|11243539|FG002|COMPLETED|Overall Study||201
10112603|NCT02504268|11243540|FG003|COMPLETED|Overall Study||0
10112604|NCT02504268|11243541|FG004|COMPLETED|Overall Study||0
10112605|NCT02504268|11243542|FG005|COMPLETED|Overall Study||0
10112606|NCT02504268|11243543|FG006|COMPLETED|Overall Study||0
10112607|NCT02504268|11243544|FG007|COMPLETED|Overall Study||0
10112608|NCT02504268|11243545|FG008|COMPLETED|Overall Study||0
10112609|NCT02504268|11243537|FG000|NOT COMPLETED|Overall Study||63
10112610|NCT02504268|11243538|FG001|NOT COMPLETED|Overall Study||68
10112611|NCT02504268|11243539|FG002|NOT COMPLETED|Overall Study||41
10112612|NCT02504268|11243540|FG003|NOT COMPLETED|Overall Study||0
10112613|NCT02504268|11243541|FG004|NOT COMPLETED|Overall Study||0
10112614|NCT02504268|11243542|FG005|NOT COMPLETED|Overall Study||0
10112615|NCT02504268|11243543|FG006|NOT COMPLETED|Overall Study||0
10112616|NCT02504268|11243544|FG007|NOT COMPLETED|Overall Study||0
10112617|NCT02504268|11243545|FG008|NOT COMPLETED|Overall Study||0
10112618|NCT02504294|11243567|FG000|STARTED|Overall Study||212
9825385|NCT00740584|10936266|FG000|STARTED|Overall Study||12
9825386|NCT00740584|10936266|FG000|COMPLETED|Overall Study||11
9825387|NCT00740584|10936266|FG000|NOT COMPLETED|Overall Study||1
9825388|NCT00740636|10936273|FG000|STARTED|Overall Study||25
9825389|NCT00740636|10936274|FG001|STARTED|Overall Study||67
9825390|NCT00740636|10936273|FG000|COMPLETED|Overall Study||23
9825391|NCT00740636|10936274|FG001|COMPLETED|Overall Study||63
9825392|NCT00740636|10936273|FG000|NOT COMPLETED|Overall Study||2
9825393|NCT00740636|10936274|FG001|NOT COMPLETED|Overall Study||4
10017334|NCT01815840|11140204|FG001|NOT COMPLETED|Overall Study||63
10017335|NCT01815918|11140212|FG000|STARTED|Overall Study||30
10017336|NCT01815918|11140213|FG001|STARTED|Overall Study||30
9825394|NCT00740714|10936283|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196
9825395|NCT00740714|10936284|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201
9825396|NCT00740714|10936285|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203
9825397|NCT00740714|10936283|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86
9825398|NCT00740714|10936284|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87
9825399|NCT00740714|10936285|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94
9825400|NCT00740714|10936283|FG000|Active Patients at Study Termination|Overall Study||24
9825401|NCT00740714|10936284|FG001|Active Patients at Study Termination|Overall Study||12
9825402|NCT00740714|10936285|FG002|Active Patients at Study Termination|Overall Study||33
9825403|NCT00740714|10936283|FG000|COMPLETED|Overall Study||179
9825404|NCT00740714|10936284|FG001|COMPLETED|Overall Study||182
9825405|NCT00740714|10936285|FG002|COMPLETED|Overall Study||174
9825406|NCT00740714|10936283|FG000|NOT COMPLETED|Overall Study||17
9825407|NCT00740714|10936284|FG001|NOT COMPLETED|Overall Study||19
9825408|NCT00740714|10936285|FG002|NOT COMPLETED|Overall Study||29
9825409|NCT00740779|10936296|FG000|STARTED|Overall Study||52
9825410|NCT00740779|10936297|FG001|STARTED|Overall Study||45
9825411|NCT00740779|10936298|FG002|STARTED|Overall Study||54
9825412|NCT00740779|10936296|FG000|COMPLETED|Overall Study||43
9825413|NCT00740779|10936297|FG001|COMPLETED|Overall Study||31
9825414|NCT00740779|10936298|FG002|COMPLETED|Overall Study||41
9825415|NCT00740779|10936296|FG000|NOT COMPLETED|Overall Study||9
9825416|NCT00740779|10936297|FG001|NOT COMPLETED|Overall Study||14
9825417|NCT00740779|10936298|FG002|NOT COMPLETED|Overall Study||13
9825418|NCT00740792|10936310|FG000|STARTED|Overall Study||193
9825419|NCT00740792|10936311|FG001|STARTED|Overall Study||194
9825420|NCT00740792|10936312|FG002|STARTED|Overall Study||189
9825421|NCT00740792|10936313|FG003|STARTED|Overall Study||200
9825422|NCT00740792|10936310|FG000|COMPLETED|Overall Study||183
9825423|NCT00740792|10936311|FG001|COMPLETED|Overall Study||186
9825424|NCT00740792|10936312|FG002|COMPLETED|Overall Study||180
9825425|NCT00740792|10936313|FG003|COMPLETED|Overall Study||190
9825426|NCT00740792|10936310|FG000|NOT COMPLETED|Overall Study||10
9825427|NCT00740792|10936311|FG001|NOT COMPLETED|Overall Study||8
9825428|NCT00740792|10936312|FG002|NOT COMPLETED|Overall Study||9
9825429|NCT00740792|10936313|FG003|NOT COMPLETED|Overall Study||10
9825430|NCT00740831|10936326|FG000|STARTED|Overall Study|Safety population|97
9825431|NCT00740831|10936327|FG001|STARTED|Overall Study|Safety population|103
9825432|NCT00740831|10936328|FG002|STARTED|Overall Study|Safety population|101
9825433|NCT00740831|10936326|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
9825434|NCT00740831|10936327|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
9825435|NCT00740831|10936328|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
9825436|NCT00740831|10936326|FG000|NOT COMPLETED|Overall Study||4
9825437|NCT00740831|10936327|FG001|NOT COMPLETED|Overall Study||3
9825438|NCT00740831|10936328|FG002|NOT COMPLETED|Overall Study||6
9825439|NCT00740857|10936339|FG000|STARTED|Overall Study||33
9825440|NCT00740857|10936340|FG001|STARTED|Overall Study||88
9825441|NCT00740857|10936341|FG002|STARTED|Overall Study||90
9825442|NCT00740857|10936339|FG000|COMPLETED|Overall Study||32
9825443|NCT00740857|10936340|FG001|COMPLETED|Overall Study||88
9825444|NCT00740857|10936341|FG002|COMPLETED|Overall Study||90
9825445|NCT00740857|10936339|FG000|NOT COMPLETED|Overall Study||1
9825446|NCT00740857|10936340|FG001|NOT COMPLETED|Overall Study||0
9825447|NCT00740857|10936341|FG002|NOT COMPLETED|Overall Study||0
9825448|NCT00740870|10936349|FG000|STARTED|Overall Study||171
9825449|NCT00740870|10936349|FG000|COMPLETED|Overall Study||150
10112619|NCT02504294|11243568|FG001|STARTED|Overall Study||206
10112620|NCT02504294|11243567|FG000|COMPLETED|Overall Study||156
9825450|NCT00740870|10936349|FG000|NOT COMPLETED|Overall Study||21
9825451|NCT00741013|10936359|FG000|STARTED|Overall Study||7
9825452|NCT00741013|10936360|FG001|STARTED|Overall Study||8
9825453|NCT00741013|10936361|FG002|STARTED|Overall Study||7
9825454|NCT00741013|10936359|FG000|COMPLETED|Overall Study||6
9825455|NCT00741013|10936360|FG001|COMPLETED|Overall Study||6
9825456|NCT00741013|10936361|FG002|COMPLETED|Overall Study||6
9825457|NCT00741013|10936359|FG000|NOT COMPLETED|Overall Study||1
9825458|NCT00741013|10936360|FG001|NOT COMPLETED|Overall Study||2
9825459|NCT00741013|10936361|FG002|NOT COMPLETED|Overall Study||1
9825460|NCT00741026|10936369|FG000|STARTED|Overall Study||15
9825461|NCT00741026|10936369|FG000|COMPLETED|Overall Study||15
9825462|NCT00741026|10936369|FG000|NOT COMPLETED|Overall Study||0
10017337|NCT01815918|11140212|FG000|COMPLETED|Overall Study||12
9825463|NCT00741039|10936377|FG000|STARTED|Overall Study||102
9825464|NCT00741039|10936378|FG001|STARTED|Overall Study||25
9825465|NCT00741039|10936377|FG000|COMPLETED|Overall Study||100
9825466|NCT00741039|10936378|FG001|COMPLETED|Overall Study||25
9825467|NCT00741039|10936377|FG000|NOT COMPLETED|Overall Study||2
10017338|NCT01815918|11140213|FG001|COMPLETED|Overall Study||11
9825468|NCT00741039|10936378|FG001|NOT COMPLETED|Overall Study||0
9825469|NCT00741091|10936384|FG000|STARTED|Overall Study||1097
9825470|NCT00741091|10936384|FG000|COMPLETED|Overall Study||1040
9825471|NCT00741091|10936384|FG000|NOT COMPLETED|Overall Study||57
9825472|NCT00741104|10936388|FG000|STARTED|Overall Study||363
9825473|NCT00741104|10936388|FG000|COMPLETED|Overall Study||363
9825474|NCT00741104|10936388|FG000|NOT COMPLETED|Overall Study||0
9825475|NCT00741156|10936392|FG000|STARTED|Overall Study||12
9825476|NCT00741156|10936392|FG000|COMPLETED|Overall Study||12
9825477|NCT00741156|10936392|FG000|NOT COMPLETED|Overall Study||0
9825478|NCT00741260|10936414|FG000|STARTED|Overall Study||6
9825479|NCT00741260|10936415|FG001|STARTED|Overall Study||8
9825480|NCT00741260|10936416|FG002|STARTED|Overall Study||4
9825481|NCT00741260|10936417|FG003|STARTED|Overall Study||6
9825482|NCT00741260|10936418|FG004|STARTED|Overall Study||9
9825483|NCT00741260|10936419|FG005|STARTED|Overall Study||65
10236858|NCT00802659|11367619|FG001|NOT COMPLETED|Overall Study||1
10236859|NCT00802659|11367620|FG002|NOT COMPLETED|Overall Study||0
10236860|NCT00802659|11367621|FG003|NOT COMPLETED|Overall Study||0
10236861|NCT00807365|11367631|FG000|STARTED|Overall Study||5
10236862|NCT00807365|11367631|FG000|COMPLETED|Overall Study||0
10236863|NCT00807365|11367631|FG000|NOT COMPLETED|Overall Study||5
10236864|NCT00814333|11367637|FG000|STARTED|Enrollment||1
10236865|NCT00814333|11367638|FG001|STARTED|Enrollment||0
10236866|NCT00814333|11367637|FG000|COMPLETED|Enrollment||0
10236867|NCT00814333|11367638|FG001|COMPLETED|Enrollment||0
10236868|NCT00814333|11367637|FG000|NOT COMPLETED|Enrollment||1
10236869|NCT00814333|11367638|FG001|NOT COMPLETED|Enrollment||0
10236870|NCT00814333|11367637|FG000|STARTED|Treatment Period||0
10236871|NCT00814333|11367638|FG001|STARTED|Treatment Period||0
10236872|NCT00814333|11367637|FG000|COMPLETED|Treatment Period||0
10236873|NCT00814333|11367638|FG001|COMPLETED|Treatment Period||0
10236874|NCT00814333|11367637|FG000|NOT COMPLETED|Treatment Period||0
10236875|NCT00814333|11367638|FG001|NOT COMPLETED|Treatment Period||0
10236876|NCT00808080|11367644|FG000|STARTED|Overall Study||6
10236877|NCT00808080|11367644|FG000|COMPLETED|Overall Study||0
10236878|NCT00808080|11367644|FG000|NOT COMPLETED|Overall Study||6
9825484|NCT00741260|10936420|FG006|STARTED|Overall Study||7
9825485|NCT00741260|10936414|FG000|COMPLETED|Overall Study||0
9825486|NCT00741260|10936415|FG001|COMPLETED|Overall Study||0
9825487|NCT00741260|10936416|FG002|COMPLETED|Overall Study||0
9825488|NCT00741260|10936417|FG003|COMPLETED|Overall Study||0
9825489|NCT00741260|10936418|FG004|COMPLETED|Overall Study||0
9825490|NCT00741260|10936419|FG005|COMPLETED|Overall Study||20
9825491|NCT00741260|10936420|FG006|COMPLETED|Overall Study||0
9825492|NCT00741260|10936414|FG000|NOT COMPLETED|Overall Study||6
9825493|NCT00741260|10936415|FG001|NOT COMPLETED|Overall Study||8
9825494|NCT00741260|10936416|FG002|NOT COMPLETED|Overall Study||4
9825495|NCT00741260|10936417|FG003|NOT COMPLETED|Overall Study||6
10017339|NCT01815918|11140212|FG000|NOT COMPLETED|Overall Study||18
10017340|NCT01815918|11140213|FG001|NOT COMPLETED|Overall Study||19
10017341|NCT01816048|11140223|FG000|STARTED|Overall Study||8
10017342|NCT01816048|11140223|FG000|COMPLETED|Overall Study||2
10236879|NCT00802893|11367649|FG000|STARTED|Overall Study||3
10236880|NCT00802893|11367649|FG000|COMPLETED|Overall Study||0
9825496|NCT00741260|10936418|FG004|NOT COMPLETED|Overall Study||9
9825497|NCT00741260|10936419|FG005|NOT COMPLETED|Overall Study||45
9825498|NCT00741260|10936420|FG006|NOT COMPLETED|Overall Study||7
9825499|NCT00741273|10936443|FG000|STARTED|Overall Study||8
9825500|NCT00741273|10936444|FG001|STARTED|Overall Study||8
9825501|NCT00741273|10936443|FG000|COMPLETED|Overall Study||8
9825502|NCT00741273|10936444|FG001|COMPLETED|Overall Study||8
9825503|NCT00741273|10936443|FG000|NOT COMPLETED|Overall Study||0
9825504|NCT00741273|10936444|FG001|NOT COMPLETED|Overall Study||0
9825505|NCT00741286|10936456|FG000|STARTED|Overall Study||103
9825506|NCT00741286|10936457|FG001|STARTED|Overall Study||100
9825507|NCT00741286|10936456|FG000|COMPLETED|Overall Study||83
9825508|NCT00741286|10936457|FG001|COMPLETED|Overall Study||81
9825509|NCT00741286|10936456|FG000|NOT COMPLETED|Overall Study||20
9825510|NCT00741286|10936457|FG001|NOT COMPLETED|Overall Study||19
9825511|NCT00741338|10936465|FG000|STARTED|Overall Study||3
9825512|NCT00741338|10936466|FG001|STARTED|Overall Study||3
9825513|NCT00741338|10936465|FG000|COMPLETED|Overall Study||3
9825514|NCT00741338|10936466|FG001|COMPLETED|Overall Study||2
10236881|NCT00802893|11367649|FG000|NOT COMPLETED|Overall Study||3
10236882|NCT00809341|11367655|FG000|STARTED|Overall Study||20
10236883|NCT00809341|11367656|FG001|STARTED|Overall Study||5
10236884|NCT00809341|11367655|FG000|COMPLETED|Overall Study||20
10236885|NCT00809341|11367656|FG001|COMPLETED|Overall Study||4
10236886|NCT00809341|11367655|FG000|NOT COMPLETED|Overall Study||0
10236887|NCT00809341|11367656|FG001|NOT COMPLETED|Overall Study||1
9825515|NCT00741338|10936465|FG000|NOT COMPLETED|Overall Study||0
9825516|NCT00741338|10936466|FG001|NOT COMPLETED|Overall Study||1
9825517|NCT00741390|10936472|FG000|STARTED|Visit 1||62
9825518|NCT00741390|10936473|FG001|STARTED|Visit 1||63
9825519|NCT00741390|10936474|FG002|STARTED|Visit 1||62
9825520|NCT00741390|10936475|FG003|STARTED|Visit 1||63
9825521|NCT00741390|10936472|FG000|COMPLETED|Visit 1||60
9825522|NCT00741390|10936473|FG001|COMPLETED|Visit 1||63
9825523|NCT00741390|10936474|FG002|COMPLETED|Visit 1||55
9825524|NCT00741390|10936475|FG003|COMPLETED|Visit 1||62
10017343|NCT01816048|11140223|FG000|NOT COMPLETED|Overall Study||6
10236888|NCT00804349|11367664|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
9825525|NCT00741390|10936472|FG000|NOT COMPLETED|Visit 1||2
9825526|NCT00741390|10936473|FG001|NOT COMPLETED|Visit 1||0
9825527|NCT00741390|10936474|FG002|NOT COMPLETED|Visit 1||7
9825528|NCT00741390|10936475|FG003|NOT COMPLETED|Visit 1||1
9825529|NCT00741390|10936472|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
9825530|NCT00741390|10936473|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
9825531|NCT00741390|10936474|FG002|STARTED|Visit 2||55
9825532|NCT00741390|10936475|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
9825533|NCT00741390|10936472|FG000|COMPLETED|Visit 2||59
9825534|NCT00741390|10936473|FG001|COMPLETED|Visit 2||61
9825535|NCT00741390|10936474|FG002|COMPLETED|Visit 2||54
9825536|NCT00741390|10936475|FG003|COMPLETED|Visit 2||60
9825537|NCT00741390|10936472|FG000|NOT COMPLETED|Visit 2||0
9825538|NCT00741390|10936473|FG001|NOT COMPLETED|Visit 2||0
9825539|NCT00741390|10936474|FG002|NOT COMPLETED|Visit 2||1
9825540|NCT00741390|10936475|FG003|NOT COMPLETED|Visit 2||1
9825541|NCT00741455|10936494|FG000|STARTED|Overall Study||18
9825542|NCT00741455|10936494|FG000|COMPLETED|Overall Study||17
9825543|NCT00741455|10936494|FG000|NOT COMPLETED|Overall Study||1
9825544|NCT00741468|10936498|FG000|STARTED|Overall Study||18
9825545|NCT00741468|10936498|FG000|COMPLETED|Overall Study||18
9825546|NCT00741468|10936498|FG000|NOT COMPLETED|Overall Study||0
9825547|NCT00741598|10936508|FG000|STARTED|Overall Study||33
9825548|NCT00741598|10936509|FG001|STARTED|Overall Study||39
9825549|NCT00741598|10936508|FG000|COMPLETED|Overall Study||24
9825550|NCT00741598|10936509|FG001|COMPLETED|Overall Study||30
9825551|NCT00741598|10936508|FG000|NOT COMPLETED|Overall Study||9
9825552|NCT00741598|10936509|FG001|NOT COMPLETED|Overall Study||9
9825553|NCT00741611|10936519|FG000|STARTED|Overall Study||4
9825554|NCT00741611|10936520|FG001|STARTED|Overall Study||3
9825555|NCT00741611|10936521|FG002|STARTED|Overall Study||29
9825556|NCT00741611|10936519|FG000|COMPLETED|Overall Study||4
9825557|NCT00741611|10936520|FG001|COMPLETED|Overall Study||1
9825558|NCT00741611|10936521|FG002|COMPLETED|Overall Study||26
9825559|NCT00741611|10936519|FG000|NOT COMPLETED|Overall Study||0
9825560|NCT00741611|10936520|FG001|NOT COMPLETED|Overall Study||2
9825561|NCT00741611|10936521|FG002|NOT COMPLETED|Overall Study||3
9825562|NCT00741819|10936530|FG000|STARTED|Overall Study||73
9825563|NCT00741819|10936530|FG000|COMPLETED|Overall Study||65
9825564|NCT00741819|10936530|FG000|NOT COMPLETED|Overall Study||8
9825565|NCT00741858|10936538|FG000|STARTED|Overall Study||16
9825566|NCT00741858|10936539|FG001|STARTED|Overall Study||18
9825567|NCT00741858|10936538|FG000|COMPLETED|Overall Study||16
9825568|NCT00741858|10936539|FG001|COMPLETED|Overall Study||18
9825569|NCT00741858|10936538|FG000|NOT COMPLETED|Overall Study||0
9825570|NCT00741858|10936539|FG001|NOT COMPLETED|Overall Study||0
9825571|NCT00741936|10936547|FG000|STARTED|Overall Study||60
9825572|NCT00741936|10936548|FG001|STARTED|Overall Study||60
9825573|NCT00741936|10936547|FG000|COMPLETED|Overall Study||51
9825574|NCT00741936|10936548|FG001|COMPLETED|Overall Study||52
9825575|NCT00741936|10936547|FG000|NOT COMPLETED|Overall Study||9
9825576|NCT00741936|10936548|FG001|NOT COMPLETED|Overall Study||8
9825577|NCT00742001|10936557|FG000|STARTED|Overall Study||4
9825578|NCT00742001|10936558|FG001|STARTED|Overall Study||4
9825579|NCT00742001|10936559|FG002|STARTED|Overall Study||4
9825580|NCT00742001|10936557|FG000|COMPLETED|Overall Study||4
9825581|NCT00742001|10936558|FG001|COMPLETED|Overall Study||4
9825582|NCT00742001|10936559|FG002|COMPLETED|Overall Study||3
9825583|NCT00742001|10936557|FG000|NOT COMPLETED|Overall Study||0
9825584|NCT00742001|10936558|FG001|NOT COMPLETED|Overall Study||0
9825585|NCT00742001|10936559|FG002|NOT COMPLETED|Overall Study||1
9825586|NCT00742027|10936570|FG000|STARTED|Overall Study||129
10017344|NCT01816061|11140230|FG000|STARTED|Overall Study||40
10017345|NCT01816061|11140231|FG001|STARTED|Overall Study||51
9825587|NCT00742027|10936570|FG000|COMPLETED|Overall Study||0
9825588|NCT00742027|10936570|FG000|NOT COMPLETED|Overall Study||129
9825589|NCT00742053|10936574|FG000|STARTED|Overall Study||7
9825590|NCT00742053|10936574|FG000|COMPLETED|Overall Study||7
9825591|NCT00742053|10936574|FG000|NOT COMPLETED|Overall Study||0
9825592|NCT00742079|10936580|FG000|STARTED|Overall Study||11
9825593|NCT00742079|10936581|FG001|STARTED|Overall Study||10
9825594|NCT00742079|10936580|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11
9825595|NCT00742079|10936581|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9
9825596|NCT00742079|10936580|FG000|Week 2 (Received Dose 2)|Overall Study||11
9825597|NCT00742079|10936581|FG001|Week 2 (Received Dose 2)|Overall Study||9
9825598|NCT00742079|10936580|FG000|COMPLETED|Overall Study||11
9825599|NCT00742079|10936581|FG001|COMPLETED|Overall Study||9
9825600|NCT00742079|10936580|FG000|NOT COMPLETED|Overall Study||0
9825601|NCT00742079|10936581|FG001|NOT COMPLETED|Overall Study||1
9825602|NCT00742170|10936589|FG000|STARTED|Overall Study||26
9825603|NCT00742170|10936590|FG001|STARTED|Overall Study||29
9825604|NCT00742170|10936589|FG000|COMPLETED|Overall Study||24
9825605|NCT00742170|10936590|FG001|COMPLETED|Overall Study||24
9825606|NCT00742170|10936589|FG000|NOT COMPLETED|Overall Study||2
10017346|NCT01816061|11140230|FG000|COMPLETED|Overall Study||27
10017347|NCT01816061|11140231|FG001|COMPLETED|Overall Study||27
9825607|NCT00742170|10936590|FG001|NOT COMPLETED|Overall Study||5
9825608|NCT00742183|10936598|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
9825609|NCT00742183|10936599|FG001|STARTED|Overall Study||51
9825610|NCT00742183|10936598|FG000|COMPLETED|Overall Study||40
10017348|NCT01816061|11140230|FG000|NOT COMPLETED|Overall Study||13
9825611|NCT00742183|10936599|FG001|COMPLETED|Overall Study||39
9825612|NCT00742183|10936598|FG000|NOT COMPLETED|Overall Study||9
9825613|NCT00742183|10936599|FG001|NOT COMPLETED|Overall Study||12
9825614|NCT00742209|10936610|FG000|STARTED|Overall Study||129
9825615|NCT00742209|10936611|FG001|STARTED|Overall Study||67
9825616|NCT00742209|10936612|FG002|STARTED|Overall Study||134
9825617|NCT00742209|10936613|FG003|STARTED|Overall Study||134
9825618|NCT00742209|10936614|FG004|STARTED|Overall Study||62
9825619|NCT00742209|10936610|FG000|COMPLETED|Overall Study||95
9825620|NCT00742209|10936611|FG001|COMPLETED|Overall Study||49
9825621|NCT00742209|10936612|FG002|COMPLETED|Overall Study||88
9825622|NCT00742209|10936613|FG003|COMPLETED|Overall Study||97
9825623|NCT00742209|10936614|FG004|COMPLETED|Overall Study||37
9825624|NCT00742209|10936610|FG000|NOT COMPLETED|Overall Study||34
9825625|NCT00742209|10936611|FG001|NOT COMPLETED|Overall Study||18
9825626|NCT00742209|10936612|FG002|NOT COMPLETED|Overall Study||46
9825627|NCT00742209|10936613|FG003|NOT COMPLETED|Overall Study||37
9825628|NCT00742209|10936614|FG004|NOT COMPLETED|Overall Study||25
9825629|NCT00742235|10936629|FG000|STARTED|Overall Study||32
9825630|NCT00742235|10936630|FG001|STARTED|Overall Study||67
9825631|NCT00742235|10936629|FG000|COMPLETED|Overall Study||32
9825632|NCT00742235|10936630|FG001|COMPLETED|Overall Study||36
9825633|NCT00742235|10936629|FG000|NOT COMPLETED|Overall Study||0
9825634|NCT00742235|10936630|FG001|NOT COMPLETED|Overall Study||31
9825635|NCT00742274|10936638|FG000|STARTED|Overall Study||30
9825636|NCT00742274|10936639|FG001|STARTED|Overall Study||31
9825637|NCT00742274|10936638|FG000|COMPLETED|Overall Study||27
9825638|NCT00742274|10936639|FG001|COMPLETED|Overall Study||28
9825639|NCT00742274|10936638|FG000|NOT COMPLETED|Overall Study||3
9825640|NCT00742274|10936639|FG001|NOT COMPLETED|Overall Study||3
9825641|NCT00742313|10936647|FG000|STARTED|Overall Study||25
9825642|NCT00742313|10936648|FG001|STARTED|Overall Study||19
9825643|NCT00742313|10936647|FG000|COMPLETED|Overall Study||24
9825644|NCT00742313|10936648|FG001|COMPLETED|Overall Study||19
9825645|NCT00742313|10936647|FG000|NOT COMPLETED|Overall Study||1
9825646|NCT00742313|10936648|FG001|NOT COMPLETED|Overall Study||0
9825647|NCT00742326|10936656|FG000|STARTED|Overall Study||6
9825648|NCT00742326|10936657|FG001|STARTED|Overall Study||7
9825649|NCT00742326|10936656|FG000|COMPLETED|Overall Study||6
9825650|NCT00742326|10936657|FG001|COMPLETED|Overall Study||6
9825651|NCT00742326|10936656|FG000|NOT COMPLETED|Overall Study||0
9825652|NCT00742326|10936657|FG001|NOT COMPLETED|Overall Study||1
9825653|NCT00742391|10936665|FG000|STARTED|Overall Study||126
9825654|NCT00742391|10936666|FG001|STARTED|Overall Study||129
9825655|NCT00742391|10936665|FG000|COMPLETED|Overall Study||122
9825656|NCT00742391|10936666|FG001|COMPLETED|Overall Study||128
9825657|NCT00742391|10936665|FG000|NOT COMPLETED|Overall Study||4
9825658|NCT00742391|10936666|FG001|NOT COMPLETED|Overall Study||1
9825659|NCT00742417|10936674|FG000|STARTED|Randomized||21
9825660|NCT00742417|10936675|FG001|STARTED|Randomized||21
9825661|NCT00742417|10936674|FG000|COMPLETED|Randomized||19
9825662|NCT00742417|10936675|FG001|COMPLETED|Randomized||20
9825663|NCT00742417|10936674|FG000|NOT COMPLETED|Randomized||2
9825664|NCT00742417|10936675|FG001|NOT COMPLETED|Randomized||1
9825665|NCT00742417|10936674|FG000|STARTED|Intensive Period||19
9825666|NCT00742417|10936675|FG001|STARTED|Intensive Period||20
10236889|NCT00804349|11367665|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
10236890|NCT00804349|11367664|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
10236891|NCT00804349|11367665|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
10236892|NCT00804349|11367664|FG000|NOT COMPLETED|Overall Study||0
10236893|NCT00804349|11367665|FG001|NOT COMPLETED|Overall Study||0
10236894|NCT00803283|11367673|FG000|STARTED|Overall Study||1
10236895|NCT00803283|11367674|FG001|STARTED|Overall Study||1
10236896|NCT00803283|11367673|FG000|COMPLETED|Overall Study||1
10236897|NCT00803283|11367674|FG001|COMPLETED|Overall Study||1
10236898|NCT00803283|11367673|FG000|NOT COMPLETED|Overall Study||0
10236899|NCT00803283|11367674|FG001|NOT COMPLETED|Overall Study||0
10236900|NCT00811590|11367680|FG000|STARTED|Overall Study||3
10236901|NCT00811590|11367680|FG000|COMPLETED|Overall Study||3
9825667|NCT00742417|10936674|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
10236902|NCT00811590|11367680|FG000|NOT COMPLETED|Overall Study||0
10236903|NCT00808899|11367684|FG000|STARTED|Overall Study||4
10236904|NCT00808899|11367684|FG000|COMPLETED|Overall Study||0
10236905|NCT00808899|11367684|FG000|NOT COMPLETED|Overall Study||4
10236906|NCT00808769|11367688|FG000|STARTED|First Intervention||15
10236907|NCT00808769|11367689|FG001|STARTED|First Intervention||15
9825668|NCT00742417|10936675|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
9825669|NCT00742417|10936674|FG000|NOT COMPLETED|Intensive Period||3
9825670|NCT00742417|10936675|FG001|NOT COMPLETED|Intensive Period||1
9825671|NCT00742417|10936674|FG000|STARTED|Maintenance I||16
9825672|NCT00742417|10936675|FG001|STARTED|Maintenance I||19
9825673|NCT00742417|10936674|FG000|COMPLETED|Maintenance I||16
9825674|NCT00742417|10936675|FG001|COMPLETED|Maintenance I||19
9825675|NCT00742417|10936674|FG000|NOT COMPLETED|Maintenance I||0
9825676|NCT00742417|10936675|FG001|NOT COMPLETED|Maintenance I||0
9825677|NCT00742417|10936674|FG000|STARTED|Maintenance II||16
9825678|NCT00742417|10936675|FG001|STARTED|Maintenance II||19
9825679|NCT00742417|10936674|FG000|COMPLETED|Maintenance II||16
9825680|NCT00742417|10936675|FG001|COMPLETED|Maintenance II||19
9825681|NCT00742417|10936674|FG000|NOT COMPLETED|Maintenance II||0
9825682|NCT00742417|10936675|FG001|NOT COMPLETED|Maintenance II||0
9825683|NCT00742469|10936685|FG000|STARTED|Overall Study||106
9825684|NCT00742469|10936686|FG001|STARTED|Overall Study||104
9825685|NCT00742469|10936685|FG000|COMPLETED|Overall Study||88
9825686|NCT00742469|10936686|FG001|COMPLETED|Overall Study||69
9825687|NCT00742469|10936685|FG000|NOT COMPLETED|Overall Study||18
9825688|NCT00742469|10936686|FG001|NOT COMPLETED|Overall Study||35
9825689|NCT00742508|10936694|FG000|STARTED|8-Week Primary Evaluation Period||22
9825690|NCT00742508|10936695|FG001|STARTED|8-Week Primary Evaluation Period||19
9825691|NCT00742508|10936694|FG000|COMPLETED|8-Week Primary Evaluation Period||11
9825692|NCT00742508|10936695|FG001|COMPLETED|8-Week Primary Evaluation Period||8
9825693|NCT00742508|10936694|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11
9825694|NCT00742508|10936695|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11
9825695|NCT00742508|10936694|FG000|STARTED|4-Week Exploratory Evaluation Period||0
9825696|NCT00742508|10936695|FG001|STARTED|4-Week Exploratory Evaluation Period||8
9825697|NCT00742508|10936694|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0
9825698|NCT00742508|10936695|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7
9825699|NCT00742508|10936694|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
9825700|NCT00742508|10936695|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
9825701|NCT00742560|10936706|FG000|STARTED|Overall Study||3
9825702|NCT00742560|10936707|FG001|STARTED|Overall Study||3
9825703|NCT00742560|10936708|FG002|STARTED|Overall Study||22
9825704|NCT00742560|10936709|FG003|STARTED|Overall Study||36
9825705|NCT00742560|10936710|FG004|STARTED|Overall Study||37
9825706|NCT00742560|10936706|FG000|COMPLETED|Overall Study||0
9825707|NCT00742560|10936707|FG001|COMPLETED|Overall Study||0
9825708|NCT00742560|10936708|FG002|COMPLETED|Overall Study||0
9825709|NCT00742560|10936709|FG003|COMPLETED|Overall Study||0
9825710|NCT00742560|10936710|FG004|COMPLETED|Overall Study||0
9825711|NCT00742560|10936706|FG000|NOT COMPLETED|Overall Study||3
9825712|NCT00742560|10936707|FG001|NOT COMPLETED|Overall Study||3
9825713|NCT00742560|10936708|FG002|NOT COMPLETED|Overall Study||22
9825714|NCT00742560|10936709|FG003|NOT COMPLETED|Overall Study||36
9825715|NCT00742560|10936710|FG004|NOT COMPLETED|Overall Study||37
9825716|NCT00742573|10936743|FG000|STARTED|Overall Study||83
9825717|NCT00742573|10936744|FG001|STARTED|Overall Study||87
9825718|NCT00742573|10936743|FG000|Week 12|Overall Study||46
9825719|NCT00742573|10936744|FG001|Week 12|Overall Study||51
9825720|NCT00742573|10936743|FG000|Week 24|Overall Study||39
9825721|NCT00742573|10936744|FG001|Week 24|Overall Study||37
9825722|NCT00742573|10936743|FG000|Week 52|Overall Study||26
9825723|NCT00742573|10936744|FG001|Week 52|Overall Study||25
9825724|NCT00742573|10936743|FG000|COMPLETED|Overall Study||26
9825725|NCT00742573|10936744|FG001|COMPLETED|Overall Study||25
9825726|NCT00742573|10936743|FG000|NOT COMPLETED|Overall Study||57
9825727|NCT00742573|10936744|FG001|NOT COMPLETED|Overall Study||62
9825728|NCT00742625|10936750|FG000|STARTED|Remission Induction||95
9825729|NCT00742625|10936750|FG000|COMPLETED|Remission Induction||41
10236908|NCT00808769|11367688|FG000|COMPLETED|First Intervention||15
10236909|NCT00808769|11367689|FG001|COMPLETED|First Intervention||15
10236910|NCT00808769|11367688|FG000|NOT COMPLETED|First Intervention||0
10236911|NCT00808769|11367689|FG001|NOT COMPLETED|First Intervention||0
10236912|NCT00808769|11367688|FG000|STARTED|Second Intervention||15
10236913|NCT00808769|11367689|FG001|STARTED|Second Intervention||15
10236914|NCT00808769|11367688|FG000|COMPLETED|Second Intervention||15
10236915|NCT00808769|11367689|FG001|COMPLETED|Second Intervention||15
10236916|NCT00808769|11367688|FG000|NOT COMPLETED|Second Intervention||0
10236917|NCT00808769|11367689|FG001|NOT COMPLETED|Second Intervention||0
9825730|NCT00742625|10936750|FG000|NOT COMPLETED|Remission Induction||54
9825731|NCT00742625|10936750|FG000|STARTED|Consolidation||41
9825732|NCT00742625|10936750|FG000|COMPLETED|Consolidation||20
9825733|NCT00742625|10936750|FG000|NOT COMPLETED|Consolidation||21
9825734|NCT00742781|10936757|FG000|STARTED|Overall Study||21
9825735|NCT00742781|10936757|FG000|COMPLETED|Overall Study||18
9825736|NCT00742781|10936757|FG000|NOT COMPLETED|Overall Study||3
9825737|NCT00742859|10936766|FG000|STARTED|Overall Study||127
9825738|NCT00742859|10936767|FG001|STARTED|Overall Study||127
9825739|NCT00742859|10936768|FG002|STARTED|Overall Study||127
9825740|NCT00742859|10936769|FG003|STARTED|Overall Study||127
9825741|NCT00742859|10936766|FG000|COMPLETED|Overall Study||116
9825742|NCT00742859|10936767|FG001|COMPLETED|Overall Study||115
9825743|NCT00742859|10936768|FG002|COMPLETED|Overall Study||116
9825744|NCT00742859|10936769|FG003|COMPLETED|Overall Study||119
10236918|NCT00803179|11367695|FG000|STARTED|Overall Study||5
10236919|NCT00803179|11367695|FG000|COMPLETED|Overall Study||2
10236920|NCT00803179|11367695|FG000|NOT COMPLETED|Overall Study||3
10236921|NCT00801931|11367699|FG000|STARTED|Overall Study||1
10236922|NCT00801931|11367699|FG000|COMPLETED|Overall Study||1
10236923|NCT00801931|11367699|FG000|NOT COMPLETED|Overall Study||0
10236924|NCT00793520|11367705|FG000|STARTED|Milnacipran Crossover to Placebo||1
10236925|NCT00793520|11367706|FG001|STARTED|Milnacipran Crossover to Placebo||0
10239766|NCT02126878|11371476|FG002|COMPLETED|Overall Study||0
10236926|NCT00793520|11367705|FG000|COMPLETED|Milnacipran Crossover to Placebo||0
10236927|NCT00793520|11367706|FG001|COMPLETED|Milnacipran Crossover to Placebo||0
10236928|NCT00793520|11367705|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1
10236929|NCT00793520|11367706|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0
9825745|NCT00742859|10936766|FG000|NOT COMPLETED|Overall Study||11
9825746|NCT00742859|10936767|FG001|NOT COMPLETED|Overall Study||12
9825747|NCT00742859|10936768|FG002|NOT COMPLETED|Overall Study||11
9825748|NCT00742859|10936769|FG003|NOT COMPLETED|Overall Study||8
9825749|NCT00742872|10936781|FG000|STARTED|Overall Study||21
9825750|NCT00742872|10936782|FG001|STARTED|Overall Study||20
9825751|NCT00742872|10936781|FG000|COMPLETED|Overall Study||9
9825752|NCT00742872|10936782|FG001|COMPLETED|Overall Study||12
9825753|NCT00742872|10936781|FG000|NOT COMPLETED|Overall Study||12
9825754|NCT00742872|10936782|FG001|NOT COMPLETED|Overall Study||8
9825755|NCT00742885|10936790|FG000|STARTED|Overall Study||50
9825756|NCT00742885|10936791|FG001|STARTED|Overall Study||50
9825757|NCT00742885|10936790|FG000|COMPLETED|Overall Study|to Day 182|49
9825758|NCT00742885|10936791|FG001|COMPLETED|Overall Study|to Day 182|50
9825759|NCT00742885|10936790|FG000|NOT COMPLETED|Overall Study||1
9825760|NCT00742885|10936791|FG001|NOT COMPLETED|Overall Study||0
9825761|NCT00742924|10936804|FG000|STARTED|Overall Study||6
9825762|NCT00742924|10936805|FG001|STARTED|Overall Study||6
9825763|NCT00742924|10936806|FG002|STARTED|Overall Study||6
9825764|NCT00742924|10936807|FG003|STARTED|Overall Study||6
9825765|NCT00742924|10936804|FG000|COMPLETED|Overall Study||1
9825766|NCT00742924|10936805|FG001|COMPLETED|Overall Study||4
9825767|NCT00742924|10936806|FG002|COMPLETED|Overall Study||2
9825768|NCT00742924|10936807|FG003|COMPLETED|Overall Study||0
9825769|NCT00742924|10936804|FG000|NOT COMPLETED|Overall Study||5
9825770|NCT00742924|10936805|FG001|NOT COMPLETED|Overall Study||2
9825771|NCT00742924|10936806|FG002|NOT COMPLETED|Overall Study||4
9825772|NCT00742924|10936807|FG003|NOT COMPLETED|Overall Study||6
9825773|NCT00742963|10936817|FG000|STARTED|Overall Study||101
9825774|NCT00742963|10936817|FG000|Completed All Treatment Cycles|Overall Study||68
9825775|NCT00742963|10936817|FG000|COMPLETED|Overall Study||68
9825776|NCT00742963|10936817|FG000|NOT COMPLETED|Overall Study||33
9825777|NCT00743093|10936823|FG000|STARTED|Base Study Period||224
9825778|NCT00743093|10936824|FG001|STARTED|Base Study Period||52
9825779|NCT00743093|10936823|FG000|COMPLETED|Base Study Period||205
9825780|NCT00743093|10936824|FG001|COMPLETED|Base Study Period||47
9825781|NCT00743093|10936823|FG000|NOT COMPLETED|Base Study Period||19
9825782|NCT00743093|10936824|FG001|NOT COMPLETED|Base Study Period||5
9825783|NCT00743093|10936823|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
9825784|NCT00743093|10936824|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
9825785|NCT00743093|10936823|FG000|COMPLETED|Extended Dosing Period||48
9825786|NCT00743093|10936824|FG001|COMPLETED|Extended Dosing Period||1
9825787|NCT00743093|10936823|FG000|NOT COMPLETED|Extended Dosing Period||3
9825788|NCT00743093|10936824|FG001|NOT COMPLETED|Extended Dosing Period||0
9825789|NCT00743106|10936832|FG000|STARTED|Overall Study||42
9825790|NCT00743106|10936833|FG001|STARTED|Overall Study||48
9825791|NCT00743106|10936832|FG000|COMPLETED|Overall Study||34
9825792|NCT00743106|10936833|FG001|COMPLETED|Overall Study||43
9825793|NCT00743106|10936832|FG000|NOT COMPLETED|Overall Study||8
9825794|NCT00743106|10936833|FG001|NOT COMPLETED|Overall Study||5
9825795|NCT00743119|10936839|FG000|STARTED|Overall Study||34
9825796|NCT00743119|10936839|FG000|COMPLETED|Overall Study||30
9825797|NCT00743119|10936839|FG000|NOT COMPLETED|Overall Study||4
9825798|NCT00743145|10936851|FG000|STARTED|Overall Study||23
9825799|NCT00743145|10936851|FG000|COMPLETED|Overall Study||19
9825800|NCT00743145|10936851|FG000|NOT COMPLETED|Overall Study||4
9825801|NCT00743249|10936867|FG000|STARTED|Overall Study||30
9825802|NCT00743249|10936868|FG001|STARTED|Overall Study||30
9825803|NCT00743249|10936867|FG000|COMPLETED|Overall Study||28
9825804|NCT00743249|10936868|FG001|COMPLETED|Overall Study||24
9825805|NCT00743249|10936867|FG000|NOT COMPLETED|Overall Study||2
9825806|NCT00743249|10936868|FG001|NOT COMPLETED|Overall Study||6
9825807|NCT00743262|10936874|FG000|STARTED|Overall Study||15
9825808|NCT00743262|10936874|FG000|COMPLETED|Overall Study||15
9825809|NCT00743262|10936874|FG000|NOT COMPLETED|Overall Study||0
9825810|NCT00743275|10936880|FG000|STARTED|Overall Study||59
9825811|NCT00743275|10936881|FG001|STARTED|Overall Study||61
9825812|NCT00743275|10936880|FG000|COMPLETED|Overall Study||59
9825813|NCT00743275|10936881|FG001|COMPLETED|Overall Study||60
9825814|NCT00743275|10936880|FG000|NOT COMPLETED|Overall Study||0
9825815|NCT00743275|10936881|FG001|NOT COMPLETED|Overall Study||1
9825816|NCT00743288|10936887|FG000|STARTED|Overall Study||3
9825817|NCT00743288|10936888|FG001|STARTED|Overall Study||3
9825818|NCT00743288|10936889|FG002|STARTED|Overall Study||6
9825819|NCT00743288|10936890|FG003|STARTED|Overall Study||7
10236930|NCT00793520|11367705|FG000|STARTED|Placebo Crossover to Milnacipran||0
9825820|NCT00743288|10936891|FG004|STARTED|Overall Study||6
9825821|NCT00743288|10936892|FG005|STARTED|Overall Study||6
9825822|NCT00743288|10936893|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
9825823|NCT00743288|10936887|FG000|COMPLETED|Overall Study||0
9825824|NCT00743288|10936888|FG001|COMPLETED|Overall Study||0
10236931|NCT00793520|11367706|FG001|STARTED|Placebo Crossover to Milnacipran||1
9825825|NCT00743288|10936889|FG002|COMPLETED|Overall Study||1
9825826|NCT00743288|10936890|FG003|COMPLETED|Overall Study||0
9825827|NCT00743288|10936891|FG004|COMPLETED|Overall Study||0
9825828|NCT00743288|10936892|FG005|COMPLETED|Overall Study||1
9825829|NCT00743288|10936893|FG006|COMPLETED|Overall Study||0
9825830|NCT00743288|10936887|FG000|NOT COMPLETED|Overall Study||3
9825831|NCT00743288|10936888|FG001|NOT COMPLETED|Overall Study||3
9825832|NCT00743288|10936889|FG002|NOT COMPLETED|Overall Study||5
9825833|NCT00743288|10936890|FG003|NOT COMPLETED|Overall Study||7
9825834|NCT00743288|10936891|FG004|NOT COMPLETED|Overall Study||6
9825835|NCT00743288|10936892|FG005|NOT COMPLETED|Overall Study||5
9825836|NCT00743288|10936893|FG006|NOT COMPLETED|Overall Study||9
9825837|NCT00743340|10936904|FG000|STARTED|Overall Study||50
9825838|NCT00743340|10936904|FG000|COMPLETED|Overall Study||9
9825839|NCT00743340|10936904|FG000|NOT COMPLETED|Overall Study||41
9825840|NCT00743366|10936908|FG000|STARTED|Intervention 1 (8 Days)||10
9825841|NCT00743366|10936909|FG001|STARTED|Intervention 1 (8 Days)||10
9825842|NCT00743366|10936908|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
9825843|NCT00743366|10936909|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
9825844|NCT00743366|10936908|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3
9825845|NCT00743366|10936909|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3
9825846|NCT00743366|10936908|FG000|STARTED|Intervention 2 (8 Days)||7
9825847|NCT00743366|10936909|FG001|STARTED|Intervention 2 (8 Days)||7
9825848|NCT00743366|10936908|FG000|COMPLETED|Intervention 2 (8 Days)||7
9825849|NCT00743366|10936909|FG001|COMPLETED|Intervention 2 (8 Days)||7
9825850|NCT00743366|10936908|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
9825851|NCT00743366|10936909|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
9832303|NCT00772590|10943087|FG001|NOT COMPLETED|Overall Study||0
9832304|NCT00772590|10943088|FG002|NOT COMPLETED|Overall Study||0
9832305|NCT00772590|10943089|FG003|NOT COMPLETED|Overall Study||0
9832306|NCT00772603|10943102|FG000|STARTED|Overall Study||123
9832307|NCT00772603|10943103|FG001|STARTED|Overall Study||122
9832308|NCT00772603|10943104|FG002|STARTED|Overall Study||121
9832309|NCT00772603|10943102|FG000|COMPLETED|Overall Study||71
9832310|NCT00772603|10943103|FG001|COMPLETED|Overall Study||82
9832311|NCT00772603|10943104|FG002|COMPLETED|Overall Study||95
9832312|NCT00772603|10943102|FG000|NOT COMPLETED|Overall Study||52
9832313|NCT00772603|10943103|FG001|NOT COMPLETED|Overall Study||40
9832314|NCT00772603|10943104|FG002|NOT COMPLETED|Overall Study||26
9832315|NCT00772629|10943117|FG000|STARTED|Overall Study||17
9832316|NCT00772629|10943118|FG001|STARTED|Overall Study||1
9832317|NCT00772629|10943117|FG000|COMPLETED|Overall Study||16
9832318|NCT00772629|10943118|FG001|COMPLETED|Overall Study||1
9832319|NCT00772629|10943117|FG000|NOT COMPLETED|Overall Study||1
9832320|NCT00772629|10943118|FG001|NOT COMPLETED|Overall Study||0
9832321|NCT00772668|10943124|FG000|STARTED|Overall Study||3
9832322|NCT00772668|10943124|FG000|COMPLETED|Overall Study||0
9832323|NCT00772668|10943124|FG000|NOT COMPLETED|Overall Study||3
9832324|NCT00772707|10943129|FG000|STARTED|Overall Study||114
9832325|NCT00772707|10943129|FG000|COMPLETED|Overall Study||111
9832326|NCT00772707|10943129|FG000|NOT COMPLETED|Overall Study||3
9832327|NCT00772772|10943133|FG000|STARTED|Overall Study||12
9832328|NCT00772772|10943133|FG000|COMPLETED|Overall Study||12
9832329|NCT00772772|10943133|FG000|NOT COMPLETED|Overall Study||0
9832330|NCT00772889|10943141|FG000|STARTED|Overall Study||375
9832331|NCT00772889|10943142|FG001|STARTED|Overall Study||393
9832332|NCT00772889|10943143|FG002|STARTED|Overall Study||203
9832333|NCT00772889|10943141|FG000|Completed at Day 21|Overall Study||374
9832334|NCT00772889|10943142|FG001|Completed at Day 21|Overall Study||390
9832335|NCT00772889|10943143|FG002|Completed at Day 21|Overall Study||203
9832336|NCT00772889|10943141|FG000|COMPLETED|Overall Study||353
9832337|NCT00772889|10943142|FG001|COMPLETED|Overall Study||375
9832338|NCT00772889|10943143|FG002|COMPLETED|Overall Study||187
9832339|NCT00772889|10943141|FG000|NOT COMPLETED|Overall Study||22
9832340|NCT00772889|10943142|FG001|NOT COMPLETED|Overall Study||18
9832341|NCT00772889|10943143|FG002|NOT COMPLETED|Overall Study||16
9832342|NCT00772915|10943151|FG000|STARTED|Overall Study||38
9832343|NCT00772915|10943151|FG000|COMPLETED|Overall Study||23
9832344|NCT00772915|10943151|FG000|NOT COMPLETED|Overall Study||15
9832345|NCT00772928|10943157|FG000|STARTED|Overall Study||587
9832346|NCT00772928|10943158|FG001|STARTED|Overall Study||579
9832347|NCT00772928|10943157|FG000|COMPLETED|Overall Study||543
9832348|NCT00772928|10943158|FG001|COMPLETED|Overall Study||538
9832349|NCT00772928|10943157|FG000|NOT COMPLETED|Overall Study||44
9832350|NCT00772928|10943158|FG001|NOT COMPLETED|Overall Study||41
9832351|NCT00772941|10943164|FG000|STARTED|Overall Study||3939
9832352|NCT00772941|10943164|FG000|COMPLETED|Overall Study||3257
9832353|NCT00772941|10943164|FG000|NOT COMPLETED|Overall Study||682
9832354|NCT00772954|10943194|FG000|STARTED|Overall Study||12
9832355|NCT00772954|10943195|FG001|STARTED|Overall Study||12
9832356|NCT00772954|10943196|FG002|STARTED|Overall Study||12
9832357|NCT00772954|10943194|FG000|COMPLETED|Overall Study||12
9832358|NCT00772954|10943195|FG001|COMPLETED|Overall Study||12
9832359|NCT00772954|10943196|FG002|COMPLETED|Overall Study||11
9832360|NCT00772954|10943194|FG000|NOT COMPLETED|Overall Study||0
9832361|NCT00772954|10943195|FG001|NOT COMPLETED|Overall Study||0
9832362|NCT00772954|10943196|FG002|NOT COMPLETED|Overall Study||1
9832363|NCT00772967|10943204|FG000|STARTED|Crossover Treatment 1||3
9832364|NCT00772967|10943205|FG001|STARTED|Crossover Treatment 1||5
9832365|NCT00772967|10943206|FG002|STARTED|Crossover Treatment 1||3
9832366|NCT00772967|10943207|FG003|STARTED|Crossover Treatment 1||4
9825852|NCT00743431|10936915|FG000|STARTED|Overall Study||224
9825853|NCT00743431|10936915|FG000|COMPLETED|Overall Study||98
9825854|NCT00743431|10936915|FG000|NOT COMPLETED|Overall Study||126
9825855|NCT00743444|10936919|FG000|STARTED|First Intervention||14
9825856|NCT00743444|10936920|FG001|STARTED|First Intervention||13
9825857|NCT00743444|10936919|FG000|COMPLETED|First Intervention||14
9825858|NCT00743444|10936920|FG001|COMPLETED|First Intervention||12
9825859|NCT00743444|10936919|FG000|NOT COMPLETED|First Intervention||0
9825860|NCT00743444|10936920|FG001|NOT COMPLETED|First Intervention||1
9825861|NCT00743444|10936919|FG000|STARTED|Washout Period||14
9825862|NCT00743444|10936920|FG001|STARTED|Washout Period||12
9825863|NCT00743444|10936919|FG000|COMPLETED|Washout Period||14
9825864|NCT00743444|10936920|FG001|COMPLETED|Washout Period||11
9825865|NCT00743444|10936919|FG000|NOT COMPLETED|Washout Period||0
9825866|NCT00743444|10936920|FG001|NOT COMPLETED|Washout Period||1
9825867|NCT00743444|10936919|FG000|STARTED|Second Intervention||14
9825868|NCT00743444|10936920|FG001|STARTED|Second Intervention||11
9825869|NCT00743444|10936919|FG000|COMPLETED|Second Intervention||14
9825870|NCT00743444|10936920|FG001|COMPLETED|Second Intervention||11
9825871|NCT00743444|10936919|FG000|NOT COMPLETED|Second Intervention||0
9825872|NCT00743444|10936920|FG001|NOT COMPLETED|Second Intervention||0
9825873|NCT00743483|10936926|FG000|STARTED|Baseline Period||15
9825874|NCT00743483|10936926|FG000|COMPLETED|Baseline Period||14
9825875|NCT00743483|10936926|FG000|NOT COMPLETED|Baseline Period||1
9825876|NCT00743483|10936926|FG000|STARTED|Treatment Period||14
9825877|NCT00743483|10936926|FG000|COMPLETED|Treatment Period||13
9825878|NCT00743483|10936926|FG000|NOT COMPLETED|Treatment Period||1
9825879|NCT00743509|10936930|FG000|STARTED|Overall Study||49
9825880|NCT00743509|10936930|FG000|COMPLETED|Overall Study||47
9825881|NCT00743509|10936930|FG000|NOT COMPLETED|Overall Study||2
9825882|NCT00743574|10936934|FG000|STARTED|Overall Study||36
9825883|NCT00743574|10936934|FG000|Dropped Out Before Eligibility Testing|Overall Study||13
9825884|NCT00743574|10936934|FG000|Further Exclusions|Overall Study||8
9825885|NCT00743574|10936934|FG000|Dropped Out After Initiating Trial|Overall Study||3
9825886|NCT00743574|10936934|FG000|COMPLETED|Overall Study||12
9825887|NCT00743574|10936934|FG000|NOT COMPLETED|Overall Study||24
9825888|NCT00743652|10936943|FG000|STARTED|Overall Study||151
9825889|NCT00743652|10936944|FG001|STARTED|Overall Study||51
9825890|NCT00743652|10936945|FG002|STARTED|Overall Study||25
9825891|NCT00743652|10936946|FG003|STARTED|Overall Study||67
9825892|NCT00743652|10936947|FG004|STARTED|Overall Study||79
9825893|NCT00743652|10936943|FG000|Vaccinated Dose 1|Overall Study||151
9825894|NCT00743652|10936944|FG001|Vaccinated Dose 1|Overall Study||51
9825895|NCT00743652|10936945|FG002|Vaccinated Dose 1|Overall Study||25
9825896|NCT00743652|10936946|FG003|Vaccinated Dose 1|Overall Study||66
9825897|NCT00743652|10936947|FG004|Vaccinated Dose 1|Overall Study||79
9825898|NCT00743652|10936943|FG000|Vaccinated Dose 2|Overall Study||112
9825899|NCT00743652|10936944|FG001|Vaccinated Dose 2|Overall Study||41
9825900|NCT00743652|10936945|FG002|Vaccinated Dose 2|Overall Study||0
9825901|NCT00743652|10936946|FG003|Vaccinated Dose 2|Overall Study||49
9825902|NCT00743652|10936947|FG004|Vaccinated Dose 2|Overall Study||0
9825903|NCT00743652|10936943|FG000|Vaccinated Dose 3|Overall Study||74
9825904|NCT00743652|10936944|FG001|Vaccinated Dose 3|Overall Study||0
9825905|NCT00743652|10936945|FG002|Vaccinated Dose 3|Overall Study||0
9825906|NCT00743652|10936946|FG003|Vaccinated Dose 3|Overall Study||0
9825907|NCT00743652|10936947|FG004|Vaccinated Dose 3|Overall Study||0
9825908|NCT00743652|10936943|FG000|Toddler Dose|Overall Study||15
9825909|NCT00743652|10936944|FG001|Toddler Dose|Overall Study||23
9825910|NCT00743652|10936945|FG002|Toddler Dose|Overall Study||16
9825911|NCT00743652|10936946|FG003|Toddler Dose|Overall Study||0
9825912|NCT00743652|10936947|FG004|Toddler Dose|Overall Study||0
9825913|NCT00743652|10936943|FG000|COMPLETED|Overall Study||141
9825914|NCT00743652|10936944|FG001|COMPLETED|Overall Study||48
9825915|NCT00743652|10936945|FG002|COMPLETED|Overall Study||23
9825916|NCT00743652|10936946|FG003|COMPLETED|Overall Study||63
9825917|NCT00743652|10936947|FG004|COMPLETED|Overall Study||79
9825918|NCT00743652|10936943|FG000|NOT COMPLETED|Overall Study||10
9825919|NCT00743652|10936944|FG001|NOT COMPLETED|Overall Study||3
9825920|NCT00743652|10936945|FG002|NOT COMPLETED|Overall Study||2
9825921|NCT00743652|10936946|FG003|NOT COMPLETED|Overall Study||4
9825922|NCT00743652|10936947|FG004|NOT COMPLETED|Overall Study||0
9825923|NCT00743717|10936965|FG000|STARTED|Overall Study||2
9825924|NCT00743717|10936966|FG001|STARTED|Overall Study||2
9825925|NCT00743717|10936965|FG000|COMPLETED|Overall Study||2
9825926|NCT00743717|10936966|FG001|COMPLETED|Overall Study||2
9825927|NCT00743717|10936965|FG000|NOT COMPLETED|Overall Study||0
9825928|NCT00743717|10936966|FG001|NOT COMPLETED|Overall Study||0
9825929|NCT00743730|10936975|FG000|STARTED|Overall Study||27
9825930|NCT00743730|10936976|FG001|STARTED|Overall Study||34
9825931|NCT00743730|10936977|FG002|STARTED|Overall Study||33
9825932|NCT00743730|10936975|FG000|COMPLETED|Overall Study||22
9825933|NCT00743730|10936976|FG001|COMPLETED|Overall Study||30
9825934|NCT00743730|10936977|FG002|COMPLETED|Overall Study||28
9825935|NCT00743730|10936975|FG000|NOT COMPLETED|Overall Study||5
9825936|NCT00743730|10936976|FG001|NOT COMPLETED|Overall Study||4
9825937|NCT00743730|10936977|FG002|NOT COMPLETED|Overall Study||5
9825938|NCT00744042|10936989|FG000|STARTED|Overall Study||11
9825939|NCT00744042|10936989|FG000|COMPLETED|Overall Study||10
9825940|NCT00744042|10936989|FG000|NOT COMPLETED|Overall Study||1
9825941|NCT00744055|10937001|FG000|STARTED|Overall Study||50
9825942|NCT00744055|10937002|FG001|STARTED|Overall Study||46
9825943|NCT00744055|10937001|FG000|COMPLETED|Overall Study||43
9825944|NCT00744055|10937002|FG001|COMPLETED|Overall Study||32
9825945|NCT00744055|10937001|FG000|NOT COMPLETED|Overall Study||7
9825946|NCT00744055|10937002|FG001|NOT COMPLETED|Overall Study||14
9825947|NCT00744211|10937011|FG000|STARTED|Baseline||10
9825948|NCT00744211|10937012|FG001|STARTED|Baseline||9
9825949|NCT00744211|10937013|FG002|STARTED|Baseline||10
9825950|NCT00744211|10937011|FG000|COMPLETED|Baseline||10
9825951|NCT00744211|10937012|FG001|COMPLETED|Baseline||9
9825952|NCT00744211|10937013|FG002|COMPLETED|Baseline||10
9825953|NCT00744211|10937011|FG000|NOT COMPLETED|Baseline||0
9825954|NCT00744211|10937012|FG001|NOT COMPLETED|Baseline||0
9825955|NCT00744211|10937013|FG002|NOT COMPLETED|Baseline||0
9825956|NCT00744211|10937011|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
9825957|NCT00744211|10937012|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
9825958|NCT00744211|10937013|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
9825959|NCT00744211|10937011|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
9825960|NCT00744211|10937012|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
9825961|NCT00744211|10937013|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
9825962|NCT00744211|10937011|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
9825963|NCT00744211|10937012|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
9825964|NCT00744211|10937013|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
9825965|NCT00744211|10937011|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10
9825966|NCT00744211|10937012|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9
9825967|NCT00744211|10937013|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10
9825968|NCT00744211|10937011|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
9825969|NCT00744211|10937012|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
9825970|NCT00744211|10937013|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
9825971|NCT00744211|10937011|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
9825972|NCT00744211|10937012|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
9825973|NCT00744211|10937013|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
9825974|NCT00744211|10937011|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10
9825975|NCT00744211|10937012|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9
9825976|NCT00744211|10937013|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10
9825977|NCT00744211|10937011|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
9825978|NCT00744211|10937012|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
9825979|NCT00744211|10937013|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
9825980|NCT00744211|10937011|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
9825981|NCT00744211|10937012|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
9825982|NCT00744211|10937013|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
9825983|NCT00744211|10937011|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10
9825984|NCT00744211|10937012|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9
9825985|NCT00744211|10937013|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10
9825986|NCT00744211|10937011|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
9825987|NCT00744211|10937012|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
9825988|NCT00744211|10937013|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
9825989|NCT00744211|10937011|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
9825990|NCT00744211|10937012|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
9825991|NCT00744211|10937013|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
9825992|NCT00744237|10937027|FG000|STARTED|Overall Study||83
9825993|NCT00744237|10937028|FG001|STARTED|Overall Study||73
9825994|NCT00744237|10937029|FG002|STARTED|Overall Study||74
9825995|NCT00744237|10937027|FG000|COMPLETED|Overall Study||56
9825996|NCT00744237|10937028|FG001|COMPLETED|Overall Study||46
9825997|NCT00744237|10937029|FG002|COMPLETED|Overall Study||59
9825998|NCT00744237|10937027|FG000|NOT COMPLETED|Overall Study||27
9825999|NCT00744237|10937028|FG001|NOT COMPLETED|Overall Study||27
9826000|NCT00744237|10937029|FG002|NOT COMPLETED|Overall Study||15
9826001|NCT00744263|10937039|FG000|STARTED|Overall Study||42240
9826002|NCT00744263|10937040|FG001|STARTED|Overall Study||42256
9826003|NCT00744263|10937039|FG000|COMPLETED|Overall Study||37004
9826004|NCT00744263|10937040|FG001|COMPLETED|Overall Study||36936
9826005|NCT00744263|10937039|FG000|NOT COMPLETED|Overall Study||5236
10017349|NCT01816061|11140231|FG001|NOT COMPLETED|Overall Study||24
10017350|NCT01816074|11140241|FG000|STARTED|Phase 1||11
10017351|NCT01816074|11140242|FG001|STARTED|Phase 1||9
10017352|NCT01816074|11140243|FG002|STARTED|Phase 1||11
10017353|NCT01816074|11140244|FG003|STARTED|Phase 1||10
9826006|NCT00744263|10937040|FG001|NOT COMPLETED|Overall Study||5320
9826007|NCT00744328|10937051|FG000|STARTED|Overall Study||26
9826008|NCT00744328|10937052|FG001|STARTED|Overall Study||30
9826009|NCT00744328|10937053|FG002|STARTED|Overall Study||29
9826010|NCT00744328|10937051|FG000|COMPLETED|Overall Study||19
9826011|NCT00744328|10937052|FG001|COMPLETED|Overall Study||22
9826012|NCT00744328|10937053|FG002|COMPLETED|Overall Study||21
9826013|NCT00744328|10937051|FG000|NOT COMPLETED|Overall Study||7
9826014|NCT00744328|10937052|FG001|NOT COMPLETED|Overall Study||8
10017354|NCT01816074|11140241|FG000|COMPLETED|Phase 1||11
10017355|NCT01816074|11140242|FG001|COMPLETED|Phase 1||9
9826015|NCT00744328|10937053|FG002|NOT COMPLETED|Overall Study||8
9826016|NCT00744380|10937063|FG000|STARTED|Overall Study||12
9826017|NCT00744380|10937064|FG001|STARTED|Overall Study||11
9826018|NCT00744380|10937063|FG000|COMPLETED|Overall Study||12
9826019|NCT00744380|10937064|FG001|COMPLETED|Overall Study||11
10017356|NCT01816074|11140243|FG002|COMPLETED|Phase 1||10
9826020|NCT00744380|10937063|FG000|NOT COMPLETED|Overall Study||0
9826021|NCT00744380|10937064|FG001|NOT COMPLETED|Overall Study||0
9826022|NCT00744471|10937075|FG000|STARTED|Overall Study||156
9826023|NCT00744471|10937076|FG001|STARTED|Overall Study||156
9826024|NCT00744471|10937077|FG002|STARTED|Overall Study||158
9826025|NCT00744471|10937078|FG003|STARTED|Overall Study||157
9826026|NCT00744471|10937075|FG000|Treated|Overall Study||155
9826027|NCT00744471|10937076|FG001|Treated|Overall Study||155
9826028|NCT00744471|10937077|FG002|Treated|Overall Study||154
9826029|NCT00744471|10937078|FG003|Treated|Overall Study||157
9826030|NCT00744471|10937075|FG000|COMPLETED|Overall Study||13
9826031|NCT00744471|10937076|FG001|COMPLETED|Overall Study||11
9826032|NCT00744471|10937077|FG002|COMPLETED|Overall Study||6
9826033|NCT00744471|10937078|FG003|COMPLETED|Overall Study||9
9826034|NCT00744471|10937075|FG000|NOT COMPLETED|Overall Study||143
9826035|NCT00744471|10937076|FG001|NOT COMPLETED|Overall Study||145
9826036|NCT00744471|10937077|FG002|NOT COMPLETED|Overall Study||152
9826037|NCT00744471|10937078|FG003|NOT COMPLETED|Overall Study||148
9826038|NCT00744497|10937090|FG000|STARTED|Overall Study|Randomized|760
9826039|NCT00744497|10937091|FG001|STARTED|Overall Study|Randomized|762
9826040|NCT00744497|10937090|FG000|Received Treatment|Overall Study||757
9826041|NCT00744497|10937091|FG001|Received Treatment|Overall Study||761
9826042|NCT00744497|10937090|FG000|COMPLETED|Overall Study||0
9826043|NCT00744497|10937091|FG001|COMPLETED|Overall Study||0
9826044|NCT00744497|10937090|FG000|NOT COMPLETED|Overall Study||760
9826045|NCT00744497|10937091|FG001|NOT COMPLETED|Overall Study||762
9826046|NCT00744523|10937099|FG000|STARTED|Procedure||37
9826047|NCT00744523|10937100|FG001|STARTED|Procedure||225
9826048|NCT00744523|10937099|FG000|COMPLETED|Procedure||37
9826049|NCT00744523|10937100|FG001|COMPLETED|Procedure||225
9826050|NCT00744523|10937099|FG000|NOT COMPLETED|Procedure||0
9826051|NCT00744523|10937100|FG001|NOT COMPLETED|Procedure||0
9826052|NCT00744523|10937099|FG000|STARTED|30 Days After the Procedure||37
9826053|NCT00744523|10937100|FG001|STARTED|30 Days After the Procedure||225
9826054|NCT00744523|10937099|FG000|COMPLETED|30 Days After the Procedure||37
9826055|NCT00744523|10937100|FG001|COMPLETED|30 Days After the Procedure||220
9826056|NCT00744523|10937099|FG000|NOT COMPLETED|30 Days After the Procedure||0
9826057|NCT00744523|10937100|FG001|NOT COMPLETED|30 Days After the Procedure||5
9826058|NCT00744627|10937110|FG000|STARTED|Overall Study||151
9826059|NCT00744627|10937111|FG001|STARTED|Overall Study||150
9826060|NCT00744627|10937110|FG000|Treated|Overall Study||150
9826061|NCT00744627|10937111|FG001|Treated|Overall Study||150
9826062|NCT00744627|10937110|FG000|COMPLETED|Overall Study||126
9826063|NCT00744627|10937111|FG001|COMPLETED|Overall Study||128
9826064|NCT00744627|10937110|FG000|NOT COMPLETED|Overall Study||25
9826065|NCT00744627|10937111|FG001|NOT COMPLETED|Overall Study||22
9826066|NCT00744653|10937117|FG000|STARTED|Overall Study||17
9826067|NCT00744653|10937117|FG000|COMPLETED|Overall Study||1
9826068|NCT00744653|10937117|FG000|NOT COMPLETED|Overall Study||16
9826069|NCT00744692|10937122|FG000|STARTED|Overall Study||22
9826070|NCT00744692|10937122|FG000|COMPLETED|Overall Study||22
9826071|NCT00744692|10937122|FG000|NOT COMPLETED|Overall Study||0
9826072|NCT00744757|10937126|FG000|STARTED|Overall Study||37
9826073|NCT00744757|10937126|FG000|COMPLETED|Overall Study||16
9826074|NCT00744757|10937126|FG000|NOT COMPLETED|Overall Study||21
9826075|NCT00744796|10937130|FG000|STARTED|Pre-operative||21
9826076|NCT00744796|10937130|FG000|COMPLETED|Pre-operative||21
9826077|NCT00744796|10937130|FG000|NOT COMPLETED|Pre-operative||0
9826078|NCT00744796|10937130|FG000|STARTED|Post-Operative Day 1||21
9826079|NCT00744796|10937130|FG000|COMPLETED|Post-Operative Day 1||21
9826080|NCT00744796|10937130|FG000|NOT COMPLETED|Post-Operative Day 1||0
9826081|NCT00744796|10937130|FG000|STARTED|Post-Operative 3-6 Months||21
9826082|NCT00744796|10937130|FG000|COMPLETED|Post-Operative 3-6 Months||21
9826083|NCT00744796|10937130|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0
9826084|NCT00744796|10937130|FG000|STARTED|Post-Operative 6-9 Months||21
9826085|NCT00744796|10937130|FG000|COMPLETED|Post-Operative 6-9 Months||9
9826086|NCT00744796|10937130|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12
9826087|NCT00744848|10937136|FG000|STARTED|Overall Study||103
9826088|NCT00744848|10937137|FG001|STARTED|Overall Study||101
9826089|NCT00744848|10937136|FG000|COMPLETED|Overall Study||103
9826090|NCT00744848|10937137|FG001|COMPLETED|Overall Study||101
9826091|NCT00744848|10937136|FG000|NOT COMPLETED|Overall Study||0
9826092|NCT00744848|10937137|FG001|NOT COMPLETED|Overall Study||0
9826093|NCT00744861|10937147|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
9826094|NCT00744861|10937148|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
9826095|NCT00744861|10937149|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
9826096|NCT00744861|10937150|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
9826097|NCT00744861|10937147|FG000|COMPLETED|Feasibility Stage 1||7
9826098|NCT00744861|10937148|FG001|COMPLETED|Feasibility Stage 1||8
9826099|NCT00744861|10937149|FG002|COMPLETED|Feasibility Stage 1||0
9826100|NCT00744861|10937150|FG003|COMPLETED|Feasibility Stage 1||0
9826101|NCT00744861|10937147|FG000|NOT COMPLETED|Feasibility Stage 1||1
9826102|NCT00744861|10937148|FG001|NOT COMPLETED|Feasibility Stage 1||2
9826103|NCT00744861|10937149|FG002|NOT COMPLETED|Feasibility Stage 1||0
9826104|NCT00744861|10937150|FG003|NOT COMPLETED|Feasibility Stage 1||0
9826105|NCT00744861|10937147|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
9832367|NCT00772967|10943208|FG004|STARTED|Crossover Treatment 1||4
9826106|NCT00744861|10937148|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
9826107|NCT00744861|10937149|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
9826108|NCT00744861|10937150|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
9826109|NCT00744861|10937147|FG000|COMPLETED|Pivotal Stage 2||0
9826110|NCT00744861|10937148|FG001|COMPLETED|Pivotal Stage 2||0
9826111|NCT00744861|10937149|FG002|COMPLETED|Pivotal Stage 2||52
10017357|NCT01816074|11140244|FG003|COMPLETED|Phase 1||10
10017358|NCT01816074|11140241|FG000|NOT COMPLETED|Phase 1||0
10017359|NCT01816074|11140242|FG001|NOT COMPLETED|Phase 1||0
10017360|NCT01816074|11140243|FG002|NOT COMPLETED|Phase 1||1
10017361|NCT01816074|11140244|FG003|NOT COMPLETED|Phase 1||0
10017362|NCT01816074|11140241|FG000|STARTED|Phase 2||11
10017363|NCT01816074|11140242|FG001|STARTED|Phase 2||9
10017364|NCT01816074|11140243|FG002|STARTED|Phase 2||10
10017365|NCT01816074|11140244|FG003|STARTED|Phase 2||10
10236932|NCT00793520|11367705|FG000|COMPLETED|Placebo Crossover to Milnacipran||0
10236933|NCT00793520|11367706|FG001|COMPLETED|Placebo Crossover to Milnacipran||0
10236934|NCT00793520|11367705|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0
9826112|NCT00744861|10937150|FG003|COMPLETED|Pivotal Stage 2||51
9826113|NCT00744861|10937147|FG000|NOT COMPLETED|Pivotal Stage 2||0
9826114|NCT00744861|10937148|FG001|NOT COMPLETED|Pivotal Stage 2||0
9826115|NCT00744861|10937149|FG002|NOT COMPLETED|Pivotal Stage 2||102
9826116|NCT00744861|10937150|FG003|NOT COMPLETED|Pivotal Stage 2||105
9826117|NCT00744874|10937158|FG000|STARTED|Overall Study||55
9826118|NCT00744874|10937158|FG000|COMPLETED|Overall Study||51
9826119|NCT00744874|10937158|FG000|NOT COMPLETED|Overall Study||4
9826120|NCT00744939|10937173|FG000|STARTED|Overall Study||168
9826121|NCT00744939|10937173|FG000|Treatment Received|Overall Study||141
9826122|NCT00744939|10937173|FG000|COMPLETED|Overall Study||77
9826123|NCT00744939|10937173|FG000|NOT COMPLETED|Overall Study||91
9826124|NCT00744965|10937187|FG000|STARTED|Overall Study||197
9826125|NCT00744965|10937188|FG001|STARTED|Overall Study||198
9826126|NCT00744965|10937187|FG000|COMPLETED|Overall Study||186
9826127|NCT00744965|10937188|FG001|COMPLETED|Overall Study||189
9826128|NCT00744965|10937187|FG000|NOT COMPLETED|Overall Study||11
9826129|NCT00744965|10937188|FG001|NOT COMPLETED|Overall Study||9
9826130|NCT00744978|10937196|FG000|STARTED|Period 1||32
9826131|NCT00744978|10937197|FG001|STARTED|Period 1||34
9826132|NCT00744978|10937196|FG000|Treated|Period 1||31
9826133|NCT00744978|10937197|FG001|Treated|Period 1||33
9826134|NCT00744978|10937196|FG000|COMPLETED|Period 1||26
9826135|NCT00744978|10937197|FG001|COMPLETED|Period 1||29
9826136|NCT00744978|10937196|FG000|NOT COMPLETED|Period 1||6
9826137|NCT00744978|10937197|FG001|NOT COMPLETED|Period 1||5
9826138|NCT00744978|10937196|FG000|STARTED|Placebo Washout||26
9826139|NCT00744978|10937197|FG001|STARTED|Placebo Washout||29
9826140|NCT00744978|10937196|FG000|COMPLETED|Placebo Washout||26
9826141|NCT00744978|10937197|FG001|COMPLETED|Placebo Washout||29
9826142|NCT00744978|10937196|FG000|NOT COMPLETED|Placebo Washout||0
9826143|NCT00744978|10937197|FG001|NOT COMPLETED|Placebo Washout||0
9826144|NCT00744978|10937196|FG000|STARTED|Period 2||26
9826145|NCT00744978|10937197|FG001|STARTED|Period 2||29
9826146|NCT00744978|10937196|FG000|COMPLETED|Period 2||26
9826147|NCT00744978|10937197|FG001|COMPLETED|Period 2||28
9826148|NCT00744978|10937196|FG000|NOT COMPLETED|Period 2||0
9826149|NCT00744978|10937197|FG001|NOT COMPLETED|Period 2||1
9826150|NCT00744991|10937203|FG000|STARTED|Overall Study||25
9826151|NCT00744991|10937203|FG000|Received at Least 1 Dose|Overall Study||25
9826152|NCT00744991|10937203|FG000|COMPLETED|Overall Study||0
9826153|NCT00744991|10937203|FG000|NOT COMPLETED|Overall Study||25
9826154|NCT00745095|10937216|FG000|STARTED|Overall Study||15
10236935|NCT00793520|11367706|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1
10236936|NCT00795236|11367714|FG000|STARTED|Overall Study||0
10236937|NCT00795236|11367715|FG001|STARTED|Overall Study||0
10236938|NCT00795236|11367714|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
10236939|NCT00795236|11367715|FG001|COMPLETED|Overall Study||0
10236940|NCT00795236|11367714|FG000|NOT COMPLETED|Overall Study||0
10236941|NCT00795236|11367715|FG001|NOT COMPLETED|Overall Study||0
10236942|NCT00799773|11367725|FG000|STARTED|Overall Study||2
9826155|NCT00745095|10937217|FG001|STARTED|Overall Study||15
9826156|NCT00745095|10937218|FG002|STARTED|Overall Study||15
9826157|NCT00745095|10937219|FG003|STARTED|Overall Study||15
9826158|NCT00745095|10937220|FG004|STARTED|Overall Study||150
9826159|NCT00745095|10937221|FG005|STARTED|Overall Study||150
9826160|NCT00745095|10937216|FG000|COMPLETED|Overall Study||14
9826161|NCT00745095|10937217|FG001|COMPLETED|Overall Study||13
9826162|NCT00745095|10937218|FG002|COMPLETED|Overall Study||12
9826163|NCT00745095|10937219|FG003|COMPLETED|Overall Study||12
9826164|NCT00745095|10937220|FG004|COMPLETED|Overall Study||28
9826165|NCT00745095|10937221|FG005|COMPLETED|Overall Study||27
9826166|NCT00745095|10937216|FG000|NOT COMPLETED|Overall Study||1
9826167|NCT00745095|10937217|FG001|NOT COMPLETED|Overall Study||2
10017366|NCT01816074|11140241|FG000|COMPLETED|Phase 2||9
10017367|NCT01816074|11140242|FG001|COMPLETED|Phase 2||7
10017368|NCT01816074|11140243|FG002|COMPLETED|Phase 2||10
10236943|NCT00799773|11367726|FG001|STARTED|Overall Study||1
10017369|NCT01816074|11140244|FG003|COMPLETED|Phase 2||9
10017370|NCT01816074|11140241|FG000|NOT COMPLETED|Phase 2||2
9826168|NCT00745095|10937218|FG002|NOT COMPLETED|Overall Study||3
10017371|NCT01816074|11140242|FG001|NOT COMPLETED|Phase 2||2
10236944|NCT00799773|11367725|FG000|COMPLETED|Overall Study||2
9826169|NCT00745095|10937219|FG003|NOT COMPLETED|Overall Study||3
9826170|NCT00745095|10937220|FG004|NOT COMPLETED|Overall Study||122
9826171|NCT00745095|10937221|FG005|NOT COMPLETED|Overall Study||123
9826172|NCT00745121|10937240|FG000|STARTED|Overall Study||20
9826173|NCT00745121|10937241|FG001|STARTED|Overall Study||28
9826174|NCT00745121|10937240|FG000|COMPLETED|Overall Study||11
9826175|NCT00745121|10937241|FG001|COMPLETED|Overall Study||26
9826176|NCT00745121|10937240|FG000|NOT COMPLETED|Overall Study||9
9826177|NCT00745121|10937241|FG001|NOT COMPLETED|Overall Study||2
9826178|NCT00745251|10937249|FG000|STARTED|Overall Study||23
9826179|NCT00745251|10937250|FG001|STARTED|Overall Study||22
9826180|NCT00745251|10937249|FG000|COMPLETED|Overall Study||21
9826181|NCT00745251|10937250|FG001|COMPLETED|Overall Study||19
9826182|NCT00745251|10937249|FG000|NOT COMPLETED|Overall Study||2
9826183|NCT00745251|10937250|FG001|NOT COMPLETED|Overall Study||3
9826184|NCT00745290|10937258|FG000|STARTED|Overall Study||123
9826185|NCT00745290|10937259|FG001|STARTED|Overall Study||122
9826186|NCT00745290|10937258|FG000|COMPLETED|Overall Study||123
9826187|NCT00745290|10937259|FG001|COMPLETED|Overall Study||122
9826188|NCT00745290|10937258|FG000|NOT COMPLETED|Overall Study||0
9826189|NCT00745290|10937259|FG001|NOT COMPLETED|Overall Study||0
10017372|NCT01816074|11140243|FG002|NOT COMPLETED|Phase 2||0
10017373|NCT01816074|11140244|FG003|NOT COMPLETED|Phase 2||1
10017374|NCT01816230|11140268|FG000|STARTED|Overall Study||36
10017375|NCT01816230|11140268|FG000|COMPLETED|Overall Study||36
10017376|NCT01816230|11140268|FG000|NOT COMPLETED|Overall Study||0
10017377|NCT01816243|11140272|FG000|STARTED|Overall Study||39
10017378|NCT01816243|11140272|FG000|COMPLETED|Overall Study||27
10017379|NCT01816243|11140272|FG000|NOT COMPLETED|Overall Study||12
9826190|NCT00745368|10937265|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
9826191|NCT00745368|10937265|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
9826192|NCT00745368|10937265|FG000|NOT COMPLETED|Overall Study||3
9826193|NCT00745420|10937269|FG000|STARTED|Overall Study||30
9826194|NCT00745420|10937269|FG000|COMPLETED|Overall Study||29
9826195|NCT00745420|10937269|FG000|NOT COMPLETED|Overall Study||1
9826196|NCT00745498|10937276|FG000|STARTED|Overall Study||41
9826197|NCT00745498|10937277|FG001|STARTED|Overall Study||43
9826198|NCT00745498|10937278|FG002|STARTED|Overall Study||42
9826199|NCT00745498|10937276|FG000|COMPLETED|Overall Study||36
9826200|NCT00745498|10937277|FG001|COMPLETED|Overall Study||37
9826201|NCT00745498|10937278|FG002|COMPLETED|Overall Study||34
9826202|NCT00745498|10937276|FG000|NOT COMPLETED|Overall Study||5
9826203|NCT00745498|10937277|FG001|NOT COMPLETED|Overall Study||6
9826204|NCT00745498|10937278|FG002|NOT COMPLETED|Overall Study||8
9826205|NCT00745615|10937290|FG000|STARTED|Double-Blind Extension (36 Weeks)||80
9826206|NCT00745615|10937291|FG001|STARTED|Double-Blind Extension (36 Weeks)||94
9826207|NCT00745615|10937292|FG002|STARTED|Double-Blind Extension (36 Weeks)||39
9826208|NCT00745615|10937293|FG003|STARTED|Double-Blind Extension (36 Weeks)||44
9826209|NCT00745615|10937294|FG004|STARTED|Double-Blind Extension (36 Weeks)||0
9826210|NCT00745615|10937295|FG005|STARTED|Double-Blind Extension (36 Weeks)||0
9826211|NCT00745615|10937290|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75
9826212|NCT00745615|10937291|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87
9826213|NCT00745615|10937292|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38
9826214|NCT00745615|10937293|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39
9826215|NCT00745615|10937294|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0
9826216|NCT00745615|10937295|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0
9826217|NCT00745615|10937290|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
9826218|NCT00745615|10937291|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
9826219|NCT00745615|10937292|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
9826220|NCT00745615|10937293|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
9826221|NCT00745615|10937294|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
9826222|NCT00745615|10937295|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
9826223|NCT00745615|10937290|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0
9826224|NCT00745615|10937291|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0
9826225|NCT00745615|10937292|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0
9826226|NCT00745615|10937293|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0
9826227|NCT00745615|10937294|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96
9826228|NCT00745615|10937295|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113
9826229|NCT00745615|10937290|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
9826230|NCT00745615|10937291|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
9826231|NCT00745615|10937292|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
9826232|NCT00745615|10937293|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
9826233|NCT00745615|10937294|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
9826234|NCT00745615|10937295|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
9826235|NCT00745615|10937290|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
9826236|NCT00745615|10937291|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10017380|NCT01816295|11140278|FG000|STARTED|Double Blind Phase||357
9826237|NCT00745615|10937292|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
9826238|NCT00745615|10937293|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
9826239|NCT00745615|10937294|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
9826240|NCT00745615|10937295|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
9826241|NCT00745823|10937309|FG000|STARTED|Overall Study||386
9826242|NCT00745823|10937310|FG001|STARTED|Overall Study||389
9826243|NCT00745823|10937309|FG000|TREATED Week 0 - 96|Overall Study||382
9826244|NCT00745823|10937310|FG001|TREATED Week 0 - 96|Overall Study||388
9826245|NCT00745823|10937309|FG000|COMPLETED|Overall Study||1
9826246|NCT00745823|10937310|FG001|COMPLETED|Overall Study||3
9826247|NCT00745823|10937309|FG000|NOT COMPLETED|Overall Study||385
9826248|NCT00745823|10937310|FG001|NOT COMPLETED|Overall Study||386
9826249|NCT00745849|10937318|FG000|STARTED|First Intervention||21
9826250|NCT00745849|10937319|FG001|STARTED|First Intervention||22
9826251|NCT00745849|10937318|FG000|COMPLETED|First Intervention||20
9826252|NCT00745849|10937319|FG001|COMPLETED|First Intervention||20
9826253|NCT00745849|10937318|FG000|NOT COMPLETED|First Intervention||1
9826254|NCT00745849|10937319|FG001|NOT COMPLETED|First Intervention||2
9826255|NCT00745849|10937318|FG000|STARTED|Washout Period||20
9826256|NCT00745849|10937319|FG001|STARTED|Washout Period||20
9826257|NCT00745849|10937318|FG000|COMPLETED|Washout Period||20
9826258|NCT00745849|10937319|FG001|COMPLETED|Washout Period||20
9826259|NCT00745849|10937318|FG000|NOT COMPLETED|Washout Period||0
9826260|NCT00745849|10937319|FG001|NOT COMPLETED|Washout Period||0
9826261|NCT00745849|10937318|FG000|STARTED|Second Intervention||20
9826262|NCT00745849|10937319|FG001|STARTED|Second Intervention||20
9826263|NCT00745849|10937318|FG000|COMPLETED|Second Intervention||18
9826264|NCT00745849|10937319|FG001|COMPLETED|Second Intervention||19
9826265|NCT00745849|10937318|FG000|NOT COMPLETED|Second Intervention||2
9826266|NCT00745849|10937319|FG001|NOT COMPLETED|Second Intervention||1
9826267|NCT00745875|10937327|FG000|STARTED|Overall Study|Started - Number of patients randomised|36
9826268|NCT00745875|10937328|FG001|STARTED|Overall Study|Started - Number of patients randomised|30
9826269|NCT00745875|10937327|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
9826270|NCT00745875|10937328|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
9826271|NCT00745875|10937327|FG000|NOT COMPLETED|Overall Study||4
9826272|NCT00745875|10937328|FG001|NOT COMPLETED|Overall Study||4
9826273|NCT00745901|10937336|FG000|STARTED|Overall Study|Number of Patients Randomized|178
9826274|NCT00745901|10937337|FG001|STARTED|Overall Study|Number of Patients Randomized|177
9826275|NCT00745901|10937336|FG000|COMPLETED|Overall Study||154
9826276|NCT00745901|10937337|FG001|COMPLETED|Overall Study||156
9826277|NCT00745901|10937336|FG000|NOT COMPLETED|Overall Study||24
9826278|NCT00745901|10937337|FG001|NOT COMPLETED|Overall Study||21
9826279|NCT00745940|10937345|FG000|STARTED|Overall Study||57
9826280|NCT00745940|10937346|FG001|STARTED|Overall Study||48
9826281|NCT00745940|10937345|FG000|COMPLETED|Overall Study||38
9826282|NCT00745940|10937346|FG001|COMPLETED|Overall Study||38
9826283|NCT00745940|10937345|FG000|NOT COMPLETED|Overall Study||19
9826284|NCT00745940|10937346|FG001|NOT COMPLETED|Overall Study||10
9826285|NCT00746096|10937354|FG000|STARTED|Overall Study||58
9826286|NCT00746096|10937355|FG001|STARTED|Overall Study||57
9826287|NCT00746096|10937354|FG000|COMPLETED|Overall Study||48
9826288|NCT00746096|10937355|FG001|COMPLETED|Overall Study||54
9826289|NCT00746096|10937354|FG000|NOT COMPLETED|Overall Study||10
9826290|NCT00746096|10937355|FG001|NOT COMPLETED|Overall Study||3
9826291|NCT00746122|10937363|FG000|STARTED|Overall Study||297
9826292|NCT00746122|10937364|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
9826293|NCT00746122|10937363|FG000|COMPLETED|Overall Study||297
9826294|NCT00746122|10937364|FG001|COMPLETED|Overall Study||316
9826295|NCT00746122|10937363|FG000|NOT COMPLETED|Overall Study||0
9826296|NCT00746122|10937364|FG001|NOT COMPLETED|Overall Study||0
9826297|NCT00746187|10937372|FG000|STARTED|Overall Study||18
9826298|NCT00746187|10937373|FG001|STARTED|Overall Study||18
9826299|NCT00746187|10937372|FG000|COMPLETED|Overall Study||15
9826300|NCT00746187|10937373|FG001|COMPLETED|Overall Study||16
9826301|NCT00746187|10937372|FG000|NOT COMPLETED|Overall Study||3
9826302|NCT00746187|10937373|FG001|NOT COMPLETED|Overall Study||2
9826303|NCT00746252|10937381|FG000|STARTED|Overall Study||1
9826304|NCT00746252|10937382|FG001|STARTED|Overall Study||2
9826305|NCT00746252|10937381|FG000|COMPLETED|Overall Study||0
9826306|NCT00746252|10937382|FG001|COMPLETED|Overall Study||0
9826307|NCT00746252|10937381|FG000|NOT COMPLETED|Overall Study||1
9826308|NCT00746252|10937382|FG001|NOT COMPLETED|Overall Study||2
9826309|NCT00746330|10937392|FG000|STARTED|Period 1||7
9826310|NCT00746330|10937393|FG001|STARTED|Period 1||9
9826311|NCT00746330|10937394|FG002|STARTED|Period 1||9
9826312|NCT00746330|10937395|FG003|STARTED|Period 1||7
9826313|NCT00746330|10937392|FG000|COMPLETED|Period 1||7
9826314|NCT00746330|10937393|FG001|COMPLETED|Period 1||9
9826315|NCT00746330|10937394|FG002|COMPLETED|Period 1||8
9826316|NCT00746330|10937395|FG003|COMPLETED|Period 1||7
9826317|NCT00746330|10937392|FG000|NOT COMPLETED|Period 1||0
9826318|NCT00746330|10937393|FG001|NOT COMPLETED|Period 1||0
9826319|NCT00746330|10937394|FG002|NOT COMPLETED|Period 1||1
9826320|NCT00746330|10937395|FG003|NOT COMPLETED|Period 1||0
9826321|NCT00746330|10937392|FG000|STARTED|Period 2||7
9826322|NCT00746330|10937393|FG001|STARTED|Period 2||9
9826323|NCT00746330|10937394|FG002|STARTED|Period 2||8
9826324|NCT00746330|10937395|FG003|STARTED|Period 2||7
9826325|NCT00746330|10937392|FG000|COMPLETED|Period 2||7
9826326|NCT00746330|10937393|FG001|COMPLETED|Period 2||9
9826327|NCT00746330|10937394|FG002|COMPLETED|Period 2||8
9826328|NCT00746330|10937395|FG003|COMPLETED|Period 2||7
9826329|NCT00746330|10937392|FG000|NOT COMPLETED|Period 2||0
9826330|NCT00746330|10937393|FG001|NOT COMPLETED|Period 2||0
9826331|NCT00746330|10937394|FG002|NOT COMPLETED|Period 2||0
9826332|NCT00746330|10937395|FG003|NOT COMPLETED|Period 2||0
9826333|NCT00746330|10937392|FG000|STARTED|Period 3||7
9826334|NCT00746330|10937393|FG001|STARTED|Period 3||9
9826335|NCT00746330|10937394|FG002|STARTED|Period 3||8
9826336|NCT00746330|10937395|FG003|STARTED|Period 3||7
9826337|NCT00746330|10937392|FG000|COMPLETED|Period 3||7
9826338|NCT00746330|10937393|FG001|COMPLETED|Period 3||9
9826339|NCT00746330|10937394|FG002|COMPLETED|Period 3||8
9826340|NCT00746330|10937395|FG003|COMPLETED|Period 3||7
9826341|NCT00746330|10937392|FG000|NOT COMPLETED|Period 3||0
9826342|NCT00746330|10937393|FG001|NOT COMPLETED|Period 3||0
9826343|NCT00746330|10937394|FG002|NOT COMPLETED|Period 3||0
9826344|NCT00746330|10937395|FG003|NOT COMPLETED|Period 3||0
9826345|NCT00746330|10937392|FG000|STARTED|Period 4||7
9826346|NCT00746330|10937393|FG001|STARTED|Period 4||9
9826347|NCT00746330|10937394|FG002|STARTED|Period 4||8
9826348|NCT00746330|10937395|FG003|STARTED|Period 4||7
9826349|NCT00746330|10937392|FG000|COMPLETED|Period 4||7
9826350|NCT00746330|10937393|FG001|COMPLETED|Period 4||9
9826351|NCT00746330|10937394|FG002|COMPLETED|Period 4||8
9826352|NCT00746330|10937395|FG003|COMPLETED|Period 4||7
9826353|NCT00746330|10937392|FG000|NOT COMPLETED|Period 4||0
9826354|NCT00746330|10937393|FG001|NOT COMPLETED|Period 4||0
9826355|NCT00746330|10937394|FG002|NOT COMPLETED|Period 4||0
9826356|NCT00746330|10937395|FG003|NOT COMPLETED|Period 4||0
9826357|NCT00746356|10937406|FG000|STARTED|Overall Study||81
9826358|NCT00746356|10937407|FG001|STARTED|Overall Study||47
9826359|NCT00746356|10937406|FG000|COMPLETED|Overall Study||70
9826360|NCT00746356|10937407|FG001|COMPLETED|Overall Study||40
9826361|NCT00746356|10937406|FG000|NOT COMPLETED|Overall Study||11
9826362|NCT00746356|10937407|FG001|NOT COMPLETED|Overall Study||7
9826363|NCT00746395|10937417|FG000|STARTED|Overall Study||20
9826364|NCT00746395|10937418|FG001|STARTED|Overall Study||20
9826365|NCT00746395|10937417|FG000|COMPLETED|Overall Study||20
9826366|NCT00746395|10937418|FG001|COMPLETED|Overall Study||20
9826367|NCT00746395|10937417|FG000|NOT COMPLETED|Overall Study||0
9826368|NCT00746395|10937418|FG001|NOT COMPLETED|Overall Study||0
9826369|NCT00746421|10937426|FG000|STARTED|Overall Study||12
9826370|NCT00746421|10937427|FG001|STARTED|Overall Study||11
9826371|NCT00746421|10937426|FG000|COMPLETED|Overall Study||5
9826372|NCT00746421|10937427|FG001|COMPLETED|Overall Study||9
9826373|NCT00746421|10937426|FG000|NOT COMPLETED|Overall Study||7
9826374|NCT00746421|10937427|FG001|NOT COMPLETED|Overall Study||2
9826375|NCT00746512|10937437|FG000|STARTED|Overall Study||8
9826376|NCT00746512|10937438|FG001|STARTED|Overall Study||10
9826377|NCT00746512|10937439|FG002|STARTED|Overall Study||18
9826378|NCT00746512|10937440|FG003|STARTED|Overall Study||9
9826379|NCT00746512|10937437|FG000|COMPLETED|Overall Study||8
9826380|NCT00746512|10937438|FG001|COMPLETED|Overall Study||10
9826381|NCT00746512|10937439|FG002|COMPLETED|Overall Study||18
9826382|NCT00746512|10937440|FG003|COMPLETED|Overall Study||9
9826383|NCT00746512|10937437|FG000|NOT COMPLETED|Overall Study||0
9826384|NCT00746512|10937438|FG001|NOT COMPLETED|Overall Study||0
9826385|NCT00746512|10937439|FG002|NOT COMPLETED|Overall Study||0
9826386|NCT00746512|10937440|FG003|NOT COMPLETED|Overall Study||0
9826387|NCT00746551|10937452|FG000|STARTED|At Gestational Age of 36 Weeks||40
9826388|NCT00746551|10937453|FG001|STARTED|At Gestational Age of 36 Weeks||40
9826389|NCT00746551|10937452|FG000|COMPLETED|At Gestational Age of 36 Weeks||38
9826390|NCT00746551|10937453|FG001|COMPLETED|At Gestational Age of 36 Weeks||36
9826391|NCT00746551|10937452|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2
9826392|NCT00746551|10937453|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4
9826393|NCT00746551|10937452|FG000|STARTED|At Delivery (GA of 39 Weeks)||40
10236945|NCT00799773|11367726|FG001|COMPLETED|Overall Study||1
10236946|NCT00799773|11367725|FG000|NOT COMPLETED|Overall Study||0
10236947|NCT00799773|11367726|FG001|NOT COMPLETED|Overall Study||0
10236948|NCT00790452|11367734|FG000|STARTED|Overall Study||1
10236949|NCT00790452|11367735|FG001|STARTED|Overall Study||0
9826394|NCT00746551|10937453|FG001|STARTED|At Delivery (GA of 39 Weeks)||40
9826395|NCT00746551|10937452|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25
9826396|NCT00746551|10937453|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25
9826397|NCT00746551|10937452|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
9826398|NCT00746551|10937453|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
9826399|NCT00746564|10937459|FG000|STARTED|Overall Study||75
9826400|NCT00746564|10937459|FG000|COMPLETED|Overall Study||73
9826401|NCT00746564|10937459|FG000|NOT COMPLETED|Overall Study||2
9826402|NCT00746668|10937465|FG000|STARTED|Overall Study||6
9826403|NCT00746668|10937466|FG001|STARTED|Overall Study||5
9826404|NCT00746668|10937467|FG002|STARTED|Overall Study||5
9826405|NCT00746668|10937468|FG003|STARTED|Overall Study||5
9826406|NCT00746668|10937469|FG004|STARTED|Overall Study||5
9826407|NCT00746668|10937470|FG005|STARTED|Overall Study||5
9826408|NCT00746668|10937471|FG006|STARTED|Overall Study||5
9826409|NCT00746668|10937465|FG000|COMPLETED|Overall Study||6
9826410|NCT00746668|10937466|FG001|COMPLETED|Overall Study||5
9826411|NCT00746668|10937467|FG002|COMPLETED|Overall Study||5
9826412|NCT00746668|10937468|FG003|COMPLETED|Overall Study||5
9826413|NCT00746668|10937469|FG004|COMPLETED|Overall Study||5
9826414|NCT00746668|10937470|FG005|COMPLETED|Overall Study||5
9826415|NCT00746668|10937471|FG006|COMPLETED|Overall Study||5
9826416|NCT00746668|10937465|FG000|NOT COMPLETED|Overall Study||0
9826417|NCT00746668|10937466|FG001|NOT COMPLETED|Overall Study||0
10236950|NCT00790452|11367734|FG000|COMPLETED|Overall Study||0
9826418|NCT00746668|10937467|FG002|NOT COMPLETED|Overall Study||0
9826419|NCT00746668|10937468|FG003|NOT COMPLETED|Overall Study||0
9826420|NCT00746668|10937469|FG004|NOT COMPLETED|Overall Study||0
9826421|NCT00746668|10937470|FG005|NOT COMPLETED|Overall Study||0
9826422|NCT00746668|10937471|FG006|NOT COMPLETED|Overall Study||0
9826423|NCT00746694|10937484|FG000|STARTED|Overall Study||154
9826424|NCT00746694|10937484|FG000|COMPLETED|Overall Study||154
9826425|NCT00746694|10937484|FG000|NOT COMPLETED|Overall Study||0
9826426|NCT00746733|10937488|FG000|STARTED|First Intervention||12
9826427|NCT00746733|10937489|FG001|STARTED|First Intervention||12
9826428|NCT00746733|10937488|FG000|COMPLETED|First Intervention||12
9826429|NCT00746733|10937489|FG001|COMPLETED|First Intervention||12
9826430|NCT00746733|10937488|FG000|NOT COMPLETED|First Intervention||0
9826431|NCT00746733|10937489|FG001|NOT COMPLETED|First Intervention||0
9826432|NCT00746733|10937488|FG000|STARTED|Second Intervention||12
9826433|NCT00746733|10937489|FG001|STARTED|Second Intervention||12
9826434|NCT00746733|10937488|FG000|COMPLETED|Second Intervention||11
9826435|NCT00746733|10937489|FG001|COMPLETED|Second Intervention||12
9826436|NCT00746733|10937488|FG000|NOT COMPLETED|Second Intervention||1
9826437|NCT00746733|10937489|FG001|NOT COMPLETED|Second Intervention||0
9826438|NCT00746733|10937488|FG000|STARTED|Third Intervention||11
9826439|NCT00746733|10937489|FG001|STARTED|Third Intervention||12
9826440|NCT00746733|10937488|FG000|COMPLETED|Third Intervention||10
9826441|NCT00746733|10937489|FG001|COMPLETED|Third Intervention||11
9826442|NCT00746733|10937488|FG000|NOT COMPLETED|Third Intervention||1
9826443|NCT00746733|10937489|FG001|NOT COMPLETED|Third Intervention||1
9826444|NCT00746733|10937488|FG000|STARTED|Fourth Intervention||10
9826445|NCT00746733|10937489|FG001|STARTED|Fourth Intervention||11
9826446|NCT00746733|10937488|FG000|COMPLETED|Fourth Intervention||10
9826447|NCT00746733|10937489|FG001|COMPLETED|Fourth Intervention||11
9826448|NCT00746733|10937488|FG000|NOT COMPLETED|Fourth Intervention||0
9826449|NCT00746733|10937489|FG001|NOT COMPLETED|Fourth Intervention||0
9826450|NCT00746785|10937505|FG000|STARTED|Overall Study||43
9826451|NCT00746785|10937506|FG001|STARTED|Overall Study||46
9826452|NCT00746785|10937507|FG002|STARTED|Overall Study||40
9826453|NCT00746785|10937505|FG000|COMPLETED|Overall Study||14
9826454|NCT00746785|10937506|FG001|COMPLETED|Overall Study||21
9826455|NCT00746785|10937507|FG002|COMPLETED|Overall Study||13
9826456|NCT00746785|10937505|FG000|NOT COMPLETED|Overall Study||29
9826457|NCT00746785|10937506|FG001|NOT COMPLETED|Overall Study||25
9826458|NCT00746785|10937507|FG002|NOT COMPLETED|Overall Study||27
9826459|NCT00746798|10937519|FG000|STARTED|Overall Study||122
9826460|NCT00746798|10937520|FG001|STARTED|Overall Study||124
9826461|NCT00746798|10937521|FG002|STARTED|Overall Study||113
9826462|NCT00746798|10937522|FG003|STARTED|Overall Study||120
9826463|NCT00746798|10937519|FG000|COMPLETED|Overall Study||121
9826464|NCT00746798|10937520|FG001|COMPLETED|Overall Study||122
9826465|NCT00746798|10937521|FG002|COMPLETED|Overall Study||110
9826466|NCT00746798|10937522|FG003|COMPLETED|Overall Study||120
10236951|NCT00790452|11367735|FG001|COMPLETED|Overall Study||0
10236952|NCT00790452|11367734|FG000|NOT COMPLETED|Overall Study||1
10236953|NCT00790452|11367735|FG001|NOT COMPLETED|Overall Study||0
10236954|NCT00795665|11367741|FG000|STARTED|Overall Study||7
10236955|NCT00795665|11367741|FG000|COMPLETED|Overall Study||7
10236956|NCT00795665|11367741|FG000|NOT COMPLETED|Overall Study||0
10236957|NCT00787917|11367747|FG000|STARTED|Blinded Treatment||9
10236958|NCT00787917|11367748|FG001|STARTED|Blinded Treatment||5
10236959|NCT00787917|11367747|FG000|COMPLETED|Blinded Treatment||4
10236960|NCT00787917|11367748|FG001|COMPLETED|Blinded Treatment||3
10236961|NCT00787917|11367747|FG000|NOT COMPLETED|Blinded Treatment||5
10236962|NCT00787917|11367748|FG001|NOT COMPLETED|Blinded Treatment||2
10236963|NCT00787917|11367747|FG000|STARTED|Open Label||7
10236964|NCT00787917|11367748|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
10236965|NCT00787917|11367747|FG000|COMPLETED|Open Label||3
9826467|NCT00746798|10937519|FG000|NOT COMPLETED|Overall Study||1
9826468|NCT00746798|10937520|FG001|NOT COMPLETED|Overall Study||2
9826469|NCT00746798|10937521|FG002|NOT COMPLETED|Overall Study||3
9826470|NCT00746798|10937522|FG003|NOT COMPLETED|Overall Study||0
9826471|NCT00746863|10937534|FG000|STARTED|Overall Study||21
9826472|NCT00746863|10937535|FG001|STARTED|Overall Study||21
9826473|NCT00746863|10937534|FG000|COMPLETED|Overall Study||21
10236966|NCT00787917|11367748|FG001|COMPLETED|Open Label||0
10236967|NCT00787917|11367747|FG000|NOT COMPLETED|Open Label||4
10236968|NCT00787917|11367748|FG001|NOT COMPLETED|Open Label||0
10236969|NCT00798590|11367758|FG000|STARTED|Overall Study||11
9826474|NCT00746863|10937535|FG001|COMPLETED|Overall Study||21
9826475|NCT00746863|10937534|FG000|NOT COMPLETED|Overall Study||0
9826476|NCT00746863|10937535|FG001|NOT COMPLETED|Overall Study||0
9826477|NCT00746889|10937543|FG000|STARTED|Overall Study||40
9826478|NCT00746889|10937544|FG001|STARTED|Overall Study||39
9826479|NCT00746889|10937543|FG000|COMPLETED|Overall Study||36
9826480|NCT00746889|10937544|FG001|COMPLETED|Overall Study||35
9826481|NCT00746889|10937543|FG000|NOT COMPLETED|Overall Study||4
9826482|NCT00746889|10937544|FG001|NOT COMPLETED|Overall Study||4
9826483|NCT00746941|10937556|FG000|STARTED|Overall Study||7
9826484|NCT00746941|10937557|FG001|STARTED|Overall Study||5
9826485|NCT00746941|10937558|FG002|STARTED|Overall Study||5
9826486|NCT00746941|10937559|FG003|STARTED|Overall Study||20
9826487|NCT00746941|10937556|FG000|COMPLETED|Overall Study||0
9826488|NCT00746941|10937557|FG001|COMPLETED|Overall Study||1
9826489|NCT00746941|10937558|FG002|COMPLETED|Overall Study||3
9826490|NCT00746941|10937559|FG003|COMPLETED|Overall Study||7
9826491|NCT00746941|10937556|FG000|NOT COMPLETED|Overall Study||7
9826492|NCT00746941|10937557|FG001|NOT COMPLETED|Overall Study||4
9826493|NCT00746941|10937558|FG002|NOT COMPLETED|Overall Study||2
9826494|NCT00746941|10937559|FG003|NOT COMPLETED|Overall Study||13
9826495|NCT00746954|10937568|FG000|STARTED|Overall Study||3
9826496|NCT00746954|10937569|FG001|STARTED|Overall Study||3
9826497|NCT00746954|10937570|FG002|STARTED|Overall Study||2
9826498|NCT00746954|10937568|FG000|COMPLETED|Overall Study||3
9826499|NCT00746954|10937569|FG001|COMPLETED|Overall Study||3
9826500|NCT00746954|10937570|FG002|COMPLETED|Overall Study||2
9826501|NCT00746954|10937568|FG000|NOT COMPLETED|Overall Study||0
9826502|NCT00746954|10937569|FG001|NOT COMPLETED|Overall Study||0
9826503|NCT00746954|10937570|FG002|NOT COMPLETED|Overall Study||0
9826504|NCT00747006|10937579|FG000|STARTED|Overall Study||7
9826505|NCT00747006|10937580|FG001|STARTED|Overall Study||8
9826506|NCT00747006|10937581|FG002|STARTED|Overall Study||3
9826507|NCT00747006|10937579|FG000|COMPLETED|Overall Study||4
9826508|NCT00747006|10937580|FG001|COMPLETED|Overall Study||7
9826509|NCT00747006|10937581|FG002|COMPLETED|Overall Study||2
9826510|NCT00747006|10937579|FG000|NOT COMPLETED|Overall Study||3
9826511|NCT00747006|10937580|FG001|NOT COMPLETED|Overall Study||1
9826512|NCT00747006|10937581|FG002|NOT COMPLETED|Overall Study||1
9826513|NCT00747149|10937594|FG000|STARTED|Overall Study||154
9826514|NCT00747149|10937595|FG001|STARTED|Overall Study||444
9826515|NCT00747149|10937594|FG000|COMPLETED|Overall Study||153
9826516|NCT00747149|10937595|FG001|COMPLETED|Overall Study||401
9826517|NCT00747149|10937594|FG000|NOT COMPLETED|Overall Study||1
9826518|NCT00747149|10937595|FG001|NOT COMPLETED|Overall Study||43
9826519|NCT00747214|10937609|FG000|STARTED|Overall Study||27
9826520|NCT00747214|10937610|FG001|STARTED|Overall Study||32
9826521|NCT00747214|10937609|FG000|COMPLETED|Overall Study||19
9826522|NCT00747214|10937610|FG001|COMPLETED|Overall Study||29
9826523|NCT00747214|10937609|FG000|NOT COMPLETED|Overall Study||8
9826524|NCT00747214|10937610|FG001|NOT COMPLETED|Overall Study||3
9826525|NCT00747227|10937618|FG000|STARTED|Overall Study||126
9826526|NCT00747227|10937619|FG001|STARTED|Overall Study||124
9826527|NCT00747227|10937618|FG000|COMPLETED|Overall Study||120
9826528|NCT00747227|10937619|FG001|COMPLETED|Overall Study||120
9826529|NCT00747227|10937618|FG000|NOT COMPLETED|Overall Study||6
9826530|NCT00747227|10937619|FG001|NOT COMPLETED|Overall Study||4
9826531|NCT00747344|10937627|FG000|STARTED|Controlled Period||60
9826532|NCT00747344|10937628|FG001|STARTED|Controlled Period||61
9826533|NCT00747344|10937629|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9826534|NCT00747344|10937630|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
9826535|NCT00747344|10937627|FG000|COMPLETED|Controlled Period||55
9826536|NCT00747344|10937628|FG001|COMPLETED|Controlled Period||57
9826537|NCT00747344|10937629|FG002|COMPLETED|Controlled Period||0
9826538|NCT00747344|10937630|FG003|COMPLETED|Controlled Period||0
9826539|NCT00747344|10937627|FG000|NOT COMPLETED|Controlled Period||5
9826540|NCT00747344|10937628|FG001|NOT COMPLETED|Controlled Period||4
9826541|NCT00747344|10937629|FG002|NOT COMPLETED|Controlled Period||0
9826542|NCT00747344|10937630|FG003|NOT COMPLETED|Controlled Period||0
9826543|NCT00747344|10937627|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9826544|NCT00747344|10937628|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
9826545|NCT00747344|10937629|FG002|STARTED|After Controlled Period||55
9826546|NCT00747344|10937630|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
9826547|NCT00747344|10937627|FG000|COMPLETED|After Controlled Period||0
9826548|NCT00747344|10937628|FG001|COMPLETED|After Controlled Period||0
9826549|NCT00747344|10937629|FG002|COMPLETED|After Controlled Period||55
9826550|NCT00747344|10937630|FG003|COMPLETED|After Controlled Period||56
9826551|NCT00747344|10937627|FG000|NOT COMPLETED|After Controlled Period||0
9826552|NCT00747344|10937628|FG001|NOT COMPLETED|After Controlled Period||0
10017381|NCT01816295|11140279|FG001|STARTED|Double Blind Phase||358
9826553|NCT00747344|10937629|FG002|NOT COMPLETED|After Controlled Period||0
9826554|NCT00747344|10937630|FG003|NOT COMPLETED|After Controlled Period||1
9826555|NCT00747435|10937638|FG000|STARTED|Overall Study||73
9826556|NCT00747435|10937638|FG000|COMPLETED|Overall Study||67
9826557|NCT00747435|10937638|FG000|NOT COMPLETED|Overall Study||6
9826558|NCT00747474|10937642|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
9826559|NCT00747474|10937643|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826560|NCT00747474|10937644|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826561|NCT00747474|10937645|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826562|NCT00747474|10937646|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826563|NCT00747474|10937647|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826564|NCT00747474|10937648|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826565|NCT00747474|10937649|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826566|NCT00747474|10937650|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826567|NCT00747474|10937651|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826568|NCT00747474|10937652|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826569|NCT00747474|10937653|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
9826570|NCT00747474|10937642|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
9826571|NCT00747474|10937643|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826572|NCT00747474|10937644|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826573|NCT00747474|10937645|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826574|NCT00747474|10937646|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826575|NCT00747474|10937647|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826576|NCT00747474|10937648|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826577|NCT00747474|10937649|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826578|NCT00747474|10937650|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826579|NCT00747474|10937651|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826580|NCT00747474|10937652|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826581|NCT00747474|10937653|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826582|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826583|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826584|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826585|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826586|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826587|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826588|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826589|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826590|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826591|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826592|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826593|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
9826594|NCT00747474|10937642|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826595|NCT00747474|10937643|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4
9826596|NCT00747474|10937644|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826597|NCT00747474|10937645|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826598|NCT00747474|10937646|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826599|NCT00747474|10937647|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826600|NCT00747474|10937648|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826601|NCT00747474|10937649|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826602|NCT00747474|10937650|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826603|NCT00747474|10937651|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826604|NCT00747474|10937652|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826605|NCT00747474|10937653|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0
9826606|NCT00747474|10937642|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826607|NCT00747474|10937643|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
9826608|NCT00747474|10937644|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826609|NCT00747474|10937645|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826610|NCT00747474|10937646|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826611|NCT00747474|10937647|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826612|NCT00747474|10937648|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826613|NCT00747474|10937649|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826614|NCT00747474|10937650|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826615|NCT00747474|10937651|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826616|NCT00747474|10937652|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826617|NCT00747474|10937653|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826618|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826619|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826620|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826621|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826622|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826623|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826624|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826625|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826626|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826627|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826628|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826629|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
9826630|NCT00747474|10937642|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826631|NCT00747474|10937643|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826632|NCT00747474|10937644|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3
9826633|NCT00747474|10937645|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826634|NCT00747474|10937646|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826635|NCT00747474|10937647|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826636|NCT00747474|10937648|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826637|NCT00747474|10937649|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826638|NCT00747474|10937650|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826639|NCT00747474|10937651|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826640|NCT00747474|10937652|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826641|NCT00747474|10937653|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0
9826642|NCT00747474|10937642|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826643|NCT00747474|10937643|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826644|NCT00747474|10937644|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
9826645|NCT00747474|10937645|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826646|NCT00747474|10937646|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826647|NCT00747474|10937647|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826648|NCT00747474|10937648|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826649|NCT00747474|10937649|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826650|NCT00747474|10937650|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826651|NCT00747474|10937651|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826652|NCT00747474|10937652|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826653|NCT00747474|10937653|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826654|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826655|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826656|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826657|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826658|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826659|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826660|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826661|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826662|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826663|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826664|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826665|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
9826666|NCT00747474|10937642|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826667|NCT00747474|10937643|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826668|NCT00747474|10937644|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826669|NCT00747474|10937645|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4
9826670|NCT00747474|10937646|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826671|NCT00747474|10937647|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826672|NCT00747474|10937648|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826673|NCT00747474|10937649|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826674|NCT00747474|10937650|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826675|NCT00747474|10937651|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826676|NCT00747474|10937652|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826677|NCT00747474|10937653|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0
9826678|NCT00747474|10937642|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826679|NCT00747474|10937643|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826680|NCT00747474|10937644|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826681|NCT00747474|10937645|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
9826682|NCT00747474|10937646|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826683|NCT00747474|10937647|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826684|NCT00747474|10937648|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826685|NCT00747474|10937649|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826686|NCT00747474|10937650|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826687|NCT00747474|10937651|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826688|NCT00747474|10937652|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826689|NCT00747474|10937653|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826690|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826691|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826692|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826693|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826694|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826695|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826696|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826697|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826698|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10112621|NCT02504294|11243568|FG001|COMPLETED|Overall Study||158
10112622|NCT02504294|11243567|FG000|NOT COMPLETED|Overall Study||56
10112623|NCT02504294|11243568|FG001|NOT COMPLETED|Overall Study||48
10112624|NCT02504320|11243578|FG000|STARTED|Treatment Period 1||19
10112625|NCT02504320|11243579|FG001|STARTED|Treatment Period 1||19
10112626|NCT02504320|11243580|FG002|STARTED|Treatment Period 1||20
10112627|NCT02504320|11243581|FG003|STARTED|Treatment Period 1||20
10236970|NCT00798590|11367759|FG001|STARTED|Overall Study||8
10236971|NCT00798590|11367758|FG000|COMPLETED|Overall Study||0
10236972|NCT00798590|11367759|FG001|COMPLETED|Overall Study||0
10236973|NCT00798590|11367758|FG000|NOT COMPLETED|Overall Study||11
10236974|NCT00798590|11367759|FG001|NOT COMPLETED|Overall Study||8
10236975|NCT00796510|11367767|FG000|STARTED|Overall Study||3
10236976|NCT00796510|11367768|FG001|STARTED|Overall Study||0
10236977|NCT00796510|11367767|FG000|COMPLETED|Overall Study||0
10236978|NCT00796510|11367768|FG001|COMPLETED|Overall Study||0
10236979|NCT00796510|11367767|FG000|NOT COMPLETED|Overall Study||3
10236980|NCT00796510|11367768|FG001|NOT COMPLETED|Overall Study||0
10236981|NCT00796861|11367774|FG000|STARTED|Overall Study||4
10236982|NCT00796861|11367774|FG000|COMPLETED|Overall Study||0
10236983|NCT00796861|11367774|FG000|NOT COMPLETED|Overall Study||4
9826699|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826700|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10112628|NCT02504320|11243578|FG000|COMPLETED|Treatment Period 1||19
10112629|NCT02504320|11243579|FG001|COMPLETED|Treatment Period 1||19
10112630|NCT02504320|11243580|FG002|COMPLETED|Treatment Period 1||19
10112631|NCT02504320|11243581|FG003|COMPLETED|Treatment Period 1||20
10112632|NCT02504320|11243578|FG000|NOT COMPLETED|Treatment Period 1||0
10112633|NCT02504320|11243579|FG001|NOT COMPLETED|Treatment Period 1||0
10112634|NCT02504320|11243580|FG002|NOT COMPLETED|Treatment Period 1||1
10112635|NCT02504320|11243581|FG003|NOT COMPLETED|Treatment Period 1||0
10236984|NCT00791076|11367778|FG000|STARTED|Overall Study||8
10236985|NCT00791076|11367778|FG000|COMPLETED|Overall Study||0
10236986|NCT00791076|11367778|FG000|NOT COMPLETED|Overall Study||8
10236987|NCT00790478|11367786|FG000|STARTED|Overall Study||0
10236988|NCT00790478|11367787|FG001|STARTED|Overall Study||0
9826701|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
9826702|NCT00747474|10937642|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826703|NCT00747474|10937643|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826704|NCT00747474|10937644|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826705|NCT00747474|10937645|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826706|NCT00747474|10937646|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
9826707|NCT00747474|10937647|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826708|NCT00747474|10937648|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826709|NCT00747474|10937649|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826710|NCT00747474|10937650|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826711|NCT00747474|10937651|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826712|NCT00747474|10937652|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826713|NCT00747474|10937653|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
9826714|NCT00747474|10937642|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826715|NCT00747474|10937643|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826716|NCT00747474|10937644|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826717|NCT00747474|10937645|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826718|NCT00747474|10937646|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
9826719|NCT00747474|10937647|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826720|NCT00747474|10937648|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826721|NCT00747474|10937649|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826722|NCT00747474|10937650|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826723|NCT00747474|10937651|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826724|NCT00747474|10937652|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826725|NCT00747474|10937653|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826726|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826727|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826728|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826729|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826730|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826731|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826732|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826733|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826734|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826735|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826736|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826737|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
9826738|NCT00747474|10937642|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826739|NCT00747474|10937643|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826740|NCT00747474|10937644|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826741|NCT00747474|10937645|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826742|NCT00747474|10937646|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826743|NCT00747474|10937647|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4
9826744|NCT00747474|10937648|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826745|NCT00747474|10937649|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826746|NCT00747474|10937650|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826747|NCT00747474|10937651|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826748|NCT00747474|10937652|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826749|NCT00747474|10937653|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0
9826750|NCT00747474|10937642|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826751|NCT00747474|10937643|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826752|NCT00747474|10937644|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826753|NCT00747474|10937645|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826754|NCT00747474|10937646|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826755|NCT00747474|10937647|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
9826756|NCT00747474|10937648|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826757|NCT00747474|10937649|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826758|NCT00747474|10937650|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826759|NCT00747474|10937651|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826760|NCT00747474|10937652|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826761|NCT00747474|10937653|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826762|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826763|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10236989|NCT00790478|11367786|FG000|COMPLETED|Overall Study||0
10236990|NCT00790478|11367787|FG001|COMPLETED|Overall Study||0
10236991|NCT00790478|11367786|FG000|NOT COMPLETED|Overall Study||0
10236992|NCT00790478|11367787|FG001|NOT COMPLETED|Overall Study||0
10236993|NCT00796107|11367793|FG000|STARTED|Overall Study||6
10236994|NCT00796107|11367793|FG000|COMPLETED|Overall Study||0
10236995|NCT00796107|11367793|FG000|NOT COMPLETED|Overall Study||6
10236996|NCT00791336|11367797|FG000|STARTED|Overall Study||1
10236997|NCT00791336|11367797|FG000|COMPLETED|Overall Study||1
10236998|NCT00791336|11367797|FG000|NOT COMPLETED|Overall Study||0
10236999|NCT00786682|11367801|FG000|STARTED|Overall Study||11
10237000|NCT00786682|11367801|FG000|COMPLETED|Overall Study||11
10237001|NCT00786682|11367801|FG000|NOT COMPLETED|Overall Study||0
10237002|NCT00787124|11367807|FG000|STARTED|Overall Study||4
10237003|NCT00787124|11367808|FG001|STARTED|Overall Study||4
10237004|NCT00787124|11367807|FG000|COMPLETED|Overall Study||4
10237005|NCT00787124|11367808|FG001|COMPLETED|Overall Study||4
10237006|NCT00787124|11367807|FG000|NOT COMPLETED|Overall Study||0
10237007|NCT00787124|11367808|FG001|NOT COMPLETED|Overall Study||0
9826764|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826765|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826766|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826767|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826768|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826769|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826770|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826771|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826772|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826773|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
9826774|NCT00747474|10937642|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826775|NCT00747474|10937643|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826776|NCT00747474|10937644|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826777|NCT00747474|10937645|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826778|NCT00747474|10937646|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826779|NCT00747474|10937647|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826780|NCT00747474|10937648|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4
9826781|NCT00747474|10937649|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826782|NCT00747474|10937650|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826783|NCT00747474|10937651|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826784|NCT00747474|10937652|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826785|NCT00747474|10937653|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0
9826786|NCT00747474|10937642|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826787|NCT00747474|10937643|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826788|NCT00747474|10937644|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826789|NCT00747474|10937645|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826790|NCT00747474|10937646|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826791|NCT00747474|10937647|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826792|NCT00747474|10937648|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
9826793|NCT00747474|10937649|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826794|NCT00747474|10937650|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826795|NCT00747474|10937651|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826796|NCT00747474|10937652|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826797|NCT00747474|10937653|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826798|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826799|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826800|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826801|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826802|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826803|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826804|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826805|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826806|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826807|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826808|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826809|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
9826810|NCT00747474|10937642|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826811|NCT00747474|10937643|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826812|NCT00747474|10937644|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826813|NCT00747474|10937645|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826814|NCT00747474|10937646|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826815|NCT00747474|10937647|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826816|NCT00747474|10937648|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826817|NCT00747474|10937649|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6
9826818|NCT00747474|10937650|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826819|NCT00747474|10937651|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826820|NCT00747474|10937652|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826821|NCT00747474|10937653|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0
9826822|NCT00747474|10937642|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10017382|NCT01816295|11140278|FG000|Received Study Drug|Double Blind Phase||356
10017383|NCT01816295|11140279|FG001|Received Study Drug|Double Blind Phase||354
10017384|NCT01816295|11140278|FG000|COMPLETED|Double Blind Phase||294
10017385|NCT01816295|11140279|FG001|COMPLETED|Double Blind Phase||302
10017386|NCT01816295|11140278|FG000|NOT COMPLETED|Double Blind Phase||63
10017387|NCT01816295|11140279|FG001|NOT COMPLETED|Double Blind Phase||56
10017388|NCT01816295|11140278|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
10017389|NCT01816295|11140279|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
10017390|NCT01816295|11140278|FG000|COMPLETED|OLE Phase||222
10017391|NCT01816295|11140279|FG001|COMPLETED|OLE Phase||227
10017392|NCT01816295|11140278|FG000|NOT COMPLETED|OLE Phase||53
10017393|NCT01816295|11140279|FG001|NOT COMPLETED|OLE Phase||56
10017394|NCT01816451|11140289|FG000|STARTED|Overall Study||13
10017395|NCT01816451|11140290|FG001|STARTED|Overall Study||11
10017396|NCT01816451|11140291|FG002|STARTED|Overall Study||8
10017397|NCT01816451|11140289|FG000|COMPLETED|Overall Study||13
10017398|NCT01816451|11140290|FG001|COMPLETED|Overall Study||11
9826823|NCT00747474|10937643|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826824|NCT00747474|10937644|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826825|NCT00747474|10937645|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10017399|NCT01816451|11140291|FG002|COMPLETED|Overall Study||8
10017400|NCT01816451|11140289|FG000|NOT COMPLETED|Overall Study||0
10017401|NCT01816451|11140290|FG001|NOT COMPLETED|Overall Study||0
10017402|NCT01816451|11140291|FG002|NOT COMPLETED|Overall Study||0
10017403|NCT01816477|11140303|FG000|STARTED|Overall Study||43
10017404|NCT01816477|11140304|FG001|STARTED|Overall Study||42
10017405|NCT01816477|11140303|FG000|COMPLETED|Overall Study||27
10017406|NCT01816477|11140304|FG001|COMPLETED|Overall Study||41
10017407|NCT01816477|11140303|FG000|NOT COMPLETED|Overall Study||16
10017408|NCT01816477|11140304|FG001|NOT COMPLETED|Overall Study||1
10017409|NCT01816594|11140312|FG000|STARTED|Overall Study||25
10017410|NCT01816594|11140313|FG001|STARTED|Overall Study||25
10017411|NCT01816594|11140312|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
10017412|NCT01816594|11140313|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
10017413|NCT01816594|11140312|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
10017414|NCT01816594|11140313|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
10237008|NCT00785356|11367817|FG000|STARTED|Overall Study||8
10237009|NCT00785356|11367817|FG000|COMPLETED|Overall Study||0
9826826|NCT00747474|10937646|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826827|NCT00747474|10937647|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826828|NCT00747474|10937648|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826829|NCT00747474|10937649|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
9826830|NCT00747474|10937650|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826831|NCT00747474|10937651|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826832|NCT00747474|10937652|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826833|NCT00747474|10937653|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826834|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10237010|NCT00785356|11367817|FG000|NOT COMPLETED|Overall Study||8
10237011|NCT00782483|11367825|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
10237012|NCT00782483|11367825|FG000|COMPLETED|Overall Study||0
9826835|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826836|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826837|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826838|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826839|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826840|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826841|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
9826842|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826843|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826844|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826845|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
9826846|NCT00747474|10937642|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826847|NCT00747474|10937643|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826848|NCT00747474|10937644|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826849|NCT00747474|10937645|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0
10017415|NCT01816594|11140312|FG000|COMPLETED|Overall Study||14
10237013|NCT00782483|11367825|FG000|NOT COMPLETED|Overall Study||6
10237014|NCT00791843|11367829|FG000|STARTED|Overall Study|Data unavailable for the study|0
10237015|NCT00791843|11367829|FG000|COMPLETED|Overall Study|Data unavailable for the study|0
10237016|NCT00791843|11367829|FG000|NOT COMPLETED|Overall Study||0
10237017|NCT00784043|11367835|FG000|STARTED|Overall Study||31
10237018|NCT00784043|11367836|FG001|STARTED|Overall Study||6
10237019|NCT00784043|11367835|FG000|COMPLETED|Overall Study||0
10237020|NCT00784043|11367836|FG001|COMPLETED|Overall Study||0
10237021|NCT00784043|11367835|FG000|NOT COMPLETED|Overall Study||31
10237022|NCT00784043|11367836|FG001|NOT COMPLETED|Overall Study||6
10237023|NCT00787618|11367845|FG000|STARTED|Overall Study||3
10237024|NCT00787618|11367846|FG001|STARTED|Overall Study||0
10237025|NCT00787618|11367847|FG002|STARTED|Overall Study||3
10237026|NCT00787618|11367845|FG000|COMPLETED|Overall Study||3
10237027|NCT00787618|11367846|FG001|COMPLETED|Overall Study||0
10237028|NCT00787618|11367847|FG002|COMPLETED|Overall Study||3
10237029|NCT00787618|11367845|FG000|NOT COMPLETED|Overall Study||0
10237030|NCT00787618|11367846|FG001|NOT COMPLETED|Overall Study||0
10237031|NCT00787618|11367847|FG002|NOT COMPLETED|Overall Study||0
10237032|NCT00774306|11367859|FG000|STARTED|Overall Study||24
10237033|NCT00774306|11367860|FG001|STARTED|Overall Study||5
10237034|NCT00774306|11367861|FG002|STARTED|Overall Study||16
10237035|NCT00774306|11367862|FG003|STARTED|Overall Study||7
10237036|NCT00774306|11367859|FG000|COMPLETED|Overall Study||6
10237037|NCT00774306|11367860|FG001|COMPLETED|Overall Study||3
10237038|NCT00774306|11367861|FG002|COMPLETED|Overall Study||8
10237039|NCT00774306|11367862|FG003|COMPLETED|Overall Study||2
10237040|NCT00774306|11367859|FG000|NOT COMPLETED|Overall Study||18
10237041|NCT00774306|11367860|FG001|NOT COMPLETED|Overall Study||2
10237042|NCT00774306|11367861|FG002|NOT COMPLETED|Overall Study||8
10237043|NCT00774306|11367862|FG003|NOT COMPLETED|Overall Study||5
10237044|NCT00771602|11367875|FG000|STARTED|Overall Study||1
10237045|NCT00771602|11367876|FG001|STARTED|Overall Study||0
10237046|NCT00771602|11367877|FG002|STARTED|Overall Study||0
10237047|NCT00771602|11367875|FG000|COMPLETED|Overall Study||1
10237048|NCT00771602|11367876|FG001|COMPLETED|Overall Study||0
10237049|NCT00771602|11367877|FG002|COMPLETED|Overall Study||0
10237050|NCT00771602|11367875|FG000|NOT COMPLETED|Overall Study||0
10237051|NCT00771602|11367876|FG001|NOT COMPLETED|Overall Study||0
9826850|NCT00747474|10937646|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826851|NCT00747474|10937647|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0
10237052|NCT00771602|11367877|FG002|NOT COMPLETED|Overall Study||0
9826852|NCT00747474|10937648|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826853|NCT00747474|10937649|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826854|NCT00747474|10937650|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4
9826855|NCT00747474|10937651|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826856|NCT00747474|10937652|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826857|NCT00747474|10937653|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0
9826858|NCT00747474|10937642|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826859|NCT00747474|10937643|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826860|NCT00747474|10937644|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826861|NCT00747474|10937645|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826862|NCT00747474|10937646|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826863|NCT00747474|10937647|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826864|NCT00747474|10937648|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826865|NCT00747474|10937649|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826866|NCT00747474|10937650|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
9826867|NCT00747474|10937651|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826868|NCT00747474|10937652|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826869|NCT00747474|10937653|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826870|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826871|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826872|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826873|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826874|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826875|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826876|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826877|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826878|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826879|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826880|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826881|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9826882|NCT00747474|10937642|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826883|NCT00747474|10937643|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826884|NCT00747474|10937644|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826885|NCT00747474|10937645|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826886|NCT00747474|10937646|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826887|NCT00747474|10937647|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826888|NCT00747474|10937648|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826889|NCT00747474|10937649|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826890|NCT00747474|10937650|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826891|NCT00747474|10937651|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7
9826892|NCT00747474|10937652|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826893|NCT00747474|10937653|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0
9826894|NCT00747474|10937642|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826895|NCT00747474|10937643|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826896|NCT00747474|10937644|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826897|NCT00747474|10937645|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826898|NCT00747474|10937646|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826899|NCT00747474|10937647|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826900|NCT00747474|10937648|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826901|NCT00747474|10937649|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826902|NCT00747474|10937650|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826903|NCT00747474|10937651|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
9826904|NCT00747474|10937652|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826905|NCT00747474|10937653|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826906|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826907|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826908|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826909|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826910|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826911|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826912|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826913|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826914|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826915|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826916|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826917|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
9826918|NCT00747474|10937642|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826919|NCT00747474|10937643|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826920|NCT00747474|10937644|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826921|NCT00747474|10937645|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826922|NCT00747474|10937646|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826923|NCT00747474|10937647|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826924|NCT00747474|10937648|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826925|NCT00747474|10937649|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826926|NCT00747474|10937650|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826927|NCT00747474|10937651|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826928|NCT00747474|10937652|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5
9826929|NCT00747474|10937653|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0
9826930|NCT00747474|10937642|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826931|NCT00747474|10937643|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826932|NCT00747474|10937644|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826933|NCT00747474|10937645|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826934|NCT00747474|10937646|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826935|NCT00747474|10937647|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826936|NCT00747474|10937648|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826937|NCT00747474|10937649|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826938|NCT00747474|10937650|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826939|NCT00747474|10937651|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826940|NCT00747474|10937652|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
9826941|NCT00747474|10937653|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826942|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826943|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826944|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826945|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826946|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826947|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826948|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826949|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826950|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826951|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826952|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826953|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
9826954|NCT00747474|10937642|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826955|NCT00747474|10937643|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826956|NCT00747474|10937644|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826957|NCT00747474|10937645|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826958|NCT00747474|10937646|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826959|NCT00747474|10937647|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826960|NCT00747474|10937648|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826961|NCT00747474|10937649|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826962|NCT00747474|10937650|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826963|NCT00747474|10937651|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826964|NCT00747474|10937652|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0
9826965|NCT00747474|10937653|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6
9826966|NCT00747474|10937642|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826967|NCT00747474|10937643|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826968|NCT00747474|10937644|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826969|NCT00747474|10937645|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826970|NCT00747474|10937646|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826971|NCT00747474|10937647|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826972|NCT00747474|10937648|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826973|NCT00747474|10937649|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826974|NCT00747474|10937650|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826975|NCT00747474|10937651|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826976|NCT00747474|10937652|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826977|NCT00747474|10937653|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
9826978|NCT00747474|10937642|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826979|NCT00747474|10937643|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826980|NCT00747474|10937644|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826981|NCT00747474|10937645|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826982|NCT00747474|10937646|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826983|NCT00747474|10937647|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826984|NCT00747474|10937648|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826985|NCT00747474|10937649|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826986|NCT00747474|10937650|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826987|NCT00747474|10937651|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826988|NCT00747474|10937652|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826989|NCT00747474|10937653|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
9826990|NCT00747552|10937658|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
9826991|NCT00747552|10937658|FG000|COMPLETED|Overall Study||30
9826992|NCT00747552|10937658|FG000|NOT COMPLETED|Overall Study||0
9826993|NCT00747565|10937664|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
9826994|NCT00747565|10937665|FG001|STARTED|Overall Study||123
9826995|NCT00747565|10937664|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
9826996|NCT00747565|10937665|FG001|COMPLETED|Overall Study||116
9826997|NCT00747565|10937664|FG000|NOT COMPLETED|Overall Study||14
9826998|NCT00747565|10937665|FG001|NOT COMPLETED|Overall Study||7
9826999|NCT00747617|10937673|FG000|STARTED|Overall Study||13
9827000|NCT00747617|10937674|FG001|STARTED|Overall Study||12
9827001|NCT00747617|10937673|FG000|COMPLETED|Overall Study||10
9827002|NCT00747617|10937674|FG001|COMPLETED|Overall Study||11
9827003|NCT00747617|10937673|FG000|NOT COMPLETED|Overall Study||3
9827004|NCT00747617|10937674|FG001|NOT COMPLETED|Overall Study||1
9827005|NCT00747643|10937682|FG000|STARTED|Overall Study||82
9827006|NCT00747643|10937683|FG001|STARTED|Overall Study||81
9827007|NCT00747643|10937682|FG000|COMPLETED|Overall Study||46
9827008|NCT00747643|10937683|FG001|COMPLETED|Overall Study||54
9827009|NCT00747643|10937682|FG000|NOT COMPLETED|Overall Study||36
9827010|NCT00747643|10937683|FG001|NOT COMPLETED|Overall Study||27
9827011|NCT00747747|10937692|FG000|STARTED|Overall Study||14
9827012|NCT00747747|10937693|FG001|STARTED|Overall Study||14
9827013|NCT00747747|10937694|FG002|STARTED|Overall Study||21
9827014|NCT00747747|10937692|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
9827015|NCT00747747|10937693|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
9827016|NCT00747747|10937694|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
9827017|NCT00747747|10937692|FG000|NOT COMPLETED|Overall Study||0
9827018|NCT00747747|10937693|FG001|NOT COMPLETED|Overall Study||0
9827019|NCT00747747|10937694|FG002|NOT COMPLETED|Overall Study||0
9827020|NCT00747812|10937704|FG000|STARTED|Overall Study||5
9827021|NCT00747812|10937705|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
9827022|NCT00747812|10937704|FG000|COMPLETED|Overall Study||0
9827023|NCT00747812|10937705|FG001|COMPLETED|Overall Study||0
9827024|NCT00747812|10937704|FG000|NOT COMPLETED|Overall Study||5
9827025|NCT00747812|10937705|FG001|NOT COMPLETED|Overall Study||3
9827026|NCT00748033|10937713|FG000|STARTED|Overall Study||12
9827027|NCT00748033|10937714|FG001|STARTED|Overall Study||13
9827028|NCT00748033|10937713|FG000|COMPLETED|Overall Study||12
9827029|NCT00748033|10937714|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
9827030|NCT00748033|10937713|FG000|NOT COMPLETED|Overall Study||0
9827031|NCT00748033|10937714|FG001|NOT COMPLETED|Overall Study||1
9827032|NCT00748072|10937730|FG000|STARTED|Overall Study||82
9827033|NCT00748072|10937731|FG001|STARTED|Overall Study||80
9827034|NCT00748072|10937730|FG000|COMPLETED|Overall Study||82
9827035|NCT00748072|10937731|FG001|COMPLETED|Overall Study||80
9827036|NCT00748072|10937730|FG000|NOT COMPLETED|Overall Study||0
9827037|NCT00748072|10937731|FG001|NOT COMPLETED|Overall Study||0
9827038|NCT00748098|10937737|FG000|STARTED|First Treatment Intervention Period||69
9827039|NCT00748098|10937738|FG001|STARTED|First Treatment Intervention Period||67
9827040|NCT00748098|10937737|FG000|COMPLETED|First Treatment Intervention Period||64
9827041|NCT00748098|10937738|FG001|COMPLETED|First Treatment Intervention Period||66
9827042|NCT00748098|10937737|FG000|NOT COMPLETED|First Treatment Intervention Period||5
9827043|NCT00748098|10937738|FG001|NOT COMPLETED|First Treatment Intervention Period||1
9827044|NCT00748098|10937737|FG000|STARTED|First Taper Period||64
9827045|NCT00748098|10937738|FG001|STARTED|First Taper Period||66
9827046|NCT00748098|10937737|FG000|COMPLETED|First Taper Period||61
9827047|NCT00748098|10937738|FG001|COMPLETED|First Taper Period||65
9827048|NCT00748098|10937737|FG000|NOT COMPLETED|First Taper Period||3
9827049|NCT00748098|10937738|FG001|NOT COMPLETED|First Taper Period||1
9827050|NCT00748098|10937737|FG000|STARTED|1-Week Washout Period||61
9827051|NCT00748098|10937738|FG001|STARTED|1-Week Washout Period||65
9827052|NCT00748098|10937737|FG000|COMPLETED|1-Week Washout Period||59
9827053|NCT00748098|10937738|FG001|COMPLETED|1-Week Washout Period||64
9827054|NCT00748098|10937737|FG000|NOT COMPLETED|1-Week Washout Period||2
9827055|NCT00748098|10937738|FG001|NOT COMPLETED|1-Week Washout Period||1
9827056|NCT00748098|10937737|FG000|STARTED|Second Treatment Intervention Period||59
9827057|NCT00748098|10937738|FG001|STARTED|Second Treatment Intervention Period||64
9827058|NCT00748098|10937737|FG000|COMPLETED|Second Treatment Intervention Period||53
9827059|NCT00748098|10937738|FG001|COMPLETED|Second Treatment Intervention Period||61
9827060|NCT00748098|10937737|FG000|NOT COMPLETED|Second Treatment Intervention Period||6
9827061|NCT00748098|10937738|FG001|NOT COMPLETED|Second Treatment Intervention Period||3
9827062|NCT00748098|10937737|FG000|STARTED|Second Taper Period||53
9827063|NCT00748098|10937738|FG001|STARTED|Second Taper Period||61
9827064|NCT00748098|10937737|FG000|COMPLETED|Second Taper Period||53
9827065|NCT00748098|10937738|FG001|COMPLETED|Second Taper Period||61
9827066|NCT00748098|10937737|FG000|NOT COMPLETED|Second Taper Period||0
9827067|NCT00748098|10937738|FG001|NOT COMPLETED|Second Taper Period||0
9827068|NCT00748189|10937747|FG000|STARTED|Overall Study||226
10237053|NCT00779038|11367885|FG000|STARTED|Overall Study||13
10237054|NCT00779038|11367885|FG000|COMPLETED|Overall Study||0
10237055|NCT00779038|11367885|FG000|NOT COMPLETED|Overall Study||13
10237056|NCT00780455|11367891|FG000|STARTED|Overall Study||2
10237057|NCT00780455|11367892|FG001|STARTED|Overall Study||2
10237058|NCT00780455|11367891|FG000|COMPLETED|Overall Study||2
10237059|NCT00780455|11367892|FG001|COMPLETED|Overall Study||2
10237060|NCT00780455|11367891|FG000|NOT COMPLETED|Overall Study||0
10237061|NCT00780455|11367892|FG001|NOT COMPLETED|Overall Study||0
10237062|NCT00776100|11367900|FG000|STARTED|Overall Study||1
10237063|NCT00776100|11367901|FG001|STARTED|Overall Study||1
10237064|NCT00776100|11367900|FG000|COMPLETED|Overall Study||0
10237065|NCT00776100|11367901|FG001|COMPLETED|Overall Study||1
10237066|NCT00776100|11367900|FG000|NOT COMPLETED|Overall Study||1
10237067|NCT00776100|11367901|FG001|NOT COMPLETED|Overall Study||0
10237068|NCT00771316|11367909|FG000|STARTED|Overall Study||4
10237069|NCT00771316|11367910|FG001|STARTED|Overall Study||2
10237070|NCT00771316|11367909|FG000|COMPLETED|Overall Study||2
10237071|NCT00771316|11367910|FG001|COMPLETED|Overall Study||1
10237072|NCT00771316|11367909|FG000|NOT COMPLETED|Overall Study||2
10237073|NCT00771316|11367910|FG001|NOT COMPLETED|Overall Study||1
9827069|NCT00748189|10937748|FG001|STARTED|Overall Study||221
9827070|NCT00748189|10937747|FG000|COMPLETED|Overall Study||10
10237074|NCT00780481|11367916|FG000|STARTED|Overall Study||13
10237075|NCT00780481|11367916|FG000|COMPLETED|Overall Study||13
10237076|NCT00780481|11367916|FG000|NOT COMPLETED|Overall Study||0
10237077|NCT00769652|11367922|FG000|STARTED|Overall Study||6
9827071|NCT00748189|10937748|FG001|COMPLETED|Overall Study||9
9827072|NCT00748189|10937747|FG000|NOT COMPLETED|Overall Study||216
9827073|NCT00748189|10937748|FG001|NOT COMPLETED|Overall Study||212
9827074|NCT00748215|10937761|FG000|STARTED|Overall Study||50
9827075|NCT00748215|10937762|FG001|STARTED|Overall Study||50
10017416|NCT01816594|11140313|FG001|COMPLETED|Overall Study||23
10017417|NCT01816594|11140312|FG000|NOT COMPLETED|Overall Study||11
10017418|NCT01816594|11140313|FG001|NOT COMPLETED|Overall Study||2
10017419|NCT01816685|11140327|FG000|STARTED|Overall Study||68
10017420|NCT01816685|11140328|FG001|STARTED|Overall Study||67
10017421|NCT01816685|11140327|FG000|COMPLETED|Overall Study||58
10017422|NCT01816685|11140328|FG001|COMPLETED|Overall Study||56
10017423|NCT01816685|11140327|FG000|NOT COMPLETED|Overall Study||10
9827076|NCT00748215|10937761|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
9827077|NCT00748215|10937762|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
9827078|NCT00748215|10937761|FG000|COMPLETED|Overall Study||41
9827079|NCT00748215|10937762|FG001|COMPLETED|Overall Study||32
9827080|NCT00748215|10937761|FG000|NOT COMPLETED|Overall Study||9
9827081|NCT00748215|10937762|FG001|NOT COMPLETED|Overall Study||18
9827082|NCT00748241|10937768|FG000|STARTED|Overall Study||19
9827083|NCT00748241|10937768|FG000|COMPLETED|Overall Study||11
9827084|NCT00748241|10937768|FG000|NOT COMPLETED|Overall Study||8
9827085|NCT00748410|10937774|FG000|STARTED|Overall Study||1
9827086|NCT00748410|10937775|FG001|STARTED|Overall Study||2
9827087|NCT00748410|10937774|FG000|COMPLETED|Overall Study||1
9827088|NCT00748410|10937775|FG001|COMPLETED|Overall Study||2
9827089|NCT00748410|10937774|FG000|NOT COMPLETED|Overall Study||0
9827090|NCT00748410|10937775|FG001|NOT COMPLETED|Overall Study||0
9827091|NCT00748540|10937781|FG000|STARTED|Overall Study||50
9827092|NCT00748540|10937781|FG000|COMPLETED|Overall Study||49
9827093|NCT00748540|10937781|FG000|NOT COMPLETED|Overall Study||1
9827094|NCT00748553|10937787|FG000|STARTED|Overall Study||16
9827095|NCT00748553|10937788|FG001|STARTED|Overall Study||14
9827096|NCT00748553|10937787|FG000|COMPLETED|Overall Study||13
9827097|NCT00748553|10937788|FG001|COMPLETED|Overall Study||13
9827098|NCT00748553|10937787|FG000|NOT COMPLETED|Overall Study||3
9827099|NCT00748553|10937788|FG001|NOT COMPLETED|Overall Study||1
9827100|NCT00748566|10937793|FG000|STARTED|Overall Study||172
9827101|NCT00748566|10937793|FG000|COMPLETED|Overall Study||60
9827102|NCT00748566|10937793|FG000|NOT COMPLETED|Overall Study||112
9827103|NCT00748657|10937797|FG000|STARTED|Overall Study||36
10017424|NCT01816685|11140328|FG001|NOT COMPLETED|Overall Study||11
10017425|NCT01816711|11140336|FG000|STARTED|Overall Study||121
10017426|NCT01816711|11140337|FG001|STARTED|Overall Study||83
10017427|NCT01816711|11140336|FG000|COMPLETED|Overall Study||121
10017428|NCT01816711|11140337|FG001|COMPLETED|Overall Study||83
10017429|NCT01816711|11140336|FG000|NOT COMPLETED|Overall Study||0
10017430|NCT01816711|11140337|FG001|NOT COMPLETED|Overall Study||0
10017431|NCT01816763|11140346|FG000|STARTED|Overall Study||195
10017432|NCT01816763|11140347|FG001|STARTED|Overall Study||194
10017433|NCT01816763|11140348|FG002|STARTED|Overall Study||180
10017434|NCT01816763|11140346|FG000|COMPLETED|Overall Study||191
10017435|NCT01816763|11140347|FG001|COMPLETED|Overall Study||179
10017436|NCT01816763|11140348|FG002|COMPLETED|Overall Study||169
10017437|NCT01816763|11140346|FG000|NOT COMPLETED|Overall Study||4
10237078|NCT00769652|11367923|FG001|STARTED|Overall Study||1
10237079|NCT00769652|11367922|FG000|COMPLETED|Overall Study||6
10237080|NCT00769652|11367923|FG001|COMPLETED|Overall Study||1
10237081|NCT00769652|11367922|FG000|NOT COMPLETED|Overall Study||0
10237082|NCT00769652|11367923|FG001|NOT COMPLETED|Overall Study||0
10237083|NCT00768040|11367931|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
10237084|NCT00768040|11367932|FG001|STARTED|Overall Study||19
10237085|NCT00768040|11367931|FG000|COMPLETED|Overall Study||16
10237086|NCT00768040|11367932|FG001|COMPLETED|Overall Study||16
10237087|NCT00768040|11367931|FG000|NOT COMPLETED|Overall Study||4
10237088|NCT00768040|11367932|FG001|NOT COMPLETED|Overall Study||3
10237089|NCT00776555|11367940|FG000|STARTED|Overall Study||3
10237090|NCT00776555|11367941|FG001|STARTED|Overall Study||0
10237091|NCT00776555|11367940|FG000|COMPLETED|Overall Study||0
10237092|NCT00776555|11367941|FG001|COMPLETED|Overall Study||0
10237093|NCT00776555|11367940|FG000|NOT COMPLETED|Overall Study||3
10237094|NCT00776555|11367941|FG001|NOT COMPLETED|Overall Study||0
10237095|NCT00775190|11367949|FG000|STARTED|Overall Study||7
10237096|NCT00775190|11367950|FG001|STARTED|Overall Study||5
10237097|NCT00775190|11367949|FG000|COMPLETED|Overall Study||3
10237098|NCT00775190|11367950|FG001|COMPLETED|Overall Study||0
10237099|NCT00775190|11367949|FG000|NOT COMPLETED|Overall Study||4
9827104|NCT00748657|10937797|FG000|COMPLETED|Overall Study||36
9827105|NCT00748657|10937797|FG000|NOT COMPLETED|Overall Study||0
10237100|NCT00775190|11367950|FG001|NOT COMPLETED|Overall Study||5
10237101|NCT00755261|11367956|FG000|STARTED|Overall Study||6
10237102|NCT00755261|11367956|FG000|COMPLETED|Overall Study||4
9827106|NCT00748709|10937807|FG000|STARTED|Overall Study|Treated|20
9827107|NCT00748709|10937807|FG000|COMPLETED|Overall Study||0
9827108|NCT00748709|10937807|FG000|NOT COMPLETED|Overall Study||20
10017438|NCT01816763|11140347|FG001|NOT COMPLETED|Overall Study||15
10017439|NCT01816763|11140348|FG002|NOT COMPLETED|Overall Study||11
10017440|NCT01816776|11140361|FG000|STARTED|Overall Study||73
10017441|NCT01816776|11140362|FG001|STARTED|Overall Study||78
10017442|NCT01816776|11140361|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68
10017443|NCT01816776|11140362|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73
9827109|NCT00748826|10937811|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
9827110|NCT00748826|10937811|FG000|COMPLETED|Overall Study||207
9827111|NCT00748826|10937811|FG000|NOT COMPLETED|Overall Study||301
9827112|NCT00748865|10937815|FG000|STARTED|Overall Study||10
9827113|NCT00748865|10937816|FG001|STARTED|Overall Study||10
9827114|NCT00748865|10937815|FG000|COMPLETED|Overall Study||10
9827115|NCT00748865|10937816|FG001|COMPLETED|Overall Study||10
9827116|NCT00748865|10937815|FG000|NOT COMPLETED|Overall Study||0
9827117|NCT00748865|10937816|FG001|NOT COMPLETED|Overall Study||0
9827118|NCT00748956|10937825|FG000|STARTED|Overall Study||0
9827119|NCT00748956|10937826|FG001|STARTED|Overall Study||5
9827120|NCT00748956|10937827|FG002|STARTED|Overall Study||5
9827121|NCT00748956|10937825|FG000|COMPLETED|Overall Study||0
9827122|NCT00748956|10937826|FG001|COMPLETED|Overall Study||5
9827123|NCT00748956|10937827|FG002|COMPLETED|Overall Study||5
9827124|NCT00748956|10937825|FG000|NOT COMPLETED|Overall Study||0
9827125|NCT00748956|10937826|FG001|NOT COMPLETED|Overall Study||0
9827126|NCT00748956|10937827|FG002|NOT COMPLETED|Overall Study||0
9827127|NCT00748969|10937837|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
9827128|NCT00748969|10937838|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
9827129|NCT00748969|10937837|FG000|COMPLETED|Overall Study||0
9827130|NCT00748969|10937838|FG001|COMPLETED|Overall Study||0
9827131|NCT00748969|10937837|FG000|NOT COMPLETED|Overall Study||1
9827132|NCT00748969|10937838|FG001|NOT COMPLETED|Overall Study||1
9827133|NCT00748982|10937846|FG000|STARTED|Overall Study||12
9827134|NCT00748982|10937847|FG001|STARTED|Overall Study||4
9827135|NCT00748982|10937846|FG000|COMPLETED|Overall Study||12
9827136|NCT00748982|10937847|FG001|COMPLETED|Overall Study||4
9827137|NCT00748982|10937846|FG000|NOT COMPLETED|Overall Study||0
9827138|NCT00748982|10937847|FG001|NOT COMPLETED|Overall Study||0
9827139|NCT00749073|10937853|FG000|STARTED|Overall Study||10
9827140|NCT00749073|10937853|FG000|COMPLETED|Overall Study||10
9827141|NCT00749073|10937853|FG000|NOT COMPLETED|Overall Study||0
9827142|NCT00749125|10937860|FG000|STARTED|Overall Study||47
9827143|NCT00749125|10937861|FG001|STARTED|Overall Study||52
9827144|NCT00749125|10937860|FG000|COMPLETED|Overall Study||36
9827145|NCT00749125|10937861|FG001|COMPLETED|Overall Study||34
9827146|NCT00749125|10937860|FG000|NOT COMPLETED|Overall Study||11
9827147|NCT00749125|10937861|FG001|NOT COMPLETED|Overall Study||18
9827148|NCT00749190|10937874|FG000|STARTED|Overall Study||71
9827149|NCT00749190|10937875|FG001|STARTED|Overall Study||71
9827150|NCT00749190|10937876|FG002|STARTED|Overall Study||71
9827151|NCT00749190|10937877|FG003|STARTED|Overall Study||71
9827152|NCT00749190|10937878|FG004|STARTED|Overall Study||70
9827153|NCT00749190|10937879|FG005|STARTED|Overall Study||70
9827154|NCT00749190|10937880|FG006|STARTED|Overall Study||71
9827155|NCT00749190|10937874|FG000|COMPLETED|Overall Study||66
9827156|NCT00749190|10937875|FG001|COMPLETED|Overall Study||66
9827157|NCT00749190|10937876|FG002|COMPLETED|Overall Study||70
9827158|NCT00749190|10937877|FG003|COMPLETED|Overall Study||66
9827159|NCT00749190|10937878|FG004|COMPLETED|Overall Study||70
9827160|NCT00749190|10937879|FG005|COMPLETED|Overall Study||65
9827161|NCT00749190|10937880|FG006|COMPLETED|Overall Study||70
9827162|NCT00749190|10937874|FG000|NOT COMPLETED|Overall Study||5
9827163|NCT00749190|10937875|FG001|NOT COMPLETED|Overall Study||5
9827164|NCT00749190|10937876|FG002|NOT COMPLETED|Overall Study||1
9827165|NCT00749190|10937877|FG003|NOT COMPLETED|Overall Study||5
9827166|NCT00749190|10937878|FG004|NOT COMPLETED|Overall Study||0
9827167|NCT00749190|10937879|FG005|NOT COMPLETED|Overall Study||5
9827168|NCT00749190|10937880|FG006|NOT COMPLETED|Overall Study||1
9827169|NCT00749203|10937903|FG000|STARTED|First Infusion Day 1||22
9827170|NCT00749203|10937904|FG001|STARTED|First Infusion Day 1||19
9827171|NCT00749203|10937903|FG000|COMPLETED|First Infusion Day 1||22
9827172|NCT00749203|10937904|FG001|COMPLETED|First Infusion Day 1||19
9827173|NCT00749203|10937903|FG000|NOT COMPLETED|First Infusion Day 1||0
9827174|NCT00749203|10937904|FG001|NOT COMPLETED|First Infusion Day 1||0
9827175|NCT00749203|10937903|FG000|STARTED|no Infusion at Week 1||22
9827176|NCT00749203|10937904|FG001|STARTED|no Infusion at Week 1||19
9827177|NCT00749203|10937903|FG000|COMPLETED|no Infusion at Week 1||22
9827178|NCT00749203|10937904|FG001|COMPLETED|no Infusion at Week 1||15
9827179|NCT00749203|10937903|FG000|NOT COMPLETED|no Infusion at Week 1||0
9827180|NCT00749203|10937904|FG001|NOT COMPLETED|no Infusion at Week 1||4
9827181|NCT00749203|10937903|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
9827182|NCT00749203|10937904|FG001|STARTED|Second Infusion at 2 Weeks||15
9827183|NCT00749203|10937903|FG000|COMPLETED|Second Infusion at 2 Weeks||16
9827184|NCT00749203|10937904|FG001|COMPLETED|Second Infusion at 2 Weeks||13
9827185|NCT00749203|10937903|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0
9827186|NCT00749203|10937904|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2
9827187|NCT00749268|10937914|FG000|STARTED|Overall Study||106
9827188|NCT00749268|10937915|FG001|STARTED|Overall Study||110
9827189|NCT00749268|10937914|FG000|COMPLETED|Overall Study||72
9827190|NCT00749268|10937915|FG001|COMPLETED|Overall Study||74
9827191|NCT00749268|10937914|FG000|NOT COMPLETED|Overall Study||34
9827192|NCT00749268|10937915|FG001|NOT COMPLETED|Overall Study||36
9827193|NCT00749398|10937925|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
9827194|NCT00749398|10937925|FG000|COMPLETED|Overall Study||71
9827195|NCT00749398|10937925|FG000|NOT COMPLETED|Overall Study||53
9827196|NCT00749411|10937931|FG000|STARTED|Overall Study||21
9827197|NCT00749411|10937932|FG001|STARTED|Overall Study||40
9827198|NCT00749411|10937931|FG000|COMPLETED|Overall Study||20
9827199|NCT00749411|10937932|FG001|COMPLETED|Overall Study||35
9827200|NCT00749411|10937931|FG000|NOT COMPLETED|Overall Study||1
9827201|NCT00749411|10937932|FG001|NOT COMPLETED|Overall Study||5
9832368|NCT00772967|10943209|FG005|STARTED|Crossover Treatment 1||3
9832369|NCT00772967|10943204|FG000|COMPLETED|Crossover Treatment 1||3
9832370|NCT00772967|10943205|FG001|COMPLETED|Crossover Treatment 1||5
9832371|NCT00772967|10943206|FG002|COMPLETED|Crossover Treatment 1||3
9832372|NCT00772967|10943207|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
9832373|NCT00772967|10943208|FG004|COMPLETED|Crossover Treatment 1||4
9832374|NCT00772967|10943209|FG005|COMPLETED|Crossover Treatment 1||3
9832375|NCT00772967|10943204|FG000|NOT COMPLETED|Crossover Treatment 1||0
9832376|NCT00772967|10943205|FG001|NOT COMPLETED|Crossover Treatment 1||0
9832377|NCT00772967|10943206|FG002|NOT COMPLETED|Crossover Treatment 1||0
9832378|NCT00772967|10943207|FG003|NOT COMPLETED|Crossover Treatment 1||1
9832379|NCT00772967|10943208|FG004|NOT COMPLETED|Crossover Treatment 1||0
9832380|NCT00772967|10943209|FG005|NOT COMPLETED|Crossover Treatment 1||0
9832381|NCT00772967|10943204|FG000|STARTED|Break 1 (4-7 Days)||3
9832382|NCT00772967|10943205|FG001|STARTED|Break 1 (4-7 Days)||5
9832383|NCT00772967|10943206|FG002|STARTED|Break 1 (4-7 Days)||3
9832384|NCT00772967|10943207|FG003|STARTED|Break 1 (4-7 Days)||3
9832385|NCT00772967|10943208|FG004|STARTED|Break 1 (4-7 Days)||4
9832386|NCT00772967|10943209|FG005|STARTED|Break 1 (4-7 Days)||3
9832387|NCT00772967|10943204|FG000|COMPLETED|Break 1 (4-7 Days)||3
9832388|NCT00772967|10943205|FG001|COMPLETED|Break 1 (4-7 Days)||4
9832389|NCT00772967|10943206|FG002|COMPLETED|Break 1 (4-7 Days)||3
9832390|NCT00772967|10943207|FG003|COMPLETED|Break 1 (4-7 Days)||3
9832391|NCT00772967|10943208|FG004|COMPLETED|Break 1 (4-7 Days)||4
9832392|NCT00772967|10943209|FG005|COMPLETED|Break 1 (4-7 Days)||3
9832393|NCT00772967|10943204|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0
9832394|NCT00772967|10943205|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1
9832395|NCT00772967|10943206|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0
10237103|NCT00755261|11367956|FG000|NOT COMPLETED|Overall Study||2
10237104|NCT00762723|11367963|FG000|STARTED|Overall Study||5
10237105|NCT00762723|11367964|FG001|STARTED|Overall Study||11
10237106|NCT00762723|11367965|FG002|STARTED|Overall Study||3
10237107|NCT00762723|11367963|FG000|COMPLETED|Overall Study||0
10237108|NCT00762723|11367964|FG001|COMPLETED|Overall Study||6
10237109|NCT00762723|11367965|FG002|COMPLETED|Overall Study||0
10237110|NCT00762723|11367963|FG000|NOT COMPLETED|Overall Study||5
10237111|NCT00762723|11367964|FG001|NOT COMPLETED|Overall Study||5
10237112|NCT00762723|11367965|FG002|NOT COMPLETED|Overall Study||3
10237113|NCT00770965|11367977|FG000|STARTED|Safety Set||2
10237114|NCT00770965|11367978|FG001|STARTED|Safety Set||4
10237115|NCT00770965|11367979|FG002|STARTED|Safety Set||4
10237116|NCT00770965|11367980|FG003|STARTED|Safety Set||5
10237117|NCT00770965|11367977|FG000|COMPLETED|Safety Set||2
10237118|NCT00770965|11367978|FG001|COMPLETED|Safety Set||4
10237119|NCT00770965|11367979|FG002|COMPLETED|Safety Set||3
10237120|NCT00770965|11367980|FG003|COMPLETED|Safety Set||4
10237121|NCT00770965|11367977|FG000|NOT COMPLETED|Safety Set||0
10237122|NCT00770965|11367978|FG001|NOT COMPLETED|Safety Set||0
10237123|NCT00770965|11367979|FG002|NOT COMPLETED|Safety Set||1
10237124|NCT00770965|11367980|FG003|NOT COMPLETED|Safety Set||1
10237125|NCT00770965|11367977|FG000|STARTED|Excluded Set||18
10237126|NCT00770965|11367978|FG001|STARTED|Excluded Set||16
10237127|NCT00770965|11367979|FG002|STARTED|Excluded Set||16
10237128|NCT00770965|11367980|FG003|STARTED|Excluded Set||15
10237129|NCT00770965|11367977|FG000|COMPLETED|Excluded Set||3
10237130|NCT00770965|11367978|FG001|COMPLETED|Excluded Set||3
10237131|NCT00770965|11367979|FG002|COMPLETED|Excluded Set||2
10237132|NCT00770965|11367980|FG003|COMPLETED|Excluded Set||2
10237133|NCT00770965|11367977|FG000|NOT COMPLETED|Excluded Set||15
10237134|NCT00770965|11367978|FG001|NOT COMPLETED|Excluded Set||13
10237135|NCT00770965|11367979|FG002|NOT COMPLETED|Excluded Set||14
10237136|NCT00770965|11367980|FG003|NOT COMPLETED|Excluded Set||13
10237137|NCT00769002|11367994|FG000|STARTED|Overall Study||9
10237138|NCT00769002|11367995|FG001|STARTED|Overall Study||9
10237139|NCT00769002|11367994|FG000|COMPLETED|Overall Study||0
10237140|NCT00769002|11367995|FG001|COMPLETED|Overall Study||0
10237141|NCT00769002|11367994|FG000|NOT COMPLETED|Overall Study||9
10237142|NCT00769002|11367995|FG001|NOT COMPLETED|Overall Study||9
10237143|NCT00766636|11368002|FG000|STARTED|Overall Study||3
9832396|NCT00772967|10943207|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0
9832397|NCT00772967|10943208|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0
9832398|NCT00772967|10943209|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0
9832399|NCT00772967|10943204|FG000|STARTED|Crossover Treatment 2||3
9832400|NCT00772967|10943205|FG001|STARTED|Crossover Treatment 2||4
10237144|NCT00766636|11368003|FG001|STARTED|Overall Study||2
10237145|NCT00766636|11368002|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
10237146|NCT00766636|11368003|FG001|COMPLETED|Overall Study||0
10237147|NCT00766636|11368002|FG000|NOT COMPLETED|Overall Study||3
10237148|NCT00766636|11368003|FG001|NOT COMPLETED|Overall Study||2
10237149|NCT00768248|11368011|FG000|STARTED|Overall Study||1
10237150|NCT00768248|11368012|FG001|STARTED|Overall Study||1
10237151|NCT00768248|11368011|FG000|COMPLETED|Overall Study||0
10237152|NCT00768248|11368012|FG001|COMPLETED|Overall Study||0
9827202|NCT00749463|10937941|FG000|STARTED|Overall Study||86
9827203|NCT00749463|10937942|FG001|STARTED|Overall Study||64
9827204|NCT00749463|10937943|FG002|STARTED|Overall Study||150
9827205|NCT00749463|10937941|FG000|COMPLETED|Overall Study||85
9827206|NCT00749463|10937942|FG001|COMPLETED|Overall Study||60
9827207|NCT00749463|10937943|FG002|COMPLETED|Overall Study||149
9827208|NCT00749463|10937941|FG000|NOT COMPLETED|Overall Study||1
9827209|NCT00749463|10937942|FG001|NOT COMPLETED|Overall Study||4
9827210|NCT00749463|10937943|FG002|NOT COMPLETED|Overall Study||1
9827211|NCT00749515|10937953|FG000|STARTED|Overall Study||10
9827212|NCT00749515|10937954|FG001|STARTED|Overall Study||5
9827213|NCT00749515|10937953|FG000|COMPLETED|Overall Study||10
9827214|NCT00749515|10937954|FG001|COMPLETED|Overall Study||5
9827215|NCT00749515|10937953|FG000|NOT COMPLETED|Overall Study||0
9827216|NCT00749515|10937954|FG001|NOT COMPLETED|Overall Study||0
9827217|NCT00749580|10937962|FG000|STARTED|Overall Study|September 2008|21
9827218|NCT00749580|10937963|FG001|STARTED|Overall Study||25
9827219|NCT00749580|10937962|FG000|COMPLETED|Overall Study|December 2010|17
9827220|NCT00749580|10937963|FG001|COMPLETED|Overall Study||16
9827221|NCT00749580|10937962|FG000|NOT COMPLETED|Overall Study||4
9827222|NCT00749580|10937963|FG001|NOT COMPLETED|Overall Study||9
9827223|NCT00749606|10937971|FG000|STARTED|Year 1||129
9827224|NCT00749606|10937972|FG001|STARTED|Year 1||128
9827225|NCT00749606|10937971|FG000|COMPLETED|Year 1||74
9827226|NCT00749606|10937972|FG001|COMPLETED|Year 1||80
9827227|NCT00749606|10937971|FG000|NOT COMPLETED|Year 1||55
9827228|NCT00749606|10937972|FG001|NOT COMPLETED|Year 1||48
9827229|NCT00749606|10937971|FG000|STARTED|Year 2||74
9827230|NCT00749606|10937972|FG001|STARTED|Year 2||80
9827231|NCT00749606|10937971|FG000|COMPLETED|Year 2||63
9827232|NCT00749606|10937972|FG001|COMPLETED|Year 2||72
9827233|NCT00749606|10937971|FG000|NOT COMPLETED|Year 2||11
9827234|NCT00749606|10937972|FG001|NOT COMPLETED|Year 2||8
9827235|NCT00749606|10937971|FG000|STARTED|Year 3 (Observation)||63
9827236|NCT00749606|10937972|FG001|STARTED|Year 3 (Observation)||72
9827237|NCT00749606|10937971|FG000|COMPLETED|Year 3 (Observation)||63
9827238|NCT00749606|10937972|FG001|COMPLETED|Year 3 (Observation)||69
9827239|NCT00749606|10937971|FG000|NOT COMPLETED|Year 3 (Observation)||0
9827240|NCT00749606|10937972|FG001|NOT COMPLETED|Year 3 (Observation)||3
9827241|NCT00749671|10937982|FG000|STARTED|Overall Study||11
9827242|NCT00749671|10937983|FG001|STARTED|Overall Study||9
9827243|NCT00749671|10937982|FG000|COMPLETED|Overall Study||11
9827244|NCT00749671|10937983|FG001|COMPLETED|Overall Study||9
9827245|NCT00749671|10937982|FG000|NOT COMPLETED|Overall Study||0
9827246|NCT00749671|10937983|FG001|NOT COMPLETED|Overall Study||0
10237153|NCT00768248|11368011|FG000|NOT COMPLETED|Overall Study||1
10237154|NCT00768248|11368012|FG001|NOT COMPLETED|Overall Study||1
10237155|NCT00765765|11368018|FG000|STARTED|Overall Study||6
10237156|NCT00765765|11368018|FG000|COMPLETED|Overall Study||6
10237157|NCT00765765|11368018|FG000|NOT COMPLETED|Overall Study||0
10237158|NCT00764699|11368022|FG000|STARTED|Overall Study||3
10237159|NCT00764699|11368022|FG000|COMPLETED|Overall Study||0
10237160|NCT00764699|11368022|FG000|NOT COMPLETED|Overall Study||3
10237161|NCT00759577|11368026|FG000|STARTED|Overall Study||36
10237162|NCT00759577|11368026|FG000|COMPLETED|Overall Study||36
10237163|NCT00759577|11368026|FG000|NOT COMPLETED|Overall Study||0
10237164|NCT00763009|11368030|FG000|STARTED|Overall Study||8
10237165|NCT00763009|11368030|FG000|COMPLETED|Overall Study||7
10237166|NCT00763009|11368030|FG000|NOT COMPLETED|Overall Study||1
10237167|NCT00761176|11368037|FG000|STARTED|Overall Study||4
10237168|NCT00761176|11368038|FG001|STARTED|Overall Study||4
10237169|NCT00761176|11368037|FG000|COMPLETED|Overall Study||2
10237170|NCT00761176|11368038|FG001|COMPLETED|Overall Study||3
10237171|NCT00761176|11368037|FG000|NOT COMPLETED|Overall Study||2
10237172|NCT00761176|11368038|FG001|NOT COMPLETED|Overall Study||1
10237173|NCT00749476|11368044|FG000|STARTED|Overall Study||1
10237174|NCT00749476|11368044|FG000|COMPLETED|Overall Study||1
10237175|NCT00749476|11368044|FG000|NOT COMPLETED|Overall Study||0
10237176|NCT00760461|11368048|FG000|STARTED|Overall Study||44
10237177|NCT00760461|11368048|FG000|COMPLETED|Overall Study||0
10237178|NCT00760461|11368048|FG000|NOT COMPLETED|Overall Study||44
10237179|NCT00749658|11368054|FG000|STARTED|Overall Study||60
10237180|NCT00749658|11368055|FG001|STARTED|Overall Study||61
10237181|NCT00749658|11368054|FG000|COMPLETED|Overall Study||60
10237182|NCT00749658|11368055|FG001|COMPLETED|Overall Study||61
9827247|NCT00749684|10937991|FG000|STARTED|Overall Study||138
9827248|NCT00749684|10937991|FG000|COMPLETED|Overall Study||56
9827249|NCT00749684|10937991|FG000|NOT COMPLETED|Overall Study||82
9827250|NCT00749749|10937997|FG000|STARTED|Overall Study||14
10237183|NCT00749658|11368054|FG000|NOT COMPLETED|Overall Study||0
10237184|NCT00749658|11368055|FG001|NOT COMPLETED|Overall Study||0
10237185|NCT00754793|11368063|FG000|STARTED|Overall Study||1
10237186|NCT00754793|11368064|FG001|STARTED|Overall Study||2
10237187|NCT00754793|11368063|FG000|COMPLETED|Overall Study||1
10237188|NCT00754793|11368064|FG001|COMPLETED|Overall Study||1
10237189|NCT00754793|11368063|FG000|NOT COMPLETED|Overall Study||0
10237190|NCT00754793|11368064|FG001|NOT COMPLETED|Overall Study||1
9827251|NCT00749749|10937998|FG001|STARTED|Overall Study||13
9827252|NCT00749749|10937997|FG000|COMPLETED|Overall Study||14
9827253|NCT00749749|10937998|FG001|COMPLETED|Overall Study||13
9827254|NCT00749749|10937997|FG000|NOT COMPLETED|Overall Study||0
9827255|NCT00749749|10937998|FG001|NOT COMPLETED|Overall Study||0
10237191|NCT00754052|11368072|FG000|STARTED|Overall Study||5
10237192|NCT00754052|11368073|FG001|STARTED|Overall Study||3
9827256|NCT00749775|10938004|FG000|STARTED|Overall Study||3317
9827257|NCT00749775|10938004|FG000|COMPLETED|Overall Study||3210
9827258|NCT00749775|10938004|FG000|NOT COMPLETED|Overall Study||107
9827259|NCT00749879|10938018|FG000|STARTED|Overall Study||12
9827260|NCT00749879|10938018|FG000|COMPLETED|Overall Study||12
9827261|NCT00749879|10938018|FG000|NOT COMPLETED|Overall Study||0
9827262|NCT00749892|10938030|FG000|STARTED|Overall Study||34
9827263|NCT00749892|10938030|FG000|COMPLETED|Overall Study||31
9827264|NCT00749892|10938030|FG000|NOT COMPLETED|Overall Study||3
9827265|NCT00749931|10938036|FG000|STARTED|Overall Study||298
9827266|NCT00749931|10938037|FG001|STARTED|Overall Study||298
9827267|NCT00749931|10938038|FG002|STARTED|Overall Study||68
9827268|NCT00749931|10938036|FG000|COMPLETED|Overall Study||298
9827269|NCT00749931|10938037|FG001|COMPLETED|Overall Study||298
9827270|NCT00749931|10938038|FG002|COMPLETED|Overall Study||68
9827271|NCT00749931|10938036|FG000|NOT COMPLETED|Overall Study||0
9827272|NCT00749931|10938037|FG001|NOT COMPLETED|Overall Study||0
9827273|NCT00749931|10938038|FG002|NOT COMPLETED|Overall Study||0
9827274|NCT00749944|10938047|FG000|STARTED|Overall Study||55
9827275|NCT00749944|10938048|FG001|STARTED|Overall Study||55
9827276|NCT00749944|10938047|FG000|COMPLETED|Overall Study||50
9827277|NCT00749944|10938048|FG001|COMPLETED|Overall Study||54
9827278|NCT00749944|10938047|FG000|NOT COMPLETED|Overall Study||5
9827279|NCT00749944|10938048|FG001|NOT COMPLETED|Overall Study||1
9827280|NCT00749957|10938056|FG000|STARTED|Overall Study||6
9827281|NCT00749957|10938057|FG001|STARTED|Overall Study||6
9827282|NCT00749957|10938056|FG000|COMPLETED|Overall Study||6
9827283|NCT00749957|10938057|FG001|COMPLETED|Overall Study||6
9827284|NCT00749957|10938056|FG000|NOT COMPLETED|Overall Study||0
9827285|NCT00749957|10938057|FG001|NOT COMPLETED|Overall Study||0
9827286|NCT00749996|10938067|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
9827287|NCT00749996|10938068|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
9827288|NCT00749996|10938067|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
9827289|NCT00749996|10938068|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
9827290|NCT00749996|10938067|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
10237193|NCT00754052|11368072|FG000|COMPLETED|Overall Study||0
10237194|NCT00754052|11368073|FG001|COMPLETED|Overall Study||0
10237195|NCT00754052|11368072|FG000|NOT COMPLETED|Overall Study||5
10237196|NCT00754052|11368073|FG001|NOT COMPLETED|Overall Study||3
10237197|NCT00750555|11368079|FG000|STARTED|Overall Study||0
10237198|NCT00750555|11368079|FG000|COMPLETED|Overall Study||0
10237199|NCT00750555|11368079|FG000|NOT COMPLETED|Overall Study||0
10237200|NCT00754767|11368086|FG000|STARTED|Overall Study||2
10237201|NCT00754767|11368087|FG001|STARTED|Overall Study||0
10237202|NCT00754767|11368086|FG000|COMPLETED|Overall Study||2
10237203|NCT00754767|11368087|FG001|COMPLETED|Overall Study||0
10237204|NCT00754767|11368086|FG000|NOT COMPLETED|Overall Study||0
10237205|NCT00754767|11368087|FG001|NOT COMPLETED|Overall Study||0
10237206|NCT00750204|11368095|FG000|STARTED|Overall Study||1
10237207|NCT00750204|11368096|FG001|STARTED|Overall Study||1
10237208|NCT00750204|11368095|FG000|COMPLETED|Overall Study||0
10237209|NCT00750204|11368096|FG001|COMPLETED|Overall Study||0
10237210|NCT00750204|11368095|FG000|NOT COMPLETED|Overall Study||1
10237211|NCT00750204|11368096|FG001|NOT COMPLETED|Overall Study||1
10237212|NCT00748579|11368104|FG000|STARTED|Overall Study||2
10237213|NCT00748579|11368105|FG001|STARTED|Overall Study||0
10237214|NCT00748579|11368104|FG000|COMPLETED|Overall Study||2
10237215|NCT00748579|11368105|FG001|COMPLETED|Overall Study||0
10237216|NCT00748579|11368104|FG000|NOT COMPLETED|Overall Study||0
10237217|NCT00748579|11368105|FG001|NOT COMPLETED|Overall Study||0
10237218|NCT00748085|11368111|FG000|STARTED|Overall Study||5
10237219|NCT00748085|11368111|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
10237220|NCT00748085|11368111|FG000|NOT COMPLETED|Overall Study||0
10237221|NCT00752986|11368118|FG000|STARTED|Overall Study||16
10237222|NCT00752986|11368119|FG001|STARTED|Overall Study||12
10237223|NCT00752986|11368120|FG002|STARTED|Overall Study||11
10237224|NCT00752986|11368118|FG000|COMPLETED|Overall Study||11
10237225|NCT00752986|11368119|FG001|COMPLETED|Overall Study||11
10237226|NCT00752986|11368120|FG002|COMPLETED|Overall Study||9
10237227|NCT00752986|11368118|FG000|NOT COMPLETED|Overall Study||5
10237228|NCT00752986|11368119|FG001|NOT COMPLETED|Overall Study||1
10237229|NCT00752986|11368120|FG002|NOT COMPLETED|Overall Study||2
10237230|NCT00751335|11368130|FG000|STARTED|Overall Study||0
10237231|NCT00751335|11368131|FG001|STARTED|Overall Study||0
10237232|NCT00751335|11368130|FG000|COMPLETED|Overall Study||0
9827291|NCT00749996|10938068|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
9827292|NCT00749996|10938067|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
9827293|NCT00749996|10938068|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
9827294|NCT00749996|10938067|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
10237233|NCT00751335|11368131|FG001|COMPLETED|Overall Study||0
10237234|NCT00751335|11368130|FG000|NOT COMPLETED|Overall Study||0
10237235|NCT00751335|11368131|FG001|NOT COMPLETED|Overall Study||0
10237236|NCT00746239|11368137|FG000|STARTED|Overall Study||11
10237237|NCT00746239|11368137|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
10237238|NCT00746239|11368137|FG000|NOT COMPLETED|Overall Study||6
10237239|NCT00754013|11368143|FG000|STARTED|Overall Study||4
10237240|NCT00754013|11368144|FG001|STARTED|Overall Study||5
9827295|NCT00749996|10938068|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
9827296|NCT00749996|10938067|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
9827297|NCT00749996|10938068|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
9827298|NCT00749996|10938067|FG000|COMPLETED|Overall Study||57
9827299|NCT00749996|10938068|FG001|COMPLETED|Overall Study||58
9827300|NCT00749996|10938067|FG000|NOT COMPLETED|Overall Study||18
9827301|NCT00749996|10938068|FG001|NOT COMPLETED|Overall Study||13
9827302|NCT00750061|10938076|FG000|STARTED|Overall Study||20
9827303|NCT00750061|10938077|FG001|STARTED|Overall Study||20
9827304|NCT00750061|10938076|FG000|COMPLETED|Overall Study||18
9827305|NCT00750061|10938077|FG001|COMPLETED|Overall Study||18
9827306|NCT00750061|10938076|FG000|NOT COMPLETED|Overall Study||2
9827307|NCT00750061|10938077|FG001|NOT COMPLETED|Overall Study||2
9827308|NCT00750139|10938087|FG000|STARTED|Overall Study||234
9827309|NCT00750139|10938088|FG001|STARTED|Overall Study||118
9827310|NCT00750139|10938089|FG002|STARTED|Overall Study||236
9827311|NCT00750139|10938090|FG003|STARTED|Overall Study||119
9827312|NCT00750139|10938087|FG000|COMPLETED|Overall Study||145
9827313|NCT00750139|10938088|FG001|COMPLETED|Overall Study||59
9827314|NCT00750139|10938089|FG002|COMPLETED|Overall Study||135
9827315|NCT00750139|10938090|FG003|COMPLETED|Overall Study||73
9827316|NCT00750139|10938087|FG000|NOT COMPLETED|Overall Study||89
9827317|NCT00750139|10938088|FG001|NOT COMPLETED|Overall Study||59
9827318|NCT00750139|10938089|FG002|NOT COMPLETED|Overall Study||101
9827319|NCT00750139|10938090|FG003|NOT COMPLETED|Overall Study||46
9827320|NCT00750152|10938104|FG000|STARTED|Overall Study||166
9827321|NCT00750152|10938105|FG001|STARTED|Overall Study||168
9827322|NCT00750152|10938104|FG000|COMPLETED|Overall Study||144
9827323|NCT00750152|10938105|FG001|COMPLETED|Overall Study||141
9827324|NCT00750152|10938104|FG000|NOT COMPLETED|Overall Study||22
9827325|NCT00750152|10938105|FG001|NOT COMPLETED|Overall Study||27
9827326|NCT00750165|10938111|FG000|STARTED|Overall Study||32
9827327|NCT00750165|10938111|FG000|COMPLETED|Overall Study||21
9827328|NCT00750165|10938111|FG000|NOT COMPLETED|Overall Study||11
9827329|NCT00750191|10938117|FG000|STARTED|Overall Study||27
9827330|NCT00750191|10938118|FG001|STARTED|Overall Study||30
10017444|NCT01816776|11140361|FG000|COMPLETED|Overall Study||60
10017445|NCT01816776|11140362|FG001|COMPLETED|Overall Study||70
10237241|NCT00754013|11368143|FG000|COMPLETED|Overall Study||0
10237242|NCT00754013|11368144|FG001|COMPLETED|Overall Study||0
10237243|NCT00754013|11368143|FG000|NOT COMPLETED|Overall Study||4
10237244|NCT00754013|11368144|FG001|NOT COMPLETED|Overall Study||5
10237245|NCT00735553|11368153|FG000|STARTED|Overall Study||77
10237246|NCT00735553|11368153|FG000|COMPLETED|Overall Study||0
10237247|NCT00735553|11368153|FG000|NOT COMPLETED|Overall Study||77
10237248|NCT00751933|11368161|FG000|STARTED|Overall Study||0
10237249|NCT00751933|11368162|FG001|STARTED|Overall Study||1
10237250|NCT00751933|11368163|FG002|STARTED|Overall Study||1
10237251|NCT00751933|11368164|FG003|STARTED|Overall Study||1
10237252|NCT00751933|11368161|FG000|COMPLETED|Overall Study||0
10237253|NCT00751933|11368162|FG001|COMPLETED|Overall Study||0
10237254|NCT00751933|11368163|FG002|COMPLETED|Overall Study||0
10237255|NCT00751933|11368164|FG003|COMPLETED|Overall Study||0
10237256|NCT00751933|11368161|FG000|NOT COMPLETED|Overall Study||0
10237257|NCT00751933|11368162|FG001|NOT COMPLETED|Overall Study||1
10237258|NCT00751933|11368163|FG002|NOT COMPLETED|Overall Study||1
10237259|NCT00751933|11368164|FG003|NOT COMPLETED|Overall Study||1
10239767|NCT02126878|11371474|FG000|NOT COMPLETED|Overall Study||0
10239768|NCT02126878|11371475|FG001|NOT COMPLETED|Overall Study||0
10239769|NCT02126878|11371476|FG002|NOT COMPLETED|Overall Study||0
10239770|NCT02221817|11371486|FG000|STARTED|Overall Study||0
10239771|NCT02221817|11371487|FG001|STARTED|Overall Study||0
10239772|NCT02221817|11371486|FG000|COMPLETED|Overall Study||0
10239773|NCT02221817|11371487|FG001|COMPLETED|Overall Study||0
10239774|NCT02221817|11371486|FG000|NOT COMPLETED|Overall Study||0
10239775|NCT02221817|11371487|FG001|NOT COMPLETED|Overall Study||0
10239776|NCT02595996|11371493|FG000|STARTED|Overall Study||1
10239777|NCT02595996|11371493|FG000|COMPLETED|Overall Study||1
10239778|NCT02595996|11371493|FG000|NOT COMPLETED|Overall Study||0
10239779|NCT03879044|11371497|FG000|STARTED|Overall Study||30
10239780|NCT03879044|11371497|FG000|COMPLETED|Overall Study||26
10239781|NCT03879044|11371497|FG000|NOT COMPLETED|Overall Study||4
9827331|NCT00750191|10938117|FG000|COMPLETED|Overall Study||22
9827332|NCT00750191|10938118|FG001|COMPLETED|Overall Study||20
9827333|NCT00750191|10938117|FG000|NOT COMPLETED|Overall Study||5
9827334|NCT00750191|10938118|FG001|NOT COMPLETED|Overall Study||10
9827335|NCT00750282|10938128|FG000|STARTED|Overall Study||69
9827336|NCT00750282|10938129|FG001|STARTED|Overall Study||82
9827337|NCT00750282|10938130|FG002|STARTED|Overall Study||126
9827338|NCT00750282|10938131|FG003|STARTED|Overall Study||148
10239782|NCT03198156|11371503|FG000|STARTED|Overall Study||19
10239783|NCT03198156|11371504|FG001|STARTED|Overall Study||19
10239784|NCT03198156|11371503|FG000|COMPLETED|Overall Study||19
10239785|NCT03198156|11371504|FG001|COMPLETED|Overall Study||19
10239786|NCT03198156|11371503|FG000|NOT COMPLETED|Overall Study||0
10239787|NCT03198156|11371504|FG001|NOT COMPLETED|Overall Study||0
10239788|NCT02009384|11371510|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2
10239789|NCT02009384|11371510|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0
9827339|NCT00750282|10938128|FG000|COMPLETED|Overall Study||69
9827340|NCT00750282|10938129|FG001|COMPLETED|Overall Study||81
9827341|NCT00750282|10938130|FG002|COMPLETED|Overall Study||125
9827342|NCT00750282|10938131|FG003|COMPLETED|Overall Study||147
9827343|NCT00750282|10938128|FG000|NOT COMPLETED|Overall Study||0
9827344|NCT00750282|10938129|FG001|NOT COMPLETED|Overall Study||1
9827345|NCT00750282|10938130|FG002|NOT COMPLETED|Overall Study||1
9827346|NCT00750282|10938131|FG003|NOT COMPLETED|Overall Study||1
9827347|NCT00750308|10938155|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2
9827348|NCT00750308|10938156|FG001|STARTED|First Treatment||3
9827349|NCT00750308|10938157|FG002|STARTED|First Treatment||2
9827350|NCT00750308|10938158|FG003|STARTED|First Treatment||2
9827351|NCT00750308|10938159|FG004|STARTED|First Treatment||2
9827352|NCT00750308|10938160|FG005|STARTED|First Treatment||3
9827353|NCT00750308|10938161|FG006|STARTED|First Treatment||2
9827354|NCT00750308|10938162|FG007|STARTED|First Treatment||3
9827355|NCT00750308|10938163|FG008|STARTED|First Treatment||2
9827356|NCT00750308|10938164|FG009|STARTED|First Treatment||2
9827357|NCT00750308|10938165|FG010|STARTED|First Treatment||2
9827358|NCT00750308|10938166|FG011|STARTED|First Treatment||2
10237260|NCT00747916|11368168|FG000|STARTED|Overall Study||3
10237261|NCT00747916|11368168|FG000|COMPLETED|Overall Study||3
10237262|NCT00747916|11368168|FG000|NOT COMPLETED|Overall Study||0
10237263|NCT00745030|11368174|FG000|STARTED|Overall Study||1
10237264|NCT00745030|11368175|FG001|STARTED|Overall Study||2
10237265|NCT00745030|11368174|FG000|COMPLETED|Overall Study||1
10237266|NCT00745030|11368175|FG001|COMPLETED|Overall Study||2
10237267|NCT00745030|11368174|FG000|NOT COMPLETED|Overall Study||0
10237268|NCT00745030|11368175|FG001|NOT COMPLETED|Overall Study||0
10237269|NCT00747461|11368181|FG000|STARTED|Overall Study||5
10237270|NCT00747461|11368181|FG000|COMPLETED|Overall Study||0
10237271|NCT00747461|11368181|FG000|NOT COMPLETED|Overall Study||5
10237272|NCT00746018|11368186|FG000|STARTED|Overall Study||39
10237273|NCT00746018|11368186|FG000|COMPLETED|Overall Study||39
10237274|NCT00746018|11368186|FG000|NOT COMPLETED|Overall Study||0
10237275|NCT00746603|11368190|FG000|STARTED|Overall Study||3
10237276|NCT00746603|11368190|FG000|COMPLETED|Overall Study||3
10237277|NCT00746603|11368190|FG000|NOT COMPLETED|Overall Study||0
10237278|NCT00736385|11368196|FG000|STARTED|Overall Study||4
10237279|NCT00736385|11368197|FG001|STARTED|Overall Study||5
10237280|NCT00736385|11368196|FG000|COMPLETED|Overall Study||2
10237281|NCT00736385|11368197|FG001|COMPLETED|Overall Study||2
10237282|NCT00736385|11368196|FG000|NOT COMPLETED|Overall Study||2
10237283|NCT00736385|11368197|FG001|NOT COMPLETED|Overall Study||3
10237284|NCT00738972|11368207|FG000|STARTED|Overall Study||3
10237285|NCT00738972|11368208|FG001|STARTED|Overall Study||3
10237286|NCT00738972|11368209|FG002|STARTED|Overall Study||3
10237287|NCT00738972|11368210|FG003|STARTED|Overall Study||3
10237288|NCT00738972|11368207|FG000|COMPLETED|Overall Study||3
10237289|NCT00738972|11368208|FG001|COMPLETED|Overall Study||3
10237290|NCT00738972|11368209|FG002|COMPLETED|Overall Study||3
10237291|NCT00738972|11368210|FG003|COMPLETED|Overall Study||2
10237292|NCT00738972|11368207|FG000|NOT COMPLETED|Overall Study||0
10237293|NCT00738972|11368208|FG001|NOT COMPLETED|Overall Study||0
10237294|NCT00738972|11368209|FG002|NOT COMPLETED|Overall Study||0
10237295|NCT00738972|11368210|FG003|NOT COMPLETED|Overall Study||1
10237296|NCT00739063|11368220|FG000|STARTED|Overall Study||11
10237297|NCT00739063|11368220|FG000|COMPLETED|Overall Study||3
10237298|NCT00739063|11368220|FG000|NOT COMPLETED|Overall Study||8
10237299|NCT00740597|11368224|FG000|STARTED|Overall Study||1
10237300|NCT00740597|11368224|FG000|COMPLETED|Overall Study||0
10237301|NCT00740597|11368224|FG000|NOT COMPLETED|Overall Study||1
10237302|NCT00737594|11368231|FG000|STARTED|Overall Study||0
10237303|NCT00737594|11368232|FG001|STARTED|Overall Study||0
10237304|NCT00737594|11368233|FG002|STARTED|Overall Study||0
10237305|NCT00737594|11368231|FG000|COMPLETED|Overall Study||0
10237306|NCT00737594|11368232|FG001|COMPLETED|Overall Study||0
10237307|NCT00737594|11368233|FG002|COMPLETED|Overall Study||0
10237308|NCT00737594|11368231|FG000|NOT COMPLETED|Overall Study||0
10237309|NCT00737594|11368232|FG001|NOT COMPLETED|Overall Study||0
10237310|NCT00737594|11368233|FG002|NOT COMPLETED|Overall Study||0
10237311|NCT00737282|11368243|FG000|STARTED|Overall Study||175
10237312|NCT00737282|11368243|FG000|COMPLETED|Overall Study||0
10237313|NCT00737282|11368243|FG000|NOT COMPLETED|Overall Study||175
10237314|NCT00739882|11368251|FG000|STARTED|Double-blind Period||51
10237315|NCT00739882|11368252|FG001|STARTED|Double-blind Period||25
10237316|NCT00739882|11368251|FG000|COMPLETED|Double-blind Period||32
9827359|NCT00750308|10938155|FG000|COMPLETED|First Treatment||2
9827360|NCT00750308|10938156|FG001|COMPLETED|First Treatment||2
9827361|NCT00750308|10938157|FG002|COMPLETED|First Treatment||2
9827362|NCT00750308|10938158|FG003|COMPLETED|First Treatment||1
10237317|NCT00739882|11368252|FG001|COMPLETED|Double-blind Period||14
9827363|NCT00750308|10938159|FG004|COMPLETED|First Treatment||2
9827364|NCT00750308|10938160|FG005|COMPLETED|First Treatment||3
9827365|NCT00750308|10938161|FG006|COMPLETED|First Treatment||2
9827366|NCT00750308|10938162|FG007|COMPLETED|First Treatment||2
10237318|NCT00739882|11368251|FG000|NOT COMPLETED|Double-blind Period||19
10237319|NCT00739882|11368252|FG001|NOT COMPLETED|Double-blind Period||11
10237320|NCT00739882|11368251|FG000|STARTED|Open-label Period||17
10237321|NCT00739882|11368252|FG001|STARTED|Open-label Period||14
10237322|NCT00739882|11368251|FG000|COMPLETED|Open-label Period||7
10237323|NCT00739882|11368252|FG001|COMPLETED|Open-label Period||9
10237324|NCT00739882|11368251|FG000|NOT COMPLETED|Open-label Period||10
9827367|NCT00750308|10938163|FG008|COMPLETED|First Treatment||2
9827368|NCT00750308|10938164|FG009|COMPLETED|First Treatment||2
9827369|NCT00750308|10938165|FG010|COMPLETED|First Treatment||1
9827370|NCT00750308|10938166|FG011|COMPLETED|First Treatment||1
9827371|NCT00750308|10938155|FG000|NOT COMPLETED|First Treatment||0
9827372|NCT00750308|10938156|FG001|NOT COMPLETED|First Treatment||1
9827373|NCT00750308|10938157|FG002|NOT COMPLETED|First Treatment||0
9827374|NCT00750308|10938158|FG003|NOT COMPLETED|First Treatment||1
9827375|NCT00750308|10938159|FG004|NOT COMPLETED|First Treatment||0
9827376|NCT00750308|10938160|FG005|NOT COMPLETED|First Treatment||0
9827377|NCT00750308|10938161|FG006|NOT COMPLETED|First Treatment||0
9827378|NCT00750308|10938162|FG007|NOT COMPLETED|First Treatment||1
9827379|NCT00750308|10938163|FG008|NOT COMPLETED|First Treatment||0
9827380|NCT00750308|10938164|FG009|NOT COMPLETED|First Treatment||0
9827381|NCT00750308|10938165|FG010|NOT COMPLETED|First Treatment||1
9827382|NCT00750308|10938166|FG011|NOT COMPLETED|First Treatment||1
9827383|NCT00750308|10938155|FG000|STARTED|Washout||2
9827384|NCT00750308|10938156|FG001|STARTED|Washout||2
9827385|NCT00750308|10938157|FG002|STARTED|Washout||2
9827386|NCT00750308|10938158|FG003|STARTED|Washout||1
9827387|NCT00750308|10938159|FG004|STARTED|Washout||2
9827388|NCT00750308|10938160|FG005|STARTED|Washout||3
9827389|NCT00750308|10938161|FG006|STARTED|Washout||2
9827390|NCT00750308|10938162|FG007|STARTED|Washout||2
9827391|NCT00750308|10938163|FG008|STARTED|Washout||2
9827392|NCT00750308|10938164|FG009|STARTED|Washout||2
9827393|NCT00750308|10938165|FG010|STARTED|Washout||1
9827394|NCT00750308|10938166|FG011|STARTED|Washout||1
9827395|NCT00750308|10938155|FG000|COMPLETED|Washout||2
9827396|NCT00750308|10938156|FG001|COMPLETED|Washout||2
9827397|NCT00750308|10938157|FG002|COMPLETED|Washout||2
9827398|NCT00750308|10938158|FG003|COMPLETED|Washout||1
9827399|NCT00750308|10938159|FG004|COMPLETED|Washout||2
9827400|NCT00750308|10938160|FG005|COMPLETED|Washout||3
10017446|NCT01816776|11140361|FG000|NOT COMPLETED|Overall Study||13
10017447|NCT01816776|11140362|FG001|NOT COMPLETED|Overall Study||8
10017448|NCT01816893|11140370|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10017449|NCT01816893|11140371|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10017450|NCT01816893|11140370|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10237325|NCT00739882|11368252|FG001|NOT COMPLETED|Open-label Period||5
10237326|NCT00739024|11368262|FG000|STARTED|Overall Study||7
10237327|NCT00739024|11368263|FG001|STARTED|Overall Study||6
10237328|NCT00739024|11368262|FG000|COMPLETED|Overall Study||7
10237329|NCT00739024|11368263|FG001|COMPLETED|Overall Study||6
10237330|NCT00739024|11368262|FG000|NOT COMPLETED|Overall Study||0
10237331|NCT00739024|11368263|FG001|NOT COMPLETED|Overall Study||0
10237332|NCT00731770|11368271|FG000|STARTED|Overall Study||5
10237333|NCT00731770|11368272|FG001|STARTED|Overall Study||5
10237334|NCT00731770|11368271|FG000|COMPLETED|Overall Study||5
10237335|NCT00731770|11368272|FG001|COMPLETED|Overall Study||5
10237336|NCT00731770|11368271|FG000|NOT COMPLETED|Overall Study||0
10237337|NCT00731770|11368272|FG001|NOT COMPLETED|Overall Study||0
10237338|NCT00735254|11368284|FG000|STARTED|Overall Study||1
10237339|NCT00735254|11368285|FG001|STARTED|Overall Study||1
10237340|NCT00735254|11368286|FG002|STARTED|Overall Study||1
10237341|NCT00735254|11368287|FG003|STARTED|Overall Study||0
10237342|NCT00735254|11368284|FG000|COMPLETED|Overall Study||0
10237343|NCT00735254|11368285|FG001|COMPLETED|Overall Study||0
10237344|NCT00735254|11368286|FG002|COMPLETED|Overall Study||0
10237345|NCT00735254|11368287|FG003|COMPLETED|Overall Study||0
10237346|NCT00735254|11368284|FG000|NOT COMPLETED|Overall Study||1
10237347|NCT00735254|11368285|FG001|NOT COMPLETED|Overall Study||1
10237348|NCT00735254|11368286|FG002|NOT COMPLETED|Overall Study||1
10237349|NCT00735254|11368287|FG003|NOT COMPLETED|Overall Study||0
10237350|NCT00729365|11368300|FG000|STARTED|Overall Study||33
10237351|NCT00729365|11368301|FG001|STARTED|Overall Study||6
10237352|NCT00729365|11368302|FG002|STARTED|Overall Study||7
10237353|NCT00729365|11368300|FG000|COMPLETED|Overall Study|Study terminated|0
10237354|NCT00729365|11368301|FG001|COMPLETED|Overall Study|Study Terminated|0
10237355|NCT00729365|11368302|FG002|COMPLETED|Overall Study|Study terminated|0
10237356|NCT00729365|11368300|FG000|NOT COMPLETED|Overall Study||33
10237357|NCT00729365|11368301|FG001|NOT COMPLETED|Overall Study||6
10237358|NCT00729365|11368302|FG002|NOT COMPLETED|Overall Study||7
10237359|NCT00732680|11368312|FG000|STARTED|Overall Study||9
10237360|NCT00732680|11368312|FG000|COMPLETED|Overall Study||9
10237361|NCT00732680|11368312|FG000|NOT COMPLETED|Overall Study||0
9827401|NCT00750308|10938161|FG006|COMPLETED|Washout||2
10237362|NCT00726180|11368316|FG000|STARTED|Overall Study||1
10237363|NCT00726180|11368316|FG000|COMPLETED|Overall Study||1
10237364|NCT00726180|11368316|FG000|NOT COMPLETED|Overall Study||0
10237365|NCT00724282|11368320|FG000|STARTED|Overall Study||20
9827402|NCT00750308|10938162|FG007|COMPLETED|Washout||2
9827403|NCT00750308|10938163|FG008|COMPLETED|Washout||2
10237366|NCT00724282|11368320|FG000|COMPLETED|Overall Study||16
9827404|NCT00750308|10938164|FG009|COMPLETED|Washout||2
10237367|NCT00724282|11368320|FG000|NOT COMPLETED|Overall Study||4
10237368|NCT00730886|11368326|FG000|STARTED|Overall Study||2
10237369|NCT00730886|11368327|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
9827405|NCT00750308|10938165|FG010|COMPLETED|Washout||1
9827406|NCT00750308|10938166|FG011|COMPLETED|Washout||1
9827407|NCT00750308|10938155|FG000|NOT COMPLETED|Washout||0
9827408|NCT00750308|10938156|FG001|NOT COMPLETED|Washout||0
9827409|NCT00750308|10938157|FG002|NOT COMPLETED|Washout||0
9827410|NCT00750308|10938158|FG003|NOT COMPLETED|Washout||0
9827411|NCT00750308|10938159|FG004|NOT COMPLETED|Washout||0
9827412|NCT00750308|10938160|FG005|NOT COMPLETED|Washout||0
9827413|NCT00750308|10938161|FG006|NOT COMPLETED|Washout||0
9827414|NCT00750308|10938162|FG007|NOT COMPLETED|Washout||0
9827415|NCT00750308|10938163|FG008|NOT COMPLETED|Washout||0
9827416|NCT00750308|10938164|FG009|NOT COMPLETED|Washout||0
9827417|NCT00750308|10938165|FG010|NOT COMPLETED|Washout||0
9827418|NCT00750308|10938166|FG011|NOT COMPLETED|Washout||0
9827419|NCT00750308|10938155|FG000|STARTED|Second Treatment||2
9827420|NCT00750308|10938156|FG001|STARTED|Second Treatment||2
9827421|NCT00750308|10938157|FG002|STARTED|Second Treatment||2
9827422|NCT00750308|10938158|FG003|STARTED|Second Treatment||1
9827423|NCT00750308|10938159|FG004|STARTED|Second Treatment||2
9827424|NCT00750308|10938160|FG005|STARTED|Second Treatment||3
9827425|NCT00750308|10938161|FG006|STARTED|Second Treatment||2
9827426|NCT00750308|10938162|FG007|STARTED|Second Treatment||2
9827427|NCT00750308|10938163|FG008|STARTED|Second Treatment||2
9827428|NCT00750308|10938164|FG009|STARTED|Second Treatment||2
9827429|NCT00750308|10938165|FG010|STARTED|Second Treatment||1
9827430|NCT00750308|10938166|FG011|STARTED|Second Treatment||1
9827431|NCT00750308|10938155|FG000|COMPLETED|Second Treatment||2
9827432|NCT00750308|10938156|FG001|COMPLETED|Second Treatment||2
10237370|NCT00730886|11368326|FG000|COMPLETED|Overall Study||0
10237371|NCT00730886|11368327|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
10237372|NCT00730886|11368326|FG000|NOT COMPLETED|Overall Study||2
10237373|NCT00730886|11368327|FG001|NOT COMPLETED|Overall Study||0
10237374|NCT00728845|11368335|FG000|STARTED|Overall Study||8
10237375|NCT00728845|11368336|FG001|STARTED|Overall Study||0
10237376|NCT00728845|11368335|FG000|COMPLETED|Overall Study||8
10237377|NCT00728845|11368336|FG001|COMPLETED|Overall Study||0
10237378|NCT00728845|11368335|FG000|NOT COMPLETED|Overall Study||0
10237379|NCT00728845|11368336|FG001|NOT COMPLETED|Overall Study||0
10237380|NCT00726830|11368344|FG000|STARTED|Overall Study||1
10237381|NCT00726830|11368345|FG001|STARTED|Overall Study||0
10237382|NCT00726830|11368344|FG000|COMPLETED|Overall Study||1
10237383|NCT00726830|11368345|FG001|COMPLETED|Overall Study||0
10237384|NCT00726830|11368344|FG000|NOT COMPLETED|Overall Study||0
10237385|NCT00726830|11368345|FG001|NOT COMPLETED|Overall Study||0
10237386|NCT00726037|11368351|FG000|STARTED|Overall Study||7
10237387|NCT00726037|11368351|FG000|COMPLETED|Overall Study||7
10237388|NCT00726037|11368351|FG000|NOT COMPLETED|Overall Study||0
10237389|NCT00729560|11368355|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
10237390|NCT00729560|11368355|FG000|COMPLETED|Overall Study||5
10237391|NCT00729560|11368355|FG000|NOT COMPLETED|Overall Study||3
10237392|NCT00716807|11368363|FG000|STARTED|Overall Study||8
10237393|NCT00716807|11368364|FG001|STARTED|Overall Study||5
10237394|NCT00716807|11368365|FG002|STARTED|Overall Study||18
10237395|NCT00716807|11368366|FG003|STARTED|Overall Study||15
10237396|NCT00716807|11368363|FG000|COMPLETED|Overall Study||8
10237397|NCT00716807|11368364|FG001|COMPLETED|Overall Study||5
10237398|NCT00716807|11368365|FG002|COMPLETED|Overall Study||18
10237399|NCT00716807|11368366|FG003|COMPLETED|Overall Study||15
10237400|NCT00716807|11368363|FG000|NOT COMPLETED|Overall Study||0
10237401|NCT00716807|11368364|FG001|NOT COMPLETED|Overall Study||0
10237402|NCT00716807|11368365|FG002|NOT COMPLETED|Overall Study||0
10237403|NCT00716807|11368366|FG003|NOT COMPLETED|Overall Study||0
10237404|NCT00714948|11368376|FG000|STARTED|Overall Study||2
10237405|NCT00714948|11368376|FG000|COMPLETED|Overall Study||0
10237406|NCT00714948|11368376|FG000|NOT COMPLETED|Overall Study||2
10237407|NCT00720343|11368380|FG000|STARTED|Overall Study||54
10237408|NCT00720343|11368380|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
10237409|NCT00720343|11368380|FG000|NOT COMPLETED|Overall Study||6
10237410|NCT00719914|11368388|FG000|STARTED|Overall Study||10
10237411|NCT00719914|11368389|FG001|STARTED|Overall Study||7
10237412|NCT00719914|11368388|FG000|COMPLETED|Overall Study||10
10237413|NCT00719914|11368389|FG001|COMPLETED|Overall Study||7
10237414|NCT00719914|11368388|FG000|NOT COMPLETED|Overall Study||0
10237415|NCT00719914|11368389|FG001|NOT COMPLETED|Overall Study||0
10237416|NCT00718640|11368395|FG000|STARTED|Overall Study||10
10237417|NCT00718640|11368395|FG000|COMPLETED|Overall Study||3
10237418|NCT00718640|11368395|FG000|NOT COMPLETED|Overall Study||7
10237419|NCT00720083|11368401|FG000|STARTED|Overall Study||17
10237420|NCT00720083|11368402|FG001|STARTED|Overall Study||15
10237421|NCT00720083|11368401|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
10237422|NCT00720083|11368402|FG001|COMPLETED|Overall Study||13
10237423|NCT00720083|11368401|FG000|NOT COMPLETED|Overall Study||1
10237424|NCT00720083|11368402|FG001|NOT COMPLETED|Overall Study||2
9827433|NCT00750308|10938157|FG002|COMPLETED|Second Treatment||2
9827434|NCT00750308|10938158|FG003|COMPLETED|Second Treatment||1
10237425|NCT00717275|11368408|FG000|STARTED|Overall Study||3
10237426|NCT00717275|11368408|FG000|COMPLETED|Overall Study||0
10237427|NCT00717275|11368408|FG000|NOT COMPLETED|Overall Study||3
9827435|NCT00750308|10938159|FG004|COMPLETED|Second Treatment||1
9827436|NCT00750308|10938160|FG005|COMPLETED|Second Treatment||2
9827437|NCT00750308|10938161|FG006|COMPLETED|Second Treatment||2
9827438|NCT00750308|10938162|FG007|COMPLETED|Second Treatment||2
9827439|NCT00750308|10938163|FG008|COMPLETED|Second Treatment||1
9827440|NCT00750308|10938164|FG009|COMPLETED|Second Treatment||2
9827441|NCT00750308|10938165|FG010|COMPLETED|Second Treatment||1
9827442|NCT00750308|10938166|FG011|COMPLETED|Second Treatment||1
9827443|NCT00750308|10938155|FG000|NOT COMPLETED|Second Treatment||0
9827444|NCT00750308|10938156|FG001|NOT COMPLETED|Second Treatment||0
10237428|NCT00708734|11368412|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
10237429|NCT00708734|11368412|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
10237430|NCT00708734|11368412|FG000|NOT COMPLETED|Overall Study||7
10237431|NCT00711087|11368418|FG000|STARTED|Overall Study||1
10237432|NCT00711087|11368419|FG001|STARTED|Overall Study||0
10237433|NCT00711087|11368418|FG000|COMPLETED|Overall Study||0
10237434|NCT00711087|11368419|FG001|COMPLETED|Overall Study||0
10237435|NCT00711087|11368418|FG000|NOT COMPLETED|Overall Study||1
10237436|NCT00711087|11368419|FG001|NOT COMPLETED|Overall Study||0
10237437|NCT00706797|11368427|FG000|STARTED|Overall Study||70
10237438|NCT00706797|11368428|FG001|STARTED|Overall Study||71
10237439|NCT00706797|11368427|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
10237440|NCT00706797|11368428|FG001|Safety Population|Overall Study||71
10237441|NCT00706797|11368427|FG000|COMPLETED|Overall Study||1
10237442|NCT00706797|11368428|FG001|COMPLETED|Overall Study||0
10237443|NCT00706797|11368427|FG000|NOT COMPLETED|Overall Study||69
10237444|NCT00706797|11368428|FG001|NOT COMPLETED|Overall Study||71
10237445|NCT00713596|11368437|FG000|STARTED|Overall Study||9
10237446|NCT00713596|11368438|FG001|STARTED|Overall Study||8
10237447|NCT00713596|11368439|FG002|STARTED|Overall Study||8
10237448|NCT00713596|11368437|FG000|COMPLETED|Overall Study||7
10237449|NCT00713596|11368438|FG001|COMPLETED|Overall Study||5
10237450|NCT00713596|11368439|FG002|COMPLETED|Overall Study||6
10237451|NCT00713596|11368437|FG000|NOT COMPLETED|Overall Study||2
10237452|NCT00713596|11368438|FG001|NOT COMPLETED|Overall Study||3
10237453|NCT00713596|11368439|FG002|NOT COMPLETED|Overall Study||2
10237454|NCT00703885|11368447|FG000|STARTED|Overall Study||16
10237455|NCT00703885|11368447|FG000|COMPLETED|Overall Study||16
10237456|NCT00703885|11368447|FG000|NOT COMPLETED|Overall Study||0
10237457|NCT00703092|11368452|FG000|STARTED|Overall Study||2
10237458|NCT00703092|11368452|FG000|COMPLETED|Overall Study||0
10237459|NCT00703092|11368452|FG000|NOT COMPLETED|Overall Study||2
10237460|NCT00713258|11368458|FG000|STARTED|Overall Study||41
10237461|NCT00713258|11368459|FG001|STARTED|Overall Study||34
10237462|NCT00713258|11368458|FG000|COMPLETED|Overall Study||36
10237463|NCT00713258|11368459|FG001|COMPLETED|Overall Study||28
10237464|NCT00713258|11368458|FG000|NOT COMPLETED|Overall Study||5
10237465|NCT00713258|11368459|FG001|NOT COMPLETED|Overall Study||6
10237466|NCT00706329|11368465|FG000|STARTED|Overall Study||25
10237467|NCT00706329|11368465|FG000|COMPLETED|Overall Study||25
10237468|NCT00706329|11368465|FG000|NOT COMPLETED|Overall Study||0
10237469|NCT00707434|11368469|FG000|STARTED|Overall Study||6
10237470|NCT00707434|11368469|FG000|COMPLETED|Overall Study||5
10237471|NCT00707434|11368469|FG000|NOT COMPLETED|Overall Study||1
10237472|NCT00707161|11368473|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
10237473|NCT00707161|11368473|FG000|COMPLETED|Overall Study||0
10237474|NCT00707161|11368473|FG000|NOT COMPLETED|Overall Study||6
10237475|NCT00704496|11368479|FG000|STARTED|Overall Study||0
10237476|NCT00704496|11368480|FG001|STARTED|Overall Study||0
10237477|NCT00704496|11368479|FG000|COMPLETED|Overall Study||0
10237478|NCT00704496|11368480|FG001|COMPLETED|Overall Study||0
10237479|NCT00704496|11368479|FG000|NOT COMPLETED|Overall Study||0
10237480|NCT00704496|11368480|FG001|NOT COMPLETED|Overall Study||0
10237481|NCT00708916|11368486|FG000|STARTED|Overall Study||12
10237482|NCT00708916|11368486|FG000|COMPLETED|Overall Study||8
10237483|NCT00708916|11368486|FG000|NOT COMPLETED|Overall Study||4
10237484|NCT00700778|11368491|FG000|STARTED|Overall Study||2
10237485|NCT00700778|11368491|FG000|COMPLETED|Overall Study||0
10237486|NCT00700778|11368491|FG000|NOT COMPLETED|Overall Study||2
10237487|NCT00699842|11368498|FG000|STARTED|Overall Study||3
10237488|NCT00699842|11368499|FG001|STARTED|Overall Study||5
10237489|NCT00699842|11368500|FG002|STARTED|Overall Study||0
10237490|NCT00699842|11368498|FG000|COMPLETED|Overall Study||3
10237491|NCT00699842|11368499|FG001|COMPLETED|Overall Study||4
10237492|NCT00699842|11368500|FG002|COMPLETED|Overall Study||0
10237493|NCT00699842|11368498|FG000|NOT COMPLETED|Overall Study||0
10237494|NCT00699842|11368499|FG001|NOT COMPLETED|Overall Study||1
10237495|NCT00699842|11368500|FG002|NOT COMPLETED|Overall Study||0
9827445|NCT00750308|10938157|FG002|NOT COMPLETED|Second Treatment||0
9827446|NCT00750308|10938158|FG003|NOT COMPLETED|Second Treatment||0
9827447|NCT00750308|10938159|FG004|NOT COMPLETED|Second Treatment||1
9827448|NCT00750308|10938160|FG005|NOT COMPLETED|Second Treatment||1
9827449|NCT00750308|10938161|FG006|NOT COMPLETED|Second Treatment||0
9827450|NCT00750308|10938162|FG007|NOT COMPLETED|Second Treatment||0
9827451|NCT00750308|10938163|FG008|NOT COMPLETED|Second Treatment||1
9827452|NCT00750308|10938164|FG009|NOT COMPLETED|Second Treatment||0
9827453|NCT00750308|10938165|FG010|NOT COMPLETED|Second Treatment||0
9827454|NCT00750308|10938166|FG011|NOT COMPLETED|Second Treatment||0
9827455|NCT00750308|10938155|FG000|STARTED|Washout||2
10237496|NCT00702962|11368510|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
10237497|NCT00702962|11368511|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
10237498|NCT00702962|11368510|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
9827456|NCT00750308|10938156|FG001|STARTED|Washout||2
9827457|NCT00750308|10938157|FG002|STARTED|Washout||2
9827458|NCT00750308|10938158|FG003|STARTED|Washout||1
9827459|NCT00750308|10938159|FG004|STARTED|Washout||1
9827460|NCT00750308|10938160|FG005|STARTED|Washout||2
9827461|NCT00750308|10938161|FG006|STARTED|Washout||2
9827462|NCT00750308|10938162|FG007|STARTED|Washout||2
9827463|NCT00750308|10938163|FG008|STARTED|Washout||1
9827464|NCT00750308|10938164|FG009|STARTED|Washout||2
9827465|NCT00750308|10938165|FG010|STARTED|Washout||1
9827466|NCT00750308|10938166|FG011|STARTED|Washout||1
9827467|NCT00750308|10938155|FG000|COMPLETED|Washout||2
9827468|NCT00750308|10938156|FG001|COMPLETED|Washout||2
9827469|NCT00750308|10938157|FG002|COMPLETED|Washout||2
9827470|NCT00750308|10938158|FG003|COMPLETED|Washout||1
9827471|NCT00750308|10938159|FG004|COMPLETED|Washout||1
9827472|NCT00750308|10938160|FG005|COMPLETED|Washout||2
9827473|NCT00750308|10938161|FG006|COMPLETED|Washout||2
9827474|NCT00750308|10938162|FG007|COMPLETED|Washout||2
9827475|NCT00750308|10938163|FG008|COMPLETED|Washout||1
9827476|NCT00750308|10938164|FG009|COMPLETED|Washout||2
9827477|NCT00750308|10938165|FG010|COMPLETED|Washout||1
9827478|NCT00750308|10938166|FG011|COMPLETED|Washout||1
9827479|NCT00750308|10938155|FG000|NOT COMPLETED|Washout||0
9827480|NCT00750308|10938156|FG001|NOT COMPLETED|Washout||0
9827481|NCT00750308|10938157|FG002|NOT COMPLETED|Washout||0
9827482|NCT00750308|10938158|FG003|NOT COMPLETED|Washout||0
9827483|NCT00750308|10938159|FG004|NOT COMPLETED|Washout||0
9827484|NCT00750308|10938160|FG005|NOT COMPLETED|Washout||0
9827485|NCT00750308|10938161|FG006|NOT COMPLETED|Washout||0
9827486|NCT00750308|10938162|FG007|NOT COMPLETED|Washout||0
9827487|NCT00750308|10938163|FG008|NOT COMPLETED|Washout||0
9827488|NCT00750308|10938164|FG009|NOT COMPLETED|Washout||0
9827489|NCT00750308|10938165|FG010|NOT COMPLETED|Washout||0
9827490|NCT00750308|10938166|FG011|NOT COMPLETED|Washout||0
9827491|NCT00750308|10938155|FG000|STARTED|Third Treatment||2
9827492|NCT00750308|10938156|FG001|STARTED|Third Treatment||2
9827493|NCT00750308|10938157|FG002|STARTED|Third Treatment||2
9827494|NCT00750308|10938158|FG003|STARTED|Third Treatment||1
9827495|NCT00750308|10938159|FG004|STARTED|Third Treatment||1
9827496|NCT00750308|10938160|FG005|STARTED|Third Treatment||2
9827497|NCT00750308|10938161|FG006|STARTED|Third Treatment||2
9827498|NCT00750308|10938162|FG007|STARTED|Third Treatment||2
9827499|NCT00750308|10938163|FG008|STARTED|Third Treatment||1
9827500|NCT00750308|10938164|FG009|STARTED|Third Treatment||2
9827501|NCT00750308|10938165|FG010|STARTED|Third Treatment||1
9827502|NCT00750308|10938166|FG011|STARTED|Third Treatment||1
9827503|NCT00750308|10938155|FG000|COMPLETED|Third Treatment||2
9827504|NCT00750308|10938156|FG001|COMPLETED|Third Treatment||1
9827505|NCT00750308|10938157|FG002|COMPLETED|Third Treatment||2
9827506|NCT00750308|10938158|FG003|COMPLETED|Third Treatment||1
9827507|NCT00750308|10938159|FG004|COMPLETED|Third Treatment||1
9827508|NCT00750308|10938160|FG005|COMPLETED|Third Treatment||2
9827509|NCT00750308|10938161|FG006|COMPLETED|Third Treatment||2
9827510|NCT00750308|10938162|FG007|COMPLETED|Third Treatment||2
9827511|NCT00750308|10938163|FG008|COMPLETED|Third Treatment||1
10237499|NCT00702962|11368511|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
10237500|NCT00702962|11368510|FG000|NOT COMPLETED|Overall Study||1
10237501|NCT00702962|11368511|FG001|NOT COMPLETED|Overall Study||1
10237502|NCT00703534|11368521|FG000|STARTED|Overall Study||235
10237503|NCT00703534|11368522|FG001|STARTED|Overall Study||243
10237504|NCT00703534|11368521|FG000|COMPLETED|Overall Study||205
10237505|NCT00703534|11368522|FG001|COMPLETED|Overall Study||218
10237506|NCT00703534|11368521|FG000|NOT COMPLETED|Overall Study||30
10237507|NCT00703534|11368522|FG001|NOT COMPLETED|Overall Study||25
10237508|NCT00698009|11368528|FG000|STARTED|Overall Study||1
10237509|NCT00698009|11368528|FG000|COMPLETED|Overall Study||0
10237510|NCT00698009|11368528|FG000|NOT COMPLETED|Overall Study||1
10237511|NCT00703339|11368532|FG000|STARTED|Overall Study||1
10237512|NCT00703339|11368532|FG000|COMPLETED|Overall Study||1
10237513|NCT00703339|11368532|FG000|NOT COMPLETED|Overall Study||0
10237514|NCT00691444|11368539|FG000|STARTED|Overall Study||0
10237515|NCT00691444|11368540|FG001|STARTED|Overall Study||0
10237516|NCT00691444|11368541|FG002|STARTED|Overall Study||0
10237517|NCT00691444|11368539|FG000|COMPLETED|Overall Study||0
9827512|NCT00750308|10938164|FG009|COMPLETED|Third Treatment||2
9827513|NCT00750308|10938165|FG010|COMPLETED|Third Treatment||1
9827514|NCT00750308|10938166|FG011|COMPLETED|Third Treatment||1
9827515|NCT00750308|10938155|FG000|NOT COMPLETED|Third Treatment||0
9827516|NCT00750308|10938156|FG001|NOT COMPLETED|Third Treatment||1
9827517|NCT00750308|10938157|FG002|NOT COMPLETED|Third Treatment||0
9827518|NCT00750308|10938158|FG003|NOT COMPLETED|Third Treatment||0
9827519|NCT00750308|10938159|FG004|NOT COMPLETED|Third Treatment||0
9827520|NCT00750308|10938160|FG005|NOT COMPLETED|Third Treatment||0
9827521|NCT00750308|10938161|FG006|NOT COMPLETED|Third Treatment||0
9827522|NCT00750308|10938162|FG007|NOT COMPLETED|Third Treatment||0
9827523|NCT00750308|10938163|FG008|NOT COMPLETED|Third Treatment||0
9827524|NCT00750308|10938164|FG009|NOT COMPLETED|Third Treatment||0
9827525|NCT00750308|10938165|FG010|NOT COMPLETED|Third Treatment||0
10237518|NCT00691444|11368540|FG001|COMPLETED|Overall Study||0
10237519|NCT00691444|11368541|FG002|COMPLETED|Overall Study||0
9827526|NCT00750308|10938166|FG011|NOT COMPLETED|Third Treatment||0
9827527|NCT00750308|10938155|FG000|STARTED|Washout||2
9827528|NCT00750308|10938156|FG001|STARTED|Washout||1
9827529|NCT00750308|10938157|FG002|STARTED|Washout||2
9827530|NCT00750308|10938158|FG003|STARTED|Washout||1
9827531|NCT00750308|10938159|FG004|STARTED|Washout||1
9827532|NCT00750308|10938160|FG005|STARTED|Washout||2
9827533|NCT00750308|10938161|FG006|STARTED|Washout||2
9827534|NCT00750308|10938162|FG007|STARTED|Washout||2
9827535|NCT00750308|10938163|FG008|STARTED|Washout||1
9827536|NCT00750308|10938164|FG009|STARTED|Washout||2
9827537|NCT00750308|10938165|FG010|STARTED|Washout||1
9827538|NCT00750308|10938166|FG011|STARTED|Washout||1
9827539|NCT00750308|10938155|FG000|COMPLETED|Washout||2
9827540|NCT00750308|10938156|FG001|COMPLETED|Washout||1
9827541|NCT00750308|10938157|FG002|COMPLETED|Washout||2
9827542|NCT00750308|10938158|FG003|COMPLETED|Washout||1
9827543|NCT00750308|10938159|FG004|COMPLETED|Washout||1
9827544|NCT00750308|10938160|FG005|COMPLETED|Washout||2
9827545|NCT00750308|10938161|FG006|COMPLETED|Washout||2
9827546|NCT00750308|10938162|FG007|COMPLETED|Washout||2
9827547|NCT00750308|10938163|FG008|COMPLETED|Washout||1
9827548|NCT00750308|10938164|FG009|COMPLETED|Washout||2
9827549|NCT00750308|10938165|FG010|COMPLETED|Washout||1
9827550|NCT00750308|10938166|FG011|COMPLETED|Washout||1
9827551|NCT00750308|10938155|FG000|NOT COMPLETED|Washout||0
9827552|NCT00750308|10938156|FG001|NOT COMPLETED|Washout||0
9827553|NCT00750308|10938157|FG002|NOT COMPLETED|Washout||0
9827554|NCT00750308|10938158|FG003|NOT COMPLETED|Washout||0
9827555|NCT00750308|10938159|FG004|NOT COMPLETED|Washout||0
9827556|NCT00750308|10938160|FG005|NOT COMPLETED|Washout||0
9827557|NCT00750308|10938161|FG006|NOT COMPLETED|Washout||0
9827558|NCT00750308|10938162|FG007|NOT COMPLETED|Washout||0
10237520|NCT00691444|11368539|FG000|NOT COMPLETED|Overall Study||0
10237521|NCT00691444|11368540|FG001|NOT COMPLETED|Overall Study||0
10237522|NCT00691444|11368541|FG002|NOT COMPLETED|Overall Study||0
10237523|NCT00702702|11368552|FG000|STARTED|Overall Study||56
10237524|NCT00702702|11368552|FG000|COMPLETED|Overall Study||0
10237525|NCT00702702|11368552|FG000|NOT COMPLETED|Overall Study||56
10237526|NCT00693628|11368562|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
10237527|NCT00693628|11368563|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
10237528|NCT00693628|11368562|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
10237529|NCT00693628|11368563|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
10237530|NCT00693628|11368562|FG000|NOT COMPLETED|Overall Study||0
10237531|NCT00693628|11368563|FG001|NOT COMPLETED|Overall Study||0
10237532|NCT00699413|11368571|FG000|STARTED|Overall Study||4
10237533|NCT00699413|11368572|FG001|STARTED|Overall Study||4
10237534|NCT00699413|11368571|FG000|COMPLETED|Overall Study||0
10237535|NCT00699413|11368572|FG001|COMPLETED|Overall Study||0
10237536|NCT00699413|11368571|FG000|NOT COMPLETED|Overall Study||4
10237537|NCT00699413|11368572|FG001|NOT COMPLETED|Overall Study||4
10237538|NCT00691652|11368578|FG000|STARTED|Overall Study||2
10237539|NCT00691652|11368578|FG000|COMPLETED|Overall Study||1
10237540|NCT00691652|11368578|FG000|NOT COMPLETED|Overall Study||1
10237541|NCT00686972|11368582|FG000|STARTED|Overall Study||51
10237542|NCT00686972|11368582|FG000|COMPLETED|Overall Study||0
10237543|NCT00686972|11368582|FG000|NOT COMPLETED|Overall Study||51
10237544|NCT00693017|11368588|FG000|STARTED|Overall Study||2
10237545|NCT00693017|11368589|FG001|STARTED|Overall Study||2
10237546|NCT00693017|11368588|FG000|COMPLETED|Overall Study||0
10237547|NCT00693017|11368589|FG001|COMPLETED|Overall Study||0
10237548|NCT00693017|11368588|FG000|NOT COMPLETED|Overall Study||2
10237549|NCT00693017|11368589|FG001|NOT COMPLETED|Overall Study||2
10237550|NCT00691574|11368597|FG000|STARTED|Overall Study||0
10237551|NCT00691574|11368598|FG001|STARTED|Overall Study||0
10237552|NCT00691574|11368597|FG000|COMPLETED|Overall Study||0
10237553|NCT00691574|11368598|FG001|COMPLETED|Overall Study||0
10237554|NCT00691574|11368597|FG000|NOT COMPLETED|Overall Study||0
10237555|NCT00691574|11368598|FG001|NOT COMPLETED|Overall Study||0
10237556|NCT00692094|11368608|FG000|STARTED|Overall Study||0
10237557|NCT00692094|11368609|FG001|STARTED|Overall Study||0
10237558|NCT00692094|11368610|FG002|STARTED|Overall Study||0
10237559|NCT00692094|11368611|FG003|STARTED|Overall Study||0
10237560|NCT00692094|11368608|FG000|COMPLETED|Overall Study||0
10237561|NCT00692094|11368609|FG001|COMPLETED|Overall Study||0
9827559|NCT00750308|10938163|FG008|NOT COMPLETED|Washout||0
10237562|NCT00692094|11368610|FG002|COMPLETED|Overall Study||0
10237563|NCT00692094|11368611|FG003|COMPLETED|Overall Study||0
10237564|NCT00692094|11368608|FG000|NOT COMPLETED|Overall Study||0
10237565|NCT00692094|11368609|FG001|NOT COMPLETED|Overall Study||0
10237566|NCT00692094|11368610|FG002|NOT COMPLETED|Overall Study||0
10237567|NCT00692094|11368611|FG003|NOT COMPLETED|Overall Study||0
9827560|NCT00750308|10938164|FG009|NOT COMPLETED|Washout||0
9827561|NCT00750308|10938165|FG010|NOT COMPLETED|Washout||0
9827562|NCT00750308|10938166|FG011|NOT COMPLETED|Washout||0
9827563|NCT00750308|10938155|FG000|STARTED|Fourth Treatment||2
9827564|NCT00750308|10938156|FG001|STARTED|Fourth Treatment||1
10237568|NCT00689884|11368621|FG000|STARTED|Overall Study||7
10237569|NCT00689884|11368621|FG000|COMPLETED|Overall Study||7
10237570|NCT00689884|11368621|FG000|NOT COMPLETED|Overall Study||0
10237571|NCT00692003|11368628|FG000|STARTED|Overall Study||5
10237572|NCT00692003|11368629|FG001|STARTED|Overall Study||1
10237573|NCT00692003|11368628|FG000|COMPLETED|Overall Study||0
9827565|NCT00750308|10938157|FG002|STARTED|Fourth Treatment||2
9827566|NCT00750308|10938158|FG003|STARTED|Fourth Treatment||1
9827567|NCT00750308|10938159|FG004|STARTED|Fourth Treatment||1
9827568|NCT00750308|10938160|FG005|STARTED|Fourth Treatment||2
9827569|NCT00750308|10938161|FG006|STARTED|Fourth Treatment||2
9827570|NCT00750308|10938162|FG007|STARTED|Fourth Treatment||2
9827571|NCT00750308|10938163|FG008|STARTED|Fourth Treatment||1
9827572|NCT00750308|10938164|FG009|STARTED|Fourth Treatment||2
9827573|NCT00750308|10938165|FG010|STARTED|Fourth Treatment||1
9827574|NCT00750308|10938166|FG011|STARTED|Fourth Treatment||1
9827575|NCT00750308|10938155|FG000|COMPLETED|Fourth Treatment||2
9827576|NCT00750308|10938156|FG001|COMPLETED|Fourth Treatment||1
9827577|NCT00750308|10938157|FG002|COMPLETED|Fourth Treatment||2
9827578|NCT00750308|10938158|FG003|COMPLETED|Fourth Treatment||1
9827579|NCT00750308|10938159|FG004|COMPLETED|Fourth Treatment||1
9827580|NCT00750308|10938160|FG005|COMPLETED|Fourth Treatment||2
9827581|NCT00750308|10938161|FG006|COMPLETED|Fourth Treatment||2
9827582|NCT00750308|10938162|FG007|COMPLETED|Fourth Treatment||2
9827583|NCT00750308|10938163|FG008|COMPLETED|Fourth Treatment||1
9827584|NCT00750308|10938164|FG009|COMPLETED|Fourth Treatment||2
9827585|NCT00750308|10938165|FG010|COMPLETED|Fourth Treatment||1
9827586|NCT00750308|10938166|FG011|COMPLETED|Fourth Treatment||1
9827587|NCT00750308|10938155|FG000|NOT COMPLETED|Fourth Treatment||0
9827588|NCT00750308|10938156|FG001|NOT COMPLETED|Fourth Treatment||0
9827589|NCT00750308|10938157|FG002|NOT COMPLETED|Fourth Treatment||0
9827590|NCT00750308|10938158|FG003|NOT COMPLETED|Fourth Treatment||0
9827591|NCT00750308|10938159|FG004|NOT COMPLETED|Fourth Treatment||0
9827592|NCT00750308|10938160|FG005|NOT COMPLETED|Fourth Treatment||0
9827593|NCT00750308|10938161|FG006|NOT COMPLETED|Fourth Treatment||0
9827594|NCT00750308|10938162|FG007|NOT COMPLETED|Fourth Treatment||0
9827595|NCT00750308|10938163|FG008|NOT COMPLETED|Fourth Treatment||0
9827596|NCT00750308|10938164|FG009|NOT COMPLETED|Fourth Treatment||0
9827597|NCT00750308|10938165|FG010|NOT COMPLETED|Fourth Treatment||0
9827598|NCT00750308|10938166|FG011|NOT COMPLETED|Fourth Treatment||0
9827599|NCT00750360|10938186|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
9827600|NCT00750360|10938187|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
9827601|NCT00750360|10938188|FG002|STARTED|Overall Study||384
9827602|NCT00750360|10938189|FG003|STARTED|Overall Study||79
9827603|NCT00750360|10938190|FG004|STARTED|Overall Study||46
9827604|NCT00750360|10938191|FG005|STARTED|Overall Study||71
9827605|NCT00750360|10938186|FG000|COMPLETED|Overall Study||294
9827606|NCT00750360|10938187|FG001|COMPLETED|Overall Study||1
9827607|NCT00750360|10938188|FG002|COMPLETED|Overall Study||384
9827608|NCT00750360|10938189|FG003|COMPLETED|Overall Study||79
9827609|NCT00750360|10938190|FG004|COMPLETED|Overall Study||46
9827610|NCT00750360|10938191|FG005|COMPLETED|Overall Study||71
10017451|NCT01816893|11140371|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10017452|NCT01816893|11140370|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
10017453|NCT01816893|11140371|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
10237574|NCT00692003|11368629|FG001|COMPLETED|Overall Study||0
10237575|NCT00692003|11368628|FG000|NOT COMPLETED|Overall Study||5
10237576|NCT00692003|11368629|FG001|NOT COMPLETED|Overall Study||1
9827611|NCT00750360|10938186|FG000|NOT COMPLETED|Overall Study||0
9827612|NCT00750360|10938187|FG001|NOT COMPLETED|Overall Study||0
9827613|NCT00750360|10938188|FG002|NOT COMPLETED|Overall Study||0
9827614|NCT00750360|10938189|FG003|NOT COMPLETED|Overall Study||0
9827615|NCT00750360|10938190|FG004|NOT COMPLETED|Overall Study||0
9827616|NCT00750360|10938191|FG005|NOT COMPLETED|Overall Study||0
9827617|NCT00750373|10938213|FG000|STARTED|Overall Study||39
9827618|NCT00750373|10938214|FG001|STARTED|Overall Study||37
9827619|NCT00750373|10938213|FG000|COMPLETED|Overall Study||39
10237577|NCT00678288|11368637|FG000|STARTED|Overall Study||10
10237578|NCT00678288|11368638|FG001|STARTED|Overall Study||6
10237579|NCT00678288|11368637|FG000|COMPLETED|Overall Study||0
10237580|NCT00678288|11368638|FG001|COMPLETED|Overall Study||0
10237581|NCT00678288|11368637|FG000|NOT COMPLETED|Overall Study||10
10237582|NCT00678288|11368638|FG001|NOT COMPLETED|Overall Study||6
10237583|NCT00676026|11368644|FG000|STARTED|Overall Study||8
10237584|NCT00676026|11368644|FG000|COMPLETED|Overall Study||8
10237585|NCT00676026|11368644|FG000|NOT COMPLETED|Overall Study||0
10237586|NCT00689052|11368650|FG000|STARTED|Overall Study||31
10237587|NCT00689052|11368651|FG001|STARTED|Overall Study||30
10237588|NCT00689052|11368650|FG000|COMPLETED|Overall Study||0
10237589|NCT00689052|11368651|FG001|COMPLETED|Overall Study||0
10237590|NCT00689052|11368650|FG000|NOT COMPLETED|Overall Study||31
10237591|NCT00689052|11368651|FG001|NOT COMPLETED|Overall Study||30
10237592|NCT00678574|11368661|FG000|STARTED|Overall Study||18
10237593|NCT00678574|11368662|FG001|STARTED|Overall Study||27
10237594|NCT00678574|11368661|FG000|COMPLETED|Overall Study||18
10237595|NCT00678574|11368662|FG001|COMPLETED|Overall Study||27
9827620|NCT00750373|10938214|FG001|COMPLETED|Overall Study||37
9827621|NCT00750373|10938213|FG000|NOT COMPLETED|Overall Study||0
9827622|NCT00750373|10938214|FG001|NOT COMPLETED|Overall Study||0
9827623|NCT00750438|10938222|FG000|STARTED|Overall Study||31
9827624|NCT00750438|10938223|FG001|STARTED|Overall Study||29
10237596|NCT00678574|11368661|FG000|NOT COMPLETED|Overall Study||0
10237597|NCT00678574|11368662|FG001|NOT COMPLETED|Overall Study||0
9827625|NCT00750438|10938222|FG000|COMPLETED|Overall Study||24
9827626|NCT00750438|10938223|FG001|COMPLETED|Overall Study||25
9827627|NCT00750438|10938222|FG000|NOT COMPLETED|Overall Study||7
9827628|NCT00750438|10938223|FG001|NOT COMPLETED|Overall Study||4
10237598|NCT00683917|11368671|FG000|STARTED|Overall Study||10
10237599|NCT00683917|11368671|FG000|COMPLETED|Overall Study||0
10237600|NCT00683917|11368671|FG000|NOT COMPLETED|Overall Study||10
9827629|NCT00750737|10938231|FG000|STARTED|Overall Study||24
9827630|NCT00750737|10938232|FG001|STARTED|Overall Study||22
9827631|NCT00750737|10938231|FG000|COMPLETED|Overall Study||21
9827632|NCT00750737|10938232|FG001|COMPLETED|Overall Study||19
9827633|NCT00750737|10938231|FG000|NOT COMPLETED|Overall Study||3
9827634|NCT00750737|10938232|FG001|NOT COMPLETED|Overall Study||3
9827635|NCT00750815|10938240|FG000|STARTED|Overall Study||12
9827636|NCT00750815|10938241|FG001|STARTED|Overall Study||46
9827637|NCT00750815|10938240|FG000|COMPLETED|Overall Study||12
9827638|NCT00750815|10938241|FG001|COMPLETED|Overall Study||46
9827639|NCT00750815|10938240|FG000|NOT COMPLETED|Overall Study||0
9827640|NCT00750815|10938241|FG001|NOT COMPLETED|Overall Study||0
9827641|NCT00750867|10938251|FG000|STARTED|Overall Study||9
9827642|NCT00750867|10938251|FG000|COMPLETED|Overall Study||7
9827643|NCT00750867|10938251|FG000|NOT COMPLETED|Overall Study||2
9827644|NCT00750880|10938255|FG000|STARTED|Overall Study||1681
9827645|NCT00750880|10938255|FG000|COMPLETED|Overall Study||1466
9827646|NCT00750880|10938255|FG000|NOT COMPLETED|Overall Study||215
9827647|NCT00750893|10938260|FG000|STARTED|Overall Study||3111
9827648|NCT00750893|10938260|FG000|COMPLETED|Overall Study||2569
9827649|NCT00750893|10938260|FG000|NOT COMPLETED|Overall Study||542
9827650|NCT00750919|10938264|FG000|STARTED|Overall Study||184
9827651|NCT00750919|10938264|FG000|COMPLETED|Overall Study||126
9827652|NCT00750919|10938264|FG000|NOT COMPLETED|Overall Study||58
9827653|NCT00751023|10938270|FG000|STARTED|Overall Study||20
9827654|NCT00751023|10938271|FG001|STARTED|Overall Study||20
9827655|NCT00751023|10938270|FG000|COMPLETED|Overall Study||9
9827656|NCT00751023|10938271|FG001|COMPLETED|Overall Study||13
9827657|NCT00751023|10938270|FG000|NOT COMPLETED|Overall Study||11
9827658|NCT00751023|10938271|FG001|NOT COMPLETED|Overall Study||7
9827659|NCT00751036|10938279|FG000|STARTED|Overall Study|Started = Treated|48
9827660|NCT00751036|10938280|FG001|STARTED|Overall Study|Started = Treated|46
9827661|NCT00751036|10938279|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
9827662|NCT00751036|10938280|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
9827663|NCT00751036|10938279|FG000|NOT COMPLETED|Overall Study||48
9827664|NCT00751036|10938280|FG001|NOT COMPLETED|Overall Study||46
9827665|NCT00751101|10938288|FG000|STARTED|Overall Study||12
9827666|NCT00751101|10938289|FG001|STARTED|Overall Study||12
9827667|NCT00751101|10938288|FG000|Started Capecitabine|Overall Study||11
9827668|NCT00751101|10938289|FG001|Started Capecitabine|Overall Study||11
9827669|NCT00751101|10938288|FG000|COMPLETED|Overall Study||10
9827670|NCT00751101|10938289|FG001|COMPLETED|Overall Study||7
9827671|NCT00751101|10938288|FG000|NOT COMPLETED|Overall Study||2
9827672|NCT00751101|10938289|FG001|NOT COMPLETED|Overall Study||5
9827673|NCT00751114|10938301|FG000|STARTED|Overall Study|randomized|250
9827674|NCT00751114|10938302|FG001|STARTED|Overall Study||265
9827675|NCT00751114|10938301|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
9827676|NCT00751114|10938302|FG001|TREATED = Safety Population|Overall Study||264
9827677|NCT00751114|10938301|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
9827678|NCT00751114|10938302|FG001|mITT Population|Overall Study||253
9827679|NCT00751114|10938301|FG000|COMPLETED|Overall Study||212
9827680|NCT00751114|10938302|FG001|COMPLETED|Overall Study||233
9827681|NCT00751114|10938301|FG000|NOT COMPLETED|Overall Study||38
9827682|NCT00751114|10938302|FG001|NOT COMPLETED|Overall Study||32
9827683|NCT00751140|10938308|FG000|STARTED|Overall Study||20
9827684|NCT00751140|10938308|FG000|COMPLETED|Overall Study||19
9827685|NCT00751140|10938308|FG000|NOT COMPLETED|Overall Study||1
9827686|NCT00751179|10938318|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
9827687|NCT00751179|10938319|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
9827688|NCT00751179|10938318|FG000|COMPLETED|Overall Study||62
9827689|NCT00751179|10938319|FG001|COMPLETED|Overall Study||70
9827690|NCT00751179|10938318|FG000|NOT COMPLETED|Overall Study||14
9827691|NCT00751179|10938319|FG001|NOT COMPLETED|Overall Study||15
9827692|NCT00751296|10938326|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
9827693|NCT00751296|10938326|FG000|COMPLETED|Overall Study||25
9827694|NCT00751296|10938326|FG000|NOT COMPLETED|Overall Study||2
9827695|NCT00751348|10938332|FG000|STARTED|Overall Study||313
9827696|NCT00751348|10938333|FG001|STARTED|Overall Study||161
9827697|NCT00751348|10938332|FG000|COMPLETED|Overall Study||307
9827698|NCT00751348|10938333|FG001|COMPLETED|Overall Study||159
9827699|NCT00751348|10938332|FG000|NOT COMPLETED|Overall Study||6
9827700|NCT00751348|10938333|FG001|NOT COMPLETED|Overall Study||2
9827701|NCT00751400|10938339|FG000|STARTED|Overall Study||497
9827702|NCT00751400|10938339|FG000|Subjects Provided Drug|Overall Study||497
9827703|NCT00751400|10938339|FG000|Subjects Consumed Drug|Overall Study||485
9827704|NCT00751400|10938339|FG000|Subjects Provided Detailed Use Data|Overall Study||467
9827705|NCT00751400|10938339|FG000|COMPLETED|Overall Study||487
9827706|NCT00751400|10938339|FG000|NOT COMPLETED|Overall Study||10
9827707|NCT00751530|10938345|FG000|STARTED|Overall Study||332
9827708|NCT00751530|10938346|FG001|STARTED|Overall Study||110
9827709|NCT00751530|10938345|FG000|COMPLETED|Overall Study||332
9827710|NCT00751530|10938346|FG001|COMPLETED|Overall Study||110
9827711|NCT00751530|10938345|FG000|NOT COMPLETED|Overall Study||0
9827712|NCT00751530|10938346|FG001|NOT COMPLETED|Overall Study||0
9827713|NCT00751621|10938352|FG000|STARTED|Overall Study||40
9827714|NCT00751621|10938352|FG000|COMPLETED|Overall Study||36
9827715|NCT00751621|10938352|FG000|NOT COMPLETED|Overall Study||4
9827716|NCT00751634|10938358|FG000|STARTED|Overall Study||20
9827717|NCT00751634|10938358|FG000|COMPLETED|Overall Study||20
9827718|NCT00751634|10938358|FG000|NOT COMPLETED|Overall Study||0
9827719|NCT00751777|10938365|FG000|STARTED|Overall Study||81
9827720|NCT00751777|10938366|FG001|STARTED|Overall Study||39
9827721|NCT00751777|10938365|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70
9827722|NCT00751777|10938366|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
9827723|NCT00751777|10938365|FG000|NOT COMPLETED|Overall Study||11
9827724|NCT00751777|10938366|FG001|NOT COMPLETED|Overall Study||3
9827725|NCT00751790|10938372|FG000|STARTED|Overall Study||120
9827726|NCT00751790|10938372|FG000|COMPLETED|Overall Study||115
9827727|NCT00751790|10938372|FG000|NOT COMPLETED|Overall Study||5
9827728|NCT00751881|10938379|FG000|STARTED|Core Treatment Period|Randomized|389
9827729|NCT00751881|10938380|FG001|STARTED|Core Treatment Period|Randomized|408
9827730|NCT00751881|10938381|FG002|STARTED|Core Treatment Period|Randomized|372
9827731|NCT00751881|10938379|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
9827732|NCT00751881|10938380|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
9827733|NCT00751881|10938381|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
9827734|NCT00751881|10938379|FG000|COMPLETED|Core Treatment Period||263
9827735|NCT00751881|10938380|FG001|COMPLETED|Core Treatment Period||273
9827736|NCT00751881|10938381|FG002|COMPLETED|Core Treatment Period||244
9827737|NCT00751881|10938379|FG000|NOT COMPLETED|Core Treatment Period||126
9827738|NCT00751881|10938380|FG001|NOT COMPLETED|Core Treatment Period||135
9827739|NCT00751881|10938381|FG002|NOT COMPLETED|Core Treatment Period||128
9827740|NCT00751881|10938379|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
9827741|NCT00751881|10938380|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
9827742|NCT00751881|10938381|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
9827743|NCT00751881|10938379|FG000|COMPLETED|Extension Study Period||188
9827744|NCT00751881|10938380|FG001|COMPLETED|Extension Study Period||194
9827745|NCT00751881|10938381|FG002|COMPLETED|Extension Study Period||167
9827746|NCT00751881|10938379|FG000|NOT COMPLETED|Extension Study Period||65
9827747|NCT00751881|10938380|FG001|NOT COMPLETED|Extension Study Period||71
9827748|NCT00751881|10938381|FG002|NOT COMPLETED|Extension Study Period||66
9827749|NCT00751972|10938397|FG000|STARTED|Overall Study||140
9827750|NCT00751972|10938398|FG001|STARTED|Overall Study||499
9827751|NCT00751972|10938397|FG000|COMPLETED|Overall Study||140
9827752|NCT00751972|10938398|FG001|COMPLETED|Overall Study||499
9827753|NCT00751972|10938397|FG000|NOT COMPLETED|Overall Study||0
9827754|NCT00751972|10938398|FG001|NOT COMPLETED|Overall Study||0
9827755|NCT00751998|10938403|FG000|STARTED|Overall Study||297
9827756|NCT00751998|10938403|FG000|COMPLETED|Overall Study||277
9827757|NCT00751998|10938403|FG000|NOT COMPLETED|Overall Study||20
9827758|NCT00752089|10938407|FG000|STARTED|Overall Study||20
9827759|NCT00752089|10938407|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
9827760|NCT00752089|10938407|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
9827761|NCT00752089|10938407|FG000|Received NaF|Overall Study||18
9827762|NCT00752089|10938407|FG000|Received Placebo|Overall Study||18
9827763|NCT00752089|10938407|FG000|COMPLETED|Overall Study||14
9827764|NCT00752089|10938407|FG000|NOT COMPLETED|Overall Study||6
9827765|NCT00752102|10938420|FG000|STARTED|Overall Study||22
9827766|NCT00752102|10938421|FG001|STARTED|Overall Study||22
10237601|NCT00688935|11368679|FG000|STARTED|Overall Study||0
10237602|NCT00688935|11368679|FG000|COMPLETED|Overall Study||0
10237603|NCT00688935|11368679|FG000|NOT COMPLETED|Overall Study||0
10237604|NCT00685880|11368685|FG000|STARTED|Overall Study||0
10237605|NCT00685880|11368686|FG001|STARTED|Overall Study||2
10237606|NCT00685880|11368685|FG000|COMPLETED|Overall Study||0
10237607|NCT00685880|11368686|FG001|COMPLETED|Overall Study||2
10237608|NCT00685880|11368685|FG000|NOT COMPLETED|Overall Study||0
10237609|NCT00685880|11368686|FG001|NOT COMPLETED|Overall Study||0
10237610|NCT00686036|11368694|FG000|STARTED|Overall Study||9
10237611|NCT00686036|11368695|FG001|STARTED|Overall Study||8
10237612|NCT00686036|11368694|FG000|COMPLETED|Overall Study||0
10237613|NCT00686036|11368695|FG001|COMPLETED|Overall Study||2
10237614|NCT00686036|11368694|FG000|NOT COMPLETED|Overall Study||9
10237615|NCT00686036|11368695|FG001|NOT COMPLETED|Overall Study||6
10237616|NCT00681044|11368701|FG000|STARTED|Overall Study||4
10237617|NCT00681044|11368701|FG000|COMPLETED|Overall Study||4
10237618|NCT00681044|11368701|FG000|NOT COMPLETED|Overall Study||0
10237619|NCT00676455|11368705|FG000|STARTED|Overall Study||14
10237620|NCT00676455|11368705|FG000|COMPLETED|Overall Study||14
10237621|NCT00676455|11368705|FG000|NOT COMPLETED|Overall Study||0
10237622|NCT00684255|11368709|FG000|STARTED|Overall Study||1
10237623|NCT00684255|11368709|FG000|COMPLETED|Overall Study||1
9827767|NCT00752102|10938420|FG000|COMPLETED|Overall Study||19
9827768|NCT00752102|10938421|FG001|COMPLETED|Overall Study||21
10237624|NCT00684255|11368709|FG000|NOT COMPLETED|Overall Study||0
10237625|NCT00683787|11368717|FG000|STARTED|Overall Study||3
10237626|NCT00683787|11368718|FG001|STARTED|Overall Study||3
10237627|NCT00683787|11368719|FG002|STARTED|Overall Study||2
10237628|NCT00683787|11368717|FG000|COMPLETED|Overall Study||0
10237629|NCT00683787|11368718|FG001|COMPLETED|Overall Study||0
10237630|NCT00683787|11368719|FG002|COMPLETED|Overall Study||0
10237631|NCT00683787|11368717|FG000|NOT COMPLETED|Overall Study||3
10237632|NCT00683787|11368718|FG001|NOT COMPLETED|Overall Study||3
9827769|NCT00752102|10938420|FG000|NOT COMPLETED|Overall Study||3
9827770|NCT00752102|10938421|FG001|NOT COMPLETED|Overall Study||1
9827771|NCT00752128|10938427|FG000|STARTED|Overall Study||2349
9827772|NCT00752128|10938427|FG000|COMPLETED|Overall Study||2345
9827773|NCT00752128|10938427|FG000|NOT COMPLETED|Overall Study||4
9827774|NCT00752206|10938434|FG000|STARTED|Overall Study||19
9827775|NCT00752206|10938435|FG001|STARTED|Overall Study||19
9827776|NCT00752206|10938434|FG000|COMPLETED|Overall Study||10
9827777|NCT00752206|10938435|FG001|COMPLETED|Overall Study||8
9827778|NCT00752206|10938434|FG000|NOT COMPLETED|Overall Study||9
9827779|NCT00752206|10938435|FG001|NOT COMPLETED|Overall Study||11
9827780|NCT00752219|10938443|FG000|STARTED|Overall Study||102
9827781|NCT00752219|10938444|FG001|STARTED|Overall Study||102
9827782|NCT00752219|10938443|FG000|Treated|Overall Study||101
9827783|NCT00752219|10938444|FG001|Treated|Overall Study||102
9827784|NCT00752219|10938443|FG000|COMPLETED|Overall Study||91
9827785|NCT00752219|10938444|FG001|COMPLETED|Overall Study||96
9827786|NCT00752219|10938443|FG000|NOT COMPLETED|Overall Study||11
9827787|NCT00752219|10938444|FG001|NOT COMPLETED|Overall Study||6
9827788|NCT00752232|10938457|FG000|STARTED|Overall Study||6
9827789|NCT00752232|10938458|FG001|STARTED|Overall Study||6
9827790|NCT00752232|10938459|FG002|STARTED|Overall Study||6
9827791|NCT00752232|10938460|FG003|STARTED|Overall Study||6
9827792|NCT00752232|10938461|FG004|STARTED|Overall Study||6
9827793|NCT00752232|10938462|FG005|STARTED|Overall Study||6
9827794|NCT00752232|10938463|FG006|STARTED|Overall Study||4
9827795|NCT00752232|10938457|FG000|COMPLETED|Overall Study||4
9827796|NCT00752232|10938458|FG001|COMPLETED|Overall Study||6
9827797|NCT00752232|10938459|FG002|COMPLETED|Overall Study||5
9827798|NCT00752232|10938460|FG003|COMPLETED|Overall Study||5
9827799|NCT00752232|10938461|FG004|COMPLETED|Overall Study||3
9827800|NCT00752232|10938462|FG005|COMPLETED|Overall Study||5
9827801|NCT00752232|10938463|FG006|COMPLETED|Overall Study||4
9827802|NCT00752232|10938457|FG000|NOT COMPLETED|Overall Study||2
9827803|NCT00752232|10938458|FG001|NOT COMPLETED|Overall Study||0
9827804|NCT00752232|10938459|FG002|NOT COMPLETED|Overall Study||1
9827805|NCT00752232|10938460|FG003|NOT COMPLETED|Overall Study||1
9827806|NCT00752232|10938461|FG004|NOT COMPLETED|Overall Study||3
9827807|NCT00752232|10938462|FG005|NOT COMPLETED|Overall Study||1
9827808|NCT00752232|10938463|FG006|NOT COMPLETED|Overall Study||0
9827809|NCT00752557|10938483|FG000|STARTED|Overall Study||17
9827810|NCT00752557|10938484|FG001|STARTED|Overall Study||16
9827811|NCT00752557|10938485|FG002|STARTED|Overall Study||17
9827812|NCT00752557|10938483|FG000|COMPLETED|Overall Study||12
9827813|NCT00752557|10938484|FG001|COMPLETED|Overall Study||11
9827814|NCT00752557|10938485|FG002|COMPLETED|Overall Study||11
9827815|NCT00752557|10938483|FG000|NOT COMPLETED|Overall Study||5
9827816|NCT00752557|10938484|FG001|NOT COMPLETED|Overall Study||5
9827817|NCT00752557|10938485|FG002|NOT COMPLETED|Overall Study||6
9827818|NCT00752609|10938497|FG000|STARTED|Overall Study||53
9827819|NCT00752609|10938498|FG001|STARTED|Overall Study||49
9827820|NCT00752609|10938497|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
9827821|NCT00752609|10938498|FG001|Full Analysis Set|Overall Study||49
9827822|NCT00752609|10938497|FG000|COMPLETED|Overall Study||44
9827823|NCT00752609|10938498|FG001|COMPLETED|Overall Study||47
9827824|NCT00752609|10938497|FG000|NOT COMPLETED|Overall Study||9
9827825|NCT00752609|10938498|FG001|NOT COMPLETED|Overall Study||2
9827826|NCT00752622|10938507|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
9827827|NCT00752622|10938507|FG000|COMPLETED|Induction Phase||65
9827828|NCT00752622|10938507|FG000|NOT COMPLETED|Induction Phase||35
9827829|NCT00752622|10938507|FG000|STARTED|Observational Phase||65
9827830|NCT00752622|10938507|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
9827831|NCT00752622|10938507|FG000|NOT COMPLETED|Observational Phase||43
9827832|NCT00752622|10938507|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
9827833|NCT00752622|10938507|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
9827834|NCT00752622|10938507|FG000|NOT COMPLETED|Interventional Phase||8
9827835|NCT00752726|10938514|FG000|STARTED|Overall Study||65
9827836|NCT00752726|10938515|FG001|STARTED|Overall Study||66
9827837|NCT00752726|10938514|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
9827838|NCT00752726|10938515|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
9827839|NCT00752726|10938514|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
9827840|NCT00752726|10938515|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
9827841|NCT00752726|10938514|FG000|COMPLETED|Overall Study||54
9827842|NCT00752726|10938515|FG001|COMPLETED|Overall Study||53
9827843|NCT00752726|10938514|FG000|NOT COMPLETED|Overall Study||11
9827844|NCT00752726|10938515|FG001|NOT COMPLETED|Overall Study||13
9827845|NCT00752791|10938521|FG000|STARTED|Overall Study||59
9827846|NCT00752791|10938521|FG000|COMPLETED|Overall Study||43
9827847|NCT00752791|10938521|FG000|NOT COMPLETED|Overall Study||16
9827848|NCT00752856|10938527|FG000|STARTED|Overall Study||26
9827849|NCT00752856|10938528|FG001|STARTED|Overall Study||25
9827850|NCT00752856|10938527|FG000|COMPLETED|Overall Study||26
9827851|NCT00752856|10938528|FG001|COMPLETED|Overall Study||24
9827852|NCT00752856|10938527|FG000|NOT COMPLETED|Overall Study||0
9827853|NCT00752856|10938528|FG001|NOT COMPLETED|Overall Study||1
9827854|NCT00752895|10938536|FG000|STARTED|Overall Study||147
9827855|NCT00752895|10938537|FG001|STARTED|Overall Study||146
9827856|NCT00752895|10938536|FG000|COMPLETED|Overall Study||139
9827857|NCT00752895|10938537|FG001|COMPLETED|Overall Study||143
9827858|NCT00752895|10938536|FG000|NOT COMPLETED|Overall Study||8
9827859|NCT00752895|10938537|FG001|NOT COMPLETED|Overall Study||3
9827860|NCT00752908|10938545|FG000|STARTED|Overall Study||14
9827861|NCT00752908|10938546|FG001|STARTED|Overall Study||13
9827862|NCT00752908|10938545|FG000|COMPLETED|Overall Study||14
9827863|NCT00752908|10938546|FG001|COMPLETED|Overall Study||13
10017454|NCT01816893|11140370|FG000|STARTED|Washout Period||11
10017455|NCT01816893|11140371|FG001|STARTED|Washout Period||11
10237633|NCT00683787|11368719|FG002|NOT COMPLETED|Overall Study||2
10237634|NCT00679926|11368727|FG000|STARTED|Overall Study||15
10237635|NCT00679926|11368727|FG000|COMPLETED|Overall Study||2
10237636|NCT00679926|11368727|FG000|NOT COMPLETED|Overall Study||13
9827864|NCT00752908|10938545|FG000|NOT COMPLETED|Overall Study||0
9827865|NCT00752908|10938546|FG001|NOT COMPLETED|Overall Study||0
9827866|NCT00752973|10938552|FG000|STARTED|Overall Study||12
9827867|NCT00752973|10938552|FG000|COMPLETED|Overall Study||12
9827868|NCT00752973|10938552|FG000|NOT COMPLETED|Overall Study||0
9827869|NCT00753012|10938560|FG000|STARTED|Overall Study||15
9827870|NCT00753012|10938561|FG001|STARTED|Overall Study||9
9827871|NCT00753012|10938560|FG000|COMPLETED|Overall Study||7
9827872|NCT00753012|10938561|FG001|COMPLETED|Overall Study||8
9827873|NCT00753012|10938560|FG000|NOT COMPLETED|Overall Study||8
9827874|NCT00753012|10938561|FG001|NOT COMPLETED|Overall Study||1
9827875|NCT00753142|10938571|FG000|STARTED|Overall Study||8
9827876|NCT00753142|10938572|FG001|STARTED|Overall Study||7
9827877|NCT00753142|10938573|FG002|STARTED|Overall Study||13
9827878|NCT00753142|10938571|FG000|COMPLETED|Overall Study||8
9827879|NCT00753142|10938572|FG001|COMPLETED|Overall Study||7
9827880|NCT00753142|10938573|FG002|COMPLETED|Overall Study||13
9827881|NCT00753142|10938571|FG000|NOT COMPLETED|Overall Study||0
9827882|NCT00753142|10938572|FG001|NOT COMPLETED|Overall Study||0
10237637|NCT00678041|11368734|FG000|STARTED|Overall Study||5
10237638|NCT00678041|11368735|FG001|STARTED|Overall Study||5
10237639|NCT00678041|11368734|FG000|COMPLETED|Overall Study||0
10237640|NCT00678041|11368735|FG001|COMPLETED|Overall Study||0
10237641|NCT00678041|11368734|FG000|NOT COMPLETED|Overall Study||5
10237642|NCT00678041|11368735|FG001|NOT COMPLETED|Overall Study||5
10237643|NCT00680316|11368744|FG000|STARTED|Overall Study||1
10237644|NCT00680316|11368745|FG001|STARTED|Overall Study||2
10237645|NCT00680316|11368744|FG000|COMPLETED|Overall Study||1
10237646|NCT00680316|11368745|FG001|COMPLETED|Overall Study||2
10237647|NCT00680316|11368744|FG000|NOT COMPLETED|Overall Study||0
10237648|NCT00680316|11368745|FG001|NOT COMPLETED|Overall Study||0
10237649|NCT00681629|11368753|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5
10237650|NCT00681629|11368754|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2
10237651|NCT00681629|11368753|FG000|COMPLETED|Overall Study||0
10237652|NCT00681629|11368754|FG001|COMPLETED|Overall Study||0
10237653|NCT00681629|11368753|FG000|NOT COMPLETED|Overall Study||5
10237654|NCT00681629|11368754|FG001|NOT COMPLETED|Overall Study||2
10237655|NCT00669461|11368760|FG000|STARTED|Overall Study||1
10237656|NCT00669461|11368760|FG000|COMPLETED|Overall Study||1
10237657|NCT00669461|11368760|FG000|NOT COMPLETED|Overall Study||0
10237658|NCT00671606|11368765|FG000|STARTED|Overall Study||5
10237659|NCT00671606|11368765|FG000|COMPLETED|Overall Study||5
10237660|NCT00671606|11368765|FG000|NOT COMPLETED|Overall Study||0
10237661|NCT00673309|11368779|FG000|STARTED|Overall Study||64
10237662|NCT00673309|11368780|FG001|STARTED|Overall Study||14
10237663|NCT00673309|11368781|FG002|STARTED|Overall Study||14
10237664|NCT00673309|11368782|FG003|STARTED|Overall Study||25
10237665|NCT00673309|11368783|FG004|STARTED|Overall Study||18
10237666|NCT00673309|11368784|FG005|STARTED|Overall Study||35
10237667|NCT00673309|11368785|FG006|STARTED|Overall Study||14
10237668|NCT00673309|11368786|FG007|STARTED|Overall Study||13
10237669|NCT00673309|11368787|FG008|STARTED|Overall Study||17
10237670|NCT00673309|11368788|FG009|STARTED|Overall Study||30
10237671|NCT00673309|11368779|FG000|COMPLETED|Overall Study||64
10237672|NCT00673309|11368780|FG001|COMPLETED|Overall Study||14
10237673|NCT00673309|11368781|FG002|COMPLETED|Overall Study||14
10237674|NCT00673309|11368782|FG003|COMPLETED|Overall Study||25
9827883|NCT00753142|10938573|FG002|NOT COMPLETED|Overall Study||0
9827884|NCT00753220|10938581|FG000|STARTED|Overall Study||7
9827885|NCT00753220|10938581|FG000|COMPLETED|Overall Study||2
9827886|NCT00753220|10938581|FG000|NOT COMPLETED|Overall Study||5
9827887|NCT00753272|10938587|FG000|STARTED|Overall Study||21893
9827888|NCT00753272|10938588|FG001|STARTED|Overall Study||21802
9827889|NCT00753272|10938587|FG000|COMPLETED|Overall Study||16911
10017456|NCT01816893|11140370|FG000|COMPLETED|Washout Period||9
10017457|NCT01816893|11140371|FG001|COMPLETED|Washout Period||11
10017458|NCT01816893|11140370|FG000|NOT COMPLETED|Washout Period||2
9827890|NCT00753272|10938588|FG001|COMPLETED|Overall Study||16895
9827891|NCT00753272|10938587|FG000|NOT COMPLETED|Overall Study||4982
10237675|NCT00673309|11368783|FG004|COMPLETED|Overall Study||18
10237676|NCT00673309|11368784|FG005|COMPLETED|Overall Study||35
10237677|NCT00673309|11368785|FG006|COMPLETED|Overall Study||14
10237678|NCT00673309|11368786|FG007|COMPLETED|Overall Study||13
10237679|NCT00673309|11368787|FG008|COMPLETED|Overall Study||17
10237680|NCT00673309|11368788|FG009|COMPLETED|Overall Study||30
10237681|NCT00673309|11368779|FG000|NOT COMPLETED|Overall Study||0
9827892|NCT00753272|10938588|FG001|NOT COMPLETED|Overall Study||4907
9827893|NCT00753298|10938599|FG000|STARTED|Overall Study||97
9827894|NCT00753298|10938600|FG001|STARTED|Overall Study||98
9827895|NCT00753298|10938599|FG000|COMPLETED|Overall Study||89
9827896|NCT00753298|10938600|FG001|COMPLETED|Overall Study||94
9827897|NCT00753298|10938599|FG000|NOT COMPLETED|Overall Study||8
9827898|NCT00753298|10938600|FG001|NOT COMPLETED|Overall Study||4
9827899|NCT00753337|10938606|FG000|STARTED|Overall Study||123
9827900|NCT00753337|10938606|FG000|COMPLETED|Overall Study||123
9827901|NCT00753337|10938606|FG000|NOT COMPLETED|Overall Study||0
9827902|NCT00753363|10938613|FG000|STARTED|Overall Study||59
9827903|NCT00753363|10938614|FG001|STARTED|Overall Study||60
10017459|NCT01816893|11140371|FG001|NOT COMPLETED|Washout Period||0
10017460|NCT01816893|11140370|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
10017461|NCT01816893|11140371|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
10017462|NCT01816893|11140370|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
10017463|NCT01816893|11140371|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
10237682|NCT00673309|11368780|FG001|NOT COMPLETED|Overall Study||0
10237683|NCT00673309|11368781|FG002|NOT COMPLETED|Overall Study||0
10237684|NCT00673309|11368782|FG003|NOT COMPLETED|Overall Study||0
10237685|NCT00673309|11368783|FG004|NOT COMPLETED|Overall Study||0
10237686|NCT00673309|11368784|FG005|NOT COMPLETED|Overall Study||0
10237687|NCT00673309|11368785|FG006|NOT COMPLETED|Overall Study||0
10237688|NCT00673309|11368786|FG007|NOT COMPLETED|Overall Study||0
10237689|NCT00673309|11368787|FG008|NOT COMPLETED|Overall Study||0
10237690|NCT00673309|11368788|FG009|NOT COMPLETED|Overall Study||0
10237691|NCT00672178|11368801|FG000|STARTED|Overall Study||1
10237692|NCT00672178|11368801|FG000|COMPLETED|Overall Study||1
10237693|NCT00672178|11368801|FG000|NOT COMPLETED|Overall Study||0
10237694|NCT00673595|11368807|FG000|STARTED|Overall Study||8
10237695|NCT00673595|11368808|FG001|STARTED|Overall Study||11
10237696|NCT00673595|11368807|FG000|COMPLETED|Overall Study||8
10237697|NCT00673595|11368808|FG001|COMPLETED|Overall Study||11
10237698|NCT00673595|11368807|FG000|NOT COMPLETED|Overall Study||0
10237699|NCT00673595|11368808|FG001|NOT COMPLETED|Overall Study||0
10237700|NCT00673361|11368814|FG000|STARTED|Overall Study||9
10237701|NCT00673361|11368814|FG000|COMPLETED|Overall Study||7
10237702|NCT00673361|11368814|FG000|NOT COMPLETED|Overall Study||2
10237703|NCT00670631|11368818|FG000|STARTED|Overall Study||0
10237704|NCT00670631|11368818|FG000|COMPLETED|Overall Study||0
10237705|NCT00670631|11368818|FG000|NOT COMPLETED|Overall Study||0
10237706|NCT00668785|11368823|FG000|STARTED|Overall Study||6
10237707|NCT00668785|11368823|FG000|COMPLETED|Overall Study||6
10237708|NCT00668785|11368823|FG000|NOT COMPLETED|Overall Study||0
10237709|NCT00673179|11368831|FG000|STARTED|Overall Study||7
10237710|NCT00673179|11368832|FG001|STARTED|Overall Study||0
10237711|NCT00673179|11368831|FG000|COMPLETED|Overall Study||4
10237712|NCT00673179|11368832|FG001|COMPLETED|Overall Study||0
10237713|NCT00673179|11368831|FG000|NOT COMPLETED|Overall Study||3
10237714|NCT00673179|11368832|FG001|NOT COMPLETED|Overall Study||0
10237715|NCT00668265|11368840|FG000|STARTED|Overall Study||9
10237716|NCT00668265|11368841|FG001|STARTED|Overall Study||5
10237717|NCT00668265|11368840|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
10237718|NCT00668265|11368841|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
10237719|NCT00668265|11368840|FG000|NOT COMPLETED|Overall Study||9
10237720|NCT00668265|11368841|FG001|NOT COMPLETED|Overall Study||5
10237721|NCT00660348|11368851|FG000|STARTED|Overall Study||1
10237722|NCT00660348|11368852|FG001|STARTED|Overall Study||0
10237723|NCT00660348|11368851|FG000|COMPLETED|Overall Study||0
10237724|NCT00660348|11368852|FG001|COMPLETED|Overall Study||0
10237725|NCT00660348|11368851|FG000|NOT COMPLETED|Overall Study||1
10237726|NCT00660348|11368852|FG001|NOT COMPLETED|Overall Study||0
10237727|NCT00664066|11368858|FG000|STARTED|Overall Study||3
10237728|NCT00664066|11368858|FG000|COMPLETED|Overall Study||0
10237729|NCT00664066|11368858|FG000|NOT COMPLETED|Overall Study||3
10237730|NCT00667017|11368862|FG000|STARTED|Overall Study||1
10237731|NCT00667017|11368862|FG000|COMPLETED|Overall Study||0
10237732|NCT00667017|11368862|FG000|NOT COMPLETED|Overall Study||1
10237733|NCT00665444|11368866|FG000|STARTED|Overall Study||3
10237734|NCT00665444|11368866|FG000|COMPLETED|Overall Study||1
10237735|NCT00665444|11368866|FG000|NOT COMPLETED|Overall Study||2
10237736|NCT00656916|11368872|FG000|STARTED|Overall Study||1
10237737|NCT00656916|11368873|FG001|STARTED|Overall Study||0
10237738|NCT00656916|11368872|FG000|COMPLETED|Overall Study||1
9827904|NCT00753363|10938613|FG000|COMPLETED|Overall Study||19
9827905|NCT00753363|10938614|FG001|COMPLETED|Overall Study||21
9827906|NCT00753363|10938613|FG000|NOT COMPLETED|Overall Study||40
10237739|NCT00656916|11368873|FG001|COMPLETED|Overall Study||0
10237740|NCT00656916|11368872|FG000|NOT COMPLETED|Overall Study||0
10237741|NCT00656916|11368873|FG001|NOT COMPLETED|Overall Study||0
10237742|NCT00660595|11368881|FG000|STARTED|Overall Study||19
10237743|NCT00660595|11368882|FG001|STARTED|Overall Study||10
10237744|NCT00660595|11368881|FG000|COMPLETED|Overall Study||1
10237745|NCT00660595|11368882|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1
10237746|NCT00660595|11368881|FG000|NOT COMPLETED|Overall Study||18
10237747|NCT00660595|11368882|FG001|NOT COMPLETED|Overall Study||9
10237748|NCT00661466|11368890|FG000|STARTED|Overall Study|Participants|4
10237749|NCT00661466|11368891|FG001|STARTED|Overall Study|Participants|3
9827907|NCT00753363|10938614|FG001|NOT COMPLETED|Overall Study||39
9827908|NCT00753415|10938625|FG000|STARTED|Part A||3
9827909|NCT00753415|10938626|FG001|STARTED|Part A||3
9827910|NCT00753415|10938627|FG002|STARTED|Part A||10
9827911|NCT00753415|10938628|FG003|STARTED|Part A||11
9827912|NCT00753415|10938629|FG004|STARTED|Part A||10
9827913|NCT00753415|10938630|FG005|STARTED|Part A||0
9827914|NCT00753415|10938631|FG006|STARTED|Part A||0
9827915|NCT00753415|10938632|FG007|STARTED|Part A||0
9827916|NCT00753415|10938633|FG008|STARTED|Part A||0
9827917|NCT00753415|10938634|FG009|STARTED|Part A||0
9827918|NCT00753415|10938625|FG000|COMPLETED|Part A||2
9827919|NCT00753415|10938626|FG001|COMPLETED|Part A||3
10237750|NCT00661466|11368890|FG000|COMPLETED|Overall Study|Participants|4
10237751|NCT00661466|11368891|FG001|COMPLETED|Overall Study|Participants|3
10237752|NCT00661466|11368890|FG000|NOT COMPLETED|Overall Study||0
10237753|NCT00661466|11368891|FG001|NOT COMPLETED|Overall Study||0
10237754|NCT00646282|11368899|FG000|STARTED|Overall Study||4
10237755|NCT00646282|11368900|FG001|STARTED|Overall Study||4
10237756|NCT00646282|11368899|FG000|COMPLETED|Overall Study||0
10237757|NCT00646282|11368900|FG001|COMPLETED|Overall Study||0
10237758|NCT00646282|11368899|FG000|NOT COMPLETED|Overall Study||4
10237759|NCT00646282|11368900|FG001|NOT COMPLETED|Overall Study||4
10237760|NCT00657553|11368908|FG000|STARTED|Overall Study||5
10237761|NCT00657553|11368909|FG001|STARTED|Overall Study||5
10237762|NCT00657553|11368908|FG000|COMPLETED|Overall Study||0
10237763|NCT00657553|11368909|FG001|COMPLETED|Overall Study||0
10237764|NCT00657553|11368908|FG000|NOT COMPLETED|Overall Study||5
10237765|NCT00657553|11368909|FG001|NOT COMPLETED|Overall Study||5
10237766|NCT00655057|11368918|FG000|STARTED|Overall Study||0
10237767|NCT00655057|11368919|FG001|STARTED|Overall Study||0
10237768|NCT00655057|11368920|FG002|STARTED|Overall Study||0
10237769|NCT00655057|11368918|FG000|COMPLETED|Overall Study||0
10237770|NCT00655057|11368919|FG001|COMPLETED|Overall Study||0
10237771|NCT00655057|11368920|FG002|COMPLETED|Overall Study||0
10237772|NCT00655057|11368918|FG000|NOT COMPLETED|Overall Study||0
10237773|NCT00655057|11368919|FG001|NOT COMPLETED|Overall Study||0
10237774|NCT00655057|11368920|FG002|NOT COMPLETED|Overall Study||0
10237775|NCT00648895|11368930|FG000|STARTED|Overall Study||6
10237776|NCT00648895|11368931|FG001|STARTED|Overall Study||6
10237777|NCT00648895|11368930|FG000|COMPLETED|Overall Study||6
10237778|NCT00648895|11368931|FG001|COMPLETED|Overall Study||5
10237779|NCT00648895|11368930|FG000|NOT COMPLETED|Overall Study||0
10237780|NCT00648895|11368931|FG001|NOT COMPLETED|Overall Study||1
10237781|NCT00647426|11368937|FG000|STARTED|Overall Study||7
10237782|NCT00647426|11368937|FG000|COMPLETED|Overall Study||5
10237783|NCT00647426|11368937|FG000|NOT COMPLETED|Overall Study||2
10237784|NCT00645567|11368942|FG000|STARTED|Overall Study||5
10237785|NCT00645567|11368942|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
10237786|NCT00645567|11368942|FG000|NOT COMPLETED|Overall Study||1
10237787|NCT00637806|11368953|FG000|STARTED|Double-blind Phase||2
10237788|NCT00637806|11368954|FG001|STARTED|Double-blind Phase||0
10237789|NCT00637806|11368955|FG002|STARTED|Double-blind Phase||2
10237790|NCT00637806|11368956|FG003|STARTED|Double-blind Phase||0
10237791|NCT00637806|11368953|FG000|COMPLETED|Double-blind Phase||0
10237792|NCT00637806|11368954|FG001|COMPLETED|Double-blind Phase||0
10237793|NCT00637806|11368955|FG002|COMPLETED|Double-blind Phase||1
10237794|NCT00637806|11368956|FG003|COMPLETED|Double-blind Phase||0
10237795|NCT00637806|11368953|FG000|NOT COMPLETED|Double-blind Phase||2
10237796|NCT00637806|11368954|FG001|NOT COMPLETED|Double-blind Phase||0
10237797|NCT00637806|11368955|FG002|NOT COMPLETED|Double-blind Phase||1
10237798|NCT00637806|11368956|FG003|NOT COMPLETED|Double-blind Phase||0
10237799|NCT00637806|11368953|FG000|STARTED|Extension Phase||0
10237800|NCT00637806|11368954|FG001|STARTED|Extension Phase||0
10237801|NCT00637806|11368955|FG002|STARTED|Extension Phase||0
10237802|NCT00637806|11368956|FG003|STARTED|Extension Phase||1
10237803|NCT00637806|11368953|FG000|COMPLETED|Extension Phase||0
10237804|NCT00637806|11368954|FG001|COMPLETED|Extension Phase||0
10237805|NCT00637806|11368955|FG002|COMPLETED|Extension Phase||0
10237806|NCT00637806|11368956|FG003|COMPLETED|Extension Phase||0
9827920|NCT00753415|10938627|FG002|COMPLETED|Part A||8
9827921|NCT00753415|10938628|FG003|COMPLETED|Part A||9
9827922|NCT00753415|10938629|FG004|COMPLETED|Part A||10
9827923|NCT00753415|10938630|FG005|COMPLETED|Part A||0
9827924|NCT00753415|10938631|FG006|COMPLETED|Part A||0
9827925|NCT00753415|10938632|FG007|COMPLETED|Part A||0
9827926|NCT00753415|10938633|FG008|COMPLETED|Part A||0
9827927|NCT00753415|10938634|FG009|COMPLETED|Part A||0
9827928|NCT00753415|10938625|FG000|NOT COMPLETED|Part A||1
9827929|NCT00753415|10938626|FG001|NOT COMPLETED|Part A||0
10237807|NCT00637806|11368953|FG000|NOT COMPLETED|Extension Phase||0
10237808|NCT00637806|11368954|FG001|NOT COMPLETED|Extension Phase||0
10237809|NCT00637806|11368955|FG002|NOT COMPLETED|Extension Phase||0
10237810|NCT00637806|11368956|FG003|NOT COMPLETED|Extension Phase||1
10239790|NCT02009384|11371510|FG000|NOT COMPLETED|Overall Study||2
10239791|NCT04558125|11371514|FG000|STARTED|Overall Study||2
10239792|NCT04558125|11371514|FG000|COMPLETED|Overall Study||1
10239793|NCT04558125|11371514|FG000|NOT COMPLETED|Overall Study||1
10239794|NCT02401308|11371520|FG000|STARTED|Overall Study||0
10239795|NCT02401308|11371521|FG001|STARTED|Overall Study||1
10239796|NCT02401308|11371520|FG000|COMPLETED|Overall Study||0
10239797|NCT02401308|11371521|FG001|COMPLETED|Overall Study||0
10239798|NCT02401308|11371520|FG000|NOT COMPLETED|Overall Study||0
10239799|NCT02401308|11371521|FG001|NOT COMPLETED|Overall Study||1
9827930|NCT00753415|10938627|FG002|NOT COMPLETED|Part A||2
9827931|NCT00753415|10938628|FG003|NOT COMPLETED|Part A||2
9827932|NCT00753415|10938629|FG004|NOT COMPLETED|Part A||0
9827933|NCT00753415|10938630|FG005|NOT COMPLETED|Part A||0
9827934|NCT00753415|10938631|FG006|NOT COMPLETED|Part A||0
9827935|NCT00753415|10938632|FG007|NOT COMPLETED|Part A||0
9827936|NCT00753415|10938633|FG008|NOT COMPLETED|Part A||0
9827937|NCT00753415|10938634|FG009|NOT COMPLETED|Part A||0
9827938|NCT00753415|10938625|FG000|STARTED|Part B||0
9827939|NCT00753415|10938626|FG001|STARTED|Part B||0
10237811|NCT00652457|11368965|FG000|STARTED|Overall Study||23
10237812|NCT00652457|11368966|FG001|STARTED|Overall Study||27
10237813|NCT00652457|11368965|FG000|COMPLETED|Overall Study||23
10237814|NCT00652457|11368966|FG001|COMPLETED|Overall Study||27
10237815|NCT00652457|11368965|FG000|NOT COMPLETED|Overall Study||0
10237816|NCT00652457|11368966|FG001|NOT COMPLETED|Overall Study||0
10237817|NCT00642603|11368974|FG000|STARTED|Overall Study||21
10237818|NCT00642603|11368975|FG001|STARTED|Overall Study||20
10237819|NCT00642603|11368974|FG000|Safety Population|Overall Study||19
10237820|NCT00642603|11368975|FG001|Safety Population|Overall Study||20
10237821|NCT00642603|11368974|FG000|COMPLETED|Overall Study||0
10237822|NCT00642603|11368975|FG001|COMPLETED|Overall Study||2
10237823|NCT00642603|11368974|FG000|NOT COMPLETED|Overall Study||21
10237824|NCT00642603|11368975|FG001|NOT COMPLETED|Overall Study||18
10237825|NCT00629798|11368981|FG000|STARTED|Overall Study||64
10237826|NCT00629798|11368981|FG000|COMPLETED|Overall Study||60
10237827|NCT00629798|11368981|FG000|NOT COMPLETED|Overall Study||4
10237828|NCT00645359|11368985|FG000|STARTED|Overall Study||9
10237829|NCT00645359|11368985|FG000|COMPLETED|Overall Study||9
10237830|NCT00645359|11368985|FG000|NOT COMPLETED|Overall Study||0
10237831|NCT00637728|11368991|FG000|STARTED|Double-blind Phase||4
10237832|NCT00637728|11368992|FG001|STARTED|Double-blind Phase||1
10237833|NCT00637728|11368993|FG002|STARTED|Double-blind Phase||0
10237834|NCT00637728|11368991|FG000|COMPLETED|Double-blind Phase||0
10237835|NCT00637728|11368992|FG001|COMPLETED|Double-blind Phase||0
10237836|NCT00637728|11368993|FG002|COMPLETED|Double-blind Phase||0
10237837|NCT00637728|11368991|FG000|NOT COMPLETED|Double-blind Phase||4
10237838|NCT00637728|11368992|FG001|NOT COMPLETED|Double-blind Phase||1
10237839|NCT00637728|11368993|FG002|NOT COMPLETED|Double-blind Phase||0
10237840|NCT00637728|11368991|FG000|STARTED|Extension Phase||0
10237841|NCT00637728|11368992|FG001|STARTED|Extension Phase||0
10237842|NCT00637728|11368993|FG002|STARTED|Extension Phase||0
10237843|NCT00637728|11368991|FG000|COMPLETED|Extension Phase||0
10237844|NCT00637728|11368992|FG001|COMPLETED|Extension Phase||0
10237845|NCT00637728|11368993|FG002|COMPLETED|Extension Phase||0
10237846|NCT00637728|11368991|FG000|NOT COMPLETED|Extension Phase||0
10237847|NCT00637728|11368992|FG001|NOT COMPLETED|Extension Phase||0
10237848|NCT00637728|11368993|FG002|NOT COMPLETED|Extension Phase||0
10237849|NCT00639626|11369000|FG000|STARTED|Overall Study||0
10237850|NCT00639626|11369000|FG000|COMPLETED|Overall Study||0
10237851|NCT00639626|11369000|FG000|NOT COMPLETED|Overall Study||0
10237852|NCT00634582|11369004|FG000|STARTED|Overall Study||2
10237853|NCT00634582|11369004|FG000|COMPLETED|Overall Study||2
10237854|NCT00634582|11369004|FG000|NOT COMPLETED|Overall Study||0
10237855|NCT00641108|11369010|FG000|STARTED|Overall Study||0
10237856|NCT00641108|11369011|FG001|STARTED|Overall Study||0
10237857|NCT00641108|11369010|FG000|COMPLETED|Overall Study||0
10237858|NCT00641108|11369011|FG001|COMPLETED|Overall Study||0
10237859|NCT00641108|11369010|FG000|NOT COMPLETED|Overall Study||0
10237860|NCT00641108|11369011|FG001|NOT COMPLETED|Overall Study||0
10237861|NCT00642382|11369019|FG000|STARTED|Overall Study||0
10237862|NCT00642382|11369020|FG001|STARTED|Overall Study||0
10237863|NCT00642382|11369019|FG000|COMPLETED|Overall Study||0
10237864|NCT00642382|11369020|FG001|COMPLETED|Overall Study||0
10237865|NCT00642382|11369019|FG000|NOT COMPLETED|Overall Study||0
10237866|NCT00642382|11369020|FG001|NOT COMPLETED|Overall Study||0
10237867|NCT00637416|11369028|FG000|STARTED|Overall Study||4
10237868|NCT00637416|11369029|FG001|STARTED|Overall Study||5
10237869|NCT00637416|11369028|FG000|COMPLETED|Overall Study||3
10237870|NCT00637416|11369029|FG001|COMPLETED|Overall Study||3
9827940|NCT00753415|10938627|FG002|STARTED|Part B||0
9827941|NCT00753415|10938628|FG003|STARTED|Part B||0
9827942|NCT00753415|10938629|FG004|STARTED|Part B||0
9827943|NCT00753415|10938630|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
9827944|NCT00753415|10938631|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
10237871|NCT00637416|11369028|FG000|NOT COMPLETED|Overall Study||1
10237872|NCT00637416|11369029|FG001|NOT COMPLETED|Overall Study||2
10237873|NCT00635167|11369035|FG000|STARTED|Overall Study||1
10237874|NCT00635167|11369035|FG000|COMPLETED|Overall Study||1
10237875|NCT00635167|11369035|FG000|NOT COMPLETED|Overall Study||0
10237876|NCT00637312|11369041|FG000|STARTED|Overall Study||72
10237877|NCT00637312|11369042|FG001|STARTED|Overall Study||36
10237878|NCT00637312|11369041|FG000|COMPLETED|Overall Study||30
10237879|NCT00637312|11369042|FG001|COMPLETED|Overall Study||19
10237880|NCT00637312|11369041|FG000|NOT COMPLETED|Overall Study||42
10237881|NCT00637312|11369042|FG001|NOT COMPLETED|Overall Study||17
10237882|NCT00638222|11369051|FG000|STARTED|Overall Study||0
10237883|NCT00638222|11369052|FG001|STARTED|Overall Study||0
10237884|NCT00638222|11369053|FG002|STARTED|Overall Study||6
10237885|NCT00638222|11369051|FG000|COMPLETED|Overall Study||0
10237886|NCT00638222|11369052|FG001|COMPLETED|Overall Study||0
10237887|NCT00638222|11369053|FG002|COMPLETED|Overall Study||6
10237888|NCT00638222|11369051|FG000|NOT COMPLETED|Overall Study||0
9827945|NCT00753415|10938632|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
9827946|NCT00753415|10938633|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
9827947|NCT00753415|10938634|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
9827948|NCT00753415|10938625|FG000|COMPLETED|Part B||0
9827949|NCT00753415|10938626|FG001|COMPLETED|Part B||0
9827950|NCT00753415|10938627|FG002|COMPLETED|Part B||0
9827951|NCT00753415|10938628|FG003|COMPLETED|Part B||0
9827952|NCT00753415|10938629|FG004|COMPLETED|Part B||0
9827953|NCT00753415|10938630|FG005|COMPLETED|Part B||1
9827954|NCT00753415|10938631|FG006|COMPLETED|Part B||2
9827955|NCT00753415|10938632|FG007|COMPLETED|Part B||6
9827956|NCT00753415|10938633|FG008|COMPLETED|Part B||6
9827957|NCT00753415|10938634|FG009|COMPLETED|Part B||8
9827958|NCT00753415|10938625|FG000|NOT COMPLETED|Part B||0
9827959|NCT00753415|10938626|FG001|NOT COMPLETED|Part B||0
9827960|NCT00753415|10938627|FG002|NOT COMPLETED|Part B||0
9827961|NCT00753415|10938628|FG003|NOT COMPLETED|Part B||0
9827962|NCT00753415|10938629|FG004|NOT COMPLETED|Part B||0
10237889|NCT00638222|11369052|FG001|NOT COMPLETED|Overall Study||0
10237890|NCT00638222|11369053|FG002|NOT COMPLETED|Overall Study||0
10237891|NCT00634322|11369063|FG000|STARTED|Overall Study||1
10237892|NCT00634322|11369064|FG001|STARTED|Overall Study||1
10237893|NCT00634322|11369065|FG002|STARTED|Overall Study||5
10237894|NCT00634322|11369063|FG000|COMPLETED|Overall Study||1
10237895|NCT00634322|11369064|FG001|COMPLETED|Overall Study||1
10237896|NCT00634322|11369065|FG002|COMPLETED|Overall Study||5
10237897|NCT00634322|11369063|FG000|NOT COMPLETED|Overall Study||0
10237898|NCT00634322|11369064|FG001|NOT COMPLETED|Overall Study||0
10237899|NCT00634322|11369065|FG002|NOT COMPLETED|Overall Study||0
10237900|NCT00633087|11369073|FG000|STARTED|Overall Study||12
10237901|NCT00633087|11369073|FG000|COMPLETED|Overall Study||12
10237902|NCT00633087|11369073|FG000|NOT COMPLETED|Overall Study||0
10237903|NCT00631137|11369079|FG000|STARTED|Overall Study||1
10237904|NCT00631137|11369080|FG001|STARTED|Overall Study||0
10237905|NCT00631137|11369079|FG000|COMPLETED|Overall Study||0
10237906|NCT00631137|11369080|FG001|COMPLETED|Overall Study||0
10237907|NCT00631137|11369079|FG000|NOT COMPLETED|Overall Study||1
10237908|NCT00631137|11369080|FG001|NOT COMPLETED|Overall Study||0
10237909|NCT00634972|11369088|FG000|STARTED|Overall Study||40
10237910|NCT00634972|11369089|FG001|STARTED|Overall Study||43
10237911|NCT00634972|11369088|FG000|COMPLETED|Overall Study||40
10237912|NCT00634972|11369089|FG001|COMPLETED|Overall Study||43
10237913|NCT00634972|11369088|FG000|NOT COMPLETED|Overall Study||0
10237914|NCT00634972|11369089|FG001|NOT COMPLETED|Overall Study||0
10237915|NCT00633061|11369097|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
10237916|NCT00633061|11369098|FG001|STARTED|Overall Study||0
10237917|NCT00633061|11369097|FG000|Met Criteria for Imaging|Overall Study||25
10237918|NCT00633061|11369098|FG001|Met Criteria for Imaging|Overall Study||0
10237919|NCT00633061|11369097|FG000|Had Prior Thrombosis Identified|Overall Study||25
10237920|NCT00633061|11369098|FG001|Had Prior Thrombosis Identified|Overall Study||0
10237921|NCT00633061|11369097|FG000|COMPLETED|Overall Study||50
10237922|NCT00633061|11369098|FG001|COMPLETED|Overall Study||0
10237923|NCT00633061|11369097|FG000|NOT COMPLETED|Overall Study||86
10237924|NCT00633061|11369098|FG001|NOT COMPLETED|Overall Study||0
10237925|NCT00626444|11369106|FG000|STARTED|Overall Study||2
10237926|NCT00626444|11369106|FG000|COMPLETED|Overall Study||2
10237927|NCT00626444|11369106|FG000|NOT COMPLETED|Overall Study||0
10237928|NCT00630292|11369110|FG000|STARTED|Overall Study||6
10237929|NCT00630292|11369110|FG000|COMPLETED|Overall Study||5
10237930|NCT00630292|11369110|FG000|NOT COMPLETED|Overall Study||1
10237931|NCT00634010|11369116|FG000|STARTED|Overall Study||18
10237932|NCT00634010|11369117|FG001|STARTED|Overall Study||18
10237933|NCT00634010|11369116|FG000|COMPLETED|Overall Study||8
10237934|NCT00634010|11369117|FG001|COMPLETED|Overall Study||4
10237935|NCT00634010|11369116|FG000|NOT COMPLETED|Overall Study||10
10237936|NCT00634010|11369117|FG001|NOT COMPLETED|Overall Study||14
10237937|NCT00630487|11369125|FG000|STARTED|Overall Study||0
10237938|NCT00630487|11369126|FG001|STARTED|Overall Study||0
10237939|NCT00630487|11369125|FG000|COMPLETED|Overall Study||0
10237940|NCT00630487|11369126|FG001|COMPLETED|Overall Study||0
10237941|NCT00630487|11369125|FG000|NOT COMPLETED|Overall Study||0
10237942|NCT00630487|11369126|FG001|NOT COMPLETED|Overall Study||0
10237943|NCT00629850|11369134|FG000|STARTED|Overall Study||1
10237944|NCT00629850|11369135|FG001|STARTED|Overall Study||0
10237945|NCT00629850|11369134|FG000|COMPLETED|Overall Study||1
9827963|NCT00753415|10938630|FG005|NOT COMPLETED|Part B||0
9827964|NCT00753415|10938631|FG006|NOT COMPLETED|Part B||0
9827965|NCT00753415|10938632|FG007|NOT COMPLETED|Part B||1
10237946|NCT00629850|11369135|FG001|COMPLETED|Overall Study||0
10237947|NCT00629850|11369134|FG000|NOT COMPLETED|Overall Study||0
10237948|NCT00629850|11369135|FG001|NOT COMPLETED|Overall Study||0
10237949|NCT00623974|11369145|FG000|STARTED|Overall Study||0
10237950|NCT00623974|11369146|FG001|STARTED|Overall Study||0
10237951|NCT00623974|11369147|FG002|STARTED|Overall Study||0
10237952|NCT00623974|11369148|FG003|STARTED|Overall Study||0
10237953|NCT00623974|11369145|FG000|COMPLETED|Overall Study||0
10237954|NCT00623974|11369146|FG001|COMPLETED|Overall Study||0
10237955|NCT00623974|11369147|FG002|COMPLETED|Overall Study||0
10237956|NCT00623974|11369148|FG003|COMPLETED|Overall Study||0
10237957|NCT00623974|11369145|FG000|NOT COMPLETED|Overall Study||0
10237958|NCT00623974|11369146|FG001|NOT COMPLETED|Overall Study||0
9827966|NCT00753415|10938633|FG008|NOT COMPLETED|Part B||3
9827967|NCT00753415|10938634|FG009|NOT COMPLETED|Part B||1
9827968|NCT00753454|10938658|FG000|STARTED|Overall Study||168
9827969|NCT00753454|10938658|FG000|COMPLETED|Overall Study||154
9827970|NCT00753454|10938658|FG000|NOT COMPLETED|Overall Study||14
9827971|NCT00753506|10938664|FG000|STARTED|Overall Study||33
9827972|NCT00753506|10938665|FG001|STARTED|Overall Study||33
9827973|NCT00753506|10938664|FG000|COMPLETED|Overall Study||26
9827974|NCT00753506|10938665|FG001|COMPLETED|Overall Study||31
9827975|NCT00753506|10938664|FG000|NOT COMPLETED|Overall Study||7
9827976|NCT00753506|10938665|FG001|NOT COMPLETED|Overall Study||2
9827977|NCT00753519|10938673|FG000|STARTED|Overall Study||13
9827978|NCT00753519|10938674|FG001|STARTED|Overall Study||15
9827979|NCT00753519|10938673|FG000|COMPLETED|Overall Study||13
9827980|NCT00753519|10938674|FG001|COMPLETED|Overall Study||13
9827981|NCT00753519|10938673|FG000|NOT COMPLETED|Overall Study||0
9827982|NCT00753519|10938674|FG001|NOT COMPLETED|Overall Study||2
9827983|NCT00753623|10938684|FG000|STARTED|Phase I (14 Days)||11
9827984|NCT00753623|10938685|FG001|STARTED|Phase I (14 Days)||12
9827985|NCT00753623|10938684|FG000|COMPLETED|Phase I (14 Days)||9
9827986|NCT00753623|10938685|FG001|COMPLETED|Phase I (14 Days)||8
9827987|NCT00753623|10938684|FG000|NOT COMPLETED|Phase I (14 Days)||2
9827988|NCT00753623|10938685|FG001|NOT COMPLETED|Phase I (14 Days)||4
9827989|NCT00753623|10938684|FG000|STARTED|Washout (7 Days)||9
9827990|NCT00753623|10938685|FG001|STARTED|Washout (7 Days)||8
9827991|NCT00753623|10938684|FG000|COMPLETED|Washout (7 Days)||8
9827992|NCT00753623|10938685|FG001|COMPLETED|Washout (7 Days)||8
9827993|NCT00753623|10938684|FG000|NOT COMPLETED|Washout (7 Days)||1
9827994|NCT00753623|10938685|FG001|NOT COMPLETED|Washout (7 Days)||0
9827995|NCT00753623|10938684|FG000|STARTED|Phase II (14 Days)||8
9827996|NCT00753623|10938685|FG001|STARTED|Phase II (14 Days)||8
9827997|NCT00753623|10938684|FG000|COMPLETED|Phase II (14 Days)||8
9827998|NCT00753623|10938685|FG001|COMPLETED|Phase II (14 Days)||7
9827999|NCT00753623|10938684|FG000|NOT COMPLETED|Phase II (14 Days)||0
9828000|NCT00753623|10938685|FG001|NOT COMPLETED|Phase II (14 Days)||1
9828001|NCT00753636|10938691|FG000|STARTED|Overall Study||31
9828002|NCT00753636|10938691|FG000|COMPLETED|Overall Study||25
10237959|NCT00623974|11369147|FG002|NOT COMPLETED|Overall Study||0
10237960|NCT00623974|11369148|FG003|NOT COMPLETED|Overall Study||0
10237961|NCT00624650|11369160|FG000|STARTED|Overall Study||17
10237962|NCT00624650|11369161|FG001|STARTED|Overall Study||16
10237963|NCT00624650|11369160|FG000|COMPLETED|Overall Study||16
10237964|NCT00624650|11369161|FG001|COMPLETED|Overall Study||15
10237965|NCT00624650|11369160|FG000|NOT COMPLETED|Overall Study||1
10237966|NCT00624650|11369161|FG001|NOT COMPLETED|Overall Study||1
10237967|NCT00626561|11369167|FG000|STARTED|Overall Study||4
10237968|NCT00626561|11369167|FG000|COMPLETED|Overall Study||0
10237969|NCT00626561|11369167|FG000|NOT COMPLETED|Overall Study||4
10237970|NCT00613730|11369171|FG000|STARTED|Overall Study||3
10237971|NCT00613730|11369171|FG000|COMPLETED|Overall Study||0
10237972|NCT00613730|11369171|FG000|NOT COMPLETED|Overall Study||3
10237973|NCT00625586|11369175|FG000|STARTED|Overall Study||2
10237974|NCT00625586|11369175|FG000|COMPLETED|Overall Study||1
10237975|NCT00625586|11369175|FG000|NOT COMPLETED|Overall Study||1
10237976|NCT00625703|11369179|FG000|STARTED|Overall Study||0
10237977|NCT00625703|11369179|FG000|COMPLETED|Overall Study||0
10237978|NCT00625703|11369179|FG000|NOT COMPLETED|Overall Study||0
10237979|NCT00625742|11369183|FG000|STARTED|Overall Study||15
10237980|NCT00625742|11369183|FG000|COMPLETED|Overall Study||3
10237981|NCT00625742|11369183|FG000|NOT COMPLETED|Overall Study||12
10237982|NCT00619242|11369187|FG000|STARTED|Overall Study||3
10237983|NCT00619242|11369187|FG000|COMPLETED|Overall Study||3
10237984|NCT00619242|11369187|FG000|NOT COMPLETED|Overall Study||0
10237985|NCT00619151|11369193|FG000|STARTED|Overall Study||2
10237986|NCT00619151|11369194|FG001|STARTED|Overall Study||0
10237987|NCT00619151|11369193|FG000|COMPLETED|Overall Study||1
10237988|NCT00619151|11369194|FG001|COMPLETED|Overall Study||0
10237989|NCT00619151|11369193|FG000|NOT COMPLETED|Overall Study||1
10237990|NCT00619151|11369194|FG001|NOT COMPLETED|Overall Study||0
10237991|NCT00622167|11369200|FG000|STARTED|Overall Study||24
10237992|NCT00622167|11369200|FG000|COMPLETED|Overall Study||4
10237993|NCT00622167|11369200|FG000|NOT COMPLETED|Overall Study||20
10237994|NCT00616577|11369207|FG000|STARTED|Overall Study||6
10237995|NCT00616577|11369208|FG001|STARTED|Overall Study||9
10237996|NCT00616577|11369209|FG002|STARTED|Overall Study||7
9828003|NCT00753636|10938691|FG000|NOT COMPLETED|Overall Study||6
9828004|NCT00753649|10938697|FG000|STARTED|Overall Study||112
9828005|NCT00753649|10938698|FG001|STARTED|Overall Study||112
9828006|NCT00753649|10938697|FG000|COMPLETED|Overall Study||105
9828007|NCT00753649|10938698|FG001|COMPLETED|Overall Study||112
9828008|NCT00753649|10938697|FG000|NOT COMPLETED|Overall Study||7
9828009|NCT00753649|10938698|FG001|NOT COMPLETED|Overall Study||0
9828010|NCT00753675|10938707|FG000|STARTED|Overall Study||59
9828011|NCT00753675|10938708|FG001|STARTED|Overall Study||59
10237997|NCT00616577|11369207|FG000|COMPLETED|Overall Study||6
10237998|NCT00616577|11369208|FG001|COMPLETED|Overall Study||9
10237999|NCT00616577|11369209|FG002|COMPLETED|Overall Study||7
10238000|NCT00616577|11369207|FG000|NOT COMPLETED|Overall Study||0
10238001|NCT00616577|11369208|FG001|NOT COMPLETED|Overall Study||0
10238002|NCT00616577|11369209|FG002|NOT COMPLETED|Overall Study||0
10238003|NCT00616759|11369219|FG000|STARTED|Overall Study||10
10238004|NCT00616759|11369220|FG001|STARTED|Overall Study||10
10238005|NCT00616759|11369219|FG000|COMPLETED|Overall Study||7
9828012|NCT00753675|10938709|FG002|STARTED|Overall Study||56
9828013|NCT00753675|10938707|FG000|COMPLETED|Overall Study||0
9828014|NCT00753675|10938708|FG001|COMPLETED|Overall Study||0
10112636|NCT02504320|11243578|FG000|STARTED|Treatment Period 2||19
10112637|NCT02504320|11243579|FG001|STARTED|Treatment Period 2||19
10238006|NCT00616759|11369220|FG001|COMPLETED|Overall Study||8
10238007|NCT00616759|11369219|FG000|NOT COMPLETED|Overall Study||3
10238008|NCT00616759|11369220|FG001|NOT COMPLETED|Overall Study||2
10238009|NCT00616642|11369228|FG000|STARTED|Overall Study||0
10238010|NCT00616642|11369229|FG001|STARTED|Overall Study||1
10238011|NCT00616642|11369228|FG000|COMPLETED|Overall Study||0
10238012|NCT00616642|11369229|FG001|COMPLETED|Overall Study||0
10238013|NCT00616642|11369228|FG000|NOT COMPLETED|Overall Study||0
10238014|NCT00616642|11369229|FG001|NOT COMPLETED|Overall Study||1
10238015|NCT00619515|11369235|FG000|STARTED|Overall Study||73
10238016|NCT00619515|11369235|FG000|COMPLETED|Overall Study||0
10238017|NCT00619515|11369235|FG000|NOT COMPLETED|Overall Study||73
10238018|NCT00616343|11369239|FG000|STARTED|Overall Study||9
10238019|NCT00616343|11369239|FG000|COMPLETED|Overall Study||9
10238020|NCT00616343|11369239|FG000|NOT COMPLETED|Overall Study||0
10238021|NCT00612677|11369243|FG000|STARTED|Overall Study||1
10238022|NCT00612677|11369243|FG000|COMPLETED|Overall Study||0
10238023|NCT00612677|11369243|FG000|NOT COMPLETED|Overall Study||1
10238024|NCT00616603|11369250|FG000|STARTED|Overall Study||14
10238025|NCT00616603|11369251|FG001|STARTED|Overall Study||14
10238026|NCT00616603|11369252|FG002|STARTED|Overall Study||15
10238027|NCT00616603|11369250|FG000|COMPLETED|Overall Study||12
10238028|NCT00616603|11369251|FG001|COMPLETED|Overall Study||14
10238029|NCT00616603|11369252|FG002|COMPLETED|Overall Study||13
10112638|NCT02504320|11243580|FG002|STARTED|Treatment Period 2||19
10112639|NCT02504320|11243581|FG003|STARTED|Treatment Period 2||20
10238030|NCT00616603|11369250|FG000|NOT COMPLETED|Overall Study||2
10238031|NCT00616603|11369251|FG001|NOT COMPLETED|Overall Study||0
10238032|NCT00616603|11369252|FG002|NOT COMPLETED|Overall Study||2
10238033|NCT00613886|11369260|FG000|STARTED|Overall Study||24
10238034|NCT00613886|11369260|FG000|COMPLETED|Overall Study||0
10238035|NCT00613886|11369260|FG000|NOT COMPLETED|Overall Study||24
10238036|NCT00610467|11369267|FG000|STARTED|Overall Study||1
10238037|NCT00610467|11369268|FG001|STARTED|Overall Study||1
10238038|NCT00610467|11369267|FG000|COMPLETED|Overall Study||1
10238039|NCT00610467|11369268|FG001|COMPLETED|Overall Study||1
10238040|NCT00610467|11369267|FG000|NOT COMPLETED|Overall Study||0
10238041|NCT00610467|11369268|FG001|NOT COMPLETED|Overall Study||0
10238042|NCT00610558|11369277|FG000|STARTED|Overall Study||20
10238043|NCT00610558|11369278|FG001|STARTED|Overall Study||20
10238044|NCT00610558|11369279|FG002|STARTED|Overall Study||20
10238045|NCT00610558|11369277|FG000|COMPLETED|Overall Study||15
10238046|NCT00610558|11369278|FG001|COMPLETED|Overall Study||14
10238047|NCT00610558|11369279|FG002|COMPLETED|Overall Study||14
10238048|NCT00610558|11369277|FG000|NOT COMPLETED|Overall Study||5
10238049|NCT00610558|11369278|FG001|NOT COMPLETED|Overall Study||6
10238050|NCT00610558|11369279|FG002|NOT COMPLETED|Overall Study||6
10238051|NCT00610532|11369287|FG000|STARTED|Intravenous Phenytoin Alone||8
10238052|NCT00610532|11369287|FG000|COMPLETED|Intravenous Phenytoin Alone||8
10238053|NCT00610532|11369287|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0
10238054|NCT00610532|11369287|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
10238055|NCT00610532|11369287|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
10238056|NCT00610532|11369287|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
10238057|NCT00609765|11369293|FG000|STARTED|Overall Study||1
10238058|NCT00609765|11369293|FG000|COMPLETED|Overall Study||0
10238059|NCT00609765|11369293|FG000|NOT COMPLETED|Overall Study||1
10238060|NCT00608465|11369297|FG000|STARTED|Overall Study||4
10238061|NCT00608465|11369297|FG000|COMPLETED|Overall Study||4
10238062|NCT00608465|11369297|FG000|NOT COMPLETED|Overall Study||0
10238063|NCT00608777|11369301|FG000|STARTED|Overall Study||6
10238064|NCT00608777|11369301|FG000|COMPLETED|Overall Study||6
10238065|NCT00608777|11369301|FG000|NOT COMPLETED|Overall Study||0
10238066|NCT00601848|11369305|FG000|STARTED|Overall Study||9
10238067|NCT00601848|11369305|FG000|COMPLETED|Overall Study||0
10238068|NCT00601848|11369305|FG000|NOT COMPLETED|Overall Study||9
10238069|NCT00607477|11369311|FG000|STARTED|Overall Study||0
10238070|NCT00607477|11369312|FG001|STARTED|Overall Study||2
10238071|NCT00607477|11369311|FG000|COMPLETED|Overall Study||0
10238072|NCT00607477|11369312|FG001|COMPLETED|Overall Study||2
10238073|NCT00607477|11369311|FG000|NOT COMPLETED|Overall Study||0
10238074|NCT00607477|11369312|FG001|NOT COMPLETED|Overall Study||0
10238075|NCT00595920|11369318|FG000|STARTED|Overall Study||116
10238076|NCT00595920|11369318|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
10238077|NCT00595920|11369318|FG000|COMPLETED|Overall Study||0
10238078|NCT00595920|11369318|FG000|NOT COMPLETED|Overall Study||116
9828015|NCT00753675|10938709|FG002|COMPLETED|Overall Study||0
10238079|NCT00596947|11369324|FG000|STARTED|Overall Study||9
10238080|NCT00596947|11369325|FG001|STARTED|Overall Study||9
10238081|NCT00596947|11369324|FG000|COMPLETED|Overall Study||3
10238082|NCT00596947|11369325|FG001|COMPLETED|Overall Study||6
10238083|NCT00596947|11369324|FG000|NOT COMPLETED|Overall Study||6
10238084|NCT00596947|11369325|FG001|NOT COMPLETED|Overall Study||3
10238085|NCT00584012|11369331|FG000|STARTED|Overall Study||9
10238086|NCT00584012|11369331|FG000|COMPLETED|Overall Study||8
10238087|NCT00584012|11369331|FG000|NOT COMPLETED|Overall Study||1
10238088|NCT00599131|11369335|FG000|STARTED|Overall Study||4
9828016|NCT00753675|10938707|FG000|NOT COMPLETED|Overall Study||59
9828017|NCT00753675|10938708|FG001|NOT COMPLETED|Overall Study||59
10112640|NCT02504320|11243578|FG000|COMPLETED|Treatment Period 2||19
10238089|NCT00599131|11369335|FG000|COMPLETED|Overall Study||4
10238090|NCT00599131|11369335|FG000|NOT COMPLETED|Overall Study||0
10238091|NCT00597909|11369342|FG000|STARTED|Overall Study||0
10238092|NCT00597909|11369343|FG001|STARTED|Overall Study||0
10238093|NCT00597909|11369344|FG002|STARTED|Overall Study||0
10238094|NCT00597909|11369342|FG000|COMPLETED|Overall Study||0
10238095|NCT00597909|11369343|FG001|COMPLETED|Overall Study||0
10238096|NCT00597909|11369344|FG002|COMPLETED|Overall Study||0
10238097|NCT00597909|11369342|FG000|NOT COMPLETED|Overall Study||0
10238098|NCT00597909|11369343|FG001|NOT COMPLETED|Overall Study||0
10238099|NCT00597909|11369344|FG002|NOT COMPLETED|Overall Study||0
10238100|NCT00593320|11369354|FG000|STARTED|Overall Study||1
10238101|NCT00593320|11369355|FG001|STARTED|Overall Study||1
10238102|NCT00593320|11369354|FG000|COMPLETED|Overall Study||1
10238103|NCT00593320|11369355|FG001|COMPLETED|Overall Study||1
10238104|NCT00593320|11369354|FG000|NOT COMPLETED|Overall Study||0
10238105|NCT00593320|11369355|FG001|NOT COMPLETED|Overall Study||0
10238106|NCT00589550|11369361|FG000|STARTED|Overall Study||1
10238107|NCT00589550|11369361|FG000|Withdrew From Study|Overall Study||1
10238108|NCT00589550|11369361|FG000|COMPLETED|Overall Study||0
10238109|NCT00589550|11369361|FG000|NOT COMPLETED|Overall Study||1
10238110|NCT00577772|11369367|FG000|STARTED|Overall Study||10
10238111|NCT00577772|11369368|FG001|STARTED|Overall Study||7
10238112|NCT00577772|11369367|FG000|COMPLETED|Overall Study||10
10238113|NCT00577772|11369368|FG001|COMPLETED|Overall Study||6
10238114|NCT00577772|11369367|FG000|NOT COMPLETED|Overall Study||0
10238115|NCT00577772|11369368|FG001|NOT COMPLETED|Overall Study||1
10238116|NCT00592007|11369374|FG000|STARTED|Overall Study||7
10238117|NCT00592007|11369374|FG000|COMPLETED|Overall Study||5
10238118|NCT00592007|11369374|FG000|NOT COMPLETED|Overall Study||2
10238119|NCT00595582|11369378|FG000|STARTED|Overall Study||10
10238120|NCT00595582|11369378|FG000|COMPLETED|Overall Study||0
10238121|NCT00595582|11369378|FG000|NOT COMPLETED|Overall Study||10
10238122|NCT00588146|11369382|FG000|STARTED|First Intervention (Baseline to 6 mo)||5
10238123|NCT00588146|11369383|FG001|STARTED|First Intervention (Baseline to 6 mo)||5
10238124|NCT00588146|11369382|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1
10112641|NCT02504320|11243579|FG001|COMPLETED|Treatment Period 2||18
10112642|NCT02504320|11243580|FG002|COMPLETED|Treatment Period 2||19
10112643|NCT02504320|11243581|FG003|COMPLETED|Treatment Period 2||20
10112644|NCT02504320|11243578|FG000|NOT COMPLETED|Treatment Period 2||0
10112645|NCT02504320|11243579|FG001|NOT COMPLETED|Treatment Period 2||1
10112646|NCT02504320|11243580|FG002|NOT COMPLETED|Treatment Period 2||0
10112647|NCT02504320|11243581|FG003|NOT COMPLETED|Treatment Period 2||0
10238125|NCT00588146|11369383|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2
10238126|NCT00588146|11369382|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
10238127|NCT00588146|11369383|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
10238128|NCT00588146|11369382|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1
10238129|NCT00588146|11369383|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2
10238130|NCT00588146|11369382|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1
10238131|NCT00588146|11369383|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2
10238132|NCT00588146|11369382|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
10238133|NCT00588146|11369383|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
10238134|NCT00586209|11369391|FG000|STARTED|Overall Study||5
10238135|NCT00586209|11369392|FG001|STARTED|Overall Study||10
10238136|NCT00586209|11369391|FG000|COMPLETED|Overall Study||5
10238137|NCT00586209|11369392|FG001|COMPLETED|Overall Study||10
10238138|NCT00586209|11369391|FG000|NOT COMPLETED|Overall Study||0
10238139|NCT00586209|11369392|FG001|NOT COMPLETED|Overall Study||0
10238140|NCT00590538|11369398|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
10238141|NCT00590538|11369398|FG000|COMPLETED|Overall Study||7
10238142|NCT00590538|11369398|FG000|NOT COMPLETED|Overall Study||2
10238143|NCT00583115|11369402|FG000|STARTED|Overall Study||1
10238144|NCT00583115|11369402|FG000|COMPLETED|Overall Study||0
10238145|NCT00583115|11369402|FG000|NOT COMPLETED|Overall Study||1
10238146|NCT00582712|11369406|FG000|STARTED|Overall Study||5
10238147|NCT00582712|11369406|FG000|COMPLETED|Overall Study||1
10238148|NCT00582712|11369406|FG000|NOT COMPLETED|Overall Study||4
10238149|NCT00586716|11369412|FG000|STARTED|Overall Study||14
10238150|NCT00586716|11369413|FG001|STARTED|Overall Study||8
10238151|NCT00586716|11369412|FG000|COMPLETED|Overall Study||14
10238152|NCT00586716|11369413|FG001|COMPLETED|Overall Study||8
10238153|NCT00586716|11369412|FG000|NOT COMPLETED|Overall Study||0
10238154|NCT00586716|11369413|FG001|NOT COMPLETED|Overall Study||0
10238155|NCT00583466|11369420|FG000|STARTED|Overall Study||18
10238156|NCT00583466|11369420|FG000|COMPLETED|Overall Study||18
10238157|NCT00583466|11369420|FG000|NOT COMPLETED|Overall Study||0
10238158|NCT00588471|11369428|FG000|STARTED|Overall Study||28
9828018|NCT00753675|10938709|FG002|NOT COMPLETED|Overall Study||56
10112648|NCT02504320|11243578|FG000|STARTED|Treatment Period 3||19
10238159|NCT00588471|11369429|FG001|STARTED|Overall Study||29
10238160|NCT00588471|11369428|FG000|COMPLETED|Overall Study||28
10238161|NCT00588471|11369429|FG001|COMPLETED|Overall Study||29
10238162|NCT00588471|11369428|FG000|NOT COMPLETED|Overall Study||0
10238163|NCT00588471|11369429|FG001|NOT COMPLETED|Overall Study||0
10238164|NCT00587795|11369437|FG000|STARTED|Overall Study||1
9828019|NCT00753688|10938719|FG000|STARTED|Overall Study||123
9828020|NCT00753688|10938720|FG001|STARTED|Overall Study||246
9828021|NCT00753688|10938719|FG000|Ongoing - in Follow-up|Overall Study||15
9828022|NCT00753688|10938720|FG001|Ongoing - in Follow-up|Overall Study||31
9828023|NCT00753688|10938719|FG000|COMPLETED|Overall Study||0
9828024|NCT00753688|10938720|FG001|COMPLETED|Overall Study||0
9828025|NCT00753688|10938719|FG000|NOT COMPLETED|Overall Study||123
10238165|NCT00587795|11369438|FG001|STARTED|Overall Study||0
10238166|NCT00587795|11369437|FG000|COMPLETED|Overall Study||0
10238167|NCT00587795|11369438|FG001|COMPLETED|Overall Study||0
10238168|NCT00587795|11369437|FG000|NOT COMPLETED|Overall Study||1
10238169|NCT00587795|11369438|FG001|NOT COMPLETED|Overall Study||0
10238170|NCT00590135|11369444|FG000|STARTED|Overall Study||59
10238171|NCT00590135|11369444|FG000|COMPLETED|Overall Study||0
10238172|NCT00590135|11369444|FG000|NOT COMPLETED|Overall Study||59
10238173|NCT00582036|11369451|FG000|STARTED|Overall Study||5
10238174|NCT00582036|11369452|FG001|STARTED|Overall Study||6
10238175|NCT00582036|11369451|FG000|COMPLETED|Overall Study||5
10238176|NCT00582036|11369452|FG001|COMPLETED|Overall Study|One patient withdrew consent|5
10238177|NCT00582036|11369451|FG000|NOT COMPLETED|Overall Study||0
10238178|NCT00582036|11369452|FG001|NOT COMPLETED|Overall Study||1
10238179|NCT00585585|11369458|FG000|STARTED|Overall Study||1
10238180|NCT00585585|11369458|FG000|Patients Receiving Drug|Overall Study||1
10238181|NCT00585585|11369458|FG000|COMPLETED|Overall Study||0
10238182|NCT00585585|11369458|FG000|NOT COMPLETED|Overall Study||1
10238183|NCT00585221|11369462|FG000|STARTED|Overall Study||8
10238184|NCT00585221|11369462|FG000|COMPLETED|Overall Study||0
10238185|NCT00585221|11369462|FG000|NOT COMPLETED|Overall Study||8
10238186|NCT00581113|11369468|FG000|STARTED|Overall Study||4
10238187|NCT00581113|11369469|FG001|STARTED|Overall Study||4
10238188|NCT00581113|11369468|FG000|COMPLETED|Overall Study||4
10238189|NCT00581113|11369469|FG001|COMPLETED|Overall Study||3
10238190|NCT00581113|11369468|FG000|NOT COMPLETED|Overall Study||0
10238191|NCT00581113|11369469|FG001|NOT COMPLETED|Overall Study||1
10238192|NCT00579254|11369475|FG000|STARTED|Overall Study||112
10238193|NCT00579254|11369475|FG000|COMPLETED|Overall Study||0
10238194|NCT00579254|11369475|FG000|NOT COMPLETED|Overall Study||112
10238195|NCT00587223|11369479|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
10238196|NCT00587223|11369479|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
10238197|NCT00587223|11369479|FG000|NOT COMPLETED|Overall Study||1
10238198|NCT00585611|11369488|FG000|STARTED|Overall Study||0
10238199|NCT00585611|11369489|FG001|STARTED|Overall Study||0
10238200|NCT00585611|11369488|FG000|COMPLETED|Overall Study||0
10238201|NCT00585611|11369489|FG001|COMPLETED|Overall Study||0
10238202|NCT00585611|11369488|FG000|NOT COMPLETED|Overall Study||0
10238203|NCT00585611|11369489|FG001|NOT COMPLETED|Overall Study||0
10238204|NCT00572260|11369495|FG000|STARTED|Overall Study||11
10238205|NCT00572260|11369495|FG000|COMPLETED|Overall Study||11
10238206|NCT00572260|11369495|FG000|NOT COMPLETED|Overall Study||0
10238207|NCT00571194|11369499|FG000|STARTED|Overall Study||7
10238208|NCT00571194|11369499|FG000|COMPLETED|Overall Study||7
10238209|NCT00571194|11369499|FG000|NOT COMPLETED|Overall Study||0
10238210|NCT00584935|11369503|FG000|STARTED|Overall Study||3
10238211|NCT00584935|11369503|FG000|COMPLETED|Overall Study||3
10238212|NCT00584935|11369503|FG000|NOT COMPLETED|Overall Study||0
10238213|NCT00577395|11369510|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
10238214|NCT00577395|11369511|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
10238215|NCT00577395|11369510|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
10238216|NCT00577395|11369511|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
10238217|NCT00577395|11369510|FG000|NOT COMPLETED|Overall Study||7
10238218|NCT00577395|11369511|FG001|NOT COMPLETED|Overall Study||6
10238219|NCT00573391|11369519|FG000|STARTED|Overall Study||3
10238220|NCT00573391|11369520|FG001|STARTED|Overall Study||2
10238221|NCT00573391|11369519|FG000|COMPLETED|Overall Study||0
10238222|NCT00573391|11369520|FG001|COMPLETED|Overall Study||0
10238223|NCT00573391|11369519|FG000|NOT COMPLETED|Overall Study||3
10238224|NCT00573391|11369520|FG001|NOT COMPLETED|Overall Study||2
10238225|NCT00570258|11369528|FG000|STARTED|Overall Study||12
10238226|NCT00570258|11369529|FG001|STARTED|Overall Study||15
10238227|NCT00570258|11369528|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
10238228|NCT00570258|11369529|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
10238229|NCT00570258|11369528|FG000|NOT COMPLETED|Overall Study||12
10238230|NCT00570258|11369529|FG001|NOT COMPLETED|Overall Study||15
10238231|NCT00568802|11369537|FG000|STARTED|Overall Study||27
10238232|NCT00568802|11369537|FG000|COMPLETED|Overall Study||24
10238233|NCT00568802|11369537|FG000|NOT COMPLETED|Overall Study||3
10238234|NCT00576524|11369545|FG000|STARTED|Overall Study||2
10238235|NCT00576524|11369546|FG001|STARTED|Overall Study||0
10238236|NCT00576524|11369545|FG000|COMPLETED|Overall Study||2
10238237|NCT00576524|11369546|FG001|COMPLETED|Overall Study||0
10238238|NCT00576524|11369545|FG000|NOT COMPLETED|Overall Study||0
9828026|NCT00753688|10938720|FG001|NOT COMPLETED|Overall Study||246
10238239|NCT00576524|11369546|FG001|NOT COMPLETED|Overall Study||0
10238240|NCT00568698|11369556|FG000|STARTED|Overall Study||29
10238241|NCT00568698|11369556|FG000|COMPLETED|Overall Study||18
10238242|NCT00568698|11369556|FG000|NOT COMPLETED|Overall Study||11
10238243|NCT00574080|11369564|FG000|STARTED|Overall Study||10
10238244|NCT00574080|11369565|FG001|STARTED|Overall Study||10
10238245|NCT00574080|11369564|FG000|COMPLETED|Overall Study||0
10238246|NCT00574080|11369565|FG001|COMPLETED|Overall Study||0
10238247|NCT00574080|11369564|FG000|NOT COMPLETED|Overall Study||10
10238248|NCT00574080|11369565|FG001|NOT COMPLETED|Overall Study||10
10238249|NCT00558558|11369571|FG000|STARTED|Overall Study||6
10238250|NCT00558558|11369571|FG000|COMPLETED|Overall Study||0
10238251|NCT00558558|11369571|FG000|NOT COMPLETED|Overall Study||6
10238252|NCT00577356|11369575|FG000|STARTED|Overall Study||6
10238253|NCT00577356|11369575|FG000|COMPLETED|Overall Study||6
10238254|NCT00577356|11369575|FG000|NOT COMPLETED|Overall Study||0
10238255|NCT00573937|11369581|FG000|STARTED|Overall Study||0
10238256|NCT00573937|11369582|FG001|STARTED|Overall Study||1
10238257|NCT00573937|11369581|FG000|COMPLETED|Overall Study||0
10238258|NCT00573937|11369582|FG001|COMPLETED|Overall Study||0
10238259|NCT00573937|11369581|FG000|NOT COMPLETED|Overall Study||0
10238260|NCT00573937|11369582|FG001|NOT COMPLETED|Overall Study||1
10238261|NCT00577317|11369590|FG000|STARTED|Overall Study||0
10238262|NCT00577317|11369591|FG001|STARTED|Overall Study||2
10238263|NCT00577317|11369590|FG000|COMPLETED|Overall Study||0
10238264|NCT00577317|11369591|FG001|COMPLETED|Overall Study||0
10238265|NCT00577317|11369590|FG000|NOT COMPLETED|Overall Study||0
10238266|NCT00577317|11369591|FG001|NOT COMPLETED|Overall Study||2
10238267|NCT00571922|11369599|FG000|STARTED|Overall Study||36
10238268|NCT00571922|11369600|FG001|STARTED|Overall Study||36
10238269|NCT00571922|11369599|FG000|COMPLETED|Overall Study||0
10238270|NCT00571922|11369600|FG001|COMPLETED|Overall Study||0
10238271|NCT00571922|11369599|FG000|NOT COMPLETED|Overall Study||36
10238272|NCT00571922|11369600|FG001|NOT COMPLETED|Overall Study||36
10238273|NCT00569868|11369606|FG000|STARTED|Overall Study||11
10238274|NCT00569868|11369606|FG000|COMPLETED|Overall Study||11
10238275|NCT00569868|11369606|FG000|NOT COMPLETED|Overall Study||0
10238276|NCT00573157|11369612|FG000|STARTED|Overall Study||4
10238277|NCT00573157|11369613|FG001|STARTED|Overall Study||2
10238278|NCT00573157|11369612|FG000|COMPLETED|Overall Study||0
10238279|NCT00573157|11369613|FG001|COMPLETED|Overall Study||0
10238280|NCT00573157|11369612|FG000|NOT COMPLETED|Overall Study||4
10238281|NCT00573157|11369613|FG001|NOT COMPLETED|Overall Study||2
10238282|NCT00570531|11369619|FG000|STARTED|Overall Study||6
10238283|NCT00570531|11369619|FG000|COMPLETED|Overall Study||6
10238284|NCT00570531|11369619|FG000|NOT COMPLETED|Overall Study||0
10238285|NCT00566462|11369625|FG000|STARTED|Overall Study||1
10238286|NCT00566462|11369626|FG001|STARTED|Overall Study||0
10238287|NCT00566462|11369625|FG000|COMPLETED|Overall Study||1
10238288|NCT00566462|11369626|FG001|COMPLETED|Overall Study||0
10238289|NCT00566462|11369625|FG000|NOT COMPLETED|Overall Study||0
10238290|NCT00566462|11369626|FG001|NOT COMPLETED|Overall Study||0
10238291|NCT00561912|11369632|FG000|STARTED|Overall Study||2
10238292|NCT00561912|11369632|FG000|COMPLETED|Overall Study||1
10238293|NCT00561912|11369632|FG000|NOT COMPLETED|Overall Study||1
10238294|NCT00561795|11369638|FG000|STARTED|Overall Study||6
10238295|NCT00561795|11369639|FG001|STARTED|Overall Study||6
10238296|NCT00561795|11369640|FG002|STARTED|Overall Study||0
10238297|NCT00561795|11369641|FG003|STARTED|Overall Study||0
10238298|NCT00561795|11369638|FG000|COMPLETED|Overall Study||2
10238299|NCT00561795|11369639|FG001|COMPLETED|Overall Study||0
10238300|NCT00561795|11369640|FG002|COMPLETED|Overall Study||0
10238301|NCT00561795|11369641|FG003|COMPLETED|Overall Study||0
10238302|NCT00561795|11369638|FG000|NOT COMPLETED|Overall Study||4
10238303|NCT00561795|11369639|FG001|NOT COMPLETED|Overall Study||6
10238304|NCT00561795|11369640|FG002|NOT COMPLETED|Overall Study||0
10238305|NCT00561795|11369641|FG003|NOT COMPLETED|Overall Study||0
10238306|NCT00564876|11369649|FG000|STARTED|Overall Study||2
10238307|NCT00564876|11369649|FG000|COMPLETED|Overall Study||2
10238308|NCT00564876|11369649|FG000|NOT COMPLETED|Overall Study||0
10238309|NCT00558870|11369655|FG000|STARTED|Overall Study||2
10238310|NCT00558870|11369656|FG001|STARTED|Overall Study||2
10238311|NCT00558870|11369655|FG000|COMPLETED|Overall Study||2
10238312|NCT00558870|11369656|FG001|COMPLETED|Overall Study||2
10238313|NCT00558870|11369655|FG000|NOT COMPLETED|Overall Study||0
10238314|NCT00558870|11369656|FG001|NOT COMPLETED|Overall Study||0
10238315|NCT00559897|11369662|FG000|STARTED|Overall Study||6
10238316|NCT00559897|11369662|FG000|COMPLETED|Overall Study||6
10238317|NCT00559897|11369662|FG000|NOT COMPLETED|Overall Study||0
10239800|NCT04381988|11371529|FG000|STARTED|Overall Study||4
10239801|NCT04381988|11371530|FG001|STARTED|Overall Study||0
10239802|NCT04381988|11371529|FG000|COMPLETED|Overall Study||0
10239803|NCT04381988|11371530|FG001|COMPLETED|Overall Study||0
10239804|NCT04381988|11371529|FG000|NOT COMPLETED|Overall Study||4
10239805|NCT04381988|11371530|FG001|NOT COMPLETED|Overall Study||0
10239806|NCT00521885|11371538|FG000|STARTED|Overall Study||0
10239807|NCT00521885|11371539|FG001|STARTED|Overall Study||0
10239808|NCT00521885|11371538|FG000|COMPLETED|Overall Study||0
10239809|NCT00521885|11371539|FG001|COMPLETED|Overall Study||0
10239810|NCT00521885|11371538|FG000|NOT COMPLETED|Overall Study||0
10239811|NCT00521885|11371539|FG001|NOT COMPLETED|Overall Study||0
10239812|NCT02376946|11371547|FG000|STARTED|Overall Study|study terminated prior to being conducted|0
10239813|NCT02376946|11371548|FG001|STARTED|Overall Study|study terminated prior to being conducted|0
10239814|NCT02376946|11371547|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0
10239815|NCT02376946|11371548|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0
10239816|NCT02376946|11371547|FG000|NOT COMPLETED|Overall Study||0
10238318|NCT00556400|11369668|FG000|STARTED|Overall Study||1
10238319|NCT00556400|11369669|FG001|STARTED|Overall Study||0
10238320|NCT00556400|11369668|FG000|COMPLETED|Overall Study||1
10238321|NCT00556400|11369669|FG001|COMPLETED|Overall Study||0
10238322|NCT00556400|11369668|FG000|NOT COMPLETED|Overall Study||0
10238323|NCT00556400|11369669|FG001|NOT COMPLETED|Overall Study||0
10238324|NCT00556075|11369677|FG000|STARTED|Overall Study||22
10238325|NCT00556075|11369678|FG001|STARTED|Overall Study||22
10238326|NCT00556075|11369679|FG002|STARTED|Overall Study||23
10238327|NCT00556075|11369677|FG000|COMPLETED|Overall Study||9
10238328|NCT00556075|11369678|FG001|COMPLETED|Overall Study||13
10238329|NCT00556075|11369679|FG002|COMPLETED|Overall Study||15
10238330|NCT00556075|11369677|FG000|NOT COMPLETED|Overall Study||13
10238331|NCT00556075|11369678|FG001|NOT COMPLETED|Overall Study||9
10238332|NCT00556075|11369679|FG002|NOT COMPLETED|Overall Study||8
10238333|NCT00556166|11369691|FG000|STARTED|Overall Study||4
10238334|NCT00556166|11369691|FG000|COMPLETED|Overall Study||3
10238335|NCT00556166|11369691|FG000|NOT COMPLETED|Overall Study||1
10238336|NCT00521924|11369697|FG000|STARTED|Overall Study|Subjects randomized|4
10238337|NCT00521924|11369698|FG001|STARTED|Overall Study|Subjects randomized|4
10238338|NCT00521924|11369697|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
10238339|NCT00521924|11369698|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
10238340|NCT00521924|11369697|FG000|NOT COMPLETED|Overall Study||4
10238341|NCT00521924|11369698|FG001|NOT COMPLETED|Overall Study||4
10238342|NCT00548886|11369704|FG000|STARTED|Overall Study||7
10238343|NCT00548886|11369704|FG000|COMPLETED|Overall Study||7
10238344|NCT00548886|11369704|FG000|NOT COMPLETED|Overall Study||0
10238345|NCT00547456|11369708|FG000|STARTED|Overall Study||20
10238346|NCT00547456|11369708|FG000|COMPLETED|Overall Study||20
10238347|NCT00547456|11369708|FG000|NOT COMPLETED|Overall Study||0
10238348|NCT00539838|11369715|FG000|STARTED|Overall Study||12
10238349|NCT00539838|11369716|FG001|STARTED|Overall Study||11
10238350|NCT00539838|11369717|FG002|STARTED|Overall Study||10
10238351|NCT00539838|11369715|FG000|COMPLETED|Overall Study||5
10238352|NCT00539838|11369716|FG001|COMPLETED|Overall Study||5
10238353|NCT00539838|11369717|FG002|COMPLETED|Overall Study||1
10238354|NCT00539838|11369715|FG000|NOT COMPLETED|Overall Study||7
10238355|NCT00539838|11369716|FG001|NOT COMPLETED|Overall Study||6
10238356|NCT00539838|11369717|FG002|NOT COMPLETED|Overall Study||9
10238357|NCT00549328|11369727|FG000|STARTED|Overall Study||14
10238358|NCT00549328|11369727|FG000|COMPLETED|Overall Study||0
10238359|NCT00549328|11369727|FG000|NOT COMPLETED|Overall Study||14
10238360|NCT00548327|11369733|FG000|STARTED|Overall Study||6
10238361|NCT00548327|11369734|FG001|STARTED|Overall Study||5
10238362|NCT00548327|11369733|FG000|COMPLETED|Overall Study||6
10238363|NCT00548327|11369734|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
10238364|NCT00548327|11369733|FG000|NOT COMPLETED|Overall Study||0
10238365|NCT00548327|11369734|FG001|NOT COMPLETED|Overall Study||1
10238366|NCT00542542|11369747|FG000|STARTED|Overall Study||44
10238367|NCT00542542|11369748|FG001|STARTED|Overall Study||44
10238368|NCT00542542|11369747|FG000|COMPLETED|Overall Study||44
10238369|NCT00542542|11369748|FG001|COMPLETED|Overall Study||44
10238370|NCT00542542|11369747|FG000|NOT COMPLETED|Overall Study||0
10238371|NCT00542542|11369748|FG001|NOT COMPLETED|Overall Study||0
10238372|NCT00545506|11369756|FG000|STARTED|Overall Study||3
10238373|NCT00545506|11369757|FG001|STARTED|Overall Study||3
10238374|NCT00545506|11369756|FG000|COMPLETED|Overall Study||3
10238375|NCT00545506|11369757|FG001|COMPLETED|Overall Study||3
10238376|NCT00545506|11369756|FG000|NOT COMPLETED|Overall Study||0
10238377|NCT00545506|11369757|FG001|NOT COMPLETED|Overall Study||0
10238378|NCT00547300|11369765|FG000|STARTED|Overall Study||25
10238379|NCT00547300|11369766|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
10238380|NCT00547300|11369765|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
10238381|NCT00547300|11369766|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
10238382|NCT00547300|11369765|FG000|NOT COMPLETED|Overall Study||25
10238383|NCT00547300|11369766|FG001|NOT COMPLETED|Overall Study||26
10238384|NCT00539617|11369772|FG000|STARTED|Pre-screening Period||7
10238385|NCT00539617|11369772|FG000|COMPLETED|Pre-screening Period||4
10238386|NCT00539617|11369772|FG000|NOT COMPLETED|Pre-screening Period||3
10238387|NCT00539617|11369772|FG000|STARTED|Run-In Period||4
10238388|NCT00539617|11369772|FG000|COMPLETED|Run-In Period||3
10238389|NCT00539617|11369772|FG000|NOT COMPLETED|Run-In Period||1
10238390|NCT00539617|11369772|FG000|STARTED|Treatment Period||3
10238391|NCT00539617|11369772|FG000|COMPLETED|Treatment Period||3
10238392|NCT00539617|11369772|FG000|NOT COMPLETED|Treatment Period||0
10238393|NCT00546455|11369778|FG000|STARTED|Overall Study||0
10238394|NCT00546455|11369779|FG001|STARTED|Overall Study||0
10238395|NCT00546455|11369778|FG000|COMPLETED|Overall Study||0
10238396|NCT00546455|11369779|FG001|COMPLETED|Overall Study||0
10238397|NCT00546455|11369778|FG000|NOT COMPLETED|Overall Study||0
10238398|NCT00546455|11369779|FG001|NOT COMPLETED|Overall Study||0
10238399|NCT00538980|11369785|FG000|STARTED|Overall Study||10
10238400|NCT00538980|11369785|FG000|COMPLETED|Overall Study||0
10238401|NCT00538980|11369785|FG000|NOT COMPLETED|Overall Study||10
10238402|NCT00540969|11369791|FG000|STARTED|Overall Study||2
10238403|NCT00540969|11369792|FG001|STARTED|Overall Study||1
10238404|NCT00540969|11369791|FG000|COMPLETED|Overall Study||2
10238405|NCT00540969|11369792|FG001|COMPLETED|Overall Study||1
10112649|NCT02504320|11243579|FG001|STARTED|Treatment Period 3||18
10112650|NCT02504320|11243580|FG002|STARTED|Treatment Period 3||19
10112651|NCT02504320|11243581|FG003|STARTED|Treatment Period 3||20
10112652|NCT02504320|11243578|FG000|COMPLETED|Treatment Period 3||19
10112653|NCT02504320|11243579|FG001|COMPLETED|Treatment Period 3||18
10112654|NCT02504320|11243580|FG002|COMPLETED|Treatment Period 3||18
10112655|NCT02504320|11243581|FG003|COMPLETED|Treatment Period 3||19
10112656|NCT02504320|11243578|FG000|NOT COMPLETED|Treatment Period 3||0
10112657|NCT02504320|11243579|FG001|NOT COMPLETED|Treatment Period 3||0
10238406|NCT00540969|11369791|FG000|NOT COMPLETED|Overall Study||0
10238407|NCT00540969|11369792|FG001|NOT COMPLETED|Overall Study||0
10017464|NCT01816893|11140370|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
10238408|NCT00535262|11369798|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
10238409|NCT00535262|11369798|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
10238410|NCT00535262|11369798|FG000|NOT COMPLETED|Overall Study||3
10238411|NCT00529464|11369805|FG000|STARTED|Overall Study||0
10238412|NCT00529464|11369806|FG001|STARTED|Overall Study||0
10238413|NCT00529464|11369807|FG002|STARTED|Overall Study||0
10238414|NCT00529464|11369805|FG000|COMPLETED|Overall Study||0
10238415|NCT00529464|11369806|FG001|COMPLETED|Overall Study||0
10238416|NCT00529464|11369807|FG002|COMPLETED|Overall Study||0
10238417|NCT00529464|11369805|FG000|NOT COMPLETED|Overall Study||0
10238418|NCT00529464|11369806|FG001|NOT COMPLETED|Overall Study||0
10238419|NCT00529464|11369807|FG002|NOT COMPLETED|Overall Study||0
10238420|NCT00537199|11369815|FG000|STARTED|Overall Study||1
10238421|NCT00537199|11369815|FG000|COMPLETED|Overall Study||0
10238422|NCT00537199|11369815|FG000|NOT COMPLETED|Overall Study||1
10238423|NCT00537446|11369819|FG000|STARTED|Overall Study||8
10238424|NCT00537446|11369819|FG000|COMPLETED|Overall Study||8
10238425|NCT00537446|11369819|FG000|NOT COMPLETED|Overall Study||0
10238426|NCT00536978|11369825|FG000|STARTED|Overall Study||22
10238427|NCT00536978|11369825|FG000|COMPLETED|Overall Study||0
10238428|NCT00536978|11369825|FG000|NOT COMPLETED|Overall Study||22
10238429|NCT00524485|11369829|FG000|STARTED|Overall Study||12
10238430|NCT00524485|11369829|FG000|COMPLETED|Overall Study||7
10238431|NCT00524485|11369829|FG000|NOT COMPLETED|Overall Study||5
10238432|NCT00533351|11369835|FG000|STARTED|Period 1||7
10238433|NCT00533351|11369836|FG001|STARTED|Period 1||2
10238434|NCT00533351|11369835|FG000|COMPLETED|Period 1||5
10238435|NCT00533351|11369836|FG001|COMPLETED|Period 1||1
10238436|NCT00533351|11369835|FG000|NOT COMPLETED|Period 1||2
10238437|NCT00533351|11369836|FG001|NOT COMPLETED|Period 1||1
10238438|NCT00533351|11369835|FG000|STARTED|Period 2||5
10238439|NCT00533351|11369836|FG001|STARTED|Period 2||1
10238440|NCT00533351|11369835|FG000|COMPLETED|Period 2||5
10238441|NCT00533351|11369836|FG001|COMPLETED|Period 2||1
10238442|NCT00533351|11369835|FG000|NOT COMPLETED|Period 2||0
10238443|NCT00533351|11369836|FG001|NOT COMPLETED|Period 2||0
10238444|NCT00533351|11369835|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
10238445|NCT00533351|11369836|FG001|STARTED|Period 3|No patients continued to Period 3|0
10238446|NCT00533351|11369835|FG000|COMPLETED|Period 3||3
10238447|NCT00533351|11369836|FG001|COMPLETED|Period 3||0
10238448|NCT00533351|11369835|FG000|NOT COMPLETED|Period 3||0
10238449|NCT00533351|11369836|FG001|NOT COMPLETED|Period 3||0
10238450|NCT00529282|11369844|FG000|STARTED|Overall Study||0
10238451|NCT00529282|11369845|FG001|STARTED|Overall Study||2
10238452|NCT00529282|11369844|FG000|COMPLETED|Overall Study||0
10238453|NCT00529282|11369845|FG001|COMPLETED|Overall Study||2
10238454|NCT00529282|11369844|FG000|NOT COMPLETED|Overall Study||0
9828027|NCT00753714|10938728|FG000|STARTED|Overall Study||61
9828028|NCT00753714|10938729|FG001|STARTED|Overall Study||63
9828029|NCT00753714|10938728|FG000|COMPLETED|Overall Study||1
9828030|NCT00753714|10938729|FG001|COMPLETED|Overall Study||1
10017465|NCT01816893|11140371|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
10017466|NCT01816906|11140379|FG000|STARTED|Six Months||41
10017467|NCT01816906|11140380|FG001|STARTED|Six Months||41
10017468|NCT01816906|11140379|FG000|COMPLETED|Six Months||20
10017469|NCT01816906|11140380|FG001|COMPLETED|Six Months||19
10017470|NCT01816906|11140379|FG000|NOT COMPLETED|Six Months||21
10017471|NCT01816906|11140380|FG001|NOT COMPLETED|Six Months||22
10017472|NCT01816906|11140379|FG000|STARTED|12 Months||20
10112658|NCT02504320|11243580|FG002|NOT COMPLETED|Treatment Period 3||1
10238455|NCT00529282|11369845|FG001|NOT COMPLETED|Overall Study||0
10238456|NCT00524134|11369851|FG000|STARTED|Overall Study||6
10238457|NCT00524134|11369851|FG000|COMPLETED|Overall Study||4
10238458|NCT00524134|11369851|FG000|NOT COMPLETED|Overall Study||2
9828031|NCT00753714|10938728|FG000|NOT COMPLETED|Overall Study||60
9828032|NCT00753714|10938729|FG001|NOT COMPLETED|Overall Study||62
10238459|NCT00527748|11369855|FG000|STARTED|Overall Study||26
10238460|NCT00527748|11369855|FG000|COMPLETED|Overall Study||23
10238461|NCT00527748|11369855|FG000|NOT COMPLETED|Overall Study||3
10238462|NCT00517699|11369859|FG000|STARTED|Overall Study||5
10017473|NCT01816906|11140380|FG001|STARTED|12 Months||19
10017474|NCT01816906|11140379|FG000|COMPLETED|12 Months||16
10112659|NCT02504320|11243581|FG003|NOT COMPLETED|Treatment Period 3||1
10238463|NCT00517699|11369859|FG000|COMPLETED|Overall Study||0
10238464|NCT00517699|11369859|FG000|NOT COMPLETED|Overall Study||5
10238465|NCT00528775|11369863|FG000|STARTED|Overall Study||6
10238466|NCT00528775|11369863|FG000|COMPLETED|Overall Study||5
10238467|NCT00528775|11369863|FG000|NOT COMPLETED|Overall Study||1
10238468|NCT00528437|11369867|FG000|STARTED|Overall Study||46
10238469|NCT00528437|11369867|FG000|COMPLETED|Overall Study||46
10238470|NCT00528437|11369867|FG000|NOT COMPLETED|Overall Study||0
10238471|NCT00524511|11369873|FG000|STARTED|Overall Study||68
10238472|NCT00524511|11369874|FG001|STARTED|Overall Study||68
10238473|NCT00524511|11369873|FG000|COMPLETED|Overall Study||64
10238474|NCT00524511|11369874|FG001|COMPLETED|Overall Study||61
10238475|NCT00524511|11369873|FG000|NOT COMPLETED|Overall Study||4
10238476|NCT00524511|11369874|FG001|NOT COMPLETED|Overall Study||7
10238477|NCT00517075|11369884|FG000|STARTED|Overall Study||0
10238478|NCT00517075|11369885|FG001|STARTED|Overall Study||0
10238479|NCT00517075|11369886|FG002|STARTED|Overall Study||0
10238480|NCT00517075|11369887|FG003|STARTED|Overall Study||0
10238481|NCT00517075|11369884|FG000|COMPLETED|Overall Study||0
10238482|NCT00517075|11369885|FG001|COMPLETED|Overall Study||0
10238483|NCT00517075|11369886|FG002|COMPLETED|Overall Study||0
10238484|NCT00517075|11369887|FG003|COMPLETED|Overall Study||0
10238485|NCT00517075|11369884|FG000|NOT COMPLETED|Overall Study||0
10238486|NCT00517075|11369885|FG001|NOT COMPLETED|Overall Study||0
10238487|NCT00517075|11369886|FG002|NOT COMPLETED|Overall Study||0
10238488|NCT00517075|11369887|FG003|NOT COMPLETED|Overall Study||0
10238489|NCT00527982|11369899|FG000|STARTED|Overall Study||1
10238490|NCT00527982|11369900|FG001|STARTED|Overall Study||0
10238491|NCT00527982|11369899|FG000|COMPLETED|Overall Study||0
10238492|NCT00527982|11369900|FG001|COMPLETED|Overall Study||0
10238493|NCT00527982|11369899|FG000|NOT COMPLETED|Overall Study||1
10238494|NCT00527982|11369900|FG001|NOT COMPLETED|Overall Study||0
10238495|NCT00524459|11369906|FG000|STARTED|Overall Study||6
10238496|NCT00524459|11369906|FG000|COMPLETED|Overall Study||4
10238497|NCT00524459|11369906|FG000|NOT COMPLETED|Overall Study||2
10238498|NCT00517361|11369910|FG000|STARTED|Overall Study||11
10238499|NCT00517361|11369910|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
10238500|NCT00517361|11369910|FG000|NOT COMPLETED|Overall Study||11
10238501|NCT00523939|11369916|FG000|STARTED|Overall Study||2
10238502|NCT00523939|11369917|FG001|STARTED|Overall Study||2
10238503|NCT00523939|11369916|FG000|COMPLETED|Overall Study||2
10238504|NCT00523939|11369917|FG001|COMPLETED|Overall Study||2
10238505|NCT00523939|11369916|FG000|NOT COMPLETED|Overall Study||0
10238506|NCT00523939|11369917|FG001|NOT COMPLETED|Overall Study||0
10238507|NCT00522457|11369922|FG000|STARTED|Overall Study||19
10238508|NCT00522457|11369922|FG000|COMPLETED|Overall Study||1
10238509|NCT00522457|11369922|FG000|NOT COMPLETED|Overall Study||18
10238510|NCT00526331|11369926|FG000|STARTED|Overall Study||55
10238511|NCT00526331|11369926|FG000|COMPLETED|Overall Study||0
10238512|NCT00526331|11369926|FG000|NOT COMPLETED|Overall Study||55
10238513|NCT00519090|11369932|FG000|STARTED|Overall Study||2
10238514|NCT00519090|11369933|FG001|STARTED|Overall Study||4
10238515|NCT00519090|11369932|FG000|COMPLETED|Overall Study||2
10238516|NCT00519090|11369933|FG001|COMPLETED|Overall Study||4
10238517|NCT00519090|11369932|FG000|NOT COMPLETED|Overall Study||0
10238518|NCT00519090|11369933|FG001|NOT COMPLETED|Overall Study||0
10238519|NCT00524394|11369939|FG000|STARTED|Overall Study||2
10238520|NCT00524394|11369939|FG000|COMPLETED|Overall Study||1
10238521|NCT00524394|11369939|FG000|NOT COMPLETED|Overall Study||1
10238522|NCT00523809|11369943|FG000|STARTED|Overall Study||5
10238523|NCT00523809|11369943|FG000|COMPLETED|Overall Study||5
10238524|NCT00523809|11369943|FG000|NOT COMPLETED|Overall Study||0
10238525|NCT00522301|11369947|FG000|STARTED|Overall Study||6
10238526|NCT00522301|11369947|FG000|COMPLETED|Overall Study||0
10238527|NCT00522301|11369947|FG000|NOT COMPLETED|Overall Study||6
10238528|NCT00517192|11369953|FG000|STARTED|Overall Study||19
10238529|NCT00517192|11369954|FG001|STARTED|Overall Study||20
10238530|NCT00517192|11369953|FG000|COMPLETED|Overall Study||0
10238531|NCT00517192|11369954|FG001|COMPLETED|Overall Study||0
10238532|NCT00517192|11369953|FG000|NOT COMPLETED|Overall Study||19
10238533|NCT00517192|11369954|FG001|NOT COMPLETED|Overall Study||20
10238534|NCT00504985|11369960|FG000|STARTED|Overall Study||14
10238535|NCT00504985|11369960|FG000|COMPLETED|Overall Study||14
10238536|NCT00504985|11369960|FG000|NOT COMPLETED|Overall Study||0
10238537|NCT00503581|11369967|FG000|STARTED|Overall Study||3
10238538|NCT00503581|11369968|FG001|STARTED|Overall Study||4
10238539|NCT00503581|11369969|FG002|STARTED|Overall Study||2
10238540|NCT00503581|11369967|FG000|COMPLETED|Overall Study||0
10238541|NCT00503581|11369968|FG001|COMPLETED|Overall Study||0
10238542|NCT00503581|11369969|FG002|COMPLETED|Overall Study||0
10238543|NCT00503581|11369967|FG000|NOT COMPLETED|Overall Study||3
10238544|NCT00503581|11369968|FG001|NOT COMPLETED|Overall Study||4
10238545|NCT00503581|11369969|FG002|NOT COMPLETED|Overall Study||2
10238546|NCT00509600|11369977|FG000|STARTED|Overall Study||1
10238547|NCT00509600|11369977|FG000|COMPLETED|Overall Study||0
10238548|NCT00509600|11369977|FG000|NOT COMPLETED|Overall Study||1
10238549|NCT00515112|11369983|FG000|STARTED|Overall Study||3
10238550|NCT00515112|11369984|FG001|STARTED|Overall Study||3
10238551|NCT00515112|11369983|FG000|COMPLETED|Overall Study||0
10238552|NCT00515112|11369984|FG001|COMPLETED|Overall Study||0
10238553|NCT00515112|11369983|FG000|NOT COMPLETED|Overall Study||3
10238554|NCT00515112|11369984|FG001|NOT COMPLETED|Overall Study||3
10238555|NCT00508872|11369990|FG000|STARTED|Overall Study||2
10238556|NCT00508872|11369990|FG000|COMPLETED|Overall Study||0
10238557|NCT00508872|11369990|FG000|NOT COMPLETED|Overall Study||2
10238558|NCT00514813|11369998|FG000|STARTED|Overall Study||15
10238559|NCT00514813|11369999|FG001|STARTED|Overall Study||86
9968037|NCT01518699|11088412|FG005|STARTED|Period 2||9
9968038|NCT01518699|11088407|FG000|COMPLETED|Period 2||8
9968039|NCT01518699|11088408|FG001|COMPLETED|Period 2||7
9968040|NCT01518699|11088409|FG002|COMPLETED|Period 2||9
9968041|NCT01518699|11088410|FG003|COMPLETED|Period 2||10
9968042|NCT01518699|11088411|FG004|COMPLETED|Period 2||10
9968043|NCT01518699|11088412|FG005|COMPLETED|Period 2||9
9968044|NCT01518699|11088407|FG000|NOT COMPLETED|Period 2||2
9968045|NCT01518699|11088408|FG001|NOT COMPLETED|Period 2||2
9968046|NCT01518699|11088409|FG002|NOT COMPLETED|Period 2||0
9968047|NCT01518699|11088410|FG003|NOT COMPLETED|Period 2||0
9968048|NCT01518699|11088411|FG004|NOT COMPLETED|Period 2||0
9968049|NCT01518699|11088412|FG005|NOT COMPLETED|Period 2||0
9968050|NCT01518699|11088407|FG000|STARTED|Period 3||8
9968051|NCT01518699|11088408|FG001|STARTED|Period 3||7
9968052|NCT01518699|11088409|FG002|STARTED|Period 3||9
9968053|NCT01518699|11088410|FG003|STARTED|Period 3||10
9968054|NCT01518699|11088411|FG004|STARTED|Period 3||10
9968055|NCT01518699|11088412|FG005|STARTED|Period 3||9
9968056|NCT01518699|11088407|FG000|COMPLETED|Period 3||8
9968057|NCT01518699|11088408|FG001|COMPLETED|Period 3||7
9968058|NCT01518699|11088409|FG002|COMPLETED|Period 3||9
9968059|NCT01518699|11088410|FG003|COMPLETED|Period 3||10
9968060|NCT01518699|11088411|FG004|COMPLETED|Period 3||10
9968061|NCT01518699|11088412|FG005|COMPLETED|Period 3||9
9968062|NCT01518699|11088407|FG000|NOT COMPLETED|Period 3||0
9968063|NCT01518699|11088408|FG001|NOT COMPLETED|Period 3||0
9968064|NCT01518699|11088409|FG002|NOT COMPLETED|Period 3||0
9968065|NCT01518699|11088410|FG003|NOT COMPLETED|Period 3||0
9968066|NCT01518699|11088411|FG004|NOT COMPLETED|Period 3||0
9968067|NCT01518699|11088412|FG005|NOT COMPLETED|Period 3||0
9968068|NCT01518868|11088420|FG000|STARTED|Overall Study||63
9968069|NCT01518868|11088421|FG001|STARTED|Overall Study||63
9968070|NCT01518868|11088420|FG000|COMPLETED|Overall Study||59
9968071|NCT01518868|11088421|FG001|COMPLETED|Overall Study||59
9968072|NCT01518868|11088420|FG000|NOT COMPLETED|Overall Study||4
9968073|NCT01518868|11088421|FG001|NOT COMPLETED|Overall Study||4
10019189|NCT01828515|11142356|FG000|STARTED|Washout (23 Days)||11
10019190|NCT01828515|11142357|FG001|STARTED|Washout (23 Days)||9
10019191|NCT01828515|11142356|FG000|COMPLETED|Washout (23 Days)||6
10019192|NCT01828515|11142357|FG001|COMPLETED|Washout (23 Days)||8
10019193|NCT01828515|11142356|FG000|NOT COMPLETED|Washout (23 Days)||5
10019194|NCT01828515|11142357|FG001|NOT COMPLETED|Washout (23 Days)||1
10019195|NCT01828515|11142356|FG000|STARTED|Second Intervention (19 Days)||6
10019196|NCT01828515|11142357|FG001|STARTED|Second Intervention (19 Days)||8
10019197|NCT01828515|11142356|FG000|COMPLETED|Second Intervention (19 Days)||6
10019198|NCT01828515|11142357|FG001|COMPLETED|Second Intervention (19 Days)||5
10019199|NCT01828515|11142356|FG000|NOT COMPLETED|Second Intervention (19 Days)||0
10019200|NCT01828515|11142357|FG001|NOT COMPLETED|Second Intervention (19 Days)||3
10019201|NCT01828554|11142363|FG000|STARTED|Overall Study||8
10019202|NCT01828554|11142363|FG000|COMPLETED|Overall Study||8
10019203|NCT01828554|11142363|FG000|NOT COMPLETED|Overall Study||0
10019204|NCT01828567|11142369|FG000|STARTED|Overall Study||208
10019205|NCT01828567|11142370|FG001|STARTED|Overall Study||209
10019206|NCT01828567|11142369|FG000|1 Month|Overall Study||172
10019207|NCT01828567|11142370|FG001|1 Month|Overall Study||192
10019208|NCT01828567|11142369|FG000|COMPLETED|Overall Study||177
10019209|NCT01828567|11142370|FG001|COMPLETED|Overall Study||199
10019210|NCT01828567|11142369|FG000|NOT COMPLETED|Overall Study||31
10019211|NCT01828567|11142370|FG001|NOT COMPLETED|Overall Study||10
10019212|NCT01828593|11142379|FG000|STARTED|Placebo-Controlled Phase||36
10019213|NCT01828593|11142380|FG001|STARTED|Placebo-Controlled Phase||34
10019214|NCT01828593|11142381|FG002|STARTED|Placebo-Controlled Phase||33
10019215|NCT01828593|11142379|FG000|COMPLETED|Placebo-Controlled Phase||36
10019216|NCT01828593|11142380|FG001|COMPLETED|Placebo-Controlled Phase||34
10019217|NCT01828593|11142381|FG002|COMPLETED|Placebo-Controlled Phase||32
10019218|NCT01828593|11142379|FG000|NOT COMPLETED|Placebo-Controlled Phase||0
10019219|NCT01828593|11142380|FG001|NOT COMPLETED|Placebo-Controlled Phase||0
10019220|NCT01828593|11142381|FG002|NOT COMPLETED|Placebo-Controlled Phase||1
10019221|NCT01828593|11142379|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
10019222|NCT01828593|11142380|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
10019223|NCT01828593|11142381|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
10019224|NCT01828593|11142379|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
10019225|NCT01828593|11142380|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
10019226|NCT01828593|11142381|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
10239848|NCT04422210|11371592|FG007|COMPLETED|Overall Study||0
10239849|NCT04422210|11371585|FG000|NOT COMPLETED|Overall Study||0
10239850|NCT04422210|11371586|FG001|NOT COMPLETED|Overall Study||0
10019227|NCT01828593|11142379|FG000|NOT COMPLETED|Placebo-Free Phase||0
10019228|NCT01828593|11142380|FG001|NOT COMPLETED|Placebo-Free Phase||6
10019229|NCT01828593|11142381|FG002|NOT COMPLETED|Placebo-Free Phase||6
10239851|NCT04422210|11371587|FG002|NOT COMPLETED|Overall Study||0
10239852|NCT04422210|11371588|FG003|NOT COMPLETED|Overall Study||0
10239853|NCT04422210|11371589|FG004|NOT COMPLETED|Overall Study||0
10239854|NCT04422210|11371590|FG005|NOT COMPLETED|Overall Study||0
10239855|NCT04422210|11371591|FG006|NOT COMPLETED|Overall Study||0
10239856|NCT04422210|11371592|FG007|NOT COMPLETED|Overall Study||0
10239857|NCT04298918|11371615|FG000|STARTED|Overall Study||0
10239858|NCT04298918|11371616|FG001|STARTED|Overall Study||0
10239859|NCT04298918|11371617|FG002|STARTED|Overall Study||0
10239860|NCT04298918|11371618|FG003|STARTED|Overall Study||0
10239861|NCT04298918|11371615|FG000|COMPLETED|Overall Study||0
10239862|NCT04298918|11371616|FG001|COMPLETED|Overall Study||0
10239863|NCT04298918|11371617|FG002|COMPLETED|Overall Study||0
10239864|NCT04298918|11371618|FG003|COMPLETED|Overall Study||0
10239865|NCT04298918|11371615|FG000|NOT COMPLETED|Overall Study||0
10239866|NCT04298918|11371616|FG001|NOT COMPLETED|Overall Study||0
10239867|NCT04298918|11371617|FG002|NOT COMPLETED|Overall Study||0
10239868|NCT04298918|11371618|FG003|NOT COMPLETED|Overall Study||0
10239869|NCT01996371|11371636|FG000|STARTED|Overall Study||5
10239870|NCT01996371|11371637|FG001|STARTED|Overall Study||4
10239871|NCT01996371|11371638|FG002|STARTED|Overall Study||6
10239872|NCT01996371|11371636|FG000|COMPLETED|Overall Study||5
10239873|NCT01996371|11371637|FG001|COMPLETED|Overall Study||4
10239874|NCT01996371|11371638|FG002|COMPLETED|Overall Study||6
10239875|NCT01996371|11371636|FG000|NOT COMPLETED|Overall Study||0
10239876|NCT01996371|11371637|FG001|NOT COMPLETED|Overall Study||0
10239877|NCT01996371|11371638|FG002|NOT COMPLETED|Overall Study||0
10239878|NCT01561378|11371651|FG000|STARTED|Overall Study||11
10239879|NCT01561378|11371652|FG001|STARTED|Overall Study||11
10239880|NCT01561378|11371651|FG000|COMPLETED|Overall Study||11
10239881|NCT01561378|11371652|FG001|COMPLETED|Overall Study||11
10239882|NCT01561378|11371651|FG000|NOT COMPLETED|Overall Study||0
10239883|NCT01561378|11371652|FG001|NOT COMPLETED|Overall Study||0
10239884|NCT00955929|11371661|FG000|STARTED|Overall Study||13
10239885|NCT00955929|11371662|FG001|STARTED|Overall Study||30
10239886|NCT00955929|11371663|FG002|STARTED|Overall Study||33
10239887|NCT00955929|11371661|FG000|COMPLETED|Overall Study||13
10239888|NCT00955929|11371662|FG001|COMPLETED|Overall Study||30
10239889|NCT00955929|11371663|FG002|COMPLETED|Overall Study||33
10239890|NCT00955929|11371661|FG000|NOT COMPLETED|Overall Study||0
10239891|NCT00955929|11371662|FG001|NOT COMPLETED|Overall Study||0
10239892|NCT00955929|11371663|FG002|NOT COMPLETED|Overall Study||0
10239893|NCT00402883|11371671|FG000|STARTED|Induction Therapy||5
10239894|NCT00402883|11371671|FG000|COMPLETED|Induction Therapy||5
10239895|NCT00402883|11371671|FG000|NOT COMPLETED|Induction Therapy||0
10239896|NCT00402883|11371671|FG000|STARTED|Consolidation Therapy||5
10239897|NCT00402883|11371671|FG000|COMPLETED|Consolidation Therapy||5
10239898|NCT00402883|11371671|FG000|NOT COMPLETED|Consolidation Therapy||0
10239899|NCT00402883|11371671|FG000|STARTED|Maintenance Therapy||5
10239900|NCT00402883|11371671|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
10239901|NCT00402883|11371671|FG000|NOT COMPLETED|Maintenance Therapy||0
10239902|NCT03482505|11371676|FG000|STARTED|Overall Study||10
10239903|NCT03482505|11371676|FG000|COMPLETED|Overall Study||10
10239904|NCT03482505|11371676|FG000|NOT COMPLETED|Overall Study||0
10239905|NCT02934503|11371680|FG000|STARTED|Overall Study||5
10239906|NCT02934503|11371680|FG000|COMPLETED|Overall Study||1
10239907|NCT02934503|11371680|FG000|NOT COMPLETED|Overall Study||4
10239908|NCT02137252|11371686|FG000|STARTED|Overall Study||2
10239909|NCT02137252|11371687|FG001|STARTED|Overall Study||1
10239910|NCT02137252|11371686|FG000|COMPLETED|Overall Study||0
10239911|NCT02137252|11371687|FG001|COMPLETED|Overall Study||0
10239912|NCT02137252|11371686|FG000|NOT COMPLETED|Overall Study||2
10239913|NCT02137252|11371687|FG001|NOT COMPLETED|Overall Study||1
10239914|NCT03863522|11371693|FG000|STARTED|Overall Study||116
10239915|NCT03863522|11371693|FG000|COMPLETED|Overall Study||116
10239916|NCT03863522|11371693|FG000|NOT COMPLETED|Overall Study||0
10239917|NCT01294670|11371702|FG000|STARTED|Overall Study||7
10239918|NCT01294670|11371703|FG001|STARTED|Overall Study||3
10239919|NCT01294670|11371704|FG002|STARTED|Overall Study||3
10239920|NCT01294670|11371705|FG003|STARTED|Overall Study||9
10239921|NCT01294670|11371706|FG004|STARTED|Overall Study||5
10239922|NCT01294670|11371702|FG000|COMPLETED|Overall Study||6
10239923|NCT01294670|11371703|FG001|COMPLETED|Overall Study||3
10239924|NCT01294670|11371704|FG002|COMPLETED|Overall Study||3
10239925|NCT01294670|11371705|FG003|COMPLETED|Overall Study||9
10239926|NCT01294670|11371706|FG004|COMPLETED|Overall Study||5
10239927|NCT01294670|11371702|FG000|NOT COMPLETED|Overall Study||1
10239928|NCT01294670|11371703|FG001|NOT COMPLETED|Overall Study||0
10239929|NCT01294670|11371704|FG002|NOT COMPLETED|Overall Study||0
10239930|NCT01294670|11371705|FG003|NOT COMPLETED|Overall Study||0
10239931|NCT01294670|11371706|FG004|NOT COMPLETED|Overall Study||0
10239932|NCT03095287|11371718|FG000|STARTED|Overall Study||2
10239933|NCT03095287|11371718|FG000|COMPLETED|Overall Study||0
10239934|NCT03095287|11371718|FG000|NOT COMPLETED|Overall Study||2
10239935|NCT03236662|11371722|FG000|STARTED|Overall Study||2
10239936|NCT03236662|11371722|FG000|COMPLETED|Overall Study||2
10239937|NCT03236662|11371722|FG000|NOT COMPLETED|Overall Study||0
10239938|NCT02930122|11371728|FG000|STARTED|Overall Study||3
10239939|NCT02930122|11371729|FG001|STARTED|Overall Study||3
10239940|NCT02930122|11371728|FG000|COMPLETED|Overall Study||0
10239941|NCT02930122|11371729|FG001|COMPLETED|Overall Study||0
10239942|NCT02930122|11371728|FG000|NOT COMPLETED|Overall Study||3
10239943|NCT02930122|11371729|FG001|NOT COMPLETED|Overall Study||3
10239944|NCT01444209|11371736|FG000|STARTED|Overall Study||2
10239945|NCT01444209|11371736|FG000|COMPLETED|Overall Study||2
10239946|NCT01444209|11371736|FG000|NOT COMPLETED|Overall Study||0
10239947|NCT04267380|11371742|FG000|STARTED|Overall Study||149
10239948|NCT04267380|11371743|FG001|STARTED|Overall Study||149
10239949|NCT04267380|11371742|FG000|COMPLETED|Overall Study||149
10239950|NCT04267380|11371743|FG001|COMPLETED|Overall Study||149
10239951|NCT04267380|11371742|FG000|NOT COMPLETED|Overall Study||0
10239952|NCT04267380|11371743|FG001|NOT COMPLETED|Overall Study||0
10239953|NCT04144166|11371749|FG000|STARTED|Overall Study||60
10239954|NCT04144166|11371749|FG000|COMPLETED|Overall Study||57
10239955|NCT04144166|11371749|FG000|NOT COMPLETED|Overall Study||3
10239956|NCT04090164|11371760|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
10239957|NCT04090164|11371761|FG001|STARTED|Overall Study||145
10239958|NCT04090164|11371760|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405
10239959|NCT04090164|11371761|FG001|COMPLETED|Overall Study||145
10239960|NCT04090164|11371760|FG000|NOT COMPLETED|Overall Study||245
10239961|NCT04090164|11371761|FG001|NOT COMPLETED|Overall Study||0
10239962|NCT04047121|11371774|FG000|STARTED|Overall Study||310
10239963|NCT04047121|11371775|FG001|STARTED|Overall Study||299
10239964|NCT04047121|11371776|FG002|STARTED|Overall Study||79
10239965|NCT04047121|11371777|FG003|STARTED|Overall Study||287
10239966|NCT04047121|11371778|FG004|STARTED|Overall Study||112
10239967|NCT04047121|11371779|FG005|STARTED|Overall Study||262
10239968|NCT04047121|11371774|FG000|COMPLETED|Overall Study||310
10239969|NCT04047121|11371775|FG001|COMPLETED|Overall Study||299
10239970|NCT04047121|11371776|FG002|COMPLETED|Overall Study||79
10239971|NCT04047121|11371777|FG003|COMPLETED|Overall Study||287
10239972|NCT04047121|11371778|FG004|COMPLETED|Overall Study||112
10239973|NCT04047121|11371779|FG005|COMPLETED|Overall Study||262
10239974|NCT04047121|11371774|FG000|NOT COMPLETED|Overall Study||0
10239975|NCT04047121|11371775|FG001|NOT COMPLETED|Overall Study||0
10239976|NCT04047121|11371776|FG002|NOT COMPLETED|Overall Study||0
10239977|NCT04047121|11371777|FG003|NOT COMPLETED|Overall Study||0
10239978|NCT04047121|11371778|FG004|NOT COMPLETED|Overall Study||0
10239979|NCT04047121|11371779|FG005|NOT COMPLETED|Overall Study||0
10239980|NCT04018001|11371795|FG000|STARTED|Overall Study||678
10239981|NCT04018001|11371796|FG001|STARTED|Overall Study||379
10239982|NCT04018001|11371795|FG000|COMPLETED|Overall Study||678
10239983|NCT04018001|11371796|FG001|COMPLETED|Overall Study||379
10239984|NCT04018001|11371795|FG000|NOT COMPLETED|Overall Study||0
10239985|NCT04018001|11371796|FG001|NOT COMPLETED|Overall Study||0
10239986|NCT04017754|11371802|FG000|STARTED|Overall Study||267
10239987|NCT04017754|11371803|FG001|STARTED|Overall Study||185
10239988|NCT04017754|11371802|FG000|COMPLETED|Overall Study||267
10239989|NCT04017754|11371803|FG001|COMPLETED|Overall Study||185
10239990|NCT04017754|11371802|FG000|NOT COMPLETED|Overall Study||0
10239991|NCT04017754|11371803|FG001|NOT COMPLETED|Overall Study||0
10239992|NCT04010370|11371846|FG000|STARTED|Overall Study||25
10239993|NCT04010370|11371846|FG000|COMPLETED|Overall Study||25
10239994|NCT04010370|11371846|FG000|NOT COMPLETED|Overall Study||0
10239995|NCT03997825|11371850|FG000|STARTED|Overall Study||117
10239996|NCT03997825|11371850|FG000|COMPLETED|Overall Study||100
10239997|NCT03997825|11371850|FG000|NOT COMPLETED|Overall Study||17
10239998|NCT03975790|11371857|FG000|STARTED|Overall Study||337
10239999|NCT03975790|11371858|FG001|STARTED|Overall Study||94
10240000|NCT03975790|11371859|FG002|STARTED|Overall Study||48
10240001|NCT03975790|11371857|FG000|COMPLETED|Overall Study||337
10240002|NCT03975790|11371858|FG001|COMPLETED|Overall Study||94
10240003|NCT03975790|11371859|FG002|COMPLETED|Overall Study||48
10240004|NCT03975790|11371857|FG000|NOT COMPLETED|Overall Study||0
10240005|NCT03975790|11371858|FG001|NOT COMPLETED|Overall Study||0
10019230|NCT01828983|11142394|FG000|STARTED|Overall Study||80
10019231|NCT01828983|11142395|FG001|STARTED|Overall Study||81
10019232|NCT01828983|11142394|FG000|COMPLETED|Overall Study||80
10240006|NCT03975790|11371859|FG002|NOT COMPLETED|Overall Study||0
10240007|NCT03979079|11371867|FG000|STARTED|Overall Study||2384
10240008|NCT03979079|11371867|FG000|COMPLETED|Overall Study||2384
10240009|NCT03979079|11371867|FG000|NOT COMPLETED|Overall Study||0
10240010|NCT03895632|11371872|FG000|STARTED|Overall Study||25
10240011|NCT03895632|11371872|FG000|COMPLETED|Overall Study||25
10019233|NCT01828983|11142395|FG001|COMPLETED|Overall Study||81
10240012|NCT03895632|11371872|FG000|NOT COMPLETED|Overall Study||0
10240013|NCT03859622|11371876|FG000|STARTED|Overall Study||289
10240014|NCT03859622|11371876|FG000|COMPLETED|Overall Study||289
10240015|NCT03859622|11371876|FG000|NOT COMPLETED|Overall Study||0
10240016|NCT03764813|11371887|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
10240017|NCT03764813|11371888|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
10240018|NCT03764813|11371889|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
10240019|NCT03764813|11371890|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
10240020|NCT03764813|11371887|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14
10240021|NCT03764813|11371888|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2
10240022|NCT03764813|11371889|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3
10240023|NCT03764813|11371890|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4
10240024|NCT03764813|11371887|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
10240025|NCT03764813|11371888|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
10240026|NCT03764813|11371889|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
10240027|NCT03764813|11371890|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
10240028|NCT03764813|11371887|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
10240029|NCT03764813|11371888|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
10240030|NCT03764813|11371889|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
10240031|NCT03764813|11371890|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
10240032|NCT03764813|11371887|FG000|COMPLETED|From Enrollment to the Last HbF Test||13
10240033|NCT03764813|11371888|FG001|COMPLETED|From Enrollment to the Last HbF Test||3
10240034|NCT03764813|11371889|FG002|COMPLETED|From Enrollment to the Last HbF Test||4
10240035|NCT03764813|11371890|FG003|COMPLETED|From Enrollment to the Last HbF Test||5
10240036|NCT03764813|11371887|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10240037|NCT03764813|11371888|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10240038|NCT03764813|11371889|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10240039|NCT03764813|11371890|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10240040|NCT04941521|11371906|FG000|STARTED|Overall Study||3
10240041|NCT04941521|11371906|FG000|COMPLETED|Overall Study||3
10240042|NCT04941521|11371906|FG000|NOT COMPLETED|Overall Study||0
10240043|NCT04584788|11371910|FG000|STARTED|Overall Study||37
10240044|NCT04584788|11371910|FG000|COMPLETED|Overall Study||25
10240045|NCT04584788|11371910|FG000|NOT COMPLETED|Overall Study||12
10240046|NCT04219618|11371916|FG000|STARTED|Overall Study||1
10240047|NCT04219618|11371917|FG001|STARTED|Overall Study||1
10240048|NCT04219618|11371916|FG000|COMPLETED|Overall Study||1
10240049|NCT04219618|11371917|FG001|COMPLETED|Overall Study||1
10240050|NCT04219618|11371916|FG000|NOT COMPLETED|Overall Study||0
10240051|NCT04219618|11371917|FG001|NOT COMPLETED|Overall Study||0
10240052|NCT03783923|11371925|FG000|STARTED|Placebo-Controlled Period (26 Weeks)||5
10240053|NCT03783923|11371926|FG001|STARTED|Placebo-Controlled Period (26 Weeks)||6
10240054|NCT03783923|11371925|FG000|Safety Population|Placebo-Controlled Period (26 Weeks)||5
10240055|NCT03783923|11371926|FG001|Safety Population|Placebo-Controlled Period (26 Weeks)|2 participants who received placebo in placebo-controlled period transitioned to receive deflazacort in open-label extension.|2
10240056|NCT03783923|11371925|FG000|COMPLETED|Placebo-Controlled Period (26 Weeks)||1
10240057|NCT03783923|11371926|FG001|COMPLETED|Placebo-Controlled Period (26 Weeks)||2
10240058|NCT03783923|11371925|FG000|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4
10240059|NCT03783923|11371926|FG001|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4
10240060|NCT03783923|11371925|FG000|STARTED|Open-Label Extension (26 Weeks)||1
10240061|NCT03783923|11371926|FG001|STARTED|Open-Label Extension (26 Weeks)||2
10240062|NCT03783923|11371925|FG000|COMPLETED|Open-Label Extension (26 Weeks)||0
10240063|NCT03783923|11371926|FG001|COMPLETED|Open-Label Extension (26 Weeks)||0
10240064|NCT03783923|11371925|FG000|NOT COMPLETED|Open-Label Extension (26 Weeks)||1
10240065|NCT03783923|11371926|FG001|NOT COMPLETED|Open-Label Extension (26 Weeks)||2
10240066|NCT03718429|11371934|FG000|STARTED|Baseline Treatment||20
10240067|NCT03718429|11371935|FG001|STARTED|Baseline Treatment||21
10240068|NCT03718429|11371936|FG002|STARTED|Baseline Treatment||21
10240069|NCT03718429|11371937|FG003|STARTED|Baseline Treatment||20
10240070|NCT03718429|11371934|FG000|COMPLETED|Baseline Treatment||20
10240071|NCT03718429|11371935|FG001|COMPLETED|Baseline Treatment||21
10240072|NCT03718429|11371936|FG002|COMPLETED|Baseline Treatment||21
10240073|NCT03718429|11371937|FG003|COMPLETED|Baseline Treatment||20
10240074|NCT03718429|11371934|FG000|NOT COMPLETED|Baseline Treatment||0
10240075|NCT03718429|11371935|FG001|NOT COMPLETED|Baseline Treatment||0
10240076|NCT03718429|11371936|FG002|NOT COMPLETED|Baseline Treatment||0
10240077|NCT03718429|11371937|FG003|NOT COMPLETED|Baseline Treatment||0
10240078|NCT03718429|11371934|FG000|STARTED|Adjunctive Rivaroxaban 2.5 mg||20
10240079|NCT03718429|11371935|FG001|STARTED|Adjunctive Rivaroxaban 2.5 mg||21
10240080|NCT03718429|11371936|FG002|STARTED|Adjunctive Rivaroxaban 2.5 mg||21
10240081|NCT03718429|11371937|FG003|STARTED|Adjunctive Rivaroxaban 2.5 mg||0
10240082|NCT03718429|11371934|FG000|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
10240083|NCT03718429|11371935|FG001|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
10240084|NCT03718429|11371936|FG002|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
10240085|NCT03718429|11371937|FG003|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
10240086|NCT03718429|11371934|FG000|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
10240087|NCT03718429|11371935|FG001|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1
10240088|NCT03718429|11371936|FG002|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1
10240089|NCT03718429|11371937|FG003|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
10240090|NCT03718429|11371934|FG000|STARTED|Stopping Aspirin||20
10240091|NCT03718429|11371935|FG001|STARTED|Stopping Aspirin||20
10240092|NCT03718429|11371936|FG002|STARTED|Stopping Aspirin||20
10240093|NCT03718429|11371937|FG003|STARTED|Stopping Aspirin||0
10240094|NCT03718429|11371934|FG000|COMPLETED|Stopping Aspirin||20
10240095|NCT03718429|11371935|FG001|COMPLETED|Stopping Aspirin||20
10240096|NCT03718429|11371936|FG002|COMPLETED|Stopping Aspirin||20
10240097|NCT03718429|11371937|FG003|COMPLETED|Stopping Aspirin||0
10240098|NCT03718429|11371934|FG000|NOT COMPLETED|Stopping Aspirin||0
10240099|NCT03718429|11371935|FG001|NOT COMPLETED|Stopping Aspirin||0
10240100|NCT03718429|11371936|FG002|NOT COMPLETED|Stopping Aspirin||0
9957091|NCT01449370|11076241|FG006|NOT COMPLETED|Overall Study||3
9957092|NCT01449370|11076242|FG007|NOT COMPLETED|Overall Study||3
9957093|NCT01449370|11076243|FG008|NOT COMPLETED|Overall Study||12
9957094|NCT01449370|11076244|FG009|NOT COMPLETED|Overall Study||3
9957095|NCT01449370|11076245|FG010|NOT COMPLETED|Overall Study||3
9957096|NCT01449370|11076246|FG011|NOT COMPLETED|Overall Study||3
10240101|NCT03718429|11371937|FG003|NOT COMPLETED|Stopping Aspirin||0
10240102|NCT03315130|11371960|FG000|STARTED|Main Portion (12 Weeks)||15
9957097|NCT01449370|11076247|FG012|NOT COMPLETED|Overall Study||3
9957098|NCT01449370|11076248|FG013|NOT COMPLETED|Overall Study||11
9957099|NCT01449370|11076249|FG014|NOT COMPLETED|Overall Study||3
9957100|NCT01449370|11076250|FG015|NOT COMPLETED|Overall Study||3
9957101|NCT01449370|11076251|FG016|NOT COMPLETED|Overall Study||7
9957102|NCT01449370|11076252|FG017|NOT COMPLETED|Overall Study||3
9957103|NCT01449370|11076253|FG018|NOT COMPLETED|Overall Study||3
9957104|NCT01449370|11076254|FG019|NOT COMPLETED|Overall Study||3
10240103|NCT03315130|11371961|FG001|STARTED|Main Portion (12 Weeks)||15
10240104|NCT03315130|11371962|FG002|STARTED|Main Portion (12 Weeks)||15
10240105|NCT03315130|11371963|FG003|STARTED|Main Portion (12 Weeks)||0
10240106|NCT03315130|11371960|FG000|COMPLETED|Main Portion (12 Weeks)||15
10240107|NCT03315130|11371961|FG001|COMPLETED|Main Portion (12 Weeks)||13
10240108|NCT03315130|11371962|FG002|COMPLETED|Main Portion (12 Weeks)||15
10240109|NCT03315130|11371963|FG003|COMPLETED|Main Portion (12 Weeks)||0
10240110|NCT03315130|11371960|FG000|NOT COMPLETED|Main Portion (12 Weeks)||0
10240111|NCT03315130|11371961|FG001|NOT COMPLETED|Main Portion (12 Weeks)||2
10240112|NCT03315130|11371962|FG002|NOT COMPLETED|Main Portion (12 Weeks)||0
10240113|NCT03315130|11371963|FG003|NOT COMPLETED|Main Portion (12 Weeks)||0
10240114|NCT03315130|11371960|FG000|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(15 [who received RA101495 0.1 mg/kg] + 7 [crossover from placebo])|22
10240115|NCT03315130|11371961|FG001|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(14 [who received RA101495 0.3 mg/kg + 7 [crossover from placebo] + 1 [Subject who withdrew consent in Main Portion rejoined])|21
10240116|NCT03315130|11371962|FG002|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10240117|NCT03315130|11371963|FG003|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10240118|NCT03315130|11371960|FG000|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21
10240119|NCT03315130|11371961|FG001|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21
10240120|NCT03315130|11371962|FG002|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10240121|NCT03315130|11371963|FG003|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10240122|NCT03315130|11371960|FG000|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||1
10240123|NCT03315130|11371961|FG001|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10240124|NCT03315130|11371962|FG002|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10240125|NCT03315130|11371963|FG003|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10240126|NCT03315130|11371960|FG000|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10240127|NCT03315130|11371961|FG001|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21
10240128|NCT03315130|11371962|FG002|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10240129|NCT03315130|11371963|FG003|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21
10240130|NCT03315130|11371960|FG000|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10240131|NCT03315130|11371961|FG001|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||17
10019234|NCT01828983|11142394|FG000|NOT COMPLETED|Overall Study||0
10019235|NCT01828983|11142395|FG001|NOT COMPLETED|Overall Study||0
10019236|NCT01829048|11142406|FG000|STARTED|Overall Study||6
10019237|NCT01829048|11142407|FG001|STARTED|Overall Study||8
10019238|NCT01829048|11142408|FG002|STARTED|Overall Study||7
10019239|NCT01829048|11142409|FG003|STARTED|Overall Study||14
10019240|NCT01829048|11142410|FG004|STARTED|Overall Study||2
10019241|NCT01829048|11142406|FG000|COMPLETED|Overall Study||6
10019242|NCT01829048|11142407|FG001|COMPLETED|Overall Study||8
10019243|NCT01829048|11142408|FG002|COMPLETED|Overall Study||7
10240132|NCT03315130|11371962|FG002|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10240133|NCT03315130|11371963|FG003|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||20
10240134|NCT03315130|11371960|FG000|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10240135|NCT03315130|11371961|FG001|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||4
10240136|NCT03315130|11371962|FG002|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10240137|NCT03315130|11371963|FG003|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||1
10240138|NCT03206476|11371985|FG000|STARTED|Overall Study||54
10240139|NCT03206476|11371986|FG001|STARTED|Overall Study||53
10240140|NCT03206476|11371985|FG000|Completed Short-term Evaluation (4 Months)|Overall Study||48
10240141|NCT03206476|11371986|FG001|Completed Short-term Evaluation (4 Months)|Overall Study||40
10240142|NCT03206476|11371985|FG000|COMPLETED|Overall Study||42
10240143|NCT03206476|11371986|FG001|COMPLETED|Overall Study||37
10240144|NCT03206476|11371985|FG000|NOT COMPLETED|Overall Study||12
10240145|NCT03206476|11371986|FG001|NOT COMPLETED|Overall Study||16
10240146|NCT03057106|11371994|FG000|STARTED|Overall Study|1 patient refused the treatment|149
10240147|NCT03057106|11371995|FG001|STARTED|Overall Study|3 patients refused the treatment|148
10240148|NCT03057106|11371994|FG000|COMPLETED|Overall Study||149
10240149|NCT03057106|11371995|FG001|COMPLETED|Overall Study||148
10240150|NCT03057106|11371994|FG000|NOT COMPLETED|Overall Study||0
10240151|NCT03057106|11371995|FG001|NOT COMPLETED|Overall Study||0
10240152|NCT03022461|11372001|FG000|STARTED|Overall Study||25
10240153|NCT03022461|11372001|FG000|COMPLETED|Overall Study||22
10240154|NCT03022461|11372001|FG000|NOT COMPLETED|Overall Study||3
10240155|NCT02927262|11372008|FG000|STARTED|Overall Study||63
10240156|NCT02927262|11372009|FG001|STARTED|Overall Study||35
10240157|NCT02927262|11372008|FG000|COMPLETED|Overall Study||20
10240158|NCT02927262|11372009|FG001|COMPLETED|Overall Study||12
10240159|NCT02927262|11372008|FG000|NOT COMPLETED|Overall Study||43
10240160|NCT02927262|11372009|FG001|NOT COMPLETED|Overall Study||23
10240161|NCT02892955|11372015|FG000|STARTED|Overall Study||1685
10240162|NCT02892955|11372015|FG000|COMPLETED|Overall Study||1685
10240163|NCT02892955|11372015|FG000|NOT COMPLETED|Overall Study||0
10240164|NCT02689349|11372021|FG000|STARTED|Overall Study||59
10240165|NCT02689349|11372022|FG001|STARTED|Overall Study||58
10240166|NCT02689349|11372021|FG000|COMPLETED|Overall Study||46
10240167|NCT02689349|11372022|FG001|COMPLETED|Overall Study||58
10240168|NCT02689349|11372021|FG000|NOT COMPLETED|Overall Study||13
10240169|NCT02689349|11372022|FG001|NOT COMPLETED|Overall Study||0
10240170|NCT02680574|11372033|FG000|STARTED|Overall Study||862
10240171|NCT02680574|11372034|FG001|STARTED|Overall Study||863
10240172|NCT02680574|11372033|FG000|COMPLETED|Overall Study||704
10240173|NCT02680574|11372034|FG001|COMPLETED|Overall Study||711
10240174|NCT02680574|11372033|FG000|NOT COMPLETED|Overall Study||158
10019244|NCT01829048|11142409|FG003|COMPLETED|Overall Study||12
10240175|NCT02680574|11372034|FG001|NOT COMPLETED|Overall Study||152
10240176|NCT02648347|11372042|FG000|STARTED|Overall Study||879
10240177|NCT02648347|11372043|FG001|STARTED|Overall Study||872
10240178|NCT02648347|11372042|FG000|COMPLETED|Overall Study||670
10240179|NCT02648347|11372043|FG001|COMPLETED|Overall Study||675
10240180|NCT02648347|11372042|FG000|NOT COMPLETED|Overall Study||209
10240181|NCT02648347|11372043|FG001|NOT COMPLETED|Overall Study||197
10240182|NCT02396342|11372051|FG000|STARTED|Overall Study||5
10240183|NCT02396342|11372052|FG001|STARTED|Overall Study||5
10240184|NCT02396342|11372051|FG000|COMPLETED|Overall Study||5
10240185|NCT02396342|11372052|FG001|COMPLETED|Overall Study||5
10240186|NCT02396342|11372051|FG000|NOT COMPLETED|Overall Study||0
10240187|NCT02396342|11372052|FG001|NOT COMPLETED|Overall Study||0
10240188|NCT02307253|11372058|FG000|STARTED|Overall Study||246
10240189|NCT02307253|11372058|FG000|COMPLETED|Overall Study||246
10240190|NCT02307253|11372058|FG000|NOT COMPLETED|Overall Study||0
10240191|NCT02224755|11372064|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
10240192|NCT02224755|11372065|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
10240193|NCT02224755|11372064|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
10240194|NCT02224755|11372065|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
10240195|NCT02224755|11372064|FG000|NOT COMPLETED|Randomization to Device Implant||7
10240196|NCT02224755|11372065|FG001|NOT COMPLETED|Randomization to Device Implant||1
10240197|NCT02224755|11372064|FG000|STARTED|Two Year Follow up Post-implant||505
10240198|NCT02224755|11372065|FG001|STARTED|Two Year Follow up Post-implant||515
10240199|NCT02224755|11372064|FG000|COMPLETED|Two Year Follow up Post-implant||247
10240200|NCT02224755|11372065|FG001|COMPLETED|Two Year Follow up Post-implant||289
10240201|NCT02224755|11372064|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258
10240202|NCT02224755|11372065|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226
10240203|NCT02170363|11372075|FG000|STARTED|Overall Study||50
10240204|NCT02170363|11372075|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
10240205|NCT02170363|11372075|FG000|NOT COMPLETED|Overall Study||0
10240206|NCT02090114|11372085|FG000|STARTED|Overall Study||30
10240207|NCT02090114|11372086|FG001|STARTED|Overall Study||29
10240208|NCT02090114|11372087|FG002|STARTED|Overall Study||29
10240209|NCT02090114|11372088|FG003|STARTED|Overall Study||8
10240210|NCT02090114|11372085|FG000|COMPLETED|Overall Study||0
10240211|NCT02090114|11372086|FG001|COMPLETED|Overall Study||0
10240212|NCT02090114|11372087|FG002|COMPLETED|Overall Study||0
10240213|NCT02090114|11372088|FG003|COMPLETED|Overall Study||0
10240214|NCT02090114|11372085|FG000|NOT COMPLETED|Overall Study||30
10240215|NCT02090114|11372086|FG001|NOT COMPLETED|Overall Study||29
10240216|NCT02090114|11372087|FG002|NOT COMPLETED|Overall Study||29
10240217|NCT02090114|11372088|FG003|NOT COMPLETED|Overall Study||8
10240218|NCT01915498|11372116|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10240219|NCT01915498|11372117|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10240220|NCT01915498|11372118|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10240221|NCT01915498|11372119|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
10240222|NCT01915498|11372120|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
10240223|NCT01915498|11372121|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
10240224|NCT01915498|11372122|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10240225|NCT01915498|11372123|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
10240226|NCT01915498|11372124|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
10240227|NCT01915498|11372125|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
10240228|NCT01915498|11372126|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
10240229|NCT01915498|11372127|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
10240230|NCT01915498|11372128|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10240231|NCT01915498|11372129|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
10240232|NCT01915498|11372130|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
10240233|NCT01915498|11372131|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
10240234|NCT01915498|11372132|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
10240235|NCT01915498|11372133|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
10240236|NCT01915498|11372134|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
10240237|NCT01915498|11372116|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240238|NCT01915498|11372117|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240239|NCT01915498|11372118|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240240|NCT01915498|11372119|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240241|NCT01915498|11372120|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240242|NCT01915498|11372121|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240243|NCT01915498|11372122|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240244|NCT01915498|11372123|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
10240245|NCT01915498|11372124|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240246|NCT01915498|11372125|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240247|NCT01915498|11372126|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240248|NCT01915498|11372127|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
10240249|NCT01915498|11372128|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240250|NCT01915498|11372129|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
10240251|NCT01915498|11372130|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240252|NCT01915498|11372131|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
10240253|NCT01915498|11372132|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
10240254|NCT01915498|11372133|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
10240255|NCT01915498|11372134|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240256|NCT01915498|11372116|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10240257|NCT01915498|11372117|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10240258|NCT01915498|11372118|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10240259|NCT01915498|11372119|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
10240260|NCT01915498|11372120|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
10240261|NCT01915498|11372121|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
10240262|NCT01915498|11372122|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10240263|NCT01915498|11372123|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
10240264|NCT01915498|11372124|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
10240265|NCT01915498|11372125|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
10240266|NCT01915498|11372126|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
10240267|NCT01915498|11372127|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
10240268|NCT01915498|11372128|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10240269|NCT01915498|11372129|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
10240270|NCT01915498|11372130|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
10240271|NCT01915498|11372131|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
10240272|NCT01915498|11372132|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
10240273|NCT01915498|11372133|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
10240274|NCT01915498|11372134|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10240275|NCT01915498|11372116|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240276|NCT01915498|11372117|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240277|NCT01915498|11372118|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240278|NCT01915498|11372119|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240279|NCT01915498|11372120|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240280|NCT01915498|11372121|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240281|NCT01915498|11372122|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240282|NCT01915498|11372123|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240283|NCT01915498|11372124|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240284|NCT01915498|11372125|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240285|NCT01915498|11372126|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240286|NCT01915498|11372127|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240287|NCT01915498|11372128|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240288|NCT01915498|11372129|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240289|NCT01915498|11372130|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240290|NCT01915498|11372131|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240291|NCT01915498|11372132|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240292|NCT01915498|11372133|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10240293|NCT01915498|11372134|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
10240294|NCT01915498|11372116|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240295|NCT01915498|11372117|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240296|NCT01915498|11372118|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240297|NCT01915498|11372119|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240298|NCT01915498|11372120|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240299|NCT01915498|11372121|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240300|NCT01915498|11372122|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240301|NCT01915498|11372123|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240302|NCT01915498|11372124|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240303|NCT01915498|11372125|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240304|NCT01915498|11372126|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240305|NCT01915498|11372127|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240306|NCT01915498|11372128|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240307|NCT01915498|11372129|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240308|NCT01915498|11372130|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240309|NCT01915498|11372131|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10019245|NCT01829048|11142410|FG004|COMPLETED|Overall Study||2
10240310|NCT01915498|11372132|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240311|NCT01915498|11372133|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240312|NCT01915498|11372134|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
10240313|NCT01915498|11372116|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240314|NCT01915498|11372117|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240315|NCT01915498|11372118|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240316|NCT01915498|11372119|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240317|NCT01915498|11372120|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240318|NCT01915498|11372121|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240319|NCT01915498|11372122|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240320|NCT01915498|11372123|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240321|NCT01915498|11372124|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240322|NCT01915498|11372125|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240323|NCT01915498|11372126|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240324|NCT01915498|11372127|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240325|NCT01915498|11372128|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10019246|NCT01829048|11142406|FG000|NOT COMPLETED|Overall Study||0
10240326|NCT01915498|11372129|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240327|NCT01915498|11372130|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240328|NCT01915498|11372131|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240329|NCT01915498|11372132|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240330|NCT01915498|11372133|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10240331|NCT01915498|11372134|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
10240332|NCT01568424|11372222|FG000|STARTED|Overall Study||25
10240333|NCT01568424|11372222|FG000|COMPLETED|Overall Study||25
10240334|NCT01568424|11372222|FG000|NOT COMPLETED|Overall Study||0
10240335|NCT00819793|11372226|FG000|STARTED|Overall Study||32
10240336|NCT00819793|11372226|FG000|COMPLETED|Overall Study||32
10240337|NCT00819793|11372226|FG000|NOT COMPLETED|Overall Study||0
10240338|NCT00121485|11372233|FG000|STARTED|Overall Study||134
10240339|NCT00121485|11372234|FG001|STARTED|Overall Study||66
10240340|NCT00121485|11372233|FG000|COMPLETED|Overall Study||133
10240341|NCT00121485|11372234|FG001|COMPLETED|Overall Study||59
10240342|NCT00121485|11372233|FG000|NOT COMPLETED|Overall Study||1
10240343|NCT00121485|11372234|FG001|NOT COMPLETED|Overall Study||7
10240344|NCT00121472|11372241|FG000|STARTED|Overall Study||194
10240345|NCT00121472|11372241|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
10240346|NCT00121472|11372241|FG000|NOT COMPLETED|Overall Study||0
9719202|NCT00038857|10818710|FG000|STARTED|Overall Study||29
9719203|NCT00038857|10818710|FG000|COMPLETED|Overall Study||28
9719204|NCT00038857|10818710|FG000|NOT COMPLETED|Overall Study||1
9719205|NCT00038948|10818716|FG000|STARTED|Overall Study||555
9719206|NCT00038948|10818717|FG001|STARTED|Overall Study||275
9719207|NCT00038948|10818716|FG000|COMPLETED|Overall Study||386
9719208|NCT00038948|10818717|FG001|COMPLETED|Overall Study||198
9719209|NCT00038948|10818716|FG000|NOT COMPLETED|Overall Study||169
9719210|NCT00038948|10818717|FG001|NOT COMPLETED|Overall Study||77
9719211|NCT00039130|10818729|FG000|STARTED|Overall Study||105
9719212|NCT00039130|10818729|FG000|COMPLETED|Overall Study||75
9719213|NCT00039130|10818729|FG000|NOT COMPLETED|Overall Study||30
9719214|NCT00039195|10818733|FG000|STARTED|Overall Study||98
9719215|NCT00039195|10818733|FG000|COMPLETED|Overall Study||98
9719216|NCT00039195|10818733|FG000|NOT COMPLETED|Overall Study||0
9719217|NCT00039377|10818737|FG000|STARTED|Initial Registration||57
9719218|NCT00039377|10818738|FG001|STARTED|Initial Registration||0
9719219|NCT00039377|10818739|FG002|STARTED|Initial Registration||0
9719220|NCT00039377|10818740|FG003|STARTED|Initial Registration||0
9719221|NCT00039377|10818737|FG000|COMPLETED|Initial Registration||35
9719222|NCT00039377|10818738|FG001|COMPLETED|Initial Registration||0
9719223|NCT00039377|10818739|FG002|COMPLETED|Initial Registration||0
9719224|NCT00039377|10818740|FG003|COMPLETED|Initial Registration||0
10240347|NCT00078806|11372249|FG000|STARTED|Part 1A||19
10240348|NCT00078806|11372250|FG001|STARTED|Part 1A||0
10240349|NCT00078806|11372251|FG002|STARTED|Part 1A||0
10240350|NCT00078806|11372252|FG003|STARTED|Part 1A||0
10240351|NCT00078806|11372249|FG000|COMPLETED|Part 1A||9
10240352|NCT00078806|11372250|FG001|COMPLETED|Part 1A||0
10240353|NCT00078806|11372251|FG002|COMPLETED|Part 1A||0
10240354|NCT00078806|11372252|FG003|COMPLETED|Part 1A||0
10240355|NCT00078806|11372249|FG000|NOT COMPLETED|Part 1A||10
10240356|NCT00078806|11372250|FG001|NOT COMPLETED|Part 1A||0
10240357|NCT00078806|11372251|FG002|NOT COMPLETED|Part 1A||0
10240358|NCT00078806|11372252|FG003|NOT COMPLETED|Part 1A||0
10240359|NCT00078806|11372249|FG000|STARTED|Part 1B||10
10240360|NCT00078806|11372250|FG001|STARTED|Part 1B||0
10240361|NCT00078806|11372251|FG002|STARTED|Part 1B||0
10240362|NCT00078806|11372252|FG003|STARTED|Part 1B||0
10240363|NCT00078806|11372249|FG000|COMPLETED|Part 1B||2
10240364|NCT00078806|11372250|FG001|COMPLETED|Part 1B||0
10240365|NCT00078806|11372251|FG002|COMPLETED|Part 1B||0
10240366|NCT00078806|11372252|FG003|COMPLETED|Part 1B||0
10240367|NCT00078806|11372249|FG000|NOT COMPLETED|Part 1B||8
10240368|NCT00078806|11372250|FG001|NOT COMPLETED|Part 1B||0
10240369|NCT00078806|11372251|FG002|NOT COMPLETED|Part 1B||0
10240370|NCT00078806|11372252|FG003|NOT COMPLETED|Part 1B||0
10240371|NCT00078806|11372249|FG000|STARTED|Part 2||0
10240372|NCT00078806|11372250|FG001|STARTED|Part 2||6
10240373|NCT00078806|11372251|FG002|STARTED|Part 2||4
10240374|NCT00078806|11372252|FG003|STARTED|Part 2||0
10240375|NCT00078806|11372249|FG000|Received Study Drug|Part 2||0
10240376|NCT00078806|11372250|FG001|Received Study Drug|Part 2||5
10240377|NCT00078806|11372251|FG002|Received Study Drug|Part 2||4
10240378|NCT00078806|11372252|FG003|Received Study Drug|Part 2||0
10240379|NCT00078806|11372249|FG000|COMPLETED|Part 2||0
10240380|NCT00078806|11372250|FG001|COMPLETED|Part 2||5
10240381|NCT00078806|11372251|FG002|COMPLETED|Part 2||4
10240382|NCT00078806|11372252|FG003|COMPLETED|Part 2||0
10240383|NCT00078806|11372249|FG000|NOT COMPLETED|Part 2||0
10240384|NCT00078806|11372250|FG001|NOT COMPLETED|Part 2||1
10240385|NCT00078806|11372251|FG002|NOT COMPLETED|Part 2||0
10240386|NCT00078806|11372252|FG003|NOT COMPLETED|Part 2||0
10240387|NCT00078806|11372249|FG000|STARTED|Part 3||0
10240388|NCT00078806|11372250|FG001|STARTED|Part 3||0
10240389|NCT00078806|11372251|FG002|STARTED|Part 3||0
10240390|NCT00078806|11372252|FG003|STARTED|Part 3||9
10240391|NCT00078806|11372249|FG000|COMPLETED|Part 3||0
10240392|NCT00078806|11372250|FG001|COMPLETED|Part 3||0
10240393|NCT00078806|11372251|FG002|COMPLETED|Part 3||0
10240394|NCT00078806|11372252|FG003|COMPLETED|Part 3||9
10240395|NCT00078806|11372249|FG000|NOT COMPLETED|Part 3||0
10240396|NCT00078806|11372250|FG001|NOT COMPLETED|Part 3||0
10240397|NCT00078806|11372251|FG002|NOT COMPLETED|Part 3||0
10240398|NCT00078806|11372252|FG003|NOT COMPLETED|Part 3||0
10240399|NCT00162370|11372267|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
10240400|NCT00162370|11372267|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
10240401|NCT00162370|11372267|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0
10240402|NCT00162370|11372267|FG000|STARTED|Efficacy Population||366
10240403|NCT00162370|11372267|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
10240404|NCT00162370|11372267|FG000|NOT COMPLETED|Efficacy Population||51
10240405|NCT00204737|11372276|FG000|STARTED|Overall Study||6
10240406|NCT00204737|11372277|FG001|STARTED|Overall Study||6
10240407|NCT00204737|11372276|FG000|COMPLETED|Overall Study||6
10240408|NCT00204737|11372277|FG001|COMPLETED|Overall Study||6
10240409|NCT00204737|11372276|FG000|NOT COMPLETED|Overall Study||0
10240410|NCT00204737|11372277|FG001|NOT COMPLETED|Overall Study||0
10240411|NCT00214500|11372283|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
10240412|NCT00214500|11372283|FG000|Safety Population|Treatment Period||9
10240413|NCT00214500|11372283|FG000|Pharmacokinetic (PK) Population|Treatment Period||9
10240414|NCT00214500|11372283|FG000|Pharmacodynamic (PD) Population|Treatment Period||9
10240415|NCT00214500|11372283|FG000|COMPLETED|Treatment Period||8
10240416|NCT00214500|11372283|FG000|NOT COMPLETED|Treatment Period||1
10240417|NCT00214500|11372283|FG000|STARTED|Extension Period||8
10240418|NCT00214500|11372283|FG000|COMPLETED|Extension Period||6
10240419|NCT00214500|11372283|FG000|NOT COMPLETED|Extension Period||2
10240420|NCT00278343|11372290|FG000|STARTED|Overall Study||74
10240421|NCT00278343|11372290|FG000|COMPLETED|Overall Study||74
10240422|NCT00278343|11372290|FG000|NOT COMPLETED|Overall Study||0
10240423|NCT00283959|11372295|FG000|STARTED|Treatment Period||4
10240424|NCT00283959|11372295|FG000|Safety Population|Treatment Period||4
10240425|NCT00283959|11372295|FG000|Pharmacodynamics (PD) Population|Treatment Period||4
10240426|NCT00283959|11372295|FG000|COMPLETED|Treatment Period||4
10240427|NCT00283959|11372295|FG000|NOT COMPLETED|Treatment Period||0
10240428|NCT00283959|11372295|FG000|STARTED|Extension Period||4
10240429|NCT00283959|11372295|FG000|COMPLETED|Extension Period||3
10240430|NCT00283959|11372295|FG000|NOT COMPLETED|Extension Period||1
10240431|NCT00290758|11372301|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62
10240432|NCT00290758|11372302|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64
10240433|NCT00290758|11372301|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
10240434|NCT00290758|11372302|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
10240435|NCT00290758|11372301|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62
10240436|NCT00290758|11372302|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62
10240437|NCT00290758|11372301|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61
10240438|NCT00290758|11372302|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64
10240439|NCT00290758|11372301|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
10240440|NCT00290758|11372302|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
10240441|NCT00290758|11372301|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
10240442|NCT00290758|11372302|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
10240443|NCT00290758|11372301|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
10240444|NCT00290758|11372302|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
10240445|NCT00290758|11372301|FG000|STARTED|Post Intervention rFNA||55
10240446|NCT00290758|11372302|FG001|STARTED|Post Intervention rFNA||54
10240447|NCT00290758|11372301|FG000|COMPLETED|Post Intervention rFNA||49
10240448|NCT00290758|11372302|FG001|COMPLETED|Post Intervention rFNA||49
10240449|NCT00290758|11372301|FG000|NOT COMPLETED|Post Intervention rFNA||6
10240450|NCT00290758|11372302|FG001|NOT COMPLETED|Post Intervention rFNA||5
9957105|NCT01449370|11076255|FG020|NOT COMPLETED|Overall Study||6
9957106|NCT01449370|11076256|FG021|NOT COMPLETED|Overall Study||4
9957107|NCT01449370|11076257|FG022|NOT COMPLETED|Overall Study||4
9957108|NCT01449370|11076258|FG023|NOT COMPLETED|Overall Study||10
9957109|NCT01449370|11076259|FG024|NOT COMPLETED|Overall Study||8
9957110|NCT01449461|11076338|FG000|STARTED|Overall Study||6
9957111|NCT01449461|11076339|FG001|STARTED|Overall Study||18
9957112|NCT01449461|11076340|FG002|STARTED|Overall Study||18
9957113|NCT01449461|11076341|FG003|STARTED|Overall Study||32
9957114|NCT01449461|11076342|FG004|STARTED|Overall Study||48
10240451|NCT00310388|11372312|FG000|STARTED|Primary Reporting Phase||376
10240452|NCT00310388|11372313|FG001|STARTED|Primary Reporting Phase||0
10240453|NCT00310388|11372312|FG000|COMPLETED|Primary Reporting Phase||30
10240454|NCT00310388|11372313|FG001|COMPLETED|Primary Reporting Phase||0
10240455|NCT00310388|11372312|FG000|NOT COMPLETED|Primary Reporting Phase||346
10240456|NCT00310388|11372313|FG001|NOT COMPLETED|Primary Reporting Phase||0
10240457|NCT00310388|11372312|FG000|STARTED|Safety Follow-up Continuation Phase||0
10240458|NCT00310388|11372313|FG001|STARTED|Safety Follow-up Continuation Phase||26
10240459|NCT00310388|11372312|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
10240460|NCT00310388|11372313|FG001|COMPLETED|Safety Follow-up Continuation Phase||13
10240461|NCT00310388|11372312|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
10240462|NCT00310388|11372313|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13
10240463|NCT00345358|11372322|FG000|STARTED|Primary Vaccination Phase||150
10240464|NCT00345358|11372323|FG001|STARTED|Primary Vaccination Phase||150
10240465|NCT00345358|11372324|FG002|STARTED|Primary Vaccination Phase||150
10240466|NCT00345358|11372325|FG003|STARTED|Primary Vaccination Phase||150
10240467|NCT00345358|11372322|FG000|COMPLETED|Primary Vaccination Phase||145
10240468|NCT00345358|11372323|FG001|COMPLETED|Primary Vaccination Phase||146
10240469|NCT00345358|11372324|FG002|COMPLETED|Primary Vaccination Phase||142
10240470|NCT00345358|11372325|FG003|COMPLETED|Primary Vaccination Phase||148
10240471|NCT00345358|11372322|FG000|NOT COMPLETED|Primary Vaccination Phase||5
10240472|NCT00345358|11372323|FG001|NOT COMPLETED|Primary Vaccination Phase||4
10240473|NCT00345358|11372324|FG002|NOT COMPLETED|Primary Vaccination Phase||8
10240474|NCT00345358|11372325|FG003|NOT COMPLETED|Primary Vaccination Phase||2
10240475|NCT00345358|11372322|FG000|STARTED|Booster Vaccination Phase||145
10240476|NCT00345358|11372323|FG001|STARTED|Booster Vaccination Phase||145
10240477|NCT00345358|11372324|FG002|STARTED|Booster Vaccination Phase||0
10240478|NCT00345358|11372325|FG003|STARTED|Booster Vaccination Phase||0
10240479|NCT00345358|11372322|FG000|COMPLETED|Booster Vaccination Phase||141
10240480|NCT00345358|11372323|FG001|COMPLETED|Booster Vaccination Phase||145
10240481|NCT00345358|11372324|FG002|COMPLETED|Booster Vaccination Phase||0
10240482|NCT00345358|11372325|FG003|COMPLETED|Booster Vaccination Phase||0
10240483|NCT00345358|11372322|FG000|NOT COMPLETED|Booster Vaccination Phase||4
10240484|NCT00345358|11372323|FG001|NOT COMPLETED|Booster Vaccination Phase||0
10240485|NCT00345358|11372324|FG002|NOT COMPLETED|Booster Vaccination Phase||0
10240486|NCT00345358|11372325|FG003|NOT COMPLETED|Booster Vaccination Phase||0
10240487|NCT00345800|11372335|FG000|STARTED|Overall Study||25
10240488|NCT00345800|11372335|FG000|COMPLETED|Overall Study||25
10240489|NCT00345800|11372335|FG000|NOT COMPLETED|Overall Study||0
10240490|NCT00372229|11372341|FG000|STARTED|Study Phase||148
10240491|NCT00372229|11372342|FG001|STARTED|Study Phase||151
10240492|NCT00372229|11372341|FG000|COMPLETED|Study Phase||117
10240493|NCT00372229|11372342|FG001|COMPLETED|Study Phase||122
10240494|NCT00372229|11372341|FG000|NOT COMPLETED|Study Phase||31
10240495|NCT00372229|11372342|FG001|NOT COMPLETED|Study Phase||29
10240496|NCT00372229|11372341|FG000|STARTED|Follow-Up Phase||117
10240497|NCT00372229|11372342|FG001|STARTED|Follow-Up Phase||122
10240498|NCT00372229|11372341|FG000|COMPLETED|Follow-Up Phase||71
10240499|NCT00372229|11372342|FG001|COMPLETED|Follow-Up Phase||70
10240500|NCT00372229|11372341|FG000|NOT COMPLETED|Follow-Up Phase||46
10240501|NCT00372229|11372342|FG001|NOT COMPLETED|Follow-Up Phase||52
10240502|NCT00383708|11372352|FG000|STARTED|Enrolment Through Start Treatment||125
10240503|NCT00383708|11372352|FG000|COMPLETED|Enrolment Through Start Treatment||92
10240504|NCT00383708|11372352|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33
10240505|NCT00383708|11372352|FG000|STARTED|Run-in Period||92
10240506|NCT00383708|11372352|FG000|COMPLETED|Run-in Period||85
10240507|NCT00383708|11372352|FG000|NOT COMPLETED|Run-in Period||7
10240508|NCT00383708|11372352|FG000|STARTED|Co-administration Period||57
10240509|NCT00383708|11372352|FG000|COMPLETED|Co-administration Period||52
10240510|NCT00383708|11372352|FG000|NOT COMPLETED|Co-administration Period||5
10240511|NCT00413699|11372359|FG000|STARTED|Initial Period||1123
10240512|NCT00413699|11372360|FG001|STARTED|Initial Period||3358
10240513|NCT00413699|11372361|FG002|STARTED|Initial Period||0
10240514|NCT00413699|11372359|FG000|COMPLETED|Initial Period||484
10240515|NCT00413699|11372360|FG001|COMPLETED|Initial Period||1653
10240516|NCT00413699|11372361|FG002|COMPLETED|Initial Period||0
10240517|NCT00413699|11372359|FG000|NOT COMPLETED|Initial Period||639
10240518|NCT00413699|11372360|FG001|NOT COMPLETED|Initial Period||1705
10240519|NCT00413699|11372361|FG002|NOT COMPLETED|Initial Period||0
10240520|NCT00413699|11372359|FG000|STARTED|Extension Period||0
10240521|NCT00413699|11372360|FG001|STARTED|Extension Period||0
10240522|NCT00413699|11372361|FG002|STARTED|Extension Period||48
10240523|NCT00413699|11372359|FG000|COMPLETED|Extension Period||0
10240524|NCT00413699|11372360|FG001|COMPLETED|Extension Period||0
10240525|NCT00413699|11372361|FG002|COMPLETED|Extension Period||43
10240526|NCT00413699|11372359|FG000|NOT COMPLETED|Extension Period||0
10240527|NCT00413699|11372360|FG001|NOT COMPLETED|Extension Period||0
10240528|NCT00413699|11372361|FG002|NOT COMPLETED|Extension Period||5
10240529|NCT00435227|11372389|FG000|STARTED|Overall Study||5
10240530|NCT00435227|11372390|FG001|STARTED|Overall Study||7
10240531|NCT00435227|11372389|FG000|COMPLETED|Overall Study||5
10240532|NCT00435227|11372390|FG001|COMPLETED|Overall Study||7
10240533|NCT00435227|11372389|FG000|NOT COMPLETED|Overall Study||0
10240534|NCT00435227|11372390|FG001|NOT COMPLETED|Overall Study||0
10240589|NCT00442546|11372423|FG000|STARTED|Overall Study||103
10240590|NCT00442546|11372424|FG001|STARTED|Overall Study||100
10240591|NCT00442546|11372425|FG002|STARTED|Overall Study||104
10240535|NCT00436826|11372399|FG000|STARTED|Double Blind Period (DBP)||124
10240536|NCT00436826|11372400|FG001|STARTED|Double Blind Period (DBP)||48
10240537|NCT00436826|11372401|FG002|STARTED|Double Blind Period (DBP)||0
10240538|NCT00436826|11372402|FG003|STARTED|Double Blind Period (DBP)||0
10240539|NCT00436826|11372403|FG004|STARTED|Double Blind Period (DBP)||0
10240540|NCT00436826|11372404|FG005|STARTED|Double Blind Period (DBP)||0
10240541|NCT00436826|11372399|FG000|COMPLETED|Double Blind Period (DBP)||111
10240542|NCT00436826|11372400|FG001|COMPLETED|Double Blind Period (DBP)||37
10240543|NCT00436826|11372401|FG002|COMPLETED|Double Blind Period (DBP)||0
10240544|NCT00436826|11372402|FG003|COMPLETED|Double Blind Period (DBP)||0
10240545|NCT00436826|11372403|FG004|COMPLETED|Double Blind Period (DBP)||0
10240546|NCT00436826|11372404|FG005|COMPLETED|Double Blind Period (DBP)||0
10240547|NCT00436826|11372399|FG000|NOT COMPLETED|Double Blind Period (DBP)||13
10240548|NCT00436826|11372400|FG001|NOT COMPLETED|Double Blind Period (DBP)||11
10240549|NCT00436826|11372401|FG002|NOT COMPLETED|Double Blind Period (DBP)||0
10240550|NCT00436826|11372402|FG003|NOT COMPLETED|Double Blind Period (DBP)||0
10240551|NCT00436826|11372403|FG004|NOT COMPLETED|Double Blind Period (DBP)||0
10240552|NCT00436826|11372404|FG005|NOT COMPLETED|Double Blind Period (DBP)||0
10240553|NCT00436826|11372399|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0
10240554|NCT00436826|11372400|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0
10240555|NCT00436826|11372401|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47
10240556|NCT00436826|11372402|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28
10240557|NCT00436826|11372403|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0
10240558|NCT00436826|11372404|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0
10240559|NCT00436826|11372399|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240560|NCT00436826|11372400|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240561|NCT00436826|11372401|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1
10240562|NCT00436826|11372402|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2
10240563|NCT00436826|11372403|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240564|NCT00436826|11372404|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240565|NCT00436826|11372399|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240566|NCT00436826|11372400|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240567|NCT00436826|11372401|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
10240568|NCT00436826|11372402|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
10240569|NCT00436826|11372403|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240570|NCT00436826|11372404|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10240571|NCT00436826|11372399|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0
10240572|NCT00436826|11372400|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0
10240573|NCT00436826|11372401|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0
10240574|NCT00436826|11372402|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0
10240575|NCT00436826|11372403|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52
10240576|NCT00436826|11372404|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7
10240577|NCT00436826|11372399|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240578|NCT00436826|11372400|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240579|NCT00436826|11372401|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240580|NCT00436826|11372402|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240581|NCT00436826|11372403|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1
10240582|NCT00436826|11372404|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240583|NCT00436826|11372399|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240584|NCT00436826|11372400|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240585|NCT00436826|11372401|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240586|NCT00436826|11372402|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10240587|NCT00436826|11372403|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
10240588|NCT00436826|11372404|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
10240592|NCT00442546|11372423|FG000|Received Treatment|Overall Study||98
10240593|NCT00442546|11372424|FG001|Received Treatment|Overall Study||96
10240594|NCT00442546|11372425|FG002|Received Treatment|Overall Study||98
10240595|NCT00442546|11372423|FG000|COMPLETED|Overall Study||77
10240596|NCT00442546|11372424|FG001|COMPLETED|Overall Study||63
10240597|NCT00442546|11372425|FG002|COMPLETED|Overall Study||71
10240598|NCT00442546|11372423|FG000|NOT COMPLETED|Overall Study||26
10240599|NCT00442546|11372424|FG001|NOT COMPLETED|Overall Study||37
10240600|NCT00442546|11372425|FG002|NOT COMPLETED|Overall Study||33
10240601|NCT04715932|11372437|FG000|STARTED|Overall Study||107
10240602|NCT04715932|11372438|FG001|STARTED|Overall Study||109
10240603|NCT04715932|11372437|FG000|COMPLETED|Overall Study||106
10240604|NCT04715932|11372438|FG001|COMPLETED|Overall Study||109
10240605|NCT04715932|11372437|FG000|NOT COMPLETED|Overall Study||1
10240606|NCT04715932|11372438|FG001|NOT COMPLETED|Overall Study||0
10240607|NCT04666441|11372452|FG000|STARTED|Overall Study||82
10240608|NCT04666441|11372453|FG001|STARTED|Overall Study||165
10240609|NCT04666441|11372454|FG002|STARTED|Overall Study||162
10240610|NCT04666441|11372455|FG003|STARTED|Overall Study||165
10240611|NCT04666441|11372456|FG004|STARTED|Overall Study||166
10240612|NCT04666441|11372457|FG005|STARTED|Overall Study||82
10240613|NCT04666441|11372458|FG006|STARTED|Overall Study||163
10240614|NCT04666441|11372459|FG007|STARTED|Overall Study||164
10240615|NCT04666441|11372452|FG000|COMPLETED|Overall Study||80
10240616|NCT04666441|11372453|FG001|COMPLETED|Overall Study||160
10240617|NCT04666441|11372454|FG002|COMPLETED|Overall Study||158
10240618|NCT04666441|11372455|FG003|COMPLETED|Overall Study||161
10240619|NCT04666441|11372456|FG004|COMPLETED|Overall Study||166
10240620|NCT04666441|11372457|FG005|COMPLETED|Overall Study||79
10240621|NCT04666441|11372458|FG006|COMPLETED|Overall Study||158
10240622|NCT04666441|11372459|FG007|COMPLETED|Overall Study||160
10240623|NCT04666441|11372452|FG000|NOT COMPLETED|Overall Study||2
10240624|NCT04666441|11372453|FG001|NOT COMPLETED|Overall Study||5
10240625|NCT04666441|11372454|FG002|NOT COMPLETED|Overall Study||4
10240626|NCT04666441|11372455|FG003|NOT COMPLETED|Overall Study||4
10240627|NCT04666441|11372456|FG004|NOT COMPLETED|Overall Study||0
10240628|NCT04666441|11372457|FG005|NOT COMPLETED|Overall Study||3
10240629|NCT04666441|11372458|FG006|NOT COMPLETED|Overall Study||5
10240630|NCT04666441|11372459|FG007|NOT COMPLETED|Overall Study||4
10240654|NCT03959423|11372522|FG000|STARTED|Overall Study||160
10240655|NCT03959423|11372523|FG001|STARTED|Overall Study||128
10240656|NCT03959423|11372522|FG000|COMPLETED|Overall Study||151
10240657|NCT03959423|11372523|FG001|COMPLETED|Overall Study||124
10240658|NCT03959423|11372522|FG000|NOT COMPLETED|Overall Study||9
10240659|NCT03959423|11372523|FG001|NOT COMPLETED|Overall Study||4
10240660|NCT03713320|11372531|FG000|STARTED|Randomized Period||19
10240661|NCT03713320|11372532|FG001|STARTED|Randomized Period||18
10240662|NCT03713320|11372533|FG002|STARTED|Randomized Period||0
10240663|NCT03713320|11372531|FG000|COMPLETED|Randomized Period||4
10240664|NCT03713320|11372532|FG001|COMPLETED|Randomized Period||8
10240665|NCT03713320|11372533|FG002|COMPLETED|Randomized Period||0
10240666|NCT03713320|11372531|FG000|NOT COMPLETED|Randomized Period||15
10240667|NCT03713320|11372532|FG001|NOT COMPLETED|Randomized Period||10
10240668|NCT03713320|11372533|FG002|NOT COMPLETED|Randomized Period||0
10240669|NCT03713320|11372531|FG000|STARTED|Cobomarsen Crossover Period||0
10240670|NCT03713320|11372532|FG001|STARTED|Cobomarsen Crossover Period||0
10240671|NCT03713320|11372533|FG002|STARTED|Cobomarsen Crossover Period||7
10240672|NCT03713320|11372531|FG000|COMPLETED|Cobomarsen Crossover Period||0
10240673|NCT03713320|11372532|FG001|COMPLETED|Cobomarsen Crossover Period||0
10240674|NCT03713320|11372533|FG002|COMPLETED|Cobomarsen Crossover Period||0
10240675|NCT03713320|11372531|FG000|NOT COMPLETED|Cobomarsen Crossover Period||0
10240676|NCT03713320|11372532|FG001|NOT COMPLETED|Cobomarsen Crossover Period||0
10240677|NCT03713320|11372533|FG002|NOT COMPLETED|Cobomarsen Crossover Period||7
10240678|NCT03429049|11372542|FG000|STARTED|Overall Study||138
10240679|NCT03429049|11372543|FG001|STARTED|Overall Study||194
10240680|NCT03429049|11372542|FG000|Treated|Overall Study||136
10240681|NCT03429049|11372543|FG001|Treated|Overall Study||189
10240682|NCT03429049|11372542|FG000|COMPLETED|Overall Study||110
10240683|NCT03429049|11372543|FG001|COMPLETED|Overall Study||152
10240684|NCT03429049|11372542|FG000|NOT COMPLETED|Overall Study||28
10240685|NCT03429049|11372543|FG001|NOT COMPLETED|Overall Study||42
10240686|NCT03409731|11372549|FG000|STARTED|Overall Study||135
10240687|NCT03409731|11372549|FG000|COMPLETED|Overall Study||132
10240688|NCT03409731|11372549|FG000|NOT COMPLETED|Overall Study||3
10240689|NCT03283566|11372555|FG000|STARTED|Overall Study||4
10240690|NCT03283566|11372556|FG001|STARTED|Overall Study||5
10240691|NCT03283566|11372555|FG000|COMPLETED|Overall Study||3
10240692|NCT03283566|11372556|FG001|COMPLETED|Overall Study||3
10240693|NCT03283566|11372555|FG000|NOT COMPLETED|Overall Study||1
10240694|NCT03283566|11372556|FG001|NOT COMPLETED|Overall Study||2
10240695|NCT03077412|11372565|FG000|STARTED|Overall Study||17
10240696|NCT03077412|11372566|FG001|STARTED|Overall Study||25
10240697|NCT03077412|11372567|FG002|STARTED|Overall Study||15
10240698|NCT03077412|11372565|FG000|COMPLETED|Overall Study||14
10240699|NCT03077412|11372566|FG001|COMPLETED|Overall Study||12
10240700|NCT03077412|11372567|FG002|COMPLETED|Overall Study||6
10240701|NCT03077412|11372565|FG000|NOT COMPLETED|Overall Study||3
10240702|NCT03077412|11372566|FG001|NOT COMPLETED|Overall Study||13
10240703|NCT03077412|11372567|FG002|NOT COMPLETED|Overall Study||9
10240704|NCT03026504|11372575|FG000|STARTED|Overall Study||15
10240705|NCT03026504|11372575|FG000|COMPLETED|Overall Study||14
10240706|NCT03026504|11372575|FG000|NOT COMPLETED|Overall Study||1
10240707|NCT02971956|11372579|FG000|STARTED|Overall Study||49
10240708|NCT02971956|11372579|FG000|COMPLETED|Overall Study||49
10240709|NCT02971956|11372579|FG000|NOT COMPLETED|Overall Study||0
10240710|NCT02915367|11372585|FG000|STARTED|Overall Study||173
10240711|NCT02915367|11372586|FG001|STARTED|Overall Study||175
10240712|NCT02915367|11372585|FG000|COMPLETED|Overall Study||136
10240713|NCT02915367|11372586|FG001|COMPLETED|Overall Study||144
10240714|NCT02915367|11372585|FG000|NOT COMPLETED|Overall Study||37
10240715|NCT02915367|11372586|FG001|NOT COMPLETED|Overall Study||31
10240631|NCT04593641|11372490|FG000|STARTED|Overall Study||5
10240632|NCT04593641|11372491|FG001|STARTED|Overall Study||5
10240633|NCT04593641|11372492|FG002|STARTED|Overall Study||5
10240634|NCT04593641|11372493|FG003|STARTED|Overall Study||3
10240635|NCT04593641|11372490|FG000|COMPLETED|Overall Study||4
10240636|NCT04593641|11372491|FG001|COMPLETED|Overall Study||5
10240637|NCT04593641|11372492|FG002|COMPLETED|Overall Study||5
10240638|NCT04593641|11372493|FG003|COMPLETED|Overall Study||3
10240639|NCT04593641|11372490|FG000|NOT COMPLETED|Overall Study||1
10240640|NCT04593641|11372491|FG001|NOT COMPLETED|Overall Study||0
10240641|NCT04593641|11372492|FG002|NOT COMPLETED|Overall Study||0
10240642|NCT04593641|11372493|FG003|NOT COMPLETED|Overall Study||0
10240643|NCT04381052|11372505|FG000|STARTED|Overall Study||1
10240644|NCT04381052|11372505|FG000|COMPLETED|Overall Study||1
10240645|NCT04381052|11372505|FG000|NOT COMPLETED|Overall Study||0
10240646|NCT04259346|11372513|FG000|STARTED|Overall Study||126
10240647|NCT04259346|11372514|FG001|STARTED|Overall Study||119
10240648|NCT04259346|11372513|FG000|Received at Least One Dose of Study Drug|Overall Study||126
10240649|NCT04259346|11372514|FG001|Received at Least One Dose of Study Drug|Overall Study||119
10240650|NCT04259346|11372513|FG000|COMPLETED|Overall Study||122
10240651|NCT04259346|11372514|FG001|COMPLETED|Overall Study||115
10240652|NCT04259346|11372513|FG000|NOT COMPLETED|Overall Study||4
10240653|NCT04259346|11372514|FG001|NOT COMPLETED|Overall Study||4
10240716|NCT02665143|11372592|FG000|STARTED|Phase 1||6
10240717|NCT02665143|11372592|FG000|COMPLETED|Phase 1||6
10240718|NCT02665143|11372592|FG000|NOT COMPLETED|Phase 1||0
10240719|NCT02665143|11372592|FG000|STARTED|Phase 2|19 Participants were enrolled in Phase 2.|19
10240720|NCT02665143|11372592|FG000|Completed 0 Cycles|Phase 2||1
10240721|NCT02665143|11372592|FG000|Completed 1 Cycle|Phase 2||12
10240722|NCT02665143|11372592|FG000|Completed 2 Cycles|Phase 2||3
10240723|NCT02665143|11372592|FG000|Completed 3 Cycles|Phase 2||3
10240724|NCT02665143|11372592|FG000|COMPLETED|Phase 2||19
10240725|NCT02665143|11372592|FG000|NOT COMPLETED|Phase 2||0
10240726|NCT02550470|11372600|FG000|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10240727|NCT02550470|11372601|FG001|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10240728|NCT02550470|11372602|FG002|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10240729|NCT02550470|11372600|FG000|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10240730|NCT02550470|11372601|FG001|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10240731|NCT02550470|11372602|FG002|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10240732|NCT02550470|11372600|FG000|NOT COMPLETED|Overall Study||
10240733|NCT02550470|11372601|FG001|NOT COMPLETED|Overall Study||
10240734|NCT02550470|11372602|FG002|NOT COMPLETED|Overall Study||
10240735|NCT02384850|11372612|FG000|STARTED|Overall Study||4
10240736|NCT02384850|11372613|FG001|STARTED|Overall Study||6
10240737|NCT02384850|11372612|FG000|COMPLETED|Overall Study||2
10240738|NCT02384850|11372613|FG001|COMPLETED|Overall Study||4
10240739|NCT02384850|11372612|FG000|NOT COMPLETED|Overall Study||2
10240740|NCT02384850|11372613|FG001|NOT COMPLETED|Overall Study||2
10240741|NCT02352090|11372622|FG000|STARTED|Overall Study||20
10240742|NCT02352090|11372623|FG001|STARTED|Overall Study||20
10240743|NCT02352090|11372624|FG002|STARTED|Overall Study||19
10240744|NCT02352090|11372622|FG000|COMPLETED|Overall Study||19
10240745|NCT02352090|11372623|FG001|COMPLETED|Overall Study||20
10240746|NCT02352090|11372624|FG002|COMPLETED|Overall Study||17
10240747|NCT02352090|11372622|FG000|NOT COMPLETED|Overall Study||1
10240748|NCT02352090|11372623|FG001|NOT COMPLETED|Overall Study||0
10240749|NCT02352090|11372624|FG002|NOT COMPLETED|Overall Study||2
10240750|NCT01976091|11372635|FG000|STARTED|Overall Study||1
10240751|NCT01976091|11372636|FG001|STARTED|Overall Study||3
10240752|NCT01976091|11372637|FG002|STARTED|Overall Study||2
10240753|NCT01976091|11372635|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
10240754|NCT01976091|11372636|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10240755|NCT01976091|11372637|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2
10240756|NCT01976091|11372635|FG000|COMPLETED|Overall Study||1
10240757|NCT01976091|11372636|FG001|COMPLETED|Overall Study||3
10240758|NCT01976091|11372637|FG002|COMPLETED|Overall Study||2
10240759|NCT01976091|11372635|FG000|NOT COMPLETED|Overall Study||0
10240760|NCT01976091|11372636|FG001|NOT COMPLETED|Overall Study||0
10240761|NCT01976091|11372637|FG002|NOT COMPLETED|Overall Study||0
10240762|NCT01145209|11372647|FG000|STARTED|Overall Study||13
10240763|NCT01145209|11372648|FG001|STARTED|Overall Study||19
10240764|NCT01145209|11372647|FG000|COMPLETED|Overall Study||10
10240765|NCT01145209|11372648|FG001|COMPLETED|Overall Study||18
10240766|NCT01145209|11372647|FG000|NOT COMPLETED|Overall Study||3
10240767|NCT01145209|11372648|FG001|NOT COMPLETED|Overall Study||1
10240768|NCT01078662|11372659|FG000|STARTED|Overall Study||62
10240769|NCT01078662|11372660|FG001|STARTED|Overall Study||193
10240770|NCT01078662|11372661|FG002|STARTED|Overall Study||23
10240771|NCT01078662|11372662|FG003|STARTED|Overall Study||8
10240772|NCT01078662|11372663|FG004|STARTED|Overall Study||12
10240773|NCT01078662|11372659|FG000|COMPLETED|Overall Study||4
10240774|NCT01078662|11372660|FG001|COMPLETED|Overall Study||25
10240775|NCT01078662|11372661|FG002|COMPLETED|Overall Study||2
10240776|NCT01078662|11372662|FG003|COMPLETED|Overall Study||1
10240777|NCT01078662|11372663|FG004|COMPLETED|Overall Study||1
10240778|NCT01078662|11372659|FG000|NOT COMPLETED|Overall Study||58
10240779|NCT01078662|11372660|FG001|NOT COMPLETED|Overall Study||168
10240780|NCT01078662|11372661|FG002|NOT COMPLETED|Overall Study||21
10240781|NCT01078662|11372662|FG003|NOT COMPLETED|Overall Study||7
10240782|NCT01078662|11372663|FG004|NOT COMPLETED|Overall Study||11
10240783|NCT00971867|11372672|FG000|STARTED|Overall Study||11
10240784|NCT00971867|11372672|FG000|COMPLETED|Overall Study||0
10240785|NCT00971867|11372672|FG000|NOT COMPLETED|Overall Study||11
10240786|NCT00853307|11372678|FG000|STARTED|Overall Study||6
10240787|NCT00853307|11372679|FG001|STARTED|Overall Study||25
10240788|NCT00853307|11372678|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
10240789|NCT00853307|11372679|FG001|COMPLETED|Overall Study||20
10240790|NCT00853307|11372678|FG000|NOT COMPLETED|Overall Study||2
10240791|NCT00853307|11372679|FG001|NOT COMPLETED|Overall Study||5
10240792|NCT00583804|11372685|FG000|STARTED|Overall Study||10
10240793|NCT00583804|11372685|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
10019247|NCT01829048|11142407|FG001|NOT COMPLETED|Overall Study||0
10019248|NCT01829048|11142408|FG002|NOT COMPLETED|Overall Study||0
10240794|NCT00583804|11372685|FG000|NOT COMPLETED|Overall Study||0
10240795|NCT00545129|11372693|FG000|STARTED|Overall Study||29
10240796|NCT00545129|11372694|FG001|STARTED|Overall Study||30
10240797|NCT00545129|11372693|FG000|COMPLETED|Overall Study||12
10240798|NCT00545129|11372694|FG001|COMPLETED|Overall Study||6
10240799|NCT00545129|11372693|FG000|NOT COMPLETED|Overall Study||17
10240800|NCT00545129|11372694|FG001|NOT COMPLETED|Overall Study||24
10240807|NCT00554606|11372712|FG000|STARTED|Overall Study||115
10240808|NCT00554606|11372712|FG000|COMPLETED|Overall Study||30
10240809|NCT00554606|11372712|FG000|NOT COMPLETED|Overall Study||85
10240816|NCT00565461|11372731|FG000|STARTED|Overall Study||40
10240817|NCT00565461|11372732|FG001|STARTED|Overall Study||40
10240818|NCT00565461|11372733|FG002|STARTED|Overall Study||40
10240819|NCT00565461|11372734|FG003|STARTED|Overall Study||40
10240820|NCT00565461|11372731|FG000|COMPLETED|Overall Study||40
10240821|NCT00565461|11372732|FG001|COMPLETED|Overall Study||39
10240822|NCT00565461|11372733|FG002|COMPLETED|Overall Study||39
10240823|NCT00565461|11372734|FG003|COMPLETED|Overall Study||37
10240824|NCT00565461|11372731|FG000|NOT COMPLETED|Overall Study||0
10240825|NCT00565461|11372732|FG001|NOT COMPLETED|Overall Study||1
10240826|NCT00565461|11372733|FG002|NOT COMPLETED|Overall Study||1
10240827|NCT00565461|11372734|FG003|NOT COMPLETED|Overall Study||3
10240831|NCT00586924|11372760|FG000|STARTED|Overall Study||3
10240832|NCT00586924|11372761|FG001|STARTED|Overall Study||3
10240833|NCT00586924|11372762|FG002|STARTED|Overall Study||3
10240834|NCT00586924|11372763|FG003|STARTED|Overall Study||3
10240835|NCT00586924|11372764|FG004|STARTED|Overall Study||4
10240836|NCT00586924|11372765|FG005|STARTED|Overall Study||33
10240837|NCT00586924|11372760|FG000|COMPLETED|Overall Study||0
10240838|NCT00586924|11372761|FG001|COMPLETED|Overall Study||0
10240839|NCT00586924|11372762|FG002|COMPLETED|Overall Study||0
10240840|NCT00586924|11372763|FG003|COMPLETED|Overall Study||0
10240841|NCT00586924|11372764|FG004|COMPLETED|Overall Study||0
10240842|NCT00586924|11372765|FG005|COMPLETED|Overall Study||0
10240843|NCT00586924|11372760|FG000|NOT COMPLETED|Overall Study||3
10240844|NCT00586924|11372761|FG001|NOT COMPLETED|Overall Study||3
10240845|NCT00586924|11372762|FG002|NOT COMPLETED|Overall Study||3
10240846|NCT00586924|11372763|FG003|NOT COMPLETED|Overall Study||3
10240847|NCT00586924|11372764|FG004|NOT COMPLETED|Overall Study||4
10240848|NCT00586924|11372765|FG005|NOT COMPLETED|Overall Study||33
10240897|NCT00602030|11372792|FG000|STARTED|Lead-in Phase||3
10019249|NCT01829048|11142409|FG003|NOT COMPLETED|Overall Study||2
10240898|NCT00602030|11372793|FG001|STARTED|Lead-in Phase||6
10240899|NCT00602030|11372794|FG002|STARTED|Lead-in Phase||0
10240900|NCT00602030|11372795|FG003|STARTED|Lead-in Phase||0
10240901|NCT00602030|11372796|FG004|STARTED|Lead-in Phase||0
10240902|NCT00602030|11372792|FG000|COMPLETED|Lead-in Phase||1
10240903|NCT00602030|11372793|FG001|COMPLETED|Lead-in Phase||1
10240904|NCT00602030|11372794|FG002|COMPLETED|Lead-in Phase||0
10240905|NCT00602030|11372795|FG003|COMPLETED|Lead-in Phase||0
10240906|NCT00602030|11372796|FG004|COMPLETED|Lead-in Phase||0
10240907|NCT00602030|11372792|FG000|NOT COMPLETED|Lead-in Phase||2
10240908|NCT00602030|11372793|FG001|NOT COMPLETED|Lead-in Phase||5
10240909|NCT00602030|11372794|FG002|NOT COMPLETED|Lead-in Phase||0
10240910|NCT00602030|11372795|FG003|NOT COMPLETED|Lead-in Phase||0
10240801|NCT00548093|11372702|FG000|STARTED|Overall Study||50
10240802|NCT00548093|11372703|FG001|STARTED|Overall Study||16
10240803|NCT00548093|11372702|FG000|COMPLETED|Overall Study||0
10240804|NCT00548093|11372703|FG001|COMPLETED|Overall Study||0
10240805|NCT00548093|11372702|FG000|NOT COMPLETED|Overall Study||50
10240806|NCT00548093|11372703|FG001|NOT COMPLETED|Overall Study||16
10240810|NCT00555009|11372720|FG000|STARTED|Overall Study||4
10240811|NCT00555009|11372721|FG001|STARTED|Overall Study||6
10240812|NCT00555009|11372720|FG000|COMPLETED|Overall Study||2
10240813|NCT00555009|11372721|FG001|COMPLETED|Overall Study||0
10240814|NCT00555009|11372720|FG000|NOT COMPLETED|Overall Study||2
10240815|NCT00555009|11372721|FG001|NOT COMPLETED|Overall Study||6
10240828|NCT00566995|11372750|FG000|STARTED|Overall Study||37
10240829|NCT00566995|11372750|FG000|COMPLETED|Overall Study||30
10240830|NCT00566995|11372750|FG000|NOT COMPLETED|Overall Study||7
10240849|NCT00588861|11372781|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
10240850|NCT00588861|11372782|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
10240851|NCT00588861|11372781|FG000|COMPLETED|Pre-Operative||107
10240852|NCT00588861|11372782|FG001|COMPLETED|Pre-Operative||114
10240853|NCT00588861|11372781|FG000|NOT COMPLETED|Pre-Operative||95
10240854|NCT00588861|11372782|FG001|NOT COMPLETED|Pre-Operative||86
10240855|NCT00588861|11372781|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
10240856|NCT00588861|11372782|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
10240857|NCT00588861|11372781|FG000|COMPLETED|6 Months||9
10240858|NCT00588861|11372782|FG001|COMPLETED|6 Months||41
10240859|NCT00588861|11372781|FG000|NOT COMPLETED|6 Months||98
10240860|NCT00588861|11372782|FG001|NOT COMPLETED|6 Months||73
10240861|NCT00588861|11372781|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
10240862|NCT00588861|11372782|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
10240863|NCT00588861|11372781|FG000|COMPLETED|1 Year||18
10240864|NCT00588861|11372782|FG001|COMPLETED|1 Year||32
10240865|NCT00588861|11372781|FG000|NOT COMPLETED|1 Year||89
10240866|NCT00588861|11372782|FG001|NOT COMPLETED|1 Year||82
10240867|NCT00588861|11372781|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
10240868|NCT00588861|11372782|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
10240869|NCT00588861|11372781|FG000|COMPLETED|2 Years||15
10240870|NCT00588861|11372782|FG001|COMPLETED|2 Years||27
10240871|NCT00588861|11372781|FG000|NOT COMPLETED|2 Years||92
10240872|NCT00588861|11372782|FG001|NOT COMPLETED|2 Years||87
10019250|NCT01829048|11142410|FG004|NOT COMPLETED|Overall Study||0
10019251|NCT01829113|11142425|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
10019252|NCT01829113|11142426|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
10019253|NCT01829113|11142425|FG000|COMPLETED|Overall Study||0
10240873|NCT00588861|11372781|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
10240874|NCT00588861|11372782|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
10240875|NCT00588861|11372781|FG000|COMPLETED|4 Years||16
10240876|NCT00588861|11372782|FG001|COMPLETED|4 Years||11
10240877|NCT00588861|11372781|FG000|NOT COMPLETED|4 Years||91
10240878|NCT00588861|11372782|FG001|NOT COMPLETED|4 Years||103
10240879|NCT00588861|11372781|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
10240880|NCT00588861|11372782|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
10240881|NCT00588861|11372781|FG000|COMPLETED|6 Years||3
10240882|NCT00588861|11372782|FG001|COMPLETED|6 Years||5
10240883|NCT00588861|11372781|FG000|NOT COMPLETED|6 Years||104
10240884|NCT00588861|11372782|FG001|NOT COMPLETED|6 Years||109
10240885|NCT00588861|11372781|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
10240886|NCT00588861|11372782|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
10240887|NCT00588861|11372781|FG000|COMPLETED|8 Years||2
10240888|NCT00588861|11372782|FG001|COMPLETED|8 Years||0
10240889|NCT00588861|11372781|FG000|NOT COMPLETED|8 Years||105
10240890|NCT00588861|11372782|FG001|NOT COMPLETED|8 Years||114
10240891|NCT00588861|11372781|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
10240892|NCT00588861|11372782|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
10240893|NCT00588861|11372781|FG000|COMPLETED|10 Years||0
10240894|NCT00588861|11372782|FG001|COMPLETED|10 Years||0
10240895|NCT00588861|11372781|FG000|NOT COMPLETED|10 Years||107
10240896|NCT00588861|11372782|FG001|NOT COMPLETED|10 Years||114
9832550|NCT00773734|10943325|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
9832551|NCT00773734|10943326|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
10240911|NCT00602030|11372796|FG004|NOT COMPLETED|Lead-in Phase||0
10240912|NCT00602030|11372792|FG000|STARTED|Double-blind Phase||0
10240913|NCT00602030|11372793|FG001|STARTED|Double-blind Phase||0
10240914|NCT00602030|11372794|FG002|STARTED|Double-blind Phase||65
10240915|NCT00602030|11372795|FG003|STARTED|Double-blind Phase||67
10240916|NCT00602030|11372796|FG004|STARTED|Double-blind Phase||0
10240917|NCT00602030|11372792|FG000|Received Treatment|Double-blind Phase||0
10240918|NCT00602030|11372793|FG001|Received Treatment|Double-blind Phase||0
10240919|NCT00602030|11372794|FG002|Received Treatment|Double-blind Phase||63
10240920|NCT00602030|11372795|FG003|Received Treatment|Double-blind Phase||65
10240921|NCT00602030|11372796|FG004|Received Treatment|Double-blind Phase||0
10240922|NCT00602030|11372792|FG000|COMPLETED|Double-blind Phase||0
10240923|NCT00602030|11372793|FG001|COMPLETED|Double-blind Phase||0
10240924|NCT00602030|11372794|FG002|COMPLETED|Double-blind Phase||11
10240925|NCT00602030|11372795|FG003|COMPLETED|Double-blind Phase||8
10240926|NCT00602030|11372796|FG004|COMPLETED|Double-blind Phase||0
10240927|NCT00602030|11372792|FG000|NOT COMPLETED|Double-blind Phase||0
10240928|NCT00602030|11372793|FG001|NOT COMPLETED|Double-blind Phase||0
10240929|NCT00602030|11372794|FG002|NOT COMPLETED|Double-blind Phase||54
10240930|NCT00602030|11372795|FG003|NOT COMPLETED|Double-blind Phase||59
10240931|NCT00602030|11372796|FG004|NOT COMPLETED|Double-blind Phase||0
10240932|NCT00602030|11372792|FG000|STARTED|Crossover Phase||0
10240933|NCT00602030|11372793|FG001|STARTED|Crossover Phase||0
10240934|NCT00602030|11372794|FG002|STARTED|Crossover Phase||0
10240935|NCT00602030|11372795|FG003|STARTED|Crossover Phase||0
10240936|NCT00602030|11372796|FG004|STARTED|Crossover Phase||16
10240937|NCT00602030|11372792|FG000|COMPLETED|Crossover Phase||0
10240938|NCT00602030|11372793|FG001|COMPLETED|Crossover Phase||0
10240939|NCT00602030|11372794|FG002|COMPLETED|Crossover Phase||0
10240940|NCT00602030|11372795|FG003|COMPLETED|Crossover Phase||0
10240941|NCT00602030|11372796|FG004|COMPLETED|Crossover Phase||0
10240942|NCT00602030|11372792|FG000|NOT COMPLETED|Crossover Phase||0
10240943|NCT00602030|11372793|FG001|NOT COMPLETED|Crossover Phase||0
10240944|NCT00602030|11372794|FG002|NOT COMPLETED|Crossover Phase||0
10240945|NCT00602030|11372795|FG003|NOT COMPLETED|Crossover Phase||0
10240946|NCT00602030|11372796|FG004|NOT COMPLETED|Crossover Phase||16
9832552|NCT00773734|10943327|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
9832553|NCT00773734|10943328|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
10240947|NCT03288142|11372810|FG000|STARTED|Overall Study||166
10240948|NCT03288142|11372811|FG001|STARTED|Overall Study||167
10240949|NCT03288142|11372810|FG000|COMPLETED|Overall Study||144
10240950|NCT03288142|11372811|FG001|COMPLETED|Overall Study||152
10019254|NCT01829113|11142426|FG001|COMPLETED|Overall Study||0
10019255|NCT01829113|11142425|FG000|NOT COMPLETED|Overall Study||77
10019256|NCT01829113|11142426|FG001|NOT COMPLETED|Overall Study||78
10019257|NCT01829165|11142436|FG000|STARTED|Overall Study||20
10019258|NCT01829165|11142437|FG001|STARTED|Overall Study||13
10240951|NCT03288142|11372810|FG000|NOT COMPLETED|Overall Study||22
10240952|NCT03288142|11372811|FG001|NOT COMPLETED|Overall Study||15
10240953|NCT03112603|11372821|FG000|STARTED|End of Randomization Period||165
10240954|NCT03112603|11372822|FG001|STARTED|End of Randomization Period||164
10240955|NCT03112603|11372823|FG002|STARTED|End of Randomization Period||0
10240956|NCT03112603|11372821|FG000|COMPLETED|End of Randomization Period||0
10240957|NCT03112603|11372822|FG001|COMPLETED|End of Randomization Period||0
10240958|NCT03112603|11372823|FG002|COMPLETED|End of Randomization Period||0
10240959|NCT03112603|11372821|FG000|NOT COMPLETED|End of Randomization Period||165
10240960|NCT03112603|11372822|FG001|NOT COMPLETED|End of Randomization Period||164
10240961|NCT03112603|11372823|FG002|NOT COMPLETED|End of Randomization Period||0
10240962|NCT03112603|11372821|FG000|STARTED|End of Cross Over Period||0
10240963|NCT03112603|11372822|FG001|STARTED|End of Cross Over Period||0
10240964|NCT03112603|11372823|FG002|STARTED|End of Cross Over Period||61
10240965|NCT03112603|11372821|FG000|COMPLETED|End of Cross Over Period||0
10240966|NCT03112603|11372822|FG001|COMPLETED|End of Cross Over Period||0
10240967|NCT03112603|11372823|FG002|COMPLETED|End of Cross Over Period||0
10240968|NCT03112603|11372821|FG000|NOT COMPLETED|End of Cross Over Period||0
10240969|NCT03112603|11372822|FG001|NOT COMPLETED|End of Cross Over Period||0
10240970|NCT03112603|11372823|FG002|NOT COMPLETED|End of Cross Over Period||61
10240971|NCT02908672|11372831|FG000|STARTED|Overall Study||258
10240972|NCT02908672|11372832|FG001|STARTED|Overall Study||256
10240973|NCT02908672|11372831|FG000|COMPLETED|Overall Study||0
10240974|NCT02908672|11372832|FG001|COMPLETED|Overall Study||0
10240975|NCT02908672|11372831|FG000|NOT COMPLETED|Overall Study||258
10240976|NCT02908672|11372832|FG001|NOT COMPLETED|Overall Study||256
9832554|NCT00773734|10943329|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
9832555|NCT00773734|10943324|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
10019259|NCT01829165|11142436|FG000|COMPLETED|Overall Study||18
10241055|NCT01972217|11372900|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
10241056|NCT01972217|11372901|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
10241057|NCT01972217|11372898|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
10241058|NCT01972217|11372899|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
10241059|NCT01972217|11372900|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
10241060|NCT01972217|11372901|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
10241061|NCT01972217|11372898|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0
10241062|NCT01972217|11372899|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0
10241063|NCT01972217|11372900|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71
10241064|NCT01972217|11372901|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71
10241065|NCT01972217|11372898|FG000|COMPLETED|Part B Double-blind, Randomised Period||0
10241066|NCT01972217|11372899|FG001|COMPLETED|Part B Double-blind, Randomised Period||0
10241067|NCT01972217|11372900|FG002|COMPLETED|Part B Double-blind, Randomised Period||25
10241068|NCT01972217|11372901|FG003|COMPLETED|Part B Double-blind, Randomised Period||24
10241069|NCT01972217|11372898|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0
10241070|NCT01972217|11372899|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0
10241071|NCT01972217|11372900|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46
10241072|NCT01972217|11372901|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47
10241073|NCT01849874|11372915|FG000|STARTED|Overall Study||201
10241074|NCT01849874|11372916|FG001|STARTED|Overall Study||102
10241075|NCT01849874|11372915|FG000|Treated|Overall Study||200
10241076|NCT01849874|11372916|FG001|Treated|Overall Study||94
10241077|NCT01849874|11372915|FG000|COMPLETED|Overall Study||0
10241078|NCT01849874|11372916|FG001|COMPLETED|Overall Study||0
10241079|NCT01849874|11372915|FG000|NOT COMPLETED|Overall Study||201
10241080|NCT01849874|11372916|FG001|NOT COMPLETED|Overall Study||102
10241081|NCT01724866|11372926|FG000|STARTED|Overall Study||39
10241082|NCT01724866|11372927|FG001|STARTED|Overall Study||37
10241083|NCT01724866|11372928|FG002|STARTED|Overall Study||36
10241084|NCT01724866|11372929|FG003|STARTED|Overall Study||36
10241085|NCT01724866|11372926|FG000|Evaluable Population|Overall Study||39
10241086|NCT01724866|11372927|FG001|Evaluable Population|Overall Study||36
10241087|NCT01724866|11372928|FG002|Evaluable Population|Overall Study||36
10019260|NCT01829165|11142437|FG001|COMPLETED|Overall Study||13
10019261|NCT01829165|11142436|FG000|NOT COMPLETED|Overall Study||2
10241088|NCT01724866|11372929|FG003|Evaluable Population|Overall Study||36
10241089|NCT01724866|11372926|FG000|COMPLETED|Overall Study||38
10241090|NCT01724866|11372927|FG001|COMPLETED|Overall Study||32
10241091|NCT01724866|11372928|FG002|COMPLETED|Overall Study||33
10241092|NCT01724866|11372929|FG003|COMPLETED|Overall Study||35
10241093|NCT01724866|11372926|FG000|NOT COMPLETED|Overall Study||1
10241094|NCT01724866|11372927|FG001|NOT COMPLETED|Overall Study||5
10241095|NCT01724866|11372928|FG002|NOT COMPLETED|Overall Study||3
10241096|NCT01724866|11372929|FG003|NOT COMPLETED|Overall Study||1
10240977|NCT02767570|11372840|FG000|STARTED|Overall Study||34
10240978|NCT02767570|11372841|FG001|STARTED|Overall Study||34
10240979|NCT02767570|11372840|FG000|Per Protocol Week 6|Overall Study||31
10240980|NCT02767570|11372841|FG001|Per Protocol Week 6|Overall Study||33
10240981|NCT02767570|11372840|FG000|COMPLETED|Overall Study||25
10240982|NCT02767570|11372841|FG001|COMPLETED|Overall Study||24
10240983|NCT02767570|11372840|FG000|NOT COMPLETED|Overall Study||9
10240984|NCT02767570|11372841|FG001|NOT COMPLETED|Overall Study||10
10240985|NCT02702180|11372850|FG000|STARTED|Double-blind Treatment Period||46
10240986|NCT02702180|11372851|FG001|STARTED|Double-blind Treatment Period||45
10240987|NCT02702180|11372852|FG002|STARTED|Double-blind Treatment Period||47
10240988|NCT02702180|11372850|FG000|COMPLETED|Double-blind Treatment Period||45
10240989|NCT02702180|11372851|FG001|COMPLETED|Double-blind Treatment Period||44
10240990|NCT02702180|11372852|FG002|COMPLETED|Double-blind Treatment Period||43
10240991|NCT02702180|11372850|FG000|NOT COMPLETED|Double-blind Treatment Period||1
10240992|NCT02702180|11372851|FG001|NOT COMPLETED|Double-blind Treatment Period||1
10240993|NCT02702180|11372852|FG002|NOT COMPLETED|Double-blind Treatment Period||4
10240994|NCT02702180|11372850|FG000|STARTED|Open-label Treatment Period||45
10240995|NCT02702180|11372851|FG001|STARTED|Open-label Treatment Period||43
10240996|NCT02702180|11372852|FG002|STARTED|Open-label Treatment Period||43
10240997|NCT02702180|11372850|FG000|COMPLETED|Open-label Treatment Period||45
10240998|NCT02702180|11372851|FG001|COMPLETED|Open-label Treatment Period||42
10240999|NCT02702180|11372852|FG002|COMPLETED|Open-label Treatment Period||41
10241000|NCT02702180|11372850|FG000|NOT COMPLETED|Open-label Treatment Period||0
10241001|NCT02702180|11372851|FG001|NOT COMPLETED|Open-label Treatment Period||1
10241002|NCT02702180|11372852|FG002|NOT COMPLETED|Open-label Treatment Period||2
10241003|NCT02545049|11372863|FG000|STARTED|Overall Study||3723
10241004|NCT02545049|11372864|FG001|STARTED|Overall Study||3714
10241005|NCT02545049|11372863|FG000|Treated|Overall Study||3683
10241006|NCT02545049|11372864|FG001|Treated|Overall Study||3658
10241007|NCT02545049|11372863|FG000|Included in FAS|Overall Study||3686
10241008|NCT02545049|11372864|FG001|Included in FAS|Overall Study||3666
10241009|NCT02545049|11372863|FG000|COMPLETED|Overall Study||3681
10241010|NCT02545049|11372864|FG001|COMPLETED|Overall Study||3653
10241011|NCT02545049|11372863|FG000|NOT COMPLETED|Overall Study||42
10241012|NCT02545049|11372864|FG001|NOT COMPLETED|Overall Study||61
10241013|NCT02448381|11372872|FG000|STARTED|Overall Study||118
10241014|NCT02448381|11372873|FG001|STARTED|Overall Study||51
10241015|NCT02448381|11372872|FG000|Randomized, Not Treated|Overall Study||2
10241016|NCT02448381|11372873|FG001|Randomized, Not Treated|Overall Study||1
10241017|NCT02448381|11372872|FG000|Cycle 1|Overall Study||116
10241018|NCT02448381|11372873|FG001|Cycle 1|Overall Study||50
10241019|NCT02448381|11372872|FG000|Cycle 2|Overall Study||110
10241020|NCT02448381|11372873|FG001|Cycle 2|Overall Study||45
10241021|NCT02448381|11372872|FG000|Cycle 3|Overall Study||78
10241022|NCT02448381|11372873|FG001|Cycle 3|Overall Study||32
10241023|NCT02448381|11372872|FG000|Follow-up Period|Overall Study||98
10241024|NCT02448381|11372873|FG001|Follow-up Period|Overall Study||39
10241025|NCT02448381|11372872|FG000|COMPLETED|Overall Study||83
10241026|NCT02448381|11372873|FG001|COMPLETED|Overall Study||32
10241027|NCT02448381|11372872|FG000|NOT COMPLETED|Overall Study||35
10241028|NCT02448381|11372873|FG001|NOT COMPLETED|Overall Study||19
10241029|NCT02151981|11372887|FG000|STARTED|Overall Study||279
10241030|NCT02151981|11372888|FG001|STARTED|Overall Study||140
10241031|NCT02151981|11372887|FG000|Received Randomised Treatment Only|Overall Study||279
10241032|NCT02151981|11372888|FG001|Received Randomised Treatment Only|Overall Study||136
10241033|NCT02151981|11372887|FG000|Did Not Receive Treatment|Overall Study||0
10241034|NCT02151981|11372888|FG001|Did Not Receive Treatment|Overall Study||4
10241035|NCT02151981|11372887|FG000|Crossed Over Osimertinib|Overall Study||0
10241036|NCT02151981|11372888|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
10241037|NCT02151981|11372887|FG000|COMPLETED|Overall Study||0
10241038|NCT02151981|11372888|FG001|COMPLETED|Overall Study||0
10241039|NCT02151981|11372887|FG000|NOT COMPLETED|Overall Study||279
10241040|NCT02151981|11372888|FG001|NOT COMPLETED|Overall Study||140
10241041|NCT01972217|11372898|FG000|STARTED|Part A: Open-label Safety Run-in Period||3
10241042|NCT01972217|11372899|FG001|STARTED|Part A: Open-label Safety Run-in Period||13
10241043|NCT01972217|11372900|FG002|STARTED|Part A: Open-label Safety Run-in Period||0
10241044|NCT01972217|11372901|FG003|STARTED|Part A: Open-label Safety Run-in Period||0
10241045|NCT01972217|11372898|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2
10241046|NCT01972217|11372899|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1
9957115|NCT01449461|11076343|FG005|STARTED|Overall Study||15
9957116|NCT01449461|11076338|FG000|COMPLETED|Overall Study||0
10241047|NCT01972217|11372900|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0
10241048|NCT01972217|11372901|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0
10241049|NCT01972217|11372898|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
10241050|NCT01972217|11372899|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
10241051|NCT01972217|11372900|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
10241052|NCT01972217|11372901|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
10241053|NCT01972217|11372898|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
10241054|NCT01972217|11372899|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
10241097|NCT01670877|11372943|FG000|STARTED|Part I and Part 2||16
9957117|NCT01449461|11076339|FG001|COMPLETED|Overall Study||0
10241098|NCT01670877|11372944|FG001|STARTED|Part I and Part 2||5
10241099|NCT01670877|11372945|FG002|STARTED|Part I and Part 2||11
10241100|NCT01670877|11372946|FG003|STARTED|Part I and Part 2||24
10241101|NCT01670877|11372947|FG004|STARTED|Part I and Part 2||0
10241102|NCT01670877|11372948|FG005|STARTED|Part I and Part 2||0
10241103|NCT01670877|11372943|FG000|COMPLETED|Part I and Part 2||16
10241104|NCT01670877|11372944|FG001|COMPLETED|Part I and Part 2||4
10241105|NCT01670877|11372945|FG002|COMPLETED|Part I and Part 2||10
10241106|NCT01670877|11372946|FG003|COMPLETED|Part I and Part 2||21
10241107|NCT01670877|11372947|FG004|COMPLETED|Part I and Part 2||0
10241108|NCT01670877|11372948|FG005|COMPLETED|Part I and Part 2||0
10241109|NCT01670877|11372943|FG000|NOT COMPLETED|Part I and Part 2||0
9832556|NCT00773734|10943325|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
9832557|NCT00773734|10943326|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
9832558|NCT00773734|10943327|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
9832559|NCT00773734|10943328|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
9832560|NCT00773734|10943329|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
9832561|NCT00773734|10943324|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
9832562|NCT00773734|10943325|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
9832563|NCT00773734|10943326|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66
9832564|NCT00773734|10943327|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
9832565|NCT00773734|10943328|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34
9832566|NCT00773734|10943329|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36
9832567|NCT00773734|10943324|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0
9832568|NCT00773734|10943325|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65
9832569|NCT00773734|10943326|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59
9832570|NCT00773734|10943327|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65
9832571|NCT00773734|10943328|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33
9832572|NCT00773734|10943329|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31
9832573|NCT00773734|10943324|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
9832574|NCT00773734|10943325|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
9832575|NCT00773734|10943326|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
9832576|NCT00773734|10943327|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
9832577|NCT00773734|10943328|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
9832578|NCT00773734|10943329|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
9832579|NCT00773734|10943324|FG000|STARTED|Extension: Active Treatment Week 24-52||0
9832580|NCT00773734|10943325|FG001|STARTED|Extension: Active Treatment Week 24-52||47
9832581|NCT00773734|10943326|FG002|STARTED|Extension: Active Treatment Week 24-52||50
9957118|NCT01449461|11076340|FG002|COMPLETED|Overall Study||0
9957119|NCT01449461|11076341|FG003|COMPLETED|Overall Study||0
9957120|NCT01449461|11076342|FG004|COMPLETED|Overall Study||0
9957121|NCT01449461|11076343|FG005|COMPLETED|Overall Study||0
9957122|NCT01449461|11076338|FG000|NOT COMPLETED|Overall Study||6
9957123|NCT01449461|11076339|FG001|NOT COMPLETED|Overall Study||18
10241110|NCT01670877|11372944|FG001|NOT COMPLETED|Part I and Part 2||1
10241111|NCT01670877|11372945|FG002|NOT COMPLETED|Part I and Part 2||1
10241112|NCT01670877|11372946|FG003|NOT COMPLETED|Part I and Part 2||3
10241113|NCT01670877|11372947|FG004|NOT COMPLETED|Part I and Part 2||0
10241114|NCT01670877|11372948|FG005|NOT COMPLETED|Part I and Part 2||0
9957124|NCT01449461|11076340|FG002|NOT COMPLETED|Overall Study||18
10241115|NCT01670877|11372943|FG000|STARTED|Crossover||0
10241116|NCT01670877|11372944|FG001|STARTED|Crossover||0
10241117|NCT01670877|11372945|FG002|STARTED|Crossover||0
10241118|NCT01670877|11372946|FG003|STARTED|Crossover||0
10241119|NCT01670877|11372947|FG004|STARTED|Crossover||3
10241120|NCT01670877|11372948|FG005|STARTED|Crossover||5
10241121|NCT01670877|11372943|FG000|COMPLETED|Crossover||0
10241122|NCT01670877|11372944|FG001|COMPLETED|Crossover||0
10241123|NCT01670877|11372945|FG002|COMPLETED|Crossover||0
10241124|NCT01670877|11372946|FG003|COMPLETED|Crossover||0
10241125|NCT01670877|11372947|FG004|COMPLETED|Crossover||3
10241126|NCT01670877|11372948|FG005|COMPLETED|Crossover||5
10241127|NCT01670877|11372943|FG000|NOT COMPLETED|Crossover||0
10241128|NCT01670877|11372944|FG001|NOT COMPLETED|Crossover||0
10241129|NCT01670877|11372945|FG002|NOT COMPLETED|Crossover||0
10241130|NCT01670877|11372946|FG003|NOT COMPLETED|Crossover||0
10241131|NCT01670877|11372947|FG004|NOT COMPLETED|Crossover||0
10241132|NCT01670877|11372948|FG005|NOT COMPLETED|Crossover||0
9832582|NCT00773734|10943327|FG003|STARTED|Extension: Active Treatment Week 24-52||58
9832583|NCT00773734|10943328|FG004|STARTED|Extension: Active Treatment Week 24-52||27
9832584|NCT00773734|10943329|FG005|STARTED|Extension: Active Treatment Week 24-52||27
9832585|NCT00773734|10943324|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
9832586|NCT00773734|10943325|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
9832587|NCT00773734|10943326|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
9832588|NCT00773734|10943327|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
9832589|NCT00773734|10943328|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
10019262|NCT01829165|11142437|FG001|NOT COMPLETED|Overall Study||0
10019263|NCT01829191|11142445|FG000|STARTED|Overall Study||63
10019264|NCT01829191|11142446|FG001|STARTED|Overall Study||64
10019265|NCT01829191|11142445|FG000|COMPLETED|Overall Study||56
10019266|NCT01829191|11142446|FG001|COMPLETED|Overall Study||50
10019267|NCT01829191|11142445|FG000|NOT COMPLETED|Overall Study||7
10019268|NCT01829191|11142446|FG001|NOT COMPLETED|Overall Study||14
9832590|NCT00773734|10943329|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
9832591|NCT00773734|10943324|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0
9832592|NCT00773734|10943325|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
9832593|NCT00773734|10943326|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33
9832594|NCT00773734|10943327|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48
9832595|NCT00773734|10943328|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22
9832596|NCT00773734|10943329|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19
9832597|NCT00773734|10943324|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
9832598|NCT00773734|10943325|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
9832599|NCT00773734|10943326|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
9832600|NCT00773734|10943327|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
9832601|NCT00773734|10943328|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
9832602|NCT00773734|10943329|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
9832603|NCT00773734|10943324|FG000|STARTED|LTE Period: Week 52 to 6 Years||0
9832604|NCT00773734|10943325|FG001|STARTED|LTE Period: Week 52 to 6 Years||0
9832605|NCT00773734|10943326|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
9832606|NCT00773734|10943327|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
9832607|NCT00773734|10943328|FG004|STARTED|LTE Period: Week 52 to 6 Years||0
9832608|NCT00773734|10943329|FG005|STARTED|LTE Period: Week 52 to 6 Years||0
9832609|NCT00773734|10943324|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0
9832610|NCT00773734|10943325|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0
9832611|NCT00773734|10943326|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
9832612|NCT00773734|10943327|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
9832613|NCT00773734|10943328|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0
9832614|NCT00773734|10943329|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0
9832615|NCT00773734|10943324|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
9832616|NCT00773734|10943325|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
9832617|NCT00773734|10943326|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
9832618|NCT00773734|10943327|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
9832619|NCT00773734|10943328|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
9832620|NCT00773734|10943329|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
9832621|NCT00773747|10943388|FG000|STARTED|Overall Study||317
9832622|NCT00773747|10943389|FG001|STARTED|Overall Study||320
9832623|NCT00773747|10943388|FG000|Treated|Overall Study||315
9832624|NCT00773747|10943389|FG001|Treated|Overall Study||320
9832625|NCT00773747|10943388|FG000|COMPLETED|Overall Study||20
9832626|NCT00773747|10943389|FG001|COMPLETED|Overall Study||24
9832627|NCT00773747|10943388|FG000|NOT COMPLETED|Overall Study||297
9832628|NCT00773747|10943389|FG001|NOT COMPLETED|Overall Study||296
10019269|NCT01829217|11142451|FG000|STARTED|Overall Study||13
10019270|NCT01829217|11142451|FG000|COMPLETED|Overall Study||13
10241133|NCT01602380|11372964|FG000|STARTED|Overall Study||230
10241134|NCT01602380|11372965|FG001|STARTED|Overall Study||232
10241135|NCT01602380|11372964|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
10241136|NCT01602380|11372965|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
10241137|NCT01602380|11372964|FG000|NOT COMPLETED|Overall Study||93
10241138|NCT01602380|11372965|FG001|NOT COMPLETED|Overall Study||101
10241139|NCT01412333|11372973|FG000|STARTED|Overall Study||418
10241140|NCT01412333|11372974|FG001|STARTED|Overall Study||417
10241141|NCT01412333|11372973|FG000|COMPLETED|Overall Study||320
10241142|NCT01412333|11372974|FG001|COMPLETED|Overall Study||360
10241143|NCT01412333|11372973|FG000|NOT COMPLETED|Overall Study||98
10241144|NCT01412333|11372974|FG001|NOT COMPLETED|Overall Study||57
10241145|NCT01247324|11372983|FG000|STARTED|Overall Study||411
10241146|NCT01247324|11372984|FG001|STARTED|Overall Study||410
10241147|NCT01247324|11372983|FG000|COMPLETED|Overall Study||340
10241148|NCT01247324|11372984|FG001|COMPLETED|Overall Study||366
10241149|NCT01247324|11372983|FG000|NOT COMPLETED|Overall Study||71
10241150|NCT01247324|11372984|FG001|NOT COMPLETED|Overall Study||44
10241151|NCT00667628|11372993|FG000|STARTED|Overall Study||25
10241152|NCT00667628|11372994|FG001|STARTED|Overall Study||27
10241153|NCT00667628|11372993|FG000|COMPLETED|Overall Study||0
10241154|NCT00667628|11372994|FG001|COMPLETED|Overall Study||0
10241155|NCT00667628|11372993|FG000|NOT COMPLETED|Overall Study||25
10241156|NCT00667628|11372994|FG001|NOT COMPLETED|Overall Study||27
10019271|NCT01829217|11142451|FG000|NOT COMPLETED|Overall Study||0
10019272|NCT01829230|11142457|FG000|STARTED|Overall Study||40
10019273|NCT01829230|11142458|FG001|STARTED|Overall Study||42
10019274|NCT01829230|11142457|FG000|COMPLETED|Overall Study||39
10019275|NCT01829230|11142458|FG001|COMPLETED|Overall Study||38
10019276|NCT01829230|11142457|FG000|NOT COMPLETED|Overall Study||1
10241157|NCT04286529|11373004|FG000|STARTED|Overall Study||4
10241158|NCT04286529|11373005|FG001|STARTED|Overall Study||4
10241159|NCT04286529|11373006|FG002|STARTED|Overall Study||5
10241160|NCT04286529|11373007|FG003|STARTED|Overall Study||4
10241161|NCT04286529|11373004|FG000|COMPLETED|Overall Study||3
10241162|NCT04286529|11373005|FG001|COMPLETED|Overall Study||1
10241163|NCT04286529|11373006|FG002|COMPLETED|Overall Study||3
10241164|NCT04286529|11373007|FG003|COMPLETED|Overall Study||1
10241165|NCT04286529|11373004|FG000|NOT COMPLETED|Overall Study||1
10241166|NCT04286529|11373005|FG001|NOT COMPLETED|Overall Study||3
10241167|NCT04286529|11373006|FG002|NOT COMPLETED|Overall Study||2
10241168|NCT04286529|11373007|FG003|NOT COMPLETED|Overall Study||3
10241169|NCT03581786|11373019|FG000|STARTED|Overall Study||143
10241170|NCT03581786|11373020|FG001|STARTED|Overall Study||146
10241171|NCT03581786|11373019|FG000|COMPLETED|Overall Study||0
10241172|NCT03581786|11373020|FG001|COMPLETED|Overall Study||0
10241173|NCT03581786|11373019|FG000|NOT COMPLETED|Overall Study||143
10241174|NCT03581786|11373020|FG001|NOT COMPLETED|Overall Study||146
10241175|NCT03573518|11373030|FG000|STARTED|Overall Study||92
10241176|NCT03573518|11373031|FG001|STARTED|Overall Study||92
10241177|NCT03573518|11373032|FG002|STARTED|Overall Study||92
10241178|NCT03573518|11373033|FG003|STARTED|Overall Study||92
10241179|NCT03573518|11373030|FG000|COMPLETED|Overall Study||69
10241180|NCT03573518|11373031|FG001|COMPLETED|Overall Study||77
10241181|NCT03573518|11373032|FG002|COMPLETED|Overall Study||70
10241182|NCT03573518|11373033|FG003|COMPLETED|Overall Study||81
10241183|NCT03573518|11373030|FG000|NOT COMPLETED|Overall Study||23
10241184|NCT03573518|11373031|FG001|NOT COMPLETED|Overall Study||15
10019277|NCT01829230|11142458|FG001|NOT COMPLETED|Overall Study||4
10019278|NCT01829243|11142464|FG000|STARTED|First Intervention||11
10019279|NCT01829243|11142465|FG001|STARTED|First Intervention||15
10019280|NCT01829243|11142464|FG000|COMPLETED|First Intervention||7
10019281|NCT01829243|11142465|FG001|COMPLETED|First Intervention||13
10019282|NCT01829243|11142464|FG000|NOT COMPLETED|First Intervention||4
10019283|NCT01829243|11142465|FG001|NOT COMPLETED|First Intervention||2
10019284|NCT01829243|11142464|FG000|STARTED|Washout Period of 1 Week||7
10019285|NCT01829243|11142465|FG001|STARTED|Washout Period of 1 Week||13
10019286|NCT01829243|11142464|FG000|COMPLETED|Washout Period of 1 Week||7
10019287|NCT01829243|11142465|FG001|COMPLETED|Washout Period of 1 Week||13
10019288|NCT01829243|11142464|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10241185|NCT03573518|11373032|FG002|NOT COMPLETED|Overall Study||22
10241186|NCT03573518|11373033|FG003|NOT COMPLETED|Overall Study||11
10241187|NCT03486314|11373043|FG000|STARTED|Part A||20
10241188|NCT03486314|11373044|FG001|STARTED|Part A||0
10241189|NCT03486314|11373045|FG002|STARTED|Part A||0
10241190|NCT03486314|11373043|FG000|COMPLETED|Part A||17
10241191|NCT03486314|11373044|FG001|COMPLETED|Part A||0
10241192|NCT03486314|11373045|FG002|COMPLETED|Part A||0
10241193|NCT03486314|11373043|FG000|NOT COMPLETED|Part A||3
10241194|NCT03486314|11373044|FG001|NOT COMPLETED|Part A||0
10241195|NCT03486314|11373045|FG002|NOT COMPLETED|Part A||0
10241196|NCT03486314|11373043|FG000|STARTED|Part B||0
10241197|NCT03486314|11373044|FG001|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|9
10241198|NCT03486314|11373045|FG002|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|8
10241199|NCT03486314|11373043|FG000|COMPLETED|Part B||0
10241200|NCT03486314|11373044|FG001|COMPLETED|Part B||9
10241201|NCT03486314|11373045|FG002|COMPLETED|Part B||8
10241202|NCT03486314|11373043|FG000|NOT COMPLETED|Part B||0
10241203|NCT03486314|11373044|FG001|NOT COMPLETED|Part B||0
10241204|NCT03486314|11373045|FG002|NOT COMPLETED|Part B||0
10241205|NCT02988713|11373053|FG000|STARTED|Overall Study||35
10241206|NCT02988713|11373053|FG000|COMPLETED|Overall Study||32
10241207|NCT02988713|11373053|FG000|NOT COMPLETED|Overall Study||3
10241208|NCT02794883|11373060|FG000|STARTED|Pre-Surgical Treatment||12
10241209|NCT02794883|11373061|FG001|STARTED|Pre-Surgical Treatment||12
10241210|NCT02794883|11373062|FG002|STARTED|Pre-Surgical Treatment||12
10241211|NCT02794883|11373060|FG000|Registered for Study|Pre-Surgical Treatment||12
10241212|NCT02794883|11373061|FG001|Registered for Study|Pre-Surgical Treatment||12
10241213|NCT02794883|11373062|FG002|Registered for Study|Pre-Surgical Treatment||12
10241214|NCT02794883|11373060|FG000|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||12
10241215|NCT02794883|11373061|FG001|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
10241216|NCT02794883|11373062|FG002|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
10241217|NCT02794883|11373060|FG000|COMPLETED|Pre-Surgical Treatment||12
10241218|NCT02794883|11373061|FG001|COMPLETED|Pre-Surgical Treatment||11
10241219|NCT02794883|11373062|FG002|COMPLETED|Pre-Surgical Treatment||11
10241220|NCT02794883|11373060|FG000|NOT COMPLETED|Pre-Surgical Treatment||0
10241221|NCT02794883|11373061|FG001|NOT COMPLETED|Pre-Surgical Treatment||1
10241222|NCT02794883|11373062|FG002|NOT COMPLETED|Pre-Surgical Treatment||1
10241223|NCT02794883|11373060|FG000|STARTED|Post-Surgery Treatment (Adjuvant)||12
10241224|NCT02794883|11373061|FG001|STARTED|Post-Surgery Treatment (Adjuvant)||11
10241225|NCT02794883|11373062|FG002|STARTED|Post-Surgery Treatment (Adjuvant)||11
10241226|NCT02794883|11373060|FG000|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
10241227|NCT02794883|11373061|FG001|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||8
10241228|NCT02794883|11373062|FG002|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
10241229|NCT02794883|11373060|FG000|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||7
10241230|NCT02794883|11373061|FG001|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||8
10241231|NCT02794883|11373062|FG002|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||11
10241232|NCT02794883|11373060|FG000|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||3
10241233|NCT02794883|11373061|FG001|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||7
10241234|NCT02794883|11373062|FG002|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||4
10241235|NCT02794883|11373060|FG000|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
10241236|NCT02794883|11373061|FG001|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||5
10241237|NCT02794883|11373062|FG002|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
10241238|NCT02794883|11373060|FG000|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
10241239|NCT02794883|11373061|FG001|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||3
10241240|NCT02794883|11373062|FG002|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
10241241|NCT02794883|11373060|FG000|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||0
10241242|NCT02794883|11373061|FG001|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||3
10241243|NCT02794883|11373062|FG002|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||2
10241244|NCT02794883|11373060|FG000|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||0
10241245|NCT02794883|11373061|FG001|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||3
10241246|NCT02794883|11373062|FG002|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||1
10241247|NCT02794883|11373060|FG000|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||0
10241248|NCT02794883|11373061|FG001|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||3
10241249|NCT02794883|11373062|FG002|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||1
10241250|NCT02794883|11373060|FG000|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||0
10241251|NCT02794883|11373061|FG001|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||3
10241252|NCT02794883|11373062|FG002|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||1
10241253|NCT02794883|11373060|FG000|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||0
10241254|NCT02794883|11373061|FG001|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||2
10241255|NCT02794883|11373062|FG002|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||1
10241256|NCT02794883|11373060|FG000|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||0
10241257|NCT02794883|11373061|FG001|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||2
10241258|NCT02794883|11373062|FG002|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||1
10241259|NCT02794883|11373060|FG000|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||0
10241260|NCT02794883|11373061|FG001|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
10241261|NCT02794883|11373062|FG002|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
10241262|NCT02794883|11373060|FG000|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||0
10241263|NCT02794883|11373061|FG001|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
10241264|NCT02794883|11373062|FG002|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
10241265|NCT02794883|11373060|FG000|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||0
10241266|NCT02794883|11373061|FG001|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
10241267|NCT02794883|11373062|FG002|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
10241268|NCT02794883|11373060|FG000|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
10241269|NCT02794883|11373061|FG001|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
10241270|NCT02794883|11373062|FG002|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||1
10241271|NCT02794883|11373060|FG000|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
10241272|NCT02794883|11373061|FG001|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
10241273|NCT02794883|11373062|FG002|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||1
10241274|NCT02794883|11373060|FG000|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10241275|NCT02794883|11373061|FG001|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10241276|NCT02794883|11373062|FG002|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10241277|NCT02794883|11373060|FG000|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10241278|NCT02794883|11373061|FG001|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10241279|NCT02794883|11373062|FG002|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10241280|NCT02794883|11373060|FG000|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||12
10241281|NCT02794883|11373061|FG001|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
10241282|NCT02794883|11373062|FG002|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
10241283|NCT02794883|11373060|FG000|STARTED|Follow-up Period (up to 2 Years)||12
10241284|NCT02794883|11373061|FG001|STARTED|Follow-up Period (up to 2 Years)||11
10241285|NCT02794883|11373062|FG002|STARTED|Follow-up Period (up to 2 Years)||11
10241286|NCT02794883|11373060|FG000|COMPLETED|Follow-up Period (up to 2 Years)||0
10241287|NCT02794883|11373061|FG001|COMPLETED|Follow-up Period (up to 2 Years)||1
10241288|NCT02794883|11373062|FG002|COMPLETED|Follow-up Period (up to 2 Years)||1
10241289|NCT02794883|11373060|FG000|NOT COMPLETED|Follow-up Period (up to 2 Years)||12
10241290|NCT02794883|11373061|FG001|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
10241291|NCT02794883|11373062|FG002|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
10241292|NCT02677987|11373072|FG000|STARTED|Overall Study||23
10241293|NCT02677987|11373073|FG001|STARTED|Overall Study||24
10241294|NCT02677987|11373072|FG000|COMPLETED|Overall Study||19
10241295|NCT02677987|11373073|FG001|COMPLETED|Overall Study||24
10241296|NCT02677987|11373072|FG000|NOT COMPLETED|Overall Study||4
10241297|NCT02677987|11373073|FG001|NOT COMPLETED|Overall Study||0
10241298|NCT02659059|11373085|FG000|STARTED|Overall Study||288
10241299|NCT02659059|11373086|FG001|STARTED|Overall Study||36
10241300|NCT02659059|11373085|FG000|COMPLETED|Overall Study||88
10241301|NCT02659059|11373086|FG001|COMPLETED|Overall Study||4
10241302|NCT02659059|11373085|FG000|NOT COMPLETED|Overall Study||200
10241303|NCT02659059|11373086|FG001|NOT COMPLETED|Overall Study||32
10241304|NCT02337829|11373097|FG000|STARTED|Overall Study||18
10241305|NCT02337829|11373098|FG001|STARTED|Overall Study||14
10241306|NCT02337829|11373099|FG002|STARTED|Overall Study||6
10241307|NCT02337829|11373100|FG003|STARTED|Overall Study||10
10241308|NCT02337829|11373097|FG000|COMPLETED|Overall Study||0
10241309|NCT02337829|11373098|FG001|COMPLETED|Overall Study||0
10241310|NCT02337829|11373099|FG002|COMPLETED|Overall Study||0
10241311|NCT02337829|11373100|FG003|COMPLETED|Overall Study||0
10241312|NCT02337829|11373097|FG000|NOT COMPLETED|Overall Study||18
10241313|NCT02337829|11373098|FG001|NOT COMPLETED|Overall Study||14
10241314|NCT02337829|11373099|FG002|NOT COMPLETED|Overall Study||6
10241315|NCT02337829|11373100|FG003|NOT COMPLETED|Overall Study||10
10241316|NCT01928394|11373135|FG000|STARTED|Treatment Period||18
10241317|NCT01928394|11373136|FG001|STARTED|Treatment Period||3
10241318|NCT01928394|11373137|FG002|STARTED|Treatment Period||18
10241319|NCT01928394|11373138|FG003|STARTED|Treatment Period||59
10241320|NCT01928394|11373139|FG004|STARTED|Treatment Period||3
10241321|NCT01928394|11373140|FG005|STARTED|Treatment Period||49
10241322|NCT01928394|11373141|FG006|STARTED|Treatment Period||52
10241323|NCT01928394|11373142|FG007|STARTED|Treatment Period||18
10241324|NCT01928394|11373143|FG008|STARTED|Treatment Period||3
10241325|NCT01928394|11373144|FG009|STARTED|Treatment Period||18
10241326|NCT01928394|11373145|FG010|STARTED|Treatment Period||30
10241327|NCT01928394|11373146|FG011|STARTED|Treatment Period||98
10241328|NCT01928394|11373147|FG012|STARTED|Treatment Period||61
10241329|NCT01928394|11373148|FG013|STARTED|Treatment Period||147
10241330|NCT01928394|11373149|FG014|STARTED|Treatment Period||96
10241331|NCT01928394|11373150|FG015|STARTED|Treatment Period||3
10241332|NCT01928394|11373151|FG016|STARTED|Treatment Period||55
10241333|NCT01928394|11373152|FG017|STARTED|Treatment Period||78
10241334|NCT01928394|11373153|FG018|STARTED|Treatment Period||92
10241335|NCT01928394|11373154|FG019|STARTED|Treatment Period||104
10241336|NCT01928394|11373155|FG020|STARTED|Treatment Period||41
10241337|NCT01928394|11373156|FG021|STARTED|Treatment Period||43
10241338|NCT01928394|11373157|FG022|STARTED|Treatment Period||42
10241339|NCT01928394|11373135|FG000|Transition|Treatment Period||3
10241340|NCT01928394|11373136|FG001|Transition|Treatment Period||0
10241341|NCT01928394|11373137|FG002|Transition|Treatment Period||0
10241342|NCT01928394|11373138|FG003|Transition|Treatment Period||9
10241343|NCT01928394|11373139|FG004|Transition|Treatment Period||0
9832629|NCT00773786|10943395|FG000|STARTED|First Intervention (1 Week)||10
9832630|NCT00773786|10943396|FG001|STARTED|First Intervention (1 Week)||10
9832631|NCT00773786|10943395|FG000|COMPLETED|First Intervention (1 Week)||10
9832632|NCT00773786|10943396|FG001|COMPLETED|First Intervention (1 Week)||10
9957125|NCT01449461|11076341|FG003|NOT COMPLETED|Overall Study||32
9957126|NCT01449461|11076342|FG004|NOT COMPLETED|Overall Study||48
9957127|NCT01449461|11076343|FG005|NOT COMPLETED|Overall Study||15
9957128|NCT01449513|11076368|FG000|STARTED|Overall Study||16
10241344|NCT01928394|11373140|FG005|Transition|Treatment Period||0
10241345|NCT01928394|11373141|FG006|Transition|Treatment Period||0
10241346|NCT01928394|11373142|FG007|Transition|Treatment Period||2
10241347|NCT01928394|11373143|FG008|Transition|Treatment Period||0
10241348|NCT01928394|11373144|FG009|Transition|Treatment Period||0
10241349|NCT01928394|11373145|FG010|Transition|Treatment Period||0
9957129|NCT01449513|11076369|FG001|STARTED|Overall Study||8
9957130|NCT01449513|11076368|FG000|COMPLETED|Overall Study||16
9957131|NCT01449513|11076369|FG001|COMPLETED|Overall Study||8
9957132|NCT01449513|11076368|FG000|NOT COMPLETED|Overall Study||0
9957133|NCT01449513|11076369|FG001|NOT COMPLETED|Overall Study||0
9957134|NCT01449526|11076377|FG000|STARTED|Overall Study||83
9957135|NCT01449526|11076378|FG001|STARTED|Overall Study||83
9957136|NCT01449526|11076377|FG000|COMPLETED|Overall Study||81
9957137|NCT01449526|11076378|FG001|COMPLETED|Overall Study||77
9957138|NCT01449526|11076377|FG000|NOT COMPLETED|Overall Study||2
9957139|NCT01449526|11076378|FG001|NOT COMPLETED|Overall Study||6
9957140|NCT01449539|11076384|FG000|STARTED|Overall Study||8
10241350|NCT01928394|11373146|FG011|Transition|Treatment Period||17
10241351|NCT01928394|11373147|FG012|Transition|Treatment Period||0
10241352|NCT01928394|11373148|FG013|Transition|Treatment Period||2
10241353|NCT01928394|11373149|FG014|Transition|Treatment Period||0
10241354|NCT01928394|11373150|FG015|Transition|Treatment Period||0
9832633|NCT00773786|10943395|FG000|NOT COMPLETED|First Intervention (1 Week)||0
9832634|NCT00773786|10943396|FG001|NOT COMPLETED|First Intervention (1 Week)||0
9832635|NCT00773786|10943395|FG000|STARTED|Washout (1 Week)||10
9832636|NCT00773786|10943396|FG001|STARTED|Washout (1 Week)||10
9832637|NCT00773786|10943395|FG000|COMPLETED|Washout (1 Week)||10
9832638|NCT00773786|10943396|FG001|COMPLETED|Washout (1 Week)||10
9832639|NCT00773786|10943395|FG000|NOT COMPLETED|Washout (1 Week)||0
9832640|NCT00773786|10943396|FG001|NOT COMPLETED|Washout (1 Week)||0
9832641|NCT00773786|10943395|FG000|STARTED|Second Intervention (1 Week)||10
9832642|NCT00773786|10943396|FG001|STARTED|Second Intervention (1 Week)||10
10241355|NCT01928394|11373151|FG016|Transition|Treatment Period||0
9957141|NCT01449539|11076384|FG000|COMPLETED|Overall Study||4
10241356|NCT01928394|11373152|FG017|Transition|Treatment Period||20
9957142|NCT01449539|11076384|FG000|NOT COMPLETED|Overall Study||4
9957143|NCT01449630|11076397|FG000|STARTED|Period 1||2
9957144|NCT01449630|11076398|FG001|STARTED|Period 1||6
9957145|NCT01449630|11076399|FG002|STARTED|Period 1||2
10241357|NCT01928394|11373153|FG018|Transition|Treatment Period||0
10241358|NCT01928394|11373154|FG019|Transition|Treatment Period||0
10241359|NCT01928394|11373155|FG020|Transition|Treatment Period||0
10241360|NCT01928394|11373156|FG021|Transition|Treatment Period||0
10241361|NCT01928394|11373157|FG022|Transition|Treatment Period||0
10241362|NCT01928394|11373135|FG000|Transition- Continued|Treatment Period||0
10241363|NCT01928394|11373136|FG001|Transition- Continued|Treatment Period||0
10241364|NCT01928394|11373137|FG002|Transition- Continued|Treatment Period||3
10241365|NCT01928394|11373138|FG003|Transition- Continued|Treatment Period||0
10241366|NCT01928394|11373139|FG004|Transition- Continued|Treatment Period||0
10241367|NCT01928394|11373140|FG005|Transition- Continued|Treatment Period||3
10241368|NCT01928394|11373141|FG006|Transition- Continued|Treatment Period||6
10241369|NCT01928394|11373142|FG007|Transition- Continued|Treatment Period||0
10241370|NCT01928394|11373143|FG008|Transition- Continued|Treatment Period||1
10241371|NCT01928394|11373144|FG009|Transition- Continued|Treatment Period||1
10241372|NCT01928394|11373145|FG010|Transition- Continued|Treatment Period||0
10241373|NCT01928394|11373146|FG011|Transition- Continued|Treatment Period||0
10241374|NCT01928394|11373147|FG012|Transition- Continued|Treatment Period||17
10241375|NCT01928394|11373148|FG013|Transition- Continued|Treatment Period||0
10241376|NCT01928394|11373149|FG014|Transition- Continued|Treatment Period||2
10241377|NCT01928394|11373150|FG015|Transition- Continued|Treatment Period||0
10241378|NCT01928394|11373151|FG016|Transition- Continued|Treatment Period||0
10241379|NCT01928394|11373152|FG017|Transition- Continued|Treatment Period||0
10241380|NCT01928394|11373153|FG018|Transition- Continued|Treatment Period||1
10241381|NCT01928394|11373154|FG019|Transition- Continued|Treatment Period||19
10241382|NCT01928394|11373155|FG020|Transition- Continued|Treatment Period||0
10241383|NCT01928394|11373156|FG021|Transition- Continued|Treatment Period||0
10241384|NCT01928394|11373157|FG022|Transition- Continued|Treatment Period||0
10241385|NCT01928394|11373135|FG000|COMPLETED|Treatment Period||0
10241386|NCT01928394|11373136|FG001|COMPLETED|Treatment Period||0
10241387|NCT01928394|11373137|FG002|COMPLETED|Treatment Period||0
10241388|NCT01928394|11373138|FG003|COMPLETED|Treatment Period||3
10241389|NCT01928394|11373139|FG004|COMPLETED|Treatment Period||0
10241390|NCT01928394|11373140|FG005|COMPLETED|Treatment Period||6
10241391|NCT01928394|11373141|FG006|COMPLETED|Treatment Period||3
10241392|NCT01928394|11373142|FG007|COMPLETED|Treatment Period||0
10241393|NCT01928394|11373143|FG008|COMPLETED|Treatment Period||0
10241394|NCT01928394|11373144|FG009|COMPLETED|Treatment Period||0
10241395|NCT01928394|11373145|FG010|COMPLETED|Treatment Period||0
10241396|NCT01928394|11373146|FG011|COMPLETED|Treatment Period||5
10241397|NCT01928394|11373147|FG012|COMPLETED|Treatment Period||6
10241398|NCT01928394|11373148|FG013|COMPLETED|Treatment Period||8
10241399|NCT01928394|11373149|FG014|COMPLETED|Treatment Period||8
10241400|NCT01928394|11373150|FG015|COMPLETED|Treatment Period||1
10241401|NCT01928394|11373151|FG016|COMPLETED|Treatment Period||5
10241402|NCT01928394|11373152|FG017|COMPLETED|Treatment Period||7
10241403|NCT01928394|11373153|FG018|COMPLETED|Treatment Period||22
10241404|NCT01928394|11373154|FG019|COMPLETED|Treatment Period||8
10241405|NCT01928394|11373155|FG020|COMPLETED|Treatment Period||1
10241406|NCT01928394|11373156|FG021|COMPLETED|Treatment Period||1
10241407|NCT01928394|11373157|FG022|COMPLETED|Treatment Period||3
10241408|NCT01928394|11373135|FG000|NOT COMPLETED|Treatment Period||18
10241409|NCT01928394|11373136|FG001|NOT COMPLETED|Treatment Period||3
10241410|NCT01928394|11373137|FG002|NOT COMPLETED|Treatment Period||18
10241411|NCT01928394|11373138|FG003|NOT COMPLETED|Treatment Period||56
10241412|NCT01928394|11373139|FG004|NOT COMPLETED|Treatment Period||3
10241413|NCT01928394|11373140|FG005|NOT COMPLETED|Treatment Period||43
10241414|NCT01928394|11373141|FG006|NOT COMPLETED|Treatment Period||49
10241415|NCT01928394|11373142|FG007|NOT COMPLETED|Treatment Period||18
10241416|NCT01928394|11373143|FG008|NOT COMPLETED|Treatment Period||3
10241417|NCT01928394|11373144|FG009|NOT COMPLETED|Treatment Period||18
10241418|NCT01928394|11373145|FG010|NOT COMPLETED|Treatment Period||30
10241419|NCT01928394|11373146|FG011|NOT COMPLETED|Treatment Period||93
10241420|NCT01928394|11373147|FG012|NOT COMPLETED|Treatment Period||55
10241421|NCT01928394|11373148|FG013|NOT COMPLETED|Treatment Period||139
10241422|NCT01928394|11373149|FG014|NOT COMPLETED|Treatment Period||88
10241423|NCT01928394|11373150|FG015|NOT COMPLETED|Treatment Period||2
10241424|NCT01928394|11373151|FG016|NOT COMPLETED|Treatment Period||50
10241425|NCT01928394|11373152|FG017|NOT COMPLETED|Treatment Period||71
10241426|NCT01928394|11373153|FG018|NOT COMPLETED|Treatment Period||70
10241427|NCT01928394|11373154|FG019|NOT COMPLETED|Treatment Period||96
10241428|NCT01928394|11373155|FG020|NOT COMPLETED|Treatment Period||40
10241429|NCT01928394|11373156|FG021|NOT COMPLETED|Treatment Period||42
10241430|NCT01928394|11373157|FG022|NOT COMPLETED|Treatment Period||39
10241431|NCT01928394|11373135|FG000|STARTED|Follow-up Period||15
10241432|NCT01928394|11373136|FG001|STARTED|Follow-up Period||3
10241433|NCT01928394|11373137|FG002|STARTED|Follow-up Period||18
10241434|NCT01928394|11373138|FG003|STARTED|Follow-up Period||50
10241435|NCT01928394|11373139|FG004|STARTED|Follow-up Period||3
10241436|NCT01928394|11373140|FG005|STARTED|Follow-up Period||49
10241437|NCT01928394|11373141|FG006|STARTED|Follow-up Period||52
10241438|NCT01928394|11373142|FG007|STARTED|Follow-up Period||16
10241439|NCT01928394|11373143|FG008|STARTED|Follow-up Period||3
10241440|NCT01928394|11373144|FG009|STARTED|Follow-up Period||18
10241441|NCT01928394|11373145|FG010|STARTED|Follow-up Period||30
10241442|NCT01928394|11373146|FG011|STARTED|Follow-up Period||81
10241443|NCT01928394|11373147|FG012|STARTED|Follow-up Period||61
10241444|NCT01928394|11373148|FG013|STARTED|Follow-up Period||145
10241445|NCT01928394|11373149|FG014|STARTED|Follow-up Period||96
10241446|NCT01928394|11373150|FG015|STARTED|Follow-up Period||3
10241447|NCT01928394|11373151|FG016|STARTED|Follow-up Period||55
10241448|NCT01928394|11373152|FG017|STARTED|Follow-up Period||58
10241449|NCT01928394|11373153|FG018|STARTED|Follow-up Period||92
10241450|NCT01928394|11373154|FG019|STARTED|Follow-up Period||104
10241451|NCT01928394|11373155|FG020|STARTED|Follow-up Period||41
10241452|NCT01928394|11373156|FG021|STARTED|Follow-up Period||43
10241453|NCT01928394|11373157|FG022|STARTED|Follow-up Period||42
10241454|NCT01928394|11373135|FG000|COMPLETED|Follow-up Period||12
10241455|NCT01928394|11373136|FG001|COMPLETED|Follow-up Period||3
10241456|NCT01928394|11373137|FG002|COMPLETED|Follow-up Period||15
10241457|NCT01928394|11373138|FG003|COMPLETED|Follow-up Period||40
10241458|NCT01928394|11373139|FG004|COMPLETED|Follow-up Period||3
10241459|NCT01928394|11373140|FG005|COMPLETED|Follow-up Period||41
10241460|NCT01928394|11373141|FG006|COMPLETED|Follow-up Period||40
10241461|NCT01928394|11373142|FG007|COMPLETED|Follow-up Period||10
10241462|NCT01928394|11373143|FG008|COMPLETED|Follow-up Period||2
10241463|NCT01928394|11373144|FG009|COMPLETED|Follow-up Period||16
10241464|NCT01928394|11373145|FG010|COMPLETED|Follow-up Period||19
10241465|NCT01928394|11373146|FG011|COMPLETED|Follow-up Period||59
10241466|NCT01928394|11373147|FG012|COMPLETED|Follow-up Period||47
10241467|NCT01928394|11373148|FG013|COMPLETED|Follow-up Period||107
10241468|NCT01928394|11373149|FG014|COMPLETED|Follow-up Period||66
10241469|NCT01928394|11373150|FG015|COMPLETED|Follow-up Period||3
10241470|NCT01928394|11373151|FG016|COMPLETED|Follow-up Period||41
10241471|NCT01928394|11373152|FG017|COMPLETED|Follow-up Period||50
10241472|NCT01928394|11373153|FG018|COMPLETED|Follow-up Period||76
10241473|NCT01928394|11373154|FG019|COMPLETED|Follow-up Period||83
10241474|NCT01928394|11373155|FG020|COMPLETED|Follow-up Period||32
10241475|NCT01928394|11373156|FG021|COMPLETED|Follow-up Period||34
10241476|NCT01928394|11373157|FG022|COMPLETED|Follow-up Period||36
10241477|NCT01928394|11373135|FG000|NOT COMPLETED|Follow-up Period||3
10241478|NCT01928394|11373136|FG001|NOT COMPLETED|Follow-up Period||0
10241479|NCT01928394|11373137|FG002|NOT COMPLETED|Follow-up Period||3
10241480|NCT01928394|11373138|FG003|NOT COMPLETED|Follow-up Period||10
10241481|NCT01928394|11373139|FG004|NOT COMPLETED|Follow-up Period||0
10241482|NCT01928394|11373140|FG005|NOT COMPLETED|Follow-up Period||8
10241483|NCT01928394|11373141|FG006|NOT COMPLETED|Follow-up Period||12
10241484|NCT01928394|11373142|FG007|NOT COMPLETED|Follow-up Period||6
10241485|NCT01928394|11373143|FG008|NOT COMPLETED|Follow-up Period||1
10241486|NCT01928394|11373144|FG009|NOT COMPLETED|Follow-up Period||2
10241487|NCT01928394|11373145|FG010|NOT COMPLETED|Follow-up Period||11
10241488|NCT01928394|11373146|FG011|NOT COMPLETED|Follow-up Period||22
10241489|NCT01928394|11373147|FG012|NOT COMPLETED|Follow-up Period||14
10241490|NCT01928394|11373148|FG013|NOT COMPLETED|Follow-up Period||38
10241491|NCT01928394|11373149|FG014|NOT COMPLETED|Follow-up Period||30
10241492|NCT01928394|11373150|FG015|NOT COMPLETED|Follow-up Period||0
10241493|NCT01928394|11373151|FG016|NOT COMPLETED|Follow-up Period||14
10241494|NCT01928394|11373152|FG017|NOT COMPLETED|Follow-up Period||8
10241495|NCT01928394|11373153|FG018|NOT COMPLETED|Follow-up Period||16
10241496|NCT01928394|11373154|FG019|NOT COMPLETED|Follow-up Period||21
10241497|NCT01928394|11373155|FG020|NOT COMPLETED|Follow-up Period||9
10241498|NCT01928394|11373156|FG021|NOT COMPLETED|Follow-up Period||9
10241499|NCT01928394|11373157|FG022|NOT COMPLETED|Follow-up Period||6
10241500|NCT01657500|11373207|FG000|STARTED|Overall Study||32
10241501|NCT01657500|11373208|FG001|STARTED|Overall Study||32
10241502|NCT01657500|11373207|FG000|COMPLETED|Overall Study||27
10241503|NCT01657500|11373208|FG001|COMPLETED|Overall Study||27
10241504|NCT01657500|11373207|FG000|NOT COMPLETED|Overall Study||5
10241505|NCT01657500|11373208|FG001|NOT COMPLETED|Overall Study||5
10241506|NCT04810221|11373214|FG000|STARTED|Overall Study||16
10241507|NCT04810221|11373214|FG000|COMPLETED|Overall Study|"Included in the 13 subjects which completed the study, it is necessary to consider the case 0, a pilot test for the verification of study procedures. Data from this subject were not used in the statistical evaluation, which therefore included data from 12 eligible subjects that completed the study."|13
10241508|NCT04810221|11373214|FG000|NOT COMPLETED|Overall Study||3
10241509|NCT04575038|11373220|FG000|STARTED|Overall Study||56
10241510|NCT04575038|11373221|FG001|STARTED|Overall Study||59
10241511|NCT04575038|11373220|FG000|COMPLETED|Overall Study||55
10241512|NCT04575038|11373221|FG001|COMPLETED|Overall Study||58
10241513|NCT04575038|11373220|FG000|NOT COMPLETED|Overall Study||1
10241514|NCT04575038|11373221|FG001|NOT COMPLETED|Overall Study||1
10241554|NCT04112303|11373290|FG000|STARTED|Overall Study||37
10241555|NCT04112303|11373290|FG000|COMPLETED|Overall Study||36
10241556|NCT04112303|11373290|FG000|NOT COMPLETED|Overall Study||1
10241557|NCT03896477|11373297|FG000|STARTED|Overall Study||220
10241558|NCT03896477|11373298|FG001|STARTED|Overall Study||220
10241559|NCT03896477|11373299|FG002|STARTED|Overall Study||220
10241560|NCT03896477|11373297|FG000|Received First Vaccination|Overall Study||220
10241561|NCT03896477|11373298|FG001|Received First Vaccination|Overall Study||220
10241562|NCT03896477|11373299|FG002|Received First Vaccination|Overall Study||220
10241563|NCT03896477|11373297|FG000|Received Second Vaccination|Overall Study||217
10241564|NCT03896477|11373298|FG001|Received Second Vaccination|Overall Study||213
10241565|NCT03896477|11373299|FG002|Received Second Vaccination|Overall Study||213
10241566|NCT03896477|11373297|FG000|Received Booster Vaccination|Overall Study||208
10241567|NCT03896477|11373298|FG001|Received Booster Vaccination|Overall Study||206
10241568|NCT03896477|11373299|FG002|Received Booster Vaccination|Overall Study||206
10241569|NCT03896477|11373297|FG000|COMPLETED|Overall Study||203
10241570|NCT03896477|11373298|FG001|COMPLETED|Overall Study||200
10241571|NCT03896477|11373299|FG002|COMPLETED|Overall Study||200
10241572|NCT03896477|11373297|FG000|NOT COMPLETED|Overall Study||17
10241573|NCT03896477|11373298|FG001|NOT COMPLETED|Overall Study||20
10241574|NCT03896477|11373299|FG002|NOT COMPLETED|Overall Study||20
10241575|NCT03760185|11373310|FG000|STARTED|Overall Study||13
10241576|NCT03760185|11373311|FG001|STARTED|Overall Study||13
10241577|NCT03760185|11373310|FG000|COMPLETED|Overall Study||12
10241578|NCT03760185|11373311|FG001|COMPLETED|Overall Study||12
10241579|NCT03760185|11373310|FG000|NOT COMPLETED|Overall Study||1
10241580|NCT03760185|11373311|FG001|NOT COMPLETED|Overall Study||1
10241581|NCT03732534|11373319|FG000|STARTED|Overall Study||6
10241582|NCT03732534|11373319|FG000|COMPLETED|Overall Study||0
10241583|NCT03732534|11373319|FG000|NOT COMPLETED|Overall Study||6
10241584|NCT03692910|11373323|FG000|STARTED|Overall Study||35
10241585|NCT03692910|11373324|FG001|STARTED|Overall Study||0
10241586|NCT03692910|11373325|FG002|STARTED|Overall Study||0
10241587|NCT03692910|11373323|FG000|COMPLETED|Overall Study||29
10241588|NCT03692910|11373324|FG001|COMPLETED|Overall Study||0
10241589|NCT03692910|11373325|FG002|COMPLETED|Overall Study||0
10241590|NCT03692910|11373323|FG000|NOT COMPLETED|Overall Study||6
10241591|NCT03692910|11373324|FG001|NOT COMPLETED|Overall Study||0
10241592|NCT03692910|11373325|FG002|NOT COMPLETED|Overall Study||0
10241593|NCT03673956|11373335|FG000|STARTED|Overall Study||12
10241594|NCT03673956|11373336|FG001|STARTED|Overall Study||1
10241595|NCT03673956|11373337|FG002|STARTED|Overall Study||5
10241596|NCT03673956|11373338|FG003|STARTED|Overall Study||1
10241597|NCT03673956|11373335|FG000|COMPLETED|Overall Study||10
10241598|NCT03673956|11373336|FG001|COMPLETED|Overall Study||1
10241599|NCT03673956|11373337|FG002|COMPLETED|Overall Study||5
10241600|NCT03673956|11373338|FG003|COMPLETED|Overall Study||1
10019289|NCT01829243|11142465|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10019290|NCT01829243|11142464|FG000|STARTED|Second Intervention||7
10241601|NCT03673956|11373335|FG000|NOT COMPLETED|Overall Study||2
10241602|NCT03673956|11373336|FG001|NOT COMPLETED|Overall Study||0
10241603|NCT03673956|11373337|FG002|NOT COMPLETED|Overall Study||0
10241604|NCT03673956|11373338|FG003|NOT COMPLETED|Overall Study||0
10241605|NCT03649347|11373352|FG000|STARTED|Overall Study||13
10241606|NCT03649347|11373353|FG001|STARTED|Overall Study||12
10241607|NCT03649347|11373354|FG002|STARTED|Overall Study||0
10241608|NCT03649347|11373355|FG003|STARTED|Overall Study||0
10241609|NCT03649347|11373352|FG000|COMPLETED|Overall Study||13
10241610|NCT03649347|11373353|FG001|COMPLETED|Overall Study||12
10241611|NCT03649347|11373354|FG002|COMPLETED|Overall Study||0
10241612|NCT03649347|11373355|FG003|COMPLETED|Overall Study||0
10241613|NCT03649347|11373352|FG000|NOT COMPLETED|Overall Study||0
10241614|NCT03649347|11373353|FG001|NOT COMPLETED|Overall Study||0
10241615|NCT03649347|11373354|FG002|NOT COMPLETED|Overall Study||0
10241616|NCT03649347|11373355|FG003|NOT COMPLETED|Overall Study||0
10241617|NCT03641326|11373365|FG000|STARTED|Overall Study||2
10241618|NCT03641326|11373366|FG001|STARTED|Overall Study||3
10241619|NCT03641326|11373365|FG000|COMPLETED|Overall Study||2
10241620|NCT03641326|11373366|FG001|COMPLETED|Overall Study||3
10241621|NCT03641326|11373365|FG000|NOT COMPLETED|Overall Study||0
10241622|NCT03641326|11373366|FG001|NOT COMPLETED|Overall Study||0
10241623|NCT03618420|11373377|FG000|STARTED|Overall Study||50
10241624|NCT03618420|11373377|FG000|COMPLETED|Overall Study||50
10241515|NCT04545567|11373229|FG000|STARTED|Overall Study||10
10241516|NCT04545567|11373230|FG001|STARTED|Overall Study||11
10241517|NCT04545567|11373229|FG000|COMPLETED|Overall Study||9
10241518|NCT04545567|11373230|FG001|COMPLETED|Overall Study||9
10241519|NCT04545567|11373229|FG000|NOT COMPLETED|Overall Study||1
10241520|NCT04545567|11373230|FG001|NOT COMPLETED|Overall Study||2
10241521|NCT04425538|11373236|FG000|STARTED|Overall Study||17
10241522|NCT04425538|11373236|FG000|COMPLETED|Overall Study||17
10241523|NCT04425538|11373236|FG000|NOT COMPLETED|Overall Study||0
10241524|NCT04397757|11373242|FG000|STARTED|Overall Study||41
10241525|NCT04397757|11373243|FG001|STARTED|Overall Study||39
10241526|NCT04397757|11373242|FG000|Treated|Overall Study||39
10241527|NCT04397757|11373243|FG001|Treated|Overall Study||39
10241528|NCT04397757|11373242|FG000|COMPLETED|Overall Study||32
10241529|NCT04397757|11373243|FG001|COMPLETED|Overall Study||25
10241530|NCT04397757|11373242|FG000|NOT COMPLETED|Overall Study||9
10241531|NCT04397757|11373243|FG001|NOT COMPLETED|Overall Study||14
10241532|NCT04388683|11373256|FG000|STARTED|Overall Study||6
10241533|NCT04388683|11373257|FG001|STARTED|Overall Study||3
10241534|NCT04388683|11373256|FG000|COMPLETED|Overall Study||5
10241535|NCT04388683|11373257|FG001|COMPLETED|Overall Study||3
10241536|NCT04388683|11373256|FG000|NOT COMPLETED|Overall Study||1
10241537|NCT04388683|11373257|FG001|NOT COMPLETED|Overall Study||0
10241538|NCT04382651|11373265|FG000|STARTED|Overall Study||69
10241539|NCT04382651|11373266|FG001|STARTED|Overall Study||71
10241540|NCT04382651|11373265|FG000|Safety Analysis Set|Overall Study||68
10241541|NCT04382651|11373266|FG001|Safety Analysis Set|Overall Study||70
10241542|NCT04382651|11373265|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||63
10241543|NCT04382651|11373266|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10241544|NCT04382651|11373265|FG000|COMPLETED|Overall Study||38
10241545|NCT04382651|11373266|FG001|COMPLETED|Overall Study||43
10241546|NCT04382651|11373265|FG000|NOT COMPLETED|Overall Study||31
10241547|NCT04382651|11373266|FG001|NOT COMPLETED|Overall Study||28
10241548|NCT04329832|11373275|FG000|STARTED|Overall Study||42
10241549|NCT04329832|11373276|FG001|STARTED|Overall Study||43
10241550|NCT04329832|11373275|FG000|COMPLETED|Overall Study||42
10241551|NCT04329832|11373276|FG001|COMPLETED|Overall Study||43
10241552|NCT04329832|11373275|FG000|NOT COMPLETED|Overall Study||0
10241553|NCT04329832|11373276|FG001|NOT COMPLETED|Overall Study||0
10241625|NCT03618420|11373377|FG000|NOT COMPLETED|Overall Study||0
10241626|NCT03411031|11373383|FG000|STARTED|Overall Study||9
9832643|NCT00773786|10943395|FG000|COMPLETED|Second Intervention (1 Week)||10
9832644|NCT00773786|10943396|FG001|COMPLETED|Second Intervention (1 Week)||10
9832645|NCT00773786|10943395|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
9832646|NCT00773786|10943396|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
9832647|NCT00773838|10943403|FG000|STARTED|Overall Study||143
9832648|NCT00773838|10943403|FG000|COMPLETED|Overall Study||0
9832649|NCT00773838|10943403|FG000|NOT COMPLETED|Overall Study||143
9832650|NCT00773955|10943407|FG000|STARTED|Overall Study||15
9832651|NCT00773955|10943407|FG000|COMPLETED|Overall Study||15
9832652|NCT00773955|10943407|FG000|NOT COMPLETED|Overall Study||0
9832653|NCT00773968|10943411|FG000|STARTED|Overall Study||140
9832654|NCT00773968|10943411|FG000|Treated|Overall Study||111
9832655|NCT00773968|10943411|FG000|COMPLETED|Overall Study||95
9832656|NCT00773968|10943411|FG000|NOT COMPLETED|Overall Study||45
9832657|NCT00774046|10943415|FG000|STARTED|Screening||116
9832658|NCT00774046|10943415|FG000|COMPLETED|Screening||60
9832659|NCT00774046|10943415|FG000|NOT COMPLETED|Screening||56
9832660|NCT00774046|10943415|FG000|STARTED|Enrollment||60
9832661|NCT00774046|10943415|FG000|COMPLETED|Enrollment||32
9832662|NCT00774046|10943415|FG000|NOT COMPLETED|Enrollment||28
9832663|NCT00774046|10943415|FG000|STARTED|Induction Therapy||32
9832664|NCT00774046|10943415|FG000|COMPLETED|Induction Therapy||32
9832665|NCT00774046|10943415|FG000|NOT COMPLETED|Induction Therapy||0
9832666|NCT00774046|10943415|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
9832667|NCT00774046|10943415|FG000|COMPLETED|Stem Cell Mobilization||7
9832668|NCT00774046|10943415|FG000|NOT COMPLETED|Stem Cell Mobilization||3
9832669|NCT00774046|10943415|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
9832670|NCT00774046|10943415|FG000|COMPLETED|Autologous Transplant||4
9832671|NCT00774046|10943415|FG000|NOT COMPLETED|Autologous Transplant||0
9832672|NCT00774163|10943421|FG000|STARTED|Overall Study||30
9957146|NCT01449630|11076400|FG003|STARTED|Period 1||2
10241627|NCT03411031|11373384|FG001|STARTED|Overall Study||9
10241628|NCT03411031|11373383|FG000|COMPLETED|Overall Study||9
10241629|NCT03411031|11373384|FG001|COMPLETED|Overall Study||9
10241630|NCT03411031|11373383|FG000|NOT COMPLETED|Overall Study||0
10241631|NCT03411031|11373384|FG001|NOT COMPLETED|Overall Study||0
10241632|NCT03365752|11373393|FG000|STARTED|Overall Study||13
10241633|NCT03365752|11373394|FG001|STARTED|Overall Study||13
10241634|NCT03365752|11373395|FG002|STARTED|Overall Study||13
9832673|NCT00774163|10943422|FG001|STARTED|Overall Study||15
9832674|NCT00774163|10943421|FG000|COMPLETED|Overall Study||30
9832675|NCT00774163|10943422|FG001|COMPLETED|Overall Study||15
9832676|NCT00774163|10943421|FG000|NOT COMPLETED|Overall Study||0
9832677|NCT00774163|10943422|FG001|NOT COMPLETED|Overall Study||0
9832678|NCT00774202|10943430|FG000|STARTED|Overall Study||9
9832679|NCT00774202|10943431|FG001|STARTED|Overall Study||8
9832680|NCT00774202|10943430|FG000|COMPLETED|Overall Study||9
9832681|NCT00774202|10943431|FG001|COMPLETED|Overall Study||8
10241635|NCT03365752|11373393|FG000|COMPLETED|Overall Study||13
10241636|NCT03365752|11373394|FG001|COMPLETED|Overall Study||13
10241637|NCT03365752|11373395|FG002|COMPLETED|Overall Study||13
9832682|NCT00774202|10943430|FG000|NOT COMPLETED|Overall Study||0
9832683|NCT00774202|10943431|FG001|NOT COMPLETED|Overall Study||0
9832684|NCT00774267|10943445|FG000|STARTED|Overall Study||132
9832685|NCT00774267|10943446|FG001|STARTED|Overall Study||111
9957147|NCT01449630|11076401|FG004|STARTED|Period 1||5
9957148|NCT01449630|11076402|FG005|STARTED|Period 1||2
10241638|NCT03365752|11373393|FG000|NOT COMPLETED|Overall Study||0
10241639|NCT03365752|11373394|FG001|NOT COMPLETED|Overall Study||0
10241640|NCT03365752|11373395|FG002|NOT COMPLETED|Overall Study||0
10241641|NCT03364036|11373403|FG000|STARTED|Overall Study||270
10241642|NCT03364036|11373403|FG000|Full Analysis Set (FAS)|Overall Study||270
10241643|NCT03364036|11373403|FG000|COMPLETED|Overall Study||264
10241644|NCT03364036|11373403|FG000|NOT COMPLETED|Overall Study||6
9832686|NCT00774267|10943447|FG002|STARTED|Overall Study||129
9832687|NCT00774267|10943448|FG003|STARTED|Overall Study||135
9832688|NCT00774267|10943445|FG000|COMPLETED|Overall Study||132
9832689|NCT00774267|10943446|FG001|COMPLETED|Overall Study||111
9832690|NCT00774267|10943447|FG002|COMPLETED|Overall Study||129
9832691|NCT00774267|10943448|FG003|COMPLETED|Overall Study||135
9832692|NCT00774267|10943445|FG000|NOT COMPLETED|Overall Study||0
9957149|NCT01449630|11076403|FG006|STARTED|Period 1||2
9957150|NCT01449630|11076404|FG007|STARTED|Period 1||6
9832693|NCT00774267|10943446|FG001|NOT COMPLETED|Overall Study||0
9832694|NCT00774267|10943447|FG002|NOT COMPLETED|Overall Study||0
9957151|NCT01449630|11076405|FG008|STARTED|Period 1||2
10241645|NCT03205163|11373409|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
10241646|NCT03205163|11373410|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
10241647|NCT03205163|11373409|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
10241648|NCT03205163|11373410|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
10241649|NCT03205163|11373409|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
10241650|NCT03205163|11373410|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
10241651|NCT03205163|11373409|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
10241652|NCT03205163|11373410|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
10241653|NCT03205163|11373409|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
9832695|NCT00774267|10943448|FG003|NOT COMPLETED|Overall Study||0
9832696|NCT00774397|10943465|FG000|STARTED|Overall Study||71
9832697|NCT00774397|10943466|FG001|STARTED|Overall Study||69
9832698|NCT00774397|10943467|FG002|STARTED|Overall Study||143
9832699|NCT00774397|10943468|FG003|STARTED|Overall Study||146
9832700|NCT00774397|10943469|FG004|STARTED|Overall Study||143
9832701|NCT00774397|10943470|FG005|STARTED|Overall Study||76
9832702|NCT00774397|10943471|FG006|STARTED|Overall Study||71
9832703|NCT00774397|10943465|FG000|COMPLETED|Overall Study||57
9832704|NCT00774397|10943466|FG001|COMPLETED|Overall Study||56
9832705|NCT00774397|10943467|FG002|COMPLETED|Overall Study||113
9832706|NCT00774397|10943468|FG003|COMPLETED|Overall Study||129
9832707|NCT00774397|10943469|FG004|COMPLETED|Overall Study||97
9832708|NCT00774397|10943470|FG005|COMPLETED|Overall Study||54
9832709|NCT00774397|10943471|FG006|COMPLETED|Overall Study||41
9832710|NCT00774397|10943465|FG000|NOT COMPLETED|Overall Study||14
9832711|NCT00774397|10943466|FG001|NOT COMPLETED|Overall Study||13
9832712|NCT00774397|10943467|FG002|NOT COMPLETED|Overall Study||30
9832713|NCT00774397|10943468|FG003|NOT COMPLETED|Overall Study||17
9832714|NCT00774397|10943469|FG004|NOT COMPLETED|Overall Study||46
9832715|NCT00774397|10943470|FG005|NOT COMPLETED|Overall Study||22
9832716|NCT00774397|10943471|FG006|NOT COMPLETED|Overall Study||30
10019291|NCT01829243|11142465|FG001|STARTED|Second Intervention||13
10019292|NCT01829243|11142464|FG000|COMPLETED|Second Intervention||7
10019293|NCT01829243|11142465|FG001|COMPLETED|Second Intervention||13
10019294|NCT01829243|11142464|FG000|NOT COMPLETED|Second Intervention||0
10019295|NCT01829243|11142465|FG001|NOT COMPLETED|Second Intervention||0
10241654|NCT03205163|11373410|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
9832717|NCT00774566|10943496|FG000|STARTED|Overall Study||159
9832718|NCT00774566|10943497|FG001|STARTED|Overall Study||156
9832719|NCT00774566|10943496|FG000|6 Month Follow up|Overall Study||154
9832720|NCT00774566|10943497|FG001|6 Month Follow up|Overall Study||150
9832721|NCT00774566|10943496|FG000|12 Month Follow up|Overall Study||141
9832722|NCT00774566|10943497|FG001|12 Month Follow up|Overall Study||141
9832723|NCT00774566|10943496|FG000|COMPLETED|Overall Study||141
10019296|NCT01829295|11142475|FG000|STARTED|0-6 Months||107
10019297|NCT01829295|11142476|FG001|STARTED|0-6 Months||109
10019298|NCT01829295|11142477|FG002|STARTED|0-6 Months||0
10019299|NCT01829295|11142478|FG003|STARTED|0-6 Months||0
10241655|NCT03205163|11373409|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
10241656|NCT03205163|11373410|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
10241657|NCT03205163|11373409|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
10241658|NCT03205163|11373410|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
10241659|NCT03205163|11373409|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
9832724|NCT00774566|10943497|FG001|COMPLETED|Overall Study||141
9832725|NCT00774566|10943496|FG000|NOT COMPLETED|Overall Study||18
9832726|NCT00774566|10943497|FG001|NOT COMPLETED|Overall Study||15
9832727|NCT00774579|10943505|FG000|STARTED|Overall Study||9
9832728|NCT00774579|10943506|FG001|STARTED|Overall Study||9
9832729|NCT00774579|10943505|FG000|COMPLETED|Overall Study||9
9832730|NCT00774579|10943506|FG001|COMPLETED|Overall Study||9
10241660|NCT03205163|11373410|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
10241661|NCT03178045|11373427|FG000|STARTED|Overall Study||1396
10241662|NCT03178045|11373428|FG001|STARTED|Overall Study||1397
10241663|NCT03178045|11373427|FG000|COMPLETED|Overall Study||1310
10241664|NCT03178045|11373428|FG001|COMPLETED|Overall Study||1314
10241665|NCT03178045|11373427|FG000|NOT COMPLETED|Overall Study||86
10241666|NCT03178045|11373428|FG001|NOT COMPLETED|Overall Study||83
10241667|NCT03145766|11373440|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10241668|NCT03145766|11373441|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10241669|NCT03145766|11373442|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10241670|NCT03145766|11373443|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
10241671|NCT03145766|11373444|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
10241672|NCT03145766|11373440|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10241673|NCT03145766|11373441|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10241674|NCT03145766|11373442|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10241675|NCT03145766|11373443|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
10241676|NCT03145766|11373444|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
10241677|NCT03145766|11373440|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
10241678|NCT03145766|11373441|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
10241679|NCT03145766|11373442|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
10241680|NCT03145766|11373443|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
10241681|NCT03145766|11373444|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
10241682|NCT03145766|11373440|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
10241683|NCT03145766|11373441|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
10241684|NCT03145766|11373442|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
10241685|NCT03145766|11373443|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
10241686|NCT03145766|11373444|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
10241687|NCT03145766|11373440|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
10241688|NCT03145766|11373441|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
10241689|NCT03145766|11373442|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
10241690|NCT03145766|11373443|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
10241691|NCT03145766|11373444|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
10241692|NCT03145766|11373440|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
10241693|NCT03145766|11373441|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
10241694|NCT03145766|11373442|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
10241695|NCT03145766|11373443|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
10241696|NCT03145766|11373444|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
10241697|NCT03145766|11373440|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
10241698|NCT03145766|11373441|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
10241699|NCT03145766|11373442|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
10241700|NCT03145766|11373443|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
10241701|NCT03145766|11373444|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
10241702|NCT03145766|11373440|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
10241703|NCT03145766|11373441|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
10241704|NCT03145766|11373442|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
10241705|NCT03145766|11373443|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
10241706|NCT03145766|11373444|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
10241707|NCT03145766|11373440|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
10241708|NCT03145766|11373441|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
10241709|NCT03145766|11373442|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
10241710|NCT03145766|11373443|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
10241711|NCT03145766|11373444|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
10241712|NCT03145766|11373440|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
10241713|NCT03145766|11373441|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
10241714|NCT03145766|11373442|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
10241715|NCT03145766|11373443|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
10241716|NCT03145766|11373444|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
10241717|NCT03145766|11373440|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
10241718|NCT03145766|11373441|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
10241719|NCT03145766|11373442|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
10241720|NCT03145766|11373443|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
10241721|NCT03145766|11373444|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
10241722|NCT03106987|11373461|FG000|STARTED|Overall Study||74
10241723|NCT03106987|11373462|FG001|STARTED|Overall Study||38
10241724|NCT03106987|11373463|FG002|STARTED|Overall Study||72
10241725|NCT03106987|11373464|FG003|STARTED|Overall Study||36
10241726|NCT03106987|11373461|FG000|COMPLETED|Overall Study||30
10241727|NCT03106987|11373462|FG001|COMPLETED|Overall Study||15
10241728|NCT03106987|11373463|FG002|COMPLETED|Overall Study||54
10241729|NCT03106987|11373464|FG003|COMPLETED|Overall Study||25
10241730|NCT03106987|11373461|FG000|NOT COMPLETED|Overall Study||44
10241731|NCT03106987|11373462|FG001|NOT COMPLETED|Overall Study||23
10241732|NCT03106987|11373463|FG002|NOT COMPLETED|Overall Study||18
10241733|NCT03106987|11373464|FG003|NOT COMPLETED|Overall Study||11
10241734|NCT03103087|11373477|FG000|STARTED|Overall Study||126
10241735|NCT03103087|11373478|FG001|STARTED|Overall Study||127
10241736|NCT03103087|11373479|FG002|STARTED|Overall Study||129
10241737|NCT03103087|11373477|FG000|COMPLETED|Overall Study||102
10241738|NCT03103087|11373478|FG001|COMPLETED|Overall Study||98
10241739|NCT03103087|11373479|FG002|COMPLETED|Overall Study||102
10241740|NCT03103087|11373477|FG000|NOT COMPLETED|Overall Study||24
10241741|NCT03103087|11373478|FG001|NOT COMPLETED|Overall Study||29
10241742|NCT03103087|11373479|FG002|NOT COMPLETED|Overall Study||27
10241743|NCT03049735|11373492|FG000|STARTED|Overall Study||128
10241744|NCT03049735|11373493|FG001|STARTED|Overall Study||132
10241745|NCT03049735|11373494|FG002|STARTED|Overall Study||128
10241746|NCT03049735|11373492|FG000|Received at Least 1 Dose of Study Drug|Overall Study||128
10241747|NCT03049735|11373493|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
10241748|NCT03049735|11373494|FG002|Received at Least 1 Dose of Study Drug|Overall Study||127
10241749|NCT03049735|11373492|FG000|COMPLETED|Overall Study||100
10241750|NCT03049735|11373493|FG001|COMPLETED|Overall Study||103
10241751|NCT03049735|11373494|FG002|COMPLETED|Overall Study||105
10241752|NCT03049735|11373492|FG000|NOT COMPLETED|Overall Study||28
10241753|NCT03049735|11373493|FG001|NOT COMPLETED|Overall Study||29
10241754|NCT03049735|11373494|FG002|NOT COMPLETED|Overall Study||23
10241755|NCT03021551|11373502|FG000|STARTED|Overall Study||80
10241756|NCT03021551|11373502|FG000|COMPLETED|Overall Study||77
10241757|NCT03021551|11373502|FG000|NOT COMPLETED|Overall Study||3
10241758|NCT02990338|11373508|FG000|STARTED|Overall Study||153
10241759|NCT02990338|11373509|FG001|STARTED|Overall Study||154
10241760|NCT02990338|11373508|FG000|Treated|Overall Study||149
10241761|NCT02990338|11373509|FG001|Treated|Overall Study||152
10241762|NCT02990338|11373508|FG000|Ongoing|Overall Study||35
10241763|NCT02990338|11373509|FG001|Ongoing|Overall Study||65
10241764|NCT02990338|11373508|FG000|COMPLETED|Overall Study||35
10241765|NCT02990338|11373509|FG001|COMPLETED|Overall Study||65
10241766|NCT02990338|11373508|FG000|NOT COMPLETED|Overall Study||118
10241767|NCT02990338|11373509|FG001|NOT COMPLETED|Overall Study||89
10241768|NCT02972996|11373518|FG000|STARTED|Overall Study||27
10241769|NCT02972996|11373519|FG001|STARTED|Overall Study||28
10241770|NCT02972996|11373518|FG000|COMPLETED|Overall Study||26
10241771|NCT02972996|11373519|FG001|COMPLETED|Overall Study||26
10241772|NCT02972996|11373518|FG000|NOT COMPLETED|Overall Study||1
10241773|NCT02972996|11373519|FG001|NOT COMPLETED|Overall Study||2
10241774|NCT02932332|11373529|FG000|STARTED|Overall Study||5
10241775|NCT02932332|11373530|FG001|STARTED|Overall Study||4
10241776|NCT02932332|11373531|FG002|STARTED|Overall Study||5
10241777|NCT02932332|11373532|FG003|STARTED|Overall Study||5
10241778|NCT02932332|11373529|FG000|Intervention 1|Overall Study||4
10241779|NCT02932332|11373530|FG001|Intervention 1|Overall Study||4
10241780|NCT02932332|11373531|FG002|Intervention 1|Overall Study||5
10241781|NCT02932332|11373532|FG003|Intervention 1|Overall Study||4
10241782|NCT02932332|11373529|FG000|Intervention 2|Overall Study||4
10241783|NCT02932332|11373530|FG001|Intervention 2|Overall Study||3
10241784|NCT02932332|11373531|FG002|Intervention 2|Overall Study||4
10241785|NCT02932332|11373532|FG003|Intervention 2|Overall Study||4
10241786|NCT02932332|11373529|FG000|Intervention 3|Overall Study||3
10241787|NCT02932332|11373530|FG001|Intervention 3|Overall Study||2
10241788|NCT02932332|11373531|FG002|Intervention 3|Overall Study||4
10241789|NCT02932332|11373532|FG003|Intervention 3|Overall Study||3
10241790|NCT02932332|11373529|FG000|Intervention 4|Overall Study||3
10241791|NCT02932332|11373530|FG001|Intervention 4|Overall Study||1
10241792|NCT02932332|11373531|FG002|Intervention 4|Overall Study||4
10241793|NCT02932332|11373532|FG003|Intervention 4|Overall Study||3
10241794|NCT02932332|11373529|FG000|COMPLETED|Overall Study||3
10241795|NCT02932332|11373530|FG001|COMPLETED|Overall Study||1
10241796|NCT02932332|11373531|FG002|COMPLETED|Overall Study||4
10241797|NCT02932332|11373532|FG003|COMPLETED|Overall Study||3
10241798|NCT02932332|11373529|FG000|NOT COMPLETED|Overall Study||2
10241799|NCT02932332|11373530|FG001|NOT COMPLETED|Overall Study||3
10241800|NCT02932332|11373531|FG002|NOT COMPLETED|Overall Study||1
10241801|NCT02932332|11373532|FG003|NOT COMPLETED|Overall Study||2
10241802|NCT02845440|11373547|FG000|STARTED|Overall Study||333
10241803|NCT02845440|11373548|FG001|STARTED|Overall Study||336
10241804|NCT02845440|11373549|FG002|STARTED|Overall Study||341
10241805|NCT02845440|11373550|FG003|STARTED|Overall Study||78
10241806|NCT02845440|11373551|FG004|STARTED|Overall Study||77
10241807|NCT02845440|11373547|FG000|COMPLETED|Overall Study||201
10241808|NCT02845440|11373548|FG001|COMPLETED|Overall Study||203
10241809|NCT02845440|11373549|FG002|COMPLETED|Overall Study||204
10241810|NCT02845440|11373550|FG003|COMPLETED|Overall Study||49
10241811|NCT02845440|11373551|FG004|COMPLETED|Overall Study||39
10241812|NCT02845440|11373547|FG000|NOT COMPLETED|Overall Study||132
10241813|NCT02845440|11373548|FG001|NOT COMPLETED|Overall Study||133
10241814|NCT02845440|11373549|FG002|NOT COMPLETED|Overall Study||137
10241815|NCT02845440|11373550|FG003|NOT COMPLETED|Overall Study||29
10241816|NCT02845440|11373551|FG004|NOT COMPLETED|Overall Study||38
10241817|NCT02786394|11373568|FG000|STARTED|Overall Study||11
10241818|NCT02786394|11373568|FG000|COMPLETED|Overall Study||10
10241819|NCT02786394|11373568|FG000|NOT COMPLETED|Overall Study||1
10241820|NCT02588248|11373575|FG000|STARTED|Overall Study||42
10241821|NCT02588248|11373576|FG001|STARTED|Overall Study||40
10241822|NCT02588248|11373575|FG000|COMPLETED|Overall Study||38
10241823|NCT02588248|11373576|FG001|COMPLETED|Overall Study||37
10241824|NCT02588248|11373575|FG000|NOT COMPLETED|Overall Study||4
10241825|NCT02588248|11373576|FG001|NOT COMPLETED|Overall Study||3
10241826|NCT02535065|11373587|FG000|STARTED|Overall Study||62
10241827|NCT02535065|11373587|FG000|1-Month Follow-up|Overall Study||62
10241828|NCT02535065|11373587|FG000|12-Month Follow-up|Overall Study||61
10241829|NCT02535065|11373587|FG000|COMPLETED|Overall Study||42
10241830|NCT02535065|11373587|FG000|NOT COMPLETED|Overall Study||20
10241831|NCT02510885|11373591|FG000|STARTED|Overall Study||39
10241832|NCT02510885|11373591|FG000|COMPLETED|Overall Study||39
10241833|NCT02510885|11373591|FG000|NOT COMPLETED|Overall Study||0
10241834|NCT02451358|11373599|FG000|STARTED|Overall Study||100
10241835|NCT02451358|11373600|FG001|STARTED|Overall Study||100
10241836|NCT02451358|11373601|FG002|STARTED|Overall Study||100
10241837|NCT02451358|11373602|FG003|STARTED|Overall Study||100
10241838|NCT02451358|11373599|FG000|Vaccinated at Day 0|Overall Study||100
10241839|NCT02451358|11373600|FG001|Vaccinated at Day 0|Overall Study||100
10241840|NCT02451358|11373601|FG002|Vaccinated at Day 0|Overall Study||100
10241841|NCT02451358|11373602|FG003|Vaccinated at Day 0|Overall Study||100
10241842|NCT02451358|11373599|FG000|Vaccinated at Day 28|Overall Study||99
10241843|NCT02451358|11373600|FG001|Vaccinated at Day 28|Overall Study||98
10241844|NCT02451358|11373601|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
10241845|NCT02451358|11373602|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
10241846|NCT02451358|11373599|FG000|COMPLETED|Overall Study||99
10241847|NCT02451358|11373600|FG001|COMPLETED|Overall Study||98
10241848|NCT02451358|11373601|FG002|COMPLETED|Overall Study||99
10241849|NCT02451358|11373602|FG003|COMPLETED|Overall Study||100
10241850|NCT02451358|11373599|FG000|NOT COMPLETED|Overall Study||1
10241851|NCT02451358|11373600|FG001|NOT COMPLETED|Overall Study||2
10241852|NCT02451358|11373601|FG002|NOT COMPLETED|Overall Study||1
10241853|NCT02451358|11373602|FG003|NOT COMPLETED|Overall Study||0
10241854|NCT02268175|11373614|FG000|STARTED|Overall Study||50
10241855|NCT02268175|11373615|FG001|STARTED|Overall Study||25
10241856|NCT02268175|11373614|FG000|COMPLETED|Overall Study||50
10241857|NCT02268175|11373615|FG001|COMPLETED|Overall Study||25
10241858|NCT02268175|11373614|FG000|NOT COMPLETED|Overall Study||0
10241859|NCT02268175|11373615|FG001|NOT COMPLETED|Overall Study||0
10241860|NCT02178709|11373621|FG000|STARTED|Overall Study||48
10241861|NCT02178709|11373621|FG000|COMPLETED|Overall Study||32
10241862|NCT02178709|11373621|FG000|NOT COMPLETED|Overall Study||16
10241863|NCT02163681|11373625|FG000|STARTED|Overall Study||45
10241864|NCT02163681|11373625|FG000|COMPLETED|Overall Study||44
10241865|NCT02163681|11373625|FG000|NOT COMPLETED|Overall Study||1
10241866|NCT01980017|11373631|FG000|STARTED|Overall Study||114
10241867|NCT01980017|11373632|FG001|STARTED|Overall Study||199
10241868|NCT01980017|11373631|FG000|COMPLETED|Overall Study||84
10241869|NCT01980017|11373632|FG001|COMPLETED|Overall Study||177
10241870|NCT01980017|11373631|FG000|NOT COMPLETED|Overall Study||30
10241871|NCT01980017|11373632|FG001|NOT COMPLETED|Overall Study||22
10241872|NCT01890759|11373643|FG000|STARTED|Overall Study||100
10241873|NCT01890759|11373644|FG001|STARTED|Overall Study||200
10241874|NCT01890759|11373643|FG000|COMPLETED|Overall Study||98
10241875|NCT01890759|11373644|FG001|COMPLETED|Overall Study||188
10241876|NCT01890759|11373643|FG000|NOT COMPLETED|Overall Study||2
9832731|NCT00774579|10943505|FG000|NOT COMPLETED|Overall Study||0
10019300|NCT01829295|11142475|FG000|COMPLETED|0-6 Months||96
10019301|NCT01829295|11142476|FG001|COMPLETED|0-6 Months||98
10019302|NCT01829295|11142477|FG002|COMPLETED|0-6 Months||0
10019303|NCT01829295|11142478|FG003|COMPLETED|0-6 Months||0
10019304|NCT01829295|11142475|FG000|NOT COMPLETED|0-6 Months||11
10019305|NCT01829295|11142476|FG001|NOT COMPLETED|0-6 Months||11
10241877|NCT01890759|11373644|FG001|NOT COMPLETED|Overall Study||12
10241878|NCT01855867|11373650|FG000|STARTED|Overall Study||100
10241879|NCT01855867|11373650|FG000|COMPLETED|Overall Study||100
10241880|NCT01855867|11373650|FG000|NOT COMPLETED|Overall Study||0
9832732|NCT00774579|10943506|FG001|NOT COMPLETED|Overall Study||0
9832733|NCT00774748|10943512|FG000|STARTED|Overall Study||21
9832734|NCT00774748|10943512|FG000|COMPLETED|Overall Study||18
10019306|NCT01829295|11142477|FG002|NOT COMPLETED|0-6 Months||0
10019307|NCT01829295|11142478|FG003|NOT COMPLETED|0-6 Months||0
10019308|NCT01829295|11142475|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
10019309|NCT01829295|11142476|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
10019310|NCT01829295|11142477|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
10241881|NCT01721746|11373657|FG000|STARTED|Pre-Treatment||272
10241882|NCT01721746|11373658|FG001|STARTED|Pre-Treatment||133
10241883|NCT01721746|11373657|FG000|COMPLETED|Pre-Treatment||268
10241884|NCT01721746|11373658|FG001|COMPLETED|Pre-Treatment||102
10241885|NCT01721746|11373657|FG000|NOT COMPLETED|Pre-Treatment||4
10241886|NCT01721746|11373658|FG001|NOT COMPLETED|Pre-Treatment||31
10241887|NCT01721746|11373657|FG000|STARTED|Treatment||268
10241888|NCT01721746|11373658|FG001|STARTED|Treatment||102
10241889|NCT01721746|11373657|FG000|COMPLETED|Treatment||0
10241890|NCT01721746|11373658|FG001|COMPLETED|Treatment||0
10241891|NCT01721746|11373657|FG000|NOT COMPLETED|Treatment||268
10241892|NCT01721746|11373658|FG001|NOT COMPLETED|Treatment||102
10241893|NCT01705977|11373667|FG000|STARTED|Overall Study||2002
10241894|NCT01705977|11373668|FG001|STARTED|Overall Study||2001
10241895|NCT01705977|11373667|FG000|COMPLETED|Overall Study||1729
10241896|NCT01705977|11373668|FG001|COMPLETED|Overall Study||1741
10241897|NCT01705977|11373667|FG000|NOT COMPLETED|Overall Study||273
10241898|NCT01705977|11373668|FG001|NOT COMPLETED|Overall Study||260
10241899|NCT01587040|11373678|FG000|STARTED|Overall Study||17
10241900|NCT01587040|11373679|FG001|STARTED|Overall Study||3
10241901|NCT01587040|11373680|FG002|STARTED|Overall Study||37
10241902|NCT01587040|11373681|FG003|STARTED|Overall Study||4
10241903|NCT01587040|11373678|FG000|COMPLETED|Overall Study||0
10241904|NCT01587040|11373679|FG001|COMPLETED|Overall Study||0
10241905|NCT01587040|11373680|FG002|COMPLETED|Overall Study||0
10241906|NCT01587040|11373681|FG003|COMPLETED|Overall Study||0
10241907|NCT01587040|11373678|FG000|NOT COMPLETED|Overall Study||17
10241908|NCT01587040|11373679|FG001|NOT COMPLETED|Overall Study||3
10241909|NCT01587040|11373680|FG002|NOT COMPLETED|Overall Study||37
10241910|NCT01587040|11373681|FG003|NOT COMPLETED|Overall Study||4
10241911|NCT01293682|11373691|FG000|STARTED|Overall Study||12
10241912|NCT01293682|11373691|FG000|COMPLETED|Overall Study||12
10241913|NCT01293682|11373691|FG000|NOT COMPLETED|Overall Study||0
10241914|NCT01254409|11373699|FG000|STARTED|Overall Study||6
10241915|NCT01254409|11373700|FG001|STARTED|Overall Study||6
10241916|NCT01254409|11373701|FG002|STARTED|Overall Study||5
10241917|NCT01254409|11373702|FG003|STARTED|Overall Study||4
10241918|NCT01254409|11373699|FG000|COMPLETED|Overall Study||6
10241919|NCT01254409|11373700|FG001|COMPLETED|Overall Study||5
10241920|NCT01254409|11373701|FG002|COMPLETED|Overall Study||5
10241921|NCT01254409|11373702|FG003|COMPLETED|Overall Study||4
10241922|NCT01254409|11373699|FG000|NOT COMPLETED|Overall Study||0
10241923|NCT01254409|11373700|FG001|NOT COMPLETED|Overall Study||1
10241924|NCT01254409|11373701|FG002|NOT COMPLETED|Overall Study||0
10241925|NCT01254409|11373702|FG003|NOT COMPLETED|Overall Study||0
10241926|NCT01253161|11373715|FG000|STARTED|Overall Study||29
10241927|NCT01253161|11373715|FG000|COMPLETED|Overall Study||28
10241928|NCT01253161|11373715|FG000|NOT COMPLETED|Overall Study||1
10241929|NCT01084252|11373733|FG000|STARTED|Phase 1 (120 Weeks)||16
10241930|NCT01084252|11373734|FG001|STARTED|Phase 1 (120 Weeks)||6
10241931|NCT01084252|11373735|FG002|STARTED|Phase 1 (120 Weeks)||3
10241932|NCT01084252|11373736|FG003|STARTED|Phase 1 (120 Weeks)||26
10241933|NCT01084252|11373737|FG004|STARTED|Phase 1 (120 Weeks)||18
10241934|NCT01084252|11373738|FG005|STARTED|Phase 1 (120 Weeks)||6
10241935|NCT01084252|11373739|FG006|STARTED|Phase 1 (120 Weeks)||7
10241936|NCT01084252|11373740|FG007|STARTED|Phase 1 (120 Weeks)||7
10241937|NCT01084252|11373741|FG008|STARTED|Phase 1 (120 Weeks)||0
10241938|NCT01084252|11373742|FG009|STARTED|Phase 1 (120 Weeks)||0
10241939|NCT01084252|11373743|FG010|STARTED|Phase 1 (120 Weeks)||0
10241940|NCT01084252|11373744|FG011|STARTED|Phase 1 (120 Weeks)||0
10241941|NCT01084252|11373745|FG012|STARTED|Phase 1 (120 Weeks)||0
10241942|NCT01084252|11373746|FG013|STARTED|Phase 1 (120 Weeks)||0
10241943|NCT01084252|11373733|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16
10241944|NCT01084252|11373734|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6
10241945|NCT01084252|11373735|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3
10241946|NCT01084252|11373736|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26
10241947|NCT01084252|11373737|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18
10241948|NCT01084252|11373738|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6
10241949|NCT01084252|11373739|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7
10241950|NCT01084252|11373740|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7
10241951|NCT01084252|11373741|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10241952|NCT01084252|11373742|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10241953|NCT01084252|11373743|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10241954|NCT01084252|11373744|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10241955|NCT01084252|11373745|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10241956|NCT01084252|11373746|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10241957|NCT01084252|11373733|FG000|COMPLETED|Phase 1 (120 Weeks)||0
10241958|NCT01084252|11373734|FG001|COMPLETED|Phase 1 (120 Weeks)||0
10241959|NCT01084252|11373735|FG002|COMPLETED|Phase 1 (120 Weeks)||0
10241960|NCT01084252|11373736|FG003|COMPLETED|Phase 1 (120 Weeks)||0
10241961|NCT01084252|11373737|FG004|COMPLETED|Phase 1 (120 Weeks)||0
10241962|NCT01084252|11373738|FG005|COMPLETED|Phase 1 (120 Weeks)||0
10241963|NCT01084252|11373739|FG006|COMPLETED|Phase 1 (120 Weeks)||0
10241964|NCT01084252|11373740|FG007|COMPLETED|Phase 1 (120 Weeks)||0
10241965|NCT01084252|11373741|FG008|COMPLETED|Phase 1 (120 Weeks)||0
10241966|NCT01084252|11373742|FG009|COMPLETED|Phase 1 (120 Weeks)||0
10241967|NCT01084252|11373743|FG010|COMPLETED|Phase 1 (120 Weeks)||0
10241968|NCT01084252|11373744|FG011|COMPLETED|Phase 1 (120 Weeks)||0
10241969|NCT01084252|11373745|FG012|COMPLETED|Phase 1 (120 Weeks)||0
10241970|NCT01084252|11373746|FG013|COMPLETED|Phase 1 (120 Weeks)||0
10241971|NCT01084252|11373733|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16
10241972|NCT01084252|11373734|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6
10241973|NCT01084252|11373735|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3
10241974|NCT01084252|11373736|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26
10241975|NCT01084252|11373737|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18
10241976|NCT01084252|11373738|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6
10241977|NCT01084252|11373739|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7
10241978|NCT01084252|11373740|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7
10241979|NCT01084252|11373741|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0
10241980|NCT01084252|11373742|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0
10241981|NCT01084252|11373743|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0
10241982|NCT01084252|11373744|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0
10241983|NCT01084252|11373745|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0
10241984|NCT01084252|11373746|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0
10241985|NCT01084252|11373733|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241986|NCT01084252|11373734|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241987|NCT01084252|11373735|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241988|NCT01084252|11373736|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241989|NCT01084252|11373737|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241990|NCT01084252|11373738|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241991|NCT01084252|11373739|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241992|NCT01084252|11373740|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241993|NCT01084252|11373741|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
10241994|NCT01084252|11373742|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
10241995|NCT01084252|11373743|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
10241996|NCT01084252|11373744|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
10241997|NCT01084252|11373745|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241998|NCT01084252|11373746|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10241999|NCT01084252|11373733|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242000|NCT01084252|11373734|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242001|NCT01084252|11373735|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242002|NCT01084252|11373736|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242003|NCT01084252|11373737|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242004|NCT01084252|11373738|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242005|NCT01084252|11373739|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242006|NCT01084252|11373740|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242007|NCT01084252|11373741|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
10242008|NCT01084252|11373742|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
10242009|NCT01084252|11373743|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10242010|NCT01084252|11373744|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10242011|NCT01084252|11373745|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242012|NCT01084252|11373746|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242013|NCT01084252|11373733|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242014|NCT01084252|11373734|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242015|NCT01084252|11373735|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242016|NCT01084252|11373736|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10019311|NCT01829295|11142478|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
10019312|NCT01829295|11142475|FG000|COMPLETED|6-12 Months||60
10019313|NCT01829295|11142476|FG001|COMPLETED|6-12 Months||54
10019314|NCT01829295|11142477|FG002|COMPLETED|6-12 Months||20
10242017|NCT01084252|11373737|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242018|NCT01084252|11373738|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242019|NCT01084252|11373739|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242020|NCT01084252|11373740|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242021|NCT01084252|11373741|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242022|NCT01084252|11373742|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242023|NCT01084252|11373743|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242024|NCT01084252|11373744|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242025|NCT01084252|11373745|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242026|NCT01084252|11373746|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242027|NCT01084252|11373733|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242028|NCT01084252|11373734|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242029|NCT01084252|11373735|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242030|NCT01084252|11373736|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242031|NCT01084252|11373737|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242032|NCT01084252|11373738|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242033|NCT01084252|11373739|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242034|NCT01084252|11373740|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242035|NCT01084252|11373741|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
10242036|NCT01084252|11373742|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
10242037|NCT01084252|11373743|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10242038|NCT01084252|11373744|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10242039|NCT01084252|11373745|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242040|NCT01084252|11373746|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10242041|NCT01084252|11373733|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242042|NCT01084252|11373734|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10019315|NCT01829295|11142478|FG003|COMPLETED|6-12 Months||29
10242043|NCT01084252|11373735|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242044|NCT01084252|11373736|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242045|NCT01084252|11373737|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242046|NCT01084252|11373738|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242047|NCT01084252|11373739|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242048|NCT01084252|11373740|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242049|NCT01084252|11373741|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242050|NCT01084252|11373742|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242051|NCT01084252|11373743|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242052|NCT01084252|11373744|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10242053|NCT01084252|11373745|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
10242054|NCT01084252|11373746|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
10242055|NCT01084252|11373733|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242056|NCT01084252|11373734|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242057|NCT01084252|11373735|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242058|NCT01084252|11373736|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242059|NCT01084252|11373737|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242060|NCT01084252|11373738|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242061|NCT01084252|11373739|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242062|NCT01084252|11373740|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242063|NCT01084252|11373741|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242064|NCT01084252|11373742|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10019316|NCT01829295|11142475|FG000|NOT COMPLETED|6-12 Months||4
10019317|NCT01829295|11142476|FG001|NOT COMPLETED|6-12 Months||2
10019318|NCT01829295|11142477|FG002|NOT COMPLETED|6-12 Months||12
10019319|NCT01829295|11142478|FG003|NOT COMPLETED|6-12 Months||13
10019320|NCT01829347|11142490|FG000|STARTED|VTI-210||9
10019321|NCT01829347|11142491|FG001|STARTED|VTI-210||9
10019322|NCT01829347|11142490|FG000|COMPLETED|VTI-210||3
10019323|NCT01829347|11142491|FG001|COMPLETED|VTI-210||6
10019324|NCT01829347|11142490|FG000|NOT COMPLETED|VTI-210||6
10019325|NCT01829347|11142491|FG001|NOT COMPLETED|VTI-210||3
10019326|NCT01829347|11142490|FG000|STARTED|VTI-210E||3
10019327|NCT01829347|11142491|FG001|STARTED|VTI-210E||6
10242065|NCT01084252|11373743|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242066|NCT01084252|11373744|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10242067|NCT01084252|11373745|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109
10242068|NCT01084252|11373746|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55
9832735|NCT00774748|10943512|FG000|NOT COMPLETED|Overall Study||3
9832736|NCT00774787|10943520|FG000|STARTED|Overall Study||27
9832737|NCT00774787|10943520|FG000|COMPLETED|Overall Study||26
10019328|NCT01829347|11142490|FG000|COMPLETED|VTI-210E||0
10019329|NCT01829347|11142491|FG001|COMPLETED|VTI-210E||0
10242069|NCT01084252|11373733|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242070|NCT01084252|11373734|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242071|NCT01084252|11373735|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10019330|NCT01829347|11142490|FG000|NOT COMPLETED|VTI-210E||3
10019331|NCT01829347|11142491|FG001|NOT COMPLETED|VTI-210E||6
10019332|NCT01829360|11142501|FG000|STARTED|Overall Study||8
10019333|NCT01829360|11142502|FG001|STARTED|Overall Study||9
10019334|NCT01829360|11142503|FG002|STARTED|Overall Study||10
10019335|NCT01829360|11142504|FG003|STARTED|Overall Study||8
10242072|NCT01084252|11373736|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242073|NCT01084252|11373737|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242074|NCT01084252|11373738|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242075|NCT01084252|11373739|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242076|NCT01084252|11373740|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242077|NCT01084252|11373741|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242078|NCT01084252|11373742|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242079|NCT01084252|11373743|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242080|NCT01084252|11373744|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242081|NCT01084252|11373745|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242082|NCT01084252|11373746|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242083|NCT01084252|11373733|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10019336|NCT01829360|11142501|FG000|COMPLETED|Overall Study||8
10242084|NCT01084252|11373734|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242085|NCT01084252|11373735|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242086|NCT01084252|11373736|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242087|NCT01084252|11373737|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9832738|NCT00774787|10943520|FG000|NOT COMPLETED|Overall Study||1
10019337|NCT01829360|11142502|FG001|COMPLETED|Overall Study||9
10019338|NCT01829360|11142503|FG002|COMPLETED|Overall Study||9
10019339|NCT01829360|11142504|FG003|COMPLETED|Overall Study||8
10019340|NCT01829360|11142501|FG000|NOT COMPLETED|Overall Study||0
10019341|NCT01829360|11142502|FG001|NOT COMPLETED|Overall Study||0
10019342|NCT01829360|11142503|FG002|NOT COMPLETED|Overall Study||1
10242088|NCT01084252|11373738|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242089|NCT01084252|11373739|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242090|NCT01084252|11373740|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242091|NCT01084252|11373741|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242092|NCT01084252|11373742|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242093|NCT01084252|11373743|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242094|NCT01084252|11373744|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10242095|NCT01084252|11373745|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
10242096|NCT01084252|11373746|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
10242097|NCT00867321|11373813|FG000|STARTED|Overall Study||4
10242098|NCT00867321|11373814|FG001|STARTED|Overall Study||3
10242099|NCT00867321|11373815|FG002|STARTED|Overall Study||3
10242100|NCT00867321|11373816|FG003|STARTED|Overall Study||6
10242101|NCT00867321|11373817|FG004|STARTED|Overall Study||5
10242102|NCT00867321|11373818|FG005|STARTED|Overall Study||3
10242103|NCT00867321|11373813|FG000|COMPLETED|Overall Study||4
10242104|NCT00867321|11373814|FG001|COMPLETED|Overall Study||2
10242105|NCT00867321|11373815|FG002|COMPLETED|Overall Study||3
10242106|NCT00867321|11373816|FG003|COMPLETED|Overall Study||6
10242107|NCT00867321|11373817|FG004|COMPLETED|Overall Study||5
10242108|NCT00867321|11373818|FG005|COMPLETED|Overall Study||3
10242109|NCT00867321|11373813|FG000|NOT COMPLETED|Overall Study||0
10242110|NCT00867321|11373814|FG001|NOT COMPLETED|Overall Study||1
10242111|NCT00867321|11373815|FG002|NOT COMPLETED|Overall Study||0
10242112|NCT00867321|11373816|FG003|NOT COMPLETED|Overall Study||0
10242113|NCT00867321|11373817|FG004|NOT COMPLETED|Overall Study||0
10242114|NCT00867321|11373818|FG005|NOT COMPLETED|Overall Study||0
10242115|NCT00728962|11373833|FG000|STARTED|Implant Placement Surgery||75
10242116|NCT00728962|11373833|FG000|COMPLETED|Implant Placement Surgery||65
10242117|NCT00728962|11373833|FG000|NOT COMPLETED|Implant Placement Surgery||10
10242118|NCT00728962|11373833|FG000|STARTED|Permanent Prosthesis Placement||65
10242119|NCT00728962|11373833|FG000|COMPLETED|Permanent Prosthesis Placement||62
10242120|NCT00728962|11373833|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
10242121|NCT00728962|11373833|FG000|STARTED|One Year Post Placement Follow-up||62
10242122|NCT00728962|11373833|FG000|COMPLETED|One Year Post Placement Follow-up||62
10242123|NCT00728962|11373833|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0
10242124|NCT00728962|11373833|FG000|STARTED|Two Year Post Placement Follow-up||62
10242125|NCT00728962|11373833|FG000|COMPLETED|Two Year Post Placement Follow-up||59
10242126|NCT00728962|11373833|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3
10242127|NCT00728754|11373839|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
10242128|NCT00728754|11373840|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
10242129|NCT00728754|11373839|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
10242130|NCT00728754|11373840|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
10242131|NCT00728754|11373839|FG000|NOT COMPLETED|Implant Placement Surgery||0
10242132|NCT00728754|11373840|FG001|NOT COMPLETED|Implant Placement Surgery||0
10242133|NCT00728754|11373839|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
10242134|NCT00728754|11373840|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
10242135|NCT00728754|11373839|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
10242136|NCT00728754|11373840|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
10242137|NCT00728754|11373839|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4
10242138|NCT00728754|11373840|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4
10242139|NCT00728754|11373839|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
10242140|NCT00728754|11373840|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
10242141|NCT00728754|11373839|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
10242142|NCT00728754|11373840|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
10242143|NCT00728754|11373839|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
10242144|NCT00728754|11373840|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0
10242145|NCT00728754|11373839|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
10242146|NCT00728754|11373840|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
10242147|NCT00728754|11373839|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
10242148|NCT00728754|11373840|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
10242149|NCT00728754|11373839|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10242150|NCT00728754|11373840|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
10242151|NCT00723944|11373848|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
10242152|NCT00723944|11373849|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
10242153|NCT00723944|11373848|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
10242154|NCT00723944|11373849|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
10242155|NCT00723944|11373848|FG000|NOT COMPLETED|Implant Placement Surgery||0
10242156|NCT00723944|11373849|FG001|NOT COMPLETED|Implant Placement Surgery||0
10242157|NCT00723944|11373848|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
10242158|NCT00723944|11373849|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
10242159|NCT00723944|11373848|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
10242160|NCT00723944|11373849|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
10242161|NCT00723944|11373848|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
10242162|NCT00723944|11373849|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9
10242163|NCT00723944|11373848|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
10242164|NCT00723944|11373849|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
10242165|NCT00723944|11373848|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
10242166|NCT00723944|11373849|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
10242167|NCT00723944|11373848|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
10242168|NCT00723944|11373849|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4
10242169|NCT00723944|11373848|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
10242170|NCT00723944|11373849|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
10242171|NCT00723944|11373848|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
10242172|NCT00723944|11373849|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
10242173|NCT00723944|11373848|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10242174|NCT00723944|11373849|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
10242175|NCT00467142|11373855|FG000|STARTED|Overall Study||62
10242176|NCT00467142|11373855|FG000|COMPLETED|Overall Study||59
10242177|NCT00467142|11373855|FG000|NOT COMPLETED|Overall Study||3
9832739|NCT00774800|10943524|FG000|STARTED|Intervention 1||22
9832740|NCT00774800|10943524|FG000|Received at Least One Dose of Study Drug|Intervention 1||22
9832741|NCT00774800|10943524|FG000|COMPLETED|Intervention 1||22
9832742|NCT00774800|10943524|FG000|NOT COMPLETED|Intervention 1||0
9832743|NCT00774800|10943524|FG000|STARTED|Washout (3 to 10 Days)||22
9832744|NCT00774800|10943524|FG000|COMPLETED|Washout (3 to 10 Days)||22
9832745|NCT00774800|10943524|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
9957152|NCT01449630|11076397|FG000|Received at Least 1 Dose|Period 1||2
9957153|NCT01449630|11076398|FG001|Received at Least 1 Dose|Period 1||6
9957154|NCT01449630|11076399|FG002|Received at Least 1 Dose|Period 1||2
9832746|NCT00774800|10943524|FG000|STARTED|Intervention 2||22
9832747|NCT00774800|10943524|FG000|Received at Least One Dose of Study Drug|Intervention 2||22
9832748|NCT00774800|10943524|FG000|COMPLETED|Intervention 2||22
9832749|NCT00774800|10943524|FG000|NOT COMPLETED|Intervention 2||0
9832750|NCT00774800|10943524|FG000|STARTED|Washout (3 to 10 Days)||22
9832751|NCT00774800|10943524|FG000|COMPLETED|Washout (3 to 10 Days)||22
9832752|NCT00774800|10943524|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
9832753|NCT00774800|10943524|FG000|STARTED|Intervention 3||22
9832754|NCT00774800|10943524|FG000|Received at Least One Dose of Study Drug|Intervention 3||22
9832755|NCT00774800|10943524|FG000|COMPLETED|Intervention 3||22
9832756|NCT00774800|10943524|FG000|NOT COMPLETED|Intervention 3||0
9832757|NCT00774800|10943524|FG000|STARTED|Washout (3 to 10 Days)||22
9832758|NCT00774800|10943524|FG000|COMPLETED|Washout (3 to 10 Days)||22
9832759|NCT00774800|10943524|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
9832760|NCT00774800|10943524|FG000|STARTED|Intervention 4||22
9832761|NCT00774800|10943524|FG000|Received at Least One Dose of Study Drug|Intervention 4||21
9832762|NCT00774800|10943524|FG000|COMPLETED|Intervention 4||21
9832763|NCT00774800|10943524|FG000|NOT COMPLETED|Intervention 4||1
9832764|NCT00774852|10943536|FG000|STARTED|Overall Study||69
9832765|NCT00774852|10943537|FG001|STARTED|Overall Study||68
9832766|NCT00774852|10943536|FG000|COMPLETED|Overall Study||24
9832767|NCT00774852|10943537|FG001|COMPLETED|Overall Study||27
9832768|NCT00774852|10943536|FG000|NOT COMPLETED|Overall Study||45
9832769|NCT00774852|10943537|FG001|NOT COMPLETED|Overall Study||41
9832770|NCT00774930|10943555|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
9957155|NCT01449630|11076400|FG003|Received at Least 1 Dose|Period 1||2
9957156|NCT01449630|11076401|FG004|Received at Least 1 Dose|Period 1||5
9957157|NCT01449630|11076402|FG005|Received at Least 1 Dose|Period 1||1
9957158|NCT01449630|11076403|FG006|Received at Least 1 Dose|Period 1||2
9957159|NCT01449630|11076404|FG007|Received at Least 1 Dose|Period 1||6
9957160|NCT01449630|11076405|FG008|Received at Least 1 Dose|Period 1||2
9957161|NCT01449630|11076397|FG000|COMPLETED|Period 1||1
9957162|NCT01449630|11076398|FG001|COMPLETED|Period 1||6
9957163|NCT01449630|11076399|FG002|COMPLETED|Period 1||2
9957164|NCT01449630|11076400|FG003|COMPLETED|Period 1||1
9957165|NCT01449630|11076401|FG004|COMPLETED|Period 1||5
9957166|NCT01449630|11076402|FG005|COMPLETED|Period 1||1
9957167|NCT01449630|11076403|FG006|COMPLETED|Period 1||2
9957168|NCT01449630|11076404|FG007|COMPLETED|Period 1||6
9957169|NCT01449630|11076405|FG008|COMPLETED|Period 1||2
9957170|NCT01449630|11076397|FG000|NOT COMPLETED|Period 1||1
9832771|NCT00774930|10943556|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
9832772|NCT00774930|10943555|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
9832773|NCT00774930|10943556|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
10242178|NCT04878172|11373863|FG000|STARTED|Overall Study||2
10242179|NCT04878172|11373864|FG001|STARTED|Overall Study||2
10242180|NCT04878172|11373865|FG002|STARTED|Overall Study||2
10242181|NCT04878172|11373866|FG003|STARTED|Overall Study||3
10242182|NCT04878172|11373863|FG000|COMPLETED|Overall Study||2
10242183|NCT04878172|11373864|FG001|COMPLETED|Overall Study||2
10242184|NCT04878172|11373865|FG002|COMPLETED|Overall Study||2
10242185|NCT04878172|11373866|FG003|COMPLETED|Overall Study||3
10242186|NCT04878172|11373863|FG000|NOT COMPLETED|Overall Study||0
10242187|NCT04878172|11373864|FG001|NOT COMPLETED|Overall Study||0
10242188|NCT04878172|11373865|FG002|NOT COMPLETED|Overall Study||0
10242189|NCT04878172|11373866|FG003|NOT COMPLETED|Overall Study||0
10242190|NCT04671017|11373879|FG000|STARTED|Overall Study||51
10242191|NCT04671017|11373880|FG001|STARTED|Overall Study||51
10242192|NCT04671017|11373881|FG002|STARTED|Overall Study||51
10242193|NCT04671017|11373879|FG000|COMPLETED|Overall Study||51
10242194|NCT04671017|11373880|FG001|COMPLETED|Overall Study||51
10242195|NCT04671017|11373881|FG002|COMPLETED|Overall Study||51
10242196|NCT04671017|11373879|FG000|NOT COMPLETED|Overall Study||0
10242197|NCT04671017|11373880|FG001|NOT COMPLETED|Overall Study||0
10242198|NCT04671017|11373881|FG002|NOT COMPLETED|Overall Study||0
10242199|NCT04557371|11373892|FG000|STARTED|Overall Study||50
10242200|NCT04557371|11373893|FG001|STARTED|Overall Study||49
10242201|NCT04557371|11373894|FG002|STARTED|Overall Study||51
10242202|NCT04557371|11373892|FG000|COMPLETED|Overall Study||49
10242203|NCT04557371|11373893|FG001|COMPLETED|Overall Study||47
10242204|NCT04557371|11373894|FG002|COMPLETED|Overall Study||51
10242205|NCT04557371|11373892|FG000|NOT COMPLETED|Overall Study||1
10242206|NCT04557371|11373893|FG001|NOT COMPLETED|Overall Study||2
10242207|NCT04557371|11373894|FG002|NOT COMPLETED|Overall Study||0
10242232|NCT04115644|11373934|FG000|STARTED|Overall Study||26
9832774|NCT00774930|10943555|FG000|NOT COMPLETED|DB Phase||14
9832775|NCT00774930|10943556|FG001|NOT COMPLETED|DB Phase||22
9832776|NCT00774930|10943555|FG000|STARTED|IOL Phase||56
9832777|NCT00774930|10943556|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
9832778|NCT00774930|10943555|FG000|COMPLETED|IOL Phase||43
9832779|NCT00774930|10943556|FG001|COMPLETED|IOL Phase||37
9832780|NCT00774930|10943555|FG000|NOT COMPLETED|IOL Phase||13
9832781|NCT00774930|10943556|FG001|NOT COMPLETED|IOL Phase||9
9832782|NCT00774930|10943555|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
9832783|NCT00774930|10943556|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
9832784|NCT00774930|10943555|FG000|COMPLETED|LTOLE Phase||17
9832785|NCT00774930|10943556|FG001|COMPLETED|LTOLE Phase||8
9832786|NCT00774930|10943555|FG000|NOT COMPLETED|LTOLE Phase||15
9832787|NCT00774930|10943556|FG001|NOT COMPLETED|LTOLE Phase||17
10242233|NCT04115644|11373935|FG001|STARTED|Overall Study||30
10242234|NCT04115644|11373936|FG002|STARTED|Overall Study||26
10242235|NCT04115644|11373934|FG000|COMPLETED|Overall Study||26
10242236|NCT04115644|11373935|FG001|COMPLETED|Overall Study||30
10242237|NCT04115644|11373936|FG002|COMPLETED|Overall Study||25
10242238|NCT04115644|11373934|FG000|NOT COMPLETED|Overall Study||0
10242239|NCT04115644|11373935|FG001|NOT COMPLETED|Overall Study||0
10242240|NCT04115644|11373936|FG002|NOT COMPLETED|Overall Study||1
10242241|NCT04005859|11373946|FG000|STARTED|Overall Study||32
10242242|NCT04005859|11373947|FG001|STARTED|Overall Study||29
10242243|NCT04005859|11373946|FG000|COMPLETED|Overall Study||28
10242244|NCT04005859|11373947|FG001|COMPLETED|Overall Study||25
10242245|NCT04005859|11373946|FG000|NOT COMPLETED|Overall Study||4
10242246|NCT04005859|11373947|FG001|NOT COMPLETED|Overall Study||4
10242247|NCT03969589|11373955|FG000|STARTED|Overall Study||20
10242248|NCT03969589|11373956|FG001|STARTED|Overall Study||20
10242249|NCT03969589|11373955|FG000|COMPLETED|Overall Study||17
10242250|NCT03969589|11373956|FG001|COMPLETED|Overall Study||17
10242251|NCT03969589|11373955|FG000|NOT COMPLETED|Overall Study||3
10242252|NCT03969589|11373956|FG001|NOT COMPLETED|Overall Study||3
10242253|NCT03875664|11373964|FG000|STARTED|Overall Study||37
10242254|NCT03875664|11373965|FG001|STARTED|Overall Study||35
10242255|NCT03875664|11373964|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
10242256|NCT03875664|11373965|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
10242257|NCT03875664|11373964|FG000|NOT COMPLETED|Overall Study||0
10242258|NCT03875664|11373965|FG001|NOT COMPLETED|Overall Study||0
10242259|NCT03812588|11373975|FG000|STARTED|Overall Study||5
10242260|NCT03812588|11373976|FG001|STARTED|Overall Study||7
10242261|NCT03812588|11373977|FG002|STARTED|Overall Study||5
10242262|NCT03812588|11373978|FG003|STARTED|Overall Study||8
10242263|NCT03812588|11373975|FG000|COMPLETED|Overall Study||3
10242264|NCT03812588|11373976|FG001|COMPLETED|Overall Study||5
10242265|NCT03812588|11373977|FG002|COMPLETED|Overall Study||3
10242266|NCT03812588|11373978|FG003|COMPLETED|Overall Study||8
10242267|NCT03812588|11373975|FG000|NOT COMPLETED|Overall Study||2
10242268|NCT03812588|11373976|FG001|NOT COMPLETED|Overall Study||2
9832788|NCT00774995|10943568|FG000|STARTED|Overall Study||9
9832789|NCT00774995|10943569|FG001|STARTED|Overall Study||16
9832790|NCT00774995|10943570|FG002|STARTED|Overall Study||8
10242269|NCT03812588|11373977|FG002|NOT COMPLETED|Overall Study||2
10242270|NCT03812588|11373978|FG003|NOT COMPLETED|Overall Study||0
10242271|NCT03690674|11373988|FG000|STARTED|Overall Study||35
10242272|NCT03690674|11373989|FG001|STARTED|Overall Study||35
10242273|NCT03690674|11373988|FG000|COMPLETED|Overall Study||32
10242274|NCT03690674|11373989|FG001|COMPLETED|Overall Study||32
10242208|NCT04540952|11373904|FG000|STARTED|Overall Study||34
10242209|NCT04540952|11373905|FG001|STARTED|Overall Study||34
10242210|NCT04540952|11373904|FG000|COMPLETED|Overall Study||34
10242211|NCT04540952|11373905|FG001|COMPLETED|Overall Study||34
10242212|NCT04540952|11373904|FG000|NOT COMPLETED|Overall Study||0
10242213|NCT04540952|11373905|FG001|NOT COMPLETED|Overall Study||0
10242214|NCT04369742|11373915|FG000|STARTED|Overall Study||67
10242215|NCT04369742|11373916|FG001|STARTED|Overall Study||61
10242216|NCT04369742|11373915|FG000|COMPLETED|Overall Study||53
10242217|NCT04369742|11373916|FG001|COMPLETED|Overall Study||50
10242218|NCT04369742|11373915|FG000|NOT COMPLETED|Overall Study||14
10242219|NCT04369742|11373916|FG001|NOT COMPLETED|Overall Study||11
10242220|NCT04346628|11373924|FG000|STARTED|Overall Study||74
10242221|NCT04346628|11373925|FG001|STARTED|Overall Study||75
10242222|NCT04346628|11373924|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||74
10242223|NCT04346628|11373925|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||75
10242224|NCT04346628|11373924|FG000|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||70
10242225|NCT04346628|11373925|FG001|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||65
10242226|NCT04346628|11373924|FG000|Modified ITT (mITT) Analysis|Overall Study||57
10242227|NCT04346628|11373925|FG001|Modified ITT (mITT) Analysis|Overall Study||59
10242228|NCT04346628|11373924|FG000|COMPLETED|Overall Study||68
10242229|NCT04346628|11373925|FG001|COMPLETED|Overall Study||62
10242230|NCT04346628|11373924|FG000|NOT COMPLETED|Overall Study||6
10242231|NCT04346628|11373925|FG001|NOT COMPLETED|Overall Study||13
10242275|NCT03690674|11373988|FG000|NOT COMPLETED|Overall Study||3
10242276|NCT03690674|11373989|FG001|NOT COMPLETED|Overall Study||3
10242277|NCT03655691|11373999|FG000|STARTED|Overall Study||26
10242278|NCT03655691|11374000|FG001|STARTED|Overall Study||26
10242279|NCT03655691|11374001|FG002|STARTED|Overall Study||27
10242280|NCT03655691|11373999|FG000|COMPLETED|Overall Study||24
10242281|NCT03655691|11374000|FG001|COMPLETED|Overall Study||23
10242282|NCT03655691|11374001|FG002|COMPLETED|Overall Study||24
10242283|NCT03655691|11373999|FG000|NOT COMPLETED|Overall Study||2
10242284|NCT03655691|11374000|FG001|NOT COMPLETED|Overall Study||3
10242285|NCT03655691|11374001|FG002|NOT COMPLETED|Overall Study||3
10242286|NCT03608670|11374009|FG000|STARTED|Overall Study||26
10242287|NCT03608670|11374009|FG000|Implant Attempted|Overall Study||21
10242288|NCT03608670|11374009|FG000|Successfully Implanted|Overall Study||17
10242289|NCT03608670|11374009|FG000|2-week Follow-up|Overall Study||17
10242290|NCT03608670|11374009|FG000|4-6 Weeks Follow-up|Overall Study||17
10242291|NCT03608670|11374009|FG000|COMPLETED|Overall Study||16
10242292|NCT03608670|11374009|FG000|NOT COMPLETED|Overall Study||10
9832791|NCT00774995|10943571|FG003|STARTED|Overall Study||16
9832792|NCT00774995|10943568|FG000|COMPLETED|Overall Study||9
9832793|NCT00774995|10943569|FG001|COMPLETED|Overall Study||16
10242293|NCT03364686|11374013|FG000|STARTED|Overall Study||6
10242294|NCT03364686|11374013|FG000|COMPLETED|Overall Study||4
10242295|NCT03364686|11374013|FG000|NOT COMPLETED|Overall Study||2
10019343|NCT01829360|11142504|FG003|NOT COMPLETED|Overall Study||0
10019344|NCT01829399|11142520|FG000|STARTED|Visit 1||12
10019345|NCT01829399|11142521|FG001|STARTED|Visit 1||12
10242296|NCT03345771|11374019|FG000|STARTED|Overall Study||115
10242297|NCT03345771|11374020|FG001|STARTED|Overall Study||115
10242298|NCT03345771|11374019|FG000|COMPLETED|Overall Study||115
10242299|NCT03345771|11374020|FG001|COMPLETED|Overall Study||115
10242300|NCT03345771|11374019|FG000|NOT COMPLETED|Overall Study||0
10242301|NCT03345771|11374020|FG001|NOT COMPLETED|Overall Study||0
10242302|NCT03326856|11374031|FG000|STARTED|Overall Study||13
10242303|NCT03326856|11374032|FG001|STARTED|Overall Study||9
10242304|NCT03326856|11374033|FG002|STARTED|Overall Study||9
10242305|NCT03326856|11374034|FG003|STARTED|Overall Study||9
10242306|NCT03326856|11374035|FG004|STARTED|Overall Study||8
10242307|NCT03326856|11374031|FG000|COMPLETED|Overall Study||12
10242308|NCT03326856|11374032|FG001|COMPLETED|Overall Study||8
10019346|NCT01829399|11142520|FG000|COMPLETED|Visit 1||12
10019347|NCT01829399|11142521|FG001|COMPLETED|Visit 1||12
10019348|NCT01829399|11142520|FG000|NOT COMPLETED|Visit 1||0
10019349|NCT01829399|11142521|FG001|NOT COMPLETED|Visit 1||0
10019350|NCT01829399|11142520|FG000|STARTED|Visit 2 (One Month Later)||12
10242309|NCT03326856|11374033|FG002|COMPLETED|Overall Study||9
10242310|NCT03326856|11374034|FG003|COMPLETED|Overall Study||9
10242311|NCT03326856|11374035|FG004|COMPLETED|Overall Study||8
10242312|NCT03326856|11374031|FG000|NOT COMPLETED|Overall Study||1
10242313|NCT03326856|11374032|FG001|NOT COMPLETED|Overall Study||1
10242314|NCT03326856|11374033|FG002|NOT COMPLETED|Overall Study||0
10242315|NCT03326856|11374034|FG003|NOT COMPLETED|Overall Study||0
10242316|NCT03326856|11374035|FG004|NOT COMPLETED|Overall Study||0
10242317|NCT03287947|11374047|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5
10242318|NCT03287947|11374047|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
10242319|NCT03287947|11374047|FG000|NOT COMPLETED|Overall Study||0
10242320|NCT03287089|11374053|FG000|STARTED|Overall Study||82
10242321|NCT03287089|11374054|FG001|STARTED|Overall Study||82
10242322|NCT03287089|11374053|FG000|COMPLETED|Overall Study||82
10242323|NCT03287089|11374054|FG001|COMPLETED|Overall Study||76
10242324|NCT03287089|11374053|FG000|NOT COMPLETED|Overall Study||0
10242325|NCT03287089|11374054|FG001|NOT COMPLETED|Overall Study||6
10242326|NCT03240692|11374060|FG000|STARTED|Overall Study||23
10242327|NCT03240692|11374060|FG000|COMPLETED|Overall Study||21
10242328|NCT03240692|11374060|FG000|NOT COMPLETED|Overall Study||2
10242329|NCT03227029|11374067|FG000|STARTED|Overall Study||26
10242330|NCT03227029|11374068|FG001|STARTED|Overall Study||26
10242331|NCT03227029|11374069|FG002|STARTED|Overall Study||13
10242332|NCT03227029|11374067|FG000|Received Inoculation|Overall Study||26
10242333|NCT03227029|11374068|FG001|Received Inoculation|Overall Study||25
10242334|NCT03227029|11374069|FG002|Received Inoculation|Overall Study||12
10242335|NCT03227029|11374067|FG000|COMPLETED|Overall Study||22
10242336|NCT03227029|11374068|FG001|COMPLETED|Overall Study||22
10242337|NCT03227029|11374069|FG002|COMPLETED|Overall Study||9
10242338|NCT03227029|11374067|FG000|NOT COMPLETED|Overall Study||4
10242339|NCT03227029|11374068|FG001|NOT COMPLETED|Overall Study||4
10242340|NCT03227029|11374069|FG002|NOT COMPLETED|Overall Study||4
10242341|NCT03207776|11374079|FG000|STARTED|Overall Study||2479
10242342|NCT03207776|11374080|FG001|STARTED|Overall Study||2353
10242343|NCT03207776|11374079|FG000|COMPLETED|Overall Study||2479
10242344|NCT03207776|11374080|FG001|COMPLETED|Overall Study||2353
10242345|NCT03207776|11374079|FG000|NOT COMPLETED|Overall Study||0
10242346|NCT03207776|11374080|FG001|NOT COMPLETED|Overall Study||0
10242347|NCT03204643|11374088|FG000|STARTED|Overall Study||323
10242348|NCT03204643|11374089|FG001|STARTED|Overall Study||314
10242349|NCT03204643|11374088|FG000|COMPLETED|Overall Study||323
10242350|NCT03204643|11374089|FG001|COMPLETED|Overall Study||314
10242351|NCT03204643|11374088|FG000|NOT COMPLETED|Overall Study||0
10242352|NCT03204643|11374089|FG001|NOT COMPLETED|Overall Study||0
10242353|NCT03182829|11374097|FG000|STARTED|Overall Study||467
10242354|NCT03182829|11374098|FG001|STARTED|Overall Study||444
10242355|NCT03182829|11374097|FG000|COMPLETED|Overall Study||451
10242356|NCT03182829|11374098|FG001|COMPLETED|Overall Study||429
10242357|NCT03182829|11374097|FG000|NOT COMPLETED|Overall Study||16
10242358|NCT03182829|11374098|FG001|NOT COMPLETED|Overall Study||15
10242359|NCT03181789|11374108|FG000|STARTED|Overall Study||25
10242360|NCT03181789|11374109|FG001|STARTED|Overall Study||25
10242361|NCT03181789|11374110|FG002|STARTED|Overall Study||3
10019351|NCT01829399|11142521|FG001|STARTED|Visit 2 (One Month Later)||12
10019352|NCT01829399|11142520|FG000|COMPLETED|Visit 2 (One Month Later)||12
10019353|NCT01829399|11142521|FG001|COMPLETED|Visit 2 (One Month Later)||12
10019354|NCT01829399|11142520|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0
10019355|NCT01829399|11142521|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0
10242362|NCT03181789|11374111|FG003|STARTED|Overall Study||3
10242363|NCT03181789|11374108|FG000|Safety Population|Overall Study||25
10242364|NCT03181789|11374109|FG001|Safety Population|Overall Study||25
10242365|NCT03181789|11374110|FG002|Safety Population|Overall Study||3
10242366|NCT03181789|11374111|FG003|Safety Population|Overall Study||3
10242367|NCT03181789|11374108|FG000|COMPLETED|Overall Study||18
10242368|NCT03181789|11374109|FG001|COMPLETED|Overall Study||22
10242369|NCT03181789|11374110|FG002|COMPLETED|Overall Study||2
10242370|NCT03181789|11374111|FG003|COMPLETED|Overall Study||3
10242371|NCT03181789|11374108|FG000|NOT COMPLETED|Overall Study||7
10242372|NCT03181789|11374109|FG001|NOT COMPLETED|Overall Study||3
10242373|NCT03181789|11374110|FG002|NOT COMPLETED|Overall Study||1
10242374|NCT03181789|11374111|FG003|NOT COMPLETED|Overall Study||0
10242375|NCT03164356|11374126|FG000|STARTED|Overall Study||19
10242376|NCT03164356|11374127|FG001|STARTED|Overall Study||15
10242377|NCT03164356|11374128|FG002|STARTED|Overall Study||17
10242378|NCT03164356|11374129|FG003|STARTED|Overall Study||17
10242379|NCT03164356|11374126|FG000|COMPLETED|Overall Study||14
10242380|NCT03164356|11374127|FG001|COMPLETED|Overall Study||10
10242381|NCT03164356|11374128|FG002|COMPLETED|Overall Study||11
10242382|NCT03164356|11374129|FG003|COMPLETED|Overall Study||15
10242383|NCT03164356|11374126|FG000|NOT COMPLETED|Overall Study||5
10242384|NCT03164356|11374127|FG001|NOT COMPLETED|Overall Study||5
10242385|NCT03164356|11374128|FG002|NOT COMPLETED|Overall Study||6
10242386|NCT03164356|11374129|FG003|NOT COMPLETED|Overall Study||2
10242387|NCT02975700|11374149|FG000|STARTED|Overall Study||6
10242388|NCT02975700|11374149|FG000|COMPLETED|Overall Study||0
10242389|NCT02975700|11374149|FG000|NOT COMPLETED|Overall Study||6
10242390|NCT02941549|11374156|FG000|STARTED|Overall Study||31
10242391|NCT02941549|11374157|FG001|STARTED|Overall Study||32
10242392|NCT02941549|11374158|FG002|STARTED|Overall Study||33
10242393|NCT02941549|11374156|FG000|COMPLETED|Overall Study||28
10242394|NCT02941549|11374157|FG001|COMPLETED|Overall Study||31
10242395|NCT02941549|11374158|FG002|COMPLETED|Overall Study||31
10242396|NCT02941549|11374156|FG000|NOT COMPLETED|Overall Study||3
10242397|NCT02941549|11374157|FG001|NOT COMPLETED|Overall Study||1
10242398|NCT02941549|11374158|FG002|NOT COMPLETED|Overall Study||2
10242399|NCT02937766|11374171|FG000|STARTED|Overall Study||30
10242400|NCT02937766|11374172|FG001|STARTED|Overall Study||30
10242401|NCT02937766|11374171|FG000|COMPLETED|Overall Study||23
10242402|NCT02937766|11374172|FG001|COMPLETED|Overall Study||30
10242403|NCT02937766|11374171|FG000|NOT COMPLETED|Overall Study||7
10242404|NCT02937766|11374172|FG001|NOT COMPLETED|Overall Study||0
10242405|NCT02927938|11374182|FG000|STARTED|Overall Study||1
10242406|NCT02927938|11374183|FG001|STARTED|Overall Study||6
10242407|NCT02927938|11374184|FG002|STARTED|Overall Study||4
10242408|NCT02927938|11374185|FG003|STARTED|Overall Study||7
10242409|NCT02927938|11374182|FG000|COMPLETED|Overall Study||0
10242410|NCT02927938|11374183|FG001|COMPLETED|Overall Study||0
10242411|NCT02927938|11374184|FG002|COMPLETED|Overall Study||0
10242412|NCT02927938|11374185|FG003|COMPLETED|Overall Study||0
10242413|NCT02927938|11374182|FG000|NOT COMPLETED|Overall Study||1
10242414|NCT02927938|11374183|FG001|NOT COMPLETED|Overall Study||6
10242415|NCT02927938|11374184|FG002|NOT COMPLETED|Overall Study||4
10242416|NCT02927938|11374185|FG003|NOT COMPLETED|Overall Study||7
10242417|NCT02913131|11374195|FG000|STARTED|Overall Study||18
10242418|NCT02913131|11374196|FG001|STARTED|Overall Study|Two of the five participants enrolled in Part B were previously enrolled in Part A.|5
10242419|NCT02913131|11374195|FG000|COMPLETED|Overall Study||18
10242420|NCT02913131|11374196|FG001|COMPLETED|Overall Study||5
10242421|NCT02913131|11374195|FG000|NOT COMPLETED|Overall Study||0
10242422|NCT02913131|11374196|FG001|NOT COMPLETED|Overall Study||0
10242423|NCT02883400|11374205|FG000|STARTED|Overall Study||22
10242424|NCT02883400|11374206|FG001|STARTED|Overall Study||8
10242425|NCT02883400|11374205|FG000|COMPLETED|Overall Study||22
10242426|NCT02883400|11374206|FG001|COMPLETED|Overall Study||8
10242427|NCT02883400|11374205|FG000|NOT COMPLETED|Overall Study||0
10242428|NCT02883400|11374206|FG001|NOT COMPLETED|Overall Study||0
10242429|NCT02855060|11374214|FG000|STARTED|Overall Study||22
10242430|NCT02855060|11374215|FG001|STARTED|Overall Study||28
10242431|NCT02855060|11374214|FG000|COMPLETED|Overall Study||20
10242432|NCT02855060|11374215|FG001|COMPLETED|Overall Study||23
10242433|NCT02855060|11374214|FG000|NOT COMPLETED|Overall Study||2
10242434|NCT02855060|11374215|FG001|NOT COMPLETED|Overall Study||5
10242435|NCT02823574|11374225|FG000|STARTED|Pre-Treatment Period||159
10242436|NCT02823574|11374226|FG001|STARTED|Pre-Treatment Period||82
10242437|NCT02823574|11374227|FG002|STARTED|Pre-Treatment Period||123
10242438|NCT02823574|11374228|FG003|STARTED|Pre-Treatment Period||61
9832794|NCT00774995|10943570|FG002|COMPLETED|Overall Study||7
9832795|NCT00774995|10943571|FG003|COMPLETED|Overall Study||16
9832796|NCT00774995|10943568|FG000|NOT COMPLETED|Overall Study||0
9832797|NCT00774995|10943569|FG001|NOT COMPLETED|Overall Study||0
9832798|NCT00774995|10943570|FG002|NOT COMPLETED|Overall Study||1
9832799|NCT00774995|10943571|FG003|NOT COMPLETED|Overall Study||0
9832800|NCT00775021|10943581|FG000|STARTED|First Intervention||63
9832801|NCT00775021|10943582|FG001|STARTED|First Intervention||60
9832802|NCT00775021|10943581|FG000|COMPLETED|First Intervention||62
9832803|NCT00775021|10943582|FG001|COMPLETED|First Intervention||60
9832804|NCT00775021|10943581|FG000|NOT COMPLETED|First Intervention||1
9832805|NCT00775021|10943582|FG001|NOT COMPLETED|First Intervention||0
9832806|NCT00775021|10943581|FG000|STARTED|Second Intervention||62
9832807|NCT00775021|10943582|FG001|STARTED|Second Intervention||60
9832808|NCT00775021|10943581|FG000|COMPLETED|Second Intervention||62
9832809|NCT00775021|10943582|FG001|COMPLETED|Second Intervention||59
9832810|NCT00775021|10943581|FG000|NOT COMPLETED|Second Intervention||0
9832811|NCT00775021|10943582|FG001|NOT COMPLETED|Second Intervention||1
9832812|NCT00775138|10943592|FG000|STARTED|Overall Study||24
9832813|NCT00775138|10943593|FG001|STARTED|Overall Study||10
9832814|NCT00775138|10943594|FG002|STARTED|Overall Study||20
9832815|NCT00775138|10943595|FG003|STARTED|Overall Study||10
9832816|NCT00775138|10943592|FG000|COMPLETED|Overall Study||24
9832817|NCT00775138|10943593|FG001|COMPLETED|Overall Study||10
9832818|NCT00775138|10943594|FG002|COMPLETED|Overall Study||17
9832819|NCT00775138|10943595|FG003|COMPLETED|Overall Study||8
9832820|NCT00775138|10943592|FG000|NOT COMPLETED|Overall Study||0
9832821|NCT00775138|10943593|FG001|NOT COMPLETED|Overall Study||0
9832822|NCT00775138|10943594|FG002|NOT COMPLETED|Overall Study||3
9832823|NCT00775138|10943595|FG003|NOT COMPLETED|Overall Study||2
9832824|NCT00775203|10943609|FG000|STARTED|Overall Study||206
9832825|NCT00775203|10943610|FG001|STARTED|Overall Study||206
9832826|NCT00775203|10943609|FG000|Received Study Medication|Overall Study||202
9832827|NCT00775203|10943610|FG001|Received Study Medication|Overall Study||204
9832828|NCT00775203|10943609|FG000|COMPLETED|Overall Study||144
9832829|NCT00775203|10943610|FG001|COMPLETED|Overall Study||163
9832830|NCT00775203|10943609|FG000|NOT COMPLETED|Overall Study||62
9832831|NCT00775203|10943610|FG001|NOT COMPLETED|Overall Study||43
9832832|NCT00775229|10943618|FG000|STARTED|Overall Study||25
9832833|NCT00775229|10943619|FG001|STARTED|Overall Study||26
9832834|NCT00775229|10943618|FG000|COMPLETED|Overall Study||20
9832835|NCT00775229|10943619|FG001|COMPLETED|Overall Study||24
9832836|NCT00775229|10943618|FG000|NOT COMPLETED|Overall Study||5
9832837|NCT00775229|10943619|FG001|NOT COMPLETED|Overall Study||2
9832838|NCT00775268|10943627|FG000|STARTED|Baseline||9
9832839|NCT00775268|10943628|FG001|STARTED|Baseline||22
9832840|NCT00775268|10943627|FG000|COMPLETED|Baseline||8
9832841|NCT00775268|10943628|FG001|COMPLETED|Baseline||21
9832842|NCT00775268|10943627|FG000|NOT COMPLETED|Baseline||1
9832843|NCT00775268|10943628|FG001|NOT COMPLETED|Baseline||1
9832844|NCT00775268|10943627|FG000|STARTED|After 2 Cycles||8
9832845|NCT00775268|10943628|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
9832846|NCT00775268|10943627|FG000|COMPLETED|After 2 Cycles||7
9832847|NCT00775268|10943628|FG001|COMPLETED|After 2 Cycles||0
9832848|NCT00775268|10943627|FG000|NOT COMPLETED|After 2 Cycles||1
9832849|NCT00775268|10943628|FG001|NOT COMPLETED|After 2 Cycles||0
9832850|NCT00775268|10943627|FG000|STARTED|After Completion||7
9832851|NCT00775268|10943628|FG001|STARTED|After Completion||0
9832852|NCT00775268|10943627|FG000|COMPLETED|After Completion||6
9832853|NCT00775268|10943628|FG001|COMPLETED|After Completion||0
9832854|NCT00775268|10943627|FG000|NOT COMPLETED|After Completion||1
9832855|NCT00775268|10943628|FG001|NOT COMPLETED|After Completion||0
9832856|NCT00775346|10943645|FG000|STARTED|Overall Study||92
9832857|NCT00775346|10943645|FG000|COMPLETED|Overall Study||92
9832858|NCT00775346|10943645|FG000|NOT COMPLETED|Overall Study||0
9832859|NCT00775411|10943649|FG000|STARTED|Overall Study||44
9832860|NCT00775411|10943649|FG000|COMPLETED|Overall Study||43
10242439|NCT02823574|11374225|FG000|COMPLETED|Pre-Treatment Period||158
9832861|NCT00775411|10943649|FG000|NOT COMPLETED|Overall Study||1
9832862|NCT00775437|10943653|FG000|STARTED|Overall Study||32
9832863|NCT00775437|10943653|FG000|COMPLETED|Overall Study||26
9832864|NCT00775437|10943653|FG000|NOT COMPLETED|Overall Study||6
9832865|NCT00775450|10943662|FG000|STARTED|Overall Study||295
9832866|NCT00775450|10943663|FG001|STARTED|Overall Study||98
9832867|NCT00775450|10943664|FG002|STARTED|Overall Study||105
9832868|NCT00775450|10943665|FG003|STARTED|Overall Study||108
9832869|NCT00775450|10943666|FG004|STARTED|Overall Study||201
9832870|NCT00775450|10943662|FG000|COMPLETED|Overall Study||292
9832871|NCT00775450|10943663|FG001|COMPLETED|Overall Study||98
9832872|NCT00775450|10943664|FG002|COMPLETED|Overall Study||105
10242440|NCT02823574|11374226|FG001|COMPLETED|Pre-Treatment Period||82
10242441|NCT02823574|11374227|FG002|COMPLETED|Pre-Treatment Period||122
10242442|NCT02823574|11374228|FG003|COMPLETED|Pre-Treatment Period||61
10242443|NCT02823574|11374225|FG000|NOT COMPLETED|Pre-Treatment Period||1
10242444|NCT02823574|11374226|FG001|NOT COMPLETED|Pre-Treatment Period||0
10242445|NCT02823574|11374227|FG002|NOT COMPLETED|Pre-Treatment Period||1
10242446|NCT02823574|11374228|FG003|NOT COMPLETED|Pre-Treatment Period||0
10242447|NCT02823574|11374225|FG000|STARTED|Treatment Period||158
10242448|NCT02823574|11374226|FG001|STARTED|Treatment Period||82
10242449|NCT02823574|11374227|FG002|STARTED|Treatment Period||122
10242450|NCT02823574|11374228|FG003|STARTED|Treatment Period||61
10242451|NCT02823574|11374225|FG000|COMPLETED|Treatment Period||19
10242452|NCT02823574|11374226|FG001|COMPLETED|Treatment Period||16
10242453|NCT02823574|11374227|FG002|COMPLETED|Treatment Period||14
10242454|NCT02823574|11374228|FG003|COMPLETED|Treatment Period||10
10242455|NCT02823574|11374225|FG000|NOT COMPLETED|Treatment Period||139
10242456|NCT02823574|11374226|FG001|NOT COMPLETED|Treatment Period||66
10242457|NCT02823574|11374227|FG002|NOT COMPLETED|Treatment Period||108
10242458|NCT02823574|11374228|FG003|NOT COMPLETED|Treatment Period||51
10242459|NCT02771990|11374243|FG000|STARTED|Overall Study||11
10242460|NCT02771990|11374244|FG001|STARTED|Overall Study||10
10242461|NCT02771990|11374243|FG000|COMPLETED|Overall Study||11
10242462|NCT02771990|11374244|FG001|COMPLETED|Overall Study||10
10242463|NCT02771990|11374243|FG000|NOT COMPLETED|Overall Study||0
10242464|NCT02771990|11374244|FG001|NOT COMPLETED|Overall Study||0
10242465|NCT02743819|11374250|FG000|STARTED|Overall Study||70
10242466|NCT02743819|11374250|FG000|COMPLETED|Overall Study||62
10242467|NCT02743819|11374250|FG000|NOT COMPLETED|Overall Study||8
10242468|NCT02729753|11374256|FG000|STARTED|Overall Study|First patient enrolled April 2016|3
10242469|NCT02729753|11374257|FG001|STARTED|Overall Study|First patient enrolled April 2016|7
10242470|NCT02729753|11374256|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
10242471|NCT02729753|11374257|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
10242472|NCT02729753|11374256|FG000|NOT COMPLETED|Overall Study||0
10242473|NCT02729753|11374257|FG001|NOT COMPLETED|Overall Study||1
10242474|NCT02704130|11374268|FG000|STARTED|Overall Study||5
10242475|NCT02704130|11374269|FG001|STARTED|Overall Study||3
10242476|NCT02704130|11374268|FG000|COMPLETED|Overall Study||0
10242477|NCT02704130|11374269|FG001|COMPLETED|Overall Study||0
10242478|NCT02704130|11374268|FG000|NOT COMPLETED|Overall Study||5
10242479|NCT02704130|11374269|FG001|NOT COMPLETED|Overall Study||3
10242480|NCT02701192|11374275|FG000|STARTED|Overall Study||100
10242481|NCT02701192|11374275|FG000|COMPLETED|Overall Study||94
10242482|NCT02701192|11374275|FG000|NOT COMPLETED|Overall Study||6
10242483|NCT02685709|11374283|FG000|STARTED|Run-in Phase||146
10242484|NCT02685709|11374284|FG001|STARTED|Run-in Phase||0
10242485|NCT02685709|11374285|FG002|STARTED|Run-in Phase||0
10242486|NCT02685709|11374286|FG003|STARTED|Run-in Phase||0
10242487|NCT02685709|11374283|FG000|COMPLETED|Run-in Phase|30 patients early terminated the Run-in phase and 24 patient were not randomized to RCT|116
10242488|NCT02685709|11374284|FG001|COMPLETED|Run-in Phase||0
10242489|NCT02685709|11374285|FG002|COMPLETED|Run-in Phase||0
10242490|NCT02685709|11374286|FG003|COMPLETED|Run-in Phase||0
10242491|NCT02685709|11374283|FG000|NOT COMPLETED|Run-in Phase||30
10242492|NCT02685709|11374284|FG001|NOT COMPLETED|Run-in Phase||0
10242493|NCT02685709|11374285|FG002|NOT COMPLETED|Run-in Phase||0
10242494|NCT02685709|11374286|FG003|NOT COMPLETED|Run-in Phase||0
10242495|NCT02685709|11374283|FG000|STARTED|RCT Phase|116 patients completed the Run-in phase, out of which 92 were randomized to the RCT phase, and 24 were not randomized to the RCT phase. Out of these 24, 11 patients eneterd the combination phase.|0
10242496|NCT02685709|11374284|FG001|STARTED|RCT Phase||55
10242497|NCT02685709|11374285|FG002|STARTED|RCT Phase||37
10242498|NCT02685709|11374286|FG003|STARTED|RCT Phase||0
10242499|NCT02685709|11374283|FG000|COMPLETED|RCT Phase||0
10242500|NCT02685709|11374284|FG001|COMPLETED|RCT Phase||54
10242501|NCT02685709|11374285|FG002|COMPLETED|RCT Phase||35
10242502|NCT02685709|11374286|FG003|COMPLETED|RCT Phase||0
10242503|NCT02685709|11374283|FG000|NOT COMPLETED|RCT Phase||0
10242504|NCT02685709|11374284|FG001|NOT COMPLETED|RCT Phase||1
10242505|NCT02685709|11374285|FG002|NOT COMPLETED|RCT Phase||2
10242506|NCT02685709|11374286|FG003|NOT COMPLETED|RCT Phase||0
10242507|NCT02685709|11374283|FG000|STARTED|Combination Phase||0
10242508|NCT02685709|11374284|FG001|STARTED|Combination Phase||0
10242509|NCT02685709|11374285|FG002|STARTED|Combination Phase||0
10242510|NCT02685709|11374286|FG003|STARTED|Combination Phase|14 patients entered the combination phase (3 patients early discontinued the Run-in phase, and 11 patients completed Run-in and were not eligible to RCT phase).|14
10242511|NCT02685709|11374283|FG000|COMPLETED|Combination Phase||0
10242512|NCT02685709|11374284|FG001|COMPLETED|Combination Phase||0
10242513|NCT02685709|11374285|FG002|COMPLETED|Combination Phase||0
10242514|NCT02685709|11374286|FG003|COMPLETED|Combination Phase||8
10242515|NCT02685709|11374283|FG000|NOT COMPLETED|Combination Phase||0
10242516|NCT02685709|11374284|FG001|NOT COMPLETED|Combination Phase||0
10242517|NCT02685709|11374285|FG002|NOT COMPLETED|Combination Phase||0
10242518|NCT02685709|11374286|FG003|NOT COMPLETED|Combination Phase||6
10242519|NCT02684851|11374298|FG000|STARTED|Overall Study||42
10242520|NCT02684851|11374299|FG001|STARTED|Overall Study||45
10242521|NCT02684851|11374298|FG000|COMPLETED|Overall Study||42
10242522|NCT02684851|11374299|FG001|COMPLETED|Overall Study||45
10242523|NCT02684851|11374298|FG000|NOT COMPLETED|Overall Study||0
10242524|NCT02684851|11374299|FG001|NOT COMPLETED|Overall Study||0
10242525|NCT02653482|11374309|FG000|STARTED|Overall Study||131
10242526|NCT02653482|11374310|FG001|STARTED|Overall Study||132
10242527|NCT02653482|11374309|FG000|COMPLETED|Overall Study||130
10242528|NCT02653482|11374310|FG001|COMPLETED|Overall Study||131
10242529|NCT02653482|11374309|FG000|NOT COMPLETED|Overall Study||1
10242530|NCT02653482|11374310|FG001|NOT COMPLETED|Overall Study||1
10242531|NCT02632409|11374318|FG000|STARTED|Randomized||356
10242532|NCT02632409|11374319|FG001|STARTED|Randomized||353
10242533|NCT02632409|11374318|FG000|COMPLETED|Randomized||348
10242534|NCT02632409|11374319|FG001|COMPLETED|Randomized||351
9832873|NCT00775450|10943665|FG003|COMPLETED|Overall Study||108
9832874|NCT00775450|10943666|FG004|COMPLETED|Overall Study||199
9832875|NCT00775450|10943662|FG000|NOT COMPLETED|Overall Study||3
9832876|NCT00775450|10943663|FG001|NOT COMPLETED|Overall Study||0
9832877|NCT00775450|10943664|FG002|NOT COMPLETED|Overall Study||0
9832878|NCT00775450|10943665|FG003|NOT COMPLETED|Overall Study||0
9832879|NCT00775450|10943666|FG004|NOT COMPLETED|Overall Study||2
9832880|NCT00775463|10943680|FG000|STARTED|Overall Study||76
9832881|NCT00775463|10943681|FG001|STARTED|Overall Study||72
9832882|NCT00775463|10943680|FG000|COMPLETED|Overall Study||65
9832883|NCT00775463|10943681|FG001|COMPLETED|Overall Study||59
9832884|NCT00775463|10943680|FG000|NOT COMPLETED|Overall Study||11
9832885|NCT00775463|10943681|FG001|NOT COMPLETED|Overall Study||13
9832886|NCT00775528|10943694|FG000|STARTED|Overall Study|Started means number of patients who consented|19
9832887|NCT00775528|10943694|FG000|COMPLETED|Overall Study||18
9832888|NCT00775528|10943694|FG000|NOT COMPLETED|Overall Study||1
9832889|NCT00775593|10943698|FG000|STARTED|Overall Study||60
9832890|NCT00775593|10943698|FG000|COMPLETED|Overall Study||53
9832891|NCT00775593|10943698|FG000|NOT COMPLETED|Overall Study||7
9832892|NCT00775606|10943704|FG000|STARTED|Overall Study||8
9832893|NCT00775606|10943705|FG001|STARTED|Overall Study||5
9832894|NCT00775606|10943704|FG000|COMPLETED|Overall Study||5
9832895|NCT00775606|10943705|FG001|COMPLETED|Overall Study||5
9832896|NCT00775606|10943704|FG000|NOT COMPLETED|Overall Study||3
9832897|NCT00775606|10943705|FG001|NOT COMPLETED|Overall Study||0
9832898|NCT00775645|10943715|FG000|STARTED|Overall Study||208
9832899|NCT00775645|10943716|FG001|STARTED|Overall Study||201
9832900|NCT00775645|10943715|FG000|COMPLETED|Overall Study||191
9832901|NCT00775645|10943716|FG001|COMPLETED|Overall Study||181
9832902|NCT00775645|10943715|FG000|NOT COMPLETED|Overall Study||17
9832903|NCT00775645|10943716|FG001|NOT COMPLETED|Overall Study||20
9832904|NCT00775658|10943722|FG000|STARTED|First Intervention||10
9832905|NCT00775658|10943723|FG001|STARTED|First Intervention||11
9832906|NCT00775658|10943722|FG000|COMPLETED|First Intervention||10
9832907|NCT00775658|10943723|FG001|COMPLETED|First Intervention||11
9832908|NCT00775658|10943722|FG000|NOT COMPLETED|First Intervention||0
9832909|NCT00775658|10943723|FG001|NOT COMPLETED|First Intervention||0
9832910|NCT00775658|10943722|FG000|STARTED|Second Intervention||10
9832911|NCT00775658|10943723|FG001|STARTED|Second Intervention||11
9832912|NCT00775658|10943722|FG000|COMPLETED|Second Intervention||10
9832913|NCT00775658|10943723|FG001|COMPLETED|Second Intervention||11
9832914|NCT00775658|10943722|FG000|NOT COMPLETED|Second Intervention||0
9832915|NCT00775658|10943723|FG001|NOT COMPLETED|Second Intervention||0
9832916|NCT00775671|10943731|FG000|STARTED|Overall Study||23
9832917|NCT00775671|10943732|FG001|STARTED|Overall Study||23
9832918|NCT00775671|10943731|FG000|COMPLETED|Overall Study||23
9832919|NCT00775671|10943732|FG001|COMPLETED|Overall Study||23
9832920|NCT00775671|10943731|FG000|NOT COMPLETED|Overall Study||0
9832921|NCT00775671|10943732|FG001|NOT COMPLETED|Overall Study||0
9832922|NCT00775931|10943740|FG000|STARTED|Overall Study||6
9832923|NCT00775931|10943741|FG001|STARTED|Overall Study||1
9832924|NCT00775931|10943740|FG000|COMPLETED|Overall Study||6
9832925|NCT00775931|10943741|FG001|COMPLETED|Overall Study||1
9832926|NCT00775931|10943740|FG000|NOT COMPLETED|Overall Study||0
9832927|NCT00775931|10943741|FG001|NOT COMPLETED|Overall Study||0
9832928|NCT00775944|10943751|FG000|STARTED|Overall Study||648
9832929|NCT00775944|10943752|FG001|STARTED|Overall Study||647
9832930|NCT00775944|10943753|FG002|STARTED|Overall Study||648
9832931|NCT00775944|10943754|FG003|STARTED|Overall Study||648
9832932|NCT00775944|10943751|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633
9832933|NCT00775944|10943752|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638
9832934|NCT00775944|10943753|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632
10242535|NCT02632409|11374318|FG000|NOT COMPLETED|Randomized||8
10242536|NCT02632409|11374319|FG001|NOT COMPLETED|Randomized||2
10242537|NCT02632409|11374318|FG000|STARTED|Treatment Period||348
10242538|NCT02632409|11374319|FG001|STARTED|Treatment Period||351
10242539|NCT02632409|11374318|FG000|COMPLETED|Treatment Period||132
10242540|NCT02632409|11374319|FG001|COMPLETED|Treatment Period||143
10242541|NCT02632409|11374318|FG000|NOT COMPLETED|Treatment Period||216
10242542|NCT02632409|11374319|FG001|NOT COMPLETED|Treatment Period||208
10242543|NCT02612194|11374328|FG000|STARTED|Overall Study||6
9832935|NCT00775944|10943754|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632
9832936|NCT00775944|10943751|FG000|NOT COMPLETED|Overall Study||15
9832937|NCT00775944|10943752|FG001|NOT COMPLETED|Overall Study||9
9832938|NCT00775944|10943753|FG002|NOT COMPLETED|Overall Study||16
9832939|NCT00775944|10943754|FG003|NOT COMPLETED|Overall Study||16
9832940|NCT00775983|10943766|FG000|STARTED|Overall Study||36
10242544|NCT02612194|11374329|FG001|STARTED|Overall Study||0
10242545|NCT02612194|11374330|FG002|STARTED|Overall Study||2
10242546|NCT02612194|11374328|FG000|COMPLETED|Overall Study||0
10242547|NCT02612194|11374329|FG001|COMPLETED|Overall Study||0
10242548|NCT02612194|11374330|FG002|COMPLETED|Overall Study||0
10242549|NCT02612194|11374328|FG000|NOT COMPLETED|Overall Study||6
10242550|NCT02612194|11374329|FG001|NOT COMPLETED|Overall Study||0
10242551|NCT02612194|11374330|FG002|NOT COMPLETED|Overall Study||2
10242552|NCT02586207|11374337|FG000|STARTED|Overall Study||59
10242553|NCT02586207|11374337|FG000|COMPLETED|Overall Study||57
10242554|NCT02586207|11374337|FG000|NOT COMPLETED|Overall Study||2
10242555|NCT02542397|11374341|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
10242556|NCT02542397|11374341|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
10242557|NCT02542397|11374341|FG000|NOT COMPLETED|Overall Study||16
10242558|NCT02519777|11374349|FG000|STARTED|Overall Study||63
10242559|NCT02519777|11374350|FG001|STARTED|Overall Study||67
10242560|NCT02519777|11374351|FG002|STARTED|Overall Study||61
10242561|NCT02519777|11374349|FG000|COMPLETED|Overall Study||57
10242562|NCT02519777|11374350|FG001|COMPLETED|Overall Study||59
10242563|NCT02519777|11374351|FG002|COMPLETED|Overall Study||57
10242564|NCT02519777|11374349|FG000|NOT COMPLETED|Overall Study||6
10242565|NCT02519777|11374350|FG001|NOT COMPLETED|Overall Study||8
10242566|NCT02519777|11374351|FG002|NOT COMPLETED|Overall Study||4
10242567|NCT02484443|11374359|FG000|STARTED|Overall Study||41
10242568|NCT02484443|11374359|FG000|COMPLETED|Overall Study||9
10242569|NCT02484443|11374359|FG000|NOT COMPLETED|Overall Study||32
10242570|NCT02395666|11374365|FG000|STARTED|Overall Study||101
10242571|NCT02395666|11374366|FG001|STARTED|Overall Study||39
10242572|NCT02395666|11374365|FG000|COMPLETED|Overall Study||95
10242573|NCT02395666|11374366|FG001|COMPLETED|Overall Study||38
10242574|NCT02395666|11374365|FG000|NOT COMPLETED|Overall Study||6
10242575|NCT02395666|11374366|FG001|NOT COMPLETED|Overall Study||1
10242576|NCT02357810|11374376|FG000|STARTED|Registered and Started Treatment||178
10242577|NCT02357810|11374376|FG000|Signed Consent|Registered and Started Treatment||178
10242578|NCT02357810|11374376|FG000|Registered to Study|Registered and Started Treatment||152
10242579|NCT02357810|11374376|FG000|Initiated Treatment on Study|Registered and Started Treatment||151
10242580|NCT02357810|11374376|FG000|COMPLETED|Registered and Started Treatment||151
10242581|NCT02357810|11374376|FG000|NOT COMPLETED|Registered and Started Treatment||27
10242582|NCT02357810|11374376|FG000|STARTED|Reached 12 Weeks Response||151
10242583|NCT02357810|11374376|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
10242584|NCT02357810|11374376|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129
10242585|NCT02357810|11374376|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
10242586|NCT02357810|11374376|FG000|COMPLETED|Reached 12 Weeks Response||95
10242587|NCT02357810|11374376|FG000|NOT COMPLETED|Reached 12 Weeks Response||56
10242588|NCT02357810|11374376|FG000|STARTED|12 Week Response and Further Treatment||95
10242589|NCT02357810|11374376|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
10242590|NCT02357810|11374376|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73
10242591|NCT02357810|11374376|FG000|COMPLETED|12 Week Response and Further Treatment||73
10242592|NCT02357810|11374376|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22
10242593|NCT02357810|11374376|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
10242594|NCT02357810|11374376|FG000|COMPLETED|Follow-up at Treatment Discontinuation||144
10242595|NCT02357810|11374376|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||7
10242596|NCT02343549|11374380|FG000|STARTED|Overall Study||13
10242597|NCT02343549|11374380|FG000|COMPLETED|Overall Study||0
10242598|NCT02343549|11374380|FG000|NOT COMPLETED|Overall Study||13
10242599|NCT02339233|11374384|FG000|STARTED|Overall Study||8
10242600|NCT02339233|11374384|FG000|COMPLETED|Overall Study||8
10242601|NCT02339233|11374384|FG000|NOT COMPLETED|Overall Study||0
10242602|NCT02328105|11374388|FG000|STARTED|Overall Study||11
10242603|NCT02328105|11374388|FG000|COMPLETED|Overall Study||0
10242604|NCT02328105|11374388|FG000|NOT COMPLETED|Overall Study||11
10242605|NCT02327195|11374394|FG000|STARTED|Overall Study||27
10242606|NCT02327195|11374395|FG001|STARTED|Overall Study||27
10242607|NCT02327195|11374394|FG000|COMPLETED|Overall Study||27
10242608|NCT02327195|11374395|FG001|COMPLETED|Overall Study||27
10242609|NCT02327195|11374394|FG000|NOT COMPLETED|Overall Study||0
10242610|NCT02327195|11374395|FG001|NOT COMPLETED|Overall Study||0
10242611|NCT02315066|11374415|FG000|STARTED|Overall Study||2
10242612|NCT02315066|11374416|FG001|STARTED|Overall Study||10
10242613|NCT02315066|11374417|FG002|STARTED|Overall Study||11
10242614|NCT02315066|11374418|FG003|STARTED|Overall Study||12
10242615|NCT02315066|11374419|FG004|STARTED|Overall Study||13
10242616|NCT02315066|11374420|FG005|STARTED|Overall Study||4
10242617|NCT02315066|11374421|FG006|STARTED|Overall Study||16
10242618|NCT02315066|11374422|FG007|STARTED|Overall Study||19
10242619|NCT02315066|11374423|FG008|STARTED|Overall Study||11
10242620|NCT02315066|11374424|FG009|STARTED|Overall Study||12
10242621|NCT02315066|11374425|FG010|STARTED|Overall Study||12
10242622|NCT02315066|11374426|FG011|STARTED|Overall Study||11
10242623|NCT02315066|11374427|FG012|STARTED|Overall Study||11
10242624|NCT02315066|11374428|FG013|STARTED|Overall Study||30
10242625|NCT02315066|11374415|FG000|COMPLETED|Overall Study||0
10242626|NCT02315066|11374416|FG001|COMPLETED|Overall Study||0
10242627|NCT02315066|11374417|FG002|COMPLETED|Overall Study||2
10242628|NCT02315066|11374418|FG003|COMPLETED|Overall Study||1
10242629|NCT02315066|11374419|FG004|COMPLETED|Overall Study||2
10242630|NCT02315066|11374420|FG005|COMPLETED|Overall Study||1
10242631|NCT02315066|11374421|FG006|COMPLETED|Overall Study||3
10242632|NCT02315066|11374422|FG007|COMPLETED|Overall Study||5
10242633|NCT02315066|11374423|FG008|COMPLETED|Overall Study||0
10242634|NCT02315066|11374424|FG009|COMPLETED|Overall Study||1
10242635|NCT02315066|11374425|FG010|COMPLETED|Overall Study||0
10242636|NCT02315066|11374426|FG011|COMPLETED|Overall Study||0
10242637|NCT02315066|11374427|FG012|COMPLETED|Overall Study||1
10242638|NCT02315066|11374428|FG013|COMPLETED|Overall Study||0
10242639|NCT02315066|11374415|FG000|NOT COMPLETED|Overall Study||2
10242640|NCT02315066|11374416|FG001|NOT COMPLETED|Overall Study||10
10242641|NCT02315066|11374417|FG002|NOT COMPLETED|Overall Study||9
10242642|NCT02315066|11374418|FG003|NOT COMPLETED|Overall Study||11
10242643|NCT02315066|11374419|FG004|NOT COMPLETED|Overall Study||11
10242644|NCT02315066|11374420|FG005|NOT COMPLETED|Overall Study||3
10242645|NCT02315066|11374421|FG006|NOT COMPLETED|Overall Study||13
10242646|NCT02315066|11374422|FG007|NOT COMPLETED|Overall Study||14
10242647|NCT02315066|11374423|FG008|NOT COMPLETED|Overall Study||11
10242648|NCT02315066|11374424|FG009|NOT COMPLETED|Overall Study||11
10242649|NCT02315066|11374425|FG010|NOT COMPLETED|Overall Study||12
10242650|NCT02315066|11374426|FG011|NOT COMPLETED|Overall Study||11
10242651|NCT02315066|11374427|FG012|NOT COMPLETED|Overall Study||10
10242652|NCT02315066|11374428|FG013|NOT COMPLETED|Overall Study||30
10242653|NCT02265367|11374460|FG000|STARTED|Overall Study||28
10242654|NCT02265367|11374461|FG001|STARTED|Overall Study||28
10242655|NCT02265367|11374460|FG000|Completed First 3-week Period|Overall Study||24
10242656|NCT02265367|11374461|FG001|Completed First 3-week Period|Overall Study||26
10242657|NCT02265367|11374460|FG000|COMPLETED|Overall Study||18
10242658|NCT02265367|11374461|FG001|COMPLETED|Overall Study||22
10242659|NCT02265367|11374460|FG000|NOT COMPLETED|Overall Study||10
10242660|NCT02265367|11374461|FG001|NOT COMPLETED|Overall Study||6
10242661|NCT02256631|11374474|FG000|STARTED|Overall Study||13
10242662|NCT02256631|11374475|FG001|STARTED|Overall Study||14
10242663|NCT02256631|11374476|FG002|STARTED|Overall Study||13
10242664|NCT02256631|11374477|FG003|STARTED|Overall Study||10
10242665|NCT02256631|11374478|FG004|STARTED|Overall Study||11
10242666|NCT02256631|11374479|FG005|STARTED|Overall Study||11
10242667|NCT02256631|11374480|FG006|STARTED|Overall Study||11
10242668|NCT02256631|11374474|FG000|COMPLETED|Overall Study||12
10242669|NCT02256631|11374475|FG001|COMPLETED|Overall Study||11
10242670|NCT02256631|11374476|FG002|COMPLETED|Overall Study||13
10242671|NCT02256631|11374477|FG003|COMPLETED|Overall Study||6
10242672|NCT02256631|11374478|FG004|COMPLETED|Overall Study||10
10242673|NCT02256631|11374479|FG005|COMPLETED|Overall Study||9
10242674|NCT02256631|11374480|FG006|COMPLETED|Overall Study||7
10242675|NCT02256631|11374474|FG000|NOT COMPLETED|Overall Study||1
10242676|NCT02256631|11374475|FG001|NOT COMPLETED|Overall Study||3
10242677|NCT02256631|11374476|FG002|NOT COMPLETED|Overall Study||0
10242678|NCT02256631|11374477|FG003|NOT COMPLETED|Overall Study||4
10242679|NCT02256631|11374478|FG004|NOT COMPLETED|Overall Study||1
10242680|NCT02256631|11374479|FG005|NOT COMPLETED|Overall Study||2
10242681|NCT02256631|11374480|FG006|NOT COMPLETED|Overall Study||4
10242682|NCT02173379|11374498|FG000|STARTED|Overall Study||1296
10242683|NCT02173379|11374499|FG001|STARTED|Overall Study||1308
10242684|NCT02173379|11374498|FG000|COMPLETED|Overall Study||1205
10242685|NCT02173379|11374499|FG001|COMPLETED|Overall Study||1231
10242686|NCT02173379|11374498|FG000|NOT COMPLETED|Overall Study||91
10242687|NCT02173379|11374499|FG001|NOT COMPLETED|Overall Study||77
10242688|NCT02129348|11374508|FG000|STARTED|Overall Study||38
10242689|NCT02129348|11374509|FG001|STARTED|Overall Study||39
10242690|NCT02129348|11374508|FG000|COMPLETED|Overall Study||29
10242691|NCT02129348|11374509|FG001|COMPLETED|Overall Study||29
10242692|NCT02129348|11374508|FG000|NOT COMPLETED|Overall Study||9
10242693|NCT02129348|11374509|FG001|NOT COMPLETED|Overall Study||10
10242694|NCT02080260|11374515|FG000|STARTED|Overall Study||20
10242695|NCT02080260|11374515|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
10242696|NCT02080260|11374515|FG000|NOT COMPLETED|Overall Study||19
10242697|NCT02051933|11374521|FG000|STARTED|Overall Study||5
10242698|NCT02051933|11374522|FG001|STARTED|Overall Study||5
10242699|NCT02051933|11374521|FG000|COMPLETED|Overall Study||5
10242700|NCT02051933|11374522|FG001|COMPLETED|Overall Study||4
10242701|NCT02051933|11374521|FG000|NOT COMPLETED|Overall Study||0
10242702|NCT02051933|11374522|FG001|NOT COMPLETED|Overall Study||1
10242703|NCT02047929|11374536|FG000|STARTED|Overall Study||1503
10242704|NCT02047929|11374537|FG001|STARTED|Overall Study||2523
10242705|NCT02047929|11374538|FG002|STARTED|Overall Study||2248
10242706|NCT02047929|11374536|FG000|Practice Rollout|Overall Study||1503
10242707|NCT02047929|11374537|FG001|Practice Rollout|Overall Study||2523
10242708|NCT02047929|11374538|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
10242709|NCT02047929|11374536|FG000|Practice Refresher|Overall Study||1503
10242710|NCT02047929|11374537|FG001|Practice Refresher|Overall Study||2523
10242711|NCT02047929|11374538|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
10242712|NCT02047929|11374536|FG000|Surveys Collected|Overall Study||1503
10242713|NCT02047929|11374537|FG001|Surveys Collected|Overall Study||2523
10242714|NCT02047929|11374538|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
10242715|NCT02047929|11374536|FG000|COMPLETED|Overall Study||1503
10242716|NCT02047929|11374537|FG001|COMPLETED|Overall Study||2523
10242717|NCT02047929|11374538|FG002|COMPLETED|Overall Study||2248
10019356|NCT01829425|11142531|FG000|STARTED|Overall Study||78
10019357|NCT01829425|11142532|FG001|STARTED|Overall Study||74
10242718|NCT02047929|11374536|FG000|NOT COMPLETED|Overall Study||0
10242719|NCT02047929|11374537|FG001|NOT COMPLETED|Overall Study||0
10242720|NCT02047929|11374538|FG002|NOT COMPLETED|Overall Study||0
10242721|NCT01999569|11374549|FG000|STARTED|Control Cycle|First cycle no meds|10
10242722|NCT01999569|11374549|FG000|COMPLETED|Control Cycle||10
10242723|NCT01999569|11374549|FG000|NOT COMPLETED|Control Cycle||0
10242724|NCT01999569|11374549|FG000|STARTED|Letrozole Treatment Cycle||10
10242725|NCT01999569|11374549|FG000|COMPLETED|Letrozole Treatment Cycle||10
10242726|NCT01999569|11374549|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0
10242727|NCT01969812|11374558|FG000|STARTED|Overall Study||12
10242728|NCT01969812|11374559|FG001|STARTED|Overall Study||10
10242729|NCT01969812|11374558|FG000|COMPLETED|Overall Study||12
10242730|NCT01969812|11374559|FG001|COMPLETED|Overall Study||10
10242731|NCT01969812|11374558|FG000|NOT COMPLETED|Overall Study||0
10242732|NCT01969812|11374559|FG001|NOT COMPLETED|Overall Study||0
9832941|NCT00775983|10943767|FG001|STARTED|Overall Study||36
9832942|NCT00775983|10943766|FG000|COMPLETED|Overall Study||35
9832943|NCT00775983|10943767|FG001|COMPLETED|Overall Study||34
10242733|NCT01959464|11374567|FG000|STARTED|Overall Study||10
10242734|NCT01959464|11374568|FG001|STARTED|Overall Study||10
10242735|NCT01959464|11374567|FG000|COMPLETED|Overall Study||9
10242736|NCT01959464|11374568|FG001|COMPLETED|Overall Study||10
10242737|NCT01959464|11374567|FG000|NOT COMPLETED|Overall Study||1
10242738|NCT01959464|11374568|FG001|NOT COMPLETED|Overall Study||0
10242739|NCT01921166|11374576|FG000|STARTED|Overall Study||8
10242740|NCT01921166|11374577|FG001|STARTED|Overall Study||15
10242741|NCT01921166|11374576|FG000|COMPLETED|Overall Study||8
10242742|NCT01921166|11374577|FG001|COMPLETED|Overall Study||15
10242743|NCT01921166|11374576|FG000|NOT COMPLETED|Overall Study||0
10242744|NCT01921166|11374577|FG001|NOT COMPLETED|Overall Study||0
10242745|NCT01886963|11374585|FG000|STARTED|Overall Study||57
10242746|NCT01886963|11374586|FG001|STARTED|Overall Study||58
10242747|NCT01886963|11374585|FG000|2 Week Follow Up|Overall Study||55
10242748|NCT01886963|11374586|FG001|2 Week Follow Up|Overall Study||55
10242749|NCT01886963|11374585|FG000|4 Week Follow Up|Overall Study||50
10242750|NCT01886963|11374586|FG001|4 Week Follow Up|Overall Study||51
10242751|NCT01886963|11374585|FG000|12 Week Follow Up|Overall Study||46
10242752|NCT01886963|11374586|FG001|12 Week Follow Up|Overall Study||49
10242753|NCT01886963|11374585|FG000|COMPLETED|Overall Study||46
10242754|NCT01886963|11374586|FG001|COMPLETED|Overall Study||49
10242755|NCT01886963|11374585|FG000|NOT COMPLETED|Overall Study||11
10242756|NCT01886963|11374586|FG001|NOT COMPLETED|Overall Study||9
9832944|NCT00775983|10943766|FG000|NOT COMPLETED|Overall Study||1
10019358|NCT01829425|11142531|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
10081096|NCT02257684|11209557|FG000|STARTED|Overall Study||4
10242757|NCT01802281|11374594|FG000|STARTED|Overall Study||93
10242758|NCT01802281|11374595|FG001|STARTED|Overall Study||90
10242759|NCT01802281|11374594|FG000|Eligible and Received Randomized Treatment|Overall Study||88
10242760|NCT01802281|11374595|FG001|Eligible and Received Randomized Treatment|Overall Study||87
10242761|NCT01802281|11374594|FG000|Completed Year 1 Follow-up|Overall Study||88
10242762|NCT01802281|11374595|FG001|Completed Year 1 Follow-up|Overall Study||86
10242763|NCT01802281|11374594|FG000|Completed Year 2 Follow-up|Overall Study||87
10242764|NCT01802281|11374595|FG001|Completed Year 2 Follow-up|Overall Study||84
10242765|NCT01802281|11374594|FG000|COMPLETED|Overall Study||85
10242766|NCT01802281|11374595|FG001|COMPLETED|Overall Study||84
10242767|NCT01802281|11374594|FG000|NOT COMPLETED|Overall Study||8
10242768|NCT01802281|11374595|FG001|NOT COMPLETED|Overall Study||6
10242769|NCT01774253|11374601|FG000|STARTED|Overall Study||9
10242770|NCT01774253|11374601|FG000|COMPLETED|Overall Study||0
10242771|NCT01774253|11374601|FG000|NOT COMPLETED|Overall Study||9
10242772|NCT01666145|11374605|FG000|STARTED|Overall Study||14
10242773|NCT01666145|11374605|FG000|COMPLETED|Overall Study||14
10242774|NCT01666145|11374605|FG000|NOT COMPLETED|Overall Study||0
10242775|NCT01505608|11374611|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
10242776|NCT01505608|11374612|FG001|STARTED|Phase I||8
10242777|NCT01505608|11374611|FG000|COMPLETED|Phase I||0
10242778|NCT01505608|11374612|FG001|COMPLETED|Phase I||2
10242779|NCT01505608|11374611|FG000|NOT COMPLETED|Phase I||0
10242780|NCT01505608|11374612|FG001|NOT COMPLETED|Phase I||6
10242781|NCT01505608|11374611|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
10242782|NCT01505608|11374612|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
10242783|NCT01505608|11374611|FG000|COMPLETED|Phase II||0
10242784|NCT01505608|11374612|FG001|COMPLETED|Phase II||2
10242785|NCT01505608|11374611|FG000|NOT COMPLETED|Phase II||2
10242786|NCT01505608|11374612|FG001|NOT COMPLETED|Phase II||2
10242787|NCT01483820|11374621|FG000|STARTED|Overall Study||8
10242788|NCT01483820|11374621|FG000|COMPLETED|Overall Study||0
10242789|NCT01483820|11374621|FG000|NOT COMPLETED|Overall Study||8
10242790|NCT01355679|11374625|FG000|STARTED|Overall Study||16
10242791|NCT01355679|11374625|FG000|COMPLETED|Overall Study||14
10242792|NCT01355679|11374625|FG000|NOT COMPLETED|Overall Study||2
10242793|NCT01227616|11374632|FG000|STARTED|Overall Study||196
10242794|NCT01227616|11374633|FG001|STARTED|Overall Study||97
10242795|NCT01227616|11374632|FG000|COMPLETED|Overall Study||142
10242796|NCT01227616|11374633|FG001|COMPLETED|Overall Study||74
10242797|NCT01227616|11374632|FG000|NOT COMPLETED|Overall Study||54
10242798|NCT01227616|11374633|FG001|NOT COMPLETED|Overall Study||23
10242799|NCT01192698|11374641|FG000|STARTED|Overall Study||10
10242800|NCT01192698|11374642|FG001|STARTED|Overall Study||5
10242801|NCT01192698|11374641|FG000|COMPLETED|Overall Study||10
10242802|NCT01192698|11374642|FG001|COMPLETED|Overall Study||5
10242803|NCT01192698|11374641|FG000|NOT COMPLETED|Overall Study||0
10242804|NCT01192698|11374642|FG001|NOT COMPLETED|Overall Study||0
10242805|NCT01166386|11374650|FG000|STARTED|Overall Study||82
10242806|NCT01166386|11374651|FG001|STARTED|Overall Study||83
10242807|NCT01166386|11374650|FG000|COMPLETED|Overall Study||79
10242808|NCT01166386|11374651|FG001|COMPLETED|Overall Study||78
10242809|NCT01166386|11374650|FG000|NOT COMPLETED|Overall Study||3
10242810|NCT01166386|11374651|FG001|NOT COMPLETED|Overall Study||5
10242811|NCT01114217|11374659|FG000|STARTED|Overall Study||337
10242812|NCT01114217|11374660|FG001|STARTED|Overall Study||297
10242813|NCT01114217|11374659|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
10242814|NCT01114217|11374660|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
10242815|NCT01114217|11374659|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
10242816|NCT01114217|11374660|FG001|COMPLETED|Overall Study||199
10242817|NCT01114217|11374659|FG000|NOT COMPLETED|Overall Study||75
10242818|NCT01114217|11374660|FG001|NOT COMPLETED|Overall Study||98
10242819|NCT01114204|11374666|FG000|STARTED|Overall Study||406
10242820|NCT01114204|11374667|FG001|STARTED|Overall Study||199
10242821|NCT01114204|11374666|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406
10242822|NCT01114204|11374667|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
10242823|NCT01114204|11374666|FG000|COMPLETED|Overall Study||385
10242824|NCT01114204|11374667|FG001|COMPLETED|Overall Study||191
10242825|NCT01114204|11374666|FG000|NOT COMPLETED|Overall Study||21
10242826|NCT01114204|11374667|FG001|NOT COMPLETED|Overall Study||8
10242827|NCT01114139|11374675|FG000|STARTED|Overall Study||609
10242828|NCT01114139|11374676|FG001|STARTED|Overall Study||203
10242829|NCT01114139|11374675|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608
10242830|NCT01114139|11374676|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200
10242831|NCT01114139|11374675|FG000|COMPLETED|Overall Study||569
10242832|NCT01114139|11374676|FG001|COMPLETED|Overall Study||187
10242833|NCT01114139|11374675|FG000|NOT COMPLETED|Overall Study||40
10242834|NCT01114139|11374676|FG001|NOT COMPLETED|Overall Study||16
10242835|NCT01059071|11374682|FG000|STARTED|Overall Study||4
10242836|NCT01059071|11374683|FG001|STARTED|Overall Study||5
10242837|NCT01059071|11374684|FG002|STARTED|Overall Study||3
10242838|NCT01059071|11374685|FG003|STARTED|Overall Study||9
10242839|NCT01059071|11374682|FG000|COMPLETED|Overall Study||2
10242840|NCT01059071|11374683|FG001|COMPLETED|Overall Study||1
10242841|NCT01059071|11374684|FG002|COMPLETED|Overall Study||1
10242842|NCT01059071|11374685|FG003|COMPLETED|Overall Study||3
10242843|NCT01059071|11374682|FG000|NOT COMPLETED|Overall Study||2
10242844|NCT01059071|11374683|FG001|NOT COMPLETED|Overall Study||4
10242845|NCT01059071|11374684|FG002|NOT COMPLETED|Overall Study||2
10242846|NCT01059071|11374685|FG003|NOT COMPLETED|Overall Study||6
10242847|NCT01027702|11374693|FG000|STARTED|Overall Study||4
10242848|NCT01027702|11374694|FG001|STARTED|Overall Study||4
10242849|NCT01027702|11374695|FG002|STARTED|Overall Study||3
10242850|NCT01027702|11374696|FG003|STARTED|Overall Study||14
10242851|NCT01027702|11374697|FG004|STARTED|Overall Study||10
10242852|NCT01027702|11374698|FG005|STARTED|Overall Study||1
10242853|NCT01027702|11374699|FG006|STARTED|Overall Study||2
10242854|NCT01027702|11374693|FG000|COMPLETED|Overall Study||3
10242855|NCT01027702|11374694|FG001|COMPLETED|Overall Study||2
10242856|NCT01027702|11374695|FG002|COMPLETED|Overall Study||2
10242857|NCT01027702|11374696|FG003|COMPLETED|Overall Study||10
10242858|NCT01027702|11374697|FG004|COMPLETED|Overall Study||9
10242859|NCT01027702|11374698|FG005|COMPLETED|Overall Study||1
10242860|NCT01027702|11374699|FG006|COMPLETED|Overall Study||1
10242861|NCT01027702|11374693|FG000|NOT COMPLETED|Overall Study||1
10242862|NCT01027702|11374694|FG001|NOT COMPLETED|Overall Study||2
10242863|NCT01027702|11374695|FG002|NOT COMPLETED|Overall Study||1
10242864|NCT01027702|11374696|FG003|NOT COMPLETED|Overall Study||4
10242865|NCT01027702|11374697|FG004|NOT COMPLETED|Overall Study||1
10242866|NCT01027702|11374698|FG005|NOT COMPLETED|Overall Study||0
10242867|NCT01027702|11374699|FG006|NOT COMPLETED|Overall Study||1
10242868|NCT00991887|11374712|FG000|STARTED|Overall Study||26
10242869|NCT00991887|11374713|FG001|STARTED|Overall Study||22
10242870|NCT00991887|11374712|FG000|COMPLETED|Overall Study||24
10242871|NCT00991887|11374713|FG001|COMPLETED|Overall Study||21
10242872|NCT00991887|11374712|FG000|NOT COMPLETED|Overall Study||2
10242873|NCT00991887|11374713|FG001|NOT COMPLETED|Overall Study||1
10242874|NCT00968864|11374719|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
10242875|NCT00968864|11374719|FG000|COMPLETED|Overall Study||52
10242876|NCT00968864|11374719|FG000|NOT COMPLETED|Overall Study||1
10242877|NCT00934700|11374730|FG000|STARTED|Overall Study||46
10242878|NCT00934700|11374731|FG001|STARTED|Overall Study||46
10242879|NCT00934700|11374730|FG000|COMPLETED|Overall Study||33
10242880|NCT00934700|11374731|FG001|COMPLETED|Overall Study||34
10242881|NCT00934700|11374730|FG000|NOT COMPLETED|Overall Study||13
10242882|NCT00934700|11374731|FG001|NOT COMPLETED|Overall Study||12
10242883|NCT00867568|11374738|FG000|STARTED|Overall Study||18
10242884|NCT00867568|11374738|FG000|COMPLETED|Overall Study||3
10242885|NCT00867568|11374738|FG000|NOT COMPLETED|Overall Study||15
10242886|NCT00785291|11374745|FG000|STARTED|Overall Study||283
10242887|NCT00785291|11374746|FG001|STARTED|Overall Study||271
10242888|NCT00785291|11374747|FG002|STARTED|Overall Study||245
10242889|NCT00785291|11374745|FG000|COMPLETED|Overall Study||147
10242890|NCT00785291|11374746|FG001|COMPLETED|Overall Study||122
10242891|NCT00785291|11374747|FG002|COMPLETED|Overall Study||139
10242892|NCT00785291|11374745|FG000|NOT COMPLETED|Overall Study||136
10242893|NCT00785291|11374746|FG001|NOT COMPLETED|Overall Study||149
10242894|NCT00785291|11374747|FG002|NOT COMPLETED|Overall Study||106
10242895|NCT00782288|11374758|FG000|STARTED|Overall Study||8
10242896|NCT00782288|11374759|FG001|STARTED|Overall Study||8
10242897|NCT00782288|11374760|FG002|STARTED|Overall Study||8
10242898|NCT00782288|11374758|FG000|COMPLETED|Overall Study||8
10242899|NCT00782288|11374759|FG001|COMPLETED|Overall Study||8
10242900|NCT00782288|11374760|FG002|COMPLETED|Overall Study||8
10242901|NCT00782288|11374758|FG000|NOT COMPLETED|Overall Study||0
10242902|NCT00782288|11374759|FG001|NOT COMPLETED|Overall Study||0
10242903|NCT00782288|11374760|FG002|NOT COMPLETED|Overall Study||0
10242913|NCT00643864|11374783|FG000|STARTED|Pre-test Assessment||3
10242914|NCT00643864|11374783|FG000|COMPLETED|Pre-test Assessment||3
10242915|NCT00643864|11374783|FG000|NOT COMPLETED|Pre-test Assessment||0
10242916|NCT00643864|11374783|FG000|STARTED|Post-test Assessment||3
10242917|NCT00643864|11374783|FG000|COMPLETED|Post-test Assessment||3
10242918|NCT00643864|11374783|FG000|NOT COMPLETED|Post-test Assessment||0
10242919|NCT00628446|11374788|FG000|STARTED|Overall Study||45
10242920|NCT00628446|11374788|FG000|COMPLETED|Overall Study||38
10242921|NCT00628446|11374788|FG000|NOT COMPLETED|Overall Study||7
10242922|NCT00621751|11374795|FG000|STARTED|Overall Study||35
10242923|NCT00621751|11374796|FG001|STARTED|Overall Study||35
10242924|NCT00621751|11374795|FG000|COMPLETED|Overall Study||35
10242925|NCT00621751|11374796|FG001|COMPLETED|Overall Study||34
10242926|NCT00621751|11374795|FG000|NOT COMPLETED|Overall Study||0
10242927|NCT00621751|11374796|FG001|NOT COMPLETED|Overall Study||1
10242928|NCT00605215|11374805|FG000|STARTED|Overall Study||450
10242929|NCT00605215|11374806|FG001|STARTED|Overall Study||434
10242930|NCT00605215|11374807|FG002|STARTED|Overall Study||447
10242931|NCT00605215|11374805|FG000|Received at Least 1 Dose of Study Drug|Overall Study||449
10242932|NCT00605215|11374806|FG001|Received at Least 1 Dose of Study Drug|Overall Study||433
10242933|NCT00605215|11374807|FG002|Received at Least 1 Dose of Study Drug|Overall Study||442
10242934|NCT00605215|11374805|FG000|COMPLETED|Overall Study||359
10242935|NCT00605215|11374806|FG001|COMPLETED|Overall Study||353
10242936|NCT00605215|11374807|FG002|COMPLETED|Overall Study||378
10019359|NCT01829425|11142532|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
10019360|NCT01829425|11142531|FG000|NOT COMPLETED|Overall Study||6
10242937|NCT00605215|11374805|FG000|NOT COMPLETED|Overall Study||91
10242938|NCT00605215|11374806|FG001|NOT COMPLETED|Overall Study||81
10242939|NCT00605215|11374807|FG002|NOT COMPLETED|Overall Study||69
10242940|NCT00605150|11374815|FG000|STARTED|Overall Study|11 started|11
10242941|NCT00605150|11374815|FG000|COMPLETED|Overall Study||10
10242942|NCT00605150|11374815|FG000|NOT COMPLETED|Overall Study||1
10242943|NCT00552513|11374821|FG000|STARTED|Overall Study||1593
10242944|NCT00552513|11374822|FG001|STARTED|Overall Study||1438
10242945|NCT00552513|11374821|FG000|COMPLETED|Overall Study||1588
10242946|NCT00552513|11374822|FG001|COMPLETED|Overall Study||1437
10242947|NCT00552513|11374821|FG000|NOT COMPLETED|Overall Study||5
10242948|NCT00552513|11374822|FG001|NOT COMPLETED|Overall Study||1
10242949|NCT00368836|11374832|FG000|STARTED|Phase II||350
10242950|NCT00368836|11374832|FG000|COMPLETED|Phase II||329
10242951|NCT00368836|11374832|FG000|NOT COMPLETED|Phase II||21
10242952|NCT00368836|11374832|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
10242953|NCT00368836|11374832|FG000|COMPLETED|Phase I Pre-op/Post-op||104
10242954|NCT00368836|11374832|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21
10242955|NCT00290511|11374839|FG000|STARTED|Overall Study||49
10242956|NCT00290511|11374839|FG000|No Treatment Per Protocol|Overall Study||2
10242957|NCT00290511|11374839|FG000|Toxicity Assessment|Overall Study||47
10242958|NCT00290511|11374839|FG000|Response Assessment|Overall Study||45
10242959|NCT00290511|11374839|FG000|COMPLETED|Overall Study||45
10242960|NCT00290511|11374839|FG000|NOT COMPLETED|Overall Study||4
10242961|NCT00265798|11374843|FG000|STARTED|Overall Study||38
10242962|NCT00265798|11374843|FG000|COMPLETED|Overall Study||38
10242963|NCT00265798|11374843|FG000|NOT COMPLETED|Overall Study||0
10242964|NCT00641537|11374852|FG000|STARTED|96-week Period||98
10242965|NCT00641537|11374853|FG001|STARTED|96-week Period||92
10242966|NCT00641537|11374854|FG002|STARTED|96-week Period||186
10019361|NCT01829425|11142532|FG001|NOT COMPLETED|Overall Study||4
10019362|NCT01829464|11142541|FG000|STARTED|Overall Study||30
10019363|NCT01829464|11142542|FG001|STARTED|Overall Study||31
10019364|NCT01829464|11142543|FG002|STARTED|Overall Study||29
10019365|NCT01829464|11142541|FG000|COMPLETED|Overall Study||2
10019366|NCT01829464|11142542|FG001|COMPLETED|Overall Study||2
10242967|NCT00641537|11374855|FG003|STARTED|96-week Period||186
10242968|NCT00641537|11374856|FG004|STARTED|96-week Period||244
10242969|NCT00641537|11374857|FG005|STARTED|96-week Period||22
10242970|NCT00641537|11374858|FG006|STARTED|96-week Period||17
10242971|NCT00641537|11374859|FG007|STARTED|96-week Period||22
10242972|NCT00641537|11374852|FG000|COMPLETED|96-week Period||89
10242973|NCT00641537|11374853|FG001|COMPLETED|96-week Period||82
10242974|NCT00641537|11374854|FG002|COMPLETED|96-week Period||166
10242975|NCT00641537|11374855|FG003|COMPLETED|96-week Period||174
10242976|NCT00641537|11374856|FG004|COMPLETED|96-week Period||227
10242977|NCT00641537|11374857|FG005|COMPLETED|96-week Period||15
10242978|NCT00641537|11374858|FG006|COMPLETED|96-week Period||12
10242979|NCT00641537|11374859|FG007|COMPLETED|96-week Period||16
10242980|NCT00641537|11374852|FG000|NOT COMPLETED|96-week Period||9
10242981|NCT00641537|11374853|FG001|NOT COMPLETED|96-week Period||10
10242982|NCT00641537|11374854|FG002|NOT COMPLETED|96-week Period||20
10242983|NCT00641537|11374855|FG003|NOT COMPLETED|96-week Period||12
10242984|NCT00641537|11374856|FG004|NOT COMPLETED|96-week Period||17
10242985|NCT00641537|11374857|FG005|NOT COMPLETED|96-week Period||7
10242986|NCT00641537|11374858|FG006|NOT COMPLETED|96-week Period||5
10242987|NCT00641537|11374859|FG007|NOT COMPLETED|96-week Period||6
10242988|NCT00641537|11374852|FG000|STARTED|24-Week Supplemental Follow-up Period||75
10242989|NCT00641537|11374853|FG001|STARTED|24-Week Supplemental Follow-up Period||69
10242990|NCT00641537|11374854|FG002|STARTED|24-Week Supplemental Follow-up Period||143
10242991|NCT00641537|11374855|FG003|STARTED|24-Week Supplemental Follow-up Period||151
10242992|NCT00641537|11374856|FG004|STARTED|24-Week Supplemental Follow-up Period||198
10242993|NCT00641537|11374857|FG005|STARTED|24-Week Supplemental Follow-up Period||15
10242994|NCT00641537|11374858|FG006|STARTED|24-Week Supplemental Follow-up Period||9
10242995|NCT00641537|11374859|FG007|STARTED|24-Week Supplemental Follow-up Period||11
10242996|NCT00641537|11374852|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75
10019367|NCT01829464|11142543|FG002|COMPLETED|Overall Study||3
10242997|NCT00641537|11374853|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66
10242998|NCT00641537|11374854|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140
10242999|NCT00641537|11374855|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147
10243000|NCT00641537|11374856|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193
10243001|NCT00641537|11374857|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14
10243002|NCT00641537|11374858|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8
10243003|NCT00641537|11374859|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10
10243004|NCT00641537|11374852|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
10243005|NCT00641537|11374853|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
10243006|NCT00641537|11374854|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
10243007|NCT00641537|11374855|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
10243008|NCT00641537|11374856|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
10243009|NCT00641537|11374857|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10243010|NCT00641537|11374858|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10243011|NCT00641537|11374859|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10243012|NCT00655824|11374877|FG000|STARTED|Overall Study||92
10243013|NCT00655824|11374877|FG000|COMPLETED|Overall Study||8
10243014|NCT00655824|11374877|FG000|NOT COMPLETED|Overall Study||84
10243015|NCT00663052|11374883|FG000|STARTED|Overall Study||136
10243016|NCT00663052|11374884|FG001|STARTED|Overall Study||137
10243017|NCT00663052|11374883|FG000|COMPLETED|Overall Study||124
10243018|NCT00663052|11374884|FG001|COMPLETED|Overall Study||127
10243019|NCT00663052|11374883|FG000|NOT COMPLETED|Overall Study||12
10243020|NCT00663052|11374884|FG001|NOT COMPLETED|Overall Study||10
10243021|NCT00686374|11374890|FG000|STARTED|Overall Study||100
10243022|NCT00686374|11374890|FG000|COMPLETED|Overall Study||39
10243023|NCT00686374|11374890|FG000|NOT COMPLETED|Overall Study||61
10243024|NCT00698828|11374897|FG000|STARTED|Overall Study||76
10243025|NCT00698828|11374898|FG001|STARTED|Overall Study||75
10243026|NCT00698828|11374899|FG002|STARTED|Overall Study||76
10243027|NCT00698828|11374897|FG000|COMPLETED|Overall Study||67
10019368|NCT01829464|11142541|FG000|NOT COMPLETED|Overall Study||28
10019369|NCT01829464|11142542|FG001|NOT COMPLETED|Overall Study||29
10019370|NCT01829464|11142543|FG002|NOT COMPLETED|Overall Study||26
10243028|NCT00698828|11374898|FG001|COMPLETED|Overall Study||60
10243029|NCT00698828|11374899|FG002|COMPLETED|Overall Study||65
10243030|NCT00698828|11374897|FG000|NOT COMPLETED|Overall Study||9
10243031|NCT00698828|11374898|FG001|NOT COMPLETED|Overall Study||15
10243032|NCT00698828|11374899|FG002|NOT COMPLETED|Overall Study||11
10243033|NCT00712933|11374907|FG000|STARTED|Overall Study||735
10243034|NCT00712933|11374907|FG000|COMPLETED|Overall Study||368
10243035|NCT00712933|11374907|FG000|NOT COMPLETED|Overall Study||367
10243045|NCT00725985|11374931|FG000|STARTED|ITP- Treatment Disposition||205
10243046|NCT00725985|11374932|FG001|STARTED|ITP- Treatment Disposition||206
10243047|NCT00725985|11374933|FG002|STARTED|ITP- Treatment Disposition||206
10243048|NCT00725985|11374934|FG003|STARTED|ITP- Treatment Disposition||0
10243036|NCT00715273|11374918|FG000|STARTED|Overall Study||71
10243037|NCT00715273|11374919|FG001|STARTED|Overall Study||73
10243038|NCT00715273|11374920|FG002|STARTED|Overall Study||73
10243039|NCT00715273|11374918|FG000|COMPLETED|Overall Study||63
10243040|NCT00715273|11374919|FG001|COMPLETED|Overall Study||65
10243041|NCT00715273|11374920|FG002|COMPLETED|Overall Study||68
10243042|NCT00715273|11374918|FG000|NOT COMPLETED|Overall Study||8
10243043|NCT00715273|11374919|FG001|NOT COMPLETED|Overall Study||8
10243044|NCT00715273|11374920|FG002|NOT COMPLETED|Overall Study||5
10243049|NCT00725985|11374935|FG004|STARTED|ITP- Treatment Disposition||0
10019371|NCT01829503|11142551|FG000|STARTED|Overall Study||44
10019372|NCT01829503|11142551|FG000|COMPLETED|Overall Study||44
10019373|NCT01829503|11142551|FG000|NOT COMPLETED|Overall Study||0
10019374|NCT01829516|11142557|FG000|STARTED|First Intervention||18
10019375|NCT01829516|11142558|FG001|STARTED|First Intervention||14
10019376|NCT01829516|11142557|FG000|COMPLETED|First Intervention||18
10019377|NCT01829516|11142558|FG001|COMPLETED|First Intervention||14
10019378|NCT01829516|11142557|FG000|NOT COMPLETED|First Intervention||0
10019379|NCT01829516|11142558|FG001|NOT COMPLETED|First Intervention||0
10019380|NCT01829516|11142557|FG000|STARTED|Washout Period - 1 Week||18
10019381|NCT01829516|11142558|FG001|STARTED|Washout Period - 1 Week||14
10019382|NCT01829516|11142557|FG000|COMPLETED|Washout Period - 1 Week||18
10019383|NCT01829516|11142558|FG001|COMPLETED|Washout Period - 1 Week||14
10019384|NCT01829516|11142557|FG000|NOT COMPLETED|Washout Period - 1 Week||0
10019385|NCT01829516|11142558|FG001|NOT COMPLETED|Washout Period - 1 Week||0
10019386|NCT01829516|11142557|FG000|STARTED|2nd Intervention||18
10019387|NCT01829516|11142558|FG001|STARTED|2nd Intervention||14
10019388|NCT01829516|11142557|FG000|COMPLETED|2nd Intervention||18
10019389|NCT01829516|11142558|FG001|COMPLETED|2nd Intervention||14
9957171|NCT01449630|11076398|FG001|NOT COMPLETED|Period 1||0
9957172|NCT01449630|11076399|FG002|NOT COMPLETED|Period 1||0
9957173|NCT01449630|11076400|FG003|NOT COMPLETED|Period 1||1
9957174|NCT01449630|11076401|FG004|NOT COMPLETED|Period 1||0
9957175|NCT01449630|11076402|FG005|NOT COMPLETED|Period 1||1
9957176|NCT01449630|11076403|FG006|NOT COMPLETED|Period 1||0
9957177|NCT01449630|11076404|FG007|NOT COMPLETED|Period 1||0
9957178|NCT01449630|11076405|FG008|NOT COMPLETED|Period 1||0
9957179|NCT01449630|11076397|FG000|STARTED|Period 2||1
9957180|NCT01449630|11076398|FG001|STARTED|Period 2||6
9957181|NCT01449630|11076399|FG002|STARTED|Period 2||2
9957182|NCT01449630|11076400|FG003|STARTED|Period 2||1
9957183|NCT01449630|11076401|FG004|STARTED|Period 2||5
9957184|NCT01449630|11076402|FG005|STARTED|Period 2||1
9957185|NCT01449630|11076403|FG006|STARTED|Period 2||2
9957186|NCT01449630|11076404|FG007|STARTED|Period 2||6
10019390|NCT01829516|11142557|FG000|NOT COMPLETED|2nd Intervention||0
10019391|NCT01829516|11142558|FG001|NOT COMPLETED|2nd Intervention||0
10019392|NCT01829919|11142566|FG000|STARTED|Overall Study||24
10019393|NCT01829919|11142566|FG000|COMPLETED|Overall Study||24
10243050|NCT00725985|11374936|FG005|STARTED|ITP- Treatment Disposition||0
10243051|NCT00725985|11374937|FG006|STARTED|ITP- Treatment Disposition||0
10243052|NCT00725985|11374938|FG007|STARTED|ITP- Treatment Disposition||0
10243053|NCT00725985|11374939|FG008|STARTED|ITP- Treatment Disposition||0
10243054|NCT00725985|11374940|FG009|STARTED|ITP- Treatment Disposition||0
10243055|NCT00725985|11374941|FG010|STARTED|ITP- Treatment Disposition||0
10243056|NCT00725985|11374942|FG011|STARTED|ITP- Treatment Disposition||0
10243057|NCT00725985|11374931|FG000|Treated|ITP- Treatment Disposition||204
10243058|NCT00725985|11374932|FG001|Treated|ITP- Treatment Disposition||206
10243059|NCT00725985|11374933|FG002|Treated|ITP- Treatment Disposition||206
10243060|NCT00725985|11374934|FG003|Treated|ITP- Treatment Disposition||0
9832945|NCT00775983|10943767|FG001|NOT COMPLETED|Overall Study||2
9832946|NCT00776009|10943779|FG000|STARTED|Period 1: First Intervention||26
9832947|NCT00776009|10943780|FG001|STARTED|Period 1: First Intervention||28
9832948|NCT00776009|10943781|FG002|STARTED|Period 1: First Intervention||29
9832949|NCT00776009|10943782|FG003|STARTED|Period 1: First Intervention||27
10243061|NCT00725985|11374935|FG004|Treated|ITP- Treatment Disposition||0
10243062|NCT00725985|11374936|FG005|Treated|ITP- Treatment Disposition||0
10243063|NCT00725985|11374937|FG006|Treated|ITP- Treatment Disposition||0
10243064|NCT00725985|11374938|FG007|Treated|ITP- Treatment Disposition||0
10243065|NCT00725985|11374939|FG008|Treated|ITP- Treatment Disposition||0
10243066|NCT00725985|11374940|FG009|Treated|ITP- Treatment Disposition||0
10243067|NCT00725985|11374941|FG010|Treated|ITP- Treatment Disposition||0
10243068|NCT00725985|11374942|FG011|Treated|ITP- Treatment Disposition||0
10243069|NCT00725985|11374931|FG000|COMPLETED|ITP- Treatment Disposition||104
10243070|NCT00725985|11374932|FG001|COMPLETED|ITP- Treatment Disposition||131
10243071|NCT00725985|11374933|FG002|COMPLETED|ITP- Treatment Disposition||104
10243072|NCT00725985|11374934|FG003|COMPLETED|ITP- Treatment Disposition||0
10243073|NCT00725985|11374935|FG004|COMPLETED|ITP- Treatment Disposition||0
10243074|NCT00725985|11374936|FG005|COMPLETED|ITP- Treatment Disposition||0
10243075|NCT00725985|11374937|FG006|COMPLETED|ITP- Treatment Disposition||0
10243076|NCT00725985|11374938|FG007|COMPLETED|ITP- Treatment Disposition||0
10243077|NCT00725985|11374939|FG008|COMPLETED|ITP- Treatment Disposition||0
10243078|NCT00725985|11374940|FG009|COMPLETED|ITP- Treatment Disposition||0
10243079|NCT00725985|11374941|FG010|COMPLETED|ITP- Treatment Disposition||0
10243080|NCT00725985|11374942|FG011|COMPLETED|ITP- Treatment Disposition||0
10243081|NCT00725985|11374931|FG000|NOT COMPLETED|ITP- Treatment Disposition||101
10243082|NCT00725985|11374932|FG001|NOT COMPLETED|ITP- Treatment Disposition||75
10243083|NCT00725985|11374933|FG002|NOT COMPLETED|ITP- Treatment Disposition||102
10243084|NCT00725985|11374934|FG003|NOT COMPLETED|ITP- Treatment Disposition||0
10243085|NCT00725985|11374935|FG004|NOT COMPLETED|ITP- Treatment Disposition||0
10243086|NCT00725985|11374936|FG005|NOT COMPLETED|ITP- Treatment Disposition||0
10243087|NCT00725985|11374937|FG006|NOT COMPLETED|ITP- Treatment Disposition||0
10243088|NCT00725985|11374938|FG007|NOT COMPLETED|ITP- Treatment Disposition||0
10243089|NCT00725985|11374939|FG008|NOT COMPLETED|ITP- Treatment Disposition||0
10243090|NCT00725985|11374940|FG009|NOT COMPLETED|ITP- Treatment Disposition||0
10243091|NCT00725985|11374941|FG010|NOT COMPLETED|ITP- Treatment Disposition||0
10243092|NCT00725985|11374942|FG011|NOT COMPLETED|ITP- Treatment Disposition||0
10243093|NCT00725985|11374931|FG000|STARTED|OLMP (Up to 96 Weeks)||0
10243094|NCT00725985|11374932|FG001|STARTED|OLMP (Up to 96 Weeks)||0
10243095|NCT00725985|11374933|FG002|STARTED|OLMP (Up to 96 Weeks)||0
10243096|NCT00725985|11374934|FG003|STARTED|OLMP (Up to 96 Weeks)||24
10243097|NCT00725985|11374935|FG004|STARTED|OLMP (Up to 96 Weeks)||25
10243098|NCT00725985|11374936|FG005|STARTED|OLMP (Up to 96 Weeks)||60
10243099|NCT00725985|11374937|FG006|STARTED|OLMP (Up to 96 Weeks)||0
10243100|NCT00725985|11374938|FG007|STARTED|OLMP (Up to 96 Weeks)||0
10243101|NCT00725985|11374939|FG008|STARTED|OLMP (Up to 96 Weeks)||0
10243102|NCT00725985|11374940|FG009|STARTED|OLMP (Up to 96 Weeks)||0
10243103|NCT00725985|11374941|FG010|STARTED|OLMP (Up to 96 Weeks)||0
10243104|NCT00725985|11374942|FG011|STARTED|OLMP (Up to 96 Weeks)||0
10243105|NCT00725985|11374931|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0
10243106|NCT00725985|11374932|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0
10243107|NCT00725985|11374933|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0
10243108|NCT00725985|11374934|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6
10243109|NCT00725985|11374935|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2
10243110|NCT00725985|11374936|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7
10243111|NCT00725985|11374937|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0
10243112|NCT00725985|11374938|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0
10243113|NCT00725985|11374939|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0
10243114|NCT00725985|11374940|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0
10243115|NCT00725985|11374941|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0
10243116|NCT00725985|11374942|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0
10243117|NCT00725985|11374931|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243118|NCT00725985|11374932|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243119|NCT00725985|11374933|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243120|NCT00725985|11374934|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
10243121|NCT00725985|11374935|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
10243122|NCT00725985|11374936|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
10243123|NCT00725985|11374937|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243124|NCT00725985|11374938|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243125|NCT00725985|11374939|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243126|NCT00725985|11374940|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243127|NCT00725985|11374941|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243128|NCT00725985|11374942|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10243129|NCT00725985|11374931|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243130|NCT00725985|11374932|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243131|NCT00725985|11374933|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243132|NCT00725985|11374934|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243133|NCT00725985|11374935|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243134|NCT00725985|11374936|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243135|NCT00725985|11374937|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
10243136|NCT00725985|11374938|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
10243137|NCT00725985|11374939|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
10243138|NCT00725985|11374940|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243139|NCT00725985|11374941|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243140|NCT00725985|11374942|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243141|NCT00725985|11374931|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243142|NCT00725985|11374932|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243143|NCT00725985|11374933|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243144|NCT00725985|11374934|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243145|NCT00725985|11374935|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243146|NCT00725985|11374936|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243147|NCT00725985|11374937|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243148|NCT00725985|11374938|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243149|NCT00725985|11374939|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243150|NCT00725985|11374940|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9832950|NCT00776009|10943783|FG004|STARTED|Period 1: First Intervention||28
9832951|NCT00776009|10943784|FG005|STARTED|Period 1: First Intervention||27
9832952|NCT00776009|10943779|FG000|COMPLETED|Period 1: First Intervention||26
9832953|NCT00776009|10943780|FG001|COMPLETED|Period 1: First Intervention||27
9832954|NCT00776009|10943781|FG002|COMPLETED|Period 1: First Intervention||28
9832955|NCT00776009|10943782|FG003|COMPLETED|Period 1: First Intervention||27
9832956|NCT00776009|10943783|FG004|COMPLETED|Period 1: First Intervention||26
9832957|NCT00776009|10943784|FG005|COMPLETED|Period 1: First Intervention||27
9832958|NCT00776009|10943779|FG000|NOT COMPLETED|Period 1: First Intervention||0
9832959|NCT00776009|10943780|FG001|NOT COMPLETED|Period 1: First Intervention||1
9832960|NCT00776009|10943781|FG002|NOT COMPLETED|Period 1: First Intervention||1
9832961|NCT00776009|10943782|FG003|NOT COMPLETED|Period 1: First Intervention||0
9832962|NCT00776009|10943783|FG004|NOT COMPLETED|Period 1: First Intervention||2
9832963|NCT00776009|10943784|FG005|NOT COMPLETED|Period 1: First Intervention||0
9832964|NCT00776009|10943779|FG000|STARTED|Period 2: Second Intervention||26
9832965|NCT00776009|10943780|FG001|STARTED|Period 2: Second Intervention||27
9832966|NCT00776009|10943781|FG002|STARTED|Period 2: Second Intervention||28
9832967|NCT00776009|10943782|FG003|STARTED|Period 2: Second Intervention||27
9832968|NCT00776009|10943783|FG004|STARTED|Period 2: Second Intervention||26
9832969|NCT00776009|10943784|FG005|STARTED|Period 2: Second Intervention||27
9832970|NCT00776009|10943779|FG000|COMPLETED|Period 2: Second Intervention||25
9832971|NCT00776009|10943780|FG001|COMPLETED|Period 2: Second Intervention||27
9832972|NCT00776009|10943781|FG002|COMPLETED|Period 2: Second Intervention||27
9832973|NCT00776009|10943782|FG003|COMPLETED|Period 2: Second Intervention||27
9832974|NCT00776009|10943783|FG004|COMPLETED|Period 2: Second Intervention||26
9832975|NCT00776009|10943784|FG005|COMPLETED|Period 2: Second Intervention||26
9832976|NCT00776009|10943779|FG000|NOT COMPLETED|Period 2: Second Intervention||1
9957187|NCT01449630|11076405|FG008|STARTED|Period 2||2
9957188|NCT01449630|11076397|FG000|COMPLETED|Period 2||1
9957189|NCT01449630|11076398|FG001|COMPLETED|Period 2||6
9957190|NCT01449630|11076399|FG002|COMPLETED|Period 2||2
9957191|NCT01449630|11076400|FG003|COMPLETED|Period 2||1
9957192|NCT01449630|11076401|FG004|COMPLETED|Period 2||5
9957193|NCT01449630|11076402|FG005|COMPLETED|Period 2||1
9957194|NCT01449630|11076403|FG006|COMPLETED|Period 2||1
9957195|NCT01449630|11076404|FG007|COMPLETED|Period 2||6
9957196|NCT01449630|11076405|FG008|COMPLETED|Period 2||2
9957197|NCT01449630|11076397|FG000|NOT COMPLETED|Period 2||0
9957198|NCT01449630|11076398|FG001|NOT COMPLETED|Period 2||0
9957199|NCT01449630|11076399|FG002|NOT COMPLETED|Period 2||0
9957200|NCT01449630|11076400|FG003|NOT COMPLETED|Period 2||0
9957201|NCT01449630|11076401|FG004|NOT COMPLETED|Period 2||0
9957202|NCT01449630|11076402|FG005|NOT COMPLETED|Period 2||0
9957203|NCT01449630|11076403|FG006|NOT COMPLETED|Period 2||1
9957204|NCT01449630|11076404|FG007|NOT COMPLETED|Period 2||0
9957205|NCT01449630|11076405|FG008|NOT COMPLETED|Period 2||0
9957206|NCT01449630|11076397|FG000|STARTED|Period 3||1
9957207|NCT01449630|11076398|FG001|STARTED|Period 3||6
9957208|NCT01449630|11076399|FG002|STARTED|Period 3||2
10243151|NCT00725985|11374941|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9832977|NCT00776009|10943780|FG001|NOT COMPLETED|Period 2: Second Intervention||0
9832978|NCT00776009|10943781|FG002|NOT COMPLETED|Period 2: Second Intervention||1
9832979|NCT00776009|10943782|FG003|NOT COMPLETED|Period 2: Second Intervention||0
9832980|NCT00776009|10943783|FG004|NOT COMPLETED|Period 2: Second Intervention||0
9957209|NCT01449630|11076400|FG003|STARTED|Period 3||1
9957210|NCT01449630|11076401|FG004|STARTED|Period 3||5
9957211|NCT01449630|11076402|FG005|STARTED|Period 3||1
9957212|NCT01449630|11076403|FG006|STARTED|Period 3||1
9957213|NCT01449630|11076404|FG007|STARTED|Period 3||6
9957214|NCT01449630|11076405|FG008|STARTED|Period 3||2
9957215|NCT01449630|11076397|FG000|COMPLETED|Period 3||1
10243152|NCT00725985|11374942|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243153|NCT00725985|11374931|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243154|NCT00725985|11374932|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243155|NCT00725985|11374933|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243156|NCT00725985|11374934|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243157|NCT00725985|11374935|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243158|NCT00725985|11374936|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243159|NCT00725985|11374937|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
10243160|NCT00725985|11374938|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
10243161|NCT00725985|11374939|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
10243162|NCT00725985|11374940|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243163|NCT00725985|11374941|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243164|NCT00725985|11374942|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10243165|NCT00725985|11374931|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243166|NCT00725985|11374932|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243167|NCT00725985|11374933|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243168|NCT00725985|11374934|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243169|NCT00725985|11374935|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243170|NCT00725985|11374936|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243171|NCT00725985|11374937|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243172|NCT00725985|11374938|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243173|NCT00725985|11374939|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10243174|NCT00725985|11374940|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34
10243175|NCT00725985|11374941|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36
10243176|NCT00725985|11374942|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14
10243177|NCT00725985|11374931|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243178|NCT00725985|11374932|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243179|NCT00725985|11374933|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243180|NCT00725985|11374934|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243181|NCT00725985|11374935|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243182|NCT00725985|11374936|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243183|NCT00725985|11374937|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243184|NCT00725985|11374938|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243185|NCT00725985|11374939|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243186|NCT00725985|11374940|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243187|NCT00725985|11374941|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243188|NCT00725985|11374942|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243189|NCT00725985|11374931|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243190|NCT00725985|11374932|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243191|NCT00725985|11374933|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243192|NCT00725985|11374934|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243193|NCT00725985|11374935|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243194|NCT00725985|11374936|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243195|NCT00725985|11374937|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243196|NCT00725985|11374938|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243197|NCT00725985|11374939|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10243198|NCT00725985|11374940|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
10243199|NCT00725985|11374941|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
10243200|NCT00725985|11374942|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
10243201|NCT04860258|11374975|FG000|STARTED|Overall Study||1
10243202|NCT04860258|11374976|FG001|STARTED|Overall Study||1
10243203|NCT04860258|11374977|FG002|STARTED|Overall Study||52
10243204|NCT04860258|11374978|FG003|STARTED|Overall Study||33
10243205|NCT04860258|11374979|FG004|STARTED|Overall Study||33
10243206|NCT04860258|11374980|FG005|STARTED|Overall Study||7
10243207|NCT04860258|11374981|FG006|STARTED|Overall Study||2
10243208|NCT04860258|11374975|FG000|COMPLETED|Overall Study||1
10243209|NCT04860258|11374976|FG001|COMPLETED|Overall Study||1
10243210|NCT04860258|11374977|FG002|COMPLETED|Overall Study||48
10243211|NCT04860258|11374978|FG003|COMPLETED|Overall Study||32
10243212|NCT04860258|11374979|FG004|COMPLETED|Overall Study||29
10243213|NCT04860258|11374980|FG005|COMPLETED|Overall Study||6
10243214|NCT04860258|11374981|FG006|COMPLETED|Overall Study||2
10243215|NCT04860258|11374975|FG000|NOT COMPLETED|Overall Study||0
10243216|NCT04860258|11374976|FG001|NOT COMPLETED|Overall Study||0
10243217|NCT04860258|11374977|FG002|NOT COMPLETED|Overall Study||4
10243218|NCT04860258|11374978|FG003|NOT COMPLETED|Overall Study||1
10243219|NCT04860258|11374979|FG004|NOT COMPLETED|Overall Study||4
10243220|NCT04860258|11374980|FG005|NOT COMPLETED|Overall Study||1
10243221|NCT04860258|11374981|FG006|NOT COMPLETED|Overall Study||0
10243222|NCT04428645|11374997|FG000|STARTED|Run in Visit Training (2 Hours)||25
10243223|NCT04428645|11374997|FG000|COMPLETED|Run in Visit Training (2 Hours)||25
10243224|NCT04428645|11374997|FG000|NOT COMPLETED|Run in Visit Training (2 Hours)||0
10243225|NCT04428645|11374997|FG000|STARTED|First at Home Period (~2 Weeks)||25
10243226|NCT04428645|11374997|FG000|COMPLETED|First at Home Period (~2 Weeks)||25
10243227|NCT04428645|11374997|FG000|NOT COMPLETED|First at Home Period (~2 Weeks)||0
10243228|NCT04428645|11374997|FG000|STARTED|DailyDose Training Visit (2 Hours)||25
10243229|NCT04428645|11374997|FG000|COMPLETED|DailyDose Training Visit (2 Hours)||25
10243230|NCT04428645|11374997|FG000|NOT COMPLETED|DailyDose Training Visit (2 Hours)||0
10243231|NCT04428645|11374997|FG000|STARTED|Second at Home Period (8 Weeks)||25
10243232|NCT04428645|11374997|FG000|COMPLETED|Second at Home Period (8 Weeks)||24
10243233|NCT04428645|11374997|FG000|NOT COMPLETED|Second at Home Period (8 Weeks)||1
10243234|NCT04428645|11374997|FG000|STARTED|Study Close-out Visit (30 Minutes)||24
10243235|NCT04428645|11374997|FG000|COMPLETED|Study Close-out Visit (30 Minutes)||24
9957216|NCT01449630|11076398|FG001|COMPLETED|Period 3||6
9957217|NCT01449630|11076399|FG002|COMPLETED|Period 3||2
9957218|NCT01449630|11076400|FG003|COMPLETED|Period 3||1
9957219|NCT01449630|11076401|FG004|COMPLETED|Period 3||5
9957220|NCT01449630|11076402|FG005|COMPLETED|Period 3||1
9957221|NCT01449630|11076403|FG006|COMPLETED|Period 3||1
9957222|NCT01449630|11076404|FG007|COMPLETED|Period 3||6
9957223|NCT01449630|11076405|FG008|COMPLETED|Period 3||2
9957224|NCT01449630|11076397|FG000|NOT COMPLETED|Period 3||0
9957225|NCT01449630|11076398|FG001|NOT COMPLETED|Period 3||0
9957226|NCT01449630|11076399|FG002|NOT COMPLETED|Period 3||0
9957227|NCT01449630|11076400|FG003|NOT COMPLETED|Period 3||0
9957228|NCT01449630|11076401|FG004|NOT COMPLETED|Period 3||0
9957229|NCT01449630|11076402|FG005|NOT COMPLETED|Period 3||0
9957230|NCT01449630|11076403|FG006|NOT COMPLETED|Period 3||0
9957231|NCT01449630|11076404|FG007|NOT COMPLETED|Period 3||0
9957232|NCT01449630|11076405|FG008|NOT COMPLETED|Period 3||0
9957233|NCT01449682|11076429|FG000|STARTED|Overall Study||5
9957234|NCT01449682|11076430|FG001|STARTED|Overall Study||5
9957235|NCT01449682|11076429|FG000|COMPLETED|Overall Study||4
9957236|NCT01449682|11076430|FG001|COMPLETED|Overall Study||4
9957237|NCT01449682|11076429|FG000|NOT COMPLETED|Overall Study||1
9957238|NCT01449682|11076430|FG001|NOT COMPLETED|Overall Study||1
9957239|NCT01449708|11076438|FG000|STARTED|Overall Study||61
9957240|NCT01449708|11076439|FG001|STARTED|Overall Study||63
9957241|NCT01449708|11076438|FG000|COMPLETED|Overall Study||59
9957242|NCT01449708|11076439|FG001|COMPLETED|Overall Study||60
9957243|NCT01449708|11076438|FG000|NOT COMPLETED|Overall Study||2
10243236|NCT04428645|11374997|FG000|NOT COMPLETED|Study Close-out Visit (30 Minutes)||0
10243237|NCT04318210|11375001|FG000|STARTED|Overall Study||229
10243238|NCT04318210|11375001|FG000|COMPLETED|Overall Study||153
10243239|NCT04318210|11375001|FG000|NOT COMPLETED|Overall Study||76
10243240|NCT04237207|11375007|FG000|STARTED|Overall Study|Due to differences in speed of enrollment between the two cohorts and the delay in enrollment due to the Coronavirus (COVID-19) pandemic, enrollment for the electric only cohort was capped at 10 subjects, which exceeds the minimum sample size of 8 subjects per cohort.|10
10243241|NCT04237207|11375008|FG001|STARTED|Overall Study||12
10243242|NCT04237207|11375007|FG000|COMPLETED|Overall Study||10
10243243|NCT04237207|11375008|FG001|COMPLETED|Overall Study||12
10243244|NCT04237207|11375007|FG000|NOT COMPLETED|Overall Study||0
10243245|NCT04237207|11375008|FG001|NOT COMPLETED|Overall Study||0
10243246|NCT03787303|11375014|FG000|STARTED|Overall Study||7
10243247|NCT03787303|11375014|FG000|COMPLETED|Overall Study||5
10243248|NCT03787303|11375014|FG000|NOT COMPLETED|Overall Study||2
10243249|NCT03702283|11375018|FG000|STARTED|Overall Study|Recruitment and observation began on March 31, 2019|205
10243250|NCT03702283|11375018|FG000|COMPLETED|Overall Study|Recruitment and observation ended on March 31, 2021|205
9957244|NCT01449708|11076439|FG001|NOT COMPLETED|Overall Study||3
9957245|NCT01449721|11076450|FG000|STARTED|Overall Study||112
9957246|NCT01449721|11076451|FG001|STARTED|Overall Study||30
9957247|NCT01449721|11076450|FG000|COMPLETED|Overall Study||112
9957248|NCT01449721|11076451|FG001|COMPLETED|Overall Study||28
9957249|NCT01449721|11076450|FG000|NOT COMPLETED|Overall Study||0
9957250|NCT01449721|11076451|FG001|NOT COMPLETED|Overall Study||2
9957251|NCT01449734|11076457|FG000|STARTED|Overall Study||215
10243251|NCT03702283|11375018|FG000|NOT COMPLETED|Overall Study||0
10243252|NCT03673098|11375024|FG000|STARTED|Overall Study||23
10243253|NCT03673098|11375025|FG001|STARTED|Overall Study||21
10243254|NCT03673098|11375024|FG000|COMPLETED|Overall Study||13
10243255|NCT03673098|11375025|FG001|COMPLETED|Overall Study||17
10243256|NCT03673098|11375024|FG000|NOT COMPLETED|Overall Study||10
10243257|NCT03673098|11375025|FG001|NOT COMPLETED|Overall Study||4
10243258|NCT03525678|11375041|FG000|STARTED|Overall Study||97
10243259|NCT03525678|11375042|FG001|STARTED|Overall Study||99
10243260|NCT03525678|11375043|FG002|STARTED|Overall Study||25
10243261|NCT03525678|11375041|FG000|Received Study Treatment|Overall Study||95
10243262|NCT03525678|11375042|FG001|Received Study Treatment|Overall Study||99
10243263|NCT03525678|11375043|FG002|Received Study Treatment|Overall Study||24
10243264|NCT03525678|11375041|FG000|COMPLETED|Overall Study||0
10243265|NCT03525678|11375042|FG001|COMPLETED|Overall Study||0
10243266|NCT03525678|11375043|FG002|COMPLETED|Overall Study||0
10243267|NCT03525678|11375041|FG000|NOT COMPLETED|Overall Study||97
10243268|NCT03525678|11375042|FG001|NOT COMPLETED|Overall Study||99
10243269|NCT03525678|11375043|FG002|NOT COMPLETED|Overall Study||25
10243270|NCT03520569|11375051|FG000|STARTED|Overall Study||15
10243271|NCT03520569|11375051|FG000|Octreotide-Euglycemia|Overall Study||13
10243272|NCT03520569|11375051|FG000|Octreotide-Euglycemia-Insulin Clamp|Overall Study||14
10243273|NCT03520569|11375051|FG000|Octreotide-Hyperglycemia|Overall Study||10
10243274|NCT03520569|11375051|FG000|Octreotide-Hyperglycemia-Insulin Clamp|Overall Study||12
10243275|NCT03520569|11375051|FG000|COMPLETED|Overall Study||14
10243276|NCT03520569|11375051|FG000|NOT COMPLETED|Overall Study||1
10243277|NCT03499899|11375064|FG000|STARTED|Overall Study||20
10243278|NCT03499899|11375065|FG001|STARTED|Overall Study||34
10243279|NCT03499899|11375066|FG002|STARTED|Overall Study||34
10243280|NCT03499899|11375064|FG000|COMPLETED|Overall Study||0
10243281|NCT03499899|11375065|FG001|COMPLETED|Overall Study||0
10243282|NCT03499899|11375066|FG002|COMPLETED|Overall Study||0
10243283|NCT03499899|11375064|FG000|NOT COMPLETED|Overall Study||20
10243284|NCT03499899|11375065|FG001|NOT COMPLETED|Overall Study||34
10243285|NCT03499899|11375066|FG002|NOT COMPLETED|Overall Study||34
10243286|NCT03462563|11375076|FG000|STARTED|Overall Study||94
10243287|NCT03462563|11375077|FG001|STARTED|Overall Study||81
10243288|NCT03462563|11375076|FG000|COMPLETED|Overall Study||79
10243289|NCT03462563|11375077|FG001|COMPLETED|Overall Study||64
10243290|NCT03462563|11375076|FG000|NOT COMPLETED|Overall Study||15
10243291|NCT03462563|11375077|FG001|NOT COMPLETED|Overall Study||17
10243292|NCT03419741|11375085|FG000|STARTED|Overall Study||5
10243293|NCT03419741|11375086|FG001|STARTED|Overall Study||6
10243294|NCT03419741|11375085|FG000|Treated|Overall Study||4
10243295|NCT03419741|11375086|FG001|Treated|Overall Study||4
10243296|NCT03419741|11375085|FG000|COMPLETED|Overall Study||3
10243297|NCT03419741|11375086|FG001|COMPLETED|Overall Study||4
10243298|NCT03419741|11375085|FG000|NOT COMPLETED|Overall Study||2
10243299|NCT03419741|11375086|FG001|NOT COMPLETED|Overall Study||2
10243300|NCT03401918|11375094|FG000|STARTED|Overall Study||25
10243301|NCT03401918|11375095|FG001|STARTED|Overall Study||16
10243302|NCT03401918|11375094|FG000|COMPLETED|Overall Study||25
10243303|NCT03401918|11375095|FG001|COMPLETED|Overall Study||16
10243304|NCT03401918|11375094|FG000|NOT COMPLETED|Overall Study||0
10243305|NCT03401918|11375095|FG001|NOT COMPLETED|Overall Study||0
9957252|NCT01449734|11076457|FG000|COMPLETED|Overall Study||215
9957253|NCT01449734|11076457|FG000|NOT COMPLETED|Overall Study||0
9957254|NCT01449747|11076463|FG000|STARTED|Overall Study||12
10019394|NCT01829919|11142566|FG000|NOT COMPLETED|Overall Study||0
10019395|NCT01829997|11142570|FG000|STARTED|Overall Study||22
10019396|NCT01829997|11142570|FG000|COMPLETED|Overall Study||16
10019397|NCT01829997|11142570|FG000|NOT COMPLETED|Overall Study||6
10019398|NCT01830127|11142576|FG000|STARTED|Overall Study||18
9957255|NCT01449747|11076464|FG001|STARTED|Overall Study||12
9957256|NCT01449747|11076463|FG000|COMPLETED|Overall Study||12
9957257|NCT01449747|11076464|FG001|COMPLETED|Overall Study||12
9832981|NCT00776009|10943784|FG005|NOT COMPLETED|Period 2: Second Intervention||1
9832982|NCT00776009|10943779|FG000|STARTED|Period 3: Third Intervention||25
9832983|NCT00776009|10943780|FG001|STARTED|Period 3: Third Intervention||27
9832984|NCT00776009|10943781|FG002|STARTED|Period 3: Third Intervention||27
9832985|NCT00776009|10943782|FG003|STARTED|Period 3: Third Intervention||27
10243306|NCT02759185|11375105|FG000|STARTED|Stage 1||20
10243307|NCT02759185|11375106|FG001|STARTED|Stage 1||20
10243308|NCT02759185|11375107|FG002|STARTED|Stage 1||20
10243309|NCT02759185|11375108|FG003|STARTED|Stage 1||20
10243310|NCT02759185|11375109|FG004|STARTED|Stage 1||0
10243311|NCT02759185|11375110|FG005|STARTED|Stage 1||0
10243312|NCT02759185|11375111|FG006|STARTED|Stage 1||0
10243313|NCT02759185|11375105|FG000|COMPLETED|Stage 1||19
10243314|NCT02759185|11375106|FG001|COMPLETED|Stage 1||19
10243315|NCT02759185|11375107|FG002|COMPLETED|Stage 1||17
10243316|NCT02759185|11375108|FG003|COMPLETED|Stage 1||20
10243317|NCT02759185|11375109|FG004|COMPLETED|Stage 1||0
10243318|NCT02759185|11375110|FG005|COMPLETED|Stage 1||0
10243319|NCT02759185|11375111|FG006|COMPLETED|Stage 1||0
10243320|NCT02759185|11375105|FG000|NOT COMPLETED|Stage 1||1
10243321|NCT02759185|11375106|FG001|NOT COMPLETED|Stage 1||1
10243322|NCT02759185|11375107|FG002|NOT COMPLETED|Stage 1||3
10243323|NCT02759185|11375108|FG003|NOT COMPLETED|Stage 1||0
10243324|NCT02759185|11375109|FG004|NOT COMPLETED|Stage 1||0
10243325|NCT02759185|11375110|FG005|NOT COMPLETED|Stage 1||0
10243326|NCT02759185|11375111|FG006|NOT COMPLETED|Stage 1||0
10243327|NCT02759185|11375105|FG000|STARTED|Stage 2||0
10243328|NCT02759185|11375106|FG001|STARTED|Stage 2||0
10243329|NCT02759185|11375107|FG002|STARTED|Stage 2||0
10243330|NCT02759185|11375108|FG003|STARTED|Stage 2||0
10243331|NCT02759185|11375109|FG004|STARTED|Stage 2||29
10243332|NCT02759185|11375110|FG005|STARTED|Stage 2||27
10243333|NCT02759185|11375111|FG006|STARTED|Stage 2||18
10243334|NCT02759185|11375105|FG000|COMPLETED|Stage 2||0
10243335|NCT02759185|11375106|FG001|COMPLETED|Stage 2||0
10243336|NCT02759185|11375107|FG002|COMPLETED|Stage 2||0
10243337|NCT02759185|11375108|FG003|COMPLETED|Stage 2||0
10243338|NCT02759185|11375109|FG004|COMPLETED|Stage 2||27
10243339|NCT02759185|11375110|FG005|COMPLETED|Stage 2||24
10243340|NCT02759185|11375111|FG006|COMPLETED|Stage 2||17
10243341|NCT02759185|11375105|FG000|NOT COMPLETED|Stage 2||0
10243342|NCT02759185|11375106|FG001|NOT COMPLETED|Stage 2||0
10243343|NCT02759185|11375107|FG002|NOT COMPLETED|Stage 2||0
10243344|NCT02759185|11375108|FG003|NOT COMPLETED|Stage 2||0
10243345|NCT02759185|11375109|FG004|NOT COMPLETED|Stage 2||2
10243346|NCT02759185|11375110|FG005|NOT COMPLETED|Stage 2||3
10243347|NCT02759185|11375111|FG006|NOT COMPLETED|Stage 2||1
10243348|NCT02704156|11375135|FG000|STARTED|Overall Study||85
10243349|NCT02704156|11375136|FG001|STARTED|Overall Study||85
10243350|NCT02704156|11375135|FG000|COMPLETED|Overall Study||85
10243351|NCT02704156|11375136|FG001|COMPLETED|Overall Study||85
10243352|NCT02704156|11375135|FG000|NOT COMPLETED|Overall Study||0
10243353|NCT02704156|11375136|FG001|NOT COMPLETED|Overall Study||0
10243354|NCT02688530|11375146|FG000|STARTED|Overall Study||35
10243355|NCT02688530|11375147|FG001|STARTED|Overall Study||35
10243356|NCT02688530|11375148|FG002|STARTED|Overall Study||35
10243357|NCT02688530|11375149|FG003|STARTED|Overall Study||35
10243358|NCT02688530|11375146|FG000|COMPLETED|Overall Study||35
10243359|NCT02688530|11375147|FG001|COMPLETED|Overall Study||34
10243360|NCT02688530|11375148|FG002|COMPLETED|Overall Study||33
10243361|NCT02688530|11375149|FG003|COMPLETED|Overall Study||35
10243362|NCT02688530|11375146|FG000|NOT COMPLETED|Overall Study||0
10243363|NCT02688530|11375147|FG001|NOT COMPLETED|Overall Study||1
10243364|NCT02688530|11375148|FG002|NOT COMPLETED|Overall Study||2
10243365|NCT02688530|11375149|FG003|NOT COMPLETED|Overall Study||0
10243366|NCT02657434|11375165|FG000|STARTED|Overall Study||286
10243367|NCT02657434|11375166|FG001|STARTED|Overall Study||292
10243368|NCT02657434|11375165|FG000|COMPLETED|Overall Study||0
10243369|NCT02657434|11375166|FG001|COMPLETED|Overall Study||0
10243370|NCT02657434|11375165|FG000|NOT COMPLETED|Overall Study||286
10243371|NCT02657434|11375166|FG001|NOT COMPLETED|Overall Study||292
10243372|NCT02383966|11375175|FG000|STARTED|Overall Study||164
10243373|NCT02383966|11375176|FG001|STARTED|Overall Study||79
10243374|NCT02383966|11375175|FG000|COMPLETED|Overall Study||138
10243375|NCT02383966|11375176|FG001|COMPLETED|Overall Study||72
10243376|NCT02383966|11375175|FG000|NOT COMPLETED|Overall Study||26
10243377|NCT02383966|11375176|FG001|NOT COMPLETED|Overall Study||7
10243378|NCT02073565|11375184|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
10243379|NCT02073565|11375185|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
10243380|NCT02073565|11375184|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
9832986|NCT00776009|10943783|FG004|STARTED|Period 3: Third Intervention||26
9832987|NCT00776009|10943784|FG005|STARTED|Period 3: Third Intervention||26
10243381|NCT02073565|11375185|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
10243382|NCT02073565|11375184|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
10243383|NCT02073565|11375185|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
10243384|NCT02073565|11375184|FG000|STARTED|Cohort A||16
10243385|NCT02073565|11375185|FG001|STARTED|Cohort A||14
10243386|NCT02073565|11375184|FG000|COMPLETED|Cohort A||15
10243387|NCT02073565|11375185|FG001|COMPLETED|Cohort A||14
10243388|NCT02073565|11375184|FG000|NOT COMPLETED|Cohort A||1
10243389|NCT02073565|11375185|FG001|NOT COMPLETED|Cohort A||0
10243390|NCT02073565|11375184|FG000|STARTED|Cohort B||54
10243391|NCT02073565|11375185|FG001|STARTED|Cohort B||56
10243392|NCT02073565|11375184|FG000|COMPLETED|Cohort B||53
10243393|NCT02073565|11375185|FG001|COMPLETED|Cohort B||54
10243394|NCT02073565|11375184|FG000|NOT COMPLETED|Cohort B||1
10243395|NCT02073565|11375185|FG001|NOT COMPLETED|Cohort B||2
10243396|NCT02073565|11375184|FG000|STARTED|Cohort C||217
10243397|NCT02073565|11375185|FG001|STARTED|Cohort C||215
10243398|NCT02073565|11375184|FG000|COMPLETED|Cohort C||217
10243399|NCT02073565|11375185|FG001|COMPLETED|Cohort C||211
10243400|NCT02073565|11375184|FG000|NOT COMPLETED|Cohort C||0
10243401|NCT02073565|11375185|FG001|NOT COMPLETED|Cohort C||4
10243402|NCT02060487|11375194|FG000|STARTED|Overall Study||129
10243403|NCT02060487|11375195|FG001|STARTED|Overall Study||128
10243404|NCT02060487|11375196|FG002|STARTED|Overall Study||128
10243405|NCT02060487|11375194|FG000|COMPLETED|Overall Study||0
10243406|NCT02060487|11375195|FG001|COMPLETED|Overall Study||0
10243407|NCT02060487|11375196|FG002|COMPLETED|Overall Study||0
10243408|NCT02060487|11375194|FG000|NOT COMPLETED|Overall Study||129
10243409|NCT02060487|11375195|FG001|NOT COMPLETED|Overall Study||128
10243410|NCT02060487|11375196|FG002|NOT COMPLETED|Overall Study||128
10243411|NCT00732212|11375208|FG000|STARTED|Overall Study||112
10243412|NCT00732212|11375209|FG001|STARTED|Overall Study||123
10243413|NCT00732212|11375208|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
10243414|NCT00732212|11375209|FG001|Temporarily Suspended|Overall Study||50
10243415|NCT00732212|11375208|FG000|COMPLETED|Overall Study||112
10243416|NCT00732212|11375209|FG001|COMPLETED|Overall Study||123
10243417|NCT00732212|11375208|FG000|NOT COMPLETED|Overall Study||0
10243418|NCT00732212|11375209|FG001|NOT COMPLETED|Overall Study||0
10243419|NCT00331773|11375241|FG000|STARTED|Overall Study||558
10243420|NCT00331773|11375242|FG001|STARTED|Overall Study||557
10243421|NCT00331773|11375241|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
10243422|NCT00331773|11375242|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
10243423|NCT00331773|11375241|FG000|NOT COMPLETED|Overall Study||16
10243424|NCT00331773|11375242|FG001|NOT COMPLETED|Overall Study||7
10243425|NCT00321698|11375254|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3
10243426|NCT00321698|11375255|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3
10243427|NCT00321698|11375256|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3
10243428|NCT00321698|11375257|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3
10243429|NCT00321698|11375258|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0
10243430|NCT00321698|11375254|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10243431|NCT00321698|11375255|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10243432|NCT00321698|11375256|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10243433|NCT00321698|11375257|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10243434|NCT00321698|11375258|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0
10243435|NCT00321698|11375254|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10243436|NCT00321698|11375255|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10243437|NCT00321698|11375256|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10243438|NCT00321698|11375257|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10243439|NCT00321698|11375258|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10243440|NCT00321698|11375254|FG000|STARTED|Phase II, MTD Dose||0
10243441|NCT00321698|11375255|FG001|STARTED|Phase II, MTD Dose||0
10243442|NCT00321698|11375256|FG002|STARTED|Phase II, MTD Dose||0
10243443|NCT00321698|11375257|FG003|STARTED|Phase II, MTD Dose||0
10243444|NCT00321698|11375258|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13
10243445|NCT00321698|11375254|FG000|COMPLETED|Phase II, MTD Dose||0
10243446|NCT00321698|11375255|FG001|COMPLETED|Phase II, MTD Dose||0
10243447|NCT00321698|11375256|FG002|COMPLETED|Phase II, MTD Dose||0
10243448|NCT00321698|11375257|FG003|COMPLETED|Phase II, MTD Dose||0
10243449|NCT00321698|11375258|FG004|COMPLETED|Phase II, MTD Dose||13
10243450|NCT00321698|11375254|FG000|NOT COMPLETED|Phase II, MTD Dose||0
10243451|NCT00321698|11375255|FG001|NOT COMPLETED|Phase II, MTD Dose||0
10243452|NCT00321698|11375256|FG002|NOT COMPLETED|Phase II, MTD Dose||0
10243453|NCT00321698|11375257|FG003|NOT COMPLETED|Phase II, MTD Dose||0
10243454|NCT00321698|11375258|FG004|NOT COMPLETED|Phase II, MTD Dose||0
10243455|NCT05343156|11375272|FG000|STARTED|Overall Study||99
10243456|NCT05343156|11375273|FG001|STARTED|Overall Study||45
10243457|NCT05343156|11375272|FG000|COMPLETED|Overall Study||91
10243458|NCT05343156|11375273|FG001|COMPLETED|Overall Study||42
10243459|NCT05343156|11375272|FG000|NOT COMPLETED|Overall Study||8
10243460|NCT05343156|11375273|FG001|NOT COMPLETED|Overall Study||3
10243461|NCT04913636|11375281|FG000|STARTED|Overall Study||18
10243462|NCT04913636|11375282|FG001|STARTED|Overall Study||20
10243463|NCT04913636|11375281|FG000|COMPLETED|Overall Study||18
10243464|NCT04913636|11375282|FG001|COMPLETED|Overall Study||20
10243465|NCT04913636|11375281|FG000|NOT COMPLETED|Overall Study||0
10243466|NCT04913636|11375282|FG001|NOT COMPLETED|Overall Study||0
10243467|NCT04882995|11375290|FG000|STARTED|Overall Study||41
10243468|NCT04882995|11375291|FG001|STARTED|Overall Study||43
10243469|NCT04882995|11375290|FG000|COMPLETED|Overall Study||35
10243470|NCT04882995|11375291|FG001|COMPLETED|Overall Study||36
10243471|NCT04882995|11375290|FG000|NOT COMPLETED|Overall Study||6
10243472|NCT04882995|11375291|FG001|NOT COMPLETED|Overall Study||7
10243473|NCT04707573|11375299|FG000|STARTED|Overall Study||10
10243474|NCT04707573|11375300|FG001|STARTED|Overall Study||12
10243475|NCT04707573|11375299|FG000|COMPLETED|Overall Study||10
10019399|NCT01830127|11142577|FG001|STARTED|Overall Study||17
10019400|NCT01830127|11142576|FG000|COMPLETED|Overall Study||13
10243476|NCT04707573|11375300|FG001|COMPLETED|Overall Study||12
10243477|NCT04707573|11375299|FG000|NOT COMPLETED|Overall Study||0
10243478|NCT04707573|11375300|FG001|NOT COMPLETED|Overall Study||0
10243479|NCT04640168|11375308|FG000|STARTED|Overall Study||516
10243480|NCT04640168|11375309|FG001|STARTED|Overall Study||494
10243481|NCT04640168|11375308|FG000|Treated|Overall Study||503
10243482|NCT04640168|11375309|FG001|Treated|Overall Study||482
10243483|NCT04640168|11375308|FG000|ITT and Modified ITT Population|Overall Study||516
10243484|NCT04640168|11375309|FG001|ITT and Modified ITT Population|Overall Study||494
10243485|NCT04640168|11375308|FG000|As Treated Population|Overall Study||503
10243486|NCT04640168|11375309|FG001|As Treated Population|Overall Study||482
10243487|NCT04640168|11375308|FG000|COMPLETED|Overall Study||495
10243488|NCT04640168|11375309|FG001|COMPLETED|Overall Study||475
10243489|NCT04640168|11375308|FG000|NOT COMPLETED|Overall Study||21
10243490|NCT04640168|11375309|FG001|NOT COMPLETED|Overall Study||19
10243491|NCT04465630|11375315|FG000|STARTED|Overall Study||78
10243492|NCT04465630|11375315|FG000|COMPLETED|Overall Study||0
10243493|NCT04465630|11375315|FG000|NOT COMPLETED|Overall Study||78
10243494|NCT04459598|11375322|FG000|STARTED|Overall Study||16
10243495|NCT04459598|11375323|FG001|STARTED|Overall Study||16
10243496|NCT04459598|11375322|FG000|COMPLETED|Overall Study||15
10243497|NCT04459598|11375323|FG001|COMPLETED|Overall Study||15
10243498|NCT04459598|11375322|FG000|NOT COMPLETED|Overall Study||1
10243499|NCT04459598|11375323|FG001|NOT COMPLETED|Overall Study||1
10243500|NCT04439344|11375329|FG000|STARTED|Overall Study||53
10243501|NCT04439344|11375329|FG000|Started Protocol Therapy|Overall Study||50
10243502|NCT04439344|11375329|FG000|Eligible|Overall Study||47
10243503|NCT04439344|11375329|FG000|COMPLETED|Overall Study||0
10243504|NCT04439344|11375329|FG000|NOT COMPLETED|Overall Study||53
10243505|NCT04439279|11375333|FG000|STARTED|Overall Study||35
10243506|NCT04439279|11375333|FG000|Started Protocol Therapy|Overall Study||35
10243507|NCT04439279|11375333|FG000|Eligible|Overall Study||33
10243508|NCT04439279|11375333|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
10243509|NCT04439279|11375333|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
10243510|NCT04439279|11375333|FG000|NOT COMPLETED|Overall Study||35
10243511|NCT04439123|11375337|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
10243512|NCT04439123|11375337|FG000|COMPLETED|Overall Study||0
10243513|NCT04439123|11375337|FG000|NOT COMPLETED|Overall Study||35
10243514|NCT04439110|11375341|FG000|STARTED|Overall Study||38
10019401|NCT01830127|11142577|FG001|COMPLETED|Overall Study||8
10243515|NCT04439110|11375341|FG000|Eligible|Overall Study||36
10243516|NCT04439110|11375341|FG000|COMPLETED|Overall Study||0
10243517|NCT04439110|11375341|FG000|NOT COMPLETED|Overall Study||38
10243518|NCT04387136|11375347|FG000|STARTED|Overall Study||26
10019402|NCT01830127|11142576|FG000|NOT COMPLETED|Overall Study||5
10019403|NCT01830127|11142577|FG001|NOT COMPLETED|Overall Study||9
10019404|NCT01830140|11142585|FG000|STARTED|Overall Study||233
10019405|NCT01830140|11142586|FG001|STARTED|Overall Study||233
10019406|NCT01830140|11142585|FG000|COMPLETED|Overall Study||226
10019407|NCT01830140|11142586|FG001|COMPLETED|Overall Study||229
10019408|NCT01830140|11142585|FG000|NOT COMPLETED|Overall Study||7
10243519|NCT04387136|11375348|FG001|STARTED|Overall Study||27
10243520|NCT04387136|11375347|FG000|COMPLETED|Overall Study||25
10019409|NCT01830140|11142586|FG001|NOT COMPLETED|Overall Study||4
10019410|NCT01830205|11142596|FG000|STARTED|Overall Study||12
10019411|NCT01830205|11142597|FG001|STARTED|Overall Study||6
10019412|NCT01830205|11142598|FG002|STARTED|Overall Study||6
10243521|NCT04387136|11375348|FG001|COMPLETED|Overall Study||25
10243522|NCT04387136|11375347|FG000|NOT COMPLETED|Overall Study||1
10243523|NCT04387136|11375348|FG001|NOT COMPLETED|Overall Study||2
10243524|NCT04351269|11375357|FG000|STARTED|Overall Study||237
10243525|NCT04351269|11375358|FG001|STARTED|Overall Study||260
10243526|NCT04351269|11375359|FG002|STARTED|Overall Study||100
10243527|NCT04351269|11375357|FG000|COMPLETED|Overall Study||165
10243528|NCT04351269|11375358|FG001|COMPLETED|Overall Study||219
10243529|NCT04351269|11375359|FG002|COMPLETED|Overall Study||71
10243530|NCT04351269|11375357|FG000|NOT COMPLETED|Overall Study||72
10243531|NCT04351269|11375358|FG001|NOT COMPLETED|Overall Study||41
10243532|NCT04351269|11375359|FG002|NOT COMPLETED|Overall Study||29
10243533|NCT04292301|11375370|FG000|STARTED|Overall Study||92
10243534|NCT04292301|11375370|FG000|COMPLETED|Overall Study||89
10243535|NCT04292301|11375370|FG000|NOT COMPLETED|Overall Study||3
10243536|NCT04285229|11375376|FG000|STARTED|Overall Study||73
10243537|NCT04285229|11375377|FG001|STARTED|Overall Study||74
10243538|NCT04285229|11375376|FG000|Received at Least One Dose of Study Drug|Overall Study||73
10243539|NCT04285229|11375377|FG001|Received at Least One Dose of Study Drug|Overall Study||74
10243540|NCT04285229|11375376|FG000|COMPLETED|Overall Study||70
10243541|NCT04285229|11375377|FG001|COMPLETED|Overall Study||72
10243542|NCT04285229|11375376|FG000|NOT COMPLETED|Overall Study||3
10243543|NCT04285229|11375377|FG001|NOT COMPLETED|Overall Study||2
10243544|NCT04148521|11375388|FG000|STARTED|Overall Study||534
10243545|NCT04148521|11375389|FG001|STARTED|Overall Study||555
10243546|NCT04148521|11375388|FG000|COMPLETED|Overall Study||534
10243547|NCT04148521|11375389|FG001|COMPLETED|Overall Study||555
10243548|NCT04148521|11375388|FG000|NOT COMPLETED|Overall Study||0
10243549|NCT04148521|11375389|FG001|NOT COMPLETED|Overall Study||0
10243550|NCT03897348|11375399|FG000|STARTED|ADP Session 1||1
10243551|NCT03897348|11375400|FG001|STARTED|ADP Session 1||1
10243552|NCT03897348|11375401|FG002|STARTED|ADP Session 1||1
10243553|NCT03897348|11375402|FG003|STARTED|ADP Session 1||1
10243554|NCT03897348|11375399|FG000|COMPLETED|ADP Session 1||1
10243555|NCT03897348|11375400|FG001|COMPLETED|ADP Session 1||1
10243556|NCT03897348|11375401|FG002|COMPLETED|ADP Session 1||1
10243557|NCT03897348|11375402|FG003|COMPLETED|ADP Session 1||1
10243558|NCT03897348|11375399|FG000|NOT COMPLETED|ADP Session 1||0
10243559|NCT03897348|11375400|FG001|NOT COMPLETED|ADP Session 1||0
10243560|NCT03897348|11375401|FG002|NOT COMPLETED|ADP Session 1||0
10243561|NCT03897348|11375402|FG003|NOT COMPLETED|ADP Session 1||0
10243562|NCT03897348|11375399|FG000|STARTED|ADP Session 2||1
10243563|NCT03897348|11375400|FG001|STARTED|ADP Session 2||1
10243564|NCT03897348|11375401|FG002|STARTED|ADP Session 2||1
10243565|NCT03897348|11375402|FG003|STARTED|ADP Session 2||1
10243566|NCT03897348|11375399|FG000|COMPLETED|ADP Session 2||1
10243567|NCT03897348|11375400|FG001|COMPLETED|ADP Session 2||1
10243568|NCT03897348|11375401|FG002|COMPLETED|ADP Session 2||1
10243569|NCT03897348|11375402|FG003|COMPLETED|ADP Session 2||1
10243570|NCT03897348|11375399|FG000|NOT COMPLETED|ADP Session 2||0
10243571|NCT03897348|11375400|FG001|NOT COMPLETED|ADP Session 2||0
10243572|NCT03897348|11375401|FG002|NOT COMPLETED|ADP Session 2||0
10243573|NCT03897348|11375402|FG003|NOT COMPLETED|ADP Session 2||0
10243574|NCT03897348|11375399|FG000|STARTED|ADP Session 3||1
10243575|NCT03897348|11375400|FG001|STARTED|ADP Session 3||1
10243576|NCT03897348|11375401|FG002|STARTED|ADP Session 3||0
10243577|NCT03897348|11375402|FG003|STARTED|ADP Session 3||1
10243578|NCT03897348|11375399|FG000|COMPLETED|ADP Session 3||1
10243579|NCT03897348|11375400|FG001|COMPLETED|ADP Session 3||1
10243580|NCT03897348|11375401|FG002|COMPLETED|ADP Session 3||0
10243581|NCT03897348|11375402|FG003|COMPLETED|ADP Session 3||1
10243582|NCT03897348|11375399|FG000|NOT COMPLETED|ADP Session 3||0
10243583|NCT03897348|11375400|FG001|NOT COMPLETED|ADP Session 3||0
10243584|NCT03897348|11375401|FG002|NOT COMPLETED|ADP Session 3||0
10243585|NCT03897348|11375402|FG003|NOT COMPLETED|ADP Session 3||0
10243586|NCT03682601|11375414|FG000|STARTED|Overall Study||12
10243587|NCT03682601|11375415|FG001|STARTED|Overall Study||7
10243588|NCT03682601|11375416|FG002|STARTED|Overall Study||13
10243589|NCT03682601|11375414|FG000|COMPLETED|Overall Study||12
10243590|NCT03682601|11375415|FG001|COMPLETED|Overall Study||7
10243591|NCT03682601|11375416|FG002|COMPLETED|Overall Study||13
10243592|NCT03682601|11375414|FG000|NOT COMPLETED|Overall Study||0
10243593|NCT03682601|11375415|FG001|NOT COMPLETED|Overall Study||0
10243594|NCT03682601|11375416|FG002|NOT COMPLETED|Overall Study||0
10243595|NCT03668808|11375427|FG000|STARTED|First Intervention||13
10243596|NCT03668808|11375428|FG001|STARTED|First Intervention||12
10243597|NCT03668808|11375427|FG000|COMPLETED|First Intervention||11
10243598|NCT03668808|11375428|FG001|COMPLETED|First Intervention||10
10243599|NCT03668808|11375427|FG000|NOT COMPLETED|First Intervention||2
10243600|NCT03668808|11375428|FG001|NOT COMPLETED|First Intervention||2
10243601|NCT03668808|11375427|FG000|STARTED|Washout Period||11
10243602|NCT03668808|11375428|FG001|STARTED|Washout Period||10
10243603|NCT03668808|11375427|FG000|COMPLETED|Washout Period||11
10243604|NCT03668808|11375428|FG001|COMPLETED|Washout Period||10
10243605|NCT03668808|11375427|FG000|NOT COMPLETED|Washout Period||0
10243606|NCT03668808|11375428|FG001|NOT COMPLETED|Washout Period||0
10243607|NCT03668808|11375427|FG000|STARTED|Second Intervention||11
10243608|NCT03668808|11375428|FG001|STARTED|Second Intervention||10
10243609|NCT03668808|11375427|FG000|COMPLETED|Second Intervention||11
10243610|NCT03668808|11375428|FG001|COMPLETED|Second Intervention||10
10243611|NCT03668808|11375427|FG000|NOT COMPLETED|Second Intervention||0
10243612|NCT03668808|11375428|FG001|NOT COMPLETED|Second Intervention||0
10243613|NCT03658642|11375438|FG000|STARTED|Patients||2787
10243614|NCT03658642|11375439|FG001|STARTED|Patients||2260
10243615|NCT03658642|11375438|FG000|COMPLETED|Patients||2787
10243616|NCT03658642|11375439|FG001|COMPLETED|Patients||2260
10243617|NCT03658642|11375438|FG000|NOT COMPLETED|Patients||0
10243618|NCT03658642|11375439|FG001|NOT COMPLETED|Patients||0
10243619|NCT03658642|11375438|FG000|STARTED|Physicians|A total of 599 physicians were also included in the study.|340
10243620|NCT03658642|11375439|FG001|STARTED|Physicians|A total of 599 physicians were also included in the study.|259
10243621|NCT03658642|11375438|FG000|COMPLETED|Physicians||340
10243622|NCT03658642|11375439|FG001|COMPLETED|Physicians||259
10243623|NCT03658642|11375438|FG000|NOT COMPLETED|Physicians||0
10243624|NCT03658642|11375439|FG001|NOT COMPLETED|Physicians||0
10243625|NCT03656874|11375447|FG000|STARTED|Overall Study||13
10243626|NCT03656874|11375448|FG001|STARTED|Overall Study||43
10243627|NCT03656874|11375447|FG000|COMPLETED|Overall Study||10
10243628|NCT03656874|11375448|FG001|COMPLETED|Overall Study||26
10243629|NCT03656874|11375447|FG000|NOT COMPLETED|Overall Study||3
10243630|NCT03656874|11375448|FG001|NOT COMPLETED|Overall Study||17
10243631|NCT03584009|11375456|FG000|STARTED|Overall Study||51
10243632|NCT03584009|11375457|FG001|STARTED|Overall Study||52
10243633|NCT03584009|11375456|FG000|COMPLETED|Overall Study||0
10243634|NCT03584009|11375457|FG001|COMPLETED|Overall Study||0
10243635|NCT03584009|11375456|FG000|NOT COMPLETED|Overall Study||51
10243636|NCT03584009|11375457|FG001|NOT COMPLETED|Overall Study||52
10243637|NCT03583359|11375468|FG000|STARTED|Overall Study||123
10243638|NCT03583359|11375469|FG001|STARTED|Overall Study||57
10243639|NCT03583359|11375468|FG000|Treated Participants|Overall Study||122
10243640|NCT03583359|11375469|FG001|Treated Participants|Overall Study||53
10243641|NCT03583359|11375468|FG000|COMPLETED|Overall Study||94
10243642|NCT03583359|11375469|FG001|COMPLETED|Overall Study||45
10243643|NCT03583359|11375468|FG000|NOT COMPLETED|Overall Study||29
10243644|NCT03583359|11375469|FG001|NOT COMPLETED|Overall Study||12
10243645|NCT03568162|11375481|FG000|STARTED|Overall Study||76
10243646|NCT03568162|11375482|FG001|STARTED|Overall Study||80
10243647|NCT03568162|11375483|FG002|STARTED|Overall Study||77
10243648|NCT03568162|11375484|FG003|STARTED|Overall Study||80
10243649|NCT03568162|11375485|FG004|STARTED|Overall Study||75
10243650|NCT03568162|11375486|FG005|STARTED|Overall Study||74
10243651|NCT03568162|11375481|FG000|COMPLETED|Overall Study||54
10243652|NCT03568162|11375482|FG001|COMPLETED|Overall Study||57
10243653|NCT03568162|11375483|FG002|COMPLETED|Overall Study||42
10243654|NCT03568162|11375484|FG003|COMPLETED|Overall Study||50
10243655|NCT03568162|11375485|FG004|COMPLETED|Overall Study||61
10243656|NCT03568162|11375486|FG005|COMPLETED|Overall Study||60
10243657|NCT03568162|11375481|FG000|NOT COMPLETED|Overall Study||22
10243658|NCT03568162|11375482|FG001|NOT COMPLETED|Overall Study||23
10243659|NCT03568162|11375483|FG002|NOT COMPLETED|Overall Study||35
10243660|NCT03568162|11375484|FG003|NOT COMPLETED|Overall Study||30
10243661|NCT03568162|11375485|FG004|NOT COMPLETED|Overall Study||14
10243662|NCT03568162|11375486|FG005|NOT COMPLETED|Overall Study||14
10243663|NCT03557307|11375503|FG000|STARTED|To End of OCS Reduction Phase||598
10243664|NCT03557307|11375503|FG000|COMPLETED|To End of OCS Reduction Phase||563
10243665|NCT03557307|11375503|FG000|NOT COMPLETED|To End of OCS Reduction Phase||35
10243666|NCT03557307|11375503|FG000|STARTED|Maintenance Phase||563
10243667|NCT03557307|11375503|FG000|COMPLETED|Maintenance Phase||536
10243668|NCT03557307|11375503|FG000|NOT COMPLETED|Maintenance Phase||27
10243669|NCT03492463|11375511|FG000|STARTED|Overall Study||37
10243670|NCT03492463|11375512|FG001|STARTED|Overall Study||33
10243671|NCT03492463|11375513|FG002|STARTED|Overall Study||11
10243672|NCT03492463|11375514|FG003|STARTED|Overall Study||13
10243673|NCT03492463|11375511|FG000|COMPLETED|Overall Study||26
10243674|NCT03492463|11375512|FG001|COMPLETED|Overall Study||19
10243675|NCT03492463|11375513|FG002|COMPLETED|Overall Study||7
10243676|NCT03492463|11375514|FG003|COMPLETED|Overall Study||10
10243677|NCT03492463|11375511|FG000|NOT COMPLETED|Overall Study||11
10243678|NCT03492463|11375512|FG001|NOT COMPLETED|Overall Study||14
10243679|NCT03492463|11375513|FG002|NOT COMPLETED|Overall Study||4
10019413|NCT01830205|11142599|FG003|STARTED|Overall Study||12
10019414|NCT01830205|11142596|FG000|COMPLETED|Overall Study||12
10243680|NCT03492463|11375514|FG003|NOT COMPLETED|Overall Study||3
10243681|NCT03417687|11375526|FG000|STARTED|Overall Study|4 subjects were randomized to the 129Xe before 133Xe group but discontinued prior to receiving the first treatment.|18
10243682|NCT03417687|11375527|FG001|STARTED|Overall Study||20
10243683|NCT03417687|11375526|FG000|Received 129Xe|Overall Study||14
10243684|NCT03417687|11375527|FG001|Received 129Xe|Overall Study||20
10243685|NCT03417687|11375526|FG000|Received 133Xe|Overall Study||13
10243686|NCT03417687|11375527|FG001|Received 133Xe|Overall Study||20
10243687|NCT03417687|11375526|FG000|COMPLETED|Overall Study||14
10243688|NCT03417687|11375527|FG001|COMPLETED|Overall Study||20
10243689|NCT03417687|11375526|FG000|NOT COMPLETED|Overall Study||4
10243690|NCT03417687|11375527|FG001|NOT COMPLETED|Overall Study||0
10243691|NCT03402230|11375541|FG000|STARTED|Overall Study||25
10243692|NCT03402230|11375542|FG001|STARTED|Overall Study||24
10243693|NCT03402230|11375541|FG000|COMPLETED|Overall Study||25
10243694|NCT03402230|11375542|FG001|COMPLETED|Overall Study||23
10243695|NCT03402230|11375541|FG000|NOT COMPLETED|Overall Study||0
10243696|NCT03402230|11375542|FG001|NOT COMPLETED|Overall Study||1
10243697|NCT03379675|11375550|FG000|STARTED|Overall Study||24
10243698|NCT03379675|11375551|FG001|STARTED|Overall Study||24
10019415|NCT01830205|11142597|FG001|COMPLETED|Overall Study||6
10243699|NCT03379675|11375552|FG002|STARTED|Overall Study||24
10243700|NCT03379675|11375550|FG000|COMPLETED|Overall Study||20
10243701|NCT03379675|11375551|FG001|COMPLETED|Overall Study||22
10243702|NCT03379675|11375552|FG002|COMPLETED|Overall Study||22
10243703|NCT03379675|11375550|FG000|NOT COMPLETED|Overall Study||4
10243704|NCT03379675|11375551|FG001|NOT COMPLETED|Overall Study||2
10243705|NCT03379675|11375552|FG002|NOT COMPLETED|Overall Study||2
10243706|NCT03373435|11375562|FG000|STARTED|Treatment Period 1 (14 Days)||8
10243707|NCT03373435|11375563|FG001|STARTED|Treatment Period 1 (14 Days)||10
10243708|NCT03373435|11375562|FG000|COMPLETED|Treatment Period 1 (14 Days)||8
10243709|NCT03373435|11375563|FG001|COMPLETED|Treatment Period 1 (14 Days)||10
10243710|NCT03373435|11375562|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10243711|NCT03373435|11375563|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10243712|NCT03373435|11375562|FG000|STARTED|Treatment Period 2 (14 Days)||8
10243713|NCT03373435|11375563|FG001|STARTED|Treatment Period 2 (14 Days)||10
10243714|NCT03373435|11375562|FG000|COMPLETED|Treatment Period 2 (14 Days)||8
10243715|NCT03373435|11375563|FG001|COMPLETED|Treatment Period 2 (14 Days)||10
10243716|NCT03373435|11375562|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10243717|NCT03373435|11375563|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10243718|NCT03373435|11375562|FG000|STARTED|Treatment Period 3 (14 Days)||8
10019416|NCT01830205|11142598|FG002|COMPLETED|Overall Study||6
10019417|NCT01830205|11142599|FG003|COMPLETED|Overall Study||12
10019418|NCT01830205|11142596|FG000|NOT COMPLETED|Overall Study||0
10019419|NCT01830205|11142597|FG001|NOT COMPLETED|Overall Study||0
10019420|NCT01830205|11142598|FG002|NOT COMPLETED|Overall Study||0
10019421|NCT01830205|11142599|FG003|NOT COMPLETED|Overall Study||0
10019422|NCT01830543|11142623|FG000|STARTED|Overall Study||709
10019423|NCT01830543|11142624|FG001|STARTED|Overall Study||709
10243719|NCT03373435|11375563|FG001|STARTED|Treatment Period 3 (14 Days)||10
10243720|NCT03373435|11375562|FG000|COMPLETED|Treatment Period 3 (14 Days)||8
10243721|NCT03373435|11375563|FG001|COMPLETED|Treatment Period 3 (14 Days)||10
10243722|NCT03373435|11375562|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10243723|NCT03373435|11375563|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10243724|NCT03336619|11375573|FG000|STARTED|Overall Study||515
10243725|NCT03336619|11375574|FG001|STARTED|Overall Study||515
10243726|NCT03336619|11375573|FG000|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||314
10243727|NCT03336619|11375574|FG001|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||306
10243728|NCT03336619|11375573|FG000|COMPLETED|Overall Study||301
10243729|NCT03336619|11375574|FG001|COMPLETED|Overall Study||290
10243730|NCT03336619|11375573|FG000|NOT COMPLETED|Overall Study||214
10243731|NCT03336619|11375574|FG001|NOT COMPLETED|Overall Study||225
10243732|NCT03274687|11375585|FG000|STARTED|Overall Study||152
9832988|NCT00776009|10943779|FG000|COMPLETED|Period 3: Third Intervention||24
9832989|NCT00776009|10943780|FG001|COMPLETED|Period 3: Third Intervention||27
9832990|NCT00776009|10943781|FG002|COMPLETED|Period 3: Third Intervention||27
9832991|NCT00776009|10943782|FG003|COMPLETED|Period 3: Third Intervention||27
9832992|NCT00776009|10943783|FG004|COMPLETED|Period 3: Third Intervention||26
9832993|NCT00776009|10943784|FG005|COMPLETED|Period 3: Third Intervention||26
9832994|NCT00776009|10943779|FG000|NOT COMPLETED|Period 3: Third Intervention||1
9832995|NCT00776009|10943780|FG001|NOT COMPLETED|Period 3: Third Intervention||0
9832996|NCT00776009|10943781|FG002|NOT COMPLETED|Period 3: Third Intervention||0
9832997|NCT00776009|10943782|FG003|NOT COMPLETED|Period 3: Third Intervention||0
10019424|NCT01830543|11142625|FG002|STARTED|Overall Study||706
9832998|NCT00776009|10943783|FG004|NOT COMPLETED|Period 3: Third Intervention||0
9832999|NCT00776009|10943784|FG005|NOT COMPLETED|Period 3: Third Intervention||0
9833000|NCT00776230|10943795|FG000|STARTED|Overall Study||99
10019425|NCT01830543|11142623|FG000|Treated|Overall Study||696
10243733|NCT03274687|11375586|FG001|STARTED|Overall Study||144
10019426|NCT01830543|11142624|FG001|Treated|Overall Study||706
10243734|NCT03274687|11375585|FG000|Eligible|Overall Study||151
10243735|NCT03274687|11375586|FG001|Eligible|Overall Study||143
10243736|NCT03274687|11375585|FG000|Eligible With Adverse Event Data|Overall Study||148
10243737|NCT03274687|11375586|FG001|Eligible With Adverse Event Data|Overall Study||141
10243738|NCT03274687|11375585|FG000|COMPLETED|Overall Study||151
10243739|NCT03274687|11375586|FG001|COMPLETED|Overall Study||143
10243740|NCT03274687|11375585|FG000|NOT COMPLETED|Overall Study||1
10243741|NCT03274687|11375586|FG001|NOT COMPLETED|Overall Study||1
10243742|NCT03245450|11375599|FG000|STARTED|Overall Study||3
10243743|NCT03245450|11375600|FG001|STARTED|Overall Study||4
10243744|NCT03245450|11375601|FG002|STARTED|Overall Study||3
10243745|NCT03245450|11375602|FG003|STARTED|Overall Study||3
10243746|NCT03245450|11375603|FG004|STARTED|Overall Study||9
10243747|NCT03245450|11375604|FG005|STARTED|Overall Study||9
10243748|NCT03245450|11375605|FG006|STARTED|Overall Study||9
10243749|NCT03245450|11375599|FG000|COMPLETED|Overall Study||0
10243750|NCT03245450|11375600|FG001|COMPLETED|Overall Study||0
10243751|NCT03245450|11375601|FG002|COMPLETED|Overall Study||0
10243752|NCT03245450|11375602|FG003|COMPLETED|Overall Study||0
10243753|NCT03245450|11375603|FG004|COMPLETED|Overall Study||0
10243754|NCT03245450|11375604|FG005|COMPLETED|Overall Study||0
10243755|NCT03245450|11375605|FG006|COMPLETED|Overall Study||0
10019427|NCT01830543|11142625|FG002|Treated|Overall Study||697
10019428|NCT01830543|11142623|FG000|COMPLETED|Overall Study||550
10019429|NCT01830543|11142624|FG001|COMPLETED|Overall Study||557
10019430|NCT01830543|11142625|FG002|COMPLETED|Overall Study||492
10019431|NCT01830543|11142623|FG000|NOT COMPLETED|Overall Study||159
9833001|NCT00776230|10943796|FG001|STARTED|Overall Study||103
9833002|NCT00776230|10943797|FG002|STARTED|Overall Study||102
9833003|NCT00776230|10943795|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98
9833004|NCT00776230|10943796|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103
9833005|NCT00776230|10943797|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102
9833006|NCT00776230|10943795|FG000|COMPLETED|Overall Study||96
9833007|NCT00776230|10943796|FG001|COMPLETED|Overall Study||100
9833008|NCT00776230|10943797|FG002|COMPLETED|Overall Study||97
9833009|NCT00776230|10943795|FG000|NOT COMPLETED|Overall Study||3
9833010|NCT00776230|10943796|FG001|NOT COMPLETED|Overall Study||3
9833011|NCT00776230|10943797|FG002|NOT COMPLETED|Overall Study||5
9833012|NCT00776295|10943805|FG000|STARTED|Overall Study||2
10243756|NCT03245450|11375599|FG000|NOT COMPLETED|Overall Study||3
10243757|NCT03245450|11375600|FG001|NOT COMPLETED|Overall Study||4
10243758|NCT03245450|11375601|FG002|NOT COMPLETED|Overall Study||3
10243759|NCT03245450|11375602|FG003|NOT COMPLETED|Overall Study||3
10243760|NCT03245450|11375603|FG004|NOT COMPLETED|Overall Study||9
10243761|NCT03245450|11375604|FG005|NOT COMPLETED|Overall Study||9
10243762|NCT03245450|11375605|FG006|NOT COMPLETED|Overall Study||9
10243763|NCT03086369|11375632|FG000|STARTED|Overall Study||3
10243764|NCT03086369|11375633|FG001|STARTED|Overall Study||7
10243765|NCT03086369|11375634|FG002|STARTED|Overall Study||12
10243766|NCT03086369|11375635|FG003|STARTED|Overall Study||82
10243767|NCT03086369|11375636|FG004|STARTED|Overall Study||80
10243768|NCT03086369|11375632|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10243769|NCT03086369|11375633|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
10243770|NCT03086369|11375634|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
10243771|NCT03086369|11375635|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
10243772|NCT03086369|11375636|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78
10243773|NCT03086369|11375632|FG000|COMPLETED|Overall Study||2
10243774|NCT03086369|11375633|FG001|COMPLETED|Overall Study||7
10243775|NCT03086369|11375634|FG002|COMPLETED|Overall Study||12
10243776|NCT03086369|11375635|FG003|COMPLETED|Overall Study||73
10243777|NCT03086369|11375636|FG004|COMPLETED|Overall Study||73
10243778|NCT03086369|11375632|FG000|NOT COMPLETED|Overall Study||1
10243779|NCT03086369|11375633|FG001|NOT COMPLETED|Overall Study||0
10243780|NCT03086369|11375634|FG002|NOT COMPLETED|Overall Study||0
10243781|NCT03086369|11375635|FG003|NOT COMPLETED|Overall Study||9
10243782|NCT03086369|11375636|FG004|NOT COMPLETED|Overall Study||7
10243783|NCT03083808|11375650|FG000|STARTED|Overall Study||35
9833013|NCT00776295|10943805|FG000|COMPLETED|Overall Study||2
9833014|NCT00776295|10943805|FG000|NOT COMPLETED|Overall Study||0
10019432|NCT01830543|11142624|FG001|NOT COMPLETED|Overall Study||152
10243784|NCT03083808|11375650|FG000|COMPLETED|Overall Study||35
10243785|NCT03083808|11375650|FG000|NOT COMPLETED|Overall Study||0
10243786|NCT02951767|11375654|FG000|STARTED|Overall Study||119
10243787|NCT02951767|11375654|FG000|COMPLETED|Overall Study||0
10243788|NCT02951767|11375654|FG000|NOT COMPLETED|Overall Study||119
10243789|NCT02927847|11375660|FG000|STARTED|Overall Study||16
10243790|NCT02927847|11375661|FG001|STARTED|Overall Study||19
10243791|NCT02927847|11375660|FG000|COMPLETED|Overall Study||10
10243792|NCT02927847|11375661|FG001|COMPLETED|Overall Study||16
10243793|NCT02927847|11375660|FG000|NOT COMPLETED|Overall Study||6
10019433|NCT01830543|11142625|FG002|NOT COMPLETED|Overall Study||214
10243794|NCT02927847|11375661|FG001|NOT COMPLETED|Overall Study||3
10243795|NCT02903355|11375669|FG000|STARTED|Overall Study||186
10243796|NCT02903355|11375670|FG001|STARTED|Overall Study||165
10243797|NCT02903355|11375669|FG000|COMPLETED|Overall Study||142
10243798|NCT02903355|11375670|FG001|COMPLETED|Overall Study||124
10019434|NCT01830595|11142633|FG000|STARTED|First Period||26
10019435|NCT01830595|11142634|FG001|STARTED|First Period||28
10243799|NCT02903355|11375669|FG000|NOT COMPLETED|Overall Study||44
10243800|NCT02903355|11375670|FG001|NOT COMPLETED|Overall Study||41
10243801|NCT02892149|11375678|FG000|STARTED|Overall Study||1777
10243802|NCT02892149|11375679|FG001|STARTED|Overall Study||1777
10243803|NCT02892149|11375678|FG000|COMPLETED|Overall Study||1425
10243804|NCT02892149|11375679|FG001|COMPLETED|Overall Study||1421
10243805|NCT02892149|11375678|FG000|NOT COMPLETED|Overall Study||352
10243806|NCT02892149|11375679|FG001|NOT COMPLETED|Overall Study||356
10113444|NCT02509117|11244190|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113445|NCT02509117|11244191|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113446|NCT02509117|11244192|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113447|NCT02509117|11244193|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113448|NCT02509117|11244194|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113449|NCT02509117|11244195|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10243807|NCT02872116|11375688|FG000|STARTED|Pre-Treatment||789
10243808|NCT02872116|11375689|FG001|STARTED|Pre-Treatment||833
10243809|NCT02872116|11375690|FG002|STARTED|Pre-Treatment||409
10243810|NCT02872116|11375688|FG000|COMPLETED|Pre-Treatment||782
10243811|NCT02872116|11375689|FG001|COMPLETED|Pre-Treatment||806
10243812|NCT02872116|11375690|FG002|COMPLETED|Pre-Treatment||403
10243813|NCT02872116|11375688|FG000|NOT COMPLETED|Pre-Treatment||7
10243814|NCT02872116|11375689|FG001|NOT COMPLETED|Pre-Treatment||27
10243815|NCT02872116|11375690|FG002|NOT COMPLETED|Pre-Treatment||6
10243816|NCT02872116|11375688|FG000|STARTED|Treatment||782
10243817|NCT02872116|11375689|FG001|STARTED|Treatment||806
10243818|NCT02872116|11375690|FG002|STARTED|Treatment||403
10243819|NCT02872116|11375688|FG000|COMPLETED|Treatment||623
10243820|NCT02872116|11375689|FG001|COMPLETED|Treatment||653
10243821|NCT02872116|11375690|FG002|COMPLETED|Treatment||319
10243822|NCT02872116|11375688|FG000|NOT COMPLETED|Treatment||159
10243823|NCT02872116|11375689|FG001|NOT COMPLETED|Treatment||153
10243824|NCT02872116|11375690|FG002|NOT COMPLETED|Treatment||84
10243825|NCT02870920|11375704|FG000|STARTED|Overall Study||61
10243826|NCT02870920|11375705|FG001|STARTED|Overall Study||119
10243827|NCT02870920|11375704|FG000|COMPLETED|Overall Study||61
10019436|NCT01830595|11142633|FG000|Received at Least One Dose|First Period||26
10019437|NCT01830595|11142634|FG001|Received at Least One Dose|First Period||28
10019438|NCT01830595|11142633|FG000|COMPLETED|First Period||25
10019439|NCT01830595|11142634|FG001|COMPLETED|First Period||25
10019440|NCT01830595|11142633|FG000|NOT COMPLETED|First Period||1
10019441|NCT01830595|11142634|FG001|NOT COMPLETED|First Period||3
10019442|NCT01830595|11142633|FG000|STARTED|Washout||25
10019443|NCT01830595|11142634|FG001|STARTED|Washout||25
10019444|NCT01830595|11142633|FG000|COMPLETED|Washout||23
10019445|NCT01830595|11142634|FG001|COMPLETED|Washout||23
10019446|NCT01830595|11142633|FG000|NOT COMPLETED|Washout||2
10019447|NCT01830595|11142634|FG001|NOT COMPLETED|Washout||2
10019448|NCT01830595|11142633|FG000|STARTED|Second Period||23
10019449|NCT01830595|11142634|FG001|STARTED|Second Period||23
10019450|NCT01830595|11142633|FG000|COMPLETED|Second Period||23
10019451|NCT01830595|11142634|FG001|COMPLETED|Second Period||23
10019452|NCT01830595|11142633|FG000|NOT COMPLETED|Second Period||0
10019453|NCT01830595|11142634|FG001|NOT COMPLETED|Second Period||0
10019454|NCT01830621|11142642|FG000|STARTED|Overall Study||138
10019455|NCT01830621|11142643|FG001|STARTED|Overall Study||144
10019456|NCT01830621|11142642|FG000|COMPLETED|Overall Study||138
10019457|NCT01830621|11142643|FG001|COMPLETED|Overall Study||144
10019458|NCT01830621|11142642|FG000|NOT COMPLETED|Overall Study||0
10019459|NCT01830621|11142643|FG001|NOT COMPLETED|Overall Study||0
10019460|NCT01830699|11142651|FG000|STARTED|Overall Study||13
10019461|NCT01830699|11142652|FG001|STARTED|Overall Study||20
10019462|NCT01830699|11142651|FG000|COMPLETED|Overall Study||13
10113450|NCT02509117|11244196|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113451|NCT02509117|11244197|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10243828|NCT02870920|11375705|FG001|COMPLETED|Overall Study||119
10243829|NCT02870920|11375704|FG000|NOT COMPLETED|Overall Study||0
10019463|NCT01830699|11142652|FG001|COMPLETED|Overall Study||20
10243830|NCT02870920|11375705|FG001|NOT COMPLETED|Overall Study||0
10243831|NCT02720523|11375715|FG000|STARTED|Period 1: Placebo-controlled Period||49
10243832|NCT02720523|11375716|FG001|STARTED|Period 1: Placebo-controlled Period||49
10243833|NCT02720523|11375717|FG002|STARTED|Period 1: Placebo-controlled Period||49
10243834|NCT02720523|11375718|FG003|STARTED|Period 1: Placebo-controlled Period||50
10243835|NCT02720523|11375719|FG004|STARTED|Period 1: Placebo-controlled Period||0
10243836|NCT02720523|11375720|FG005|STARTED|Period 1: Placebo-controlled Period||0
10019464|NCT01830699|11142651|FG000|NOT COMPLETED|Overall Study||0
10019465|NCT01830699|11142652|FG001|NOT COMPLETED|Overall Study||0
10019466|NCT01830816|11142661|FG000|STARTED|Overall Study||20
10019467|NCT01830816|11142662|FG001|STARTED|Overall Study||14
10019468|NCT01830816|11142663|FG002|STARTED|Overall Study||7
10019469|NCT01830816|11142661|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
10243837|NCT02720523|11375721|FG006|STARTED|Period 1: Placebo-controlled Period||0
10243838|NCT02720523|11375715|FG000|COMPLETED|Period 1: Placebo-controlled Period||47
10243839|NCT02720523|11375716|FG001|COMPLETED|Period 1: Placebo-controlled Period||49
10243840|NCT02720523|11375717|FG002|COMPLETED|Period 1: Placebo-controlled Period||47
10243841|NCT02720523|11375718|FG003|COMPLETED|Period 1: Placebo-controlled Period||44
10243842|NCT02720523|11375719|FG004|COMPLETED|Period 1: Placebo-controlled Period||0
10243843|NCT02720523|11375720|FG005|COMPLETED|Period 1: Placebo-controlled Period||0
10243844|NCT02720523|11375721|FG006|COMPLETED|Period 1: Placebo-controlled Period||0
10243845|NCT02720523|11375715|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2
10243846|NCT02720523|11375716|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10243847|NCT02720523|11375717|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2
10243848|NCT02720523|11375718|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6
10243849|NCT02720523|11375719|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10243850|NCT02720523|11375720|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10243851|NCT02720523|11375721|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10243852|NCT02720523|11375715|FG000|STARTED|Period 2: Long-term Extension Period||0
10243853|NCT02720523|11375716|FG001|STARTED|Period 2: Long-term Extension Period||0
10243854|NCT02720523|11375717|FG002|STARTED|Period 2: Long-term Extension Period||0
10243855|NCT02720523|11375718|FG003|STARTED|Period 2: Long-term Extension Period||0
10243856|NCT02720523|11375719|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
10243857|NCT02720523|11375720|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
10243858|NCT02720523|11375721|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
10243859|NCT02720523|11375715|FG000|COMPLETED|Period 2: Long-term Extension Period||0
10243860|NCT02720523|11375716|FG001|COMPLETED|Period 2: Long-term Extension Period||0
10243861|NCT02720523|11375717|FG002|COMPLETED|Period 2: Long-term Extension Period||0
10243862|NCT02720523|11375718|FG003|COMPLETED|Period 2: Long-term Extension Period||0
10243863|NCT02720523|11375719|FG004|COMPLETED|Period 2: Long-term Extension Period||0
10243864|NCT02720523|11375720|FG005|COMPLETED|Period 2: Long-term Extension Period||0
10243865|NCT02720523|11375721|FG006|COMPLETED|Period 2: Long-term Extension Period||0
10243866|NCT02720523|11375715|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0
10243867|NCT02720523|11375716|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0
10243868|NCT02720523|11375717|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0
10243869|NCT02720523|11375718|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0
10243870|NCT02720523|11375719|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65
10243871|NCT02720523|11375720|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62
10243872|NCT02720523|11375721|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60
10243873|NCT02625324|11375734|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
10243874|NCT02625324|11375734|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
10243875|NCT02625324|11375734|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
10243876|NCT02625324|11375734|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
10243877|NCT02625324|11375734|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
10243878|NCT02625324|11375734|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
10243879|NCT02625324|11375734|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
10243880|NCT02625324|11375734|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91
10243881|NCT02625324|11375734|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
10243882|NCT02625324|11375734|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
10243883|NCT02625324|11375734|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
10243884|NCT02625324|11375734|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
10243885|NCT02625324|11375734|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
10243886|NCT02625324|11375734|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
10243887|NCT02625324|11375734|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
10243888|NCT02625324|11375734|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
10243889|NCT02625324|11375734|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
10243890|NCT02625324|11375734|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
10243891|NCT02581930|11375745|FG000|STARTED|Overall Study||18
10243892|NCT02581930|11375745|FG000|COMPLETED|Overall Study||16
10243893|NCT02581930|11375745|FG000|NOT COMPLETED|Overall Study||2
10243894|NCT02581137|11375749|FG000|STARTED|Overall Study||26
10243895|NCT02581137|11375749|FG000|COMPLETED|Overall Study||22
10243896|NCT02581137|11375749|FG000|NOT COMPLETED|Overall Study||4
10243897|NCT02568566|11375753|FG000|STARTED|Overall Study||201
10243898|NCT02568566|11375753|FG000|COMPLETED|Overall Study||187
10243899|NCT02568566|11375753|FG000|NOT COMPLETED|Overall Study||14
10243900|NCT02550652|11375759|FG000|STARTED|Overall Study||63
10243901|NCT02550652|11375760|FG001|STARTED|Overall Study||62
10243902|NCT02550652|11375759|FG000|COMPLETED|Overall Study||42
10243903|NCT02550652|11375760|FG001|COMPLETED|Overall Study||41
10243904|NCT02550652|11375759|FG000|NOT COMPLETED|Overall Study||21
10243905|NCT02550652|11375760|FG001|NOT COMPLETED|Overall Study||21
10243906|NCT02498600|11375768|FG000|STARTED|Overall Study||49
9833015|NCT00776594|10943811|FG000|STARTED|Overall Study||66
9833016|NCT00776594|10943812|FG001|STARTED|Overall Study||36
9833017|NCT00776594|10943811|FG000|COMPLETED|Overall Study||62
9833018|NCT00776594|10943812|FG001|COMPLETED|Overall Study||34
9833019|NCT00776594|10943811|FG000|NOT COMPLETED|Overall Study||4
9833020|NCT00776594|10943812|FG001|NOT COMPLETED|Overall Study||2
9833021|NCT00776659|10943820|FG000|STARTED|Overall Study||39
9833022|NCT00776659|10943820|FG000|COMPLETED|Overall Study||13
10243907|NCT02498600|11375769|FG001|STARTED|Overall Study||51
10243908|NCT02498600|11375768|FG000|COMPLETED|Overall Study||49
10243909|NCT02498600|11375769|FG001|COMPLETED|Overall Study||51
10243910|NCT02498600|11375768|FG000|NOT COMPLETED|Overall Study||0
10243911|NCT02498600|11375769|FG001|NOT COMPLETED|Overall Study||0
10243912|NCT02468778|11375778|FG000|STARTED|Overall Study||18
10243913|NCT02468778|11375779|FG001|STARTED|Overall Study||26
10243914|NCT02468778|11375780|FG002|STARTED|Overall Study||10
10243915|NCT02468778|11375778|FG000|COMPLETED|Overall Study||15
10243916|NCT02468778|11375779|FG001|COMPLETED|Overall Study||22
10243917|NCT02468778|11375780|FG002|COMPLETED|Overall Study||7
10243918|NCT02468778|11375778|FG000|NOT COMPLETED|Overall Study||3
10243919|NCT02468778|11375779|FG001|NOT COMPLETED|Overall Study||4
10243920|NCT02468778|11375780|FG002|NOT COMPLETED|Overall Study||3
10243921|NCT02435849|11375788|FG000|STARTED|Overall Study||97
10243922|NCT02435849|11375788|FG000|Enrolled and Infused|Overall Study||79
10243923|NCT02435849|11375788|FG000|Enrolled But Not Infused|Overall Study||18
10243924|NCT02435849|11375788|FG000|Discontinued Study Follow-up|Overall Study||34
10243925|NCT02435849|11375788|FG000|COMPLETED|Overall Study||0
10243926|NCT02435849|11375788|FG000|NOT COMPLETED|Overall Study||97
10243927|NCT02432274|11375800|FG000|STARTED|Overall Study||3
10243928|NCT02432274|11375801|FG001|STARTED|Overall Study||9
10243929|NCT02432274|11375802|FG002|STARTED|Overall Study||11
10243930|NCT02432274|11375803|FG003|STARTED|Overall Study||1
10243931|NCT02432274|11375804|FG004|STARTED|Overall Study||31
10243932|NCT02432274|11375805|FG005|STARTED|Overall Study||7
10243933|NCT02432274|11375806|FG006|STARTED|Overall Study||15
10243934|NCT02432274|11375807|FG007|STARTED|Overall Study||20
10243935|NCT02432274|11375800|FG000|Underwent Run-in Period|Overall Study||1
10243936|NCT02432274|11375801|FG001|Underwent Run-in Period|Overall Study||1
10243937|NCT02432274|11375802|FG002|Underwent Run-in Period|Overall Study||0
10243938|NCT02432274|11375803|FG003|Underwent Run-in Period|Overall Study||0
10243939|NCT02432274|11375804|FG004|Underwent Run-in Period|Overall Study||0
10243940|NCT02432274|11375805|FG005|Underwent Run-in Period|Overall Study||0
10243941|NCT02432274|11375806|FG006|Underwent Run-in Period|Overall Study||0
10243942|NCT02432274|11375807|FG007|Underwent Run-in Period|Overall Study||0
10243943|NCT02432274|11375800|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
10243944|NCT02432274|11375801|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
10243945|NCT02432274|11375802|FG002|Treated (Safety Population)|Overall Study||7
10243946|NCT02432274|11375803|FG003|Treated (Safety Population)|Overall Study||1
10243947|NCT02432274|11375804|FG004|Treated (Safety Population)|Overall Study||31
10243948|NCT02432274|11375805|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
10243949|NCT02432274|11375806|FG006|Treated (Safety Population)|Overall Study||11
10243950|NCT02432274|11375807|FG007|Treated (Safety Population)|Overall Study||20
10243951|NCT02432274|11375800|FG000|COMPLETED|Overall Study||0
10243952|NCT02432274|11375801|FG001|COMPLETED|Overall Study||0
10243953|NCT02432274|11375802|FG002|COMPLETED|Overall Study||0
10243954|NCT02432274|11375803|FG003|COMPLETED|Overall Study||0
10243955|NCT02432274|11375804|FG004|COMPLETED|Overall Study||0
10243956|NCT02432274|11375805|FG005|COMPLETED|Overall Study||0
10243957|NCT02432274|11375806|FG006|COMPLETED|Overall Study||0
10243958|NCT02432274|11375807|FG007|COMPLETED|Overall Study||0
10243959|NCT02432274|11375800|FG000|NOT COMPLETED|Overall Study||3
10243960|NCT02432274|11375801|FG001|NOT COMPLETED|Overall Study||9
10243961|NCT02432274|11375802|FG002|NOT COMPLETED|Overall Study||11
10243962|NCT02432274|11375803|FG003|NOT COMPLETED|Overall Study||1
10243963|NCT02432274|11375804|FG004|NOT COMPLETED|Overall Study||31
10243964|NCT02432274|11375805|FG005|NOT COMPLETED|Overall Study||7
10243965|NCT02432274|11375806|FG006|NOT COMPLETED|Overall Study||15
10243966|NCT02432274|11375807|FG007|NOT COMPLETED|Overall Study||20
10243967|NCT02428192|11375839|FG000|STARTED|Overall Study||12
10243968|NCT02428192|11375840|FG001|STARTED|Overall Study||8
10243969|NCT02428192|11375839|FG000|COMPLETED|Overall Study||0
10243970|NCT02428192|11375840|FG001|COMPLETED|Overall Study||7
10243971|NCT02428192|11375839|FG000|NOT COMPLETED|Overall Study||12
10243972|NCT02428192|11375840|FG001|NOT COMPLETED|Overall Study||1
10243973|NCT02399215|11375847|FG000|STARTED|Overall Study||32
10243974|NCT02399215|11375847|FG000|COMPLETED|Overall Study||30
10243975|NCT02399215|11375847|FG000|NOT COMPLETED|Overall Study||2
10243976|NCT02311478|11375851|FG000|STARTED|Overall Study||79
10243977|NCT02311478|11375851|FG000|IUD Insertion|Overall Study||78
10243978|NCT02311478|11375851|FG000|COMPLETED|Overall Study||72
10243979|NCT02311478|11375851|FG000|NOT COMPLETED|Overall Study||7
10243980|NCT02292238|11375858|FG000|STARTED|Overall Study||34
10243981|NCT02292238|11375859|FG001|STARTED|Overall Study||37
10243982|NCT02292238|11375858|FG000|COMPLETED|Overall Study||30
10243983|NCT02292238|11375859|FG001|COMPLETED|Overall Study||33
10243984|NCT02292238|11375858|FG000|NOT COMPLETED|Overall Study||4
10243985|NCT02292238|11375859|FG001|NOT COMPLETED|Overall Study||4
10243986|NCT02287818|11375868|FG000|STARTED|Overall Study||60
10243987|NCT02287818|11375869|FG001|STARTED|Overall Study||67
10243988|NCT02287818|11375868|FG000|COMPLETED|Overall Study||53
10243989|NCT02287818|11375869|FG001|COMPLETED|Overall Study||54
10243990|NCT02287818|11375868|FG000|NOT COMPLETED|Overall Study||7
10243991|NCT02287818|11375869|FG001|NOT COMPLETED|Overall Study||13
10243992|NCT02277119|11375878|FG000|STARTED|Overall Study||58
10243993|NCT02277119|11375879|FG001|STARTED|Overall Study||24
10243994|NCT02277119|11375880|FG002|STARTED|Overall Study||27
10243995|NCT02277119|11375878|FG000|COMPLETED|Overall Study||55
10243996|NCT02277119|11375879|FG001|COMPLETED|Overall Study||20
10243997|NCT02277119|11375880|FG002|COMPLETED|Overall Study||19
10243998|NCT02277119|11375878|FG000|NOT COMPLETED|Overall Study||3
10243999|NCT02277119|11375879|FG001|NOT COMPLETED|Overall Study||4
10019470|NCT01830816|11142662|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14
10019471|NCT01830816|11142663|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6
10244000|NCT02277119|11375880|FG002|NOT COMPLETED|Overall Study||8
10244001|NCT02264977|11375888|FG000|STARTED|Overall Study||9
10244002|NCT02264977|11375888|FG000|COMPLETED|Overall Study||4
10244003|NCT02264977|11375888|FG000|NOT COMPLETED|Overall Study||5
10244004|NCT02255097|11375892|FG000|STARTED|Overall Study||172
10244005|NCT02255097|11375892|FG000|Treated|Overall Study||171
10244006|NCT02255097|11375892|FG000|Received Second Course of Pembrolizumab|Overall Study||3
10244007|NCT02255097|11375892|FG000|COMPLETED|Overall Study||0
10244008|NCT02255097|11375892|FG000|NOT COMPLETED|Overall Study||172
10244009|NCT02218164|11375897|FG000|STARTED|Overall Study||8
10244010|NCT02218164|11375897|FG000|COMPLETED|Overall Study||8
10244011|NCT02218164|11375897|FG000|NOT COMPLETED|Overall Study||0
10244012|NCT02200614|11375903|FG000|STARTED|Double Blind Treatment||955
10244013|NCT02200614|11375904|FG001|STARTED|Double Blind Treatment||554
10244014|NCT02200614|11375903|FG000|COMPLETED|Double Blind Treatment||591
10244015|NCT02200614|11375904|FG001|COMPLETED|Double Blind Treatment||170
10244016|NCT02200614|11375903|FG000|NOT COMPLETED|Double Blind Treatment||364
10244017|NCT02200614|11375904|FG001|NOT COMPLETED|Double Blind Treatment||384
10244018|NCT02200614|11375903|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
10244019|NCT02200614|11375904|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
10244020|NCT02200614|11375903|FG000|COMPLETED|Open Label||295
10244021|NCT02200614|11375904|FG001|COMPLETED|Open Label||114
10244022|NCT02200614|11375903|FG000|NOT COMPLETED|Open Label||296
10244023|NCT02200614|11375904|FG001|NOT COMPLETED|Open Label||56
10244024|NCT02108652|11375912|FG000|STARTED|Overall Study||310
10244025|NCT02108652|11375912|FG000|COMPLETED|Overall Study||0
10244026|NCT02108652|11375912|FG000|NOT COMPLETED|Overall Study||310
10244027|NCT02083081|11375918|FG000|STARTED|Overall Study||188
10244028|NCT02083081|11375919|FG001|STARTED|Overall Study||164
10244029|NCT02083081|11375918|FG000|COMPLETED|Overall Study||157
10244030|NCT02083081|11375919|FG001|COMPLETED|Overall Study||155
10244031|NCT02083081|11375918|FG000|NOT COMPLETED|Overall Study||31
10244032|NCT02083081|11375919|FG001|NOT COMPLETED|Overall Study||9
10244033|NCT02069899|11375928|FG000|STARTED|Overall Study||37
10244034|NCT02069899|11375929|FG001|STARTED|Overall Study||14
10244035|NCT02069899|11375930|FG002|STARTED|Overall Study||7
10244036|NCT02069899|11375928|FG000|Treated in Current Study|Overall Study||22
10244037|NCT02069899|11375929|FG001|Treated in Current Study|Overall Study||0
10244038|NCT02069899|11375930|FG002|Treated in Current Study|Overall Study||5
10244039|NCT02069899|11375928|FG000|COMPLETED|Overall Study||24
10244040|NCT02069899|11375929|FG001|COMPLETED|Overall Study||13
10244041|NCT02069899|11375930|FG002|COMPLETED|Overall Study||4
10244042|NCT02069899|11375928|FG000|NOT COMPLETED|Overall Study||13
10244043|NCT02069899|11375929|FG001|NOT COMPLETED|Overall Study||1
10244044|NCT02069899|11375930|FG002|NOT COMPLETED|Overall Study||3
10244045|NCT02021812|11375939|FG000|STARTED|Overall Study||31
10244046|NCT02021812|11375939|FG000|COMPLETED|Overall Study||9
10244047|NCT02021812|11375939|FG000|NOT COMPLETED|Overall Study||22
10244048|NCT02018861|11375953|FG000|STARTED|Parsaclisib Monotherapy: 21-day Cycles||1
10244049|NCT02018861|11375954|FG001|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3
10244050|NCT02018861|11375955|FG002|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3
10244051|NCT02018861|11375956|FG003|STARTED|Parsaclisib Monotherapy: 21-day Cycles||34
10244052|NCT02018861|11375957|FG004|STARTED|Parsaclisib Monotherapy: 21-day Cycles||27
10244053|NCT02018861|11375958|FG005|STARTED|Parsaclisib Monotherapy: 21-day Cycles||4
10244054|NCT02018861|11375959|FG006|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10244055|NCT02018861|11375960|FG007|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10244056|NCT02018861|11375961|FG008|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10244057|NCT02018861|11375962|FG009|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10244058|NCT02018861|11375953|FG000|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244059|NCT02018861|11375954|FG001|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244060|NCT02018861|11375955|FG002|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244061|NCT02018861|11375956|FG003|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4
10244062|NCT02018861|11375957|FG004|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244063|NCT02018861|11375958|FG005|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244064|NCT02018861|11375959|FG006|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244065|NCT02018861|11375960|FG007|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244066|NCT02018861|11375961|FG008|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244067|NCT02018861|11375962|FG009|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244068|NCT02018861|11375953|FG000|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||1
10244069|NCT02018861|11375954|FG001|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3
10244070|NCT02018861|11375955|FG002|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3
10244071|NCT02018861|11375956|FG003|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||30
10244072|NCT02018861|11375957|FG004|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||27
10244073|NCT02018861|11375958|FG005|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4
10244074|NCT02018861|11375959|FG006|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244075|NCT02018861|11375960|FG007|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244076|NCT02018861|11375961|FG008|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244077|NCT02018861|11375962|FG009|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10244078|NCT02018861|11375953|FG000|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244079|NCT02018861|11375954|FG001|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244080|NCT02018861|11375955|FG002|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244081|NCT02018861|11375956|FG003|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244082|NCT02018861|11375957|FG004|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244083|NCT02018861|11375958|FG005|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244084|NCT02018861|11375959|FG006|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||8
10244085|NCT02018861|11375960|FG007|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||3
10244086|NCT02018861|11375961|FG008|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244087|NCT02018861|11375962|FG009|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244088|NCT02018861|11375953|FG000|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244089|NCT02018861|11375954|FG001|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244090|NCT02018861|11375955|FG002|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244091|NCT02018861|11375956|FG003|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244092|NCT02018861|11375957|FG004|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244093|NCT02018861|11375958|FG005|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244094|NCT02018861|11375959|FG006|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244095|NCT02018861|11375960|FG007|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244096|NCT02018861|11375961|FG008|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244097|NCT02018861|11375962|FG009|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244098|NCT02018861|11375953|FG000|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244099|NCT02018861|11375954|FG001|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244100|NCT02018861|11375955|FG002|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244101|NCT02018861|11375956|FG003|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244102|NCT02018861|11375957|FG004|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244103|NCT02018861|11375958|FG005|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244104|NCT02018861|11375959|FG006|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||8
10244105|NCT02018861|11375960|FG007|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||3
10244106|NCT02018861|11375961|FG008|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244107|NCT02018861|11375962|FG009|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10244108|NCT02018861|11375953|FG000|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244109|NCT02018861|11375954|FG001|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244110|NCT02018861|11375955|FG002|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244111|NCT02018861|11375956|FG003|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244112|NCT02018861|11375957|FG004|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244113|NCT02018861|11375958|FG005|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244114|NCT02018861|11375959|FG006|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244115|NCT02018861|11375960|FG007|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10244116|NCT02018861|11375961|FG008|STARTED|Parsaclisib + R-ICE; 21-day Cycles||4
10244117|NCT02018861|11375962|FG009|STARTED|Parsaclisib + R-ICE; 21-day Cycles||1
10244118|NCT02018861|11375953|FG000|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244119|NCT02018861|11375954|FG001|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244120|NCT02018861|11375955|FG002|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244121|NCT02018861|11375956|FG003|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244122|NCT02018861|11375957|FG004|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244123|NCT02018861|11375958|FG005|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244124|NCT02018861|11375959|FG006|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244125|NCT02018861|11375960|FG007|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244126|NCT02018861|11375961|FG008|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1
10244127|NCT02018861|11375962|FG009|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1
10244128|NCT02018861|11375953|FG000|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244129|NCT02018861|11375954|FG001|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244130|NCT02018861|11375955|FG002|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244131|NCT02018861|11375956|FG003|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244132|NCT02018861|11375957|FG004|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244133|NCT02018861|11375958|FG005|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244134|NCT02018861|11375959|FG006|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244135|NCT02018861|11375960|FG007|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244136|NCT02018861|11375961|FG008|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||3
10244137|NCT02018861|11375962|FG009|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10244138|NCT01772472|11375993|FG000|STARTED|Overall Study||743
10244139|NCT01772472|11375994|FG001|STARTED|Overall Study||743
10244140|NCT01772472|11375993|FG000|COMPLETED|Overall Study||0
10244141|NCT01772472|11375994|FG001|COMPLETED|Overall Study||0
10244142|NCT01772472|11375993|FG000|NOT COMPLETED|Overall Study||743
10244143|NCT01772472|11375994|FG001|NOT COMPLETED|Overall Study||743
10244144|NCT01721759|11376000|FG000|STARTED|Treatment Period||117
10244145|NCT01721759|11376000|FG000|COMPLETED|Treatment Period||0
10244146|NCT01721759|11376000|FG000|NOT COMPLETED|Treatment Period||117
10244147|NCT01721759|11376000|FG000|STARTED|End of Study Period||117
10244148|NCT01721759|11376000|FG000|COMPLETED|End of Study Period||0
10244149|NCT01721759|11376000|FG000|NOT COMPLETED|End of Study Period||117
10244150|NCT01711541|11376009|FG000|STARTED|Overall Study||4
10244151|NCT01711541|11376010|FG001|STARTED|Overall Study||4
10244152|NCT01711541|11376011|FG002|STARTED|Overall Study||3
10244153|NCT01711541|11376012|FG003|STARTED|Overall Study||6
10244154|NCT01711541|11376013|FG004|STARTED|Overall Study||7
10244155|NCT01711541|11376009|FG000|COMPLETED|Overall Study||4
10244156|NCT01711541|11376010|FG001|COMPLETED|Overall Study||3
10244157|NCT01711541|11376011|FG002|COMPLETED|Overall Study||3
10244158|NCT01711541|11376012|FG003|COMPLETED|Overall Study||5
10244159|NCT01711541|11376013|FG004|COMPLETED|Overall Study||7
10244160|NCT01711541|11376009|FG000|NOT COMPLETED|Overall Study||0
10244161|NCT01711541|11376010|FG001|NOT COMPLETED|Overall Study||1
10244162|NCT01711541|11376011|FG002|NOT COMPLETED|Overall Study||0
10244163|NCT01711541|11376012|FG003|NOT COMPLETED|Overall Study||1
9833023|NCT00776659|10943820|FG000|NOT COMPLETED|Overall Study||26
9833024|NCT00776789|10943826|FG000|STARTED|Overall Study||20
10244164|NCT01711541|11376013|FG004|NOT COMPLETED|Overall Study||0
10244165|NCT01696994|11376032|FG000|STARTED|Overall Study||39111
10244166|NCT01696994|11376033|FG001|STARTED|Overall Study||39105
9833025|NCT00776789|10943827|FG001|STARTED|Overall Study||21
10244167|NCT01696994|11376032|FG000|COMPLETED|Overall Study||33919
10019472|NCT01830816|11142661|FG000|COMPLETED|Overall Study||0
10019473|NCT01830816|11142662|FG001|COMPLETED|Overall Study||0
10244168|NCT01696994|11376033|FG001|COMPLETED|Overall Study||30668
10244169|NCT01696994|11376032|FG000|NOT COMPLETED|Overall Study||5192
10244170|NCT01696994|11376033|FG001|NOT COMPLETED|Overall Study||8437
10244171|NCT01696981|11376043|FG000|STARTED|Overall Study||77455
10244172|NCT01696981|11376044|FG001|STARTED|Overall Study||77445
10244173|NCT01696981|11376043|FG000|COMPLETED|Overall Study||76254
10244174|NCT01696981|11376044|FG001|COMPLETED|Overall Study||67071
10244175|NCT01696981|11376043|FG000|NOT COMPLETED|Overall Study||1201
10244176|NCT01696981|11376044|FG001|NOT COMPLETED|Overall Study||10374
10244177|NCT01696968|11376052|FG000|STARTED|Overall Study||77456
10244178|NCT01696968|11376053|FG001|STARTED|Overall Study||77445
10244179|NCT01696968|11376052|FG000|COMPLETED|Overall Study||76255
10244180|NCT01696968|11376053|FG001|COMPLETED|Overall Study||70633
10244181|NCT01696968|11376052|FG000|NOT COMPLETED|Overall Study||1201
10244182|NCT01696968|11376053|FG001|NOT COMPLETED|Overall Study||6812
10244183|NCT01553149|11376062|FG000|STARTED|Overall Study||37
10244184|NCT01553149|11376063|FG001|STARTED|Overall Study||38
10244185|NCT01553149|11376062|FG000|COMPLETED|Overall Study||32
10244186|NCT01553149|11376063|FG001|COMPLETED|Overall Study||18
10244187|NCT01553149|11376062|FG000|NOT COMPLETED|Overall Study||5
10244188|NCT01553149|11376063|FG001|NOT COMPLETED|Overall Study||20
10244189|NCT01544335|11376069|FG000|STARTED|Overall Study||191
10244190|NCT01544335|11376069|FG000|COMPLETED|Overall Study||138
10244191|NCT01544335|11376069|FG000|NOT COMPLETED|Overall Study||53
10244192|NCT01522976|11376076|FG000|STARTED|Overall Study||97
10244193|NCT01522976|11376077|FG001|STARTED|Overall Study||92
10244194|NCT01522976|11376078|FG002|STARTED|Overall Study||93
10244195|NCT01522976|11376076|FG000|COMPLETED|Overall Study||0
10244196|NCT01522976|11376077|FG001|COMPLETED|Overall Study||0
10244197|NCT01522976|11376078|FG002|COMPLETED|Overall Study||0
10244198|NCT01522976|11376076|FG000|NOT COMPLETED|Overall Study||97
10244199|NCT01522976|11376077|FG001|NOT COMPLETED|Overall Study||92
10244200|NCT01522976|11376078|FG002|NOT COMPLETED|Overall Study||93
10244201|NCT01468896|11376091|FG000|STARTED|Overall Study||6
10244202|NCT01468896|11376092|FG001|STARTED|Overall Study||17
10244203|NCT01468896|11376091|FG000|COMPLETED|Overall Study||6
10244204|NCT01468896|11376092|FG001|COMPLETED|Overall Study||17
10244205|NCT01468896|11376091|FG000|NOT COMPLETED|Overall Study||0
10244206|NCT01468896|11376092|FG001|NOT COMPLETED|Overall Study||0
10244207|NCT01451515|11376102|FG000|STARTED|Overall Study||12
10244208|NCT01451515|11376103|FG001|STARTED|Overall Study||7
10244209|NCT01451515|11376104|FG002|STARTED|Overall Study||4
10244210|NCT01451515|11376102|FG000|COMPLETED|Overall Study||11
10244211|NCT01451515|11376103|FG001|COMPLETED|Overall Study||4
10244212|NCT01451515|11376104|FG002|COMPLETED|Overall Study||3
10244213|NCT01451515|11376102|FG000|NOT COMPLETED|Overall Study||1
10244214|NCT01451515|11376103|FG001|NOT COMPLETED|Overall Study||3
10244215|NCT01451515|11376104|FG002|NOT COMPLETED|Overall Study||1
10244216|NCT01420926|11376117|FG000|STARTED|Overall Study||82
10244217|NCT01420926|11376118|FG001|STARTED|Overall Study||81
10244218|NCT01420926|11376117|FG000|COMPLETED|Overall Study||22
10244219|NCT01420926|11376118|FG001|COMPLETED|Overall Study||16
10244220|NCT01420926|11376117|FG000|NOT COMPLETED|Overall Study||60
10244221|NCT01420926|11376118|FG001|NOT COMPLETED|Overall Study||65
10244222|NCT01413399|11376126|FG000|STARTED|Overall Study||208
10244223|NCT01413399|11376127|FG001|STARTED|Overall Study||334
10244224|NCT01413399|11376126|FG000|COMPLETED|Overall Study||208
10244225|NCT01413399|11376127|FG001|COMPLETED|Overall Study||334
10244226|NCT01413399|11376126|FG000|NOT COMPLETED|Overall Study||0
10244227|NCT01413399|11376127|FG001|NOT COMPLETED|Overall Study||0
10244228|NCT01386385|11376138|FG000|STARTED|Phase I 40mg: Concurrent CRT||8
10244229|NCT01386385|11376139|FG001|STARTED|Phase I 40mg: Concurrent CRT||0
10244230|NCT01386385|11376140|FG002|STARTED|Phase I 40mg: Concurrent CRT||0
10244231|NCT01386385|11376141|FG003|STARTED|Phase I 40mg: Concurrent CRT||0
10244232|NCT01386385|11376142|FG004|STARTED|Phase I 40mg: Concurrent CRT||0
10244233|NCT01386385|11376143|FG005|STARTED|Phase I 40mg: Concurrent CRT||0
10244234|NCT01386385|11376144|FG006|STARTED|Phase I 40mg: Concurrent CRT||0
10244235|NCT01386385|11376145|FG007|STARTED|Phase I 40mg: Concurrent CRT||0
10244236|NCT01386385|11376138|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6
10244237|NCT01386385|11376139|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0
10244238|NCT01386385|11376140|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0
10244239|NCT01386385|11376141|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0
10244240|NCT01386385|11376142|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0
10244241|NCT01386385|11376143|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0
10244242|NCT01386385|11376144|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0
10244243|NCT01386385|11376145|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0
10244244|NCT01386385|11376138|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
10244245|NCT01386385|11376139|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10244246|NCT01386385|11376140|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10244247|NCT01386385|11376141|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10244248|NCT01386385|11376142|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10244249|NCT01386385|11376143|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10019474|NCT01830816|11142663|FG002|COMPLETED|Overall Study||0
10019475|NCT01830816|11142661|FG000|NOT COMPLETED|Overall Study||20
10244250|NCT01386385|11376144|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10244251|NCT01386385|11376145|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10244252|NCT01386385|11376138|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0
10244253|NCT01386385|11376139|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4
10244254|NCT01386385|11376140|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0
10244255|NCT01386385|11376141|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0
10244256|NCT01386385|11376142|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0
10244257|NCT01386385|11376143|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0
10244258|NCT01386385|11376144|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0
10244259|NCT01386385|11376145|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0
10244260|NCT01386385|11376138|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244261|NCT01386385|11376139|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4
10244262|NCT01386385|11376140|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10019476|NCT01830816|11142662|FG001|NOT COMPLETED|Overall Study||14
10019477|NCT01830816|11142663|FG002|NOT COMPLETED|Overall Study||7
10019478|NCT01830842|11142676|FG000|STARTED|Overall Study||30
10019479|NCT01830842|11142677|FG001|STARTED|Overall Study||24
10019480|NCT01830842|11142676|FG000|COMPLETED|Overall Study||25
10019481|NCT01830842|11142677|FG001|COMPLETED|Overall Study||22
10019482|NCT01830842|11142676|FG000|NOT COMPLETED|Overall Study||5
10019483|NCT01830842|11142677|FG001|NOT COMPLETED|Overall Study||2
10019484|NCT01830855|11142687|FG000|STARTED|Overall Study||1508
10019485|NCT01830855|11142688|FG001|STARTED|Overall Study||598
10019486|NCT01830855|11142689|FG002|STARTED|Overall Study||587
10019487|NCT01830855|11142690|FG003|STARTED|Overall Study||897
10019488|NCT01830855|11142687|FG000|COMPLETED|Overall Study||1353
10019489|NCT01830855|11142688|FG001|COMPLETED|Overall Study||537
10019490|NCT01830855|11142689|FG002|COMPLETED|Overall Study||521
10113452|NCT02509117|11244198|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113453|NCT02509117|11244199|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10113454|NCT02509117|11244190|FG000|STARTED|Period 4 -Part A: 4 Days||2
10113455|NCT02509117|11244191|FG001|STARTED|Period 4 -Part A: 4 Days||2
10113456|NCT02509117|11244192|FG002|STARTED|Period 4 -Part A: 4 Days||2
10113457|NCT02509117|11244193|FG003|STARTED|Period 4 -Part A: 4 Days||2
10113458|NCT02509117|11244194|FG004|STARTED|Period 4 -Part A: 4 Days||0
10113459|NCT02509117|11244195|FG005|STARTED|Period 4 -Part A: 4 Days||0
10113460|NCT02509117|11244196|FG006|STARTED|Period 4 -Part A: 4 Days||0
10113461|NCT02509117|11244197|FG007|STARTED|Period 4 -Part A: 4 Days||0
10113462|NCT02509117|11244198|FG008|STARTED|Period 4 -Part A: 4 Days||0
10113463|NCT02509117|11244199|FG009|STARTED|Period 4 -Part A: 4 Days||0
10113464|NCT02509117|11244190|FG000|COMPLETED|Period 4 -Part A: 4 Days||2
10113465|NCT02509117|11244191|FG001|COMPLETED|Period 4 -Part A: 4 Days||2
10113466|NCT02509117|11244192|FG002|COMPLETED|Period 4 -Part A: 4 Days||2
10113467|NCT02509117|11244193|FG003|COMPLETED|Period 4 -Part A: 4 Days||2
10113468|NCT02509117|11244194|FG004|COMPLETED|Period 4 -Part A: 4 Days||0
10113469|NCT02509117|11244195|FG005|COMPLETED|Period 4 -Part A: 4 Days||0
10113470|NCT02509117|11244196|FG006|COMPLETED|Period 4 -Part A: 4 Days||0
10113471|NCT02509117|11244197|FG007|COMPLETED|Period 4 -Part A: 4 Days||0
10113472|NCT02509117|11244198|FG008|COMPLETED|Period 4 -Part A: 4 Days||0
10113473|NCT02509117|11244199|FG009|COMPLETED|Period 4 -Part A: 4 Days||0
10113474|NCT02509117|11244190|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113475|NCT02509117|11244191|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113476|NCT02509117|11244192|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113477|NCT02509117|11244193|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113478|NCT02509117|11244194|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113479|NCT02509117|11244195|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113480|NCT02509117|11244196|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113481|NCT02509117|11244197|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113482|NCT02509117|11244198|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113483|NCT02509117|11244199|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10113484|NCT02509156|11244239|FG000|STARTED|Open-Label Lead-In Phase||6
10113485|NCT02509156|11244240|FG001|STARTED|Open-Label Lead-In Phase||0
10113486|NCT02509156|11244239|FG000|COMPLETED|Open-Label Lead-In Phase||6
10113487|NCT02509156|11244240|FG001|COMPLETED|Open-Label Lead-In Phase||0
10113488|NCT02509156|11244239|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0
10113489|NCT02509156|11244240|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0
10113490|NCT02509156|11244239|FG000|STARTED|Randomized Phase|Includes randomized participants only|14
10113491|NCT02509156|11244240|FG001|STARTED|Randomized Phase||17
10113492|NCT02509156|11244239|FG000|COMPLETED|Randomized Phase||12
10113493|NCT02509156|11244240|FG001|COMPLETED|Randomized Phase||16
10113494|NCT02509156|11244239|FG000|NOT COMPLETED|Randomized Phase||2
10113495|NCT02509156|11244240|FG001|NOT COMPLETED|Randomized Phase||1
10113496|NCT02509481|11244248|FG000|STARTED|Overall Study||1265
10113497|NCT02509481|11244249|FG001|STARTED|Overall Study||1447
10113498|NCT02509481|11244248|FG000|COMPLETED|Overall Study||1265
10113499|NCT02509481|11244249|FG001|COMPLETED|Overall Study||1447
10019491|NCT01830855|11142690|FG003|COMPLETED|Overall Study||815
10019492|NCT01830855|11142687|FG000|NOT COMPLETED|Overall Study||155
10019493|NCT01830855|11142688|FG001|NOT COMPLETED|Overall Study||61
10019494|NCT01830855|11142689|FG002|NOT COMPLETED|Overall Study||66
10019495|NCT01830855|11142690|FG003|NOT COMPLETED|Overall Study||82
10019496|NCT01830881|11142707|FG000|STARTED|Overall Study||62
10019497|NCT01830881|11142708|FG001|STARTED|Overall Study||62
10244263|NCT01386385|11376141|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244264|NCT01386385|11376142|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244265|NCT01386385|11376143|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244266|NCT01386385|11376144|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244267|NCT01386385|11376145|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244268|NCT01386385|11376138|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244269|NCT01386385|11376139|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244270|NCT01386385|11376140|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244271|NCT01386385|11376141|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244272|NCT01386385|11376142|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244273|NCT01386385|11376143|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244274|NCT01386385|11376144|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244275|NCT01386385|11376145|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10244276|NCT01386385|11376138|FG000|STARTED|Phase I 80mg: Concurrent CRT||0
10244277|NCT01386385|11376139|FG001|STARTED|Phase I 80mg: Concurrent CRT||0
10244278|NCT01386385|11376140|FG002|STARTED|Phase I 80mg: Concurrent CRT||7
10244279|NCT01386385|11376141|FG003|STARTED|Phase I 80mg: Concurrent CRT||0
10244280|NCT01386385|11376142|FG004|STARTED|Phase I 80mg: Concurrent CRT||0
10244281|NCT01386385|11376143|FG005|STARTED|Phase I 80mg: Concurrent CRT||0
10244282|NCT01386385|11376144|FG006|STARTED|Phase I 80mg: Concurrent CRT||0
10244283|NCT01386385|11376145|FG007|STARTED|Phase I 80mg: Concurrent CRT||0
10244284|NCT01386385|11376138|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0
10244285|NCT01386385|11376139|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0
10244286|NCT01386385|11376140|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5
10019498|NCT01830881|11142707|FG000|COMPLETED|Overall Study||62
10113500|NCT02509481|11244248|FG000|NOT COMPLETED|Overall Study||0
10244287|NCT01386385|11376141|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0
10244288|NCT01386385|11376142|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0
10244289|NCT01386385|11376143|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0
10244290|NCT01386385|11376144|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0
10244291|NCT01386385|11376145|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0
10244292|NCT01386385|11376138|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10244293|NCT01386385|11376139|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10244294|NCT01386385|11376140|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
10244295|NCT01386385|11376141|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10244296|NCT01386385|11376142|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10244297|NCT01386385|11376143|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10244298|NCT01386385|11376144|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10244299|NCT01386385|11376145|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10244300|NCT01386385|11376138|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0
10244301|NCT01386385|11376139|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0
10244302|NCT01386385|11376140|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0
10244303|NCT01386385|11376141|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5
10244304|NCT01386385|11376142|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0
10244305|NCT01386385|11376143|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0
10244306|NCT01386385|11376144|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0
10244307|NCT01386385|11376145|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0
10244308|NCT01386385|11376138|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244309|NCT01386385|11376139|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244310|NCT01386385|11376140|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244311|NCT01386385|11376141|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5
10244312|NCT01386385|11376142|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244313|NCT01386385|11376143|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244314|NCT01386385|11376144|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244315|NCT01386385|11376145|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244316|NCT01386385|11376138|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244317|NCT01386385|11376139|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244318|NCT01386385|11376140|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244319|NCT01386385|11376141|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244320|NCT01386385|11376142|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10019499|NCT01830881|11142708|FG001|COMPLETED|Overall Study||61
10019500|NCT01830881|11142707|FG000|NOT COMPLETED|Overall Study||0
10019501|NCT01830881|11142708|FG001|NOT COMPLETED|Overall Study||1
10019502|NCT01830920|11142721|FG000|STARTED|Overall Study||126
10019503|NCT01830920|11142722|FG001|STARTED|Overall Study||46
10019504|NCT01830920|11142723|FG002|STARTED|Overall Study||48
10019505|NCT01830920|11142724|FG003|STARTED|Overall Study||125
10019506|NCT01830920|11142725|FG004|STARTED|Overall Study||107
10113501|NCT02509481|11244249|FG001|NOT COMPLETED|Overall Study||0
10113502|NCT02509585|11244255|FG000|STARTED|Overall Study||18
10113503|NCT02509585|11244255|FG000|COMPLETED|Overall Study||18
10113504|NCT02509585|11244255|FG000|NOT COMPLETED|Overall Study||0
10113505|NCT02509624|11244264|FG000|STARTED|Overall Study||10
10113506|NCT02509624|11244265|FG001|STARTED|Overall Study||10
10113507|NCT02509624|11244266|FG002|STARTED|Overall Study||10
10019507|NCT01830920|11142721|FG000|Received Allocated Drug|Overall Study||115
10113508|NCT02509624|11244267|FG003|STARTED|Overall Study||22
10113509|NCT02509624|11244264|FG000|COMPLETED|Overall Study||10
10113510|NCT02509624|11244265|FG001|COMPLETED|Overall Study||10
10244321|NCT01386385|11376143|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244322|NCT01386385|11376144|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244323|NCT01386385|11376145|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10244324|NCT01386385|11376138|FG000|STARTED|Phase I 120mg: Concurrent CRT||0
10244325|NCT01386385|11376139|FG001|STARTED|Phase I 120mg: Concurrent CRT||0
10244326|NCT01386385|11376140|FG002|STARTED|Phase I 120mg: Concurrent CRT||0
10244327|NCT01386385|11376141|FG003|STARTED|Phase I 120mg: Concurrent CRT||0
10244328|NCT01386385|11376142|FG004|STARTED|Phase I 120mg: Concurrent CRT||6
10244329|NCT01386385|11376143|FG005|STARTED|Phase I 120mg: Concurrent CRT||0
10244330|NCT01386385|11376144|FG006|STARTED|Phase I 120mg: Concurrent CRT||0
10244331|NCT01386385|11376145|FG007|STARTED|Phase I 120mg: Concurrent CRT||0
10244332|NCT01386385|11376138|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0
10244333|NCT01386385|11376139|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0
10244334|NCT01386385|11376140|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0
10244335|NCT01386385|11376141|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0
10244336|NCT01386385|11376142|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5
10244337|NCT01386385|11376143|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0
10244338|NCT01386385|11376144|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0
10244339|NCT01386385|11376145|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0
10244340|NCT01386385|11376138|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10244341|NCT01386385|11376139|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10244342|NCT01386385|11376140|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10244343|NCT01386385|11376141|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10244344|NCT01386385|11376142|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
10244345|NCT01386385|11376143|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10244346|NCT01386385|11376144|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10244347|NCT01386385|11376145|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10244348|NCT01386385|11376138|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0
10244349|NCT01386385|11376139|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0
10244350|NCT01386385|11376140|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0
10244351|NCT01386385|11376141|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0
10244352|NCT01386385|11376142|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0
10244353|NCT01386385|11376143|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5
10244354|NCT01386385|11376144|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0
9833026|NCT00776789|10943826|FG000|COMPLETED|Overall Study||17
9833027|NCT00776789|10943827|FG001|COMPLETED|Overall Study||18
9833028|NCT00776789|10943826|FG000|NOT COMPLETED|Overall Study||3
9833029|NCT00776789|10943827|FG001|NOT COMPLETED|Overall Study||3
9833030|NCT00776919|10943839|FG000|STARTED|Overall Study||327
9833031|NCT00776919|10943840|FG001|STARTED|Overall Study||328
10244355|NCT01386385|11376145|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0
10244356|NCT01386385|11376138|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244357|NCT01386385|11376139|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244358|NCT01386385|11376140|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244359|NCT01386385|11376141|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244360|NCT01386385|11376142|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244361|NCT01386385|11376143|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5
10244362|NCT01386385|11376144|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244363|NCT01386385|11376145|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244364|NCT01386385|11376138|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244365|NCT01386385|11376139|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244366|NCT01386385|11376140|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244367|NCT01386385|11376141|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244368|NCT01386385|11376142|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244369|NCT01386385|11376143|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244370|NCT01386385|11376144|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244371|NCT01386385|11376145|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10244372|NCT01386385|11376138|FG000|STARTED|Phase II Concurrent CRT||0
10244373|NCT01386385|11376139|FG001|STARTED|Phase II Concurrent CRT||0
10244374|NCT01386385|11376140|FG002|STARTED|Phase II Concurrent CRT||0
10244375|NCT01386385|11376141|FG003|STARTED|Phase II Concurrent CRT||0
10244376|NCT01386385|11376142|FG004|STARTED|Phase II Concurrent CRT||0
10244377|NCT01386385|11376143|FG005|STARTED|Phase II Concurrent CRT||0
10244378|NCT01386385|11376144|FG006|STARTED|Phase II Concurrent CRT||18
10244379|NCT01386385|11376145|FG007|STARTED|Phase II Concurrent CRT||13
10244380|NCT01386385|11376138|FG000|COMPLETED|Phase II Concurrent CRT||0
10244381|NCT01386385|11376139|FG001|COMPLETED|Phase II Concurrent CRT||0
10244382|NCT01386385|11376140|FG002|COMPLETED|Phase II Concurrent CRT||0
10244383|NCT01386385|11376141|FG003|COMPLETED|Phase II Concurrent CRT||0
10244384|NCT01386385|11376142|FG004|COMPLETED|Phase II Concurrent CRT||0
10244385|NCT01386385|11376143|FG005|COMPLETED|Phase II Concurrent CRT||0
10244386|NCT01386385|11376144|FG006|COMPLETED|Phase II Concurrent CRT||12
10244387|NCT01386385|11376145|FG007|COMPLETED|Phase II Concurrent CRT||10
10244388|NCT01386385|11376138|FG000|NOT COMPLETED|Phase II Concurrent CRT||0
10244389|NCT01386385|11376139|FG001|NOT COMPLETED|Phase II Concurrent CRT||0
10244390|NCT01386385|11376140|FG002|NOT COMPLETED|Phase II Concurrent CRT||0
10244391|NCT01386385|11376141|FG003|NOT COMPLETED|Phase II Concurrent CRT||0
10244392|NCT01386385|11376142|FG004|NOT COMPLETED|Phase II Concurrent CRT||0
10244393|NCT01386385|11376143|FG005|NOT COMPLETED|Phase II Concurrent CRT||0
10244394|NCT01386385|11376144|FG006|NOT COMPLETED|Phase II Concurrent CRT||6
10244395|NCT01386385|11376145|FG007|NOT COMPLETED|Phase II Concurrent CRT||3
10244396|NCT01386385|11376138|FG000|STARTED|Phase II: Consolidation Therapy||0
10244397|NCT01386385|11376139|FG001|STARTED|Phase II: Consolidation Therapy||0
10244398|NCT01386385|11376140|FG002|STARTED|Phase II: Consolidation Therapy||0
10244399|NCT01386385|11376141|FG003|STARTED|Phase II: Consolidation Therapy||0
10244400|NCT01386385|11376142|FG004|STARTED|Phase II: Consolidation Therapy||0
10244401|NCT01386385|11376143|FG005|STARTED|Phase II: Consolidation Therapy||0
10244402|NCT01386385|11376144|FG006|STARTED|Phase II: Consolidation Therapy||13
10244403|NCT01386385|11376145|FG007|STARTED|Phase II: Consolidation Therapy||10
10244404|NCT01386385|11376138|FG000|COMPLETED|Phase II: Consolidation Therapy||0
10244405|NCT01386385|11376139|FG001|COMPLETED|Phase II: Consolidation Therapy||0
10244406|NCT01386385|11376140|FG002|COMPLETED|Phase II: Consolidation Therapy||0
10244407|NCT01386385|11376141|FG003|COMPLETED|Phase II: Consolidation Therapy||0
10244408|NCT01386385|11376142|FG004|COMPLETED|Phase II: Consolidation Therapy||0
10244409|NCT01386385|11376143|FG005|COMPLETED|Phase II: Consolidation Therapy||0
10244410|NCT01386385|11376144|FG006|COMPLETED|Phase II: Consolidation Therapy||8
10244411|NCT01386385|11376145|FG007|COMPLETED|Phase II: Consolidation Therapy||8
10244412|NCT01386385|11376138|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0
10244413|NCT01386385|11376139|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0
10244414|NCT01386385|11376140|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0
10244415|NCT01386385|11376141|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0
10244416|NCT01386385|11376142|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0
10244417|NCT01386385|11376143|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0
10244418|NCT01386385|11376144|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5
10244419|NCT01386385|11376145|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2
10244420|NCT01371981|11376172|FG000|STARTED|Overall Study||580
10244421|NCT01371981|11376173|FG001|STARTED|Overall Study||591
10244422|NCT01371981|11376174|FG002|STARTED|Overall Study||12
10244423|NCT01371981|11376175|FG003|STARTED|Overall Study||33
10244424|NCT01371981|11376176|FG004|STARTED|Overall Study||47
10244425|NCT01371981|11376177|FG005|STARTED|Overall Study||382
10244426|NCT01371981|11376172|FG000|COMPLETED|Overall Study||396
10244427|NCT01371981|11376173|FG001|COMPLETED|Overall Study||399
10244428|NCT01371981|11376174|FG002|COMPLETED|Overall Study||6
10244429|NCT01371981|11376175|FG003|COMPLETED|Overall Study||12
10244430|NCT01371981|11376176|FG004|COMPLETED|Overall Study||15
10244431|NCT01371981|11376177|FG005|COMPLETED|Overall Study||368
10244432|NCT01371981|11376172|FG000|NOT COMPLETED|Overall Study||184
10244433|NCT01371981|11376173|FG001|NOT COMPLETED|Overall Study||192
10244434|NCT01371981|11376174|FG002|NOT COMPLETED|Overall Study||6
10244435|NCT01371981|11376175|FG003|NOT COMPLETED|Overall Study||21
10244436|NCT01371981|11376176|FG004|NOT COMPLETED|Overall Study||32
10244437|NCT01371981|11376177|FG005|NOT COMPLETED|Overall Study||14
10244438|NCT01302834|11376198|FG000|STARTED|Overall Study||424
10244439|NCT01302834|11376199|FG001|STARTED|Overall Study||425
10244440|NCT01302834|11376198|FG000|Eligible|Overall Study||406
10244441|NCT01302834|11376199|FG001|Eligible|Overall Study||399
10244442|NCT01302834|11376198|FG000|Started Treatment|Overall Study||398
10244443|NCT01302834|11376199|FG001|Started Treatment|Overall Study||394
10244444|NCT01302834|11376198|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
10244445|NCT01302834|11376199|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
10244446|NCT01302834|11376198|FG000|AE Assessed 3 Months PT|Overall Study||359
10244447|NCT01302834|11376199|FG001|AE Assessed 3 Months PT|Overall Study||367
10244448|NCT01302834|11376198|FG000|AE Assessed 6 Months PT|Overall Study||361
10244449|NCT01302834|11376199|FG001|AE Assessed 6 Months PT|Overall Study||352
10244450|NCT01302834|11376198|FG000|AE Assessment 1 Year PT|Overall Study||360
10244451|NCT01302834|11376199|FG001|AE Assessment 1 Year PT|Overall Study||351
10244452|NCT01302834|11376198|FG000|AE Assessed 2 Years PT|Overall Study||311
10244453|NCT01302834|11376199|FG001|AE Assessed 2 Years PT|Overall Study||303
10244454|NCT01302834|11376198|FG000|AE Assessed 5 Years PT|Overall Study||92
10244455|NCT01302834|11376199|FG001|AE Assessed 5 Years PT|Overall Study||86
10244456|NCT01302834|11376198|FG000|Dental Health Assessed 1 Year PT|Overall Study||267
10244457|NCT01302834|11376199|FG001|Dental Health Assessed 1 Year PT|Overall Study||267
10244458|NCT01302834|11376198|FG000|Dental Health Assessed 2 Years PT|Overall Study||208
10244459|NCT01302834|11376199|FG001|Dental Health Assessed 2 Years PT|Overall Study||201
10244460|NCT01302834|11376198|FG000|Dental Health Assessed 5 Years PT|Overall Study||44
10244461|NCT01302834|11376199|FG001|Dental Health Assessed 5 Years PT|Overall Study||43
10244462|NCT01302834|11376198|FG000|Feeding Tube Assessed|Overall Study||368
10244463|NCT01302834|11376199|FG001|Feeding Tube Assessed|Overall Study||356
10019508|NCT01830920|11142722|FG001|Received Allocated Drug|Overall Study||45
10019509|NCT01830920|11142723|FG002|Received Allocated Drug|Overall Study||47
10019510|NCT01830920|11142724|FG003|Received Allocated Drug|Overall Study||119
10019511|NCT01830920|11142725|FG004|Received Allocated Drug|Overall Study||105
10019512|NCT01830920|11142721|FG000|COMPLETED|Overall Study||105
10019513|NCT01830920|11142722|FG001|COMPLETED|Overall Study||40
10019514|NCT01830920|11142723|FG002|COMPLETED|Overall Study||40
10019515|NCT01830920|11142724|FG003|COMPLETED|Overall Study||109
10019516|NCT01830920|11142725|FG004|COMPLETED|Overall Study||99
10113511|NCT02509624|11244266|FG002|COMPLETED|Overall Study||10
10244464|NCT01302834|11376198|FG000|Progressed|Overall Study||76
10113512|NCT02509624|11244267|FG003|COMPLETED|Overall Study||22
10244465|NCT01302834|11376199|FG001|Progressed|Overall Study||122
10244466|NCT01302834|11376198|FG000|COMPLETED|Overall Study||406
10244467|NCT01302834|11376199|FG001|COMPLETED|Overall Study||399
10244468|NCT01302834|11376198|FG000|NOT COMPLETED|Overall Study||18
10244469|NCT01302834|11376199|FG001|NOT COMPLETED|Overall Study||26
10244470|NCT01286272|11376207|FG000|STARTED|Overall Study||67
10244471|NCT01286272|11376208|FG001|STARTED|Overall Study||65
10244472|NCT01286272|11376207|FG000|COMPLETED|Overall Study||66
10244473|NCT01286272|11376208|FG001|COMPLETED|Overall Study||62
10244474|NCT01286272|11376207|FG000|NOT COMPLETED|Overall Study||1
10244475|NCT01286272|11376208|FG001|NOT COMPLETED|Overall Study||3
10244476|NCT01275313|11376216|FG000|STARTED|Overall Study||127
10244477|NCT01275313|11376217|FG001|STARTED|Overall Study||131
10244478|NCT01275313|11376216|FG000|COMPLETED|Overall Study||102
10244479|NCT01275313|11376217|FG001|COMPLETED|Overall Study||79
10244480|NCT01275313|11376216|FG000|NOT COMPLETED|Overall Study||25
10244481|NCT01275313|11376217|FG001|NOT COMPLETED|Overall Study||52
10244482|NCT01267955|11376223|FG000|STARTED|Stage 1 (6 Months)||20
10244483|NCT01267955|11376223|FG000|COMPLETED|Stage 1 (6 Months)||17
10244484|NCT01267955|11376223|FG000|NOT COMPLETED|Stage 1 (6 Months)||3
10244485|NCT01267955|11376223|FG000|STARTED|Stage 2 (6 Months)||45
10244486|NCT01267955|11376223|FG000|COMPLETED|Stage 2 (6 Months)||39
10244487|NCT01267955|11376223|FG000|NOT COMPLETED|Stage 2 (6 Months)||6
10244488|NCT01253070|11376227|FG000|STARTED|Overall Study||54
10244489|NCT01253070|11376227|FG000|COMPLETED|Overall Study||54
10244490|NCT01253070|11376227|FG000|NOT COMPLETED|Overall Study||0
10244491|NCT01238211|11376232|FG000|STARTED|Overall Study||61
10244492|NCT01238211|11376232|FG000|COMPLETED|Overall Study||3
10244493|NCT01238211|11376232|FG000|NOT COMPLETED|Overall Study||58
10244494|NCT01177540|11376238|FG000|STARTED|Overall Study||11
10244495|NCT01177540|11376239|FG001|STARTED|Overall Study||14
10244496|NCT01177540|11376238|FG000|COMPLETED|Overall Study||10
10244497|NCT01177540|11376239|FG001|COMPLETED|Overall Study||14
10244498|NCT01177540|11376238|FG000|NOT COMPLETED|Overall Study||1
10244499|NCT01177540|11376239|FG001|NOT COMPLETED|Overall Study||0
10244500|NCT01038778|11376247|FG000|STARTED|Overall Study||3
10244501|NCT01038778|11376248|FG001|STARTED|Overall Study||8
10244502|NCT01038778|11376249|FG002|STARTED|Overall Study||36
10244503|NCT01038778|11376247|FG000|COMPLETED|Overall Study||3
10244504|NCT01038778|11376248|FG001|COMPLETED|Overall Study||6
10244505|NCT01038778|11376249|FG002|COMPLETED|Overall Study||33
10113513|NCT02509624|11244264|FG000|NOT COMPLETED|Overall Study||0
10113514|NCT02509624|11244265|FG001|NOT COMPLETED|Overall Study||0
10113515|NCT02509624|11244266|FG002|NOT COMPLETED|Overall Study||0
10113516|NCT02509624|11244267|FG003|NOT COMPLETED|Overall Study||0
10113517|NCT02509767|11244282|FG000|STARTED|Overall Study||201
10113518|NCT02509767|11244283|FG001|STARTED|Overall Study||200
10113519|NCT02509767|11244282|FG000|COMPLETED|Overall Study||157
10244506|NCT01038778|11376247|FG000|NOT COMPLETED|Overall Study||0
10244507|NCT01038778|11376248|FG001|NOT COMPLETED|Overall Study||2
10244508|NCT01038778|11376249|FG002|NOT COMPLETED|Overall Study||3
10244509|NCT00980538|11376256|FG000|STARTED|Overall Study||180
10244510|NCT00980538|11376256|FG000|COMPLETED|Overall Study||0
10244511|NCT00980538|11376256|FG000|NOT COMPLETED|Overall Study||180
10244512|NCT00980460|11376265|FG000|STARTED|Overall Study||8
10244513|NCT00980460|11376266|FG001|STARTED|Overall Study||51
10244514|NCT00980460|11376267|FG002|STARTED|Overall Study||105
10244515|NCT00980460|11376268|FG003|STARTED|Overall Study||32
10244516|NCT00980460|11376269|FG004|STARTED|Overall Study||40
10019517|NCT01830920|11142721|FG000|NOT COMPLETED|Overall Study||21
10019518|NCT01830920|11142722|FG001|NOT COMPLETED|Overall Study||6
10244517|NCT00980460|11376265|FG000|COMPLETED|Overall Study||8
10244518|NCT00980460|11376266|FG001|COMPLETED|Overall Study||47
10244519|NCT00980460|11376267|FG002|COMPLETED|Overall Study||70
10244520|NCT00980460|11376268|FG003|COMPLETED|Overall Study||14
10113520|NCT02509767|11244283|FG001|COMPLETED|Overall Study||159
10113521|NCT02509767|11244282|FG000|NOT COMPLETED|Overall Study||44
10113522|NCT02509767|11244283|FG001|NOT COMPLETED|Overall Study||41
10113523|NCT02509936|11244294|FG000|STARTED|Overall Study||163
10244521|NCT00980460|11376269|FG004|COMPLETED|Overall Study||24
10244522|NCT00980460|11376265|FG000|NOT COMPLETED|Overall Study||0
10244523|NCT00980460|11376266|FG001|NOT COMPLETED|Overall Study||4
10244524|NCT00980460|11376267|FG002|NOT COMPLETED|Overall Study||35
10244525|NCT00980460|11376268|FG003|NOT COMPLETED|Overall Study||18
9833032|NCT00776919|10943841|FG002|STARTED|Overall Study||328
9833033|NCT00776919|10943842|FG003|STARTED|Overall Study||332
9833034|NCT00776919|10943839|FG000|COMPLETED|Overall Study||300
9833035|NCT00776919|10943840|FG001|COMPLETED|Overall Study||295
9833036|NCT00776919|10943841|FG002|COMPLETED|Overall Study||296
9833037|NCT00776919|10943842|FG003|COMPLETED|Overall Study||293
9833038|NCT00776919|10943839|FG000|NOT COMPLETED|Overall Study||27
9833039|NCT00776919|10943840|FG001|NOT COMPLETED|Overall Study||33
9833040|NCT00776919|10943841|FG002|NOT COMPLETED|Overall Study||32
9833041|NCT00776919|10943842|FG003|NOT COMPLETED|Overall Study||39
9833042|NCT00776984|10943854|FG000|STARTED|Overall Study||234
9833043|NCT00776984|10943855|FG001|STARTED|Overall Study||219
9833044|NCT00776984|10943854|FG000|COMPLETED|Overall Study||203
9833045|NCT00776984|10943855|FG001|COMPLETED|Overall Study||198
9833046|NCT00776984|10943854|FG000|NOT COMPLETED|Overall Study||31
9833047|NCT00776984|10943855|FG001|NOT COMPLETED|Overall Study||21
9833048|NCT00776997|10943861|FG000|STARTED|Overall Study||100
9833049|NCT00776997|10943861|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
9833050|NCT00776997|10943861|FG000|NOT COMPLETED|Overall Study||2
9833051|NCT00777023|10943868|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
9833052|NCT00777023|10943869|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
9833053|NCT00777023|10943870|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
9833054|NCT00777023|10943868|FG000|COMPLETED|Overall Study||151
9833055|NCT00777023|10943869|FG001|COMPLETED|Overall Study||149
9833056|NCT00777023|10943870|FG002|COMPLETED|Overall Study||146
9833057|NCT00777023|10943868|FG000|NOT COMPLETED|Overall Study||35
9833058|NCT00777023|10943869|FG001|NOT COMPLETED|Overall Study||41
9833059|NCT00777023|10943870|FG002|NOT COMPLETED|Overall Study||37
9833060|NCT00777049|10943880|FG000|STARTED|Overall Study||33
9833061|NCT00777049|10943881|FG001|STARTED|Overall Study||21
10244526|NCT00980460|11376269|FG004|NOT COMPLETED|Overall Study||16
10244527|NCT00972478|11376290|FG000|STARTED|Overall Study||11
10244528|NCT00972478|11376291|FG001|STARTED|Overall Study||72
10244529|NCT00972478|11376290|FG000|Eligible and Began Protocol Therapy|Overall Study||9
10244530|NCT00972478|11376291|FG001|Eligible and Began Protocol Therapy|Overall Study||63
10244531|NCT00972478|11376290|FG000|COMPLETED|Overall Study||4
10244532|NCT00972478|11376291|FG001|COMPLETED|Overall Study||34
10244533|NCT00972478|11376290|FG000|NOT COMPLETED|Overall Study||7
10244534|NCT00972478|11376291|FG001|NOT COMPLETED|Overall Study||38
10244535|NCT00792259|11376301|FG000|STARTED|Overall Study||15
10244536|NCT00792259|11376302|FG001|STARTED|Overall Study||20
10244537|NCT00792259|11376303|FG002|STARTED|Overall Study||13
10244538|NCT00792259|11376301|FG000|COMPLETED|Overall Study||14
10244539|NCT00792259|11376302|FG001|COMPLETED|Overall Study||20
10244540|NCT00792259|11376303|FG002|COMPLETED|Overall Study||13
10244541|NCT00792259|11376301|FG000|NOT COMPLETED|Overall Study||1
10244542|NCT00792259|11376302|FG001|NOT COMPLETED|Overall Study||0
10244543|NCT00792259|11376303|FG002|NOT COMPLETED|Overall Study||0
10244544|NCT00662792|11376311|FG000|STARTED|Period 1||34
10244545|NCT00662792|11376312|FG001|STARTED|Period 1||38
10244546|NCT00662792|11376313|FG002|STARTED|Period 1||36
10244547|NCT00662792|11376314|FG003|STARTED|Period 1||39
10244548|NCT00662792|11376311|FG000|Treated|Period 1||34
10244549|NCT00662792|11376312|FG001|Treated|Period 1||37
10244550|NCT00662792|11376313|FG002|Treated|Period 1||36
10244551|NCT00662792|11376314|FG003|Treated|Period 1||39
10244552|NCT00662792|11376311|FG000|COMPLETED|Period 1||32
10244553|NCT00662792|11376312|FG001|COMPLETED|Period 1||31
10244554|NCT00662792|11376313|FG002|COMPLETED|Period 1||32
10244555|NCT00662792|11376314|FG003|COMPLETED|Period 1||39
10244556|NCT00662792|11376311|FG000|NOT COMPLETED|Period 1||2
10244557|NCT00662792|11376312|FG001|NOT COMPLETED|Period 1||7
10244558|NCT00662792|11376313|FG002|NOT COMPLETED|Period 1||4
10244559|NCT00662792|11376314|FG003|NOT COMPLETED|Period 1||0
10244560|NCT00662792|11376311|FG000|STARTED|Period 2||32
10244561|NCT00662792|11376312|FG001|STARTED|Period 2||31
10244562|NCT00662792|11376313|FG002|STARTED|Period 2||32
10244563|NCT00662792|11376314|FG003|STARTED|Period 2||39
10244564|NCT00662792|11376311|FG000|Treated|Period 2||32
10244565|NCT00662792|11376312|FG001|Treated|Period 2||31
10244566|NCT00662792|11376313|FG002|Treated|Period 2||32
10244567|NCT00662792|11376314|FG003|Treated|Period 2||39
10244568|NCT00662792|11376311|FG000|COMPLETED|Period 2||31
10244569|NCT00662792|11376312|FG001|COMPLETED|Period 2||31
10244570|NCT00662792|11376313|FG002|COMPLETED|Period 2||32
10244571|NCT00662792|11376314|FG003|COMPLETED|Period 2||36
10244572|NCT00662792|11376311|FG000|NOT COMPLETED|Period 2||1
10244573|NCT00662792|11376312|FG001|NOT COMPLETED|Period 2||0
10244574|NCT00662792|11376313|FG002|NOT COMPLETED|Period 2||0
10244575|NCT00662792|11376314|FG003|NOT COMPLETED|Period 2||3
10244576|NCT00662792|11376311|FG000|STARTED|Period 3||31
10244577|NCT00662792|11376312|FG001|STARTED|Period 3||31
10244578|NCT00662792|11376313|FG002|STARTED|Period 3||32
10244579|NCT00662792|11376314|FG003|STARTED|Period 3||36
10244580|NCT00662792|11376311|FG000|Treated|Period 3||31
10244581|NCT00662792|11376312|FG001|Treated|Period 3||31
10244582|NCT00662792|11376313|FG002|Treated|Period 3||32
10244583|NCT00662792|11376314|FG003|Treated|Period 3||36
10244584|NCT00662792|11376311|FG000|COMPLETED|Period 3||30
10244585|NCT00662792|11376312|FG001|COMPLETED|Period 3||31
10244586|NCT00662792|11376313|FG002|COMPLETED|Period 3||30
10244587|NCT00662792|11376314|FG003|COMPLETED|Period 3||35
10244588|NCT00662792|11376311|FG000|NOT COMPLETED|Period 3||1
10244589|NCT00662792|11376312|FG001|NOT COMPLETED|Period 3||0
10244590|NCT00662792|11376313|FG002|NOT COMPLETED|Period 3||2
10244591|NCT00662792|11376314|FG003|NOT COMPLETED|Period 3||1
10244592|NCT00662792|11376311|FG000|STARTED|Period 4||30
10244593|NCT00662792|11376312|FG001|STARTED|Period 4||31
10244594|NCT00662792|11376313|FG002|STARTED|Period 4||30
10244595|NCT00662792|11376314|FG003|STARTED|Period 4||35
10244596|NCT00662792|11376311|FG000|Treated|Period 4||30
10244597|NCT00662792|11376312|FG001|Treated|Period 4||31
10244598|NCT00662792|11376313|FG002|Treated|Period 4||30
10244599|NCT00662792|11376314|FG003|Treated|Period 4||35
10244600|NCT00662792|11376311|FG000|COMPLETED|Period 4||29
10244601|NCT00662792|11376312|FG001|COMPLETED|Period 4||30
10244602|NCT00662792|11376313|FG002|COMPLETED|Period 4||30
10244603|NCT00662792|11376314|FG003|COMPLETED|Period 4||34
10244604|NCT00662792|11376311|FG000|NOT COMPLETED|Period 4||1
10244605|NCT00662792|11376312|FG001|NOT COMPLETED|Period 4||1
10244606|NCT00662792|11376313|FG002|NOT COMPLETED|Period 4||0
10244607|NCT00662792|11376314|FG003|NOT COMPLETED|Period 4||1
10244608|NCT00602459|11376330|FG000|STARTED|Initial Registration/Randomization||138
10244609|NCT00602459|11376331|FG001|STARTED|Initial Registration/Randomization||140
10244610|NCT00602459|11376332|FG002|STARTED|Initial Registration/Randomization||140
10244611|NCT00602459|11376333|FG003|STARTED|Initial Registration/Randomization||0
10244612|NCT00602459|11376330|FG000|COMPLETED|Initial Registration/Randomization||133
10244613|NCT00602459|11376331|FG001|COMPLETED|Initial Registration/Randomization||130
10244614|NCT00602459|11376332|FG002|COMPLETED|Initial Registration/Randomization||137
10244615|NCT00602459|11376333|FG003|COMPLETED|Initial Registration/Randomization||0
10244616|NCT00602459|11376330|FG000|NOT COMPLETED|Initial Registration/Randomization||5
10244617|NCT00602459|11376331|FG001|NOT COMPLETED|Initial Registration/Randomization||10
10244618|NCT00602459|11376332|FG002|NOT COMPLETED|Initial Registration/Randomization||3
10244619|NCT00602459|11376333|FG003|NOT COMPLETED|Initial Registration/Randomization||0
10244620|NCT00602459|11376330|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123
10244621|NCT00602459|11376331|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109
10244622|NCT00602459|11376332|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137
10244623|NCT00602459|11376333|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31
10244624|NCT00602459|11376330|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
10244625|NCT00602459|11376331|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
10244626|NCT00602459|11376332|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
10244627|NCT00602459|11376333|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
10244628|NCT00602459|11376330|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10244629|NCT00602459|11376331|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10244630|NCT00602459|11376332|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10244631|NCT00602459|11376333|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
9833062|NCT00777049|10943880|FG000|COMPLETED|Overall Study||32
9833063|NCT00777049|10943881|FG001|COMPLETED|Overall Study||20
9833064|NCT00777049|10943880|FG000|NOT COMPLETED|Overall Study||1
9833065|NCT00777049|10943881|FG001|NOT COMPLETED|Overall Study||1
9833066|NCT00777062|10943889|FG000|STARTED|Overall Study||39
9833067|NCT00777062|10943890|FG001|STARTED|Overall Study||41
9833068|NCT00777062|10943889|FG000|COMPLETED|Overall Study||36
9833069|NCT00777062|10943890|FG001|COMPLETED|Overall Study||36
9833070|NCT00777062|10943889|FG000|NOT COMPLETED|Overall Study||3
9833071|NCT00777062|10943890|FG001|NOT COMPLETED|Overall Study||5
9833072|NCT00777088|10943896|FG000|STARTED|Overall Study||108
9833073|NCT00777088|10943896|FG000|COMPLETED|Overall Study||107
9833074|NCT00777088|10943896|FG000|NOT COMPLETED|Overall Study||1
9833075|NCT00777101|10943903|FG000|STARTED|Overall Study||117
9833076|NCT00777101|10943904|FG001|STARTED|Overall Study||116
9833077|NCT00777101|10943903|FG000|Treated|Overall Study||116
9833078|NCT00777101|10943904|FG001|Treated|Overall Study||115
9833079|NCT00777101|10943903|FG000|COMPLETED|Overall Study||55
9833080|NCT00777101|10943904|FG001|COMPLETED|Overall Study||65
9833081|NCT00777101|10943903|FG000|NOT COMPLETED|Overall Study||62
9833082|NCT00777101|10943904|FG001|NOT COMPLETED|Overall Study||51
9833083|NCT00777153|10943914|FG000|STARTED|Overall Study||131
9833084|NCT00777153|10943915|FG001|STARTED|Overall Study||129
9833085|NCT00777153|10943916|FG002|STARTED|Overall Study||65
9833086|NCT00777153|10943914|FG000|COMPLETED|Overall Study||41
9833087|NCT00777153|10943915|FG001|COMPLETED|Overall Study||46
9833088|NCT00777153|10943916|FG002|COMPLETED|Overall Study||28
9833089|NCT00777153|10943914|FG000|NOT COMPLETED|Overall Study||90
10113524|NCT02509936|11244295|FG001|STARTED|Overall Study||161
10113525|NCT02509936|11244294|FG000|COMPLETED|Overall Study||151
10113526|NCT02509936|11244295|FG001|COMPLETED|Overall Study||145
10113527|NCT02509936|11244294|FG000|NOT COMPLETED|Overall Study||12
10113528|NCT02509936|11244295|FG001|NOT COMPLETED|Overall Study||16
10113529|NCT02510001|11244309|FG000|STARTED|Overall Study||6
10113530|NCT02510001|11244310|FG001|STARTED|Overall Study||5
10113531|NCT02510001|11244311|FG002|STARTED|Overall Study||6
10113532|NCT02510001|11244312|FG003|STARTED|Overall Study||8
10113533|NCT02510001|11244313|FG004|STARTED|Overall Study||8
10113534|NCT02510001|11244314|FG005|STARTED|Overall Study||7
10113535|NCT02510001|11244315|FG006|STARTED|Overall Study||5
10113536|NCT02510001|11244316|FG007|STARTED|Overall Study||37
10113537|NCT02510001|11244309|FG000|COMPLETED|Overall Study||6
10113538|NCT02510001|11244310|FG001|COMPLETED|Overall Study||5
10113539|NCT02510001|11244311|FG002|COMPLETED|Overall Study||6
10113540|NCT02510001|11244312|FG003|COMPLETED|Overall Study||6
10113541|NCT02510001|11244313|FG004|COMPLETED|Overall Study||4
10113542|NCT02510001|11244314|FG005|COMPLETED|Overall Study||5
10113543|NCT02510001|11244315|FG006|COMPLETED|Overall Study||3
10113544|NCT02510001|11244316|FG007|COMPLETED|Overall Study||30
10113545|NCT02510001|11244309|FG000|NOT COMPLETED|Overall Study||0
10113546|NCT02510001|11244310|FG001|NOT COMPLETED|Overall Study||0
10113547|NCT02510001|11244311|FG002|NOT COMPLETED|Overall Study||0
10113548|NCT02510001|11244312|FG003|NOT COMPLETED|Overall Study||2
10113549|NCT02510001|11244313|FG004|NOT COMPLETED|Overall Study||4
10113550|NCT02510001|11244314|FG005|NOT COMPLETED|Overall Study||2
10113551|NCT02510001|11244315|FG006|NOT COMPLETED|Overall Study||2
10113552|NCT02510001|11244316|FG007|NOT COMPLETED|Overall Study||7
10113553|NCT02510014|11244354|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508
10113554|NCT02510014|11244355|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267
10113555|NCT02510014|11244354|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412
10113556|NCT02510014|11244355|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257
10113557|NCT02510014|11244354|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
10113558|NCT02510014|11244355|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
10113559|NCT02510014|11244354|FG000|STARTED|Treatment Period||412
10113560|NCT02510014|11244355|FG001|STARTED|Treatment Period||257
10113561|NCT02510014|11244354|FG000|COMPLETED|Treatment Period||206
10113562|NCT02510014|11244355|FG001|COMPLETED|Treatment Period||200
10113563|NCT02510014|11244354|FG000|NOT COMPLETED|Treatment Period||206
10113564|NCT02510014|11244355|FG001|NOT COMPLETED|Treatment Period||57
10113565|NCT02510144|11244363|FG000|STARTED|Overall Study||39
10113566|NCT02510144|11244364|FG001|STARTED|Overall Study||41
10113567|NCT02510144|11244363|FG000|COMPLETED|Overall Study||39
10113568|NCT02510144|11244364|FG001|COMPLETED|Overall Study||41
10113569|NCT02510144|11244363|FG000|NOT COMPLETED|Overall Study||0
10113570|NCT02510144|11244364|FG001|NOT COMPLETED|Overall Study||0
10113571|NCT02510664|11244373|FG000|STARTED|Overall Study||84
10113572|NCT02510664|11244374|FG001|STARTED|Overall Study||84
10113573|NCT02510664|11244375|FG002|STARTED|Overall Study||4
10113574|NCT02510664|11244373|FG000|COMPLETED|Overall Study||64
10113575|NCT02510664|11244374|FG001|COMPLETED|Overall Study||64
10113576|NCT02510664|11244375|FG002|COMPLETED|Overall Study||4
10113577|NCT02510664|11244373|FG000|NOT COMPLETED|Overall Study||20
10113578|NCT02510664|11244374|FG001|NOT COMPLETED|Overall Study||20
10113579|NCT02510664|11244375|FG002|NOT COMPLETED|Overall Study||0
10244632|NCT00593840|11376349|FG000|STARTED|Overall Study||73
10244633|NCT00593840|11376349|FG000|COMPLETED|Overall Study||72
10244634|NCT00593840|11376349|FG000|NOT COMPLETED|Overall Study||1
10244635|NCT00567580|11376356|FG000|STARTED|Overall Study||592
10244636|NCT00567580|11376357|FG001|STARTED|Overall Study||602
10244637|NCT00567580|11376358|FG002|STARTED|Overall Study||598
10244638|NCT00567580|11376356|FG000|Eligible|Overall Study||564
10244639|NCT00567580|11376357|FG001|Eligible|Overall Study||578
10244640|NCT00567580|11376358|FG002|Eligible|Overall Study||574
10244641|NCT00567580|11376356|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
10244642|NCT00567580|11376357|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
10244643|NCT00567580|11376358|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
10244644|NCT00567580|11376356|FG000|COMPLETED|Overall Study||564
10244645|NCT00567580|11376357|FG001|COMPLETED|Overall Study||578
10244646|NCT00567580|11376358|FG002|COMPLETED|Overall Study||574
10244647|NCT00567580|11376356|FG000|NOT COMPLETED|Overall Study||28
10244648|NCT00567580|11376357|FG001|NOT COMPLETED|Overall Study||24
10244649|NCT00567580|11376358|FG002|NOT COMPLETED|Overall Study||24
10244650|NCT00528021|11376373|FG000|STARTED|Overall Study||59
10244651|NCT00528021|11376374|FG001|STARTED|Overall Study||59
10244652|NCT00528021|11376375|FG002|STARTED|Overall Study||56
10244653|NCT00528021|11376376|FG003|STARTED|Overall Study||56
10244654|NCT00528021|11376373|FG000|COMPLETED|Overall Study||42
10244655|NCT00528021|11376374|FG001|COMPLETED|Overall Study||46
10244656|NCT00528021|11376375|FG002|COMPLETED|Overall Study||49
10244657|NCT00528021|11376376|FG003|COMPLETED|Overall Study||47
10244658|NCT00528021|11376373|FG000|NOT COMPLETED|Overall Study||17
10244659|NCT00528021|11376374|FG001|NOT COMPLETED|Overall Study||13
10244660|NCT00528021|11376375|FG002|NOT COMPLETED|Overall Study||7
10244661|NCT00528021|11376376|FG003|NOT COMPLETED|Overall Study||9
10244662|NCT00485693|11376388|FG000|STARTED|Overall Study||34
10244663|NCT00485693|11376389|FG001|STARTED|Overall Study||104
10244664|NCT00485693|11376388|FG000|COMPLETED|Overall Study||34
10244665|NCT00485693|11376389|FG001|COMPLETED|Overall Study||104
10244666|NCT00485693|11376388|FG000|NOT COMPLETED|Overall Study||0
10244667|NCT00485693|11376389|FG001|NOT COMPLETED|Overall Study||0
10244668|NCT00390325|11376400|FG000|STARTED|Overall Study||5
10244669|NCT00390325|11376401|FG001|STARTED|Overall Study||16
10244670|NCT00390325|11376400|FG000|COMPLETED|Overall Study||5
10244671|NCT00390325|11376401|FG001|COMPLETED|Overall Study||16
10244672|NCT00390325|11376400|FG000|NOT COMPLETED|Overall Study||0
10244673|NCT00390325|11376401|FG001|NOT COMPLETED|Overall Study||0
10244674|NCT00381641|11376413|FG000|STARTED|Overall Study||38
10244675|NCT00381641|11376414|FG001|STARTED|Overall Study||25
10244676|NCT00381641|11376413|FG000|COMPLETED|Overall Study||38
10244677|NCT00381641|11376414|FG001|COMPLETED|Overall Study||23
10244678|NCT00381641|11376413|FG000|NOT COMPLETED|Overall Study||0
10244679|NCT00381641|11376414|FG001|NOT COMPLETED|Overall Study||2
10244680|NCT00114101|11376422|FG000|STARTED|Overall Study||231
10244681|NCT00114101|11376423|FG001|STARTED|Overall Study||229
10244682|NCT00114101|11376422|FG000|COMPLETED|Overall Study||231
10244683|NCT00114101|11376423|FG001|COMPLETED|Overall Study||229
10244684|NCT00114101|11376422|FG000|NOT COMPLETED|Overall Study||0
10244685|NCT00114101|11376423|FG001|NOT COMPLETED|Overall Study||0
10244686|NCT00026312|11376433|FG000|STARTED|Overall Study||116
10244687|NCT00026312|11376434|FG001|STARTED|Overall Study||1333
10244688|NCT00026312|11376433|FG000|COMPLETED|Overall Study||82
10244689|NCT00026312|11376434|FG001|COMPLETED|Overall Study||1064
10244690|NCT00026312|11376433|FG000|NOT COMPLETED|Overall Study||34
10244691|NCT00026312|11376434|FG001|NOT COMPLETED|Overall Study||269
10244692|NCT00006436|11376444|FG000|STARTED|Overall Study||68
10244693|NCT00006436|11376444|FG000|COMPLETED|Overall Study||65
10244694|NCT00006436|11376444|FG000|NOT COMPLETED|Overall Study||3
10244695|NCT00002540|11376453|FG000|STARTED|Overall Study||38345
10244696|NCT00002540|11376454|FG001|STARTED|Overall Study||38340
10244697|NCT00002540|11376453|FG000|COMPLETED|Overall Study||37544
10244698|NCT00002540|11376454|FG001|COMPLETED|Overall Study||35876
10244699|NCT00002540|11376453|FG000|NOT COMPLETED|Overall Study||801
10244700|NCT00002540|11376454|FG001|NOT COMPLETED|Overall Study||2464
10244701|NCT00788671|11376460|FG000|STARTED|Overall Study||57
10244702|NCT00788671|11376460|FG000|COMPLETED|Overall Study||47
10244703|NCT00788671|11376460|FG000|NOT COMPLETED|Overall Study||10
10244704|NCT00799266|11376466|FG000|STARTED|Overall Study||18
10244705|NCT00799266|11376467|FG001|STARTED|Overall Study||16
10244706|NCT00799266|11376466|FG000|Modified Intention-to-treat (MITT)|Overall Study||17
10244707|NCT00799266|11376467|FG001|Modified Intention-to-treat (MITT)|Overall Study||16
10244708|NCT00799266|11376466|FG000|Safety Set|Overall Study||18
10244709|NCT00799266|11376467|FG001|Safety Set|Overall Study||16
10244710|NCT00799266|11376466|FG000|COMPLETED|Overall Study||15
10244711|NCT00799266|11376467|FG001|COMPLETED|Overall Study||15
10244712|NCT00799266|11376466|FG000|NOT COMPLETED|Overall Study||3
10244713|NCT00799266|11376467|FG001|NOT COMPLETED|Overall Study||1
10244714|NCT00810446|11376473|FG000|STARTED|Overall Study||72
10244715|NCT00810446|11376473|FG000|COMPLETED|Overall Study||72
10244716|NCT00810446|11376473|FG000|NOT COMPLETED|Overall Study||0
10244717|NCT00844480|11376479|FG000|STARTED|Overall Study||8
10244718|NCT00844480|11376480|FG001|STARTED|Overall Study||9
10244719|NCT00844480|11376479|FG000|COMPLETED|Overall Study||6
10244720|NCT00844480|11376480|FG001|COMPLETED|Overall Study||6
10244721|NCT00844480|11376479|FG000|NOT COMPLETED|Overall Study||2
10244722|NCT00844480|11376480|FG001|NOT COMPLETED|Overall Study||3
10244723|NCT00864474|11376486|FG000|STARTED|Overall Study||68
10244724|NCT00864474|11376486|FG000|COMPLETED|Overall Study||68
10244725|NCT00864474|11376486|FG000|NOT COMPLETED|Overall Study||0
10244726|NCT00873366|11376490|FG000|STARTED|Overall Study||77
10244727|NCT00873366|11376490|FG000|COMPLETED|Overall Study||71
10244728|NCT00873366|11376490|FG000|NOT COMPLETED|Overall Study||6
10244729|NCT00923247|11376496|FG000|STARTED|Overall Study||21
10244730|NCT00923247|11376497|FG001|STARTED|Overall Study||1
10244731|NCT00923247|11376496|FG000|COMPLETED|Overall Study||21
10244732|NCT00923247|11376497|FG001|COMPLETED|Overall Study||1
10244733|NCT00923247|11376496|FG000|NOT COMPLETED|Overall Study||0
10244734|NCT00923247|11376497|FG001|NOT COMPLETED|Overall Study||0
10244735|NCT00928226|11376513|FG000|STARTED|Overall Study||20
10244736|NCT00928226|11376514|FG001|STARTED|Overall Study||12
10244737|NCT00928226|11376515|FG002|STARTED|Overall Study||12
10244738|NCT00928226|11376516|FG003|STARTED|Overall Study||12
10244739|NCT00928226|11376513|FG000|Strata A: Small Tumor, Resected|Overall Study||6
10244740|NCT00928226|11376514|FG001|Strata A: Small Tumor, Resected|Overall Study||6
10244741|NCT00928226|11376515|FG002|Strata A: Small Tumor, Resected|Overall Study||6
10244742|NCT00928226|11376516|FG003|Strata A: Small Tumor, Resected|Overall Study||6
10244743|NCT00928226|11376513|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5
10244744|NCT00928226|11376514|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0
10244745|NCT00928226|11376515|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0
10244746|NCT00928226|11376516|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0
10244747|NCT00928226|11376513|FG000|Strata C: Large Tumor, Resected|Overall Study||8
10244748|NCT00928226|11376514|FG001|Strata C: Large Tumor, Resected|Overall Study||6
10244749|NCT00928226|11376515|FG002|Strata C: Large Tumor, Resected|Overall Study||6
10244750|NCT00928226|11376516|FG003|Strata C: Large Tumor, Resected|Overall Study||6
10244751|NCT00928226|11376513|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1
10244752|NCT00928226|11376514|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0
10244753|NCT00928226|11376515|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0
10244754|NCT00928226|11376516|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0
10244755|NCT00928226|11376513|FG000|COMPLETED|Overall Study||20
10244756|NCT00928226|11376514|FG001|COMPLETED|Overall Study||12
10244757|NCT00928226|11376515|FG002|COMPLETED|Overall Study||12
10244758|NCT00928226|11376516|FG003|COMPLETED|Overall Study||12
10244759|NCT00928226|11376513|FG000|NOT COMPLETED|Overall Study||0
10244760|NCT00928226|11376514|FG001|NOT COMPLETED|Overall Study||0
10244761|NCT00928226|11376515|FG002|NOT COMPLETED|Overall Study||0
10244762|NCT00928226|11376516|FG003|NOT COMPLETED|Overall Study||0
10244766|NCT00940498|11376538|FG000|STARTED|Overall Study||4
10244767|NCT00940498|11376539|FG001|STARTED|Overall Study||4
10244768|NCT00940498|11376540|FG002|STARTED|Overall Study||4
10244769|NCT00940498|11376541|FG003|STARTED|Overall Study||4
10244770|NCT00940498|11376542|FG004|STARTED|Overall Study||43
10244771|NCT00940498|11376543|FG005|STARTED|Overall Study||7
10244772|NCT00940498|11376544|FG006|STARTED|Overall Study||8
10244773|NCT00940498|11376545|FG007|STARTED|Overall Study||4
10244774|NCT00940498|11376538|FG000|COMPLETED|Overall Study||1
10244775|NCT00940498|11376539|FG001|COMPLETED|Overall Study||3
10244776|NCT00940498|11376540|FG002|COMPLETED|Overall Study||1
10244777|NCT00940498|11376541|FG003|COMPLETED|Overall Study||2
10244778|NCT00940498|11376542|FG004|COMPLETED|Overall Study||34
10244779|NCT00940498|11376543|FG005|COMPLETED|Overall Study||6
10244780|NCT00940498|11376544|FG006|COMPLETED|Overall Study||7
10244781|NCT00940498|11376545|FG007|COMPLETED|Overall Study||3
10244782|NCT00940498|11376538|FG000|NOT COMPLETED|Overall Study||3
10244783|NCT00940498|11376539|FG001|NOT COMPLETED|Overall Study||1
10244784|NCT00940498|11376540|FG002|NOT COMPLETED|Overall Study||3
10244785|NCT00940498|11376541|FG003|NOT COMPLETED|Overall Study||2
10244786|NCT00940498|11376542|FG004|NOT COMPLETED|Overall Study||9
10244787|NCT00940498|11376543|FG005|NOT COMPLETED|Overall Study||1
10244788|NCT00940498|11376544|FG006|NOT COMPLETED|Overall Study||1
10244789|NCT00940498|11376545|FG007|NOT COMPLETED|Overall Study||1
10244790|NCT04720547|11376571|FG000|STARTED|Overall Study||6
10244763|NCT00930722|11376526|FG000|STARTED|Overall Study||329
10244764|NCT00930722|11376526|FG000|COMPLETED|Overall Study||302
10244765|NCT00930722|11376526|FG000|NOT COMPLETED|Overall Study||27
10244791|NCT04720547|11376572|FG001|STARTED|Overall Study||8
10244792|NCT04720547|11376571|FG000|COMPLETED|Overall Study||6
10244793|NCT04720547|11376572|FG001|COMPLETED|Overall Study||5
10244794|NCT04720547|11376571|FG000|NOT COMPLETED|Overall Study||0
10244795|NCT04720547|11376572|FG001|NOT COMPLETED|Overall Study||3
10244796|NCT04553913|11376578|FG000|STARTED|Overall Study||15
10244797|NCT04553913|11376578|FG000|COMPLETED|Overall Study||9
10244798|NCT04553913|11376578|FG000|NOT COMPLETED|Overall Study||6
10019519|NCT01830920|11142723|FG002|NOT COMPLETED|Overall Study||8
10019520|NCT01830920|11142724|FG003|NOT COMPLETED|Overall Study||16
10019521|NCT01830920|11142725|FG004|NOT COMPLETED|Overall Study||8
10019522|NCT01830933|11142739|FG000|STARTED|Overall Study||823
10244799|NCT04079452|11376583|FG000|STARTED|Overall Study||15
10244800|NCT04079452|11376583|FG000|COMPLETED|Overall Study||15
10244801|NCT04079452|11376583|FG000|NOT COMPLETED|Overall Study||0
10244802|NCT04009824|11376593|FG000|STARTED|Overall Study||10
10244803|NCT04009824|11376594|FG001|STARTED|Overall Study||10
10244804|NCT04009824|11376595|FG002|STARTED|Overall Study||11
10244805|NCT04009824|11376596|FG003|STARTED|Overall Study||10
10244806|NCT04009824|11376597|FG004|STARTED|Overall Study||10
10244807|NCT04009824|11376593|FG000|COMPLETED|Overall Study||8
10244808|NCT04009824|11376594|FG001|COMPLETED|Overall Study||7
10244809|NCT04009824|11376595|FG002|COMPLETED|Overall Study||6
10244810|NCT04009824|11376596|FG003|COMPLETED|Overall Study||8
10244811|NCT04009824|11376597|FG004|COMPLETED|Overall Study||7
10244812|NCT04009824|11376593|FG000|NOT COMPLETED|Overall Study||2
10244813|NCT04009824|11376594|FG001|NOT COMPLETED|Overall Study||3
10244814|NCT04009824|11376595|FG002|NOT COMPLETED|Overall Study||5
10244815|NCT04009824|11376596|FG003|NOT COMPLETED|Overall Study||2
10244816|NCT04009824|11376597|FG004|NOT COMPLETED|Overall Study||3
10244848|NCT03222973|11376628|FG002|STARTED|Part 2 (Week 73 to Week 168)|6 participants who completed Part 1 did not enter Part 2.|101
10244849|NCT03222973|11376629|FG003|STARTED|Part 2 (Week 73 to Week 168)|5 participants who completed Part 1 did not enter Part 2.|113
10244850|NCT03222973|11376626|FG000|ITT Population|Part 2 (Week 73 to Week 168)||0
10244851|NCT03222973|11376627|FG001|ITT Population|Part 2 (Week 73 to Week 168)||0
10244852|NCT03222973|11376628|FG002|ITT Population|Part 2 (Week 73 to Week 168)||100
10244853|NCT03222973|11376629|FG003|ITT Population|Part 2 (Week 73 to Week 168)||113
10244854|NCT03222973|11376626|FG000|Safety Population|Part 2 (Week 73 to Week 168)||0
10244855|NCT03222973|11376627|FG001|Safety Population|Part 2 (Week 73 to Week 168)||0
10244856|NCT03222973|11376628|FG002|Safety Population|Part 2 (Week 73 to Week 168)||100
10244857|NCT03222973|11376629|FG003|Safety Population|Part 2 (Week 73 to Week 168)||113
10244858|NCT03222973|11376626|FG000|COMPLETED|Part 2 (Week 73 to Week 168)||0
10244859|NCT03222973|11376627|FG001|COMPLETED|Part 2 (Week 73 to Week 168)||0
10244860|NCT03222973|11376628|FG002|COMPLETED|Part 2 (Week 73 to Week 168)||0
10244861|NCT03222973|11376629|FG003|COMPLETED|Part 2 (Week 73 to Week 168)||0
10244862|NCT03222973|11376626|FG000|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
10244863|NCT03222973|11376627|FG001|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
10244864|NCT03222973|11376628|FG002|NOT COMPLETED|Part 2 (Week 73 to Week 168)||101
10244865|NCT03222973|11376629|FG003|NOT COMPLETED|Part 2 (Week 73 to Week 168)||113
10244866|NCT03187262|11376639|FG000|STARTED|Induction||13
10244867|NCT03187262|11376639|FG000|COMPLETED|Induction||7
10244868|NCT03187262|11376639|FG000|NOT COMPLETED|Induction||6
10244869|NCT03187262|11376639|FG000|STARTED|Consolidation||7
10244870|NCT03187262|11376639|FG000|COMPLETED|Consolidation||2
10244871|NCT03187262|11376639|FG000|NOT COMPLETED|Consolidation||5
10244872|NCT03187262|11376639|FG000|STARTED|Maintenance||2
10244873|NCT03187262|11376639|FG000|COMPLETED|Maintenance||2
10244874|NCT03187262|11376639|FG000|NOT COMPLETED|Maintenance||0
10244875|NCT03137693|11376643|FG000|STARTED|Overall Study||20
10244876|NCT03137693|11376643|FG000|COMPLETED|Overall Study||20
10244877|NCT03137693|11376643|FG000|NOT COMPLETED|Overall Study||0
10244878|NCT02987959|11376647|FG000|STARTED|Overall Study||6
10244879|NCT02987959|11376647|FG000|COMPLETED|Overall Study||0
10244880|NCT02987959|11376647|FG000|NOT COMPLETED|Overall Study||6
10244881|NCT02985541|11376651|FG000|STARTED|Overall Study||364
10244882|NCT02985541|11376651|FG000|Valid for FAS|Overall Study||362
10244883|NCT02985541|11376651|FG000|Continued Into Year 7 of Mirena Use|Overall Study||305
10244884|NCT02985541|11376651|FG000|Continued Into Year 8 of Mirena Use|Overall Study||243
10244885|NCT02985541|11376651|FG000|COMPLETED|Overall Study||223
10244886|NCT02985541|11376651|FG000|NOT COMPLETED|Overall Study||141
10244887|NCT02960893|11376657|FG000|STARTED|Randomization Phase (8-week)||71
10244888|NCT02960893|11376658|FG001|STARTED|Randomization Phase (8-week)||70
10244889|NCT02960893|11376657|FG000|COMPLETED|Randomization Phase (8-week)||64
10244890|NCT02960893|11376658|FG001|COMPLETED|Randomization Phase (8-week)||68
10244891|NCT02960893|11376657|FG000|NOT COMPLETED|Randomization Phase (8-week)||7
10244892|NCT02960893|11376658|FG001|NOT COMPLETED|Randomization Phase (8-week)||2
10244893|NCT02960893|11376657|FG000|STARTED|Extension Phase (48-week)||64
10244894|NCT02960893|11376658|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
10244895|NCT02960893|11376657|FG000|COMPLETED|Extension Phase (48-week)||50
10244896|NCT02960893|11376658|FG001|COMPLETED|Extension Phase (48-week)||54
10244897|NCT02960893|11376657|FG000|NOT COMPLETED|Extension Phase (48-week)||14
10244898|NCT02960893|11376658|FG001|NOT COMPLETED|Extension Phase (48-week)||13
10244899|NCT02940522|11376673|FG000|STARTED|Overall Study||59
10244900|NCT02940522|11376674|FG001|STARTED|Overall Study||61
10244901|NCT02940522|11376673|FG000|COMPLETED|Overall Study||57
10244902|NCT02940522|11376674|FG001|COMPLETED|Overall Study||59
10244903|NCT02940522|11376673|FG000|NOT COMPLETED|Overall Study||2
10244904|NCT02940522|11376674|FG001|NOT COMPLETED|Overall Study||2
10244817|NCT03867383|11376611|FG000|STARTED|Overall Study||20
10244818|NCT03867383|11376612|FG001|STARTED|Overall Study||20
10244819|NCT03867383|11376611|FG000|COMPLETED|Overall Study||20
10244820|NCT03867383|11376612|FG001|COMPLETED|Overall Study||20
10244821|NCT03867383|11376611|FG000|NOT COMPLETED|Overall Study||0
10244822|NCT03867383|11376612|FG001|NOT COMPLETED|Overall Study||0
10244823|NCT03449758|11376619|FG000|STARTED|Overall Study||84
10244824|NCT03449758|11376619|FG000|COMPLETED|Overall Study||65
10244825|NCT03449758|11376619|FG000|NOT COMPLETED|Overall Study||19
10244826|NCT03222973|11376626|FG000|STARTED|Part 1 (Week 0 to Week 72)||131
10244827|NCT03222973|11376627|FG001|STARTED|Part 1 (Week 0 to Week 72)||132
10244828|NCT03222973|11376628|FG002|STARTED|Part 1 (Week 0 to Week 72)||0
10244829|NCT03222973|11376629|FG003|STARTED|Part 1 (Week 0 to Week 72)||0
10244830|NCT03222973|11376626|FG000|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||131
10244831|NCT03222973|11376627|FG001|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||132
10244832|NCT03222973|11376628|FG002|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
10244833|NCT03222973|11376629|FG003|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
10244834|NCT03222973|11376626|FG000|Safety Population|Part 1 (Week 0 to Week 72)||131
10244835|NCT03222973|11376627|FG001|Safety Population|Part 1 (Week 0 to Week 72)||132
10244836|NCT03222973|11376628|FG002|Safety Population|Part 1 (Week 0 to Week 72)||0
10244837|NCT03222973|11376629|FG003|Safety Population|Part 1 (Week 0 to Week 72)||0
10244838|NCT03222973|11376626|FG000|COMPLETED|Part 1 (Week 0 to Week 72)||107
9833090|NCT00777153|10943915|FG001|NOT COMPLETED|Overall Study||83
9833091|NCT00777153|10943916|FG002|NOT COMPLETED|Overall Study||37
9833092|NCT00777179|10943930|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
9833093|NCT00777179|10943931|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
9833094|NCT00777179|10943930|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
9833095|NCT00777179|10943931|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
9833096|NCT00777179|10943930|FG000|NOT COMPLETED|Overall Study||0
9833097|NCT00777179|10943931|FG001|NOT COMPLETED|Overall Study||0
10019523|NCT01830933|11142740|FG001|STARTED|Overall Study||812
10019524|NCT01830933|11142739|FG000|Completed Meet-up|Overall Study||675
9833098|NCT00777205|10943939|FG000|STARTED|Overall Study||243
9833099|NCT00777205|10943940|FG001|STARTED|Overall Study||200
9833100|NCT00777205|10943939|FG000|Intervention Interruption|Overall Study||0
9833101|NCT00777205|10943940|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
9833102|NCT00777205|10943939|FG000|COMPLETED|Overall Study||212
9833103|NCT00777205|10943940|FG001|COMPLETED|Overall Study||129
9833104|NCT00777205|10943939|FG000|NOT COMPLETED|Overall Study||31
9833105|NCT00777205|10943940|FG001|NOT COMPLETED|Overall Study||71
9833106|NCT00777257|10943951|FG000|STARTED|Overall Study||444
9833107|NCT00777257|10943952|FG001|STARTED|Overall Study||450
9833108|NCT00777257|10943953|FG002|STARTED|Overall Study||451
9833109|NCT00777257|10943951|FG000|COMPLETED|Overall Study||433
9833110|NCT00777257|10943952|FG001|COMPLETED|Overall Study||438
9833111|NCT00777257|10943953|FG002|COMPLETED|Overall Study||442
9833112|NCT00777257|10943951|FG000|NOT COMPLETED|Overall Study||11
9833113|NCT00777257|10943952|FG001|NOT COMPLETED|Overall Study||12
9833114|NCT00777257|10943953|FG002|NOT COMPLETED|Overall Study||9
9833115|NCT00777296|10943965|FG000|STARTED|Overall Study||21
9833116|NCT00777296|10943966|FG001|STARTED|Overall Study||11
9833117|NCT00777296|10943967|FG002|STARTED|Overall Study||23
9833118|NCT00777296|10943968|FG003|STARTED|Overall Study||11
9833119|NCT00777296|10943965|FG000|COMPLETED|Overall Study||20
9833120|NCT00777296|10943966|FG001|COMPLETED|Overall Study||10
9833121|NCT00777296|10943967|FG002|COMPLETED|Overall Study||21
9833122|NCT00777296|10943968|FG003|COMPLETED|Overall Study||10
9833123|NCT00777296|10943965|FG000|NOT COMPLETED|Overall Study||1
9833124|NCT00777296|10943966|FG001|NOT COMPLETED|Overall Study||1
9833125|NCT00777296|10943967|FG002|NOT COMPLETED|Overall Study||2
9833126|NCT00777296|10943968|FG003|NOT COMPLETED|Overall Study||1
9833127|NCT00777335|10943992|FG000|STARTED|Overall Study||2
9833128|NCT00777335|10943993|FG001|STARTED|Overall Study||2
9833129|NCT00777335|10943992|FG000|COMPLETED|Overall Study||2
9833130|NCT00777335|10943993|FG001|COMPLETED|Overall Study||2
9833131|NCT00777335|10943992|FG000|NOT COMPLETED|Overall Study||0
9833132|NCT00777335|10943993|FG001|NOT COMPLETED|Overall Study||0
9833133|NCT00777556|10943999|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343
9833134|NCT00777556|10943999|FG000|Dispensed Product|Overall Study||307
10244839|NCT03222973|11376627|FG001|COMPLETED|Part 1 (Week 0 to Week 72)||118
10244840|NCT03222973|11376628|FG002|COMPLETED|Part 1 (Week 0 to Week 72)||0
10244841|NCT03222973|11376629|FG003|COMPLETED|Part 1 (Week 0 to Week 72)||0
10244842|NCT03222973|11376626|FG000|NOT COMPLETED|Part 1 (Week 0 to Week 72)||24
10244843|NCT03222973|11376627|FG001|NOT COMPLETED|Part 1 (Week 0 to Week 72)||14
10244844|NCT03222973|11376628|FG002|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
10244845|NCT03222973|11376629|FG003|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
10244846|NCT03222973|11376626|FG000|STARTED|Part 2 (Week 73 to Week 168)||0
10244847|NCT03222973|11376627|FG001|STARTED|Part 2 (Week 73 to Week 168)||0
9833135|NCT00777556|10943999|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
9833136|NCT00777556|10943999|FG000|Used Product|Overall Study||297
9833137|NCT00777556|10943999|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
10244905|NCT02711137|11376695|FG000|STARTED|Overall Study||4
10244906|NCT02711137|11376696|FG001|STARTED|Overall Study||5
10244907|NCT02711137|11376697|FG002|STARTED|Overall Study||8
10244908|NCT02711137|11376698|FG003|STARTED|Overall Study||7
10244909|NCT02711137|11376699|FG004|STARTED|Overall Study||5
10244910|NCT02711137|11376700|FG005|STARTED|Overall Study||1
10244911|NCT02711137|11376701|FG006|STARTED|Overall Study||86
10244912|NCT02711137|11376702|FG007|STARTED|Overall Study||5
10244913|NCT02711137|11376703|FG008|STARTED|Overall Study||1
10244914|NCT02711137|11376704|FG009|STARTED|Overall Study||2
10244915|NCT02711137|11376705|FG010|STARTED|Overall Study||4
10244916|NCT02711137|11376706|FG011|STARTED|Overall Study||3
10244917|NCT02711137|11376707|FG012|STARTED|Overall Study||1
10244918|NCT02711137|11376708|FG013|STARTED|Overall Study||2
10244919|NCT02711137|11376709|FG014|STARTED|Overall Study||3
10244920|NCT02711137|11376695|FG000|COMPLETED|Overall Study||0
10244921|NCT02711137|11376696|FG001|COMPLETED|Overall Study||0
10244922|NCT02711137|11376697|FG002|COMPLETED|Overall Study||0
10244923|NCT02711137|11376698|FG003|COMPLETED|Overall Study||0
10244924|NCT02711137|11376699|FG004|COMPLETED|Overall Study||0
10244925|NCT02711137|11376700|FG005|COMPLETED|Overall Study||0
10244926|NCT02711137|11376701|FG006|COMPLETED|Overall Study||0
10244927|NCT02711137|11376702|FG007|COMPLETED|Overall Study||0
10244928|NCT02711137|11376703|FG008|COMPLETED|Overall Study||0
10244929|NCT02711137|11376704|FG009|COMPLETED|Overall Study||0
10244930|NCT02711137|11376705|FG010|COMPLETED|Overall Study||0
10244931|NCT02711137|11376706|FG011|COMPLETED|Overall Study||0
10244932|NCT02711137|11376707|FG012|COMPLETED|Overall Study||0
10244933|NCT02711137|11376708|FG013|COMPLETED|Overall Study||0
10244934|NCT02711137|11376709|FG014|COMPLETED|Overall Study||0
10244935|NCT02711137|11376695|FG000|NOT COMPLETED|Overall Study||4
10244936|NCT02711137|11376696|FG001|NOT COMPLETED|Overall Study||5
10244937|NCT02711137|11376697|FG002|NOT COMPLETED|Overall Study||8
10244938|NCT02711137|11376698|FG003|NOT COMPLETED|Overall Study||7
10244939|NCT02711137|11376699|FG004|NOT COMPLETED|Overall Study||5
10244940|NCT02711137|11376700|FG005|NOT COMPLETED|Overall Study||1
10244941|NCT02711137|11376701|FG006|NOT COMPLETED|Overall Study||86
10244942|NCT02711137|11376702|FG007|NOT COMPLETED|Overall Study||5
10244943|NCT02711137|11376703|FG008|NOT COMPLETED|Overall Study||1
10244944|NCT02711137|11376704|FG009|NOT COMPLETED|Overall Study||2
10244945|NCT02711137|11376705|FG010|NOT COMPLETED|Overall Study||4
10244946|NCT02711137|11376706|FG011|NOT COMPLETED|Overall Study||3
10244947|NCT02711137|11376707|FG012|NOT COMPLETED|Overall Study||1
10244948|NCT02711137|11376708|FG013|NOT COMPLETED|Overall Study||2
10244949|NCT02711137|11376709|FG014|NOT COMPLETED|Overall Study||3
10244950|NCT02630459|11376750|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136
10244951|NCT02630459|11376751|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67
10244952|NCT02630459|11376752|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135
10244953|NCT02630459|11376753|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137
10244954|NCT02630459|11376754|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0
10244955|NCT02630459|11376755|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0
10244956|NCT02630459|11376756|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0
10244957|NCT02630459|11376757|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0
10244958|NCT02630459|11376750|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
10244959|NCT02630459|11376751|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
10244960|NCT02630459|11376752|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
10244961|NCT02630459|11376753|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
10244962|NCT02630459|11376754|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10244963|NCT02630459|11376755|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10244964|NCT02630459|11376756|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10244965|NCT02630459|11376757|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10244966|NCT02630459|11376750|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
10244967|NCT02630459|11376751|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
10244968|NCT02630459|11376752|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
10244969|NCT02630459|11376753|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
10244970|NCT02630459|11376754|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244971|NCT02630459|11376755|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244972|NCT02630459|11376756|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244973|NCT02630459|11376757|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244974|NCT02630459|11376750|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
10244975|NCT02630459|11376751|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
10244976|NCT02630459|11376752|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
10244977|NCT02630459|11376753|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
10244978|NCT02630459|11376754|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244979|NCT02630459|11376755|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244980|NCT02630459|11376756|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244981|NCT02630459|11376757|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10244982|NCT02630459|11376750|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0
10244983|NCT02630459|11376751|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0
10244984|NCT02630459|11376752|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0
10244985|NCT02630459|11376753|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0
10244986|NCT02630459|11376754|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386
10244987|NCT02630459|11376755|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73
10244988|NCT02630459|11376756|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0
10244989|NCT02630459|11376757|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0
10244990|NCT02630459|11376750|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244991|NCT02630459|11376751|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244992|NCT02630459|11376752|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244993|NCT02630459|11376753|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244994|NCT02630459|11376754|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
10244995|NCT02630459|11376755|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244996|NCT02630459|11376756|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244997|NCT02630459|11376757|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244998|NCT02630459|11376750|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10244999|NCT02630459|11376751|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245000|NCT02630459|11376752|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245001|NCT02630459|11376753|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245002|NCT02630459|11376754|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245003|NCT02630459|11376755|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
10245004|NCT02630459|11376756|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245005|NCT02630459|11376757|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245006|NCT02630459|11376750|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245007|NCT02630459|11376751|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245008|NCT02630459|11376752|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245009|NCT02630459|11376753|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245010|NCT02630459|11376754|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
10245011|NCT02630459|11376755|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245012|NCT02630459|11376756|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245013|NCT02630459|11376757|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10245014|NCT02630459|11376750|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245015|NCT02630459|11376751|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245016|NCT02630459|11376752|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245017|NCT02630459|11376753|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245018|NCT02630459|11376754|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357
10245019|NCT02630459|11376755|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69
10245020|NCT02630459|11376756|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10019525|NCT01830933|11142740|FG001|Completed Meet-up|Overall Study||603
10019526|NCT01830933|11142739|FG000|COMPLETED|Overall Study||655
10019527|NCT01830933|11142740|FG001|COMPLETED|Overall Study||580
10019528|NCT01830933|11142739|FG000|NOT COMPLETED|Overall Study||168
9833138|NCT00777556|10943999|FG000|NOT COMPLETED|Overall Study||66
9833139|NCT00777608|10944005|FG000|STARTED|Overall Study||53
9833140|NCT00777608|10944006|FG001|STARTED|Overall Study||53
9833141|NCT00777608|10944005|FG000|COMPLETED|Overall Study||49
9833142|NCT00777608|10944006|FG001|COMPLETED|Overall Study||47
9833143|NCT00777608|10944005|FG000|NOT COMPLETED|Overall Study||4
9833144|NCT00777608|10944006|FG001|NOT COMPLETED|Overall Study||6
9833145|NCT00777634|10944014|FG000|STARTED|Overall Study||134
9833146|NCT00777634|10944015|FG001|STARTED|Overall Study||134
9833147|NCT00777634|10944014|FG000|COMPLETED|Overall Study||129
9833148|NCT00777634|10944015|FG001|COMPLETED|Overall Study||133
9833149|NCT00777634|10944014|FG000|NOT COMPLETED|Overall Study||5
9833150|NCT00777634|10944015|FG001|NOT COMPLETED|Overall Study||1
9833151|NCT00777764|10944023|FG000|STARTED|Overall Study||30
9833152|NCT00777764|10944024|FG001|STARTED|Overall Study||30
9957258|NCT01449747|11076463|FG000|NOT COMPLETED|Overall Study||0
9957259|NCT01449747|11076464|FG001|NOT COMPLETED|Overall Study||0
9957260|NCT01449812|11076473|FG000|STARTED|Overall Study||272
9957261|NCT01449812|11076474|FG001|STARTED|Overall Study||273
9957262|NCT01449812|11076475|FG002|STARTED|Overall Study||280
9957263|NCT01449812|11076473|FG000|COMPLETED|Overall Study||270
9957264|NCT01449812|11076474|FG001|COMPLETED|Overall Study||273
9957265|NCT01449812|11076475|FG002|COMPLETED|Overall Study||279
9957266|NCT01449812|11076473|FG000|NOT COMPLETED|Overall Study||2
9957267|NCT01449812|11076474|FG001|NOT COMPLETED|Overall Study||0
9957268|NCT01449812|11076475|FG002|NOT COMPLETED|Overall Study||1
9957269|NCT01449864|11076483|FG000|STARTED|Overall Study||22
9957270|NCT01449864|11076483|FG000|COMPLETED|Overall Study||17
9957271|NCT01449864|11076483|FG000|NOT COMPLETED|Overall Study||5
9957272|NCT01449929|11076489|FG000|STARTED|Randomization Phase 96 Week||242
9957273|NCT01449929|11076490|FG001|STARTED|Randomization Phase 96 Week||242
9957274|NCT01449929|11076491|FG002|STARTED|Randomization Phase 96 Week||0
9957275|NCT01449929|11076489|FG000|COMPLETED|Randomization Phase 96 Week||209
9957276|NCT01449929|11076490|FG001|COMPLETED|Randomization Phase 96 Week||189
9957277|NCT01449929|11076491|FG002|COMPLETED|Randomization Phase 96 Week||0
9957278|NCT01449929|11076489|FG000|NOT COMPLETED|Randomization Phase 96 Week||33
9957279|NCT01449929|11076490|FG001|NOT COMPLETED|Randomization Phase 96 Week||53
9957280|NCT01449929|11076491|FG002|NOT COMPLETED|Randomization Phase 96 Week||0
10019529|NCT01830933|11142740|FG001|NOT COMPLETED|Overall Study||232
9833153|NCT00777764|10944023|FG000|COMPLETED|Overall Study||30
10245021|NCT02630459|11376757|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245022|NCT02630459|11376750|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245023|NCT02630459|11376751|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245024|NCT02630459|11376752|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245025|NCT02630459|11376753|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245026|NCT02630459|11376754|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
10245027|NCT02630459|11376755|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
10245028|NCT02630459|11376756|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245029|NCT02630459|11376757|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10245030|NCT02630459|11376750|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0
10245031|NCT02630459|11376751|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0
10245032|NCT02630459|11376752|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0
10245033|NCT02630459|11376753|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0
10245034|NCT02630459|11376754|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0
10245035|NCT02630459|11376755|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0
10245036|NCT02630459|11376756|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24
10245037|NCT02630459|11376757|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25
10245038|NCT02630459|11376750|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245039|NCT02630459|11376751|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245040|NCT02630459|11376752|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245041|NCT02630459|11376753|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245042|NCT02630459|11376754|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245043|NCT02630459|11376755|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245044|NCT02630459|11376756|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
10245045|NCT02630459|11376757|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
10245046|NCT02630459|11376750|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245047|NCT02630459|11376751|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245048|NCT02630459|11376752|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245049|NCT02630459|11376753|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245050|NCT02630459|11376754|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245051|NCT02630459|11376755|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245052|NCT02630459|11376756|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245053|NCT02630459|11376757|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10245054|NCT02586857|11376784|FG000|STARTED|Overall Study||15
10245055|NCT02586857|11376785|FG001|STARTED|Overall Study||9
10245056|NCT02586857|11376784|FG000|Enrolled|Overall Study||15
10245057|NCT02586857|11376785|FG001|Enrolled|Overall Study||9
10245058|NCT02586857|11376784|FG000|Received Study Medication|Overall Study||15
10245059|NCT02586857|11376785|FG001|Received Study Medication|Overall Study||9
10245060|NCT02586857|11376784|FG000|Discontinued Study|Overall Study||14
10245061|NCT02586857|11376785|FG001|Discontinued Study|Overall Study||9
10245062|NCT02586857|11376784|FG000|COMPLETED|Overall Study||14
10245063|NCT02586857|11376785|FG001|COMPLETED|Overall Study||9
10245064|NCT02586857|11376784|FG000|NOT COMPLETED|Overall Study||1
10245065|NCT02586857|11376785|FG001|NOT COMPLETED|Overall Study||0
10245066|NCT02575976|11376794|FG000|STARTED|Overall Study||37
10245067|NCT02575976|11376795|FG001|STARTED|Overall Study||39
10245068|NCT02575976|11376796|FG002|STARTED|Overall Study||39
10245069|NCT02575976|11376794|FG000|COMPLETED|Overall Study||32
10245070|NCT02575976|11376795|FG001|COMPLETED|Overall Study||31
10245071|NCT02575976|11376796|FG002|COMPLETED|Overall Study||30
10245072|NCT02575976|11376794|FG000|NOT COMPLETED|Overall Study||5
10019530|NCT01830972|11142748|FG000|STARTED|Part I||46
10019531|NCT01830972|11142749|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
10019532|NCT01830972|11142748|FG000|COMPLETED|Part I||46
10245073|NCT02575976|11376795|FG001|NOT COMPLETED|Overall Study||8
10245074|NCT02575976|11376796|FG002|NOT COMPLETED|Overall Study||9
10245075|NCT02545868|11376807|FG000|STARTED|Immunization Study Period (ISP)||33
10245076|NCT02545868|11376808|FG001|STARTED|Immunization Study Period (ISP)||35
10245077|NCT02545868|11376809|FG002|STARTED|Immunization Study Period (ISP)||34
10245078|NCT02545868|11376807|FG000|COMPLETED|Immunization Study Period (ISP)||33
10245079|NCT02545868|11376808|FG001|COMPLETED|Immunization Study Period (ISP)||35
10245080|NCT02545868|11376809|FG002|COMPLETED|Immunization Study Period (ISP)||34
10245081|NCT02545868|11376807|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0
10245082|NCT02545868|11376808|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0
10245083|NCT02545868|11376809|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0
10245084|NCT02545868|11376807|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
10245085|NCT02545868|11376808|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
10245086|NCT02545868|11376809|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
10245087|NCT02545868|11376807|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10245088|NCT02545868|11376808|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10245089|NCT02545868|11376809|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10245090|NCT02545868|11376807|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
10245091|NCT02545868|11376808|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
10245092|NCT02545868|11376809|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
10245093|NCT02470091|11376824|FG000|STARTED|Overall Study||16
10245094|NCT02470091|11376825|FG001|STARTED|Overall Study||40
10245095|NCT02470091|11376824|FG000|Follow-up Report|Overall Study||1
10245096|NCT02470091|11376825|FG001|Follow-up Report|Overall Study||10
10245097|NCT02470091|11376824|FG000|COMPLETED|Overall Study||15
10245098|NCT02470091|11376825|FG001|COMPLETED|Overall Study||38
10245099|NCT02470091|11376824|FG000|NOT COMPLETED|Overall Study||1
10245100|NCT02470091|11376825|FG001|NOT COMPLETED|Overall Study||2
10245101|NCT02440425|11376833|FG000|STARTED|Overall Study||42
10245102|NCT02440425|11376833|FG000|COMPLETED|Overall Study||37
10245103|NCT02440425|11376833|FG000|NOT COMPLETED|Overall Study||5
10245104|NCT02343120|11376842|FG000|STARTED|Part 1: Dose Escalation||3
10245105|NCT02343120|11376843|FG001|STARTED|Part 1: Dose Escalation||4
10245106|NCT02343120|11376844|FG002|STARTED|Part 1: Dose Escalation||5
10245107|NCT02343120|11376845|FG003|STARTED|Part 1: Dose Escalation||4
10245108|NCT02343120|11376846|FG004|STARTED|Part 1: Dose Escalation||1
10245109|NCT02343120|11376842|FG000|COMPLETED|Part 1: Dose Escalation||0
10245110|NCT02343120|11376843|FG001|COMPLETED|Part 1: Dose Escalation||0
10245111|NCT02343120|11376844|FG002|COMPLETED|Part 1: Dose Escalation||0
10245112|NCT02343120|11376845|FG003|COMPLETED|Part 1: Dose Escalation||0
10245113|NCT02343120|11376846|FG004|COMPLETED|Part 1: Dose Escalation||0
10245114|NCT02343120|11376842|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
10245115|NCT02343120|11376843|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
10245116|NCT02343120|11376844|FG002|NOT COMPLETED|Part 1: Dose Escalation||5
10245117|NCT02343120|11376845|FG003|NOT COMPLETED|Part 1: Dose Escalation||4
10245118|NCT02343120|11376846|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
10245119|NCT02343120|11376842|FG000|STARTED|Part 2: Expansion||0
10245120|NCT02343120|11376843|FG001|STARTED|Part 2: Expansion||0
10245121|NCT02343120|11376844|FG002|STARTED|Part 2: Expansion||0
10245122|NCT02343120|11376845|FG003|STARTED|Part 2: Expansion||274
10245123|NCT02343120|11376846|FG004|STARTED|Part 2: Expansion||94
10245124|NCT02343120|11376842|FG000|COMPLETED|Part 2: Expansion||0
10245125|NCT02343120|11376843|FG001|COMPLETED|Part 2: Expansion||0
10245126|NCT02343120|11376844|FG002|COMPLETED|Part 2: Expansion||0
10245127|NCT02343120|11376845|FG003|COMPLETED|Part 2: Expansion||0
10245128|NCT02343120|11376846|FG004|COMPLETED|Part 2: Expansion||0
10245129|NCT02343120|11376842|FG000|NOT COMPLETED|Part 2: Expansion||0
10245130|NCT02343120|11376843|FG001|NOT COMPLETED|Part 2: Expansion||0
10245131|NCT02343120|11376844|FG002|NOT COMPLETED|Part 2: Expansion||0
10245132|NCT02343120|11376845|FG003|NOT COMPLETED|Part 2: Expansion||274
10245133|NCT02343120|11376846|FG004|NOT COMPLETED|Part 2: Expansion||94
10245134|NCT02066415|11376868|FG000|STARTED|Overall Study||286
10245135|NCT02066415|11376869|FG001|STARTED|Overall Study||191
10245136|NCT02066415|11376870|FG002|STARTED|Overall Study||190
10245137|NCT02066415|11376868|FG000|Received Study Drug|Overall Study||282
10245138|NCT02066415|11376869|FG001|Received Study Drug|Overall Study||190
10245139|NCT02066415|11376870|FG002|Received Study Drug|Overall Study||188
10245140|NCT02066415|11376868|FG000|COMPLETED|Overall Study||265
10245141|NCT02066415|11376869|FG001|COMPLETED|Overall Study||184
10245142|NCT02066415|11376870|FG002|COMPLETED|Overall Study||182
10245143|NCT02066415|11376868|FG000|NOT COMPLETED|Overall Study||21
10245144|NCT02066415|11376869|FG001|NOT COMPLETED|Overall Study||7
10245145|NCT02066415|11376870|FG002|NOT COMPLETED|Overall Study||8
10245146|NCT01952574|11376882|FG000|STARTED|Double-blind Treatment Phase||160
10245147|NCT01952574|11376883|FG001|STARTED|Double-blind Treatment Phase||108
10245148|NCT01952574|11376884|FG002|STARTED|Double-blind Treatment Phase||108
10245149|NCT01952574|11376885|FG003|STARTED|Double-blind Treatment Phase||107
10245150|NCT01952574|11376886|FG004|STARTED|Double-blind Treatment Phase||0
10245151|NCT01952574|11376887|FG005|STARTED|Double-blind Treatment Phase||0
10245152|NCT01952574|11376888|FG006|STARTED|Double-blind Treatment Phase||0
10245153|NCT01952574|11376882|FG000|Received Study Drug|Double-blind Treatment Phase||153
10245154|NCT01952574|11376883|FG001|Received Study Drug|Double-blind Treatment Phase||108
10245155|NCT01952574|11376884|FG002|Received Study Drug|Double-blind Treatment Phase||105
10245156|NCT01952574|11376885|FG003|Received Study Drug|Double-blind Treatment Phase||106
10245157|NCT01952574|11376886|FG004|Received Study Drug|Double-blind Treatment Phase||0
10245158|NCT01952574|11376887|FG005|Received Study Drug|Double-blind Treatment Phase||0
10245159|NCT01952574|11376888|FG006|Received Study Drug|Double-blind Treatment Phase||0
10245160|NCT01952574|11376882|FG000|COMPLETED|Double-blind Treatment Phase||143
10245161|NCT01952574|11376883|FG001|COMPLETED|Double-blind Treatment Phase||105
10245162|NCT01952574|11376884|FG002|COMPLETED|Double-blind Treatment Phase||99
10245163|NCT01952574|11376885|FG003|COMPLETED|Double-blind Treatment Phase||101
10245164|NCT01952574|11376886|FG004|COMPLETED|Double-blind Treatment Phase||0
10245165|NCT01952574|11376887|FG005|COMPLETED|Double-blind Treatment Phase||0
10245166|NCT01952574|11376888|FG006|COMPLETED|Double-blind Treatment Phase||0
10245167|NCT01952574|11376882|FG000|NOT COMPLETED|Double-blind Treatment Phase||17
10245168|NCT01952574|11376883|FG001|NOT COMPLETED|Double-blind Treatment Phase||3
10245169|NCT01952574|11376884|FG002|NOT COMPLETED|Double-blind Treatment Phase||9
10245170|NCT01952574|11376885|FG003|NOT COMPLETED|Double-blind Treatment Phase||6
10245171|NCT01952574|11376886|FG004|NOT COMPLETED|Double-blind Treatment Phase||0
10245172|NCT01952574|11376887|FG005|NOT COMPLETED|Double-blind Treatment Phase||0
10245173|NCT01952574|11376888|FG006|NOT COMPLETED|Double-blind Treatment Phase||0
10245174|NCT01952574|11376882|FG000|STARTED|Open-label Treatment Phase||0
10245175|NCT01952574|11376883|FG001|STARTED|Open-label Treatment Phase||0
10245176|NCT01952574|11376884|FG002|STARTED|Open-label Treatment Phase||0
10245177|NCT01952574|11376885|FG003|STARTED|Open-label Treatment Phase||0
10245178|NCT01952574|11376886|FG004|STARTED|Open-label Treatment Phase||383
10245179|NCT01952574|11376887|FG005|STARTED|Open-label Treatment Phase||0
10245180|NCT01952574|11376888|FG006|STARTED|Open-label Treatment Phase||0
10245181|NCT01952574|11376882|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0
10245182|NCT01952574|11376883|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0
10245183|NCT01952574|11376884|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0
10245184|NCT01952574|11376885|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0
10245185|NCT01952574|11376886|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383
10245186|NCT01952574|11376887|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0
10245187|NCT01952574|11376888|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0
10245188|NCT01952574|11376882|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0
10245189|NCT01952574|11376883|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0
10245190|NCT01952574|11376884|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0
10245191|NCT01952574|11376885|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0
10245192|NCT01952574|11376886|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250
10245193|NCT01952574|11376887|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0
10245194|NCT01952574|11376888|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0
10245195|NCT01952574|11376882|FG000|COMPLETED|Open-label Treatment Phase||0
10245196|NCT01952574|11376883|FG001|COMPLETED|Open-label Treatment Phase||0
10245197|NCT01952574|11376884|FG002|COMPLETED|Open-label Treatment Phase||0
10245198|NCT01952574|11376885|FG003|COMPLETED|Open-label Treatment Phase||0
10245199|NCT01952574|11376886|FG004|COMPLETED|Open-label Treatment Phase||221
10245200|NCT01952574|11376887|FG005|COMPLETED|Open-label Treatment Phase||0
10245201|NCT01952574|11376888|FG006|COMPLETED|Open-label Treatment Phase||0
10245202|NCT01952574|11376882|FG000|NOT COMPLETED|Open-label Treatment Phase||0
10245203|NCT01952574|11376883|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10245204|NCT01952574|11376884|FG002|NOT COMPLETED|Open-label Treatment Phase||0
10245205|NCT01952574|11376885|FG003|NOT COMPLETED|Open-label Treatment Phase||0
10245206|NCT01952574|11376886|FG004|NOT COMPLETED|Open-label Treatment Phase||162
10245207|NCT01952574|11376887|FG005|NOT COMPLETED|Open-label Treatment Phase||0
10245208|NCT01952574|11376888|FG006|NOT COMPLETED|Open-label Treatment Phase||0
10245209|NCT01952574|11376882|FG000|STARTED|Clinical Home Use Substudy||0
10245210|NCT01952574|11376883|FG001|STARTED|Clinical Home Use Substudy||0
10245211|NCT01952574|11376884|FG002|STARTED|Clinical Home Use Substudy||0
10245212|NCT01952574|11376885|FG003|STARTED|Clinical Home Use Substudy||0
10245213|NCT01952574|11376886|FG004|STARTED|Clinical Home Use Substudy||0
10245214|NCT01952574|11376887|FG005|STARTED|Clinical Home Use Substudy||42
10245215|NCT01952574|11376888|FG006|STARTED|Clinical Home Use Substudy||41
10245216|NCT01952574|11376882|FG000|COMPLETED|Clinical Home Use Substudy||0
10245217|NCT01952574|11376883|FG001|COMPLETED|Clinical Home Use Substudy||0
10245218|NCT01952574|11376884|FG002|COMPLETED|Clinical Home Use Substudy||0
10245219|NCT01952574|11376885|FG003|COMPLETED|Clinical Home Use Substudy||0
10245220|NCT01952574|11376886|FG004|COMPLETED|Clinical Home Use Substudy||0
10245221|NCT01952574|11376887|FG005|COMPLETED|Clinical Home Use Substudy||39
10245222|NCT01952574|11376888|FG006|COMPLETED|Clinical Home Use Substudy||40
10245223|NCT01952574|11376882|FG000|NOT COMPLETED|Clinical Home Use Substudy||0
10245224|NCT01952574|11376883|FG001|NOT COMPLETED|Clinical Home Use Substudy||0
10245225|NCT01952574|11376884|FG002|NOT COMPLETED|Clinical Home Use Substudy||0
10245226|NCT01952574|11376885|FG003|NOT COMPLETED|Clinical Home Use Substudy||0
10245227|NCT01952574|11376886|FG004|NOT COMPLETED|Clinical Home Use Substudy||0
10245228|NCT01952574|11376887|FG005|NOT COMPLETED|Clinical Home Use Substudy||3
10245229|NCT01952574|11376888|FG006|NOT COMPLETED|Clinical Home Use Substudy||1
10245230|NCT01659151|11376913|FG000|STARTED|Overall Study||17
10245231|NCT01659151|11376913|FG000|COMPLETED|Overall Study||16
10245232|NCT01659151|11376913|FG000|NOT COMPLETED|Overall Study||1
10245233|NCT01634048|11376919|FG000|STARTED|Overall Study||21
10245234|NCT01634048|11376920|FG001|STARTED|Overall Study||18
10245235|NCT01634048|11376919|FG000|COMPLETED|Overall Study||15
10245236|NCT01634048|11376920|FG001|COMPLETED|Overall Study||15
10245237|NCT01634048|11376919|FG000|NOT COMPLETED|Overall Study||6
10245238|NCT01634048|11376920|FG001|NOT COMPLETED|Overall Study||3
10245239|NCT01539863|11376928|FG000|STARTED|Overall Study||166
10245240|NCT01539863|11376929|FG001|STARTED|Overall Study||162
10245241|NCT01539863|11376928|FG000|COMPLETED|Overall Study||161
10245242|NCT01539863|11376929|FG001|COMPLETED|Overall Study||158
10245243|NCT01539863|11376928|FG000|NOT COMPLETED|Overall Study||5
10245244|NCT01539863|11376929|FG001|NOT COMPLETED|Overall Study||4
10245245|NCT01505062|11376938|FG000|STARTED|Overall Study||3
10245246|NCT01505062|11376939|FG001|STARTED|Overall Study||3
10245247|NCT01505062|11376940|FG002|STARTED|Overall Study||3
10245248|NCT01505062|11376938|FG000|COMPLETED|Overall Study||3
10245249|NCT01505062|11376939|FG001|COMPLETED|Overall Study||3
10245250|NCT01505062|11376940|FG002|COMPLETED|Overall Study||3
10245251|NCT01505062|11376938|FG000|NOT COMPLETED|Overall Study||0
10245252|NCT01505062|11376939|FG001|NOT COMPLETED|Overall Study||0
10245253|NCT01505062|11376940|FG002|NOT COMPLETED|Overall Study||0
10245254|NCT01439165|11376950|FG000|STARTED|Overall Study||1002
10245255|NCT01439165|11376951|FG001|STARTED|Overall Study||328
10245256|NCT01439165|11376950|FG000|COMPLETED|Overall Study||981
10245257|NCT01439165|11376951|FG001|COMPLETED|Overall Study||326
10245258|NCT01439165|11376950|FG000|NOT COMPLETED|Overall Study||21
10245259|NCT01439165|11376951|FG001|NOT COMPLETED|Overall Study||2
10245260|NCT01264679|11376957|FG000|STARTED|Overall Study||8
10245261|NCT01264679|11376957|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10245262|NCT01264679|11376957|FG000|COMPLETED|Overall Study||3
10245263|NCT01264679|11376957|FG000|NOT COMPLETED|Overall Study||5
10245264|NCT01155388|11376964|FG000|STARTED|Overall Study||8
10245265|NCT01155388|11376965|FG001|STARTED|Overall Study||6
10245266|NCT01155388|11376964|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10245267|NCT01155388|11376965|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10245268|NCT01155388|11376964|FG000|COMPLETED|Overall Study||7
10245269|NCT01155388|11376965|FG001|COMPLETED|Overall Study||6
10245270|NCT01155388|11376964|FG000|NOT COMPLETED|Overall Study||1
10245271|NCT01155388|11376965|FG001|NOT COMPLETED|Overall Study||0
10245272|NCT01137435|11376972|FG000|STARTED|Overall Study||687
10245273|NCT01137435|11376972|FG000|COMPLETED|Overall Study||659
10245274|NCT01137435|11376972|FG000|NOT COMPLETED|Overall Study||28
10245275|NCT01095003|11376978|FG000|STARTED|Overall Study||384
10245276|NCT01095003|11376979|FG001|STARTED|Overall Study||386
10245277|NCT01095003|11376978|FG000|COMPLETED|Overall Study||0
10245278|NCT01095003|11376979|FG001|COMPLETED|Overall Study||0
10245279|NCT01095003|11376978|FG000|NOT COMPLETED|Overall Study||384
10245280|NCT01095003|11376979|FG001|NOT COMPLETED|Overall Study||386
10113580|NCT02510794|11244392|FG000|STARTED|Overall Study||59
10113581|NCT02510794|11244393|FG001|STARTED|Overall Study||62
10245281|NCT01064817|11376989|FG000|STARTED|All Study Treatment Days 1-9||62
10245282|NCT01064817|11376990|FG001|STARTED|All Study Treatment Days 1-9||62
10245283|NCT01064817|11376989|FG000|COMPLETED|All Study Treatment Days 1-9||62
10245284|NCT01064817|11376990|FG001|COMPLETED|All Study Treatment Days 1-9||62
10245285|NCT01064817|11376989|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0
10245286|NCT01064817|11376990|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0
10245287|NCT01064817|11376989|FG000|STARTED|Study Completion||62
10245288|NCT01064817|11376990|FG001|STARTED|Study Completion||62
10245289|NCT01064817|11376989|FG000|COMPLETED|Study Completion||60
10245290|NCT01064817|11376990|FG001|COMPLETED|Study Completion||62
10245291|NCT01064817|11376989|FG000|NOT COMPLETED|Study Completion||2
10245292|NCT01064817|11376990|FG001|NOT COMPLETED|Study Completion||0
10245293|NCT01026220|11376996|FG000|STARTED|Induction||166
10245294|NCT01026220|11376997|FG001|STARTED|Induction||0
10113582|NCT02510794|11244394|FG002|STARTED|Overall Study||63
10113583|NCT02510794|11244395|FG003|STARTED|Overall Study||41
10113584|NCT02510794|11244392|FG000|COMPLETED|Overall Study||51
10113585|NCT02510794|11244393|FG001|COMPLETED|Overall Study||56
10113586|NCT02510794|11244394|FG002|COMPLETED|Overall Study||56
10113587|NCT02510794|11244395|FG003|COMPLETED|Overall Study||36
10113588|NCT02510794|11244392|FG000|NOT COMPLETED|Overall Study||8
10113589|NCT02510794|11244393|FG001|NOT COMPLETED|Overall Study||6
10113590|NCT02510794|11244394|FG002|NOT COMPLETED|Overall Study||7
10245295|NCT01026220|11376998|FG002|STARTED|Induction||0
10245296|NCT01026220|11376996|FG000|COMPLETED|Induction||141
10245297|NCT01026220|11376997|FG001|COMPLETED|Induction||0
10245298|NCT01026220|11376998|FG002|COMPLETED|Induction||0
10245299|NCT01026220|11376996|FG000|NOT COMPLETED|Induction||25
10245300|NCT01026220|11376997|FG001|NOT COMPLETED|Induction||0
10113591|NCT02510794|11244395|FG003|NOT COMPLETED|Overall Study||5
10113592|NCT02510820|11244407|FG000|STARTED|First Intervention (4 Weeks)||21
10113593|NCT02510820|11244408|FG001|STARTED|First Intervention (4 Weeks)||27
10245301|NCT01026220|11376998|FG002|NOT COMPLETED|Induction||0
10113594|NCT02510820|11244407|FG000|COMPLETED|First Intervention (4 Weeks)||21
10113595|NCT02510820|11244408|FG001|COMPLETED|First Intervention (4 Weeks)||26
10113596|NCT02510820|11244407|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10113597|NCT02510820|11244408|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10113598|NCT02510820|11244407|FG000|STARTED|Washout (1 Week)||21
10113599|NCT02510820|11244408|FG001|STARTED|Washout (1 Week)||26
10245302|NCT01026220|11376996|FG000|STARTED|Consolidation Maintenance||0
10245303|NCT01026220|11376997|FG001|STARTED|Consolidation Maintenance||81
10245304|NCT01026220|11376998|FG002|STARTED|Consolidation Maintenance||80
10245305|NCT01026220|11376996|FG000|COMPLETED|Consolidation Maintenance||0
10245306|NCT01026220|11376997|FG001|COMPLETED|Consolidation Maintenance||75
10245307|NCT01026220|11376998|FG002|COMPLETED|Consolidation Maintenance||66
10245308|NCT01026220|11376996|FG000|NOT COMPLETED|Consolidation Maintenance||0
10245309|NCT01026220|11376997|FG001|NOT COMPLETED|Consolidation Maintenance||6
10245310|NCT01026220|11376998|FG002|NOT COMPLETED|Consolidation Maintenance||14
10245311|NCT00961714|11377013|FG000|STARTED|Overall Study||15
10245312|NCT00961714|11377013|FG000|COMPLETED|Overall Study||13
10245313|NCT00961714|11377013|FG000|NOT COMPLETED|Overall Study||2
10245314|NCT00567567|11377020|FG000|STARTED|Overall Study||210
10245315|NCT00567567|11377021|FG001|STARTED|Overall Study||176
10245316|NCT00567567|11377022|FG002|STARTED|Overall Study||279
10245317|NCT00567567|11377020|FG000|COMPLETED|Overall Study||58
10245318|NCT00567567|11377021|FG001|COMPLETED|Overall Study||42
10245319|NCT00567567|11377022|FG002|COMPLETED|Overall Study||1
10245320|NCT00567567|11377020|FG000|NOT COMPLETED|Overall Study||152
10245321|NCT00567567|11377021|FG001|NOT COMPLETED|Overall Study||134
10245322|NCT00567567|11377022|FG002|NOT COMPLETED|Overall Study||278
10245323|NCT00450450|11377034|FG000|STARTED|Overall Study||13
10245324|NCT00450450|11377035|FG001|STARTED|Overall Study||14
10245325|NCT00450450|11377034|FG000|COMPLETED|Overall Study||8
10245326|NCT00450450|11377035|FG001|COMPLETED|Overall Study||11
10245327|NCT00450450|11377034|FG000|NOT COMPLETED|Overall Study||5
10245328|NCT00450450|11377035|FG001|NOT COMPLETED|Overall Study||3
10245329|NCT00346164|11377045|FG000|STARTED|Overall Study||222
10245330|NCT00346164|11377046|FG001|STARTED|Overall Study||21
10245331|NCT00346164|11377047|FG002|STARTED|Overall Study||122
10245332|NCT00346164|11377048|FG003|STARTED|Overall Study||223
10245333|NCT00346164|11377045|FG000|COMPLETED|Overall Study||205
10245334|NCT00346164|11377046|FG001|COMPLETED|Overall Study||14
10245335|NCT00346164|11377047|FG002|COMPLETED|Overall Study||96
10245336|NCT00346164|11377048|FG003|COMPLETED|Overall Study||117
10245337|NCT00346164|11377045|FG000|NOT COMPLETED|Overall Study||17
10245338|NCT00346164|11377046|FG001|NOT COMPLETED|Overall Study||7
10245339|NCT00346164|11377047|FG002|NOT COMPLETED|Overall Study||26
10245340|NCT00346164|11377048|FG003|NOT COMPLETED|Overall Study||106
9833154|NCT00777764|10944024|FG001|COMPLETED|Overall Study||29
9833155|NCT00777764|10944023|FG000|NOT COMPLETED|Overall Study||0
9833156|NCT00777764|10944024|FG001|NOT COMPLETED|Overall Study||1
9833157|NCT00777790|10944035|FG000|STARTED|Overall Study||76
9967658|NCT01515540|11088005|FG001|COMPLETED|Overall Study||15
10113600|NCT02510820|11244407|FG000|COMPLETED|Washout (1 Week)||21
10113601|NCT02510820|11244408|FG001|COMPLETED|Washout (1 Week)||26
10113602|NCT02510820|11244407|FG000|NOT COMPLETED|Washout (1 Week)||0
9833158|NCT00777790|10944036|FG001|STARTED|Overall Study||77
10113603|NCT02510820|11244408|FG001|NOT COMPLETED|Washout (1 Week)||0
10113604|NCT02510820|11244407|FG000|STARTED|Second Intervention (4 Weeks)||21
10245341|NCT00972179|11377081|FG000|STARTED|Overall Study||6
10245342|NCT00972179|11377082|FG001|STARTED|Overall Study||6
10245343|NCT00972179|11377083|FG002|STARTED|Overall Study||6
10245344|NCT00972179|11377084|FG003|STARTED|Overall Study||6
10245345|NCT00972179|11377085|FG004|STARTED|Overall Study||7
10245346|NCT00972179|11377086|FG005|STARTED|Overall Study||6
10245347|NCT00972179|11377087|FG006|STARTED|Overall Study||12
10245348|NCT00972179|11377081|FG000|COMPLETED|Overall Study||5
10245349|NCT00972179|11377082|FG001|COMPLETED|Overall Study||3
10245350|NCT00972179|11377083|FG002|COMPLETED|Overall Study||5
10245351|NCT00972179|11377084|FG003|COMPLETED|Overall Study||5
10245352|NCT00972179|11377085|FG004|COMPLETED|Overall Study||5
10245353|NCT00972179|11377086|FG005|COMPLETED|Overall Study||3
10245354|NCT00972179|11377087|FG006|COMPLETED|Overall Study||8
10245355|NCT00972179|11377081|FG000|NOT COMPLETED|Overall Study||1
10245356|NCT00972179|11377082|FG001|NOT COMPLETED|Overall Study||3
10245357|NCT00972179|11377083|FG002|NOT COMPLETED|Overall Study||1
10245358|NCT00972179|11377084|FG003|NOT COMPLETED|Overall Study||1
10245359|NCT00972179|11377085|FG004|NOT COMPLETED|Overall Study||2
10245360|NCT00972179|11377086|FG005|NOT COMPLETED|Overall Study||3
10245361|NCT00972179|11377087|FG006|NOT COMPLETED|Overall Study||4
9957281|NCT01449929|11076489|FG000|STARTED|Extension Phase Approximately 3 Years||0
9957282|NCT01449929|11076490|FG001|STARTED|Extension Phase Approximately 3 Years||0
9957283|NCT01449929|11076491|FG002|STARTED|Extension Phase Approximately 3 Years||123
9957284|NCT01449929|11076489|FG000|COMPLETED|Extension Phase Approximately 3 Years||0
9957285|NCT01449929|11076490|FG001|COMPLETED|Extension Phase Approximately 3 Years||0
9957286|NCT01449929|11076491|FG002|COMPLETED|Extension Phase Approximately 3 Years||115
9957287|NCT01449929|11076489|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0
9957288|NCT01449929|11076490|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0
9957289|NCT01449929|11076491|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8
9957290|NCT01449955|11076503|FG000|STARTED|Overall Study||28
9957291|NCT01449955|11076504|FG001|STARTED|Overall Study||26
9957292|NCT01449955|11076503|FG000|COMPLETED|Overall Study||27
9957293|NCT01449955|11076504|FG001|COMPLETED|Overall Study||24
10019533|NCT01830972|11142749|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
10245362|NCT04360187|11377109|FG000|STARTED|Double-Blind Treatment||131
10245363|NCT04360187|11377110|FG001|STARTED|Double-Blind Treatment||260
10245364|NCT04360187|11377109|FG000|COMPLETED|Double-Blind Treatment||108
10245365|NCT04360187|11377110|FG001|COMPLETED|Double-Blind Treatment||245
10245366|NCT04360187|11377109|FG000|NOT COMPLETED|Double-Blind Treatment||23
10245367|NCT04360187|11377110|FG001|NOT COMPLETED|Double-Blind Treatment||15
10245368|NCT04360187|11377109|FG000|STARTED|Follow-Up||114
10245369|NCT04360187|11377110|FG001|STARTED|Follow-Up||232
10245370|NCT04360187|11377109|FG000|COMPLETED|Follow-Up||113
10245371|NCT04360187|11377110|FG001|COMPLETED|Follow-Up||232
10245372|NCT04360187|11377109|FG000|NOT COMPLETED|Follow-Up||1
10245373|NCT04360187|11377110|FG001|NOT COMPLETED|Follow-Up||0
10245442|NCT03794089|11377191|FG001|COMPLETED|Overall Study||17
10245443|NCT03794089|11377190|FG000|NOT COMPLETED|Overall Study||6
10245444|NCT03794089|11377191|FG001|NOT COMPLETED|Overall Study||1
10245445|NCT03638011|11377199|FG000|STARTED|Overall Study||38
9957294|NCT01449955|11076503|FG000|NOT COMPLETED|Overall Study||1
10019534|NCT01830972|11142748|FG000|NOT COMPLETED|Part I||0
10019535|NCT01830972|11142749|FG001|NOT COMPLETED|Part I||0
10019536|NCT01830972|11142748|FG000|STARTED|Part II||46
10019537|NCT01830972|11142749|FG001|STARTED|Part II|Entered study at Part 2|13
10019538|NCT01830972|11142748|FG000|COMPLETED|Part II||44
10019539|NCT01830972|11142749|FG001|COMPLETED|Part II||11
10019540|NCT01830972|11142748|FG000|NOT COMPLETED|Part II||2
10019541|NCT01830972|11142749|FG001|NOT COMPLETED|Part II||2
10019542|NCT01830972|11142748|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
10019543|NCT01830972|11142749|FG001|STARTED|Part III||11
10019544|NCT01830972|11142748|FG000|COMPLETED|Part III||42
10019545|NCT01830972|11142749|FG001|COMPLETED|Part III||11
10019546|NCT01830972|11142748|FG000|NOT COMPLETED|Part III||2
10019547|NCT01830972|11142749|FG001|NOT COMPLETED|Part III||0
10019548|NCT01830972|11142748|FG000|STARTED|Part IV||42
10019549|NCT01830972|11142749|FG001|STARTED|Part IV||11
10019550|NCT01830972|11142748|FG000|COMPLETED|Part IV||39
10019551|NCT01830972|11142749|FG001|COMPLETED|Part IV||10
10019552|NCT01830972|11142748|FG000|NOT COMPLETED|Part IV||3
10019553|NCT01830972|11142749|FG001|NOT COMPLETED|Part IV||1
10019554|NCT01831089|11142771|FG000|STARTED|Cohort I: Dose Level 1||3
10019555|NCT01831089|11142772|FG001|STARTED|Cohort I: Dose Level 1||0
10019556|NCT01831089|11142773|FG002|STARTED|Cohort I: Dose Level 1||0
10019557|NCT01831089|11142774|FG003|STARTED|Cohort I: Dose Level 1||0
10019558|NCT01831089|11142775|FG004|STARTED|Cohort I: Dose Level 1||0
10019559|NCT01831089|11142776|FG005|STARTED|Cohort I: Dose Level 1||0
10019560|NCT01831089|11142771|FG000|COMPLETED|Cohort I: Dose Level 1||0
10019561|NCT01831089|11142772|FG001|COMPLETED|Cohort I: Dose Level 1||0
10019562|NCT01831089|11142773|FG002|COMPLETED|Cohort I: Dose Level 1||0
10019563|NCT01831089|11142774|FG003|COMPLETED|Cohort I: Dose Level 1||0
10019564|NCT01831089|11142775|FG004|COMPLETED|Cohort I: Dose Level 1||0
10019565|NCT01831089|11142776|FG005|COMPLETED|Cohort I: Dose Level 1||0
10245446|NCT03638011|11377200|FG001|STARTED|Overall Study||33
10245447|NCT03638011|11377199|FG000|COMPLETED|Overall Study||38
10245448|NCT03638011|11377200|FG001|COMPLETED|Overall Study||33
10245449|NCT03638011|11377199|FG000|NOT COMPLETED|Overall Study||0
10245450|NCT03638011|11377200|FG001|NOT COMPLETED|Overall Study||0
10245451|NCT03631407|11377208|FG000|STARTED|Overall Study||21
10245374|NCT04025632|11377118|FG000|STARTED|Overall Study||15
10245375|NCT04025632|11377119|FG001|STARTED|Overall Study||12
10245376|NCT04025632|11377118|FG000|Completed Main Portion|Overall Study||15
10245377|NCT04025632|11377119|FG001|Completed Main Portion|Overall Study||12
10245378|NCT04025632|11377118|FG000|Started Main Portion Safety Follow-up|Overall Study||2
10245379|NCT04025632|11377119|FG001|Started Main Portion Safety Follow-up|Overall Study||0
10245380|NCT04025632|11377118|FG000|Completed Main Portion Safety Follow-up|Overall Study||0
10245381|NCT04025632|11377119|FG001|Completed Main Portion Safety Follow-up|Overall Study||0
10245382|NCT04025632|11377118|FG000|Started Extension Portion|Overall Study||13
10245383|NCT04025632|11377119|FG001|Started Extension Portion|Overall Study||12
10245384|NCT04025632|11377118|FG000|COMPLETED|Overall Study||0
10245385|NCT04025632|11377119|FG001|COMPLETED|Overall Study||0
10245386|NCT04025632|11377118|FG000|NOT COMPLETED|Overall Study||15
10245387|NCT04025632|11377119|FG001|NOT COMPLETED|Overall Study||12
10245388|NCT03978091|11377134|FG000|STARTED|Overall Study||8
10245389|NCT03978091|11377135|FG001|STARTED|Overall Study||8
10245390|NCT03978091|11377136|FG002|STARTED|Overall Study||8
10245391|NCT03978091|11377137|FG003|STARTED|Overall Study||8
10245392|NCT03978091|11377138|FG004|STARTED|Overall Study||8
10245393|NCT03978091|11377139|FG005|STARTED|Overall Study||8
10245394|NCT03978091|11377134|FG000|COMPLETED|Overall Study||8
10245395|NCT03978091|11377135|FG001|COMPLETED|Overall Study||8
10245396|NCT03978091|11377136|FG002|COMPLETED|Overall Study||7
10245397|NCT03978091|11377137|FG003|COMPLETED|Overall Study||7
10245398|NCT03978091|11377138|FG004|COMPLETED|Overall Study||7
10245399|NCT03978091|11377139|FG005|COMPLETED|Overall Study||8
10245400|NCT03978091|11377134|FG000|NOT COMPLETED|Overall Study||0
10245401|NCT03978091|11377135|FG001|NOT COMPLETED|Overall Study||0
10245402|NCT03978091|11377136|FG002|NOT COMPLETED|Overall Study||1
10245403|NCT03978091|11377137|FG003|NOT COMPLETED|Overall Study||1
10245404|NCT03978091|11377138|FG004|NOT COMPLETED|Overall Study||1
10245405|NCT03978091|11377139|FG005|NOT COMPLETED|Overall Study||0
10245406|NCT03903640|11377153|FG000|STARTED|Overall Study||2
10245407|NCT03903640|11377153|FG000|COMPLETED|Overall Study||2
10245408|NCT03903640|11377153|FG000|NOT COMPLETED|Overall Study||0
10245409|NCT03853291|11377163|FG000|STARTED|Overall Study||18
10245410|NCT03853291|11377164|FG001|STARTED|Overall Study||16
10245411|NCT03853291|11377165|FG002|STARTED|Overall Study||18
10245412|NCT03853291|11377166|FG003|STARTED|Overall Study||16
10245413|NCT03853291|11377167|FG004|STARTED|Overall Study||6
10245414|NCT03853291|11377168|FG005|STARTED|Overall Study||11
10245415|NCT03853291|11377163|FG000|COMPLETED|Overall Study||16
10245416|NCT03853291|11377164|FG001|COMPLETED|Overall Study||13
10245417|NCT03853291|11377165|FG002|COMPLETED|Overall Study||18
10245418|NCT03853291|11377166|FG003|COMPLETED|Overall Study||16
10245419|NCT03853291|11377167|FG004|COMPLETED|Overall Study||6
10245420|NCT03853291|11377168|FG005|COMPLETED|Overall Study||11
10245421|NCT03853291|11377163|FG000|NOT COMPLETED|Overall Study||2
10245422|NCT03853291|11377164|FG001|NOT COMPLETED|Overall Study||3
10245423|NCT03853291|11377165|FG002|NOT COMPLETED|Overall Study||0
10245424|NCT03853291|11377166|FG003|NOT COMPLETED|Overall Study||0
10113605|NCT02510820|11244408|FG001|STARTED|Second Intervention (4 Weeks)||26
10113606|NCT02510820|11244407|FG000|COMPLETED|Second Intervention (4 Weeks)||20
10113607|NCT02510820|11244408|FG001|COMPLETED|Second Intervention (4 Weeks)||26
10113608|NCT02510820|11244407|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10113609|NCT02510820|11244408|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10113610|NCT02511184|11244417|FG000|STARTED|Overall Study||2
10245425|NCT03853291|11377167|FG004|NOT COMPLETED|Overall Study||0
10245426|NCT03853291|11377168|FG005|NOT COMPLETED|Overall Study||0
10245427|NCT03850444|11377181|FG000|STARTED|Overall Study||128
10245428|NCT03850444|11377182|FG001|STARTED|Overall Study||134
10245429|NCT03850444|11377181|FG000|COMPLETED|Overall Study||0
10245430|NCT03850444|11377182|FG001|COMPLETED|Overall Study||0
10245431|NCT03850444|11377181|FG000|NOT COMPLETED|Overall Study||128
10113611|NCT02511184|11244418|FG001|STARTED|Overall Study||7
10113612|NCT02511184|11244417|FG000|COMPLETED|Overall Study||0
10113613|NCT02511184|11244418|FG001|COMPLETED|Overall Study||0
10113614|NCT02511184|11244417|FG000|NOT COMPLETED|Overall Study||2
10113615|NCT02511184|11244418|FG001|NOT COMPLETED|Overall Study||7
10113616|NCT02511236|11244427|FG000|STARTED|Overall Study||165
10113617|NCT02511236|11244428|FG001|STARTED|Overall Study||191
10113618|NCT02511236|11244427|FG000|COMPLETED|Overall Study||125
10113619|NCT02511236|11244428|FG001|COMPLETED|Overall Study||146
10113620|NCT02511236|11244427|FG000|NOT COMPLETED|Overall Study||40
10245432|NCT03850444|11377182|FG001|NOT COMPLETED|Overall Study||134
10245433|NCT03794089|11377190|FG000|STARTED|Overall Study||17
10113621|NCT02511236|11244428|FG001|NOT COMPLETED|Overall Study||45
10113622|NCT02511379|11244434|FG000|STARTED|Overall Study||14
10113623|NCT02511379|11244434|FG000|COMPLETED|Overall Study||14
10113624|NCT02511379|11244434|FG000|NOT COMPLETED|Overall Study||0
10113625|NCT02511431|11244444|FG000|STARTED|Treatment||4
10113626|NCT02511431|11244445|FG001|STARTED|Treatment||4
10245434|NCT03794089|11377191|FG001|STARTED|Overall Study||18
10245435|NCT03794089|11377190|FG000|Completed 4-week Assessment|Overall Study||16
10245436|NCT03794089|11377191|FG001|Completed 4-week Assessment|Overall Study||18
10245437|NCT03794089|11377190|FG000|Completed 8-week Assessment|Overall Study||14
10245438|NCT03794089|11377191|FG001|Completed 8-week Assessment|Overall Study||18
10245439|NCT03794089|11377190|FG000|Completed 12-week Assessment|Overall Study||13
10245440|NCT03794089|11377191|FG001|Completed 12-week Assessment|Overall Study||17
10245441|NCT03794089|11377190|FG000|COMPLETED|Overall Study||11
10113627|NCT02511431|11244446|FG002|STARTED|Treatment||4
10245452|NCT03631407|11377209|FG001|STARTED|Overall Study||20
10245453|NCT03631407|11377208|FG000|Treated|Overall Study||20
10245454|NCT03631407|11377209|FG001|Treated|Overall Study||20
10245455|NCT03631407|11377208|FG000|COMPLETED|Overall Study||1
10245456|NCT03631407|11377209|FG001|COMPLETED|Overall Study||0
10245457|NCT03631407|11377208|FG000|NOT COMPLETED|Overall Study||20
10245458|NCT03631407|11377209|FG001|NOT COMPLETED|Overall Study||20
10245459|NCT03617926|11377217|FG000|STARTED|Overall Study||35
10245460|NCT03617926|11377218|FG001|STARTED|Overall Study||35
10245461|NCT03617926|11377217|FG000|COMPLETED|Overall Study||35
10245462|NCT03617926|11377218|FG001|COMPLETED|Overall Study||35
10245463|NCT03617926|11377217|FG000|NOT COMPLETED|Overall Study||0
10245464|NCT03617926|11377218|FG001|NOT COMPLETED|Overall Study||0
10245465|NCT03457129|11377231|FG000|STARTED|Overall Study||10
10245466|NCT03457129|11377232|FG001|STARTED|Overall Study||10
10245467|NCT03457129|11377231|FG000|COMPLETED|Overall Study||7
10245468|NCT03457129|11377232|FG001|COMPLETED|Overall Study||8
10245469|NCT03457129|11377231|FG000|NOT COMPLETED|Overall Study||3
10245470|NCT03457129|11377232|FG001|NOT COMPLETED|Overall Study||2
10245471|NCT03358472|11377241|FG000|STARTED|Overall Study||35
10245472|NCT03358472|11377242|FG001|STARTED|Overall Study||19
10245473|NCT03358472|11377243|FG002|STARTED|Overall Study||35
10245474|NCT03358472|11377241|FG000|Intention-to-Treat (ITT)|Overall Study||35
10245475|NCT03358472|11377242|FG001|Intention-to-Treat (ITT)|Overall Study||19
10245476|NCT03358472|11377243|FG002|Intention-to-Treat (ITT)|Overall Study||35
10245477|NCT03358472|11377241|FG000|All Participants as Treated (APaT)|Overall Study||34
10245478|NCT03358472|11377242|FG001|All Participants as Treated (APaT)|Overall Study||19
10245479|NCT03358472|11377243|FG002|All Participants as Treated (APaT)|Overall Study||34
10245480|NCT03358472|11377241|FG000|COMPLETED|Overall Study||20
10245481|NCT03358472|11377242|FG001|COMPLETED|Overall Study||9
10245482|NCT03358472|11377243|FG002|COMPLETED|Overall Study||19
10245483|NCT03358472|11377241|FG000|NOT COMPLETED|Overall Study||15
10245484|NCT03358472|11377242|FG001|NOT COMPLETED|Overall Study||10
10245485|NCT03358472|11377243|FG002|NOT COMPLETED|Overall Study||16
10245486|NCT03281304|11377253|FG000|STARTED|Overall Study||70
10245487|NCT03281304|11377254|FG001|STARTED|Overall Study||70
10245488|NCT03281304|11377253|FG000|COMPLETED|Overall Study||57
10245489|NCT03281304|11377254|FG001|COMPLETED|Overall Study||58
10245490|NCT03281304|11377253|FG000|NOT COMPLETED|Overall Study||13
10245491|NCT03281304|11377254|FG001|NOT COMPLETED|Overall Study||12
10245492|NCT03274804|11377260|FG000|STARTED|Overall Study||20
10245493|NCT03274804|11377260|FG000|COMPLETED|Overall Study||20
10245494|NCT03274804|11377260|FG000|NOT COMPLETED|Overall Study||0
10245495|NCT03197935|11377267|FG000|STARTED|Overall Study||168
10245496|NCT03197935|11377268|FG001|STARTED|Overall Study||165
10245497|NCT03197935|11377267|FG000|COMPLETED|Overall Study||0
10245498|NCT03197935|11377268|FG001|COMPLETED|Overall Study||0
10245499|NCT03197935|11377267|FG000|NOT COMPLETED|Overall Study||168
10245500|NCT03197935|11377268|FG001|NOT COMPLETED|Overall Study||165
10245501|NCT03190460|11377277|FG000|STARTED|Overall Study||40
10245502|NCT03190460|11377278|FG001|STARTED|Overall Study||20
10245503|NCT03190460|11377277|FG000|COMPLETED|Overall Study||3
10245504|NCT03190460|11377278|FG001|COMPLETED|Overall Study||2
10245505|NCT03190460|11377277|FG000|NOT COMPLETED|Overall Study||37
10245506|NCT03190460|11377278|FG001|NOT COMPLETED|Overall Study||18
10245507|NCT03164616|11377287|FG000|STARTED|Overall Study||338
10245508|NCT03164616|11377288|FG001|STARTED|Overall Study||338
10245509|NCT03164616|11377289|FG002|STARTED|Overall Study||337
10245510|NCT03164616|11377287|FG000|Received Treatment|Overall Study||331
10245511|NCT03164616|11377288|FG001|Received Treatment|Overall Study||335
10245512|NCT03164616|11377289|FG002|Received Treatment|Overall Study||331
10245513|NCT03164616|11377287|FG000|COMPLETED|Overall Study||80
10245514|NCT03164616|11377288|FG001|COMPLETED|Overall Study||65
10245515|NCT03164616|11377289|FG002|COMPLETED|Overall Study||40
10245516|NCT03164616|11377287|FG000|NOT COMPLETED|Overall Study||258
10245517|NCT03164616|11377288|FG001|NOT COMPLETED|Overall Study||273
10245518|NCT03164616|11377289|FG002|NOT COMPLETED|Overall Study||297
10113628|NCT02511431|11244447|FG003|STARTED|Treatment||3
10113629|NCT02511431|11244448|FG004|STARTED|Treatment||3
10113630|NCT02511431|11244449|FG005|STARTED|Treatment||3
10113631|NCT02511431|11244444|FG000|COMPLETED|Treatment||4
10113632|NCT02511431|11244445|FG001|COMPLETED|Treatment||4
10113633|NCT02511431|11244446|FG002|COMPLETED|Treatment||3
10113634|NCT02511431|11244447|FG003|COMPLETED|Treatment||3
10113635|NCT02511431|11244448|FG004|COMPLETED|Treatment||3
10113636|NCT02511431|11244449|FG005|COMPLETED|Treatment||2
10113637|NCT02511431|11244444|FG000|NOT COMPLETED|Treatment||0
10245519|NCT03120949|11377301|FG000|STARTED|Overall Study|One subject was randomized in error and did not receive any dose of study drug.|1058
10245520|NCT03120949|11377302|FG001|STARTED|Overall Study||1047
10245521|NCT03120949|11377301|FG000|mITT|Overall Study||1057
10245522|NCT03120949|11377302|FG001|mITT|Overall Study||1047
10245523|NCT03120949|11377301|FG000|Safety Population|Overall Study||1043
10245524|NCT03120949|11377302|FG001|Safety Population|Overall Study||1061
10245525|NCT03120949|11377301|FG000|COMPLETED|Overall Study||830
10245526|NCT03120949|11377302|FG001|COMPLETED|Overall Study||844
10245527|NCT03120949|11377301|FG000|NOT COMPLETED|Overall Study||228
10245528|NCT03120949|11377302|FG001|NOT COMPLETED|Overall Study||203
10245529|NCT03119766|11377314|FG000|STARTED|Overall Study||151
10245530|NCT03119766|11377315|FG001|STARTED|Overall Study||158
10245531|NCT03119766|11377314|FG000|COMPLETED|Overall Study||151
10245532|NCT03119766|11377315|FG001|COMPLETED|Overall Study||158
10245533|NCT03119766|11377314|FG000|NOT COMPLETED|Overall Study||0
10245534|NCT03119766|11377315|FG001|NOT COMPLETED|Overall Study||0
10245535|NCT03077698|11377323|FG000|STARTED|Progestin Monotherapy||16
10245536|NCT03077698|11377324|FG001|STARTED|Progestin Monotherapy||0
10245537|NCT03077698|11377323|FG000|COMPLETED|Progestin Monotherapy||6
10245538|NCT03077698|11377324|FG001|COMPLETED|Progestin Monotherapy||0
10245539|NCT03077698|11377323|FG000|NOT COMPLETED|Progestin Monotherapy||10
10245540|NCT03077698|11377324|FG001|NOT COMPLETED|Progestin Monotherapy||0
10245541|NCT03077698|11377323|FG000|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects with disease progression after progestin monotherapy will roll over into treatment period 2, and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|6
10245542|NCT03077698|11377324|FG001|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects determined to have PrR negative status from a tumor tissue sample at Screening will enroll directly into Treatment Period 2 and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|9
10245543|NCT03077698|11377323|FG000|COMPLETED|Sodium Cridanimod & Progestin Therapy||0
10245544|NCT03077698|11377324|FG001|COMPLETED|Sodium Cridanimod & Progestin Therapy||0
10245545|NCT03077698|11377323|FG000|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||6
10245546|NCT03077698|11377324|FG001|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||9
10245547|NCT03077698|11377323|FG000|STARTED|Safety Follow Up||6
10245548|NCT03077698|11377324|FG001|STARTED|Safety Follow Up||9
10245549|NCT03077698|11377323|FG000|COMPLETED|Safety Follow Up||3
10245550|NCT03077698|11377324|FG001|COMPLETED|Safety Follow Up||8
10245551|NCT03077698|11377323|FG000|NOT COMPLETED|Safety Follow Up||3
10245552|NCT03077698|11377324|FG001|NOT COMPLETED|Safety Follow Up||1
10113638|NCT02511431|11244445|FG001|NOT COMPLETED|Treatment||0
10113639|NCT02511431|11244446|FG002|NOT COMPLETED|Treatment||1
10113640|NCT02511431|11244447|FG003|NOT COMPLETED|Treatment||0
10245553|NCT02911935|11377331|FG000|STARTED|Overall Study||101
10245554|NCT02911935|11377332|FG001|STARTED|Overall Study||99
10245555|NCT02911935|11377331|FG000|COMPLETED|Overall Study||96
10245556|NCT02911935|11377332|FG001|COMPLETED|Overall Study||92
10245557|NCT02911935|11377331|FG000|NOT COMPLETED|Overall Study||5
10245558|NCT02911935|11377332|FG001|NOT COMPLETED|Overall Study||7
10245559|NCT02874742|11377341|FG000|STARTED|Overall Study||103
10245560|NCT02874742|11377342|FG001|STARTED|Overall Study||104
10245561|NCT02874742|11377343|FG002|STARTED|Overall Study||16
10245562|NCT02874742|11377341|FG000|Safety|Overall Study||102
10245563|NCT02874742|11377342|FG001|Safety|Overall Study||99
10245564|NCT02874742|11377343|FG002|Safety|Overall Study||16
10245565|NCT02874742|11377341|FG000|COMPLETED|Overall Study||0
10245566|NCT02874742|11377342|FG001|COMPLETED|Overall Study||0
10245567|NCT02874742|11377343|FG002|COMPLETED|Overall Study||0
10245568|NCT02874742|11377341|FG000|NOT COMPLETED|Overall Study||103
9833159|NCT00777790|10944037|FG002|STARTED|Overall Study||88
9833160|NCT00777790|10944035|FG000|COMPLETED|Overall Study||76
10113641|NCT02511431|11244448|FG004|NOT COMPLETED|Treatment||0
10113642|NCT02511431|11244449|FG005|NOT COMPLETED|Treatment||1
10113643|NCT02511431|11244444|FG000|STARTED|Post-treatment Follow-up||4
10113644|NCT02511431|11244445|FG001|STARTED|Post-treatment Follow-up||4
10113645|NCT02511431|11244446|FG002|STARTED|Post-treatment Follow-up||3
10113646|NCT02511431|11244447|FG003|STARTED|Post-treatment Follow-up||3
10113647|NCT02511431|11244448|FG004|STARTED|Post-treatment Follow-up||3
10113648|NCT02511431|11244449|FG005|STARTED|Post-treatment Follow-up||2
10245569|NCT02874742|11377342|FG001|NOT COMPLETED|Overall Study||104
10245570|NCT02874742|11377343|FG002|NOT COMPLETED|Overall Study||16
10245571|NCT02644525|11377355|FG000|STARTED|Group 1||2
10245572|NCT02644525|11377356|FG001|STARTED|Group 1||5
10245573|NCT02644525|11377357|FG002|STARTED|Group 1||0
10245574|NCT02644525|11377358|FG003|STARTED|Group 1||0
10245575|NCT02644525|11377355|FG000|COMPLETED|Group 1||2
10245576|NCT02644525|11377356|FG001|COMPLETED|Group 1||5
10245577|NCT02644525|11377357|FG002|COMPLETED|Group 1||0
10245578|NCT02644525|11377358|FG003|COMPLETED|Group 1||0
10245579|NCT02644525|11377355|FG000|NOT COMPLETED|Group 1||0
10245580|NCT02644525|11377356|FG001|NOT COMPLETED|Group 1||0
10245581|NCT02644525|11377357|FG002|NOT COMPLETED|Group 1||0
10245582|NCT02644525|11377358|FG003|NOT COMPLETED|Group 1||0
10245583|NCT02644525|11377355|FG000|STARTED|Group 2||2
10245584|NCT02644525|11377356|FG001|STARTED|Group 2||0
9833161|NCT00777790|10944036|FG001|COMPLETED|Overall Study||77
10113649|NCT02511431|11244444|FG000|COMPLETED|Post-treatment Follow-up||4
10113650|NCT02511431|11244445|FG001|COMPLETED|Post-treatment Follow-up||4
10113651|NCT02511431|11244446|FG002|COMPLETED|Post-treatment Follow-up||3
10245585|NCT02644525|11377357|FG002|STARTED|Group 2||5
10245586|NCT02644525|11377358|FG003|STARTED|Group 2||0
10245587|NCT02644525|11377355|FG000|COMPLETED|Group 2||2
10245588|NCT02644525|11377356|FG001|COMPLETED|Group 2||0
10245589|NCT02644525|11377357|FG002|COMPLETED|Group 2||5
10245590|NCT02644525|11377358|FG003|COMPLETED|Group 2||0
10245591|NCT02644525|11377355|FG000|NOT COMPLETED|Group 2||0
10245592|NCT02644525|11377356|FG001|NOT COMPLETED|Group 2||0
10245593|NCT02644525|11377357|FG002|NOT COMPLETED|Group 2||0
10245594|NCT02644525|11377358|FG003|NOT COMPLETED|Group 2||0
10245595|NCT02644525|11377355|FG000|STARTED|Group 3||1
10245596|NCT02644525|11377356|FG001|STARTED|Group 3||0
10245597|NCT02644525|11377357|FG002|STARTED|Group 3||0
9833162|NCT00777790|10944037|FG002|COMPLETED|Overall Study||88
9833163|NCT00777790|10944035|FG000|NOT COMPLETED|Overall Study||0
9833164|NCT00777790|10944036|FG001|NOT COMPLETED|Overall Study||0
9833165|NCT00777790|10944037|FG002|NOT COMPLETED|Overall Study||0
9833166|NCT00777803|10944047|FG000|STARTED|Overall Study||284
9833167|NCT00777803|10944048|FG001|STARTED|Overall Study||97
9833168|NCT00777803|10944047|FG000|COMPLETED|Overall Study||269
9833169|NCT00777803|10944048|FG001|COMPLETED|Overall Study||90
9833170|NCT00777803|10944047|FG000|NOT COMPLETED|Overall Study||15
9833171|NCT00777803|10944048|FG001|NOT COMPLETED|Overall Study||7
9833172|NCT00777829|10944054|FG000|STARTED|Overall Study||15
9833173|NCT00777829|10944055|FG001|STARTED|Overall Study||15
9833174|NCT00777829|10944054|FG000|Study Orientation|Overall Study||15
9833175|NCT00777829|10944055|FG001|Study Orientation|Overall Study||13
9833176|NCT00777829|10944054|FG000|COMPLETED|Overall Study||15
9833177|NCT00777829|10944055|FG001|COMPLETED|Overall Study||13
9833178|NCT00777829|10944054|FG000|NOT COMPLETED|Overall Study||0
9833179|NCT00777829|10944055|FG001|NOT COMPLETED|Overall Study||2
9833180|NCT00777855|10944063|FG000|STARTED|First Intervention||5
9833181|NCT00777855|10944064|FG001|STARTED|First Intervention||5
9833182|NCT00777855|10944063|FG000|COMPLETED|First Intervention||5
9833183|NCT00777855|10944064|FG001|COMPLETED|First Intervention||5
9833184|NCT00777855|10944063|FG000|NOT COMPLETED|First Intervention||0
9833185|NCT00777855|10944064|FG001|NOT COMPLETED|First Intervention||0
9833186|NCT00777855|10944063|FG000|STARTED|Washout Period (>= 14 Days)||5
9833187|NCT00777855|10944064|FG001|STARTED|Washout Period (>= 14 Days)||5
9833188|NCT00777855|10944063|FG000|COMPLETED|Washout Period (>= 14 Days)||5
9833189|NCT00777855|10944064|FG001|COMPLETED|Washout Period (>= 14 Days)||5
9833190|NCT00777855|10944063|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0
9833191|NCT00777855|10944064|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0
9833192|NCT00777855|10944063|FG000|STARTED|Second Intervention||5
9833193|NCT00777855|10944064|FG001|STARTED|Second Intervention||5
9833194|NCT00777855|10944063|FG000|COMPLETED|Second Intervention||5
9833195|NCT00777855|10944064|FG001|COMPLETED|Second Intervention||5
9833196|NCT00777855|10944063|FG000|NOT COMPLETED|Second Intervention||0
9833197|NCT00777855|10944064|FG001|NOT COMPLETED|Second Intervention||0
9833198|NCT00777920|10944069|FG000|STARTED|Overall Study||140
9833199|NCT00777920|10944069|FG000|COMPLETED|Overall Study||90
9833200|NCT00777920|10944069|FG000|NOT COMPLETED|Overall Study||50
9833201|NCT00777946|10944076|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
9833202|NCT00777946|10944077|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
9833203|NCT00777946|10944078|FG002|STARTED|Overall Study||260
9833204|NCT00777946|10944076|FG000|Safety & Full Analysis Sets|Overall Study||282
9833205|NCT00777946|10944077|FG001|Safety & Full Analysis Sets|Overall Study||276
9833206|NCT00777946|10944078|FG002|Safety & Full Analysis Sets|Overall Study||260
9833207|NCT00777946|10944076|FG000|COMPLETED|Overall Study||262
9833208|NCT00777946|10944077|FG001|COMPLETED|Overall Study||271
9833209|NCT00777946|10944078|FG002|COMPLETED|Overall Study||244
9833210|NCT00777946|10944076|FG000|NOT COMPLETED|Overall Study||21
9833211|NCT00777946|10944077|FG001|NOT COMPLETED|Overall Study||6
9833212|NCT00777946|10944078|FG002|NOT COMPLETED|Overall Study||16
9833213|NCT00778102|10944088|FG000|STARTED|Overall Study||39
9833214|NCT00778102|10944089|FG001|STARTED|Overall Study||41
9833215|NCT00778102|10944088|FG000|COMPLETED|Overall Study||18
9833216|NCT00778102|10944089|FG001|COMPLETED|Overall Study||19
9833217|NCT00778102|10944088|FG000|NOT COMPLETED|Overall Study||21
9833218|NCT00778102|10944089|FG001|NOT COMPLETED|Overall Study||22
9833219|NCT00778167|10944098|FG000|STARTED|Overall Study||6
10245598|NCT02644525|11377358|FG003|STARTED|Group 3||5
10245599|NCT02644525|11377355|FG000|COMPLETED|Group 3||1
10245600|NCT02644525|11377356|FG001|COMPLETED|Group 3||0
10245601|NCT02644525|11377357|FG002|COMPLETED|Group 3||0
10245602|NCT02644525|11377358|FG003|COMPLETED|Group 3||5
10245603|NCT02644525|11377355|FG000|NOT COMPLETED|Group 3||0
10245604|NCT02644525|11377356|FG001|NOT COMPLETED|Group 3||0
10245605|NCT02644525|11377357|FG002|NOT COMPLETED|Group 3||0
9833220|NCT00778167|10944099|FG001|STARTED|Overall Study||8
9833221|NCT00778167|10944100|FG002|STARTED|Overall Study||4
9833222|NCT00778167|10944098|FG000|COMPLETED|Overall Study||6
9833223|NCT00778167|10944099|FG001|COMPLETED|Overall Study||8
10245606|NCT02644525|11377358|FG003|NOT COMPLETED|Group 3||0
10245607|NCT02610777|11377370|FG000|STARTED|Overall Study||62
9833224|NCT00778167|10944100|FG002|COMPLETED|Overall Study||4
9833225|NCT00778167|10944098|FG000|NOT COMPLETED|Overall Study||0
9833226|NCT00778167|10944099|FG001|NOT COMPLETED|Overall Study||0
9833227|NCT00778167|10944100|FG002|NOT COMPLETED|Overall Study||0
10245608|NCT02610777|11377371|FG001|STARTED|Overall Study||58
10245609|NCT02610777|11377370|FG000|COMPLETED|Overall Study||41
10245610|NCT02610777|11377371|FG001|COMPLETED|Overall Study||36
10245611|NCT02610777|11377370|FG000|NOT COMPLETED|Overall Study||21
10245612|NCT02610777|11377371|FG001|NOT COMPLETED|Overall Study||22
10245613|NCT02557672|11377379|FG000|STARTED|Overall Study||53
10245614|NCT02557672|11377380|FG001|STARTED|Overall Study||53
10245615|NCT02557672|11377379|FG000|COMPLETED|Overall Study||49
10245616|NCT02557672|11377380|FG001|COMPLETED|Overall Study||51
10245617|NCT02557672|11377379|FG000|NOT COMPLETED|Overall Study||4
10245618|NCT02557672|11377380|FG001|NOT COMPLETED|Overall Study||2
10245619|NCT02524379|11377386|FG000|STARTED|Overall Study||3
10245620|NCT02524379|11377386|FG000|COMPLETED|Overall Study||2
10245621|NCT02524379|11377386|FG000|NOT COMPLETED|Overall Study||1
10245622|NCT02509312|11377392|FG000|STARTED|Overall Study||35
10245623|NCT02509312|11377393|FG001|STARTED|Overall Study||35
10245624|NCT02509312|11377392|FG000|Intraoperative Checkpoint|Overall Study||28
10245625|NCT02509312|11377393|FG001|Intraoperative Checkpoint|Overall Study||30
10245626|NCT02509312|11377392|FG000|COMPLETED|Overall Study||28
10245627|NCT02509312|11377393|FG001|COMPLETED|Overall Study||30
10245628|NCT02509312|11377392|FG000|NOT COMPLETED|Overall Study||7
10245629|NCT02509312|11377393|FG001|NOT COMPLETED|Overall Study||5
10245630|NCT02379247|11377405|FG000|STARTED|Overall Study||3
10245631|NCT02379247|11377406|FG001|STARTED|Overall Study||3
10245632|NCT02379247|11377407|FG002|STARTED|Overall Study||7
10245633|NCT02379247|11377408|FG003|STARTED|Overall Study||30
10245634|NCT02379247|11377405|FG000|COMPLETED|Overall Study||3
10245635|NCT02379247|11377406|FG001|COMPLETED|Overall Study||3
10245636|NCT02379247|11377407|FG002|COMPLETED|Overall Study||7
10245637|NCT02379247|11377408|FG003|COMPLETED|Overall Study||30
10245638|NCT02379247|11377405|FG000|NOT COMPLETED|Overall Study||0
10245639|NCT02379247|11377406|FG001|NOT COMPLETED|Overall Study||0
10245640|NCT02379247|11377407|FG002|NOT COMPLETED|Overall Study||0
10245641|NCT02379247|11377408|FG003|NOT COMPLETED|Overall Study||0
10245642|NCT02360280|11377423|FG000|STARTED|Overall Study||28
10245643|NCT02360280|11377424|FG001|STARTED|Overall Study||30
10245644|NCT02360280|11377423|FG000|COMPLETED|Overall Study||25
10245645|NCT02360280|11377424|FG001|COMPLETED|Overall Study||29
10245646|NCT02360280|11377423|FG000|NOT COMPLETED|Overall Study||3
10245647|NCT02360280|11377424|FG001|NOT COMPLETED|Overall Study||1
10245648|NCT02294461|11377432|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202
10245649|NCT02294461|11377433|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193
10245650|NCT02294461|11377432|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202
10245651|NCT02294461|11377433|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193
10245652|NCT02294461|11377432|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84
10245653|NCT02294461|11377433|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1
10245654|NCT02294461|11377432|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118
10245655|NCT02294461|11377433|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192
10245656|NCT02294461|11377432|FG000|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|85
10245657|NCT02294461|11377433|FG001|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|51
10245658|NCT02294461|11377432|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0
10245659|NCT02294461|11377433|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0
10245660|NCT02294461|11377432|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85
10245661|NCT02294461|11377433|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51
10245662|NCT02163395|11377451|FG000|STARTED|Overall Study||44
10245663|NCT02163395|11377451|FG000|COMPLETED|Overall Study||39
10245664|NCT02163395|11377451|FG000|NOT COMPLETED|Overall Study||5
10245665|NCT02097134|11377455|FG000|STARTED|Overall Study||14
10245666|NCT02097134|11377455|FG000|COMPLETED|Overall Study||5
10245667|NCT02097134|11377455|FG000|NOT COMPLETED|Overall Study||9
10245668|NCT02096588|11377462|FG000|STARTED|Overall Study||15
10245669|NCT02096588|11377463|FG001|STARTED|Overall Study||16
10245670|NCT02096588|11377462|FG000|COMPLETED|Overall Study||13
10245671|NCT02096588|11377463|FG001|COMPLETED|Overall Study||15
10245672|NCT02096588|11377462|FG000|NOT COMPLETED|Overall Study||2
10245673|NCT02096588|11377463|FG001|NOT COMPLETED|Overall Study||1
10245674|NCT02053350|11377469|FG000|STARTED|Overall Study||7
10245675|NCT02053350|11377469|FG000|COMPLETED|Overall Study||2
10245676|NCT02053350|11377469|FG000|NOT COMPLETED|Overall Study||5
10245677|NCT02005471|11377475|FG000|STARTED|Overall Study||195
10245678|NCT02005471|11377476|FG001|STARTED|Overall Study||194
10245679|NCT02005471|11377475|FG000|Treated|Overall Study||188
10245680|NCT02005471|11377476|FG001|Treated|Overall Study||194
10245681|NCT02005471|11377475|FG000|COMPLETED|Overall Study||0
10245682|NCT02005471|11377476|FG001|COMPLETED|Overall Study||0
10245683|NCT02005471|11377475|FG000|NOT COMPLETED|Overall Study||195
10245684|NCT02005471|11377476|FG001|NOT COMPLETED|Overall Study||194
10245685|NCT01965704|11377489|FG000|STARTED|Overall Study||48
10245686|NCT01965704|11377490|FG001|STARTED|Overall Study||48
10245687|NCT01965704|11377491|FG002|STARTED|Overall Study||50
10245688|NCT01965704|11377492|FG003|STARTED|Overall Study||50
10245689|NCT01965704|11377489|FG000|Received Intervention|Overall Study||45
10245690|NCT01965704|11377490|FG001|Received Intervention|Overall Study||45
10245691|NCT01965704|11377491|FG002|Received Intervention|Overall Study||47
10245692|NCT01965704|11377492|FG003|Received Intervention|Overall Study||47
10245693|NCT01965704|11377489|FG000|Analyzable Population|Overall Study||45
10245694|NCT01965704|11377490|FG001|Analyzable Population|Overall Study||45
10245695|NCT01965704|11377491|FG002|Analyzable Population|Overall Study||41
10245696|NCT01965704|11377492|FG003|Analyzable Population|Overall Study||41
10245697|NCT01965704|11377489|FG000|COMPLETED|Overall Study||45
10245698|NCT01965704|11377490|FG001|COMPLETED|Overall Study||45
10245699|NCT01965704|11377491|FG002|COMPLETED|Overall Study||45
10245700|NCT01965704|11377492|FG003|COMPLETED|Overall Study||45
10245701|NCT01965704|11377489|FG000|NOT COMPLETED|Overall Study||3
10245702|NCT01965704|11377490|FG001|NOT COMPLETED|Overall Study||3
10245703|NCT01965704|11377491|FG002|NOT COMPLETED|Overall Study||5
10245704|NCT01965704|11377492|FG003|NOT COMPLETED|Overall Study||5
10245705|NCT01913795|11377504|FG000|STARTED|Overall Study||4
10245706|NCT01913795|11377505|FG001|STARTED|Overall Study||10
10245707|NCT01913795|11377506|FG002|STARTED|Overall Study||9
10245708|NCT01913795|11377507|FG003|STARTED|Overall Study||6
10245709|NCT01913795|11377504|FG000|COMPLETED|Overall Study||4
10245710|NCT01913795|11377505|FG001|COMPLETED|Overall Study||7
10245711|NCT01913795|11377506|FG002|COMPLETED|Overall Study||9
10245712|NCT01913795|11377507|FG003|COMPLETED|Overall Study||5
10245713|NCT01913795|11377504|FG000|NOT COMPLETED|Overall Study||0
10245714|NCT01913795|11377505|FG001|NOT COMPLETED|Overall Study||3
10245715|NCT01913795|11377506|FG002|NOT COMPLETED|Overall Study||0
10245716|NCT01913795|11377507|FG003|NOT COMPLETED|Overall Study||1
10245717|NCT01855412|11377520|FG000|STARTED|Overall Study||501
10245718|NCT01855412|11377521|FG001|STARTED|Overall Study||603
10245719|NCT01855412|11377522|FG002|STARTED|Overall Study||100
10245720|NCT01855412|11377520|FG000|COMPLETED|Overall Study||289
10245721|NCT01855412|11377521|FG001|COMPLETED|Overall Study||260
10245722|NCT01855412|11377522|FG002|COMPLETED|Overall Study||24
10245723|NCT01855412|11377520|FG000|NOT COMPLETED|Overall Study||212
10245724|NCT01855412|11377521|FG001|NOT COMPLETED|Overall Study||343
10245725|NCT01855412|11377522|FG002|NOT COMPLETED|Overall Study||76
10245726|NCT01664182|11377538|FG000|STARTED|Overall Study||19
10245727|NCT01664182|11377539|FG001|STARTED|Overall Study||22
10245728|NCT01664182|11377538|FG000|COMPLETED|Overall Study||17
10245729|NCT01664182|11377539|FG001|COMPLETED|Overall Study||18
10245730|NCT01664182|11377538|FG000|NOT COMPLETED|Overall Study||2
10245731|NCT01664182|11377539|FG001|NOT COMPLETED|Overall Study||4
10245732|NCT01661881|11377545|FG000|STARTED|Overall Study||23
10245733|NCT01661881|11377545|FG000|COMPLETED|Overall Study||22
10245734|NCT01661881|11377545|FG000|NOT COMPLETED|Overall Study||1
10245735|NCT01646814|11377551|FG000|STARTED|Overall Study||121
10245736|NCT01646814|11377552|FG001|STARTED|Overall Study||126
10245737|NCT01646814|11377551|FG000|COMPLETED|Overall Study||110
10245738|NCT01646814|11377552|FG001|COMPLETED|Overall Study||120
10245739|NCT01646814|11377551|FG000|NOT COMPLETED|Overall Study||11
10245740|NCT01646814|11377552|FG001|NOT COMPLETED|Overall Study||6
10245741|NCT01621568|11377560|FG000|STARTED|Treatment Week 1-4||41
10245742|NCT01621568|11377561|FG001|STARTED|Treatment Week 1-4||15
10245743|NCT01621568|11377560|FG000|COMPLETED|Treatment Week 1-4||41
10245744|NCT01621568|11377561|FG001|COMPLETED|Treatment Week 1-4||15
10245745|NCT01621568|11377560|FG000|NOT COMPLETED|Treatment Week 1-4||0
10245746|NCT01621568|11377561|FG001|NOT COMPLETED|Treatment Week 1-4||0
10245747|NCT01621568|11377560|FG000|STARTED|Week 5-6 No Treatment||41
10245748|NCT01621568|11377561|FG001|STARTED|Week 5-6 No Treatment||15
10245749|NCT01621568|11377560|FG000|COMPLETED|Week 5-6 No Treatment||39
10245750|NCT01621568|11377561|FG001|COMPLETED|Week 5-6 No Treatment||15
10245751|NCT01621568|11377560|FG000|NOT COMPLETED|Week 5-6 No Treatment||2
10245752|NCT01621568|11377561|FG001|NOT COMPLETED|Week 5-6 No Treatment||0
10245753|NCT01416636|11377572|FG000|STARTED|Overall Study||53
10245754|NCT01416636|11377573|FG001|STARTED|Overall Study||52
10245755|NCT01416636|11377572|FG000|COMPLETED|Overall Study||45
10245756|NCT01416636|11377573|FG001|COMPLETED|Overall Study||46
10245757|NCT01416636|11377572|FG000|NOT COMPLETED|Overall Study||8
10245758|NCT01416636|11377573|FG001|NOT COMPLETED|Overall Study||6
10245759|NCT01070069|11377584|FG000|STARTED|Overall Study||50
10245760|NCT01070069|11377585|FG001|STARTED|Overall Study||50
10245761|NCT01070069|11377586|FG002|STARTED|Overall Study||51
10245762|NCT01070069|11377587|FG003|STARTED|Overall Study||19
10245763|NCT01070069|11377588|FG004|STARTED|Overall Study||22
10245764|NCT01070069|11377584|FG000|COMPLETED|Overall Study||44
10245765|NCT01070069|11377585|FG001|COMPLETED|Overall Study||48
10245766|NCT01070069|11377586|FG002|COMPLETED|Overall Study||45
10245767|NCT01070069|11377587|FG003|COMPLETED|Overall Study||19
10245768|NCT01070069|11377588|FG004|COMPLETED|Overall Study||18
10245769|NCT01070069|11377584|FG000|NOT COMPLETED|Overall Study||6
10245770|NCT01070069|11377585|FG001|NOT COMPLETED|Overall Study||2
10245771|NCT01070069|11377586|FG002|NOT COMPLETED|Overall Study||6
10245772|NCT01070069|11377587|FG003|NOT COMPLETED|Overall Study||0
10245773|NCT01070069|11377588|FG004|NOT COMPLETED|Overall Study||4
10245774|NCT00775684|11377606|FG000|STARTED|Overall Study||17
10245775|NCT00775684|11377607|FG001|STARTED|Overall Study||13
10245776|NCT00775684|11377608|FG002|STARTED|Overall Study||17
10245777|NCT00775684|11377606|FG000|COMPLETED|Overall Study||14
10245778|NCT00775684|11377607|FG001|COMPLETED|Overall Study||12
10245779|NCT00775684|11377608|FG002|COMPLETED|Overall Study||14
10245780|NCT00775684|11377606|FG000|NOT COMPLETED|Overall Study||3
10245781|NCT00775684|11377607|FG001|NOT COMPLETED|Overall Study||1
10245782|NCT00775684|11377608|FG002|NOT COMPLETED|Overall Study||3
10245783|NCT00501046|11377627|FG000|STARTED|Overall Study||508
10245784|NCT00501046|11377628|FG001|STARTED|Overall Study||507
10245785|NCT00501046|11377627|FG000|COMPLETED|Overall Study||238
10245786|NCT00501046|11377628|FG001|COMPLETED|Overall Study||213
10245787|NCT00501046|11377627|FG000|NOT COMPLETED|Overall Study||270
10245788|NCT00501046|11377628|FG001|NOT COMPLETED|Overall Study||294
10245789|NCT00500682|11377636|FG000|STARTED|Overall Study||510
10245790|NCT00500682|11377637|FG001|STARTED|Overall Study||510
10245791|NCT00500682|11377636|FG000|COMPLETED|Overall Study||204
10245792|NCT00500682|11377637|FG001|COMPLETED|Overall Study||223
10245793|NCT00500682|11377636|FG000|NOT COMPLETED|Overall Study||306
10245794|NCT00500682|11377637|FG001|NOT COMPLETED|Overall Study||287
10245795|NCT00334815|11377645|FG000|STARTED|Overall Study||16
10245796|NCT00334815|11377646|FG001|STARTED|Overall Study||13
10245797|NCT00334815|11377645|FG000|COMPLETED|Overall Study||9
10245798|NCT00334815|11377646|FG001|COMPLETED|Overall Study||3
10245799|NCT00334815|11377645|FG000|NOT COMPLETED|Overall Study||7
10245800|NCT00334815|11377646|FG001|NOT COMPLETED|Overall Study||10
10245801|NCT00001277|11377657|FG000|STARTED|Overall Study||634
10245802|NCT00001277|11377658|FG001|STARTED|Overall Study||900
10245803|NCT00001277|11377659|FG002|STARTED|Overall Study||19
10245804|NCT00001277|11377657|FG000|COMPLETED|Overall Study||634
10245805|NCT00001277|11377658|FG001|COMPLETED|Overall Study||900
10245806|NCT00001277|11377659|FG002|COMPLETED|Overall Study||16
10245807|NCT00001277|11377657|FG000|NOT COMPLETED|Overall Study||0
10245808|NCT00001277|11377658|FG001|NOT COMPLETED|Overall Study||0
10245809|NCT00001277|11377659|FG002|NOT COMPLETED|Overall Study||3
10019566|NCT01831089|11142771|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3
10019567|NCT01831089|11142772|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0
10019568|NCT01831089|11142773|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0
10019569|NCT01831089|11142774|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0
10019570|NCT01831089|11142775|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0
10019571|NCT01831089|11142776|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0
10245810|NCT01009294|11377668|FG000|STARTED|Overall Study||6
10245811|NCT01009294|11377668|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10245812|NCT01009294|11377668|FG000|COMPLETED|Overall Study||0
10245813|NCT01009294|11377668|FG000|NOT COMPLETED|Overall Study||6
10245814|NCT01053637|11377674|FG000|STARTED|Overall Study||43
10245815|NCT01053637|11377675|FG001|STARTED|Overall Study||42
10245816|NCT01053637|11377674|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43
10245817|NCT01053637|11377675|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
10245818|NCT01053637|11377674|FG000|NOT COMPLETED|Overall Study||0
10245819|NCT01053637|11377675|FG001|NOT COMPLETED|Overall Study||0
10245820|NCT01072175|11377693|FG000|STARTED|Part A (Drug-Drug Interaction)||8
10245821|NCT01072175|11377694|FG001|STARTED|Part A (Drug-Drug Interaction)||0
10245822|NCT01072175|11377695|FG002|STARTED|Part A (Drug-Drug Interaction)||0
10245823|NCT01072175|11377696|FG003|STARTED|Part A (Drug-Drug Interaction)||0
10245824|NCT01072175|11377697|FG004|STARTED|Part A (Drug-Drug Interaction)||0
10245825|NCT01072175|11377698|FG005|STARTED|Part A (Drug-Drug Interaction)||0
10245826|NCT01072175|11377699|FG006|STARTED|Part A (Drug-Drug Interaction)||0
10245827|NCT01072175|11377700|FG007|STARTED|Part A (Drug-Drug Interaction)||0
10245828|NCT01072175|11377701|FG008|STARTED|Part A (Drug-Drug Interaction)||0
10245829|NCT01072175|11377702|FG009|STARTED|Part A (Drug-Drug Interaction)||0
10245830|NCT01072175|11377703|FG010|STARTED|Part A (Drug-Drug Interaction)||0
10245831|NCT01072175|11377704|FG011|STARTED|Part A (Drug-Drug Interaction)||0
10245832|NCT01072175|11377705|FG012|STARTED|Part A (Drug-Drug Interaction)||0
10245833|NCT01072175|11377693|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0
10245834|NCT01072175|11377694|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0
10245835|NCT01072175|11377695|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0
10245836|NCT01072175|11377696|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0
10245837|NCT01072175|11377697|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0
10245838|NCT01072175|11377698|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0
10245839|NCT01072175|11377699|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0
10245840|NCT01072175|11377700|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0
10245841|NCT01072175|11377701|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0
10245842|NCT01072175|11377702|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0
10245843|NCT01072175|11377703|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0
10245844|NCT01072175|11377704|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0
10245845|NCT01072175|11377705|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0
10245846|NCT01072175|11377693|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
10245847|NCT01072175|11377694|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245848|NCT01072175|11377695|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245849|NCT01072175|11377696|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245850|NCT01072175|11377697|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245851|NCT01072175|11377698|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245852|NCT01072175|11377699|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245853|NCT01072175|11377700|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245854|NCT01072175|11377701|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245855|NCT01072175|11377702|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245856|NCT01072175|11377703|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245857|NCT01072175|11377704|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245858|NCT01072175|11377705|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10245859|NCT01072175|11377693|FG000|STARTED|Part B (Dose Escalation and Expansion)||0
10245860|NCT01072175|11377694|FG001|STARTED|Part B (Dose Escalation and Expansion)||6
10245861|NCT01072175|11377695|FG002|STARTED|Part B (Dose Escalation and Expansion)||23
10245862|NCT01072175|11377696|FG003|STARTED|Part B (Dose Escalation and Expansion)||27
10245863|NCT01072175|11377697|FG004|STARTED|Part B (Dose Escalation and Expansion)||94
10245864|NCT01072175|11377698|FG005|STARTED|Part B (Dose Escalation and Expansion)||0
10245865|NCT01072175|11377699|FG006|STARTED|Part B (Dose Escalation and Expansion)||0
10245866|NCT01072175|11377700|FG007|STARTED|Part B (Dose Escalation and Expansion)||0
10245867|NCT01072175|11377701|FG008|STARTED|Part B (Dose Escalation and Expansion)||0
10245868|NCT01072175|11377702|FG009|STARTED|Part B (Dose Escalation and Expansion)||0
10245869|NCT01072175|11377703|FG010|STARTED|Part B (Dose Escalation and Expansion)||0
10245870|NCT01072175|11377704|FG011|STARTED|Part B (Dose Escalation and Expansion)||0
10245871|NCT01072175|11377705|FG012|STARTED|Part B (Dose Escalation and Expansion)||0
10245872|NCT01072175|11377693|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245873|NCT01072175|11377694|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245874|NCT01072175|11377695|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245875|NCT01072175|11377696|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245876|NCT01072175|11377697|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245877|NCT01072175|11377698|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245878|NCT01072175|11377699|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245879|NCT01072175|11377700|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245880|NCT01072175|11377701|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245881|NCT01072175|11377702|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245882|NCT01072175|11377703|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245883|NCT01072175|11377704|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245884|NCT01072175|11377705|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0
10245885|NCT01072175|11377693|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245886|NCT01072175|11377694|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
10245887|NCT01072175|11377695|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
10245888|NCT01072175|11377696|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
10245889|NCT01072175|11377697|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
10245890|NCT01072175|11377698|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245891|NCT01072175|11377699|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245892|NCT01072175|11377700|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245893|NCT01072175|11377701|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245894|NCT01072175|11377702|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245895|NCT01072175|11377703|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245896|NCT01072175|11377704|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245897|NCT01072175|11377705|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10245898|NCT01072175|11377693|FG000|STARTED|Part C (Phase II: Randomized Phase)||0
10245899|NCT01072175|11377694|FG001|STARTED|Part C (Phase II: Randomized Phase)||0
10245900|NCT01072175|11377695|FG002|STARTED|Part C (Phase II: Randomized Phase)||0
10245901|NCT01072175|11377696|FG003|STARTED|Part C (Phase II: Randomized Phase)||0
10245902|NCT01072175|11377697|FG004|STARTED|Part C (Phase II: Randomized Phase)||0
10245903|NCT01072175|11377698|FG005|STARTED|Part C (Phase II: Randomized Phase)||54
10245904|NCT01072175|11377699|FG006|STARTED|Part C (Phase II: Randomized Phase)||54
10245905|NCT01072175|11377700|FG007|STARTED|Part C (Phase II: Randomized Phase)||54
10245906|NCT01072175|11377701|FG008|STARTED|Part C (Phase II: Randomized Phase)||0
10245907|NCT01072175|11377702|FG009|STARTED|Part C (Phase II: Randomized Phase)||0
10245908|NCT01072175|11377703|FG010|STARTED|Part C (Phase II: Randomized Phase)||0
10245909|NCT01072175|11377704|FG011|STARTED|Part C (Phase II: Randomized Phase)||0
10245910|NCT01072175|11377705|FG012|STARTED|Part C (Phase II: Randomized Phase)||0
10245911|NCT01072175|11377693|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245912|NCT01072175|11377694|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245913|NCT01072175|11377695|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245914|NCT01072175|11377696|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245915|NCT01072175|11377697|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245916|NCT01072175|11377698|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245917|NCT01072175|11377699|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245918|NCT01072175|11377700|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245919|NCT01072175|11377701|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245920|NCT01072175|11377702|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245921|NCT01072175|11377703|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245922|NCT01072175|11377704|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245923|NCT01072175|11377705|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0
10245924|NCT01072175|11377693|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245925|NCT01072175|11377694|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245926|NCT01072175|11377695|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245927|NCT01072175|11377696|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245928|NCT01072175|11377697|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245929|NCT01072175|11377698|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10245930|NCT01072175|11377699|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10245931|NCT01072175|11377700|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10245932|NCT01072175|11377701|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245933|NCT01072175|11377702|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245934|NCT01072175|11377703|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245935|NCT01072175|11377704|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245936|NCT01072175|11377705|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10245937|NCT01072175|11377693|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245938|NCT01072175|11377694|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245939|NCT01072175|11377695|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245940|NCT01072175|11377696|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245941|NCT01072175|11377697|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245942|NCT01072175|11377698|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245943|NCT01072175|11377699|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245944|NCT01072175|11377700|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245945|NCT01072175|11377701|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45
10245946|NCT01072175|11377702|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245947|NCT01072175|11377703|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245948|NCT01072175|11377704|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245949|NCT01072175|11377705|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10245950|NCT01072175|11377693|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245951|NCT01072175|11377694|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245952|NCT01072175|11377695|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245953|NCT01072175|11377696|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245954|NCT01072175|11377697|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245955|NCT01072175|11377698|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245956|NCT01072175|11377699|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245957|NCT01072175|11377700|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245958|NCT01072175|11377701|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245959|NCT01072175|11377702|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245960|NCT01072175|11377703|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245961|NCT01072175|11377704|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245962|NCT01072175|11377705|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245963|NCT01072175|11377693|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245964|NCT01072175|11377694|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245965|NCT01072175|11377695|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245966|NCT01072175|11377696|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245967|NCT01072175|11377697|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245968|NCT01072175|11377698|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245969|NCT01072175|11377699|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245970|NCT01072175|11377700|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245971|NCT01072175|11377701|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
10245972|NCT01072175|11377702|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245973|NCT01072175|11377703|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245974|NCT01072175|11377704|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245975|NCT01072175|11377705|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10245976|NCT01072175|11377693|FG000|STARTED|Part D (HPMC Capsules)||0
10245977|NCT01072175|11377694|FG001|STARTED|Part D (HPMC Capsules)||0
10245978|NCT01072175|11377695|FG002|STARTED|Part D (HPMC Capsules)||0
10245979|NCT01072175|11377696|FG003|STARTED|Part D (HPMC Capsules)||0
10245980|NCT01072175|11377697|FG004|STARTED|Part D (HPMC Capsules)||0
10245981|NCT01072175|11377698|FG005|STARTED|Part D (HPMC Capsules)||0
10245982|NCT01072175|11377699|FG006|STARTED|Part D (HPMC Capsules)||0
10245983|NCT01072175|11377700|FG007|STARTED|Part D (HPMC Capsules)||0
10245984|NCT01072175|11377701|FG008|STARTED|Part D (HPMC Capsules)||0
10245985|NCT01072175|11377702|FG009|STARTED|Part D (HPMC Capsules)||12
10245986|NCT01072175|11377703|FG010|STARTED|Part D (HPMC Capsules)||16
10245987|NCT01072175|11377704|FG011|STARTED|Part D (HPMC Capsules)||43
10245988|NCT01072175|11377705|FG012|STARTED|Part D (HPMC Capsules)||39
10245989|NCT01072175|11377693|FG000|COMPLETED|Part D (HPMC Capsules)||0
10245990|NCT01072175|11377694|FG001|COMPLETED|Part D (HPMC Capsules)||0
10245991|NCT01072175|11377695|FG002|COMPLETED|Part D (HPMC Capsules)||0
10245992|NCT01072175|11377696|FG003|COMPLETED|Part D (HPMC Capsules)||0
10245993|NCT01072175|11377697|FG004|COMPLETED|Part D (HPMC Capsules)||0
10245994|NCT01072175|11377698|FG005|COMPLETED|Part D (HPMC Capsules)||0
10245995|NCT01072175|11377699|FG006|COMPLETED|Part D (HPMC Capsules)||0
10245996|NCT01072175|11377700|FG007|COMPLETED|Part D (HPMC Capsules)||0
10245997|NCT01072175|11377701|FG008|COMPLETED|Part D (HPMC Capsules)||0
10245998|NCT01072175|11377702|FG009|COMPLETED|Part D (HPMC Capsules)||0
10245999|NCT01072175|11377703|FG010|COMPLETED|Part D (HPMC Capsules)||0
10246000|NCT01072175|11377704|FG011|COMPLETED|Part D (HPMC Capsules)||0
10246001|NCT01072175|11377705|FG012|COMPLETED|Part D (HPMC Capsules)||0
10246002|NCT01072175|11377693|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0
10246003|NCT01072175|11377694|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0
10246004|NCT01072175|11377695|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0
10246005|NCT01072175|11377696|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0
10246006|NCT01072175|11377697|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0
10246007|NCT01072175|11377698|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0
10246008|NCT01072175|11377699|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0
10246009|NCT01072175|11377700|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0
10246010|NCT01072175|11377701|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0
10246011|NCT01072175|11377702|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12
10246012|NCT01072175|11377703|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16
10246013|NCT01072175|11377704|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43
10246014|NCT01072175|11377705|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39
10246015|NCT01087203|11377739|FG000|STARTED|Overall Study||35
10246016|NCT01087203|11377740|FG001|STARTED|Overall Study||38
10246017|NCT01087203|11377739|FG000|COMPLETED|Overall Study||3
10246018|NCT01087203|11377740|FG001|COMPLETED|Overall Study||3
10246019|NCT01087203|11377739|FG000|NOT COMPLETED|Overall Study||32
10246020|NCT01087203|11377740|FG001|NOT COMPLETED|Overall Study||35
10246024|NCT01108055|11377751|FG000|STARTED|Overall Study||43
10246025|NCT01108055|11377751|FG000|Eligible and Started Treatment|Overall Study||32
10246026|NCT01108055|11377751|FG000|COMPLETED|Overall Study||28
10246027|NCT01108055|11377751|FG000|NOT COMPLETED|Overall Study||15
10246028|NCT01111019|11377755|FG000|STARTED|Overall Study||19
10246029|NCT01111019|11377755|FG000|COMPLETED|Overall Study||16
10246030|NCT01111019|11377755|FG000|NOT COMPLETED|Overall Study||3
10246031|NCT01136967|11377761|FG000|STARTED|Overall Study||93
10246032|NCT01136967|11377762|FG001|STARTED|Overall Study||89
10246033|NCT01136967|11377761|FG000|Disease Progression|Overall Study||55
10246034|NCT01136967|11377762|FG001|Disease Progression|Overall Study||56
10246035|NCT01136967|11377761|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
10246036|NCT01136967|11377762|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
10246037|NCT01136967|11377761|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
10246038|NCT01136967|11377762|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
10246039|NCT01136967|11377761|FG000|NOT COMPLETED|Overall Study||24
10246040|NCT01136967|11377762|FG001|NOT COMPLETED|Overall Study||27
10246041|NCT01136980|11377770|FG000|STARTED|Overall Study||42
10246042|NCT01136980|11377771|FG001|STARTED|Overall Study||87
10246043|NCT01136980|11377770|FG000|COMPLETED|Overall Study||28
10246044|NCT01136980|11377771|FG001|COMPLETED|Overall Study||76
10246045|NCT01136980|11377770|FG000|NOT COMPLETED|Overall Study||14
10246046|NCT01136980|11377771|FG001|NOT COMPLETED|Overall Study||11
10246047|NCT01137955|11377779|FG000|STARTED|Overall Study||25
9833228|NCT00778258|10944117|FG000|STARTED|Overall Study||16
9833229|NCT00778258|10944118|FG001|STARTED|Overall Study||5
9833230|NCT00778258|10944119|FG002|STARTED|Overall Study||20
9833231|NCT00778258|10944120|FG003|STARTED|Overall Study||15
9833232|NCT00778258|10944121|FG004|STARTED|Overall Study||6
9833233|NCT00778258|10944122|FG005|STARTED|Overall Study||23
10246048|NCT01137955|11377780|FG001|STARTED|Overall Study||25
10246049|NCT01137955|11377779|FG000|COMPLETED|Overall Study||20
10246050|NCT01137955|11377780|FG001|COMPLETED|Overall Study||21
10246051|NCT01137955|11377779|FG000|NOT COMPLETED|Overall Study||5
10246052|NCT01137955|11377780|FG001|NOT COMPLETED|Overall Study||4
10246053|NCT01140451|11377789|FG000|STARTED|Overall Study||95
10246054|NCT01140451|11377790|FG001|STARTED|Overall Study||96
10246055|NCT01140451|11377789|FG000|Completed 24 Weeks|Overall Study||89
10246056|NCT01140451|11377790|FG001|Completed 24 Weeks|Overall Study||86
10246057|NCT01140451|11377789|FG000|Completed 48 Weeks|Overall Study||78
10246058|NCT01140451|11377790|FG001|Completed 48 Weeks|Overall Study||70
10246059|NCT01140451|11377789|FG000|Completed 72 Weeks|Overall Study||63
10246060|NCT01140451|11377790|FG001|Completed 72 Weeks|Overall Study||62
10246061|NCT01140451|11377789|FG000|Completed 96 Weeks|Overall Study||57
10246062|NCT01140451|11377790|FG001|Completed 96 Weeks|Overall Study||54
10246063|NCT01140451|11377789|FG000|As-Treated Population|Overall Study||95
10246064|NCT01140451|11377790|FG001|As-Treated Population|Overall Study||96
10246065|NCT01140451|11377789|FG000|96-Week Completer Population|Overall Study||78
10246066|NCT01140451|11377790|FG001|96-Week Completer Population|Overall Study||70
10246067|NCT01140451|11377789|FG000|144-Week Completer Population|Overall Study||57
10246068|NCT01140451|11377790|FG001|144-Week Completer Population|Overall Study||54
10246069|NCT01140451|11377789|FG000|COMPLETED|Overall Study||57
10246070|NCT01140451|11377790|FG001|COMPLETED|Overall Study||54
10246071|NCT01140451|11377789|FG000|NOT COMPLETED|Overall Study||38
10246072|NCT01140451|11377790|FG001|NOT COMPLETED|Overall Study||42
10246073|NCT01174563|11377797|FG000|STARTED|Overall Study||60
10246074|NCT01174563|11377797|FG000|Efficacy Set|Overall Study||59
10246075|NCT01174563|11377797|FG000|Safety Set|Overall Study||59
10246076|NCT01174563|11377797|FG000|COMPLETED|Overall Study||0
10246077|NCT01174563|11377797|FG000|NOT COMPLETED|Overall Study||60
10246078|NCT01190202|11377805|FG000|STARTED|Overall Study||6404
10246079|NCT01190202|11377806|FG001|STARTED|Overall Study||6414
10246080|NCT01190202|11377807|FG002|STARTED|Overall Study||6400
10246081|NCT01190202|11377808|FG003|STARTED|Overall Study||2400
10246082|NCT01190202|11377805|FG000|COMPLETED|Overall Study||6404
10246083|NCT01190202|11377806|FG001|COMPLETED|Overall Study||6414
10246084|NCT01190202|11377807|FG002|COMPLETED|Overall Study||6400
10246085|NCT01190202|11377808|FG003|COMPLETED|Overall Study||2400
10246086|NCT01190202|11377805|FG000|NOT COMPLETED|Overall Study||0
10246087|NCT01190202|11377806|FG001|NOT COMPLETED|Overall Study||0
10246088|NCT01190202|11377807|FG002|NOT COMPLETED|Overall Study||0
10246089|NCT01190202|11377808|FG003|NOT COMPLETED|Overall Study||0
10246090|NCT01200862|11377853|FG000|STARTED|Part 1||14
10246091|NCT01200862|11377854|FG001|STARTED|Part 1||0
10246092|NCT01200862|11377855|FG002|STARTED|Part 1||0
10246093|NCT01200862|11377853|FG000|COMPLETED|Part 1||13
10246094|NCT01200862|11377854|FG001|COMPLETED|Part 1||0
10246095|NCT01200862|11377855|FG002|COMPLETED|Part 1||0
10246096|NCT01200862|11377853|FG000|NOT COMPLETED|Part 1||1
10246097|NCT01200862|11377854|FG001|NOT COMPLETED|Part 1||0
10246098|NCT01200862|11377855|FG002|NOT COMPLETED|Part 1||0
10246099|NCT01200862|11377853|FG000|STARTED|Part 2||0
9833234|NCT00778258|10944123|FG006|STARTED|Overall Study||34
10246021|NCT01088815|11377747|FG000|STARTED|Overall Study||72
10246022|NCT01088815|11377747|FG000|COMPLETED|Overall Study||72
10246023|NCT01088815|11377747|FG000|NOT COMPLETED|Overall Study||0
10246100|NCT01200862|11377854|FG001|STARTED|Part 2||7
10246101|NCT01200862|11377855|FG002|STARTED|Part 2||8
10246102|NCT01200862|11377853|FG000|COMPLETED|Part 2||0
10246103|NCT01200862|11377854|FG001|COMPLETED|Part 2||6
10246104|NCT01200862|11377855|FG002|COMPLETED|Part 2||8
10246105|NCT01200862|11377853|FG000|NOT COMPLETED|Part 2||0
10246106|NCT01200862|11377854|FG001|NOT COMPLETED|Part 2||1
10246107|NCT01200862|11377855|FG002|NOT COMPLETED|Part 2||0
10019572|NCT01831089|11142771|FG000|STARTED|Cohort II: Dose Level 2||0
10019573|NCT01831089|11142772|FG001|STARTED|Cohort II: Dose Level 2||3
10019574|NCT01831089|11142773|FG002|STARTED|Cohort II: Dose Level 2||0
10019575|NCT01831089|11142774|FG003|STARTED|Cohort II: Dose Level 2||0
10019576|NCT01831089|11142775|FG004|STARTED|Cohort II: Dose Level 2||0
10019577|NCT01831089|11142776|FG005|STARTED|Cohort II: Dose Level 2||0
10019578|NCT01831089|11142771|FG000|COMPLETED|Cohort II: Dose Level 2||0
10019579|NCT01831089|11142772|FG001|COMPLETED|Cohort II: Dose Level 2||0
10019580|NCT01831089|11142773|FG002|COMPLETED|Cohort II: Dose Level 2||0
10019581|NCT01831089|11142774|FG003|COMPLETED|Cohort II: Dose Level 2||0
10019582|NCT01831089|11142775|FG004|COMPLETED|Cohort II: Dose Level 2||0
10019583|NCT01831089|11142776|FG005|COMPLETED|Cohort II: Dose Level 2||0
10019584|NCT01831089|11142771|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0
10019585|NCT01831089|11142772|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3
10019586|NCT01831089|11142773|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0
10019587|NCT01831089|11142774|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0
10019588|NCT01831089|11142775|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0
10019589|NCT01831089|11142776|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0
10019590|NCT01831089|11142771|FG000|STARTED|Cohort III: Dose Level 3||0
10019591|NCT01831089|11142772|FG001|STARTED|Cohort III: Dose Level 3||0
10019592|NCT01831089|11142773|FG002|STARTED|Cohort III: Dose Level 3||6
10019593|NCT01831089|11142774|FG003|STARTED|Cohort III: Dose Level 3||0
10019594|NCT01831089|11142775|FG004|STARTED|Cohort III: Dose Level 3||0
10019595|NCT01831089|11142776|FG005|STARTED|Cohort III: Dose Level 3||0
10019596|NCT01831089|11142771|FG000|COMPLETED|Cohort III: Dose Level 3||0
10019597|NCT01831089|11142772|FG001|COMPLETED|Cohort III: Dose Level 3||0
10019598|NCT01831089|11142773|FG002|COMPLETED|Cohort III: Dose Level 3||0
10019599|NCT01831089|11142774|FG003|COMPLETED|Cohort III: Dose Level 3||0
10019600|NCT01831089|11142775|FG004|COMPLETED|Cohort III: Dose Level 3||0
10019601|NCT01831089|11142776|FG005|COMPLETED|Cohort III: Dose Level 3||0
10019602|NCT01831089|11142771|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0
10019603|NCT01831089|11142772|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0
10019604|NCT01831089|11142773|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6
10019605|NCT01831089|11142774|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0
10019606|NCT01831089|11142775|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0
10019607|NCT01831089|11142776|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0
10246108|NCT01225341|11377866|FG000|STARTED|Overall Study||0
10246109|NCT01225341|11377867|FG001|STARTED|Overall Study||0
10246110|NCT01225341|11377866|FG000|COMPLETED|Overall Study||0
10246111|NCT01225341|11377867|FG001|COMPLETED|Overall Study||0
10246112|NCT01225341|11377866|FG000|NOT COMPLETED|Overall Study||0
10246113|NCT01225341|11377867|FG001|NOT COMPLETED|Overall Study||0
10246114|NCT01235962|11377877|FG000|STARTED|Overall Study||198
10246115|NCT01235962|11377878|FG001|STARTED|Overall Study||205
10246116|NCT01235962|11377879|FG002|STARTED|Overall Study||571
10246117|NCT01235962|11377880|FG003|STARTED|Overall Study||564
10246118|NCT01235962|11377877|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
10246119|NCT01235962|11377878|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
10246120|NCT01235962|11377879|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
10246121|NCT01235962|11377880|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
10246122|NCT01235962|11377877|FG000|All Deaths|Overall Study||43
10246123|NCT01235962|11377878|FG001|All Deaths|Overall Study||46
10246124|NCT01235962|11377879|FG002|All Deaths|Overall Study||102
10246125|NCT01235962|11377880|FG003|All Deaths|Overall Study||104
10246126|NCT01235962|11377877|FG000|COMPLETED|Overall Study||152
10246127|NCT01235962|11377878|FG001|COMPLETED|Overall Study||170
10246128|NCT01235962|11377879|FG002|COMPLETED|Overall Study||453
10246129|NCT01235962|11377880|FG003|COMPLETED|Overall Study||478
10246130|NCT01235962|11377877|FG000|NOT COMPLETED|Overall Study||46
10246131|NCT01235962|11377878|FG001|NOT COMPLETED|Overall Study||35
10246132|NCT01235962|11377879|FG002|NOT COMPLETED|Overall Study||118
10246133|NCT01235962|11377880|FG003|NOT COMPLETED|Overall Study||86
10246134|NCT01239368|11377908|FG000|STARTED|Overall Study||2
10246135|NCT01239368|11377909|FG001|STARTED|Overall Study||1
10246136|NCT01239368|11377910|FG002|STARTED|Overall Study||1
10246137|NCT01239368|11377911|FG003|STARTED|Overall Study||2
10246138|NCT01239368|11377912|FG004|STARTED|Overall Study||7
10246139|NCT01239368|11377913|FG005|STARTED|Overall Study||5
10246140|NCT01239368|11377914|FG006|STARTED|Overall Study||7
10246141|NCT01239368|11377915|FG007|STARTED|Overall Study||0
10246142|NCT01239368|11377916|FG008|STARTED|Overall Study||1
10246143|NCT01239368|11377917|FG009|STARTED|Overall Study||5
10246144|NCT01239368|11377908|FG000|COMPLETED|Overall Study||0
10246145|NCT01239368|11377909|FG001|COMPLETED|Overall Study||0
10246146|NCT01239368|11377910|FG002|COMPLETED|Overall Study||0
10246147|NCT01239368|11377911|FG003|COMPLETED|Overall Study||1
10246148|NCT01239368|11377912|FG004|COMPLETED|Overall Study||2
10246149|NCT01239368|11377913|FG005|COMPLETED|Overall Study||1
10246150|NCT01239368|11377914|FG006|COMPLETED|Overall Study||1
10246151|NCT01239368|11377915|FG007|COMPLETED|Overall Study||0
10246152|NCT01239368|11377916|FG008|COMPLETED|Overall Study||1
10246153|NCT01239368|11377917|FG009|COMPLETED|Overall Study||1
10246154|NCT01239368|11377908|FG000|NOT COMPLETED|Overall Study||2
10246155|NCT01239368|11377909|FG001|NOT COMPLETED|Overall Study||1
10246156|NCT01239368|11377910|FG002|NOT COMPLETED|Overall Study||1
10246157|NCT01239368|11377911|FG003|NOT COMPLETED|Overall Study||1
10246158|NCT01239368|11377912|FG004|NOT COMPLETED|Overall Study||5
10246159|NCT01239368|11377913|FG005|NOT COMPLETED|Overall Study||4
10246160|NCT01239368|11377914|FG006|NOT COMPLETED|Overall Study||6
10246161|NCT01239368|11377915|FG007|NOT COMPLETED|Overall Study||0
10246162|NCT01239368|11377916|FG008|NOT COMPLETED|Overall Study||0
10246163|NCT01239368|11377917|FG009|NOT COMPLETED|Overall Study||4
10246164|NCT01247701|11377950|FG000|STARTED|Overall Study||16
10246165|NCT01247701|11377950|FG000|COMPLETED|Overall Study||6
10246166|NCT01247701|11377950|FG000|NOT COMPLETED|Overall Study||10
10246167|NCT01266031|11377957|FG000|STARTED|Overall Study||6
10246168|NCT01266031|11377958|FG001|STARTED|Overall Study||41
10246169|NCT01266031|11377959|FG002|STARTED|Overall Study||49
10246170|NCT01266031|11377957|FG000|COMPLETED|Overall Study||6
10246171|NCT01266031|11377958|FG001|COMPLETED|Overall Study||38
10019608|NCT01831089|11142771|FG000|STARTED|Cohort IV: Dose Level 4||0
10019609|NCT01831089|11142772|FG001|STARTED|Cohort IV: Dose Level 4||0
10019610|NCT01831089|11142773|FG002|STARTED|Cohort IV: Dose Level 4||0
10019611|NCT01831089|11142774|FG003|STARTED|Cohort IV: Dose Level 4||6
10246172|NCT01266031|11377959|FG002|COMPLETED|Overall Study||47
10246173|NCT01266031|11377957|FG000|NOT COMPLETED|Overall Study||0
10246174|NCT01266031|11377958|FG001|NOT COMPLETED|Overall Study||3
10246175|NCT01266031|11377959|FG002|NOT COMPLETED|Overall Study||2
10246176|NCT01287741|11377980|FG000|STARTED|Overall Study||712
10246177|NCT01287741|11377981|FG001|STARTED|Overall Study||706
10246178|NCT01287741|11377980|FG000|COMPLETED|Overall Study||86
10246179|NCT01287741|11377981|FG001|COMPLETED|Overall Study||91
10246180|NCT01287741|11377980|FG000|NOT COMPLETED|Overall Study||626
10246181|NCT01287741|11377981|FG001|NOT COMPLETED|Overall Study||615
10246182|NCT01304316|11377988|FG000|STARTED|Overall Study||12
10246183|NCT01304316|11377988|FG000|COMPLETED|Overall Study||12
10019612|NCT01831089|11142775|FG004|STARTED|Cohort IV: Dose Level 4||0
10246184|NCT01304316|11377988|FG000|NOT COMPLETED|Overall Study||0
10246185|NCT01313689|11377998|FG000|STARTED|24-Week Randomization 1||79
10246186|NCT01313689|11377999|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
10246187|NCT01313689|11378000|FG002|STARTED|24-Week Randomization 1||0
10246188|NCT01313689|11378001|FG003|STARTED|24-Week Randomization 1||0
10246189|NCT01313689|11378002|FG004|STARTED|24-Week Randomization 1||0
10246190|NCT01313689|11377998|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
10246191|NCT01313689|11377999|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
10246192|NCT01313689|11378000|FG002|COMPLETED|24-Week Randomization 1||0
10246193|NCT01313689|11378001|FG003|COMPLETED|24-Week Randomization 1||0
10246194|NCT01313689|11378002|FG004|COMPLETED|24-Week Randomization 1||0
10246195|NCT01313689|11377998|FG000|NOT COMPLETED|24-Week Randomization 1||19
10246196|NCT01313689|11377999|FG001|NOT COMPLETED|24-Week Randomization 1||10
10246197|NCT01313689|11378000|FG002|NOT COMPLETED|24-Week Randomization 1||0
10246198|NCT01313689|11378001|FG003|NOT COMPLETED|24-Week Randomization 1||0
10246199|NCT01313689|11378002|FG004|NOT COMPLETED|24-Week Randomization 1||0
10246200|NCT01313689|11377998|FG000|STARTED|24-Week Randomization 2||0
10246201|NCT01313689|11377999|FG001|STARTED|24-Week Randomization 2||0
10246202|NCT01313689|11378000|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
10246203|NCT01313689|11378001|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
10246204|NCT01313689|11378002|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
10246205|NCT01313689|11377998|FG000|COMPLETED|24-Week Randomization 2||0
10246206|NCT01313689|11377999|FG001|COMPLETED|24-Week Randomization 2||0
10246207|NCT01313689|11378000|FG002|COMPLETED|24-Week Randomization 2||21
10246208|NCT01313689|11378001|FG003|COMPLETED|24-Week Randomization 2||12
10246209|NCT01313689|11378002|FG004|COMPLETED|24-Week Randomization 2||27
10246210|NCT01313689|11377998|FG000|NOT COMPLETED|24-Week Randomization 2||0
10246211|NCT01313689|11377999|FG001|NOT COMPLETED|24-Week Randomization 2||0
10246212|NCT01313689|11378000|FG002|NOT COMPLETED|24-Week Randomization 2||3
10246213|NCT01313689|11378001|FG003|NOT COMPLETED|24-Week Randomization 2||1
10246214|NCT01313689|11378002|FG004|NOT COMPLETED|24-Week Randomization 2||15
9833235|NCT00778258|10944124|FG007|STARTED|Overall Study||41
9833236|NCT00778258|10944125|FG008|STARTED|Overall Study||10
9833237|NCT00778258|10944117|FG000|COMPLETED|Overall Study||9
9833238|NCT00778258|10944118|FG001|COMPLETED|Overall Study||3
10019613|NCT01831089|11142776|FG005|STARTED|Cohort IV: Dose Level 4||0
10019614|NCT01831089|11142771|FG000|COMPLETED|Cohort IV: Dose Level 4||0
10019615|NCT01831089|11142772|FG001|COMPLETED|Cohort IV: Dose Level 4||0
9833239|NCT00778258|10944119|FG002|COMPLETED|Overall Study||10
9833240|NCT00778258|10944120|FG003|COMPLETED|Overall Study||12
9833241|NCT00778258|10944121|FG004|COMPLETED|Overall Study||6
9833242|NCT00778258|10944122|FG005|COMPLETED|Overall Study||13
9957295|NCT01449955|11076504|FG001|NOT COMPLETED|Overall Study||2
9957296|NCT01450007|11076520|FG000|STARTED|Overall Study||44
9957297|NCT01450007|11076521|FG001|STARTED|Overall Study||42
9957298|NCT01450007|11076522|FG002|STARTED|Overall Study||44
9957299|NCT01450007|11076520|FG000|COMPLETED|Overall Study||42
9833243|NCT00778258|10944123|FG006|COMPLETED|Overall Study||19
9957300|NCT01450007|11076521|FG001|COMPLETED|Overall Study||37
9957301|NCT01450007|11076522|FG002|COMPLETED|Overall Study||41
9957302|NCT01450007|11076520|FG000|NOT COMPLETED|Overall Study||2
9957303|NCT01450007|11076521|FG001|NOT COMPLETED|Overall Study||5
9957304|NCT01450007|11076522|FG002|NOT COMPLETED|Overall Study||3
9957305|NCT01450098|11076532|FG000|STARTED|Period 1||8
10019616|NCT01831089|11142773|FG002|COMPLETED|Cohort IV: Dose Level 4||0
10019617|NCT01831089|11142774|FG003|COMPLETED|Cohort IV: Dose Level 4||0
10246215|NCT01315353|11378024|FG000|STARTED|Overall Study||145
10246216|NCT01315353|11378025|FG001|STARTED|Overall Study||143
10246217|NCT01315353|11378026|FG002|STARTED|Overall Study||179
10246218|NCT01315353|11378024|FG000|COMPLETED|Overall Study||116
10246219|NCT01315353|11378025|FG001|COMPLETED|Overall Study||120
10246220|NCT01315353|11378026|FG002|COMPLETED|Overall Study||166
10246221|NCT01315353|11378024|FG000|NOT COMPLETED|Overall Study||29
10246222|NCT01315353|11378025|FG001|NOT COMPLETED|Overall Study||23
10246223|NCT01315353|11378026|FG002|NOT COMPLETED|Overall Study||13
10019618|NCT01831089|11142775|FG004|COMPLETED|Cohort IV: Dose Level 4||0
10019619|NCT01831089|11142776|FG005|COMPLETED|Cohort IV: Dose Level 4||0
10246224|NCT01318993|11378034|FG000|STARTED|Overall Study||398
10246225|NCT01318993|11378034|FG000|COMPLETED|Overall Study||0
10246226|NCT01318993|11378034|FG000|NOT COMPLETED|Overall Study||398
10246227|NCT01335685|11378042|FG000|STARTED|Overall Study||7
10246228|NCT01335685|11378043|FG001|STARTED|Overall Study||4
10246229|NCT01335685|11378044|FG002|STARTED|Overall Study||3
10246230|NCT01335685|11378045|FG003|STARTED|Overall Study||26
10246231|NCT01335685|11378046|FG004|STARTED|Overall Study||5
10246232|NCT01335685|11378047|FG005|STARTED|Overall Study||6
10246233|NCT01335685|11378048|FG006|STARTED|Overall Study||4
10246234|NCT01335685|11378049|FG007|STARTED|Overall Study||6
10246235|NCT01335685|11378042|FG000|COMPLETED|Overall Study||4
10246236|NCT01335685|11378043|FG001|COMPLETED|Overall Study||3
10246237|NCT01335685|11378044|FG002|COMPLETED|Overall Study||1
10246238|NCT01335685|11378045|FG003|COMPLETED|Overall Study||15
10246239|NCT01335685|11378046|FG004|COMPLETED|Overall Study||5
10246240|NCT01335685|11378047|FG005|COMPLETED|Overall Study||1
10246241|NCT01335685|11378048|FG006|COMPLETED|Overall Study||2
10246242|NCT01335685|11378049|FG007|COMPLETED|Overall Study||3
10246243|NCT01335685|11378042|FG000|NOT COMPLETED|Overall Study||3
10246244|NCT01335685|11378043|FG001|NOT COMPLETED|Overall Study||1
10246245|NCT01335685|11378044|FG002|NOT COMPLETED|Overall Study||2
10246246|NCT01335685|11378045|FG003|NOT COMPLETED|Overall Study||11
10246247|NCT01335685|11378046|FG004|NOT COMPLETED|Overall Study||0
10246248|NCT01335685|11378047|FG005|NOT COMPLETED|Overall Study||5
10246249|NCT01335685|11378048|FG006|NOT COMPLETED|Overall Study||2
10246250|NCT01335685|11378049|FG007|NOT COMPLETED|Overall Study||3
10246257|NCT04391036|11378081|FG000|STARTED|Overall Study||15
10246258|NCT04391036|11378082|FG001|STARTED|Overall Study||15
10246259|NCT04391036|11378081|FG000|COMPLETED|Overall Study||15
10246260|NCT04391036|11378082|FG001|COMPLETED|Overall Study||15
10246261|NCT04391036|11378081|FG000|NOT COMPLETED|Overall Study||0
10246262|NCT04391036|11378082|FG001|NOT COMPLETED|Overall Study||0
10246313|NCT02959944|11378168|FG000|STARTED|Overall Study||95
10246314|NCT02959944|11378169|FG001|STARTED|Overall Study||98
10246315|NCT02959944|11378168|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
10246316|NCT02959944|11378169|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96
10246317|NCT02959944|11378168|FG000|COMPLETED|Overall Study||95
10246318|NCT02959944|11378169|FG001|COMPLETED|Overall Study||98
10246319|NCT02959944|11378168|FG000|NOT COMPLETED|Overall Study||0
10246320|NCT02959944|11378169|FG001|NOT COMPLETED|Overall Study||0
10246321|NCT02903823|11378175|FG000|STARTED|Overall Study|First subject enrollment|27
10246322|NCT02903823|11378175|FG000|COMPLETED|Overall Study||20
10246323|NCT02903823|11378175|FG000|NOT COMPLETED|Overall Study||7
10019620|NCT01831089|11142771|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0
10019621|NCT01831089|11142772|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0
10019622|NCT01831089|11142773|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0
10019623|NCT01831089|11142774|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6
10019624|NCT01831089|11142775|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0
10019625|NCT01831089|11142776|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0
10246324|NCT02666183|11378183|FG000|STARTED|Overall Study||137
10246325|NCT02666183|11378184|FG001|STARTED|Overall Study||141
10246326|NCT02666183|11378185|FG002|STARTED|Overall Study||119
10246327|NCT02666183|11378183|FG000|COMPLETED|Overall Study||103
10246328|NCT02666183|11378184|FG001|COMPLETED|Overall Study||106
10246329|NCT02666183|11378185|FG002|COMPLETED|Overall Study||93
10246330|NCT02666183|11378183|FG000|NOT COMPLETED|Overall Study||34
10246331|NCT02666183|11378184|FG001|NOT COMPLETED|Overall Study||35
10246332|NCT02666183|11378185|FG002|NOT COMPLETED|Overall Study||26
10246333|NCT01547117|11378197|FG000|STARTED|Overall Study||12
10246334|NCT01547117|11378198|FG001|STARTED|Overall Study||5
10246335|NCT01547117|11378199|FG002|STARTED|Overall Study||10
10246336|NCT01547117|11378200|FG003|STARTED|Overall Study||11
10246337|NCT01547117|11378197|FG000|Phase 1 Baseline Labs|Overall Study||12
10246338|NCT01547117|11378198|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
10246339|NCT01547117|11378199|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
10246340|NCT01547117|11378200|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
10246341|NCT01547117|11378197|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
10246342|NCT01547117|11378198|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
10246343|NCT01547117|11378199|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
10246344|NCT01547117|11378200|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
10246251|NCT01336621|11378072|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
10246252|NCT01336621|11378072|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
10246253|NCT01336621|11378072|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
10246254|NCT01336621|11378072|FG000|STARTED|SFUCP (up to 2.6 Years)||9
10246255|NCT01336621|11378072|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0
10246256|NCT01336621|11378072|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
10246263|NCT04170296|11378092|FG000|STARTED|Overall Study||81
10246264|NCT04170296|11378093|FG001|STARTED|Overall Study||72
10246265|NCT04170296|11378092|FG000|COMPLETED|Overall Study||73
10246266|NCT04170296|11378093|FG001|COMPLETED|Overall Study||68
10246267|NCT04170296|11378092|FG000|NOT COMPLETED|Overall Study||8
10246268|NCT04170296|11378093|FG001|NOT COMPLETED|Overall Study||4
10246269|NCT04039217|11378105|FG000|STARTED|Overall Study||20
10246270|NCT04039217|11378105|FG000|Started Study Arm A.1|Overall Study||4
10246271|NCT04039217|11378105|FG000|Completed Study Arm A.1|Overall Study||4
10246272|NCT04039217|11378105|FG000|Started Study Arm A.2|Overall Study||4
10246273|NCT04039217|11378105|FG000|Completed Study Arm A.2|Overall Study||4
10246274|NCT04039217|11378105|FG000|Started Study Arm A.3|Overall Study||4
10246275|NCT04039217|11378105|FG000|Completed Study Arm A.3|Overall Study||4
10246276|NCT04039217|11378105|FG000|Started Study Arm B.1|Overall Study||4
10246277|NCT04039217|11378105|FG000|Completed Study Arm B.1|Overall Study||4
10246278|NCT04039217|11378105|FG000|Started Study Arm B.2|Overall Study||4
10246279|NCT04039217|11378105|FG000|Completed Study Arm B.2|Overall Study||4
10246280|NCT04039217|11378105|FG000|Started Study Arm C.1|Overall Study||5
10246281|NCT04039217|11378105|FG000|Completed Study Arm C.1|Overall Study||4
10246282|NCT04039217|11378105|FG000|Started Study Arm C.2|Overall Study||0
10246283|NCT04039217|11378105|FG000|Completed Study Arm C.2|Overall Study||0
10246284|NCT04039217|11378105|FG000|COMPLETED|Overall Study||19
10246285|NCT04039217|11378105|FG000|NOT COMPLETED|Overall Study||1
10246286|NCT03998046|11378115|FG000|STARTED|Overall Study||38
10246287|NCT03998046|11378116|FG001|STARTED|Overall Study||42
10246288|NCT03998046|11378115|FG000|COMPLETED|Overall Study||38
10246289|NCT03998046|11378116|FG001|COMPLETED|Overall Study||42
10246290|NCT03998046|11378115|FG000|NOT COMPLETED|Overall Study||0
10246291|NCT03998046|11378116|FG001|NOT COMPLETED|Overall Study||0
10246292|NCT03160521|11378126|FG000|STARTED|Overall Study|From 145 randomized patients in the 75 mg dose arm, one of them withdrew consent before receiving the study treatment. Due to, only 144 patients received allocated intervention.|144
10246293|NCT03160521|11378127|FG001|STARTED|Overall Study||146
10246294|NCT03160521|11378128|FG002|STARTED|Overall Study||147
10246295|NCT03160521|11378126|FG000|COMPLETED|Overall Study||107
10246296|NCT03160521|11378127|FG001|COMPLETED|Overall Study||95
10246297|NCT03160521|11378128|FG002|COMPLETED|Overall Study||88
10246298|NCT03160521|11378126|FG000|NOT COMPLETED|Overall Study||37
10246299|NCT03160521|11378127|FG001|NOT COMPLETED|Overall Study||51
10246300|NCT03160521|11378128|FG002|NOT COMPLETED|Overall Study||59
10246301|NCT03143816|11378144|FG000|STARTED|Overall Study||26
10246302|NCT03143816|11378145|FG001|STARTED|Overall Study||34
10246303|NCT03143816|11378144|FG000|COMPLETED|Overall Study||22
10246304|NCT03143816|11378145|FG001|COMPLETED|Overall Study||34
10246305|NCT03143816|11378144|FG000|NOT COMPLETED|Overall Study||4
10246306|NCT03143816|11378145|FG001|NOT COMPLETED|Overall Study||0
10246307|NCT03078192|11378159|FG000|STARTED|Overall Study||30
10246308|NCT03078192|11378160|FG001|STARTED|Overall Study||32
10246309|NCT03078192|11378159|FG000|COMPLETED|Overall Study||28
10246310|NCT03078192|11378160|FG001|COMPLETED|Overall Study||28
10246311|NCT03078192|11378159|FG000|NOT COMPLETED|Overall Study||2
10246312|NCT03078192|11378160|FG001|NOT COMPLETED|Overall Study||4
10246345|NCT01547117|11378197|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
10246346|NCT01547117|11378198|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
10246347|NCT01547117|11378199|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
10246348|NCT01547117|11378200|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
10246349|NCT01547117|11378197|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
10246350|NCT01547117|11378198|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2
10246351|NCT01547117|11378199|FG002|Phase 1-finish|Overall Study||8
10246352|NCT01547117|11378200|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
10246353|NCT01547117|11378197|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
10246354|NCT01547117|11378198|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
10246355|NCT01547117|11378199|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
10246356|NCT01547117|11378200|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
10246357|NCT01547117|11378197|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
10246358|NCT01547117|11378198|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
10246359|NCT01547117|11378199|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
10246360|NCT01547117|11378200|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
10246361|NCT01547117|11378197|FG000|Phase 2-finish|Overall Study||11
10246362|NCT01547117|11378198|FG001|Phase 2-finish|Overall Study||2
10246363|NCT01547117|11378199|FG002|Phase 2-finish|Overall Study||8
10246364|NCT01547117|11378200|FG003|Phase 2-finish|Overall Study||6
9957306|NCT01450098|11076533|FG001|STARTED|Period 1||31
9957307|NCT01450098|11076532|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
9957308|NCT01450098|11076533|FG001|Received at Least 1 Dose of Study Drug|Period 1||31
10246365|NCT01547117|11378197|FG000|COMPLETED|Overall Study||11
10246366|NCT01547117|11378198|FG001|COMPLETED|Overall Study||2
10246367|NCT01547117|11378199|FG002|COMPLETED|Overall Study||8
10246368|NCT01547117|11378200|FG003|COMPLETED|Overall Study||6
10246369|NCT01547117|11378197|FG000|NOT COMPLETED|Overall Study||1
10246370|NCT01547117|11378198|FG001|NOT COMPLETED|Overall Study||3
10246371|NCT01547117|11378199|FG002|NOT COMPLETED|Overall Study||2
10246372|NCT01547117|11378200|FG003|NOT COMPLETED|Overall Study||5
10246373|NCT01431508|11378226|FG000|STARTED|Overall Study||15
10246374|NCT01431508|11378226|FG000|COMPLETED|Overall Study||13
10246375|NCT01431508|11378226|FG000|NOT COMPLETED|Overall Study||2
10246376|NCT00871351|11378233|FG000|STARTED|Overall Study||47
10246377|NCT00871351|11378234|FG001|STARTED|Overall Study||46
10246378|NCT00871351|11378235|FG002|STARTED|Overall Study||32
10246379|NCT00871351|11378233|FG000|COMPLETED|Overall Study||43
10246380|NCT00871351|11378234|FG001|COMPLETED|Overall Study||45
10246381|NCT00871351|11378235|FG002|COMPLETED|Overall Study||32
10246382|NCT00871351|11378233|FG000|NOT COMPLETED|Overall Study||4
10246383|NCT00871351|11378234|FG001|NOT COMPLETED|Overall Study||1
10246384|NCT00871351|11378235|FG002|NOT COMPLETED|Overall Study||0
10246385|NCT00832455|11378243|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
10246386|NCT00832455|11378243|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
10246387|NCT00832455|11378243|FG000|Week 4|Overall Study||411
10246388|NCT00832455|11378243|FG000|Week 8 (Optional)|Overall Study||247
10246389|NCT00832455|11378243|FG000|Week 12|Overall Study||373
10246390|NCT00832455|11378243|FG000|COMPLETED|Overall Study||373
10246391|NCT00832455|11378243|FG000|NOT COMPLETED|Overall Study||72
10246392|NCT00812006|11378259|FG000|STARTED|Overall Study||36
10246393|NCT00812006|11378260|FG001|STARTED|Overall Study||36
10246394|NCT00812006|11378261|FG002|STARTED|Overall Study||36
10246395|NCT00812006|11378259|FG000|COMPLETED|Overall Study||30
10246396|NCT00812006|11378260|FG001|COMPLETED|Overall Study||33
10246397|NCT00812006|11378261|FG002|COMPLETED|Overall Study||30
10246398|NCT00812006|11378259|FG000|NOT COMPLETED|Overall Study||6
10246399|NCT00812006|11378260|FG001|NOT COMPLETED|Overall Study||3
10246400|NCT00812006|11378261|FG002|NOT COMPLETED|Overall Study||6
10246401|NCT00739050|11378267|FG000|STARTED|Overall Study||4
10246402|NCT00739050|11378268|FG001|STARTED|Overall Study||0
10246403|NCT00739050|11378267|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
10246404|NCT00739050|11378268|FG001|COMPLETED|Overall Study||0
10246405|NCT00739050|11378267|FG000|NOT COMPLETED|Overall Study||1
10246406|NCT00739050|11378268|FG001|NOT COMPLETED|Overall Study||0
10246407|NCT00687531|11378274|FG000|STARTED|Overall Study|Completed screening procedures|385
10246408|NCT00687531|11378274|FG000|RECEIVED TREATMENT|Overall Study||281
10246409|NCT00687531|11378274|FG000|COMPLETED|Overall Study||250
10246410|NCT00687531|11378274|FG000|NOT COMPLETED|Overall Study||135
10246411|NCT00654628|11378278|FG000|STARTED|6-week Active Treatment Period||173
10246412|NCT00654628|11378278|FG000|COMPLETED|6-week Active Treatment Period||152
10246413|NCT00654628|11378278|FG000|NOT COMPLETED|6-week Active Treatment Period||21
10246414|NCT00654628|11378278|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
10246415|NCT00654628|11378278|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55
10246416|NCT00654628|11378278|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
10246417|NCT00604812|11378285|FG000|STARTED|Overall Study||9
10246418|NCT00604812|11378286|FG001|STARTED|Overall Study||3
10246419|NCT00604812|11378287|FG002|STARTED|Overall Study||10
10246420|NCT00604812|11378288|FG003|STARTED|Overall Study||3
10246421|NCT00604812|11378289|FG004|STARTED|Overall Study||5
10246422|NCT00604812|11378290|FG005|STARTED|Overall Study||1
10246423|NCT00604812|11378285|FG000|COMPLETED|Overall Study||9
10246424|NCT00604812|11378286|FG001|COMPLETED|Overall Study||3
10246425|NCT00604812|11378287|FG002|COMPLETED|Overall Study||10
10246426|NCT00604812|11378288|FG003|COMPLETED|Overall Study||3
10246427|NCT00604812|11378289|FG004|COMPLETED|Overall Study||5
10246428|NCT00604812|11378290|FG005|COMPLETED|Overall Study||1
10246429|NCT00604812|11378285|FG000|NOT COMPLETED|Overall Study||0
10246430|NCT00604812|11378286|FG001|NOT COMPLETED|Overall Study||0
10246431|NCT00604812|11378287|FG002|NOT COMPLETED|Overall Study||0
10246432|NCT00604812|11378288|FG003|NOT COMPLETED|Overall Study||0
10246433|NCT00604812|11378289|FG004|NOT COMPLETED|Overall Study||0
10246434|NCT00604812|11378290|FG005|NOT COMPLETED|Overall Study||0
10246435|NCT00536380|11378304|FG000|STARTED|Overall Study||106
10246436|NCT00536380|11378305|FG001|STARTED|Overall Study||104
10246437|NCT00536380|11378306|FG002|STARTED|Overall Study||104
10246438|NCT00536380|11378304|FG000|COMPLETED|Overall Study||94
10246439|NCT00536380|11378305|FG001|COMPLETED|Overall Study||95
10246440|NCT00536380|11378306|FG002|COMPLETED|Overall Study||94
10246441|NCT00536380|11378304|FG000|NOT COMPLETED|Overall Study||12
10246442|NCT00536380|11378305|FG001|NOT COMPLETED|Overall Study||9
10246443|NCT00536380|11378306|FG002|NOT COMPLETED|Overall Study||10
10246444|NCT00521599|11378317|FG000|STARTED|Overall Study||268
10246445|NCT00521599|11378318|FG001|STARTED|Overall Study||268
10246446|NCT00521599|11378319|FG002|STARTED|Overall Study||136
10246447|NCT00521599|11378317|FG000|COMPLETED|Overall Study||243
10246448|NCT00521599|11378318|FG001|COMPLETED|Overall Study||239
10246449|NCT00521599|11378319|FG002|COMPLETED|Overall Study||100
10246450|NCT00521599|11378317|FG000|NOT COMPLETED|Overall Study||25
10246451|NCT00521599|11378318|FG001|NOT COMPLETED|Overall Study||29
10246452|NCT00521599|11378319|FG002|NOT COMPLETED|Overall Study||36
10246453|NCT00496834|11378330|FG000|STARTED|Overall Study||101
10246454|NCT00496834|11378331|FG001|STARTED|Overall Study||100
10246455|NCT00496834|11378330|FG000|COMPLETED|Overall Study||83
10246456|NCT00496834|11378331|FG001|COMPLETED|Overall Study||87
10246457|NCT00496834|11378330|FG000|NOT COMPLETED|Overall Study||18
10246458|NCT00496834|11378331|FG001|NOT COMPLETED|Overall Study||13
10246459|NCT00442897|11378341|FG000|STARTED|Base Study (12 Week Follow-up)||118
10246460|NCT00442897|11378342|FG001|STARTED|Base Study (12 Week Follow-up)||111
10246461|NCT00442897|11378341|FG000|COMPLETED|Base Study (12 Week Follow-up)||101
10246462|NCT00442897|11378342|FG001|COMPLETED|Base Study (12 Week Follow-up)||99
10246463|NCT00442897|11378341|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17
10246464|NCT00442897|11378342|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12
10246465|NCT00442897|11378341|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
10246466|NCT00442897|11378342|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
10246467|NCT00442897|11378341|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29
10246468|NCT00442897|11378342|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28
10246469|NCT00442897|11378341|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
10246470|NCT00442897|11378342|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
10246471|NCT00423579|11378350|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
10246472|NCT00423579|11378351|FG001|STARTED|Overall Study||60
10246473|NCT00423579|11378350|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
10246474|NCT00423579|11378351|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
10246475|NCT00423579|11378350|FG000|NOT COMPLETED|Overall Study||4
10246476|NCT00423579|11378351|FG001|NOT COMPLETED|Overall Study||4
10246477|NCT00394355|11378361|FG000|STARTED|Overall Study||140
10246478|NCT00394355|11378362|FG001|STARTED|Overall Study||137
10246479|NCT00394355|11378363|FG002|STARTED|Overall Study||147
10246480|NCT00394355|11378364|FG003|STARTED|Overall Study||142
10246481|NCT00394355|11378361|FG000|COMPLETED|Overall Study||105
10246482|NCT00394355|11378362|FG001|COMPLETED|Overall Study||103
10246483|NCT00394355|11378363|FG002|COMPLETED|Overall Study||109
10246484|NCT00394355|11378364|FG003|COMPLETED|Overall Study||111
10246485|NCT00394355|11378361|FG000|NOT COMPLETED|Overall Study||35
10246486|NCT00394355|11378362|FG001|NOT COMPLETED|Overall Study||34
10246487|NCT00394355|11378363|FG002|NOT COMPLETED|Overall Study||38
10246488|NCT00394355|11378364|FG003|NOT COMPLETED|Overall Study||31
10246489|NCT00359216|11378376|FG000|STARTED|Overall Study||20
10246490|NCT00359216|11378377|FG001|STARTED|Overall Study||10
10246491|NCT00359216|11378376|FG000|COMPLETED|Overall Study||20
10246492|NCT00359216|11378377|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
10246493|NCT00359216|11378376|FG000|NOT COMPLETED|Overall Study||0
10246494|NCT00359216|11378377|FG001|NOT COMPLETED|Overall Study||1
10246495|NCT00166504|11378385|FG000|STARTED|Overall Study||108
10246496|NCT00166504|11378386|FG001|STARTED|Overall Study||95
10246497|NCT00166504|11378385|FG000|COMPLETED|Overall Study||103
10246498|NCT00166504|11378386|FG001|COMPLETED|Overall Study||91
10246499|NCT00166504|11378385|FG000|NOT COMPLETED|Overall Study||5
10246500|NCT00166504|11378386|FG001|NOT COMPLETED|Overall Study||4
10246501|NCT01345240|11378397|FG000|STARTED|Overall Study||142
10246502|NCT01345240|11378398|FG001|STARTED|Overall Study||142
10246503|NCT01345240|11378399|FG002|STARTED|Overall Study||141
10246504|NCT01345240|11378400|FG003|STARTED|Overall Study||141
10246505|NCT01345240|11378401|FG004|STARTED|Overall Study||139
10246506|NCT01345240|11378397|FG000|COMPLETED|Overall Study||131
10246507|NCT01345240|11378398|FG001|COMPLETED|Overall Study||128
10246508|NCT01345240|11378399|FG002|COMPLETED|Overall Study||123
10246509|NCT01345240|11378400|FG003|COMPLETED|Overall Study||132
10246510|NCT01345240|11378401|FG004|COMPLETED|Overall Study||129
10246511|NCT01345240|11378397|FG000|NOT COMPLETED|Overall Study||11
10246512|NCT01345240|11378398|FG001|NOT COMPLETED|Overall Study||14
10246513|NCT01345240|11378399|FG002|NOT COMPLETED|Overall Study||18
10246514|NCT01345240|11378400|FG003|NOT COMPLETED|Overall Study||9
10246515|NCT01345240|11378401|FG004|NOT COMPLETED|Overall Study||10
10246516|NCT01371305|11378428|FG000|STARTED|Overall Study||6
10246517|NCT01371305|11378429|FG001|STARTED|Overall Study||6
10246518|NCT01371305|11378430|FG002|STARTED|Overall Study||6
10246519|NCT01371305|11378431|FG003|STARTED|Overall Study||7
10246520|NCT01371305|11378432|FG004|STARTED|Overall Study||6
10246521|NCT01371305|11378433|FG005|STARTED|Overall Study||10
10246522|NCT01371305|11378428|FG000|COMPLETED|Overall Study||6
10246523|NCT01371305|11378429|FG001|COMPLETED|Overall Study||6
10246524|NCT01371305|11378430|FG002|COMPLETED|Overall Study||6
10246525|NCT01371305|11378431|FG003|COMPLETED|Overall Study||5
10246526|NCT01371305|11378432|FG004|COMPLETED|Overall Study||2
10246527|NCT01371305|11378433|FG005|COMPLETED|Overall Study||8
10246528|NCT01371305|11378428|FG000|NOT COMPLETED|Overall Study||0
10246529|NCT01371305|11378429|FG001|NOT COMPLETED|Overall Study||0
10246530|NCT01371305|11378430|FG002|NOT COMPLETED|Overall Study||0
10246531|NCT01371305|11378431|FG003|NOT COMPLETED|Overall Study||2
10246532|NCT01371305|11378432|FG004|NOT COMPLETED|Overall Study||4
10246533|NCT01371305|11378433|FG005|NOT COMPLETED|Overall Study||2
10246534|NCT01376323|11378453|FG000|STARTED|Overall Study||20
10246535|NCT01376323|11378454|FG001|STARTED|Overall Study||18
10246536|NCT01376323|11378455|FG002|STARTED|Overall Study||19
10246537|NCT01376323|11378456|FG003|STARTED|Overall Study||19
10246538|NCT01376323|11378457|FG004|STARTED|Overall Study||18
10246539|NCT01376323|11378453|FG000|COMPLETED|Overall Study||18
10246540|NCT01376323|11378454|FG001|COMPLETED|Overall Study||17
10246541|NCT01376323|11378455|FG002|COMPLETED|Overall Study||16
10246542|NCT01376323|11378456|FG003|COMPLETED|Overall Study||14
10246543|NCT01376323|11378457|FG004|COMPLETED|Overall Study||17
10246544|NCT01376323|11378453|FG000|NOT COMPLETED|Overall Study||2
10246545|NCT01376323|11378454|FG001|NOT COMPLETED|Overall Study||1
10246546|NCT01376323|11378455|FG002|NOT COMPLETED|Overall Study||3
10246547|NCT01376323|11378456|FG003|NOT COMPLETED|Overall Study||5
10246548|NCT01376323|11378457|FG004|NOT COMPLETED|Overall Study||1
10246549|NCT01386658|11378481|FG000|STARTED|Initial Icatibant Exposure||11
10246550|NCT01386658|11378482|FG001|STARTED|Initial Icatibant Exposure||21
10246551|NCT01386658|11378481|FG000|COMPLETED|Initial Icatibant Exposure||11
10246552|NCT01386658|11378482|FG001|COMPLETED|Initial Icatibant Exposure||9
10246553|NCT01386658|11378481|FG000|NOT COMPLETED|Initial Icatibant Exposure||0
10246554|NCT01386658|11378482|FG001|NOT COMPLETED|Initial Icatibant Exposure||12
10246555|NCT01386658|11378481|FG000|STARTED|Icatibant Exposure 2||0
10246556|NCT01386658|11378482|FG001|STARTED|Icatibant Exposure 2||9
10246557|NCT01386658|11378481|FG000|COMPLETED|Icatibant Exposure 2||0
10246558|NCT01386658|11378482|FG001|COMPLETED|Icatibant Exposure 2||9
10246559|NCT01386658|11378481|FG000|NOT COMPLETED|Icatibant Exposure 2||0
10246560|NCT01386658|11378482|FG001|NOT COMPLETED|Icatibant Exposure 2||0
10246561|NCT01386658|11378481|FG000|STARTED|Icatibant Exposure 3||0
10246562|NCT01386658|11378482|FG001|STARTED|Icatibant Exposure 3||9
10246563|NCT01386658|11378481|FG000|COMPLETED|Icatibant Exposure 3||0
10246564|NCT01386658|11378482|FG001|COMPLETED|Icatibant Exposure 3||9
10246565|NCT01386658|11378481|FG000|NOT COMPLETED|Icatibant Exposure 3||0
10246566|NCT01386658|11378482|FG001|NOT COMPLETED|Icatibant Exposure 3||0
10246567|NCT01386684|11378492|FG000|STARTED|Overall Study||552
10246568|NCT01386684|11378492|FG000|COMPLETED|Overall Study||259
10246569|NCT01386684|11378492|FG000|NOT COMPLETED|Overall Study||293
10246570|NCT01386879|11378499|FG000|STARTED|Overall Study||17
10246571|NCT01386879|11378500|FG001|STARTED|Overall Study||17
10246572|NCT01386879|11378501|FG002|STARTED|Overall Study||16
10246573|NCT01386879|11378499|FG000|COMPLETED|Overall Study||17
10246574|NCT01386879|11378500|FG001|COMPLETED|Overall Study||17
10246575|NCT01386879|11378501|FG002|COMPLETED|Overall Study||16
10246576|NCT01386879|11378499|FG000|NOT COMPLETED|Overall Study||0
10246577|NCT01386879|11378500|FG001|NOT COMPLETED|Overall Study||0
10246578|NCT01386879|11378501|FG002|NOT COMPLETED|Overall Study||0
10246579|NCT04980014|11378509|FG000|STARTED|Overall Study||730
10246580|NCT04980014|11378509|FG000|Safety Analysis Set|Overall Study||655
10246581|NCT04980014|11378509|FG000|Effectiveness Analysis Set|Overall Study||482
10246582|NCT04980014|11378509|FG000|COMPLETED|Overall Study||655
10246583|NCT04980014|11378509|FG000|NOT COMPLETED|Overall Study||75
10246584|NCT04503603|11378515|FG000|STARTED|Overall Study||9
10246585|NCT04503603|11378516|FG001|STARTED|Overall Study||3
10246586|NCT04503603|11378515|FG000|COMPLETED|Overall Study||9
10246587|NCT04503603|11378516|FG001|COMPLETED|Overall Study||3
10246588|NCT04503603|11378515|FG000|NOT COMPLETED|Overall Study||0
10246589|NCT04503603|11378516|FG001|NOT COMPLETED|Overall Study||0
10246590|NCT04454918|11378522|FG000|STARTED|Treatment Period 1 (Day 1)||6
10246591|NCT04454918|11378522|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
10246592|NCT04454918|11378522|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10246593|NCT04454918|11378522|FG000|STARTED|Washout Period (Day 2 to 8)||6
10246594|NCT04454918|11378522|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
10246595|NCT04454918|11378522|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
10246596|NCT04454918|11378522|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
10246597|NCT04454918|11378522|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
10246598|NCT04454918|11378522|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
10246599|NCT04427501|11378540|FG000|STARTED|Overall Study||156
10246600|NCT04427501|11378541|FG001|STARTED|Overall Study||101
10246601|NCT04427501|11378542|FG002|STARTED|Overall Study||107
10246602|NCT04427501|11378543|FG003|STARTED|Overall Study||101
10246603|NCT04427501|11378544|FG004|STARTED|Overall Study||112
10246604|NCT04427501|11378545|FG005|STARTED|Overall Study|Participants in Placebo for Phase 3: 2800 mg Bamlanivimab + 2800 mg Etesevimab and Phase 3: 700 mg Bamlanivimab + 1400 mg Etesevimab were combined to avoid double counting.|776
10246605|NCT04427501|11378546|FG006|STARTED|Overall Study||518
10246606|NCT04427501|11378547|FG007|STARTED|Overall Study||513
10246607|NCT04427501|11378548|FG008|STARTED|Overall Study||141
10246608|NCT04427501|11378549|FG009|STARTED|Overall Study||213
10246609|NCT04427501|11378540|FG000|Received at Least One Dose of Study Drug|Overall Study||156
10246610|NCT04427501|11378541|FG001|Received at Least One Dose of Study Drug|Overall Study||101
10246611|NCT04427501|11378542|FG002|Received at Least One Dose of Study Drug|Overall Study||107
10246612|NCT04427501|11378543|FG003|Received at Least One Dose of Study Drug|Overall Study||101
10246613|NCT04427501|11378544|FG004|Received at Least One Dose of Study Drug|Overall Study||112
10246614|NCT04427501|11378545|FG005|Received at Least One Dose of Study Drug|Overall Study||776
10246615|NCT04427501|11378546|FG006|Received at Least One Dose of Study Drug|Overall Study||518
10246616|NCT04427501|11378547|FG007|Received at Least One Dose of Study Drug|Overall Study||513
10246617|NCT04427501|11378548|FG008|Received at Least One Dose of Study Drug|Overall Study||141
10246618|NCT04427501|11378549|FG009|Received at Least One Dose of Study Drug|Overall Study||213
10246619|NCT04427501|11378540|FG000|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246620|NCT04427501|11378541|FG001|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246621|NCT04427501|11378542|FG002|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246622|NCT04427501|11378543|FG003|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246623|NCT04427501|11378544|FG004|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246624|NCT04427501|11378545|FG005|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||517
10246625|NCT04427501|11378546|FG006|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246626|NCT04427501|11378547|FG007|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246627|NCT04427501|11378548|FG008|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246628|NCT04427501|11378549|FG009|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10246629|NCT04427501|11378540|FG000|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246630|NCT04427501|11378541|FG001|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246631|NCT04427501|11378542|FG002|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246632|NCT04427501|11378543|FG003|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246633|NCT04427501|11378544|FG004|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246634|NCT04427501|11378545|FG005|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||776
10246635|NCT04427501|11378546|FG006|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246636|NCT04427501|11378547|FG007|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246637|NCT04427501|11378548|FG008|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246638|NCT04427501|11378549|FG009|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10246639|NCT04427501|11378540|FG000|COMPLETED|Overall Study||141
10246640|NCT04427501|11378541|FG001|COMPLETED|Overall Study||95
10246641|NCT04427501|11378542|FG002|COMPLETED|Overall Study||103
10246642|NCT04427501|11378543|FG003|COMPLETED|Overall Study||98
10246643|NCT04427501|11378544|FG004|COMPLETED|Overall Study||103
10246644|NCT04427501|11378545|FG005|COMPLETED|Overall Study||719
10246645|NCT04427501|11378546|FG006|COMPLETED|Overall Study||485
10246646|NCT04427501|11378547|FG007|COMPLETED|Overall Study||496
10246647|NCT04427501|11378548|FG008|COMPLETED|Overall Study||135
10246648|NCT04427501|11378549|FG009|COMPLETED|Overall Study||207
10246649|NCT04427501|11378540|FG000|NOT COMPLETED|Overall Study||15
10246650|NCT04427501|11378541|FG001|NOT COMPLETED|Overall Study||6
10246651|NCT04427501|11378542|FG002|NOT COMPLETED|Overall Study||4
10246652|NCT04427501|11378543|FG003|NOT COMPLETED|Overall Study||3
10246653|NCT04427501|11378544|FG004|NOT COMPLETED|Overall Study||9
10246654|NCT04427501|11378545|FG005|NOT COMPLETED|Overall Study||57
10246655|NCT04427501|11378546|FG006|NOT COMPLETED|Overall Study||33
10246656|NCT04427501|11378547|FG007|NOT COMPLETED|Overall Study||17
10246657|NCT04427501|11378548|FG008|NOT COMPLETED|Overall Study||6
10246658|NCT04427501|11378549|FG009|NOT COMPLETED|Overall Study||6
10246659|NCT03735849|11378585|FG000|STARTED|Overall Study||11
10246660|NCT03735849|11378586|FG001|STARTED|Overall Study||13
10246661|NCT03735849|11378587|FG002|STARTED|Overall Study||4
10246662|NCT03735849|11378585|FG000|Safety Population|Overall Study||11
10246663|NCT03735849|11378586|FG001|Safety Population|Overall Study||13
10246664|NCT03735849|11378587|FG002|Safety Population|Overall Study||4
10246665|NCT03735849|11378585|FG000|COMPLETED|Overall Study||9
10246666|NCT03735849|11378586|FG001|COMPLETED|Overall Study||13
10246667|NCT03735849|11378587|FG002|COMPLETED|Overall Study||0
10246668|NCT03735849|11378585|FG000|NOT COMPLETED|Overall Study||2
10246669|NCT03735849|11378586|FG001|NOT COMPLETED|Overall Study||0
10246670|NCT03735849|11378587|FG002|NOT COMPLETED|Overall Study||4
10246671|NCT03552822|11378596|FG000|STARTED|Overall Study||112
10246672|NCT03552822|11378597|FG001|STARTED|Overall Study||429
10246673|NCT03552822|11378596|FG000|COMPLETED|Overall Study||112
10246674|NCT03552822|11378597|FG001|COMPLETED|Overall Study||429
10246675|NCT03552822|11378596|FG000|NOT COMPLETED|Overall Study||0
10246676|NCT03552822|11378597|FG001|NOT COMPLETED|Overall Study||0
10246677|NCT03552393|11378603|FG000|STARTED|Core Period||40
10246678|NCT03552393|11378603|FG000|COMPLETED|Core Period||38
10246679|NCT03552393|11378603|FG000|NOT COMPLETED|Core Period||2
10246680|NCT03552393|11378603|FG000|STARTED|Safety Extension Period||25
10246681|NCT03552393|11378603|FG000|COMPLETED|Safety Extension Period||21
10246682|NCT03552393|11378603|FG000|NOT COMPLETED|Safety Extension Period||4
10246683|NCT03412747|11378610|FG000|STARTED|Initial Treatment Period: Wk0-Wk16||161
10246684|NCT03412747|11378611|FG001|STARTED|Initial Treatment Period: Wk0-Wk16||158
10246685|NCT03412747|11378612|FG002|STARTED|Initial Treatment Period: Wk0-Wk16||159
10246686|NCT03412747|11378610|FG000|COMPLETED|Initial Treatment Period: Wk0-Wk16||154
10246687|NCT03412747|11378611|FG001|COMPLETED|Initial Treatment Period: Wk0-Wk16||153
10246688|NCT03412747|11378612|FG002|COMPLETED|Initial Treatment Period: Wk0-Wk16||150
10246689|NCT03412747|11378610|FG000|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||7
10246690|NCT03412747|11378611|FG001|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||5
10246691|NCT03412747|11378612|FG002|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||9
10246692|NCT03412747|11378610|FG000|STARTED|Maintenance Treatment Period: Wk16-Wk24||154
10246693|NCT03412747|11378611|FG001|STARTED|Maintenance Treatment Period: Wk16-Wk24||153
10246694|NCT03412747|11378612|FG002|STARTED|Maintenance Treatment Period: Wk16-Wk24||150
10246695|NCT03412747|11378610|FG000|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
10246696|NCT03412747|11378611|FG001|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||152
10246697|NCT03412747|11378612|FG002|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
10246698|NCT03412747|11378610|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||5
10246699|NCT03412747|11378611|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
10246700|NCT03412747|11378612|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
10246701|NCT03412747|11378610|FG000|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
10246702|NCT03412747|11378611|FG001|STARTED|Maintenance Treatment Period: Wk24-Wk56||152
10246703|NCT03412747|11378612|FG002|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
10246704|NCT03412747|11378610|FG000|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
10246705|NCT03412747|11378611|FG001|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
10246706|NCT03412747|11378612|FG002|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||133
10246707|NCT03412747|11378610|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||6
10246708|NCT03412747|11378611|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||9
10246709|NCT03412747|11378612|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||16
10246710|NCT03333382|11378632|FG000|STARTED|Overall Study||1
10246711|NCT03333382|11378633|FG001|STARTED|Overall Study||0
10246712|NCT03333382|11378632|FG000|COMPLETED|Overall Study||0
10246713|NCT03333382|11378633|FG001|COMPLETED|Overall Study||0
10246714|NCT03333382|11378632|FG000|NOT COMPLETED|Overall Study||1
10246715|NCT03333382|11378633|FG001|NOT COMPLETED|Overall Study||0
10246716|NCT03245827|11378643|FG000|STARTED|Overall Study||1
10246717|NCT03245827|11378644|FG001|STARTED|Overall Study||0
10246718|NCT03245827|11378645|FG002|STARTED|Overall Study||3
10246719|NCT03245827|11378646|FG003|STARTED|Overall Study||5
10246720|NCT03245827|11378643|FG000|COMPLETED|Overall Study||1
10246721|NCT03245827|11378644|FG001|COMPLETED|Overall Study||0
9833244|NCT00778258|10944124|FG007|COMPLETED|Overall Study||26
9833245|NCT00778258|10944125|FG008|COMPLETED|Overall Study||6
9833246|NCT00778258|10944117|FG000|NOT COMPLETED|Overall Study||7
10246722|NCT03245827|11378645|FG002|COMPLETED|Overall Study||3
10246723|NCT03245827|11378646|FG003|COMPLETED|Overall Study||5
10246724|NCT03245827|11378643|FG000|NOT COMPLETED|Overall Study||0
10246725|NCT03245827|11378644|FG001|NOT COMPLETED|Overall Study||0
10246726|NCT03245827|11378645|FG002|NOT COMPLETED|Overall Study||0
10246727|NCT03245827|11378646|FG003|NOT COMPLETED|Overall Study||0
10246728|NCT03129321|11378657|FG000|STARTED|Overall Study||351
10246729|NCT03129321|11378658|FG001|STARTED|Overall Study||350
10246730|NCT03129321|11378659|FG002|STARTED|Overall Study||175
10246731|NCT03129321|11378657|FG000|COMPLETED|Overall Study||253
10246732|NCT03129321|11378658|FG001|COMPLETED|Overall Study||241
10246733|NCT03129321|11378659|FG002|COMPLETED|Overall Study||120
10246734|NCT03129321|11378657|FG000|NOT COMPLETED|Overall Study||98
10246735|NCT03129321|11378658|FG001|NOT COMPLETED|Overall Study||109
10246736|NCT03129321|11378659|FG002|NOT COMPLETED|Overall Study||55
10246737|NCT03107611|11378672|FG000|STARTED|Overall Study||217
10246738|NCT03107611|11378673|FG001|STARTED|Overall Study||216
10246739|NCT03107611|11378674|FG002|STARTED|Overall Study||221
10246740|NCT03107611|11378672|FG000|Dosed|Overall Study||215
10246741|NCT03107611|11378673|FG001|Dosed|Overall Study||214
10246742|NCT03107611|11378674|FG002|Dosed|Overall Study||220
10246743|NCT03107611|11378672|FG000|COMPLETED|Overall Study||210
10246744|NCT03107611|11378673|FG001|COMPLETED|Overall Study||212
10246745|NCT03107611|11378674|FG002|COMPLETED|Overall Study||212
10246746|NCT03107611|11378672|FG000|NOT COMPLETED|Overall Study||7
10246747|NCT03107611|11378673|FG001|NOT COMPLETED|Overall Study||4
10246748|NCT03107611|11378674|FG002|NOT COMPLETED|Overall Study||9
10246749|NCT02720016|11378685|FG000|STARTED|Overall Study||92
10246750|NCT02720016|11378686|FG001|STARTED|Overall Study||92
10246751|NCT02720016|11378687|FG002|STARTED|Overall Study||90
9833247|NCT00778258|10944118|FG001|NOT COMPLETED|Overall Study||2
9833248|NCT00778258|10944119|FG002|NOT COMPLETED|Overall Study||10
9957309|NCT01450098|11076532|FG000|COMPLETED|Period 1||8
9957310|NCT01450098|11076533|FG001|COMPLETED|Period 1||31
9957311|NCT01450098|11076532|FG000|NOT COMPLETED|Period 1||0
9957312|NCT01450098|11076533|FG001|NOT COMPLETED|Period 1||0
9957313|NCT01450098|11076532|FG000|STARTED|Washout Period of at Least 14 Days||8
10246752|NCT02720016|11378685|FG000|Y1|Overall Study||26
10246753|NCT02720016|11378686|FG001|Y1|Overall Study||26
10246754|NCT02720016|11378687|FG002|Y1|Overall Study||28
10246755|NCT02720016|11378685|FG000|Y2|Overall Study||34
10246756|NCT02720016|11378686|FG001|Y2|Overall Study||32
10246757|NCT02720016|11378687|FG002|Y2|Overall Study||34
10246758|NCT02720016|11378685|FG000|Y3|Overall Study||28
9967659|NCT01515540|11088004|FG000|NOT COMPLETED|Overall Study||5
10246759|NCT02720016|11378686|FG001|Y3|Overall Study||30
10246760|NCT02720016|11378687|FG002|Y3|Overall Study||24
10246761|NCT02720016|11378685|FG000|Y4|Overall Study||4
10246762|NCT02720016|11378686|FG001|Y4|Overall Study||4
10246763|NCT02720016|11378687|FG002|Y4|Overall Study||4
10246764|NCT02720016|11378685|FG000|Veteran Total|Overall Study||46
10246765|NCT02720016|11378686|FG001|Veteran Total|Overall Study||46
10246766|NCT02720016|11378687|FG002|Veteran Total|Overall Study||45
10246767|NCT02720016|11378685|FG000|Intimate Partner Total|Overall Study||46
10246768|NCT02720016|11378686|FG001|Intimate Partner Total|Overall Study||46
10246769|NCT02720016|11378687|FG002|Intimate Partner Total|Overall Study||45
10246770|NCT02720016|11378685|FG000|COMPLETED|Overall Study||72
10246771|NCT02720016|11378686|FG001|COMPLETED|Overall Study||72
10246772|NCT02720016|11378687|FG002|COMPLETED|Overall Study||70
10246773|NCT02720016|11378685|FG000|NOT COMPLETED|Overall Study||20
10246774|NCT02720016|11378686|FG001|NOT COMPLETED|Overall Study||20
10246775|NCT02720016|11378687|FG002|NOT COMPLETED|Overall Study||20
10246776|NCT02607956|11378698|FG000|STARTED|Double-Blinded Phase||327
10246777|NCT02607956|11378699|FG001|STARTED|Double-Blinded Phase||330
10246778|NCT02607956|11378700|FG002|STARTED|Double-Blinded Phase||0
10246779|NCT02607956|11378701|FG003|STARTED|Double-Blinded Phase||0
10246780|NCT02607956|11378698|FG000|COMPLETED|Double-Blinded Phase||266
10246781|NCT02607956|11378699|FG001|COMPLETED|Double-Blinded Phase||277
10246782|NCT02607956|11378700|FG002|COMPLETED|Double-Blinded Phase||0
10246783|NCT02607956|11378701|FG003|COMPLETED|Double-Blinded Phase||0
10246784|NCT02607956|11378698|FG000|NOT COMPLETED|Double-Blinded Phase||61
10246785|NCT02607956|11378699|FG001|NOT COMPLETED|Double-Blinded Phase||53
10246786|NCT02607956|11378700|FG002|NOT COMPLETED|Double-Blinded Phase||0
10246787|NCT02607956|11378701|FG003|NOT COMPLETED|Double-Blinded Phase||0
10246788|NCT02607956|11378698|FG000|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10246789|NCT02607956|11378699|FG001|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10246790|NCT02607956|11378700|FG002|STARTED|Open-Label Extension Phase|66 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|254
10246791|NCT02607956|11378701|FG003|STARTED|Open-Label Extension Phase|60 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|265
10246792|NCT02607956|11378698|FG000|COMPLETED|Open-Label Extension Phase||0
10246793|NCT02607956|11378699|FG001|COMPLETED|Open-Label Extension Phase||0
10246794|NCT02607956|11378700|FG002|COMPLETED|Open-Label Extension Phase||225
10246795|NCT02607956|11378701|FG003|COMPLETED|Open-Label Extension Phase||235
10246796|NCT02607956|11378698|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10246797|NCT02607956|11378699|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10246798|NCT02607956|11378700|FG002|NOT COMPLETED|Open-Label Extension Phase||29
10246799|NCT02607956|11378701|FG003|NOT COMPLETED|Open-Label Extension Phase||30
10246800|NCT02564523|11378731|FG000|STARTED|Overall Study||225
10246801|NCT02564523|11378732|FG001|STARTED|Overall Study||43
10246802|NCT02564523|11378733|FG002|STARTED|Overall Study||224
10246803|NCT02564523|11378734|FG003|STARTED|Overall Study||44
10246804|NCT02564523|11378735|FG004|STARTED|Overall Study||110
10246805|NCT02564523|11378736|FG005|STARTED|Overall Study||22
10246806|NCT02564523|11378737|FG006|STARTED|Overall Study||59
10246807|NCT02564523|11378738|FG007|STARTED|Overall Study||12
10246808|NCT02564523|11378739|FG008|STARTED|Overall Study||59
10246809|NCT02564523|11378740|FG009|STARTED|Overall Study||12
10246810|NCT02564523|11378741|FG010|STARTED|Overall Study||55
10246811|NCT02564523|11378742|FG011|STARTED|Overall Study||11
10246812|NCT02564523|11378743|FG012|STARTED|Overall Study||55
10246813|NCT02564523|11378744|FG013|STARTED|Overall Study||10
10246814|NCT02564523|11378745|FG014|STARTED|Overall Study||54
10246815|NCT02564523|11378746|FG015|STARTED|Overall Study||12
10246816|NCT02564523|11378747|FG016|STARTED|Overall Study||54
10246817|NCT02564523|11378748|FG017|STARTED|Overall Study||12
10246818|NCT02564523|11378731|FG000|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||34
10246819|NCT02564523|11378732|FG001|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||8
10246820|NCT02564523|11378733|FG002|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||39
10246821|NCT02564523|11378734|FG003|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||9
10246822|NCT02564523|11378735|FG004|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246823|NCT02564523|11378736|FG005|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246824|NCT02564523|11378737|FG006|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246825|NCT02564523|11378738|FG007|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246826|NCT02564523|11378739|FG008|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246827|NCT02564523|11378740|FG009|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246828|NCT02564523|11378741|FG010|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246829|NCT02564523|11378742|FG011|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246830|NCT02564523|11378743|FG012|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246831|NCT02564523|11378744|FG013|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246832|NCT02564523|11378745|FG014|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246833|NCT02564523|11378746|FG015|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246834|NCT02564523|11378747|FG016|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246835|NCT02564523|11378748|FG017|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10246836|NCT02564523|11378731|FG000|COMPLETED|Overall Study||215
10246837|NCT02564523|11378732|FG001|COMPLETED|Overall Study||40
10246838|NCT02564523|11378733|FG002|COMPLETED|Overall Study||214
10246839|NCT02564523|11378734|FG003|COMPLETED|Overall Study||43
10246840|NCT02564523|11378735|FG004|COMPLETED|Overall Study||106
10246841|NCT02564523|11378736|FG005|COMPLETED|Overall Study||22
10246842|NCT02564523|11378737|FG006|COMPLETED|Overall Study||56
10246843|NCT02564523|11378738|FG007|COMPLETED|Overall Study||12
10246844|NCT02564523|11378739|FG008|COMPLETED|Overall Study||59
10246845|NCT02564523|11378740|FG009|COMPLETED|Overall Study||12
10246846|NCT02564523|11378741|FG010|COMPLETED|Overall Study||52
10246847|NCT02564523|11378742|FG011|COMPLETED|Overall Study||10
10246848|NCT02564523|11378743|FG012|COMPLETED|Overall Study||53
10246849|NCT02564523|11378744|FG013|COMPLETED|Overall Study||10
10246850|NCT02564523|11378745|FG014|COMPLETED|Overall Study||54
10246851|NCT02564523|11378746|FG015|COMPLETED|Overall Study||12
10246852|NCT02564523|11378747|FG016|COMPLETED|Overall Study||54
10246853|NCT02564523|11378748|FG017|COMPLETED|Overall Study||11
10246854|NCT02564523|11378731|FG000|NOT COMPLETED|Overall Study||10
10246855|NCT02564523|11378732|FG001|NOT COMPLETED|Overall Study||3
10246856|NCT02564523|11378733|FG002|NOT COMPLETED|Overall Study||10
10246857|NCT02564523|11378734|FG003|NOT COMPLETED|Overall Study||1
10246858|NCT02564523|11378735|FG004|NOT COMPLETED|Overall Study||4
10246859|NCT02564523|11378736|FG005|NOT COMPLETED|Overall Study||0
10246860|NCT02564523|11378737|FG006|NOT COMPLETED|Overall Study||3
10019626|NCT01831089|11142771|FG000|STARTED|Cohort V: Dose Level 5||0
10019627|NCT01831089|11142772|FG001|STARTED|Cohort V: Dose Level 5||0
10019628|NCT01831089|11142773|FG002|STARTED|Cohort V: Dose Level 5||0
10019629|NCT01831089|11142774|FG003|STARTED|Cohort V: Dose Level 5||0
10019630|NCT01831089|11142775|FG004|STARTED|Cohort V: Dose Level 5||37
10246861|NCT02564523|11378738|FG007|NOT COMPLETED|Overall Study||0
10246862|NCT02564523|11378739|FG008|NOT COMPLETED|Overall Study||0
10246863|NCT02564523|11378740|FG009|NOT COMPLETED|Overall Study||0
10246864|NCT02564523|11378741|FG010|NOT COMPLETED|Overall Study||3
10246865|NCT02564523|11378742|FG011|NOT COMPLETED|Overall Study||1
10246866|NCT02564523|11378743|FG012|NOT COMPLETED|Overall Study||2
10246867|NCT02564523|11378744|FG013|NOT COMPLETED|Overall Study||0
10246868|NCT02564523|11378745|FG014|NOT COMPLETED|Overall Study||0
10246869|NCT02564523|11378746|FG015|NOT COMPLETED|Overall Study||0
10246870|NCT02564523|11378747|FG016|NOT COMPLETED|Overall Study||0
10246871|NCT02564523|11378748|FG017|NOT COMPLETED|Overall Study||1
10246872|NCT02094716|11378805|FG000|STARTED|Overall Study||43
10246873|NCT02094716|11378806|FG001|STARTED|Overall Study||43
10246874|NCT02094716|11378807|FG002|STARTED|Overall Study||44
10246875|NCT02094716|11378805|FG000|Received Second Dose at Day 14|Overall Study||15
10246876|NCT02094716|11378806|FG001|Received Second Dose at Day 14|Overall Study||10
10246877|NCT02094716|11378807|FG002|Received Second Dose at Day 14|Overall Study||17
10246878|NCT02094716|11378805|FG000|COMPLETED|Overall Study||41
10246879|NCT02094716|11378806|FG001|COMPLETED|Overall Study||36
10246880|NCT02094716|11378807|FG002|COMPLETED|Overall Study||40
10246881|NCT02094716|11378805|FG000|NOT COMPLETED|Overall Study||2
10246882|NCT02094716|11378806|FG001|NOT COMPLETED|Overall Study||7
10246883|NCT02094716|11378807|FG002|NOT COMPLETED|Overall Study||4
10246884|NCT01988493|11378832|FG000|STARTED|Overall Study||7
10246885|NCT01988493|11378833|FG001|STARTED|Overall Study||14
10246886|NCT01988493|11378834|FG002|STARTED|Overall Study||6
10246887|NCT01988493|11378835|FG003|STARTED|Overall Study||45
10246888|NCT01988493|11378836|FG004|STARTED|Overall Study||45
10246889|NCT01988493|11378832|FG000|Treated|Overall Study||7
10246890|NCT01988493|11378833|FG001|Treated|Overall Study||14
10246891|NCT01988493|11378834|FG002|Treated|Overall Study||6
10246892|NCT01988493|11378835|FG003|Treated|Overall Study||45
10246893|NCT01988493|11378836|FG004|Treated|Overall Study||44
10246894|NCT01988493|11378832|FG000|Safety Population|Overall Study||7
10246895|NCT01988493|11378833|FG001|Safety Population|Overall Study||14
10246896|NCT01988493|11378834|FG002|Safety Population|Overall Study||6
10246897|NCT01988493|11378835|FG003|Safety Population|Overall Study||45
10246898|NCT01988493|11378836|FG004|Safety Population|Overall Study||44
10246899|NCT01988493|11378832|FG000|COMPLETED|Overall Study||7
10019631|NCT01831089|11142776|FG005|STARTED|Cohort V: Dose Level 5||0
10019632|NCT01831089|11142771|FG000|COMPLETED|Cohort V: Dose Level 5||0
10019633|NCT01831089|11142772|FG001|COMPLETED|Cohort V: Dose Level 5||0
10246900|NCT01988493|11378833|FG001|COMPLETED|Overall Study||14
10246901|NCT01988493|11378834|FG002|COMPLETED|Overall Study||6
10246902|NCT01988493|11378835|FG003|COMPLETED|Overall Study||45
10246903|NCT01988493|11378836|FG004|COMPLETED|Overall Study||44
10246904|NCT01988493|11378832|FG000|NOT COMPLETED|Overall Study||0
10019634|NCT01831089|11142773|FG002|COMPLETED|Cohort V: Dose Level 5||0
10246905|NCT01988493|11378833|FG001|NOT COMPLETED|Overall Study||0
10246906|NCT01988493|11378834|FG002|NOT COMPLETED|Overall Study||0
10246907|NCT01988493|11378835|FG003|NOT COMPLETED|Overall Study||0
10246908|NCT01988493|11378836|FG004|NOT COMPLETED|Overall Study||1
10246909|NCT01868139|11378848|FG000|STARTED|Overall Study||1
10246910|NCT01868139|11378848|FG000|COMPLETED|Overall Study||0
10246911|NCT01868139|11378848|FG000|NOT COMPLETED|Overall Study||1
10246912|NCT01798004|11378853|FG000|STARTED|Overall Study||150
10246913|NCT01798004|11378853|FG000|COMPLETED|Overall Study||63
10246914|NCT01798004|11378853|FG000|NOT COMPLETED|Overall Study||87
10246915|NCT01620658|11378860|FG000|STARTED|Overall Study||59
10246916|NCT01620658|11378861|FG001|STARTED|Overall Study||74
10246917|NCT01620658|11378862|FG002|STARTED|Overall Study||64
10246918|NCT01620658|11378860|FG000|COMPLETED|Overall Study||35
10246919|NCT01620658|11378861|FG001|COMPLETED|Overall Study||45
10246920|NCT01620658|11378862|FG002|COMPLETED|Overall Study||44
10246921|NCT01620658|11378860|FG000|NOT COMPLETED|Overall Study||24
10246922|NCT01620658|11378861|FG001|NOT COMPLETED|Overall Study||29
10246923|NCT01620658|11378862|FG002|NOT COMPLETED|Overall Study||20
10246924|NCT01447628|11378880|FG000|STARTED|Week 0 to Week 12 (1st Intervention)||19
10246925|NCT01447628|11378881|FG001|STARTED|Week 0 to Week 12 (1st Intervention)||20
10246926|NCT01447628|11378882|FG002|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|12
10246927|NCT01447628|11378883|FG003|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|5
10246928|NCT01447628|11378880|FG000|COMPLETED|Week 0 to Week 12 (1st Intervention)||19
10246929|NCT01447628|11378881|FG001|COMPLETED|Week 0 to Week 12 (1st Intervention)||20
10246930|NCT01447628|11378882|FG002|COMPLETED|Week 0 to Week 12 (1st Intervention)||12
9833249|NCT00778258|10944120|FG003|NOT COMPLETED|Overall Study||3
9833250|NCT00778258|10944121|FG004|NOT COMPLETED|Overall Study||0
9833251|NCT00778258|10944122|FG005|NOT COMPLETED|Overall Study||10
9833252|NCT00778258|10944123|FG006|NOT COMPLETED|Overall Study||15
9833253|NCT00778258|10944124|FG007|NOT COMPLETED|Overall Study||15
9833254|NCT00778258|10944125|FG008|NOT COMPLETED|Overall Study||4
9833255|NCT00778310|10944153|FG000|STARTED|Overall Study||17
9833256|NCT00778310|10944154|FG001|STARTED|Overall Study||26
9833257|NCT00778310|10944153|FG000|Usable Data|Overall Study||14
9833258|NCT00778310|10944154|FG001|Usable Data|Overall Study||21
9833259|NCT00778310|10944153|FG000|COMPLETED|Overall Study||17
9957314|NCT01450098|11076533|FG001|STARTED|Washout Period of at Least 14 Days||31
9957315|NCT01450098|11076532|FG000|COMPLETED|Washout Period of at Least 14 Days||8
9957316|NCT01450098|11076533|FG001|COMPLETED|Washout Period of at Least 14 Days||31
9957317|NCT01450098|11076532|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
9957318|NCT01450098|11076533|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
9957319|NCT01450098|11076532|FG000|STARTED|Period 2||8
9957320|NCT01450098|11076533|FG001|STARTED|Period 2||31
9957321|NCT01450098|11076532|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
9957322|NCT01450098|11076533|FG001|Received at Least 1 Dose of Study Drug|Period 2||31
9957323|NCT01450098|11076532|FG000|COMPLETED|Period 2||8
9957324|NCT01450098|11076533|FG001|COMPLETED|Period 2||31
9957325|NCT01450098|11076532|FG000|NOT COMPLETED|Period 2||0
9957326|NCT01450098|11076533|FG001|NOT COMPLETED|Period 2||0
9957327|NCT01450098|11076532|FG000|STARTED|Washout of at Least 14 Days||8
9957328|NCT01450098|11076533|FG001|STARTED|Washout of at Least 14 Days||31
9957329|NCT01450098|11076532|FG000|COMPLETED|Washout of at Least 14 Days||8
9957330|NCT01450098|11076533|FG001|COMPLETED|Washout of at Least 14 Days||31
9957331|NCT01450098|11076532|FG000|NOT COMPLETED|Washout of at Least 14 Days||0
9957332|NCT01450098|11076533|FG001|NOT COMPLETED|Washout of at Least 14 Days||0
9957333|NCT01450098|11076532|FG000|STARTED|Period 3||8
9957334|NCT01450098|11076533|FG001|STARTED|Period 3||31
9957335|NCT01450098|11076532|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
9957336|NCT01450098|11076533|FG001|Received at Least 1 Dose of Study Drug|Period 3||30
9957337|NCT01450098|11076532|FG000|COMPLETED|Period 3||8
9957338|NCT01450098|11076533|FG001|COMPLETED|Period 3||28
9957339|NCT01450098|11076532|FG000|NOT COMPLETED|Period 3||0
9957340|NCT01450098|11076533|FG001|NOT COMPLETED|Period 3||3
9957341|NCT01450137|11076548|FG000|STARTED|Up to Week 12||20
9957342|NCT01450137|11076549|FG001|STARTED|Up to Week 12||10
9957343|NCT01450137|11076548|FG000|COMPLETED|Up to Week 12||18
9957344|NCT01450137|11076549|FG001|COMPLETED|Up to Week 12||7
9957345|NCT01450137|11076548|FG000|NOT COMPLETED|Up to Week 12||2
9957346|NCT01450137|11076549|FG001|NOT COMPLETED|Up to Week 12||3
9957347|NCT01450137|11076548|FG000|STARTED|Week 12 to Study End||18
9957348|NCT01450137|11076549|FG001|STARTED|Week 12 to Study End||7
9957349|NCT01450137|11076548|FG000|COMPLETED|Week 12 to Study End||18
9957350|NCT01450137|11076549|FG001|COMPLETED|Week 12 to Study End||5
10019635|NCT01831089|11142774|FG003|COMPLETED|Cohort V: Dose Level 5||0
10019636|NCT01831089|11142775|FG004|COMPLETED|Cohort V: Dose Level 5||0
10019637|NCT01831089|11142776|FG005|COMPLETED|Cohort V: Dose Level 5||0
10019638|NCT01831089|11142771|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0
10246931|NCT01447628|11378883|FG003|COMPLETED|Week 0 to Week 12 (1st Intervention)||4
9957351|NCT01450137|11076548|FG000|NOT COMPLETED|Week 12 to Study End||0
9957352|NCT01450137|11076549|FG001|NOT COMPLETED|Week 12 to Study End||2
9957353|NCT01450189|11076558|FG000|STARTED|Overall Study||9
9957354|NCT01450189|11076559|FG001|STARTED|Overall Study||18
10246932|NCT01447628|11378880|FG000|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10246933|NCT01447628|11378881|FG001|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10246934|NCT01447628|11378882|FG002|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10246935|NCT01447628|11378883|FG003|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||1
9957355|NCT01450189|11076560|FG002|STARTED|Overall Study||19
9957356|NCT01450189|11076558|FG000|COMPLETED|Overall Study||9
9957357|NCT01450189|11076559|FG001|COMPLETED|Overall Study||18
10019639|NCT01831089|11142772|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0
10019640|NCT01831089|11142773|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0
10246936|NCT01447628|11378880|FG000|STARTED|Week 12 to Week 24 (2nd Intervention)||19
10246937|NCT01447628|11378881|FG001|STARTED|Week 12 to Week 24 (2nd Intervention)||20
10246938|NCT01447628|11378882|FG002|STARTED|Week 12 to Week 24 (2nd Intervention)||12
10246939|NCT01447628|11378883|FG003|STARTED|Week 12 to Week 24 (2nd Intervention)||4
10246940|NCT01447628|11378880|FG000|COMPLETED|Week 12 to Week 24 (2nd Intervention)||19
10246941|NCT01447628|11378881|FG001|COMPLETED|Week 12 to Week 24 (2nd Intervention)||20
10246942|NCT01447628|11378882|FG002|COMPLETED|Week 12 to Week 24 (2nd Intervention)||12
10246943|NCT01447628|11378883|FG003|COMPLETED|Week 12 to Week 24 (2nd Intervention)||4
10246944|NCT01447628|11378880|FG000|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10246945|NCT01447628|11378881|FG001|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10246946|NCT01447628|11378882|FG002|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10246947|NCT01447628|11378883|FG003|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10246948|NCT01175356|11378903|FG000|STARTED|Overall Study||99
10246949|NCT01175356|11378903|FG000|COMPLETED|Overall Study||18
10246950|NCT01175356|11378903|FG000|NOT COMPLETED|Overall Study||81
10246951|NCT00515853|11378909|FG000|STARTED|Overall Study||61
10246952|NCT00515853|11378910|FG001|STARTED|Overall Study||60
10246953|NCT00515853|11378909|FG000|COMPLETED|Overall Study||46
10246954|NCT00515853|11378910|FG001|COMPLETED|Overall Study||43
10246955|NCT00515853|11378909|FG000|NOT COMPLETED|Overall Study||15
10246956|NCT00515853|11378910|FG001|NOT COMPLETED|Overall Study||17
10246957|NCT00003458|11378916|FG000|STARTED|Overall Study||34
10246958|NCT00003458|11378916|FG000|COMPLETED|Overall Study||30
10246959|NCT00003458|11378916|FG000|NOT COMPLETED|Overall Study||4
9833260|NCT00778310|10944154|FG001|COMPLETED|Overall Study||26
9833261|NCT00778310|10944153|FG000|NOT COMPLETED|Overall Study||0
9833262|NCT00778310|10944154|FG001|NOT COMPLETED|Overall Study||0
9833263|NCT00778336|10944166|FG000|STARTED|Index Procedure-Discharge||198
9833264|NCT00778336|10944167|FG001|STARTED|Index Procedure-Discharge||170
9833265|NCT00778336|10944168|FG002|STARTED|Index Procedure-Discharge||72
9833266|NCT00778336|10944169|FG003|STARTED|Index Procedure-Discharge||12
9833267|NCT00778336|10944166|FG000|COMPLETED|Index Procedure-Discharge||192
9833268|NCT00778336|10944167|FG001|COMPLETED|Index Procedure-Discharge||167
10246960|NCT04871815|11378921|FG000|STARTED|Baseline Day 1-7||22
10246961|NCT04871815|11378921|FG000|COMPLETED|Baseline Day 1-7||22
10246962|NCT04871815|11378921|FG000|NOT COMPLETED|Baseline Day 1-7||0
10246963|NCT04871815|11378921|FG000|STARTED|N115 Treatment Day 8-14||22
10246964|NCT04871815|11378921|FG000|COMPLETED|N115 Treatment Day 8-14||22
10246965|NCT04871815|11378921|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0
10246966|NCT04772560|11378933|FG000|STARTED|Overall Study||11
10246967|NCT04772560|11378934|FG001|STARTED|Overall Study||12
10246968|NCT04772560|11378933|FG000|COMPLETED|Overall Study||11
10246969|NCT04772560|11378934|FG001|COMPLETED|Overall Study||12
10246970|NCT04772560|11378933|FG000|NOT COMPLETED|Overall Study||0
10246971|NCT04772560|11378934|FG001|NOT COMPLETED|Overall Study||0
10246972|NCT04613739|11378941|FG000|STARTED|Overall Study||19
10246973|NCT04613739|11378942|FG001|STARTED|Overall Study||37
10246974|NCT04613739|11378941|FG000|COMPLETED|Overall Study||12
10246975|NCT04613739|11378942|FG001|COMPLETED|Overall Study||25
10246976|NCT04613739|11378941|FG000|NOT COMPLETED|Overall Study||7
10246977|NCT04613739|11378942|FG001|NOT COMPLETED|Overall Study||12
10246984|NCT04432272|11378959|FG000|STARTED|Overall Study||43
10246985|NCT04432272|11378960|FG001|STARTED|Overall Study||28
10246986|NCT04432272|11378959|FG000|COMPLETED|Overall Study||43
10019641|NCT01831089|11142774|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0
10019642|NCT01831089|11142775|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37
10019643|NCT01831089|11142776|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0
10019644|NCT01831089|11142771|FG000|STARTED|Cohort B: Arm B||0
10019645|NCT01831089|11142772|FG001|STARTED|Cohort B: Arm B||0
10019646|NCT01831089|11142773|FG002|STARTED|Cohort B: Arm B||0
10019647|NCT01831089|11142774|FG003|STARTED|Cohort B: Arm B||0
10019648|NCT01831089|11142775|FG004|STARTED|Cohort B: Arm B||0
10019649|NCT01831089|11142776|FG005|STARTED|Cohort B: Arm B||14
10019650|NCT01831089|11142771|FG000|COMPLETED|Cohort B: Arm B||0
10019651|NCT01831089|11142772|FG001|COMPLETED|Cohort B: Arm B||0
10019652|NCT01831089|11142773|FG002|COMPLETED|Cohort B: Arm B||0
10019653|NCT01831089|11142774|FG003|COMPLETED|Cohort B: Arm B||0
10019654|NCT01831089|11142775|FG004|COMPLETED|Cohort B: Arm B||0
10019655|NCT01831089|11142776|FG005|COMPLETED|Cohort B: Arm B||0
10019656|NCT01831089|11142771|FG000|NOT COMPLETED|Cohort B: Arm B||0
10019657|NCT01831089|11142772|FG001|NOT COMPLETED|Cohort B: Arm B||0
10019658|NCT01831089|11142773|FG002|NOT COMPLETED|Cohort B: Arm B||0
10019659|NCT01831089|11142774|FG003|NOT COMPLETED|Cohort B: Arm B||0
10019660|NCT01831089|11142775|FG004|NOT COMPLETED|Cohort B: Arm B||0
10019661|NCT01831089|11142776|FG005|NOT COMPLETED|Cohort B: Arm B||14
10019662|NCT01831154|11142794|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
10019663|NCT01831154|11142795|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
10019664|NCT01831154|11142796|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
10246987|NCT04432272|11378960|FG001|COMPLETED|Overall Study||28
10246988|NCT04432272|11378959|FG000|NOT COMPLETED|Overall Study||0
10246989|NCT04432272|11378960|FG001|NOT COMPLETED|Overall Study||0
10246990|NCT04407806|11378969|FG000|STARTED|Overall Study||3
10246991|NCT04407806|11378970|FG001|STARTED|Overall Study||3
10246992|NCT04407806|11378969|FG000|COMPLETED|Overall Study||2
10246993|NCT04407806|11378970|FG001|COMPLETED|Overall Study||1
10246994|NCT04407806|11378969|FG000|NOT COMPLETED|Overall Study||1
10246995|NCT04407806|11378970|FG001|NOT COMPLETED|Overall Study||2
10246996|NCT04324021|11378979|FG000|STARTED|Overall Study||5
10246997|NCT04324021|11378980|FG001|STARTED|Overall Study||5
10246998|NCT04324021|11378981|FG002|STARTED|Overall Study||6
10246999|NCT04324021|11378979|FG000|COMPLETED|Overall Study||3
10247000|NCT04324021|11378980|FG001|COMPLETED|Overall Study||4
10247001|NCT04324021|11378981|FG002|COMPLETED|Overall Study||5
10247002|NCT04324021|11378979|FG000|NOT COMPLETED|Overall Study||2
10247003|NCT04324021|11378980|FG001|NOT COMPLETED|Overall Study||1
10247004|NCT04324021|11378981|FG002|NOT COMPLETED|Overall Study||1
10247005|NCT04209621|11378992|FG000|STARTED|Overall Study||3
10247006|NCT04209621|11378992|FG000|Dose Level 1|Overall Study||3
10247007|NCT04209621|11378992|FG000|COMPLETED|Overall Study||0
10247008|NCT04209621|11378992|FG000|NOT COMPLETED|Overall Study||3
10247009|NCT04186663|11378997|FG000|STARTED|Overall Study||59
10247010|NCT04186663|11378997|FG000|COMPLETED|Overall Study||55
10247011|NCT04186663|11378997|FG000|NOT COMPLETED|Overall Study||4
10247012|NCT04158219|11379001|FG000|STARTED|Overall Study||8
10247013|NCT04158219|11379001|FG000|COMPLETED|Overall Study||7
10247014|NCT04158219|11379001|FG000|NOT COMPLETED|Overall Study||1
10247015|NCT04131959|11379005|FG000|STARTED|Overall Study||5
10247016|NCT04131959|11379005|FG000|COMPLETED|Overall Study||5
10247017|NCT04131959|11379005|FG000|NOT COMPLETED|Overall Study||0
10247018|NCT04084990|11379012|FG000|STARTED|Overall Study||2
10019665|NCT01831154|11142794|FG000|COMPLETED|Overall Study||15
10019666|NCT01831154|11142795|FG001|COMPLETED|Overall Study||11
10019667|NCT01831154|11142796|FG002|COMPLETED|Overall Study||11
10019668|NCT01831154|11142794|FG000|NOT COMPLETED|Overall Study||0
10247019|NCT04084990|11379013|FG001|STARTED|Overall Study||1
10247020|NCT04084990|11379012|FG000|COMPLETED|Overall Study||2
10247021|NCT04084990|11379013|FG001|COMPLETED|Overall Study||1
10247022|NCT04084990|11379012|FG000|NOT COMPLETED|Overall Study||0
10247023|NCT04084990|11379013|FG001|NOT COMPLETED|Overall Study||0
10247024|NCT04056299|11379021|FG000|STARTED|Overall Study||9
10247025|NCT04056299|11379022|FG001|STARTED|Overall Study||6
10247026|NCT04056299|11379021|FG000|COMPLETED|Overall Study||6
10247027|NCT04056299|11379022|FG001|COMPLETED|Overall Study||3
10246978|NCT04573972|11378950|FG000|STARTED|Overall Study||88
10246979|NCT04573972|11378951|FG001|STARTED|Overall Study||84
10246980|NCT04573972|11378950|FG000|COMPLETED|Overall Study||56
10246981|NCT04573972|11378951|FG001|COMPLETED|Overall Study||70
10246982|NCT04573972|11378950|FG000|NOT COMPLETED|Overall Study||32
10246983|NCT04573972|11378951|FG001|NOT COMPLETED|Overall Study||14
10247028|NCT04056299|11379021|FG000|NOT COMPLETED|Overall Study||3
10019669|NCT01831154|11142795|FG001|NOT COMPLETED|Overall Study||0
10019670|NCT01831154|11142796|FG002|NOT COMPLETED|Overall Study||0
10019671|NCT01831219|11142806|FG000|STARTED|Overall Study||73
10019672|NCT01831219|11142807|FG001|STARTED|Overall Study||45
10019673|NCT01831219|11142806|FG000|COMPLETED|Overall Study||40
10019674|NCT01831219|11142807|FG001|COMPLETED|Overall Study||21
10019675|NCT01831219|11142806|FG000|NOT COMPLETED|Overall Study||33
10019676|NCT01831219|11142807|FG001|NOT COMPLETED|Overall Study||24
10019677|NCT01831232|11142813|FG000|STARTED|Overall Study||24
10247029|NCT04056299|11379022|FG001|NOT COMPLETED|Overall Study||3
10019678|NCT01831232|11142813|FG000|COMPLETED|Overall Study||24
10019679|NCT01831232|11142813|FG000|NOT COMPLETED|Overall Study||0
10019680|NCT01831258|11142817|FG000|STARTED|Overall Study||35
10019681|NCT01831258|11142818|FG001|STARTED|Overall Study||35
10019682|NCT01831258|11142817|FG000|COMPLETED|Overall Study||30
10019683|NCT01831258|11142818|FG001|COMPLETED|Overall Study||32
10019684|NCT01831258|11142817|FG000|NOT COMPLETED|Overall Study||5
10247030|NCT04020718|11379030|FG000|STARTED|Pre-assessment and Adaptation||16
10247031|NCT04020718|11379031|FG001|STARTED|Pre-assessment and Adaptation||19
10247032|NCT04020718|11379032|FG002|STARTED|Pre-assessment and Adaptation||0
10247033|NCT04020718|11379033|FG003|STARTED|Pre-assessment and Adaptation||0
10247034|NCT04020718|11379034|FG004|STARTED|Pre-assessment and Adaptation||0
10247035|NCT04020718|11379035|FG005|STARTED|Pre-assessment and Adaptation||0
10247036|NCT04020718|11379036|FG006|STARTED|Pre-assessment and Adaptation||0
10247037|NCT04020718|11379037|FG007|STARTED|Pre-assessment and Adaptation||0
10247038|NCT04020718|11379030|FG000|COMPLETED|Pre-assessment and Adaptation||16
10247039|NCT04020718|11379031|FG001|COMPLETED|Pre-assessment and Adaptation||15
10247040|NCT04020718|11379032|FG002|COMPLETED|Pre-assessment and Adaptation||0
10247041|NCT04020718|11379033|FG003|COMPLETED|Pre-assessment and Adaptation||0
10247042|NCT04020718|11379034|FG004|COMPLETED|Pre-assessment and Adaptation||0
10247043|NCT04020718|11379035|FG005|COMPLETED|Pre-assessment and Adaptation||0
10247044|NCT04020718|11379036|FG006|COMPLETED|Pre-assessment and Adaptation||0
10247045|NCT04020718|11379037|FG007|COMPLETED|Pre-assessment and Adaptation||0
10247046|NCT04020718|11379030|FG000|NOT COMPLETED|Pre-assessment and Adaptation||0
10247047|NCT04020718|11379031|FG001|NOT COMPLETED|Pre-assessment and Adaptation||4
10247048|NCT04020718|11379032|FG002|NOT COMPLETED|Pre-assessment and Adaptation||0
10247049|NCT04020718|11379033|FG003|NOT COMPLETED|Pre-assessment and Adaptation||0
10247050|NCT04020718|11379034|FG004|NOT COMPLETED|Pre-assessment and Adaptation||0
10247051|NCT04020718|11379035|FG005|NOT COMPLETED|Pre-assessment and Adaptation||0
10247052|NCT04020718|11379036|FG006|NOT COMPLETED|Pre-assessment and Adaptation||0
10247053|NCT04020718|11379037|FG007|NOT COMPLETED|Pre-assessment and Adaptation||0
10247054|NCT04020718|11379030|FG000|STARTED|Post-assessment and Adaptation||0
10247055|NCT04020718|11379031|FG001|STARTED|Post-assessment and Adaptation||0
10247056|NCT04020718|11379032|FG002|STARTED|Post-assessment and Adaptation||8
10247057|NCT04020718|11379033|FG003|STARTED|Post-assessment and Adaptation||6
10247058|NCT04020718|11379034|FG004|STARTED|Post-assessment and Adaptation||8
10247059|NCT04020718|11379035|FG005|STARTED|Post-assessment and Adaptation||7
10247060|NCT04020718|11379036|FG006|STARTED|Post-assessment and Adaptation||2
10247061|NCT04020718|11379037|FG007|STARTED|Post-assessment and Adaptation||0
10247062|NCT04020718|11379030|FG000|COMPLETED|Post-assessment and Adaptation||0
10247063|NCT04020718|11379031|FG001|COMPLETED|Post-assessment and Adaptation||0
10247064|NCT04020718|11379032|FG002|COMPLETED|Post-assessment and Adaptation||8
10247065|NCT04020718|11379033|FG003|COMPLETED|Post-assessment and Adaptation||5
10247066|NCT04020718|11379034|FG004|COMPLETED|Post-assessment and Adaptation||8
10247067|NCT04020718|11379035|FG005|COMPLETED|Post-assessment and Adaptation||7
10247068|NCT04020718|11379036|FG006|COMPLETED|Post-assessment and Adaptation||2
10247069|NCT04020718|11379037|FG007|COMPLETED|Post-assessment and Adaptation||0
10247070|NCT04020718|11379030|FG000|NOT COMPLETED|Post-assessment and Adaptation||0
10247071|NCT04020718|11379031|FG001|NOT COMPLETED|Post-assessment and Adaptation||0
10247072|NCT04020718|11379032|FG002|NOT COMPLETED|Post-assessment and Adaptation||0
10247073|NCT04020718|11379033|FG003|NOT COMPLETED|Post-assessment and Adaptation||1
10247074|NCT04020718|11379034|FG004|NOT COMPLETED|Post-assessment and Adaptation||0
10247075|NCT04020718|11379035|FG005|NOT COMPLETED|Post-assessment and Adaptation||0
10247076|NCT04020718|11379036|FG006|NOT COMPLETED|Post-assessment and Adaptation||0
10247077|NCT04020718|11379037|FG007|NOT COMPLETED|Post-assessment and Adaptation||0
10247078|NCT03970109|11379058|FG000|STARTED|Overall Study||15
10247079|NCT03970109|11379059|FG001|STARTED|Overall Study||13
10247080|NCT03970109|11379060|FG002|STARTED|Overall Study||15
10247081|NCT03970109|11379058|FG000|COMPLETED|Overall Study||14
10247082|NCT03970109|11379059|FG001|COMPLETED|Overall Study||10
10247083|NCT03970109|11379060|FG002|COMPLETED|Overall Study||15
10247084|NCT03970109|11379058|FG000|NOT COMPLETED|Overall Study||1
10247085|NCT03970109|11379059|FG001|NOT COMPLETED|Overall Study||3
10247086|NCT03970109|11379060|FG002|NOT COMPLETED|Overall Study||0
10247087|NCT03954743|11379070|FG000|STARTED|Overall Study||677
10247088|NCT03954743|11379071|FG001|STARTED|Overall Study||674
10247089|NCT03954743|11379070|FG000|COMPLETED|Overall Study||653
10247090|NCT03954743|11379071|FG001|COMPLETED|Overall Study||657
10247091|NCT03954743|11379070|FG000|NOT COMPLETED|Overall Study||24
10247092|NCT03954743|11379071|FG001|NOT COMPLETED|Overall Study||17
10247093|NCT03880565|11379079|FG000|STARTED|Overall Study||15
10247094|NCT03880565|11379080|FG001|STARTED|Overall Study||15
10247095|NCT03880565|11379079|FG000|COMPLETED|Overall Study||14
10247096|NCT03880565|11379080|FG001|COMPLETED|Overall Study||15
10247097|NCT03880565|11379079|FG000|NOT COMPLETED|Overall Study||1
10247098|NCT03880565|11379080|FG001|NOT COMPLETED|Overall Study||0
10247099|NCT03833661|11379086|FG000|STARTED|Overall Study||159
9833269|NCT00778336|10944168|FG002|COMPLETED|Index Procedure-Discharge||70
9833270|NCT00778336|10944169|FG003|COMPLETED|Index Procedure-Discharge||12
10247100|NCT03833661|11379086|FG000|COMPLETED|Overall Study||150
10247101|NCT03833661|11379086|FG000|NOT COMPLETED|Overall Study||9
10247102|NCT03809663|11379094|FG000|STARTED|Overall Study||63
10247103|NCT03809663|11379095|FG001|STARTED|Overall Study||62
10247104|NCT03809663|11379096|FG002|STARTED|Overall Study||63
10247105|NCT03809663|11379097|FG003|STARTED|Overall Study||63
10247106|NCT03809663|11379098|FG004|STARTED|Overall Study||0
10247107|NCT03809663|11379099|FG005|STARTED|Overall Study||0
10247108|NCT03809663|11379094|FG000|Participants Who Received Investigational Product|Overall Study||63
10247109|NCT03809663|11379095|FG001|Participants Who Received Investigational Product|Overall Study||61
10247110|NCT03809663|11379096|FG002|Participants Who Received Investigational Product|Overall Study||63
10247111|NCT03809663|11379097|FG003|Participants Who Received Investigational Product|Overall Study||63
10247112|NCT03809663|11379098|FG004|Participants Who Received Investigational Product|Overall Study||0
10247113|NCT03809663|11379099|FG005|Participants Who Received Investigational Product|Overall Study||0
10247114|NCT03809663|11379094|FG000|EASI 50 Non-responder at Week 16|Overall Study||40
10247115|NCT03809663|11379095|FG001|EASI 50 Non-responder at Week 16|Overall Study||26
10247116|NCT03809663|11379096|FG002|EASI 50 Non-responder at Week 16|Overall Study||30
10247117|NCT03809663|11379097|FG003|EASI 50 Non-responder at Week 16|Overall Study||38
10247118|NCT03809663|11379098|FG004|EASI 50 Non-responder at Week 16|Overall Study||0
10247119|NCT03809663|11379099|FG005|EASI 50 Non-responder at Week 16|Overall Study||0
10247120|NCT03809663|11379094|FG000|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||39
10247121|NCT03809663|11379095|FG001|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||24
10247122|NCT03809663|11379096|FG002|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||30
10247123|NCT03809663|11379097|FG003|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||38
10247124|NCT03809663|11379098|FG004|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
10247125|NCT03809663|11379099|FG005|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
10247126|NCT03809663|11379094|FG000|COMPLETED|Overall Study||12
10247127|NCT03809663|11379095|FG001|COMPLETED|Overall Study||18
10247128|NCT03809663|11379096|FG002|COMPLETED|Overall Study||15
10247129|NCT03809663|11379097|FG003|COMPLETED|Overall Study||16
10247130|NCT03809663|11379098|FG004|COMPLETED|Overall Study||0
10247131|NCT03809663|11379099|FG005|COMPLETED|Overall Study||0
10247132|NCT03809663|11379094|FG000|NOT COMPLETED|Overall Study||51
10247133|NCT03809663|11379095|FG001|NOT COMPLETED|Overall Study||44
10247134|NCT03809663|11379096|FG002|NOT COMPLETED|Overall Study||48
10247135|NCT03809663|11379097|FG003|NOT COMPLETED|Overall Study||47
10247136|NCT03809663|11379098|FG004|NOT COMPLETED|Overall Study||0
10247137|NCT03809663|11379099|FG005|NOT COMPLETED|Overall Study||0
10247138|NCT03782792|11379126|FG000|STARTED|Overall Study||18
10247139|NCT03782792|11379127|FG001|STARTED|Overall Study||35
10247140|NCT03782792|11379126|FG000|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||15
10247141|NCT03782792|11379127|FG001|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||12
10247142|NCT03782792|11379126|FG000|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||2
10247143|NCT03782792|11379127|FG001|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||4
10247144|NCT03782792|11379126|FG000|COMPLETED|Overall Study||17
10247145|NCT03782792|11379127|FG001|COMPLETED|Overall Study||32
10247146|NCT03782792|11379126|FG000|NOT COMPLETED|Overall Study||1
10247147|NCT03782792|11379127|FG001|NOT COMPLETED|Overall Study||3
10247148|NCT03750461|11379137|FG000|STARTED|Overall Study||20
10247149|NCT03750461|11379138|FG001|STARTED|Overall Study||92
10247150|NCT03750461|11379137|FG000|Primary Endpoint|Overall Study||20
10247151|NCT03750461|11379138|FG001|Primary Endpoint|Overall Study|Considered study completion for the Historical Controls.|92
10247152|NCT03750461|11379137|FG000|Secondary Endpoint|Overall Study||19
10247153|NCT03750461|11379138|FG001|Secondary Endpoint|Overall Study|Not applicable for the historical controls.|0
10247154|NCT03750461|11379137|FG000|COMPLETED|Overall Study||19
10247155|NCT03750461|11379138|FG001|COMPLETED|Overall Study|Not applicable for the historical controls; no follow-up data was collected.|0
10247156|NCT03750461|11379137|FG000|NOT COMPLETED|Overall Study||1
10247157|NCT03750461|11379138|FG001|NOT COMPLETED|Overall Study||92
10247158|NCT03733119|11379146|FG000|STARTED|Overall Study||2
10247159|NCT03733119|11379147|FG001|STARTED|Overall Study||2
10247160|NCT03733119|11379146|FG000|Treated|Overall Study||2
10247161|NCT03733119|11379147|FG001|Treated|Overall Study||1
10247162|NCT03733119|11379146|FG000|Stopped Treatment After 1 Dose|Overall Study||1
10247163|NCT03733119|11379147|FG001|Stopped Treatment After 1 Dose|Overall Study||0
10247164|NCT03733119|11379146|FG000|Stopped Treatment After 3 Cycles|Overall Study||1
10247165|NCT03733119|11379147|FG001|Stopped Treatment After 3 Cycles|Overall Study||1
10247166|NCT03733119|11379146|FG000|COMPLETED|Overall Study||0
10247167|NCT03733119|11379147|FG001|COMPLETED|Overall Study||0
10247168|NCT03733119|11379146|FG000|NOT COMPLETED|Overall Study||2
10247169|NCT03733119|11379147|FG001|NOT COMPLETED|Overall Study||2
10247170|NCT03661996|11379158|FG000|STARTED|Overall Study||162
10247171|NCT03661996|11379159|FG001|STARTED|Overall Study||180
10247172|NCT03661996|11379160|FG002|STARTED|Overall Study||176
10247173|NCT03661996|11379161|FG003|STARTED|Overall Study||163
10247174|NCT03661996|11379162|FG004|STARTED|Overall Study||173
10247175|NCT03661996|11379158|FG000|Treated|Overall Study||162
10247176|NCT03661996|11379159|FG001|Treated|Overall Study||179
10247177|NCT03661996|11379160|FG002|Treated|Overall Study||175
10247178|NCT03661996|11379161|FG003|Treated|Overall Study||160
10247179|NCT03661996|11379162|FG004|Treated|Overall Study||172
10247180|NCT03661996|11379158|FG000|COMPLETED|Overall Study||150
10247181|NCT03661996|11379159|FG001|COMPLETED|Overall Study||172
10247182|NCT03661996|11379160|FG002|COMPLETED|Overall Study||170
10247183|NCT03661996|11379161|FG003|COMPLETED|Overall Study||150
10247184|NCT03661996|11379162|FG004|COMPLETED|Overall Study||159
10247185|NCT03661996|11379158|FG000|NOT COMPLETED|Overall Study||12
10247186|NCT03661996|11379159|FG001|NOT COMPLETED|Overall Study||8
10247187|NCT03661996|11379160|FG002|NOT COMPLETED|Overall Study||6
10247188|NCT03661996|11379161|FG003|NOT COMPLETED|Overall Study||13
10247189|NCT03661996|11379162|FG004|NOT COMPLETED|Overall Study||14
10247190|NCT03633461|11379179|FG000|STARTED|Overall Study||34
10247191|NCT03633461|11379180|FG001|STARTED|Overall Study||19
10247192|NCT03633461|11379179|FG000|COMPLETED|Overall Study||34
10247193|NCT03633461|11379180|FG001|COMPLETED|Overall Study||18
10247194|NCT03633461|11379179|FG000|NOT COMPLETED|Overall Study||0
10247195|NCT03633461|11379180|FG001|NOT COMPLETED|Overall Study||1
10247196|NCT03622658|11379188|FG000|STARTED|Overall Study||6
10247197|NCT03622658|11379189|FG001|STARTED|Overall Study||36
10247198|NCT03622658|11379188|FG000|COMPLETED|Overall Study||3
10247199|NCT03622658|11379189|FG001|COMPLETED|Overall Study||32
10247200|NCT03622658|11379188|FG000|NOT COMPLETED|Overall Study||3
10247201|NCT03622658|11379189|FG001|NOT COMPLETED|Overall Study||4
9833271|NCT00778336|10944166|FG000|NOT COMPLETED|Index Procedure-Discharge||6
9833272|NCT00778336|10944167|FG001|NOT COMPLETED|Index Procedure-Discharge||3
9833273|NCT00778336|10944168|FG002|NOT COMPLETED|Index Procedure-Discharge||2
9833274|NCT00778336|10944169|FG003|NOT COMPLETED|Index Procedure-Discharge||0
9833275|NCT00778336|10944166|FG000|STARTED|3 Month Follow Up||192
9833276|NCT00778336|10944167|FG001|STARTED|3 Month Follow Up||167
9833277|NCT00778336|10944168|FG002|STARTED|3 Month Follow Up||70
9833278|NCT00778336|10944169|FG003|STARTED|3 Month Follow Up||12
9833279|NCT00778336|10944166|FG000|COMPLETED|3 Month Follow Up||169
9833280|NCT00778336|10944167|FG001|COMPLETED|3 Month Follow Up||144
9833281|NCT00778336|10944168|FG002|COMPLETED|3 Month Follow Up||65
9833282|NCT00778336|10944169|FG003|COMPLETED|3 Month Follow Up||12
9833283|NCT00778336|10944166|FG000|NOT COMPLETED|3 Month Follow Up||23
9833284|NCT00778336|10944167|FG001|NOT COMPLETED|3 Month Follow Up||23
9833285|NCT00778336|10944168|FG002|NOT COMPLETED|3 Month Follow Up||5
9833286|NCT00778336|10944169|FG003|NOT COMPLETED|3 Month Follow Up||0
9833287|NCT00778375|10944179|FG000|STARTED|Overall Study||122
9833288|NCT00778375|10944179|FG000|COMPLETED|Overall Study||119
9833289|NCT00778375|10944179|FG000|NOT COMPLETED|Overall Study||3
9833290|NCT00778622|10944188|FG000|STARTED|Overall Study||125
9833291|NCT00778622|10944189|FG001|STARTED|Overall Study||122
9833292|NCT00778622|10944190|FG002|STARTED|Overall Study||124
9833293|NCT00778622|10944188|FG000|COMPLETED|Overall Study||109
9833294|NCT00778622|10944189|FG001|COMPLETED|Overall Study||107
9833295|NCT00778622|10944190|FG002|COMPLETED|Overall Study||109
9833296|NCT00778622|10944188|FG000|NOT COMPLETED|Overall Study||16
9833297|NCT00778622|10944189|FG001|NOT COMPLETED|Overall Study||15
9833298|NCT00778622|10944190|FG002|NOT COMPLETED|Overall Study||15
9957358|NCT01450189|11076560|FG002|COMPLETED|Overall Study||19
9957359|NCT01450189|11076558|FG000|NOT COMPLETED|Overall Study||0
9957360|NCT01450189|11076559|FG001|NOT COMPLETED|Overall Study||0
9957361|NCT01450189|11076560|FG002|NOT COMPLETED|Overall Study||0
9957362|NCT01450306|11076577|FG000|STARTED|Overall Study||10
9833299|NCT00778648|10944204|FG000|STARTED|Overall Study||272
9833300|NCT00778648|10944205|FG001|STARTED|Overall Study||271
9833301|NCT00778648|10944204|FG000|COMPLETED|Overall Study||263
9833302|NCT00778648|10944205|FG001|COMPLETED|Overall Study||266
9957363|NCT01450306|11076578|FG001|STARTED|Overall Study||10
9957364|NCT01450306|11076577|FG000|COMPLETED|Overall Study||10
9957365|NCT01450306|11076578|FG001|COMPLETED|Overall Study||10
10247202|NCT03600142|11379197|FG000|STARTED|Overall Study||777
10247203|NCT03600142|11379198|FG001|STARTED|Overall Study||762
10247204|NCT03600142|11379197|FG000|COMPLETED|Overall Study||773
10247205|NCT03600142|11379198|FG001|COMPLETED|Overall Study||758
10247206|NCT03600142|11379197|FG000|NOT COMPLETED|Overall Study||4
10247207|NCT03600142|11379198|FG001|NOT COMPLETED|Overall Study||4
9833303|NCT00778648|10944204|FG000|NOT COMPLETED|Overall Study||9
9833304|NCT00778648|10944205|FG001|NOT COMPLETED|Overall Study||5
9833305|NCT00778817|10944211|FG000|STARTED|Overall Study||20
9833306|NCT00778817|10944211|FG000|COMPLETED|Overall Study||16
9833307|NCT00778817|10944211|FG000|NOT COMPLETED|Overall Study||4
9833308|NCT00778830|10944217|FG000|STARTED|Overall Study||101
9833309|NCT00778830|10944218|FG001|STARTED|Overall Study||188
9833310|NCT00778830|10944217|FG000|COMPLETED|Overall Study||101
9833311|NCT00778830|10944218|FG001|COMPLETED|Overall Study||187
9833312|NCT00778830|10944217|FG000|NOT COMPLETED|Overall Study||0
9833313|NCT00778830|10944218|FG001|NOT COMPLETED|Overall Study||1
9833314|NCT00778869|10944224|FG000|STARTED|Overall Study||10
9833315|NCT00778869|10944224|FG000|COMPLETED|Overall Study||10
9833316|NCT00778869|10944224|FG000|NOT COMPLETED|Overall Study||0
9833317|NCT00778895|10944231|FG000|STARTED|Active Phase||164
9833318|NCT00778895|10944232|FG001|STARTED|Active Phase||167
9833319|NCT00778895|10944233|FG002|STARTED|Active Phase||43
9833320|NCT00778895|10944231|FG000|COMPLETED|Active Phase||157
9833321|NCT00778895|10944232|FG001|COMPLETED|Active Phase||161
9833322|NCT00778895|10944233|FG002|COMPLETED|Active Phase||43
9833323|NCT00778895|10944231|FG000|NOT COMPLETED|Active Phase||7
9833324|NCT00778895|10944232|FG001|NOT COMPLETED|Active Phase||6
9833325|NCT00778895|10944233|FG002|NOT COMPLETED|Active Phase||0
9833326|NCT00778895|10944231|FG000|STARTED|ESFU Phase||164
9833327|NCT00778895|10944232|FG001|STARTED|ESFU Phase||167
9833328|NCT00778895|10944233|FG002|STARTED|ESFU Phase||43
10247208|NCT03517722|11379208|FG000|STARTED|Double Blind Period: Week 0-52||208
10247209|NCT03517722|11379209|FG001|STARTED|Double Blind Period: Week 0-52||308
10247210|NCT03517722|11379208|FG000|Treated|Double Blind Period: Week 0-52||208
10247211|NCT03517722|11379209|FG001|Treated|Double Blind Period: Week 0-52||307
10247212|NCT03517722|11379208|FG000|COMPLETED|Double Blind Period: Week 0-52||105
10247213|NCT03517722|11379209|FG001|COMPLETED|Double Blind Period: Week 0-52||153
10247214|NCT03517722|11379208|FG000|NOT COMPLETED|Double Blind Period: Week 0-52||103
10247215|NCT03517722|11379209|FG001|NOT COMPLETED|Double Blind Period: Week 0-52||155
10247216|NCT03517722|11379208|FG000|STARTED|Open-label Extension Period: Week 52-113||88
10247217|NCT03517722|11379209|FG001|STARTED|Open-label Extension Period: Week 52-113||137
10247218|NCT03517722|11379208|FG000|COMPLETED|Open-label Extension Period: Week 52-113||0
10247219|NCT03517722|11379209|FG001|COMPLETED|Open-label Extension Period: Week 52-113||0
10247220|NCT03517722|11379208|FG000|NOT COMPLETED|Open-label Extension Period: Week 52-113||88
10247221|NCT03517722|11379209|FG001|NOT COMPLETED|Open-label Extension Period: Week 52-113||137
10247222|NCT03499314|11379218|FG000|STARTED|Overall Study||33
10247223|NCT03499314|11379219|FG001|STARTED|Overall Study||32
10247224|NCT03499314|11379218|FG000|COMPLETED|Overall Study||31
10247225|NCT03499314|11379219|FG001|COMPLETED|Overall Study||29
10247226|NCT03499314|11379218|FG000|NOT COMPLETED|Overall Study||2
10247227|NCT03499314|11379219|FG001|NOT COMPLETED|Overall Study||3
10247228|NCT03439124|11379227|FG000|STARTED|Overall Study||94
10247229|NCT03439124|11379228|FG001|STARTED|Overall Study||44
10247230|NCT03439124|11379227|FG000|COMPLETED|Overall Study||90
10247231|NCT03439124|11379228|FG001|COMPLETED|Overall Study||44
10247232|NCT03439124|11379227|FG000|NOT COMPLETED|Overall Study||4
10247233|NCT03439124|11379228|FG001|NOT COMPLETED|Overall Study||0
10247234|NCT03369431|11379236|FG000|STARTED|Overall Study||35
10247235|NCT03369431|11379237|FG001|STARTED|Overall Study||34
10247236|NCT03369431|11379236|FG000|Taste Test (1 Week)|Overall Study||35
10247237|NCT03369431|11379237|FG001|Taste Test (1 Week)|Overall Study||34
10247238|NCT03369431|11379236|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34
10247239|NCT03369431|11379237|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34
10247240|NCT03369431|11379236|FG000|Washout (4 Weeks)|Overall Study||34
10247241|NCT03369431|11379237|FG001|Washout (4 Weeks)|Overall Study||32
10247242|NCT03369431|11379236|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34
10247243|NCT03369431|11379237|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32
10247244|NCT03369431|11379236|FG000|COMPLETED|Overall Study||31
10247245|NCT03369431|11379237|FG001|COMPLETED|Overall Study||27
10247246|NCT03369431|11379236|FG000|NOT COMPLETED|Overall Study||4
10247247|NCT03369431|11379237|FG001|NOT COMPLETED|Overall Study||7
10247248|NCT03343054|11379246|FG000|STARTED|Dose Escalation Period (Up to 286 Days)||3
10247249|NCT03343054|11379247|FG001|STARTED|Dose Escalation Period (Up to 286 Days)||6
10247250|NCT03343054|11379248|FG002|STARTED|Dose Escalation Period (Up to 286 Days)|Dose escalation and Dose expansion were separate populations.|0
10247251|NCT03343054|11379246|FG000|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10247252|NCT03343054|11379247|FG001|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10247253|NCT03343054|11379248|FG002|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10247254|NCT03343054|11379246|FG000|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||3
10247255|NCT03343054|11379247|FG001|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||6
10247256|NCT03343054|11379248|FG002|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10247257|NCT03343054|11379246|FG000|STARTED|Dose Expansion Period (Up to 502 Days)||0
10247258|NCT03343054|11379247|FG001|STARTED|Dose Expansion Period (Up to 502 Days)||0
10247259|NCT03343054|11379248|FG002|STARTED|Dose Expansion Period (Up to 502 Days)|Dose escalation and Dose expansion were separate populations.|19
10247260|NCT03343054|11379246|FG000|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10247261|NCT03343054|11379247|FG001|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10247262|NCT03343054|11379248|FG002|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10247263|NCT03343054|11379246|FG000|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10247264|NCT03343054|11379247|FG001|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10247265|NCT03343054|11379248|FG002|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||19
10247266|NCT03336866|11379260|FG000|STARTED|Overall Study||20
10247267|NCT03336866|11379261|FG001|STARTED|Overall Study||18
10247268|NCT03336866|11379262|FG002|STARTED|Overall Study||18
10247269|NCT03336866|11379260|FG000|COMPLETED|Overall Study||17
10247270|NCT03336866|11379261|FG001|COMPLETED|Overall Study||17
10247271|NCT03336866|11379262|FG002|COMPLETED|Overall Study||14
10247272|NCT03336866|11379260|FG000|NOT COMPLETED|Overall Study||3
10247273|NCT03336866|11379261|FG001|NOT COMPLETED|Overall Study||1
10247274|NCT03336866|11379262|FG002|NOT COMPLETED|Overall Study||4
10247275|NCT03332173|11379275|FG000|STARTED|Overall Study||44
10247276|NCT03332173|11379275|FG000|COMPLETED|Overall Study||0
10247277|NCT03332173|11379275|FG000|NOT COMPLETED|Overall Study||44
10247278|NCT03322293|11379282|FG000|STARTED|Overall Study||8
10247279|NCT03322293|11379283|FG001|STARTED|Overall Study||8
10247280|NCT03322293|11379284|FG002|STARTED|Overall Study||8
10247281|NCT03322293|11379282|FG000|COMPLETED|Overall Study||8
10247282|NCT03322293|11379283|FG001|COMPLETED|Overall Study||8
10247283|NCT03322293|11379284|FG002|COMPLETED|Overall Study||7
10247284|NCT03322293|11379282|FG000|NOT COMPLETED|Overall Study||0
10247285|NCT03322293|11379283|FG001|NOT COMPLETED|Overall Study||0
10247286|NCT03322293|11379284|FG002|NOT COMPLETED|Overall Study||1
10247287|NCT03315039|11379294|FG000|STARTED|Overall Study||4
10247288|NCT03315039|11379295|FG001|STARTED|Overall Study||3
10247289|NCT03315039|11379294|FG000|COMPLETED|Overall Study||4
10247290|NCT03315039|11379295|FG001|COMPLETED|Overall Study||3
10247291|NCT03315039|11379294|FG000|NOT COMPLETED|Overall Study||0
10247292|NCT03315039|11379295|FG001|NOT COMPLETED|Overall Study||0
10247293|NCT03254394|11379306|FG000|STARTED|Overall Study||12
10247294|NCT03254394|11379307|FG001|STARTED|Overall Study||14
10247295|NCT03254394|11379306|FG000|COMPLETED|Overall Study||12
10247296|NCT03254394|11379307|FG001|COMPLETED|Overall Study||12
10247297|NCT03254394|11379306|FG000|NOT COMPLETED|Overall Study||0
10247298|NCT03254394|11379307|FG001|NOT COMPLETED|Overall Study||2
10247299|NCT03253809|11379313|FG000|STARTED|Overall Study||14
10247300|NCT03253809|11379313|FG000|COMPLETED|Overall Study||0
10247301|NCT03253809|11379313|FG000|NOT COMPLETED|Overall Study||14
10247302|NCT03180294|11379320|FG000|STARTED|Overall Study||79
10247303|NCT03180294|11379321|FG001|STARTED|Overall Study||74
10247304|NCT03180294|11379322|FG002|STARTED|Overall Study||77
10247305|NCT03180294|11379320|FG000|Eligible Population|Overall Study||79
10247306|NCT03180294|11379321|FG001|Eligible Population|Overall Study||74
10247307|NCT03180294|11379322|FG002|Eligible Population|Overall Study||77
10247308|NCT03180294|11379320|FG000|Adverse Event Population|Overall Study||77
10247309|NCT03180294|11379321|FG001|Adverse Event Population|Overall Study||73
10247310|NCT03180294|11379322|FG002|Adverse Event Population|Overall Study||76
10247311|NCT03180294|11379320|FG000|COMPLETED|Overall Study||79
10247312|NCT03180294|11379321|FG001|COMPLETED|Overall Study||74
10247313|NCT03180294|11379322|FG002|COMPLETED|Overall Study||77
10247314|NCT03180294|11379320|FG000|NOT COMPLETED|Overall Study||0
10247315|NCT03180294|11379321|FG001|NOT COMPLETED|Overall Study||0
10247316|NCT03180294|11379322|FG002|NOT COMPLETED|Overall Study||0
10247317|NCT03151408|11379333|FG000|STARTED|Overall Study|Screened patients|203
10247318|NCT03151408|11379334|FG001|STARTED|Overall Study|Screened patients|203
10247319|NCT03151408|11379333|FG000|Treated|Overall Study||201
10247320|NCT03151408|11379334|FG001|Treated|Overall Study||201
10247321|NCT03151408|11379333|FG000|COMPLETED|Overall Study||0
10247322|NCT03151408|11379334|FG001|COMPLETED|Overall Study||0
10247323|NCT03151408|11379333|FG000|NOT COMPLETED|Overall Study||203
10247324|NCT03151408|11379334|FG001|NOT COMPLETED|Overall Study||203
10247325|NCT03137173|11379342|FG000|STARTED|Overall Study||335
10247326|NCT03137173|11379343|FG001|STARTED|Overall Study||344
10247327|NCT03137173|11379342|FG000|COMPLETED|Overall Study||309
10247328|NCT03137173|11379343|FG001|COMPLETED|Overall Study||308
10247329|NCT03137173|11379342|FG000|NOT COMPLETED|Overall Study||26
10247330|NCT03137173|11379343|FG001|NOT COMPLETED|Overall Study||36
10247331|NCT03111030|11379352|FG000|STARTED|Overall Study||14
10247332|NCT03111030|11379353|FG001|STARTED|Overall Study||14
10247333|NCT03111030|11379352|FG000|COMPLETED|Overall Study||14
10247334|NCT03111030|11379353|FG001|COMPLETED|Overall Study||14
10247335|NCT03111030|11379352|FG000|NOT COMPLETED|Overall Study||0
10247336|NCT03111030|11379353|FG001|NOT COMPLETED|Overall Study||0
10247337|NCT03081052|11379363|FG000|STARTED|Overall Study||98
10247338|NCT03081052|11379364|FG001|STARTED|Overall Study||103
10247339|NCT03081052|11379365|FG002|STARTED|Overall Study||111
10247340|NCT03081052|11379366|FG003|STARTED|Overall Study||120
10247341|NCT03081052|11379363|FG000|COMPLETED|Overall Study||98
10247342|NCT03081052|11379364|FG001|COMPLETED|Overall Study||103
10247343|NCT03081052|11379365|FG002|COMPLETED|Overall Study||111
10247344|NCT03081052|11379366|FG003|COMPLETED|Overall Study||120
10247345|NCT03081052|11379363|FG000|NOT COMPLETED|Overall Study||0
10247346|NCT03081052|11379364|FG001|NOT COMPLETED|Overall Study||0
10247347|NCT03081052|11379365|FG002|NOT COMPLETED|Overall Study||0
10247348|NCT03081052|11379366|FG003|NOT COMPLETED|Overall Study||0
10247349|NCT03028740|11379382|FG000|STARTED|Overall Study||593
10247350|NCT03028740|11379383|FG001|STARTED|Overall Study||1185
10247351|NCT03028740|11379382|FG000|Full Study Cohort: Received Study Drug|Overall Study||589
10247352|NCT03028740|11379383|FG001|Full Study Cohort: Received Study Drug|Overall Study||1180
10247353|NCT03028740|11379382|FG000|Participated in Part 1|Overall Study||432
10247354|NCT03028740|11379383|FG001|Participated in Part 1|Overall Study||861
10247355|NCT03028740|11379382|FG000|Part 1: Received Study Drug|Overall Study||429
10247356|NCT03028740|11379383|FG001|Part 1: Received Study Drug|Overall Study||859
10247357|NCT03028740|11379382|FG000|COMPLETED|Overall Study||0
10247358|NCT03028740|11379383|FG001|COMPLETED|Overall Study||0
10247359|NCT03028740|11379382|FG000|NOT COMPLETED|Overall Study||593
10247360|NCT03028740|11379383|FG001|NOT COMPLETED|Overall Study||1185
10247361|NCT03015142|11379392|FG000|STARTED|Overall Study||21
10247362|NCT03015142|11379392|FG000|COMPLETED|Overall Study||20
10247363|NCT03015142|11379392|FG000|NOT COMPLETED|Overall Study||1
10247364|NCT03012672|11379400|FG000|STARTED|Overall Study||20
10247365|NCT03012672|11379401|FG001|STARTED|Overall Study||30
10247366|NCT03012672|11379400|FG000|COMPLETED|Overall Study||20
10247367|NCT03012672|11379401|FG001|COMPLETED|Overall Study||30
10247368|NCT03012672|11379400|FG000|NOT COMPLETED|Overall Study||0
10247369|NCT03012672|11379401|FG001|NOT COMPLETED|Overall Study||0
10247370|NCT03011775|11379408|FG000|STARTED|Overall Study||20
10247371|NCT03011775|11379409|FG001|STARTED|Overall Study||23
10247372|NCT03011775|11379408|FG000|COMPLETED|Overall Study||20
10247373|NCT03011775|11379409|FG001|COMPLETED|Overall Study||23
10247374|NCT03011775|11379408|FG000|NOT COMPLETED|Overall Study||0
10247375|NCT03011775|11379409|FG001|NOT COMPLETED|Overall Study||0
10247376|NCT03007485|11379421|FG000|STARTED|Overall Study||98
10247377|NCT03007485|11379422|FG001|STARTED|Overall Study||111
10247378|NCT03007485|11379421|FG000|COMPLETED|Overall Study||28
10247379|NCT03007485|11379422|FG001|COMPLETED|Overall Study||57
10247380|NCT03007485|11379421|FG000|NOT COMPLETED|Overall Study||70
10247381|NCT03007485|11379422|FG001|NOT COMPLETED|Overall Study||54
10247382|NCT02998476|11379435|FG000|STARTED|Overall Study||55
10247383|NCT02998476|11379436|FG001|STARTED|Overall Study||5
10247384|NCT02998476|11379435|FG000|COMPLETED|Overall Study||0
10247385|NCT02998476|11379436|FG001|COMPLETED|Overall Study||0
10247386|NCT02998476|11379435|FG000|NOT COMPLETED|Overall Study||55
10247387|NCT02998476|11379436|FG001|NOT COMPLETED|Overall Study||5
10247388|NCT02960997|11379445|FG000|STARTED|First Intervention, 12 Weeks||4
10247389|NCT02960997|11379446|FG001|STARTED|First Intervention, 12 Weeks||4
10247390|NCT02960997|11379445|FG000|COMPLETED|First Intervention, 12 Weeks||4
10247391|NCT02960997|11379446|FG001|COMPLETED|First Intervention, 12 Weeks||4
10247392|NCT02960997|11379445|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0
10247393|NCT02960997|11379446|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0
10247394|NCT02960997|11379445|FG000|STARTED|Washout Period, 4 Weeks||4
10247395|NCT02960997|11379446|FG001|STARTED|Washout Period, 4 Weeks||4
10247396|NCT02960997|11379445|FG000|COMPLETED|Washout Period, 4 Weeks||4
10247397|NCT02960997|11379446|FG001|COMPLETED|Washout Period, 4 Weeks||4
10247398|NCT02960997|11379445|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0
10247399|NCT02960997|11379446|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0
10247400|NCT02960997|11379445|FG000|STARTED|Second Treatment, 12 Weeks||4
10247401|NCT02960997|11379446|FG001|STARTED|Second Treatment, 12 Weeks||4
10247402|NCT02960997|11379445|FG000|COMPLETED|Second Treatment, 12 Weeks||4
10247403|NCT02960997|11379446|FG001|COMPLETED|Second Treatment, 12 Weeks||4
10247404|NCT02960997|11379445|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0
10247405|NCT02960997|11379446|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0
10247406|NCT02960997|11379445|FG000|STARTED|Follow-up Period, 4 Weeks||4
10247407|NCT02960997|11379446|FG001|STARTED|Follow-up Period, 4 Weeks||4
10247408|NCT02960997|11379445|FG000|COMPLETED|Follow-up Period, 4 Weeks||4
10247409|NCT02960997|11379446|FG001|COMPLETED|Follow-up Period, 4 Weeks||4
10247410|NCT02960997|11379445|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0
10247411|NCT02960997|11379446|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0
10247412|NCT02949128|11379452|FG000|STARTED|Initial Evaluation Period||58
10247413|NCT02949128|11379452|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
10247414|NCT02949128|11379452|FG000|COMPLETED|Initial Evaluation Period||49
10247415|NCT02949128|11379452|FG000|NOT COMPLETED|Initial Evaluation Period||9
10247416|NCT02949128|11379452|FG000|STARTED|Extension Period||49
10247417|NCT02949128|11379452|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47
10247418|NCT02949128|11379452|FG000|COMPLETED|Extension Period||47
10247419|NCT02949128|11379452|FG000|NOT COMPLETED|Extension Period||2
10247420|NCT02924064|11379458|FG000|STARTED|Overall Study||123
10247421|NCT02924064|11379459|FG001|STARTED|Overall Study||124
10247422|NCT02924064|11379458|FG000|FAS|Overall Study||122
10247423|NCT02924064|11379459|FG001|FAS|Overall Study||124
10247424|NCT02924064|11379458|FG000|COMPLETED|Overall Study||99
10247425|NCT02924064|11379459|FG001|COMPLETED|Overall Study||81
10247426|NCT02924064|11379458|FG000|NOT COMPLETED|Overall Study||24
10247427|NCT02924064|11379459|FG001|NOT COMPLETED|Overall Study||43
10247428|NCT02916706|11379467|FG000|STARTED|Overall Study||127
10247429|NCT02916706|11379468|FG001|STARTED|Overall Study||127
10247430|NCT02916706|11379467|FG000|FAS|Overall Study||125
10247431|NCT02916706|11379468|FG001|FAS|Overall Study||126
10247432|NCT02916706|11379467|FG000|COMPLETED|Overall Study||112
10247433|NCT02916706|11379468|FG001|COMPLETED|Overall Study||96
10247434|NCT02916706|11379467|FG000|NOT COMPLETED|Overall Study||15
10247435|NCT02916706|11379468|FG001|NOT COMPLETED|Overall Study||31
10247436|NCT02889900|11379474|FG000|STARTED|Overall Study||62
10247437|NCT02889900|11379474|FG000|Received Treatment|Overall Study||60
10247438|NCT02889900|11379474|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
10247439|NCT02889900|11379474|FG000|NOT COMPLETED|Overall Study||57
10247440|NCT02866695|11379478|FG000|STARTED|Overall Study||20
10247441|NCT02866695|11379478|FG000|COMPLETED|Overall Study||18
10247442|NCT02866695|11379478|FG000|NOT COMPLETED|Overall Study||2
10247443|NCT02854436|11379482|FG000|STARTED|Overall Study||289
10247444|NCT02854436|11379482|FG000|Intent to Treat Participants (Breast Cancer Gene [BRCA] and Non-BRCA Participants)|Overall Study|There were 142 BRCA participants and 81 non-BRCA participants.|223
10247445|NCT02854436|11379482|FG000|COMPLETED|Overall Study||0
10247446|NCT02854436|11379482|FG000|NOT COMPLETED|Overall Study||289
10247447|NCT02834793|11379488|FG000|STARTED|Core Study (Up to 18 Weeks)||36
10247448|NCT02834793|11379489|FG001|STARTED|Core Study (Up to 18 Weeks)||34
10247449|NCT02834793|11379490|FG002|STARTED|Core Study (Up to 18 Weeks)||0
10247450|NCT02834793|11379491|FG003|STARTED|Core Study (Up to 18 Weeks)||0
10247451|NCT02834793|11379488|FG000|COMPLETED|Core Study (Up to 18 Weeks)||32
10247452|NCT02834793|11379489|FG001|COMPLETED|Core Study (Up to 18 Weeks)||29
10247453|NCT02834793|11379490|FG002|COMPLETED|Core Study (Up to 18 Weeks)||0
10247454|NCT02834793|11379491|FG003|COMPLETED|Core Study (Up to 18 Weeks)||0
10247455|NCT02834793|11379488|FG000|NOT COMPLETED|Core Study (Up to 18 Weeks)||4
10247456|NCT02834793|11379489|FG001|NOT COMPLETED|Core Study (Up to 18 Weeks)||5
10247457|NCT02834793|11379490|FG002|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
10247458|NCT02834793|11379491|FG003|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
10247459|NCT02834793|11379488|FG000|STARTED|Extension Phase A (up to 52 Weeks)||0
10247460|NCT02834793|11379489|FG001|STARTED|Extension Phase A (up to 52 Weeks)||0
10247461|NCT02834793|11379490|FG002|STARTED|Extension Phase A (up to 52 Weeks)|Only eligible participants who completed Core Study entered into Extension Phase A.|58
10247462|NCT02834793|11379491|FG003|STARTED|Extension Phase A (up to 52 Weeks)||0
10247463|NCT02834793|11379488|FG000|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10247464|NCT02834793|11379489|FG001|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10247465|NCT02834793|11379490|FG002|COMPLETED|Extension Phase A (up to 52 Weeks)||32
10247466|NCT02834793|11379491|FG003|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10247467|NCT02834793|11379488|FG000|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10247468|NCT02834793|11379489|FG001|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10247469|NCT02834793|11379490|FG002|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||26
10247470|NCT02834793|11379491|FG003|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10247471|NCT02834793|11379488|FG000|STARTED|Extension Phase B (up to 188 Weeks)||0
10247472|NCT02834793|11379489|FG001|STARTED|Extension Phase B (up to 188 Weeks)||0
10247473|NCT02834793|11379490|FG002|STARTED|Extension Phase B (up to 188 Weeks)||0
10247474|NCT02834793|11379491|FG003|STARTED|Extension Phase B (up to 188 Weeks)|Only eligible participants who completed Extension Phase A entered into Extension Phase B.|13
10247475|NCT02834793|11379488|FG000|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10247476|NCT02834793|11379489|FG001|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10247477|NCT02834793|11379490|FG002|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10247478|NCT02834793|11379491|FG003|COMPLETED|Extension Phase B (up to 188 Weeks)||1
10247479|NCT02834793|11379488|FG000|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10247480|NCT02834793|11379489|FG001|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10247481|NCT02834793|11379490|FG002|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10247482|NCT02834793|11379491|FG003|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||12
10247483|NCT02810457|11379501|FG000|STARTED|Overall Study|362 patients received study treatment|364
10247484|NCT02810457|11379502|FG001|STARTED|Overall Study|366 patients received study treatment|367
10247485|NCT02810457|11379501|FG000|COMPLETED|Overall Study||37
10247486|NCT02810457|11379502|FG001|COMPLETED|Overall Study||38
10247487|NCT02810457|11379501|FG000|NOT COMPLETED|Overall Study||327
10247488|NCT02810457|11379502|FG001|NOT COMPLETED|Overall Study||329
10247489|NCT02797964|11379514|FG000|STARTED|Overall Study||32
10247490|NCT02797964|11379515|FG001|STARTED|Overall Study||37
10247491|NCT02797964|11379516|FG002|STARTED|Overall Study||10
10247492|NCT02797964|11379517|FG003|STARTED|Overall Study||16
10247493|NCT02797964|11379518|FG004|STARTED|Overall Study||4
10247494|NCT02797964|11379519|FG005|STARTED|Overall Study||8
10247495|NCT02797964|11379514|FG000|COMPLETED|Overall Study||32
10247496|NCT02797964|11379515|FG001|COMPLETED|Overall Study||37
10247497|NCT02797964|11379516|FG002|COMPLETED|Overall Study||10
10247498|NCT02797964|11379517|FG003|COMPLETED|Overall Study||16
10247499|NCT02797964|11379518|FG004|COMPLETED|Overall Study||4
10247500|NCT02797964|11379519|FG005|COMPLETED|Overall Study||8
10247501|NCT02797964|11379514|FG000|NOT COMPLETED|Overall Study||0
10247502|NCT02797964|11379515|FG001|NOT COMPLETED|Overall Study||0
10247503|NCT02797964|11379516|FG002|NOT COMPLETED|Overall Study||0
10247504|NCT02797964|11379517|FG003|NOT COMPLETED|Overall Study||0
10247505|NCT02797964|11379518|FG004|NOT COMPLETED|Overall Study||0
10247506|NCT02797964|11379519|FG005|NOT COMPLETED|Overall Study||0
10247507|NCT02746809|11379532|FG000|STARTED|Baseline- 30 Days||60
10247508|NCT02746809|11379532|FG000|COMPLETED|Baseline- 30 Days||59
10247509|NCT02746809|11379532|FG000|NOT COMPLETED|Baseline- 30 Days||1
10247510|NCT02746809|11379532|FG000|STARTED|Baseline-6 Months||59
10247511|NCT02746809|11379532|FG000|COMPLETED|Baseline-6 Months||54
10247512|NCT02746809|11379532|FG000|NOT COMPLETED|Baseline-6 Months||5
10247513|NCT02745535|11379538|FG000|STARTED|Overall Study||77
10247514|NCT02745535|11379538|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
10247515|NCT02745535|11379538|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
10247516|NCT02745535|11379538|FG000|NOT COMPLETED|Overall Study||6
10247517|NCT02738853|11379542|FG000|STARTED|Baseline -30 Days||60
10247518|NCT02738853|11379542|FG000|COMPLETED|Baseline -30 Days||59
10247519|NCT02738853|11379542|FG000|NOT COMPLETED|Baseline -30 Days||1
10019685|NCT01831258|11142818|FG001|NOT COMPLETED|Overall Study||3
10019686|NCT01831427|11142837|FG000|STARTED|Overall Study||5
10019687|NCT01831427|11142838|FG001|STARTED|Overall Study||5
10019688|NCT01831427|11142839|FG002|STARTED|Overall Study||5
10019689|NCT01831427|11142840|FG003|STARTED|Overall Study||5
10019690|NCT01831427|11142841|FG004|STARTED|Overall Study||4
10019691|NCT01831427|11142842|FG005|STARTED|Overall Study||8
10019692|NCT01831427|11142843|FG006|STARTED|Overall Study||8
10019693|NCT01831427|11142844|FG007|STARTED|Overall Study||8
10019694|NCT01831427|11142845|FG008|STARTED|Overall Study||8
10019695|NCT01831427|11142846|FG009|STARTED|Overall Study||10
10247520|NCT02738853|11379542|FG000|STARTED|30 Days- 6 Months||59
10247521|NCT02738853|11379542|FG000|COMPLETED|30 Days- 6 Months||57
10247522|NCT02738853|11379542|FG000|NOT COMPLETED|30 Days- 6 Months||2
10247523|NCT02729701|11379546|FG000|STARTED|Overall Study||28
10247524|NCT02729701|11379546|FG000|COMPLETED|Overall Study||28
10247525|NCT02729701|11379546|FG000|NOT COMPLETED|Overall Study||0
10247526|NCT02684253|11379552|FG000|STARTED|Overall Study||32
10247527|NCT02684253|11379553|FG001|STARTED|Overall Study||33
10247528|NCT02684253|11379552|FG000|COMPLETED|Overall Study||32
10247529|NCT02684253|11379553|FG001|COMPLETED|Overall Study||33
10247530|NCT02684253|11379552|FG000|NOT COMPLETED|Overall Study||0
10247531|NCT02684253|11379553|FG001|NOT COMPLETED|Overall Study||0
10247532|NCT02681406|11379563|FG000|STARTED|Overall Study||65
10247533|NCT02681406|11379564|FG001|STARTED|Overall Study||59
10247534|NCT02681406|11379565|FG002|STARTED|Overall Study||68
10247535|NCT02681406|11379566|FG003|STARTED|Overall Study||70
10247536|NCT02681406|11379563|FG000|COMPLETED|Overall Study||49
10247537|NCT02681406|11379564|FG001|COMPLETED|Overall Study||35
10247538|NCT02681406|11379565|FG002|COMPLETED|Overall Study||42
10247539|NCT02681406|11379566|FG003|COMPLETED|Overall Study||58
10247540|NCT02681406|11379563|FG000|NOT COMPLETED|Overall Study||16
10247541|NCT02681406|11379564|FG001|NOT COMPLETED|Overall Study||24
10247542|NCT02681406|11379565|FG002|NOT COMPLETED|Overall Study||26
10247543|NCT02681406|11379566|FG003|NOT COMPLETED|Overall Study||12
10247544|NCT02625090|11379576|FG000|STARTED|Overall Study||42
10247545|NCT02625090|11379576|FG000|COMPLETED|Overall Study||0
10247546|NCT02625090|11379576|FG000|NOT COMPLETED|Overall Study||42
10019696|NCT01831427|11142847|FG010|STARTED|Overall Study||8
10019697|NCT01831427|11142837|FG000|COMPLETED|Overall Study||5
10019698|NCT01831427|11142838|FG001|COMPLETED|Overall Study||4
10019699|NCT01831427|11142839|FG002|COMPLETED|Overall Study||5
10019700|NCT01831427|11142840|FG003|COMPLETED|Overall Study||4
10019701|NCT01831427|11142841|FG004|COMPLETED|Overall Study||4
10247547|NCT02539225|11379583|FG000|STARTED|Part A||97
10247548|NCT02539225|11379584|FG001|STARTED|Part A||94
10247549|NCT02539225|11379583|FG000|Received Any Quantity of Study Drug|Part A||96
10247550|NCT02539225|11379584|FG001|Received Any Quantity of Study Drug|Part A||93
10247551|NCT02539225|11379583|FG000|COMPLETED|Part A||77
10247552|NCT02539225|11379584|FG001|COMPLETED|Part A||78
10247553|NCT02539225|11379583|FG000|NOT COMPLETED|Part A||20
10247554|NCT02539225|11379584|FG001|NOT COMPLETED|Part A||16
10247555|NCT02539225|11379583|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
10247556|NCT02539225|11379584|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
10247557|NCT02539225|11379583|FG000|COMPLETED|Pre Treatment for Part B||58
10247558|NCT02539225|11379584|FG001|COMPLETED|Pre Treatment for Part B||64
10247559|NCT02539225|11379583|FG000|NOT COMPLETED|Pre Treatment for Part B||5
10247560|NCT02539225|11379584|FG001|NOT COMPLETED|Pre Treatment for Part B||2
10247561|NCT02539225|11379583|FG000|STARTED|Part B||58
10247562|NCT02539225|11379584|FG001|STARTED|Part B||64
10247563|NCT02539225|11379583|FG000|COMPLETED|Part B||54
10247564|NCT02539225|11379584|FG001|COMPLETED|Part B||48
10247565|NCT02539225|11379583|FG000|NOT COMPLETED|Part B||4
10247566|NCT02539225|11379584|FG001|NOT COMPLETED|Part B||16
10247567|NCT02528500|11379595|FG000|STARTED|Overall Study||10
10247568|NCT02528500|11379595|FG000|COMPLETED|Overall Study||10
10247569|NCT02528500|11379595|FG000|NOT COMPLETED|Overall Study||0
10247570|NCT02527681|11379599|FG000|STARTED|Overall Study||15
10247571|NCT02527681|11379599|FG000|COMPLETED|Overall Study||15
10247572|NCT02527681|11379599|FG000|NOT COMPLETED|Overall Study||0
10247573|NCT02526017|11379612|FG000|STARTED|Overall Study||3
10247574|NCT02526017|11379613|FG001|STARTED|Overall Study||10
10247575|NCT02526017|11379614|FG002|STARTED|Overall Study||11
10247576|NCT02526017|11379615|FG003|STARTED|Overall Study||4
10247577|NCT02526017|11379616|FG004|STARTED|Overall Study||4
10247578|NCT02526017|11379617|FG005|STARTED|Overall Study||3
9833329|NCT00778895|10944231|FG000|COMPLETED|ESFU Phase||153
9833330|NCT00778895|10944232|FG001|COMPLETED|ESFU Phase||155
9833331|NCT00778895|10944233|FG002|COMPLETED|ESFU Phase||41
9833332|NCT00778895|10944231|FG000|NOT COMPLETED|ESFU Phase||11
9833333|NCT00778895|10944232|FG001|NOT COMPLETED|ESFU Phase||12
9833334|NCT00778895|10944233|FG002|NOT COMPLETED|ESFU Phase||2
9833335|NCT00778921|10944245|FG000|STARTED|Overall Study||279
9833336|NCT00778921|10944246|FG001|STARTED|Overall Study||285
9833337|NCT00778921|10944247|FG002|STARTED|Overall Study||283
9833338|NCT00778921|10944245|FG000|COMPLETED|Overall Study||261
9833339|NCT00778921|10944246|FG001|COMPLETED|Overall Study||266
9833340|NCT00778921|10944247|FG002|COMPLETED|Overall Study||255
9833341|NCT00778921|10944245|FG000|NOT COMPLETED|Overall Study||18
9833342|NCT00778921|10944246|FG001|NOT COMPLETED|Overall Study||19
9833343|NCT00778921|10944247|FG002|NOT COMPLETED|Overall Study||28
9833344|NCT00779025|10944255|FG000|STARTED|Overall Study||82
9833345|NCT00779025|10944255|FG000|COMPLETED|Overall Study||81
9833346|NCT00779025|10944255|FG000|NOT COMPLETED|Overall Study||1
9833347|NCT00779103|10944260|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
9957366|NCT01450306|11076577|FG000|NOT COMPLETED|Overall Study||0
9957367|NCT01450306|11076578|FG001|NOT COMPLETED|Overall Study||0
9957368|NCT01450319|11076584|FG000|STARTED|Overall Study||70
9957369|NCT01450319|11076584|FG000|COMPLETED|Overall Study||70
9957370|NCT01450319|11076584|FG000|NOT COMPLETED|Overall Study||0
9957371|NCT01450397|11076588|FG000|STARTED|Overall Study||5
9957372|NCT01450397|11076588|FG000|COMPLETED|Overall Study||5
9957373|NCT01450397|11076588|FG000|NOT COMPLETED|Overall Study||0
9957374|NCT01450540|11076594|FG000|STARTED|Overall Study||123
9957375|NCT01450540|11076595|FG001|STARTED|Overall Study||118
9957376|NCT01450540|11076594|FG000|COMPLETED|Overall Study||101
9957377|NCT01450540|11076595|FG001|COMPLETED|Overall Study||82
9957378|NCT01450540|11076594|FG000|NOT COMPLETED|Overall Study||22
9957379|NCT01450540|11076595|FG001|NOT COMPLETED|Overall Study||36
9957380|NCT01450631|11076605|FG000|STARTED|Overall Study||46
9957381|NCT01450631|11076606|FG001|STARTED|Overall Study||46
9957382|NCT01450631|11076605|FG000|COMPLETED|Overall Study||43
9957383|NCT01450631|11076606|FG001|COMPLETED|Overall Study||42
9957384|NCT01450631|11076605|FG000|NOT COMPLETED|Overall Study||3
9957385|NCT01450631|11076606|FG001|NOT COMPLETED|Overall Study||4
9957386|NCT01450683|11076612|FG000|STARTED|Overall Study||4
9957387|NCT01450683|11076612|FG000|COMPLETED|Overall Study||2
9957388|NCT01450683|11076612|FG000|NOT COMPLETED|Overall Study||2
9957389|NCT01450696|11076618|FG000|STARTED|Overall Study||148
9957390|NCT01450696|11076619|FG001|STARTED|Overall Study||148
9957391|NCT01450696|11076618|FG000|Treated (Safety Population)|Overall Study||147
9957392|NCT01450696|11076619|FG001|Treated (Safety Population)|Overall Study||147
9957393|NCT01450696|11076618|FG000|COMPLETED|Overall Study||0
9957394|NCT01450696|11076619|FG001|COMPLETED|Overall Study||0
9957395|NCT01450696|11076618|FG000|NOT COMPLETED|Overall Study||148
9957396|NCT01450696|11076619|FG001|NOT COMPLETED|Overall Study||148
9957397|NCT01450761|11076627|FG000|STARTED|Randomization||566
9957398|NCT01450761|11076628|FG001|STARTED|Randomization||566
10247579|NCT02526017|11379618|FG006|STARTED|Overall Study||6
10247580|NCT02526017|11379619|FG007|STARTED|Overall Study||10
10247581|NCT02526017|11379620|FG008|STARTED|Overall Study||262
10247582|NCT02526017|11379612|FG000|Received Study Treatment|Overall Study||3
10247583|NCT02526017|11379613|FG001|Received Study Treatment|Overall Study||10
9957399|NCT01450761|11076627|FG000|COMPLETED|Randomization||562
9957400|NCT01450761|11076628|FG001|COMPLETED|Randomization||561
10247584|NCT02526017|11379614|FG002|Received Study Treatment|Overall Study||11
10247585|NCT02526017|11379615|FG003|Received Study Treatment|Overall Study||4
10247586|NCT02526017|11379616|FG004|Received Study Treatment|Overall Study||3
10247587|NCT02526017|11379617|FG005|Received Study Treatment|Overall Study||3
10247588|NCT02526017|11379618|FG006|Received Study Treatment|Overall Study||6
10247589|NCT02526017|11379619|FG007|Received Study Treatment|Overall Study||10
10247590|NCT02526017|11379620|FG008|Received Study Treatment|Overall Study||262
10247591|NCT02526017|11379612|FG000|COMPLETED|Overall Study||3
10247592|NCT02526017|11379613|FG001|COMPLETED|Overall Study||10
10247593|NCT02526017|11379614|FG002|COMPLETED|Overall Study||11
10247594|NCT02526017|11379615|FG003|COMPLETED|Overall Study||4
10247595|NCT02526017|11379616|FG004|COMPLETED|Overall Study||3
10247596|NCT02526017|11379617|FG005|COMPLETED|Overall Study||3
10247597|NCT02526017|11379618|FG006|COMPLETED|Overall Study||6
10247598|NCT02526017|11379619|FG007|COMPLETED|Overall Study||10
10247599|NCT02526017|11379620|FG008|COMPLETED|Overall Study||262
10247600|NCT02526017|11379612|FG000|NOT COMPLETED|Overall Study||0
10247601|NCT02526017|11379613|FG001|NOT COMPLETED|Overall Study||0
10247602|NCT02526017|11379614|FG002|NOT COMPLETED|Overall Study||0
10247603|NCT02526017|11379615|FG003|NOT COMPLETED|Overall Study||0
10247604|NCT02526017|11379616|FG004|NOT COMPLETED|Overall Study||1
10247605|NCT02526017|11379617|FG005|NOT COMPLETED|Overall Study||0
10247606|NCT02526017|11379618|FG006|NOT COMPLETED|Overall Study||0
10247607|NCT02526017|11379619|FG007|NOT COMPLETED|Overall Study||0
10247608|NCT02526017|11379620|FG008|NOT COMPLETED|Overall Study||0
10247609|NCT02482233|11379682|FG000|STARTED|Overall Study||10
10247610|NCT02482233|11379683|FG001|STARTED|Overall Study||20
10247611|NCT02482233|11379682|FG000|COMPLETED|Overall Study||9
10247612|NCT02482233|11379683|FG001|COMPLETED|Overall Study||19
10247613|NCT02482233|11379682|FG000|NOT COMPLETED|Overall Study||1
10247614|NCT02482233|11379683|FG001|NOT COMPLETED|Overall Study||1
10247615|NCT02450331|11379693|FG000|STARTED|Overall Study||403
10247616|NCT02450331|11379694|FG001|STARTED|Overall Study||406
10247617|NCT02450331|11379693|FG000|COMPLETED|Overall Study||0
10247618|NCT02450331|11379694|FG001|COMPLETED|Overall Study||0
10247619|NCT02450331|11379693|FG000|NOT COMPLETED|Overall Study||403
10247620|NCT02450331|11379694|FG001|NOT COMPLETED|Overall Study||406
10247621|NCT02417415|11379701|FG000|STARTED|Overall Study||13
10247622|NCT02417415|11379702|FG001|STARTED|Overall Study||9
10247623|NCT02417415|11379701|FG000|COMPLETED|Overall Study||13
10247624|NCT02417415|11379702|FG001|COMPLETED|Overall Study||9
10247625|NCT02417415|11379701|FG000|NOT COMPLETED|Overall Study||0
10247626|NCT02417415|11379702|FG001|NOT COMPLETED|Overall Study||0
10247627|NCT02400736|11379710|FG000|STARTED|Overall Study||58
10247628|NCT02400736|11379711|FG001|STARTED|Overall Study||61
10247629|NCT02400736|11379710|FG000|COMPLETED|Overall Study||47
10247630|NCT02400736|11379711|FG001|COMPLETED|Overall Study||53
10247631|NCT02400736|11379710|FG000|NOT COMPLETED|Overall Study||11
10247632|NCT02400736|11379711|FG001|NOT COMPLETED|Overall Study||8
10247633|NCT02369653|11379723|FG000|STARTED|Overall Study||256
10247634|NCT02369653|11379724|FG001|STARTED|Overall Study||256
10247635|NCT02369653|11379723|FG000|Adverse Event Analysis Population|Overall Study|Out of the 256 participants randomized to Apixaban only 250 participants received an apixaban dose.|250
10247636|NCT02369653|11379724|FG001|Adverse Event Analysis Population|Overall Study|The 6 subjects who were randomized to apixaban but received no dose were analyzed in Standard of Care.|262
10247637|NCT02369653|11379723|FG000|COMPLETED|Overall Study||242
10247638|NCT02369653|11379724|FG001|COMPLETED|Overall Study||249
10247639|NCT02369653|11379723|FG000|NOT COMPLETED|Overall Study||14
10247640|NCT02369653|11379724|FG001|NOT COMPLETED|Overall Study||7
10247641|NCT02335424|11379734|FG000|STARTED|Overall Study||374
10247642|NCT02335424|11379734|FG000|Treated|Overall Study||370
10247643|NCT02335424|11379734|FG000|COMPLETED|Overall Study||0
10247644|NCT02335424|11379734|FG000|NOT COMPLETED|Overall Study||374
9833348|NCT00779103|10944260|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
9833349|NCT00779103|10944260|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
9833350|NCT00779103|10944260|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
9833351|NCT00779103|10944260|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36
9833352|NCT00779103|10944260|FG000|NOT COMPLETED|Overall Study||0
9833353|NCT00779142|10944268|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5
9833354|NCT00779142|10944268|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
9833355|NCT00779142|10944268|FG000|NOT COMPLETED|Overall Study||3
9833356|NCT00779155|10944275|FG000|STARTED|Overall Study||6
9833357|NCT00779155|10944276|FG001|STARTED|Overall Study||6
9833358|NCT00779155|10944275|FG000|COMPLETED|Overall Study||6
10247645|NCT02326974|11379738|FG000|STARTED|Overall Study||164
10247646|NCT02326974|11379738|FG000|Treated|Overall Study||163
10247647|NCT02326974|11379738|FG000|COMPLETED|Overall Study||157
10247648|NCT02326974|11379738|FG000|NOT COMPLETED|Overall Study||7
10247649|NCT02284568|11379749|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140
10247650|NCT02284568|11379750|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139
10247651|NCT02284568|11379751|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95
10247652|NCT02284568|11379749|FG000|Safety Population|Overall Study||140
10247653|NCT02284568|11379750|FG001|Safety Population|Overall Study||138
10247654|NCT02284568|11379751|FG002|Safety Population|Overall Study||95
10247655|NCT02284568|11379749|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113
10247656|NCT02284568|11379750|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107
10247657|NCT02284568|11379751|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0
10247658|NCT02284568|11379749|FG000|COMPLETED|Overall Study||109
10247659|NCT02284568|11379750|FG001|COMPLETED|Overall Study||93
10247660|NCT02284568|11379751|FG002|COMPLETED|Overall Study||0
10247661|NCT02284568|11379749|FG000|NOT COMPLETED|Overall Study||31
10247662|NCT02284568|11379750|FG001|NOT COMPLETED|Overall Study||46
10247663|NCT02284568|11379751|FG002|NOT COMPLETED|Overall Study||95
10247664|NCT02228525|11379759|FG000|STARTED|Overall Study||25
10247665|NCT02228525|11379759|FG000|COMPLETED|Overall Study||25
10247666|NCT02228525|11379759|FG000|NOT COMPLETED|Overall Study||0
10247667|NCT02227238|11379765|FG000|STARTED|Overall Study||312
10247668|NCT02227238|11379766|FG001|STARTED|Overall Study||312
10247669|NCT02227238|11379765|FG000|COMPLETED|Overall Study||275
10247670|NCT02227238|11379766|FG001|COMPLETED|Overall Study||245
10247671|NCT02227238|11379765|FG000|NOT COMPLETED|Overall Study||37
10247672|NCT02227238|11379766|FG001|NOT COMPLETED|Overall Study||67
10247673|NCT02195986|11379775|FG000|STARTED|Overall Study||146
10247674|NCT02195986|11379776|FG001|STARTED|Overall Study||147
10247675|NCT02195986|11379777|FG002|STARTED|Overall Study||73
10247676|NCT02195986|11379775|FG000|COMPLETED|Overall Study||143
10247677|NCT02195986|11379776|FG001|COMPLETED|Overall Study||142
10247678|NCT02195986|11379777|FG002|COMPLETED|Overall Study||71
10247679|NCT02195986|11379775|FG000|NOT COMPLETED|Overall Study||3
10247680|NCT02195986|11379776|FG001|NOT COMPLETED|Overall Study||5
10247681|NCT02195986|11379777|FG002|NOT COMPLETED|Overall Study||2
10247682|NCT02128958|11379787|FG000|STARTED|Overall Study||50
10247683|NCT02128958|11379788|FG001|STARTED|Overall Study||28
10247684|NCT02128958|11379787|FG000|COMPLETED|Overall Study||29
10247685|NCT02128958|11379788|FG001|COMPLETED|Overall Study||18
10247686|NCT02128958|11379787|FG000|NOT COMPLETED|Overall Study||21
10247687|NCT02128958|11379788|FG001|NOT COMPLETED|Overall Study||10
10247688|NCT02086448|11379798|FG000|STARTED|Overall Study||25
10247689|NCT02086448|11379799|FG001|STARTED|Overall Study||26
10247690|NCT02086448|11379800|FG002|STARTED|Overall Study||20
10247691|NCT02086448|11379801|FG003|STARTED|Overall Study||18
10247692|NCT02086448|11379798|FG000|COMPLETED|Overall Study||24
10247693|NCT02086448|11379799|FG001|COMPLETED|Overall Study||26
10247694|NCT02086448|11379800|FG002|COMPLETED|Overall Study||20
10247695|NCT02086448|11379801|FG003|COMPLETED|Overall Study||16
10247696|NCT02086448|11379798|FG000|NOT COMPLETED|Overall Study||1
10247697|NCT02086448|11379799|FG001|NOT COMPLETED|Overall Study||0
10247698|NCT02086448|11379800|FG002|NOT COMPLETED|Overall Study||0
10247699|NCT02086448|11379801|FG003|NOT COMPLETED|Overall Study||2
10247700|NCT01982630|11379819|FG000|STARTED|Overall Study||10
10247701|NCT01982630|11379820|FG001|STARTED|Overall Study||8
10247702|NCT01982630|11379821|FG002|STARTED|Overall Study||13
10247703|NCT01982630|11379822|FG003|STARTED|Overall Study||9
10247704|NCT01982630|11379823|FG004|STARTED|Overall Study||19
10247705|NCT01982630|11379824|FG005|STARTED|Overall Study||14
10247706|NCT01982630|11379825|FG006|STARTED|Overall Study||6
10247707|NCT01982630|11379826|FG007|STARTED|Overall Study||8
10247708|NCT01982630|11379819|FG000|Treated|Overall Study||9
10247709|NCT01982630|11379820|FG001|Treated|Overall Study||8
10247710|NCT01982630|11379821|FG002|Treated|Overall Study||11
10247711|NCT01982630|11379822|FG003|Treated|Overall Study||9
10247712|NCT01982630|11379823|FG004|Treated|Overall Study||18
10247713|NCT01982630|11379824|FG005|Treated|Overall Study||14
10247714|NCT01982630|11379825|FG006|Treated|Overall Study||6
10247715|NCT01982630|11379826|FG007|Treated|Overall Study||8
10247716|NCT01982630|11379819|FG000|COMPLETED|Overall Study||7
10247717|NCT01982630|11379820|FG001|COMPLETED|Overall Study||8
10247718|NCT01982630|11379821|FG002|COMPLETED|Overall Study||8
10247719|NCT01982630|11379822|FG003|COMPLETED|Overall Study||8
10247720|NCT01982630|11379823|FG004|COMPLETED|Overall Study||16
10247721|NCT01982630|11379824|FG005|COMPLETED|Overall Study||11
10247722|NCT01982630|11379825|FG006|COMPLETED|Overall Study||5
10247723|NCT01982630|11379826|FG007|COMPLETED|Overall Study||8
10247724|NCT01982630|11379819|FG000|NOT COMPLETED|Overall Study||3
9833359|NCT00779155|10944276|FG001|COMPLETED|Overall Study||6
9833360|NCT00779155|10944275|FG000|NOT COMPLETED|Overall Study||0
9833361|NCT00779155|10944276|FG001|NOT COMPLETED|Overall Study||0
9833362|NCT00779246|10944284|FG000|STARTED|Overall Study||750
9833363|NCT00779246|10944285|FG001|STARTED|Overall Study||768
9833364|NCT00779246|10944284|FG000|COMPLETED|Overall Study||717
10247725|NCT01982630|11379820|FG001|NOT COMPLETED|Overall Study||0
10247726|NCT01982630|11379821|FG002|NOT COMPLETED|Overall Study||5
10247727|NCT01982630|11379822|FG003|NOT COMPLETED|Overall Study||1
10247728|NCT01982630|11379823|FG004|NOT COMPLETED|Overall Study||3
10247729|NCT01982630|11379824|FG005|NOT COMPLETED|Overall Study||3
10247730|NCT01982630|11379825|FG006|NOT COMPLETED|Overall Study||1
10247731|NCT01982630|11379826|FG007|NOT COMPLETED|Overall Study||0
10247732|NCT01982448|11379881|FG000|STARTED|Preoperative Chemotherapy||75
10247733|NCT01982448|11379882|FG001|STARTED|Preoperative Chemotherapy||72
10247734|NCT01982448|11379881|FG000|Eligible & Treated|Preoperative Chemotherapy||72
10247735|NCT01982448|11379882|FG001|Eligible & Treated|Preoperative Chemotherapy||70
10247736|NCT01982448|11379881|FG000|Evaluable for Safety|Preoperative Chemotherapy||72
10247737|NCT01982448|11379882|FG001|Evaluable for Safety|Preoperative Chemotherapy||68
10247738|NCT01982448|11379881|FG000|COMPLETED|Preoperative Chemotherapy||72
10247739|NCT01982448|11379882|FG001|COMPLETED|Preoperative Chemotherapy||67
10247740|NCT01982448|11379881|FG000|NOT COMPLETED|Preoperative Chemotherapy||3
10247741|NCT01982448|11379882|FG001|NOT COMPLETED|Preoperative Chemotherapy||5
10247742|NCT01982448|11379881|FG000|STARTED|Definitive Breast Surgery||72
10247743|NCT01982448|11379882|FG001|STARTED|Definitive Breast Surgery||67
10247744|NCT01982448|11379881|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
10247745|NCT01982448|11379882|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
10247746|NCT01982448|11379881|FG000|COMPLETED|Definitive Breast Surgery||72
10247747|NCT01982448|11379882|FG001|COMPLETED|Definitive Breast Surgery||67
10247748|NCT01982448|11379881|FG000|NOT COMPLETED|Definitive Breast Surgery||0
10247749|NCT01982448|11379882|FG001|NOT COMPLETED|Definitive Breast Surgery||0
10247750|NCT01879228|11379894|FG000|STARTED|Overall Study||13
10247751|NCT01879228|11379895|FG001|STARTED|Overall Study||13
10247752|NCT01879228|11379894|FG000|COMPLETED|Overall Study||12
10247753|NCT01879228|11379895|FG001|COMPLETED|Overall Study||12
10247754|NCT01879228|11379894|FG000|NOT COMPLETED|Overall Study||1
10247755|NCT01879228|11379895|FG001|NOT COMPLETED|Overall Study||1
10247756|NCT01783041|11379903|FG000|STARTED|First 2 Weeks of Life||72
10247757|NCT01783041|11379904|FG001|STARTED|First 2 Weeks of Life||72
10247758|NCT01783041|11379903|FG000|COMPLETED|First 2 Weeks of Life||69
10247759|NCT01783041|11379904|FG001|COMPLETED|First 2 Weeks of Life||71
10247760|NCT01783041|11379903|FG000|NOT COMPLETED|First 2 Weeks of Life||3
10247761|NCT01783041|11379904|FG001|NOT COMPLETED|First 2 Weeks of Life||1
10247762|NCT01783041|11379903|FG000|STARTED|NNNS Examination at Term Equivalent Age||69
10247763|NCT01783041|11379904|FG001|STARTED|NNNS Examination at Term Equivalent Age||71
10247764|NCT01783041|11379903|FG000|COMPLETED|NNNS Examination at Term Equivalent Age||60
10247765|NCT01783041|11379904|FG001|COMPLETED|NNNS Examination at Term Equivalent Age||59
10247766|NCT01783041|11379903|FG000|NOT COMPLETED|NNNS Examination at Term Equivalent Age||9
10247767|NCT01783041|11379904|FG001|NOT COMPLETED|NNNS Examination at Term Equivalent Age||12
10247768|NCT01752920|11379914|FG000|STARTED|Overall Study||29
10247769|NCT01752920|11379915|FG001|STARTED|Overall Study||13
10247770|NCT01752920|11379916|FG002|STARTED|Overall Study||19
10247771|NCT01752920|11379917|FG003|STARTED|Overall Study||58
10247772|NCT01752920|11379914|FG000|COMPLETED|Overall Study||0
10247773|NCT01752920|11379915|FG001|COMPLETED|Overall Study||0
10247774|NCT01752920|11379916|FG002|COMPLETED|Overall Study||0
10247775|NCT01752920|11379917|FG003|COMPLETED|Overall Study||0
10247776|NCT01752920|11379914|FG000|NOT COMPLETED|Overall Study||29
10247777|NCT01752920|11379915|FG001|NOT COMPLETED|Overall Study||13
10247778|NCT01752920|11379916|FG002|NOT COMPLETED|Overall Study||19
10247779|NCT01752920|11379917|FG003|NOT COMPLETED|Overall Study||58
10247780|NCT01744093|11379931|FG000|STARTED|Overall Study||18
10247781|NCT01744093|11379932|FG001|STARTED|Overall Study||9
10247782|NCT01744093|11379931|FG000|COMPLETED|Overall Study||12
10247783|NCT01744093|11379932|FG001|COMPLETED|Overall Study||8
9833365|NCT00779246|10944285|FG001|COMPLETED|Overall Study||715
9833366|NCT00779246|10944284|FG000|NOT COMPLETED|Overall Study||33
9833367|NCT00779246|10944285|FG001|NOT COMPLETED|Overall Study||53
10019702|NCT01831427|11142842|FG005|COMPLETED|Overall Study||7
10019703|NCT01831427|11142843|FG006|COMPLETED|Overall Study||6
9833368|NCT00779259|10944291|FG000|STARTED|Theophylline Alone||24
9833369|NCT00779259|10944291|FG000|COMPLETED|Theophylline Alone||24
9833370|NCT00779259|10944291|FG000|NOT COMPLETED|Theophylline Alone||0
9833371|NCT00779259|10944291|FG000|STARTED|4 Day Washout Period||24
9833372|NCT00779259|10944291|FG000|COMPLETED|4 Day Washout Period||24
9833373|NCT00779259|10944291|FG000|NOT COMPLETED|4 Day Washout Period||0
9833374|NCT00779259|10944291|FG000|STARTED|Quinine Alone||24
9833375|NCT00779259|10944291|FG000|COMPLETED|Quinine Alone||22
10019704|NCT01831427|11142844|FG007|COMPLETED|Overall Study||7
10247784|NCT01744093|11379931|FG000|NOT COMPLETED|Overall Study||6
10247785|NCT01744093|11379932|FG001|NOT COMPLETED|Overall Study||1
10247786|NCT01740297|11379949|FG000|STARTED|Overall Study||19
10247787|NCT01740297|11379950|FG001|STARTED|Overall Study||100
10247788|NCT01740297|11379951|FG002|STARTED|Overall Study||98
10247789|NCT01740297|11379949|FG000|Received Talimogene Laherparepvec|Overall Study||19
10247790|NCT01740297|11379950|FG001|Received Talimogene Laherparepvec|Overall Study||0
10247791|NCT01740297|11379951|FG002|Received Talimogene Laherparepvec|Overall Study||95
10247792|NCT01740297|11379949|FG000|Received Ipilimumab|Overall Study||18
10247793|NCT01740297|11379950|FG001|Received Ipilimumab|Overall Study||95
10247794|NCT01740297|11379951|FG002|Received Ipilimumab|Overall Study||92
9833376|NCT00779259|10944291|FG000|NOT COMPLETED|Quinine Alone||2
10247795|NCT01740297|11379949|FG000|COMPLETED|Overall Study||6
10247796|NCT01740297|11379950|FG001|COMPLETED|Overall Study||36
10247797|NCT01740297|11379951|FG002|COMPLETED|Overall Study||37
10247798|NCT01740297|11379949|FG000|NOT COMPLETED|Overall Study||13
10247799|NCT01740297|11379950|FG001|NOT COMPLETED|Overall Study||64
10247800|NCT01740297|11379951|FG002|NOT COMPLETED|Overall Study||61
10247801|NCT01729754|11379965|FG000|STARTED|Part 1||20
10247802|NCT01729754|11379966|FG001|STARTED|Part 1||184
10247803|NCT01729754|11379967|FG002|STARTED|Part 1||110
10247804|NCT01729754|11379968|FG003|STARTED|Part 1||18
10247805|NCT01729754|11379969|FG004|STARTED|Part 1||21
10247806|NCT01729754|11379970|FG005|STARTED|Part 1||268
10247807|NCT01729754|11379971|FG006|STARTED|Part 1||14
10247808|NCT01729754|11379972|FG007|STARTED|Part 1||72
10247809|NCT01729754|11379973|FG008|STARTED|Part 1||70
10247810|NCT01729754|11379974|FG009|STARTED|Part 1||313
10247811|NCT01729754|11379965|FG000|COMPLETED|Part 1||6
10247812|NCT01729754|11379966|FG001|COMPLETED|Part 1||184
10247813|NCT01729754|11379967|FG002|COMPLETED|Part 1||110
10247814|NCT01729754|11379968|FG003|COMPLETED|Part 1||6
10247815|NCT01729754|11379969|FG004|COMPLETED|Part 1||21
10247816|NCT01729754|11379970|FG005|COMPLETED|Part 1||268
10247817|NCT01729754|11379971|FG006|COMPLETED|Part 1||0
10247818|NCT01729754|11379972|FG007|COMPLETED|Part 1||72
10247819|NCT01729754|11379973|FG008|COMPLETED|Part 1||70
10247820|NCT01729754|11379974|FG009|COMPLETED|Part 1||289
10247821|NCT01729754|11379965|FG000|NOT COMPLETED|Part 1||14
10247822|NCT01729754|11379966|FG001|NOT COMPLETED|Part 1||0
10247823|NCT01729754|11379967|FG002|NOT COMPLETED|Part 1||0
10247824|NCT01729754|11379968|FG003|NOT COMPLETED|Part 1||12
10247825|NCT01729754|11379969|FG004|NOT COMPLETED|Part 1||0
10247826|NCT01729754|11379970|FG005|NOT COMPLETED|Part 1||0
10247827|NCT01729754|11379971|FG006|NOT COMPLETED|Part 1||14
10247828|NCT01729754|11379972|FG007|NOT COMPLETED|Part 1||0
10247829|NCT01729754|11379973|FG008|NOT COMPLETED|Part 1||0
10247830|NCT01729754|11379974|FG009|NOT COMPLETED|Part 1||24
10247831|NCT01729754|11379965|FG000|STARTED|Part 2||6
10247832|NCT01729754|11379966|FG001|STARTED|Part 2||184
10247833|NCT01729754|11379967|FG002|STARTED|Part 2||110
10247834|NCT01729754|11379968|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
10247835|NCT01729754|11379969|FG004|STARTED|Part 2||21
10247836|NCT01729754|11379970|FG005|STARTED|Part 2||268
10247837|NCT01729754|11379971|FG006|STARTED|Part 2||0
10247838|NCT01729754|11379972|FG007|STARTED|Part 2||72
10247839|NCT01729754|11379973|FG008|STARTED|Part 2||70
10247840|NCT01729754|11379974|FG009|STARTED|Part 2||289
10247841|NCT01729754|11379965|FG000|COMPLETED|Part 2||0
10247842|NCT01729754|11379966|FG001|COMPLETED|Part 2||184
10247843|NCT01729754|11379967|FG002|COMPLETED|Part 2||110
10247844|NCT01729754|11379968|FG003|COMPLETED|Part 2||0
10247845|NCT01729754|11379969|FG004|COMPLETED|Part 2||21
10247846|NCT01729754|11379970|FG005|COMPLETED|Part 2||268
10247847|NCT01729754|11379971|FG006|COMPLETED|Part 2||0
10247848|NCT01729754|11379972|FG007|COMPLETED|Part 2||69
10247849|NCT01729754|11379973|FG008|COMPLETED|Part 2||66
10247850|NCT01729754|11379974|FG009|COMPLETED|Part 2||277
10247851|NCT01729754|11379965|FG000|NOT COMPLETED|Part 2||6
10247852|NCT01729754|11379966|FG001|NOT COMPLETED|Part 2||0
10247853|NCT01729754|11379967|FG002|NOT COMPLETED|Part 2||0
10247854|NCT01729754|11379968|FG003|NOT COMPLETED|Part 2||5
10247855|NCT01729754|11379969|FG004|NOT COMPLETED|Part 2||0
10247856|NCT01729754|11379970|FG005|NOT COMPLETED|Part 2||0
10247857|NCT01729754|11379971|FG006|NOT COMPLETED|Part 2||0
10247858|NCT01729754|11379972|FG007|NOT COMPLETED|Part 2||3
10247859|NCT01729754|11379973|FG008|NOT COMPLETED|Part 2||4
10247860|NCT01729754|11379974|FG009|NOT COMPLETED|Part 2||12
10247861|NCT01729754|11379965|FG000|STARTED|Part 3||0
10247862|NCT01729754|11379966|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
10247863|NCT01729754|11379967|FG002|STARTED|Part 3||110
10247864|NCT01729754|11379968|FG003|STARTED|Part 3||0
10247865|NCT01729754|11379969|FG004|STARTED|Part 3||21
10247866|NCT01729754|11379970|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
10247867|NCT01729754|11379971|FG006|STARTED|Part 3||0
10247868|NCT01729754|11379972|FG007|STARTED|Part 3||69
10247869|NCT01729754|11379973|FG008|STARTED|Part 3||66
10247870|NCT01729754|11379974|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
10247871|NCT01729754|11379965|FG000|COMPLETED|Part 3||0
10247872|NCT01729754|11379966|FG001|COMPLETED|Part 3||165
10247873|NCT01729754|11379967|FG002|COMPLETED|Part 3||105
10247874|NCT01729754|11379968|FG003|COMPLETED|Part 3||0
10247875|NCT01729754|11379969|FG004|COMPLETED|Part 3||17
10247876|NCT01729754|11379970|FG005|COMPLETED|Part 3||224
10247877|NCT01729754|11379971|FG006|COMPLETED|Part 3||0
10247878|NCT01729754|11379972|FG007|COMPLETED|Part 3||66
10247879|NCT01729754|11379973|FG008|COMPLETED|Part 3||65
10247880|NCT01729754|11379974|FG009|COMPLETED|Part 3||114
10247881|NCT01729754|11379965|FG000|NOT COMPLETED|Part 3||0
10247882|NCT01729754|11379966|FG001|NOT COMPLETED|Part 3||5
10247883|NCT01729754|11379967|FG002|NOT COMPLETED|Part 3||5
10247884|NCT01729754|11379968|FG003|NOT COMPLETED|Part 3||0
10247885|NCT01729754|11379969|FG004|NOT COMPLETED|Part 3||4
10247886|NCT01729754|11379970|FG005|NOT COMPLETED|Part 3||13
10247887|NCT01729754|11379971|FG006|NOT COMPLETED|Part 3||0
10247888|NCT01729754|11379972|FG007|NOT COMPLETED|Part 3||3
10247889|NCT01729754|11379973|FG008|NOT COMPLETED|Part 3||1
10247890|NCT01729754|11379974|FG009|NOT COMPLETED|Part 3||7
10247891|NCT01684826|11380004|FG000|STARTED|Overall Study||49
10247892|NCT01684826|11380004|FG000|Collected Dose and Image Information|Overall Study||39
10247893|NCT01684826|11380004|FG000|COMPLETED|Overall Study||39
10247894|NCT01684826|11380004|FG000|NOT COMPLETED|Overall Study||10
10247895|NCT01672242|11380008|FG000|STARTED|Period 1||4
10247896|NCT01672242|11380009|FG001|STARTED|Period 1||2
10247897|NCT01672242|11380008|FG000|COMPLETED|Period 1||4
10247898|NCT01672242|11380009|FG001|COMPLETED|Period 1||2
10247899|NCT01672242|11380008|FG000|NOT COMPLETED|Period 1||0
10247900|NCT01672242|11380009|FG001|NOT COMPLETED|Period 1||0
10247901|NCT01672242|11380008|FG000|STARTED|Period 2||4
10247902|NCT01672242|11380009|FG001|STARTED|Period 2||2
10247903|NCT01672242|11380008|FG000|COMPLETED|Period 2||4
10247904|NCT01672242|11380009|FG001|COMPLETED|Period 2||2
10247905|NCT01672242|11380008|FG000|NOT COMPLETED|Period 2||0
10247906|NCT01672242|11380009|FG001|NOT COMPLETED|Period 2||0
10247907|NCT01668784|11380017|FG000|STARTED|Randomized (Pre-treatment)||410
10247908|NCT01668784|11380018|FG001|STARTED|Randomized (Pre-treatment)||411
10247909|NCT01668784|11380017|FG000|COMPLETED|Randomized (Pre-treatment)||406
10247910|NCT01668784|11380018|FG001|COMPLETED|Randomized (Pre-treatment)||397
10247911|NCT01668784|11380017|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4
10247912|NCT01668784|11380018|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14
10247913|NCT01668784|11380017|FG000|STARTED|Treated (Overall)||406
10247914|NCT01668784|11380018|FG001|STARTED|Treated (Overall)||397
10247915|NCT01668784|11380017|FG000|COMPLETED|Treated (Overall)||67
10247916|NCT01668784|11380018|FG001|COMPLETED|Treated (Overall)||28
10247917|NCT01668784|11380017|FG000|NOT COMPLETED|Treated (Overall)||339
10019705|NCT01831427|11142845|FG008|COMPLETED|Overall Study||8
10019706|NCT01831427|11142846|FG009|COMPLETED|Overall Study||9
10019707|NCT01831427|11142847|FG010|COMPLETED|Overall Study||5
10019708|NCT01831427|11142837|FG000|NOT COMPLETED|Overall Study||0
10019709|NCT01831427|11142838|FG001|NOT COMPLETED|Overall Study||1
10019710|NCT01831427|11142839|FG002|NOT COMPLETED|Overall Study||0
10019711|NCT01831427|11142840|FG003|NOT COMPLETED|Overall Study||1
10019712|NCT01831427|11142841|FG004|NOT COMPLETED|Overall Study||0
10019713|NCT01831427|11142842|FG005|NOT COMPLETED|Overall Study||1
10019714|NCT01831427|11142843|FG006|NOT COMPLETED|Overall Study||2
10019715|NCT01831427|11142844|FG007|NOT COMPLETED|Overall Study||1
10019716|NCT01831427|11142845|FG008|NOT COMPLETED|Overall Study||0
10019717|NCT01831427|11142846|FG009|NOT COMPLETED|Overall Study||1
10019718|NCT01831427|11142847|FG010|NOT COMPLETED|Overall Study||3
10019719|NCT01831466|11142894|FG000|STARTED|Overall Study|Treated|71
10019720|NCT01831466|11142895|FG001|STARTED|Overall Study|Treated|70
10019721|NCT01831466|11142896|FG002|STARTED|Overall Study|Treated|71
10019722|NCT01831466|11142897|FG003|STARTED|Overall Study|Treated|70
10019723|NCT01831466|11142898|FG004|STARTED|Overall Study|Treated|74
10019724|NCT01831466|11142899|FG005|STARTED|Overall Study|Treated|74
10019725|NCT01831466|11142900|FG006|STARTED|Overall Study|Treated|7
10247918|NCT01668784|11380018|FG001|NOT COMPLETED|Treated (Overall)||369
10247919|NCT01599741|11380024|FG000|STARTED|Overall Study||51
10247920|NCT01599741|11380024|FG000|Collected Dose and Image Information|Overall Study||48
10247921|NCT01599741|11380024|FG000|COMPLETED|Overall Study||48
10247922|NCT01599741|11380024|FG000|NOT COMPLETED|Overall Study||3
10247923|NCT01593852|11380030|FG000|STARTED|Overall Study||68
10247924|NCT01593852|11380031|FG001|STARTED|Overall Study||68
10247925|NCT01593852|11380030|FG000|COMPLETED|Overall Study||68
10247926|NCT01593852|11380031|FG001|COMPLETED|Overall Study||68
10247927|NCT01593852|11380030|FG000|NOT COMPLETED|Overall Study||0
10247928|NCT01593852|11380031|FG001|NOT COMPLETED|Overall Study||0
10247929|NCT01564537|11380039|FG000|STARTED|Overall Study||360
10247930|NCT01564537|11380040|FG001|STARTED|Overall Study||362
10247931|NCT01564537|11380039|FG000|Safety Population: Received Study Drug|Overall Study||360
10247932|NCT01564537|11380040|FG001|Safety Population: Received Study Drug|Overall Study||360
10247933|NCT01564537|11380039|FG000|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
10247934|NCT01564537|11380040|FG001|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
10247935|NCT01564537|11380039|FG000|NOT COMPLETED|Overall Study||6
10247936|NCT01564537|11380040|FG001|NOT COMPLETED|Overall Study||6
10247937|NCT01515306|11380049|FG000|STARTED|Overall Study||24
10247938|NCT01515306|11380050|FG001|STARTED|Overall Study||16
10247939|NCT01515306|11380049|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
10247940|NCT01515306|11380050|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10247941|NCT01515306|11380049|FG000|Cycle 1|Overall Study||24
10247942|NCT01515306|11380050|FG001|Cycle 1|Overall Study||16
10247943|NCT01515306|11380049|FG000|Cycle 2|Overall Study||21
10247944|NCT01515306|11380050|FG001|Cycle 2|Overall Study||15
10247945|NCT01515306|11380049|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
10247946|NCT01515306|11380050|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
10247947|NCT01515306|11380049|FG000|COMPLETED|Overall Study||0
10247948|NCT01515306|11380050|FG001|COMPLETED|Overall Study||2
10247949|NCT01515306|11380049|FG000|NOT COMPLETED|Overall Study||24
10247950|NCT01515306|11380050|FG001|NOT COMPLETED|Overall Study||14
10247951|NCT01423851|11380071|FG000|STARTED|Whole Study||3
10247952|NCT01423851|11380072|FG001|STARTED|Whole Study||3
10247953|NCT01423851|11380073|FG002|STARTED|Whole Study||3
10247954|NCT01423851|11380074|FG003|STARTED|Whole Study||6
10247955|NCT01423851|11380075|FG004|STARTED|Whole Study||3
10247956|NCT01423851|11380076|FG005|STARTED|Whole Study||3
10247957|NCT01423851|11380077|FG006|STARTED|Whole Study||3
10247958|NCT01423851|11380078|FG007|STARTED|Whole Study||8
10247959|NCT01423851|11380079|FG008|STARTED|Whole Study||8
10247960|NCT01423851|11380080|FG009|STARTED|Whole Study||8
10247961|NCT01423851|11380081|FG010|STARTED|Whole Study||29
10247962|NCT01423851|11380071|FG000|COMPLETED|Whole Study||0
10247963|NCT01423851|11380072|FG001|COMPLETED|Whole Study||0
10247964|NCT01423851|11380073|FG002|COMPLETED|Whole Study||0
10247965|NCT01423851|11380074|FG003|COMPLETED|Whole Study||0
10247966|NCT01423851|11380075|FG004|COMPLETED|Whole Study||0
10247967|NCT01423851|11380076|FG005|COMPLETED|Whole Study||0
10019726|NCT01831466|11142901|FG007|STARTED|Overall Study|Treated|7
10019727|NCT01831466|11142902|FG008|STARTED|Overall Study|Treated|7
10019728|NCT01831466|11142903|FG009|STARTED|Overall Study|Treated|7
10019729|NCT01831466|11142904|FG010|STARTED|Overall Study|Treated|6
10019730|NCT01831466|11142905|FG011|STARTED|Overall Study|Treated|7
10019731|NCT01831466|11142894|FG000|COMPLETED|Overall Study||55
10019732|NCT01831466|11142895|FG001|COMPLETED|Overall Study||52
10019733|NCT01831466|11142896|FG002|COMPLETED|Overall Study||48
10019734|NCT01831466|11142897|FG003|COMPLETED|Overall Study||51
10019735|NCT01831466|11142898|FG004|COMPLETED|Overall Study||57
10019736|NCT01831466|11142899|FG005|COMPLETED|Overall Study||48
10019737|NCT01831466|11142900|FG006|COMPLETED|Overall Study||6
10019738|NCT01831466|11142901|FG007|COMPLETED|Overall Study||5
10019739|NCT01831466|11142902|FG008|COMPLETED|Overall Study||4
10019740|NCT01831466|11142903|FG009|COMPLETED|Overall Study||2
10019741|NCT01831466|11142904|FG010|COMPLETED|Overall Study||4
10019742|NCT01831466|11142905|FG011|COMPLETED|Overall Study||3
10019743|NCT01831466|11142894|FG000|NOT COMPLETED|Overall Study||16
10019744|NCT01831466|11142895|FG001|NOT COMPLETED|Overall Study||18
10019745|NCT01831466|11142896|FG002|NOT COMPLETED|Overall Study||23
10019746|NCT01831466|11142897|FG003|NOT COMPLETED|Overall Study||19
10019747|NCT01831466|11142898|FG004|NOT COMPLETED|Overall Study||17
10247968|NCT01423851|11380077|FG006|COMPLETED|Whole Study||0
10247969|NCT01423851|11380078|FG007|COMPLETED|Whole Study||0
10247970|NCT01423851|11380079|FG008|COMPLETED|Whole Study||0
10247971|NCT01423851|11380080|FG009|COMPLETED|Whole Study||0
10247972|NCT01423851|11380081|FG010|COMPLETED|Whole Study||0
10247973|NCT01423851|11380071|FG000|NOT COMPLETED|Whole Study||3
10247974|NCT01423851|11380072|FG001|NOT COMPLETED|Whole Study||3
10247975|NCT01423851|11380073|FG002|NOT COMPLETED|Whole Study||3
10247976|NCT01423851|11380074|FG003|NOT COMPLETED|Whole Study||6
10247977|NCT01423851|11380075|FG004|NOT COMPLETED|Whole Study||3
10247978|NCT01423851|11380076|FG005|NOT COMPLETED|Whole Study||3
10247979|NCT01423851|11380077|FG006|NOT COMPLETED|Whole Study||3
10247980|NCT01423851|11380078|FG007|NOT COMPLETED|Whole Study||8
10247981|NCT01423851|11380079|FG008|NOT COMPLETED|Whole Study||8
10247982|NCT01423851|11380080|FG009|NOT COMPLETED|Whole Study||8
10247983|NCT01423851|11380081|FG010|NOT COMPLETED|Whole Study||29
10247984|NCT01423851|11380071|FG000|STARTED|Dose Finding Period - Escalation||0
10247985|NCT01423851|11380072|FG001|STARTED|Dose Finding Period - Escalation||1
10247986|NCT01423851|11380073|FG002|STARTED|Dose Finding Period - Escalation||4
10247987|NCT01423851|11380074|FG003|STARTED|Dose Finding Period - Escalation||4
10247988|NCT01423851|11380075|FG004|STARTED|Dose Finding Period - Escalation||0
10247989|NCT01423851|11380076|FG005|STARTED|Dose Finding Period - Escalation||0
10247990|NCT01423851|11380077|FG006|STARTED|Dose Finding Period - Escalation||2
10247991|NCT01423851|11380078|FG007|STARTED|Dose Finding Period - Escalation||0
10247992|NCT01423851|11380079|FG008|STARTED|Dose Finding Period - Escalation||1
10247993|NCT01423851|11380080|FG009|STARTED|Dose Finding Period - Escalation||0
10247994|NCT01423851|11380081|FG010|STARTED|Dose Finding Period - Escalation||0
10247995|NCT01423851|11380071|FG000|COMPLETED|Dose Finding Period - Escalation||0
10247996|NCT01423851|11380072|FG001|COMPLETED|Dose Finding Period - Escalation||0
10247997|NCT01423851|11380073|FG002|COMPLETED|Dose Finding Period - Escalation||0
10247998|NCT01423851|11380074|FG003|COMPLETED|Dose Finding Period - Escalation||0
10247999|NCT01423851|11380075|FG004|COMPLETED|Dose Finding Period - Escalation||0
10248000|NCT01423851|11380076|FG005|COMPLETED|Dose Finding Period - Escalation||0
10248001|NCT01423851|11380077|FG006|COMPLETED|Dose Finding Period - Escalation||0
10248002|NCT01423851|11380078|FG007|COMPLETED|Dose Finding Period - Escalation||0
10248003|NCT01423851|11380079|FG008|COMPLETED|Dose Finding Period - Escalation||0
10248004|NCT01423851|11380080|FG009|COMPLETED|Dose Finding Period - Escalation||0
10019748|NCT01831466|11142899|FG005|NOT COMPLETED|Overall Study||26
10248005|NCT01423851|11380081|FG010|COMPLETED|Dose Finding Period - Escalation||0
10248006|NCT01423851|11380071|FG000|NOT COMPLETED|Dose Finding Period - Escalation||0
10248007|NCT01423851|11380072|FG001|NOT COMPLETED|Dose Finding Period - Escalation||1
10248008|NCT01423851|11380073|FG002|NOT COMPLETED|Dose Finding Period - Escalation||4
10248009|NCT01423851|11380074|FG003|NOT COMPLETED|Dose Finding Period - Escalation||4
10248010|NCT01423851|11380075|FG004|NOT COMPLETED|Dose Finding Period - Escalation||0
10248011|NCT01423851|11380076|FG005|NOT COMPLETED|Dose Finding Period - Escalation||0
10248012|NCT01423851|11380077|FG006|NOT COMPLETED|Dose Finding Period - Escalation||2
10248013|NCT01423851|11380078|FG007|NOT COMPLETED|Dose Finding Period - Escalation||0
10248014|NCT01423851|11380079|FG008|NOT COMPLETED|Dose Finding Period - Escalation||1
10248015|NCT01423851|11380080|FG009|NOT COMPLETED|Dose Finding Period - Escalation||0
10248016|NCT01423851|11380081|FG010|NOT COMPLETED|Dose Finding Period - Escalation||0
10248017|NCT01423851|11380071|FG000|STARTED|Dose Finding Period - Reduction||0
10248018|NCT01423851|11380072|FG001|STARTED|Dose Finding Period - Reduction||0
10248019|NCT01423851|11380073|FG002|STARTED|Dose Finding Period - Reduction||3
10248020|NCT01423851|11380074|FG003|STARTED|Dose Finding Period - Reduction||5
10248021|NCT01423851|11380075|FG004|STARTED|Dose Finding Period - Reduction||1
10248022|NCT01423851|11380076|FG005|STARTED|Dose Finding Period - Reduction||2
10248023|NCT01423851|11380077|FG006|STARTED|Dose Finding Period - Reduction||8
10248024|NCT01423851|11380078|FG007|STARTED|Dose Finding Period - Reduction||0
10248025|NCT01423851|11380079|FG008|STARTED|Dose Finding Period - Reduction||3
10248026|NCT01423851|11380080|FG009|STARTED|Dose Finding Period - Reduction||0
10248027|NCT01423851|11380081|FG010|STARTED|Dose Finding Period - Reduction||0
10248028|NCT01423851|11380071|FG000|COMPLETED|Dose Finding Period - Reduction||0
10248029|NCT01423851|11380072|FG001|COMPLETED|Dose Finding Period - Reduction||0
10248030|NCT01423851|11380073|FG002|COMPLETED|Dose Finding Period - Reduction||0
10248031|NCT01423851|11380074|FG003|COMPLETED|Dose Finding Period - Reduction||0
10248032|NCT01423851|11380075|FG004|COMPLETED|Dose Finding Period - Reduction||0
10248033|NCT01423851|11380076|FG005|COMPLETED|Dose Finding Period - Reduction||0
10248034|NCT01423851|11380077|FG006|COMPLETED|Dose Finding Period - Reduction||0
10248035|NCT01423851|11380078|FG007|COMPLETED|Dose Finding Period - Reduction||0
10248036|NCT01423851|11380079|FG008|COMPLETED|Dose Finding Period - Reduction||0
10248037|NCT01423851|11380080|FG009|COMPLETED|Dose Finding Period - Reduction||0
10248038|NCT01423851|11380081|FG010|COMPLETED|Dose Finding Period - Reduction||0
10248039|NCT01423851|11380071|FG000|NOT COMPLETED|Dose Finding Period - Reduction||0
10248040|NCT01423851|11380072|FG001|NOT COMPLETED|Dose Finding Period - Reduction||0
10248041|NCT01423851|11380073|FG002|NOT COMPLETED|Dose Finding Period - Reduction||3
10248042|NCT01423851|11380074|FG003|NOT COMPLETED|Dose Finding Period - Reduction||5
10248043|NCT01423851|11380075|FG004|NOT COMPLETED|Dose Finding Period - Reduction||1
10248044|NCT01423851|11380076|FG005|NOT COMPLETED|Dose Finding Period - Reduction||2
10248045|NCT01423851|11380077|FG006|NOT COMPLETED|Dose Finding Period - Reduction||8
10248046|NCT01423851|11380078|FG007|NOT COMPLETED|Dose Finding Period - Reduction||0
10248047|NCT01423851|11380079|FG008|NOT COMPLETED|Dose Finding Period - Reduction||3
10248048|NCT01423851|11380080|FG009|NOT COMPLETED|Dose Finding Period - Reduction||0
10248049|NCT01423851|11380081|FG010|NOT COMPLETED|Dose Finding Period - Reduction||0
10248050|NCT01385176|11380112|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
10248051|NCT01385176|11380113|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
10248052|NCT01385176|11380112|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
10248053|NCT01385176|11380113|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
10248054|NCT01385176|11380112|FG000|NOT COMPLETED|Randomization Phase||1
10248055|NCT01385176|11380113|FG001|NOT COMPLETED|Randomization Phase||2
10248056|NCT01385176|11380112|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
10248057|NCT01385176|11380113|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
10248058|NCT01385176|11380112|FG000|COMPLETED|6-18 Month All VNS Active||58
10248059|NCT01385176|11380113|FG001|COMPLETED|6-18 Month All VNS Active||27
10248060|NCT01385176|11380112|FG000|NOT COMPLETED|6-18 Month All VNS Active||4
10248061|NCT01385176|11380113|FG001|NOT COMPLETED|6-18 Month All VNS Active||3
10248062|NCT01360593|11380124|FG000|STARTED|Overall Study||35
10248063|NCT01360593|11380124|FG000|COMPLETED|Overall Study||35
10248064|NCT01360593|11380124|FG000|NOT COMPLETED|Overall Study||0
10248065|NCT01354977|11380130|FG000|STARTED|Overall Study||12
10248066|NCT01354977|11380131|FG001|STARTED|Overall Study||8
10248067|NCT01354977|11380130|FG000|COMPLETED|Overall Study||12
10248068|NCT01354977|11380131|FG001|COMPLETED|Overall Study||8
10248069|NCT01354977|11380130|FG000|NOT COMPLETED|Overall Study||0
10248070|NCT01354977|11380131|FG001|NOT COMPLETED|Overall Study||0
10248071|NCT01334606|11380137|FG000|STARTED|Overall Study||21
10248072|NCT01334606|11380137|FG000|COMPLETED|Overall Study||3
10248073|NCT01334606|11380137|FG000|NOT COMPLETED|Overall Study||18
10248074|NCT01317875|11380153|FG000|STARTED|Overall Study||5
10248075|NCT01317875|11380154|FG001|STARTED|Overall Study||3
10248076|NCT01317875|11380155|FG002|STARTED|Overall Study||20
10248077|NCT01317875|11380156|FG003|STARTED|Overall Study||4
10248078|NCT01317875|11380157|FG004|STARTED|Overall Study||12
10248079|NCT01317875|11380158|FG005|STARTED|Overall Study||3
10248080|NCT01317875|11380159|FG006|STARTED|Overall Study||4
10248081|NCT01317875|11380160|FG007|STARTED|Overall Study||18
10248082|NCT01317875|11380161|FG008|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 4|0
10248083|NCT01317875|11380162|FG009|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 5|0
10248084|NCT01317875|11380153|FG000|COMPLETED|Overall Study||2
10248085|NCT01317875|11380154|FG001|COMPLETED|Overall Study||1
10248086|NCT01317875|11380155|FG002|COMPLETED|Overall Study||11
10248087|NCT01317875|11380156|FG003|COMPLETED|Overall Study||2
10248088|NCT01317875|11380157|FG004|COMPLETED|Overall Study||3
10248089|NCT01317875|11380158|FG005|COMPLETED|Overall Study||1
10248090|NCT01317875|11380159|FG006|COMPLETED|Overall Study||2
10248091|NCT01317875|11380160|FG007|COMPLETED|Overall Study||3
10248092|NCT01317875|11380161|FG008|COMPLETED|Overall Study||0
10248093|NCT01317875|11380162|FG009|COMPLETED|Overall Study||0
10248094|NCT01317875|11380153|FG000|NOT COMPLETED|Overall Study||3
10248095|NCT01317875|11380154|FG001|NOT COMPLETED|Overall Study||2
10019749|NCT01831466|11142900|FG006|NOT COMPLETED|Overall Study||1
10019750|NCT01831466|11142901|FG007|NOT COMPLETED|Overall Study||2
10019751|NCT01831466|11142902|FG008|NOT COMPLETED|Overall Study||3
10019752|NCT01831466|11142903|FG009|NOT COMPLETED|Overall Study||5
10248096|NCT01317875|11380155|FG002|NOT COMPLETED|Overall Study||9
10248097|NCT01317875|11380156|FG003|NOT COMPLETED|Overall Study||2
10248098|NCT01317875|11380157|FG004|NOT COMPLETED|Overall Study||9
10248099|NCT01317875|11380158|FG005|NOT COMPLETED|Overall Study||2
10248100|NCT01317875|11380159|FG006|NOT COMPLETED|Overall Study||2
10248101|NCT01317875|11380160|FG007|NOT COMPLETED|Overall Study||15
10248102|NCT01317875|11380161|FG008|NOT COMPLETED|Overall Study||0
10248103|NCT01317875|11380162|FG009|NOT COMPLETED|Overall Study||0
10248104|NCT01226732|11380198|FG000|STARTED|Overall Study||3
10248105|NCT01226732|11380199|FG001|STARTED|Overall Study||3
10248106|NCT01226732|11380200|FG002|STARTED|Overall Study||3
10248107|NCT01226732|11380201|FG003|STARTED|Overall Study||5
10248108|NCT01226732|11380202|FG004|STARTED|Overall Study||3
10248109|NCT01226732|11380203|FG005|STARTED|Overall Study||6
10248110|NCT01226732|11380198|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10248111|NCT01226732|11380199|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10248112|NCT01226732|11380200|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10248113|NCT01226732|11380201|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10248114|NCT01226732|11380202|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10248115|NCT01226732|11380203|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10248116|NCT01226732|11380198|FG000|NOT COMPLETED|Overall Study||3
10248117|NCT01226732|11380199|FG001|NOT COMPLETED|Overall Study||3
10248118|NCT01226732|11380200|FG002|NOT COMPLETED|Overall Study||3
10248119|NCT01226732|11380201|FG003|NOT COMPLETED|Overall Study||5
10248120|NCT01226732|11380202|FG004|NOT COMPLETED|Overall Study||3
10248121|NCT01226732|11380203|FG005|NOT COMPLETED|Overall Study||6
10019753|NCT01831466|11142904|FG010|NOT COMPLETED|Overall Study||2
10248122|NCT01216683|11380227|FG000|STARTED|Induction||65
10248123|NCT01216683|11380228|FG001|STARTED|Induction||99
10248124|NCT01216683|11380229|FG002|STARTED|Induction||125
10248125|NCT01216683|11380227|FG000|Received Treatment and Assessed for Toxicities|Induction||65
10248126|NCT01216683|11380228|FG001|Received Treatment and Assessed for Toxicities|Induction||93
10248127|NCT01216683|11380229|FG002|Received Treatment and Assessed for Toxicities|Induction||122
10248128|NCT01216683|11380227|FG000|Eligible and Treated|Induction||59
10248129|NCT01216683|11380228|FG001|Eligible and Treated|Induction||85
10019754|NCT01831466|11142905|FG011|NOT COMPLETED|Overall Study||4
10019755|NCT01831544|11142925|FG000|STARTED|Overall Study||11
10019756|NCT01831544|11142925|FG000|COMPLETED|Overall Study||8
10019757|NCT01831544|11142925|FG000|NOT COMPLETED|Overall Study||3
10019758|NCT01831726|11142929|FG000|STARTED|Overall Study||80
10248130|NCT01216683|11380229|FG002|Eligible and Treated|Induction||114
10248131|NCT01216683|11380227|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
10019759|NCT01831726|11142929|FG000|COMPLETED|Overall Study||0
10248132|NCT01216683|11380228|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
10248133|NCT01216683|11380229|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
10248134|NCT01216683|11380227|FG000|COMPLETED|Induction||61
10248135|NCT01216683|11380228|FG001|COMPLETED|Induction||80
10248136|NCT01216683|11380229|FG002|COMPLETED|Induction||104
10248137|NCT01216683|11380227|FG000|NOT COMPLETED|Induction||4
10248138|NCT01216683|11380228|FG001|NOT COMPLETED|Induction||19
10248139|NCT01216683|11380229|FG002|NOT COMPLETED|Induction||21
10248140|NCT01216683|11380227|FG000|STARTED|Continuation||59
10248141|NCT01216683|11380228|FG001|STARTED|Continuation||71
10248142|NCT01216683|11380229|FG002|STARTED|Continuation||94
10248143|NCT01216683|11380227|FG000|Received Continuation Treatment|Continuation||59
10248144|NCT01216683|11380228|FG001|Received Continuation Treatment|Continuation||70
10248145|NCT01216683|11380229|FG002|Received Continuation Treatment|Continuation||89
10248146|NCT01216683|11380227|FG000|COMPLETED|Continuation||44
10248147|NCT01216683|11380228|FG001|COMPLETED|Continuation||56
10248148|NCT01216683|11380229|FG002|COMPLETED|Continuation||51
10248149|NCT01216683|11380227|FG000|NOT COMPLETED|Continuation||15
10248150|NCT01216683|11380228|FG001|NOT COMPLETED|Continuation||15
10248151|NCT01216683|11380229|FG002|NOT COMPLETED|Continuation||43
10248152|NCT01085097|11380253|FG000|STARTED|Overall Study||15
10248153|NCT01085097|11380254|FG001|STARTED|Overall Study||16
10248154|NCT01085097|11380255|FG002|STARTED|Overall Study||15
10248155|NCT01085097|11380253|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10248156|NCT01085097|11380254|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10248157|NCT01085097|11380255|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10248158|NCT01085097|11380253|FG000|COMPLETED|Overall Study||13
10248159|NCT01085097|11380254|FG001|COMPLETED|Overall Study||16
10248160|NCT01085097|11380255|FG002|COMPLETED|Overall Study||13
10248161|NCT01085097|11380253|FG000|NOT COMPLETED|Overall Study||2
10248162|NCT01085097|11380254|FG001|NOT COMPLETED|Overall Study||0
10248163|NCT01085097|11380255|FG002|NOT COMPLETED|Overall Study||2
10248164|NCT00920621|11380267|FG000|STARTED|Overall Study||440
10248165|NCT00920621|11380268|FG001|STARTED|Overall Study||436
10248166|NCT00920621|11380269|FG002|STARTED|Overall Study||440
10248167|NCT00920621|11380270|FG003|STARTED|Overall Study||436
10248168|NCT00920621|11380267|FG000|COMPLETED|Overall Study||386
10248169|NCT00920621|11380268|FG001|COMPLETED|Overall Study||391
10248170|NCT00920621|11380269|FG002|COMPLETED|Overall Study||405
10248171|NCT00920621|11380270|FG003|COMPLETED|Overall Study||401
10248172|NCT00920621|11380267|FG000|NOT COMPLETED|Overall Study||54
10248173|NCT00920621|11380268|FG001|NOT COMPLETED|Overall Study||45
10248174|NCT00920621|11380269|FG002|NOT COMPLETED|Overall Study||35
10248175|NCT00920621|11380270|FG003|NOT COMPLETED|Overall Study||35
10248176|NCT00828308|11380281|FG000|STARTED|Overall Study||16
10248177|NCT00828308|11380281|FG000|COMPLETED|Overall Study||16
10248178|NCT00828308|11380281|FG000|NOT COMPLETED|Overall Study||0
9719225|NCT00039377|10818737|FG000|NOT COMPLETED|Initial Registration||22
10248179|NCT00680901|11380287|FG000|STARTED|Overall Study||272
10248180|NCT00680901|11380288|FG001|STARTED|Overall Study||273
10248181|NCT00680901|11380287|FG000|Ongoing: On Study Treatment|Overall Study||16
10248182|NCT00680901|11380288|FG001|Ongoing: On Study Treatment|Overall Study||13
10248183|NCT00680901|11380287|FG000|Ongoing: In Follow Up|Overall Study||45
10248184|NCT00680901|11380288|FG001|Ongoing: In Follow Up|Overall Study||41
10248185|NCT00680901|11380287|FG000|COMPLETED|Overall Study||199
10248186|NCT00680901|11380288|FG001|COMPLETED|Overall Study||197
10248187|NCT00680901|11380287|FG000|NOT COMPLETED|Overall Study||73
10248188|NCT00680901|11380288|FG001|NOT COMPLETED|Overall Study||76
10248189|NCT00667251|11380296|FG000|STARTED|Overall Study||326
10019760|NCT01831726|11142929|FG000|NOT COMPLETED|Overall Study||80
10019761|NCT01831765|11142936|FG000|STARTED|Overall Study||381
10019762|NCT01831765|11142937|FG001|STARTED|Overall Study||382
10248190|NCT00667251|11380297|FG001|STARTED|Overall Study||326
10248191|NCT00667251|11380296|FG000|Combination Rx|Overall Study||322
10248192|NCT00667251|11380297|FG001|Combination Rx|Overall Study||325
10248193|NCT00667251|11380296|FG000|Monotherapy|Overall Study||225
10248194|NCT00667251|11380297|FG001|Monotherapy|Overall Study||232
10248195|NCT00667251|11380296|FG000|Not Started|Overall Study||4
10248196|NCT00667251|11380297|FG001|Not Started|Overall Study||1
10248197|NCT00667251|11380296|FG000|COMPLETED|Overall Study||256
10248198|NCT00667251|11380297|FG001|COMPLETED|Overall Study||231
10248199|NCT00667251|11380296|FG000|NOT COMPLETED|Overall Study||70
10248200|NCT00667251|11380297|FG001|NOT COMPLETED|Overall Study||95
10248201|NCT00600015|11380305|FG000|STARTED|Overall Study||111
10248202|NCT00600015|11380306|FG001|STARTED|Overall Study||55
10248203|NCT00600015|11380305|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51
10248204|NCT00600015|11380306|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20
10248205|NCT00600015|11380305|FG000|NOT COMPLETED|Overall Study||60
10248206|NCT00600015|11380306|FG001|NOT COMPLETED|Overall Study||35
10248207|NCT00500071|11380313|FG000|STARTED|Screening and Washout Phase||318
10248208|NCT00500071|11380313|FG000|COMPLETED|Screening and Washout Phase||317
10248209|NCT00500071|11380313|FG000|NOT COMPLETED|Screening and Washout Phase||1
10248210|NCT00500071|11380313|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
10248211|NCT00500071|11380313|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295
10248212|NCT00500071|11380313|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
10248213|NCT00500071|11380313|FG000|STARTED|30-day Safety Follow-up||295
10248214|NCT00500071|11380313|FG000|COMPLETED|30-day Safety Follow-up||278
10248215|NCT00500071|11380313|FG000|NOT COMPLETED|30-day Safety Follow-up||17
10248216|NCT00447122|11380321|FG000|STARTED|Overall Study||3
10248217|NCT00447122|11380322|FG001|STARTED|Overall Study||11
10248218|NCT00447122|11380323|FG002|STARTED|Overall Study||6
10248219|NCT00447122|11380324|FG003|STARTED|Overall Study||5
10248220|NCT00447122|11380321|FG000|COMPLETED|Overall Study||3
10248221|NCT00447122|11380322|FG001|COMPLETED|Overall Study||10
10248222|NCT00447122|11380323|FG002|COMPLETED|Overall Study||6
10248223|NCT00447122|11380324|FG003|COMPLETED|Overall Study||5
10248224|NCT00447122|11380321|FG000|NOT COMPLETED|Overall Study||0
10248225|NCT00447122|11380322|FG001|NOT COMPLETED|Overall Study||1
10248226|NCT00447122|11380323|FG002|NOT COMPLETED|Overall Study||0
10248227|NCT00447122|11380324|FG003|NOT COMPLETED|Overall Study||0
10248228|NCT00382252|11380334|FG000|STARTED|Overall Study||89
10248229|NCT00382252|11380334|FG000|COMPLETED|Overall Study||76
10248230|NCT00382252|11380334|FG000|NOT COMPLETED|Overall Study||13
10248231|NCT00324805|11380340|FG000|STARTED|Overall Study||749
10248232|NCT00324805|11380341|FG001|STARTED|Overall Study||752
10248233|NCT00324805|11380340|FG000|Started Assigned Therapy|Overall Study||737
10248234|NCT00324805|11380341|FG001|Started Assigned Therapy|Overall Study||735
10248235|NCT00324805|11380340|FG000|COMPLETED|Overall Study||599
10248236|NCT00324805|11380341|FG001|COMPLETED|Overall Study||269
10248237|NCT00324805|11380340|FG000|NOT COMPLETED|Overall Study||150
10248238|NCT00324805|11380341|FG001|NOT COMPLETED|Overall Study||483
10248239|NCT00310180|11380351|FG000|STARTED|Overall Study||1629
10248240|NCT00310180|11380352|FG001|STARTED|Overall Study||3458
10248241|NCT00310180|11380353|FG002|STARTED|Overall Study||3449
10248242|NCT00310180|11380354|FG003|STARTED|Overall Study||1737
10019763|NCT01831765|11142938|FG002|STARTED|Overall Study||380
10019764|NCT01831765|11142936|FG000|Completed 26 Weeks|Overall Study||351
10019765|NCT01831765|11142937|FG001|Completed 26 Weeks|Overall Study||355
10248243|NCT00310180|11380351|FG000|No On-study Data|Overall Study||0
10248244|NCT00310180|11380352|FG001|No On-study Data|Overall Study||2
10248245|NCT00310180|11380353|FG002|No On-study Data|Overall Study||10
10113652|NCT02511431|11244447|FG003|COMPLETED|Post-treatment Follow-up||3
10248246|NCT00310180|11380354|FG003|No On-study Data|Overall Study||172
10248247|NCT00310180|11380351|FG000|Ineligible|Overall Study||3
10248248|NCT00310180|11380352|FG001|Ineligible|Overall Study||4
10248249|NCT00310180|11380353|FG002|Ineligible|Overall Study||6
10248250|NCT00310180|11380354|FG003|Ineligible|Overall Study||7
10248251|NCT00310180|11380351|FG000|No Follow-up Data|Overall Study||7
10248252|NCT00310180|11380352|FG001|No Follow-up Data|Overall Study||55
10019766|NCT01831765|11142938|FG002|Completed 26 Weeks|Overall Study||356
10248253|NCT00310180|11380353|FG002|No Follow-up Data|Overall Study||131
10019767|NCT01831765|11142936|FG000|Completed 52 Weeks|Overall Study||337
10019768|NCT01831765|11142937|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
10248254|NCT00310180|11380354|FG003|No Follow-up Data|Overall Study||245
10248255|NCT00310180|11380351|FG000|COMPLETED|Overall Study||1619
10248256|NCT00310180|11380352|FG001|COMPLETED|Overall Study||3399
10248257|NCT00310180|11380353|FG002|COMPLETED|Overall Study||3312
10248258|NCT00310180|11380354|FG003|COMPLETED|Overall Study||1389
10248259|NCT00310180|11380351|FG000|NOT COMPLETED|Overall Study||10
10248260|NCT00310180|11380352|FG001|NOT COMPLETED|Overall Study||59
10248261|NCT00310180|11380353|FG002|NOT COMPLETED|Overall Study||137
10248262|NCT00310180|11380354|FG003|NOT COMPLETED|Overall Study||348
10248263|NCT00309985|11380366|FG000|STARTED|Overall Study||397
10248264|NCT00309985|11380367|FG001|STARTED|Overall Study||393
10248265|NCT00309985|11380366|FG000|Toxicity Analysis|Overall Study||390
10248266|NCT00309985|11380367|FG001|Toxicity Analysis|Overall Study||392
10248267|NCT00309985|11380366|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334
10248268|NCT00309985|11380367|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299
10248269|NCT00309985|11380366|FG000|COMPLETED|Overall Study||335
10248270|NCT00309985|11380367|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
10248271|NCT00309985|11380366|FG000|NOT COMPLETED|Overall Study||62
10248272|NCT00309985|11380367|FG001|NOT COMPLETED|Overall Study||1
10248273|NCT00290251|11380376|FG000|STARTED|Baseline (Month 1)||14
10248274|NCT00290251|11380377|FG001|STARTED|Baseline (Month 1)||14
10248275|NCT00290251|11380378|FG002|STARTED|Baseline (Month 1)||14
10248276|NCT00290251|11380379|FG003|STARTED|Baseline (Month 1)||0
10019769|NCT01831765|11142938|FG002|Completed 52 Weeks|Overall Study||338
10019770|NCT01831765|11142936|FG000|COMPLETED|Overall Study||337
10019771|NCT01831765|11142937|FG001|COMPLETED|Overall Study||355
10019772|NCT01831765|11142938|FG002|COMPLETED|Overall Study||338
10248277|NCT00290251|11380380|FG004|STARTED|Baseline (Month 1)||0
10248278|NCT00290251|11380381|FG005|STARTED|Baseline (Month 1)||0
10248279|NCT00290251|11380376|FG000|COMPLETED|Baseline (Month 1)||14
10248280|NCT00290251|11380377|FG001|COMPLETED|Baseline (Month 1)||14
10248281|NCT00290251|11380378|FG002|COMPLETED|Baseline (Month 1)||14
10248282|NCT00290251|11380379|FG003|COMPLETED|Baseline (Month 1)||0
10248283|NCT00290251|11380380|FG004|COMPLETED|Baseline (Month 1)||0
10248284|NCT00290251|11380381|FG005|COMPLETED|Baseline (Month 1)||0
10248285|NCT00290251|11380376|FG000|NOT COMPLETED|Baseline (Month 1)||0
10248286|NCT00290251|11380377|FG001|NOT COMPLETED|Baseline (Month 1)||0
10248287|NCT00290251|11380378|FG002|NOT COMPLETED|Baseline (Month 1)||0
10248288|NCT00290251|11380379|FG003|NOT COMPLETED|Baseline (Month 1)||0
10248289|NCT00290251|11380380|FG004|NOT COMPLETED|Baseline (Month 1)||0
10248290|NCT00290251|11380381|FG005|NOT COMPLETED|Baseline (Month 1)||0
10248291|NCT00290251|11380376|FG000|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
10248292|NCT00290251|11380377|FG001|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
10248293|NCT00290251|11380378|FG002|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
10248294|NCT00290251|11380379|FG003|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10248295|NCT00290251|11380380|FG004|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10248296|NCT00290251|11380381|FG005|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10248297|NCT00290251|11380376|FG000|COMPLETED|Treatment 1 (Months 2-4)||0
10248298|NCT00290251|11380377|FG001|COMPLETED|Treatment 1 (Months 2-4)||0
10248299|NCT00290251|11380378|FG002|COMPLETED|Treatment 1 (Months 2-4)||0
10248300|NCT00290251|11380379|FG003|COMPLETED|Treatment 1 (Months 2-4)||13
10248301|NCT00290251|11380380|FG004|COMPLETED|Treatment 1 (Months 2-4)||13
10248302|NCT00290251|11380381|FG005|COMPLETED|Treatment 1 (Months 2-4)||12
10248303|NCT00290251|11380376|FG000|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10248304|NCT00290251|11380377|FG001|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10248305|NCT00290251|11380378|FG002|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10248306|NCT00290251|11380379|FG003|NOT COMPLETED|Treatment 1 (Months 2-4)||1
10248307|NCT00290251|11380380|FG004|NOT COMPLETED|Treatment 1 (Months 2-4)||1
10248308|NCT00290251|11380381|FG005|NOT COMPLETED|Treatment 1 (Months 2-4)||2
10248309|NCT00066963|11380397|FG000|STARTED|Overall Study||126
10248310|NCT00066963|11380398|FG001|STARTED|Overall Study||124
10248311|NCT00066963|11380399|FG002|STARTED|Overall Study||126
10248312|NCT00066963|11380397|FG000|COMPLETED|Overall Study|any follow-up|100
10248313|NCT00066963|11380398|FG001|COMPLETED|Overall Study||93
10248314|NCT00066963|11380399|FG002|COMPLETED|Overall Study||87
10248315|NCT00066963|11380397|FG000|NOT COMPLETED|Overall Study||26
10248316|NCT00066963|11380398|FG001|NOT COMPLETED|Overall Study||31
10248317|NCT00066963|11380399|FG002|NOT COMPLETED|Overall Study||39
10019773|NCT01831765|11142936|FG000|NOT COMPLETED|Overall Study||44
10019774|NCT01831765|11142937|FG001|NOT COMPLETED|Overall Study||27
10019775|NCT01831765|11142938|FG002|NOT COMPLETED|Overall Study||42
10019776|NCT01831791|11142948|FG000|STARTED|Overall Study||120
10019777|NCT01831791|11142948|FG000|COMPLETED|Overall Study||110
10019778|NCT01831791|11142948|FG000|NOT COMPLETED|Overall Study||10
10019779|NCT01831804|11142961|FG000|STARTED|Overall Study||4
10019780|NCT01831804|11142962|FG001|STARTED|Overall Study||3
10019781|NCT01831804|11142963|FG002|STARTED|Overall Study||9
10019782|NCT01831804|11142964|FG003|STARTED|Overall Study||5
10019783|NCT01831804|11142965|FG004|STARTED|Overall Study||5
10019784|NCT01831804|11142966|FG005|STARTED|Overall Study||3
10019785|NCT01831804|11142967|FG006|STARTED|Overall Study||4
10019786|NCT01831804|11142968|FG007|STARTED|Overall Study||26
10019787|NCT01831804|11142969|FG008|STARTED|Overall Study||4
10019788|NCT01831804|11142961|FG000|COMPLETED|Overall Study||3
10019789|NCT01831804|11142962|FG001|COMPLETED|Overall Study||1
10019790|NCT01831804|11142963|FG002|COMPLETED|Overall Study||3
10019791|NCT01831804|11142964|FG003|COMPLETED|Overall Study||5
10019792|NCT01831804|11142965|FG004|COMPLETED|Overall Study||3
10019793|NCT01831804|11142966|FG005|COMPLETED|Overall Study||3
10019794|NCT01831804|11142967|FG006|COMPLETED|Overall Study||3
10019795|NCT01831804|11142968|FG007|COMPLETED|Overall Study||23
10019796|NCT01831804|11142969|FG008|COMPLETED|Overall Study||2
10019797|NCT01831804|11142961|FG000|NOT COMPLETED|Overall Study||1
10019798|NCT01831804|11142962|FG001|NOT COMPLETED|Overall Study||2
10019799|NCT01831804|11142963|FG002|NOT COMPLETED|Overall Study||6
10019800|NCT01831804|11142964|FG003|NOT COMPLETED|Overall Study||0
10019801|NCT01831804|11142965|FG004|NOT COMPLETED|Overall Study||2
10019802|NCT01831804|11142966|FG005|NOT COMPLETED|Overall Study||0
10019803|NCT01831804|11142967|FG006|NOT COMPLETED|Overall Study||1
10019804|NCT01831804|11142968|FG007|NOT COMPLETED|Overall Study||3
10019805|NCT01831804|11142969|FG008|NOT COMPLETED|Overall Study||2
10113653|NCT02511431|11244448|FG004|COMPLETED|Post-treatment Follow-up||3
10113654|NCT02511431|11244449|FG005|COMPLETED|Post-treatment Follow-up||2
10248318|NCT01403948|11380417|FG000|STARTED|Overall Study||1
10248319|NCT01403948|11380418|FG001|STARTED|Overall Study||4
10248320|NCT01403948|11380419|FG002|STARTED|Overall Study||3
10248321|NCT01403948|11380420|FG003|STARTED|Overall Study||4
10248322|NCT01403948|11380421|FG004|STARTED|Overall Study||6
10248323|NCT01403948|11380422|FG005|STARTED|Overall Study||7
10248324|NCT01403948|11380423|FG006|STARTED|Overall Study||6
10248325|NCT01403948|11380424|FG007|STARTED|Overall Study||4
10248326|NCT01403948|11380425|FG008|STARTED|Overall Study||6
10248327|NCT01403948|11380426|FG009|STARTED|Overall Study||7
10248328|NCT01403948|11380417|FG000|COMPLETED|Overall Study||0
10248329|NCT01403948|11380418|FG001|COMPLETED|Overall Study||0
10248330|NCT01403948|11380419|FG002|COMPLETED|Overall Study||0
10248331|NCT01403948|11380420|FG003|COMPLETED|Overall Study||0
10248332|NCT01403948|11380421|FG004|COMPLETED|Overall Study||0
10248333|NCT01403948|11380422|FG005|COMPLETED|Overall Study||0
10248334|NCT01403948|11380423|FG006|COMPLETED|Overall Study||0
10248335|NCT01403948|11380424|FG007|COMPLETED|Overall Study||0
10248336|NCT01403948|11380425|FG008|COMPLETED|Overall Study||0
10248337|NCT01403948|11380426|FG009|COMPLETED|Overall Study||0
10248338|NCT01403948|11380417|FG000|NOT COMPLETED|Overall Study||1
10248339|NCT01403948|11380418|FG001|NOT COMPLETED|Overall Study||4
10248340|NCT01403948|11380419|FG002|NOT COMPLETED|Overall Study||3
10248341|NCT01403948|11380420|FG003|NOT COMPLETED|Overall Study||4
10248342|NCT01403948|11380421|FG004|NOT COMPLETED|Overall Study||6
10248343|NCT01403948|11380422|FG005|NOT COMPLETED|Overall Study||7
10019806|NCT01831817|11143002|FG000|STARTED|Overall Study||35
10019807|NCT01831817|11143003|FG001|STARTED|Overall Study||34
10019808|NCT01831817|11143004|FG002|STARTED|Overall Study||35
10019809|NCT01831817|11143005|FG003|STARTED|Overall Study||36
10019810|NCT01831817|11143002|FG000|COMPLETED|Overall Study||31
10019811|NCT01831817|11143003|FG001|COMPLETED|Overall Study||34
10019812|NCT01831817|11143004|FG002|COMPLETED|Overall Study||35
10019813|NCT01831817|11143005|FG003|COMPLETED|Overall Study||36
10019814|NCT01831817|11143002|FG000|NOT COMPLETED|Overall Study||4
10019815|NCT01831817|11143003|FG001|NOT COMPLETED|Overall Study||0
10019816|NCT01831817|11143004|FG002|NOT COMPLETED|Overall Study||0
10019817|NCT01831817|11143005|FG003|NOT COMPLETED|Overall Study||0
10019818|NCT01831856|11143017|FG000|STARTED|Overall Study||67
10019819|NCT01831856|11143018|FG001|STARTED|Overall Study||67
10019820|NCT01831856|11143017|FG000|COMPLETED|Overall Study||33
10019821|NCT01831856|11143018|FG001|COMPLETED|Overall Study||30
10019822|NCT01831856|11143017|FG000|NOT COMPLETED|Overall Study||34
10019823|NCT01831856|11143018|FG001|NOT COMPLETED|Overall Study||37
10019824|NCT01831921|11143026|FG000|STARTED|Overall Study||150
10019825|NCT01831921|11143027|FG001|STARTED|Overall Study||75
10019826|NCT01831921|11143026|FG000|6 Months|Overall Study||122
10019827|NCT01831921|11143027|FG001|6 Months|Overall Study||63
10019828|NCT01831921|11143026|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
10019829|NCT01831921|11143027|FG001|12 Months|Overall Study||62
10019830|NCT01831921|11143026|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90
10019831|NCT01831921|11143027|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49
10019832|NCT01831921|11143026|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
10019833|NCT01831921|11143027|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
10248344|NCT01403948|11380423|FG006|NOT COMPLETED|Overall Study||6
10019834|NCT01831921|11143026|FG000|NOT COMPLETED|Overall Study||84
10019835|NCT01831921|11143027|FG001|NOT COMPLETED|Overall Study||39
10019836|NCT01831934|11143038|FG000|STARTED|Overall Study||12
10248345|NCT01403948|11380424|FG007|NOT COMPLETED|Overall Study||4
10248346|NCT01403948|11380425|FG008|NOT COMPLETED|Overall Study||6
10019837|NCT01831934|11143039|FG001|STARTED|Overall Study||10
10019838|NCT01831934|11143038|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
10019839|NCT01831934|11143039|FG001|COMPLETED|Overall Study||10
10248347|NCT01403948|11380426|FG009|NOT COMPLETED|Overall Study||7
10248348|NCT01404312|11380454|FG000|STARTED|Overall Study||1496
10248349|NCT01404312|11380455|FG001|STARTED|Overall Study||1504
10248350|NCT01404312|11380454|FG000|COMPLETED|Overall Study||1198
10248351|NCT01404312|11380455|FG001|COMPLETED|Overall Study||1193
10248352|NCT01404312|11380454|FG000|NOT COMPLETED|Overall Study||298
10248353|NCT01404312|11380455|FG001|NOT COMPLETED|Overall Study||311
10248354|NCT01425008|11380481|FG000|STARTED|Dose Escalation Phase||4
10248355|NCT01425008|11380482|FG001|STARTED|Dose Escalation Phase||3
10248356|NCT01425008|11380483|FG002|STARTED|Dose Escalation Phase||3
10248357|NCT01425008|11380484|FG003|STARTED|Dose Escalation Phase||3
10248358|NCT01425008|11380485|FG004|STARTED|Dose Escalation Phase||7
10248359|NCT01425008|11380486|FG005|STARTED|Dose Escalation Phase||7
10248360|NCT01425008|11380487|FG006|STARTED|Dose Escalation Phase||3
10248361|NCT01425008|11380488|FG007|STARTED|Dose Escalation Phase||3
10248362|NCT01425008|11380489|FG008|STARTED|Dose Escalation Phase||13
10248363|NCT01425008|11380490|FG009|STARTED|Dose Escalation Phase||4
10248364|NCT01425008|11380491|FG010|STARTED|Dose Escalation Phase||0
10248365|NCT01425008|11380492|FG011|STARTED|Dose Escalation Phase||0
10248366|NCT01425008|11380493|FG012|STARTED|Dose Escalation Phase||0
10248367|NCT01425008|11380494|FG013|STARTED|Dose Escalation Phase||0
10248368|NCT01425008|11380495|FG014|STARTED|Dose Escalation Phase||0
10248369|NCT01425008|11380496|FG015|STARTED|Dose Escalation Phase||0
10248370|NCT01425008|11380497|FG016|STARTED|Dose Escalation Phase||0
10248371|NCT01425008|11380498|FG017|STARTED|Dose Escalation Phase||0
10248372|NCT01425008|11380499|FG018|STARTED|Dose Escalation Phase||0
10248373|NCT01425008|11380481|FG000|COMPLETED|Dose Escalation Phase||0
10248374|NCT01425008|11380482|FG001|COMPLETED|Dose Escalation Phase||0
10248375|NCT01425008|11380483|FG002|COMPLETED|Dose Escalation Phase||0
10248376|NCT01425008|11380484|FG003|COMPLETED|Dose Escalation Phase||0
10248377|NCT01425008|11380485|FG004|COMPLETED|Dose Escalation Phase||0
10248378|NCT01425008|11380486|FG005|COMPLETED|Dose Escalation Phase||0
10248379|NCT01425008|11380487|FG006|COMPLETED|Dose Escalation Phase||0
10248380|NCT01425008|11380488|FG007|COMPLETED|Dose Escalation Phase||0
10248381|NCT01425008|11380489|FG008|COMPLETED|Dose Escalation Phase||0
10248382|NCT01425008|11380490|FG009|COMPLETED|Dose Escalation Phase||0
10248383|NCT01425008|11380491|FG010|COMPLETED|Dose Escalation Phase||0
10248384|NCT01425008|11380492|FG011|COMPLETED|Dose Escalation Phase||0
10248385|NCT01425008|11380493|FG012|COMPLETED|Dose Escalation Phase||0
10248386|NCT01425008|11380494|FG013|COMPLETED|Dose Escalation Phase||0
10248387|NCT01425008|11380495|FG014|COMPLETED|Dose Escalation Phase||0
10248388|NCT01425008|11380496|FG015|COMPLETED|Dose Escalation Phase||0
10248389|NCT01425008|11380497|FG016|COMPLETED|Dose Escalation Phase||0
10248390|NCT01425008|11380498|FG017|COMPLETED|Dose Escalation Phase||0
10248391|NCT01425008|11380499|FG018|COMPLETED|Dose Escalation Phase||0
10248392|NCT01425008|11380481|FG000|NOT COMPLETED|Dose Escalation Phase||4
10248393|NCT01425008|11380482|FG001|NOT COMPLETED|Dose Escalation Phase||3
10248394|NCT01425008|11380483|FG002|NOT COMPLETED|Dose Escalation Phase||3
10248395|NCT01425008|11380484|FG003|NOT COMPLETED|Dose Escalation Phase||3
10248396|NCT01425008|11380485|FG004|NOT COMPLETED|Dose Escalation Phase||7
10248397|NCT01425008|11380486|FG005|NOT COMPLETED|Dose Escalation Phase||7
10248398|NCT01425008|11380487|FG006|NOT COMPLETED|Dose Escalation Phase||3
10248399|NCT01425008|11380488|FG007|NOT COMPLETED|Dose Escalation Phase||3
10248400|NCT01425008|11380489|FG008|NOT COMPLETED|Dose Escalation Phase||13
10248401|NCT01425008|11380490|FG009|NOT COMPLETED|Dose Escalation Phase||4
10248402|NCT01425008|11380491|FG010|NOT COMPLETED|Dose Escalation Phase||0
10248403|NCT01425008|11380492|FG011|NOT COMPLETED|Dose Escalation Phase||0
10248404|NCT01425008|11380493|FG012|NOT COMPLETED|Dose Escalation Phase||0
10248405|NCT01425008|11380494|FG013|NOT COMPLETED|Dose Escalation Phase||0
10248406|NCT01425008|11380495|FG014|NOT COMPLETED|Dose Escalation Phase||0
10248407|NCT01425008|11380496|FG015|NOT COMPLETED|Dose Escalation Phase||0
10248408|NCT01425008|11380497|FG016|NOT COMPLETED|Dose Escalation Phase||0
10248409|NCT01425008|11380498|FG017|NOT COMPLETED|Dose Escalation Phase||0
10248410|NCT01425008|11380499|FG018|NOT COMPLETED|Dose Escalation Phase||0
10248411|NCT01425008|11380481|FG000|STARTED|Dose Expansion Phase||0
10248412|NCT01425008|11380482|FG001|STARTED|Dose Expansion Phase||0
10248413|NCT01425008|11380483|FG002|STARTED|Dose Expansion Phase||0
10248414|NCT01425008|11380484|FG003|STARTED|Dose Expansion Phase||0
10248415|NCT01425008|11380485|FG004|STARTED|Dose Expansion Phase||0
10248416|NCT01425008|11380486|FG005|STARTED|Dose Expansion Phase||0
10248417|NCT01425008|11380487|FG006|STARTED|Dose Expansion Phase||0
10248418|NCT01425008|11380488|FG007|STARTED|Dose Expansion Phase||0
10248419|NCT01425008|11380489|FG008|STARTED|Dose Expansion Phase||0
10248420|NCT01425008|11380490|FG009|STARTED|Dose Expansion Phase||0
10248421|NCT01425008|11380491|FG010|STARTED|Dose Expansion Phase||16
10248422|NCT01425008|11380492|FG011|STARTED|Dose Expansion Phase||8
10248423|NCT01425008|11380493|FG012|STARTED|Dose Expansion Phase||16
10248424|NCT01425008|11380494|FG013|STARTED|Dose Expansion Phase||1
10248425|NCT01425008|11380495|FG014|STARTED|Dose Expansion Phase||6
10248426|NCT01425008|11380496|FG015|STARTED|Dose Expansion Phase||11
10248427|NCT01425008|11380497|FG016|STARTED|Dose Expansion Phase||20
10248428|NCT01425008|11380498|FG017|STARTED|Dose Expansion Phase||2
10248429|NCT01425008|11380499|FG018|STARTED|Dose Expansion Phase||19
10248430|NCT01425008|11380481|FG000|COMPLETED|Dose Expansion Phase||0
10248431|NCT01425008|11380482|FG001|COMPLETED|Dose Expansion Phase||0
10248432|NCT01425008|11380483|FG002|COMPLETED|Dose Expansion Phase||0
10248433|NCT01425008|11380484|FG003|COMPLETED|Dose Expansion Phase||0
10248434|NCT01425008|11380485|FG004|COMPLETED|Dose Expansion Phase||0
10248435|NCT01425008|11380486|FG005|COMPLETED|Dose Expansion Phase||0
10248436|NCT01425008|11380487|FG006|COMPLETED|Dose Expansion Phase||0
10248437|NCT01425008|11380488|FG007|COMPLETED|Dose Expansion Phase||0
10248438|NCT01425008|11380489|FG008|COMPLETED|Dose Expansion Phase||0
10248439|NCT01425008|11380490|FG009|COMPLETED|Dose Expansion Phase||0
10248440|NCT01425008|11380491|FG010|COMPLETED|Dose Expansion Phase||1
10248441|NCT01425008|11380492|FG011|COMPLETED|Dose Expansion Phase||0
10248442|NCT01425008|11380493|FG012|COMPLETED|Dose Expansion Phase||0
10248443|NCT01425008|11380494|FG013|COMPLETED|Dose Expansion Phase||0
10248444|NCT01425008|11380495|FG014|COMPLETED|Dose Expansion Phase||0
10248445|NCT01425008|11380496|FG015|COMPLETED|Dose Expansion Phase||0
10248446|NCT01425008|11380497|FG016|COMPLETED|Dose Expansion Phase||0
10248447|NCT01425008|11380498|FG017|COMPLETED|Dose Expansion Phase||0
10248448|NCT01425008|11380499|FG018|COMPLETED|Dose Expansion Phase||0
10248449|NCT01425008|11380481|FG000|NOT COMPLETED|Dose Expansion Phase||0
10248450|NCT01425008|11380482|FG001|NOT COMPLETED|Dose Expansion Phase||0
10248451|NCT01425008|11380483|FG002|NOT COMPLETED|Dose Expansion Phase||0
10248452|NCT01425008|11380484|FG003|NOT COMPLETED|Dose Expansion Phase||0
10248453|NCT01425008|11380485|FG004|NOT COMPLETED|Dose Expansion Phase||0
10248454|NCT01425008|11380486|FG005|NOT COMPLETED|Dose Expansion Phase||0
10248455|NCT01425008|11380487|FG006|NOT COMPLETED|Dose Expansion Phase||0
10248456|NCT01425008|11380488|FG007|NOT COMPLETED|Dose Expansion Phase||0
10248457|NCT01425008|11380489|FG008|NOT COMPLETED|Dose Expansion Phase||0
10248458|NCT01425008|11380490|FG009|NOT COMPLETED|Dose Expansion Phase||0
10248459|NCT01425008|11380491|FG010|NOT COMPLETED|Dose Expansion Phase||15
9833377|NCT00779259|10944291|FG000|STARTED|Theophylline With Quinine||22
9833378|NCT00779259|10944291|FG000|COMPLETED|Theophylline With Quinine||22
9833379|NCT00779259|10944291|FG000|NOT COMPLETED|Theophylline With Quinine||0
9833380|NCT00779285|10944309|FG000|STARTED|Overall Study||1
9833381|NCT00779285|10944309|FG000|COMPLETED|Overall Study||1
9833382|NCT00779285|10944309|FG000|NOT COMPLETED|Overall Study||0
9833383|NCT00779311|10944318|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
9833384|NCT00779311|10944319|FG001|STARTED|Overall Study||0
9833385|NCT00779311|10944320|FG002|STARTED|Overall Study||0
9833386|NCT00779311|10944321|FG003|STARTED|Overall Study||0
9833387|NCT00779311|10944322|FG004|STARTED|Overall Study||0
9833388|NCT00779311|10944318|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
9833389|NCT00779311|10944319|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
9833390|NCT00779311|10944320|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
9833391|NCT00779311|10944321|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
9833392|NCT00779311|10944322|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
9833393|NCT00779311|10944318|FG000|COMPLETED|Overall Study||8
9833394|NCT00779311|10944319|FG001|COMPLETED|Overall Study||0
9833395|NCT00779311|10944320|FG002|COMPLETED|Overall Study||0
10248460|NCT01425008|11380492|FG011|NOT COMPLETED|Dose Expansion Phase||8
10248461|NCT01425008|11380493|FG012|NOT COMPLETED|Dose Expansion Phase||16
10248462|NCT01425008|11380494|FG013|NOT COMPLETED|Dose Expansion Phase||1
10248463|NCT01425008|11380495|FG014|NOT COMPLETED|Dose Expansion Phase||6
10248464|NCT01425008|11380496|FG015|NOT COMPLETED|Dose Expansion Phase||11
10248465|NCT01425008|11380497|FG016|NOT COMPLETED|Dose Expansion Phase||20
10248466|NCT01425008|11380498|FG017|NOT COMPLETED|Dose Expansion Phase||2
10248467|NCT01425008|11380499|FG018|NOT COMPLETED|Dose Expansion Phase||19
9833396|NCT00779311|10944321|FG003|COMPLETED|Overall Study||0
9833397|NCT00779311|10944322|FG004|COMPLETED|Overall Study||0
9833398|NCT00779311|10944318|FG000|NOT COMPLETED|Overall Study||0
9833399|NCT00779311|10944319|FG001|NOT COMPLETED|Overall Study||0
9833400|NCT00779311|10944320|FG002|NOT COMPLETED|Overall Study||0
9833401|NCT00779311|10944321|FG003|NOT COMPLETED|Overall Study||0
9833402|NCT00779311|10944322|FG004|NOT COMPLETED|Overall Study||0
9833403|NCT00779324|10944336|FG000|STARTED|Overall Study||82
9833404|NCT00779324|10944337|FG001|STARTED|Overall Study||86
9833405|NCT00779324|10944336|FG000|Completed 28-day Mid-point|Overall Study||80
9833406|NCT00779324|10944337|FG001|Completed 28-day Mid-point|Overall Study||81
9833407|NCT00779324|10944336|FG000|COMPLETED|Overall Study||75
9833408|NCT00779324|10944337|FG001|COMPLETED|Overall Study||82
9833409|NCT00779324|10944336|FG000|NOT COMPLETED|Overall Study||7
9833410|NCT00779324|10944337|FG001|NOT COMPLETED|Overall Study||4
9833411|NCT00779402|10944345|FG000|STARTED|Treatment Phase 1||117
9833412|NCT00779402|10944346|FG001|STARTED|Treatment Phase 1||59
9833413|NCT00779402|10944345|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
9833414|NCT00779402|10944346|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
9833415|NCT00779402|10944345|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
10248468|NCT04425902|11380552|FG000|STARTED|Treatment Period 1 (Days 1 to 10)||20
10248469|NCT04425902|11380552|FG000|COMPLETED|Treatment Period 1 (Days 1 to 10)||20
10248470|NCT04425902|11380552|FG000|NOT COMPLETED|Treatment Period 1 (Days 1 to 10)||0
10248471|NCT04425902|11380552|FG000|STARTED|Treatment Period 2 (Days 11 to 20)||20
10248472|NCT04425902|11380552|FG000|COMPLETED|Treatment Period 2 (Days 11 to 20)||19
10248473|NCT04425902|11380552|FG000|NOT COMPLETED|Treatment Period 2 (Days 11 to 20)||1
10248474|NCT04425902|11380552|FG000|STARTED|Treatment Period 3 (Days 21 to 26)||19
10248475|NCT04425902|11380552|FG000|COMPLETED|Treatment Period 3 (Days 21 to 26)||19
10248476|NCT04425902|11380552|FG000|NOT COMPLETED|Treatment Period 3 (Days 21 to 26)||0
10248477|NCT04072146|11380565|FG000|STARTED|Overall Study||11
9833416|NCT00779402|10944346|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
10248478|NCT04072146|11380566|FG001|STARTED|Overall Study||11
10248479|NCT04072146|11380565|FG000|COMPLETED|Overall Study||11
10248480|NCT04072146|11380566|FG001|COMPLETED|Overall Study||10
10248481|NCT04072146|11380565|FG000|NOT COMPLETED|Overall Study||0
10248482|NCT04072146|11380566|FG001|NOT COMPLETED|Overall Study||1
10248483|NCT03861481|11380580|FG000|STARTED|Overall Study||17
10248484|NCT03861481|11380581|FG001|STARTED|Overall Study||17
10248485|NCT03861481|11380580|FG000|COMPLETED|Overall Study||11
10248486|NCT03861481|11380581|FG001|COMPLETED|Overall Study||10
10248487|NCT03861481|11380580|FG000|NOT COMPLETED|Overall Study||6
10248488|NCT03861481|11380581|FG001|NOT COMPLETED|Overall Study||7
10248489|NCT03708198|11380587|FG000|STARTED|Overall Study||15
10248490|NCT03708198|11380587|FG000|COMPLETED|Overall Study||15
10248491|NCT03708198|11380587|FG000|NOT COMPLETED|Overall Study||0
10248492|NCT03692052|11380591|FG000|STARTED|Core Period (Day 1 to Week 24)||20
10248493|NCT03692052|11380591|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19
10248494|NCT03692052|11380591|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1
10248495|NCT03692052|11380591|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19
10248496|NCT03692052|11380591|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0
10248497|NCT03692052|11380591|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19
10248498|NCT03648476|11380597|FG000|STARTED|Overall Study||10
10248499|NCT03648476|11380598|FG001|STARTED|Overall Study||14
10248500|NCT03648476|11380597|FG000|COMPLETED|Overall Study||8
10248501|NCT03648476|11380598|FG001|COMPLETED|Overall Study||13
10248502|NCT03648476|11380597|FG000|NOT COMPLETED|Overall Study||2
10248503|NCT03648476|11380598|FG001|NOT COMPLETED|Overall Study||1
10248504|NCT03375203|11380610|FG000|STARTED|Overall Study||75
10248505|NCT03375203|11380611|FG001|STARTED|Overall Study||72
10248506|NCT03375203|11380612|FG002|STARTED|Overall Study||74
10248507|NCT03375203|11380613|FG003|STARTED|Overall Study||71
10248508|NCT03375203|11380614|FG004|STARTED|Overall Study||73
10248509|NCT03375203|11380610|FG000|COMPLETED|Overall Study||69
10248510|NCT03375203|11380611|FG001|COMPLETED|Overall Study||68
10248511|NCT03375203|11380612|FG002|COMPLETED|Overall Study||72
10248512|NCT03375203|11380613|FG003|COMPLETED|Overall Study||69
10248513|NCT03375203|11380614|FG004|COMPLETED|Overall Study||69
10248514|NCT03375203|11380610|FG000|NOT COMPLETED|Overall Study||6
10248515|NCT03375203|11380611|FG001|NOT COMPLETED|Overall Study||4
10248516|NCT03375203|11380612|FG002|NOT COMPLETED|Overall Study||2
10248517|NCT03375203|11380613|FG003|NOT COMPLETED|Overall Study||2
10248518|NCT03375203|11380614|FG004|NOT COMPLETED|Overall Study||4
10248519|NCT02926833|11380631|FG000|STARTED|Overall Study||3
10248520|NCT02926833|11380632|FG001|STARTED|Overall Study||4
10248521|NCT02926833|11380633|FG002|STARTED|Overall Study||7
10248522|NCT02926833|11380634|FG003|STARTED|Overall Study||23
10248523|NCT02926833|11380631|FG000|COMPLETED|Overall Study||0
10248524|NCT02926833|11380632|FG001|COMPLETED|Overall Study||0
10248525|NCT02926833|11380633|FG002|COMPLETED|Overall Study||0
10248526|NCT02926833|11380634|FG003|COMPLETED|Overall Study||0
10248527|NCT02926833|11380631|FG000|NOT COMPLETED|Overall Study||3
10248528|NCT02926833|11380632|FG001|NOT COMPLETED|Overall Study||4
10248529|NCT02926833|11380633|FG002|NOT COMPLETED|Overall Study||7
10248530|NCT02926833|11380634|FG003|NOT COMPLETED|Overall Study||23
10248531|NCT02899299|11380647|FG000|STARTED|Pre-treatment||303
10248532|NCT02899299|11380648|FG001|STARTED|Pre-treatment||302
10248533|NCT02899299|11380647|FG000|COMPLETED|Pre-treatment||300
10248534|NCT02899299|11380648|FG001|COMPLETED|Pre-treatment||284
10248535|NCT02899299|11380647|FG000|NOT COMPLETED|Pre-treatment||3
10248536|NCT02899299|11380648|FG001|NOT COMPLETED|Pre-treatment||18
10248537|NCT02899299|11380647|FG000|STARTED|Treatment||300
10248538|NCT02899299|11380648|FG001|STARTED|Treatment||284
10248539|NCT02899299|11380647|FG000|COMPLETED|Treatment||5
10248540|NCT02899299|11380648|FG001|COMPLETED|Treatment||0
10248541|NCT02899299|11380647|FG000|NOT COMPLETED|Treatment||295
10248542|NCT02899299|11380648|FG001|NOT COMPLETED|Treatment||284
10248543|NCT02879448|11380656|FG000|STARTED|Overall Study||934
10248544|NCT02879448|11380657|FG001|STARTED|Overall Study||944
10248545|NCT02879448|11380656|FG000|COMPLETED|Overall Study||796
10248546|NCT02879448|11380657|FG001|COMPLETED|Overall Study||742
10248547|NCT02879448|11380656|FG000|NOT COMPLETED|Overall Study||138
9719226|NCT00039377|10818738|FG001|NOT COMPLETED|Initial Registration||0
10248548|NCT02879448|11380657|FG001|NOT COMPLETED|Overall Study||202
10248549|NCT02547662|11380663|FG000|STARTED|Overall Study||17
10248550|NCT02547662|11380663|FG000|COMPLETED|Overall Study||17
10248551|NCT02547662|11380663|FG000|NOT COMPLETED|Overall Study||0
10248552|NCT02348216|11380674|FG000|STARTED|Overall Study||8
10248553|NCT02348216|11380675|FG001|STARTED|Overall Study||81
10248554|NCT02348216|11380676|FG002|STARTED|Overall Study||30
10248555|NCT02348216|11380677|FG003|STARTED|Overall Study||42
10248556|NCT02348216|11380678|FG004|STARTED|Overall Study||46
10248557|NCT02348216|11380679|FG005|STARTED|Overall Study||58
10248558|NCT02348216|11380680|FG006|STARTED|Overall Study||42
10248559|NCT02348216|11380674|FG000|COMPLETED|Overall Study||0
10248560|NCT02348216|11380675|FG001|COMPLETED|Overall Study||0
10248561|NCT02348216|11380676|FG002|COMPLETED|Overall Study||0
10248562|NCT02348216|11380677|FG003|COMPLETED|Overall Study||0
10019840|NCT01831934|11143038|FG000|NOT COMPLETED|Overall Study||1
10019841|NCT01831934|11143039|FG001|NOT COMPLETED|Overall Study||0
10019842|NCT01831960|11143047|FG000|STARTED|Overall Study||20
10019843|NCT01831960|11143048|FG001|STARTED|Overall Study||22
10019844|NCT01831960|11143047|FG000|COMPLETED|Overall Study||20
10019845|NCT01831960|11143048|FG001|COMPLETED|Overall Study||22
10019846|NCT01831960|11143047|FG000|NOT COMPLETED|Overall Study||0
10019847|NCT01831960|11143048|FG001|NOT COMPLETED|Overall Study||0
10019848|NCT01832038|11143055|FG000|STARTED|Overall Study||473
10019849|NCT01832038|11143055|FG000|COMPLETED|Overall Study||238
10019850|NCT01832038|11143055|FG000|NOT COMPLETED|Overall Study||235
10019851|NCT01832090|11143062|FG000|STARTED|Overall Study||89
10248563|NCT02348216|11380678|FG004|COMPLETED|Overall Study||0
10248564|NCT02348216|11380679|FG005|COMPLETED|Overall Study||0
10248565|NCT02348216|11380680|FG006|COMPLETED|Overall Study||0
10248566|NCT02348216|11380674|FG000|NOT COMPLETED|Overall Study||8
10248567|NCT02348216|11380675|FG001|NOT COMPLETED|Overall Study||81
10248568|NCT02348216|11380676|FG002|NOT COMPLETED|Overall Study||30
10019852|NCT01832090|11143063|FG001|STARTED|Overall Study||29
10019853|NCT01832090|11143062|FG000|COMPLETED|Overall Study||83
10019854|NCT01832090|11143063|FG001|COMPLETED|Overall Study||28
10019855|NCT01832090|11143062|FG000|NOT COMPLETED|Overall Study||6
10019856|NCT01832090|11143063|FG001|NOT COMPLETED|Overall Study||1
10019857|NCT01832155|11143091|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18
10248569|NCT02348216|11380677|FG003|NOT COMPLETED|Overall Study||42
10248570|NCT02348216|11380678|FG004|NOT COMPLETED|Overall Study||46
10248571|NCT02348216|11380679|FG005|NOT COMPLETED|Overall Study||58
10248572|NCT02348216|11380680|FG006|NOT COMPLETED|Overall Study||42
10248573|NCT02275559|11380720|FG000|STARTED|Overall Study||115
10248574|NCT02275559|11380721|FG001|STARTED|Overall Study||118
10248575|NCT02275559|11380720|FG000|COMPLETED|Overall Study||115
10248576|NCT02275559|11380721|FG001|COMPLETED|Overall Study||118
10248577|NCT02275559|11380720|FG000|NOT COMPLETED|Overall Study||0
10248578|NCT02275559|11380721|FG001|NOT COMPLETED|Overall Study||0
10248582|NCT01332968|11380735|FG000|STARTED|Induction Period||699
10248583|NCT01332968|11380736|FG001|STARTED|Induction Period||702
10019858|NCT01832155|11143092|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18
10248584|NCT01332968|11380737|FG002|STARTED|Induction Period||0
10248585|NCT01332968|11380738|FG003|STARTED|Induction Period||0
10248586|NCT01332968|11380739|FG004|STARTED|Induction Period||0
10248587|NCT01332968|11380740|FG005|STARTED|Induction Period||0
10248588|NCT01332968|11380741|FG006|STARTED|Induction Period||0
10248589|NCT01332968|11380742|FG007|STARTED|Induction Period||0
10248590|NCT01332968|11380735|FG000|COMPLETED|Induction Period||641
10248591|NCT01332968|11380736|FG001|COMPLETED|Induction Period||646
10248592|NCT01332968|11380737|FG002|COMPLETED|Induction Period||0
10248593|NCT01332968|11380738|FG003|COMPLETED|Induction Period||0
10248594|NCT01332968|11380739|FG004|COMPLETED|Induction Period||0
10248595|NCT01332968|11380740|FG005|COMPLETED|Induction Period||0
10248596|NCT01332968|11380741|FG006|COMPLETED|Induction Period||0
10248597|NCT01332968|11380742|FG007|COMPLETED|Induction Period||0
10019859|NCT01832155|11143091|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17
10019860|NCT01832155|11143092|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18
10019861|NCT01832155|11143091|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
10019862|NCT01832155|11143092|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
10019863|NCT01832155|11143091|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17
10019864|NCT01832155|11143092|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18
10019865|NCT01832155|11143091|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
10019866|NCT01832155|11143092|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
10019867|NCT01832155|11143091|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
10019868|NCT01832155|11143092|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
10019869|NCT01832155|11143091|FG000|STARTED|End of Study: 4 - 8 Weeks||16
10019870|NCT01832155|11143092|FG001|STARTED|End of Study: 4 - 8 Weeks||18
10019871|NCT01832155|11143091|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16
10019872|NCT01832155|11143092|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18
10019873|NCT01832155|11143091|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
10019874|NCT01832155|11143092|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
10019875|NCT01832259|11143106|FG000|STARTED|Overall Study||15
10019876|NCT01832259|11143107|FG001|STARTED|Overall Study||15
10019877|NCT01832259|11143106|FG000|COMPLETED|Overall Study||15
10019878|NCT01832259|11143107|FG001|COMPLETED|Overall Study||15
10019879|NCT01832259|11143106|FG000|NOT COMPLETED|Overall Study||0
10019880|NCT01832259|11143107|FG001|NOT COMPLETED|Overall Study||0
10248598|NCT01332968|11380735|FG000|NOT COMPLETED|Induction Period||58
10248599|NCT01332968|11380736|FG001|NOT COMPLETED|Induction Period||56
10248600|NCT01332968|11380737|FG002|NOT COMPLETED|Induction Period||0
10019881|NCT01832402|11143115|FG000|STARTED|Overall Study||19
10019882|NCT01832402|11143116|FG001|STARTED|Overall Study||16
10019883|NCT01832402|11143115|FG000|Received Allocated Medication|Overall Study||12
10248601|NCT01332968|11380738|FG003|NOT COMPLETED|Induction Period||0
10248602|NCT01332968|11380739|FG004|NOT COMPLETED|Induction Period||0
10248603|NCT01332968|11380740|FG005|NOT COMPLETED|Induction Period||0
10248604|NCT01332968|11380741|FG006|NOT COMPLETED|Induction Period||0
10248605|NCT01332968|11380742|FG007|NOT COMPLETED|Induction Period||0
10248606|NCT01332968|11380735|FG000|STARTED|Maintenance/Observation Period||0
10248607|NCT01332968|11380736|FG001|STARTED|Maintenance/Observation Period||0
10248608|NCT01332968|11380737|FG002|STARTED|Maintenance/Observation Period||612
10248609|NCT01332968|11380738|FG003|STARTED|Maintenance/Observation Period||624
9833417|NCT00779402|10944345|FG000|Received Booster Infusion|Treatment Phase 1||50
9833418|NCT00779402|10944346|FG001|Received Booster Infusion|Treatment Phase 1||30
9833419|NCT00779402|10944345|FG000|COMPLETED|Treatment Phase 1||84
9833420|NCT00779402|10944346|FG001|COMPLETED|Treatment Phase 1||44
9833421|NCT00779402|10944345|FG000|NOT COMPLETED|Treatment Phase 1||33
9957401|NCT01450761|11076627|FG000|NOT COMPLETED|Randomization||4
10248610|NCT01332968|11380739|FG004|STARTED|Maintenance/Observation Period||12
10248611|NCT01332968|11380740|FG005|STARTED|Maintenance/Observation Period||11
10248612|NCT01332968|11380741|FG006|STARTED|Maintenance/Observation Period||0
10248613|NCT01332968|11380742|FG007|STARTED|Maintenance/Observation Period||0
10248614|NCT01332968|11380735|FG000|COMPLETED|Maintenance/Observation Period||0
10248615|NCT01332968|11380736|FG001|COMPLETED|Maintenance/Observation Period||0
10248616|NCT01332968|11380737|FG002|COMPLETED|Maintenance/Observation Period||399
10248617|NCT01332968|11380738|FG003|COMPLETED|Maintenance/Observation Period||417
10248618|NCT01332968|11380739|FG004|COMPLETED|Maintenance/Observation Period||2
10248619|NCT01332968|11380740|FG005|COMPLETED|Maintenance/Observation Period||2
10248620|NCT01332968|11380741|FG006|COMPLETED|Maintenance/Observation Period||0
10248621|NCT01332968|11380742|FG007|COMPLETED|Maintenance/Observation Period||0
10248622|NCT01332968|11380735|FG000|NOT COMPLETED|Maintenance/Observation Period||0
10248623|NCT01332968|11380736|FG001|NOT COMPLETED|Maintenance/Observation Period||0
10248624|NCT01332968|11380737|FG002|NOT COMPLETED|Maintenance/Observation Period||213
10248625|NCT01332968|11380738|FG003|NOT COMPLETED|Maintenance/Observation Period||207
10248626|NCT01332968|11380739|FG004|NOT COMPLETED|Maintenance/Observation Period||10
10248627|NCT01332968|11380740|FG005|NOT COMPLETED|Maintenance/Observation Period||9
10248628|NCT01332968|11380741|FG006|NOT COMPLETED|Maintenance/Observation Period||0
10248629|NCT01332968|11380742|FG007|NOT COMPLETED|Maintenance/Observation Period||0
10248630|NCT01332968|11380735|FG000|STARTED|Follow-Up Period||0
10248631|NCT01332968|11380736|FG001|STARTED|Follow-Up Period||0
10248632|NCT01332968|11380737|FG002|STARTED|Follow-Up Period||0
10248633|NCT01332968|11380738|FG003|STARTED|Follow-Up Period||0
10248634|NCT01332968|11380739|FG004|STARTED|Follow-Up Period||0
10248635|NCT01332968|11380740|FG005|STARTED|Follow-Up Period||0
10248636|NCT01332968|11380741|FG006|STARTED|Follow-Up Period||542
10248637|NCT01332968|11380742|FG007|STARTED|Follow-Up Period||531
10248638|NCT01332968|11380735|FG000|COMPLETED|Follow-Up Period||0
10248639|NCT01332968|11380736|FG001|COMPLETED|Follow-Up Period||0
10248640|NCT01332968|11380737|FG002|COMPLETED|Follow-Up Period||0
10248641|NCT01332968|11380738|FG003|COMPLETED|Follow-Up Period||0
10248642|NCT01332968|11380739|FG004|COMPLETED|Follow-Up Period||0
10248643|NCT01332968|11380740|FG005|COMPLETED|Follow-Up Period||0
10248644|NCT01332968|11380741|FG006|COMPLETED|Follow-Up Period||0
10248645|NCT01332968|11380742|FG007|COMPLETED|Follow-Up Period||0
10248646|NCT01332968|11380735|FG000|NOT COMPLETED|Follow-Up Period||0
10248647|NCT01332968|11380736|FG001|NOT COMPLETED|Follow-Up Period||0
10248648|NCT01332968|11380737|FG002|NOT COMPLETED|Follow-Up Period||0
10248649|NCT01332968|11380738|FG003|NOT COMPLETED|Follow-Up Period||0
10248650|NCT01332968|11380739|FG004|NOT COMPLETED|Follow-Up Period||0
10248651|NCT01332968|11380740|FG005|NOT COMPLETED|Follow-Up Period||0
10248652|NCT01332968|11380741|FG006|NOT COMPLETED|Follow-Up Period||542
10248653|NCT01332968|11380742|FG007|NOT COMPLETED|Follow-Up Period||531
10248654|NCT01231906|11380752|FG000|STARTED|Overall Study||319
10248655|NCT01231906|11380753|FG001|STARTED|Overall Study||323
10248656|NCT01231906|11380752|FG000|Received Therapy|Overall Study||308
10248657|NCT01231906|11380753|FG001|Received Therapy|Overall Study||318
10248658|NCT01231906|11380752|FG000|COMPLETED|Overall Study||198
10248659|NCT01231906|11380753|FG001|COMPLETED|Overall Study||222
10248660|NCT01231906|11380752|FG000|NOT COMPLETED|Overall Study||121
10248661|NCT01231906|11380753|FG001|NOT COMPLETED|Overall Study||101
9957402|NCT01450761|11076628|FG001|NOT COMPLETED|Randomization||5
10248662|NCT01470326|11380759|FG000|STARTED|Overall Study||3187
10248663|NCT01470326|11380759|FG000|COMPLETED|Overall Study||3034
10248664|NCT01470326|11380759|FG000|NOT COMPLETED|Overall Study||153
10248665|NCT01480180|11380765|FG000|STARTED|Main Phase||174
10248666|NCT01480180|11380766|FG001|STARTED|Main Phase||12
10248667|NCT01480180|11380767|FG002|STARTED|Main Phase|Not applicable for this phase|0
10248668|NCT01480180|11380768|FG003|STARTED|Main Phase|Not applicable for this phase|0
10248669|NCT01480180|11380769|FG004|STARTED|Main Phase|Not applicable for this phase|0
10248670|NCT01480180|11380770|FG005|STARTED|Main Phase|Not applicable for this phase|0
10248671|NCT01480180|11380765|FG000|Max. Participants After Switching|Main Phase||175
10248672|NCT01480180|11380766|FG001|Max. Participants After Switching|Main Phase||11
10248673|NCT01480180|11380767|FG002|Max. Participants After Switching|Main Phase||0
10248674|NCT01480180|11380768|FG003|Max. Participants After Switching|Main Phase||0
10248675|NCT01480180|11380769|FG004|Max. Participants After Switching|Main Phase||0
10248676|NCT01480180|11380770|FG005|Max. Participants After Switching|Main Phase||0
10248677|NCT01480180|11380765|FG000|COMPLETED|Main Phase||155
10248678|NCT01480180|11380766|FG001|COMPLETED|Main Phase||11
10248679|NCT01480180|11380767|FG002|COMPLETED|Main Phase|Not applicable for this phase|0
10248680|NCT01480180|11380768|FG003|COMPLETED|Main Phase|Not applicable for this phase|0
10248681|NCT01480180|11380769|FG004|COMPLETED|Main Phase|Not applicable for this phase|0
10248682|NCT01480180|11380770|FG005|COMPLETED|Main Phase|Not applicable for this phase|0
10248683|NCT01480180|11380765|FG000|NOT COMPLETED|Main Phase||19
10248684|NCT01480180|11380766|FG001|NOT COMPLETED|Main Phase||1
10248685|NCT01480180|11380767|FG002|NOT COMPLETED|Main Phase||0
10248686|NCT01480180|11380768|FG003|NOT COMPLETED|Main Phase||0
10248687|NCT01480180|11380769|FG004|NOT COMPLETED|Main Phase||0
10248688|NCT01480180|11380770|FG005|NOT COMPLETED|Main Phase||0
10248689|NCT01480180|11380765|FG000|STARTED|Extension Phase, Part 1||0
10248690|NCT01480180|11380766|FG001|STARTED|Extension Phase, Part 1||0
10248691|NCT01480180|11380767|FG002|STARTED|Extension Phase, Part 1||105
10248692|NCT01480180|11380768|FG003|STARTED|Extension Phase, Part 1||38
10248693|NCT01480180|11380769|FG004|STARTED|Extension Phase, Part 1||7
10248694|NCT01480180|11380770|FG005|STARTED|Extension Phase, Part 1||0
10248695|NCT01480180|11380765|FG000|COMPLETED|Extension Phase, Part 1||0
10248696|NCT01480180|11380766|FG001|COMPLETED|Extension Phase, Part 1||0
10248697|NCT01480180|11380767|FG002|COMPLETED|Extension Phase, Part 1||95
10248698|NCT01480180|11380768|FG003|COMPLETED|Extension Phase, Part 1||28
10248699|NCT01480180|11380769|FG004|COMPLETED|Extension Phase, Part 1||7
10248700|NCT01480180|11380770|FG005|COMPLETED|Extension Phase, Part 1||0
10248701|NCT01480180|11380765|FG000|NOT COMPLETED|Extension Phase, Part 1||0
10248702|NCT01480180|11380766|FG001|NOT COMPLETED|Extension Phase, Part 1||0
10248703|NCT01480180|11380767|FG002|NOT COMPLETED|Extension Phase, Part 1||10
10248704|NCT01480180|11380768|FG003|NOT COMPLETED|Extension Phase, Part 1||10
10248705|NCT01480180|11380769|FG004|NOT COMPLETED|Extension Phase, Part 1||0
10248706|NCT01480180|11380770|FG005|NOT COMPLETED|Extension Phase, Part 1||0
10248707|NCT01480180|11380765|FG000|STARTED|Extension Phase, Part 2||0
10248708|NCT01480180|11380766|FG001|STARTED|Extension Phase, Part 2||0
10248709|NCT01480180|11380767|FG002|STARTED|Extension Phase, Part 2||94
10248710|NCT01480180|11380768|FG003|STARTED|Extension Phase, Part 2||40
10248711|NCT01480180|11380769|FG004|STARTED|Extension Phase, Part 2||5
10248712|NCT01480180|11380770|FG005|STARTED|Extension Phase, Part 2||0
10248713|NCT01480180|11380765|FG000|COMPLETED|Extension Phase, Part 2||0
10248714|NCT01480180|11380766|FG001|COMPLETED|Extension Phase, Part 2||0
10248715|NCT01480180|11380767|FG002|COMPLETED|Extension Phase, Part 2||77
10248716|NCT01480180|11380768|FG003|COMPLETED|Extension Phase, Part 2||33
10248717|NCT01480180|11380769|FG004|COMPLETED|Extension Phase, Part 2||3
10248718|NCT01480180|11380770|FG005|COMPLETED|Extension Phase, Part 2||0
10248719|NCT01480180|11380765|FG000|NOT COMPLETED|Extension Phase, Part 2||0
10248720|NCT01480180|11380766|FG001|NOT COMPLETED|Extension Phase, Part 2||0
10248721|NCT01480180|11380767|FG002|NOT COMPLETED|Extension Phase, Part 2||17
10248722|NCT01480180|11380768|FG003|NOT COMPLETED|Extension Phase, Part 2||7
10248723|NCT01480180|11380769|FG004|NOT COMPLETED|Extension Phase, Part 2||2
10248724|NCT01480180|11380770|FG005|NOT COMPLETED|Extension Phase, Part 2||0
10248725|NCT01504438|11380793|FG000|STARTED|Overall Study||48
10248726|NCT01504438|11380794|FG001|STARTED|Overall Study||50
10248727|NCT01504438|11380793|FG000|COMPLETED|Overall Study||22
10248728|NCT01504438|11380794|FG001|COMPLETED|Overall Study||25
10248729|NCT01504438|11380793|FG000|NOT COMPLETED|Overall Study||26
10248730|NCT01504438|11380794|FG001|NOT COMPLETED|Overall Study||25
10248731|NCT01545050|11380806|FG000|STARTED|Overall Study||18
10248732|NCT01545050|11380807|FG001|STARTED|Overall Study||9
10248733|NCT01545050|11380808|FG002|STARTED|Overall Study||9
10248734|NCT01545050|11380809|FG003|STARTED|Overall Study||18
10248735|NCT01545050|11380810|FG004|STARTED|Overall Study||18
10248736|NCT01545050|11380806|FG000|COMPLETED|Overall Study||11
10248737|NCT01545050|11380807|FG001|COMPLETED|Overall Study||4
10248738|NCT01545050|11380808|FG002|COMPLETED|Overall Study||4
10248739|NCT01545050|11380809|FG003|COMPLETED|Overall Study||6
10248740|NCT01545050|11380810|FG004|COMPLETED|Overall Study||9
10248741|NCT01545050|11380806|FG000|NOT COMPLETED|Overall Study||7
10248742|NCT01545050|11380807|FG001|NOT COMPLETED|Overall Study||5
10248743|NCT01545050|11380808|FG002|NOT COMPLETED|Overall Study||5
10248744|NCT01545050|11380809|FG003|NOT COMPLETED|Overall Study||12
10248745|NCT01545050|11380810|FG004|NOT COMPLETED|Overall Study||9
10248746|NCT01550302|11380828|FG000|STARTED|Overall Study||5
10248747|NCT01550302|11380829|FG001|STARTED|Overall Study||5
10248748|NCT01550302|11380828|FG000|COMPLETED|Overall Study||5
10248749|NCT01550302|11380829|FG001|COMPLETED|Overall Study||5
10248750|NCT01550302|11380828|FG000|NOT COMPLETED|Overall Study||0
10248751|NCT01550302|11380829|FG001|NOT COMPLETED|Overall Study||0
10019884|NCT01832402|11143116|FG001|Received Allocated Medication|Overall Study||12
10019885|NCT01832402|11143115|FG000|Completed Study With Correct Dose|Overall Study||10
10019886|NCT01832402|11143116|FG001|Completed Study With Correct Dose|Overall Study||9
10019887|NCT01832402|11143115|FG000|Completed Study With Incorrect Dose|Overall Study||2
10019888|NCT01832402|11143116|FG001|Completed Study With Incorrect Dose|Overall Study||3
10019889|NCT01832402|11143115|FG000|COMPLETED|Overall Study||12
10019890|NCT01832402|11143116|FG001|COMPLETED|Overall Study||12
10019891|NCT01832402|11143115|FG000|NOT COMPLETED|Overall Study||7
10019892|NCT01832402|11143116|FG001|NOT COMPLETED|Overall Study||4
10248752|NCT01555021|11380837|FG000|STARTED|Overall Study||2
10248753|NCT01555021|11380838|FG001|STARTED|Overall Study||2
10248754|NCT01555021|11380837|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
10248755|NCT01555021|11380838|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
10248756|NCT01555021|11380837|FG000|NOT COMPLETED|Overall Study||1
10248757|NCT01555021|11380838|FG001|NOT COMPLETED|Overall Study||2
10248758|NCT01561430|11380854|FG000|STARTED|Overall Study||9
10248759|NCT01561430|11380855|FG001|STARTED|Overall Study||23
10248760|NCT01561430|11380856|FG002|STARTED|Overall Study||18
10248761|NCT01561430|11380857|FG003|STARTED|Overall Study||20
10248762|NCT01561430|11380854|FG000|Received at Least One Dose of Study Drug|Overall Study||9
10248763|NCT01561430|11380855|FG001|Received at Least One Dose of Study Drug|Overall Study||23
10248764|NCT01561430|11380856|FG002|Received at Least One Dose of Study Drug|Overall Study||18
10248765|NCT01561430|11380857|FG003|Received at Least One Dose of Study Drug|Overall Study||20
10248766|NCT01561430|11380854|FG000|COMPLETED|Overall Study||8
10248767|NCT01561430|11380855|FG001|COMPLETED|Overall Study||8
10248768|NCT01561430|11380856|FG002|COMPLETED|Overall Study||1
10248769|NCT01561430|11380857|FG003|COMPLETED|Overall Study||7
10248770|NCT01561430|11380854|FG000|NOT COMPLETED|Overall Study||1
10248771|NCT01561430|11380855|FG001|NOT COMPLETED|Overall Study||15
10248772|NCT01561430|11380856|FG002|NOT COMPLETED|Overall Study||17
10248773|NCT01561430|11380857|FG003|NOT COMPLETED|Overall Study||13
10248774|NCT01580813|11380868|FG000|STARTED|Overall Study||4
10248775|NCT01580813|11380869|FG001|STARTED|Overall Study||3
10248776|NCT01580813|11380868|FG000|Completed First Intervention|Overall Study||4
10248777|NCT01580813|11380869|FG001|Completed First Intervention|Overall Study||3
10248778|NCT01580813|11380868|FG000|Completed 1 Week Washout|Overall Study||4
10248779|NCT01580813|11380869|FG001|Completed 1 Week Washout|Overall Study||3
10248780|NCT01580813|11380868|FG000|Started Second Intervention|Overall Study||4
10248781|NCT01580813|11380869|FG001|Started Second Intervention|Overall Study||3
10248782|NCT01580813|11380868|FG000|COMPLETED|Overall Study||4
10248783|NCT01580813|11380869|FG001|COMPLETED|Overall Study||3
10248784|NCT01580813|11380868|FG000|NOT COMPLETED|Overall Study||0
10248785|NCT01580813|11380869|FG001|NOT COMPLETED|Overall Study||0
10248786|NCT01595009|11380877|FG000|STARTED|Core||126
10248787|NCT01595009|11380878|FG001|STARTED|Core||120
10248788|NCT01595009|11380879|FG002|STARTED|Core||0
10248789|NCT01595009|11380880|FG003|STARTED|Core||0
10248790|NCT01595009|11380877|FG000|COMPLETED|Core||0
10248791|NCT01595009|11380878|FG001|COMPLETED|Core||0
10248792|NCT01595009|11380879|FG002|COMPLETED|Core||0
10248793|NCT01595009|11380880|FG003|COMPLETED|Core||0
10248794|NCT01595009|11380877|FG000|NOT COMPLETED|Core||126
10248795|NCT01595009|11380878|FG001|NOT COMPLETED|Core||120
10248796|NCT01595009|11380879|FG002|NOT COMPLETED|Core||0
10248797|NCT01595009|11380880|FG003|NOT COMPLETED|Core||0
10248798|NCT01595009|11380877|FG000|STARTED|Extension||0
10248799|NCT01595009|11380878|FG001|STARTED|Extension||0
10248800|NCT01595009|11380879|FG002|STARTED|Extension||4
10248801|NCT01595009|11380880|FG003|STARTED|Extension||11
10248802|NCT01595009|11380877|FG000|COMPLETED|Extension||0
10248803|NCT01595009|11380878|FG001|COMPLETED|Extension||0
10248804|NCT01595009|11380879|FG002|COMPLETED|Extension||0
10248805|NCT01595009|11380880|FG003|COMPLETED|Extension||0
10248806|NCT01595009|11380877|FG000|NOT COMPLETED|Extension||0
10248807|NCT01595009|11380878|FG001|NOT COMPLETED|Extension||0
10248808|NCT01595009|11380879|FG002|NOT COMPLETED|Extension||4
10248809|NCT01595009|11380880|FG003|NOT COMPLETED|Extension||11
10248810|NCT01613807|11380897|FG000|STARTED|Overall Study||20
10248811|NCT01613807|11380898|FG001|STARTED|Overall Study||20
10248812|NCT01613807|11380897|FG000|COMPLETED|Overall Study||20
10248813|NCT01613807|11380898|FG001|COMPLETED|Overall Study||20
10248814|NCT01613807|11380897|FG000|NOT COMPLETED|Overall Study||0
10248815|NCT01613807|11380898|FG001|NOT COMPLETED|Overall Study||0
10248816|NCT01620944|11380908|FG000|STARTED|Overall Study||2
10248817|NCT01620944|11380909|FG001|STARTED|Overall Study||1
10248818|NCT01620944|11380908|FG000|COMPLETED|Overall Study||0
10248819|NCT01620944|11380909|FG001|COMPLETED|Overall Study||0
10248820|NCT01620944|11380908|FG000|NOT COMPLETED|Overall Study||2
10248821|NCT01620944|11380909|FG001|NOT COMPLETED|Overall Study||1
10248822|NCT01627561|11380917|FG000|STARTED|Overall Study||74
10248823|NCT01627561|11380918|FG001|STARTED|Overall Study||74
10248824|NCT01627561|11380917|FG000|COMPLETED|Overall Study||73
10248825|NCT01627561|11380918|FG001|COMPLETED|Overall Study||71
10248826|NCT01627561|11380917|FG000|NOT COMPLETED|Overall Study||1
10248827|NCT01627561|11380918|FG001|NOT COMPLETED|Overall Study||3
10248840|NCT01652534|11380943|FG000|STARTED|Overall Study||2
10248841|NCT01652534|11380944|FG001|STARTED|Overall Study||1
10248842|NCT01652534|11380943|FG000|COMPLETED|Overall Study||1
10248843|NCT01652534|11380944|FG001|COMPLETED|Overall Study||1
10248844|NCT01652534|11380943|FG000|NOT COMPLETED|Overall Study||1
10248845|NCT01652534|11380944|FG001|NOT COMPLETED|Overall Study||0
10248846|NCT01670565|11380952|FG000|STARTED|Overall Study||10
10248847|NCT01670565|11380953|FG001|STARTED|Overall Study||10
10248848|NCT01670565|11380952|FG000|COMPLETED|Overall Study||9
10248849|NCT01670565|11380953|FG001|COMPLETED|Overall Study||9
10248850|NCT01670565|11380952|FG000|NOT COMPLETED|Overall Study||1
10248851|NCT01670565|11380953|FG001|NOT COMPLETED|Overall Study||1
10248852|NCT04871425|11380963|FG000|STARTED|Overall Study||57
10248853|NCT04871425|11380964|FG001|STARTED|Overall Study||53
10248828|NCT01629511|11380928|FG000|STARTED|Overall Study||4
10248829|NCT01629511|11380929|FG001|STARTED|Overall Study||0
10248830|NCT01629511|11380930|FG002|STARTED|Overall Study||8
10248831|NCT01629511|11380931|FG003|STARTED|Overall Study||3
10248832|NCT01629511|11380928|FG000|COMPLETED|Overall Study||4
10248833|NCT01629511|11380929|FG001|COMPLETED|Overall Study||0
10248834|NCT01629511|11380930|FG002|COMPLETED|Overall Study||8
10248835|NCT01629511|11380931|FG003|COMPLETED|Overall Study||3
10248836|NCT01629511|11380928|FG000|NOT COMPLETED|Overall Study||0
10248837|NCT01629511|11380929|FG001|NOT COMPLETED|Overall Study||0
10248838|NCT01629511|11380930|FG002|NOT COMPLETED|Overall Study||0
10248839|NCT01629511|11380931|FG003|NOT COMPLETED|Overall Study||0
10248854|NCT04871425|11380963|FG000|COMPLETED|Overall Study||42
10248855|NCT04871425|11380964|FG001|COMPLETED|Overall Study||45
10248856|NCT04871425|11380963|FG000|NOT COMPLETED|Overall Study||15
10248857|NCT04871425|11380964|FG001|NOT COMPLETED|Overall Study||8
9833422|NCT00779402|10944346|FG001|NOT COMPLETED|Treatment Phase 1||15
9833423|NCT00779402|10944345|FG000|STARTED|Surveillance Phase||84
9833424|NCT00779402|10944346|FG001|STARTED|Surveillance Phase||44
9833425|NCT00779402|10944345|FG000|COMPLETED|Surveillance Phase||41
9833426|NCT00779402|10944346|FG001|COMPLETED|Surveillance Phase||13
9833427|NCT00779402|10944345|FG000|NOT COMPLETED|Surveillance Phase||43
9833428|NCT00779402|10944346|FG001|NOT COMPLETED|Surveillance Phase||31
9833429|NCT00779402|10944345|FG000|STARTED|Long-term Follow-up||41
9833430|NCT00779402|10944346|FG001|STARTED|Long-term Follow-up||13
9833431|NCT00779402|10944345|FG000|COMPLETED|Long-term Follow-up||20
9833432|NCT00779402|10944346|FG001|COMPLETED|Long-term Follow-up||7
9833433|NCT00779402|10944345|FG000|NOT COMPLETED|Long-term Follow-up||21
9833434|NCT00779402|10944346|FG001|NOT COMPLETED|Long-term Follow-up||6
9833435|NCT00779467|10944356|FG000|STARTED|Overall Study||53
9833436|NCT00779467|10944357|FG001|STARTED|Overall Study||45
9833437|NCT00779467|10944358|FG002|STARTED|Overall Study||48
9833438|NCT00779467|10944359|FG003|STARTED|Overall Study||54
9833439|NCT00779467|10944356|FG000|COMPLETED|Overall Study||38
9833440|NCT00779467|10944357|FG001|COMPLETED|Overall Study||40
9833441|NCT00779467|10944358|FG002|COMPLETED|Overall Study||38
9833442|NCT00779467|10944359|FG003|COMPLETED|Overall Study||35
9833443|NCT00779467|10944356|FG000|NOT COMPLETED|Overall Study||15
9833444|NCT00779467|10944357|FG001|NOT COMPLETED|Overall Study||5
9833445|NCT00779467|10944358|FG002|NOT COMPLETED|Overall Study||10
9833446|NCT00779467|10944359|FG003|NOT COMPLETED|Overall Study||19
9833447|NCT00779506|10944369|FG000|STARTED|Overall Study||96
9833448|NCT00779506|10944369|FG000|Enrolled|Overall Study||96
9833449|NCT00779506|10944369|FG000|Screen Failed|Overall Study||2
9833450|NCT00779506|10944369|FG000|Assigned|Overall Study||94
9833451|NCT00779506|10944369|FG000|MITT|Overall Study||89
9833452|NCT00779506|10944369|FG000|Treatment Complete|Overall Study||67
9833453|NCT00779506|10944369|FG000|Withdrawal Treatment|Overall Study||27
9833454|NCT00779506|10944369|FG000|COMPLETED|Overall Study||67
9833455|NCT00779506|10944369|FG000|NOT COMPLETED|Overall Study||29
9833456|NCT00779558|10944375|FG000|STARTED|Overall Study||57
9833457|NCT00779558|10944376|FG001|STARTED|Overall Study||44
9833458|NCT00779558|10944375|FG000|COMPLETED|Overall Study||53
9833459|NCT00779558|10944376|FG001|COMPLETED|Overall Study||37
9833460|NCT00779558|10944375|FG000|NOT COMPLETED|Overall Study||4
9833461|NCT00779558|10944376|FG001|NOT COMPLETED|Overall Study||7
9833462|NCT00779584|10944391|FG000|STARTED|Overall Study||3
9833463|NCT00779584|10944392|FG001|STARTED|Overall Study||3
10248858|NCT04799405|11380970|FG000|STARTED|Phase 1 - Acute Stimulation, Daily tDCS||5
10248859|NCT04799405|11380970|FG000|COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||3
10248860|NCT04799405|11380970|FG000|NOT COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||2
10248861|NCT04799405|11380970|FG000|STARTED|Phase 2 - Tapered Stimulation Schedule||3
10248862|NCT04799405|11380970|FG000|COMPLETED|Phase 2 - Tapered Stimulation Schedule||3
10248863|NCT04799405|11380970|FG000|NOT COMPLETED|Phase 2 - Tapered Stimulation Schedule||0
10248864|NCT04799405|11380970|FG000|STARTED|Phase 3 - Follow up Phase||3
10248865|NCT04799405|11380970|FG000|COMPLETED|Phase 3 - Follow up Phase||3
10248866|NCT04799405|11380970|FG000|NOT COMPLETED|Phase 3 - Follow up Phase||0
10248867|NCT04748458|11380974|FG000|STARTED|Overall Study||85
10248868|NCT04748458|11380974|FG000|COMPLETED|Overall Study||85
10248869|NCT04748458|11380974|FG000|NOT COMPLETED|Overall Study||0
10248870|NCT04537949|11380986|FG000|STARTED|Overall Study||12
10248871|NCT04537949|11380987|FG001|STARTED|Overall Study||12
10248872|NCT04537949|11380988|FG002|STARTED|Overall Study||12
10248873|NCT04537949|11380989|FG003|STARTED|Overall Study||12
10248874|NCT04537949|11380990|FG004|STARTED|Overall Study||12
10248875|NCT04537949|11380991|FG005|STARTED|Overall Study||12
10248876|NCT04537949|11380992|FG006|STARTED|Overall Study||12
10248877|NCT04537949|11380993|FG007|STARTED|Overall Study||12
10248878|NCT04537949|11380986|FG000|COMPLETED|Overall Study||11
10019893|NCT01832480|11143128|FG000|STARTED|Overall Study||311
10019894|NCT01832480|11143129|FG001|STARTED|Overall Study||312
10019895|NCT01832480|11143128|FG000|COMPLETED|Overall Study||270
10019896|NCT01832480|11143129|FG001|COMPLETED|Overall Study||270
10019897|NCT01832480|11143128|FG000|NOT COMPLETED|Overall Study||41
10019898|NCT01832480|11143129|FG001|NOT COMPLETED|Overall Study||42
10019899|NCT01832493|11143135|FG000|STARTED|Overall Study||50
10248879|NCT04537949|11380987|FG001|COMPLETED|Overall Study||12
10248880|NCT04537949|11380988|FG002|COMPLETED|Overall Study||12
10248881|NCT04537949|11380989|FG003|COMPLETED|Overall Study||12
10248882|NCT04537949|11380990|FG004|COMPLETED|Overall Study||12
10248883|NCT04537949|11380991|FG005|COMPLETED|Overall Study||12
10248884|NCT04537949|11380992|FG006|COMPLETED|Overall Study||12
10248885|NCT04537949|11380993|FG007|COMPLETED|Overall Study||12
10248886|NCT04537949|11380986|FG000|NOT COMPLETED|Overall Study||1
10019900|NCT01832493|11143135|FG000|COMPLETED|Overall Study||42
10019901|NCT01832493|11143135|FG000|NOT COMPLETED|Overall Study||8
10019902|NCT01832506|11143142|FG000|STARTED|Overall Study||3
10248887|NCT04537949|11380987|FG001|NOT COMPLETED|Overall Study||0
10248888|NCT04537949|11380988|FG002|NOT COMPLETED|Overall Study||0
10248889|NCT04537949|11380989|FG003|NOT COMPLETED|Overall Study||0
10019903|NCT01832506|11143143|FG001|STARTED|Overall Study||3
10019904|NCT01832506|11143144|FG002|STARTED|Overall Study||6
10019905|NCT01832506|11143142|FG000|COMPLETED|Overall Study||3
10019906|NCT01832506|11143143|FG001|COMPLETED|Overall Study||3
10019907|NCT01832506|11143144|FG002|COMPLETED|Overall Study||6
10019908|NCT01832506|11143142|FG000|NOT COMPLETED|Overall Study||0
10019909|NCT01832506|11143143|FG001|NOT COMPLETED|Overall Study||0
10019910|NCT01832506|11143144|FG002|NOT COMPLETED|Overall Study||0
10019911|NCT01832532|11143159|FG000|STARTED|Overall Study||23
10019912|NCT01832532|11143160|FG001|STARTED|Overall Study||11
10019913|NCT01832532|11143159|FG000|COMPLETED|Overall Study||18
10019914|NCT01832532|11143160|FG001|COMPLETED|Overall Study||9
10019915|NCT01832532|11143159|FG000|NOT COMPLETED|Overall Study||5
10019916|NCT01832532|11143160|FG001|NOT COMPLETED|Overall Study||2
10019917|NCT01832610|11143166|FG000|STARTED|Overall Study||101
10019918|NCT01832610|11143166|FG000|COMPLETED|Overall Study||97
10019919|NCT01832610|11143166|FG000|NOT COMPLETED|Overall Study||4
10019920|NCT01832727|11143179|FG000|STARTED|Overall Study||9
10019921|NCT01832727|11143180|FG001|STARTED|Overall Study||7
10019922|NCT01832727|11143181|FG002|STARTED|Overall Study||3
10019923|NCT01832727|11143182|FG003|STARTED|Overall Study||4
10019924|NCT01832727|11143183|FG004|STARTED|Overall Study||4
10019925|NCT01832727|11143184|FG005|STARTED|Overall Study||6
10019926|NCT01832727|11143185|FG006|STARTED|Overall Study||8
10019927|NCT01832727|11143186|FG007|STARTED|Overall Study||6
10019928|NCT01832727|11143187|FG008|STARTED|Overall Study||18
10019929|NCT01832727|11143179|FG000|COMPLETED|Overall Study||0
10019930|NCT01832727|11143180|FG001|COMPLETED|Overall Study||0
10019931|NCT01832727|11143181|FG002|COMPLETED|Overall Study||0
10019932|NCT01832727|11143182|FG003|COMPLETED|Overall Study||0
10019933|NCT01832727|11143183|FG004|COMPLETED|Overall Study||0
10019934|NCT01832727|11143184|FG005|COMPLETED|Overall Study||0
10019935|NCT01832727|11143185|FG006|COMPLETED|Overall Study||0
10019936|NCT01832727|11143186|FG007|COMPLETED|Overall Study||0
10019937|NCT01832727|11143187|FG008|COMPLETED|Overall Study||0
10019938|NCT01832727|11143179|FG000|NOT COMPLETED|Overall Study||9
10019939|NCT01832727|11143180|FG001|NOT COMPLETED|Overall Study||7
10019940|NCT01832727|11143181|FG002|NOT COMPLETED|Overall Study||3
10019941|NCT01832727|11143182|FG003|NOT COMPLETED|Overall Study||4
10019942|NCT01832727|11143183|FG004|NOT COMPLETED|Overall Study||4
10019943|NCT01832727|11143184|FG005|NOT COMPLETED|Overall Study||6
10248890|NCT04537949|11380990|FG004|NOT COMPLETED|Overall Study||0
10248891|NCT04537949|11380991|FG005|NOT COMPLETED|Overall Study||0
10248892|NCT04537949|11380992|FG006|NOT COMPLETED|Overall Study||0
10248893|NCT04537949|11380993|FG007|NOT COMPLETED|Overall Study||0
10248894|NCT04529499|11381013|FG000|STARTED|Overall Study||175
10248895|NCT04529499|11381014|FG001|STARTED|Overall Study||178
10248896|NCT04529499|11381013|FG000|Discharged From Hospital Before Day 28|Overall Study||136
10248897|NCT04529499|11381014|FG001|Discharged From Hospital Before Day 28|Overall Study||136
10248898|NCT04529499|11381013|FG000|Completed 10-day Treatment Course of IMP|Overall Study||150
10248899|NCT04529499|11381014|FG001|Completed 10-day Treatment Course of IMP|Overall Study||147
10248900|NCT04529499|11381013|FG000|Completed Day 14 Telephonic Visit|Overall Study||107
10248901|NCT04529499|11381014|FG001|Completed Day 14 Telephonic Visit|Overall Study||102
10248902|NCT04529499|11381013|FG000|Completed Day 21 Telephonic Visit|Overall Study||119
10248903|NCT04529499|11381014|FG001|Completed Day 21 Telephonic Visit|Overall Study||120
10248904|NCT04529499|11381013|FG000|Completed Day 28 Telephonic Visit|Overall Study||134
10248905|NCT04529499|11381014|FG001|Completed Day 28 Telephonic Visit|Overall Study||131
10248906|NCT04529499|11381013|FG000|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||98
10248907|NCT04529499|11381014|FG001|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||94
10248908|NCT04529499|11381013|FG000|Continue to be in Hospital as of Day 28|Overall Study||6
10248909|NCT04529499|11381014|FG001|Continue to be in Hospital as of Day 28|Overall Study||4
10248910|NCT04529499|11381013|FG000|Completed Day 42 Telephonic Visit|Overall Study||136
10248911|NCT04529499|11381014|FG001|Completed Day 42 Telephonic Visit|Overall Study||135
10248912|NCT04529499|11381013|FG000|Completed Day 60 Telephonic Visit|Overall Study||129
10248913|NCT04529499|11381014|FG001|Completed Day 60 Telephonic Visit|Overall Study||132
10248914|NCT04529499|11381013|FG000|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||126
10248915|NCT04529499|11381014|FG001|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||130
10248916|NCT04529499|11381013|FG000|Continued to be in Hospital When Study Was Terminated|Overall Study||11
10248917|NCT04529499|11381014|FG001|Continued to be in Hospital When Study Was Terminated|Overall Study||17
10248918|NCT04529499|11381013|FG000|COMPLETED|Overall Study||139
10248919|NCT04529499|11381014|FG001|COMPLETED|Overall Study||138
10248920|NCT04529499|11381013|FG000|NOT COMPLETED|Overall Study||36
10248921|NCT04529499|11381014|FG001|NOT COMPLETED|Overall Study||40
10248922|NCT04501094|11381022|FG000|STARTED|Overall Study||1
10248923|NCT04501094|11381023|FG001|STARTED|Overall Study||1
10248924|NCT04501094|11381022|FG000|COMPLETED|Overall Study||0
10248925|NCT04501094|11381023|FG001|COMPLETED|Overall Study||1
10248926|NCT04501094|11381022|FG000|NOT COMPLETED|Overall Study||1
10248927|NCT04501094|11381023|FG001|NOT COMPLETED|Overall Study||0
10248928|NCT04414618|11381031|FG000|STARTED|Overall Study||23
10248929|NCT04414618|11381032|FG001|STARTED|Overall Study||19
10248930|NCT04414618|11381031|FG000|COMPLETED|Overall Study||15
10248931|NCT04414618|11381032|FG001|COMPLETED|Overall Study||12
10248932|NCT04414618|11381031|FG000|NOT COMPLETED|Overall Study||8
10248933|NCT04414618|11381032|FG001|NOT COMPLETED|Overall Study||7
10248934|NCT04412057|11381041|FG000|STARTED|Overall Study||41
10248935|NCT04412057|11381042|FG001|STARTED|Overall Study||42
10248936|NCT04412057|11381041|FG000|Randomized Analysis Set|Overall Study||41
10248937|NCT04412057|11381042|FG001|Randomized Analysis Set|Overall Study||42
10248938|NCT04412057|11381041|FG000|Safety Analysis Set|Overall Study||40
10248939|NCT04412057|11381042|FG001|Safety Analysis Set|Overall Study||42
10248940|NCT04412057|11381041|FG000|Full Analysis Set|Overall Study||40
10248941|NCT04412057|11381042|FG001|Full Analysis Set|Overall Study||42
10248942|NCT04412057|11381041|FG000|Primary Analysis Set|Overall Study||31
10248943|NCT04412057|11381042|FG001|Primary Analysis Set|Overall Study||31
10248944|NCT04412057|11381041|FG000|COMPLETED|Overall Study||37
10248945|NCT04412057|11381042|FG001|COMPLETED|Overall Study||35
10248946|NCT04412057|11381041|FG000|NOT COMPLETED|Overall Study||4
10248947|NCT04412057|11381042|FG001|NOT COMPLETED|Overall Study||7
10248948|NCT04402060|11381051|FG000|STARTED|Overall Study||6
10248949|NCT04402060|11381052|FG001|STARTED|Overall Study||34
10248950|NCT04402060|11381053|FG002|STARTED|Overall Study||32
10248951|NCT04402060|11381051|FG000|Received Treatment|Overall Study||6
10248952|NCT04402060|11381052|FG001|Received Treatment|Overall Study||33
10248953|NCT04402060|11381053|FG002|Received Treatment|Overall Study||32
10248954|NCT04402060|11381051|FG000|COMPLETED|Overall Study||5
10248955|NCT04402060|11381052|FG001|COMPLETED|Overall Study||18
10248956|NCT04402060|11381053|FG002|COMPLETED|Overall Study||21
10248957|NCT04402060|11381051|FG000|NOT COMPLETED|Overall Study||1
10248958|NCT04402060|11381052|FG001|NOT COMPLETED|Overall Study||16
10248959|NCT04402060|11381053|FG002|NOT COMPLETED|Overall Study||11
10248960|NCT04396626|11381066|FG000|STARTED|Overall Study||975
10248961|NCT04396626|11381066|FG000|COMPLETED|Overall Study||0
10248962|NCT04396626|11381066|FG000|NOT COMPLETED|Overall Study||975
10248963|NCT04391179|11381072|FG000|STARTED|Overall Study||49
10248964|NCT04391179|11381073|FG001|STARTED|Overall Study||50
10248965|NCT04391179|11381072|FG000|COMPLETED|Overall Study||34
10248966|NCT04391179|11381073|FG001|COMPLETED|Overall Study||34
10248967|NCT04391179|11381072|FG000|NOT COMPLETED|Overall Study||15
10248968|NCT04391179|11381073|FG001|NOT COMPLETED|Overall Study||16
10248969|NCT04386096|11381081|FG000|STARTED|Overall Study||20
10248970|NCT04386096|11381082|FG001|STARTED|Overall Study||20
10248971|NCT04386096|11381081|FG000|COMPLETED|Overall Study||20
10248972|NCT04386096|11381082|FG001|COMPLETED|Overall Study||20
10248973|NCT04386096|11381081|FG000|NOT COMPLETED|Overall Study||0
10248974|NCT04386096|11381082|FG001|NOT COMPLETED|Overall Study||0
10248975|NCT04376684|11381092|FG000|STARTED|Part 1 (Up to Day 60)||403
10248976|NCT04376684|11381093|FG001|STARTED|Part 1 (Up to Day 60)||403
10248977|NCT04376684|11381094|FG002|STARTED|Part 1 (Up to Day 60)||0
10248978|NCT04376684|11381095|FG003|STARTED|Part 1 (Up to Day 60)||0
10248979|NCT04376684|11381092|FG000|COMPLETED|Part 1 (Up to Day 60)||388
10248980|NCT04376684|11381093|FG001|COMPLETED|Part 1 (Up to Day 60)||379
10248981|NCT04376684|11381094|FG002|COMPLETED|Part 1 (Up to Day 60)||0
10248982|NCT04376684|11381095|FG003|COMPLETED|Part 1 (Up to Day 60)||0
10248983|NCT04376684|11381092|FG000|NOT COMPLETED|Part 1 (Up to Day 60)||15
10248984|NCT04376684|11381093|FG001|NOT COMPLETED|Part 1 (Up to Day 60)||24
10248985|NCT04376684|11381094|FG002|NOT COMPLETED|Part 1 (Up to Day 60)||0
10248986|NCT04376684|11381095|FG003|NOT COMPLETED|Part 1 (Up to Day 60)||0
10248987|NCT04376684|11381092|FG000|STARTED|Part 2 (Up to Day 60)||0
10248988|NCT04376684|11381093|FG001|STARTED|Part 2 (Up to Day 60)||0
10248989|NCT04376684|11381094|FG002|STARTED|Part 2 (Up to Day 60)||175
10248990|NCT04376684|11381095|FG003|STARTED|Part 2 (Up to Day 60)||175
10248991|NCT04376684|11381092|FG000|COMPLETED|Part 2 (Up to Day 60)||0
10248992|NCT04376684|11381093|FG001|COMPLETED|Part 2 (Up to Day 60)||0
10248993|NCT04376684|11381094|FG002|COMPLETED|Part 2 (Up to Day 60)||170
10248994|NCT04376684|11381095|FG003|COMPLETED|Part 2 (Up to Day 60)||171
10248995|NCT04376684|11381092|FG000|NOT COMPLETED|Part 2 (Up to Day 60)||0
10248996|NCT04376684|11381093|FG001|NOT COMPLETED|Part 2 (Up to Day 60)||0
10248997|NCT04376684|11381094|FG002|NOT COMPLETED|Part 2 (Up to Day 60)||5
10248998|NCT04376684|11381095|FG003|NOT COMPLETED|Part 2 (Up to Day 60)||4
10248999|NCT04353284|11381107|FG000|STARTED|Overall Study||35
10249000|NCT04353284|11381108|FG001|STARTED|Overall Study||35
10249001|NCT04353284|11381107|FG000|COMPLETED|Overall Study||33
10249002|NCT04353284|11381108|FG001|COMPLETED|Overall Study||34
10249003|NCT04353284|11381107|FG000|NOT COMPLETED|Overall Study||2
10249004|NCT04353284|11381108|FG001|NOT COMPLETED|Overall Study||1
10249005|NCT04294147|11381116|FG000|STARTED|Overall Study||32
10249006|NCT04294147|11381117|FG001|STARTED|Overall Study||33
10249007|NCT04294147|11381116|FG000|Received at Least One Dose of Study Drug|Overall Study||32
10249008|NCT04294147|11381117|FG001|Received at Least One Dose of Study Drug|Overall Study||33
10249009|NCT04294147|11381116|FG000|COMPLETED|Overall Study||30
10249010|NCT04294147|11381117|FG001|COMPLETED|Overall Study||33
10249011|NCT04294147|11381116|FG000|NOT COMPLETED|Overall Study||2
10249012|NCT04294147|11381117|FG001|NOT COMPLETED|Overall Study||0
10249013|NCT04269707|11381123|FG000|STARTED|Overall Study||7
10249014|NCT04269707|11381123|FG000|COMPLETED|Overall Study||7
10249015|NCT04269707|11381123|FG000|NOT COMPLETED|Overall Study||0
10249016|NCT04231825|11381129|FG000|STARTED|Overall Study||23
10249017|NCT04231825|11381130|FG001|STARTED|Overall Study||24
10249018|NCT04231825|11381129|FG000|COMPLETED|Overall Study||20
10249019|NCT04231825|11381130|FG001|COMPLETED|Overall Study||20
10249020|NCT04231825|11381129|FG000|NOT COMPLETED|Overall Study||3
10249021|NCT04231825|11381130|FG001|NOT COMPLETED|Overall Study||4
10249022|NCT04196686|11381136|FG000|STARTED|First Treatment (4 Minutes)||78
10249023|NCT04196686|11381137|FG001|STARTED|First Treatment (4 Minutes)||78
10249024|NCT04196686|11381136|FG000|COMPLETED|First Treatment (4 Minutes)||78
10249025|NCT04196686|11381137|FG001|COMPLETED|First Treatment (4 Minutes)||75
10249026|NCT04196686|11381136|FG000|NOT COMPLETED|First Treatment (4 Minutes)||0
10249027|NCT04196686|11381137|FG001|NOT COMPLETED|First Treatment (4 Minutes)||3
10249028|NCT04196686|11381136|FG000|STARTED|Second Treatment (4 Minutes)||78
10249029|NCT04196686|11381137|FG001|STARTED|Second Treatment (4 Minutes)||75
10249030|NCT04196686|11381136|FG000|COMPLETED|Second Treatment (4 Minutes)||78
10249031|NCT04196686|11381137|FG001|COMPLETED|Second Treatment (4 Minutes)||75
10249032|NCT04196686|11381136|FG000|NOT COMPLETED|Second Treatment (4 Minutes)||0
10249033|NCT04196686|11381137|FG001|NOT COMPLETED|Second Treatment (4 Minutes)||0
10249034|NCT04178772|11381143|FG000|STARTED|Overall Study||27
10249035|NCT04178772|11381143|FG000|COMPLETED|Overall Study||19
10249036|NCT04178772|11381143|FG000|NOT COMPLETED|Overall Study||8
10249037|NCT04148651|11381147|FG000|STARTED|Overall Study||12
10249038|NCT04148651|11381147|FG000|COMPLETED|Overall Study|2 subjects did not complete the final follow-up due to COVID-19 pandemic|10
10249039|NCT04148651|11381147|FG000|NOT COMPLETED|Overall Study||2
10249040|NCT04113304|11381152|FG000|STARTED|Overall Study||6
10249041|NCT04113304|11381152|FG000|COMPLETED|Overall Study||6
10249042|NCT04113304|11381152|FG000|NOT COMPLETED|Overall Study||0
10249043|NCT03929588|11381156|FG000|STARTED|Overall Study||230
10249044|NCT03929588|11381156|FG000|COMPLETED|Overall Study||143
10249045|NCT03929588|11381156|FG000|NOT COMPLETED|Overall Study||87
10019944|NCT01832727|11143185|FG006|NOT COMPLETED|Overall Study||8
10249046|NCT03893448|11381162|FG000|STARTED|Overall Study||860
10249047|NCT03893448|11381163|FG001|STARTED|Overall Study||860
10249048|NCT03893448|11381162|FG000|Treated|Overall Study||858
10249049|NCT03893448|11381163|FG001|Treated|Overall Study||856
10249050|NCT03893448|11381162|FG000|COMPLETED|Overall Study||758
10249051|NCT03893448|11381163|FG001|COMPLETED|Overall Study||734
10249052|NCT03893448|11381162|FG000|NOT COMPLETED|Overall Study||102
10249053|NCT03893448|11381163|FG001|NOT COMPLETED|Overall Study||126
10249054|NCT03870880|11381176|FG000|STARTED|Overall Study||27
10249055|NCT03870880|11381177|FG001|STARTED|Overall Study||58
10249056|NCT03870880|11381178|FG002|STARTED|Overall Study||31
10249057|NCT03870880|11381179|FG003|STARTED|Overall Study||28
10249058|NCT03870880|11381180|FG004|STARTED|Overall Study||61
10249059|NCT03870880|11381181|FG005|STARTED|Overall Study||10
10249060|NCT03870880|11381176|FG000|COMPLETED|Overall Study||21
10249061|NCT03870880|11381177|FG001|COMPLETED|Overall Study||43
10249062|NCT03870880|11381178|FG002|COMPLETED|Overall Study||26
10249063|NCT03870880|11381179|FG003|COMPLETED|Overall Study||20
10249064|NCT03870880|11381180|FG004|COMPLETED|Overall Study||44
10249065|NCT03870880|11381181|FG005|COMPLETED|Overall Study||7
10249066|NCT03870880|11381176|FG000|NOT COMPLETED|Overall Study||6
10249067|NCT03870880|11381177|FG001|NOT COMPLETED|Overall Study||15
10249068|NCT03870880|11381178|FG002|NOT COMPLETED|Overall Study||5
10249069|NCT03870880|11381179|FG003|NOT COMPLETED|Overall Study||8
10249070|NCT03870880|11381180|FG004|NOT COMPLETED|Overall Study||17
10249071|NCT03870880|11381181|FG005|NOT COMPLETED|Overall Study||3
10249072|NCT03831347|11381200|FG000|STARTED|Overall Study||11
10249073|NCT03831347|11381200|FG000|COMPLETED|Overall Study||9
10249074|NCT03831347|11381200|FG000|NOT COMPLETED|Overall Study||2
10249075|NCT03814590|11381218|FG000|STARTED|Overall Study||12
10249076|NCT03814590|11381219|FG001|STARTED|Overall Study||12
10249077|NCT03814590|11381220|FG002|STARTED|Overall Study||12
10249078|NCT03814590|11381221|FG003|STARTED|Overall Study||12
10249079|NCT03814590|11381222|FG004|STARTED|Overall Study||101
10249080|NCT03814590|11381223|FG005|STARTED|Overall Study||97
10249081|NCT03814590|11381224|FG006|STARTED|Overall Study||100
10249082|NCT03814590|11381225|FG007|STARTED|Overall Study||101
10249083|NCT03814590|11381226|FG008|STARTED|Overall Study||101
10249084|NCT03814590|11381227|FG009|STARTED|Overall Study||100
10249085|NCT03814590|11381228|FG010|STARTED|Overall Study||103
10249086|NCT03814590|11381229|FG011|STARTED|Overall Study||100
10249087|NCT03814590|11381230|FG012|STARTED|Overall Study||101
10249088|NCT03814590|11381231|FG013|STARTED|Overall Study||101
10249089|NCT03814590|11381218|FG000|COMPLETED|Overall Study||12
10249090|NCT03814590|11381219|FG001|COMPLETED|Overall Study||10
10249091|NCT03814590|11381220|FG002|COMPLETED|Overall Study||11
10249092|NCT03814590|11381221|FG003|COMPLETED|Overall Study||12
10249093|NCT03814590|11381222|FG004|COMPLETED|Overall Study||100
10249094|NCT03814590|11381223|FG005|COMPLETED|Overall Study||92
10249095|NCT03814590|11381224|FG006|COMPLETED|Overall Study||97
10249096|NCT03814590|11381225|FG007|COMPLETED|Overall Study||95
10249097|NCT03814590|11381226|FG008|COMPLETED|Overall Study||101
10249098|NCT03814590|11381227|FG009|COMPLETED|Overall Study||95
10249099|NCT03814590|11381228|FG010|COMPLETED|Overall Study||100
10249100|NCT03814590|11381229|FG011|COMPLETED|Overall Study||100
10249101|NCT03814590|11381230|FG012|COMPLETED|Overall Study||97
10249102|NCT03814590|11381231|FG013|COMPLETED|Overall Study||98
10249103|NCT03814590|11381218|FG000|NOT COMPLETED|Overall Study||0
10249104|NCT03814590|11381219|FG001|NOT COMPLETED|Overall Study||2
10249105|NCT03814590|11381220|FG002|NOT COMPLETED|Overall Study||1
10249106|NCT03814590|11381221|FG003|NOT COMPLETED|Overall Study||0
10249107|NCT03814590|11381222|FG004|NOT COMPLETED|Overall Study||1
10249108|NCT03814590|11381223|FG005|NOT COMPLETED|Overall Study||5
10249109|NCT03814590|11381224|FG006|NOT COMPLETED|Overall Study||3
10249110|NCT03814590|11381225|FG007|NOT COMPLETED|Overall Study||6
10249111|NCT03814590|11381226|FG008|NOT COMPLETED|Overall Study||0
10249112|NCT03814590|11381227|FG009|NOT COMPLETED|Overall Study||5
10249113|NCT03814590|11381228|FG010|NOT COMPLETED|Overall Study||3
10249114|NCT03814590|11381229|FG011|NOT COMPLETED|Overall Study||0
10249115|NCT03814590|11381230|FG012|NOT COMPLETED|Overall Study||4
10249116|NCT03814590|11381231|FG013|NOT COMPLETED|Overall Study||3
9833464|NCT00779584|10944393|FG002|STARTED|Overall Study||7
9833465|NCT00779584|10944394|FG003|STARTED|Overall Study||6
9833466|NCT00779584|10944395|FG004|STARTED|Overall Study||7
9833467|NCT00779584|10944396|FG005|STARTED|Overall Study||6
9957403|NCT01450761|11076627|FG000|STARTED|Lead-in Chemotherapy||562
9957404|NCT01450761|11076628|FG001|STARTED|Lead-in Chemotherapy||561
9957405|NCT01450761|11076627|FG000|COMPLETED|Lead-in Chemotherapy||478
9957406|NCT01450761|11076628|FG001|COMPLETED|Lead-in Chemotherapy||476
9957407|NCT01450761|11076627|FG000|NOT COMPLETED|Lead-in Chemotherapy||84
9833468|NCT00779584|10944397|FG006|STARTED|Overall Study||8
9957408|NCT01450761|11076628|FG001|NOT COMPLETED|Lead-in Chemotherapy||85
9957409|NCT01450761|11076627|FG000|STARTED|Treatment With Blinded Study Therapy||478
9957410|NCT01450761|11076628|FG001|STARTED|Treatment With Blinded Study Therapy||476
9957411|NCT01450761|11076627|FG000|COMPLETED|Treatment With Blinded Study Therapy||0
9833469|NCT00779584|10944398|FG007|STARTED|Overall Study||3
9833470|NCT00779584|10944399|FG008|STARTED|Overall Study||2
10249117|NCT03811574|11381274|FG000|STARTED|Overall Study||101
10249118|NCT03811574|11381275|FG001|STARTED|Overall Study||199
10249119|NCT03811574|11381276|FG002|STARTED|Overall Study||101
10249120|NCT03811574|11381274|FG000|Full Analysis Set (FAS)|Overall Study||101
10249121|NCT03811574|11381275|FG001|Full Analysis Set (FAS)|Overall Study||199
10249122|NCT03811574|11381276|FG002|Full Analysis Set (FAS)|Overall Study||101
10249123|NCT03811574|11381274|FG000|Safety Analysis Set (SAS)|Overall Study||100
10249124|NCT03811574|11381275|FG001|Safety Analysis Set (SAS)|Overall Study||199
10249125|NCT03811574|11381276|FG002|Safety Analysis Set (SAS)|Overall Study||101
10249126|NCT03811574|11381274|FG000|Treated|Overall Study||100
10249127|NCT03811574|11381275|FG001|Treated|Overall Study||199
10249128|NCT03811574|11381276|FG002|Treated|Overall Study||101
10249129|NCT03811574|11381274|FG000|COMPLETED|Overall Study||99
10249130|NCT03811574|11381275|FG001|COMPLETED|Overall Study||195
10249131|NCT03811574|11381276|FG002|COMPLETED|Overall Study||101
10249132|NCT03811574|11381274|FG000|NOT COMPLETED|Overall Study||2
10249133|NCT03811574|11381275|FG001|NOT COMPLETED|Overall Study||4
10249134|NCT03811574|11381276|FG002|NOT COMPLETED|Overall Study||0
10249135|NCT03800420|11381286|FG000|STARTED|Overall Study||12
10249136|NCT03800420|11381287|FG001|STARTED|Overall Study||4
10249137|NCT03800420|11381286|FG000|COMPLETED|Overall Study||10
10249138|NCT03800420|11381287|FG001|COMPLETED|Overall Study||3
10249139|NCT03800420|11381286|FG000|NOT COMPLETED|Overall Study||2
10249140|NCT03800420|11381287|FG001|NOT COMPLETED|Overall Study||1
10249141|NCT03759184|11381297|FG000|STARTED|Overall Study||1
10249142|NCT03759184|11381297|FG000|COMPLETED|Overall Study||1
10249143|NCT03759184|11381297|FG000|NOT COMPLETED|Overall Study||0
10249144|NCT03747640|11381303|FG000|STARTED|Overall Study||15
10249145|NCT03747640|11381304|FG001|STARTED|Overall Study||15
10249146|NCT03747640|11381303|FG000|COMPLETED|Overall Study||15
10249147|NCT03747640|11381304|FG001|COMPLETED|Overall Study||15
10249148|NCT03747640|11381303|FG000|NOT COMPLETED|Overall Study||0
10249149|NCT03747640|11381304|FG001|NOT COMPLETED|Overall Study||0
10249150|NCT03727750|11381312|FG000|STARTED|Overall Study||51
10249151|NCT03727750|11381312|FG000|Safety Set|Overall Study||50
10249152|NCT03727750|11381312|FG000|COMPLETED|Overall Study||2
10249153|NCT03727750|11381312|FG000|NOT COMPLETED|Overall Study||49
10249154|NCT03715829|11381322|FG000|STARTED|Dose Ranging Period||65
10249155|NCT03715829|11381323|FG001|STARTED|Dose Ranging Period||67
10249156|NCT03715829|11381324|FG002|STARTED|Dose Ranging Period||67
10249157|NCT03715829|11381325|FG003|STARTED|Dose Ranging Period||50
10249158|NCT03715829|11381326|FG004|STARTED|Dose Ranging Period||49
10249159|NCT03715829|11381327|FG005|STARTED|Dose Ranging Period||66
10249160|NCT03715829|11381328|FG006|STARTED|Dose Ranging Period||0
10249161|NCT03715829|11381329|FG007|STARTED|Dose Ranging Period||0
10249162|NCT03715829|11381330|FG008|STARTED|Dose Ranging Period||0
10249163|NCT03715829|11381331|FG009|STARTED|Dose Ranging Period||0
10249164|NCT03715829|11381332|FG010|STARTED|Dose Ranging Period||0
10249165|NCT03715829|11381322|FG000|COMPLETED|Dose Ranging Period||53
10249166|NCT03715829|11381323|FG001|COMPLETED|Dose Ranging Period||58
10249167|NCT03715829|11381324|FG002|COMPLETED|Dose Ranging Period||54
10249168|NCT03715829|11381325|FG003|COMPLETED|Dose Ranging Period||36
10249169|NCT03715829|11381326|FG004|COMPLETED|Dose Ranging Period||42
10249170|NCT03715829|11381327|FG005|COMPLETED|Dose Ranging Period||55
10249171|NCT03715829|11381328|FG006|COMPLETED|Dose Ranging Period||0
10249172|NCT03715829|11381329|FG007|COMPLETED|Dose Ranging Period||0
10249173|NCT03715829|11381330|FG008|COMPLETED|Dose Ranging Period||0
10249174|NCT03715829|11381331|FG009|COMPLETED|Dose Ranging Period||0
10249175|NCT03715829|11381332|FG010|COMPLETED|Dose Ranging Period||0
10249176|NCT03715829|11381322|FG000|NOT COMPLETED|Dose Ranging Period||12
10249177|NCT03715829|11381323|FG001|NOT COMPLETED|Dose Ranging Period||9
10249178|NCT03715829|11381324|FG002|NOT COMPLETED|Dose Ranging Period||13
10249179|NCT03715829|11381325|FG003|NOT COMPLETED|Dose Ranging Period||14
10249180|NCT03715829|11381326|FG004|NOT COMPLETED|Dose Ranging Period||7
10249181|NCT03715829|11381327|FG005|NOT COMPLETED|Dose Ranging Period||11
10249182|NCT03715829|11381328|FG006|NOT COMPLETED|Dose Ranging Period||0
10249183|NCT03715829|11381329|FG007|NOT COMPLETED|Dose Ranging Period||0
10249184|NCT03715829|11381330|FG008|NOT COMPLETED|Dose Ranging Period||0
10249185|NCT03715829|11381331|FG009|NOT COMPLETED|Dose Ranging Period||0
10249186|NCT03715829|11381332|FG010|NOT COMPLETED|Dose Ranging Period||0
10249187|NCT03715829|11381322|FG000|STARTED|Extension Period||0
10249188|NCT03715829|11381323|FG001|STARTED|Extension Period||0
10249189|NCT03715829|11381324|FG002|STARTED|Extension Period||0
10249190|NCT03715829|11381325|FG003|STARTED|Extension Period||0
10249191|NCT03715829|11381326|FG004|STARTED|Extension Period||0
10249192|NCT03715829|11381327|FG005|STARTED|Extension Period||0
10249193|NCT03715829|11381328|FG006|STARTED|Extension Period||55
10249194|NCT03715829|11381329|FG007|STARTED|Extension Period||43
10249195|NCT03715829|11381330|FG008|STARTED|Extension Period||187
10249196|NCT03715829|11381331|FG009|STARTED|Extension Period||6
10249197|NCT03715829|11381332|FG010|STARTED|Extension Period||2
10249198|NCT03715829|11381322|FG000|COMPLETED|Extension Period||0
10249199|NCT03715829|11381323|FG001|COMPLETED|Extension Period||0
10249200|NCT03715829|11381324|FG002|COMPLETED|Extension Period||0
10249201|NCT03715829|11381325|FG003|COMPLETED|Extension Period||0
10249202|NCT03715829|11381326|FG004|COMPLETED|Extension Period||0
10249203|NCT03715829|11381327|FG005|COMPLETED|Extension Period||0
10249204|NCT03715829|11381328|FG006|COMPLETED|Extension Period||47
10249205|NCT03715829|11381329|FG007|COMPLETED|Extension Period||27
10249206|NCT03715829|11381330|FG008|COMPLETED|Extension Period||158
10249207|NCT03715829|11381331|FG009|COMPLETED|Extension Period||3
10249208|NCT03715829|11381332|FG010|COMPLETED|Extension Period||2
10249209|NCT03715829|11381322|FG000|NOT COMPLETED|Extension Period||0
10249210|NCT03715829|11381323|FG001|NOT COMPLETED|Extension Period||0
10249211|NCT03715829|11381324|FG002|NOT COMPLETED|Extension Period||0
10249212|NCT03715829|11381325|FG003|NOT COMPLETED|Extension Period||0
10249213|NCT03715829|11381326|FG004|NOT COMPLETED|Extension Period||0
10249214|NCT03715829|11381327|FG005|NOT COMPLETED|Extension Period||0
10249215|NCT03715829|11381328|FG006|NOT COMPLETED|Extension Period||8
10249216|NCT03715829|11381329|FG007|NOT COMPLETED|Extension Period||16
10249217|NCT03715829|11381330|FG008|NOT COMPLETED|Extension Period||29
10249218|NCT03715829|11381331|FG009|NOT COMPLETED|Extension Period||3
10249219|NCT03715829|11381332|FG010|NOT COMPLETED|Extension Period||0
10249220|NCT03693430|11381360|FG000|STARTED|Overall Study||152
10249221|NCT03693430|11381361|FG001|STARTED|Overall Study||152
10249222|NCT03693430|11381360|FG000|Full Analysis Set (FAS)|Overall Study||152
10249223|NCT03693430|11381361|FG001|Full Analysis Set (FAS)|Overall Study||152
10249224|NCT03693430|11381360|FG000|Safety Analysis Set (SAS)|Overall Study||152
10249225|NCT03693430|11381361|FG001|Safety Analysis Set (SAS)|Overall Study||152
10249226|NCT03693430|11381360|FG000|COMPLETED|Overall Study||148
10249227|NCT03693430|11381361|FG001|COMPLETED|Overall Study||134
10249228|NCT03693430|11381360|FG000|NOT COMPLETED|Overall Study||4
10249229|NCT03693430|11381361|FG001|NOT COMPLETED|Overall Study||18
10249230|NCT03677934|11381369|FG000|STARTED|Overall Study||248
10249231|NCT03677934|11381370|FG001|STARTED|Overall Study||167
10249232|NCT03677934|11381369|FG000|COMPLETED|Overall Study||0
10249233|NCT03677934|11381370|FG001|COMPLETED|Overall Study||0
10249234|NCT03677934|11381369|FG000|NOT COMPLETED|Overall Study||248
10249235|NCT03677934|11381370|FG001|NOT COMPLETED|Overall Study||167
10249236|NCT03660839|11381380|FG000|STARTED|Overall Study||35
10249237|NCT03660839|11381381|FG001|STARTED|Overall Study||36
10249238|NCT03660839|11381382|FG002|STARTED|Overall Study||36
10249239|NCT03660839|11381383|FG003|STARTED|Overall Study||33
10249240|NCT03660839|11381380|FG000|COMPLETED|Overall Study||35
10249241|NCT03660839|11381381|FG001|COMPLETED|Overall Study||36
10249242|NCT03660839|11381382|FG002|COMPLETED|Overall Study||36
10249243|NCT03660839|11381383|FG003|COMPLETED|Overall Study||33
10249244|NCT03660839|11381380|FG000|NOT COMPLETED|Overall Study||0
10249245|NCT03660839|11381381|FG001|NOT COMPLETED|Overall Study||0
10249246|NCT03660839|11381382|FG002|NOT COMPLETED|Overall Study||0
10249247|NCT03660839|11381383|FG003|NOT COMPLETED|Overall Study||0
9833471|NCT00779584|10944391|FG000|Treated|Overall Study||3
9833472|NCT00779584|10944392|FG001|Treated|Overall Study||3
9833473|NCT00779584|10944393|FG002|Treated|Overall Study||7
9833474|NCT00779584|10944394|FG003|Treated|Overall Study||6
9833475|NCT00779584|10944395|FG004|Treated|Overall Study||7
9833476|NCT00779584|10944396|FG005|Treated|Overall Study||4
9833477|NCT00779584|10944397|FG006|Treated|Overall Study||8
10249248|NCT03660241|11381399|FG000|STARTED|Overall Study||8
10249249|NCT03660241|11381400|FG001|STARTED|Overall Study||7
10249250|NCT03660241|11381401|FG002|STARTED|Overall Study||8
10249251|NCT03660241|11381399|FG000|COMPLETED|Overall Study||8
10249252|NCT03660241|11381400|FG001|COMPLETED|Overall Study||7
10249253|NCT03660241|11381401|FG002|COMPLETED|Overall Study||8
10249254|NCT03660241|11381399|FG000|NOT COMPLETED|Overall Study||0
10249255|NCT03660241|11381400|FG001|NOT COMPLETED|Overall Study||0
10249256|NCT03660241|11381401|FG002|NOT COMPLETED|Overall Study||0
10249257|NCT03575104|11381412|FG000|STARTED|Overall Study||307
10249258|NCT03575104|11381413|FG001|STARTED|Overall Study||309
10019945|NCT01832727|11143186|FG007|NOT COMPLETED|Overall Study||6
10019946|NCT01832727|11143187|FG008|NOT COMPLETED|Overall Study||18
10019947|NCT01832753|11143219|FG000|STARTED|Observation Phase (Months 0-6)||5
10249259|NCT03575104|11381414|FG002|STARTED|Overall Study||308
10249260|NCT03575104|11381412|FG000|COMPLETED|Overall Study||283
10249261|NCT03575104|11381413|FG001|COMPLETED|Overall Study||280
10249262|NCT03575104|11381414|FG002|COMPLETED|Overall Study||286
10249263|NCT03575104|11381412|FG000|NOT COMPLETED|Overall Study||24
10249264|NCT03575104|11381413|FG001|NOT COMPLETED|Overall Study||29
10249265|NCT03575104|11381414|FG002|NOT COMPLETED|Overall Study||22
10249266|NCT03569475|11381425|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||164
10249267|NCT03569475|11381426|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||169
10249268|NCT03569475|11381427|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||168
10249269|NCT03569475|11381425|FG000|Safety Population|Double-blind Treatment Period (8 Weeks)||160
10249270|NCT03569475|11381426|FG001|Safety Population|Double-blind Treatment Period (8 Weeks)||166
10249271|NCT03569475|11381427|FG002|Safety Population|Double-blind Treatment Period (8 Weeks)||166
10249272|NCT03569475|11381425|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
10019948|NCT01832753|11143220|FG001|STARTED|Observation Phase (Months 0-6)||4
10019949|NCT01832753|11143221|FG002|STARTED|Observation Phase (Months 0-6)||3
10019950|NCT01832753|11143219|FG000|COMPLETED|Observation Phase (Months 0-6)||5
10019951|NCT01832753|11143220|FG001|COMPLETED|Observation Phase (Months 0-6)||4
10019952|NCT01832753|11143221|FG002|COMPLETED|Observation Phase (Months 0-6)||1
10019953|NCT01832753|11143219|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0
10019954|NCT01832753|11143220|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0
10019955|NCT01832753|11143221|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2
10019956|NCT01832753|11143219|FG000|STARTED|Randomization Phase (Months 6-12)||5
10019957|NCT01832753|11143220|FG001|STARTED|Randomization Phase (Months 6-12)||4
10019958|NCT01832753|11143221|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
10019959|NCT01832753|11143219|FG000|COMPLETED|Randomization Phase (Months 6-12)||4
10019960|NCT01832753|11143220|FG001|COMPLETED|Randomization Phase (Months 6-12)||3
10019961|NCT01832753|11143221|FG002|COMPLETED|Randomization Phase (Months 6-12)||0
10019962|NCT01832753|11143219|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1
10019963|NCT01832753|11143220|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1
10019964|NCT01832753|11143221|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0
10019965|NCT01832753|11143219|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3
10019966|NCT01832753|11143220|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3
10019967|NCT01832753|11143221|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0
10019968|NCT01832753|11143219|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3
10019969|NCT01832753|11143220|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3
10019970|NCT01832753|11143221|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0
10019971|NCT01832753|11143219|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
10019972|NCT01832753|11143220|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
10019973|NCT01832753|11143221|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
10019974|NCT01832766|11143230|FG000|STARTED|First Intervention||7
10019975|NCT01832766|11143231|FG001|STARTED|First Intervention||6
10019976|NCT01832766|11143230|FG000|COMPLETED|First Intervention||7
10019977|NCT01832766|11143231|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6
10019978|NCT01832766|11143230|FG000|NOT COMPLETED|First Intervention||0
10019979|NCT01832766|11143231|FG001|NOT COMPLETED|First Intervention||0
10019980|NCT01832766|11143230|FG000|STARTED|Washout||7
10019981|NCT01832766|11143231|FG001|STARTED|Washout||6
10019982|NCT01832766|11143230|FG000|COMPLETED|Washout||7
10019983|NCT01832766|11143231|FG001|COMPLETED|Washout||5
10019984|NCT01832766|11143230|FG000|NOT COMPLETED|Washout||0
10019985|NCT01832766|11143231|FG001|NOT COMPLETED|Washout||1
10019986|NCT01832766|11143230|FG000|STARTED|Second Intervention||7
10019987|NCT01832766|11143231|FG001|STARTED|Second Intervention||5
10019988|NCT01832766|11143230|FG000|COMPLETED|Second Intervention||7
10019989|NCT01832766|11143231|FG001|COMPLETED|Second Intervention||5
10019990|NCT01832766|11143230|FG000|NOT COMPLETED|Second Intervention||0
10019991|NCT01832766|11143231|FG001|NOT COMPLETED|Second Intervention||0
10019992|NCT01832818|11143237|FG000|STARTED|Overall Study||14
10019993|NCT01832818|11143237|FG000|COMPLETED|Overall Study||8
10019994|NCT01832818|11143237|FG000|NOT COMPLETED|Overall Study||6
10019995|NCT01832961|11143241|FG000|STARTED|First Intervention||8
10019996|NCT01832961|11143242|FG001|STARTED|First Intervention||7
10019997|NCT01832961|11143241|FG000|COMPLETED|First Intervention||8
10249273|NCT03569475|11381426|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
10249274|NCT03569475|11381427|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||144
10249275|NCT03569475|11381425|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||18
10113655|NCT02511431|11244444|FG000|NOT COMPLETED|Post-treatment Follow-up||0
10113656|NCT02511431|11244445|FG001|NOT COMPLETED|Post-treatment Follow-up||0
10113657|NCT02511431|11244446|FG002|NOT COMPLETED|Post-treatment Follow-up||0
10113658|NCT02511431|11244447|FG003|NOT COMPLETED|Post-treatment Follow-up||0
10113659|NCT02511431|11244448|FG004|NOT COMPLETED|Post-treatment Follow-up||0
10113660|NCT02511431|11244449|FG005|NOT COMPLETED|Post-treatment Follow-up||0
10113661|NCT02511535|11244467|FG000|STARTED|Overall Study||49
10113662|NCT02511535|11244468|FG001|STARTED|Overall Study||21
10113663|NCT02511535|11244469|FG002|STARTED|Overall Study||49
10113664|NCT02511535|11244467|FG000|COMPLETED|Overall Study||49
10113665|NCT02511535|11244468|FG001|COMPLETED|Overall Study||21
10019998|NCT01832961|11143242|FG001|COMPLETED|First Intervention||7
10019999|NCT01832961|11143241|FG000|NOT COMPLETED|First Intervention||0
10020000|NCT01832961|11143242|FG001|NOT COMPLETED|First Intervention||0
10020001|NCT01832961|11143241|FG000|STARTED|Washout||8
10020002|NCT01832961|11143242|FG001|STARTED|Washout||7
10020003|NCT01832961|11143241|FG000|COMPLETED|Washout||8
10020004|NCT01832961|11143242|FG001|COMPLETED|Washout||7
10020005|NCT01832961|11143241|FG000|NOT COMPLETED|Washout||0
10020006|NCT01832961|11143242|FG001|NOT COMPLETED|Washout||0
10020007|NCT01832961|11143241|FG000|STARTED|Second Intervention||8
10020008|NCT01832961|11143242|FG001|STARTED|Second Intervention||7
10020009|NCT01832961|11143241|FG000|COMPLETED|Second Intervention||8
10020010|NCT01832961|11143242|FG001|COMPLETED|Second Intervention||7
10020011|NCT01832961|11143241|FG000|NOT COMPLETED|Second Intervention||0
10020012|NCT01832961|11143242|FG001|NOT COMPLETED|Second Intervention||0
10020013|NCT01832961|11143241|FG000|STARTED|Third Intervention||8
10020014|NCT01832961|11143242|FG001|STARTED|Third Intervention||7
10020015|NCT01832961|11143241|FG000|COMPLETED|Third Intervention||8
10113666|NCT02511535|11244469|FG002|COMPLETED|Overall Study||49
10113667|NCT02511535|11244467|FG000|NOT COMPLETED|Overall Study||0
10113668|NCT02511535|11244468|FG001|NOT COMPLETED|Overall Study||0
10113669|NCT02511535|11244469|FG002|NOT COMPLETED|Overall Study||0
10113670|NCT02511561|11244480|FG000|STARTED|Overall Study||25
10113671|NCT02511561|11244481|FG001|STARTED|Overall Study||25
10113672|NCT02511561|11244482|FG002|STARTED|Overall Study||25
10113673|NCT02511561|11244480|FG000|COMPLETED|Overall Study||25
10113674|NCT02511561|11244481|FG001|COMPLETED|Overall Study||25
10113675|NCT02511561|11244482|FG002|COMPLETED|Overall Study||25
10020016|NCT01832961|11143242|FG001|COMPLETED|Third Intervention||7
10020017|NCT01832961|11143241|FG000|NOT COMPLETED|Third Intervention||0
10020018|NCT01832961|11143242|FG001|NOT COMPLETED|Third Intervention||0
10020019|NCT01833026|11143259|FG000|STARTED|Overall Study||22
10020020|NCT01833026|11143260|FG001|STARTED|Overall Study||34
10020021|NCT01833026|11143259|FG000|COMPLETED|Overall Study||22
10020022|NCT01833026|11143260|FG001|COMPLETED|Overall Study||34
10020023|NCT01833026|11143259|FG000|NOT COMPLETED|Overall Study||0
10020024|NCT01833026|11143260|FG001|NOT COMPLETED|Overall Study||0
10020025|NCT01833065|11143269|FG000|STARTED|Overall Study|Randomized patients - As treated|65
10020026|NCT01833065|11143270|FG001|STARTED|Overall Study|Randomized patients - As treated|53
10020027|NCT01833065|11143271|FG002|STARTED|Overall Study|Randomized patients - As treated|35
10020028|NCT01833065|11143272|FG003|STARTED|Overall Study|Randomized patients - As treated|50
10020029|NCT01833065|11143273|FG004|STARTED|Overall Study|Randomized patients - As treated|110
10113676|NCT02511561|11244480|FG000|NOT COMPLETED|Overall Study||0
10113677|NCT02511561|11244481|FG001|NOT COMPLETED|Overall Study||0
10113678|NCT02511561|11244482|FG002|NOT COMPLETED|Overall Study||0
10113679|NCT02511587|11244493|FG000|STARTED|Overall Study||58
10113680|NCT02511587|11244494|FG001|STARTED|Overall Study||58
10113681|NCT02511587|11244493|FG000|COMPLETED|Overall Study||58
10113682|NCT02511587|11244494|FG001|COMPLETED|Overall Study||58
10113683|NCT02511587|11244493|FG000|NOT COMPLETED|Overall Study||0
10113684|NCT02511587|11244494|FG001|NOT COMPLETED|Overall Study||0
10113685|NCT02511678|11244500|FG000|STARTED|Overall Study||73
10113686|NCT02511678|11244500|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
10113687|NCT02511678|11244500|FG000|Participants Discontinued Pre-Treatment|Overall Study||7
10113688|NCT02511678|11244500|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
10113689|NCT02511678|11244500|FG000|COMPLETED|Overall Study||37
10113690|NCT02511678|11244500|FG000|NOT COMPLETED|Overall Study||36
10113691|NCT02511717|11244507|FG000|STARTED|Overall Study||10
10113692|NCT02511717|11244508|FG001|STARTED|Overall Study||10
10113693|NCT02511717|11244507|FG000|COMPLETED|Overall Study||8
10113694|NCT02511717|11244508|FG001|COMPLETED|Overall Study||10
10113695|NCT02511717|11244507|FG000|NOT COMPLETED|Overall Study||2
10020030|NCT01833065|11143269|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
10020031|NCT01833065|11143270|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
10020032|NCT01833065|11143271|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
10020033|NCT01833065|11143272|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
10113696|NCT02511717|11244508|FG001|NOT COMPLETED|Overall Study||0
10113697|NCT02511730|11244514|FG000|STARTED|First Reading Session||50
10113698|NCT02511730|11244515|FG001|STARTED|First Reading Session||50
10113699|NCT02511730|11244514|FG000|COMPLETED|First Reading Session||50
10020034|NCT01833065|11143273|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
10020035|NCT01833065|11143269|FG000|COMPLETED|Overall Study||41
10113700|NCT02511730|11244515|FG001|COMPLETED|First Reading Session||50
10113701|NCT02511730|11244514|FG000|NOT COMPLETED|First Reading Session||0
10113702|NCT02511730|11244515|FG001|NOT COMPLETED|First Reading Session||0
10113703|NCT02511730|11244514|FG000|STARTED|4 Week Memory Washout Period||50
10113704|NCT02511730|11244515|FG001|STARTED|4 Week Memory Washout Period||50
10113705|NCT02511730|11244514|FG000|COMPLETED|4 Week Memory Washout Period||50
10113706|NCT02511730|11244515|FG001|COMPLETED|4 Week Memory Washout Period||50
10113707|NCT02511730|11244514|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10113708|NCT02511730|11244515|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
10113709|NCT02511730|11244514|FG000|STARTED|Session Reading Session||50
10113710|NCT02511730|11244515|FG001|STARTED|Session Reading Session||50
10113711|NCT02511730|11244514|FG000|COMPLETED|Session Reading Session||50
10113712|NCT02511730|11244515|FG001|COMPLETED|Session Reading Session||50
10113713|NCT02511730|11244514|FG000|NOT COMPLETED|Session Reading Session||0
10113714|NCT02511730|11244515|FG001|NOT COMPLETED|Session Reading Session||0
10113715|NCT02511782|11244524|FG000|STARTED|Overall Study||51
10113716|NCT02511782|11244525|FG001|STARTED|Overall Study||2
10113717|NCT02511782|11244526|FG002|STARTED|Overall Study||10
10113718|NCT02511782|11244524|FG000|COMPLETED|Overall Study||50
10113719|NCT02511782|11244525|FG001|COMPLETED|Overall Study||2
10113720|NCT02511782|11244526|FG002|COMPLETED|Overall Study||10
10113721|NCT02511782|11244524|FG000|NOT COMPLETED|Overall Study||1
10113722|NCT02511782|11244525|FG001|NOT COMPLETED|Overall Study||0
10113723|NCT02511782|11244526|FG002|NOT COMPLETED|Overall Study||0
10113724|NCT02512042|11244536|FG000|STARTED|Overall Study||495
10113725|NCT02512042|11244537|FG001|STARTED|Overall Study||478
10113726|NCT02512042|11244536|FG000|COMPLETED|Overall Study||472
10113727|NCT02512042|11244537|FG001|COMPLETED|Overall Study||453
10113728|NCT02512042|11244536|FG000|NOT COMPLETED|Overall Study||23
10113729|NCT02512042|11244537|FG001|NOT COMPLETED|Overall Study||25
10113730|NCT02512068|11244545|FG000|STARTED|Overall Study||55
10113731|NCT02512068|11244546|FG001|STARTED|Overall Study||52
10113732|NCT02512068|11244545|FG000|COMPLETED|Overall Study||43
10113733|NCT02512068|11244546|FG001|COMPLETED|Overall Study||39
10113734|NCT02512068|11244545|FG000|NOT COMPLETED|Overall Study||12
10113735|NCT02512068|11244546|FG001|NOT COMPLETED|Overall Study||13
10113736|NCT02512094|11244552|FG000|STARTED|Overall Study||53
10113737|NCT02512094|11244552|FG000|COMPLETED|Overall Study||53
10113738|NCT02512094|11244552|FG000|NOT COMPLETED|Overall Study||0
10113739|NCT02512224|11244558|FG000|STARTED|Overall Study||2912
10113740|NCT02512224|11244559|FG001|STARTED|Overall Study||2912
10113741|NCT02512224|11244558|FG000|COMPLETED|Overall Study||2912
10113742|NCT02512224|11244559|FG001|COMPLETED|Overall Study||2912
10113743|NCT02512224|11244558|FG000|NOT COMPLETED|Overall Study||0
10113744|NCT02512224|11244559|FG001|NOT COMPLETED|Overall Study||0
10113745|NCT02512276|11244567|FG000|STARTED|Overall Study||2038
10113746|NCT02512276|11244568|FG001|STARTED|Overall Study||2040
10113747|NCT02512276|11244567|FG000|COMPLETED|Overall Study||2030
10113748|NCT02512276|11244568|FG001|COMPLETED|Overall Study||2029
10113749|NCT02512276|11244567|FG000|NOT COMPLETED|Overall Study||8
10113750|NCT02512276|11244568|FG001|NOT COMPLETED|Overall Study||11
10113751|NCT02512302|11244574|FG000|STARTED|Period 1||3
10113752|NCT02512302|11244575|FG001|STARTED|Period 1||3
10113753|NCT02512302|11244576|FG002|STARTED|Period 1||4
10113754|NCT02512302|11244577|FG003|STARTED|Period 1||3
10113755|NCT02512302|11244578|FG004|STARTED|Period 1||3
10113756|NCT02512302|11244579|FG005|STARTED|Period 1||3
10113757|NCT02512302|11244580|FG006|STARTED|Period 1||2
10113758|NCT02512302|11244581|FG007|STARTED|Period 1||3
10249276|NCT03569475|11381426|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||23
10249277|NCT03569475|11381427|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||24
10249278|NCT03569475|11381425|FG000|STARTED|Double-blind Down-taper Period (1 Week)||140
10249279|NCT03569475|11381426|FG001|STARTED|Double-blind Down-taper Period (1 Week)||141
10249280|NCT03569475|11381427|FG002|STARTED|Double-blind Down-taper Period (1 Week)||140
10249281|NCT03569475|11381425|FG000|COMPLETED|Double-blind Down-taper Period (1 Week)||140
10113759|NCT02512302|11244582|FG008|STARTED|Period 1||3
10113760|NCT02512302|11244583|FG009|STARTED|Period 1||3
10249282|NCT03569475|11381426|FG001|COMPLETED|Double-blind Down-taper Period (1 Week)||139
10249283|NCT03569475|11381427|FG002|COMPLETED|Double-blind Down-taper Period (1 Week)||138
10249284|NCT03569475|11381425|FG000|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||0
10249285|NCT03569475|11381426|FG001|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
10249286|NCT03569475|11381427|FG002|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
10249287|NCT03554798|11381447|FG000|STARTED|Overall Study||50
10113761|NCT02512302|11244574|FG000|COMPLETED|Period 1||3
10113762|NCT02512302|11244575|FG001|COMPLETED|Period 1||2
10113763|NCT02512302|11244576|FG002|COMPLETED|Period 1||4
10113764|NCT02512302|11244577|FG003|COMPLETED|Period 1||3
10113765|NCT02512302|11244578|FG004|COMPLETED|Period 1||3
10113766|NCT02512302|11244579|FG005|COMPLETED|Period 1||3
10249288|NCT03554798|11381448|FG001|STARTED|Overall Study||50
10249289|NCT03554798|11381449|FG002|STARTED|Overall Study||51
10249290|NCT03554798|11381450|FG003|STARTED|Overall Study||156
10249291|NCT03554798|11381451|FG004|STARTED|Overall Study||144
10249292|NCT03554798|11381452|FG005|STARTED|Overall Study||138
10249293|NCT03554798|11381453|FG006|STARTED|Overall Study||150
10249294|NCT03554798|11381454|FG007|STARTED|Overall Study||135
10249295|NCT03554798|11381455|FG008|STARTED|Overall Study||151
10249296|NCT03554798|11381447|FG000|COMPLETED|Overall Study||45
10249297|NCT03554798|11381448|FG001|COMPLETED|Overall Study||47
10249298|NCT03554798|11381449|FG002|COMPLETED|Overall Study||48
10249299|NCT03554798|11381450|FG003|COMPLETED|Overall Study||154
10249300|NCT03554798|11381451|FG004|COMPLETED|Overall Study||141
10249301|NCT03554798|11381452|FG005|COMPLETED|Overall Study||137
10249302|NCT03554798|11381453|FG006|COMPLETED|Overall Study||149
10249303|NCT03554798|11381454|FG007|COMPLETED|Overall Study||133
10249304|NCT03554798|11381455|FG008|COMPLETED|Overall Study||149
10249305|NCT03554798|11381447|FG000|NOT COMPLETED|Overall Study||5
10249306|NCT03554798|11381448|FG001|NOT COMPLETED|Overall Study||3
10249307|NCT03554798|11381449|FG002|NOT COMPLETED|Overall Study||3
10249308|NCT03554798|11381450|FG003|NOT COMPLETED|Overall Study||2
10249309|NCT03554798|11381451|FG004|NOT COMPLETED|Overall Study||3
10249310|NCT03554798|11381452|FG005|NOT COMPLETED|Overall Study||1
10249311|NCT03554798|11381453|FG006|NOT COMPLETED|Overall Study||1
10249312|NCT03554798|11381454|FG007|NOT COMPLETED|Overall Study||2
10249313|NCT03554798|11381455|FG008|NOT COMPLETED|Overall Study||2
10249314|NCT03545191|11381481|FG000|STARTED|Overall Study||310
10249315|NCT03545191|11381482|FG001|STARTED|Overall Study||310
10249316|NCT03545191|11381483|FG002|STARTED|Overall Study||310
10249317|NCT03545191|11381481|FG000|COMPLETED|Overall Study||288
10249318|NCT03545191|11381482|FG001|COMPLETED|Overall Study||285
10249319|NCT03545191|11381483|FG002|COMPLETED|Overall Study||280
10249320|NCT03545191|11381481|FG000|NOT COMPLETED|Overall Study||22
10249321|NCT03545191|11381482|FG001|NOT COMPLETED|Overall Study||25
10249322|NCT03545191|11381483|FG002|NOT COMPLETED|Overall Study||30
10249323|NCT03500549|11381493|FG000|STARTED|Run-in Period (Day -28 to ≤Day 1)||41
10249324|NCT03500549|11381494|FG001|STARTED|Run-in Period (Day -28 to ≤Day 1)||39
10249325|NCT03500549|11381493|FG000|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||41
10249326|NCT03500549|11381494|FG001|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||39
10249327|NCT03500549|11381493|FG000|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
10249328|NCT03500549|11381494|FG001|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
10249329|NCT03500549|11381493|FG000|STARTED|RCP (Day 1 - Week 16)||41
10249330|NCT03500549|11381494|FG001|STARTED|RCP (Day 1 - Week 16)||39
10249331|NCT03500549|11381493|FG000|COMPLETED|RCP (Day 1 - Week 16)||38
10249332|NCT03500549|11381494|FG001|COMPLETED|RCP (Day 1 - Week 16)||39
10249333|NCT03500549|11381493|FG000|NOT COMPLETED|RCP (Day 1 - Week 16)||3
10249334|NCT03500549|11381494|FG001|NOT COMPLETED|RCP (Day 1 - Week 16)||0
10249335|NCT03500549|11381493|FG000|STARTED|Open-label Period (Week 17 to Week 48)||38
10249336|NCT03500549|11381494|FG001|STARTED|Open-label Period (Week 17 to Week 48)||39
10249337|NCT03500549|11381493|FG000|COMPLETED|Open-label Period (Week 17 to Week 48)||35
10249338|NCT03500549|11381494|FG001|COMPLETED|Open-label Period (Week 17 to Week 48)||32
10249339|NCT03500549|11381493|FG000|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||3
10249340|NCT03500549|11381494|FG001|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||7
10249341|NCT03456700|11381505|FG000|STARTED|Overall Study||22
10249342|NCT03456700|11381505|FG000|COMPLETED|Overall Study||21
10249343|NCT03456700|11381505|FG000|NOT COMPLETED|Overall Study||1
10249344|NCT03435185|11381511|FG000|STARTED|Overall Study||44
10249345|NCT03435185|11381512|FG001|STARTED|Overall Study||43
10249346|NCT03435185|11381511|FG000|COMPLETED|Overall Study||43
9833478|NCT00779584|10944398|FG007|Treated|Overall Study||3
9833479|NCT00779584|10944399|FG008|Treated|Overall Study||2
10249347|NCT03435185|11381512|FG001|COMPLETED|Overall Study||28
10249348|NCT03435185|11381511|FG000|NOT COMPLETED|Overall Study||1
10249349|NCT03435185|11381512|FG001|NOT COMPLETED|Overall Study||15
10249350|NCT03427411|11381520|FG000|STARTED|Overall Study||30
10249351|NCT03427411|11381521|FG001|STARTED|Overall Study||27
10249352|NCT03427411|11381520|FG000|COMPLETED|Overall Study||30
10249353|NCT03427411|11381521|FG001|COMPLETED|Overall Study||26
10249354|NCT03427411|11381520|FG000|NOT COMPLETED|Overall Study||0
10249355|NCT03427411|11381521|FG001|NOT COMPLETED|Overall Study||1
10249356|NCT03387150|11381534|FG000|STARTED|Overall Study||19
10249357|NCT03387150|11381535|FG001|STARTED|Overall Study||19
10249358|NCT03387150|11381536|FG002|STARTED|Overall Study||21
10249359|NCT03387150|11381537|FG003|STARTED|Overall Study||21
10249360|NCT03387150|11381538|FG004|STARTED|Overall Study||20
10249361|NCT03387150|11381539|FG005|STARTED|Overall Study||21
10249362|NCT03387150|11381540|FG006|STARTED|Overall Study||3
10249363|NCT03387150|11381534|FG000|Safety Population|Overall Study||19
10249364|NCT03387150|11381535|FG001|Safety Population|Overall Study||19
10249365|NCT03387150|11381536|FG002|Safety Population|Overall Study||21
10249366|NCT03387150|11381537|FG003|Safety Population|Overall Study||21
10249367|NCT03387150|11381538|FG004|Safety Population|Overall Study||20
10249368|NCT03387150|11381539|FG005|Safety Population|Overall Study||21
10249369|NCT03387150|11381540|FG006|Safety Population|Overall Study||3
10249370|NCT03387150|11381534|FG000|COMPLETED|Overall Study||13
10249371|NCT03387150|11381535|FG001|COMPLETED|Overall Study||16
10249372|NCT03387150|11381536|FG002|COMPLETED|Overall Study||16
10249373|NCT03387150|11381537|FG003|COMPLETED|Overall Study||14
10249374|NCT03387150|11381538|FG004|COMPLETED|Overall Study||14
10249375|NCT03387150|11381539|FG005|COMPLETED|Overall Study||14
10249376|NCT03387150|11381540|FG006|COMPLETED|Overall Study||3
10249377|NCT03387150|11381534|FG000|NOT COMPLETED|Overall Study||6
10249378|NCT03387150|11381535|FG001|NOT COMPLETED|Overall Study||3
10249379|NCT03387150|11381536|FG002|NOT COMPLETED|Overall Study||5
10249380|NCT03387150|11381537|FG003|NOT COMPLETED|Overall Study||7
10249381|NCT03387150|11381538|FG004|NOT COMPLETED|Overall Study||6
10249382|NCT03387150|11381539|FG005|NOT COMPLETED|Overall Study||7
10249383|NCT03387150|11381540|FG006|NOT COMPLETED|Overall Study||0
10249384|NCT03370133|11381559|FG000|STARTED|Initial Treatment Period (WK 16)||83
10249385|NCT03370133|11381560|FG001|STARTED|Initial Treatment Period (WK 16)||321
10249386|NCT03370133|11381561|FG002|STARTED|Initial Treatment Period (WK 16)||163
10249387|NCT03370133|11381562|FG003|STARTED|Initial Treatment Period (WK 16)||0
10249388|NCT03370133|11381563|FG004|STARTED|Initial Treatment Period (WK 16)||0
10249389|NCT03370133|11381564|FG005|STARTED|Initial Treatment Period (WK 16)||0
10249390|NCT03370133|11381559|FG000|COMPLETED|Initial Treatment Period (WK 16)||74
10249391|NCT03370133|11381560|FG001|COMPLETED|Initial Treatment Period (WK 16)||306
10249392|NCT03370133|11381561|FG002|COMPLETED|Initial Treatment Period (WK 16)||157
10249393|NCT03370133|11381562|FG003|COMPLETED|Initial Treatment Period (WK 16)||0
10249394|NCT03370133|11381563|FG004|COMPLETED|Initial Treatment Period (WK 16)||0
10249395|NCT03370133|11381564|FG005|COMPLETED|Initial Treatment Period (WK 16)||0
10249396|NCT03370133|11381559|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9
10249397|NCT03370133|11381560|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15
10249398|NCT03370133|11381561|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6
10249399|NCT03370133|11381562|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10249400|NCT03370133|11381563|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10249401|NCT03370133|11381564|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10249402|NCT03370133|11381559|FG000|STARTED|Maintenance Treatment Period (WK 52)||0
10249403|NCT03370133|11381560|FG001|STARTED|Maintenance Treatment Period (WK 52)||0
10249404|NCT03370133|11381561|FG002|STARTED|Maintenance Treatment Period (WK 52)||0
10249405|NCT03370133|11381562|FG003|STARTED|Maintenance Treatment Period (WK 52)||74
10249406|NCT03370133|11381563|FG004|STARTED|Maintenance Treatment Period (WK 52)||306
10249407|NCT03370133|11381564|FG005|STARTED|Maintenance Treatment Period (WK 52)||157
10249408|NCT03370133|11381559|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0
10249409|NCT03370133|11381560|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0
10249410|NCT03370133|11381561|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0
10249411|NCT03370133|11381562|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69
10249412|NCT03370133|11381563|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283
10249413|NCT03370133|11381564|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141
10249414|NCT03370133|11381559|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10249415|NCT03370133|11381560|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10249416|NCT03370133|11381561|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10249417|NCT03370133|11381562|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5
10249418|NCT03370133|11381563|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23
10249419|NCT03370133|11381564|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16
9833480|NCT00779584|10944391|FG000|COMPLETED|Overall Study||0
10249420|NCT03366792|11381582|FG000|STARTED|Overall Study||46
10249421|NCT03366792|11381582|FG000|COMPLETED|Overall Study||31
10249422|NCT03366792|11381582|FG000|NOT COMPLETED|Overall Study||15
10249423|NCT03366337|11381590|FG000|STARTED|Overall Study||31
10249424|NCT03366337|11381591|FG001|STARTED|Overall Study||26
10249425|NCT03366337|11381592|FG002|STARTED|Overall Study||28
10249426|NCT03366337|11381593|FG003|STARTED|Overall Study||18
10249427|NCT03366337|11381590|FG000|COMPLETED|Overall Study||28
10249428|NCT03366337|11381591|FG001|COMPLETED|Overall Study||26
10249429|NCT03366337|11381592|FG002|COMPLETED|Overall Study||26
10249430|NCT03366337|11381593|FG003|COMPLETED|Overall Study||17
10249431|NCT03366337|11381590|FG000|NOT COMPLETED|Overall Study||3
10249432|NCT03366337|11381591|FG001|NOT COMPLETED|Overall Study||0
10249433|NCT03366337|11381592|FG002|NOT COMPLETED|Overall Study||2
10249434|NCT03366337|11381593|FG003|NOT COMPLETED|Overall Study||1
10249435|NCT03342053|11381605|FG000|STARTED|Overall Study||23
10249436|NCT03342053|11381606|FG001|STARTED|Overall Study||23
10249437|NCT03342053|11381605|FG000|COMPLETED|Overall Study||21
10249438|NCT03342053|11381606|FG001|COMPLETED|Overall Study||22
10249439|NCT03342053|11381605|FG000|NOT COMPLETED|Overall Study||2
10249440|NCT03342053|11381606|FG001|NOT COMPLETED|Overall Study||1
10249441|NCT03330847|11381615|FG000|STARTED|Overall Study||114
10249442|NCT03330847|11381616|FG001|STARTED|Overall Study||112
10249443|NCT03330847|11381617|FG002|STARTED|Overall Study||47
10249444|NCT03330847|11381615|FG000|COMPLETED|Overall Study||52
10249445|NCT03330847|11381616|FG001|COMPLETED|Overall Study||47
10249446|NCT03330847|11381617|FG002|COMPLETED|Overall Study||32
10249447|NCT03330847|11381615|FG000|NOT COMPLETED|Overall Study||62
10249448|NCT03330847|11381616|FG001|NOT COMPLETED|Overall Study||65
10249449|NCT03330847|11381617|FG002|NOT COMPLETED|Overall Study||15
10249450|NCT03283241|11381629|FG000|STARTED|Overall Study||32
10249451|NCT03283241|11381630|FG001|STARTED|Overall Study||30
10249452|NCT03283241|11381629|FG000|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
10249453|NCT03283241|11381630|FG001|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
10249454|NCT03283241|11381629|FG000|COMPLETED|Overall Study|Completed 24 month|28
10249455|NCT03283241|11381630|FG001|COMPLETED|Overall Study|Completed 24 month|27
10249456|NCT03283241|11381629|FG000|NOT COMPLETED|Overall Study||4
10249457|NCT03283241|11381630|FG001|NOT COMPLETED|Overall Study||3
10249458|NCT03242772|11381638|FG000|STARTED|Overall Study||9
10249459|NCT03242772|11381639|FG001|STARTED|Overall Study||9
10249460|NCT03242772|11381638|FG000|COMPLETED|Overall Study||6
10249461|NCT03242772|11381639|FG001|COMPLETED|Overall Study||8
10249462|NCT03242772|11381638|FG000|NOT COMPLETED|Overall Study||3
10249463|NCT03242772|11381639|FG001|NOT COMPLETED|Overall Study||1
10249464|NCT03236311|11381647|FG000|STARTED|Overall Study||5
10249465|NCT03236311|11381648|FG001|STARTED|Overall Study||5
10249466|NCT03236311|11381647|FG000|COMPLETED|Overall Study||5
10249467|NCT03236311|11381648|FG001|COMPLETED|Overall Study||2
10249468|NCT03236311|11381647|FG000|NOT COMPLETED|Overall Study||0
10249469|NCT03236311|11381648|FG001|NOT COMPLETED|Overall Study||3
10249470|NCT03192046|11381656|FG000|STARTED|Overall Study||5
10249471|NCT03192046|11381657|FG001|STARTED|Overall Study||4
10249472|NCT03192046|11381656|FG000|COMPLETED|Overall Study||4
10249473|NCT03192046|11381657|FG001|COMPLETED|Overall Study||3
10249474|NCT03192046|11381656|FG000|NOT COMPLETED|Overall Study||1
10249475|NCT03192046|11381657|FG001|NOT COMPLETED|Overall Study||1
10249476|NCT03190369|11381665|FG000|STARTED|Overall Study||220
10249477|NCT03190369|11381666|FG001|STARTED|Overall Study||220
10249478|NCT03190369|11381665|FG000|Treated|Overall Study||220
10249479|NCT03190369|11381666|FG001|Treated|Overall Study||218
10249480|NCT03190369|11381665|FG000|COMPLETED|Overall Study||219
10249481|NCT03190369|11381666|FG001|COMPLETED|Overall Study||212
10249482|NCT03190369|11381665|FG000|NOT COMPLETED|Overall Study||1
10249483|NCT03190369|11381666|FG001|NOT COMPLETED|Overall Study||8
10249484|NCT04657198|11381675|FG000|STARTED|Overall Study||40
10249485|NCT04657198|11381676|FG001|STARTED|Overall Study||39
10249486|NCT04657198|11381677|FG002|STARTED|Overall Study||43
10249487|NCT04657198|11381675|FG000|COMPLETED|Overall Study||39
10249488|NCT04657198|11381676|FG001|COMPLETED|Overall Study||39
10249489|NCT04657198|11381677|FG002|COMPLETED|Overall Study||43
10249490|NCT04657198|11381675|FG000|NOT COMPLETED|Overall Study||1
10249491|NCT04657198|11381676|FG001|NOT COMPLETED|Overall Study||0
10249492|NCT04657198|11381677|FG002|NOT COMPLETED|Overall Study||0
10249493|NCT04590586|11381691|FG000|STARTED|Overall Study||28
10249494|NCT04590586|11381692|FG001|STARTED|Overall Study||1
10249495|NCT04590586|11381693|FG002|STARTED|Overall Study||194
10249496|NCT04590586|11381694|FG003|STARTED|Overall Study||184
10249497|NCT04590586|11381695|FG004|STARTED|Overall Study||100
10249498|NCT04590586|11381696|FG005|STARTED|Overall Study||8
10249499|NCT04590586|11381691|FG000|Received Study Drug|Overall Study||27
10249500|NCT04590586|11381692|FG001|Received Study Drug|Overall Study||1
10249501|NCT04590586|11381693|FG002|Received Study Drug|Overall Study||189
10249502|NCT04590586|11381694|FG003|Received Study Drug|Overall Study||182
10249503|NCT04590586|11381695|FG004|Received Study Drug|Overall Study||95
10249504|NCT04590586|11381696|FG005|Received Study Drug|Overall Study||7
10249505|NCT04590586|11381691|FG000|Full Analysis Set|Overall Study||28
10249506|NCT04590586|11381692|FG001|Full Analysis Set|Overall Study|Includes participants randomized to this arm (1) and 32 participants from Apremilast Placebo + SOC group and 1 participant from Zilucoplan Placebo + SOC group.|34
10249507|NCT04590586|11381693|FG002|Full Analysis Set|Overall Study||194
10249508|NCT04590586|11381694|FG003|Full Analysis Set|Overall Study|Includes participants randomized to this arm (184) and 1 participant from Lanadelumab Placebo + SOC group and 5 participants from Zilucoplan Placebo + SOC group.|190
10249509|NCT04590586|11381695|FG004|Full Analysis Set|Overall Study||100
10249510|NCT04590586|11381696|FG005|Full Analysis Set|Overall Study|Includes participants randomized to this arm (8) and 1 participant from Lanadelumab Placebo + SOC group and 66 participants from the Apremilast Placebo + SOC group.|75
10249511|NCT04590586|11381691|FG000|COMPLETED|Overall Study||15
10249512|NCT04590586|11381692|FG001|COMPLETED|Overall Study||0
10249513|NCT04590586|11381693|FG002|COMPLETED|Overall Study||139
10249514|NCT04590586|11381694|FG003|COMPLETED|Overall Study||138
10249515|NCT04590586|11381695|FG004|COMPLETED|Overall Study||70
10249516|NCT04590586|11381696|FG005|COMPLETED|Overall Study||4
10249517|NCT04590586|11381691|FG000|NOT COMPLETED|Overall Study||13
10249518|NCT04590586|11381692|FG001|NOT COMPLETED|Overall Study||1
10249519|NCT04590586|11381693|FG002|NOT COMPLETED|Overall Study||55
10249520|NCT04590586|11381694|FG003|NOT COMPLETED|Overall Study||46
10249521|NCT04590586|11381695|FG004|NOT COMPLETED|Overall Study||30
10249522|NCT04590586|11381696|FG005|NOT COMPLETED|Overall Study||4
10249523|NCT04312009|11381722|FG000|STARTED|Overall Study||104
10249524|NCT04312009|11381723|FG001|STARTED|Overall Study||101
10249525|NCT04312009|11381722|FG000|COMPLETED|Overall Study||102
10249526|NCT04312009|11381723|FG001|COMPLETED|Overall Study||100
10249527|NCT04312009|11381722|FG000|NOT COMPLETED|Overall Study||2
10249528|NCT04312009|11381723|FG001|NOT COMPLETED|Overall Study||1
10249529|NCT04191382|11381732|FG000|STARTED|Overall Study||34
10249530|NCT04191382|11381733|FG001|STARTED|Overall Study||36
10249531|NCT04191382|11381734|FG002|STARTED|Overall Study||35
10249532|NCT04191382|11381732|FG000|Treated|Overall Study||33
10249533|NCT04191382|11381733|FG001|Treated|Overall Study||36
10249534|NCT04191382|11381734|FG002|Treated|Overall Study||35
10249535|NCT04191382|11381732|FG000|COMPLETED|Overall Study||33
10249536|NCT04191382|11381733|FG001|COMPLETED|Overall Study||36
10249537|NCT04191382|11381734|FG002|COMPLETED|Overall Study||35
10249538|NCT04191382|11381732|FG000|NOT COMPLETED|Overall Study||1
10249539|NCT04191382|11381733|FG001|NOT COMPLETED|Overall Study||0
10249540|NCT04191382|11381734|FG002|NOT COMPLETED|Overall Study||0
10249541|NCT03964337|11381744|FG000|STARTED|Overall Study||3
10249542|NCT03964337|11381745|FG001|STARTED|Overall Study||0
10249543|NCT03964337|11381744|FG000|COMPLETED|Overall Study||3
10249544|NCT03964337|11381745|FG001|COMPLETED|Overall Study||0
10249545|NCT03964337|11381744|FG000|NOT COMPLETED|Overall Study||0
10249546|NCT03964337|11381745|FG001|NOT COMPLETED|Overall Study||0
10249547|NCT03937466|11381751|FG000|STARTED|Overall Study||38
10249548|NCT03937466|11381751|FG000|COMPLETED|Overall Study||15
10249549|NCT03937466|11381751|FG000|NOT COMPLETED|Overall Study||23
10249550|NCT03850483|11381764|FG000|STARTED|Treatment for Stage 1||37
10249551|NCT03850483|11381765|FG001|STARTED|Treatment for Stage 1||37
10249552|NCT03850483|11381766|FG002|STARTED|Treatment for Stage 1||37
10249553|NCT03850483|11381767|FG003|STARTED|Treatment for Stage 1||36
10249554|NCT03850483|11381768|FG004|STARTED|Treatment for Stage 1||37
10249555|NCT03850483|11381769|FG005|STARTED|Treatment for Stage 1||38
10249556|NCT03850483|11381770|FG006|STARTED|Treatment for Stage 1||36
10249557|NCT03850483|11381771|FG007|STARTED|Treatment for Stage 1||36
10249558|NCT03850483|11381772|FG008|STARTED|Treatment for Stage 1||0
10249559|NCT03850483|11381773|FG009|STARTED|Treatment for Stage 1||0
10249560|NCT03850483|11381764|FG000|Treated|Treatment for Stage 1||37
10249561|NCT03850483|11381765|FG001|Treated|Treatment for Stage 1||37
10249562|NCT03850483|11381766|FG002|Treated|Treatment for Stage 1||37
10249563|NCT03850483|11381767|FG003|Treated|Treatment for Stage 1||36
10249564|NCT03850483|11381768|FG004|Treated|Treatment for Stage 1||37
10249565|NCT03850483|11381769|FG005|Treated|Treatment for Stage 1||37
10249566|NCT03850483|11381770|FG006|Treated|Treatment for Stage 1||36
10249567|NCT03850483|11381771|FG007|Treated|Treatment for Stage 1||36
10249568|NCT03850483|11381772|FG008|Treated|Treatment for Stage 1||0
10249569|NCT03850483|11381773|FG009|Treated|Treatment for Stage 1||0
10249570|NCT03850483|11381764|FG000|COMPLETED|Treatment for Stage 1||29
10249571|NCT03850483|11381765|FG001|COMPLETED|Treatment for Stage 1||29
10249572|NCT03850483|11381766|FG002|COMPLETED|Treatment for Stage 1||26
10249573|NCT03850483|11381767|FG003|COMPLETED|Treatment for Stage 1||30
10249574|NCT03850483|11381768|FG004|COMPLETED|Treatment for Stage 1||28
10249575|NCT03850483|11381769|FG005|COMPLETED|Treatment for Stage 1||27
10249576|NCT03850483|11381770|FG006|COMPLETED|Treatment for Stage 1||25
10249577|NCT03850483|11381771|FG007|COMPLETED|Treatment for Stage 1||30
10249578|NCT03850483|11381772|FG008|COMPLETED|Treatment for Stage 1||0
10249579|NCT03850483|11381773|FG009|COMPLETED|Treatment for Stage 1||0
10249580|NCT03850483|11381764|FG000|NOT COMPLETED|Treatment for Stage 1||8
10249581|NCT03850483|11381765|FG001|NOT COMPLETED|Treatment for Stage 1||8
10249582|NCT03850483|11381766|FG002|NOT COMPLETED|Treatment for Stage 1||11
10249583|NCT03850483|11381767|FG003|NOT COMPLETED|Treatment for Stage 1||6
10249584|NCT03850483|11381768|FG004|NOT COMPLETED|Treatment for Stage 1||9
10249585|NCT03850483|11381769|FG005|NOT COMPLETED|Treatment for Stage 1||11
10249586|NCT03850483|11381770|FG006|NOT COMPLETED|Treatment for Stage 1||11
10249587|NCT03850483|11381771|FG007|NOT COMPLETED|Treatment for Stage 1||6
10249588|NCT03850483|11381772|FG008|NOT COMPLETED|Treatment for Stage 1||0
10249589|NCT03850483|11381773|FG009|NOT COMPLETED|Treatment for Stage 1||0
10249590|NCT03850483|11381764|FG000|STARTED|Follow-up for Stage 1||37
10249591|NCT03850483|11381765|FG001|STARTED|Follow-up for Stage 1||37
10249592|NCT03850483|11381766|FG002|STARTED|Follow-up for Stage 1||37
10249593|NCT03850483|11381767|FG003|STARTED|Follow-up for Stage 1||36
10249594|NCT03850483|11381768|FG004|STARTED|Follow-up for Stage 1||37
10249595|NCT03850483|11381769|FG005|STARTED|Follow-up for Stage 1||37
10249596|NCT03850483|11381770|FG006|STARTED|Follow-up for Stage 1||36
10249597|NCT03850483|11381771|FG007|STARTED|Follow-up for Stage 1||36
10249598|NCT03850483|11381772|FG008|STARTED|Follow-up for Stage 1||0
10249599|NCT03850483|11381773|FG009|STARTED|Follow-up for Stage 1||0
10249600|NCT03850483|11381764|FG000|COMPLETED|Follow-up for Stage 1||37
10249601|NCT03850483|11381765|FG001|COMPLETED|Follow-up for Stage 1||34
10249602|NCT03850483|11381766|FG002|COMPLETED|Follow-up for Stage 1||35
10249603|NCT03850483|11381767|FG003|COMPLETED|Follow-up for Stage 1||34
10249604|NCT03850483|11381768|FG004|COMPLETED|Follow-up for Stage 1||34
10249605|NCT03850483|11381769|FG005|COMPLETED|Follow-up for Stage 1||33
10249606|NCT03850483|11381770|FG006|COMPLETED|Follow-up for Stage 1||34
10249607|NCT03850483|11381771|FG007|COMPLETED|Follow-up for Stage 1||33
10249608|NCT03850483|11381772|FG008|COMPLETED|Follow-up for Stage 1||0
10249609|NCT03850483|11381773|FG009|COMPLETED|Follow-up for Stage 1||0
10249610|NCT03850483|11381764|FG000|NOT COMPLETED|Follow-up for Stage 1||0
10249611|NCT03850483|11381765|FG001|NOT COMPLETED|Follow-up for Stage 1||3
10249612|NCT03850483|11381766|FG002|NOT COMPLETED|Follow-up for Stage 1||2
10249613|NCT03850483|11381767|FG003|NOT COMPLETED|Follow-up for Stage 1||2
10249614|NCT03850483|11381768|FG004|NOT COMPLETED|Follow-up for Stage 1||3
10249615|NCT03850483|11381769|FG005|NOT COMPLETED|Follow-up for Stage 1||4
10249616|NCT03850483|11381770|FG006|NOT COMPLETED|Follow-up for Stage 1||2
10249617|NCT03850483|11381771|FG007|NOT COMPLETED|Follow-up for Stage 1||3
10249618|NCT03850483|11381772|FG008|NOT COMPLETED|Follow-up for Stage 1||0
10249619|NCT03850483|11381773|FG009|NOT COMPLETED|Follow-up for Stage 1||0
10249620|NCT03850483|11381764|FG000|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249621|NCT03850483|11381765|FG001|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249622|NCT03850483|11381766|FG002|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249623|NCT03850483|11381767|FG003|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249624|NCT03850483|11381768|FG004|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249625|NCT03850483|11381769|FG005|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249626|NCT03850483|11381770|FG006|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249627|NCT03850483|11381771|FG007|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10249628|NCT03850483|11381772|FG008|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|12
10249629|NCT03850483|11381773|FG009|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|38
10249630|NCT03850483|11381764|FG000|COMPLETED|Treatment for Stage 2||0
10249631|NCT03850483|11381765|FG001|COMPLETED|Treatment for Stage 2||0
10249632|NCT03850483|11381766|FG002|COMPLETED|Treatment for Stage 2||0
10249633|NCT03850483|11381767|FG003|COMPLETED|Treatment for Stage 2||0
10249634|NCT03850483|11381768|FG004|COMPLETED|Treatment for Stage 2||0
10249635|NCT03850483|11381769|FG005|COMPLETED|Treatment for Stage 2||0
10249636|NCT03850483|11381770|FG006|COMPLETED|Treatment for Stage 2||0
10249637|NCT03850483|11381771|FG007|COMPLETED|Treatment for Stage 2||0
10249638|NCT03850483|11381772|FG008|COMPLETED|Treatment for Stage 2||7
10249639|NCT03850483|11381773|FG009|COMPLETED|Treatment for Stage 2||27
10249640|NCT03850483|11381764|FG000|NOT COMPLETED|Treatment for Stage 2||0
10249641|NCT03850483|11381765|FG001|NOT COMPLETED|Treatment for Stage 2||0
10249642|NCT03850483|11381766|FG002|NOT COMPLETED|Treatment for Stage 2||0
10249643|NCT03850483|11381767|FG003|NOT COMPLETED|Treatment for Stage 2||0
10249644|NCT03850483|11381768|FG004|NOT COMPLETED|Treatment for Stage 2||0
10249645|NCT03850483|11381769|FG005|NOT COMPLETED|Treatment for Stage 2||0
10249646|NCT03850483|11381770|FG006|NOT COMPLETED|Treatment for Stage 2||0
10249647|NCT03850483|11381771|FG007|NOT COMPLETED|Treatment for Stage 2||0
10249648|NCT03850483|11381772|FG008|NOT COMPLETED|Treatment for Stage 2||5
10249649|NCT03850483|11381773|FG009|NOT COMPLETED|Treatment for Stage 2||11
10249650|NCT03850483|11381764|FG000|STARTED|Follow-up For Stage 2||0
10249651|NCT03850483|11381765|FG001|STARTED|Follow-up For Stage 2||0
10249652|NCT03850483|11381766|FG002|STARTED|Follow-up For Stage 2||0
10249653|NCT03850483|11381767|FG003|STARTED|Follow-up For Stage 2||0
10249654|NCT03850483|11381768|FG004|STARTED|Follow-up For Stage 2||0
10249655|NCT03850483|11381769|FG005|STARTED|Follow-up For Stage 2||0
10249656|NCT03850483|11381770|FG006|STARTED|Follow-up For Stage 2||0
10249657|NCT03850483|11381771|FG007|STARTED|Follow-up For Stage 2||0
10249658|NCT03850483|11381772|FG008|STARTED|Follow-up For Stage 2||12
10249659|NCT03850483|11381773|FG009|STARTED|Follow-up For Stage 2||38
10249660|NCT03850483|11381764|FG000|COMPLETED|Follow-up For Stage 2||0
10249661|NCT03850483|11381765|FG001|COMPLETED|Follow-up For Stage 2||0
10249662|NCT03850483|11381766|FG002|COMPLETED|Follow-up For Stage 2||0
10249663|NCT03850483|11381767|FG003|COMPLETED|Follow-up For Stage 2||0
10249664|NCT03850483|11381768|FG004|COMPLETED|Follow-up For Stage 2||0
10249665|NCT03850483|11381769|FG005|COMPLETED|Follow-up For Stage 2||0
10249666|NCT03850483|11381770|FG006|COMPLETED|Follow-up For Stage 2||0
10249667|NCT03850483|11381771|FG007|COMPLETED|Follow-up For Stage 2||0
10249668|NCT03850483|11381772|FG008|COMPLETED|Follow-up For Stage 2||12
10249669|NCT03850483|11381773|FG009|COMPLETED|Follow-up For Stage 2||36
10249670|NCT03850483|11381764|FG000|NOT COMPLETED|Follow-up For Stage 2||0
10249671|NCT03850483|11381765|FG001|NOT COMPLETED|Follow-up For Stage 2||0
10249672|NCT03850483|11381766|FG002|NOT COMPLETED|Follow-up For Stage 2||0
10249673|NCT03850483|11381767|FG003|NOT COMPLETED|Follow-up For Stage 2||0
10249674|NCT03850483|11381768|FG004|NOT COMPLETED|Follow-up For Stage 2||0
10249675|NCT03850483|11381769|FG005|NOT COMPLETED|Follow-up For Stage 2||0
10249676|NCT03850483|11381770|FG006|NOT COMPLETED|Follow-up For Stage 2||0
10249677|NCT03850483|11381771|FG007|NOT COMPLETED|Follow-up For Stage 2||0
10249678|NCT03850483|11381772|FG008|NOT COMPLETED|Follow-up For Stage 2||0
10249679|NCT03850483|11381773|FG009|NOT COMPLETED|Follow-up For Stage 2||2
10249680|NCT03804879|11381795|FG000|STARTED|Overall Study||41
10249681|NCT03804879|11381796|FG001|STARTED|Overall Study||42
10249682|NCT03804879|11381795|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||41
10249683|NCT03804879|11381796|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10249684|NCT03804879|11381795|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study||41
10249685|NCT03804879|11381796|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study||41
10249686|NCT03804879|11381795|FG000|COMPLETED|Overall Study||25
10249687|NCT03804879|11381796|FG001|COMPLETED|Overall Study||29
10249688|NCT03804879|11381795|FG000|NOT COMPLETED|Overall Study||16
10249689|NCT03804879|11381796|FG001|NOT COMPLETED|Overall Study||13
10249690|NCT03804684|11381805|FG000|STARTED|Overall Study||28
10249691|NCT03804684|11381806|FG001|STARTED|Overall Study||44
10249692|NCT03804684|11381805|FG000|COMPLETED|Overall Study||25
10249693|NCT03804684|11381806|FG001|COMPLETED|Overall Study||26
10249694|NCT03804684|11381805|FG000|NOT COMPLETED|Overall Study||3
10249695|NCT03804684|11381806|FG001|NOT COMPLETED|Overall Study||18
10249696|NCT03631706|11381816|FG000|STARTED|Overall Study||152
10249697|NCT03631706|11381817|FG001|STARTED|Overall Study||152
10249698|NCT03631706|11381816|FG000|Treated|Overall Study||151
10249699|NCT03631706|11381817|FG001|Treated|Overall Study||152
10249700|NCT03631706|11381816|FG000|COMPLETED|Overall Study||60
10249701|NCT03631706|11381817|FG001|COMPLETED|Overall Study||54
10249702|NCT03631706|11381816|FG000|NOT COMPLETED|Overall Study||92
10249703|NCT03631706|11381817|FG001|NOT COMPLETED|Overall Study||98
10249704|NCT03537014|11381825|FG000|STARTED|Overall Study||46
10249705|NCT03537014|11381826|FG001|STARTED|Overall Study||45
10249706|NCT03537014|11381825|FG000|Withdrew Consent Before Dosing|Overall Study||0
10249707|NCT03537014|11381826|FG001|Withdrew Consent Before Dosing|Overall Study||1
10249708|NCT03537014|11381825|FG000|Completed First Experimental Session|Overall Study||46
10249709|NCT03537014|11381826|FG001|Completed First Experimental Session|Overall Study||44
10249710|NCT03537014|11381825|FG000|Completed Second Experimental Session|Overall Study||43
10249711|NCT03537014|11381826|FG001|Completed Second Experimental Session|Overall Study||41
10249712|NCT03537014|11381825|FG000|COMPLETED|Overall Study||42
10249713|NCT03537014|11381826|FG001|COMPLETED|Overall Study||40
10249714|NCT03537014|11381825|FG000|NOT COMPLETED|Overall Study||4
10249715|NCT03537014|11381826|FG001|NOT COMPLETED|Overall Study||5
10249716|NCT03529799|11381834|FG000|STARTED|Overall Study||14
10249717|NCT03529799|11381835|FG001|STARTED|Overall Study||26
10249718|NCT03529799|11381834|FG000|COMPLETED|Overall Study||14
10249719|NCT03529799|11381835|FG001|COMPLETED|Overall Study||26
10249720|NCT03529799|11381834|FG000|NOT COMPLETED|Overall Study||0
10249721|NCT03529799|11381835|FG001|NOT COMPLETED|Overall Study||0
10249722|NCT03485287|11381841|FG000|STARTED|Overall Study||4
10249723|NCT03485287|11381841|FG000|COMPLETED|Overall Study||3
10249724|NCT03485287|11381841|FG000|NOT COMPLETED|Overall Study||1
10249725|NCT03473925|11381847|FG000|STARTED|Overall Study||52
10249726|NCT03473925|11381848|FG001|STARTED|Overall Study||55
10249727|NCT03473925|11381847|FG000|Treated|Overall Study||51
10249728|NCT03473925|11381848|FG001|Treated|Overall Study||54
9719227|NCT00039377|10818739|FG002|NOT COMPLETED|Initial Registration||0
9719228|NCT00039377|10818740|FG003|NOT COMPLETED|Initial Registration||0
9719229|NCT00039377|10818737|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
9719230|NCT00039377|10818738|FG001|STARTED|Course 5 (Transplant Assignments)||15
9719231|NCT00039377|10818739|FG002|STARTED|Course 5 (Transplant Assignments)||19
9719232|NCT00039377|10818740|FG003|STARTED|Course 5 (Transplant Assignments)||1
9719233|NCT00039377|10818737|FG000|COMPLETED|Course 5 (Transplant Assignments)||0
9719234|NCT00039377|10818738|FG001|COMPLETED|Course 5 (Transplant Assignments)||15
9719235|NCT00039377|10818739|FG002|COMPLETED|Course 5 (Transplant Assignments)||19
9719236|NCT00039377|10818740|FG003|COMPLETED|Course 5 (Transplant Assignments)||1
9719237|NCT00039377|10818737|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0
9719238|NCT00039377|10818738|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0
9719239|NCT00039377|10818739|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0
9719240|NCT00039377|10818740|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0
9719241|NCT00039741|10818752|FG000|STARTED|Overall Study||66
9719242|NCT00039741|10818753|FG001|STARTED|Overall Study||68
9719243|NCT00039741|10818754|FG002|STARTED|Overall Study||65
9719244|NCT00039741|10818755|FG003|STARTED|Overall Study||64
10249729|NCT03473925|11381847|FG000|COMPLETED|Overall Study||0
9719245|NCT00039741|10818752|FG000|Death|Overall Study||0
9719246|NCT00039741|10818753|FG001|Death|Overall Study||1
9719247|NCT00039741|10818754|FG002|Death|Overall Study||0
9719248|NCT00039741|10818755|FG003|Death|Overall Study||0
10249730|NCT03473925|11381848|FG001|COMPLETED|Overall Study||0
9719249|NCT00039741|10818752|FG000|COMPLETED|Overall Study||51
9719250|NCT00039741|10818753|FG001|COMPLETED|Overall Study||56
9719251|NCT00039741|10818754|FG002|COMPLETED|Overall Study||54
9719252|NCT00039741|10818755|FG003|COMPLETED|Overall Study||50
9719253|NCT00039741|10818752|FG000|NOT COMPLETED|Overall Study||15
9719254|NCT00039741|10818753|FG001|NOT COMPLETED|Overall Study||12
9719255|NCT00039741|10818754|FG002|NOT COMPLETED|Overall Study||11
10249731|NCT03473925|11381847|FG000|NOT COMPLETED|Overall Study||52
10249732|NCT03473925|11381848|FG001|NOT COMPLETED|Overall Study||55
10249733|NCT03462641|11381856|FG000|STARTED|Visit 1||19
10249734|NCT03462641|11381857|FG001|STARTED|Visit 1||11
10249735|NCT03462641|11381856|FG000|Actually Received Drug or Placebo|Visit 1||18
9833481|NCT00779584|10944392|FG001|COMPLETED|Overall Study||0
9833482|NCT00779584|10944393|FG002|COMPLETED|Overall Study||0
9833483|NCT00779584|10944394|FG003|COMPLETED|Overall Study||0
9833484|NCT00779584|10944395|FG004|COMPLETED|Overall Study||0
9833485|NCT00779584|10944396|FG005|COMPLETED|Overall Study||0
10113767|NCT02512302|11244580|FG006|COMPLETED|Period 1||2
10249736|NCT03462641|11381857|FG001|Actually Received Drug or Placebo|Visit 1||11
10249737|NCT03462641|11381856|FG000|COMPLETED|Visit 1||18
10249738|NCT03462641|11381857|FG001|COMPLETED|Visit 1||11
10249739|NCT03462641|11381856|FG000|NOT COMPLETED|Visit 1||1
10249740|NCT03462641|11381857|FG001|NOT COMPLETED|Visit 1||0
10249741|NCT03462641|11381856|FG000|STARTED|Visit 2||18
10249742|NCT03462641|11381857|FG001|STARTED|Visit 2||11
10249743|NCT03462641|11381856|FG000|Actually Received Drug or Placebo|Visit 2||18
10249744|NCT03462641|11381857|FG001|Actually Received Drug or Placebo|Visit 2||10
10249745|NCT03462641|11381856|FG000|COMPLETED|Visit 2||18
10249746|NCT03462641|11381857|FG001|COMPLETED|Visit 2||10
10249747|NCT03462641|11381856|FG000|NOT COMPLETED|Visit 2||0
10249748|NCT03462641|11381857|FG001|NOT COMPLETED|Visit 2||1
10249749|NCT03360396|11381867|FG000|STARTED|Overall Study||80
10249750|NCT03360396|11381868|FG001|STARTED|Overall Study||40
10249751|NCT03360396|11381867|FG000|COMPLETED|Overall Study||0
10249752|NCT03360396|11381868|FG001|COMPLETED|Overall Study||0
10249753|NCT03360396|11381867|FG000|NOT COMPLETED|Overall Study||80
10249754|NCT03360396|11381868|FG001|NOT COMPLETED|Overall Study||40
10249755|NCT03230097|11381876|FG000|STARTED|Overall Study||24
10249756|NCT03230097|11381877|FG001|STARTED|Overall Study||26
10249757|NCT03230097|11381876|FG000|COMPLETED|Overall Study||9
10249758|NCT03230097|11381877|FG001|COMPLETED|Overall Study||10
10249759|NCT03230097|11381876|FG000|NOT COMPLETED|Overall Study||15
10249760|NCT03230097|11381877|FG001|NOT COMPLETED|Overall Study||16
10113768|NCT02512302|11244581|FG007|COMPLETED|Period 1||3
10113769|NCT02512302|11244582|FG008|COMPLETED|Period 1||3
10113770|NCT02512302|11244583|FG009|COMPLETED|Period 1||3
10113771|NCT02512302|11244574|FG000|NOT COMPLETED|Period 1||0
10113772|NCT02512302|11244575|FG001|NOT COMPLETED|Period 1||1
10113773|NCT02512302|11244576|FG002|NOT COMPLETED|Period 1||0
10113774|NCT02512302|11244577|FG003|NOT COMPLETED|Period 1||0
10113775|NCT02512302|11244578|FG004|NOT COMPLETED|Period 1||0
10113776|NCT02512302|11244579|FG005|NOT COMPLETED|Period 1||0
10113777|NCT02512302|11244580|FG006|NOT COMPLETED|Period 1||0
10113778|NCT02512302|11244581|FG007|NOT COMPLETED|Period 1||0
10113779|NCT02512302|11244582|FG008|NOT COMPLETED|Period 1||0
10113780|NCT02512302|11244583|FG009|NOT COMPLETED|Period 1||0
10113781|NCT02512302|11244574|FG000|STARTED|Period 2||3
10113782|NCT02512302|11244575|FG001|STARTED|Period 2||2
10113783|NCT02512302|11244576|FG002|STARTED|Period 2||4
10113784|NCT02512302|11244577|FG003|STARTED|Period 2||3
10113785|NCT02512302|11244578|FG004|STARTED|Period 2||3
10113786|NCT02512302|11244579|FG005|STARTED|Period 2||3
10113787|NCT02512302|11244580|FG006|STARTED|Period 2||2
10113788|NCT02512302|11244581|FG007|STARTED|Period 2||3
10113789|NCT02512302|11244582|FG008|STARTED|Period 2||3
10113790|NCT02512302|11244583|FG009|STARTED|Period 2||3
10113791|NCT02512302|11244574|FG000|COMPLETED|Period 2||3
10113792|NCT02512302|11244575|FG001|COMPLETED|Period 2||2
10113793|NCT02512302|11244576|FG002|COMPLETED|Period 2||4
10113794|NCT02512302|11244577|FG003|COMPLETED|Period 2||3
10113795|NCT02512302|11244578|FG004|COMPLETED|Period 2||3
10113796|NCT02512302|11244579|FG005|COMPLETED|Period 2||3
10113797|NCT02512302|11244580|FG006|COMPLETED|Period 2||2
10113798|NCT02512302|11244581|FG007|COMPLETED|Period 2||3
10113799|NCT02512302|11244582|FG008|COMPLETED|Period 2||3
10113800|NCT02512302|11244583|FG009|COMPLETED|Period 2||2
10113801|NCT02512302|11244574|FG000|NOT COMPLETED|Period 2||0
10113802|NCT02512302|11244575|FG001|NOT COMPLETED|Period 2||0
10113803|NCT02512302|11244576|FG002|NOT COMPLETED|Period 2||0
10113804|NCT02512302|11244577|FG003|NOT COMPLETED|Period 2||0
10113805|NCT02512302|11244578|FG004|NOT COMPLETED|Period 2||0
10113806|NCT02512302|11244579|FG005|NOT COMPLETED|Period 2||0
10113807|NCT02512302|11244580|FG006|NOT COMPLETED|Period 2||0
10113808|NCT02512302|11244581|FG007|NOT COMPLETED|Period 2||0
10113809|NCT02512302|11244582|FG008|NOT COMPLETED|Period 2||0
10113810|NCT02512302|11244583|FG009|NOT COMPLETED|Period 2||1
10113811|NCT02512302|11244574|FG000|STARTED|Period 3||3
10113812|NCT02512302|11244575|FG001|STARTED|Period 3||2
10113813|NCT02512302|11244576|FG002|STARTED|Period 3||4
10113814|NCT02512302|11244577|FG003|STARTED|Period 3||3
10113815|NCT02512302|11244578|FG004|STARTED|Period 3||3
9833486|NCT00779584|10944397|FG006|COMPLETED|Overall Study||0
9833487|NCT00779584|10944398|FG007|COMPLETED|Overall Study||0
9833488|NCT00779584|10944399|FG008|COMPLETED|Overall Study||0
10113816|NCT02512302|11244579|FG005|STARTED|Period 3||3
10113817|NCT02512302|11244580|FG006|STARTED|Period 3||2
10113818|NCT02512302|11244581|FG007|STARTED|Period 3||3
10113819|NCT02512302|11244582|FG008|STARTED|Period 3||3
10113820|NCT02512302|11244583|FG009|STARTED|Period 3||2
10113821|NCT02512302|11244574|FG000|COMPLETED|Period 3||3
10113822|NCT02512302|11244575|FG001|COMPLETED|Period 3||2
10113823|NCT02512302|11244576|FG002|COMPLETED|Period 3||3
10249761|NCT03226067|11381886|FG000|STARTED|Overall Study||36
10249762|NCT03226067|11381887|FG001|STARTED|Overall Study||38
10249763|NCT03226067|11381888|FG002|STARTED|Overall Study||37
10249764|NCT03226067|11381886|FG000|COMPLETED|Overall Study||36
10249765|NCT03226067|11381887|FG001|COMPLETED|Overall Study||38
9833489|NCT00779584|10944391|FG000|NOT COMPLETED|Overall Study||3
9833490|NCT00779584|10944392|FG001|NOT COMPLETED|Overall Study||3
9833491|NCT00779584|10944393|FG002|NOT COMPLETED|Overall Study||7
9833492|NCT00779584|10944394|FG003|NOT COMPLETED|Overall Study||6
9833493|NCT00779584|10944395|FG004|NOT COMPLETED|Overall Study||7
9833494|NCT00779584|10944396|FG005|NOT COMPLETED|Overall Study||6
9833495|NCT00779584|10944397|FG006|NOT COMPLETED|Overall Study||8
9833496|NCT00779584|10944398|FG007|NOT COMPLETED|Overall Study||3
9833497|NCT00779584|10944399|FG008|NOT COMPLETED|Overall Study||2
9833498|NCT00779675|10944419|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
9833499|NCT00779675|10944419|FG000|COMPLETED|Treatment Period||328
9833500|NCT00779675|10944419|FG000|NOT COMPLETED|Treatment Period||332
9833501|NCT00779675|10944419|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
9833502|NCT00779675|10944419|FG000|COMPLETED|Extended Treatment Period||147
9833503|NCT00779675|10944419|FG000|NOT COMPLETED|Extended Treatment Period||46
9957412|NCT01450761|11076628|FG001|COMPLETED|Treatment With Blinded Study Therapy||0
9957413|NCT01450761|11076627|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478
9957414|NCT01450761|11076628|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476
9957415|NCT01450787|11076636|FG000|STARTED|Overall Study||38
9957416|NCT01450787|11076637|FG001|STARTED|Overall Study||25
9957417|NCT01450787|11076636|FG000|COMPLETED|Overall Study||38
9957418|NCT01450787|11076637|FG001|COMPLETED|Overall Study||25
9957419|NCT01450787|11076636|FG000|NOT COMPLETED|Overall Study||0
9957420|NCT01450787|11076637|FG001|NOT COMPLETED|Overall Study||0
9957421|NCT01450800|11076645|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
9957422|NCT01450800|11076646|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81
9957423|NCT01450800|11076645|FG000|COMPLETED|Overall Study||81
9957424|NCT01450800|11076646|FG001|COMPLETED|Overall Study||78
9957425|NCT01450800|11076645|FG000|NOT COMPLETED|Overall Study||1
9957426|NCT01450800|11076646|FG001|NOT COMPLETED|Overall Study||3
9957427|NCT01450813|11076658|FG000|STARTED|Overall Study||20
9957428|NCT01450813|11076659|FG001|STARTED|Overall Study||20
9957429|NCT01450813|11076660|FG002|STARTED|Overall Study||20
9957430|NCT01450813|11076661|FG003|STARTED|Overall Study||20
9957431|NCT01450813|11076658|FG000|COMPLETED|Overall Study||19
9957432|NCT01450813|11076659|FG001|COMPLETED|Overall Study||19
9957433|NCT01450813|11076660|FG002|COMPLETED|Overall Study||20
9957434|NCT01450813|11076661|FG003|COMPLETED|Overall Study||17
9957435|NCT01450813|11076658|FG000|NOT COMPLETED|Overall Study||1
9957436|NCT01450813|11076659|FG001|NOT COMPLETED|Overall Study||1
9957437|NCT01450813|11076660|FG002|NOT COMPLETED|Overall Study||0
9957438|NCT01450813|11076661|FG003|NOT COMPLETED|Overall Study||3
9957439|NCT01450826|11076675|FG000|STARTED|Overall Study||70
9957440|NCT01450826|11076676|FG001|STARTED|Overall Study||66
9957441|NCT01450826|11076675|FG000|COMPLETED|Overall Study||70
9957442|NCT01450826|11076676|FG001|COMPLETED|Overall Study||66
10020036|NCT01833065|11143270|FG001|COMPLETED|Overall Study||40
10020037|NCT01833065|11143271|FG002|COMPLETED|Overall Study||23
9957443|NCT01450826|11076675|FG000|NOT COMPLETED|Overall Study||0
9957444|NCT01450826|11076676|FG001|NOT COMPLETED|Overall Study||0
9957445|NCT01450943|11076685|FG000|STARTED|Overall Study||28
10020038|NCT01833065|11143272|FG003|COMPLETED|Overall Study||41
10020039|NCT01833065|11143273|FG004|COMPLETED|Overall Study||74
10020040|NCT01833065|11143269|FG000|NOT COMPLETED|Overall Study||24
10020041|NCT01833065|11143270|FG001|NOT COMPLETED|Overall Study||13
10020042|NCT01833065|11143271|FG002|NOT COMPLETED|Overall Study||12
10020043|NCT01833065|11143272|FG003|NOT COMPLETED|Overall Study||9
10020044|NCT01833065|11143273|FG004|NOT COMPLETED|Overall Study||36
9957446|NCT01450943|11076686|FG001|STARTED|Overall Study||42
10020045|NCT01833078|11143283|FG000|STARTED|Overall Study||5
10020046|NCT01833078|11143283|FG000|COMPLETED|Overall Study||5
10113824|NCT02512302|11244577|FG003|COMPLETED|Period 3||3
10113825|NCT02512302|11244578|FG004|COMPLETED|Period 3||3
10113826|NCT02512302|11244579|FG005|COMPLETED|Period 3||3
10113827|NCT02512302|11244580|FG006|COMPLETED|Period 3||2
10113828|NCT02512302|11244581|FG007|COMPLETED|Period 3||3
10113829|NCT02512302|11244582|FG008|COMPLETED|Period 3||3
10113830|NCT02512302|11244583|FG009|COMPLETED|Period 3||2
10113831|NCT02512302|11244574|FG000|NOT COMPLETED|Period 3||0
10113832|NCT02512302|11244575|FG001|NOT COMPLETED|Period 3||0
10113833|NCT02512302|11244576|FG002|NOT COMPLETED|Period 3||1
10113834|NCT02512302|11244577|FG003|NOT COMPLETED|Period 3||0
10113835|NCT02512302|11244578|FG004|NOT COMPLETED|Period 3||0
10113836|NCT02512302|11244579|FG005|NOT COMPLETED|Period 3||0
10113837|NCT02512302|11244580|FG006|NOT COMPLETED|Period 3||0
10113838|NCT02512302|11244581|FG007|NOT COMPLETED|Period 3||0
10113839|NCT02512302|11244582|FG008|NOT COMPLETED|Period 3||0
10113840|NCT02512302|11244583|FG009|NOT COMPLETED|Period 3||0
10113841|NCT02512302|11244574|FG000|STARTED|Period 4||3
10113842|NCT02512302|11244575|FG001|STARTED|Period 4||2
10113843|NCT02512302|11244576|FG002|STARTED|Period 4||3
10113844|NCT02512302|11244577|FG003|STARTED|Period 4||3
10113845|NCT02512302|11244578|FG004|STARTED|Period 4||3
10113846|NCT02512302|11244579|FG005|STARTED|Period 4||3
10113847|NCT02512302|11244580|FG006|STARTED|Period 4||2
10113848|NCT02512302|11244581|FG007|STARTED|Period 4||3
10113849|NCT02512302|11244582|FG008|STARTED|Period 4||3
10113850|NCT02512302|11244583|FG009|STARTED|Period 4||2
10113851|NCT02512302|11244574|FG000|COMPLETED|Period 4||3
10113852|NCT02512302|11244575|FG001|COMPLETED|Period 4||2
10113853|NCT02512302|11244576|FG002|COMPLETED|Period 4||3
10113854|NCT02512302|11244577|FG003|COMPLETED|Period 4||3
10113855|NCT02512302|11244578|FG004|COMPLETED|Period 4||3
10113856|NCT02512302|11244579|FG005|COMPLETED|Period 4||3
10113857|NCT02512302|11244580|FG006|COMPLETED|Period 4||1
10113858|NCT02512302|11244581|FG007|COMPLETED|Period 4||3
10113859|NCT02512302|11244582|FG008|COMPLETED|Period 4||3
10113860|NCT02512302|11244583|FG009|COMPLETED|Period 4||2
10113861|NCT02512302|11244574|FG000|NOT COMPLETED|Period 4||0
10113862|NCT02512302|11244575|FG001|NOT COMPLETED|Period 4||0
10113863|NCT02512302|11244576|FG002|NOT COMPLETED|Period 4||0
9833504|NCT00779701|10944427|FG000|STARTED|Overall Study||27
9833505|NCT00779701|10944427|FG000|COMPLETED|Overall Study||27
9833506|NCT00779701|10944427|FG000|NOT COMPLETED|Overall Study||0
9833507|NCT00779766|10944433|FG000|STARTED|Month 24||3026
9833508|NCT00779766|10944434|FG001|STARTED|Month 24||3025
9833509|NCT00779766|10944433|FG000|COMPLETED|Month 24||2694
9833510|NCT00779766|10944434|FG001|COMPLETED|Month 24||2693
9833511|NCT00779766|10944433|FG000|NOT COMPLETED|Month 24||332
9833512|NCT00779766|10944434|FG001|NOT COMPLETED|Month 24||332
9833513|NCT00779766|10944433|FG000|STARTED|Month 48||2703
9833514|NCT00779766|10944434|FG001|STARTED|Month 48||2727
9833515|NCT00779766|10944433|FG000|COMPLETED|Month 48||2529
9833516|NCT00779766|10944434|FG001|COMPLETED|Month 48||2559
9833517|NCT00779766|10944433|FG000|NOT COMPLETED|Month 48||174
9833518|NCT00779766|10944434|FG001|NOT COMPLETED|Month 48||168
9833519|NCT00779766|10944433|FG000|STARTED|Month 72||2319
9833520|NCT00779766|10944434|FG001|STARTED|Month 72||2347
9833521|NCT00779766|10944433|FG000|COMPLETED|Month 72||2134
9833522|NCT00779766|10944434|FG001|COMPLETED|Month 72||2158
9833523|NCT00779766|10944433|FG000|NOT COMPLETED|Month 72||185
9833524|NCT00779766|10944434|FG001|NOT COMPLETED|Month 72||189
9833525|NCT00779779|10944441|FG000|STARTED|Overall Study||522
10113864|NCT02512302|11244577|FG003|NOT COMPLETED|Period 4||0
10113865|NCT02512302|11244578|FG004|NOT COMPLETED|Period 4||0
10113866|NCT02512302|11244579|FG005|NOT COMPLETED|Period 4||0
10113867|NCT02512302|11244580|FG006|NOT COMPLETED|Period 4||1
10113868|NCT02512302|11244581|FG007|NOT COMPLETED|Period 4||0
10113869|NCT02512302|11244582|FG008|NOT COMPLETED|Period 4||0
10113870|NCT02512302|11244583|FG009|NOT COMPLETED|Period 4||0
10113871|NCT02512302|11244574|FG000|STARTED|Period 5||3
9833526|NCT00779779|10944441|FG000|COMPLETED|Overall Study||498
10113872|NCT02512302|11244575|FG001|STARTED|Period 5||2
10113873|NCT02512302|11244576|FG002|STARTED|Period 5||3
10113874|NCT02512302|11244577|FG003|STARTED|Period 5||3
10113875|NCT02512302|11244578|FG004|STARTED|Period 5||3
10113876|NCT02512302|11244579|FG005|STARTED|Period 5||3
9833527|NCT00779779|10944441|FG000|NOT COMPLETED|Overall Study||24
9833528|NCT00779857|10944445|FG000|STARTED|Overall Study|70 patients treated|70
10113877|NCT02512302|11244580|FG006|STARTED|Period 5||1
10113878|NCT02512302|11244581|FG007|STARTED|Period 5||3
10113879|NCT02512302|11244582|FG008|STARTED|Period 5||3
10113880|NCT02512302|11244583|FG009|STARTED|Period 5||2
9833529|NCT00779857|10944445|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68
9957447|NCT01450943|11076687|FG002|STARTED|Overall Study||48
9957448|NCT01450943|11076685|FG000|COMPLETED|Overall Study||26
9957449|NCT01450943|11076686|FG001|COMPLETED|Overall Study||35
9957450|NCT01450943|11076687|FG002|COMPLETED|Overall Study||42
9957451|NCT01450943|11076685|FG000|NOT COMPLETED|Overall Study||2
9957452|NCT01450943|11076686|FG001|NOT COMPLETED|Overall Study||7
9957453|NCT01450943|11076687|FG002|NOT COMPLETED|Overall Study||6
9967660|NCT01515540|11088005|FG001|NOT COMPLETED|Overall Study||3
9967661|NCT01515566|11088013|FG000|STARTED|Overall Study||10
9967662|NCT01515566|11088014|FG001|STARTED|Overall Study||10
9967663|NCT01515566|11088013|FG000|COMPLETED|Overall Study||10
9967664|NCT01515566|11088014|FG001|COMPLETED|Overall Study||10
9967665|NCT01515566|11088013|FG000|NOT COMPLETED|Overall Study||0
9967666|NCT01515566|11088014|FG001|NOT COMPLETED|Overall Study||0
9967667|NCT01515657|11088020|FG000|STARTED|First Intervention||14
10113881|NCT02512302|11244574|FG000|COMPLETED|Period 5||3
10113882|NCT02512302|11244575|FG001|COMPLETED|Period 5||2
10113883|NCT02512302|11244576|FG002|COMPLETED|Period 5||3
10113884|NCT02512302|11244577|FG003|COMPLETED|Period 5||3
10113885|NCT02512302|11244578|FG004|COMPLETED|Period 5||3
10113886|NCT02512302|11244579|FG005|COMPLETED|Period 5||3
10020047|NCT01833078|11143283|FG000|NOT COMPLETED|Overall Study||0
10020048|NCT01833117|11143289|FG000|STARTED|Overall Study||43
10020049|NCT01833117|11143290|FG001|STARTED|Overall Study||19
10020050|NCT01833117|11143289|FG000|COMPLETED|Overall Study||43
10020051|NCT01833117|11143290|FG001|COMPLETED|Overall Study||19
10113887|NCT02512302|11244580|FG006|COMPLETED|Period 5||1
10249766|NCT03226067|11381888|FG002|COMPLETED|Overall Study||37
10249767|NCT03226067|11381886|FG000|NOT COMPLETED|Overall Study||0
10249768|NCT03226067|11381887|FG001|NOT COMPLETED|Overall Study||0
10249769|NCT03226067|11381888|FG002|NOT COMPLETED|Overall Study||0
10249770|NCT03029780|11381898|FG000|STARTED|Overall Study||52
10249771|NCT03029780|11381899|FG001|STARTED|Overall Study||52
10249772|NCT03029780|11381898|FG000|COMPLETED|Overall Study||1
10249773|NCT03029780|11381899|FG001|COMPLETED|Overall Study||1
10249774|NCT03029780|11381898|FG000|NOT COMPLETED|Overall Study||51
10249775|NCT03029780|11381899|FG001|NOT COMPLETED|Overall Study||51
10249776|NCT03018730|11381906|FG000|STARTED|Overall Study||22
10249777|NCT03018730|11381906|FG000|COMPLETED|Overall Study||20
10249778|NCT03018730|11381906|FG000|NOT COMPLETED|Overall Study||2
10249779|NCT02968940|11381913|FG000|STARTED|Overall Study||6
10249780|NCT02968940|11381913|FG000|COMPLETED|Overall Study||6
10249781|NCT02968940|11381913|FG000|NOT COMPLETED|Overall Study||0
10249782|NCT02893930|11381917|FG000|STARTED|Overall Study||13
10249783|NCT02893930|11381917|FG000|Eligible and Treated|Overall Study||12
10249784|NCT02893930|11381917|FG000|COMPLETED|Overall Study||0
10249785|NCT02893930|11381917|FG000|NOT COMPLETED|Overall Study||13
10249786|NCT02890355|11381923|FG000|STARTED|Overall Study||59
10249787|NCT02890355|11381924|FG001|STARTED|Overall Study||58
10249788|NCT02890355|11381923|FG000|Treated & Assessed for AEs|Overall Study||56
10249789|NCT02890355|11381924|FG001|Treated & Assessed for AEs|Overall Study||50
10249790|NCT02890355|11381923|FG000|COMPLETED|Overall Study||0
10249791|NCT02890355|11381924|FG001|COMPLETED|Overall Study||0
10249792|NCT02890355|11381923|FG000|NOT COMPLETED|Overall Study||59
10249793|NCT02890355|11381924|FG001|NOT COMPLETED|Overall Study||58
10249794|NCT02853305|11381935|FG000|STARTED|Overall Study||351
10249795|NCT02853305|11381936|FG001|STARTED|Overall Study||307
9833530|NCT00779857|10944445|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
9833531|NCT00779857|10944445|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
9833532|NCT00779857|10944445|FG000|NOT COMPLETED|Overall Study||6
9833533|NCT00779870|10944452|FG000|STARTED|Overall Study||5
9833534|NCT00779870|10944453|FG001|STARTED|Overall Study||6
9833535|NCT00779870|10944454|FG002|STARTED|Overall Study||7
9833536|NCT00779870|10944452|FG000|COMPLETED|Overall Study||5
10020052|NCT01833117|11143289|FG000|NOT COMPLETED|Overall Study||0
10020053|NCT01833117|11143290|FG001|NOT COMPLETED|Overall Study||0
10249796|NCT02853305|11381937|FG002|STARTED|Overall Study||352
10249797|NCT02853305|11381935|FG000|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
10249798|NCT02853305|11381936|FG001|Treated|Overall Study||302
10249799|NCT02853305|11381937|FG002|Treated|Overall Study||342
10249800|NCT02853305|11381935|FG000|COMPLETED|Overall Study||0
10249801|NCT02853305|11381936|FG001|COMPLETED|Overall Study||0
10249802|NCT02853305|11381937|FG002|COMPLETED|Overall Study||0
10249803|NCT02853305|11381935|FG000|NOT COMPLETED|Overall Study||351
10249804|NCT02853305|11381936|FG001|NOT COMPLETED|Overall Study||307
10249805|NCT02853305|11381937|FG002|NOT COMPLETED|Overall Study||352
10249806|NCT02803593|11381947|FG000|STARTED|Overall Study||95
9833537|NCT00779870|10944453|FG001|COMPLETED|Overall Study||6
9833538|NCT00779870|10944454|FG002|COMPLETED|Overall Study||7
10020054|NCT01833130|11143298|FG000|STARTED|Overall Study||25
10020055|NCT01833130|11143299|FG001|STARTED|Overall Study||27
10020056|NCT01833130|11143298|FG000|COMPLETED|Overall Study||15
10113888|NCT02512302|11244581|FG007|COMPLETED|Period 5||3
10113889|NCT02512302|11244582|FG008|COMPLETED|Period 5||3
10113890|NCT02512302|11244583|FG009|COMPLETED|Period 5||2
10113891|NCT02512302|11244574|FG000|NOT COMPLETED|Period 5||0
10113892|NCT02512302|11244575|FG001|NOT COMPLETED|Period 5||0
10113893|NCT02512302|11244576|FG002|NOT COMPLETED|Period 5||0
10113894|NCT02512302|11244577|FG003|NOT COMPLETED|Period 5||0
10113895|NCT02512302|11244578|FG004|NOT COMPLETED|Period 5||0
10113896|NCT02512302|11244579|FG005|NOT COMPLETED|Period 5||0
10113897|NCT02512302|11244580|FG006|NOT COMPLETED|Period 5||0
10113898|NCT02512302|11244581|FG007|NOT COMPLETED|Period 5||0
10113899|NCT02512302|11244582|FG008|NOT COMPLETED|Period 5||0
10113900|NCT02512302|11244583|FG009|NOT COMPLETED|Period 5||0
10113901|NCT02512393|11244598|FG000|STARTED|Overall Study||21
10113902|NCT02512393|11244599|FG001|STARTED|Overall Study||20
10113903|NCT02512393|11244598|FG000|COMPLETED|Overall Study||20
10113904|NCT02512393|11244599|FG001|COMPLETED|Overall Study||20
10249807|NCT02803593|11381948|FG001|STARTED|Overall Study||104
10249808|NCT02803593|11381947|FG000|Completed Month 1 Assessment|Overall Study||83
10249809|NCT02803593|11381948|FG001|Completed Month 1 Assessment|Overall Study||76
10249810|NCT02803593|11381947|FG000|COMPLETED|Overall Study||78
10249811|NCT02803593|11381948|FG001|COMPLETED|Overall Study||69
10249812|NCT02803593|11381947|FG000|NOT COMPLETED|Overall Study||17
10249813|NCT02803593|11381948|FG001|NOT COMPLETED|Overall Study||35
10249814|NCT02663908|11381956|FG000|STARTED|Overall Study||276
10249815|NCT02663908|11381957|FG001|STARTED|Overall Study||269
10249816|NCT02663908|11381956|FG000|Full Analysis Set (FAS)|Overall Study||275
10249817|NCT02663908|11381957|FG001|Full Analysis Set (FAS)|Overall Study||269
10249818|NCT02663908|11381956|FG000|COMPLETED|Overall Study||244
10249819|NCT02663908|11381957|FG001|COMPLETED|Overall Study||245
10249820|NCT02663908|11381956|FG000|NOT COMPLETED|Overall Study||32
10249821|NCT02663908|11381957|FG001|NOT COMPLETED|Overall Study||24
10249822|NCT02650284|11381965|FG000|STARTED|Overall Study||8
10249823|NCT02650284|11381966|FG001|STARTED|Overall Study||9
10249824|NCT02650284|11381965|FG000|COMPLETED|Overall Study||5
10249825|NCT02650284|11381966|FG001|COMPLETED|Overall Study||5
10249826|NCT02650284|11381965|FG000|NOT COMPLETED|Overall Study||3
10249827|NCT02650284|11381966|FG001|NOT COMPLETED|Overall Study||4
10249828|NCT02642042|11381972|FG000|STARTED|Overall Study||54
10249829|NCT02642042|11381972|FG000|COMPLETED|Overall Study||0
10249830|NCT02642042|11381972|FG000|NOT COMPLETED|Overall Study||54
10249885|NCT02535338|11382007|FG000|STARTED|Overall Study||3
10249886|NCT02535338|11382008|FG001|STARTED|Overall Study||8
10249887|NCT02535338|11382007|FG000|COMPLETED|Overall Study||3
10249888|NCT02535338|11382008|FG001|COMPLETED|Overall Study||8
10249889|NCT02535338|11382007|FG000|NOT COMPLETED|Overall Study||0
10249890|NCT02535338|11382008|FG001|NOT COMPLETED|Overall Study||0
10249891|NCT02500797|11382028|FG000|STARTED|Overall Study||43
10249892|NCT02500797|11382029|FG001|STARTED|Overall Study||42
10249893|NCT02500797|11382030|FG002|STARTED|Overall Study||15
10249894|NCT02500797|11382031|FG003|STARTED|Overall Study||14
10249895|NCT02500797|11382032|FG004|STARTED|Overall Study||14
10249896|NCT02500797|11382033|FG005|STARTED|Overall Study||15
10249897|NCT02500797|11382034|FG006|STARTED|Overall Study||10
10249898|NCT02500797|11382035|FG007|STARTED|Overall Study||11
10249899|NCT02500797|11382028|FG000|Arm I Crossover|Overall Study||4
10249900|NCT02500797|11382029|FG001|Arm I Crossover|Overall Study||0
10249901|NCT02500797|11382030|FG002|Arm I Crossover|Overall Study||6
10249902|NCT02500797|11382031|FG003|Arm I Crossover|Overall Study||0
10249903|NCT02500797|11382032|FG004|Arm I Crossover|Overall Study||1
10249904|NCT02500797|11382033|FG005|Arm I Crossover|Overall Study||0
10249905|NCT02500797|11382034|FG006|Arm I Crossover|Overall Study||2
10249906|NCT02500797|11382035|FG007|Arm I Crossover|Overall Study||0
10249907|NCT02500797|11382028|FG000|COMPLETED|Overall Study||42
10249908|NCT02500797|11382029|FG001|COMPLETED|Overall Study||42
10249909|NCT02500797|11382030|FG002|COMPLETED|Overall Study||15
10249910|NCT02500797|11382031|FG003|COMPLETED|Overall Study||14
10249911|NCT02500797|11382032|FG004|COMPLETED|Overall Study||13
10249912|NCT02500797|11382033|FG005|COMPLETED|Overall Study||14
10249913|NCT02500797|11382034|FG006|COMPLETED|Overall Study||10
10249914|NCT02500797|11382035|FG007|COMPLETED|Overall Study||11
10249915|NCT02500797|11382028|FG000|NOT COMPLETED|Overall Study||1
10249916|NCT02500797|11382029|FG001|NOT COMPLETED|Overall Study||0
10249917|NCT02500797|11382030|FG002|NOT COMPLETED|Overall Study||0
10249918|NCT02500797|11382031|FG003|NOT COMPLETED|Overall Study||0
10249919|NCT02500797|11382032|FG004|NOT COMPLETED|Overall Study||1
10249920|NCT02500797|11382033|FG005|NOT COMPLETED|Overall Study||1
10249921|NCT02500797|11382034|FG006|NOT COMPLETED|Overall Study||0
10249922|NCT02500797|11382035|FG007|NOT COMPLETED|Overall Study||0
10249923|NCT02447133|11382060|FG000|STARTED|Overall Study||12
10249924|NCT02447133|11382060|FG000|COMPLETED|Overall Study||12
10249925|NCT02447133|11382060|FG000|NOT COMPLETED|Overall Study||0
10249926|NCT02446600|11382070|FG000|STARTED|Overall Study||187
10249927|NCT02446600|11382071|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
10249928|NCT02446600|11382072|FG002|STARTED|Overall Study||189
10249929|NCT02446600|11382073|FG003|STARTED|Overall Study||13
10249930|NCT02446600|11382070|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
10249931|NCT02446600|11382071|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
10249932|NCT02446600|11382072|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
10249933|NCT02446600|11382073|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
10249934|NCT02446600|11382070|FG000|NOT COMPLETED|Overall Study||40
10249935|NCT02446600|11382071|FG001|NOT COMPLETED|Overall Study||12
10249936|NCT02446600|11382072|FG002|NOT COMPLETED|Overall Study||27
10249937|NCT02446600|11382073|FG003|NOT COMPLETED|Overall Study||1
10249938|NCT02426658|11382083|FG000|STARTED|Overall Study||16
10249939|NCT02426658|11382083|FG000|COMPLETED|Overall Study||13
10249940|NCT02426658|11382083|FG000|NOT COMPLETED|Overall Study||3
10249941|NCT02281084|11382091|FG000|STARTED|Overall Study||32
10249942|NCT02281084|11382092|FG001|STARTED|Overall Study||22
10249943|NCT02281084|11382093|FG002|STARTED|Overall Study||6
10249944|NCT02281084|11382094|FG003|STARTED|Overall Study||5
10249945|NCT02281084|11382091|FG000|COMPLETED|Overall Study||10
10249946|NCT02281084|11382092|FG001|COMPLETED|Overall Study||4
10249947|NCT02281084|11382093|FG002|COMPLETED|Overall Study||2
10249948|NCT02281084|11382094|FG003|COMPLETED|Overall Study||0
10249949|NCT02281084|11382091|FG000|NOT COMPLETED|Overall Study||22
10249950|NCT02281084|11382092|FG001|NOT COMPLETED|Overall Study||18
10249951|NCT02281084|11382093|FG002|NOT COMPLETED|Overall Study||4
10249952|NCT02281084|11382094|FG003|NOT COMPLETED|Overall Study||5
10249953|NCT02277106|11382104|FG000|STARTED|Stage 1: Treatment Period 1||13
10249954|NCT02277106|11382105|FG001|STARTED|Stage 1: Treatment Period 1||12
10249955|NCT02277106|11382106|FG002|STARTED|Stage 1: Treatment Period 1||0
10249956|NCT02277106|11382104|FG000|COMPLETED|Stage 1: Treatment Period 1||13
10249957|NCT02277106|11382105|FG001|COMPLETED|Stage 1: Treatment Period 1||12
10249958|NCT02277106|11382106|FG002|COMPLETED|Stage 1: Treatment Period 1||0
10249959|NCT02277106|11382104|FG000|NOT COMPLETED|Stage 1: Treatment Period 1||0
10249960|NCT02277106|11382105|FG001|NOT COMPLETED|Stage 1: Treatment Period 1||0
10249961|NCT02277106|11382106|FG002|NOT COMPLETED|Stage 1: Treatment Period 1||0
10249962|NCT02277106|11382104|FG000|STARTED|Washout||13
10249963|NCT02277106|11382105|FG001|STARTED|Washout||12
10249964|NCT02277106|11382106|FG002|STARTED|Washout||0
10249965|NCT02277106|11382104|FG000|COMPLETED|Washout||13
10249966|NCT02277106|11382105|FG001|COMPLETED|Washout||12
10249967|NCT02277106|11382106|FG002|COMPLETED|Washout||0
10249968|NCT02277106|11382104|FG000|NOT COMPLETED|Washout||0
10249969|NCT02277106|11382105|FG001|NOT COMPLETED|Washout||0
10249970|NCT02277106|11382106|FG002|NOT COMPLETED|Washout||0
10249971|NCT02277106|11382104|FG000|STARTED|Stage 1: Treatment Period 2||13
10249972|NCT02277106|11382105|FG001|STARTED|Stage 1: Treatment Period 2||12
10249973|NCT02277106|11382106|FG002|STARTED|Stage 1: Treatment Period 2||0
10249974|NCT02277106|11382104|FG000|COMPLETED|Stage 1: Treatment Period 2||13
10249975|NCT02277106|11382105|FG001|COMPLETED|Stage 1: Treatment Period 2||12
10249976|NCT02277106|11382106|FG002|COMPLETED|Stage 1: Treatment Period 2||0
10249977|NCT02277106|11382104|FG000|NOT COMPLETED|Stage 1: Treatment Period 2||0
10249978|NCT02277106|11382105|FG001|NOT COMPLETED|Stage 1: Treatment Period 2||0
10249979|NCT02277106|11382106|FG002|NOT COMPLETED|Stage 1: Treatment Period 2||0
10249980|NCT02277106|11382104|FG000|STARTED|Stage 2||0
10249981|NCT02277106|11382105|FG001|STARTED|Stage 2||0
10249982|NCT02277106|11382106|FG002|STARTED|Stage 2|Out of 25, 17 participants entered Stage 2 after Screening at Stage 2.|17
10249983|NCT02277106|11382104|FG000|COMPLETED|Stage 2||0
10249984|NCT02277106|11382105|FG001|COMPLETED|Stage 2||0
10249985|NCT02277106|11382106|FG002|COMPLETED|Stage 2||16
10249986|NCT02277106|11382104|FG000|NOT COMPLETED|Stage 2||0
10249987|NCT02277106|11382105|FG001|NOT COMPLETED|Stage 2||0
10249988|NCT02277106|11382106|FG002|NOT COMPLETED|Stage 2||1
10249989|NCT02175030|11382119|FG000|STARTED|Overall Study||356
10249990|NCT02175030|11382120|FG001|STARTED|Overall Study||355
10249991|NCT02175030|11382119|FG000|COMPLETED|Overall Study||321
10249992|NCT02175030|11382120|FG001|COMPLETED|Overall Study||317
10249993|NCT02175030|11382119|FG000|NOT COMPLETED|Overall Study||35
10249994|NCT02175030|11382120|FG001|NOT COMPLETED|Overall Study||38
10249995|NCT02059265|11382126|FG000|STARTED|Overall Study||32
10249996|NCT02059265|11382126|FG000|COMPLETED|Overall Study||28
10249997|NCT02059265|11382126|FG000|NOT COMPLETED|Overall Study||4
10249998|NCT02017717|11382139|FG000|STARTED|Before Treatment Period||10
10249999|NCT02017717|11382140|FG001|STARTED|Before Treatment Period||10
10250000|NCT02017717|11382141|FG002|STARTED|Before Treatment Period||20
10250001|NCT02017717|11382142|FG003|STARTED|Before Treatment Period||184
10250002|NCT02017717|11382143|FG004|STARTED|Before Treatment Period||185
10250003|NCT02017717|11382144|FG005|STARTED|Before Treatment Period||31
9833539|NCT00779870|10944452|FG000|NOT COMPLETED|Overall Study||0
10250004|NCT02017717|11382145|FG006|STARTED|Before Treatment Period||30
9833540|NCT00779870|10944453|FG001|NOT COMPLETED|Overall Study||0
9833541|NCT00779870|10944454|FG002|NOT COMPLETED|Overall Study||0
10250005|NCT02017717|11382146|FG007|STARTED|Before Treatment Period||29
10250006|NCT02017717|11382147|FG008|STARTED|Before Treatment Period||30
10250007|NCT02017717|11382139|FG000|Randomized|Before Treatment Period||10
10250008|NCT02017717|11382140|FG001|Randomized|Before Treatment Period||10
10250009|NCT02017717|11382141|FG002|Randomized|Before Treatment Period||0
10250010|NCT02017717|11382142|FG003|Randomized|Before Treatment Period||184
10250011|NCT02017717|11382143|FG004|Randomized|Before Treatment Period||185
10250012|NCT02017717|11382144|FG005|Randomized|Before Treatment Period||0
10250013|NCT02017717|11382145|FG006|Randomized|Before Treatment Period||0
10250014|NCT02017717|11382146|FG007|Randomized|Before Treatment Period||29
10250015|NCT02017717|11382147|FG008|Randomized|Before Treatment Period||30
10250016|NCT02017717|11382139|FG000|COMPLETED|Before Treatment Period||10
10250017|NCT02017717|11382140|FG001|COMPLETED|Before Treatment Period||10
10250018|NCT02017717|11382141|FG002|COMPLETED|Before Treatment Period||20
10250019|NCT02017717|11382142|FG003|COMPLETED|Before Treatment Period||182
10250020|NCT02017717|11382143|FG004|COMPLETED|Before Treatment Period||165
10250021|NCT02017717|11382144|FG005|COMPLETED|Before Treatment Period||31
10250022|NCT02017717|11382145|FG006|COMPLETED|Before Treatment Period||30
10250023|NCT02017717|11382146|FG007|COMPLETED|Before Treatment Period||28
10250024|NCT02017717|11382147|FG008|COMPLETED|Before Treatment Period||28
10250025|NCT02017717|11382139|FG000|NOT COMPLETED|Before Treatment Period||0
10250026|NCT02017717|11382140|FG001|NOT COMPLETED|Before Treatment Period||0
10250027|NCT02017717|11382141|FG002|NOT COMPLETED|Before Treatment Period||0
10250028|NCT02017717|11382142|FG003|NOT COMPLETED|Before Treatment Period||2
10250029|NCT02017717|11382143|FG004|NOT COMPLETED|Before Treatment Period||20
10250030|NCT02017717|11382144|FG005|NOT COMPLETED|Before Treatment Period||0
10250031|NCT02017717|11382145|FG006|NOT COMPLETED|Before Treatment Period||0
10250032|NCT02017717|11382146|FG007|NOT COMPLETED|Before Treatment Period||1
10250033|NCT02017717|11382147|FG008|NOT COMPLETED|Before Treatment Period||2
10250034|NCT02017717|11382139|FG000|STARTED|Treatment Period||10
10250035|NCT02017717|11382140|FG001|STARTED|Treatment Period||10
10250036|NCT02017717|11382141|FG002|STARTED|Treatment Period||20
10250037|NCT02017717|11382142|FG003|STARTED|Treatment Period||182
10250038|NCT02017717|11382143|FG004|STARTED|Treatment Period||165
10250039|NCT02017717|11382144|FG005|STARTED|Treatment Period||31
10113905|NCT02512393|11244598|FG000|NOT COMPLETED|Overall Study||1
10113906|NCT02512393|11244599|FG001|NOT COMPLETED|Overall Study||0
10113907|NCT02512419|11244607|FG000|STARTED|Overall Study||24
10113908|NCT02512419|11244608|FG001|STARTED|Overall Study||24
10113909|NCT02512419|11244607|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
10250040|NCT02017717|11382145|FG006|STARTED|Treatment Period||30
10250041|NCT02017717|11382146|FG007|STARTED|Treatment Period||28
9833542|NCT00779909|10944466|FG000|STARTED|Overall Study||10
9833543|NCT00779909|10944467|FG001|STARTED|Overall Study||9
9833544|NCT00779909|10944468|FG002|STARTED|Overall Study||8
9833545|NCT00779909|10944469|FG003|STARTED|Overall Study||8
9833546|NCT00779909|10944466|FG000|COMPLETED|Overall Study||9
9833547|NCT00779909|10944467|FG001|COMPLETED|Overall Study||8
9833548|NCT00779909|10944468|FG002|COMPLETED|Overall Study||8
9833549|NCT00779909|10944469|FG003|COMPLETED|Overall Study||7
9833550|NCT00779909|10944466|FG000|NOT COMPLETED|Overall Study||1
9833551|NCT00779909|10944467|FG001|NOT COMPLETED|Overall Study||1
9833552|NCT00779909|10944468|FG002|NOT COMPLETED|Overall Study||0
10113910|NCT02512419|11244608|FG001|COMPLETED|Overall Study||24
10113911|NCT02512419|11244607|FG000|NOT COMPLETED|Overall Study||2
10250042|NCT02017717|11382147|FG008|STARTED|Treatment Period||28
10250043|NCT02017717|11382139|FG000|COMPLETED|Treatment Period||0
10250044|NCT02017717|11382140|FG001|COMPLETED|Treatment Period||1
10250045|NCT02017717|11382141|FG002|COMPLETED|Treatment Period||0
10250046|NCT02017717|11382142|FG003|COMPLETED|Treatment Period||1
10250047|NCT02017717|11382143|FG004|COMPLETED|Treatment Period||1
10250048|NCT02017717|11382144|FG005|COMPLETED|Treatment Period||2
10250049|NCT02017717|11382145|FG006|COMPLETED|Treatment Period||0
10250050|NCT02017717|11382146|FG007|COMPLETED|Treatment Period||0
10250051|NCT02017717|11382147|FG008|COMPLETED|Treatment Period||0
10250052|NCT02017717|11382139|FG000|NOT COMPLETED|Treatment Period||10
10250053|NCT02017717|11382140|FG001|NOT COMPLETED|Treatment Period||9
10250054|NCT02017717|11382141|FG002|NOT COMPLETED|Treatment Period||20
10250055|NCT02017717|11382142|FG003|NOT COMPLETED|Treatment Period||181
10250056|NCT02017717|11382143|FG004|NOT COMPLETED|Treatment Period||164
10250057|NCT02017717|11382144|FG005|NOT COMPLETED|Treatment Period||29
10250058|NCT02017717|11382145|FG006|NOT COMPLETED|Treatment Period||30
10250059|NCT02017717|11382146|FG007|NOT COMPLETED|Treatment Period||28
10250060|NCT02017717|11382147|FG008|NOT COMPLETED|Treatment Period||28
10250061|NCT01886872|11382174|FG000|STARTED|Overall Study||183
10250062|NCT01886872|11382175|FG001|STARTED|Overall Study||182
10250063|NCT01886872|11382176|FG002|STARTED|Overall Study||182
10250064|NCT01886872|11382174|FG000|Evaluable for Secondary Endpoints|Overall Study||183
10250065|NCT01886872|11382175|FG001|Evaluable for Secondary Endpoints|Overall Study||182
10250066|NCT01886872|11382176|FG002|Evaluable for Secondary Endpoints|Overall Study||182
10250067|NCT01886872|11382174|FG000|Evaluable for Adverse Events|Overall Study||176
10250068|NCT01886872|11382175|FG001|Evaluable for Adverse Events|Overall Study||180
10250069|NCT01886872|11382176|FG002|Evaluable for Adverse Events|Overall Study||181
10250070|NCT01886872|11382174|FG000|Crossover Cohort|Overall Study||30
10250071|NCT01886872|11382175|FG001|Crossover Cohort|Overall Study||0
10250072|NCT01886872|11382176|FG002|Crossover Cohort|Overall Study||0
10250073|NCT01886872|11382174|FG000|COMPLETED|Overall Study||176
10250074|NCT01886872|11382175|FG001|COMPLETED|Overall Study||178
10250075|NCT01886872|11382176|FG002|COMPLETED|Overall Study||170
10250076|NCT01886872|11382174|FG000|NOT COMPLETED|Overall Study||7
10113912|NCT02512419|11244608|FG001|NOT COMPLETED|Overall Study||0
10113913|NCT02512575|11244624|FG000|STARTED|Overall Study||6
10020057|NCT01833130|11143299|FG001|COMPLETED|Overall Study||8
10020058|NCT01833130|11143298|FG000|NOT COMPLETED|Overall Study||10
10020059|NCT01833130|11143299|FG001|NOT COMPLETED|Overall Study||19
10020060|NCT01833143|11143305|FG000|STARTED|Overall Study||17
10020061|NCT01833143|11143305|FG000|COMPLETED|Overall Study||16
10020062|NCT01833143|11143305|FG000|NOT COMPLETED|Overall Study||1
10020063|NCT01833169|11143309|FG000|STARTED|Overall Study||146
10020064|NCT01833169|11143309|FG000|Consented to be Followed for Survival|Overall Study||128
10020065|NCT01833169|11143309|FG000|COMPLETED|Overall Study||0
10020066|NCT01833169|11143309|FG000|NOT COMPLETED|Overall Study||146
10020067|NCT01833247|11143313|FG000|STARTED|Overall Study||12
10113914|NCT02512575|11244625|FG001|STARTED|Overall Study||6
10020068|NCT01833247|11143313|FG000|COMPLETED|Overall Study||12
10020069|NCT01833247|11143313|FG000|NOT COMPLETED|Overall Study||0
10250077|NCT01886872|11382175|FG001|NOT COMPLETED|Overall Study||4
10250078|NCT01886872|11382176|FG002|NOT COMPLETED|Overall Study||12
10250079|NCT01880957|11382187|FG000|STARTED|Overall Study||47
10250080|NCT01880957|11382188|FG001|STARTED|Overall Study||29
10250081|NCT01880957|11382187|FG000|COMPLETED|Overall Study||19
10020070|NCT01833403|11143317|FG000|STARTED|Overall Study||4
10020071|NCT01833403|11143317|FG000|COMPLETED|Overall Study||4
10020072|NCT01833403|11143317|FG000|NOT COMPLETED|Overall Study||0
10020073|NCT01833455|11143324|FG000|STARTED|Overall Study||4
10020074|NCT01833455|11143325|FG001|STARTED|Overall Study||4
10020075|NCT01833455|11143324|FG000|Completed 1st Baseline|Overall Study||4
10020076|NCT01833455|11143325|FG001|Completed 1st Baseline|Overall Study||4
10020077|NCT01833455|11143324|FG000|Completed 1st Intervention|Overall Study||3
10020078|NCT01833455|11143325|FG001|Completed 1st Intervention|Overall Study||4
10020079|NCT01833455|11143324|FG000|Completed 2nd Baseline (Washout)|Overall Study||3
10020080|NCT01833455|11143325|FG001|Completed 2nd Baseline (Washout)|Overall Study||4
10020081|NCT01833455|11143324|FG000|COMPLETED|Overall Study||3
10020082|NCT01833455|11143325|FG001|COMPLETED|Overall Study||4
10250082|NCT01880957|11382188|FG001|COMPLETED|Overall Study||29
10250083|NCT01880957|11382187|FG000|NOT COMPLETED|Overall Study||28
10250084|NCT01880957|11382188|FG001|NOT COMPLETED|Overall Study||0
10250085|NCT01856192|11382205|FG000|STARTED|Overall Study||173
10250086|NCT01856192|11382206|FG001|STARTED|Overall Study||176
10250087|NCT01856192|11382205|FG000|Treated Patients|Overall Study||166
10250088|NCT01856192|11382206|FG001|Treated Patients|Overall Study||171
10250089|NCT01856192|11382205|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145
10250090|NCT01856192|11382206|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135
10250091|NCT01856192|11382205|FG000|COMPLETED|Overall Study||124
10250092|NCT01856192|11382206|FG001|COMPLETED|Overall Study||116
10250093|NCT01856192|11382205|FG000|NOT COMPLETED|Overall Study||49
10250094|NCT01856192|11382206|FG001|NOT COMPLETED|Overall Study||60
10250103|NCT01767194|11382224|FG000|STARTED|Overall Study||19
10250104|NCT01767194|11382225|FG001|STARTED|Overall Study||54
10250105|NCT01767194|11382224|FG000|COMPLETED|Overall Study||1
10250106|NCT01767194|11382225|FG001|COMPLETED|Overall Study||11
10250107|NCT01767194|11382224|FG000|NOT COMPLETED|Overall Study||18
10020083|NCT01833455|11143324|FG000|NOT COMPLETED|Overall Study||1
10020084|NCT01833455|11143325|FG001|NOT COMPLETED|Overall Study||0
10081097|NCT02257684|11209557|FG000|COMPLETED|Overall Study||0
10250108|NCT01767194|11382225|FG001|NOT COMPLETED|Overall Study||43
10250109|NCT01746173|11382232|FG000|STARTED|Overall Study||5
10250110|NCT01746173|11382232|FG000|COMPLETED|Overall Study||3
10250111|NCT01746173|11382232|FG000|NOT COMPLETED|Overall Study||2
10250112|NCT01734512|11382236|FG000|STARTED|Overall Study||65
10250113|NCT01734512|11382236|FG000|COMPLETED|Overall Study||65
10250114|NCT01734512|11382236|FG000|NOT COMPLETED|Overall Study||0
10250115|NCT01708954|11382243|FG000|STARTED|Step 1||42
10250116|NCT01708954|11382244|FG001|STARTED|Step 1||40
10250117|NCT01708954|11382245|FG002|STARTED|Step 1||43
10250118|NCT01708954|11382243|FG000|Started Protocol Therapy|Step 1||40
10250119|NCT01708954|11382244|FG001|Started Protocol Therapy|Step 1||40
10250120|NCT01708954|11382245|FG002|Started Protocol Therapy|Step 1||39
10250121|NCT01708954|11382243|FG000|Eligible and Treated|Step 1||38
10250122|NCT01708954|11382244|FG001|Eligible and Treated|Step 1||38
10250123|NCT01708954|11382245|FG002|Eligible and Treated|Step 1||35
10250124|NCT01708954|11382243|FG000|Patients With MET Status Data Available|Step 1||30
10250125|NCT01708954|11382244|FG001|Patients With MET Status Data Available|Step 1||32
10250126|NCT01708954|11382245|FG002|Patients With MET Status Data Available|Step 1||24
10250127|NCT01708954|11382243|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10250128|NCT01708954|11382244|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10250129|NCT01708954|11382245|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10250130|NCT01708954|11382243|FG000|NOT COMPLETED|Step 1||42
10250131|NCT01708954|11382244|FG001|NOT COMPLETED|Step 1||40
10250132|NCT01708954|11382245|FG002|NOT COMPLETED|Step 1||43
10250133|NCT01708954|11382243|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
10250134|NCT01708954|11382244|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
10250135|NCT01708954|11382245|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
10250136|NCT01708954|11382243|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
10250137|NCT01708954|11382244|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
10250138|NCT01708954|11382245|FG002|COMPLETED|Step 2||0
10250139|NCT01708954|11382243|FG000|NOT COMPLETED|Step 2||13
10250140|NCT01708954|11382244|FG001|NOT COMPLETED|Step 2||7
10250141|NCT01708954|11382245|FG002|NOT COMPLETED|Step 2||0
10250142|NCT01708941|11382258|FG000|STARTED|Overall Study||21
10250143|NCT01708941|11382259|FG001|STARTED|Overall Study||23
10250144|NCT01708941|11382260|FG002|STARTED|Overall Study||22
10250145|NCT01708941|11382261|FG003|STARTED|Overall Study||22
10250146|NCT01708941|11382258|FG000|Eligible and Started Treatment|Overall Study||18
10250147|NCT01708941|11382259|FG001|Eligible and Started Treatment|Overall Study||22
10250148|NCT01708941|11382260|FG002|Eligible and Started Treatment|Overall Study||19
10250149|NCT01708941|11382261|FG003|Eligible and Started Treatment|Overall Study||22
10250150|NCT01708941|11382258|FG000|COMPLETED|Overall Study||3
10250151|NCT01708941|11382259|FG001|COMPLETED|Overall Study||5
10250152|NCT01708941|11382260|FG002|COMPLETED|Overall Study||3
10250153|NCT01708941|11382261|FG003|COMPLETED|Overall Study||4
10250154|NCT01708941|11382258|FG000|NOT COMPLETED|Overall Study||18
10250155|NCT01708941|11382259|FG001|NOT COMPLETED|Overall Study||18
10250156|NCT01708941|11382260|FG002|NOT COMPLETED|Overall Study||19
10250157|NCT01708941|11382261|FG003|NOT COMPLETED|Overall Study||18
10250158|NCT01555541|11382271|FG000|STARTED|Salvage Response Assessment||19
10250159|NCT01555541|11382271|FG000|COMPLETED|Salvage Response Assessment||19
10250160|NCT01555541|11382271|FG000|NOT COMPLETED|Salvage Response Assessment||0
10250161|NCT01555541|11382271|FG000|STARTED|OVA Treatment||19
10250162|NCT01555541|11382271|FG000|COMPLETED|OVA Treatment||19
10250163|NCT01555541|11382271|FG000|NOT COMPLETED|OVA Treatment||0
9833553|NCT00779909|10944469|FG003|NOT COMPLETED|Overall Study||1
10250164|NCT01555541|11382271|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients did not move forward due to non-response/progression on last line of therapy prior to Autologous Stem Cell Transplantation (ASCT)|12
10250165|NCT01555541|11382271|FG000|COMPLETED|Autologous Stem Cell Transplantation||12
10250166|NCT01555541|11382271|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0
10250167|NCT01398852|11382275|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
10250168|NCT01398852|11382275|FG000|COMPLETED|Overall Study||0
10250169|NCT01398852|11382275|FG000|NOT COMPLETED|Overall Study||372
10250170|NCT01398839|11382281|FG000|STARTED|Overall Study||35
10250171|NCT01398839|11382282|FG001|STARTED|Overall Study||37
10250172|NCT01398839|11382281|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
10250173|NCT01398839|11382282|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
10250174|NCT01398839|11382281|FG000|NOT COMPLETED|Overall Study||0
10250175|NCT01398839|11382282|FG001|NOT COMPLETED|Overall Study||0
10250176|NCT01349959|11382288|FG000|STARTED|Overall Study||40
10250177|NCT01349959|11382288|FG000|COMPLETED|Overall Study||33
10250178|NCT01349959|11382288|FG000|NOT COMPLETED|Overall Study||7
10250179|NCT01275677|11382294|FG000|STARTED|Overall Study||1630
10250180|NCT01275677|11382295|FG001|STARTED|Overall Study||1640
10250181|NCT01275677|11382294|FG000|COMPLETED|Overall Study||1602
10250182|NCT01275677|11382295|FG001|COMPLETED|Overall Study||1598
10250183|NCT01275677|11382294|FG000|NOT COMPLETED|Overall Study||28
10250184|NCT01275677|11382295|FG001|NOT COMPLETED|Overall Study||42
10250185|NCT01251861|11382303|FG000|STARTED|Overall Study||54
10250186|NCT01251861|11382304|FG001|STARTED|Overall Study||54
10250187|NCT01251861|11382303|FG000|Pts Who Received Protocol Therapy|Overall Study||50
10250188|NCT01251861|11382304|FG001|Pts Who Received Protocol Therapy|Overall Study||53
10250189|NCT01251861|11382303|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
10250190|NCT01251861|11382304|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
10250191|NCT01251861|11382303|FG000|Pts With PSA Response|Overall Study||44
10250192|NCT01251861|11382304|FG001|Pts With PSA Response|Overall Study||36
10250193|NCT01251861|11382303|FG000|COMPLETED|Overall Study||36
10250194|NCT01251861|11382304|FG001|COMPLETED|Overall Study||26
10250195|NCT01251861|11382303|FG000|NOT COMPLETED|Overall Study||18
10250196|NCT01251861|11382304|FG001|NOT COMPLETED|Overall Study||28
9833554|NCT00780026|10944488|FG000|STARTED|Overall Study||50
9833555|NCT00780026|10944489|FG001|STARTED|Overall Study||50
9833556|NCT00780026|10944488|FG000|COMPLETED|Overall Study||50
9833557|NCT00780026|10944489|FG001|COMPLETED|Overall Study||50
9833558|NCT00780026|10944488|FG000|NOT COMPLETED|Overall Study||0
9833559|NCT00780026|10944489|FG001|NOT COMPLETED|Overall Study||0
9833560|NCT00780143|10944495|FG000|STARTED|Overall Study||3
9833561|NCT00780143|10944495|FG000|COMPLETED|Overall Study||0
9833562|NCT00780143|10944495|FG000|NOT COMPLETED|Overall Study||3
9833563|NCT00780208|10944499|FG000|STARTED|Overall Study||14
9833564|NCT00780208|10944499|FG000|COMPLETED|Overall Study||8
9833565|NCT00780208|10944499|FG000|NOT COMPLETED|Overall Study||6
9833566|NCT00780234|10944505|FG000|STARTED|Overall Study||47
9833567|NCT00780234|10944506|FG001|STARTED|Overall Study||45
9833568|NCT00780234|10944505|FG000|COMPLETED|Overall Study||39
9833569|NCT00780234|10944506|FG001|COMPLETED|Overall Study||37
9833570|NCT00780234|10944505|FG000|NOT COMPLETED|Overall Study||8
9833571|NCT00780234|10944506|FG001|NOT COMPLETED|Overall Study||8
10250197|NCT01196390|11382312|FG000|STARTED|Overall Study||102
10250198|NCT01196390|11382313|FG001|STARTED|Overall Study||101
10250199|NCT01196390|11382312|FG000|Eligible|Overall Study||98
10250200|NCT01196390|11382313|FG001|Eligible|Overall Study||96
10250201|NCT01196390|11382312|FG000|Eligible and Started Study Treatment|Overall Study||95
10250202|NCT01196390|11382313|FG001|Eligible and Started Study Treatment|Overall Study||96
10250203|NCT01196390|11382312|FG000|Eligible and Had Surgery|Overall Study||82
10250204|NCT01196390|11382313|FG001|Eligible and Had Surgery|Overall Study||78
10250205|NCT01196390|11382312|FG000|COMPLETED|Overall Study||98
10250206|NCT01196390|11382313|FG001|COMPLETED|Overall Study||96
10250207|NCT01196390|11382312|FG000|NOT COMPLETED|Overall Study||4
10250208|NCT01196390|11382313|FG001|NOT COMPLETED|Overall Study||5
10250209|NCT01168219|11382321|FG000|STARTED|Overall Study||68
10020085|NCT01833481|11143346|FG000|STARTED|Overall Study||10
10020086|NCT01833481|11143347|FG001|STARTED|Overall Study||10
10020087|NCT01833481|11143348|FG002|STARTED|Overall Study||10
10020088|NCT01833481|11143346|FG000|COMPLETED|Overall Study||10
10250210|NCT01168219|11382321|FG000|COMPLETED|Overall Study||63
10250211|NCT01168219|11382321|FG000|NOT COMPLETED|Overall Study||5
10250212|NCT01145495|11382325|FG000|STARTED|Overall Study||63
10250213|NCT01145495|11382325|FG000|COMPLETED|Overall Study||51
10250214|NCT01145495|11382325|FG000|NOT COMPLETED|Overall Study||12
10250215|NCT01142388|11382331|FG000|STARTED|Overall Study||47
10250216|NCT01142388|11382332|FG001|STARTED|Overall Study||47
10250217|NCT01142388|11382331|FG000|Eligible|Overall Study||43
10250218|NCT01142388|11382332|FG001|Eligible|Overall Study||44
10250219|NCT01142388|11382331|FG000|Treated|Overall Study||40
9833572|NCT00780273|10944512|FG000|STARTED|Overall Study||19
9833573|NCT00780273|10944512|FG000|COMPLETED|Overall Study||17
9833574|NCT00780273|10944512|FG000|NOT COMPLETED|Overall Study||2
9833575|NCT00780338|10944519|FG000|STARTED|Baseline to Mid (1 Year)||174
10020089|NCT01833481|11143347|FG001|COMPLETED|Overall Study||10
10020090|NCT01833481|11143348|FG002|COMPLETED|Overall Study||10
10250220|NCT01142388|11382332|FG001|Treated|Overall Study||44
10250221|NCT01142388|11382331|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
10250222|NCT01142388|11382332|FG001|COMPLETED|Overall Study||0
10250223|NCT01142388|11382331|FG000|NOT COMPLETED|Overall Study||47
10250224|NCT01142388|11382332|FG001|NOT COMPLETED|Overall Study||47
10250225|NCT01134614|11382340|FG000|STARTED|Overall Study||123
10250226|NCT01134614|11382341|FG001|STARTED|Overall Study||122
10250227|NCT01134614|11382340|FG000|Treated|Overall Study||119
10250228|NCT01134614|11382341|FG001|Treated|Overall Study||121
10250229|NCT01134614|11382340|FG000|Treated and Toxicity Assessed|Overall Study||118
10250230|NCT01134614|11382341|FG001|Treated and Toxicity Assessed|Overall Study||120
10250231|NCT01134614|11382340|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
10250232|NCT01134614|11382341|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
10250233|NCT01134614|11382340|FG000|NOT COMPLETED|Overall Study||123
10250234|NCT01134614|11382341|FG001|NOT COMPLETED|Overall Study||122
10250235|NCT01116648|11382362|FG000|STARTED|Phase 1 Dose Level 0||3
10250236|NCT01116648|11382363|FG001|STARTED|Phase 1 Dose Level 0||0
10250237|NCT01116648|11382364|FG002|STARTED|Phase 1 Dose Level 0||0
10250238|NCT01116648|11382365|FG003|STARTED|Phase 1 Dose Level 0||0
10250239|NCT01116648|11382366|FG004|STARTED|Phase 1 Dose Level 0||0
10250240|NCT01116648|11382367|FG005|STARTED|Phase 1 Dose Level 0||0
10250241|NCT01116648|11382368|FG006|STARTED|Phase 1 Dose Level 0||0
10250242|NCT01116648|11382369|FG007|STARTED|Phase 1 Dose Level 0||0
10250243|NCT01116648|11382370|FG008|STARTED|Phase 1 Dose Level 0||0
10250244|NCT01116648|11382371|FG009|STARTED|Phase 1 Dose Level 0||0
10250245|NCT01116648|11382372|FG010|STARTED|Phase 1 Dose Level 0||0
10250246|NCT01116648|11382373|FG011|STARTED|Phase 1 Dose Level 0||0
10250247|NCT01116648|11382374|FG012|STARTED|Phase 1 Dose Level 0||0
10250248|NCT01116648|11382375|FG013|STARTED|Phase 1 Dose Level 0||0
10250249|NCT01116648|11382376|FG014|STARTED|Phase 1 Dose Level 0||0
10250250|NCT01116648|11382362|FG000|COMPLETED|Phase 1 Dose Level 0||3
10250251|NCT01116648|11382363|FG001|COMPLETED|Phase 1 Dose Level 0||0
10250252|NCT01116648|11382364|FG002|COMPLETED|Phase 1 Dose Level 0||0
10250253|NCT01116648|11382365|FG003|COMPLETED|Phase 1 Dose Level 0||0
10250254|NCT01116648|11382366|FG004|COMPLETED|Phase 1 Dose Level 0||0
10250255|NCT01116648|11382367|FG005|COMPLETED|Phase 1 Dose Level 0||0
10250256|NCT01116648|11382368|FG006|COMPLETED|Phase 1 Dose Level 0||0
10250257|NCT01116648|11382369|FG007|COMPLETED|Phase 1 Dose Level 0||0
10250258|NCT01116648|11382370|FG008|COMPLETED|Phase 1 Dose Level 0||0
10250259|NCT01116648|11382371|FG009|COMPLETED|Phase 1 Dose Level 0||0
10250260|NCT01116648|11382372|FG010|COMPLETED|Phase 1 Dose Level 0||0
10250261|NCT01116648|11382373|FG011|COMPLETED|Phase 1 Dose Level 0||0
10250262|NCT01116648|11382374|FG012|COMPLETED|Phase 1 Dose Level 0||0
10250263|NCT01116648|11382375|FG013|COMPLETED|Phase 1 Dose Level 0||0
10250264|NCT01116648|11382376|FG014|COMPLETED|Phase 1 Dose Level 0||0
10250265|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0
10250266|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0
10250267|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0
10250268|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0
10250269|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0
10250270|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0
10250271|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0
10250272|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0
10250273|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0
10250274|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0
10250275|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0
10250276|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0
10250277|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0
10250278|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0
10250279|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0
10250280|NCT01116648|11382362|FG000|STARTED|Phase 1 Dose Level 1||0
10250281|NCT01116648|11382363|FG001|STARTED|Phase 1 Dose Level 1||3
10250282|NCT01116648|11382364|FG002|STARTED|Phase 1 Dose Level 1||0
10250283|NCT01116648|11382365|FG003|STARTED|Phase 1 Dose Level 1||0
10250284|NCT01116648|11382366|FG004|STARTED|Phase 1 Dose Level 1||0
10250285|NCT01116648|11382367|FG005|STARTED|Phase 1 Dose Level 1||0
10250286|NCT01116648|11382368|FG006|STARTED|Phase 1 Dose Level 1||0
10250287|NCT01116648|11382369|FG007|STARTED|Phase 1 Dose Level 1||0
10250288|NCT01116648|11382370|FG008|STARTED|Phase 1 Dose Level 1||0
10250289|NCT01116648|11382371|FG009|STARTED|Phase 1 Dose Level 1||0
10250290|NCT01116648|11382372|FG010|STARTED|Phase 1 Dose Level 1||0
10250291|NCT01116648|11382373|FG011|STARTED|Phase 1 Dose Level 1||0
10250292|NCT01116648|11382374|FG012|STARTED|Phase 1 Dose Level 1||0
10250293|NCT01116648|11382375|FG013|STARTED|Phase 1 Dose Level 1||0
10250294|NCT01116648|11382376|FG014|STARTED|Phase 1 Dose Level 1||0
10250295|NCT01116648|11382362|FG000|COMPLETED|Phase 1 Dose Level 1||0
10250296|NCT01116648|11382363|FG001|COMPLETED|Phase 1 Dose Level 1||3
10250297|NCT01116648|11382364|FG002|COMPLETED|Phase 1 Dose Level 1||0
10250298|NCT01116648|11382365|FG003|COMPLETED|Phase 1 Dose Level 1||0
10250299|NCT01116648|11382366|FG004|COMPLETED|Phase 1 Dose Level 1||0
10250300|NCT01116648|11382367|FG005|COMPLETED|Phase 1 Dose Level 1||0
10250301|NCT01116648|11382368|FG006|COMPLETED|Phase 1 Dose Level 1||0
10250302|NCT01116648|11382369|FG007|COMPLETED|Phase 1 Dose Level 1||0
10250303|NCT01116648|11382370|FG008|COMPLETED|Phase 1 Dose Level 1||0
10250304|NCT01116648|11382371|FG009|COMPLETED|Phase 1 Dose Level 1||0
10250305|NCT01116648|11382372|FG010|COMPLETED|Phase 1 Dose Level 1||0
10250306|NCT01116648|11382373|FG011|COMPLETED|Phase 1 Dose Level 1||0
10250307|NCT01116648|11382374|FG012|COMPLETED|Phase 1 Dose Level 1||0
10250308|NCT01116648|11382375|FG013|COMPLETED|Phase 1 Dose Level 1||0
10250309|NCT01116648|11382376|FG014|COMPLETED|Phase 1 Dose Level 1||0
10250310|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0
10250311|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0
10250312|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0
10250313|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0
10250314|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0
10250315|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0
10250316|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0
10250317|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0
10250318|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0
10250319|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0
10250320|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0
10250321|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0
10250322|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0
10250323|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0
10250324|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0
10250325|NCT01116648|11382362|FG000|STARTED|Phase 1 Dose Level 2||0
10250326|NCT01116648|11382363|FG001|STARTED|Phase 1 Dose Level 2||0
10250327|NCT01116648|11382364|FG002|STARTED|Phase 1 Dose Level 2||7
10250328|NCT01116648|11382365|FG003|STARTED|Phase 1 Dose Level 2||0
10250329|NCT01116648|11382366|FG004|STARTED|Phase 1 Dose Level 2||0
10250330|NCT01116648|11382367|FG005|STARTED|Phase 1 Dose Level 2||0
10250331|NCT01116648|11382368|FG006|STARTED|Phase 1 Dose Level 2||0
10250332|NCT01116648|11382369|FG007|STARTED|Phase 1 Dose Level 2||0
10250333|NCT01116648|11382370|FG008|STARTED|Phase 1 Dose Level 2||0
10250334|NCT01116648|11382371|FG009|STARTED|Phase 1 Dose Level 2||0
10250335|NCT01116648|11382372|FG010|STARTED|Phase 1 Dose Level 2||0
10250336|NCT01116648|11382373|FG011|STARTED|Phase 1 Dose Level 2||0
10250337|NCT01116648|11382374|FG012|STARTED|Phase 1 Dose Level 2||0
10250338|NCT01116648|11382375|FG013|STARTED|Phase 1 Dose Level 2||0
10250339|NCT01116648|11382376|FG014|STARTED|Phase 1 Dose Level 2||0
10250340|NCT01116648|11382362|FG000|COMPLETED|Phase 1 Dose Level 2||0
10250341|NCT01116648|11382363|FG001|COMPLETED|Phase 1 Dose Level 2||0
10250342|NCT01116648|11382364|FG002|COMPLETED|Phase 1 Dose Level 2||7
10250343|NCT01116648|11382365|FG003|COMPLETED|Phase 1 Dose Level 2||0
10250344|NCT01116648|11382366|FG004|COMPLETED|Phase 1 Dose Level 2||0
10250345|NCT01116648|11382367|FG005|COMPLETED|Phase 1 Dose Level 2||0
10250346|NCT01116648|11382368|FG006|COMPLETED|Phase 1 Dose Level 2||0
9833576|NCT00780338|10944520|FG001|STARTED|Baseline to Mid (1 Year)||202
9833577|NCT00780338|10944519|FG000|COMPLETED|Baseline to Mid (1 Year)||169
9833578|NCT00780338|10944520|FG001|COMPLETED|Baseline to Mid (1 Year)||164
9833579|NCT00780338|10944519|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5
9833580|NCT00780338|10944520|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38
9833581|NCT00780338|10944519|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
9833582|NCT00780338|10944520|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
9833583|NCT00780338|10944519|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
9833584|NCT00780338|10944520|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
9833585|NCT00780338|10944519|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
9833586|NCT00780338|10944520|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
9833587|NCT00780416|10944532|FG000|STARTED|Overall Study||126
9833588|NCT00780416|10944533|FG001|STARTED|Overall Study||63
9833589|NCT00780416|10944532|FG000|COMPLETED|Overall Study||114
9833590|NCT00780416|10944533|FG001|COMPLETED|Overall Study||54
9833591|NCT00780416|10944532|FG000|NOT COMPLETED|Overall Study||12
9833592|NCT00780416|10944533|FG001|NOT COMPLETED|Overall Study||9
9833593|NCT00780442|10944541|FG000|STARTED|Overall Study||12
9833594|NCT00780442|10944542|FG001|STARTED|Overall Study||15
9833595|NCT00780442|10944541|FG000|COMPLETED|Overall Study||12
9833596|NCT00780442|10944542|FG001|COMPLETED|Overall Study||15
9833597|NCT00780442|10944541|FG000|NOT COMPLETED|Overall Study||0
9833598|NCT00780442|10944542|FG001|NOT COMPLETED|Overall Study||0
9833599|NCT00780494|10944548|FG000|STARTED|Overall Study||35
9833600|NCT00780494|10944548|FG000|COMPLETED|Overall Study||35
9833601|NCT00780494|10944548|FG000|NOT COMPLETED|Overall Study||0
9833602|NCT00780559|10944554|FG000|STARTED|Overall Study||32
9833603|NCT00780559|10944555|FG001|STARTED|Overall Study||40
9833604|NCT00780559|10944554|FG000|COMPLETED|Overall Study||29
9833605|NCT00780559|10944555|FG001|COMPLETED|Overall Study||33
9833606|NCT00780559|10944554|FG000|NOT COMPLETED|Overall Study||3
9833607|NCT00780559|10944555|FG001|NOT COMPLETED|Overall Study||7
9833608|NCT00780572|10944565|FG000|STARTED|Overall Study||297
9833609|NCT00780572|10944566|FG001|STARTED|Overall Study||298
9833610|NCT00780572|10944565|FG000|COMPLETED|Overall Study||297
9833611|NCT00780572|10944566|FG001|COMPLETED|Overall Study||298
9833612|NCT00780572|10944565|FG000|NOT COMPLETED|Overall Study||0
9833613|NCT00780572|10944566|FG001|NOT COMPLETED|Overall Study||0
9833614|NCT00780676|10944577|FG000|STARTED|Overall Study||9
9833615|NCT00780676|10944578|FG001|STARTED|Overall Study||8
9833616|NCT00780676|10944579|FG002|STARTED|Overall Study||13
9833617|NCT00780676|10944580|FG003|STARTED|Overall Study||0
9833618|NCT00780676|10944581|FG004|STARTED|Overall Study||0
9833619|NCT00780676|10944577|FG000|COMPLETED|Overall Study||9
9833620|NCT00780676|10944578|FG001|COMPLETED|Overall Study||8
9833621|NCT00780676|10944579|FG002|COMPLETED|Overall Study||13
9833622|NCT00780676|10944580|FG003|COMPLETED|Overall Study||0
9833623|NCT00780676|10944581|FG004|COMPLETED|Overall Study||0
9833624|NCT00780676|10944577|FG000|NOT COMPLETED|Overall Study||0
9833625|NCT00780676|10944578|FG001|NOT COMPLETED|Overall Study||0
10250347|NCT01116648|11382369|FG007|COMPLETED|Phase 1 Dose Level 2||0
10250348|NCT01116648|11382370|FG008|COMPLETED|Phase 1 Dose Level 2||0
10250349|NCT01116648|11382371|FG009|COMPLETED|Phase 1 Dose Level 2||0
10250350|NCT01116648|11382372|FG010|COMPLETED|Phase 1 Dose Level 2||0
10020091|NCT01833481|11143346|FG000|NOT COMPLETED|Overall Study||0
10020092|NCT01833481|11143347|FG001|NOT COMPLETED|Overall Study||0
10020093|NCT01833481|11143348|FG002|NOT COMPLETED|Overall Study||0
10020094|NCT01833494|11143356|FG000|STARTED|Overall Study||161
10020095|NCT01833494|11143356|FG000|COMPLETED|Overall Study||116
10020096|NCT01833494|11143356|FG000|NOT COMPLETED|Overall Study||45
10020097|NCT01833520|11143362|FG000|STARTED|Overall Study||3
10020098|NCT01833520|11143363|FG001|STARTED|Overall Study||3
10020099|NCT01833520|11143364|FG002|STARTED|Overall Study||9
10020100|NCT01833520|11143365|FG003|STARTED|Overall Study||3
10020101|NCT01833520|11143362|FG000|COMPLETED|Overall Study||0
10020102|NCT01833520|11143363|FG001|COMPLETED|Overall Study||0
10020103|NCT01833520|11143364|FG002|COMPLETED|Overall Study||1
10020104|NCT01833520|11143365|FG003|COMPLETED|Overall Study||0
10020105|NCT01833520|11143362|FG000|NOT COMPLETED|Overall Study||3
10020106|NCT01833520|11143363|FG001|NOT COMPLETED|Overall Study||3
10020107|NCT01833520|11143364|FG002|NOT COMPLETED|Overall Study||8
10020108|NCT01833520|11143365|FG003|NOT COMPLETED|Overall Study||3
10113915|NCT02512575|11244626|FG002|STARTED|Overall Study||6
10113916|NCT02512575|11244627|FG003|STARTED|Overall Study||6
10113917|NCT02512575|11244628|FG004|STARTED|Overall Study||6
10113918|NCT02512575|11244629|FG005|STARTED|Overall Study||6
10113919|NCT02512575|11244630|FG006|STARTED|Overall Study||6
10113920|NCT02512575|11244631|FG007|STARTED|Overall Study||6
10113921|NCT02512575|11244632|FG008|STARTED|Overall Study||6
10113922|NCT02512575|11244633|FG009|STARTED|Overall Study||18
10113923|NCT02512575|11244624|FG000|COMPLETED|Overall Study||6
10113924|NCT02512575|11244625|FG001|COMPLETED|Overall Study||6
10113925|NCT02512575|11244626|FG002|COMPLETED|Overall Study||6
10113926|NCT02512575|11244627|FG003|COMPLETED|Overall Study||6
10020109|NCT01833533|11143379|FG000|STARTED|Overall Study||100
10020110|NCT01833533|11143380|FG001|STARTED|Overall Study||205
10020111|NCT01833533|11143379|FG000|COMPLETED|Overall Study||94
10020112|NCT01833533|11143380|FG001|COMPLETED|Overall Study||184
10113927|NCT02512575|11244628|FG004|COMPLETED|Overall Study||6
10113928|NCT02512575|11244629|FG005|COMPLETED|Overall Study||6
10250351|NCT01116648|11382373|FG011|COMPLETED|Phase 1 Dose Level 2||0
10250352|NCT01116648|11382374|FG012|COMPLETED|Phase 1 Dose Level 2||0
10250353|NCT01116648|11382375|FG013|COMPLETED|Phase 1 Dose Level 2||0
10250354|NCT01116648|11382376|FG014|COMPLETED|Phase 1 Dose Level 2||0
10250355|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0
10250356|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0
10250357|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0
10250358|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0
10250359|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0
10250360|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0
10250361|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0
10250362|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0
10250363|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0
10250364|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0
10250365|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0
10250366|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0
10250367|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0
10250368|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0
10250369|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0
10250370|NCT01116648|11382362|FG000|STARTED|Phase 1 Dose Level 3||0
10250371|NCT01116648|11382363|FG001|STARTED|Phase 1 Dose Level 3||0
10250372|NCT01116648|11382364|FG002|STARTED|Phase 1 Dose Level 3||0
10250373|NCT01116648|11382365|FG003|STARTED|Phase 1 Dose Level 3||6
10250374|NCT01116648|11382366|FG004|STARTED|Phase 1 Dose Level 3||0
10250375|NCT01116648|11382367|FG005|STARTED|Phase 1 Dose Level 3||0
10250376|NCT01116648|11382368|FG006|STARTED|Phase 1 Dose Level 3||0
10250377|NCT01116648|11382369|FG007|STARTED|Phase 1 Dose Level 3||0
10250378|NCT01116648|11382370|FG008|STARTED|Phase 1 Dose Level 3||0
10250379|NCT01116648|11382371|FG009|STARTED|Phase 1 Dose Level 3||0
10250380|NCT01116648|11382372|FG010|STARTED|Phase 1 Dose Level 3||0
10250381|NCT01116648|11382373|FG011|STARTED|Phase 1 Dose Level 3||0
10250382|NCT01116648|11382374|FG012|STARTED|Phase 1 Dose Level 3||0
10250383|NCT01116648|11382375|FG013|STARTED|Phase 1 Dose Level 3||0
10250384|NCT01116648|11382376|FG014|STARTED|Phase 1 Dose Level 3||0
10250385|NCT01116648|11382362|FG000|COMPLETED|Phase 1 Dose Level 3||0
10250386|NCT01116648|11382363|FG001|COMPLETED|Phase 1 Dose Level 3||0
10250387|NCT01116648|11382364|FG002|COMPLETED|Phase 1 Dose Level 3||0
10250388|NCT01116648|11382365|FG003|COMPLETED|Phase 1 Dose Level 3||4
10250389|NCT01116648|11382366|FG004|COMPLETED|Phase 1 Dose Level 3||0
10250390|NCT01116648|11382367|FG005|COMPLETED|Phase 1 Dose Level 3||0
10250391|NCT01116648|11382368|FG006|COMPLETED|Phase 1 Dose Level 3||0
10250392|NCT01116648|11382369|FG007|COMPLETED|Phase 1 Dose Level 3||0
10250393|NCT01116648|11382370|FG008|COMPLETED|Phase 1 Dose Level 3||0
10250394|NCT01116648|11382371|FG009|COMPLETED|Phase 1 Dose Level 3||0
10250395|NCT01116648|11382372|FG010|COMPLETED|Phase 1 Dose Level 3||0
10250396|NCT01116648|11382373|FG011|COMPLETED|Phase 1 Dose Level 3||0
10250397|NCT01116648|11382374|FG012|COMPLETED|Phase 1 Dose Level 3||0
10250398|NCT01116648|11382375|FG013|COMPLETED|Phase 1 Dose Level 3||0
10250399|NCT01116648|11382376|FG014|COMPLETED|Phase 1 Dose Level 3||0
10250400|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0
10250401|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0
9833626|NCT00780676|10944579|FG002|NOT COMPLETED|Overall Study||0
9833627|NCT00780676|10944580|FG003|NOT COMPLETED|Overall Study||0
9833628|NCT00780676|10944581|FG004|NOT COMPLETED|Overall Study||0
9833629|NCT00780715|10944591|FG000|STARTED|Overall Study||6
9833630|NCT00780715|10944592|FG001|STARTED|Overall Study||6
9833631|NCT00780715|10944593|FG002|STARTED|Overall Study||6
9833632|NCT00780715|10944594|FG003|STARTED|Overall Study||11
10250402|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0
10250403|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2
10250404|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0
10250405|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0
10250406|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0
10250407|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0
10250408|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0
10250409|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0
10250410|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0
10250411|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0
10250412|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0
10250413|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0
10250414|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0
10250415|NCT01116648|11382362|FG000|STARTED|Expansion at Maximum Tolerated Dose||0
10250416|NCT01116648|11382363|FG001|STARTED|Expansion at Maximum Tolerated Dose||0
10250417|NCT01116648|11382364|FG002|STARTED|Expansion at Maximum Tolerated Dose||0
10250418|NCT01116648|11382365|FG003|STARTED|Expansion at Maximum Tolerated Dose||0
10250419|NCT01116648|11382366|FG004|STARTED|Expansion at Maximum Tolerated Dose||9
10250420|NCT01116648|11382367|FG005|STARTED|Expansion at Maximum Tolerated Dose||0
10250421|NCT01116648|11382368|FG006|STARTED|Expansion at Maximum Tolerated Dose||0
10250422|NCT01116648|11382369|FG007|STARTED|Expansion at Maximum Tolerated Dose||0
10250423|NCT01116648|11382370|FG008|STARTED|Expansion at Maximum Tolerated Dose||0
10250424|NCT01116648|11382371|FG009|STARTED|Expansion at Maximum Tolerated Dose||0
10250425|NCT01116648|11382372|FG010|STARTED|Expansion at Maximum Tolerated Dose||0
10250426|NCT01116648|11382373|FG011|STARTED|Expansion at Maximum Tolerated Dose||0
10250427|NCT01116648|11382374|FG012|STARTED|Expansion at Maximum Tolerated Dose||0
10250428|NCT01116648|11382375|FG013|STARTED|Expansion at Maximum Tolerated Dose||0
10250429|NCT01116648|11382376|FG014|STARTED|Expansion at Maximum Tolerated Dose||0
10250430|NCT01116648|11382362|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250431|NCT01116648|11382363|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250432|NCT01116648|11382364|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250433|NCT01116648|11382365|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250434|NCT01116648|11382366|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9
10250435|NCT01116648|11382367|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250436|NCT01116648|11382368|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250437|NCT01116648|11382369|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250438|NCT01116648|11382370|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250439|NCT01116648|11382371|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250440|NCT01116648|11382372|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250441|NCT01116648|11382373|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250442|NCT01116648|11382374|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250443|NCT01116648|11382375|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250444|NCT01116648|11382376|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0
10250445|NCT01116648|11382362|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250446|NCT01116648|11382363|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
9833633|NCT00780715|10944591|FG000|COMPLETED|Overall Study||6
9833634|NCT00780715|10944592|FG001|COMPLETED|Overall Study||6
9833635|NCT00780715|10944593|FG002|COMPLETED|Overall Study||6
9833636|NCT00780715|10944594|FG003|COMPLETED|Overall Study||11
9833637|NCT00780715|10944591|FG000|NOT COMPLETED|Overall Study||0
9833638|NCT00780715|10944592|FG001|NOT COMPLETED|Overall Study||0
9833639|NCT00780715|10944593|FG002|NOT COMPLETED|Overall Study||0
9833640|NCT00780715|10944594|FG003|NOT COMPLETED|Overall Study||0
9833641|NCT00780741|10944606|FG000|STARTED|Overall Study|randomized|82
9833642|NCT00780741|10944607|FG001|STARTED|Overall Study|randomized|81
9833643|NCT00780741|10944606|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
9833644|NCT00780741|10944607|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
9833645|NCT00780741|10944606|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
9833646|NCT00780741|10944607|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
9833647|NCT00780741|10944606|FG000|NOT COMPLETED|Overall Study||7
9833648|NCT00780741|10944607|FG001|NOT COMPLETED|Overall Study||10
9833649|NCT00780910|10944614|FG000|STARTED|Overall Study||109
9833650|NCT00780910|10944614|FG000|COMPLETED|Overall Study||107
9833651|NCT00780910|10944614|FG000|NOT COMPLETED|Overall Study||2
9957454|NCT01451164|11076703|FG000|STARTED|Overall Study||115
9957455|NCT01451164|11076704|FG001|STARTED|Overall Study||115
9957456|NCT01451164|11076705|FG002|STARTED|Overall Study||113
9957457|NCT01451164|11076706|FG003|STARTED|Overall Study||116
9957458|NCT01451164|11076703|FG000|COMPLETED|Overall Study||72
9957459|NCT01451164|11076704|FG001|COMPLETED|Overall Study||81
9957460|NCT01451164|11076705|FG002|COMPLETED|Overall Study||68
9957461|NCT01451164|11076706|FG003|COMPLETED|Overall Study||70
9957462|NCT01451164|11076703|FG000|NOT COMPLETED|Overall Study||43
9957463|NCT01451164|11076704|FG001|NOT COMPLETED|Overall Study||34
9957464|NCT01451164|11076705|FG002|NOT COMPLETED|Overall Study||45
9957465|NCT01451164|11076706|FG003|NOT COMPLETED|Overall Study||46
9957466|NCT01451203|11076718|FG000|STARTED|Double-blind Treatment Period||158
9957467|NCT01451203|11076719|FG001|STARTED|Double-blind Treatment Period||161
9957468|NCT01451203|11076718|FG000|Received Treatment|Double-blind Treatment Period||157
9957469|NCT01451203|11076719|FG001|Received Treatment|Double-blind Treatment Period||159
9957470|NCT01451203|11076718|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
9957471|NCT01451203|11076719|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
9957472|NCT01451203|11076718|FG000|COMPLETED|Double-blind Treatment Period||73
9957473|NCT01451203|11076719|FG001|COMPLETED|Double-blind Treatment Period||111
9957474|NCT01451203|11076718|FG000|NOT COMPLETED|Double-blind Treatment Period||85
9957475|NCT01451203|11076719|FG001|NOT COMPLETED|Double-blind Treatment Period||50
9957476|NCT01451203|11076718|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
10020113|NCT01833533|11143379|FG000|NOT COMPLETED|Overall Study||6
9833652|NCT00780962|10944620|FG000|STARTED|Overall Study||200
9957477|NCT01451203|11076719|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
10020114|NCT01833533|11143380|FG001|NOT COMPLETED|Overall Study||21
9833653|NCT00780962|10944621|FG001|STARTED|Overall Study||199
10020115|NCT01833546|11143390|FG000|STARTED|Overall Study||3
10020116|NCT01833546|11143391|FG001|STARTED|Overall Study||3
10020117|NCT01833546|11143392|FG002|STARTED|Overall Study||8
10020118|NCT01833546|11143393|FG003|STARTED|Overall Study||6
10020119|NCT01833546|11143390|FG000|COMPLETED|Overall Study||3
10020120|NCT01833546|11143391|FG001|COMPLETED|Overall Study||3
10250447|NCT01116648|11382364|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250448|NCT01116648|11382365|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250449|NCT01116648|11382366|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250450|NCT01116648|11382367|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250451|NCT01116648|11382368|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250452|NCT01116648|11382369|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250453|NCT01116648|11382370|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250454|NCT01116648|11382371|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250455|NCT01116648|11382372|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250456|NCT01116648|11382373|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250457|NCT01116648|11382374|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250458|NCT01116648|11382375|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250459|NCT01116648|11382376|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10250460|NCT01116648|11382362|FG000|STARTED|Phase 2||0
10250461|NCT01116648|11382363|FG001|STARTED|Phase 2||0
10250462|NCT01116648|11382364|FG002|STARTED|Phase 2||0
10250463|NCT01116648|11382365|FG003|STARTED|Phase 2||0
10250464|NCT01116648|11382366|FG004|STARTED|Phase 2||0
10020121|NCT01833546|11143392|FG002|COMPLETED|Overall Study||8
10020122|NCT01833546|11143393|FG003|COMPLETED|Overall Study||6
10020123|NCT01833546|11143390|FG000|NOT COMPLETED|Overall Study||0
10020124|NCT01833546|11143391|FG001|NOT COMPLETED|Overall Study||0
10020125|NCT01833546|11143392|FG002|NOT COMPLETED|Overall Study||0
10020126|NCT01833546|11143393|FG003|NOT COMPLETED|Overall Study||0
10020127|NCT01833741|11143404|FG000|STARTED|Overall Study||1137
10020128|NCT01833741|11143404|FG000|COMPLETED|Overall Study||997
10020129|NCT01833741|11143404|FG000|NOT COMPLETED|Overall Study||140
10020130|NCT01833754|11143411|FG000|STARTED|Overall Study||8
10020131|NCT01833754|11143412|FG001|STARTED|Overall Study||8
10020132|NCT01833754|11143413|FG002|STARTED|Overall Study||8
10020133|NCT01833754|11143411|FG000|COMPLETED|Overall Study||8
10020134|NCT01833754|11143412|FG001|COMPLETED|Overall Study||8
10250465|NCT01116648|11382367|FG005|STARTED|Phase 2||46
10250466|NCT01116648|11382368|FG006|STARTED|Phase 2||44
10250467|NCT01116648|11382369|FG007|STARTED|Phase 2||0
10250468|NCT01116648|11382370|FG008|STARTED|Phase 2||0
10250469|NCT01116648|11382371|FG009|STARTED|Phase 2||0
10250470|NCT01116648|11382372|FG010|STARTED|Phase 2||0
10250471|NCT01116648|11382373|FG011|STARTED|Phase 2||0
10250472|NCT01116648|11382374|FG012|STARTED|Phase 2||0
10250473|NCT01116648|11382375|FG013|STARTED|Phase 2||0
10250474|NCT01116648|11382376|FG014|STARTED|Phase 2||0
10250475|NCT01116648|11382362|FG000|COMPLETED|Phase 2||0
10250476|NCT01116648|11382363|FG001|COMPLETED|Phase 2||0
10250477|NCT01116648|11382364|FG002|COMPLETED|Phase 2||0
10250478|NCT01116648|11382365|FG003|COMPLETED|Phase 2||0
10250479|NCT01116648|11382366|FG004|COMPLETED|Phase 2||0
10250480|NCT01116648|11382367|FG005|COMPLETED|Phase 2||46
10250481|NCT01116648|11382368|FG006|COMPLETED|Phase 2||44
10250482|NCT01116648|11382369|FG007|COMPLETED|Phase 2||0
10250483|NCT01116648|11382370|FG008|COMPLETED|Phase 2||0
10250484|NCT01116648|11382371|FG009|COMPLETED|Phase 2||0
10250485|NCT01116648|11382372|FG010|COMPLETED|Phase 2||0
10250486|NCT01116648|11382373|FG011|COMPLETED|Phase 2||0
10250487|NCT01116648|11382374|FG012|COMPLETED|Phase 2||0
10250488|NCT01116648|11382375|FG013|COMPLETED|Phase 2||0
10250489|NCT01116648|11382376|FG014|COMPLETED|Phase 2||0
10250490|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 2||0
10250491|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 2||0
10250492|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 2||0
10250493|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 2||0
10250494|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 2||0
10250495|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 2||0
10250496|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 2||0
10250497|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 2||0
10250498|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 2||0
10250499|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 2||0
10250500|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 2||0
10250501|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 2||0
10250502|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 2||0
10250503|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 2||0
10250504|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 2||0
10250505|NCT01116648|11382362|FG000|STARTED|Phase 1-T Dose Level 0-TA||0
10250506|NCT01116648|11382363|FG001|STARTED|Phase 1-T Dose Level 0-TA||0
10250507|NCT01116648|11382364|FG002|STARTED|Phase 1-T Dose Level 0-TA||0
10250508|NCT01116648|11382365|FG003|STARTED|Phase 1-T Dose Level 0-TA||0
10250509|NCT01116648|11382366|FG004|STARTED|Phase 1-T Dose Level 0-TA||0
10250510|NCT01116648|11382367|FG005|STARTED|Phase 1-T Dose Level 0-TA||0
10250511|NCT01116648|11382368|FG006|STARTED|Phase 1-T Dose Level 0-TA||0
10250512|NCT01116648|11382369|FG007|STARTED|Phase 1-T Dose Level 0-TA||3
10250513|NCT01116648|11382370|FG008|STARTED|Phase 1-T Dose Level 0-TA||0
10250514|NCT01116648|11382371|FG009|STARTED|Phase 1-T Dose Level 0-TA||0
10250515|NCT01116648|11382372|FG010|STARTED|Phase 1-T Dose Level 0-TA||0
10250516|NCT01116648|11382373|FG011|STARTED|Phase 1-T Dose Level 0-TA||0
10250517|NCT01116648|11382374|FG012|STARTED|Phase 1-T Dose Level 0-TA||0
10250518|NCT01116648|11382375|FG013|STARTED|Phase 1-T Dose Level 0-TA||0
10250519|NCT01116648|11382376|FG014|STARTED|Phase 1-T Dose Level 0-TA||0
10250520|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250521|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250522|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250523|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250524|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250525|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250526|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250527|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3
10250528|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250529|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250530|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0
9833654|NCT00780962|10944620|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185
9833655|NCT00780962|10944621|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172
9833656|NCT00780962|10944620|FG000|COMPLETED|Overall Study||185
9833657|NCT00780962|10944621|FG001|COMPLETED|Overall Study||172
10250531|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250532|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0
9833658|NCT00780962|10944620|FG000|NOT COMPLETED|Overall Study||15
9833659|NCT00780962|10944621|FG001|NOT COMPLETED|Overall Study||27
9833660|NCT00780975|10944627|FG000|STARTED|Overall Study||8
9833661|NCT00780975|10944627|FG000|COMPLETED|Overall Study||0
10250533|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250534|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0
10250535|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250536|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250537|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250538|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250539|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250540|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250541|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250542|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250543|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250544|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250545|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250546|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250547|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250548|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250549|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10250550|NCT01116648|11382362|FG000|STARTED|Phase 1-T Dose Level 1-TA||0
10250551|NCT01116648|11382363|FG001|STARTED|Phase 1-T Dose Level 1-TA||0
10250552|NCT01116648|11382364|FG002|STARTED|Phase 1-T Dose Level 1-TA||0
10250553|NCT01116648|11382365|FG003|STARTED|Phase 1-T Dose Level 1-TA||0
10250554|NCT01116648|11382366|FG004|STARTED|Phase 1-T Dose Level 1-TA||0
10250555|NCT01116648|11382367|FG005|STARTED|Phase 1-T Dose Level 1-TA||0
10020135|NCT01833754|11143413|FG002|COMPLETED|Overall Study||8
10020136|NCT01833754|11143411|FG000|NOT COMPLETED|Overall Study||0
10020137|NCT01833754|11143412|FG001|NOT COMPLETED|Overall Study||0
10020138|NCT01833754|11143413|FG002|NOT COMPLETED|Overall Study||0
10020139|NCT01833832|11143421|FG000|STARTED|Overall Study||11
10020140|NCT01833832|11143421|FG000|COMPLETED|Overall Study||10
10020141|NCT01833832|11143421|FG000|NOT COMPLETED|Overall Study||1
10020142|NCT01833845|11143425|FG000|STARTED|Overall Study||4
10250556|NCT01116648|11382368|FG006|STARTED|Phase 1-T Dose Level 1-TA||0
10250557|NCT01116648|11382369|FG007|STARTED|Phase 1-T Dose Level 1-TA||0
10250558|NCT01116648|11382370|FG008|STARTED|Phase 1-T Dose Level 1-TA||6
10250559|NCT01116648|11382371|FG009|STARTED|Phase 1-T Dose Level 1-TA||0
10250560|NCT01116648|11382372|FG010|STARTED|Phase 1-T Dose Level 1-TA||0
10250561|NCT01116648|11382373|FG011|STARTED|Phase 1-T Dose Level 1-TA||0
10250562|NCT01116648|11382374|FG012|STARTED|Phase 1-T Dose Level 1-TA||0
10250563|NCT01116648|11382375|FG013|STARTED|Phase 1-T Dose Level 1-TA||0
10250564|NCT01116648|11382376|FG014|STARTED|Phase 1-T Dose Level 1-TA||0
9833662|NCT00780975|10944627|FG000|NOT COMPLETED|Overall Study||8
9833663|NCT00781079|10944633|FG000|STARTED|Overall Study||149
9833664|NCT00781079|10944634|FG001|STARTED|Overall Study||133
9833665|NCT00781079|10944633|FG000|COMPLETED|Overall Study||122
9833666|NCT00781079|10944634|FG001|COMPLETED|Overall Study||116
9833667|NCT00781079|10944633|FG000|NOT COMPLETED|Overall Study||27
9833668|NCT00781079|10944634|FG001|NOT COMPLETED|Overall Study||17
9833669|NCT00781274|10944640|FG000|STARTED|Overall Study||32
9833670|NCT00781274|10944640|FG000|COMPLETED|Overall Study||30
9833671|NCT00781274|10944640|FG000|NOT COMPLETED|Overall Study||2
9833672|NCT00781326|10944644|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
9833673|NCT00781326|10944644|FG000|COMPLETED|Phase I||2
9833674|NCT00781326|10944644|FG000|NOT COMPLETED|Phase I||4
9833675|NCT00781326|10944644|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
9833676|NCT00781326|10944644|FG000|COMPLETED|Phase 2||0
9833677|NCT00781326|10944644|FG000|NOT COMPLETED|Phase 2||0
9833678|NCT00781365|10944650|FG000|STARTED|Overall Study||228
9833679|NCT00781365|10944651|FG001|STARTED|Overall Study||222
9833680|NCT00781365|10944650|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
9833681|NCT00781365|10944651|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
9833682|NCT00781365|10944650|FG000|NOT COMPLETED|Overall Study||34
9833683|NCT00781365|10944651|FG001|NOT COMPLETED|Overall Study||36
9833684|NCT00781391|10944660|FG000|STARTED|Overall Study||7036
9833685|NCT00781391|10944661|FG001|STARTED|Overall Study||7035
9833686|NCT00781391|10944662|FG002|STARTED|Overall Study||7034
9833687|NCT00781391|10944660|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012
9833688|NCT00781391|10944661|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012
9833689|NCT00781391|10944662|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002
9833690|NCT00781391|10944660|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012
9957478|NCT01451203|11076718|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
9957479|NCT01451203|11076719|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
9957480|NCT01451203|11076718|FG000|COMPLETED|Post-treatment Period||57
9957481|NCT01451203|11076719|FG001|COMPLETED|Post-treatment Period||74
9957482|NCT01451203|11076718|FG000|NOT COMPLETED|Post-treatment Period||14
9957483|NCT01451203|11076719|FG001|NOT COMPLETED|Post-treatment Period||34
9957484|NCT01451372|11076725|FG000|STARTED|Overall Study||69
9957485|NCT01451372|11076725|FG000|COMPLETED|Overall Study||69
9957486|NCT01451372|11076725|FG000|NOT COMPLETED|Overall Study||0
9957487|NCT01451385|11076729|FG000|STARTED|Overall Study||376
9957488|NCT01451385|11076729|FG000|COMPLETED|Overall Study||285
9957489|NCT01451385|11076729|FG000|NOT COMPLETED|Overall Study||91
10020143|NCT01833845|11143425|FG000|COMPLETED|Overall Study||4
10020144|NCT01833845|11143425|FG000|NOT COMPLETED|Overall Study||0
10250565|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250566|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0
9957490|NCT01451398|11076735|FG000|STARTED|Overall Study||177
9957491|NCT01451398|11076736|FG001|STARTED|Overall Study||176
10020145|NCT01833897|11143429|FG000|STARTED|Overall Study||8
10020146|NCT01833897|11143429|FG000|COMPLETED|Overall Study||7
10020147|NCT01833897|11143429|FG000|NOT COMPLETED|Overall Study||1
10250567|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250568|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250569|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250570|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250571|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250572|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250573|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6
10250574|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250575|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250576|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250577|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250578|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250579|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0
10250580|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250581|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250582|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250583|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250584|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250585|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250586|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250587|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250588|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250589|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250590|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250591|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250592|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250593|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250594|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10250595|NCT01116648|11382362|FG000|STARTED|Phase 1-T Dose Level 2-TA||0
10250596|NCT01116648|11382363|FG001|STARTED|Phase 1-T Dose Level 2-TA||0
10250597|NCT01116648|11382364|FG002|STARTED|Phase 1-T Dose Level 2-TA||0
10250598|NCT01116648|11382365|FG003|STARTED|Phase 1-T Dose Level 2-TA||0
10250599|NCT01116648|11382366|FG004|STARTED|Phase 1-T Dose Level 2-TA||0
10250600|NCT01116648|11382367|FG005|STARTED|Phase 1-T Dose Level 2-TA||0
10250601|NCT01116648|11382368|FG006|STARTED|Phase 1-T Dose Level 2-TA||0
10250602|NCT01116648|11382369|FG007|STARTED|Phase 1-T Dose Level 2-TA||0
10250603|NCT01116648|11382370|FG008|STARTED|Phase 1-T Dose Level 2-TA||0
10250604|NCT01116648|11382371|FG009|STARTED|Phase 1-T Dose Level 2-TA||3
10250605|NCT01116648|11382372|FG010|STARTED|Phase 1-T Dose Level 2-TA||0
10250606|NCT01116648|11382373|FG011|STARTED|Phase 1-T Dose Level 2-TA||0
10250607|NCT01116648|11382374|FG012|STARTED|Phase 1-T Dose Level 2-TA||0
10250608|NCT01116648|11382375|FG013|STARTED|Phase 1-T Dose Level 2-TA||0
10250609|NCT01116648|11382376|FG014|STARTED|Phase 1-T Dose Level 2-TA||0
10250610|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250611|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250612|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250613|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250614|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250615|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250616|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250617|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250618|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250619|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3
10250620|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250621|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250622|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250623|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250624|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0
10250625|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250626|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250627|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250628|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250629|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250630|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250631|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250632|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250633|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250634|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250635|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250636|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250637|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250638|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250639|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10250640|NCT01116648|11382362|FG000|STARTED|Phase 1-T Dose Level 0-TB||0
10250641|NCT01116648|11382363|FG001|STARTED|Phase 1-T Dose Level 0-TB||0
10250642|NCT01116648|11382364|FG002|STARTED|Phase 1-T Dose Level 0-TB||0
10250643|NCT01116648|11382365|FG003|STARTED|Phase 1-T Dose Level 0-TB||0
10250644|NCT01116648|11382366|FG004|STARTED|Phase 1-T Dose Level 0-TB||0
10250645|NCT01116648|11382367|FG005|STARTED|Phase 1-T Dose Level 0-TB||0
10250646|NCT01116648|11382368|FG006|STARTED|Phase 1-T Dose Level 0-TB||0
10250647|NCT01116648|11382369|FG007|STARTED|Phase 1-T Dose Level 0-TB||0
10250648|NCT01116648|11382370|FG008|STARTED|Phase 1-T Dose Level 0-TB||0
10250649|NCT01116648|11382371|FG009|STARTED|Phase 1-T Dose Level 0-TB||0
10250650|NCT01116648|11382372|FG010|STARTED|Phase 1-T Dose Level 0-TB||3
10250651|NCT01116648|11382373|FG011|STARTED|Phase 1-T Dose Level 0-TB||0
10250652|NCT01116648|11382374|FG012|STARTED|Phase 1-T Dose Level 0-TB||0
10250653|NCT01116648|11382375|FG013|STARTED|Phase 1-T Dose Level 0-TB||0
10250654|NCT01116648|11382376|FG014|STARTED|Phase 1-T Dose Level 0-TB||0
10250655|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250656|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250657|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0
10020148|NCT01833936|11143435|FG000|STARTED|Overall Study||20
10020149|NCT01833936|11143436|FG001|STARTED|Overall Study||20
10020150|NCT01833936|11143435|FG000|COMPLETED|Overall Study||16
10020151|NCT01833936|11143436|FG001|COMPLETED|Overall Study||18
10020152|NCT01833936|11143435|FG000|NOT COMPLETED|Overall Study||4
10020153|NCT01833936|11143436|FG001|NOT COMPLETED|Overall Study||2
10250658|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250659|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250660|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250661|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250662|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250663|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250664|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250665|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3
10250666|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250667|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250668|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250669|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0
10250670|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250671|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250672|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250673|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250674|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250675|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250676|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250677|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250678|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250679|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10020154|NCT01833988|11143442|FG000|STARTED|Overall Study||16
10020155|NCT01833988|11143443|FG001|STARTED|Overall Study||16
10020156|NCT01833988|11143442|FG000|COMPLETED|Overall Study||16
10250680|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250681|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250682|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250683|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10020157|NCT01833988|11143443|FG001|COMPLETED|Overall Study||16
10020158|NCT01833988|11143442|FG000|NOT COMPLETED|Overall Study||0
10020159|NCT01833988|11143443|FG001|NOT COMPLETED|Overall Study||0
10250684|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10250685|NCT01116648|11382362|FG000|STARTED|Phase 1-T Dose Level 1-TB||0
10250686|NCT01116648|11382363|FG001|STARTED|Phase 1-T Dose Level 1-TB||0
10250687|NCT01116648|11382364|FG002|STARTED|Phase 1-T Dose Level 1-TB||0
10250688|NCT01116648|11382365|FG003|STARTED|Phase 1-T Dose Level 1-TB||0
10250689|NCT01116648|11382366|FG004|STARTED|Phase 1-T Dose Level 1-TB||0
10250690|NCT01116648|11382367|FG005|STARTED|Phase 1-T Dose Level 1-TB||0
10250691|NCT01116648|11382368|FG006|STARTED|Phase 1-T Dose Level 1-TB||0
10250692|NCT01116648|11382369|FG007|STARTED|Phase 1-T Dose Level 1-TB||0
10250693|NCT01116648|11382370|FG008|STARTED|Phase 1-T Dose Level 1-TB||0
10250694|NCT01116648|11382371|FG009|STARTED|Phase 1-T Dose Level 1-TB||0
10250695|NCT01116648|11382372|FG010|STARTED|Phase 1-T Dose Level 1-TB||0
10250696|NCT01116648|11382373|FG011|STARTED|Phase 1-T Dose Level 1-TB||3
10250697|NCT01116648|11382374|FG012|STARTED|Phase 1-T Dose Level 1-TB||0
10250698|NCT01116648|11382375|FG013|STARTED|Phase 1-T Dose Level 1-TB||0
10250699|NCT01116648|11382376|FG014|STARTED|Phase 1-T Dose Level 1-TB||0
10250700|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250701|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250702|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250703|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250704|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250705|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250706|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250707|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250708|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250709|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250710|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250711|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3
10250712|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250713|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250714|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0
10250715|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250716|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250717|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250718|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10020160|NCT01834027|11143456|FG000|STARTED|Overall Study||28
10020161|NCT01834027|11143457|FG001|STARTED|Overall Study||28
10020162|NCT01834027|11143456|FG000|COMPLETED|Overall Study||28
10020163|NCT01834027|11143457|FG001|COMPLETED|Overall Study||28
10250719|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250720|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250721|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250722|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250723|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250724|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250725|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250726|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250727|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250728|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250729|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10250730|NCT01116648|11382362|FG000|STARTED|Phase 1-T Dose Level 2-TB||0
10250731|NCT01116648|11382363|FG001|STARTED|Phase 1-T Dose Level 2-TB||0
10250732|NCT01116648|11382364|FG002|STARTED|Phase 1-T Dose Level 2-TB||0
10250733|NCT01116648|11382365|FG003|STARTED|Phase 1-T Dose Level 2-TB||0
10250734|NCT01116648|11382366|FG004|STARTED|Phase 1-T Dose Level 2-TB||0
10250735|NCT01116648|11382367|FG005|STARTED|Phase 1-T Dose Level 2-TB||0
10250736|NCT01116648|11382368|FG006|STARTED|Phase 1-T Dose Level 2-TB||0
10250737|NCT01116648|11382369|FG007|STARTED|Phase 1-T Dose Level 2-TB||0
10250738|NCT01116648|11382370|FG008|STARTED|Phase 1-T Dose Level 2-TB||0
10250739|NCT01116648|11382371|FG009|STARTED|Phase 1-T Dose Level 2-TB||0
10250740|NCT01116648|11382372|FG010|STARTED|Phase 1-T Dose Level 2-TB||0
10250741|NCT01116648|11382373|FG011|STARTED|Phase 1-T Dose Level 2-TB||0
10250742|NCT01116648|11382374|FG012|STARTED|Phase 1-T Dose Level 2-TB||6
10250743|NCT01116648|11382375|FG013|STARTED|Phase 1-T Dose Level 2-TB||0
10250744|NCT01116648|11382376|FG014|STARTED|Phase 1-T Dose Level 2-TB||0
10250745|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250746|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250747|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250748|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250749|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250750|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250751|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250752|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250753|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250754|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250755|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250756|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250757|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6
10250758|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250759|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0
10250760|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250761|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250762|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
9833691|NCT00781391|10944661|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012
9833692|NCT00781391|10944662|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002
9833693|NCT00781391|10944660|FG000|Per Protocol Analysis Set|Overall Study||6993
9833694|NCT00781391|10944661|FG001|Per Protocol Analysis Set|Overall Study||6995
9833695|NCT00781391|10944662|FG002|Per Protocol Analysis Set|Overall Study||6982
9833696|NCT00781391|10944660|FG000|COMPLETED|Overall Study||6157
9833697|NCT00781391|10944661|FG001|COMPLETED|Overall Study||6228
9833698|NCT00781391|10944662|FG002|COMPLETED|Overall Study||6250
9833699|NCT00781391|10944660|FG000|NOT COMPLETED|Overall Study||879
9833700|NCT00781391|10944661|FG001|NOT COMPLETED|Overall Study||807
9833701|NCT00781391|10944662|FG002|NOT COMPLETED|Overall Study||784
9833702|NCT00781456|10944672|FG000|STARTED|Overall Study||58
9833703|NCT00781456|10944673|FG001|STARTED|Overall Study||51
9833704|NCT00781456|10944672|FG000|Received Study Drug|Overall Study||57
9833705|NCT00781456|10944673|FG001|Received Study Drug|Overall Study||49
9833706|NCT00781456|10944672|FG000|COMPLETED|Overall Study||37
9833707|NCT00781456|10944673|FG001|COMPLETED|Overall Study||35
9833708|NCT00781456|10944672|FG000|NOT COMPLETED|Overall Study||21
9833709|NCT00781456|10944673|FG001|NOT COMPLETED|Overall Study||16
9833710|NCT00781508|10944681|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
9833711|NCT00781508|10944682|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
9833712|NCT00781508|10944681|FG000|COMPLETED|Overall Study||5
9833713|NCT00781508|10944682|FG001|COMPLETED|Overall Study||5
9833714|NCT00781508|10944681|FG000|NOT COMPLETED|Overall Study||0
9833715|NCT00781508|10944682|FG001|NOT COMPLETED|Overall Study||0
9833716|NCT00781599|10944692|FG000|STARTED|Overall Study||36
9833717|NCT00781599|10944693|FG001|STARTED|Overall Study||36
9833718|NCT00781599|10944692|FG000|COMPLETED|Overall Study||29
9833719|NCT00781599|10944693|FG001|COMPLETED|Overall Study||32
9833720|NCT00781599|10944692|FG000|NOT COMPLETED|Overall Study||7
9833721|NCT00781599|10944693|FG001|NOT COMPLETED|Overall Study||4
9833722|NCT00781768|10944701|FG000|STARTED|Overall Study||89
9833723|NCT00781768|10944702|FG001|STARTED|Overall Study||92
9833724|NCT00781768|10944701|FG000|COMPLETED|Overall Study||89
9833725|NCT00781768|10944702|FG001|COMPLETED|Overall Study||90
9833726|NCT00781768|10944701|FG000|NOT COMPLETED|Overall Study||0
9833727|NCT00781768|10944702|FG001|NOT COMPLETED|Overall Study||2
9833728|NCT00781859|10944710|FG000|STARTED|Overall Study||219
9833729|NCT00781859|10944711|FG001|STARTED|Overall Study||107
9833730|NCT00781859|10944710|FG000|COMPLETED|Overall Study||200
9833731|NCT00781859|10944711|FG001|COMPLETED|Overall Study||98
10250763|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250764|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250765|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250766|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250767|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250768|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250769|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250770|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250771|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250772|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250773|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250774|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10250775|NCT01116648|11382362|FG000|STARTED|Phase 1-T PKOlap Expansion||0
10250776|NCT01116648|11382363|FG001|STARTED|Phase 1-T PKOlap Expansion||0
10250777|NCT01116648|11382364|FG002|STARTED|Phase 1-T PKOlap Expansion||0
10250778|NCT01116648|11382365|FG003|STARTED|Phase 1-T PKOlap Expansion||0
10250779|NCT01116648|11382366|FG004|STARTED|Phase 1-T PKOlap Expansion||0
10250780|NCT01116648|11382367|FG005|STARTED|Phase 1-T PKOlap Expansion||0
10250781|NCT01116648|11382368|FG006|STARTED|Phase 1-T PKOlap Expansion||0
10250782|NCT01116648|11382369|FG007|STARTED|Phase 1-T PKOlap Expansion||0
10250783|NCT01116648|11382370|FG008|STARTED|Phase 1-T PKOlap Expansion||0
10250784|NCT01116648|11382371|FG009|STARTED|Phase 1-T PKOlap Expansion||0
10250785|NCT01116648|11382372|FG010|STARTED|Phase 1-T PKOlap Expansion||0
10250786|NCT01116648|11382373|FG011|STARTED|Phase 1-T PKOlap Expansion||0
10250787|NCT01116648|11382374|FG012|STARTED|Phase 1-T PKOlap Expansion||0
10250788|NCT01116648|11382375|FG013|STARTED|Phase 1-T PKOlap Expansion||6
10250789|NCT01116648|11382376|FG014|STARTED|Phase 1-T PKOlap Expansion||0
10250790|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0
10250791|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0
10250792|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0
10250793|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0
10250794|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0
10250795|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0
10250796|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0
10250797|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0
10250798|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0
10250799|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0
10250800|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0
10250801|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0
10250802|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0
10250803|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6
10250804|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0
9957492|NCT01451398|11076735|FG000|COMPLETED|Overall Study||150
9957493|NCT01451398|11076736|FG001|COMPLETED|Overall Study||139
10250805|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250806|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
9957494|NCT01451398|11076735|FG000|NOT COMPLETED|Overall Study||27
9957495|NCT01451398|11076736|FG001|NOT COMPLETED|Overall Study||37
10250807|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250808|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250809|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250810|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250811|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250812|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250813|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250814|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250815|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250816|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250817|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250818|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250819|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10250820|NCT01116648|11382362|FG000|STARTED|Phase 1-T PKCed Expansion||0
10250821|NCT01116648|11382363|FG001|STARTED|Phase 1-T PKCed Expansion||0
10250822|NCT01116648|11382364|FG002|STARTED|Phase 1-T PKCed Expansion||0
10250823|NCT01116648|11382365|FG003|STARTED|Phase 1-T PKCed Expansion||0
10250824|NCT01116648|11382366|FG004|STARTED|Phase 1-T PKCed Expansion||0
10250825|NCT01116648|11382367|FG005|STARTED|Phase 1-T PKCed Expansion||0
10250826|NCT01116648|11382368|FG006|STARTED|Phase 1-T PKCed Expansion||0
10250827|NCT01116648|11382369|FG007|STARTED|Phase 1-T PKCed Expansion||0
10250828|NCT01116648|11382370|FG008|STARTED|Phase 1-T PKCed Expansion||0
10250829|NCT01116648|11382371|FG009|STARTED|Phase 1-T PKCed Expansion||0
10250830|NCT01116648|11382372|FG010|STARTED|Phase 1-T PKCed Expansion||0
10250831|NCT01116648|11382373|FG011|STARTED|Phase 1-T PKCed Expansion||0
10250832|NCT01116648|11382374|FG012|STARTED|Phase 1-T PKCed Expansion||0
10250833|NCT01116648|11382375|FG013|STARTED|Phase 1-T PKCed Expansion||0
10250834|NCT01116648|11382376|FG014|STARTED|Phase 1-T PKCed Expansion||7
10250835|NCT01116648|11382362|FG000|COMPLETED|Phase 1-T PKCed Expansion||0
10250836|NCT01116648|11382363|FG001|COMPLETED|Phase 1-T PKCed Expansion||0
10250837|NCT01116648|11382364|FG002|COMPLETED|Phase 1-T PKCed Expansion||0
10250838|NCT01116648|11382365|FG003|COMPLETED|Phase 1-T PKCed Expansion||0
10250839|NCT01116648|11382366|FG004|COMPLETED|Phase 1-T PKCed Expansion||0
10250840|NCT01116648|11382367|FG005|COMPLETED|Phase 1-T PKCed Expansion||0
10250841|NCT01116648|11382368|FG006|COMPLETED|Phase 1-T PKCed Expansion||0
10250842|NCT01116648|11382369|FG007|COMPLETED|Phase 1-T PKCed Expansion||0
10250843|NCT01116648|11382370|FG008|COMPLETED|Phase 1-T PKCed Expansion||0
10250844|NCT01116648|11382371|FG009|COMPLETED|Phase 1-T PKCed Expansion||0
10250845|NCT01116648|11382372|FG010|COMPLETED|Phase 1-T PKCed Expansion||0
10250846|NCT01116648|11382373|FG011|COMPLETED|Phase 1-T PKCed Expansion||0
10250847|NCT01116648|11382374|FG012|COMPLETED|Phase 1-T PKCed Expansion||0
10250848|NCT01116648|11382375|FG013|COMPLETED|Phase 1-T PKCed Expansion||0
10250849|NCT01116648|11382376|FG014|COMPLETED|Phase 1-T PKCed Expansion||7
10250850|NCT01116648|11382362|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250851|NCT01116648|11382363|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250852|NCT01116648|11382364|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250853|NCT01116648|11382365|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250854|NCT01116648|11382366|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0
9833732|NCT00781859|10944710|FG000|NOT COMPLETED|Overall Study||19
9833733|NCT00781859|10944711|FG001|NOT COMPLETED|Overall Study||9
9833734|NCT00781885|10944717|FG000|STARTED|Overall Study||19
9833735|NCT00781885|10944717|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
9833736|NCT00781885|10944717|FG000|COMPLETED|Overall Study||18
9833737|NCT00781885|10944717|FG000|NOT COMPLETED|Overall Study||1
9833738|NCT00781898|10944723|FG000|STARTED|Overall Study||153
9833739|NCT00781898|10944724|FG001|STARTED|Overall Study||155
9833740|NCT00781898|10944723|FG000|COMPLETED|Overall Study||119
9833741|NCT00781898|10944724|FG001|COMPLETED|Overall Study||126
9833742|NCT00781898|10944723|FG000|NOT COMPLETED|Overall Study||34
9833743|NCT00781898|10944724|FG001|NOT COMPLETED|Overall Study||29
9833744|NCT00781911|10944732|FG000|STARTED|Overall Study||31
9833745|NCT00781911|10944733|FG001|STARTED|Overall Study||12
9833746|NCT00781911|10944732|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
9833747|NCT00781911|10944733|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
9833748|NCT00781911|10944732|FG000|COMPLETED|Overall Study||25
9833749|NCT00781911|10944733|FG001|COMPLETED|Overall Study||4
9833750|NCT00781911|10944732|FG000|NOT COMPLETED|Overall Study||6
9833751|NCT00781911|10944733|FG001|NOT COMPLETED|Overall Study||8
9833752|NCT00781937|10944743|FG000|STARTED|Main Trial Period Through Week 56||212
9833753|NCT00781937|10944744|FG001|STARTED|Main Trial Period Through Week 56||210
9833754|NCT00781937|10944743|FG000|COMPLETED|Main Trial Period Through Week 56||159
9833755|NCT00781937|10944744|FG001|COMPLETED|Main Trial Period Through Week 56||146
9833756|NCT00781937|10944743|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53
9833757|NCT00781937|10944744|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64
9833758|NCT00781937|10944743|FG000|STARTED|Follow up Period (Week 56-68)||159
9833759|NCT00781937|10944744|FG001|STARTED|Follow up Period (Week 56-68)||146
9833760|NCT00781937|10944743|FG000|COMPLETED|Follow up Period (Week 56-68)||153
9833761|NCT00781937|10944744|FG001|COMPLETED|Follow up Period (Week 56-68)||141
9833762|NCT00781937|10944743|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6
9833763|NCT00781937|10944744|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5
9833764|NCT00781950|10944752|FG000|STARTED|Overall Study||52
9833765|NCT00781950|10944753|FG001|STARTED|Overall Study||58
9833766|NCT00781950|10944752|FG000|COMPLETED|Overall Study||41
9833767|NCT00781950|10944753|FG001|COMPLETED|Overall Study||45
9833768|NCT00781950|10944752|FG000|NOT COMPLETED|Overall Study||11
9833769|NCT00781950|10944753|FG001|NOT COMPLETED|Overall Study||13
9833770|NCT00781963|10944762|FG000|STARTED|Overall Study||106
10250855|NCT01116648|11382367|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250856|NCT01116648|11382368|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250857|NCT01116648|11382369|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250858|NCT01116648|11382370|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250859|NCT01116648|11382371|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250860|NCT01116648|11382372|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250861|NCT01116648|11382373|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250862|NCT01116648|11382374|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250863|NCT01116648|11382375|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250864|NCT01116648|11382376|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10250865|NCT01065454|11382405|FG000|STARTED|Treatment||67
10250866|NCT01065454|11382406|FG001|STARTED|Treatment||33
10250867|NCT01065454|11382407|FG002|STARTED|Treatment||32
10250868|NCT01065454|11382408|FG003|STARTED|Treatment||69
10250869|NCT01065454|11382405|FG000|COMPLETED|Treatment||54
10250870|NCT01065454|11382406|FG001|COMPLETED|Treatment||28
10250871|NCT01065454|11382407|FG002|COMPLETED|Treatment||23
10250872|NCT01065454|11382408|FG003|COMPLETED|Treatment||57
10250873|NCT01065454|11382405|FG000|NOT COMPLETED|Treatment||13
10250874|NCT01065454|11382406|FG001|NOT COMPLETED|Treatment||5
10250875|NCT01065454|11382407|FG002|NOT COMPLETED|Treatment||9
10250876|NCT01065454|11382408|FG003|NOT COMPLETED|Treatment||12
10250877|NCT01065454|11382405|FG000|STARTED|Follow up||54
10250878|NCT01065454|11382406|FG001|STARTED|Follow up||28
10250879|NCT01065454|11382407|FG002|STARTED|Follow up||23
10250880|NCT01065454|11382408|FG003|STARTED|Follow up||57
10250881|NCT01065454|11382405|FG000|Entering Follow-up|Follow up||49
10250882|NCT01065454|11382406|FG001|Entering Follow-up|Follow up||27
10250883|NCT01065454|11382407|FG002|Entering Follow-up|Follow up||23
10250884|NCT01065454|11382408|FG003|Entering Follow-up|Follow up||51
10250885|NCT01065454|11382405|FG000|COMPLETED|Follow up||15
10250886|NCT01065454|11382406|FG001|COMPLETED|Follow up||4
10250887|NCT01065454|11382407|FG002|COMPLETED|Follow up||6
10250888|NCT01065454|11382408|FG003|COMPLETED|Follow up||13
10250889|NCT01065454|11382405|FG000|NOT COMPLETED|Follow up||39
10250890|NCT01065454|11382406|FG001|NOT COMPLETED|Follow up||24
10250891|NCT01065454|11382407|FG002|NOT COMPLETED|Follow up||17
10250892|NCT01065454|11382408|FG003|NOT COMPLETED|Follow up||44
10250893|NCT01064648|11382421|FG000|STARTED|Phase I Cohort1: Dose Level 1||7
10250894|NCT01064648|11382422|FG001|STARTED|Phase I Cohort1: Dose Level 1||0
10250895|NCT01064648|11382423|FG002|STARTED|Phase I Cohort1: Dose Level 1||0
10250896|NCT01064648|11382424|FG003|STARTED|Phase I Cohort1: Dose Level 1||0
10250897|NCT01064648|11382421|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0
10250898|NCT01064648|11382422|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0
10250899|NCT01064648|11382423|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0
10250900|NCT01064648|11382424|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0
10250901|NCT01064648|11382421|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
10250902|NCT01064648|11382422|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10250903|NCT01064648|11382423|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10250904|NCT01064648|11382424|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10250905|NCT01064648|11382421|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0
10250906|NCT01064648|11382422|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13
10250907|NCT01064648|11382423|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0
10250908|NCT01064648|11382424|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0
10250909|NCT01064648|11382421|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10250910|NCT01064648|11382422|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0
9833771|NCT00781963|10944763|FG001|STARTED|Overall Study||53
9833772|NCT00781963|10944762|FG000|COMPLETED|Overall Study||89
9833773|NCT00781963|10944763|FG001|COMPLETED|Overall Study||51
9833774|NCT00781963|10944762|FG000|NOT COMPLETED|Overall Study||17
9833775|NCT00781963|10944763|FG001|NOT COMPLETED|Overall Study||2
9833776|NCT00782067|10944769|FG000|STARTED|Overall Study||116
9833777|NCT00782067|10944769|FG000|Safety Set (SS)|Overall Study||116
9833778|NCT00782067|10944769|FG000|Primary Efficacy Population (PEP)|Overall Study||89
9833779|NCT00782067|10944769|FG000|COMPLETED|Overall Study||0
9833780|NCT00782067|10944769|FG000|NOT COMPLETED|Overall Study||116
9833781|NCT00782171|10944775|FG000|STARTED|Overall Study||146
9833782|NCT00782171|10944776|FG001|STARTED|Overall Study||134
9833783|NCT00782171|10944775|FG000|20-23 Weeks|Overall Study||135
9833784|NCT00782171|10944776|FG001|20-23 Weeks|Overall Study||124
9833785|NCT00782171|10944775|FG000|1 Year|Overall Study||131
9833786|NCT00782171|10944776|FG001|1 Year|Overall Study||120
9833787|NCT00782171|10944775|FG000|Surgery (Baseline)|Overall Study||138
9833788|NCT00782171|10944776|FG001|Surgery (Baseline)|Overall Study||128
9833789|NCT00782171|10944775|FG000|COMPLETED|Overall Study||124
9833790|NCT00782171|10944776|FG001|COMPLETED|Overall Study||115
9833791|NCT00782171|10944775|FG000|NOT COMPLETED|Overall Study||22
9833792|NCT00782171|10944776|FG001|NOT COMPLETED|Overall Study||19
9833793|NCT00782210|10944785|FG000|STARTED|Overall Study||209
9833794|NCT00782210|10944786|FG001|STARTED|Overall Study||208
10250911|NCT01064648|11382423|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10250912|NCT01064648|11382424|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10250913|NCT01064648|11382421|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10250914|NCT01064648|11382422|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
10250915|NCT01064648|11382423|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10250916|NCT01064648|11382424|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10250917|NCT01064648|11382421|FG000|STARTED|Phase II||0
10250918|NCT01064648|11382422|FG001|STARTED|Phase II||0
10250919|NCT01064648|11382423|FG002|STARTED|Phase II||49
10250920|NCT01064648|11382424|FG003|STARTED|Phase II||48
10250921|NCT01064648|11382421|FG000|COMPLETED|Phase II||0
10250922|NCT01064648|11382422|FG001|COMPLETED|Phase II||0
10250923|NCT01064648|11382423|FG002|COMPLETED|Phase II||0
10250924|NCT01064648|11382424|FG003|COMPLETED|Phase II||0
10250925|NCT01064648|11382421|FG000|NOT COMPLETED|Phase II||0
10250926|NCT01064648|11382422|FG001|NOT COMPLETED|Phase II||0
10250927|NCT01064648|11382423|FG002|NOT COMPLETED|Phase II||49
10250928|NCT01064648|11382424|FG003|NOT COMPLETED|Phase II||48
10250929|NCT01063517|11382439|FG000|STARTED|Overall Study||62
10250930|NCT01063517|11382440|FG001|STARTED|Overall Study||62
10250931|NCT01063517|11382439|FG000|Received Randomised Treatment|Overall Study||61
10250932|NCT01063517|11382440|FG001|Received Randomised Treatment|Overall Study||62
10250933|NCT01063517|11382439|FG000|COMPLETED|Overall Study||4
10250934|NCT01063517|11382440|FG001|COMPLETED|Overall Study||2
10250935|NCT01063517|11382439|FG000|NOT COMPLETED|Overall Study||58
10250936|NCT01063517|11382440|FG001|NOT COMPLETED|Overall Study||60
10250937|NCT01015833|11382448|FG000|STARTED|Overall Study||180
10250938|NCT01015833|11382449|FG001|STARTED|Overall Study||176
10250939|NCT01015833|11382448|FG000|COMPLETED|Overall Study||167
10250940|NCT01015833|11382449|FG001|COMPLETED|Overall Study||171
10250941|NCT01015833|11382448|FG000|NOT COMPLETED|Overall Study||13
10250942|NCT01015833|11382449|FG001|NOT COMPLETED|Overall Study||5
10250943|NCT00937937|11382455|FG000|STARTED|Overall Study||72
10250944|NCT00937937|11382455|FG000|COMPLETED|Overall Study||0
10250945|NCT00937937|11382455|FG000|NOT COMPLETED|Overall Study||72
10250946|NCT00843882|11382463|FG000|STARTED|Step 1||38
10250947|NCT00843882|11382464|FG001|STARTED|Step 1||103
10250948|NCT00843882|11382465|FG002|STARTED|Step 1||106
10250949|NCT00843882|11382463|FG000|Treated Patients|Step 1||36
10250950|NCT00843882|11382464|FG001|Treated Patients|Step 1||103
10250951|NCT00843882|11382465|FG002|Treated Patients|Step 1||106
10250952|NCT00843882|11382463|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0
10250953|NCT00843882|11382464|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96
10250954|NCT00843882|11382465|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99
10250955|NCT00843882|11382463|FG000|Patients With Cytogenetic Response Data Available|Step 1||0
10250956|NCT00843882|11382464|FG001|Patients With Cytogenetic Response Data Available|Step 1||55
10250957|NCT00843882|11382465|FG002|Patients With Cytogenetic Response Data Available|Step 1||51
10250958|NCT00843882|11382463|FG000|COMPLETED|Step 1||6
10250959|NCT00843882|11382464|FG001|COMPLETED|Step 1||48
10250960|NCT00843882|11382465|FG002|COMPLETED|Step 1||41
10250961|NCT00843882|11382463|FG000|NOT COMPLETED|Step 1||32
10250962|NCT00843882|11382464|FG001|NOT COMPLETED|Step 1||55
10250963|NCT00843882|11382465|FG002|NOT COMPLETED|Step 1||65
10250964|NCT00843882|11382463|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
10250965|NCT00843882|11382464|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
10250966|NCT00843882|11382465|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
10250967|NCT00843882|11382463|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
10250968|NCT00843882|11382464|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
10250969|NCT00843882|11382465|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
10250970|NCT00843882|11382463|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3
10250971|NCT00843882|11382464|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20
10250972|NCT00843882|11382465|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0
10250973|NCT00843882|11382463|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
10250974|NCT00843882|11382464|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
10250975|NCT00843882|11382465|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
10250976|NCT00792948|11382478|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97
10250977|NCT00792948|11382478|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
10250978|NCT00792948|11382478|FG000|NOT COMPLETED|Overall Study||28
10250979|NCT00770809|11382488|FG000|STARTED|Overall Study||118
10250980|NCT00770809|11382489|FG001|STARTED|Overall Study||120
10250981|NCT00770809|11382490|FG002|STARTED|Overall Study||67
10250982|NCT00770809|11382488|FG000|COMPLETED|Overall Study||101
10250983|NCT00770809|11382489|FG001|COMPLETED|Overall Study||110
10250984|NCT00770809|11382490|FG002|COMPLETED|Overall Study||44
10250985|NCT00770809|11382488|FG000|NOT COMPLETED|Overall Study||17
10250986|NCT00770809|11382489|FG001|NOT COMPLETED|Overall Study||10
10250987|NCT00770809|11382490|FG002|NOT COMPLETED|Overall Study||23
10250988|NCT00769379|11382500|FG000|STARTED|Overall Study||1008
10250989|NCT00769379|11382501|FG001|STARTED|Overall Study||1006
10250990|NCT00769379|11382500|FG000|COMPLETED|Overall Study||1005
10250991|NCT00769379|11382501|FG001|COMPLETED|Overall Study||993
10250992|NCT00769379|11382500|FG000|NOT COMPLETED|Overall Study||3
10250993|NCT00769379|11382501|FG001|NOT COMPLETED|Overall Study||13
10250994|NCT00731731|11382510|FG000|STARTED|Overall Study||12
10250995|NCT00731731|11382511|FG001|STARTED|Overall Study||3
10250996|NCT00731731|11382512|FG002|STARTED|Overall Study||110
10250997|NCT00731731|11382510|FG000|COMPLETED|Overall Study||12
10250998|NCT00731731|11382511|FG001|COMPLETED|Overall Study||3
10250999|NCT00731731|11382512|FG002|COMPLETED|Overall Study||107
10251000|NCT00731731|11382510|FG000|NOT COMPLETED|Overall Study||0
10251001|NCT00731731|11382511|FG001|NOT COMPLETED|Overall Study||0
10251002|NCT00731731|11382512|FG002|NOT COMPLETED|Overall Study||3
10251003|NCT00700882|11382525|FG000|STARTED|Overall Study||81
10251004|NCT00700882|11382525|FG000|Received Protocol Therapy|Overall Study||75
10251005|NCT00700882|11382525|FG000|Eligible and Treated Patients|Overall Study||73
10251006|NCT00700882|11382525|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22
10251007|NCT00700882|11382525|FG000|COMPLETED|Overall Study||22
10251008|NCT00700882|11382525|FG000|NOT COMPLETED|Overall Study||59
10251009|NCT00658814|11382531|FG000|STARTED|Remission Induction Chemotherapy||83
10251010|NCT00658814|11382532|FG001|STARTED|Remission Induction Chemotherapy||59
10251011|NCT00658814|11382531|FG000|Eligible|Remission Induction Chemotherapy||82
10251012|NCT00658814|11382532|FG001|Eligible|Remission Induction Chemotherapy||57
10251013|NCT00658814|11382531|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
10251014|NCT00658814|11382532|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
10251015|NCT00658814|11382531|FG000|COMPLETED|Remission Induction Chemotherapy||75
10251016|NCT00658814|11382532|FG001|COMPLETED|Remission Induction Chemotherapy||41
10251017|NCT00658814|11382531|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8
10251018|NCT00658814|11382532|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18
10251019|NCT00658814|11382531|FG000|STARTED|Consolidation Therapy||24
10251020|NCT00658814|11382532|FG001|STARTED|Consolidation Therapy||13
10251021|NCT00658814|11382531|FG000|Eligible|Consolidation Therapy||22
10251022|NCT00658814|11382532|FG001|Eligible|Consolidation Therapy||11
10251023|NCT00658814|11382531|FG000|COMPLETED|Consolidation Therapy||22
10251024|NCT00658814|11382532|FG001|COMPLETED|Consolidation Therapy||10
10251025|NCT00658814|11382531|FG000|NOT COMPLETED|Consolidation Therapy||2
10251026|NCT00658814|11382532|FG001|NOT COMPLETED|Consolidation Therapy||3
10251027|NCT00658814|11382531|FG000|STARTED|Maintenance Therapy||20
10251028|NCT00658814|11382532|FG001|STARTED|Maintenance Therapy||8
10251029|NCT00658814|11382531|FG000|Eligible|Maintenance Therapy||19
10251030|NCT00658814|11382532|FG001|Eligible|Maintenance Therapy||8
10251031|NCT00658814|11382531|FG000|COMPLETED|Maintenance Therapy||17
10251032|NCT00658814|11382532|FG001|COMPLETED|Maintenance Therapy||7
10251033|NCT00658814|11382531|FG000|NOT COMPLETED|Maintenance Therapy||3
10251034|NCT00658814|11382532|FG001|NOT COMPLETED|Maintenance Therapy||1
10251035|NCT00644228|11382544|FG000|STARTED|Randomization & Eligibility||261
10251036|NCT00644228|11382545|FG001|STARTED|Randomization & Eligibility||264
10251037|NCT00644228|11382544|FG000|Eligible and Analyzable|Randomization & Eligibility||229
10251038|NCT00644228|11382545|FG001|Eligible and Analyzable|Randomization & Eligibility||242
10251039|NCT00644228|11382544|FG000|COMPLETED|Randomization & Eligibility||229
10251040|NCT00644228|11382545|FG001|COMPLETED|Randomization & Eligibility||242
10251041|NCT00644228|11382544|FG000|NOT COMPLETED|Randomization & Eligibility||32
10251042|NCT00644228|11382545|FG001|NOT COMPLETED|Randomization & Eligibility||22
10251043|NCT00644228|11382544|FG000|STARTED|Induction Therapy||229
10251044|NCT00644228|11382545|FG001|STARTED|Induction Therapy||242
10251045|NCT00644228|11382544|FG000|COMPLETED|Induction Therapy||146
10251046|NCT00644228|11382545|FG001|COMPLETED|Induction Therapy||137
10251047|NCT00644228|11382544|FG000|NOT COMPLETED|Induction Therapy||83
10251048|NCT00644228|11382545|FG001|NOT COMPLETED|Induction Therapy||105
10251049|NCT00644228|11382544|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
10251050|NCT00644228|11382545|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
10251051|NCT00644228|11382544|FG000|COMPLETED|Maintenance||0
10251052|NCT00644228|11382545|FG001|COMPLETED|Maintenance||0
10251053|NCT00644228|11382544|FG000|NOT COMPLETED|Maintenance||143
10251054|NCT00644228|11382545|FG001|NOT COMPLETED|Maintenance||135
10251055|NCT00602641|11382553|FG000|STARTED|Overall Study||154
10251056|NCT00602641|11382554|FG001|STARTED|Overall Study||152
10251057|NCT00602641|11382553|FG000|Started Protocol Therapy|Overall Study||148
10251058|NCT00602641|11382554|FG001|Started Protocol Therapy|Overall Study||150
10251059|NCT00602641|11382553|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
10251060|NCT00602641|11382554|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
10251061|NCT00602641|11382553|FG000|NOT COMPLETED|Overall Study||154
10251062|NCT00602641|11382554|FG001|NOT COMPLETED|Overall Study||152
10251063|NCT00408005|11382562|FG000|STARTED|Induction||1596
10251064|NCT00408005|11382563|FG001|STARTED|Induction||299
10251065|NCT00408005|11382564|FG002|STARTED|Induction||0
10251066|NCT00408005|11382565|FG003|STARTED|Induction||0
10251067|NCT00408005|11382566|FG004|STARTED|Induction||0
10251068|NCT00408005|11382567|FG005|STARTED|Induction||0
10251069|NCT00408005|11382568|FG006|STARTED|Induction||0
10251070|NCT00408005|11382569|FG007|STARTED|Induction||0
10251071|NCT00408005|11382562|FG000|COMPLETED|Induction||1189
10251072|NCT00408005|11382563|FG001|COMPLETED|Induction||205
10251073|NCT00408005|11382564|FG002|COMPLETED|Induction||0
10251074|NCT00408005|11382565|FG003|COMPLETED|Induction||0
10251075|NCT00408005|11382566|FG004|COMPLETED|Induction||0
10251076|NCT00408005|11382567|FG005|COMPLETED|Induction||0
10251077|NCT00408005|11382568|FG006|COMPLETED|Induction||0
10251078|NCT00408005|11382569|FG007|COMPLETED|Induction||0
10251079|NCT00408005|11382562|FG000|NOT COMPLETED|Induction||407
10251080|NCT00408005|11382563|FG001|NOT COMPLETED|Induction||94
10251081|NCT00408005|11382564|FG002|NOT COMPLETED|Induction||0
10251082|NCT00408005|11382565|FG003|NOT COMPLETED|Induction||0
10251083|NCT00408005|11382566|FG004|NOT COMPLETED|Induction||0
10251084|NCT00408005|11382567|FG005|NOT COMPLETED|Induction||0
10251085|NCT00408005|11382568|FG006|NOT COMPLETED|Induction||0
10251086|NCT00408005|11382569|FG007|NOT COMPLETED|Induction||0
10251087|NCT00408005|11382562|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
10251088|NCT00408005|11382563|FG001|STARTED|Post Induction Therapy by Tx Assignment||0
10251089|NCT00408005|11382564|FG002|STARTED|Post Induction Therapy by Tx Assignment||372
10251090|NCT00408005|11382565|FG003|STARTED|Post Induction Therapy by Tx Assignment||147
10251091|NCT00408005|11382566|FG004|STARTED|Post Induction Therapy by Tx Assignment||451
10251092|NCT00408005|11382567|FG005|STARTED|Post Induction Therapy by Tx Assignment||219
10251093|NCT00408005|11382568|FG006|STARTED|Post Induction Therapy by Tx Assignment||143
10251094|NCT00408005|11382569|FG007|STARTED|Post Induction Therapy by Tx Assignment||62
10251095|NCT00408005|11382562|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0
10251096|NCT00408005|11382563|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0
10251097|NCT00408005|11382564|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217
10251098|NCT00408005|11382565|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0
10251099|NCT00408005|11382566|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55
10251100|NCT00408005|11382567|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0
10251101|NCT00408005|11382568|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0
10251102|NCT00408005|11382569|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0
10251103|NCT00408005|11382562|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10251104|NCT00408005|11382563|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10251105|NCT00408005|11382564|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
10251106|NCT00408005|11382565|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
10251107|NCT00408005|11382566|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
10251108|NCT00408005|11382567|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
10251109|NCT00408005|11382568|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10251110|NCT00408005|11382569|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10251111|NCT00408005|11382562|FG000|High Risk|Post Induction Therapy by Tx Assignment||0
10251112|NCT00408005|11382563|FG001|High Risk|Post Induction Therapy by Tx Assignment||0
10251113|NCT00408005|11382564|FG002|High Risk|Post Induction Therapy by Tx Assignment||56
10251114|NCT00408005|11382565|FG003|High Risk|Post Induction Therapy by Tx Assignment||52
10251115|NCT00408005|11382566|FG004|High Risk|Post Induction Therapy by Tx Assignment||55
10251116|NCT00408005|11382567|FG005|High Risk|Post Induction Therapy by Tx Assignment||52
10251117|NCT00408005|11382568|FG006|High Risk|Post Induction Therapy by Tx Assignment||0
10251118|NCT00408005|11382569|FG007|High Risk|Post Induction Therapy by Tx Assignment||0
10251119|NCT00408005|11382562|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10251120|NCT00408005|11382563|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10251121|NCT00408005|11382564|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10251122|NCT00408005|11382565|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10251123|NCT00408005|11382566|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
10251124|NCT00408005|11382567|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
10251125|NCT00408005|11382568|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10251126|NCT00408005|11382569|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10251127|NCT00408005|11382562|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10251128|NCT00408005|11382563|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10251129|NCT00408005|11382564|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10251130|NCT00408005|11382565|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10251131|NCT00408005|11382566|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10251132|NCT00408005|11382567|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
10251133|NCT00408005|11382568|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10251134|NCT00408005|11382569|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10251135|NCT00408005|11382562|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10251136|NCT00408005|11382563|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10251137|NCT00408005|11382564|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10251138|NCT00408005|11382565|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10251139|NCT00408005|11382566|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10251140|NCT00408005|11382567|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10251141|NCT00408005|11382568|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
10251142|NCT00408005|11382569|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10251143|NCT00408005|11382562|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10251144|NCT00408005|11382563|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
9833795|NCT00782210|10944787|FG002|STARTED|Overall Study||207
9833796|NCT00782210|10944785|FG000|COMPLETED|Overall Study||159
9833797|NCT00782210|10944786|FG001|COMPLETED|Overall Study||173
9833798|NCT00782210|10944787|FG002|COMPLETED|Overall Study||172
9833799|NCT00782210|10944785|FG000|NOT COMPLETED|Overall Study||50
9833800|NCT00782210|10944786|FG001|NOT COMPLETED|Overall Study||35
9833801|NCT00782210|10944787|FG002|NOT COMPLETED|Overall Study||35
9833802|NCT00782275|10944804|FG000|STARTED|Overall Study||41
9833803|NCT00782275|10944804|FG000|Treated|Overall Study||40
9833804|NCT00782275|10944804|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
9833805|NCT00782275|10944804|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
9833806|NCT00782275|10944804|FG000|NOT COMPLETED|Overall Study||41
9833807|NCT00782340|10944811|FG000|STARTED|Open Label Titration||263
9833808|NCT00782340|10944812|FG001|STARTED|Open Label Titration||0
9833809|NCT00782340|10944813|FG002|STARTED|Open Label Titration||0
9833810|NCT00782340|10944811|FG000|COMPLETED|Open Label Titration||162
9833811|NCT00782340|10944812|FG001|COMPLETED|Open Label Titration||0
9833812|NCT00782340|10944813|FG002|COMPLETED|Open Label Titration||0
9833813|NCT00782340|10944811|FG000|NOT COMPLETED|Open Label Titration||101
9833814|NCT00782340|10944812|FG001|NOT COMPLETED|Open Label Titration||0
9833815|NCT00782340|10944813|FG002|NOT COMPLETED|Open Label Titration||0
9833816|NCT00782340|10944811|FG000|STARTED|Randomized Double Blind||0
9833817|NCT00782340|10944812|FG001|STARTED|Randomized Double Blind||82
9833818|NCT00782340|10944813|FG002|STARTED|Randomized Double Blind||80
9833819|NCT00782340|10944811|FG000|COMPLETED|Randomized Double Blind||0
9833820|NCT00782340|10944812|FG001|COMPLETED|Randomized Double Blind||82
9833821|NCT00782340|10944813|FG002|COMPLETED|Randomized Double Blind||80
9833822|NCT00782340|10944811|FG000|NOT COMPLETED|Randomized Double Blind||0
9833823|NCT00782340|10944812|FG001|NOT COMPLETED|Randomized Double Blind||0
9833824|NCT00782340|10944813|FG002|NOT COMPLETED|Randomized Double Blind||0
10251145|NCT00408005|11382564|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10251146|NCT00408005|11382565|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10251147|NCT00408005|11382566|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10251148|NCT00408005|11382567|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10251149|NCT00408005|11382568|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
10251150|NCT00408005|11382569|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
10251151|NCT00408005|11382562|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10251152|NCT00408005|11382563|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10251153|NCT00408005|11382564|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10251154|NCT00408005|11382565|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10251155|NCT00408005|11382566|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10251156|NCT00408005|11382567|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10251157|NCT00408005|11382568|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10251158|NCT00408005|11382569|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
10251159|NCT00408005|11382562|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
10251160|NCT00408005|11382563|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0
10251161|NCT00408005|11382564|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287
10251162|NCT00408005|11382565|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103
10251163|NCT00408005|11382566|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319
10251164|NCT00408005|11382567|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118
10251165|NCT00408005|11382568|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115
10251166|NCT00408005|11382569|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48
10251167|NCT00408005|11382562|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10251168|NCT00408005|11382563|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10251169|NCT00408005|11382564|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
10251170|NCT00408005|11382565|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
10251171|NCT00408005|11382566|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
10251172|NCT00408005|11382567|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
10251173|NCT00408005|11382568|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
10020164|NCT01834027|11143456|FG000|NOT COMPLETED|Overall Study||0
10020165|NCT01834027|11143457|FG001|NOT COMPLETED|Overall Study||0
10020166|NCT01834222|11143463|FG000|STARTED|Overall Study||659
10020167|NCT01834222|11143463|FG000|Treated|Overall Study||658
10020168|NCT01834222|11143463|FG000|COMPLETED|Overall Study||658
10020169|NCT01834222|11143463|FG000|NOT COMPLETED|Overall Study||1
10251174|NCT00408005|11382569|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
10251175|NCT00378482|11382589|FG000|STARTED|Overall Study||37
10251176|NCT00378482|11382589|FG000|COMPLETED|Overall Study||6
10251177|NCT00378482|11382589|FG000|NOT COMPLETED|Overall Study||31
10251178|NCT00316888|11382595|FG000|STARTED|Overall Study||28
10251179|NCT00316888|11382596|FG001|STARTED|Overall Study||35
10251180|NCT00316888|11382595|FG000|Eligible|Overall Study||28
10020170|NCT01834261|11143469|FG000|STARTED|MIT fMRI and MEG Resting State Study||11
10020171|NCT01834261|11143470|FG001|STARTED|MIT fMRI and MEG Resting State Study||10
10020172|NCT01834261|11143469|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
10020173|NCT01834261|11143470|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9
10020174|NCT01834261|11143469|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
10113929|NCT02512575|11244630|FG006|COMPLETED|Overall Study||6
10251181|NCT00316888|11382596|FG001|Eligible|Overall Study||35
10251182|NCT00316888|11382595|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
10251183|NCT00316888|11382596|FG001|Treated|Overall Study||34
10251184|NCT00316888|11382595|FG000|Started Induction Chemotherapy|Overall Study||28
10251185|NCT00316888|11382596|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
10251186|NCT00316888|11382595|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
10251187|NCT00316888|11382596|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34
10251188|NCT00316888|11382595|FG000|COMPLETED|Overall Study||22
10251189|NCT00316888|11382596|FG001|COMPLETED|Overall Study||27
10251190|NCT00316888|11382595|FG000|NOT COMPLETED|Overall Study||6
10251191|NCT00316888|11382596|FG001|NOT COMPLETED|Overall Study||8
10251192|NCT00098475|11382604|FG000|STARTED|Step 1||223
10251193|NCT00098475|11382605|FG001|STARTED|Step 1||222
10251194|NCT00098475|11382606|FG002|STARTED|Step 1||4
10251195|NCT00098475|11382607|FG003|STARTED|Step 1||3
10251196|NCT00098475|11382604|FG000|Treated|Step 1||223
10251197|NCT00098475|11382605|FG001|Treated|Step 1||220
10251198|NCT00098475|11382606|FG002|Treated|Step 1||4
10251199|NCT00098475|11382607|FG003|Treated|Step 1||3
10251200|NCT00098475|11382604|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
10251201|NCT00098475|11382605|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
10251202|NCT00098475|11382606|FG002|Eligible|Step 1||4
10251203|NCT00098475|11382607|FG003|Eligible|Step 1||3
10251204|NCT00098475|11382604|FG000|COMPLETED|Step 1||52
10251205|NCT00098475|11382605|FG001|COMPLETED|Step 1||49
10251206|NCT00098475|11382606|FG002|COMPLETED|Step 1||0
10251207|NCT00098475|11382607|FG003|COMPLETED|Step 1||0
10251208|NCT00098475|11382604|FG000|NOT COMPLETED|Step 1||171
10251209|NCT00098475|11382605|FG001|NOT COMPLETED|Step 1||173
10251210|NCT00098475|11382606|FG002|NOT COMPLETED|Step 1||4
10251211|NCT00098475|11382607|FG003|NOT COMPLETED|Step 1||3
10251212|NCT00098475|11382604|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
10251213|NCT00098475|11382605|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
10251214|NCT00098475|11382606|FG002|STARTED|Step 2||0
10251215|NCT00098475|11382607|FG003|STARTED|Step 2||0
10251216|NCT00098475|11382604|FG000|Treated|Step 2||4
10251217|NCT00098475|11382605|FG001|Treated|Step 2||14
10251218|NCT00098475|11382606|FG002|Treated|Step 2||0
10251219|NCT00098475|11382607|FG003|Treated|Step 2||0
10251220|NCT00098475|11382604|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
10251221|NCT00098475|11382605|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
10251222|NCT00098475|11382606|FG002|Eligible|Step 2||0
10251223|NCT00098475|11382607|FG003|Eligible|Step 2||0
10251224|NCT00098475|11382604|FG000|COMPLETED|Step 2||0
10251225|NCT00098475|11382605|FG001|COMPLETED|Step 2||5
10251226|NCT00098475|11382606|FG002|COMPLETED|Step 2||0
10251227|NCT00098475|11382607|FG003|COMPLETED|Step 2||0
10251228|NCT00098475|11382604|FG000|NOT COMPLETED|Step 2||5
10251229|NCT00098475|11382605|FG001|NOT COMPLETED|Step 2||10
10251230|NCT00098475|11382606|FG002|NOT COMPLETED|Step 2||0
10251231|NCT00098475|11382607|FG003|NOT COMPLETED|Step 2||0
10251232|NCT00095784|11382617|FG000|STARTED|Overall Study||21
10251233|NCT00095784|11382617|FG000|COMPLETED|Overall Study||21
10251234|NCT00095784|11382617|FG000|NOT COMPLETED|Overall Study||0
10251235|NCT00070499|11382626|FG000|STARTED|Overall Study||75
10251236|NCT00070499|11382627|FG001|STARTED|Overall Study||78
10251237|NCT00070499|11382628|FG002|STARTED|Overall Study||126
10020175|NCT01834261|11143470|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
10020176|NCT01834261|11143469|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
10020177|NCT01834261|11143470|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
10020178|NCT01834261|11143469|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
10113930|NCT02512575|11244631|FG007|COMPLETED|Overall Study||6
10251238|NCT00070499|11382629|FG003|STARTED|Overall Study||127
10251239|NCT00070499|11382626|FG000|Eligible|Overall Study||73
10251240|NCT00070499|11382627|FG001|Eligible|Overall Study||73
10251241|NCT00070499|11382628|FG002|Eligible|Overall Study||123
10251242|NCT00070499|11382629|FG003|Eligible|Overall Study||125
10251243|NCT00070499|11382626|FG000|Eligible and Treated|Overall Study||72
10251244|NCT00070499|11382627|FG001|Eligible and Treated|Overall Study||73
10251245|NCT00070499|11382628|FG002|Eligible and Treated|Overall Study||123
10251246|NCT00070499|11382629|FG003|Eligible and Treated|Overall Study||123
10251247|NCT00070499|11382626|FG000|COMPLETED|Overall Study||37
10251248|NCT00070499|11382627|FG001|COMPLETED|Overall Study||52
10251249|NCT00070499|11382628|FG002|COMPLETED|Overall Study||6
10251250|NCT00070499|11382629|FG003|COMPLETED|Overall Study||17
10251251|NCT00070499|11382626|FG000|NOT COMPLETED|Overall Study||38
10251252|NCT00070499|11382627|FG001|NOT COMPLETED|Overall Study||26
10251253|NCT00070499|11382628|FG002|NOT COMPLETED|Overall Study||120
10251254|NCT00070499|11382629|FG003|NOT COMPLETED|Overall Study||110
10251255|NCT03178487|11382649|FG000|STARTED|Overall Study||94
10251256|NCT03178487|11382650|FG001|STARTED|Overall Study||93
10251257|NCT03178487|11382649|FG000|Received Treatment|Overall Study||94
10251258|NCT03178487|11382650|FG001|Received Treatment|Overall Study||93
10251259|NCT03178487|11382649|FG000|COMPLETED|Overall Study||90
10251260|NCT03178487|11382650|FG001|COMPLETED|Overall Study||89
10251261|NCT03178487|11382649|FG000|NOT COMPLETED|Overall Study||4
10251262|NCT03178487|11382650|FG001|NOT COMPLETED|Overall Study||4
10251263|NCT03155932|11382656|FG000|STARTED|Overall Study||2
10251264|NCT03155932|11382656|FG000|Participants Escalated to 2 mg Dose of APD334 at Week 12 to Week 24|Overall Study||2
10251265|NCT03155932|11382656|FG000|COMPLETED|Overall Study||2
10251266|NCT03155932|11382656|FG000|NOT COMPLETED|Overall Study||0
10251267|NCT03106779|11382663|FG000|STARTED|Overall Study||157
10251268|NCT03106779|11382664|FG001|STARTED|Overall Study||76
10251269|NCT03106779|11382663|FG000|Treated|Overall Study||156
10251270|NCT03106779|11382664|FG001|Treated|Overall Study||0
10251271|NCT03106779|11382663|FG000|Not Treated|Overall Study||1
10251272|NCT03106779|11382664|FG001|Not Treated|Overall Study||0
10251273|NCT03106779|11382663|FG000|COMPLETED|Overall Study||97
10251274|NCT03106779|11382664|FG001|COMPLETED|Overall Study||22
10251275|NCT03106779|11382663|FG000|NOT COMPLETED|Overall Study||60
10251276|NCT03106779|11382664|FG001|NOT COMPLETED|Overall Study||54
10251277|NCT03096834|11382672|FG000|STARTED|Double-Blind Treatment Epoch||121
10251278|NCT03096834|11382673|FG001|STARTED|Double-Blind Treatment Epoch||125
10251279|NCT03096834|11382674|FG002|STARTED|Double-Blind Treatment Epoch||0
10251280|NCT03096834|11382675|FG003|STARTED|Double-Blind Treatment Epoch||0
10251281|NCT03096834|11382672|FG000|COMPLETED|Double-Blind Treatment Epoch||118
10251282|NCT03096834|11382673|FG001|COMPLETED|Double-Blind Treatment Epoch||122
10251283|NCT03096834|11382674|FG002|COMPLETED|Double-Blind Treatment Epoch||0
10251284|NCT03096834|11382675|FG003|COMPLETED|Double-Blind Treatment Epoch||0
10251285|NCT03096834|11382672|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3
10251286|NCT03096834|11382673|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3
10251287|NCT03096834|11382674|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0
10251288|NCT03096834|11382675|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0
10251289|NCT03096834|11382672|FG000|STARTED|Open-Label Treatment Epoch||0
10251290|NCT03096834|11382673|FG001|STARTED|Open-Label Treatment Epoch||0
10251291|NCT03096834|11382674|FG002|STARTED|Open-Label Treatment Epoch||118
10251292|NCT03096834|11382675|FG003|STARTED|Open-Label Treatment Epoch||122
10251293|NCT03096834|11382672|FG000|COMPLETED|Open-Label Treatment Epoch||0
10251294|NCT03096834|11382673|FG001|COMPLETED|Open-Label Treatment Epoch||0
10251295|NCT03096834|11382674|FG002|COMPLETED|Open-Label Treatment Epoch||86
10251296|NCT03096834|11382675|FG003|COMPLETED|Open-Label Treatment Epoch||83
10251297|NCT03096834|11382672|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0
10251298|NCT03096834|11382673|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0
10251299|NCT03096834|11382674|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32
10251300|NCT03096834|11382675|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39
10251301|NCT03096834|11382672|FG000|STARTED|Safety Follow-Up Epoch||0
10251302|NCT03096834|11382673|FG001|STARTED|Safety Follow-Up Epoch||0
10251303|NCT03096834|11382674|FG002|STARTED|Safety Follow-Up Epoch||66
10251304|NCT03096834|11382675|FG003|STARTED|Safety Follow-Up Epoch||61
10251305|NCT03096834|11382672|FG000|COMPLETED|Safety Follow-Up Epoch||0
10251306|NCT03096834|11382673|FG001|COMPLETED|Safety Follow-Up Epoch||0
10251307|NCT03096834|11382674|FG002|COMPLETED|Safety Follow-Up Epoch||65
10251308|NCT03096834|11382675|FG003|COMPLETED|Safety Follow-Up Epoch||59
10251309|NCT03096834|11382672|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0
10251310|NCT03096834|11382673|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0
10251311|NCT03096834|11382674|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1
10251312|NCT03096834|11382675|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2
10251313|NCT03096834|11382672|FG000|STARTED|Post-Trial Access Epoch||0
10251314|NCT03096834|11382673|FG001|STARTED|Post-Trial Access Epoch||0
10251315|NCT03096834|11382674|FG002|STARTED|Post-Trial Access Epoch||21
10251316|NCT03096834|11382675|FG003|STARTED|Post-Trial Access Epoch||15
10251317|NCT03096834|11382672|FG000|COMPLETED|Post-Trial Access Epoch||0
10251318|NCT03096834|11382673|FG001|COMPLETED|Post-Trial Access Epoch||0
10251319|NCT03096834|11382674|FG002|COMPLETED|Post-Trial Access Epoch||21
10251320|NCT03096834|11382675|FG003|COMPLETED|Post-Trial Access Epoch||15
10251321|NCT03096834|11382672|FG000|NOT COMPLETED|Post-Trial Access Epoch||0
10251322|NCT03096834|11382673|FG001|NOT COMPLETED|Post-Trial Access Epoch||0
10251323|NCT03096834|11382674|FG002|NOT COMPLETED|Post-Trial Access Epoch||0
10251324|NCT03096834|11382675|FG003|NOT COMPLETED|Post-Trial Access Epoch||0
10251325|NCT03089853|11382686|FG000|STARTED|Overall Study||4
10251326|NCT03089853|11382687|FG001|STARTED|Overall Study||3
10251327|NCT03089853|11382686|FG000|COMPLETED|Overall Study||2
10251328|NCT03089853|11382687|FG001|COMPLETED|Overall Study||2
10251329|NCT03089853|11382686|FG000|NOT COMPLETED|Overall Study||2
10251330|NCT03089853|11382687|FG001|NOT COMPLETED|Overall Study||1
10251331|NCT03070392|11382695|FG000|STARTED|Overall Study||252
10251332|NCT03070392|11382696|FG001|STARTED|Overall Study||7
10251333|NCT03070392|11382697|FG002|STARTED|Overall Study||16
10251334|NCT03070392|11382698|FG003|STARTED|Overall Study||103
10251335|NCT03070392|11382695|FG000|COMPLETED|Overall Study||0
10251336|NCT03070392|11382696|FG001|COMPLETED|Overall Study||0
10251337|NCT03070392|11382697|FG002|COMPLETED|Overall Study||10
10251338|NCT03070392|11382698|FG003|COMPLETED|Overall Study||0
10251339|NCT03070392|11382695|FG000|NOT COMPLETED|Overall Study||252
10251340|NCT03070392|11382696|FG001|NOT COMPLETED|Overall Study||7
10251341|NCT03070392|11382697|FG002|NOT COMPLETED|Overall Study||6
10251342|NCT03070392|11382698|FG003|NOT COMPLETED|Overall Study||103
10251343|NCT03048578|11382706|FG000|STARTED|Overall Study||89
10251344|NCT03048578|11382707|FG001|STARTED|Overall Study||43
10251345|NCT03048578|11382706|FG000|COMPLETED|Overall Study||58
10251346|NCT03048578|11382707|FG001|COMPLETED|Overall Study||23
10251347|NCT03048578|11382706|FG000|NOT COMPLETED|Overall Study||31
10251348|NCT03048578|11382707|FG001|NOT COMPLETED|Overall Study||20
10251349|NCT03015194|11382713|FG000|STARTED|Overall Study||30
10251350|NCT03015194|11382713|FG000|COMPLETED|Overall Study||18
10251351|NCT03015194|11382713|FG000|NOT COMPLETED|Overall Study||12
10251352|NCT03012815|11382720|FG000|STARTED|Overall Study||46
10251353|NCT03012815|11382721|FG001|STARTED|Overall Study||42
10251354|NCT03012815|11382720|FG000|COMPLETED|Overall Study||41
10251355|NCT03012815|11382721|FG001|COMPLETED|Overall Study||40
10251356|NCT03012815|11382720|FG000|NOT COMPLETED|Overall Study||5
10251357|NCT03012815|11382721|FG001|NOT COMPLETED|Overall Study||2
10251358|NCT03001011|11382730|FG000|STARTED|Overall Study||101
10251359|NCT03001011|11382731|FG001|STARTED|Overall Study||101
10251360|NCT03001011|11382730|FG000|COMPLETED|Overall Study||74
10251361|NCT03001011|11382731|FG001|COMPLETED|Overall Study||80
10251362|NCT03001011|11382730|FG000|NOT COMPLETED|Overall Study||27
10251363|NCT03001011|11382731|FG001|NOT COMPLETED|Overall Study||21
10251364|NCT02999633|11382738|FG000|STARTED|Overall Study||14
10251365|NCT02999633|11382738|FG000|COMPLETED|Overall Study||0
10251366|NCT02999633|11382738|FG000|NOT COMPLETED|Overall Study||14
10251367|NCT02993757|11382744|FG000|STARTED|Overall Study||266
10251368|NCT02993757|11382745|FG001|STARTED|Overall Study||262
10251369|NCT02993757|11382744|FG000|Safety Analysis Set (SafAS)|Overall Study||263
10251370|NCT02993757|11382745|FG001|Safety Analysis Set (SafAS)|Overall Study||260
10251371|NCT02993757|11382744|FG000|COMPLETED|Overall Study||102
10251372|NCT02993757|11382745|FG001|COMPLETED|Overall Study||84
10251373|NCT02993757|11382744|FG000|NOT COMPLETED|Overall Study||164
10251374|NCT02993757|11382745|FG001|NOT COMPLETED|Overall Study||178
10251375|NCT02992418|11382753|FG000|STARTED|Overall Study||346
10251376|NCT02992418|11382754|FG001|STARTED|Overall Study||342
10251377|NCT02992418|11382753|FG000|Safety Analysis Set (SafAS)|Overall Study||338
10251378|NCT02992418|11382754|FG001|Safety Analysis Set (SafAS)|Overall Study||342
10251379|NCT02992418|11382753|FG000|COMPLETED|Overall Study||0
10251380|NCT02992418|11382754|FG001|COMPLETED|Overall Study||0
10251381|NCT02992418|11382753|FG000|NOT COMPLETED|Overall Study||346
10251382|NCT02992418|11382754|FG001|NOT COMPLETED|Overall Study||342
10251383|NCT02979535|11382762|FG000|STARTED|Overall Study||239
10251384|NCT02979535|11382763|FG001|STARTED|Overall Study||241
10251385|NCT02979535|11382762|FG000|Safety Analysis Set|Overall Study||237
10251386|NCT02979535|11382763|FG001|Safety Analysis Set|Overall Study||241
10251387|NCT02979535|11382762|FG000|COMPLETED|Overall Study||144
10251388|NCT02979535|11382763|FG001|COMPLETED|Overall Study||140
10251389|NCT02979535|11382762|FG000|NOT COMPLETED|Overall Study||95
10251390|NCT02979535|11382763|FG001|NOT COMPLETED|Overall Study||101
10251391|NCT02978716|11382772|FG000|STARTED|Overall Study||34
10251392|NCT02978716|11382773|FG001|STARTED|Overall Study||33
10251393|NCT02978716|11382774|FG002|STARTED|Overall Study||35
10251394|NCT02978716|11382772|FG000|ITT Population|Overall Study||34
10251395|NCT02978716|11382773|FG001|ITT Population|Overall Study||33
10251396|NCT02978716|11382774|FG002|ITT Population|Overall Study||35
10251397|NCT02978716|11382772|FG000|Safety Analysis Set|Overall Study||30
10251398|NCT02978716|11382773|FG001|Safety Analysis Set|Overall Study||33
10251399|NCT02978716|11382774|FG002|Safety Analysis Set|Overall Study||35
10251400|NCT02978716|11382772|FG000|Treated|Overall Study||30
10251401|NCT02978716|11382773|FG001|Treated|Overall Study||33
10251402|NCT02978716|11382774|FG002|Treated|Overall Study||35
10251403|NCT02978716|11382772|FG000|COMPLETED|Overall Study||0
10251404|NCT02978716|11382773|FG001|COMPLETED|Overall Study||0
10251405|NCT02978716|11382774|FG002|COMPLETED|Overall Study||0
10251406|NCT02978716|11382772|FG000|NOT COMPLETED|Overall Study||34
10251407|NCT02978716|11382773|FG001|NOT COMPLETED|Overall Study||33
10251408|NCT02978716|11382774|FG002|NOT COMPLETED|Overall Study||35
10251409|NCT02973321|11382789|FG000|STARTED|Overall Study||33
10251410|NCT02973321|11382790|FG001|STARTED|Overall Study||66
10251411|NCT02973321|11382791|FG002|STARTED|Overall Study||66
10251412|NCT02973321|11382792|FG003|STARTED|Overall Study||64
10251413|NCT02973321|11382793|FG004|STARTED|Overall Study||67
10251414|NCT02973321|11382789|FG000|COMPLETED|Overall Study||32
10251415|NCT02973321|11382790|FG001|COMPLETED|Overall Study||51
10251416|NCT02973321|11382791|FG002|COMPLETED|Overall Study||52
10251417|NCT02973321|11382792|FG003|COMPLETED|Overall Study||48
10251418|NCT02973321|11382793|FG004|COMPLETED|Overall Study||62
10251419|NCT02973321|11382789|FG000|NOT COMPLETED|Overall Study||1
10251420|NCT02973321|11382790|FG001|NOT COMPLETED|Overall Study||15
10251421|NCT02973321|11382791|FG002|NOT COMPLETED|Overall Study||14
10251422|NCT02973321|11382792|FG003|NOT COMPLETED|Overall Study||16
10251423|NCT02973321|11382793|FG004|NOT COMPLETED|Overall Study||5
10251424|NCT02943785|11382808|FG000|STARTED|Overall Study||713
10251425|NCT02943785|11382809|FG001|STARTED|Overall Study||713
10251426|NCT02943785|11382808|FG000|COMPLETED|Overall Study||431
10251427|NCT02943785|11382809|FG001|COMPLETED|Overall Study||350
10251428|NCT02943785|11382808|FG000|NOT COMPLETED|Overall Study||282
10251429|NCT02943785|11382809|FG001|NOT COMPLETED|Overall Study||363
10251430|NCT02923674|11382818|FG000|STARTED|Overall Study||60
10251431|NCT02923674|11382819|FG001|STARTED|Overall Study||60
10251432|NCT02923674|11382820|FG002|STARTED|Overall Study||63
10251433|NCT02923674|11382818|FG000|COMPLETED|Overall Study||32
10251434|NCT02923674|11382819|FG001|COMPLETED|Overall Study||32
10251435|NCT02923674|11382820|FG002|COMPLETED|Overall Study||38
10251436|NCT02923674|11382818|FG000|NOT COMPLETED|Overall Study||28
10251437|NCT02923674|11382819|FG001|NOT COMPLETED|Overall Study||28
10251438|NCT02923674|11382820|FG002|NOT COMPLETED|Overall Study||25
10251439|NCT02921971|11382830|FG000|STARTED|Overall Study||49
10251440|NCT02921971|11382831|FG001|STARTED|Overall Study||48
10251441|NCT02921971|11382830|FG000|COMPLETED|Overall Study||43
10251442|NCT02921971|11382831|FG001|COMPLETED|Overall Study||44
10251443|NCT02921971|11382830|FG000|NOT COMPLETED|Overall Study||6
10251444|NCT02921971|11382831|FG001|NOT COMPLETED|Overall Study||4
10251445|NCT02886286|11382839|FG000|STARTED|Overall Study||8
10251446|NCT02886286|11382840|FG001|STARTED|Overall Study||9
10251447|NCT02886286|11382839|FG000|COMPLETED|Overall Study||8
10251448|NCT02886286|11382840|FG001|COMPLETED|Overall Study||8
10251449|NCT02886286|11382839|FG000|NOT COMPLETED|Overall Study||0
10251450|NCT02886286|11382840|FG001|NOT COMPLETED|Overall Study||1
10251451|NCT02865187|11382848|FG000|STARTED|Overall Study||33
10251452|NCT02865187|11382849|FG001|STARTED|Overall Study||14
10251453|NCT02865187|11382848|FG000|Visit 2 - at 3 Months|Overall Study||23
10251454|NCT02865187|11382849|FG001|Visit 2 - at 3 Months|Overall Study||7
10251455|NCT02865187|11382848|FG000|COMPLETED|Overall Study||20
10251456|NCT02865187|11382849|FG001|COMPLETED|Overall Study||7
10251457|NCT02865187|11382848|FG000|NOT COMPLETED|Overall Study||13
10251458|NCT02865187|11382849|FG001|NOT COMPLETED|Overall Study||7
10251459|NCT02836249|11382857|FG000|STARTED|Overall Study||123
10251460|NCT02836249|11382858|FG001|STARTED|Overall Study||58
10251461|NCT02836249|11382857|FG000|COMPLETED|Overall Study||0
10251462|NCT02836249|11382858|FG001|COMPLETED|Overall Study||0
10251463|NCT02836249|11382857|FG000|NOT COMPLETED|Overall Study||123
10251464|NCT02836249|11382858|FG001|NOT COMPLETED|Overall Study||58
10251465|NCT02829918|11382864|FG000|STARTED|Overall Study||54
10251466|NCT02829918|11382864|FG000|COMPLETED|Overall Study||46
10251467|NCT02829918|11382864|FG000|NOT COMPLETED|Overall Study||8
10251468|NCT02824198|11382870|FG000|STARTED|Overall Study||89
10251469|NCT02824198|11382871|FG001|STARTED|Overall Study||29
10251470|NCT02824198|11382870|FG000|COMPLETED|Overall Study||74
10251471|NCT02824198|11382871|FG001|COMPLETED|Overall Study||26
10251472|NCT02824198|11382870|FG000|NOT COMPLETED|Overall Study||15
10251473|NCT02824198|11382871|FG001|NOT COMPLETED|Overall Study||3
10251474|NCT02821754|11382882|FG000|STARTED|Overall Study||36
10251475|NCT02821754|11382883|FG001|STARTED|Overall Study||16
10251476|NCT02821754|11382884|FG002|STARTED|Overall Study|No results data were collected for these participants.|2
10251477|NCT02821754|11382882|FG000|COMPLETED|Overall Study||20
10251478|NCT02821754|11382883|FG001|COMPLETED|Overall Study||4
10251479|NCT02821754|11382884|FG002|COMPLETED|Overall Study||0
10251480|NCT02821754|11382882|FG000|NOT COMPLETED|Overall Study||16
10251481|NCT02821754|11382883|FG001|NOT COMPLETED|Overall Study||12
10251482|NCT02821754|11382884|FG002|NOT COMPLETED|Overall Study||2
10251483|NCT02787551|11382892|FG000|STARTED|Core Period: 26 Weeks||257
10251484|NCT02787551|11382893|FG001|STARTED|Core Period: 26 Weeks||257
10251485|NCT02787551|11382892|FG000|Treated|Core Period: 26 Weeks||255
10251486|NCT02787551|11382893|FG001|Treated|Core Period: 26 Weeks||256
10251487|NCT02787551|11382892|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
10251488|NCT02787551|11382893|FG001|COMPLETED|Core Period: 26 Weeks||246
10251489|NCT02787551|11382892|FG000|NOT COMPLETED|Core Period: 26 Weeks||27
10251490|NCT02787551|11382893|FG001|NOT COMPLETED|Core Period: 26 Weeks||11
10251491|NCT02787551|11382892|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
10251492|NCT02787551|11382893|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10251493|NCT02787551|11382892|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
10251494|NCT02787551|11382893|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10251495|NCT02787551|11382892|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
10251496|NCT02787551|11382893|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10251497|NCT02747121|11382904|FG000|STARTED|Overall Study||3594
10251498|NCT02747121|11382905|FG001|STARTED|Overall Study||3813
10251499|NCT02747121|11382904|FG000|COMPLETED|Overall Study||3594
10251500|NCT02747121|11382905|FG001|COMPLETED|Overall Study||3813
9833825|NCT00782379|10944820|FG000|STARTED|Overall Study||20
9833826|NCT00782379|10944820|FG000|COMPLETED|Overall Study||20
10251501|NCT02747121|11382904|FG000|NOT COMPLETED|Overall Study||0
10251502|NCT02747121|11382905|FG001|NOT COMPLETED|Overall Study||0
10251503|NCT02735044|11382913|FG000|STARTED|Overall Study||233
10251504|NCT02735044|11382914|FG001|STARTED|Overall Study||230
10251505|NCT02735044|11382913|FG000|Treated|Overall Study||233
10251506|NCT02735044|11382914|FG001|Treated|Overall Study||228
10251507|NCT02735044|11382913|FG000|COMPLETED|Overall Study||217
10251508|NCT02735044|11382914|FG001|COMPLETED|Overall Study||207
10251509|NCT02735044|11382913|FG000|NOT COMPLETED|Overall Study||16
10251510|NCT02735044|11382914|FG001|NOT COMPLETED|Overall Study||23
10251511|NCT02720744|11382922|FG000|STARTED|Overall Study||107
10251512|NCT02720744|11382923|FG001|STARTED|Overall Study||105
10251513|NCT02720744|11382922|FG000|COMPLETED|Overall Study||69
10251514|NCT02720744|11382923|FG001|COMPLETED|Overall Study||79
9833827|NCT00782379|10944820|FG000|NOT COMPLETED|Overall Study||0
10251515|NCT02720744|11382922|FG000|NOT COMPLETED|Overall Study||38
10251516|NCT02720744|11382923|FG001|NOT COMPLETED|Overall Study||26
10251517|NCT02713867|11382931|FG000|STARTED|Randomization||180
10251518|NCT02713867|11382932|FG001|STARTED|Randomization||183
10251519|NCT02713867|11382931|FG000|COMPLETED|Randomization||178
10251520|NCT02713867|11382932|FG001|COMPLETED|Randomization||180
10251521|NCT02713867|11382931|FG000|NOT COMPLETED|Randomization||2
10251522|NCT02713867|11382932|FG001|NOT COMPLETED|Randomization||3
10251523|NCT02713867|11382931|FG000|STARTED|Treatment Period||178
10251524|NCT02713867|11382932|FG001|STARTED|Treatment Period||180
10251525|NCT02713867|11382931|FG000|COMPLETED|Treatment Period||31
10251526|NCT02713867|11382932|FG001|COMPLETED|Treatment Period||30
10251527|NCT02713867|11382931|FG000|NOT COMPLETED|Treatment Period||147
10251528|NCT02713867|11382932|FG001|NOT COMPLETED|Treatment Period||150
10251529|NCT02704403|11382940|FG000|STARTED|Overall Study||1437
10251530|NCT02704403|11382941|FG001|STARTED|Overall Study||720
10251531|NCT02704403|11382940|FG000|Full Intent-to-Treat Population|Overall Study||1437
10251532|NCT02704403|11382941|FG001|Full Intent-to-Treat Population|Overall Study||720
10251533|NCT02704403|11382940|FG000|Full Safety Population|Overall Study||1433
10251534|NCT02704403|11382941|FG001|Full Safety Population|Overall Study||717
10251535|NCT02704403|11382940|FG000|COMPLETED|Overall Study||0
10251536|NCT02704403|11382941|FG001|COMPLETED|Overall Study||0
10251537|NCT02704403|11382940|FG000|NOT COMPLETED|Overall Study||1437
10251538|NCT02704403|11382941|FG001|NOT COMPLETED|Overall Study||720
10251539|NCT02694185|11382949|FG000|STARTED|Overall Study||476
10251540|NCT02694185|11382950|FG001|STARTED|Overall Study||4793
10251541|NCT02694185|11382949|FG000|COMPLETED|Overall Study||431
10251542|NCT02694185|11382950|FG001|COMPLETED|Overall Study||4793
10251543|NCT02694185|11382949|FG000|NOT COMPLETED|Overall Study||45
10251544|NCT02694185|11382950|FG001|NOT COMPLETED|Overall Study||0
10251545|NCT02692651|11382958|FG000|STARTED|Study Treatment||70
10251546|NCT02692651|11382959|FG001|STARTED|Study Treatment||74
10251547|NCT02692651|11382958|FG000|COMPLETED|Study Treatment||54
10251548|NCT02692651|11382959|FG001|COMPLETED|Study Treatment||64
10251549|NCT02692651|11382958|FG000|NOT COMPLETED|Study Treatment||16
10251550|NCT02692651|11382959|FG001|NOT COMPLETED|Study Treatment||10
10251551|NCT02692651|11382958|FG000|STARTED|Post Study Treatment Follow-up||54
10251552|NCT02692651|11382959|FG001|STARTED|Post Study Treatment Follow-up||64
10251553|NCT02692651|11382958|FG000|COMPLETED|Post Study Treatment Follow-up||50
10251554|NCT02692651|11382959|FG001|COMPLETED|Post Study Treatment Follow-up||60
10251555|NCT02692651|11382958|FG000|NOT COMPLETED|Post Study Treatment Follow-up||4
10251556|NCT02692651|11382959|FG001|NOT COMPLETED|Post Study Treatment Follow-up||4
10251557|NCT02674061|11382967|FG000|STARTED|Overall Study||285
9833828|NCT00782418|10944824|FG000|STARTED|Period 1 Procedure/Treatment Groups||3
9833829|NCT00782418|10944825|FG001|STARTED|Period 1 Procedure/Treatment Groups||4
10113931|NCT02512575|11244632|FG008|COMPLETED|Overall Study||6
10113932|NCT02512575|11244633|FG009|COMPLETED|Overall Study||18
10251558|NCT02674061|11382968|FG001|STARTED|Overall Study||91
10251559|NCT02674061|11382967|FG000|COMPLETED|Overall Study||0
10251560|NCT02674061|11382968|FG001|COMPLETED|Overall Study||0
10251561|NCT02674061|11382967|FG000|NOT COMPLETED|Overall Study||285
10251562|NCT02674061|11382968|FG001|NOT COMPLETED|Overall Study||91
10251563|NCT02656706|11382976|FG000|STARTED|Overall Study||22
10251564|NCT02656706|11382976|FG000|COMPLETED|Overall Study||21
10251565|NCT02656706|11382976|FG000|NOT COMPLETED|Overall Study||1
10251566|NCT02654314|11382982|FG000|STARTED|Overall Study||136
10251567|NCT02654314|11382983|FG001|STARTED|Overall Study||141
10251568|NCT02654314|11382982|FG000|COMPLETED|Overall Study||136
10251569|NCT02654314|11382983|FG001|COMPLETED|Overall Study||141
10251570|NCT02654314|11382982|FG000|NOT COMPLETED|Overall Study||0
10251571|NCT02654314|11382983|FG001|NOT COMPLETED|Overall Study||0
10251572|NCT02628444|11382992|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
10251573|NCT02628444|11382993|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
10251574|NCT02628444|11382994|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
10251575|NCT02628444|11382995|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251576|NCT02628444|11382996|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251577|NCT02628444|11382997|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251578|NCT02628444|11382998|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251579|NCT02628444|11382999|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251580|NCT02628444|11383000|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251581|NCT02628444|11382992|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
10251582|NCT02628444|11382993|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
10251583|NCT02628444|11382994|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
10251584|NCT02628444|11382995|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251585|NCT02628444|11382996|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251586|NCT02628444|11382997|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251587|NCT02628444|11382998|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251588|NCT02628444|11382999|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251589|NCT02628444|11383000|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251590|NCT02628444|11382992|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
10251591|NCT02628444|11382993|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
10251592|NCT02628444|11382994|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
10251593|NCT02628444|11382995|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251594|NCT02628444|11382996|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251595|NCT02628444|11382997|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251596|NCT02628444|11382998|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251597|NCT02628444|11382999|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251598|NCT02628444|11383000|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251599|NCT02628444|11382992|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
10251600|NCT02628444|11382993|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
10251601|NCT02628444|11382994|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
10251602|NCT02628444|11382995|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251603|NCT02628444|11382996|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251604|NCT02628444|11382997|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251605|NCT02628444|11382998|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251606|NCT02628444|11382999|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251607|NCT02628444|11383000|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251608|NCT02628444|11382992|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
10251609|NCT02628444|11382993|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
10251610|NCT02628444|11382994|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
10251611|NCT02628444|11382995|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251612|NCT02628444|11382996|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251613|NCT02628444|11382997|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251614|NCT02628444|11382998|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251615|NCT02628444|11382999|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251616|NCT02628444|11383000|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10251617|NCT02628444|11382992|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251618|NCT02628444|11382993|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251619|NCT02628444|11382994|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251620|NCT02628444|11382995|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
10251621|NCT02628444|11382996|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
10251622|NCT02628444|11382997|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
10251623|NCT02628444|11382998|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
10251624|NCT02628444|11382999|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
10251625|NCT02628444|11383000|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
10251626|NCT02628444|11382992|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251627|NCT02628444|11382993|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251628|NCT02628444|11382994|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251629|NCT02628444|11382995|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
10251630|NCT02628444|11382996|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
10251631|NCT02628444|11382997|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
10020179|NCT01834261|11143470|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
10251632|NCT02628444|11382998|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10251633|NCT02628444|11382999|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
10251634|NCT02628444|11383000|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10251635|NCT02628444|11382992|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251636|NCT02628444|11382993|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251637|NCT02628444|11382994|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251638|NCT02628444|11382995|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
10251639|NCT02628444|11382996|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
10251640|NCT02628444|11382997|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
10251641|NCT02628444|11382998|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10251642|NCT02628444|11382999|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
10251643|NCT02628444|11383000|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
10251644|NCT02628444|11382992|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251645|NCT02628444|11382993|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251646|NCT02628444|11382994|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10251647|NCT02628444|11382995|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
10251648|NCT02628444|11382996|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
10251649|NCT02628444|11382997|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
10251650|NCT02628444|11382998|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
10251651|NCT02628444|11382999|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
10251652|NCT02628444|11383000|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
10251653|NCT02623998|11383027|FG000|STARTED|Overall Study||50
10251654|NCT02623998|11383028|FG001|STARTED|Overall Study||52
10251655|NCT02623998|11383027|FG000|COMPLETED|Overall Study||48
10251656|NCT02623998|11383028|FG001|COMPLETED|Overall Study||51
10251657|NCT02623998|11383027|FG000|NOT COMPLETED|Overall Study||2
10251658|NCT02623998|11383028|FG001|NOT COMPLETED|Overall Study||1
10251659|NCT02623725|11383036|FG000|STARTED|Overall Study||187
10251660|NCT02623725|11383037|FG001|STARTED|Overall Study||64
10251661|NCT02623725|11383036|FG000|COMPLETED|Overall Study||171
10251662|NCT02623725|11383037|FG001|COMPLETED|Overall Study||58
10251663|NCT02623725|11383036|FG000|NOT COMPLETED|Overall Study||16
10251664|NCT02623725|11383037|FG001|NOT COMPLETED|Overall Study||6
10251665|NCT02608684|11383045|FG000|STARTED|Overall Study||21
10251666|NCT02608684|11383045|FG000|COMPLETED|Overall Study||18
10251667|NCT02608684|11383045|FG000|NOT COMPLETED|Overall Study||3
10251668|NCT02603887|11383049|FG000|STARTED|Stage 1||12
10251669|NCT02603887|11383049|FG000|Cycle 1|Stage 1||12
10251670|NCT02603887|11383049|FG000|Cycle 8|Stage 1||7
10251671|NCT02603887|11383049|FG000|COMPLETED|Stage 1||7
10251672|NCT02603887|11383049|FG000|NOT COMPLETED|Stage 1||5
10251673|NCT02603887|11383049|FG000|STARTED|Stage 2||1
10251674|NCT02603887|11383049|FG000|Cycle 1|Stage 2||1
10251675|NCT02603887|11383049|FG000|Cycle 8|Stage 2||0
10251676|NCT02603887|11383049|FG000|COMPLETED|Stage 2||0
10251677|NCT02603887|11383049|FG000|NOT COMPLETED|Stage 2||1
10251678|NCT02587520|11383071|FG000|STARTED|Overall Study||80
10251679|NCT02587520|11383072|FG001|STARTED|Overall Study||71
10251680|NCT02587520|11383073|FG002|STARTED|Overall Study||78
10251681|NCT02587520|11383074|FG003|STARTED|Overall Study||79
10251682|NCT02587520|11383075|FG004|STARTED|Overall Study||75
10251683|NCT02587520|11383076|FG005|STARTED|Overall Study||75
10251684|NCT02587520|11383077|FG006|STARTED|Overall Study||76
10251685|NCT02587520|11383078|FG007|STARTED|Overall Study||73
10251686|NCT02587520|11383079|FG008|STARTED|Overall Study||76
10251687|NCT02587520|11383080|FG009|STARTED|Overall Study||76
10251688|NCT02587520|11383081|FG010|STARTED|Overall Study||76
10251689|NCT02587520|11383082|FG011|STARTED|Overall Study||73
10251690|NCT02587520|11383083|FG012|STARTED|Overall Study||77
10251691|NCT02587520|11383084|FG013|STARTED|Overall Study||74
10251692|NCT02587520|11383085|FG014|STARTED|Overall Study||78
10251693|NCT02587520|11383086|FG015|STARTED|Overall Study||72
10251694|NCT02587520|11383087|FG016|STARTED|Overall Study||76
10251695|NCT02587520|11383088|FG017|STARTED|Overall Study||78
10251696|NCT02587520|11383071|FG000|Safety Analysis Set (SafAS)|Overall Study||79
10251697|NCT02587520|11383072|FG001|Safety Analysis Set (SafAS)|Overall Study||71
10251698|NCT02587520|11383073|FG002|Safety Analysis Set (SafAS)|Overall Study||77
10251699|NCT02587520|11383074|FG003|Safety Analysis Set (SafAS)|Overall Study||77
10251700|NCT02587520|11383075|FG004|Safety Analysis Set (SafAS)|Overall Study||75
10251701|NCT02587520|11383076|FG005|Safety Analysis Set (SafAS)|Overall Study||75
10251702|NCT02587520|11383077|FG006|Safety Analysis Set (SafAS)|Overall Study||76
10251703|NCT02587520|11383078|FG007|Safety Analysis Set (SafAS)|Overall Study||73
10251704|NCT02587520|11383079|FG008|Safety Analysis Set (SafAS)|Overall Study||76
10251705|NCT02587520|11383080|FG009|Safety Analysis Set (SafAS)|Overall Study||76
10251706|NCT02587520|11383081|FG010|Safety Analysis Set (SafAS)|Overall Study||76
10251707|NCT02587520|11383082|FG011|Safety Analysis Set (SafAS)|Overall Study||72
10251708|NCT02587520|11383083|FG012|Safety Analysis Set (SafAS)|Overall Study||77
10251709|NCT02587520|11383084|FG013|Safety Analysis Set (SafAS)|Overall Study||73
10251710|NCT02587520|11383085|FG014|Safety Analysis Set (SafAS)|Overall Study||78
10251711|NCT02587520|11383086|FG015|Safety Analysis Set (SafAS)|Overall Study||72
10251712|NCT02587520|11383087|FG016|Safety Analysis Set (SafAS)|Overall Study||76
10251713|NCT02587520|11383088|FG017|Safety Analysis Set (SafAS)|Overall Study||78
10251714|NCT02587520|11383071|FG000|COMPLETED|Overall Study||78
10251715|NCT02587520|11383072|FG001|COMPLETED|Overall Study||69
10251716|NCT02587520|11383073|FG002|COMPLETED|Overall Study||77
10251717|NCT02587520|11383074|FG003|COMPLETED|Overall Study||74
10251718|NCT02587520|11383075|FG004|COMPLETED|Overall Study||75
10251719|NCT02587520|11383076|FG005|COMPLETED|Overall Study||72
10251720|NCT02587520|11383077|FG006|COMPLETED|Overall Study||73
10251721|NCT02587520|11383078|FG007|COMPLETED|Overall Study||71
10251722|NCT02587520|11383079|FG008|COMPLETED|Overall Study||73
10251723|NCT02587520|11383080|FG009|COMPLETED|Overall Study||71
10251724|NCT02587520|11383081|FG010|COMPLETED|Overall Study||73
10251725|NCT02587520|11383082|FG011|COMPLETED|Overall Study||69
10251726|NCT02587520|11383083|FG012|COMPLETED|Overall Study||77
10251727|NCT02587520|11383084|FG013|COMPLETED|Overall Study||73
10251728|NCT02587520|11383085|FG014|COMPLETED|Overall Study||78
10251729|NCT02587520|11383086|FG015|COMPLETED|Overall Study||72
10251730|NCT02587520|11383087|FG016|COMPLETED|Overall Study||76
10251731|NCT02587520|11383088|FG017|COMPLETED|Overall Study||78
10251732|NCT02587520|11383071|FG000|NOT COMPLETED|Overall Study||2
10251733|NCT02587520|11383072|FG001|NOT COMPLETED|Overall Study||2
10251734|NCT02587520|11383073|FG002|NOT COMPLETED|Overall Study||1
10251735|NCT02587520|11383074|FG003|NOT COMPLETED|Overall Study||5
10251736|NCT02587520|11383075|FG004|NOT COMPLETED|Overall Study||0
10251737|NCT02587520|11383076|FG005|NOT COMPLETED|Overall Study||3
10251738|NCT02587520|11383077|FG006|NOT COMPLETED|Overall Study||3
10251739|NCT02587520|11383078|FG007|NOT COMPLETED|Overall Study||2
10251740|NCT02587520|11383079|FG008|NOT COMPLETED|Overall Study||3
10251741|NCT02587520|11383080|FG009|NOT COMPLETED|Overall Study||5
10251742|NCT02587520|11383081|FG010|NOT COMPLETED|Overall Study||3
10251743|NCT02587520|11383082|FG011|NOT COMPLETED|Overall Study||4
10251744|NCT02587520|11383083|FG012|NOT COMPLETED|Overall Study||0
10251745|NCT02587520|11383084|FG013|NOT COMPLETED|Overall Study||1
10251746|NCT02587520|11383085|FG014|NOT COMPLETED|Overall Study||0
10251747|NCT02587520|11383086|FG015|NOT COMPLETED|Overall Study||0
10251748|NCT02587520|11383087|FG016|NOT COMPLETED|Overall Study||0
10251749|NCT02587520|11383088|FG017|NOT COMPLETED|Overall Study||0
10251750|NCT02584829|11383128|FG000|STARTED|Overall Study||1
10251751|NCT02584829|11383129|FG001|STARTED|Overall Study||7
10251752|NCT02584829|11383128|FG000|COMPLETED|Overall Study||0
10251753|NCT02584829|11383129|FG001|COMPLETED|Overall Study||3
10251754|NCT02584829|11383128|FG000|NOT COMPLETED|Overall Study||1
10251755|NCT02584829|11383129|FG001|NOT COMPLETED|Overall Study||4
10251756|NCT02570308|11383142|FG000|STARTED|Overall Study||3
10251757|NCT02570308|11383143|FG001|STARTED|Overall Study||6
10251758|NCT02570308|11383144|FG002|STARTED|Overall Study||4
10251759|NCT02570308|11383145|FG003|STARTED|Overall Study||6
10251760|NCT02570308|11383146|FG004|STARTED|Overall Study||127
10251761|NCT02570308|11383142|FG000|COMPLETED|Overall Study||2
10251762|NCT02570308|11383143|FG001|COMPLETED|Overall Study||1
10251763|NCT02570308|11383144|FG002|COMPLETED|Overall Study||0
10251764|NCT02570308|11383145|FG003|COMPLETED|Overall Study||2
10251765|NCT02570308|11383146|FG004|COMPLETED|Overall Study||53
10251766|NCT02570308|11383142|FG000|NOT COMPLETED|Overall Study||1
10251767|NCT02570308|11383143|FG001|NOT COMPLETED|Overall Study||5
10251768|NCT02570308|11383144|FG002|NOT COMPLETED|Overall Study||4
10251769|NCT02570308|11383145|FG003|NOT COMPLETED|Overall Study||4
10251770|NCT02570308|11383146|FG004|NOT COMPLETED|Overall Study||74
10251771|NCT02516241|11383167|FG000|STARTED|Overall Study||342
10251772|NCT02516241|11383168|FG001|STARTED|Overall Study||346
10251773|NCT02516241|11383169|FG002|STARTED|Overall Study||344
10251774|NCT02516241|11383167|FG000|Received Treatment|Overall Study||340
10251775|NCT02516241|11383168|FG001|Received Treatment|Overall Study||345
10251776|NCT02516241|11383169|FG002|Received Treatment|Overall Study||313
10251777|NCT02516241|11383167|FG000|COMPLETED|Overall Study||0
10251778|NCT02516241|11383168|FG001|COMPLETED|Overall Study||0
10251779|NCT02516241|11383169|FG002|COMPLETED|Overall Study||0
10251780|NCT02516241|11383167|FG000|NOT COMPLETED|Overall Study||342
10251781|NCT02516241|11383168|FG001|NOT COMPLETED|Overall Study||346
10251782|NCT02516241|11383169|FG002|NOT COMPLETED|Overall Study||344
10251783|NCT02514083|11383182|FG000|STARTED|Overall Study||29
10251784|NCT02514083|11383182|FG000|COMPLETED|Overall Study||28
10251785|NCT02514083|11383182|FG000|NOT COMPLETED|Overall Study||1
10251786|NCT02497612|11383190|FG000|STARTED|Overall Study||93
10251787|NCT02497612|11383191|FG001|STARTED|Overall Study||94
10251788|NCT02497612|11383192|FG002|STARTED|Overall Study||97
10251789|NCT02497612|11383193|FG003|STARTED|Overall Study||93
10251790|NCT02497612|11383190|FG000|Treated|Overall Study||92
10251791|NCT02497612|11383191|FG001|Treated|Overall Study||94
10251792|NCT02497612|11383192|FG002|Treated|Overall Study||96
10251793|NCT02497612|11383193|FG003|Treated|Overall Study||91
10251794|NCT02497612|11383190|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14
10251795|NCT02497612|11383191|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15
10251796|NCT02497612|11383192|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18
10251797|NCT02497612|11383193|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16
10251798|NCT02497612|11383190|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6
10251799|NCT02497612|11383191|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5
10251800|NCT02497612|11383192|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6
10251801|NCT02497612|11383193|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5
10251802|NCT02497612|11383190|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66
10251803|NCT02497612|11383191|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66
10251804|NCT02497612|11383192|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67
10251805|NCT02497612|11383193|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65
10251806|NCT02497612|11383190|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7
10251807|NCT02497612|11383191|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8
10251808|NCT02497612|11383192|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6
10251809|NCT02497612|11383193|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7
10251810|NCT02497612|11383190|FG000|COMPLETED|Overall Study||27
10251811|NCT02497612|11383191|FG001|COMPLETED|Overall Study||37
10251812|NCT02497612|11383192|FG002|COMPLETED|Overall Study||48
10251813|NCT02497612|11383193|FG003|COMPLETED|Overall Study||46
10251814|NCT02497612|11383190|FG000|NOT COMPLETED|Overall Study||66
10251815|NCT02497612|11383191|FG001|NOT COMPLETED|Overall Study||57
10251816|NCT02497612|11383192|FG002|NOT COMPLETED|Overall Study||49
10251817|NCT02497612|11383193|FG003|NOT COMPLETED|Overall Study||47
10251818|NCT02460458|11383203|FG000|STARTED|Retrospective Phase||265
10251819|NCT02460458|11383203|FG000|COMPLETED|Retrospective Phase||265
10251820|NCT02460458|11383203|FG000|NOT COMPLETED|Retrospective Phase||0
10251821|NCT02460458|11383203|FG000|STARTED|Confirmatory Phase||265
10251822|NCT02460458|11383203|FG000|COMPLETED|Confirmatory Phase||177
10251823|NCT02460458|11383203|FG000|NOT COMPLETED|Confirmatory Phase||88
10251824|NCT02460458|11383203|FG000|STARTED|First Prospective Phase||177
10251825|NCT02460458|11383203|FG000|COMPLETED|First Prospective Phase||161
10251826|NCT02460458|11383203|FG000|NOT COMPLETED|First Prospective Phase||16
10251827|NCT02460458|11383203|FG000|STARTED|Confirmation of Clinical Phase Data||161
10251828|NCT02460458|11383203|FG000|COMPLETED|Confirmation of Clinical Phase Data||152
10251829|NCT02460458|11383203|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9
10251830|NCT02460458|11383203|FG000|STARTED|Second Prospective Phase||152
10251831|NCT02460458|11383203|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
10251832|NCT02460458|11383203|FG000|NOT COMPLETED|Second Prospective Phase||152
10251833|NCT02457559|11383218|FG000|STARTED|Overall Study||2
10251834|NCT02457559|11383219|FG001|STARTED|Overall Study||3
10251835|NCT02457559|11383220|FG002|STARTED|Overall Study||7
10251836|NCT02457559|11383221|FG003|STARTED|Overall Study||2
10251837|NCT02457559|11383222|FG004|STARTED|Overall Study||1
10251838|NCT02457559|11383223|FG005|STARTED|Overall Study||2
10251839|NCT02457559|11383224|FG006|STARTED|Overall Study||2
10251840|NCT02457559|11383225|FG007|STARTED|Overall Study||1
10251841|NCT02457559|11383226|FG008|STARTED|Overall Study||3
10251842|NCT02457559|11383227|FG009|STARTED|Overall Study||4
10251843|NCT02457559|11383228|FG010|STARTED|Overall Study||2
10251844|NCT02457559|11383218|FG000|COMPLETED|Overall Study||0
10251845|NCT02457559|11383219|FG001|COMPLETED|Overall Study||0
10251846|NCT02457559|11383220|FG002|COMPLETED|Overall Study||0
10251847|NCT02457559|11383221|FG003|COMPLETED|Overall Study||2
10251848|NCT02457559|11383222|FG004|COMPLETED|Overall Study||0
10251849|NCT02457559|11383223|FG005|COMPLETED|Overall Study||0
10251850|NCT02457559|11383224|FG006|COMPLETED|Overall Study||0
10251851|NCT02457559|11383225|FG007|COMPLETED|Overall Study||1
10251852|NCT02457559|11383226|FG008|COMPLETED|Overall Study||0
10251853|NCT02457559|11383227|FG009|COMPLETED|Overall Study||0
10251854|NCT02457559|11383228|FG010|COMPLETED|Overall Study||0
10251855|NCT02457559|11383218|FG000|NOT COMPLETED|Overall Study||2
10251856|NCT02457559|11383219|FG001|NOT COMPLETED|Overall Study||3
10251857|NCT02457559|11383220|FG002|NOT COMPLETED|Overall Study||7
10251858|NCT02457559|11383221|FG003|NOT COMPLETED|Overall Study||0
10251859|NCT02457559|11383222|FG004|NOT COMPLETED|Overall Study||1
10251860|NCT02457559|11383223|FG005|NOT COMPLETED|Overall Study||2
10251861|NCT02457559|11383224|FG006|NOT COMPLETED|Overall Study||2
10251862|NCT02457559|11383225|FG007|NOT COMPLETED|Overall Study||0
10251863|NCT02457559|11383226|FG008|NOT COMPLETED|Overall Study||3
10251864|NCT02457559|11383227|FG009|NOT COMPLETED|Overall Study||4
10251865|NCT02457559|11383228|FG010|NOT COMPLETED|Overall Study||2
10251866|NCT02442349|11383266|FG000|STARTED|Overall Study||171
10251867|NCT02442349|11383266|FG000|COMPLETED|Overall Study||0
10251868|NCT02442349|11383266|FG000|NOT COMPLETED|Overall Study||171
10251869|NCT02417974|11383272|FG000|STARTED|Overall Study||15
10251870|NCT02417974|11383273|FG001|STARTED|Overall Study||9
10251871|NCT02417974|11383272|FG000|COMPLETED|Overall Study||15
10251872|NCT02417974|11383273|FG001|COMPLETED|Overall Study||9
10251873|NCT02417974|11383272|FG000|NOT COMPLETED|Overall Study||0
10251874|NCT02417974|11383273|FG001|NOT COMPLETED|Overall Study||0
10251875|NCT02381652|11383282|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
10251876|NCT02381652|11383283|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
10251877|NCT02381652|11383284|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
10251878|NCT02381652|11383282|FG000|COMPLETED|Overall Study||94
10251879|NCT02381652|11383283|FG001|COMPLETED|Overall Study||98
10251880|NCT02381652|11383284|FG002|COMPLETED|Overall Study||49
10251881|NCT02381652|11383282|FG000|NOT COMPLETED|Overall Study||0
10251882|NCT02381652|11383283|FG001|NOT COMPLETED|Overall Study||0
10251883|NCT02381652|11383284|FG002|NOT COMPLETED|Overall Study||1
10251884|NCT02367794|11383293|FG000|STARTED|Overall Study||340
10251885|NCT02367794|11383294|FG001|STARTED|Overall Study||343
10251886|NCT02367794|11383295|FG002|STARTED|Overall Study||338
10251887|NCT02367794|11383293|FG000|COMPLETED|Overall Study||0
10251888|NCT02367794|11383294|FG001|COMPLETED|Overall Study||0
10251889|NCT02367794|11383295|FG002|COMPLETED|Overall Study||0
10251890|NCT02367794|11383293|FG000|NOT COMPLETED|Overall Study||340
10251891|NCT02367794|11383294|FG001|NOT COMPLETED|Overall Study||343
10251892|NCT02367794|11383295|FG002|NOT COMPLETED|Overall Study||338
10251893|NCT02363998|11383308|FG000|STARTED|Overall Study||286
10251894|NCT02363998|11383308|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
10251895|NCT02363998|11383308|FG000|NOT COMPLETED|Overall Study||118
10251896|NCT02353832|11383328|FG000|STARTED|Overall Study||44
10251897|NCT02353832|11383328|FG000|COMPLETED|Overall Study||42
10251898|NCT02353832|11383328|FG000|NOT COMPLETED|Overall Study||2
10251899|NCT02353728|11383332|FG000|STARTED|Overall Study||16
10251900|NCT02353728|11383332|FG000|COMPLETED|Overall Study||15
10251901|NCT02353728|11383332|FG000|NOT COMPLETED|Overall Study||1
10251902|NCT02345070|11383339|FG000|STARTED|Overall Study||110
10251903|NCT02345070|11383340|FG001|STARTED|Overall Study||109
10251904|NCT02345070|11383341|FG002|STARTED|Overall Study||108
10251905|NCT02345070|11383339|FG000|Treated|Overall Study||109
10251906|NCT02345070|11383340|FG001|Treated|Overall Study||108
10251907|NCT02345070|11383341|FG002|Treated|Overall Study||108
10251908|NCT02345070|11383339|FG000|COMPLETED|Overall Study||90
10251909|NCT02345070|11383340|FG001|COMPLETED|Overall Study||98
10251910|NCT02345070|11383341|FG002|COMPLETED|Overall Study||85
10251911|NCT02345070|11383339|FG000|NOT COMPLETED|Overall Study||20
10251912|NCT02345070|11383340|FG001|NOT COMPLETED|Overall Study||11
10251913|NCT02345070|11383341|FG002|NOT COMPLETED|Overall Study||23
10251914|NCT02325466|11383349|FG000|STARTED|Period 1 Timeframe - Baseline to Week 4||23
10251915|NCT02325466|11383350|FG001|STARTED|Period 1 Timeframe - Baseline to Week 4||23
10251916|NCT02325466|11383351|FG002|STARTED|Period 1 Timeframe - Baseline to Week 4||24
10251917|NCT02325466|11383349|FG000|COMPLETED|Period 1 Timeframe - Baseline to Week 4||22
10251918|NCT02325466|11383350|FG001|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
10251919|NCT02325466|11383351|FG002|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
10251920|NCT02325466|11383349|FG000|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||1
10251921|NCT02325466|11383350|FG001|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||2
10251922|NCT02325466|11383351|FG002|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||3
10251923|NCT02325466|11383349|FG000|STARTED|Period 2 - Timeframe Week 4 to Week 10||22
10251924|NCT02325466|11383350|FG001|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
10251925|NCT02325466|11383351|FG002|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
10251926|NCT02325466|11383349|FG000|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||19
10251927|NCT02325466|11383350|FG001|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||20
10251928|NCT02325466|11383351|FG002|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||21
10251929|NCT02325466|11383349|FG000|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||3
10251930|NCT02325466|11383350|FG001|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||1
10251931|NCT02325466|11383351|FG002|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||0
10251932|NCT02325466|11383349|FG000|STARTED|3rd Crossover - Week 10 to Week 16||19
10251933|NCT02325466|11383350|FG001|STARTED|3rd Crossover - Week 10 to Week 16||20
10251934|NCT02325466|11383351|FG002|STARTED|3rd Crossover - Week 10 to Week 16||21
10251935|NCT02325466|11383349|FG000|COMPLETED|3rd Crossover - Week 10 to Week 16||18
10251936|NCT02325466|11383350|FG001|COMPLETED|3rd Crossover - Week 10 to Week 16||18
10251937|NCT02325466|11383351|FG002|COMPLETED|3rd Crossover - Week 10 to Week 16||21
10251938|NCT02325466|11383349|FG000|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||1
10251939|NCT02325466|11383350|FG001|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||2
10251940|NCT02325466|11383351|FG002|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||0
10251941|NCT02322710|11383362|FG000|STARTED|Overall Study||105
10251942|NCT02322710|11383363|FG001|STARTED|Overall Study||99
10251943|NCT02322710|11383362|FG000|Safety Population|Overall Study||105
10251944|NCT02322710|11383363|FG001|Safety Population|Overall Study||99
10251945|NCT02322710|11383362|FG000|Full Analysis Population|Overall Study||105
10251946|NCT02322710|11383363|FG001|Full Analysis Population|Overall Study||98
10251947|NCT02322710|11383362|FG000|COMPLETED|Overall Study||85
10251948|NCT02322710|11383363|FG001|COMPLETED|Overall Study||73
10251949|NCT02322710|11383362|FG000|NOT COMPLETED|Overall Study||20
10251950|NCT02322710|11383363|FG001|NOT COMPLETED|Overall Study||26
10251951|NCT02303548|11383371|FG000|STARTED|Overall Study||25
10251952|NCT02303548|11383372|FG001|STARTED|Overall Study||25
10251953|NCT02303548|11383371|FG000|COMPLETED|Overall Study||25
10251954|NCT02303548|11383372|FG001|COMPLETED|Overall Study||25
10251955|NCT02303548|11383371|FG000|NOT COMPLETED|Overall Study||0
10251956|NCT02303548|11383372|FG001|NOT COMPLETED|Overall Study||0
10251957|NCT02292654|11383381|FG000|STARTED|Overall Study||4
10251958|NCT02292654|11383382|FG001|STARTED|Overall Study||9
10251959|NCT02292654|11383383|FG002|STARTED|Overall Study||7
10251960|NCT02292654|11383381|FG000|COMPLETED|Overall Study||4
10251961|NCT02292654|11383382|FG001|COMPLETED|Overall Study||9
10251962|NCT02292654|11383383|FG002|COMPLETED|Overall Study||7
10251963|NCT02292654|11383381|FG000|NOT COMPLETED|Overall Study||0
10251964|NCT02292654|11383382|FG001|NOT COMPLETED|Overall Study||0
10251965|NCT02292654|11383383|FG002|NOT COMPLETED|Overall Study||0
10251966|NCT02251548|11383397|FG000|STARTED|Overall Study||85
10251967|NCT02251548|11383397|FG000|COMPLETED|Overall Study||0
10251968|NCT02251548|11383397|FG000|NOT COMPLETED|Overall Study||85
10251969|NCT02239354|11383404|FG000|STARTED|Overall Study||19
10251970|NCT02239354|11383405|FG001|STARTED|Overall Study||0
10251971|NCT02239354|11383404|FG000|COMPLETED|Overall Study||9
10251972|NCT02239354|11383405|FG001|COMPLETED|Overall Study||0
10251973|NCT02239354|11383404|FG000|NOT COMPLETED|Overall Study||10
10251974|NCT02239354|11383405|FG001|NOT COMPLETED|Overall Study||0
10251975|NCT02234310|11383411|FG000|STARTED|Overall Study||33
10251976|NCT02234310|11383411|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
10251977|NCT02234310|11383411|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
10251978|NCT02234310|11383411|FG000|COMPLETED|Overall Study||27
10251979|NCT02234310|11383411|FG000|NOT COMPLETED|Overall Study||6
10251980|NCT02212015|11383415|FG000|STARTED|Overall Study||26
10251981|NCT02212015|11383415|FG000|COMPLETED|Overall Study||25
10251982|NCT02212015|11383415|FG000|NOT COMPLETED|Overall Study||1
10251983|NCT02158091|11383425|FG000|STARTED|Overall Study||6
10251984|NCT02158091|11383426|FG001|STARTED|Overall Study||6
10251985|NCT02158091|11383427|FG002|STARTED|Overall Study||20
10251986|NCT02158091|11383425|FG000|COMPLETED|Overall Study||4
10251987|NCT02158091|11383426|FG001|COMPLETED|Overall Study||5
10251988|NCT02158091|11383427|FG002|COMPLETED|Overall Study||20
10251989|NCT02158091|11383425|FG000|NOT COMPLETED|Overall Study||2
10251990|NCT02158091|11383426|FG001|NOT COMPLETED|Overall Study||1
9833830|NCT00782418|10944826|FG002|STARTED|Period 1 Procedure/Treatment Groups||4
9833831|NCT00782418|10944827|FG003|STARTED|Period 1 Procedure/Treatment Groups||2
9833832|NCT00782418|10944828|FG004|STARTED|Period 1 Procedure/Treatment Groups||5
9833833|NCT00782418|10944829|FG005|STARTED|Period 1 Procedure/Treatment Groups||5
9833834|NCT00782418|10944830|FG006|STARTED|Period 1 Procedure/Treatment Groups||4
9833835|NCT00782418|10944824|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1
9833836|NCT00782418|10944825|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4
9833837|NCT00782418|10944826|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4
9833838|NCT00782418|10944827|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2
9833839|NCT00782418|10944828|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4
9833840|NCT00782418|10944829|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4
9833841|NCT00782418|10944830|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4
9833842|NCT00782418|10944824|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
9833843|NCT00782418|10944825|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
9833844|NCT00782418|10944826|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
9833845|NCT00782418|10944827|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
9833846|NCT00782418|10944828|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
9833847|NCT00782418|10944829|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
9833848|NCT00782418|10944830|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
9833849|NCT00782418|10944824|FG000|STARTED|Period 2 Procedure/Treatment Groups||3
9833850|NCT00782418|10944825|FG001|STARTED|Period 2 Procedure/Treatment Groups||4
9833851|NCT00782418|10944826|FG002|STARTED|Period 2 Procedure/Treatment Groups||4
9833852|NCT00782418|10944827|FG003|STARTED|Period 2 Procedure/Treatment Groups||1
9833853|NCT00782418|10944828|FG004|STARTED|Period 2 Procedure/Treatment Groups||3
9833854|NCT00782418|10944829|FG005|STARTED|Period 2 Procedure/Treatment Groups||4
9833855|NCT00782418|10944830|FG006|STARTED|Period 2 Procedure/Treatment Groups||4
9833856|NCT00782418|10944824|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3
9833857|NCT00782418|10944825|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4
9833858|NCT00782418|10944826|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4
9833859|NCT00782418|10944827|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1
9833860|NCT00782418|10944828|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3
9833861|NCT00782418|10944829|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4
9833862|NCT00782418|10944830|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4
9957496|NCT01451411|11076744|FG000|STARTED|Overall Study||3
9957497|NCT01451411|11076745|FG001|STARTED|Overall Study||1
10020180|NCT01834261|11143469|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
10020181|NCT01834261|11143470|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
10020182|NCT01834274|11143478|FG000|STARTED|Overall Study||50
10020183|NCT01834274|11143479|FG001|STARTED|Overall Study||46
10020184|NCT01834274|11143478|FG000|COMPLETED|Overall Study||3
10020185|NCT01834274|11143479|FG001|COMPLETED|Overall Study||5
10020186|NCT01834274|11143478|FG000|NOT COMPLETED|Overall Study||47
10020187|NCT01834274|11143479|FG001|NOT COMPLETED|Overall Study||41
10251991|NCT02158091|11383427|FG002|NOT COMPLETED|Overall Study||0
10020188|NCT01834326|11143487|FG000|STARTED|Overall Study||10
10020189|NCT01834326|11143488|FG001|STARTED|Overall Study||8
10020190|NCT01834326|11143487|FG000|COMPLETED|Overall Study||8
10251992|NCT02139436|11383438|FG000|STARTED|Overall Study||41
10251993|NCT02139436|11383439|FG001|STARTED|Overall Study||14
10251994|NCT02139436|11383440|FG002|STARTED|Overall Study||13
10251995|NCT02139436|11383438|FG000|COMPLETED|Overall Study||41
10251996|NCT02139436|11383439|FG001|COMPLETED|Overall Study||14
10251997|NCT02139436|11383440|FG002|COMPLETED|Overall Study||13
10251998|NCT02139436|11383438|FG000|NOT COMPLETED|Overall Study||0
10251999|NCT02139436|11383439|FG001|NOT COMPLETED|Overall Study||0
10252000|NCT02139436|11383440|FG002|NOT COMPLETED|Overall Study||0
10252001|NCT02120079|11383456|FG000|STARTED|Baseline||17
10252002|NCT02120079|11383457|FG001|STARTED|Baseline||20
10252003|NCT02120079|11383456|FG000|COMPLETED|Baseline||17
10252004|NCT02120079|11383457|FG001|COMPLETED|Baseline||20
10252005|NCT02120079|11383456|FG000|NOT COMPLETED|Baseline||0
10252006|NCT02120079|11383457|FG001|NOT COMPLETED|Baseline||0
10252007|NCT02120079|11383456|FG000|STARTED|2 Weeks||17
10252008|NCT02120079|11383457|FG001|STARTED|2 Weeks||20
10252009|NCT02120079|11383456|FG000|COMPLETED|2 Weeks||17
10252010|NCT02120079|11383457|FG001|COMPLETED|2 Weeks||20
10252011|NCT02120079|11383456|FG000|NOT COMPLETED|2 Weeks||0
10252012|NCT02120079|11383457|FG001|NOT COMPLETED|2 Weeks||0
10252013|NCT02120079|11383456|FG000|STARTED|6 Weeks||17
10252014|NCT02120079|11383457|FG001|STARTED|6 Weeks||20
10252015|NCT02120079|11383456|FG000|COMPLETED|6 Weeks||17
10252016|NCT02120079|11383457|FG001|COMPLETED|6 Weeks||20
10252017|NCT02120079|11383456|FG000|NOT COMPLETED|6 Weeks||0
10252018|NCT02120079|11383457|FG001|NOT COMPLETED|6 Weeks||0
10252019|NCT02106195|11383464|FG000|STARTED|Overall Study||8
10252020|NCT02106195|11383464|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5
10252021|NCT02106195|11383464|FG000|NOT COMPLETED|Overall Study||3
10252022|NCT02104180|11383476|FG000|STARTED|Overall Study||31
10252023|NCT02104180|11383477|FG001|STARTED|Overall Study||31
10252024|NCT02104180|11383476|FG000|COMPLETED|Overall Study||30
10020191|NCT01834326|11143488|FG001|COMPLETED|Overall Study||2
10252025|NCT02104180|11383477|FG001|COMPLETED|Overall Study||31
10252026|NCT02104180|11383476|FG000|NOT COMPLETED|Overall Study||1
10252027|NCT02104180|11383477|FG001|NOT COMPLETED|Overall Study||0
10252028|NCT02066181|11383485|FG000|STARTED|Overall Study||50
10020192|NCT01834326|11143487|FG000|NOT COMPLETED|Overall Study||2
10252029|NCT02066181|11383486|FG001|STARTED|Overall Study||37
10252030|NCT02066181|11383485|FG000|Crossed Over|Overall Study||0
10252031|NCT02066181|11383486|FG001|Crossed Over|Overall Study||28
10252032|NCT02066181|11383485|FG000|COMPLETED|Overall Study||49
10252033|NCT02066181|11383486|FG001|COMPLETED|Overall Study||36
10252034|NCT02066181|11383485|FG000|NOT COMPLETED|Overall Study||1
10252035|NCT02066181|11383486|FG001|NOT COMPLETED|Overall Study||1
10252036|NCT02050919|11383495|FG000|STARTED|Overall Study||20
10252037|NCT02050919|11383495|FG000|COMPLETED|Overall Study||20
10252038|NCT02050919|11383495|FG000|NOT COMPLETED|Overall Study||0
10252039|NCT02040857|11383499|FG000|STARTED|Overall Study||162
10020193|NCT01834326|11143488|FG001|NOT COMPLETED|Overall Study||6
10020194|NCT01834404|11143496|FG000|STARTED|Overall Study||12
10252040|NCT02040857|11383499|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
10252041|NCT02040857|11383499|FG000|COMPLETED|Overall Study||102
10252042|NCT02040857|11383499|FG000|NOT COMPLETED|Overall Study||60
10252043|NCT01997463|11383508|FG000|STARTED|Overall Study||192
10252044|NCT01997463|11383509|FG001|STARTED|Overall Study||250
10252045|NCT01997463|11383508|FG000|COMPLETED|Overall Study||107
10252046|NCT01997463|11383509|FG001|COMPLETED|Overall Study||147
10252047|NCT01997463|11383508|FG000|NOT COMPLETED|Overall Study||85
10252048|NCT01997463|11383509|FG001|NOT COMPLETED|Overall Study||103
10252049|NCT01943825|11383519|FG000|STARTED|Overall Study||25
10252050|NCT01943825|11383520|FG001|STARTED|Overall Study||15
10252051|NCT01943825|11383521|FG002|STARTED|Overall Study||25
10252052|NCT01943825|11383522|FG003|STARTED|Overall Study||25
10252053|NCT01943825|11383519|FG000|COMPLETED|Overall Study||15
10252054|NCT01943825|11383520|FG001|COMPLETED|Overall Study||11
9833863|NCT00782418|10944824|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
9833864|NCT00782418|10944825|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
9833865|NCT00782418|10944826|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
9833866|NCT00782418|10944827|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
9833867|NCT00782418|10944828|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
9833868|NCT00782418|10944829|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
9833869|NCT00782418|10944830|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
9833870|NCT00782496|10944846|FG000|STARTED|Overall Study||106
9833871|NCT00782496|10944847|FG001|STARTED|Overall Study||105
9833872|NCT00782496|10944846|FG000|COMPLETED|Overall Study||92
9833873|NCT00782496|10944847|FG001|COMPLETED|Overall Study||90
9833874|NCT00782496|10944846|FG000|NOT COMPLETED|Overall Study||14
9833875|NCT00782496|10944847|FG001|NOT COMPLETED|Overall Study||15
9833876|NCT00782509|10944857|FG000|STARTED|Overall Study||216
9833877|NCT00782509|10944858|FG001|STARTED|Overall Study||209
9833878|NCT00782509|10944859|FG002|STARTED|Overall Study||217
9833879|NCT00782509|10944857|FG000|COMPLETED|Overall Study||175
9833880|NCT00782509|10944858|FG001|COMPLETED|Overall Study||185
10252055|NCT01943825|11383521|FG002|COMPLETED|Overall Study||10
10252056|NCT01943825|11383522|FG003|COMPLETED|Overall Study||14
10252057|NCT01943825|11383519|FG000|NOT COMPLETED|Overall Study||10
10252058|NCT01943825|11383520|FG001|NOT COMPLETED|Overall Study||4
10252059|NCT01943825|11383521|FG002|NOT COMPLETED|Overall Study||15
10252060|NCT01943825|11383522|FG003|NOT COMPLETED|Overall Study||11
10252061|NCT01940471|11383538|FG000|STARTED|Double-Blind Phase||582
10252062|NCT01940471|11383539|FG001|STARTED|Double-Blind Phase||293
10252063|NCT01940471|11383538|FG000|COMPLETED|Double-Blind Phase||14
10252064|NCT01940471|11383539|FG001|COMPLETED|Double-Blind Phase||8
10252065|NCT01940471|11383538|FG000|NOT COMPLETED|Double-Blind Phase||568
9833881|NCT00782509|10944859|FG002|COMPLETED|Overall Study||181
9833882|NCT00782509|10944857|FG000|NOT COMPLETED|Overall Study||41
10020195|NCT01834404|11143497|FG001|STARTED|Overall Study||12
10020196|NCT01834404|11143496|FG000|COMPLETED|Overall Study||12
10020197|NCT01834404|11143497|FG001|COMPLETED|Overall Study||12
10020198|NCT01834404|11143496|FG000|NOT COMPLETED|Overall Study||0
10252066|NCT01940471|11383539|FG001|NOT COMPLETED|Double-Blind Phase||285
10252067|NCT01940471|11383538|FG000|STARTED|Open-Label Extension||14
10252068|NCT01940471|11383539|FG001|STARTED|Open-Label Extension||8
10252069|NCT01940471|11383538|FG000|COMPLETED|Open-Label Extension||0
10252070|NCT01940471|11383539|FG001|COMPLETED|Open-Label Extension||0
10252071|NCT01940471|11383538|FG000|NOT COMPLETED|Open-Label Extension||14
10252072|NCT01940471|11383539|FG001|NOT COMPLETED|Open-Label Extension||8
10252073|NCT01874353|11383548|FG000|STARTED|Overall Study||196
10252074|NCT01874353|11383549|FG001|STARTED|Overall Study||99
10252075|NCT01874353|11383550|FG002|STARTED|Overall Study||22
10252076|NCT01874353|11383551|FG003|STARTED|Overall Study||10
10252077|NCT01874353|11383548|FG000|COMPLETED|Overall Study||69
10252078|NCT01874353|11383549|FG001|COMPLETED|Overall Study||26
10252079|NCT01874353|11383550|FG002|COMPLETED|Overall Study||7
10252080|NCT01874353|11383551|FG003|COMPLETED|Overall Study||3
10252081|NCT01874353|11383548|FG000|NOT COMPLETED|Overall Study||127
10252082|NCT01874353|11383549|FG001|NOT COMPLETED|Overall Study||73
10252083|NCT01874353|11383550|FG002|NOT COMPLETED|Overall Study||15
10252084|NCT01874353|11383551|FG003|NOT COMPLETED|Overall Study||7
10252085|NCT01863186|11383566|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
10252086|NCT01863186|11383567|FG001|STARTED|Double-blind Phase||222
10252087|NCT01863186|11383568|FG002|STARTED|Double-blind Phase||151
10252088|NCT01863186|11383569|FG003|STARTED|Double-blind Phase||0
10252089|NCT01863186|11383566|FG000|COMPLETED|Double-blind Phase||95
10252090|NCT01863186|11383567|FG001|COMPLETED|Double-blind Phase||88
10252091|NCT01863186|11383568|FG002|COMPLETED|Double-blind Phase||42
10252092|NCT01863186|11383569|FG003|COMPLETED|Double-blind Phase||0
10252093|NCT01863186|11383566|FG000|NOT COMPLETED|Double-blind Phase||134
10252094|NCT01863186|11383567|FG001|NOT COMPLETED|Double-blind Phase||134
10252095|NCT01863186|11383568|FG002|NOT COMPLETED|Double-blind Phase||109
10252096|NCT01863186|11383569|FG003|NOT COMPLETED|Double-blind Phase||0
10252097|NCT01863186|11383566|FG000|STARTED|Open-label Phase||0
10252098|NCT01863186|11383567|FG001|STARTED|Open-label Phase||0
10252099|NCT01863186|11383568|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
10252100|NCT01863186|11383569|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
10252101|NCT01863186|11383566|FG000|COMPLETED|Open-label Phase||0
10252102|NCT01863186|11383567|FG001|COMPLETED|Open-label Phase||0
10252103|NCT01863186|11383568|FG002|COMPLETED|Open-label Phase||0
10252104|NCT01863186|11383569|FG003|COMPLETED|Open-label Phase||70
10252105|NCT01863186|11383566|FG000|NOT COMPLETED|Open-label Phase||0
10252106|NCT01863186|11383567|FG001|NOT COMPLETED|Open-label Phase||0
10252107|NCT01863186|11383568|FG002|NOT COMPLETED|Open-label Phase||0
10252108|NCT01863186|11383569|FG003|NOT COMPLETED|Open-label Phase||13
10252109|NCT01853748|11383580|FG000|STARTED|Allocation||384
10252110|NCT01853748|11383581|FG001|STARTED|Allocation||128
10252111|NCT01853748|11383580|FG000|COMPLETED|Allocation||383
10252112|NCT01853748|11383581|FG001|COMPLETED|Allocation||114
10252113|NCT01853748|11383580|FG000|NOT COMPLETED|Allocation||1
10252114|NCT01853748|11383581|FG001|NOT COMPLETED|Allocation||14
10252115|NCT01853748|11383580|FG000|STARTED|Follow-Up||383
10252116|NCT01853748|11383581|FG001|STARTED|Follow-Up||114
10252117|NCT01853748|11383580|FG000|COMPLETED|Follow-Up||293
10252118|NCT01853748|11383581|FG001|COMPLETED|Follow-Up||97
10252119|NCT01853748|11383580|FG000|NOT COMPLETED|Follow-Up||90
10252120|NCT01853748|11383581|FG001|NOT COMPLETED|Follow-Up||17
10252121|NCT01817751|11383596|FG000|STARTED|Overall Study||47
10252122|NCT01817751|11383596|FG000|COMPLETED|Overall Study||46
10252123|NCT01817751|11383596|FG000|NOT COMPLETED|Overall Study||1
10252124|NCT01722331|11383603|FG000|STARTED|Part 1||308
10252125|NCT01722331|11383604|FG001|STARTED|Part 1||249
10252126|NCT01722331|11383605|FG002|STARTED|Part 1||41
10252127|NCT01722331|11383606|FG003|STARTED|Part 1||19
10252128|NCT01722331|11383607|FG004|STARTED|Part 1||9
10252129|NCT01722331|11383608|FG005|STARTED|Part 1||72
10252130|NCT01722331|11383609|FG006|STARTED|Part 1||74
10252131|NCT01722331|11383603|FG000|COMPLETED|Part 1||298
10252132|NCT01722331|11383604|FG001|COMPLETED|Part 1||249
10252133|NCT01722331|11383605|FG002|COMPLETED|Part 1||32
10252134|NCT01722331|11383606|FG003|COMPLETED|Part 1||19
10252135|NCT01722331|11383607|FG004|COMPLETED|Part 1||0
10252136|NCT01722331|11383608|FG005|COMPLETED|Part 1||72
10252137|NCT01722331|11383609|FG006|COMPLETED|Part 1||74
10252138|NCT01722331|11383603|FG000|NOT COMPLETED|Part 1||10
10252139|NCT01722331|11383604|FG001|NOT COMPLETED|Part 1||0
10252140|NCT01722331|11383605|FG002|NOT COMPLETED|Part 1||9
10252141|NCT01722331|11383606|FG003|NOT COMPLETED|Part 1||0
10252142|NCT01722331|11383607|FG004|NOT COMPLETED|Part 1||9
10252143|NCT01722331|11383608|FG005|NOT COMPLETED|Part 1||0
10252144|NCT01722331|11383609|FG006|NOT COMPLETED|Part 1||0
10252145|NCT01722331|11383603|FG000|STARTED|Part 2||298
10252146|NCT01722331|11383604|FG001|STARTED|Part 2||249
10252147|NCT01722331|11383605|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
10252148|NCT01722331|11383606|FG003|STARTED|Part 2||19
10252149|NCT01722331|11383607|FG004|STARTED|Part 2||0
10252150|NCT01722331|11383608|FG005|STARTED|Part 2||72
10252151|NCT01722331|11383609|FG006|STARTED|Part 2||74
10020199|NCT01834404|11143497|FG001|NOT COMPLETED|Overall Study||0
10020200|NCT01834586|11143503|FG000|STARTED|Overall Study||30
10252152|NCT01722331|11383603|FG000|COMPLETED|Part 2||279
10252153|NCT01722331|11383604|FG001|COMPLETED|Part 2||249
10252154|NCT01722331|11383605|FG002|COMPLETED|Part 2||0
10252155|NCT01722331|11383606|FG003|COMPLETED|Part 2||19
10252156|NCT01722331|11383607|FG004|COMPLETED|Part 2||0
10252157|NCT01722331|11383608|FG005|COMPLETED|Part 2||62
10252158|NCT01722331|11383609|FG006|COMPLETED|Part 2||67
10252159|NCT01722331|11383603|FG000|NOT COMPLETED|Part 2||19
10252160|NCT01722331|11383604|FG001|NOT COMPLETED|Part 2||0
10252161|NCT01722331|11383605|FG002|NOT COMPLETED|Part 2||31
10252162|NCT01722331|11383606|FG003|NOT COMPLETED|Part 2||0
10252163|NCT01722331|11383607|FG004|NOT COMPLETED|Part 2||0
10252164|NCT01722331|11383608|FG005|NOT COMPLETED|Part 2||10
10252165|NCT01722331|11383609|FG006|NOT COMPLETED|Part 2||7
10252166|NCT01722331|11383603|FG000|STARTED|Part 3||279
10252167|NCT01722331|11383604|FG001|STARTED|Part 3||249
10252168|NCT01722331|11383605|FG002|STARTED|Part 3||0
10252169|NCT01722331|11383606|FG003|STARTED|Part 3||19
10252170|NCT01722331|11383607|FG004|STARTED|Part 3||0
10252171|NCT01722331|11383608|FG005|STARTED|Part 3||62
10252172|NCT01722331|11383609|FG006|STARTED|Part 3||67
10252173|NCT01722331|11383603|FG000|COMPLETED|Part 3||264
10252174|NCT01722331|11383604|FG001|COMPLETED|Part 3||232
10252175|NCT01722331|11383605|FG002|COMPLETED|Part 3||0
10252176|NCT01722331|11383606|FG003|COMPLETED|Part 3||18
10252177|NCT01722331|11383607|FG004|COMPLETED|Part 3||0
10252178|NCT01722331|11383608|FG005|COMPLETED|Part 3||59
10252179|NCT01722331|11383609|FG006|COMPLETED|Part 3||65
10252180|NCT01722331|11383603|FG000|NOT COMPLETED|Part 3||15
10252181|NCT01722331|11383604|FG001|NOT COMPLETED|Part 3||17
10252182|NCT01722331|11383605|FG002|NOT COMPLETED|Part 3||0
10252183|NCT01722331|11383606|FG003|NOT COMPLETED|Part 3||1
10252184|NCT01722331|11383607|FG004|NOT COMPLETED|Part 3||0
9833883|NCT00782509|10944858|FG001|NOT COMPLETED|Overall Study||24
9833884|NCT00782509|10944859|FG002|NOT COMPLETED|Overall Study||36
9833885|NCT00782626|10944874|FG000|STARTED|Overall Study||23
9833886|NCT00782626|10944874|FG000|COMPLETED|Overall Study||16
9833887|NCT00782626|10944874|FG000|NOT COMPLETED|Overall Study||7
9833888|NCT00782639|10944880|FG000|STARTED|Overall Study||12
9957498|NCT01451411|11076744|FG000|COMPLETED|Overall Study||3
9957499|NCT01451411|11076745|FG001|COMPLETED|Overall Study||1
9957500|NCT01451411|11076744|FG000|NOT COMPLETED|Overall Study||0
9957501|NCT01451411|11076745|FG001|NOT COMPLETED|Overall Study||0
10252185|NCT01722331|11383608|FG005|NOT COMPLETED|Part 3||3
10252186|NCT01722331|11383609|FG006|NOT COMPLETED|Part 3||2
10252187|NCT01716117|11383623|FG000|STARTED|Overall Study||180
10252188|NCT01716117|11383624|FG001|STARTED|Overall Study||33
10252189|NCT01716117|11383623|FG000|Discharge|Overall Study||177
10252190|NCT01716117|11383624|FG001|Discharge|Overall Study||33
10252191|NCT01716117|11383623|FG000|1-Month Visit|Overall Study||176
10252192|NCT01716117|11383624|FG001|1-Month Visit|Overall Study||33
10252193|NCT01716117|11383623|FG000|6-Month Visit|Overall Study||174
10252194|NCT01716117|11383624|FG001|6-Month Visit|Overall Study||32
10252195|NCT01716117|11383623|FG000|COMPLETED|Overall Study||173
10252196|NCT01716117|11383624|FG001|COMPLETED|Overall Study||31
10252197|NCT01716117|11383623|FG000|NOT COMPLETED|Overall Study||7
10252198|NCT01716117|11383624|FG001|NOT COMPLETED|Overall Study||2
10252199|NCT01698905|11383638|FG000|STARTED|Overall Study||163
10252200|NCT01698905|11383638|FG000|Still on Study Phase|Overall Study||0
10252201|NCT01698905|11383638|FG000|TFR Phase|Overall Study||126
10252202|NCT01698905|11383638|FG000|NTRI Phase|Overall Study||51
10252203|NCT01698905|11383638|FG000|NTCT Phase|Overall Study||26
10252204|NCT01698905|11383638|FG000|TFR-2 Phase|Overall Study||2
10252205|NCT01698905|11383638|FG000|NTRI-2 Phase|Overall Study||1
10252206|NCT01698905|11383638|FG000|NTCT-P Phase Phase|Overall Study||6
10252207|NCT01698905|11383638|FG000|COMPLETED|Overall Study||152
10252208|NCT01698905|11383638|FG000|NOT COMPLETED|Overall Study||11
10252209|NCT01676350|11383651|FG000|STARTED|Overall Study||11
10252210|NCT01676350|11383652|FG001|STARTED|Overall Study||11
10252211|NCT01676350|11383651|FG000|COMPLETED|Overall Study||11
10252212|NCT01676350|11383652|FG001|COMPLETED|Overall Study||11
10252213|NCT01676350|11383651|FG000|NOT COMPLETED|Overall Study||0
10252214|NCT01676350|11383652|FG001|NOT COMPLETED|Overall Study||0
10252215|NCT01630590|11383659|FG000|STARTED|Overall Study||62
10252216|NCT01630590|11383659|FG000|COMPLETED|Overall Study||5
10252217|NCT01630590|11383659|FG000|NOT COMPLETED|Overall Study||57
10252218|NCT01619085|11383663|FG000|STARTED|Overall Study||752
10252219|NCT01619085|11383663|FG000|Treated|Overall Study||751
9833889|NCT00782639|10944881|FG001|STARTED|Overall Study||11
10252220|NCT01619085|11383663|FG000|COMPLETED|Overall Study||227
10252221|NCT01619085|11383663|FG000|NOT COMPLETED|Overall Study||525
10252222|NCT01499095|11383676|FG000|STARTED|Overall Study||404
10252223|NCT01499095|11383677|FG001|STARTED|Overall Study||407
10252224|NCT01499095|11383676|FG000|Treated|Overall Study||403
10252225|NCT01499095|11383677|FG001|Treated|Overall Study||406
10252226|NCT01499095|11383676|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
10252227|NCT01499095|11383677|FG001|Participated in Substudy|Overall Study||0
10252228|NCT01499095|11383676|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
10252229|NCT01499095|11383677|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
10252230|NCT01499095|11383676|FG000|COMPLETED|Overall Study||315
10252231|NCT01499095|11383677|FG001|COMPLETED|Overall Study||314
10252232|NCT01499095|11383676|FG000|NOT COMPLETED|Overall Study||89
10252233|NCT01499095|11383677|FG001|NOT COMPLETED|Overall Study||93
10252234|NCT01499082|11383688|FG000|STARTED|Overall Study||404
10252235|NCT01499082|11383689|FG001|STARTED|Overall Study||403
10252236|NCT01499082|11383688|FG000|Treated|Overall Study||404
10252237|NCT01499082|11383689|FG001|Treated|Overall Study||402
10252238|NCT01499082|11383688|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
10252239|NCT01499082|11383689|FG001|Participated in Substudy|Overall Study||0
10252240|NCT01499082|11383688|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
10252241|NCT01499082|11383689|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
10252242|NCT01499082|11383688|FG000|COMPLETED|Overall Study||359
10020201|NCT01834586|11143503|FG000|COMPLETED|Overall Study||29
10020202|NCT01834586|11143503|FG000|NOT COMPLETED|Overall Study||1
10020203|NCT01834651|11143507|FG000|STARTED|Overall Study||17
10252243|NCT01499082|11383689|FG001|COMPLETED|Overall Study||355
10252244|NCT01499082|11383688|FG000|NOT COMPLETED|Overall Study||45
10252245|NCT01499082|11383689|FG001|NOT COMPLETED|Overall Study||48
10252246|NCT01496976|11383697|FG000|STARTED|Overall Study||45
10252247|NCT01496976|11383697|FG000|COMPLETED|Overall Study||44
10252248|NCT01496976|11383697|FG000|NOT COMPLETED|Overall Study||1
10252249|NCT01488890|11383705|FG000|STARTED|Overall Study||120
10252250|NCT01488890|11383706|FG001|STARTED|Overall Study||120
10252251|NCT01488890|11383707|FG002|STARTED|Overall Study||120
10252252|NCT01488890|11383708|FG003|STARTED|Overall Study||30
10252253|NCT01488890|11383705|FG000|Treated|Overall Study||120
10252254|NCT01488890|11383706|FG001|Treated|Overall Study||120
10252255|NCT01488890|11383707|FG002|Treated|Overall Study||119
10252256|NCT01488890|11383708|FG003|Treated|Overall Study||30
10252257|NCT01488890|11383705|FG000|COMPLETED|Overall Study||88
10252258|NCT01488890|11383706|FG001|COMPLETED|Overall Study||100
10252259|NCT01488890|11383707|FG002|COMPLETED|Overall Study||85
10252260|NCT01488890|11383708|FG003|COMPLETED|Overall Study||25
10252261|NCT01488890|11383705|FG000|NOT COMPLETED|Overall Study||32
10252262|NCT01488890|11383706|FG001|NOT COMPLETED|Overall Study||20
9833890|NCT00782639|10944880|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
9833891|NCT00782639|10944881|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
9833892|NCT00782639|10944880|FG000|NOT COMPLETED|Overall Study||0
9833893|NCT00782639|10944881|FG001|NOT COMPLETED|Overall Study||0
9833894|NCT00782717|10944891|FG000|STARTED|Overall Study||133
9833895|NCT00782717|10944892|FG001|STARTED|Overall Study||130
9833896|NCT00782717|10944891|FG000|COMPLETED|Overall Study||118
9833897|NCT00782717|10944892|FG001|COMPLETED|Overall Study||102
9833898|NCT00782717|10944891|FG000|NOT COMPLETED|Overall Study||15
9833899|NCT00782717|10944892|FG001|NOT COMPLETED|Overall Study||28
9833900|NCT00782756|10944898|FG000|STARTED|Overall Study||40
9833901|NCT00782756|10944898|FG000|COMPLETED|Overall Study||40
9833902|NCT00782756|10944898|FG000|NOT COMPLETED|Overall Study||0
9833903|NCT00782795|10944904|FG000|STARTED|Overall Study||17
9833904|NCT00782795|10944905|FG001|STARTED|Overall Study||8
9833905|NCT00782795|10944904|FG000|6 Weeks (1st Apptment)|Overall Study||16
9833906|NCT00782795|10944905|FG001|6 Weeks (1st Apptment)|Overall Study||7
9833907|NCT00782795|10944904|FG000|24 Week Appointment|Overall Study||16
9833908|NCT00782795|10944905|FG001|24 Week Appointment|Overall Study||7
9833909|NCT00782795|10944904|FG000|COMPLETED|Overall Study||16
9833910|NCT00782795|10944905|FG001|COMPLETED|Overall Study||6
9833911|NCT00782795|10944904|FG000|NOT COMPLETED|Overall Study||1
9833912|NCT00782795|10944905|FG001|NOT COMPLETED|Overall Study||2
9833913|NCT00782821|10944915|FG000|STARTED|Overall Study||10
9833914|NCT00782821|10944916|FG001|STARTED|Overall Study||10
9833915|NCT00782821|10944917|FG002|STARTED|Overall Study||10
9833916|NCT00782821|10944918|FG003|STARTED|Overall Study||10
9833917|NCT00782821|10944915|FG000|COMPLETED|Overall Study||10
9833918|NCT00782821|10944916|FG001|COMPLETED|Overall Study||10
9833919|NCT00782821|10944917|FG002|COMPLETED|Overall Study||9
9833920|NCT00782821|10944918|FG003|COMPLETED|Overall Study||8
9833921|NCT00782821|10944915|FG000|NOT COMPLETED|Overall Study||0
9833922|NCT00782821|10944916|FG001|NOT COMPLETED|Overall Study||0
9833923|NCT00782821|10944917|FG002|NOT COMPLETED|Overall Study||1
9833924|NCT00782821|10944918|FG003|NOT COMPLETED|Overall Study||2
9833925|NCT00782834|10944935|FG000|STARTED|Screened Patients||15
9833926|NCT00782834|10944935|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
9833927|NCT00782834|10944935|FG000|NOT COMPLETED|Screened Patients||1
9833928|NCT00782834|10944935|FG000|STARTED|Treatment Phase||14
9833929|NCT00782834|10944935|FG000|COMPLETED|Treatment Phase||13
9833930|NCT00782834|10944935|FG000|NOT COMPLETED|Treatment Phase||1
9833931|NCT00783094|10944942|FG000|STARTED|Randomized Double-Blind Treatment Period||142
9833932|NCT00783094|10944943|FG001|STARTED|Randomized Double-Blind Treatment Period||140
9833933|NCT00783094|10944944|FG002|STARTED|Randomized Double-Blind Treatment Period||140
9833934|NCT00783094|10944942|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135
9833935|NCT00783094|10944943|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128
9833936|NCT00783094|10944944|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131
10081098|NCT02257684|11209557|FG000|NOT COMPLETED|Overall Study||4
10252263|NCT01488890|11383707|FG002|NOT COMPLETED|Overall Study||35
10252264|NCT01488890|11383708|FG003|NOT COMPLETED|Overall Study||5
10252265|NCT01436396|11383724|FG000|STARTED|Overall Study||396
10252266|NCT01436396|11383725|FG001|STARTED|Overall Study||396
10252267|NCT01436396|11383724|FG000|Vaccinated|Overall Study||394
10252268|NCT01436396|11383725|FG001|Vaccinated|Overall Study||393
10252269|NCT01436396|11383724|FG000|COMPLETED|Overall Study||364
10252270|NCT01436396|11383725|FG001|COMPLETED|Overall Study||354
10252271|NCT01436396|11383724|FG000|NOT COMPLETED|Overall Study||32
10252272|NCT01436396|11383725|FG001|NOT COMPLETED|Overall Study||42
10252273|NCT01411241|11383733|FG000|STARTED|Overall Study||309
10252274|NCT01411241|11383734|FG001|STARTED|Overall Study||315
10252275|NCT01411241|11383733|FG000|COMPLETED|Overall Study||298
10252276|NCT01411241|11383734|FG001|COMPLETED|Overall Study||293
10252277|NCT01411241|11383733|FG000|NOT COMPLETED|Overall Study||11
10252278|NCT01411241|11383734|FG001|NOT COMPLETED|Overall Study||22
10252279|NCT01374516|11383742|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920
10252280|NCT01374516|11383743|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949
10252281|NCT01374516|11383742|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
10252282|NCT01374516|11383743|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
10252283|NCT01374516|11383742|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
10252284|NCT01374516|11383743|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
10252285|NCT01374516|11383742|FG000|STARTED|Surveillance Expansion Period||13281
10252286|NCT01374516|11383743|FG001|STARTED|Surveillance Expansion Period||6640
10252287|NCT01374516|11383742|FG000|COMPLETED|Surveillance Expansion Period||10932
10252288|NCT01374516|11383743|FG001|COMPLETED|Surveillance Expansion Period||5387
10252289|NCT01374516|11383742|FG000|NOT COMPLETED|Surveillance Expansion Period||2349
10252290|NCT01374516|11383743|FG001|NOT COMPLETED|Surveillance Expansion Period||1253
10252291|NCT01373281|11383758|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851
10252292|NCT01373281|11383759|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424
10252293|NCT01373281|11383758|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
10252294|NCT01373281|11383759|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
10252295|NCT01373281|11383758|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
10252296|NCT01373281|11383759|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
10252297|NCT01373281|11383758|FG000|STARTED|Surveillance Expansion Period||6797
10252298|NCT01373281|11383759|FG001|STARTED|Surveillance Expansion Period||3397
10252299|NCT01373281|11383758|FG000|COMPLETED|Surveillance Expansion Period||6595
10252300|NCT01373281|11383759|FG001|COMPLETED|Surveillance Expansion Period||3279
10252301|NCT01373281|11383758|FG000|NOT COMPLETED|Surveillance Expansion Period||202
10252302|NCT01373281|11383759|FG001|NOT COMPLETED|Surveillance Expansion Period||118
10252303|NCT01302847|11383780|FG000|STARTED|Overall Study||23
10252304|NCT01302847|11383781|FG001|STARTED|Overall Study||23
10252305|NCT01302847|11383782|FG002|STARTED|Overall Study||17
10252306|NCT01302847|11383783|FG003|STARTED|Overall Study||15
10252307|NCT01302847|11383784|FG004|STARTED|Overall Study||7
10252308|NCT01302847|11383785|FG005|STARTED|Overall Study||36
10252309|NCT01302847|11383786|FG006|STARTED|Overall Study||35
10252310|NCT01302847|11383787|FG007|STARTED|Overall Study||25
10252311|NCT01302847|11383780|FG000|COMPLETED|Overall Study||10
10252312|NCT01302847|11383781|FG001|COMPLETED|Overall Study||16
10252313|NCT01302847|11383782|FG002|COMPLETED|Overall Study||15
10252314|NCT01302847|11383783|FG003|COMPLETED|Overall Study||14
10252315|NCT01302847|11383784|FG004|COMPLETED|Overall Study||5
10252316|NCT01302847|11383785|FG005|COMPLETED|Overall Study||6
10252317|NCT01302847|11383786|FG006|COMPLETED|Overall Study||9
10252318|NCT01302847|11383787|FG007|COMPLETED|Overall Study||3
10252319|NCT01302847|11383780|FG000|NOT COMPLETED|Overall Study||13
10252320|NCT01302847|11383781|FG001|NOT COMPLETED|Overall Study||7
10252321|NCT01302847|11383782|FG002|NOT COMPLETED|Overall Study||2
10252322|NCT01302847|11383783|FG003|NOT COMPLETED|Overall Study||1
10252323|NCT01302847|11383784|FG004|NOT COMPLETED|Overall Study||2
10252324|NCT01302847|11383785|FG005|NOT COMPLETED|Overall Study||30
10252325|NCT01302847|11383786|FG006|NOT COMPLETED|Overall Study||26
10252326|NCT01302847|11383787|FG007|NOT COMPLETED|Overall Study||22
10252327|NCT01287611|11383816|FG000|STARTED|Overall Study||84
10252328|NCT01287611|11383817|FG001|STARTED|Overall Study||84
10252329|NCT01287611|11383816|FG000|The Number of Patients Who Underwent C/S|Overall Study||84
10252330|NCT01287611|11383817|FG001|The Number of Patients Who Underwent C/S|Overall Study||84
10252331|NCT01287611|11383816|FG000|COMPLETED|Overall Study||51
10252332|NCT01287611|11383817|FG001|COMPLETED|Overall Study||65
10252333|NCT01287611|11383816|FG000|NOT COMPLETED|Overall Study||33
10252334|NCT01287611|11383817|FG001|NOT COMPLETED|Overall Study||19
10252335|NCT01254422|11383827|FG000|STARTED|Overall Study||199
10252336|NCT01254422|11383828|FG001|STARTED|Overall Study||51
10252337|NCT01254422|11383827|FG000|COMPLETED|Overall Study||196
10252338|NCT01254422|11383828|FG001|COMPLETED|Overall Study||50
10252339|NCT01254422|11383827|FG000|NOT COMPLETED|Overall Study||3
10252340|NCT01254422|11383828|FG001|NOT COMPLETED|Overall Study||1
10252341|NCT01187433|11383836|FG000|STARTED|Overall Study||100
9833937|NCT00783094|10944942|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
9833938|NCT00783094|10944943|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
10252342|NCT01187433|11383837|FG001|STARTED|Overall Study||50
10252343|NCT01187433|11383836|FG000|COMPLETED|Overall Study||89
10252344|NCT01187433|11383837|FG001|COMPLETED|Overall Study||46
10252345|NCT01187433|11383836|FG000|NOT COMPLETED|Overall Study||11
10252346|NCT01187433|11383837|FG001|NOT COMPLETED|Overall Study||4
10252347|NCT01150045|11383847|FG000|STARTED|Overall Study||615
10252348|NCT01150045|11383848|FG001|STARTED|Overall Study||647
10252349|NCT01150045|11383849|FG002|STARTED|Overall Study||646
10252350|NCT01150045|11383850|FG003|STARTED|Overall Study||618
10252351|NCT01150045|11383847|FG000|COMPLETED|Overall Study||615
10252352|NCT01150045|11383848|FG001|COMPLETED|Overall Study||646
10252353|NCT01150045|11383849|FG002|COMPLETED|Overall Study||646
10252354|NCT01150045|11383850|FG003|COMPLETED|Overall Study||617
10252355|NCT01150045|11383847|FG000|NOT COMPLETED|Overall Study||0
10252356|NCT01150045|11383848|FG001|NOT COMPLETED|Overall Study||1
10252357|NCT01150045|11383849|FG002|NOT COMPLETED|Overall Study||0
10252358|NCT01150045|11383850|FG003|NOT COMPLETED|Overall Study||1
10252359|NCT01098032|11383860|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
10252360|NCT01098032|11383861|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
10252361|NCT01098032|11383860|FG000|COMPLETED|Overall Study||146
10252362|NCT01098032|11383861|FG001|COMPLETED|Overall Study||146
10252363|NCT01098032|11383860|FG000|NOT COMPLETED|Overall Study||1
10252364|NCT01098032|11383861|FG001|NOT COMPLETED|Overall Study||1
10252365|NCT01034306|11383869|FG000|STARTED|Overall Study||42
10252366|NCT01034306|11383870|FG001|STARTED|Overall Study||37
10252367|NCT01034306|11383869|FG000|COMPLETED|Overall Study||37
10252368|NCT01034306|11383870|FG001|COMPLETED|Overall Study||34
10252369|NCT01034306|11383869|FG000|NOT COMPLETED|Overall Study||5
10252370|NCT01034306|11383870|FG001|NOT COMPLETED|Overall Study||3
10252371|NCT01005745|11383876|FG000|STARTED|Overall Study||19
10252372|NCT01005745|11383876|FG000|COMPLETED|Overall Study||13
10252373|NCT01005745|11383876|FG000|NOT COMPLETED|Overall Study||6
10252374|NCT00993447|11383882|FG000|STARTED|Overall Study||401
10252375|NCT00993447|11383883|FG001|STARTED|Overall Study||199
10252376|NCT00993447|11383882|FG000|COMPLETED|Overall Study||364
10252377|NCT00993447|11383883|FG001|COMPLETED|Overall Study||180
10252378|NCT00993447|11383882|FG000|NOT COMPLETED|Overall Study||37
10252379|NCT00993447|11383883|FG001|NOT COMPLETED|Overall Study||19
10252380|NCT00945009|11383892|FG000|STARTED|Overall Study||201
10252381|NCT00945009|11383893|FG001|STARTED|Overall Study||39
10252382|NCT00945009|11383894|FG002|STARTED|Overall Study||9
10252383|NCT00945009|11383892|FG000|COMPLETED|Overall Study||156
10252384|NCT00945009|11383893|FG001|COMPLETED|Overall Study||32
10252385|NCT00945009|11383894|FG002|COMPLETED|Overall Study||6
10252386|NCT00945009|11383892|FG000|NOT COMPLETED|Overall Study||45
10252387|NCT00945009|11383893|FG001|NOT COMPLETED|Overall Study||7
10252388|NCT00945009|11383894|FG002|NOT COMPLETED|Overall Study||3
10252389|NCT00942877|11383904|FG000|STARTED|Overall Study||46
10252390|NCT00942877|11383905|FG001|STARTED|Overall Study||7
10252391|NCT00942877|11383904|FG000|COMPLETED|Overall Study||1
10252392|NCT00942877|11383905|FG001|COMPLETED|Overall Study||3
10252393|NCT00942877|11383904|FG000|NOT COMPLETED|Overall Study||45
10252394|NCT00942877|11383905|FG001|NOT COMPLETED|Overall Study||4
10252395|NCT00896389|11383912|FG000|STARTED|Salt Loading||124
10252396|NCT00896389|11383912|FG000|COMPLETED|Salt Loading||124
10252397|NCT00896389|11383912|FG000|NOT COMPLETED|Salt Loading||0
10252398|NCT00896389|11383912|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
10252399|NCT00896389|11383912|FG000|COMPLETED|HCTZ Low Dose||28
10252400|NCT00896389|11383912|FG000|NOT COMPLETED|HCTZ Low Dose||0
10252401|NCT00896389|11383912|FG000|STARTED|HCTZ High Dose||25
10252402|NCT00896389|11383912|FG000|COMPLETED|HCTZ High Dose||25
10252403|NCT00896389|11383912|FG000|NOT COMPLETED|HCTZ High Dose||0
10252404|NCT00880893|11383920|FG000|STARTED|Overall Study||898
10252405|NCT00880893|11383921|FG001|STARTED|Overall Study||300
10252406|NCT00880893|11383920|FG000|COMPLETED|Overall Study||791
10020204|NCT01834651|11143507|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
10020205|NCT01834651|11143507|FG000|NOT COMPLETED|Overall Study||1
10252407|NCT00880893|11383921|FG001|COMPLETED|Overall Study||255
10252408|NCT00880893|11383920|FG000|NOT COMPLETED|Overall Study||107
10252409|NCT00880893|11383921|FG001|NOT COMPLETED|Overall Study||45
10252410|NCT00866918|11383929|FG000|STARTED|Overall Study||69
10252411|NCT00866918|11383930|FG001|STARTED|Overall Study||39
10252412|NCT00866918|11383929|FG000|COMPLETED|Overall Study||53
10252413|NCT00866918|11383930|FG001|COMPLETED|Overall Study||27
10252414|NCT00866918|11383929|FG000|NOT COMPLETED|Overall Study||16
10252415|NCT00866918|11383930|FG001|NOT COMPLETED|Overall Study||12
10252422|NCT00587301|11383945|FG000|STARTED|Overall Study||119
10252423|NCT00587301|11383945|FG000|COMPLETED|Overall Study||74
10252424|NCT00587301|11383945|FG000|NOT COMPLETED|Overall Study||45
10252425|NCT00579527|11383949|FG000|STARTED|Overall Study||14
10252426|NCT00579527|11383949|FG000|COMPLETED|Overall Study||10
10252427|NCT00579527|11383949|FG000|NOT COMPLETED|Overall Study||4
10252428|NCT00576836|11383954|FG000|STARTED|Overall Study||0
10252429|NCT00576836|11383955|FG001|STARTED|Overall Study||7
10252430|NCT00576836|11383954|FG000|COMPLETED|Overall Study||0
10252431|NCT00576836|11383955|FG001|COMPLETED|Overall Study||5
10252432|NCT00576836|11383954|FG000|NOT COMPLETED|Overall Study||0
10252433|NCT00576836|11383955|FG001|NOT COMPLETED|Overall Study||2
10252434|NCT00576407|11383959|FG000|STARTED|Overall Study||26
10252435|NCT00576407|11383959|FG000|COMPLETED|Overall Study||18
10252436|NCT00576407|11383959|FG000|NOT COMPLETED|Overall Study||8
10252437|NCT00557193|11383964|FG000|STARTED|Induction||218
10252438|NCT00557193|11383965|FG001|STARTED|Induction||0
10252439|NCT00557193|11383966|FG002|STARTED|Induction||0
10252440|NCT00557193|11383967|FG003|STARTED|Induction||0
10252441|NCT00557193|11383968|FG004|STARTED|Induction||0
10252442|NCT00557193|11383969|FG005|STARTED|Induction||0
10252443|NCT00557193|11383964|FG000|COMPLETED|Induction||192
10252444|NCT00557193|11383965|FG001|COMPLETED|Induction||0
10252445|NCT00557193|11383966|FG002|COMPLETED|Induction||0
10252446|NCT00557193|11383967|FG003|COMPLETED|Induction||0
10252447|NCT00557193|11383968|FG004|COMPLETED|Induction||0
10252448|NCT00557193|11383969|FG005|COMPLETED|Induction||0
10252449|NCT00557193|11383964|FG000|NOT COMPLETED|Induction||26
10252450|NCT00557193|11383965|FG001|NOT COMPLETED|Induction||0
10252451|NCT00557193|11383966|FG002|NOT COMPLETED|Induction||0
10252452|NCT00557193|11383967|FG003|NOT COMPLETED|Induction||0
10252453|NCT00557193|11383968|FG004|NOT COMPLETED|Induction||0
10252454|NCT00557193|11383969|FG005|NOT COMPLETED|Induction||0
10252455|NCT00557193|11383964|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
10252456|NCT00557193|11383965|FG001|STARTED|Post Induction Therapy by Tx Assignment||60
10252457|NCT00557193|11383966|FG002|STARTED|Post Induction Therapy by Tx Assignment||54
10252458|NCT00557193|11383967|FG003|STARTED|Post Induction Therapy by Tx Assignment||11
10252459|NCT00557193|11383968|FG004|STARTED|Post Induction Therapy by Tx Assignment||11
10252460|NCT00557193|11383969|FG005|STARTED|Post Induction Therapy by Tx Assignment||56
10252461|NCT00557193|11383964|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
10252462|NCT00557193|11383965|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50
10252463|NCT00557193|11383966|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22
10252464|NCT00557193|11383967|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4
10252465|NCT00557193|11383968|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4
10252466|NCT00557193|11383969|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19
10252467|NCT00557193|11383964|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10252468|NCT00557193|11383965|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
10252469|NCT00557193|11383966|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
10252470|NCT00557193|11383967|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
10252471|NCT00557193|11383968|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
10252472|NCT00557193|11383969|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
10252473|NCT00547339|11383998|FG000|STARTED|Overall Study||15
10252474|NCT00547339|11383999|FG001|STARTED|Overall Study||15
10252475|NCT00547339|11384000|FG002|STARTED|Overall Study||15
10252476|NCT00547339|11384001|FG003|STARTED|Overall Study||47
10252477|NCT00547339|11383998|FG000|COMPLETED|Overall Study||15
10252478|NCT00547339|11383999|FG001|COMPLETED|Overall Study||15
10252479|NCT00547339|11384000|FG002|COMPLETED|Overall Study||14
10252480|NCT00547339|11384001|FG003|COMPLETED|Overall Study||47
10252481|NCT00547339|11383998|FG000|NOT COMPLETED|Overall Study||0
10252482|NCT00547339|11383999|FG001|NOT COMPLETED|Overall Study||0
10252483|NCT00547339|11384000|FG002|NOT COMPLETED|Overall Study||1
10252484|NCT00547339|11384001|FG003|NOT COMPLETED|Overall Study||0
10252485|NCT00531232|11384023|FG000|STARTED|Overall Study||4
10020206|NCT01834716|11143515|FG000|STARTED|Overall Study||4
10020207|NCT01834716|11143516|FG001|STARTED|Overall Study||12
10252486|NCT00531232|11384024|FG001|STARTED|Overall Study||9
10252487|NCT00531232|11384025|FG002|STARTED|Overall Study||25
10252488|NCT00531232|11384023|FG000|Treated|Overall Study||4
10252489|NCT00531232|11384024|FG001|Treated|Overall Study||8
10252490|NCT00531232|11384025|FG002|Treated|Overall Study||24
10252491|NCT00531232|11384023|FG000|COMPLETED|Overall Study||0
10252492|NCT00531232|11384024|FG001|COMPLETED|Overall Study||0
10252493|NCT00531232|11384025|FG002|COMPLETED|Overall Study||0
10252494|NCT00531232|11384023|FG000|NOT COMPLETED|Overall Study||4
10252495|NCT00531232|11384024|FG001|NOT COMPLETED|Overall Study||9
10252496|NCT00531232|11384025|FG002|NOT COMPLETED|Overall Study||25
10252497|NCT00379340|11384041|FG000|STARTED|Overall Study||120
10252498|NCT00379340|11384042|FG001|STARTED|Overall Study||135
10252499|NCT00379340|11384043|FG002|STARTED|Overall Study||52
10252500|NCT00379340|11384044|FG003|STARTED|Overall Study||50
10252501|NCT00379340|11384045|FG004|STARTED|Overall Study||23
10252502|NCT00379340|11384041|FG000|COMPLETED|Overall Study||107
10252503|NCT00379340|11384042|FG001|COMPLETED|Overall Study||132
10020208|NCT01834716|11143515|FG000|COMPLETED|Overall Study||4
10252504|NCT00379340|11384043|FG002|COMPLETED|Overall Study||50
10252505|NCT00379340|11384044|FG003|COMPLETED|Overall Study||37
10252506|NCT00379340|11384045|FG004|COMPLETED|Overall Study||9
10252507|NCT00379340|11384041|FG000|NOT COMPLETED|Overall Study||13
10252508|NCT00379340|11384042|FG001|NOT COMPLETED|Overall Study||3
10252509|NCT00379340|11384043|FG002|NOT COMPLETED|Overall Study||2
10252510|NCT00379340|11384044|FG003|NOT COMPLETED|Overall Study||13
10252511|NCT00379340|11384045|FG004|NOT COMPLETED|Overall Study||14
10252512|NCT00304070|11384061|FG000|STARTED|Overall Study||24
10252513|NCT00304070|11384062|FG001|STARTED|Overall Study||15
10020209|NCT01834716|11143516|FG001|COMPLETED|Overall Study||11
10252514|NCT00304070|11384063|FG002|STARTED|Overall Study||39
10252515|NCT00304070|11384061|FG000|COMPLETED|Overall Study||21
10020210|NCT01834716|11143515|FG000|NOT COMPLETED|Overall Study||0
10020211|NCT01834716|11143516|FG001|NOT COMPLETED|Overall Study||1
10252516|NCT00304070|11384062|FG001|COMPLETED|Overall Study||8
10252517|NCT00304070|11384063|FG002|COMPLETED|Overall Study||27
10252518|NCT00304070|11384061|FG000|NOT COMPLETED|Overall Study||3
10252519|NCT00304070|11384062|FG001|NOT COMPLETED|Overall Study||7
10252520|NCT00304070|11384063|FG002|NOT COMPLETED|Overall Study||12
10252521|NCT00001322|11384075|FG000|STARTED|Phase 1 - Lupron Only||92
10252522|NCT00001322|11384076|FG001|STARTED|Phase 1 - Lupron Only||0
10252523|NCT00001322|11384077|FG002|STARTED|Phase 1 - Lupron Only||0
10252524|NCT00001322|11384075|FG000|COMPLETED|Phase 1 - Lupron Only||92
10252525|NCT00001322|11384076|FG001|COMPLETED|Phase 1 - Lupron Only||0
10252526|NCT00001322|11384077|FG002|COMPLETED|Phase 1 - Lupron Only||0
10252527|NCT00001322|11384075|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0
10252528|NCT00001322|11384076|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0
10252529|NCT00001322|11384077|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0
10252530|NCT00001322|11384075|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0
10252531|NCT00001322|11384076|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42
10252532|NCT00001322|11384077|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40
10252533|NCT00001322|11384075|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10252534|NCT00001322|11384076|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42
10252535|NCT00001322|11384077|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40
10252536|NCT00001322|11384075|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10252537|NCT00001322|11384076|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10252538|NCT00001322|11384077|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10252539|NCT00001322|11384075|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0
10252540|NCT00001322|11384076|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42
10252541|NCT00001322|11384077|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40
10252542|NCT00001322|11384075|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10252543|NCT00001322|11384076|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42
10252544|NCT00001322|11384077|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40
10252545|NCT00001322|11384075|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10252546|NCT00001322|11384076|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10252547|NCT00001322|11384077|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10252548|NCT01701583|11384087|FG000|STARTED|Overall Study||7
10252549|NCT01701583|11384088|FG001|STARTED|Overall Study||3
10252550|NCT01701583|11384087|FG000|COMPLETED|Overall Study||5
10252551|NCT01701583|11384088|FG001|COMPLETED|Overall Study||3
10252552|NCT01701583|11384087|FG000|NOT COMPLETED|Overall Study||2
10252553|NCT01701583|11384088|FG001|NOT COMPLETED|Overall Study||0
10252554|NCT01714817|11384097|FG000|STARTED|Year 1 Period||203
10252555|NCT01714817|11384098|FG001|STARTED|Year 1 Period||203
10252556|NCT01714817|11384097|FG000|Treated|Year 1 Period||202
10252557|NCT01714817|11384098|FG001|Treated|Year 1 Period||203
10252558|NCT01714817|11384097|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
10252559|NCT01714817|11384098|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
10252560|NCT01714817|11384097|FG000|NOT COMPLETED|Year 1 Period||48
10252561|NCT01714817|11384098|FG001|NOT COMPLETED|Year 1 Period||42
10252562|NCT01714817|11384097|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155
10252563|NCT01714817|11384098|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161
10252564|NCT01714817|11384097|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
10252565|NCT01714817|11384098|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
10252566|NCT01714817|11384097|FG000|NOT COMPLETED|Year 2 Period||26
10252567|NCT01714817|11384098|FG001|NOT COMPLETED|Year 2 Period||38
10252568|NCT01714817|11384097|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
10252569|NCT01714817|11384098|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
10252570|NCT01714817|11384097|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
10252571|NCT01714817|11384098|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
10252572|NCT01714817|11384097|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67
10252573|NCT01714817|11384098|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70
10252574|NCT01755689|11384111|FG000|STARTED|Overall Study||259
10252575|NCT01755689|11384112|FG001|STARTED|Overall Study||259
10252576|NCT01755689|11384113|FG002|STARTED|Overall Study||261
10252577|NCT01755689|11384114|FG003|STARTED|Overall Study||260
10252578|NCT01755689|11384115|FG004|STARTED|Overall Study||261
10252579|NCT01755689|11384111|FG000|COMPLETED|Overall Study||256
10252580|NCT01755689|11384112|FG001|COMPLETED|Overall Study||254
10252581|NCT01755689|11384113|FG002|COMPLETED|Overall Study||255
10252582|NCT01755689|11384114|FG003|COMPLETED|Overall Study||254
10252583|NCT01755689|11384115|FG004|COMPLETED|Overall Study||255
10252584|NCT01755689|11384111|FG000|NOT COMPLETED|Overall Study||3
10252585|NCT01755689|11384112|FG001|NOT COMPLETED|Overall Study||5
10252586|NCT01755689|11384113|FG002|NOT COMPLETED|Overall Study||6
10252587|NCT01755689|11384114|FG003|NOT COMPLETED|Overall Study||6
10252588|NCT01755689|11384115|FG004|NOT COMPLETED|Overall Study||6
10252589|NCT01762761|11384137|FG000|STARTED|Overall Study||51
10252590|NCT01762761|11384138|FG001|STARTED|Overall Study||104
10252591|NCT01762761|11384137|FG000|COMPLETED|Overall Study||12
10252592|NCT01762761|11384138|FG001|COMPLETED|Overall Study||39
10252593|NCT01762761|11384137|FG000|NOT COMPLETED|Overall Study||39
10252594|NCT01762761|11384138|FG001|NOT COMPLETED|Overall Study||65
10020212|NCT01834729|11143526|FG000|STARTED|Overall Study||18
10020213|NCT01834729|11143527|FG001|STARTED|Overall Study||20
10020214|NCT01834729|11143528|FG002|STARTED|Overall Study||18
10020215|NCT01834729|11143529|FG003|STARTED|Overall Study||18
10252595|NCT01763788|11384149|FG000|STARTED|Overall Study||3
10252596|NCT01763788|11384150|FG001|STARTED|Overall Study||6
10113933|NCT02512575|11244624|FG000|NOT COMPLETED|Overall Study||0
10252597|NCT01763788|11384151|FG002|STARTED|Overall Study||91
10252598|NCT01763788|11384152|FG003|STARTED|Overall Study||92
10252599|NCT01763788|11384149|FG000|Received at Least 1dose of Study Drug|Overall Study||3
10252600|NCT01763788|11384150|FG001|Received at Least 1dose of Study Drug|Overall Study||6
10252601|NCT01763788|11384151|FG002|Received at Least 1dose of Study Drug|Overall Study||90
10252602|NCT01763788|11384152|FG003|Received at Least 1dose of Study Drug|Overall Study||91
10252603|NCT01763788|11384149|FG000|COMPLETED|Overall Study||3
10113934|NCT02512575|11244625|FG001|NOT COMPLETED|Overall Study||0
10113935|NCT02512575|11244626|FG002|NOT COMPLETED|Overall Study||0
10113936|NCT02512575|11244627|FG003|NOT COMPLETED|Overall Study||0
10113937|NCT02512575|11244628|FG004|NOT COMPLETED|Overall Study||0
10113938|NCT02512575|11244629|FG005|NOT COMPLETED|Overall Study||0
10113939|NCT02512575|11244630|FG006|NOT COMPLETED|Overall Study||0
10113940|NCT02512575|11244631|FG007|NOT COMPLETED|Overall Study||0
10113941|NCT02512575|11244632|FG008|NOT COMPLETED|Overall Study||0
10252604|NCT01763788|11384150|FG001|COMPLETED|Overall Study||6
10252605|NCT01763788|11384151|FG002|COMPLETED|Overall Study||90
9833939|NCT00783094|10944944|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
9833940|NCT00783094|10944942|FG000|STARTED|Open-Label Extension Period||135
9833941|NCT00783094|10944943|FG001|STARTED|Open-Label Extension Period||128
9833942|NCT00783094|10944944|FG002|STARTED|Open-Label Extension Period||131
9957502|NCT01451424|11076755|FG000|STARTED|Overall Study||9
9957503|NCT01451424|11076756|FG001|STARTED|Overall Study||9
9957504|NCT01451424|11076757|FG002|STARTED|Overall Study||12
9957505|NCT01451424|11076758|FG003|STARTED|Overall Study||10
9957506|NCT01451424|11076755|FG000|COMPLETED|Overall Study||8
9957507|NCT01451424|11076756|FG001|COMPLETED|Overall Study||7
9957508|NCT01451424|11076757|FG002|COMPLETED|Overall Study||11
9957509|NCT01451424|11076758|FG003|COMPLETED|Overall Study||5
9957510|NCT01451424|11076755|FG000|NOT COMPLETED|Overall Study||1
9957511|NCT01451424|11076756|FG001|NOT COMPLETED|Overall Study||2
9957512|NCT01451424|11076757|FG002|NOT COMPLETED|Overall Study||1
9957513|NCT01451424|11076758|FG003|NOT COMPLETED|Overall Study||5
9957514|NCT01451437|11076782|FG000|STARTED|Overall Study||1
9957515|NCT01451437|11076783|FG001|STARTED|Overall Study||1
9957516|NCT01451437|11076784|FG002|STARTED|Overall Study||3
9957517|NCT01451437|11076785|FG003|STARTED|Overall Study||1
9957518|NCT01451437|11076786|FG004|STARTED|Overall Study||4
9957519|NCT01451437|11076787|FG005|STARTED|Overall Study||3
9957520|NCT01451437|11076788|FG006|STARTED|Overall Study||6
10252606|NCT01763788|11384152|FG003|COMPLETED|Overall Study||92
10252607|NCT01763788|11384149|FG000|NOT COMPLETED|Overall Study||0
10252608|NCT01763788|11384150|FG001|NOT COMPLETED|Overall Study||0
10252609|NCT01763788|11384151|FG002|NOT COMPLETED|Overall Study||1
10252610|NCT01763788|11384152|FG003|NOT COMPLETED|Overall Study||0
9833943|NCT00783094|10944942|FG000|COMPLETED|Open-Label Extension Period||113
9833944|NCT00783094|10944943|FG001|COMPLETED|Open-Label Extension Period||109
9957521|NCT01451437|11076789|FG007|STARTED|Overall Study||3
9833945|NCT00783094|10944944|FG002|COMPLETED|Open-Label Extension Period||101
9957522|NCT01451437|11076790|FG008|STARTED|Overall Study||4
9957523|NCT01451437|11076782|FG000|COMPLETED|Overall Study||0
9957524|NCT01451437|11076783|FG001|COMPLETED|Overall Study||0
9957525|NCT01451437|11076784|FG002|COMPLETED|Overall Study||0
10252611|NCT01774370|11384162|FG000|STARTED|Overall Study||3182
10252612|NCT01774370|11384162|FG000|COMPLETED|Overall Study||3053
10252613|NCT01774370|11384162|FG000|NOT COMPLETED|Overall Study||129
10252614|NCT01777295|11384168|FG000|STARTED|Overall Study||40
10252615|NCT01777295|11384169|FG001|STARTED|Overall Study||41
10252616|NCT01777295|11384168|FG000|COMPLETED|Overall Study||36
10252617|NCT01777295|11384169|FG001|COMPLETED|Overall Study||38
10252618|NCT01777295|11384168|FG000|NOT COMPLETED|Overall Study||4
10252619|NCT01777295|11384169|FG001|NOT COMPLETED|Overall Study||3
10252620|NCT01787552|11384189|FG000|STARTED|Overall Study||8
10252621|NCT01787552|11384190|FG001|STARTED|Overall Study||10
10252622|NCT01787552|11384191|FG002|STARTED|Overall Study||5
10252623|NCT01787552|11384192|FG003|STARTED|Overall Study||27
10252624|NCT01787552|11384189|FG000|COMPLETED|Overall Study||0
10252625|NCT01787552|11384190|FG001|COMPLETED|Overall Study||1
10252626|NCT01787552|11384191|FG002|COMPLETED|Overall Study||0
10252627|NCT01787552|11384192|FG003|COMPLETED|Overall Study||0
10252628|NCT01787552|11384189|FG000|NOT COMPLETED|Overall Study||8
10252629|NCT01787552|11384190|FG001|NOT COMPLETED|Overall Study||9
10252630|NCT01787552|11384191|FG002|NOT COMPLETED|Overall Study||5
10252631|NCT01787552|11384192|FG003|NOT COMPLETED|Overall Study||27
10252632|NCT01807117|11384207|FG000|STARTED|Overall Study||15
10252633|NCT01807117|11384207|FG000|COMPLETED|Overall Study||12
10252634|NCT01807117|11384207|FG000|NOT COMPLETED|Overall Study||3
10252635|NCT01808261|11384215|FG000|STARTED|Overall Study||68
10252636|NCT01808261|11384216|FG001|STARTED|Overall Study||65
10252637|NCT01808261|11384215|FG000|COMPLETED|Overall Study||32
10252638|NCT01808261|11384216|FG001|COMPLETED|Overall Study||32
10252639|NCT01808261|11384215|FG000|NOT COMPLETED|Overall Study||36
10252640|NCT01808261|11384216|FG001|NOT COMPLETED|Overall Study||33
10252641|NCT01814826|11384235|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
10252642|NCT01814826|11384236|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
10252643|NCT01814826|11384237|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
10252644|NCT01814826|11384235|FG000|COMPLETED|Overall Study||0
10252645|NCT01814826|11384236|FG001|COMPLETED|Overall Study||0
10252646|NCT01814826|11384237|FG002|COMPLETED|Overall Study||0
10252647|NCT01814826|11384235|FG000|NOT COMPLETED|Overall Study||32
10252648|NCT01814826|11384236|FG001|NOT COMPLETED|Overall Study||29
10252649|NCT01814826|11384237|FG002|NOT COMPLETED|Overall Study||3
10252650|NCT01829711|11384246|FG000|STARTED|Overall Study||80
10252651|NCT01829711|11384246|FG000|COMPLETED|Overall Study||37
10252652|NCT01829711|11384246|FG000|NOT COMPLETED|Overall Study||43
9833946|NCT00783094|10944942|FG000|NOT COMPLETED|Open-Label Extension Period||22
10020216|NCT01834729|11143526|FG000|COMPLETED|Overall Study||17
10252653|NCT01846273|11384253|FG000|STARTED|Overall Study||168
10252654|NCT01846273|11384254|FG001|STARTED|Overall Study||113
9833947|NCT00783094|10944943|FG001|NOT COMPLETED|Open-Label Extension Period||19
9833948|NCT00783094|10944944|FG002|NOT COMPLETED|Open-Label Extension Period||30
9833949|NCT00783198|10944958|FG000|STARTED|Overall Study||190
9833950|NCT00783198|10944959|FG001|STARTED|Overall Study||187
9833951|NCT00783198|10944960|FG002|STARTED|Overall Study||188
9833952|NCT00783198|10944958|FG000|COMPLETED|Overall Study||133
9833953|NCT00783198|10944959|FG001|COMPLETED|Overall Study||144
9833954|NCT00783198|10944960|FG002|COMPLETED|Overall Study||146
9833955|NCT00783198|10944958|FG000|NOT COMPLETED|Overall Study||57
9833956|NCT00783198|10944959|FG001|NOT COMPLETED|Overall Study||43
9833957|NCT00783198|10944960|FG002|NOT COMPLETED|Overall Study||42
9833958|NCT00783289|10944972|FG000|STARTED|Overall Study||6
9833959|NCT00783289|10944973|FG001|STARTED|Overall Study||7
9833960|NCT00783289|10944974|FG002|STARTED|Overall Study||6
9833961|NCT00783289|10944975|FG003|STARTED|Overall Study||6
10252655|NCT01846273|11384255|FG002|STARTED|Overall Study||41
10252656|NCT01846273|11384253|FG000|Safety Analysis Set|Overall Study||172
9833962|NCT00783289|10944972|FG000|COMPLETED|Overall Study||6
9833963|NCT00783289|10944973|FG001|COMPLETED|Overall Study||6
9833964|NCT00783289|10944974|FG002|COMPLETED|Overall Study||6
9833965|NCT00783289|10944975|FG003|COMPLETED|Overall Study||6
9833966|NCT00783289|10944972|FG000|NOT COMPLETED|Overall Study||0
9833967|NCT00783289|10944973|FG001|NOT COMPLETED|Overall Study||1
9833968|NCT00783289|10944974|FG002|NOT COMPLETED|Overall Study||0
9833969|NCT00783289|10944975|FG003|NOT COMPLETED|Overall Study||0
9833970|NCT00783302|10944988|FG000|STARTED|Overall Study||885
9833971|NCT00783302|10944988|FG000|COMPLETED|Overall Study||850
9833972|NCT00783302|10944988|FG000|NOT COMPLETED|Overall Study||35
10252657|NCT01846273|11384254|FG001|Safety Analysis Set|Overall Study||135
10252658|NCT01846273|11384255|FG002|Safety Analysis Set|Overall Study||14
10252659|NCT01846273|11384253|FG000|COMPLETED|Overall Study||146
10252660|NCT01846273|11384254|FG001|COMPLETED|Overall Study||87
10252661|NCT01846273|11384255|FG002|COMPLETED|Overall Study||41
10252662|NCT01846273|11384253|FG000|NOT COMPLETED|Overall Study||22
9833973|NCT00783432|10945008|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
9957526|NCT01451437|11076785|FG003|COMPLETED|Overall Study||0
9957527|NCT01451437|11076786|FG004|COMPLETED|Overall Study||0
9957528|NCT01451437|11076787|FG005|COMPLETED|Overall Study||0
9957529|NCT01451437|11076788|FG006|COMPLETED|Overall Study||0
9957530|NCT01451437|11076789|FG007|COMPLETED|Overall Study||0
9957531|NCT01451437|11076790|FG008|COMPLETED|Overall Study||0
9957532|NCT01451437|11076782|FG000|NOT COMPLETED|Overall Study||1
9957533|NCT01451437|11076783|FG001|NOT COMPLETED|Overall Study||1
10252663|NCT01846273|11384254|FG001|NOT COMPLETED|Overall Study||26
10252664|NCT01846273|11384255|FG002|NOT COMPLETED|Overall Study||0
9833974|NCT00783432|10945009|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
9833975|NCT00783432|10945008|FG000|COMPLETED|Overall Study||345
9833976|NCT00783432|10945009|FG001|COMPLETED|Overall Study||354
9833977|NCT00783432|10945008|FG000|NOT COMPLETED|Overall Study||85
9833978|NCT00783432|10945009|FG001|NOT COMPLETED|Overall Study||78
10252665|NCT01875185|11384265|FG000|STARTED|Overall Study||52
10252666|NCT01875185|11384266|FG001|STARTED|Overall Study||48
10252667|NCT01875185|11384265|FG000|COMPLETED|Overall Study||0
10252668|NCT01875185|11384266|FG001|COMPLETED|Overall Study||0
10252669|NCT01875185|11384265|FG000|NOT COMPLETED|Overall Study||52
10252670|NCT01875185|11384266|FG001|NOT COMPLETED|Overall Study||48
10252671|NCT01887743|11384279|FG000|STARTED|Overall Study||20
10252672|NCT01887743|11384280|FG001|STARTED|Overall Study||19
10252673|NCT01887743|11384281|FG002|STARTED|Overall Study||32
10252674|NCT01887743|11384279|FG000|COMPLETED|Overall Study||19
10252675|NCT01887743|11384280|FG001|COMPLETED|Overall Study||17
10252676|NCT01887743|11384281|FG002|COMPLETED|Overall Study||29
10252677|NCT01887743|11384279|FG000|NOT COMPLETED|Overall Study||1
10252678|NCT01887743|11384280|FG001|NOT COMPLETED|Overall Study||2
10252679|NCT01887743|11384281|FG002|NOT COMPLETED|Overall Study||3
10252680|NCT01891643|11384292|FG000|STARTED|Overall Study||13
10252681|NCT01891643|11384293|FG001|STARTED|Overall Study||10
10252682|NCT01891643|11384292|FG000|COMPLETED|Overall Study||3
10252683|NCT01891643|11384293|FG001|COMPLETED|Overall Study||0
10252684|NCT01891643|11384292|FG000|NOT COMPLETED|Overall Study||10
10252685|NCT01891643|11384293|FG001|NOT COMPLETED|Overall Study||10
10252686|NCT01900691|11384299|FG000|STARTED|Overall Study||130
10252687|NCT01900691|11384299|FG000|COMPLETED|Overall Study||111
10252688|NCT01900691|11384299|FG000|NOT COMPLETED|Overall Study||19
10252715|NCT01917318|11384344|FG000|STARTED|First Treatment||0
10252716|NCT01917318|11384345|FG001|STARTED|First Treatment||1
10252717|NCT01917318|11384344|FG000|COMPLETED|First Treatment||0
10252718|NCT01917318|11384345|FG001|COMPLETED|First Treatment||0
10252719|NCT01917318|11384344|FG000|NOT COMPLETED|First Treatment||0
10252720|NCT01917318|11384345|FG001|NOT COMPLETED|First Treatment||1
10252721|NCT01917318|11384344|FG000|STARTED|Second Treatment||0
10252722|NCT01917318|11384345|FG001|STARTED|Second Treatment||0
10252723|NCT01917318|11384344|FG000|COMPLETED|Second Treatment||0
10252724|NCT01917318|11384345|FG001|COMPLETED|Second Treatment||0
10252725|NCT01917318|11384344|FG000|NOT COMPLETED|Second Treatment||0
10252726|NCT01917318|11384345|FG001|NOT COMPLETED|Second Treatment||0
10252727|NCT01921218|11384353|FG000|STARTED|Overall Study||6
10252728|NCT01921218|11384354|FG001|STARTED|Overall Study||7
10252729|NCT01921218|11384353|FG000|COMPLETED|Overall Study||3
10252730|NCT01921218|11384354|FG001|COMPLETED|Overall Study||3
10252731|NCT01921218|11384353|FG000|NOT COMPLETED|Overall Study||3
10252732|NCT01921218|11384354|FG001|NOT COMPLETED|Overall Study||4
9833979|NCT00783614|10945019|FG000|STARTED|Overall Study||6
9833980|NCT00783614|10945020|FG001|STARTED|Overall Study||6
9833981|NCT00783614|10945021|FG002|STARTED|Overall Study||5
9833982|NCT00783614|10945022|FG003|STARTED|Overall Study||5
9833983|NCT00783614|10945019|FG000|COMPLETED|Overall Study||6
9833984|NCT00783614|10945020|FG001|COMPLETED|Overall Study||6
9833985|NCT00783614|10945021|FG002|COMPLETED|Overall Study||5
9833986|NCT00783614|10945022|FG003|COMPLETED|Overall Study||5
9833987|NCT00783614|10945019|FG000|NOT COMPLETED|Overall Study||0
9833988|NCT00783614|10945020|FG001|NOT COMPLETED|Overall Study||0
9833989|NCT00783614|10945021|FG002|NOT COMPLETED|Overall Study||0
9833990|NCT00783614|10945022|FG003|NOT COMPLETED|Overall Study||0
9833991|NCT00783692|10945035|FG000|STARTED|Induction Phase||148
9833992|NCT00783692|10945036|FG001|STARTED|Induction Phase||220
9833993|NCT00783692|10945037|FG002|STARTED|Induction Phase||748
9833994|NCT00783692|10945038|FG003|STARTED|Induction Phase||0
9833995|NCT00783692|10945039|FG004|STARTED|Induction Phase||0
9833996|NCT00783692|10945040|FG005|STARTED|Induction Phase||0
10020217|NCT01834729|11143527|FG001|COMPLETED|Overall Study||19
10252689|NCT01901432|11384309|FG000|STARTED|Overall Study||3
10252690|NCT01901432|11384310|FG001|STARTED|Overall Study||3
10252691|NCT01901432|11384311|FG002|STARTED|Overall Study||3
10252692|NCT01901432|11384312|FG003|STARTED|Overall Study||3
10252693|NCT01901432|11384313|FG004|STARTED|Overall Study||36
10252694|NCT01901432|11384309|FG000|Received Study Drug|Overall Study||3
10252695|NCT01901432|11384310|FG001|Received Study Drug|Overall Study||3
10252696|NCT01901432|11384311|FG002|Received Study Drug|Overall Study||3
10252697|NCT01901432|11384312|FG003|Received Study Drug|Overall Study||3
10252698|NCT01901432|11384313|FG004|Received Study Drug|Overall Study||35
10252699|NCT01901432|11384309|FG000|COMPLETED|Overall Study||3
10252700|NCT01901432|11384310|FG001|COMPLETED|Overall Study||2
10252701|NCT01901432|11384311|FG002|COMPLETED|Overall Study||1
10252702|NCT01901432|11384312|FG003|COMPLETED|Overall Study||3
10252703|NCT01901432|11384313|FG004|COMPLETED|Overall Study||27
10252704|NCT01901432|11384309|FG000|NOT COMPLETED|Overall Study||0
10252705|NCT01901432|11384310|FG001|NOT COMPLETED|Overall Study||1
10252706|NCT01901432|11384311|FG002|NOT COMPLETED|Overall Study||2
10252707|NCT01901432|11384312|FG003|NOT COMPLETED|Overall Study||0
10252708|NCT01901432|11384313|FG004|NOT COMPLETED|Overall Study||9
10252733|NCT01923168|11384363|FG000|STARTED|Overall Study||131
10252734|NCT01923168|11384364|FG001|STARTED|Overall Study||83
10252735|NCT01923168|11384365|FG002|STARTED|Overall Study||126
10252736|NCT01923168|11384363|FG000|COMPLETED|Overall Study||94
10252737|NCT01923168|11384364|FG001|COMPLETED|Overall Study||44
10252738|NCT01923168|11384365|FG002|COMPLETED|Overall Study||109
10252739|NCT01923168|11384363|FG000|NOT COMPLETED|Overall Study||37
10252740|NCT01923168|11384364|FG001|NOT COMPLETED|Overall Study||39
10252741|NCT01923168|11384365|FG002|NOT COMPLETED|Overall Study||17
10252742|NCT01923480|11384376|FG000|STARTED|Period 1 (Hours 1-7)||1
10252743|NCT01923480|11384377|FG001|STARTED|Period 1 (Hours 1-7)||2
10252744|NCT01923480|11384378|FG002|STARTED|Period 1 (Hours 1-7)||2
10252745|NCT01923480|11384379|FG003|STARTED|Period 1 (Hours 1-7)||2
10252746|NCT01923480|11384380|FG004|STARTED|Period 1 (Hours 1-7)||2
10252747|NCT01923480|11384381|FG005|STARTED|Period 1 (Hours 1-7)||2
10252748|NCT01923480|11384376|FG000|COMPLETED|Period 1 (Hours 1-7)||1
10252749|NCT01923480|11384377|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
10252750|NCT01923480|11384378|FG002|COMPLETED|Period 1 (Hours 1-7)||2
10020218|NCT01834729|11143528|FG002|COMPLETED|Overall Study||15
10020219|NCT01834729|11143529|FG003|COMPLETED|Overall Study||16
10020220|NCT01834729|11143526|FG000|NOT COMPLETED|Overall Study||1
10020221|NCT01834729|11143527|FG001|NOT COMPLETED|Overall Study||1
10020222|NCT01834729|11143528|FG002|NOT COMPLETED|Overall Study||3
10020223|NCT01834729|11143529|FG003|NOT COMPLETED|Overall Study||2
10020224|NCT01835015|11143545|FG000|STARTED|Overall Study||6
10020225|NCT01835015|11143546|FG001|STARTED|Overall Study||6
10020226|NCT01835015|11143547|FG002|STARTED|Overall Study||7
10020227|NCT01835015|11143548|FG003|STARTED|Overall Study||6
10020228|NCT01835015|11143549|FG004|STARTED|Overall Study||6
10020229|NCT01835015|11143545|FG000|COMPLETED|Overall Study||6
10020230|NCT01835015|11143546|FG001|COMPLETED|Overall Study||6
10020231|NCT01835015|11143547|FG002|COMPLETED|Overall Study||6
10020232|NCT01835015|11143548|FG003|COMPLETED|Overall Study||6
10020233|NCT01835015|11143549|FG004|COMPLETED|Overall Study||6
10020234|NCT01835015|11143545|FG000|NOT COMPLETED|Overall Study||0
10020235|NCT01835015|11143546|FG001|NOT COMPLETED|Overall Study||0
10113942|NCT02512575|11244633|FG009|NOT COMPLETED|Overall Study||0
10113943|NCT02512679|11244655|FG000|STARTED|Overall Study||20
10113944|NCT02512679|11244656|FG001|STARTED|Overall Study||0
10113945|NCT02512679|11244655|FG000|COMPLETED|Overall Study||20
10113946|NCT02512679|11244656|FG001|COMPLETED|Overall Study||0
10113947|NCT02512679|11244655|FG000|NOT COMPLETED|Overall Study||0
10252751|NCT01923480|11384379|FG003|COMPLETED|Period 1 (Hours 1-7)||2
10252752|NCT01923480|11384380|FG004|COMPLETED|Period 1 (Hours 1-7)||2
10252753|NCT01923480|11384381|FG005|COMPLETED|Period 1 (Hours 1-7)||2
10252754|NCT01923480|11384376|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0
10252755|NCT01923480|11384377|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0
10252756|NCT01923480|11384378|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0
10252757|NCT01923480|11384379|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0
10252758|NCT01923480|11384380|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0
10252759|NCT01923480|11384381|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0
10252760|NCT01923480|11384376|FG000|STARTED|Period 2 (Hours 1-7)||1
10252761|NCT01923480|11384377|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
10252762|NCT01923480|11384378|FG002|STARTED|Period 2 (Hours 1-7)||2
10252763|NCT01923480|11384379|FG003|STARTED|Period 2 (Hours 1-7)||2
10252764|NCT01923480|11384380|FG004|STARTED|Period 2 (Hours 1-7)||2
10020236|NCT01835015|11143547|FG002|NOT COMPLETED|Overall Study||1
10020237|NCT01835015|11143548|FG003|NOT COMPLETED|Overall Study||0
10020238|NCT01835015|11143549|FG004|NOT COMPLETED|Overall Study||0
10020239|NCT01835132|11143562|FG000|STARTED|Initial Phase||8
10020240|NCT01835132|11143562|FG000|COMPLETED|Initial Phase||6
10020241|NCT01835132|11143562|FG000|NOT COMPLETED|Initial Phase||2
10113948|NCT02512679|11244656|FG001|NOT COMPLETED|Overall Study||0
10113949|NCT02512783|11244662|FG000|STARTED|Overall Study||96
10113950|NCT02512783|11244663|FG001|STARTED|Overall Study||75
10113951|NCT02512783|11244662|FG000|COMPLETED|Overall Study||96
10252765|NCT01923480|11384381|FG005|STARTED|Period 2 (Hours 1-7)||2
10252766|NCT01923480|11384376|FG000|COMPLETED|Period 2 (Hours 1-7)||1
10252709|NCT01904279|11384334|FG000|STARTED|Overall Study||27
10252710|NCT01904279|11384335|FG001|STARTED|Overall Study||25
10252711|NCT01904279|11384334|FG000|COMPLETED|Overall Study||24
10252712|NCT01904279|11384335|FG001|COMPLETED|Overall Study||22
10252713|NCT01904279|11384334|FG000|NOT COMPLETED|Overall Study||3
10252714|NCT01904279|11384335|FG001|NOT COMPLETED|Overall Study||3
10252767|NCT01923480|11384377|FG001|COMPLETED|Period 2 (Hours 1-7)||1
10252768|NCT01923480|11384378|FG002|COMPLETED|Period 2 (Hours 1-7)||2
9833997|NCT00783692|10945041|FG006|STARTED|Induction Phase||0
9833998|NCT00783692|10945035|FG000|Treated|Induction Phase||148
9833999|NCT00783692|10945036|FG001|Treated|Induction Phase||220
9834000|NCT00783692|10945037|FG002|Treated|Induction Phase||747
9834001|NCT00783692|10945038|FG003|Treated|Induction Phase||0
9834002|NCT00783692|10945039|FG004|Treated|Induction Phase||0
9834003|NCT00783692|10945040|FG005|Treated|Induction Phase||0
9834004|NCT00783692|10945041|FG006|Treated|Induction Phase||0
9834005|NCT00783692|10945035|FG000|COMPLETED|Induction Phase||137
9834006|NCT00783692|10945036|FG001|COMPLETED|Induction Phase||199
9834007|NCT00783692|10945037|FG002|COMPLETED|Induction Phase||674
9834008|NCT00783692|10945038|FG003|COMPLETED|Induction Phase||0
9834009|NCT00783692|10945039|FG004|COMPLETED|Induction Phase||0
9834010|NCT00783692|10945040|FG005|COMPLETED|Induction Phase||0
9834011|NCT00783692|10945041|FG006|COMPLETED|Induction Phase||0
9834012|NCT00783692|10945035|FG000|NOT COMPLETED|Induction Phase||11
9834013|NCT00783692|10945036|FG001|NOT COMPLETED|Induction Phase||21
9834014|NCT00783692|10945037|FG002|NOT COMPLETED|Induction Phase||74
9834015|NCT00783692|10945038|FG003|NOT COMPLETED|Induction Phase||0
9834016|NCT00783692|10945039|FG004|NOT COMPLETED|Induction Phase||0
9834017|NCT00783692|10945040|FG005|NOT COMPLETED|Induction Phase||0
9834018|NCT00783692|10945041|FG006|NOT COMPLETED|Induction Phase||0
9834019|NCT00783692|10945035|FG000|STARTED|Maintenance Phase||137
9834020|NCT00783692|10945036|FG001|STARTED|Maintenance Phase||0
9834021|NCT00783692|10945037|FG002|STARTED|Maintenance Phase||0
9834022|NCT00783692|10945038|FG003|STARTED|Maintenance Phase||153
9834023|NCT00783692|10945039|FG004|STARTED|Maintenance Phase||154
9834024|NCT00783692|10945040|FG005|STARTED|Maintenance Phase||154
9834025|NCT00783692|10945041|FG006|STARTED|Maintenance Phase||412
9834026|NCT00783692|10945035|FG000|COMPLETED|Maintenance Phase||42
9834027|NCT00783692|10945036|FG001|COMPLETED|Maintenance Phase||0
9834028|NCT00783692|10945037|FG002|COMPLETED|Maintenance Phase||0
9834029|NCT00783692|10945038|FG003|COMPLETED|Maintenance Phase||64
9834030|NCT00783692|10945039|FG004|COMPLETED|Maintenance Phase||73
9834031|NCT00783692|10945040|FG005|COMPLETED|Maintenance Phase||82
9834032|NCT00783692|10945041|FG006|COMPLETED|Maintenance Phase||163
9834033|NCT00783692|10945035|FG000|NOT COMPLETED|Maintenance Phase||95
9834034|NCT00783692|10945036|FG001|NOT COMPLETED|Maintenance Phase||0
9834035|NCT00783692|10945037|FG002|NOT COMPLETED|Maintenance Phase||0
9834036|NCT00783692|10945038|FG003|NOT COMPLETED|Maintenance Phase||89
9834037|NCT00783692|10945039|FG004|NOT COMPLETED|Maintenance Phase||81
9834038|NCT00783692|10945040|FG005|NOT COMPLETED|Maintenance Phase||72
9834039|NCT00783692|10945041|FG006|NOT COMPLETED|Maintenance Phase||249
9834040|NCT00783705|10945056|FG000|STARTED|Overall Study||44
9834041|NCT00783705|10945057|FG001|STARTED|Overall Study||41
9834042|NCT00783705|10945056|FG000|COMPLETED|Overall Study||38
9834043|NCT00783705|10945057|FG001|COMPLETED|Overall Study||36
9834044|NCT00783705|10945056|FG000|NOT COMPLETED|Overall Study||6
9834045|NCT00783705|10945057|FG001|NOT COMPLETED|Overall Study||5
9834046|NCT00783718|10945066|FG000|STARTED|Induction Phase||149
9834047|NCT00783718|10945067|FG001|STARTED|Induction Phase||225
9834048|NCT00783718|10945068|FG002|STARTED|Induction Phase||521
9834049|NCT00783718|10945069|FG003|STARTED|Induction Phase||0
9834050|NCT00783718|10945070|FG004|STARTED|Induction Phase||0
9834051|NCT00783718|10945071|FG005|STARTED|Induction Phase||0
9834052|NCT00783718|10945072|FG006|STARTED|Induction Phase||0
9834053|NCT00783718|10945066|FG000|COMPLETED|Induction Phase||135
9834054|NCT00783718|10945067|FG001|COMPLETED|Induction Phase||218
9834055|NCT00783718|10945068|FG002|COMPLETED|Induction Phase||485
9834056|NCT00783718|10945069|FG003|COMPLETED|Induction Phase||0
9834057|NCT00783718|10945070|FG004|COMPLETED|Induction Phase||0
10252769|NCT01923480|11384379|FG003|COMPLETED|Period 2 (Hours 1-7)||2
10252770|NCT01923480|11384380|FG004|COMPLETED|Period 2 (Hours 1-7)||2
10252771|NCT01923480|11384381|FG005|COMPLETED|Period 2 (Hours 1-7)||2
9834058|NCT00783718|10945071|FG005|COMPLETED|Induction Phase||0
9834059|NCT00783718|10945072|FG006|COMPLETED|Induction Phase||0
9834060|NCT00783718|10945066|FG000|NOT COMPLETED|Induction Phase||14
9834061|NCT00783718|10945067|FG001|NOT COMPLETED|Induction Phase||7
9834062|NCT00783718|10945068|FG002|NOT COMPLETED|Induction Phase||36
9834063|NCT00783718|10945069|FG003|NOT COMPLETED|Induction Phase||0
9834064|NCT00783718|10945070|FG004|NOT COMPLETED|Induction Phase||0
9834065|NCT00783718|10945071|FG005|NOT COMPLETED|Induction Phase||0
9834066|NCT00783718|10945072|FG006|NOT COMPLETED|Induction Phase||0
9834067|NCT00783718|10945066|FG000|STARTED|Maintenance Phase||135
9834068|NCT00783718|10945067|FG001|STARTED|Maintenance Phase||0
9957534|NCT01451437|11076784|FG002|NOT COMPLETED|Overall Study||3
9957535|NCT01451437|11076785|FG003|NOT COMPLETED|Overall Study||1
9957536|NCT01451437|11076786|FG004|NOT COMPLETED|Overall Study||4
9957537|NCT01451437|11076787|FG005|NOT COMPLETED|Overall Study||3
9834069|NCT00783718|10945068|FG002|STARTED|Maintenance Phase||0
9834070|NCT00783718|10945069|FG003|STARTED|Maintenance Phase||126
9834071|NCT00783718|10945070|FG004|STARTED|Maintenance Phase||122
9834072|NCT00783718|10945071|FG005|STARTED|Maintenance Phase||125
9834073|NCT00783718|10945072|FG006|STARTED|Maintenance Phase||330
10252772|NCT01923480|11384376|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0
10252773|NCT01923480|11384377|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0
10252774|NCT01923480|11384378|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0
10252775|NCT01923480|11384379|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0
10252776|NCT01923480|11384380|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0
10252777|NCT01923480|11384381|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0
10252778|NCT01931098|11384395|FG000|STARTED|Overall Study||9
10252779|NCT01931098|11384396|FG001|STARTED|Overall Study||26
10252780|NCT01931098|11384395|FG000|COMPLETED|Overall Study||9
10252781|NCT01931098|11384396|FG001|COMPLETED|Overall Study||22
10252782|NCT01931098|11384395|FG000|NOT COMPLETED|Overall Study||0
10252783|NCT01931098|11384396|FG001|NOT COMPLETED|Overall Study||4
10252784|NCT01945021|11384404|FG000|STARTED|Overall Study||127
10252785|NCT01945021|11384404|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
10252786|NCT01945021|11384404|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
10252787|NCT01945021|11384404|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
10252788|NCT01945021|11384404|FG000|COMPLETED|Overall Study||44
10252789|NCT01945021|11384404|FG000|NOT COMPLETED|Overall Study||83
10252790|NCT04747808|11384408|FG000|STARTED|Overall Study||5
10252791|NCT04747808|11384408|FG000|COMPLETED|Overall Study||5
10252792|NCT04747808|11384408|FG000|NOT COMPLETED|Overall Study||0
10252793|NCT04466384|11384412|FG000|STARTED|First Phase||14
10252794|NCT04466384|11384413|FG001|STARTED|First Phase||10
10252795|NCT04466384|11384412|FG000|COMPLETED|First Phase||12
10252796|NCT04466384|11384413|FG001|COMPLETED|First Phase||10
10252797|NCT04466384|11384412|FG000|NOT COMPLETED|First Phase||2
10252798|NCT04466384|11384413|FG001|NOT COMPLETED|First Phase||0
10252799|NCT04466384|11384412|FG000|STARTED|Cross Over Phase||14
10252800|NCT04466384|11384413|FG001|STARTED|Cross Over Phase||10
10252801|NCT04466384|11384412|FG000|COMPLETED|Cross Over Phase||13
10252802|NCT04466384|11384413|FG001|COMPLETED|Cross Over Phase||9
10252803|NCT04466384|11384412|FG000|NOT COMPLETED|Cross Over Phase||1
10252804|NCT04466384|11384413|FG001|NOT COMPLETED|Cross Over Phase||1
10252805|NCT04411953|11384423|FG000|STARTED|Treatment Period 1 (8 Days)||16
10252806|NCT04411953|11384424|FG001|STARTED|Treatment Period 1 (8 Days)||16
10252807|NCT04411953|11384423|FG000|COMPLETED|Treatment Period 1 (8 Days)||16
10252808|NCT04411953|11384424|FG001|COMPLETED|Treatment Period 1 (8 Days)||16
10252809|NCT04411953|11384423|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10252810|NCT04411953|11384424|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10252811|NCT04411953|11384423|FG000|STARTED|Washout Period (14 Days)||16
10252812|NCT04411953|11384424|FG001|STARTED|Washout Period (14 Days)||16
10252813|NCT04411953|11384423|FG000|COMPLETED|Washout Period (14 Days)||16
10252814|NCT04411953|11384424|FG001|COMPLETED|Washout Period (14 Days)||15
10252815|NCT04411953|11384423|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10252816|NCT04411953|11384424|FG001|NOT COMPLETED|Washout Period (14 Days)||1
10252817|NCT04411953|11384423|FG000|STARTED|Treatment Period 2 (8 Days)||16
10252818|NCT04411953|11384424|FG001|STARTED|Treatment Period 2 (8 Days)||15
10252819|NCT04411953|11384423|FG000|COMPLETED|Treatment Period 2 (8 Days)||16
10252820|NCT04411953|11384424|FG001|COMPLETED|Treatment Period 2 (8 Days)||15
10252821|NCT04411953|11384423|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10252822|NCT04411953|11384424|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10252823|NCT04411940|11384432|FG000|STARTED|Treatment Period 1 (8 Days)||16
10252824|NCT04411940|11384433|FG001|STARTED|Treatment Period 1 (8 Days)||16
10252825|NCT04411940|11384432|FG000|COMPLETED|Treatment Period 1 (8 Days)||16
10252826|NCT04411940|11384433|FG001|COMPLETED|Treatment Period 1 (8 Days)||16
10252827|NCT04411940|11384432|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10252828|NCT04411940|11384433|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10252829|NCT04411940|11384432|FG000|STARTED|Washout Period (14 Days)||16
10252830|NCT04411940|11384433|FG001|STARTED|Washout Period (14 Days)||16
10252831|NCT04411940|11384432|FG000|COMPLETED|Washout Period (14 Days)||16
10252832|NCT04411940|11384433|FG001|COMPLETED|Washout Period (14 Days)||16
10252833|NCT04411940|11384432|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10252834|NCT04411940|11384433|FG001|NOT COMPLETED|Washout Period (14 Days)||0
10252835|NCT04411940|11384432|FG000|STARTED|Treatment Period 2 (8 Days)||16
10252836|NCT04411940|11384433|FG001|STARTED|Treatment Period 2 (8 Days)||16
10252837|NCT04411940|11384432|FG000|COMPLETED|Treatment Period 2 (8 Days)||16
10252838|NCT04411940|11384433|FG001|COMPLETED|Treatment Period 2 (8 Days)||16
10252839|NCT04411940|11384432|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10252840|NCT04411940|11384433|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10252841|NCT04068792|11384441|FG000|STARTED|Overall Study||11
10252842|NCT04068792|11384442|FG001|STARTED|Overall Study||11
10252843|NCT04068792|11384441|FG000|COMPLETED|Overall Study||11
10252844|NCT04068792|11384442|FG001|COMPLETED|Overall Study||11
10252845|NCT04068792|11384441|FG000|NOT COMPLETED|Overall Study||0
10252846|NCT04068792|11384442|FG001|NOT COMPLETED|Overall Study||0
10252847|NCT03960541|11384450|FG000|STARTED|Overall Study||4
10252848|NCT03960541|11384451|FG001|STARTED|Overall Study||4
10252849|NCT03960541|11384450|FG000|COMPLETED|Overall Study||4
10252850|NCT03960541|11384451|FG001|COMPLETED|Overall Study||4
10252851|NCT03960541|11384450|FG000|NOT COMPLETED|Overall Study||0
10252852|NCT03960541|11384451|FG001|NOT COMPLETED|Overall Study||0
10252853|NCT03951077|11384463|FG000|STARTED|Overall Study||27
10252854|NCT03951077|11384464|FG001|STARTED|Overall Study||18
10252855|NCT03951077|11384465|FG002|STARTED|Overall Study||18
10252856|NCT03951077|11384466|FG003|STARTED|Overall Study||18
10252857|NCT03951077|11384467|FG004|STARTED|Overall Study||19
10252858|NCT03951077|11384468|FG005|STARTED|Overall Study||18
10252859|NCT03951077|11384463|FG000|Randomized and Treated|Overall Study||26
10252860|NCT03951077|11384464|FG001|Randomized and Treated|Overall Study||18
10252861|NCT03951077|11384465|FG002|Randomized and Treated|Overall Study||17
10252862|NCT03951077|11384466|FG003|Randomized and Treated|Overall Study||17
10252863|NCT03951077|11384467|FG004|Randomized and Treated|Overall Study||18
10252864|NCT03951077|11384468|FG005|Randomized and Treated|Overall Study||18
10252865|NCT03951077|11384463|FG000|COMPLETED|Overall Study||9
10252866|NCT03951077|11384464|FG001|COMPLETED|Overall Study||4
10252867|NCT03951077|11384465|FG002|COMPLETED|Overall Study||5
10252868|NCT03951077|11384466|FG003|COMPLETED|Overall Study||6
10252869|NCT03951077|11384467|FG004|COMPLETED|Overall Study||3
10252870|NCT03951077|11384468|FG005|COMPLETED|Overall Study||7
10252871|NCT03951077|11384463|FG000|NOT COMPLETED|Overall Study||18
10252872|NCT03951077|11384464|FG001|NOT COMPLETED|Overall Study||14
10252873|NCT03951077|11384465|FG002|NOT COMPLETED|Overall Study||13
10252874|NCT03951077|11384466|FG003|NOT COMPLETED|Overall Study||12
10252875|NCT03951077|11384467|FG004|NOT COMPLETED|Overall Study||16
10252876|NCT03951077|11384468|FG005|NOT COMPLETED|Overall Study||11
10252877|NCT03873246|11384485|FG000|STARTED|Overall Study||41
10252878|NCT03873246|11384486|FG001|STARTED|Overall Study||41
10252879|NCT03873246|11384487|FG002|STARTED|Overall Study||41
10252880|NCT03873246|11384485|FG000|COMPLETED|Overall Study||36
10252881|NCT03873246|11384486|FG001|COMPLETED|Overall Study||29
10252882|NCT03873246|11384487|FG002|COMPLETED|Overall Study||32
10252883|NCT03873246|11384485|FG000|NOT COMPLETED|Overall Study||5
10252884|NCT03873246|11384486|FG001|NOT COMPLETED|Overall Study||12
10252885|NCT03873246|11384487|FG002|NOT COMPLETED|Overall Study||9
10252886|NCT03807349|11384496|FG000|STARTED|Overall Study||12
10252887|NCT03807349|11384496|FG000|COMPLETED|Overall Study||3
10252888|NCT03807349|11384496|FG000|NOT COMPLETED|Overall Study||9
10252889|NCT03769649|11384500|FG000|STARTED|Overall Study||15
10252890|NCT03769649|11384500|FG000|COMPLETED|Overall Study||11
10252891|NCT03769649|11384500|FG000|NOT COMPLETED|Overall Study||4
10252892|NCT03714880|11384506|FG000|STARTED|Overall Study||20
10252893|NCT03714880|11384507|FG001|STARTED|Overall Study||24
10252894|NCT03714880|11384506|FG000|COMPLETED|Overall Study||19
10252895|NCT03714880|11384507|FG001|COMPLETED|Overall Study||22
10252896|NCT03714880|11384506|FG000|NOT COMPLETED|Overall Study||1
10252897|NCT03714880|11384507|FG001|NOT COMPLETED|Overall Study||2
10252898|NCT03645941|11384517|FG000|STARTED|Overall Study||30
10252899|NCT03645941|11384518|FG001|STARTED|Overall Study||31
10252900|NCT03645941|11384517|FG000|COMPLETED|Overall Study||16
10252901|NCT03645941|11384518|FG001|COMPLETED|Overall Study||19
10252902|NCT03645941|11384517|FG000|NOT COMPLETED|Overall Study||14
10252903|NCT03645941|11384518|FG001|NOT COMPLETED|Overall Study||12
10252904|NCT03598088|11384524|FG000|STARTED|Screening/Baseline PCT Visits 1-4||38
10252905|NCT03598088|11384524|FG000|COMPLETED|Screening/Baseline PCT Visits 1-4||38
10252906|NCT03598088|11384524|FG000|NOT COMPLETED|Screening/Baseline PCT Visits 1-4||0
10252907|NCT03598088|11384524|FG000|STARTED|Caya PCT Cycle, Visit 5 & 6||38
10252908|NCT03598088|11384524|FG000|COMPLETED|Caya PCT Cycle, Visit 5 & 6||35
10252909|NCT03598088|11384524|FG000|NOT COMPLETED|Caya PCT Cycle, Visit 5 & 6||3
10252910|NCT03598088|11384524|FG000|STARTED|OVP Safety Cycle Visits 7-11||33
10252911|NCT03598088|11384524|FG000|Used the OVP Device During the Study|OVP Safety Cycle Visits 7-11|Any subject that used the OVP device at least one time during the study.|33
10252912|NCT03598088|11384524|FG000|COMPLETED|OVP Safety Cycle Visits 7-11||28
10252913|NCT03598088|11384524|FG000|NOT COMPLETED|OVP Safety Cycle Visits 7-11||5
10252914|NCT03598088|11384524|FG000|STARTED|OVP PCT Cycle A Visits 12-16||28
10252915|NCT03598088|11384524|FG000|Completed 1 OVP PCT Cycle|OVP PCT Cycle A Visits 12-16|Subjects Completed One PCT Visit|26
10252916|NCT03598088|11384524|FG000|COMPLETED|OVP PCT Cycle A Visits 12-16||24
9719256|NCT00039741|10818755|FG003|NOT COMPLETED|Overall Study||14
9719257|NCT00039871|10818765|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
9719258|NCT00039871|10818765|FG000|COMPLETED|Overall Study||928
9719259|NCT00039871|10818765|FG000|NOT COMPLETED|Overall Study||1384
9719260|NCT00040365|10818769|FG000|STARTED|Overall Study||30
9719261|NCT00040365|10818769|FG000|Completed Follow Up Phase|Overall Study||19
9719262|NCT00040365|10818769|FG000|COMPLETED|Overall Study||19
9719263|NCT00040365|10818769|FG000|NOT COMPLETED|Overall Study||11
9719264|NCT00040443|10818775|FG000|STARTED|Overall Study||84
9719265|NCT00040443|10818776|FG001|STARTED|Overall Study||91
9719266|NCT00040443|10818775|FG000|COMPLETED|Overall Study||84
9719267|NCT00040443|10818776|FG001|COMPLETED|Overall Study||91
9719268|NCT00040443|10818775|FG000|NOT COMPLETED|Overall Study||0
10020242|NCT01835132|11143562|FG000|STARTED|1st Extension Phase||6
10020243|NCT01835132|11143562|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
10020244|NCT01835132|11143562|FG000|NOT COMPLETED|1st Extension Phase||0
10020245|NCT01835132|11143562|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
9719269|NCT00040443|10818776|FG001|NOT COMPLETED|Overall Study||0
9719270|NCT00040664|10818782|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
10020246|NCT01835132|11143562|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
10252917|NCT03598088|11384524|FG000|NOT COMPLETED|OVP PCT Cycle A Visits 12-16||4
9719271|NCT00040664|10818783|FG001|STARTED|Overall Study||17
10252918|NCT03598088|11384524|FG000|STARTED|OVP PCT Cycle B Visits 17-21||24
10252919|NCT03598088|11384524|FG000|COMPLETED|OVP PCT Cycle B Visits 17-21||23
10252920|NCT03598088|11384524|FG000|NOT COMPLETED|OVP PCT Cycle B Visits 17-21||1
10252921|NCT03408444|11384565|FG000|STARTED|Overall Study||50
10252922|NCT03408444|11384566|FG001|STARTED|Overall Study||48
10252923|NCT03408444|11384567|FG002|STARTED|Overall Study||50
10252924|NCT03408444|11384568|FG003|STARTED|Overall Study||51
10252925|NCT03408444|11384565|FG000|COMPLETED|Overall Study||49
10252926|NCT03408444|11384566|FG001|COMPLETED|Overall Study||45
10252927|NCT03408444|11384567|FG002|COMPLETED|Overall Study||44
10252928|NCT03408444|11384568|FG003|COMPLETED|Overall Study||47
10252929|NCT03408444|11384565|FG000|NOT COMPLETED|Overall Study||1
10252930|NCT03408444|11384566|FG001|NOT COMPLETED|Overall Study||3
10252931|NCT03408444|11384567|FG002|NOT COMPLETED|Overall Study||6
10252932|NCT03408444|11384568|FG003|NOT COMPLETED|Overall Study||4
10020247|NCT01835132|11143562|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
10020248|NCT01835158|11143568|FG000|STARTED|Overall Study||79
10020249|NCT01835158|11143569|FG001|STARTED|Overall Study||78
10020250|NCT01835158|11143568|FG000|COMPLETED|Overall Study||78
10020251|NCT01835158|11143569|FG001|COMPLETED|Overall Study||72
10020252|NCT01835158|11143568|FG000|NOT COMPLETED|Overall Study||1
10020253|NCT01835158|11143569|FG001|NOT COMPLETED|Overall Study||6
10020254|NCT01835223|11143577|FG000|STARTED|Overall Study||30
10020255|NCT01835223|11143578|FG001|STARTED|Overall Study||3
10020256|NCT01835223|11143577|FG000|COMPLETED|Overall Study||21
10020257|NCT01835223|11143578|FG001|COMPLETED|Overall Study||2
10020258|NCT01835223|11143577|FG000|NOT COMPLETED|Overall Study||9
10020259|NCT01835223|11143578|FG001|NOT COMPLETED|Overall Study||1
10020260|NCT01835262|11143588|FG000|STARTED|Overall Study||45
10020261|NCT01835262|11143589|FG001|STARTED|Overall Study||45
10020262|NCT01835262|11143588|FG000|COMPLETED|Overall Study||45
10020263|NCT01835262|11143589|FG001|COMPLETED|Overall Study||45
10020264|NCT01835262|11143588|FG000|NOT COMPLETED|Overall Study||0
10020265|NCT01835262|11143589|FG001|NOT COMPLETED|Overall Study||0
10020266|NCT01835379|11143597|FG000|STARTED|Overall Study||41
10020267|NCT01835379|11143598|FG001|STARTED|Overall Study||41
10020268|NCT01835379|11143597|FG000|COMPLETED|Overall Study||41
10020269|NCT01835379|11143598|FG001|COMPLETED|Overall Study||41
10020270|NCT01835379|11143597|FG000|NOT COMPLETED|Overall Study||0
10020271|NCT01835379|11143598|FG001|NOT COMPLETED|Overall Study||0
10020272|NCT01835431|11143606|FG000|STARTED|Overall Study||182
10020273|NCT01835431|11143607|FG001|STARTED|Overall Study||180
10020274|NCT01835431|11143606|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181
10020275|NCT01835431|11143607|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179
10252933|NCT03282123|11384578|FG000|STARTED|Overall Study||38
10252934|NCT03282123|11384578|FG000|COMPLETED|Overall Study||33
10252935|NCT03282123|11384578|FG000|NOT COMPLETED|Overall Study||5
10252936|NCT03112590|11384586|FG000|STARTED|Overall Study||3
10252937|NCT03112590|11384587|FG001|STARTED|Overall Study||6
10252938|NCT03112590|11384588|FG002|STARTED|Overall Study||42
10252939|NCT03112590|11384586|FG000|COMPLETED|Overall Study||3
10252940|NCT03112590|11384587|FG001|COMPLETED|Overall Study||5
10252941|NCT03112590|11384588|FG002|COMPLETED|Overall Study||42
10252942|NCT03112590|11384586|FG000|NOT COMPLETED|Overall Study||0
10252943|NCT03112590|11384587|FG001|NOT COMPLETED|Overall Study||1
10252944|NCT03112590|11384588|FG002|NOT COMPLETED|Overall Study||0
10252945|NCT03070444|11384598|FG000|STARTED|Overall Study||52
10252946|NCT03070444|11384599|FG001|STARTED|Overall Study||52
10252947|NCT03070444|11384598|FG000|COMPLETED|Overall Study||39
10252948|NCT03070444|11384599|FG001|COMPLETED|Overall Study||35
10252949|NCT03070444|11384598|FG000|NOT COMPLETED|Overall Study||13
10252950|NCT03070444|11384599|FG001|NOT COMPLETED|Overall Study||17
10252951|NCT02952534|11384610|FG000|STARTED|Overall Study||172
10252952|NCT02952534|11384611|FG001|STARTED|Overall Study||59
10252953|NCT02952534|11384612|FG002|STARTED|Overall Study||14
10252954|NCT02952534|11384613|FG003|STARTED|Overall Study||7
10252955|NCT02952534|11384614|FG004|STARTED|Overall Study||25
10252956|NCT02952534|11384610|FG000|COMPLETED|Overall Study||172
10252957|NCT02952534|11384611|FG001|COMPLETED|Overall Study||59
10252958|NCT02952534|11384612|FG002|COMPLETED|Overall Study||14
10252959|NCT02952534|11384613|FG003|COMPLETED|Overall Study||7
10252960|NCT02952534|11384614|FG004|COMPLETED|Overall Study||25
10252961|NCT02952534|11384610|FG000|NOT COMPLETED|Overall Study||0
10252962|NCT02952534|11384611|FG001|NOT COMPLETED|Overall Study||0
10252963|NCT02952534|11384612|FG002|NOT COMPLETED|Overall Study||0
10252964|NCT02952534|11384613|FG003|NOT COMPLETED|Overall Study||0
10252965|NCT02952534|11384614|FG004|NOT COMPLETED|Overall Study||0
10252966|NCT02862548|11384627|FG000|STARTED|Randomized Phase (Up to Week 48)||26
10252967|NCT02862548|11384628|FG001|STARTED|Randomized Phase (Up to Week 48)||25
10252968|NCT02862548|11384627|FG000|COMPLETED|Randomized Phase (Up to Week 48)||26
10252969|NCT02862548|11384628|FG001|COMPLETED|Randomized Phase (Up to Week 48)||24
10252970|NCT02862548|11384627|FG000|NOT COMPLETED|Randomized Phase (Up to Week 48)||0
10252971|NCT02862548|11384628|FG001|NOT COMPLETED|Randomized Phase (Up to Week 48)||1
10252972|NCT02862548|11384627|FG000|STARTED|OLE Phase (Week 49 to Week 192)||26
10252973|NCT02862548|11384628|FG001|STARTED|OLE Phase (Week 49 to Week 192)||24
10252974|NCT02862548|11384627|FG000|COMPLETED|OLE Phase (Week 49 to Week 192)||23
10252975|NCT02862548|11384628|FG001|COMPLETED|OLE Phase (Week 49 to Week 192)||23
10252976|NCT02862548|11384627|FG000|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||3
10252977|NCT02862548|11384628|FG001|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||1
10252978|NCT02377089|11384638|FG000|STARTED|Overall Study||31
10252979|NCT02377089|11384639|FG001|STARTED|Overall Study||29
10252980|NCT02377089|11384638|FG000|COMPLETED|Overall Study||22
10252981|NCT02377089|11384639|FG001|COMPLETED|Overall Study||24
10252982|NCT02377089|11384638|FG000|NOT COMPLETED|Overall Study||9
10252983|NCT02377089|11384639|FG001|NOT COMPLETED|Overall Study||5
10252984|NCT02335099|11384647|FG000|STARTED|Treatment||22
10252985|NCT02335099|11384648|FG001|STARTED|Treatment||22
10252986|NCT02335099|11384647|FG000|COMPLETED|Treatment||17
10252987|NCT02335099|11384648|FG001|COMPLETED|Treatment||17
10252988|NCT02335099|11384647|FG000|NOT COMPLETED|Treatment||5
10252989|NCT02335099|11384648|FG001|NOT COMPLETED|Treatment||5
10252990|NCT02335099|11384647|FG000|STARTED|Follow-up||17
10252991|NCT02335099|11384648|FG001|STARTED|Follow-up||17
10252992|NCT02335099|11384647|FG000|COMPLETED|Follow-up||17
10252993|NCT02335099|11384648|FG001|COMPLETED|Follow-up||16
10252994|NCT02335099|11384647|FG000|NOT COMPLETED|Follow-up||0
10252995|NCT02335099|11384648|FG001|NOT COMPLETED|Follow-up||1
10252996|NCT02330562|11384665|FG000|STARTED|Overall Study||6
10252997|NCT02330562|11384666|FG001|STARTED|Overall Study||3
10252998|NCT02330562|11384667|FG002|STARTED|Overall Study||27
10252999|NCT02330562|11384668|FG003|STARTED|Overall Study||30
10253000|NCT02330562|11384669|FG004|STARTED|Overall Study||31
10253001|NCT02330562|11384670|FG005|STARTED|Overall Study||10
10253002|NCT02330562|11384671|FG006|STARTED|Overall Study||1
10253003|NCT02330562|11384672|FG007|STARTED|Overall Study||1
10253004|NCT02330562|11384673|FG008|STARTED|Overall Study||1
10253005|NCT02330562|11384674|FG009|STARTED|Overall Study||5
10253006|NCT02330562|11384675|FG010|STARTED|Overall Study||6
10253007|NCT02330562|11384665|FG000|COMPLETED|Overall Study||0
10253008|NCT02330562|11384666|FG001|COMPLETED|Overall Study||0
10253009|NCT02330562|11384667|FG002|COMPLETED|Overall Study||0
10253010|NCT02330562|11384668|FG003|COMPLETED|Overall Study||0
10253011|NCT02330562|11384669|FG004|COMPLETED|Overall Study||0
10253012|NCT02330562|11384670|FG005|COMPLETED|Overall Study||0
10253013|NCT02330562|11384671|FG006|COMPLETED|Overall Study||0
10253014|NCT02330562|11384672|FG007|COMPLETED|Overall Study||0
10253015|NCT02330562|11384673|FG008|COMPLETED|Overall Study||0
10253016|NCT02330562|11384674|FG009|COMPLETED|Overall Study||0
10253017|NCT02330562|11384675|FG010|COMPLETED|Overall Study||0
10253018|NCT02330562|11384665|FG000|NOT COMPLETED|Overall Study||6
10253019|NCT02330562|11384666|FG001|NOT COMPLETED|Overall Study||3
10253020|NCT02330562|11384667|FG002|NOT COMPLETED|Overall Study||27
10253021|NCT02330562|11384668|FG003|NOT COMPLETED|Overall Study||30
10253022|NCT02330562|11384669|FG004|NOT COMPLETED|Overall Study||31
10253023|NCT02330562|11384670|FG005|NOT COMPLETED|Overall Study||10
10253024|NCT02330562|11384671|FG006|NOT COMPLETED|Overall Study||1
10253025|NCT02330562|11384672|FG007|NOT COMPLETED|Overall Study||1
10253026|NCT02330562|11384673|FG008|NOT COMPLETED|Overall Study||1
10253027|NCT02330562|11384674|FG009|NOT COMPLETED|Overall Study||5
10253028|NCT02330562|11384675|FG010|NOT COMPLETED|Overall Study||6
10253029|NCT02053363|11384722|FG000|STARTED|Overall Study||25
10253030|NCT02053363|11384723|FG001|STARTED|Overall Study||27
10253031|NCT02053363|11384722|FG000|COMPLETED|Overall Study||25
10253032|NCT02053363|11384723|FG001|COMPLETED|Overall Study||27
10253033|NCT02053363|11384722|FG000|NOT COMPLETED|Overall Study||0
10253034|NCT02053363|11384723|FG001|NOT COMPLETED|Overall Study||0
10253035|NCT02035137|11384732|FG000|STARTED|Overall Study||38
10253036|NCT02035137|11384733|FG001|STARTED|Overall Study||37
10253037|NCT02035137|11384734|FG002|STARTED|Overall Study||39
10253038|NCT02035137|11384732|FG000|COMPLETED|Overall Study||36
10253039|NCT02035137|11384733|FG001|COMPLETED|Overall Study||35
10253040|NCT02035137|11384734|FG002|COMPLETED|Overall Study||34
10253041|NCT02035137|11384732|FG000|NOT COMPLETED|Overall Study||2
10253042|NCT02035137|11384733|FG001|NOT COMPLETED|Overall Study||2
10253043|NCT02035137|11384734|FG002|NOT COMPLETED|Overall Study||5
10253044|NCT01975571|11384745|FG000|STARTED|Overall Study||15
10253045|NCT01975571|11384746|FG001|STARTED|Overall Study||5
10253046|NCT01975571|11384747|FG002|STARTED|Overall Study||0
10253047|NCT01975571|11384745|FG000|COMPLETED|Overall Study||14
10253048|NCT01975571|11384746|FG001|COMPLETED|Overall Study||3
10253049|NCT01975571|11384747|FG002|COMPLETED|Overall Study||0
10253050|NCT01975571|11384745|FG000|NOT COMPLETED|Overall Study||1
10253051|NCT01975571|11384746|FG001|NOT COMPLETED|Overall Study||2
10253052|NCT01975571|11384747|FG002|NOT COMPLETED|Overall Study||0
10253053|NCT01660451|11384758|FG000|STARTED|Overall Study||33
10253054|NCT01660451|11384759|FG001|STARTED|Overall Study||51
10253055|NCT01660451|11384760|FG002|STARTED|Overall Study||142
10253056|NCT01660451|11384758|FG000|COMPLETED|Overall Study||16
10253057|NCT01660451|11384759|FG001|COMPLETED|Overall Study||34
10253058|NCT01660451|11384760|FG002|COMPLETED|Overall Study||37
10253059|NCT01660451|11384758|FG000|NOT COMPLETED|Overall Study||17
10253060|NCT01660451|11384759|FG001|NOT COMPLETED|Overall Study||17
10253061|NCT01660451|11384760|FG002|NOT COMPLETED|Overall Study||105
10253062|NCT01589523|11384769|FG000|STARTED|Overall Study||5
10253063|NCT01589523|11384769|FG000|COMPLETED|Overall Study||4
10253064|NCT01589523|11384769|FG000|NOT COMPLETED|Overall Study||1
10253065|NCT01566695|11384777|FG000|STARTED|Overall Study||107
10253066|NCT01566695|11384778|FG001|STARTED|Overall Study||109
10253067|NCT01566695|11384777|FG000|COMPLETED|Overall Study||12
10253068|NCT01566695|11384778|FG001|COMPLETED|Overall Study||10
10253069|NCT01566695|11384777|FG000|NOT COMPLETED|Overall Study||95
10253070|NCT01566695|11384778|FG001|NOT COMPLETED|Overall Study||99
9957538|NCT01451437|11076788|FG006|NOT COMPLETED|Overall Study||6
10253071|NCT01256398|11384784|FG000|STARTED|Overall Study||66
10253072|NCT01256398|11384784|FG000|COMPLETED|Overall Study||65
10253073|NCT01256398|11384784|FG000|NOT COMPLETED|Overall Study||1
10253074|NCT01157091|11384788|FG000|STARTED|Overall Study||28
10253075|NCT01157091|11384788|FG000|COMPLETED|Overall Study||28
10253076|NCT01157091|11384788|FG000|NOT COMPLETED|Overall Study||0
10253077|NCT01100775|11384792|FG000|STARTED|Overall Study||6
10253078|NCT01100775|11384793|FG001|STARTED|Overall Study||6
10253079|NCT01100775|11384792|FG000|COMPLETED|Overall Study||6
10253080|NCT01100775|11384793|FG001|COMPLETED|Overall Study||6
10253081|NCT01100775|11384792|FG000|NOT COMPLETED|Overall Study||0
10253082|NCT01100775|11384793|FG001|NOT COMPLETED|Overall Study||0
10253083|NCT00777036|11384802|FG000|STARTED|On Treatment||29
10253084|NCT00777036|11384803|FG001|STARTED|On Treatment||17
10253085|NCT00777036|11384804|FG002|STARTED|On Treatment||84
10253086|NCT00777036|11384802|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14
10253087|NCT00777036|11384803|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1
10253088|NCT00777036|11384804|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61
10253089|NCT00777036|11384802|FG000|NOT COMPLETED|On Treatment||15
10253090|NCT00777036|11384803|FG001|NOT COMPLETED|On Treatment||16
10253091|NCT00777036|11384804|FG002|NOT COMPLETED|On Treatment||23
10253092|NCT00777036|11384802|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
10253093|NCT00777036|11384803|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
10253094|NCT00777036|11384804|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
10253095|NCT00777036|11384802|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
10253096|NCT00777036|11384803|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
10253097|NCT00777036|11384804|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
10253098|NCT00777036|11384802|FG000|NOT COMPLETED|Follow-Up||5
10253099|NCT00777036|11384803|FG001|NOT COMPLETED|Follow-Up||8
10253100|NCT00777036|11384804|FG002|NOT COMPLETED|Follow-Up||4
10253101|NCT00504712|11384821|FG000|STARTED|Overall Study||11
10253102|NCT00504712|11384822|FG001|STARTED|Overall Study||13
10253103|NCT00504712|11384821|FG000|COMPLETED|Overall Study||11
10253104|NCT00504712|11384822|FG001|COMPLETED|Overall Study||13
10253105|NCT00504712|11384821|FG000|NOT COMPLETED|Overall Study||0
10253106|NCT00504712|11384822|FG001|NOT COMPLETED|Overall Study||0
10253107|NCT05097157|11384828|FG000|STARTED|Overall Study||79
10253108|NCT05097157|11384828|FG000|COMPLETED|Overall Study||56
10253109|NCT05097157|11384828|FG000|NOT COMPLETED|Overall Study||23
10253110|NCT04331795|11384834|FG000|STARTED|Overall Study||12
10253111|NCT04331795|11384835|FG001|STARTED|Overall Study||20
10253112|NCT04331795|11384834|FG000|COMPLETED|Overall Study||12
10253113|NCT04331795|11384835|FG001|COMPLETED|Overall Study||20
10253114|NCT04331795|11384834|FG000|NOT COMPLETED|Overall Study||0
10253115|NCT04331795|11384835|FG001|NOT COMPLETED|Overall Study||0
10253116|NCT04175730|11384843|FG000|STARTED|Overall Study||27
10253117|NCT04175730|11384844|FG001|STARTED|Overall Study||21
10253118|NCT04175730|11384843|FG000|COMPLETED|Overall Study||27
10253119|NCT04175730|11384844|FG001|COMPLETED|Overall Study||21
10253120|NCT04175730|11384843|FG000|NOT COMPLETED|Overall Study||0
10253121|NCT04175730|11384844|FG001|NOT COMPLETED|Overall Study||0
10020276|NCT01835431|11143606|FG000|COMPLETED|Overall Study||174
10020277|NCT01835431|11143607|FG001|COMPLETED|Overall Study||168
10020278|NCT01835431|11143606|FG000|NOT COMPLETED|Overall Study||8
10020279|NCT01835431|11143607|FG001|NOT COMPLETED|Overall Study||12
10020280|NCT01835470|11143613|FG000|STARTED|Short Term Treatment Period (to Week 16)||20
10020281|NCT01835470|11143613|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20
10020282|NCT01835470|11143613|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
10020283|NCT01835470|11143613|FG000|STARTED|Long Term Treatment Period||20
10020284|NCT01835470|11143613|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16
10020285|NCT01835470|11143613|FG000|NOT COMPLETED|Long Term Treatment Period||4
10020286|NCT01835496|11143618|FG000|STARTED|Overall Study||8
10020287|NCT01835496|11143618|FG000|COMPLETED|Overall Study||8
10020288|NCT01835496|11143618|FG000|NOT COMPLETED|Overall Study||0
10020289|NCT01835548|11143624|FG000|STARTED|Screening/Washout Period||0
10020290|NCT01835548|11143625|FG001|STARTED|Screening/Washout Period||0
10253122|NCT03724487|11384852|FG000|STARTED|Overall Study||30
10253123|NCT03724487|11384853|FG001|STARTED|Overall Study||30
10253124|NCT03724487|11384852|FG000|COMPLETED|Overall Study||30
10253125|NCT03724487|11384853|FG001|COMPLETED|Overall Study||30
10253126|NCT03724487|11384852|FG000|NOT COMPLETED|Overall Study||0
10253127|NCT03724487|11384853|FG001|NOT COMPLETED|Overall Study||0
10253128|NCT03703102|11384865|FG000|STARTED|Overall Study||54
10253129|NCT03703102|11384866|FG001|STARTED|Overall Study||53
10253130|NCT03703102|11384867|FG002|STARTED|Overall Study||55
10253131|NCT03703102|11384868|FG003|STARTED|Overall Study||54
10253132|NCT03703102|11384869|FG004|STARTED|Overall Study||57
10253133|NCT03703102|11384865|FG000|Completed Treatment Period A|Overall Study||42
10253134|NCT03703102|11384866|FG001|Completed Treatment Period A|Overall Study||41
10253135|NCT03703102|11384867|FG002|Completed Treatment Period A|Overall Study||42
10253136|NCT03703102|11384868|FG003|Completed Treatment Period A|Overall Study||46
10253137|NCT03703102|11384869|FG004|Completed Treatment Period A|Overall Study||34
10253138|NCT03703102|11384865|FG000|Completed Treatment Period B|Overall Study||33
10253139|NCT03703102|11384866|FG001|Completed Treatment Period B|Overall Study||39
10253140|NCT03703102|11384867|FG002|Completed Treatment Period B|Overall Study||37
10253141|NCT03703102|11384868|FG003|Completed Treatment Period B|Overall Study||38
10253142|NCT03703102|11384869|FG004|Completed Treatment Period B|Overall Study||26
10253143|NCT03703102|11384865|FG000|COMPLETED|Overall Study||32
10253144|NCT03703102|11384866|FG001|COMPLETED|Overall Study||38
10253145|NCT03703102|11384867|FG002|COMPLETED|Overall Study||33
10253146|NCT03703102|11384868|FG003|COMPLETED|Overall Study||37
10253147|NCT03703102|11384869|FG004|COMPLETED|Overall Study||24
10253148|NCT03703102|11384865|FG000|NOT COMPLETED|Overall Study||22
10253149|NCT03703102|11384866|FG001|NOT COMPLETED|Overall Study||15
10253150|NCT03703102|11384867|FG002|NOT COMPLETED|Overall Study||22
10253151|NCT03703102|11384868|FG003|NOT COMPLETED|Overall Study||17
10253152|NCT03703102|11384869|FG004|NOT COMPLETED|Overall Study||33
10253153|NCT03395704|11384888|FG000|STARTED|Overall Study||34
10253154|NCT03395704|11384889|FG001|STARTED|Overall Study||36
10253155|NCT03395704|11384888|FG000|Safety Population|Overall Study||34
10253156|NCT03395704|11384889|FG001|Safety Population|Overall Study||35
10253157|NCT03395704|11384888|FG000|Analysis Population|Overall Study||21
10253158|NCT03395704|11384889|FG001|Analysis Population|Overall Study||28
10253159|NCT03395704|11384888|FG000|COMPLETED|Overall Study||30
10253160|NCT03395704|11384889|FG001|COMPLETED|Overall Study||33
10253161|NCT03395704|11384888|FG000|NOT COMPLETED|Overall Study||4
10253162|NCT03395704|11384889|FG001|NOT COMPLETED|Overall Study||3
10253163|NCT03335813|11384895|FG000|STARTED|Overall Study||7
10253164|NCT03335813|11384895|FG000|COMPLETED|Overall Study||6
10253165|NCT03335813|11384895|FG000|NOT COMPLETED|Overall Study||1
10253166|NCT03246503|11384899|FG000|STARTED|Overall Study||203
10253167|NCT03246503|11384899|FG000|COMPLETED|Overall Study||150
10253168|NCT03246503|11384899|FG000|NOT COMPLETED|Overall Study||53
10253169|NCT03039595|11384903|FG000|STARTED|Overall Study||150
10253170|NCT03039595|11384903|FG000|COMPLETED|Overall Study||143
10253171|NCT03039595|11384903|FG000|NOT COMPLETED|Overall Study||7
10253172|NCT02864368|11384912|FG000|STARTED|Overall Study||4
10253173|NCT02864368|11384913|FG001|STARTED|Overall Study||1
10253174|NCT02864368|11384914|FG002|STARTED|Overall Study||6
10253175|NCT02864368|11384915|FG003|STARTED|Overall Study||8
10253176|NCT02864368|11384916|FG004|STARTED|Overall Study||8
10253177|NCT02864368|11384912|FG000|COMPLETED|Overall Study||4
10253178|NCT02864368|11384913|FG001|COMPLETED|Overall Study||1
10253179|NCT02864368|11384914|FG002|COMPLETED|Overall Study||6
10253180|NCT02864368|11384915|FG003|COMPLETED|Overall Study||8
10253181|NCT02864368|11384916|FG004|COMPLETED|Overall Study||8
10253182|NCT02864368|11384912|FG000|NOT COMPLETED|Overall Study||0
10253183|NCT02864368|11384913|FG001|NOT COMPLETED|Overall Study||0
10253184|NCT02864368|11384914|FG002|NOT COMPLETED|Overall Study||0
10253185|NCT02864368|11384915|FG003|NOT COMPLETED|Overall Study||0
10253186|NCT02864368|11384916|FG004|NOT COMPLETED|Overall Study||0
10253187|NCT02856698|11384935|FG000|STARTED|Overall Study||55
10253188|NCT02856698|11384936|FG001|STARTED|Overall Study||56
10253189|NCT02856698|11384935|FG000|COMPLETED|Overall Study||48
10253190|NCT02856698|11384936|FG001|COMPLETED|Overall Study||46
10253191|NCT02856698|11384935|FG000|NOT COMPLETED|Overall Study||7
10253192|NCT02856698|11384936|FG001|NOT COMPLETED|Overall Study||10
10253193|NCT02625610|11384944|FG000|STARTED|Overall Study||250
10253194|NCT02625610|11384945|FG001|STARTED|Overall Study||249
10253195|NCT02625610|11384944|FG000|Safety-Maintenance Analysis Set|Overall Study||238
10253196|NCT02625610|11384945|FG001|Safety-Maintenance Analysis Set|Overall Study||243
10253197|NCT02625610|11384944|FG000|COMPLETED|Overall Study||250
10253198|NCT02625610|11384945|FG001|COMPLETED|Overall Study||249
10253199|NCT02625610|11384944|FG000|NOT COMPLETED|Overall Study||0
10253200|NCT02625610|11384945|FG001|NOT COMPLETED|Overall Study||0
10253201|NCT02514447|11384960|FG000|STARTED|Overall Study||29
10253202|NCT02514447|11384961|FG001|STARTED|Overall Study||30
10253203|NCT02514447|11384962|FG002|STARTED|Overall Study||32
10253204|NCT02514447|11384963|FG003|STARTED|Overall Study||2
10253205|NCT02514447|11384964|FG004|STARTED|Overall Study||3
10253206|NCT02514447|11384965|FG005|STARTED|Overall Study||4
10253207|NCT02514447|11384966|FG006|STARTED|Overall Study||8
10253208|NCT02514447|11384967|FG007|STARTED|Overall Study||7
10253209|NCT02514447|11384968|FG008|STARTED|Overall Study||8
10253210|NCT02514447|11384960|FG000|COMPLETED|Overall Study||0
10253211|NCT02514447|11384961|FG001|COMPLETED|Overall Study||0
10253212|NCT02514447|11384962|FG002|COMPLETED|Overall Study||0
10253213|NCT02514447|11384963|FG003|COMPLETED|Overall Study||0
10253214|NCT02514447|11384964|FG004|COMPLETED|Overall Study||0
10253215|NCT02514447|11384965|FG005|COMPLETED|Overall Study||0
10253216|NCT02514447|11384966|FG006|COMPLETED|Overall Study||0
10253217|NCT02514447|11384967|FG007|COMPLETED|Overall Study||0
10253218|NCT02514447|11384968|FG008|COMPLETED|Overall Study||0
10253219|NCT02514447|11384960|FG000|NOT COMPLETED|Overall Study||29
10253220|NCT02514447|11384961|FG001|NOT COMPLETED|Overall Study||30
10253221|NCT02514447|11384962|FG002|NOT COMPLETED|Overall Study||32
10253222|NCT02514447|11384963|FG003|NOT COMPLETED|Overall Study||2
10253223|NCT02514447|11384964|FG004|NOT COMPLETED|Overall Study||3
10253224|NCT02514447|11384965|FG005|NOT COMPLETED|Overall Study||4
10253225|NCT02514447|11384966|FG006|NOT COMPLETED|Overall Study||8
10253226|NCT02514447|11384967|FG007|NOT COMPLETED|Overall Study||7
10253227|NCT02514447|11384968|FG008|NOT COMPLETED|Overall Study||8
10253228|NCT02288247|11385008|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688
10253229|NCT02288247|11385009|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0
10253230|NCT02288247|11385008|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687
10253231|NCT02288247|11385009|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0
10253232|NCT02288247|11385008|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41
10253233|NCT02288247|11385009|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
10020291|NCT01835548|11143626|FG002|STARTED|Screening/Washout Period||87
10020292|NCT01835548|11143624|FG000|COMPLETED|Screening/Washout Period||0
10020293|NCT01835548|11143625|FG001|COMPLETED|Screening/Washout Period||0
10020294|NCT01835548|11143626|FG002|COMPLETED|Screening/Washout Period||87
10020295|NCT01835548|11143624|FG000|NOT COMPLETED|Screening/Washout Period||0
10020296|NCT01835548|11143625|FG001|NOT COMPLETED|Screening/Washout Period||0
10020297|NCT01835548|11143626|FG002|NOT COMPLETED|Screening/Washout Period||0
10020298|NCT01835548|11143624|FG000|STARTED|Dose Optimization Period||0
10020299|NCT01835548|11143625|FG001|STARTED|Dose Optimization Period||0
10020300|NCT01835548|11143626|FG002|STARTED|Dose Optimization Period||87
10020301|NCT01835548|11143624|FG000|COMPLETED|Dose Optimization Period||0
10020302|NCT01835548|11143625|FG001|COMPLETED|Dose Optimization Period||0
10020303|NCT01835548|11143626|FG002|COMPLETED|Dose Optimization Period||85
10020304|NCT01835548|11143624|FG000|NOT COMPLETED|Dose Optimization Period||0
10253234|NCT02288247|11385008|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647
10253235|NCT02288247|11385009|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
10253236|NCT02288247|11385008|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137
10253237|NCT02288247|11385009|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136
10020305|NCT01835548|11143625|FG001|NOT COMPLETED|Dose Optimization Period||0
10020306|NCT01835548|11143626|FG002|NOT COMPLETED|Dose Optimization Period||2
10020307|NCT01835548|11143624|FG000|STARTED|Dose Stabilization Period||0
10253238|NCT02288247|11385008|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136
10253239|NCT02288247|11385009|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135
10253240|NCT02288247|11385008|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
10253241|NCT02288247|11385009|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
10253242|NCT02288247|11385008|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136
10253243|NCT02288247|11385009|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135
10253244|NCT02031978|11385017|FG000|STARTED|Overall Study||4367
10253245|NCT02031978|11385017|FG000|COMPLETED|Overall Study||4367
10253246|NCT02031978|11385017|FG000|NOT COMPLETED|Overall Study||0
10253247|NCT01785563|11385021|FG000|STARTED|Overall Study||40
10253248|NCT01785563|11385021|FG000|COMPLETED|Overall Study||27
10253249|NCT01785563|11385021|FG000|NOT COMPLETED|Overall Study||13
10253250|NCT01732120|11385027|FG000|STARTED|Overall Study||40
10253251|NCT01732120|11385028|FG001|STARTED|Overall Study||40
10253252|NCT01732120|11385027|FG000|COMPLETED|Overall Study||40
10253253|NCT01732120|11385028|FG001|COMPLETED|Overall Study||40
10253254|NCT01732120|11385027|FG000|NOT COMPLETED|Overall Study||0
10253255|NCT01732120|11385028|FG001|NOT COMPLETED|Overall Study||0
10253256|NCT01434290|11385036|FG000|STARTED|Overall Study||127
10253257|NCT01434290|11385037|FG001|STARTED|Overall Study||128
10253258|NCT01434290|11385036|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119
10253259|NCT01434290|11385037|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121
10253260|NCT01434290|11385036|FG000|NOT COMPLETED|Overall Study||8
10253261|NCT01434290|11385037|FG001|NOT COMPLETED|Overall Study||7
10253262|NCT01062399|11385049|FG000|STARTED|Overall Study||8
10253263|NCT01062399|11385050|FG001|STARTED|Overall Study||10
10253264|NCT01062399|11385051|FG002|STARTED|Overall Study||8
10253265|NCT01062399|11385052|FG003|STARTED|Overall Study||89
10253266|NCT01062399|11385053|FG004|STARTED|Overall Study||92
10253267|NCT01062399|11385049|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
10253268|NCT01062399|11385050|FG001|COMPLETED|Overall Study||9
10253269|NCT01062399|11385051|FG002|COMPLETED|Overall Study||8
10253270|NCT01062399|11385052|FG003|COMPLETED|Overall Study||83
10253271|NCT01062399|11385053|FG004|COMPLETED|Overall Study||88
10253272|NCT01062399|11385049|FG000|NOT COMPLETED|Overall Study||0
10253273|NCT01062399|11385050|FG001|NOT COMPLETED|Overall Study||1
10253274|NCT01062399|11385051|FG002|NOT COMPLETED|Overall Study||0
10253275|NCT01062399|11385052|FG003|NOT COMPLETED|Overall Study||6
10253276|NCT01062399|11385053|FG004|NOT COMPLETED|Overall Study||4
10253277|NCT00750269|11385070|FG000|STARTED|Overall Study||8
10253278|NCT00750269|11385071|FG001|STARTED|Overall Study||8
10253279|NCT00750269|11385072|FG002|STARTED|Overall Study||18
10253280|NCT00750269|11385073|FG003|STARTED|Overall Study||43
10253281|NCT00750269|11385074|FG004|STARTED|Overall Study||43
10253282|NCT00750269|11385070|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
10253283|NCT00750269|11385071|FG001|COMPLETED|Overall Study||7
10253284|NCT00750269|11385072|FG002|COMPLETED|Overall Study||14
10253285|NCT00750269|11385073|FG003|COMPLETED|Overall Study||38
10253286|NCT00750269|11385074|FG004|COMPLETED|Overall Study||33
10253287|NCT00750269|11385070|FG000|NOT COMPLETED|Overall Study||0
10253288|NCT00750269|11385071|FG001|NOT COMPLETED|Overall Study||1
10253289|NCT00750269|11385072|FG002|NOT COMPLETED|Overall Study||4
10253290|NCT00750269|11385073|FG003|NOT COMPLETED|Overall Study||5
10253291|NCT00750269|11385074|FG004|NOT COMPLETED|Overall Study||10
9834074|NCT00783718|10945066|FG000|COMPLETED|Maintenance Phase||30
9834075|NCT00783718|10945067|FG001|COMPLETED|Maintenance Phase||0
9834076|NCT00783718|10945068|FG002|COMPLETED|Maintenance Phase||0
9834077|NCT00783718|10945069|FG003|COMPLETED|Maintenance Phase||48
9834078|NCT00783718|10945070|FG004|COMPLETED|Maintenance Phase||77
9834079|NCT00783718|10945071|FG005|COMPLETED|Maintenance Phase||84
9834080|NCT00783718|10945072|FG006|COMPLETED|Maintenance Phase||135
10020308|NCT01835548|11143625|FG001|STARTED|Dose Stabilization Period||0
10253292|NCT00712322|11385096|FG000|STARTED|Overall Study||12
10253293|NCT00712322|11385097|FG001|STARTED|Overall Study||14
10253294|NCT00712322|11385098|FG002|STARTED|Overall Study||9
10253295|NCT00712322|11385096|FG000|COMPLETED|Overall Study||12
10253296|NCT00712322|11385097|FG001|COMPLETED|Overall Study||13
10253297|NCT00712322|11385098|FG002|COMPLETED|Overall Study||9
10253298|NCT00712322|11385096|FG000|NOT COMPLETED|Overall Study||0
10253299|NCT00712322|11385097|FG001|NOT COMPLETED|Overall Study||1
10253300|NCT00712322|11385098|FG002|NOT COMPLETED|Overall Study||0
10253301|NCT00323856|11385106|FG000|STARTED|Overall Study||50
10253302|NCT00323856|11385106|FG000|COMPLETED|Overall Study||45
10253303|NCT00323856|11385106|FG000|NOT COMPLETED|Overall Study||5
10253304|NCT00103038|11385110|FG000|STARTED|Overall Study||155
10253305|NCT00103038|11385110|FG000|COMPLETED|Overall Study||142
10253306|NCT00103038|11385110|FG000|NOT COMPLETED|Overall Study||13
9834081|NCT00783718|10945066|FG000|NOT COMPLETED|Maintenance Phase||105
9834082|NCT00783718|10945067|FG001|NOT COMPLETED|Maintenance Phase||0
9834083|NCT00783718|10945068|FG002|NOT COMPLETED|Maintenance Phase||0
10253307|NCT05086835|11385117|FG000|STARTED|Overall Study||10
10253308|NCT05086835|11385117|FG000|COMPLETED|Overall Study||10
10253309|NCT05086835|11385117|FG000|NOT COMPLETED|Overall Study||0
10253310|NCT04524663|11385126|FG000|STARTED|Overall Study||25
10253311|NCT04524663|11385127|FG001|STARTED|Overall Study||24
10253312|NCT04524663|11385126|FG000|COMPLETED|Overall Study||25
10253313|NCT04524663|11385127|FG001|COMPLETED|Overall Study||22
10253314|NCT04524663|11385126|FG000|NOT COMPLETED|Overall Study||0
10253315|NCT04524663|11385127|FG001|NOT COMPLETED|Overall Study||2
10253316|NCT04435795|11385135|FG000|STARTED|Overall Study||108
10253317|NCT04435795|11385136|FG001|STARTED|Overall Study||107
10253318|NCT04435795|11385135|FG000|COMPLETED|Overall Study||105
10253319|NCT04435795|11385136|FG001|COMPLETED|Overall Study||98
10253320|NCT04435795|11385135|FG000|NOT COMPLETED|Overall Study||3
10253321|NCT04435795|11385136|FG001|NOT COMPLETED|Overall Study||9
10253322|NCT04350593|11385144|FG000|STARTED|Overall Study||625
10253323|NCT04350593|11385145|FG001|STARTED|Overall Study||625
10253324|NCT04350593|11385144|FG000|COMPLETED|Overall Study||617
10253325|NCT04350593|11385145|FG001|COMPLETED|Overall Study||620
10253326|NCT04350593|11385144|FG000|NOT COMPLETED|Overall Study||8
10253327|NCT04350593|11385145|FG001|NOT COMPLETED|Overall Study||5
10253328|NCT04208243|11385151|FG000|STARTED|Overall Study||83
10253329|NCT04208243|11385151|FG000|COMPLETED|Overall Study||83
10253330|NCT04208243|11385151|FG000|NOT COMPLETED|Overall Study||0
10253331|NCT04067518|11385157|FG000|STARTED|Overall Study||3
10020309|NCT01835548|11143626|FG002|STARTED|Dose Stabilization Period||85
10253332|NCT04067518|11385158|FG001|STARTED|Overall Study||25
10020310|NCT01835548|11143624|FG000|COMPLETED|Dose Stabilization Period||0
10253333|NCT04067518|11385157|FG000|Safety Analysis Set|Overall Study||3
10253334|NCT04067518|11385158|FG001|Safety Analysis Set|Overall Study||23
10253335|NCT04067518|11385157|FG000|Full Analysis Set|Overall Study||0
10253336|NCT04067518|11385158|FG001|Full Analysis Set|Overall Study||23
10253337|NCT04067518|11385157|FG000|Immunogenicity Analysis Set|Overall Study||3
10253338|NCT04067518|11385158|FG001|Immunogenicity Analysis Set|Overall Study||22
10253339|NCT04067518|11385157|FG000|Pharmacokinetic Analysis Set|Overall Study||3
10253340|NCT04067518|11385158|FG001|Pharmacokinetic Analysis Set|Overall Study||23
10253341|NCT04067518|11385157|FG000|COMPLETED|Overall Study||0
10253342|NCT04067518|11385158|FG001|COMPLETED|Overall Study||0
10253343|NCT04067518|11385157|FG000|NOT COMPLETED|Overall Study||3
10253344|NCT04067518|11385158|FG001|NOT COMPLETED|Overall Study||25
10253345|NCT03866473|11385167|FG000|STARTED|Phase 1||69
10253346|NCT03866473|11385168|FG001|STARTED|Phase 1||66
10253347|NCT03866473|11385167|FG000|COMPLETED|Phase 1||68
10253348|NCT03866473|11385168|FG001|COMPLETED|Phase 1||66
10253349|NCT03866473|11385167|FG000|NOT COMPLETED|Phase 1||1
10253350|NCT03866473|11385168|FG001|NOT COMPLETED|Phase 1||0
10253351|NCT03866473|11385167|FG000|STARTED|Phase 2|Three participants completed the study by receiving alternate treatment for diabetic macular edema in phase 1 and 3 were dropped.|62
10253352|NCT03866473|11385168|FG001|STARTED|Phase 2||61
10253353|NCT03866473|11385167|FG000|COMPLETED|Phase 2||60
10253354|NCT03866473|11385168|FG001|COMPLETED|Phase 2|One participant completed the study by receiving alternate treatment for diabetic macular edema in Phase 1 and 4 participants were dropped.|58
10253355|NCT03866473|11385167|FG000|NOT COMPLETED|Phase 2||2
10253356|NCT03866473|11385168|FG001|NOT COMPLETED|Phase 2||3
10253357|NCT03738423|11385183|FG000|STARTED|Overall Study||25
10253358|NCT03738423|11385184|FG001|STARTED|Overall Study||26
10253359|NCT03738423|11385185|FG002|STARTED|Overall Study||27
10253360|NCT03738423|11385186|FG003|STARTED|Overall Study||25
10253361|NCT03738423|11385187|FG004|STARTED|Overall Study||26
10253362|NCT03738423|11385183|FG000|Treated|Overall Study||25
10253363|NCT03738423|11385184|FG001|Treated|Overall Study||26
10253364|NCT03738423|11385185|FG002|Treated|Overall Study||26
10253365|NCT03738423|11385186|FG003|Treated|Overall Study||24
10253366|NCT03738423|11385187|FG004|Treated|Overall Study||26
10253367|NCT03738423|11385183|FG000|COMPLETED|Overall Study||11
10253368|NCT03738423|11385184|FG001|COMPLETED|Overall Study||13
10253369|NCT03738423|11385185|FG002|COMPLETED|Overall Study||14
10253370|NCT03738423|11385186|FG003|COMPLETED|Overall Study||10
10253371|NCT03738423|11385187|FG004|COMPLETED|Overall Study||11
9834084|NCT00783718|10945069|FG003|NOT COMPLETED|Maintenance Phase||78
9834085|NCT00783718|10945070|FG004|NOT COMPLETED|Maintenance Phase||45
9834086|NCT00783718|10945071|FG005|NOT COMPLETED|Maintenance Phase||41
9834087|NCT00783718|10945072|FG006|NOT COMPLETED|Maintenance Phase||195
9834088|NCT00783796|10945082|FG000|STARTED|Overall Study||150
9834089|NCT00783796|10945082|FG000|COMPLETED|Overall Study||144
9834090|NCT00783796|10945082|FG000|NOT COMPLETED|Overall Study||6
9834091|NCT00783835|10945088|FG000|STARTED|Overall Study||60
9834092|NCT00783835|10945088|FG000|COMPLETED|Overall Study||50
9834093|NCT00783835|10945088|FG000|NOT COMPLETED|Overall Study||10
9834094|NCT00783952|10945092|FG000|STARTED|Overall Study||8
9834095|NCT00783952|10945092|FG000|COMPLETED|Overall Study||8
9834096|NCT00783952|10945092|FG000|NOT COMPLETED|Overall Study||0
9834097|NCT00783965|10945099|FG000|STARTED|First Intervention (12 Months)||5
9834098|NCT00783965|10945100|FG001|STARTED|First Intervention (12 Months)||29
9834099|NCT00783965|10945099|FG000|COMPLETED|First Intervention (12 Months)||2
9834100|NCT00783965|10945100|FG001|COMPLETED|First Intervention (12 Months)||25
9834101|NCT00783965|10945099|FG000|NOT COMPLETED|First Intervention (12 Months)||3
9834102|NCT00783965|10945100|FG001|NOT COMPLETED|First Intervention (12 Months)||4
9834103|NCT00783965|10945099|FG000|STARTED|Second Intervention (24 Months)||2
9834104|NCT00783965|10945100|FG001|STARTED|Second Intervention (24 Months)||25
9834105|NCT00783965|10945099|FG000|COMPLETED|Second Intervention (24 Months)||2
9834106|NCT00783965|10945100|FG001|COMPLETED|Second Intervention (24 Months)||16
9834107|NCT00783965|10945099|FG000|NOT COMPLETED|Second Intervention (24 Months)||0
9834108|NCT00783965|10945100|FG001|NOT COMPLETED|Second Intervention (24 Months)||9
9834109|NCT00784030|10945108|FG000|STARTED|Overall Study||13
9834110|NCT00784030|10945109|FG001|STARTED|Overall Study||10
9834111|NCT00784030|10945108|FG000|COMPLETED|Overall Study||13
9834112|NCT00784030|10945109|FG001|COMPLETED|Overall Study||10
9834113|NCT00784030|10945108|FG000|NOT COMPLETED|Overall Study||0
9834114|NCT00784030|10945109|FG001|NOT COMPLETED|Overall Study||0
9834115|NCT00784095|10945118|FG000|STARTED|Overall Study||12
9834116|NCT00784095|10945119|FG001|STARTED|Overall Study||12
9834117|NCT00784095|10945120|FG002|STARTED|Overall Study||12
9834118|NCT00784095|10945118|FG000|COMPLETED|Overall Study||12
9834119|NCT00784095|10945119|FG001|COMPLETED|Overall Study||11
10253372|NCT03738423|11385183|FG000|NOT COMPLETED|Overall Study||14
10253373|NCT03738423|11385184|FG001|NOT COMPLETED|Overall Study||13
10253374|NCT03738423|11385185|FG002|NOT COMPLETED|Overall Study||13
9834120|NCT00784095|10945120|FG002|COMPLETED|Overall Study||11
9834121|NCT00784095|10945118|FG000|NOT COMPLETED|Overall Study||0
10253375|NCT03738423|11385186|FG003|NOT COMPLETED|Overall Study||15
10253376|NCT03738423|11385187|FG004|NOT COMPLETED|Overall Study||15
9834122|NCT00784095|10945119|FG001|NOT COMPLETED|Overall Study||1
9834123|NCT00784095|10945120|FG002|NOT COMPLETED|Overall Study||1
9834124|NCT00784134|10945133|FG000|STARTED|Overall Study||249
9834125|NCT00784134|10945134|FG001|STARTED|Overall Study||251
9834126|NCT00784134|10945133|FG000|COMPLETED|Overall Study||246
9834127|NCT00784134|10945134|FG001|COMPLETED|Overall Study||245
9834128|NCT00784134|10945133|FG000|NOT COMPLETED|Overall Study||3
9834129|NCT00784134|10945134|FG001|NOT COMPLETED|Overall Study||6
9834130|NCT00784147|10945142|FG000|STARTED|Overall Study||59
10253377|NCT03600818|11385201|FG000|STARTED|Overall Study||58
10253378|NCT03600818|11385202|FG001|STARTED|Overall Study||60
10253379|NCT03600818|11385201|FG000|Safety Population|Overall Study||58
10253380|NCT03600818|11385202|FG001|Safety Population|Overall Study||59
10253381|NCT03600818|11385201|FG000|COMPLETED|Overall Study||36
10253382|NCT03600818|11385202|FG001|COMPLETED|Overall Study||42
10253383|NCT03600818|11385201|FG000|NOT COMPLETED|Overall Study||22
10253384|NCT03600818|11385202|FG001|NOT COMPLETED|Overall Study||18
10253385|NCT03578276|11385211|FG000|STARTED|Overall Study||35
10113952|NCT02512783|11244663|FG001|COMPLETED|Overall Study||75
10253386|NCT03578276|11385212|FG001|STARTED|Overall Study||35
10253387|NCT03578276|11385211|FG000|COMPLETED|Overall Study||33
10253388|NCT03578276|11385212|FG001|COMPLETED|Overall Study||33
10253389|NCT03578276|11385211|FG000|NOT COMPLETED|Overall Study||2
10253390|NCT03578276|11385212|FG001|NOT COMPLETED|Overall Study||2
10253391|NCT03257696|11385220|FG000|STARTED|Overall Study||123
10253392|NCT03257696|11385221|FG001|STARTED|Overall Study||29
10253393|NCT03257696|11385220|FG000|COMPLETED|Overall Study||123
10253394|NCT03257696|11385221|FG001|COMPLETED|Overall Study||29
10253395|NCT03257696|11385220|FG000|NOT COMPLETED|Overall Study||0
10253396|NCT03257696|11385221|FG001|NOT COMPLETED|Overall Study||0
10253397|NCT03035409|11385227|FG000|STARTED|Overall Study||45
10253398|NCT03035409|11385227|FG000|Day 15|Overall Study||28
10253399|NCT03035409|11385227|FG000|Day 29|Overall Study||28
10253400|NCT03035409|11385227|FG000|Day 43|Overall Study||28
10253401|NCT03035409|11385227|FG000|COMPLETED|Overall Study||28
10253402|NCT03035409|11385227|FG000|NOT COMPLETED|Overall Study||17
10253403|NCT02971761|11385231|FG000|STARTED|Overall Study||18
10253404|NCT02971761|11385231|FG000|COMPLETED|Overall Study||16
10253405|NCT02971761|11385231|FG000|NOT COMPLETED|Overall Study||2
10253406|NCT02900560|11385239|FG000|STARTED|Overall Study||9
10253407|NCT02900560|11385240|FG001|STARTED|Overall Study||10
10253408|NCT02900560|11385241|FG002|STARTED|Overall Study||7
10253409|NCT02900560|11385242|FG003|STARTED|Overall Study||8
10253410|NCT02900560|11385239|FG000|COMPLETED|Overall Study||7
10253411|NCT02900560|11385240|FG001|COMPLETED|Overall Study||10
10253412|NCT02900560|11385241|FG002|COMPLETED|Overall Study||7
10253413|NCT02900560|11385242|FG003|COMPLETED|Overall Study||8
10253414|NCT02900560|11385239|FG000|NOT COMPLETED|Overall Study||2
10253415|NCT02900560|11385240|FG001|NOT COMPLETED|Overall Study||0
10253416|NCT02900560|11385241|FG002|NOT COMPLETED|Overall Study||0
10253417|NCT02900560|11385242|FG003|NOT COMPLETED|Overall Study||0
10253418|NCT02366403|11385254|FG000|STARTED|Overall Study||41
10253419|NCT02366403|11385255|FG001|STARTED|Overall Study||44
10253420|NCT02366403|11385254|FG000|COMPLETED|Overall Study||30
10253421|NCT02366403|11385255|FG001|COMPLETED|Overall Study||29
10253422|NCT02366403|11385254|FG000|NOT COMPLETED|Overall Study||11
10253423|NCT02366403|11385255|FG001|NOT COMPLETED|Overall Study||15
10253424|NCT02220894|11385263|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637
10253425|NCT02220894|11385264|FG001|STARTED|Overall Study||637
10253426|NCT02220894|11385263|FG000|Treated|Overall Study||636
10253427|NCT02220894|11385264|FG001|Treated|Overall Study||615
10253428|NCT02220894|11385263|FG000|COMPLETED|Overall Study||0
10253429|NCT02220894|11385264|FG001|COMPLETED|Overall Study||0
10253430|NCT02220894|11385263|FG000|NOT COMPLETED|Overall Study||637
10253431|NCT02220894|11385264|FG001|NOT COMPLETED|Overall Study||637
10253432|NCT02112526|11385272|FG000|STARTED|Overall Study||11
10253433|NCT02112526|11385273|FG001|STARTED|Overall Study||10
10253434|NCT02112526|11385272|FG000|Enrolled|Overall Study||11
10253435|NCT02112526|11385273|FG001|Enrolled|Overall Study||10
10253436|NCT02112526|11385272|FG000|Received Study Medication|Overall Study||11
10253437|NCT02112526|11385273|FG001|Received Study Medication|Overall Study||10
10253438|NCT02112526|11385272|FG000|Discontinued Study|Overall Study||11
10253439|NCT02112526|11385273|FG001|Discontinued Study|Overall Study||9
10253440|NCT02112526|11385272|FG000|Subjects Continuing Study Medication|Overall Study||0
10253441|NCT02112526|11385273|FG001|Subjects Continuing Study Medication|Overall Study||1
10253442|NCT02112526|11385272|FG000|COMPLETED|Overall Study||0
10253443|NCT02112526|11385273|FG001|COMPLETED|Overall Study||1
10253444|NCT02112526|11385272|FG000|NOT COMPLETED|Overall Study||11
10253445|NCT02112526|11385273|FG001|NOT COMPLETED|Overall Study||9
10253446|NCT01968213|11385281|FG000|STARTED|Overall Study||375
10253447|NCT01968213|11385282|FG001|STARTED|Overall Study||189
10253448|NCT01968213|11385281|FG000|COMPLETED|Overall Study||285
10253449|NCT01968213|11385282|FG001|COMPLETED|Overall Study||180
10253450|NCT01968213|11385281|FG000|NOT COMPLETED|Overall Study||90
10253451|NCT01968213|11385282|FG001|NOT COMPLETED|Overall Study||9
10253452|NCT01843374|11385290|FG000|STARTED|Overall Study||189
10253453|NCT01843374|11385291|FG001|STARTED|Overall Study||382
10253454|NCT01843374|11385290|FG000|RANDOMIZED|Overall Study||189
10253455|NCT01843374|11385291|FG001|RANDOMIZED|Overall Study||382
10253456|NCT01843374|11385290|FG000|COMPLETED|Overall Study||0
10253457|NCT01843374|11385291|FG001|COMPLETED|Overall Study||3
10253458|NCT01843374|11385290|FG000|NOT COMPLETED|Overall Study||189
10253459|NCT01843374|11385291|FG001|NOT COMPLETED|Overall Study||379
10253460|NCT01656486|11385300|FG000|STARTED|Overall Study||1
10253461|NCT01656486|11385300|FG000|COMPLETED|Overall Study||1
10253462|NCT01656486|11385300|FG000|NOT COMPLETED|Overall Study||0
10253463|NCT01627574|11385306|FG000|STARTED|Overall Study||142
10253464|NCT01627574|11385307|FG001|STARTED|Overall Study||130
10253465|NCT01627574|11385306|FG000|COMPLETED|Overall Study||121
10253466|NCT01627574|11385307|FG001|COMPLETED|Overall Study||112
10253467|NCT01627574|11385306|FG000|NOT COMPLETED|Overall Study||21
10253468|NCT01627574|11385307|FG001|NOT COMPLETED|Overall Study||18
10253469|NCT01498458|11385313|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
10253470|NCT01498458|11385313|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
10253471|NCT01498458|11385313|FG000|NOT COMPLETED|Overall Study||7
10253472|NCT01427712|11385322|FG000|STARTED|Overall Study||24
10253473|NCT01427712|11385322|FG000|Collected CRFs|Overall Study||21
10253474|NCT01427712|11385322|FG000|Safety Analysis Set|Overall Study||21
10253475|NCT01427712|11385322|FG000|COMPLETED|Overall Study||17
10253476|NCT01427712|11385322|FG000|NOT COMPLETED|Overall Study||7
10253477|NCT01369147|11385329|FG000|STARTED|Overall Study||3
10253478|NCT01369147|11385330|FG001|STARTED|Overall Study||5
10253479|NCT01369147|11385331|FG002|STARTED|Overall Study||4
10253480|NCT01369147|11385329|FG000|COMPLETED|Overall Study||3
10253481|NCT01369147|11385330|FG001|COMPLETED|Overall Study||4
10253482|NCT01369147|11385331|FG002|COMPLETED|Overall Study||4
10253483|NCT01369147|11385329|FG000|NOT COMPLETED|Overall Study||0
9834131|NCT00784147|10945143|FG001|STARTED|Overall Study||54
9834132|NCT00784147|10945142|FG000|COMPLETED|Overall Study||51
9834133|NCT00784147|10945143|FG001|COMPLETED|Overall Study||45
9834134|NCT00784147|10945142|FG000|NOT COMPLETED|Overall Study||8
9834135|NCT00784147|10945143|FG001|NOT COMPLETED|Overall Study||9
9834136|NCT00784225|10945153|FG000|STARTED|Overall Study||3375
10253484|NCT01369147|11385330|FG001|NOT COMPLETED|Overall Study||1
10253485|NCT01369147|11385331|FG002|NOT COMPLETED|Overall Study||0
10253486|NCT01097746|11385339|FG000|STARTED|Overall Study||33
10253487|NCT01097746|11385339|FG000|COMPLETED|Overall Study||28
10253488|NCT01097746|11385339|FG000|NOT COMPLETED|Overall Study||5
10253489|NCT01079780|11385346|FG000|STARTED|Overall Study||70
10253490|NCT01079780|11385347|FG001|STARTED|Overall Study||16
10253491|NCT01079780|11385348|FG002|STARTED|Overall Study||50
10253492|NCT01079780|11385346|FG000|Started Protocol Therapy|Overall Study||69
10253493|NCT01079780|11385347|FG001|Started Protocol Therapy|Overall Study||16
10253494|NCT01079780|11385348|FG002|Started Protocol Therapy|Overall Study||48
10253495|NCT01079780|11385346|FG000|Treated Patients With Toxicity Data Available|Overall Study||68
10253496|NCT01079780|11385347|FG001|Treated Patients With Toxicity Data Available|Overall Study||16
10253497|NCT01079780|11385348|FG002|Treated Patients With Toxicity Data Available|Overall Study||48
10253498|NCT01079780|11385346|FG000|Eligible and Treated|Overall Study||62
10253499|NCT01079780|11385347|FG001|Eligible and Treated|Overall Study||16
10253500|NCT01079780|11385348|FG002|Eligible and Treated|Overall Study||45
10253501|NCT01079780|11385346|FG000|Analyzable Patients for Efficacy Analysis|Overall Study||44
10253502|NCT01079780|11385347|FG001|Analyzable Patients for Efficacy Analysis|Overall Study||0
10253503|NCT01079780|11385348|FG002|Analyzable Patients for Efficacy Analysis|Overall Study||45
10253504|NCT01079780|11385346|FG000|COMPLETED|Overall Study||0
10253505|NCT01079780|11385347|FG001|COMPLETED|Overall Study||0
10253506|NCT01079780|11385348|FG002|COMPLETED|Overall Study||0
10253507|NCT01079780|11385346|FG000|NOT COMPLETED|Overall Study||70
10253508|NCT01079780|11385347|FG001|NOT COMPLETED|Overall Study||16
10253509|NCT01079780|11385348|FG002|NOT COMPLETED|Overall Study||50
10253510|NCT00075946|11385360|FG000|STARTED|Overall Study||148
10253511|NCT00075946|11385361|FG001|STARTED|Overall Study||151
10253512|NCT00075946|11385362|FG002|STARTED|Overall Study||28
10253513|NCT00075946|11385363|FG003|STARTED|Overall Study||30
9834137|NCT00784225|10945154|FG001|STARTED|Overall Study||3357
9834138|NCT00784225|10945155|FG002|STARTED|Overall Study||3369
9834139|NCT00784225|10945156|FG003|STARTED|Overall Study||3374
9834140|NCT00784225|10945153|FG000|COMPLETED|Overall Study||3375
9834141|NCT00784225|10945154|FG001|COMPLETED|Overall Study||3357
9834142|NCT00784225|10945155|FG002|COMPLETED|Overall Study||3369
9834143|NCT00784225|10945156|FG003|COMPLETED|Overall Study||3374
9834144|NCT00784225|10945153|FG000|NOT COMPLETED|Overall Study||0
9834145|NCT00784225|10945154|FG001|NOT COMPLETED|Overall Study||0
9834146|NCT00784225|10945155|FG002|NOT COMPLETED|Overall Study||0
9834147|NCT00784225|10945156|FG003|NOT COMPLETED|Overall Study||0
9834148|NCT00784238|10945170|FG000|STARTED|Overall Study||289
9834149|NCT00784238|10945170|FG000|COMPLETED|Overall Study||170
9834150|NCT00784238|10945170|FG000|NOT COMPLETED|Overall Study||119
9834151|NCT00784277|10945181|FG000|STARTED|IR Treatment||148
9834152|NCT00784277|10945182|FG001|STARTED|IR Treatment||151
9834153|NCT00784277|10945183|FG002|STARTED|IR Treatment||154
9834154|NCT00784277|10945184|FG003|STARTED|IR Treatment||143
9834155|NCT00784277|10945185|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
10253514|NCT00075946|11385364|FG004|STARTED|Overall Study||188
10253515|NCT00075946|11385360|FG000|Treated and With Toxicity Data Available|Overall Study||142
10253516|NCT00075946|11385361|FG001|Treated and With Toxicity Data Available|Overall Study||148
10253517|NCT00075946|11385362|FG002|Treated and With Toxicity Data Available|Overall Study||27
9834156|NCT00784277|10945186|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
9957539|NCT01451437|11076789|FG007|NOT COMPLETED|Overall Study||3
9834157|NCT00784277|10945187|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
9834158|NCT00784277|10945181|FG000|COMPLETED|IR Treatment||132
9834159|NCT00784277|10945182|FG001|COMPLETED|IR Treatment||134
9834160|NCT00784277|10945183|FG002|COMPLETED|IR Treatment||126
9834161|NCT00784277|10945184|FG003|COMPLETED|IR Treatment||100
9834162|NCT00784277|10945185|FG004|COMPLETED|IR Treatment||0
9834163|NCT00784277|10945186|FG005|COMPLETED|IR Treatment||0
9834164|NCT00784277|10945187|FG006|COMPLETED|IR Treatment||0
9834165|NCT00784277|10945181|FG000|NOT COMPLETED|IR Treatment||16
9834166|NCT00784277|10945182|FG001|NOT COMPLETED|IR Treatment||17
10253518|NCT00075946|11385363|FG003|Treated and With Toxicity Data Available|Overall Study||29
10253519|NCT00075946|11385364|FG004|Treated and With Toxicity Data Available|Overall Study||154
10253520|NCT00075946|11385360|FG000|Included in Primary Analysis|Overall Study||143
10253521|NCT00075946|11385361|FG001|Included in Primary Analysis|Overall Study||146
10253522|NCT00075946|11385362|FG002|Included in Primary Analysis|Overall Study||23
10253523|NCT00075946|11385363|FG003|Included in Primary Analysis|Overall Study||29
10253524|NCT00075946|11385364|FG004|Included in Primary Analysis|Overall Study||0
10253525|NCT00075946|11385360|FG000|COMPLETED|Overall Study||0
9834167|NCT00784277|10945183|FG002|NOT COMPLETED|IR Treatment||28
9834168|NCT00784277|10945184|FG003|NOT COMPLETED|IR Treatment||43
9834169|NCT00784277|10945185|FG004|NOT COMPLETED|IR Treatment||0
9834170|NCT00784277|10945186|FG005|NOT COMPLETED|IR Treatment||0
9834171|NCT00784277|10945187|FG006|NOT COMPLETED|IR Treatment||0
9834172|NCT00784277|10945181|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
9834173|NCT00784277|10945182|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
9834174|NCT00784277|10945183|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
9834175|NCT00784277|10945184|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
9834176|NCT00784277|10945185|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
9834177|NCT00784277|10945186|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
9834178|NCT00784277|10945187|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
9834179|NCT00784277|10945181|FG000|COMPLETED|ER Treatment||0
9834180|NCT00784277|10945182|FG001|COMPLETED|ER Treatment||0
9834181|NCT00784277|10945183|FG002|COMPLETED|ER Treatment||0
9834182|NCT00784277|10945184|FG003|COMPLETED|ER Treatment||0
9834183|NCT00784277|10945185|FG004|COMPLETED|ER Treatment||113
9834184|NCT00784277|10945186|FG005|COMPLETED|ER Treatment||226
9834185|NCT00784277|10945187|FG006|COMPLETED|ER Treatment||76
9834186|NCT00784277|10945181|FG000|NOT COMPLETED|ER Treatment||0
9834187|NCT00784277|10945182|FG001|NOT COMPLETED|ER Treatment||0
9834188|NCT00784277|10945183|FG002|NOT COMPLETED|ER Treatment||0
9834189|NCT00784277|10945184|FG003|NOT COMPLETED|ER Treatment||0
9834190|NCT00784277|10945185|FG004|NOT COMPLETED|ER Treatment||9
9834191|NCT00784277|10945186|FG005|NOT COMPLETED|ER Treatment||24
9834192|NCT00784277|10945187|FG006|NOT COMPLETED|ER Treatment||15
9834193|NCT00784303|10945202|FG000|STARTED|Overall Study||58
9834194|NCT00784303|10945203|FG001|STARTED|Overall Study||59
9834195|NCT00784303|10945202|FG000|COMPLETED|Overall Study||58
9834196|NCT00784303|10945203|FG001|COMPLETED|Overall Study||59
9834197|NCT00784303|10945202|FG000|NOT COMPLETED|Overall Study||0
9834198|NCT00784303|10945203|FG001|NOT COMPLETED|Overall Study||0
9834199|NCT00784368|10945213|FG000|STARTED|Overall Study||16
9834200|NCT00784368|10945214|FG001|STARTED|Overall Study||16
9834201|NCT00784368|10945215|FG002|STARTED|Overall Study||23
9834202|NCT00784368|10945213|FG000|COMPLETED|Overall Study||8
9834203|NCT00784368|10945214|FG001|COMPLETED|Overall Study||5
9834204|NCT00784368|10945215|FG002|COMPLETED|Overall Study||12
9834205|NCT00784368|10945213|FG000|NOT COMPLETED|Overall Study||8
9834206|NCT00784368|10945214|FG001|NOT COMPLETED|Overall Study||11
9834207|NCT00784368|10945215|FG002|NOT COMPLETED|Overall Study||11
9834208|NCT00784459|10945228|FG000|STARTED|Overall Study||11
9834209|NCT00784459|10945229|FG001|STARTED|Overall Study||13
9834210|NCT00784459|10945228|FG000|COMPLETED|Overall Study||11
9834211|NCT00784459|10945229|FG001|COMPLETED|Overall Study||11
9834212|NCT00784459|10945228|FG000|NOT COMPLETED|Overall Study||0
9834213|NCT00784459|10945229|FG001|NOT COMPLETED|Overall Study||2
9834214|NCT00784524|10945235|FG000|STARTED|Overall Study||14
9834215|NCT00784524|10945235|FG000|COMPLETED|Overall Study||14
9834216|NCT00784524|10945235|FG000|NOT COMPLETED|Overall Study||0
9834217|NCT00784550|10945241|FG000|STARTED|Overall Study||173
9834218|NCT00784550|10945242|FG001|STARTED|Overall Study||169
9834219|NCT00784550|10945241|FG000|COMPLETED|Overall Study||137
9834220|NCT00784550|10945242|FG001|COMPLETED|Overall Study||127
9834221|NCT00784550|10945241|FG000|NOT COMPLETED|Overall Study||36
9834222|NCT00784550|10945242|FG001|NOT COMPLETED|Overall Study||42
9834223|NCT00784563|10945251|FG000|STARTED|Years 1 & 2||21
9834224|NCT00784563|10945252|FG001|STARTED|Years 1 & 2||22
9834225|NCT00784563|10945253|FG002|STARTED|Years 1 & 2||0
9834226|NCT00784563|10945251|FG000|COMPLETED|Years 1 & 2||18
9834227|NCT00784563|10945252|FG001|COMPLETED|Years 1 & 2||17
9834228|NCT00784563|10945253|FG002|COMPLETED|Years 1 & 2||0
9834229|NCT00784563|10945251|FG000|NOT COMPLETED|Years 1 & 2||3
9834230|NCT00784563|10945252|FG001|NOT COMPLETED|Years 1 & 2||5
9834231|NCT00784563|10945253|FG002|NOT COMPLETED|Years 1 & 2||0
9834232|NCT00784563|10945251|FG000|STARTED|Year 3||0
10253526|NCT00075946|11385361|FG001|COMPLETED|Overall Study||0
10253527|NCT00075946|11385362|FG002|COMPLETED|Overall Study||0
10253528|NCT00075946|11385363|FG003|COMPLETED|Overall Study||0
10253529|NCT00075946|11385364|FG004|COMPLETED|Overall Study||0
10253530|NCT00075946|11385360|FG000|NOT COMPLETED|Overall Study||148
10253531|NCT00075946|11385361|FG001|NOT COMPLETED|Overall Study||151
10253532|NCT00075946|11385362|FG002|NOT COMPLETED|Overall Study||28
10253533|NCT00075946|11385363|FG003|NOT COMPLETED|Overall Study||30
10253534|NCT00075946|11385364|FG004|NOT COMPLETED|Overall Study||188
10253535|NCT00003641|11385377|FG000|STARTED|Overall Study||569
10253536|NCT00003641|11385378|FG001|STARTED|Overall Study||581
10253537|NCT00003641|11385377|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
10253538|NCT00003641|11385378|FG001|Treated|Overall Study||569
10253539|NCT00003641|11385377|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
10253540|NCT00003641|11385378|FG001|Toxicity Assessed|Overall Study||568
10253541|NCT00003641|11385377|FG000|COMPLETED|Overall Study||0
10253542|NCT00003641|11385378|FG001|COMPLETED|Overall Study||407
10253543|NCT00003641|11385377|FG000|NOT COMPLETED|Overall Study||569
10253544|NCT00003641|11385378|FG001|NOT COMPLETED|Overall Study||174
9834233|NCT00784563|10945252|FG001|STARTED|Year 3||0
9834234|NCT00784563|10945253|FG002|STARTED|Year 3||17
9834235|NCT00784563|10945251|FG000|COMPLETED|Year 3||0
9834236|NCT00784563|10945252|FG001|COMPLETED|Year 3||0
9834237|NCT00784563|10945253|FG002|COMPLETED|Year 3||14
9834238|NCT00784563|10945251|FG000|NOT COMPLETED|Year 3||0
9834239|NCT00784563|10945252|FG001|NOT COMPLETED|Year 3||0
9834240|NCT00784563|10945253|FG002|NOT COMPLETED|Year 3||3
9834241|NCT00784641|10945262|FG000|STARTED|Overall Study||189
9834242|NCT00784641|10945263|FG001|STARTED|Overall Study||189
9834243|NCT00784641|10945264|FG002|STARTED|Overall Study||189
10253545|NCT01956669|11385391|FG000|STARTED|Overall Study||12
10253546|NCT01956669|11385392|FG001|STARTED|Overall Study||11
10253547|NCT01956669|11385393|FG002|STARTED|Overall Study||10
10253548|NCT01956669|11385394|FG003|STARTED|Overall Study||10
10253549|NCT01956669|11385395|FG004|STARTED|Overall Study||4
10253550|NCT01956669|11385396|FG005|STARTED|Overall Study||4
10253551|NCT01956669|11385397|FG006|STARTED|Overall Study||6
10253552|NCT01956669|11385391|FG000|PK Set|Overall Study||11
10253553|NCT01956669|11385392|FG001|PK Set|Overall Study||11
10253554|NCT01956669|11385393|FG002|PK Set|Overall Study||10
10253555|NCT01956669|11385394|FG003|PK Set|Overall Study||10
10253556|NCT01956669|11385395|FG004|PK Set|Overall Study||4
10253557|NCT01956669|11385396|FG005|PK Set|Overall Study||4
10253558|NCT01956669|11385397|FG006|PK Set|Overall Study||6
10253559|NCT01956669|11385391|FG000|PKES Set|Overall Study||4
10253560|NCT01956669|11385392|FG001|PKES Set|Overall Study||0
10253561|NCT01956669|11385393|FG002|PKES Set|Overall Study||3
10253562|NCT01956669|11385394|FG003|PKES Set|Overall Study||0
10253563|NCT01956669|11385395|FG004|PKES Set|Overall Study||1
10253564|NCT01956669|11385396|FG005|PKES Set|Overall Study||1
10253565|NCT01956669|11385397|FG006|PKES Set|Overall Study||5
10253566|NCT01956669|11385391|FG000|Biomarker Set|Overall Study||12
10253567|NCT01956669|11385392|FG001|Biomarker Set|Overall Study||11
10253568|NCT01956669|11385393|FG002|Biomarker Set|Overall Study||9
10253569|NCT01956669|11385394|FG003|Biomarker Set|Overall Study||9
10253570|NCT01956669|11385395|FG004|Biomarker Set|Overall Study||3
10253571|NCT01956669|11385396|FG005|Biomarker Set|Overall Study||4
10253572|NCT01956669|11385397|FG006|Biomarker Set|Overall Study||3
10253573|NCT01956669|11385391|FG000|Per Protocol Set (PP Set)|Overall Study||9
10253574|NCT01956669|11385392|FG001|Per Protocol Set (PP Set)|Overall Study||10
10253575|NCT01956669|11385393|FG002|Per Protocol Set (PP Set)|Overall Study||6
10253576|NCT01956669|11385394|FG003|Per Protocol Set (PP Set)|Overall Study||9
10253577|NCT01956669|11385395|FG004|Per Protocol Set (PP Set)|Overall Study||4
10253578|NCT01956669|11385396|FG005|Per Protocol Set (PP Set)|Overall Study||4
10253579|NCT01956669|11385397|FG006|Per Protocol Set (PP Set)|Overall Study||5
10253580|NCT01956669|11385391|FG000|COMPLETED|Overall Study||0
10253581|NCT01956669|11385392|FG001|COMPLETED|Overall Study||0
10253582|NCT01956669|11385393|FG002|COMPLETED|Overall Study||0
10253583|NCT01956669|11385394|FG003|COMPLETED|Overall Study||0
10253584|NCT01956669|11385395|FG004|COMPLETED|Overall Study||0
10253585|NCT01956669|11385396|FG005|COMPLETED|Overall Study||0
10253586|NCT01956669|11385397|FG006|COMPLETED|Overall Study||0
10253587|NCT01956669|11385391|FG000|NOT COMPLETED|Overall Study||12
10253588|NCT01956669|11385392|FG001|NOT COMPLETED|Overall Study||11
10253589|NCT01956669|11385393|FG002|NOT COMPLETED|Overall Study||10
10253590|NCT01956669|11385394|FG003|NOT COMPLETED|Overall Study||10
10253591|NCT01956669|11385395|FG004|NOT COMPLETED|Overall Study||4
10253592|NCT01956669|11385396|FG005|NOT COMPLETED|Overall Study||4
10253593|NCT01956669|11385397|FG006|NOT COMPLETED|Overall Study||6
10253594|NCT01967823|11385422|FG000|STARTED|Overall Study||11
10253595|NCT01967823|11385422|FG000|COMPLETED|Overall Study||10
10253596|NCT01967823|11385422|FG000|NOT COMPLETED|Overall Study||1
10253597|NCT01989676|11385432|FG000|STARTED|Overall Study||352
10253598|NCT01989676|11385433|FG001|STARTED|Overall Study||355
10253599|NCT01989676|11385432|FG000|Treated|Overall Study||349
10253600|NCT01989676|11385433|FG001|Treated|Overall Study||353
10253601|NCT01989676|11385432|FG000|COMPLETED|Overall Study||234
10253602|NCT01989676|11385433|FG001|COMPLETED|Overall Study||217
10253603|NCT01989676|11385432|FG000|NOT COMPLETED|Overall Study||118
10253604|NCT01989676|11385433|FG001|NOT COMPLETED|Overall Study||138
10253605|NCT01992653|11385448|FG000|STARTED|Overall Study||3
10253606|NCT01992653|11385449|FG001|STARTED|Overall Study||3
10253607|NCT01992653|11385450|FG002|STARTED|Overall Study||6
10253608|NCT01992653|11385451|FG003|STARTED|Overall Study||1
10253609|NCT01992653|11385452|FG004|STARTED|Overall Study||6
10253610|NCT01992653|11385453|FG005|STARTED|Overall Study||6
10253611|NCT01992653|11385454|FG006|STARTED|Overall Study||40
10253612|NCT01992653|11385455|FG007|STARTED|Overall Study||17
10253613|NCT01992653|11385448|FG000|COMPLETED|Overall Study||3
10253614|NCT01992653|11385449|FG001|COMPLETED|Overall Study||3
10253615|NCT01992653|11385450|FG002|COMPLETED|Overall Study||5
10253616|NCT01992653|11385451|FG003|COMPLETED|Overall Study||1
10253617|NCT01992653|11385452|FG004|COMPLETED|Overall Study||5
10253618|NCT01992653|11385453|FG005|COMPLETED|Overall Study||6
10253619|NCT01992653|11385454|FG006|COMPLETED|Overall Study||32
10253620|NCT01992653|11385455|FG007|COMPLETED|Overall Study||13
10253621|NCT01992653|11385448|FG000|NOT COMPLETED|Overall Study||0
10253622|NCT01992653|11385449|FG001|NOT COMPLETED|Overall Study||0
10253623|NCT01992653|11385450|FG002|NOT COMPLETED|Overall Study||1
10253624|NCT01992653|11385451|FG003|NOT COMPLETED|Overall Study||0
10253625|NCT01992653|11385452|FG004|NOT COMPLETED|Overall Study||1
10253626|NCT01992653|11385453|FG005|NOT COMPLETED|Overall Study||0
10253627|NCT01992653|11385454|FG006|NOT COMPLETED|Overall Study||8
10253628|NCT01992653|11385455|FG007|NOT COMPLETED|Overall Study||4
10253629|NCT02001974|11385476|FG000|STARTED|Run-in Period||4
10253630|NCT02001974|11385477|FG001|STARTED|Run-in Period||3
10253631|NCT02001974|11385478|FG002|STARTED|Run-in Period||26
10253632|NCT02001974|11385476|FG000|COMPLETED|Run-in Period||4
10253633|NCT02001974|11385477|FG001|COMPLETED|Run-in Period||3
10253634|NCT02001974|11385478|FG002|COMPLETED|Run-in Period||26
10253635|NCT02001974|11385476|FG000|NOT COMPLETED|Run-in Period||0
10253636|NCT02001974|11385477|FG001|NOT COMPLETED|Run-in Period||0
10253637|NCT02001974|11385478|FG002|NOT COMPLETED|Run-in Period||0
10253638|NCT02001974|11385476|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
10253639|NCT02001974|11385477|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
10253640|NCT02001974|11385478|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
10253641|NCT02001974|11385476|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10253642|NCT02001974|11385477|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10253643|NCT02001974|11385478|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10253644|NCT02001974|11385476|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
10253645|NCT02001974|11385477|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
10253646|NCT02001974|11385478|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
10020311|NCT01835548|11143625|FG001|COMPLETED|Dose Stabilization Period||0
10020312|NCT01835548|11143626|FG002|COMPLETED|Dose Stabilization Period||85
10020313|NCT01835548|11143624|FG000|NOT COMPLETED|Dose Stabilization Period||0
10020314|NCT01835548|11143625|FG001|NOT COMPLETED|Dose Stabilization Period||0
10020315|NCT01835548|11143626|FG002|NOT COMPLETED|Dose Stabilization Period||0
10020316|NCT01835548|11143624|FG000|STARTED|Double-Blind Treatment Period||44
10020317|NCT01835548|11143625|FG001|STARTED|Double-Blind Treatment Period||41
10020318|NCT01835548|11143626|FG002|STARTED|Double-Blind Treatment Period||0
10020319|NCT01835548|11143624|FG000|COMPLETED|Double-Blind Treatment Period||44
10020320|NCT01835548|11143625|FG001|COMPLETED|Double-Blind Treatment Period||39
10020321|NCT01835548|11143626|FG002|COMPLETED|Double-Blind Treatment Period||0
10020322|NCT01835548|11143624|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10020323|NCT01835548|11143625|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
10020324|NCT01835548|11143626|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
10020325|NCT01835587|11143642|FG000|STARTED|Overall Study||3
10020326|NCT01835587|11143643|FG001|STARTED|Overall Study||4
10020327|NCT01835587|11143644|FG002|STARTED|Overall Study||4
10020328|NCT01835587|11143645|FG003|STARTED|Overall Study||19
10020329|NCT01835587|11143642|FG000|COMPLETED|Overall Study||1
10020330|NCT01835587|11143643|FG001|COMPLETED|Overall Study||0
10020331|NCT01835587|11143644|FG002|COMPLETED|Overall Study||2
10020332|NCT01835587|11143645|FG003|COMPLETED|Overall Study||10
10020333|NCT01835587|11143642|FG000|NOT COMPLETED|Overall Study||2
10020334|NCT01835587|11143643|FG001|NOT COMPLETED|Overall Study||4
10253647|NCT02014558|11385499|FG000|STARTED|Overall Study||5
10253648|NCT02014558|11385500|FG001|STARTED|Overall Study||3
10253649|NCT02014558|11385501|FG002|STARTED|Overall Study||3
10253650|NCT02014558|11385502|FG003|STARTED|Overall Study||3
10253651|NCT02014558|11385503|FG004|STARTED|Overall Study||4
10253652|NCT02014558|11385504|FG005|STARTED|Overall Study||3
10253653|NCT02014558|11385505|FG006|STARTED|Overall Study||4
10253654|NCT02014558|11385506|FG007|STARTED|Overall Study||11
10253655|NCT02014558|11385507|FG008|STARTED|Overall Study||15
10253656|NCT02014558|11385508|FG009|STARTED|Overall Study||21
10253657|NCT02014558|11385509|FG010|STARTED|Overall Study||69
10253658|NCT02014558|11385510|FG011|STARTED|Overall Study||102
10253659|NCT02014558|11385511|FG012|STARTED|Overall Study||17
10253660|NCT02014558|11385499|FG000|Treated|Overall Study||5
10253661|NCT02014558|11385500|FG001|Treated|Overall Study||3
10253662|NCT02014558|11385501|FG002|Treated|Overall Study||3
10253663|NCT02014558|11385502|FG003|Treated|Overall Study||3
10253664|NCT02014558|11385503|FG004|Treated|Overall Study||3
10253665|NCT02014558|11385504|FG005|Treated|Overall Study||3
10253666|NCT02014558|11385505|FG006|Treated|Overall Study||3
10253667|NCT02014558|11385506|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
10253668|NCT02014558|11385507|FG008|Treated|Overall Study||13
10253669|NCT02014558|11385508|FG009|Treated|Overall Study||21
10253670|NCT02014558|11385509|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
10253671|NCT02014558|11385510|FG011|Treated|Overall Study||100
10253672|NCT02014558|11385511|FG012|Treated|Overall Study||17
10253673|NCT02014558|11385499|FG000|COMPLETED|Overall Study||0
10253674|NCT02014558|11385500|FG001|COMPLETED|Overall Study||0
10253675|NCT02014558|11385501|FG002|COMPLETED|Overall Study||0
10253676|NCT02014558|11385502|FG003|COMPLETED|Overall Study||0
10253677|NCT02014558|11385503|FG004|COMPLETED|Overall Study||0
10253678|NCT02014558|11385504|FG005|COMPLETED|Overall Study||0
10253679|NCT02014558|11385505|FG006|COMPLETED|Overall Study||0
10253680|NCT02014558|11385506|FG007|COMPLETED|Overall Study||0
10253681|NCT02014558|11385507|FG008|COMPLETED|Overall Study||0
10253682|NCT02014558|11385508|FG009|COMPLETED|Overall Study||0
10253683|NCT02014558|11385509|FG010|COMPLETED|Overall Study||0
10253684|NCT02014558|11385510|FG011|COMPLETED|Overall Study||0
10253685|NCT02014558|11385511|FG012|COMPLETED|Overall Study||0
10253686|NCT02014558|11385499|FG000|NOT COMPLETED|Overall Study||5
10253687|NCT02014558|11385500|FG001|NOT COMPLETED|Overall Study||3
10253688|NCT02014558|11385501|FG002|NOT COMPLETED|Overall Study||3
10253689|NCT02014558|11385502|FG003|NOT COMPLETED|Overall Study||3
10253690|NCT02014558|11385503|FG004|NOT COMPLETED|Overall Study||4
10253691|NCT02014558|11385504|FG005|NOT COMPLETED|Overall Study||3
10253692|NCT02014558|11385505|FG006|NOT COMPLETED|Overall Study||4
10253693|NCT02014558|11385506|FG007|NOT COMPLETED|Overall Study||11
10253694|NCT02014558|11385507|FG008|NOT COMPLETED|Overall Study||15
10253695|NCT02014558|11385508|FG009|NOT COMPLETED|Overall Study||21
10253696|NCT02014558|11385509|FG010|NOT COMPLETED|Overall Study||69
10253697|NCT02014558|11385510|FG011|NOT COMPLETED|Overall Study||102
10253698|NCT02014558|11385511|FG012|NOT COMPLETED|Overall Study||17
10020335|NCT01835587|11143644|FG002|NOT COMPLETED|Overall Study||2
10020336|NCT01835587|11143645|FG003|NOT COMPLETED|Overall Study||9
10020337|NCT01835626|11143662|FG000|STARTED|Overall Study||24
10253699|NCT02015455|11385555|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233
10253700|NCT02015455|11385556|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0
10253701|NCT02015455|11385555|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135
10253702|NCT02015455|11385556|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0
10253703|NCT02015455|11385555|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233
10253704|NCT02015455|11385556|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10253705|NCT02015455|11385555|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10253706|NCT02015455|11385556|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10253707|NCT02015455|11385555|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074
10253708|NCT02015455|11385556|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455
10253709|NCT02015455|11385555|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390
10253710|NCT02015455|11385556|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208
10253711|NCT02015455|11385555|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074
9834244|NCT00784641|10945262|FG000|COMPLETED|Overall Study||183
9834245|NCT00784641|10945263|FG001|COMPLETED|Overall Study||186
9957540|NCT01451437|11076790|FG008|NOT COMPLETED|Overall Study||4
9957541|NCT01451463|11076819|FG000|STARTED|Overall Study||11
9957542|NCT01451463|11076819|FG000|COMPLETED|Overall Study||11
10253712|NCT02015455|11385556|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455
10253713|NCT02015455|11385555|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
10253714|NCT02015455|11385556|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
10253715|NCT02015455|11385555|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139
10253716|NCT02015455|11385556|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285
10253717|NCT02015455|11385555|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98
10253718|NCT02015455|11385556|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511
10253719|NCT02015455|11385555|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139
10253720|NCT02015455|11385556|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285
10253721|NCT02015455|11385555|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
9957543|NCT01451463|11076819|FG000|NOT COMPLETED|Overall Study||0
9957544|NCT01451541|11076831|FG000|STARTED|Overall Study||283
9957545|NCT01451541|11076832|FG001|STARTED|Overall Study||282
9957546|NCT01451541|11076833|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
9957547|NCT01451541|11076831|FG000|COMPLETED|Overall Study||247
9957548|NCT01451541|11076832|FG001|COMPLETED|Overall Study||257
9957549|NCT01451541|11076833|FG002|COMPLETED|Overall Study||254
9957550|NCT01451541|11076831|FG000|NOT COMPLETED|Overall Study||36
9957551|NCT01451541|11076832|FG001|NOT COMPLETED|Overall Study||25
9957552|NCT01451541|11076833|FG002|NOT COMPLETED|Overall Study||27
9957553|NCT01451554|11076845|FG000|STARTED|Overall Study||33
9957554|NCT01451554|11076846|FG001|STARTED|Overall Study||32
9957555|NCT01451554|11076845|FG000|COMPLETED|Overall Study||19
9957556|NCT01451554|11076846|FG001|COMPLETED|Overall Study||23
9957557|NCT01451554|11076845|FG000|NOT COMPLETED|Overall Study||14
10253722|NCT02015455|11385556|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
10253723|NCT02015455|11385555|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135
10253724|NCT02015455|11385556|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661
10253725|NCT02015455|11385555|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72
10253726|NCT02015455|11385556|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915
10253727|NCT02015455|11385555|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135
10253728|NCT02015455|11385556|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661
10253729|NCT02015455|11385555|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
10253730|NCT02015455|11385556|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
10253731|NCT02015455|11385555|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874
10253732|NCT02015455|11385556|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316
10253733|NCT02015455|11385555|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76
10253734|NCT02015455|11385556|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742
10253735|NCT02015455|11385555|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874
10253736|NCT02015455|11385556|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316
10253737|NCT02015455|11385555|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
10253738|NCT02015455|11385556|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
10253739|NCT02015455|11385555|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0
10253740|NCT02015455|11385556|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714
10253741|NCT02015455|11385555|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0
10253742|NCT02015455|11385556|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512
10253743|NCT02015455|11385555|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10253744|NCT02015455|11385556|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714
10253745|NCT02015455|11385555|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10253746|NCT02015455|11385556|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10253747|NCT02024555|11385566|FG000|STARTED|Overall Study||49
10253748|NCT02024555|11385567|FG001|STARTED|Overall Study||48
10253749|NCT02024555|11385566|FG000|COMPLETED|Overall Study||43
10253750|NCT02024555|11385567|FG001|COMPLETED|Overall Study||46
10253751|NCT02024555|11385566|FG000|NOT COMPLETED|Overall Study||6
10253752|NCT02024555|11385567|FG001|NOT COMPLETED|Overall Study||2
10253753|NCT02034123|11385591|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
10253754|NCT02034123|11385592|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
10253755|NCT02034123|11385593|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
10253756|NCT02034123|11385594|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
10253757|NCT02034123|11385595|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
10253758|NCT02034123|11385596|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
10253759|NCT02034123|11385597|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
10253760|NCT02034123|11385598|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
10253761|NCT02034123|11385599|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
10253762|NCT02034123|11385600|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253763|NCT02034123|11385601|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253764|NCT02034123|11385602|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253765|NCT02034123|11385603|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253766|NCT02034123|11385604|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253767|NCT02034123|11385605|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253768|NCT02034123|11385606|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253769|NCT02034123|11385607|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253770|NCT02034123|11385608|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10253771|NCT02034123|11385591|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10253772|NCT02034123|11385592|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10253773|NCT02034123|11385593|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
10253774|NCT02034123|11385594|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10253775|NCT02034123|11385595|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
10253776|NCT02034123|11385596|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
10253777|NCT02034123|11385597|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10253778|NCT02034123|11385598|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
10253779|NCT02034123|11385599|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253780|NCT02034123|11385600|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253781|NCT02034123|11385601|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253782|NCT02034123|11385602|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253783|NCT02034123|11385603|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253784|NCT02034123|11385604|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253785|NCT02034123|11385605|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253786|NCT02034123|11385606|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253787|NCT02034123|11385607|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253788|NCT02034123|11385608|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253789|NCT02034123|11385591|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253790|NCT02034123|11385592|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253791|NCT02034123|11385593|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253792|NCT02034123|11385594|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10253793|NCT02034123|11385595|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10253794|NCT02034123|11385596|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253795|NCT02034123|11385597|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253796|NCT02034123|11385598|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10253797|NCT02034123|11385599|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10253798|NCT02034123|11385600|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253799|NCT02034123|11385601|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253800|NCT02034123|11385602|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253801|NCT02034123|11385603|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253802|NCT02034123|11385604|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253803|NCT02034123|11385605|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253804|NCT02034123|11385606|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253805|NCT02034123|11385607|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253806|NCT02034123|11385608|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10253807|NCT02034123|11385591|FG000|STARTED|Part2(Up to 2 Years)||0
10253808|NCT02034123|11385592|FG001|STARTED|Part2(Up to 2 Years)||0
10253809|NCT02034123|11385593|FG002|STARTED|Part2(Up to 2 Years)||0
10253810|NCT02034123|11385594|FG003|STARTED|Part2(Up to 2 Years)||0
10253811|NCT02034123|11385595|FG004|STARTED|Part2(Up to 2 Years)||0
10253812|NCT02034123|11385596|FG005|STARTED|Part2(Up to 2 Years)||0
10253813|NCT02034123|11385597|FG006|STARTED|Part2(Up to 2 Years)||0
10253814|NCT02034123|11385598|FG007|STARTED|Part2(Up to 2 Years)||0
10253815|NCT02034123|11385599|FG008|STARTED|Part2(Up to 2 Years)||0
10253816|NCT02034123|11385600|FG009|STARTED|Part2(Up to 2 Years)||0
10253817|NCT02034123|11385601|FG010|STARTED|Part2(Up to 2 Years)||0
10253818|NCT02034123|11385602|FG011|STARTED|Part2(Up to 2 Years)||0
10253819|NCT02034123|11385603|FG012|STARTED|Part2(Up to 2 Years)||0
10253820|NCT02034123|11385604|FG013|STARTED|Part2(Up to 2 Years)||0
10253821|NCT02034123|11385605|FG014|STARTED|Part2(Up to 2 Years)||0
10253822|NCT02034123|11385606|FG015|STARTED|Part2(Up to 2 Years)||0
10253823|NCT02034123|11385607|FG016|STARTED|Part2(Up to 2 Years)||0
10253824|NCT02034123|11385608|FG017|STARTED|Part2(Up to 2 Years)||0
10253825|NCT02034123|11385591|FG000|COMPLETED|Part2(Up to 2 Years)||0
10253826|NCT02034123|11385592|FG001|COMPLETED|Part2(Up to 2 Years)||0
10253827|NCT02034123|11385593|FG002|COMPLETED|Part2(Up to 2 Years)||0
10253828|NCT02034123|11385594|FG003|COMPLETED|Part2(Up to 2 Years)||0
10253829|NCT02034123|11385595|FG004|COMPLETED|Part2(Up to 2 Years)||0
10253830|NCT02034123|11385596|FG005|COMPLETED|Part2(Up to 2 Years)||0
10253831|NCT02034123|11385597|FG006|COMPLETED|Part2(Up to 2 Years)||0
10253832|NCT02034123|11385598|FG007|COMPLETED|Part2(Up to 2 Years)||0
10253833|NCT02034123|11385599|FG008|COMPLETED|Part2(Up to 2 Years)||0
10253834|NCT02034123|11385600|FG009|COMPLETED|Part2(Up to 2 Years)||0
10253835|NCT02034123|11385601|FG010|COMPLETED|Part2(Up to 2 Years)||0
10253836|NCT02034123|11385602|FG011|COMPLETED|Part2(Up to 2 Years)||0
10253837|NCT02034123|11385603|FG012|COMPLETED|Part2(Up to 2 Years)||0
10253838|NCT02034123|11385604|FG013|COMPLETED|Part2(Up to 2 Years)||0
10253839|NCT02034123|11385605|FG014|COMPLETED|Part2(Up to 2 Years)||0
10253840|NCT02034123|11385606|FG015|COMPLETED|Part2(Up to 2 Years)||0
10253841|NCT02034123|11385607|FG016|COMPLETED|Part2(Up to 2 Years)||0
10253842|NCT02034123|11385608|FG017|COMPLETED|Part2(Up to 2 Years)||0
10253843|NCT02034123|11385591|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0
10253844|NCT02034123|11385592|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0
10253845|NCT02034123|11385593|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0
10253846|NCT02034123|11385594|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0
10253847|NCT02034123|11385595|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0
10253848|NCT02034123|11385596|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0
10253849|NCT02034123|11385597|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0
10253850|NCT02034123|11385598|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0
10253851|NCT02034123|11385599|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0
10253852|NCT02034123|11385600|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0
10253853|NCT02034123|11385601|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0
10253854|NCT02034123|11385602|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0
10253855|NCT02034123|11385603|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0
10253856|NCT02034123|11385604|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0
10253857|NCT02034123|11385605|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0
10253858|NCT02034123|11385606|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0
10253859|NCT02034123|11385607|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0
10253860|NCT02034123|11385608|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0
10020338|NCT01835626|11143662|FG000|COMPLETED|Overall Study||17
10020339|NCT01835626|11143662|FG000|NOT COMPLETED|Overall Study||7
10020340|NCT01835743|11143668|FG000|STARTED|Overall Study||37
10253861|NCT02040584|11385653|FG000|STARTED|Overall Study||105
10253862|NCT02040584|11385654|FG001|STARTED|Overall Study||106
10253863|NCT02040584|11385653|FG000|COMPLETED|Overall Study||70
10253864|NCT02040584|11385654|FG001|COMPLETED|Overall Study||74
10253865|NCT02040584|11385653|FG000|NOT COMPLETED|Overall Study||35
10253866|NCT02040584|11385654|FG001|NOT COMPLETED|Overall Study||32
10253867|NCT02045797|11385673|FG000|STARTED|Overall Study||58
10253868|NCT02045797|11385674|FG001|STARTED|Overall Study||39
10253869|NCT02045797|11385675|FG002|STARTED|Overall Study||25
10253870|NCT02045797|11385673|FG000|COMPLETED|Overall Study||51
10253871|NCT02045797|11385674|FG001|COMPLETED|Overall Study||32
10253872|NCT02045797|11385675|FG002|COMPLETED|Overall Study||24
10253873|NCT02045797|11385673|FG000|NOT COMPLETED|Overall Study||7
10253874|NCT02045797|11385674|FG001|NOT COMPLETED|Overall Study||7
10253875|NCT02045797|11385675|FG002|NOT COMPLETED|Overall Study||1
10253876|NCT02049710|11385685|FG000|STARTED|Overall Study||653
10253877|NCT02049710|11385686|FG001|STARTED|Overall Study||664
10253878|NCT02049710|11385685|FG000|COMPLETED|Overall Study||334
10253879|NCT02049710|11385686|FG001|COMPLETED|Overall Study||340
10253880|NCT02049710|11385685|FG000|NOT COMPLETED|Overall Study||319
10253881|NCT02049710|11385686|FG001|NOT COMPLETED|Overall Study||324
10253882|NCT02055547|11385692|FG000|STARTED|Overall Study||2
10253883|NCT02055547|11385693|FG001|STARTED|Overall Study||2
10253884|NCT02055547|11385694|FG002|STARTED|Overall Study||5
10253885|NCT02055547|11385695|FG003|STARTED|Overall Study||2
10253886|NCT02055547|11385696|FG004|STARTED|Overall Study||2
10253887|NCT02055547|11385697|FG005|STARTED|Overall Study||2
10253888|NCT02055547|11385698|FG006|STARTED|Overall Study||2
10253889|NCT02055547|11385699|FG007|STARTED|Overall Study||6
10253890|NCT02055547|11385700|FG008|STARTED|Overall Study||6
10253891|NCT02055547|11385701|FG009|STARTED|Overall Study||6
10253892|NCT02055547|11385702|FG010|STARTED|Overall Study||6
10253893|NCT02055547|11385703|FG011|STARTED|Overall Study||6
10253894|NCT02055547|11385704|FG012|STARTED|Overall Study||2
10253895|NCT02055547|11385705|FG013|STARTED|Overall Study||2
10253896|NCT02055547|11385706|FG014|STARTED|Overall Study||2
10253897|NCT02055547|11385707|FG015|STARTED|Overall Study||2
10253898|NCT02055547|11385708|FG016|STARTED|Overall Study||2
10253899|NCT02055547|11385709|FG017|STARTED|Overall Study||2
10253900|NCT02055547|11385710|FG018|STARTED|Overall Study||2
10253901|NCT02055547|11385692|FG000|COMPLETED|Overall Study||2
10253902|NCT02055547|11385693|FG001|COMPLETED|Overall Study||1
10253903|NCT02055547|11385694|FG002|COMPLETED|Overall Study||2
10253904|NCT02055547|11385695|FG003|COMPLETED|Overall Study||2
10253905|NCT02055547|11385696|FG004|COMPLETED|Overall Study||1
10253906|NCT02055547|11385697|FG005|COMPLETED|Overall Study||1
10253907|NCT02055547|11385698|FG006|COMPLETED|Overall Study||0
10253908|NCT02055547|11385699|FG007|COMPLETED|Overall Study||6
10253909|NCT02055547|11385700|FG008|COMPLETED|Overall Study||4
10253910|NCT02055547|11385701|FG009|COMPLETED|Overall Study||5
10253911|NCT02055547|11385702|FG010|COMPLETED|Overall Study||5
10253912|NCT02055547|11385703|FG011|COMPLETED|Overall Study||6
10253913|NCT02055547|11385704|FG012|COMPLETED|Overall Study||2
10253914|NCT02055547|11385705|FG013|COMPLETED|Overall Study||1
10253915|NCT02055547|11385706|FG014|COMPLETED|Overall Study||2
10253916|NCT02055547|11385707|FG015|COMPLETED|Overall Study||1
10253917|NCT02055547|11385708|FG016|COMPLETED|Overall Study||2
10253918|NCT02055547|11385709|FG017|COMPLETED|Overall Study||2
10253919|NCT02055547|11385710|FG018|COMPLETED|Overall Study||2
10253920|NCT02055547|11385692|FG000|NOT COMPLETED|Overall Study||0
10253921|NCT02055547|11385693|FG001|NOT COMPLETED|Overall Study||1
10253922|NCT02055547|11385694|FG002|NOT COMPLETED|Overall Study||3
10253923|NCT02055547|11385695|FG003|NOT COMPLETED|Overall Study||0
10253924|NCT02055547|11385696|FG004|NOT COMPLETED|Overall Study||1
10253925|NCT02055547|11385697|FG005|NOT COMPLETED|Overall Study||1
9834246|NCT00784641|10945264|FG002|COMPLETED|Overall Study||187
9834247|NCT00784641|10945262|FG000|NOT COMPLETED|Overall Study||6
9957558|NCT01451554|11076846|FG001|NOT COMPLETED|Overall Study||9
10253926|NCT02055547|11385698|FG006|NOT COMPLETED|Overall Study||2
9834248|NCT00784641|10945263|FG001|NOT COMPLETED|Overall Study||3
9834249|NCT00784641|10945264|FG002|NOT COMPLETED|Overall Study||2
9834250|NCT00784654|10945272|FG000|STARTED|Open-Label Period (Non-Randomized)||276
10253927|NCT02055547|11385699|FG007|NOT COMPLETED|Overall Study||0
10253928|NCT02055547|11385700|FG008|NOT COMPLETED|Overall Study||2
10253929|NCT02055547|11385701|FG009|NOT COMPLETED|Overall Study||1
10253930|NCT02055547|11385702|FG010|NOT COMPLETED|Overall Study||1
10253931|NCT02055547|11385703|FG011|NOT COMPLETED|Overall Study||0
10253932|NCT02055547|11385704|FG012|NOT COMPLETED|Overall Study||0
10253933|NCT02055547|11385705|FG013|NOT COMPLETED|Overall Study||1
10253934|NCT02055547|11385706|FG014|NOT COMPLETED|Overall Study||0
10253935|NCT02055547|11385707|FG015|NOT COMPLETED|Overall Study||1
10253936|NCT02055547|11385708|FG016|NOT COMPLETED|Overall Study||0
10253937|NCT02055547|11385709|FG017|NOT COMPLETED|Overall Study||0
10253938|NCT02055547|11385710|FG018|NOT COMPLETED|Overall Study||0
10253939|NCT02064387|11385756|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1
10253940|NCT02064387|11385757|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1
10253941|NCT02064387|11385758|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10253942|NCT02064387|11385759|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10253943|NCT02064387|11385760|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10253944|NCT02064387|11385761|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3
10253945|NCT02064387|11385762|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10253946|NCT02064387|11385763|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8
10253947|NCT02064387|11385764|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3
10253948|NCT02064387|11385765|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6
10253949|NCT02064387|11385766|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0
10253950|NCT02064387|11385767|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0
10253951|NCT02064387|11385756|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10253952|NCT02064387|11385757|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10253953|NCT02064387|11385758|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10253954|NCT02064387|11385759|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10253955|NCT02064387|11385760|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10253956|NCT02064387|11385761|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
10253957|NCT02064387|11385762|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10253958|NCT02064387|11385763|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
10253959|NCT02064387|11385764|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
10253960|NCT02064387|11385765|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
10253961|NCT02064387|11385766|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253962|NCT02064387|11385767|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253963|NCT02064387|11385756|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253964|NCT02064387|11385757|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253965|NCT02064387|11385758|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253966|NCT02064387|11385759|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253967|NCT02064387|11385760|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253968|NCT02064387|11385761|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253969|NCT02064387|11385762|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253970|NCT02064387|11385763|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
10253971|NCT02064387|11385764|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10253972|NCT02064387|11385765|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10253973|NCT02064387|11385766|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253974|NCT02064387|11385767|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10253975|NCT02064387|11385756|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0
10253976|NCT02064387|11385757|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0
10253977|NCT02064387|11385758|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0
10253978|NCT02064387|11385759|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0
10253979|NCT02064387|11385760|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0
10253980|NCT02064387|11385761|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0
10253981|NCT02064387|11385762|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0
10253982|NCT02064387|11385763|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0
10253983|NCT02064387|11385764|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0
10253984|NCT02064387|11385765|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0
10253985|NCT02064387|11385766|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35
10253986|NCT02064387|11385767|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6
10253987|NCT02064387|11385756|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253988|NCT02064387|11385757|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253989|NCT02064387|11385758|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253990|NCT02064387|11385759|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253991|NCT02064387|11385760|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253992|NCT02064387|11385761|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253993|NCT02064387|11385762|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253994|NCT02064387|11385763|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253995|NCT02064387|11385764|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253996|NCT02064387|11385765|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10253997|NCT02064387|11385766|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29
10253998|NCT02064387|11385767|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3
10253999|NCT02064387|11385756|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254000|NCT02064387|11385757|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254001|NCT02064387|11385758|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254002|NCT02064387|11385759|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254003|NCT02064387|11385760|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254004|NCT02064387|11385761|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254005|NCT02064387|11385762|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254006|NCT02064387|11385763|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254007|NCT02064387|11385764|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254008|NCT02064387|11385765|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10254009|NCT02064387|11385766|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
10254010|NCT02064387|11385767|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
9834251|NCT00784654|10945273|FG001|STARTED|Open-Label Period (Non-Randomized)||0
9834252|NCT00784654|10945274|FG002|STARTED|Open-Label Period (Non-Randomized)||0
9834253|NCT00784654|10945272|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165
9834254|NCT00784654|10945273|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0
9834255|NCT00784654|10945274|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0
9834256|NCT00784654|10945272|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
9834257|NCT00784654|10945273|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
9834258|NCT00784654|10945274|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
9834259|NCT00784654|10945272|FG000|STARTED|Randomized Withdrawal Period||0
9834260|NCT00784654|10945273|FG001|STARTED|Randomized Withdrawal Period||78
9834261|NCT00784654|10945274|FG002|STARTED|Randomized Withdrawal Period||79
9834262|NCT00784654|10945272|FG000|COMPLETED|Randomized Withdrawal Period||0
9834263|NCT00784654|10945273|FG001|COMPLETED|Randomized Withdrawal Period||60
9834264|NCT00784654|10945274|FG002|COMPLETED|Randomized Withdrawal Period||16
9834265|NCT00784654|10945272|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
9834266|NCT00784654|10945273|FG001|NOT COMPLETED|Randomized Withdrawal Period||18
9834267|NCT00784654|10945274|FG002|NOT COMPLETED|Randomized Withdrawal Period||63
10254011|NCT02076178|11385808|FG000|STARTED|Oral Phase||21
10254012|NCT02076178|11385809|FG001|STARTED|Oral Phase||106
10254013|NCT02076178|11385808|FG000|COMPLETED|Oral Phase||21
10254014|NCT02076178|11385809|FG001|COMPLETED|Oral Phase||94
10254015|NCT02076178|11385808|FG000|NOT COMPLETED|Oral Phase||0
10254016|NCT02076178|11385809|FG001|NOT COMPLETED|Oral Phase||12
10254017|NCT02076178|11385808|FG000|STARTED|Injection Phase||21
10254018|NCT02076178|11385809|FG001|STARTED|Injection Phase||94
10254019|NCT02076178|11385808|FG000|COMPLETED|Injection Phase||20
10254020|NCT02076178|11385809|FG001|COMPLETED|Injection Phase||87
10254021|NCT02076178|11385808|FG000|NOT COMPLETED|Injection Phase||1
10254022|NCT02076178|11385809|FG001|NOT COMPLETED|Injection Phase||7
10254023|NCT02079766|11385819|FG000|STARTED|Overall Study||30
10254024|NCT02079766|11385820|FG001|STARTED|Overall Study||11
10254025|NCT02079766|11385819|FG000|COMPLETED|Overall Study||28
10254026|NCT02079766|11385820|FG001|COMPLETED|Overall Study||11
10254027|NCT02079766|11385819|FG000|NOT COMPLETED|Overall Study||2
10254028|NCT02079766|11385820|FG001|NOT COMPLETED|Overall Study||0
10254053|NCT02087189|11385853|FG000|STARTED|Overall Study||30
10254054|NCT02087189|11385853|FG000|COMPLETED|Overall Study||28
10254055|NCT02087189|11385853|FG000|NOT COMPLETED|Overall Study||2
10254056|NCT02096055|11385861|FG000|STARTED|Overall Study||13
10254057|NCT02096055|11385862|FG001|STARTED|Overall Study||9
10254058|NCT02096055|11385863|FG002|STARTED|Overall Study||13
10254059|NCT02096055|11385864|FG003|STARTED|Overall Study||9
10254060|NCT02096055|11385861|FG000|COMPLETED|Overall Study||13
10254061|NCT02096055|11385862|FG001|COMPLETED|Overall Study||9
10254062|NCT02096055|11385863|FG002|COMPLETED|Overall Study||13
10254063|NCT02096055|11385864|FG003|COMPLETED|Overall Study||9
10254064|NCT02096055|11385861|FG000|NOT COMPLETED|Overall Study||0
10254065|NCT02096055|11385862|FG001|NOT COMPLETED|Overall Study||0
10254066|NCT02096055|11385863|FG002|NOT COMPLETED|Overall Study||0
10254067|NCT02096055|11385864|FG003|NOT COMPLETED|Overall Study||0
10254068|NCT02112916|11385878|FG000|STARTED|Overall Study||312
10254069|NCT02112916|11385879|FG001|STARTED|Overall Study||315
10254070|NCT02112916|11385880|FG002|STARTED|Overall Study||111
10254071|NCT02112916|11385881|FG003|STARTED|Overall Study||109
10254072|NCT02112916|11385878|FG000|COMPLETED|Overall Study||108
10254073|NCT02112916|11385879|FG001|COMPLETED|Overall Study||123
10254029|NCT02081391|11385830|FG000|STARTED|12-hour Treatment||108
10254030|NCT02081391|11385831|FG001|STARTED|12-hour Treatment||52
10254031|NCT02081391|11385832|FG002|STARTED|12-hour Treatment||11
10254032|NCT02081391|11385833|FG003|STARTED|12-hour Treatment||4
10254033|NCT02081391|11385830|FG000|COMPLETED|12-hour Treatment||90
10254034|NCT02081391|11385831|FG001|COMPLETED|12-hour Treatment||46
10254035|NCT02081391|11385832|FG002|COMPLETED|12-hour Treatment||10
10254036|NCT02081391|11385833|FG003|COMPLETED|12-hour Treatment||4
10254037|NCT02081391|11385830|FG000|NOT COMPLETED|12-hour Treatment||18
10254038|NCT02081391|11385831|FG001|NOT COMPLETED|12-hour Treatment||6
10254039|NCT02081391|11385832|FG002|NOT COMPLETED|12-hour Treatment||1
10254040|NCT02081391|11385833|FG003|NOT COMPLETED|12-hour Treatment||0
10254041|NCT02081391|11385830|FG000|STARTED|24-hour Treatment and Trial Completion||90
10254042|NCT02081391|11385831|FG001|STARTED|24-hour Treatment and Trial Completion||46
10254043|NCT02081391|11385832|FG002|STARTED|24-hour Treatment and Trial Completion||10
10254044|NCT02081391|11385833|FG003|STARTED|24-hour Treatment and Trial Completion||4
10254045|NCT02081391|11385830|FG000|COMPLETED|24-hour Treatment and Trial Completion||63
10254046|NCT02081391|11385831|FG001|COMPLETED|24-hour Treatment and Trial Completion||28
10254047|NCT02081391|11385832|FG002|COMPLETED|24-hour Treatment and Trial Completion||9
10254048|NCT02081391|11385833|FG003|COMPLETED|24-hour Treatment and Trial Completion||4
10254049|NCT02081391|11385830|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27
10254050|NCT02081391|11385831|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18
10254051|NCT02081391|11385832|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1
10254052|NCT02081391|11385833|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0
10254074|NCT02112916|11385880|FG002|COMPLETED|Overall Study||52
10254075|NCT02112916|11385881|FG003|COMPLETED|Overall Study||62
10254076|NCT02112916|11385878|FG000|NOT COMPLETED|Overall Study||204
10254077|NCT02112916|11385879|FG001|NOT COMPLETED|Overall Study||192
10254078|NCT02112916|11385880|FG002|NOT COMPLETED|Overall Study||59
10254079|NCT02112916|11385881|FG003|NOT COMPLETED|Overall Study||47
10020341|NCT01835743|11143669|FG001|STARTED|Overall Study||32
10020342|NCT01835743|11143668|FG000|COMPLETED|Overall Study||37
10020343|NCT01835743|11143669|FG001|COMPLETED|Overall Study||32
10020344|NCT01835743|11143668|FG000|NOT COMPLETED|Overall Study||0
10020345|NCT01835743|11143669|FG001|NOT COMPLETED|Overall Study||0
10020346|NCT01835756|11143677|FG000|STARTED|Overall Study||31
10020347|NCT01835756|11143678|FG001|STARTED|Overall Study||31
10020348|NCT01835756|11143677|FG000|COMPLETED|Overall Study||31
10020349|NCT01835756|11143678|FG001|COMPLETED|Overall Study||31
10020350|NCT01835756|11143677|FG000|NOT COMPLETED|Overall Study||0
10020351|NCT01835756|11143678|FG001|NOT COMPLETED|Overall Study||0
10020352|NCT01835899|11143689|FG000|STARTED|Overall Study||6
10020353|NCT01835899|11143690|FG001|STARTED|Overall Study||9
10254080|NCT02114697|11385898|FG000|STARTED|Overall Study||5
10254081|NCT02114697|11385899|FG001|STARTED|Overall Study||4
10254082|NCT02114697|11385898|FG000|Completed Month 18 Visit|Overall Study||0
10254083|NCT02114697|11385899|FG001|Completed Month 18 Visit|Overall Study||1
10254084|NCT02114697|11385898|FG000|COMPLETED|Overall Study||0
10254085|NCT02114697|11385899|FG001|COMPLETED|Overall Study||0
10254086|NCT02114697|11385898|FG000|NOT COMPLETED|Overall Study||5
10254087|NCT02114697|11385899|FG001|NOT COMPLETED|Overall Study||4
10254088|NCT02134717|11385905|FG000|STARTED|Overall Study||3
10254089|NCT02134717|11385905|FG000|COMPLETED|Overall Study||3
10254090|NCT02134717|11385905|FG000|NOT COMPLETED|Overall Study||0
10254091|NCT02135029|11385912|FG000|STARTED|Overall Study||73
10254092|NCT02135029|11385913|FG001|STARTED|Overall Study||74
10254093|NCT02135029|11385914|FG002|STARTED|Overall Study||37
10254094|NCT02135029|11385912|FG000|Treated|Overall Study||73
10254095|NCT02135029|11385913|FG001|Treated|Overall Study||74
10254096|NCT02135029|11385914|FG002|Treated|Overall Study||36
10254097|NCT02135029|11385912|FG000|COMPLETED|Overall Study||69
10254098|NCT02135029|11385913|FG001|COMPLETED|Overall Study||69
10254099|NCT02135029|11385914|FG002|COMPLETED|Overall Study||34
10254100|NCT02135029|11385912|FG000|NOT COMPLETED|Overall Study||4
10254101|NCT02135029|11385913|FG001|NOT COMPLETED|Overall Study||5
10254102|NCT02135029|11385914|FG002|NOT COMPLETED|Overall Study||3
10020354|NCT01835899|11143691|FG002|STARTED|Overall Study||9
10113953|NCT02512783|11244662|FG000|NOT COMPLETED|Overall Study||0
10113954|NCT02512783|11244663|FG001|NOT COMPLETED|Overall Study||0
10113955|NCT02512809|11244672|FG000|STARTED|Overall Study||25
10113956|NCT02512809|11244672|FG000|COMPLETED|Overall Study||25
10113957|NCT02512809|11244672|FG000|NOT COMPLETED|Overall Study||0
10113958|NCT02512861|11244678|FG000|STARTED|Overall Study||44
10113959|NCT02512861|11244679|FG001|STARTED|Overall Study||49
10113960|NCT02512861|11244678|FG000|COMPLETED|Overall Study||38
10113961|NCT02512861|11244679|FG001|COMPLETED|Overall Study||40
10113962|NCT02512861|11244678|FG000|NOT COMPLETED|Overall Study||6
10113963|NCT02512861|11244679|FG001|NOT COMPLETED|Overall Study||9
10113964|NCT02512874|11244685|FG000|STARTED|Overall Study||65
10113965|NCT02512874|11244685|FG000|COMPLETED|Overall Study||63
10113966|NCT02512874|11244685|FG000|NOT COMPLETED|Overall Study||2
10113967|NCT02512900|11244691|FG000|STARTED|Overall Study||11
10113968|NCT02512900|11244692|FG001|STARTED|Overall Study||10
10113969|NCT02512900|11244691|FG000|COMPLETED|Overall Study||11
10113970|NCT02512900|11244692|FG001|COMPLETED|Overall Study||10
10113971|NCT02512900|11244691|FG000|NOT COMPLETED|Overall Study||0
10113972|NCT02512900|11244692|FG001|NOT COMPLETED|Overall Study||0
10113973|NCT02512965|11244701|FG000|STARTED|Overall Study||115
10113974|NCT02512965|11244702|FG001|STARTED|Overall Study||114
10113975|NCT02512965|11244701|FG000|COMPLETED|Overall Study||115
10113976|NCT02512965|11244702|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
10113977|NCT02512965|11244701|FG000|NOT COMPLETED|Overall Study||0
10113978|NCT02512965|11244702|FG001|NOT COMPLETED|Overall Study||4
10113979|NCT02513095|11244710|FG000|STARTED|Overall Study||17
10113980|NCT02513095|11244711|FG001|STARTED|Overall Study||17
10113981|NCT02513095|11244710|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17
10113982|NCT02513095|11244711|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17
10113983|NCT02513095|11244710|FG000|COMPLETED|Overall Study||17
10113984|NCT02513095|11244711|FG001|COMPLETED|Overall Study||17
10113985|NCT02513095|11244710|FG000|NOT COMPLETED|Overall Study||0
10113986|NCT02513095|11244711|FG001|NOT COMPLETED|Overall Study||0
10113987|NCT02513121|11244719|FG000|STARTED|Overall Study||20
10113988|NCT02513121|11244720|FG001|STARTED|Overall Study||20
10113989|NCT02513121|11244719|FG000|COMPLETED|Overall Study||20
10113990|NCT02513121|11244720|FG001|COMPLETED|Overall Study||20
10113991|NCT02513121|11244719|FG000|NOT COMPLETED|Overall Study||0
10113992|NCT02513121|11244720|FG001|NOT COMPLETED|Overall Study||0
10113993|NCT02513160|11244732|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
10113994|NCT02513160|11244733|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
10113995|NCT02513160|11244734|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
10113996|NCT02513160|11244735|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
10113997|NCT02513160|11244732|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425
10113998|NCT02513160|11244733|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10113999|NCT02513160|11244734|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10254103|NCT02137239|11385925|FG000|STARTED|Overall Study||26
10254104|NCT02137239|11385926|FG001|STARTED|Overall Study||32
10254105|NCT02137239|11385925|FG000|COMPLETED|Overall Study||23
10254106|NCT02137239|11385926|FG001|COMPLETED|Overall Study||26
10254107|NCT02137239|11385925|FG000|NOT COMPLETED|Overall Study||3
10254108|NCT02137239|11385926|FG001|NOT COMPLETED|Overall Study||6
10254109|NCT02148133|11385932|FG000|STARTED|Overall Study||21
10254110|NCT02148133|11385932|FG000|Safety Set (SS)|Overall Study||21
10254111|NCT02148133|11385932|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
10254112|NCT02148133|11385932|FG000|COMPLETED|Overall Study||16
10254113|NCT02148133|11385932|FG000|NOT COMPLETED|Overall Study||5
10020355|NCT01835899|11143689|FG000|COMPLETED|Overall Study||6
10020356|NCT01835899|11143690|FG001|COMPLETED|Overall Study||8
10020357|NCT01835899|11143691|FG002|COMPLETED|Overall Study||8
10020358|NCT01835899|11143689|FG000|NOT COMPLETED|Overall Study||0
10020359|NCT01835899|11143690|FG001|NOT COMPLETED|Overall Study||1
10020360|NCT01835899|11143691|FG002|NOT COMPLETED|Overall Study||1
10020361|NCT01835912|11143701|FG000|STARTED|Overall Study||10
10254114|NCT02151383|11385939|FG000|STARTED|Overall Study||8
10020362|NCT01835912|11143701|FG000|Acute|Overall Study||10
10020363|NCT01835912|11143701|FG000|Acute Placebo|Overall Study||10
10020364|NCT01835912|11143701|FG000|Chronic|Overall Study||10
10020365|NCT01835912|11143701|FG000|Chronic Placebo|Overall Study||10
10114000|NCT02513160|11244735|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10114001|NCT02513160|11244732|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
10114002|NCT02513160|11244733|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10254115|NCT02151383|11385940|FG001|STARTED|Overall Study||3
10254116|NCT02151383|11385941|FG002|STARTED|Overall Study||1
10254117|NCT02151383|11385939|FG000|Low-dose|Overall Study||2
10254118|NCT02151383|11385940|FG001|Low-dose|Overall Study||3
10254119|NCT02151383|11385941|FG002|Low-dose|Overall Study||1
10254120|NCT02151383|11385939|FG000|High-dose|Overall Study||6
10254121|NCT02151383|11385940|FG001|High-dose|Overall Study||0
10254122|NCT02151383|11385941|FG002|High-dose|Overall Study||0
10254123|NCT02151383|11385939|FG000|COMPLETED|Overall Study||8
10254124|NCT02151383|11385940|FG001|COMPLETED|Overall Study||3
10254125|NCT02151383|11385941|FG002|COMPLETED|Overall Study||1
10254126|NCT02151383|11385939|FG000|NOT COMPLETED|Overall Study||0
10254127|NCT02151383|11385940|FG001|NOT COMPLETED|Overall Study||0
10254128|NCT02151383|11385941|FG002|NOT COMPLETED|Overall Study||0
10020366|NCT01835912|11143701|FG000|COMPLETED|Overall Study||10
10254129|NCT02165215|11385952|FG000|STARTED|Induction Phase||359
10254130|NCT02165215|11385953|FG001|STARTED|Induction Phase||0
10254131|NCT02165215|11385954|FG002|STARTED|Induction Phase||0
10254132|NCT02165215|11385952|FG000|Dosed|Induction Phase||358
10254133|NCT02165215|11385953|FG001|Dosed|Induction Phase||0
10254134|NCT02165215|11385954|FG002|Dosed|Induction Phase||0
10254135|NCT02165215|11385952|FG000|COMPLETED|Induction Phase||336
10254136|NCT02165215|11385953|FG001|COMPLETED|Induction Phase||0
10254137|NCT02165215|11385954|FG002|COMPLETED|Induction Phase||0
10254138|NCT02165215|11385952|FG000|NOT COMPLETED|Induction Phase||23
10254139|NCT02165215|11385953|FG001|NOT COMPLETED|Induction Phase||0
10254140|NCT02165215|11385954|FG002|NOT COMPLETED|Induction Phase||0
10254141|NCT02165215|11385952|FG000|STARTED|Maintenance Phase||0
10254142|NCT02165215|11385953|FG001|STARTED|Maintenance Phase||108
10254143|NCT02165215|11385954|FG002|STARTED|Maintenance Phase||106
10254144|NCT02165215|11385952|FG000|Dosed|Maintenance Phase||0
10254145|NCT02165215|11385953|FG001|Dosed|Maintenance Phase||108
10254146|NCT02165215|11385954|FG002|Dosed|Maintenance Phase||102
10254147|NCT02165215|11385952|FG000|COMPLETED|Maintenance Phase||0
10254148|NCT02165215|11385953|FG001|COMPLETED|Maintenance Phase||96
10254149|NCT02165215|11385954|FG002|COMPLETED|Maintenance Phase||101
10254150|NCT02165215|11385952|FG000|NOT COMPLETED|Maintenance Phase||0
10254151|NCT02165215|11385953|FG001|NOT COMPLETED|Maintenance Phase||12
10254152|NCT02165215|11385954|FG002|NOT COMPLETED|Maintenance Phase||5
10254153|NCT02180217|11385968|FG000|STARTED|Overall Study||36
10254154|NCT02180217|11385969|FG001|STARTED|Overall Study||35
10254155|NCT02180217|11385970|FG002|STARTED|Overall Study||66
10254156|NCT02180217|11385968|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
10254157|NCT02180217|11385969|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
10254158|NCT02180217|11385970|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
10254159|NCT02180217|11385968|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0
10254160|NCT02180217|11385969|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0
10254161|NCT02180217|11385970|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12
10254162|NCT02180217|11385968|FG000|Discontinued Prior to W48 But After W26|Overall Study||0
10254163|NCT02180217|11385969|FG001|Discontinued Prior to W48 But After W26|Overall Study||2
10254164|NCT02180217|11385970|FG002|Discontinued Prior to W48 But After W26|Overall Study||3
10254165|NCT02180217|11385968|FG000|Completed Week 48 (Core Phase)|Overall Study||36
10254166|NCT02180217|11385969|FG001|Completed Week 48 (Core Phase)|Overall Study||33
10254167|NCT02180217|11385970|FG002|Completed Week 48 (Core Phase)|Overall Study||44
10254168|NCT02180217|11385968|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
10254169|NCT02180217|11385969|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
10254170|NCT02180217|11385970|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
10254171|NCT02180217|11385968|FG000|Completed W48, Entered Ext. Phase|Overall Study||35
10254172|NCT02180217|11385969|FG001|Completed W48, Entered Ext. Phase|Overall Study||30
10254173|NCT02180217|11385970|FG002|Completed W48, Entered Ext. Phase|Overall Study||41
10254174|NCT02180217|11385968|FG000|Discontinued Extension Phase|Overall Study||12
10254175|NCT02180217|11385969|FG001|Discontinued Extension Phase|Overall Study||6
10254176|NCT02180217|11385970|FG002|Discontinued Extension Phase|Overall Study||16
10254177|NCT02180217|11385968|FG000|Completed Ext. Phase|Overall Study||23
10254178|NCT02180217|11385969|FG001|Completed Ext. Phase|Overall Study||24
10254179|NCT02180217|11385970|FG002|Completed Ext. Phase|Overall Study||25
9834268|NCT00784693|10945287|FG000|STARTED|Overall Study||23
9834269|NCT00784693|10945288|FG001|STARTED|Overall Study||25
9957559|NCT01451606|11076854|FG000|STARTED|Overall Study||16
9957560|NCT01451606|11076855|FG001|STARTED|Overall Study||18
9957561|NCT01451606|11076854|FG000|COMPLETED|Overall Study||12
9957562|NCT01451606|11076855|FG001|COMPLETED|Overall Study||15
9957563|NCT01451606|11076854|FG000|NOT COMPLETED|Overall Study||4
9957564|NCT01451606|11076855|FG001|NOT COMPLETED|Overall Study||3
9957565|NCT01451632|11076863|FG000|STARTED|Overall Study||8
9957566|NCT01451632|11076864|FG001|STARTED|Overall Study||4
10254180|NCT02180217|11385968|FG000|COMPLETED|Overall Study||24
10254181|NCT02180217|11385969|FG001|COMPLETED|Overall Study||27
10254182|NCT02180217|11385970|FG002|COMPLETED|Overall Study||28
10254183|NCT02180217|11385968|FG000|NOT COMPLETED|Overall Study||12
10254184|NCT02180217|11385969|FG001|NOT COMPLETED|Overall Study||8
10254185|NCT02180217|11385970|FG002|NOT COMPLETED|Overall Study||38
9834270|NCT00784693|10945287|FG000|Treated|Overall Study||22
9834271|NCT00784693|10945288|FG001|Treated|Overall Study||25
9834272|NCT00784693|10945287|FG000|COMPLETED|Overall Study||20
9834273|NCT00784693|10945288|FG001|COMPLETED|Overall Study||19
9834274|NCT00784693|10945287|FG000|NOT COMPLETED|Overall Study||3
9834275|NCT00784693|10945288|FG001|NOT COMPLETED|Overall Study||6
9834276|NCT00784719|10945301|FG000|STARTED|Overall Study||47
9834277|NCT00784719|10945302|FG001|STARTED|Overall Study||46
9957567|NCT01451632|11076865|FG002|STARTED|Overall Study||3
9834278|NCT00784719|10945303|FG002|STARTED|Overall Study||47
10254186|NCT02186457|11385987|FG000|STARTED|Overall Study||95
10254187|NCT02186457|11385988|FG001|STARTED|Overall Study||95
10254188|NCT02186457|11385987|FG000|COMPLETED|Overall Study||95
10254189|NCT02186457|11385988|FG001|COMPLETED|Overall Study||95
10254190|NCT02186457|11385987|FG000|NOT COMPLETED|Overall Study||0
10254191|NCT02186457|11385988|FG001|NOT COMPLETED|Overall Study||0
10254192|NCT02193867|11385994|FG000|STARTED|Overall Study||10
10254193|NCT02193867|11385994|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10
10254194|NCT02193867|11385994|FG000|Completed 18 Months Of Treatment|Overall Study||8
10254195|NCT02193867|11385994|FG000|COMPLETED|Overall Study||6
10254196|NCT02193867|11385994|FG000|NOT COMPLETED|Overall Study||4
10254197|NCT02215096|11386001|FG000|STARTED|Run-In Period (Up to Week 2)||37
10254198|NCT02215096|11386002|FG001|STARTED|Run-In Period (Up to Week 2)||0
10254199|NCT02215096|11386003|FG002|STARTED|Run-In Period (Up to Week 2)||0
10254200|NCT02215096|11386004|FG003|STARTED|Run-In Period (Up to Week 2)||0
10254201|NCT02215096|11386005|FG004|STARTED|Run-In Period (Up to Week 2)||0
10254202|NCT02215096|11386001|FG000|COMPLETED|Run-In Period (Up to Week 2)||36
10254203|NCT02215096|11386002|FG001|COMPLETED|Run-In Period (Up to Week 2)||0
10254204|NCT02215096|11386003|FG002|COMPLETED|Run-In Period (Up to Week 2)||0
10254205|NCT02215096|11386004|FG003|COMPLETED|Run-In Period (Up to Week 2)||0
10254206|NCT02215096|11386005|FG004|COMPLETED|Run-In Period (Up to Week 2)||0
10254207|NCT02215096|11386001|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1
10254208|NCT02215096|11386002|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10254209|NCT02215096|11386003|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10254210|NCT02215096|11386004|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10254211|NCT02215096|11386005|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10254212|NCT02215096|11386001|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0
10254213|NCT02215096|11386002|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11
10254214|NCT02215096|11386003|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11
10254215|NCT02215096|11386004|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12
10254216|NCT02215096|11386005|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2
10254217|NCT02215096|11386001|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
10254218|NCT02215096|11386002|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
10254219|NCT02215096|11386003|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
10254220|NCT02215096|11386004|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
10254221|NCT02215096|11386005|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10254222|NCT02215096|11386001|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
10254223|NCT02215096|11386002|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
10254224|NCT02215096|11386003|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10254225|NCT02215096|11386004|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
10254226|NCT02215096|11386005|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10254227|NCT02218697|11386023|FG000|STARTED|Overall Study||179
10254228|NCT02218697|11386024|FG001|STARTED|Overall Study||177
10254229|NCT02218697|11386023|FG000|COMPLETED|Overall Study||177
10254230|NCT02218697|11386024|FG001|COMPLETED|Overall Study||171
10254231|NCT02218697|11386023|FG000|NOT COMPLETED|Overall Study||2
10254232|NCT02218697|11386024|FG001|NOT COMPLETED|Overall Study||6
10254245|NCT02224456|11386051|FG000|STARTED|Overall Study||197
10254246|NCT02224456|11386051|FG000|COMPLETED|Overall Study||161
10254247|NCT02224456|11386051|FG000|NOT COMPLETED|Overall Study||36
10254248|NCT02231762|11386055|FG000|STARTED|Combination Phase||57
10254249|NCT02231762|11386056|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10254250|NCT02231762|11386057|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10254251|NCT02231762|11386058|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10254252|NCT02231762|11386055|FG000|COMPLETED|Combination Phase||37
10254253|NCT02231762|11386056|FG001|COMPLETED|Combination Phase||0
10254254|NCT02231762|11386057|FG002|COMPLETED|Combination Phase||0
10254255|NCT02231762|11386058|FG003|COMPLETED|Combination Phase||0
10254256|NCT02231762|11386055|FG000|NOT COMPLETED|Combination Phase||20
10254257|NCT02231762|11386056|FG001|NOT COMPLETED|Combination Phase||0
10254258|NCT02231762|11386057|FG002|NOT COMPLETED|Combination Phase||0
10254259|NCT02231762|11386058|FG003|NOT COMPLETED|Combination Phase||0
10254260|NCT02231762|11386055|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
10254261|NCT02231762|11386056|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
10254262|NCT02231762|11386057|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
10254263|NCT02231762|11386058|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
10254264|NCT02231762|11386055|FG000|COMPLETED|Maintenance Phase||0
10254265|NCT02231762|11386056|FG001|COMPLETED|Maintenance Phase||8
10254266|NCT02231762|11386057|FG002|COMPLETED|Maintenance Phase||9
10254267|NCT02231762|11386058|FG003|COMPLETED|Maintenance Phase||7
10254268|NCT02231762|11386055|FG000|NOT COMPLETED|Maintenance Phase||0
10254269|NCT02231762|11386056|FG001|NOT COMPLETED|Maintenance Phase||3
10254270|NCT02231762|11386057|FG002|NOT COMPLETED|Maintenance Phase||5
10254271|NCT02231762|11386058|FG003|NOT COMPLETED|Maintenance Phase||5
10254272|NCT02234843|11386082|FG000|STARTED|Overall Study||184
10254273|NCT02234843|11386083|FG001|STARTED|Overall Study||67
10254274|NCT02234843|11386084|FG002|STARTED|Overall Study||47
10254275|NCT02234843|11386085|FG003|STARTED|Overall Study||21
10254276|NCT02234843|11386086|FG004|STARTED|Overall Study||16
10254233|NCT02221037|11386034|FG000|STARTED|Overall Study||5
10254234|NCT02221037|11386035|FG001|STARTED|Overall Study||11
10254235|NCT02221037|11386036|FG002|STARTED|Overall Study||8
10254236|NCT02221037|11386037|FG003|STARTED|Overall Study||9
10254237|NCT02221037|11386034|FG000|COMPLETED|Overall Study||5
10254238|NCT02221037|11386035|FG001|COMPLETED|Overall Study||11
10254239|NCT02221037|11386036|FG002|COMPLETED|Overall Study||7
10254240|NCT02221037|11386037|FG003|COMPLETED|Overall Study||9
10254241|NCT02221037|11386034|FG000|NOT COMPLETED|Overall Study||0
10254242|NCT02221037|11386035|FG001|NOT COMPLETED|Overall Study||0
10254243|NCT02221037|11386036|FG002|NOT COMPLETED|Overall Study||1
10254244|NCT02221037|11386037|FG003|NOT COMPLETED|Overall Study||0
10254277|NCT02234843|11386087|FG005|STARTED|Overall Study||92
10254278|NCT02234843|11386088|FG006|STARTED|Overall Study||34
10020367|NCT01835912|11143701|FG000|NOT COMPLETED|Overall Study||0
10020368|NCT01836029|11143713|FG000|STARTED|Overall Study||100
10020369|NCT01836029|11143714|FG001|STARTED|Overall Study||95
10254279|NCT02234843|11386089|FG007|STARTED|Overall Study||22
10254280|NCT02234843|11386090|FG008|STARTED|Overall Study||9
10254281|NCT02234843|11386091|FG009|STARTED|Overall Study||8
10254282|NCT02234843|11386082|FG000|COMPLETED|Overall Study||162
10254283|NCT02234843|11386083|FG001|COMPLETED|Overall Study||61
10254284|NCT02234843|11386084|FG002|COMPLETED|Overall Study||44
10254285|NCT02234843|11386085|FG003|COMPLETED|Overall Study||16
10254286|NCT02234843|11386086|FG004|COMPLETED|Overall Study||14
10254287|NCT02234843|11386087|FG005|COMPLETED|Overall Study||79
10020370|NCT01836029|11143713|FG000|COMPLETED|Overall Study||100
10020371|NCT01836029|11143714|FG001|COMPLETED|Overall Study||95
10020372|NCT01836029|11143713|FG000|NOT COMPLETED|Overall Study||0
10020373|NCT01836029|11143714|FG001|NOT COMPLETED|Overall Study||0
10020374|NCT01836042|11143723|FG000|STARTED|Overall Study||51
10020375|NCT01836042|11143724|FG001|STARTED|Overall Study||35
10020376|NCT01836042|11143725|FG002|STARTED|Overall Study||22
10020377|NCT01836042|11143723|FG000|COMPLETED|Overall Study||51
10020378|NCT01836042|11143724|FG001|COMPLETED|Overall Study||35
10020379|NCT01836042|11143725|FG002|COMPLETED|Overall Study||22
10020380|NCT01836042|11143723|FG000|NOT COMPLETED|Overall Study||0
10020381|NCT01836042|11143724|FG001|NOT COMPLETED|Overall Study||0
10254288|NCT02234843|11386088|FG006|COMPLETED|Overall Study||32
10254289|NCT02234843|11386089|FG007|COMPLETED|Overall Study||20
10254290|NCT02234843|11386090|FG008|COMPLETED|Overall Study||8
10254291|NCT02234843|11386091|FG009|COMPLETED|Overall Study||8
10254292|NCT02234843|11386082|FG000|NOT COMPLETED|Overall Study||22
10254293|NCT02234843|11386083|FG001|NOT COMPLETED|Overall Study||6
10254294|NCT02234843|11386084|FG002|NOT COMPLETED|Overall Study||3
10254295|NCT02234843|11386085|FG003|NOT COMPLETED|Overall Study||5
10254296|NCT02234843|11386086|FG004|NOT COMPLETED|Overall Study||2
10254297|NCT02234843|11386087|FG005|NOT COMPLETED|Overall Study||13
10254298|NCT02234843|11386088|FG006|NOT COMPLETED|Overall Study||2
10254299|NCT02234843|11386089|FG007|NOT COMPLETED|Overall Study||2
10254300|NCT02234843|11386090|FG008|NOT COMPLETED|Overall Study||1
10254301|NCT02234843|11386091|FG009|NOT COMPLETED|Overall Study||0
10020382|NCT01836042|11143725|FG002|NOT COMPLETED|Overall Study||0
10020383|NCT01836133|11143733|FG000|STARTED|Overall Study||70
10020384|NCT01836133|11143733|FG000|COMPLETED|Overall Study||70
10020385|NCT01836133|11143733|FG000|NOT COMPLETED|Overall Study||0
10020386|NCT01836185|11143741|FG000|STARTED|Overall Study||10
10020387|NCT01836185|11143742|FG001|STARTED|Overall Study||8
10020388|NCT01836185|11143743|FG002|STARTED|Overall Study||8
10020389|NCT01836185|11143744|FG003|STARTED|Overall Study||6
10254302|NCT02243306|11386126|FG000|STARTED|Overall Study||1
10254303|NCT02243306|11386127|FG001|STARTED|Overall Study||7
10254304|NCT02243306|11386126|FG000|COMPLETED|Overall Study||1
10254305|NCT02243306|11386127|FG001|COMPLETED|Overall Study||4
10254306|NCT02243306|11386126|FG000|NOT COMPLETED|Overall Study||0
10254307|NCT02243306|11386127|FG001|NOT COMPLETED|Overall Study||3
10254308|NCT02246621|11386136|FG000|STARTED|Overall Study||328
10254309|NCT02246621|11386137|FG001|STARTED|Overall Study||165
10254310|NCT02246621|11386136|FG000|Received At Least One Dose of Study Drug|Overall Study||327
10254311|NCT02246621|11386137|FG001|Received At Least One Dose of Study Drug|Overall Study||161
10254312|NCT02246621|11386136|FG000|COMPLETED|Overall Study||63
10020390|NCT01836185|11143741|FG000|Received Single Dose of Study Treatment|Overall Study||10
10020391|NCT01836185|11143742|FG001|Received Single Dose of Study Treatment|Overall Study||8
10020392|NCT01836185|11143743|FG002|Received Single Dose of Study Treatment|Overall Study||8
10020393|NCT01836185|11143744|FG003|Received Single Dose of Study Treatment|Overall Study||6
10020394|NCT01836185|11143741|FG000|COMPLETED|Overall Study||10
10020395|NCT01836185|11143742|FG001|COMPLETED|Overall Study||8
10020396|NCT01836185|11143743|FG002|COMPLETED|Overall Study||8
10020397|NCT01836185|11143744|FG003|COMPLETED|Overall Study||6
10020398|NCT01836185|11143741|FG000|NOT COMPLETED|Overall Study||0
10020399|NCT01836185|11143742|FG001|NOT COMPLETED|Overall Study||0
10020400|NCT01836185|11143743|FG002|NOT COMPLETED|Overall Study||0
10020401|NCT01836185|11143744|FG003|NOT COMPLETED|Overall Study||0
10020402|NCT01836198|11143756|FG000|STARTED|Part A, Period 1||15
10020403|NCT01836198|11143757|FG001|STARTED|Part A, Period 1||15
10020404|NCT01836198|11143758|FG002|STARTED|Part A, Period 1||0
10020405|NCT01836198|11143756|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
10020406|NCT01836198|11143757|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
10020407|NCT01836198|11143758|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
10020408|NCT01836198|11143756|FG000|COMPLETED|Part A, Period 1||15
10020409|NCT01836198|11143757|FG001|COMPLETED|Part A, Period 1||15
10020410|NCT01836198|11143758|FG002|COMPLETED|Part A, Period 1||0
10020411|NCT01836198|11143756|FG000|NOT COMPLETED|Part A, Period 1||0
10254313|NCT02246621|11386137|FG001|COMPLETED|Overall Study||30
10254314|NCT02246621|11386136|FG000|NOT COMPLETED|Overall Study||265
10020412|NCT01836198|11143757|FG001|NOT COMPLETED|Part A, Period 1||0
10020413|NCT01836198|11143758|FG002|NOT COMPLETED|Part A, Period 1||0
10020414|NCT01836198|11143756|FG000|STARTED|Part A, Period 2||15
10020415|NCT01836198|11143757|FG001|STARTED|Part A, Period 2||15
10020416|NCT01836198|11143758|FG002|STARTED|Part A, Period 2||0
10020417|NCT01836198|11143756|FG000|Completed Part A, Entered Part B|Part A, Period 2||6
10020418|NCT01836198|11143757|FG001|Completed Part A, Entered Part B|Part A, Period 2||6
10020419|NCT01836198|11143758|FG002|Completed Part A, Entered Part B|Part A, Period 2||0
10020420|NCT01836198|11143756|FG000|COMPLETED|Part A, Period 2||15
10020421|NCT01836198|11143757|FG001|COMPLETED|Part A, Period 2||14
10020422|NCT01836198|11143758|FG002|COMPLETED|Part A, Period 2||0
10020423|NCT01836198|11143756|FG000|NOT COMPLETED|Part A, Period 2||0
10020424|NCT01836198|11143757|FG001|NOT COMPLETED|Part A, Period 2||1
10020425|NCT01836198|11143758|FG002|NOT COMPLETED|Part A, Period 2||0
10020426|NCT01836198|11143756|FG000|STARTED|Part B||0
10020427|NCT01836198|11143757|FG001|STARTED|Part B||0
10020428|NCT01836198|11143758|FG002|STARTED|Part B||12
10020429|NCT01836198|11143756|FG000|Received at Least 1 Dose of Study Drug|Part B||0
10020430|NCT01836198|11143757|FG001|Received at Least 1 Dose of Study Drug|Part B||0
10020431|NCT01836198|11143758|FG002|Received at Least 1 Dose of Study Drug|Part B||12
10020432|NCT01836198|11143756|FG000|COMPLETED|Part B||0
10020433|NCT01836198|11143757|FG001|COMPLETED|Part B||0
10020434|NCT01836198|11143758|FG002|COMPLETED|Part B||12
10020435|NCT01836198|11143756|FG000|NOT COMPLETED|Part B||0
10020436|NCT01836198|11143757|FG001|NOT COMPLETED|Part B||0
10020437|NCT01836198|11143758|FG002|NOT COMPLETED|Part B||0
10020438|NCT01836276|11143776|FG000|STARTED|Overall Study||224
10020439|NCT01836276|11143777|FG001|STARTED|Overall Study||225
10020440|NCT01836276|11143776|FG000|Week 4|Overall Study||198
10020441|NCT01836276|11143777|FG001|Week 4|Overall Study||186
10020442|NCT01836276|11143776|FG000|Week 12|Overall Study||183
10020443|NCT01836276|11143777|FG001|Week 12|Overall Study||165
10020444|NCT01836276|11143776|FG000|COMPLETED|Overall Study||196
10020445|NCT01836276|11143777|FG001|COMPLETED|Overall Study||174
10020446|NCT01836276|11143776|FG000|NOT COMPLETED|Overall Study||28
10020447|NCT01836276|11143777|FG001|NOT COMPLETED|Overall Study||51
10020448|NCT01836445|11143785|FG000|STARTED|Intervention Modules||445
10020449|NCT01836445|11143786|FG001|STARTED|Intervention Modules||456
10020450|NCT01836445|11143785|FG000|COMPLETED|Intervention Modules||375
10020451|NCT01836445|11143786|FG001|COMPLETED|Intervention Modules||434
10020452|NCT01836445|11143785|FG000|NOT COMPLETED|Intervention Modules||70
10020453|NCT01836445|11143786|FG001|NOT COMPLETED|Intervention Modules||22
10020454|NCT01836445|11143785|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10020455|NCT01836445|11143786|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
10020456|NCT01836445|11143785|FG000|COMPLETED|3 Month Follow-up Assessment||348
10020457|NCT01836445|11143786|FG001|COMPLETED|3 Month Follow-up Assessment||409
10020458|NCT01836445|11143785|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97
10020459|NCT01836445|11143786|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47
10020460|NCT01836445|11143785|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10020461|NCT01836445|11143786|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10020462|NCT01836445|11143785|FG000|COMPLETED|6 Month Follow-up Assessment||342
10020463|NCT01836445|11143786|FG001|COMPLETED|6 Month Follow-up Assessment||380
10020464|NCT01836445|11143785|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103
10020465|NCT01836445|11143786|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75
10020466|NCT01836445|11143785|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10020467|NCT01836445|11143786|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10020468|NCT01836445|11143785|FG000|COMPLETED|12 Month Follow-up Assessment||370
10020469|NCT01836445|11143786|FG001|COMPLETED|12 Month Follow-up Assessment||391
10020470|NCT01836445|11143785|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75
10020471|NCT01836445|11143786|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64
10020472|NCT01836445|11143785|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10254315|NCT02246621|11386137|FG001|NOT COMPLETED|Overall Study||135
10020473|NCT01836445|11143786|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10020474|NCT01836445|11143785|FG000|COMPLETED|12 Month STI Testing||365
10020475|NCT01836445|11143786|FG001|COMPLETED|12 Month STI Testing||378
10020476|NCT01836445|11143785|FG000|NOT COMPLETED|12 Month STI Testing||80
10020477|NCT01836445|11143786|FG001|NOT COMPLETED|12 Month STI Testing||77
10020478|NCT01836458|11143796|FG000|STARTED|Overall Study||7
10020479|NCT01836458|11143797|FG001|STARTED|Overall Study||4
10020480|NCT01836458|11143798|FG002|STARTED|Overall Study||7
10020481|NCT01836458|11143799|FG003|STARTED|Overall Study||7
10020482|NCT01836458|11143796|FG000|COMPLETED|Overall Study||4
10020483|NCT01836458|11143797|FG001|COMPLETED|Overall Study||2
10020484|NCT01836458|11143798|FG002|COMPLETED|Overall Study||2
10020485|NCT01836458|11143799|FG003|COMPLETED|Overall Study||1
10020486|NCT01836458|11143796|FG000|NOT COMPLETED|Overall Study||3
10020487|NCT01836458|11143797|FG001|NOT COMPLETED|Overall Study||2
10020488|NCT01836458|11143798|FG002|NOT COMPLETED|Overall Study||5
10020489|NCT01836458|11143799|FG003|NOT COMPLETED|Overall Study||6
10020490|NCT01836471|11143814|FG000|STARTED|Overall Study||93
10020491|NCT01836471|11143815|FG001|STARTED|Overall Study||94
10020492|NCT01836471|11143816|FG002|STARTED|Overall Study||51
10020493|NCT01836471|11143817|FG003|STARTED|Overall Study||42
10020494|NCT01836471|11143818|FG004|STARTED|Overall Study||54
10020495|NCT01836471|11143814|FG000|COMPLETED|Overall Study||82
10020496|NCT01836471|11143815|FG001|COMPLETED|Overall Study||85
10020497|NCT01836471|11143816|FG002|COMPLETED|Overall Study||49
10020498|NCT01836471|11143817|FG003|COMPLETED|Overall Study||40
10020499|NCT01836471|11143818|FG004|COMPLETED|Overall Study||49
10020500|NCT01836471|11143814|FG000|NOT COMPLETED|Overall Study||11
10020501|NCT01836471|11143815|FG001|NOT COMPLETED|Overall Study||9
10020502|NCT01836471|11143816|FG002|NOT COMPLETED|Overall Study||2
10020503|NCT01836471|11143817|FG003|NOT COMPLETED|Overall Study||2
10020504|NCT01836471|11143818|FG004|NOT COMPLETED|Overall Study||5
10020505|NCT01836523|11143835|FG000|STARTED|Overall Study||351
10020506|NCT01836523|11143836|FG001|STARTED|Overall Study||350
10020507|NCT01836523|11143837|FG002|STARTED|Overall Study||349
10020508|NCT01836523|11143838|FG003|STARTED|Overall Study||348
10020509|NCT01836523|11143835|FG000|Exposed|Overall Study||350
10020510|NCT01836523|11143836|FG001|Exposed|Overall Study||348
10020511|NCT01836523|11143837|FG002|Exposed|Overall Study||347
10020512|NCT01836523|11143838|FG003|Exposed|Overall Study||348
10020513|NCT01836523|11143835|FG000|COMPLETED|Overall Study||300
10020514|NCT01836523|11143836|FG001|COMPLETED|Overall Study||265
10020515|NCT01836523|11143837|FG002|COMPLETED|Overall Study||258
10020516|NCT01836523|11143838|FG003|COMPLETED|Overall Study||274
10020517|NCT01836523|11143835|FG000|NOT COMPLETED|Overall Study||51
10020518|NCT01836523|11143836|FG001|NOT COMPLETED|Overall Study||85
10020519|NCT01836523|11143837|FG002|NOT COMPLETED|Overall Study||91
10020520|NCT01836523|11143838|FG003|NOT COMPLETED|Overall Study||74
10020521|NCT01836549|11143854|FG000|STARTED|Overall Study||1
10020522|NCT01836549|11143855|FG001|STARTED|Overall Study||1
10020523|NCT01836549|11143856|FG002|STARTED|Overall Study||1
10020524|NCT01836549|11143857|FG003|STARTED|Overall Study||9
10020525|NCT01836549|11143858|FG004|STARTED|Overall Study||18
10020526|NCT01836549|11143859|FG005|STARTED|Overall Study||4
10020527|NCT01836549|11143860|FG006|STARTED|Overall Study||9
10020528|NCT01836549|11143854|FG000|COMPLETED|Overall Study||1
10020529|NCT01836549|11143855|FG001|COMPLETED|Overall Study||1
10020530|NCT01836549|11143856|FG002|COMPLETED|Overall Study||0
10020531|NCT01836549|11143857|FG003|COMPLETED|Overall Study||8
10020532|NCT01836549|11143858|FG004|COMPLETED|Overall Study||18
10020533|NCT01836549|11143859|FG005|COMPLETED|Overall Study||4
10020534|NCT01836549|11143860|FG006|COMPLETED|Overall Study||8
10020535|NCT01836549|11143854|FG000|NOT COMPLETED|Overall Study||0
10020536|NCT01836549|11143855|FG001|NOT COMPLETED|Overall Study||0
10020537|NCT01836549|11143856|FG002|NOT COMPLETED|Overall Study||1
10020538|NCT01836549|11143857|FG003|NOT COMPLETED|Overall Study||1
10020539|NCT01836549|11143858|FG004|NOT COMPLETED|Overall Study||0
10020540|NCT01836549|11143859|FG005|NOT COMPLETED|Overall Study||0
10020541|NCT01836549|11143860|FG006|NOT COMPLETED|Overall Study||1
10020542|NCT01837069|11143878|FG000|STARTED|Overall Study||103
10020543|NCT01837069|11143879|FG001|STARTED|Overall Study||95
10020544|NCT01837069|11143878|FG000|COMPLETED|Overall Study||103
10020545|NCT01837069|11143879|FG001|COMPLETED|Overall Study||95
10020546|NCT01837069|11143878|FG000|NOT COMPLETED|Overall Study||0
10020547|NCT01837069|11143879|FG001|NOT COMPLETED|Overall Study||0
10020548|NCT01837524|11143887|FG000|STARTED|Overall Study||28
10020549|NCT01837524|11143888|FG001|STARTED|Overall Study||27
10020550|NCT01837524|11143887|FG000|COMPLETED|Overall Study||25
10020551|NCT01837524|11143888|FG001|COMPLETED|Overall Study||25
10020552|NCT01837524|11143887|FG000|NOT COMPLETED|Overall Study||3
10020553|NCT01837524|11143888|FG001|NOT COMPLETED|Overall Study||2
10020554|NCT01837537|11143894|FG000|STARTED|Overall Study||90
10020555|NCT01837537|11143894|FG000|COMPLETED|Overall Study||90
10020556|NCT01837537|11143894|FG000|NOT COMPLETED|Overall Study||0
10020557|NCT01837550|11143900|FG000|STARTED|T0-T1, 5 Weeks||37
10020558|NCT01837550|11143901|FG001|STARTED|T0-T1, 5 Weeks||37
10020559|NCT01837550|11143900|FG000|COMPLETED|T0-T1, 5 Weeks||37
10020560|NCT01837550|11143901|FG001|COMPLETED|T0-T1, 5 Weeks||37
10020561|NCT01837550|11143900|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0
10020562|NCT01837550|11143901|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0
10020563|NCT01837550|11143900|FG000|STARTED|T0-T2, 6 Months Follow-up||37
10020564|NCT01837550|11143901|FG001|STARTED|T0-T2, 6 Months Follow-up||37
10020565|NCT01837550|11143900|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37
10020566|NCT01837550|11143901|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37
10020567|NCT01837550|11143900|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
10020568|NCT01837550|11143901|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
10020569|NCT01837654|11143909|FG000|STARTED|Overall Study||11
10020570|NCT01837654|11143910|FG001|STARTED|Overall Study||11
10020571|NCT01837654|11143909|FG000|COMPLETED|Overall Study||11
10020572|NCT01837654|11143910|FG001|COMPLETED|Overall Study||11
10020573|NCT01837654|11143909|FG000|NOT COMPLETED|Overall Study||0
10020574|NCT01837654|11143910|FG001|NOT COMPLETED|Overall Study||0
10020575|NCT01837680|11143918|FG000|STARTED|Overall Study||52
10020576|NCT01837680|11143919|FG001|STARTED|Overall Study||53
10020577|NCT01837680|11143918|FG000|COMPLETED|Overall Study||42
10020578|NCT01837680|11143919|FG001|COMPLETED|Overall Study||45
10020579|NCT01837680|11143918|FG000|NOT COMPLETED|Overall Study||10
10020580|NCT01837680|11143919|FG001|NOT COMPLETED|Overall Study||8
10020581|NCT01837719|11143925|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
10020582|NCT01837719|11143925|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
10020583|NCT01837719|11143925|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
10020584|NCT01837719|11143925|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
10020585|NCT01837719|11143925|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
10020586|NCT01837719|11143925|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
10020587|NCT01837719|11143925|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
10020588|NCT01837719|11143925|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
10020589|NCT01837719|11143925|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
10020590|NCT01837719|11143925|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
10020591|NCT01837719|11143925|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
10020592|NCT01837719|11143925|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
10020593|NCT01837719|11143925|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
10020594|NCT01837719|11143925|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
10020595|NCT01837719|11143925|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
10020596|NCT01837797|11143943|FG000|STARTED|Period 1||129
10020597|NCT01837797|11143944|FG001|STARTED|Period 1||0
10020598|NCT01837797|11143945|FG002|STARTED|Period 1||0
10020599|NCT01837797|11143946|FG003|STARTED|Period 1||0
10020600|NCT01837797|11143947|FG004|STARTED|Period 1||0
10020601|NCT01837797|11143943|FG000|COMPLETED|Period 1||27
10020602|NCT01837797|11143944|FG001|COMPLETED|Period 1||0
10254316|NCT04093843|11386143|FG000|STARTED|Overall Study||6
10254317|NCT04093843|11386143|FG000|COMPLETED|Overall Study||6
10254318|NCT04093843|11386143|FG000|NOT COMPLETED|Overall Study||0
10020603|NCT01837797|11143945|FG002|COMPLETED|Period 1||0
10020604|NCT01837797|11143946|FG003|COMPLETED|Period 1||0
10020605|NCT01837797|11143947|FG004|COMPLETED|Period 1||0
10020606|NCT01837797|11143943|FG000|NOT COMPLETED|Period 1||102
10020607|NCT01837797|11143944|FG001|NOT COMPLETED|Period 1||0
10020608|NCT01837797|11143945|FG002|NOT COMPLETED|Period 1||0
10020609|NCT01837797|11143946|FG003|NOT COMPLETED|Period 1||0
10020610|NCT01837797|11143947|FG004|NOT COMPLETED|Period 1||0
10254319|NCT03926611|11386154|FG000|STARTED|Overall Study||44
10020611|NCT01837797|11143943|FG000|STARTED|Period 2||0
10020612|NCT01837797|11143944|FG001|STARTED|Period 2||6
10020613|NCT01837797|11143945|FG002|STARTED|Period 2||3
10020614|NCT01837797|11143946|FG003|STARTED|Period 2||6
10020615|NCT01837797|11143947|FG004|STARTED|Period 2||0
10020616|NCT01837797|11143943|FG000|COMPLETED|Period 2||0
10020617|NCT01837797|11143944|FG001|COMPLETED|Period 2||1
10020618|NCT01837797|11143945|FG002|COMPLETED|Period 2||1
10020619|NCT01837797|11143946|FG003|COMPLETED|Period 2||1
10020620|NCT01837797|11143947|FG004|COMPLETED|Period 2||0
10020621|NCT01837797|11143943|FG000|NOT COMPLETED|Period 2||0
10020622|NCT01837797|11143944|FG001|NOT COMPLETED|Period 2||5
10020623|NCT01837797|11143945|FG002|NOT COMPLETED|Period 2||2
10020624|NCT01837797|11143946|FG003|NOT COMPLETED|Period 2||5
10114003|NCT02513160|11244734|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10114004|NCT02513160|11244735|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10254320|NCT03926611|11386155|FG001|STARTED|Overall Study||44
10254321|NCT03926611|11386156|FG002|STARTED|Overall Study||47
10254322|NCT03926611|11386157|FG003|STARTED|Overall Study||44
10254323|NCT03926611|11386158|FG004|STARTED|Overall Study||44
10254324|NCT03926611|11386159|FG005|STARTED|Overall Study||45
10254325|NCT03926611|11386160|FG006|STARTED|Overall Study||43
10254326|NCT03926611|11386154|FG000|Randomized Set (RAN)|Overall Study||44
10254327|NCT03926611|11386155|FG001|Randomized Set (RAN)|Overall Study||44
10254328|NCT03926611|11386156|FG002|Randomized Set (RAN)|Overall Study||47
10254329|NCT03926611|11386157|FG003|Randomized Set (RAN)|Overall Study||44
10254330|NCT03926611|11386158|FG004|Randomized Set (RAN)|Overall Study||44
10254331|NCT03926611|11386159|FG005|Randomized Set (RAN)|Overall Study||45
10254332|NCT03926611|11386160|FG006|Randomized Set (RAN)|Overall Study||43
10254333|NCT03926611|11386154|FG000|Full Analysis Set (FAS)|Overall Study||44
10254334|NCT03926611|11386155|FG001|Full Analysis Set (FAS)|Overall Study||44
10254335|NCT03926611|11386156|FG002|Full Analysis Set (FAS)|Overall Study||47
10254336|NCT03926611|11386157|FG003|Full Analysis Set (FAS)|Overall Study||44
10254337|NCT03926611|11386158|FG004|Full Analysis Set (FAS)|Overall Study||43
10254338|NCT03926611|11386159|FG005|Full Analysis Set (FAS)|Overall Study||45
10254339|NCT03926611|11386160|FG006|Full Analysis Set (FAS)|Overall Study||42
10254340|NCT03926611|11386154|FG000|Safety Set (SAF)|Overall Study||44
10254341|NCT03926611|11386155|FG001|Safety Set (SAF)|Overall Study||44
10254342|NCT03926611|11386156|FG002|Safety Set (SAF)|Overall Study||47
10254343|NCT03926611|11386157|FG003|Safety Set (SAF)|Overall Study||44
10254344|NCT03926611|11386158|FG004|Safety Set (SAF)|Overall Study||43
10254345|NCT03926611|11386159|FG005|Safety Set (SAF)|Overall Study||45
10254346|NCT03926611|11386160|FG006|Safety Set (SAF)|Overall Study||42
10254347|NCT03926611|11386154|FG000|COMPLETED|Overall Study||41
10254348|NCT03926611|11386155|FG001|COMPLETED|Overall Study||41
10254349|NCT03926611|11386156|FG002|COMPLETED|Overall Study||45
10254350|NCT03926611|11386157|FG003|COMPLETED|Overall Study||40
10254351|NCT03926611|11386158|FG004|COMPLETED|Overall Study||40
10254352|NCT03926611|11386159|FG005|COMPLETED|Overall Study||36
10254353|NCT03926611|11386160|FG006|COMPLETED|Overall Study||38
10254354|NCT03926611|11386154|FG000|NOT COMPLETED|Overall Study||3
10254355|NCT03926611|11386155|FG001|NOT COMPLETED|Overall Study||3
10254356|NCT03926611|11386156|FG002|NOT COMPLETED|Overall Study||2
10254357|NCT03926611|11386157|FG003|NOT COMPLETED|Overall Study||4
10254358|NCT03926611|11386158|FG004|NOT COMPLETED|Overall Study||4
10254359|NCT03926611|11386159|FG005|NOT COMPLETED|Overall Study||9
10254360|NCT03926611|11386160|FG006|NOT COMPLETED|Overall Study||5
10254361|NCT03838484|11386184|FG000|STARTED|Overall Study||5
10254362|NCT03838484|11386185|FG001|STARTED|Overall Study||5
10254363|NCT03838484|11386186|FG002|STARTED|Overall Study||4
10254364|NCT03838484|11386187|FG003|STARTED|Overall Study||4
10254365|NCT03838484|11386184|FG000|COMPLETED|Overall Study||5
10254366|NCT03838484|11386185|FG001|COMPLETED|Overall Study||4
10254367|NCT03838484|11386186|FG002|COMPLETED|Overall Study||4
10254368|NCT03838484|11386187|FG003|COMPLETED|Overall Study||4
10254369|NCT03838484|11386184|FG000|NOT COMPLETED|Overall Study||0
10254370|NCT03838484|11386185|FG001|NOT COMPLETED|Overall Study||1
10254371|NCT03838484|11386186|FG002|NOT COMPLETED|Overall Study||0
10254372|NCT03838484|11386187|FG003|NOT COMPLETED|Overall Study||0
10254373|NCT03814720|11386208|FG000|STARTED|Overall Study||5
10254374|NCT03814720|11386209|FG001|STARTED|Overall Study||12
10020625|NCT01837797|11143947|FG004|NOT COMPLETED|Period 2||0
10020626|NCT01837797|11143943|FG000|STARTED|Period 3||0
10020627|NCT01837797|11143944|FG001|STARTED|Period 3||0
10020628|NCT01837797|11143945|FG002|STARTED|Period 3||0
10020629|NCT01837797|11143946|FG003|STARTED|Period 3||0
10196023|NCT03358147|11324399|FG004|COMPLETED|Overall Study||105
10020630|NCT01837797|11143947|FG004|STARTED|Period 3||47
10020631|NCT01837797|11143943|FG000|COMPLETED|Period 3||0
10020632|NCT01837797|11143944|FG001|COMPLETED|Period 3||0
10196024|NCT03358147|11324395|FG000|NOT COMPLETED|Overall Study||34
10196025|NCT03358147|11324396|FG001|NOT COMPLETED|Overall Study||39
10196026|NCT03358147|11324397|FG002|NOT COMPLETED|Overall Study||34
10196027|NCT03358147|11324398|FG003|NOT COMPLETED|Overall Study||36
10196028|NCT03358147|11324399|FG004|NOT COMPLETED|Overall Study||14
10196029|NCT03358238|11324413|FG000|STARTED|Overall Study||23
10196030|NCT03358238|11324414|FG001|STARTED|Overall Study||25
10196031|NCT03358238|11324413|FG000|COMPLETED|Overall Study||23
10196032|NCT03358238|11324414|FG001|COMPLETED|Overall Study||24
10196033|NCT03358238|11324413|FG000|NOT COMPLETED|Overall Study||0
10196034|NCT03358238|11324414|FG001|NOT COMPLETED|Overall Study||1
10254375|NCT03814720|11386210|FG002|STARTED|Overall Study||12
10254376|NCT03814720|11386211|FG003|STARTED|Overall Study||12
10254377|NCT03814720|11386212|FG004|STARTED|Overall Study||11
10254378|NCT03814720|11386208|FG000|Received First Product Administration|Overall Study||5
10254379|NCT03814720|11386209|FG001|Received First Product Administration|Overall Study||12
10254380|NCT03814720|11386210|FG002|Received First Product Administration|Overall Study||12
10254381|NCT03814720|11386211|FG003|Received First Product Administration|Overall Study||12
10254382|NCT03814720|11386212|FG004|Received First Product Administration|Overall Study||11
10254383|NCT03814720|11386208|FG000|Received All Product Administrations|Overall Study||5
10254384|NCT03814720|11386209|FG001|Received All Product Administrations|Overall Study||12
10254385|NCT03814720|11386210|FG002|Received All Product Administrations|Overall Study|One participant did not receive the second dose due to moving out of area and 4 participants did not receive the second dose due to the COVID-19 pandemic|7
10254386|NCT03814720|11386211|FG003|Received All Product Administrations|Overall Study|Three (3) participants did not receive the second dose due to the COVID-19 pandemic|9
10254387|NCT03814720|11386212|FG004|Received All Product Administrations|Overall Study|Four (4) participants did not receive the second dose due to the COVID-19 pandemic|7
10254388|NCT03814720|11386208|FG000|COMPLETED|Overall Study||5
10254389|NCT03814720|11386209|FG001|COMPLETED|Overall Study||11
10254390|NCT03814720|11386210|FG002|COMPLETED|Overall Study||12
10254391|NCT03814720|11386211|FG003|COMPLETED|Overall Study||12
10254392|NCT03814720|11386212|FG004|COMPLETED|Overall Study||11
10254393|NCT03814720|11386208|FG000|NOT COMPLETED|Overall Study||0
10254394|NCT03814720|11386209|FG001|NOT COMPLETED|Overall Study||1
10254395|NCT03814720|11386210|FG002|NOT COMPLETED|Overall Study||0
10254396|NCT03814720|11386211|FG003|NOT COMPLETED|Overall Study||0
10254397|NCT03814720|11386212|FG004|NOT COMPLETED|Overall Study||0
10254398|NCT03635424|11386226|FG000|STARTED|Overall Study||150
10254399|NCT03635424|11386226|FG000|COMPLETED|Overall Study||147
10254400|NCT03635424|11386226|FG000|NOT COMPLETED|Overall Study||3
10254401|NCT03529110|11386232|FG000|STARTED|Overall Study||261
10254402|NCT03529110|11386233|FG001|STARTED|Overall Study||263
10254403|NCT03529110|11386232|FG000|COMPLETED|Overall Study||136
10254404|NCT03529110|11386233|FG001|COMPLETED|Overall Study||49
10254405|NCT03529110|11386232|FG000|NOT COMPLETED|Overall Study||125
10254406|NCT03529110|11386233|FG001|NOT COMPLETED|Overall Study||214
10254407|NCT03517540|11386243|FG000|STARTED|Overall Study||50
10254408|NCT03517540|11386244|FG001|STARTED|Overall Study||48
10254409|NCT03517540|11386245|FG002|STARTED|Overall Study||47
10254410|NCT03517540|11386246|FG003|STARTED|Overall Study||48
10254411|NCT03517540|11386243|FG000|COMPLETED|Overall Study||36
10254412|NCT03517540|11386244|FG001|COMPLETED|Overall Study||41
10254413|NCT03517540|11386245|FG002|COMPLETED|Overall Study||38
10254414|NCT03517540|11386246|FG003|COMPLETED|Overall Study||43
10254415|NCT03517540|11386243|FG000|NOT COMPLETED|Overall Study||14
10254416|NCT03517540|11386244|FG001|NOT COMPLETED|Overall Study||7
10254417|NCT03517540|11386245|FG002|NOT COMPLETED|Overall Study||9
10254418|NCT03517540|11386246|FG003|NOT COMPLETED|Overall Study||5
10254419|NCT03443635|11386258|FG000|STARTED|Overall Study||2616
10254420|NCT03443635|11386259|FG001|STARTED|Overall Study||4576
10254421|NCT03443635|11386258|FG000|COMPLETED|Overall Study||2127
10254422|NCT03443635|11386259|FG001|COMPLETED|Overall Study||3720
10254423|NCT03443635|11386258|FG000|NOT COMPLETED|Overall Study||489
10254424|NCT03443635|11386259|FG001|NOT COMPLETED|Overall Study||856
10254425|NCT03437278|11386268|FG000|STARTED|Overall Study||24
10254426|NCT03437278|11386269|FG001|STARTED|Overall Study||13
10254427|NCT03437278|11386270|FG002|STARTED|Overall Study||12
10254428|NCT03437278|11386268|FG000|COMPLETED|Overall Study||22
10254429|NCT03437278|11386269|FG001|COMPLETED|Overall Study||13
10254430|NCT03437278|11386270|FG002|COMPLETED|Overall Study||10
10254431|NCT03437278|11386268|FG000|NOT COMPLETED|Overall Study||2
10254432|NCT03437278|11386269|FG001|NOT COMPLETED|Overall Study||0
10254433|NCT03437278|11386270|FG002|NOT COMPLETED|Overall Study||2
10254434|NCT03350815|11386280|FG000|STARTED|Period 1||322
10254435|NCT03350815|11386281|FG001|STARTED|Period 1||0
10254436|NCT03350815|11386282|FG002|STARTED|Period 1||0
10254437|NCT03350815|11386283|FG003|STARTED|Period 1||0
10254438|NCT03350815|11386280|FG000|Non-responders|Period 1||50
10254439|NCT03350815|11386281|FG001|Non-responders|Period 1||0
10254440|NCT03350815|11386282|FG002|Non-responders|Period 1||0
10254441|NCT03350815|11386283|FG003|Non-responders|Period 1||0
10254442|NCT03350815|11386280|FG000|Inadequate Responders|Period 1||207
10254443|NCT03350815|11386281|FG001|Inadequate Responders|Period 1||0
10254444|NCT03350815|11386282|FG002|Inadequate Responders|Period 1||0
10254445|NCT03350815|11386283|FG003|Inadequate Responders|Period 1||0
10254446|NCT03350815|11386280|FG000|Responders|Period 1||22
10254447|NCT03350815|11386281|FG001|Responders|Period 1||0
10254448|NCT03350815|11386282|FG002|Responders|Period 1||0
10254449|NCT03350815|11386283|FG003|Responders|Period 1||0
10254450|NCT03350815|11386280|FG000|COMPLETED|Period 1||279
10254451|NCT03350815|11386281|FG001|COMPLETED|Period 1||0
10254452|NCT03350815|11386282|FG002|COMPLETED|Period 1||0
10254453|NCT03350815|11386283|FG003|COMPLETED|Period 1||0
10254454|NCT03350815|11386280|FG000|NOT COMPLETED|Period 1||43
10254455|NCT03350815|11386281|FG001|NOT COMPLETED|Period 1||0
10254456|NCT03350815|11386282|FG002|NOT COMPLETED|Period 1||0
10254457|NCT03350815|11386283|FG003|NOT COMPLETED|Period 1||0
10254458|NCT03350815|11386280|FG000|STARTED|Period 2||0
10254459|NCT03350815|11386281|FG001|STARTED|Period 2||102
10254460|NCT03350815|11386282|FG002|STARTED|Period 2||105
10254461|NCT03350815|11386283|FG003|STARTED|Period 2||22
10254462|NCT03350815|11386280|FG000|COMPLETED|Period 2||0
10254463|NCT03350815|11386281|FG001|COMPLETED|Period 2||86
10254464|NCT03350815|11386282|FG002|COMPLETED|Period 2||88
10254465|NCT03350815|11386283|FG003|COMPLETED|Period 2||22
10254466|NCT03350815|11386280|FG000|NOT COMPLETED|Period 2||0
10254467|NCT03350815|11386281|FG001|NOT COMPLETED|Period 2||16
10254468|NCT03350815|11386282|FG002|NOT COMPLETED|Period 2||17
10254469|NCT03350815|11386283|FG003|NOT COMPLETED|Period 2||0
10020633|NCT01837797|11143945|FG002|COMPLETED|Period 3||0
10020634|NCT01837797|11143946|FG003|COMPLETED|Period 3||0
10020635|NCT01837797|11143947|FG004|COMPLETED|Period 3||24
10020636|NCT01837797|11143943|FG000|NOT COMPLETED|Period 3||0
10020637|NCT01837797|11143944|FG001|NOT COMPLETED|Period 3||0
10020638|NCT01837797|11143945|FG002|NOT COMPLETED|Period 3||0
10020639|NCT01837797|11143946|FG003|NOT COMPLETED|Period 3||0
10020640|NCT01837797|11143947|FG004|NOT COMPLETED|Period 3||23
10020641|NCT01837823|11143955|FG000|STARTED|Overall Study||91
10020642|NCT01837823|11143955|FG000|COMPLETED|Overall Study||85
10020643|NCT01837823|11143955|FG000|NOT COMPLETED|Overall Study||6
10020644|NCT01837901|11143966|FG000|STARTED|Overall Study||22
10020645|NCT01837901|11143967|FG001|STARTED|Overall Study||21
10020646|NCT01837901|11143968|FG002|STARTED|Overall Study||20
10020647|NCT01837901|11143966|FG000|COMPLETED|Overall Study||20
10020648|NCT01837901|11143967|FG001|COMPLETED|Overall Study||15
10020649|NCT01837901|11143968|FG002|COMPLETED|Overall Study||17
10020650|NCT01837901|11143966|FG000|NOT COMPLETED|Overall Study||2
10020651|NCT01837901|11143967|FG001|NOT COMPLETED|Overall Study||6
10254470|NCT03249714|11386296|FG000|STARTED|Double-blind Treatment (Core Part)||43
10254471|NCT03249714|11386297|FG001|STARTED|Double-blind Treatment (Core Part)||21
10254472|NCT03249714|11386296|FG000|COMPLETED|Double-blind Treatment (Core Part)||40
10254473|NCT03249714|11386297|FG001|COMPLETED|Double-blind Treatment (Core Part)||19
10254474|NCT03249714|11386296|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3
10254475|NCT03249714|11386297|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2
10254476|NCT03249714|11386296|FG000|STARTED|Open-label Treatment (Extension Part)||40
10254477|NCT03249714|11386297|FG001|STARTED|Open-label Treatment (Extension Part)||19
10254478|NCT03249714|11386296|FG000|COMPLETED|Open-label Treatment (Extension Part)||38
10254479|NCT03249714|11386297|FG001|COMPLETED|Open-label Treatment (Extension Part)||19
10254480|NCT03249714|11386296|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2
10254481|NCT03249714|11386297|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0
10254482|NCT03170882|11386321|FG000|STARTED|Overall Study||49
10254483|NCT03170882|11386322|FG001|STARTED|Overall Study||73
10254484|NCT03170882|11386321|FG000|Treated: Safety Population|Overall Study||47
10254485|NCT03170882|11386322|FG001|Treated: Safety Population|Overall Study||72
10254486|NCT03170882|11386321|FG000|ITT PRO Population|Overall Study||45
10254487|NCT03170882|11386322|FG001|ITT PRO Population|Overall Study||70
10254488|NCT03170882|11386321|FG000|COMPLETED|Overall Study||20
10254489|NCT03170882|11386322|FG001|COMPLETED|Overall Study||22
10254490|NCT03170882|11386321|FG000|NOT COMPLETED|Overall Study||29
10254491|NCT03170882|11386322|FG001|NOT COMPLETED|Overall Study||51
10254492|NCT03074318|11386332|FG000|STARTED|Overall Study||6
10254493|NCT03074318|11386333|FG001|STARTED|Overall Study||7
10254494|NCT03074318|11386334|FG002|STARTED|Overall Study||6
10254495|NCT03074318|11386335|FG003|STARTED|Overall Study||16
10254496|NCT03074318|11386332|FG000|COMPLETED|Overall Study||2
10254497|NCT03074318|11386333|FG001|COMPLETED|Overall Study||2
10254498|NCT03074318|11386334|FG002|COMPLETED|Overall Study||0
10254499|NCT03074318|11386335|FG003|COMPLETED|Overall Study||0
10254500|NCT03074318|11386332|FG000|NOT COMPLETED|Overall Study||4
10254501|NCT03074318|11386333|FG001|NOT COMPLETED|Overall Study||5
10254502|NCT03074318|11386334|FG002|NOT COMPLETED|Overall Study||6
10254503|NCT03074318|11386335|FG003|NOT COMPLETED|Overall Study||16
10254504|NCT03010319|11386356|FG000|STARTED|Overall Study||110
10254505|NCT03010319|11386357|FG001|STARTED|Overall Study||116
10254506|NCT03010319|11386356|FG000|COMPLETED|Overall Study||84
10254507|NCT03010319|11386357|FG001|COMPLETED|Overall Study||87
10254508|NCT03010319|11386356|FG000|NOT COMPLETED|Overall Study||26
10254509|NCT03010319|11386357|FG001|NOT COMPLETED|Overall Study||29
10254510|NCT02915016|11386371|FG000|STARTED|Overall Study||30
10254511|NCT02915016|11386372|FG001|STARTED|Overall Study||50
10254512|NCT02915016|11386373|FG002|STARTED|Overall Study||50
10254513|NCT02915016|11386374|FG003|STARTED|Overall Study||30
10254514|NCT02915016|11386375|FG004|STARTED|Overall Study||50
10254515|NCT02915016|11386376|FG005|STARTED|Overall Study||50
10254516|NCT02915016|11386377|FG006|STARTED|Overall Study||50
10254517|NCT02915016|11386378|FG007|STARTED|Overall Study||24
10254518|NCT02915016|11386371|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23
10254519|NCT02915016|11386372|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49
10254520|NCT02915016|11386373|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46
10254521|NCT02915016|11386374|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26
10254522|NCT02915016|11386375|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43
10254523|NCT02915016|11386376|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42
10254524|NCT02915016|11386377|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42
10254525|NCT02915016|11386378|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21
10254526|NCT02915016|11386371|FG000|COMPLETED|Overall Study||23
10254527|NCT02915016|11386372|FG001|COMPLETED|Overall Study||47
10254528|NCT02915016|11386373|FG002|COMPLETED|Overall Study||42
10254529|NCT02915016|11386374|FG003|COMPLETED|Overall Study||26
10254530|NCT02915016|11386375|FG004|COMPLETED|Overall Study||43
10254531|NCT02915016|11386376|FG005|COMPLETED|Overall Study||44
10254532|NCT02915016|11386377|FG006|COMPLETED|Overall Study||38
10254533|NCT02915016|11386378|FG007|COMPLETED|Overall Study||20
10254534|NCT02915016|11386371|FG000|NOT COMPLETED|Overall Study||7
10254535|NCT02915016|11386372|FG001|NOT COMPLETED|Overall Study||3
10254536|NCT02915016|11386373|FG002|NOT COMPLETED|Overall Study||8
10254537|NCT02915016|11386374|FG003|NOT COMPLETED|Overall Study||4
10254538|NCT02915016|11386375|FG004|NOT COMPLETED|Overall Study||7
10254539|NCT02915016|11386376|FG005|NOT COMPLETED|Overall Study||6
10254540|NCT02915016|11386377|FG006|NOT COMPLETED|Overall Study||12
10254541|NCT02915016|11386378|FG007|NOT COMPLETED|Overall Study||4
10254542|NCT02871401|11386398|FG000|STARTED|Overall Study||20
10254543|NCT02871401|11386399|FG001|STARTED|Overall Study||11
10254544|NCT02871401|11386398|FG000|COMPLETED|Overall Study||19
10254545|NCT02871401|11386399|FG001|COMPLETED|Overall Study||11
10254546|NCT02871401|11386398|FG000|NOT COMPLETED|Overall Study||1
10254547|NCT02871401|11386399|FG001|NOT COMPLETED|Overall Study||0
10254548|NCT02811913|11386405|FG000|STARTED|Overall Study||20
10254549|NCT02811913|11386405|FG000|COMPLETED|Overall Study||16
10254550|NCT02811913|11386405|FG000|NOT COMPLETED|Overall Study||4
10254551|NCT02701283|11386417|FG000|STARTED|Overall Study||737
10254552|NCT02701283|11386418|FG001|STARTED|Overall Study||741
10254553|NCT02701283|11386419|FG002|STARTED|Overall Study||745
10254554|NCT02701283|11386417|FG000|As Treated (Attempted Implant)|Overall Study||730
10254555|NCT02701283|11386418|FG001|As Treated (Attempted Implant)|Overall Study||684
10254556|NCT02701283|11386419|FG002|As Treated (Attempted Implant)|Overall Study||745
10254557|NCT02701283|11386417|FG000|Implanted|Overall Study||727
10254558|NCT02701283|11386418|FG001|Implanted|Overall Study||686
10254559|NCT02701283|11386419|FG002|Implanted|Overall Study||745
10254560|NCT02701283|11386417|FG000|COMPLETED|Overall Study||668
10254561|NCT02701283|11386418|FG001|COMPLETED|Overall Study||579
10254562|NCT02701283|11386419|FG002|COMPLETED|Overall Study||724
10254563|NCT02701283|11386417|FG000|NOT COMPLETED|Overall Study||69
10254564|NCT02701283|11386418|FG001|NOT COMPLETED|Overall Study||162
10254565|NCT02701283|11386419|FG002|NOT COMPLETED|Overall Study||21
10254566|NCT02696031|11386433|FG000|STARTED|Up to Week 24||185
10254567|NCT02696031|11386434|FG001|STARTED|Up to Week 24||184
10254568|NCT02696031|11386435|FG002|STARTED|Up to Week 24||186
10254569|NCT02696031|11386436|FG003|STARTED|Up to Week 24||0
10254570|NCT02696031|11386437|FG004|STARTED|Up to Week 24||0
10254571|NCT02696031|11386438|FG005|STARTED|Up to Week 24||0
10254572|NCT02696031|11386433|FG000|COMPLETED|Up to Week 24||175
10254573|NCT02696031|11386434|FG001|COMPLETED|Up to Week 24||177
10254574|NCT02696031|11386435|FG002|COMPLETED|Up to Week 24||175
10254575|NCT02696031|11386436|FG003|COMPLETED|Up to Week 24||0
10254576|NCT02696031|11386437|FG004|COMPLETED|Up to Week 24||0
10254577|NCT02696031|11386438|FG005|COMPLETED|Up to Week 24||0
10254578|NCT02696031|11386433|FG000|NOT COMPLETED|Up to Week 24||10
10254579|NCT02696031|11386434|FG001|NOT COMPLETED|Up to Week 24||7
10254580|NCT02696031|11386435|FG002|NOT COMPLETED|Up to Week 24||11
10254581|NCT02696031|11386436|FG003|NOT COMPLETED|Up to Week 24||0
10254582|NCT02696031|11386437|FG004|NOT COMPLETED|Up to Week 24||0
10254583|NCT02696031|11386438|FG005|NOT COMPLETED|Up to Week 24||0
10254584|NCT02696031|11386433|FG000|STARTED|Up to Week 52||185
10254585|NCT02696031|11386434|FG001|STARTED|Up to Week 52||184
10254586|NCT02696031|11386435|FG002|STARTED|Up to Week 52||186
10254587|NCT02696031|11386436|FG003|STARTED|Up to Week 52||0
10254588|NCT02696031|11386437|FG004|STARTED|Up to Week 52||0
10254589|NCT02696031|11386438|FG005|STARTED|Up to Week 52||0
10254590|NCT02696031|11386433|FG000|COMPLETED|Up to Week 52||156
9834279|NCT00784719|10945304|FG003|STARTED|Overall Study||48
9834280|NCT00784719|10945305|FG004|STARTED|Overall Study||48
9834281|NCT00784719|10945306|FG005|STARTED|Overall Study||44
9834282|NCT00784719|10945307|FG006|STARTED|Overall Study||47
9834283|NCT00784719|10945301|FG000|COMPLETED|Overall Study||44
9834284|NCT00784719|10945302|FG001|COMPLETED|Overall Study||43
9834285|NCT00784719|10945303|FG002|COMPLETED|Overall Study||46
9834286|NCT00784719|10945304|FG003|COMPLETED|Overall Study||48
9834287|NCT00784719|10945305|FG004|COMPLETED|Overall Study||42
9834288|NCT00784719|10945306|FG005|COMPLETED|Overall Study||41
9834289|NCT00784719|10945307|FG006|COMPLETED|Overall Study||42
9834290|NCT00784719|10945301|FG000|NOT COMPLETED|Overall Study||3
9834291|NCT00784719|10945302|FG001|NOT COMPLETED|Overall Study||3
9834292|NCT00784719|10945303|FG002|NOT COMPLETED|Overall Study||1
9834293|NCT00784719|10945304|FG003|NOT COMPLETED|Overall Study||0
9834294|NCT00784719|10945305|FG004|NOT COMPLETED|Overall Study||6
9834295|NCT00784719|10945306|FG005|NOT COMPLETED|Overall Study||3
9834296|NCT00784719|10945307|FG006|NOT COMPLETED|Overall Study||5
10254591|NCT02696031|11386434|FG001|COMPLETED|Up to Week 52||165
10254592|NCT02696031|11386435|FG002|COMPLETED|Up to Week 52||160
10254593|NCT02696031|11386436|FG003|COMPLETED|Up to Week 52||0
10254594|NCT02696031|11386437|FG004|COMPLETED|Up to Week 52||0
10254595|NCT02696031|11386438|FG005|COMPLETED|Up to Week 52||0
9834297|NCT00784758|10945325|FG000|STARTED|Overall Study||42
10254596|NCT02696031|11386433|FG000|NOT COMPLETED|Up to Week 52||29
10254597|NCT02696031|11386434|FG001|NOT COMPLETED|Up to Week 52||19
10254598|NCT02696031|11386435|FG002|NOT COMPLETED|Up to Week 52||26
10254599|NCT02696031|11386436|FG003|NOT COMPLETED|Up to Week 52||0
10254600|NCT02696031|11386437|FG004|NOT COMPLETED|Up to Week 52||0
9834298|NCT00784758|10945326|FG001|STARTED|Overall Study||39
9834299|NCT00784758|10945325|FG000|Began Treatment|Overall Study||41
9834300|NCT00784758|10945326|FG001|Began Treatment|Overall Study||39
10254601|NCT02696031|11386438|FG005|NOT COMPLETED|Up to Week 52||0
10254602|NCT02696031|11386433|FG000|STARTED|Up to Week 104||185
10254603|NCT02696031|11386434|FG001|STARTED|Up to Week 104||184
10254604|NCT02696031|11386435|FG002|STARTED|Up to Week 104||186
10254605|NCT02696031|11386436|FG003|STARTED|Up to Week 104||0
10254606|NCT02696031|11386437|FG004|STARTED|Up to Week 104||0
10254607|NCT02696031|11386438|FG005|STARTED|Up to Week 104||0
10254608|NCT02696031|11386433|FG000|COMPLETED|Up to Week 104||146
10254609|NCT02696031|11386434|FG001|COMPLETED|Up to Week 104||143
10254610|NCT02696031|11386435|FG002|COMPLETED|Up to Week 104||149
10020652|NCT01837901|11143968|FG002|NOT COMPLETED|Overall Study||3
10020653|NCT01837966|11143978|FG000|STARTED|Overall Study||47
10020654|NCT01837966|11143979|FG001|STARTED|Overall Study||46
10020655|NCT01837966|11143978|FG000|COMPLETED|Overall Study||45
10020656|NCT01837966|11143979|FG001|COMPLETED|Overall Study||45
10020657|NCT01837966|11143978|FG000|NOT COMPLETED|Overall Study||2
10020658|NCT01837966|11143979|FG001|NOT COMPLETED|Overall Study||1
10020659|NCT01838044|11143987|FG000|STARTED|Overall Study||89
10020660|NCT01838044|11143988|FG001|STARTED|Overall Study||91
10020661|NCT01838044|11143987|FG000|COMPLETED|Overall Study||81
10020662|NCT01838044|11143988|FG001|COMPLETED|Overall Study||75
10254611|NCT02696031|11386436|FG003|COMPLETED|Up to Week 104||0
10254612|NCT02696031|11386437|FG004|COMPLETED|Up to Week 104||0
10254613|NCT02696031|11386438|FG005|COMPLETED|Up to Week 104||0
10254614|NCT02696031|11386433|FG000|NOT COMPLETED|Up to Week 104||39
10254615|NCT02696031|11386434|FG001|NOT COMPLETED|Up to Week 104||41
10254616|NCT02696031|11386435|FG002|NOT COMPLETED|Up to Week 104||37
10254617|NCT02696031|11386436|FG003|NOT COMPLETED|Up to Week 104||0
10254618|NCT02696031|11386437|FG004|NOT COMPLETED|Up to Week 104||0
10254619|NCT02696031|11386438|FG005|NOT COMPLETED|Up to Week 104||0
10254620|NCT02696031|11386433|FG000|STARTED|Extension Phase From wk 104 to wk 208||0
10254621|NCT02696031|11386434|FG001|STARTED|Extension Phase From wk 104 to wk 208||0
10254622|NCT02696031|11386435|FG002|STARTED|Extension Phase From wk 104 to wk 208||0
10254623|NCT02696031|11386436|FG003|STARTED|Extension Phase From wk 104 to wk 208||147
10254624|NCT02696031|11386437|FG004|STARTED|Extension Phase From wk 104 to wk 208||147
10254625|NCT02696031|11386438|FG005|STARTED|Extension Phase From wk 104 to wk 208||78
10254626|NCT02696031|11386433|FG000|COMPLETED|Extension Phase From wk 104 to wk 208||0
10254627|NCT02696031|11386434|FG001|COMPLETED|Extension Phase From wk 104 to wk 208||0
10254628|NCT02696031|11386435|FG002|COMPLETED|Extension Phase From wk 104 to wk 208||0
10254629|NCT02696031|11386436|FG003|COMPLETED|Extension Phase From wk 104 to wk 208||137
10254630|NCT02696031|11386437|FG004|COMPLETED|Extension Phase From wk 104 to wk 208||132
10254631|NCT02696031|11386438|FG005|COMPLETED|Extension Phase From wk 104 to wk 208||72
10254632|NCT02696031|11386433|FG000|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10254633|NCT02696031|11386434|FG001|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10254634|NCT02696031|11386435|FG002|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10254635|NCT02696031|11386436|FG003|NOT COMPLETED|Extension Phase From wk 104 to wk 208||10
10254636|NCT02696031|11386437|FG004|NOT COMPLETED|Extension Phase From wk 104 to wk 208||15
10254637|NCT02696031|11386438|FG005|NOT COMPLETED|Extension Phase From wk 104 to wk 208||6
10254638|NCT02689453|11386450|FG000|STARTED|Overall Study||3
10254639|NCT02689453|11386451|FG001|STARTED|Overall Study||4
10254640|NCT02689453|11386452|FG002|STARTED|Overall Study||4
10254641|NCT02689453|11386450|FG000|COMPLETED|Overall Study||3
10254642|NCT02689453|11386451|FG001|COMPLETED|Overall Study||3
10254643|NCT02689453|11386452|FG002|COMPLETED|Overall Study||3
10254644|NCT02689453|11386450|FG000|NOT COMPLETED|Overall Study||0
10254645|NCT02689453|11386451|FG001|NOT COMPLETED|Overall Study||1
10254646|NCT02689453|11386452|FG002|NOT COMPLETED|Overall Study||1
10254647|NCT02476851|11386464|FG000|STARTED|Overall Study||31
10254648|NCT02476851|11386465|FG001|STARTED|Overall Study||31
10254649|NCT02476851|11386464|FG000|COMPLETED|Overall Study||30
10254650|NCT02476851|11386465|FG001|COMPLETED|Overall Study||30
10254651|NCT02476851|11386464|FG000|NOT COMPLETED|Overall Study||1
10254652|NCT02476851|11386465|FG001|NOT COMPLETED|Overall Study||1
10254653|NCT02389946|11386473|FG000|STARTED|Overall Study||884
10254654|NCT02389946|11386474|FG001|STARTED|Overall Study||450
10254655|NCT02389946|11386473|FG000|COMPLETED|Overall Study||860
10254656|NCT02389946|11386474|FG001|COMPLETED|Overall Study||435
10254657|NCT02389946|11386473|FG000|NOT COMPLETED|Overall Study||24
10254658|NCT02389946|11386474|FG001|NOT COMPLETED|Overall Study||15
10254659|NCT02310919|11386482|FG000|STARTED|Overall Study||54
10254660|NCT02310919|11386483|FG001|STARTED|Overall Study||51
10254661|NCT02310919|11386482|FG000|COMPLETED|Overall Study|Four participants receiving the study trigger deviated from protocol. One patient was randomized before her E2 resulted >5,000 pg/ml. Another elected to convert to intrauterine insemination while another underwent oocyte cryopreservation as their male partner was unable to produce a fresh sperm sample for fertilization. The 4th patient inadvertently spilled a portion of the trigger prior to injection. Since her post-trigger hCG was <18 IU/L, she was unblinded and re-triggered with 10,000 IU hCG.|54
10254662|NCT02310919|11386483|FG001|COMPLETED|Overall Study|Two participants that received the standard trigger requested exclusionary embryo co-culture to be added post-trigger.|51
10254663|NCT02310919|11386482|FG000|NOT COMPLETED|Overall Study||0
10254664|NCT02310919|11386483|FG001|NOT COMPLETED|Overall Study||0
10254665|NCT02208024|11386490|FG000|STARTED|Overall Study||18
10254666|NCT02208024|11386490|FG000|COMPLETED|Overall Study||17
10020663|NCT01838044|11143987|FG000|NOT COMPLETED|Overall Study||8
10020664|NCT01838044|11143988|FG001|NOT COMPLETED|Overall Study||16
10254667|NCT02208024|11386490|FG000|NOT COMPLETED|Overall Study||1
10254668|NCT02180867|11386501|FG000|STARTED|Overall Study||10
10254669|NCT02180867|11386502|FG001|STARTED|Overall Study||11
10254670|NCT02180867|11386503|FG002|STARTED|Overall Study||10
10254671|NCT02180867|11386504|FG003|STARTED|Overall Study||49
10254672|NCT02180867|11386505|FG004|STARTED|Overall Study||48
10254673|NCT02180867|11386506|FG005|STARTED|Overall Study||6
10254674|NCT02180867|11386507|FG006|STARTED|Overall Study||6
10254675|NCT02180867|11386501|FG000|Pediatric Patients|Overall Study||6
10020665|NCT01838200|11143997|FG000|STARTED|Overall Study||3
10020666|NCT01838200|11143998|FG001|STARTED|Overall Study||2
10020667|NCT01838200|11143997|FG000|COMPLETED|Overall Study||0
10254676|NCT02180867|11386502|FG001|Pediatric Patients|Overall Study||4
10254677|NCT02180867|11386503|FG002|Pediatric Patients|Overall Study||3
10254678|NCT02180867|11386504|FG003|Pediatric Patients|Overall Study||18
10254679|NCT02180867|11386505|FG004|Pediatric Patients|Overall Study||19
10254680|NCT02180867|11386506|FG005|Pediatric Patients|Overall Study||1
10254681|NCT02180867|11386507|FG006|Pediatric Patients|Overall Study||0
10254682|NCT02180867|11386501|FG000|Adult Patients|Overall Study||4
10254683|NCT02180867|11386502|FG001|Adult Patients|Overall Study||7
10254684|NCT02180867|11386503|FG002|Adult Patients|Overall Study||7
10254685|NCT02180867|11386504|FG003|Adult Patients|Overall Study||31
10254686|NCT02180867|11386505|FG004|Adult Patients|Overall Study||29
10254687|NCT02180867|11386506|FG005|Adult Patients|Overall Study||5
10254688|NCT02180867|11386507|FG006|Adult Patients|Overall Study||6
10254689|NCT02180867|11386501|FG000|COMPLETED|Overall Study||4
10254690|NCT02180867|11386502|FG001|COMPLETED|Overall Study||0
10254691|NCT02180867|11386503|FG002|COMPLETED|Overall Study||6
10254692|NCT02180867|11386504|FG003|COMPLETED|Overall Study||23
10254693|NCT02180867|11386505|FG004|COMPLETED|Overall Study||21
10254694|NCT02180867|11386506|FG005|COMPLETED|Overall Study||3
10254695|NCT02180867|11386507|FG006|COMPLETED|Overall Study||1
10254696|NCT02180867|11386501|FG000|NOT COMPLETED|Overall Study||6
10254697|NCT02180867|11386502|FG001|NOT COMPLETED|Overall Study||11
10254698|NCT02180867|11386503|FG002|NOT COMPLETED|Overall Study||4
10254699|NCT02180867|11386504|FG003|NOT COMPLETED|Overall Study||26
10254700|NCT02180867|11386505|FG004|NOT COMPLETED|Overall Study||27
10254701|NCT02180867|11386506|FG005|NOT COMPLETED|Overall Study||3
10254702|NCT02180867|11386507|FG006|NOT COMPLETED|Overall Study||5
10254703|NCT01866111|11386539|FG000|STARTED|Double-blind Period of Study YKP3089C017||108
10254704|NCT01866111|11386540|FG001|STARTED|Double-blind Period of Study YKP3089C017||108
10254705|NCT01866111|11386541|FG002|STARTED|Double-blind Period of Study YKP3089C017||110
10254706|NCT01866111|11386542|FG003|STARTED|Double-blind Period of Study YKP3089C017||111
10254707|NCT01866111|11386539|FG000|COMPLETED|Double-blind Period of Study YKP3089C017||94
10254708|NCT01866111|11386540|FG001|COMPLETED|Double-blind Period of Study YKP3089C017||95
10254709|NCT01866111|11386541|FG002|COMPLETED|Double-blind Period of Study YKP3089C017||90
10254710|NCT01866111|11386542|FG003|COMPLETED|Double-blind Period of Study YKP3089C017||81
10254711|NCT01866111|11386539|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C017||14
10254712|NCT01866111|11386540|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C017||13
10254713|NCT01866111|11386541|FG002|NOT COMPLETED|Double-blind Period of Study YKP3089C017||20
10254714|NCT01866111|11386542|FG003|NOT COMPLETED|Double-blind Period of Study YKP3089C017||30
10254715|NCT01866111|11386539|FG000|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|91
10254716|NCT01866111|11386540|FG001|STARTED|Open-label Extension Study YKP3089C017||95
10254717|NCT01866111|11386541|FG002|STARTED|Open-label Extension Study YKP3089C017||90
10254718|NCT01866111|11386542|FG003|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|80
10254719|NCT01866111|11386539|FG000|COMPLETED|Open-label Extension Study YKP3089C017||26
10254720|NCT01866111|11386540|FG001|COMPLETED|Open-label Extension Study YKP3089C017||28
10254721|NCT01866111|11386541|FG002|COMPLETED|Open-label Extension Study YKP3089C017||27
10254722|NCT01866111|11386542|FG003|COMPLETED|Open-label Extension Study YKP3089C017||28
10254723|NCT01866111|11386539|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C017||65
10254724|NCT01866111|11386540|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C017||67
10254725|NCT01866111|11386541|FG002|NOT COMPLETED|Open-label Extension Study YKP3089C017||63
10254726|NCT01866111|11386542|FG003|NOT COMPLETED|Open-label Extension Study YKP3089C017||52
10254727|NCT01767129|11386552|FG000|STARTED|Treatment Period 1 (14 Days)||7
10254728|NCT01767129|11386553|FG001|STARTED|Treatment Period 1 (14 Days)||7
10254729|NCT01767129|11386552|FG000|COMPLETED|Treatment Period 1 (14 Days)||6
10254730|NCT01767129|11386553|FG001|COMPLETED|Treatment Period 1 (14 Days)||7
10254731|NCT01767129|11386552|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10254732|NCT01767129|11386553|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10254733|NCT01767129|11386552|FG000|STARTED|Treatment Period 2 (14 Days)||6
10254734|NCT01767129|11386553|FG001|STARTED|Treatment Period 2 (14 Days)||7
10254735|NCT01767129|11386552|FG000|COMPLETED|Treatment Period 2 (14 Days)||6
10254736|NCT01767129|11386553|FG001|COMPLETED|Treatment Period 2 (14 Days)||7
10254737|NCT01767129|11386552|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10254738|NCT01767129|11386553|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10254739|NCT01622868|11386562|FG000|STARTED|Overall Study||72
10254740|NCT01622868|11386563|FG001|STARTED|Overall Study||71
10254741|NCT01622868|11386562|FG000|Eligible|Overall Study||65
10254742|NCT01622868|11386563|FG001|Eligible|Overall Study||71
10254743|NCT01622868|11386562|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
10254744|NCT01622868|11386563|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
10254745|NCT01622868|11386562|FG000|COMPLETED|Overall Study||65
10254746|NCT01622868|11386563|FG001|COMPLETED|Overall Study||71
10254747|NCT01622868|11386562|FG000|NOT COMPLETED|Overall Study||7
10254748|NCT01622868|11386563|FG001|NOT COMPLETED|Overall Study||0
10254749|NCT01609790|11386572|FG000|STARTED|Overall Study||7
10254750|NCT01609790|11386573|FG001|STARTED|Overall Study||65
10254751|NCT01609790|11386574|FG002|STARTED|Overall Study||65
10254752|NCT01609790|11386572|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
10254753|NCT01609790|11386573|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
10254754|NCT01609790|11386574|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
10254755|NCT01609790|11386572|FG000|NOT COMPLETED|Overall Study||1
10254756|NCT01609790|11386573|FG001|NOT COMPLETED|Overall Study||7
10254757|NCT01609790|11386574|FG002|NOT COMPLETED|Overall Study||8
10254758|NCT01586910|11386584|FG000|STARTED|Overall Study||879
10254759|NCT01586910|11386585|FG001|STARTED|Overall Study||867
10254760|NCT01586910|11386584|FG000|COMPLETED|Overall Study||864
10254761|NCT01586910|11386585|FG001|COMPLETED|Overall Study||796
10254762|NCT01586910|11386584|FG000|NOT COMPLETED|Overall Study||15
10254763|NCT01586910|11386585|FG001|NOT COMPLETED|Overall Study||71
10254764|NCT01236560|11386599|FG000|STARTED|Overall Study||6
10254765|NCT01236560|11386600|FG001|STARTED|Overall Study||32
10254766|NCT01236560|11386601|FG002|STARTED|Overall Study||31
10254767|NCT01236560|11386602|FG003|STARTED|Overall Study||32
10254768|NCT01236560|11386603|FG004|STARTED|Overall Study||0
10254769|NCT01236560|11386604|FG005|STARTED|Overall Study||0
10254770|NCT01236560|11386599|FG000|COMPLETED|Overall Study||1
10254771|NCT01236560|11386600|FG001|COMPLETED|Overall Study||8
10254772|NCT01236560|11386601|FG002|COMPLETED|Overall Study||11
10254773|NCT01236560|11386602|FG003|COMPLETED|Overall Study||10
10254774|NCT01236560|11386603|FG004|COMPLETED|Overall Study||0
10254775|NCT01236560|11386604|FG005|COMPLETED|Overall Study||0
10254776|NCT01236560|11386599|FG000|NOT COMPLETED|Overall Study||5
10254777|NCT01236560|11386600|FG001|NOT COMPLETED|Overall Study||24
10254778|NCT01236560|11386601|FG002|NOT COMPLETED|Overall Study||20
10254779|NCT01236560|11386602|FG003|NOT COMPLETED|Overall Study||22
10254780|NCT01236560|11386603|FG004|NOT COMPLETED|Overall Study||0
10254781|NCT01236560|11386604|FG005|NOT COMPLETED|Overall Study||0
10254782|NCT01236547|11386619|FG000|STARTED|Overall Study||11
10254783|NCT01236547|11386620|FG001|STARTED|Overall Study||11
10254784|NCT01236547|11386621|FG002|STARTED|Overall Study||12
10254785|NCT01236547|11386622|FG003|STARTED|Overall Study||42
10254786|NCT01236547|11386623|FG004|STARTED|Overall Study||47
10254787|NCT01236547|11386619|FG000|Eligible|Overall Study||11
10254788|NCT01236547|11386620|FG001|Eligible|Overall Study||10
10254789|NCT01236547|11386621|FG002|Eligible|Overall Study||11
10254790|NCT01236547|11386622|FG003|Eligible|Overall Study||36
10254791|NCT01236547|11386623|FG004|Eligible|Overall Study||35
10254792|NCT01236547|11386619|FG000|Eligible and Started Study Treatment|Overall Study||11
10254793|NCT01236547|11386620|FG001|Eligible and Started Study Treatment|Overall Study||10
10254794|NCT01236547|11386621|FG002|Eligible and Started Study Treatment|Overall Study||11
10254795|NCT01236547|11386622|FG003|Eligible and Started Study Treatment|Overall Study||36
10254796|NCT01236547|11386623|FG004|Eligible and Started Study Treatment|Overall Study||34
10254797|NCT01236547|11386619|FG000|Eligible and Response Assessed|Overall Study||0
10254798|NCT01236547|11386620|FG001|Eligible and Response Assessed|Overall Study||0
10254799|NCT01236547|11386621|FG002|Eligible and Response Assessed|Overall Study||0
10254800|NCT01236547|11386622|FG003|Eligible and Response Assessed|Overall Study||23
10254801|NCT01236547|11386623|FG004|Eligible and Response Assessed|Overall Study||27
10254802|NCT01236547|11386619|FG000|COMPLETED|Overall Study||11
10254803|NCT01236547|11386620|FG001|COMPLETED|Overall Study||10
10254804|NCT01236547|11386621|FG002|COMPLETED|Overall Study||11
10254805|NCT01236547|11386622|FG003|COMPLETED|Overall Study||36
10254806|NCT01236547|11386623|FG004|COMPLETED|Overall Study||35
10254807|NCT01236547|11386619|FG000|NOT COMPLETED|Overall Study||0
10254808|NCT01236547|11386620|FG001|NOT COMPLETED|Overall Study||1
10254809|NCT01236547|11386621|FG002|NOT COMPLETED|Overall Study||1
10254810|NCT01236547|11386622|FG003|NOT COMPLETED|Overall Study||6
10254811|NCT01236547|11386623|FG004|NOT COMPLETED|Overall Study||12
10254812|NCT01062425|11386638|FG000|STARTED|Overall Study||55
10254813|NCT01062425|11386639|FG001|STARTED|Overall Study||103
10254814|NCT01062425|11386638|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
10254815|NCT01062425|11386639|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
10254816|NCT01062425|11386638|FG000|NOT COMPLETED|Overall Study||3
10254817|NCT01062425|11386639|FG001|NOT COMPLETED|Overall Study||6
10254818|NCT00559936|11386645|FG000|STARTED|Overall Study||24
10254819|NCT00559936|11386645|FG000|COMPLETED|Overall Study||20
10254820|NCT00559936|11386645|FG000|NOT COMPLETED|Overall Study||4
10254821|NCT00504582|11386652|FG000|STARTED|Overall Study||47
10254822|NCT00504582|11386653|FG001|STARTED|Overall Study||45
10254823|NCT00504582|11386654|FG002|STARTED|Overall Study||20
10254824|NCT00504582|11386652|FG000|COMPLETED|Overall Study||46
10254825|NCT00504582|11386653|FG001|COMPLETED|Overall Study||45
10254826|NCT00504582|11386654|FG002|COMPLETED|Overall Study||20
10254827|NCT00504582|11386652|FG000|NOT COMPLETED|Overall Study||1
10254828|NCT00504582|11386653|FG001|NOT COMPLETED|Overall Study||0
10254829|NCT00504582|11386654|FG002|NOT COMPLETED|Overall Study||0
10254830|NCT02255487|11386664|FG000|STARTED|Overall Study||309
10254831|NCT02255487|11386665|FG001|STARTED|Overall Study||308
10254832|NCT02255487|11386664|FG000|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|293
10254833|NCT02255487|11386665|FG001|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|291
10254834|NCT02255487|11386664|FG000|COMPLETED|Overall Study||218
10254835|NCT02255487|11386665|FG001|COMPLETED|Overall Study||230
10254836|NCT02255487|11386664|FG000|NOT COMPLETED|Overall Study||91
10254837|NCT02255487|11386665|FG001|NOT COMPLETED|Overall Study||78
10254870|NCT02290431|11386720|FG000|STARTED|Overall Study||31
10254871|NCT02290431|11386720|FG000|Subjects. Discont. Prematurely|Overall Study||27
10254872|NCT02290431|11386720|FG000|Subjects Completed Study Per Protocol|Overall Study||8
10254873|NCT02290431|11386720|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
10254874|NCT02290431|11386720|FG000|Subjects Entered Survival f/u Phase|Overall Study||24
10254875|NCT02290431|11386720|FG000|Entered Treatment Phase 2|Overall Study||17
10254876|NCT02290431|11386720|FG000|COMPLETED|Overall Study||4
10254877|NCT02290431|11386720|FG000|NOT COMPLETED|Overall Study||27
10254878|NCT02314923|11386734|FG000|STARTED|Overall Study||64
10254879|NCT02314923|11386735|FG001|STARTED|Overall Study||64
10254880|NCT02314923|11386736|FG002|STARTED|Overall Study||64
10254881|NCT02314923|11386737|FG003|STARTED|Overall Study||64
10254882|NCT02314923|11386738|FG004|STARTED|Overall Study||74
10254883|NCT02314923|11386739|FG005|STARTED|Overall Study||20
10254884|NCT02314923|11386740|FG006|STARTED|Overall Study||48
10254885|NCT02314923|11386741|FG007|STARTED|Overall Study||47
10254886|NCT02314923|11386742|FG008|STARTED|Overall Study||48
10254887|NCT02314923|11386743|FG009|STARTED|Overall Study||20
10254888|NCT02314923|11386734|FG000|Treated|Overall Study||64
10254889|NCT02314923|11386735|FG001|Treated|Overall Study||64
10254890|NCT02314923|11386736|FG002|Treated|Overall Study||64
10254891|NCT02314923|11386737|FG003|Treated|Overall Study||64
10254892|NCT02314923|11386738|FG004|Treated|Overall Study||74
10254893|NCT02314923|11386739|FG005|Treated|Overall Study||20
10254894|NCT02314923|11386740|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
10254895|NCT02314923|11386741|FG007|Treated|Overall Study||47
10254896|NCT02314923|11386742|FG008|Treated|Overall Study||48
10254897|NCT02314923|11386743|FG009|Treated|Overall Study||20
10254898|NCT02314923|11386734|FG000|COMPLETED|Overall Study||61
10254899|NCT02314923|11386735|FG001|COMPLETED|Overall Study||60
10254900|NCT02314923|11386736|FG002|COMPLETED|Overall Study||62
10254901|NCT02314923|11386737|FG003|COMPLETED|Overall Study||63
10254902|NCT02314923|11386738|FG004|COMPLETED|Overall Study||73
10254903|NCT02314923|11386739|FG005|COMPLETED|Overall Study||19
10254904|NCT02314923|11386740|FG006|COMPLETED|Overall Study||43
10254905|NCT02314923|11386741|FG007|COMPLETED|Overall Study||42
10254906|NCT02314923|11386742|FG008|COMPLETED|Overall Study||46
10254907|NCT02314923|11386743|FG009|COMPLETED|Overall Study||20
10254908|NCT02314923|11386734|FG000|NOT COMPLETED|Overall Study||3
10254909|NCT02314923|11386735|FG001|NOT COMPLETED|Overall Study||4
10254910|NCT02314923|11386736|FG002|NOT COMPLETED|Overall Study||2
10254911|NCT02314923|11386737|FG003|NOT COMPLETED|Overall Study||1
10020668|NCT01838200|11143998|FG001|COMPLETED|Overall Study||0
10020669|NCT01838200|11143997|FG000|NOT COMPLETED|Overall Study||3
10254912|NCT02314923|11386738|FG004|NOT COMPLETED|Overall Study||1
10254913|NCT02314923|11386739|FG005|NOT COMPLETED|Overall Study||1
10254914|NCT02314923|11386740|FG006|NOT COMPLETED|Overall Study||5
10254915|NCT02314923|11386741|FG007|NOT COMPLETED|Overall Study||5
10254916|NCT02314923|11386742|FG008|NOT COMPLETED|Overall Study||2
10254917|NCT02314923|11386743|FG009|NOT COMPLETED|Overall Study||0
10254918|NCT04821362|11386769|FG000|STARTED|Overall Study||90
10254919|NCT04821362|11386770|FG001|STARTED|Overall Study||90
10254920|NCT04821362|11386771|FG002|STARTED|Overall Study||90
10254921|NCT04821362|11386769|FG000|COMPLETED|Overall Study||90
10254922|NCT04821362|11386770|FG001|COMPLETED|Overall Study||90
10254923|NCT04821362|11386771|FG002|COMPLETED|Overall Study||90
10254924|NCT04821362|11386769|FG000|NOT COMPLETED|Overall Study||0
10254925|NCT04821362|11386770|FG001|NOT COMPLETED|Overall Study||0
10254926|NCT04821362|11386771|FG002|NOT COMPLETED|Overall Study||0
10020670|NCT01838200|11143998|FG001|NOT COMPLETED|Overall Study||2
10254838|NCT02257918|11386675|FG000|STARTED|Overall Study||72
10254839|NCT02257918|11386676|FG001|STARTED|Overall Study||67
10254840|NCT02257918|11386677|FG002|STARTED|Overall Study||41
10254841|NCT02257918|11386675|FG000|Test of Cure Visit|Overall Study||72
10254842|NCT02257918|11386676|FG001|Test of Cure Visit|Overall Study||67
10254843|NCT02257918|11386677|FG002|Test of Cure Visit|Overall Study||40
10254844|NCT02257918|11386675|FG000|COMPLETED|Overall Study||68
10254845|NCT02257918|11386676|FG001|COMPLETED|Overall Study||66
10254846|NCT02257918|11386677|FG002|COMPLETED|Overall Study||39
10254847|NCT02257918|11386675|FG000|NOT COMPLETED|Overall Study||4
10254848|NCT02257918|11386676|FG001|NOT COMPLETED|Overall Study||1
10254849|NCT02257918|11386677|FG002|NOT COMPLETED|Overall Study||2
10254850|NCT02258542|11386689|FG000|STARTED|Overall Study||953
10254851|NCT02258542|11386690|FG001|STARTED|Overall Study||973
10254852|NCT02258542|11386691|FG002|STARTED|Overall Study||100
10254853|NCT02258542|11386692|FG003|STARTED|Overall Study||97
10254854|NCT02258542|11386689|FG000|Treated|Overall Study||953
10254855|NCT02258542|11386690|FG001|Treated|Overall Study||971
10254856|NCT02258542|11386691|FG002|Treated|Overall Study||100
10254857|NCT02258542|11386692|FG003|Treated|Overall Study||97
10254858|NCT02258542|11386689|FG000|Adolescents Only|Overall Study||25
10254859|NCT02258542|11386690|FG001|Adolescents Only|Overall Study||61
10254860|NCT02258542|11386691|FG002|Adolescents Only|Overall Study||0
10254861|NCT02258542|11386692|FG003|Adolescents Only|Overall Study||0
10254862|NCT02258542|11386689|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
10254863|NCT02258542|11386690|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
10254864|NCT02258542|11386691|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
10254865|NCT02258542|11386692|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
9834301|NCT00784758|10945325|FG000|Completed Treatment|Overall Study||40
9834302|NCT00784758|10945326|FG001|Completed Treatment|Overall Study||39
9834303|NCT00784758|10945325|FG000|COMPLETED|Overall Study||38
9834304|NCT00784758|10945326|FG001|COMPLETED|Overall Study||39
9834305|NCT00784758|10945325|FG000|NOT COMPLETED|Overall Study||4
9834306|NCT00784758|10945326|FG001|NOT COMPLETED|Overall Study||0
9834307|NCT00784784|10945336|FG000|STARTED|Overall Study||22
9834308|NCT00784784|10945337|FG001|STARTED|Overall Study||42
9834309|NCT00784784|10945336|FG000|COMPLETED|Overall Study||20
9834310|NCT00784784|10945337|FG001|COMPLETED|Overall Study||40
9834311|NCT00784784|10945336|FG000|NOT COMPLETED|Overall Study||2
9834312|NCT00784784|10945337|FG001|NOT COMPLETED|Overall Study||2
9834313|NCT00784810|10945345|FG000|STARTED|Overall Study||124
9834314|NCT00784810|10945346|FG001|STARTED|Overall Study||123
9834315|NCT00784810|10945345|FG000|COMPLETED|Overall Study||61
9834316|NCT00784810|10945346|FG001|COMPLETED|Overall Study||74
9834317|NCT00784810|10945345|FG000|NOT COMPLETED|Overall Study||63
9834318|NCT00784810|10945346|FG001|NOT COMPLETED|Overall Study||49
9834319|NCT00784836|10945352|FG000|STARTED|Overall Study||3
9834320|NCT00784836|10945352|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
9834321|NCT00784836|10945352|FG000|NOT COMPLETED|Overall Study||3
9834322|NCT00784849|10945356|FG000|STARTED|Overall Study||62
9834323|NCT00784849|10945356|FG000|COMPLETED|Overall Study||62
9834324|NCT00784849|10945356|FG000|NOT COMPLETED|Overall Study||0
9834325|NCT00784875|10945364|FG000|STARTED|Period A - Baseline||0
9834326|NCT00784875|10945365|FG001|STARTED|Period A - Baseline||0
9834327|NCT00784875|10945366|FG002|STARTED|Period A - Baseline||0
9834328|NCT00784875|10945367|FG003|STARTED|Period A - Baseline||643
9834329|NCT00784875|10945364|FG000|COMPLETED|Period A - Baseline||0
9834330|NCT00784875|10945365|FG001|COMPLETED|Period A - Baseline||0
9834331|NCT00784875|10945366|FG002|COMPLETED|Period A - Baseline||0
9834332|NCT00784875|10945367|FG003|COMPLETED|Period A - Baseline||461
9834333|NCT00784875|10945364|FG000|NOT COMPLETED|Period A - Baseline||0
9834334|NCT00784875|10945365|FG001|NOT COMPLETED|Period A - Baseline||0
9834335|NCT00784875|10945366|FG002|NOT COMPLETED|Period A - Baseline||0
9834336|NCT00784875|10945367|FG003|NOT COMPLETED|Period A - Baseline||182
9834337|NCT00784875|10945364|FG000|STARTED|Period B - Efficacy Endpoint||114
9834338|NCT00784875|10945365|FG001|STARTED|Period B - Efficacy Endpoint||113
9834339|NCT00784875|10945366|FG002|STARTED|Period B - Efficacy Endpoint||117
9834340|NCT00784875|10945367|FG003|STARTED|Period B - Efficacy Endpoint||117
9834341|NCT00784875|10945364|FG000|Cohort 2|Period B - Efficacy Endpoint||102
9834342|NCT00784875|10945365|FG001|Cohort 2|Period B - Efficacy Endpoint||102
9834343|NCT00784875|10945366|FG002|Cohort 2|Period B - Efficacy Endpoint||102
10254866|NCT02258542|11386689|FG000|NOT COMPLETED|Overall Study||42
10254867|NCT02258542|11386690|FG001|NOT COMPLETED|Overall Study||49
10254868|NCT02258542|11386691|FG002|NOT COMPLETED|Overall Study||8
10254869|NCT02258542|11386692|FG003|NOT COMPLETED|Overall Study||5
9834344|NCT00784875|10945367|FG003|Cohort 2|Period B - Efficacy Endpoint||101
9834345|NCT00784875|10945364|FG000|COMPLETED|Period B - Efficacy Endpoint||100
9834346|NCT00784875|10945365|FG001|COMPLETED|Period B - Efficacy Endpoint||101
9834347|NCT00784875|10945366|FG002|COMPLETED|Period B - Efficacy Endpoint||96
9834348|NCT00784875|10945367|FG003|COMPLETED|Period B - Efficacy Endpoint||98
9834349|NCT00784875|10945364|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14
10254927|NCT04524507|11386784|FG000|STARTED|Overall Study||15
10254928|NCT04524507|11386785|FG001|STARTED|Overall Study||41
10254929|NCT04524507|11386784|FG000|Received Intervention|Overall Study||14
10254930|NCT04524507|11386785|FG001|Received Intervention|Overall Study||41
10254931|NCT04524507|11386784|FG000|Hospital Discharge|Overall Study||13
10254932|NCT04524507|11386785|FG001|Hospital Discharge|Overall Study||27
10254933|NCT04524507|11386784|FG000|COMPLETED|Overall Study||9
10254934|NCT04524507|11386785|FG001|COMPLETED|Overall Study||18
10254935|NCT04524507|11386784|FG000|NOT COMPLETED|Overall Study||6
10254936|NCT04524507|11386785|FG001|NOT COMPLETED|Overall Study||23
10254937|NCT04382924|11386794|FG000|STARTED|Overall Study||52
10254938|NCT04382924|11386795|FG001|STARTED|Overall Study||56
10254939|NCT04382924|11386796|FG002|STARTED|Overall Study||60
10254940|NCT04382924|11386794|FG000|COMPLETED|Overall Study||44
10254941|NCT04382924|11386795|FG001|COMPLETED|Overall Study||46
10254942|NCT04382924|11386796|FG002|COMPLETED|Overall Study||48
10254943|NCT04382924|11386794|FG000|NOT COMPLETED|Overall Study||8
10254944|NCT04382924|11386795|FG001|NOT COMPLETED|Overall Study||10
10254945|NCT04382924|11386796|FG002|NOT COMPLETED|Overall Study||12
10254946|NCT04166214|11386806|FG000|STARTED|Overall Study||12
10254947|NCT04166214|11386807|FG001|STARTED|Overall Study||39
10254948|NCT04166214|11386806|FG000|COMPLETED|Overall Study||12
10254949|NCT04166214|11386807|FG001|COMPLETED|Overall Study||39
10254950|NCT04166214|11386806|FG000|NOT COMPLETED|Overall Study||0
10254951|NCT04166214|11386807|FG001|NOT COMPLETED|Overall Study||0
10254952|NCT03947788|11386815|FG000|STARTED|Overall Study||69
10254953|NCT03947788|11386816|FG001|STARTED|Overall Study||74
10254954|NCT03947788|11386815|FG000|COMPLETED|Overall Study||69
10254955|NCT03947788|11386816|FG001|COMPLETED|Overall Study||74
10254956|NCT03947788|11386815|FG000|NOT COMPLETED|Overall Study||0
10254957|NCT03947788|11386816|FG001|NOT COMPLETED|Overall Study||0
10254958|NCT03842436|11386827|FG000|STARTED|Overall Study||16
10254959|NCT03842436|11386827|FG000|COMPLETED|Overall Study||15
10254960|NCT03842436|11386827|FG000|NOT COMPLETED|Overall Study||1
10254961|NCT03646162|11386834|FG000|STARTED|Overall Study||31
10254962|NCT03646162|11386835|FG001|STARTED|Overall Study||31
10254963|NCT03646162|11386836|FG002|STARTED|Overall Study||31
10254964|NCT03646162|11386834|FG000|COMPLETED|Overall Study||26
10254965|NCT03646162|11386835|FG001|COMPLETED|Overall Study||27
10254966|NCT03646162|11386836|FG002|COMPLETED|Overall Study||30
10254967|NCT03646162|11386834|FG000|NOT COMPLETED|Overall Study||5
10254968|NCT03646162|11386835|FG001|NOT COMPLETED|Overall Study||4
10254969|NCT03646162|11386836|FG002|NOT COMPLETED|Overall Study||1
10254970|NCT03462030|11386848|FG000|STARTED|Overall Study||15
10254971|NCT03462030|11386849|FG001|STARTED|Overall Study||15
10254972|NCT03462030|11386848|FG000|End of Build-up|Overall Study||14
10254973|NCT03462030|11386849|FG001|End of Build-up|Overall Study||14
10254974|NCT03462030|11386848|FG000|Month 12 Food Challenge|Overall Study||14
10254975|NCT03462030|11386849|FG001|Month 12 Food Challenge|Overall Study||14
10254976|NCT03462030|11386848|FG000|COMPLETED|Overall Study||14
10254977|NCT03462030|11386849|FG001|COMPLETED|Overall Study||14
10254978|NCT03462030|11386848|FG000|NOT COMPLETED|Overall Study||1
10254979|NCT03462030|11386849|FG001|NOT COMPLETED|Overall Study||1
10254980|NCT03446768|11386857|FG000|STARTED|Overall Study||141
10254981|NCT03446768|11386858|FG001|STARTED|Overall Study||153
9834350|NCT00784875|10945365|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12
9834351|NCT00784875|10945366|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21
9834352|NCT00784875|10945367|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19
9834353|NCT00784875|10945364|FG000|STARTED|Period C||103
9834354|NCT00784875|10945365|FG001|STARTED|Period C||97
9834355|NCT00784875|10945366|FG002|STARTED|Period C||97
9834356|NCT00784875|10945367|FG003|STARTED|Period C||98
9834357|NCT00784875|10945364|FG000|COMPLETED|Period C||96
9834358|NCT00784875|10945365|FG001|COMPLETED|Period C||91
9834359|NCT00784875|10945366|FG002|COMPLETED|Period C||84
9834360|NCT00784875|10945367|FG003|COMPLETED|Period C||91
9834361|NCT00784875|10945364|FG000|NOT COMPLETED|Period C||7
9834362|NCT00784875|10945365|FG001|NOT COMPLETED|Period C||6
9834363|NCT00784875|10945366|FG002|NOT COMPLETED|Period C||13
9834364|NCT00784875|10945367|FG003|NOT COMPLETED|Period C||7
9834365|NCT00784875|10945364|FG000|STARTED|Period D||91
9834366|NCT00784875|10945365|FG001|STARTED|Period D||89
9834367|NCT00784875|10945366|FG002|STARTED|Period D||94
9834368|NCT00784875|10945367|FG003|STARTED|Period D||88
9834369|NCT00784875|10945364|FG000|COMPLETED|Period D||86
9834370|NCT00784875|10945365|FG001|COMPLETED|Period D||85
9834371|NCT00784875|10945366|FG002|COMPLETED|Period D||88
9834372|NCT00784875|10945367|FG003|COMPLETED|Period D||87
9834373|NCT00784875|10945364|FG000|NOT COMPLETED|Period D||5
9834374|NCT00784875|10945365|FG001|NOT COMPLETED|Period D||4
9834375|NCT00784875|10945366|FG002|NOT COMPLETED|Period D||6
9834376|NCT00784875|10945367|FG003|NOT COMPLETED|Period D||1
9834377|NCT00784927|10945390|FG000|STARTED|Overall Study||36
9834378|NCT00784927|10945390|FG000|COMPLETED|Overall Study||33
9834379|NCT00784927|10945390|FG000|NOT COMPLETED|Overall Study||3
9834380|NCT00784979|10945395|FG000|STARTED|Overall Study||26
9834381|NCT00784979|10945395|FG000|COMPLETED|Overall Study||20
9834382|NCT00784979|10945395|FG000|NOT COMPLETED|Overall Study||6
9834383|NCT00785044|10945399|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964
9834384|NCT00785044|10945399|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
9834385|NCT00785044|10945399|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
9834386|NCT00785044|10945399|FG000|NOT COMPLETED|Overall Study||496
9834387|NCT00785213|10945404|FG000|STARTED|Rosiglitazone Alone||23
9834388|NCT00785213|10945404|FG000|COMPLETED|Rosiglitazone Alone||23
9834389|NCT00785213|10945404|FG000|NOT COMPLETED|Rosiglitazone Alone||0
9834390|NCT00785213|10945404|FG000|STARTED|2 Day Washout Period||23
9834391|NCT00785213|10945404|FG000|COMPLETED|2 Day Washout Period||23
9834392|NCT00785213|10945404|FG000|NOT COMPLETED|2 Day Washout Period||0
9834393|NCT00785213|10945404|FG000|STARTED|Quinine Sulfate Alone||23
9834394|NCT00785213|10945404|FG000|COMPLETED|Quinine Sulfate Alone||19
9834395|NCT00785213|10945404|FG000|NOT COMPLETED|Quinine Sulfate Alone||4
9834396|NCT00785213|10945404|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19
9834397|NCT00785213|10945404|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18
9834398|NCT00785213|10945404|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
10254982|NCT03446768|11386857|FG000|COMPLETED|Overall Study||141
10254983|NCT03446768|11386858|FG001|COMPLETED|Overall Study||152
10254984|NCT03446768|11386857|FG000|NOT COMPLETED|Overall Study||0
10254985|NCT03446768|11386858|FG001|NOT COMPLETED|Overall Study||1
10254986|NCT03348514|11386872|FG000|STARTED|Overall Study||1
9834399|NCT00785486|10945411|FG000|STARTED|Midazolam Alone||24
9834400|NCT00785486|10945411|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
9834401|NCT00785486|10945411|FG000|NOT COMPLETED|Midazolam Alone||1
9834402|NCT00785486|10945411|FG000|STARTED|3 Day Washout||23
9834403|NCT00785486|10945411|FG000|COMPLETED|3 Day Washout||23
10254987|NCT03348514|11386873|FG001|STARTED|Overall Study||1
10254988|NCT03348514|11386874|FG002|STARTED|Overall Study||1
9834404|NCT00785486|10945411|FG000|NOT COMPLETED|3 Day Washout||0
9834405|NCT00785486|10945411|FG000|STARTED|Qualaquin Alone at Steady State||23
10254989|NCT03348514|11386875|FG003|STARTED|Overall Study||1
10254990|NCT03348514|11386876|FG004|STARTED|Overall Study||3
10254991|NCT03348514|11386877|FG005|STARTED|Overall Study||4
9834406|NCT00785486|10945411|FG000|COMPLETED|Qualaquin Alone at Steady State||23
10020671|NCT01838213|11144006|FG000|STARTED|Overall Study||247
10020672|NCT01838213|11144007|FG001|STARTED|Overall Study||453
10020673|NCT01838213|11144006|FG000|COMPLETED|Overall Study||81
10254992|NCT03348514|11386878|FG006|STARTED|Overall Study||6
10020674|NCT01838213|11144007|FG001|COMPLETED|Overall Study||262
10254993|NCT03348514|11386879|FG007|STARTED|Overall Study||2
10254994|NCT03348514|11386872|FG000|COMPLETED|Overall Study||1
10254995|NCT03348514|11386873|FG001|COMPLETED|Overall Study||1
10254996|NCT03348514|11386874|FG002|COMPLETED|Overall Study||1
10254997|NCT03348514|11386875|FG003|COMPLETED|Overall Study||1
10254998|NCT03348514|11386876|FG004|COMPLETED|Overall Study||3
10254999|NCT03348514|11386877|FG005|COMPLETED|Overall Study||4
10255000|NCT03348514|11386878|FG006|COMPLETED|Overall Study||6
10255001|NCT03348514|11386879|FG007|COMPLETED|Overall Study||2
10255002|NCT03348514|11386872|FG000|NOT COMPLETED|Overall Study||0
10020675|NCT01838213|11144006|FG000|NOT COMPLETED|Overall Study||166
10255003|NCT03348514|11386873|FG001|NOT COMPLETED|Overall Study||0
10255004|NCT03348514|11386874|FG002|NOT COMPLETED|Overall Study||0
10114005|NCT02513160|11244732|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
10114006|NCT02513160|11244733|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
10114007|NCT02513160|11244734|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
10196035|NCT03358251|11324424|FG000|STARTED|Overall Study||34
10255005|NCT03348514|11386875|FG003|NOT COMPLETED|Overall Study||0
10255006|NCT03348514|11386876|FG004|NOT COMPLETED|Overall Study||0
10255007|NCT03348514|11386877|FG005|NOT COMPLETED|Overall Study||0
10255008|NCT03348514|11386878|FG006|NOT COMPLETED|Overall Study||0
10255009|NCT03348514|11386879|FG007|NOT COMPLETED|Overall Study||0
10255010|NCT03253393|11386903|FG000|STARTED|First Intervention||12
10255011|NCT03253393|11386904|FG001|STARTED|First Intervention||13
10255012|NCT03253393|11386905|FG002|STARTED|First Intervention||0
10255013|NCT03253393|11386903|FG000|COMPLETED|First Intervention||12
10255014|NCT03253393|11386904|FG001|COMPLETED|First Intervention||13
10255015|NCT03253393|11386905|FG002|COMPLETED|First Intervention||0
10255016|NCT03253393|11386903|FG000|NOT COMPLETED|First Intervention||0
10255017|NCT03253393|11386904|FG001|NOT COMPLETED|First Intervention||0
10255018|NCT03253393|11386905|FG002|NOT COMPLETED|First Intervention||0
10255019|NCT03253393|11386903|FG000|STARTED|Washout (Minimum 48 Hours)||12
10255020|NCT03253393|11386904|FG001|STARTED|Washout (Minimum 48 Hours)||13
10255021|NCT03253393|11386905|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10255022|NCT03253393|11386903|FG000|COMPLETED|Washout (Minimum 48 Hours)||12
10255023|NCT03253393|11386904|FG001|COMPLETED|Washout (Minimum 48 Hours)||13
10255024|NCT03253393|11386905|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10255025|NCT03253393|11386903|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10255026|NCT03253393|11386904|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10255027|NCT03253393|11386905|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10255028|NCT03253393|11386903|FG000|STARTED|Second Intervention||12
10255029|NCT03253393|11386904|FG001|STARTED|Second Intervention||13
10255030|NCT03253393|11386905|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
10255031|NCT03253393|11386903|FG000|COMPLETED|Second Intervention||12
10255032|NCT03253393|11386904|FG001|COMPLETED|Second Intervention||13
10255033|NCT03253393|11386905|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
10255034|NCT03253393|11386903|FG000|NOT COMPLETED|Second Intervention||0
10255035|NCT03253393|11386904|FG001|NOT COMPLETED|Second Intervention||0
10255036|NCT03253393|11386905|FG002|NOT COMPLETED|Second Intervention||0
10255037|NCT03253393|11386903|FG000|STARTED|Washout (Minimum 48 Hours)||12
10255038|NCT03253393|11386904|FG001|STARTED|Washout (Minimum 48 Hours)||13
10255039|NCT03253393|11386905|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10255040|NCT03253393|11386903|FG000|COMPLETED|Washout (Minimum 48 Hours)||6
10255041|NCT03253393|11386904|FG001|COMPLETED|Washout (Minimum 48 Hours)||6
10255042|NCT03253393|11386905|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10255043|NCT03253393|11386903|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6
10255044|NCT03253393|11386904|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7
10255045|NCT03253393|11386905|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10255046|NCT03253393|11386903|FG000|STARTED|Third Intervention||6
10255047|NCT03253393|11386904|FG001|STARTED|Third Intervention||6
10255048|NCT03253393|11386905|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
10255049|NCT03253393|11386903|FG000|COMPLETED|Third Intervention||6
10255050|NCT03253393|11386904|FG001|COMPLETED|Third Intervention||6
10255051|NCT03253393|11386905|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
10255052|NCT03253393|11386903|FG000|NOT COMPLETED|Third Intervention||0
10255053|NCT03253393|11386904|FG001|NOT COMPLETED|Third Intervention||0
10255054|NCT03253393|11386905|FG002|NOT COMPLETED|Third Intervention||0
10255055|NCT03188822|11386919|FG000|STARTED|Overall Study||9
10255056|NCT03188822|11386919|FG000|COMPLETED|Overall Study||2
10255057|NCT03188822|11386919|FG000|NOT COMPLETED|Overall Study||7
10255058|NCT03128671|11386925|FG000|STARTED|Enrollment||89
10255059|NCT03128671|11386926|FG001|STARTED|Enrollment||89
10255060|NCT03128671|11386925|FG000|COMPLETED|Enrollment||89
10255061|NCT03128671|11386926|FG001|COMPLETED|Enrollment||89
10255062|NCT03128671|11386925|FG000|NOT COMPLETED|Enrollment||0
10255063|NCT03128671|11386926|FG001|NOT COMPLETED|Enrollment||0
10255064|NCT03128671|11386925|FG000|STARTED|Allocation||89
10255065|NCT03128671|11386926|FG001|STARTED|Allocation||89
10255066|NCT03128671|11386925|FG000|COMPLETED|Allocation||80
10255067|NCT03128671|11386926|FG001|COMPLETED|Allocation||89
10255068|NCT03128671|11386925|FG000|NOT COMPLETED|Allocation||9
10255069|NCT03128671|11386926|FG001|NOT COMPLETED|Allocation||0
10255070|NCT03128671|11386925|FG000|STARTED|Intervention||80
10255071|NCT03128671|11386926|FG001|STARTED|Intervention||89
10255072|NCT03128671|11386925|FG000|COMPLETED|Intervention||44
10255073|NCT03128671|11386926|FG001|COMPLETED|Intervention||55
10255074|NCT03128671|11386925|FG000|NOT COMPLETED|Intervention||36
10255075|NCT03128671|11386926|FG001|NOT COMPLETED|Intervention||34
10255076|NCT03111732|11386932|FG000|STARTED|Overall Study||11
10255077|NCT03111732|11386932|FG000|COMPLETED|Overall Study||6
10255078|NCT03111732|11386932|FG000|NOT COMPLETED|Overall Study||5
10255079|NCT03065244|11386943|FG000|STARTED|Overall Study||50
10255080|NCT03065244|11386944|FG001|STARTED|Overall Study||55
10255081|NCT03065244|11386943|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22
10255082|NCT03065244|11386944|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9
10255083|NCT03065244|11386943|FG000|COMPLETED|Overall Study||47
10255084|NCT03065244|11386944|FG001|COMPLETED|Overall Study||51
10255085|NCT03065244|11386943|FG000|NOT COMPLETED|Overall Study||3
10255086|NCT03065244|11386944|FG001|NOT COMPLETED|Overall Study||4
10255087|NCT02879305|11386952|FG000|STARTED|Overall Study||1487
10255088|NCT02879305|11386953|FG001|STARTED|Overall Study||1477
10255089|NCT02879305|11386952|FG000|COMPLETED|Overall Study||1370
10255090|NCT02879305|11386953|FG001|COMPLETED|Overall Study||1366
10255091|NCT02879305|11386952|FG000|NOT COMPLETED|Overall Study||117
10255092|NCT02879305|11386953|FG001|NOT COMPLETED|Overall Study||111
10255093|NCT02816736|11386961|FG000|STARTED|Overall Study||179
10255094|NCT02816736|11386962|FG001|STARTED|Overall Study||186
10020676|NCT01838213|11144007|FG001|NOT COMPLETED|Overall Study||191
10020677|NCT01838226|11144015|FG000|STARTED|Overall Study||202
10020678|NCT01838226|11144016|FG001|STARTED|Overall Study||199
10020679|NCT01838226|11144015|FG000|COMPLETED|Overall Study||126
10255095|NCT02816736|11386961|FG000|COMPLETED|Overall Study||164
10255096|NCT02816736|11386962|FG001|COMPLETED|Overall Study||166
10255097|NCT02816736|11386961|FG000|NOT COMPLETED|Overall Study||15
10255098|NCT02816736|11386962|FG001|NOT COMPLETED|Overall Study||20
10255099|NCT02787850|11386970|FG000|STARTED|Overall Study||10
10255100|NCT02787850|11386971|FG001|STARTED|Overall Study||10
10255101|NCT02787850|11386970|FG000|COMPLETED|Overall Study||10
10255102|NCT02787850|11386971|FG001|COMPLETED|Overall Study||9
10255103|NCT02787850|11386970|FG000|NOT COMPLETED|Overall Study||0
10255104|NCT02787850|11386971|FG001|NOT COMPLETED|Overall Study||1
10255105|NCT02713373|11386986|FG000|STARTED|Overall Study||44
10255106|NCT02713373|11386986|FG000|COMPLETED|Overall Study||44
10255107|NCT02713373|11386986|FG000|NOT COMPLETED|Overall Study||0
10255108|NCT02676284|11386990|FG000|STARTED|Overall Study||36
10255109|NCT02676284|11386990|FG000|COMPLETED|Overall Study||35
10255110|NCT02676284|11386990|FG000|NOT COMPLETED|Overall Study||1
10255111|NCT02431702|11386994|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273
10255112|NCT02431702|11386995|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10255113|NCT02431702|11386996|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10255114|NCT02431702|11386997|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10255115|NCT02431702|11386998|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10255116|NCT02431702|11386999|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10255117|NCT02431702|11387000|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64
10255118|NCT02431702|11386994|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
10255119|NCT02431702|11386995|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255120|NCT02431702|11386996|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255121|NCT02431702|11386997|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255122|NCT02431702|11386998|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255123|NCT02431702|11386999|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255124|NCT02431702|11387000|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
10255125|NCT02431702|11386994|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
10255126|NCT02431702|11386995|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255127|NCT02431702|11386996|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255128|NCT02431702|11386997|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255129|NCT02431702|11386998|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255130|NCT02431702|11386999|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10255131|NCT02431702|11387000|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
10255132|NCT02431702|11386994|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0
10255133|NCT02431702|11386995|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
10255134|NCT02431702|11386996|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
10255135|NCT02431702|11386997|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0
10255136|NCT02431702|11386998|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0
10255137|NCT02431702|11386999|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0
10255138|NCT02431702|11387000|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0
10255139|NCT02431702|11386994|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255140|NCT02431702|11386995|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52
10255141|NCT02431702|11386996|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128
10255142|NCT02431702|11386997|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255143|NCT02431702|11386998|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255144|NCT02431702|11386999|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255145|NCT02431702|11387000|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255146|NCT02431702|11386994|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255147|NCT02431702|11386995|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
10255148|NCT02431702|11386996|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
10020680|NCT01838226|11144016|FG001|COMPLETED|Overall Study||128
10020681|NCT01838226|11144015|FG000|NOT COMPLETED|Overall Study||76
10255149|NCT02431702|11386997|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255150|NCT02431702|11386998|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255151|NCT02431702|11386999|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255152|NCT02431702|11387000|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10255153|NCT02431702|11386994|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0
10255154|NCT02431702|11386995|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0
10255155|NCT02431702|11386996|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0
10255156|NCT02431702|11386997|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
10255157|NCT02431702|11386998|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
10255158|NCT02431702|11386999|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
10255159|NCT02431702|11387000|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0
10255160|NCT02431702|11386994|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255161|NCT02431702|11386995|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255162|NCT02431702|11386996|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255163|NCT02431702|11386997|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40
10255164|NCT02431702|11386998|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47
10255165|NCT02431702|11386999|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46
10255166|NCT02431702|11387000|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255167|NCT02431702|11386994|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255168|NCT02431702|11386995|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255169|NCT02431702|11386996|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255170|NCT02431702|11386997|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
10255171|NCT02431702|11386998|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
10255172|NCT02431702|11386999|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
10255173|NCT02431702|11387000|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10255174|NCT02368002|11387020|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233
10255175|NCT02368002|11387021|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10255176|NCT02368002|11387022|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10255177|NCT02368002|11387023|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235
10255178|NCT02368002|11387024|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10255179|NCT02368002|11387025|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10255180|NCT02368002|11387020|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228
10255181|NCT02368002|11387021|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255182|NCT02368002|11387022|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255183|NCT02368002|11387023|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214
10255184|NCT02368002|11387024|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255185|NCT02368002|11387025|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255186|NCT02368002|11387020|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5
10255187|NCT02368002|11387021|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255188|NCT02368002|11387022|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255189|NCT02368002|11387023|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21
10255190|NCT02368002|11387024|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255191|NCT02368002|11387025|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10255192|NCT02368002|11387020|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88
10255193|NCT02368002|11387021|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
10255194|NCT02368002|11387022|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
10255195|NCT02368002|11387023|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10255196|NCT02368002|11387024|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10255197|NCT02368002|11387025|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10255198|NCT02368002|11387020|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86
10255199|NCT02368002|11387021|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60
10255200|NCT02368002|11387022|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64
10255201|NCT02368002|11387023|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10255202|NCT02368002|11387024|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10255203|NCT02368002|11387025|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10255204|NCT02368002|11387020|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2
10255205|NCT02368002|11387021|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10
10255206|NCT02368002|11387022|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6
10255207|NCT02368002|11387023|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10255208|NCT02368002|11387024|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10255209|NCT02368002|11387025|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10255210|NCT02368002|11387020|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10255211|NCT02368002|11387021|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10255212|NCT02368002|11387022|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10255213|NCT02368002|11387023|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95
10255214|NCT02368002|11387024|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57
10255215|NCT02368002|11387025|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62
10255216|NCT02368002|11387020|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10255217|NCT02368002|11387021|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10255218|NCT02368002|11387022|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10255219|NCT02368002|11387023|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94
10255220|NCT02368002|11387024|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53
10255221|NCT02368002|11387025|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59
10255222|NCT02368002|11387020|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10255223|NCT02368002|11387021|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10255224|NCT02368002|11387022|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10255225|NCT02368002|11387023|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1
10255226|NCT02368002|11387024|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4
10255227|NCT02368002|11387025|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3
10255228|NCT02200770|11387037|FG000|STARTED|Randomized-controlled Period (RCP)||56
10255229|NCT02200770|11387038|FG001|STARTED|Randomized-controlled Period (RCP)||175
10255230|NCT02200770|11387037|FG000|Treated|Randomized-controlled Period (RCP)||56
10255231|NCT02200770|11387038|FG001|Treated|Randomized-controlled Period (RCP)||174
10255232|NCT02200770|11387037|FG000|COMPLETED|Randomized-controlled Period (RCP)||54
10255233|NCT02200770|11387038|FG001|COMPLETED|Randomized-controlled Period (RCP)||169
10255234|NCT02200770|11387037|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2
10255235|NCT02200770|11387038|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6
10255236|NCT02200770|11387037|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51
10255237|NCT02200770|11387038|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165
10255238|NCT02200770|11387037|FG000|COMPLETED|Open-label Period (OLP)||43
10255239|NCT02200770|11387038|FG001|COMPLETED|Open-label Period (OLP)||131
10255240|NCT02200770|11387037|FG000|NOT COMPLETED|Open-label Period (OLP)||8
10255241|NCT02200770|11387038|FG001|NOT COMPLETED|Open-label Period (OLP)||34
10255242|NCT02136069|11387048|FG000|STARTED|Overall Study||199
9834407|NCT00785486|10945411|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0
9834408|NCT00785486|10945411|FG000|STARTED|Midazolam With Qualaquin at Steady State||23
9834409|NCT00785486|10945411|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23
9834410|NCT00785486|10945411|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
9834411|NCT00785512|10945434|FG000|STARTED|Overall Study||102
9834412|NCT00785512|10945435|FG001|STARTED|Overall Study||105
9834413|NCT00785512|10945434|FG000|COMPLETED|Overall Study||99
9834414|NCT00785512|10945435|FG001|COMPLETED|Overall Study||101
9834415|NCT00785512|10945434|FG000|NOT COMPLETED|Overall Study||3
9957568|NCT01451632|11076866|FG003|STARTED|Overall Study||3
9957569|NCT01451632|11076867|FG004|STARTED|Overall Study||4
9957570|NCT01451632|11076868|FG005|STARTED|Overall Study||4
9957571|NCT01451632|11076869|FG006|STARTED|Overall Study||8
9957572|NCT01451632|11076870|FG007|STARTED|Overall Study||6
9957573|NCT01451632|11076871|FG008|STARTED|Overall Study||4
9957574|NCT01451632|11076872|FG009|STARTED|Overall Study||4
10255243|NCT02136069|11387049|FG001|STARTED|Overall Study||198
10255244|NCT02136069|11387048|FG000|COMPLETED|Overall Study||165
10255245|NCT02136069|11387049|FG001|COMPLETED|Overall Study||170
10255246|NCT02136069|11387048|FG000|NOT COMPLETED|Overall Study||34
10255247|NCT02136069|11387049|FG001|NOT COMPLETED|Overall Study||28
10255248|NCT02086552|11387055|FG000|STARTED|Overall Study||28
10255249|NCT02086552|11387055|FG000|COMPLETED|Overall Study||27
10255250|NCT02086552|11387055|FG000|NOT COMPLETED|Overall Study||1
10255251|NCT01517659|11387059|FG000|STARTED|Overall Study||45
10255252|NCT01517659|11387059|FG000|COMPLETED|Overall Study||45
10255253|NCT01517659|11387059|FG000|NOT COMPLETED|Overall Study||0
10255254|NCT01209767|11387064|FG000|STARTED|Overall Study||22
10255255|NCT01209767|11387064|FG000|COMPLETED|Overall Study||18
10255256|NCT01209767|11387064|FG000|NOT COMPLETED|Overall Study||4
10255257|NCT01186848|11387072|FG000|STARTED|Overall Study||30
10255258|NCT01186848|11387072|FG000|COMPLETED|Overall Study||22
10255259|NCT01186848|11387072|FG000|NOT COMPLETED|Overall Study||8
10255260|NCT01040624|11387080|FG000|STARTED|Overall Study||58
10255261|NCT01040624|11387081|FG001|STARTED|Overall Study||19
10255262|NCT01040624|11387080|FG000|COMPLETED|Overall Study||58
10255263|NCT01040624|11387081|FG001|COMPLETED|Overall Study||19
10255264|NCT01040624|11387080|FG000|NOT COMPLETED|Overall Study||0
10255265|NCT01040624|11387081|FG001|NOT COMPLETED|Overall Study||0
10255266|NCT01024608|11387089|FG000|STARTED|Overall Study||169
10255267|NCT01024608|11387090|FG001|STARTED|Overall Study||171
10255268|NCT01024608|11387089|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
10255269|NCT01024608|11387090|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
10255270|NCT01024608|11387089|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
10255271|NCT01024608|11387090|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
10255272|NCT01024608|11387089|FG000|COMPLETED|Overall Study||165
10255273|NCT01024608|11387090|FG001|COMPLETED|Overall Study||167
10255274|NCT01024608|11387089|FG000|NOT COMPLETED|Overall Study||4
10255275|NCT01024608|11387090|FG001|NOT COMPLETED|Overall Study||4
10255276|NCT00988247|11387098|FG000|STARTED|Overall Study||418
10255277|NCT00988247|11387099|FG001|STARTED|Overall Study||111
10255278|NCT00988247|11387098|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
10255279|NCT00988247|11387099|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
10255280|NCT00988247|11387098|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
10255281|NCT00988247|11387099|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
10255282|NCT00988247|11387098|FG000|COMPLETED|Overall Study||335
10255283|NCT00988247|11387099|FG001|COMPLETED|Overall Study||85
10255284|NCT00988247|11387098|FG000|NOT COMPLETED|Overall Study||83
10255285|NCT00988247|11387099|FG001|NOT COMPLETED|Overall Study||26
10255286|NCT00838981|11387109|FG000|STARTED|Week 1 Days 1-3||26
10255287|NCT00838981|11387110|FG001|STARTED|Week 1 Days 1-3||19
10255288|NCT00838981|11387111|FG002|STARTED|Week 1 Days 1-3||27
10255289|NCT00838981|11387112|FG003|STARTED|Week 1 Days 1-3||19
10255290|NCT00838981|11387109|FG000|COMPLETED|Week 1 Days 1-3||26
10255291|NCT00838981|11387110|FG001|COMPLETED|Week 1 Days 1-3||19
10255292|NCT00838981|11387111|FG002|COMPLETED|Week 1 Days 1-3||27
10255293|NCT00838981|11387112|FG003|COMPLETED|Week 1 Days 1-3||19
10255294|NCT00838981|11387109|FG000|NOT COMPLETED|Week 1 Days 1-3||0
10255295|NCT00838981|11387110|FG001|NOT COMPLETED|Week 1 Days 1-3||0
10255296|NCT00838981|11387111|FG002|NOT COMPLETED|Week 1 Days 1-3||0
10255297|NCT00838981|11387112|FG003|NOT COMPLETED|Week 1 Days 1-3||0
10255298|NCT00838981|11387109|FG000|STARTED|Day 4 to Week 11||26
10255299|NCT00838981|11387110|FG001|STARTED|Day 4 to Week 11||19
10255300|NCT00838981|11387111|FG002|STARTED|Day 4 to Week 11||27
10255301|NCT00838981|11387112|FG003|STARTED|Day 4 to Week 11||19
10255302|NCT00838981|11387109|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22
10255303|NCT00838981|11387110|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13
10255304|NCT00838981|11387111|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17
10255305|NCT00838981|11387112|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14
10255306|NCT00838981|11387109|FG000|COMPLETED|Day 4 to Week 11||19
10255307|NCT00838981|11387110|FG001|COMPLETED|Day 4 to Week 11||11
10255308|NCT00838981|11387111|FG002|COMPLETED|Day 4 to Week 11||16
10255309|NCT00838981|11387112|FG003|COMPLETED|Day 4 to Week 11||12
10255310|NCT00838981|11387109|FG000|NOT COMPLETED|Day 4 to Week 11||7
10255311|NCT00838981|11387110|FG001|NOT COMPLETED|Day 4 to Week 11||8
10255312|NCT00838981|11387111|FG002|NOT COMPLETED|Day 4 to Week 11||11
10255313|NCT00838981|11387112|FG003|NOT COMPLETED|Day 4 to Week 11||7
10255314|NCT00730639|11387131|FG000|STARTED|Overall Study||17
10255315|NCT00730639|11387132|FG001|STARTED|Overall Study||18
10255316|NCT00730639|11387133|FG002|STARTED|Overall Study||86
10255317|NCT00730639|11387134|FG003|STARTED|Overall Study||54
10255318|NCT00730639|11387135|FG004|STARTED|Overall Study||131
10255319|NCT00730639|11387131|FG000|COMPLETED|Overall Study||0
10255320|NCT00730639|11387132|FG001|COMPLETED|Overall Study||0
10255321|NCT00730639|11387133|FG002|COMPLETED|Overall Study||0
10255322|NCT00730639|11387134|FG003|COMPLETED|Overall Study||0
10255323|NCT00730639|11387135|FG004|COMPLETED|Overall Study||0
10255324|NCT00730639|11387131|FG000|NOT COMPLETED|Overall Study||17
10255325|NCT00730639|11387132|FG001|NOT COMPLETED|Overall Study||18
10255326|NCT00730639|11387133|FG002|NOT COMPLETED|Overall Study||86
10255327|NCT00730639|11387134|FG003|NOT COMPLETED|Overall Study||54
10255328|NCT00730639|11387135|FG004|NOT COMPLETED|Overall Study||131
10255329|NCT00363038|11387158|FG000|STARTED|Overall Study||16
10255330|NCT00363038|11387158|FG000|COMPLETED|Overall Study||16
10255331|NCT00363038|11387158|FG000|NOT COMPLETED|Overall Study||0
10255332|NCT04834362|11387164|FG000|STARTED|Overall Study||53
10255333|NCT04834362|11387165|FG001|STARTED|Overall Study||52
10255334|NCT04834362|11387164|FG000|COMPLETED|Overall Study||52
10255335|NCT04834362|11387165|FG001|COMPLETED|Overall Study||50
10255336|NCT04834362|11387164|FG000|NOT COMPLETED|Overall Study||1
10255337|NCT04834362|11387165|FG001|NOT COMPLETED|Overall Study||2
10255338|NCT04681482|11387175|FG000|STARTED|Overall Study||35051
10255339|NCT04681482|11387176|FG001|STARTED|Overall Study||38756
10255340|NCT04681482|11387177|FG002|STARTED|Overall Study||12148
10255341|NCT04681482|11387178|FG003|STARTED|Overall Study||21428
10255342|NCT04681482|11387175|FG000|COMPLETED|Overall Study||35051
10255343|NCT04681482|11387176|FG001|COMPLETED|Overall Study||38756
10255344|NCT04681482|11387177|FG002|COMPLETED|Overall Study||12148
10255345|NCT04681482|11387178|FG003|COMPLETED|Overall Study||21428
10255346|NCT04681482|11387175|FG000|NOT COMPLETED|Overall Study||0
10255347|NCT04681482|11387176|FG001|NOT COMPLETED|Overall Study||0
10255348|NCT04681482|11387177|FG002|NOT COMPLETED|Overall Study||0
10255349|NCT04681482|11387178|FG003|NOT COMPLETED|Overall Study||0
10255350|NCT04611789|11387191|FG000|STARTED|Overall Study||4
10255351|NCT04611789|11387192|FG001|STARTED|Overall Study||7
10255352|NCT04611789|11387193|FG002|STARTED|Overall Study||7
10255353|NCT04611789|11387191|FG000|COMPLETED|Overall Study||3
10255354|NCT04611789|11387192|FG001|COMPLETED|Overall Study||7
10255355|NCT04611789|11387193|FG002|COMPLETED|Overall Study||7
10255356|NCT04611789|11387191|FG000|NOT COMPLETED|Overall Study||1
10255357|NCT04611789|11387192|FG001|NOT COMPLETED|Overall Study||0
10255358|NCT04611789|11387193|FG002|NOT COMPLETED|Overall Study||0
10255359|NCT04537910|11387204|FG000|STARTED|Overall Study||6
10255360|NCT04537910|11387205|FG001|STARTED|Overall Study||5
10255361|NCT04537910|11387206|FG002|STARTED|Overall Study||7
10255362|NCT04537910|11387207|FG003|STARTED|Overall Study||7
10255363|NCT04537910|11387204|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10255364|NCT04537910|11387205|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10255365|NCT04537910|11387206|FG002|Received at Least One Dose of Study Drug|Overall Study||7
10255366|NCT04537910|11387207|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10255367|NCT04537910|11387204|FG000|COMPLETED|Overall Study||6
10255368|NCT04537910|11387205|FG001|COMPLETED|Overall Study||5
10255369|NCT04537910|11387206|FG002|COMPLETED|Overall Study||7
10255370|NCT04537910|11387207|FG003|COMPLETED|Overall Study||7
10255371|NCT04537910|11387204|FG000|NOT COMPLETED|Overall Study||0
10255372|NCT04537910|11387205|FG001|NOT COMPLETED|Overall Study||0
10255373|NCT04537910|11387206|FG002|NOT COMPLETED|Overall Study||0
10255374|NCT04537910|11387207|FG003|NOT COMPLETED|Overall Study||0
10255375|NCT04441931|11387220|FG000|STARTED|Overall Study||6
10255376|NCT04441931|11387221|FG001|STARTED|Overall Study||7
10255377|NCT04441931|11387222|FG002|STARTED|Overall Study||7
10255378|NCT04441931|11387223|FG003|STARTED|Overall Study||6
10255379|NCT04441931|11387220|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10255380|NCT04441931|11387221|FG001|Received at Least One Dose of Study Drug|Overall Study||7
10255381|NCT04441931|11387222|FG002|Received at Least One Dose of Study Drug|Overall Study||7
10255382|NCT04441931|11387223|FG003|Received at Least One Dose of Study Drug|Overall Study||6
10255383|NCT04441931|11387220|FG000|COMPLETED|Overall Study||6
10255384|NCT04441931|11387221|FG001|COMPLETED|Overall Study||7
10255385|NCT04441931|11387222|FG002|COMPLETED|Overall Study||7
10255386|NCT04441931|11387223|FG003|COMPLETED|Overall Study||6
10255387|NCT04441931|11387220|FG000|NOT COMPLETED|Overall Study||0
10255388|NCT04441931|11387221|FG001|NOT COMPLETED|Overall Study||0
10255389|NCT04441931|11387222|FG002|NOT COMPLETED|Overall Study||0
10255390|NCT04441931|11387223|FG003|NOT COMPLETED|Overall Study||0
10255391|NCT04355728|11387238|FG000|STARTED|Overall Study||12
10255392|NCT04355728|11387239|FG001|STARTED|Overall Study||12
10255393|NCT04355728|11387238|FG000|COMPLETED|Overall Study||12
10255394|NCT04355728|11387239|FG001|COMPLETED|Overall Study||12
10255395|NCT04355728|11387238|FG000|NOT COMPLETED|Overall Study||0
10255396|NCT04355728|11387239|FG001|NOT COMPLETED|Overall Study||0
10255397|NCT04344535|11387247|FG000|STARTED|Overall Study||59
10255398|NCT04344535|11387248|FG001|STARTED|Overall Study||15
10255399|NCT04344535|11387247|FG000|COMPLETED|Overall Study||59
10255400|NCT04344535|11387248|FG001|COMPLETED|Overall Study||15
10255401|NCT04344535|11387247|FG000|NOT COMPLETED|Overall Study||0
10255402|NCT04344535|11387248|FG001|NOT COMPLETED|Overall Study||0
10255403|NCT04254809|11387256|FG000|STARTED|Overall Study||48
10255404|NCT04254809|11387257|FG001|STARTED|Overall Study||48
10255405|NCT04254809|11387256|FG000|COMPLETED|Overall Study||43
10255406|NCT04254809|11387257|FG001|COMPLETED|Overall Study||38
10255407|NCT04254809|11387256|FG000|NOT COMPLETED|Overall Study||5
10255408|NCT04254809|11387257|FG001|NOT COMPLETED|Overall Study||10
10255409|NCT04230122|11387265|FG000|STARTED|Overall Study||3
10255410|NCT04230122|11387266|FG001|STARTED|Overall Study||1
10255411|NCT04230122|11387265|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10255412|NCT04230122|11387266|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
10255413|NCT04230122|11387265|FG000|COMPLETED|Overall Study||2
10255414|NCT04230122|11387266|FG001|COMPLETED|Overall Study||1
10255415|NCT04230122|11387265|FG000|NOT COMPLETED|Overall Study||1
10255416|NCT04230122|11387266|FG001|NOT COMPLETED|Overall Study||0
10255417|NCT04110366|11387274|FG000|STARTED|Overall Study||40
10255418|NCT04110366|11387275|FG001|STARTED|Overall Study||8
10255419|NCT04110366|11387274|FG000|COMPLETED|Overall Study||40
10255420|NCT04110366|11387275|FG001|COMPLETED|Overall Study||8
10255421|NCT04110366|11387274|FG000|NOT COMPLETED|Overall Study||0
10255422|NCT04110366|11387275|FG001|NOT COMPLETED|Overall Study||0
10255423|NCT04086693|11387284|FG000|STARTED|Overall Study||175
10255424|NCT04086693|11387285|FG001|STARTED|Overall Study||175
10255425|NCT04086693|11387284|FG000|COMPLETED|Overall Study||174
10255426|NCT04086693|11387285|FG001|COMPLETED|Overall Study||171
10255427|NCT04086693|11387284|FG000|NOT COMPLETED|Overall Study||1
10255428|NCT04086693|11387285|FG001|NOT COMPLETED|Overall Study||4
10255429|NCT04033068|11387295|FG000|STARTED|Overall Study||14
10255430|NCT04033068|11387296|FG001|STARTED|Overall Study||14
10255431|NCT04033068|11387297|FG002|STARTED|Overall Study||12
10255432|NCT04033068|11387298|FG003|STARTED|Overall Study||8
10255433|NCT04033068|11387295|FG000|First Dose|Overall Study||14
10255434|NCT04033068|11387296|FG001|First Dose|Overall Study||14
10255435|NCT04033068|11387297|FG002|First Dose|Overall Study||12
10255436|NCT04033068|11387298|FG003|First Dose|Overall Study||8
10255437|NCT04033068|11387295|FG000|Second Dose|Overall Study||14
10255438|NCT04033068|11387296|FG001|Second Dose|Overall Study||14
10255439|NCT04033068|11387297|FG002|Second Dose|Overall Study||11
10255440|NCT04033068|11387298|FG003|Second Dose|Overall Study||7
10255441|NCT04033068|11387295|FG000|COMPLETED|Overall Study||14
10255442|NCT04033068|11387296|FG001|COMPLETED|Overall Study||13
10255443|NCT04033068|11387297|FG002|COMPLETED|Overall Study||11
10255444|NCT04033068|11387298|FG003|COMPLETED|Overall Study||7
10255445|NCT04033068|11387295|FG000|NOT COMPLETED|Overall Study||0
10255446|NCT04033068|11387296|FG001|NOT COMPLETED|Overall Study||1
10255447|NCT04033068|11387297|FG002|NOT COMPLETED|Overall Study||1
10255448|NCT04033068|11387298|FG003|NOT COMPLETED|Overall Study||1
10255449|NCT03561597|11387308|FG000|STARTED|Overall Study|Recruited|40
10255450|NCT03561597|11387308|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21
10255451|NCT03561597|11387308|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20
10255452|NCT03561597|11387308|FG000|NOT COMPLETED|Overall Study||20
10255453|NCT03402607|11387314|FG000|STARTED|Overall Study||6
10255454|NCT03402607|11387315|FG001|STARTED|Overall Study||6
10255455|NCT03402607|11387314|FG000|COMPLETED|Overall Study||6
10255456|NCT03402607|11387315|FG001|COMPLETED|Overall Study||6
10255457|NCT03402607|11387314|FG000|NOT COMPLETED|Overall Study||0
10255458|NCT03402607|11387315|FG001|NOT COMPLETED|Overall Study||0
10255459|NCT03350984|11387323|FG000|STARTED|Overall Study||39
10255460|NCT03350984|11387324|FG001|STARTED|Overall Study||36
10255461|NCT03350984|11387323|FG000|COMPLETED|Overall Study||31
10255462|NCT03350984|11387324|FG001|COMPLETED|Overall Study||28
10255463|NCT03350984|11387323|FG000|NOT COMPLETED|Overall Study||8
10255464|NCT03350984|11387324|FG001|NOT COMPLETED|Overall Study||8
10255465|NCT03277261|11387332|FG000|STARTED|Overall Study||274
10255466|NCT03277261|11387333|FG001|STARTED|Overall Study||275
10255467|NCT03277261|11387332|FG000|COMPLETED|Overall Study||240
10255468|NCT03277261|11387333|FG001|COMPLETED|Overall Study||252
10255469|NCT03277261|11387332|FG000|NOT COMPLETED|Overall Study||34
10255470|NCT03277261|11387333|FG001|NOT COMPLETED|Overall Study||23
10255471|NCT03277248|11387342|FG000|STARTED|Overall Study||272
10255472|NCT03277248|11387343|FG001|STARTED|Overall Study||273
10255473|NCT03277248|11387342|FG000|COMPLETED|Overall Study||254
10255474|NCT03277248|11387343|FG001|COMPLETED|Overall Study||239
10255475|NCT03277248|11387342|FG000|NOT COMPLETED|Overall Study||18
10255476|NCT03277248|11387343|FG001|NOT COMPLETED|Overall Study||34
10255477|NCT03179462|11387352|FG000|STARTED|Overall Study||9
10255478|NCT03179462|11387353|FG001|STARTED|Overall Study||10
10255479|NCT03179462|11387354|FG002|STARTED|Overall Study||8
10255480|NCT03179462|11387352|FG000|COMPLETED|Overall Study||8
10255481|NCT03179462|11387353|FG001|COMPLETED|Overall Study||8
10255482|NCT03179462|11387354|FG002|COMPLETED|Overall Study||8
10255483|NCT03179462|11387352|FG000|NOT COMPLETED|Overall Study||1
10255484|NCT03179462|11387353|FG001|NOT COMPLETED|Overall Study||2
10255485|NCT03179462|11387354|FG002|NOT COMPLETED|Overall Study||0
9834416|NCT00785512|10945435|FG001|NOT COMPLETED|Overall Study||4
9834417|NCT00785538|10945446|FG000|STARTED|PK Period||7
9834418|NCT00785538|10945447|FG001|STARTED|PK Period||1
9834419|NCT00785538|10945448|FG002|STARTED|PK Period||1
9834420|NCT00785538|10945449|FG003|STARTED|PK Period||0
9834421|NCT00785538|10945446|FG000|COMPLETED|PK Period||7
9834422|NCT00785538|10945447|FG001|COMPLETED|PK Period||1
9834423|NCT00785538|10945448|FG002|COMPLETED|PK Period||1
9834424|NCT00785538|10945449|FG003|COMPLETED|PK Period||0
9834425|NCT00785538|10945446|FG000|NOT COMPLETED|PK Period||0
9834426|NCT00785538|10945447|FG001|NOT COMPLETED|PK Period||0
9834427|NCT00785538|10945448|FG002|NOT COMPLETED|PK Period||0
9834428|NCT00785538|10945449|FG003|NOT COMPLETED|PK Period||0
9834429|NCT00785538|10945446|FG000|STARTED|Treatment Period||7
9834430|NCT00785538|10945447|FG001|STARTED|Treatment Period||9
9834431|NCT00785538|10945448|FG002|STARTED|Treatment Period||6
9834432|NCT00785538|10945449|FG003|STARTED|Treatment Period||2
9834433|NCT00785538|10945446|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7
9834434|NCT00785538|10945447|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9
9834435|NCT00785538|10945448|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6
9957575|NCT01451632|11076863|FG000|COMPLETED|Overall Study||8
9957576|NCT01451632|11076864|FG001|COMPLETED|Overall Study||4
9957577|NCT01451632|11076865|FG002|COMPLETED|Overall Study||3
9957578|NCT01451632|11076866|FG003|COMPLETED|Overall Study||3
9957579|NCT01451632|11076867|FG004|COMPLETED|Overall Study||4
9957580|NCT01451632|11076868|FG005|COMPLETED|Overall Study||4
9957581|NCT01451632|11076869|FG006|COMPLETED|Overall Study||8
9957582|NCT01451632|11076870|FG007|COMPLETED|Overall Study||6
9957583|NCT01451632|11076871|FG008|COMPLETED|Overall Study||4
9957584|NCT01451632|11076872|FG009|COMPLETED|Overall Study||4
9957585|NCT01451632|11076863|FG000|NOT COMPLETED|Overall Study||0
9957586|NCT01451632|11076864|FG001|NOT COMPLETED|Overall Study||0
9957587|NCT01451632|11076865|FG002|NOT COMPLETED|Overall Study||0
9957588|NCT01451632|11076866|FG003|NOT COMPLETED|Overall Study||0
9957589|NCT01451632|11076867|FG004|NOT COMPLETED|Overall Study||0
9957590|NCT01451632|11076868|FG005|NOT COMPLETED|Overall Study||0
9957591|NCT01451632|11076869|FG006|NOT COMPLETED|Overall Study||0
9957592|NCT01451632|11076870|FG007|NOT COMPLETED|Overall Study||0
9957593|NCT01451632|11076871|FG008|NOT COMPLETED|Overall Study||0
9957594|NCT01451632|11076872|FG009|NOT COMPLETED|Overall Study||0
9957595|NCT01451645|11076899|FG000|STARTED|Overall Study||41
9957596|NCT01451645|11076900|FG001|STARTED|Overall Study||41
9957597|NCT01451645|11076899|FG000|COMPLETED|Overall Study||32
9957598|NCT01451645|11076900|FG001|COMPLETED|Overall Study||33
9957599|NCT01451645|11076899|FG000|NOT COMPLETED|Overall Study||9
9957600|NCT01451645|11076900|FG001|NOT COMPLETED|Overall Study||8
9957601|NCT01451749|11076908|FG000|STARTED|Overall Study||216
9957602|NCT01451749|11076909|FG001|STARTED|Overall Study||108
9957603|NCT01451749|11076908|FG000|COMPLETED|Overall Study||184
9957604|NCT01451749|11076909|FG001|COMPLETED|Overall Study||94
9957605|NCT01451749|11076908|FG000|NOT COMPLETED|Overall Study||32
9957606|NCT01451749|11076909|FG001|NOT COMPLETED|Overall Study||14
9957607|NCT01451762|11076920|FG000|STARTED|Overall Study||30
9957608|NCT01451762|11076921|FG001|STARTED|Overall Study||30
9957609|NCT01451762|11076922|FG002|STARTED|Overall Study||30
9957610|NCT01451762|11076920|FG000|COMPLETED|Overall Study||27
9957611|NCT01451762|11076921|FG001|COMPLETED|Overall Study||24
9957612|NCT01451762|11076922|FG002|COMPLETED|Overall Study||24
9957613|NCT01451762|11076920|FG000|NOT COMPLETED|Overall Study||3
9957614|NCT01451762|11076921|FG001|NOT COMPLETED|Overall Study||6
9957615|NCT01451762|11076922|FG002|NOT COMPLETED|Overall Study||6
9957616|NCT01451775|11076930|FG000|STARTED|Overall Study||3
9957617|NCT01451775|11076931|FG001|STARTED|Overall Study||3
9957618|NCT01451775|11076932|FG002|STARTED|Overall Study||3
9957619|NCT01451775|11076933|FG003|STARTED|Overall Study||3
9957620|NCT01451775|11076934|FG004|STARTED|Overall Study||3
9957621|NCT01451775|11076935|FG005|STARTED|Overall Study||3
9957622|NCT01451775|11076930|FG000|COMPLETED|Overall Study||3
9957623|NCT01451775|11076931|FG001|COMPLETED|Overall Study||3
9957624|NCT01451775|11076932|FG002|COMPLETED|Overall Study||3
9957625|NCT01451775|11076933|FG003|COMPLETED|Overall Study||3
9957626|NCT01451775|11076934|FG004|COMPLETED|Overall Study||3
9957627|NCT01451775|11076935|FG005|COMPLETED|Overall Study||3
9957628|NCT01451775|11076930|FG000|NOT COMPLETED|Overall Study||0
9957629|NCT01451775|11076931|FG001|NOT COMPLETED|Overall Study||0
9957630|NCT01451775|11076932|FG002|NOT COMPLETED|Overall Study||0
9834436|NCT00785538|10945449|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2
9834437|NCT00785538|10945446|FG000|COMPLETED|Treatment Period||6
9834438|NCT00785538|10945447|FG001|COMPLETED|Treatment Period||7
9834439|NCT00785538|10945448|FG002|COMPLETED|Treatment Period||4
10255486|NCT03099707|11387364|FG000|STARTED|Overall Study||43
10255487|NCT03099707|11387365|FG001|STARTED|Overall Study||41
10255488|NCT03099707|11387364|FG000|COMPLETED|Overall Study||43
10255489|NCT03099707|11387365|FG001|COMPLETED|Overall Study||37
10255490|NCT03099707|11387364|FG000|NOT COMPLETED|Overall Study||0
10255491|NCT03099707|11387365|FG001|NOT COMPLETED|Overall Study||4
10255492|NCT03064763|11387371|FG000|STARTED|Overall Study||18
10255493|NCT03064763|11387371|FG000|Received Treatment|Overall Study||18
10255494|NCT03064763|11387371|FG000|COMPLETED|Overall Study||0
10255495|NCT03064763|11387371|FG000|NOT COMPLETED|Overall Study||18
10255496|NCT03036267|11387375|FG000|STARTED|Overall Study||46
10255497|NCT03036267|11387375|FG000|COMPLETED|Overall Study||46
10255498|NCT03036267|11387375|FG000|NOT COMPLETED|Overall Study||0
10255499|NCT02941146|11387379|FG000|STARTED|Overall Study||15
10255500|NCT02941146|11387379|FG000|COMPLETED|Overall Study||15
10255501|NCT02941146|11387379|FG000|NOT COMPLETED|Overall Study||0
10255502|NCT02922985|11387385|FG000|STARTED|Overall Study||60
10255503|NCT02922985|11387386|FG001|STARTED|Overall Study||60
10255504|NCT02922985|11387385|FG000|COMPLETED|Overall Study||60
10255505|NCT02922985|11387386|FG001|COMPLETED|Overall Study||60
10255506|NCT02922985|11387385|FG000|NOT COMPLETED|Overall Study||0
10255507|NCT02922985|11387386|FG001|NOT COMPLETED|Overall Study||0
10255508|NCT02906033|11387396|FG000|STARTED|Baseline||231
10255509|NCT02906033|11387397|FG001|STARTED|Baseline||222
10255510|NCT02906033|11387396|FG000|15 D at Baseline|Baseline||211
10255511|NCT02906033|11387397|FG001|15 D at Baseline|Baseline||189
10255512|NCT02906033|11387396|FG000|STATE at Baseline|Baseline||199
10255513|NCT02906033|11387397|FG001|STATE at Baseline|Baseline||190
10255514|NCT02906033|11387396|FG000|TRAIT at Baseline|Baseline||194
9719272|NCT00040664|10818784|FG002|STARTED|Overall Study||17
9719273|NCT00040664|10818785|FG003|STARTED|Overall Study||35
9719274|NCT00040664|10818782|FG000|COMPLETED|Overall Study||16
9719275|NCT00040664|10818783|FG001|COMPLETED|Overall Study||4
9719276|NCT00040664|10818784|FG002|COMPLETED|Overall Study||4
9719277|NCT00040664|10818785|FG003|COMPLETED|Overall Study||8
9719278|NCT00040664|10818782|FG000|NOT COMPLETED|Overall Study||53
9719279|NCT00040664|10818783|FG001|NOT COMPLETED|Overall Study||13
9719280|NCT00040664|10818784|FG002|NOT COMPLETED|Overall Study||13
9719281|NCT00040664|10818785|FG003|NOT COMPLETED|Overall Study||27
9719282|NCT00040742|10818807|FG000|STARTED|Overall Study||188
9719283|NCT00040742|10818808|FG001|STARTED|Overall Study||183
9719284|NCT00040742|10818809|FG002|STARTED|Overall Study||187
9719285|NCT00040742|10818810|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
9719286|NCT00040742|10818807|FG000|COMPLETED|Overall Study||149
9719287|NCT00040742|10818808|FG001|COMPLETED|Overall Study||134
9719288|NCT00040742|10818809|FG002|COMPLETED|Overall Study||141
9719289|NCT00040742|10818810|FG003|COMPLETED|Overall Study||152
9719290|NCT00040742|10818807|FG000|NOT COMPLETED|Overall Study||39
9719291|NCT00040742|10818808|FG001|NOT COMPLETED|Overall Study||49
9719292|NCT00040742|10818809|FG002|NOT COMPLETED|Overall Study||46
9719293|NCT00040742|10818810|FG003|NOT COMPLETED|Overall Study||34
9719294|NCT00040846|10818826|FG000|STARTED|Overall Study||60
9719295|NCT00040846|10818827|FG001|STARTED|Overall Study||0
9719296|NCT00040846|10818828|FG002|STARTED|Overall Study||0
9719297|NCT00040846|10818829|FG003|STARTED|Overall Study||0
9719298|NCT00040846|10818830|FG004|STARTED|Overall Study||0
9719299|NCT00040846|10818831|FG005|STARTED|Overall Study||0
9719300|NCT00040846|10818826|FG000|COMPLETED|Overall Study||60
9719301|NCT00040846|10818827|FG001|COMPLETED|Overall Study||0
9719302|NCT00040846|10818828|FG002|COMPLETED|Overall Study||0
9719303|NCT00040846|10818829|FG003|COMPLETED|Overall Study||0
9719304|NCT00040846|10818830|FG004|COMPLETED|Overall Study||0
9719305|NCT00040846|10818831|FG005|COMPLETED|Overall Study||0
9719306|NCT00040846|10818826|FG000|NOT COMPLETED|Overall Study||0
9719307|NCT00040846|10818827|FG001|NOT COMPLETED|Overall Study||0
9719308|NCT00040846|10818828|FG002|NOT COMPLETED|Overall Study||0
9719309|NCT00040846|10818829|FG003|NOT COMPLETED|Overall Study||0
9719310|NCT00040846|10818830|FG004|NOT COMPLETED|Overall Study||0
9719311|NCT00040846|10818831|FG005|NOT COMPLETED|Overall Study||0
9719312|NCT00040937|10818845|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
9719313|NCT00040937|10818845|FG000|COMPLETED|Induction/PBSC Mobilization||110
9719314|NCT00040937|10818845|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37
9957631|NCT01451775|11076933|FG003|NOT COMPLETED|Overall Study||0
10255515|NCT02906033|11387397|FG001|TRAIT at Baseline|Baseline||189
10255516|NCT02906033|11387396|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194
10255517|NCT02906033|11387397|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189
10255518|NCT02906033|11387396|FG000|NOT COMPLETED|Baseline||37
10255519|NCT02906033|11387397|FG001|NOT COMPLETED|Baseline||33
10255520|NCT02906033|11387396|FG000|STARTED|Follow-up||194
10255521|NCT02906033|11387397|FG001|STARTED|Follow-up||189
10255522|NCT02906033|11387396|FG000|15 D at Follow-up|Follow-up||151
10255523|NCT02906033|11387397|FG001|15 D at Follow-up|Follow-up||135
10255524|NCT02906033|11387396|FG000|STATE at Follow-up|Follow-up||154
10255525|NCT02906033|11387397|FG001|STATE at Follow-up|Follow-up||135
10255526|NCT02906033|11387396|FG000|TRAIT at Follow-up|Follow-up||148
10255527|NCT02906033|11387397|FG001|TRAIT at Follow-up|Follow-up||127
10020682|NCT01838226|11144016|FG001|NOT COMPLETED|Overall Study||71
10020683|NCT01838304|11144024|FG000|STARTED|Overall Study||20
10020684|NCT01838304|11144025|FG001|STARTED|Overall Study||20
10020685|NCT01838304|11144024|FG000|COMPLETED|Overall Study||19
10020686|NCT01838304|11144025|FG001|COMPLETED|Overall Study||20
10255528|NCT02906033|11387396|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148
10255529|NCT02906033|11387397|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127
10255530|NCT02906033|11387396|FG000|NOT COMPLETED|Follow-up||46
10255531|NCT02906033|11387397|FG001|NOT COMPLETED|Follow-up||62
10255532|NCT02837783|11387405|FG000|STARTED|Overall Study||9
10255533|NCT02837783|11387406|FG001|STARTED|Overall Study||11
10255534|NCT02837783|11387405|FG000|Received >= 1 Dose of Study Drug|Overall Study||9
10255535|NCT02837783|11387406|FG001|Received >= 1 Dose of Study Drug|Overall Study||10
10255536|NCT02837783|11387405|FG000|COMPLETED|Overall Study||7
10255537|NCT02837783|11387406|FG001|COMPLETED|Overall Study||9
10255538|NCT02837783|11387405|FG000|NOT COMPLETED|Overall Study||2
10255539|NCT02837783|11387406|FG001|NOT COMPLETED|Overall Study||2
10255540|NCT02786537|11387418|FG000|STARTED|As Randomized||56
10255541|NCT02786537|11387419|FG001|STARTED|As Randomized||644
10255542|NCT02786537|11387420|FG002|STARTED|As Randomized||15
10255543|NCT02786537|11387421|FG003|STARTED|As Randomized||413
10255544|NCT02786537|11387422|FG004|STARTED|As Randomized||99
9834440|NCT00785538|10945449|FG003|COMPLETED|Treatment Period||1
9834441|NCT00785538|10945446|FG000|NOT COMPLETED|Treatment Period||1
9834442|NCT00785538|10945447|FG001|NOT COMPLETED|Treatment Period||2
10255545|NCT02786537|11387423|FG005|STARTED|As Randomized||48
10255546|NCT02786537|11387418|FG000|COMPLETED|As Randomized||50
10255547|NCT02786537|11387419|FG001|COMPLETED|As Randomized||582
10255548|NCT02786537|11387420|FG002|COMPLETED|As Randomized||15
10255549|NCT02786537|11387421|FG003|COMPLETED|As Randomized||378
10255550|NCT02786537|11387422|FG004|COMPLETED|As Randomized||87
9834443|NCT00785538|10945448|FG002|NOT COMPLETED|Treatment Period||2
9834444|NCT00785538|10945449|FG003|NOT COMPLETED|Treatment Period||1
9834445|NCT00785577|10945465|FG000|STARTED|Study Period 2: Therapy Phase||89
9834446|NCT00785577|10945466|FG001|STARTED|Study Period 2: Therapy Phase||45
9834447|NCT00785577|10945467|FG002|STARTED|Study Period 2: Therapy Phase||43
9834448|NCT00785577|10945468|FG003|STARTED|Study Period 2: Therapy Phase||49
10255551|NCT02786537|11387423|FG005|COMPLETED|As Randomized||41
10255552|NCT02786537|11387418|FG000|NOT COMPLETED|As Randomized||6
10255553|NCT02786537|11387419|FG001|NOT COMPLETED|As Randomized||62
10255554|NCT02786537|11387420|FG002|NOT COMPLETED|As Randomized||0
10255555|NCT02786537|11387421|FG003|NOT COMPLETED|As Randomized||35
10255556|NCT02786537|11387422|FG004|NOT COMPLETED|As Randomized||12
10255557|NCT02786537|11387423|FG005|NOT COMPLETED|As Randomized||7
10255558|NCT02786537|11387418|FG000|STARTED|As Treated||56
10255559|NCT02786537|11387419|FG001|STARTED|As Treated||664
9834449|NCT00785577|10945469|FG004|STARTED|Study Period 2: Therapy Phase||47
9834450|NCT00785577|10945465|FG000|COMPLETED|Study Period 2: Therapy Phase||78
9834451|NCT00785577|10945466|FG001|COMPLETED|Study Period 2: Therapy Phase||36
9834452|NCT00785577|10945467|FG002|COMPLETED|Study Period 2: Therapy Phase||25
10255560|NCT02786537|11387420|FG002|STARTED|As Treated||15
10255561|NCT02786537|11387421|FG003|STARTED|As Treated||394
10255562|NCT02786537|11387422|FG004|STARTED|As Treated||99
10255563|NCT02786537|11387423|FG005|STARTED|As Treated||47
10255564|NCT02786537|11387418|FG000|COMPLETED|As Treated||50
10255565|NCT02786537|11387419|FG001|COMPLETED|As Treated||602
10255566|NCT02786537|11387420|FG002|COMPLETED|As Treated||15
10255567|NCT02786537|11387421|FG003|COMPLETED|As Treated||359
10255568|NCT02786537|11387422|FG004|COMPLETED|As Treated||87
10255569|NCT02786537|11387423|FG005|COMPLETED|As Treated||40
10255570|NCT02786537|11387418|FG000|NOT COMPLETED|As Treated||6
10255571|NCT02786537|11387419|FG001|NOT COMPLETED|As Treated||62
10255572|NCT02786537|11387420|FG002|NOT COMPLETED|As Treated||0
9834453|NCT00785577|10945468|FG003|COMPLETED|Study Period 2: Therapy Phase||36
9834454|NCT00785577|10945469|FG004|COMPLETED|Study Period 2: Therapy Phase||27
9834455|NCT00785577|10945465|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11
9834456|NCT00785577|10945466|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9
9834457|NCT00785577|10945467|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18
9834458|NCT00785577|10945468|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13
9834459|NCT00785577|10945469|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20
9834460|NCT00785577|10945465|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78
9834461|NCT00785577|10945466|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36
9834462|NCT00785577|10945467|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25
9834463|NCT00785577|10945468|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36
9834464|NCT00785577|10945469|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27
9834465|NCT00785577|10945465|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78
9834466|NCT00785577|10945466|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36
9834467|NCT00785577|10945467|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25
9834468|NCT00785577|10945468|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35
9834469|NCT00785577|10945469|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26
9957632|NCT01451775|11076934|FG004|NOT COMPLETED|Overall Study||0
10255573|NCT02786537|11387421|FG003|NOT COMPLETED|As Treated||35
10255574|NCT02786537|11387422|FG004|NOT COMPLETED|As Treated||12
10255575|NCT02786537|11387423|FG005|NOT COMPLETED|As Treated||7
10255576|NCT02740231|11387533|FG000|STARTED|Overall Study||41
10255577|NCT02740231|11387534|FG001|STARTED|Overall Study||41
10255578|NCT02740231|11387535|FG002|STARTED|Overall Study||41
10255579|NCT02740231|11387536|FG003|STARTED|Overall Study||41
10255580|NCT02740231|11387533|FG000|COMPLETED|Overall Study||39
10255581|NCT02740231|11387534|FG001|COMPLETED|Overall Study||35
10255582|NCT02740231|11387535|FG002|COMPLETED|Overall Study||40
10255583|NCT02740231|11387536|FG003|COMPLETED|Overall Study||33
10255584|NCT02740231|11387533|FG000|NOT COMPLETED|Overall Study||2
10255585|NCT02740231|11387534|FG001|NOT COMPLETED|Overall Study||6
10255586|NCT02740231|11387535|FG002|NOT COMPLETED|Overall Study||1
10255587|NCT02740231|11387536|FG003|NOT COMPLETED|Overall Study||8
10255588|NCT02710084|11387548|FG000|STARTED|First Phase - 12 Weeks||10
10255589|NCT02710084|11387549|FG001|STARTED|First Phase - 12 Weeks||8
10255590|NCT02710084|11387548|FG000|COMPLETED|First Phase - 12 Weeks||7
10255591|NCT02710084|11387549|FG001|COMPLETED|First Phase - 12 Weeks||7
10255592|NCT02710084|11387548|FG000|NOT COMPLETED|First Phase - 12 Weeks||3
10255593|NCT02710084|11387549|FG001|NOT COMPLETED|First Phase - 12 Weeks||1
10255594|NCT02710084|11387548|FG000|STARTED|Open Label Phase: Week 12 to 24||7
10255595|NCT02710084|11387549|FG001|STARTED|Open Label Phase: Week 12 to 24||7
10255596|NCT02710084|11387548|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7
10255597|NCT02710084|11387549|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7
10255598|NCT02710084|11387548|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
10255599|NCT02710084|11387549|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
10255600|NCT02660034|11387570|FG000|STARTED|Overall Study||12
10255601|NCT02660034|11387571|FG001|STARTED|Overall Study||12
10255602|NCT02660034|11387572|FG002|STARTED|Overall Study||6
10255603|NCT02660034|11387573|FG003|STARTED|Overall Study||13
10255604|NCT02660034|11387574|FG004|STARTED|Overall Study||6
9834470|NCT00785577|10945465|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
9834471|NCT00785577|10945466|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
9834472|NCT00785577|10945467|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
9834473|NCT00785577|10945468|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
10020687|NCT01838304|11144024|FG000|NOT COMPLETED|Overall Study||1
10020688|NCT01838304|11144025|FG001|NOT COMPLETED|Overall Study||0
10020689|NCT01838317|11144033|FG000|STARTED|Overall Study||9
10020690|NCT01838317|11144034|FG001|STARTED|Overall Study||5
10255605|NCT02660034|11387575|FG005|STARTED|Overall Study||23
9834474|NCT00785577|10945469|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
9834475|NCT00785629|10945495|FG000|STARTED|Overall Study||30
9834476|NCT00785629|10945496|FG001|STARTED|Overall Study||30
9834477|NCT00785629|10945497|FG002|STARTED|Overall Study||28
9834478|NCT00785629|10945498|FG003|STARTED|Overall Study||57
9834479|NCT00785629|10945495|FG000|COMPLETED|Overall Study|8 not completed|22
9834480|NCT00785629|10945496|FG001|COMPLETED|Overall Study|5 not completed|25
9834481|NCT00785629|10945497|FG002|COMPLETED|Overall Study|10 not completed|18
9834482|NCT00785629|10945498|FG003|COMPLETED|Overall Study|16 not completed|41
9834483|NCT00785629|10945495|FG000|NOT COMPLETED|Overall Study||8
9834484|NCT00785629|10945496|FG001|NOT COMPLETED|Overall Study||5
9834485|NCT00785629|10945497|FG002|NOT COMPLETED|Overall Study||10
9834486|NCT00785629|10945498|FG003|NOT COMPLETED|Overall Study||16
9957633|NCT01451775|11076935|FG005|NOT COMPLETED|Overall Study||0
9957634|NCT01451814|11076945|FG000|STARTED|Overall Study||35
9957635|NCT01451814|11076946|FG001|STARTED|Overall Study||31
9957636|NCT01451814|11076945|FG000|Attended a Session|Overall Study||35
9957637|NCT01451814|11076946|FG001|Attended a Session|Overall Study||31
9957638|NCT01451814|11076945|FG000|COMPLETED|Overall Study||29
9957639|NCT01451814|11076946|FG001|COMPLETED|Overall Study||26
9957640|NCT01451814|11076945|FG000|NOT COMPLETED|Overall Study||6
9957641|NCT01451814|11076946|FG001|NOT COMPLETED|Overall Study||5
9957642|NCT01451827|11076956|FG000|STARTED|Overall Study||45
9957643|NCT01451827|11076957|FG001|STARTED|Overall Study||45
9957644|NCT01451827|11076958|FG002|STARTED|Overall Study||44
9957645|NCT01451827|11076959|FG003|STARTED|Overall Study||43
9957646|NCT01451827|11076956|FG000|COMPLETED|Overall Study||42
9957647|NCT01451827|11076957|FG001|COMPLETED|Overall Study||40
9957648|NCT01451827|11076958|FG002|COMPLETED|Overall Study||42
9957649|NCT01451827|11076959|FG003|COMPLETED|Overall Study||39
9957650|NCT01451827|11076956|FG000|NOT COMPLETED|Overall Study||3
9957651|NCT01451827|11076957|FG001|NOT COMPLETED|Overall Study||5
9957652|NCT01451827|11076958|FG002|NOT COMPLETED|Overall Study||2
9957653|NCT01451827|11076959|FG003|NOT COMPLETED|Overall Study||4
9957654|NCT01451931|11076972|FG000|STARTED|Overall Study||909
9957655|NCT01451931|11076973|FG001|STARTED|Overall Study||901
9957656|NCT01451931|11076974|FG002|STARTED|Overall Study||966
9957657|NCT01451931|11076972|FG000|Baseline Data Collection|Overall Study||908
10255606|NCT02660034|11387576|FG006|STARTED|Overall Study||23
10255607|NCT02660034|11387577|FG007|STARTED|Overall Study||19
10255608|NCT02660034|11387578|FG008|STARTED|Overall Study||20
10255609|NCT02660034|11387579|FG009|STARTED|Overall Study||23
10255610|NCT02660034|11387580|FG010|STARTED|Overall Study||20
10255611|NCT02660034|11387581|FG011|STARTED|Overall Study||21
10255612|NCT02660034|11387582|FG012|STARTED|Overall Study||21
10255613|NCT02660034|11387583|FG013|STARTED|Overall Study||10
10255614|NCT02660034|11387570|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
10255615|NCT02660034|11387571|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
10255616|NCT02660034|11387572|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
10255617|NCT02660034|11387573|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13
10255618|NCT02660034|11387574|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
10255619|NCT02660034|11387575|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
9957658|NCT01451931|11076973|FG001|Baseline Data Collection|Overall Study||893
9957659|NCT01451931|11076974|FG002|Baseline Data Collection|Overall Study||958
10020691|NCT01838317|11144033|FG000|COMPLETED|Overall Study||9
10255620|NCT02660034|11387576|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
9957660|NCT01451931|11076972|FG000|6-month Follow up|Overall Study||876
9957661|NCT01451931|11076973|FG001|6-month Follow up|Overall Study||843
9957662|NCT01451931|11076974|FG002|6-month Follow up|Overall Study||923
9834487|NCT00785707|10945506|FG000|STARTED|Overall Study||31
9834488|NCT00785707|10945506|FG000|COMPLETED|Overall Study||24
9834489|NCT00785707|10945506|FG000|NOT COMPLETED|Overall Study||7
9834490|NCT00785772|10945510|FG000|STARTED|Overall Study||1
9834491|NCT00785772|10945510|FG000|COMPLETED|Overall Study||1
9834492|NCT00785772|10945510|FG000|NOT COMPLETED|Overall Study||0
9834493|NCT00785785|10945516|FG000|STARTED|Core Phase up to 36 Months||324
9834494|NCT00785785|10945517|FG001|STARTED|Core Phase up to 36 Months||320
9834495|NCT00785785|10945516|FG000|COMPLETED|Core Phase up to 36 Months||0
9834496|NCT00785785|10945517|FG001|COMPLETED|Core Phase up to 36 Months||0
9834497|NCT00785785|10945516|FG000|NOT COMPLETED|Core Phase up to 36 Months||324
9834498|NCT00785785|10945517|FG001|NOT COMPLETED|Core Phase up to 36 Months||320
9834499|NCT00785785|10945516|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39
9834500|NCT00785785|10945517|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125
9834501|NCT00785785|10945516|FG000|COMPLETED|Optional Extension Phase||0
9834502|NCT00785785|10945517|FG001|COMPLETED|Optional Extension Phase||0
9834503|NCT00785785|10945516|FG000|NOT COMPLETED|Optional Extension Phase||39
9834504|NCT00785785|10945517|FG001|NOT COMPLETED|Optional Extension Phase||125
9834505|NCT00785928|10945532|FG000|STARTED|Treatment Phase||36
9834506|NCT00785928|10945533|FG001|STARTED|Treatment Phase||30
9834507|NCT00785928|10945534|FG002|STARTED|Treatment Phase||20
9834508|NCT00785928|10945535|FG003|STARTED|Treatment Phase||15
9834509|NCT00785928|10945536|FG004|STARTED|Treatment Phase||18
9834510|NCT00785928|10945537|FG005|STARTED|Treatment Phase||13
9834511|NCT00785928|10945538|FG006|STARTED|Treatment Phase||26
9834512|NCT00785928|10945532|FG000|COMPLETED|Treatment Phase||33
9834513|NCT00785928|10945533|FG001|COMPLETED|Treatment Phase||25
9834514|NCT00785928|10945534|FG002|COMPLETED|Treatment Phase||17
9834515|NCT00785928|10945535|FG003|COMPLETED|Treatment Phase||15
9834516|NCT00785928|10945536|FG004|COMPLETED|Treatment Phase||16
9834517|NCT00785928|10945537|FG005|COMPLETED|Treatment Phase||13
9834518|NCT00785928|10945538|FG006|COMPLETED|Treatment Phase||23
9834519|NCT00785928|10945532|FG000|NOT COMPLETED|Treatment Phase||3
9834520|NCT00785928|10945533|FG001|NOT COMPLETED|Treatment Phase||5
9834521|NCT00785928|10945534|FG002|NOT COMPLETED|Treatment Phase||3
9834522|NCT00785928|10945535|FG003|NOT COMPLETED|Treatment Phase||0
9834523|NCT00785928|10945536|FG004|NOT COMPLETED|Treatment Phase||2
9834524|NCT00785928|10945537|FG005|NOT COMPLETED|Treatment Phase||0
9834525|NCT00785928|10945538|FG006|NOT COMPLETED|Treatment Phase||3
9834526|NCT00785928|10945532|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
9834527|NCT00785928|10945533|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
9834528|NCT00785928|10945534|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
10255621|NCT02660034|11387577|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19
10255622|NCT02660034|11387578|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
10255623|NCT02660034|11387579|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
9834529|NCT00785928|10945535|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
9834530|NCT00785928|10945536|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
9834531|NCT00785928|10945537|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
9834532|NCT00785928|10945538|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
9834533|NCT00785928|10945532|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7
9834534|NCT00785928|10945533|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5
9834535|NCT00785928|10945534|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4
9834536|NCT00785928|10945535|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4
9834537|NCT00785928|10945536|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4
9834538|NCT00785928|10945537|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0
9834539|NCT00785928|10945538|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9
9834540|NCT00785928|10945532|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
9834541|NCT00785928|10945533|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
9834542|NCT00785928|10945534|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
9834543|NCT00785928|10945535|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
10020692|NCT01838317|11144034|FG001|COMPLETED|Overall Study||5
10020693|NCT01838317|11144033|FG000|NOT COMPLETED|Overall Study||0
10020694|NCT01838317|11144034|FG001|NOT COMPLETED|Overall Study||0
10020695|NCT01838447|11144042|FG000|STARTED|Overall Study||22
10020696|NCT01838447|11144043|FG001|STARTED|Overall Study||24
9834544|NCT00785928|10945536|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
9834545|NCT00785928|10945537|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
9834546|NCT00785928|10945538|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
9834547|NCT00785980|10945576|FG000|STARTED|Quinine Sulfate Alone||24
9834548|NCT00785980|10945576|FG000|COMPLETED|Quinine Sulfate Alone||24
9834549|NCT00785980|10945576|FG000|NOT COMPLETED|Quinine Sulfate Alone||0
9834550|NCT00785980|10945576|FG000|STARTED|7 Day Washout Period||24
9834551|NCT00785980|10945576|FG000|COMPLETED|7 Day Washout Period||21
9834552|NCT00785980|10945576|FG000|NOT COMPLETED|7 Day Washout Period||3
10020697|NCT01838447|11144042|FG000|COMPLETED|Overall Study||20
10020698|NCT01838447|11144043|FG001|COMPLETED|Overall Study||21
9834553|NCT00785980|10945576|FG000|STARTED|Ciprofloxacin Alone||21
9834554|NCT00785980|10945576|FG000|COMPLETED|Ciprofloxacin Alone||21
10255624|NCT02660034|11387580|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
10255625|NCT02660034|11387581|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
10255626|NCT02660034|11387582|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
10255627|NCT02660034|11387583|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10
10255628|NCT02660034|11387570|FG000|COMPLETED|Overall Study||0
10255629|NCT02660034|11387571|FG001|COMPLETED|Overall Study||0
10255630|NCT02660034|11387572|FG002|COMPLETED|Overall Study||0
10255631|NCT02660034|11387573|FG003|COMPLETED|Overall Study||0
10255632|NCT02660034|11387574|FG004|COMPLETED|Overall Study||0
10255633|NCT02660034|11387575|FG005|COMPLETED|Overall Study||0
10255634|NCT02660034|11387576|FG006|COMPLETED|Overall Study||0
10255635|NCT02660034|11387577|FG007|COMPLETED|Overall Study||0
10255636|NCT02660034|11387578|FG008|COMPLETED|Overall Study||0
10255637|NCT02660034|11387579|FG009|COMPLETED|Overall Study||0
10255638|NCT02660034|11387580|FG010|COMPLETED|Overall Study||0
10255639|NCT02660034|11387581|FG011|COMPLETED|Overall Study||0
9834555|NCT00785980|10945576|FG000|NOT COMPLETED|Ciprofloxacin Alone||0
9834556|NCT00785980|10945576|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21
9834557|NCT00785980|10945576|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
10255640|NCT02660034|11387582|FG012|COMPLETED|Overall Study||0
10255641|NCT02660034|11387583|FG013|COMPLETED|Overall Study||0
10255642|NCT02660034|11387570|FG000|NOT COMPLETED|Overall Study||12
10255643|NCT02660034|11387571|FG001|NOT COMPLETED|Overall Study||12
10255644|NCT02660034|11387572|FG002|NOT COMPLETED|Overall Study||6
10255645|NCT02660034|11387573|FG003|NOT COMPLETED|Overall Study||13
10255646|NCT02660034|11387574|FG004|NOT COMPLETED|Overall Study||6
10255647|NCT02660034|11387575|FG005|NOT COMPLETED|Overall Study||23
10255648|NCT02660034|11387576|FG006|NOT COMPLETED|Overall Study||23
10255649|NCT02660034|11387577|FG007|NOT COMPLETED|Overall Study||19
10255650|NCT02660034|11387578|FG008|NOT COMPLETED|Overall Study||20
10255651|NCT02660034|11387579|FG009|NOT COMPLETED|Overall Study||23
10255652|NCT02660034|11387580|FG010|NOT COMPLETED|Overall Study||20
10255653|NCT02660034|11387581|FG011|NOT COMPLETED|Overall Study||21
10255654|NCT02660034|11387582|FG012|NOT COMPLETED|Overall Study||21
10255655|NCT02660034|11387583|FG013|NOT COMPLETED|Overall Study||10
10255656|NCT02640625|11387617|FG000|STARTED|Overall Study||20
10255657|NCT02640625|11387617|FG000|COMPLETED|Overall Study||19
10255658|NCT02640625|11387617|FG000|NOT COMPLETED|Overall Study||1
10255659|NCT02561962|11387631|FG000|STARTED|Overall Study||3
10255660|NCT02561962|11387632|FG001|STARTED|Overall Study||3
10255661|NCT02561962|11387633|FG002|STARTED|Overall Study||3
10255662|NCT02561962|11387634|FG003|STARTED|Overall Study||3
10255663|NCT02561962|11387635|FG004|STARTED|Overall Study||6
10255664|NCT02561962|11387636|FG005|STARTED|Overall Study||6
10255665|NCT02561962|11387637|FG006|STARTED|Overall Study||5
10255666|NCT02561962|11387638|FG007|STARTED|Overall Study||11
10255667|NCT02561962|11387639|FG008|STARTED|Overall Study||2
10255668|NCT02561962|11387631|FG000|Received Treatment|Overall Study||3
10255669|NCT02561962|11387632|FG001|Received Treatment|Overall Study||3
10255670|NCT02561962|11387633|FG002|Received Treatment|Overall Study||3
10255671|NCT02561962|11387634|FG003|Received Treatment|Overall Study||3
10255672|NCT02561962|11387635|FG004|Received Treatment|Overall Study||6
9834558|NCT00785980|10945576|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
9834559|NCT00786019|10945585|FG000|STARTED|Overall Study||20
9834560|NCT00786019|10945586|FG001|STARTED|Overall Study||27
9834561|NCT00786019|10945585|FG000|COMPLETED|Overall Study||15
9834562|NCT00786019|10945586|FG001|COMPLETED|Overall Study||17
9834563|NCT00786019|10945585|FG000|NOT COMPLETED|Overall Study||5
9834564|NCT00786019|10945586|FG001|NOT COMPLETED|Overall Study||10
9834565|NCT00786032|10945594|FG000|STARTED|Overall Study||27
9834566|NCT00786032|10945594|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
9834567|NCT00786032|10945594|FG000|COMPLETED|Overall Study||3
9834568|NCT00786032|10945594|FG000|NOT COMPLETED|Overall Study||24
9834569|NCT00786188|10945602|FG000|STARTED|Overall Study||50
9834570|NCT00786188|10945603|FG001|STARTED|Overall Study||52
9834571|NCT00786188|10945602|FG000|COMPLETED|Overall Study||45
9957663|NCT01451931|11076972|FG000|COMPLETED|Overall Study||876
9957664|NCT01451931|11076973|FG001|COMPLETED|Overall Study||843
9957665|NCT01451931|11076974|FG002|COMPLETED|Overall Study||923
9957666|NCT01451931|11076972|FG000|NOT COMPLETED|Overall Study||33
10255673|NCT02561962|11387636|FG005|Received Treatment|Overall Study||6
10255674|NCT02561962|11387637|FG006|Received Treatment|Overall Study||5
10255675|NCT02561962|11387638|FG007|Received Treatment|Overall Study||9
10255676|NCT02561962|11387639|FG008|Received Treatment|Overall Study||2
10255677|NCT02561962|11387631|FG000|COMPLETED|Overall Study||1
10255678|NCT02561962|11387632|FG001|COMPLETED|Overall Study||3
10255679|NCT02561962|11387633|FG002|COMPLETED|Overall Study||3
10255680|NCT02561962|11387634|FG003|COMPLETED|Overall Study||2
10255681|NCT02561962|11387635|FG004|COMPLETED|Overall Study||4
10255682|NCT02561962|11387636|FG005|COMPLETED|Overall Study||2
10255683|NCT02561962|11387637|FG006|COMPLETED|Overall Study||3
10255684|NCT02561962|11387638|FG007|COMPLETED|Overall Study||3
10255685|NCT02561962|11387639|FG008|COMPLETED|Overall Study||1
9957667|NCT01451931|11076973|FG001|NOT COMPLETED|Overall Study||58
9957668|NCT01451931|11076974|FG002|NOT COMPLETED|Overall Study||43
10255686|NCT02561962|11387631|FG000|NOT COMPLETED|Overall Study||2
10255687|NCT02561962|11387632|FG001|NOT COMPLETED|Overall Study||0
10255688|NCT02561962|11387633|FG002|NOT COMPLETED|Overall Study||0
9834572|NCT00786188|10945603|FG001|COMPLETED|Overall Study||51
9834573|NCT00786188|10945602|FG000|NOT COMPLETED|Overall Study||5
9834574|NCT00786188|10945603|FG001|NOT COMPLETED|Overall Study||1
9834575|NCT00786409|10945611|FG000|STARTED|Overall Study||27
9834576|NCT00786409|10945611|FG000|COMPLETED|Overall Study||20
9834577|NCT00786409|10945611|FG000|NOT COMPLETED|Overall Study||7
9834578|NCT00786422|10945615|FG000|STARTED|Rivaroxaban Treatment||25
9834579|NCT00786422|10945615|FG000|COMPLETED|Rivaroxaban Treatment||14
9834580|NCT00786422|10945615|FG000|NOT COMPLETED|Rivaroxaban Treatment||11
9834581|NCT00786422|10945615|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
9834582|NCT00786422|10945615|FG000|COMPLETED|Follow-up Period||17
9834583|NCT00786422|10945615|FG000|NOT COMPLETED|Follow-up Period||3
9834584|NCT00786474|10945623|FG000|STARTED|Overall Study||950
9834585|NCT00786474|10945624|FG001|STARTED|Overall Study||934
9834586|NCT00786474|10945623|FG000|COMPLETED|Overall Study||913
9834587|NCT00786474|10945624|FG001|COMPLETED|Overall Study||891
9834588|NCT00786474|10945623|FG000|NOT COMPLETED|Overall Study||37
9834589|NCT00786474|10945624|FG001|NOT COMPLETED|Overall Study||43
9834590|NCT00786487|10945634|FG000|STARTED|Overall Study||10
9834591|NCT00786487|10945635|FG001|STARTED|Overall Study||7
9834592|NCT00786487|10945636|FG002|STARTED|Overall Study||9
9834593|NCT00786487|10945637|FG003|STARTED|Overall Study||7
9834594|NCT00786487|10945634|FG000|COMPLETED|Overall Study||10
9834595|NCT00786487|10945635|FG001|COMPLETED|Overall Study||7
9834596|NCT00786487|10945636|FG002|COMPLETED|Overall Study||9
9834597|NCT00786487|10945637|FG003|COMPLETED|Overall Study||7
9834598|NCT00786487|10945634|FG000|NOT COMPLETED|Overall Study||0
9834599|NCT00786487|10945635|FG001|NOT COMPLETED|Overall Study||0
9834600|NCT00786487|10945636|FG002|NOT COMPLETED|Overall Study||0
9834601|NCT00786487|10945637|FG003|NOT COMPLETED|Overall Study||0
9834602|NCT00786565|10945647|FG000|STARTED|Enrollment Prior to Surgery||75
9834603|NCT00786565|10945647|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
9834604|NCT00786565|10945647|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6
9834605|NCT00786565|10945647|FG000|STARTED|Post Surgery||69
9834606|NCT00786565|10945647|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
9834607|NCT00786565|10945647|FG000|NOT COMPLETED|Post Surgery||2
10255689|NCT02561962|11387634|FG003|NOT COMPLETED|Overall Study||1
10255690|NCT02561962|11387635|FG004|NOT COMPLETED|Overall Study||2
10255691|NCT02561962|11387636|FG005|NOT COMPLETED|Overall Study||4
10255692|NCT02561962|11387637|FG006|NOT COMPLETED|Overall Study||2
10255693|NCT02561962|11387638|FG007|NOT COMPLETED|Overall Study||8
10255694|NCT02561962|11387639|FG008|NOT COMPLETED|Overall Study||1
10255695|NCT02500589|11387661|FG000|STARTED|Overall Study||175
10255696|NCT02500589|11387662|FG001|STARTED|Overall Study||175
10255697|NCT02500589|11387661|FG000|COMPLETED|Overall Study||147
10255698|NCT02500589|11387662|FG001|COMPLETED|Overall Study||143
10255699|NCT02500589|11387661|FG000|NOT COMPLETED|Overall Study||28
10255700|NCT02500589|11387662|FG001|NOT COMPLETED|Overall Study||32
10255701|NCT02474329|11387672|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304
10255702|NCT02474329|11387672|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291
10255703|NCT02474329|11387672|FG000|NOT COMPLETED|Overall Study||13
10255704|NCT01976273|11387679|FG000|STARTED|Overall Study||10
10255705|NCT01976273|11387680|FG001|STARTED|Overall Study||10
10255706|NCT01976273|11387679|FG000|COMPLETED|Overall Study||9
10255707|NCT01976273|11387680|FG001|COMPLETED|Overall Study||9
9834608|NCT00786643|10945655|FG000|STARTED|Overall Study||20
9834609|NCT00786643|10945656|FG001|STARTED|Overall Study||28
9834610|NCT00786643|10945655|FG000|COMPLETED|Overall Study||20
9834611|NCT00786643|10945656|FG001|COMPLETED|Overall Study||28
9834612|NCT00786643|10945655|FG000|NOT COMPLETED|Overall Study||0
9834613|NCT00786643|10945656|FG001|NOT COMPLETED|Overall Study||0
9834614|NCT00786799|10945664|FG000|STARTED|Overall Study||14
9834615|NCT00786799|10945665|FG001|STARTED|Overall Study||13
9834616|NCT00786799|10945664|FG000|COMPLETED|Overall Study||13
9834617|NCT00786799|10945665|FG001|COMPLETED|Overall Study||12
10255708|NCT01976273|11387679|FG000|NOT COMPLETED|Overall Study||1
10255709|NCT01976273|11387680|FG001|NOT COMPLETED|Overall Study||1
10255710|NCT01722929|11387686|FG000|STARTED|Overall Study||4
10255711|NCT01722929|11387686|FG000|COMPLETED|Overall Study||4
10255712|NCT01722929|11387686|FG000|NOT COMPLETED|Overall Study||0
9834618|NCT00786799|10945664|FG000|NOT COMPLETED|Overall Study||1
9834619|NCT00786799|10945665|FG001|NOT COMPLETED|Overall Study||1
9834620|NCT00786825|10945678|FG000|STARTED|Overall Study||5
9834621|NCT00786825|10945679|FG001|STARTED|Overall Study||5
9834622|NCT00786825|10945678|FG000|COMPLETED|Overall Study||5
9834623|NCT00786825|10945679|FG001|COMPLETED|Overall Study||5
9834624|NCT00786825|10945678|FG000|NOT COMPLETED|Overall Study||0
9834625|NCT00786825|10945679|FG001|NOT COMPLETED|Overall Study||0
9834626|NCT00786838|10945685|FG000|STARTED|Overall Study||75
9834627|NCT00786838|10945685|FG000|COMPLETED|Overall Study||26
9834628|NCT00786838|10945685|FG000|NOT COMPLETED|Overall Study||49
9834629|NCT00786864|10945696|FG000|STARTED|Overall Study||39
9834630|NCT00786864|10945697|FG001|STARTED|Overall Study||33
9834631|NCT00786864|10945696|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
9834632|NCT00786864|10945697|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
9834633|NCT00786864|10945696|FG000|NOT COMPLETED|Overall Study||1
9834634|NCT00786864|10945697|FG001|NOT COMPLETED|Overall Study||1
9834635|NCT00786916|10945706|FG000|STARTED|Overall Study||39
9834636|NCT00786916|10945707|FG001|STARTED|Overall Study||36
9834637|NCT00786916|10945708|FG002|STARTED|Overall Study||34
9834638|NCT00786916|10945706|FG000|COMPLETED|Overall Study||39
9834639|NCT00786916|10945707|FG001|COMPLETED|Overall Study||36
9834640|NCT00786916|10945708|FG002|COMPLETED|Overall Study||34
9834641|NCT00786916|10945706|FG000|NOT COMPLETED|Overall Study||0
9834642|NCT00786916|10945707|FG001|NOT COMPLETED|Overall Study||0
9834643|NCT00786916|10945708|FG002|NOT COMPLETED|Overall Study||0
9834644|NCT00786994|10945720|FG000|STARTED|Overall Study||57
9834645|NCT00786994|10945721|FG001|STARTED|Overall Study||54
9834646|NCT00786994|10945722|FG002|STARTED|Overall Study||26
9834647|NCT00786994|10945723|FG003|STARTED|Overall Study||28
9834648|NCT00786994|10945720|FG000|ITT|Overall Study||53
9834649|NCT00786994|10945721|FG001|ITT|Overall Study||51
9834650|NCT00786994|10945722|FG002|ITT|Overall Study||25
9834651|NCT00786994|10945723|FG003|ITT|Overall Study||28
9834652|NCT00786994|10945720|FG000|COMPLETED|Overall Study||47
9834653|NCT00786994|10945721|FG001|COMPLETED|Overall Study||39
9834654|NCT00786994|10945722|FG002|COMPLETED|Overall Study||24
9834655|NCT00786994|10945723|FG003|COMPLETED|Overall Study||22
9834656|NCT00786994|10945720|FG000|NOT COMPLETED|Overall Study||10
10255713|NCT01500733|11387693|FG000|STARTED|Overall Study||35
10255714|NCT01500733|11387694|FG001|STARTED|Overall Study||51
10255715|NCT01500733|11387693|FG000|COMPLETED|Overall Study||33
10255716|NCT01500733|11387694|FG001|COMPLETED|Overall Study||48
10255717|NCT01500733|11387693|FG000|NOT COMPLETED|Overall Study||2
10255718|NCT01500733|11387694|FG001|NOT COMPLETED|Overall Study||3
10255719|NCT01388491|11387702|FG000|STARTED|Overall Study|number randomized|150
10255720|NCT01388491|11387703|FG001|STARTED|Overall Study||143
10255721|NCT01388491|11387702|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
10255722|NCT01388491|11387703|FG001|Safety Population|Overall Study||142
10255723|NCT01388491|11387702|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
10255724|NCT01388491|11387703|FG001|Intent-to-Treat (ITT) Population|Overall Study||136
10255725|NCT01388491|11387702|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
10255726|NCT01388491|11387703|FG001|Per Protocol (PP) Population|Overall Study||121
10255727|NCT01388491|11387702|FG000|COMPLETED|Overall Study||116
10255728|NCT01388491|11387703|FG001|COMPLETED|Overall Study||114
10255729|NCT01388491|11387702|FG000|NOT COMPLETED|Overall Study||34
10255730|NCT01388491|11387703|FG001|NOT COMPLETED|Overall Study||29
10255731|NCT01373151|11387716|FG000|STARTED|Period 1||61
10255732|NCT01373151|11387717|FG001|STARTED|Period 1||59
9834657|NCT00786994|10945721|FG001|NOT COMPLETED|Overall Study||15
9834658|NCT00786994|10945722|FG002|NOT COMPLETED|Overall Study||2
9834659|NCT00786994|10945723|FG003|NOT COMPLETED|Overall Study||6
9834660|NCT00787020|10945734|FG000|STARTED|Overall Study||24
9834661|NCT00787020|10945735|FG001|STARTED|Overall Study||13
9834662|NCT00787020|10945734|FG000|COMPLETED|Overall Study||24
9834663|NCT00787020|10945735|FG001|COMPLETED|Overall Study||13
9834664|NCT00787020|10945734|FG000|NOT COMPLETED|Overall Study||0
9834665|NCT00787020|10945735|FG001|NOT COMPLETED|Overall Study||0
9834666|NCT00787137|10945744|FG000|STARTED|Overall Study||6
9834667|NCT00787137|10945745|FG001|STARTED|Overall Study||6
9834668|NCT00787137|10945746|FG002|STARTED|Overall Study||5
9834669|NCT00787137|10945744|FG000|COMPLETED|Overall Study||6
9834670|NCT00787137|10945745|FG001|COMPLETED|Overall Study||6
9834671|NCT00787137|10945746|FG002|COMPLETED|Overall Study||4
9834672|NCT00787137|10945744|FG000|NOT COMPLETED|Overall Study||0
9834673|NCT00787137|10945745|FG001|NOT COMPLETED|Overall Study||0
9834674|NCT00787137|10945746|FG002|NOT COMPLETED|Overall Study||1
9834675|NCT00787150|10945757|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
9834676|NCT00787150|10945758|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
9834677|NCT00787150|10945759|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
9834678|NCT00787150|10945757|FG000|COMPLETED|Overall Study||66
9834679|NCT00787150|10945758|FG001|COMPLETED|Overall Study||65
9834680|NCT00787150|10945759|FG002|COMPLETED|Overall Study||66
9834681|NCT00787150|10945757|FG000|NOT COMPLETED|Overall Study||9
9834682|NCT00787150|10945758|FG001|NOT COMPLETED|Overall Study||7
9834683|NCT00787150|10945759|FG002|NOT COMPLETED|Overall Study||5
9834684|NCT00787189|10945771|FG000|STARTED|Overall Study||32
9834685|NCT00787189|10945772|FG001|STARTED|Overall Study||32
9834686|NCT00787189|10945771|FG000|COMPLETED|Overall Study|To study end point.|30
9834687|NCT00787189|10945772|FG001|COMPLETED|Overall Study|To study end point.|30
9834688|NCT00787189|10945771|FG000|NOT COMPLETED|Overall Study||2
9834689|NCT00787189|10945772|FG001|NOT COMPLETED|Overall Study||2
9834690|NCT00787202|10945783|FG000|STARTED|Overall Study||49
9834691|NCT00787202|10945784|FG001|STARTED|Overall Study||31
9834692|NCT00787202|10945785|FG002|STARTED|Overall Study||33
9834693|NCT00787202|10945786|FG003|STARTED|Overall Study||33
9834694|NCT00787202|10945787|FG004|STARTED|Overall Study||49
9834695|NCT00787202|10945783|FG000|Treated|Overall Study||48
9834696|NCT00787202|10945784|FG001|Treated|Overall Study||31
9834697|NCT00787202|10945785|FG002|Treated|Overall Study||33
9834698|NCT00787202|10945786|FG003|Treated|Overall Study||33
9834699|NCT00787202|10945787|FG004|Treated|Overall Study||49
9834700|NCT00787202|10945783|FG000|COMPLETED|Overall Study||35
9834701|NCT00787202|10945784|FG001|COMPLETED|Overall Study||20
9834702|NCT00787202|10945785|FG002|COMPLETED|Overall Study||26
9834703|NCT00787202|10945786|FG003|COMPLETED|Overall Study||31
9834704|NCT00787202|10945787|FG004|COMPLETED|Overall Study||45
9834705|NCT00787202|10945783|FG000|NOT COMPLETED|Overall Study||14
9834706|NCT00787202|10945784|FG001|NOT COMPLETED|Overall Study||11
9834707|NCT00787202|10945785|FG002|NOT COMPLETED|Overall Study||7
9834708|NCT00787202|10945786|FG003|NOT COMPLETED|Overall Study||2
9834709|NCT00787202|10945787|FG004|NOT COMPLETED|Overall Study||4
9834710|NCT00787241|10945806|FG000|STARTED|Overall Study||261
9834711|NCT00787241|10945807|FG001|STARTED|Overall Study||143
9834712|NCT00787241|10945808|FG002|STARTED|Overall Study||41
9834713|NCT00787241|10945806|FG000|COMPLETED|Overall Study||261
9834714|NCT00787241|10945807|FG001|COMPLETED|Overall Study||143
9834715|NCT00787241|10945808|FG002|COMPLETED|Overall Study||41
9834716|NCT00787241|10945806|FG000|NOT COMPLETED|Overall Study||0
9834717|NCT00787241|10945807|FG001|NOT COMPLETED|Overall Study||0
9834718|NCT00787241|10945808|FG002|NOT COMPLETED|Overall Study||0
9834719|NCT00787254|10945818|FG000|STARTED|Overall Study||185
9834720|NCT00787254|10945819|FG001|STARTED|Overall Study||181
9834721|NCT00787254|10945818|FG000|COMPLETED|Overall Study||109
9834722|NCT00787254|10945819|FG001|COMPLETED|Overall Study||99
9834723|NCT00787254|10945818|FG000|NOT COMPLETED|Overall Study||76
9834724|NCT00787254|10945819|FG001|NOT COMPLETED|Overall Study||82
9834725|NCT00787267|10945825|FG000|STARTED|Overall Study|Signed a consent form|37
9834726|NCT00787267|10945825|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25
9834727|NCT00787267|10945825|FG000|NOT COMPLETED|Overall Study||12
9834728|NCT00787319|10945829|FG000|STARTED|Overall Study||108
9834729|NCT00787319|10945829|FG000|COMPLETED|Overall Study||45
9834730|NCT00787319|10945829|FG000|NOT COMPLETED|Overall Study||63
9834731|NCT00787332|10945835|FG000|STARTED|Overall Study||8
9834732|NCT00787332|10945836|FG001|STARTED|Overall Study||8
9834733|NCT00787332|10945835|FG000|COMPLETED|Overall Study||8
9834734|NCT00787332|10945836|FG001|COMPLETED|Overall Study||8
9957669|NCT01451983|11076987|FG000|STARTED|Overall Study||26
10255733|NCT01373151|11387718|FG002|STARTED|Period 1||60
10255734|NCT01373151|11387719|FG003|STARTED|Period 1||60
10255735|NCT01373151|11387720|FG004|STARTED|Period 1||59
10255736|NCT01373151|11387721|FG005|STARTED|Period 1||60
10255737|NCT01373151|11387722|FG006|STARTED|Period 1||59
10255738|NCT01373151|11387716|FG000|COMPLETED|Period 1||56
10255739|NCT01373151|11387717|FG001|COMPLETED|Period 1||59
10255740|NCT01373151|11387718|FG002|COMPLETED|Period 1||56
10255741|NCT01373151|11387719|FG003|COMPLETED|Period 1||59
10255742|NCT01373151|11387720|FG004|COMPLETED|Period 1||54
10255743|NCT01373151|11387721|FG005|COMPLETED|Period 1||56
10255744|NCT01373151|11387722|FG006|COMPLETED|Period 1||59
10255745|NCT01373151|11387716|FG000|NOT COMPLETED|Period 1||5
9834735|NCT00787332|10945835|FG000|NOT COMPLETED|Overall Study||0
9834736|NCT00787332|10945836|FG001|NOT COMPLETED|Overall Study||0
9834737|NCT00787527|10945842|FG000|STARTED|Overall Study||14
9834738|NCT00787527|10945842|FG000|COMPLETED|Overall Study||11
9834739|NCT00787527|10945842|FG000|NOT COMPLETED|Overall Study||3
9834740|NCT00787566|10945853|FG000|STARTED|Overall Study||21
9834741|NCT00787566|10945854|FG001|STARTED|Overall Study||25
9834742|NCT00787566|10945855|FG002|STARTED|Overall Study||22
9834743|NCT00787566|10945853|FG000|COMPLETED|Overall Study||21
9834744|NCT00787566|10945854|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
9834745|NCT00787566|10945855|FG002|COMPLETED|Overall Study||22
10255746|NCT01373151|11387717|FG001|NOT COMPLETED|Period 1||0
10255747|NCT01373151|11387718|FG002|NOT COMPLETED|Period 1||4
10255748|NCT01373151|11387719|FG003|NOT COMPLETED|Period 1||1
9834746|NCT00787566|10945853|FG000|NOT COMPLETED|Overall Study||0
9834747|NCT00787566|10945854|FG001|NOT COMPLETED|Overall Study||1
9834748|NCT00787566|10945855|FG002|NOT COMPLETED|Overall Study||0
9834749|NCT00787605|10945865|FG000|STARTED|Overall Study||428
9834750|NCT00787605|10945866|FG001|STARTED|Overall Study||432
9834751|NCT00787605|10945865|FG000|COMPLETED|Overall Study||382
9834752|NCT00787605|10945866|FG001|COMPLETED|Overall Study||376
9834753|NCT00787605|10945865|FG000|NOT COMPLETED|Overall Study||46
9834754|NCT00787605|10945866|FG001|NOT COMPLETED|Overall Study||56
9834755|NCT00787644|10945874|FG000|STARTED|Overall Study||12
9834756|NCT00787644|10945875|FG001|STARTED|Overall Study||11
9834757|NCT00787644|10945874|FG000|COMPLETED|Overall Study||10
9834758|NCT00787644|10945875|FG001|COMPLETED|Overall Study||9
9834759|NCT00787644|10945874|FG000|NOT COMPLETED|Overall Study||2
9834760|NCT00787644|10945875|FG001|NOT COMPLETED|Overall Study||2
10255749|NCT01373151|11387720|FG004|NOT COMPLETED|Period 1||5
10255750|NCT01373151|11387721|FG005|NOT COMPLETED|Period 1||4
10255751|NCT01373151|11387722|FG006|NOT COMPLETED|Period 1||0
10255752|NCT01373151|11387716|FG000|STARTED|Period 2||56
10255753|NCT01373151|11387717|FG001|STARTED|Period 2||58
10255754|NCT01373151|11387718|FG002|STARTED|Period 2||56
9834761|NCT00787722|10945881|FG000|STARTED|Overall Study||13
9834762|NCT00787722|10945881|FG000|COMPLETED|Overall Study||12
9834763|NCT00787722|10945881|FG000|NOT COMPLETED|Overall Study||1
9834764|NCT00787761|10945886|FG000|STARTED|Overall Study||24
9834765|NCT00787761|10945886|FG000|COMPLETED|Overall Study||24
9834766|NCT00787761|10945886|FG000|NOT COMPLETED|Overall Study||0
9834767|NCT00787787|10945892|FG000|STARTED|Overall Study||7
9834768|NCT00787787|10945892|FG000|COMPLETED|Overall Study||0
9834769|NCT00787787|10945892|FG000|NOT COMPLETED|Overall Study||7
10255755|NCT01373151|11387719|FG003|STARTED|Period 2||59
10255756|NCT01373151|11387720|FG004|STARTED|Period 2||54
10255757|NCT01373151|11387721|FG005|STARTED|Period 2||55
10255758|NCT01373151|11387722|FG006|STARTED|Period 2||59
10255759|NCT01373151|11387716|FG000|COMPLETED|Period 2||47
10255760|NCT01373151|11387717|FG001|COMPLETED|Period 2||57
10255761|NCT01373151|11387718|FG002|COMPLETED|Period 2||52
10255762|NCT01373151|11387719|FG003|COMPLETED|Period 2||54
10255763|NCT01373151|11387720|FG004|COMPLETED|Period 2||52
9834770|NCT00787800|10945898|FG000|STARTED|Overall Study||50
9834771|NCT00787800|10945899|FG001|STARTED|Overall Study||50
9834772|NCT00787800|10945898|FG000|COMPLETED|Overall Study||47
9834773|NCT00787800|10945899|FG001|COMPLETED|Overall Study||43
9834774|NCT00787800|10945898|FG000|NOT COMPLETED|Overall Study||3
10255764|NCT01373151|11387721|FG005|COMPLETED|Period 2||55
10255765|NCT01373151|11387722|FG006|COMPLETED|Period 2||54
10255766|NCT01373151|11387716|FG000|NOT COMPLETED|Period 2||9
10255767|NCT01373151|11387717|FG001|NOT COMPLETED|Period 2||1
9834775|NCT00787800|10945899|FG001|NOT COMPLETED|Overall Study||7
9834776|NCT00787839|10945906|FG000|STARTED|Overall Study||1939
9834777|NCT00787839|10945906|FG000|Consented|Overall Study|consented|1939
9834778|NCT00787839|10945906|FG000|Completed GCT Screening|Overall Study||1876
9834779|NCT00787839|10945906|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
9834780|NCT00787839|10945906|FG000|COMPLETED|Overall Study||1535
9834781|NCT00787839|10945906|FG000|NOT COMPLETED|Overall Study||404
9834782|NCT00787852|10945929|FG000|STARTED|Overall Study||6
9834783|NCT00787852|10945930|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
9834784|NCT00787852|10945929|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
9834785|NCT00787852|10945930|FG001|COMPLETED|Overall Study||5
9834786|NCT00787852|10945929|FG000|NOT COMPLETED|Overall Study||1
9834787|NCT00787852|10945930|FG001|NOT COMPLETED|Overall Study||0
9834788|NCT00787891|10945938|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65
9834789|NCT00787891|10945939|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62
9834790|NCT00787891|10945938|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55
9834791|NCT00787891|10945939|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53
9834792|NCT00787891|10945938|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
9834793|NCT00787891|10945939|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
9834794|NCT00787891|10945938|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33
9834795|NCT00787891|10945939|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31
9834796|NCT00787891|10945938|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
9834797|NCT00787891|10945939|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
9834798|NCT00787891|10945938|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
9834799|NCT00787891|10945939|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
9834800|NCT00787904|10945949|FG000|STARTED|Overall Study||6
9834801|NCT00787904|10945950|FG001|STARTED|Overall Study||13
9957670|NCT01451983|11076988|FG001|STARTED|Overall Study||27
9957671|NCT01451983|11076989|FG002|STARTED|Overall Study||61
9957672|NCT01451983|11076990|FG003|STARTED|Overall Study||24
9957673|NCT01451983|11076987|FG000|COMPLETED|Overall Study||26
9957674|NCT01451983|11076988|FG001|COMPLETED|Overall Study||27
10255768|NCT01373151|11387718|FG002|NOT COMPLETED|Period 2||4
10255769|NCT01373151|11387719|FG003|NOT COMPLETED|Period 2||5
10255770|NCT01373151|11387720|FG004|NOT COMPLETED|Period 2||2
10255771|NCT01373151|11387721|FG005|NOT COMPLETED|Period 2||0
9834802|NCT00787904|10945949|FG000|COMPLETED|Overall Study||6
9834803|NCT00787904|10945950|FG001|COMPLETED|Overall Study||13
10255772|NCT01373151|11387722|FG006|NOT COMPLETED|Period 2||5
10255773|NCT01328587|11387738|FG000|STARTED|Overall Study||34
10255774|NCT01328587|11387738|FG000|COMPLETED|Overall Study||34
10255775|NCT01328587|11387738|FG000|NOT COMPLETED|Overall Study||0
10255776|NCT01285947|11387744|FG000|STARTED|Overall Study||10
10255777|NCT01285947|11387745|FG001|STARTED|Overall Study||10
10255778|NCT01285947|11387744|FG000|COMPLETED|Overall Study||10
10255779|NCT01285947|11387745|FG001|COMPLETED|Overall Study||10
10255780|NCT01285947|11387744|FG000|NOT COMPLETED|Overall Study||0
10255781|NCT01285947|11387745|FG001|NOT COMPLETED|Overall Study||0
10255782|NCT01281644|11387751|FG000|STARTED|Overall Study||23
10255783|NCT01281644|11387751|FG000|COMPLETED|Overall Study||18
10255784|NCT01281644|11387751|FG000|NOT COMPLETED|Overall Study||5
10255785|NCT01274611|11387757|FG000|STARTED|Overall Study||20
10255786|NCT01274611|11387757|FG000|COMPLETED|Overall Study||20
10255787|NCT01274611|11387757|FG000|NOT COMPLETED|Overall Study||0
10255788|NCT00960297|11387763|FG000|STARTED|Overall Study||4
10255789|NCT00960297|11387763|FG000|COMPLETED|Overall Study||1
10255790|NCT00960297|11387763|FG000|NOT COMPLETED|Overall Study||3
10255791|NCT00910650|11387767|FG000|STARTED|Overall Study||14
10255792|NCT00910650|11387767|FG000|COMPLETED|Overall Study||12
10255793|NCT00910650|11387767|FG000|NOT COMPLETED|Overall Study||2
10255794|NCT00793169|11387771|FG000|STARTED|Overall Study||19
10255795|NCT00793169|11387771|FG000|COMPLETED|Overall Study||19
10255796|NCT00793169|11387771|FG000|NOT COMPLETED|Overall Study||0
10255797|NCT00703326|11387777|FG000|STARTED|Overall Study||759
10255798|NCT00703326|11387778|FG001|STARTED|Overall Study||385
10255799|NCT00703326|11387777|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752
9834804|NCT00787904|10945949|FG000|NOT COMPLETED|Overall Study||0
9834805|NCT00787904|10945950|FG001|NOT COMPLETED|Overall Study||0
9834806|NCT00787930|10945956|FG000|STARTED|Acute Treatment -- 3 Weeks||19
9834807|NCT00787930|10945956|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19
9834808|NCT00787930|10945956|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
9834809|NCT00787930|10945956|FG000|STARTED|Continuation Treatment -- up to 12 Month||19
9834810|NCT00787930|10945956|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16
9834811|NCT00787930|10945956|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
9834812|NCT00787943|10945966|FG000|STARTED|Overall Study||10
9834813|NCT00787943|10945966|FG000|COMPLETED|Overall Study||10
9834814|NCT00787943|10945966|FG000|NOT COMPLETED|Overall Study||0
9834815|NCT00788008|10945976|FG000|STARTED|Overall Study||98
9957675|NCT01451983|11076989|FG002|COMPLETED|Overall Study||61
9957676|NCT01451983|11076990|FG003|COMPLETED|Overall Study||24
9957677|NCT01451983|11076987|FG000|NOT COMPLETED|Overall Study||0
9957678|NCT01451983|11076988|FG001|NOT COMPLETED|Overall Study||0
9957679|NCT01451983|11076989|FG002|NOT COMPLETED|Overall Study||0
9957680|NCT01451983|11076990|FG003|NOT COMPLETED|Overall Study||0
9957681|NCT01451996|11077004|FG000|STARTED|Overall Study||83
9957682|NCT01451996|11077005|FG001|STARTED|Overall Study||87
9957683|NCT01451996|11077006|FG002|STARTED|Overall Study||85
9957684|NCT01451996|11077007|FG003|STARTED|Overall Study||85
9957685|NCT01451996|11077004|FG000|COMPLETED|Overall Study||83
9957686|NCT01451996|11077005|FG001|COMPLETED|Overall Study||87
9957687|NCT01451996|11077006|FG002|COMPLETED|Overall Study||85
9957688|NCT01451996|11077007|FG003|COMPLETED|Overall Study||85
9957689|NCT01451996|11077004|FG000|NOT COMPLETED|Overall Study||0
9957690|NCT01451996|11077005|FG001|NOT COMPLETED|Overall Study||0
9957691|NCT01451996|11077006|FG002|NOT COMPLETED|Overall Study||0
9957692|NCT01451996|11077007|FG003|NOT COMPLETED|Overall Study||0
9957693|NCT01452126|11077017|FG000|STARTED|Overall Study||49
9957694|NCT01452126|11077017|FG000|COMPLETED|Overall Study||49
9957695|NCT01452126|11077017|FG000|NOT COMPLETED|Overall Study||0
9957696|NCT01452191|11077028|FG000|STARTED|Overall Study||373
9957697|NCT01452191|11077029|FG001|STARTED|Overall Study||369
9957698|NCT01452191|11077030|FG002|STARTED|Overall Study||370
9957699|NCT01452191|11077028|FG000|COMPLETED|Overall Study||241
9957700|NCT01452191|11077029|FG001|COMPLETED|Overall Study||252
9957701|NCT01452191|11077030|FG002|COMPLETED|Overall Study||258
9957702|NCT01452191|11077028|FG000|NOT COMPLETED|Overall Study||132
9957703|NCT01452191|11077029|FG001|NOT COMPLETED|Overall Study||117
9957704|NCT01452191|11077030|FG002|NOT COMPLETED|Overall Study||112
9957705|NCT01452269|11077040|FG000|STARTED|Overall Study||48
9957706|NCT01452269|11077041|FG001|STARTED|Overall Study||56
9957707|NCT01452269|11077040|FG000|COMPLETED|Overall Study||47
9957708|NCT01452269|11077041|FG001|COMPLETED|Overall Study||51
10255800|NCT00703326|11387778|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382
10255801|NCT00703326|11387777|FG000|COMPLETED|Overall Study||657
10255802|NCT00703326|11387778|FG001|COMPLETED|Overall Study||347
10255803|NCT00703326|11387777|FG000|NOT COMPLETED|Overall Study||102
10255804|NCT00703326|11387778|FG001|NOT COMPLETED|Overall Study||38
10255805|NCT00602667|11387788|FG000|STARTED|Overall Study||57
10255806|NCT00602667|11387789|FG001|STARTED|Overall Study||156
10255807|NCT00602667|11387790|FG002|STARTED|Overall Study||77
10255808|NCT00602667|11387788|FG000|COMPLETED|Overall Study||38
10255809|NCT00602667|11387789|FG001|COMPLETED|Overall Study||75
10255810|NCT00602667|11387790|FG002|COMPLETED|Overall Study||14
9834816|NCT00788008|10945977|FG001|STARTED|Overall Study||101
9834817|NCT00788008|10945976|FG000|COMPLETED|Overall Study||98
9834818|NCT00788008|10945977|FG001|COMPLETED|Overall Study||101
9957709|NCT01452269|11077040|FG000|NOT COMPLETED|Overall Study||1
9957710|NCT01452269|11077041|FG001|NOT COMPLETED|Overall Study||5
9957711|NCT01452347|11077049|FG000|STARTED|Overall Study||168
9957712|NCT01452347|11077050|FG001|STARTED|Overall Study||84
9957713|NCT01452347|11077049|FG000|COMPLETED|Overall Study||151
9957714|NCT01452347|11077050|FG001|COMPLETED|Overall Study||77
9957715|NCT01452347|11077049|FG000|NOT COMPLETED|Overall Study||17
10255811|NCT00602667|11387788|FG000|NOT COMPLETED|Overall Study||19
10255812|NCT00602667|11387789|FG001|NOT COMPLETED|Overall Study||81
10255813|NCT00602667|11387790|FG002|NOT COMPLETED|Overall Study||63
10255814|NCT00535990|11387825|FG000|STARTED|Overall Study||250
10255815|NCT00535990|11387825|FG000|COMPLETED|Overall Study||250
10255816|NCT00535990|11387825|FG000|NOT COMPLETED|Overall Study||0
10255817|NCT00472186|11387831|FG000|STARTED|Overall Study||2
10255818|NCT00472186|11387832|FG001|STARTED|Overall Study||0
10255819|NCT00472186|11387831|FG000|COMPLETED|Overall Study||1
10255820|NCT00472186|11387832|FG001|COMPLETED|Overall Study||0
10255821|NCT00472186|11387831|FG000|NOT COMPLETED|Overall Study||1
10255822|NCT00472186|11387832|FG001|NOT COMPLETED|Overall Study||0
9834819|NCT00788008|10945976|FG000|NOT COMPLETED|Overall Study||0
9834820|NCT00788008|10945977|FG001|NOT COMPLETED|Overall Study||0
9957716|NCT01452347|11077050|FG001|NOT COMPLETED|Overall Study||7
9957717|NCT01452412|11077060|FG000|STARTED|Overall Study||74
9957718|NCT01452412|11077061|FG001|STARTED|Overall Study||75
9957719|NCT01452412|11077060|FG000|COMPLETED|Overall Study||46
9957720|NCT01452412|11077061|FG001|COMPLETED|Overall Study||58
9957721|NCT01452412|11077060|FG000|NOT COMPLETED|Overall Study||28
9957722|NCT01452412|11077061|FG001|NOT COMPLETED|Overall Study||17
9957723|NCT01452425|11077067|FG000|STARTED|Overall Study||10
9957724|NCT01452425|11077067|FG000|COMPLETED|Overall Study||10
9957725|NCT01452425|11077067|FG000|NOT COMPLETED|Overall Study||0
9957726|NCT01452529|11077074|FG000|STARTED|Run-in Period||905
9957727|NCT01452529|11077075|FG001|STARTED|Run-in Period||0
9957728|NCT01452529|11077076|FG002|STARTED|Run-in Period||0
9957729|NCT01452529|11077074|FG000|COMPLETED|Run-in Period||592
9957730|NCT01452529|11077075|FG001|COMPLETED|Run-in Period||0
9957731|NCT01452529|11077076|FG002|COMPLETED|Run-in Period||0
9957732|NCT01452529|11077074|FG000|NOT COMPLETED|Run-in Period||313
9957733|NCT01452529|11077075|FG001|NOT COMPLETED|Run-in Period||0
9957734|NCT01452529|11077076|FG002|NOT COMPLETED|Run-in Period||0
9957735|NCT01452529|11077074|FG000|STARTED|Double-blind (DB) Period||0
9957736|NCT01452529|11077075|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
9957737|NCT01452529|11077076|FG002|STARTED|Double-blind (DB) Period||292
9957738|NCT01452529|11077074|FG000|COMPLETED|Double-blind (DB) Period||0
9957739|NCT01452529|11077075|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
9957740|NCT01452529|11077076|FG002|COMPLETED|Double-blind (DB) Period||210
9957741|NCT01452529|11077074|FG000|NOT COMPLETED|Double-blind (DB) Period||0
9957742|NCT01452529|11077075|FG001|NOT COMPLETED|Double-blind (DB) Period||67
9957743|NCT01452529|11077076|FG002|NOT COMPLETED|Double-blind (DB) Period||82
9957744|NCT01452789|11077085|FG000|STARTED|Overall Study||33
9957745|NCT01452789|11077086|FG001|STARTED|Overall Study||30
9957746|NCT01452789|11077085|FG000|COMPLETED|Overall Study||30
9957747|NCT01452789|11077086|FG001|COMPLETED|Overall Study||28
9957748|NCT01452789|11077085|FG000|NOT COMPLETED|Overall Study||3
9957749|NCT01452789|11077086|FG001|NOT COMPLETED|Overall Study||2
9957750|NCT01452919|11077092|FG000|STARTED|Open-Label Treatment||123
9834821|NCT00788073|10945985|FG000|STARTED|STX209 Then Placebo||30
9834822|NCT00788073|10945986|FG001|STARTED|STX209 Then Placebo||33
9834823|NCT00788073|10945985|FG000|COMPLETED|STX209 Then Placebo||29
9957751|NCT01452919|11077093|FG001|STARTED|Open-Label Treatment||0
9957752|NCT01452919|11077094|FG002|STARTED|Open-Label Treatment||0
9967668|NCT01515657|11088021|FG001|STARTED|First Intervention||13
9834824|NCT00788073|10945986|FG001|COMPLETED|STX209 Then Placebo||30
9834825|NCT00788073|10945985|FG000|NOT COMPLETED|STX209 Then Placebo||1
9834826|NCT00788073|10945986|FG001|NOT COMPLETED|STX209 Then Placebo||3
9834827|NCT00788073|10945985|FG000|STARTED|Placebo Then STX209||29
9834828|NCT00788073|10945986|FG001|STARTED|Placebo Then STX209||30
9834829|NCT00788073|10945985|FG000|COMPLETED|Placebo Then STX209||27
9834830|NCT00788073|10945986|FG001|COMPLETED|Placebo Then STX209||29
9834831|NCT00788073|10945985|FG000|NOT COMPLETED|Placebo Then STX209||2
9834832|NCT00788073|10945986|FG001|NOT COMPLETED|Placebo Then STX209||1
9957753|NCT01452919|11077092|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123
9957754|NCT01452919|11077093|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
9957755|NCT01452919|11077094|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
9957756|NCT01452919|11077092|FG000|COMPLETED|Open-Label Treatment||103
9957757|NCT01452919|11077093|FG001|COMPLETED|Open-Label Treatment||0
9957758|NCT01452919|11077094|FG002|COMPLETED|Open-Label Treatment||0
9957759|NCT01452919|11077092|FG000|NOT COMPLETED|Open-Label Treatment||20
9957760|NCT01452919|11077093|FG001|NOT COMPLETED|Open-Label Treatment||0
9957761|NCT01452919|11077094|FG002|NOT COMPLETED|Open-Label Treatment||0
9957762|NCT01452919|11077092|FG000|STARTED|Randomization Treatment||0
9957763|NCT01452919|11077093|FG001|STARTED|Randomization Treatment||50
9957764|NCT01452919|11077094|FG002|STARTED|Randomization Treatment||53
9957765|NCT01452919|11077092|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0
9957766|NCT01452919|11077093|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50
10020699|NCT01838447|11144042|FG000|NOT COMPLETED|Overall Study||2
10020700|NCT01838447|11144043|FG001|NOT COMPLETED|Overall Study||3
10255823|NCT03996876|11387842|FG000|STARTED|Overall Study||14
10255824|NCT03996876|11387843|FG001|STARTED|Overall Study||14
10255825|NCT03996876|11387842|FG000|COMPLETED|Overall Study||12
10255826|NCT03996876|11387843|FG001|COMPLETED|Overall Study||10
10255827|NCT03996876|11387842|FG000|NOT COMPLETED|Overall Study||2
10255828|NCT03996876|11387843|FG001|NOT COMPLETED|Overall Study||4
10255829|NCT03589976|11387852|FG000|STARTED|Overall Study||35
10255830|NCT03589976|11387853|FG001|STARTED|Overall Study||12
10255831|NCT03589976|11387852|FG000|COMPLETED|Overall Study||16
10255832|NCT03589976|11387853|FG001|COMPLETED|Overall Study||6
10255833|NCT03589976|11387852|FG000|NOT COMPLETED|Overall Study||19
10255834|NCT03589976|11387853|FG001|NOT COMPLETED|Overall Study||6
10255835|NCT03490227|11387859|FG000|STARTED|Overall Study||10
10255836|NCT03490227|11387859|FG000|COMPLETED|Overall Study||10
10255837|NCT03490227|11387859|FG000|NOT COMPLETED|Overall Study||0
10255838|NCT03401190|11387868|FG000|STARTED|Overall Study||8
10255839|NCT03401190|11387869|FG001|STARTED|Overall Study||6
10255840|NCT03401190|11387870|FG002|STARTED|Overall Study||7
10255841|NCT03401190|11387868|FG000|COMPLETED|Overall Study||8
10255842|NCT03401190|11387869|FG001|COMPLETED|Overall Study||4
10255843|NCT03401190|11387870|FG002|COMPLETED|Overall Study||7
10255844|NCT03401190|11387868|FG000|NOT COMPLETED|Overall Study||0
10255845|NCT03401190|11387869|FG001|NOT COMPLETED|Overall Study||2
10255846|NCT03401190|11387870|FG002|NOT COMPLETED|Overall Study||0
10255847|NCT03392753|11387884|FG000|STARTED|Overall Study||83
10255848|NCT03392753|11387885|FG001|STARTED|Overall Study||84
10255849|NCT03392753|11387884|FG000|COMPLETED|Overall Study||47
10255850|NCT03392753|11387885|FG001|COMPLETED|Overall Study||50
10255851|NCT03392753|11387884|FG000|NOT COMPLETED|Overall Study||36
10255852|NCT03392753|11387885|FG001|NOT COMPLETED|Overall Study||34
10255853|NCT03212963|11387891|FG000|STARTED|Overall Study||16
10255854|NCT03212963|11387891|FG000|COMPLETED|Overall Study||16
10255855|NCT03212963|11387891|FG000|NOT COMPLETED|Overall Study||0
10255856|NCT03135262|11387900|FG000|STARTED|Overall Study||9
10255857|NCT03135262|11387901|FG001|STARTED|Overall Study||6
10255858|NCT03135262|11387902|FG002|STARTED|Overall Study||7
10255859|NCT03135262|11387903|FG003|STARTED|Overall Study||6
10255860|NCT03135262|11387904|FG004|STARTED|Overall Study||1
10255861|NCT03135262|11387900|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10255862|NCT03135262|11387901|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10255863|NCT03135262|11387902|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10255864|NCT03135262|11387903|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
9834833|NCT00788255|10945992|FG000|STARTED|Overall Study||25
9834834|NCT00788255|10945992|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
9834835|NCT00788255|10945992|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
9834836|NCT00788255|10945992|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
9834837|NCT00788255|10945992|FG000|Oxytocin: 0 μU/mL|Overall Study||25
9957767|NCT01452919|11077094|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53
10020701|NCT01838499|11144051|FG000|STARTED|Overall Study||55
10020702|NCT01838499|11144052|FG001|STARTED|Overall Study||54
10020703|NCT01838499|11144051|FG000|COMPLETED|Overall Study||31
10020704|NCT01838499|11144052|FG001|COMPLETED|Overall Study||37
10020705|NCT01838499|11144051|FG000|NOT COMPLETED|Overall Study||24
10020706|NCT01838499|11144052|FG001|NOT COMPLETED|Overall Study||17
10020707|NCT01838551|11144058|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
10020708|NCT01838551|11144058|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
10020709|NCT01838551|11144058|FG000|NOT COMPLETED|Overall Study||48
10020710|NCT01838590|11144066|FG000|STARTED|Overall Study||52
10020711|NCT01838590|11144067|FG001|STARTED|Overall Study||51
10020712|NCT01838590|11144066|FG000|COMPLETED|Overall Study||40
10020713|NCT01838590|11144067|FG001|COMPLETED|Overall Study||46
10020714|NCT01838590|11144066|FG000|NOT COMPLETED|Overall Study||12
10020715|NCT01838590|11144067|FG001|NOT COMPLETED|Overall Study||5
10020716|NCT01838616|11144079|FG000|STARTED|Titration Period||130
10020717|NCT01838616|11144080|FG001|STARTED|Titration Period||128
10020718|NCT01838616|11144079|FG000|No Post Baseline Pain Intensity Values|Titration Period||0
10020719|NCT01838616|11144080|FG001|No Post Baseline Pain Intensity Values|Titration Period||2
10114008|NCT02513160|11244735|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
10255865|NCT03135262|11387904|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10255866|NCT03135262|11387900|FG000|NOT COMPLETED|Overall Study||9
10255867|NCT03135262|11387901|FG001|NOT COMPLETED|Overall Study||6
10255868|NCT03135262|11387902|FG002|NOT COMPLETED|Overall Study||7
10255869|NCT03135262|11387903|FG003|NOT COMPLETED|Overall Study||6
10255870|NCT03135262|11387904|FG004|NOT COMPLETED|Overall Study||1
10255871|NCT03104075|11387936|FG000|STARTED|Overall Study||20
10255872|NCT03104075|11387937|FG001|STARTED|Overall Study||20
10255873|NCT03104075|11387936|FG000|COMPLETED|Overall Study||19
10255874|NCT03104075|11387937|FG001|COMPLETED|Overall Study||20
10255875|NCT03104075|11387936|FG000|NOT COMPLETED|Overall Study||1
10255876|NCT03104075|11387937|FG001|NOT COMPLETED|Overall Study||0
10255877|NCT03038087|11387944|FG000|STARTED|Overall Study||10
10255878|NCT03038087|11387944|FG000|COMPLETED|Overall Study||9
10255879|NCT03038087|11387944|FG000|NOT COMPLETED|Overall Study||1
10255880|NCT02880540|11387952|FG000|STARTED|Overall Study||13
10255881|NCT02880540|11387953|FG001|STARTED|Overall Study||13
10255882|NCT02880540|11387952|FG000|COMPLETED|Overall Study||13
10255883|NCT02880540|11387953|FG001|COMPLETED|Overall Study||13
10255884|NCT02880540|11387952|FG000|NOT COMPLETED|Overall Study||0
10255885|NCT02880540|11387953|FG001|NOT COMPLETED|Overall Study||0
10255886|NCT02740972|11387961|FG000|STARTED|4-week Double-blinded Placebo-controlled||5
10255887|NCT02740972|11387962|FG001|STARTED|4-week Double-blinded Placebo-controlled||6
10255888|NCT02740972|11387963|FG002|STARTED|4-week Double-blinded Placebo-controlled||5
10255889|NCT02740972|11387964|FG003|STARTED|4-week Double-blinded Placebo-controlled||0
10255890|NCT02740972|11387965|FG004|STARTED|4-week Double-blinded Placebo-controlled||0
10255891|NCT02740972|11387961|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5
10255892|NCT02740972|11387962|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6
10255893|NCT02740972|11387963|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5
10255894|NCT02740972|11387964|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0
10255895|NCT02740972|11387965|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0
10255896|NCT02740972|11387961|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10255897|NCT02740972|11387962|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10255898|NCT02740972|11387963|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10255899|NCT02740972|11387964|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10255900|NCT02740972|11387965|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10255901|NCT02740972|11387961|FG000|STARTED|20-week Open Label Treatment Period||0
10255902|NCT02740972|11387962|FG001|STARTED|20-week Open Label Treatment Period||0
10255903|NCT02740972|11387963|FG002|STARTED|20-week Open Label Treatment Period||0
10255904|NCT02740972|11387964|FG003|STARTED|20-week Open Label Treatment Period||8
10114009|NCT02513160|11244732|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101
10020720|NCT01838616|11144079|FG000|Major Protocol Deviations|Titration Period||13
10020721|NCT01838616|11144080|FG001|Major Protocol Deviations|Titration Period||16
10020722|NCT01838616|11144079|FG000|Switched to Pick-up Arm|Titration Period||0
10255905|NCT02740972|11387965|FG004|STARTED|20-week Open Label Treatment Period||8
10255906|NCT02740972|11387961|FG000|COMPLETED|20-week Open Label Treatment Period||0
10255907|NCT02740972|11387962|FG001|COMPLETED|20-week Open Label Treatment Period||0
10255908|NCT02740972|11387963|FG002|COMPLETED|20-week Open Label Treatment Period||0
10020723|NCT01838616|11144080|FG001|Switched to Pick-up Arm|Titration Period||43
10020724|NCT01838616|11144079|FG000|Full Analysis Set|Titration Period||130
10020725|NCT01838616|11144080|FG001|Full Analysis Set|Titration Period||128
10020726|NCT01838616|11144079|FG000|Per Protocol Set|Titration Period||117
10020727|NCT01838616|11144080|FG001|Per Protocol Set|Titration Period||112
10255909|NCT02740972|11387964|FG003|COMPLETED|20-week Open Label Treatment Period||8
10255910|NCT02740972|11387965|FG004|COMPLETED|20-week Open Label Treatment Period||8
10255911|NCT02740972|11387961|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0
10255912|NCT02740972|11387962|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0
10255913|NCT02740972|11387963|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0
10255914|NCT02740972|11387964|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0
10255915|NCT02740972|11387965|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0
10255916|NCT02662985|11387984|FG000|STARTED|Treatment Period 1||83
10255917|NCT02662985|11387985|FG001|STARTED|Treatment Period 1||83
10255918|NCT02662985|11387984|FG000|COMPLETED|Treatment Period 1||82
10255919|NCT02662985|11387985|FG001|COMPLETED|Treatment Period 1||79
10255920|NCT02662985|11387984|FG000|NOT COMPLETED|Treatment Period 1||1
10255921|NCT02662985|11387985|FG001|NOT COMPLETED|Treatment Period 1||4
10255922|NCT02662985|11387984|FG000|STARTED|Treatment Period 2||82
10255923|NCT02662985|11387985|FG001|STARTED|Treatment Period 2||79
10255924|NCT02662985|11387984|FG000|COMPLETED|Treatment Period 2||81
10255925|NCT02662985|11387985|FG001|COMPLETED|Treatment Period 2||78
10255926|NCT02662985|11387984|FG000|NOT COMPLETED|Treatment Period 2||1
10255927|NCT02662985|11387985|FG001|NOT COMPLETED|Treatment Period 2||1
10255928|NCT02662985|11387984|FG000|STARTED|Treatment Period 3 (Extension Period)||81
10255929|NCT02662985|11387985|FG001|STARTED|Treatment Period 3 (Extension Period)||78
10255930|NCT02662985|11387984|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75
10255931|NCT02662985|11387985|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69
10255932|NCT02662985|11387984|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6
10255933|NCT02662985|11387985|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9
10255934|NCT02606461|11387995|FG000|STARTED|Overall Study||27
10255935|NCT02606461|11387996|FG001|STARTED|Overall Study||30
10255936|NCT02606461|11387997|FG002|STARTED|Overall Study||188
10255937|NCT02606461|11387998|FG003|STARTED|Overall Study||97
10255938|NCT02606461|11387995|FG000|Treated|Overall Study||27
10255939|NCT02606461|11387996|FG001|Treated|Overall Study||30
10255940|NCT02606461|11387997|FG002|Treated|Overall Study||187
10255941|NCT02606461|11387998|FG003|Treated|Overall Study||97
10255942|NCT02606461|11387995|FG000|Open Label|Overall Study||0
10255943|NCT02606461|11387996|FG001|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24
10255944|NCT02606461|11387997|FG002|Open Label|Overall Study||0
10255945|NCT02606461|11387998|FG003|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|57
10255946|NCT02606461|11387995|FG000|COMPLETED|Overall Study||0
10255947|NCT02606461|11387996|FG001|COMPLETED|Overall Study||0
10255948|NCT02606461|11387997|FG002|COMPLETED|Overall Study||0
10255949|NCT02606461|11387998|FG003|COMPLETED|Overall Study||0
10255950|NCT02606461|11387995|FG000|NOT COMPLETED|Overall Study||27
10255951|NCT02606461|11387996|FG001|NOT COMPLETED|Overall Study||30
10255952|NCT02606461|11387997|FG002|NOT COMPLETED|Overall Study||188
10255953|NCT02606461|11387998|FG003|NOT COMPLETED|Overall Study||97
10255954|NCT02536339|11388011|FG000|STARTED|Overall Study||40
10255955|NCT02536339|11388011|FG000|Received at Least One Dose of Study Drug|Overall Study||39
10255956|NCT02536339|11388011|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37
10255957|NCT02536339|11388011|FG000|COMPLETED|Overall Study||12
10255958|NCT02536339|11388011|FG000|NOT COMPLETED|Overall Study||28
10255959|NCT02323295|11388017|FG000|STARTED|Overall Study||2
10255960|NCT02323295|11388018|FG001|STARTED|Overall Study||10
10255961|NCT02323295|11388017|FG000|COMPLETED|Overall Study||2
10255962|NCT02323295|11388018|FG001|COMPLETED|Overall Study||7
10255963|NCT02323295|11388017|FG000|NOT COMPLETED|Overall Study||0
10255964|NCT02323295|11388018|FG001|NOT COMPLETED|Overall Study||3
10255965|NCT02050308|11388026|FG000|STARTED|Overall Study||127
10255966|NCT02050308|11388027|FG001|STARTED|Overall Study||124
10255967|NCT02050308|11388026|FG000|COMPLETED|Overall Study||28
10255968|NCT02050308|11388027|FG001|COMPLETED|Overall Study||22
10255969|NCT02050308|11388026|FG000|NOT COMPLETED|Overall Study||99
10255970|NCT02050308|11388027|FG001|NOT COMPLETED|Overall Study||102
10255971|NCT02036970|11388048|FG000|STARTED|Part 1: Day 1 Through Week 16||6
10255972|NCT02036970|11388049|FG001|STARTED|Part 1: Day 1 Through Week 16||12
10255973|NCT02036970|11388050|FG002|STARTED|Part 1: Day 1 Through Week 16||11
10255974|NCT02036970|11388051|FG003|STARTED|Part 1: Day 1 Through Week 16||12
10255975|NCT02036970|11388052|FG004|STARTED|Part 1: Day 1 Through Week 16||2
10255976|NCT02036970|11388053|FG005|STARTED|Part 1: Day 1 Through Week 16||4
10255977|NCT02036970|11388054|FG006|STARTED|Part 1: Day 1 Through Week 16||3
10255978|NCT02036970|11388055|FG007|STARTED|Part 1: Day 1 Through Week 16||4
10255979|NCT02036970|11388056|FG008|STARTED|Part 1: Day 1 Through Week 16||74
10020728|NCT01838616|11144079|FG000|COMPLETED|Titration Period||100
10020729|NCT01838616|11144080|FG001|COMPLETED|Titration Period||62
10255980|NCT02036970|11388057|FG009|STARTED|Part 1: Day 1 Through Week 16||38
10255981|NCT02036970|11388048|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10255982|NCT02036970|11388049|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10255983|NCT02036970|11388050|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
10255984|NCT02036970|11388051|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10255985|NCT02036970|11388052|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10255986|NCT02036970|11388053|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10255987|NCT02036970|11388054|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
10255988|NCT02036970|11388055|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10255989|NCT02036970|11388056|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
10255990|NCT02036970|11388057|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
10255991|NCT02036970|11388048|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10255992|NCT02036970|11388049|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
10255993|NCT02036970|11388050|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10255994|NCT02036970|11388051|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
10255995|NCT02036970|11388052|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10255996|NCT02036970|11388053|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
10255997|NCT02036970|11388054|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10255998|NCT02036970|11388055|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
10255999|NCT02036970|11388056|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10256000|NCT02036970|11388057|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10256001|NCT02036970|11388048|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256002|NCT02036970|11388049|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256003|NCT02036970|11388050|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256004|NCT02036970|11388051|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256005|NCT02036970|11388052|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256006|NCT02036970|11388053|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256007|NCT02036970|11388054|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256008|NCT02036970|11388055|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10256009|NCT02036970|11388056|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
10256010|NCT02036970|11388057|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
10256011|NCT02036970|11388048|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256012|NCT02036970|11388049|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256013|NCT02036970|11388050|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256014|NCT02036970|11388051|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256015|NCT02036970|11388052|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256016|NCT02036970|11388053|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256017|NCT02036970|11388054|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256018|NCT02036970|11388055|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10256019|NCT02036970|11388056|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
10256020|NCT02036970|11388057|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
10256021|NCT02036970|11388048|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256022|NCT02036970|11388049|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256023|NCT02036970|11388050|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256024|NCT02036970|11388051|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256025|NCT02036970|11388052|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256026|NCT02036970|11388053|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256027|NCT02036970|11388054|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256028|NCT02036970|11388055|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10256029|NCT02036970|11388056|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
10256030|NCT02036970|11388057|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
10256031|NCT02036970|11388048|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10256032|NCT02036970|11388049|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10256033|NCT02036970|11388050|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9834838|NCT00788255|10945992|FG000|COMPLETED|Overall Study||25
9834839|NCT00788255|10945992|FG000|NOT COMPLETED|Overall Study||0
9834840|NCT00788372|10945999|FG000|STARTED|Period 1 (up to 4 Weeks)||142
9957768|NCT01452919|11077092|FG000|COMPLETED|Randomization Treatment||0
9957769|NCT01452919|11077093|FG001|COMPLETED|Randomization Treatment||47
9834841|NCT00788372|10945999|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111
9834842|NCT00788372|10945999|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
9834843|NCT00788372|10945999|FG000|STARTED|Period 2 (Week 4 to Week 52)||111
9834844|NCT00788372|10945999|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79
9834845|NCT00788372|10945999|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
9834846|NCT00788593|10946003|FG000|STARTED|Placebo Run-in Phase||82
9834847|NCT00788593|10946004|FG001|STARTED|Placebo Run-in Phase||0
9834848|NCT00788593|10946005|FG002|STARTED|Placebo Run-in Phase||0
9957770|NCT01452919|11077094|FG002|COMPLETED|Randomization Treatment||51
9957771|NCT01452919|11077092|FG000|NOT COMPLETED|Randomization Treatment||0
9957772|NCT01452919|11077093|FG001|NOT COMPLETED|Randomization Treatment||3
10256034|NCT02036970|11388051|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10256035|NCT02036970|11388052|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10256036|NCT02036970|11388053|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10256037|NCT02036970|11388054|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10256038|NCT02036970|11388055|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10256039|NCT02036970|11388056|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
10256040|NCT02036970|11388057|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
10256041|NCT02036970|11388048|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256042|NCT02036970|11388049|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256043|NCT02036970|11388050|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256044|NCT02036970|11388051|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256045|NCT02036970|11388052|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256046|NCT02036970|11388053|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256047|NCT02036970|11388054|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256048|NCT02036970|11388055|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10256049|NCT02036970|11388056|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
10256050|NCT02036970|11388057|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
10256051|NCT02036970|11388048|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256052|NCT02036970|11388049|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256053|NCT02036970|11388050|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256054|NCT02036970|11388051|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256055|NCT02036970|11388052|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256056|NCT02036970|11388053|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256057|NCT02036970|11388054|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256058|NCT02036970|11388055|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10256059|NCT02036970|11388056|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
10256060|NCT02036970|11388057|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
10256061|NCT02036970|11388048|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5
10256062|NCT02036970|11388049|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12
10256063|NCT02036970|11388050|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7
10256064|NCT02036970|11388051|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9
10256065|NCT02036970|11388052|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1
10256066|NCT02036970|11388053|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3
10256067|NCT02036970|11388054|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3
10256068|NCT02036970|11388055|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3
10256069|NCT02036970|11388056|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66
10256070|NCT02036970|11388057|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33
10256071|NCT02036970|11388048|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10256072|NCT02036970|11388049|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
10256073|NCT02036970|11388050|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
10256074|NCT02036970|11388051|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
10256075|NCT02036970|11388052|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10256076|NCT02036970|11388053|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10256077|NCT02036970|11388054|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
10256078|NCT02036970|11388055|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10256079|NCT02036970|11388056|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
10256080|NCT02036970|11388057|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
10256081|NCT02036970|11388048|FG000|STARTED|Part 2: Week 16 Onwards||5
10256082|NCT02036970|11388049|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
10256083|NCT02036970|11388050|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
10256084|NCT02036970|11388051|FG003|STARTED|Part 2: Week 16 Onwards||9
10256085|NCT02036970|11388052|FG004|STARTED|Part 2: Week 16 Onwards||1
10256086|NCT02036970|11388053|FG005|STARTED|Part 2: Week 16 Onwards||3
10256087|NCT02036970|11388054|FG006|STARTED|Part 2: Week 16 Onwards||3
10256088|NCT02036970|11388055|FG007|STARTED|Part 2: Week 16 Onwards||3
10256089|NCT02036970|11388056|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
10256090|NCT02036970|11388057|FG009|STARTED|Part 2: Week 16 Onwards||33
10256091|NCT02036970|11388048|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10256092|NCT02036970|11388049|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10256093|NCT02036970|11388050|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
10256094|NCT02036970|11388051|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10256095|NCT02036970|11388052|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
10256096|NCT02036970|11388053|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
10256097|NCT02036970|11388054|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
10256098|NCT02036970|11388055|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
10256099|NCT02036970|11388056|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
10256100|NCT02036970|11388057|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
10256101|NCT02036970|11388048|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10256102|NCT02036970|11388049|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
10256103|NCT02036970|11388050|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10256104|NCT02036970|11388051|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
10256105|NCT02036970|11388052|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10256106|NCT02036970|11388053|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
10256107|NCT02036970|11388054|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10256108|NCT02036970|11388055|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
10256109|NCT02036970|11388056|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10256110|NCT02036970|11388057|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10256111|NCT02036970|11388048|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256112|NCT02036970|11388049|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256113|NCT02036970|11388050|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256114|NCT02036970|11388051|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256115|NCT02036970|11388052|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256116|NCT02036970|11388053|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256117|NCT02036970|11388054|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256118|NCT02036970|11388055|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10256119|NCT02036970|11388056|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
10256120|NCT02036970|11388057|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
10256121|NCT02036970|11388048|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10256122|NCT02036970|11388049|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10256123|NCT02036970|11388050|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9834849|NCT00788593|10946003|FG000|COMPLETED|Placebo Run-in Phase||76
9834850|NCT00788593|10946004|FG001|COMPLETED|Placebo Run-in Phase||0
9834851|NCT00788593|10946005|FG002|COMPLETED|Placebo Run-in Phase||0
9834852|NCT00788593|10946003|FG000|NOT COMPLETED|Placebo Run-in Phase||6
9834853|NCT00788593|10946004|FG001|NOT COMPLETED|Placebo Run-in Phase||0
9834854|NCT00788593|10946005|FG002|NOT COMPLETED|Placebo Run-in Phase||0
9834855|NCT00788593|10946003|FG000|STARTED|First Intervention Period||0
9834856|NCT00788593|10946004|FG001|STARTED|First Intervention Period||39
9834857|NCT00788593|10946005|FG002|STARTED|First Intervention Period||37
9834858|NCT00788593|10946003|FG000|COMPLETED|First Intervention Period||0
9834859|NCT00788593|10946004|FG001|COMPLETED|First Intervention Period||38
9834860|NCT00788593|10946005|FG002|COMPLETED|First Intervention Period||37
9834861|NCT00788593|10946003|FG000|NOT COMPLETED|First Intervention Period||0
9834862|NCT00788593|10946004|FG001|NOT COMPLETED|First Intervention Period||1
9834863|NCT00788593|10946005|FG002|NOT COMPLETED|First Intervention Period||0
9834864|NCT00788593|10946003|FG000|STARTED|Second Intervention Period||0
9834865|NCT00788593|10946004|FG001|STARTED|Second Intervention Period||38
9834866|NCT00788593|10946005|FG002|STARTED|Second Intervention Period||37
9834867|NCT00788593|10946003|FG000|COMPLETED|Second Intervention Period||0
9834868|NCT00788593|10946004|FG001|COMPLETED|Second Intervention Period||37
9834869|NCT00788593|10946005|FG002|COMPLETED|Second Intervention Period||36
9834870|NCT00788593|10946003|FG000|NOT COMPLETED|Second Intervention Period||0
9834871|NCT00788593|10946004|FG001|NOT COMPLETED|Second Intervention Period||1
9834872|NCT00788593|10946005|FG002|NOT COMPLETED|Second Intervention Period||1
9834873|NCT00788697|10946015|FG000|STARTED|Overall Study||349
9834874|NCT00788697|10946015|FG000|COMPLETED|Overall Study||240
9834875|NCT00788697|10946015|FG000|NOT COMPLETED|Overall Study||109
9834876|NCT00788775|10946029|FG000|STARTED|Overall Study||11
9834877|NCT00788775|10946030|FG001|STARTED|Overall Study||9
9834878|NCT00788775|10946029|FG000|Treated|Overall Study||11
9834879|NCT00788775|10946030|FG001|Treated|Overall Study||8
9834880|NCT00788775|10946029|FG000|COMPLETED|Overall Study||1
9834881|NCT00788775|10946030|FG001|COMPLETED|Overall Study||1
9834882|NCT00788775|10946029|FG000|NOT COMPLETED|Overall Study||10
9834883|NCT00788775|10946030|FG001|NOT COMPLETED|Overall Study||8
9834884|NCT00788827|10946036|FG000|STARTED|Overall Study||7
9834885|NCT00788827|10946036|FG000|COMPLETED|Overall Study||5
9834886|NCT00788827|10946036|FG000|NOT COMPLETED|Overall Study||2
9834887|NCT00788892|10946044|FG000|STARTED|Overall Study||85
9834888|NCT00788892|10946045|FG001|STARTED|Overall Study||41
9834889|NCT00788892|10946044|FG000|COMPLETED|Overall Study||36
9834890|NCT00788892|10946045|FG001|COMPLETED|Overall Study||18
9834891|NCT00788892|10946044|FG000|NOT COMPLETED|Overall Study||49
9834892|NCT00788892|10946045|FG001|NOT COMPLETED|Overall Study||23
9834893|NCT00788957|10946055|FG000|STARTED|Part 1||11
9834894|NCT00788957|10946056|FG001|STARTED|Part 1||0
9834895|NCT00788957|10946057|FG002|STARTED|Part 1||0
9834896|NCT00788957|10946058|FG003|STARTED|Part 1||0
9834897|NCT00788957|10946059|FG004|STARTED|Part 1||0
9834898|NCT00788957|10946060|FG005|STARTED|Part 1||0
9834899|NCT00788957|10946055|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2
9957773|NCT01452919|11077094|FG002|NOT COMPLETED|Randomization Treatment||2
9957774|NCT01453023|11077104|FG000|STARTED|Treatment Period (TP) 1||13
10256124|NCT02036970|11388051|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9834900|NCT00788957|10946056|FG001|COMPLETED|Part 1||0
9834901|NCT00788957|10946057|FG002|COMPLETED|Part 1||0
9834902|NCT00788957|10946058|FG003|COMPLETED|Part 1||0
9834903|NCT00788957|10946059|FG004|COMPLETED|Part 1||0
9834904|NCT00788957|10946060|FG005|COMPLETED|Part 1||0
9834905|NCT00788957|10946055|FG000|NOT COMPLETED|Part 1||9
9834906|NCT00788957|10946056|FG001|NOT COMPLETED|Part 1||0
9957775|NCT01453023|11077105|FG001|STARTED|Treatment Period (TP) 1||13
9957776|NCT01453023|11077104|FG000|COMPLETED|Treatment Period (TP) 1||12
10256125|NCT02036970|11388052|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10256126|NCT02036970|11388053|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10256127|NCT02036970|11388054|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10256128|NCT02036970|11388055|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10256129|NCT02036970|11388056|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
10256130|NCT02036970|11388057|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
10256131|NCT02036970|11388048|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256132|NCT02036970|11388049|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256133|NCT02036970|11388050|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256134|NCT02036970|11388051|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256135|NCT02036970|11388052|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256136|NCT02036970|11388053|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256137|NCT02036970|11388054|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256138|NCT02036970|11388055|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10256139|NCT02036970|11388056|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
10256140|NCT02036970|11388057|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
10256141|NCT02036970|11388048|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256142|NCT02036970|11388049|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256143|NCT02036970|11388050|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256144|NCT02036970|11388051|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256145|NCT02036970|11388052|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256146|NCT02036970|11388053|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256147|NCT02036970|11388054|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256148|NCT02036970|11388055|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10256149|NCT02036970|11388056|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
10256150|NCT02036970|11388057|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
10256151|NCT02036970|11388048|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256152|NCT02036970|11388049|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256153|NCT02036970|11388050|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256154|NCT02036970|11388051|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256155|NCT02036970|11388052|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256156|NCT02036970|11388053|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256157|NCT02036970|11388054|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256158|NCT02036970|11388055|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10256159|NCT02036970|11388056|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
10256160|NCT02036970|11388057|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
10256161|NCT02036970|11388048|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256162|NCT02036970|11388049|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256163|NCT02036970|11388050|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256164|NCT02036970|11388051|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256165|NCT02036970|11388052|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256166|NCT02036970|11388053|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256167|NCT02036970|11388054|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256168|NCT02036970|11388055|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10256169|NCT02036970|11388056|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
10256170|NCT02036970|11388057|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
10256171|NCT02036970|11388048|FG000|COMPLETED|Part 2: Week 16 Onwards||5
10256172|NCT02036970|11388049|FG001|COMPLETED|Part 2: Week 16 Onwards||6
10256173|NCT02036970|11388050|FG002|COMPLETED|Part 2: Week 16 Onwards||3
10256174|NCT02036970|11388051|FG003|COMPLETED|Part 2: Week 16 Onwards||7
10256175|NCT02036970|11388052|FG004|COMPLETED|Part 2: Week 16 Onwards||0
10256176|NCT02036970|11388053|FG005|COMPLETED|Part 2: Week 16 Onwards||3
10256177|NCT02036970|11388054|FG006|COMPLETED|Part 2: Week 16 Onwards||2
10256178|NCT02036970|11388055|FG007|COMPLETED|Part 2: Week 16 Onwards||2
10256179|NCT02036970|11388056|FG008|COMPLETED|Part 2: Week 16 Onwards||54
10256180|NCT02036970|11388057|FG009|COMPLETED|Part 2: Week 16 Onwards||28
10256181|NCT02036970|11388048|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0
10256182|NCT02036970|11388049|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5
10256183|NCT02036970|11388050|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3
10256184|NCT02036970|11388051|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2
10256185|NCT02036970|11388052|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1
10256186|NCT02036970|11388053|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0
10256187|NCT02036970|11388054|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1
10256188|NCT02036970|11388055|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1
10256189|NCT02036970|11388056|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9
10256190|NCT02036970|11388057|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5
10256191|NCT01941719|11388091|FG000|STARTED|Overall Study||48
10256192|NCT01941719|11388092|FG001|STARTED|Overall Study||51
10256193|NCT01941719|11388091|FG000|Month 1|Overall Study||43
10256194|NCT01941719|11388092|FG001|Month 1|Overall Study||48
10256195|NCT01941719|11388091|FG000|Month 3|Overall Study||38
10256196|NCT01941719|11388092|FG001|Month 3|Overall Study||44
10256197|NCT01941719|11388091|FG000|Month 6|Overall Study||34
10256198|NCT01941719|11388092|FG001|Month 6|Overall Study||42
10256199|NCT01941719|11388091|FG000|Month 9|Overall Study||29
10256200|NCT01941719|11388092|FG001|Month 9|Overall Study||37
10256201|NCT01941719|11388091|FG000|Month 12|Overall Study||28
10256202|NCT01941719|11388092|FG001|Month 12|Overall Study||32
10256203|NCT01941719|11388091|FG000|COMPLETED|Overall Study||28
10256204|NCT01941719|11388092|FG001|COMPLETED|Overall Study||32
10256205|NCT01941719|11388091|FG000|NOT COMPLETED|Overall Study||20
10256206|NCT01941719|11388092|FG001|NOT COMPLETED|Overall Study||19
10256207|NCT01578967|11388099|FG000|STARTED|Overall Study||41
10256208|NCT01578967|11388099|FG000|COMPLETED|Overall Study||41
10256209|NCT01578967|11388099|FG000|NOT COMPLETED|Overall Study||0
10256210|NCT01186003|11388108|FG000|STARTED|Overall Study||14
10256211|NCT01186003|11388109|FG001|STARTED|Overall Study||16
10256212|NCT01186003|11388108|FG000|COMPLETED|Overall Study||14
10256213|NCT01186003|11388109|FG001|COMPLETED|Overall Study||16
10256214|NCT01186003|11388108|FG000|NOT COMPLETED|Overall Study||0
9957777|NCT01453023|11077105|FG001|COMPLETED|Treatment Period (TP) 1||12
9957778|NCT01453023|11077104|FG000|NOT COMPLETED|Treatment Period (TP) 1||1
10256215|NCT01186003|11388109|FG001|NOT COMPLETED|Overall Study||0
9957779|NCT01453023|11077105|FG001|NOT COMPLETED|Treatment Period (TP) 1||1
10256216|NCT00943618|11388118|FG000|STARTED|Overall Study||163
10256217|NCT00943618|11388119|FG001|STARTED|Overall Study||166
10256218|NCT00943618|11388120|FG002|STARTED|Overall Study||56
10256219|NCT00943618|11388118|FG000|COMPLETED|Overall Study||108
10256220|NCT00943618|11388119|FG001|COMPLETED|Overall Study||89
10256221|NCT00943618|11388120|FG002|COMPLETED|Overall Study||25
10256222|NCT00943618|11388118|FG000|NOT COMPLETED|Overall Study||55
10256223|NCT00943618|11388119|FG001|NOT COMPLETED|Overall Study||77
10256224|NCT00943618|11388120|FG002|NOT COMPLETED|Overall Study||31
9957780|NCT01453023|11077104|FG000|STARTED|Washout Period||12
9957781|NCT01453023|11077105|FG001|STARTED|Washout Period||12
9957782|NCT01453023|11077104|FG000|COMPLETED|Washout Period||12
9957783|NCT01453023|11077105|FG001|COMPLETED|Washout Period||12
9957784|NCT01453023|11077104|FG000|NOT COMPLETED|Washout Period||0
10256225|NCT03938272|11388130|FG000|STARTED|Overall Study||11
10256226|NCT03938272|11388131|FG001|STARTED|Overall Study||11
10256227|NCT03938272|11388130|FG000|COMPLETED|Overall Study||0
10256228|NCT03938272|11388131|FG001|COMPLETED|Overall Study||1
10256229|NCT03938272|11388130|FG000|NOT COMPLETED|Overall Study||11
10256230|NCT03938272|11388131|FG001|NOT COMPLETED|Overall Study||10
10256231|NCT03641339|11388143|FG000|STARTED|Overall Study||16
10256232|NCT03641339|11388144|FG001|STARTED|Overall Study||17
10256233|NCT03641339|11388145|FG002|STARTED|Overall Study||15
10256234|NCT03641339|11388146|FG003|STARTED|Overall Study||16
10256235|NCT03641339|11388147|FG004|STARTED|Overall Study||15
10256236|NCT03641339|11388148|FG005|STARTED|Overall Study||16
10256237|NCT03641339|11388143|FG000|COMPLETED|Overall Study||15
10256238|NCT03641339|11388144|FG001|COMPLETED|Overall Study||15
10256239|NCT03641339|11388145|FG002|COMPLETED|Overall Study||15
10256240|NCT03641339|11388146|FG003|COMPLETED|Overall Study||14
10256241|NCT03641339|11388147|FG004|COMPLETED|Overall Study||15
10256242|NCT03641339|11388148|FG005|COMPLETED|Overall Study||15
10256243|NCT03641339|11388143|FG000|NOT COMPLETED|Overall Study||1
10256244|NCT03641339|11388144|FG001|NOT COMPLETED|Overall Study||2
10256245|NCT03641339|11388145|FG002|NOT COMPLETED|Overall Study||0
10256246|NCT03641339|11388146|FG003|NOT COMPLETED|Overall Study||2
10256247|NCT03641339|11388147|FG004|NOT COMPLETED|Overall Study||0
10256248|NCT03641339|11388148|FG005|NOT COMPLETED|Overall Study||1
10256249|NCT03625466|11388164|FG000|STARTED|Overall Study||16
10256250|NCT03625466|11388165|FG001|STARTED|Overall Study||35
10256251|NCT03625466|11388164|FG000|COMPLETED|Overall Study||16
10256252|NCT03625466|11388165|FG001|COMPLETED|Overall Study||33
10256253|NCT03625466|11388164|FG000|NOT COMPLETED|Overall Study||0
10256254|NCT03625466|11388165|FG001|NOT COMPLETED|Overall Study||2
10256255|NCT03317795|11388173|FG000|STARTED|Overall Study||9
10256256|NCT03317795|11388174|FG001|STARTED|Overall Study||9
10256257|NCT03317795|11388173|FG000|COMPLETED|Overall Study||7
10256258|NCT03317795|11388174|FG001|COMPLETED|Overall Study||2
10256259|NCT03317795|11388173|FG000|NOT COMPLETED|Overall Study||2
10256260|NCT03317795|11388174|FG001|NOT COMPLETED|Overall Study||7
10256261|NCT03287245|11388184|FG000|STARTED|Overall Study||15
10256262|NCT03287245|11388185|FG001|STARTED|Overall Study||5
10256263|NCT03287245|11388186|FG002|STARTED|Overall Study||6
10256264|NCT03287245|11388187|FG003|STARTED|Overall Study||1
10256265|NCT03287245|11388184|FG000|COMPLETED|Overall Study||0
10256266|NCT03287245|11388185|FG001|COMPLETED|Overall Study||0
10256267|NCT03287245|11388186|FG002|COMPLETED|Overall Study||0
10256268|NCT03287245|11388187|FG003|COMPLETED|Overall Study||0
10256269|NCT03287245|11388184|FG000|NOT COMPLETED|Overall Study||15
10256270|NCT03287245|11388185|FG001|NOT COMPLETED|Overall Study||5
10256271|NCT03287245|11388186|FG002|NOT COMPLETED|Overall Study||6
10256272|NCT03287245|11388187|FG003|NOT COMPLETED|Overall Study||1
10256273|NCT03165916|11388219|FG000|STARTED|Overall Study||58
10256274|NCT03165916|11388220|FG001|STARTED|Overall Study||57
10256275|NCT03165916|11388219|FG000|Reconstruction Interventions|Overall Study||59
10256276|NCT03165916|11388220|FG001|Reconstruction Interventions|Overall Study||57
10256277|NCT03165916|11388219|FG000|COMPLETED|Overall Study||58
10256278|NCT03165916|11388220|FG001|COMPLETED|Overall Study||57
10256279|NCT03165916|11388219|FG000|NOT COMPLETED|Overall Study||0
10256280|NCT03165916|11388220|FG001|NOT COMPLETED|Overall Study||0
10256281|NCT03092219|11388228|FG000|STARTED|Overall Study||150
10256282|NCT03092219|11388229|FG001|STARTED|Overall Study||52
10256283|NCT03092219|11388228|FG000|Baseline / ITT Population|Overall Study||150
10256284|NCT03092219|11388229|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
10256285|NCT03092219|11388228|FG000|Primary Analysis Endpoint|Overall Study||150
10256286|NCT03092219|11388229|FG001|Primary Analysis Endpoint|Overall Study||51
10256287|NCT03092219|11388228|FG000|Pooled SAFT Population|Overall Study||150
10256288|NCT03092219|11388229|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
10256289|NCT03092219|11388228|FG000|COMPLETED|Overall Study||143
10256290|NCT03092219|11388229|FG001|COMPLETED|Overall Study||48
10256291|NCT03092219|11388228|FG000|NOT COMPLETED|Overall Study||7
10256292|NCT03092219|11388229|FG001|NOT COMPLETED|Overall Study||4
10256293|NCT03033069|11388242|FG000|STARTED|Overall Study||82
10256294|NCT03033069|11388243|FG001|STARTED|Overall Study||75
10256295|NCT03033069|11388244|FG002|STARTED|Overall Study||81
10256296|NCT03033069|11388245|FG003|STARTED|Overall Study||83
10256297|NCT03033069|11388242|FG000|Safety Sample|Overall Study||80
10256298|NCT03033069|11388243|FG001|Safety Sample|Overall Study||75
10256299|NCT03033069|11388244|FG002|Safety Sample|Overall Study||79
10256300|NCT03033069|11388245|FG003|Safety Sample|Overall Study||82
10256301|NCT03033069|11388242|FG000|Intent to Treat (ITT) Sample|Overall Study||79
10256302|NCT03033069|11388243|FG001|Intent to Treat (ITT) Sample|Overall Study||72
10256303|NCT03033069|11388244|FG002|Intent to Treat (ITT) Sample|Overall Study||77
10256304|NCT03033069|11388245|FG003|Intent to Treat (ITT) Sample|Overall Study||80
10256305|NCT03033069|11388242|FG000|COMPLETED|Overall Study||58
10256306|NCT03033069|11388243|FG001|COMPLETED|Overall Study||50
10256307|NCT03033069|11388244|FG002|COMPLETED|Overall Study||59
10256308|NCT03033069|11388245|FG003|COMPLETED|Overall Study||64
10256309|NCT03033069|11388242|FG000|NOT COMPLETED|Overall Study||24
10256310|NCT03033069|11388243|FG001|NOT COMPLETED|Overall Study||25
10256311|NCT03033069|11388244|FG002|NOT COMPLETED|Overall Study||22
10256312|NCT03033069|11388245|FG003|NOT COMPLETED|Overall Study||19
10256313|NCT02956434|11388259|FG000|STARTED|Overall Study||10
10256314|NCT02956434|11388260|FG001|STARTED|Overall Study||10
10256315|NCT02956434|11388261|FG002|STARTED|Overall Study||10
10256316|NCT02956434|11388262|FG003|STARTED|Overall Study||10
10256317|NCT02956434|11388259|FG000|COMPLETED|Overall Study||10
10256318|NCT02956434|11388260|FG001|COMPLETED|Overall Study||10
10256319|NCT02956434|11388261|FG002|COMPLETED|Overall Study||10
10256320|NCT02956434|11388262|FG003|COMPLETED|Overall Study||10
10256321|NCT02956434|11388259|FG000|NOT COMPLETED|Overall Study||0
10256322|NCT02956434|11388260|FG001|NOT COMPLETED|Overall Study||0
10256323|NCT02956434|11388261|FG002|NOT COMPLETED|Overall Study||0
10256324|NCT02956434|11388262|FG003|NOT COMPLETED|Overall Study||0
10256325|NCT02609503|11388270|FG000|STARTED|Overall Study||29
10256326|NCT02609503|11388270|FG000|COMPLETED|Overall Study||25
10256327|NCT02609503|11388270|FG000|NOT COMPLETED|Overall Study||4
10256328|NCT02587598|11388288|FG000|STARTED|Overall Study||4
10256329|NCT02587598|11388289|FG001|STARTED|Overall Study||11
10256330|NCT02587598|11388290|FG002|STARTED|Overall Study||4
10256331|NCT02587598|11388291|FG003|STARTED|Overall Study||21
10256332|NCT02587598|11388292|FG004|STARTED|Overall Study||12
10256333|NCT02587598|11388293|FG005|STARTED|Overall Study||6
10256334|NCT02587598|11388294|FG006|STARTED|Overall Study||6
10256335|NCT02587598|11388295|FG007|STARTED|Overall Study||7
10256336|NCT02587598|11388296|FG008|STARTED|Overall Study||9
10256337|NCT02587598|11388297|FG009|STARTED|Overall Study||3
10256338|NCT02587598|11388298|FG010|STARTED|Overall Study||14
10256339|NCT02587598|11388288|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256340|NCT02587598|11388289|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256341|NCT02587598|11388290|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256342|NCT02587598|11388291|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256343|NCT02587598|11388292|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256344|NCT02587598|11388293|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256345|NCT02587598|11388294|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9834907|NCT00788957|10946057|FG002|NOT COMPLETED|Part 1||0
9834908|NCT00788957|10946058|FG003|NOT COMPLETED|Part 1||0
9834909|NCT00788957|10946059|FG004|NOT COMPLETED|Part 1||0
9834910|NCT00788957|10946060|FG005|NOT COMPLETED|Part 1||0
9834911|NCT00788957|10946055|FG000|STARTED|Part 2||0
9834912|NCT00788957|10946056|FG001|STARTED|Part 2||48
9834913|NCT00788957|10946057|FG002|STARTED|Part 2||48
9834914|NCT00788957|10946058|FG003|STARTED|Part 2||46
9834915|NCT00788957|10946059|FG004|STARTED|Part 2||0
9834916|NCT00788957|10946060|FG005|STARTED|Part 2||0
9834917|NCT00788957|10946055|FG000|COMPLETED|Part 2||0
9834918|NCT00788957|10946056|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
9834919|NCT00788957|10946057|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4
9834920|NCT00788957|10946058|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5
9834921|NCT00788957|10946059|FG004|COMPLETED|Part 2||0
9834922|NCT00788957|10946060|FG005|COMPLETED|Part 2||0
9834923|NCT00788957|10946055|FG000|NOT COMPLETED|Part 2||0
9834924|NCT00788957|10946056|FG001|NOT COMPLETED|Part 2||42
10256346|NCT02587598|11388295|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256347|NCT02587598|11388296|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256348|NCT02587598|11388297|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256349|NCT02587598|11388298|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10256350|NCT02587598|11388288|FG000|NOT COMPLETED|Overall Study||4
10256351|NCT02587598|11388289|FG001|NOT COMPLETED|Overall Study||11
10256352|NCT02587598|11388290|FG002|NOT COMPLETED|Overall Study||4
10256353|NCT02587598|11388291|FG003|NOT COMPLETED|Overall Study||21
10256354|NCT02587598|11388292|FG004|NOT COMPLETED|Overall Study||12
10256355|NCT02587598|11388293|FG005|NOT COMPLETED|Overall Study||6
10256356|NCT02587598|11388294|FG006|NOT COMPLETED|Overall Study||6
10256357|NCT02587598|11388295|FG007|NOT COMPLETED|Overall Study||7
10256358|NCT02587598|11388296|FG008|NOT COMPLETED|Overall Study||9
10256359|NCT02587598|11388297|FG009|NOT COMPLETED|Overall Study||3
10256360|NCT02587598|11388298|FG010|NOT COMPLETED|Overall Study||14
10256361|NCT02485574|11388334|FG000|STARTED|Overall Study||69
10256362|NCT02485574|11388334|FG000|COMPLETED|Overall Study||65
10256363|NCT02485574|11388334|FG000|NOT COMPLETED|Overall Study||4
10256364|NCT02214160|11388346|FG000|STARTED|Overall Study||24
10256365|NCT02214160|11388347|FG001|STARTED|Overall Study||37
10256366|NCT02214160|11388348|FG002|STARTED|Overall Study||33
10256367|NCT02214160|11388346|FG000|COMPLETED|Overall Study||20
10256368|NCT02214160|11388347|FG001|COMPLETED|Overall Study||29
10256369|NCT02214160|11388348|FG002|COMPLETED|Overall Study||23
10256370|NCT02214160|11388346|FG000|NOT COMPLETED|Overall Study||4
10256371|NCT02214160|11388347|FG001|NOT COMPLETED|Overall Study||8
10256372|NCT02214160|11388348|FG002|NOT COMPLETED|Overall Study||10
10256373|NCT01899261|11388360|FG000|STARTED|Overall Study||20
10256374|NCT01899261|11388360|FG000|COMPLETED|Overall Study||20
10256375|NCT01899261|11388360|FG000|NOT COMPLETED|Overall Study||0
10256376|NCT01595503|11388364|FG000|STARTED|Overall Study||5
10256377|NCT01595503|11388364|FG000|COMPLETED|Overall Study||5
10256378|NCT01595503|11388364|FG000|NOT COMPLETED|Overall Study||0
10256379|NCT01460160|11388368|FG000|STARTED|Treatment Phase||106
10256380|NCT01460160|11388368|FG000|COMPLETED|Treatment Phase||78
10256381|NCT01460160|11388368|FG000|NOT COMPLETED|Treatment Phase||28
10256382|NCT01460160|11388368|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100
10256383|NCT01460160|11388368|FG000|COMPLETED|Follow-up Phase||0
10256384|NCT01460160|11388368|FG000|NOT COMPLETED|Follow-up Phase||100
10256385|NCT01170702|11388376|FG000|STARTED|Overall Study||34
10256386|NCT01170702|11388377|FG001|STARTED|Overall Study||32
10256387|NCT01170702|11388378|FG002|STARTED|Overall Study||25
10256388|NCT01170702|11388379|FG003|STARTED|Overall Study||29
10256389|NCT01170702|11388376|FG000|COMPLETED|Overall Study||33
10256390|NCT01170702|11388377|FG001|COMPLETED|Overall Study||30
10256391|NCT01170702|11388378|FG002|COMPLETED|Overall Study||25
10256392|NCT01170702|11388379|FG003|COMPLETED|Overall Study||27
10256393|NCT01170702|11388376|FG000|NOT COMPLETED|Overall Study||1
10256394|NCT01170702|11388377|FG001|NOT COMPLETED|Overall Study||2
10256395|NCT01170702|11388378|FG002|NOT COMPLETED|Overall Study||0
10256396|NCT01170702|11388379|FG003|NOT COMPLETED|Overall Study||2
10256397|NCT01018563|11388389|FG000|STARTED|Overall Study||2
10256398|NCT01018563|11388390|FG001|STARTED|Overall Study||1
10256399|NCT01018563|11388389|FG000|COMPLETED|Overall Study||0
10256400|NCT01018563|11388390|FG001|COMPLETED|Overall Study||0
10256401|NCT01018563|11388389|FG000|NOT COMPLETED|Overall Study||2
10256402|NCT01018563|11388390|FG001|NOT COMPLETED|Overall Study||1
10256403|NCT00805961|11388400|FG000|STARTED|Modality Therapy||68
10256404|NCT00805961|11388400|FG000|COMPLETED|Modality Therapy||64
10256405|NCT00805961|11388400|FG000|NOT COMPLETED|Modality Therapy||4
10256406|NCT00805961|11388400|FG000|STARTED|Treatment-Free Interval||64
10256407|NCT00805961|11388400|FG000|COMPLETED|Treatment-Free Interval||57
10256408|NCT00805961|11388400|FG000|NOT COMPLETED|Treatment-Free Interval||7
10256409|NCT00805961|11388400|FG000|STARTED|Maintenance Treatment||57
10256410|NCT00805961|11388400|FG000|COMPLETED|Maintenance Treatment||23
10256411|NCT00805961|11388400|FG000|NOT COMPLETED|Maintenance Treatment||34
10256412|NCT04056182|11388404|FG000|STARTED|Overall Study||20
10256413|NCT04056182|11388404|FG000|COMPLETED|Overall Study||3
10256414|NCT04056182|11388404|FG000|NOT COMPLETED|Overall Study||17
10256415|NCT03954106|11388410|FG000|STARTED|Part 1: Safety Lead In Phase||4
10256416|NCT03954106|11388411|FG001|STARTED|Part 1: Safety Lead In Phase||0
10256417|NCT03954106|11388410|FG000|COMPLETED|Part 1: Safety Lead In Phase||4
10256418|NCT03954106|11388411|FG001|COMPLETED|Part 1: Safety Lead In Phase||0
10256419|NCT03954106|11388410|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0
10256420|NCT03954106|11388411|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0
10256421|NCT03954106|11388410|FG000|STARTED|Phase 2: Treatment at RP2D||0
10256422|NCT03954106|11388411|FG001|STARTED|Phase 2: Treatment at RP2D||21
10256423|NCT03954106|11388410|FG000|COMPLETED|Phase 2: Treatment at RP2D||0
10256424|NCT03954106|11388411|FG001|COMPLETED|Phase 2: Treatment at RP2D||21
10256425|NCT03954106|11388410|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0
10256426|NCT03954106|11388411|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0
10256427|NCT03921424|11388421|FG000|STARTED|Overall Study||203
10256428|NCT03921424|11388422|FG001|STARTED|Overall Study||204
10256429|NCT03921424|11388421|FG000|Vaccination 1 - (Day 1)|Overall Study||203
10256430|NCT03921424|11388422|FG001|Vaccination 1 - (Day 1)|Overall Study||204
10256431|NCT03921424|11388421|FG000|Vaccination 2 - (Week 8)|Overall Study||203
10256432|NCT03921424|11388422|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202
10256433|NCT03921424|11388421|FG000|COMPLETED|Overall Study||203
10256434|NCT03921424|11388422|FG001|COMPLETED|Overall Study||201
10256435|NCT03921424|11388421|FG000|NOT COMPLETED|Overall Study||0
10256436|NCT03921424|11388422|FG001|NOT COMPLETED|Overall Study||3
10256437|NCT03598777|11388435|FG000|STARTED|Overall Study||13
10256438|NCT03598777|11388436|FG001|STARTED|Overall Study||8
10256439|NCT03598777|11388437|FG002|STARTED|Overall Study||8
10256440|NCT03598777|11388438|FG003|STARTED|Overall Study||14
10256441|NCT03598777|11388439|FG004|STARTED|Overall Study||17
10256442|NCT03598777|11388435|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13
10020730|NCT01838616|11144079|FG000|NOT COMPLETED|Titration Period||30
10020731|NCT01838616|11144080|FG001|NOT COMPLETED|Titration Period||66
10020732|NCT01838616|11144079|FG000|STARTED|Continuation Period||100
10020733|NCT01838616|11144080|FG001|STARTED|Continuation Period||62
10020734|NCT01838616|11144079|FG000|Switched to Pick-up Arm|Continuation Period||0
10020735|NCT01838616|11144080|FG001|Switched to Pick-up Arm|Continuation Period||7
10020736|NCT01838616|11144079|FG000|COMPLETED|Continuation Period||86
10020737|NCT01838616|11144080|FG001|COMPLETED|Continuation Period||48
10256443|NCT03598777|11388436|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
10256444|NCT03598777|11388437|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
10256445|NCT03598777|11388438|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14
10256446|NCT03598777|11388439|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17
10256447|NCT03598777|11388435|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
10256448|NCT03598777|11388436|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7
10256449|NCT03598777|11388437|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8
10256450|NCT03598777|11388438|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
10256451|NCT03598777|11388439|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11
10256452|NCT03598777|11388435|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8
10256453|NCT03598777|11388436|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
10256454|NCT03598777|11388437|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
10256455|NCT03598777|11388438|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12
10256456|NCT03598777|11388439|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2
10256457|NCT03598777|11388435|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
10256458|NCT03598777|11388436|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
10256459|NCT03598777|11388437|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
10256460|NCT03598777|11388438|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3
10256461|NCT03598777|11388439|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
10256462|NCT03598777|11388435|FG000|COMPLETED|Overall Study||7
10256463|NCT03598777|11388436|FG001|COMPLETED|Overall Study||7
10256464|NCT03598777|11388437|FG002|COMPLETED|Overall Study||8
10256465|NCT03598777|11388438|FG003|COMPLETED|Overall Study||14
10256466|NCT03598777|11388439|FG004|COMPLETED|Overall Study||2
10256467|NCT03598777|11388435|FG000|NOT COMPLETED|Overall Study||6
10256468|NCT03598777|11388436|FG001|NOT COMPLETED|Overall Study||1
10256469|NCT03598777|11388437|FG002|NOT COMPLETED|Overall Study||0
10256470|NCT03598777|11388438|FG003|NOT COMPLETED|Overall Study||0
10256471|NCT03598777|11388439|FG004|NOT COMPLETED|Overall Study||15
10256472|NCT03406078|11388456|FG000|STARTED|Overall Study||74
10256473|NCT03406078|11388457|FG001|STARTED|Overall Study||76
10256474|NCT03406078|11388456|FG000|COMPLETED|Overall Study||68
10256475|NCT03406078|11388457|FG001|COMPLETED|Overall Study||73
10256476|NCT03406078|11388456|FG000|NOT COMPLETED|Overall Study||6
10256477|NCT03406078|11388457|FG001|NOT COMPLETED|Overall Study||3
10256478|NCT03397589|11388465|FG000|STARTED|Overall Study||211
10256479|NCT03397589|11388466|FG001|STARTED|Overall Study||209
10256480|NCT03397589|11388465|FG000|COMPLETED|Overall Study||175
10256481|NCT03397589|11388466|FG001|COMPLETED|Overall Study||187
10256482|NCT03397589|11388465|FG000|NOT COMPLETED|Overall Study||36
10256483|NCT03397589|11388466|FG001|NOT COMPLETED|Overall Study||22
10256484|NCT03368066|11388472|FG000|STARTED|Overall Study||58
10256485|NCT03368066|11388473|FG001|STARTED|Overall Study||37
10256486|NCT03368066|11388472|FG000|COMPLETED|Overall Study||58
10256487|NCT03368066|11388473|FG001|COMPLETED|Overall Study||37
10256488|NCT03368066|11388472|FG000|NOT COMPLETED|Overall Study||0
10256489|NCT03368066|11388473|FG001|NOT COMPLETED|Overall Study||0
10256490|NCT03345342|11388479|FG000|STARTED|Open-Label Phase||838
10256491|NCT03345342|11388480|FG001|STARTED|Open-Label Phase||0
10256492|NCT03345342|11388481|FG002|STARTED|Open-Label Phase||0
10256493|NCT03345342|11388482|FG003|STARTED|Open-Label Phase||0
10256494|NCT03345342|11388483|FG004|STARTED|Open-Label Phase||0
10256495|NCT03345342|11388479|FG000|COMPLETED|Open-Label Phase||702
10256496|NCT03345342|11388480|FG001|COMPLETED|Open-Label Phase||0
10256497|NCT03345342|11388481|FG002|COMPLETED|Open-Label Phase||0
10256498|NCT03345342|11388482|FG003|COMPLETED|Open-Label Phase||0
10256499|NCT03345342|11388483|FG004|COMPLETED|Open-Label Phase||0
10256500|NCT03345342|11388479|FG000|NOT COMPLETED|Open-Label Phase||136
10256501|NCT03345342|11388480|FG001|NOT COMPLETED|Open-Label Phase||0
10256502|NCT03345342|11388481|FG002|NOT COMPLETED|Open-Label Phase||0
10256503|NCT03345342|11388482|FG003|NOT COMPLETED|Open-Label Phase||0
10256504|NCT03345342|11388483|FG004|NOT COMPLETED|Open-Label Phase||0
10256505|NCT03345342|11388479|FG000|STARTED|Double-Blind Phase||0
10256506|NCT03345342|11388480|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224
10256507|NCT03345342|11388481|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478
10256508|NCT03345342|11388482|FG003|STARTED|Double-Blind Phase||0
10256509|NCT03345342|11388483|FG004|STARTED|Double-Blind Phase||0
10256510|NCT03345342|11388479|FG000|COMPLETED|Double-Blind Phase||0
10256511|NCT03345342|11388480|FG001|COMPLETED|Double-Blind Phase||202
10256512|NCT03345342|11388481|FG002|COMPLETED|Double-Blind Phase||416
10256513|NCT03345342|11388482|FG003|COMPLETED|Double-Blind Phase||0
10256514|NCT03345342|11388483|FG004|COMPLETED|Double-Blind Phase||0
10256515|NCT03345342|11388479|FG000|NOT COMPLETED|Double-Blind Phase||0
10256516|NCT03345342|11388480|FG001|NOT COMPLETED|Double-Blind Phase||22
10256517|NCT03345342|11388481|FG002|NOT COMPLETED|Double-Blind Phase||62
10256518|NCT03345342|11388482|FG003|NOT COMPLETED|Double-Blind Phase||0
10256519|NCT03345342|11388483|FG004|NOT COMPLETED|Double-Blind Phase||0
10256520|NCT03345342|11388479|FG000|STARTED|Follow-Up Phase||0
10256521|NCT03345342|11388480|FG001|STARTED|Follow-Up Phase||0
10256522|NCT03345342|11388481|FG002|STARTED|Follow-Up Phase||0
10256523|NCT03345342|11388482|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42
9957785|NCT01453023|11077105|FG001|NOT COMPLETED|Washout Period||0
9957786|NCT01453023|11077104|FG000|STARTED|Treatment Period 2||12
10256524|NCT03345342|11388483|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109
10256525|NCT03345342|11388479|FG000|COMPLETED|Follow-Up Phase||0
10256526|NCT03345342|11388480|FG001|COMPLETED|Follow-Up Phase||0
10256527|NCT03345342|11388481|FG002|COMPLETED|Follow-Up Phase||0
10256528|NCT03345342|11388482|FG003|COMPLETED|Follow-Up Phase||34
10256529|NCT03345342|11388483|FG004|COMPLETED|Follow-Up Phase||78
10256530|NCT03345342|11388479|FG000|NOT COMPLETED|Follow-Up Phase||0
10256531|NCT03345342|11388480|FG001|NOT COMPLETED|Follow-Up Phase||0
10256532|NCT03345342|11388481|FG002|NOT COMPLETED|Follow-Up Phase||0
10256533|NCT03345342|11388482|FG003|NOT COMPLETED|Follow-Up Phase||8
10256534|NCT03345342|11388483|FG004|NOT COMPLETED|Follow-Up Phase||31
10256535|NCT03218995|11388495|FG000|STARTED|Overall Study||15
10256536|NCT03218995|11388495|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10256537|NCT03218995|11388495|FG000|COMPLETED|Overall Study||15
10256538|NCT03218995|11388495|FG000|NOT COMPLETED|Overall Study||0
10256539|NCT03030222|11388503|FG000|STARTED|Overall Study||33
10256540|NCT03030222|11388504|FG001|STARTED|Overall Study||32
10256541|NCT03030222|11388503|FG000|COMPLETED|Overall Study||33
10256542|NCT03030222|11388504|FG001|COMPLETED|Overall Study||32
10256543|NCT03030222|11388503|FG000|NOT COMPLETED|Overall Study||0
10256544|NCT03030222|11388504|FG001|NOT COMPLETED|Overall Study||0
10256545|NCT02880241|11388516|FG000|STARTED|Overall Study|Study terminated|8
10256546|NCT02880241|11388517|FG001|STARTED|Overall Study|Study terminated|0
10256547|NCT02880241|11388518|FG002|STARTED|Overall Study|Study terminated|0
10256548|NCT02880241|11388519|FG003|STARTED|Overall Study|Study terminated|0
10256549|NCT02880241|11388520|FG004|STARTED|Overall Study|Study terminated|0
10256550|NCT02880241|11388521|FG005|STARTED|Overall Study|Study terminated|0
10256551|NCT02880241|11388516|FG000|COMPLETED|Overall Study|Study terminated|7
10256552|NCT02880241|11388517|FG001|COMPLETED|Overall Study|Study terminated|0
10020738|NCT01838616|11144079|FG000|NOT COMPLETED|Continuation Period||14
10256553|NCT02880241|11388518|FG002|COMPLETED|Overall Study|Study terminated|0
10256554|NCT02880241|11388519|FG003|COMPLETED|Overall Study|Study terminated|0
10256555|NCT02880241|11388520|FG004|COMPLETED|Overall Study|Study terminated|0
10256556|NCT02880241|11388521|FG005|COMPLETED|Overall Study|Study terminated|0
10256557|NCT02880241|11388516|FG000|NOT COMPLETED|Overall Study||1
10256558|NCT02880241|11388517|FG001|NOT COMPLETED|Overall Study||0
10256559|NCT02880241|11388518|FG002|NOT COMPLETED|Overall Study||0
10256560|NCT02880241|11388519|FG003|NOT COMPLETED|Overall Study||0
10256561|NCT02880241|11388520|FG004|NOT COMPLETED|Overall Study||0
10256562|NCT02880241|11388521|FG005|NOT COMPLETED|Overall Study||0
10020739|NCT01838616|11144080|FG001|NOT COMPLETED|Continuation Period||14
10256563|NCT02832687|11388539|FG000|STARTED|Overall Study||41
10256564|NCT02832687|11388540|FG001|STARTED|Overall Study||47
10256565|NCT02832687|11388539|FG000|Participants Who Were Included in the Analysis|Overall Study||31
10256566|NCT02832687|11388540|FG001|Participants Who Were Included in the Analysis|Overall Study||34
10256567|NCT02832687|11388539|FG000|COMPLETED|Overall Study||41
10256568|NCT02832687|11388540|FG001|COMPLETED|Overall Study||45
10256569|NCT02832687|11388539|FG000|NOT COMPLETED|Overall Study||0
10256570|NCT02832687|11388540|FG001|NOT COMPLETED|Overall Study||2
10256571|NCT02568449|11388546|FG000|STARTED|Overall Study||20
10256572|NCT02568449|11388546|FG000|COMPLETED|Overall Study||20
10256573|NCT02568449|11388546|FG000|NOT COMPLETED|Overall Study||0
10256574|NCT02499900|11388552|FG000|STARTED|Core Study Period||430
10256575|NCT02499900|11388553|FG001|STARTED|Core Study Period||431
10256576|NCT02499900|11388552|FG000|Safety Analysis Set|Core Study Period||427
10256577|NCT02499900|11388553|FG001|Safety Analysis Set|Core Study Period||430
10256578|NCT02499900|11388552|FG000|COMPLETED|Core Study Period||395
10256579|NCT02499900|11388553|FG001|COMPLETED|Core Study Period||399
10256580|NCT02499900|11388552|FG000|NOT COMPLETED|Core Study Period||35
10256581|NCT02499900|11388553|FG001|NOT COMPLETED|Core Study Period||32
10256582|NCT02499900|11388552|FG000|STARTED|Completed Core, Continued Into Extension||395
10256583|NCT02499900|11388553|FG001|STARTED|Completed Core, Continued Into Extension||399
10020740|NCT01838616|11144079|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
10020741|NCT01838616|11144080|FG001|STARTED|Pick-up Arm||0
10020742|NCT01838616|11144079|FG000|Full Analysis Set|Pick-up Arm||49
10020743|NCT01838616|11144080|FG001|Full Analysis Set|Pick-up Arm||0
10020744|NCT01838616|11144079|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
10020745|NCT01838616|11144080|FG001|COMPLETED|Pick-up Arm||0
10256584|NCT02499900|11388552|FG000|COMPLETED|Completed Core, Continued Into Extension||392
10256585|NCT02499900|11388553|FG001|COMPLETED|Completed Core, Continued Into Extension||397
10256586|NCT02499900|11388552|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3
10256587|NCT02499900|11388553|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2
10256588|NCT02499900|11388552|FG000|STARTED|Extension Study Period||392
10256589|NCT02499900|11388553|FG001|STARTED|Extension Study Period||397
10256590|NCT02499900|11388552|FG000|Safety Analysis Set|Extension Study Period||392
10256591|NCT02499900|11388553|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
10256592|NCT02499900|11388552|FG000|COMPLETED|Extension Study Period||380
10256593|NCT02499900|11388553|FG001|COMPLETED|Extension Study Period||377
10256594|NCT02499900|11388552|FG000|NOT COMPLETED|Extension Study Period||12
10256595|NCT02499900|11388553|FG001|NOT COMPLETED|Extension Study Period||20
10256596|NCT02481986|11388567|FG000|STARTED|Overall Study||108
10020746|NCT01838616|11144079|FG000|NOT COMPLETED|Pick-up Arm||15
10020747|NCT01838616|11144080|FG001|NOT COMPLETED|Pick-up Arm||0
10020748|NCT01838642|11144091|FG000|STARTED|Overall Study||3
10020749|NCT01838642|11144091|FG000|COMPLETED|Overall Study||2
10020750|NCT01838642|11144091|FG000|NOT COMPLETED|Overall Study||1
10020751|NCT01838655|11144096|FG000|STARTED|Overall Study||5
10020752|NCT01838655|11144096|FG000|COMPLETED|Overall Study||5
10020753|NCT01838655|11144096|FG000|NOT COMPLETED|Overall Study||0
10020754|NCT01838681|11144100|FG000|STARTED|Period A||1986
10020755|NCT01838681|11144101|FG001|STARTED|Period A||0
10020756|NCT01838681|11144102|FG002|STARTED|Period A||0
10020757|NCT01838681|11144103|FG003|STARTED|Period A||0
10020758|NCT01838681|11144100|FG000|COMPLETED|Period A||1661
10020759|NCT01838681|11144101|FG001|COMPLETED|Period A||0
10020760|NCT01838681|11144102|FG002|COMPLETED|Period A||0
10020761|NCT01838681|11144103|FG003|COMPLETED|Period A||0
10020762|NCT01838681|11144100|FG000|NOT COMPLETED|Period A||325
10020763|NCT01838681|11144101|FG001|NOT COMPLETED|Period A||0
10020764|NCT01838681|11144102|FG002|NOT COMPLETED|Period A||0
10020765|NCT01838681|11144103|FG003|NOT COMPLETED|Period A||0
10020766|NCT01838681|11144100|FG000|STARTED|Period B/A+||0
10020767|NCT01838681|11144101|FG001|STARTED|Period B/A+||442
10020768|NCT01838681|11144102|FG002|STARTED|Period B/A+||444
10020769|NCT01838681|11144103|FG003|STARTED|Period B/A+||770
10020770|NCT01838681|11144100|FG000|COMPLETED|Period B/A+||0
10020771|NCT01838681|11144101|FG001|COMPLETED|Period B/A+||380
10020772|NCT01838681|11144102|FG002|COMPLETED|Period B/A+||349
10020773|NCT01838681|11144103|FG003|COMPLETED|Period B/A+||653
10020774|NCT01838681|11144100|FG000|NOT COMPLETED|Period B/A+||0
10020775|NCT01838681|11144101|FG001|NOT COMPLETED|Period B/A+||62
10020776|NCT01838681|11144102|FG002|NOT COMPLETED|Period B/A+||95
10020777|NCT01838681|11144103|FG003|NOT COMPLETED|Period B/A+||117
10256597|NCT02481986|11388568|FG001|STARTED|Overall Study||115
10256598|NCT02481986|11388567|FG000|COMPLETED|Overall Study||103
10256599|NCT02481986|11388568|FG001|COMPLETED|Overall Study||106
10020778|NCT01838694|11144111|FG000|STARTED|Overall Study||8
10020779|NCT01838694|11144112|FG001|STARTED|Overall Study||22
10020780|NCT01838694|11144111|FG000|COMPLETED|Overall Study||8
10020781|NCT01838694|11144112|FG001|COMPLETED|Overall Study||21
10020782|NCT01838694|11144111|FG000|NOT COMPLETED|Overall Study||0
10020783|NCT01838694|11144112|FG001|NOT COMPLETED|Overall Study||1
10256600|NCT02481986|11388567|FG000|NOT COMPLETED|Overall Study||5
10256601|NCT02481986|11388568|FG001|NOT COMPLETED|Overall Study||9
10020784|NCT01838785|11144121|FG000|STARTED|Overall Study||25
10020785|NCT01838785|11144121|FG000|COMPLETED|Overall Study||25
10020786|NCT01838785|11144121|FG000|NOT COMPLETED|Overall Study||0
10020787|NCT01838863|11144127|FG000|STARTED|Overall Study||75
10020788|NCT01838863|11144128|FG001|STARTED|Overall Study||69
10256602|NCT02394548|11388574|FG000|STARTED|Overall Study||26
10256603|NCT02394548|11388574|FG000|COMPLETED|Overall Study||25
10256604|NCT02394548|11388574|FG000|NOT COMPLETED|Overall Study||1
10256605|NCT02269917|11388580|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766
10256606|NCT02269917|11388581|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383
10256607|NCT02269917|11388582|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0
10256608|NCT02269917|11388580|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763
10256609|NCT02269917|11388581|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378
10256610|NCT02269917|11388582|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0
10256611|NCT02269917|11388580|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649
10256612|NCT02269917|11388581|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352
10256613|NCT02269917|11388582|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0
10256614|NCT02269917|11388580|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117
10256615|NCT02269917|11388581|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31
10256616|NCT02269917|11388582|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0
10256617|NCT02269917|11388580|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10256618|NCT02269917|11388581|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10256619|NCT02269917|11388582|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352
10256620|NCT02269917|11388580|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10256621|NCT02269917|11388581|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10256622|NCT02269917|11388582|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314
10256623|NCT02269917|11388580|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10256624|NCT02269917|11388581|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10256625|NCT02269917|11388582|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38
10256626|NCT02225366|11388593|FG000|STARTED|Overall Study||2
10256627|NCT02225366|11388594|FG001|STARTED|Overall Study||1
10256628|NCT02225366|11388593|FG000|COMPLETED|Overall Study||1
10256629|NCT02225366|11388594|FG001|COMPLETED|Overall Study||1
10256630|NCT02225366|11388593|FG000|NOT COMPLETED|Overall Study||1
10256631|NCT02225366|11388594|FG001|NOT COMPLETED|Overall Study||0
10256632|NCT01530997|11388600|FG000|STARTED|Overall Study||45
10256633|NCT01530997|11388600|FG000|COMPLETED|Overall Study||43
10256634|NCT01530997|11388600|FG000|NOT COMPLETED|Overall Study||2
10256635|NCT01109004|11388614|FG000|STARTED|Overall Study||247
10256636|NCT01109004|11388615|FG001|STARTED|Overall Study||254
10256637|NCT01109004|11388616|FG002|STARTED|Overall Study||257
10256638|NCT01109004|11388614|FG000|COMPLETED|Overall Study||247
10256639|NCT01109004|11388615|FG001|COMPLETED|Overall Study||254
10256640|NCT01109004|11388616|FG002|COMPLETED|Overall Study||257
10256641|NCT01109004|11388614|FG000|NOT COMPLETED|Overall Study||0
10256642|NCT01109004|11388615|FG001|NOT COMPLETED|Overall Study||0
10256643|NCT01109004|11388616|FG002|NOT COMPLETED|Overall Study||0
10256644|NCT01067521|11388626|FG000|STARTED|Double-Blind Placebo-Controlled Period||943
10256645|NCT01067521|11388627|FG001|STARTED|Double-Blind Placebo-Controlled Period||461
10256646|NCT01067521|11388626|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859
10256647|NCT01067521|11388627|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430
10256648|NCT01067521|11388626|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
10256649|NCT01067521|11388627|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
10256650|NCT01067521|11388626|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
10256651|NCT01067521|11388627|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
10256652|NCT01067521|11388626|FG000|COMPLETED|Open-Label Period||580
10256653|NCT01067521|11388627|FG001|COMPLETED|Open-Label Period||261
10256654|NCT01067521|11388626|FG000|NOT COMPLETED|Open-Label Period||254
10256655|NCT01067521|11388627|FG001|NOT COMPLETED|Open-Label Period||158
10256656|NCT01047319|11388641|FG000|STARTED|Overall Study||345
10256657|NCT01047319|11388642|FG001|STARTED|Overall Study||350
10256658|NCT01047319|11388643|FG002|STARTED|Overall Study||352
10256659|NCT01047319|11388641|FG000|COMPLETED|Overall Study||0
10256660|NCT01047319|11388642|FG001|COMPLETED|Overall Study||0
10256661|NCT01047319|11388643|FG002|COMPLETED|Overall Study||0
10256662|NCT01047319|11388641|FG000|NOT COMPLETED|Overall Study||345
10256663|NCT01047319|11388642|FG001|NOT COMPLETED|Overall Study||350
10256664|NCT01047319|11388643|FG002|NOT COMPLETED|Overall Study||352
10256665|NCT00988052|11388653|FG000|STARTED|Overall Study||423
10256666|NCT00988052|11388654|FG001|STARTED|Overall Study||416
10256667|NCT00988052|11388653|FG000|COMPLETED|Overall Study||0
10256668|NCT00988052|11388654|FG001|COMPLETED|Overall Study||0
10256669|NCT00988052|11388653|FG000|NOT COMPLETED|Overall Study||423
10256670|NCT00988052|11388654|FG001|NOT COMPLETED|Overall Study||416
10256671|NCT02021773|11388663|FG000|STARTED|Overall Study||89
10256672|NCT02021773|11388664|FG001|STARTED|Overall Study||88
10256673|NCT02021773|11388665|FG002|STARTED|Overall Study||87
10256674|NCT02021773|11388663|FG000|Safety Analysis Set|Overall Study||89
10256675|NCT02021773|11388664|FG001|Safety Analysis Set|Overall Study||88
10256676|NCT02021773|11388665|FG002|Safety Analysis Set|Overall Study||86
10256677|NCT02021773|11388663|FG000|Intent-to-treat (ITT)|Overall Study||89
10256678|NCT02021773|11388664|FG001|Intent-to-treat (ITT)|Overall Study||87
10256679|NCT02021773|11388665|FG002|Intent-to-treat (ITT)|Overall Study||85
10256680|NCT02021773|11388663|FG000|COMPLETED|Overall Study||77
10256681|NCT02021773|11388664|FG001|COMPLETED|Overall Study||72
10256682|NCT02021773|11388665|FG002|COMPLETED|Overall Study||76
10256683|NCT02021773|11388663|FG000|NOT COMPLETED|Overall Study||12
10256684|NCT02021773|11388664|FG001|NOT COMPLETED|Overall Study||16
10256685|NCT02021773|11388665|FG002|NOT COMPLETED|Overall Study||11
10256686|NCT04689932|11388673|FG000|STARTED|Overall Study||12
10256687|NCT04689932|11388673|FG000|COMPLETED|Overall Study||12
10256688|NCT04689932|11388673|FG000|NOT COMPLETED|Overall Study||0
10256689|NCT04635579|11388680|FG000|STARTED|Overall Study||20
10256690|NCT04635579|11388681|FG001|STARTED|Overall Study||20
10256691|NCT04635579|11388680|FG000|COMPLETED|Overall Study||20
10256692|NCT04635579|11388681|FG001|COMPLETED|Overall Study||20
10256693|NCT04635579|11388680|FG000|NOT COMPLETED|Overall Study||0
10256694|NCT04635579|11388681|FG001|NOT COMPLETED|Overall Study||0
10256695|NCT04553406|11388689|FG000|STARTED|Overall Study||1
10256696|NCT04553406|11388690|FG001|STARTED|Overall Study||1
10256697|NCT04553406|11388689|FG000|COMPLETED|Overall Study||1
10256698|NCT04553406|11388690|FG001|COMPLETED|Overall Study||0
10256699|NCT04553406|11388689|FG000|NOT COMPLETED|Overall Study||0
10256700|NCT04553406|11388690|FG001|NOT COMPLETED|Overall Study||1
10256701|NCT03792750|11388696|FG000|STARTED|Overall Study||12
10256702|NCT03792750|11388696|FG000|COMPLETED|Overall Study||9
10256703|NCT03792750|11388696|FG000|NOT COMPLETED|Overall Study||3
10256704|NCT03739593|11388704|FG000|STARTED|Overall Study||5
10256705|NCT03739593|11388705|FG001|STARTED|Overall Study||22
10256706|NCT03739593|11388706|FG002|STARTED|Overall Study||22
10256707|NCT03739593|11388704|FG000|COMPLETED|Overall Study||2
10256708|NCT03739593|11388705|FG001|COMPLETED|Overall Study||16
10256709|NCT03739593|11388706|FG002|COMPLETED|Overall Study||14
10256710|NCT03739593|11388704|FG000|NOT COMPLETED|Overall Study||3
10256711|NCT03739593|11388705|FG001|NOT COMPLETED|Overall Study||6
10256712|NCT03739593|11388706|FG002|NOT COMPLETED|Overall Study||8
10256713|NCT03739138|11388717|FG000|STARTED|Overall Study||0
10256714|NCT03739138|11388718|FG001|STARTED|Overall Study||7
10256715|NCT03739138|11388719|FG002|STARTED|Overall Study||5
10256716|NCT03739138|11388720|FG003|STARTED|Overall Study||18
10256717|NCT03739138|11388721|FG004|STARTED|Overall Study||0
10256718|NCT03739138|11388717|FG000|COMPLETED|Overall Study||0
10256719|NCT03739138|11388718|FG001|COMPLETED|Overall Study||0
10256720|NCT03739138|11388719|FG002|COMPLETED|Overall Study||0
10256721|NCT03739138|11388720|FG003|COMPLETED|Overall Study||0
10256722|NCT03739138|11388721|FG004|COMPLETED|Overall Study||0
10256723|NCT03739138|11388717|FG000|NOT COMPLETED|Overall Study||0
10256724|NCT03739138|11388718|FG001|NOT COMPLETED|Overall Study||7
10256725|NCT03739138|11388719|FG002|NOT COMPLETED|Overall Study||5
10256726|NCT03739138|11388720|FG003|NOT COMPLETED|Overall Study||18
10256727|NCT03739138|11388721|FG004|NOT COMPLETED|Overall Study||0
10256728|NCT03518086|11388731|FG000|STARTED|Overall Study||322
10256729|NCT03518086|11388732|FG001|STARTED|Overall Study||959
10256730|NCT03518086|11388733|FG002|STARTED|Overall Study||0
10256731|NCT03518086|11388734|FG003|STARTED|Overall Study||0
10256732|NCT03518086|11388731|FG000|Received at Least One Dose of Study Drug|Overall Study||321
10256733|NCT03518086|11388732|FG001|Received at Least One Dose of Study Drug|Overall Study||958
10256734|NCT03518086|11388733|FG002|Received at Least One Dose of Study Drug|Overall Study||0
10256735|NCT03518086|11388734|FG003|Received at Least One Dose of Study Drug|Overall Study||0
10256736|NCT03518086|11388731|FG000|COMPLETED|Overall Study||285
10256737|NCT03518086|11388732|FG001|COMPLETED|Overall Study||920
10256738|NCT03518086|11388733|FG002|COMPLETED|Overall Study||0
10020789|NCT01838863|11144127|FG000|COMPLETED|Overall Study||65
10020790|NCT01838863|11144128|FG001|COMPLETED|Overall Study||60
10020791|NCT01838863|11144127|FG000|NOT COMPLETED|Overall Study||10
10020792|NCT01838863|11144128|FG001|NOT COMPLETED|Overall Study||9
10256739|NCT03518086|11388734|FG003|COMPLETED|Overall Study||0
10256740|NCT03518086|11388731|FG000|NOT COMPLETED|Overall Study||37
10256741|NCT03518086|11388732|FG001|NOT COMPLETED|Overall Study||39
10256742|NCT03518086|11388733|FG002|NOT COMPLETED|Overall Study||0
10256743|NCT03518086|11388734|FG003|NOT COMPLETED|Overall Study||0
10256744|NCT03468309|11388741|FG000|STARTED|Overall Study||53
10256745|NCT03468309|11388741|FG000|COMPLETED|Overall Study||47
10256746|NCT03468309|11388741|FG000|NOT COMPLETED|Overall Study||6
10256747|NCT03347123|11388747|FG000|STARTED|Overall Study||5
10256748|NCT03347123|11388748|FG001|STARTED|Overall Study||6
10256749|NCT03347123|11388749|FG002|STARTED|Overall Study||0
10256750|NCT03347123|11388750|FG003|STARTED|Overall Study||0
10256751|NCT03347123|11388751|FG004|STARTED|Overall Study||0
10256752|NCT03347123|11388752|FG005|STARTED|Overall Study||0
10256753|NCT03347123|11388753|FG006|STARTED|Overall Study||0
10256754|NCT03347123|11388747|FG000|COMPLETED|Overall Study||0
10256755|NCT03347123|11388748|FG001|COMPLETED|Overall Study||0
10256756|NCT03347123|11388749|FG002|COMPLETED|Overall Study||0
10256757|NCT03347123|11388750|FG003|COMPLETED|Overall Study||0
10256758|NCT03347123|11388751|FG004|COMPLETED|Overall Study||0
10256759|NCT03347123|11388752|FG005|COMPLETED|Overall Study||0
10256760|NCT03347123|11388753|FG006|COMPLETED|Overall Study||0
10256761|NCT03347123|11388747|FG000|NOT COMPLETED|Overall Study||5
10256762|NCT03347123|11388748|FG001|NOT COMPLETED|Overall Study||6
10256763|NCT03347123|11388749|FG002|NOT COMPLETED|Overall Study||0
10256764|NCT03347123|11388750|FG003|NOT COMPLETED|Overall Study||0
10256765|NCT03347123|11388751|FG004|NOT COMPLETED|Overall Study||0
10256766|NCT03347123|11388752|FG005|NOT COMPLETED|Overall Study||0
10256767|NCT03347123|11388753|FG006|NOT COMPLETED|Overall Study||0
10256768|NCT03318523|11388768|FG000|STARTED|PC Period: Up to Year 1||100
10256769|NCT03318523|11388769|FG001|STARTED|PC Period: Up to Year 1||55
10256770|NCT03318523|11388770|FG002|STARTED|PC Period: Up to Year 1||102
10020793|NCT01838876|11144134|FG000|STARTED|Overall Study||442
10256771|NCT03318523|11388771|FG003|STARTED|PC Period: Up to Year 1||100
10020794|NCT01838876|11144134|FG000|Safety Population; Received Study Drug|Overall Study||345
10256772|NCT03318523|11388772|FG004|STARTED|PC Period: Up to Year 1||0
10256773|NCT03318523|11388773|FG005|STARTED|PC Period: Up to Year 1||0
10256774|NCT03318523|11388774|FG006|STARTED|PC Period: Up to Year 1||0
10256775|NCT03318523|11388775|FG007|STARTED|PC Period: Up to Year 1||0
10256776|NCT03318523|11388776|FG008|STARTED|PC Period: Up to Year 1||0
10256777|NCT03318523|11388777|FG009|STARTED|PC Period: Up to Year 1||0
10256778|NCT03318523|11388768|FG000|COMPLETED|PC Period: Up to Year 1||96
10256779|NCT03318523|11388769|FG001|COMPLETED|PC Period: Up to Year 1||53
10256780|NCT03318523|11388770|FG002|COMPLETED|PC Period: Up to Year 1||100
10256781|NCT03318523|11388771|FG003|COMPLETED|PC Period: Up to Year 1||96
10256782|NCT03318523|11388772|FG004|COMPLETED|PC Period: Up to Year 1||0
10256783|NCT03318523|11388773|FG005|COMPLETED|PC Period: Up to Year 1||0
10256784|NCT03318523|11388774|FG006|COMPLETED|PC Period: Up to Year 1||0
10256785|NCT03318523|11388775|FG007|COMPLETED|PC Period: Up to Year 1||0
10256786|NCT03318523|11388776|FG008|COMPLETED|PC Period: Up to Year 1||0
10256787|NCT03318523|11388777|FG009|COMPLETED|PC Period: Up to Year 1||0
10256788|NCT03318523|11388768|FG000|NOT COMPLETED|PC Period: Up to Year 1||4
10256789|NCT03318523|11388769|FG001|NOT COMPLETED|PC Period: Up to Year 1||2
10256790|NCT03318523|11388770|FG002|NOT COMPLETED|PC Period: Up to Year 1||2
10256791|NCT03318523|11388771|FG003|NOT COMPLETED|PC Period: Up to Year 1||4
10256792|NCT03318523|11388772|FG004|NOT COMPLETED|PC Period: Up to Year 1||0
10256793|NCT03318523|11388773|FG005|NOT COMPLETED|PC Period: Up to Year 1||0
10256794|NCT03318523|11388774|FG006|NOT COMPLETED|PC Period: Up to Year 1||0
10256795|NCT03318523|11388775|FG007|NOT COMPLETED|PC Period: Up to Year 1||0
10256796|NCT03318523|11388776|FG008|NOT COMPLETED|PC Period: Up to Year 1||0
10256797|NCT03318523|11388777|FG009|NOT COMPLETED|PC Period: Up to Year 1||0
10256798|NCT03318523|11388768|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256799|NCT03318523|11388769|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256800|NCT03318523|11388770|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256801|NCT03318523|11388771|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256802|NCT03318523|11388772|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10256803|NCT03318523|11388773|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10256804|NCT03318523|11388774|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10256805|NCT03318523|11388775|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10256806|NCT03318523|11388776|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10256807|NCT03318523|11388777|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
10256808|NCT03318523|11388768|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256809|NCT03318523|11388769|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256810|NCT03318523|11388770|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256811|NCT03318523|11388771|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256812|NCT03318523|11388772|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10256813|NCT03318523|11388773|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10256814|NCT03318523|11388774|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10256815|NCT03318523|11388775|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10256816|NCT03318523|11388776|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10256817|NCT03318523|11388777|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94
10256818|NCT03318523|11388768|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256819|NCT03318523|11388769|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256820|NCT03318523|11388770|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256821|NCT03318523|11388771|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256822|NCT03318523|11388772|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256823|NCT03318523|11388773|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256824|NCT03318523|11388774|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256825|NCT03318523|11388775|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256826|NCT03318523|11388776|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256827|NCT03318523|11388777|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9834925|NCT00788957|10946057|FG002|NOT COMPLETED|Part 2||44
9834926|NCT00788957|10946058|FG003|NOT COMPLETED|Part 2||41
9834927|NCT00788957|10946059|FG004|NOT COMPLETED|Part 2||0
9834928|NCT00788957|10946060|FG005|NOT COMPLETED|Part 2||0
9834929|NCT00788957|10946055|FG000|STARTED|Part 3||0
10256828|NCT03318523|11388768|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256829|NCT03318523|11388769|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256830|NCT03318523|11388770|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256831|NCT03318523|11388771|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10256832|NCT03318523|11388772|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10256833|NCT03318523|11388773|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10256834|NCT03318523|11388774|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10256835|NCT03318523|11388775|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10256836|NCT03318523|11388776|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10256837|NCT03318523|11388777|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
10256838|NCT02906020|11388811|FG000|STARTED|Part 1: Dose Escalation Period||4
10256839|NCT02906020|11388812|FG001|STARTED|Part 1: Dose Escalation Period||4
10256840|NCT02906020|11388813|FG002|STARTED|Part 1: Dose Escalation Period||5
9834930|NCT00788957|10946056|FG001|STARTED|Part 3||0
9834931|NCT00788957|10946057|FG002|STARTED|Part 3||0
10256841|NCT02906020|11388814|FG003|STARTED|Part 1: Dose Escalation Period||4
10256842|NCT02906020|11388815|FG004|STARTED|Part 1: Dose Escalation Period||3
10256843|NCT02906020|11388816|FG005|STARTED|Part 1: Dose Escalation Period||3
10256844|NCT02906020|11388817|FG006|STARTED|Part 1: Dose Escalation Period||3
10256845|NCT02906020|11388818|FG007|STARTED|Part 1: Dose Escalation Period||3
10256846|NCT02906020|11388819|FG008|STARTED|Part 1: Dose Escalation Period||0
10256847|NCT02906020|11388820|FG009|STARTED|Part 1: Dose Escalation Period||0
10256848|NCT02906020|11388821|FG010|STARTED|Part 1: Dose Escalation Period||0
10256849|NCT02906020|11388822|FG011|STARTED|Part 1: Dose Escalation Period||0
10256850|NCT02906020|11388823|FG012|STARTED|Part 1: Dose Escalation Period||0
10256851|NCT02906020|11388824|FG013|STARTED|Part 1: Dose Escalation Period||0
10256852|NCT02906020|11388825|FG014|STARTED|Part 1: Dose Escalation Period||0
10256853|NCT02906020|11388826|FG015|STARTED|Part 1: Dose Escalation Period||0
10256854|NCT02906020|11388811|FG000|Treated|Part 1: Dose Escalation Period||4
10256855|NCT02906020|11388812|FG001|Treated|Part 1: Dose Escalation Period||4
10256856|NCT02906020|11388813|FG002|Treated|Part 1: Dose Escalation Period||5
10256857|NCT02906020|11388814|FG003|Treated|Part 1: Dose Escalation Period||4
10256858|NCT02906020|11388815|FG004|Treated|Part 1: Dose Escalation Period||3
10256859|NCT02906020|11388816|FG005|Treated|Part 1: Dose Escalation Period||3
10256860|NCT02906020|11388817|FG006|Treated|Part 1: Dose Escalation Period||3
10256861|NCT02906020|11388818|FG007|Treated|Part 1: Dose Escalation Period||3
10256862|NCT02906020|11388819|FG008|Treated|Part 1: Dose Escalation Period||0
10256863|NCT02906020|11388820|FG009|Treated|Part 1: Dose Escalation Period||0
10256864|NCT02906020|11388821|FG010|Treated|Part 1: Dose Escalation Period||0
10256865|NCT02906020|11388822|FG011|Treated|Part 1: Dose Escalation Period||0
10256866|NCT02906020|11388823|FG012|Treated|Part 1: Dose Escalation Period||0
10256867|NCT02906020|11388824|FG013|Treated|Part 1: Dose Escalation Period||0
10256868|NCT02906020|11388825|FG014|Treated|Part 1: Dose Escalation Period||0
10256869|NCT02906020|11388826|FG015|Treated|Part 1: Dose Escalation Period||0
10256870|NCT02906020|11388811|FG000|COMPLETED|Part 1: Dose Escalation Period||4
10256871|NCT02906020|11388812|FG001|COMPLETED|Part 1: Dose Escalation Period||3
10256872|NCT02906020|11388813|FG002|COMPLETED|Part 1: Dose Escalation Period||5
10256873|NCT02906020|11388814|FG003|COMPLETED|Part 1: Dose Escalation Period||3
10256874|NCT02906020|11388815|FG004|COMPLETED|Part 1: Dose Escalation Period||3
10256875|NCT02906020|11388816|FG005|COMPLETED|Part 1: Dose Escalation Period||3
10256876|NCT02906020|11388817|FG006|COMPLETED|Part 1: Dose Escalation Period||3
10256877|NCT02906020|11388818|FG007|COMPLETED|Part 1: Dose Escalation Period||3
10256878|NCT02906020|11388819|FG008|COMPLETED|Part 1: Dose Escalation Period||0
10256879|NCT02906020|11388820|FG009|COMPLETED|Part 1: Dose Escalation Period||0
10256880|NCT02906020|11388821|FG010|COMPLETED|Part 1: Dose Escalation Period||0
10020795|NCT01838876|11144134|FG000|Entered Safety Follow-up Period|Overall Study||287
10020796|NCT01838876|11144134|FG000|COMPLETED|Overall Study||209
10020797|NCT01838876|11144134|FG000|NOT COMPLETED|Overall Study||233
10020798|NCT01838941|11144140|FG000|STARTED|Overall Study||12
10020799|NCT01838941|11144140|FG000|COMPLETED|Overall Study||10
10256881|NCT02906020|11388822|FG011|COMPLETED|Part 1: Dose Escalation Period||0
10256882|NCT02906020|11388823|FG012|COMPLETED|Part 1: Dose Escalation Period||0
10256883|NCT02906020|11388824|FG013|COMPLETED|Part 1: Dose Escalation Period||0
10256884|NCT02906020|11388825|FG014|COMPLETED|Part 1: Dose Escalation Period||0
10256885|NCT02906020|11388826|FG015|COMPLETED|Part 1: Dose Escalation Period||0
10256886|NCT02906020|11388811|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256887|NCT02906020|11388812|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1
10256888|NCT02906020|11388813|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256889|NCT02906020|11388814|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1
10256890|NCT02906020|11388815|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256891|NCT02906020|11388816|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256892|NCT02906020|11388817|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256893|NCT02906020|11388818|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256894|NCT02906020|11388819|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256895|NCT02906020|11388820|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256896|NCT02906020|11388821|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256897|NCT02906020|11388822|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256898|NCT02906020|11388823|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256899|NCT02906020|11388824|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256900|NCT02906020|11388825|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256901|NCT02906020|11388826|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0
10256902|NCT02906020|11388811|FG000|STARTED|Part 2: Double-blind Treatment Period||0
10256903|NCT02906020|11388812|FG001|STARTED|Part 2: Double-blind Treatment Period||0
10256904|NCT02906020|11388813|FG002|STARTED|Part 2: Double-blind Treatment Period||0
10256905|NCT02906020|11388814|FG003|STARTED|Part 2: Double-blind Treatment Period||0
10256906|NCT02906020|11388815|FG004|STARTED|Part 2: Double-blind Treatment Period||0
10256907|NCT02906020|11388816|FG005|STARTED|Part 2: Double-blind Treatment Period||0
10256908|NCT02906020|11388817|FG006|STARTED|Part 2: Double-blind Treatment Period||0
10256909|NCT02906020|11388818|FG007|STARTED|Part 2: Double-blind Treatment Period||0
10256910|NCT02906020|11388819|FG008|STARTED|Part 2: Double-blind Treatment Period||111
10256911|NCT02906020|11388820|FG009|STARTED|Part 2: Double-blind Treatment Period||110
10256912|NCT02906020|11388821|FG010|STARTED|Part 2: Double-blind Treatment Period||10
10020800|NCT01838941|11144140|FG000|NOT COMPLETED|Overall Study||2
10020801|NCT01838980|11144145|FG000|STARTED|Overall Study||15
10256913|NCT02906020|11388822|FG011|STARTED|Part 2: Double-blind Treatment Period||13
10256914|NCT02906020|11388823|FG012|STARTED|Part 2: Double-blind Treatment Period||0
10256915|NCT02906020|11388824|FG013|STARTED|Part 2: Double-blind Treatment Period||0
10256916|NCT02906020|11388825|FG014|STARTED|Part 2: Double-blind Treatment Period||0
10256917|NCT02906020|11388826|FG015|STARTED|Part 2: Double-blind Treatment Period||0
10256918|NCT02906020|11388811|FG000|Treated|Part 2: Double-blind Treatment Period||0
10256919|NCT02906020|11388812|FG001|Treated|Part 2: Double-blind Treatment Period||0
10256920|NCT02906020|11388813|FG002|Treated|Part 2: Double-blind Treatment Period||0
10256921|NCT02906020|11388814|FG003|Treated|Part 2: Double-blind Treatment Period||0
10256922|NCT02906020|11388815|FG004|Treated|Part 2: Double-blind Treatment Period||0
10256923|NCT02906020|11388816|FG005|Treated|Part 2: Double-blind Treatment Period||0
10256924|NCT02906020|11388817|FG006|Treated|Part 2: Double-blind Treatment Period||0
10256925|NCT02906020|11388818|FG007|Treated|Part 2: Double-blind Treatment Period||0
10256926|NCT02906020|11388819|FG008|Treated|Part 2: Double-blind Treatment Period||111
10256927|NCT02906020|11388820|FG009|Treated|Part 2: Double-blind Treatment Period||110
10256928|NCT02906020|11388821|FG010|Treated|Part 2: Double-blind Treatment Period||10
10256929|NCT02906020|11388822|FG011|Treated|Part 2: Double-blind Treatment Period||13
10256930|NCT02906020|11388823|FG012|Treated|Part 2: Double-blind Treatment Period||0
10256931|NCT02906020|11388824|FG013|Treated|Part 2: Double-blind Treatment Period||0
10256932|NCT02906020|11388825|FG014|Treated|Part 2: Double-blind Treatment Period||0
10256933|NCT02906020|11388826|FG015|Treated|Part 2: Double-blind Treatment Period||0
10256934|NCT02906020|11388811|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0
10256935|NCT02906020|11388812|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0
10256936|NCT02906020|11388813|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0
10256937|NCT02906020|11388814|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0
10256938|NCT02906020|11388815|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0
10256939|NCT02906020|11388816|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0
10256940|NCT02906020|11388817|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0
10256941|NCT02906020|11388818|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0
10256942|NCT02906020|11388819|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99
10256943|NCT02906020|11388820|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85
10256944|NCT02906020|11388821|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10
10256945|NCT02906020|11388822|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13
10256946|NCT02906020|11388823|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0
10256947|NCT02906020|11388824|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0
10256948|NCT02906020|11388825|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0
9834932|NCT00788957|10946058|FG003|STARTED|Part 3||0
9834933|NCT00788957|10946059|FG004|STARTED|Part 3||13
9834934|NCT00788957|10946060|FG005|STARTED|Part 3||12
9834935|NCT00788957|10946055|FG000|COMPLETED|Part 3||0
9834936|NCT00788957|10946056|FG001|COMPLETED|Part 3||0
9834937|NCT00788957|10946057|FG002|COMPLETED|Part 3||0
9834938|NCT00788957|10946058|FG003|COMPLETED|Part 3||0
9834939|NCT00788957|10946059|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4
9834940|NCT00788957|10946060|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1
9834941|NCT00788957|10946055|FG000|NOT COMPLETED|Part 3||0
9834942|NCT00788957|10946056|FG001|NOT COMPLETED|Part 3||0
9834943|NCT00788957|10946057|FG002|NOT COMPLETED|Part 3||0
9834944|NCT00788957|10946058|FG003|NOT COMPLETED|Part 3||0
9834945|NCT00788957|10946059|FG004|NOT COMPLETED|Part 3||9
9834946|NCT00788957|10946060|FG005|NOT COMPLETED|Part 3||11
9957787|NCT01453023|11077105|FG001|STARTED|Treatment Period 2||12
9957788|NCT01453023|11077104|FG000|COMPLETED|Treatment Period 2||12
9957789|NCT01453023|11077105|FG001|COMPLETED|Treatment Period 2||11
9957790|NCT01453023|11077104|FG000|NOT COMPLETED|Treatment Period 2||0
9957791|NCT01453023|11077105|FG001|NOT COMPLETED|Treatment Period 2||1
9957792|NCT01453036|11077114|FG000|STARTED|Overall Study||308
9957793|NCT01453036|11077115|FG001|STARTED|Overall Study||308
9957794|NCT01453036|11077116|FG002|STARTED|Overall Study||308
9957795|NCT01453036|11077114|FG000|COMPLETED|Overall Study||282
9957796|NCT01453036|11077115|FG001|COMPLETED|Overall Study||193
9957797|NCT01453036|11077116|FG002|COMPLETED|Overall Study||277
9957798|NCT01453036|11077114|FG000|NOT COMPLETED|Overall Study||26
9957799|NCT01453036|11077115|FG001|NOT COMPLETED|Overall Study||115
9957800|NCT01453036|11077116|FG002|NOT COMPLETED|Overall Study||31
9957801|NCT01453049|11077126|FG000|STARTED|Overall Study||42
9957802|NCT01453049|11077127|FG001|STARTED|Overall Study||44
9957803|NCT01453049|11077126|FG000|COMPLETED|Overall Study||1
9957804|NCT01453049|11077127|FG001|COMPLETED|Overall Study||2
9957805|NCT01453049|11077126|FG000|NOT COMPLETED|Overall Study||41
9957806|NCT01453049|11077127|FG001|NOT COMPLETED|Overall Study||42
9957807|NCT01453075|11077135|FG000|STARTED|Overall Study||16
9834947|NCT00789035|10946082|FG000|STARTED|Overall Study||82
9957808|NCT01453075|11077136|FG001|STARTED|Overall Study||15
9957809|NCT01453075|11077135|FG000|COMPLETED|Overall Study||11
9957810|NCT01453075|11077136|FG001|COMPLETED|Overall Study||14
9957811|NCT01453075|11077135|FG000|NOT COMPLETED|Overall Study||5
9957812|NCT01453075|11077136|FG001|NOT COMPLETED|Overall Study||1
9957813|NCT01453153|11077145|FG000|STARTED|Overall Study||4
9957814|NCT01453153|11077146|FG001|STARTED|Overall Study||4
9957815|NCT01453153|11077147|FG002|STARTED|Overall Study||20
9957816|NCT01453153|11077145|FG000|COMPLETED|Overall Study||0
9957817|NCT01453153|11077146|FG001|COMPLETED|Overall Study||0
9957818|NCT01453153|11077147|FG002|COMPLETED|Overall Study||0
9957819|NCT01453153|11077145|FG000|NOT COMPLETED|Overall Study||4
10256949|NCT02906020|11388826|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0
10256950|NCT02906020|11388811|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256951|NCT02906020|11388812|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256952|NCT02906020|11388813|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256953|NCT02906020|11388814|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256954|NCT02906020|11388815|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256955|NCT02906020|11388816|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256956|NCT02906020|11388817|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256957|NCT02906020|11388818|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256958|NCT02906020|11388819|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12
10256959|NCT02906020|11388820|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25
10256960|NCT02906020|11388821|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256961|NCT02906020|11388822|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256962|NCT02906020|11388823|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256963|NCT02906020|11388824|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256964|NCT02906020|11388825|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256965|NCT02906020|11388826|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10256966|NCT02906020|11388811|FG000|STARTED|Part 2: Long-term Follow-up Period||0
10256967|NCT02906020|11388812|FG001|STARTED|Part 2: Long-term Follow-up Period||0
10256968|NCT02906020|11388813|FG002|STARTED|Part 2: Long-term Follow-up Period||0
10256969|NCT02906020|11388814|FG003|STARTED|Part 2: Long-term Follow-up Period||0
10256970|NCT02906020|11388815|FG004|STARTED|Part 2: Long-term Follow-up Period||0
10256971|NCT02906020|11388816|FG005|STARTED|Part 2: Long-term Follow-up Period||0
10256972|NCT02906020|11388817|FG006|STARTED|Part 2: Long-term Follow-up Period||0
10256973|NCT02906020|11388818|FG007|STARTED|Part 2: Long-term Follow-up Period||0
10256974|NCT02906020|11388819|FG008|STARTED|Part 2: Long-term Follow-up Period||0
10256975|NCT02906020|11388820|FG009|STARTED|Part 2: Long-term Follow-up Period||0
10256976|NCT02906020|11388821|FG010|STARTED|Part 2: Long-term Follow-up Period||0
10256977|NCT02906020|11388822|FG011|STARTED|Part 2: Long-term Follow-up Period||0
10256978|NCT02906020|11388823|FG012|STARTED|Part 2: Long-term Follow-up Period||99
10256979|NCT02906020|11388824|FG013|STARTED|Part 2: Long-term Follow-up Period||85
10256980|NCT02906020|11388825|FG014|STARTED|Part 2: Long-term Follow-up Period||10
10256981|NCT02906020|11388826|FG015|STARTED|Part 2: Long-term Follow-up Period|Out of 13 completed participants in the previous part 2 DB period-arm, 2 didn't enter LTFU period.|11
10256982|NCT02906020|11388811|FG000|Treated|Part 2: Long-term Follow-up Period||0
10256983|NCT02906020|11388812|FG001|Treated|Part 2: Long-term Follow-up Period||0
10256984|NCT02906020|11388813|FG002|Treated|Part 2: Long-term Follow-up Period||0
10256985|NCT02906020|11388814|FG003|Treated|Part 2: Long-term Follow-up Period||0
10256986|NCT02906020|11388815|FG004|Treated|Part 2: Long-term Follow-up Period||0
10256987|NCT02906020|11388816|FG005|Treated|Part 2: Long-term Follow-up Period||0
10256988|NCT02906020|11388817|FG006|Treated|Part 2: Long-term Follow-up Period||0
10256989|NCT02906020|11388818|FG007|Treated|Part 2: Long-term Follow-up Period||0
10256990|NCT02906020|11388819|FG008|Treated|Part 2: Long-term Follow-up Period||0
10256991|NCT02906020|11388820|FG009|Treated|Part 2: Long-term Follow-up Period||0
10256992|NCT02906020|11388821|FG010|Treated|Part 2: Long-term Follow-up Period||0
10256993|NCT02906020|11388822|FG011|Treated|Part 2: Long-term Follow-up Period||0
10256994|NCT02906020|11388823|FG012|Treated|Part 2: Long-term Follow-up Period||87
10256995|NCT02906020|11388824|FG013|Treated|Part 2: Long-term Follow-up Period||75
10256996|NCT02906020|11388825|FG014|Treated|Part 2: Long-term Follow-up Period||10
10256997|NCT02906020|11388826|FG015|Treated|Part 2: Long-term Follow-up Period||11
10256998|NCT02906020|11388811|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0
10256999|NCT02906020|11388812|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0
10257000|NCT02906020|11388813|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0
10257001|NCT02906020|11388814|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0
10257002|NCT02906020|11388815|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0
10257003|NCT02906020|11388816|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0
10257004|NCT02906020|11388817|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0
10257005|NCT02906020|11388818|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0
10257006|NCT02906020|11388819|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0
10257007|NCT02906020|11388820|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0
10257008|NCT02906020|11388821|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0
10257009|NCT02906020|11388822|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0
10257010|NCT02906020|11388823|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0
10257011|NCT02906020|11388824|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0
10257012|NCT02906020|11388825|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0
10257013|NCT02906020|11388826|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0
10257014|NCT02906020|11388811|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257015|NCT02906020|11388812|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257016|NCT02906020|11388813|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257017|NCT02906020|11388814|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257018|NCT02906020|11388815|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257019|NCT02906020|11388816|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257020|NCT02906020|11388817|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257021|NCT02906020|11388818|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257022|NCT02906020|11388819|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257023|NCT02906020|11388820|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257024|NCT02906020|11388821|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257025|NCT02906020|11388822|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10257026|NCT02906020|11388823|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99
10257027|NCT02906020|11388824|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85
10257028|NCT02906020|11388825|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10
10257029|NCT02906020|11388826|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11
10020802|NCT01838980|11144145|FG000|COMPLETED|Overall Study||15
10020803|NCT01838980|11144145|FG000|NOT COMPLETED|Overall Study||0
10020804|NCT01839058|11144151|FG000|STARTED|Overall Study||21
10020805|NCT01839058|11144152|FG001|STARTED|Overall Study||19
10020806|NCT01839058|11144151|FG000|COMPLETED|Overall Study||17
10020807|NCT01839058|11144152|FG001|COMPLETED|Overall Study||16
10020808|NCT01839058|11144151|FG000|NOT COMPLETED|Overall Study||4
10020809|NCT01839058|11144152|FG001|NOT COMPLETED|Overall Study||3
10020810|NCT01839110|11144161|FG000|STARTED|Overall Study||7
10020811|NCT01839110|11144162|FG001|STARTED|Overall Study||6
10020812|NCT01839110|11144163|FG002|STARTED|Overall Study||9
10020813|NCT01839110|11144161|FG000|COMPLETED|Overall Study||4
10257030|NCT02891226|11388858|FG000|STARTED|Period 1 (Weeks 0 to 12)||64
10257031|NCT02891226|11388859|FG001|STARTED|Period 1 (Weeks 0 to 12)||31
10257032|NCT02891226|11388860|FG002|STARTED|Period 1 (Weeks 0 to 12)||32
10257033|NCT02891226|11388861|FG003|STARTED|Period 1 (Weeks 0 to 12)||64
10257034|NCT02891226|11388862|FG004|STARTED|Period 1 (Weeks 0 to 12)||0
10257035|NCT02891226|11388863|FG005|STARTED|Period 1 (Weeks 0 to 12)||0
10257036|NCT02891226|11388864|FG006|STARTED|Period 1 (Weeks 0 to 12)||0
10257037|NCT02891226|11388865|FG007|STARTED|Period 1 (Weeks 0 to 12)||0
10257038|NCT02891226|11388866|FG008|STARTED|Period 1 (Weeks 0 to 12)||0
10257039|NCT02891226|11388867|FG009|STARTED|Period 1 (Weeks 0 to 12)||0
10257040|NCT02891226|11388868|FG010|STARTED|Period 1 (Weeks 0 to 12)||0
10257041|NCT02891226|11388869|FG011|STARTED|Period 1 (Weeks 0 to 12)||0
10257042|NCT02891226|11388870|FG012|STARTED|Period 1 (Weeks 0 to 12)||0
10257043|NCT02891226|11388871|FG013|STARTED|Period 1 (Weeks 0 to 12)||0
10257044|NCT02891226|11388872|FG014|STARTED|Period 1 (Weeks 0 to 12)||0
10257045|NCT02891226|11388873|FG015|STARTED|Period 1 (Weeks 0 to 12)||0
10257046|NCT02891226|11388858|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
10257047|NCT02891226|11388859|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31
10257048|NCT02891226|11388860|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32
10257049|NCT02891226|11388861|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
10257050|NCT02891226|11388862|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257051|NCT02891226|11388863|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257052|NCT02891226|11388864|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257053|NCT02891226|11388865|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257054|NCT02891226|11388866|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257055|NCT02891226|11388867|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257056|NCT02891226|11388868|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257057|NCT02891226|11388869|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257058|NCT02891226|11388870|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257059|NCT02891226|11388871|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257060|NCT02891226|11388872|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257061|NCT02891226|11388873|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10257062|NCT02891226|11388858|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59
10257063|NCT02891226|11388859|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29
10257064|NCT02891226|11388860|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28
10257065|NCT02891226|11388861|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60
10257066|NCT02891226|11388862|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257067|NCT02891226|11388863|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257068|NCT02891226|11388864|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257069|NCT02891226|11388865|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257070|NCT02891226|11388866|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257071|NCT02891226|11388867|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257072|NCT02891226|11388868|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257073|NCT02891226|11388869|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257074|NCT02891226|11388870|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257075|NCT02891226|11388871|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257076|NCT02891226|11388872|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257077|NCT02891226|11388873|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0
10257078|NCT02891226|11388858|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5
10257079|NCT02891226|11388859|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2
10257080|NCT02891226|11388860|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
10257081|NCT02891226|11388861|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
10257082|NCT02891226|11388862|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257083|NCT02891226|11388863|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257084|NCT02891226|11388864|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257085|NCT02891226|11388865|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257086|NCT02891226|11388866|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257087|NCT02891226|11388867|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257088|NCT02891226|11388868|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257089|NCT02891226|11388869|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257090|NCT02891226|11388870|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257091|NCT02891226|11388871|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257092|NCT02891226|11388872|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257093|NCT02891226|11388873|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10257094|NCT02891226|11388858|FG000|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10257095|NCT02891226|11388859|FG001|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10257096|NCT02891226|11388860|FG002|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10257097|NCT02891226|11388861|FG003|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10257098|NCT02891226|11388862|FG004|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
10257099|NCT02891226|11388863|FG005|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
10257100|NCT02891226|11388864|FG006|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|23
10257101|NCT02891226|11388865|FG007|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|46
10257102|NCT02891226|11388866|FG008|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|30
10257103|NCT02891226|11388867|FG009|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|59
10257104|NCT02891226|11388868|FG010|STARTED|Period 2 (Weeks 12 to 52)||0
10257105|NCT02891226|11388869|FG011|STARTED|Period 2 (Weeks 12 to 52)||0
10257106|NCT02891226|11388870|FG012|STARTED|Period 2 (Weeks 12 to 52)||0
10257107|NCT02891226|11388871|FG013|STARTED|Period 2 (Weeks 12 to 52)||0
10257108|NCT02891226|11388872|FG014|STARTED|Period 2 (Weeks 12 to 52)||0
10257109|NCT02891226|11388873|FG015|STARTED|Period 2 (Weeks 12 to 52)||0
10257110|NCT02891226|11388858|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257111|NCT02891226|11388859|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257112|NCT02891226|11388860|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257113|NCT02891226|11388861|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257114|NCT02891226|11388862|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8
10257115|NCT02891226|11388863|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8
10257116|NCT02891226|11388864|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20
10257117|NCT02891226|11388865|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41
10257118|NCT02891226|11388866|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24
10257119|NCT02891226|11388867|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42
10257120|NCT02891226|11388868|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257121|NCT02891226|11388869|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257122|NCT02891226|11388870|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257123|NCT02891226|11388871|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257124|NCT02891226|11388872|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257125|NCT02891226|11388873|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0
10257126|NCT02891226|11388858|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257127|NCT02891226|11388859|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257128|NCT02891226|11388860|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257129|NCT02891226|11388861|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257130|NCT02891226|11388862|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
10257131|NCT02891226|11388863|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
10257132|NCT02891226|11388864|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3
10257133|NCT02891226|11388865|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5
10257134|NCT02891226|11388866|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6
10257135|NCT02891226|11388867|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17
10257136|NCT02891226|11388868|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257137|NCT02891226|11388869|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257138|NCT02891226|11388870|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257139|NCT02891226|11388871|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257140|NCT02891226|11388872|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257141|NCT02891226|11388873|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10257142|NCT02891226|11388858|FG000|STARTED|Period 3 (Weeks 52 to 208)||0
10257143|NCT02891226|11388859|FG001|STARTED|Period 3 (Weeks 52 to 208)||0
10257144|NCT02891226|11388860|FG002|STARTED|Period 3 (Weeks 52 to 208)||0
10257145|NCT02891226|11388861|FG003|STARTED|Period 3 (Weeks 52 to 208)||0
10257146|NCT02891226|11388862|FG004|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10257147|NCT02891226|11388863|FG005|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10257148|NCT02891226|11388864|FG006|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10257149|NCT02891226|11388865|FG007|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10257150|NCT02891226|11388866|FG008|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10257151|NCT02891226|11388867|FG009|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10257152|NCT02891226|11388868|FG010|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 3.|137
10257153|NCT02891226|11388869|FG011|STARTED|Period 3 (Weeks 52 to 208)||0
10257154|NCT02891226|11388870|FG012|STARTED|Period 3 (Weeks 52 to 208)||0
10257155|NCT02891226|11388871|FG013|STARTED|Period 3 (Weeks 52 to 208)||0
10257156|NCT02891226|11388872|FG014|STARTED|Period 3 (Weeks 52 to 208)||0
10257157|NCT02891226|11388873|FG015|STARTED|Period 3 (Weeks 52 to 208)||0
10257158|NCT02891226|11388858|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257159|NCT02891226|11388859|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257160|NCT02891226|11388860|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257161|NCT02891226|11388861|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257162|NCT02891226|11388862|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257163|NCT02891226|11388863|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257164|NCT02891226|11388864|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257165|NCT02891226|11388865|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257166|NCT02891226|11388866|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257167|NCT02891226|11388867|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257168|NCT02891226|11388868|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257169|NCT02891226|11388869|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257170|NCT02891226|11388870|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257171|NCT02891226|11388871|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257172|NCT02891226|11388872|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257173|NCT02891226|11388873|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0
10257174|NCT02891226|11388858|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257175|NCT02891226|11388859|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257176|NCT02891226|11388860|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257177|NCT02891226|11388861|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257178|NCT02891226|11388862|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257179|NCT02891226|11388863|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257180|NCT02891226|11388864|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257181|NCT02891226|11388865|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257182|NCT02891226|11388866|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257183|NCT02891226|11388867|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257184|NCT02891226|11388868|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137
10257185|NCT02891226|11388869|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257186|NCT02891226|11388870|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257187|NCT02891226|11388871|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257188|NCT02891226|11388872|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257189|NCT02891226|11388873|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10257190|NCT02891226|11388858|FG000|STARTED|Follow-up Period||0
10257191|NCT02891226|11388859|FG001|STARTED|Follow-up Period||0
10257192|NCT02891226|11388860|FG002|STARTED|Follow-up Period||0
10257193|NCT02891226|11388861|FG003|STARTED|Follow-up Period||0
10257194|NCT02891226|11388862|FG004|STARTED|Follow-up Period||0
10257195|NCT02891226|11388863|FG005|STARTED|Follow-up Period||0
10257196|NCT02891226|11388864|FG006|STARTED|Follow-up Period||0
10257197|NCT02891226|11388865|FG007|STARTED|Follow-up Period||0
10257198|NCT02891226|11388866|FG008|STARTED|Follow-up Period||0
10257199|NCT02891226|11388867|FG009|STARTED|Follow-up Period||0
10257200|NCT02891226|11388868|FG010|STARTED|Follow-up Period||0
10257201|NCT02891226|11388869|FG011|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10257202|NCT02891226|11388870|FG012|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|2
10257203|NCT02891226|11388871|FG013|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10257204|NCT02891226|11388872|FG014|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10257205|NCT02891226|11388873|FG015|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|3
10257206|NCT02891226|11388858|FG000|COMPLETED|Follow-up Period||0
10257207|NCT02891226|11388859|FG001|COMPLETED|Follow-up Period||0
10257208|NCT02891226|11388860|FG002|COMPLETED|Follow-up Period||0
10257209|NCT02891226|11388861|FG003|COMPLETED|Follow-up Period||0
10257210|NCT02891226|11388862|FG004|COMPLETED|Follow-up Period||0
10257211|NCT02891226|11388863|FG005|COMPLETED|Follow-up Period||0
10257212|NCT02891226|11388864|FG006|COMPLETED|Follow-up Period||0
10257213|NCT02891226|11388865|FG007|COMPLETED|Follow-up Period||0
10257214|NCT02891226|11388866|FG008|COMPLETED|Follow-up Period||0
10257215|NCT02891226|11388867|FG009|COMPLETED|Follow-up Period||0
10257216|NCT02891226|11388868|FG010|COMPLETED|Follow-up Period||0
10257217|NCT02891226|11388869|FG011|COMPLETED|Follow-up Period||0
10257218|NCT02891226|11388870|FG012|COMPLETED|Follow-up Period||2
10257219|NCT02891226|11388871|FG013|COMPLETED|Follow-up Period||1
10257220|NCT02891226|11388872|FG014|COMPLETED|Follow-up Period||0
10257221|NCT02891226|11388873|FG015|COMPLETED|Follow-up Period||2
10257222|NCT02891226|11388858|FG000|NOT COMPLETED|Follow-up Period||0
10257223|NCT02891226|11388859|FG001|NOT COMPLETED|Follow-up Period||0
10257224|NCT02891226|11388860|FG002|NOT COMPLETED|Follow-up Period||0
10257225|NCT02891226|11388861|FG003|NOT COMPLETED|Follow-up Period||0
10257226|NCT02891226|11388862|FG004|NOT COMPLETED|Follow-up Period||0
10257227|NCT02891226|11388863|FG005|NOT COMPLETED|Follow-up Period||0
10257228|NCT02891226|11388864|FG006|NOT COMPLETED|Follow-up Period||0
10257229|NCT02891226|11388865|FG007|NOT COMPLETED|Follow-up Period||0
10257230|NCT02891226|11388866|FG008|NOT COMPLETED|Follow-up Period||0
10257231|NCT02891226|11388867|FG009|NOT COMPLETED|Follow-up Period||0
9957820|NCT01453153|11077146|FG001|NOT COMPLETED|Overall Study||4
9957821|NCT01453153|11077147|FG002|NOT COMPLETED|Overall Study||20
9957822|NCT01453166|11077162|FG000|STARTED|Overall Study||42
9957823|NCT01453166|11077163|FG001|STARTED|Overall Study||41
9957824|NCT01453166|11077164|FG002|STARTED|Overall Study||39
9957825|NCT01453166|11077162|FG000|COMPLETED|Overall Study||40
10257232|NCT02891226|11388868|FG010|NOT COMPLETED|Follow-up Period||0
10257233|NCT02891226|11388869|FG011|NOT COMPLETED|Follow-up Period||1
10257234|NCT02891226|11388870|FG012|NOT COMPLETED|Follow-up Period||0
10257235|NCT02891226|11388871|FG013|NOT COMPLETED|Follow-up Period||0
10257236|NCT02891226|11388872|FG014|NOT COMPLETED|Follow-up Period||1
10257237|NCT02891226|11388873|FG015|NOT COMPLETED|Follow-up Period||1
10257238|NCT02703480|11388897|FG000|STARTED|Overall Study||11
10257239|NCT02703480|11388898|FG001|STARTED|Overall Study||11
10257240|NCT02703480|11388897|FG000|COMPLETED|Overall Study||10
10257241|NCT02703480|11388898|FG001|COMPLETED|Overall Study||10
10257242|NCT02703480|11388897|FG000|NOT COMPLETED|Overall Study||1
10257243|NCT02703480|11388898|FG001|NOT COMPLETED|Overall Study||1
10257244|NCT02549092|11388906|FG000|STARTED|Treatment Period||44
10257245|NCT02549092|11388907|FG001|STARTED|Treatment Period||45
10257246|NCT02549092|11388906|FG000|COMPLETED|Treatment Period||41
10257247|NCT02549092|11388907|FG001|COMPLETED|Treatment Period||38
10257248|NCT02549092|11388906|FG000|NOT COMPLETED|Treatment Period||3
10257249|NCT02549092|11388907|FG001|NOT COMPLETED|Treatment Period||7
10257250|NCT02549092|11388906|FG000|STARTED|Extension/Transition Period||10
10257251|NCT02549092|11388907|FG001|STARTED|Extension/Transition Period||14
10257252|NCT02549092|11388906|FG000|COMPLETED|Extension/Transition Period||5
10257253|NCT02549092|11388907|FG001|COMPLETED|Extension/Transition Period||5
10257254|NCT02549092|11388906|FG000|NOT COMPLETED|Extension/Transition Period||5
10257255|NCT02549092|11388907|FG001|NOT COMPLETED|Extension/Transition Period||9
10257256|NCT02506465|11388918|FG000|STARTED|Overall Study||128
10257257|NCT02506465|11388919|FG001|STARTED|Overall Study||57
10257258|NCT02506465|11388918|FG000|COMPLETED|Overall Study|78 patients reached 12 months FU visit.|78
10257259|NCT02506465|11388919|FG001|COMPLETED|Overall Study|The Sham arm was analyzed up to 3 months FU visit as primary endpoint timeframe in accordance with the FDA guideline for BPH treatments, published in 2010, the most recent guidance available at the time of the study.|57
10257260|NCT02506465|11388918|FG000|NOT COMPLETED|Overall Study||50
10257261|NCT02506465|11388919|FG001|NOT COMPLETED|Overall Study||0
10257262|NCT02323126|11388928|FG000|STARTED|Overall Study||18
10257263|NCT02323126|11388929|FG001|STARTED|Overall Study||16
10257264|NCT02323126|11388930|FG002|STARTED|Overall Study||30
10257265|NCT02323126|11388928|FG000|COMPLETED|Overall Study||0
10257266|NCT02323126|11388929|FG001|COMPLETED|Overall Study||0
10257267|NCT02323126|11388930|FG002|COMPLETED|Overall Study||0
10257268|NCT02323126|11388928|FG000|NOT COMPLETED|Overall Study||18
10257269|NCT02323126|11388929|FG001|NOT COMPLETED|Overall Study||16
10257270|NCT02323126|11388930|FG002|NOT COMPLETED|Overall Study||30
10257271|NCT01902290|11388943|FG000|STARTED|Overall Study||210
10257272|NCT01902290|11388944|FG001|STARTED|Overall Study||211
10257273|NCT01902290|11388943|FG000|Received Study Drug|Overall Study||207
10257274|NCT01902290|11388944|FG001|Received Study Drug|Overall Study||208
10257275|NCT01902290|11388943|FG000|COMPLETED|Overall Study||162
10257276|NCT01902290|11388944|FG001|COMPLETED|Overall Study||158
10257277|NCT01902290|11388943|FG000|NOT COMPLETED|Overall Study||48
10257278|NCT01902290|11388944|FG001|NOT COMPLETED|Overall Study||53
10257279|NCT01126749|11388955|FG000|STARTED|Phase 1b||3
10257280|NCT01126749|11388956|FG001|STARTED|Phase 1b||6
10257281|NCT01126749|11388957|FG002|STARTED|Phase 1b||0
10257282|NCT01126749|11388958|FG003|STARTED|Phase 1b||0
10257283|NCT01126749|11388955|FG000|COMPLETED|Phase 1b||0
10257284|NCT01126749|11388956|FG001|COMPLETED|Phase 1b||0
10257285|NCT01126749|11388957|FG002|COMPLETED|Phase 1b||0
10257286|NCT01126749|11388958|FG003|COMPLETED|Phase 1b||0
10257287|NCT01126749|11388955|FG000|NOT COMPLETED|Phase 1b||3
10257288|NCT01126749|11388956|FG001|NOT COMPLETED|Phase 1b||6
10257289|NCT01126749|11388957|FG002|NOT COMPLETED|Phase 1b||0
10257290|NCT01126749|11388958|FG003|NOT COMPLETED|Phase 1b||0
10257291|NCT01126749|11388955|FG000|STARTED|Phase 2||0
10257292|NCT01126749|11388956|FG001|STARTED|Phase 2||0
10257293|NCT01126749|11388957|FG002|STARTED|Phase 2||42
10257294|NCT01126749|11388958|FG003|STARTED|Phase 2||41
10257295|NCT01126749|11388955|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0
10257296|NCT01126749|11388956|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0
10257297|NCT01126749|11388957|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41
10257298|NCT01126749|11388958|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39
10257299|NCT01126749|11388955|FG000|Modified-intent-to-treat (MITT)|Phase 2||0
10257300|NCT01126749|11388956|FG001|Modified-intent-to-treat (MITT)|Phase 2||0
10257301|NCT01126749|11388957|FG002|Modified-intent-to-treat (MITT)|Phase 2||40
10257302|NCT01126749|11388958|FG003|Modified-intent-to-treat (MITT)|Phase 2||39
10257303|NCT01126749|11388955|FG000|COMPLETED|Phase 2||0
10257304|NCT01126749|11388956|FG001|COMPLETED|Phase 2||0
10257305|NCT01126749|11388957|FG002|COMPLETED|Phase 2||0
10257306|NCT01126749|11388958|FG003|COMPLETED|Phase 2||0
10257307|NCT01126749|11388955|FG000|NOT COMPLETED|Phase 2||0
10257308|NCT01126749|11388956|FG001|NOT COMPLETED|Phase 2||0
10257309|NCT01126749|11388957|FG002|NOT COMPLETED|Phase 2||42
10257310|NCT01126749|11388958|FG003|NOT COMPLETED|Phase 2||41
10257311|NCT01111110|11388970|FG000|STARTED|Overall Study||3
10257312|NCT01111110|11388971|FG001|STARTED|Overall Study||4
10257313|NCT01111110|11388970|FG000|COMPLETED|Overall Study||3
10257314|NCT01111110|11388971|FG001|COMPLETED|Overall Study||4
10257315|NCT01111110|11388970|FG000|NOT COMPLETED|Overall Study||0
10257316|NCT01111110|11388971|FG001|NOT COMPLETED|Overall Study||0
10257317|NCT01059448|11388981|FG000|STARTED|Overall Study||49
10257318|NCT01059448|11388982|FG001|STARTED|Overall Study||55
10257319|NCT01059448|11388983|FG002|STARTED|Overall Study||53
10257320|NCT01059448|11388984|FG003|STARTED|Overall Study||54
10257321|NCT01059448|11388981|FG000|COMPLETED|Overall Study||0
10257322|NCT01059448|11388982|FG001|COMPLETED|Overall Study||0
10257323|NCT01059448|11388983|FG002|COMPLETED|Overall Study||0
10257324|NCT01059448|11388984|FG003|COMPLETED|Overall Study||0
10257325|NCT01059448|11388981|FG000|NOT COMPLETED|Overall Study||49
10257326|NCT01059448|11388982|FG001|NOT COMPLETED|Overall Study||55
10257327|NCT01059448|11388983|FG002|NOT COMPLETED|Overall Study||53
10257328|NCT01059448|11388984|FG003|NOT COMPLETED|Overall Study||54
10257329|NCT00821587|11388996|FG000|STARTED|Overall Study||20
10257330|NCT00821587|11388997|FG001|STARTED|Overall Study||19
10257331|NCT00821587|11388996|FG000|COMPLETED|Overall Study||20
10257332|NCT00821587|11388997|FG001|COMPLETED|Overall Study||18
10257333|NCT00821587|11388996|FG000|NOT COMPLETED|Overall Study||0
10257334|NCT00821587|11388997|FG001|NOT COMPLETED|Overall Study||1
10257335|NCT00585195|11389024|FG000|STARTED|Overall Study||3
10257336|NCT00585195|11389025|FG001|STARTED|Overall Study||4
10257337|NCT00585195|11389026|FG002|STARTED|Overall Study||9
10257338|NCT00585195|11389027|FG003|STARTED|Overall Study||7
10257339|NCT00585195|11389028|FG004|STARTED|Overall Study||9
10257340|NCT00585195|11389029|FG005|STARTED|Overall Study||6
10257341|NCT00585195|11389030|FG006|STARTED|Overall Study||7
10257342|NCT00585195|11389031|FG007|STARTED|Overall Study||5
10257343|NCT00585195|11389032|FG008|STARTED|Overall Study||3
10257344|NCT00585195|11389033|FG009|STARTED|Overall Study||6
10257345|NCT00585195|11389034|FG010|STARTED|Overall Study||11
10257346|NCT00585195|11389035|FG011|STARTED|Overall Study||53
10257347|NCT00585195|11389036|FG012|STARTED|Overall Study||85
10257348|NCT00585195|11389037|FG013|STARTED|Overall Study||41
10257349|NCT00585195|11389038|FG014|STARTED|Overall Study||48
10257350|NCT00585195|11389039|FG015|STARTED|Overall Study||19
10257351|NCT00585195|11389040|FG016|STARTED|Overall Study||154
10257352|NCT00585195|11389041|FG017|STARTED|Overall Study||67
10257353|NCT00585195|11389042|FG018|STARTED|Overall Study||21
10257354|NCT00585195|11389043|FG019|STARTED|Overall Study||18
10257355|NCT00585195|11389044|FG020|STARTED|Overall Study||14
10257356|NCT00585195|11389024|FG000|Treated|Overall Study||3
10257357|NCT00585195|11389025|FG001|Treated|Overall Study||4
10257358|NCT00585195|11389026|FG002|Treated|Overall Study||8
10257359|NCT00585195|11389027|FG003|Treated|Overall Study||7
10257360|NCT00585195|11389028|FG004|Treated|Overall Study||8
10257361|NCT00585195|11389029|FG005|Treated|Overall Study||6
10257362|NCT00585195|11389030|FG006|Treated|Overall Study||6
10257363|NCT00585195|11389031|FG007|Treated|Overall Study||5
10257364|NCT00585195|11389032|FG008|Treated|Overall Study||3
10257365|NCT00585195|11389033|FG009|Treated|Overall Study||6
10257366|NCT00585195|11389034|FG010|Treated|Overall Study||9
10257367|NCT00585195|11389035|FG011|Treated|Overall Study||53
10257368|NCT00585195|11389036|FG012|Treated|Overall Study||85
10257369|NCT00585195|11389037|FG013|Treated|Overall Study||41
10257370|NCT00585195|11389038|FG014|Treated|Overall Study||48
10257371|NCT00585195|11389039|FG015|Treated|Overall Study||18
10257372|NCT00585195|11389040|FG016|Treated|Overall Study||154
10257373|NCT00585195|11389041|FG017|Treated|Overall Study||66
10257374|NCT00585195|11389042|FG018|Treated|Overall Study||18
10257375|NCT00585195|11389043|FG019|Treated|Overall Study||18
10257376|NCT00585195|11389044|FG020|Treated|Overall Study||12
10257377|NCT00585195|11389024|FG000|COMPLETED|Overall Study||0
10257378|NCT00585195|11389025|FG001|COMPLETED|Overall Study||0
10257379|NCT00585195|11389026|FG002|COMPLETED|Overall Study||0
10257380|NCT00585195|11389027|FG003|COMPLETED|Overall Study||0
10257381|NCT00585195|11389028|FG004|COMPLETED|Overall Study||0
10257382|NCT00585195|11389029|FG005|COMPLETED|Overall Study||0
10257383|NCT00585195|11389030|FG006|COMPLETED|Overall Study||0
10257384|NCT00585195|11389031|FG007|COMPLETED|Overall Study||0
10257385|NCT00585195|11389032|FG008|COMPLETED|Overall Study||0
10257386|NCT00585195|11389033|FG009|COMPLETED|Overall Study||0
10257387|NCT00585195|11389034|FG010|COMPLETED|Overall Study||0
10257388|NCT00585195|11389035|FG011|COMPLETED|Overall Study||0
10257389|NCT00585195|11389036|FG012|COMPLETED|Overall Study||0
10257390|NCT00585195|11389037|FG013|COMPLETED|Overall Study||0
10257391|NCT00585195|11389038|FG014|COMPLETED|Overall Study||0
10257392|NCT00585195|11389039|FG015|COMPLETED|Overall Study||0
10257393|NCT00585195|11389040|FG016|COMPLETED|Overall Study||0
10257394|NCT00585195|11389041|FG017|COMPLETED|Overall Study||0
10257395|NCT00585195|11389042|FG018|COMPLETED|Overall Study||0
10257396|NCT00585195|11389043|FG019|COMPLETED|Overall Study||0
10257397|NCT00585195|11389044|FG020|COMPLETED|Overall Study||0
10257398|NCT00585195|11389024|FG000|NOT COMPLETED|Overall Study||3
10257399|NCT00585195|11389025|FG001|NOT COMPLETED|Overall Study||4
10257400|NCT00585195|11389026|FG002|NOT COMPLETED|Overall Study||9
10257401|NCT00585195|11389027|FG003|NOT COMPLETED|Overall Study||7
10257402|NCT00585195|11389028|FG004|NOT COMPLETED|Overall Study||9
10257403|NCT00585195|11389029|FG005|NOT COMPLETED|Overall Study||6
10257404|NCT00585195|11389030|FG006|NOT COMPLETED|Overall Study||7
10257405|NCT00585195|11389031|FG007|NOT COMPLETED|Overall Study||5
10257406|NCT00585195|11389032|FG008|NOT COMPLETED|Overall Study||3
10257407|NCT00585195|11389033|FG009|NOT COMPLETED|Overall Study||6
10257408|NCT00585195|11389034|FG010|NOT COMPLETED|Overall Study||11
10257409|NCT00585195|11389035|FG011|NOT COMPLETED|Overall Study||53
10257410|NCT00585195|11389036|FG012|NOT COMPLETED|Overall Study||85
10257411|NCT00585195|11389037|FG013|NOT COMPLETED|Overall Study||41
10257412|NCT00585195|11389038|FG014|NOT COMPLETED|Overall Study||48
10257413|NCT00585195|11389039|FG015|NOT COMPLETED|Overall Study||19
10257414|NCT00585195|11389040|FG016|NOT COMPLETED|Overall Study||154
10257415|NCT00585195|11389041|FG017|NOT COMPLETED|Overall Study||67
10257416|NCT00585195|11389042|FG018|NOT COMPLETED|Overall Study||21
10257417|NCT00585195|11389043|FG019|NOT COMPLETED|Overall Study||18
10257418|NCT00585195|11389044|FG020|NOT COMPLETED|Overall Study||14
10257419|NCT04446429|11389129|FG000|STARTED|Overall Study||134
10257420|NCT04446429|11389130|FG001|STARTED|Overall Study||134
10257421|NCT04446429|11389129|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
10257422|NCT04446429|11389130|FG001|COMPLETED|Overall Study||134
10257423|NCT04446429|11389129|FG000|NOT COMPLETED|Overall Study||6
10020814|NCT01839110|11144162|FG001|COMPLETED|Overall Study||4
10020815|NCT01839110|11144163|FG002|COMPLETED|Overall Study||6
10257424|NCT04446429|11389130|FG001|NOT COMPLETED|Overall Study||0
10257425|NCT04372017|11389140|FG000|STARTED|Overall Study||1
10257426|NCT04372017|11389141|FG001|STARTED|Overall Study||0
10257427|NCT04372017|11389142|FG002|STARTED|Overall Study||0
10257428|NCT04372017|11389143|FG003|STARTED|Overall Study||0
10257429|NCT04372017|11389140|FG000|COMPLETED|Overall Study||1
10257430|NCT04372017|11389141|FG001|COMPLETED|Overall Study||0
10257431|NCT04372017|11389142|FG002|COMPLETED|Overall Study||0
10257432|NCT04372017|11389143|FG003|COMPLETED|Overall Study||0
10257433|NCT04372017|11389140|FG000|NOT COMPLETED|Overall Study||0
10257434|NCT04372017|11389141|FG001|NOT COMPLETED|Overall Study||0
10257435|NCT04372017|11389142|FG002|NOT COMPLETED|Overall Study||0
10257436|NCT04372017|11389143|FG003|NOT COMPLETED|Overall Study||0
10257437|NCT04194528|11389153|FG000|STARTED|Overall Study||2
10257438|NCT04194528|11389153|FG000|COMPLETED|Overall Study||1
10257439|NCT04194528|11389153|FG000|NOT COMPLETED|Overall Study||1
9834948|NCT00789035|10946083|FG001|STARTED|Overall Study||81
9834949|NCT00789035|10946084|FG002|STARTED|Overall Study||81
9834950|NCT00789035|10946085|FG003|STARTED|Overall Study||82
9834951|NCT00789035|10946086|FG004|STARTED|Overall Study||80
9834952|NCT00789035|10946082|FG000|COMPLETED|Overall Study||76
9834953|NCT00789035|10946083|FG001|COMPLETED|Overall Study||74
9834954|NCT00789035|10946084|FG002|COMPLETED|Overall Study||80
9834955|NCT00789035|10946085|FG003|COMPLETED|Overall Study||81
9834956|NCT00789035|10946086|FG004|COMPLETED|Overall Study||74
9834957|NCT00789035|10946082|FG000|NOT COMPLETED|Overall Study||6
9834958|NCT00789035|10946083|FG001|NOT COMPLETED|Overall Study||7
9834959|NCT00789035|10946084|FG002|NOT COMPLETED|Overall Study||1
9834960|NCT00789035|10946085|FG003|NOT COMPLETED|Overall Study||1
9834961|NCT00789035|10946086|FG004|NOT COMPLETED|Overall Study||6
9834962|NCT00789074|10946103|FG000|STARTED|Overall Study||53
9834963|NCT00789074|10946104|FG001|STARTED|Overall Study||48
9834964|NCT00789074|10946103|FG000|COMPLETED|Overall Study||42
10020816|NCT01839110|11144161|FG000|NOT COMPLETED|Overall Study||3
10020817|NCT01839110|11144162|FG001|NOT COMPLETED|Overall Study||2
9834965|NCT00789074|10946104|FG001|COMPLETED|Overall Study||35
9834966|NCT00789074|10946103|FG000|NOT COMPLETED|Overall Study||11
9834967|NCT00789074|10946104|FG001|NOT COMPLETED|Overall Study||13
10020818|NCT01839110|11144163|FG002|NOT COMPLETED|Overall Study||3
10257440|NCT04147650|11389161|FG000|STARTED|Overall Study||127
10257441|NCT04147650|11389162|FG001|STARTED|Overall Study||126
10257442|NCT04147650|11389163|FG002|STARTED|Overall Study||128
10257443|NCT04147650|11389164|FG003|STARTED|Overall Study||127
10257444|NCT04147650|11389161|FG000|Modified Intent to Treat (mITT)|Overall Study||120
10257445|NCT04147650|11389162|FG001|Modified Intent to Treat (mITT)|Overall Study||119
10257446|NCT04147650|11389163|FG002|Modified Intent to Treat (mITT)|Overall Study||122
10257447|NCT04147650|11389164|FG003|Modified Intent to Treat (mITT)|Overall Study||121
10257448|NCT04147650|11389161|FG000|COMPLETED|Overall Study||116
10257449|NCT04147650|11389162|FG001|COMPLETED|Overall Study||107
10257450|NCT04147650|11389163|FG002|COMPLETED|Overall Study||121
10257451|NCT04147650|11389164|FG003|COMPLETED|Overall Study||120
10257452|NCT04147650|11389161|FG000|NOT COMPLETED|Overall Study||11
10257453|NCT04147650|11389162|FG001|NOT COMPLETED|Overall Study||19
10257454|NCT04147650|11389163|FG002|NOT COMPLETED|Overall Study||7
10257455|NCT04147650|11389164|FG003|NOT COMPLETED|Overall Study||7
10257456|NCT03527238|11389176|FG000|STARTED|Overall Study||31
10257457|NCT03527238|11389177|FG001|STARTED|Overall Study||31
10257458|NCT03527238|11389176|FG000|COMPLETED|Overall Study||29
10257459|NCT03527238|11389177|FG001|COMPLETED|Overall Study||27
10257460|NCT03527238|11389176|FG000|NOT COMPLETED|Overall Study||2
10257461|NCT03527238|11389177|FG001|NOT COMPLETED|Overall Study||4
10257462|NCT03116685|11389185|FG000|STARTED|Overall Study||13
10257463|NCT03116685|11389186|FG001|STARTED|Overall Study||12
10257464|NCT03116685|11389185|FG000|COMPLETED|Overall Study||13
10257465|NCT03116685|11389186|FG001|COMPLETED|Overall Study||11
10257466|NCT03116685|11389185|FG000|NOT COMPLETED|Overall Study||0
10257467|NCT03116685|11389186|FG001|NOT COMPLETED|Overall Study||1
10257468|NCT03099304|11389197|FG000|STARTED|DB Period Day 1 to Week 24||32
10257469|NCT03099304|11389198|FG001|STARTED|DB Period Day 1 to Week 24||31
10257470|NCT03099304|11389199|FG002|STARTED|DB Period Day 1 to Week 24||31
10257471|NCT03099304|11389200|FG003|STARTED|DB Period Day 1 to Week 24||30
10257472|NCT03099304|11389201|FG004|STARTED|DB Period Day 1 to Week 24||33
10257473|NCT03099304|11389197|FG000|COMPLETED|DB Period Day 1 to Week 24||27
10257474|NCT03099304|11389198|FG001|COMPLETED|DB Period Day 1 to Week 24||26
10257475|NCT03099304|11389199|FG002|COMPLETED|DB Period Day 1 to Week 24||30
10257476|NCT03099304|11389200|FG003|COMPLETED|DB Period Day 1 to Week 24||26
10257477|NCT03099304|11389201|FG004|COMPLETED|DB Period Day 1 to Week 24||30
10257478|NCT03099304|11389197|FG000|NOT COMPLETED|DB Period Day 1 to Week 24||5
10257479|NCT03099304|11389198|FG001|NOT COMPLETED|DB Period Day 1 to Week 24||5
10257480|NCT03099304|11389199|FG002|NOT COMPLETED|DB Period Day 1 to Week 24||1
10257481|NCT03099304|11389200|FG003|NOT COMPLETED|DB Period Day 1 to Week 24||4
10257482|NCT03099304|11389201|FG004|NOT COMPLETED|DB Period Day 1 to Week 24||3
10257483|NCT03099304|11389197|FG000|STARTED|DB Period Weeks 24 to 52|Vehicle cream was not used after Week 24. After DB 24 week period, participants who met criteria were rerandomized to 1 of the 3 higher active blinded treatment groups.|0
10257484|NCT03099304|11389198|FG001|STARTED|DB Period Weeks 24 to 52|These subjects continued on the initial .15% QD treatment.|11
10257485|NCT03099304|11389199|FG002|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 0.5% QD and those re-randomized from vehicle cream and .15% QD to 0.5% QD.|45
10257486|NCT03099304|11389200|FG003|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% QD and those re-randomized from vehicle cream and .15% QD to 1.5% QD.|44
10257487|NCT03099304|11389201|FG004|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% BID and those re-randomized from vehicle cream and .15% QD to 1.5% BID|47
10257488|NCT03099304|11389197|FG000|COMPLETED|DB Period Weeks 24 to 52||0
10257489|NCT03099304|11389198|FG001|COMPLETED|DB Period Weeks 24 to 52||10
10257490|NCT03099304|11389199|FG002|COMPLETED|DB Period Weeks 24 to 52||43
10257491|NCT03099304|11389200|FG003|COMPLETED|DB Period Weeks 24 to 52||37
10257492|NCT03099304|11389201|FG004|COMPLETED|DB Period Weeks 24 to 52||45
10257493|NCT03099304|11389197|FG000|NOT COMPLETED|DB Period Weeks 24 to 52||0
10257494|NCT03099304|11389198|FG001|NOT COMPLETED|DB Period Weeks 24 to 52||1
10257495|NCT03099304|11389199|FG002|NOT COMPLETED|DB Period Weeks 24 to 52||2
10257496|NCT03099304|11389200|FG003|NOT COMPLETED|DB Period Weeks 24 to 52||7
10257497|NCT03099304|11389201|FG004|NOT COMPLETED|DB Period Weeks 24 to 52||2
10257498|NCT03034863|11389222|FG000|STARTED|Overall Study||38
10257499|NCT03034863|11389223|FG001|STARTED|Overall Study||40
10257500|NCT03034863|11389222|FG000|Veterans|Overall Study||19
10257501|NCT03034863|11389223|FG001|Veterans|Overall Study||20
10257502|NCT03034863|11389222|FG000|Supporting Partners|Overall Study||19
10257503|NCT03034863|11389223|FG001|Supporting Partners|Overall Study||20
10257504|NCT03034863|11389222|FG000|COMPLETED|Overall Study||28
10257505|NCT03034863|11389223|FG001|COMPLETED|Overall Study||28
10257506|NCT03034863|11389222|FG000|NOT COMPLETED|Overall Study||10
10257507|NCT03034863|11389223|FG001|NOT COMPLETED|Overall Study||12
10257508|NCT02819050|11389236|FG000|STARTED|Overall Study||40
10257509|NCT02819050|11389237|FG001|STARTED|Overall Study||40
10257510|NCT02819050|11389236|FG000|COMPLETED|Overall Study||40
10257511|NCT02819050|11389237|FG001|COMPLETED|Overall Study||40
10257512|NCT02819050|11389236|FG000|NOT COMPLETED|Overall Study||0
10257513|NCT02819050|11389237|FG001|NOT COMPLETED|Overall Study||0
10257514|NCT02682901|11389247|FG000|STARTED|Overall Study||43
10257515|NCT02682901|11389248|FG001|STARTED|Overall Study||41
10257516|NCT02682901|11389247|FG000|Completed 4 Weeks|Overall Study||38
10257517|NCT02682901|11389248|FG001|Completed 4 Weeks|Overall Study||39
10257518|NCT02682901|11389247|FG000|Completed 12 Weeks|Overall Study||36
10257519|NCT02682901|11389248|FG001|Completed 12 Weeks|Overall Study||37
10257520|NCT02682901|11389247|FG000|COMPLETED|Overall Study||33
10257521|NCT02682901|11389248|FG001|COMPLETED|Overall Study||37
10257522|NCT02682901|11389247|FG000|NOT COMPLETED|Overall Study||10
10257523|NCT02682901|11389248|FG001|NOT COMPLETED|Overall Study||4
10257524|NCT02567825|11389256|FG000|STARTED|Overall Study||129
10257525|NCT02567825|11389257|FG001|STARTED|Overall Study||121
10257526|NCT02567825|11389256|FG000|COMPLETED|Overall Study||108
10257527|NCT02567825|11389257|FG001|COMPLETED|Overall Study||100
10257528|NCT02567825|11389256|FG000|NOT COMPLETED|Overall Study||21
10257529|NCT02567825|11389257|FG001|NOT COMPLETED|Overall Study||21
10257530|NCT02555657|11389265|FG000|STARTED|Overall Study||312
10257531|NCT02555657|11389266|FG001|STARTED|Overall Study||310
10257532|NCT02555657|11389265|FG000|Treated|Overall Study||309
10257533|NCT02555657|11389266|FG001|Treated|Overall Study||292
10257534|NCT02555657|11389265|FG000|COMPLETED|Overall Study||0
10257535|NCT02555657|11389266|FG001|COMPLETED|Overall Study||0
10257536|NCT02555657|11389265|FG000|NOT COMPLETED|Overall Study||312
10257537|NCT02555657|11389266|FG001|NOT COMPLETED|Overall Study||310
10020819|NCT01839188|11144171|FG000|STARTED|Overall Study||385
10020820|NCT01839188|11144171|FG000|Treated|Overall Study||385
10020821|NCT01839188|11144171|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
10020822|NCT01839188|11144171|FG000|NOT COMPLETED|Overall Study||1
10020823|NCT01839279|11144183|FG000|STARTED|Overall Study||72
10257538|NCT02190721|11389276|FG000|STARTED|Overall Study||2
10257539|NCT02190721|11389277|FG001|STARTED|Overall Study||30
10257540|NCT02190721|11389278|FG002|STARTED|Overall Study||18
10257541|NCT02190721|11389276|FG000|Completed Treatment|Overall Study||2
10257542|NCT02190721|11389277|FG001|Completed Treatment|Overall Study||30
10257543|NCT02190721|11389278|FG002|Completed Treatment|Overall Study||18
10257544|NCT02190721|11389276|FG000|Completed 30 Day Follow-up|Overall Study||2
10257545|NCT02190721|11389277|FG001|Completed 30 Day Follow-up|Overall Study||29
10257546|NCT02190721|11389278|FG002|Completed 30 Day Follow-up|Overall Study||18
10257547|NCT02190721|11389276|FG000|Completed 90 Day Follow-up|Overall Study||2
10257548|NCT02190721|11389277|FG001|Completed 90 Day Follow-up|Overall Study||29
10257549|NCT02190721|11389278|FG002|Completed 90 Day Follow-up|Overall Study||18
10257550|NCT02190721|11389276|FG000|COMPLETED|Overall Study||2
10257551|NCT02190721|11389277|FG001|COMPLETED|Overall Study||29
10257552|NCT02190721|11389278|FG002|COMPLETED|Overall Study||18
10257553|NCT02190721|11389276|FG000|NOT COMPLETED|Overall Study||0
10257554|NCT02190721|11389277|FG001|NOT COMPLETED|Overall Study||1
10257555|NCT02190721|11389278|FG002|NOT COMPLETED|Overall Study||0
10257556|NCT00908687|11389292|FG000|STARTED|Overall Study||50
10257557|NCT00908687|11389293|FG001|STARTED|Overall Study||100
10257558|NCT00908687|11389294|FG002|STARTED|Overall Study||102
10257559|NCT00908687|11389295|FG003|STARTED|Overall Study||50
10257560|NCT00908687|11389296|FG004|STARTED|Overall Study||98
10257561|NCT00908687|11389297|FG005|STARTED|Overall Study||100
10257562|NCT00908687|11389292|FG000|COMPLETED|Overall Study||49
10257563|NCT00908687|11389293|FG001|COMPLETED|Overall Study||99
10257564|NCT00908687|11389294|FG002|COMPLETED|Overall Study||99
10257565|NCT00908687|11389295|FG003|COMPLETED|Overall Study||47
10257566|NCT00908687|11389296|FG004|COMPLETED|Overall Study||94
10257567|NCT00908687|11389297|FG005|COMPLETED|Overall Study||94
10257568|NCT00908687|11389292|FG000|NOT COMPLETED|Overall Study||1
10257569|NCT00908687|11389293|FG001|NOT COMPLETED|Overall Study||1
10257570|NCT00908687|11389294|FG002|NOT COMPLETED|Overall Study||3
10257571|NCT00908687|11389295|FG003|NOT COMPLETED|Overall Study||3
9957826|NCT01453166|11077163|FG001|COMPLETED|Overall Study||39
9957827|NCT01453166|11077164|FG002|COMPLETED|Overall Study||38
9957828|NCT01453166|11077162|FG000|NOT COMPLETED|Overall Study||2
9957829|NCT01453166|11077163|FG001|NOT COMPLETED|Overall Study||2
9957830|NCT01453166|11077164|FG002|NOT COMPLETED|Overall Study||1
9957831|NCT01453205|11077175|FG000|STARTED|Overall Study||80
9957832|NCT01453205|11077176|FG001|STARTED|Overall Study||52
9957833|NCT01453205|11077177|FG002|STARTED|Overall Study||55
9957834|NCT01453205|11077175|FG000|COMPLETED|Overall Study||0
9957835|NCT01453205|11077176|FG001|COMPLETED|Overall Study||0
9957836|NCT01453205|11077177|FG002|COMPLETED|Overall Study||1
9957837|NCT01453205|11077175|FG000|NOT COMPLETED|Overall Study||80
9957838|NCT01453205|11077176|FG001|NOT COMPLETED|Overall Study||52
10257572|NCT00908687|11389296|FG004|NOT COMPLETED|Overall Study||4
10257573|NCT00908687|11389297|FG005|NOT COMPLETED|Overall Study||6
10257574|NCT00739401|11389311|FG000|STARTED|Overall Study||44
10257575|NCT00739401|11389311|FG000|COMPLETED|Overall Study||3
10257576|NCT00739401|11389311|FG000|NOT COMPLETED|Overall Study||41
10257577|NCT00651742|11389315|FG000|STARTED|Overall Study||28
10257578|NCT00651742|11389315|FG000|Treated|Overall Study||27
10257579|NCT00651742|11389315|FG000|Efficacy Analysis Per Investigator|Overall Study||21
10257580|NCT00651742|11389315|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25
10257581|NCT00651742|11389315|FG000|COMPLETED|Overall Study||0
10257582|NCT00651742|11389315|FG000|NOT COMPLETED|Overall Study||28
10257583|NCT00308516|11389321|FG000|STARTED|Overall Study||35
10257584|NCT00308516|11389322|FG001|STARTED|Overall Study||31
10257585|NCT00308516|11389321|FG000|COMPLETED|Overall Study||6
10257586|NCT00308516|11389322|FG001|COMPLETED|Overall Study||10
10257587|NCT00308516|11389321|FG000|NOT COMPLETED|Overall Study||29
10257588|NCT00308516|11389322|FG001|NOT COMPLETED|Overall Study||21
10257589|NCT04331366|11389328|FG000|STARTED|Overall Study||2
10257590|NCT04331366|11389328|FG000|COMPLETED|Overall Study||2
10257591|NCT04331366|11389328|FG000|NOT COMPLETED|Overall Study||0
10257592|NCT04930263|11389334|FG000|STARTED|Overall Study||33
10257593|NCT04930263|11389335|FG001|STARTED|Overall Study||33
10257594|NCT04930263|11389334|FG000|COMPLETED|Overall Study||30
10257595|NCT04930263|11389335|FG001|COMPLETED|Overall Study||28
10257596|NCT04930263|11389334|FG000|NOT COMPLETED|Overall Study||3
10257597|NCT04930263|11389335|FG001|NOT COMPLETED|Overall Study||5
10257598|NCT04321252|11389350|FG000|STARTED|Overall Study||6
10257599|NCT04321252|11389351|FG001|STARTED|Overall Study||6
10257600|NCT04321252|11389352|FG002|STARTED|Overall Study||6
10257601|NCT04321252|11389353|FG003|STARTED|Overall Study||6
10257602|NCT04321252|11389354|FG004|STARTED|Overall Study||6
10257603|NCT04321252|11389355|FG005|STARTED|Overall Study||9
10257604|NCT04321252|11389356|FG006|STARTED|Overall Study||6
10257605|NCT04321252|11389357|FG007|STARTED|Overall Study||6
10257606|NCT04321252|11389358|FG008|STARTED|Overall Study||6
10257607|NCT04321252|11389350|FG000|PK Analysis Set|Overall Study||6
10257608|NCT04321252|11389351|FG001|PK Analysis Set|Overall Study||6
10257609|NCT04321252|11389352|FG002|PK Analysis Set|Overall Study||6
10257610|NCT04321252|11389353|FG003|PK Analysis Set|Overall Study||6
10257611|NCT04321252|11389354|FG004|PK Analysis Set|Overall Study||6
10257612|NCT04321252|11389355|FG005|PK Analysis Set|Overall Study||0
10257613|NCT04321252|11389356|FG006|PK Analysis Set|Overall Study||6
10257614|NCT04321252|11389357|FG007|PK Analysis Set|Overall Study||6
10257615|NCT04321252|11389358|FG008|PK Analysis Set|Overall Study||0
10257616|NCT04321252|11389350|FG000|COMPLETED|Overall Study||6
10257617|NCT04321252|11389351|FG001|COMPLETED|Overall Study||6
10257618|NCT04321252|11389352|FG002|COMPLETED|Overall Study||6
10257619|NCT04321252|11389353|FG003|COMPLETED|Overall Study||6
10257620|NCT04321252|11389354|FG004|COMPLETED|Overall Study||6
10257621|NCT04321252|11389355|FG005|COMPLETED|Overall Study||8
10257622|NCT04321252|11389356|FG006|COMPLETED|Overall Study||6
10257623|NCT04321252|11389357|FG007|COMPLETED|Overall Study||6
10257624|NCT04321252|11389358|FG008|COMPLETED|Overall Study||6
10257625|NCT04321252|11389350|FG000|NOT COMPLETED|Overall Study||0
10257626|NCT04321252|11389351|FG001|NOT COMPLETED|Overall Study||0
10257627|NCT04321252|11389352|FG002|NOT COMPLETED|Overall Study||0
10257628|NCT04321252|11389353|FG003|NOT COMPLETED|Overall Study||0
10257629|NCT04321252|11389354|FG004|NOT COMPLETED|Overall Study||0
10257630|NCT04321252|11389355|FG005|NOT COMPLETED|Overall Study||1
10257631|NCT04321252|11389356|FG006|NOT COMPLETED|Overall Study||0
10257632|NCT04321252|11389357|FG007|NOT COMPLETED|Overall Study||0
10257633|NCT04321252|11389358|FG008|NOT COMPLETED|Overall Study||0
10257634|NCT04285684|11389384|FG000|STARTED|Overall Study||4
10257635|NCT04285684|11389384|FG000|COMPLETED|Overall Study||4
10257636|NCT04285684|11389384|FG000|NOT COMPLETED|Overall Study||0
10257637|NCT04176445|11389388|FG000|STARTED|Overall Study||12
10257638|NCT04176445|11389389|FG001|STARTED|Overall Study||7
10257639|NCT04176445|11389388|FG000|COMPLETED|Overall Study||12
10257640|NCT04176445|11389389|FG001|COMPLETED|Overall Study||5
10257641|NCT04176445|11389388|FG000|NOT COMPLETED|Overall Study||0
10257642|NCT04176445|11389389|FG001|NOT COMPLETED|Overall Study||2
10257643|NCT04126213|11389401|FG000|STARTED|Overall Study||70
10257644|NCT04126213|11389402|FG001|STARTED|Overall Study||75
10257645|NCT04126213|11389403|FG002|STARTED|Overall Study||68
10257646|NCT04126213|11389404|FG003|STARTED|Overall Study||67
10257647|NCT04126213|11389405|FG004|STARTED|Overall Study||73
10257648|NCT04126213|11389406|FG005|STARTED|Overall Study||66
10257649|NCT04126213|11389401|FG000|COMPLETED|Overall Study||58
10257650|NCT04126213|11389402|FG001|COMPLETED|Overall Study||70
10257651|NCT04126213|11389403|FG002|COMPLETED|Overall Study||59
10257652|NCT04126213|11389404|FG003|COMPLETED|Overall Study||54
10257653|NCT04126213|11389405|FG004|COMPLETED|Overall Study||67
10257654|NCT04126213|11389406|FG005|COMPLETED|Overall Study||55
10257655|NCT04126213|11389401|FG000|NOT COMPLETED|Overall Study||12
10257656|NCT04126213|11389402|FG001|NOT COMPLETED|Overall Study||5
10257657|NCT04126213|11389403|FG002|NOT COMPLETED|Overall Study||9
10257658|NCT04126213|11389404|FG003|NOT COMPLETED|Overall Study||13
10257659|NCT04126213|11389405|FG004|NOT COMPLETED|Overall Study||6
10257660|NCT04126213|11389406|FG005|NOT COMPLETED|Overall Study||11
10257661|NCT03916458|11389423|FG000|STARTED|Overall Study||62
10257662|NCT03916458|11389423|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62
10257663|NCT03916458|11389423|FG000|NOT COMPLETED|Overall Study||0
10257664|NCT03672188|11389442|FG000|STARTED|Overall Study||6
10257665|NCT03672188|11389443|FG001|STARTED|Overall Study||6
10257666|NCT03672188|11389444|FG002|STARTED|Overall Study||6
10257667|NCT03672188|11389445|FG003|STARTED|Overall Study||8
10257668|NCT03672188|11389446|FG004|STARTED|Overall Study||6
10257669|NCT03672188|11389447|FG005|STARTED|Overall Study||6
10257670|NCT03672188|11389448|FG006|STARTED|Overall Study||12
10257671|NCT03672188|11389449|FG007|STARTED|Overall Study||3
10257672|NCT03672188|11389450|FG008|STARTED|Overall Study||6
10257673|NCT03672188|11389451|FG009|STARTED|Overall Study||6
10020824|NCT01839279|11144184|FG001|STARTED|Overall Study||32
10020825|NCT01839279|11144185|FG002|STARTED|Overall Study||32
10020826|NCT01839279|11144183|FG000|QT/QTc Analysis Set|Overall Study||72
10257674|NCT03672188|11389452|FG010|STARTED|Overall Study||3
10257675|NCT03672188|11389453|FG011|STARTED|Overall Study||3
10257676|NCT03672188|11389454|FG012|STARTED|Overall Study||3
10257677|NCT03672188|11389455|FG013|STARTED|Overall Study||6
10257678|NCT03672188|11389456|FG014|STARTED|Overall Study||2
10257679|NCT03672188|11389442|FG000|Dosed|Overall Study||6
10257680|NCT03672188|11389443|FG001|Dosed|Overall Study||6
10020827|NCT01839279|11144184|FG001|QT/QTc Analysis Set|Overall Study||32
10257681|NCT03672188|11389444|FG002|Dosed|Overall Study||6
10257682|NCT03672188|11389445|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7
10257683|NCT03672188|11389446|FG004|Dosed|Overall Study||6
10257684|NCT03672188|11389447|FG005|Dosed|Overall Study||6
10257685|NCT03672188|11389448|FG006|Dosed|Overall Study||12
10257686|NCT03672188|11389449|FG007|Dosed|Overall Study||3
10257687|NCT03672188|11389450|FG008|Dosed|Overall Study||6
10257688|NCT03672188|11389451|FG009|Dosed|Overall Study||6
10257689|NCT03672188|11389452|FG010|Dosed|Overall Study||3
10257690|NCT03672188|11389453|FG011|Dosed|Overall Study||3
10257691|NCT03672188|11389454|FG012|Dosed|Overall Study||3
10257692|NCT03672188|11389455|FG013|Dosed|Overall Study||6
10020828|NCT01839279|11144185|FG002|QT/QTc Analysis Set|Overall Study||32
10257693|NCT03672188|11389456|FG014|Dosed|Overall Study||2
10257694|NCT03672188|11389442|FG000|COMPLETED|Overall Study||6
10257695|NCT03672188|11389443|FG001|COMPLETED|Overall Study||6
10257696|NCT03672188|11389444|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5
10257697|NCT03672188|11389445|FG003|COMPLETED|Overall Study||5
10257698|NCT03672188|11389446|FG004|COMPLETED|Overall Study||6
10257699|NCT03672188|11389447|FG005|COMPLETED|Overall Study||6
10257700|NCT03672188|11389448|FG006|COMPLETED|Overall Study||12
10257701|NCT03672188|11389449|FG007|COMPLETED|Overall Study||3
10257702|NCT03672188|11389450|FG008|COMPLETED|Overall Study||6
10257703|NCT03672188|11389451|FG009|COMPLETED|Overall Study||6
10257704|NCT03672188|11389452|FG010|COMPLETED|Overall Study||3
10257705|NCT03672188|11389453|FG011|COMPLETED|Overall Study||3
10257706|NCT03672188|11389454|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2
10257707|NCT03672188|11389455|FG013|COMPLETED|Overall Study||6
10257708|NCT03672188|11389456|FG014|COMPLETED|Overall Study||2
10257709|NCT03672188|11389442|FG000|NOT COMPLETED|Overall Study||0
10257710|NCT03672188|11389443|FG001|NOT COMPLETED|Overall Study||0
10257711|NCT03672188|11389444|FG002|NOT COMPLETED|Overall Study||1
10257712|NCT03672188|11389445|FG003|NOT COMPLETED|Overall Study||3
10257713|NCT03672188|11389446|FG004|NOT COMPLETED|Overall Study||0
10257714|NCT03672188|11389447|FG005|NOT COMPLETED|Overall Study||0
10257715|NCT03672188|11389448|FG006|NOT COMPLETED|Overall Study||0
10257716|NCT03672188|11389449|FG007|NOT COMPLETED|Overall Study||0
10257717|NCT03672188|11389450|FG008|NOT COMPLETED|Overall Study||0
10257718|NCT03672188|11389451|FG009|NOT COMPLETED|Overall Study||0
10257719|NCT03672188|11389452|FG010|NOT COMPLETED|Overall Study||0
10257720|NCT03672188|11389453|FG011|NOT COMPLETED|Overall Study||0
10257721|NCT03672188|11389454|FG012|NOT COMPLETED|Overall Study||1
10257722|NCT03672188|11389455|FG013|NOT COMPLETED|Overall Study||0
10257723|NCT03672188|11389456|FG014|NOT COMPLETED|Overall Study||0
10257724|NCT03637959|11389522|FG000|STARTED|Overall Study||270
10257725|NCT03637959|11389522|FG000|COMPLETED|Overall Study||270
10257726|NCT03637959|11389522|FG000|NOT COMPLETED|Overall Study||0
9834968|NCT00789113|10946113|FG000|STARTED|Overall Study||12
9834969|NCT00789113|10946113|FG000|COMPLETED|Overall Study||12
9834970|NCT00789113|10946113|FG000|NOT COMPLETED|Overall Study||0
9834971|NCT00789191|10946120|FG000|STARTED|Overall Study||111
9834972|NCT00789191|10946121|FG001|STARTED|Overall Study||111
9834973|NCT00789191|10946120|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
9834974|NCT00789191|10946121|FG001|Exposed|Overall Study|1 non-compliance|110
9834975|NCT00789191|10946120|FG000|COMPLETED|Overall Study||97
9834976|NCT00789191|10946121|FG001|COMPLETED|Overall Study||92
10020829|NCT01839279|11144183|FG000|PK Analysis Set|Overall Study||70
9834977|NCT00789191|10946120|FG000|NOT COMPLETED|Overall Study||14
9834978|NCT00789191|10946121|FG001|NOT COMPLETED|Overall Study||19
9834979|NCT00789256|10946129|FG000|STARTED|Overall Study||14
9834980|NCT00789256|10946130|FG001|STARTED|Overall Study||12
9834981|NCT00789256|10946129|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
9834982|NCT00789256|10946130|FG001|COMPLETED|Overall Study||12
9834983|NCT00789256|10946129|FG000|NOT COMPLETED|Overall Study||0
10257727|NCT03230916|11389537|FG000|STARTED|Overall Study||7
10257728|NCT03230916|11389538|FG001|STARTED|Overall Study||6
10257729|NCT03230916|11389539|FG002|STARTED|Overall Study||6
10257730|NCT03230916|11389540|FG003|STARTED|Overall Study||4
10257731|NCT03230916|11389541|FG004|STARTED|Overall Study||4
10257732|NCT03230916|11389542|FG005|STARTED|Overall Study||6
9834984|NCT00789256|10946130|FG001|NOT COMPLETED|Overall Study||0
9834985|NCT00789321|10946141|FG000|STARTED|Overall Study||24
9834986|NCT00789321|10946142|FG001|STARTED|Overall Study||23
10257733|NCT03230916|11389543|FG006|STARTED|Overall Study||3
10257734|NCT03230916|11389544|FG007|STARTED|Overall Study||2
10257735|NCT03230916|11389545|FG008|STARTED|Overall Study||2
10257736|NCT03230916|11389546|FG009|STARTED|Overall Study||3
10257737|NCT03230916|11389547|FG010|STARTED|Overall Study||4
10257738|NCT03230916|11389537|FG000|Treated|Overall Study||7
10257739|NCT03230916|11389538|FG001|Treated|Overall Study||6
10257740|NCT03230916|11389539|FG002|Treated|Overall Study||6
10257741|NCT03230916|11389540|FG003|Treated|Overall Study||4
10257742|NCT03230916|11389541|FG004|Treated|Overall Study||4
10257743|NCT03230916|11389542|FG005|Treated|Overall Study||5
10257744|NCT03230916|11389543|FG006|Treated|Overall Study||3
10257745|NCT03230916|11389544|FG007|Treated|Overall Study||2
10257746|NCT03230916|11389545|FG008|Treated|Overall Study||2
10257747|NCT03230916|11389546|FG009|Treated|Overall Study||3
10257748|NCT03230916|11389547|FG010|Treated|Overall Study||4
10257749|NCT03230916|11389537|FG000|COMPLETED|Overall Study||7
10257750|NCT03230916|11389538|FG001|COMPLETED|Overall Study||6
10257751|NCT03230916|11389539|FG002|COMPLETED|Overall Study||6
10257752|NCT03230916|11389540|FG003|COMPLETED|Overall Study||4
10257753|NCT03230916|11389541|FG004|COMPLETED|Overall Study||4
10257754|NCT03230916|11389542|FG005|COMPLETED|Overall Study||5
10257755|NCT03230916|11389543|FG006|COMPLETED|Overall Study||3
10257756|NCT03230916|11389544|FG007|COMPLETED|Overall Study||2
10257757|NCT03230916|11389545|FG008|COMPLETED|Overall Study||2
10257758|NCT03230916|11389546|FG009|COMPLETED|Overall Study||3
10257759|NCT03230916|11389547|FG010|COMPLETED|Overall Study||4
10257760|NCT03230916|11389537|FG000|NOT COMPLETED|Overall Study||0
10257761|NCT03230916|11389538|FG001|NOT COMPLETED|Overall Study||0
10257762|NCT03230916|11389539|FG002|NOT COMPLETED|Overall Study||0
10257763|NCT03230916|11389540|FG003|NOT COMPLETED|Overall Study||0
10257764|NCT03230916|11389541|FG004|NOT COMPLETED|Overall Study||0
10257765|NCT03230916|11389542|FG005|NOT COMPLETED|Overall Study||1
10257766|NCT03230916|11389543|FG006|NOT COMPLETED|Overall Study||0
10257767|NCT03230916|11389544|FG007|NOT COMPLETED|Overall Study||0
10257768|NCT03230916|11389545|FG008|NOT COMPLETED|Overall Study||0
10257769|NCT03230916|11389546|FG009|NOT COMPLETED|Overall Study||0
10257770|NCT03230916|11389547|FG010|NOT COMPLETED|Overall Study||0
10257771|NCT03195894|11389590|FG000|STARTED|Overall Study||59
10257772|NCT03195894|11389591|FG001|STARTED|Overall Study||56
10257773|NCT03195894|11389590|FG000|COMPLETED|Overall Study||26
10257774|NCT03195894|11389591|FG001|COMPLETED|Overall Study||28
10257775|NCT03195894|11389590|FG000|NOT COMPLETED|Overall Study||33
10257776|NCT03195894|11389591|FG001|NOT COMPLETED|Overall Study||28
10257777|NCT03032705|11389602|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
10257778|NCT03032705|11389603|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
10257779|NCT03032705|11389602|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
10257780|NCT03032705|11389603|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
10257781|NCT03032705|11389602|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29
10257782|NCT03032705|11389603|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28
10257783|NCT03032705|11389602|FG000|NOT COMPLETED|Overall Study||22
10257784|NCT03032705|11389603|FG001|NOT COMPLETED|Overall Study||23
10257785|NCT02573259|11389616|FG000|STARTED|Overall Study||2
10257786|NCT02573259|11389617|FG001|STARTED|Overall Study||8
10257787|NCT02573259|11389618|FG002|STARTED|Overall Study||8
10257788|NCT02573259|11389619|FG003|STARTED|Overall Study||7
10257789|NCT02573259|11389620|FG004|STARTED|Overall Study||15
10257790|NCT02573259|11389621|FG005|STARTED|Overall Study||68
10257791|NCT02573259|11389622|FG006|STARTED|Overall Study||39
10257792|NCT02573259|11389616|FG000|Treated|Overall Study||2
10257793|NCT02573259|11389617|FG001|Treated|Overall Study||8
10257794|NCT02573259|11389618|FG002|Treated|Overall Study||8
10257795|NCT02573259|11389619|FG003|Treated|Overall Study||7
10257796|NCT02573259|11389620|FG004|Treated|Overall Study||15
10257797|NCT02573259|11389621|FG005|Treated|Overall Study||68
10257798|NCT02573259|11389622|FG006|Treated|Overall Study||38
10257799|NCT02573259|11389616|FG000|COMPLETED|Overall Study||1
10257800|NCT02573259|11389617|FG001|COMPLETED|Overall Study||0
10257801|NCT02573259|11389618|FG002|COMPLETED|Overall Study||2
9834987|NCT00789321|10946141|FG000|COMPLETED|Overall Study||24
10257802|NCT02573259|11389619|FG003|COMPLETED|Overall Study||1
10257803|NCT02573259|11389620|FG004|COMPLETED|Overall Study||2
10257804|NCT02573259|11389621|FG005|COMPLETED|Overall Study||10
10257805|NCT02573259|11389622|FG006|COMPLETED|Overall Study||5
10257806|NCT02573259|11389616|FG000|NOT COMPLETED|Overall Study||1
10257807|NCT02573259|11389617|FG001|NOT COMPLETED|Overall Study||8
10257808|NCT02573259|11389618|FG002|NOT COMPLETED|Overall Study||6
10257809|NCT02573259|11389619|FG003|NOT COMPLETED|Overall Study||6
10257810|NCT02573259|11389620|FG004|NOT COMPLETED|Overall Study||13
10257811|NCT02573259|11389621|FG005|NOT COMPLETED|Overall Study||58
10257812|NCT02573259|11389622|FG006|NOT COMPLETED|Overall Study||34
10257813|NCT02318329|11389664|FG000|STARTED|Overall Study||3
10257814|NCT02318329|11389665|FG001|STARTED|Overall Study||4
10257815|NCT02318329|11389666|FG002|STARTED|Overall Study||3
9834988|NCT00789321|10946142|FG001|COMPLETED|Overall Study||22
9834989|NCT00789321|10946141|FG000|NOT COMPLETED|Overall Study||0
9834990|NCT00789321|10946142|FG001|NOT COMPLETED|Overall Study||1
9834991|NCT00789360|10946150|FG000|STARTED|Overall Study||15
9834992|NCT00789360|10946151|FG001|STARTED|Overall Study||15
9834993|NCT00789360|10946150|FG000|COMPLETED|Overall Study||12
9834994|NCT00789360|10946151|FG001|COMPLETED|Overall Study||14
9834995|NCT00789360|10946150|FG000|NOT COMPLETED|Overall Study||3
9834996|NCT00789360|10946151|FG001|NOT COMPLETED|Overall Study||1
9834997|NCT00789373|10946158|FG000|STARTED|Induction||939
9834998|NCT00789373|10946159|FG001|STARTED|Induction||0
9834999|NCT00789373|10946160|FG002|STARTED|Induction||0
9835000|NCT00789373|10946158|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
9835001|NCT00789373|10946159|FG001|COMPLETED|Induction||0
9835002|NCT00789373|10946160|FG002|COMPLETED|Induction||0
9835003|NCT00789373|10946158|FG000|NOT COMPLETED|Induction||399
9835004|NCT00789373|10946159|FG001|NOT COMPLETED|Induction||0
9835005|NCT00789373|10946160|FG002|NOT COMPLETED|Induction||0
9835006|NCT00789373|10946158|FG000|STARTED|Maintenance||0
9835007|NCT00789373|10946159|FG001|STARTED|Maintenance||359
9835008|NCT00789373|10946160|FG002|STARTED|Maintenance||180
9835009|NCT00789373|10946158|FG000|COMPLETED|Maintenance||0
9835010|NCT00789373|10946159|FG001|COMPLETED|Maintenance||0
9835011|NCT00789373|10946160|FG002|COMPLETED|Maintenance||0
9835012|NCT00789373|10946158|FG000|NOT COMPLETED|Maintenance||0
9835013|NCT00789373|10946159|FG001|NOT COMPLETED|Maintenance||359
9835014|NCT00789373|10946160|FG002|NOT COMPLETED|Maintenance||180
9835015|NCT00789438|10946174|FG000|STARTED|Overall Study||21
9835016|NCT00789438|10946175|FG001|STARTED|Overall Study||20
9835017|NCT00789438|10946176|FG002|STARTED|Overall Study||28
9835018|NCT00789438|10946174|FG000|COMPLETED|Overall Study||21
9835019|NCT00789438|10946175|FG001|COMPLETED|Overall Study||20
9835020|NCT00789438|10946176|FG002|COMPLETED|Overall Study||28
9835021|NCT00789438|10946174|FG000|NOT COMPLETED|Overall Study||0
9835022|NCT00789438|10946175|FG001|NOT COMPLETED|Overall Study||0
9835023|NCT00789438|10946176|FG002|NOT COMPLETED|Overall Study||0
9835024|NCT00789477|10946189|FG000|STARTED|Overall Study|randomized|44
9835025|NCT00789477|10946190|FG001|STARTED|Overall Study|randomized|44
9835026|NCT00789477|10946191|FG002|STARTED|Overall Study|randomized|44
9835027|NCT00789477|10946192|FG003|STARTED|Overall Study|randomized|44
9835028|NCT00789477|10946193|FG004|STARTED|Overall Study|randomized|45
9835029|NCT00789477|10946189|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
9835030|NCT00789477|10946190|FG001|Participants Received Treatment|Overall Study|SAF|44
9835031|NCT00789477|10946191|FG002|Participants Received Treatment|Overall Study|SAF|44
9835032|NCT00789477|10946192|FG003|Participants Received Treatment|Overall Study|SAF|42
9835033|NCT00789477|10946193|FG004|Participants Received Treatment|Overall Study|SAF|45
9835034|NCT00789477|10946189|FG000|COMPLETED|Overall Study||33
9835035|NCT00789477|10946190|FG001|COMPLETED|Overall Study||38
9835036|NCT00789477|10946191|FG002|COMPLETED|Overall Study||33
9835037|NCT00789477|10946192|FG003|COMPLETED|Overall Study||34
9835038|NCT00789477|10946193|FG004|COMPLETED|Overall Study||38
9835039|NCT00789477|10946189|FG000|NOT COMPLETED|Overall Study||11
9835040|NCT00789477|10946190|FG001|NOT COMPLETED|Overall Study||6
9835041|NCT00789477|10946191|FG002|NOT COMPLETED|Overall Study||11
9835042|NCT00789477|10946192|FG003|NOT COMPLETED|Overall Study||10
9835043|NCT00789477|10946193|FG004|NOT COMPLETED|Overall Study||7
9835044|NCT00789529|10946209|FG000|STARTED|Overall Study||16
9835045|NCT00789529|10946210|FG001|STARTED|Overall Study||16
9835046|NCT00789529|10946209|FG000|COMPLETED|Overall Study||15
9835047|NCT00789529|10946210|FG001|COMPLETED|Overall Study||15
9835048|NCT00789529|10946209|FG000|NOT COMPLETED|Overall Study||1
9835049|NCT00789529|10946210|FG001|NOT COMPLETED|Overall Study||1
9835050|NCT00789555|10946219|FG000|STARTED|Overall Study||421
9835051|NCT00789555|10946220|FG001|STARTED|Overall Study||417
9835052|NCT00789555|10946221|FG002|STARTED|Overall Study||422
9835053|NCT00789555|10946219|FG000|COMPLETED|Overall Study||262
9835054|NCT00789555|10946220|FG001|COMPLETED|Overall Study||278
9835055|NCT00789555|10946221|FG002|COMPLETED|Overall Study||263
10257816|NCT02318329|11389667|FG003|STARTED|Overall Study||3
10257817|NCT02318329|11389668|FG004|STARTED|Overall Study||3
10257818|NCT02318329|11389669|FG005|STARTED|Overall Study||3
10257819|NCT02318329|11389670|FG006|STARTED|Overall Study||1
10257820|NCT02318329|11389671|FG007|STARTED|Overall Study||1
9835056|NCT00789555|10946219|FG000|NOT COMPLETED|Overall Study||159
9835057|NCT00789555|10946220|FG001|NOT COMPLETED|Overall Study||139
10257821|NCT02318329|11389672|FG008|STARTED|Overall Study||6
9835058|NCT00789555|10946221|FG002|NOT COMPLETED|Overall Study||159
10257822|NCT02318329|11389673|FG009|STARTED|Overall Study||52
10257823|NCT02318329|11389664|FG000|COMPLETED|Overall Study||0
10257824|NCT02318329|11389665|FG001|COMPLETED|Overall Study||0
10257825|NCT02318329|11389666|FG002|COMPLETED|Overall Study||0
10257826|NCT02318329|11389667|FG003|COMPLETED|Overall Study||0
10257827|NCT02318329|11389668|FG004|COMPLETED|Overall Study||0
10257828|NCT02318329|11389669|FG005|COMPLETED|Overall Study||0
10257829|NCT02318329|11389670|FG006|COMPLETED|Overall Study||0
10020830|NCT01839279|11144184|FG001|PK Analysis Set|Overall Study||0
10020831|NCT01839279|11144185|FG002|PK Analysis Set|Overall Study||0
10020832|NCT01839279|11144183|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0
10020833|NCT01839279|11144184|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31
10020834|NCT01839279|11144185|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30
10020835|NCT01839279|11144183|FG000|PK/QTc Analysis Set|Overall Study||70
10020836|NCT01839279|11144184|FG001|PK/QTc Analysis Set|Overall Study||0
10020837|NCT01839279|11144185|FG002|PK/QTc Analysis Set|Overall Study||0
10257830|NCT02318329|11389671|FG007|COMPLETED|Overall Study||0
10257831|NCT02318329|11389672|FG008|COMPLETED|Overall Study||0
10257832|NCT02318329|11389673|FG009|COMPLETED|Overall Study||0
10257833|NCT02318329|11389664|FG000|NOT COMPLETED|Overall Study||3
10257834|NCT02318329|11389665|FG001|NOT COMPLETED|Overall Study||4
10257835|NCT02318329|11389666|FG002|NOT COMPLETED|Overall Study||3
10257836|NCT02318329|11389667|FG003|NOT COMPLETED|Overall Study||3
10257837|NCT02318329|11389668|FG004|NOT COMPLETED|Overall Study||3
10257838|NCT02318329|11389669|FG005|NOT COMPLETED|Overall Study||3
10257839|NCT02318329|11389670|FG006|NOT COMPLETED|Overall Study||1
10257840|NCT02318329|11389671|FG007|NOT COMPLETED|Overall Study||1
10257841|NCT02318329|11389672|FG008|NOT COMPLETED|Overall Study||6
10257842|NCT02318329|11389673|FG009|NOT COMPLETED|Overall Study||52
10257843|NCT01602666|11389716|FG000|STARTED|Induction Chemotherapy||107
10257844|NCT01602666|11389717|FG001|STARTED|Induction Chemotherapy||137
10257845|NCT01602666|11389716|FG000|COMPLETED|Induction Chemotherapy||70
10257846|NCT01602666|11389717|FG001|COMPLETED|Induction Chemotherapy||113
10257847|NCT01602666|11389716|FG000|NOT COMPLETED|Induction Chemotherapy||37
10257848|NCT01602666|11389717|FG001|NOT COMPLETED|Induction Chemotherapy||24
10257849|NCT01602666|11389716|FG000|STARTED|Radiation Therapy on Protocol||70
10257850|NCT01602666|11389717|FG001|STARTED|Radiation Therapy on Protocol||113
10257851|NCT01602666|11389716|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
10257852|NCT01602666|11389717|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
10257853|NCT01602666|11389716|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
10257854|NCT01602666|11389717|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
10257855|NCT01602666|11389716|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
10257856|NCT01602666|11389717|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
10257857|NCT01602666|11389716|FG000|COMPLETED|Radiation Therapy on Protocol||60
10257858|NCT01602666|11389717|FG001|COMPLETED|Radiation Therapy on Protocol||82
10257859|NCT01602666|11389716|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10
10257860|NCT01602666|11389717|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31
10257861|NCT01375959|11389727|FG000|STARTED|First Intervention (6 Weeks)||17
10257862|NCT01375959|11389728|FG001|STARTED|First Intervention (6 Weeks)||21
10257863|NCT01375959|11389727|FG000|Received Invertention|First Intervention (6 Weeks)||17
10257864|NCT01375959|11389728|FG001|Received Invertention|First Intervention (6 Weeks)||21
10257865|NCT01375959|11389727|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
10257866|NCT01375959|11389728|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
10257867|NCT01375959|11389727|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
10257868|NCT01375959|11389728|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
10257869|NCT01375959|11389727|FG000|STARTED|Wash-Out (3 Weeks)||15
10257870|NCT01375959|11389728|FG001|STARTED|Wash-Out (3 Weeks)||18
10257871|NCT01375959|11389727|FG000|COMPLETED|Wash-Out (3 Weeks)||15
10257872|NCT01375959|11389728|FG001|COMPLETED|Wash-Out (3 Weeks)||18
10257873|NCT01375959|11389727|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0
10257874|NCT01375959|11389728|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0
10257875|NCT01375959|11389727|FG000|STARTED|Second Intervention (6 Weeks)||15
10257876|NCT01375959|11389728|FG001|STARTED|Second Intervention (6 Weeks)||18
10257877|NCT01375959|11389727|FG000|COMPLETED|Second Intervention (6 Weeks)||15
10257878|NCT01375959|11389728|FG001|COMPLETED|Second Intervention (6 Weeks)||15
10257879|NCT01375959|11389727|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10257880|NCT01375959|11389728|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
10257881|NCT01224106|11389739|FG000|STARTED|Double-Blind Treatment Phase||266
10257882|NCT01224106|11389740|FG001|STARTED|Double-Blind Treatment Phase||271
10257883|NCT01224106|11389741|FG002|STARTED|Double-Blind Treatment Phase||260
10257884|NCT01224106|11389742|FG003|STARTED|Double-Blind Treatment Phase||0
10257885|NCT01224106|11389743|FG004|STARTED|Double-Blind Treatment Phase||0
10257886|NCT01224106|11389739|FG000|COMPLETED|Double-Blind Treatment Phase||187
10257887|NCT01224106|11389740|FG001|COMPLETED|Double-Blind Treatment Phase||185
10257888|NCT01224106|11389741|FG002|COMPLETED|Double-Blind Treatment Phase||180
10257889|NCT01224106|11389742|FG003|COMPLETED|Double-Blind Treatment Phase||0
10257890|NCT01224106|11389743|FG004|COMPLETED|Double-Blind Treatment Phase||0
10020838|NCT01839279|11144183|FG000|COMPLETED|Overall Study||59
10020839|NCT01839279|11144184|FG001|COMPLETED|Overall Study||30
10020840|NCT01839279|11144185|FG002|COMPLETED|Overall Study||30
10020841|NCT01839279|11144183|FG000|NOT COMPLETED|Overall Study||13
10020842|NCT01839279|11144184|FG001|NOT COMPLETED|Overall Study||2
10257891|NCT01224106|11389739|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79
10257892|NCT01224106|11389740|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86
10257893|NCT01224106|11389741|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80
10257894|NCT01224106|11389742|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10257895|NCT01224106|11389743|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0
10020843|NCT01839279|11144185|FG002|NOT COMPLETED|Overall Study||2
10020844|NCT01839318|11144200|FG000|STARTED|Period 1, First Day of Wear||4
10020845|NCT01839318|11144201|FG001|STARTED|Period 1, First Day of Wear||4
10020846|NCT01839318|11144202|FG002|STARTED|Period 1, First Day of Wear||5
10020847|NCT01839318|11144203|FG003|STARTED|Period 1, First Day of Wear||6
10020848|NCT01839318|11144204|FG004|STARTED|Period 1, First Day of Wear||7
10020849|NCT01839318|11144205|FG005|STARTED|Period 1, First Day of Wear||2
10020850|NCT01839318|11144200|FG000|COMPLETED|Period 1, First Day of Wear||4
10020851|NCT01839318|11144201|FG001|COMPLETED|Period 1, First Day of Wear||4
10020852|NCT01839318|11144202|FG002|COMPLETED|Period 1, First Day of Wear||5
10020853|NCT01839318|11144203|FG003|COMPLETED|Period 1, First Day of Wear||6
10020854|NCT01839318|11144204|FG004|COMPLETED|Period 1, First Day of Wear||7
10020855|NCT01839318|11144205|FG005|COMPLETED|Period 1, First Day of Wear||2
10020856|NCT01839318|11144200|FG000|NOT COMPLETED|Period 1, First Day of Wear||0
10020857|NCT01839318|11144201|FG001|NOT COMPLETED|Period 1, First Day of Wear||0
10020858|NCT01839318|11144202|FG002|NOT COMPLETED|Period 1, First Day of Wear||0
10020859|NCT01839318|11144203|FG003|NOT COMPLETED|Period 1, First Day of Wear||0
10020860|NCT01839318|11144204|FG004|NOT COMPLETED|Period 1, First Day of Wear||0
10020861|NCT01839318|11144205|FG005|NOT COMPLETED|Period 1, First Day of Wear||0
10020862|NCT01839318|11144200|FG000|STARTED|Period 2, Second Day of Wear||4
10020863|NCT01839318|11144201|FG001|STARTED|Period 2, Second Day of Wear||4
10020864|NCT01839318|11144202|FG002|STARTED|Period 2, Second Day of Wear||5
10020865|NCT01839318|11144203|FG003|STARTED|Period 2, Second Day of Wear||6
10020866|NCT01839318|11144204|FG004|STARTED|Period 2, Second Day of Wear||7
10020867|NCT01839318|11144205|FG005|STARTED|Period 2, Second Day of Wear||2
10020868|NCT01839318|11144200|FG000|COMPLETED|Period 2, Second Day of Wear||4
10020869|NCT01839318|11144201|FG001|COMPLETED|Period 2, Second Day of Wear||4
10020870|NCT01839318|11144202|FG002|COMPLETED|Period 2, Second Day of Wear||5
10020871|NCT01839318|11144203|FG003|COMPLETED|Period 2, Second Day of Wear||6
10020872|NCT01839318|11144204|FG004|COMPLETED|Period 2, Second Day of Wear||7
10020873|NCT01839318|11144205|FG005|COMPLETED|Period 2, Second Day of Wear||2
10020874|NCT01839318|11144200|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0
10020875|NCT01839318|11144201|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0
10020876|NCT01839318|11144202|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0
10020877|NCT01839318|11144203|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0
10020878|NCT01839318|11144204|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0
10020879|NCT01839318|11144205|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0
10020880|NCT01839318|11144200|FG000|STARTED|Period 3, Third Day of Wear||4
10020881|NCT01839318|11144201|FG001|STARTED|Period 3, Third Day of Wear||4
10020882|NCT01839318|11144202|FG002|STARTED|Period 3, Third Day of Wear||5
10020883|NCT01839318|11144203|FG003|STARTED|Period 3, Third Day of Wear||6
10020884|NCT01839318|11144204|FG004|STARTED|Period 3, Third Day of Wear||7
10020885|NCT01839318|11144205|FG005|STARTED|Period 3, Third Day of Wear||2
10020886|NCT01839318|11144200|FG000|COMPLETED|Period 3, Third Day of Wear||4
10020887|NCT01839318|11144201|FG001|COMPLETED|Period 3, Third Day of Wear||4
10020888|NCT01839318|11144202|FG002|COMPLETED|Period 3, Third Day of Wear||5
10020889|NCT01839318|11144203|FG003|COMPLETED|Period 3, Third Day of Wear||6
10020890|NCT01839318|11144204|FG004|COMPLETED|Period 3, Third Day of Wear||7
10020891|NCT01839318|11144205|FG005|COMPLETED|Period 3, Third Day of Wear||2
10020892|NCT01839318|11144200|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0
10020893|NCT01839318|11144201|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0
10020894|NCT01839318|11144202|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0
10020895|NCT01839318|11144203|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0
10020896|NCT01839318|11144204|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0
10020897|NCT01839318|11144205|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0
10020898|NCT01839487|11144215|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
10020899|NCT01839487|11144216|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
10020900|NCT01839487|11144217|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10020901|NCT01839487|11144218|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10020902|NCT01839487|11144219|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10020903|NCT01839487|11144220|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10020904|NCT01839487|11144215|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020905|NCT01839487|11144216|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020906|NCT01839487|11144217|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020907|NCT01839487|11144218|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020908|NCT01839487|11144219|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020909|NCT01839487|11144220|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10257896|NCT01224106|11389739|FG000|STARTED|Open-Label Extension (OLE) Phase||0
10257897|NCT01224106|11389740|FG001|STARTED|Open-Label Extension (OLE) Phase||0
10020910|NCT01839487|11144215|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
10020911|NCT01839487|11144216|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
10020912|NCT01839487|11144217|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020913|NCT01839487|11144218|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020914|NCT01839487|11144219|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020915|NCT01839487|11144220|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10020916|NCT01839487|11144215|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
10257898|NCT01224106|11389741|FG002|STARTED|Open-Label Extension (OLE) Phase||0
10257899|NCT01224106|11389742|FG003|STARTED|Open-Label Extension (OLE) Phase||49
10257900|NCT01224106|11389743|FG004|STARTED|Open-Label Extension (OLE) Phase||105
10257901|NCT01224106|11389739|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0
10257902|NCT01224106|11389740|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0
10257903|NCT01224106|11389741|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0
10257904|NCT01224106|11389742|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33
10257905|NCT01224106|11389743|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71
10257906|NCT01224106|11389739|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10257907|NCT01224106|11389740|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10257908|NCT01224106|11389741|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10257909|NCT01224106|11389742|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16
10257910|NCT01224106|11389743|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34
10257911|NCT00999609|11389763|FG000|STARTED|Overall Study|Before intervention|21
10257912|NCT00999609|11389764|FG001|STARTED|Overall Study||10
10257913|NCT00999609|11389763|FG000|COMPLETED|Overall Study|1 year post intervention|20
10257914|NCT00999609|11389764|FG001|COMPLETED|Overall Study|1 year post intervention|9
10257915|NCT00999609|11389763|FG000|NOT COMPLETED|Overall Study||1
10257916|NCT00999609|11389764|FG001|NOT COMPLETED|Overall Study||1
10257917|NCT00354835|11389772|FG000|STARTED|Overall Study||239
10257918|NCT00354835|11389773|FG001|STARTED|Overall Study||242
10257919|NCT00354835|11389772|FG000|COMPLETED|Overall Study||187
10257920|NCT00354835|11389773|FG001|COMPLETED|Overall Study||181
10257921|NCT00354835|11389772|FG000|NOT COMPLETED|Overall Study||52
10257922|NCT00354835|11389773|FG001|NOT COMPLETED|Overall Study||61
10020917|NCT01839487|11144216|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
10020918|NCT01839487|11144217|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
10020919|NCT01839487|11144218|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
10020920|NCT01839487|11144219|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
10020921|NCT01839487|11144220|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
10020922|NCT01839487|11144215|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10020923|NCT01839487|11144216|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10020924|NCT01839487|11144217|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10020925|NCT01839487|11144218|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10020926|NCT01839487|11144219|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
10020927|NCT01839487|11144220|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10020928|NCT01839487|11144215|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10020929|NCT01839487|11144216|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10020930|NCT01839487|11144217|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
10020931|NCT01839487|11144218|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
10020932|NCT01839487|11144219|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
10020933|NCT01839487|11144220|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
10020934|NCT01839604|11144233|FG000|STARTED|Overall Study||6
10020935|NCT01839604|11144234|FG001|STARTED|Overall Study||6
10020936|NCT01839604|11144235|FG002|STARTED|Overall Study||7
10020937|NCT01839604|11144236|FG003|STARTED|Overall Study||5
10020938|NCT01839604|11144237|FG004|STARTED|Overall Study||15
10020939|NCT01839604|11144233|FG000|COMPLETED|Overall Study||6
10020940|NCT01839604|11144234|FG001|COMPLETED|Overall Study||6
10020941|NCT01839604|11144235|FG002|COMPLETED|Overall Study||7
10020942|NCT01839604|11144236|FG003|COMPLETED|Overall Study||5
10020943|NCT01839604|11144237|FG004|COMPLETED|Overall Study||15
10020944|NCT01839604|11144233|FG000|NOT COMPLETED|Overall Study||0
10020945|NCT01839604|11144234|FG001|NOT COMPLETED|Overall Study||0
10257923|NCT04531241|11389794|FG000|STARTED|Period 1||68
10257924|NCT04531241|11389795|FG001|STARTED|Period 1||67
10257925|NCT04531241|11389794|FG000|COMPLETED|Period 1||64
10257926|NCT04531241|11389795|FG001|COMPLETED|Period 1||65
10257927|NCT04531241|11389794|FG000|NOT COMPLETED|Period 1||4
10257928|NCT04531241|11389795|FG001|NOT COMPLETED|Period 1||2
10257929|NCT04531241|11389794|FG000|STARTED|Period 2||64
10257930|NCT04531241|11389795|FG001|STARTED|Period 2||65
10257931|NCT04531241|11389794|FG000|COMPLETED|Period 2||63
10257932|NCT04531241|11389795|FG001|COMPLETED|Period 2||64
10257933|NCT04531241|11389794|FG000|NOT COMPLETED|Period 2||1
10257934|NCT04531241|11389795|FG001|NOT COMPLETED|Period 2||1
10257935|NCT04456153|11389803|FG000|STARTED|Overall Study||19
10257936|NCT04456153|11389804|FG001|STARTED|Overall Study||41
10257937|NCT04456153|11389803|FG000|COMPLETED|Overall Study||19
10257938|NCT04456153|11389804|FG001|COMPLETED|Overall Study||41
10257939|NCT04456153|11389803|FG000|NOT COMPLETED|Overall Study||0
10257940|NCT04456153|11389804|FG001|NOT COMPLETED|Overall Study||0
10257941|NCT04351243|11389826|FG000|STARTED|Overall Study||114
10257942|NCT04351243|11389827|FG001|STARTED|Overall Study||113
10257943|NCT04351243|11389826|FG000|Completed Baseline Assessment|Overall Study||113
10257944|NCT04351243|11389827|FG001|Completed Baseline Assessment|Overall Study||112
10257945|NCT04351243|11389826|FG000|COMPLETED|Overall Study||74
10257946|NCT04351243|11389827|FG001|COMPLETED|Overall Study||75
10257947|NCT04351243|11389826|FG000|NOT COMPLETED|Overall Study||40
10257948|NCT04351243|11389827|FG001|NOT COMPLETED|Overall Study||38
10257949|NCT04312256|11389833|FG000|STARTED|Overall Study||81
10257950|NCT04312256|11389833|FG000|COMPLETED|Overall Study||81
10257951|NCT04312256|11389833|FG000|NOT COMPLETED|Overall Study||0
10258042|NCT03283371|11389941|FG003|NOT COMPLETED|Placebo-controlled||0
10258043|NCT03283371|11389938|FG000|STARTED|Open-label Phase||0
10258044|NCT03283371|11389939|FG001|STARTED|Open-label Phase||0
10258045|NCT03283371|11389940|FG002|STARTED|Open-label Phase||31
10258046|NCT03283371|11389941|FG003|STARTED|Open-label Phase||30
10258047|NCT03283371|11389938|FG000|COMPLETED|Open-label Phase||0
10258048|NCT03283371|11389939|FG001|COMPLETED|Open-label Phase||0
9835059|NCT00789581|10946231|FG000|STARTED|AC Therapy||306
10258049|NCT03283371|11389940|FG002|COMPLETED|Open-label Phase||27
10258050|NCT03283371|11389941|FG003|COMPLETED|Open-label Phase||29
10258051|NCT03283371|11389938|FG000|NOT COMPLETED|Open-label Phase||0
10258052|NCT03283371|11389939|FG001|NOT COMPLETED|Open-label Phase||0
10258053|NCT03283371|11389940|FG002|NOT COMPLETED|Open-label Phase||4
10258054|NCT03283371|11389941|FG003|NOT COMPLETED|Open-label Phase||1
10258055|NCT03257254|11389951|FG000|STARTED|Overall Study||76
10258056|NCT03257254|11389951|FG000|COMPLETED|Overall Study||55
10258057|NCT03257254|11389951|FG000|NOT COMPLETED|Overall Study||21
10258058|NCT03084718|11389960|FG000|STARTED|Overall Study||120
10258059|NCT03084718|11389961|FG001|STARTED|Overall Study||120
10258060|NCT03084718|11389962|FG002|STARTED|Overall Study||122
10258061|NCT03084718|11389963|FG003|STARTED|Overall Study||124
10258062|NCT03084718|11389964|FG004|STARTED|Overall Study||124
10258063|NCT03084718|11389960|FG000|COMPLETED|Overall Study||109
10258064|NCT03084718|11389961|FG001|COMPLETED|Overall Study||110
10258065|NCT03084718|11389962|FG002|COMPLETED|Overall Study||110
10258066|NCT03084718|11389963|FG003|COMPLETED|Overall Study||110
10257952|NCT04185220|11389840|FG000|STARTED|Dose Escalation||3
10257953|NCT04185220|11389841|FG001|STARTED|Dose Escalation||3
10257954|NCT04185220|11389840|FG000|COMPLETED|Dose Escalation||3
10257955|NCT04185220|11389841|FG001|COMPLETED|Dose Escalation||1
10257956|NCT04185220|11389840|FG000|NOT COMPLETED|Dose Escalation||0
10257957|NCT04185220|11389841|FG001|NOT COMPLETED|Dose Escalation||2
10257958|NCT04185220|11389840|FG000|STARTED|Dose Expansion||0
10257959|NCT04185220|11389841|FG001|STARTED|Dose Expansion||0
10257960|NCT04185220|11389840|FG000|COMPLETED|Dose Expansion||0
10257961|NCT04185220|11389841|FG001|COMPLETED|Dose Expansion||0
10257962|NCT04185220|11389840|FG000|NOT COMPLETED|Dose Expansion||0
10257963|NCT04185220|11389841|FG001|NOT COMPLETED|Dose Expansion||0
10257964|NCT03851107|11389848|FG000|STARTED|Overall Study||9
10257965|NCT03851107|11389848|FG000|COMPLETED|Overall Study||7
10257966|NCT03851107|11389848|FG000|NOT COMPLETED|Overall Study||2
10257967|NCT03600714|11389858|FG000|STARTED|Overall Study||26
10257968|NCT03600714|11389858|FG000|COMPLETED|Overall Study||25
10257969|NCT03600714|11389858|FG000|NOT COMPLETED|Overall Study||1
10257970|NCT03479307|11389865|FG000|STARTED|Overall Study||91
10257971|NCT03479307|11389866|FG001|STARTED|Overall Study||90
10257972|NCT03479307|11389867|FG002|STARTED|Overall Study||47
10257973|NCT03479307|11389865|FG000|COMPLETED|Overall Study||90
10257974|NCT03479307|11389866|FG001|COMPLETED|Overall Study||89
10257975|NCT03479307|11389867|FG002|COMPLETED|Overall Study||47
10257976|NCT03479307|11389865|FG000|NOT COMPLETED|Overall Study||1
10257977|NCT03479307|11389866|FG001|NOT COMPLETED|Overall Study||1
10257978|NCT03479307|11389867|FG002|NOT COMPLETED|Overall Study||0
10257979|NCT03470441|11389879|FG000|STARTED|Overall Study||29
10257980|NCT03470441|11389880|FG001|STARTED|Overall Study||31
10257981|NCT03470441|11389881|FG002|STARTED|Overall Study||31
10257982|NCT03470441|11389882|FG003|STARTED|Overall Study||29
10257983|NCT03470441|11389879|FG000|COMPLETED|Overall Study||28
10257984|NCT03470441|11389880|FG001|COMPLETED|Overall Study||26
10257985|NCT03470441|11389881|FG002|COMPLETED|Overall Study||29
10257986|NCT03470441|11389882|FG003|COMPLETED|Overall Study||25
10257987|NCT03470441|11389879|FG000|NOT COMPLETED|Overall Study||1
10257988|NCT03470441|11389880|FG001|NOT COMPLETED|Overall Study||5
10257989|NCT03470441|11389881|FG002|NOT COMPLETED|Overall Study||2
10257990|NCT03470441|11389882|FG003|NOT COMPLETED|Overall Study||4
10257991|NCT03452397|11389896|FG000|STARTED|Overall Study||41
10257992|NCT03452397|11389897|FG001|STARTED|Overall Study||41
10257993|NCT03452397|11389898|FG002|STARTED|Overall Study||41
10257994|NCT03452397|11389899|FG003|STARTED|Overall Study||42
10257995|NCT03452397|11389896|FG000|COMPLETED|Overall Study||40
10257996|NCT03452397|11389897|FG001|COMPLETED|Overall Study||41
10257997|NCT03452397|11389898|FG002|COMPLETED|Overall Study||39
10257998|NCT03452397|11389899|FG003|COMPLETED|Overall Study||41
10257999|NCT03452397|11389896|FG000|NOT COMPLETED|Overall Study||1
10258000|NCT03452397|11389897|FG001|NOT COMPLETED|Overall Study||0
10258001|NCT03452397|11389898|FG002|NOT COMPLETED|Overall Study||2
10258002|NCT03452397|11389899|FG003|NOT COMPLETED|Overall Study||1
10258003|NCT03448939|11389913|FG000|STARTED|Overall Study||243
10258004|NCT03448939|11389914|FG001|STARTED|Overall Study||118
10258005|NCT03448939|11389913|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
10258006|NCT03448939|11389914|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113
10258007|NCT03448939|11389913|FG000|COMPLETED|Overall Study||222
10258008|NCT03448939|11389914|FG001|COMPLETED|Overall Study||107
10258009|NCT03448939|11389913|FG000|NOT COMPLETED|Overall Study||21
10258010|NCT03448939|11389914|FG001|NOT COMPLETED|Overall Study||11
10258011|NCT03410108|11389920|FG000|STARTED|Overall Study||104
10258012|NCT03410108|11389920|FG000|Safety Evaluation Lead-in Part|Overall Study||9
10258013|NCT03410108|11389920|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47
10258014|NCT03410108|11389920|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16
10258015|NCT03410108|11389920|FG000|Refractory Expansion Part|Overall Study||63
10258016|NCT03410108|11389920|FG000|All Refractory Participants|Overall Study||72
10258017|NCT03410108|11389920|FG000|TKI-Naive Expansion Cohort|Overall Study||32
10258018|NCT03410108|11389920|FG000|Completed|Overall Study||0
10258019|NCT03410108|11389920|FG000|COMPLETED|Overall Study||0
10258020|NCT03410108|11389920|FG000|NOT COMPLETED|Overall Study||104
10258021|NCT03377803|11389929|FG000|STARTED|Overall Study||150
10258022|NCT03377803|11389930|FG001|STARTED|Overall Study||112
10258023|NCT03377803|11389929|FG000|COMPLETED|Overall Study||139
10258024|NCT03377803|11389930|FG001|COMPLETED|Overall Study||108
10258025|NCT03377803|11389929|FG000|NOT COMPLETED|Overall Study||11
10258026|NCT03377803|11389930|FG001|NOT COMPLETED|Overall Study||4
10258027|NCT03283371|11389938|FG000|STARTED|Placebo-controlled||34
10258028|NCT03283371|11389939|FG001|STARTED|Placebo-controlled||33
10258029|NCT03283371|11389940|FG002|STARTED|Placebo-controlled||0
10258030|NCT03283371|11389941|FG003|STARTED|Placebo-controlled||0
10258031|NCT03283371|11389938|FG000|Number of Participants Dosed|Placebo-controlled||34
10258032|NCT03283371|11389939|FG001|Number of Participants Dosed|Placebo-controlled||32
10258033|NCT03283371|11389940|FG002|Number of Participants Dosed|Placebo-controlled||0
10258034|NCT03283371|11389941|FG003|Number of Participants Dosed|Placebo-controlled||0
10258035|NCT03283371|11389938|FG000|COMPLETED|Placebo-controlled||31
10258036|NCT03283371|11389939|FG001|COMPLETED|Placebo-controlled||30
10258037|NCT03283371|11389940|FG002|COMPLETED|Placebo-controlled||0
10258038|NCT03283371|11389941|FG003|COMPLETED|Placebo-controlled||0
10258039|NCT03283371|11389938|FG000|NOT COMPLETED|Placebo-controlled||3
10258040|NCT03283371|11389939|FG001|NOT COMPLETED|Placebo-controlled||3
10258041|NCT03283371|11389940|FG002|NOT COMPLETED|Placebo-controlled||0
10258067|NCT03084718|11389964|FG004|COMPLETED|Overall Study||120
10258068|NCT03084718|11389960|FG000|NOT COMPLETED|Overall Study||11
10258069|NCT03084718|11389961|FG001|NOT COMPLETED|Overall Study||10
10258070|NCT03084718|11389962|FG002|NOT COMPLETED|Overall Study||12
10258071|NCT03084718|11389963|FG003|NOT COMPLETED|Overall Study||14
10258072|NCT03084718|11389964|FG004|NOT COMPLETED|Overall Study||4
9957839|NCT01453205|11077177|FG002|NOT COMPLETED|Overall Study||54
9957840|NCT01453296|11077188|FG000|STARTED|Treatment Period 1||14
9957841|NCT01453296|11077189|FG001|STARTED|Treatment Period 1||14
9957842|NCT01453296|11077188|FG000|COMPLETED|Treatment Period 1||13
10258073|NCT03069417|11389981|FG000|STARTED|Overall Study||14
10258074|NCT03069417|11389982|FG001|STARTED|Overall Study||9
10258075|NCT03069417|11389981|FG000|Post-Treatment Assessment|Overall Study||12
10258076|NCT03069417|11389982|FG001|Post-Treatment Assessment|Overall Study||6
10258077|NCT03069417|11389981|FG000|COMPLETED|Overall Study||8
10258078|NCT03069417|11389982|FG001|COMPLETED|Overall Study||2
10258079|NCT03069417|11389981|FG000|NOT COMPLETED|Overall Study||6
10258080|NCT03069417|11389982|FG001|NOT COMPLETED|Overall Study||7
10258081|NCT03063164|11389989|FG000|STARTED|Overall Study||7
10258082|NCT03063164|11389990|FG001|STARTED|Overall Study||7
10258083|NCT03063164|11389989|FG000|COMPLETED|Overall Study||7
10258084|NCT03063164|11389990|FG001|COMPLETED|Overall Study||7
10258085|NCT03063164|11389989|FG000|NOT COMPLETED|Overall Study||0
10258086|NCT03063164|11389990|FG001|NOT COMPLETED|Overall Study||0
10258087|NCT02952365|11389997|FG000|STARTED|Overall Study||2
10258088|NCT02952365|11389997|FG000|COMPLETED|Overall Study||2
10258089|NCT02952365|11389997|FG000|NOT COMPLETED|Overall Study||0
10258090|NCT02936323|11390011|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2
10258091|NCT02936323|11390012|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10258092|NCT02936323|11390013|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10258093|NCT02936323|11390014|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10258094|NCT02936323|11390015|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10020946|NCT01839604|11144235|FG002|NOT COMPLETED|Overall Study||0
10020947|NCT01839604|11144236|FG003|NOT COMPLETED|Overall Study||0
10258095|NCT02936323|11390016|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6
10258096|NCT02936323|11390017|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10258097|NCT02936323|11390018|FG007|STARTED|Phase 1 Dose Escalation||0
10258098|NCT02936323|11390019|FG008|STARTED|Phase 1 Dose Escalation||0
10258099|NCT02936323|11390020|FG009|STARTED|Phase 1 Dose Escalation||0
10258100|NCT02936323|11390011|FG000|COMPLETED|Phase 1 Dose Escalation||0
10258101|NCT02936323|11390012|FG001|COMPLETED|Phase 1 Dose Escalation||1
10258102|NCT02936323|11390013|FG002|COMPLETED|Phase 1 Dose Escalation||0
10258103|NCT02936323|11390014|FG003|COMPLETED|Phase 1 Dose Escalation||1
10258104|NCT02936323|11390015|FG004|COMPLETED|Phase 1 Dose Escalation||0
10020948|NCT01839604|11144237|FG004|NOT COMPLETED|Overall Study||0
10020949|NCT01839656|11144251|FG000|STARTED|Overall Study||5
10258105|NCT02936323|11390016|FG005|COMPLETED|Phase 1 Dose Escalation||1
10020950|NCT01839656|11144252|FG001|STARTED|Overall Study||16
10258106|NCT02936323|11390017|FG006|COMPLETED|Phase 1 Dose Escalation||0
10258107|NCT02936323|11390018|FG007|COMPLETED|Phase 1 Dose Escalation||0
10258108|NCT02936323|11390019|FG008|COMPLETED|Phase 1 Dose Escalation||0
10258109|NCT02936323|11390020|FG009|COMPLETED|Phase 1 Dose Escalation||0
10258110|NCT02936323|11390011|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2
10258111|NCT02936323|11390012|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2
10258112|NCT02936323|11390013|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3
10258113|NCT02936323|11390014|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2
10258114|NCT02936323|11390015|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3
10258115|NCT02936323|11390016|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5
10258116|NCT02936323|11390017|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3
10258117|NCT02936323|11390018|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
10258118|NCT02936323|11390019|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
10258119|NCT02936323|11390020|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
10258120|NCT02936323|11390011|FG000|STARTED|Phase 2a Dose Expansion||0
10258121|NCT02936323|11390012|FG001|STARTED|Phase 2a Dose Expansion||0
10258122|NCT02936323|11390013|FG002|STARTED|Phase 2a Dose Expansion||0
10258123|NCT02936323|11390014|FG003|STARTED|Phase 2a Dose Expansion||0
10258124|NCT02936323|11390015|FG004|STARTED|Phase 2a Dose Expansion||0
10258125|NCT02936323|11390016|FG005|STARTED|Phase 2a Dose Expansion||0
10258126|NCT02936323|11390017|FG006|STARTED|Phase 2a Dose Expansion||0
10258127|NCT02936323|11390018|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32
10258128|NCT02936323|11390019|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15
10258129|NCT02936323|11390020|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19
10258130|NCT02936323|11390011|FG000|COMPLETED|Phase 2a Dose Expansion||0
10258131|NCT02936323|11390012|FG001|COMPLETED|Phase 2a Dose Expansion||0
10258132|NCT02936323|11390013|FG002|COMPLETED|Phase 2a Dose Expansion||0
10258133|NCT02936323|11390014|FG003|COMPLETED|Phase 2a Dose Expansion||0
10258134|NCT02936323|11390015|FG004|COMPLETED|Phase 2a Dose Expansion||0
10258135|NCT02936323|11390016|FG005|COMPLETED|Phase 2a Dose Expansion||0
10258136|NCT02936323|11390017|FG006|COMPLETED|Phase 2a Dose Expansion||0
10258137|NCT02936323|11390018|FG007|COMPLETED|Phase 2a Dose Expansion||15
10258138|NCT02936323|11390019|FG008|COMPLETED|Phase 2a Dose Expansion||2
10258139|NCT02936323|11390020|FG009|COMPLETED|Phase 2a Dose Expansion||5
10258140|NCT02936323|11390011|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0
10258141|NCT02936323|11390012|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0
10258142|NCT02936323|11390013|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0
10258143|NCT02936323|11390014|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0
10258144|NCT02936323|11390015|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0
10258145|NCT02936323|11390016|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0
10258146|NCT02936323|11390017|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0
10258147|NCT02936323|11390018|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17
10258148|NCT02936323|11390019|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13
10258149|NCT02936323|11390020|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14
10258150|NCT02631837|11390054|FG000|STARTED|Overall Study||35
10258151|NCT02631837|11390055|FG001|STARTED|Overall Study||35
10258152|NCT02631837|11390054|FG000|COMPLETED|Overall Study||35
10258153|NCT02631837|11390055|FG001|COMPLETED|Overall Study||35
10258154|NCT02631837|11390054|FG000|NOT COMPLETED|Overall Study||0
10258155|NCT02631837|11390055|FG001|NOT COMPLETED|Overall Study||0
10258156|NCT02437318|11390063|FG000|STARTED|Overall Study||284
10258157|NCT02437318|11390064|FG001|STARTED|Overall Study||288
10258158|NCT02437318|11390063|FG000|End of Treatment (Didn't Complete)|Overall Study||229
10258159|NCT02437318|11390064|FG001|End of Treatment (Didn't Complete)|Overall Study||241
10258160|NCT02437318|11390063|FG000|Untreated (Protocol Deviation)|Overall Study||0
10258161|NCT02437318|11390064|FG001|Untreated (Protocol Deviation)|Overall Study||1
10258162|NCT02437318|11390063|FG000|COMPLETED|Overall Study||55
10258163|NCT02437318|11390064|FG001|COMPLETED|Overall Study||46
10258164|NCT02437318|11390063|FG000|NOT COMPLETED|Overall Study||229
10258165|NCT02437318|11390064|FG001|NOT COMPLETED|Overall Study||242
10258166|NCT02429791|11390072|FG000|STARTED|Early Switch Phase (Up to Week 52)||252
10258167|NCT02429791|11390073|FG001|STARTED|Early Switch Phase (Up to Week 52)||256
10258168|NCT02429791|11390072|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239
10258169|NCT02429791|11390073|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238
10258170|NCT02429791|11390072|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
10258171|NCT02429791|11390073|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
10258172|NCT02429791|11390072|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239
10258173|NCT02429791|11390073|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238
10258174|NCT02429791|11390072|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
10258175|NCT02429791|11390073|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
10258176|NCT02429791|11390072|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
10258177|NCT02429791|11390073|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
10258178|NCT02422797|11390088|FG000|STARTED|Early Switch Phase (Up to Week 52)||261
10258179|NCT02422797|11390089|FG001|STARTED|Early Switch Phase (Up to Week 52)||255
10258180|NCT02422797|11390088|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245
10258181|NCT02422797|11390089|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239
10258182|NCT02422797|11390088|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
10258183|NCT02422797|11390089|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
10258184|NCT02422797|11390088|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245
10258185|NCT02422797|11390089|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239
10258186|NCT02422797|11390088|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
10258187|NCT02422797|11390089|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
10258188|NCT02422797|11390088|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
10258189|NCT02422797|11390089|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
10258190|NCT02287493|11390107|FG000|STARTED|Overall Study||19
10258191|NCT02287493|11390108|FG001|STARTED|Overall Study||16
10258192|NCT02287493|11390107|FG000|COMPLETED|Overall Study||19
10258193|NCT02287493|11390108|FG001|COMPLETED|Overall Study||16
10258194|NCT02287493|11390107|FG000|NOT COMPLETED|Overall Study||0
10258195|NCT02287493|11390108|FG001|NOT COMPLETED|Overall Study||0
10258196|NCT02132611|11390118|FG000|STARTED|Overall Study||100
10258197|NCT02132611|11390118|FG000|COMPLETED|Overall Study||98
10258198|NCT02132611|11390118|FG000|NOT COMPLETED|Overall Study||2
10258199|NCT01147822|11390124|FG000|STARTED|Overall Study||188
10258200|NCT01147822|11390125|FG001|STARTED|Overall Study||179
10258201|NCT01147822|11390124|FG000|Not Completed/Ongoing|Overall Study||111
10258202|NCT01147822|11390125|FG001|Not Completed/Ongoing|Overall Study||102
10258203|NCT01147822|11390124|FG000|COMPLETED|Overall Study||0
10258204|NCT01147822|11390125|FG001|COMPLETED|Overall Study||0
10258205|NCT01147822|11390124|FG000|NOT COMPLETED|Overall Study||188
10258206|NCT01147822|11390125|FG001|NOT COMPLETED|Overall Study||179
10258207|NCT00328653|11390134|FG000|STARTED|Period I||40
10258208|NCT00328653|11390135|FG001|STARTED|Period I||39
10258209|NCT00328653|11390136|FG002|STARTED|Period I||39
10258210|NCT00328653|11390134|FG000|COMPLETED|Period I||36
10258211|NCT00328653|11390135|FG001|COMPLETED|Period I||39
10258212|NCT00328653|11390136|FG002|COMPLETED|Period I||36
10258213|NCT00328653|11390134|FG000|NOT COMPLETED|Period I||4
10258214|NCT00328653|11390135|FG001|NOT COMPLETED|Period I||0
10258215|NCT00328653|11390136|FG002|NOT COMPLETED|Period I||3
10258216|NCT00328653|11390134|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0
10258217|NCT00328653|11390135|FG001|STARTED|Period II||58
10258218|NCT00328653|11390136|FG002|STARTED|Period II||53
10258219|NCT00328653|11390134|FG000|COMPLETED|Period II||0
10258220|NCT00328653|11390135|FG001|COMPLETED|Period II||50
10258221|NCT00328653|11390136|FG002|COMPLETED|Period II||49
10258222|NCT00328653|11390134|FG000|NOT COMPLETED|Period II||0
10258223|NCT00328653|11390135|FG001|NOT COMPLETED|Period II||8
9835060|NCT00789581|10946232|FG001|STARTED|AC Therapy||308
9835061|NCT00789581|10946231|FG000|COMPLETED|AC Therapy||295
9835062|NCT00789581|10946232|FG001|COMPLETED|AC Therapy||291
9835063|NCT00789581|10946231|FG000|NOT COMPLETED|AC Therapy||11
9835064|NCT00789581|10946232|FG001|NOT COMPLETED|AC Therapy||17
9835065|NCT00789581|10946231|FG000|STARTED|Adjuvant Therapy||295
9835066|NCT00789581|10946232|FG001|STARTED|Adjuvant Therapy||291
9835067|NCT00789581|10946231|FG000|COMPLETED|Adjuvant Therapy||255
9835068|NCT00789581|10946232|FG001|COMPLETED|Adjuvant Therapy||234
9835069|NCT00789581|10946231|FG000|NOT COMPLETED|Adjuvant Therapy||40
9835070|NCT00789581|10946232|FG001|NOT COMPLETED|Adjuvant Therapy||57
9835071|NCT00789672|10946241|FG000|STARTED|Overall Study||16
9835072|NCT00789672|10946242|FG001|STARTED|Overall Study||17
9835073|NCT00789672|10946241|FG000|COMPLETED|Overall Study||16
9835074|NCT00789672|10946242|FG001|COMPLETED|Overall Study||17
9835075|NCT00789672|10946241|FG000|NOT COMPLETED|Overall Study||0
9835076|NCT00789672|10946242|FG001|NOT COMPLETED|Overall Study||0
9835077|NCT00789685|10946248|FG000|STARTED|Overall Study||37
9835078|NCT00789685|10946248|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25
9835079|NCT00789685|10946248|FG000|NOT COMPLETED|Overall Study||12
9835080|NCT00789698|10946256|FG000|STARTED|Overall Study||72
10258224|NCT00328653|11390136|FG002|NOT COMPLETED|Period II||4
9835081|NCT00789698|10946257|FG001|STARTED|Overall Study||79
10258225|NCT04476251|11390146|FG000|STARTED|Overall Study||1
10258226|NCT04476251|11390146|FG000|COMPLETED|Overall Study||0
10258227|NCT04476251|11390146|FG000|NOT COMPLETED|Overall Study||1
10258228|NCT03924765|11390150|FG000|STARTED|Overall Study||5
10258229|NCT03924765|11390150|FG000|COMPLETED|Overall Study||5
10258230|NCT03924765|11390150|FG000|NOT COMPLETED|Overall Study||0
10258231|NCT03915860|11390154|FG000|STARTED|Overall Study||47
10258232|NCT03915860|11390154|FG000|Treated|Overall Study||46
10258233|NCT03915860|11390154|FG000|COMPLETED|Overall Study||33
10258234|NCT03915860|11390154|FG000|NOT COMPLETED|Overall Study||14
10258235|NCT03817606|11390160|FG000|STARTED|Overall Study||2
10258236|NCT03817606|11390161|FG001|STARTED|Overall Study||2
10258237|NCT03817606|11390160|FG000|COMPLETED|Overall Study||0
10258238|NCT03817606|11390161|FG001|COMPLETED|Overall Study||0
10258239|NCT03817606|11390160|FG000|NOT COMPLETED|Overall Study||2
10258240|NCT03817606|11390161|FG001|NOT COMPLETED|Overall Study||2
10258241|NCT03795233|11390173|FG000|STARTED|Overall Study||4
10258242|NCT03795233|11390174|FG001|STARTED|Overall Study||1
10258243|NCT03795233|11390173|FG000|COMPLETED|Overall Study||0
10258244|NCT03795233|11390174|FG001|COMPLETED|Overall Study||0
10258245|NCT03795233|11390173|FG000|NOT COMPLETED|Overall Study||4
10258246|NCT03795233|11390174|FG001|NOT COMPLETED|Overall Study||1
10258247|NCT03786380|11390185|FG000|STARTED|Overall Study||35
10258248|NCT03786380|11390186|FG001|STARTED|Overall Study||22
10258249|NCT03786380|11390187|FG002|STARTED|Overall Study||54
10258250|NCT03786380|11390188|FG003|STARTED|Overall Study||63
10258251|NCT03786380|11390189|FG004|STARTED|Overall Study||28
10258252|NCT03786380|11390185|FG000|Safety Population|Overall Study||35
10258253|NCT03786380|11390186|FG001|Safety Population|Overall Study||22
10258254|NCT03786380|11390187|FG002|Safety Population|Overall Study||54
10258255|NCT03786380|11390188|FG003|Safety Population|Overall Study||62
10258256|NCT03786380|11390189|FG004|Safety Population|Overall Study||28
10258257|NCT03786380|11390185|FG000|COMPLETED|Overall Study||0
10258258|NCT03786380|11390186|FG001|COMPLETED|Overall Study||0
10258259|NCT03786380|11390187|FG002|COMPLETED|Overall Study||0
10258260|NCT03786380|11390188|FG003|COMPLETED|Overall Study||0
10258261|NCT03786380|11390189|FG004|COMPLETED|Overall Study||0
10258262|NCT03786380|11390185|FG000|NOT COMPLETED|Overall Study||35
10258263|NCT03786380|11390186|FG001|NOT COMPLETED|Overall Study||22
10258264|NCT03786380|11390187|FG002|NOT COMPLETED|Overall Study||54
10258265|NCT03786380|11390188|FG003|NOT COMPLETED|Overall Study||63
10258266|NCT03786380|11390189|FG004|NOT COMPLETED|Overall Study||28
10258267|NCT03769376|11390203|FG000|STARTED|Overall Study||20
10258268|NCT03769376|11390204|FG001|STARTED|Overall Study||18
10258269|NCT03769376|11390203|FG000|COMPLETED|Overall Study||13
10258270|NCT03769376|11390204|FG001|COMPLETED|Overall Study||11
10258271|NCT03769376|11390203|FG000|NOT COMPLETED|Overall Study||7
10258272|NCT03769376|11390204|FG001|NOT COMPLETED|Overall Study||7
10258273|NCT03645863|11390213|FG000|STARTED|Overall Study||21
10258274|NCT03645863|11390214|FG001|STARTED|Overall Study||20
10258275|NCT03645863|11390215|FG002|STARTED|Overall Study||20
10258276|NCT03645863|11390213|FG000|COMPLETED|Overall Study||20
10258277|NCT03645863|11390214|FG001|COMPLETED|Overall Study||20
10258278|NCT03645863|11390215|FG002|COMPLETED|Overall Study||20
10258279|NCT03645863|11390213|FG000|NOT COMPLETED|Overall Study||1
10258280|NCT03645863|11390214|FG001|NOT COMPLETED|Overall Study||0
10258281|NCT03645863|11390215|FG002|NOT COMPLETED|Overall Study||0
10258282|NCT03564145|11390223|FG000|STARTED|Overall Study||547
10258283|NCT03564145|11390223|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535
10258284|NCT03564145|11390223|FG000|COMPLETED|Overall Study||323
10258285|NCT03564145|11390223|FG000|NOT COMPLETED|Overall Study||224
10258286|NCT03564119|11390229|FG000|STARTED|Overall Study||250
10258287|NCT03564119|11390230|FG001|STARTED|Overall Study||122
10258288|NCT03564119|11390229|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
10258289|NCT03564119|11390230|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120
10258290|NCT03564119|11390229|FG000|COMPLETED|Overall Study||235
10258291|NCT03564119|11390230|FG001|COMPLETED|Overall Study||113
10258292|NCT03564119|11390229|FG000|NOT COMPLETED|Overall Study||15
10258293|NCT03564119|11390230|FG001|NOT COMPLETED|Overall Study||9
10258294|NCT03365635|11390242|FG000|STARTED|Overall Study||3
10258295|NCT03365635|11390243|FG001|STARTED|Overall Study||0
10258296|NCT03365635|11390244|FG002|STARTED|Overall Study||1
10258297|NCT03365635|11390245|FG003|STARTED|Overall Study||0
10258298|NCT03365635|11390246|FG004|STARTED|Overall Study||0
10258299|NCT03365635|11390247|FG005|STARTED|Overall Study||0
10258300|NCT03365635|11390242|FG000|COMPLETED|Overall Study||3
10258301|NCT03365635|11390243|FG001|COMPLETED|Overall Study||0
10258302|NCT03365635|11390244|FG002|COMPLETED|Overall Study||1
10258303|NCT03365635|11390245|FG003|COMPLETED|Overall Study||0
10258304|NCT03365635|11390246|FG004|COMPLETED|Overall Study||0
10258305|NCT03365635|11390247|FG005|COMPLETED|Overall Study||0
10258306|NCT03365635|11390242|FG000|NOT COMPLETED|Overall Study||0
10258307|NCT03365635|11390243|FG001|NOT COMPLETED|Overall Study||0
10258308|NCT03365635|11390244|FG002|NOT COMPLETED|Overall Study||0
10258309|NCT03365635|11390245|FG003|NOT COMPLETED|Overall Study||0
10258310|NCT03365635|11390246|FG004|NOT COMPLETED|Overall Study||0
10258311|NCT03365635|11390247|FG005|NOT COMPLETED|Overall Study||0
10258312|NCT03287050|11390261|FG000|STARTED|Overall Study||6
10258313|NCT03287050|11390261|FG000|COMPLETED|Overall Study||6
10258314|NCT03287050|11390261|FG000|NOT COMPLETED|Overall Study||0
10258315|NCT03223350|11390267|FG000|STARTED|Overall Study||17
10258316|NCT03223350|11390268|FG001|STARTED|Overall Study||13
10258317|NCT03223350|11390267|FG000|COMPLETED|Overall Study||17
10258318|NCT03223350|11390268|FG001|COMPLETED|Overall Study||13
10258319|NCT03223350|11390267|FG000|NOT COMPLETED|Overall Study||0
10258320|NCT03223350|11390268|FG001|NOT COMPLETED|Overall Study||0
10258321|NCT03181828|11390276|FG000|STARTED|Overall Study||2
10258322|NCT03181828|11390277|FG001|STARTED|Overall Study||2
10258323|NCT03181828|11390276|FG000|COMPLETED|Overall Study||2
10258324|NCT03181828|11390277|FG001|COMPLETED|Overall Study||2
10258325|NCT03181828|11390276|FG000|NOT COMPLETED|Overall Study||0
10258326|NCT03181828|11390277|FG001|NOT COMPLETED|Overall Study||0
10258327|NCT03181529|11390285|FG000|STARTED|Overall Study||15
10258328|NCT03181529|11390286|FG001|STARTED|Overall Study||12
10258329|NCT03181529|11390285|FG000|COMPLETED|Overall Study||13
10258330|NCT03181529|11390286|FG001|COMPLETED|Overall Study||11
10258331|NCT03181529|11390285|FG000|NOT COMPLETED|Overall Study||2
10258332|NCT03181529|11390286|FG001|NOT COMPLETED|Overall Study||1
10258333|NCT02946931|11390292|FG000|STARTED|Overall Study||1387
10258334|NCT02946931|11390292|FG000|Case Report Forms (CRFs) Collected|Overall Study||814
10258335|NCT02946931|11390292|FG000|COMPLETED|Overall Study||569
10258336|NCT02946931|11390292|FG000|NOT COMPLETED|Overall Study||818
10258337|NCT02779556|11390298|FG000|STARTED|Baseline||394
10258338|NCT02779556|11390299|FG001|STARTED|Baseline||362
10258339|NCT02779556|11390298|FG000|COMPLETED|Baseline||393
10258340|NCT02779556|11390299|FG001|COMPLETED|Baseline||362
10258341|NCT02779556|11390298|FG000|NOT COMPLETED|Baseline||1
10258342|NCT02779556|11390299|FG001|NOT COMPLETED|Baseline||0
10258343|NCT02779556|11390298|FG000|STARTED|3 Months||393
10258344|NCT02779556|11390299|FG001|STARTED|3 Months||362
10258345|NCT02779556|11390298|FG000|COMPLETED|3 Months||326
10258346|NCT02779556|11390299|FG001|COMPLETED|3 Months||314
10258347|NCT02779556|11390298|FG000|NOT COMPLETED|3 Months||67
10258348|NCT02779556|11390299|FG001|NOT COMPLETED|3 Months||48
10258349|NCT02779556|11390298|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353
10258350|NCT02779556|11390299|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333
10258351|NCT02779556|11390298|FG000|COMPLETED|6 Month||320
10258352|NCT02779556|11390299|FG001|COMPLETED|6 Month||294
10258353|NCT02779556|11390298|FG000|NOT COMPLETED|6 Month||33
10258354|NCT02779556|11390299|FG001|NOT COMPLETED|6 Month||39
10258355|NCT02779556|11390298|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
10258356|NCT02779556|11390299|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
10258357|NCT02779556|11390298|FG000|COMPLETED|6 Month HbA1c||325
10258358|NCT02779556|11390299|FG001|COMPLETED|6 Month HbA1c||312
10258359|NCT02779556|11390298|FG000|NOT COMPLETED|6 Month HbA1c||69
10258360|NCT02779556|11390299|FG001|NOT COMPLETED|6 Month HbA1c||50
10258361|NCT02779556|11390298|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
10258362|NCT02779556|11390299|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
10258363|NCT02779556|11390298|FG000|COMPLETED|12 Month HbA1c||256
10258364|NCT02779556|11390299|FG001|COMPLETED|12 Month HbA1c||260
10258365|NCT02779556|11390298|FG000|NOT COMPLETED|12 Month HbA1c||138
10258366|NCT02779556|11390299|FG001|NOT COMPLETED|12 Month HbA1c||102
10258367|NCT02724774|11390307|FG000|STARTED|Overall Study||127
10258368|NCT02724774|11390308|FG001|STARTED|Overall Study||125
10258369|NCT02724774|11390307|FG000|Infant 6 Months|Overall Study||122
10258370|NCT02724774|11390308|FG001|Infant 6 Months|Overall Study||122
10258371|NCT02724774|11390307|FG000|Infant 12 Months|Overall Study||120
10258372|NCT02724774|11390308|FG001|Infant 12 Months|Overall Study||123
10258373|NCT02724774|11390307|FG000|COMPLETED|Overall Study||120
10258374|NCT02724774|11390308|FG001|COMPLETED|Overall Study||123
10258375|NCT02724774|11390307|FG000|NOT COMPLETED|Overall Study||7
10258376|NCT02724774|11390308|FG001|NOT COMPLETED|Overall Study||2
10258377|NCT02675751|11390314|FG000|STARTED|Overall Study||167
10258378|NCT02675751|11390314|FG000|COMPLETED|Overall Study||151
10258379|NCT02675751|11390314|FG000|NOT COMPLETED|Overall Study||16
10258380|NCT02643381|11390320|FG000|STARTED|Overall Study||400
10258381|NCT02643381|11390321|FG001|STARTED|Overall Study||401
10258382|NCT02643381|11390320|FG000|COMPLETED|Overall Study||396
10258383|NCT02643381|11390321|FG001|COMPLETED|Overall Study||395
10258384|NCT02643381|11390320|FG000|NOT COMPLETED|Overall Study||4
10258385|NCT02643381|11390321|FG001|NOT COMPLETED|Overall Study||6
10258386|NCT02621424|11390329|FG000|STARTED|Overall Study||14
10258387|NCT02621424|11390330|FG001|STARTED|Overall Study||18
10258388|NCT02621424|11390329|FG000|COMPLETED|Overall Study||13
10258389|NCT02621424|11390330|FG001|COMPLETED|Overall Study||16
10258390|NCT02621424|11390329|FG000|NOT COMPLETED|Overall Study||1
10258391|NCT02621424|11390330|FG001|NOT COMPLETED|Overall Study||2
10258392|NCT02595372|11390336|FG000|STARTED|Overall Study||42
10258393|NCT02595372|11390336|FG000|COMPLETED|Overall Study||33
10258394|NCT02595372|11390336|FG000|NOT COMPLETED|Overall Study||9
10258395|NCT02334722|11390342|FG000|STARTED|Overall Study||40
10258396|NCT02334722|11390343|FG001|STARTED|Overall Study||41
10258397|NCT02334722|11390342|FG000|COMPLETED|Overall Study||33
10258398|NCT02334722|11390343|FG001|COMPLETED|Overall Study||34
10258399|NCT02334722|11390342|FG000|NOT COMPLETED|Overall Study||7
10258400|NCT02334722|11390343|FG001|NOT COMPLETED|Overall Study||7
10258401|NCT02259725|11390349|FG000|STARTED|Overall Study||3
10258402|NCT02259725|11390349|FG000|COMPLETED|Overall Study||3
10258403|NCT02259725|11390349|FG000|NOT COMPLETED|Overall Study||0
10258404|NCT01966731|11390353|FG000|STARTED|Overall Study||635
10258405|NCT01966731|11390353|FG000|Initiated Hydroxyurea|Overall Study||606
10258406|NCT01966731|11390353|FG000|Completed 3 Months of Treatment|Overall Study||600
10258407|NCT01966731|11390353|FG000|Completed Study|Overall Study||0
10258408|NCT01966731|11390353|FG000|COMPLETED|Overall Study||0
10258409|NCT01966731|11390353|FG000|NOT COMPLETED|Overall Study||635
10258410|NCT01952288|11390359|FG000|STARTED|Overall Study||3
10258411|NCT01952288|11390360|FG001|STARTED|Overall Study||2
10258412|NCT01952288|11390359|FG000|COMPLETED|Overall Study||3
10258413|NCT01952288|11390360|FG001|COMPLETED|Overall Study||2
10258414|NCT01952288|11390359|FG000|NOT COMPLETED|Overall Study||0
10258415|NCT01952288|11390360|FG001|NOT COMPLETED|Overall Study||0
10258416|NCT01850082|11390368|FG000|STARTED|Overall Study||576
10258417|NCT01850082|11390369|FG001|STARTED|Overall Study||574
10258418|NCT01850082|11390368|FG000|COMPLETED|Overall Study||576
10020951|NCT01839656|11144251|FG000|Completed Loading Dose Period|Overall Study||4
10020952|NCT01839656|11144252|FG001|Completed Loading Dose Period|Overall Study||15
10020953|NCT01839656|11144251|FG000|COMPLETED|Overall Study||2
10258419|NCT01850082|11390369|FG001|COMPLETED|Overall Study||574
10020954|NCT01839656|11144252|FG001|COMPLETED|Overall Study||0
10020955|NCT01839656|11144251|FG000|NOT COMPLETED|Overall Study||3
10258420|NCT01850082|11390368|FG000|NOT COMPLETED|Overall Study||0
10258421|NCT01850082|11390369|FG001|NOT COMPLETED|Overall Study||0
10258422|NCT01844518|11390377|FG000|STARTED|Overall Study||173
10258423|NCT01844518|11390378|FG001|STARTED|Overall Study||46
10258424|NCT01844518|11390377|FG000|COMPLETED|Overall Study||132
10258425|NCT01844518|11390378|FG001|COMPLETED|Overall Study||39
10258426|NCT01844518|11390377|FG000|NOT COMPLETED|Overall Study||41
10258427|NCT01844518|11390378|FG001|NOT COMPLETED|Overall Study||7
10258428|NCT01675479|11390387|FG000|STARTED|Overall Study||69
10258429|NCT01675479|11390387|FG000|COMPLETED|Overall Study||58
10258430|NCT01675479|11390387|FG000|NOT COMPLETED|Overall Study||11
10258431|NCT00812708|11390391|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
10258432|NCT00812708|11390391|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
9835082|NCT00789698|10946258|FG002|STARTED|Overall Study||56
9835083|NCT00789698|10946259|FG003|STARTED|Overall Study||85
9835084|NCT00789698|10946256|FG000|COMPLETED|Overall Study||32
9835085|NCT00789698|10946257|FG001|COMPLETED|Overall Study||46
9835086|NCT00789698|10946258|FG002|COMPLETED|Overall Study||29
9835087|NCT00789698|10946259|FG003|COMPLETED|Overall Study||33
9835088|NCT00789698|10946256|FG000|NOT COMPLETED|Overall Study||40
9835089|NCT00789698|10946257|FG001|NOT COMPLETED|Overall Study||33
9835090|NCT00789698|10946258|FG002|NOT COMPLETED|Overall Study||27
9835091|NCT00789698|10946259|FG003|NOT COMPLETED|Overall Study||52
9835092|NCT00789724|10946270|FG000|STARTED|Overall Study||5
9835093|NCT00789724|10946271|FG001|STARTED|Overall Study||5
9835094|NCT00789724|10946270|FG000|COMPLETED|Overall Study||5
9835095|NCT00789724|10946271|FG001|COMPLETED|Overall Study||5
9835096|NCT00789724|10946270|FG000|NOT COMPLETED|Overall Study||0
9835097|NCT00789724|10946271|FG001|NOT COMPLETED|Overall Study||0
9835098|NCT00789737|10946279|FG000|STARTED|Overall Study||176
9835099|NCT00789737|10946280|FG001|STARTED|Overall Study||181
9835100|NCT00789737|10946279|FG000|COMPLETED|Overall Study||128
9835101|NCT00789737|10946280|FG001|COMPLETED|Overall Study||126
9835102|NCT00789737|10946279|FG000|NOT COMPLETED|Overall Study||48
9835103|NCT00789737|10946280|FG001|NOT COMPLETED|Overall Study||55
9835104|NCT00789750|10946288|FG000|STARTED|Overall Study||280
9835105|NCT00789750|10946289|FG001|STARTED|Overall Study||282
9835106|NCT00789750|10946288|FG000|Dropped During run-in Period|Overall Study||6
9835107|NCT00789750|10946289|FG001|Dropped During run-in Period|Overall Study||5
9835108|NCT00789750|10946288|FG000|Safety Set|Overall Study||274
9957843|NCT01453296|11077189|FG001|COMPLETED|Treatment Period 1||13
9957844|NCT01453296|11077188|FG000|NOT COMPLETED|Treatment Period 1||1
9957845|NCT01453296|11077189|FG001|NOT COMPLETED|Treatment Period 1||1
9957846|NCT01453296|11077188|FG000|STARTED|Washout Period||13
9957847|NCT01453296|11077189|FG001|STARTED|Washout Period||13
9957848|NCT01453296|11077188|FG000|COMPLETED|Washout Period||13
9957849|NCT01453296|11077189|FG001|COMPLETED|Washout Period||13
9957850|NCT01453296|11077188|FG000|NOT COMPLETED|Washout Period||0
9957851|NCT01453296|11077189|FG001|NOT COMPLETED|Washout Period||0
9957852|NCT01453296|11077188|FG000|STARTED|Treatment Period 2||13
9957853|NCT01453296|11077189|FG001|STARTED|Treatment Period 2||13
10258433|NCT00812708|11390391|FG000|COMPLETED|Overall Study||64
10258434|NCT00812708|11390391|FG000|NOT COMPLETED|Overall Study||8
10258435|NCT00741988|11390398|FG000|STARTED|Overall Study||42
10258436|NCT00741988|11390399|FG001|STARTED|Overall Study||40
10258437|NCT00741988|11390398|FG000|COMPLETED|Overall Study||38
10258438|NCT00741988|11390399|FG001|COMPLETED|Overall Study||36
10258439|NCT00741988|11390398|FG000|NOT COMPLETED|Overall Study||4
10258440|NCT00741988|11390399|FG001|NOT COMPLETED|Overall Study||4
10258441|NCT00563576|11390407|FG000|STARTED|Overall Study||35
10258442|NCT00563576|11390408|FG001|STARTED|Overall Study||36
10258443|NCT00563576|11390407|FG000|COMPLETED|Overall Study||21
10258444|NCT00563576|11390408|FG001|COMPLETED|Overall Study||22
10258445|NCT00563576|11390407|FG000|NOT COMPLETED|Overall Study||14
10258446|NCT00563576|11390408|FG001|NOT COMPLETED|Overall Study||14
10258447|NCT00515671|11390416|FG000|STARTED|Overall Study||60
10258448|NCT00515671|11390417|FG001|STARTED|Overall Study||58
10258449|NCT00515671|11390416|FG000|COMPLETED|Overall Study||43
10258450|NCT00515671|11390417|FG001|COMPLETED|Overall Study||41
10258451|NCT00515671|11390416|FG000|NOT COMPLETED|Overall Study||17
10258452|NCT00515671|11390417|FG001|NOT COMPLETED|Overall Study||17
10258453|NCT00455403|11390425|FG000|STARTED|Overall Study||59
10258454|NCT00455403|11390426|FG001|STARTED|Overall Study||57
10258455|NCT00455403|11390425|FG000|COMPLETED|Overall Study||56
10258456|NCT00455403|11390426|FG001|COMPLETED|Overall Study||51
10258457|NCT00455403|11390425|FG000|NOT COMPLETED|Overall Study||3
10258458|NCT00455403|11390426|FG001|NOT COMPLETED|Overall Study||6
10258459|NCT00238420|11390434|FG000|STARTED|Overall Study||22
10258460|NCT00238420|11390435|FG001|STARTED|Overall Study||48
10258461|NCT00238420|11390434|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
10258462|NCT00238420|11390435|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
10258463|NCT00238420|11390434|FG000|NOT COMPLETED|Overall Study||1
10258464|NCT00238420|11390435|FG001|NOT COMPLETED|Overall Study||1
10258465|NCT04328961|11390443|FG000|STARTED|Overall Study||422
10258466|NCT04328961|11390444|FG001|STARTED|Overall Study||407
10258467|NCT04328961|11390443|FG000|COMPLETED|Overall Study||336
10258468|NCT04328961|11390444|FG001|COMPLETED|Overall Study||353
10258469|NCT04328961|11390443|FG000|NOT COMPLETED|Overall Study||86
10258470|NCT04328961|11390444|FG001|NOT COMPLETED|Overall Study||54
10258471|NCT04128319|11390450|FG000|STARTED|Overall Study||3
10258472|NCT04128319|11390450|FG000|Initiated T-Guard Treatment|Overall Study||3
10258473|NCT04128319|11390450|FG000|COMPLETED|Overall Study||0
10258474|NCT04128319|11390450|FG000|NOT COMPLETED|Overall Study||3
10258475|NCT03761810|11390456|FG000|STARTED|Overall Study||290
10258476|NCT03761810|11390457|FG001|STARTED|Overall Study||144
10258477|NCT03761810|11390456|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281
10258478|NCT03761810|11390457|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138
10258479|NCT03761810|11390456|FG000|COMPLETED|Overall Study||242
10258480|NCT03761810|11390457|FG001|COMPLETED|Overall Study||132
10258481|NCT03761810|11390456|FG000|NOT COMPLETED|Overall Study||48
10258482|NCT03761810|11390457|FG001|NOT COMPLETED|Overall Study||12
10258483|NCT03761784|11390465|FG000|STARTED|Overall Study||281
10258484|NCT03761784|11390466|FG001|STARTED|Overall Study||143
10258485|NCT03761784|11390465|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274
10258486|NCT03761784|11390466|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
10258487|NCT03761784|11390465|FG000|COMPLETED|Overall Study||249
10258488|NCT03761784|11390466|FG001|COMPLETED|Overall Study||131
10258489|NCT03761784|11390465|FG000|NOT COMPLETED|Overall Study||32
10258490|NCT03761784|11390466|FG001|NOT COMPLETED|Overall Study||12
10258491|NCT03361865|11390474|FG000|STARTED|Overall Study||44
10258492|NCT03361865|11390475|FG001|STARTED|Overall Study||49
10258493|NCT03361865|11390474|FG000|Intention-to-Treat (ITT)|Overall Study||44
10258494|NCT03361865|11390475|FG001|Intention-to-Treat (ITT)|Overall Study||49
10258495|NCT03361865|11390474|FG000|All Participants as Treated (APaT)|Overall Study||43
10258496|NCT03361865|11390475|FG001|All Participants as Treated (APaT)|Overall Study||49
10258497|NCT03361865|11390474|FG000|COMPLETED|Overall Study||25
10258498|NCT03361865|11390475|FG001|COMPLETED|Overall Study||22
10258499|NCT03361865|11390474|FG000|NOT COMPLETED|Overall Study||19
10258500|NCT03361865|11390475|FG001|NOT COMPLETED|Overall Study||27
10258501|NCT03294304|11390482|FG000|STARTED|Overall Study||43
10258502|NCT03294304|11390482|FG000|COMPLETED|Overall Study||43
10258503|NCT03294304|11390482|FG000|NOT COMPLETED|Overall Study||0
10258504|NCT03122431|11390489|FG000|STARTED|Overall Study||41
10258505|NCT03122431|11390490|FG001|STARTED|Overall Study||32
10258506|NCT03122431|11390491|FG002|STARTED|Overall Study||20
10258507|NCT03122431|11390489|FG000|COMPLETED|Overall Study||41
10258508|NCT03122431|11390490|FG001|COMPLETED|Overall Study||32
10258509|NCT03122431|11390491|FG002|COMPLETED|Overall Study||9
10258510|NCT03122431|11390489|FG000|NOT COMPLETED|Overall Study||0
10258511|NCT03122431|11390490|FG001|NOT COMPLETED|Overall Study||0
10258512|NCT03122431|11390491|FG002|NOT COMPLETED|Overall Study||11
10258513|NCT02929056|11390501|FG000|STARTED|Overall Study||1
10258514|NCT02929056|11390502|FG001|STARTED|Overall Study||1
10258515|NCT02929056|11390501|FG000|COMPLETED|Overall Study||1
10258516|NCT02929056|11390502|FG001|COMPLETED|Overall Study||0
10258517|NCT02929056|11390501|FG000|NOT COMPLETED|Overall Study||0
10258518|NCT02929056|11390502|FG001|NOT COMPLETED|Overall Study||1
10258519|NCT02896855|11390510|FG000|STARTED|Overall Study||121
10258520|NCT02896855|11390511|FG001|STARTED|Overall Study||122
10258521|NCT02896855|11390510|FG000|Received Any Study Treatment|Overall Study||120
10258522|NCT02896855|11390511|FG001|Received Any Study Treatment|Overall Study||122
10258523|NCT02896855|11390510|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12
10258524|NCT02896855|11390511|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0
10258525|NCT02896855|11390510|FG000|COMPLETED|Overall Study||49
10258526|NCT02896855|11390511|FG001|COMPLETED|Overall Study||69
10258527|NCT02896855|11390510|FG000|NOT COMPLETED|Overall Study||72
10258528|NCT02896855|11390511|FG001|NOT COMPLETED|Overall Study||53
10258529|NCT02871778|11390524|FG000|STARTED|Part A: Treatment Period 1||43
10258530|NCT02871778|11390525|FG001|STARTED|Part A: Treatment Period 1||41
10258531|NCT02871778|11390526|FG002|STARTED|Part A: Treatment Period 1||21
10258532|NCT02871778|11390527|FG003|STARTED|Part A: Treatment Period 1||18
10258533|NCT02871778|11390528|FG004|STARTED|Part A: Treatment Period 1||0
10258534|NCT02871778|11390529|FG005|STARTED|Part A: Treatment Period 1||0
10258535|NCT02871778|11390530|FG006|STARTED|Part A: Treatment Period 1||0
10258536|NCT02871778|11390531|FG007|STARTED|Part A: Treatment Period 1||0
10258537|NCT02871778|11390524|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44
10258538|NCT02871778|11390525|FG001|Safety Analysis Set|Part A: Treatment Period 1||40
10258539|NCT02871778|11390526|FG002|Safety Analysis Set|Part A: Treatment Period 1||21
10258540|NCT02871778|11390527|FG003|Safety Analysis Set|Part A: Treatment Period 1||18
10258541|NCT02871778|11390528|FG004|Safety Analysis Set|Part A: Treatment Period 1||0
10258542|NCT02871778|11390529|FG005|Safety Analysis Set|Part A: Treatment Period 1||0
10258543|NCT02871778|11390530|FG006|Safety Analysis Set|Part A: Treatment Period 1||0
10258544|NCT02871778|11390531|FG007|Safety Analysis Set|Part A: Treatment Period 1||0
10258545|NCT02871778|11390524|FG000|COMPLETED|Part A: Treatment Period 1||40
10258546|NCT02871778|11390525|FG001|COMPLETED|Part A: Treatment Period 1||37
10258547|NCT02871778|11390526|FG002|COMPLETED|Part A: Treatment Period 1||18
10258548|NCT02871778|11390527|FG003|COMPLETED|Part A: Treatment Period 1||16
10258549|NCT02871778|11390528|FG004|COMPLETED|Part A: Treatment Period 1||0
10258550|NCT02871778|11390529|FG005|COMPLETED|Part A: Treatment Period 1||0
10258551|NCT02871778|11390530|FG006|COMPLETED|Part A: Treatment Period 1||0
10258552|NCT02871778|11390531|FG007|COMPLETED|Part A: Treatment Period 1||0
10258553|NCT02871778|11390524|FG000|NOT COMPLETED|Part A: Treatment Period 1||3
10258554|NCT02871778|11390525|FG001|NOT COMPLETED|Part A: Treatment Period 1||4
10258555|NCT02871778|11390526|FG002|NOT COMPLETED|Part A: Treatment Period 1||3
10258556|NCT02871778|11390527|FG003|NOT COMPLETED|Part A: Treatment Period 1||2
10258557|NCT02871778|11390528|FG004|NOT COMPLETED|Part A: Treatment Period 1||0
10258558|NCT02871778|11390529|FG005|NOT COMPLETED|Part A: Treatment Period 1||0
10258559|NCT02871778|11390530|FG006|NOT COMPLETED|Part A: Treatment Period 1||0
10258560|NCT02871778|11390531|FG007|NOT COMPLETED|Part A: Treatment Period 1||0
10258561|NCT02871778|11390524|FG000|STARTED|Part A: Treatment Period 2||40
10258562|NCT02871778|11390525|FG001|STARTED|Part A: Treatment Period 2||37
10258563|NCT02871778|11390526|FG002|STARTED|Part A: Treatment Period 2||18
10258564|NCT02871778|11390527|FG003|STARTED|Part A: Treatment Period 2||16
10258565|NCT02871778|11390528|FG004|STARTED|Part A: Treatment Period 2||0
10258566|NCT02871778|11390529|FG005|STARTED|Part A: Treatment Period 2||0
10258567|NCT02871778|11390530|FG006|STARTED|Part A: Treatment Period 2||0
10258568|NCT02871778|11390531|FG007|STARTED|Part A: Treatment Period 2||0
10258569|NCT02871778|11390524|FG000|Safety Analysis Set|Part A: Treatment Period 2||40
10258570|NCT02871778|11390525|FG001|Safety Analysis Set|Part A: Treatment Period 2||37
10258571|NCT02871778|11390526|FG002|Safety Analysis Set|Part A: Treatment Period 2||18
10258572|NCT02871778|11390527|FG003|Safety Analysis Set|Part A: Treatment Period 2||16
10258573|NCT02871778|11390528|FG004|Safety Analysis Set|Part A: Treatment Period 2||0
10258574|NCT02871778|11390529|FG005|Safety Analysis Set|Part A: Treatment Period 2||0
10258575|NCT02871778|11390530|FG006|Safety Analysis Set|Part A: Treatment Period 2||0
10258576|NCT02871778|11390531|FG007|Safety Analysis Set|Part A: Treatment Period 2||0
10258577|NCT02871778|11390524|FG000|COMPLETED|Part A: Treatment Period 2||37
10258578|NCT02871778|11390525|FG001|COMPLETED|Part A: Treatment Period 2||35
10258579|NCT02871778|11390526|FG002|COMPLETED|Part A: Treatment Period 2||17
10258580|NCT02871778|11390527|FG003|COMPLETED|Part A: Treatment Period 2||15
10258581|NCT02871778|11390528|FG004|COMPLETED|Part A: Treatment Period 2||0
10258582|NCT02871778|11390529|FG005|COMPLETED|Part A: Treatment Period 2||0
10258583|NCT02871778|11390530|FG006|COMPLETED|Part A: Treatment Period 2||0
10258584|NCT02871778|11390531|FG007|COMPLETED|Part A: Treatment Period 2||0
10258585|NCT02871778|11390524|FG000|NOT COMPLETED|Part A: Treatment Period 2||3
10258586|NCT02871778|11390525|FG001|NOT COMPLETED|Part A: Treatment Period 2||2
10258587|NCT02871778|11390526|FG002|NOT COMPLETED|Part A: Treatment Period 2||1
10258588|NCT02871778|11390527|FG003|NOT COMPLETED|Part A: Treatment Period 2||1
10258589|NCT02871778|11390528|FG004|NOT COMPLETED|Part A: Treatment Period 2||0
10258590|NCT02871778|11390529|FG005|NOT COMPLETED|Part A: Treatment Period 2||0
10258591|NCT02871778|11390530|FG006|NOT COMPLETED|Part A: Treatment Period 2||0
10258592|NCT02871778|11390531|FG007|NOT COMPLETED|Part A: Treatment Period 2||0
10258593|NCT02871778|11390524|FG000|STARTED|Part B: Treatment Period 3||0
10258594|NCT02871778|11390525|FG001|STARTED|Part B: Treatment Period 3||0
10258595|NCT02871778|11390526|FG002|STARTED|Part B: Treatment Period 3||0
10258596|NCT02871778|11390527|FG003|STARTED|Part B: Treatment Period 3||0
10258597|NCT02871778|11390528|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11
10258598|NCT02871778|11390529|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27
10258599|NCT02871778|11390530|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7
10258600|NCT02871778|11390531|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12
10258601|NCT02871778|11390524|FG000|Safety Analysis Set|Part B: Treatment Period 3||0
10258602|NCT02871778|11390525|FG001|Safety Analysis Set|Part B: Treatment Period 3||0
10258603|NCT02871778|11390526|FG002|Safety Analysis Set|Part B: Treatment Period 3||0
10258604|NCT02871778|11390527|FG003|Safety Analysis Set|Part B: Treatment Period 3||0
10258605|NCT02871778|11390528|FG004|Safety Analysis Set|Part B: Treatment Period 3||11
10258606|NCT02871778|11390529|FG005|Safety Analysis Set|Part B: Treatment Period 3||27
10258607|NCT02871778|11390530|FG006|Safety Analysis Set|Part B: Treatment Period 3||7
10258608|NCT02871778|11390531|FG007|Safety Analysis Set|Part B: Treatment Period 3||12
10258609|NCT02871778|11390524|FG000|COMPLETED|Part B: Treatment Period 3||0
10258610|NCT02871778|11390525|FG001|COMPLETED|Part B: Treatment Period 3||0
10258611|NCT02871778|11390526|FG002|COMPLETED|Part B: Treatment Period 3||0
10258612|NCT02871778|11390527|FG003|COMPLETED|Part B: Treatment Period 3||0
10258613|NCT02871778|11390528|FG004|COMPLETED|Part B: Treatment Period 3||10
10258614|NCT02871778|11390529|FG005|COMPLETED|Part B: Treatment Period 3||26
10258615|NCT02871778|11390530|FG006|COMPLETED|Part B: Treatment Period 3||6
9835109|NCT00789750|10946289|FG001|Safety Set|Overall Study||277
9835110|NCT00789750|10946288|FG000|Intent to Treat Set|Overall Study||271
10258616|NCT02871778|11390531|FG007|COMPLETED|Part B: Treatment Period 3||12
10258617|NCT02871778|11390524|FG000|NOT COMPLETED|Part B: Treatment Period 3||0
9835111|NCT00789750|10946289|FG001|Intent to Treat Set|Overall Study||276
10258618|NCT02871778|11390525|FG001|NOT COMPLETED|Part B: Treatment Period 3||0
10258619|NCT02871778|11390526|FG002|NOT COMPLETED|Part B: Treatment Period 3||0
10258620|NCT02871778|11390527|FG003|NOT COMPLETED|Part B: Treatment Period 3||0
10258621|NCT02871778|11390528|FG004|NOT COMPLETED|Part B: Treatment Period 3||1
10258622|NCT02871778|11390529|FG005|NOT COMPLETED|Part B: Treatment Period 3||1
9835112|NCT00789750|10946288|FG000|COMPLETED|Overall Study||221
9835113|NCT00789750|10946289|FG001|COMPLETED|Overall Study||222
10258623|NCT02871778|11390530|FG006|NOT COMPLETED|Part B: Treatment Period 3||1
10258624|NCT02871778|11390531|FG007|NOT COMPLETED|Part B: Treatment Period 3||0
10258625|NCT02769000|11390555|FG000|STARTED|Overall Study||5
10258626|NCT02769000|11390556|FG001|STARTED|Overall Study||0
10258627|NCT02769000|11390555|FG000|COMPLETED|Overall Study||5
10258628|NCT02769000|11390556|FG001|COMPLETED|Overall Study||0
10258629|NCT02769000|11390555|FG000|NOT COMPLETED|Overall Study||0
9719315|NCT00040937|10818845|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
9719316|NCT00040937|10818845|FG000|COMPLETED|Autologous PBSCT||77
9719317|NCT00040937|10818845|FG000|NOT COMPLETED|Autologous PBSCT||31
9719318|NCT00040937|10818845|FG000|STARTED|Maintenance||76
9719319|NCT00040937|10818845|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
9719320|NCT00040937|10818845|FG000|NOT COMPLETED|Maintenance||0
9719321|NCT00041067|10818852|FG000|STARTED|Overall Study||76
9719322|NCT00041067|10818852|FG000|Eligible|Overall Study||74
9719323|NCT00041067|10818852|FG000|COMPLETED|Overall Study||0
9719324|NCT00041067|10818852|FG000|NOT COMPLETED|Overall Study||76
9719325|NCT00041080|10818859|FG000|STARTED|Overall Study|number patients enrolled on study|69
9719326|NCT00041080|10818860|FG001|STARTED|Overall Study|number patients enrolled on study|70
9719327|NCT00041080|10818859|FG000|COMPLETED|Overall Study||39
9719328|NCT00041080|10818860|FG001|COMPLETED|Overall Study||60
9719329|NCT00041080|10818859|FG000|NOT COMPLETED|Overall Study||30
9719330|NCT00041080|10818860|FG001|NOT COMPLETED|Overall Study||10
9719331|NCT00041119|10818870|FG000|STARTED|Overall Study||1142
9719332|NCT00041119|10818871|FG001|STARTED|Overall Study||789
9719333|NCT00041119|10818872|FG002|STARTED|Overall Study||1151
9719334|NCT00041119|10818873|FG003|STARTED|Overall Study||789
9719335|NCT00041119|10818870|FG000|COMPLETED|Overall Study||1142
9719336|NCT00041119|10818871|FG001|COMPLETED|Overall Study||789
9719337|NCT00041119|10818872|FG002|COMPLETED|Overall Study||1151
9719338|NCT00041119|10818873|FG003|COMPLETED|Overall Study||789
9719339|NCT00041119|10818870|FG000|NOT COMPLETED|Overall Study||0
9719340|NCT00041119|10818871|FG001|NOT COMPLETED|Overall Study||0
9719341|NCT00041119|10818872|FG002|NOT COMPLETED|Overall Study||0
9719342|NCT00041119|10818873|FG003|NOT COMPLETED|Overall Study||0
9719343|NCT00041132|10818887|FG000|STARTED|Overall Study||56
9719344|NCT00041132|10818887|FG000|Eligible|Overall Study||49
9719345|NCT00041132|10818887|FG000|Eligible and Began Protocol Therapy|Overall Study||49
9719346|NCT00041132|10818887|FG000|COMPLETED|Overall Study||26
9719347|NCT00041132|10818887|FG000|NOT COMPLETED|Overall Study||30
9719348|NCT00041470|10818891|FG000|STARTED|Overall Study||38
9719349|NCT00041470|10818891|FG000|COMPLETED|Overall Study||0
9719350|NCT00041470|10818891|FG000|NOT COMPLETED|Overall Study||38
9719351|NCT00041717|10818897|FG000|STARTED|Overall Study||114
9719352|NCT00041717|10818898|FG001|STARTED|Overall Study||98
9719353|NCT00041717|10818897|FG000|COMPLETED|Overall Study||81
9719354|NCT00041717|10818898|FG001|COMPLETED|Overall Study||86
9719355|NCT00041717|10818897|FG000|NOT COMPLETED|Overall Study||33
9719356|NCT00041717|10818898|FG001|NOT COMPLETED|Overall Study||12
9719357|NCT00041756|10818909|FG000|STARTED|Overall Study||77
9719358|NCT00041756|10818910|FG001|STARTED|Overall Study||80
9719359|NCT00041756|10818911|FG002|STARTED|Overall Study||79
9719360|NCT00041756|10818912|FG003|STARTED|Overall Study||80
9719361|NCT00041756|10818913|FG004|STARTED|Overall Study||79
9719362|NCT00041756|10818909|FG000|COMPLETED|Overall Study||69
9719363|NCT00041756|10818910|FG001|COMPLETED|Overall Study||65
9719364|NCT00041756|10818911|FG002|COMPLETED|Overall Study||66
9719365|NCT00041756|10818912|FG003|COMPLETED|Overall Study||64
9719366|NCT00041756|10818913|FG004|COMPLETED|Overall Study||19
9719367|NCT00041756|10818909|FG000|NOT COMPLETED|Overall Study||8
9719368|NCT00041756|10818910|FG001|NOT COMPLETED|Overall Study||15
9719369|NCT00041756|10818911|FG002|NOT COMPLETED|Overall Study||13
9719370|NCT00041756|10818912|FG003|NOT COMPLETED|Overall Study||16
9719371|NCT00041756|10818913|FG004|NOT COMPLETED|Overall Study||60
9719372|NCT00041938|10818927|FG000|STARTED|Overall Study||1163
9719373|NCT00041938|10818928|FG001|STARTED|Overall Study||1142
9719374|NCT00041938|10818927|FG000|Completed Follow-up|Overall Study||761
9719375|NCT00041938|10818928|FG001|Completed Follow-up|Overall Study||745
9719376|NCT00041938|10818927|FG000|Primary Endpoint|Overall Study||320
9719377|NCT00041938|10818928|FG001|Primary Endpoint|Overall Study||302
9719378|NCT00041938|10818927|FG000|Only Vital Status Known|Overall Study||44
9719379|NCT00041938|10818928|FG001|Only Vital Status Known|Overall Study||46
9719380|NCT00041938|10818927|FG000|Lost to Follow-up|Overall Study||18
9719381|NCT00041938|10818928|FG001|Lost to Follow-up|Overall Study||17
9835114|NCT00789750|10946288|FG000|NOT COMPLETED|Overall Study||59
9835115|NCT00789750|10946289|FG001|NOT COMPLETED|Overall Study||60
10258630|NCT02769000|11390556|FG001|NOT COMPLETED|Overall Study||0
10258631|NCT02756208|11390564|FG000|STARTED|Overall Study||18
10258632|NCT02756208|11390565|FG001|STARTED|Overall Study||16
10258633|NCT02756208|11390566|FG002|STARTED|Overall Study||15
10258634|NCT02756208|11390567|FG003|STARTED|Overall Study||16
10258635|NCT02756208|11390564|FG000|COMPLETED|Overall Study||13
10258636|NCT02756208|11390565|FG001|COMPLETED|Overall Study||14
10258637|NCT02756208|11390566|FG002|COMPLETED|Overall Study||13
10258638|NCT02756208|11390567|FG003|COMPLETED|Overall Study||12
10258639|NCT02756208|11390564|FG000|NOT COMPLETED|Overall Study||5
9835116|NCT00789776|10946297|FG000|STARTED|Overall Study||5
9835117|NCT00789776|10946298|FG001|STARTED|Overall Study||36
9835118|NCT00789776|10946297|FG000|COMPLETED|Overall Study||5
9835119|NCT00789776|10946298|FG001|COMPLETED|Overall Study||35
9835120|NCT00789776|10946297|FG000|NOT COMPLETED|Overall Study||0
9835121|NCT00789776|10946298|FG001|NOT COMPLETED|Overall Study||1
9835122|NCT00789802|10946307|FG000|STARTED|Overall Study||44
9835123|NCT00789802|10946308|FG001|STARTED|Overall Study||42
9835124|NCT00789802|10946309|FG002|STARTED|Overall Study||43
9835125|NCT00789802|10946307|FG000|COMPLETED|Overall Study||34
9835126|NCT00789802|10946308|FG001|COMPLETED|Overall Study||35
9835127|NCT00789802|10946309|FG002|COMPLETED|Overall Study||37
9835128|NCT00789802|10946307|FG000|NOT COMPLETED|Overall Study||10
9835129|NCT00789802|10946308|FG001|NOT COMPLETED|Overall Study||7
9835130|NCT00789802|10946309|FG002|NOT COMPLETED|Overall Study||6
10258640|NCT02756208|11390565|FG001|NOT COMPLETED|Overall Study||2
10258641|NCT02756208|11390566|FG002|NOT COMPLETED|Overall Study||2
10258642|NCT02756208|11390567|FG003|NOT COMPLETED|Overall Study||4
9957854|NCT01453296|11077188|FG000|COMPLETED|Treatment Period 2||11
9957855|NCT01453296|11077189|FG001|COMPLETED|Treatment Period 2||13
9957856|NCT01453296|11077188|FG000|NOT COMPLETED|Treatment Period 2||2
9957857|NCT01453296|11077189|FG001|NOT COMPLETED|Treatment Period 2||0
10114010|NCT02513160|11244733|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104
10258643|NCT02149121|11390584|FG000|STARTED|Main Study Period||161
10258644|NCT02149121|11390585|FG001|STARTED|Main Study Period||151
10258645|NCT02149121|11390586|FG002|STARTED|Main Study Period||60
10258646|NCT02149121|11390587|FG003|STARTED|Main Study Period||0
10258647|NCT02149121|11390588|FG004|STARTED|Main Study Period||0
10258648|NCT02149121|11390589|FG005|STARTED|Main Study Period||0
10258649|NCT02149121|11390590|FG006|STARTED|Main Study Period||0
10258650|NCT02149121|11390584|FG000|COMPLETED|Main Study Period||140
10258651|NCT02149121|11390585|FG001|COMPLETED|Main Study Period||134
10258652|NCT02149121|11390586|FG002|COMPLETED|Main Study Period||56
10258653|NCT02149121|11390587|FG003|COMPLETED|Main Study Period||0
10258654|NCT02149121|11390588|FG004|COMPLETED|Main Study Period||0
10258655|NCT02149121|11390589|FG005|COMPLETED|Main Study Period||0
10258656|NCT02149121|11390590|FG006|COMPLETED|Main Study Period||0
10258657|NCT02149121|11390584|FG000|NOT COMPLETED|Main Study Period||21
10258658|NCT02149121|11390585|FG001|NOT COMPLETED|Main Study Period||17
10258659|NCT02149121|11390586|FG002|NOT COMPLETED|Main Study Period||4
10258660|NCT02149121|11390587|FG003|NOT COMPLETED|Main Study Period||0
10258661|NCT02149121|11390588|FG004|NOT COMPLETED|Main Study Period||0
10258662|NCT02149121|11390589|FG005|NOT COMPLETED|Main Study Period||0
10258663|NCT02149121|11390590|FG006|NOT COMPLETED|Main Study Period||0
10258664|NCT02149121|11390584|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10258665|NCT02149121|11390585|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10258666|NCT02149121|11390586|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10258667|NCT02149121|11390587|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122
10258668|NCT02149121|11390588|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64
10258669|NCT02149121|11390589|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62
10258670|NCT02149121|11390590|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47
10258671|NCT02149121|11390584|FG000|COMPLETED|Extension Study Period||0
10258672|NCT02149121|11390585|FG001|COMPLETED|Extension Study Period||0
10258673|NCT02149121|11390586|FG002|COMPLETED|Extension Study Period||0
10258674|NCT02149121|11390587|FG003|COMPLETED|Extension Study Period||121
10258675|NCT02149121|11390588|FG004|COMPLETED|Extension Study Period||64
10258676|NCT02149121|11390589|FG005|COMPLETED|Extension Study Period||60
10258677|NCT02149121|11390590|FG006|COMPLETED|Extension Study Period||47
10258678|NCT02149121|11390584|FG000|NOT COMPLETED|Extension Study Period||0
10258679|NCT02149121|11390585|FG001|NOT COMPLETED|Extension Study Period||0
10258680|NCT02149121|11390586|FG002|NOT COMPLETED|Extension Study Period||0
10258681|NCT02149121|11390587|FG003|NOT COMPLETED|Extension Study Period||1
10258682|NCT02149121|11390588|FG004|NOT COMPLETED|Extension Study Period||0
10258683|NCT02149121|11390589|FG005|NOT COMPLETED|Extension Study Period||2
10258684|NCT02149121|11390590|FG006|NOT COMPLETED|Extension Study Period||0
10258685|NCT01889186|11390613|FG000|STARTED|Overall Study||107
10258686|NCT01889186|11390614|FG001|STARTED|Overall Study||51
10258687|NCT01889186|11390613|FG000|COMPLETED|Overall Study||0
10258688|NCT01889186|11390614|FG001|COMPLETED|Overall Study||0
10258689|NCT01889186|11390613|FG000|NOT COMPLETED|Overall Study||107
10258690|NCT01889186|11390614|FG001|NOT COMPLETED|Overall Study||51
10258691|NCT01850004|11390622|FG000|STARTED|Overall Study||84
10258692|NCT01850004|11390622|FG000|COMPLETED|Overall Study||76
10258693|NCT01850004|11390622|FG000|NOT COMPLETED|Overall Study||8
10258694|NCT01510184|11390629|FG000|STARTED|Overall Study||36
10258695|NCT01510184|11390630|FG001|STARTED|Overall Study||43
10258696|NCT01510184|11390629|FG000|COMPLETED|Overall Study||6
10258697|NCT01510184|11390630|FG001|COMPLETED|Overall Study||8
10258698|NCT01510184|11390629|FG000|NOT COMPLETED|Overall Study||30
10258699|NCT01510184|11390630|FG001|NOT COMPLETED|Overall Study||35
10258700|NCT01471444|11390638|FG000|STARTED|Overall Study||133
10258701|NCT01471444|11390639|FG001|STARTED|Overall Study||123
10258702|NCT01471444|11390638|FG000|COMPLETED|Overall Study||130
10258703|NCT01471444|11390639|FG001|COMPLETED|Overall Study||120
10258704|NCT01471444|11390638|FG000|NOT COMPLETED|Overall Study||3
10258705|NCT01471444|11390639|FG001|NOT COMPLETED|Overall Study||3
10258706|NCT00545766|11390646|FG000|STARTED|Overall Study||41
10258707|NCT00545766|11390646|FG000|COMPLETED|Overall Study||36
10258708|NCT00545766|11390646|FG000|NOT COMPLETED|Overall Study||5
9957858|NCT01453348|11077198|FG000|STARTED|Overall Study||84
9957859|NCT01453348|11077199|FG001|STARTED|Overall Study||84
9957860|NCT01453348|11077200|FG002|STARTED|Overall Study||84
10258709|NCT04101890|11390650|FG000|STARTED|Routine Diaper Care||5
10258710|NCT04101890|11390650|FG000|COMPLETED|Routine Diaper Care||5
10258711|NCT04101890|11390650|FG000|NOT COMPLETED|Routine Diaper Care||0
10258712|NCT04101890|11390650|FG000|STARTED|Diaper Care With Theraworx||5
10258713|NCT04101890|11390650|FG000|COMPLETED|Diaper Care With Theraworx||5
10258714|NCT04101890|11390650|FG000|NOT COMPLETED|Diaper Care With Theraworx||0
10258715|NCT03993314|11390658|FG000|STARTED|Overall Study||9
10258716|NCT03993314|11390659|FG001|STARTED|Overall Study||6
10258717|NCT03993314|11390658|FG000|COMPLETED|Overall Study||9
10258718|NCT03993314|11390659|FG001|COMPLETED|Overall Study||6
10258719|NCT03993314|11390658|FG000|NOT COMPLETED|Overall Study||0
10258720|NCT03993314|11390659|FG001|NOT COMPLETED|Overall Study||0
10258721|NCT03874351|11390667|FG000|STARTED|Overall Study||11
10258722|NCT03874351|11390668|FG001|STARTED|Overall Study||11
10258723|NCT03874351|11390667|FG000|COMPLETED|Overall Study||7
10258724|NCT03874351|11390668|FG001|COMPLETED|Overall Study||9
10258725|NCT03874351|11390667|FG000|NOT COMPLETED|Overall Study||4
10258726|NCT03874351|11390668|FG001|NOT COMPLETED|Overall Study||2
10258727|NCT03856359|11390674|FG000|STARTED|Overall Study||10
10258728|NCT03856359|11390674|FG000|COMPLETED|Overall Study||9
10258729|NCT03856359|11390674|FG000|NOT COMPLETED|Overall Study||1
10258730|NCT03769519|11390680|FG000|STARTED|Overall Study||14
10258731|NCT03769519|11390681|FG001|STARTED|Overall Study||15
10258732|NCT03769519|11390680|FG000|COMPLETED|Overall Study||14
10258733|NCT03769519|11390681|FG001|COMPLETED|Overall Study||14
10258734|NCT03769519|11390680|FG000|NOT COMPLETED|Overall Study||0
10258735|NCT03769519|11390681|FG001|NOT COMPLETED|Overall Study||1
10258736|NCT03745651|11390690|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124
10258737|NCT03745651|11390691|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248
10258738|NCT03745651|11390692|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246
10258739|NCT03745651|11390693|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258740|NCT03745651|11390694|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258741|NCT03745651|11390695|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258742|NCT03745651|11390696|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258743|NCT03745651|11390690|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105
10258744|NCT03745651|11390691|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209
10258745|NCT03745651|11390692|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224
10258746|NCT03745651|11390693|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258747|NCT03745651|11390694|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258748|NCT03745651|11390695|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9835131|NCT00789815|10946322|FG000|STARTED|Overall Study||250
9835132|NCT00789815|10946323|FG001|STARTED|Overall Study||250
9835133|NCT00789815|10946322|FG000|COMPLETED|Overall Study||243
9835134|NCT00789815|10946323|FG001|COMPLETED|Overall Study||249
9835135|NCT00789815|10946322|FG000|NOT COMPLETED|Overall Study||7
9835136|NCT00789815|10946323|FG001|NOT COMPLETED|Overall Study||1
9835137|NCT00789828|10946331|FG000|STARTED|Core Period (48 Weeks)||78
9835138|NCT00789828|10946332|FG001|STARTED|Core Period (48 Weeks)||39
9835139|NCT00789828|10946331|FG000|COMPLETED|Core Period (48 Weeks)||78
9835140|NCT00789828|10946332|FG001|COMPLETED|Core Period (48 Weeks)||33
9835141|NCT00789828|10946331|FG000|NOT COMPLETED|Core Period (48 Weeks)||0
9835142|NCT00789828|10946332|FG001|NOT COMPLETED|Core Period (48 Weeks)||6
9835143|NCT00789828|10946331|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
9835144|NCT00789828|10946332|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
9835145|NCT00789828|10946331|FG000|COMPLETED|Open-label Extension Period (4 Years)||82
9835146|NCT00789828|10946332|FG001|COMPLETED|Open-label Extension Period (4 Years)||0
9835147|NCT00789828|10946331|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29
9957861|NCT01453348|11077198|FG000|COMPLETED|Overall Study||83
9957862|NCT01453348|11077199|FG001|COMPLETED|Overall Study||83
9957863|NCT01453348|11077200|FG002|COMPLETED|Overall Study||83
10258749|NCT03745651|11390696|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258750|NCT03745651|11390690|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19
10258751|NCT03745651|11390691|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39
10258752|NCT03745651|11390692|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22
10258753|NCT03745651|11390693|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258754|NCT03745651|11390694|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258755|NCT03745651|11390695|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258756|NCT03745651|11390696|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258757|NCT03745651|11390690|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10258758|NCT03745651|11390691|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10258759|NCT03745651|11390692|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10258760|NCT03745651|11390693|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53
10258761|NCT03745651|11390694|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52
10258762|NCT03745651|11390695|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204
10258763|NCT03745651|11390696|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221
10258764|NCT03745651|11390690|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258765|NCT03745651|11390691|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258766|NCT03745651|11390692|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258767|NCT03745651|11390693|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33
10258768|NCT03745651|11390694|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41
10258769|NCT03745651|11390695|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151
10258770|NCT03745651|11390696|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170
10258771|NCT03745651|11390690|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258772|NCT03745651|11390691|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258773|NCT03745651|11390692|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258774|NCT03745651|11390693|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20
10258775|NCT03745651|11390694|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
10258776|NCT03745651|11390695|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53
10258777|NCT03745651|11390696|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
10258778|NCT03745638|11390715|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126
10258779|NCT03745638|11390716|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252
10258780|NCT03745638|11390717|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253
10258781|NCT03745638|11390718|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258782|NCT03745638|11390719|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258783|NCT03745638|11390720|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258784|NCT03745638|11390721|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10258785|NCT03745638|11390715|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95
10258786|NCT03745638|11390716|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222
10258787|NCT03745638|11390717|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225
10258788|NCT03745638|11390718|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258789|NCT03745638|11390719|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258790|NCT03745638|11390720|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258791|NCT03745638|11390721|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258792|NCT03745638|11390715|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31
10258793|NCT03745638|11390716|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30
10258794|NCT03745638|11390717|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28
10258795|NCT03745638|11390718|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258796|NCT03745638|11390719|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258797|NCT03745638|11390720|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258798|NCT03745638|11390721|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10258799|NCT03745638|11390715|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10258800|NCT03745638|11390716|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10258801|NCT03745638|11390717|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10258802|NCT03745638|11390718|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48
10258803|NCT03745638|11390719|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47
10258804|NCT03745638|11390720|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222
10258805|NCT03745638|11390721|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225
10258806|NCT03745638|11390715|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258807|NCT03745638|11390716|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258808|NCT03745638|11390717|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258809|NCT03745638|11390718|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37
10258810|NCT03745638|11390719|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38
10258811|NCT03745638|11390720|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176
10258812|NCT03745638|11390721|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174
10258813|NCT03745638|11390715|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258814|NCT03745638|11390716|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258815|NCT03745638|11390717|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10258816|NCT03745638|11390718|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
10258817|NCT03745638|11390719|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9
10258818|NCT03745638|11390720|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46
10258819|NCT03745638|11390721|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
10258820|NCT03715764|11390740|FG000|STARTED|Baseline (Randomized (n=69)||35
10258821|NCT03715764|11390741|FG001|STARTED|Baseline (Randomized (n=69)||34
10258822|NCT03715764|11390740|FG000|COMPLETED|Baseline (Randomized (n=69)||33
10258823|NCT03715764|11390741|FG001|COMPLETED|Baseline (Randomized (n=69)||31
10258824|NCT03715764|11390740|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2
10258825|NCT03715764|11390741|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3
10258826|NCT03715764|11390740|FG000|STARTED|3 Month Follow-up||33
10258827|NCT03715764|11390741|FG001|STARTED|3 Month Follow-up||31
10258828|NCT03715764|11390740|FG000|COMPLETED|3 Month Follow-up||30
10258829|NCT03715764|11390741|FG001|COMPLETED|3 Month Follow-up||28
10258830|NCT03715764|11390740|FG000|NOT COMPLETED|3 Month Follow-up||3
10258831|NCT03715764|11390741|FG001|NOT COMPLETED|3 Month Follow-up||3
10258832|NCT03715764|11390740|FG000|STARTED|6 Month Follow-up||30
10258833|NCT03715764|11390741|FG001|STARTED|6 Month Follow-up||28
10258834|NCT03715764|11390740|FG000|COMPLETED|6 Month Follow-up||27
10258835|NCT03715764|11390741|FG001|COMPLETED|6 Month Follow-up||28
10258836|NCT03715764|11390740|FG000|NOT COMPLETED|6 Month Follow-up||3
10258837|NCT03715764|11390741|FG001|NOT COMPLETED|6 Month Follow-up||0
10258838|NCT03715764|11390740|FG000|STARTED|12 Month Follow-up||27
10258839|NCT03715764|11390741|FG001|STARTED|12 Month Follow-up||28
10258840|NCT03715764|11390740|FG000|COMPLETED|12 Month Follow-up||21
10258841|NCT03715764|11390741|FG001|COMPLETED|12 Month Follow-up||23
10258842|NCT03715764|11390740|FG000|NOT COMPLETED|12 Month Follow-up||6
10258843|NCT03715764|11390741|FG001|NOT COMPLETED|12 Month Follow-up||5
10258844|NCT03663855|11390747|FG000|STARTED|Overall Study||10
10258845|NCT03663855|11390747|FG000|COMPLETED|Overall Study||10
10258846|NCT03663855|11390747|FG000|NOT COMPLETED|Overall Study||0
10258847|NCT03654729|11390754|FG000|STARTED|Overall Study||97
10258848|NCT03654729|11390755|FG001|STARTED|Overall Study||96
10258849|NCT03654729|11390756|FG002|STARTED|Overall Study||98
10258850|NCT03654729|11390754|FG000|Treated|Overall Study||96
10258851|NCT03654729|11390755|FG001|Treated|Overall Study||93
10258852|NCT03654729|11390756|FG002|Treated|Overall Study||96
10258853|NCT03654729|11390754|FG000|COMPLETED|Overall Study||66
10258854|NCT03654729|11390755|FG001|COMPLETED|Overall Study||70
10258855|NCT03654729|11390756|FG002|COMPLETED|Overall Study||69
10258856|NCT03654729|11390754|FG000|NOT COMPLETED|Overall Study||31
10258857|NCT03654729|11390755|FG001|NOT COMPLETED|Overall Study||26
10258858|NCT03654729|11390756|FG002|NOT COMPLETED|Overall Study||29
10258859|NCT03531112|11390766|FG000|STARTED|Overall Study||20
10258860|NCT03531112|11390767|FG001|STARTED|Overall Study||0
10258861|NCT03531112|11390766|FG000|Month 4|Overall Study||17
10258862|NCT03531112|11390767|FG001|Month 4|Overall Study||0
10258863|NCT03531112|11390766|FG000|Month 6 (Follow-Up)|Overall Study||13
10258864|NCT03531112|11390767|FG001|Month 6 (Follow-Up)|Overall Study||0
10258865|NCT03531112|11390766|FG000|COMPLETED|Overall Study||13
10258866|NCT03531112|11390767|FG001|COMPLETED|Overall Study||0
10258867|NCT03531112|11390766|FG000|NOT COMPLETED|Overall Study||7
10258868|NCT03531112|11390767|FG001|NOT COMPLETED|Overall Study||0
10258869|NCT03112902|11390783|FG000|STARTED|Overall Study||2
10258870|NCT03112902|11390784|FG001|STARTED|Overall Study||2
10258871|NCT03112902|11390785|FG002|STARTED|Overall Study||3
10258872|NCT03112902|11390786|FG003|STARTED|Overall Study||1
10258873|NCT03112902|11390787|FG004|STARTED|Overall Study||1
10258874|NCT03112902|11390788|FG005|STARTED|Overall Study||3
10258875|NCT03112902|11390789|FG006|STARTED|Overall Study||9
10258876|NCT03112902|11390790|FG007|STARTED|Overall Study||3
10258877|NCT03112902|11390791|FG008|STARTED|Overall Study||0
10258878|NCT03112902|11390792|FG009|STARTED|Overall Study||0
10258879|NCT03112902|11390783|FG000|COMPLETED|Overall Study||0
10258880|NCT03112902|11390784|FG001|COMPLETED|Overall Study||2
10258881|NCT03112902|11390785|FG002|COMPLETED|Overall Study||2
10258882|NCT03112902|11390786|FG003|COMPLETED|Overall Study||0
10258883|NCT03112902|11390787|FG004|COMPLETED|Overall Study||1
10258884|NCT03112902|11390788|FG005|COMPLETED|Overall Study||0
10258885|NCT03112902|11390789|FG006|COMPLETED|Overall Study||1
10258886|NCT03112902|11390790|FG007|COMPLETED|Overall Study||1
10258887|NCT03112902|11390791|FG008|COMPLETED|Overall Study||0
10258888|NCT03112902|11390792|FG009|COMPLETED|Overall Study||0
10258889|NCT03112902|11390783|FG000|NOT COMPLETED|Overall Study||2
10258890|NCT03112902|11390784|FG001|NOT COMPLETED|Overall Study||0
10258891|NCT03112902|11390785|FG002|NOT COMPLETED|Overall Study||1
10258892|NCT03112902|11390786|FG003|NOT COMPLETED|Overall Study||1
10258893|NCT03112902|11390787|FG004|NOT COMPLETED|Overall Study||0
10258894|NCT03112902|11390788|FG005|NOT COMPLETED|Overall Study||3
10258895|NCT03112902|11390789|FG006|NOT COMPLETED|Overall Study||8
10258896|NCT03112902|11390790|FG007|NOT COMPLETED|Overall Study||2
10258897|NCT03112902|11390791|FG008|NOT COMPLETED|Overall Study||0
10258898|NCT03112902|11390792|FG009|NOT COMPLETED|Overall Study||0
10258899|NCT02976038|11390808|FG000|STARTED|Overall Study||28
10258900|NCT02976038|11390808|FG000|COMPLETED|Overall Study||0
10258901|NCT02976038|11390808|FG000|NOT COMPLETED|Overall Study||28
10258902|NCT02631070|11390824|FG000|STARTED|Overall Study||153
10258903|NCT02631070|11390825|FG001|STARTED|Overall Study||76
10258904|NCT02631070|11390824|FG000|COMPLETED|Overall Study||4
10258905|NCT02631070|11390825|FG001|COMPLETED|Overall Study||12
10258906|NCT02631070|11390824|FG000|NOT COMPLETED|Overall Study||149
10258907|NCT02631070|11390825|FG001|NOT COMPLETED|Overall Study||64
10258908|NCT02281955|11390831|FG000|STARTED|Overall Study||114
10258909|NCT02281955|11390831|FG000|COMPLETED|Overall Study||113
10258910|NCT02281955|11390831|FG000|NOT COMPLETED|Overall Study||1
10258911|NCT02202434|11390839|FG000|STARTED|Overall Study||607
10258912|NCT02202434|11390840|FG001|STARTED|Overall Study||305
10258913|NCT02202434|11390841|FG002|STARTED|Overall Study||102
10258914|NCT02202434|11390842|FG003|STARTED|Overall Study||295
10258915|NCT02202434|11390839|FG000|COMPLETED|Overall Study||498
10258916|NCT02202434|11390840|FG001|COMPLETED|Overall Study||236
10258917|NCT02202434|11390841|FG002|COMPLETED|Overall Study||87
10258918|NCT02202434|11390842|FG003|COMPLETED|Overall Study||258
10258919|NCT02202434|11390839|FG000|NOT COMPLETED|Overall Study||109
10258920|NCT02202434|11390840|FG001|NOT COMPLETED|Overall Study||69
10258921|NCT02202434|11390841|FG002|NOT COMPLETED|Overall Study||15
10258922|NCT02202434|11390842|FG003|NOT COMPLETED|Overall Study||37
10258923|NCT01727011|11390852|FG000|STARTED|Overall Study||31
10258924|NCT01727011|11390852|FG000|COMPLETED|Overall Study||26
10258925|NCT01727011|11390852|FG000|NOT COMPLETED|Overall Study||5
10258926|NCT01230242|11390856|FG000|STARTED|Overall Study||4
10258927|NCT01230242|11390856|FG000|COMPLETED|Overall Study||1
10258928|NCT01230242|11390856|FG000|NOT COMPLETED|Overall Study||3
10258929|NCT00983437|11390860|FG000|STARTED|Overall Study||47
10258930|NCT00983437|11390860|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
10258931|NCT00983437|11390860|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
10258932|NCT00983437|11390860|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
10258933|NCT00983437|11390860|FG000|NOT COMPLETED|Overall Study||47
10258934|NCT00965757|11390866|FG000|STARTED|Double-blind Phase||165
10258935|NCT00965757|11390867|FG001|STARTED|Double-blind Phase||88
10258936|NCT00965757|11390868|FG002|STARTED|Double-blind Phase||0
10258937|NCT00965757|11390869|FG003|STARTED|Double-blind Phase||0
10258938|NCT00965757|11390866|FG000|COMPLETED|Double-blind Phase||148
10258939|NCT00965757|11390867|FG001|COMPLETED|Double-blind Phase||70
10258940|NCT00965757|11390868|FG002|COMPLETED|Double-blind Phase||0
10258941|NCT00965757|11390869|FG003|COMPLETED|Double-blind Phase||0
10258942|NCT00965757|11390866|FG000|NOT COMPLETED|Double-blind Phase||17
10258943|NCT00965757|11390867|FG001|NOT COMPLETED|Double-blind Phase||18
10258944|NCT00965757|11390868|FG002|NOT COMPLETED|Double-blind Phase||0
10258945|NCT00965757|11390869|FG003|NOT COMPLETED|Double-blind Phase||0
10258946|NCT00965757|11390866|FG000|STARTED|Extension Phase||0
10258947|NCT00965757|11390867|FG001|STARTED|Extension Phase||0
10258948|NCT00965757|11390868|FG002|STARTED|Extension Phase||165
10258949|NCT00965757|11390869|FG003|STARTED|Extension Phase||88
10258950|NCT00965757|11390866|FG000|COMPLETED|Extension Phase||0
10258951|NCT00965757|11390867|FG001|COMPLETED|Extension Phase||0
10258952|NCT00965757|11390868|FG002|COMPLETED|Extension Phase||132
10258953|NCT00965757|11390869|FG003|COMPLETED|Extension Phase||64
10258954|NCT00965757|11390866|FG000|NOT COMPLETED|Extension Phase||0
10258955|NCT00965757|11390867|FG001|NOT COMPLETED|Extension Phase||0
10258956|NCT00965757|11390868|FG002|NOT COMPLETED|Extension Phase||33
10258957|NCT00965757|11390869|FG003|NOT COMPLETED|Extension Phase||24
10258958|NCT00928447|11390877|FG000|STARTED|Overall Study||22
10258959|NCT00928447|11390877|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21
10258960|NCT00928447|11390877|FG000|Received at Least 1 Dose of Placebo|Overall Study||21
10258961|NCT00928447|11390877|FG000|COMPLETED|Overall Study||20
10258962|NCT00928447|11390877|FG000|NOT COMPLETED|Overall Study||2
10258963|NCT00893789|11390885|FG000|STARTED|Overall Study||29
10258964|NCT00893789|11390886|FG001|STARTED|Overall Study||30
10258965|NCT00893789|11390887|FG002|STARTED|Overall Study||29
10258966|NCT00893789|11390888|FG003|STARTED|Overall Study||29
10258967|NCT00893789|11390885|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
10258968|NCT00893789|11390886|FG001|Safety Analysis Set (SAS)|Overall Study||30
10258969|NCT00893789|11390887|FG002|Safety Analysis Set (SAS)|Overall Study||29
10258970|NCT00893789|11390888|FG003|Safety Analysis Set (SAS)|Overall Study||29
10258971|NCT00893789|11390885|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
10258972|NCT00893789|11390886|FG001|Full Analysis Set (FAS)|Overall Study||29
10258973|NCT00893789|11390887|FG002|Full Analysis Set (FAS)|Overall Study||28
10258974|NCT00893789|11390888|FG003|Full Analysis Set (FAS)|Overall Study||27
10258975|NCT00893789|11390885|FG000|COMPLETED|Overall Study||23
10258976|NCT00893789|11390886|FG001|COMPLETED|Overall Study||26
10258977|NCT00893789|11390887|FG002|COMPLETED|Overall Study||22
10258978|NCT00893789|11390888|FG003|COMPLETED|Overall Study||16
10258979|NCT00893789|11390885|FG000|NOT COMPLETED|Overall Study||6
10258980|NCT00893789|11390886|FG001|NOT COMPLETED|Overall Study||4
10258981|NCT00893789|11390887|FG002|NOT COMPLETED|Overall Study||7
10258982|NCT00893789|11390888|FG003|NOT COMPLETED|Overall Study||13
10258983|NCT04349150|11390898|FG000|STARTED|Overall Study||31
10258984|NCT04349150|11390898|FG000|COMPLETED|Overall Study||27
10258985|NCT04349150|11390898|FG000|NOT COMPLETED|Overall Study||4
9835148|NCT00789828|10946332|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0
9835149|NCT00789854|10946344|FG000|STARTED|Overall Study||228
9835150|NCT00789854|10946345|FG001|STARTED|Overall Study||231
9835151|NCT00789854|10946346|FG002|STARTED|Overall Study||229
9835152|NCT00789854|10946344|FG000|COMPLETED|Overall Study||179
9835153|NCT00789854|10946345|FG001|COMPLETED|Overall Study||196
9835154|NCT00789854|10946346|FG002|COMPLETED|Overall Study||182
9835155|NCT00789854|10946344|FG000|NOT COMPLETED|Overall Study||49
10259058|NCT02409368|11390999|FG000|STARTED|Overall Study||173
10259059|NCT02409368|11391000|FG001|STARTED|Overall Study||534
10259060|NCT02409368|11391001|FG002|STARTED|Overall Study||103
10259061|NCT02409368|11390999|FG000|COMPLETED|Overall Study||25
10259062|NCT02409368|11391000|FG001|COMPLETED|Overall Study||45
10259063|NCT02409368|11391001|FG002|COMPLETED|Overall Study||4
10259064|NCT02409368|11390999|FG000|NOT COMPLETED|Overall Study||148
10259065|NCT02409368|11391000|FG001|NOT COMPLETED|Overall Study||489
10259066|NCT02409368|11391001|FG002|NOT COMPLETED|Overall Study||99
10259067|NCT02322593|11391012|FG000|STARTED|Overall Study||356
10259068|NCT02322593|11391013|FG001|STARTED|Overall Study||355
10259069|NCT02322593|11391012|FG000|COMPLETED|Overall Study||356
10259070|NCT02322593|11391013|FG001|COMPLETED|Overall Study||355
10259071|NCT02322593|11391012|FG000|NOT COMPLETED|Overall Study||0
10259072|NCT02322593|11391013|FG001|NOT COMPLETED|Overall Study||0
10259073|NCT02124824|11391021|FG000|STARTED|Overall Study||15
10259074|NCT02124824|11391022|FG001|STARTED|Overall Study||15
10259075|NCT02124824|11391021|FG000|COMPLETED|Overall Study||15
10259076|NCT02124824|11391022|FG001|COMPLETED|Overall Study||15
10259077|NCT02124824|11391021|FG000|NOT COMPLETED|Overall Study||0
10259078|NCT02124824|11391022|FG001|NOT COMPLETED|Overall Study||0
10259079|NCT01772004|11391051|FG000|STARTED|Dose Escalation Phase||4
10259080|NCT01772004|11391052|FG001|STARTED|Dose Escalation Phase||13
10259081|NCT01772004|11391053|FG002|STARTED|Dose Escalation Phase||15
10259082|NCT01772004|11391054|FG003|STARTED|Dose Escalation Phase||21
10259083|NCT01772004|11391055|FG004|STARTED|Dose Escalation Phase||8
10259084|NCT01772004|11391056|FG005|STARTED|Dose Escalation Phase||0
10259085|NCT01772004|11391057|FG006|STARTED|Dose Escalation Phase||0
10259086|NCT01772004|11391058|FG007|STARTED|Dose Escalation Phase||0
10259087|NCT01772004|11391059|FG008|STARTED|Dose Escalation Phase||0
10259088|NCT01772004|11391060|FG009|STARTED|Dose Escalation Phase||0
10259089|NCT01772004|11391061|FG010|STARTED|Dose Escalation Phase||0
10259090|NCT01772004|11391062|FG011|STARTED|Dose Escalation Phase||0
10259091|NCT01772004|11391063|FG012|STARTED|Dose Escalation Phase||0
10259092|NCT01772004|11391064|FG013|STARTED|Dose Escalation Phase||0
10259093|NCT01772004|11391065|FG014|STARTED|Dose Escalation Phase||0
10259094|NCT01772004|11391066|FG015|STARTED|Dose Escalation Phase||0
10259095|NCT01772004|11391067|FG016|STARTED|Dose Escalation Phase||0
10259096|NCT01772004|11391068|FG017|STARTED|Dose Escalation Phase||0
10259097|NCT01772004|11391069|FG018|STARTED|Dose Escalation Phase||0
10259098|NCT01772004|11391070|FG019|STARTED|Dose Escalation Phase||0
10259099|NCT01772004|11391071|FG020|STARTED|Dose Escalation Phase||0
10259100|NCT01772004|11391072|FG021|STARTED|Dose Escalation Phase||0
10259101|NCT01772004|11391073|FG022|STARTED|Dose Escalation Phase||0
10259102|NCT01772004|11391051|FG000|COMPLETED|Dose Escalation Phase||4
10259103|NCT01772004|11391052|FG001|COMPLETED|Dose Escalation Phase||13
10259104|NCT01772004|11391053|FG002|COMPLETED|Dose Escalation Phase||15
10259105|NCT01772004|11391054|FG003|COMPLETED|Dose Escalation Phase||21
10259106|NCT01772004|11391055|FG004|COMPLETED|Dose Escalation Phase||8
10259107|NCT01772004|11391056|FG005|COMPLETED|Dose Escalation Phase||0
10259108|NCT01772004|11391057|FG006|COMPLETED|Dose Escalation Phase||0
10259109|NCT01772004|11391058|FG007|COMPLETED|Dose Escalation Phase||0
10259110|NCT01772004|11391059|FG008|COMPLETED|Dose Escalation Phase||0
10259111|NCT01772004|11391060|FG009|COMPLETED|Dose Escalation Phase||0
10259112|NCT01772004|11391061|FG010|COMPLETED|Dose Escalation Phase||0
10259113|NCT01772004|11391062|FG011|COMPLETED|Dose Escalation Phase||0
10259114|NCT01772004|11391063|FG012|COMPLETED|Dose Escalation Phase||0
10259115|NCT01772004|11391064|FG013|COMPLETED|Dose Escalation Phase||0
10259116|NCT01772004|11391065|FG014|COMPLETED|Dose Escalation Phase||0
10259117|NCT01772004|11391066|FG015|COMPLETED|Dose Escalation Phase||0
10259118|NCT01772004|11391067|FG016|COMPLETED|Dose Escalation Phase||0
10259119|NCT01772004|11391068|FG017|COMPLETED|Dose Escalation Phase||0
10259120|NCT01772004|11391069|FG018|COMPLETED|Dose Escalation Phase||0
9835156|NCT00789854|10946345|FG001|NOT COMPLETED|Overall Study||35
10259121|NCT01772004|11391070|FG019|COMPLETED|Dose Escalation Phase||0
10259122|NCT01772004|11391071|FG020|COMPLETED|Dose Escalation Phase||0
10259123|NCT01772004|11391072|FG021|COMPLETED|Dose Escalation Phase||0
10259124|NCT01772004|11391073|FG022|COMPLETED|Dose Escalation Phase||0
10259125|NCT01772004|11391051|FG000|NOT COMPLETED|Dose Escalation Phase||0
10259126|NCT01772004|11391052|FG001|NOT COMPLETED|Dose Escalation Phase||0
10259127|NCT01772004|11391053|FG002|NOT COMPLETED|Dose Escalation Phase||0
10259128|NCT01772004|11391054|FG003|NOT COMPLETED|Dose Escalation Phase||0
10259129|NCT01772004|11391055|FG004|NOT COMPLETED|Dose Escalation Phase||0
10259130|NCT01772004|11391056|FG005|NOT COMPLETED|Dose Escalation Phase||0
10259131|NCT01772004|11391057|FG006|NOT COMPLETED|Dose Escalation Phase||0
10258986|NCT03948698|11390902|FG000|STARTED|Overall Study||4159533
10258987|NCT03948698|11390902|FG000|COMPLETED|Overall Study||4159533
10258988|NCT03948698|11390902|FG000|NOT COMPLETED|Overall Study||0
10258989|NCT03901144|11390906|FG000|STARTED|Overall Study||50
10258990|NCT03901144|11390907|FG001|STARTED|Overall Study||50
10258991|NCT03901144|11390908|FG002|STARTED|Overall Study||50
10258992|NCT03901144|11390909|FG003|STARTED|Overall Study||50
10258993|NCT03901144|11390906|FG000|COMPLETED|Overall Study||49
10258994|NCT03901144|11390907|FG001|COMPLETED|Overall Study||49
10258995|NCT03901144|11390908|FG002|COMPLETED|Overall Study||49
10258996|NCT03901144|11390909|FG003|COMPLETED|Overall Study||49
10258997|NCT03901144|11390906|FG000|NOT COMPLETED|Overall Study||1
10258998|NCT03901144|11390907|FG001|NOT COMPLETED|Overall Study||1
10258999|NCT03901144|11390908|FG002|NOT COMPLETED|Overall Study||1
10259000|NCT03901144|11390909|FG003|NOT COMPLETED|Overall Study||1
10259001|NCT03561701|11390921|FG000|STARTED|Overall Study||220
10259002|NCT03561701|11390922|FG001|STARTED|Overall Study||110
10259003|NCT03561701|11390921|FG000|COMPLETED|Overall Study||191
10259004|NCT03561701|11390922|FG001|COMPLETED|Overall Study||91
10259005|NCT03561701|11390921|FG000|NOT COMPLETED|Overall Study||29
10259006|NCT03561701|11390922|FG001|NOT COMPLETED|Overall Study||19
10259007|NCT03525808|11390928|FG000|STARTED|Overall Study||40
10259008|NCT03525808|11390928|FG000|COMPLETED|Overall Study||34
10259009|NCT03525808|11390928|FG000|NOT COMPLETED|Overall Study||6
10259010|NCT03461211|11390934|FG000|STARTED|Overall Study||37
10259011|NCT03461211|11390935|FG001|STARTED|Overall Study||14
10259012|NCT03461211|11390934|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36
10259013|NCT03461211|11390935|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5
10259014|NCT03461211|11390934|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
10259015|NCT03461211|11390935|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
10259016|NCT03461211|11390934|FG000|COMPLETED|Overall Study||36
10259017|NCT03461211|11390935|FG001|COMPLETED|Overall Study||12
10259018|NCT03461211|11390934|FG000|NOT COMPLETED|Overall Study||1
10259019|NCT03461211|11390935|FG001|NOT COMPLETED|Overall Study||2
10259020|NCT03276780|11390945|FG000|STARTED|Overall Study||41
10259021|NCT03276780|11390946|FG001|STARTED|Overall Study||39
10259022|NCT03276780|11390945|FG000|COMPLETED|Overall Study||23
10259023|NCT03276780|11390946|FG001|COMPLETED|Overall Study||29
10259024|NCT03276780|11390945|FG000|NOT COMPLETED|Overall Study||18
10259025|NCT03276780|11390946|FG001|NOT COMPLETED|Overall Study||10
10259026|NCT03205553|11390956|FG000|STARTED|Overall Study||2
10259027|NCT03205553|11390957|FG001|STARTED|Overall Study||1
10259028|NCT03205553|11390956|FG000|COMPLETED|Overall Study||2
10259029|NCT03205553|11390957|FG001|COMPLETED|Overall Study||1
10259030|NCT03205553|11390956|FG000|NOT COMPLETED|Overall Study||0
10259031|NCT03205553|11390957|FG001|NOT COMPLETED|Overall Study||0
10259032|NCT03104205|11390963|FG000|STARTED|Overall Study||53
10259033|NCT03104205|11390963|FG000|COMPLETED|Overall Study||44
10259034|NCT03104205|11390963|FG000|NOT COMPLETED|Overall Study||9
10259035|NCT03050814|11390970|FG000|STARTED|Overall Study||10
10259036|NCT03050814|11390971|FG001|STARTED|Overall Study||16
10259037|NCT03050814|11390972|FG002|STARTED|Overall Study||4
10259038|NCT03050814|11390970|FG000|COMPLETED|Overall Study||10
10259039|NCT03050814|11390971|FG001|COMPLETED|Overall Study||16
10259040|NCT03050814|11390972|FG002|COMPLETED|Overall Study||0
10259041|NCT03050814|11390970|FG000|NOT COMPLETED|Overall Study||0
10259042|NCT03050814|11390971|FG001|NOT COMPLETED|Overall Study||0
10259043|NCT03050814|11390972|FG002|NOT COMPLETED|Overall Study||4
10259044|NCT02797262|11390980|FG000|STARTED|Overall Study||65
10259045|NCT02797262|11390981|FG001|STARTED|Overall Study||65
10259046|NCT02797262|11390980|FG000|Baseline|Overall Study||54
10259047|NCT02797262|11390981|FG001|Baseline|Overall Study||58
10259048|NCT02797262|11390980|FG000|COMPLETED|Overall Study||45
10259049|NCT02797262|11390981|FG001|COMPLETED|Overall Study||54
10259050|NCT02797262|11390980|FG000|NOT COMPLETED|Overall Study||20
10259051|NCT02797262|11390981|FG001|NOT COMPLETED|Overall Study||11
10259052|NCT02639910|11390989|FG000|STARTED|Overall Study||11
9835157|NCT00789854|10946346|FG002|NOT COMPLETED|Overall Study||47
9835158|NCT00789867|10946357|FG000|STARTED|Overall Study||17
9835159|NCT00789867|10946358|FG001|STARTED|Overall Study||10
9835160|NCT00789867|10946359|FG002|STARTED|Overall Study||8
9835161|NCT00789867|10946357|FG000|COMPLETED|Overall Study||17
9835162|NCT00789867|10946358|FG001|COMPLETED|Overall Study||10
9835163|NCT00789867|10946359|FG002|COMPLETED|Overall Study||8
9835164|NCT00789867|10946357|FG000|NOT COMPLETED|Overall Study||0
10259053|NCT02639910|11390990|FG001|STARTED|Overall Study||13
10259054|NCT02639910|11390989|FG000|COMPLETED|Overall Study||7
10259055|NCT02639910|11390990|FG001|COMPLETED|Overall Study||5
10259056|NCT02639910|11390989|FG000|NOT COMPLETED|Overall Study||4
10259057|NCT02639910|11390990|FG001|NOT COMPLETED|Overall Study||8
10259132|NCT01772004|11391058|FG007|NOT COMPLETED|Dose Escalation Phase||0
10259133|NCT01772004|11391059|FG008|NOT COMPLETED|Dose Escalation Phase||0
10259134|NCT01772004|11391060|FG009|NOT COMPLETED|Dose Escalation Phase||0
10259135|NCT01772004|11391061|FG010|NOT COMPLETED|Dose Escalation Phase||0
10259136|NCT01772004|11391062|FG011|NOT COMPLETED|Dose Escalation Phase||0
10259137|NCT01772004|11391063|FG012|NOT COMPLETED|Dose Escalation Phase||0
10259138|NCT01772004|11391064|FG013|NOT COMPLETED|Dose Escalation Phase||0
10259139|NCT01772004|11391065|FG014|NOT COMPLETED|Dose Escalation Phase||0
10259140|NCT01772004|11391066|FG015|NOT COMPLETED|Dose Escalation Phase||0
10259141|NCT01772004|11391067|FG016|NOT COMPLETED|Dose Escalation Phase||0
10259142|NCT01772004|11391068|FG017|NOT COMPLETED|Dose Escalation Phase||0
10259143|NCT01772004|11391069|FG018|NOT COMPLETED|Dose Escalation Phase||0
10259144|NCT01772004|11391070|FG019|NOT COMPLETED|Dose Escalation Phase||0
10259145|NCT01772004|11391071|FG020|NOT COMPLETED|Dose Escalation Phase||0
10259146|NCT01772004|11391072|FG021|NOT COMPLETED|Dose Escalation Phase||0
10259147|NCT01772004|11391073|FG022|NOT COMPLETED|Dose Escalation Phase||0
10259148|NCT01772004|11391051|FG000|STARTED|Dose Expansion Phase||0
10259149|NCT01772004|11391052|FG001|STARTED|Dose Expansion Phase||0
10259150|NCT01772004|11391053|FG002|STARTED|Dose Expansion Phase||0
10259151|NCT01772004|11391054|FG003|STARTED|Dose Expansion Phase||0
10259152|NCT01772004|11391055|FG004|STARTED|Dose Expansion Phase||0
10259153|NCT01772004|11391056|FG005|STARTED|Dose Expansion Phase||184
10259154|NCT01772004|11391057|FG006|STARTED|Dose Expansion Phase||156
10259155|NCT01772004|11391058|FG007|STARTED|Dose Expansion Phase||168
10259156|NCT01772004|11391059|FG008|STARTED|Dose Expansion Phase||60
10259157|NCT01772004|11391060|FG009|STARTED|Dose Expansion Phase||90
10259158|NCT01772004|11391061|FG010|STARTED|Dose Expansion Phase||21
10259159|NCT01772004|11391062|FG011|STARTED|Dose Expansion Phase||18
10259160|NCT01772004|11391063|FG012|STARTED|Dose Expansion Phase||50
10259161|NCT01772004|11391064|FG013|STARTED|Dose Expansion Phase||51
10259162|NCT01772004|11391065|FG014|STARTED|Dose Expansion Phase||53
10259163|NCT01772004|11391066|FG015|STARTED|Dose Expansion Phase||44
10259164|NCT01772004|11391067|FG016|STARTED|Dose Expansion Phase||125
10259165|NCT01772004|11391068|FG017|STARTED|Dose Expansion Phase||62
10259166|NCT01772004|11391069|FG018|STARTED|Dose Expansion Phase||20
10259167|NCT01772004|11391070|FG019|STARTED|Dose Expansion Phase||103
10259168|NCT01772004|11391071|FG020|STARTED|Dose Expansion Phase||205
10259169|NCT01772004|11391072|FG021|STARTED|Dose Expansion Phase||132
10259170|NCT01772004|11391073|FG022|STARTED|Dose Expansion Phase||153
10259171|NCT01772004|11391051|FG000|COMPLETED|Dose Expansion Phase||0
10259172|NCT01772004|11391052|FG001|COMPLETED|Dose Expansion Phase||0
10259173|NCT01772004|11391053|FG002|COMPLETED|Dose Expansion Phase||0
10259174|NCT01772004|11391054|FG003|COMPLETED|Dose Expansion Phase||0
10259175|NCT01772004|11391055|FG004|COMPLETED|Dose Expansion Phase||0
10259176|NCT01772004|11391056|FG005|COMPLETED|Dose Expansion Phase||184
10259177|NCT01772004|11391057|FG006|COMPLETED|Dose Expansion Phase||156
10259178|NCT01772004|11391058|FG007|COMPLETED|Dose Expansion Phase||168
10259179|NCT01772004|11391059|FG008|COMPLETED|Dose Expansion Phase||60
10259180|NCT01772004|11391060|FG009|COMPLETED|Dose Expansion Phase||90
10259181|NCT01772004|11391061|FG010|COMPLETED|Dose Expansion Phase||21
10259182|NCT01772004|11391062|FG011|COMPLETED|Dose Expansion Phase||18
10259183|NCT01772004|11391063|FG012|COMPLETED|Dose Expansion Phase||50
10259184|NCT01772004|11391064|FG013|COMPLETED|Dose Expansion Phase||51
10259185|NCT01772004|11391065|FG014|COMPLETED|Dose Expansion Phase||53
10259186|NCT01772004|11391066|FG015|COMPLETED|Dose Expansion Phase||44
10259187|NCT01772004|11391067|FG016|COMPLETED|Dose Expansion Phase||125
10259188|NCT01772004|11391068|FG017|COMPLETED|Dose Expansion Phase||62
10259189|NCT01772004|11391069|FG018|COMPLETED|Dose Expansion Phase||20
10259190|NCT01772004|11391070|FG019|COMPLETED|Dose Expansion Phase||103
10259191|NCT01772004|11391071|FG020|COMPLETED|Dose Expansion Phase||205
10259192|NCT01772004|11391072|FG021|COMPLETED|Dose Expansion Phase||132
10259193|NCT01772004|11391073|FG022|COMPLETED|Dose Expansion Phase||153
10259194|NCT01772004|11391051|FG000|NOT COMPLETED|Dose Expansion Phase||0
10259195|NCT01772004|11391052|FG001|NOT COMPLETED|Dose Expansion Phase||0
10259196|NCT01772004|11391053|FG002|NOT COMPLETED|Dose Expansion Phase||0
10259197|NCT01772004|11391054|FG003|NOT COMPLETED|Dose Expansion Phase||0
10259198|NCT01772004|11391055|FG004|NOT COMPLETED|Dose Expansion Phase||0
10259199|NCT01772004|11391056|FG005|NOT COMPLETED|Dose Expansion Phase||0
10259200|NCT01772004|11391057|FG006|NOT COMPLETED|Dose Expansion Phase||0
10259201|NCT01772004|11391058|FG007|NOT COMPLETED|Dose Expansion Phase||0
10259202|NCT01772004|11391059|FG008|NOT COMPLETED|Dose Expansion Phase||0
10259203|NCT01772004|11391060|FG009|NOT COMPLETED|Dose Expansion Phase||0
10259204|NCT01772004|11391061|FG010|NOT COMPLETED|Dose Expansion Phase||0
10259205|NCT01772004|11391062|FG011|NOT COMPLETED|Dose Expansion Phase||0
10259206|NCT01772004|11391063|FG012|NOT COMPLETED|Dose Expansion Phase||0
10259207|NCT01772004|11391064|FG013|NOT COMPLETED|Dose Expansion Phase||0
10259208|NCT01772004|11391065|FG014|NOT COMPLETED|Dose Expansion Phase||0
10259209|NCT01772004|11391066|FG015|NOT COMPLETED|Dose Expansion Phase||0
10259210|NCT01772004|11391067|FG016|NOT COMPLETED|Dose Expansion Phase||0
10259211|NCT01772004|11391068|FG017|NOT COMPLETED|Dose Expansion Phase||0
10259212|NCT01772004|11391069|FG018|NOT COMPLETED|Dose Expansion Phase||0
10259213|NCT01772004|11391070|FG019|NOT COMPLETED|Dose Expansion Phase||0
10259214|NCT01772004|11391071|FG020|NOT COMPLETED|Dose Expansion Phase||0
10259215|NCT01772004|11391072|FG021|NOT COMPLETED|Dose Expansion Phase||0
10259216|NCT01772004|11391073|FG022|NOT COMPLETED|Dose Expansion Phase||0
10259217|NCT01322971|11391170|FG000|STARTED|Overall Study||1
10259218|NCT01322971|11391171|FG001|STARTED|Overall Study||1
10259219|NCT01322971|11391170|FG000|COMPLETED|Overall Study||0
10259220|NCT01322971|11391171|FG001|COMPLETED|Overall Study||0
10259221|NCT01322971|11391170|FG000|NOT COMPLETED|Overall Study||1
10259222|NCT01322971|11391171|FG001|NOT COMPLETED|Overall Study||1
10259223|NCT01285102|11391177|FG000|STARTED|Overall Study||4
10259224|NCT01285102|11391177|FG000|COMPLETED|Overall Study||0
10259225|NCT01285102|11391177|FG000|NOT COMPLETED|Overall Study||4
10259226|NCT00952692|11391181|FG000|STARTED|Overall Study||12
10259227|NCT00952692|11391181|FG000|COMPLETED|Overall Study||12
10259228|NCT00952692|11391181|FG000|NOT COMPLETED|Overall Study||0
10259229|NCT00804713|11391185|FG000|STARTED|Overall Study||1978
10259230|NCT00804713|11391185|FG000|COMPLETED|Overall Study||1978
10259231|NCT00804713|11391185|FG000|NOT COMPLETED|Overall Study||0
10259232|NCT00677560|11391196|FG000|STARTED|Overall Study||20
10259233|NCT00677560|11391197|FG001|STARTED|Overall Study||23
10259234|NCT00677560|11391198|FG002|STARTED|Overall Study||29
10259235|NCT00677560|11391199|FG003|STARTED|Overall Study||20
10259236|NCT00677560|11391200|FG004|STARTED|Overall Study||34
10259237|NCT00677560|11391196|FG000|COMPLETED|Overall Study||5
10259238|NCT00677560|11391197|FG001|COMPLETED|Overall Study||13
10259239|NCT00677560|11391198|FG002|COMPLETED|Overall Study||6
10259240|NCT00677560|11391199|FG003|COMPLETED|Overall Study||3
10259241|NCT00677560|11391200|FG004|COMPLETED|Overall Study||21
10259242|NCT00677560|11391196|FG000|NOT COMPLETED|Overall Study||15
10259243|NCT00677560|11391197|FG001|NOT COMPLETED|Overall Study||10
10259244|NCT00677560|11391198|FG002|NOT COMPLETED|Overall Study||23
10259245|NCT00677560|11391199|FG003|NOT COMPLETED|Overall Study||17
10259246|NCT00677560|11391200|FG004|NOT COMPLETED|Overall Study||13
10259247|NCT00389649|11391225|FG000|STARTED|Overall Study||2
10259248|NCT00389649|11391226|FG001|STARTED|Overall Study||2
10259249|NCT00389649|11391227|FG002|STARTED|Overall Study||3
10259250|NCT00389649|11391228|FG003|STARTED|Overall Study||2
10259251|NCT00389649|11391229|FG004|STARTED|Overall Study||2
10259252|NCT00389649|11391230|FG005|STARTED|Overall Study||2
10259253|NCT00389649|11391225|FG000|COMPLETED|Overall Study||2
10259254|NCT00389649|11391226|FG001|COMPLETED|Overall Study||2
10259255|NCT00389649|11391227|FG002|COMPLETED|Overall Study||3
10259256|NCT00389649|11391228|FG003|COMPLETED|Overall Study||2
10259257|NCT00389649|11391229|FG004|COMPLETED|Overall Study||2
10259258|NCT00389649|11391230|FG005|COMPLETED|Overall Study||2
10259259|NCT00389649|11391225|FG000|NOT COMPLETED|Overall Study||0
10259260|NCT00389649|11391226|FG001|NOT COMPLETED|Overall Study||0
10259261|NCT00389649|11391227|FG002|NOT COMPLETED|Overall Study||0
10259262|NCT00389649|11391228|FG003|NOT COMPLETED|Overall Study||0
10259263|NCT00389649|11391229|FG004|NOT COMPLETED|Overall Study||0
10259264|NCT00389649|11391230|FG005|NOT COMPLETED|Overall Study||0
10259265|NCT04644328|11391240|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10020956|NCT01839656|11144252|FG001|NOT COMPLETED|Overall Study||16
10020957|NCT01839695|11144258|FG000|STARTED|Overall Study||9
10020958|NCT01839695|11144258|FG000|COMPLETED|Overall Study||9
10259266|NCT04644328|11391241|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10259267|NCT04644328|11391240|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10259268|NCT04644328|11391241|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10259269|NCT04644328|11391240|FG000|NOT COMPLETED|Thanksgiving Period||
10259270|NCT04644328|11391241|FG001|NOT COMPLETED|Thanksgiving Period||
10259271|NCT04644328|11391240|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10020959|NCT01839695|11144258|FG000|NOT COMPLETED|Overall Study||0
10020960|NCT01839708|11144264|FG000|STARTED|Overall Study||387
10020961|NCT01839708|11144265|FG001|STARTED|Overall Study||182
10020962|NCT01839708|11144264|FG000|COMPLETED|Overall Study||311
10020963|NCT01839708|11144265|FG001|COMPLETED|Overall Study||115
10020964|NCT01839708|11144264|FG000|NOT COMPLETED|Overall Study||76
10259272|NCT04644328|11391241|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10259273|NCT04644328|11391240|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10259274|NCT04644328|11391241|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10259275|NCT04644328|11391240|FG000|NOT COMPLETED|Christmas Period||
10259276|NCT04644328|11391241|FG001|NOT COMPLETED|Christmas Period||
10259277|NCT04246554|11391251|FG000|STARTED|Overall Study||26
10259278|NCT04246554|11391252|FG001|STARTED|Overall Study||23
10259279|NCT04246554|11391251|FG000|COMPLETED|Overall Study||26
10259280|NCT04246554|11391252|FG001|COMPLETED|Overall Study||22
10259281|NCT04246554|11391251|FG000|NOT COMPLETED|Overall Study||0
10259282|NCT04246554|11391252|FG001|NOT COMPLETED|Overall Study||1
10259283|NCT03877926|11391262|FG000|STARTED|Overall Study||1103
10259284|NCT03877926|11391263|FG001|STARTED|Overall Study||1103
10259285|NCT03877926|11391264|FG002|STARTED|Overall Study||1098
10259286|NCT03877926|11391265|FG003|STARTED|Overall Study||558
10259287|NCT03877926|11391262|FG000|Received at Least One Study Vaccination|Overall Study||1100
10259288|NCT03877926|11391263|FG001|Received at Least One Study Vaccination|Overall Study||1102
10259289|NCT03877926|11391264|FG002|Received at Least One Study Vaccination|Overall Study||1097
10259290|NCT03877926|11391265|FG003|Received at Least One Study Vaccination|Overall Study||558
10259291|NCT03877926|11391262|FG000|Did Not Receive Any Study Vaccination|Overall Study||3
10259292|NCT03877926|11391263|FG001|Did Not Receive Any Study Vaccination|Overall Study||1
10259293|NCT03877926|11391264|FG002|Did Not Receive Any Study Vaccination|Overall Study||1
10259294|NCT03877926|11391265|FG003|Did Not Receive Any Study Vaccination|Overall Study||0
10259295|NCT03877926|11391262|FG000|COMPLETED|Overall Study||1032
10259296|NCT03877926|11391263|FG001|COMPLETED|Overall Study||1026
10259297|NCT03877926|11391264|FG002|COMPLETED|Overall Study||1035
10259298|NCT03877926|11391265|FG003|COMPLETED|Overall Study||537
10259299|NCT03877926|11391262|FG000|NOT COMPLETED|Overall Study||71
10259300|NCT03877926|11391263|FG001|NOT COMPLETED|Overall Study||77
10259301|NCT03877926|11391264|FG002|NOT COMPLETED|Overall Study||63
10259302|NCT03877926|11391265|FG003|NOT COMPLETED|Overall Study||21
10259303|NCT03862807|11391288|FG000|STARTED|Overall Study||24
10259304|NCT03862807|11391288|FG000|Treated|Overall Study||23
10259305|NCT03862807|11391288|FG000|Completed Treatment|Overall Study||22
10259306|NCT03862807|11391288|FG000|COMPLETED|Overall Study||23
10259307|NCT03862807|11391288|FG000|NOT COMPLETED|Overall Study||1
10259308|NCT03857867|11391292|FG000|STARTED|Overall Study||7
10259309|NCT03857867|11391292|FG000|COMPLETED|Overall Study||6
10259310|NCT03857867|11391292|FG000|NOT COMPLETED|Overall Study||1
10259311|NCT03691571|11391299|FG000|STARTED|Overall Study||31
10259312|NCT03691571|11391300|FG001|STARTED|Overall Study||24
10259313|NCT03691571|11391299|FG000|COMPLETED|Overall Study||22
10259314|NCT03691571|11391300|FG001|COMPLETED|Overall Study||22
10259315|NCT03691571|11391299|FG000|NOT COMPLETED|Overall Study||9
10259316|NCT03691571|11391300|FG001|NOT COMPLETED|Overall Study||2
10259317|NCT03436199|11391310|FG000|STARTED|Overall Study||187
10259318|NCT03436199|11391311|FG001|STARTED|Overall Study||185
10259319|NCT03436199|11391312|FG002|STARTED|Overall Study||186
10259320|NCT03436199|11391310|FG000|COMPLETED|Overall Study||165
10259321|NCT03436199|11391311|FG001|COMPLETED|Overall Study||132
10259322|NCT03436199|11391312|FG002|COMPLETED|Overall Study||174
10259323|NCT03436199|11391310|FG000|NOT COMPLETED|Overall Study||22
10259324|NCT03436199|11391311|FG001|NOT COMPLETED|Overall Study||53
10259325|NCT03436199|11391312|FG002|NOT COMPLETED|Overall Study||12
10259326|NCT03353233|11391322|FG000|STARTED|Overall Study||25
10259327|NCT03353233|11391323|FG001|STARTED|Overall Study||25
10259328|NCT03353233|11391322|FG000|COMPLETED|Overall Study||25
10259329|NCT03353233|11391323|FG001|COMPLETED|Overall Study||25
10259330|NCT03353233|11391322|FG000|NOT COMPLETED|Overall Study||0
10259331|NCT03353233|11391323|FG001|NOT COMPLETED|Overall Study||0
10259332|NCT03250273|11391331|FG000|STARTED|Overall Study||13
10259333|NCT03250273|11391332|FG001|STARTED|Overall Study||30
10259334|NCT03250273|11391331|FG000|COMPLETED|Overall Study||11
10259335|NCT03250273|11391332|FG001|COMPLETED|Overall Study||18
10259336|NCT03250273|11391331|FG000|NOT COMPLETED|Overall Study||2
10259337|NCT03250273|11391332|FG001|NOT COMPLETED|Overall Study||12
10259338|NCT03217136|11391340|FG000|STARTED|Overall Study||71
10259339|NCT03217136|11391341|FG001|STARTED|Overall Study||23
10259340|NCT03217136|11391340|FG000|Treated|Overall Study||70
10259341|NCT03217136|11391341|FG001|Treated|Overall Study||21
10259342|NCT03217136|11391340|FG000|COMPLETED|Overall Study||67
10259343|NCT03217136|11391341|FG001|COMPLETED|Overall Study||20
10259344|NCT03217136|11391340|FG000|NOT COMPLETED|Overall Study||4
10259345|NCT03217136|11391341|FG001|NOT COMPLETED|Overall Study||3
10259346|NCT03181542|11391349|FG000|STARTED|Overall Study||80
10259347|NCT03181542|11391350|FG001|STARTED|Overall Study||80
10259348|NCT03181542|11391349|FG000|COMPLETED|Overall Study||79
10259349|NCT03181542|11391350|FG001|COMPLETED|Overall Study||80
10259350|NCT03181542|11391349|FG000|NOT COMPLETED|Overall Study||1
10259351|NCT03181542|11391350|FG001|NOT COMPLETED|Overall Study||0
10259352|NCT04458467|11391358|FG000|STARTED|Overall Study||35
10259353|NCT04458467|11391359|FG001|STARTED|Overall Study||35
10259354|NCT04458467|11391358|FG000|COMPLETED|Overall Study||35
10259355|NCT04458467|11391359|FG001|COMPLETED|Overall Study||35
10259356|NCT04458467|11391358|FG000|NOT COMPLETED|Overall Study||0
10259357|NCT04458467|11391359|FG001|NOT COMPLETED|Overall Study||0
10259358|NCT04411082|11391371|FG000|STARTED|Overall Study||29
10259359|NCT04411082|11391372|FG001|STARTED|Overall Study||25
10259360|NCT04411082|11391373|FG002|STARTED|Overall Study||20
10259361|NCT04411082|11391374|FG003|STARTED|Overall Study||24
10259362|NCT04411082|11391375|FG004|STARTED|Overall Study||12
10259363|NCT04411082|11391376|FG005|STARTED|Overall Study||12
10259364|NCT04411082|11391371|FG000|COMPLETED|Overall Study||18
10259365|NCT04411082|11391372|FG001|COMPLETED|Overall Study||16
10259366|NCT04411082|11391373|FG002|COMPLETED|Overall Study||16
10259367|NCT04411082|11391374|FG003|COMPLETED|Overall Study||10
10259368|NCT04411082|11391375|FG004|COMPLETED|Overall Study||8
10259369|NCT04411082|11391376|FG005|COMPLETED|Overall Study||6
10259370|NCT04411082|11391371|FG000|NOT COMPLETED|Overall Study||11
10259371|NCT04411082|11391372|FG001|NOT COMPLETED|Overall Study||9
10259372|NCT04411082|11391373|FG002|NOT COMPLETED|Overall Study||4
10259373|NCT04411082|11391374|FG003|NOT COMPLETED|Overall Study||14
10259374|NCT04411082|11391375|FG004|NOT COMPLETED|Overall Study||4
10259375|NCT04411082|11391376|FG005|NOT COMPLETED|Overall Study||6
10259376|NCT04100590|11391393|FG000|STARTED|Overall Study||1
10259377|NCT04100590|11391393|FG000|COMPLETED|Overall Study||1
10259378|NCT04100590|11391393|FG000|NOT COMPLETED|Overall Study||0
10259379|NCT03985293|11391405|FG000|STARTED|DOUBLE-BLIND TREATMENT||66
10259380|NCT03985293|11391406|FG001|STARTED|DOUBLE-BLIND TREATMENT||68
10259381|NCT03985293|11391407|FG002|STARTED|DOUBLE-BLIND TREATMENT||68
10259382|NCT03985293|11391408|FG003|STARTED|DOUBLE-BLIND TREATMENT||71
10259383|NCT03985293|11391409|FG004|STARTED|DOUBLE-BLIND TREATMENT||67
10259384|NCT03985293|11391410|FG005|STARTED|DOUBLE-BLIND TREATMENT||71
10259385|NCT03985293|11391405|FG000|COMPLETED|DOUBLE-BLIND TREATMENT||57
10259386|NCT03985293|11391406|FG001|COMPLETED|DOUBLE-BLIND TREATMENT||54
10259387|NCT03985293|11391407|FG002|COMPLETED|DOUBLE-BLIND TREATMENT||63
10259388|NCT03985293|11391408|FG003|COMPLETED|DOUBLE-BLIND TREATMENT||57
10259389|NCT03985293|11391409|FG004|COMPLETED|DOUBLE-BLIND TREATMENT||47
10259390|NCT03985293|11391410|FG005|COMPLETED|DOUBLE-BLIND TREATMENT||38
10259391|NCT03985293|11391405|FG000|NOT COMPLETED|DOUBLE-BLIND TREATMENT||9
10259392|NCT03985293|11391406|FG001|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14
10259393|NCT03985293|11391407|FG002|NOT COMPLETED|DOUBLE-BLIND TREATMENT||5
10259394|NCT03985293|11391408|FG003|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14
10259395|NCT03985293|11391409|FG004|NOT COMPLETED|DOUBLE-BLIND TREATMENT||20
10259396|NCT03985293|11391410|FG005|NOT COMPLETED|DOUBLE-BLIND TREATMENT||33
10259397|NCT03985293|11391405|FG000|STARTED|FOLLOW-UP||57
10259398|NCT03985293|11391406|FG001|STARTED|FOLLOW-UP||54
10259399|NCT03985293|11391407|FG002|STARTED|FOLLOW-UP||63
10259400|NCT03985293|11391408|FG003|STARTED|FOLLOW-UP||57
10259401|NCT03985293|11391409|FG004|STARTED|FOLLOW-UP||47
10259402|NCT03985293|11391410|FG005|STARTED|FOLLOW-UP||38
10259403|NCT03985293|11391405|FG000|COMPLETED|FOLLOW-UP||57
10259404|NCT03985293|11391406|FG001|COMPLETED|FOLLOW-UP||54
10259405|NCT03985293|11391407|FG002|COMPLETED|FOLLOW-UP||62
10259406|NCT03985293|11391408|FG003|COMPLETED|FOLLOW-UP||57
10259407|NCT03985293|11391409|FG004|COMPLETED|FOLLOW-UP||47
10259408|NCT03985293|11391410|FG005|COMPLETED|FOLLOW-UP||38
10259409|NCT03985293|11391405|FG000|NOT COMPLETED|FOLLOW-UP||0
10259410|NCT03985293|11391406|FG001|NOT COMPLETED|FOLLOW-UP||0
10259411|NCT03985293|11391407|FG002|NOT COMPLETED|FOLLOW-UP||1
10259412|NCT03985293|11391408|FG003|NOT COMPLETED|FOLLOW-UP||0
10259413|NCT03985293|11391409|FG004|NOT COMPLETED|FOLLOW-UP||0
10259414|NCT03985293|11391410|FG005|NOT COMPLETED|FOLLOW-UP||0
10259415|NCT03846427|11391424|FG000|STARTED|Overall Study||68
10259416|NCT03846427|11391424|FG000|COMPLETED|Overall Study||0
10259417|NCT03846427|11391424|FG000|NOT COMPLETED|Overall Study||68
10259418|NCT03785340|11391430|FG000|STARTED|Overall Study||126
10259419|NCT03785340|11391431|FG001|STARTED|Overall Study||126
10259420|NCT03785340|11391430|FG000|Received at Least 1 Study Treatment|Overall Study||126
10259421|NCT03785340|11391431|FG001|Received at Least 1 Study Treatment|Overall Study||126
10259422|NCT03785340|11391430|FG000|COMPLETED|Overall Study||123
10259423|NCT03785340|11391431|FG001|COMPLETED|Overall Study||126
10259424|NCT03785340|11391430|FG000|NOT COMPLETED|Overall Study||3
10259425|NCT03785340|11391431|FG001|NOT COMPLETED|Overall Study||0
10259426|NCT03776357|11391437|FG000|STARTED|Overall Study||9
10259427|NCT03776357|11391437|FG000|COMPLETED|Overall Study||6
10259428|NCT03776357|11391437|FG000|NOT COMPLETED|Overall Study||3
10259429|NCT03656068|11391441|FG000|STARTED|Overall Study||21
10259430|NCT03656068|11391441|FG000|COMPLETED|Overall Study||16
10259431|NCT03656068|11391441|FG000|NOT COMPLETED|Overall Study||5
10259432|NCT03595982|11391447|FG000|STARTED|Overall Study||3
10259433|NCT03595982|11391448|FG001|STARTED|Overall Study||2
10259434|NCT03595982|11391447|FG000|COMPLETED|Overall Study||3
10259435|NCT03595982|11391448|FG001|COMPLETED|Overall Study||2
10259436|NCT03595982|11391447|FG000|NOT COMPLETED|Overall Study||0
10259437|NCT03595982|11391448|FG001|NOT COMPLETED|Overall Study||0
10259438|NCT03400956|11391457|FG000|STARTED|Treatment Period 1||35
10259439|NCT03400956|11391458|FG001|STARTED|Treatment Period 1||34
10259440|NCT03400956|11391459|FG002|STARTED|Treatment Period 1||34
10259441|NCT03400956|11391457|FG000|Treated|Treatment Period 1||31
10259442|NCT03400956|11391458|FG001|Treated|Treatment Period 1||30
10259443|NCT03400956|11391459|FG002|Treated|Treatment Period 1||30
10259444|NCT03400956|11391457|FG000|FAS|Treatment Period 1||32
10259445|NCT03400956|11391458|FG001|FAS|Treatment Period 1||33
10259446|NCT03400956|11391459|FG002|FAS|Treatment Period 1||31
10259447|NCT03400956|11391457|FG000|COMPLETED|Treatment Period 1||31
10259448|NCT03400956|11391458|FG001|COMPLETED|Treatment Period 1||26
10259449|NCT03400956|11391459|FG002|COMPLETED|Treatment Period 1||25
10259450|NCT03400956|11391457|FG000|NOT COMPLETED|Treatment Period 1||4
10259451|NCT03400956|11391458|FG001|NOT COMPLETED|Treatment Period 1||8
10259452|NCT03400956|11391459|FG002|NOT COMPLETED|Treatment Period 1||9
10259453|NCT03400956|11391457|FG000|STARTED|Post-treatment Period 1||31
10259454|NCT03400956|11391458|FG001|STARTED|Post-treatment Period 1||26
10259455|NCT03400956|11391459|FG002|STARTED|Post-treatment Period 1||25
10259456|NCT03400956|11391457|FG000|COMPLETED|Post-treatment Period 1||9
10259457|NCT03400956|11391458|FG001|COMPLETED|Post-treatment Period 1||10
10259458|NCT03400956|11391459|FG002|COMPLETED|Post-treatment Period 1||9
10259459|NCT03400956|11391457|FG000|NOT COMPLETED|Post-treatment Period 1||22
10259460|NCT03400956|11391458|FG001|NOT COMPLETED|Post-treatment Period 1||16
9835165|NCT00789867|10946358|FG001|NOT COMPLETED|Overall Study||0
9835166|NCT00789867|10946359|FG002|NOT COMPLETED|Overall Study||0
9835167|NCT00789880|10946374|FG000|STARTED|Overall Study||16
9835168|NCT00789880|10946375|FG001|STARTED|Overall Study||16
9835169|NCT00789880|10946376|FG002|STARTED|Overall Study||8
9835170|NCT00789880|10946377|FG003|STARTED|Overall Study||16
9835171|NCT00789880|10946378|FG004|STARTED|Overall Study||18
9835172|NCT00789880|10946379|FG005|STARTED|Overall Study||8
9835173|NCT00789880|10946374|FG000|COMPLETED|Overall Study||15
10020965|NCT01839708|11144265|FG001|NOT COMPLETED|Overall Study||67
10259461|NCT03400956|11391459|FG002|NOT COMPLETED|Post-treatment Period 1||16
10259462|NCT03400956|11391457|FG000|STARTED|Treatment Period 2||9
10259463|NCT03400956|11391458|FG001|STARTED|Treatment Period 2||10
10259464|NCT03400956|11391459|FG002|STARTED|Treatment Period 2||9
10259465|NCT03400956|11391457|FG000|COMPLETED|Treatment Period 2||5
10259466|NCT03400956|11391458|FG001|COMPLETED|Treatment Period 2||7
10259467|NCT03400956|11391459|FG002|COMPLETED|Treatment Period 2||5
10259468|NCT03400956|11391457|FG000|NOT COMPLETED|Treatment Period 2||4
10259469|NCT03400956|11391458|FG001|NOT COMPLETED|Treatment Period 2||3
10259470|NCT03400956|11391459|FG002|NOT COMPLETED|Treatment Period 2||4
10259471|NCT03400956|11391457|FG000|STARTED|Follow-up Period||6
9835174|NCT00789880|10946375|FG001|COMPLETED|Overall Study||15
9835175|NCT00789880|10946376|FG002|COMPLETED|Overall Study||8
10259472|NCT03400956|11391458|FG001|STARTED|Follow-up Period||9
10259473|NCT03400956|11391459|FG002|STARTED|Follow-up Period||7
10259474|NCT03400956|11391457|FG000|COMPLETED|Follow-up Period||6
10259475|NCT03400956|11391458|FG001|COMPLETED|Follow-up Period||9
10259476|NCT03400956|11391459|FG002|COMPLETED|Follow-up Period||5
10259477|NCT03400956|11391457|FG000|NOT COMPLETED|Follow-up Period||0
10259478|NCT03400956|11391458|FG001|NOT COMPLETED|Follow-up Period||0
10259479|NCT03400956|11391459|FG002|NOT COMPLETED|Follow-up Period||2
10259480|NCT03338790|11391474|FG000|STARTED|Overall Study||88
10259481|NCT03338790|11391475|FG001|STARTED|Overall Study||71
10259482|NCT03338790|11391476|FG002|STARTED|Overall Study||84
10259483|NCT03338790|11391477|FG003|STARTED|Overall Study||49
10259484|NCT03338790|11391474|FG000|COMPLETED|Overall Study||4
10259485|NCT03338790|11391475|FG001|COMPLETED|Overall Study||4
10259486|NCT03338790|11391476|FG002|COMPLETED|Overall Study||8
10259487|NCT03338790|11391477|FG003|COMPLETED|Overall Study||4
10259488|NCT03338790|11391474|FG000|NOT COMPLETED|Overall Study||84
10259489|NCT03338790|11391475|FG001|NOT COMPLETED|Overall Study||67
10259490|NCT03338790|11391476|FG002|NOT COMPLETED|Overall Study||76
10259491|NCT03338790|11391477|FG003|NOT COMPLETED|Overall Study||45
10259492|NCT03126539|11391489|FG000|STARTED|Overall Study||9
10259493|NCT03126539|11391490|FG001|STARTED|Overall Study||9
10259494|NCT03126539|11391491|FG002|STARTED|Overall Study||9
10259495|NCT03126539|11391492|FG003|STARTED|Overall Study|Group B was not done|0
10259496|NCT03126539|11391493|FG004|STARTED|Overall Study||0
10259497|NCT03126539|11391489|FG000|COMPLETED|Overall Study||8
10259498|NCT03126539|11391490|FG001|COMPLETED|Overall Study||8
10259499|NCT03126539|11391491|FG002|COMPLETED|Overall Study||8
10259500|NCT03126539|11391492|FG003|COMPLETED|Overall Study||0
10259501|NCT03126539|11391493|FG004|COMPLETED|Overall Study||0
10259502|NCT03126539|11391489|FG000|NOT COMPLETED|Overall Study||1
10259503|NCT03126539|11391490|FG001|NOT COMPLETED|Overall Study||1
10259504|NCT03126539|11391491|FG002|NOT COMPLETED|Overall Study||1
10259505|NCT03126539|11391492|FG003|NOT COMPLETED|Overall Study||0
10259506|NCT03126539|11391493|FG004|NOT COMPLETED|Overall Study||0
10259507|NCT03057613|11391506|FG000|STARTED|Overall Study||18
10259508|NCT03057613|11391506|FG000|COMPLETED|Overall Study||18
10259509|NCT03057613|11391506|FG000|NOT COMPLETED|Overall Study||0
10259510|NCT02898259|11391515|FG000|STARTED|Overall Study||3
10259511|NCT02898259|11391516|FG001|STARTED|Overall Study||3
10259512|NCT02898259|11391517|FG002|STARTED|Overall Study||6
10259513|NCT02898259|11391518|FG003|STARTED|Overall Study||7
10259514|NCT02898259|11391519|FG004|STARTED|Overall Study||0
10259515|NCT02898259|11391515|FG000|COMPLETED|Overall Study||2
10259516|NCT02898259|11391516|FG001|COMPLETED|Overall Study||2
10259517|NCT02898259|11391517|FG002|COMPLETED|Overall Study||1
10259518|NCT02898259|11391518|FG003|COMPLETED|Overall Study||6
10259519|NCT02898259|11391519|FG004|COMPLETED|Overall Study||0
10259520|NCT02898259|11391515|FG000|NOT COMPLETED|Overall Study||1
10259521|NCT02898259|11391516|FG001|NOT COMPLETED|Overall Study||1
10259522|NCT02898259|11391517|FG002|NOT COMPLETED|Overall Study||5
10259523|NCT02898259|11391518|FG003|NOT COMPLETED|Overall Study||1
10259524|NCT02898259|11391519|FG004|NOT COMPLETED|Overall Study||0
10259525|NCT02830594|11391532|FG000|STARTED|Overall Study||14
10259526|NCT02830594|11391532|FG000|COMPLETED|Overall Study||14
10259527|NCT02830594|11391532|FG000|NOT COMPLETED|Overall Study||0
10259528|NCT02819635|11391544|FG000|STARTED|Substudy 1 and Substudy 2, Part 1||46
10259529|NCT02819635|11391545|FG001|STARTED|Substudy 1 and Substudy 2, Part 1||47
10259530|NCT02819635|11391546|FG002|STARTED|Substudy 1 and Substudy 2, Part 1||49
10259531|NCT02819635|11391547|FG003|STARTED|Substudy 1 and Substudy 2, Part 1||117
10259532|NCT02819635|11391548|FG004|STARTED|Substudy 1 and Substudy 2, Part 1||123
10259533|NCT02819635|11391549|FG005|STARTED|Substudy 1 and Substudy 2, Part 1||155
10259534|NCT02819635|11391550|FG006|STARTED|Substudy 1 and Substudy 2, Part 1||319
10259535|NCT02819635|11391551|FG007|STARTED|Substudy 1 and Substudy 2, Part 1||446
10259536|NCT02819635|11391552|FG008|STARTED|Substudy 1 and Substudy 2, Part 1||0
10259537|NCT02819635|11391553|FG009|STARTED|Substudy 1 and Substudy 2, Part 1||0
10259538|NCT02819635|11391554|FG010|STARTED|Substudy 1 and Substudy 2, Part 1||0
10259539|NCT02819635|11391555|FG011|STARTED|Substudy 1 and Substudy 2, Part 1||0
10259540|NCT02819635|11391544|FG000|COMPLETED|Substudy 1 and Substudy 2, Part 1||41
10259541|NCT02819635|11391545|FG001|COMPLETED|Substudy 1 and Substudy 2, Part 1||45
10259542|NCT02819635|11391546|FG002|COMPLETED|Substudy 1 and Substudy 2, Part 1||45
10259543|NCT02819635|11391547|FG003|COMPLETED|Substudy 1 and Substudy 2, Part 1||105
10259544|NCT02819635|11391548|FG004|COMPLETED|Substudy 1 and Substudy 2, Part 1||113
10259545|NCT02819635|11391549|FG005|COMPLETED|Substudy 1 and Substudy 2, Part 1||135
10259546|NCT02819635|11391550|FG006|COMPLETED|Substudy 1 and Substudy 2, Part 1||306
10259547|NCT02819635|11391551|FG007|COMPLETED|Substudy 1 and Substudy 2, Part 1||446
10259548|NCT02819635|11391552|FG008|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259549|NCT02819635|11391553|FG009|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259550|NCT02819635|11391554|FG010|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259551|NCT02819635|11391555|FG011|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259552|NCT02819635|11391544|FG000|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||5
10259553|NCT02819635|11391545|FG001|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||2
10259554|NCT02819635|11391546|FG002|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||4
10259555|NCT02819635|11391547|FG003|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||12
10259556|NCT02819635|11391548|FG004|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||10
10259557|NCT02819635|11391549|FG005|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||20
10259558|NCT02819635|11391550|FG006|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||13
10259559|NCT02819635|11391551|FG007|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259560|NCT02819635|11391552|FG008|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259561|NCT02819635|11391553|FG009|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259562|NCT02819635|11391554|FG010|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259563|NCT02819635|11391555|FG011|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10259564|NCT02819635|11391544|FG000|STARTED|Substudy 2, Part 2||0
10259565|NCT02819635|11391545|FG001|STARTED|Substudy 2, Part 2||0
10259566|NCT02819635|11391546|FG002|STARTED|Substudy 2, Part 2||0
10259567|NCT02819635|11391547|FG003|STARTED|Substudy 2, Part 2||0
10259568|NCT02819635|11391548|FG004|STARTED|Substudy 2, Part 2||0
10259569|NCT02819635|11391549|FG005|STARTED|Substudy 2, Part 2||85
10259570|NCT02819635|11391550|FG006|STARTED|Substudy 2, Part 2||59
10259571|NCT02819635|11391551|FG007|STARTED|Substudy 2, Part 2||0
10259572|NCT02819635|11391552|FG008|STARTED|Substudy 2, Part 2||0
10259573|NCT02819635|11391553|FG009|STARTED|Substudy 2, Part 2||0
10259574|NCT02819635|11391554|FG010|STARTED|Substudy 2, Part 2||0
10259575|NCT02819635|11391555|FG011|STARTED|Substudy 2, Part 2||0
10259576|NCT02819635|11391544|FG000|COMPLETED|Substudy 2, Part 2||0
10259577|NCT02819635|11391545|FG001|COMPLETED|Substudy 2, Part 2||0
10259578|NCT02819635|11391546|FG002|COMPLETED|Substudy 2, Part 2||0
10259579|NCT02819635|11391547|FG003|COMPLETED|Substudy 2, Part 2||0
10259580|NCT02819635|11391548|FG004|COMPLETED|Substudy 2, Part 2||0
10259581|NCT02819635|11391549|FG005|COMPLETED|Substudy 2, Part 2||74
10259582|NCT02819635|11391550|FG006|COMPLETED|Substudy 2, Part 2||47
10259583|NCT02819635|11391551|FG007|COMPLETED|Substudy 2, Part 2||0
10259584|NCT02819635|11391552|FG008|COMPLETED|Substudy 2, Part 2||0
10259585|NCT02819635|11391553|FG009|COMPLETED|Substudy 2, Part 2||0
10259586|NCT02819635|11391554|FG010|COMPLETED|Substudy 2, Part 2||0
10259587|NCT02819635|11391555|FG011|COMPLETED|Substudy 2, Part 2||0
10259588|NCT02819635|11391544|FG000|NOT COMPLETED|Substudy 2, Part 2||0
10259589|NCT02819635|11391545|FG001|NOT COMPLETED|Substudy 2, Part 2||0
10259590|NCT02819635|11391546|FG002|NOT COMPLETED|Substudy 2, Part 2||0
10259591|NCT02819635|11391547|FG003|NOT COMPLETED|Substudy 2, Part 2||0
10259592|NCT02819635|11391548|FG004|NOT COMPLETED|Substudy 2, Part 2||0
10259593|NCT02819635|11391549|FG005|NOT COMPLETED|Substudy 2, Part 2||11
10259594|NCT02819635|11391550|FG006|NOT COMPLETED|Substudy 2, Part 2||12
10259595|NCT02819635|11391551|FG007|NOT COMPLETED|Substudy 2, Part 2||0
10259596|NCT02819635|11391552|FG008|NOT COMPLETED|Substudy 2, Part 2||0
10259597|NCT02819635|11391553|FG009|NOT COMPLETED|Substudy 2, Part 2||0
10259598|NCT02819635|11391554|FG010|NOT COMPLETED|Substudy 2, Part 2||0
10259599|NCT02819635|11391555|FG011|NOT COMPLETED|Substudy 2, Part 2||0
10259600|NCT02819635|11391544|FG000|STARTED|Substudy 3||0
10259601|NCT02819635|11391545|FG001|STARTED|Substudy 3||0
10259602|NCT02819635|11391546|FG002|STARTED|Substudy 3||0
10259603|NCT02819635|11391547|FG003|STARTED|Substudy 3||0
10259604|NCT02819635|11391548|FG004|STARTED|Substudy 3||0
10259605|NCT02819635|11391549|FG005|STARTED|Substudy 3||0
10259606|NCT02819635|11391550|FG006|STARTED|Substudy 3||0
10259607|NCT02819635|11391551|FG007|STARTED|Substudy 3||0
10259608|NCT02819635|11391552|FG008|STARTED|Substudy 3||386
10259609|NCT02819635|11391553|FG009|STARTED|Substudy 3||20
10259610|NCT02819635|11391554|FG010|STARTED|Substudy 3||324
10259611|NCT02819635|11391555|FG011|STARTED|Substudy 3||316
10259612|NCT02819635|11391544|FG000|COMPLETED|Substudy 3||0
10259613|NCT02819635|11391545|FG001|COMPLETED|Substudy 3||0
10259614|NCT02819635|11391546|FG002|COMPLETED|Substudy 3||0
10259615|NCT02819635|11391547|FG003|COMPLETED|Substudy 3||0
10259616|NCT02819635|11391548|FG004|COMPLETED|Substudy 3||0
10259617|NCT02819635|11391549|FG005|COMPLETED|Substudy 3||0
10259618|NCT02819635|11391550|FG006|COMPLETED|Substudy 3||0
10259619|NCT02819635|11391551|FG007|COMPLETED|Substudy 3||0
10259620|NCT02819635|11391552|FG008|COMPLETED|Substudy 3||140
10259621|NCT02819635|11391553|FG009|COMPLETED|Substudy 3||11
10259622|NCT02819635|11391554|FG010|COMPLETED|Substudy 3||218
10259623|NCT02819635|11391555|FG011|COMPLETED|Substudy 3||248
10259624|NCT02819635|11391544|FG000|NOT COMPLETED|Substudy 3||0
10259625|NCT02819635|11391545|FG001|NOT COMPLETED|Substudy 3||0
10259626|NCT02819635|11391546|FG002|NOT COMPLETED|Substudy 3||0
10259627|NCT02819635|11391547|FG003|NOT COMPLETED|Substudy 3||0
10259628|NCT02819635|11391548|FG004|NOT COMPLETED|Substudy 3||0
10259629|NCT02819635|11391549|FG005|NOT COMPLETED|Substudy 3||0
10259630|NCT02819635|11391550|FG006|NOT COMPLETED|Substudy 3||0
10259631|NCT02819635|11391551|FG007|NOT COMPLETED|Substudy 3||0
10259632|NCT02819635|11391552|FG008|NOT COMPLETED|Substudy 3||246
10259633|NCT02819635|11391553|FG009|NOT COMPLETED|Substudy 3||9
10259634|NCT02819635|11391554|FG010|NOT COMPLETED|Substudy 3||106
10259635|NCT02819635|11391555|FG011|NOT COMPLETED|Substudy 3||68
10259636|NCT02756013|11391583|FG000|STARTED|Overall Study||3
10259637|NCT02756013|11391583|FG000|COMPLETED|Overall Study||1
10259638|NCT02756013|11391583|FG000|NOT COMPLETED|Overall Study||2
10259639|NCT02681614|11391587|FG000|STARTED|Overall Study||5
10259640|NCT02681614|11391587|FG000|COMPLETED|Overall Study||5
10259641|NCT02681614|11391587|FG000|NOT COMPLETED|Overall Study||0
10259642|NCT02667067|11391594|FG000|STARTED|Overall Study||117
10259643|NCT02667067|11391595|FG001|STARTED|Overall Study||150
10259644|NCT02667067|11391594|FG000|COMPLETED|Overall Study||96
10259645|NCT02667067|11391595|FG001|COMPLETED|Overall Study||139
10259646|NCT02667067|11391594|FG000|NOT COMPLETED|Overall Study||21
10259647|NCT02667067|11391595|FG001|NOT COMPLETED|Overall Study||11
10259648|NCT02601209|11391609|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10259649|NCT02601209|11391610|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10259650|NCT02601209|11391611|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10259651|NCT02601209|11391612|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
10259652|NCT02601209|11391613|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
10259653|NCT02601209|11391614|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
10259654|NCT02601209|11391615|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
10259655|NCT02601209|11391616|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
10259656|NCT02601209|11391617|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
10259657|NCT02601209|11391609|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10259658|NCT02601209|11391610|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10259659|NCT02601209|11391611|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10259660|NCT02601209|11391612|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
10259661|NCT02601209|11391613|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
10259662|NCT02601209|11391614|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
10259663|NCT02601209|11391615|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
10259664|NCT02601209|11391616|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
10259665|NCT02601209|11391617|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
10259666|NCT02601209|11391609|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10259667|NCT02601209|11391610|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10259668|NCT02601209|11391611|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10259669|NCT02601209|11391612|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10259670|NCT02601209|11391613|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10259671|NCT02601209|11391614|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
10259672|NCT02601209|11391615|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10259673|NCT02601209|11391616|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10259674|NCT02601209|11391617|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10259675|NCT02601209|11391609|FG000|STARTED|Optional Crossover (Up to 2 Months)||0
10259676|NCT02601209|11391610|FG001|STARTED|Optional Crossover (Up to 2 Months)||0
10259677|NCT02601209|11391611|FG002|STARTED|Optional Crossover (Up to 2 Months)||0
10259678|NCT02601209|11391612|FG003|STARTED|Optional Crossover (Up to 2 Months)||0
10259679|NCT02601209|11391613|FG004|STARTED|Optional Crossover (Up to 2 Months)||0
10259680|NCT02601209|11391614|FG005|STARTED|Optional Crossover (Up to 2 Months)||0
10259681|NCT02601209|11391615|FG006|STARTED|Optional Crossover (Up to 2 Months)||0
10259682|NCT02601209|11391616|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
10259683|NCT02601209|11391617|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
10259684|NCT02601209|11391609|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0
10259685|NCT02601209|11391610|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0
10259686|NCT02601209|11391611|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0
10259687|NCT02601209|11391612|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0
10259688|NCT02601209|11391613|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0
10259689|NCT02601209|11391614|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0
10259690|NCT02601209|11391615|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0
10259691|NCT02601209|11391616|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
10259692|NCT02601209|11391617|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
10259693|NCT02601209|11391609|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10259694|NCT02601209|11391610|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10259695|NCT02601209|11391611|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10259696|NCT02601209|11391612|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10259697|NCT02601209|11391613|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10259698|NCT02601209|11391614|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10259699|NCT02601209|11391615|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10259700|NCT02601209|11391616|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
10259701|NCT02601209|11391617|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
10259702|NCT02551718|11391631|FG000|STARTED|Overall Study||34
10259703|NCT02551718|11391631|FG000|COMPLETED|Overall Study||34
10259704|NCT02551718|11391631|FG000|NOT COMPLETED|Overall Study||0
10259705|NCT02419807|11391636|FG000|STARTED|Overall Study||102
10259706|NCT02419807|11391636|FG000|COMPLETED|Overall Study||92
10259707|NCT02419807|11391636|FG000|NOT COMPLETED|Overall Study||10
10259708|NCT02278120|11391642|FG000|STARTED|Overall Study||335
10259709|NCT02278120|11391643|FG001|STARTED|Overall Study||337
10259710|NCT02278120|11391642|FG000|COMPLETED|Overall Study||174
10259711|NCT02278120|11391643|FG001|COMPLETED|Overall Study||121
10259712|NCT02278120|11391642|FG000|NOT COMPLETED|Overall Study||161
10259713|NCT02278120|11391643|FG001|NOT COMPLETED|Overall Study||216
10259714|NCT02242942|11391652|FG000|STARTED|Overall Study||216
10259715|NCT02242942|11391653|FG001|STARTED|Overall Study||216
10259716|NCT02242942|11391654|FG002|STARTED|Overall Study||13
10259717|NCT02242942|11391652|FG000|Treated|Overall Study||214
10259718|NCT02242942|11391653|FG001|Treated|Overall Study||212
10259719|NCT02242942|11391654|FG002|Treated|Overall Study||13
10259720|NCT02242942|11391652|FG000|COMPLETED|Overall Study||0
10259721|NCT02242942|11391653|FG001|COMPLETED|Overall Study||0
10259722|NCT02242942|11391654|FG002|COMPLETED|Overall Study||0
10259723|NCT02242942|11391652|FG000|NOT COMPLETED|Overall Study||216
10259724|NCT02242942|11391653|FG001|NOT COMPLETED|Overall Study||216
10259725|NCT02242942|11391654|FG002|NOT COMPLETED|Overall Study||13
10259726|NCT02231749|11391666|FG000|STARTED|Overall Study||550
10259727|NCT02231749|11391667|FG001|STARTED|Overall Study||546
10259728|NCT02231749|11391666|FG000|Received Treatment|Overall Study||547
10259729|NCT02231749|11391667|FG001|Received Treatment|Overall Study||535
10259730|NCT02231749|11391666|FG000|COMPLETED|Overall Study||128
10259731|NCT02231749|11391667|FG001|COMPLETED|Overall Study||97
10259732|NCT02231749|11391666|FG000|NOT COMPLETED|Overall Study||422
10259733|NCT02231749|11391667|FG001|NOT COMPLETED|Overall Study||449
10259734|NCT02227199|11391676|FG000|STARTED|Overall Study||3
10259735|NCT02227199|11391677|FG001|STARTED|Overall Study||3
10259736|NCT02227199|11391678|FG002|STARTED|Overall Study||39
10259737|NCT02227199|11391676|FG000|COMPLETED|Overall Study||3
10259738|NCT02227199|11391677|FG001|COMPLETED|Overall Study||3
10259739|NCT02227199|11391678|FG002|COMPLETED|Overall Study||35
10259740|NCT02227199|11391676|FG000|NOT COMPLETED|Overall Study||0
10259741|NCT02227199|11391677|FG001|NOT COMPLETED|Overall Study||0
10259742|NCT02227199|11391678|FG002|NOT COMPLETED|Overall Study||4
10259743|NCT02181413|11391692|FG000|STARTED|Overall Study||261
10259744|NCT02181413|11391693|FG001|STARTED|Overall Study||395
10259745|NCT02181413|11391692|FG000|Intent-to-Treat (ITT) Population|Overall Study||261
10259746|NCT02181413|11391693|FG001|Intent-to-Treat (ITT) Population|Overall Study||395
10259747|NCT02181413|11391692|FG000|Safety Population|Overall Study||259
10259748|NCT02181413|11391693|FG001|Safety Population|Overall Study||394
10259749|NCT02181413|11391692|FG000|Per Protocol (PP) Population|Overall Study||256
10259750|NCT02181413|11391693|FG001|Per Protocol (PP) Population|Overall Study||387
10259751|NCT02181413|11391692|FG000|COMPLETED|Overall Study||109
10259752|NCT02181413|11391693|FG001|COMPLETED|Overall Study||198
10259753|NCT02181413|11391692|FG000|NOT COMPLETED|Overall Study||152
10259754|NCT02181413|11391693|FG001|NOT COMPLETED|Overall Study||197
10259755|NCT02095678|11391701|FG000|STARTED|Overall Study||34
10259756|NCT02095678|11391702|FG001|STARTED|Overall Study||18
10259757|NCT02095678|11391701|FG000|COMPLETED|Overall Study||17
10259758|NCT02095678|11391702|FG001|COMPLETED|Overall Study||0
10259759|NCT02095678|11391701|FG000|NOT COMPLETED|Overall Study||17
10259760|NCT02095678|11391702|FG001|NOT COMPLETED|Overall Study||18
10259761|NCT01990209|11391713|FG000|STARTED|Overall Study|One participant was found to be ineligible after starting with study treatment and hence excluded from further analyses|27
10259762|NCT01990209|11391714|FG001|STARTED|Overall Study||44
10259763|NCT01990209|11391713|FG000|COMPLETED|Overall Study||0
10259764|NCT01990209|11391714|FG001|COMPLETED|Overall Study||0
9835176|NCT00789880|10946377|FG003|COMPLETED|Overall Study||15
9835177|NCT00789880|10946378|FG004|COMPLETED|Overall Study||15
9835178|NCT00789880|10946379|FG005|COMPLETED|Overall Study||8
9835179|NCT00789880|10946374|FG000|NOT COMPLETED|Overall Study||1
9835180|NCT00789880|10946375|FG001|NOT COMPLETED|Overall Study||1
9835181|NCT00789880|10946376|FG002|NOT COMPLETED|Overall Study||0
9835182|NCT00789880|10946377|FG003|NOT COMPLETED|Overall Study||1
9835183|NCT00789880|10946378|FG004|NOT COMPLETED|Overall Study||3
9835184|NCT00789880|10946379|FG005|NOT COMPLETED|Overall Study||0
9835185|NCT00789958|10946393|FG000|STARTED|Overall Study||105
9835186|NCT00789958|10946393|FG000|Eligible and Analyzable|Overall Study||79
9835187|NCT00789958|10946393|FG000|COMPLETED|Overall Study||68
9835188|NCT00789958|10946393|FG000|NOT COMPLETED|Overall Study||37
9835189|NCT00789997|10946401|FG000|STARTED|Overall Study||41
9835190|NCT00789997|10946402|FG001|STARTED|Overall Study||40
9835191|NCT00789997|10946401|FG000|COMPLETED|Overall Study||40
10259765|NCT01990209|11391713|FG000|NOT COMPLETED|Overall Study||27
10259766|NCT01990209|11391714|FG001|NOT COMPLETED|Overall Study||44
10259767|NCT01958021|11391722|FG000|STARTED|Overall Study||334
10259768|NCT01958021|11391723|FG001|STARTED|Overall Study||334
10259769|NCT01958021|11391722|FG000|Patients Untreated|Overall Study||0
10259770|NCT01958021|11391723|FG001|Patients Untreated|Overall Study||4
10259771|NCT01958021|11391722|FG000|Patients Treated|Overall Study||334
10259772|NCT01958021|11391723|FG001|Patients Treated|Overall Study||330
10259773|NCT01958021|11391722|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195
10259774|NCT01958021|11391723|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154
10259775|NCT01958021|11391722|FG000|NOT COMPLETED|Overall Study||139
10259776|NCT01958021|11391723|FG001|NOT COMPLETED|Overall Study||180
10259777|NCT01955109|11391731|FG000|STARTED|Overall Study||123
10259778|NCT01955109|11391732|FG001|STARTED|Overall Study||48
10259779|NCT01955109|11391731|FG000|Completed Study Until Month 12|Overall Study||103
10259780|NCT01955109|11391732|FG001|Completed Study Until Month 12|Overall Study||46
10259781|NCT01955109|11391731|FG000|COMPLETED|Overall Study||78
10259782|NCT01955109|11391732|FG001|COMPLETED|Overall Study||39
10259783|NCT01955109|11391731|FG000|NOT COMPLETED|Overall Study||45
10259784|NCT01955109|11391732|FG001|NOT COMPLETED|Overall Study||9
10259785|NCT01935934|11391740|FG000|STARTED|Overall Study||70
10259786|NCT01935934|11391741|FG001|STARTED|Overall Study||32
10259787|NCT01935934|11391740|FG000|COMPLETED|Overall Study||70
10259788|NCT01935934|11391741|FG001|COMPLETED|Overall Study||32
10259789|NCT01935934|11391740|FG000|NOT COMPLETED|Overall Study||0
10259790|NCT01935934|11391741|FG001|NOT COMPLETED|Overall Study||0
10259791|NCT01902173|11391756|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3
10259792|NCT01902173|11391757|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10259793|NCT01902173|11391758|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10259794|NCT01902173|11391759|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10259795|NCT01902173|11391760|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10259796|NCT01902173|11391761|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10259797|NCT01902173|11391756|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259798|NCT01902173|11391757|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259799|NCT01902173|11391758|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259800|NCT01902173|11391759|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259801|NCT01902173|11391760|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259802|NCT01902173|11391761|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259803|NCT01902173|11391756|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
10259804|NCT01902173|11391757|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259805|NCT01902173|11391758|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259806|NCT01902173|11391759|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259807|NCT01902173|11391760|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259808|NCT01902173|11391761|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10259809|NCT01902173|11391756|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10259810|NCT01902173|11391757|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9
10259811|NCT01902173|11391758|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10259812|NCT01902173|11391759|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10259813|NCT01902173|11391760|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10259814|NCT01902173|11391761|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10259815|NCT01902173|11391756|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259816|NCT01902173|11391757|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259817|NCT01902173|11391758|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259818|NCT01902173|11391759|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259819|NCT01902173|11391760|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259820|NCT01902173|11391761|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259821|NCT01902173|11391756|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259822|NCT01902173|11391757|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
10259823|NCT01902173|11391758|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259824|NCT01902173|11391759|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259825|NCT01902173|11391760|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259826|NCT01902173|11391761|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10259827|NCT01902173|11391756|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10259828|NCT01902173|11391757|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10259829|NCT01902173|11391758|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4
10259830|NCT01902173|11391759|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10259831|NCT01902173|11391760|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10259832|NCT01902173|11391761|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10259833|NCT01902173|11391756|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259834|NCT01902173|11391757|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259835|NCT01902173|11391758|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259836|NCT01902173|11391759|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259837|NCT01902173|11391760|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259838|NCT01902173|11391761|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259839|NCT01902173|11391756|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259840|NCT01902173|11391757|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259841|NCT01902173|11391758|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
10259842|NCT01902173|11391759|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259843|NCT01902173|11391760|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259844|NCT01902173|11391761|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10259845|NCT01902173|11391756|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10259846|NCT01902173|11391757|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10259847|NCT01902173|11391758|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10259848|NCT01902173|11391759|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3
10259849|NCT01902173|11391760|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10259850|NCT01902173|11391761|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10259851|NCT01902173|11391756|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259852|NCT01902173|11391757|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259853|NCT01902173|11391758|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259854|NCT01902173|11391759|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259855|NCT01902173|11391760|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259856|NCT01902173|11391761|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259857|NCT01902173|11391756|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259858|NCT01902173|11391757|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259859|NCT01902173|11391758|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259860|NCT01902173|11391759|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
10259861|NCT01902173|11391760|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259862|NCT01902173|11391761|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10259863|NCT01902173|11391756|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10259864|NCT01902173|11391757|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10259865|NCT01902173|11391758|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10259866|NCT01902173|11391759|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10259867|NCT01902173|11391760|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3
10259868|NCT01902173|11391761|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10259869|NCT01902173|11391756|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259870|NCT01902173|11391757|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259871|NCT01902173|11391758|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259872|NCT01902173|11391759|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259873|NCT01902173|11391760|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259874|NCT01902173|11391761|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259875|NCT01902173|11391756|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259876|NCT01902173|11391757|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259877|NCT01902173|11391758|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259878|NCT01902173|11391759|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259879|NCT01902173|11391760|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
10259880|NCT01902173|11391761|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10259881|NCT01902173|11391756|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10259882|NCT01902173|11391757|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10259883|NCT01902173|11391758|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10259884|NCT01902173|11391759|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10259885|NCT01902173|11391760|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10259886|NCT01902173|11391761|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5
10259887|NCT01902173|11391756|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259888|NCT01902173|11391757|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259889|NCT01902173|11391758|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259890|NCT01902173|11391759|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259891|NCT01902173|11391760|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259892|NCT01902173|11391761|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259893|NCT01902173|11391756|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259894|NCT01902173|11391757|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259895|NCT01902173|11391758|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259896|NCT01902173|11391759|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259897|NCT01902173|11391760|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10259898|NCT01902173|11391761|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
10259899|NCT01902173|11391756|FG000|STARTED|Phase II||0
10259900|NCT01902173|11391757|FG001|STARTED|Phase II||0
10259901|NCT01902173|11391758|FG002|STARTED|Phase II||0
10259902|NCT01902173|11391759|FG003|STARTED|Phase II||0
10259903|NCT01902173|11391760|FG004|STARTED|Phase II||0
10259904|NCT01902173|11391761|FG005|STARTED|Phase II||0
10259905|NCT01902173|11391756|FG000|COMPLETED|Phase II||0
10259906|NCT01902173|11391757|FG001|COMPLETED|Phase II||0
10259907|NCT01902173|11391758|FG002|COMPLETED|Phase II||0
10259908|NCT01902173|11391759|FG003|COMPLETED|Phase II||0
10259909|NCT01902173|11391760|FG004|COMPLETED|Phase II||0
10259910|NCT01902173|11391761|FG005|COMPLETED|Phase II||0
10259911|NCT01902173|11391756|FG000|NOT COMPLETED|Phase II||0
10259912|NCT01902173|11391757|FG001|NOT COMPLETED|Phase II||0
10259913|NCT01902173|11391758|FG002|NOT COMPLETED|Phase II||0
10259914|NCT01902173|11391759|FG003|NOT COMPLETED|Phase II||0
10259915|NCT01902173|11391760|FG004|NOT COMPLETED|Phase II||0
10259916|NCT01902173|11391761|FG005|NOT COMPLETED|Phase II||0
10259917|NCT01854775|11391781|FG000|STARTED|Treatment Phase (48 Weeks)||50
10259918|NCT01854775|11391782|FG001|STARTED|Treatment Phase (48 Weeks)||52
10259919|NCT01854775|11391783|FG002|STARTED|Treatment Phase (48 Weeks)||27
10259920|NCT01854775|11391781|FG000|COMPLETED|Treatment Phase (48 Weeks)||48
10259921|NCT01854775|11391782|FG001|COMPLETED|Treatment Phase (48 Weeks)||51
10259922|NCT01854775|11391783|FG002|COMPLETED|Treatment Phase (48 Weeks)||18
10259923|NCT01854775|11391781|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2
10259924|NCT01854775|11391782|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1
10259925|NCT01854775|11391783|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9
10259926|NCT01854775|11391781|FG000|STARTED|Extension Phase||48
10259927|NCT01854775|11391782|FG001|STARTED|Extension Phase||50
10259928|NCT01854775|11391783|FG002|STARTED|Extension Phase||18
10259929|NCT01854775|11391781|FG000|COMPLETED|Extension Phase||9
10259930|NCT01854775|11391782|FG001|COMPLETED|Extension Phase||3
10259931|NCT01854775|11391783|FG002|COMPLETED|Extension Phase||0
10259932|NCT01854775|11391781|FG000|NOT COMPLETED|Extension Phase||39
10259933|NCT01854775|11391782|FG001|NOT COMPLETED|Extension Phase||47
10259934|NCT01854775|11391783|FG002|NOT COMPLETED|Extension Phase||18
10259935|NCT01849263|11391791|FG000|STARTED|Overall Study||40
10259936|NCT01849263|11391791|FG000|COMPLETED|Overall Study||40
10259937|NCT01849263|11391791|FG000|NOT COMPLETED|Overall Study||0
10259938|NCT01841736|11391797|FG000|STARTED|Overall Study||97
10259939|NCT01841736|11391798|FG001|STARTED|Overall Study||74
10259940|NCT01841736|11391797|FG000|Crossover|Overall Study||0
10259941|NCT01841736|11391798|FG001|Crossover|Overall Study||49
10259942|NCT01841736|11391797|FG000|COMPLETED|Overall Study||97
10259943|NCT01841736|11391798|FG001|COMPLETED|Overall Study||74
10259944|NCT01841736|11391797|FG000|NOT COMPLETED|Overall Study||0
10259945|NCT01841736|11391798|FG001|NOT COMPLETED|Overall Study||0
10259946|NCT01839331|11391809|FG000|STARTED|Overall Study||83
10259947|NCT01839331|11391810|FG001|STARTED|Overall Study||83
10259948|NCT01839331|11391811|FG002|STARTED|Overall Study||82
10259949|NCT01839331|11391812|FG003|STARTED|Overall Study||81
10259950|NCT01839331|11391809|FG000|Week 6|Overall Study||83
10259951|NCT01839331|11391810|FG001|Week 6|Overall Study||83
10259952|NCT01839331|11391811|FG002|Week 6|Overall Study||82
10259953|NCT01839331|11391812|FG003|Week 6|Overall Study||81
10259954|NCT01839331|11391809|FG000|COMPLETED|Overall Study||79
10259955|NCT01839331|11391810|FG001|COMPLETED|Overall Study||77
10259956|NCT01839331|11391811|FG002|COMPLETED|Overall Study||77
10259957|NCT01839331|11391812|FG003|COMPLETED|Overall Study||76
10259958|NCT01839331|11391809|FG000|NOT COMPLETED|Overall Study||4
10259959|NCT01839331|11391810|FG001|NOT COMPLETED|Overall Study||6
10259960|NCT01839331|11391811|FG002|NOT COMPLETED|Overall Study||5
10259961|NCT01839331|11391812|FG003|NOT COMPLETED|Overall Study||5
10259962|NCT01835145|11391830|FG000|STARTED|Overall Study||32
10259963|NCT01835145|11391831|FG001|STARTED|Overall Study||15
10259964|NCT01835145|11391830|FG000|COMPLETED|Overall Study||31
10259965|NCT01835145|11391831|FG001|COMPLETED|Overall Study||15
10259966|NCT01835145|11391830|FG000|NOT COMPLETED|Overall Study||1
10259967|NCT01835145|11391831|FG001|NOT COMPLETED|Overall Study||0
10259968|NCT01709123|11391841|FG000|STARTED|Overall Study||31
10259969|NCT01709123|11391842|FG001|STARTED|Overall Study||31
10259970|NCT01709123|11391841|FG000|COMPLETED|Overall Study||22
10259971|NCT01709123|11391842|FG001|COMPLETED|Overall Study||22
10259972|NCT01709123|11391841|FG000|NOT COMPLETED|Overall Study||9
10259973|NCT01709123|11391842|FG001|NOT COMPLETED|Overall Study||9
10259974|NCT01235234|11391851|FG000|STARTED|Overall Study||77
10259975|NCT01235234|11391852|FG001|STARTED|Overall Study||78
10259976|NCT01235234|11391853|FG002|STARTED|Overall Study||81
10259977|NCT01235234|11391851|FG000|COMPLETED|Overall Study||75
10259978|NCT01235234|11391852|FG001|COMPLETED|Overall Study||76
10259979|NCT01235234|11391853|FG002|COMPLETED|Overall Study||80
10259980|NCT01235234|11391851|FG000|NOT COMPLETED|Overall Study||2
10259981|NCT01235234|11391852|FG001|NOT COMPLETED|Overall Study||2
10259982|NCT01235234|11391853|FG002|NOT COMPLETED|Overall Study||1
10259983|NCT01160211|11391864|FG000|STARTED|Overall Study||120
10259984|NCT01160211|11391865|FG001|STARTED|Overall Study||118
10259985|NCT01160211|11391866|FG002|STARTED|Overall Study||117
10259986|NCT01160211|11391864|FG000|Ongoing|Overall Study||90
10259987|NCT01160211|11391865|FG001|Ongoing|Overall Study||75
10259988|NCT01160211|11391866|FG002|Ongoing|Overall Study||79
10259989|NCT01160211|11391864|FG000|COMPLETED|Overall Study||21
10259990|NCT01160211|11391865|FG001|COMPLETED|Overall Study||31
10259991|NCT01160211|11391866|FG002|COMPLETED|Overall Study||30
10259992|NCT01160211|11391864|FG000|NOT COMPLETED|Overall Study||99
10259993|NCT01160211|11391865|FG001|NOT COMPLETED|Overall Study||87
10259994|NCT01160211|11391866|FG002|NOT COMPLETED|Overall Study||87
10259995|NCT01093573|11391878|FG000|STARTED|Overall Study||3
10259996|NCT01093573|11391879|FG001|STARTED|Overall Study||3
10259997|NCT01093573|11391880|FG002|STARTED|Overall Study||28
10259998|NCT01093573|11391878|FG000|COMPLETED|Overall Study||3
10259999|NCT01093573|11391879|FG001|COMPLETED|Overall Study||3
10260000|NCT01093573|11391880|FG002|COMPLETED|Overall Study||26
10260001|NCT01093573|11391878|FG000|NOT COMPLETED|Overall Study||0
10260002|NCT01093573|11391879|FG001|NOT COMPLETED|Overall Study||0
10260003|NCT01093573|11391880|FG002|NOT COMPLETED|Overall Study||2
10260004|NCT00828854|11391891|FG000|STARTED|Overall Study||27
10260005|NCT00828854|11391891|FG000|COMPLETED|Overall Study||0
10260006|NCT00828854|11391891|FG000|NOT COMPLETED|Overall Study||27
10260007|NCT00753545|11391897|FG000|STARTED|Overall Study|Patients randomized|136
10260008|NCT00753545|11391898|FG001|STARTED|Overall Study|Patients randomized|129
10260009|NCT00753545|11391897|FG000|COMPLETED|Overall Study|Patients completing the Study|28
10260010|NCT00753545|11391898|FG001|COMPLETED|Overall Study|Patients completing the Study|11
10260011|NCT00753545|11391897|FG000|NOT COMPLETED|Overall Study||108
10260012|NCT00753545|11391898|FG001|NOT COMPLETED|Overall Study||118
10260013|NCT00494234|11391906|FG000|STARTED|Overall Study||27
10260014|NCT00494234|11391907|FG001|STARTED|Overall Study||27
10260015|NCT00494234|11391906|FG000|COMPLETED|Overall Study||12
10020966|NCT01839799|11144273|FG000|STARTED|Overall Study||17
10020967|NCT01839799|11144274|FG001|STARTED|Overall Study||15
10260016|NCT00494234|11391907|FG001|COMPLETED|Overall Study||17
10260017|NCT00494234|11391906|FG000|NOT COMPLETED|Overall Study||15
10260018|NCT00494234|11391907|FG001|NOT COMPLETED|Overall Study||10
10020968|NCT01839799|11144273|FG000|COMPLETED|Overall Study||17
10020969|NCT01839799|11144274|FG001|COMPLETED|Overall Study||15
9835192|NCT00789997|10946402|FG001|COMPLETED|Overall Study||38
9835193|NCT00789997|10946401|FG000|NOT COMPLETED|Overall Study||1
9835194|NCT00789997|10946402|FG001|NOT COMPLETED|Overall Study||2
9835195|NCT00790023|10946411|FG000|STARTED|Overall Study||237
9835196|NCT00790023|10946412|FG001|STARTED|Overall Study||235
9835197|NCT00790023|10946413|FG002|STARTED|Overall Study||235
9835198|NCT00790023|10946411|FG000|COMPLETED|Overall Study||226
9835199|NCT00790023|10946412|FG001|COMPLETED|Overall Study||225
9835200|NCT00790023|10946413|FG002|COMPLETED|Overall Study||214
9835201|NCT00790023|10946411|FG000|NOT COMPLETED|Overall Study||11
9835202|NCT00790023|10946412|FG001|NOT COMPLETED|Overall Study||10
9835203|NCT00790023|10946413|FG002|NOT COMPLETED|Overall Study||21
9835204|NCT00790036|10946424|FG000|STARTED|Overall Study||372
9835205|NCT00790036|10946425|FG001|STARTED|Overall Study||370
9835206|NCT00790036|10946424|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
9957864|NCT01453348|11077198|FG000|NOT COMPLETED|Overall Study||1
9957865|NCT01453348|11077199|FG001|NOT COMPLETED|Overall Study||1
9957866|NCT01453348|11077200|FG002|NOT COMPLETED|Overall Study||1
9957867|NCT01453361|11077211|FG000|STARTED|Overall Study||18
9957868|NCT01453361|11077211|FG000|COMPLETED|Overall Study||2
9957869|NCT01453361|11077211|FG000|NOT COMPLETED|Overall Study||16
9957870|NCT01453374|11077215|FG000|STARTED|Overall Study||27
9957871|NCT01453374|11077215|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
9957872|NCT01453374|11077215|FG000|NOT COMPLETED|Overall Study||18
9957873|NCT01453387|11077223|FG000|STARTED|Overall Study||21
9957874|NCT01453387|11077224|FG001|STARTED|Overall Study||7
9957875|NCT01453387|11077223|FG000|COMPLETED|Overall Study||21
9957876|NCT01453387|11077224|FG001|COMPLETED|Overall Study||7
9957877|NCT01453387|11077223|FG000|NOT COMPLETED|Overall Study||0
9957878|NCT01453387|11077224|FG001|NOT COMPLETED|Overall Study||0
9957879|NCT01453413|11077247|FG000|STARTED|Overall Study||297
9957880|NCT01453413|11077247|FG000|COMPLETED|Overall Study||297
9957881|NCT01453413|11077247|FG000|NOT COMPLETED|Overall Study||0
9957882|NCT01453439|11077253|FG000|STARTED|Treatment Phase||61
9957883|NCT01453439|11077254|FG001|STARTED|Treatment Phase||59
9957884|NCT01453439|11077253|FG000|COMPLETED|Treatment Phase||44
9957885|NCT01453439|11077254|FG001|COMPLETED|Treatment Phase||48
9957886|NCT01453439|11077253|FG000|NOT COMPLETED|Treatment Phase||17
9957887|NCT01453439|11077254|FG001|NOT COMPLETED|Treatment Phase||11
9957888|NCT01453439|11077253|FG000|STARTED|Follow-up||44
9957889|NCT01453439|11077254|FG001|STARTED|Follow-up||48
9957890|NCT01453439|11077253|FG000|COMPLETED|Follow-up||39
9957891|NCT01453439|11077254|FG001|COMPLETED|Follow-up||37
9957892|NCT01453439|11077253|FG000|NOT COMPLETED|Follow-up||5
9957893|NCT01453439|11077254|FG001|NOT COMPLETED|Follow-up||11
9957894|NCT01453569|11077263|FG000|STARTED|Overall Study||86
9957895|NCT01453569|11077264|FG001|STARTED|Overall Study||84
9957896|NCT01453569|11077265|FG002|STARTED|Overall Study||85
9957897|NCT01453569|11077263|FG000|COMPLETED|Overall Study||75
9957898|NCT01453569|11077264|FG001|COMPLETED|Overall Study||70
9957899|NCT01453569|11077265|FG002|COMPLETED|Overall Study||78
9957900|NCT01453569|11077263|FG000|NOT COMPLETED|Overall Study||11
9957901|NCT01453569|11077264|FG001|NOT COMPLETED|Overall Study||14
9957902|NCT01453569|11077265|FG002|NOT COMPLETED|Overall Study||7
9957903|NCT01453595|11077276|FG000|STARTED|Overall Study||2
9957904|NCT01453595|11077277|FG001|STARTED|Overall Study||6
9957905|NCT01453595|11077278|FG002|STARTED|Overall Study||2
9957906|NCT01453595|11077276|FG000|COMPLETED|Overall Study||0
9957907|NCT01453595|11077277|FG001|COMPLETED|Overall Study||5
9957908|NCT01453595|11077278|FG002|COMPLETED|Overall Study||0
9957909|NCT01453595|11077276|FG000|NOT COMPLETED|Overall Study||2
9957910|NCT01453595|11077277|FG001|NOT COMPLETED|Overall Study||1
9957911|NCT01453595|11077278|FG002|NOT COMPLETED|Overall Study||2
9957912|NCT01453725|11077286|FG000|STARTED|Overall Study||98
9957913|NCT01453725|11077287|FG001|STARTED|Overall Study||100
9957914|NCT01453725|11077286|FG000|COMPLETED|Overall Study||85
9957915|NCT01453725|11077287|FG001|COMPLETED|Overall Study||89
9957916|NCT01453725|11077286|FG000|NOT COMPLETED|Overall Study||13
9957917|NCT01453725|11077287|FG001|NOT COMPLETED|Overall Study||11
9957918|NCT01453855|11077297|FG000|STARTED|Overall Study||442
9957919|NCT01453855|11077298|FG001|STARTED|Overall Study||422
9957920|NCT01453855|11077297|FG000|COMPLETED|Overall Study||432
9957921|NCT01453855|11077298|FG001|COMPLETED|Overall Study||408
9957922|NCT01453855|11077297|FG000|NOT COMPLETED|Overall Study||10
10020970|NCT01839799|11144273|FG000|NOT COMPLETED|Overall Study||0
10020971|NCT01839799|11144274|FG001|NOT COMPLETED|Overall Study||0
10020972|NCT01839916|11144280|FG000|STARTED|Overall Study||77
9835207|NCT00790036|10946425|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
9835208|NCT00790036|10946424|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
9835209|NCT00790036|10946425|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
9835210|NCT00790036|10946424|FG000|NOT COMPLETED|Overall Study||195
9835211|NCT00790036|10946425|FG001|NOT COMPLETED|Overall Study||121
9835212|NCT00790062|10946435|FG000|STARTED|Overall Study||659
9835213|NCT00790062|10946436|FG001|STARTED|Overall Study||481
9835214|NCT00790062|10946437|FG002|STARTED|Overall Study||658
9835215|NCT00790062|10946435|FG000|COMPLETED|Overall Study||659
9835216|NCT00790062|10946436|FG001|COMPLETED|Overall Study||481
9835217|NCT00790062|10946437|FG002|COMPLETED|Overall Study||658
9835218|NCT00790062|10946435|FG000|NOT COMPLETED|Overall Study||0
9835219|NCT00790062|10946436|FG001|NOT COMPLETED|Overall Study||0
9835220|NCT00790062|10946437|FG002|NOT COMPLETED|Overall Study||0
9835221|NCT00790088|10946454|FG000|STARTED|Overall Study||274
9835222|NCT00790088|10946454|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
9835223|NCT00790088|10946454|FG000|COMPLETED|Overall Study||235
9835224|NCT00790088|10946454|FG000|NOT COMPLETED|Overall Study||39
9835225|NCT00790192|10946464|FG000|STARTED|Overall Study||125
9835226|NCT00790192|10946465|FG001|STARTED|Overall Study||121
9835227|NCT00790192|10946466|FG002|STARTED|Overall Study||120
9835228|NCT00790192|10946467|FG003|STARTED|Overall Study||122
9835229|NCT00790192|10946464|FG000|COMPLETED|Overall Study||89
9835230|NCT00790192|10946465|FG001|COMPLETED|Overall Study||93
9957923|NCT01453855|11077298|FG001|NOT COMPLETED|Overall Study||14
9957924|NCT01453894|11077306|FG000|STARTED|Overall Study||225
9957925|NCT01453894|11077307|FG001|STARTED|Overall Study||225
9957926|NCT01453894|11077306|FG000|COMPLETED|Overall Study||225
9957927|NCT01453894|11077307|FG001|COMPLETED|Overall Study||225
9957928|NCT01453894|11077306|FG000|NOT COMPLETED|Overall Study||0
9957929|NCT01453894|11077307|FG001|NOT COMPLETED|Overall Study||0
9957930|NCT01453998|11077316|FG000|STARTED|Before Protocol Amendment 2||85
9957931|NCT01453998|11077317|FG001|STARTED|Before Protocol Amendment 2||88
9957932|NCT01453998|11077318|FG002|STARTED|Before Protocol Amendment 2||99
9957933|NCT01453998|11077316|FG000|COMPLETED|Before Protocol Amendment 2||85
9835231|NCT00790192|10946466|FG002|COMPLETED|Overall Study||97
10020973|NCT01839916|11144280|FG000|COMPLETED|Overall Study||36
10020974|NCT01839916|11144280|FG000|NOT COMPLETED|Overall Study||41
9835232|NCT00790192|10946467|FG003|COMPLETED|Overall Study||74
9835233|NCT00790192|10946464|FG000|NOT COMPLETED|Overall Study||36
9835234|NCT00790192|10946465|FG001|NOT COMPLETED|Overall Study||28
9957934|NCT01453998|11077317|FG001|COMPLETED|Before Protocol Amendment 2||88
9957935|NCT01453998|11077318|FG002|COMPLETED|Before Protocol Amendment 2||99
9957936|NCT01453998|11077316|FG000|NOT COMPLETED|Before Protocol Amendment 2||0
9957937|NCT01453998|11077317|FG001|NOT COMPLETED|Before Protocol Amendment 2||0
9957938|NCT01453998|11077318|FG002|NOT COMPLETED|Before Protocol Amendment 2||0
9957939|NCT01453998|11077316|FG000|STARTED|After Protocol Amendment 2.||131
9957940|NCT01453998|11077317|FG001|STARTED|After Protocol Amendment 2.||130
9957941|NCT01453998|11077318|FG002|STARTED|After Protocol Amendment 2.||124
9957942|NCT01453998|11077316|FG000|COMPLETED|After Protocol Amendment 2.||130
9957943|NCT01453998|11077317|FG001|COMPLETED|After Protocol Amendment 2.||130
9957944|NCT01453998|11077318|FG002|COMPLETED|After Protocol Amendment 2.||124
9957945|NCT01453998|11077316|FG000|NOT COMPLETED|After Protocol Amendment 2.||1
9957946|NCT01453998|11077317|FG001|NOT COMPLETED|After Protocol Amendment 2.||0
9957947|NCT01453998|11077318|FG002|NOT COMPLETED|After Protocol Amendment 2.||0
9957948|NCT01454063|11077331|FG000|STARTED|Randomized||202
9957949|NCT01454063|11077332|FG001|STARTED|Randomized||203
9957950|NCT01454063|11077331|FG000|COMPLETED|Randomized||201
9957951|NCT01454063|11077332|FG001|COMPLETED|Randomized||201
9957952|NCT01454063|11077331|FG000|NOT COMPLETED|Randomized||1
9957953|NCT01454063|11077332|FG001|NOT COMPLETED|Randomized||2
9957954|NCT01454063|11077331|FG000|STARTED|Treated||201
9957955|NCT01454063|11077332|FG001|STARTED|Treated||201
9957956|NCT01454063|11077331|FG000|COMPLETED|Treated||199
9957957|NCT01454063|11077332|FG001|COMPLETED|Treated||201
9957958|NCT01454063|11077331|FG000|NOT COMPLETED|Treated||2
9957959|NCT01454063|11077332|FG001|NOT COMPLETED|Treated||0
9957960|NCT01454076|11077343|FG000|STARTED|Overall Study||29
9957961|NCT01454076|11077344|FG001|STARTED|Overall Study||20
9957962|NCT01454076|11077345|FG002|STARTED|Overall Study||24
9957963|NCT01454076|11077346|FG003|STARTED|Overall Study||18
9957964|NCT01454076|11077347|FG004|STARTED|Overall Study||21
9957965|NCT01454076|11077343|FG000|COMPLETED|Overall Study||16
9957966|NCT01454076|11077344|FG001|COMPLETED|Overall Study||14
9957967|NCT01454076|11077345|FG002|COMPLETED|Overall Study||15
9957968|NCT01454076|11077346|FG003|COMPLETED|Overall Study||16
9957969|NCT01454076|11077347|FG004|COMPLETED|Overall Study||15
9957970|NCT01454076|11077343|FG000|NOT COMPLETED|Overall Study||13
9957971|NCT01454076|11077344|FG001|NOT COMPLETED|Overall Study||6
9957972|NCT01454076|11077345|FG002|NOT COMPLETED|Overall Study||9
9957973|NCT01454076|11077346|FG003|NOT COMPLETED|Overall Study||2
9957974|NCT01454076|11077347|FG004|NOT COMPLETED|Overall Study||6
10020975|NCT01840072|11144286|FG000|STARTED|Overall Study||2038
10020976|NCT01840072|11144287|FG001|STARTED|Overall Study||2033
10020977|NCT01840072|11144286|FG000|COMPLETED|Overall Study||2031
10020978|NCT01840072|11144287|FG001|COMPLETED|Overall Study||1986
10020979|NCT01840072|11144286|FG000|NOT COMPLETED|Overall Study||7
10020980|NCT01840072|11144287|FG001|NOT COMPLETED|Overall Study||47
10020981|NCT01840163|11144297|FG000|STARTED|First Follow up -Primary Outcome||267
10020982|NCT01840163|11144298|FG001|STARTED|First Follow up -Primary Outcome||270
9835235|NCT00790192|10946466|FG002|NOT COMPLETED|Overall Study||23
9835236|NCT00790192|10946467|FG003|NOT COMPLETED|Overall Study||48
9835237|NCT00790205|10946479|FG000|STARTED|Overall Study||7332
9835238|NCT00790205|10946480|FG001|STARTED|Overall Study||7339
9835239|NCT00790205|10946479|FG000|Treated|Overall Study||7266
9835240|NCT00790205|10946480|FG001|Treated|Overall Study||7274
9835241|NCT00790205|10946479|FG000|COMPLETED|Overall Study||6972
9835242|NCT00790205|10946480|FG001|COMPLETED|Overall Study||6905
9835243|NCT00790205|10946479|FG000|NOT COMPLETED|Overall Study||360
9835244|NCT00790205|10946480|FG001|NOT COMPLETED|Overall Study||434
9835245|NCT00790270|10946489|FG000|STARTED|Overall Study||21
9835246|NCT00790270|10946490|FG001|STARTED|Overall Study||20
9835247|NCT00790270|10946491|FG002|STARTED|Overall Study||20
9835248|NCT00790270|10946489|FG000|COMPLETED|Overall Study||21
9835249|NCT00790270|10946490|FG001|COMPLETED|Overall Study||20
9835250|NCT00790270|10946491|FG002|COMPLETED|Overall Study||20
9835251|NCT00790270|10946489|FG000|NOT COMPLETED|Overall Study||0
9835252|NCT00790270|10946490|FG001|NOT COMPLETED|Overall Study||0
9835253|NCT00790270|10946491|FG002|NOT COMPLETED|Overall Study||0
9835254|NCT00790296|10946501|FG000|STARTED|Overall Study||5
9835255|NCT00790296|10946502|FG001|STARTED|Overall Study||6
9835256|NCT00790296|10946501|FG000|COMPLETED|Overall Study||4
9835257|NCT00790296|10946502|FG001|COMPLETED|Overall Study||4
9835258|NCT00790296|10946501|FG000|NOT COMPLETED|Overall Study||1
9835259|NCT00790296|10946502|FG001|NOT COMPLETED|Overall Study||2
9835260|NCT00790335|10946510|FG000|STARTED|Overall Study||337
9835261|NCT00790335|10946511|FG001|STARTED|Overall Study||355
9835262|NCT00790335|10946510|FG000|COMPLETED|Overall Study||257
9835263|NCT00790335|10946511|FG001|COMPLETED|Overall Study||243
9835264|NCT00790335|10946510|FG000|NOT COMPLETED|Overall Study||80
9835265|NCT00790335|10946511|FG001|NOT COMPLETED|Overall Study||112
9835266|NCT00790400|10946519|FG000|STARTED|Double-blind Period (Core Phase)||79
9835267|NCT00790400|10946520|FG001|STARTED|Double-blind Period (Core Phase)||39
9835268|NCT00790400|10946519|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
9835269|NCT00790400|10946520|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
9835270|NCT00790400|10946519|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7
9835271|NCT00790400|10946520|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13
9835272|NCT00790400|10946519|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
9957975|NCT01454102|11077384|FG000|STARTED|Overall Study||12
9957976|NCT01454102|11077385|FG001|STARTED|Overall Study||15
10020983|NCT01840163|11144297|FG000|COMPLETED|First Follow up -Primary Outcome||248
10020984|NCT01840163|11144298|FG001|COMPLETED|First Follow up -Primary Outcome||254
10020985|NCT01840163|11144297|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19
10020986|NCT01840163|11144298|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16
9835273|NCT00790400|10946520|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
9835274|NCT00790400|10946519|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
9835275|NCT00790400|10946520|FG001|COMPLETED|Everolimus Period (Core or Extension)||0
9835276|NCT00790400|10946519|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29
9835277|NCT00790400|10946520|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0
9835278|NCT00790556|10946529|FG000|STARTED|Treatment Period 1||8
9835279|NCT00790556|10946530|FG001|STARTED|Treatment Period 1||6
9835280|NCT00790556|10946529|FG000|COMPLETED|Treatment Period 1||6
9835281|NCT00790556|10946530|FG001|COMPLETED|Treatment Period 1||6
9835282|NCT00790556|10946529|FG000|NOT COMPLETED|Treatment Period 1||2
9835283|NCT00790556|10946530|FG001|NOT COMPLETED|Treatment Period 1||0
9835284|NCT00790556|10946529|FG000|STARTED|Washout After Period 1||6
9835285|NCT00790556|10946530|FG001|STARTED|Washout After Period 1||6
9835286|NCT00790556|10946529|FG000|COMPLETED|Washout After Period 1||6
9835287|NCT00790556|10946530|FG001|COMPLETED|Washout After Period 1||6
9835288|NCT00790556|10946529|FG000|NOT COMPLETED|Washout After Period 1||0
9835289|NCT00790556|10946530|FG001|NOT COMPLETED|Washout After Period 1||0
9835290|NCT00790556|10946529|FG000|STARTED|Treatment Period 2||6
9835291|NCT00790556|10946530|FG001|STARTED|Treatment Period 2||6
9835292|NCT00790556|10946529|FG000|COMPLETED|Treatment Period 2||6
9835293|NCT00790556|10946530|FG001|COMPLETED|Treatment Period 2||6
9835294|NCT00790556|10946529|FG000|NOT COMPLETED|Treatment Period 2||0
9835295|NCT00790556|10946530|FG001|NOT COMPLETED|Treatment Period 2||0
9835296|NCT00790569|10946539|FG000|STARTED|End of Treatment (6 Month Interview)||137
9835297|NCT00790569|10946540|FG001|STARTED|End of Treatment (6 Month Interview)||45
9835298|NCT00790569|10946541|FG002|STARTED|End of Treatment (6 Month Interview)||133
9835299|NCT00790569|10946539|FG000|COMPLETED|End of Treatment (6 Month Interview)||115
9835300|NCT00790569|10946540|FG001|COMPLETED|End of Treatment (6 Month Interview)||35
9835301|NCT00790569|10946541|FG002|COMPLETED|End of Treatment (6 Month Interview)||107
9835302|NCT00790569|10946539|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22
9835303|NCT00790569|10946540|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10
9835304|NCT00790569|10946541|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26
9835305|NCT00790569|10946539|FG000|STARTED|End of Study (12 Month Interview)||137
9835306|NCT00790569|10946540|FG001|STARTED|End of Study (12 Month Interview)||45
9835307|NCT00790569|10946541|FG002|STARTED|End of Study (12 Month Interview)||133
9835308|NCT00790569|10946539|FG000|COMPLETED|End of Study (12 Month Interview)||71
9835309|NCT00790569|10946540|FG001|COMPLETED|End of Study (12 Month Interview)||26
9835310|NCT00790569|10946541|FG002|COMPLETED|End of Study (12 Month Interview)||83
9835311|NCT00790569|10946539|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66
9835312|NCT00790569|10946540|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19
9835313|NCT00790569|10946541|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50
9835314|NCT00790582|10946551|FG000|STARTED|Overall Study||109
9835315|NCT00790582|10946552|FG001|STARTED|Overall Study||249
9835316|NCT00790582|10946551|FG000|COMPLETED|Overall Study||78
9835317|NCT00790582|10946552|FG001|COMPLETED|Overall Study||162
9835318|NCT00790582|10946551|FG000|NOT COMPLETED|Overall Study||31
9835319|NCT00790582|10946552|FG001|NOT COMPLETED|Overall Study||87
9835320|NCT00790647|10946560|FG000|STARTED|Overall Study||10
9835321|NCT00790647|10946560|FG000|COMPLETED|Overall Study||9
9835322|NCT00790647|10946560|FG000|NOT COMPLETED|Overall Study||1
9835323|NCT00790673|10946570|FG000|STARTED|Overall Study||6
9835324|NCT00790673|10946571|FG001|STARTED|Overall Study||6
9835325|NCT00790673|10946572|FG002|STARTED|Overall Study||12
9835326|NCT00790673|10946573|FG003|STARTED|Overall Study||8
9835327|NCT00790673|10946570|FG000|COMPLETED|Overall Study||6
9835328|NCT00790673|10946571|FG001|COMPLETED|Overall Study||6
9835329|NCT00790673|10946572|FG002|COMPLETED|Overall Study||12
9835330|NCT00790673|10946573|FG003|COMPLETED|Overall Study||8
9835331|NCT00790673|10946570|FG000|NOT COMPLETED|Overall Study||0
10020987|NCT01840163|11144297|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
10020988|NCT01840163|11144298|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
10020989|NCT01840163|11144297|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174
10020990|NCT01840163|11144298|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191
10020991|NCT01840163|11144297|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
10020992|NCT01840163|11144298|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
10020993|NCT01840228|11144306|FG000|STARTED|Overall Study||19
10020994|NCT01840228|11144307|FG001|STARTED|Overall Study||19
10020995|NCT01840228|11144306|FG000|COMPLETED|Overall Study||18
10020996|NCT01840228|11144307|FG001|COMPLETED|Overall Study||18
10020997|NCT01840228|11144306|FG000|NOT COMPLETED|Overall Study||1
10020998|NCT01840228|11144307|FG001|NOT COMPLETED|Overall Study||1
10020999|NCT01840319|11144317|FG000|STARTED|Overall Study||156
10021000|NCT01840319|11144317|FG000|COMPLETED|Overall Study||156
9835332|NCT00790673|10946571|FG001|NOT COMPLETED|Overall Study||0
9835333|NCT00790673|10946572|FG002|NOT COMPLETED|Overall Study||0
9835334|NCT00790673|10946573|FG003|NOT COMPLETED|Overall Study||0
9835335|NCT00790699|10946585|FG000|STARTED|Overall Study||17
9835336|NCT00790699|10946586|FG001|STARTED|Overall Study||14
9835337|NCT00790699|10946585|FG000|COMPLETED|Overall Study||16
9835338|NCT00790699|10946586|FG001|COMPLETED|Overall Study||14
9835339|NCT00790699|10946585|FG000|NOT COMPLETED|Overall Study||1
9835340|NCT00790699|10946586|FG001|NOT COMPLETED|Overall Study||0
9835341|NCT00790738|10946596|FG000|STARTED|Overall Study||5
9835342|NCT00790738|10946597|FG001|STARTED|Overall Study||6
9835343|NCT00790738|10946596|FG000|COMPLETED|Overall Study||3
9957977|NCT01454102|11077386|FG002|STARTED|Overall Study||15
9835344|NCT00790738|10946597|FG001|COMPLETED|Overall Study||3
9835345|NCT00790738|10946596|FG000|NOT COMPLETED|Overall Study||2
9835346|NCT00790738|10946597|FG001|NOT COMPLETED|Overall Study||3
9835347|NCT00790751|10946607|FG000|STARTED|Overall Study||162
9835348|NCT00790751|10946608|FG001|STARTED|Overall Study||161
9835349|NCT00790751|10946609|FG002|STARTED|Overall Study||161
9835350|NCT00790751|10946610|FG003|STARTED|Overall Study||162
9835351|NCT00790751|10946607|FG000|COMPLETED|Overall Study||137
9835352|NCT00790751|10946608|FG001|COMPLETED|Overall Study||131
9835353|NCT00790751|10946609|FG002|COMPLETED|Overall Study||141
10021001|NCT01840319|11144317|FG000|NOT COMPLETED|Overall Study||0
10021002|NCT01840345|11144321|FG000|STARTED|Overall Study||11
10021003|NCT01840345|11144321|FG000|COMPLETED|Overall Study||10
10021004|NCT01840345|11144321|FG000|NOT COMPLETED|Overall Study||1
10021005|NCT01840410|11144327|FG000|STARTED|Overall Study||119
9835354|NCT00790751|10946610|FG003|COMPLETED|Overall Study||141
9835355|NCT00790751|10946607|FG000|NOT COMPLETED|Overall Study||25
9835356|NCT00790751|10946608|FG001|NOT COMPLETED|Overall Study||30
9835357|NCT00790751|10946609|FG002|NOT COMPLETED|Overall Study||20
9835358|NCT00790751|10946610|FG003|NOT COMPLETED|Overall Study||21
9957978|NCT01454102|11077387|FG003|STARTED|Overall Study||12
9957979|NCT01454102|11077388|FG004|STARTED|Overall Study||21
9957980|NCT01454102|11077389|FG005|STARTED|Overall Study||52
9957981|NCT01454102|11077390|FG006|STARTED|Overall Study||24
9957982|NCT01454102|11077391|FG007|STARTED|Overall Study||25
9957983|NCT01454102|11077392|FG008|STARTED|Overall Study||13
9957984|NCT01454102|11077393|FG009|STARTED|Overall Study||13
9957985|NCT01454102|11077394|FG010|STARTED|Overall Study||12
9957986|NCT01454102|11077395|FG011|STARTED|Overall Study||31
9957987|NCT01454102|11077396|FG012|STARTED|Overall Study||40
9957988|NCT01454102|11077397|FG013|STARTED|Overall Study||38
9957989|NCT01454102|11077398|FG014|STARTED|Overall Study||39
9957990|NCT01454102|11077399|FG015|STARTED|Overall Study||14
9957991|NCT01454102|11077384|FG000|COMPLETED|Overall Study||12
9957992|NCT01454102|11077385|FG001|COMPLETED|Overall Study||15
9957993|NCT01454102|11077386|FG002|COMPLETED|Overall Study||15
9957994|NCT01454102|11077387|FG003|COMPLETED|Overall Study||12
9957995|NCT01454102|11077388|FG004|COMPLETED|Overall Study||18
9957996|NCT01454102|11077389|FG005|COMPLETED|Overall Study||49
9957997|NCT01454102|11077390|FG006|COMPLETED|Overall Study||22
9957998|NCT01454102|11077391|FG007|COMPLETED|Overall Study||25
9957999|NCT01454102|11077392|FG008|COMPLETED|Overall Study||12
9958000|NCT01454102|11077393|FG009|COMPLETED|Overall Study||13
9958001|NCT01454102|11077394|FG010|COMPLETED|Overall Study||12
9958002|NCT01454102|11077395|FG011|COMPLETED|Overall Study||27
9958003|NCT01454102|11077396|FG012|COMPLETED|Overall Study||33
9958004|NCT01454102|11077397|FG013|COMPLETED|Overall Study||34
9958005|NCT01454102|11077398|FG014|COMPLETED|Overall Study||36
9958006|NCT01454102|11077399|FG015|COMPLETED|Overall Study||13
9958007|NCT01454102|11077384|FG000|NOT COMPLETED|Overall Study||0
9958008|NCT01454102|11077385|FG001|NOT COMPLETED|Overall Study||0
9958009|NCT01454102|11077386|FG002|NOT COMPLETED|Overall Study||0
9958010|NCT01454102|11077387|FG003|NOT COMPLETED|Overall Study||0
9958011|NCT01454102|11077388|FG004|NOT COMPLETED|Overall Study||3
9958012|NCT01454102|11077389|FG005|NOT COMPLETED|Overall Study||3
9958013|NCT01454102|11077390|FG006|NOT COMPLETED|Overall Study||2
9958014|NCT01454102|11077391|FG007|NOT COMPLETED|Overall Study||0
9958015|NCT01454102|11077392|FG008|NOT COMPLETED|Overall Study||1
9958016|NCT01454102|11077393|FG009|NOT COMPLETED|Overall Study||0
9958017|NCT01454102|11077394|FG010|NOT COMPLETED|Overall Study||0
9958018|NCT01454102|11077395|FG011|NOT COMPLETED|Overall Study||4
10021006|NCT01840410|11144328|FG001|STARTED|Overall Study||59
10021007|NCT01840410|11144327|FG000|Safety Set|Overall Study||119
10021008|NCT01840410|11144328|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
10021009|NCT01840410|11144327|FG000|Full Analysis Set|Overall Study||119
9958019|NCT01454102|11077396|FG012|NOT COMPLETED|Overall Study||7
9958020|NCT01454102|11077397|FG013|NOT COMPLETED|Overall Study||4
9958021|NCT01454102|11077398|FG014|NOT COMPLETED|Overall Study||3
9958022|NCT01454102|11077399|FG015|NOT COMPLETED|Overall Study||1
9958023|NCT01454258|11077434|FG000|STARTED|Overall Study||10100
9958024|NCT01454258|11077434|FG000|COMPLETED|Overall Study||9103
9958025|NCT01454258|11077434|FG000|NOT COMPLETED|Overall Study||997
9958026|NCT01454284|11077442|FG000|STARTED|Overall Study||664
9958027|NCT01454284|11077443|FG001|STARTED|Overall Study||450
9958028|NCT01454284|11077442|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663
9958029|NCT01454284|11077443|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449
9958030|NCT01454284|11077442|FG000|COMPLETED|Overall Study||548
9958031|NCT01454284|11077443|FG001|COMPLETED|Overall Study||377
9958032|NCT01454284|11077442|FG000|NOT COMPLETED|Overall Study||116
9958033|NCT01454284|11077443|FG001|NOT COMPLETED|Overall Study||73
9958034|NCT01454362|11077451|FG000|STARTED|Overall Study||28
9958035|NCT01454362|11077452|FG001|STARTED|Overall Study||23
10021010|NCT01840410|11144328|FG001|Full Analysis Set|Overall Study||59
10021011|NCT01840410|11144327|FG000|COMPLETED|Overall Study||112
10021012|NCT01840410|11144328|FG001|COMPLETED|Overall Study||55
9958036|NCT01454362|11077451|FG000|COMPLETED|Overall Study||28
9958037|NCT01454362|11077452|FG001|COMPLETED|Overall Study||23
9958038|NCT01454362|11077451|FG000|NOT COMPLETED|Overall Study||0
9958039|NCT01454362|11077452|FG001|NOT COMPLETED|Overall Study||0
9958040|NCT01454401|11077460|FG000|STARTED|Overall Study|ITT|44
9958041|NCT01454401|11077460|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39
9958042|NCT01454401|11077460|FG000|NOT COMPLETED|Overall Study||5
9958043|NCT01454414|11077466|FG000|STARTED|Overall Study||79
9958044|NCT01454414|11077467|FG001|STARTED|Overall Study||80
9719382|NCT00041938|10818927|FG000|Withdrew Consent|Overall Study||20
9719383|NCT00041938|10818928|FG001|Withdrew Consent|Overall Study||14
9719384|NCT00041938|10818927|FG000|COMPLETED|Overall Study||1125
9719385|NCT00041938|10818928|FG001|COMPLETED|Overall Study||1111
9719386|NCT00041938|10818927|FG000|NOT COMPLETED|Overall Study||38
9719387|NCT00041938|10818928|FG001|NOT COMPLETED|Overall Study||31
9719388|NCT00042224|10818936|FG000|STARTED|Overall Study||20
9719389|NCT00042224|10818937|FG001|STARTED|Overall Study||19
9719390|NCT00042224|10818936|FG000|COMPLETED|Overall Study||17
9719391|NCT00042224|10818937|FG001|COMPLETED|Overall Study||16
9719392|NCT00042224|10818936|FG000|NOT COMPLETED|Overall Study||3
9719393|NCT00042224|10818937|FG001|NOT COMPLETED|Overall Study||3
9719394|NCT00042432|10818945|FG000|STARTED|Overall Study||27
10021013|NCT01840410|11144327|FG000|NOT COMPLETED|Overall Study||7
10021014|NCT01840410|11144328|FG001|NOT COMPLETED|Overall Study||4
9719395|NCT00042432|10818946|FG001|STARTED|Overall Study||27
9719396|NCT00042432|10818945|FG000|COMPLETED|Overall Study||18
9719397|NCT00042432|10818946|FG001|COMPLETED|Overall Study||20
9719398|NCT00042432|10818945|FG000|NOT COMPLETED|Overall Study||9
9719399|NCT00042432|10818946|FG001|NOT COMPLETED|Overall Study||7
9719400|NCT00042666|10818952|FG000|STARTED|Overall Study||55
9719401|NCT00042666|10818952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55
9719402|NCT00042666|10818952|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42
9719403|NCT00042666|10818952|FG000|COMPLETED|Overall Study||1
9719404|NCT00042666|10818952|FG000|NOT COMPLETED|Overall Study||54
9719405|NCT00042939|10818959|FG000|STARTED|Overall Study||48
9719406|NCT00042939|10818960|FG001|STARTED|Overall Study||46
9719407|NCT00042939|10818959|FG000|Treated|Overall Study||46
9719408|NCT00042939|10818960|FG001|Treated|Overall Study||45
9719409|NCT00042939|10818959|FG000|Eligible and Began Protocol Therapy|Overall Study||44
9719410|NCT00042939|10818960|FG001|Eligible and Began Protocol Therapy|Overall Study||43
9719411|NCT00042939|10818959|FG000|Patients With EGFR Results Available|Overall Study||30
9719412|NCT00042939|10818960|FG001|Patients With EGFR Results Available|Overall Study||31
9719413|NCT00042939|10818959|FG000|COMPLETED|Overall Study||24
9719414|NCT00042939|10818960|FG001|COMPLETED|Overall Study||25
9719415|NCT00042939|10818959|FG000|NOT COMPLETED|Overall Study||24
9719416|NCT00042939|10818960|FG001|NOT COMPLETED|Overall Study||21
9719417|NCT00042991|10818973|FG000|STARTED|Overall Study||6
9719418|NCT00042991|10818974|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
9719419|NCT00042991|10818975|FG002|STARTED|Overall Study||7
10021015|NCT01840579|11144346|FG000|STARTED|Overall Study||3
10021016|NCT01840579|11144347|FG001|STARTED|Overall Study||7
9719420|NCT00042991|10818976|FG003|STARTED|Overall Study||2
9719421|NCT00042991|10818977|FG004|STARTED|Overall Study||3
9719422|NCT00042991|10818978|FG005|STARTED|Overall Study||5
9719423|NCT00042991|10818979|FG006|STARTED|Overall Study||3
9719424|NCT00042991|10818973|FG000|Phase-I Trial|Overall Study||6
9835359|NCT00790790|10946623|FG000|STARTED|Study Period 2: Therapy Phase||49
9835360|NCT00790790|10946624|FG001|STARTED|Study Period 2: Therapy Phase||50
9835361|NCT00790790|10946625|FG002|STARTED|Study Period 2: Therapy Phase||48
9835362|NCT00790790|10946623|FG000|COMPLETED|Study Period 2: Therapy Phase||37
9835363|NCT00790790|10946624|FG001|COMPLETED|Study Period 2: Therapy Phase||32
9835364|NCT00790790|10946625|FG002|COMPLETED|Study Period 2: Therapy Phase||27
9835365|NCT00790790|10946623|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12
9835366|NCT00790790|10946624|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18
9835367|NCT00790790|10946625|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21
9835368|NCT00790790|10946623|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37
9835369|NCT00790790|10946624|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32
9835370|NCT00790790|10946625|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27
9835371|NCT00790790|10946623|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37
9835372|NCT00790790|10946624|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31
9835373|NCT00790790|10946625|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26
9835374|NCT00790790|10946623|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
9835375|NCT00790790|10946624|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
9835376|NCT00790790|10946625|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
9835377|NCT00790842|10946641|FG000|STARTED|Dose Level 1||6
9835378|NCT00790842|10946642|FG001|STARTED|Dose Level 1||0
9835379|NCT00790842|10946643|FG002|STARTED|Dose Level 1||0
9835380|NCT00790842|10946644|FG003|STARTED|Dose Level 1||3
9835381|NCT00790842|10946645|FG004|STARTED|Dose Level 1||0
9835382|NCT00790842|10946646|FG005|STARTED|Dose Level 1||0
9835383|NCT00790842|10946647|FG006|STARTED|Dose Level 1||0
9835384|NCT00790842|10946648|FG007|STARTED|Dose Level 1||3
9835385|NCT00790842|10946649|FG008|STARTED|Dose Level 1||0
9835386|NCT00790842|10946650|FG009|STARTED|Dose Level 1||0
9835387|NCT00790842|10946651|FG010|STARTED|Dose Level 1||0
9835388|NCT00790842|10946641|FG000|Began Treatment|Dose Level 1||6
9835389|NCT00790842|10946642|FG001|Began Treatment|Dose Level 1||0
9835390|NCT00790842|10946643|FG002|Began Treatment|Dose Level 1||0
9835391|NCT00790842|10946644|FG003|Began Treatment|Dose Level 1||3
9835392|NCT00790842|10946645|FG004|Began Treatment|Dose Level 1||0
9835393|NCT00790842|10946646|FG005|Began Treatment|Dose Level 1||0
9835394|NCT00790842|10946647|FG006|Began Treatment|Dose Level 1||0
9835395|NCT00790842|10946648|FG007|Began Treatment|Dose Level 1||3
9835396|NCT00790842|10946649|FG008|Began Treatment|Dose Level 1||0
9835397|NCT00790842|10946650|FG009|Began Treatment|Dose Level 1||0
9835398|NCT00790842|10946651|FG010|Began Treatment|Dose Level 1||0
9835399|NCT00790842|10946641|FG000|COMPLETED|Dose Level 1||3
9835400|NCT00790842|10946642|FG001|COMPLETED|Dose Level 1||0
9835401|NCT00790842|10946643|FG002|COMPLETED|Dose Level 1||0
9835402|NCT00790842|10946644|FG003|COMPLETED|Dose Level 1||1
9835403|NCT00790842|10946645|FG004|COMPLETED|Dose Level 1||0
9835404|NCT00790842|10946646|FG005|COMPLETED|Dose Level 1||0
9835405|NCT00790842|10946647|FG006|COMPLETED|Dose Level 1||0
9835406|NCT00790842|10946648|FG007|COMPLETED|Dose Level 1||1
9835407|NCT00790842|10946649|FG008|COMPLETED|Dose Level 1||0
9958045|NCT01454414|11077466|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67
9835408|NCT00790842|10946650|FG009|COMPLETED|Dose Level 1||0
9835409|NCT00790842|10946651|FG010|COMPLETED|Dose Level 1||0
9835410|NCT00790842|10946641|FG000|NOT COMPLETED|Dose Level 1||3
9835411|NCT00790842|10946642|FG001|NOT COMPLETED|Dose Level 1||0
9835412|NCT00790842|10946643|FG002|NOT COMPLETED|Dose Level 1||0
10021017|NCT01840579|11144348|FG002|STARTED|Overall Study||6
10021018|NCT01840579|11144349|FG003|STARTED|Overall Study||6
10021019|NCT01840579|11144350|FG004|STARTED|Overall Study||8
10021020|NCT01840579|11144351|FG005|STARTED|Overall Study||6
10021021|NCT01840579|11144352|FG006|STARTED|Overall Study||6
10021022|NCT01840579|11144353|FG007|STARTED|Overall Study||6
10021023|NCT01840579|11144354|FG008|STARTED|Overall Study||6
9835413|NCT00790842|10946644|FG003|NOT COMPLETED|Dose Level 1||2
9835414|NCT00790842|10946645|FG004|NOT COMPLETED|Dose Level 1||0
10021024|NCT01840579|11144355|FG009|STARTED|Overall Study||3
10021025|NCT01840579|11144346|FG000|COMPLETED|Overall Study||0
10021026|NCT01840579|11144347|FG001|COMPLETED|Overall Study||0
10021027|NCT01840579|11144348|FG002|COMPLETED|Overall Study||4
10021028|NCT01840579|11144349|FG003|COMPLETED|Overall Study||3
10021029|NCT01840579|11144350|FG004|COMPLETED|Overall Study||4
10021030|NCT01840579|11144351|FG005|COMPLETED|Overall Study||2
10021031|NCT01840579|11144352|FG006|COMPLETED|Overall Study||4
10021032|NCT01840579|11144353|FG007|COMPLETED|Overall Study||3
10021033|NCT01840579|11144354|FG008|COMPLETED|Overall Study||3
10021034|NCT01840579|11144355|FG009|COMPLETED|Overall Study||0
10021035|NCT01840579|11144346|FG000|NOT COMPLETED|Overall Study||3
10021036|NCT01840579|11144347|FG001|NOT COMPLETED|Overall Study||7
10021037|NCT01840579|11144348|FG002|NOT COMPLETED|Overall Study||2
9835415|NCT00790842|10946646|FG005|NOT COMPLETED|Dose Level 1||0
9835416|NCT00790842|10946647|FG006|NOT COMPLETED|Dose Level 1||0
9835417|NCT00790842|10946648|FG007|NOT COMPLETED|Dose Level 1||2
9835418|NCT00790842|10946649|FG008|NOT COMPLETED|Dose Level 1||0
9835419|NCT00790842|10946650|FG009|NOT COMPLETED|Dose Level 1||0
9835420|NCT00790842|10946651|FG010|NOT COMPLETED|Dose Level 1||0
9835421|NCT00790842|10946641|FG000|STARTED|Dose Level 2||0
9835422|NCT00790842|10946642|FG001|STARTED|Dose Level 2||3
9835423|NCT00790842|10946643|FG002|STARTED|Dose Level 2||0
9835424|NCT00790842|10946644|FG003|STARTED|Dose Level 2||0
9835425|NCT00790842|10946645|FG004|STARTED|Dose Level 2||3
9835426|NCT00790842|10946646|FG005|STARTED|Dose Level 2||0
9835427|NCT00790842|10946647|FG006|STARTED|Dose Level 2||0
9835428|NCT00790842|10946648|FG007|STARTED|Dose Level 2||0
9835429|NCT00790842|10946649|FG008|STARTED|Dose Level 2||3
9835430|NCT00790842|10946650|FG009|STARTED|Dose Level 2||0
9835431|NCT00790842|10946651|FG010|STARTED|Dose Level 2||0
9835432|NCT00790842|10946641|FG000|Began Treatment|Dose Level 2||0
9835433|NCT00790842|10946642|FG001|Began Treatment|Dose Level 2||3
9835434|NCT00790842|10946643|FG002|Began Treatment|Dose Level 2||0
9835435|NCT00790842|10946644|FG003|Began Treatment|Dose Level 2||0
9835436|NCT00790842|10946645|FG004|Began Treatment|Dose Level 2||3
9835437|NCT00790842|10946646|FG005|Began Treatment|Dose Level 2||0
9835438|NCT00790842|10946647|FG006|Began Treatment|Dose Level 2||0
9835439|NCT00790842|10946648|FG007|Began Treatment|Dose Level 2||0
9835440|NCT00790842|10946649|FG008|Began Treatment|Dose Level 2||3
9835441|NCT00790842|10946650|FG009|Began Treatment|Dose Level 2||0
9835442|NCT00790842|10946651|FG010|Began Treatment|Dose Level 2||0
9835443|NCT00790842|10946641|FG000|COMPLETED|Dose Level 2||0
9835444|NCT00790842|10946642|FG001|COMPLETED|Dose Level 2||0
9835445|NCT00790842|10946643|FG002|COMPLETED|Dose Level 2||0
9835446|NCT00790842|10946644|FG003|COMPLETED|Dose Level 2||0
9835447|NCT00790842|10946645|FG004|COMPLETED|Dose Level 2||2
9835448|NCT00790842|10946646|FG005|COMPLETED|Dose Level 2||0
9835449|NCT00790842|10946647|FG006|COMPLETED|Dose Level 2||0
10021038|NCT01840579|11144349|FG003|NOT COMPLETED|Overall Study||3
10021039|NCT01840579|11144350|FG004|NOT COMPLETED|Overall Study||4
10021040|NCT01840579|11144351|FG005|NOT COMPLETED|Overall Study||4
10021041|NCT01840579|11144352|FG006|NOT COMPLETED|Overall Study||2
9835450|NCT00790842|10946648|FG007|COMPLETED|Dose Level 2||0
9835451|NCT00790842|10946649|FG008|COMPLETED|Dose Level 2||1
9835452|NCT00790842|10946650|FG009|COMPLETED|Dose Level 2||0
9835453|NCT00790842|10946651|FG010|COMPLETED|Dose Level 2||0
9835454|NCT00790842|10946641|FG000|NOT COMPLETED|Dose Level 2||0
9835455|NCT00790842|10946642|FG001|NOT COMPLETED|Dose Level 2||3
10021042|NCT01840579|11144353|FG007|NOT COMPLETED|Overall Study||3
10021043|NCT01840579|11144354|FG008|NOT COMPLETED|Overall Study||3
10021044|NCT01840579|11144355|FG009|NOT COMPLETED|Overall Study||3
10021045|NCT01840605|11144391|FG000|STARTED|Overall Study||151
10021046|NCT01840605|11144392|FG001|STARTED|Overall Study||152
9835456|NCT00790842|10946643|FG002|NOT COMPLETED|Dose Level 2||0
9835457|NCT00790842|10946644|FG003|NOT COMPLETED|Dose Level 2||0
9835458|NCT00790842|10946645|FG004|NOT COMPLETED|Dose Level 2||1
9835459|NCT00790842|10946646|FG005|NOT COMPLETED|Dose Level 2||0
9835460|NCT00790842|10946647|FG006|NOT COMPLETED|Dose Level 2||0
9835461|NCT00790842|10946648|FG007|NOT COMPLETED|Dose Level 2||0
10021047|NCT01840605|11144391|FG000|COMPLETED|Overall Study||149
10114011|NCT02513160|11244734|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104
10114012|NCT02513160|11244735|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103
10114013|NCT02513160|11244732|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
10114014|NCT02513160|11244733|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
10114015|NCT02513160|11244734|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
10114016|NCT02513160|11244735|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
10114017|NCT02513212|11244748|FG000|STARTED|Overall Study||12
9835462|NCT00790842|10946649|FG008|NOT COMPLETED|Dose Level 2||2
9835463|NCT00790842|10946650|FG009|NOT COMPLETED|Dose Level 2||0
9835464|NCT00790842|10946651|FG010|NOT COMPLETED|Dose Level 2||0
9835465|NCT00790842|10946641|FG000|STARTED|Dose Level 3||0
9835466|NCT00790842|10946642|FG001|STARTED|Dose Level 3||0
9835467|NCT00790842|10946643|FG002|STARTED|Dose Level 3||7
9835468|NCT00790842|10946644|FG003|STARTED|Dose Level 3||0
9835469|NCT00790842|10946645|FG004|STARTED|Dose Level 3||0
9835470|NCT00790842|10946646|FG005|STARTED|Dose Level 3||3
9835471|NCT00790842|10946647|FG006|STARTED|Dose Level 3||0
9835472|NCT00790842|10946648|FG007|STARTED|Dose Level 3||0
9835473|NCT00790842|10946649|FG008|STARTED|Dose Level 3||0
9835474|NCT00790842|10946650|FG009|STARTED|Dose Level 3||3
9835475|NCT00790842|10946651|FG010|STARTED|Dose Level 3||0
9835476|NCT00790842|10946641|FG000|Began Treatment|Dose Level 3||0
9958046|NCT01454414|11077467|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66
9958047|NCT01454414|11077466|FG000|COMPLETED|Overall Study||66
9958048|NCT01454414|11077467|FG001|COMPLETED|Overall Study||64
9958049|NCT01454414|11077466|FG000|NOT COMPLETED|Overall Study||13
9958050|NCT01454414|11077467|FG001|NOT COMPLETED|Overall Study||16
9958051|NCT01454505|11077476|FG000|STARTED|Overall Study||35
9958052|NCT01454505|11077477|FG001|STARTED|Overall Study||15
9958053|NCT01454505|11077478|FG002|STARTED|Overall Study||40
9958054|NCT01454505|11077479|FG003|STARTED|Overall Study||20
9958055|NCT01454505|11077476|FG000|COMPLETED|Overall Study||35
9958056|NCT01454505|11077477|FG001|COMPLETED|Overall Study||15
9958057|NCT01454505|11077478|FG002|COMPLETED|Overall Study||40
9958058|NCT01454505|11077479|FG003|COMPLETED|Overall Study||20
10021048|NCT01840605|11144392|FG001|COMPLETED|Overall Study||150
9958059|NCT01454505|11077476|FG000|NOT COMPLETED|Overall Study||0
9958060|NCT01454505|11077477|FG001|NOT COMPLETED|Overall Study||0
9958061|NCT01454505|11077478|FG002|NOT COMPLETED|Overall Study||0
9958062|NCT01454505|11077479|FG003|NOT COMPLETED|Overall Study||0
9958063|NCT01454531|11077489|FG000|STARTED|Overall Study||196
9958064|NCT01454531|11077489|FG000|Subjects Treated|Overall Study||192
9958065|NCT01454531|11077489|FG000|COMPLETED|Overall Study||173
9958066|NCT01454531|11077489|FG000|NOT COMPLETED|Overall Study||23
9958067|NCT01454570|11077493|FG000|STARTED|Overall Study||19
9958068|NCT01454570|11077493|FG000|COMPLETED|Overall Study||10
9958069|NCT01454570|11077493|FG000|NOT COMPLETED|Overall Study||9
9958070|NCT01454583|11077500|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
9958071|NCT01454583|11077501|FG001|STARTED|1st Year||2696
9958072|NCT01454583|11077502|FG002|STARTED|1st Year||2113
9958073|NCT01454583|11077500|FG000|COMPLETED|1st Year||9120
9958074|NCT01454583|11077501|FG001|COMPLETED|1st Year||2378
9958075|NCT01454583|11077502|FG002|COMPLETED|1st Year||1933
9958076|NCT01454583|11077500|FG000|NOT COMPLETED|1st Year||1057
9958077|NCT01454583|11077501|FG001|NOT COMPLETED|1st Year||318
9958078|NCT01454583|11077502|FG002|NOT COMPLETED|1st Year||180
9958079|NCT01454583|11077500|FG000|STARTED|2nd Year||10177
9958080|NCT01454583|11077501|FG001|STARTED|2nd Year||2696
9958081|NCT01454583|11077502|FG002|STARTED|2nd Year||2113
9958082|NCT01454583|11077500|FG000|COMPLETED|2nd Year||6212
9835477|NCT00790842|10946642|FG001|Began Treatment|Dose Level 3||0
9835478|NCT00790842|10946643|FG002|Began Treatment|Dose Level 3||6
9835479|NCT00790842|10946644|FG003|Began Treatment|Dose Level 3||0
9835480|NCT00790842|10946645|FG004|Began Treatment|Dose Level 3||0
9835481|NCT00790842|10946646|FG005|Began Treatment|Dose Level 3||3
9835482|NCT00790842|10946647|FG006|Began Treatment|Dose Level 3||0
9835483|NCT00790842|10946648|FG007|Began Treatment|Dose Level 3||0
9835484|NCT00790842|10946649|FG008|Began Treatment|Dose Level 3||0
9835485|NCT00790842|10946650|FG009|Began Treatment|Dose Level 3||3
9835486|NCT00790842|10946651|FG010|Began Treatment|Dose Level 3||0
9835487|NCT00790842|10946641|FG000|COMPLETED|Dose Level 3||0
9835488|NCT00790842|10946642|FG001|COMPLETED|Dose Level 3||0
9835489|NCT00790842|10946643|FG002|COMPLETED|Dose Level 3||2
9835490|NCT00790842|10946644|FG003|COMPLETED|Dose Level 3||0
9835491|NCT00790842|10946645|FG004|COMPLETED|Dose Level 3||0
9835492|NCT00790842|10946646|FG005|COMPLETED|Dose Level 3||2
9835493|NCT00790842|10946647|FG006|COMPLETED|Dose Level 3||0
9835494|NCT00790842|10946648|FG007|COMPLETED|Dose Level 3||0
9835495|NCT00790842|10946649|FG008|COMPLETED|Dose Level 3||0
9835496|NCT00790842|10946650|FG009|COMPLETED|Dose Level 3||1
9835497|NCT00790842|10946651|FG010|COMPLETED|Dose Level 3||0
9835498|NCT00790842|10946641|FG000|NOT COMPLETED|Dose Level 3||0
9835499|NCT00790842|10946642|FG001|NOT COMPLETED|Dose Level 3||0
9835500|NCT00790842|10946643|FG002|NOT COMPLETED|Dose Level 3||5
9835501|NCT00790842|10946644|FG003|NOT COMPLETED|Dose Level 3||0
9835502|NCT00790842|10946645|FG004|NOT COMPLETED|Dose Level 3||0
9835503|NCT00790842|10946646|FG005|NOT COMPLETED|Dose Level 3||1
9835504|NCT00790842|10946647|FG006|NOT COMPLETED|Dose Level 3||0
9835505|NCT00790842|10946648|FG007|NOT COMPLETED|Dose Level 3||0
9835506|NCT00790842|10946649|FG008|NOT COMPLETED|Dose Level 3||0
9835507|NCT00790842|10946650|FG009|NOT COMPLETED|Dose Level 3||2
9835508|NCT00790842|10946651|FG010|NOT COMPLETED|Dose Level 3||0
9835509|NCT00790842|10946641|FG000|STARTED|Dose Level 4||0
9835510|NCT00790842|10946642|FG001|STARTED|Dose Level 4||0
9835511|NCT00790842|10946643|FG002|STARTED|Dose Level 4||0
9835512|NCT00790842|10946644|FG003|STARTED|Dose Level 4||0
9835513|NCT00790842|10946645|FG004|STARTED|Dose Level 4||0
9835514|NCT00790842|10946646|FG005|STARTED|Dose Level 4||0
9835515|NCT00790842|10946647|FG006|STARTED|Dose Level 4||8
9835516|NCT00790842|10946648|FG007|STARTED|Dose Level 4||0
9835517|NCT00790842|10946649|FG008|STARTED|Dose Level 4||0
9835518|NCT00790842|10946650|FG009|STARTED|Dose Level 4||0
9835519|NCT00790842|10946651|FG010|STARTED|Dose Level 4||5
9835520|NCT00790842|10946641|FG000|Began Treatment|Dose Level 4||0
9835521|NCT00790842|10946642|FG001|Began Treatment|Dose Level 4||0
9835522|NCT00790842|10946643|FG002|Began Treatment|Dose Level 4||0
9835523|NCT00790842|10946644|FG003|Began Treatment|Dose Level 4||0
9835524|NCT00790842|10946645|FG004|Began Treatment|Dose Level 4||0
9835525|NCT00790842|10946646|FG005|Began Treatment|Dose Level 4||0
9835526|NCT00790842|10946647|FG006|Began Treatment|Dose Level 4||8
9835527|NCT00790842|10946648|FG007|Began Treatment|Dose Level 4||0
9835528|NCT00790842|10946649|FG008|Began Treatment|Dose Level 4||0
9835529|NCT00790842|10946650|FG009|Began Treatment|Dose Level 4||0
9835530|NCT00790842|10946651|FG010|Began Treatment|Dose Level 4||5
9835531|NCT00790842|10946641|FG000|COMPLETED|Dose Level 4||0
9835532|NCT00790842|10946642|FG001|COMPLETED|Dose Level 4||0
9835533|NCT00790842|10946643|FG002|COMPLETED|Dose Level 4||0
9835534|NCT00790842|10946644|FG003|COMPLETED|Dose Level 4||0
9835535|NCT00790842|10946645|FG004|COMPLETED|Dose Level 4||0
9835536|NCT00790842|10946646|FG005|COMPLETED|Dose Level 4||0
9835537|NCT00790842|10946647|FG006|COMPLETED|Dose Level 4||6
9835538|NCT00790842|10946648|FG007|COMPLETED|Dose Level 4||0
9835539|NCT00790842|10946649|FG008|COMPLETED|Dose Level 4||0
9835540|NCT00790842|10946650|FG009|COMPLETED|Dose Level 4||0
9835541|NCT00790842|10946651|FG010|COMPLETED|Dose Level 4||3
9835542|NCT00790842|10946641|FG000|NOT COMPLETED|Dose Level 4||0
9835543|NCT00790842|10946642|FG001|NOT COMPLETED|Dose Level 4||0
9835544|NCT00790842|10946643|FG002|NOT COMPLETED|Dose Level 4||0
9835545|NCT00790842|10946644|FG003|NOT COMPLETED|Dose Level 4||0
9835546|NCT00790842|10946645|FG004|NOT COMPLETED|Dose Level 4||0
10021049|NCT01840605|11144391|FG000|NOT COMPLETED|Overall Study||2
10021050|NCT01840605|11144392|FG001|NOT COMPLETED|Overall Study||2
10081099|NCT02257957|11209563|FG000|STARTED|Overall Study||15
10081100|NCT02257957|11209564|FG001|STARTED|Overall Study||15
10081101|NCT02257957|11209563|FG000|COMPLETED|Overall Study||15
10081102|NCT02257957|11209564|FG001|COMPLETED|Overall Study||15
9835547|NCT00790842|10946646|FG005|NOT COMPLETED|Dose Level 4||0
9835548|NCT00790842|10946647|FG006|NOT COMPLETED|Dose Level 4||2
9835549|NCT00790842|10946648|FG007|NOT COMPLETED|Dose Level 4||0
9835550|NCT00790842|10946649|FG008|NOT COMPLETED|Dose Level 4||0
9835551|NCT00790842|10946650|FG009|NOT COMPLETED|Dose Level 4||0
9835552|NCT00790842|10946651|FG010|NOT COMPLETED|Dose Level 4||2
9835553|NCT00790842|10946641|FG000|STARTED|Expansion Cohort||0
9835554|NCT00790842|10946642|FG001|STARTED|Expansion Cohort||0
9835555|NCT00790842|10946643|FG002|STARTED|Expansion Cohort||14
9835556|NCT00790842|10946644|FG003|STARTED|Expansion Cohort||0
9835557|NCT00790842|10946645|FG004|STARTED|Expansion Cohort||0
9835558|NCT00790842|10946646|FG005|STARTED|Expansion Cohort||0
9835559|NCT00790842|10946647|FG006|STARTED|Expansion Cohort||2
9835560|NCT00790842|10946648|FG007|STARTED|Expansion Cohort||0
9835561|NCT00790842|10946649|FG008|STARTED|Expansion Cohort||0
9835562|NCT00790842|10946650|FG009|STARTED|Expansion Cohort||0
9835563|NCT00790842|10946651|FG010|STARTED|Expansion Cohort||0
9835564|NCT00790842|10946641|FG000|Began Treatment|Expansion Cohort||0
9835565|NCT00790842|10946642|FG001|Began Treatment|Expansion Cohort||0
9835566|NCT00790842|10946643|FG002|Began Treatment|Expansion Cohort||14
9835567|NCT00790842|10946644|FG003|Began Treatment|Expansion Cohort||0
9835568|NCT00790842|10946645|FG004|Began Treatment|Expansion Cohort||0
9835569|NCT00790842|10946646|FG005|Began Treatment|Expansion Cohort||0
9835570|NCT00790842|10946647|FG006|Began Treatment|Expansion Cohort||2
9835571|NCT00790842|10946648|FG007|Began Treatment|Expansion Cohort||0
9835572|NCT00790842|10946649|FG008|Began Treatment|Expansion Cohort||0
9835573|NCT00790842|10946650|FG009|Began Treatment|Expansion Cohort||0
10081103|NCT02257957|11209563|FG000|NOT COMPLETED|Overall Study||0
10081104|NCT02257957|11209564|FG001|NOT COMPLETED|Overall Study||0
10081105|NCT02257970|11209574|FG000|STARTED|Part 1||50
10081106|NCT02257970|11209575|FG001|STARTED|Part 1||0
10081107|NCT02257970|11209576|FG002|STARTED|Part 1||0
10081108|NCT02257970|11209577|FG003|STARTED|Part 1||0
9835574|NCT00790842|10946651|FG010|Began Treatment|Expansion Cohort||0
9835575|NCT00790842|10946641|FG000|COMPLETED|Expansion Cohort||0
9835576|NCT00790842|10946642|FG001|COMPLETED|Expansion Cohort||0
9835577|NCT00790842|10946643|FG002|COMPLETED|Expansion Cohort||7
9835578|NCT00790842|10946644|FG003|COMPLETED|Expansion Cohort||0
9835579|NCT00790842|10946645|FG004|COMPLETED|Expansion Cohort||0
9835580|NCT00790842|10946646|FG005|COMPLETED|Expansion Cohort||0
9835581|NCT00790842|10946647|FG006|COMPLETED|Expansion Cohort||1
9835582|NCT00790842|10946648|FG007|COMPLETED|Expansion Cohort||0
9835583|NCT00790842|10946649|FG008|COMPLETED|Expansion Cohort||0
9835584|NCT00790842|10946650|FG009|COMPLETED|Expansion Cohort||0
10081109|NCT02257970|11209574|FG000|COMPLETED|Part 1||50
10081110|NCT02257970|11209575|FG001|COMPLETED|Part 1||0
10081111|NCT02257970|11209576|FG002|COMPLETED|Part 1||0
10081112|NCT02257970|11209577|FG003|COMPLETED|Part 1||0
10081113|NCT02257970|11209574|FG000|NOT COMPLETED|Part 1||0
10081114|NCT02257970|11209575|FG001|NOT COMPLETED|Part 1||0
10081115|NCT02257970|11209576|FG002|NOT COMPLETED|Part 1||0
10021051|NCT01840722|11144400|FG000|STARTED|Overall Study||201
10021052|NCT01840722|11144401|FG001|STARTED|Overall Study||199
10021053|NCT01840722|11144400|FG000|COMPLETED|Overall Study||201
10021054|NCT01840722|11144401|FG001|COMPLETED|Overall Study||130
10021055|NCT01840722|11144400|FG000|NOT COMPLETED|Overall Study||0
10021056|NCT01840722|11144401|FG001|NOT COMPLETED|Overall Study||69
10021057|NCT01840943|11144409|FG000|STARTED|Overall Study||14
10021058|NCT01840943|11144410|FG001|STARTED|Overall Study||12
10021059|NCT01840943|11144409|FG000|COMPLETED|Overall Study||1
10021060|NCT01840943|11144410|FG001|COMPLETED|Overall Study||0
10021061|NCT01840943|11144409|FG000|NOT COMPLETED|Overall Study||13
10021062|NCT01840943|11144410|FG001|NOT COMPLETED|Overall Study||12
10021063|NCT01841021|11144416|FG000|STARTED|Overall Study||1
10021064|NCT01841021|11144416|FG000|COMPLETED|Overall Study||1
10021065|NCT01841021|11144416|FG000|NOT COMPLETED|Overall Study||0
9958083|NCT01454583|11077501|FG001|COMPLETED|2nd Year||1647
10021066|NCT01841047|11144420|FG000|STARTED|Overall Study||48
10021067|NCT01841047|11144420|FG000|COMPLETED|Overall Study||48
10021068|NCT01841047|11144420|FG000|NOT COMPLETED|Overall Study||0
10021069|NCT01841060|11144424|FG000|STARTED|Overall Study||42
10021070|NCT01841060|11144424|FG000|COMPLETED|Overall Study||32
10021071|NCT01841060|11144424|FG000|NOT COMPLETED|Overall Study||10
10021072|NCT01841073|11144430|FG000|STARTED|Overall Study||22
10021073|NCT01841073|11144431|FG001|STARTED|Overall Study||22
10021074|NCT01841073|11144430|FG000|COMPLETED|Overall Study||20
10114018|NCT02513212|11244749|FG001|STARTED|Overall Study||12
10114019|NCT02513212|11244748|FG000|COMPLETED|Overall Study||11
10114020|NCT02513212|11244749|FG001|COMPLETED|Overall Study||12
10114021|NCT02513212|11244748|FG000|NOT COMPLETED|Overall Study||1
10114022|NCT02513212|11244749|FG001|NOT COMPLETED|Overall Study||0
10114023|NCT02513446|11244757|FG000|STARTED|Period 1||8
10114024|NCT02513446|11244758|FG001|STARTED|Period 1||8
10114025|NCT02513446|11244757|FG000|COMPLETED|Period 1||8
10114026|NCT02513446|11244758|FG001|COMPLETED|Period 1||8
10114027|NCT02513446|11244757|FG000|NOT COMPLETED|Period 1||0
10114028|NCT02513446|11244758|FG001|NOT COMPLETED|Period 1||0
10114029|NCT02513446|11244757|FG000|STARTED|Washout Period of 10 Days||8
10114030|NCT02513446|11244758|FG001|STARTED|Washout Period of 10 Days||8
10114031|NCT02513446|11244757|FG000|COMPLETED|Washout Period of 10 Days||8
10114032|NCT02513446|11244758|FG001|COMPLETED|Washout Period of 10 Days||8
10114033|NCT02513446|11244757|FG000|NOT COMPLETED|Washout Period of 10 Days||0
10114034|NCT02513446|11244758|FG001|NOT COMPLETED|Washout Period of 10 Days||0
10114035|NCT02513446|11244757|FG000|STARTED|Period 2||8
10114036|NCT02513446|11244758|FG001|STARTED|Period 2||8
10114037|NCT02513446|11244757|FG000|COMPLETED|Period 2||8
10114038|NCT02513446|11244758|FG001|COMPLETED|Period 2||8
10114039|NCT02513446|11244757|FG000|NOT COMPLETED|Period 2||0
9835585|NCT00790842|10946651|FG010|COMPLETED|Expansion Cohort||0
9835586|NCT00790842|10946641|FG000|NOT COMPLETED|Expansion Cohort||0
9835587|NCT00790842|10946642|FG001|NOT COMPLETED|Expansion Cohort||0
9835588|NCT00790842|10946643|FG002|NOT COMPLETED|Expansion Cohort||7
9835589|NCT00790842|10946644|FG003|NOT COMPLETED|Expansion Cohort||0
9835590|NCT00790842|10946645|FG004|NOT COMPLETED|Expansion Cohort||0
9835591|NCT00790842|10946646|FG005|NOT COMPLETED|Expansion Cohort||0
9835592|NCT00790842|10946647|FG006|NOT COMPLETED|Expansion Cohort||1
9835593|NCT00790842|10946648|FG007|NOT COMPLETED|Expansion Cohort||0
9835594|NCT00790842|10946649|FG008|NOT COMPLETED|Expansion Cohort||0
9835595|NCT00790842|10946650|FG009|NOT COMPLETED|Expansion Cohort||0
9835596|NCT00790842|10946651|FG010|NOT COMPLETED|Expansion Cohort||0
9835597|NCT00790855|10946699|FG000|STARTED|Overall Study||25
9835598|NCT00790855|10946699|FG000|COMPLETED|Overall Study||25
9835599|NCT00790855|10946699|FG000|NOT COMPLETED|Overall Study||0
9835600|NCT00790868|10946706|FG000|STARTED|Overall Study||88
9835601|NCT00790868|10946707|FG001|STARTED|Overall Study||92
9835602|NCT00790868|10946706|FG000|COMPLETED|Overall Study||82
9835603|NCT00790868|10946707|FG001|COMPLETED|Overall Study||75
9835604|NCT00790868|10946706|FG000|NOT COMPLETED|Overall Study||6
9835605|NCT00790868|10946707|FG001|NOT COMPLETED|Overall Study||17
9835606|NCT00790907|10946718|FG000|STARTED|Overall Study||1209
9835607|NCT00790907|10946719|FG001|STARTED|Overall Study||1024
9835608|NCT00790907|10946720|FG002|STARTED|Overall Study||1002
9835609|NCT00790907|10946718|FG000|COMPLETED|Overall Study||754
9835610|NCT00790907|10946719|FG001|COMPLETED|Overall Study||684
9835611|NCT00790907|10946720|FG002|COMPLETED|Overall Study||663
9835612|NCT00790907|10946718|FG000|NOT COMPLETED|Overall Study||455
9835613|NCT00790907|10946719|FG001|NOT COMPLETED|Overall Study||340
9835614|NCT00790907|10946720|FG002|NOT COMPLETED|Overall Study||339
9835615|NCT00791037|10946727|FG000|STARTED|Overall Study||23
9835616|NCT00791037|10946727|FG000|Primary Outcome|Overall Study||19
9835617|NCT00791037|10946727|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
9835618|NCT00791037|10946727|FG000|COMPLETED|Overall Study||23
9835619|NCT00791037|10946727|FG000|NOT COMPLETED|Overall Study||0
9835620|NCT00791089|10946735|FG000|STARTED|Overall Study||6
9835621|NCT00791089|10946736|FG001|STARTED|Overall Study||6
9835622|NCT00791089|10946735|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6
9835623|NCT00791089|10946736|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5
9835624|NCT00791089|10946735|FG000|Six-month Data Collected|Overall Study||6
9835625|NCT00791089|10946736|FG001|Six-month Data Collected|Overall Study||5
9835626|NCT00791089|10946735|FG000|COMPLETED|Overall Study||0
9835627|NCT00791089|10946736|FG001|COMPLETED|Overall Study||0
9835628|NCT00791089|10946735|FG000|NOT COMPLETED|Overall Study||6
9835629|NCT00791089|10946736|FG001|NOT COMPLETED|Overall Study||6
9835630|NCT00791102|10946742|FG000|STARTED|Period 1||10
9835631|NCT00791102|10946743|FG001|STARTED|Period 1||10
9835632|NCT00791102|10946742|FG000|COMPLETED|Period 1||10
9835633|NCT00791102|10946743|FG001|COMPLETED|Period 1||10
9835634|NCT00791102|10946742|FG000|NOT COMPLETED|Period 1||0
9835635|NCT00791102|10946743|FG001|NOT COMPLETED|Period 1||0
9835636|NCT00791102|10946742|FG000|STARTED|Washout Period of 2 Weeks||10
9835637|NCT00791102|10946743|FG001|STARTED|Washout Period of 2 Weeks||10
9835638|NCT00791102|10946742|FG000|COMPLETED|Washout Period of 2 Weeks||10
9835639|NCT00791102|10946743|FG001|COMPLETED|Washout Period of 2 Weeks||10
9835640|NCT00791102|10946742|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9835641|NCT00791102|10946743|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9835642|NCT00791102|10946742|FG000|STARTED|Period 2||10
9835643|NCT00791102|10946743|FG001|STARTED|Period 2||10
9835644|NCT00791102|10946742|FG000|COMPLETED|Period 2||10
9835645|NCT00791102|10946743|FG001|COMPLETED|Period 2||10
9835646|NCT00791102|10946742|FG000|NOT COMPLETED|Period 2||0
9835647|NCT00791102|10946743|FG001|NOT COMPLETED|Period 2||0
9835648|NCT00791128|10946749|FG000|STARTED|Overall Study||22
9835649|NCT00791128|10946749|FG000|COMPLETED|Overall Study||13
9835650|NCT00791128|10946749|FG000|NOT COMPLETED|Overall Study||9
9835651|NCT00791219|10946756|FG000|STARTED|Overall Study||24
9835652|NCT00791219|10946757|FG001|STARTED|Overall Study||76
9835653|NCT00791219|10946758|FG002|STARTED|Overall Study||75
9835654|NCT00791219|10946756|FG000|COMPLETED|Overall Study||19
9835655|NCT00791219|10946757|FG001|COMPLETED|Overall Study||60
9835656|NCT00791219|10946758|FG002|COMPLETED|Overall Study||61
9835657|NCT00791219|10946756|FG000|NOT COMPLETED|Overall Study||5
9835658|NCT00791219|10946757|FG001|NOT COMPLETED|Overall Study||16
9835659|NCT00791219|10946758|FG002|NOT COMPLETED|Overall Study||14
9835660|NCT00791258|10946766|FG000|STARTED|Overall Study||999
9835661|NCT00791258|10946766|FG000|COMPLETED|Overall Study||736
9835662|NCT00791258|10946766|FG000|NOT COMPLETED|Overall Study||263
9835663|NCT00791323|10946772|FG000|STARTED|Overall Study||6
9835664|NCT00791323|10946773|FG001|STARTED|Overall Study||3
9835665|NCT00791323|10946772|FG000|COMPLETED|Overall Study||6
9835666|NCT00791323|10946773|FG001|COMPLETED|Overall Study||3
9835667|NCT00791323|10946772|FG000|NOT COMPLETED|Overall Study||0
9835668|NCT00791323|10946773|FG001|NOT COMPLETED|Overall Study||0
9835669|NCT00791388|10946784|FG000|STARTED|Period 1 - 50 mg Dose Group||3
9835670|NCT00791388|10946785|FG001|STARTED|Period 1 - 50 mg Dose Group||8
9835671|NCT00791388|10946786|FG002|STARTED|Period 1 - 50 mg Dose Group||0
9835672|NCT00791388|10946787|FG003|STARTED|Period 1 - 50 mg Dose Group||0
9835673|NCT00791388|10946788|FG004|STARTED|Period 1 - 50 mg Dose Group||0
9835674|NCT00791388|10946784|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3
9731545|NCT00132769|10831411|FG001|STARTED|Overall Study||53
9835675|NCT00791388|10946785|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7
9835676|NCT00791388|10946786|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0
9835677|NCT00791388|10946787|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0
9835678|NCT00791388|10946788|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0
9835679|NCT00791388|10946784|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
9835680|NCT00791388|10946785|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
9835681|NCT00791388|10946786|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
9835682|NCT00791388|10946787|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
9835683|NCT00791388|10946788|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
9958084|NCT01454583|11077502|FG002|COMPLETED|2nd Year||1376
9958085|NCT01454583|11077500|FG000|NOT COMPLETED|2nd Year||3965
9958086|NCT01454583|11077501|FG001|NOT COMPLETED|2nd Year||1049
9958087|NCT01454583|11077502|FG002|NOT COMPLETED|2nd Year||737
9958088|NCT01454583|11077500|FG000|STARTED|3rd Year||3791
9958089|NCT01454583|11077501|FG001|STARTED|3rd Year||982
9958090|NCT01454583|11077502|FG002|STARTED|3rd Year||582
9958091|NCT01454583|11077500|FG000|COMPLETED|3rd Year||1832
9958092|NCT01454583|11077501|FG001|COMPLETED|3rd Year||470
9958093|NCT01454583|11077502|FG002|COMPLETED|3rd Year||285
9958094|NCT01454583|11077500|FG000|NOT COMPLETED|3rd Year||1959
9958095|NCT01454583|11077501|FG001|NOT COMPLETED|3rd Year||512
9958096|NCT01454583|11077502|FG002|NOT COMPLETED|3rd Year||297
9958097|NCT01454596|11077522|FG000|STARTED|Overall Study||1
9958098|NCT01454596|11077523|FG001|STARTED|Overall Study||1
9958099|NCT01454596|11077524|FG002|STARTED|Overall Study||1
9958100|NCT01454596|11077525|FG003|STARTED|Overall Study||1
9958101|NCT01454596|11077526|FG004|STARTED|Overall Study||1
9958102|NCT01454596|11077527|FG005|STARTED|Overall Study||1
9958103|NCT01454596|11077528|FG006|STARTED|Overall Study||1
9958104|NCT01454596|11077529|FG007|STARTED|Overall Study||3
9958105|NCT01454596|11077530|FG008|STARTED|Overall Study||3
9958106|NCT01454596|11077531|FG009|STARTED|Overall Study||3
9958107|NCT01454596|11077532|FG010|STARTED|Overall Study||1
9958108|NCT01454596|11077533|FG011|STARTED|Overall Study||1
9958109|NCT01454596|11077522|FG000|COMPLETED|Overall Study||1
9958110|NCT01454596|11077523|FG001|COMPLETED|Overall Study||1
9958111|NCT01454596|11077524|FG002|COMPLETED|Overall Study||1
9958112|NCT01454596|11077525|FG003|COMPLETED|Overall Study||1
9958113|NCT01454596|11077526|FG004|COMPLETED|Overall Study||1
9958114|NCT01454596|11077527|FG005|COMPLETED|Overall Study||1
9958115|NCT01454596|11077528|FG006|COMPLETED|Overall Study||1
9958116|NCT01454596|11077529|FG007|COMPLETED|Overall Study||3
9958117|NCT01454596|11077530|FG008|COMPLETED|Overall Study||3
9958118|NCT01454596|11077531|FG009|COMPLETED|Overall Study||2
9958119|NCT01454596|11077532|FG010|COMPLETED|Overall Study||0
9958120|NCT01454596|11077533|FG011|COMPLETED|Overall Study||1
9958121|NCT01454596|11077522|FG000|NOT COMPLETED|Overall Study||0
9958122|NCT01454596|11077523|FG001|NOT COMPLETED|Overall Study||0
9958123|NCT01454596|11077524|FG002|NOT COMPLETED|Overall Study||0
9958124|NCT01454596|11077525|FG003|NOT COMPLETED|Overall Study||0
9958125|NCT01454596|11077526|FG004|NOT COMPLETED|Overall Study||0
9958126|NCT01454596|11077527|FG005|NOT COMPLETED|Overall Study||0
9958127|NCT01454596|11077528|FG006|NOT COMPLETED|Overall Study||0
9958128|NCT01454596|11077529|FG007|NOT COMPLETED|Overall Study||0
9958129|NCT01454596|11077530|FG008|NOT COMPLETED|Overall Study||0
9958130|NCT01454596|11077531|FG009|NOT COMPLETED|Overall Study||1
9958131|NCT01454596|11077532|FG010|NOT COMPLETED|Overall Study||1
9958132|NCT01454596|11077533|FG011|NOT COMPLETED|Overall Study||0
9958133|NCT01454726|11077561|FG000|STARTED|Overall Study||16
9958134|NCT01454726|11077562|FG001|STARTED|Overall Study||11
9958135|NCT01454726|11077561|FG000|COMPLETED|Overall Study||16
9958136|NCT01454726|11077562|FG001|COMPLETED|Overall Study||10
9958137|NCT01454726|11077561|FG000|NOT COMPLETED|Overall Study||0
9958138|NCT01454726|11077562|FG001|NOT COMPLETED|Overall Study||1
9958139|NCT01454739|11077570|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
9958140|NCT01454739|11077571|FG001|STARTED|Overall Study||179
9958141|NCT01454739|11077570|FG000|Tailored Prophylaxis|Overall Study||59
9835684|NCT00791388|10946784|FG000|STARTED|Period 2 - 100 mg Dose Group||3
9835685|NCT00791388|10946785|FG001|STARTED|Period 2 - 100 mg Dose Group||0
9835686|NCT00791388|10946786|FG002|STARTED|Period 2 - 100 mg Dose Group||8
9835687|NCT00791388|10946787|FG003|STARTED|Period 2 - 100 mg Dose Group||0
9835688|NCT00791388|10946788|FG004|STARTED|Period 2 - 100 mg Dose Group||0
9835689|NCT00791388|10946784|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2
9835690|NCT00791388|10946785|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0
9835691|NCT00791388|10946786|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8
9835692|NCT00791388|10946787|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0
9835693|NCT00791388|10946788|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0
9835694|NCT00791388|10946784|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
9835695|NCT00791388|10946785|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
9835696|NCT00791388|10946786|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
9835697|NCT00791388|10946787|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
9835698|NCT00791388|10946788|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
9835699|NCT00791388|10946784|FG000|STARTED|Period 3 - 200 mg Dose Group||3
9835700|NCT00791388|10946785|FG001|STARTED|Period 3 - 200 mg Dose Group||0
9835701|NCT00791388|10946786|FG002|STARTED|Period 3 - 200 mg Dose Group||0
9835702|NCT00791388|10946787|FG003|STARTED|Period 3 - 200 mg Dose Group||8
9835703|NCT00791388|10946788|FG004|STARTED|Period 3 - 200 mg Dose Group||0
9835704|NCT00791388|10946784|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3
9835705|NCT00791388|10946785|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0
9835706|NCT00791388|10946786|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0
9835707|NCT00791388|10946787|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8
9835708|NCT00791388|10946788|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0
9835709|NCT00791388|10946784|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
9835710|NCT00791388|10946785|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
9835711|NCT00791388|10946786|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
9835712|NCT00791388|10946787|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
9835713|NCT00791388|10946788|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
9835714|NCT00791388|10946784|FG000|STARTED|Period 4 - 400 mg Dose Group||4
9835715|NCT00791388|10946785|FG001|STARTED|Period 4 - 400 mg Dose Group||0
9835716|NCT00791388|10946786|FG002|STARTED|Period 4 - 400 mg Dose Group||0
9835717|NCT00791388|10946787|FG003|STARTED|Period 4 - 400 mg Dose Group||0
9835718|NCT00791388|10946788|FG004|STARTED|Period 4 - 400 mg Dose Group||8
9835719|NCT00791388|10946784|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4
9835720|NCT00791388|10946785|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0
9835721|NCT00791388|10946786|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0
9835722|NCT00791388|10946787|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0
9835723|NCT00791388|10946788|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4
9835724|NCT00791388|10946784|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
9835725|NCT00791388|10946785|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
9835726|NCT00791388|10946786|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
9835727|NCT00791388|10946787|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
9835728|NCT00791388|10946788|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
9835729|NCT00791479|10946806|FG000|STARTED|Overall Study||35
9835730|NCT00791479|10946807|FG001|STARTED|Overall Study||34
9835731|NCT00791479|10946808|FG002|STARTED|Overall Study||34
9835732|NCT00791479|10946809|FG003|STARTED|Overall Study||29
9835733|NCT00791479|10946810|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
9835734|NCT00791479|10946811|FG005|STARTED|Overall Study||32
9835735|NCT00791479|10946806|FG000|Received at Least One Dose of Study Drug|Overall Study||35
9835736|NCT00791479|10946807|FG001|Received at Least One Dose of Study Drug|Overall Study||34
9835737|NCT00791479|10946808|FG002|Received at Least One Dose of Study Drug|Overall Study||34
9835738|NCT00791479|10946809|FG003|Received at Least One Dose of Study Drug|Overall Study||29
9835739|NCT00791479|10946810|FG004|Received at Least One Dose of Study Drug|Overall Study||3
9835740|NCT00791479|10946811|FG005|Received at Least One Dose of Study Drug|Overall Study||32
9835741|NCT00791479|10946806|FG000|COMPLETED|Overall Study||33
9835742|NCT00791479|10946807|FG001|COMPLETED|Overall Study||31
9835743|NCT00791479|10946808|FG002|COMPLETED|Overall Study||34
9835744|NCT00791479|10946809|FG003|COMPLETED|Overall Study||25
9835745|NCT00791479|10946810|FG004|COMPLETED|Overall Study||0
9835746|NCT00791479|10946811|FG005|COMPLETED|Overall Study||29
9835747|NCT00791479|10946806|FG000|NOT COMPLETED|Overall Study||2
9835748|NCT00791479|10946807|FG001|NOT COMPLETED|Overall Study||3
9835749|NCT00791479|10946808|FG002|NOT COMPLETED|Overall Study||0
9835750|NCT00791479|10946809|FG003|NOT COMPLETED|Overall Study||4
9835751|NCT00791479|10946810|FG004|NOT COMPLETED|Overall Study||3
9835752|NCT00791479|10946811|FG005|NOT COMPLETED|Overall Study||3
9835753|NCT00791492|10946834|FG000|STARTED|Overall Study||45
9835754|NCT00791492|10946835|FG001|STARTED|Overall Study||41
9835755|NCT00791492|10946834|FG000|TREATED|Overall Study||44
9835756|NCT00791492|10946835|FG001|TREATED|Overall Study||41
9835757|NCT00791492|10946834|FG000|COMPLETED|Overall Study||39
9835758|NCT00791492|10946835|FG001|COMPLETED|Overall Study||38
9835759|NCT00791492|10946834|FG000|NOT COMPLETED|Overall Study||6
9835760|NCT00791492|10946835|FG001|NOT COMPLETED|Overall Study||3
9835761|NCT00791518|10946841|FG000|STARTED|Overall Study||1084
9835762|NCT00791518|10946841|FG000|COMPLETED|Overall Study||991
9835763|NCT00791518|10946841|FG000|NOT COMPLETED|Overall Study||93
9835764|NCT00791557|10946860|FG000|STARTED|Overall Study||2
9835765|NCT00791557|10946860|FG000|COMPLETED|Overall Study||1
9835766|NCT00791557|10946860|FG000|NOT COMPLETED|Overall Study||1
9835767|NCT00791648|10946866|FG000|STARTED|Overall Study||308
9835768|NCT00791648|10946867|FG001|STARTED|Overall Study||309
9835769|NCT00791648|10946866|FG000|COMPLETED|Overall Study||308
9835770|NCT00791648|10946867|FG001|COMPLETED|Overall Study||307
9835771|NCT00791648|10946866|FG000|NOT COMPLETED|Overall Study||0
9835772|NCT00791648|10946867|FG001|NOT COMPLETED|Overall Study||2
9835773|NCT00791661|10946876|FG000|STARTED|Period 1||8
9835774|NCT00791661|10946877|FG001|STARTED|Period 1||8
9835775|NCT00791661|10946878|FG002|STARTED|Period 1||8
9835776|NCT00791661|10946876|FG000|Received MK-1006|Period 1||6
9835777|NCT00791661|10946877|FG001|Received MK-1006|Period 1||6
9835778|NCT00791661|10946878|FG002|Received MK-1006|Period 1||6
9835779|NCT00791661|10946876|FG000|Received Matching Placebo to MK-1006|Period 1||2
9835780|NCT00791661|10946877|FG001|Received Matching Placebo to MK-1006|Period 1||2
9835781|NCT00791661|10946878|FG002|Received Matching Placebo to MK-1006|Period 1||2
9835782|NCT00791661|10946876|FG000|COMPLETED|Period 1||8
9835783|NCT00791661|10946877|FG001|COMPLETED|Period 1||8
9835784|NCT00791661|10946878|FG002|COMPLETED|Period 1||8
9835785|NCT00791661|10946876|FG000|NOT COMPLETED|Period 1||0
9835786|NCT00791661|10946877|FG001|NOT COMPLETED|Period 1||0
9835787|NCT00791661|10946878|FG002|NOT COMPLETED|Period 1||0
9835788|NCT00791661|10946876|FG000|STARTED|7 Day Wash-out||8
9835789|NCT00791661|10946877|FG001|STARTED|7 Day Wash-out||8
9835790|NCT00791661|10946878|FG002|STARTED|7 Day Wash-out||8
9835791|NCT00791661|10946876|FG000|COMPLETED|7 Day Wash-out||8
9835792|NCT00791661|10946877|FG001|COMPLETED|7 Day Wash-out||8
9835793|NCT00791661|10946878|FG002|COMPLETED|7 Day Wash-out||6
9835794|NCT00791661|10946876|FG000|NOT COMPLETED|7 Day Wash-out||0
9835795|NCT00791661|10946877|FG001|NOT COMPLETED|7 Day Wash-out||0
9835796|NCT00791661|10946878|FG002|NOT COMPLETED|7 Day Wash-out||2
9835797|NCT00791661|10946876|FG000|STARTED|Period 2||8
9835798|NCT00791661|10946877|FG001|STARTED|Period 2||8
9835799|NCT00791661|10946878|FG002|STARTED|Period 2||6
9835800|NCT00791661|10946876|FG000|Received MK-1006|Period 2||6
9835801|NCT00791661|10946877|FG001|Received MK-1006|Period 2||6
9835802|NCT00791661|10946878|FG002|Received MK-1006|Period 2||4
9835803|NCT00791661|10946876|FG000|Received Matching Placebo to MK-1006|Period 2||2
9835804|NCT00791661|10946877|FG001|Received Matching Placebo to MK-1006|Period 2||2
9835805|NCT00791661|10946878|FG002|Received Matching Placebo to MK-1006|Period 2||2
9835806|NCT00791661|10946876|FG000|COMPLETED|Period 2||8
9835807|NCT00791661|10946877|FG001|COMPLETED|Period 2||8
9835808|NCT00791661|10946878|FG002|COMPLETED|Period 2||6
9835809|NCT00791661|10946876|FG000|NOT COMPLETED|Period 2||0
9835810|NCT00791661|10946877|FG001|NOT COMPLETED|Period 2||0
9835811|NCT00791661|10946878|FG002|NOT COMPLETED|Period 2||0
9835812|NCT00791661|10946876|FG000|STARTED|7 Day Wash-out||8
9835813|NCT00791661|10946877|FG001|STARTED|7 Day Wash-out||8
9835814|NCT00791661|10946878|FG002|STARTED|7 Day Wash-out||6
9835815|NCT00791661|10946876|FG000|COMPLETED|7 Day Wash-out||8
9835816|NCT00791661|10946877|FG001|COMPLETED|7 Day Wash-out||8
9835817|NCT00791661|10946878|FG002|COMPLETED|7 Day Wash-out||6
9835818|NCT00791661|10946876|FG000|NOT COMPLETED|7 Day Wash-out||0
9835819|NCT00791661|10946877|FG001|NOT COMPLETED|7 Day Wash-out||0
9835820|NCT00791661|10946878|FG002|NOT COMPLETED|7 Day Wash-out||0
9835821|NCT00791661|10946876|FG000|STARTED|Period 3||8
9835822|NCT00791661|10946877|FG001|STARTED|Period 3||8
9835823|NCT00791661|10946878|FG002|STARTED|Period 3||6
9835824|NCT00791661|10946876|FG000|Received MK-1006|Period 3||6
9835825|NCT00791661|10946877|FG001|Received MK-1006|Period 3||6
9835826|NCT00791661|10946878|FG002|Received MK-1006|Period 3||5
9835827|NCT00791661|10946876|FG000|Received Matching Placebo to MK-1006|Period 3||2
9835828|NCT00791661|10946877|FG001|Received Matching Placebo to MK-1006|Period 3||2
9835829|NCT00791661|10946878|FG002|Received Matching Placebo to MK-1006|Period 3||1
9835830|NCT00791661|10946876|FG000|COMPLETED|Period 3||8
9835831|NCT00791661|10946877|FG001|COMPLETED|Period 3||8
9835832|NCT00791661|10946878|FG002|COMPLETED|Period 3||6
9835833|NCT00791661|10946876|FG000|NOT COMPLETED|Period 3||0
9835834|NCT00791661|10946877|FG001|NOT COMPLETED|Period 3||0
9835835|NCT00791661|10946878|FG002|NOT COMPLETED|Period 3||0
9835836|NCT00791700|10946906|FG000|STARTED|Overall Study||16
9835837|NCT00791700|10946907|FG001|STARTED|Overall Study||31
9835838|NCT00791700|10946908|FG002|STARTED|Overall Study||13
9958142|NCT01454739|11077571|FG001|Tailored Prophylaxis|Overall Study||131
9835839|NCT00791700|10946909|FG003|STARTED|Overall Study||43
9835840|NCT00791700|10946906|FG000|COMPLETED|Overall Study||10
9835841|NCT00791700|10946907|FG001|COMPLETED|Overall Study||20
9835842|NCT00791700|10946908|FG002|COMPLETED|Overall Study||7
9835843|NCT00791700|10946909|FG003|COMPLETED|Overall Study||13
9835844|NCT00791700|10946906|FG000|NOT COMPLETED|Overall Study||6
9958143|NCT01454739|11077570|FG000|Weekly Prophylaxis|Overall Study||0
10114040|NCT02513446|11244758|FG001|NOT COMPLETED|Period 2||0
10114041|NCT02513459|11244765|FG000|STARTED|Overall Study||65
10114042|NCT02513459|11244765|FG000|COMPLETED|Overall Study||44
10114043|NCT02513459|11244765|FG000|NOT COMPLETED|Overall Study||21
10114044|NCT02513498|11244774|FG000|STARTED|Overall Study||50
10114045|NCT02513498|11244774|FG000|COMPLETED|Overall Study||26
10114046|NCT02513498|11244774|FG000|NOT COMPLETED|Overall Study||24
10114047|NCT02513550|11244786|FG000|STARTED|Double Blind Treatment Period||310
10114048|NCT02513550|11244787|FG001|STARTED|Double Blind Treatment Period||306
10114049|NCT02513550|11244788|FG002|STARTED|Double Blind Treatment Period||611
9958144|NCT01454739|11077571|FG001|Weekly Prophylaxis|Overall Study||34
10021075|NCT01841073|11144431|FG001|COMPLETED|Overall Study||19
10021076|NCT01841073|11144430|FG000|NOT COMPLETED|Overall Study||2
10021077|NCT01841073|11144431|FG001|NOT COMPLETED|Overall Study||3
10021078|NCT01841216|11144441|FG000|STARTED|Overall Study||15
10021079|NCT01841216|11144442|FG001|STARTED|Overall Study||15
10021080|NCT01841216|11144441|FG000|COMPLETED|Overall Study||15
10021081|NCT01841216|11144442|FG001|COMPLETED|Overall Study||15
10021082|NCT01841216|11144441|FG000|NOT COMPLETED|Overall Study||0
10021083|NCT01841216|11144442|FG001|NOT COMPLETED|Overall Study||0
10021084|NCT01841281|11144450|FG000|STARTED|First Intervention (12 Weeks)||11
9835845|NCT00791700|10946907|FG001|NOT COMPLETED|Overall Study||11
9835846|NCT00791700|10946908|FG002|NOT COMPLETED|Overall Study||6
9835847|NCT00791700|10946909|FG003|NOT COMPLETED|Overall Study||30
9835848|NCT00791765|10946932|FG000|STARTED|Weeks 1 to 12||62
9835849|NCT00791765|10946933|FG001|STARTED|Weeks 1 to 12||62
9835850|NCT00791765|10946932|FG000|Treated|Weeks 1 to 12||62
9835851|NCT00791765|10946933|FG001|Treated|Weeks 1 to 12||59
9835852|NCT00791765|10946932|FG000|COMPLETED|Weeks 1 to 12||54
9835853|NCT00791765|10946933|FG001|COMPLETED|Weeks 1 to 12||58
9835854|NCT00791765|10946932|FG000|NOT COMPLETED|Weeks 1 to 12||8
9835855|NCT00791765|10946933|FG001|NOT COMPLETED|Weeks 1 to 12||4
9835856|NCT00791765|10946932|FG000|STARTED|Weeks 13 to 24||54
9835857|NCT00791765|10946933|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
9835858|NCT00791765|10946932|FG000|COMPLETED|Weeks 13 to 24||49
9835859|NCT00791765|10946933|FG001|COMPLETED|Weeks 13 to 24||49
9835860|NCT00791765|10946932|FG000|NOT COMPLETED|Weeks 13 to 24||5
9835861|NCT00791765|10946933|FG001|NOT COMPLETED|Weeks 13 to 24||8
9835862|NCT00791778|10946941|FG000|STARTED|Double-blind Treatment||123
9958145|NCT01454739|11077570|FG000|Personalized Prophylaxis|Overall Study||3
9835863|NCT00791778|10946942|FG001|STARTED|Double-blind Treatment||123
9835864|NCT00791778|10946941|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
9958146|NCT01454739|11077571|FG001|Personalized Prophylaxis|Overall Study||23
10021085|NCT01841281|11144451|FG001|STARTED|First Intervention (12 Weeks)||12
10021086|NCT01841281|11144452|FG002|STARTED|First Intervention (12 Weeks)||13
10021087|NCT01841281|11144453|FG003|STARTED|First Intervention (12 Weeks)||14
10021088|NCT01841281|11144450|FG000|COMPLETED|First Intervention (12 Weeks)||11
10021089|NCT01841281|11144451|FG001|COMPLETED|First Intervention (12 Weeks)||12
9835865|NCT00791778|10946942|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
9835866|NCT00791778|10946941|FG000|NOT COMPLETED|Double-blind Treatment||77
9835867|NCT00791778|10946942|FG001|NOT COMPLETED|Double-blind Treatment||48
9835868|NCT00791778|10946941|FG000|STARTED|Follow-up||100
9835869|NCT00791778|10946942|FG001|STARTED|Follow-up||91
9835870|NCT00791778|10946941|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
9835871|NCT00791778|10946942|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
9731546|NCT00132769|10831410|FG000|COMPLETED|Overall Study||42
10021090|NCT01841281|11144452|FG002|COMPLETED|First Intervention (12 Weeks)||13
10021091|NCT01841281|11144453|FG003|COMPLETED|First Intervention (12 Weeks)||14
9719425|NCT00042991|10818974|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
9719426|NCT00042991|10818975|FG002|Phase-I Trial|Overall Study||7
9719427|NCT00042991|10818976|FG003|Phase-I Trial|Overall Study||2
9719428|NCT00042991|10818977|FG004|Phase-I Trial|Overall Study||3
9719429|NCT00042991|10818978|FG005|Phase-I Trial|Overall Study||5
9719430|NCT00042991|10818979|FG006|Phase-I Trial|Overall Study||3
9719431|NCT00042991|10818973|FG000|Phase-II Trial|Overall Study||0
9719432|NCT00042991|10818974|FG001|Phase-II Trial|Overall Study||36
9719433|NCT00042991|10818975|FG002|Phase-II Trial|Overall Study||0
9719434|NCT00042991|10818976|FG003|Phase-II Trial|Overall Study||0
9719435|NCT00042991|10818977|FG004|Phase-II Trial|Overall Study||0
9719436|NCT00042991|10818978|FG005|Phase-II Trial|Overall Study||0
9719437|NCT00042991|10818979|FG006|Phase-II Trial|Overall Study||0
9719438|NCT00042991|10818973|FG000|COMPLETED|Overall Study||0
9719439|NCT00042991|10818974|FG001|COMPLETED|Overall Study||3
9719440|NCT00042991|10818975|FG002|COMPLETED|Overall Study||1
9719441|NCT00042991|10818976|FG003|COMPLETED|Overall Study||0
9719442|NCT00042991|10818977|FG004|COMPLETED|Overall Study||0
9719443|NCT00042991|10818978|FG005|COMPLETED|Overall Study||0
9719444|NCT00042991|10818979|FG006|COMPLETED|Overall Study||1
9719445|NCT00042991|10818973|FG000|NOT COMPLETED|Overall Study||6
9719446|NCT00042991|10818974|FG001|NOT COMPLETED|Overall Study||40
9719447|NCT00042991|10818975|FG002|NOT COMPLETED|Overall Study||6
9719448|NCT00042991|10818976|FG003|NOT COMPLETED|Overall Study||2
9719449|NCT00042991|10818977|FG004|NOT COMPLETED|Overall Study||3
9719450|NCT00042991|10818978|FG005|NOT COMPLETED|Overall Study||5
9719451|NCT00042991|10818979|FG006|NOT COMPLETED|Overall Study||2
9719452|NCT00043186|10819006|FG000|STARTED|Overall Study||46
9719453|NCT00043186|10819007|FG001|STARTED|Overall Study||44
9719454|NCT00043186|10819008|FG002|STARTED|Overall Study||44
9719455|NCT00043186|10819009|FG003|STARTED|Overall Study||41
9719456|NCT00043186|10819010|FG004|STARTED|Overall Study||54
9719457|NCT00043186|10819011|FG005|STARTED|Overall Study||47
9719458|NCT00043186|10819012|FG006|STARTED|Overall Study||42
9719459|NCT00043186|10819013|FG007|STARTED|Overall Study||47
9719460|NCT00043186|10819014|FG008|STARTED|Overall Study||47
9719461|NCT00043186|10819006|FG000|COMPLETED|Overall Study||29
9719462|NCT00043186|10819007|FG001|COMPLETED|Overall Study||29
9719463|NCT00043186|10819008|FG002|COMPLETED|Overall Study||24
9719464|NCT00043186|10819009|FG003|COMPLETED|Overall Study||19
9719465|NCT00043186|10819010|FG004|COMPLETED|Overall Study||36
9719466|NCT00043186|10819011|FG005|COMPLETED|Overall Study||39
9719467|NCT00043186|10819012|FG006|COMPLETED|Overall Study||25
9719468|NCT00043186|10819013|FG007|COMPLETED|Overall Study||31
9719469|NCT00043186|10819014|FG008|COMPLETED|Overall Study||30
9719470|NCT00043186|10819006|FG000|NOT COMPLETED|Overall Study||17
9719471|NCT00043186|10819007|FG001|NOT COMPLETED|Overall Study||15
9719472|NCT00043186|10819008|FG002|NOT COMPLETED|Overall Study||20
9835872|NCT00791778|10946941|FG000|NOT COMPLETED|Follow-up||5
9835873|NCT00791778|10946942|FG001|NOT COMPLETED|Follow-up||1
9835874|NCT00791817|10946950|FG000|STARTED|1: Single Dose Followed by Week Washout||5
9835875|NCT00791817|10946951|FG001|STARTED|1: Single Dose Followed by Week Washout||5
9835876|NCT00791817|10946950|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5
9835877|NCT00791817|10946951|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5
9835878|NCT00791817|10946950|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
9835879|NCT00791817|10946951|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
9835880|NCT00791817|10946950|FG000|STARTED|2: Single Dose||5
9835881|NCT00791817|10946951|FG001|STARTED|2: Single Dose||5
9835882|NCT00791817|10946950|FG000|COMPLETED|2: Single Dose||5
9835883|NCT00791817|10946951|FG001|COMPLETED|2: Single Dose||5
9835884|NCT00791817|10946950|FG000|NOT COMPLETED|2: Single Dose||0
9835885|NCT00791817|10946951|FG001|NOT COMPLETED|2: Single Dose||0
9835886|NCT00791908|10946957|FG000|STARTED|Overall Study||15
9835887|NCT00791908|10946957|FG000|COMPLETED|Overall Study||15
9835888|NCT00791908|10946957|FG000|NOT COMPLETED|Overall Study||0
9835889|NCT00791921|10946967|FG000|STARTED|Overall Study||116
9835890|NCT00791921|10946968|FG001|STARTED|Overall Study||114
9835891|NCT00791921|10946967|FG000|COMPLETED|Overall Study||82
9835892|NCT00791921|10946968|FG001|COMPLETED|Overall Study||18
9835893|NCT00791921|10946967|FG000|NOT COMPLETED|Overall Study||34
9835894|NCT00791921|10946968|FG001|NOT COMPLETED|Overall Study||96
9958147|NCT01454739|11077570|FG000|Episodic|Overall Study||0
9958148|NCT01454739|11077571|FG001|Episodic|Overall Study||13
9958149|NCT01454739|11077570|FG000|Surgery Subgroup|Overall Study||2
9958150|NCT01454739|11077571|FG001|Surgery Subgroup|Overall Study||26
9835895|NCT00791934|10946974|FG000|STARTED|Overall Study||63
9835896|NCT00791934|10946974|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
9958151|NCT01454739|11077570|FG000|COMPLETED|Overall Study||54
9958152|NCT01454739|11077571|FG001|COMPLETED|Overall Study||158
9958153|NCT01454739|11077570|FG000|NOT COMPLETED|Overall Study||7
10021092|NCT01841281|11144450|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10021093|NCT01841281|11144451|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
10021094|NCT01841281|11144452|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0
10021095|NCT01841281|11144453|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0
10021096|NCT01841281|11144450|FG000|STARTED|Washout (6 Weeks)||11
9835897|NCT00791934|10946974|FG000|NOT COMPLETED|Overall Study||15
9835898|NCT00791973|10946980|FG000|STARTED|First Intervention (1 Week)||8
9835899|NCT00791973|10946981|FG001|STARTED|First Intervention (1 Week)||7
9835900|NCT00791973|10946980|FG000|COMPLETED|First Intervention (1 Week)||8
9835901|NCT00791973|10946981|FG001|COMPLETED|First Intervention (1 Week)||7
9835902|NCT00791973|10946980|FG000|NOT COMPLETED|First Intervention (1 Week)||0
9835903|NCT00791973|10946981|FG001|NOT COMPLETED|First Intervention (1 Week)||0
9835904|NCT00791973|10946980|FG000|STARTED|Washout (1 Week)||8
9835905|NCT00791973|10946981|FG001|STARTED|Washout (1 Week)||7
9835906|NCT00791973|10946980|FG000|COMPLETED|Washout (1 Week)||8
9958154|NCT01454739|11077571|FG001|NOT COMPLETED|Overall Study||21
9958155|NCT01454778|11077584|FG000|STARTED|Overall Study||50
9958156|NCT01454778|11077584|FG000|COMPLETED|Overall Study||47
9958157|NCT01454778|11077584|FG000|NOT COMPLETED|Overall Study||3
9958158|NCT01454791|11077590|FG000|STARTED|Overall Study||20
9958159|NCT01454791|11077591|FG001|STARTED|Overall Study||20
9958160|NCT01454791|11077590|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
9958161|NCT01454791|11077591|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
9958162|NCT01454791|11077590|FG000|NOT COMPLETED|Overall Study||0
9958163|NCT01454791|11077591|FG001|NOT COMPLETED|Overall Study||0
9958164|NCT01454830|11077601|FG000|STARTED|Overall Study||61
9958165|NCT01454830|11077602|FG001|STARTED|Overall Study||57
10021097|NCT01841281|11144451|FG001|STARTED|Washout (6 Weeks)||12
9835907|NCT00791973|10946981|FG001|COMPLETED|Washout (1 Week)||7
9835908|NCT00791973|10946980|FG000|NOT COMPLETED|Washout (1 Week)||0
9835909|NCT00791973|10946981|FG001|NOT COMPLETED|Washout (1 Week)||0
9835910|NCT00791973|10946980|FG000|STARTED|Second Intervention (1 Week)||8
9835911|NCT00791973|10946981|FG001|STARTED|Second Intervention (1 Week)||7
9835912|NCT00791973|10946980|FG000|COMPLETED|Second Intervention (1 Week)||8
9835913|NCT00791973|10946981|FG001|COMPLETED|Second Intervention (1 Week)||7
10021098|NCT01841281|11144452|FG002|STARTED|Washout (6 Weeks)||13
9835914|NCT00791973|10946980|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
9835915|NCT00791973|10946981|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
9835916|NCT00791999|10946991|FG000|STARTED|Overall Study||72
9835917|NCT00791999|10946992|FG001|STARTED|Overall Study||82
9835918|NCT00791999|10946993|FG002|STARTED|Overall Study||85
9835919|NCT00791999|10946994|FG003|STARTED|Overall Study||77
9835920|NCT00791999|10946991|FG000|COMPLETED|Overall Study||51
9835921|NCT00791999|10946992|FG001|COMPLETED|Overall Study||66
9835922|NCT00791999|10946993|FG002|COMPLETED|Overall Study||65
9835923|NCT00791999|10946994|FG003|COMPLETED|Overall Study||25
9835924|NCT00791999|10946991|FG000|NOT COMPLETED|Overall Study||21
9835925|NCT00791999|10946992|FG001|NOT COMPLETED|Overall Study||16
9835926|NCT00791999|10946993|FG002|NOT COMPLETED|Overall Study||20
9835927|NCT00791999|10946994|FG003|NOT COMPLETED|Overall Study||52
9835928|NCT00792077|10947004|FG000|STARTED|Overall Study||6
9835929|NCT00792077|10947004|FG000|Day 15+/- 3 Days|Overall Study||6
9835930|NCT00792077|10947004|FG000|Day 29+/-3 Days|Overall Study||6
9835931|NCT00792077|10947004|FG000|Day 43+/-3 Days|Overall Study||6
9835932|NCT00792077|10947004|FG000|Day 57+/-3 Days|Overall Study||6
9835933|NCT00792077|10947004|FG000|COMPLETED|Overall Study||6
9835934|NCT00792077|10947004|FG000|NOT COMPLETED|Overall Study||0
9835935|NCT00792103|10947008|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
9835936|NCT00792103|10947008|FG000|COMPLETED|Overall Study||65
9835937|NCT00792103|10947008|FG000|NOT COMPLETED|Overall Study||133
9835938|NCT00792142|10947012|FG000|STARTED|Overall Study||45
9835939|NCT00792142|10947012|FG000|COMPLETED|Overall Study||45
9835940|NCT00792142|10947012|FG000|NOT COMPLETED|Overall Study||0
9958166|NCT01454830|11077601|FG000|COMPLETED|Overall Study||30
9958167|NCT01454830|11077602|FG001|COMPLETED|Overall Study||30
9958168|NCT01454830|11077601|FG000|NOT COMPLETED|Overall Study||31
9958169|NCT01454830|11077602|FG001|NOT COMPLETED|Overall Study||27
9958170|NCT01454934|11077610|FG000|STARTED|Overall Study||270
9958171|NCT01454934|11077611|FG001|STARTED|Overall Study||270
9958172|NCT01454934|11077610|FG000|COMPLETED|Overall Study||0
9958173|NCT01454934|11077611|FG001|COMPLETED|Overall Study||0
9958174|NCT01454934|11077610|FG000|NOT COMPLETED|Overall Study||270
9835941|NCT00792298|10947016|FG000|STARTED|Treatment Period 1||31
9835942|NCT00792298|10947017|FG001|STARTED|Treatment Period 1||32
9958175|NCT01454934|11077611|FG001|NOT COMPLETED|Overall Study||270
9958176|NCT01454947|11077625|FG000|STARTED|Overall Study||27
9958177|NCT01454947|11077626|FG001|STARTED|Overall Study||42
9835943|NCT00792298|10947018|FG002|STARTED|Treatment Period 1||33
9835944|NCT00792298|10947019|FG003|STARTED|Treatment Period 1||32
9835945|NCT00792298|10947020|FG004|STARTED|Treatment Period 1||32
9835946|NCT00792298|10947021|FG005|STARTED|Treatment Period 1||32
9835947|NCT00792298|10947022|FG006|STARTED|Treatment Period 1||31
9835948|NCT00792298|10947023|FG007|STARTED|Treatment Period 1||31
9835949|NCT00792298|10947016|FG000|COMPLETED|Treatment Period 1||30
9835950|NCT00792298|10947017|FG001|COMPLETED|Treatment Period 1||31
9835951|NCT00792298|10947018|FG002|COMPLETED|Treatment Period 1||31
9835952|NCT00792298|10947019|FG003|COMPLETED|Treatment Period 1||28
9835953|NCT00792298|10947020|FG004|COMPLETED|Treatment Period 1||32
9835954|NCT00792298|10947021|FG005|COMPLETED|Treatment Period 1||29
10021099|NCT01841281|11144453|FG003|STARTED|Washout (6 Weeks)||14
10021100|NCT01841281|11144450|FG000|COMPLETED|Washout (6 Weeks)||9
10021101|NCT01841281|11144451|FG001|COMPLETED|Washout (6 Weeks)||9
10021102|NCT01841281|11144452|FG002|COMPLETED|Washout (6 Weeks)||10
10021103|NCT01841281|11144453|FG003|COMPLETED|Washout (6 Weeks)||13
10021104|NCT01841281|11144450|FG000|NOT COMPLETED|Washout (6 Weeks)||2
9835955|NCT00792298|10947022|FG006|COMPLETED|Treatment Period 1||27
9835956|NCT00792298|10947023|FG007|COMPLETED|Treatment Period 1||30
9835957|NCT00792298|10947016|FG000|NOT COMPLETED|Treatment Period 1||1
9835958|NCT00792298|10947017|FG001|NOT COMPLETED|Treatment Period 1||1
9835959|NCT00792298|10947018|FG002|NOT COMPLETED|Treatment Period 1||2
9835960|NCT00792298|10947019|FG003|NOT COMPLETED|Treatment Period 1||4
10021105|NCT01841281|11144451|FG001|NOT COMPLETED|Washout (6 Weeks)||3
10021106|NCT01841281|11144452|FG002|NOT COMPLETED|Washout (6 Weeks)||3
10021107|NCT01841281|11144453|FG003|NOT COMPLETED|Washout (6 Weeks)||1
10021108|NCT01841281|11144450|FG000|STARTED|Second Intervention (12 Weeks)||9
10021109|NCT01841281|11144451|FG001|STARTED|Second Intervention (12 Weeks)||9
10021110|NCT01841281|11144452|FG002|STARTED|Second Intervention (12 Weeks)||10
10021111|NCT01841281|11144453|FG003|STARTED|Second Intervention (12 Weeks)||13
10021112|NCT01841281|11144450|FG000|COMPLETED|Second Intervention (12 Weeks)||9
9835961|NCT00792298|10947020|FG004|NOT COMPLETED|Treatment Period 1||0
9835962|NCT00792298|10947021|FG005|NOT COMPLETED|Treatment Period 1||3
9835963|NCT00792298|10947022|FG006|NOT COMPLETED|Treatment Period 1||4
9835964|NCT00792298|10947023|FG007|NOT COMPLETED|Treatment Period 1||1
9835965|NCT00792298|10947016|FG000|STARTED|Washout||30
9835966|NCT00792298|10947017|FG001|STARTED|Washout||31
9835967|NCT00792298|10947018|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
9835968|NCT00792298|10947019|FG003|STARTED|Washout||28
9835969|NCT00792298|10947020|FG004|STARTED|Washout||32
9835970|NCT00792298|10947021|FG005|STARTED|Washout||29
9835971|NCT00792298|10947022|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
9835972|NCT00792298|10947023|FG007|STARTED|Washout||30
9835973|NCT00792298|10947016|FG000|COMPLETED|Washout||30
9835974|NCT00792298|10947017|FG001|COMPLETED|Washout||31
9835975|NCT00792298|10947018|FG002|COMPLETED|Washout||31
9835976|NCT00792298|10947019|FG003|COMPLETED|Washout||28
9835977|NCT00792298|10947020|FG004|COMPLETED|Washout||32
9835978|NCT00792298|10947021|FG005|COMPLETED|Washout||27
9835979|NCT00792298|10947022|FG006|COMPLETED|Washout||29
9835980|NCT00792298|10947023|FG007|COMPLETED|Washout||30
9835981|NCT00792298|10947016|FG000|NOT COMPLETED|Washout||0
9835982|NCT00792298|10947017|FG001|NOT COMPLETED|Washout||0
9835983|NCT00792298|10947018|FG002|NOT COMPLETED|Washout||1
9835984|NCT00792298|10947019|FG003|NOT COMPLETED|Washout||0
9835985|NCT00792298|10947020|FG004|NOT COMPLETED|Washout||0
9835986|NCT00792298|10947021|FG005|NOT COMPLETED|Washout||2
9835987|NCT00792298|10947022|FG006|NOT COMPLETED|Washout||0
9835988|NCT00792298|10947023|FG007|NOT COMPLETED|Washout||0
9835989|NCT00792298|10947016|FG000|STARTED|Treatment Period 2||30
9835990|NCT00792298|10947017|FG001|STARTED|Treatment Period 2||31
9835991|NCT00792298|10947018|FG002|STARTED|Treatment Period 2||31
9835992|NCT00792298|10947019|FG003|STARTED|Treatment Period 2||28
9835993|NCT00792298|10947020|FG004|STARTED|Treatment Period 2||32
9835994|NCT00792298|10947021|FG005|STARTED|Treatment Period 2||27
9835995|NCT00792298|10947022|FG006|STARTED|Treatment Period 2||29
9835996|NCT00792298|10947023|FG007|STARTED|Treatment Period 2||30
9835997|NCT00792298|10947016|FG000|COMPLETED|Treatment Period 2||29
9835998|NCT00792298|10947017|FG001|COMPLETED|Treatment Period 2||30
9835999|NCT00792298|10947018|FG002|COMPLETED|Treatment Period 2||30
9836000|NCT00792298|10947019|FG003|COMPLETED|Treatment Period 2||26
9836001|NCT00792298|10947020|FG004|COMPLETED|Treatment Period 2||30
9836002|NCT00792298|10947021|FG005|COMPLETED|Treatment Period 2||27
9836003|NCT00792298|10947022|FG006|COMPLETED|Treatment Period 2||28
9836004|NCT00792298|10947023|FG007|COMPLETED|Treatment Period 2||28
9836005|NCT00792298|10947016|FG000|NOT COMPLETED|Treatment Period 2||1
9836006|NCT00792298|10947017|FG001|NOT COMPLETED|Treatment Period 2||1
9836007|NCT00792298|10947018|FG002|NOT COMPLETED|Treatment Period 2||1
10021113|NCT01841281|11144451|FG001|COMPLETED|Second Intervention (12 Weeks)||6
10021114|NCT01841281|11144452|FG002|COMPLETED|Second Intervention (12 Weeks)||10
9836008|NCT00792298|10947019|FG003|NOT COMPLETED|Treatment Period 2||2
9836009|NCT00792298|10947020|FG004|NOT COMPLETED|Treatment Period 2||2
9836010|NCT00792298|10947021|FG005|NOT COMPLETED|Treatment Period 2||0
9836011|NCT00792298|10947022|FG006|NOT COMPLETED|Treatment Period 2||1
9836012|NCT00792298|10947023|FG007|NOT COMPLETED|Treatment Period 2||2
9836013|NCT00792428|10947042|FG000|STARTED|Overall Study||10
9836014|NCT00792428|10947043|FG001|STARTED|Overall Study||10
9836015|NCT00792428|10947042|FG000|COMPLETED|Overall Study||10
9836016|NCT00792428|10947043|FG001|COMPLETED|Overall Study||10
9836017|NCT00792428|10947042|FG000|NOT COMPLETED|Overall Study||0
9836018|NCT00792428|10947043|FG001|NOT COMPLETED|Overall Study||0
9836019|NCT00792467|10947049|FG000|STARTED|Overall Study||24
9836020|NCT00792467|10947049|FG000|COMPLETED|Overall Study||2
9836021|NCT00792467|10947049|FG000|NOT COMPLETED|Overall Study||22
9958178|NCT01454947|11077627|FG002|STARTED|Overall Study||35
9958179|NCT01454947|11077628|FG003|STARTED|Overall Study||20
9719473|NCT00043186|10819009|FG003|NOT COMPLETED|Overall Study||22
9719474|NCT00043186|10819010|FG004|NOT COMPLETED|Overall Study||18
9719475|NCT00043186|10819011|FG005|NOT COMPLETED|Overall Study||8
9719476|NCT00043186|10819012|FG006|NOT COMPLETED|Overall Study||17
9719477|NCT00043186|10819013|FG007|NOT COMPLETED|Overall Study||16
9719478|NCT00043186|10819014|FG008|NOT COMPLETED|Overall Study||17
9719479|NCT00043550|10819038|FG000|STARTED|Overall Study||55
9719480|NCT00043550|10819039|FG001|STARTED|Overall Study||51
9719481|NCT00043550|10819040|FG002|STARTED|Overall Study||50
9719482|NCT00043550|10819038|FG000|Week 8 Completed|Overall Study||35
9719483|NCT00043550|10819039|FG001|Week 8 Completed|Overall Study||40
9836022|NCT00792571|10947054|FG000|STARTED|Overall Study||18
9836023|NCT00792571|10947054|FG000|COMPLETED|Overall Study||8
9836024|NCT00792571|10947054|FG000|NOT COMPLETED|Overall Study||10
9836025|NCT00792610|10947058|FG000|STARTED|Overall Study||127
9836026|NCT00792610|10947058|FG000|Youths|Overall Study||127
9836027|NCT00792610|10947058|FG000|COMPLETED|Overall Study||127
9836028|NCT00792610|10947058|FG000|NOT COMPLETED|Overall Study||0
9836029|NCT00792623|10947062|FG000|STARTED|Overall Study||29
9836030|NCT00792623|10947062|FG000|COMPLETED|Overall Study||22
9836031|NCT00792623|10947062|FG000|NOT COMPLETED|Overall Study||7
9836032|NCT00792636|10947070|FG000|STARTED|Overall Study||135
9836033|NCT00792636|10947071|FG001|STARTED|Overall Study||136
9836034|NCT00792636|10947072|FG002|STARTED|Overall Study||136
9836035|NCT00792636|10947070|FG000|COMPLETED|Overall Study||67
9836036|NCT00792636|10947071|FG001|COMPLETED|Overall Study||55
9836037|NCT00792636|10947072|FG002|COMPLETED|Overall Study||55
9836038|NCT00792636|10947070|FG000|NOT COMPLETED|Overall Study||68
9836039|NCT00792636|10947071|FG001|NOT COMPLETED|Overall Study||81
9836040|NCT00792636|10947072|FG002|NOT COMPLETED|Overall Study||81
9836041|NCT00792688|10947085|FG000|STARTED|Overall Study||9
9836042|NCT00792688|10947086|FG001|STARTED|Overall Study||8
9836043|NCT00792688|10947087|FG002|STARTED|Overall Study||9
9836044|NCT00792688|10947085|FG000|COMPLETED|Overall Study||9
9836045|NCT00792688|10947086|FG001|COMPLETED|Overall Study||8
9836046|NCT00792688|10947087|FG002|COMPLETED|Overall Study||9
9836047|NCT00792688|10947085|FG000|NOT COMPLETED|Overall Study||0
9836048|NCT00792688|10947086|FG001|NOT COMPLETED|Overall Study||0
9719484|NCT00043550|10819040|FG002|Week 8 Completed|Overall Study||35
9719485|NCT00043550|10819038|FG000|COMPLETED|Overall Study||33
9719486|NCT00043550|10819039|FG001|COMPLETED|Overall Study||39
9719487|NCT00043550|10819040|FG002|COMPLETED|Overall Study||30
9836049|NCT00792688|10947087|FG002|NOT COMPLETED|Overall Study||0
9836050|NCT00792701|10947097|FG000|STARTED|Overall Study||19
9836051|NCT00792701|10947098|FG001|STARTED|Overall Study||66
9836052|NCT00792701|10947097|FG000|Eligible|Overall Study||18
9836053|NCT00792701|10947098|FG001|Eligible|Overall Study||63
9836054|NCT00792701|10947097|FG000|Eligible and Analyzable|Overall Study||17
9836055|NCT00792701|10947098|FG001|Eligible and Analyzable|Overall Study||44
9836056|NCT00792701|10947097|FG000|COMPLETED|Overall Study||0
9836057|NCT00792701|10947098|FG001|COMPLETED|Overall Study||22
9836058|NCT00792701|10947097|FG000|NOT COMPLETED|Overall Study||19
9836059|NCT00792701|10947098|FG001|NOT COMPLETED|Overall Study||44
9836060|NCT00792805|10947109|FG000|STARTED|Overall Study||188
9836061|NCT00792805|10947110|FG001|STARTED|Overall Study||188
9836062|NCT00792805|10947111|FG002|STARTED|Overall Study||187
9836063|NCT00792805|10947109|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
9836064|NCT00792805|10947110|FG001|Exposed to Study Medication or Placebo|Overall Study||188
9836065|NCT00792805|10947111|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
9836066|NCT00792805|10947109|FG000|COMPLETED|Overall Study||166
9836067|NCT00792805|10947110|FG001|COMPLETED|Overall Study||162
9836068|NCT00792805|10947111|FG002|COMPLETED|Overall Study||154
9836069|NCT00792805|10947109|FG000|NOT COMPLETED|Overall Study||22
9836070|NCT00792805|10947110|FG001|NOT COMPLETED|Overall Study||26
9836071|NCT00792805|10947111|FG002|NOT COMPLETED|Overall Study||33
9836072|NCT00792909|10947122|FG000|STARTED|Overall Study||51
9836073|NCT00792909|10947123|FG001|STARTED|Overall Study||59
9836074|NCT00792909|10947124|FG002|STARTED|Overall Study||62
9836075|NCT00792909|10947122|FG000|COMPLETED|Overall Study||51
9836076|NCT00792909|10947123|FG001|COMPLETED|Overall Study||58
9836077|NCT00792909|10947124|FG002|COMPLETED|Overall Study||62
9836078|NCT00792909|10947122|FG000|NOT COMPLETED|Overall Study||0
9836079|NCT00792909|10947123|FG001|NOT COMPLETED|Overall Study||1
9958180|NCT01454947|11077629|FG004|STARTED|Overall Study||34
9958181|NCT01454947|11077630|FG005|STARTED|Overall Study||35
9958182|NCT01454947|11077631|FG006|STARTED|Overall Study||27
9958183|NCT01454947|11077632|FG007|STARTED|Overall Study||28
9958184|NCT01454947|11077625|FG000|COMPLETED|Overall Study||24
9958185|NCT01454947|11077626|FG001|COMPLETED|Overall Study||38
9958186|NCT01454947|11077627|FG002|COMPLETED|Overall Study||32
9958187|NCT01454947|11077628|FG003|COMPLETED|Overall Study||19
9958188|NCT01454947|11077629|FG004|COMPLETED|Overall Study||33
9958189|NCT01454947|11077630|FG005|COMPLETED|Overall Study||32
9958190|NCT01454947|11077631|FG006|COMPLETED|Overall Study||26
9958191|NCT01454947|11077632|FG007|COMPLETED|Overall Study||23
9958192|NCT01454947|11077625|FG000|NOT COMPLETED|Overall Study||3
9958193|NCT01454947|11077626|FG001|NOT COMPLETED|Overall Study||4
9958194|NCT01454947|11077627|FG002|NOT COMPLETED|Overall Study||3
9958195|NCT01454947|11077628|FG003|NOT COMPLETED|Overall Study||1
9958196|NCT01454947|11077629|FG004|NOT COMPLETED|Overall Study||1
9958197|NCT01454947|11077630|FG005|NOT COMPLETED|Overall Study||3
9958198|NCT01454947|11077631|FG006|NOT COMPLETED|Overall Study||1
9958199|NCT01454947|11077632|FG007|NOT COMPLETED|Overall Study||5
9958200|NCT01455012|11077652|FG000|STARTED|Overall Study||41
9958201|NCT01455012|11077653|FG001|STARTED|Overall Study||40
9958202|NCT01455012|11077652|FG000|COMPLETED|Overall Study||30
9958203|NCT01455012|11077653|FG001|COMPLETED|Overall Study||36
9958204|NCT01455012|11077652|FG000|NOT COMPLETED|Overall Study||11
9958205|NCT01455012|11077653|FG001|NOT COMPLETED|Overall Study||4
9958206|NCT01455064|11077659|FG000|STARTED|Overall Study||31
9836080|NCT00792909|10947124|FG002|NOT COMPLETED|Overall Study||0
9836081|NCT00792922|10947139|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836082|NCT00792922|10947140|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836083|NCT00792922|10947141|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836084|NCT00792922|10947142|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836085|NCT00792922|10947139|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
9836086|NCT00792922|10947140|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
9836087|NCT00792922|10947141|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
9836088|NCT00792922|10947142|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
9836089|NCT00792922|10947139|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
9958207|NCT01455064|11077659|FG000|COMPLETED|Overall Study||30
9958208|NCT01455064|11077659|FG000|NOT COMPLETED|Overall Study||1
9958209|NCT01455181|11077663|FG000|STARTED|Overall Study||24
9958210|NCT01455181|11077663|FG000|COMPLETED|Overall Study||24
9958211|NCT01455181|11077663|FG000|NOT COMPLETED|Overall Study||0
10021115|NCT01841281|11144453|FG003|COMPLETED|Second Intervention (12 Weeks)||13
10021116|NCT01841281|11144450|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10021117|NCT01841281|11144451|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3
10021118|NCT01841281|11144452|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0
10021119|NCT01841281|11144453|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0
10021120|NCT01841554|11144469|FG000|STARTED|Overall Study||61
10021121|NCT01841554|11144469|FG000|Implanted|Overall Study||60
10021122|NCT01841554|11144469|FG000|1 Year Follow Up|Overall Study||42
10114050|NCT02513550|11244789|FG003|STARTED|Double Blind Treatment Period||9
9836090|NCT00792922|10947140|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
9958212|NCT01455194|11077670|FG000|STARTED|Overall Study||153
10021123|NCT01841554|11144469|FG000|COMPLETED|Overall Study||42
10021124|NCT01841554|11144469|FG000|NOT COMPLETED|Overall Study||19
10114051|NCT02513550|11244790|FG004|STARTED|Double Blind Treatment Period||5
10114052|NCT02513550|11244791|FG005|STARTED|Double Blind Treatment Period||16
10114053|NCT02513550|11244786|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
10114054|NCT02513550|11244787|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
10114055|NCT02513550|11244788|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
10114056|NCT02513550|11244789|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
10114057|NCT02513550|11244790|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
10114058|NCT02513550|11244791|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
10114059|NCT02513550|11244786|FG000|COMPLETED|Double Blind Treatment Period||274
10021125|NCT01841567|11144473|FG000|STARTED|Overall Study||60
10021126|NCT01841567|11144473|FG000|COMPLETED|Overall Study||57
10021127|NCT01841567|11144473|FG000|NOT COMPLETED|Overall Study||3
10021128|NCT01841593|11144479|FG000|STARTED|First Intervention (Days 1 to 7)||12
10021129|NCT01841593|11144480|FG001|STARTED|First Intervention (Days 1 to 7)||7
10021130|NCT01841593|11144479|FG000|COMPLETED|First Intervention (Days 1 to 7)||12
9836091|NCT00792922|10947141|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
9836092|NCT00792922|10947142|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
9836093|NCT00792922|10947139|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
9836094|NCT00792922|10947140|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
9836095|NCT00792922|10947141|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
9958213|NCT01455194|11077671|FG001|STARTED|Overall Study||120
9958214|NCT01455194|11077672|FG002|STARTED|Overall Study||122
9958215|NCT01455194|11077673|FG003|STARTED|Overall Study||125
9958216|NCT01455194|11077670|FG000|COMPLETED|Overall Study||0
9958217|NCT01455194|11077671|FG001|COMPLETED|Overall Study||89
9958218|NCT01455194|11077672|FG002|COMPLETED|Overall Study||92
9958219|NCT01455194|11077673|FG003|COMPLETED|Overall Study||97
9958220|NCT01455194|11077670|FG000|NOT COMPLETED|Overall Study||153
9958221|NCT01455194|11077671|FG001|NOT COMPLETED|Overall Study||31
9958222|NCT01455194|11077672|FG002|NOT COMPLETED|Overall Study||30
9958223|NCT01455194|11077673|FG003|NOT COMPLETED|Overall Study||28
10021131|NCT01841593|11144480|FG001|COMPLETED|First Intervention (Days 1 to 7)||6
10021132|NCT01841593|11144479|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0
10021133|NCT01841593|11144480|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1
10021134|NCT01841593|11144479|FG000|STARTED|Second Intervention (Days 8 to 14)||12
10021135|NCT01841593|11144480|FG001|STARTED|Second Intervention (Days 8 to 14)||6
9958224|NCT01455220|11077686|FG000|STARTED|Overall Study||45
10021136|NCT01841593|11144479|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11
10021137|NCT01841593|11144480|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6
10021138|NCT01841593|11144479|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
10021139|NCT01841593|11144480|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
10021140|NCT01841593|11144479|FG000|STARTED|Third Intervention (Days 15 to 21)||11
9836096|NCT00792922|10947142|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
9836097|NCT00792922|10947139|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836098|NCT00792922|10947140|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836099|NCT00792922|10947141|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836100|NCT00792922|10947142|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
9836101|NCT00792922|10947139|FG000|NOT COMPLETED|At Baseline||
9836102|NCT00792922|10947140|FG001|NOT COMPLETED|At Baseline||
9836103|NCT00792922|10947141|FG002|NOT COMPLETED|At Baseline||
9836104|NCT00792922|10947142|FG003|NOT COMPLETED|At Baseline||
9836105|NCT00792922|10947139|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
9958225|NCT01455220|11077686|FG000|COMPLETED|Overall Study||15
9958226|NCT01455220|11077686|FG000|NOT COMPLETED|Overall Study||30
9958227|NCT01455415|11077695|FG000|STARTED|Period 1|Started=Treated|154
9958228|NCT01455415|11077696|FG001|STARTED|Period 1|Started=Treated|147
9958229|NCT01455415|11077695|FG000|COMPLETED|Period 1||135
9958230|NCT01455415|11077696|FG001|COMPLETED|Period 1||123
9958231|NCT01455415|11077695|FG000|NOT COMPLETED|Period 1||19
9958232|NCT01455415|11077696|FG001|NOT COMPLETED|Period 1||24
9958233|NCT01455415|11077695|FG000|STARTED|Washout||135
9958234|NCT01455415|11077696|FG001|STARTED|Washout||123
9958235|NCT01455415|11077695|FG000|COMPLETED|Washout||127
9958236|NCT01455415|11077696|FG001|COMPLETED|Washout||116
9958237|NCT01455415|11077695|FG000|NOT COMPLETED|Washout||8
9958238|NCT01455415|11077696|FG001|NOT COMPLETED|Washout||7
9958239|NCT01455415|11077695|FG000|STARTED|Period 2||127
9958240|NCT01455415|11077696|FG001|STARTED|Period 2||116
9958241|NCT01455415|11077695|FG000|COMPLETED|Period 2||114
9958242|NCT01455415|11077696|FG001|COMPLETED|Period 2||106
9958243|NCT01455415|11077695|FG000|NOT COMPLETED|Period 2||13
9958244|NCT01455415|11077696|FG001|NOT COMPLETED|Period 2||10
9958245|NCT01455415|11077695|FG000|STARTED|Follow-up||114
9958246|NCT01455415|11077696|FG001|STARTED|Follow-up||106
9958247|NCT01455415|11077695|FG000|COMPLETED|Follow-up||111
9958248|NCT01455415|11077696|FG001|COMPLETED|Follow-up||104
9958249|NCT01455415|11077695|FG000|NOT COMPLETED|Follow-up||3
9958250|NCT01455415|11077696|FG001|NOT COMPLETED|Follow-up||2
9958251|NCT01455428|11077704|FG000|STARTED|Overall Study||112
9958252|NCT01455428|11077705|FG001|STARTED|Overall Study||110
9958253|NCT01455428|11077704|FG000|Treated|Overall Study||111
9958254|NCT01455428|11077705|FG001|Treated|Overall Study||109
9958255|NCT01455428|11077704|FG000|COMPLETED|Overall Study||98
9958256|NCT01455428|11077705|FG001|COMPLETED|Overall Study||92
9958257|NCT01455428|11077704|FG000|NOT COMPLETED|Overall Study||14
9958258|NCT01455428|11077705|FG001|NOT COMPLETED|Overall Study||18
9958259|NCT01455519|11077713|FG000|STARTED|Overall Study||12
9958260|NCT01455519|11077714|FG001|STARTED|Overall Study||23
10021141|NCT01841593|11144480|FG001|STARTED|Third Intervention (Days 15 to 21)||6
9958261|NCT01455519|11077713|FG000|COMPLETED|Overall Study||8
9958262|NCT01455519|11077714|FG001|COMPLETED|Overall Study||18
9958263|NCT01455519|11077713|FG000|NOT COMPLETED|Overall Study||4
9958264|NCT01455519|11077714|FG001|NOT COMPLETED|Overall Study||5
9958265|NCT01455545|11077720|FG000|STARTED|Overall Study||55
9958266|NCT01455545|11077721|FG001|STARTED|Overall Study||45
9958267|NCT01455545|11077720|FG000|COMPLETED|Overall Study||55
9958268|NCT01455545|11077721|FG001|COMPLETED|Overall Study||45
9958269|NCT01455545|11077720|FG000|NOT COMPLETED|Overall Study||0
9958270|NCT01455545|11077721|FG001|NOT COMPLETED|Overall Study||0
9958271|NCT01456000|11077738|FG000|STARTED|Overall Study||178
9958272|NCT01456000|11077739|FG001|STARTED|Overall Study||175
9958273|NCT01456000|11077738|FG000|COMPLETED|Overall Study||170
9719488|NCT00043550|10819038|FG000|NOT COMPLETED|Overall Study||22
9719489|NCT00043550|10819039|FG001|NOT COMPLETED|Overall Study||12
9719490|NCT00043550|10819040|FG002|NOT COMPLETED|Overall Study||20
9719491|NCT00043979|10819050|FG000|STARTED|Period 1||30
9719492|NCT00043979|10819051|FG001|STARTED|Period 1||17
9719493|NCT00043979|10819052|FG002|STARTED|Period 1||13
9719494|NCT00043979|10819050|FG000|COMPLETED|Period 1||23
9719495|NCT00043979|10819051|FG001|COMPLETED|Period 1||13
9719496|NCT00043979|10819052|FG002|COMPLETED|Period 1||10
9719497|NCT00043979|10819050|FG000|NOT COMPLETED|Period 1||7
9719498|NCT00043979|10819051|FG001|NOT COMPLETED|Period 1||4
9719499|NCT00043979|10819052|FG002|NOT COMPLETED|Period 1||3
9719500|NCT00043979|10819050|FG000|STARTED|Period 2||0
9719501|NCT00043979|10819051|FG001|STARTED|Period 2||13
9719502|NCT00043979|10819052|FG002|STARTED|Period 2||10
9719503|NCT00043979|10819050|FG000|COMPLETED|Period 2||0
9719504|NCT00043979|10819051|FG001|COMPLETED|Period 2||13
9719505|NCT00043979|10819052|FG002|COMPLETED|Period 2||10
9719506|NCT00043979|10819050|FG000|NOT COMPLETED|Period 2||0
9719507|NCT00043979|10819051|FG001|NOT COMPLETED|Period 2||0
9719508|NCT00043979|10819052|FG002|NOT COMPLETED|Period 2||0
9719509|NCT00044005|10819061|FG000|STARTED|Overall Study||32
9719510|NCT00044005|10819062|FG001|STARTED|Overall Study||33
9719511|NCT00044005|10819063|FG002|STARTED|Overall Study||33
9719512|NCT00044005|10819061|FG000|COMPLETED|Overall Study||13
9719513|NCT00044005|10819062|FG001|COMPLETED|Overall Study||19
9719514|NCT00044005|10819063|FG002|COMPLETED|Overall Study||11
9719515|NCT00044005|10819061|FG000|NOT COMPLETED|Overall Study||19
9719516|NCT00044005|10819062|FG001|NOT COMPLETED|Overall Study||14
9836106|NCT00792922|10947140|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
9836107|NCT00792922|10947141|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
9836108|NCT00792922|10947142|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
9836109|NCT00792922|10947139|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836110|NCT00792922|10947140|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836111|NCT00792922|10947141|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836112|NCT00792922|10947142|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836113|NCT00792922|10947139|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836114|NCT00792922|10947140|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836115|NCT00792922|10947141|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836116|NCT00792922|10947142|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836117|NCT00792922|10947139|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836118|NCT00792922|10947140|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836119|NCT00792922|10947141|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
9958274|NCT01456000|11077739|FG001|COMPLETED|Overall Study||172
10021142|NCT01841593|11144479|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11
10021143|NCT01841593|11144480|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6
9719517|NCT00044005|10819063|FG002|NOT COMPLETED|Overall Study||22
9719518|NCT00044044|10819076|FG000|STARTED|Overall Study||71
9719519|NCT00044044|10819077|FG001|STARTED|Overall Study||69
9719520|NCT00044044|10819078|FG002|STARTED|Overall Study||71
9719521|NCT00044044|10819079|FG003|STARTED|Overall Study||73
9719522|NCT00044044|10819080|FG004|STARTED|Overall Study||72
9719523|NCT00044044|10819076|FG000|COMPLETED|Overall Study||27
9719524|NCT00044044|10819077|FG001|COMPLETED|Overall Study||28
9719525|NCT00044044|10819078|FG002|COMPLETED|Overall Study||31
9719526|NCT00044044|10819079|FG003|COMPLETED|Overall Study||29
9719527|NCT00044044|10819080|FG004|COMPLETED|Overall Study||36
9719528|NCT00044044|10819076|FG000|NOT COMPLETED|Overall Study||44
9719529|NCT00044044|10819077|FG001|NOT COMPLETED|Overall Study||41
9719530|NCT00044044|10819078|FG002|NOT COMPLETED|Overall Study||40
9719531|NCT00044044|10819079|FG003|NOT COMPLETED|Overall Study||44
9719532|NCT00044044|10819080|FG004|NOT COMPLETED|Overall Study||36
9719533|NCT00044083|10819094|FG000|STARTED|First Intervention (One Week)- HV's||74
9836120|NCT00792922|10947142|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836121|NCT00792922|10947139|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836122|NCT00792922|10947140|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
10021144|NCT01841593|11144479|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
10021145|NCT01841593|11144480|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
9836123|NCT00792922|10947141|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836124|NCT00792922|10947142|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
9836125|NCT00792922|10947139|FG000|NOT COMPLETED|At 3 Years||
9836126|NCT00792922|10947140|FG001|NOT COMPLETED|At 3 Years||
9836127|NCT00792922|10947141|FG002|NOT COMPLETED|At 3 Years||
9836128|NCT00792922|10947142|FG003|NOT COMPLETED|At 3 Years||
9836129|NCT00792935|10947156|FG000|STARTED|Overall Study||72
9836130|NCT00792935|10947157|FG001|STARTED|Overall Study||71
9836131|NCT00792935|10947156|FG000|COMPLETED|Overall Study||68
9836132|NCT00792935|10947157|FG001|COMPLETED|Overall Study||68
9836133|NCT00792935|10947156|FG000|NOT COMPLETED|Overall Study||4
9836134|NCT00792935|10947157|FG001|NOT COMPLETED|Overall Study||3
9836135|NCT00793104|10947163|FG000|STARTED|Overall Study||10
9836136|NCT00793104|10947163|FG000|COMPLETED|Overall Study||9
9836137|NCT00793104|10947163|FG000|NOT COMPLETED|Overall Study||1
9836138|NCT00793182|10947169|FG000|STARTED|Overall Study||2
9836139|NCT00793182|10947170|FG001|STARTED|Overall Study||4
9836140|NCT00793182|10947169|FG000|COMPLETED|Overall Study||2
9836141|NCT00793182|10947170|FG001|COMPLETED|Overall Study||3
9836142|NCT00793182|10947169|FG000|NOT COMPLETED|Overall Study||0
9836143|NCT00793182|10947170|FG001|NOT COMPLETED|Overall Study||1
9836144|NCT00793325|10947176|FG000|STARTED|Overall Study||909
9836145|NCT00793325|10947176|FG000|COMPLETED|Overall Study||890
9836146|NCT00793325|10947176|FG000|NOT COMPLETED|Overall Study||19
9836147|NCT00793403|10947199|FG000|STARTED|Overall Study||293
9836148|NCT00793403|10947199|FG000|COMPLETED|Overall Study||220
9836149|NCT00793403|10947199|FG000|NOT COMPLETED|Overall Study||73
9836150|NCT00793455|10947205|FG000|STARTED|Overall Study||314
9836151|NCT00793455|10947206|FG001|STARTED|Overall Study||314
9836152|NCT00793455|10947205|FG000|COMPLETED|Overall Study||314
9836153|NCT00793455|10947206|FG001|COMPLETED|Overall Study||314
9836154|NCT00793455|10947205|FG000|NOT COMPLETED|Overall Study||0
9836155|NCT00793455|10947206|FG001|NOT COMPLETED|Overall Study||0
9836156|NCT00793546|10947215|FG000|STARTED|Overall Study||14
9836157|NCT00793546|10947216|FG001|STARTED|Overall Study||28
9836158|NCT00793546|10947215|FG000|COMPLETED|Overall Study||0
9836159|NCT00793546|10947216|FG001|COMPLETED|Overall Study||0
9836160|NCT00793546|10947215|FG000|NOT COMPLETED|Overall Study||14
9836161|NCT00793546|10947216|FG001|NOT COMPLETED|Overall Study||28
9836162|NCT00793572|10947224|FG000|STARTED|Overall Study||32
9836163|NCT00793572|10947224|FG000|COMPLETED|Overall Study||32
9836164|NCT00793572|10947224|FG000|NOT COMPLETED|Overall Study||0
9836165|NCT00793585|10947230|FG000|STARTED|Overall Study||19
9836166|NCT00793585|10947231|FG001|STARTED|Overall Study||21
9836167|NCT00793585|10947230|FG000|COMPLETED|Overall Study||17
9836168|NCT00793585|10947231|FG001|COMPLETED|Overall Study||18
9836169|NCT00793585|10947230|FG000|NOT COMPLETED|Overall Study||2
9836170|NCT00793585|10947231|FG001|NOT COMPLETED|Overall Study||3
9836171|NCT00793598|10947242|FG000|STARTED|Overall Study||1
9836172|NCT00793598|10947243|FG001|STARTED|Overall Study||1
9836173|NCT00793598|10947244|FG002|STARTED|Overall Study||1
9836174|NCT00793598|10947245|FG003|STARTED|Overall Study||2
9836175|NCT00793598|10947246|FG004|STARTED|Overall Study||8
9836176|NCT00793598|10947247|FG005|STARTED|Overall Study||8
9836177|NCT00793598|10947248|FG006|STARTED|Overall Study||4
9836178|NCT00793598|10947249|FG007|STARTED|Overall Study||4
9836179|NCT00793598|10947242|FG000|COMPLETED|Overall Study||1
9836180|NCT00793598|10947243|FG001|COMPLETED|Overall Study||0
9836181|NCT00793598|10947244|FG002|COMPLETED|Overall Study||1
9836182|NCT00793598|10947245|FG003|COMPLETED|Overall Study||2
9836183|NCT00793598|10947246|FG004|COMPLETED|Overall Study||8
9836184|NCT00793598|10947247|FG005|COMPLETED|Overall Study||7
9836185|NCT00793598|10947248|FG006|COMPLETED|Overall Study||4
9836186|NCT00793598|10947249|FG007|COMPLETED|Overall Study||3
9836187|NCT00793598|10947242|FG000|NOT COMPLETED|Overall Study||0
10021146|NCT01841606|11144492|FG000|STARTED|Overall Study||25
10021147|NCT01841606|11144493|FG001|STARTED|Overall Study||27
10021148|NCT01841606|11144492|FG000|COMPLETED|Overall Study||25
10021149|NCT01841606|11144493|FG001|COMPLETED|Overall Study||27
9836188|NCT00793598|10947243|FG001|NOT COMPLETED|Overall Study||1
9836189|NCT00793598|10947244|FG002|NOT COMPLETED|Overall Study||0
9836190|NCT00793598|10947245|FG003|NOT COMPLETED|Overall Study||0
9836191|NCT00793598|10947246|FG004|NOT COMPLETED|Overall Study||0
9836192|NCT00793598|10947247|FG005|NOT COMPLETED|Overall Study||1
9836193|NCT00793598|10947248|FG006|NOT COMPLETED|Overall Study||0
9836194|NCT00793598|10947249|FG007|NOT COMPLETED|Overall Study||1
9836195|NCT00793611|10947273|FG000|STARTED|Overall Study||10
9836196|NCT00793611|10947274|FG001|STARTED|Overall Study||10
9836197|NCT00793611|10947273|FG000|COMPLETED|Overall Study||10
9836198|NCT00793611|10947274|FG001|COMPLETED|Overall Study||10
9836199|NCT00793611|10947273|FG000|NOT COMPLETED|Overall Study||0
9836200|NCT00793611|10947274|FG001|NOT COMPLETED|Overall Study||0
9836201|NCT00793624|10947284|FG000|STARTED|Overall Study||225
9836202|NCT00793624|10947285|FG001|STARTED|Overall Study||227
9836203|NCT00793624|10947286|FG002|STARTED|Overall Study||225
9836204|NCT00793624|10947287|FG003|STARTED|Overall Study||227
9836205|NCT00793624|10947284|FG000|COMPLETED|Overall Study||168
9836206|NCT00793624|10947285|FG001|COMPLETED|Overall Study||191
9836207|NCT00793624|10947286|FG002|COMPLETED|Overall Study||186
9836208|NCT00793624|10947287|FG003|COMPLETED|Overall Study||184
9836209|NCT00793624|10947284|FG000|NOT COMPLETED|Overall Study||57
9836210|NCT00793624|10947285|FG001|NOT COMPLETED|Overall Study||36
9836211|NCT00793624|10947286|FG002|NOT COMPLETED|Overall Study||39
9836212|NCT00793624|10947287|FG003|NOT COMPLETED|Overall Study||43
9836213|NCT00793650|10947307|FG000|STARTED|Overall Study||19
9836214|NCT00793650|10947308|FG001|STARTED|Overall Study||20
9836215|NCT00793650|10947307|FG000|COMPLETED|Overall Study||19
9836216|NCT00793650|10947308|FG001|COMPLETED|Overall Study||20
9836217|NCT00793650|10947307|FG000|NOT COMPLETED|Overall Study||0
9836218|NCT00793650|10947308|FG001|NOT COMPLETED|Overall Study||0
9836219|NCT00793780|10947318|FG000|STARTED|Overall Study||12
9836220|NCT00793780|10947319|FG001|STARTED|Overall Study||12
9836221|NCT00793780|10947318|FG000|Randomization|Overall Study||12
9836222|NCT00793780|10947319|FG001|Randomization|Overall Study||12
9836223|NCT00793780|10947318|FG000|Collected Baseline Data|Overall Study||11
9836224|NCT00793780|10947319|FG001|Collected Baseline Data|Overall Study||12
9836225|NCT00793780|10947318|FG000|COMPLETED|Overall Study||10
9836226|NCT00793780|10947319|FG001|COMPLETED|Overall Study||11
9836227|NCT00793780|10947318|FG000|NOT COMPLETED|Overall Study||2
9836228|NCT00793780|10947319|FG001|NOT COMPLETED|Overall Study||1
9836229|NCT00793793|10947337|FG000|STARTED|Overall Study||8
9836230|NCT00793793|10947338|FG001|STARTED|Overall Study||6
9836231|NCT00793793|10947339|FG002|STARTED|Overall Study||7
9836232|NCT00793793|10947340|FG003|STARTED|Overall Study||7
9836233|NCT00793793|10947341|FG004|STARTED|Overall Study||6
9719534|NCT00044083|10819095|FG001|STARTED|First Intervention (One Week)- HV's||73
9719535|NCT00044083|10819094|FG000|COMPLETED|First Intervention (One Week)- HV's||64
9719536|NCT00044083|10819095|FG001|COMPLETED|First Intervention (One Week)- HV's||66
9719537|NCT00044083|10819094|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10
9719538|NCT00044083|10819095|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7
9719539|NCT00044083|10819094|FG000|STARTED|Second Intervention (One Week) HV's||64
9719540|NCT00044083|10819095|FG001|STARTED|Second Intervention (One Week) HV's||66
9719541|NCT00044083|10819094|FG000|COMPLETED|Second Intervention (One Week) HV's||64
9719542|NCT00044083|10819095|FG001|COMPLETED|Second Intervention (One Week) HV's||66
9719543|NCT00044083|10819094|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0
9719544|NCT00044083|10819095|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0
9719545|NCT00044083|10819094|FG000|STARTED|First Intervention (One Week) Patients||31
9719546|NCT00044083|10819095|FG001|STARTED|First Intervention (One Week) Patients||32
9719547|NCT00044083|10819094|FG000|COMPLETED|First Intervention (One Week) Patients||30
9719548|NCT00044083|10819095|FG001|COMPLETED|First Intervention (One Week) Patients||30
9719549|NCT00044083|10819094|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1
9719550|NCT00044083|10819095|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2
9719551|NCT00044083|10819094|FG000|STARTED|Second Intervention (One Week) Patients||30
9719552|NCT00044083|10819095|FG001|STARTED|Second Intervention (One Week) Patients||30
9719553|NCT00044083|10819094|FG000|COMPLETED|Second Intervention (One Week) Patients||30
9719554|NCT00044083|10819095|FG001|COMPLETED|Second Intervention (One Week) Patients||29
9719555|NCT00044083|10819094|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0
9719556|NCT00044083|10819095|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1
9719557|NCT00044213|10819132|FG000|STARTED|Overall Study||421
9719558|NCT00044213|10819133|FG001|STARTED|Overall Study||418
9719559|NCT00044213|10819134|FG002|STARTED|Overall Study||432
9719560|NCT00044213|10819135|FG003|STARTED|Overall Study||437
9719561|NCT00044213|10819132|FG000|COMPLETED|Overall Study||321
9719562|NCT00044213|10819133|FG001|COMPLETED|Overall Study||306
9719563|NCT00044213|10819134|FG002|COMPLETED|Overall Study||294
9719564|NCT00044213|10819135|FG003|COMPLETED|Overall Study||301
9719565|NCT00044213|10819132|FG000|NOT COMPLETED|Overall Study||100
9719566|NCT00044213|10819133|FG001|NOT COMPLETED|Overall Study||112
9719567|NCT00044213|10819134|FG002|NOT COMPLETED|Overall Study||138
9719568|NCT00044213|10819135|FG003|NOT COMPLETED|Overall Study||136
9719569|NCT00044512|10819145|FG000|STARTED|Treatment||137
9719570|NCT00044512|10819145|FG000|COMPLETED|Treatment||137
9719571|NCT00044512|10819145|FG000|NOT COMPLETED|Treatment||0
9719572|NCT00044512|10819145|FG000|STARTED|Follow Up||137
9719573|NCT00044512|10819145|FG000|COMPLETED|Follow Up||135
9719574|NCT00044512|10819145|FG000|NOT COMPLETED|Follow Up||2
9719575|NCT00044655|10819151|FG000|STARTED|Overall Study||102
9719576|NCT00044655|10819152|FG001|STARTED|Overall Study||117
9719577|NCT00044655|10819151|FG000|COMPLETED|Overall Study||82
9719578|NCT00044655|10819152|FG001|COMPLETED|Overall Study||79
9719579|NCT00044655|10819151|FG000|NOT COMPLETED|Overall Study||20
9719580|NCT00044655|10819152|FG001|NOT COMPLETED|Overall Study||38
10021150|NCT01841606|11144492|FG000|NOT COMPLETED|Overall Study||0
10021151|NCT01841606|11144493|FG001|NOT COMPLETED|Overall Study||0
10021152|NCT01841619|11144499|FG000|STARTED|Overall Study||16
9836234|NCT00793793|10947342|FG005|STARTED|Overall Study||6
9836235|NCT00793793|10947343|FG006|STARTED|Overall Study||7
9836236|NCT00793793|10947344|FG007|STARTED|Overall Study||6
9836237|NCT00793793|10947345|FG008|STARTED|Overall Study||15
9836238|NCT00793793|10947346|FG009|STARTED|Overall Study||15
9836239|NCT00793793|10947347|FG010|STARTED|Overall Study||6
9836240|NCT00793793|10947348|FG011|STARTED|Overall Study||7
9836241|NCT00793793|10947337|FG000|COMPLETED|Overall Study||8
9958275|NCT01456000|11077738|FG000|NOT COMPLETED|Overall Study||8
9958276|NCT01456000|11077739|FG001|NOT COMPLETED|Overall Study||3
9958277|NCT01456039|11077748|FG000|STARTED|Phase 1 (First Step)||3
9958278|NCT01456039|11077749|FG001|STARTED|Phase 1 (First Step)||8
9958279|NCT01456039|11077750|FG002|STARTED|Phase 1 (First Step)||0
9958280|NCT01456039|11077748|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
9958281|NCT01456039|11077749|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
9958282|NCT01456039|11077750|FG002|COMPLETED|Phase 1 (First Step)||0
9958283|NCT01456039|11077748|FG000|NOT COMPLETED|Phase 1 (First Step)||2
9958284|NCT01456039|11077749|FG001|NOT COMPLETED|Phase 1 (First Step)||7
9958285|NCT01456039|11077750|FG002|NOT COMPLETED|Phase 1 (First Step)||0
9958286|NCT01456039|11077748|FG000|STARTED|Phase 2 (Second Step)||0
9958287|NCT01456039|11077749|FG001|STARTED|Phase 2 (Second Step)||0
9958288|NCT01456039|11077750|FG002|STARTED|Phase 2 (Second Step)||40
9958289|NCT01456039|11077748|FG000|COMPLETED|Phase 2 (Second Step)||0
9958290|NCT01456039|11077749|FG001|COMPLETED|Phase 2 (Second Step)||0
9958291|NCT01456039|11077750|FG002|COMPLETED|Phase 2 (Second Step)||7
9958292|NCT01456039|11077748|FG000|NOT COMPLETED|Phase 2 (Second Step)||0
9958293|NCT01456039|11077749|FG001|NOT COMPLETED|Phase 2 (Second Step)||0
9958294|NCT01456039|11077750|FG002|NOT COMPLETED|Phase 2 (Second Step)||33
9958295|NCT01456052|11077769|FG000|STARTED|Overall Study||10
9958296|NCT01456052|11077770|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
9958297|NCT01456052|11077771|FG002|STARTED|Overall Study||24
9958298|NCT01456052|11077769|FG000|COMPLETED|Overall Study||8
9958299|NCT01456052|11077770|FG001|COMPLETED|Overall Study||20
9958300|NCT01456052|11077771|FG002|COMPLETED|Overall Study||19
9958301|NCT01456052|11077769|FG000|NOT COMPLETED|Overall Study||2
9958302|NCT01456052|11077770|FG001|NOT COMPLETED|Overall Study||5
9958303|NCT01456052|11077771|FG002|NOT COMPLETED|Overall Study||5
9958304|NCT01456130|11077780|FG000|STARTED|Overall Study||67
9958305|NCT01456130|11077780|FG000|COMPLETED|Overall Study||57
9958306|NCT01456130|11077780|FG000|NOT COMPLETED|Overall Study||10
9958307|NCT01456143|11077784|FG000|STARTED|Overall Study||33
9958308|NCT01456143|11077784|FG000|COMPLETED|Overall Study||33
9958309|NCT01456143|11077784|FG000|NOT COMPLETED|Overall Study||0
9958310|NCT01456169|11077791|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
9958311|NCT01456169|11077792|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
9958312|NCT01456169|11077793|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
9958313|NCT01456169|11077791|FG000|COMPLETED|Overall Study||123
9958314|NCT01456169|11077792|FG001|COMPLETED|Overall Study||122
9958315|NCT01456169|11077793|FG002|COMPLETED|Overall Study||123
9958316|NCT01456169|11077791|FG000|NOT COMPLETED|Overall Study||10
9958317|NCT01456169|11077792|FG001|NOT COMPLETED|Overall Study||5
9958318|NCT01456169|11077793|FG002|NOT COMPLETED|Overall Study||12
9958319|NCT01456195|11077805|FG000|STARTED|Overall Study||143
9958320|NCT01456195|11077806|FG001|STARTED|Overall Study||137
10021153|NCT01841619|11144499|FG000|COMPLETED|Overall Study||16
10021154|NCT01841619|11144499|FG000|NOT COMPLETED|Overall Study||0
10021155|NCT01841632|11144503|FG000|STARTED|Overall Study||3
10021156|NCT01841632|11144503|FG000|COMPLETED|Overall Study||3
10021157|NCT01841632|11144503|FG000|NOT COMPLETED|Overall Study||0
10021158|NCT01841697|11144509|FG000|STARTED|Overall Study||322
10021159|NCT01841697|11144510|FG001|STARTED|Overall Study||320
10021160|NCT01841697|11144509|FG000|COMPLETED|Overall Study||302
10021161|NCT01841697|11144510|FG001|COMPLETED|Overall Study||302
10021162|NCT01841697|11144509|FG000|NOT COMPLETED|Overall Study||20
10021163|NCT01841697|11144510|FG001|NOT COMPLETED|Overall Study||18
10021164|NCT01841762|11144516|FG000|STARTED|Screening Period||335
10021165|NCT01841762|11144516|FG000|COMPLETED|Screening Period||284
10021166|NCT01841762|11144516|FG000|NOT COMPLETED|Screening Period||51
10021167|NCT01841762|11144516|FG000|STARTED|Treatment Period||284
10021168|NCT01841762|11144516|FG000|COMPLETED|Treatment Period||252
10021169|NCT01841762|11144516|FG000|NOT COMPLETED|Treatment Period||32
10021170|NCT01841762|11144516|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284
10021171|NCT01841762|11144516|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269
10021172|NCT01841762|11144516|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
9836242|NCT00793793|10947338|FG001|COMPLETED|Overall Study||5
9958321|NCT01456195|11077807|FG002|STARTED|Overall Study||141
9958322|NCT01456195|11077805|FG000|COMPLETED|Overall Study||132
9836243|NCT00793793|10947339|FG002|COMPLETED|Overall Study||5
9836244|NCT00793793|10947340|FG003|COMPLETED|Overall Study||4
9836245|NCT00793793|10947341|FG004|COMPLETED|Overall Study||4
10021173|NCT01841970|11144520|FG000|STARTED|Overall Study||20
10021174|NCT01841970|11144520|FG000|COMPLETED|Overall Study||9
10021175|NCT01841970|11144520|FG000|NOT COMPLETED|Overall Study||11
9836246|NCT00793793|10947342|FG005|COMPLETED|Overall Study||4
9836247|NCT00793793|10947343|FG006|COMPLETED|Overall Study||3
9836248|NCT00793793|10947344|FG007|COMPLETED|Overall Study||6
9836249|NCT00793793|10947345|FG008|COMPLETED|Overall Study||6
9836250|NCT00793793|10947346|FG009|COMPLETED|Overall Study||6
10021176|NCT01842061|11144529|FG000|STARTED|Overall Study||13
10021177|NCT01842061|11144530|FG001|STARTED|Overall Study||12
10021178|NCT01842061|11144529|FG000|COMPLETED|Overall Study||12
10021179|NCT01842061|11144530|FG001|COMPLETED|Overall Study||8
10021180|NCT01842061|11144529|FG000|NOT COMPLETED|Overall Study||1
10021181|NCT01842061|11144530|FG001|NOT COMPLETED|Overall Study||4
9836251|NCT00793793|10947347|FG010|COMPLETED|Overall Study||3
9836252|NCT00793793|10947348|FG011|COMPLETED|Overall Study||1
9836253|NCT00793793|10947337|FG000|NOT COMPLETED|Overall Study||0
9836254|NCT00793793|10947338|FG001|NOT COMPLETED|Overall Study||1
9836255|NCT00793793|10947339|FG002|NOT COMPLETED|Overall Study||2
9836256|NCT00793793|10947340|FG003|NOT COMPLETED|Overall Study||3
9836257|NCT00793793|10947341|FG004|NOT COMPLETED|Overall Study||2
9836258|NCT00793793|10947342|FG005|NOT COMPLETED|Overall Study||2
9836259|NCT00793793|10947343|FG006|NOT COMPLETED|Overall Study||4
9836260|NCT00793793|10947344|FG007|NOT COMPLETED|Overall Study||0
9836261|NCT00793793|10947345|FG008|NOT COMPLETED|Overall Study||9
9836262|NCT00793793|10947346|FG009|NOT COMPLETED|Overall Study||9
9836263|NCT00793793|10947347|FG010|NOT COMPLETED|Overall Study||3
9836264|NCT00793793|10947348|FG011|NOT COMPLETED|Overall Study||6
9836265|NCT00793819|10947396|FG000|STARTED|Overall Study||111
9836266|NCT00793819|10947397|FG001|STARTED|Overall Study||98
9836267|NCT00793819|10947396|FG000|COMPLETED|Overall Study||97
10021182|NCT01842308|11144541|FG000|STARTED|Overall Study||6
10021183|NCT01842308|11144542|FG001|STARTED|Overall Study||3
10021184|NCT01842308|11144543|FG002|STARTED|Overall Study||3
10021185|NCT01842308|11144544|FG003|STARTED|Overall Study||2
10021186|NCT01842308|11144545|FG004|STARTED|Overall Study||36
10021187|NCT01842308|11144541|FG000|COMPLETED|Overall Study||6
10021188|NCT01842308|11144542|FG001|COMPLETED|Overall Study||3
10021189|NCT01842308|11144543|FG002|COMPLETED|Overall Study||3
10021190|NCT01842308|11144544|FG003|COMPLETED|Overall Study||2
10021191|NCT01842308|11144545|FG004|COMPLETED|Overall Study||35
10021192|NCT01842308|11144541|FG000|NOT COMPLETED|Overall Study||0
10021193|NCT01842308|11144542|FG001|NOT COMPLETED|Overall Study||0
10021194|NCT01842308|11144543|FG002|NOT COMPLETED|Overall Study||0
10021195|NCT01842308|11144544|FG003|NOT COMPLETED|Overall Study||0
10021196|NCT01842308|11144545|FG004|NOT COMPLETED|Overall Study||1
10021197|NCT01842334|11144560|FG000|STARTED|Overall Study||5
10021198|NCT01842334|11144561|FG001|STARTED|Overall Study||7
9836268|NCT00793819|10947397|FG001|COMPLETED|Overall Study||89
9836269|NCT00793819|10947396|FG000|NOT COMPLETED|Overall Study||14
9836270|NCT00793819|10947397|FG001|NOT COMPLETED|Overall Study||9
9836271|NCT00793871|10947403|FG000|STARTED|Overall Study||60
9836272|NCT00793871|10947403|FG000|Received Treatment|Overall Study||59
9836273|NCT00793871|10947403|FG000|COMPLETED|Overall Study||0
10021199|NCT01842334|11144560|FG000|COMPLETED|Overall Study||2
10021200|NCT01842334|11144561|FG001|COMPLETED|Overall Study||3
10021201|NCT01842334|11144560|FG000|NOT COMPLETED|Overall Study||3
10021202|NCT01842334|11144561|FG001|NOT COMPLETED|Overall Study||4
10021203|NCT01842438|11144569|FG000|STARTED|T1: Immediately After the Intervention||42
10021204|NCT01842438|11144570|FG001|STARTED|T1: Immediately After the Intervention||44
10021205|NCT01842438|11144569|FG000|COMPLETED|T1: Immediately After the Intervention||36
10021206|NCT01842438|11144570|FG001|COMPLETED|T1: Immediately After the Intervention||36
10021207|NCT01842438|11144569|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6
10021208|NCT01842438|11144570|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8
10021209|NCT01842438|11144569|FG000|STARTED|T2: 6month Follow-up||36
10021210|NCT01842438|11144570|FG001|STARTED|T2: 6month Follow-up||36
9836274|NCT00793871|10947403|FG000|NOT COMPLETED|Overall Study||60
9836275|NCT00793910|10947409|FG000|STARTED|Overall Study||53
9836276|NCT00793910|10947410|FG001|STARTED|Overall Study||53
9836277|NCT00793910|10947409|FG000|COMPLETED|Overall Study||48
9836278|NCT00793910|10947410|FG001|COMPLETED|Overall Study||46
9836279|NCT00793910|10947409|FG000|NOT COMPLETED|Overall Study||5
9836280|NCT00793910|10947410|FG001|NOT COMPLETED|Overall Study||7
9836281|NCT00794040|10947418|FG000|STARTED|Overall Study||25
9836282|NCT00794040|10947419|FG001|STARTED|Overall Study||28
9836283|NCT00794040|10947418|FG000|COMPLETED|Overall Study||22
9836284|NCT00794040|10947419|FG001|COMPLETED|Overall Study||23
9836285|NCT00794040|10947418|FG000|NOT COMPLETED|Overall Study||3
9836286|NCT00794040|10947419|FG001|NOT COMPLETED|Overall Study||5
9836287|NCT00794118|10947425|FG000|STARTED|Overall Study||299
9836288|NCT00794118|10947425|FG000|COMPLETED|Overall Study||272
9836289|NCT00794118|10947425|FG000|NOT COMPLETED|Overall Study||27
9836290|NCT00794144|10947431|FG000|STARTED|Overall Study||66
9836291|NCT00794144|10947432|FG001|STARTED|Overall Study||66
9836292|NCT00794144|10947431|FG000|COMPLETED|Overall Study||63
9836293|NCT00794144|10947432|FG001|COMPLETED|Overall Study||63
9836294|NCT00794144|10947431|FG000|NOT COMPLETED|Overall Study||3
9836295|NCT00794144|10947432|FG001|NOT COMPLETED|Overall Study||3
9836296|NCT00794157|10947441|FG000|STARTED|Overall Study||114
9836297|NCT00794157|10947442|FG001|STARTED|Overall Study||116
9836298|NCT00794157|10947443|FG002|STARTED|Overall Study||117
9836299|NCT00794157|10947441|FG000|COMPLETED|Overall Study||104
9836300|NCT00794157|10947442|FG001|COMPLETED|Overall Study||106
9836301|NCT00794157|10947443|FG002|COMPLETED|Overall Study||98
9836302|NCT00794157|10947441|FG000|NOT COMPLETED|Overall Study||10
9836303|NCT00794157|10947442|FG001|NOT COMPLETED|Overall Study||10
9836304|NCT00794157|10947443|FG002|NOT COMPLETED|Overall Study||19
9836305|NCT00794170|10947453|FG000|STARTED|Overall Study||157
9836306|NCT00794170|10947454|FG001|STARTED|Overall Study||155
9836307|NCT00794170|10947453|FG000|COMPLETED|Overall Study||150
9836308|NCT00794170|10947454|FG001|COMPLETED|Overall Study||152
9836309|NCT00794170|10947453|FG000|NOT COMPLETED|Overall Study||7
9836310|NCT00794170|10947454|FG001|NOT COMPLETED|Overall Study||3
9836311|NCT00794196|10947462|FG000|STARTED|Overall Study||92
9836312|NCT00794196|10947463|FG001|STARTED|Overall Study||87
9836313|NCT00794196|10947462|FG000|COMPLETED|Overall Study||87
9836314|NCT00794196|10947463|FG001|COMPLETED|Overall Study||64
9836315|NCT00794196|10947462|FG000|NOT COMPLETED|Overall Study||5
9836316|NCT00794196|10947463|FG001|NOT COMPLETED|Overall Study||23
9836317|NCT00794313|10947469|FG000|STARTED|Overall Study||1
9836318|NCT00794313|10947470|FG001|STARTED|Overall Study||1
9836319|NCT00794313|10947471|FG002|STARTED|Overall Study||1
9836320|NCT00794313|10947469|FG000|COMPLETED|Overall Study||1
9836321|NCT00794313|10947470|FG001|COMPLETED|Overall Study||1
9836322|NCT00794313|10947471|FG002|COMPLETED|Overall Study||1
9836323|NCT00794313|10947469|FG000|NOT COMPLETED|Overall Study||0
9836324|NCT00794313|10947470|FG001|NOT COMPLETED|Overall Study||0
9836325|NCT00794313|10947471|FG002|NOT COMPLETED|Overall Study||0
9836326|NCT00794339|10947482|FG000|STARTED|Overall Study||73
9836327|NCT00794339|10947482|FG000|Eligible|Overall Study||69
9836328|NCT00794339|10947482|FG000|Evaluable|Overall Study||59
9836329|NCT00794339|10947482|FG000|COMPLETED|Overall Study||59
9719581|NCT00045032|10819161|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
9719582|NCT00045032|10819162|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
9719583|NCT00045032|10819163|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
9719584|NCT00045032|10819161|FG000|Crossover to Adjuvant Herceptin|Overall Study||888
9719585|NCT00045032|10819162|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
9719586|NCT00045032|10819163|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
9719587|NCT00045032|10819161|FG000|COMPLETED|Overall Study||834
9719588|NCT00045032|10819162|FG001|COMPLETED|Overall Study||994
9836330|NCT00794339|10947482|FG000|NOT COMPLETED|Overall Study||14
9836331|NCT00794365|10947503|FG000|STARTED|Overall Study||330
9836332|NCT00794365|10947503|FG000|COMPLETED|Overall Study||251
9836333|NCT00794365|10947503|FG000|NOT COMPLETED|Overall Study||79
9836334|NCT00794417|10947511|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
9836335|NCT00794417|10947512|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
9836336|NCT00794417|10947513|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
9836337|NCT00794417|10947514|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
9836338|NCT00794417|10947511|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
9836339|NCT00794417|10947512|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
9836340|NCT00794417|10947513|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
9836341|NCT00794417|10947514|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
9836342|NCT00794417|10947511|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
9836343|NCT00794417|10947512|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
9836344|NCT00794417|10947513|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
9836345|NCT00794417|10947514|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
9836346|NCT00794417|10947511|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
9836347|NCT00794417|10947512|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
9836348|NCT00794417|10947513|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
9836349|NCT00794417|10947514|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
9836350|NCT00794417|10947511|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
9836351|NCT00794417|10947512|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
9836352|NCT00794417|10947513|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
9836353|NCT00794417|10947514|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
9836354|NCT00794417|10947511|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
9836355|NCT00794417|10947512|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
9836356|NCT00794417|10947513|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
9836357|NCT00794417|10947514|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
9836358|NCT00794469|10947526|FG000|STARTED|Overall Study||21
9836359|NCT00794469|10947526|FG000|COMPLETED|Overall Study||21
9836360|NCT00794469|10947526|FG000|NOT COMPLETED|Overall Study||0
9836361|NCT00794508|10947530|FG000|STARTED|Overall Study||10
9836362|NCT00794508|10947530|FG000|COMPLETED|Overall Study||10
9836363|NCT00794508|10947530|FG000|NOT COMPLETED|Overall Study||0
9836364|NCT00794547|10947534|FG000|STARTED|Overall Study||18
9836365|NCT00794547|10947535|FG001|STARTED|Overall Study||16
9836366|NCT00794547|10947534|FG000|COMPLETED|Overall Study||18
9836367|NCT00794547|10947535|FG001|COMPLETED|Overall Study||16
9836368|NCT00794547|10947534|FG000|NOT COMPLETED|Overall Study||0
9836369|NCT00794547|10947535|FG001|NOT COMPLETED|Overall Study||0
9836370|NCT00794560|10947543|FG000|STARTED|Overall Study||36
9836371|NCT00794560|10947544|FG001|STARTED|Overall Study||36
9836372|NCT00794560|10947545|FG002|STARTED|Overall Study||44
9836373|NCT00794560|10947546|FG003|STARTED|Overall Study||38
9719589|NCT00045032|10819163|FG002|COMPLETED|Overall Study||974
9719590|NCT00045032|10819161|FG000|NOT COMPLETED|Overall Study||863
9719591|NCT00045032|10819162|FG001|NOT COMPLETED|Overall Study||708
9836374|NCT00794560|10947543|FG000|COMPLETED|Overall Study||33
9836375|NCT00794560|10947544|FG001|COMPLETED|Overall Study||32
9836376|NCT00794560|10947545|FG002|COMPLETED|Overall Study||40
9836377|NCT00794560|10947546|FG003|COMPLETED|Overall Study||34
9836378|NCT00794560|10947543|FG000|NOT COMPLETED|Overall Study||3
9836379|NCT00794560|10947544|FG001|NOT COMPLETED|Overall Study||4
9836380|NCT00794560|10947545|FG002|NOT COMPLETED|Overall Study||4
9836381|NCT00794560|10947546|FG003|NOT COMPLETED|Overall Study||4
9836382|NCT00794573|10947558|FG000|STARTED|Overall Study||151
9836383|NCT00794573|10947559|FG001|STARTED|Overall Study||151
9836384|NCT00794573|10947558|FG000|COMPLETED|Overall Study||113
9836385|NCT00794573|10947559|FG001|COMPLETED|Overall Study||106
9836386|NCT00794573|10947558|FG000|NOT COMPLETED|Overall Study||38
9836387|NCT00794573|10947559|FG001|NOT COMPLETED|Overall Study||45
9836388|NCT00794664|10947567|FG000|STARTED|Treatment Period||19
9836389|NCT00794664|10947568|FG001|STARTED|Treatment Period||39
9836390|NCT00794664|10947567|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
9836391|NCT00794664|10947568|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
9836392|NCT00794664|10947567|FG000|NOT COMPLETED|Treatment Period||1
9836393|NCT00794664|10947568|FG001|NOT COMPLETED|Treatment Period||12
9836394|NCT00794664|10947567|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
9836395|NCT00794664|10947568|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
9836396|NCT00794664|10947567|FG000|COMPLETED|Follow-up Period||15
9836397|NCT00794664|10947568|FG001|COMPLETED|Follow-up Period||28
9836398|NCT00794664|10947567|FG000|NOT COMPLETED|Follow-up Period||1
9836399|NCT00794664|10947568|FG001|NOT COMPLETED|Follow-up Period||5
9836400|NCT00794820|10947574|FG000|STARTED|Overall Study||66
9836401|NCT00794820|10947574|FG000|COMPLETED|Overall Study||50
9836402|NCT00794820|10947574|FG000|NOT COMPLETED|Overall Study||16
9836403|NCT00794950|10947578|FG000|STARTED|BCG Induction||43
9836404|NCT00794950|10947578|FG000|COMPLETED|BCG Induction||36
9836405|NCT00794950|10947578|FG000|NOT COMPLETED|BCG Induction||7
9836406|NCT00794950|10947578|FG000|STARTED|Beginning Sunitinib Treatment||36
9836407|NCT00794950|10947578|FG000|COMPLETED|Beginning Sunitinib Treatment||24
9836408|NCT00794950|10947578|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12
9836409|NCT00794963|10947585|FG000|STARTED|Overall Study||4
9836410|NCT00794963|10947586|FG001|STARTED|Overall Study||4
9836411|NCT00794963|10947585|FG000|COMPLETED|Overall Study||3
9836412|NCT00794963|10947586|FG001|COMPLETED|Overall Study||0
9836413|NCT00794963|10947585|FG000|NOT COMPLETED|Overall Study||1
9836414|NCT00794963|10947586|FG001|NOT COMPLETED|Overall Study||4
9836415|NCT00795002|10947594|FG000|STARTED|Overall Study||37
9836416|NCT00795002|10947595|FG001|STARTED|Overall Study||37
9836417|NCT00795002|10947594|FG000|COMPLETED|Overall Study||37
9719592|NCT00045032|10819163|FG002|NOT COMPLETED|Overall Study||726
9719593|NCT00045110|10819176|FG000|STARTED|100mg Phase 1 Dose Escalalation||6
9719594|NCT00045110|10819177|FG001|STARTED|100mg Phase 1 Dose Escalalation||59
9719595|NCT00045110|10819178|FG002|STARTED|100mg Phase 1 Dose Escalalation||45
9719596|NCT00045110|10819176|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6
9719597|NCT00045110|10819177|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53
9719598|NCT00045110|10819178|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43
9719599|NCT00045110|10819176|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
9719600|NCT00045110|10819177|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
9719601|NCT00045110|10819178|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
9719602|NCT00045110|10819176|FG000|STARTED|200mg Phase 1 Dose Escalation||4
9719603|NCT00045110|10819177|FG001|STARTED|200mg Phase 1 Dose Escalation||0
9719604|NCT00045110|10819178|FG002|STARTED|200mg Phase 1 Dose Escalation||0
9719605|NCT00045110|10819176|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4
9719606|NCT00045110|10819177|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0
9719607|NCT00045110|10819178|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0
9719608|NCT00045110|10819176|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
9719609|NCT00045110|10819177|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
9719610|NCT00045110|10819178|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
9719611|NCT00045110|10819176|FG000|STARTED|275mg Phase 1 Dose Escalation||3
9719612|NCT00045110|10819177|FG001|STARTED|275mg Phase 1 Dose Escalation||0
9719613|NCT00045110|10819178|FG002|STARTED|275mg Phase 1 Dose Escalation||0
9719614|NCT00045110|10819176|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3
9719615|NCT00045110|10819177|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0
9719616|NCT00045110|10819178|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0
9719617|NCT00045110|10819176|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
9719618|NCT00045110|10819177|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
9719619|NCT00045110|10819178|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
9719620|NCT00045110|10819176|FG000|STARTED|400mg Phase 1 Dose Escalation||3
9719621|NCT00045110|10819177|FG001|STARTED|400mg Phase 1 Dose Escalation||0
9719622|NCT00045110|10819178|FG002|STARTED|400mg Phase 1 Dose Escalation||0
9719623|NCT00045110|10819176|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3
9719624|NCT00045110|10819177|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0
9719625|NCT00045110|10819178|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0
9719626|NCT00045110|10819176|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
9719627|NCT00045110|10819177|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
9719628|NCT00045110|10819178|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
9719629|NCT00045110|10819176|FG000|STARTED|525mg Phase 1 Dose Escalation||3
9719630|NCT00045110|10819177|FG001|STARTED|525mg Phase 1 Dose Escalation||0
9719631|NCT00045110|10819178|FG002|STARTED|525mg Phase 1 Dose Escalation||0
9719632|NCT00045110|10819176|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3
9719633|NCT00045110|10819177|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0
9719634|NCT00045110|10819178|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0
9719635|NCT00045110|10819176|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
9719636|NCT00045110|10819177|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
9719637|NCT00045110|10819178|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
9719638|NCT00045110|10819176|FG000|STARTED|650mg Phase 1 Dose Escalation||6
9719639|NCT00045110|10819177|FG001|STARTED|650mg Phase 1 Dose Escalation||0
10021211|NCT01842438|11144569|FG000|COMPLETED|T2: 6month Follow-up||32
10021212|NCT01842438|11144570|FG001|COMPLETED|T2: 6month Follow-up||32
9719640|NCT00045110|10819178|FG002|STARTED|650mg Phase 1 Dose Escalation||0
9719641|NCT00045110|10819176|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6
9719642|NCT00045110|10819177|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0
9719643|NCT00045110|10819178|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0
9719644|NCT00045110|10819176|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
9719645|NCT00045110|10819177|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
9719646|NCT00045110|10819178|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
9719647|NCT00045110|10819176|FG000|STARTED|775mg Dose Escalation||7
9719648|NCT00045110|10819177|FG001|STARTED|775mg Dose Escalation||0
9836418|NCT00795002|10947595|FG001|COMPLETED|Overall Study||37
9836419|NCT00795002|10947594|FG000|NOT COMPLETED|Overall Study||0
9836420|NCT00795002|10947595|FG001|NOT COMPLETED|Overall Study||0
9836421|NCT00795132|10947601|FG000|STARTED|Overall Study||47
9836422|NCT00795132|10947601|FG000|COMPLETED|Overall Study||44
9836423|NCT00795132|10947601|FG000|NOT COMPLETED|Overall Study||3
9836424|NCT00795145|10947615|FG000|STARTED|Cohort 1||3
9836425|NCT00795145|10947616|FG001|STARTED|Cohort 1||3
9836426|NCT00795145|10947617|FG002|STARTED|Cohort 1||3
9836427|NCT00795145|10947618|FG003|STARTED|Cohort 1||0
9836428|NCT00795145|10947619|FG004|STARTED|Cohort 1||0
9836429|NCT00795145|10947620|FG005|STARTED|Cohort 1||0
9836430|NCT00795145|10947621|FG006|STARTED|Cohort 1||0
9836431|NCT00795145|10947615|FG000|COMPLETED|Cohort 1||3
9836432|NCT00795145|10947616|FG001|COMPLETED|Cohort 1||3
9836433|NCT00795145|10947617|FG002|COMPLETED|Cohort 1||3
9719649|NCT00045110|10819178|FG002|STARTED|775mg Dose Escalation||0
9719650|NCT00045110|10819176|FG000|COMPLETED|775mg Dose Escalation||7
9719651|NCT00045110|10819177|FG001|COMPLETED|775mg Dose Escalation||0
9836434|NCT00795145|10947618|FG003|COMPLETED|Cohort 1||0
10021213|NCT01842438|11144569|FG000|NOT COMPLETED|T2: 6month Follow-up||4
10021214|NCT01842438|11144570|FG001|NOT COMPLETED|T2: 6month Follow-up||4
10021215|NCT01842464|11144580|FG000|STARTED|Overall Study||44
10021216|NCT01842464|11144580|FG000|COMPLETED|Overall Study||44
10021217|NCT01842464|11144580|FG000|NOT COMPLETED|Overall Study||0
10021218|NCT01842581|11144587|FG000|STARTED|Overall Study||113
10021219|NCT01842581|11144588|FG001|STARTED|Overall Study||109
10021220|NCT01842581|11144587|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
10021221|NCT01842581|11144588|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108
10021222|NCT01842581|11144587|FG000|COMPLETED|Overall Study||69
10021223|NCT01842581|11144588|FG001|COMPLETED|Overall Study||79
10021224|NCT01842581|11144587|FG000|NOT COMPLETED|Overall Study||44
10021225|NCT01842581|11144588|FG001|NOT COMPLETED|Overall Study||30
10021226|NCT01842594|11144594|FG000|STARTED|Overall Study||13
10021227|NCT01842594|11144594|FG000|COMPLETED|Overall Study||10
10021228|NCT01842594|11144594|FG000|NOT COMPLETED|Overall Study||3
10021229|NCT01842607|11144598|FG000|STARTED|Overall Study||651
10021230|NCT01842607|11144598|FG000|COMPLETED|Overall Study||585
10021231|NCT01842607|11144598|FG000|NOT COMPLETED|Overall Study||66
10021232|NCT01842620|11144602|FG000|STARTED|Period 1||13
10021233|NCT01842620|11144603|FG001|STARTED|Period 1||12
10021234|NCT01842620|11144602|FG000|COMPLETED|Period 1||12
10021235|NCT01842620|11144603|FG001|COMPLETED|Period 1||12
10021236|NCT01842620|11144602|FG000|NOT COMPLETED|Period 1||1
10021237|NCT01842620|11144603|FG001|NOT COMPLETED|Period 1||0
10021238|NCT01842620|11144602|FG000|STARTED|Washout Period||12
10021239|NCT01842620|11144603|FG001|STARTED|Washout Period||12
10021240|NCT01842620|11144602|FG000|COMPLETED|Washout Period||12
10021241|NCT01842620|11144603|FG001|COMPLETED|Washout Period||12
10021242|NCT01842620|11144602|FG000|NOT COMPLETED|Washout Period||0
10021243|NCT01842620|11144603|FG001|NOT COMPLETED|Washout Period||0
10021244|NCT01842620|11144602|FG000|STARTED|Period 2||12
10021245|NCT01842620|11144603|FG001|STARTED|Period 2||12
10021246|NCT01842620|11144602|FG000|COMPLETED|Period 2||12
10021247|NCT01842620|11144603|FG001|COMPLETED|Period 2||12
10021248|NCT01842620|11144602|FG000|NOT COMPLETED|Period 2||0
10021249|NCT01842620|11144603|FG001|NOT COMPLETED|Period 2||0
9719652|NCT00045110|10819178|FG002|COMPLETED|775mg Dose Escalation||0
10021250|NCT01842633|11144612|FG000|STARTED|Overall Study||65
10021251|NCT01842633|11144613|FG001|STARTED|Overall Study||66
10021252|NCT01842633|11144614|FG002|STARTED|Overall Study||34
10021253|NCT01842633|11144612|FG000|COMPLETED|Overall Study||62
10021254|NCT01842633|11144613|FG001|COMPLETED|Overall Study||64
10021255|NCT01842633|11144614|FG002|COMPLETED|Overall Study||34
10021256|NCT01842633|11144612|FG000|NOT COMPLETED|Overall Study||3
10021257|NCT01842633|11144613|FG001|NOT COMPLETED|Overall Study||2
9836435|NCT00795145|10947619|FG004|COMPLETED|Cohort 1||0
9836436|NCT00795145|10947620|FG005|COMPLETED|Cohort 1||0
9836437|NCT00795145|10947621|FG006|COMPLETED|Cohort 1||0
9836438|NCT00795145|10947615|FG000|NOT COMPLETED|Cohort 1||0
9836439|NCT00795145|10947616|FG001|NOT COMPLETED|Cohort 1||0
9836440|NCT00795145|10947617|FG002|NOT COMPLETED|Cohort 1||0
9836441|NCT00795145|10947618|FG003|NOT COMPLETED|Cohort 1||0
9836442|NCT00795145|10947619|FG004|NOT COMPLETED|Cohort 1||0
9836443|NCT00795145|10947620|FG005|NOT COMPLETED|Cohort 1||0
9836444|NCT00795145|10947621|FG006|NOT COMPLETED|Cohort 1||0
9836445|NCT00795145|10947615|FG000|STARTED|Cohort 2||0
9836446|NCT00795145|10947616|FG001|STARTED|Cohort 2||0
9836447|NCT00795145|10947617|FG002|STARTED|Cohort 2||0
9836448|NCT00795145|10947618|FG003|STARTED|Cohort 2||10
9836449|NCT00795145|10947619|FG004|STARTED|Cohort 2||10
9836450|NCT00795145|10947620|FG005|STARTED|Cohort 2||10
9836451|NCT00795145|10947621|FG006|STARTED|Cohort 2||10
9836452|NCT00795145|10947615|FG000|COMPLETED|Cohort 2||0
9836453|NCT00795145|10947616|FG001|COMPLETED|Cohort 2||0
10021258|NCT01842633|11144614|FG002|NOT COMPLETED|Overall Study||0
10021259|NCT01842646|11144624|FG000|STARTED|Overall Study||35
10021260|NCT01842646|11144624|FG000|COMPLETED|Overall Study||35
9836454|NCT00795145|10947617|FG002|COMPLETED|Cohort 2||0
9836455|NCT00795145|10947618|FG003|COMPLETED|Cohort 2||10
9836456|NCT00795145|10947619|FG004|COMPLETED|Cohort 2||10
9836457|NCT00795145|10947620|FG005|COMPLETED|Cohort 2||10
9836458|NCT00795145|10947621|FG006|COMPLETED|Cohort 2||10
9836459|NCT00795145|10947615|FG000|NOT COMPLETED|Cohort 2||0
10021261|NCT01842646|11144624|FG000|NOT COMPLETED|Overall Study||0
10021262|NCT01842789|11144630|FG000|STARTED|Overall Study||10
9836460|NCT00795145|10947616|FG001|NOT COMPLETED|Cohort 2||0
9836461|NCT00795145|10947617|FG002|NOT COMPLETED|Cohort 2||0
9836462|NCT00795145|10947618|FG003|NOT COMPLETED|Cohort 2||0
9836463|NCT00795145|10947619|FG004|NOT COMPLETED|Cohort 2||0
9836464|NCT00795145|10947620|FG005|NOT COMPLETED|Cohort 2||0
9836465|NCT00795145|10947621|FG006|NOT COMPLETED|Cohort 2||0
9836466|NCT00795184|10947648|FG000|STARTED|Overall Study||65
9836467|NCT00795184|10947649|FG001|STARTED|Overall Study||57
9836468|NCT00795184|10947648|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
9836469|NCT00795184|10947649|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
9836470|NCT00795184|10947648|FG000|NOT COMPLETED|Overall Study||8
9836471|NCT00795184|10947649|FG001|NOT COMPLETED|Overall Study||13
9836472|NCT00795210|10947661|FG000|STARTED|Overall Study||8
9836473|NCT00795210|10947662|FG001|STARTED|Overall Study||12
9836474|NCT00795210|10947663|FG002|STARTED|Overall Study||5
9836475|NCT00795210|10947661|FG000|COMPLETED|Overall Study||8
10021263|NCT01842789|11144631|FG001|STARTED|Overall Study||8
10021264|NCT01842789|11144630|FG000|COMPLETED|Overall Study||10
10021265|NCT01842789|11144631|FG001|COMPLETED|Overall Study||8
10021266|NCT01842789|11144630|FG000|NOT COMPLETED|Overall Study||0
10021267|NCT01842789|11144631|FG001|NOT COMPLETED|Overall Study||0
10021268|NCT01842815|11144638|FG000|STARTED|Overall Study||20
10021269|NCT01842815|11144638|FG000|COMPLETED|Overall Study||16
10021270|NCT01842815|11144638|FG000|NOT COMPLETED|Overall Study||4
10021271|NCT01842841|11144643|FG000|STARTED|Overall Study||5
10021272|NCT01842841|11144643|FG000|COMPLETED|Overall Study||5
10021273|NCT01842841|11144643|FG000|NOT COMPLETED|Overall Study||0
10021274|NCT01842906|11144649|FG000|STARTED|Overall Study||115
9836476|NCT00795210|10947662|FG001|COMPLETED|Overall Study||11
9836477|NCT00795210|10947663|FG002|COMPLETED|Overall Study||3
9836478|NCT00795210|10947661|FG000|NOT COMPLETED|Overall Study||0
9836479|NCT00795210|10947662|FG001|NOT COMPLETED|Overall Study||1
9836480|NCT00795210|10947663|FG002|NOT COMPLETED|Overall Study||2
9836481|NCT00795275|10947673|FG000|STARTED|Overall Study||11
9836482|NCT00795275|10947674|FG001|STARTED|Overall Study||15
9836483|NCT00795275|10947673|FG000|COMPLETED|Overall Study||10
9836484|NCT00795275|10947674|FG001|COMPLETED|Overall Study||13
9836485|NCT00795275|10947673|FG000|NOT COMPLETED|Overall Study||1
9836486|NCT00795275|10947674|FG001|NOT COMPLETED|Overall Study||2
9836487|NCT00795288|10947684|FG000|STARTED|Overall Study||21
9836488|NCT00795288|10947685|FG001|STARTED|Overall Study||21
9836489|NCT00795288|10947684|FG000|COMPLETED|Overall Study||21
9836490|NCT00795288|10947685|FG001|COMPLETED|Overall Study||21
9836491|NCT00795288|10947684|FG000|NOT COMPLETED|Overall Study||0
9836492|NCT00795288|10947685|FG001|NOT COMPLETED|Overall Study||0
9836493|NCT00795340|10947695|FG000|STARTED|Overall Study||153
9836494|NCT00795340|10947696|FG001|STARTED|Overall Study||153
9836495|NCT00795340|10947695|FG000|COMPLETED|Overall Study||146
9836496|NCT00795340|10947696|FG001|COMPLETED|Overall Study||153
9836497|NCT00795340|10947695|FG000|NOT COMPLETED|Overall Study||7
9836498|NCT00795340|10947696|FG001|NOT COMPLETED|Overall Study||0
9836499|NCT00795366|10947704|FG000|STARTED|Overall Study||42
9836500|NCT00795366|10947705|FG001|STARTED|Overall Study||54
9836501|NCT00795366|10947704|FG000|COMPLETED|Overall Study||42
9836502|NCT00795366|10947705|FG001|COMPLETED|Overall Study||54
9836503|NCT00795366|10947704|FG000|NOT COMPLETED|Overall Study||0
9836504|NCT00795366|10947705|FG001|NOT COMPLETED|Overall Study||0
9836505|NCT00795509|10947711|FG000|STARTED|Overall Study||374
9836506|NCT00795509|10947711|FG000|COMPLETED|Overall Study||343
9836507|NCT00795509|10947711|FG000|NOT COMPLETED|Overall Study||31
9836508|NCT00795535|10947715|FG000|STARTED|Overall Study||95
9836509|NCT00795535|10947715|FG000|COMPLETED|Overall Study||75
9836510|NCT00795535|10947715|FG000|NOT COMPLETED|Overall Study||20
10021275|NCT01842906|11144650|FG001|STARTED|Overall Study||104
9836511|NCT00795600|10947721|FG000|STARTED|Overall Study||25
9836512|NCT00795600|10947722|FG001|STARTED|Overall Study||35
9836513|NCT00795600|10947721|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
9836514|NCT00795600|10947722|FG001|Exposed to Drug|Overall Study||35
9836515|NCT00795600|10947721|FG000|COMPLETED|Overall Study||21
9836516|NCT00795600|10947722|FG001|COMPLETED|Overall Study||31
9836517|NCT00795600|10947721|FG000|NOT COMPLETED|Overall Study||4
9836518|NCT00795600|10947722|FG001|NOT COMPLETED|Overall Study||4
10021276|NCT01842906|11144649|FG000|COMPLETED|Overall Study||115
10021277|NCT01842906|11144650|FG001|COMPLETED|Overall Study||104
9836519|NCT00795639|10947730|FG000|STARTED|Overall Study||91
9836520|NCT00795639|10947731|FG001|STARTED|Overall Study||92
9836521|NCT00795639|10947730|FG000|Randomized and Not Treated|Overall Study||0
9836522|NCT00795639|10947731|FG001|Randomized and Not Treated|Overall Study||1
9836523|NCT00795639|10947730|FG000|COMPLETED|Overall Study||70
9836524|NCT00795639|10947731|FG001|COMPLETED|Overall Study||66
9836525|NCT00795639|10947730|FG000|NOT COMPLETED|Overall Study||21
9836526|NCT00795639|10947731|FG001|NOT COMPLETED|Overall Study||26
9836527|NCT00795704|10947739|FG000|STARTED|Overall Study||12
9836528|NCT00795704|10947740|FG001|STARTED|Overall Study||12
9836529|NCT00795704|10947739|FG000|COMPLETED|Overall Study||8
9836530|NCT00795704|10947740|FG001|COMPLETED|Overall Study||9
9836531|NCT00795704|10947739|FG000|NOT COMPLETED|Overall Study||4
9836532|NCT00795704|10947740|FG001|NOT COMPLETED|Overall Study||3
9836533|NCT00795717|10947748|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
9836534|NCT00795717|10947749|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
9836535|NCT00795717|10947748|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
9836536|NCT00795717|10947749|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
9958323|NCT01456195|11077806|FG001|COMPLETED|Overall Study||127
9958324|NCT01456195|11077807|FG002|COMPLETED|Overall Study||127
9958325|NCT01456195|11077805|FG000|NOT COMPLETED|Overall Study||11
9958326|NCT01456195|11077806|FG001|NOT COMPLETED|Overall Study||10
9958327|NCT01456195|11077807|FG002|NOT COMPLETED|Overall Study||14
9958328|NCT01456221|11077817|FG000|STARTED|Overall Study||183
9958329|NCT01456221|11077818|FG001|STARTED|Overall Study||183
9958330|NCT01456221|11077817|FG000|COMPLETED|Overall Study||119
9958331|NCT01456221|11077818|FG001|COMPLETED|Overall Study||126
9958332|NCT01456221|11077817|FG000|NOT COMPLETED|Overall Study||64
9958333|NCT01456221|11077818|FG001|NOT COMPLETED|Overall Study||57
9958334|NCT01456299|11077827|FG000|STARTED|Overall Study||34
9958335|NCT01456299|11077828|FG001|STARTED|Overall Study||34
9958336|NCT01456299|11077829|FG002|STARTED|Overall Study||34
9958337|NCT01456299|11077827|FG000|COMPLETED|Overall Study||34
9958338|NCT01456299|11077828|FG001|COMPLETED|Overall Study||33
9958339|NCT01456299|11077829|FG002|COMPLETED|Overall Study||33
9958340|NCT01456299|11077827|FG000|NOT COMPLETED|Overall Study||0
9958341|NCT01456299|11077828|FG001|NOT COMPLETED|Overall Study||1
9958342|NCT01456299|11077829|FG002|NOT COMPLETED|Overall Study||1
9958343|NCT01456494|11077839|FG000|STARTED|Initial Inpatient Visit||24
9958344|NCT01456494|11077840|FG001|STARTED|Initial Inpatient Visit||26
9958345|NCT01456494|11077839|FG000|COMPLETED|Initial Inpatient Visit||24
9958346|NCT01456494|11077840|FG001|COMPLETED|Initial Inpatient Visit||26
9958347|NCT01456494|11077839|FG000|NOT COMPLETED|Initial Inpatient Visit||0
9958348|NCT01456494|11077840|FG001|NOT COMPLETED|Initial Inpatient Visit||0
9958349|NCT01456494|11077839|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
9958350|NCT01456494|11077840|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
9958351|NCT01456494|11077839|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
9958352|NCT01456494|11077840|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
9958353|NCT01456494|11077839|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
9836537|NCT00795717|10947748|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
9836538|NCT00795717|10947749|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
9836539|NCT00795717|10947748|FG000|STARTED|Phase II||18
9836540|NCT00795717|10947749|FG001|STARTED|Phase II||19
9836541|NCT00795717|10947748|FG000|COMPLETED|Phase II||18
9836542|NCT00795717|10947749|FG001|COMPLETED|Phase II||18
9836543|NCT00795717|10947748|FG000|NOT COMPLETED|Phase II||0
9836544|NCT00795717|10947749|FG001|NOT COMPLETED|Phase II||1
9836545|NCT00795769|10947756|FG000|STARTED|Overall Study||49
9836546|NCT00795769|10947756|FG000|COMPLETED|Overall Study||49
9836547|NCT00795769|10947756|FG000|NOT COMPLETED|Overall Study||0
9836548|NCT00795821|10947762|FG000|STARTED|Acute Treatment Phase||250
9836549|NCT00795821|10947763|FG001|STARTED|Acute Treatment Phase||245
9836550|NCT00795821|10947762|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
9836551|NCT00795821|10947763|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
9836552|NCT00795821|10947762|FG000|NOT COMPLETED|Acute Treatment Phase||56
9836553|NCT00795821|10947763|FG001|NOT COMPLETED|Acute Treatment Phase||31
9836554|NCT00795821|10947762|FG000|STARTED|Long-term Extension Phase||190
9836555|NCT00795821|10947763|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
9836556|NCT00795821|10947762|FG000|COMPLETED|Long-term Extension Phase||100
9836557|NCT00795821|10947763|FG001|COMPLETED|Long-term Extension Phase||115
9836558|NCT00795821|10947762|FG000|NOT COMPLETED|Long-term Extension Phase||90
9836559|NCT00795821|10947763|FG001|NOT COMPLETED|Long-term Extension Phase||92
9836560|NCT00795821|10947762|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
9836561|NCT00795821|10947763|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
9836562|NCT00795821|10947762|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
9836563|NCT00795821|10947763|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
9836564|NCT00795821|10947762|FG000|NOT COMPLETED|Taper Phase||9
9836565|NCT00795821|10947763|FG001|NOT COMPLETED|Taper Phase||0
9836566|NCT00795886|10947779|FG000|STARTED|Overall Study||63
9836567|NCT00795886|10947779|FG000|COMPLETED|Overall Study||53
9836568|NCT00795886|10947779|FG000|NOT COMPLETED|Overall Study||10
9836569|NCT00795951|10947784|FG000|STARTED|Overall Study||102
9836570|NCT00795951|10947784|FG000|COMPLETED|Overall Study||100
9836571|NCT00795951|10947784|FG000|NOT COMPLETED|Overall Study||2
9836572|NCT00796003|10947791|FG000|STARTED|Overall Study|Number of participants enrolled|3
9836573|NCT00796003|10947792|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
9836574|NCT00796003|10947791|FG000|Treated|Overall Study|Number of participants treated|3
9836575|NCT00796003|10947792|FG001|Treated|Overall Study|Number of participants treated|34
9836576|NCT00796003|10947791|FG000|COMPLETED|Overall Study||0
9836577|NCT00796003|10947792|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
9836578|NCT00796003|10947791|FG000|NOT COMPLETED|Overall Study||3
9836579|NCT00796003|10947792|FG001|NOT COMPLETED|Overall Study||29
9958354|NCT01456494|11077840|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
9958355|NCT01456780|11077849|FG000|STARTED|Overall Study||20
9958356|NCT01456780|11077850|FG001|STARTED|Overall Study||20
9958357|NCT01456780|11077851|FG002|STARTED|Overall Study||20
9958358|NCT01456780|11077849|FG000|COMPLETED|Overall Study||17
9958359|NCT01456780|11077850|FG001|COMPLETED|Overall Study||17
9958360|NCT01456780|11077851|FG002|COMPLETED|Overall Study||20
9958361|NCT01456780|11077849|FG000|NOT COMPLETED|Overall Study||3
9958362|NCT01456780|11077850|FG001|NOT COMPLETED|Overall Study||3
9958363|NCT01456780|11077851|FG002|NOT COMPLETED|Overall Study||0
9958364|NCT01456897|11077861|FG000|STARTED|Overall Study||184
9958365|NCT01456897|11077862|FG001|STARTED|Overall Study||98
9958366|NCT01456897|11077861|FG000|COMPLETED|Overall Study||109
9958367|NCT01456897|11077862|FG001|COMPLETED|Overall Study||41
9958368|NCT01456897|11077861|FG000|NOT COMPLETED|Overall Study||75
9958369|NCT01456897|11077862|FG001|NOT COMPLETED|Overall Study||57
9958370|NCT01456936|11077872|FG000|STARTED|Overall Study||2037
9958371|NCT01456936|11077873|FG001|STARTED|Overall Study||2034
10021278|NCT01842906|11144649|FG000|NOT COMPLETED|Overall Study||0
10021279|NCT01842906|11144650|FG001|NOT COMPLETED|Overall Study||0
10021280|NCT01842958|11144658|FG000|STARTED|Overall Study||25
10021281|NCT01842958|11144659|FG001|STARTED|Overall Study||25
10021282|NCT01842958|11144658|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
10021283|NCT01842958|11144659|FG001|Randomized|Overall Study||25
10021284|NCT01842958|11144658|FG000|COMPLETED|Overall Study||24
10021285|NCT01842958|11144659|FG001|COMPLETED|Overall Study||24
10021286|NCT01842958|11144658|FG000|NOT COMPLETED|Overall Study||1
9719653|NCT00045110|10819176|FG000|NOT COMPLETED|775mg Dose Escalation||0
9719654|NCT00045110|10819177|FG001|NOT COMPLETED|775mg Dose Escalation||0
9719655|NCT00045110|10819178|FG002|NOT COMPLETED|775mg Dose Escalation||0
9719656|NCT00045162|10819197|FG000|STARTED|Overall Study||336
9719657|NCT00045162|10819198|FG001|STARTED|Overall Study||335
9719658|NCT00045162|10819197|FG000|COMPLETED|Overall Study||194
9719659|NCT00045162|10819198|FG001|COMPLETED|Overall Study||217
9719660|NCT00045162|10819197|FG000|NOT COMPLETED|Overall Study||142
9719661|NCT00045162|10819198|FG001|NOT COMPLETED|Overall Study||118
9719662|NCT00045305|10819204|FG000|STARTED|Overall Study||17
9719663|NCT00045305|10819204|FG000|Eligible and Treated|Overall Study||17
9719664|NCT00045305|10819204|FG000|COMPLETED|Overall Study||3
9719665|NCT00045305|10819204|FG000|NOT COMPLETED|Overall Study||14
9719666|NCT00045435|10819208|FG000|STARTED|Overall Study||17
9719667|NCT00045435|10819208|FG000|COMPLETED|Overall Study||17
9719668|NCT00045435|10819208|FG000|NOT COMPLETED|Overall Study||0
9719669|NCT00045487|10819212|FG000|STARTED|Overall Study||41
9719670|NCT00045487|10819212|FG000|COMPLETED|Overall Study||30
9719671|NCT00045487|10819212|FG000|NOT COMPLETED|Overall Study||11
9719672|NCT00045630|10819216|FG000|STARTED|Overall Study||77
9958372|NCT01456936|11077874|FG002|STARTED|Overall Study||2038
9958373|NCT01456936|11077875|FG003|STARTED|Overall Study||2035
9958374|NCT01456936|11077872|FG000|Randomized and Treated|Overall Study||2016
9958375|NCT01456936|11077873|FG001|Randomized and Treated|Overall Study||2006
9958376|NCT01456936|11077874|FG002|Randomized and Treated|Overall Study||2022
9836580|NCT00796120|10947803|FG000|STARTED|Overall Study||61
9836581|NCT00796120|10947804|FG001|STARTED|Overall Study||60
9836582|NCT00796120|10947803|FG000|Treated|Overall Study||61
10021287|NCT01842958|11144659|FG001|NOT COMPLETED|Overall Study||1
10021288|NCT01843023|11144667|FG000|STARTED|Overall Study||144
10021289|NCT01843023|11144668|FG001|STARTED|Overall Study||144
10021290|NCT01843023|11144667|FG000|3 Months|Overall Study||110
10021291|NCT01843023|11144668|FG001|3 Months|Overall Study||114
10021292|NCT01843023|11144667|FG000|COMPLETED|Overall Study||111
10021293|NCT01843023|11144668|FG001|COMPLETED|Overall Study||109
10021294|NCT01843023|11144667|FG000|NOT COMPLETED|Overall Study||33
10021295|NCT01843023|11144668|FG001|NOT COMPLETED|Overall Study||35
10021296|NCT01843062|11144676|FG000|STARTED|Overall Study||155
10021297|NCT01843062|11144677|FG001|STARTED|Overall Study||78
10021298|NCT01843062|11144676|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155
10021299|NCT01843062|11144677|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78
10021300|NCT01843062|11144676|FG000|Safety Analysis Set|Overall Study||154
10021301|NCT01843062|11144677|FG001|Safety Analysis Set|Overall Study||77
10021302|NCT01843062|11144676|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
10021303|NCT01843062|11144677|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
10021304|NCT01843062|11144676|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
9719673|NCT00045630|10819216|FG000|Eligible|Overall Study||75
9719674|NCT00045630|10819216|FG000|Eligible and Began Protocol Therapy|Overall Study||74
9719675|NCT00045630|10819216|FG000|COMPLETED|Overall Study||71
9719676|NCT00045630|10819216|FG000|NOT COMPLETED|Overall Study||6
9719677|NCT00045708|10819223|FG000|STARTED|Phase 1||21
9719678|NCT00045708|10819224|FG001|STARTED|Phase 1||17
9719679|NCT00045708|10819225|FG002|STARTED|Phase 1||0
9719680|NCT00045708|10819223|FG000|COMPLETED|Phase 1||21
9719681|NCT00045708|10819224|FG001|COMPLETED|Phase 1||16
9719682|NCT00045708|10819225|FG002|COMPLETED|Phase 1||0
9719683|NCT00045708|10819223|FG000|NOT COMPLETED|Phase 1||0
9719684|NCT00045708|10819224|FG001|NOT COMPLETED|Phase 1||1
9719685|NCT00045708|10819225|FG002|NOT COMPLETED|Phase 1||0
9719686|NCT00045708|10819223|FG000|STARTED|Phase 2||0
9719687|NCT00045708|10819224|FG001|STARTED|Phase 2||0
9719688|NCT00045708|10819225|FG002|STARTED|Phase 2||19
9719689|NCT00045708|10819223|FG000|COMPLETED|Phase 2||0
9719690|NCT00045708|10819224|FG001|COMPLETED|Phase 2||0
9719691|NCT00045708|10819225|FG002|COMPLETED|Phase 2||19
9719692|NCT00045708|10819223|FG000|NOT COMPLETED|Phase 2||0
9719693|NCT00045708|10819224|FG001|NOT COMPLETED|Phase 2||0
9719694|NCT00045708|10819225|FG002|NOT COMPLETED|Phase 2||0
9719695|NCT00045734|10819242|FG000|STARTED|Overall Study||23
9719696|NCT00045734|10819242|FG000|COMPLETED|Overall Study||22
9719697|NCT00045734|10819242|FG000|NOT COMPLETED|Overall Study||1
9719698|NCT00045942|10819255|FG000|STARTED|PKC412A2104 (Core)||20
9719699|NCT00045942|10819256|FG001|STARTED|PKC412A2104 (Core)||0
9719700|NCT00045942|10819257|FG002|STARTED|PKC412A2104 (Core)||0
9719701|NCT00045942|10819258|FG003|STARTED|PKC412A2104 (Core)||0
9719702|NCT00045942|10819259|FG004|STARTED|PKC412A2104 (Core)||0
9719703|NCT00045942|10819260|FG005|STARTED|PKC412A2104 (Core)||0
9719704|NCT00045942|10819261|FG006|STARTED|PKC412A2104 (Core)||0
9719705|NCT00045942|10819262|FG007|STARTED|PKC412A2104 (Core)||0
9719706|NCT00045942|10819263|FG008|STARTED|PKC412A2104 (Core)||0
9719707|NCT00045942|10819255|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20
9719708|NCT00045942|10819256|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0
9719709|NCT00045942|10819257|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0
9836583|NCT00796120|10947804|FG001|Treated|Overall Study||57
9836584|NCT00796120|10947803|FG000|COMPLETED|Overall Study||0
9836585|NCT00796120|10947804|FG001|COMPLETED|Overall Study||0
9836586|NCT00796120|10947803|FG000|NOT COMPLETED|Overall Study||61
9836587|NCT00796120|10947804|FG001|NOT COMPLETED|Overall Study||60
9836588|NCT00796224|10947812|FG000|STARTED|Overall Study||19
9836589|NCT00796224|10947813|FG001|STARTED|Overall Study||19
9836590|NCT00796224|10947812|FG000|COMPLETED|Overall Study||18
9836591|NCT00796224|10947813|FG001|COMPLETED|Overall Study||18
9836592|NCT00796224|10947812|FG000|NOT COMPLETED|Overall Study||1
9836593|NCT00796224|10947813|FG001|NOT COMPLETED|Overall Study||1
9836594|NCT00796302|10947823|FG000|STARTED|Overall Study||84
9836595|NCT00796302|10947824|FG001|STARTED|Overall Study||84
9836596|NCT00796302|10947823|FG000|COMPLETED|Overall Study||71
9836597|NCT00796302|10947824|FG001|COMPLETED|Overall Study||66
9836598|NCT00796302|10947823|FG000|NOT COMPLETED|Overall Study||13
9836599|NCT00796302|10947824|FG001|NOT COMPLETED|Overall Study||18
9836600|NCT00796315|10947831|FG000|STARTED|Overall Study||9
9958377|NCT01456936|11077875|FG003|Randomized and Treated|Overall Study||2014
9958378|NCT01456936|11077872|FG000|COMPLETED|Overall Study||1598
9958379|NCT01456936|11077873|FG001|COMPLETED|Overall Study||1586
9958380|NCT01456936|11077874|FG002|COMPLETED|Overall Study||1557
9958381|NCT01456936|11077875|FG003|COMPLETED|Overall Study||1552
9958382|NCT01456936|11077872|FG000|NOT COMPLETED|Overall Study||439
9958383|NCT01456936|11077873|FG001|NOT COMPLETED|Overall Study||448
9958384|NCT01456936|11077874|FG002|NOT COMPLETED|Overall Study||481
9958385|NCT01456936|11077875|FG003|NOT COMPLETED|Overall Study||483
9958386|NCT01456949|11077885|FG000|STARTED|Enrollment||402
9958387|NCT01456949|11077885|FG000|Treated|Enrollment||359
9958388|NCT01456949|11077885|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354
9958389|NCT01456949|11077885|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
9719710|NCT00045942|10819258|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0
9719711|NCT00045942|10819259|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0
9719712|NCT00045942|10819260|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0
9719713|NCT00045942|10819261|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0
9719714|NCT00045942|10819262|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0
9719715|NCT00045942|10819263|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0
9719716|NCT00045942|10819255|FG000|COMPLETED|PKC412A2104 (Core)||0
9719717|NCT00045942|10819256|FG001|COMPLETED|PKC412A2104 (Core)||0
9836601|NCT00796315|10947832|FG001|STARTED|Overall Study||17
9836602|NCT00796315|10947833|FG002|STARTED|Overall Study||15
9836603|NCT00796315|10947831|FG000|COMPLETED|Overall Study||9
9958390|NCT01456949|11077885|FG000|NOT COMPLETED|Enrollment||37
9719718|NCT00045942|10819257|FG002|COMPLETED|PKC412A2104 (Core)||0
9836604|NCT00796315|10947832|FG001|COMPLETED|Overall Study||16
9836605|NCT00796315|10947833|FG002|COMPLETED|Overall Study||15
9836606|NCT00796315|10947831|FG000|NOT COMPLETED|Overall Study||0
9836607|NCT00796315|10947832|FG001|NOT COMPLETED|Overall Study||1
9836608|NCT00796315|10947833|FG002|NOT COMPLETED|Overall Study||0
9836609|NCT00796328|10947844|FG000|STARTED|Overall Study||46
9836610|NCT00796328|10947844|FG000|COMPLETED|Overall Study||40
9836611|NCT00796328|10947844|FG000|NOT COMPLETED|Overall Study||6
9836612|NCT00796367|10947851|FG000|STARTED|Overall Study||227
9836613|NCT00796367|10947852|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
9836614|NCT00796367|10947853|FG002|STARTED|Overall Study||295
9836615|NCT00796367|10947851|FG000|COMPLETED|Overall Study||197
9836616|NCT00796367|10947852|FG001|COMPLETED|Overall Study||129
9836617|NCT00796367|10947853|FG002|COMPLETED|Overall Study||248
9836618|NCT00796367|10947851|FG000|NOT COMPLETED|Overall Study||30
9836619|NCT00796367|10947852|FG001|NOT COMPLETED|Overall Study||25
9836620|NCT00796367|10947853|FG002|NOT COMPLETED|Overall Study||47
9836621|NCT00796419|10947863|FG000|STARTED|Overall Study||13
9836622|NCT00796419|10947864|FG001|STARTED|Overall Study||14
9836623|NCT00796419|10947863|FG000|COMPLETED|Overall Study||13
9836624|NCT00796419|10947864|FG001|COMPLETED|Overall Study||13
9836625|NCT00796419|10947863|FG000|NOT COMPLETED|Overall Study||0
10021305|NCT01843062|11144677|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
10021306|NCT01843062|11144676|FG000|COMPLETED|Overall Study||133
10021307|NCT01843062|11144677|FG001|COMPLETED|Overall Study||69
10021308|NCT01843062|11144676|FG000|NOT COMPLETED|Overall Study||22
10021309|NCT01843062|11144677|FG001|NOT COMPLETED|Overall Study||9
10021310|NCT01843192|11144686|FG000|STARTED|Overall Study||26
9836626|NCT00796419|10947864|FG001|NOT COMPLETED|Overall Study||1
9836627|NCT00796445|10947872|FG000|STARTED|Overall Study||895
9836628|NCT00796445|10947873|FG001|STARTED|Overall Study||450
9836629|NCT00796445|10947872|FG000|COMPLETED|Overall Study||310
9836630|NCT00796445|10947873|FG001|COMPLETED|Overall Study||158
9836631|NCT00796445|10947872|FG000|NOT COMPLETED|Overall Study||585
9836632|NCT00796445|10947873|FG001|NOT COMPLETED|Overall Study||292
9836633|NCT00796549|10947887|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
9836634|NCT00796549|10947887|FG000|Entered|Overall Study|entered and treated|69
9836635|NCT00796549|10947887|FG000|COMPLETED|Overall Study||0
9836636|NCT00796549|10947887|FG000|NOT COMPLETED|Overall Study||218
9836637|NCT00796562|10947893|FG000|STARTED|Overall Study||96
9836638|NCT00796562|10947893|FG000|COMPLETED|Overall Study||47
10021311|NCT01843192|11144687|FG001|STARTED|Overall Study||34
10021312|NCT01843192|11144688|FG002|STARTED|Overall Study||11
10021313|NCT01843192|11144686|FG000|COMPLETED|Overall Study||24
10021314|NCT01843192|11144687|FG001|COMPLETED|Overall Study||28
10021315|NCT01843192|11144688|FG002|COMPLETED|Overall Study||9
10021316|NCT01843192|11144686|FG000|NOT COMPLETED|Overall Study||2
10021317|NCT01843192|11144687|FG001|NOT COMPLETED|Overall Study||6
10021318|NCT01843192|11144688|FG002|NOT COMPLETED|Overall Study||2
9836639|NCT00796562|10947893|FG000|NOT COMPLETED|Overall Study||49
9836640|NCT00796614|10947901|FG000|STARTED|Overall Study||41
9836641|NCT00796614|10947902|FG001|STARTED|Overall Study||40
9836642|NCT00796614|10947903|FG002|STARTED|Overall Study||39
9836643|NCT00796614|10947904|FG003|STARTED|Overall Study||41
9836644|NCT00796614|10947901|FG000|Not Treated|Overall Study||0
9836645|NCT00796614|10947902|FG001|Not Treated|Overall Study||0
9836646|NCT00796614|10947903|FG002|Not Treated|Overall Study||1
9836647|NCT00796614|10947904|FG003|Not Treated|Overall Study||0
9836648|NCT00796614|10947901|FG000|COMPLETED|Overall Study||36
9836649|NCT00796614|10947902|FG001|COMPLETED|Overall Study||36
9836650|NCT00796614|10947903|FG002|COMPLETED|Overall Study||36
9836651|NCT00796614|10947904|FG003|COMPLETED|Overall Study||40
9836652|NCT00796614|10947901|FG000|NOT COMPLETED|Overall Study||5
9836653|NCT00796614|10947902|FG001|NOT COMPLETED|Overall Study||4
9836654|NCT00796614|10947903|FG002|NOT COMPLETED|Overall Study||3
9836655|NCT00796614|10947904|FG003|NOT COMPLETED|Overall Study||1
9836656|NCT00796627|10947916|FG000|STARTED|Overall Study||10
9836657|NCT00796627|10947917|FG001|STARTED|Overall Study||31
9836658|NCT00796627|10947916|FG000|COMPLETED|Overall Study||10
9836659|NCT00796627|10947917|FG001|COMPLETED|Overall Study||31
9836660|NCT00796627|10947916|FG000|NOT COMPLETED|Overall Study||0
9836661|NCT00796627|10947917|FG001|NOT COMPLETED|Overall Study||0
9836662|NCT00796653|10947927|FG000|STARTED|Overall Study||235
9836663|NCT00796653|10947928|FG001|STARTED|Overall Study||232
9836664|NCT00796653|10947929|FG002|STARTED|Overall Study||234
9836665|NCT00796653|10947930|FG003|STARTED|Overall Study||233
9836666|NCT00796653|10947927|FG000|COMPLETED|Overall Study||184
9836667|NCT00796653|10947928|FG001|COMPLETED|Overall Study||195
10021319|NCT01843205|11144696|FG000|STARTED|First Treatment (11 Days)||5
10021320|NCT01843205|11144697|FG001|STARTED|First Treatment (11 Days)||4
10021321|NCT01843205|11144696|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
9836668|NCT00796653|10947929|FG002|COMPLETED|Overall Study||198
9836669|NCT00796653|10947930|FG003|COMPLETED|Overall Study||193
9836670|NCT00796653|10947927|FG000|NOT COMPLETED|Overall Study||51
9836671|NCT00796653|10947928|FG001|NOT COMPLETED|Overall Study||37
9836672|NCT00796653|10947929|FG002|NOT COMPLETED|Overall Study||36
9836673|NCT00796653|10947930|FG003|NOT COMPLETED|Overall Study||40
9836674|NCT00796666|10947950|FG000|STARTED|Overall Study||67
9836675|NCT00796666|10947951|FG001|STARTED|Overall Study||64
9958391|NCT01456949|11077885|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365
9958392|NCT01456949|11077885|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
10081116|NCT02257970|11209577|FG003|NOT COMPLETED|Part 1||0
9719719|NCT00045942|10819258|FG003|COMPLETED|PKC412A2104 (Core)||0
9719720|NCT00045942|10819259|FG004|COMPLETED|PKC412A2104 (Core)||0
9719721|NCT00045942|10819260|FG005|COMPLETED|PKC412A2104 (Core)||0
9719722|NCT00045942|10819261|FG006|COMPLETED|PKC412A2104 (Core)||0
9719723|NCT00045942|10819262|FG007|COMPLETED|PKC412A2104 (Core)||0
9719724|NCT00045942|10819263|FG008|COMPLETED|PKC412A2104 (Core)||0
9719725|NCT00045942|10819255|FG000|NOT COMPLETED|PKC412A2104 (Core)||20
9719726|NCT00045942|10819256|FG001|NOT COMPLETED|PKC412A2104 (Core)||0
9719727|NCT00045942|10819257|FG002|NOT COMPLETED|PKC412A2104 (Core)||0
9719728|NCT00045942|10819258|FG003|NOT COMPLETED|PKC412A2104 (Core)||0
9719729|NCT00045942|10819259|FG004|NOT COMPLETED|PKC412A2104 (Core)||0
9719730|NCT00045942|10819260|FG005|NOT COMPLETED|PKC412A2104 (Core)||0
9719731|NCT00045942|10819261|FG006|NOT COMPLETED|PKC412A2104 (Core)||0
9719732|NCT00045942|10819262|FG007|NOT COMPLETED|PKC412A2104 (Core)||0
9719733|NCT00045942|10819263|FG008|NOT COMPLETED|PKC412A2104 (Core)||0
9719734|NCT00045942|10819255|FG000|STARTED|PKC412A2104E1||0
9719735|NCT00045942|10819256|FG001|STARTED|PKC412A2104E1||18
9719736|NCT00045942|10819257|FG002|STARTED|PKC412A2104E1||17
9719737|NCT00045942|10819258|FG003|STARTED|PKC412A2104E1||33
9719738|NCT00045942|10819259|FG004|STARTED|PKC412A2104E1||27
9719739|NCT00045942|10819260|FG005|STARTED|PKC412A2104E1||0
9719740|NCT00045942|10819261|FG006|STARTED|PKC412A2104E1||0
9719741|NCT00045942|10819262|FG007|STARTED|PKC412A2104E1||0
9719742|NCT00045942|10819263|FG008|STARTED|PKC412A2104E1||0
9719743|NCT00045942|10819255|FG000|Primary Efficacy|PKC412A2104E1||0
9719744|NCT00045942|10819256|FG001|Primary Efficacy|PKC412A2104E1||18
9719745|NCT00045942|10819257|FG002|Primary Efficacy|PKC412A2104E1||17
9719746|NCT00045942|10819258|FG003|Primary Efficacy|PKC412A2104E1||32
9719747|NCT00045942|10819259|FG004|Primary Efficacy|PKC412A2104E1||25
9719748|NCT00045942|10819260|FG005|Primary Efficacy|PKC412A2104E1||0
9719749|NCT00045942|10819261|FG006|Primary Efficacy|PKC412A2104E1||0
9719750|NCT00045942|10819262|FG007|Primary Efficacy|PKC412A2104E1||0
9719751|NCT00045942|10819263|FG008|Primary Efficacy|PKC412A2104E1||0
9719752|NCT00045942|10819255|FG000|COMPLETED|PKC412A2104E1||0
10114060|NCT02513550|11244787|FG001|COMPLETED|Double Blind Treatment Period||268
9836676|NCT00796666|10947950|FG000|Treated|Overall Study||66
9836677|NCT00796666|10947951|FG001|Treated|Overall Study||64
9836678|NCT00796666|10947950|FG000|Randomized and Not Treated|Overall Study||1
9836679|NCT00796666|10947951|FG001|Randomized and Not Treated|Overall Study||0
9836680|NCT00796666|10947950|FG000|COMPLETED|Overall Study||0
9836681|NCT00796666|10947951|FG001|COMPLETED|Overall Study||0
9836682|NCT00796666|10947950|FG000|NOT COMPLETED|Overall Study||67
9836683|NCT00796666|10947951|FG001|NOT COMPLETED|Overall Study||64
9836684|NCT00796705|10947961|FG000|STARTED|Overall Study||3
9836685|NCT00796705|10947962|FG001|STARTED|Overall Study||4
9836686|NCT00796705|10947963|FG002|STARTED|Overall Study||4
9836687|NCT00796705|10947964|FG003|STARTED|Overall Study||2
9836688|NCT00796705|10947961|FG000|COMPLETED|Overall Study||3
9836689|NCT00796705|10947962|FG001|COMPLETED|Overall Study||4
9836690|NCT00796705|10947963|FG002|COMPLETED|Overall Study||4
9836691|NCT00796705|10947964|FG003|COMPLETED|Overall Study||2
9836692|NCT00796705|10947961|FG000|NOT COMPLETED|Overall Study||0
9836693|NCT00796705|10947962|FG001|NOT COMPLETED|Overall Study||0
9836694|NCT00796705|10947963|FG002|NOT COMPLETED|Overall Study||0
9836695|NCT00796705|10947964|FG003|NOT COMPLETED|Overall Study||0
9836696|NCT00796718|10947976|FG000|STARTED|Overall Study||62
9836697|NCT00796718|10947976|FG000|COMPLETED|Overall Study||53
9836698|NCT00796718|10947976|FG000|NOT COMPLETED|Overall Study||9
9836699|NCT00796744|10947983|FG000|STARTED|Overall Study||24
9836700|NCT00796744|10947984|FG001|STARTED|Overall Study||26
9836701|NCT00796744|10947985|FG002|STARTED|Overall Study||28
9836702|NCT00796744|10947983|FG000|COMPLETED|Overall Study||24
9836703|NCT00796744|10947984|FG001|COMPLETED|Overall Study||26
9836704|NCT00796744|10947985|FG002|COMPLETED|Overall Study||27
9836705|NCT00796744|10947983|FG000|NOT COMPLETED|Overall Study||0
9836706|NCT00796744|10947984|FG001|NOT COMPLETED|Overall Study||0
9836707|NCT00796744|10947985|FG002|NOT COMPLETED|Overall Study||1
9836708|NCT00796757|10947995|FG000|STARTED|Overall Study||146
9836709|NCT00796757|10947995|FG000|COMPLETED|Overall Study||60
9836710|NCT00796757|10947995|FG000|NOT COMPLETED|Overall Study||86
9836711|NCT00796822|10948001|FG000|STARTED|Overall Study||13
9836712|NCT00796822|10948002|FG001|STARTED|Overall Study||13
9836713|NCT00796822|10948001|FG000|COMPLETED|Overall Study||10
9836714|NCT00796822|10948002|FG001|COMPLETED|Overall Study||13
9836715|NCT00796822|10948001|FG000|NOT COMPLETED|Overall Study||3
9836716|NCT00796822|10948002|FG001|NOT COMPLETED|Overall Study||0
9836717|NCT00796926|10948010|FG000|STARTED|Overall Study||15
9836718|NCT00796926|10948011|FG001|STARTED|Overall Study||15
9836719|NCT00796926|10948010|FG000|COMPLETED|Overall Study||14
9836720|NCT00796926|10948011|FG001|COMPLETED|Overall Study||15
9836721|NCT00796926|10948010|FG000|NOT COMPLETED|Overall Study||1
9836722|NCT00796926|10948011|FG001|NOT COMPLETED|Overall Study||0
9836723|NCT00796978|10948017|FG000|STARTED|Overall Study||56
9836724|NCT00796978|10948017|FG000|COMPLETED|Overall Study||44
9836725|NCT00796978|10948017|FG000|NOT COMPLETED|Overall Study||12
9836726|NCT00796991|10948024|FG000|STARTED|Overall Study||20
9836727|NCT00796991|10948025|FG001|STARTED|Overall Study||19
9836728|NCT00796991|10948026|FG002|STARTED|Overall Study||20
9836729|NCT00796991|10948024|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
9836730|NCT00796991|10948025|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
9836731|NCT00796991|10948026|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
9836732|NCT00796991|10948024|FG000|NOT COMPLETED|Overall Study||15
9836733|NCT00796991|10948025|FG001|NOT COMPLETED|Overall Study||12
9836734|NCT00796991|10948026|FG002|NOT COMPLETED|Overall Study||14
9836735|NCT00797108|10948037|FG000|STARTED|Overall Study||12
9836736|NCT00797108|10948038|FG001|STARTED|Overall Study||11
9836737|NCT00797108|10948039|FG002|STARTED|Overall Study||12
9836738|NCT00797108|10948037|FG000|Treated|Overall Study||10
9836739|NCT00797108|10948038|FG001|Treated|Overall Study||11
9836740|NCT00797108|10948039|FG002|Treated|Overall Study||12
9836741|NCT00797108|10948037|FG000|COMPLETED|Overall Study||8
9836742|NCT00797108|10948038|FG001|COMPLETED|Overall Study||9
9836743|NCT00797108|10948039|FG002|COMPLETED|Overall Study||6
9836744|NCT00797108|10948037|FG000|NOT COMPLETED|Overall Study||4
9836745|NCT00797108|10948038|FG001|NOT COMPLETED|Overall Study||2
9836746|NCT00797108|10948039|FG002|NOT COMPLETED|Overall Study||6
9836747|NCT00797212|10948047|FG000|STARTED|Overall Study||50
9836748|NCT00797212|10948047|FG000|COMPLETED|Overall Study||50
9836749|NCT00797212|10948047|FG000|NOT COMPLETED|Overall Study||0
9836750|NCT00797225|10948055|FG000|STARTED|Weeks 1 to 12||43
9836751|NCT00797225|10948056|FG001|STARTED|Weeks 1 to 12||43
9836752|NCT00797225|10948057|FG002|STARTED|Weeks 1 to 12||44
9836753|NCT00797225|10948058|FG003|STARTED|Weeks 1 to 12||44
9836754|NCT00797225|10948059|FG004|STARTED|Weeks 1 to 12||0
9836755|NCT00797225|10948060|FG005|STARTED|Weeks 1 to 12||0
9836756|NCT00797225|10948061|FG006|STARTED|Weeks 1 to 12||0
9836757|NCT00797225|10948062|FG007|STARTED|Weeks 1 to 12||0
9836758|NCT00797225|10948055|FG000|Received Study Drug|Weeks 1 to 12||43
9836759|NCT00797225|10948056|FG001|Received Study Drug|Weeks 1 to 12||43
9836760|NCT00797225|10948057|FG002|Received Study Drug|Weeks 1 to 12||44
9836761|NCT00797225|10948058|FG003|Received Study Drug|Weeks 1 to 12||44
9836762|NCT00797225|10948059|FG004|Received Study Drug|Weeks 1 to 12||0
9836763|NCT00797225|10948060|FG005|Received Study Drug|Weeks 1 to 12||0
9836764|NCT00797225|10948061|FG006|Received Study Drug|Weeks 1 to 12||0
9836765|NCT00797225|10948062|FG007|Received Study Drug|Weeks 1 to 12||0
9836766|NCT00797225|10948055|FG000|COMPLETED|Weeks 1 to 12||41
9836767|NCT00797225|10948056|FG001|COMPLETED|Weeks 1 to 12||42
9836768|NCT00797225|10948057|FG002|COMPLETED|Weeks 1 to 12||43
9836769|NCT00797225|10948058|FG003|COMPLETED|Weeks 1 to 12||44
9836770|NCT00797225|10948059|FG004|COMPLETED|Weeks 1 to 12||0
9836771|NCT00797225|10948060|FG005|COMPLETED|Weeks 1 to 12||0
9836772|NCT00797225|10948061|FG006|COMPLETED|Weeks 1 to 12||0
9836773|NCT00797225|10948062|FG007|COMPLETED|Weeks 1 to 12||0
9836774|NCT00797225|10948055|FG000|NOT COMPLETED|Weeks 1 to 12||2
10021322|NCT01843205|11144697|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
10021323|NCT01843205|11144696|FG000|NOT COMPLETED|First Treatment (11 Days)||1
9836775|NCT00797225|10948056|FG001|NOT COMPLETED|Weeks 1 to 12||1
9836776|NCT00797225|10948057|FG002|NOT COMPLETED|Weeks 1 to 12||1
9836777|NCT00797225|10948058|FG003|NOT COMPLETED|Weeks 1 to 12||0
9836778|NCT00797225|10948059|FG004|NOT COMPLETED|Weeks 1 to 12||0
10021324|NCT01843205|11144697|FG001|NOT COMPLETED|First Treatment (11 Days)||0
9836779|NCT00797225|10948060|FG005|NOT COMPLETED|Weeks 1 to 12||0
9836780|NCT00797225|10948061|FG006|NOT COMPLETED|Weeks 1 to 12||0
9836781|NCT00797225|10948062|FG007|NOT COMPLETED|Weeks 1 to 12||0
9719753|NCT00045942|10819256|FG001|COMPLETED|PKC412A2104E1||0
9836782|NCT00797225|10948055|FG000|STARTED|Weeks 13 to 24||0
9958393|NCT01456949|11077885|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
9958394|NCT01456949|11077885|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
10021325|NCT01843205|11144696|FG000|STARTED|Second Treatment (11 Days)||4
10021326|NCT01843205|11144697|FG001|STARTED|Second Treatment (11 Days)||4
10021327|NCT01843205|11144696|FG000|COMPLETED|Second Treatment (11 Days)||4
10021328|NCT01843205|11144697|FG001|COMPLETED|Second Treatment (11 Days)||4
10021329|NCT01843205|11144696|FG000|NOT COMPLETED|Second Treatment (11 Days)||0
9836783|NCT00797225|10948056|FG001|STARTED|Weeks 13 to 24||42
9836784|NCT00797225|10948057|FG002|STARTED|Weeks 13 to 24||43
9836785|NCT00797225|10948058|FG003|STARTED|Weeks 13 to 24||0
9836786|NCT00797225|10948059|FG004|STARTED|Weeks 13 to 24||20
9836787|NCT00797225|10948060|FG005|STARTED|Weeks 13 to 24||21
9836788|NCT00797225|10948061|FG006|STARTED|Weeks 13 to 24||22
9836789|NCT00797225|10948062|FG007|STARTED|Weeks 13 to 24||22
9836790|NCT00797225|10948055|FG000|COMPLETED|Weeks 13 to 24||0
9836791|NCT00797225|10948056|FG001|COMPLETED|Weeks 13 to 24||38
10021330|NCT01843205|11144697|FG001|NOT COMPLETED|Second Treatment (11 Days)||0
10021331|NCT01843348|11144706|FG000|STARTED|Overall Study||205
10021332|NCT01843348|11144707|FG001|STARTED|Overall Study||208
10021333|NCT01843348|11144708|FG002|STARTED|Overall Study||199
9836792|NCT00797225|10948057|FG002|COMPLETED|Weeks 13 to 24||41
9836793|NCT00797225|10948058|FG003|COMPLETED|Weeks 13 to 24||0
9836794|NCT00797225|10948059|FG004|COMPLETED|Weeks 13 to 24||19
9836795|NCT00797225|10948060|FG005|COMPLETED|Weeks 13 to 24||21
9836796|NCT00797225|10948061|FG006|COMPLETED|Weeks 13 to 24||20
9836797|NCT00797225|10948062|FG007|COMPLETED|Weeks 13 to 24||22
9836798|NCT00797225|10948055|FG000|NOT COMPLETED|Weeks 13 to 24||0
9836799|NCT00797225|10948056|FG001|NOT COMPLETED|Weeks 13 to 24||4
9836800|NCT00797225|10948057|FG002|NOT COMPLETED|Weeks 13 to 24||2
9836801|NCT00797225|10948058|FG003|NOT COMPLETED|Weeks 13 to 24||0
9836802|NCT00797225|10948059|FG004|NOT COMPLETED|Weeks 13 to 24||1
9836803|NCT00797225|10948060|FG005|NOT COMPLETED|Weeks 13 to 24||0
9836804|NCT00797225|10948061|FG006|NOT COMPLETED|Weeks 13 to 24||2
9836805|NCT00797225|10948062|FG007|NOT COMPLETED|Weeks 13 to 24||0
9836806|NCT00797277|10948080|FG000|STARTED|Overall Study||37
9836807|NCT00797277|10948081|FG001|STARTED|Overall Study||30
9836808|NCT00797277|10948080|FG000|COMPLETED|Overall Study||37
9836809|NCT00797277|10948081|FG001|COMPLETED|Overall Study||30
9836810|NCT00797277|10948080|FG000|NOT COMPLETED|Overall Study||0
9836811|NCT00797277|10948081|FG001|NOT COMPLETED|Overall Study||0
9836812|NCT00797316|10948090|FG000|STARTED|Overall Study||267
9836813|NCT00797316|10948091|FG001|STARTED|Overall Study||265
9836814|NCT00797316|10948090|FG000|COMPLETED|Overall Study||244
9836815|NCT00797316|10948091|FG001|COMPLETED|Overall Study||233
9836816|NCT00797316|10948090|FG000|NOT COMPLETED|Overall Study||23
9836817|NCT00797316|10948091|FG001|NOT COMPLETED|Overall Study||32
9836818|NCT00797459|10948097|FG000|STARTED|Overall Study||60
9836819|NCT00797459|10948097|FG000|COMPLETED|Overall Study||60
9836820|NCT00797459|10948097|FG000|NOT COMPLETED|Overall Study||0
9836821|NCT00797511|10948105|FG000|STARTED|Overall Study||132
9836822|NCT00797511|10948105|FG000|COMPLETED|Overall Study||131
9836823|NCT00797511|10948105|FG000|NOT COMPLETED|Overall Study||1
9836824|NCT00797563|10948110|FG000|STARTED|Overall Study|number of subjects|102
9836825|NCT00797563|10948110|FG000|COMPLETED|Overall Study||101
9836826|NCT00797563|10948110|FG000|NOT COMPLETED|Overall Study||1
9836827|NCT00797667|10948117|FG000|STARTED|Overall Study||265
9836828|NCT00797667|10948118|FG001|STARTED|Overall Study||264
9836829|NCT00797667|10948119|FG002|STARTED|Overall Study||131
9836830|NCT00797667|10948117|FG000|Treated|Overall Study||263
9836831|NCT00797667|10948118|FG001|Treated|Overall Study||263
9836832|NCT00797667|10948119|FG002|Treated|Overall Study||130
9836833|NCT00797667|10948117|FG000|COMPLETED|Overall Study||5
9836834|NCT00797667|10948118|FG001|COMPLETED|Overall Study||5
9836835|NCT00797667|10948119|FG002|COMPLETED|Overall Study||4
10081117|NCT02257970|11209574|FG000|STARTED|Part 2||0
10081118|NCT02257970|11209575|FG001|STARTED|Part 2||23
9958395|NCT01456949|11077885|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
9958396|NCT01456949|11077885|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
9958397|NCT01456949|11077885|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
9958398|NCT01456949|11077885|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
9958399|NCT01456962|11077891|FG000|STARTED|Overall Study||16
9958400|NCT01456962|11077892|FG001|STARTED|Overall Study||20
9958401|NCT01456962|11077891|FG000|COMPLETED|Overall Study||14
9958402|NCT01456962|11077892|FG001|COMPLETED|Overall Study||19
9958403|NCT01456962|11077891|FG000|NOT COMPLETED|Overall Study||2
9958404|NCT01456962|11077892|FG001|NOT COMPLETED|Overall Study||1
9958405|NCT01457014|11077898|FG000|STARTED|First Night||74
9958406|NCT01457014|11077899|FG001|STARTED|First Night||0
9958407|NCT01457014|11077900|FG002|STARTED|First Night||0
9958408|NCT01457014|11077901|FG003|STARTED|First Night||0
9958409|NCT01457014|11077898|FG000|COMPLETED|First Night||34
9958410|NCT01457014|11077899|FG001|COMPLETED|First Night||0
9958411|NCT01457014|11077900|FG002|COMPLETED|First Night||0
9958412|NCT01457014|11077901|FG003|COMPLETED|First Night||0
9958413|NCT01457014|11077898|FG000|NOT COMPLETED|First Night||40
9958414|NCT01457014|11077899|FG001|NOT COMPLETED|First Night||0
9958415|NCT01457014|11077900|FG002|NOT COMPLETED|First Night||0
9958416|NCT01457014|11077901|FG003|NOT COMPLETED|First Night||0
9958417|NCT01457014|11077898|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
9958418|NCT01457014|11077899|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
9958419|NCT01457014|11077900|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
9958420|NCT01457014|11077901|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
9958421|NCT01457014|11077898|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
9958422|NCT01457014|11077899|FG001|COMPLETED|Second Night||12
9958423|NCT01457014|11077900|FG002|COMPLETED|Second Night||11
9958424|NCT01457014|11077901|FG003|COMPLETED|Second Night||11
9958425|NCT01457014|11077898|FG000|NOT COMPLETED|Second Night||0
9958426|NCT01457014|11077899|FG001|NOT COMPLETED|Second Night||0
9958427|NCT01457014|11077900|FG002|NOT COMPLETED|Second Night||0
9958428|NCT01457014|11077901|FG003|NOT COMPLETED|Second Night||0
9958429|NCT01457014|11077898|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
9958430|NCT01457014|11077899|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
9958431|NCT01457014|11077900|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
9967669|NCT01515657|11088022|FG002|STARTED|First Intervention||13
9967670|NCT01515657|11088020|FG000|COMPLETED|First Intervention||14
9967671|NCT01515657|11088021|FG001|COMPLETED|First Intervention||12
9967672|NCT01515657|11088022|FG002|COMPLETED|First Intervention||13
9967673|NCT01515657|11088020|FG000|NOT COMPLETED|First Intervention||0
9967674|NCT01515657|11088021|FG001|NOT COMPLETED|First Intervention||1
9967675|NCT01515657|11088022|FG002|NOT COMPLETED|First Intervention||0
9967676|NCT01515657|11088020|FG000|STARTED|Second Intervention||14
9967677|NCT01515657|11088021|FG001|STARTED|Second Intervention||12
9967678|NCT01515657|11088022|FG002|STARTED|Second Intervention||13
9967679|NCT01515657|11088020|FG000|COMPLETED|Second Intervention||14
9967680|NCT01515657|11088021|FG001|COMPLETED|Second Intervention||11
9967681|NCT01515657|11088022|FG002|COMPLETED|Second Intervention||13
9967682|NCT01515657|11088020|FG000|NOT COMPLETED|Second Intervention||0
9967683|NCT01515657|11088021|FG001|NOT COMPLETED|Second Intervention||1
9967684|NCT01515657|11088022|FG002|NOT COMPLETED|Second Intervention||0
9967685|NCT01515657|11088020|FG000|STARTED|Third Intervention||14
9967686|NCT01515657|11088021|FG001|STARTED|Third Intervention||11
9967687|NCT01515657|11088022|FG002|STARTED|Third Intervention||13
9967688|NCT01515657|11088020|FG000|COMPLETED|Third Intervention||13
9967689|NCT01515657|11088021|FG001|COMPLETED|Third Intervention||11
9967690|NCT01515657|11088022|FG002|COMPLETED|Third Intervention||13
9967691|NCT01515657|11088020|FG000|NOT COMPLETED|Third Intervention||1
9958432|NCT01457014|11077901|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
9958433|NCT01457014|11077898|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
9958434|NCT01457014|11077899|FG001|COMPLETED|Third Night||11
9958435|NCT01457014|11077900|FG002|COMPLETED|Third Night||11
9958436|NCT01457014|11077901|FG003|COMPLETED|Third Night||12
9958437|NCT01457014|11077898|FG000|NOT COMPLETED|Third Night||0
9958438|NCT01457014|11077899|FG001|NOT COMPLETED|Third Night||0
9958439|NCT01457014|11077900|FG002|NOT COMPLETED|Third Night||0
9958440|NCT01457014|11077901|FG003|NOT COMPLETED|Third Night||0
9958441|NCT01457014|11077898|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
9958442|NCT01457014|11077899|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
9958443|NCT01457014|11077900|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
9958444|NCT01457014|11077901|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
9958445|NCT01457014|11077898|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
9958446|NCT01457014|11077899|FG001|COMPLETED|Fourth Night||11
9958447|NCT01457014|11077900|FG002|COMPLETED|Fourth Night||12
9958448|NCT01457014|11077901|FG003|COMPLETED|Fourth Night||11
9958449|NCT01457014|11077898|FG000|NOT COMPLETED|Fourth Night||0
9958450|NCT01457014|11077899|FG001|NOT COMPLETED|Fourth Night||0
9958451|NCT01457014|11077900|FG002|NOT COMPLETED|Fourth Night||0
9958452|NCT01457014|11077901|FG003|NOT COMPLETED|Fourth Night||0
9958453|NCT01457118|11077913|FG000|STARTED|Overall Study||20
9958454|NCT01457118|11077914|FG001|STARTED|Overall Study||4
9958455|NCT01457118|11077915|FG002|STARTED|Overall Study||1
9958456|NCT01457118|11077916|FG003|STARTED|Overall Study||2
9958457|NCT01457118|11077913|FG000|COMPLETED|Overall Study||0
9958458|NCT01457118|11077914|FG001|COMPLETED|Overall Study||0
9958459|NCT01457118|11077915|FG002|COMPLETED|Overall Study||0
9958460|NCT01457118|11077916|FG003|COMPLETED|Overall Study||0
9958461|NCT01457118|11077913|FG000|NOT COMPLETED|Overall Study||20
9958462|NCT01457118|11077914|FG001|NOT COMPLETED|Overall Study||4
10021334|NCT01843348|11144706|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
9836836|NCT00797667|10948117|FG000|NOT COMPLETED|Overall Study||260
9836837|NCT00797667|10948118|FG001|NOT COMPLETED|Overall Study||259
9836838|NCT00797667|10948119|FG002|NOT COMPLETED|Overall Study||127
9836839|NCT00797732|10948129|FG000|STARTED|Overall Study||21
9836840|NCT00797732|10948130|FG001|STARTED|Overall Study||21
9836841|NCT00797732|10948131|FG002|STARTED|Overall Study||154
9836842|NCT00797732|10948129|FG000|Evaluable at Baseline|Overall Study||18
9836843|NCT00797732|10948130|FG001|Evaluable at Baseline|Overall Study||18
9836844|NCT00797732|10948131|FG002|Evaluable at Baseline|Overall Study||0
9836845|NCT00797732|10948129|FG000|Evaluable at 20 Weeks|Overall Study||17
9836846|NCT00797732|10948130|FG001|Evaluable at 20 Weeks|Overall Study||18
9836847|NCT00797732|10948131|FG002|Evaluable at 20 Weeks|Overall Study||0
9836848|NCT00797732|10948129|FG000|Evaluable at 12 Months|Overall Study||17
9836849|NCT00797732|10948130|FG001|Evaluable at 12 Months|Overall Study||18
9836850|NCT00797732|10948131|FG002|Evaluable at 12 Months|Overall Study||0
9836851|NCT00797732|10948129|FG000|COMPLETED|Overall Study||16
9836852|NCT00797732|10948130|FG001|COMPLETED|Overall Study||18
9836853|NCT00797732|10948131|FG002|COMPLETED|Overall Study||0
9836854|NCT00797732|10948129|FG000|NOT COMPLETED|Overall Study||5
9836855|NCT00797732|10948130|FG001|NOT COMPLETED|Overall Study||3
9836856|NCT00797732|10948131|FG002|NOT COMPLETED|Overall Study||154
9836857|NCT00797797|10948139|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
9836858|NCT00797797|10948140|FG001|STARTED|Overall Study||184
9836859|NCT00797797|10948139|FG000|COMPLETED|Overall Study||123
9836860|NCT00797797|10948140|FG001|COMPLETED|Overall Study||141
9836861|NCT00797797|10948139|FG000|NOT COMPLETED|Overall Study||55
9836862|NCT00797797|10948140|FG001|NOT COMPLETED|Overall Study||43
9836863|NCT00797823|10948149|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0
9836864|NCT00797823|10948150|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0
9836865|NCT00797823|10948151|FG002|STARTED|Pilot Studies||6
9836866|NCT00797823|10948149|FG000|COMPLETED|Pilot Studies||0
9836867|NCT00797823|10948150|FG001|COMPLETED|Pilot Studies||0
9836868|NCT00797823|10948151|FG002|COMPLETED|Pilot Studies||6
9836869|NCT00797823|10948149|FG000|NOT COMPLETED|Pilot Studies||0
9836870|NCT00797823|10948150|FG001|NOT COMPLETED|Pilot Studies||0
9836871|NCT00797823|10948151|FG002|NOT COMPLETED|Pilot Studies||0
9836872|NCT00797823|10948149|FG000|STARTED|First Period (Initial Randomization)||4
10021335|NCT01843348|11144707|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
10021336|NCT01843348|11144708|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
9836873|NCT00797823|10948150|FG001|STARTED|First Period (Initial Randomization)||4
9836874|NCT00797823|10948151|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
9836875|NCT00797823|10948149|FG000|COMPLETED|First Period (Initial Randomization)||3
9836876|NCT00797823|10948150|FG001|COMPLETED|First Period (Initial Randomization)||4
9836877|NCT00797823|10948151|FG002|COMPLETED|First Period (Initial Randomization)||0
9836878|NCT00797823|10948149|FG000|NOT COMPLETED|First Period (Initial Randomization)||1
9958463|NCT01457118|11077915|FG002|NOT COMPLETED|Overall Study||1
9958464|NCT01457118|11077916|FG003|NOT COMPLETED|Overall Study||2
9958465|NCT01457196|11077926|FG000|STARTED|Overall Study||2074
9958466|NCT01457196|11077926|FG000|COMPLETED|Overall Study||2074
9958467|NCT01457196|11077926|FG000|NOT COMPLETED|Overall Study||0
9958468|NCT01457339|11077934|FG000|STARTED|Period 1 (50 mg)||7
9958469|NCT01457339|11077935|FG001|STARTED|Period 1 (50 mg)||24
9958470|NCT01457339|11077934|FG000|COMPLETED|Period 1 (50 mg)||7
9958471|NCT01457339|11077935|FG001|COMPLETED|Period 1 (50 mg)||24
9958472|NCT01457339|11077934|FG000|NOT COMPLETED|Period 1 (50 mg)||0
9719754|NCT00045942|10819257|FG002|COMPLETED|PKC412A2104E1||0
9719755|NCT00045942|10819258|FG003|COMPLETED|PKC412A2104E1||0
9719756|NCT00045942|10819259|FG004|COMPLETED|PKC412A2104E1||0
9719757|NCT00045942|10819260|FG005|COMPLETED|PKC412A2104E1||0
9719758|NCT00045942|10819261|FG006|COMPLETED|PKC412A2104E1||0
9719759|NCT00045942|10819262|FG007|COMPLETED|PKC412A2104E1||0
9719760|NCT00045942|10819263|FG008|COMPLETED|PKC412A2104E1||0
9719761|NCT00045942|10819255|FG000|NOT COMPLETED|PKC412A2104E1||0
9719762|NCT00045942|10819256|FG001|NOT COMPLETED|PKC412A2104E1||18
9719763|NCT00045942|10819257|FG002|NOT COMPLETED|PKC412A2104E1||17
9719764|NCT00045942|10819258|FG003|NOT COMPLETED|PKC412A2104E1||33
9719765|NCT00045942|10819259|FG004|NOT COMPLETED|PKC412A2104E1||27
9719766|NCT00045942|10819260|FG005|NOT COMPLETED|PKC412A2104E1||0
9719767|NCT00045942|10819261|FG006|NOT COMPLETED|PKC412A2104E1||0
9719768|NCT00045942|10819262|FG007|NOT COMPLETED|PKC412A2104E1||0
9719769|NCT00045942|10819263|FG008|NOT COMPLETED|PKC412A2104E1||0
9719770|NCT00045942|10819255|FG000|STARTED|PKC412A2104E2||0
9719771|NCT00045942|10819256|FG001|STARTED|PKC412A2104E2||0
9719772|NCT00045942|10819257|FG002|STARTED|PKC412A2104E2||0
9719773|NCT00045942|10819258|FG003|STARTED|PKC412A2104E2||0
9719774|NCT00045942|10819259|FG004|STARTED|PKC412A2104E2||0
9719775|NCT00045942|10819260|FG005|STARTED|PKC412A2104E2||9
9719776|NCT00045942|10819261|FG006|STARTED|PKC412A2104E2||7
9719777|NCT00045942|10819262|FG007|STARTED|PKC412A2104E2||7
9719778|NCT00045942|10819263|FG008|STARTED|PKC412A2104E2||6
9719779|NCT00045942|10819255|FG000|Primary Efficacy|PKC412A2104E2||0
9719780|NCT00045942|10819256|FG001|Primary Efficacy|PKC412A2104E2||0
9719781|NCT00045942|10819257|FG002|Primary Efficacy|PKC412A2104E2||0
9719782|NCT00045942|10819258|FG003|Primary Efficacy|PKC412A2104E2||0
9719783|NCT00045942|10819259|FG004|Primary Efficacy|PKC412A2104E2||0
9719784|NCT00045942|10819260|FG005|Primary Efficacy|PKC412A2104E2||9
9719785|NCT00045942|10819261|FG006|Primary Efficacy|PKC412A2104E2||7
9719786|NCT00045942|10819262|FG007|Primary Efficacy|PKC412A2104E2||7
9958473|NCT01457339|11077935|FG001|NOT COMPLETED|Period 1 (50 mg)||0
9958474|NCT01457339|11077934|FG000|STARTED|Period 2 (70 mg)||7
9958475|NCT01457339|11077935|FG001|STARTED|Period 2 (70 mg)||24
9958476|NCT01457339|11077934|FG000|COMPLETED|Period 2 (70 mg)||7
9958477|NCT01457339|11077935|FG001|COMPLETED|Period 2 (70 mg)||24
9958478|NCT01457339|11077934|FG000|NOT COMPLETED|Period 2 (70 mg)||0
9719787|NCT00045942|10819263|FG008|Primary Efficacy|PKC412A2104E2||6
9719788|NCT00045942|10819255|FG000|COMPLETED|PKC412A2104E2||0
9719789|NCT00045942|10819256|FG001|COMPLETED|PKC412A2104E2||0
9719790|NCT00045942|10819257|FG002|COMPLETED|PKC412A2104E2||0
9719791|NCT00045942|10819258|FG003|COMPLETED|PKC412A2104E2||0
9719792|NCT00045942|10819259|FG004|COMPLETED|PKC412A2104E2||0
10021337|NCT01843348|11144706|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
10021338|NCT01843348|11144707|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
10021339|NCT01843348|11144708|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
10021340|NCT01843348|11144706|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
10021341|NCT01843348|11144707|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
10021342|NCT01843348|11144708|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
9836879|NCT00797823|10948150|FG001|NOT COMPLETED|First Period (Initial Randomization)||0
9836880|NCT00797823|10948151|FG002|NOT COMPLETED|First Period (Initial Randomization)||0
9836881|NCT00797823|10948149|FG000|STARTED|Second Period (Crossover)||3
9836882|NCT00797823|10948150|FG001|STARTED|Second Period (Crossover)||4
9836883|NCT00797823|10948151|FG002|STARTED|Second Period (Crossover)||0
9836884|NCT00797823|10948149|FG000|COMPLETED|Second Period (Crossover)||3
9836885|NCT00797823|10948150|FG001|COMPLETED|Second Period (Crossover)||4
9836886|NCT00797823|10948151|FG002|COMPLETED|Second Period (Crossover)||0
9836887|NCT00797823|10948149|FG000|NOT COMPLETED|Second Period (Crossover)||0
9836888|NCT00797823|10948150|FG001|NOT COMPLETED|Second Period (Crossover)||0
9836889|NCT00797823|10948151|FG002|NOT COMPLETED|Second Period (Crossover)||0
9836890|NCT00797862|10948161|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
9836891|NCT00797862|10948162|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
9836892|NCT00797862|10948163|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
9836893|NCT00797862|10948161|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617
9836894|NCT00797862|10948162|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315
9836895|NCT00797862|10948163|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315
9836896|NCT00797862|10948161|FG000|COMPLETED|Overall Study||496
9836897|NCT00797862|10948162|FG001|COMPLETED|Overall Study||250
9836898|NCT00797862|10948163|FG002|COMPLETED|Overall Study||230
9836899|NCT00797862|10948161|FG000|NOT COMPLETED|Overall Study||124
9836900|NCT00797862|10948162|FG001|NOT COMPLETED|Overall Study||68
9836901|NCT00797862|10948163|FG002|NOT COMPLETED|Overall Study||86
9836902|NCT00797966|10948175|FG000|STARTED|Phase A||0
9836903|NCT00797966|10948176|FG001|STARTED|Phase A||0
9836904|NCT00797966|10948177|FG002|STARTED|Phase A||0
9836905|NCT00797966|10948178|FG003|STARTED|Phase A||0
9836906|NCT00797966|10948179|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
10021343|NCT01843348|11144706|FG000|COMPLETED|Overall Study||182
10021344|NCT01843348|11144707|FG001|COMPLETED|Overall Study||168
10021345|NCT01843348|11144708|FG002|COMPLETED|Overall Study||158
10021346|NCT01843348|11144706|FG000|NOT COMPLETED|Overall Study||23
10021347|NCT01843348|11144707|FG001|NOT COMPLETED|Overall Study||40
10021348|NCT01843348|11144708|FG002|NOT COMPLETED|Overall Study||41
10021349|NCT01843465|11144718|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
10021350|NCT01843465|11144718|FG000|COMPLETED|Overall Study||34
10021351|NCT01843465|11144718|FG000|NOT COMPLETED|Overall Study||0
10021352|NCT01843621|11144722|FG000|STARTED|Overall Study||7
10021353|NCT01843621|11144722|FG000|COMPLETED|Overall Study||7
10021354|NCT01843621|11144722|FG000|NOT COMPLETED|Overall Study||0
9836907|NCT00797966|10948180|FG005|STARTED|Phase A||0
9836908|NCT00797966|10948175|FG000|COMPLETED|Phase A||0
10021355|NCT01843660|11144734|FG000|STARTED|Overall Study||1059
10021356|NCT01843660|11144734|FG000|COMPLETED|Overall Study||1029
9836909|NCT00797966|10948176|FG001|COMPLETED|Phase A||0
9836910|NCT00797966|10948177|FG002|COMPLETED|Phase A||0
10114061|NCT02513550|11244788|FG002|COMPLETED|Double Blind Treatment Period||537
10114062|NCT02513550|11244789|FG003|COMPLETED|Double Blind Treatment Period||9
10114063|NCT02513550|11244790|FG004|COMPLETED|Double Blind Treatment Period||4
10114064|NCT02513550|11244791|FG005|COMPLETED|Double Blind Treatment Period||15
10114065|NCT02513550|11244786|FG000|NOT COMPLETED|Double Blind Treatment Period||36
10114066|NCT02513550|11244787|FG001|NOT COMPLETED|Double Blind Treatment Period||38
10114067|NCT02513550|11244788|FG002|NOT COMPLETED|Double Blind Treatment Period||74
10114068|NCT02513550|11244789|FG003|NOT COMPLETED|Double Blind Treatment Period||0
10114069|NCT02513550|11244790|FG004|NOT COMPLETED|Double Blind Treatment Period||1
10114070|NCT02513550|11244791|FG005|NOT COMPLETED|Double Blind Treatment Period||1
10114071|NCT02513550|11244786|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
10114072|NCT02513550|11244787|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
10114073|NCT02513550|11244788|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
10021357|NCT01843660|11144734|FG000|NOT COMPLETED|Overall Study||30
10021358|NCT01843673|11144738|FG000|STARTED|Overall Study||16
10021359|NCT01843673|11144738|FG000|COMPLETED|Overall Study||10
10021360|NCT01843673|11144738|FG000|NOT COMPLETED|Overall Study||6
10114074|NCT02513550|11244789|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
10114075|NCT02513550|11244790|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
10114076|NCT02513550|11244791|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
10114077|NCT02513550|11244786|FG000|COMPLETED|Post-Treatment Follow-up Period||254
10114078|NCT02513550|11244787|FG001|COMPLETED|Post-Treatment Follow-up Period||244
10114079|NCT02513550|11244788|FG002|COMPLETED|Post-Treatment Follow-up Period||496
10114080|NCT02513550|11244789|FG003|COMPLETED|Post-Treatment Follow-up Period||9
10114081|NCT02513550|11244790|FG004|COMPLETED|Post-Treatment Follow-up Period||4
10114082|NCT02513550|11244791|FG005|COMPLETED|Post-Treatment Follow-up Period||15
10114083|NCT02513550|11244786|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31
10114084|NCT02513550|11244787|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39
10114085|NCT02513550|11244788|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63
10114086|NCT02513550|11244789|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0
10114087|NCT02513550|11244790|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0
10114088|NCT02513550|11244791|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0
10114089|NCT02513641|11244813|FG000|STARTED|Overall Study||8
10114090|NCT02513641|11244813|FG000|COMPLETED|Overall Study||8
10114091|NCT02513641|11244813|FG000|NOT COMPLETED|Overall Study||0
10114092|NCT02513719|11244817|FG000|STARTED|At 8 Months Clinical Follow-up||312
10114093|NCT02513719|11244817|FG000|COMPLETED|At 8 Months Clinical Follow-up||312
10196036|NCT03358251|11324424|FG000|COMPLETED|Overall Study||34
10196037|NCT03358251|11324424|FG000|NOT COMPLETED|Overall Study||0
10021361|NCT01843751|11144746|FG000|STARTED|Overall Study||11
10021362|NCT01843751|11144747|FG001|STARTED|Overall Study||10
10021363|NCT01843751|11144746|FG000|COMPLETED|Overall Study||0
10021364|NCT01843751|11144747|FG001|COMPLETED|Overall Study||3
10021365|NCT01843751|11144746|FG000|NOT COMPLETED|Overall Study||11
10021366|NCT01843751|11144747|FG001|NOT COMPLETED|Overall Study||7
10021367|NCT01843777|11144755|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
10021368|NCT01843777|11144756|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10
10021369|NCT01843777|11144755|FG000|Per Protocol Population|Overall Study||11
10021370|NCT01843777|11144756|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
10021371|NCT01843777|11144755|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
10021372|NCT01843777|11144756|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
10021373|NCT01843777|11144755|FG000|NOT COMPLETED|Overall Study||1
10021374|NCT01843777|11144756|FG001|NOT COMPLETED|Overall Study||0
10021375|NCT01843803|11144764|FG000|STARTED|Overall Study||137
10021376|NCT01843803|11144765|FG001|STARTED|Overall Study||139
10196038|NCT03358290|11324436|FG000|STARTED|Overall Study||2
10196039|NCT03358290|11324437|FG001|STARTED|Overall Study||3
10196040|NCT03358290|11324438|FG002|STARTED|Overall Study||3
10196041|NCT03358290|11324439|FG003|STARTED|Overall Study||3
9836911|NCT00797966|10948178|FG003|COMPLETED|Phase A||0
9836912|NCT00797966|10948179|FG004|COMPLETED|Phase A||664
9836913|NCT00797966|10948180|FG005|COMPLETED|Phase A||0
9836914|NCT00797966|10948175|FG000|NOT COMPLETED|Phase A||0
9836915|NCT00797966|10948176|FG001|NOT COMPLETED|Phase A||0
9836916|NCT00797966|10948177|FG002|NOT COMPLETED|Phase A||0
9836917|NCT00797966|10948178|FG003|NOT COMPLETED|Phase A||0
9836918|NCT00797966|10948179|FG004|NOT COMPLETED|Phase A||185
9836919|NCT00797966|10948180|FG005|NOT COMPLETED|Phase A||0
9836920|NCT00797966|10948175|FG000|STARTED|Phase B|Randomized participants.|62
9836921|NCT00797966|10948176|FG001|STARTED|Phase B|Randomized participants.|120
9836922|NCT00797966|10948177|FG002|STARTED|Phase B|Randomized participants.|121
9958479|NCT01457339|11077935|FG001|NOT COMPLETED|Period 2 (70 mg)||0
9958480|NCT01457339|11077934|FG000|STARTED|Period 3 (100 mg)||7
9958481|NCT01457339|11077935|FG001|STARTED|Period 3 (100 mg)||24
9958482|NCT01457339|11077934|FG000|COMPLETED|Period 3 (100 mg)||7
9958483|NCT01457339|11077935|FG001|COMPLETED|Period 3 (100 mg)||23
9958484|NCT01457339|11077934|FG000|NOT COMPLETED|Period 3 (100 mg)||0
9719793|NCT00045942|10819260|FG005|COMPLETED|PKC412A2104E2||0
9719794|NCT00045942|10819261|FG006|COMPLETED|PKC412A2104E2||0
9719795|NCT00045942|10819262|FG007|COMPLETED|PKC412A2104E2||0
9719796|NCT00045942|10819263|FG008|COMPLETED|PKC412A2104E2||0
10114094|NCT02513719|11244817|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0
10114095|NCT02513719|11244817|FG000|STARTED|At 1 Year Clinical Follow-up||312
10114096|NCT02513719|11244817|FG000|COMPLETED|At 1 Year Clinical Follow-up||305
10114097|NCT02513719|11244817|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7
10114098|NCT02513719|11244817|FG000|STARTED|At 2 Years Clinical Follow-up||305
10114099|NCT02513719|11244817|FG000|COMPLETED|At 2 Years Clinical Follow-up||300
9719797|NCT00045942|10819255|FG000|NOT COMPLETED|PKC412A2104E2||0
9719798|NCT00045942|10819256|FG001|NOT COMPLETED|PKC412A2104E2||0
9719799|NCT00045942|10819257|FG002|NOT COMPLETED|PKC412A2104E2||0
9719800|NCT00045942|10819258|FG003|NOT COMPLETED|PKC412A2104E2||0
9719801|NCT00045942|10819259|FG004|NOT COMPLETED|PKC412A2104E2||0
9719802|NCT00045942|10819260|FG005|NOT COMPLETED|PKC412A2104E2||9
9719803|NCT00045942|10819261|FG006|NOT COMPLETED|PKC412A2104E2||7
9719804|NCT00045942|10819262|FG007|NOT COMPLETED|PKC412A2104E2||7
9719805|NCT00045942|10819263|FG008|NOT COMPLETED|PKC412A2104E2||6
9836923|NCT00797966|10948178|FG003|STARTED|Phase B|Randomized participants.|126
9836924|NCT00797966|10948179|FG004|STARTED|Phase B||0
9836925|NCT00797966|10948180|FG005|STARTED|Phase B||0
9836926|NCT00797966|10948175|FG000|COMPLETED|Phase B||51
9836927|NCT00797966|10948176|FG001|COMPLETED|Phase B||102
9836928|NCT00797966|10948177|FG002|COMPLETED|Phase B||100
9836929|NCT00797966|10948178|FG003|COMPLETED|Phase B||110
9836930|NCT00797966|10948179|FG004|COMPLETED|Phase B||0
10021377|NCT01843803|11144764|FG000|COMPLETED|Overall Study||136
10021378|NCT01843803|11144765|FG001|COMPLETED|Overall Study||136
10021379|NCT01843803|11144764|FG000|NOT COMPLETED|Overall Study||1
10021380|NCT01843803|11144765|FG001|NOT COMPLETED|Overall Study||3
10021381|NCT01843842|11144773|FG000|STARTED|Overall Study||154
10021382|NCT01843842|11144774|FG001|STARTED|Overall Study||152
10021383|NCT01843842|11144773|FG000|COMPLETED|Overall Study||153
10021384|NCT01843842|11144774|FG001|COMPLETED|Overall Study||151
10021385|NCT01843842|11144773|FG000|NOT COMPLETED|Overall Study||1
10021386|NCT01843842|11144774|FG001|NOT COMPLETED|Overall Study||1
10021387|NCT01843920|11144782|FG000|STARTED|Overall Study||12
10021388|NCT01843920|11144783|FG001|STARTED|Overall Study||9
9836931|NCT00797966|10948180|FG005|COMPLETED|Phase B||0
9836932|NCT00797966|10948175|FG000|NOT COMPLETED|Phase B||11
9836933|NCT00797966|10948176|FG001|NOT COMPLETED|Phase B||18
9836934|NCT00797966|10948177|FG002|NOT COMPLETED|Phase B||21
9836935|NCT00797966|10948178|FG003|NOT COMPLETED|Phase B||16
9958485|NCT01457339|11077935|FG001|NOT COMPLETED|Period 3 (100 mg)||1
9958486|NCT01457339|11077934|FG000|STARTED|Period 4 (150 mg)||7
9958487|NCT01457339|11077935|FG001|STARTED|Period 4 (150 mg)||23
9958488|NCT01457339|11077934|FG000|COMPLETED|Period 4 (150 mg)||7
9958489|NCT01457339|11077935|FG001|COMPLETED|Period 4 (150 mg)||23
9958490|NCT01457339|11077934|FG000|NOT COMPLETED|Period 4 (150 mg)||0
9836936|NCT00797966|10948179|FG004|NOT COMPLETED|Phase B||0
9836937|NCT00797966|10948180|FG005|NOT COMPLETED|Phase B||0
9836938|NCT00797966|10948175|FG000|STARTED|Phase A+||0
9836939|NCT00797966|10948176|FG001|STARTED|Phase A+||0
9958491|NCT01457339|11077935|FG001|NOT COMPLETED|Period 4 (150 mg)||0
9958492|NCT01457339|11077934|FG000|STARTED|Period 5 (200 mg)||7
9958493|NCT01457339|11077935|FG001|STARTED|Period 5 (200 mg)||23
9836940|NCT00797966|10948177|FG002|STARTED|Phase A+||0
9836941|NCT00797966|10948178|FG003|STARTED|Phase A+||0
9836942|NCT00797966|10948179|FG004|STARTED|Phase A+||0
9836943|NCT00797966|10948180|FG005|STARTED|Phase A+||235
9958494|NCT01457339|11077934|FG000|COMPLETED|Period 5 (200 mg)||7
9836944|NCT00797966|10948175|FG000|COMPLETED|Phase A+||0
9836945|NCT00797966|10948176|FG001|COMPLETED|Phase A+||0
9836946|NCT00797966|10948177|FG002|COMPLETED|Phase A+||0
9836947|NCT00797966|10948178|FG003|COMPLETED|Phase A+||0
9836948|NCT00797966|10948179|FG004|COMPLETED|Phase A+||0
9836949|NCT00797966|10948180|FG005|COMPLETED|Phase A+||207
9836950|NCT00797966|10948175|FG000|NOT COMPLETED|Phase A+||0
9836951|NCT00797966|10948176|FG001|NOT COMPLETED|Phase A+||0
9836952|NCT00797966|10948177|FG002|NOT COMPLETED|Phase A+||0
9836953|NCT00797966|10948178|FG003|NOT COMPLETED|Phase A+||0
9836954|NCT00797966|10948179|FG004|NOT COMPLETED|Phase A+||0
9836955|NCT00797966|10948180|FG005|NOT COMPLETED|Phase A+||28
9836956|NCT00798018|10948196|FG000|STARTED|Overall Study||25
9836957|NCT00798018|10948197|FG001|STARTED|Overall Study||25
9836958|NCT00798018|10948198|FG002|STARTED|Overall Study||25
9836959|NCT00798018|10948199|FG003|STARTED|Overall Study||25
9836960|NCT00798018|10948196|FG000|COMPLETED|Overall Study||25
9836961|NCT00798018|10948197|FG001|COMPLETED|Overall Study||25
9836962|NCT00798018|10948198|FG002|COMPLETED|Overall Study||25
9836963|NCT00798018|10948199|FG003|COMPLETED|Overall Study||25
9836964|NCT00798018|10948196|FG000|NOT COMPLETED|Overall Study||0
9836965|NCT00798018|10948197|FG001|NOT COMPLETED|Overall Study||0
9836966|NCT00798018|10948198|FG002|NOT COMPLETED|Overall Study||0
9836967|NCT00798018|10948199|FG003|NOT COMPLETED|Overall Study||0
9836968|NCT00798096|10948209|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
9836969|NCT00798096|10948209|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
9836970|NCT00798096|10948209|FG000|NOT COMPLETED|Overall Study||2
9836971|NCT00798135|10948213|FG000|STARTED|Overall Study||13
9836972|NCT00798135|10948213|FG000|COMPLETED|Overall Study||0
9836973|NCT00798135|10948213|FG000|NOT COMPLETED|Overall Study||13
9836974|NCT00798161|10948224|FG000|STARTED|Overall Study||72
9836975|NCT00798161|10948225|FG001|STARTED|Overall Study||144
9719806|NCT00046228|10819290|FG000|STARTED|90 Days||806
9719807|NCT00046228|10819291|FG001|STARTED|90 Days||818
9719808|NCT00046228|10819292|FG002|STARTED|90 Days||828
9719809|NCT00046228|10819290|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
9719810|NCT00046228|10819291|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
9719811|NCT00046228|10819292|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
9719812|NCT00046228|10819290|FG000|NOT COMPLETED|90 Days||13
9719813|NCT00046228|10819291|FG001|NOT COMPLETED|90 Days||8
9719814|NCT00046228|10819292|FG002|NOT COMPLETED|90 Days||15
9719815|NCT00046228|10819290|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
9719816|NCT00046228|10819291|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
9719817|NCT00046228|10819292|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
9719818|NCT00046228|10819290|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
9719819|NCT00046228|10819291|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
9719820|NCT00046228|10819292|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
9719821|NCT00046228|10819290|FG000|NOT COMPLETED|1 Year||19
9719822|NCT00046228|10819291|FG001|NOT COMPLETED|1 Year||14
9719823|NCT00046228|10819292|FG002|NOT COMPLETED|1 Year||12
9719824|NCT00046475|10819302|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
9719825|NCT00046475|10819303|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
9719826|NCT00046475|10819304|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
9719827|NCT00046475|10819302|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
9719828|NCT00046475|10819303|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
9719829|NCT00046475|10819304|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10021389|NCT01843920|11144782|FG000|COMPLETED|Overall Study||12
10021390|NCT01843920|11144783|FG001|COMPLETED|Overall Study||9
9836976|NCT00798161|10948226|FG002|STARTED|Overall Study||147
9836977|NCT00798161|10948227|FG003|STARTED|Overall Study||142
9836978|NCT00798161|10948228|FG004|STARTED|Overall Study||143
9836979|NCT00798161|10948229|FG005|STARTED|Overall Study||143
9836980|NCT00798161|10948230|FG006|STARTED|Overall Study||66
9836981|NCT00798161|10948224|FG000|COMPLETED|Overall Study||54
9836982|NCT00798161|10948225|FG001|COMPLETED|Overall Study||127
9836983|NCT00798161|10948226|FG002|COMPLETED|Overall Study||126
9958495|NCT01457339|11077935|FG001|COMPLETED|Period 5 (200 mg)||22
9958496|NCT01457339|11077934|FG000|NOT COMPLETED|Period 5 (200 mg)||0
9958497|NCT01457339|11077935|FG001|NOT COMPLETED|Period 5 (200 mg)||1
9958498|NCT01457339|11077934|FG000|STARTED|Period 6 (250 mg)||7
9958499|NCT01457339|11077935|FG001|STARTED|Period 6 (250 mg)||22
9958500|NCT01457339|11077934|FG000|COMPLETED|Period 6 (250 mg)||6
9958501|NCT01457339|11077935|FG001|COMPLETED|Period 6 (250 mg)||21
9958502|NCT01457339|11077934|FG000|NOT COMPLETED|Period 6 (250 mg)||1
9958503|NCT01457339|11077935|FG001|NOT COMPLETED|Period 6 (250 mg)||1
9958504|NCT01457352|11077960|FG000|STARTED|Period 1||392
9958505|NCT01457352|11077961|FG001|STARTED|Period 1||0
9958506|NCT01457352|11077960|FG000|COMPLETED|Period 1||376
9958507|NCT01457352|11077961|FG001|COMPLETED|Period 1||0
9958508|NCT01457352|11077960|FG000|NOT COMPLETED|Period 1||16
9958509|NCT01457352|11077961|FG001|NOT COMPLETED|Period 1||0
9958510|NCT01457352|11077960|FG000|STARTED|Period 2||376
9958511|NCT01457352|11077961|FG001|STARTED|Period 2||0
9958512|NCT01457352|11077960|FG000|COMPLETED|Period 2||296
9958513|NCT01457352|11077961|FG001|COMPLETED|Period 2||0
9958514|NCT01457352|11077960|FG000|NOT COMPLETED|Period 2||80
9958515|NCT01457352|11077961|FG001|NOT COMPLETED|Period 2||0
9958516|NCT01457352|11077960|FG000|STARTED|Period 3||147
9958517|NCT01457352|11077961|FG001|STARTED|Period 3||149
9958518|NCT01457352|11077960|FG000|Randomization|Period 3||147
9958519|NCT01457352|11077961|FG001|Randomization|Period 3||149
9958520|NCT01457352|11077960|FG000|COMPLETED|Period 3||146
9958521|NCT01457352|11077961|FG001|COMPLETED|Period 3||144
9958522|NCT01457352|11077960|FG000|NOT COMPLETED|Period 3||1
9958523|NCT01457352|11077961|FG001|NOT COMPLETED|Period 3||5
9967692|NCT01515657|11088021|FG001|NOT COMPLETED|Third Intervention||0
9967693|NCT01515657|11088022|FG002|NOT COMPLETED|Third Intervention||0
9967694|NCT01515696|11088032|FG000|STARTED|Overall Study||47
9967695|NCT01515696|11088033|FG001|STARTED|Overall Study||49
9836984|NCT00798161|10948227|FG003|COMPLETED|Overall Study||121
9836985|NCT00798161|10948228|FG004|COMPLETED|Overall Study||127
9967696|NCT01515696|11088032|FG000|COMPLETED|Overall Study||39
9967697|NCT01515696|11088033|FG001|COMPLETED|Overall Study||39
9967698|NCT01515696|11088032|FG000|NOT COMPLETED|Overall Study||8
9967699|NCT01515696|11088033|FG001|NOT COMPLETED|Overall Study||10
9967700|NCT01515865|11088039|FG000|STARTED|Part A (Open-label)||98
9967701|NCT01515865|11088040|FG001|STARTED|Part A (Open-label)||0
9967702|NCT01515865|11088041|FG002|STARTED|Part A (Open-label)||0
9967703|NCT01515865|11088039|FG000|COMPLETED|Part A (Open-label)||95
9967704|NCT01515865|11088040|FG001|COMPLETED|Part A (Open-label)||0
9967705|NCT01515865|11088041|FG002|COMPLETED|Part A (Open-label)||0
9967706|NCT01515865|11088039|FG000|NOT COMPLETED|Part A (Open-label)||3
9967707|NCT01515865|11088040|FG001|NOT COMPLETED|Part A (Open-label)||0
9836986|NCT00798161|10948229|FG005|COMPLETED|Overall Study||132
9836987|NCT00798161|10948230|FG006|COMPLETED|Overall Study||56
9836988|NCT00798161|10948224|FG000|NOT COMPLETED|Overall Study||18
9836989|NCT00798161|10948225|FG001|NOT COMPLETED|Overall Study||17
9836990|NCT00798161|10948226|FG002|NOT COMPLETED|Overall Study||21
9836991|NCT00798161|10948227|FG003|NOT COMPLETED|Overall Study||21
9836992|NCT00798161|10948228|FG004|NOT COMPLETED|Overall Study||16
9836993|NCT00798161|10948229|FG005|NOT COMPLETED|Overall Study||11
9836994|NCT00798161|10948230|FG006|NOT COMPLETED|Overall Study||10
9958524|NCT01457417|11077976|FG000|STARTED|Overall Study||3
9836995|NCT00798174|10948246|FG000|STARTED|Overall Study||16
9836996|NCT00798174|10948247|FG001|STARTED|Overall Study||16
9836997|NCT00798174|10948246|FG000|COMPLETED|Overall Study||12
9958525|NCT01457417|11077977|FG001|STARTED|Overall Study||3
9836998|NCT00798174|10948247|FG001|COMPLETED|Overall Study||13
9836999|NCT00798174|10948246|FG000|NOT COMPLETED|Overall Study||4
9837000|NCT00798174|10948247|FG001|NOT COMPLETED|Overall Study||3
9837001|NCT00798304|10948254|FG000|STARTED|Overall Study||14
9837002|NCT00798304|10948255|FG001|STARTED|Overall Study||22
9837003|NCT00798304|10948256|FG002|STARTED|Overall Study||10
9958526|NCT01457417|11077978|FG002|STARTED|Overall Study||4
9958527|NCT01457417|11077979|FG003|STARTED|Overall Study||3
9958528|NCT01457417|11077980|FG004|STARTED|Overall Study||19
9958529|NCT01457417|11077976|FG000|COMPLETED|Overall Study||3
9958530|NCT01457417|11077977|FG001|COMPLETED|Overall Study||3
9958531|NCT01457417|11077978|FG002|COMPLETED|Overall Study||4
9958532|NCT01457417|11077979|FG003|COMPLETED|Overall Study||3
9958533|NCT01457417|11077980|FG004|COMPLETED|Overall Study||19
9958534|NCT01457417|11077976|FG000|NOT COMPLETED|Overall Study||0
9958535|NCT01457417|11077977|FG001|NOT COMPLETED|Overall Study||0
9958536|NCT01457417|11077978|FG002|NOT COMPLETED|Overall Study||0
9958537|NCT01457417|11077979|FG003|NOT COMPLETED|Overall Study||0
9958538|NCT01457417|11077980|FG004|NOT COMPLETED|Overall Study||0
10021391|NCT01843920|11144782|FG000|NOT COMPLETED|Overall Study||0
10021392|NCT01843920|11144783|FG001|NOT COMPLETED|Overall Study||0
10021393|NCT01843933|11144791|FG000|STARTED|Overall Study||104
10021394|NCT01843933|11144792|FG001|STARTED|Overall Study||107
10021395|NCT01843933|11144791|FG000|COMPLETED|Overall Study||98
10021396|NCT01843933|11144792|FG001|COMPLETED|Overall Study||103
10021397|NCT01843933|11144791|FG000|NOT COMPLETED|Overall Study||6
10021398|NCT01843933|11144792|FG001|NOT COMPLETED|Overall Study||4
10021399|NCT01843972|11144808|FG000|STARTED|Overall Study||13
10021400|NCT01843972|11144809|FG001|STARTED|Overall Study||6
10021401|NCT01843972|11144810|FG002|STARTED|Overall Study||5
10021402|NCT01843972|11144811|FG003|STARTED|Overall Study||6
10021403|NCT01843972|11144812|FG004|STARTED|Overall Study||6
10021404|NCT01843972|11144813|FG005|STARTED|Overall Study||6
10021405|NCT01843972|11144814|FG006|STARTED|Overall Study||5
10021406|NCT01843972|11144815|FG007|STARTED|Overall Study||5
9837004|NCT00798304|10948254|FG000|COMPLETED|Overall Study||0
9837005|NCT00798304|10948255|FG001|COMPLETED|Overall Study||0
9837006|NCT00798304|10948256|FG002|COMPLETED|Overall Study||0
9837007|NCT00798304|10948254|FG000|NOT COMPLETED|Overall Study||14
9837008|NCT00798304|10948255|FG001|NOT COMPLETED|Overall Study||22
9719830|NCT00046475|10819302|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
9719831|NCT00046475|10819303|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10021407|NCT01843972|11144816|FG008|STARTED|Overall Study||17
10021408|NCT01843972|11144817|FG009|STARTED|Overall Study||12
9719832|NCT00046475|10819304|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
9719833|NCT00046475|10819302|FG000|STARTED|Titration (1 Week)||136
9719834|NCT00046475|10819303|FG001|STARTED|Titration (1 Week)||0
9719835|NCT00046475|10819304|FG002|STARTED|Titration (1 Week)||0
9719836|NCT00046475|10819302|FG000|COMPLETED|Titration (1 Week)||136
9719837|NCT00046475|10819303|FG001|COMPLETED|Titration (1 Week)||0
9719838|NCT00046475|10819304|FG002|COMPLETED|Titration (1 Week)||0
9719839|NCT00046475|10819302|FG000|NOT COMPLETED|Titration (1 Week)||0
9719840|NCT00046475|10819303|FG001|NOT COMPLETED|Titration (1 Week)||0
9719841|NCT00046475|10819304|FG002|NOT COMPLETED|Titration (1 Week)||0
9719842|NCT00046475|10819302|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
9719843|NCT00046475|10819303|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
9719844|NCT00046475|10819304|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
9719845|NCT00046475|10819302|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
9837009|NCT00798304|10948256|FG002|NOT COMPLETED|Overall Study||10
9837010|NCT00798317|10948266|FG000|STARTED|Overall Study||245
9837011|NCT00798317|10948267|FG001|STARTED|Overall Study||81
9837012|NCT00798317|10948266|FG000|COMPLETED|Overall Study||235
9837013|NCT00798317|10948267|FG001|COMPLETED|Overall Study||74
9837014|NCT00798317|10948266|FG000|NOT COMPLETED|Overall Study||10
9837015|NCT00798317|10948267|FG001|NOT COMPLETED|Overall Study||7
9837016|NCT00798369|10948279|FG000|STARTED|Overall Study||28
9837017|NCT00798369|10948280|FG001|STARTED|Overall Study||29
9837018|NCT00798369|10948281|FG002|STARTED|Overall Study||29
9837019|NCT00798369|10948282|FG003|STARTED|Overall Study||29
9837020|NCT00798369|10948283|FG004|STARTED|Overall Study||28
9837021|NCT00798369|10948284|FG005|STARTED|Overall Study||57
9837022|NCT00798369|10948279|FG000|COMPLETED|Overall Study||27
9837023|NCT00798369|10948280|FG001|COMPLETED|Overall Study||28
9958539|NCT01457430|11077994|FG000|STARTED|Overall Study||19
9958540|NCT01457430|11077994|FG000|COMPLETED|Overall Study||19
9958541|NCT01457430|11077994|FG000|NOT COMPLETED|Overall Study||0
9958542|NCT01457521|11078001|FG000|STARTED|Overall Study||123
9958543|NCT01457521|11078002|FG001|STARTED|Overall Study||127
9719846|NCT00046475|10819303|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
9719847|NCT00046475|10819304|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
9719848|NCT00046475|10819302|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
9719849|NCT00046475|10819303|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
9719850|NCT00046475|10819304|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
9719851|NCT00046475|10819302|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
9958544|NCT01457521|11078001|FG000|COMPLETED|Overall Study||111
9958545|NCT01457521|11078002|FG001|COMPLETED|Overall Study||117
9958546|NCT01457521|11078001|FG000|NOT COMPLETED|Overall Study||12
9958547|NCT01457521|11078002|FG001|NOT COMPLETED|Overall Study||10
9958548|NCT01457573|11078008|FG000|STARTED|Overall Study||10
9837024|NCT00798369|10948281|FG002|COMPLETED|Overall Study||27
9837025|NCT00798369|10948282|FG003|COMPLETED|Overall Study||28
9837026|NCT00798369|10948283|FG004|COMPLETED|Overall Study||27
9837027|NCT00798369|10948284|FG005|COMPLETED|Overall Study||54
9837028|NCT00798369|10948279|FG000|NOT COMPLETED|Overall Study||1
9837029|NCT00798369|10948280|FG001|NOT COMPLETED|Overall Study||1
9958549|NCT01457573|11078008|FG000|COMPLETED|Overall Study||10
9837030|NCT00798369|10948281|FG002|NOT COMPLETED|Overall Study||2
9958550|NCT01457573|11078008|FG000|NOT COMPLETED|Overall Study||0
9958551|NCT01457703|11078015|FG000|STARTED|Overall Study||29
9958552|NCT01457703|11078016|FG001|STARTED|Overall Study||33
9958553|NCT01457703|11078015|FG000|COMPLETED|Overall Study||23
9958554|NCT01457703|11078016|FG001|COMPLETED|Overall Study||22
10021409|NCT01843972|11144808|FG000|COMPLETED|Overall Study||13
10021410|NCT01843972|11144809|FG001|COMPLETED|Overall Study||6
9837031|NCT00798369|10948282|FG003|NOT COMPLETED|Overall Study||1
9837032|NCT00798369|10948283|FG004|NOT COMPLETED|Overall Study||1
9837033|NCT00798369|10948284|FG005|NOT COMPLETED|Overall Study||3
9837034|NCT00798434|10948301|FG000|STARTED|Double-Blind||396
9837035|NCT00798434|10948302|FG001|STARTED|Double-Blind||398
9837036|NCT00798434|10948301|FG000|Received Treatment|Double-Blind||393
9837037|NCT00798434|10948302|FG001|Received Treatment|Double-Blind||392
9837038|NCT00798434|10948301|FG000|COMPLETED|Double-Blind||341
9837039|NCT00798434|10948302|FG001|COMPLETED|Double-Blind||314
9837040|NCT00798434|10948301|FG000|NOT COMPLETED|Double-Blind||55
9837041|NCT00798434|10948302|FG001|NOT COMPLETED|Double-Blind||84
9837042|NCT00798434|10948301|FG000|STARTED|Open-Label||341
9837043|NCT00798434|10948302|FG001|STARTED|Open-Label||314
9837044|NCT00798434|10948301|FG000|Received Treatment|Open-Label||341
9837045|NCT00798434|10948302|FG001|Received Treatment|Open-Label||313
9837046|NCT00798434|10948301|FG000|COMPLETED|Open-Label||299
9837047|NCT00798434|10948302|FG001|COMPLETED|Open-Label||282
9837048|NCT00798434|10948301|FG000|NOT COMPLETED|Open-Label||42
9837049|NCT00798434|10948302|FG001|NOT COMPLETED|Open-Label||32
9837050|NCT00798486|10948313|FG000|STARTED|Overall Study||110
9837051|NCT00798486|10948313|FG000|COMPLETED|Overall Study||110
10021411|NCT01843972|11144810|FG002|COMPLETED|Overall Study||5
9837052|NCT00798486|10948313|FG000|NOT COMPLETED|Overall Study||0
9837053|NCT00798577|10948319|FG000|STARTED|Overall Study||17
9837054|NCT00798577|10948320|FG001|STARTED|Overall Study||7
9837055|NCT00798577|10948319|FG000|COMPLETED|Overall Study||17
9837056|NCT00798577|10948320|FG001|COMPLETED|Overall Study||7
9837057|NCT00798577|10948319|FG000|NOT COMPLETED|Overall Study||0
9837058|NCT00798577|10948320|FG001|NOT COMPLETED|Overall Study||0
10021412|NCT01843972|11144811|FG003|COMPLETED|Overall Study||6
9837059|NCT00798603|10948326|FG000|STARTED|Overall Study||62
9837060|NCT00798603|10948326|FG000|COMPLETED|Overall Study||27
9837061|NCT00798603|10948326|FG000|NOT COMPLETED|Overall Study||35
9837062|NCT00798655|10948330|FG000|STARTED|Overall Study||46
9837063|NCT00798655|10948330|FG000|COMPLETED|Overall Study||44
10021413|NCT01843972|11144812|FG004|COMPLETED|Overall Study||5
10021414|NCT01843972|11144813|FG005|COMPLETED|Overall Study||6
10021415|NCT01843972|11144814|FG006|COMPLETED|Overall Study||5
9837064|NCT00798655|10948330|FG000|NOT COMPLETED|Overall Study||2
10021416|NCT01843972|11144815|FG007|COMPLETED|Overall Study||5
10021417|NCT01843972|11144816|FG008|COMPLETED|Overall Study||17
10021418|NCT01843972|11144817|FG009|COMPLETED|Overall Study||12
10021419|NCT01843972|11144808|FG000|NOT COMPLETED|Overall Study||0
10021420|NCT01843972|11144809|FG001|NOT COMPLETED|Overall Study||0
10021421|NCT01843972|11144810|FG002|NOT COMPLETED|Overall Study||0
10021422|NCT01843972|11144811|FG003|NOT COMPLETED|Overall Study||0
10021423|NCT01843972|11144812|FG004|NOT COMPLETED|Overall Study||1
10021424|NCT01843972|11144813|FG005|NOT COMPLETED|Overall Study||0
10114100|NCT02513719|11244817|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5
10114101|NCT02513719|11244817|FG000|STARTED|At 3 Years Clinical Follow-up||300
10114102|NCT02513719|11244817|FG000|COMPLETED|At 3 Years Clinical Follow-up||289
10114103|NCT02513719|11244817|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11
10114104|NCT02513719|11244817|FG000|STARTED|At 4 Years Clinical Follow-up||289
10114105|NCT02513719|11244817|FG000|COMPLETED|At 4 Years Clinical Follow-up||273
9837065|NCT00798694|10948336|FG000|STARTED|Overall Study||30
9837066|NCT00798694|10948337|FG001|STARTED|Overall Study||28
10021425|NCT01843972|11144814|FG006|NOT COMPLETED|Overall Study||0
10114106|NCT02513719|11244817|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16
10114107|NCT02513719|11244817|FG000|STARTED|At 5 Years Clinical Follow-up||273
10114108|NCT02513719|11244817|FG000|COMPLETED|At 5 Years Clinical Follow-up||254
10021426|NCT01843972|11144815|FG007|NOT COMPLETED|Overall Study||0
10021427|NCT01843972|11144816|FG008|NOT COMPLETED|Overall Study||0
9837067|NCT00798694|10948336|FG000|COMPLETED|Overall Study||28
9837068|NCT00798694|10948337|FG001|COMPLETED|Overall Study||27
9837069|NCT00798694|10948336|FG000|NOT COMPLETED|Overall Study||2
9837070|NCT00798694|10948337|FG001|NOT COMPLETED|Overall Study||1
9837071|NCT00798707|10948352|FG000|STARTED|Overall Study||235
9837072|NCT00798707|10948353|FG001|STARTED|Overall Study||237
9837073|NCT00798707|10948354|FG002|STARTED|Overall Study||237
9837074|NCT00798707|10948352|FG000|Treated|Overall Study||231
9837075|NCT00798707|10948353|FG001|Treated|Overall Study||232
9837076|NCT00798707|10948354|FG002|Treated|Overall Study||236
9837077|NCT00798707|10948352|FG000|COMPLETED|Overall Study||209
9837078|NCT00798707|10948353|FG001|COMPLETED|Overall Study||204
9837079|NCT00798707|10948354|FG002|COMPLETED|Overall Study||215
9837080|NCT00798707|10948352|FG000|NOT COMPLETED|Overall Study||26
9837081|NCT00798707|10948353|FG001|NOT COMPLETED|Overall Study||33
9837082|NCT00798707|10948354|FG002|NOT COMPLETED|Overall Study||22
9837083|NCT00798720|10948362|FG000|STARTED|Overall Study||18
9837084|NCT00798720|10948362|FG000|COMPLETED|Overall Study||18
9837085|NCT00798720|10948362|FG000|NOT COMPLETED|Overall Study||0
9837086|NCT00798759|10948368|FG000|STARTED|Overall Study||117
9837087|NCT00798759|10948369|FG001|STARTED|Overall Study||119
9837088|NCT00798759|10948368|FG000|COMPLETED|Overall Study||109
9837089|NCT00798759|10948369|FG001|COMPLETED|Overall Study||106
9837090|NCT00798759|10948368|FG000|NOT COMPLETED|Overall Study||8
9837091|NCT00798759|10948369|FG001|NOT COMPLETED|Overall Study||13
9837092|NCT00798889|10948375|FG000|STARTED|Overall Study||314
9837093|NCT00798889|10948375|FG000|Treated|Overall Study||311
9837094|NCT00798889|10948375|FG000|COMPLETED|Overall Study||0
9837095|NCT00798889|10948375|FG000|NOT COMPLETED|Overall Study||314
9837096|NCT00798967|10948381|FG000|STARTED|Overall Study||43
9837097|NCT00798967|10948382|FG001|STARTED|Overall Study||43
9837098|NCT00798967|10948381|FG000|Discontinued During Dosing Period|Overall Study||4
9837099|NCT00798967|10948382|FG001|Discontinued During Dosing Period|Overall Study||4
9837100|NCT00798967|10948381|FG000|COMPLETED|Overall Study||39
9837101|NCT00798967|10948382|FG001|COMPLETED|Overall Study||39
9837102|NCT00798967|10948381|FG000|NOT COMPLETED|Overall Study||4
9837103|NCT00798967|10948382|FG001|NOT COMPLETED|Overall Study||4
10021428|NCT01843972|11144817|FG009|NOT COMPLETED|Overall Study||0
9837104|NCT00799227|10948389|FG000|STARTED|Overall Study||56
9837105|NCT00799227|10948389|FG000|COMPLETED|Overall Study||53
9837106|NCT00799227|10948389|FG000|NOT COMPLETED|Overall Study||3
9837107|NCT00799383|10948395|FG000|STARTED|Overall Study||23
9837108|NCT00799383|10948396|FG001|STARTED|Overall Study||24
9837109|NCT00799383|10948395|FG000|COMPLETED|Overall Study||20
9837110|NCT00799383|10948396|FG001|COMPLETED|Overall Study||18
9837111|NCT00799383|10948395|FG000|NOT COMPLETED|Overall Study||3
9837112|NCT00799383|10948396|FG001|NOT COMPLETED|Overall Study||6
9837113|NCT00799409|10948405|FG000|STARTED|Overall Study||7
9837114|NCT00799409|10948406|FG001|STARTED|Overall Study||36
10021429|NCT01844076|11144857|FG000|STARTED|Overall Study||3
10021430|NCT01844076|11144858|FG001|STARTED|Overall Study||6
10021431|NCT01844076|11144859|FG002|STARTED|Overall Study||3
10021432|NCT01844076|11144860|FG003|STARTED|Overall Study||7
10021433|NCT01844076|11144857|FG000|COMPLETED|Overall Study||1
10021434|NCT01844076|11144858|FG001|COMPLETED|Overall Study||6
9719852|NCT00046475|10819303|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
9719853|NCT00046475|10819304|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
10021435|NCT01844076|11144859|FG002|COMPLETED|Overall Study||3
10021436|NCT01844076|11144860|FG003|COMPLETED|Overall Study||7
10021437|NCT01844076|11144857|FG000|NOT COMPLETED|Overall Study||2
9719854|NCT00046475|10819302|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
9719855|NCT00046475|10819303|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
9719856|NCT00046475|10819304|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
10021438|NCT01844076|11144858|FG001|NOT COMPLETED|Overall Study||0
10021439|NCT01844076|11144859|FG002|NOT COMPLETED|Overall Study||0
10021440|NCT01844076|11144860|FG003|NOT COMPLETED|Overall Study||0
10021441|NCT01844115|11144872|FG000|STARTED|Overall Study||202
10021442|NCT01844115|11144873|FG001|STARTED|Overall Study||202
10021443|NCT01844115|11144872|FG000|COMPLETED|Overall Study||163
10021444|NCT01844115|11144873|FG001|COMPLETED|Overall Study||144
10021445|NCT01844115|11144872|FG000|NOT COMPLETED|Overall Study||39
10021446|NCT01844115|11144873|FG001|NOT COMPLETED|Overall Study||58
10021447|NCT01844193|11144881|FG000|STARTED|Overall Study||19
10021448|NCT01844193|11144882|FG001|STARTED|Overall Study||21
10021449|NCT01844193|11144881|FG000|COMPLETED|Overall Study||13
10021450|NCT01844193|11144882|FG001|COMPLETED|Overall Study||15
10021451|NCT01844193|11144881|FG000|NOT COMPLETED|Overall Study||6
10021452|NCT01844193|11144882|FG001|NOT COMPLETED|Overall Study||6
10021453|NCT01844284|11144890|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266
10021454|NCT01844284|11144891|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134
10021455|NCT01844284|11144890|FG000|COMPLETED|Overall Study||254
10021456|NCT01844284|11144891|FG001|COMPLETED|Overall Study||127
10021457|NCT01844284|11144890|FG000|NOT COMPLETED|Overall Study||12
10021458|NCT01844284|11144891|FG001|NOT COMPLETED|Overall Study||7
10021459|NCT01844375|11144899|FG000|STARTED|Overall Study||35
10021460|NCT01844375|11144900|FG001|STARTED|Overall Study||35
10021461|NCT01844375|11144899|FG000|COMPLETED|Overall Study||34
10021462|NCT01844375|11144900|FG001|COMPLETED|Overall Study||34
10021463|NCT01844375|11144899|FG000|NOT COMPLETED|Overall Study||1
10114109|NCT02513719|11244817|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19
10114110|NCT02513732|11244821|FG000|STARTED|Overall Study||100
10114111|NCT02513732|11244821|FG000|COMPLETED|Overall Study||78
10114112|NCT02513732|11244821|FG000|NOT COMPLETED|Overall Study||22
10114113|NCT02513745|11244827|FG000|STARTED|Overall Study||42
10114114|NCT02513745|11244828|FG001|STARTED|Overall Study||42
10114115|NCT02513745|11244827|FG000|COMPLETED|Overall Study||39
10114116|NCT02513745|11244828|FG001|COMPLETED|Overall Study||39
10114117|NCT02513745|11244827|FG000|NOT COMPLETED|Overall Study||3
9837115|NCT00799409|10948407|FG002|STARTED|Overall Study||35
9837116|NCT00799409|10948405|FG000|COMPLETED|Overall Study||0
9837117|NCT00799409|10948406|FG001|COMPLETED|Overall Study||36
9837118|NCT00799409|10948407|FG002|COMPLETED|Overall Study||35
9837119|NCT00799409|10948405|FG000|NOT COMPLETED|Overall Study||7
9837120|NCT00799409|10948406|FG001|NOT COMPLETED|Overall Study||0
9837121|NCT00799409|10948407|FG002|NOT COMPLETED|Overall Study||0
9837122|NCT00799422|10948415|FG000|STARTED|First Week of Wear||4
9837123|NCT00799422|10948416|FG001|STARTED|First Week of Wear||4
9837124|NCT00799422|10948417|FG002|STARTED|First Week of Wear||4
9837125|NCT00799422|10948418|FG003|STARTED|First Week of Wear||5
9837126|NCT00799422|10948419|FG004|STARTED|First Week of Wear||4
9837127|NCT00799422|10948420|FG005|STARTED|First Week of Wear||5
10114118|NCT02513745|11244828|FG001|NOT COMPLETED|Overall Study||3
9837128|NCT00799422|10948415|FG000|COMPLETED|First Week of Wear||4
9837129|NCT00799422|10948416|FG001|COMPLETED|First Week of Wear||4
9958555|NCT01457703|11078015|FG000|NOT COMPLETED|Overall Study||6
9958556|NCT01457703|11078016|FG001|NOT COMPLETED|Overall Study||11
9958557|NCT01457846|11078026|FG000|STARTED|Overall Study||41
9958558|NCT01457846|11078027|FG001|STARTED|Overall Study||30
9958559|NCT01457846|11078026|FG000|Received Treatment|Overall Study||40
9958560|NCT01457846|11078027|FG001|Received Treatment|Overall Study||27
9958561|NCT01457846|11078026|FG000|Did Not Receive Treatment|Overall Study||1
9958562|NCT01457846|11078027|FG001|Did Not Receive Treatment|Overall Study||3
9958563|NCT01457846|11078026|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1
9958564|NCT01457846|11078027|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1
9958565|NCT01457846|11078026|FG000|COMPLETED|Overall Study||0
9958566|NCT01457846|11078027|FG001|COMPLETED|Overall Study||0
9958567|NCT01457846|11078026|FG000|NOT COMPLETED|Overall Study||41
9958568|NCT01457846|11078027|FG001|NOT COMPLETED|Overall Study||30
9837130|NCT00799422|10948417|FG002|COMPLETED|First Week of Wear||3
9837131|NCT00799422|10948418|FG003|COMPLETED|First Week of Wear||4
9837132|NCT00799422|10948419|FG004|COMPLETED|First Week of Wear||4
9837133|NCT00799422|10948420|FG005|COMPLETED|First Week of Wear||5
9837134|NCT00799422|10948415|FG000|NOT COMPLETED|First Week of Wear||0
10021464|NCT01844375|11144900|FG001|NOT COMPLETED|Overall Study||1
10021465|NCT01844388|11144908|FG000|STARTED|Overall Study||244
9837135|NCT00799422|10948416|FG001|NOT COMPLETED|First Week of Wear||0
9837136|NCT00799422|10948417|FG002|NOT COMPLETED|First Week of Wear||1
9837137|NCT00799422|10948418|FG003|NOT COMPLETED|First Week of Wear||1
9837138|NCT00799422|10948419|FG004|NOT COMPLETED|First Week of Wear||0
9837139|NCT00799422|10948420|FG005|NOT COMPLETED|First Week of Wear||0
9837140|NCT00799422|10948415|FG000|STARTED|Second Week of Wear||4
9837141|NCT00799422|10948416|FG001|STARTED|Second Week of Wear||4
9837142|NCT00799422|10948417|FG002|STARTED|Second Week of Wear||3
10021466|NCT01844388|11144909|FG001|STARTED|Overall Study||121
9719857|NCT00046475|10819302|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
9719858|NCT00046475|10819303|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
9719859|NCT00046475|10819304|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
9719860|NCT00046566|10819317|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
9719861|NCT00046566|10819318|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
9719862|NCT00046566|10819319|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
9719863|NCT00046566|10819317|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
9719864|NCT00046566|10819318|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
9719865|NCT00046566|10819319|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
9719866|NCT00046566|10819317|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
9719867|NCT00046566|10819318|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
9719868|NCT00046566|10819319|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
9719869|NCT00046566|10819317|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
9719870|NCT00046566|10819318|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
9719871|NCT00046566|10819319|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
9719872|NCT00046566|10819317|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
9719873|NCT00046566|10819318|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
9719874|NCT00046566|10819319|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
9719875|NCT00046566|10819317|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
9719876|NCT00046566|10819318|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
9719877|NCT00046566|10819319|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
9719878|NCT00046566|10819317|FG000|STARTED|Intervention 3 (8 Weeks)||93
10021467|NCT01844388|11144908|FG000|COMPLETED|Overall Study||236
10021468|NCT01844388|11144909|FG001|COMPLETED|Overall Study||114
10021469|NCT01844388|11144908|FG000|NOT COMPLETED|Overall Study||8
10021470|NCT01844388|11144909|FG001|NOT COMPLETED|Overall Study||7
10021471|NCT01844479|11144915|FG000|STARTED|First Intervention up to 30 Minutes||14
10021472|NCT01844479|11144916|FG001|STARTED|First Intervention up to 30 Minutes||13
10021473|NCT01844479|11144915|FG000|COMPLETED|First Intervention up to 30 Minutes||14
10021474|NCT01844479|11144916|FG001|COMPLETED|First Intervention up to 30 Minutes||13
10021475|NCT01844479|11144915|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0
10021476|NCT01844479|11144916|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0
9958569|NCT01457885|11078033|FG000|STARTED|Overall Study||74
9837143|NCT00799422|10948418|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
9837144|NCT00799422|10948419|FG004|STARTED|Second Week of Wear||4
9837145|NCT00799422|10948420|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
9837146|NCT00799422|10948415|FG000|COMPLETED|Second Week of Wear||4
9837147|NCT00799422|10948416|FG001|COMPLETED|Second Week of Wear||4
9837148|NCT00799422|10948417|FG002|COMPLETED|Second Week of Wear||3
9837149|NCT00799422|10948418|FG003|COMPLETED|Second Week of Wear||3
9837150|NCT00799422|10948419|FG004|COMPLETED|Second Week of Wear||4
9837151|NCT00799422|10948420|FG005|COMPLETED|Second Week of Wear||4
9837152|NCT00799422|10948415|FG000|NOT COMPLETED|Second Week of Wear||0
9837153|NCT00799422|10948416|FG001|NOT COMPLETED|Second Week of Wear||0
9837154|NCT00799422|10948417|FG002|NOT COMPLETED|Second Week of Wear||0
9837155|NCT00799422|10948418|FG003|NOT COMPLETED|Second Week of Wear||0
9837156|NCT00799422|10948419|FG004|NOT COMPLETED|Second Week of Wear||0
9837157|NCT00799422|10948420|FG005|NOT COMPLETED|Second Week of Wear||0
9837158|NCT00799422|10948415|FG000|STARTED|Third Week of Wear||4
9837159|NCT00799422|10948416|FG001|STARTED|Third Week of Wear||4
9837160|NCT00799422|10948417|FG002|STARTED|Third Week of Wear||3
9837161|NCT00799422|10948418|FG003|STARTED|Third Week of Wear||3
9837162|NCT00799422|10948419|FG004|STARTED|Third Week of Wear||4
9837163|NCT00799422|10948420|FG005|STARTED|Third Week of Wear||4
9837164|NCT00799422|10948415|FG000|COMPLETED|Third Week of Wear||4
9837165|NCT00799422|10948416|FG001|COMPLETED|Third Week of Wear||4
9837166|NCT00799422|10948417|FG002|COMPLETED|Third Week of Wear||3
9837167|NCT00799422|10948418|FG003|COMPLETED|Third Week of Wear||3
9837168|NCT00799422|10948419|FG004|COMPLETED|Third Week of Wear||4
9837169|NCT00799422|10948420|FG005|COMPLETED|Third Week of Wear||4
9837170|NCT00799422|10948415|FG000|NOT COMPLETED|Third Week of Wear||0
9837171|NCT00799422|10948416|FG001|NOT COMPLETED|Third Week of Wear||0
9837172|NCT00799422|10948417|FG002|NOT COMPLETED|Third Week of Wear||0
9837173|NCT00799422|10948418|FG003|NOT COMPLETED|Third Week of Wear||0
9837174|NCT00799422|10948419|FG004|NOT COMPLETED|Third Week of Wear||0
9837175|NCT00799422|10948420|FG005|NOT COMPLETED|Third Week of Wear||0
9719879|NCT00046566|10819318|FG001|STARTED|Intervention 3 (8 Weeks)||92
9719880|NCT00046566|10819319|FG002|STARTED|Intervention 3 (8 Weeks)||88
9719881|NCT00046566|10819317|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
9719882|NCT00046566|10819318|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
9719883|NCT00046566|10819319|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
9719884|NCT00046566|10819317|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
9719885|NCT00046566|10819318|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
9719886|NCT00046566|10819319|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
9719887|NCT00046839|10819330|FG000|STARTED|Overall Study||8
9719888|NCT00046839|10819331|FG001|STARTED|Overall Study||13
9719889|NCT00046839|10819330|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
9719890|NCT00046839|10819331|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
9719891|NCT00046839|10819330|FG000|NOT COMPLETED|Overall Study||1
9719892|NCT00046839|10819331|FG001|NOT COMPLETED|Overall Study||2
9837176|NCT00799435|10948430|FG000|STARTED|Overall Study||1
9837177|NCT00799435|10948431|FG001|STARTED|Overall Study||1
9837178|NCT00799435|10948430|FG000|COMPLETED|Overall Study||1
9837179|NCT00799435|10948431|FG001|COMPLETED|Overall Study||1
9837180|NCT00799435|10948430|FG000|NOT COMPLETED|Overall Study||0
9837181|NCT00799435|10948431|FG001|NOT COMPLETED|Overall Study||0
9837182|NCT00799474|10948437|FG000|STARTED|Overall Study||609
9837183|NCT00799474|10948437|FG000|COMPLETED|Overall Study||609
9837184|NCT00799474|10948437|FG000|NOT COMPLETED|Overall Study||0
9837185|NCT00799487|10948444|FG000|STARTED|Dose Adjustment Period||21
9837186|NCT00799487|10948445|FG001|STARTED|Dose Adjustment Period||34
9837187|NCT00799487|10948446|FG002|STARTED|Dose Adjustment Period||34
9837188|NCT00799487|10948444|FG000|COMPLETED|Dose Adjustment Period||0
9837189|NCT00799487|10948445|FG001|COMPLETED|Dose Adjustment Period||34
9837190|NCT00799487|10948446|FG002|COMPLETED|Dose Adjustment Period||34
9837191|NCT00799487|10948444|FG000|NOT COMPLETED|Dose Adjustment Period||21
9837192|NCT00799487|10948445|FG001|NOT COMPLETED|Dose Adjustment Period||0
9837193|NCT00799487|10948446|FG002|NOT COMPLETED|Dose Adjustment Period||0
9837194|NCT00799487|10948444|FG000|STARTED|Double-Blind Assessment Period||0
9837195|NCT00799487|10948445|FG001|STARTED|Double-Blind Assessment Period||34
9837196|NCT00799487|10948446|FG002|STARTED|Double-Blind Assessment Period||34
9837197|NCT00799487|10948444|FG000|COMPLETED|Double-Blind Assessment Period||0
9837198|NCT00799487|10948445|FG001|COMPLETED|Double-Blind Assessment Period||33
9837199|NCT00799487|10948446|FG002|COMPLETED|Double-Blind Assessment Period||32
9837200|NCT00799487|10948444|FG000|NOT COMPLETED|Double-Blind Assessment Period||0
9837201|NCT00799487|10948445|FG001|NOT COMPLETED|Double-Blind Assessment Period||1
9837202|NCT00799487|10948446|FG002|NOT COMPLETED|Double-Blind Assessment Period||2
9837203|NCT00799578|10948457|FG000|STARTED|Overall Study||13
9837204|NCT00799578|10948457|FG000|COMPLETED|Overall Study||11
9837205|NCT00799578|10948457|FG000|NOT COMPLETED|Overall Study||2
9837206|NCT00799591|10948461|FG000|STARTED|Overall Study||156
9837207|NCT00799591|10948461|FG000|COMPLETED|Overall Study||90
9837208|NCT00799591|10948461|FG000|NOT COMPLETED|Overall Study||66
9837209|NCT00799604|10948468|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10
9837210|NCT00799604|10948469|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10
9837211|NCT00799604|10948470|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10
9837212|NCT00799604|10948468|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10
9837213|NCT00799604|10948469|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10
9837214|NCT00799604|10948470|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10
9837215|NCT00799604|10948468|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
9837216|NCT00799604|10948469|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
9837217|NCT00799604|10948470|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
9837218|NCT00799604|10948468|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
9837219|NCT00799604|10948469|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
9837220|NCT00799604|10948470|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
9837221|NCT00799604|10948468|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6
9837222|NCT00799604|10948469|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12
9837223|NCT00799604|10948470|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3
9837224|NCT00799604|10948468|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
9837225|NCT00799604|10948469|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
9837226|NCT00799604|10948470|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
9837227|NCT00799617|10948480|FG000|STARTED|Main Testosterone Trial||395
9837228|NCT00799617|10948481|FG001|STARTED|Main Testosterone Trial||395
9837229|NCT00799617|10948480|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
9837230|NCT00799617|10948481|FG001|COMPLETED|Main Testosterone Trial||374
9837231|NCT00799617|10948480|FG000|NOT COMPLETED|Main Testosterone Trial||19
9837232|NCT00799617|10948481|FG001|NOT COMPLETED|Main Testosterone Trial||21
9837233|NCT00799617|10948480|FG000|STARTED|Sexual Funtion Trial||234
9837234|NCT00799617|10948481|FG001|STARTED|Sexual Funtion Trial||236
9837235|NCT00799617|10948480|FG000|COMPLETED|Sexual Funtion Trial||218
9837236|NCT00799617|10948481|FG001|COMPLETED|Sexual Funtion Trial||215
9837237|NCT00799617|10948480|FG000|NOT COMPLETED|Sexual Funtion Trial||16
9837238|NCT00799617|10948481|FG001|NOT COMPLETED|Sexual Funtion Trial||21
9837239|NCT00799617|10948480|FG000|STARTED|Physical Function Trial||191
9837240|NCT00799617|10948481|FG001|STARTED|Physical Function Trial||196
9837241|NCT00799617|10948480|FG000|COMPLETED|Physical Function Trial||185
9837242|NCT00799617|10948481|FG001|COMPLETED|Physical Function Trial||185
9837243|NCT00799617|10948480|FG000|NOT COMPLETED|Physical Function Trial||6
9837244|NCT00799617|10948481|FG001|NOT COMPLETED|Physical Function Trial||11
9837245|NCT00799617|10948480|FG000|STARTED|Vitality Trial||236
9837246|NCT00799617|10948481|FG001|STARTED|Vitality Trial||238
9837247|NCT00799617|10948480|FG000|COMPLETED|Vitality Trial||229
9837248|NCT00799617|10948481|FG001|COMPLETED|Vitality Trial||216
9837249|NCT00799617|10948480|FG000|NOT COMPLETED|Vitality Trial||7
9837250|NCT00799617|10948481|FG001|NOT COMPLETED|Vitality Trial||22
9837251|NCT00799617|10948480|FG000|STARTED|Cardiovascular Trial||88
9837252|NCT00799617|10948481|FG001|STARTED|Cardiovascular Trial||82
9837253|NCT00799617|10948480|FG000|COMPLETED|Cardiovascular Trial||73
9837254|NCT00799617|10948481|FG001|COMPLETED|Cardiovascular Trial||65
9837255|NCT00799617|10948480|FG000|NOT COMPLETED|Cardiovascular Trial||15
9837256|NCT00799617|10948481|FG001|NOT COMPLETED|Cardiovascular Trial||17
9837257|NCT00799617|10948480|FG000|STARTED|Bone Trial||110
9837258|NCT00799617|10948481|FG001|STARTED|Bone Trial||101
10021477|NCT01844479|11144915|FG000|STARTED|Second Intervention up to 30 Minutes||14
10021478|NCT01844479|11144916|FG001|STARTED|Second Intervention up to 30 Minutes||13
10021479|NCT01844479|11144915|FG000|COMPLETED|Second Intervention up to 30 Minutes||14
9837259|NCT00799617|10948480|FG000|COMPLETED|Bone Trial||104
9837260|NCT00799617|10948481|FG001|COMPLETED|Bone Trial||85
9837261|NCT00799617|10948480|FG000|NOT COMPLETED|Bone Trial||6
9837262|NCT00799617|10948481|FG001|NOT COMPLETED|Bone Trial||16
9837263|NCT00799617|10948480|FG000|STARTED|Cognitive Function Trial||247
9837264|NCT00799617|10948481|FG001|STARTED|Cognitive Function Trial||246
9837265|NCT00799617|10948480|FG000|COMPLETED|Cognitive Function Trial||247
9837266|NCT00799617|10948481|FG001|COMPLETED|Cognitive Function Trial||245
9837267|NCT00799617|10948480|FG000|NOT COMPLETED|Cognitive Function Trial||0
9837268|NCT00799617|10948481|FG001|NOT COMPLETED|Cognitive Function Trial||1
9837269|NCT00799617|10948480|FG000|STARTED|Anemia Trial||27
9837270|NCT00799617|10948481|FG001|STARTED|Anemia Trial||35
9837271|NCT00799617|10948480|FG000|COMPLETED|Anemia Trial||24
9837272|NCT00799617|10948481|FG001|COMPLETED|Anemia Trial||32
9837273|NCT00799617|10948480|FG000|NOT COMPLETED|Anemia Trial||3
9837274|NCT00799617|10948481|FG001|NOT COMPLETED|Anemia Trial||3
9837275|NCT00799643|10948489|FG000|STARTED|Overall Study||140
9837276|NCT00799643|10948490|FG001|STARTED|Overall Study||146
9837277|NCT00799643|10948489|FG000|COMPLETED|Overall Study||115
9837278|NCT00799643|10948490|FG001|COMPLETED|Overall Study||119
9837279|NCT00799643|10948489|FG000|NOT COMPLETED|Overall Study||25
9837280|NCT00799643|10948490|FG001|NOT COMPLETED|Overall Study||27
9837281|NCT00799708|10948500|FG000|STARTED|Overall Study||10
9837282|NCT00799708|10948501|FG001|STARTED|Overall Study||6
9837283|NCT00799708|10948502|FG002|STARTED|Overall Study||11
9837284|NCT00799708|10948500|FG000|COMPLETED|Overall Study||9
9837285|NCT00799708|10948501|FG001|COMPLETED|Overall Study||6
9958570|NCT01457885|11078033|FG000|COMPLETED|Overall Study||74
9958571|NCT01457885|11078033|FG000|NOT COMPLETED|Overall Study||0
9958572|NCT01457924|11078042|FG000|STARTED|Treatment Phase (Weeks 0-24)||67
9958573|NCT01457924|11078043|FG001|STARTED|Treatment Phase (Weeks 0-24)||34
10021480|NCT01844479|11144916|FG001|COMPLETED|Second Intervention up to 30 Minutes||13
10021481|NCT01844479|11144915|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0
10081119|NCT02257970|11209576|FG002|STARTED|Part 2||0
9837286|NCT00799708|10948502|FG002|COMPLETED|Overall Study||11
9837287|NCT00799708|10948500|FG000|NOT COMPLETED|Overall Study||1
9837288|NCT00799708|10948501|FG001|NOT COMPLETED|Overall Study||0
9837289|NCT00799708|10948502|FG002|NOT COMPLETED|Overall Study||0
9837290|NCT00799812|10948512|FG000|STARTED|Overall Study||335
9837291|NCT00799812|10948512|FG000|CHG Swabstick (3 @ Once)|Overall Study||139
9837292|NCT00799812|10948512|FG000|CHG Swabstick Sequential|Overall Study||138
9837293|NCT00799812|10948512|FG000|Hibiclens|Overall Study||133
9837294|NCT00799812|10948512|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132
9837295|NCT00799812|10948512|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126
9837296|NCT00799812|10948512|FG000|COMPLETED|Overall Study||335
9958574|NCT01457924|11078044|FG002|STARTED|Treatment Phase (Weeks 0-24)||32
9958575|NCT01457924|11078045|FG003|STARTED|Treatment Phase (Weeks 0-24)||34
9958576|NCT01457924|11078046|FG004|STARTED|Treatment Phase (Weeks 0-24)||64
9958577|NCT01457924|11078042|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
9958578|NCT01457924|11078043|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
9958579|NCT01457924|11078044|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
9958580|NCT01457924|11078045|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
9958581|NCT01457924|11078046|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
9958582|NCT01457924|11078042|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64
9958583|NCT01457924|11078043|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29
9958584|NCT01457924|11078044|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30
9958585|NCT01457924|11078045|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33
9958586|NCT01457924|11078046|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58
9958587|NCT01457924|11078042|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
9958588|NCT01457924|11078043|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
9958589|NCT01457924|11078044|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
9958590|NCT01457924|11078045|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
9958591|NCT01457924|11078046|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
9958592|NCT01457924|11078042|FG000|STARTED|FUP (Weeks 24-48)||66
9958593|NCT01457924|11078043|FG001|STARTED|FUP (Weeks 24-48)||31
9837297|NCT00799812|10948512|FG000|NOT COMPLETED|Overall Study||0
9837298|NCT00799825|10948524|FG000|STARTED|Overall Study||344
9837299|NCT00799825|10948524|FG000|COMPLETED|Overall Study||296
9837300|NCT00799825|10948524|FG000|NOT COMPLETED|Overall Study||48
9837301|NCT00799903|10948530|FG000|STARTED|Overall Study||7904
9837302|NCT00799903|10948531|FG001|STARTED|Overall Study||7924
9958594|NCT01457924|11078044|FG002|STARTED|FUP (Weeks 24-48)||32
9958595|NCT01457924|11078045|FG003|STARTED|FUP (Weeks 24-48)||33
9958596|NCT01457924|11078046|FG004|STARTED|FUP (Weeks 24-48)||59
9958597|NCT01457924|11078042|FG000|COMPLETED|FUP (Weeks 24-48)||63
9958598|NCT01457924|11078043|FG001|COMPLETED|FUP (Weeks 24-48)||30
9958599|NCT01457924|11078044|FG002|COMPLETED|FUP (Weeks 24-48)||30
9958600|NCT01457924|11078045|FG003|COMPLETED|FUP (Weeks 24-48)||32
9958601|NCT01457924|11078046|FG004|COMPLETED|FUP (Weeks 24-48)||57
9958602|NCT01457924|11078042|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3
9958603|NCT01457924|11078043|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1
9958604|NCT01457924|11078044|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2
9958605|NCT01457924|11078045|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1
9958606|NCT01457924|11078046|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2
9958607|NCT01457924|11078042|FG000|STARTED|Individualized FUP (Weeks 48+)||16
9958608|NCT01457924|11078043|FG001|STARTED|Individualized FUP (Weeks 48+)||18
9958609|NCT01457924|11078044|FG002|STARTED|Individualized FUP (Weeks 48+)||16
9958610|NCT01457924|11078045|FG003|STARTED|Individualized FUP (Weeks 48+)||20
9958611|NCT01457924|11078046|FG004|STARTED|Individualized FUP (Weeks 48+)||42
9958612|NCT01457924|11078042|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11
9958613|NCT01457924|11078043|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14
9958614|NCT01457924|11078044|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12
9958615|NCT01457924|11078045|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15
9958616|NCT01457924|11078046|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36
9958617|NCT01457924|11078042|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
9958618|NCT01457924|11078043|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
9958619|NCT01457924|11078044|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
9958620|NCT01457924|11078045|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
9958621|NCT01457924|11078046|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
9958622|NCT01457950|11078060|FG000|STARTED|Double-Blind Phase||69
9958623|NCT01457950|11078061|FG001|STARTED|Double-Blind Phase||66
9958624|NCT01457950|11078062|FG002|STARTED|Double-Blind Phase||0
9958625|NCT01457950|11078063|FG003|STARTED|Double-Blind Phase||0
9958626|NCT01457950|11078060|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
9958627|NCT01457950|11078061|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
9958628|NCT01457950|11078062|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0
9958629|NCT01457950|11078063|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0
9958630|NCT01457950|11078060|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
9958631|NCT01457950|11078061|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
9958632|NCT01457950|11078062|FG002|COMPLETED|Double-Blind Phase||0
9958633|NCT01457950|11078063|FG003|COMPLETED|Double-Blind Phase||0
9958634|NCT01457950|11078060|FG000|NOT COMPLETED|Double-Blind Phase||9
9958635|NCT01457950|11078061|FG001|NOT COMPLETED|Double-Blind Phase||3
9958636|NCT01457950|11078062|FG002|NOT COMPLETED|Double-Blind Phase||0
9958637|NCT01457950|11078063|FG003|NOT COMPLETED|Double-Blind Phase||0
9958638|NCT01457950|11078060|FG000|STARTED|Open-Label Phase||0
9958639|NCT01457950|11078061|FG001|STARTED|Open-Label Phase||0
9958640|NCT01457950|11078062|FG002|STARTED|Open-Label Phase||60
9958641|NCT01457950|11078063|FG003|STARTED|Open-Label Phase||63
9958642|NCT01457950|11078060|FG000|COMPLETED|Open-Label Phase||0
9958643|NCT01457950|11078061|FG001|COMPLETED|Open-Label Phase||0
9958644|NCT01457950|11078062|FG002|COMPLETED|Open-Label Phase||58
9837303|NCT00799903|10948530|FG000|COMPLETED|Overall Study||7631
9837304|NCT00799903|10948531|FG001|COMPLETED|Overall Study||7646
9837305|NCT00799903|10948530|FG000|NOT COMPLETED|Overall Study||273
9837306|NCT00799903|10948531|FG001|NOT COMPLETED|Overall Study||278
9837307|NCT00799981|10948537|FG000|STARTED|Overall Study||10
9837308|NCT00799981|10948538|FG001|STARTED|Overall Study||9
9837309|NCT00799981|10948539|FG002|STARTED|Overall Study||10
9837310|NCT00799981|10948540|FG003|STARTED|Overall Study||10
9837311|NCT00799981|10948541|FG004|STARTED|Overall Study||11
9837312|NCT00799981|10948542|FG005|STARTED|Overall Study||10
9837313|NCT00799981|10948537|FG000|COMPLETED|Overall Study||10
9837314|NCT00799981|10948538|FG001|COMPLETED|Overall Study||9
9837315|NCT00799981|10948539|FG002|COMPLETED|Overall Study||10
9837316|NCT00799981|10948540|FG003|COMPLETED|Overall Study||10
9837317|NCT00799981|10948541|FG004|COMPLETED|Overall Study||11
9837318|NCT00799981|10948542|FG005|COMPLETED|Overall Study||10
9837319|NCT00799981|10948537|FG000|NOT COMPLETED|Overall Study||0
9837320|NCT00799981|10948538|FG001|NOT COMPLETED|Overall Study||0
9837321|NCT00799981|10948539|FG002|NOT COMPLETED|Overall Study||0
9837322|NCT00799981|10948540|FG003|NOT COMPLETED|Overall Study||0
9837323|NCT00799981|10948541|FG004|NOT COMPLETED|Overall Study||0
9837324|NCT00799981|10948542|FG005|NOT COMPLETED|Overall Study||0
9837325|NCT00800176|10948557|FG000|STARTED|Overall Study||66
9837326|NCT00800176|10948558|FG001|STARTED|Overall Study||66
9958645|NCT01457950|11078063|FG003|COMPLETED|Open-Label Phase||61
9958646|NCT01457950|11078060|FG000|NOT COMPLETED|Open-Label Phase||0
9958647|NCT01457950|11078061|FG001|NOT COMPLETED|Open-Label Phase||0
9958648|NCT01457950|11078062|FG002|NOT COMPLETED|Open-Label Phase||2
9958649|NCT01457950|11078063|FG003|NOT COMPLETED|Open-Label Phase||2
9958650|NCT01458106|11078076|FG000|STARTED|Overall Study||36
9958651|NCT01458106|11078077|FG001|STARTED|Overall Study||35
9958652|NCT01458106|11078076|FG000|PK Subgroup|Overall Study||25
9958653|NCT01458106|11078077|FG001|PK Subgroup|Overall Study||35
9958654|NCT01458106|11078076|FG000|Non-PK Subgroup|Overall Study||11
9958655|NCT01458106|11078077|FG001|Non-PK Subgroup|Overall Study||0
9958656|NCT01458106|11078076|FG000|COMPLETED|Overall Study||33
9958657|NCT01458106|11078077|FG001|COMPLETED|Overall Study||34
9958658|NCT01458106|11078076|FG000|NOT COMPLETED|Overall Study||3
9958659|NCT01458106|11078077|FG001|NOT COMPLETED|Overall Study||1
9958660|NCT01458119|11078086|FG000|STARTED|Overall Study||85
9958661|NCT01458119|11078086|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85
9958662|NCT01458119|11078086|FG000|Safety Population|Overall Study||85
9958663|NCT01458119|11078086|FG000|Intent to Treat (ITT) Population|Overall Study||85
9958664|NCT01458119|11078086|FG000|ITT-Amenable Population|Overall Study||68
9958665|NCT01458119|11078086|FG000|COMPLETED|Overall Study||65
9958666|NCT01458119|11078086|FG000|NOT COMPLETED|Overall Study||20
9958667|NCT01458132|11078093|FG000|STARTED|Overall Study||15
9958668|NCT01458132|11078094|FG001|STARTED|Overall Study||4
9958669|NCT01458132|11078093|FG000|COMPLETED|Overall Study||0
9958670|NCT01458132|11078094|FG001|COMPLETED|Overall Study||1
9958671|NCT01458132|11078093|FG000|NOT COMPLETED|Overall Study||15
9958672|NCT01458132|11078094|FG001|NOT COMPLETED|Overall Study||3
10021482|NCT01844479|11144916|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0
10021483|NCT01844531|11144927|FG000|STARTED|Overall Study||6
10021484|NCT01844531|11144928|FG001|STARTED|Overall Study||6
9958673|NCT01458171|11078100|FG000|STARTED|Overall Study||23
9958674|NCT01458171|11078100|FG000|COMPLETED|Overall Study||22
9958675|NCT01458171|11078100|FG000|NOT COMPLETED|Overall Study||1
9958676|NCT01458210|11078106|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
9958677|NCT01458210|11078106|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
9958678|NCT01458210|11078106|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
9958679|NCT01458210|11078106|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
9958680|NCT01458210|11078106|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22
9958681|NCT01458210|11078106|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
9958682|NCT01458210|11078106|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
9958683|NCT01458210|11078106|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
9958684|NCT01458210|11078106|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
9958685|NCT01458210|11078106|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
10021485|NCT01844531|11144929|FG002|STARTED|Overall Study||6
10021486|NCT01844531|11144930|FG003|STARTED|Overall Study||6
9958686|NCT01458249|11078115|FG000|STARTED|Overall Study||52
9958687|NCT01458249|11078115|FG000|Participants Treated|Overall Study||51
9958688|NCT01458249|11078115|FG000|COMPLETED|Overall Study||44
9958689|NCT01458249|11078115|FG000|NOT COMPLETED|Overall Study||8
9958690|NCT01458275|11078123|FG000|STARTED|Overall Study||283
9958691|NCT01458275|11078124|FG001|STARTED|Overall Study||282
9837327|NCT00800176|10948559|FG002|STARTED|Overall Study||65
10021487|NCT01844531|11144927|FG000|COMPLETED|Overall Study||6
10021488|NCT01844531|11144928|FG001|COMPLETED|Overall Study||5
10021489|NCT01844531|11144929|FG002|COMPLETED|Overall Study||6
10021490|NCT01844531|11144930|FG003|COMPLETED|Overall Study||6
10021491|NCT01844531|11144927|FG000|NOT COMPLETED|Overall Study||0
10021492|NCT01844531|11144928|FG001|NOT COMPLETED|Overall Study||1
10021493|NCT01844531|11144929|FG002|NOT COMPLETED|Overall Study||0
10021494|NCT01844531|11144930|FG003|NOT COMPLETED|Overall Study||0
10021495|NCT01844583|11144942|FG000|STARTED|Overall Study||26
10021496|NCT01844583|11144943|FG001|STARTED|Overall Study||29
10021497|NCT01844583|11144942|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
10021498|NCT01844583|11144943|FG001|COMPLETED|Overall Study||19
9837328|NCT00800176|10948560|FG003|STARTED|Overall Study||66
9837329|NCT00800176|10948561|FG004|STARTED|Overall Study||64
10021499|NCT01844583|11144942|FG000|NOT COMPLETED|Overall Study||8
9837330|NCT00800176|10948562|FG005|STARTED|Overall Study||67
10114119|NCT02513771|11244836|FG000|STARTED|Overall Study||45
10114120|NCT02513771|11244837|FG001|STARTED|Overall Study||45
10114121|NCT02513771|11244836|FG000|COMPLETED|Overall Study||43
10114122|NCT02513771|11244837|FG001|COMPLETED|Overall Study||44
9837331|NCT00800176|10948557|FG000|COMPLETED|Overall Study||57
9837332|NCT00800176|10948558|FG001|COMPLETED|Overall Study||60
9719893|NCT00046891|10819340|FG000|STARTED|Overall Study||113
9719894|NCT00046891|10819341|FG001|STARTED|Overall Study||113
9719895|NCT00046891|10819340|FG000|COMPLETED|Overall Study||84
9719896|NCT00046891|10819341|FG001|COMPLETED|Overall Study||83
9719897|NCT00046891|10819340|FG000|NOT COMPLETED|Overall Study||29
9719898|NCT00046891|10819341|FG001|NOT COMPLETED|Overall Study||30
9719899|NCT00046930|10819357|FG000|STARTED|Overall Study||224
9719900|NCT00046930|10819358|FG001|STARTED|Overall Study||225
9719901|NCT00046930|10819357|FG000|COMPLETED|Overall Study||212
9719902|NCT00046930|10819358|FG001|COMPLETED|Overall Study||221
9719903|NCT00046930|10819357|FG000|NOT COMPLETED|Overall Study||12
9719904|NCT00046930|10819358|FG001|NOT COMPLETED|Overall Study||4
9719905|NCT00047060|10819367|FG000|STARTED|Overall Study||5
9719906|NCT00047060|10819367|FG000|COMPLETED|Overall Study||3
9719907|NCT00047060|10819367|FG000|NOT COMPLETED|Overall Study||2
9719908|NCT00047320|10819371|FG000|STARTED|Overall Study||104
9719909|NCT00047320|10819371|FG000|COMPLETED|Overall Study||76
9719910|NCT00047320|10819371|FG000|NOT COMPLETED|Overall Study||28
9719911|NCT00047385|10819377|FG000|STARTED|Overall Study||26722
9719912|NCT00047385|10819378|FG001|STARTED|Overall Study||26732
9719913|NCT00047385|10819377|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455
9719914|NCT00047385|10819378|FG001|COMPLETED|Overall Study||26232
9719915|NCT00047385|10819377|FG000|NOT COMPLETED|Overall Study||267
9719916|NCT00047385|10819378|FG001|NOT COMPLETED|Overall Study||500
9719917|NCT00047463|10819386|FG000|STARTED|Overall Study||13
9719918|NCT00047463|10819387|FG001|STARTED|Overall Study||22
9719919|NCT00047463|10819386|FG000|COMPLETED|Overall Study||13
9719920|NCT00047463|10819387|FG001|COMPLETED|Overall Study||19
9719921|NCT00047463|10819386|FG000|NOT COMPLETED|Overall Study||0
9719922|NCT00047463|10819387|FG001|NOT COMPLETED|Overall Study||3
9719923|NCT00047619|10819398|FG000|STARTED|Overall Study||14
9719924|NCT00047619|10819399|FG001|STARTED|Overall Study||14
9719925|NCT00047619|10819398|FG000|COMPLETED|Overall Study||14
9719926|NCT00047619|10819399|FG001|COMPLETED|Overall Study||14
9719927|NCT00047619|10819398|FG000|NOT COMPLETED|Overall Study||0
9719928|NCT00047619|10819399|FG001|NOT COMPLETED|Overall Study||0
9719929|NCT00047697|10819407|FG000|STARTED|Overall Study||18
9719930|NCT00047697|10819408|FG001|STARTED|Overall Study||16
9719931|NCT00047697|10819407|FG000|COMPLETED|Overall Study||18
9719932|NCT00047697|10819408|FG001|COMPLETED|Overall Study||14
9719933|NCT00047697|10819407|FG000|NOT COMPLETED|Overall Study||0
9719934|NCT00047697|10819408|FG001|NOT COMPLETED|Overall Study||2
9719935|NCT00047879|10819417|FG000|STARTED|Overall Study||4
9719936|NCT00047879|10819418|FG001|STARTED|Overall Study||3
9719937|NCT00047879|10819417|FG000|COMPLETED|Overall Study||0
9719938|NCT00047879|10819418|FG001|COMPLETED|Overall Study||0
9719939|NCT00047879|10819417|FG000|NOT COMPLETED|Overall Study||4
9719940|NCT00047879|10819418|FG001|NOT COMPLETED|Overall Study||3
9719941|NCT00048035|10819430|FG000|STARTED|Core Period||15
9719942|NCT00048035|10819431|FG001|STARTED|Core Period||15
9719943|NCT00048035|10819432|FG002|STARTED|Core Period||15
9719944|NCT00048035|10819433|FG003|STARTED|Core Period||15
9719945|NCT00048035|10819434|FG004|STARTED|Core Period||16
9719946|NCT00048035|10819435|FG005|STARTED|Core Period||15
9719947|NCT00048035|10819436|FG006|STARTED|Core Period||0
9719948|NCT00048035|10819437|FG007|STARTED|Core Period||0
9719949|NCT00048035|10819430|FG000|COMPLETED|Core Period||11
9719950|NCT00048035|10819431|FG001|COMPLETED|Core Period||13
9719951|NCT00048035|10819432|FG002|COMPLETED|Core Period||14
9719952|NCT00048035|10819433|FG003|COMPLETED|Core Period||14
9719953|NCT00048035|10819434|FG004|COMPLETED|Core Period||15
9958692|NCT01458275|11078125|FG002|STARTED|Overall Study||282
9958693|NCT01458275|11078123|FG000|COMPLETED|Overall Study||269
9958694|NCT01458275|11078124|FG001|COMPLETED|Overall Study||269
9958695|NCT01458275|11078125|FG002|COMPLETED|Overall Study||273
9958696|NCT01458275|11078123|FG000|NOT COMPLETED|Overall Study||14
9958697|NCT01458275|11078124|FG001|NOT COMPLETED|Overall Study||13
9719954|NCT00048035|10819435|FG005|COMPLETED|Core Period||14
9958698|NCT01458275|11078125|FG002|NOT COMPLETED|Overall Study||9
9958699|NCT01458288|11078135|FG000|STARTED|Overall Study||12
9958700|NCT01458288|11078135|FG000|COMPLETED|Overall Study||12
9719955|NCT00048035|10819436|FG006|COMPLETED|Core Period||0
9719956|NCT00048035|10819437|FG007|COMPLETED|Core Period||0
9719957|NCT00048035|10819430|FG000|NOT COMPLETED|Core Period||4
9719958|NCT00048035|10819431|FG001|NOT COMPLETED|Core Period||2
9719959|NCT00048035|10819432|FG002|NOT COMPLETED|Core Period||1
9719960|NCT00048035|10819433|FG003|NOT COMPLETED|Core Period||1
9719961|NCT00048035|10819434|FG004|NOT COMPLETED|Core Period||1
9719962|NCT00048035|10819435|FG005|NOT COMPLETED|Core Period||1
9719963|NCT00048035|10819436|FG006|NOT COMPLETED|Core Period||0
9719964|NCT00048035|10819437|FG007|NOT COMPLETED|Core Period||0
9719965|NCT00048035|10819430|FG000|STARTED|Extension Year 1||0
9958701|NCT01458288|11078135|FG000|NOT COMPLETED|Overall Study||0
9958702|NCT01458327|11078140|FG000|STARTED|Overall Study||3
9958703|NCT01458327|11078140|FG000|COMPLETED|Overall Study||3
9958704|NCT01458327|11078140|FG000|NOT COMPLETED|Overall Study||0
9719966|NCT00048035|10819431|FG001|STARTED|Extension Year 1||0
10021500|NCT01844583|11144943|FG001|NOT COMPLETED|Overall Study||10
10021501|NCT01844687|11144954|FG000|STARTED|Visit 1||50
10021502|NCT01844687|11144954|FG000|COMPLETED|Visit 1||42
10021503|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 1||8
10021504|NCT01844687|11144954|FG000|STARTED|Visit 2||42
9837333|NCT00800176|10948559|FG002|COMPLETED|Overall Study||65
9837334|NCT00800176|10948560|FG003|COMPLETED|Overall Study||62
9837335|NCT00800176|10948561|FG004|COMPLETED|Overall Study||60
9837336|NCT00800176|10948562|FG005|COMPLETED|Overall Study||62
9837337|NCT00800176|10948557|FG000|NOT COMPLETED|Overall Study||9
9837338|NCT00800176|10948558|FG001|NOT COMPLETED|Overall Study||6
9837339|NCT00800176|10948559|FG002|NOT COMPLETED|Overall Study||0
9837340|NCT00800176|10948560|FG003|NOT COMPLETED|Overall Study||4
9837341|NCT00800176|10948561|FG004|NOT COMPLETED|Overall Study||4
9837342|NCT00800176|10948562|FG005|NOT COMPLETED|Overall Study||5
9837343|NCT00800202|10948578|FG000|STARTED|Overall Study||67
9837344|NCT00800202|10948579|FG001|STARTED|Overall Study||24
9837345|NCT00800202|10948578|FG000|COMPLETED|Overall Study||0
9837346|NCT00800202|10948579|FG001|COMPLETED|Overall Study||0
9837347|NCT00800202|10948578|FG000|NOT COMPLETED|Overall Study||67
9837348|NCT00800202|10948579|FG001|NOT COMPLETED|Overall Study||24
9837349|NCT00800254|10948587|FG000|STARTED|Overall Study||35
9837350|NCT00800254|10948588|FG001|STARTED|Overall Study||31
9837351|NCT00800254|10948587|FG000|3.5 Weeks Post-operatively|Overall Study||31
9837352|NCT00800254|10948588|FG001|3.5 Weeks Post-operatively|Overall Study||31
9837353|NCT00800254|10948587|FG000|COMPLETED|Overall Study||30
9837354|NCT00800254|10948588|FG001|COMPLETED|Overall Study||25
9837355|NCT00800254|10948587|FG000|NOT COMPLETED|Overall Study||5
9837356|NCT00800254|10948588|FG001|NOT COMPLETED|Overall Study||6
9837357|NCT00800345|10948594|FG000|STARTED|Overall Study||33
9837358|NCT00800345|10948594|FG000|COMPLETED|Overall Study||33
9837359|NCT00800345|10948594|FG000|NOT COMPLETED|Overall Study||0
9837360|NCT00800384|10948600|FG000|STARTED|Overall Study||1247
9837361|NCT00800384|10948601|FG001|STARTED|Overall Study||1253
9837362|NCT00800384|10948600|FG000|COMPLETED|Overall Study||1206
9837363|NCT00800384|10948601|FG001|COMPLETED|Overall Study||1210
9837364|NCT00800384|10948600|FG000|NOT COMPLETED|Overall Study||41
9837365|NCT00800384|10948601|FG001|NOT COMPLETED|Overall Study||43
9837366|NCT00800436|10948615|FG000|STARTED|Overall Study||6
9837367|NCT00800436|10948616|FG001|STARTED|Overall Study||6
9837368|NCT00800436|10948617|FG002|STARTED|Overall Study||6
9837369|NCT00800436|10948618|FG003|STARTED|Overall Study||6
9837370|NCT00800436|10948619|FG004|STARTED|Overall Study||6
9837371|NCT00800436|10948620|FG005|STARTED|Overall Study||20
9837372|NCT00800436|10948621|FG006|STARTED|Overall Study||20
9837373|NCT00800436|10948615|FG000|COMPLETED|Overall Study||6
9837374|NCT00800436|10948616|FG001|COMPLETED|Overall Study||6
9837375|NCT00800436|10948617|FG002|COMPLETED|Overall Study||5
9837376|NCT00800436|10948618|FG003|COMPLETED|Overall Study||5
9837377|NCT00800436|10948619|FG004|COMPLETED|Overall Study||6
9837378|NCT00800436|10948620|FG005|COMPLETED|Overall Study||20
9837379|NCT00800436|10948621|FG006|COMPLETED|Overall Study||20
9837380|NCT00800436|10948615|FG000|NOT COMPLETED|Overall Study||0
9837381|NCT00800436|10948616|FG001|NOT COMPLETED|Overall Study||0
9837382|NCT00800436|10948617|FG002|NOT COMPLETED|Overall Study||1
9837383|NCT00800436|10948618|FG003|NOT COMPLETED|Overall Study||1
9837384|NCT00800436|10948619|FG004|NOT COMPLETED|Overall Study||0
9837385|NCT00800436|10948620|FG005|NOT COMPLETED|Overall Study||0
9837386|NCT00800436|10948621|FG006|NOT COMPLETED|Overall Study||0
10021505|NCT01844687|11144954|FG000|COMPLETED|Visit 2||40
10021506|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 2||2
10021507|NCT01844687|11144954|FG000|STARTED|Visit 3||40
10021508|NCT01844687|11144954|FG000|COMPLETED|Visit 3||35
9837387|NCT00800540|10948637|FG000|STARTED|Period One: 6 Weeks||17
9837388|NCT00800540|10948638|FG001|STARTED|Period One: 6 Weeks||18
9837389|NCT00800540|10948637|FG000|COMPLETED|Period One: 6 Weeks||16
9837390|NCT00800540|10948638|FG001|COMPLETED|Period One: 6 Weeks||17
10021509|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 3||5
10021510|NCT01844687|11144954|FG000|STARTED|Visit 4||35
10021511|NCT01844687|11144954|FG000|COMPLETED|Visit 4||31
10021512|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 4||4
10021513|NCT01844687|11144954|FG000|STARTED|Visit 5||31
10021514|NCT01844687|11144954|FG000|COMPLETED|Visit 5||31
10021515|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 5||0
10021516|NCT01844687|11144954|FG000|STARTED|Visit 6||31
10021517|NCT01844687|11144954|FG000|COMPLETED|Visit 6||31
9837391|NCT00800540|10948637|FG000|NOT COMPLETED|Period One: 6 Weeks||1
9837392|NCT00800540|10948638|FG001|NOT COMPLETED|Period One: 6 Weeks||1
9837393|NCT00800540|10948637|FG000|STARTED|Washout: 4 Weeks||16
9837394|NCT00800540|10948638|FG001|STARTED|Washout: 4 Weeks||17
9837395|NCT00800540|10948637|FG000|COMPLETED|Washout: 4 Weeks||16
9837396|NCT00800540|10948638|FG001|COMPLETED|Washout: 4 Weeks||17
9837397|NCT00800540|10948637|FG000|NOT COMPLETED|Washout: 4 Weeks||0
9837398|NCT00800540|10948638|FG001|NOT COMPLETED|Washout: 4 Weeks||0
9837399|NCT00800540|10948637|FG000|STARTED|Period 2: 6 Weeks||16
9837400|NCT00800540|10948638|FG001|STARTED|Period 2: 6 Weeks||17
9837401|NCT00800540|10948637|FG000|COMPLETED|Period 2: 6 Weeks||16
9837402|NCT00800540|10948638|FG001|COMPLETED|Period 2: 6 Weeks||16
9837403|NCT00800540|10948637|FG000|NOT COMPLETED|Period 2: 6 Weeks||0
9837404|NCT00800540|10948638|FG001|NOT COMPLETED|Period 2: 6 Weeks||1
9837405|NCT00800683|10948646|FG000|STARTED|Overall Study|Number who started treatment|65
9837406|NCT00800683|10948647|FG001|STARTED|Overall Study|Number who started treatment|68
9837407|NCT00800683|10948646|FG000|COMPLETED|Overall Study|Number who completed treatment|48
9837408|NCT00800683|10948647|FG001|COMPLETED|Overall Study|Number who completed treatment|49
9837409|NCT00800683|10948646|FG000|NOT COMPLETED|Overall Study||17
9837410|NCT00800683|10948647|FG001|NOT COMPLETED|Overall Study||19
9837411|NCT00800735|10948653|FG000|STARTED|Overall Study||30
9837412|NCT00800735|10948653|FG000|COMPLETED|Overall Study||16
9837413|NCT00800735|10948653|FG000|NOT COMPLETED|Overall Study||14
9837414|NCT00800839|10948657|FG000|STARTED|Overall Study||56
9837415|NCT00800839|10948657|FG000|COMPLETED|Overall Study||49
9837416|NCT00800839|10948657|FG000|NOT COMPLETED|Overall Study||7
9837417|NCT00800865|10948663|FG000|STARTED|Overall Study||15
9837418|NCT00800865|10948664|FG001|STARTED|Overall Study||16
9837419|NCT00800865|10948663|FG000|COMPLETED|Overall Study||15
9837420|NCT00800865|10948664|FG001|COMPLETED|Overall Study||16
9837421|NCT00800865|10948663|FG000|NOT COMPLETED|Overall Study||0
9837422|NCT00800865|10948664|FG001|NOT COMPLETED|Overall Study||0
9837423|NCT00800982|10948672|FG000|STARTED|Overall Study||15
9837424|NCT00800982|10948673|FG001|STARTED|Overall Study||15
9837425|NCT00800982|10948672|FG000|COMPLETED|Overall Study||13
10021518|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 6||0
9837426|NCT00800982|10948673|FG001|COMPLETED|Overall Study||12
9837427|NCT00800982|10948672|FG000|NOT COMPLETED|Overall Study||2
9837428|NCT00800982|10948673|FG001|NOT COMPLETED|Overall Study||3
9837429|NCT00801099|10948679|FG000|STARTED|Overall Study||276
9837430|NCT00801099|10948679|FG000|COMPLETED|Overall Study||175
9837431|NCT00801099|10948679|FG000|NOT COMPLETED|Overall Study||101
9837432|NCT00801138|10948687|FG000|STARTED|Overall Study||54
9837433|NCT00801138|10948688|FG001|STARTED|Overall Study||56
9837434|NCT00801138|10948689|FG002|STARTED|Overall Study||54
9837435|NCT00801138|10948690|FG003|STARTED|Overall Study||54
9837436|NCT00801138|10948687|FG000|COMPLETED|Overall Study||54
9837437|NCT00801138|10948688|FG001|COMPLETED|Overall Study||56
9837438|NCT00801138|10948689|FG002|COMPLETED|Overall Study||54
9837439|NCT00801138|10948690|FG003|COMPLETED|Overall Study||54
9837440|NCT00801138|10948687|FG000|NOT COMPLETED|Overall Study||0
9837441|NCT00801138|10948688|FG001|NOT COMPLETED|Overall Study||0
9837442|NCT00801138|10948689|FG002|NOT COMPLETED|Overall Study||0
9837443|NCT00801138|10948690|FG003|NOT COMPLETED|Overall Study||0
9837444|NCT00801229|10948702|FG000|STARTED|Signed Consent||38
9837445|NCT00801229|10948703|FG001|STARTED|Signed Consent||37
9837446|NCT00801229|10948702|FG000|COMPLETED|Signed Consent||35
9837447|NCT00801229|10948703|FG001|COMPLETED|Signed Consent||34
9837448|NCT00801229|10948702|FG000|NOT COMPLETED|Signed Consent||3
9837449|NCT00801229|10948703|FG001|NOT COMPLETED|Signed Consent||3
10021519|NCT01844687|11144954|FG000|STARTED|Visit 7||31
10021520|NCT01844687|11144954|FG000|COMPLETED|Visit 7||31
10021521|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 7||0
10021522|NCT01844687|11144954|FG000|STARTED|Visit 8||31
10021523|NCT01844687|11144954|FG000|COMPLETED|Visit 8||31
10021524|NCT01844687|11144954|FG000|NOT COMPLETED|Visit 8||0
10021525|NCT01844700|11144978|FG000|STARTED|Overall Study||4
10021526|NCT01844700|11144979|FG001|STARTED|Overall Study||3
10021527|NCT01844700|11144978|FG000|COMPLETED|Overall Study||1
10021528|NCT01844700|11144979|FG001|COMPLETED|Overall Study||2
10021529|NCT01844700|11144978|FG000|NOT COMPLETED|Overall Study||3
10021530|NCT01844700|11144979|FG001|NOT COMPLETED|Overall Study||1
10021531|NCT01844765|11144987|FG000|STARTED|Overall Study||34
10021532|NCT01844765|11144988|FG001|STARTED|Overall Study||25
10021533|NCT01844765|11144987|FG000|Treated|Overall Study||33
10021534|NCT01844765|11144988|FG001|Treated|Overall Study||25
10021535|NCT01844765|11144987|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
9719967|NCT00048035|10819432|FG002|STARTED|Extension Year 1||0
9719968|NCT00048035|10819433|FG003|STARTED|Extension Year 1||0
9719969|NCT00048035|10819434|FG004|STARTED|Extension Year 1||0
9719970|NCT00048035|10819435|FG005|STARTED|Extension Year 1||0
9719971|NCT00048035|10819436|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
9719972|NCT00048035|10819437|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
9719973|NCT00048035|10819430|FG000|COMPLETED|Extension Year 1||0
9719974|NCT00048035|10819431|FG001|COMPLETED|Extension Year 1||0
9719975|NCT00048035|10819432|FG002|COMPLETED|Extension Year 1||0
9719976|NCT00048035|10819433|FG003|COMPLETED|Extension Year 1||0
9719977|NCT00048035|10819434|FG004|COMPLETED|Extension Year 1||0
9719978|NCT00048035|10819435|FG005|COMPLETED|Extension Year 1||0
9719979|NCT00048035|10819436|FG006|COMPLETED|Extension Year 1||16
9719980|NCT00048035|10819437|FG007|COMPLETED|Extension Year 1||15
9719981|NCT00048035|10819430|FG000|NOT COMPLETED|Extension Year 1||0
9719982|NCT00048035|10819431|FG001|NOT COMPLETED|Extension Year 1||0
9719983|NCT00048035|10819432|FG002|NOT COMPLETED|Extension Year 1||0
9719984|NCT00048035|10819433|FG003|NOT COMPLETED|Extension Year 1||0
9719985|NCT00048035|10819434|FG004|NOT COMPLETED|Extension Year 1||0
9719986|NCT00048035|10819435|FG005|NOT COMPLETED|Extension Year 1||0
9719987|NCT00048035|10819436|FG006|NOT COMPLETED|Extension Year 1||11
9719988|NCT00048035|10819437|FG007|NOT COMPLETED|Extension Year 1||11
9719989|NCT00048035|10819430|FG000|STARTED|Extension Year 2||0
9719990|NCT00048035|10819431|FG001|STARTED|Extension Year 2||0
9719991|NCT00048035|10819432|FG002|STARTED|Extension Year 2||0
9719992|NCT00048035|10819433|FG003|STARTED|Extension Year 2||0
10021536|NCT01844765|11144988|FG001|Untreated|Overall Study||0
10021537|NCT01844765|11144987|FG000|COMPLETED|Overall Study||19
10021538|NCT01844765|11144988|FG001|COMPLETED|Overall Study||10
10021539|NCT01844765|11144987|FG000|NOT COMPLETED|Overall Study||15
10021540|NCT01844765|11144988|FG001|NOT COMPLETED|Overall Study||15
10021541|NCT01844778|11145002|FG000|STARTED|Overall Study||14
10021542|NCT01844778|11145003|FG001|STARTED|Overall Study||28
10021543|NCT01844778|11145004|FG002|STARTED|Overall Study||18
9958705|NCT01458366|11078150|FG000|STARTED|Period 1: 70mg/m^2||5
9958706|NCT01458366|11078151|FG001|STARTED|Period 1: 70mg/m^2||0
9958707|NCT01458366|11078152|FG002|STARTED|Period 1: 70mg/m^2||0
9958708|NCT01458366|11078153|FG003|STARTED|Period 1: 70mg/m^2||0
9958709|NCT01458366|11078154|FG004|STARTED|Period 1: 70mg/m^2||0
9958710|NCT01458366|11078150|FG000|COMPLETED|Period 1: 70mg/m^2||3
9958711|NCT01458366|11078151|FG001|COMPLETED|Period 1: 70mg/m^2||0
9958712|NCT01458366|11078152|FG002|COMPLETED|Period 1: 70mg/m^2||0
9958713|NCT01458366|11078153|FG003|COMPLETED|Period 1: 70mg/m^2||0
9958714|NCT01458366|11078154|FG004|COMPLETED|Period 1: 70mg/m^2||0
9958715|NCT01458366|11078150|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2
10021544|NCT01844778|11145002|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
10021545|NCT01844778|11145003|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
10021546|NCT01844778|11145004|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
10021547|NCT01844778|11145002|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
10021548|NCT01844778|11145003|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
9837450|NCT00801229|10948702|FG000|STARTED|Received Study Drug/Placebo||35
9837451|NCT00801229|10948703|FG001|STARTED|Received Study Drug/Placebo||34
9837452|NCT00801229|10948702|FG000|COMPLETED|Received Study Drug/Placebo||31
9837453|NCT00801229|10948703|FG001|COMPLETED|Received Study Drug/Placebo||30
9837454|NCT00801229|10948702|FG000|NOT COMPLETED|Received Study Drug/Placebo||4
9837455|NCT00801229|10948703|FG001|NOT COMPLETED|Received Study Drug/Placebo||4
9837456|NCT00801242|10948709|FG000|STARTED|Overall Study|Randomized participants.|220
9837457|NCT00801242|10948709|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
9837458|NCT00801242|10948709|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
9837459|NCT00801242|10948709|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
9837460|NCT00801242|10948709|FG000|Started Cycle 2|Overall Study||35
9837461|NCT00801242|10948709|FG000|Started Cycle 3|Overall Study||2
9837462|NCT00801242|10948709|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
9837463|NCT00801242|10948709|FG000|NOT COMPLETED|Overall Study||52
9837464|NCT00801398|10948719|FG000|STARTED|Overall Study||13
9837465|NCT00801398|10948720|FG001|STARTED|Overall Study||9
9837466|NCT00801398|10948721|FG002|STARTED|Overall Study||11
9837467|NCT00801398|10948722|FG003|STARTED|Overall Study||9
9837468|NCT00801398|10948723|FG004|STARTED|Overall Study||8
9837469|NCT00801398|10948724|FG005|STARTED|Overall Study||8
9837470|NCT00801398|10948719|FG000|COMPLETED|Overall Study||7
9837471|NCT00801398|10948720|FG001|COMPLETED|Overall Study||0
9837472|NCT00801398|10948721|FG002|COMPLETED|Overall Study||4
9837473|NCT00801398|10948722|FG003|COMPLETED|Overall Study||3
9837474|NCT00801398|10948723|FG004|COMPLETED|Overall Study||1
9837475|NCT00801398|10948724|FG005|COMPLETED|Overall Study||5
9837476|NCT00801398|10948719|FG000|NOT COMPLETED|Overall Study||6
9837477|NCT00801398|10948720|FG001|NOT COMPLETED|Overall Study||9
9837478|NCT00801398|10948721|FG002|NOT COMPLETED|Overall Study||7
9958716|NCT01458366|11078151|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0
9958717|NCT01458366|11078152|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0
9958718|NCT01458366|11078153|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0
9958719|NCT01458366|11078154|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0
9958720|NCT01458366|11078150|FG000|STARTED|Period 2: 50mg/m^2||0
9958721|NCT01458366|11078151|FG001|STARTED|Period 2: 50mg/m^2||0
9958722|NCT01458366|11078152|FG002|STARTED|Period 2: 50mg/m^2||0
9958723|NCT01458366|11078153|FG003|STARTED|Period 2: 50mg/m^2||0
9958724|NCT01458366|11078154|FG004|STARTED|Period 2: 50mg/m^2||0
9958725|NCT01458366|11078150|FG000|COMPLETED|Period 2: 50mg/m^2||0
9958726|NCT01458366|11078151|FG001|COMPLETED|Period 2: 50mg/m^2||0
9958727|NCT01458366|11078152|FG002|COMPLETED|Period 2: 50mg/m^2||0
10021549|NCT01844778|11145004|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
10021550|NCT01844778|11145002|FG000|COMPLETED|Overall Study||12
9837479|NCT00801398|10948722|FG003|NOT COMPLETED|Overall Study||6
9837480|NCT00801398|10948723|FG004|NOT COMPLETED|Overall Study||7
9837481|NCT00801398|10948724|FG005|NOT COMPLETED|Overall Study||3
9837482|NCT00801632|10948752|FG000|STARTED|Overall Study||5
9837483|NCT00801632|10948752|FG000|COMPLETED|Overall Study||4
9837484|NCT00801632|10948752|FG000|NOT COMPLETED|Overall Study||1
9837485|NCT00801684|10948756|FG000|STARTED|Overall Study||24
9837486|NCT00801684|10948756|FG000|COMPLETED|Overall Study||24
9837487|NCT00801684|10948756|FG000|NOT COMPLETED|Overall Study||0
9837488|NCT00801723|10948775|FG000|STARTED|Overall Study||61
9837489|NCT00801723|10948776|FG001|STARTED|Overall Study||62
9837490|NCT00801723|10948775|FG000|COMPLETED|Overall Study||25
9837491|NCT00801723|10948776|FG001|COMPLETED|Overall Study||27
9837492|NCT00801723|10948775|FG000|NOT COMPLETED|Overall Study||36
9837493|NCT00801723|10948776|FG001|NOT COMPLETED|Overall Study||35
9837494|NCT00801801|10948782|FG000|STARTED|Overall Study||5
9837495|NCT00801801|10948782|FG000|COMPLETED|Overall Study||5
9837496|NCT00801801|10948782|FG000|NOT COMPLETED|Overall Study||0
9837497|NCT00801827|10948787|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
9837498|NCT00801827|10948787|FG000|COMPLETED|Overall Study||5
9837499|NCT00801827|10948787|FG000|NOT COMPLETED|Overall Study||0
9837500|NCT00801892|10948793|FG000|STARTED|Main Study Period||12
9837501|NCT00801892|10948794|FG001|STARTED|Main Study Period||11
9837502|NCT00801892|10948793|FG000|COMPLETED|Main Study Period||12
9837503|NCT00801892|10948794|FG001|COMPLETED|Main Study Period||10
9837504|NCT00801892|10948793|FG000|NOT COMPLETED|Main Study Period||0
9837505|NCT00801892|10948794|FG001|NOT COMPLETED|Main Study Period||1
9837506|NCT00801892|10948793|FG000|STARTED|Sham Crossover Period||0
9837507|NCT00801892|10948794|FG001|STARTED|Sham Crossover Period||7
9837508|NCT00801892|10948793|FG000|COMPLETED|Sham Crossover Period||0
9837509|NCT00801892|10948794|FG001|COMPLETED|Sham Crossover Period||5
9837510|NCT00801892|10948793|FG000|NOT COMPLETED|Sham Crossover Period||0
9837511|NCT00801892|10948794|FG001|NOT COMPLETED|Sham Crossover Period||2
9837512|NCT00801983|10948804|FG000|STARTED|Period 1||44
9837513|NCT00801983|10948805|FG001|STARTED|Period 1||41
9837514|NCT00801983|10948804|FG000|COMPLETED|Period 1||40
9837515|NCT00801983|10948805|FG001|COMPLETED|Period 1||33
9837516|NCT00801983|10948804|FG000|NOT COMPLETED|Period 1||4
9958728|NCT01458366|11078153|FG003|COMPLETED|Period 2: 50mg/m^2||0
9837517|NCT00801983|10948805|FG001|NOT COMPLETED|Period 1||8
9837518|NCT00801983|10948804|FG000|STARTED|Period 2||40
9837519|NCT00801983|10948805|FG001|STARTED|Period 2||33
9837520|NCT00801983|10948804|FG000|COMPLETED|Period 2||38
9837521|NCT00801983|10948805|FG001|COMPLETED|Period 2||32
9837522|NCT00801983|10948804|FG000|NOT COMPLETED|Period 2||2
9837523|NCT00801983|10948805|FG001|NOT COMPLETED|Period 2||1
9837524|NCT00802074|10948817|FG000|STARTED|Overall Study||9
9837525|NCT00802074|10948818|FG001|STARTED|Overall Study||8
9837526|NCT00802074|10948819|FG002|STARTED|Overall Study||7
9837527|NCT00802074|10948820|FG003|STARTED|Overall Study||7
9837528|NCT00802074|10948821|FG004|STARTED|Overall Study||7
9837529|NCT00802074|10948822|FG005|STARTED|Overall Study||7
9837530|NCT00802074|10948817|FG000|COMPLETED|Overall Study||7
9837531|NCT00802074|10948818|FG001|COMPLETED|Overall Study||7
9837532|NCT00802074|10948819|FG002|COMPLETED|Overall Study||6
9837533|NCT00802074|10948820|FG003|COMPLETED|Overall Study||7
9837534|NCT00802074|10948821|FG004|COMPLETED|Overall Study||7
9837535|NCT00802074|10948822|FG005|COMPLETED|Overall Study||7
9837536|NCT00802074|10948817|FG000|NOT COMPLETED|Overall Study||2
9837537|NCT00802074|10948818|FG001|NOT COMPLETED|Overall Study||1
9837538|NCT00802074|10948819|FG002|NOT COMPLETED|Overall Study||1
9837539|NCT00802074|10948820|FG003|NOT COMPLETED|Overall Study||0
9837540|NCT00802074|10948821|FG004|NOT COMPLETED|Overall Study||0
9837541|NCT00802074|10948822|FG005|NOT COMPLETED|Overall Study||0
9837542|NCT00802100|10948842|FG000|STARTED|Overall Study||6
9837543|NCT00802100|10948843|FG001|STARTED|Overall Study||9
9837544|NCT00802100|10948844|FG002|STARTED|Overall Study||6
9837545|NCT00802100|10948842|FG000|COMPLETED|Overall Study||0
9837546|NCT00802100|10948843|FG001|COMPLETED|Overall Study||2
9837547|NCT00802100|10948844|FG002|COMPLETED|Overall Study||2
9837548|NCT00802100|10948842|FG000|NOT COMPLETED|Overall Study||6
9837549|NCT00802100|10948843|FG001|NOT COMPLETED|Overall Study||7
9837550|NCT00802100|10948844|FG002|NOT COMPLETED|Overall Study||4
9837551|NCT00802113|10948855|FG000|STARTED|Overall Study||6
9837552|NCT00802113|10948856|FG001|STARTED|Overall Study||17
9837553|NCT00802113|10948855|FG000|COMPLETED|Overall Study||6
9837554|NCT00802113|10948856|FG001|COMPLETED|Overall Study||17
9837555|NCT00802113|10948855|FG000|NOT COMPLETED|Overall Study||0
9837556|NCT00802113|10948856|FG001|NOT COMPLETED|Overall Study||0
9837557|NCT00802178|10948862|FG000|STARTED|Overall Study||2448
9837558|NCT00802178|10948862|FG000|COMPLETED|Overall Study||2335
9837559|NCT00802178|10948862|FG000|NOT COMPLETED|Overall Study||113
9958729|NCT01458366|11078154|FG004|COMPLETED|Period 2: 50mg/m^2||0
9958730|NCT01458366|11078150|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0
9958731|NCT01458366|11078151|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0
9958732|NCT01458366|11078152|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0
9958733|NCT01458366|11078153|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0
9958734|NCT01458366|11078154|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0
9958735|NCT01458366|11078150|FG000|STARTED|Period 3: 90mg/m^2||0
9958736|NCT01458366|11078151|FG001|STARTED|Period 3: 90mg/m^2||0
9958737|NCT01458366|11078152|FG002|STARTED|Period 3: 90mg/m^2||3
9958738|NCT01458366|11078153|FG003|STARTED|Period 3: 90mg/m^2||0
9958739|NCT01458366|11078154|FG004|STARTED|Period 3: 90mg/m^2||0
9958740|NCT01458366|11078150|FG000|COMPLETED|Period 3: 90mg/m^2||0
9958741|NCT01458366|11078151|FG001|COMPLETED|Period 3: 90mg/m^2||0
9958742|NCT01458366|11078152|FG002|COMPLETED|Period 3: 90mg/m^2||3
10021551|NCT01844778|11145003|FG001|COMPLETED|Overall Study||25
10021552|NCT01844778|11145004|FG002|COMPLETED|Overall Study||14
10021553|NCT01844778|11145002|FG000|NOT COMPLETED|Overall Study||2
10021554|NCT01844778|11145003|FG001|NOT COMPLETED|Overall Study||3
10021555|NCT01844778|11145004|FG002|NOT COMPLETED|Overall Study||4
10021556|NCT01844817|11145018|FG000|STARTED|Enrolled and Randomized||66
10021557|NCT01844817|11145019|FG001|STARTED|Enrolled and Randomized||66
10114123|NCT02513771|11244836|FG000|NOT COMPLETED|Overall Study||2
10114124|NCT02513771|11244837|FG001|NOT COMPLETED|Overall Study||1
10114125|NCT02513823|11244843|FG000|STARTED|Overall Study||27
9719993|NCT00048035|10819434|FG004|STARTED|Extension Year 2||0
9719994|NCT00048035|10819435|FG005|STARTED|Extension Year 2||0
9719995|NCT00048035|10819436|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
9719996|NCT00048035|10819437|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
9719997|NCT00048035|10819430|FG000|COMPLETED|Extension Year 2||0
9719998|NCT00048035|10819431|FG001|COMPLETED|Extension Year 2||0
9719999|NCT00048035|10819432|FG002|COMPLETED|Extension Year 2||0
9720000|NCT00048035|10819433|FG003|COMPLETED|Extension Year 2||0
9720001|NCT00048035|10819434|FG004|COMPLETED|Extension Year 2||0
9720002|NCT00048035|10819435|FG005|COMPLETED|Extension Year 2||0
9720003|NCT00048035|10819436|FG006|COMPLETED|Extension Year 2||11
9720004|NCT00048035|10819437|FG007|COMPLETED|Extension Year 2||10
9720005|NCT00048035|10819430|FG000|NOT COMPLETED|Extension Year 2||0
9720006|NCT00048035|10819431|FG001|NOT COMPLETED|Extension Year 2||0
9720007|NCT00048035|10819432|FG002|NOT COMPLETED|Extension Year 2||0
9720008|NCT00048035|10819433|FG003|NOT COMPLETED|Extension Year 2||0
9720009|NCT00048035|10819434|FG004|NOT COMPLETED|Extension Year 2||0
9720010|NCT00048035|10819435|FG005|NOT COMPLETED|Extension Year 2||0
9720011|NCT00048035|10819436|FG006|NOT COMPLETED|Extension Year 2||3
9720012|NCT00048035|10819437|FG007|NOT COMPLETED|Extension Year 2||3
9720013|NCT00048048|10819461|FG000|STARTED|Core Treatment||6
9720014|NCT00048048|10819462|FG001|STARTED|Core Treatment||6
9720015|NCT00048048|10819463|FG002|STARTED|Core Treatment||10
9720016|NCT00048048|10819464|FG003|STARTED|Core Treatment||6
9720017|NCT00048048|10819465|FG004|STARTED|Core Treatment||6
9720018|NCT00048048|10819466|FG005|STARTED|Core Treatment||9
9720019|NCT00048048|10819467|FG006|STARTED|Core Treatment||6
10021558|NCT01844817|11145018|FG000|COMPLETED|Enrolled and Randomized||64
10021559|NCT01844817|11145019|FG001|COMPLETED|Enrolled and Randomized||63
10021560|NCT01844817|11145018|FG000|NOT COMPLETED|Enrolled and Randomized||2
9720020|NCT00048048|10819468|FG007|STARTED|Core Treatment||6
9720021|NCT00048048|10819469|FG008|STARTED|Core Treatment||10
9720022|NCT00048048|10819470|FG009|STARTED|Core Treatment||0
10021561|NCT01844817|11145019|FG001|NOT COMPLETED|Enrolled and Randomized||3
10021562|NCT01844817|11145018|FG000|STARTED|Treatment||64
9720023|NCT00048048|10819471|FG010|STARTED|Core Treatment||0
9720024|NCT00048048|10819472|FG011|STARTED|Core Treatment||0
9720025|NCT00048048|10819461|FG000|COMPLETED|Core Treatment||6
9720026|NCT00048048|10819462|FG001|COMPLETED|Core Treatment||6
9720027|NCT00048048|10819463|FG002|COMPLETED|Core Treatment||9
9720028|NCT00048048|10819464|FG003|COMPLETED|Core Treatment||6
9720029|NCT00048048|10819465|FG004|COMPLETED|Core Treatment||6
10021563|NCT01844817|11145019|FG001|STARTED|Treatment||63
10021564|NCT01844817|11145018|FG000|COMPLETED|Treatment||0
10021565|NCT01844817|11145019|FG001|COMPLETED|Treatment||0
10021566|NCT01844817|11145018|FG000|NOT COMPLETED|Treatment||64
10021567|NCT01844817|11145019|FG001|NOT COMPLETED|Treatment||63
10021568|NCT01844830|11145028|FG000|STARTED|Overall Study||60
10021569|NCT01844830|11145029|FG001|STARTED|Overall Study||30
10021570|NCT01844830|11145028|FG000|100 µL Dose|Overall Study||16
10021571|NCT01844830|11145029|FG001|100 µL Dose|Overall Study||8
9837560|NCT00802204|10948868|FG000|STARTED|Overall Study||9
9837561|NCT00802204|10948869|FG001|STARTED|Overall Study||19
9837562|NCT00802204|10948868|FG000|COMPLETED|Overall Study||8
9837563|NCT00802204|10948869|FG001|COMPLETED|Overall Study||18
9837564|NCT00802204|10948868|FG000|NOT COMPLETED|Overall Study||1
9837565|NCT00802204|10948869|FG001|NOT COMPLETED|Overall Study||1
9837566|NCT00802360|10948882|FG000|STARTED|Overall Study||42
10021572|NCT01844830|11145028|FG000|200 µL Dose|Overall Study||24
10021573|NCT01844830|11145029|FG001|200 µL Dose|Overall Study||12
10021574|NCT01844830|11145028|FG000|400 µL Dose|Overall Study||20
10021575|NCT01844830|11145029|FG001|400 µL Dose|Overall Study||10
10021576|NCT01844830|11145028|FG000|COMPLETED|Overall Study||59
10021577|NCT01844830|11145029|FG001|COMPLETED|Overall Study||30
9837567|NCT00802360|10948883|FG001|STARTED|Overall Study||42
9837568|NCT00802360|10948884|FG002|STARTED|Overall Study||42
9837569|NCT00802360|10948885|FG003|STARTED|Overall Study||39
9837570|NCT00802360|10948882|FG000|COMPLETED|Overall Study||18
9837571|NCT00802360|10948883|FG001|COMPLETED|Overall Study||16
9837572|NCT00802360|10948884|FG002|COMPLETED|Overall Study||17
9837573|NCT00802360|10948885|FG003|COMPLETED|Overall Study||17
9837574|NCT00802360|10948882|FG000|NOT COMPLETED|Overall Study||24
10021578|NCT01844830|11145028|FG000|NOT COMPLETED|Overall Study||1
9837575|NCT00802360|10948883|FG001|NOT COMPLETED|Overall Study||26
9837576|NCT00802360|10948884|FG002|NOT COMPLETED|Overall Study||25
9837577|NCT00802360|10948885|FG003|NOT COMPLETED|Overall Study||22
9837578|NCT00802412|10948899|FG000|STARTED|Overall Study||65
9837579|NCT00802412|10948900|FG001|STARTED|Overall Study||67
9837580|NCT00802412|10948899|FG000|COMPLETED|Overall Study||63
9837581|NCT00802412|10948900|FG001|COMPLETED|Overall Study||66
9837582|NCT00802412|10948899|FG000|NOT COMPLETED|Overall Study||2
9837583|NCT00802412|10948900|FG001|NOT COMPLETED|Overall Study||1
9837584|NCT00802438|10948906|FG000|STARTED|Overall Study||38
9837585|NCT00802438|10948906|FG000|COMPLETED|Overall Study||10
9837586|NCT00802438|10948906|FG000|NOT COMPLETED|Overall Study||28
9837587|NCT00802464|10948914|FG000|STARTED|Month 0 - Month 8||38
9837588|NCT00802464|10948915|FG001|STARTED|Month 0 - Month 8||73
9837589|NCT00802464|10948916|FG002|STARTED|Month 0 - Month 8||149
9837590|NCT00802464|10948917|FG003|STARTED|Month 0 - Month 8||150
9837591|NCT00802464|10948914|FG000|COMPLETED|Month 0 - Month 8||38
9837592|NCT00802464|10948915|FG001|COMPLETED|Month 0 - Month 8||70
9837593|NCT00802464|10948916|FG002|COMPLETED|Month 0 - Month 8||142
9837594|NCT00802464|10948917|FG003|COMPLETED|Month 0 - Month 8||141
9837595|NCT00802464|10948914|FG000|NOT COMPLETED|Month 0 - Month 8||0
9837596|NCT00802464|10948915|FG001|NOT COMPLETED|Month 0 - Month 8||3
9837597|NCT00802464|10948916|FG002|NOT COMPLETED|Month 0 - Month 8||7
9837598|NCT00802464|10948917|FG003|NOT COMPLETED|Month 0 - Month 8||9
9958743|NCT01458366|11078153|FG003|COMPLETED|Period 3: 90mg/m^2||0
9837599|NCT00802464|10948914|FG000|STARTED|Month 8 - Month 14||34
9837600|NCT00802464|10948915|FG001|STARTED|Month 8 - Month 14||65
9837601|NCT00802464|10948916|FG002|STARTED|Month 8 - Month 14||130
9837602|NCT00802464|10948917|FG003|STARTED|Month 8 - Month 14||126
9837603|NCT00802464|10948914|FG000|COMPLETED|Month 8 - Month 14||33
9837604|NCT00802464|10948915|FG001|COMPLETED|Month 8 - Month 14||63
9837605|NCT00802464|10948916|FG002|COMPLETED|Month 8 - Month 14||129
9837606|NCT00802464|10948917|FG003|COMPLETED|Month 8 - Month 14||126
9837607|NCT00802464|10948914|FG000|NOT COMPLETED|Month 8 - Month 14||1
9837608|NCT00802464|10948915|FG001|NOT COMPLETED|Month 8 - Month 14||2
9837609|NCT00802464|10948916|FG002|NOT COMPLETED|Month 8 - Month 14||1
9958744|NCT01458366|11078154|FG004|COMPLETED|Period 3: 90mg/m^2||0
9837610|NCT00802464|10948917|FG003|NOT COMPLETED|Month 8 - Month 14||0
9837611|NCT00802503|10948931|FG000|STARTED|Overall Study||152
9837612|NCT00802503|10948932|FG001|STARTED|Overall Study||153
9837613|NCT00802503|10948931|FG000|COMPLETED|Overall Study||142
9837614|NCT00802503|10948932|FG001|COMPLETED|Overall Study||133
9837615|NCT00802503|10948931|FG000|NOT COMPLETED|Overall Study||10
9837616|NCT00802503|10948932|FG001|NOT COMPLETED|Overall Study||20
9837617|NCT00802529|10948944|FG000|STARTED|Overall Study||30
9837618|NCT00802529|10948945|FG001|STARTED|Overall Study||30
9837619|NCT00802529|10948944|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
9837620|NCT00802529|10948945|FG001|COMPLETED|Overall Study||29
9837621|NCT00802529|10948944|FG000|NOT COMPLETED|Overall Study||0
9837622|NCT00802529|10948945|FG001|NOT COMPLETED|Overall Study||1
9837623|NCT00802633|10948953|FG000|STARTED|Overall Study||40
9837624|NCT00802633|10948954|FG001|STARTED|Overall Study||40
9837625|NCT00802633|10948953|FG000|COMPLETED|Overall Study||40
9837626|NCT00802633|10948954|FG001|COMPLETED|Overall Study||40
9837627|NCT00802633|10948953|FG000|NOT COMPLETED|Overall Study||0
9837628|NCT00802633|10948954|FG001|NOT COMPLETED|Overall Study||0
9837629|NCT00802672|10948963|FG000|STARTED|Overall Study||224
9837630|NCT00802672|10948964|FG001|STARTED|Overall Study||226
9837631|NCT00802672|10948965|FG002|STARTED|Overall Study||111
9837632|NCT00802672|10948963|FG000|COMPLETED|Overall Study||156
9837633|NCT00802672|10948964|FG001|COMPLETED|Overall Study||174
9837634|NCT00802672|10948965|FG002|COMPLETED|Overall Study||77
9837635|NCT00802672|10948963|FG000|NOT COMPLETED|Overall Study||68
9837636|NCT00802672|10948964|FG001|NOT COMPLETED|Overall Study||52
9837637|NCT00802672|10948965|FG002|NOT COMPLETED|Overall Study||34
9837638|NCT00802685|10948975|FG000|STARTED|Overall Study||54
9837639|NCT00802685|10948976|FG001|STARTED|Overall Study||51
9837640|NCT00802685|10948975|FG000|COMPLETED|Overall Study||54
9837641|NCT00802685|10948976|FG001|COMPLETED|Overall Study||51
9837642|NCT00802685|10948975|FG000|NOT COMPLETED|Overall Study||0
9837643|NCT00802685|10948976|FG001|NOT COMPLETED|Overall Study||0
9837644|NCT00802737|10948985|FG000|STARTED|Overall Study||17
9837645|NCT00802737|10948986|FG001|STARTED|Overall Study||11
9837646|NCT00802737|10948987|FG002|STARTED|Overall Study||1
9837647|NCT00802737|10948985|FG000|COMPLETED|Overall Study||0
9837648|NCT00802737|10948986|FG001|COMPLETED|Overall Study||0
9837649|NCT00802737|10948987|FG002|COMPLETED|Overall Study||0
9837650|NCT00802737|10948985|FG000|NOT COMPLETED|Overall Study||17
9837651|NCT00802737|10948986|FG001|NOT COMPLETED|Overall Study||11
9837652|NCT00802737|10948987|FG002|NOT COMPLETED|Overall Study||1
9837653|NCT00802841|10948998|FG000|STARTED|Overall Study||96
9837654|NCT00802841|10948999|FG001|STARTED|Overall Study||95
9837655|NCT00802841|10948998|FG000|Full Analysis Set|Overall Study||96
9837656|NCT00802841|10948999|FG001|Full Analysis Set|Overall Study||95
9837657|NCT00802841|10948998|FG000|Safety Set|Overall Study||96
9837658|NCT00802841|10948999|FG001|Safety Set|Overall Study||93
9837659|NCT00802841|10948998|FG000|Cross-over Set|Overall Study||13
9837660|NCT00802841|10948999|FG001|Cross-over Set|Overall Study||56
9837661|NCT00802841|10948998|FG000|COMPLETED|Overall Study||0
9837662|NCT00802841|10948999|FG001|COMPLETED|Overall Study||0
9837663|NCT00802841|10948998|FG000|NOT COMPLETED|Overall Study||96
9837664|NCT00802841|10948999|FG001|NOT COMPLETED|Overall Study||95
9837665|NCT00802854|10949007|FG000|STARTED|Overall Study||244
9837666|NCT00802854|10949007|FG000|COMPLETED|Overall Study||244
9837667|NCT00802854|10949007|FG000|NOT COMPLETED|Overall Study||0
9837668|NCT00802867|10949011|FG000|STARTED|Overall Study||989
9837669|NCT00802867|10949011|FG000|COMPLETED|Overall Study||976
9837670|NCT00802867|10949011|FG000|NOT COMPLETED|Overall Study||13
9837671|NCT00802880|10949015|FG000|STARTED|Overall Study||80
9837672|NCT00802880|10949015|FG000|COMPLETED|Overall Study||80
9837673|NCT00802880|10949015|FG000|NOT COMPLETED|Overall Study||0
9837674|NCT00802919|10949025|FG000|STARTED|Overall Study||45
9837675|NCT00802919|10949026|FG001|STARTED|Overall Study||46
9837676|NCT00802919|10949025|FG000|COMPLETED|Overall Study||42
9837677|NCT00802919|10949026|FG001|COMPLETED|Overall Study||45
9837678|NCT00802919|10949025|FG000|NOT COMPLETED|Overall Study||3
9837679|NCT00802919|10949026|FG001|NOT COMPLETED|Overall Study||1
9837680|NCT00802945|10949035|FG000|STARTED|Overall Study||35
10021579|NCT01844830|11145029|FG001|NOT COMPLETED|Overall Study||0
10021580|NCT01844895|11145035|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
9837681|NCT00802945|10949036|FG001|STARTED|Overall Study||35
9837682|NCT00802945|10949035|FG000|COMPLETED|Overall Study||0
9837683|NCT00802945|10949036|FG001|COMPLETED|Overall Study||0
9837684|NCT00802945|10949035|FG000|NOT COMPLETED|Overall Study||35
9837685|NCT00802945|10949036|FG001|NOT COMPLETED|Overall Study||35
9837686|NCT00802997|10949046|FG000|STARTED|Baseline to 3 Months||34
9837687|NCT00802997|10949047|FG001|STARTED|Baseline to 3 Months||17
9837688|NCT00802997|10949046|FG000|COMPLETED|Baseline to 3 Months||34
9837689|NCT00802997|10949047|FG001|COMPLETED|Baseline to 3 Months||17
9837690|NCT00802997|10949046|FG000|NOT COMPLETED|Baseline to 3 Months||0
9837691|NCT00802997|10949047|FG001|NOT COMPLETED|Baseline to 3 Months||0
9837692|NCT00802997|10949046|FG000|STARTED|3 Months to 6 Months||34
9837693|NCT00802997|10949047|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
9837694|NCT00802997|10949046|FG000|COMPLETED|3 Months to 6 Months||27
9837695|NCT00802997|10949047|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
9837696|NCT00802997|10949046|FG000|NOT COMPLETED|3 Months to 6 Months||7
9837697|NCT00802997|10949047|FG001|NOT COMPLETED|3 Months to 6 Months||0
9837698|NCT00802997|10949046|FG000|STARTED|6 Month to 9 Months||27
9837699|NCT00802997|10949047|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
9837700|NCT00802997|10949046|FG000|COMPLETED|6 Month to 9 Months||25
9837701|NCT00802997|10949047|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
9837702|NCT00802997|10949046|FG000|NOT COMPLETED|6 Month to 9 Months||2
9837703|NCT00802997|10949047|FG001|NOT COMPLETED|6 Month to 9 Months||0
9837704|NCT00803010|10949055|FG000|STARTED|Overall Study||37
9837705|NCT00803010|10949056|FG001|STARTED|Overall Study||37
9837706|NCT00803010|10949055|FG000|COMPLETED|Overall Study||37
9837707|NCT00803010|10949056|FG001|COMPLETED|Overall Study||37
9837708|NCT00803010|10949055|FG000|NOT COMPLETED|Overall Study||0
9837709|NCT00803010|10949056|FG001|NOT COMPLETED|Overall Study||0
9837710|NCT00803023|10949066|FG000|STARTED|Overall Study||32
10021581|NCT01844895|11145035|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
10021582|NCT01844895|11145035|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
10021583|NCT01844895|11145035|FG000|STARTED|Day 29 - Day113 - Autoinjector||117
10021584|NCT01844895|11145035|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111
10021585|NCT01844895|11145035|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
10021586|NCT01845025|11145050|FG000|STARTED|Overall Study||411
10021587|NCT01845025|11145051|FG001|STARTED|Overall Study||409
9837711|NCT00803023|10949067|FG001|STARTED|Overall Study||33
9837712|NCT00803023|10949068|FG002|STARTED|Overall Study||31
9837713|NCT00803023|10949069|FG003|STARTED|Overall Study||33
9837714|NCT00803023|10949066|FG000|COMPLETED|Overall Study||27
9837715|NCT00803023|10949067|FG001|COMPLETED|Overall Study||25
9837716|NCT00803023|10949068|FG002|COMPLETED|Overall Study||20
9837717|NCT00803023|10949069|FG003|COMPLETED|Overall Study||25
9837718|NCT00803023|10949066|FG000|NOT COMPLETED|Overall Study||5
9837719|NCT00803023|10949067|FG001|NOT COMPLETED|Overall Study||8
9837720|NCT00803023|10949068|FG002|NOT COMPLETED|Overall Study||11
9837721|NCT00803023|10949069|FG003|NOT COMPLETED|Overall Study||8
9837722|NCT00803049|10949083|FG000|STARTED|Overall Study|Randomized in extension study|129
9837723|NCT00803049|10949084|FG001|STARTED|Overall Study|Randomized in extension study|252
9837724|NCT00803049|10949085|FG002|STARTED|Overall Study|Randomized in extension study|108
9837725|NCT00803049|10949086|FG003|STARTED|Overall Study|Randomized in extension study|253
9837726|NCT00803049|10949083|FG000|Treated|Overall Study||129
9837727|NCT00803049|10949084|FG001|Treated|Overall Study||252
9837728|NCT00803049|10949085|FG002|Treated|Overall Study||108
9837729|NCT00803049|10949086|FG003|Treated|Overall Study||251
9837730|NCT00803049|10949083|FG000|Safety Population|Overall Study||129
9837731|NCT00803049|10949084|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
9837732|NCT00803049|10949085|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
9837733|NCT00803049|10949086|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
9837734|NCT00803049|10949083|FG000|COMPLETED|Overall Study||68
9837735|NCT00803049|10949084|FG001|COMPLETED|Overall Study||134
9837736|NCT00803049|10949085|FG002|COMPLETED|Overall Study||64
9837737|NCT00803049|10949086|FG003|COMPLETED|Overall Study||151
9837738|NCT00803049|10949083|FG000|NOT COMPLETED|Overall Study||61
9837739|NCT00803049|10949084|FG001|NOT COMPLETED|Overall Study||118
9837740|NCT00803049|10949085|FG002|NOT COMPLETED|Overall Study||44
9837741|NCT00803049|10949086|FG003|NOT COMPLETED|Overall Study||102
9837742|NCT00803062|10949100|FG000|STARTED|Overall Study||114
9837743|NCT00803062|10949101|FG001|STARTED|Overall Study||115
9837744|NCT00803062|10949102|FG002|STARTED|Overall Study||111
9837745|NCT00803062|10949103|FG003|STARTED|Overall Study||112
9837746|NCT00803062|10949100|FG000|COMPLETED|Overall Study||114
9837747|NCT00803062|10949101|FG001|COMPLETED|Overall Study||115
9837748|NCT00803062|10949102|FG002|COMPLETED|Overall Study||111
9837749|NCT00803062|10949103|FG003|COMPLETED|Overall Study||112
9837750|NCT00803062|10949100|FG000|NOT COMPLETED|Overall Study||0
9837751|NCT00803062|10949101|FG001|NOT COMPLETED|Overall Study||0
9837752|NCT00803062|10949102|FG002|NOT COMPLETED|Overall Study||0
9837753|NCT00803062|10949103|FG003|NOT COMPLETED|Overall Study||0
9837754|NCT00803101|10949115|FG000|STARTED|Overall Study||88
9837755|NCT00803101|10949116|FG001|STARTED|Overall Study||88
9837756|NCT00803101|10949115|FG000|COMPLETED|Overall Study||70
9837757|NCT00803101|10949116|FG001|COMPLETED|Overall Study||66
9958745|NCT01458366|11078150|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0
9958746|NCT01458366|11078151|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0
9958747|NCT01458366|11078152|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0
9958748|NCT01458366|11078153|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0
9958749|NCT01458366|11078154|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0
9958750|NCT01458366|11078150|FG000|STARTED|Period 4: 120mg/m^2||0
9958751|NCT01458366|11078151|FG001|STARTED|Period 4: 120mg/m^2||0
9958752|NCT01458366|11078152|FG002|STARTED|Period 4: 120mg/m^2||0
9958753|NCT01458366|11078153|FG003|STARTED|Period 4: 120mg/m^2||3
9958754|NCT01458366|11078154|FG004|STARTED|Period 4: 120mg/m^2||0
9958755|NCT01458366|11078150|FG000|COMPLETED|Period 4: 120mg/m^2||0
9958756|NCT01458366|11078151|FG001|COMPLETED|Period 4: 120mg/m^2||0
9958757|NCT01458366|11078152|FG002|COMPLETED|Period 4: 120mg/m^2||0
9958758|NCT01458366|11078153|FG003|COMPLETED|Period 4: 120mg/m^2||3
9958759|NCT01458366|11078154|FG004|COMPLETED|Period 4: 120mg/m^2||0
9958760|NCT01458366|11078150|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0
9958761|NCT01458366|11078151|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0
9958762|NCT01458366|11078152|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0
9958763|NCT01458366|11078153|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0
9958764|NCT01458366|11078154|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0
9958765|NCT01458366|11078150|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
9720030|NCT00048048|10819466|FG005|COMPLETED|Core Treatment||9
9720031|NCT00048048|10819467|FG006|COMPLETED|Core Treatment||6
9720032|NCT00048048|10819468|FG007|COMPLETED|Core Treatment||5
9720033|NCT00048048|10819469|FG008|COMPLETED|Core Treatment||10
9720034|NCT00048048|10819470|FG009|COMPLETED|Core Treatment||0
9720035|NCT00048048|10819471|FG010|COMPLETED|Core Treatment||0
9720036|NCT00048048|10819472|FG011|COMPLETED|Core Treatment||0
9720037|NCT00048048|10819461|FG000|NOT COMPLETED|Core Treatment||0
9720038|NCT00048048|10819462|FG001|NOT COMPLETED|Core Treatment||0
9720039|NCT00048048|10819463|FG002|NOT COMPLETED|Core Treatment||1
9720040|NCT00048048|10819464|FG003|NOT COMPLETED|Core Treatment||0
9720041|NCT00048048|10819465|FG004|NOT COMPLETED|Core Treatment||0
9720042|NCT00048048|10819466|FG005|NOT COMPLETED|Core Treatment||0
9720043|NCT00048048|10819467|FG006|NOT COMPLETED|Core Treatment||0
9720044|NCT00048048|10819468|FG007|NOT COMPLETED|Core Treatment||1
9720045|NCT00048048|10819469|FG008|NOT COMPLETED|Core Treatment||0
9720046|NCT00048048|10819470|FG009|NOT COMPLETED|Core Treatment||0
9720047|NCT00048048|10819471|FG010|NOT COMPLETED|Core Treatment||0
9720048|NCT00048048|10819472|FG011|NOT COMPLETED|Core Treatment||0
9720049|NCT00048048|10819461|FG000|STARTED|Extension Year 1||0
9720050|NCT00048048|10819462|FG001|STARTED|Extension Year 1||0
9720051|NCT00048048|10819463|FG002|STARTED|Extension Year 1||0
9720052|NCT00048048|10819464|FG003|STARTED|Extension Year 1||0
9720053|NCT00048048|10819465|FG004|STARTED|Extension Year 1||0
9720054|NCT00048048|10819466|FG005|STARTED|Extension Year 1||0
9720055|NCT00048048|10819467|FG006|STARTED|Extension Year 1||0
9720056|NCT00048048|10819468|FG007|STARTED|Extension Year 1||0
9720057|NCT00048048|10819469|FG008|STARTED|Extension Year 1||0
9720058|NCT00048048|10819470|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
10021588|NCT01845025|11145050|FG000|COMPLETED|Overall Study||326
10021589|NCT01845025|11145051|FG001|COMPLETED|Overall Study||332
10021590|NCT01845025|11145050|FG000|NOT COMPLETED|Overall Study||85
10021591|NCT01845025|11145051|FG001|NOT COMPLETED|Overall Study||77
10021592|NCT01845077|11145060|FG000|STARTED|Treatment Period 1||12
10021593|NCT01845077|11145061|FG001|STARTED|Treatment Period 1||12
9720059|NCT00048048|10819471|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
9720060|NCT00048048|10819472|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
9720061|NCT00048048|10819461|FG000|COMPLETED|Extension Year 1||0
9720062|NCT00048048|10819462|FG001|COMPLETED|Extension Year 1||0
9720063|NCT00048048|10819463|FG002|COMPLETED|Extension Year 1||0
9720064|NCT00048048|10819464|FG003|COMPLETED|Extension Year 1||0
9720065|NCT00048048|10819465|FG004|COMPLETED|Extension Year 1||0
9720066|NCT00048048|10819466|FG005|COMPLETED|Extension Year 1||0
9720067|NCT00048048|10819467|FG006|COMPLETED|Extension Year 1||0
9720068|NCT00048048|10819468|FG007|COMPLETED|Extension Year 1||0
9720069|NCT00048048|10819469|FG008|COMPLETED|Extension Year 1||0
9720070|NCT00048048|10819470|FG009|COMPLETED|Extension Year 1||14
9720071|NCT00048048|10819471|FG010|COMPLETED|Extension Year 1||14
9720072|NCT00048048|10819472|FG011|COMPLETED|Extension Year 1||15
9720073|NCT00048048|10819461|FG000|NOT COMPLETED|Extension Year 1||0
9720074|NCT00048048|10819462|FG001|NOT COMPLETED|Extension Year 1||0
9720075|NCT00048048|10819463|FG002|NOT COMPLETED|Extension Year 1||0
9720076|NCT00048048|10819464|FG003|NOT COMPLETED|Extension Year 1||0
9720077|NCT00048048|10819465|FG004|NOT COMPLETED|Extension Year 1||0
9720078|NCT00048048|10819466|FG005|NOT COMPLETED|Extension Year 1||0
9720079|NCT00048048|10819467|FG006|NOT COMPLETED|Extension Year 1||0
9720080|NCT00048048|10819468|FG007|NOT COMPLETED|Extension Year 1||0
9720081|NCT00048048|10819469|FG008|NOT COMPLETED|Extension Year 1||0
9720082|NCT00048048|10819470|FG009|NOT COMPLETED|Extension Year 1||2
9720083|NCT00048048|10819471|FG010|NOT COMPLETED|Extension Year 1||2
9720084|NCT00048048|10819472|FG011|NOT COMPLETED|Extension Year 1||4
9720085|NCT00048048|10819461|FG000|STARTED|Extension Year 2||0
9720086|NCT00048048|10819462|FG001|STARTED|Extension Year 2||0
9720087|NCT00048048|10819463|FG002|STARTED|Extension Year 2||0
9720088|NCT00048048|10819464|FG003|STARTED|Extension Year 2||0
9720089|NCT00048048|10819465|FG004|STARTED|Extension Year 2||0
9720090|NCT00048048|10819466|FG005|STARTED|Extension Year 2||0
9720091|NCT00048048|10819467|FG006|STARTED|Extension Year 2||0
9720092|NCT00048048|10819468|FG007|STARTED|Extension Year 2||0
9720093|NCT00048048|10819469|FG008|STARTED|Extension Year 2||0
9720094|NCT00048048|10819470|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
9720095|NCT00048048|10819471|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
9720096|NCT00048048|10819472|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
9720097|NCT00048048|10819461|FG000|COMPLETED|Extension Year 2||0
9720098|NCT00048048|10819462|FG001|COMPLETED|Extension Year 2||0
9720099|NCT00048048|10819463|FG002|COMPLETED|Extension Year 2||0
9720100|NCT00048048|10819464|FG003|COMPLETED|Extension Year 2||0
9720101|NCT00048048|10819465|FG004|COMPLETED|Extension Year 2||0
9720102|NCT00048048|10819466|FG005|COMPLETED|Extension Year 2||0
9720103|NCT00048048|10819467|FG006|COMPLETED|Extension Year 2||0
9720104|NCT00048048|10819468|FG007|COMPLETED|Extension Year 2||0
9720105|NCT00048048|10819469|FG008|COMPLETED|Extension Year 2||0
9720106|NCT00048048|10819470|FG009|COMPLETED|Extension Year 2||2
9720107|NCT00048048|10819471|FG010|COMPLETED|Extension Year 2||19
10021594|NCT01845077|11145062|FG002|STARTED|Treatment Period 1||12
10021595|NCT01845077|11145063|FG003|STARTED|Treatment Period 1||12
10021596|NCT01845077|11145064|FG004|STARTED|Treatment Period 1||12
10021597|NCT01845077|11145065|FG005|STARTED|Treatment Period 1||12
10021598|NCT01845077|11145060|FG000|COMPLETED|Treatment Period 1||12
10021599|NCT01845077|11145061|FG001|COMPLETED|Treatment Period 1||12
10021600|NCT01845077|11145062|FG002|COMPLETED|Treatment Period 1||12
9837758|NCT00803101|10949115|FG000|NOT COMPLETED|Overall Study||18
9837759|NCT00803101|10949116|FG001|NOT COMPLETED|Overall Study||22
9837760|NCT00803205|10949124|FG000|STARTED|Overall Study||120
9837761|NCT00803205|10949125|FG001|STARTED|Overall Study||118
9837762|NCT00803205|10949124|FG000|Completed Week 16|Overall Study||107
9837763|NCT00803205|10949125|FG001|Completed Week 16|Overall Study||113
9837764|NCT00803205|10949124|FG000|Completed Week 24|Overall Study||103
9837765|NCT00803205|10949125|FG001|Completed Week 24|Overall Study||110
9837766|NCT00803205|10949124|FG000|As-Treated Population*|Overall Study||120
9837767|NCT00803205|10949125|FG001|As-Treated Population*|Overall Study||118
9837768|NCT00803205|10949124|FG000|ITT Population|Overall Study||116
9837769|NCT00803205|10949125|FG001|ITT Population|Overall Study||116
9837770|NCT00803205|10949124|FG000|Per Protocol Population|Overall Study||100
9837771|NCT00803205|10949125|FG001|Per Protocol Population|Overall Study||103
9837772|NCT00803205|10949124|FG000|COMPLETED|Overall Study||100
9837773|NCT00803205|10949125|FG001|COMPLETED|Overall Study||104
9837774|NCT00803205|10949124|FG000|NOT COMPLETED|Overall Study||20
9837775|NCT00803205|10949125|FG001|NOT COMPLETED|Overall Study||14
9837776|NCT00803244|10949133|FG000|STARTED|Overall Study||188
9837777|NCT00803244|10949134|FG001|STARTED|Overall Study||193
9837778|NCT00803244|10949133|FG000|COMPLETED|Overall Study||181
9837779|NCT00803244|10949134|FG001|COMPLETED|Overall Study||178
9837780|NCT00803244|10949133|FG000|NOT COMPLETED|Overall Study||7
9837781|NCT00803244|10949134|FG001|NOT COMPLETED|Overall Study||15
9837782|NCT00803270|10949142|FG000|STARTED|Overall Study||13
9837783|NCT00803270|10949143|FG001|STARTED|Overall Study||14
9837784|NCT00803270|10949142|FG000|COMPLETED|Overall Study||12
9837785|NCT00803270|10949143|FG001|COMPLETED|Overall Study||12
9837786|NCT00803270|10949142|FG000|NOT COMPLETED|Overall Study||1
9837787|NCT00803270|10949143|FG001|NOT COMPLETED|Overall Study||2
9837788|NCT00803361|10949151|FG000|STARTED|Overall Study||108
9837789|NCT00803361|10949152|FG001|STARTED|Overall Study||102
9837790|NCT00803361|10949151|FG000|COMPLETED|Overall Study||82
9837791|NCT00803361|10949152|FG001|COMPLETED|Overall Study||74
9837792|NCT00803361|10949151|FG000|NOT COMPLETED|Overall Study||26
9837793|NCT00803361|10949152|FG001|NOT COMPLETED|Overall Study||28
9837794|NCT00803400|10949160|FG000|STARTED|Overall Study||75
9837795|NCT00803400|10949161|FG001|STARTED|Overall Study||75
9837796|NCT00803400|10949160|FG000|COMPLETED|Overall Study||55
9837797|NCT00803400|10949161|FG001|COMPLETED|Overall Study||51
9837798|NCT00803400|10949160|FG000|NOT COMPLETED|Overall Study||20
9837799|NCT00803400|10949161|FG001|NOT COMPLETED|Overall Study||24
9837800|NCT00803452|10949170|FG000|STARTED|Overall Study||9
9837801|NCT00803452|10949171|FG001|STARTED|Overall Study||22
9837802|NCT00803452|10949170|FG000|COMPLETED|Overall Study||9
9837803|NCT00803452|10949171|FG001|COMPLETED|Overall Study||17
9837804|NCT00803452|10949170|FG000|NOT COMPLETED|Overall Study||0
9837805|NCT00803452|10949171|FG001|NOT COMPLETED|Overall Study||5
9837806|NCT00803543|10949179|FG000|STARTED|Overall Study||69
9837807|NCT00803543|10949180|FG001|STARTED|Overall Study||34
9837808|NCT00803543|10949179|FG000|COMPLETED|Overall Study||45
9720108|NCT00048048|10819472|FG011|COMPLETED|Extension Year 2||13
9720109|NCT00048048|10819461|FG000|NOT COMPLETED|Extension Year 2||0
9720110|NCT00048048|10819462|FG001|NOT COMPLETED|Extension Year 2||0
9720111|NCT00048048|10819463|FG002|NOT COMPLETED|Extension Year 2||0
9720112|NCT00048048|10819464|FG003|NOT COMPLETED|Extension Year 2||0
9720113|NCT00048048|10819465|FG004|NOT COMPLETED|Extension Year 2||0
9720114|NCT00048048|10819466|FG005|NOT COMPLETED|Extension Year 2||0
9720115|NCT00048048|10819467|FG006|NOT COMPLETED|Extension Year 2||0
9720116|NCT00048048|10819468|FG007|NOT COMPLETED|Extension Year 2||0
9720117|NCT00048048|10819469|FG008|NOT COMPLETED|Extension Year 2||0
9720118|NCT00048048|10819470|FG009|NOT COMPLETED|Extension Year 2||0
9720119|NCT00048048|10819471|FG010|NOT COMPLETED|Extension Year 2||4
9720120|NCT00048048|10819472|FG011|NOT COMPLETED|Extension Year 2||2
9720121|NCT00048061|10819503|FG000|STARTED|Overall Study||400
9720122|NCT00048061|10819504|FG001|STARTED|Overall Study||401
9720123|NCT00048061|10819505|FG002|STARTED|Overall Study||400
9720124|NCT00048061|10819506|FG003|STARTED|Overall Study||401
9720125|NCT00048061|10819503|FG000|COMPLETED|Overall Study||325
9720126|NCT00048061|10819504|FG001|COMPLETED|Overall Study||328
9720127|NCT00048061|10819505|FG002|COMPLETED|Overall Study||316
9720128|NCT00048061|10819506|FG003|COMPLETED|Overall Study||322
9720129|NCT00048061|10819503|FG000|NOT COMPLETED|Overall Study||75
9720130|NCT00048061|10819504|FG001|NOT COMPLETED|Overall Study||73
9720131|NCT00048061|10819505|FG002|NOT COMPLETED|Overall Study||84
9720132|NCT00048061|10819506|FG003|NOT COMPLETED|Overall Study||79
9720133|NCT00048074|10819519|FG000|STARTED|Overall Study||465
9720134|NCT00048074|10819520|FG001|STARTED|Overall Study||448
9720135|NCT00048074|10819521|FG002|STARTED|Overall Study||469
9720136|NCT00048074|10819519|FG000|COMPLETED|Overall Study||384
9720137|NCT00048074|10819520|FG001|COMPLETED|Overall Study||361
9720138|NCT00048074|10819521|FG002|COMPLETED|Overall Study||372
9720139|NCT00048074|10819519|FG000|NOT COMPLETED|Overall Study||81
9720140|NCT00048074|10819520|FG001|NOT COMPLETED|Overall Study||87
9720141|NCT00048074|10819521|FG002|NOT COMPLETED|Overall Study||97
9720142|NCT00048165|10819531|FG000|STARTED|Completed 6 Months Study||216
9720143|NCT00048165|10819532|FG001|STARTED|Completed 6 Months Study||218
9720144|NCT00048165|10819531|FG000|COMPLETED|Completed 6 Months Study||165
9720145|NCT00048165|10819532|FG001|COMPLETED|Completed 6 Months Study||170
9720146|NCT00048165|10819531|FG000|NOT COMPLETED|Completed 6 Months Study||51
9720147|NCT00048165|10819532|FG001|NOT COMPLETED|Completed 6 Months Study||48
9720148|NCT00048165|10819531|FG000|STARTED|Completed 12 Months Study||165
9720149|NCT00048165|10819532|FG001|STARTED|Completed 12 Months Study||170
9720150|NCT00048165|10819531|FG000|COMPLETED|Completed 12 Months Study||162
9720151|NCT00048165|10819532|FG001|COMPLETED|Completed 12 Months Study||167
9720152|NCT00048165|10819531|FG000|NOT COMPLETED|Completed 12 Months Study||3
9720153|NCT00048165|10819532|FG001|NOT COMPLETED|Completed 12 Months Study||3
9720154|NCT00048347|10819540|FG000|STARTED|Overall Study||18
9720155|NCT00048347|10819540|FG000|COMPLETED|Overall Study||16
9720156|NCT00048347|10819540|FG000|NOT COMPLETED|Overall Study||2
9720157|NCT00048542|10819548|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
9720158|NCT00048542|10819549|FG001|STARTED|Double-Blind Phase||37
9720159|NCT00048542|10819550|FG002|STARTED|Double-Blind Phase||30
9720160|NCT00048542|10819551|FG003|STARTED|Double-Blind Phase||28
9720161|NCT00048542|10819552|FG004|STARTED|Double-Blind Phase||0
9720162|NCT00048542|10819553|FG005|STARTED|Double-Blind Phase||0
9720163|NCT00048542|10819554|FG006|STARTED|Double-Blind Phase||0
9720164|NCT00048542|10819555|FG007|STARTED|Double-Blind Phase||0
9720165|NCT00048542|10819548|FG000|COMPLETED|Double-Blind Phase||35
9720166|NCT00048542|10819549|FG001|COMPLETED|Double-Blind Phase||36
9720167|NCT00048542|10819550|FG002|COMPLETED|Double-Blind Phase||29
9720168|NCT00048542|10819551|FG003|COMPLETED|Double-Blind Phase||28
9720169|NCT00048542|10819552|FG004|COMPLETED|Double-Blind Phase||0
9967708|NCT01515865|11088041|FG002|NOT COMPLETED|Part A (Open-label)||0
9720170|NCT00048542|10819553|FG005|COMPLETED|Double-Blind Phase||0
9720171|NCT00048542|10819554|FG006|COMPLETED|Double-Blind Phase||0
9720172|NCT00048542|10819555|FG007|COMPLETED|Double-Blind Phase||0
9720173|NCT00048542|10819548|FG000|NOT COMPLETED|Double-Blind Phase||3
9720174|NCT00048542|10819549|FG001|NOT COMPLETED|Double-Blind Phase||1
9720175|NCT00048542|10819550|FG002|NOT COMPLETED|Double-Blind Phase||1
9720176|NCT00048542|10819551|FG003|NOT COMPLETED|Double-Blind Phase||0
9720177|NCT00048542|10819552|FG004|NOT COMPLETED|Double-Blind Phase||0
9720178|NCT00048542|10819553|FG005|NOT COMPLETED|Double-Blind Phase||0
9720179|NCT00048542|10819554|FG006|NOT COMPLETED|Double-Blind Phase||0
9720180|NCT00048542|10819555|FG007|NOT COMPLETED|Double-Blind Phase||0
9720181|NCT00048542|10819548|FG000|STARTED|Open-Label Extension BSA Phase||0
9720182|NCT00048542|10819549|FG001|STARTED|Open-Label Extension BSA Phase||0
9837809|NCT00803543|10949180|FG001|COMPLETED|Overall Study||22
9837810|NCT00803543|10949179|FG000|NOT COMPLETED|Overall Study||24
9837811|NCT00803543|10949180|FG001|NOT COMPLETED|Overall Study||12
9837812|NCT00803569|10949186|FG000|STARTED|Overall Study||13
9837813|NCT00803569|10949186|FG000|COMPLETED|Overall Study||9
9837814|NCT00803569|10949186|FG000|NOT COMPLETED|Overall Study||4
9837815|NCT00803595|10949193|FG000|STARTED|Overall Study||337
9837816|NCT00803595|10949194|FG001|STARTED|Overall Study||327
9837817|NCT00803595|10949195|FG002|STARTED|Overall Study||338
9837818|NCT00803595|10949193|FG000|COMPLETED|Overall Study||322
9837819|NCT00803595|10949194|FG001|COMPLETED|Overall Study||319
9837820|NCT00803595|10949195|FG002|COMPLETED|Overall Study||322
9837821|NCT00803595|10949193|FG000|NOT COMPLETED|Overall Study||15
9837822|NCT00803595|10949194|FG001|NOT COMPLETED|Overall Study||8
9837823|NCT00803595|10949195|FG002|NOT COMPLETED|Overall Study||16
9837824|NCT00803634|10949205|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
9837825|NCT00803634|10949206|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
9837826|NCT00803634|10949205|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
9837827|NCT00803634|10949206|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
9837828|NCT00803634|10949205|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
9837829|NCT00803634|10949206|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
9837830|NCT00803634|10949205|FG000|NOT COMPLETED|Overall Study||6
9837831|NCT00803634|10949206|FG001|NOT COMPLETED|Overall Study||5
9837832|NCT00803647|10949213|FG000|STARTED|Overall Study||20
9837833|NCT00803647|10949213|FG000|COMPLETED|Overall Study||20
9837834|NCT00803647|10949213|FG000|NOT COMPLETED|Overall Study||0
9837835|NCT00803686|10949221|FG000|STARTED|Part 1, Period 1||6
9837836|NCT00803686|10949222|FG001|STARTED|Part 1, Period 1||6
9837837|NCT00803686|10949223|FG002|STARTED|Part 1, Period 1||0
9837838|NCT00803686|10949224|FG003|STARTED|Part 1, Period 1||0
9837839|NCT00803686|10949221|FG000|COMPLETED|Part 1, Period 1||6
9837840|NCT00803686|10949222|FG001|COMPLETED|Part 1, Period 1||6
9837841|NCT00803686|10949223|FG002|COMPLETED|Part 1, Period 1||0
9837842|NCT00803686|10949224|FG003|COMPLETED|Part 1, Period 1||0
9837843|NCT00803686|10949221|FG000|NOT COMPLETED|Part 1, Period 1||0
9837844|NCT00803686|10949222|FG001|NOT COMPLETED|Part 1, Period 1||0
9720183|NCT00048542|10819550|FG002|STARTED|Open-Label Extension BSA Phase||0
9720184|NCT00048542|10819551|FG003|STARTED|Open-Label Extension BSA Phase||0
9720185|NCT00048542|10819552|FG004|STARTED|Open-Label Extension BSA Phase||71
9720186|NCT00048542|10819553|FG005|STARTED|Open-Label Extension BSA Phase||57
9720187|NCT00048542|10819554|FG006|STARTED|Open-Label Extension BSA Phase||0
9720188|NCT00048542|10819555|FG007|STARTED|Open-Label Extension BSA Phase||0
9720189|NCT00048542|10819548|FG000|COMPLETED|Open-Label Extension BSA Phase||0
9720190|NCT00048542|10819549|FG001|COMPLETED|Open-Label Extension BSA Phase||0
9720191|NCT00048542|10819550|FG002|COMPLETED|Open-Label Extension BSA Phase||0
9720192|NCT00048542|10819551|FG003|COMPLETED|Open-Label Extension BSA Phase||0
9720193|NCT00048542|10819552|FG004|COMPLETED|Open-Label Extension BSA Phase||59
9720194|NCT00048542|10819553|FG005|COMPLETED|Open-Label Extension BSA Phase||47
9720195|NCT00048542|10819554|FG006|COMPLETED|Open-Label Extension BSA Phase||0
9720196|NCT00048542|10819555|FG007|COMPLETED|Open-Label Extension BSA Phase||0
9720197|NCT00048542|10819548|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0
9720198|NCT00048542|10819549|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0
9720199|NCT00048542|10819550|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0
9720200|NCT00048542|10819551|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0
9720201|NCT00048542|10819552|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12
9720202|NCT00048542|10819553|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10
9720203|NCT00048542|10819554|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0
9720204|NCT00048542|10819555|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0
9720205|NCT00048542|10819548|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0
9720206|NCT00048542|10819549|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0
9720207|NCT00048542|10819550|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0
9720208|NCT00048542|10819551|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0
9720209|NCT00048542|10819552|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0
9720210|NCT00048542|10819553|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0
9720211|NCT00048542|10819554|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59
9720212|NCT00048542|10819555|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47
9720213|NCT00048542|10819548|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720214|NCT00048542|10819549|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720215|NCT00048542|10819550|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720216|NCT00048542|10819551|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720217|NCT00048542|10819552|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720218|NCT00048542|10819553|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720219|NCT00048542|10819554|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37
9720220|NCT00048542|10819555|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25
9720221|NCT00048542|10819548|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720222|NCT00048542|10819549|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720223|NCT00048542|10819550|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720224|NCT00048542|10819551|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720225|NCT00048542|10819552|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720226|NCT00048542|10819553|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
9720227|NCT00048542|10819554|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
9720228|NCT00048542|10819555|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
9720229|NCT00048568|10819586|FG000|STARTED|Double-Blind Period Days 1 to 169||433
9720230|NCT00048568|10819587|FG001|STARTED|Double-Blind Period Days 1 to 169||219
9720231|NCT00048568|10819588|FG002|STARTED|Double-Blind Period Days 1 to 169||0
9720232|NCT00048568|10819586|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401
9720233|NCT00048568|10819587|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174
9720234|NCT00048568|10819588|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0
9720235|NCT00048568|10819586|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
9720236|NCT00048568|10819587|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
9958766|NCT01458366|11078151|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
9958767|NCT01458366|11078152|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
9958768|NCT01458366|11078153|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
9720237|NCT00048568|10819588|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
9720238|NCT00048568|10819586|FG000|STARTED|Double-Blind Period Days 170 to 365||401
9720239|NCT00048568|10819587|FG001|STARTED|Double-Blind Period Days 170 to 365||174
9720240|NCT00048568|10819588|FG002|STARTED|Double-Blind Period Days 170 to 365||0
9720241|NCT00048568|10819586|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385
9720242|NCT00048568|10819587|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162
9720243|NCT00048568|10819588|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0
10021601|NCT01845077|11145063|FG003|COMPLETED|Treatment Period 1||12
10021602|NCT01845077|11145064|FG004|COMPLETED|Treatment Period 1||12
10021603|NCT01845077|11145065|FG005|COMPLETED|Treatment Period 1||12
10021604|NCT01845077|11145060|FG000|NOT COMPLETED|Treatment Period 1||0
10021605|NCT01845077|11145061|FG001|NOT COMPLETED|Treatment Period 1||0
10021606|NCT01845077|11145062|FG002|NOT COMPLETED|Treatment Period 1||0
10021607|NCT01845077|11145063|FG003|NOT COMPLETED|Treatment Period 1||0
9720244|NCT00048568|10819586|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
9720245|NCT00048568|10819587|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
9720246|NCT00048568|10819588|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
9720247|NCT00048568|10819586|FG000|STARTED|Open-Label Period||0
9720248|NCT00048568|10819587|FG001|STARTED|Open-Label Period||0
9720249|NCT00048568|10819588|FG002|STARTED|Open-Label Period||539
9720250|NCT00048568|10819586|FG000|COMPLETED|Open-Label Period||0
9720251|NCT00048568|10819587|FG001|COMPLETED|Open-Label Period||0
9720252|NCT00048568|10819588|FG002|COMPLETED|Open-Label Period||379
9720253|NCT00048568|10819586|FG000|NOT COMPLETED|Open-Label Period||0
9720254|NCT00048568|10819587|FG001|NOT COMPLETED|Open-Label Period||0
9720255|NCT00048568|10819588|FG002|NOT COMPLETED|Open-Label Period||160
9720256|NCT00048581|10819611|FG000|STARTED|Double-Blind Period||258
9720257|NCT00048581|10819612|FG001|STARTED|Double-Blind Period||133
9720258|NCT00048581|10819613|FG002|STARTED|Double-Blind Period||0
9720259|NCT00048581|10819611|FG000|COMPLETED|Double-Blind Period||223
9720260|NCT00048581|10819612|FG001|COMPLETED|Double-Blind Period||99
9720261|NCT00048581|10819613|FG002|COMPLETED|Double-Blind Period||0
9720262|NCT00048581|10819611|FG000|NOT COMPLETED|Double-Blind Period||35
9720263|NCT00048581|10819612|FG001|NOT COMPLETED|Double-Blind Period||34
9720264|NCT00048581|10819613|FG002|NOT COMPLETED|Double-Blind Period||0
9720265|NCT00048581|10819611|FG000|STARTED|Open-Label Period||0
9720266|NCT00048581|10819612|FG001|STARTED|Open-Label Period||0
9720267|NCT00048581|10819613|FG002|STARTED|Open-Label Period||317
9720268|NCT00048581|10819611|FG000|COMPLETED|Open-Label Period||0
9720269|NCT00048581|10819612|FG001|COMPLETED|Open-Label Period||0
9720270|NCT00048581|10819613|FG002|COMPLETED|Open-Label Period||150
9720271|NCT00048581|10819611|FG000|NOT COMPLETED|Open-Label Period||0
9720272|NCT00048581|10819612|FG001|NOT COMPLETED|Open-Label Period||0
9720273|NCT00048581|10819613|FG002|NOT COMPLETED|Open-Label Period||167
9720274|NCT00048724|10819628|FG000|STARTED|Overall Study||311
9720275|NCT00048724|10819629|FG001|STARTED|Overall Study||315
9720276|NCT00048724|10819628|FG000|COMPLETED|Overall Study||195
9720277|NCT00048724|10819629|FG001|COMPLETED|Overall Study||197
9720278|NCT00048724|10819628|FG000|NOT COMPLETED|Overall Study||116
9720279|NCT00048724|10819629|FG001|NOT COMPLETED|Overall Study||118
9720280|NCT00048737|10819635|FG000|STARTED|Overall Study||70
9720281|NCT00048737|10819635|FG000|COMPLETED|Overall Study||70
9720282|NCT00048737|10819635|FG000|NOT COMPLETED|Overall Study||0
9720283|NCT00048815|10819642|FG000|STARTED|Overall Study||24
9720284|NCT00048815|10819643|FG001|STARTED|Overall Study||26
9720285|NCT00048815|10819644|FG002|STARTED|Overall Study||23
9720286|NCT00048815|10819642|FG000|COMPLETED|Overall Study||18
9720287|NCT00048815|10819643|FG001|COMPLETED|Overall Study||22
9720288|NCT00048815|10819644|FG002|COMPLETED|Overall Study||19
9720289|NCT00048815|10819642|FG000|NOT COMPLETED|Overall Study||6
9720290|NCT00048815|10819643|FG001|NOT COMPLETED|Overall Study||4
9720291|NCT00048815|10819644|FG002|NOT COMPLETED|Overall Study||4
9720292|NCT00048893|10819652|FG000|STARTED|Overall Study||37
9720293|NCT00048893|10819652|FG000|COMPLETED|Overall Study||37
9720294|NCT00048893|10819652|FG000|NOT COMPLETED|Overall Study||0
9720295|NCT00048932|10819658|FG000|STARTED|Double Blind Period (DB)|Number Treated|959
9720296|NCT00048932|10819659|FG001|STARTED|Double Blind Period (DB)|Number Treated|482
9720297|NCT00048932|10819660|FG002|STARTED|Double Blind Period (DB)||0
9720298|NCT00048932|10819658|FG000|COMPLETED|Double Blind Period (DB)||836
9720299|NCT00048932|10819659|FG001|COMPLETED|Double Blind Period (DB)||395
9720300|NCT00048932|10819660|FG002|COMPLETED|Double Blind Period (DB)||0
9720301|NCT00048932|10819658|FG000|NOT COMPLETED|Double Blind Period (DB)||123
9720302|NCT00048932|10819659|FG001|NOT COMPLETED|Double Blind Period (DB)||87
9720303|NCT00048932|10819660|FG002|NOT COMPLETED|Double Blind Period (DB)||0
9720304|NCT00048932|10819658|FG000|STARTED|Open Label Period (OL)||0
9720305|NCT00048932|10819659|FG001|STARTED|Open Label Period (OL)||0
9720306|NCT00048932|10819660|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
9720307|NCT00048932|10819658|FG000|COMPLETED|Open Label Period (OL)||0
9720308|NCT00048932|10819659|FG001|COMPLETED|Open Label Period (OL)||0
9720309|NCT00048932|10819660|FG002|COMPLETED|Open Label Period (OL)||743
9720310|NCT00048932|10819658|FG000|NOT COMPLETED|Open Label Period (OL)||0
9720311|NCT00048932|10819659|FG001|NOT COMPLETED|Open Label Period (OL)||0
9720312|NCT00048932|10819660|FG002|NOT COMPLETED|Open Label Period (OL)||441
9731547|NCT00132769|10831411|FG001|COMPLETED|Overall Study||42
9731548|NCT00132769|10831410|FG000|NOT COMPLETED|Overall Study||11
9731549|NCT00132769|10831411|FG001|NOT COMPLETED|Overall Study||11
9731550|NCT00132808|10831420|FG000|STARTED|Stratum I||77
9731551|NCT00132808|10831421|FG001|STARTED|Stratum I||70
9731552|NCT00132808|10831422|FG002|STARTED|Stratum I||77
9731553|NCT00132808|10831420|FG000|COMPLETED|Stratum I||68
9731554|NCT00132808|10831421|FG001|COMPLETED|Stratum I||58
9731555|NCT00132808|10831422|FG002|COMPLETED|Stratum I||72
9731556|NCT00132808|10831420|FG000|NOT COMPLETED|Stratum I||9
9731557|NCT00132808|10831421|FG001|NOT COMPLETED|Stratum I||12
9731558|NCT00132808|10831422|FG002|NOT COMPLETED|Stratum I||5
9731559|NCT00132808|10831420|FG000|STARTED|Stratum II||121
9731560|NCT00132808|10831421|FG001|STARTED|Stratum II||111
9731561|NCT00132808|10831422|FG002|STARTED|Stratum II||125
9731562|NCT00132808|10831420|FG000|COMPLETED|Stratum II||113
9837845|NCT00803686|10949223|FG002|NOT COMPLETED|Part 1, Period 1||0
9837846|NCT00803686|10949224|FG003|NOT COMPLETED|Part 1, Period 1||0
9837847|NCT00803686|10949221|FG000|STARTED|Part 1, Period 2||6
9837848|NCT00803686|10949222|FG001|STARTED|Part 1, Period 2||6
9837849|NCT00803686|10949223|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
9837850|NCT00803686|10949224|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
9837851|NCT00803686|10949221|FG000|COMPLETED|Part 1, Period 2||6
9837852|NCT00803686|10949222|FG001|COMPLETED|Part 1, Period 2||6
9837853|NCT00803686|10949223|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0
9837854|NCT00803686|10949224|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0
9837855|NCT00803686|10949221|FG000|NOT COMPLETED|Part 1, Period 2||0
9837856|NCT00803686|10949222|FG001|NOT COMPLETED|Part 1, Period 2||0
9837857|NCT00803686|10949223|FG002|NOT COMPLETED|Part 1, Period 2||0
9837858|NCT00803686|10949224|FG003|NOT COMPLETED|Part 1, Period 2||0
9837859|NCT00803686|10949221|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0
9837860|NCT00803686|10949222|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
9837861|NCT00803686|10949223|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
9837862|NCT00803686|10949224|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
9837863|NCT00803686|10949221|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
9837864|NCT00803686|10949222|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
9837865|NCT00803686|10949223|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5
9837866|NCT00803686|10949224|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4
9837867|NCT00803686|10949221|FG000|NOT COMPLETED|Part 2, Period 3||0
9837868|NCT00803686|10949222|FG001|NOT COMPLETED|Part 2, Period 3||0
9837869|NCT00803686|10949223|FG002|NOT COMPLETED|Part 2, Period 3||0
9837870|NCT00803686|10949224|FG003|NOT COMPLETED|Part 2, Period 3||0
9837871|NCT00803712|10949238|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
9837872|NCT00803712|10949239|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155
9837873|NCT00803712|10949238|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
9837874|NCT00803712|10949239|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
9837875|NCT00803712|10949238|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
9837876|NCT00803712|10949239|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154
9837877|NCT00803712|10949238|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
9837878|NCT00803712|10949239|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
9837879|NCT00803712|10949238|FG000|NOT COMPLETED|Overall Study||36
9837880|NCT00803712|10949239|FG001|NOT COMPLETED|Overall Study||27
9837881|NCT00803738|10949247|FG000|STARTED|Overall Study||286
9837882|NCT00803738|10949248|FG001|STARTED|Overall Study||286
9837883|NCT00803738|10949247|FG000|COMPLETED|Overall Study||192
9837884|NCT00803738|10949248|FG001|COMPLETED|Overall Study||176
9837885|NCT00803738|10949247|FG000|NOT COMPLETED|Overall Study||94
9837886|NCT00803738|10949248|FG001|NOT COMPLETED|Overall Study||110
9837887|NCT00803751|10949256|FG000|STARTED|Overall Study||26
9837888|NCT00803751|10949257|FG001|STARTED|Overall Study||23
9837889|NCT00803751|10949256|FG000|COMPLETED|Overall Study||26
9837890|NCT00803751|10949257|FG001|COMPLETED|Overall Study||23
9837891|NCT00803751|10949256|FG000|NOT COMPLETED|Overall Study||0
9837892|NCT00803751|10949257|FG001|NOT COMPLETED|Overall Study||0
9837893|NCT00803777|10949263|FG000|STARTED|Overall Study||147
9837894|NCT00803777|10949263|FG000|COMPLETED|Overall Study||147
9837895|NCT00803777|10949263|FG000|NOT COMPLETED|Overall Study||0
9837896|NCT00803959|10949269|FG000|STARTED|Overall Study||315
9837897|NCT00803959|10949270|FG001|STARTED|Overall Study||315
9837898|NCT00803959|10949269|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266
9837899|NCT00803959|10949270|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272
9837900|NCT00803959|10949269|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
9837901|NCT00803959|10949270|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
9837902|NCT00803959|10949269|FG000|NOT COMPLETED|Overall Study||56
9837903|NCT00803959|10949270|FG001|NOT COMPLETED|Overall Study||51
9837904|NCT00804141|10949276|FG000|STARTED|Overall Study||1040
9837905|NCT00804141|10949276|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034
9837906|NCT00804141|10949276|FG000|COMPLETED|Overall Study||477
9837907|NCT00804141|10949276|FG000|NOT COMPLETED|Overall Study||563
9837908|NCT00804193|10949283|FG000|STARTED|Overall Study||220
9837909|NCT00804193|10949284|FG001|STARTED|Overall Study||224
9958769|NCT01458366|11078154|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
10021608|NCT01845077|11145064|FG004|NOT COMPLETED|Treatment Period 1||0
10021609|NCT01845077|11145065|FG005|NOT COMPLETED|Treatment Period 1||0
9837910|NCT00804193|10949285|FG002|STARTED|Overall Study||109
9837911|NCT00804193|10949283|FG000|COMPLETED|Overall Study||181
9837912|NCT00804193|10949284|FG001|COMPLETED|Overall Study||180
9958770|NCT01458366|11078150|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9958771|NCT01458366|11078151|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9958772|NCT01458366|11078152|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9837913|NCT00804193|10949285|FG002|COMPLETED|Overall Study||77
9837914|NCT00804193|10949283|FG000|NOT COMPLETED|Overall Study||39
9837915|NCT00804193|10949284|FG001|NOT COMPLETED|Overall Study||44
9958773|NCT01458366|11078153|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9958774|NCT01458366|11078154|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
9958775|NCT01458366|11078150|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9958776|NCT01458366|11078151|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9958777|NCT01458366|11078152|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9958778|NCT01458366|11078153|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
9958779|NCT01458366|11078154|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
9958780|NCT01458392|11078165|FG000|STARTED|Overall Study||2
9958781|NCT01458392|11078166|FG001|STARTED|Overall Study||13
9958782|NCT01458392|11078167|FG002|STARTED|Overall Study||31
9958783|NCT01458392|11078165|FG000|COMPLETED|Overall Study||0
9958784|NCT01458392|11078166|FG001|COMPLETED|Overall Study||0
9958785|NCT01458392|11078167|FG002|COMPLETED|Overall Study||0
9958786|NCT01458392|11078165|FG000|NOT COMPLETED|Overall Study||2
9720313|NCT00048997|10819671|FG000|STARTED|Overall Study||176
9720314|NCT00048997|10819672|FG001|STARTED|Overall Study||180
9720315|NCT00048997|10819671|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
9720316|NCT00048997|10819672|FG001|COMPLETED|Overall Study||177
9720317|NCT00048997|10819671|FG000|NOT COMPLETED|Overall Study||13
9720318|NCT00048997|10819672|FG001|NOT COMPLETED|Overall Study||3
9720319|NCT00049036|10819679|FG000|STARTED|Overall Study||51
9720320|NCT00049036|10819680|FG001|STARTED|Overall Study||55
9720321|NCT00049036|10819679|FG000|COMPLETED|Overall Study||51
9720322|NCT00049036|10819680|FG001|COMPLETED|Overall Study||55
9720323|NCT00049036|10819679|FG000|NOT COMPLETED|Overall Study||0
9720324|NCT00049036|10819680|FG001|NOT COMPLETED|Overall Study||0
9720325|NCT00049127|10819691|FG000|STARTED|Overall Study||12
9720326|NCT00049127|10819692|FG001|STARTED|Overall Study||0
9720327|NCT00049127|10819693|FG002|STARTED|Overall Study||40
9720328|NCT00049127|10819694|FG003|STARTED|Overall Study||0
9720329|NCT00049127|10819695|FG004|STARTED|Overall Study||12
9720330|NCT00049127|10819691|FG000|COMPLETED|Overall Study||12
9720331|NCT00049127|10819692|FG001|COMPLETED|Overall Study||0
9720332|NCT00049127|10819693|FG002|COMPLETED|Overall Study||39
9720333|NCT00049127|10819694|FG003|COMPLETED|Overall Study||0
9720334|NCT00049127|10819695|FG004|COMPLETED|Overall Study||12
9720335|NCT00049127|10819691|FG000|NOT COMPLETED|Overall Study||0
9720336|NCT00049127|10819692|FG001|NOT COMPLETED|Overall Study||0
9720337|NCT00049127|10819693|FG002|NOT COMPLETED|Overall Study||1
9720338|NCT00049127|10819694|FG003|NOT COMPLETED|Overall Study||0
9720339|NCT00049127|10819695|FG004|NOT COMPLETED|Overall Study||0
9720340|NCT00049257|10819707|FG000|STARTED|Carboplatin, Paclitaxel||58
9720341|NCT00049257|10819707|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
9720342|NCT00049257|10819707|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13
9720343|NCT00049257|10819707|FG000|STARTED|Follow-up Period for Survival Status||45
9720344|NCT00049257|10819707|FG000|COMPLETED|Follow-up Period for Survival Status||41
9720345|NCT00049257|10819707|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4
9720346|NCT00049322|10819713|FG000|STARTED|Overall Study||15
10021610|NCT01845077|11145060|FG000|STARTED|Washout Period||12
10021611|NCT01845077|11145061|FG001|STARTED|Washout Period||12
9720347|NCT00049322|10819714|FG001|STARTED|Overall Study||15
9720348|NCT00049322|10819713|FG000|COMPLETED|Overall Study||14
9720349|NCT00049322|10819714|FG001|COMPLETED|Overall Study||9
9720350|NCT00049322|10819713|FG000|NOT COMPLETED|Overall Study||1
9720351|NCT00049322|10819714|FG001|NOT COMPLETED|Overall Study||6
9720352|NCT00049504|10819722|FG000|STARTED|Overall Study||55
9720353|NCT00049504|10819722|FG000|COMPLETED|Overall Study||55
9720354|NCT00049504|10819722|FG000|NOT COMPLETED|Overall Study||0
10021612|NCT01845077|11145062|FG002|STARTED|Washout Period||12
10021613|NCT01845077|11145063|FG003|STARTED|Washout Period||12
9720355|NCT00049517|10819728|FG000|STARTED|Induction||79
9720356|NCT00049517|10819729|FG001|STARTED|Induction||90
9720357|NCT00049517|10819730|FG002|STARTED|Induction||63
9720358|NCT00049517|10819731|FG003|STARTED|Induction||75
9720359|NCT00049517|10819732|FG004|STARTED|Induction||188
9720360|NCT00049517|10819733|FG005|STARTED|Induction||162
9720361|NCT00049517|10819728|FG000|Treated|Induction||79
9720362|NCT00049517|10819729|FG001|Treated|Induction||90
9720363|NCT00049517|10819730|FG002|Treated|Induction||63
9720364|NCT00049517|10819731|FG003|Treated|Induction||75
9720365|NCT00049517|10819732|FG004|Treated|Induction||186
9720366|NCT00049517|10819733|FG005|Treated|Induction||160
9837916|NCT00804193|10949285|FG002|NOT COMPLETED|Overall Study||32
9837917|NCT00804570|10949295|FG000|STARTED|Overall Study||187
9837918|NCT00804570|10949296|FG001|STARTED|Overall Study||188
9837919|NCT00804570|10949295|FG000|COMPLETED|Overall Study||115
9837920|NCT00804570|10949296|FG001|COMPLETED|Overall Study||94
9837921|NCT00804570|10949295|FG000|NOT COMPLETED|Overall Study||72
9837922|NCT00804570|10949296|FG001|NOT COMPLETED|Overall Study||94
9837923|NCT00804596|10949303|FG000|STARTED|Overall Study||74
9837924|NCT00804596|10949303|FG000|COMPLETED|Overall Study||74
9837925|NCT00804596|10949303|FG000|NOT COMPLETED|Overall Study||0
9958787|NCT01458392|11078166|FG001|NOT COMPLETED|Overall Study||13
9958788|NCT01458392|11078167|FG002|NOT COMPLETED|Overall Study||31
9958789|NCT01458418|11078183|FG000|STARTED|Overall Study||0
9958790|NCT01458418|11078184|FG001|STARTED|Overall Study||0
9958791|NCT01458418|11078185|FG002|STARTED|Overall Study||0
9958792|NCT01458418|11078186|FG003|STARTED|Overall Study||4
9958793|NCT01458418|11078183|FG000|COMPLETED|Overall Study||0
9958794|NCT01458418|11078184|FG001|COMPLETED|Overall Study||0
9958795|NCT01458418|11078185|FG002|COMPLETED|Overall Study||0
9958796|NCT01458418|11078186|FG003|COMPLETED|Overall Study||4
9958797|NCT01458418|11078183|FG000|NOT COMPLETED|Overall Study||0
9958798|NCT01458418|11078184|FG001|NOT COMPLETED|Overall Study||0
9958799|NCT01458418|11078185|FG002|NOT COMPLETED|Overall Study||0
9958800|NCT01458418|11078186|FG003|NOT COMPLETED|Overall Study||0
9958801|NCT01458522|11078198|FG000|STARTED|Overall Study||37
9958802|NCT01458522|11078199|FG001|STARTED|Overall Study||37
9958803|NCT01458522|11078198|FG000|Received First Drug|Overall Study||35
9958804|NCT01458522|11078199|FG001|Received First Drug|Overall Study||35
9958805|NCT01458522|11078198|FG000|Crossover to Second Drug|Overall Study||15
9958806|NCT01458522|11078199|FG001|Crossover to Second Drug|Overall Study||10
9958807|NCT01458522|11078198|FG000|COMPLETED|Overall Study||34
9958808|NCT01458522|11078199|FG001|COMPLETED|Overall Study||26
9958809|NCT01458522|11078198|FG000|NOT COMPLETED|Overall Study||3
9958810|NCT01458522|11078199|FG001|NOT COMPLETED|Overall Study||11
9958811|NCT01458535|11078217|FG000|STARTED|Overall Study||10
9958812|NCT01458535|11078218|FG001|STARTED|Overall Study||10
9958813|NCT01458535|11078219|FG002|STARTED|Overall Study||10
9958814|NCT01458535|11078220|FG003|STARTED|Overall Study||10
9958815|NCT01458535|11078221|FG004|STARTED|Overall Study||10
9958816|NCT01458535|11078222|FG005|STARTED|Overall Study||11
9958817|NCT01458535|11078217|FG000|COMPLETED|Overall Study||10
9958818|NCT01458535|11078218|FG001|COMPLETED|Overall Study||8
9958819|NCT01458535|11078219|FG002|COMPLETED|Overall Study||8
9958820|NCT01458535|11078220|FG003|COMPLETED|Overall Study||6
9958821|NCT01458535|11078221|FG004|COMPLETED|Overall Study||6
9958822|NCT01458535|11078222|FG005|COMPLETED|Overall Study||7
9958823|NCT01458535|11078217|FG000|NOT COMPLETED|Overall Study||0
9958824|NCT01458535|11078218|FG001|NOT COMPLETED|Overall Study||2
9958825|NCT01458535|11078219|FG002|NOT COMPLETED|Overall Study||2
9958826|NCT01458535|11078220|FG003|NOT COMPLETED|Overall Study||4
9958827|NCT01458535|11078221|FG004|NOT COMPLETED|Overall Study||4
9958828|NCT01458535|11078222|FG005|NOT COMPLETED|Overall Study||4
9958829|NCT01458561|11078238|FG000|STARTED|Overall Study||0
9958830|NCT01458561|11078239|FG001|STARTED|Overall Study||1
9958831|NCT01458561|11078238|FG000|COMPLETED|Overall Study||0
9958832|NCT01458561|11078239|FG001|COMPLETED|Overall Study||1
9958833|NCT01458561|11078238|FG000|NOT COMPLETED|Overall Study||0
9837926|NCT00804609|10949309|FG000|STARTED|Overall Study||15
9837927|NCT00804609|10949310|FG001|STARTED|Overall Study||15
9837928|NCT00804609|10949309|FG000|COMPLETED|Overall Study||15
9837929|NCT00804609|10949310|FG001|COMPLETED|Overall Study||14
9958834|NCT01458561|11078239|FG001|NOT COMPLETED|Overall Study||0
9958835|NCT01458574|11078278|FG000|STARTED|Overall Study||198
9958836|NCT01458574|11078279|FG001|STARTED|Overall Study||197
9958837|NCT01458574|11078280|FG002|STARTED|Overall Study||198
9958838|NCT01458574|11078278|FG000|Treated|Overall Study||198
9958839|NCT01458574|11078279|FG001|Treated|Overall Study||196
9958840|NCT01458574|11078280|FG002|Treated|Overall Study||198
9958841|NCT01458574|11078278|FG000|COMPLETED|Overall Study||111
9958842|NCT01458574|11078279|FG001|COMPLETED|Overall Study||126
9958843|NCT01458574|11078280|FG002|COMPLETED|Overall Study||53
9958844|NCT01458574|11078278|FG000|NOT COMPLETED|Overall Study||87
9958845|NCT01458574|11078279|FG001|NOT COMPLETED|Overall Study||71
9958846|NCT01458574|11078280|FG002|NOT COMPLETED|Overall Study||145
9958847|NCT01458587|11078290|FG000|STARTED|Overall Study||35
9958848|NCT01458587|11078291|FG001|STARTED|Overall Study||35
9958849|NCT01458587|11078290|FG000|COMPLETED|Overall Study||34
9958850|NCT01458587|11078291|FG001|COMPLETED|Overall Study||35
9958851|NCT01458587|11078290|FG000|NOT COMPLETED|Overall Study||1
9958852|NCT01458587|11078291|FG001|NOT COMPLETED|Overall Study||0
9958853|NCT01458639|11078299|FG000|STARTED|Overall Study||18
9958854|NCT01458639|11078299|FG000|COMPLETED|Overall Study||12
9958855|NCT01458639|11078299|FG000|NOT COMPLETED|Overall Study||6
9958856|NCT01458951|11078306|FG000|STARTED|Overall Study||429
9958857|NCT01458951|11078307|FG001|STARTED|Overall Study||6
9958858|NCT01458951|11078308|FG002|STARTED|Overall Study||112
9958859|NCT01458951|11078306|FG000|COMPLETED|Overall Study||397
9958860|NCT01458951|11078307|FG001|COMPLETED|Overall Study||5
9958861|NCT01458951|11078308|FG002|COMPLETED|Overall Study||97
9958862|NCT01458951|11078306|FG000|NOT COMPLETED|Overall Study||32
9720367|NCT00049517|10819728|FG000|COMPLETED|Induction||79
9720368|NCT00049517|10819729|FG001|COMPLETED|Induction||90
9720369|NCT00049517|10819730|FG002|COMPLETED|Induction||63
9720370|NCT00049517|10819731|FG003|COMPLETED|Induction||75
9720371|NCT00049517|10819732|FG004|COMPLETED|Induction||128
9720372|NCT00049517|10819733|FG005|COMPLETED|Induction||108
9720373|NCT00049517|10819728|FG000|NOT COMPLETED|Induction||0
9720374|NCT00049517|10819729|FG001|NOT COMPLETED|Induction||0
9720375|NCT00049517|10819730|FG002|NOT COMPLETED|Induction||0
9720376|NCT00049517|10819731|FG003|NOT COMPLETED|Induction||0
9720377|NCT00049517|10819732|FG004|NOT COMPLETED|Induction||60
9720378|NCT00049517|10819733|FG005|NOT COMPLETED|Induction||54
9720379|NCT00049517|10819728|FG000|STARTED|Conditioning/Transplant||79
9720380|NCT00049517|10819729|FG001|STARTED|Conditioning/Transplant||90
9720381|NCT00049517|10819730|FG002|STARTED|Conditioning/Transplant||63
9720382|NCT00049517|10819731|FG003|STARTED|Conditioning/Transplant||75
9720383|NCT00049517|10819732|FG004|STARTED|Conditioning/Transplant||21
9720384|NCT00049517|10819733|FG005|STARTED|Conditioning/Transplant||24
9720385|NCT00049517|10819728|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
9720386|NCT00049517|10819729|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
9720387|NCT00049517|10819730|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
9720388|NCT00049517|10819731|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
9720389|NCT00049517|10819732|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
9720390|NCT00049517|10819733|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
9720391|NCT00049517|10819728|FG000|COMPLETED|Conditioning/Transplant||27
9720392|NCT00049517|10819729|FG001|COMPLETED|Conditioning/Transplant||40
9720393|NCT00049517|10819730|FG002|COMPLETED|Conditioning/Transplant||25
9720394|NCT00049517|10819731|FG003|COMPLETED|Conditioning/Transplant||32
9720395|NCT00049517|10819732|FG004|COMPLETED|Conditioning/Transplant||15
9720396|NCT00049517|10819733|FG005|COMPLETED|Conditioning/Transplant||18
9720397|NCT00049517|10819728|FG000|NOT COMPLETED|Conditioning/Transplant||52
9720398|NCT00049517|10819729|FG001|NOT COMPLETED|Conditioning/Transplant||50
9720399|NCT00049517|10819730|FG002|NOT COMPLETED|Conditioning/Transplant||38
9720400|NCT00049517|10819731|FG003|NOT COMPLETED|Conditioning/Transplant||43
9720401|NCT00049517|10819732|FG004|NOT COMPLETED|Conditioning/Transplant||6
9720402|NCT00049517|10819733|FG005|NOT COMPLETED|Conditioning/Transplant||6
9720403|NCT00049530|10819741|FG000|STARTED|Overall Study||32
9720404|NCT00049530|10819741|FG000|Eligible and Treated|Overall Study||29
9720405|NCT00049530|10819741|FG000|COMPLETED|Overall Study||0
9720406|NCT00049530|10819741|FG000|NOT COMPLETED|Overall Study||32
9720407|NCT00049543|10819747|FG000|STARTED|Overall Study||251
9720408|NCT00049543|10819748|FG001|STARTED|Overall Study||252
9720409|NCT00049543|10819747|FG000|COMPLETED|Overall Study||249
9720410|NCT00049543|10819748|FG001|COMPLETED|Overall Study||243
9720411|NCT00049543|10819747|FG000|NOT COMPLETED|Overall Study||2
9720412|NCT00049543|10819748|FG001|NOT COMPLETED|Overall Study||9
9720413|NCT00049673|10819756|FG000|STARTED|Overall Study||166
9720414|NCT00049673|10819757|FG001|STARTED|Overall Study||166
9720415|NCT00049673|10819756|FG000|COMPLETED|Overall Study||165
9720416|NCT00049673|10819757|FG001|COMPLETED|Overall Study||163
9720417|NCT00049673|10819756|FG000|NOT COMPLETED|Overall Study||1
9720418|NCT00049673|10819757|FG001|NOT COMPLETED|Overall Study||3
9720419|NCT00049842|10819765|FG000|STARTED|Treatment Phase||270
9720420|NCT00049842|10819766|FG001|STARTED|Treatment Phase||270
9720421|NCT00049842|10819765|FG000|COMPLETED|Treatment Phase||177
9720422|NCT00049842|10819766|FG001|COMPLETED|Treatment Phase||192
9720423|NCT00049842|10819765|FG000|NOT COMPLETED|Treatment Phase||93
9720424|NCT00049842|10819766|FG001|NOT COMPLETED|Treatment Phase||78
9720425|NCT00049842|10819765|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
9720426|NCT00049842|10819766|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
9720427|NCT00049842|10819765|FG000|COMPLETED|Follow-up Phase||211
9720428|NCT00049842|10819766|FG001|COMPLETED|Follow-up Phase||189
9720429|NCT00049842|10819765|FG000|NOT COMPLETED|Follow-up Phase||7
9720430|NCT00049842|10819766|FG001|NOT COMPLETED|Follow-up Phase||5
10021614|NCT01845077|11145064|FG004|STARTED|Washout Period||12
10021615|NCT01845077|11145065|FG005|STARTED|Washout Period||12
10021616|NCT01845077|11145060|FG000|COMPLETED|Washout Period||11
10021617|NCT01845077|11145061|FG001|COMPLETED|Washout Period||11
9720431|NCT00050011|10819774|FG000|STARTED|Overall Study||301
9837930|NCT00804609|10949309|FG000|NOT COMPLETED|Overall Study||0
9837931|NCT00804609|10949310|FG001|NOT COMPLETED|Overall Study||1
9837932|NCT00804648|10949316|FG000|STARTED|First Intervention||3
9837933|NCT00804648|10949317|FG001|STARTED|First Intervention||5
9837934|NCT00804648|10949318|FG002|STARTED|First Intervention||6
9837935|NCT00804648|10949319|FG003|STARTED|First Intervention||4
9837936|NCT00804648|10949320|FG004|STARTED|First Intervention||4
9837937|NCT00804648|10949321|FG005|STARTED|First Intervention||8
9837938|NCT00804648|10949316|FG000|COMPLETED|First Intervention||3
9837939|NCT00804648|10949317|FG001|COMPLETED|First Intervention||5
9837940|NCT00804648|10949318|FG002|COMPLETED|First Intervention||6
9837941|NCT00804648|10949319|FG003|COMPLETED|First Intervention||4
9837942|NCT00804648|10949320|FG004|COMPLETED|First Intervention||4
9837943|NCT00804648|10949321|FG005|COMPLETED|First Intervention||8
9837944|NCT00804648|10949316|FG000|NOT COMPLETED|First Intervention||0
9837945|NCT00804648|10949317|FG001|NOT COMPLETED|First Intervention||0
9837946|NCT00804648|10949318|FG002|NOT COMPLETED|First Intervention||0
9837947|NCT00804648|10949319|FG003|NOT COMPLETED|First Intervention||0
9837948|NCT00804648|10949320|FG004|NOT COMPLETED|First Intervention||0
9837949|NCT00804648|10949321|FG005|NOT COMPLETED|First Intervention||0
9837950|NCT00804648|10949316|FG000|STARTED|Second Intervention||3
9837951|NCT00804648|10949317|FG001|STARTED|Second Intervention||5
9837952|NCT00804648|10949318|FG002|STARTED|Second Intervention||6
9837953|NCT00804648|10949319|FG003|STARTED|Second Intervention||4
9837954|NCT00804648|10949320|FG004|STARTED|Second Intervention||4
9837955|NCT00804648|10949321|FG005|STARTED|Second Intervention||8
9837956|NCT00804648|10949316|FG000|COMPLETED|Second Intervention||3
9837957|NCT00804648|10949317|FG001|COMPLETED|Second Intervention||5
9837958|NCT00804648|10949318|FG002|COMPLETED|Second Intervention||6
9837959|NCT00804648|10949319|FG003|COMPLETED|Second Intervention||4
9837960|NCT00804648|10949320|FG004|COMPLETED|Second Intervention||4
9837961|NCT00804648|10949321|FG005|COMPLETED|Second Intervention||8
9837962|NCT00804648|10949316|FG000|NOT COMPLETED|Second Intervention||0
9837963|NCT00804648|10949317|FG001|NOT COMPLETED|Second Intervention||0
9837964|NCT00804648|10949318|FG002|NOT COMPLETED|Second Intervention||0
9837965|NCT00804648|10949319|FG003|NOT COMPLETED|Second Intervention||0
9837966|NCT00804648|10949320|FG004|NOT COMPLETED|Second Intervention||0
9837967|NCT00804648|10949321|FG005|NOT COMPLETED|Second Intervention||0
9837968|NCT00804648|10949316|FG000|STARTED|Third Invervention||3
9837969|NCT00804648|10949317|FG001|STARTED|Third Invervention||5
9837970|NCT00804648|10949318|FG002|STARTED|Third Invervention||6
9958863|NCT01458951|11078307|FG001|NOT COMPLETED|Overall Study||1
9958864|NCT01458951|11078308|FG002|NOT COMPLETED|Overall Study||15
9958865|NCT01458990|11078317|FG000|STARTED|Overall Study||45
9958866|NCT01458990|11078318|FG001|STARTED|Overall Study||15
9958867|NCT01458990|11078317|FG000|COMPLETED|Overall Study||45
9958868|NCT01458990|11078318|FG001|COMPLETED|Overall Study||15
9958869|NCT01458990|11078317|FG000|NOT COMPLETED|Overall Study||0
9958870|NCT01458990|11078318|FG001|NOT COMPLETED|Overall Study||0
9958871|NCT01459016|11078326|FG000|STARTED|Overall Study||56
9958872|NCT01459016|11078326|FG000|COMPLETED|Overall Study||41
9958873|NCT01459016|11078326|FG000|NOT COMPLETED|Overall Study||15
9958874|NCT01459068|11078332|FG000|STARTED|Overall Study||165
9958875|NCT01459068|11078333|FG001|STARTED|Overall Study||182
9958876|NCT01459068|11078332|FG000|COMPLETED|Overall Study||126
9958877|NCT01459068|11078333|FG001|COMPLETED|Overall Study||148
9958878|NCT01459068|11078332|FG000|NOT COMPLETED|Overall Study||39
9958879|NCT01459068|11078333|FG001|NOT COMPLETED|Overall Study||34
9958880|NCT01459588|11078343|FG000|STARTED|Overall Study||105
9958881|NCT01459588|11078344|FG001|STARTED|Overall Study||51
9958882|NCT01459588|11078345|FG002|STARTED|Overall Study||103
9958883|NCT01459588|11078346|FG003|STARTED|Overall Study||56
9958884|NCT01459588|11078343|FG000|COMPLETED|Overall Study||104
9958885|NCT01459588|11078344|FG001|COMPLETED|Overall Study||49
9958886|NCT01459588|11078345|FG002|COMPLETED|Overall Study||102
9958887|NCT01459588|11078346|FG003|COMPLETED|Overall Study||55
9958888|NCT01459588|11078343|FG000|NOT COMPLETED|Overall Study||1
9958889|NCT01459588|11078344|FG001|NOT COMPLETED|Overall Study||2
9958890|NCT01459588|11078345|FG002|NOT COMPLETED|Overall Study||1
9958891|NCT01459588|11078346|FG003|NOT COMPLETED|Overall Study||1
9958892|NCT01459614|11078358|FG000|STARTED|Overall Study||29
9958893|NCT01459614|11078359|FG001|STARTED|Overall Study||10
9958894|NCT01459614|11078358|FG000|COMPLETED|Overall Study||28
9958895|NCT01459614|11078359|FG001|COMPLETED|Overall Study||10
9958896|NCT01459614|11078358|FG000|NOT COMPLETED|Overall Study||1
9958897|NCT01459614|11078359|FG001|NOT COMPLETED|Overall Study||0
9958898|NCT01459653|11078365|FG000|STARTED|Overall Study||1496
9958899|NCT01459653|11078365|FG000|COMPLETED|Overall Study||828
9958900|NCT01459653|11078365|FG000|NOT COMPLETED|Overall Study||668
9958901|NCT01459705|11078439|FG000|STARTED|Overall Study||54
9958902|NCT01459705|11078440|FG001|STARTED|Overall Study||54
9958903|NCT01459705|11078441|FG002|STARTED|Overall Study||54
9958904|NCT01459705|11078439|FG000|COMPLETED|Overall Study||32
9958905|NCT01459705|11078440|FG001|COMPLETED|Overall Study||30
9958906|NCT01459705|11078441|FG002|COMPLETED|Overall Study||47
10021618|NCT01845077|11145062|FG002|COMPLETED|Washout Period||11
9720432|NCT00050011|10819775|FG001|STARTED|Overall Study||301
9720433|NCT00050011|10819774|FG000|Intent-to-treat Population|Overall Study||300
9720434|NCT00050011|10819775|FG001|Intent-to-treat Population|Overall Study||300
9720435|NCT00050011|10819774|FG000|COMPLETED|Overall Study||180
9720436|NCT00050011|10819775|FG001|COMPLETED|Overall Study||175
9720437|NCT00050011|10819774|FG000|NOT COMPLETED|Overall Study||121
9720438|NCT00050011|10819775|FG001|NOT COMPLETED|Overall Study||126
9720439|NCT00050089|10819786|FG000|STARTED|Overall Study||106
9720440|NCT00050089|10819787|FG001|STARTED|Overall Study||98
9720441|NCT00050089|10819788|FG002|STARTED|Overall Study||86
9720442|NCT00050089|10819789|FG003|STARTED|Overall Study||78
9720443|NCT00050089|10819786|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
9720444|NCT00050089|10819787|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
9720445|NCT00050089|10819788|FG002|Baseline|Overall Study||86
9720446|NCT00050089|10819789|FG003|Baseline|Overall Study||78
9720447|NCT00050089|10819786|FG000|COMPLETED|Overall Study|For primary outcome assessment|106
9720448|NCT00050089|10819787|FG001|COMPLETED|Overall Study|For primary outcome assessment|98
9720449|NCT00050089|10819788|FG002|COMPLETED|Overall Study|For primary outcome assessment|86
9720450|NCT00050089|10819789|FG003|COMPLETED|Overall Study|For primary outcome assessment|78
9720451|NCT00050089|10819786|FG000|NOT COMPLETED|Overall Study||0
9720452|NCT00050089|10819787|FG001|NOT COMPLETED|Overall Study||0
9720453|NCT00050089|10819788|FG002|NOT COMPLETED|Overall Study||0
9720454|NCT00050089|10819789|FG003|NOT COMPLETED|Overall Study||0
9720455|NCT00050167|10819805|FG000|STARTED|Overall Study||302
9720456|NCT00050167|10819806|FG001|STARTED|Overall Study||301
9720457|NCT00050167|10819805|FG000|COMPLETED|Overall Study||301
9720458|NCT00050167|10819806|FG001|COMPLETED|Overall Study||300
9720459|NCT00050167|10819805|FG000|NOT COMPLETED|Overall Study||1
9720460|NCT00050167|10819806|FG001|NOT COMPLETED|Overall Study||1
9720461|NCT00050622|10819812|FG000|STARTED|Overall Study||154
9720462|NCT00050622|10819812|FG000|COMPLETED|Overall Study||153
9720463|NCT00050622|10819812|FG000|NOT COMPLETED|Overall Study||1
9720464|NCT00050778|10819839|FG000|STARTED|Overall Study|Randomized.|111
9720465|NCT00050778|10819840|FG001|STARTED|Overall Study||113
9720466|NCT00050778|10819841|FG002|STARTED|Overall Study||110
9720467|NCT00050778|10819839|FG000|Treated|Overall Study||107
9720468|NCT00050778|10819840|FG001|Treated|Overall Study||108
9720469|NCT00050778|10819841|FG002|Treated|Overall Study||108
9720470|NCT00050778|10819839|FG000|COMPLETED|Overall Study||66
9720471|NCT00050778|10819840|FG001|COMPLETED|Overall Study||92
9720472|NCT00050778|10819841|FG002|COMPLETED|Overall Study||92
9720473|NCT00050778|10819839|FG000|NOT COMPLETED|Overall Study||45
9720474|NCT00050778|10819840|FG001|NOT COMPLETED|Overall Study||21
9720475|NCT00050778|10819841|FG002|NOT COMPLETED|Overall Study||18
9720476|NCT00050960|10819853|FG000|STARTED|Overall Study||306
9720477|NCT00050960|10819854|FG001|STARTED|Overall Study||306
9720478|NCT00050960|10819853|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
9720479|NCT00050960|10819854|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
9720480|NCT00050960|10819853|FG000|NOT COMPLETED|Overall Study||302
9720481|NCT00050960|10819854|FG001|NOT COMPLETED|Overall Study||304
9720482|NCT00050986|10819860|FG000|STARTED|Overall Study||55
9720483|NCT00050986|10819860|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
9720484|NCT00050986|10819860|FG000|NOT COMPLETED|Overall Study||2
9720485|NCT00051025|10819866|FG000|STARTED|Overall Study||5
10021619|NCT01845077|11145063|FG003|COMPLETED|Washout Period||10
10021620|NCT01845077|11145064|FG004|COMPLETED|Washout Period||11
9720486|NCT00051025|10819867|FG001|STARTED|Overall Study||4
9720487|NCT00051025|10819866|FG000|COMPLETED|Overall Study||3
10021621|NCT01845077|11145065|FG005|COMPLETED|Washout Period||11
9720488|NCT00051025|10819867|FG001|COMPLETED|Overall Study||0
9720489|NCT00051025|10819866|FG000|NOT COMPLETED|Overall Study||2
9720490|NCT00051025|10819867|FG001|NOT COMPLETED|Overall Study||4
9720491|NCT00051168|10819873|FG000|STARTED|Overall Study||502
9720492|NCT00051168|10819873|FG000|COMPLETED|Overall Study||367
9720493|NCT00051168|10819873|FG000|NOT COMPLETED|Overall Study||135
9720494|NCT00051311|10819879|FG000|STARTED|Overall Study||31
9720495|NCT00051311|10819880|FG001|STARTED|Overall Study||31
9720496|NCT00051311|10819879|FG000|COMPLETED|Overall Study||19
9720497|NCT00051311|10819880|FG001|COMPLETED|Overall Study||17
9720498|NCT00051311|10819879|FG000|NOT COMPLETED|Overall Study||12
9720499|NCT00051311|10819880|FG001|NOT COMPLETED|Overall Study||14
9720500|NCT00051363|10819886|FG000|STARTED|Overall Study||558
9720501|NCT00051363|10819887|FG001|STARTED|Overall Study||547
9720502|NCT00051363|10819886|FG000|Randomized & Analyzed|Overall Study||556
9720503|NCT00051363|10819887|FG001|Randomized & Analyzed|Overall Study||542
9720504|NCT00051363|10819886|FG000|Completed 2M Visit On-Treatment|Overall Study||456
9720505|NCT00051363|10819887|FG001|Completed 2M Visit On-Treatment|Overall Study||417
9720506|NCT00051363|10819886|FG000|Completed 2M Visit On-Study|Overall Study||468
9720507|NCT00051363|10819887|FG001|Completed 2M Visit On-Study|Overall Study||432
9720508|NCT00051363|10819886|FG000|Completed 6M Visit On-Treatment|Overall Study||427
9720509|NCT00051363|10819887|FG001|Completed 6M Visit On-Treatment|Overall Study||372
9720510|NCT00051363|10819886|FG000|Completed 6M Vist On-Study|Overall Study||443
9720511|NCT00051363|10819887|FG001|Completed 6M Vist On-Study|Overall Study||403
9720512|NCT00051363|10819886|FG000|COMPLETED|Overall Study||443
9720513|NCT00051363|10819887|FG001|COMPLETED|Overall Study||403
9720514|NCT00051363|10819886|FG000|NOT COMPLETED|Overall Study||115
9720515|NCT00051363|10819887|FG001|NOT COMPLETED|Overall Study||144
9720516|NCT00051558|10819895|FG000|STARTED|Overall Study||214
9720517|NCT00051558|10819896|FG001|STARTED|Overall Study||214
9720518|NCT00051558|10819895|FG000|COMPLETED|Overall Study||123
9720519|NCT00051558|10819896|FG001|COMPLETED|Overall Study||118
9720520|NCT00051558|10819895|FG000|NOT COMPLETED|Overall Study||91
9720521|NCT00051558|10819896|FG001|NOT COMPLETED|Overall Study||96
9720522|NCT00051636|10819904|FG000|STARTED|Period 1 - Core||90
9720523|NCT00051636|10819905|FG001|STARTED|Period 1 - Core||82
9720524|NCT00051636|10819904|FG000|COMPLETED|Period 1 - Core||86
9720525|NCT00051636|10819905|FG001|COMPLETED|Period 1 - Core||76
9720526|NCT00051636|10819904|FG000|NOT COMPLETED|Period 1 - Core||4
9720527|NCT00051636|10819905|FG001|NOT COMPLETED|Period 1 - Core||6
9720528|NCT00051636|10819904|FG000|STARTED|Period 2- Extended Observation Period||75
9720529|NCT00051636|10819905|FG001|STARTED|Period 2- Extended Observation Period||52
9731563|NCT00132808|10831421|FG001|COMPLETED|Stratum II||96
9837971|NCT00804648|10949319|FG003|STARTED|Third Invervention||4
9837972|NCT00804648|10949320|FG004|STARTED|Third Invervention||4
9837973|NCT00804648|10949321|FG005|STARTED|Third Invervention||8
9837974|NCT00804648|10949316|FG000|COMPLETED|Third Invervention||3
9837975|NCT00804648|10949317|FG001|COMPLETED|Third Invervention||5
9837976|NCT00804648|10949318|FG002|COMPLETED|Third Invervention||6
9837977|NCT00804648|10949319|FG003|COMPLETED|Third Invervention||4
9837978|NCT00804648|10949320|FG004|COMPLETED|Third Invervention||4
9837979|NCT00804648|10949321|FG005|COMPLETED|Third Invervention||8
9837980|NCT00804648|10949316|FG000|NOT COMPLETED|Third Invervention||0
9837981|NCT00804648|10949317|FG001|NOT COMPLETED|Third Invervention||0
9837982|NCT00804648|10949318|FG002|NOT COMPLETED|Third Invervention||0
9837983|NCT00804648|10949319|FG003|NOT COMPLETED|Third Invervention||0
9837984|NCT00804648|10949320|FG004|NOT COMPLETED|Third Invervention||0
9837985|NCT00804648|10949321|FG005|NOT COMPLETED|Third Invervention||0
9837986|NCT00804687|10949329|FG000|STARTED|Period 1: Treatment Period||9
9837987|NCT00804687|10949330|FG001|STARTED|Period 1: Treatment Period||9
9837988|NCT00804687|10949331|FG002|STARTED|Period 1: Treatment Period||9
9837989|NCT00804687|10949332|FG003|STARTED|Period 1: Treatment Period||9
9837990|NCT00804687|10949333|FG004|STARTED|Period 1: Treatment Period||9
9837991|NCT00804687|10949334|FG005|STARTED|Period 1: Treatment Period||8
9837992|NCT00804687|10949329|FG000|COMPLETED|Period 1: Treatment Period||9
9837993|NCT00804687|10949330|FG001|COMPLETED|Period 1: Treatment Period||9
10021622|NCT01845077|11145060|FG000|NOT COMPLETED|Washout Period||1
10021623|NCT01845077|11145061|FG001|NOT COMPLETED|Washout Period||1
9837994|NCT00804687|10949331|FG002|COMPLETED|Period 1: Treatment Period||9
9837995|NCT00804687|10949332|FG003|COMPLETED|Period 1: Treatment Period||9
9837996|NCT00804687|10949333|FG004|COMPLETED|Period 1: Treatment Period||9
9837997|NCT00804687|10949334|FG005|COMPLETED|Period 1: Treatment Period||8
9837998|NCT00804687|10949329|FG000|NOT COMPLETED|Period 1: Treatment Period||0
9837999|NCT00804687|10949330|FG001|NOT COMPLETED|Period 1: Treatment Period||0
10021624|NCT01845077|11145062|FG002|NOT COMPLETED|Washout Period||1
10021625|NCT01845077|11145063|FG003|NOT COMPLETED|Washout Period||2
9838000|NCT00804687|10949331|FG002|NOT COMPLETED|Period 1: Treatment Period||0
9838001|NCT00804687|10949332|FG003|NOT COMPLETED|Period 1: Treatment Period||0
9838002|NCT00804687|10949333|FG004|NOT COMPLETED|Period 1: Treatment Period||0
9838003|NCT00804687|10949334|FG005|NOT COMPLETED|Period 1: Treatment Period||0
9838004|NCT00804687|10949329|FG000|STARTED|Period 2: Washout Period||9
9838005|NCT00804687|10949330|FG001|STARTED|Period 2: Washout Period||9
9838006|NCT00804687|10949331|FG002|STARTED|Period 2: Washout Period||9
9838007|NCT00804687|10949332|FG003|STARTED|Period 2: Washout Period||9
9838008|NCT00804687|10949333|FG004|STARTED|Period 2: Washout Period||9
9838009|NCT00804687|10949334|FG005|STARTED|Period 2: Washout Period||8
9838010|NCT00804687|10949329|FG000|COMPLETED|Period 2: Washout Period||9
9838011|NCT00804687|10949330|FG001|COMPLETED|Period 2: Washout Period||9
9838012|NCT00804687|10949331|FG002|COMPLETED|Period 2: Washout Period||9
9838013|NCT00804687|10949332|FG003|COMPLETED|Period 2: Washout Period||9
9838014|NCT00804687|10949333|FG004|COMPLETED|Period 2: Washout Period||9
9838015|NCT00804687|10949334|FG005|COMPLETED|Period 2: Washout Period||8
9838016|NCT00804687|10949329|FG000|NOT COMPLETED|Period 2: Washout Period||0
9838017|NCT00804687|10949330|FG001|NOT COMPLETED|Period 2: Washout Period||0
9838018|NCT00804687|10949331|FG002|NOT COMPLETED|Period 2: Washout Period||0
9838019|NCT00804687|10949332|FG003|NOT COMPLETED|Period 2: Washout Period||0
9838020|NCT00804687|10949333|FG004|NOT COMPLETED|Period 2: Washout Period||0
9720530|NCT00051636|10819904|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
9720531|NCT00051636|10819905|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
9720532|NCT00051636|10819904|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70
9720533|NCT00051636|10819905|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30
9720534|NCT00052078|10819915|FG000|STARTED|Overall Study||133
9720535|NCT00052078|10819916|FG001|STARTED|Overall Study||139
9720536|NCT00052078|10819917|FG002|STARTED|Overall Study||140
9720537|NCT00052078|10819918|FG003|STARTED|Overall Study||76
9720538|NCT00052078|10819915|FG000|COMPLETED|Overall Study||110
9720539|NCT00052078|10819916|FG001|COMPLETED|Overall Study||133
9720540|NCT00052078|10819917|FG002|COMPLETED|Overall Study||127
9720541|NCT00052078|10819918|FG003|COMPLETED|Overall Study||61
9720542|NCT00052078|10819915|FG000|NOT COMPLETED|Overall Study||23
9720543|NCT00052078|10819916|FG001|NOT COMPLETED|Overall Study||6
9720544|NCT00052078|10819917|FG002|NOT COMPLETED|Overall Study||13
9720545|NCT00052078|10819918|FG003|NOT COMPLETED|Overall Study||15
9720546|NCT00052429|10819928|FG000|STARTED|Overall Study||25
9720547|NCT00052429|10819928|FG000|COMPLETED|Overall Study||25
9720548|NCT00052429|10819928|FG000|NOT COMPLETED|Overall Study||0
9720549|NCT00052442|10819937|FG000|STARTED|Overall Study||16
9720550|NCT00052442|10819938|FG001|STARTED|Overall Study||3
9720551|NCT00052442|10819939|FG002|STARTED|Overall Study||27
9720552|NCT00052442|10819940|FG003|STARTED|Overall Study||11
9720553|NCT00052442|10819941|FG004|STARTED|Overall Study||15
9720554|NCT00052442|10819937|FG000|COMPLETED|Overall Study||16
9720555|NCT00052442|10819938|FG001|COMPLETED|Overall Study||3
9720556|NCT00052442|10819939|FG002|COMPLETED|Overall Study||27
9720557|NCT00052442|10819940|FG003|COMPLETED|Overall Study||11
9720558|NCT00052442|10819941|FG004|COMPLETED|Overall Study||15
9720559|NCT00052442|10819937|FG000|NOT COMPLETED|Overall Study||0
9720560|NCT00052442|10819938|FG001|NOT COMPLETED|Overall Study||0
9720561|NCT00052442|10819939|FG002|NOT COMPLETED|Overall Study||0
9720562|NCT00052442|10819940|FG003|NOT COMPLETED|Overall Study||0
9720563|NCT00052442|10819941|FG004|NOT COMPLETED|Overall Study||0
9720564|NCT00052715|10819953|FG000|STARTED|Overall Study||31
9720565|NCT00052715|10819953|FG000|COMPLETED|Overall Study||30
9720566|NCT00052715|10819953|FG000|NOT COMPLETED|Overall Study||1
9720567|NCT00052910|10819959|FG000|STARTED|Overall Study||280
9720568|NCT00052910|10819960|FG001|STARTED|Overall Study||266
9720569|NCT00052910|10819959|FG000|COMPLETED|Overall Study||280
9720570|NCT00052910|10819960|FG001|COMPLETED|Overall Study||266
9720571|NCT00052910|10819959|FG000|NOT COMPLETED|Overall Study||0
9720572|NCT00052910|10819960|FG001|NOT COMPLETED|Overall Study||0
9720573|NCT00052962|10819968|FG000|STARTED|Overall Study||13
9720574|NCT00052962|10819969|FG001|STARTED|Overall Study||17
9720575|NCT00052962|10819968|FG000|COMPLETED|Overall Study||12
9838021|NCT00804687|10949334|FG005|NOT COMPLETED|Period 2: Washout Period||0
9838022|NCT00804687|10949329|FG000|STARTED|Period 3: Treatment Period||9
9838023|NCT00804687|10949330|FG001|STARTED|Period 3: Treatment Period||9
9838024|NCT00804687|10949331|FG002|STARTED|Period 3: Treatment Period||9
9838025|NCT00804687|10949332|FG003|STARTED|Period 3: Treatment Period||9
9838026|NCT00804687|10949333|FG004|STARTED|Period 3: Treatment Period||9
9838027|NCT00804687|10949334|FG005|STARTED|Period 3: Treatment Period||8
9838028|NCT00804687|10949329|FG000|COMPLETED|Period 3: Treatment Period||9
9838029|NCT00804687|10949330|FG001|COMPLETED|Period 3: Treatment Period||9
9838030|NCT00804687|10949331|FG002|COMPLETED|Period 3: Treatment Period||9
9838031|NCT00804687|10949332|FG003|COMPLETED|Period 3: Treatment Period||8
9838032|NCT00804687|10949333|FG004|COMPLETED|Period 3: Treatment Period||9
9838033|NCT00804687|10949334|FG005|COMPLETED|Period 3: Treatment Period||8
9838034|NCT00804687|10949329|FG000|NOT COMPLETED|Period 3: Treatment Period||0
9838035|NCT00804687|10949330|FG001|NOT COMPLETED|Period 3: Treatment Period||0
9838036|NCT00804687|10949331|FG002|NOT COMPLETED|Period 3: Treatment Period||0
9838037|NCT00804687|10949332|FG003|NOT COMPLETED|Period 3: Treatment Period||1
9838038|NCT00804687|10949333|FG004|NOT COMPLETED|Period 3: Treatment Period||0
9838039|NCT00804687|10949334|FG005|NOT COMPLETED|Period 3: Treatment Period||0
9838040|NCT00804687|10949329|FG000|STARTED|Period 4: Washout Period||9
9838041|NCT00804687|10949330|FG001|STARTED|Period 4: Washout Period||9
9838042|NCT00804687|10949331|FG002|STARTED|Period 4: Washout Period||9
9838043|NCT00804687|10949332|FG003|STARTED|Period 4: Washout Period||8
9838044|NCT00804687|10949333|FG004|STARTED|Period 4: Washout Period||9
9838045|NCT00804687|10949334|FG005|STARTED|Period 4: Washout Period||8
9838046|NCT00804687|10949329|FG000|COMPLETED|Period 4: Washout Period||9
9838047|NCT00804687|10949330|FG001|COMPLETED|Period 4: Washout Period||9
9838048|NCT00804687|10949331|FG002|COMPLETED|Period 4: Washout Period||9
9838049|NCT00804687|10949332|FG003|COMPLETED|Period 4: Washout Period||8
9838050|NCT00804687|10949333|FG004|COMPLETED|Period 4: Washout Period||9
9838051|NCT00804687|10949334|FG005|COMPLETED|Period 4: Washout Period||8
9838052|NCT00804687|10949329|FG000|NOT COMPLETED|Period 4: Washout Period||0
9838053|NCT00804687|10949330|FG001|NOT COMPLETED|Period 4: Washout Period||0
9838054|NCT00804687|10949331|FG002|NOT COMPLETED|Period 4: Washout Period||0
9838055|NCT00804687|10949332|FG003|NOT COMPLETED|Period 4: Washout Period||0
9838056|NCT00804687|10949333|FG004|NOT COMPLETED|Period 4: Washout Period||0
9838057|NCT00804687|10949334|FG005|NOT COMPLETED|Period 4: Washout Period||0
9838058|NCT00804687|10949329|FG000|STARTED|Period 5: Treatment Period||9
9838059|NCT00804687|10949330|FG001|STARTED|Period 5: Treatment Period||9
9838060|NCT00804687|10949331|FG002|STARTED|Period 5: Treatment Period||9
9838061|NCT00804687|10949332|FG003|STARTED|Period 5: Treatment Period||8
9838062|NCT00804687|10949333|FG004|STARTED|Period 5: Treatment Period||9
9838063|NCT00804687|10949334|FG005|STARTED|Period 5: Treatment Period||8
9838064|NCT00804687|10949329|FG000|COMPLETED|Period 5: Treatment Period||8
9838065|NCT00804687|10949330|FG001|COMPLETED|Period 5: Treatment Period||9
9838066|NCT00804687|10949331|FG002|COMPLETED|Period 5: Treatment Period||8
9838067|NCT00804687|10949332|FG003|COMPLETED|Period 5: Treatment Period||8
9838068|NCT00804687|10949333|FG004|COMPLETED|Period 5: Treatment Period||8
9838069|NCT00804687|10949334|FG005|COMPLETED|Period 5: Treatment Period||8
9838070|NCT00804687|10949329|FG000|NOT COMPLETED|Period 5: Treatment Period||1
9838071|NCT00804687|10949330|FG001|NOT COMPLETED|Period 5: Treatment Period||0
9838072|NCT00804687|10949331|FG002|NOT COMPLETED|Period 5: Treatment Period||1
9838073|NCT00804687|10949332|FG003|NOT COMPLETED|Period 5: Treatment Period||0
9838074|NCT00804687|10949333|FG004|NOT COMPLETED|Period 5: Treatment Period||1
9838075|NCT00804687|10949334|FG005|NOT COMPLETED|Period 5: Treatment Period||0
9838076|NCT00804843|10949344|FG000|STARTED|Overall Study||50
9838077|NCT00804843|10949345|FG001|STARTED|Overall Study||50
9838078|NCT00804843|10949344|FG000|COMPLETED|Overall Study||40
9838079|NCT00804843|10949345|FG001|COMPLETED|Overall Study||43
9838080|NCT00804843|10949344|FG000|NOT COMPLETED|Overall Study||10
9838081|NCT00804843|10949345|FG001|NOT COMPLETED|Overall Study||7
9838082|NCT00804908|10949355|FG000|STARTED|Overall Study||115
9838083|NCT00804908|10949356|FG001|STARTED|Overall Study||116
9838084|NCT00804908|10949357|FG002|STARTED|Overall Study||115
9838085|NCT00804908|10949355|FG000|COMPLETED|Overall Study||0
9838086|NCT00804908|10949356|FG001|COMPLETED|Overall Study||0
9838087|NCT00804908|10949357|FG002|COMPLETED|Overall Study||1
9838088|NCT00804908|10949355|FG000|NOT COMPLETED|Overall Study||115
9838089|NCT00804908|10949356|FG001|NOT COMPLETED|Overall Study||116
9838090|NCT00804908|10949357|FG002|NOT COMPLETED|Overall Study||114
9838091|NCT00804973|10949368|FG000|STARTED|Overall Study||40
9958907|NCT01459705|11078439|FG000|NOT COMPLETED|Overall Study||22
9958908|NCT01459705|11078440|FG001|NOT COMPLETED|Overall Study||24
9958909|NCT01459705|11078441|FG002|NOT COMPLETED|Overall Study||7
9958910|NCT01459718|11078449|FG000|STARTED|Overall Study||13
9958911|NCT01459718|11078449|FG000|Safety Analysis Set|Overall Study||13
9958912|NCT01459718|11078449|FG000|COMPLETED|Overall Study||10
9838092|NCT00804973|10949369|FG001|STARTED|Overall Study||40
9838093|NCT00804973|10949370|FG002|STARTED|Overall Study||40
9838094|NCT00804973|10949368|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
9838095|NCT00804973|10949369|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
9958913|NCT01459718|11078449|FG000|NOT COMPLETED|Overall Study||3
10114126|NCT02513823|11244843|FG000|COMPLETED|Overall Study||22
9838096|NCT00804973|10949370|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
9838097|NCT00804973|10949368|FG000|COMPLETED|Overall Study||40
9838098|NCT00804973|10949369|FG001|COMPLETED|Overall Study||40
9838099|NCT00804973|10949370|FG002|COMPLETED|Overall Study||40
9838100|NCT00804973|10949368|FG000|NOT COMPLETED|Overall Study||0
9838101|NCT00804973|10949369|FG001|NOT COMPLETED|Overall Study||0
9838102|NCT00804973|10949370|FG002|NOT COMPLETED|Overall Study||0
9838103|NCT00804986|10949384|FG000|STARTED|Overall Study||36
9838104|NCT00804986|10949385|FG001|STARTED|Overall Study||43
9838105|NCT00804986|10949386|FG002|STARTED|Overall Study||42
9838106|NCT00804986|10949387|FG003|STARTED|Overall Study||42
9838107|NCT00804986|10949388|FG004|STARTED|Overall Study||43
9838108|NCT00804986|10949389|FG005|STARTED|Overall Study||41
9838109|NCT00804986|10949384|FG000|COMPLETED|Overall Study||35
9838110|NCT00804986|10949385|FG001|COMPLETED|Overall Study||35
9838111|NCT00804986|10949386|FG002|COMPLETED|Overall Study||40
9838112|NCT00804986|10949387|FG003|COMPLETED|Overall Study||34
9838113|NCT00804986|10949388|FG004|COMPLETED|Overall Study||34
9838114|NCT00804986|10949389|FG005|COMPLETED|Overall Study||31
9838115|NCT00804986|10949384|FG000|NOT COMPLETED|Overall Study||1
9838116|NCT00804986|10949385|FG001|NOT COMPLETED|Overall Study||8
9838117|NCT00804986|10949386|FG002|NOT COMPLETED|Overall Study||2
9838118|NCT00804986|10949387|FG003|NOT COMPLETED|Overall Study||8
9838119|NCT00804986|10949388|FG004|NOT COMPLETED|Overall Study||9
9838120|NCT00804986|10949389|FG005|NOT COMPLETED|Overall Study||10
9838121|NCT00804999|10949407|FG000|STARTED|Overall Study||15
9838122|NCT00804999|10949408|FG001|STARTED|Overall Study||12
9838123|NCT00804999|10949409|FG002|STARTED|Overall Study||14
9838124|NCT00804999|10949410|FG003|STARTED|Overall Study||10
9838125|NCT00804999|10949407|FG000|COMPLETED|Overall Study||15
9838126|NCT00804999|10949408|FG001|COMPLETED|Overall Study||12
9838127|NCT00804999|10949409|FG002|COMPLETED|Overall Study||14
9838128|NCT00804999|10949410|FG003|COMPLETED|Overall Study||10
9838129|NCT00804999|10949407|FG000|NOT COMPLETED|Overall Study||0
9838130|NCT00804999|10949408|FG001|NOT COMPLETED|Overall Study||0
9838131|NCT00804999|10949409|FG002|NOT COMPLETED|Overall Study||0
9838132|NCT00804999|10949410|FG003|NOT COMPLETED|Overall Study||0
9838133|NCT00805025|10949420|FG000|STARTED|Overall Study||131
9838134|NCT00805025|10949420|FG000|Enrolled and Treated|Overall Study||89
10114127|NCT02513823|11244843|FG000|NOT COMPLETED|Overall Study||5
10114128|NCT02513940|11244847|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
10114129|NCT02513940|11244848|FG001|STARTED|Overall Study||3
10114130|NCT02513940|11244849|FG002|STARTED|Overall Study||2
10114131|NCT02513940|11244850|FG003|STARTED|Overall Study||2
9838135|NCT00805025|10949420|FG000|COMPLETED|Overall Study||82
9838136|NCT00805025|10949420|FG000|NOT COMPLETED|Overall Study||49
9838137|NCT00805038|10949426|FG000|STARTED|Overall Study||75
9838138|NCT00805038|10949427|FG001|STARTED|Overall Study||92
9838139|NCT00805038|10949426|FG000|COMPLETED|Overall Study||75
9838140|NCT00805038|10949427|FG001|COMPLETED|Overall Study||92
9838141|NCT00805038|10949426|FG000|NOT COMPLETED|Overall Study||0
9838142|NCT00805038|10949427|FG001|NOT COMPLETED|Overall Study||0
9838143|NCT00805142|10949435|FG000|STARTED|Titration Period||36
9838144|NCT00805142|10949436|FG001|STARTED|Titration Period||42
9838145|NCT00805142|10949435|FG000|COMPLETED|Titration Period||30
9838146|NCT00805142|10949436|FG001|COMPLETED|Titration Period||32
9838147|NCT00805142|10949435|FG000|NOT COMPLETED|Titration Period||6
9838148|NCT00805142|10949436|FG001|NOT COMPLETED|Titration Period||10
9838149|NCT00805142|10949435|FG000|STARTED|Maintenance Period||30
9838150|NCT00805142|10949436|FG001|STARTED|Maintenance Period||32
9958914|NCT01459783|11078455|FG000|STARTED|Baseline to 6 Months||71
9958915|NCT01459783|11078456|FG001|STARTED|Baseline to 6 Months||73
9720576|NCT00052962|10819969|FG001|COMPLETED|Overall Study||15
9720577|NCT00052962|10819968|FG000|NOT COMPLETED|Overall Study||1
9720578|NCT00052962|10819969|FG001|NOT COMPLETED|Overall Study||2
9720579|NCT00053014|10819975|FG000|STARTED|Overall Study||5
9720580|NCT00053014|10819975|FG000|COMPLETED|Overall Study||5
9720581|NCT00053014|10819975|FG000|NOT COMPLETED|Overall Study||0
9720582|NCT00053352|10819981|FG000|STARTED|Overall Study||190
9720583|NCT00053352|10819982|FG001|STARTED|Overall Study||112
9720584|NCT00053352|10819981|FG000|COMPLETED|Overall Study||169
9720585|NCT00053352|10819982|FG001|COMPLETED|Overall Study||102
9720586|NCT00053352|10819981|FG000|NOT COMPLETED|Overall Study||21
9720587|NCT00053352|10819982|FG001|NOT COMPLETED|Overall Study||10
9720588|NCT00053365|10819989|FG000|STARTED|Overall Study||61
9720589|NCT00053365|10819989|FG000|COMPLETED|Overall Study||55
9720590|NCT00053365|10819989|FG000|NOT COMPLETED|Overall Study||6
9720591|NCT00053417|10819999|FG000|STARTED|Overall Study||47
9720592|NCT00053417|10820000|FG001|STARTED|Overall Study||52
9720593|NCT00053417|10820001|FG002|STARTED|Overall Study||50
9720594|NCT00053417|10820002|FG003|STARTED|Overall Study||57
9720595|NCT00053417|10819999|FG000|COMPLETED|Overall Study||45
9720596|NCT00053417|10820000|FG001|COMPLETED|Overall Study||50
9720597|NCT00053417|10820001|FG002|COMPLETED|Overall Study||49
9720598|NCT00053417|10820002|FG003|COMPLETED|Overall Study||51
9720599|NCT00053417|10819999|FG000|NOT COMPLETED|Overall Study||2
9720600|NCT00053417|10820000|FG001|NOT COMPLETED|Overall Study||2
9720601|NCT00053417|10820001|FG002|NOT COMPLETED|Overall Study||1
9720602|NCT00053417|10820002|FG003|NOT COMPLETED|Overall Study||6
9720603|NCT00053482|10820017|FG000|STARTED|Overall Study||51
9720604|NCT00053482|10820018|FG001|STARTED|Overall Study||102
9720605|NCT00053482|10820019|FG002|STARTED|Overall Study||102
9720606|NCT00053482|10820020|FG003|STARTED|Overall Study||50
9720607|NCT00053482|10820021|FG004|STARTED|Overall Study||52
9720608|NCT00053482|10820017|FG000|COMPLETED|Overall Study||51
9720609|NCT00053482|10820018|FG001|COMPLETED|Overall Study||102
9720610|NCT00053482|10820019|FG002|COMPLETED|Overall Study||102
9720611|NCT00053482|10820020|FG003|COMPLETED|Overall Study||50
9720612|NCT00053482|10820021|FG004|COMPLETED|Overall Study||52
9720613|NCT00053482|10820017|FG000|NOT COMPLETED|Overall Study||0
9720614|NCT00053482|10820018|FG001|NOT COMPLETED|Overall Study||0
9720615|NCT00053482|10820019|FG002|NOT COMPLETED|Overall Study||0
9720616|NCT00053482|10820020|FG003|NOT COMPLETED|Overall Study||0
9720617|NCT00053482|10820021|FG004|NOT COMPLETED|Overall Study||0
9720618|NCT00041392|10820035|FG000|STARTED|Overall Study||198
9720619|NCT00041392|10820036|FG001|STARTED|Overall Study||191
9720620|NCT00041392|10820035|FG000|COMPLETED|Overall Study||198
9720621|NCT00041392|10820036|FG001|COMPLETED|Overall Study||191
9720622|NCT00041392|10820035|FG000|NOT COMPLETED|Overall Study||0
9720623|NCT00041392|10820036|FG001|NOT COMPLETED|Overall Study||0
9720624|NCT00053495|10820047|FG000|STARTED|Overall Study||51
9720625|NCT00053495|10820048|FG001|STARTED|Overall Study||101
9720626|NCT00053495|10820049|FG002|STARTED|Overall Study||101
9720627|NCT00053495|10820050|FG003|STARTED|Overall Study||51
9720628|NCT00053495|10820051|FG004|STARTED|Overall Study||49
9720629|NCT00053495|10820047|FG000|COMPLETED|Overall Study||51
9720630|NCT00053495|10820048|FG001|COMPLETED|Overall Study||101
9720631|NCT00053495|10820049|FG002|COMPLETED|Overall Study||101
9720632|NCT00053495|10820050|FG003|COMPLETED|Overall Study||51
9720633|NCT00053495|10820051|FG004|COMPLETED|Overall Study||49
9720634|NCT00053495|10820047|FG000|NOT COMPLETED|Overall Study||0
9720635|NCT00053495|10820048|FG001|NOT COMPLETED|Overall Study||0
9720636|NCT00053495|10820049|FG002|NOT COMPLETED|Overall Study||0
9720637|NCT00053495|10820050|FG003|NOT COMPLETED|Overall Study||0
9720638|NCT00053495|10820051|FG004|NOT COMPLETED|Overall Study||0
9720639|NCT00053677|10820065|FG000|STARTED|Overall Study||58
9720640|NCT00053677|10820066|FG001|STARTED|Overall Study||19
9720641|NCT00053677|10820065|FG000|COMPLETED|Overall Study||36
9720642|NCT00053677|10820066|FG001|COMPLETED|Overall Study||13
9720643|NCT00053677|10820065|FG000|NOT COMPLETED|Overall Study||22
9720644|NCT00053677|10820066|FG001|NOT COMPLETED|Overall Study||6
9720645|NCT00053703|10820075|FG000|STARTED|Overall Study||35
9720646|NCT00053703|10820076|FG001|STARTED|Overall Study||41
9720647|NCT00053703|10820077|FG002|STARTED|Overall Study||40
9720648|NCT00053703|10820075|FG000|COMPLETED|Overall Study||17
9720649|NCT00053703|10820076|FG001|COMPLETED|Overall Study||28
9720650|NCT00053703|10820077|FG002|COMPLETED|Overall Study||25
9720651|NCT00053703|10820075|FG000|NOT COMPLETED|Overall Study||18
9720652|NCT00053703|10820076|FG001|NOT COMPLETED|Overall Study||13
10021626|NCT01845077|11145064|FG004|NOT COMPLETED|Washout Period||1
10021627|NCT01845077|11145065|FG005|NOT COMPLETED|Washout Period||1
10021628|NCT01845077|11145060|FG000|STARTED|Treatment Period 2||11
10021629|NCT01845077|11145061|FG001|STARTED|Treatment Period 2||11
10021630|NCT01845077|11145062|FG002|STARTED|Treatment Period 2||11
10021631|NCT01845077|11145063|FG003|STARTED|Treatment Period 2||10
10021632|NCT01845077|11145064|FG004|STARTED|Treatment Period 2||11
9838151|NCT00805142|10949435|FG000|COMPLETED|Maintenance Period||30
9838152|NCT00805142|10949436|FG001|COMPLETED|Maintenance Period||30
9838153|NCT00805142|10949435|FG000|NOT COMPLETED|Maintenance Period||0
9838154|NCT00805142|10949436|FG001|NOT COMPLETED|Maintenance Period||2
9838155|NCT00805194|10949451|FG000|STARTED|Overall Study|randomised patients|655
9838156|NCT00805194|10949452|FG001|STARTED|Overall Study|randomised patients|659
9838157|NCT00805194|10949451|FG000|COMPLETED|Overall Study||6
9838158|NCT00805194|10949452|FG001|COMPLETED|Overall Study||5
9838159|NCT00805194|10949451|FG000|NOT COMPLETED|Overall Study||649
9838160|NCT00805194|10949452|FG001|NOT COMPLETED|Overall Study||654
9838161|NCT00805207|10949472|FG000|STARTED|Overall Study||1
9838162|NCT00805207|10949473|FG001|STARTED|Overall Study||9
9838163|NCT00805207|10949474|FG002|STARTED|Overall Study||12
9838164|NCT00805207|10949475|FG003|STARTED|Overall Study||6
9838165|NCT00805207|10949476|FG004|STARTED|Overall Study||3
9838166|NCT00805207|10949477|FG005|STARTED|Overall Study||12
9838167|NCT00805207|10949478|FG006|STARTED|Overall Study||6
9838168|NCT00805207|10949479|FG007|STARTED|Overall Study||6
9838169|NCT00805207|10949480|FG008|STARTED|Overall Study||6
9838170|NCT00805207|10949472|FG000|COMPLETED|Overall Study||1
9838171|NCT00805207|10949473|FG001|COMPLETED|Overall Study||7
9838172|NCT00805207|10949474|FG002|COMPLETED|Overall Study||11
9838173|NCT00805207|10949475|FG003|COMPLETED|Overall Study||6
9838174|NCT00805207|10949476|FG004|COMPLETED|Overall Study||2
9838175|NCT00805207|10949477|FG005|COMPLETED|Overall Study||9
9838176|NCT00805207|10949478|FG006|COMPLETED|Overall Study||6
9838177|NCT00805207|10949479|FG007|COMPLETED|Overall Study||6
9838178|NCT00805207|10949480|FG008|COMPLETED|Overall Study||6
9838179|NCT00805207|10949472|FG000|NOT COMPLETED|Overall Study||0
9838180|NCT00805207|10949473|FG001|NOT COMPLETED|Overall Study||2
9838181|NCT00805207|10949474|FG002|NOT COMPLETED|Overall Study||1
9838182|NCT00805207|10949475|FG003|NOT COMPLETED|Overall Study||0
9958916|NCT01459783|11078455|FG000|COMPLETED|Baseline to 6 Months||39
9838183|NCT00805207|10949476|FG004|NOT COMPLETED|Overall Study||1
9838184|NCT00805207|10949477|FG005|NOT COMPLETED|Overall Study||3
9838185|NCT00805207|10949478|FG006|NOT COMPLETED|Overall Study||0
9838186|NCT00805207|10949479|FG007|NOT COMPLETED|Overall Study||0
9838187|NCT00805207|10949480|FG008|NOT COMPLETED|Overall Study||0
9838188|NCT00805285|10949504|FG000|STARTED|Overall Study||1
9838189|NCT00805285|10949504|FG000|COMPLETED|Overall Study||0
9838190|NCT00805285|10949504|FG000|NOT COMPLETED|Overall Study||1
9838191|NCT00805389|10949513|FG000|STARTED|Overall Study||143
9838192|NCT00805389|10949514|FG001|STARTED|Overall Study||142
9838193|NCT00805389|10949515|FG002|STARTED|Overall Study||141
9838194|NCT00805389|10949516|FG003|STARTED|Overall Study||145
9838195|NCT00805389|10949517|FG004|STARTED|Overall Study||142
9838196|NCT00805389|10949513|FG000|COMPLETED|Overall Study||136
9838197|NCT00805389|10949514|FG001|COMPLETED|Overall Study||137
9838198|NCT00805389|10949515|FG002|COMPLETED|Overall Study||129
9838199|NCT00805389|10949516|FG003|COMPLETED|Overall Study||128
9838200|NCT00805389|10949517|FG004|COMPLETED|Overall Study||129
9838201|NCT00805389|10949513|FG000|NOT COMPLETED|Overall Study||7
9838202|NCT00805389|10949514|FG001|NOT COMPLETED|Overall Study||5
9838203|NCT00805389|10949515|FG002|NOT COMPLETED|Overall Study||12
9838204|NCT00805389|10949516|FG003|NOT COMPLETED|Overall Study||17
9838205|NCT00805389|10949517|FG004|NOT COMPLETED|Overall Study||13
9838206|NCT00805441|10949541|FG000|STARTED|Overall Study||94
9838207|NCT00805441|10949542|FG001|STARTED|Overall Study||96
9838208|NCT00805441|10949541|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
9838209|NCT00805441|10949542|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
9838210|NCT00805441|10949541|FG000|COMPLETED|Overall Study||60
9838211|NCT00805441|10949542|FG001|COMPLETED|Overall Study||60
9838212|NCT00805441|10949541|FG000|NOT COMPLETED|Overall Study||34
9838213|NCT00805441|10949542|FG001|NOT COMPLETED|Overall Study||36
9838214|NCT00805467|10949552|FG000|STARTED|Overall Study|Patients who received treatment|1
9838215|NCT00805467|10949553|FG001|STARTED|Overall Study|Patients who received treatment|59
9838216|NCT00805467|10949554|FG002|STARTED|Overall Study|Patients who received treatment|183
9838217|NCT00805467|10949555|FG003|STARTED|Overall Study|Patients who received treatment|381
9838218|NCT00805467|10949552|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0
9838219|NCT00805467|10949553|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
9838220|NCT00805467|10949554|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0
9838221|NCT00805467|10949555|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0
9838222|NCT00805467|10949552|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1
9838223|NCT00805467|10949553|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25
9838224|NCT00805467|10949554|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80
9838225|NCT00805467|10949555|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144
9838226|NCT00805467|10949552|FG000|NOT COMPLETED|Overall Study||0
9838227|NCT00805467|10949553|FG001|NOT COMPLETED|Overall Study||34
9838228|NCT00805467|10949554|FG002|NOT COMPLETED|Overall Study||103
9838229|NCT00805467|10949555|FG003|NOT COMPLETED|Overall Study||237
9838230|NCT00805480|10949569|FG000|STARTED|Overall Study||30
9838231|NCT00805480|10949570|FG001|STARTED|Overall Study||29
9838232|NCT00805480|10949571|FG002|STARTED|Overall Study||31
9838233|NCT00805480|10949572|FG003|STARTED|Overall Study||10
9838234|NCT00805480|10949569|FG000|Pharmacodynamic Analysis Set|Overall Study||30
9838235|NCT00805480|10949570|FG001|Pharmacodynamic Analysis Set|Overall Study||25
9838236|NCT00805480|10949571|FG002|Pharmacodynamic Analysis Set|Overall Study||29
9958917|NCT01459783|11078456|FG001|COMPLETED|Baseline to 6 Months||53
9958918|NCT01459783|11078455|FG000|NOT COMPLETED|Baseline to 6 Months||32
9958919|NCT01459783|11078456|FG001|NOT COMPLETED|Baseline to 6 Months||20
9958920|NCT01459783|11078455|FG000|STARTED|6 Months to 12 Months||39
9958921|NCT01459783|11078456|FG001|STARTED|6 Months to 12 Months||53
9958922|NCT01459783|11078455|FG000|COMPLETED|6 Months to 12 Months||20
9958923|NCT01459783|11078456|FG001|COMPLETED|6 Months to 12 Months||23
9958924|NCT01459783|11078455|FG000|NOT COMPLETED|6 Months to 12 Months||19
9958925|NCT01459783|11078456|FG001|NOT COMPLETED|6 Months to 12 Months||30
9958926|NCT01459796|11078464|FG000|STARTED|Overall Study||94
9958927|NCT01459796|11078465|FG001|STARTED|Overall Study||126
9958928|NCT01459796|11078464|FG000|COMPLETED|Overall Study||0
9958929|NCT01459796|11078465|FG001|COMPLETED|Overall Study||0
9958930|NCT01459796|11078464|FG000|NOT COMPLETED|Overall Study||94
9958931|NCT01459796|11078465|FG001|NOT COMPLETED|Overall Study||126
9958932|NCT01459913|11078475|FG000|STARTED|Overall Study||106
9958933|NCT01459913|11078476|FG001|STARTED|Overall Study||52
9958934|NCT01459913|11078477|FG002|STARTED|Overall Study||19
9958935|NCT01459913|11078478|FG003|STARTED|Overall Study||62
9958936|NCT01459913|11078475|FG000|COMPLETED|Overall Study||65
9958937|NCT01459913|11078476|FG001|COMPLETED|Overall Study||32
9958938|NCT01459913|11078477|FG002|COMPLETED|Overall Study||6
9958939|NCT01459913|11078478|FG003|COMPLETED|Overall Study||29
9958940|NCT01459913|11078475|FG000|NOT COMPLETED|Overall Study||41
9958941|NCT01459913|11078476|FG001|NOT COMPLETED|Overall Study||20
9958942|NCT01459913|11078477|FG002|NOT COMPLETED|Overall Study||13
9958943|NCT01459913|11078478|FG003|NOT COMPLETED|Overall Study||33
9958944|NCT01460225|11078490|FG000|STARTED|Overall Study|January 2009.|19
9958945|NCT01460225|11078490|FG000|COMPLETED|Overall Study|November 2010|19
9958946|NCT01460225|11078490|FG000|NOT COMPLETED|Overall Study||0
9958947|NCT01460290|11078495|FG000|STARTED|Overall Study||15
9720653|NCT00053703|10820077|FG002|NOT COMPLETED|Overall Study||15
9720654|NCT00053846|10820087|FG000|STARTED|Overall Study||213
10021633|NCT01845077|11145065|FG005|STARTED|Treatment Period 2||11
10021634|NCT01845077|11145060|FG000|COMPLETED|Treatment Period 2||11
10021635|NCT01845077|11145061|FG001|COMPLETED|Treatment Period 2||11
10021636|NCT01845077|11145062|FG002|COMPLETED|Treatment Period 2||11
10021637|NCT01845077|11145063|FG003|COMPLETED|Treatment Period 2||10
9720655|NCT00053846|10820088|FG001|STARTED|Overall Study||219
9720656|NCT00053846|10820087|FG000|COMPLETED|Overall Study||187
9720657|NCT00053846|10820088|FG001|COMPLETED|Overall Study||192
9720658|NCT00053846|10820087|FG000|NOT COMPLETED|Overall Study||26
9720659|NCT00053846|10820088|FG001|NOT COMPLETED|Overall Study||27
9720660|NCT00053898|10820096|FG000|STARTED|Overall Study||1552
9720661|NCT00053898|10820097|FG001|STARTED|Overall Study||1552
9720662|NCT00053898|10820096|FG000|COMPLETED|Overall Study||1538
9720663|NCT00053898|10820097|FG001|COMPLETED|Overall Study||1539
9720664|NCT00053898|10820096|FG000|NOT COMPLETED|Overall Study||14
9720665|NCT00053898|10820097|FG001|NOT COMPLETED|Overall Study||13
9720666|NCT00053989|10820103|FG000|STARTED|Overall Study||41
9720667|NCT00053989|10820103|FG000|COMPLETED|Overall Study||41
9720668|NCT00053989|10820103|FG000|NOT COMPLETED|Overall Study||0
9720669|NCT00054028|10820109|FG000|STARTED|Overall Study||31
9720670|NCT00054028|10820109|FG000|Phase I|Overall Study||9
9720671|NCT00054028|10820109|FG000|Phase II|Overall Study||22
9720672|NCT00054028|10820109|FG000|COMPLETED|Overall Study||31
9720673|NCT00054028|10820109|FG000|NOT COMPLETED|Overall Study||0
9720674|NCT00054132|10820114|FG000|STARTED|Overall Study||38
9720675|NCT00054132|10820114|FG000|COMPLETED|Overall Study||37
9720676|NCT00054132|10820114|FG000|NOT COMPLETED|Overall Study||1
9720677|NCT00054275|10820119|FG000|STARTED|Overall Study||39
9720678|NCT00054275|10820119|FG000|COMPLETED|Overall Study||28
9720679|NCT00054275|10820119|FG000|NOT COMPLETED|Overall Study||11
9720680|NCT00054327|10820129|FG000|STARTED|Overall Study||11
9720681|NCT00054327|10820130|FG001|STARTED|Overall Study||4
9720682|NCT00054327|10820131|FG002|STARTED|Overall Study||3
9720683|NCT00054327|10820132|FG003|STARTED|Overall Study||4
9720684|NCT00054327|10820133|FG004|STARTED|Overall Study||10
9720685|NCT00054327|10820134|FG005|STARTED|Overall Study||2
9720686|NCT00054327|10820129|FG000|COMPLETED|Overall Study||10
10021638|NCT01845077|11145064|FG004|COMPLETED|Treatment Period 2||11
10021639|NCT01845077|11145065|FG005|COMPLETED|Treatment Period 2||11
9720687|NCT00054327|10820130|FG001|COMPLETED|Overall Study||4
9720688|NCT00054327|10820131|FG002|COMPLETED|Overall Study||3
9838237|NCT00805480|10949572|FG003|Pharmacodynamic Analysis Set|Overall Study||10
9838238|NCT00805480|10949569|FG000|COMPLETED|Overall Study||16
9838239|NCT00805480|10949570|FG001|COMPLETED|Overall Study||22
9838240|NCT00805480|10949571|FG002|COMPLETED|Overall Study||19
9838241|NCT00805480|10949572|FG003|COMPLETED|Overall Study||5
9838242|NCT00805480|10949569|FG000|NOT COMPLETED|Overall Study||14
9838243|NCT00805480|10949570|FG001|NOT COMPLETED|Overall Study||7
9838244|NCT00805480|10949571|FG002|NOT COMPLETED|Overall Study||12
9838245|NCT00805480|10949572|FG003|NOT COMPLETED|Overall Study||5
9838246|NCT00805493|10949585|FG000|STARTED|Overall Study||3
9838247|NCT00805493|10949586|FG001|STARTED|Overall Study||2
9838248|NCT00805493|10949587|FG002|STARTED|Overall Study||1
9838249|NCT00805493|10949585|FG000|COMPLETED|Overall Study||1
9838250|NCT00805493|10949586|FG001|COMPLETED|Overall Study||2
9838251|NCT00805493|10949587|FG002|COMPLETED|Overall Study||0
9838252|NCT00805493|10949585|FG000|NOT COMPLETED|Overall Study||2
9838253|NCT00805493|10949586|FG001|NOT COMPLETED|Overall Study||0
9838254|NCT00805493|10949587|FG002|NOT COMPLETED|Overall Study||1
9838255|NCT00805532|10949600|FG000|STARTED|Overall Study||42
9838256|NCT00805532|10949601|FG001|STARTED|Overall Study||39
9838257|NCT00805532|10949600|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
9838258|NCT00805532|10949601|FG001|COMPLETED|Overall Study||38
9838259|NCT00805532|10949600|FG000|NOT COMPLETED|Overall Study||0
9838260|NCT00805532|10949601|FG001|NOT COMPLETED|Overall Study||1
9958948|NCT01460290|11078495|FG000|COMPLETED|Overall Study||11
9958949|NCT01460290|11078495|FG000|NOT COMPLETED|Overall Study||4
9958950|NCT01460303|11078502|FG000|STARTED|Overall Study||25
9958951|NCT01460303|11078503|FG001|STARTED|Overall Study||24
9958952|NCT01460303|11078502|FG000|COMPLETED|Overall Study||25
9958953|NCT01460303|11078503|FG001|COMPLETED|Overall Study||24
9958954|NCT01460303|11078502|FG000|NOT COMPLETED|Overall Study||0
9958955|NCT01460303|11078503|FG001|NOT COMPLETED|Overall Study||0
9958956|NCT01460342|11078511|FG000|STARTED|Overall Study||304
9958957|NCT01460342|11078512|FG001|STARTED|Overall Study||306
9958958|NCT01460342|11078511|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
9720689|NCT00054327|10820132|FG003|COMPLETED|Overall Study||4
9720690|NCT00054327|10820133|FG004|COMPLETED|Overall Study||10
9720691|NCT00054327|10820134|FG005|COMPLETED|Overall Study||2
9720692|NCT00054327|10820129|FG000|NOT COMPLETED|Overall Study||1
9720693|NCT00054327|10820130|FG001|NOT COMPLETED|Overall Study||0
9720694|NCT00054327|10820131|FG002|NOT COMPLETED|Overall Study||0
9720695|NCT00054327|10820132|FG003|NOT COMPLETED|Overall Study||0
9720696|NCT00054327|10820133|FG004|NOT COMPLETED|Overall Study||0
9720697|NCT00054327|10820134|FG005|NOT COMPLETED|Overall Study||0
9720698|NCT00054353|10820150|FG000|STARTED|Overall Study||12
9720699|NCT00054353|10820151|FG001|STARTED|Overall Study||4
9720700|NCT00054353|10820150|FG000|COMPLETED|Overall Study||12
10021640|NCT01845077|11145060|FG000|NOT COMPLETED|Treatment Period 2||0
10021641|NCT01845077|11145061|FG001|NOT COMPLETED|Treatment Period 2||0
10021642|NCT01845077|11145062|FG002|NOT COMPLETED|Treatment Period 2||0
10021643|NCT01845077|11145063|FG003|NOT COMPLETED|Treatment Period 2||0
10021644|NCT01845077|11145064|FG004|NOT COMPLETED|Treatment Period 2||0
10021645|NCT01845077|11145065|FG005|NOT COMPLETED|Treatment Period 2||0
10021646|NCT01845103|11145080|FG000|STARTED|Overall Study||1
10021647|NCT01845103|11145080|FG000|COMPLETED|Overall Study||1
9720701|NCT00054353|10820151|FG001|COMPLETED|Overall Study||4
9720702|NCT00054353|10820150|FG000|NOT COMPLETED|Overall Study||0
9720703|NCT00054353|10820151|FG001|NOT COMPLETED|Overall Study||0
9720704|NCT00054639|10820161|FG000|STARTED|Overall Study||48
9720705|NCT00054639|10820161|FG000|COMPLETED|Overall Study||46
9720706|NCT00054639|10820161|FG000|NOT COMPLETED|Overall Study||2
9720707|NCT00054665|10820165|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
9720708|NCT00054665|10820166|FG001|STARTED|Part A||0
9720709|NCT00054665|10820165|FG000|COMPLETED|Part A||23
9720710|NCT00054665|10820166|FG001|COMPLETED|Part A||0
9720711|NCT00054665|10820165|FG000|NOT COMPLETED|Part A||0
9720712|NCT00054665|10820166|FG001|NOT COMPLETED|Part A||0
9720713|NCT00054665|10820165|FG000|STARTED|Part B||0
9720714|NCT00054665|10820166|FG001|STARTED|Part B|26 participants received only Part B|44
9720715|NCT00054665|10820165|FG000|COMPLETED|Part B||0
9720716|NCT00054665|10820166|FG001|COMPLETED|Part B||44
9720717|NCT00054665|10820165|FG000|NOT COMPLETED|Part B||0
9720718|NCT00054665|10820166|FG001|NOT COMPLETED|Part B||0
9720719|NCT00054691|10820174|FG000|STARTED|Overall Study||40
9720720|NCT00054691|10820174|FG000|COMPLETED|Overall Study||37
9720721|NCT00054691|10820174|FG000|NOT COMPLETED|Overall Study||3
9720722|NCT00054704|10820180|FG000|STARTED|Overall Study||8
9720723|NCT00054704|10820181|FG001|STARTED|Overall Study||11
9720724|NCT00054704|10820180|FG000|COMPLETED|Overall Study||3
9720725|NCT00054704|10820181|FG001|COMPLETED|Overall Study||6
9720726|NCT00054704|10820180|FG000|NOT COMPLETED|Overall Study||5
9720727|NCT00054704|10820181|FG001|NOT COMPLETED|Overall Study||5
9720728|NCT00054717|10820189|FG000|STARTED|Overall Study||313
9720729|NCT00054717|10820190|FG001|STARTED|Overall Study||317
9720730|NCT00054717|10820189|FG000|COMPLETED|Overall Study||51
9720731|NCT00054717|10820190|FG001|COMPLETED|Overall Study||18
9720732|NCT00054717|10820189|FG000|NOT COMPLETED|Overall Study||262
9720733|NCT00054717|10820190|FG001|NOT COMPLETED|Overall Study||299
9720734|NCT00054756|10820196|FG000|STARTED|Overall Study||96
9720735|NCT00054756|10820196|FG000|COMPLETED|Overall Study||94
9720736|NCT00054756|10820196|FG000|NOT COMPLETED|Overall Study||2
9720737|NCT00054847|10820202|FG000|STARTED|Overall Study||367
9720738|NCT00054847|10820203|FG001|STARTED|Overall Study||366
9720739|NCT00054847|10820202|FG000|COMPLETED|Overall Study||269
9720740|NCT00054847|10820203|FG001|COMPLETED|Overall Study||266
9720741|NCT00054847|10820202|FG000|NOT COMPLETED|Overall Study||98
9720742|NCT00054847|10820203|FG001|NOT COMPLETED|Overall Study||100
9720743|NCT00055237|10820215|FG000|STARTED|Overall Study||17
9720744|NCT00055237|10820216|FG001|STARTED|Overall Study||2
9720745|NCT00055237|10820215|FG000|COMPLETED|Overall Study||17
9720746|NCT00055237|10820216|FG001|COMPLETED|Overall Study||2
9720747|NCT00055237|10820215|FG000|NOT COMPLETED|Overall Study||0
10021648|NCT01845103|11145080|FG000|NOT COMPLETED|Overall Study||0
10021649|NCT01845155|11145086|FG000|STARTED|Overall Study||146
9838261|NCT00805545|10949611|FG000|STARTED|Overall Study||200
9838262|NCT00805545|10949612|FG001|STARTED|Overall Study||200
9838263|NCT00805545|10949611|FG000|COMPLETED|Overall Study||194
9838264|NCT00805545|10949612|FG001|COMPLETED|Overall Study||197
9838265|NCT00805545|10949611|FG000|NOT COMPLETED|Overall Study||6
9838266|NCT00805545|10949612|FG001|NOT COMPLETED|Overall Study||3
9838267|NCT00805675|10949621|FG000|STARTED|Overall Study||16
9838268|NCT00805675|10949622|FG001|STARTED|Overall Study||14
9838269|NCT00805675|10949623|FG002|STARTED|Overall Study||16
9838270|NCT00805675|10949621|FG000|COMPLETED|Overall Study||16
9838271|NCT00805675|10949622|FG001|COMPLETED|Overall Study||14
9838272|NCT00805675|10949623|FG002|COMPLETED|Overall Study||15
9838273|NCT00805675|10949621|FG000|NOT COMPLETED|Overall Study||0
9838274|NCT00805675|10949622|FG001|NOT COMPLETED|Overall Study||0
9838275|NCT00805675|10949623|FG002|NOT COMPLETED|Overall Study||1
9838276|NCT00805740|10949633|FG000|STARTED|Overall Study||28
9838277|NCT00805740|10949634|FG001|STARTED|Overall Study||13
9838278|NCT00805740|10949633|FG000|Treated|Overall Study||26
9838279|NCT00805740|10949634|FG001|Treated|Overall Study||13
9838280|NCT00805740|10949633|FG000|COMPLETED|Overall Study||17
9838281|NCT00805740|10949634|FG001|COMPLETED|Overall Study||9
9838282|NCT00805740|10949633|FG000|NOT COMPLETED|Overall Study||11
9838283|NCT00805740|10949634|FG001|NOT COMPLETED|Overall Study||4
9838284|NCT00805766|10949640|FG000|STARTED|Screening Period||45
9838285|NCT00805766|10949640|FG000|COMPLETED|Screening Period||39
9838286|NCT00805766|10949640|FG000|NOT COMPLETED|Screening Period||6
9838287|NCT00805766|10949640|FG000|STARTED|Increased Dose Period||39
9838288|NCT00805766|10949640|FG000|COMPLETED|Increased Dose Period||26
9838289|NCT00805766|10949640|FG000|NOT COMPLETED|Increased Dose Period||13
9838290|NCT00805792|10949648|FG000|STARTED|Overall Study||33
9838291|NCT00805792|10949648|FG000|COMPLETED|Overall Study||28
9838292|NCT00805792|10949648|FG000|NOT COMPLETED|Overall Study||5
9838293|NCT00805870|10949654|FG000|STARTED|Overall Study||10
9838294|NCT00805870|10949655|FG001|STARTED|Overall Study||10
9838295|NCT00805870|10949654|FG000|COMPLETED|Overall Study||10
9838296|NCT00805870|10949655|FG001|COMPLETED|Overall Study||10
9838297|NCT00805870|10949654|FG000|NOT COMPLETED|Overall Study||0
9838298|NCT00805870|10949655|FG001|NOT COMPLETED|Overall Study||0
9838299|NCT00805935|10949665|FG000|STARTED|Overall Study||25
9838300|NCT00805935|10949666|FG001|STARTED|Overall Study||27
9838301|NCT00805935|10949667|FG002|STARTED|Overall Study||28
9838302|NCT00805935|10949668|FG003|STARTED|Overall Study||30
9838303|NCT00805935|10949665|FG000|COMPLETED|Overall Study||12
9838304|NCT00805935|10949666|FG001|COMPLETED|Overall Study||8
9838305|NCT00805935|10949667|FG002|COMPLETED|Overall Study||13
9838306|NCT00805935|10949668|FG003|COMPLETED|Overall Study||19
9838307|NCT00805935|10949665|FG000|NOT COMPLETED|Overall Study||13
9838308|NCT00805935|10949666|FG001|NOT COMPLETED|Overall Study||19
9838309|NCT00805935|10949667|FG002|NOT COMPLETED|Overall Study||15
9838310|NCT00805935|10949668|FG003|NOT COMPLETED|Overall Study||11
9838311|NCT00805948|10949682|FG000|STARTED|Overall Study||154
9838312|NCT00805948|10949683|FG001|STARTED|Overall Study||195
9838313|NCT00805948|10949682|FG000|COMPLETED|Overall Study||86
9838314|NCT00805948|10949683|FG001|COMPLETED|Overall Study||99
9838315|NCT00805948|10949682|FG000|NOT COMPLETED|Overall Study||68
9838316|NCT00805948|10949683|FG001|NOT COMPLETED|Overall Study||96
9838317|NCT00806026|10949696|FG000|STARTED|Overall Study||185
9838318|NCT00806026|10949697|FG001|STARTED|Overall Study||183
9838319|NCT00806026|10949698|FG002|STARTED|Overall Study||182
9838320|NCT00806026|10949699|FG003|STARTED|Overall Study||61
9838321|NCT00806026|10949700|FG004|STARTED|Overall Study||59
9838322|NCT00806026|10949701|FG005|STARTED|Overall Study||61
9838323|NCT00806026|10949696|FG000|Treated|Overall Study||182
9838324|NCT00806026|10949697|FG001|Treated|Overall Study||178
9838325|NCT00806026|10949698|FG002|Treated|Overall Study||180
9838326|NCT00806026|10949699|FG003|Treated|Overall Study||59
9838327|NCT00806026|10949700|FG004|Treated|Overall Study||59
9838328|NCT00806026|10949701|FG005|Treated|Overall Study||61
9838329|NCT00806026|10949696|FG000|COMPLETED|Overall Study||93
9838330|NCT00806026|10949697|FG001|COMPLETED|Overall Study||82
9838331|NCT00806026|10949698|FG002|COMPLETED|Overall Study||89
9838332|NCT00806026|10949699|FG003|COMPLETED|Overall Study||32
9838333|NCT00806026|10949700|FG004|COMPLETED|Overall Study||29
9838334|NCT00806026|10949701|FG005|COMPLETED|Overall Study||29
9838335|NCT00806026|10949696|FG000|NOT COMPLETED|Overall Study||92
9838336|NCT00806026|10949697|FG001|NOT COMPLETED|Overall Study||101
10021650|NCT01845155|11145087|FG001|STARTED|Overall Study||144
10021651|NCT01845155|11145086|FG000|COMPLETED|Overall Study||145
9838337|NCT00806026|10949698|FG002|NOT COMPLETED|Overall Study||93
10021652|NCT01845155|11145087|FG001|COMPLETED|Overall Study||144
9838338|NCT00806026|10949699|FG003|NOT COMPLETED|Overall Study||29
9838339|NCT00806026|10949700|FG004|NOT COMPLETED|Overall Study||30
9838340|NCT00806026|10949701|FG005|NOT COMPLETED|Overall Study||32
9838341|NCT00806078|10949715|FG000|STARTED|First Intervention||9
9838342|NCT00806078|10949716|FG001|STARTED|First Intervention||9
9838343|NCT00806078|10949715|FG000|COMPLETED|First Intervention||9
9838344|NCT00806078|10949716|FG001|COMPLETED|First Intervention||9
9958959|NCT01460342|11078512|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306
9958960|NCT01460342|11078511|FG000|COMPLETED|Overall Study||293
9958961|NCT01460342|11078512|FG001|COMPLETED|Overall Study||292
9958962|NCT01460342|11078511|FG000|NOT COMPLETED|Overall Study||11
9958963|NCT01460342|11078512|FG001|NOT COMPLETED|Overall Study||14
9958964|NCT01460368|11078520|FG000|STARTED|Part A||7
9958965|NCT01460368|11078521|FG001|STARTED|Part A||0
9958966|NCT01460368|11078522|FG002|STARTED|Part A||0
9958967|NCT01460368|11078523|FG003|STARTED|Part A||0
9958968|NCT01460368|11078524|FG004|STARTED|Part A||0
9958969|NCT01460368|11078525|FG005|STARTED|Part A||0
9958970|NCT01460368|11078526|FG006|STARTED|Part A||0
9958971|NCT01460368|11078520|FG000|Received at Least One Dose of Study Drug|Part A||7
9958972|NCT01460368|11078521|FG001|Received at Least One Dose of Study Drug|Part A||0
9958973|NCT01460368|11078522|FG002|Received at Least One Dose of Study Drug|Part A||0
9958974|NCT01460368|11078523|FG003|Received at Least One Dose of Study Drug|Part A||0
9958975|NCT01460368|11078524|FG004|Received at Least One Dose of Study Drug|Part A||0
9958976|NCT01460368|11078525|FG005|Received at Least One Dose of Study Drug|Part A||0
9958977|NCT01460368|11078526|FG006|Received at Least One Dose of Study Drug|Part A||0
9958978|NCT01460368|11078520|FG000|COMPLETED|Part A||7
9958979|NCT01460368|11078521|FG001|COMPLETED|Part A||0
9958980|NCT01460368|11078522|FG002|COMPLETED|Part A||0
9958981|NCT01460368|11078523|FG003|COMPLETED|Part A||0
9958982|NCT01460368|11078524|FG004|COMPLETED|Part A||0
9958983|NCT01460368|11078525|FG005|COMPLETED|Part A||0
9958984|NCT01460368|11078526|FG006|COMPLETED|Part A||0
9958985|NCT01460368|11078520|FG000|NOT COMPLETED|Part A||0
9958986|NCT01460368|11078521|FG001|NOT COMPLETED|Part A||0
9958987|NCT01460368|11078522|FG002|NOT COMPLETED|Part A||0
9958988|NCT01460368|11078523|FG003|NOT COMPLETED|Part A||0
9958989|NCT01460368|11078524|FG004|NOT COMPLETED|Part A||0
9958990|NCT01460368|11078525|FG005|NOT COMPLETED|Part A||0
9958991|NCT01460368|11078526|FG006|NOT COMPLETED|Part A||0
9958992|NCT01460368|11078520|FG000|STARTED|Part B: First Intervention (Period 1)||0
9958993|NCT01460368|11078521|FG001|STARTED|Part B: First Intervention (Period 1)||10
9958994|NCT01460368|11078522|FG002|STARTED|Part B: First Intervention (Period 1)||10
9958995|NCT01460368|11078523|FG003|STARTED|Part B: First Intervention (Period 1)||10
9958996|NCT01460368|11078524|FG004|STARTED|Part B: First Intervention (Period 1)||10
9958997|NCT01460368|11078525|FG005|STARTED|Part B: First Intervention (Period 1)||10
9958998|NCT01460368|11078526|FG006|STARTED|Part B: First Intervention (Period 1)||10
9958999|NCT01460368|11078520|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
9959000|NCT01460368|11078521|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
9959001|NCT01460368|11078522|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
9959002|NCT01460368|11078523|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
9959003|NCT01460368|11078524|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
9959004|NCT01460368|11078525|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
9959005|NCT01460368|11078526|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
9959006|NCT01460368|11078520|FG000|COMPLETED|Part B: First Intervention (Period 1)||0
9959007|NCT01460368|11078521|FG001|COMPLETED|Part B: First Intervention (Period 1)||10
9959008|NCT01460368|11078522|FG002|COMPLETED|Part B: First Intervention (Period 1)||10
9959009|NCT01460368|11078523|FG003|COMPLETED|Part B: First Intervention (Period 1)||10
9959010|NCT01460368|11078524|FG004|COMPLETED|Part B: First Intervention (Period 1)||9
9959011|NCT01460368|11078525|FG005|COMPLETED|Part B: First Intervention (Period 1)||10
9959012|NCT01460368|11078526|FG006|COMPLETED|Part B: First Intervention (Period 1)||10
9959013|NCT01460368|11078520|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0
9838345|NCT00806078|10949715|FG000|NOT COMPLETED|First Intervention||0
9838346|NCT00806078|10949716|FG001|NOT COMPLETED|First Intervention||0
9959014|NCT01460368|11078521|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0
9959015|NCT01460368|11078522|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0
9959016|NCT01460368|11078523|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0
9959017|NCT01460368|11078524|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1
9959018|NCT01460368|11078525|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0
9720748|NCT00055237|10820216|FG001|NOT COMPLETED|Overall Study||0
9720749|NCT00055471|10820224|FG000|STARTED|Period 1: Dose Escalation Period||3
9720750|NCT00055471|10820225|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
9720751|NCT00055471|10820226|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
9720752|NCT00055471|10820224|FG000|COMPLETED|Period 1: Dose Escalation Period||3
9720753|NCT00055471|10820225|FG001|COMPLETED|Period 1: Dose Escalation Period||8
9720754|NCT00055471|10820226|FG002|COMPLETED|Period 1: Dose Escalation Period||0
9720755|NCT00055471|10820224|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0
9720756|NCT00055471|10820225|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2
9720757|NCT00055471|10820226|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3
9720758|NCT00055471|10820224|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
9720759|NCT00055471|10820225|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
9720760|NCT00055471|10820226|FG002|STARTED|Period 2: Extension Period||0
9720761|NCT00055471|10820224|FG000|COMPLETED|Period 2: Extension Period||3
9720762|NCT00055471|10820225|FG001|COMPLETED|Period 2: Extension Period||6
9720763|NCT00055471|10820226|FG002|COMPLETED|Period 2: Extension Period||0
9720764|NCT00055471|10820224|FG000|NOT COMPLETED|Period 2: Extension Period||0
9720765|NCT00055471|10820225|FG001|NOT COMPLETED|Period 2: Extension Period||0
9720766|NCT00055471|10820226|FG002|NOT COMPLETED|Period 2: Extension Period||0
9720767|NCT00055497|10820238|FG000|STARTED|Overall Study||18
9720768|NCT00055497|10820239|FG001|STARTED|Overall Study||19
9720769|NCT00055497|10820240|FG002|STARTED|Overall Study||18
9720770|NCT00055497|10820241|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
9720771|NCT00055497|10820238|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
9720772|NCT00055497|10820239|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
9720773|NCT00055497|10820240|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
9720774|NCT00055497|10820241|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
9720775|NCT00055497|10820238|FG000|NOT COMPLETED|Overall Study||5
9720776|NCT00055497|10820239|FG001|NOT COMPLETED|Overall Study||3
9720777|NCT00055497|10820240|FG002|NOT COMPLETED|Overall Study||2
9720778|NCT00055497|10820241|FG003|NOT COMPLETED|Overall Study||90
9720779|NCT00055601|10820258|FG000|STARTED|Overall Study||48
9720780|NCT00055601|10820259|FG001|STARTED|Overall Study||49
9838347|NCT00806078|10949715|FG000|STARTED|7 Day Washout Period||9
9838348|NCT00806078|10949716|FG001|STARTED|7 Day Washout Period||9
9838349|NCT00806078|10949715|FG000|COMPLETED|7 Day Washout Period||9
9838350|NCT00806078|10949716|FG001|COMPLETED|7 Day Washout Period||9
9838351|NCT00806078|10949715|FG000|NOT COMPLETED|7 Day Washout Period||0
9838352|NCT00806078|10949716|FG001|NOT COMPLETED|7 Day Washout Period||0
9838353|NCT00806078|10949715|FG000|STARTED|Second Intervention||9
9838354|NCT00806078|10949716|FG001|STARTED|Second Intervention||9
9838355|NCT00806078|10949715|FG000|COMPLETED|Second Intervention||9
9838356|NCT00806078|10949716|FG001|COMPLETED|Second Intervention||9
9838357|NCT00806078|10949715|FG000|NOT COMPLETED|Second Intervention||0
9838358|NCT00806078|10949716|FG001|NOT COMPLETED|Second Intervention||0
9838359|NCT00806156|10949724|FG000|STARTED|Overall Study||39
9838360|NCT00806156|10949725|FG001|STARTED|Overall Study||139
9838361|NCT00806156|10949724|FG000|COMPLETED|Overall Study||0
9838362|NCT00806156|10949725|FG001|COMPLETED|Overall Study||0
9838363|NCT00806156|10949724|FG000|NOT COMPLETED|Overall Study||39
9838364|NCT00806156|10949725|FG001|NOT COMPLETED|Overall Study||139
9838365|NCT00806195|10949747|FG000|STARTED|Overall Study||4363
9838366|NCT00806195|10949748|FG001|STARTED|Overall Study||1483
9838367|NCT00806195|10949749|FG002|STARTED|Overall Study||1409
9838368|NCT00806195|10949750|FG003|STARTED|Overall Study||489
9838369|NCT00806195|10949747|FG000|COMPLETED|Overall Study||3849
9838370|NCT00806195|10949748|FG001|COMPLETED|Overall Study||1321
9838371|NCT00806195|10949749|FG002|COMPLETED|Overall Study||1139
9838372|NCT00806195|10949750|FG003|COMPLETED|Overall Study||383
9838373|NCT00806195|10949747|FG000|NOT COMPLETED|Overall Study||514
10021653|NCT01845155|11145086|FG000|NOT COMPLETED|Overall Study||1
10021654|NCT01845155|11145087|FG001|NOT COMPLETED|Overall Study||0
10021655|NCT01845220|11145093|FG000|STARTED|Overall Study||30
10021656|NCT01845220|11145094|FG001|STARTED|Overall Study||30
10021657|NCT01845220|11145093|FG000|COMPLETED|Overall Study||30
10021658|NCT01845220|11145094|FG001|COMPLETED|Overall Study||30
9838374|NCT00806195|10949748|FG001|NOT COMPLETED|Overall Study||162
9838375|NCT00806195|10949749|FG002|NOT COMPLETED|Overall Study||270
9838376|NCT00806195|10949750|FG003|NOT COMPLETED|Overall Study||106
9838377|NCT00806221|10949762|FG000|STARTED|Overall Study||22
9838378|NCT00806221|10949762|FG000|COMPLETED|Overall Study||20
9838379|NCT00806221|10949762|FG000|NOT COMPLETED|Overall Study||2
10021659|NCT01845220|11145093|FG000|NOT COMPLETED|Overall Study||0
9838380|NCT00806234|10949769|FG000|STARTED|Overall Study||47
9838381|NCT00806234|10949770|FG001|STARTED|Overall Study||31
9838382|NCT00806234|10949771|FG002|STARTED|Overall Study||49
9838383|NCT00806234|10949769|FG000|COMPLETED|Overall Study||34
9838384|NCT00806234|10949770|FG001|COMPLETED|Overall Study||19
9838385|NCT00806234|10949771|FG002|COMPLETED|Overall Study||37
9838386|NCT00806234|10949769|FG000|NOT COMPLETED|Overall Study||13
9838387|NCT00806234|10949770|FG001|NOT COMPLETED|Overall Study||12
9838388|NCT00806234|10949771|FG002|NOT COMPLETED|Overall Study||12
9838389|NCT00806260|10949785|FG000|STARTED|Period 1 (1 Day)||15
9838390|NCT00806260|10949786|FG001|STARTED|Period 1 (1 Day)||8
9838391|NCT00806260|10949787|FG002|STARTED|Period 1 (1 Day)||8
9838392|NCT00806260|10949788|FG003|STARTED|Period 1 (1 Day)||14
9838393|NCT00806260|10949789|FG004|STARTED|Period 1 (1 Day)||18
9838394|NCT00806260|10949790|FG005|STARTED|Period 1 (1 Day)||17
9838395|NCT00806260|10949785|FG000|COMPLETED|Period 1 (1 Day)||15
9838396|NCT00806260|10949786|FG001|COMPLETED|Period 1 (1 Day)||8
9838397|NCT00806260|10949787|FG002|COMPLETED|Period 1 (1 Day)||8
9838398|NCT00806260|10949788|FG003|COMPLETED|Period 1 (1 Day)||14
9838399|NCT00806260|10949789|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
9838400|NCT00806260|10949790|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
9959019|NCT01460368|11078526|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0
9959020|NCT01460368|11078520|FG000|STARTED|Part B: Washout (up to 15 Days)||0
9959021|NCT01460368|11078521|FG001|STARTED|Part B: Washout (up to 15 Days)||10
9959022|NCT01460368|11078522|FG002|STARTED|Part B: Washout (up to 15 Days)||10
9959023|NCT01460368|11078523|FG003|STARTED|Part B: Washout (up to 15 Days)||10
9959024|NCT01460368|11078524|FG004|STARTED|Part B: Washout (up to 15 Days)||9
9959025|NCT01460368|11078525|FG005|STARTED|Part B: Washout (up to 15 Days)||10
9959026|NCT01460368|11078526|FG006|STARTED|Part B: Washout (up to 15 Days)||10
9959027|NCT01460368|11078520|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
9959028|NCT01460368|11078521|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10
9959029|NCT01460368|11078522|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10
9959030|NCT01460368|11078523|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
9959031|NCT01460368|11078524|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
9959032|NCT01460368|11078525|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
9959033|NCT01460368|11078526|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10
9959034|NCT01460368|11078520|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9838401|NCT00806260|10949785|FG000|NOT COMPLETED|Period 1 (1 Day)||0
9838402|NCT00806260|10949786|FG001|NOT COMPLETED|Period 1 (1 Day)||0
9838403|NCT00806260|10949787|FG002|NOT COMPLETED|Period 1 (1 Day)||0
9838404|NCT00806260|10949788|FG003|NOT COMPLETED|Period 1 (1 Day)||0
9838405|NCT00806260|10949789|FG004|NOT COMPLETED|Period 1 (1 Day)||3
10021660|NCT01845220|11145094|FG001|NOT COMPLETED|Overall Study||0
10021661|NCT01845636|11145100|FG000|STARTED|Overall Study||41
10021662|NCT01845636|11145100|FG000|COMPLETED|Overall Study||37
10021663|NCT01845636|11145100|FG000|NOT COMPLETED|Overall Study||4
10021664|NCT01845792|11145106|FG000|STARTED|Overall Study||5
9838406|NCT00806260|10949790|FG005|NOT COMPLETED|Period 1 (1 Day)||0
9838407|NCT00806260|10949785|FG000|STARTED|Period 2||15
9838408|NCT00806260|10949786|FG001|STARTED|Period 2||8
9838409|NCT00806260|10949787|FG002|STARTED|Period 2||8
9838410|NCT00806260|10949788|FG003|STARTED|Period 2||14
9838411|NCT00806260|10949789|FG004|STARTED|Period 2||0
9838412|NCT00806260|10949790|FG005|STARTED|Period 2||0
9838413|NCT00806260|10949785|FG000|COMPLETED|Period 2||13
9838414|NCT00806260|10949786|FG001|COMPLETED|Period 2||8
9838415|NCT00806260|10949787|FG002|COMPLETED|Period 2||6
9838416|NCT00806260|10949788|FG003|COMPLETED|Period 2||12
9838417|NCT00806260|10949789|FG004|COMPLETED|Period 2||0
9838418|NCT00806260|10949790|FG005|COMPLETED|Period 2||0
9838419|NCT00806260|10949785|FG000|NOT COMPLETED|Period 2||2
9838420|NCT00806260|10949786|FG001|NOT COMPLETED|Period 2||0
9838421|NCT00806260|10949787|FG002|NOT COMPLETED|Period 2||2
9838422|NCT00806260|10949788|FG003|NOT COMPLETED|Period 2||2
9838423|NCT00806260|10949789|FG004|NOT COMPLETED|Period 2||0
9838424|NCT00806260|10949790|FG005|NOT COMPLETED|Period 2||0
9838425|NCT00806260|10949785|FG000|STARTED|Period 3||13
9838426|NCT00806260|10949786|FG001|STARTED|Period 3||8
9838427|NCT00806260|10949787|FG002|STARTED|Period 3||6
9838428|NCT00806260|10949788|FG003|STARTED|Period 3||12
9838429|NCT00806260|10949789|FG004|STARTED|Period 3||0
9838430|NCT00806260|10949790|FG005|STARTED|Period 3||0
9838431|NCT00806260|10949785|FG000|COMPLETED|Period 3||12
9838432|NCT00806260|10949786|FG001|COMPLETED|Period 3||7
9838433|NCT00806260|10949787|FG002|COMPLETED|Period 3||5
9838434|NCT00806260|10949788|FG003|COMPLETED|Period 3||12
9838435|NCT00806260|10949789|FG004|COMPLETED|Period 3||0
9838436|NCT00806260|10949790|FG005|COMPLETED|Period 3||0
9838437|NCT00806260|10949785|FG000|NOT COMPLETED|Period 3||1
9838438|NCT00806260|10949786|FG001|NOT COMPLETED|Period 3||1
9838439|NCT00806260|10949787|FG002|NOT COMPLETED|Period 3||1
9838440|NCT00806260|10949788|FG003|NOT COMPLETED|Period 3||0
9838441|NCT00806260|10949789|FG004|NOT COMPLETED|Period 3||0
9838442|NCT00806260|10949790|FG005|NOT COMPLETED|Period 3||0
9838443|NCT00806286|10949805|FG000|STARTED|Overall Study||54
9838444|NCT00806286|10949806|FG001|STARTED|Overall Study||54
9838445|NCT00806286|10949807|FG002|STARTED|Overall Study||3
9838446|NCT00806286|10949805|FG000|COMPLETED|Overall Study||0
9838447|NCT00806286|10949806|FG001|COMPLETED|Overall Study||0
9838448|NCT00806286|10949807|FG002|COMPLETED|Overall Study||0
9838449|NCT00806286|10949805|FG000|NOT COMPLETED|Overall Study||54
9838450|NCT00806286|10949806|FG001|NOT COMPLETED|Overall Study||54
9838451|NCT00806286|10949807|FG002|NOT COMPLETED|Overall Study||3
9838452|NCT00806351|10949817|FG000|STARTED|Overall Study||15
9838453|NCT00806351|10949818|FG001|STARTED|Overall Study||6
9838454|NCT00806351|10949817|FG000|COMPLETED|Overall Study||10
9838455|NCT00806351|10949818|FG001|COMPLETED|Overall Study||2
9838456|NCT00806351|10949817|FG000|NOT COMPLETED|Overall Study||5
9838457|NCT00806351|10949818|FG001|NOT COMPLETED|Overall Study||4
9838458|NCT00806442|10949824|FG000|STARTED|Overall Study||18
9838459|NCT00806442|10949825|FG001|STARTED|Overall Study||21
9838460|NCT00806442|10949824|FG000|First Intervention (3 Wks)|Overall Study||18
9838461|NCT00806442|10949825|FG001|First Intervention (3 Wks)|Overall Study||21
9838462|NCT00806442|10949824|FG000|Washout (3 Wks)|Overall Study||15
9838463|NCT00806442|10949825|FG001|Washout (3 Wks)|Overall Study||14
9838464|NCT00806442|10949824|FG000|Second Intervention (3 Wks)|Overall Study||15
9838465|NCT00806442|10949825|FG001|Second Intervention (3 Wks)|Overall Study||14
9838466|NCT00806442|10949824|FG000|COMPLETED|Overall Study||14
9838467|NCT00806442|10949825|FG001|COMPLETED|Overall Study||14
9838468|NCT00806442|10949824|FG000|NOT COMPLETED|Overall Study||4
9838469|NCT00806442|10949825|FG001|NOT COMPLETED|Overall Study||7
9838470|NCT00806494|10949833|FG000|STARTED|Overall Study||331
9838471|NCT00806494|10949833|FG000|COMPLETED|Overall Study||251
9838472|NCT00806494|10949833|FG000|NOT COMPLETED|Overall Study||80
9720781|NCT00055601|10820258|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
9720782|NCT00055601|10820259|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
9720783|NCT00055601|10820258|FG000|NOT COMPLETED|Overall Study||2
9720784|NCT00055601|10820259|FG001|NOT COMPLETED|Overall Study||2
9720785|NCT00055692|10820265|FG000|STARTED|Overall Study||46
9720786|NCT00055692|10820265|FG000|COMPLETED|Overall Study||46
9720787|NCT00055692|10820265|FG000|NOT COMPLETED|Overall Study||0
9720788|NCT00056160|10820273|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177
9720789|NCT00056160|10820274|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176
9720790|NCT00056160|10820273|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64
9720791|NCT00056160|10820274|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13
9720792|NCT00056160|10820273|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
9720793|NCT00056160|10820274|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
9720794|NCT00056160|10820273|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
9720795|NCT00056160|10820274|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
9720796|NCT00056160|10820273|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
9720797|NCT00056160|10820274|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
9720798|NCT00056160|10820273|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
9720799|NCT00056160|10820274|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
9720800|NCT00056160|10820273|FG000|STARTED|Final Follow-up||6
9720801|NCT00056160|10820274|FG001|STARTED|Final Follow-up||0
9720802|NCT00056160|10820273|FG000|COMPLETED|Final Follow-up||0
9720803|NCT00056160|10820274|FG001|COMPLETED|Final Follow-up||0
9720804|NCT00056160|10820273|FG000|NOT COMPLETED|Final Follow-up||6
9720805|NCT00056160|10820274|FG001|NOT COMPLETED|Final Follow-up||0
9720806|NCT00056316|10820282|FG000|STARTED|Overall Study||33
9720807|NCT00056316|10820283|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
9720808|NCT00056316|10820282|FG000|COMPLETED|Overall Study||30
9720809|NCT00056316|10820283|FG001|COMPLETED|Overall Study||38
10021665|NCT01845792|11145107|FG001|STARTED|Overall Study||2
10021666|NCT01845792|11145106|FG000|COMPLETED|Overall Study||5
10021667|NCT01845792|11145107|FG001|COMPLETED|Overall Study||2
10021668|NCT01845792|11145106|FG000|NOT COMPLETED|Overall Study||0
10021669|NCT01845792|11145107|FG001|NOT COMPLETED|Overall Study||0
10021670|NCT01845818|11145115|FG000|STARTED|Overall Study||126
10021671|NCT01845818|11145116|FG001|STARTED|Overall Study||57
10021672|NCT01845818|11145115|FG000|COMPLETED|Overall Study||81
10021673|NCT01845818|11145116|FG001|COMPLETED|Overall Study||40
10021674|NCT01845818|11145115|FG000|NOT COMPLETED|Overall Study||45
10021675|NCT01845818|11145116|FG001|NOT COMPLETED|Overall Study||17
10021676|NCT01845831|11145126|FG000|STARTED|Inpatient Phase||140
10021677|NCT01845831|11145127|FG001|STARTED|Inpatient Phase||139
9720810|NCT00056316|10820282|FG000|NOT COMPLETED|Overall Study||3
9720811|NCT00056316|10820283|FG001|NOT COMPLETED|Overall Study||3
9720812|NCT00056407|10820291|FG000|STARTED|Overall Study||4126
9720813|NCT00056407|10820292|FG001|STARTED|Overall Study||4105
10021678|NCT01845831|11145128|FG002|STARTED|Inpatient Phase||0
10021679|NCT01845831|11145129|FG003|STARTED|Inpatient Phase||0
10021680|NCT01845831|11145130|FG004|STARTED|Inpatient Phase||0
10021681|NCT01845831|11145126|FG000|COMPLETED|Inpatient Phase||139
9720814|NCT00056407|10820291|FG000|COMPLETED|Overall Study||2915
10021682|NCT01845831|11145127|FG001|COMPLETED|Inpatient Phase||138
10021683|NCT01845831|11145128|FG002|COMPLETED|Inpatient Phase||0
9720815|NCT00056407|10820292|FG001|COMPLETED|Overall Study||2912
9720816|NCT00056407|10820291|FG000|NOT COMPLETED|Overall Study||1211
9720817|NCT00056407|10820292|FG001|NOT COMPLETED|Overall Study||1193
9720818|NCT00056472|10820300|FG000|STARTED|Overall Study||129
9720819|NCT00056472|10820301|FG001|STARTED|Overall Study||130
9720820|NCT00056472|10820300|FG000|COMPLETED|Overall Study||81
9720821|NCT00056472|10820301|FG001|COMPLETED|Overall Study||61
9720822|NCT00056472|10820300|FG000|NOT COMPLETED|Overall Study||48
9720823|NCT00056472|10820301|FG001|NOT COMPLETED|Overall Study||69
9720824|NCT00056498|10820309|FG000|STARTED|Overall Study||30
9720825|NCT00056498|10820310|FG001|STARTED|Overall Study||35
9720826|NCT00056498|10820309|FG000|COMPLETED|Overall Study||25
9720827|NCT00056498|10820310|FG001|COMPLETED|Overall Study||28
9720828|NCT00056498|10820309|FG000|NOT COMPLETED|Overall Study||5
9720829|NCT00056498|10820310|FG001|NOT COMPLETED|Overall Study||7
9720830|NCT00056550|10820316|FG000|STARTED|Overall Study||14
9720831|NCT00056550|10820316|FG000|COMPLETED|Overall Study||14
9720832|NCT00056550|10820316|FG000|NOT COMPLETED|Overall Study||0
9720833|NCT00056563|10820323|FG000|STARTED|Overall Study||121
9720834|NCT00056563|10820324|FG001|STARTED|Overall Study||134
9720835|NCT00056563|10820323|FG000|COMPLETED|Overall Study||121
9720836|NCT00056563|10820324|FG001|COMPLETED|Overall Study||134
9720837|NCT00056563|10820323|FG000|NOT COMPLETED|Overall Study||0
9720838|NCT00056563|10820324|FG001|NOT COMPLETED|Overall Study||0
9720839|NCT00056862|10820332|FG000|STARTED|Overall Study||31
9838473|NCT00806546|10949838|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
9838474|NCT00806546|10949838|FG000|COMPLETED|Overall Study||207
9838475|NCT00806546|10949838|FG000|NOT COMPLETED|Overall Study||307
9838476|NCT00806585|10949847|FG000|STARTED|Overall Study||137
9838477|NCT00806585|10949848|FG001|STARTED|Overall Study||134
9838478|NCT00806585|10949849|FG002|STARTED|Overall Study||141
9838479|NCT00806585|10949850|FG003|STARTED|Overall Study||71
9838480|NCT00806585|10949851|FG004|STARTED|Overall Study||137
9838481|NCT00806585|10949847|FG000|COMPLETED|Overall Study||105
9838482|NCT00806585|10949848|FG001|COMPLETED|Overall Study||103
9838483|NCT00806585|10949849|FG002|COMPLETED|Overall Study||109
9838484|NCT00806585|10949850|FG003|COMPLETED|Overall Study||56
9838485|NCT00806585|10949851|FG004|COMPLETED|Overall Study||106
9838486|NCT00806585|10949847|FG000|NOT COMPLETED|Overall Study||32
9838487|NCT00806585|10949848|FG001|NOT COMPLETED|Overall Study||31
9838488|NCT00806585|10949849|FG002|NOT COMPLETED|Overall Study||32
9838489|NCT00806585|10949850|FG003|NOT COMPLETED|Overall Study||15
9838490|NCT00806585|10949851|FG004|NOT COMPLETED|Overall Study||31
9838491|NCT00806598|10949863|FG000|STARTED|Overall Study||48
9838492|NCT00806598|10949863|FG000|COMPLETED|Overall Study||48
9838493|NCT00806598|10949863|FG000|NOT COMPLETED|Overall Study||0
9838494|NCT00806624|10949870|FG000|STARTED|Overall Study||79
9838495|NCT00806624|10949871|FG001|STARTED|Overall Study||80
9838496|NCT00806624|10949872|FG002|STARTED|Overall Study||75
9838497|NCT00806624|10949870|FG000|COMPLETED|Overall Study||70
9838498|NCT00806624|10949871|FG001|COMPLETED|Overall Study||68
9838499|NCT00806624|10949872|FG002|COMPLETED|Overall Study||69
9838500|NCT00806624|10949870|FG000|NOT COMPLETED|Overall Study||9
9838501|NCT00806624|10949871|FG001|NOT COMPLETED|Overall Study||12
9838502|NCT00806624|10949872|FG002|NOT COMPLETED|Overall Study||6
9838503|NCT00806676|10949883|FG000|STARTED|Overall Study||29
9838504|NCT00806676|10949884|FG001|STARTED|Overall Study||9
9838505|NCT00806676|10949885|FG002|STARTED|Overall Study||29
9838506|NCT00806676|10949883|FG000|COMPLETED|Overall Study||25
9838507|NCT00806676|10949884|FG001|COMPLETED|Overall Study||9
9838508|NCT00806676|10949885|FG002|COMPLETED|Overall Study||23
9838509|NCT00806676|10949883|FG000|NOT COMPLETED|Overall Study||4
9838510|NCT00806676|10949884|FG001|NOT COMPLETED|Overall Study||0
9838511|NCT00806676|10949885|FG002|NOT COMPLETED|Overall Study||6
9838512|NCT00806819|10949896|FG000|STARTED|Overall Study|randomised patients|353
9838513|NCT00806819|10949897|FG001|STARTED|Overall Study|randomised patients|360
9959035|NCT01460368|11078521|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959036|NCT01460368|11078522|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959037|NCT01460368|11078523|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9720840|NCT00056862|10820333|FG001|STARTED|Overall Study||27
9720841|NCT00056862|10820332|FG000|COMPLETED|Overall Study||30
9720842|NCT00056862|10820333|FG001|COMPLETED|Overall Study||27
9720843|NCT00056862|10820332|FG000|NOT COMPLETED|Overall Study||1
9720844|NCT00056862|10820333|FG001|NOT COMPLETED|Overall Study||0
9720845|NCT00057330|10820341|FG000|STARTED|Overall Study||4577
9720846|NCT00057330|10820342|FG001|STARTED|Overall Study||3746
9720847|NCT00057330|10820341|FG000|COMPLETED|Overall Study||3445
9720848|NCT00057330|10820342|FG001|COMPLETED|Overall Study||2826
9720849|NCT00057330|10820341|FG000|NOT COMPLETED|Overall Study||1132
9720850|NCT00057330|10820342|FG001|NOT COMPLETED|Overall Study||920
9720851|NCT00057551|10820351|FG000|STARTED|Overall Study||200
9720852|NCT00057551|10820352|FG001|STARTED|Overall Study||195
9720853|NCT00057551|10820353|FG002|STARTED|Overall Study||96
9720854|NCT00057551|10820351|FG000|COMPLETED|Overall Study||175
9720855|NCT00057551|10820352|FG001|COMPLETED|Overall Study||168
9720856|NCT00057551|10820353|FG002|COMPLETED|Overall Study||80
9720857|NCT00057551|10820351|FG000|NOT COMPLETED|Overall Study||25
9720858|NCT00057551|10820352|FG001|NOT COMPLETED|Overall Study||27
9720859|NCT00057551|10820353|FG002|NOT COMPLETED|Overall Study||16
9720860|NCT00057577|10820363|FG000|STARTED|Overall Study||227
9838514|NCT00806819|10949896|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
9838515|NCT00806819|10949897|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
9838516|NCT00806819|10949896|FG000|NOT COMPLETED|Overall Study||346
9838517|NCT00806819|10949897|FG001|NOT COMPLETED|Overall Study||358
9838518|NCT00806988|10949906|FG000|STARTED|Overall Study||150
9838519|NCT00806988|10949907|FG001|STARTED|Overall Study||151
9838520|NCT00806988|10949906|FG000|COMPLETED|Overall Study||123
9838521|NCT00806988|10949907|FG001|COMPLETED|Overall Study||108
9838522|NCT00806988|10949906|FG000|NOT COMPLETED|Overall Study||27
9838523|NCT00806988|10949907|FG001|NOT COMPLETED|Overall Study||43
9838524|NCT00807001|10949918|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
9838525|NCT00807001|10949919|FG001|STARTED|Overall Study||8
9838526|NCT00807001|10949920|FG002|STARTED|Overall Study||8
9838527|NCT00807001|10949921|FG003|STARTED|Overall Study||8
9838528|NCT00807001|10949922|FG004|STARTED|Overall Study||9
9838529|NCT00807001|10949918|FG000|COMPLETED|Overall Study||8
9838530|NCT00807001|10949919|FG001|COMPLETED|Overall Study||7
9838531|NCT00807001|10949920|FG002|COMPLETED|Overall Study||8
9838532|NCT00807001|10949921|FG003|COMPLETED|Overall Study||8
9838533|NCT00807001|10949922|FG004|COMPLETED|Overall Study||9
9838534|NCT00807001|10949918|FG000|NOT COMPLETED|Overall Study||0
9838535|NCT00807001|10949919|FG001|NOT COMPLETED|Overall Study||1
9838536|NCT00807001|10949920|FG002|NOT COMPLETED|Overall Study||0
9838537|NCT00807001|10949921|FG003|NOT COMPLETED|Overall Study||0
9838538|NCT00807001|10949922|FG004|NOT COMPLETED|Overall Study||0
9838539|NCT00807014|10949936|FG000|STARTED|Overall Study||83
9838540|NCT00807014|10949937|FG001|STARTED|Overall Study||85
9838541|NCT00807014|10949936|FG000|COMPLETED|Overall Study||56
9838542|NCT00807014|10949937|FG001|COMPLETED|Overall Study||58
9838543|NCT00807014|10949936|FG000|NOT COMPLETED|Overall Study||27
9838544|NCT00807014|10949937|FG001|NOT COMPLETED|Overall Study||27
9838545|NCT00807040|10949945|FG000|STARTED|Overall Study||126
9838546|NCT00807040|10949946|FG001|STARTED|Overall Study||125
9838547|NCT00807040|10949945|FG000|COMPLETED|Overall Study||90
9838548|NCT00807040|10949946|FG001|COMPLETED|Overall Study||84
9838549|NCT00807040|10949945|FG000|NOT COMPLETED|Overall Study||36
9838550|NCT00807040|10949946|FG001|NOT COMPLETED|Overall Study||41
9838551|NCT00807092|10949954|FG000|STARTED|Overall Study||72
9838552|NCT00807092|10949955|FG001|STARTED|Overall Study||73
9838553|NCT00807092|10949954|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
9838554|NCT00807092|10949955|FG001|Exposed to Drug|Overall Study||73
9959038|NCT01460368|11078524|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9838555|NCT00807092|10949954|FG000|COMPLETED|Overall Study||71
9838556|NCT00807092|10949955|FG001|COMPLETED|Overall Study||69
9720861|NCT00057577|10820364|FG001|STARTED|Overall Study||225
9720862|NCT00057577|10820363|FG000|COMPLETED|Overall Study||227
9720863|NCT00057577|10820364|FG001|COMPLETED|Overall Study||225
9720864|NCT00057577|10820363|FG000|NOT COMPLETED|Overall Study||0
9720865|NCT00057577|10820364|FG001|NOT COMPLETED|Overall Study||0
9720866|NCT00057681|10820378|FG000|STARTED|Overall Study||137
9720867|NCT00057681|10820379|FG001|STARTED|Overall Study||139
9720868|NCT00057681|10820380|FG002|STARTED|Overall Study||103
9720869|NCT00057681|10820378|FG000|COMPLETED|Overall Study||72
9720870|NCT00057681|10820379|FG001|COMPLETED|Overall Study||67
9720871|NCT00057681|10820380|FG002|COMPLETED|Overall Study||69
9720872|NCT00057681|10820378|FG000|NOT COMPLETED|Overall Study||65
9720873|NCT00057681|10820379|FG001|NOT COMPLETED|Overall Study||72
9720874|NCT00057681|10820380|FG002|NOT COMPLETED|Overall Study||34
9720875|NCT00057746|10820391|FG000|STARTED|Overall Study||131
9720876|NCT00057746|10820392|FG001|STARTED|Overall Study||67
9720877|NCT00057746|10820393|FG002|STARTED|Overall Study||67
9720878|NCT00057746|10820391|FG000|COMPLETED|Overall Study||131
9720879|NCT00057746|10820392|FG001|COMPLETED|Overall Study||67
9720880|NCT00057746|10820393|FG002|COMPLETED|Overall Study||66
9720881|NCT00057746|10820391|FG000|NOT COMPLETED|Overall Study||0
9720882|NCT00057746|10820392|FG001|NOT COMPLETED|Overall Study||0
9720883|NCT00057746|10820393|FG002|NOT COMPLETED|Overall Study||1
9720884|NCT00057785|10820401|FG000|STARTED|Overall Study||68
9720885|NCT00057785|10820401|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
9720886|NCT00057785|10820401|FG000|NOT COMPLETED|Overall Study||0
9720887|NCT00057811|10820407|FG000|STARTED|Overall Study||51
9720888|NCT00057811|10820408|FG001|STARTED|Overall Study||46
9720889|NCT00057811|10820407|FG000|COMPLETED|Overall Study||41
9720890|NCT00057811|10820408|FG001|COMPLETED|Overall Study||34
9720891|NCT00057811|10820407|FG000|NOT COMPLETED|Overall Study||10
9720892|NCT00057811|10820408|FG001|NOT COMPLETED|Overall Study||12
9720893|NCT00057837|10820416|FG000|STARTED|Overall Study||70
9720894|NCT00057837|10820417|FG001|STARTED|Overall Study||70
9720895|NCT00057837|10820416|FG000|Treated|Overall Study||69
9720896|NCT00057837|10820417|FG001|Treated|Overall Study||68
9720897|NCT00057837|10820416|FG000|Eligible and Treated|Overall Study||66
9720898|NCT00057837|10820417|FG001|Eligible and Treated|Overall Study||66
9720899|NCT00057837|10820416|FG000|Patients With Response|Overall Study||46
9720900|NCT00057837|10820417|FG001|Patients With Response|Overall Study||38
9720901|NCT00057837|10820416|FG000|COMPLETED|Overall Study||39
9720902|NCT00057837|10820417|FG001|COMPLETED|Overall Study||31
9720903|NCT00057837|10820416|FG000|NOT COMPLETED|Overall Study||31
9720904|NCT00057837|10820417|FG001|NOT COMPLETED|Overall Study||39
9720905|NCT00057863|10820423|FG000|STARTED|Overall Study||35
9720906|NCT00057863|10820423|FG000|COMPLETED|Overall Study||32
9720907|NCT00057863|10820423|FG000|NOT COMPLETED|Overall Study||3
9720908|NCT00057876|10820429|FG000|STARTED|Overall Study||38
9720909|NCT00057876|10820430|FG001|STARTED|Overall Study||36
9720910|NCT00057876|10820429|FG000|Eligible|Overall Study||37
9720911|NCT00057876|10820430|FG001|Eligible|Overall Study||34
9720912|NCT00057876|10820429|FG000|Began Protocol Therapy|Overall Study||35
9720913|NCT00057876|10820430|FG001|Began Protocol Therapy|Overall Study||34
9720914|NCT00057876|10820429|FG000|Eligible and Treated|Overall Study||34
9720915|NCT00057876|10820430|FG001|Eligible and Treated|Overall Study||34
9720916|NCT00057876|10820429|FG000|COMPLETED|Overall Study||9
9720917|NCT00057876|10820430|FG001|COMPLETED|Overall Study||9
9720918|NCT00057876|10820429|FG000|NOT COMPLETED|Overall Study||29
9720919|NCT00057876|10820430|FG001|NOT COMPLETED|Overall Study||27
9720920|NCT00057941|10820438|FG000|STARTED|Overall Study||74
9720921|NCT00057941|10820439|FG001|STARTED|Overall Study||74
9720922|NCT00057941|10820438|FG000|Treated|Overall Study||74
9720923|NCT00057941|10820439|FG001|Treated|Overall Study||74
9720924|NCT00057941|10820438|FG000|Eligible|Overall Study||72
9720925|NCT00057941|10820439|FG001|Eligible|Overall Study||69
9720926|NCT00057941|10820438|FG000|COMPLETED|Overall Study||0
9720927|NCT00057941|10820439|FG001|COMPLETED|Overall Study||0
9720928|NCT00057941|10820438|FG000|NOT COMPLETED|Overall Study||74
9720929|NCT00057941|10820439|FG001|NOT COMPLETED|Overall Study||74
9720930|NCT00057954|10820445|FG000|STARTED|Overall Study||6
9720931|NCT00057954|10820445|FG000|COMPLETED|Overall Study||4
9838557|NCT00807092|10949954|FG000|NOT COMPLETED|Overall Study||1
9959039|NCT01460368|11078525|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959040|NCT01460368|11078526|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959041|NCT01460368|11078520|FG000|STARTED|Part B: Second Intervention (Period 2)||0
9838558|NCT00807092|10949955|FG001|NOT COMPLETED|Overall Study||4
9838559|NCT00807144|10949963|FG000|STARTED|Overall Study||52
9838560|NCT00807144|10949964|FG001|STARTED|Overall Study||50
9838561|NCT00807144|10949963|FG000|COMPLETED|Overall Study||52
9838562|NCT00807144|10949964|FG001|COMPLETED|Overall Study||49
9838563|NCT00807144|10949963|FG000|NOT COMPLETED|Overall Study||0
9838564|NCT00807144|10949964|FG001|NOT COMPLETED|Overall Study||1
9838565|NCT00807209|10949973|FG000|STARTED|Overall Study||1
9838566|NCT00807209|10949974|FG001|STARTED|Overall Study||1
9838567|NCT00807209|10949975|FG002|STARTED|Overall Study||1
9838568|NCT00807209|10949973|FG000|COMPLETED|Overall Study||1
9838569|NCT00807209|10949974|FG001|COMPLETED|Overall Study||1
9838570|NCT00807209|10949975|FG002|COMPLETED|Overall Study||1
9838571|NCT00807209|10949973|FG000|NOT COMPLETED|Overall Study||0
9838572|NCT00807209|10949974|FG001|NOT COMPLETED|Overall Study||0
9838573|NCT00807209|10949975|FG002|NOT COMPLETED|Overall Study||0
9838574|NCT00807235|10949985|FG000|STARTED|Overall Study||11
9838575|NCT00807235|10949986|FG001|STARTED|Overall Study||6
9838576|NCT00807235|10949985|FG000|COMPLETED|Overall Study||10
9838577|NCT00807235|10949986|FG001|COMPLETED|Overall Study||6
9838578|NCT00807235|10949985|FG000|NOT COMPLETED|Overall Study||1
9838579|NCT00807235|10949986|FG001|NOT COMPLETED|Overall Study||0
9838580|NCT00807248|10949996|FG000|STARTED|Overall Study||71
9838581|NCT00807248|10949997|FG001|STARTED|Overall Study||140
9838582|NCT00807248|10949998|FG002|STARTED|Overall Study||139
9959042|NCT01460368|11078521|FG001|STARTED|Part B: Second Intervention (Period 2)||10
9959043|NCT01460368|11078522|FG002|STARTED|Part B: Second Intervention (Period 2)||10
9959044|NCT01460368|11078523|FG003|STARTED|Part B: Second Intervention (Period 2)||10
9959045|NCT01460368|11078524|FG004|STARTED|Part B: Second Intervention (Period 2)||9
9838583|NCT00807248|10949999|FG003|STARTED|Overall Study||140
9838584|NCT00807248|10949996|FG000|COMPLETED|Overall Study||50
9838585|NCT00807248|10949997|FG001|COMPLETED|Overall Study||128
10114132|NCT02513940|11244851|FG004|STARTED|Overall Study||2
10114133|NCT02513940|11244852|FG005|STARTED|Overall Study||3
10114134|NCT02513940|11244847|FG000|COMPLETED|Overall Study||2
10114135|NCT02513940|11244848|FG001|COMPLETED|Overall Study||3
10114136|NCT02513940|11244849|FG002|COMPLETED|Overall Study||2
10114137|NCT02513940|11244850|FG003|COMPLETED|Overall Study||2
9838586|NCT00807248|10949998|FG002|COMPLETED|Overall Study||121
9838587|NCT00807248|10949999|FG003|COMPLETED|Overall Study||126
9838588|NCT00807248|10949996|FG000|NOT COMPLETED|Overall Study||21
9838589|NCT00807248|10949997|FG001|NOT COMPLETED|Overall Study||12
9838590|NCT00807248|10949998|FG002|NOT COMPLETED|Overall Study||18
9838591|NCT00807248|10949999|FG003|NOT COMPLETED|Overall Study||14
9838592|NCT00807456|10950009|FG000|STARTED|Overall Study||65
9838593|NCT00807456|10950009|FG000|COMPLETED|Overall Study||65
9838594|NCT00807456|10950009|FG000|NOT COMPLETED|Overall Study||0
9838595|NCT00807495|10950018|FG000|STARTED|Overall Study||22
9838596|NCT00807495|10950019|FG001|STARTED|Overall Study||13
9838597|NCT00807495|10950020|FG002|STARTED|Overall Study||5
9838598|NCT00807495|10950021|FG003|STARTED|Overall Study||1
9838599|NCT00807495|10950022|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
9838600|NCT00807495|10950018|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
9838601|NCT00807495|10950019|FG001|COMPLETED|Overall Study||7
9838602|NCT00807495|10950020|FG002|COMPLETED|Overall Study||1
9838603|NCT00807495|10950021|FG003|COMPLETED|Overall Study||0
9838604|NCT00807495|10950022|FG004|COMPLETED|Overall Study||2
9838605|NCT00807495|10950018|FG000|NOT COMPLETED|Overall Study||8
9838606|NCT00807495|10950019|FG001|NOT COMPLETED|Overall Study||6
9838607|NCT00807495|10950020|FG002|NOT COMPLETED|Overall Study||4
9838608|NCT00807495|10950021|FG003|NOT COMPLETED|Overall Study||1
9838609|NCT00807495|10950022|FG004|NOT COMPLETED|Overall Study||5
9959046|NCT01460368|11078525|FG005|STARTED|Part B: Second Intervention (Period 2)||10
9959047|NCT01460368|11078526|FG006|STARTED|Part B: Second Intervention (Period 2)||10
9959048|NCT01460368|11078520|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0
9959049|NCT01460368|11078521|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8
9959050|NCT01460368|11078522|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10
9959051|NCT01460368|11078523|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10
9959052|NCT01460368|11078524|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9
9838610|NCT00807560|10950036|FG000|STARTED|Overall Study||38
9838611|NCT00807560|10950037|FG001|STARTED|Overall Study||39
9838612|NCT00807560|10950036|FG000|COMPLETED|Overall Study||38
9838613|NCT00807560|10950037|FG001|COMPLETED|Overall Study||39
9838614|NCT00807560|10950036|FG000|NOT COMPLETED|Overall Study||0
9838615|NCT00807560|10950037|FG001|NOT COMPLETED|Overall Study||0
9838616|NCT00807573|10950043|FG000|STARTED|Overall Study||44
9838617|NCT00807573|10950043|FG000|COMPLETED|Overall Study||42
9838618|NCT00807573|10950043|FG000|NOT COMPLETED|Overall Study||2
9838619|NCT00807586|10950049|FG000|STARTED|Overall Study||60
9838620|NCT00807586|10950050|FG001|STARTED|Overall Study||59
9838621|NCT00807586|10950049|FG000|COMPLETED|Overall Study||54
9838622|NCT00807586|10950050|FG001|COMPLETED|Overall Study||58
9838623|NCT00807586|10950049|FG000|NOT COMPLETED|Overall Study||6
9838624|NCT00807586|10950050|FG001|NOT COMPLETED|Overall Study||1
9838625|NCT00807599|10950058|FG000|STARTED|Overall Study||26
9838626|NCT00807599|10950059|FG001|STARTED|Overall Study||24
9838627|NCT00807599|10950060|FG002|STARTED|Overall Study||17
9838628|NCT00807599|10950058|FG000|COMPLETED|Overall Study||26
9838629|NCT00807599|10950059|FG001|COMPLETED|Overall Study||24
9838630|NCT00807599|10950060|FG002|COMPLETED|Overall Study||0
9838631|NCT00807599|10950058|FG000|NOT COMPLETED|Overall Study||0
9838632|NCT00807599|10950059|FG001|NOT COMPLETED|Overall Study||0
9838633|NCT00807599|10950060|FG002|NOT COMPLETED|Overall Study||17
9838634|NCT00807664|10950068|FG000|STARTED|Overall Study||88
9838635|NCT00807664|10950069|FG001|STARTED|Overall Study||94
9838636|NCT00807664|10950068|FG000|COMPLETED|Overall Study||77
9838637|NCT00807664|10950069|FG001|COMPLETED|Overall Study||75
9838638|NCT00807664|10950068|FG000|NOT COMPLETED|Overall Study||11
9838639|NCT00807664|10950069|FG001|NOT COMPLETED|Overall Study||19
9838640|NCT00807742|10950078|FG000|STARTED|Overall Study||172
9959053|NCT01460368|11078525|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10
9959054|NCT01460368|11078526|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9
9959055|NCT01460368|11078520|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
9959056|NCT01460368|11078521|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
9959057|NCT01460368|11078522|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
9959058|NCT01460368|11078523|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
9959059|NCT01460368|11078524|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
9959060|NCT01460368|11078525|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
9959061|NCT01460368|11078526|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
9959062|NCT01460368|11078520|FG000|STARTED|Part B: Washout (up to 15 Days)||0
9959063|NCT01460368|11078521|FG001|STARTED|Part B: Washout (up to 15 Days)||8
9959064|NCT01460368|11078522|FG002|STARTED|Part B: Washout (up to 15 Days)||10
9959065|NCT01460368|11078523|FG003|STARTED|Part B: Washout (up to 15 Days)||10
9959066|NCT01460368|11078524|FG004|STARTED|Part B: Washout (up to 15 Days)||9
9959067|NCT01460368|11078525|FG005|STARTED|Part B: Washout (up to 15 Days)||10
9959068|NCT01460368|11078526|FG006|STARTED|Part B: Washout (up to 15 Days)||9
9959069|NCT01460368|11078520|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
9959070|NCT01460368|11078521|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8
9959071|NCT01460368|11078522|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9
9959072|NCT01460368|11078523|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
9959073|NCT01460368|11078524|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
9959074|NCT01460368|11078525|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
9959075|NCT01460368|11078526|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9
9959076|NCT01460368|11078520|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959077|NCT01460368|11078521|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959078|NCT01460368|11078522|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
9959079|NCT01460368|11078523|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959080|NCT01460368|11078524|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959081|NCT01460368|11078525|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959082|NCT01460368|11078526|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
9959083|NCT01460368|11078520|FG000|STARTED|Part B: Third Interventions (Period 3)||0
9959084|NCT01460368|11078521|FG001|STARTED|Part B: Third Interventions (Period 3)||8
9959085|NCT01460368|11078522|FG002|STARTED|Part B: Third Interventions (Period 3)||9
9959086|NCT01460368|11078523|FG003|STARTED|Part B: Third Interventions (Period 3)||10
9959087|NCT01460368|11078524|FG004|STARTED|Part B: Third Interventions (Period 3)||9
9959088|NCT01460368|11078525|FG005|STARTED|Part B: Third Interventions (Period 3)||10
9959089|NCT01460368|11078526|FG006|STARTED|Part B: Third Interventions (Period 3)||9
9959090|NCT01460368|11078520|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0
9959091|NCT01460368|11078521|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8
9838641|NCT00807742|10950079|FG001|STARTED|Overall Study||168
9838642|NCT00807742|10950078|FG000|COMPLETED|Overall Study||126
9838643|NCT00807742|10950079|FG001|COMPLETED|Overall Study||114
9838644|NCT00807742|10950078|FG000|NOT COMPLETED|Overall Study||46
9838645|NCT00807742|10950079|FG001|NOT COMPLETED|Overall Study||54
9838646|NCT00807768|10950087|FG000|STARTED|Overall Study||301
9838647|NCT00807768|10950088|FG001|STARTED|Overall Study||300
9838648|NCT00807768|10950087|FG000|COMPLETED|Overall Study||301
10021684|NCT01845831|11145129|FG003|COMPLETED|Inpatient Phase||0
10021685|NCT01845831|11145130|FG004|COMPLETED|Inpatient Phase||0
10021686|NCT01845831|11145126|FG000|NOT COMPLETED|Inpatient Phase||1
10021687|NCT01845831|11145127|FG001|NOT COMPLETED|Inpatient Phase||1
10021688|NCT01845831|11145128|FG002|NOT COMPLETED|Inpatient Phase||0
10021689|NCT01845831|11145129|FG003|NOT COMPLETED|Inpatient Phase||0
10021690|NCT01845831|11145130|FG004|NOT COMPLETED|Inpatient Phase||0
10021691|NCT01845831|11145126|FG000|STARTED|Outpatient Phase||0
10021692|NCT01845831|11145127|FG001|STARTED|Outpatient Phase||0
10021693|NCT01845831|11145128|FG002|STARTED|Outpatient Phase||68
10021694|NCT01845831|11145129|FG003|STARTED|Outpatient Phase||98
10021695|NCT01845831|11145130|FG004|STARTED|Outpatient Phase||87
10021696|NCT01845831|11145126|FG000|COMPLETED|Outpatient Phase||0
9720932|NCT00057954|10820445|FG000|NOT COMPLETED|Overall Study||2
10021697|NCT01845831|11145127|FG001|COMPLETED|Outpatient Phase||0
10021698|NCT01845831|11145128|FG002|COMPLETED|Outpatient Phase||68
9720933|NCT00058019|10820451|FG000|STARTED|Overall Study||39
9720934|NCT00058019|10820452|FG001|STARTED|Overall Study||12
9838649|NCT00807768|10950088|FG001|COMPLETED|Overall Study||300
9838650|NCT00807768|10950087|FG000|NOT COMPLETED|Overall Study||0
9838651|NCT00807768|10950088|FG001|NOT COMPLETED|Overall Study||0
9838652|NCT00807846|10950096|FG000|STARTED|Overall Study||100
9838653|NCT00807846|10950097|FG001|STARTED|Overall Study||98
9838654|NCT00807846|10950096|FG000|COMPLETED|Overall Study||88
9838655|NCT00807846|10950097|FG001|COMPLETED|Overall Study||94
9838656|NCT00807846|10950096|FG000|NOT COMPLETED|Overall Study||12
9959092|NCT01460368|11078522|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8
9959093|NCT01460368|11078523|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9
9959094|NCT01460368|11078524|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9
9959095|NCT01460368|11078525|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9
9959096|NCT01460368|11078526|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9
9959097|NCT01460368|11078520|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
9959098|NCT01460368|11078521|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
9959099|NCT01460368|11078522|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
9959100|NCT01460368|11078523|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
9959101|NCT01460368|11078524|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
9959102|NCT01460368|11078525|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
9959103|NCT01460368|11078526|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
9959104|NCT01460381|11078537|FG000|STARTED|Period 1 (Days 1-7)||7
9959105|NCT01460381|11078538|FG001|STARTED|Period 1 (Days 1-7)||11
9838657|NCT00807846|10950097|FG001|NOT COMPLETED|Overall Study||4
10021699|NCT01845831|11145129|FG003|COMPLETED|Outpatient Phase||98
10021700|NCT01845831|11145130|FG004|COMPLETED|Outpatient Phase||87
10021701|NCT01845831|11145126|FG000|NOT COMPLETED|Outpatient Phase||0
10021702|NCT01845831|11145127|FG001|NOT COMPLETED|Outpatient Phase||0
10021703|NCT01845831|11145128|FG002|NOT COMPLETED|Outpatient Phase||0
10021704|NCT01845831|11145129|FG003|NOT COMPLETED|Outpatient Phase||0
10021705|NCT01845831|11145130|FG004|NOT COMPLETED|Outpatient Phase||0
10021706|NCT01845974|11145143|FG000|STARTED|Overall Study||4
10021707|NCT01845974|11145144|FG001|STARTED|Overall Study||9
10021708|NCT01845974|11145143|FG000|COMPLETED|Overall Study||3
10021709|NCT01845974|11145144|FG001|COMPLETED|Overall Study||9
10021710|NCT01845974|11145143|FG000|NOT COMPLETED|Overall Study||1
10021711|NCT01845974|11145144|FG001|NOT COMPLETED|Overall Study||0
10021712|NCT01846039|11145150|FG000|STARTED|Overall Study||29
10021713|NCT01846039|11145150|FG000|COMPLETED|Overall Study||27
10021714|NCT01846039|11145150|FG000|NOT COMPLETED|Overall Study||2
10021715|NCT01846104|11145154|FG000|STARTED|Overall Study||4
9720935|NCT00058019|10820451|FG000|COMPLETED|Overall Study||39
9720936|NCT00058019|10820452|FG001|COMPLETED|Overall Study||12
9720937|NCT00058019|10820451|FG000|NOT COMPLETED|Overall Study||0
9720938|NCT00058019|10820452|FG001|NOT COMPLETED|Overall Study||0
9720939|NCT00058058|10820457|FG000|STARTED|Overall Study||1007
9720940|NCT00058058|10820457|FG000|COMPLETED|Overall Study||969
9720941|NCT00058058|10820457|FG000|NOT COMPLETED|Overall Study||38
9720942|NCT00058123|10820462|FG000|STARTED|Overall Study||55
9720943|NCT00058123|10820462|FG000|COMPLETED|Overall Study||45
9720944|NCT00058123|10820462|FG000|NOT COMPLETED|Overall Study||10
9720945|NCT00058214|10820467|FG000|STARTED|Overall Study||25
9720946|NCT00058214|10820467|FG000|COMPLETED|Overall Study||24
9720947|NCT00058214|10820467|FG000|NOT COMPLETED|Overall Study||1
9720948|NCT00058240|10820475|FG000|STARTED|First Dose Level||20
9720949|NCT00058240|10820476|FG001|STARTED|First Dose Level||3
9720950|NCT00058240|10820477|FG002|STARTED|First Dose Level||17
9720951|NCT00058240|10820478|FG003|STARTED|First Dose Level||12
9720952|NCT00058240|10820475|FG000|Treated|First Dose Level||20
9720953|NCT00058240|10820476|FG001|Treated|First Dose Level||3
9720954|NCT00058240|10820477|FG002|Treated|First Dose Level||17
9720955|NCT00058240|10820478|FG003|Treated|First Dose Level||12
9720956|NCT00058240|10820475|FG000|COMPLETED|First Dose Level||20
9720957|NCT00058240|10820476|FG001|COMPLETED|First Dose Level||3
9720958|NCT00058240|10820477|FG002|COMPLETED|First Dose Level||17
9720959|NCT00058240|10820478|FG003|COMPLETED|First Dose Level||12
9720960|NCT00058240|10820475|FG000|NOT COMPLETED|First Dose Level||0
9720961|NCT00058240|10820476|FG001|NOT COMPLETED|First Dose Level||0
9720962|NCT00058240|10820477|FG002|NOT COMPLETED|First Dose Level||0
9720963|NCT00058240|10820478|FG003|NOT COMPLETED|First Dose Level||0
9720964|NCT00058240|10820475|FG000|STARTED|Second Dose Level||0
9720965|NCT00058240|10820476|FG001|STARTED|Second Dose Level||0
9720966|NCT00058240|10820477|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
9720967|NCT00058240|10820478|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
9720968|NCT00058240|10820475|FG000|COMPLETED|Second Dose Level||0
9720969|NCT00058240|10820476|FG001|COMPLETED|Second Dose Level||0
9720970|NCT00058240|10820477|FG002|COMPLETED|Second Dose Level||2
10021716|NCT01846104|11145154|FG000|COMPLETED|Overall Study||3
10021717|NCT01846104|11145154|FG000|NOT COMPLETED|Overall Study||1
10021718|NCT01846208|11145161|FG000|STARTED|Overall Study||28
10021719|NCT01846208|11145162|FG001|STARTED|Overall Study||24
10021720|NCT01846208|11145163|FG002|STARTED|Overall Study||40
10021721|NCT01846208|11145161|FG000|Initiatiated Treatment|Overall Study||27
10021722|NCT01846208|11145162|FG001|Initiatiated Treatment|Overall Study||23
9720971|NCT00058240|10820478|FG003|COMPLETED|Second Dose Level||4
9720972|NCT00058240|10820475|FG000|NOT COMPLETED|Second Dose Level||0
9959106|NCT01460381|11078537|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
9959107|NCT01460381|11078538|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
9959108|NCT01460381|11078537|FG000|COMPLETED|Period 1 (Days 1-7)||7
9959109|NCT01460381|11078538|FG001|COMPLETED|Period 1 (Days 1-7)||11
9959110|NCT01460381|11078537|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0
9959111|NCT01460381|11078538|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0
9959112|NCT01460381|11078537|FG000|STARTED|Period 2 (Days 8-15)||7
9959113|NCT01460381|11078538|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
9959114|NCT01460381|11078537|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
9959115|NCT01460381|11078538|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
9959116|NCT01460381|11078537|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1
9959117|NCT01460381|11078538|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0
9959118|NCT01460407|11078546|FG000|STARTED|Period 1: Day 1 to Day 5||14
9959119|NCT01460407|11078547|FG001|STARTED|Period 1: Day 1 to Day 5||0
9959120|NCT01460407|11078546|FG000|COMPLETED|Period 1: Day 1 to Day 5||14
10021723|NCT01846208|11145163|FG002|Initiatiated Treatment|Overall Study||39
10021724|NCT01846208|11145161|FG000|Year 1 Desensitization OFC|Overall Study||23
10021725|NCT01846208|11145162|FG001|Year 1 Desensitization OFC|Overall Study||20
10021726|NCT01846208|11145163|FG002|Year 1 Desensitization OFC|Overall Study||34
10021727|NCT01846208|11145161|FG000|Year 2 Desensitization OFC|Overall Study||19
10021728|NCT01846208|11145162|FG001|Year 2 Desensitization OFC|Overall Study||20
10021729|NCT01846208|11145163|FG002|Year 2 Desensitization OFC|Overall Study||33
10021730|NCT01846208|11145161|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
9959121|NCT01460407|11078547|FG001|COMPLETED|Period 1: Day 1 to Day 5||0
9959122|NCT01460407|11078546|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0
9959123|NCT01460407|11078547|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0
9959124|NCT01460407|11078546|FG000|STARTED|Period 2: Day 6 to Day 14||0
10021731|NCT01846208|11145162|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
9959125|NCT01460407|11078547|FG001|STARTED|Period 2: Day 6 to Day 14||14
9959126|NCT01460407|11078546|FG000|COMPLETED|Period 2: Day 6 to Day 14||0
9959127|NCT01460407|11078547|FG001|COMPLETED|Period 2: Day 6 to Day 14||13
9959128|NCT01460407|11078546|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0
9959129|NCT01460407|11078547|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1
9959130|NCT01460446|11078556|FG000|STARTED|Overall Study||105
9838658|NCT00807885|10950112|FG000|STARTED|Overall Study||10
9838659|NCT00807885|10950113|FG001|STARTED|Overall Study||11
9838660|NCT00807885|10950114|FG002|STARTED|Overall Study||11
9838661|NCT00807885|10950115|FG003|STARTED|Overall Study||10
9838662|NCT00807885|10950116|FG004|STARTED|Overall Study||12
9838663|NCT00807885|10950117|FG005|STARTED|Overall Study||12
9838664|NCT00807885|10950118|FG006|STARTED|Overall Study||12
9838665|NCT00807885|10950119|FG007|STARTED|Overall Study||11
9838666|NCT00807885|10950120|FG008|STARTED|Overall Study||11
9838667|NCT00807885|10950112|FG000|COMPLETED|Overall Study||10
9838668|NCT00807885|10950113|FG001|COMPLETED|Overall Study||11
9838669|NCT00807885|10950114|FG002|COMPLETED|Overall Study||11
9838670|NCT00807885|10950115|FG003|COMPLETED|Overall Study||10
9838671|NCT00807885|10950116|FG004|COMPLETED|Overall Study||12
9838672|NCT00807885|10950117|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
9838673|NCT00807885|10950118|FG006|COMPLETED|Overall Study||12
9959131|NCT01460446|11078557|FG001|STARTED|Overall Study||113
9959132|NCT01460446|11078556|FG000|COMPLETED|Overall Study||100
9959133|NCT01460446|11078557|FG001|COMPLETED|Overall Study||93
9959134|NCT01460446|11078556|FG000|NOT COMPLETED|Overall Study||5
9959135|NCT01460446|11078557|FG001|NOT COMPLETED|Overall Study||20
9959136|NCT01460628|11078564|FG000|STARTED|Overall Study||25
9959137|NCT01460628|11078564|FG000|COMPLETED|Overall Study||20
9959138|NCT01460628|11078564|FG000|NOT COMPLETED|Overall Study||5
9959139|NCT01460719|11078568|FG000|STARTED|Overall Study||80
9959140|NCT01460719|11078568|FG000|Vaccination 1 (Day 1)|Overall Study||80
9959141|NCT01460719|11078568|FG000|Vaccination 2 (~Day 30)|Overall Study||78
9959142|NCT01460719|11078568|FG000|Vaccination 3 (~Day 60)|Overall Study||78
9959143|NCT01460719|11078568|FG000|Vaccination 4 (~Day 90)|Overall Study||78
9959144|NCT01460719|11078568|FG000|COMPLETED|Overall Study||78
9959145|NCT01460719|11078568|FG000|NOT COMPLETED|Overall Study||2
9959146|NCT01460732|11078572|FG000|STARTED|Overall Study||81
9959147|NCT01460732|11078572|FG000|COMPLETED|Overall Study||81
9959148|NCT01460732|11078572|FG000|NOT COMPLETED|Overall Study||0
9959149|NCT01460875|11078578|FG000|STARTED|Overall Study||34
9959150|NCT01460875|11078578|FG000|COMPLETED|Overall Study||34
9959151|NCT01460875|11078578|FG000|NOT COMPLETED|Overall Study||0
9959152|NCT01460901|11078582|FG000|STARTED|Overall Study|First enrollment|5
9959153|NCT01460901|11078582|FG000|tV-CTL Infusion|Overall Study||3
9959154|NCT01460901|11078582|FG000|COMPLETED|Overall Study|Follow-up completed|3
9959155|NCT01460901|11078582|FG000|NOT COMPLETED|Overall Study||2
9959156|NCT01460927|11078589|FG000|STARTED|Overall Study||25
9959157|NCT01460927|11078589|FG000|COMPLETED|Overall Study||25
9959158|NCT01460927|11078589|FG000|NOT COMPLETED|Overall Study||0
9959159|NCT01460940|11078597|FG000|STARTED|Overall Study||24
9959160|NCT01460940|11078597|FG000|COMPLETED|Overall Study||24
9959161|NCT01460940|11078597|FG000|NOT COMPLETED|Overall Study||0
9959162|NCT01461005|11078601|FG000|STARTED|Overall Study||1
9959163|NCT01461005|11078601|FG000|COMPLETED|Overall Study||0
9959164|NCT01461005|11078601|FG000|NOT COMPLETED|Overall Study||1
9959165|NCT01461044|11078608|FG000|STARTED|Overall Study||150
9959166|NCT01461044|11078609|FG001|STARTED|Overall Study||77
9959167|NCT01461044|11078608|FG000|Participants Alive at Inclusion|Overall Study||127
9959168|NCT01461044|11078609|FG001|Participants Alive at Inclusion|Overall Study||58
9959169|NCT01461044|11078608|FG000|COMPLETED|Overall Study||80
9959170|NCT01461044|11078609|FG001|COMPLETED|Overall Study||37
9959171|NCT01461044|11078608|FG000|NOT COMPLETED|Overall Study||70
9838674|NCT00807885|10950119|FG007|COMPLETED|Overall Study||11
9838675|NCT00807885|10950120|FG008|COMPLETED|Overall Study||11
9838676|NCT00807885|10950112|FG000|NOT COMPLETED|Overall Study||0
9838677|NCT00807885|10950113|FG001|NOT COMPLETED|Overall Study||0
9838678|NCT00807885|10950114|FG002|NOT COMPLETED|Overall Study||0
9838679|NCT00807885|10950115|FG003|NOT COMPLETED|Overall Study||0
9720973|NCT00058240|10820476|FG001|NOT COMPLETED|Second Dose Level||0
9720974|NCT00058240|10820477|FG002|NOT COMPLETED|Second Dose Level||0
9720975|NCT00058240|10820478|FG003|NOT COMPLETED|Second Dose Level||0
9720976|NCT00058370|10820488|FG000|STARTED|Overall Study||6
9720977|NCT00058370|10820488|FG000|COMPLETED|Overall Study||6
9720978|NCT00058370|10820488|FG000|NOT COMPLETED|Overall Study||0
9720979|NCT00058422|10820492|FG000|STARTED|Overall Study||65
9720980|NCT00058422|10820492|FG000|COMPLETED|Overall Study||63
9720981|NCT00058422|10820492|FG000|NOT COMPLETED|Overall Study||2
9720982|NCT00058539|10820496|FG000|STARTED|Overall Study||42
9720983|NCT00058539|10820496|FG000|COMPLETED|Overall Study||0
9720984|NCT00058539|10820496|FG000|NOT COMPLETED|Overall Study||42
9720985|NCT00058552|10820502|FG000|STARTED|Overall Study||65
9720986|NCT00058552|10820503|FG001|STARTED|Overall Study||64
9720987|NCT00058552|10820502|FG000|COMPLETED|Overall Study||0
9720988|NCT00058552|10820503|FG001|COMPLETED|Overall Study||2
9720989|NCT00058552|10820502|FG000|NOT COMPLETED|Overall Study||65
9720990|NCT00058552|10820503|FG001|NOT COMPLETED|Overall Study||62
9720991|NCT00058825|10820511|FG000|STARTED|Overall Study||27
9720992|NCT00058825|10820511|FG000|COMPLETED|Overall Study||5
9720993|NCT00058825|10820511|FG000|NOT COMPLETED|Overall Study||22
9720994|NCT00059202|10820519|FG000|STARTED|Overall Study||76
9720995|NCT00059202|10820520|FG001|STARTED|Overall Study||74
9720996|NCT00059202|10820519|FG000|COMPLETED|Overall Study||70
9720997|NCT00059202|10820520|FG001|COMPLETED|Overall Study||59
9720998|NCT00059202|10820519|FG000|NOT COMPLETED|Overall Study||6
9720999|NCT00059202|10820520|FG001|NOT COMPLETED|Overall Study||15
9721000|NCT00059215|10820533|FG000|STARTED|Overall Study||200
9721001|NCT00059215|10820534|FG001|STARTED|Overall Study||200
9721002|NCT00059215|10820535|FG002|STARTED|Overall Study||251
9721003|NCT00059215|10820536|FG003|STARTED|Overall Study||254
9721004|NCT00059215|10820533|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
9721005|NCT00059215|10820534|FG001|COMPLETED|Overall Study||186
9721006|NCT00059215|10820535|FG002|COMPLETED|Overall Study||236
9721007|NCT00059215|10820536|FG003|COMPLETED|Overall Study||239
9721008|NCT00059215|10820533|FG000|NOT COMPLETED|Overall Study||13
9721009|NCT00059215|10820534|FG001|NOT COMPLETED|Overall Study||14
9721010|NCT00059215|10820535|FG002|NOT COMPLETED|Overall Study||15
9721011|NCT00059215|10820536|FG003|NOT COMPLETED|Overall Study||15
9721012|NCT00059228|10820549|FG000|STARTED|Overall Study||6
9721013|NCT00059228|10820550|FG001|STARTED|Overall Study||6
9721014|NCT00059228|10820549|FG000|COMPLETED|Overall Study||6
9721015|NCT00059228|10820550|FG001|COMPLETED|Overall Study||5
9721016|NCT00059228|10820549|FG000|NOT COMPLETED|Overall Study||0
9721017|NCT00059228|10820550|FG001|NOT COMPLETED|Overall Study||1
9721018|NCT00059332|10820558|FG000|STARTED|Overall Study||843
9721019|NCT00059332|10820559|FG001|STARTED|Overall Study||857
9721020|NCT00059332|10820558|FG000|COMPLETED|Overall Study||840
9721021|NCT00059332|10820559|FG001|COMPLETED|Overall Study||855
9721022|NCT00059332|10820558|FG000|NOT COMPLETED|Overall Study||3
9721023|NCT00059332|10820559|FG001|NOT COMPLETED|Overall Study||2
9721024|NCT00059475|10820573|FG000|STARTED|Overall Study||33
9721025|NCT00059475|10820574|FG001|STARTED|Overall Study||2
9721026|NCT00059475|10820575|FG002|STARTED|Overall Study||24
9721027|NCT00059475|10820576|FG003|STARTED|Overall Study||3
9721028|NCT00059475|10820577|FG004|STARTED|Overall Study||33
9721029|NCT00059475|10820578|FG005|STARTED|Overall Study||2
9721030|NCT00059475|10820579|FG006|STARTED|Overall Study||34
9721031|NCT00059475|10820580|FG007|STARTED|Overall Study||7
9838680|NCT00807885|10950116|FG004|NOT COMPLETED|Overall Study||0
9838681|NCT00807885|10950117|FG005|NOT COMPLETED|Overall Study||1
9838682|NCT00807885|10950118|FG006|NOT COMPLETED|Overall Study||0
9838683|NCT00807885|10950119|FG007|NOT COMPLETED|Overall Study||0
9838684|NCT00807885|10950120|FG008|NOT COMPLETED|Overall Study||0
9838685|NCT00807937|10950144|FG000|STARTED|Overall Study||93
9838686|NCT00807937|10950145|FG001|STARTED|Overall Study||92
9838687|NCT00807937|10950146|FG002|STARTED|Overall Study||92
9838688|NCT00807937|10950147|FG003|STARTED|Overall Study||92
9838689|NCT00807937|10950144|FG000|COMPLETED|Overall Study||66
9838690|NCT00807937|10950145|FG001|COMPLETED|Overall Study||67
9838691|NCT00807937|10950146|FG002|COMPLETED|Overall Study||78
9838692|NCT00807937|10950147|FG003|COMPLETED|Overall Study||77
10021732|NCT01846208|11145163|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
10021733|NCT01846208|11145161|FG000|COMPLETED|Overall Study||19
10021734|NCT01846208|11145162|FG001|COMPLETED|Overall Study||20
10021735|NCT01846208|11145163|FG002|COMPLETED|Overall Study||32
10021736|NCT01846208|11145161|FG000|NOT COMPLETED|Overall Study||9
10021737|NCT01846208|11145162|FG001|NOT COMPLETED|Overall Study||4
10021738|NCT01846208|11145163|FG002|NOT COMPLETED|Overall Study||8
10021739|NCT01846221|11145173|FG000|STARTED|Overall Study||50
9838693|NCT00807937|10950144|FG000|NOT COMPLETED|Overall Study||27
9838694|NCT00807937|10950145|FG001|NOT COMPLETED|Overall Study||25
9959172|NCT01461044|11078609|FG001|NOT COMPLETED|Overall Study||40
9959173|NCT01461057|11078620|FG000|STARTED|Overall Study||15
9959174|NCT01461057|11078621|FG001|STARTED|Overall Study||15
9959175|NCT01461057|11078620|FG000|COMPLETED|Overall Study||0
9959176|NCT01461057|11078621|FG001|COMPLETED|Overall Study||0
9959177|NCT01461057|11078620|FG000|NOT COMPLETED|Overall Study||15
9959178|NCT01461057|11078621|FG001|NOT COMPLETED|Overall Study||15
9959179|NCT01461096|11078629|FG000|STARTED|Overall Study||288
9959180|NCT01461096|11078630|FG001|STARTED|Overall Study||287
9959181|NCT01461096|11078629|FG000|Did Not Start Treatment|Overall Study||0
9959182|NCT01461096|11078630|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
9959183|NCT01461096|11078629|FG000|COMPLETED|Overall Study||226
9959184|NCT01461096|11078630|FG001|COMPLETED|Overall Study||226
9959185|NCT01461096|11078629|FG000|NOT COMPLETED|Overall Study||62
9959186|NCT01461096|11078630|FG001|NOT COMPLETED|Overall Study||61
10021740|NCT01846221|11145174|FG001|STARTED|Overall Study||51
10021741|NCT01846221|11145173|FG000|COMPLETED|Overall Study||47
10021742|NCT01846221|11145174|FG001|COMPLETED|Overall Study||51
9838695|NCT00807937|10950146|FG002|NOT COMPLETED|Overall Study||14
9838696|NCT00807937|10950147|FG003|NOT COMPLETED|Overall Study||15
10021743|NCT01846221|11145173|FG000|NOT COMPLETED|Overall Study||3
9838697|NCT00807989|10950159|FG000|STARTED|Overall Study||107
9838698|NCT00807989|10950160|FG001|STARTED|Overall Study||100
9838699|NCT00807989|10950159|FG000|COMPLETED|Overall Study||104
9838700|NCT00807989|10950160|FG001|COMPLETED|Overall Study||98
9838701|NCT00807989|10950159|FG000|NOT COMPLETED|Overall Study||3
9838702|NCT00807989|10950160|FG001|NOT COMPLETED|Overall Study||2
9838703|NCT00808015|10950166|FG000|STARTED|Overall Study||1377
9838704|NCT00808015|10950166|FG000|Treated|Overall Study||1373
9838705|NCT00808015|10950166|FG000|COMPLETED|Overall Study||1033
9838706|NCT00808015|10950166|FG000|NOT COMPLETED|Overall Study||344
9838707|NCT00808028|10950174|FG000|STARTED|Stage 1 (6 Months)||121
9838708|NCT00808028|10950175|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
9838709|NCT00808028|10950176|FG002|STARTED|Stage 1 (6 Months)||198
9838710|NCT00808028|10950177|FG003|STARTED|Stage 1 (6 Months)||198
9838711|NCT00808028|10950174|FG000|COMPLETED|Stage 1 (6 Months)||116
9838712|NCT00808028|10950175|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
9838713|NCT00808028|10950176|FG002|COMPLETED|Stage 1 (6 Months)||191
10021744|NCT01846221|11145174|FG001|NOT COMPLETED|Overall Study||0
10021745|NCT01846299|11145182|FG000|STARTED|Overall Study||118
10021746|NCT01846299|11145183|FG001|STARTED|Overall Study||60
10021747|NCT01846299|11145182|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
10021748|NCT01846299|11145183|FG001|Full Analysis Set|Overall Study||60
9838714|NCT00808028|10950177|FG003|COMPLETED|Stage 1 (6 Months)||183
9838715|NCT00808028|10950174|FG000|NOT COMPLETED|Stage 1 (6 Months)||5
9838716|NCT00808028|10950175|FG001|NOT COMPLETED|Stage 1 (6 Months)||1
9838717|NCT00808028|10950176|FG002|NOT COMPLETED|Stage 1 (6 Months)||7
9838718|NCT00808028|10950177|FG003|NOT COMPLETED|Stage 1 (6 Months)||15
9838719|NCT00808028|10950174|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
9838720|NCT00808028|10950175|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0
9838721|NCT00808028|10950176|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170
9838722|NCT00808028|10950177|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151
9838723|NCT00808028|10950174|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
9838724|NCT00808028|10950175|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0
9838725|NCT00808028|10950176|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141
9838726|NCT00808028|10950177|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128
9838727|NCT00808028|10950174|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
9838728|NCT00808028|10950175|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
9838729|NCT00808028|10950176|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
9838730|NCT00808028|10950177|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
9838731|NCT00808067|10950199|FG000|STARTED|Overall Study|Number of patients which are treated.|2927
9838732|NCT00808067|10950200|FG001|STARTED|Overall Study|Number of patients which are treated.|2956
9838733|NCT00808067|10950199|FG000|COMPLETED|Overall Study||2446
9838734|NCT00808067|10950200|FG001|COMPLETED|Overall Study||2438
9838735|NCT00808067|10950199|FG000|NOT COMPLETED|Overall Study||481
9838736|NCT00808067|10950200|FG001|NOT COMPLETED|Overall Study||518
9838737|NCT00808132|10950211|FG000|STARTED|Overall Study||455
10021749|NCT01846299|11145182|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
10021750|NCT01846299|11145183|FG001|Safety Set|Overall Study||58
10021751|NCT01846299|11145182|FG000|COMPLETED|Overall Study||106
10021752|NCT01846299|11145183|FG001|COMPLETED|Overall Study||50
9838738|NCT00808132|10950212|FG001|STARTED|Overall Study||481
9838739|NCT00808132|10950213|FG002|STARTED|Overall Study||239
9721032|NCT00059475|10820573|FG000|COMPLETED|Overall Study||33
9721033|NCT00059475|10820574|FG001|COMPLETED|Overall Study||2
9721034|NCT00059475|10820575|FG002|COMPLETED|Overall Study||24
9721035|NCT00059475|10820576|FG003|COMPLETED|Overall Study||3
9721036|NCT00059475|10820577|FG004|COMPLETED|Overall Study||33
9721037|NCT00059475|10820578|FG005|COMPLETED|Overall Study||2
9721038|NCT00059475|10820579|FG006|COMPLETED|Overall Study||34
9721039|NCT00059475|10820580|FG007|COMPLETED|Overall Study||7
9721040|NCT00059475|10820573|FG000|NOT COMPLETED|Overall Study||0
9721041|NCT00059475|10820574|FG001|NOT COMPLETED|Overall Study||0
9721042|NCT00059475|10820575|FG002|NOT COMPLETED|Overall Study||0
9721043|NCT00059475|10820576|FG003|NOT COMPLETED|Overall Study||0
9721044|NCT00059475|10820577|FG004|NOT COMPLETED|Overall Study||0
9721045|NCT00059475|10820578|FG005|NOT COMPLETED|Overall Study||0
9721046|NCT00059475|10820579|FG006|NOT COMPLETED|Overall Study||0
9721047|NCT00059475|10820580|FG007|NOT COMPLETED|Overall Study||0
9721048|NCT00059787|10820605|FG000|STARTED|Overall Study||56
9721049|NCT00059787|10820605|FG000|COMPLETED|Overall Study||36
9721050|NCT00059787|10820605|FG000|NOT COMPLETED|Overall Study||20
9721051|NCT00059839|10820612|FG000|STARTED|Overall Study||65
9721052|NCT00059839|10820613|FG001|STARTED|Overall Study||64
9721053|NCT00059839|10820612|FG000|COMPLETED|Overall Study||53
9721054|NCT00059839|10820613|FG001|COMPLETED|Overall Study||47
9721055|NCT00059839|10820612|FG000|NOT COMPLETED|Overall Study||12
9721056|NCT00059839|10820613|FG001|NOT COMPLETED|Overall Study||17
9721057|NCT00060008|10820619|FG000|STARTED|Overall Study||18
9721058|NCT00060008|10820619|FG000|COMPLETED|Overall Study||18
9721059|NCT00060008|10820619|FG000|NOT COMPLETED|Overall Study||0
9721060|NCT00060333|10820624|FG000|STARTED|Overall Study||20
9721061|NCT00060333|10820624|FG000|COMPLETED|Overall Study||20
9721062|NCT00060333|10820624|FG000|NOT COMPLETED|Overall Study||0
9721063|NCT00060346|10820631|FG000|STARTED|Overall Study||16
9721064|NCT00060346|10820631|FG000|Eligible and Treated|Overall Study||16
9721065|NCT00060346|10820631|FG000|COMPLETED|Overall Study||16
9721066|NCT00060346|10820631|FG000|NOT COMPLETED|Overall Study||0
9721067|NCT00060424|10820635|FG000|STARTED|Overall Study||21
9721068|NCT00060424|10820635|FG000|COMPLETED|Overall Study||21
9721069|NCT00060424|10820635|FG000|NOT COMPLETED|Overall Study||0
9731564|NCT00132808|10831422|FG002|COMPLETED|Stratum II||116
9731565|NCT00132808|10831420|FG000|NOT COMPLETED|Stratum II||8
9838740|NCT00808132|10950214|FG003|STARTED|Overall Study||228
9838741|NCT00808132|10950215|FG004|STARTED|Overall Study||483
9838742|NCT00808132|10950211|FG000|Treated|Overall Study||445
9838743|NCT00808132|10950212|FG001|Treated|Overall Study||474
9838744|NCT00808132|10950213|FG002|Treated|Overall Study||230
9838745|NCT00808132|10950214|FG003|Treated|Overall Study||220
9838746|NCT00808132|10950215|FG004|Treated|Overall Study||474
9838747|NCT00808132|10950211|FG000|COMPLETED|Overall Study||357
9838748|NCT00808132|10950212|FG001|COMPLETED|Overall Study||393
9838749|NCT00808132|10950213|FG002|COMPLETED|Overall Study||185
10114138|NCT02513940|11244851|FG004|COMPLETED|Overall Study||2
9838750|NCT00808132|10950214|FG003|COMPLETED|Overall Study||159
9838751|NCT00808132|10950215|FG004|COMPLETED|Overall Study||383
9838752|NCT00808132|10950211|FG000|NOT COMPLETED|Overall Study||98
9838753|NCT00808132|10950212|FG001|NOT COMPLETED|Overall Study||88
9838754|NCT00808132|10950213|FG002|NOT COMPLETED|Overall Study||54
9838755|NCT00808132|10950214|FG003|NOT COMPLETED|Overall Study||69
10114139|NCT02513940|11244852|FG005|COMPLETED|Overall Study||3
9721070|NCT00060528|10820639|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
9721071|NCT00060528|10820640|FG001|STARTED|Overall Study||9
9721072|NCT00060528|10820641|FG002|STARTED|Overall Study||7
9721073|NCT00060528|10820642|FG003|STARTED|Overall Study||8
9721074|NCT00060528|10820639|FG000|COMPLETED|Overall Study||8
9721075|NCT00060528|10820640|FG001|COMPLETED|Overall Study||9
9721076|NCT00060528|10820641|FG002|COMPLETED|Overall Study||7
9721077|NCT00060528|10820642|FG003|COMPLETED|Overall Study||8
9721078|NCT00060528|10820639|FG000|NOT COMPLETED|Overall Study||0
9721079|NCT00060528|10820640|FG001|NOT COMPLETED|Overall Study||0
9838756|NCT00808132|10950215|FG004|NOT COMPLETED|Overall Study||100
9838757|NCT00808210|10950229|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15
9838758|NCT00808210|10950230|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13
9838759|NCT00808210|10950229|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6
9838760|NCT00808210|10950230|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4
9838761|NCT00808210|10950229|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
9838762|NCT00808210|10950230|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
9838763|NCT00808210|10950229|FG000|STARTED|Double-Blind TX Period||15
9838764|NCT00808210|10950230|FG001|STARTED|Double-Blind TX Period||13
9838765|NCT00808210|10950229|FG000|COMPLETED|Double-Blind TX Period||13
9838766|NCT00808210|10950230|FG001|COMPLETED|Double-Blind TX Period||10
9838767|NCT00808210|10950229|FG000|NOT COMPLETED|Double-Blind TX Period||2
9838768|NCT00808210|10950230|FG001|NOT COMPLETED|Double-Blind TX Period||3
9838769|NCT00808210|10950229|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9
9838770|NCT00808210|10950230|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4
9838771|NCT00808210|10950229|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0
9838772|NCT00808210|10950230|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0
9838773|NCT00808210|10950229|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
9838774|NCT00808210|10950230|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
9838775|NCT00808236|10950238|FG000|STARTED|Overall Study||96
9838776|NCT00808236|10950239|FG001|STARTED|Overall Study||104
9838777|NCT00808236|10950238|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
9838778|NCT00808236|10950239|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
9838779|NCT00808236|10950238|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
9838780|NCT00808236|10950239|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
9838781|NCT00808236|10950238|FG000|Achieved ROSC|Overall Study||33
9838782|NCT00808236|10950239|FG001|Achieved ROSC|Overall Study||43
9838783|NCT00808236|10950238|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
9838784|NCT00808236|10950239|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
9838785|NCT00808236|10950238|FG000|COMPLETED|Overall Study||14
9838786|NCT00808236|10950239|FG001|COMPLETED|Overall Study||13
9838787|NCT00808236|10950238|FG000|NOT COMPLETED|Overall Study||82
9838788|NCT00808236|10950239|FG001|NOT COMPLETED|Overall Study||91
9838789|NCT00808249|10950249|FG000|STARTED|Overall Study||107
9838790|NCT00808249|10950250|FG001|STARTED|Overall Study||106
9838791|NCT00808249|10950251|FG002|STARTED|Overall Study||105
9838792|NCT00808249|10950252|FG003|STARTED|Overall Study||106
9838793|NCT00808249|10950249|FG000|COMPLETED|Overall Study||90
9838794|NCT00808249|10950250|FG001|COMPLETED|Overall Study||91
9838795|NCT00808249|10950251|FG002|COMPLETED|Overall Study||83
9838796|NCT00808249|10950252|FG003|COMPLETED|Overall Study||90
9838797|NCT00808249|10950249|FG000|NOT COMPLETED|Overall Study||17
9838798|NCT00808249|10950250|FG001|NOT COMPLETED|Overall Study||15
9838799|NCT00808249|10950251|FG002|NOT COMPLETED|Overall Study||22
9838800|NCT00808249|10950252|FG003|NOT COMPLETED|Overall Study||16
9838801|NCT00808340|10950262|FG000|STARTED|First Intervention||4
9838802|NCT00808340|10950263|FG001|STARTED|First Intervention||9
9838803|NCT00808340|10950264|FG002|STARTED|First Intervention||7
9838804|NCT00808340|10950265|FG003|STARTED|First Intervention||3
9838805|NCT00808340|10950266|FG004|STARTED|First Intervention||5
9721080|NCT00060528|10820641|FG002|NOT COMPLETED|Overall Study||0
9721081|NCT00060528|10820642|FG003|NOT COMPLETED|Overall Study||0
9721082|NCT00060606|10820657|FG000|STARTED|Overall Study||91
9721083|NCT00060606|10820658|FG001|STARTED|Overall Study||92
9721084|NCT00060606|10820657|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
10021753|NCT01846299|11145182|FG000|NOT COMPLETED|Overall Study||12
10021754|NCT01846299|11145183|FG001|NOT COMPLETED|Overall Study||10
10021755|NCT01846416|11145194|FG000|STARTED|Treatment Phase||31
10021756|NCT01846416|11145195|FG001|STARTED|Treatment Phase||93
10021757|NCT01846416|11145196|FG002|STARTED|Treatment Phase||13
10021758|NCT01846416|11145194|FG000|COMPLETED|Treatment Phase||0
10021759|NCT01846416|11145195|FG001|COMPLETED|Treatment Phase||0
10021760|NCT01846416|11145196|FG002|COMPLETED|Treatment Phase||0
10021761|NCT01846416|11145194|FG000|NOT COMPLETED|Treatment Phase||31
10021762|NCT01846416|11145195|FG001|NOT COMPLETED|Treatment Phase||93
10021763|NCT01846416|11145196|FG002|NOT COMPLETED|Treatment Phase||13
10021764|NCT01846416|11145194|FG000|STARTED|Survival Follow-up||28
10021765|NCT01846416|11145195|FG001|STARTED|Survival Follow-up||80
10021766|NCT01846416|11145196|FG002|STARTED|Survival Follow-up||12
10021767|NCT01846416|11145194|FG000|COMPLETED|Survival Follow-up||0
10021768|NCT01846416|11145195|FG001|COMPLETED|Survival Follow-up||0
10021769|NCT01846416|11145196|FG002|COMPLETED|Survival Follow-up||0
9838806|NCT00808340|10950267|FG005|STARTED|First Intervention||6
9838807|NCT00808340|10950262|FG000|COMPLETED|First Intervention||4
9838808|NCT00808340|10950263|FG001|COMPLETED|First Intervention||9
9838809|NCT00808340|10950264|FG002|COMPLETED|First Intervention||7
10021770|NCT01846416|11145194|FG000|NOT COMPLETED|Survival Follow-up||28
10021771|NCT01846416|11145195|FG001|NOT COMPLETED|Survival Follow-up||80
10021772|NCT01846416|11145196|FG002|NOT COMPLETED|Survival Follow-up||12
10114140|NCT02513940|11244847|FG000|NOT COMPLETED|Overall Study||0
10114141|NCT02513940|11244848|FG001|NOT COMPLETED|Overall Study||0
9838810|NCT00808340|10950265|FG003|COMPLETED|First Intervention||3
10021773|NCT01846442|11145209|FG000|STARTED|Overall Study||54
10021774|NCT01846442|11145210|FG001|STARTED|Overall Study||54
10021775|NCT01846442|11145211|FG002|STARTED|Overall Study||56
10114142|NCT02513940|11244849|FG002|NOT COMPLETED|Overall Study||0
10114143|NCT02513940|11244850|FG003|NOT COMPLETED|Overall Study||0
9959187|NCT01461369|11078640|FG000|STARTED|Overall Study||104
9959188|NCT01461369|11078641|FG001|STARTED|Overall Study||98
9959189|NCT01461369|11078642|FG002|STARTED|Overall Study||103
9721085|NCT00060606|10820658|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
9721086|NCT00060606|10820657|FG000|COMPLETED|Overall Study||91
9721087|NCT00060606|10820658|FG001|COMPLETED|Overall Study||91
9721088|NCT00060606|10820657|FG000|NOT COMPLETED|Overall Study||0
9721089|NCT00060606|10820658|FG001|NOT COMPLETED|Overall Study||1
9721090|NCT00060840|10820666|FG000|STARTED|Overall Study||73
9721091|NCT00060840|10820667|FG001|STARTED|Overall Study||77
9721092|NCT00060840|10820666|FG000|COMPLETED|Overall Study||69
9721093|NCT00060840|10820667|FG001|COMPLETED|Overall Study||68
9721094|NCT00060840|10820666|FG000|NOT COMPLETED|Overall Study||4
9721095|NCT00060840|10820667|FG001|NOT COMPLETED|Overall Study||9
9721096|NCT00060944|10820675|FG000|STARTED|Overall Study||136
9721097|NCT00060944|10820676|FG001|STARTED|Overall Study||134
9721098|NCT00060944|10820675|FG000|Treated|Overall Study||130
9721099|NCT00060944|10820676|FG001|Treated|Overall Study||130
9721100|NCT00060944|10820675|FG000|COMPLETED|Overall Study||0
9721101|NCT00060944|10820676|FG001|COMPLETED|Overall Study||0
9721102|NCT00060944|10820675|FG000|NOT COMPLETED|Overall Study||136
9721103|NCT00060944|10820676|FG001|NOT COMPLETED|Overall Study||134
9721104|NCT00061048|10820682|FG000|STARTED|Overall Study||29
9721105|NCT00061048|10820682|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
9721106|NCT00061048|10820682|FG000|NOT COMPLETED|Overall Study||22
9721107|NCT00061373|10820688|FG000|STARTED|Overall Study||15
9721108|NCT00061373|10820689|FG001|STARTED|Overall Study||3
9721109|NCT00061373|10820688|FG000|Aspirin and Tinzaparin|Overall Study||15
9838811|NCT00808340|10950266|FG004|COMPLETED|First Intervention||5
9838812|NCT00808340|10950267|FG005|COMPLETED|First Intervention||6
9838813|NCT00808340|10950262|FG000|NOT COMPLETED|First Intervention||0
9721110|NCT00061373|10820689|FG001|Aspirin and Tinzaparin|Overall Study||3
9721111|NCT00061373|10820688|FG000|COMPLETED|Overall Study||15
9721112|NCT00061373|10820689|FG001|COMPLETED|Overall Study||3
9721113|NCT00061373|10820688|FG000|NOT COMPLETED|Overall Study||0
9721114|NCT00061373|10820689|FG001|NOT COMPLETED|Overall Study||0
9721115|NCT00061633|10820697|FG000|STARTED|Overall Study||84
9721116|NCT00061633|10820698|FG001|STARTED|Overall Study||85
9721117|NCT00061633|10820697|FG000|COMPLETED|Overall Study||79
9721118|NCT00061633|10820698|FG001|COMPLETED|Overall Study||74
9721119|NCT00061633|10820697|FG000|NOT COMPLETED|Overall Study||5
9721120|NCT00061633|10820698|FG001|NOT COMPLETED|Overall Study||11
9721121|NCT00061893|10820704|FG000|STARTED|Overall Study||38
9721122|NCT00061893|10820704|FG000|COMPLETED|Overall Study||20
9721123|NCT00061893|10820704|FG000|NOT COMPLETED|Overall Study||18
9721124|NCT00061932|10820710|FG000|STARTED|Overall Study||29
9721125|NCT00061932|10820711|FG001|STARTED|Overall Study||12
9721126|NCT00061932|10820710|FG000|COMPLETED|Overall Study||16
9721127|NCT00061932|10820711|FG001|COMPLETED|Overall Study||8
9721128|NCT00061932|10820710|FG000|NOT COMPLETED|Overall Study||13
9838814|NCT00808340|10950263|FG001|NOT COMPLETED|First Intervention||0
9721129|NCT00061932|10820711|FG001|NOT COMPLETED|Overall Study||4
9721130|NCT00062010|10820718|FG000|STARTED|Overall Study||37
10021776|NCT01846442|11145212|FG003|STARTED|Overall Study||54
9838815|NCT00808340|10950264|FG002|NOT COMPLETED|First Intervention||0
9838816|NCT00808340|10950265|FG003|NOT COMPLETED|First Intervention||0
9838817|NCT00808340|10950266|FG004|NOT COMPLETED|First Intervention||0
9838818|NCT00808340|10950267|FG005|NOT COMPLETED|First Intervention||0
9838819|NCT00808340|10950262|FG000|STARTED|Second Intervention||4
9838820|NCT00808340|10950263|FG001|STARTED|Second Intervention||9
9838821|NCT00808340|10950264|FG002|STARTED|Second Intervention||7
9838822|NCT00808340|10950265|FG003|STARTED|Second Intervention||3
9838823|NCT00808340|10950266|FG004|STARTED|Second Intervention||5
10021777|NCT01846442|11145209|FG000|Safety Population|Overall Study||54
9838824|NCT00808340|10950267|FG005|STARTED|Second Intervention||6
10021778|NCT01846442|11145210|FG001|Safety Population|Overall Study||53
10021779|NCT01846442|11145211|FG002|Safety Population|Overall Study||56
10021780|NCT01846442|11145212|FG003|Safety Population|Overall Study||54
10021781|NCT01846442|11145209|FG000|ITT Population|Overall Study||53
10021782|NCT01846442|11145210|FG001|ITT Population|Overall Study||53
10021783|NCT01846442|11145211|FG002|ITT Population|Overall Study||56
9838825|NCT00808340|10950262|FG000|COMPLETED|Second Intervention||4
9838826|NCT00808340|10950263|FG001|COMPLETED|Second Intervention||9
9838827|NCT00808340|10950264|FG002|COMPLETED|Second Intervention||7
9838828|NCT00808340|10950265|FG003|COMPLETED|Second Intervention||3
9838829|NCT00808340|10950266|FG004|COMPLETED|Second Intervention||5
9838830|NCT00808340|10950267|FG005|COMPLETED|Second Intervention||6
9838831|NCT00808340|10950262|FG000|NOT COMPLETED|Second Intervention||0
9838832|NCT00808340|10950263|FG001|NOT COMPLETED|Second Intervention||0
9838833|NCT00808340|10950264|FG002|NOT COMPLETED|Second Intervention||0
9838834|NCT00808340|10950265|FG003|NOT COMPLETED|Second Intervention||0
9838835|NCT00808340|10950266|FG004|NOT COMPLETED|Second Intervention||0
9838836|NCT00808340|10950267|FG005|NOT COMPLETED|Second Intervention||0
9838837|NCT00808340|10950262|FG000|STARTED|Third Intervention||4
9838838|NCT00808340|10950263|FG001|STARTED|Third Intervention||9
9838839|NCT00808340|10950264|FG002|STARTED|Third Intervention||7
9838840|NCT00808340|10950265|FG003|STARTED|Third Intervention||3
9838841|NCT00808340|10950266|FG004|STARTED|Third Intervention||5
9838842|NCT00808340|10950267|FG005|STARTED|Third Intervention||6
9838843|NCT00808340|10950262|FG000|COMPLETED|Third Intervention||4
9838844|NCT00808340|10950263|FG001|COMPLETED|Third Intervention||9
9838845|NCT00808340|10950264|FG002|COMPLETED|Third Intervention||7
9838846|NCT00808340|10950265|FG003|COMPLETED|Third Intervention||3
9838847|NCT00808340|10950266|FG004|COMPLETED|Third Intervention||5
9838848|NCT00808340|10950267|FG005|COMPLETED|Third Intervention||6
9838849|NCT00808340|10950262|FG000|NOT COMPLETED|Third Intervention||0
10021784|NCT01846442|11145212|FG003|ITT Population|Overall Study||54
9838850|NCT00808340|10950263|FG001|NOT COMPLETED|Third Intervention||0
9838851|NCT00808340|10950264|FG002|NOT COMPLETED|Third Intervention||0
9838852|NCT00808340|10950265|FG003|NOT COMPLETED|Third Intervention||0
9838853|NCT00808340|10950266|FG004|NOT COMPLETED|Third Intervention||0
9838854|NCT00808340|10950267|FG005|NOT COMPLETED|Third Intervention||0
9838855|NCT00808405|10950277|FG000|STARTED|Overall Study||61
9721131|NCT00062010|10820718|FG000|Eligible and Treated|Overall Study||34
9721132|NCT00062010|10820718|FG000|COMPLETED|Overall Study||34
9721133|NCT00062010|10820718|FG000|NOT COMPLETED|Overall Study||3
9721134|NCT00062166|10820722|FG000|STARTED|Overall Study||340
9721135|NCT00062166|10820722|FG000|COMPLETED|Overall Study||334
9721136|NCT00062166|10820722|FG000|NOT COMPLETED|Overall Study||6
9721137|NCT00062374|10820727|FG000|STARTED|Overall Study||55
9721138|NCT00062374|10820727|FG000|COMPLETED|Overall Study||43
9721139|NCT00062374|10820727|FG000|NOT COMPLETED|Overall Study||12
9721140|NCT00062439|10820731|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46
9721141|NCT00062439|10820731|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38
9721142|NCT00062439|10820731|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
9721143|NCT00062439|10820731|FG000|STARTED|Post Chemoradiation Assessment||38
9721144|NCT00062439|10820731|FG000|COMPLETED|Post Chemoradiation Assessment||29
9721145|NCT00062439|10820731|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9
9721146|NCT00062439|10820731|FG000|STARTED|Surgery||29
9721147|NCT00062439|10820731|FG000|COMPLETED|Surgery||22
9721148|NCT00062439|10820731|FG000|NOT COMPLETED|Surgery||7
9721149|NCT00062439|10820731|FG000|STARTED|Consolidation Chemotherapy||22
9721150|NCT00062439|10820731|FG000|COMPLETED|Consolidation Chemotherapy||20
9721151|NCT00062439|10820731|FG000|NOT COMPLETED|Consolidation Chemotherapy||2
9721152|NCT00062647|10820742|FG000|STARTED|Overall Study||30
9721153|NCT00062647|10820743|FG001|STARTED|Overall Study||30
9721154|NCT00062647|10820742|FG000|COMPLETED|Overall Study||14
9721155|NCT00062647|10820743|FG001|COMPLETED|Overall Study||17
9721156|NCT00062647|10820742|FG000|NOT COMPLETED|Overall Study||16
9721157|NCT00062647|10820743|FG001|NOT COMPLETED|Overall Study||13
9721158|NCT00062738|10820752|FG000|STARTED|Overall Study||17
9721159|NCT00062738|10820753|FG001|STARTED|Overall Study||18
9721160|NCT00062738|10820754|FG002|STARTED|Overall Study||17
9721161|NCT00062738|10820752|FG000|COMPLETED|Overall Study||17
9721162|NCT00062738|10820753|FG001|COMPLETED|Overall Study||18
9721163|NCT00062738|10820754|FG002|COMPLETED|Overall Study||17
9721164|NCT00062738|10820752|FG000|NOT COMPLETED|Overall Study||0
9721165|NCT00062738|10820753|FG001|NOT COMPLETED|Overall Study||0
9721166|NCT00062738|10820754|FG002|NOT COMPLETED|Overall Study||0
10021785|NCT01846442|11145209|FG000|COMPLETED|Overall Study||48
10021786|NCT01846442|11145210|FG001|COMPLETED|Overall Study||48
10021787|NCT01846442|11145211|FG002|COMPLETED|Overall Study||52
10021788|NCT01846442|11145212|FG003|COMPLETED|Overall Study||51
10021789|NCT01846442|11145209|FG000|NOT COMPLETED|Overall Study||6
10021790|NCT01846442|11145210|FG001|NOT COMPLETED|Overall Study||6
9721167|NCT00062764|10820765|FG000|STARTED|Overall Study||18
9721168|NCT00062764|10820765|FG000|COMPLETED|Overall Study||18
9721169|NCT00062764|10820765|FG000|NOT COMPLETED|Overall Study||0
9721170|NCT00062868|10820790|FG000|STARTED|Dose Level 1||3
9721171|NCT00062868|10820791|FG001|STARTED|Dose Level 1||0
9721172|NCT00062868|10820792|FG002|STARTED|Dose Level 1||0
9721173|NCT00062868|10820793|FG003|STARTED|Dose Level 1||3
9721174|NCT00062868|10820794|FG004|STARTED|Dose Level 1||0
9721175|NCT00062868|10820795|FG005|STARTED|Dose Level 1||0
9721176|NCT00062868|10820796|FG006|STARTED|Dose Level 1||4
10021791|NCT01846442|11145211|FG002|NOT COMPLETED|Overall Study||4
10021792|NCT01846442|11145212|FG003|NOT COMPLETED|Overall Study||3
10021793|NCT01846455|11145227|FG000|STARTED|Overall Study||9
10021794|NCT01846455|11145228|FG001|STARTED|Overall Study||8
10021795|NCT01846455|11145229|FG002|STARTED|Overall Study||8
10021796|NCT01846455|11145230|FG003|STARTED|Overall Study||10
10021797|NCT01846455|11145231|FG004|STARTED|Overall Study||8
10021798|NCT01846455|11145227|FG000|PK Population|Overall Study||6
9721177|NCT00062868|10820797|FG007|STARTED|Dose Level 1||0
9721178|NCT00062868|10820798|FG008|STARTED|Dose Level 1||0
9721179|NCT00062868|10820799|FG009|STARTED|Dose Level 1||3
9721180|NCT00062868|10820800|FG010|STARTED|Dose Level 1||0
9721181|NCT00062868|10820801|FG011|STARTED|Dose Level 1||0
9721182|NCT00062868|10820802|FG012|STARTED|Dose Level 1||3
9721183|NCT00062868|10820803|FG013|STARTED|Dose Level 1||0
9721184|NCT00062868|10820804|FG014|STARTED|Dose Level 1||0
9721185|NCT00062868|10820805|FG015|STARTED|Dose Level 1||3
9721186|NCT00062868|10820806|FG016|STARTED|Dose Level 1||0
9721187|NCT00062868|10820807|FG017|STARTED|Dose Level 1||0
9721188|NCT00062868|10820808|FG018|STARTED|Dose Level 1||16
9721189|NCT00062868|10820809|FG019|STARTED|Dose Level 1||2
9721190|NCT00062868|10820810|FG020|STARTED|Dose Level 1||3
9721191|NCT00062868|10820790|FG000|COMPLETED|Dose Level 1||1
10021799|NCT01846455|11145228|FG001|PK Population|Overall Study||7
9838856|NCT00808405|10950278|FG001|STARTED|Overall Study||27
9838857|NCT00808405|10950277|FG000|COMPLETED|Overall Study||61
9838858|NCT00808405|10950278|FG001|COMPLETED|Overall Study||27
9838859|NCT00808405|10950277|FG000|NOT COMPLETED|Overall Study||0
9838860|NCT00808405|10950278|FG001|NOT COMPLETED|Overall Study||0
9838861|NCT00808444|10950286|FG000|STARTED|Overall Study||233
9838862|NCT00808444|10950287|FG001|STARTED|Overall Study||233
9838863|NCT00808444|10950286|FG000|COMPLETED|Overall Study||232
9838864|NCT00808444|10950287|FG001|COMPLETED|Overall Study||232
9838865|NCT00808444|10950286|FG000|NOT COMPLETED|Overall Study||1
9838866|NCT00808444|10950287|FG001|NOT COMPLETED|Overall Study||1
9838867|NCT00808470|10950295|FG000|STARTED|Overall Study||37
9838868|NCT00808470|10950296|FG001|STARTED|Overall Study||35
9838869|NCT00808470|10950295|FG000|COMPLETED|Overall Study||35
9838870|NCT00808470|10950296|FG001|COMPLETED|Overall Study||35
9838871|NCT00808470|10950295|FG000|NOT COMPLETED|Overall Study||2
9838872|NCT00808470|10950296|FG001|NOT COMPLETED|Overall Study||0
9838873|NCT00808483|10950308|FG000|STARTED|From 3 to 5 Months After Surgery||35
9838874|NCT00808483|10950309|FG001|STARTED|From 3 to 5 Months After Surgery||33
9838875|NCT00808483|10950308|FG000|COMPLETED|From 3 to 5 Months After Surgery||33
9838876|NCT00808483|10950309|FG001|COMPLETED|From 3 to 5 Months After Surgery||32
9838877|NCT00808483|10950308|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2
9838878|NCT00808483|10950309|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1
9838879|NCT00808483|10950308|FG000|STARTED|From 5 Months to 12 Months||33
9838880|NCT00808483|10950309|FG001|STARTED|From 5 Months to 12 Months||32
9838881|NCT00808483|10950308|FG000|COMPLETED|From 5 Months to 12 Months||32
9838882|NCT00808483|10950309|FG001|COMPLETED|From 5 Months to 12 Months||32
9838883|NCT00808483|10950308|FG000|NOT COMPLETED|From 5 Months to 12 Months||1
9838884|NCT00808483|10950309|FG001|NOT COMPLETED|From 5 Months to 12 Months||0
9838885|NCT00808509|10950324|FG000|STARTED|Randomized Phase||17
9838886|NCT00808509|10950325|FG001|STARTED|Randomized Phase||16
9838887|NCT00808509|10950324|FG000|Received Rescue Therapy|Randomized Phase||0
9838888|NCT00808509|10950325|FG001|Received Rescue Therapy|Randomized Phase||9
9838889|NCT00808509|10950324|FG000|COMPLETED|Randomized Phase||15
9838890|NCT00808509|10950325|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
9838891|NCT00808509|10950324|FG000|NOT COMPLETED|Randomized Phase||2
9838892|NCT00808509|10950325|FG001|NOT COMPLETED|Randomized Phase||5
9838893|NCT00808509|10950324|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16
9959190|NCT01461369|11078640|FG000|COMPLETED|Overall Study||91
9838894|NCT00808509|10950325|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15
9838895|NCT00808509|10950324|FG000|COMPLETED|Observation Phase||16
9838896|NCT00808509|10950325|FG001|COMPLETED|Observation Phase||15
9838897|NCT00808509|10950324|FG000|NOT COMPLETED|Observation Phase||0
9838898|NCT00808509|10950325|FG001|NOT COMPLETED|Observation Phase||0
9838899|NCT00808639|10950333|FG000|STARTED|Overall Study||39
9838900|NCT00808639|10950333|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
9838901|NCT00808639|10950333|FG000|NOT COMPLETED|Overall Study||1
9838902|NCT00808665|10950339|FG000|STARTED|Overall Study||31
9838903|NCT00808665|10950340|FG001|STARTED|Overall Study||32
9838904|NCT00808665|10950339|FG000|Medication Started|Overall Study||30
9838905|NCT00808665|10950340|FG001|Medication Started|Overall Study||32
9838906|NCT00808665|10950339|FG000|Completed Intra-operative Dose|Overall Study||26
9838907|NCT00808665|10950340|FG001|Completed Intra-operative Dose|Overall Study||32
9838908|NCT00808665|10950339|FG000|Completed Post Operative Doses|Overall Study||25
9838909|NCT00808665|10950340|FG001|Completed Post Operative Doses|Overall Study||29
9838910|NCT00808665|10950339|FG000|COMPLETED|Overall Study||25
9838911|NCT00808665|10950340|FG001|COMPLETED|Overall Study||29
9838912|NCT00808665|10950339|FG000|NOT COMPLETED|Overall Study||6
9838913|NCT00808665|10950340|FG001|NOT COMPLETED|Overall Study||3
9838914|NCT00808808|10950349|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078
9838915|NCT00808808|10950350|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757
9838916|NCT00808808|10950351|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387
9838917|NCT00808808|10950349|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
9838918|NCT00808808|10950350|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
9838919|NCT00808808|10950351|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
9838920|NCT00808808|10950349|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
9838921|NCT00808808|10950350|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
9838922|NCT00808808|10950351|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
9838923|NCT00808808|10950349|FG000|NOT COMPLETED|Overall Study||2817
9838924|NCT00808808|10950350|FG001|NOT COMPLETED|Overall Study||2437
9838925|NCT00808808|10950351|FG002|NOT COMPLETED|Overall Study||2557
9838926|NCT00808834|10950365|FG000|STARTED|Period 1||97
9838927|NCT00808834|10950366|FG001|STARTED|Period 1||99
9838928|NCT00808834|10950365|FG000|COMPLETED|Period 1||97
9838929|NCT00808834|10950366|FG001|COMPLETED|Period 1||99
9838930|NCT00808834|10950365|FG000|NOT COMPLETED|Period 1||0
9838931|NCT00808834|10950366|FG001|NOT COMPLETED|Period 1||0
9838932|NCT00808834|10950365|FG000|STARTED|Period 2||97
9838933|NCT00808834|10950366|FG001|STARTED|Period 2||99
9838934|NCT00808834|10950365|FG000|COMPLETED|Period 2||97
9838935|NCT00808834|10950366|FG001|COMPLETED|Period 2||99
9838936|NCT00808834|10950365|FG000|NOT COMPLETED|Period 2||0
9838937|NCT00808834|10950366|FG001|NOT COMPLETED|Period 2||0
9838938|NCT00809055|10950374|FG000|STARTED|Overall Study||37
9838939|NCT00809055|10950375|FG001|STARTED|Overall Study||37
9959191|NCT01461369|11078641|FG001|COMPLETED|Overall Study||81
9959192|NCT01461369|11078642|FG002|COMPLETED|Overall Study||86
9959193|NCT01461369|11078640|FG000|NOT COMPLETED|Overall Study||13
9959194|NCT01461369|11078641|FG001|NOT COMPLETED|Overall Study||17
9959195|NCT01461369|11078642|FG002|NOT COMPLETED|Overall Study||17
9959196|NCT01461473|11078652|FG000|STARTED|Overall Study||72
9959197|NCT01461473|11078653|FG001|STARTED|Overall Study||59
9959198|NCT01461473|11078652|FG000|COMPLETED|Overall Study||67
9959199|NCT01461473|11078653|FG001|COMPLETED|Overall Study||55
9959200|NCT01461473|11078652|FG000|NOT COMPLETED|Overall Study||5
9959201|NCT01461473|11078653|FG001|NOT COMPLETED|Overall Study||4
9959202|NCT01461499|11078661|FG000|STARTED|Overall Study||119
9959203|NCT01461499|11078662|FG001|STARTED|Overall Study||118
9959204|NCT01461499|11078661|FG000|COMPLETED|Overall Study||111
9959205|NCT01461499|11078662|FG001|COMPLETED|Overall Study||114
9959206|NCT01461499|11078661|FG000|NOT COMPLETED|Overall Study||8
9959207|NCT01461499|11078662|FG001|NOT COMPLETED|Overall Study||4
9959208|NCT01461538|11078673|FG000|STARTED|Overall Study||46
9959209|NCT01461538|11078674|FG001|STARTED|Overall Study||28
9959210|NCT01461538|11078675|FG002|STARTED|Overall Study||9
9959211|NCT01461538|11078673|FG000|COMPLETED|Overall Study||28
9959212|NCT01461538|11078674|FG001|COMPLETED|Overall Study||20
9959213|NCT01461538|11078675|FG002|COMPLETED|Overall Study||7
9959214|NCT01461538|11078673|FG000|NOT COMPLETED|Overall Study||18
9959215|NCT01461538|11078674|FG001|NOT COMPLETED|Overall Study||8
9838940|NCT00809055|10950374|FG000|COMPLETED|Overall Study||28
9838941|NCT00809055|10950375|FG001|COMPLETED|Overall Study||30
9838942|NCT00809055|10950374|FG000|NOT COMPLETED|Overall Study||9
9838943|NCT00809055|10950375|FG001|NOT COMPLETED|Overall Study||7
9838944|NCT00809094|10950383|FG000|STARTED|Overall Study||36
9838945|NCT00809094|10950384|FG001|STARTED|Overall Study||34
9838946|NCT00809094|10950383|FG000|COMPLETED|Overall Study||36
9838947|NCT00809094|10950384|FG001|COMPLETED|Overall Study||33
9838948|NCT00809094|10950383|FG000|NOT COMPLETED|Overall Study||0
9838949|NCT00809094|10950384|FG001|NOT COMPLETED|Overall Study||1
9838950|NCT00809133|10950404|FG000|STARTED|Overall Study||3
9838951|NCT00809133|10950405|FG001|STARTED|Overall Study||7
9838952|NCT00809133|10950406|FG002|STARTED|Overall Study||6
9838953|NCT00809133|10950407|FG003|STARTED|Overall Study||3
9838954|NCT00809133|10950408|FG004|STARTED|Overall Study||5
9838955|NCT00809133|10950409|FG005|STARTED|Overall Study||7
9838956|NCT00809133|10950410|FG006|STARTED|Overall Study||6
9838957|NCT00809133|10950411|FG007|STARTED|Overall Study||8
9838958|NCT00809133|10950412|FG008|STARTED|Overall Study||3
9838959|NCT00809133|10950413|FG009|STARTED|Overall Study||9
9838960|NCT00809133|10950414|FG010|STARTED|Overall Study||6
9838961|NCT00809133|10950415|FG011|STARTED|Overall Study||8
9838962|NCT00809133|10950416|FG012|STARTED|Overall Study||5
9838963|NCT00809133|10950417|FG013|STARTED|Overall Study||7
9838964|NCT00809133|10950404|FG000|COMPLETED|Overall Study||0
9838965|NCT00809133|10950405|FG001|COMPLETED|Overall Study||0
9838966|NCT00809133|10950406|FG002|COMPLETED|Overall Study||0
9838967|NCT00809133|10950407|FG003|COMPLETED|Overall Study||0
9838968|NCT00809133|10950408|FG004|COMPLETED|Overall Study||0
9838969|NCT00809133|10950409|FG005|COMPLETED|Overall Study||0
9838970|NCT00809133|10950410|FG006|COMPLETED|Overall Study||0
9838971|NCT00809133|10950411|FG007|COMPLETED|Overall Study||0
9838972|NCT00809133|10950412|FG008|COMPLETED|Overall Study||0
9838973|NCT00809133|10950413|FG009|COMPLETED|Overall Study||0
9838974|NCT00809133|10950414|FG010|COMPLETED|Overall Study||0
10021800|NCT01846455|11145229|FG002|PK Population|Overall Study||6
10021801|NCT01846455|11145230|FG003|PK Population|Overall Study||6
10021802|NCT01846455|11145231|FG004|PK Population|Overall Study||8
10021803|NCT01846455|11145227|FG000|COMPLETED|Overall Study||9
10021804|NCT01846455|11145228|FG001|COMPLETED|Overall Study||8
10021805|NCT01846455|11145229|FG002|COMPLETED|Overall Study||8
10021806|NCT01846455|11145230|FG003|COMPLETED|Overall Study||10
10021807|NCT01846455|11145231|FG004|COMPLETED|Overall Study||8
10021808|NCT01846455|11145227|FG000|NOT COMPLETED|Overall Study||0
10021809|NCT01846455|11145228|FG001|NOT COMPLETED|Overall Study||0
10021810|NCT01846455|11145229|FG002|NOT COMPLETED|Overall Study||0
10021811|NCT01846455|11145230|FG003|NOT COMPLETED|Overall Study||0
10021812|NCT01846455|11145231|FG004|NOT COMPLETED|Overall Study||0
10021813|NCT01846494|11145245|FG000|STARTED|Overall Study||50
10021814|NCT01846494|11145246|FG001|STARTED|Overall Study||63
10021815|NCT01846494|11145245|FG000|COMPLETED|Overall Study||20
10021816|NCT01846494|11145246|FG001|COMPLETED|Overall Study||25
10021817|NCT01846494|11145245|FG000|NOT COMPLETED|Overall Study||30
10021818|NCT01846494|11145246|FG001|NOT COMPLETED|Overall Study||38
10021819|NCT01846507|11145252|FG000|STARTED|Overall Study||32
9838975|NCT00809133|10950415|FG011|COMPLETED|Overall Study||0
9838976|NCT00809133|10950416|FG012|COMPLETED|Overall Study||0
9838977|NCT00809133|10950417|FG013|COMPLETED|Overall Study||0
9838978|NCT00809133|10950404|FG000|NOT COMPLETED|Overall Study||3
9838979|NCT00809133|10950405|FG001|NOT COMPLETED|Overall Study||7
10114144|NCT02513940|11244851|FG004|NOT COMPLETED|Overall Study||0
10114145|NCT02513940|11244852|FG005|NOT COMPLETED|Overall Study||0
10021820|NCT01846507|11145252|FG000|COMPLETED|Overall Study||25
10021821|NCT01846507|11145252|FG000|NOT COMPLETED|Overall Study||7
10021822|NCT01846611|11145260|FG000|STARTED|Overall Study||289
10021823|NCT01846611|11145261|FG001|STARTED|Overall Study||287
10021824|NCT01846611|11145260|FG000|Treated|Overall Study||286
10021825|NCT01846611|11145261|FG001|Treated|Overall Study||282
10114146|NCT02514044|11244862|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
10114147|NCT02514044|11244862|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
10021826|NCT01846611|11145260|FG000|COMPLETED|Overall Study||251
10021827|NCT01846611|11145261|FG001|COMPLETED|Overall Study||244
10021828|NCT01846611|11145260|FG000|NOT COMPLETED|Overall Study||38
10021829|NCT01846611|11145261|FG001|NOT COMPLETED|Overall Study||43
10021830|NCT01846624|11145267|FG000|STARTED|Overall Study||13
10021831|NCT01846624|11145267|FG000|COMPLETED|Overall Study||12
10114148|NCT02514044|11244862|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
10114149|NCT02514044|11244862|FG000|STARTED|Washout (1 Week)||10
10114150|NCT02514044|11244862|FG000|COMPLETED|Washout (1 Week)||10
10114151|NCT02514044|11244862|FG000|NOT COMPLETED|Washout (1 Week)||0
9838980|NCT00809133|10950406|FG002|NOT COMPLETED|Overall Study||6
9838981|NCT00809133|10950407|FG003|NOT COMPLETED|Overall Study||3
9838982|NCT00809133|10950408|FG004|NOT COMPLETED|Overall Study||5
9838983|NCT00809133|10950409|FG005|NOT COMPLETED|Overall Study||7
9838984|NCT00809133|10950410|FG006|NOT COMPLETED|Overall Study||6
9838985|NCT00809133|10950411|FG007|NOT COMPLETED|Overall Study||8
9838986|NCT00809133|10950412|FG008|NOT COMPLETED|Overall Study||3
9838987|NCT00809133|10950413|FG009|NOT COMPLETED|Overall Study||9
9838988|NCT00809133|10950414|FG010|NOT COMPLETED|Overall Study||6
9838989|NCT00809133|10950415|FG011|NOT COMPLETED|Overall Study||8
9838990|NCT00809133|10950416|FG012|NOT COMPLETED|Overall Study||5
9838991|NCT00809133|10950417|FG013|NOT COMPLETED|Overall Study||7
9838992|NCT00809146|10950462|FG000|STARTED|Overall Study||448
9838993|NCT00809146|10950463|FG001|STARTED|Overall Study||445
9838994|NCT00809146|10950462|FG000|COMPLETED|Overall Study||448
9838995|NCT00809146|10950463|FG001|COMPLETED|Overall Study||445
9838996|NCT00809146|10950462|FG000|NOT COMPLETED|Overall Study||0
9838997|NCT00809146|10950463|FG001|NOT COMPLETED|Overall Study||0
9838998|NCT00809159|10950473|FG000|STARTED|Part 1||24
9838999|NCT00809159|10950474|FG001|STARTED|Part 1||6
9839000|NCT00809159|10950475|FG002|STARTED|Part 1||0
9721192|NCT00062868|10820791|FG001|COMPLETED|Dose Level 1||0
9721193|NCT00062868|10820792|FG002|COMPLETED|Dose Level 1||0
9721194|NCT00062868|10820793|FG003|COMPLETED|Dose Level 1||1
9721195|NCT00062868|10820794|FG004|COMPLETED|Dose Level 1||0
9721196|NCT00062868|10820795|FG005|COMPLETED|Dose Level 1||0
9721197|NCT00062868|10820796|FG006|COMPLETED|Dose Level 1||1
9721198|NCT00062868|10820797|FG007|COMPLETED|Dose Level 1||0
9721199|NCT00062868|10820798|FG008|COMPLETED|Dose Level 1||0
9721200|NCT00062868|10820799|FG009|COMPLETED|Dose Level 1||3
9721201|NCT00062868|10820800|FG010|COMPLETED|Dose Level 1||0
9721202|NCT00062868|10820801|FG011|COMPLETED|Dose Level 1||0
9721203|NCT00062868|10820802|FG012|COMPLETED|Dose Level 1||2
9721204|NCT00062868|10820803|FG013|COMPLETED|Dose Level 1||0
9721205|NCT00062868|10820804|FG014|COMPLETED|Dose Level 1||0
9721206|NCT00062868|10820805|FG015|COMPLETED|Dose Level 1||3
9721207|NCT00062868|10820806|FG016|COMPLETED|Dose Level 1||0
9721208|NCT00062868|10820807|FG017|COMPLETED|Dose Level 1||0
9721209|NCT00062868|10820808|FG018|COMPLETED|Dose Level 1||7
9721210|NCT00062868|10820809|FG019|COMPLETED|Dose Level 1||2
9721211|NCT00062868|10820810|FG020|COMPLETED|Dose Level 1||1
9721212|NCT00062868|10820790|FG000|NOT COMPLETED|Dose Level 1||2
9721213|NCT00062868|10820791|FG001|NOT COMPLETED|Dose Level 1||0
9721214|NCT00062868|10820792|FG002|NOT COMPLETED|Dose Level 1||0
9721215|NCT00062868|10820793|FG003|NOT COMPLETED|Dose Level 1||2
9721216|NCT00062868|10820794|FG004|NOT COMPLETED|Dose Level 1||0
9721217|NCT00062868|10820795|FG005|NOT COMPLETED|Dose Level 1||0
9721218|NCT00062868|10820796|FG006|NOT COMPLETED|Dose Level 1||3
9721219|NCT00062868|10820797|FG007|NOT COMPLETED|Dose Level 1||0
9721220|NCT00062868|10820798|FG008|NOT COMPLETED|Dose Level 1||0
9721221|NCT00062868|10820799|FG009|NOT COMPLETED|Dose Level 1||0
9721222|NCT00062868|10820800|FG010|NOT COMPLETED|Dose Level 1||0
9721223|NCT00062868|10820801|FG011|NOT COMPLETED|Dose Level 1||0
10021832|NCT01846624|11145267|FG000|NOT COMPLETED|Overall Study||1
10021833|NCT01846702|11145278|FG000|STARTED|Overall Study||6
9721224|NCT00062868|10820802|FG012|NOT COMPLETED|Dose Level 1||1
9721225|NCT00062868|10820803|FG013|NOT COMPLETED|Dose Level 1||0
9721226|NCT00062868|10820804|FG014|NOT COMPLETED|Dose Level 1||0
9721227|NCT00062868|10820805|FG015|NOT COMPLETED|Dose Level 1||0
9721228|NCT00062868|10820806|FG016|NOT COMPLETED|Dose Level 1||0
9721229|NCT00062868|10820807|FG017|NOT COMPLETED|Dose Level 1||0
9721230|NCT00062868|10820808|FG018|NOT COMPLETED|Dose Level 1||9
9721231|NCT00062868|10820809|FG019|NOT COMPLETED|Dose Level 1||0
9721232|NCT00062868|10820810|FG020|NOT COMPLETED|Dose Level 1||2
9721233|NCT00062868|10820790|FG000|STARTED|Dose Level 2||0
9721234|NCT00062868|10820791|FG001|STARTED|Dose Level 2||6
9721235|NCT00062868|10820792|FG002|STARTED|Dose Level 2||0
9721236|NCT00062868|10820793|FG003|STARTED|Dose Level 2||0
9721237|NCT00062868|10820794|FG004|STARTED|Dose Level 2||3
9721238|NCT00062868|10820795|FG005|STARTED|Dose Level 2||0
9721239|NCT00062868|10820796|FG006|STARTED|Dose Level 2||0
9721240|NCT00062868|10820797|FG007|STARTED|Dose Level 2||0
9721241|NCT00062868|10820798|FG008|STARTED|Dose Level 2||0
9721242|NCT00062868|10820799|FG009|STARTED|Dose Level 2||0
9721243|NCT00062868|10820800|FG010|STARTED|Dose Level 2||4
9721244|NCT00062868|10820801|FG011|STARTED|Dose Level 2||0
9721245|NCT00062868|10820802|FG012|STARTED|Dose Level 2||0
9721246|NCT00062868|10820803|FG013|STARTED|Dose Level 2||3
9721247|NCT00062868|10820804|FG014|STARTED|Dose Level 2||0
10021834|NCT01846702|11145279|FG001|STARTED|Overall Study||6
10021835|NCT01846702|11145280|FG002|STARTED|Overall Study||7
10021836|NCT01846702|11145281|FG003|STARTED|Overall Study||6
10021837|NCT01846702|11145282|FG004|STARTED|Overall Study||6
10021838|NCT01846702|11145283|FG005|STARTED|Overall Study||6
10021839|NCT01846702|11145284|FG006|STARTED|Overall Study||6
10021840|NCT01846702|11145278|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10021841|NCT01846702|11145279|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10021842|NCT01846702|11145280|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10021843|NCT01846702|11145281|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10021844|NCT01846702|11145282|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
9721248|NCT00062868|10820805|FG015|STARTED|Dose Level 2||0
9721249|NCT00062868|10820806|FG016|STARTED|Dose Level 2||3
9721250|NCT00062868|10820807|FG017|STARTED|Dose Level 2||0
9721251|NCT00062868|10820808|FG018|STARTED|Dose Level 2||0
9721252|NCT00062868|10820809|FG019|STARTED|Dose Level 2||0
9721253|NCT00062868|10820810|FG020|STARTED|Dose Level 2||0
9721254|NCT00062868|10820790|FG000|COMPLETED|Dose Level 2||0
9721255|NCT00062868|10820791|FG001|COMPLETED|Dose Level 2||3
9721256|NCT00062868|10820792|FG002|COMPLETED|Dose Level 2||0
9721257|NCT00062868|10820793|FG003|COMPLETED|Dose Level 2||0
9721258|NCT00062868|10820794|FG004|COMPLETED|Dose Level 2||1
9721259|NCT00062868|10820795|FG005|COMPLETED|Dose Level 2||0
9721260|NCT00062868|10820796|FG006|COMPLETED|Dose Level 2||0
9721261|NCT00062868|10820797|FG007|COMPLETED|Dose Level 2||0
9721262|NCT00062868|10820798|FG008|COMPLETED|Dose Level 2||0
9721263|NCT00062868|10820799|FG009|COMPLETED|Dose Level 2||0
9721264|NCT00062868|10820800|FG010|COMPLETED|Dose Level 2||3
9721265|NCT00062868|10820801|FG011|COMPLETED|Dose Level 2||0
9721266|NCT00062868|10820802|FG012|COMPLETED|Dose Level 2||0
9721267|NCT00062868|10820803|FG013|COMPLETED|Dose Level 2||2
9721268|NCT00062868|10820804|FG014|COMPLETED|Dose Level 2||0
9721269|NCT00062868|10820805|FG015|COMPLETED|Dose Level 2||0
9721270|NCT00062868|10820806|FG016|COMPLETED|Dose Level 2||0
9721271|NCT00062868|10820807|FG017|COMPLETED|Dose Level 2||0
9721272|NCT00062868|10820808|FG018|COMPLETED|Dose Level 2||0
9721273|NCT00062868|10820809|FG019|COMPLETED|Dose Level 2||0
9721274|NCT00062868|10820810|FG020|COMPLETED|Dose Level 2||0
9721275|NCT00062868|10820790|FG000|NOT COMPLETED|Dose Level 2||0
9721276|NCT00062868|10820791|FG001|NOT COMPLETED|Dose Level 2||3
9721277|NCT00062868|10820792|FG002|NOT COMPLETED|Dose Level 2||0
9721278|NCT00062868|10820793|FG003|NOT COMPLETED|Dose Level 2||0
9721279|NCT00062868|10820794|FG004|NOT COMPLETED|Dose Level 2||2
9721280|NCT00062868|10820795|FG005|NOT COMPLETED|Dose Level 2||0
9721281|NCT00062868|10820796|FG006|NOT COMPLETED|Dose Level 2||0
9721282|NCT00062868|10820797|FG007|NOT COMPLETED|Dose Level 2||0
9721283|NCT00062868|10820798|FG008|NOT COMPLETED|Dose Level 2||0
9721284|NCT00062868|10820799|FG009|NOT COMPLETED|Dose Level 2||0
9721285|NCT00062868|10820800|FG010|NOT COMPLETED|Dose Level 2||1
9721286|NCT00062868|10820801|FG011|NOT COMPLETED|Dose Level 2||0
9721287|NCT00062868|10820802|FG012|NOT COMPLETED|Dose Level 2||0
9721288|NCT00062868|10820803|FG013|NOT COMPLETED|Dose Level 2||1
9721289|NCT00062868|10820804|FG014|NOT COMPLETED|Dose Level 2||0
9721290|NCT00062868|10820805|FG015|NOT COMPLETED|Dose Level 2||0
9721291|NCT00062868|10820806|FG016|NOT COMPLETED|Dose Level 2||3
9721292|NCT00062868|10820807|FG017|NOT COMPLETED|Dose Level 2||0
9721293|NCT00062868|10820808|FG018|NOT COMPLETED|Dose Level 2||0
9721294|NCT00062868|10820809|FG019|NOT COMPLETED|Dose Level 2||0
9721295|NCT00062868|10820810|FG020|NOT COMPLETED|Dose Level 2||0
9721296|NCT00062868|10820790|FG000|STARTED|Dose Level 3||0
9721297|NCT00062868|10820791|FG001|STARTED|Dose Level 3||0
9721298|NCT00062868|10820792|FG002|STARTED|Dose Level 3||3
9721299|NCT00062868|10820793|FG003|STARTED|Dose Level 3||0
9721300|NCT00062868|10820794|FG004|STARTED|Dose Level 3||0
9839001|NCT00809159|10950476|FG003|STARTED|Part 1||0
9839002|NCT00809159|10950477|FG004|STARTED|Part 1||0
9839003|NCT00809159|10950478|FG005|STARTED|Part 1||0
9839004|NCT00809159|10950473|FG000|PK Analysis Set|Part 1||24
9839005|NCT00809159|10950474|FG001|PK Analysis Set|Part 1||6
9839006|NCT00809159|10950475|FG002|PK Analysis Set|Part 1||0
9839007|NCT00809159|10950476|FG003|PK Analysis Set|Part 1||0
9839008|NCT00809159|10950477|FG004|PK Analysis Set|Part 1||0
9839009|NCT00809159|10950478|FG005|PK Analysis Set|Part 1||0
9839010|NCT00809159|10950473|FG000|PD Analysis Set|Part 1||23
9839011|NCT00809159|10950474|FG001|PD Analysis Set|Part 1||6
9839012|NCT00809159|10950475|FG002|PD Analysis Set|Part 1||0
9839013|NCT00809159|10950476|FG003|PD Analysis Set|Part 1||0
9839014|NCT00809159|10950477|FG004|PD Analysis Set|Part 1||0
9839015|NCT00809159|10950478|FG005|PD Analysis Set|Part 1||0
9839016|NCT00809159|10950473|FG000|COMPLETED|Part 1||16
9839017|NCT00809159|10950474|FG001|COMPLETED|Part 1||3
9839018|NCT00809159|10950475|FG002|COMPLETED|Part 1||0
9721301|NCT00062868|10820795|FG005|STARTED|Dose Level 3||0
9721302|NCT00062868|10820796|FG006|STARTED|Dose Level 3||0
9721303|NCT00062868|10820797|FG007|STARTED|Dose Level 3||0
9721304|NCT00062868|10820798|FG008|STARTED|Dose Level 3||0
9721305|NCT00062868|10820799|FG009|STARTED|Dose Level 3||0
9721306|NCT00062868|10820800|FG010|STARTED|Dose Level 3||0
9721307|NCT00062868|10820801|FG011|STARTED|Dose Level 3||5
9721308|NCT00062868|10820802|FG012|STARTED|Dose Level 3||0
9721309|NCT00062868|10820803|FG013|STARTED|Dose Level 3||0
9721310|NCT00062868|10820804|FG014|STARTED|Dose Level 3||3
9721311|NCT00062868|10820805|FG015|STARTED|Dose Level 3||0
9721312|NCT00062868|10820806|FG016|STARTED|Dose Level 3||0
9839019|NCT00809159|10950476|FG003|COMPLETED|Part 1||0
9839020|NCT00809159|10950477|FG004|COMPLETED|Part 1||0
9839021|NCT00809159|10950478|FG005|COMPLETED|Part 1||0
9839022|NCT00809159|10950473|FG000|NOT COMPLETED|Part 1||8
9839023|NCT00809159|10950474|FG001|NOT COMPLETED|Part 1||3
9839024|NCT00809159|10950475|FG002|NOT COMPLETED|Part 1||0
9839025|NCT00809159|10950476|FG003|NOT COMPLETED|Part 1||0
9839026|NCT00809159|10950477|FG004|NOT COMPLETED|Part 1||0
9839027|NCT00809159|10950478|FG005|NOT COMPLETED|Part 1||0
10021845|NCT01846702|11145283|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
10021846|NCT01846702|11145284|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10021847|NCT01846702|11145278|FG000|COMPLETED|Overall Study||6
10021848|NCT01846702|11145279|FG001|COMPLETED|Overall Study||6
10021849|NCT01846702|11145280|FG002|COMPLETED|Overall Study||6
9721313|NCT00062868|10820807|FG017|STARTED|Dose Level 3||4
9721314|NCT00062868|10820808|FG018|STARTED|Dose Level 3||0
9721315|NCT00062868|10820809|FG019|STARTED|Dose Level 3||0
9721316|NCT00062868|10820810|FG020|STARTED|Dose Level 3||0
9721317|NCT00062868|10820790|FG000|COMPLETED|Dose Level 3||0
9721318|NCT00062868|10820791|FG001|COMPLETED|Dose Level 3||0
9721319|NCT00062868|10820792|FG002|COMPLETED|Dose Level 3||1
9721320|NCT00062868|10820793|FG003|COMPLETED|Dose Level 3||0
9721321|NCT00062868|10820794|FG004|COMPLETED|Dose Level 3||0
9721322|NCT00062868|10820795|FG005|COMPLETED|Dose Level 3||0
9721323|NCT00062868|10820796|FG006|COMPLETED|Dose Level 3||0
9721324|NCT00062868|10820797|FG007|COMPLETED|Dose Level 3||0
9721325|NCT00062868|10820798|FG008|COMPLETED|Dose Level 3||0
9721326|NCT00062868|10820799|FG009|COMPLETED|Dose Level 3||0
9721327|NCT00062868|10820800|FG010|COMPLETED|Dose Level 3||0
9721328|NCT00062868|10820801|FG011|COMPLETED|Dose Level 3||4
9721329|NCT00062868|10820802|FG012|COMPLETED|Dose Level 3||0
9721330|NCT00062868|10820803|FG013|COMPLETED|Dose Level 3||0
9721331|NCT00062868|10820804|FG014|COMPLETED|Dose Level 3||2
10021850|NCT01846702|11145281|FG003|COMPLETED|Overall Study||6
10021851|NCT01846702|11145282|FG004|COMPLETED|Overall Study||6
10021852|NCT01846702|11145283|FG005|COMPLETED|Overall Study||6
10021853|NCT01846702|11145284|FG006|COMPLETED|Overall Study||6
10021854|NCT01846702|11145278|FG000|NOT COMPLETED|Overall Study||0
9721332|NCT00062868|10820805|FG015|COMPLETED|Dose Level 3||0
9721333|NCT00062868|10820806|FG016|COMPLETED|Dose Level 3||0
9721334|NCT00062868|10820807|FG017|COMPLETED|Dose Level 3||3
9721335|NCT00062868|10820808|FG018|COMPLETED|Dose Level 3||0
9721336|NCT00062868|10820809|FG019|COMPLETED|Dose Level 3||0
9721337|NCT00062868|10820810|FG020|COMPLETED|Dose Level 3||0
9721338|NCT00062868|10820790|FG000|NOT COMPLETED|Dose Level 3||0
9721339|NCT00062868|10820791|FG001|NOT COMPLETED|Dose Level 3||0
9721340|NCT00062868|10820792|FG002|NOT COMPLETED|Dose Level 3||2
9721341|NCT00062868|10820793|FG003|NOT COMPLETED|Dose Level 3||0
9721342|NCT00062868|10820794|FG004|NOT COMPLETED|Dose Level 3||0
9721343|NCT00062868|10820795|FG005|NOT COMPLETED|Dose Level 3||0
9721344|NCT00062868|10820796|FG006|NOT COMPLETED|Dose Level 3||0
9721345|NCT00062868|10820797|FG007|NOT COMPLETED|Dose Level 3||0
9721346|NCT00062868|10820798|FG008|NOT COMPLETED|Dose Level 3||0
9721347|NCT00062868|10820799|FG009|NOT COMPLETED|Dose Level 3||0
9721348|NCT00062868|10820800|FG010|NOT COMPLETED|Dose Level 3||0
9721349|NCT00062868|10820801|FG011|NOT COMPLETED|Dose Level 3||1
9721350|NCT00062868|10820802|FG012|NOT COMPLETED|Dose Level 3||0
9721351|NCT00062868|10820803|FG013|NOT COMPLETED|Dose Level 3||0
9839028|NCT00809159|10950473|FG000|STARTED|Part 1 and 2||0
9839029|NCT00809159|10950474|FG001|STARTED|Part 1 and 2||0
9839030|NCT00809159|10950475|FG002|STARTED|Part 1 and 2||30
9839031|NCT00809159|10950476|FG003|STARTED|Part 1 and 2||12
9839032|NCT00809159|10950477|FG004|STARTED|Part 1 and 2||12
9839033|NCT00809159|10950478|FG005|STARTED|Part 1 and 2||6
9839034|NCT00809159|10950473|FG000|PK Analysis Set|Part 1 and 2||0
9839035|NCT00809159|10950474|FG001|PK Analysis Set|Part 1 and 2||0
9839036|NCT00809159|10950475|FG002|PK Analysis Set|Part 1 and 2||30
9839037|NCT00809159|10950476|FG003|PK Analysis Set|Part 1 and 2||12
9839038|NCT00809159|10950477|FG004|PK Analysis Set|Part 1 and 2||12
9839039|NCT00809159|10950478|FG005|PK Analysis Set|Part 1 and 2||6
9839040|NCT00809159|10950473|FG000|PD Analysis Set|Part 1 and 2||0
9839041|NCT00809159|10950474|FG001|PD Analysis Set|Part 1 and 2||0
9839042|NCT00809159|10950475|FG002|PD Analysis Set|Part 1 and 2||28
9839043|NCT00809159|10950476|FG003|PD Analysis Set|Part 1 and 2||12
9959216|NCT01461538|11078675|FG002|NOT COMPLETED|Overall Study||2
10021855|NCT01846702|11145279|FG001|NOT COMPLETED|Overall Study||0
10021856|NCT01846702|11145280|FG002|NOT COMPLETED|Overall Study||1
10021857|NCT01846702|11145281|FG003|NOT COMPLETED|Overall Study||0
10021858|NCT01846702|11145282|FG004|NOT COMPLETED|Overall Study||0
10021859|NCT01846702|11145283|FG005|NOT COMPLETED|Overall Study||0
10021860|NCT01846702|11145284|FG006|NOT COMPLETED|Overall Study||0
9721352|NCT00062868|10820804|FG014|NOT COMPLETED|Dose Level 3||1
10021861|NCT01846728|11145308|FG000|STARTED|Overall Study||6
9721353|NCT00062868|10820805|FG015|NOT COMPLETED|Dose Level 3||0
9839044|NCT00809159|10950477|FG004|PD Analysis Set|Part 1 and 2||12
9839045|NCT00809159|10950478|FG005|PD Analysis Set|Part 1 and 2||6
9839046|NCT00809159|10950473|FG000|COMPLETED|Part 1 and 2||0
9839047|NCT00809159|10950474|FG001|COMPLETED|Part 1 and 2||0
9839048|NCT00809159|10950475|FG002|COMPLETED|Part 1 and 2||20
9839049|NCT00809159|10950476|FG003|COMPLETED|Part 1 and 2||7
9839050|NCT00809159|10950477|FG004|COMPLETED|Part 1 and 2||6
9839051|NCT00809159|10950478|FG005|COMPLETED|Part 1 and 2||3
9839052|NCT00809159|10950473|FG000|NOT COMPLETED|Part 1 and 2||0
9839053|NCT00809159|10950474|FG001|NOT COMPLETED|Part 1 and 2||0
9839054|NCT00809159|10950475|FG002|NOT COMPLETED|Part 1 and 2||10
9839055|NCT00809159|10950476|FG003|NOT COMPLETED|Part 1 and 2||5
9839056|NCT00809159|10950477|FG004|NOT COMPLETED|Part 1 and 2||6
9839057|NCT00809159|10950478|FG005|NOT COMPLETED|Part 1 and 2||3
9839058|NCT00809185|10950492|FG000|STARTED|Overall Study||7
9839059|NCT00809185|10950492|FG000|COMPLETED|Overall Study||7
9839060|NCT00809185|10950492|FG000|NOT COMPLETED|Overall Study||0
9839061|NCT00809276|10950497|FG000|STARTED|Overall Study||92
9839062|NCT00809276|10950497|FG000|COMPLETED|Overall Study||92
9839063|NCT00809276|10950497|FG000|NOT COMPLETED|Overall Study||0
9839064|NCT00809328|10950501|FG000|STARTED|Overall Study||102
9839065|NCT00809328|10950501|FG000|COMPLETED|Overall Study||73
9839066|NCT00809328|10950501|FG000|NOT COMPLETED|Overall Study||29
9839067|NCT00809354|10950515|FG000|STARTED|Overall Study||288
9839068|NCT00809354|10950516|FG001|STARTED|Overall Study||289
9959217|NCT01461551|11078688|FG000|STARTED|Overall Study||35
9839069|NCT00809354|10950517|FG002|STARTED|Overall Study||286
9839070|NCT00809354|10950518|FG003|STARTED|Overall Study||288
9839071|NCT00809354|10950519|FG004|STARTED|Overall Study||288
9839072|NCT00809354|10950520|FG005|STARTED|Overall Study||256
9839073|NCT00809354|10950521|FG006|STARTED|Overall Study||255
9839074|NCT00809354|10950522|FG007|STARTED|Overall Study||257
9839075|NCT00809354|10950523|FG008|STARTED|Overall Study||256
9839076|NCT00809354|10950524|FG009|STARTED|Overall Study||257
9839077|NCT00809354|10950515|FG000|Treated|Overall Study||285
9839078|NCT00809354|10950516|FG001|Treated|Overall Study||288
9721354|NCT00062868|10820806|FG016|NOT COMPLETED|Dose Level 3||0
9721355|NCT00062868|10820807|FG017|NOT COMPLETED|Dose Level 3||1
9721356|NCT00062868|10820808|FG018|NOT COMPLETED|Dose Level 3||0
9721357|NCT00062868|10820809|FG019|NOT COMPLETED|Dose Level 3||0
9721358|NCT00062868|10820810|FG020|NOT COMPLETED|Dose Level 3||0
9721359|NCT00063154|10820854|FG000|STARTED|Overall Study||51
9721360|NCT00063154|10820854|FG000|COMPLETED|Overall Study||0
9721361|NCT00063154|10820854|FG000|NOT COMPLETED|Overall Study||51
9721362|NCT00063232|10820858|FG000|STARTED|Overall Study||26
9721363|NCT00063232|10820858|FG000|COMPLETED|Overall Study||26
9721364|NCT00063232|10820858|FG000|NOT COMPLETED|Overall Study||0
9721365|NCT00063258|10820864|FG000|STARTED|Overall Study||5
9721366|NCT00063258|10820865|FG001|STARTED|Overall Study||0
9721367|NCT00063258|10820864|FG000|COMPLETED|Overall Study||1
9721368|NCT00063258|10820865|FG001|COMPLETED|Overall Study||0
9721369|NCT00063258|10820864|FG000|NOT COMPLETED|Overall Study||4
9721370|NCT00063258|10820865|FG001|NOT COMPLETED|Overall Study||0
9721371|NCT00063362|10820873|FG000|STARTED|Overall Study||23
9721372|NCT00063362|10820874|FG001|STARTED|Overall Study||26
9721373|NCT00063362|10820873|FG000|COMPLETED|Overall Study||19
9721374|NCT00063362|10820874|FG001|COMPLETED|Overall Study||22
9721375|NCT00063362|10820873|FG000|NOT COMPLETED|Overall Study||4
9721376|NCT00063362|10820874|FG001|NOT COMPLETED|Overall Study||4
9721377|NCT00063570|10820882|FG000|STARTED|Overall Study||52
9721378|NCT00063570|10820883|FG001|STARTED|Overall Study||21
9721379|NCT00063570|10820882|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
9721380|NCT00063570|10820883|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
9721381|NCT00063570|10820882|FG000|NOT COMPLETED|Overall Study||0
9721382|NCT00063570|10820883|FG001|NOT COMPLETED|Overall Study||0
9721383|NCT00063622|10820892|FG000|STARTED|Overall Study||80
9721384|NCT00063622|10820893|FG001|STARTED|Overall Study||84
9721385|NCT00063622|10820894|FG002|STARTED|Overall Study||83
9721386|NCT00063622|10820892|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
9721387|NCT00063622|10820893|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
9721388|NCT00063622|10820894|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
9721389|NCT00063622|10820892|FG000|NOT COMPLETED|Overall Study||10
9721390|NCT00063622|10820893|FG001|NOT COMPLETED|Overall Study||4
9721391|NCT00063622|10820894|FG002|NOT COMPLETED|Overall Study||11
9721392|NCT00063635|10820905|FG000|STARTED|Overall Study||57
9721393|NCT00063635|10820906|FG001|STARTED|Overall Study||58
9721394|NCT00063635|10820907|FG002|STARTED|Overall Study||58
9721395|NCT00063635|10820905|FG000|COMPLETED|Overall Study||51
9721396|NCT00063635|10820906|FG001|COMPLETED|Overall Study||50
9721397|NCT00063635|10820907|FG002|COMPLETED|Overall Study||49
9721398|NCT00063635|10820905|FG000|NOT COMPLETED|Overall Study||6
9721399|NCT00063635|10820906|FG001|NOT COMPLETED|Overall Study||8
9721400|NCT00063635|10820907|FG002|NOT COMPLETED|Overall Study||9
9721401|NCT00063882|10820917|FG000|STARTED|Overall Study||292
9721402|NCT00063882|10820918|FG001|STARTED|Overall Study||296
9721403|NCT00063882|10820917|FG000|Has Acute Adverse Event Data|Overall Study||282
9721404|NCT00063882|10820918|FG001|Has Acute Adverse Event Data|Overall Study||288
9721405|NCT00063882|10820917|FG000|Has Late Adverse Event Data|Overall Study||282
9721406|NCT00063882|10820918|FG001|Has Late Adverse Event Data|Overall Study||287
9721407|NCT00063882|10820917|FG000|Has Baseline/4-month EPIC Data|Overall Study||222
9721408|NCT00063882|10820918|FG001|Has Baseline/4-month EPIC Data|Overall Study||241
9721409|NCT00063882|10820917|FG000|Has Baseline/24-month EPIC Data|Overall Study||201
9721410|NCT00063882|10820918|FG001|Has Baseline/24-month EPIC Data|Overall Study||219
9721411|NCT00063882|10820917|FG000|Eligible Patients|Overall Study||287
9721412|NCT00063882|10820918|FG001|Eligible Patients|Overall Study||292
9721413|NCT00063882|10820917|FG000|COMPLETED|Overall Study||287
9721414|NCT00063882|10820918|FG001|COMPLETED|Overall Study||292
9721415|NCT00063882|10820917|FG000|NOT COMPLETED|Overall Study||5
9721416|NCT00063882|10820918|FG001|NOT COMPLETED|Overall Study||4
9721417|NCT00063934|10820924|FG000|STARTED|Overall Study||31
9721418|NCT00063934|10820924|FG000|COMPLETED|Overall Study||30
9839079|NCT00809354|10950517|FG002|Treated|Overall Study||280
9839080|NCT00809354|10950518|FG003|Treated|Overall Study||288
9839081|NCT00809354|10950519|FG004|Treated|Overall Study||283
9959218|NCT01461551|11078689|FG001|STARTED|Overall Study||35
9959219|NCT01461551|11078690|FG002|STARTED|Overall Study||35
9721419|NCT00063934|10820924|FG000|NOT COMPLETED|Overall Study||1
9721420|NCT00063986|10820928|FG000|STARTED|Overall Study||110
9721421|NCT00063986|10820928|FG000|Treated|Overall Study||105
9721422|NCT00063986|10820928|FG000|Eligible and Treated|Overall Study||104
9721423|NCT00063986|10820928|FG000|COMPLETED|Overall Study||104
9721424|NCT00063986|10820928|FG000|NOT COMPLETED|Overall Study||6
9721425|NCT00063999|10820934|FG000|STARTED|Overall Study||692
9721426|NCT00063999|10820935|FG001|STARTED|Overall Study||689
9839082|NCT00809354|10950520|FG005|Treated|Overall Study||256
9839083|NCT00809354|10950521|FG006|Treated|Overall Study||254
9839084|NCT00809354|10950522|FG007|Treated|Overall Study||256
9839085|NCT00809354|10950523|FG008|Treated|Overall Study||254
10021862|NCT01846728|11145308|FG000|COMPLETED|Overall Study||6
10021863|NCT01846728|11145308|FG000|NOT COMPLETED|Overall Study||0
10021864|NCT01846741|11145312|FG000|STARTED|Baseline Visit||22
10021865|NCT01846741|11145312|FG000|COMPLETED|Baseline Visit||20
10021866|NCT01846741|11145312|FG000|NOT COMPLETED|Baseline Visit||2
10021867|NCT01846741|11145312|FG000|STARTED|Implantation to 18-Month/End of Study||20
10021868|NCT01846741|11145312|FG000|COMPLETED|Implantation to 18-Month/End of Study||20
10021869|NCT01846741|11145312|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0
10021870|NCT01846871|11145351|FG000|STARTED|Overall Study||10
10021871|NCT01846871|11145351|FG000|COMPLETED|Overall Study||10
9839086|NCT00809354|10950524|FG009|Treated|Overall Study||256
9839087|NCT00809354|10950515|FG000|COMPLETED|Overall Study||33
9839088|NCT00809354|10950516|FG001|COMPLETED|Overall Study||31
9839089|NCT00809354|10950517|FG002|COMPLETED|Overall Study||32
9839090|NCT00809354|10950518|FG003|COMPLETED|Overall Study||32
9839091|NCT00809354|10950519|FG004|COMPLETED|Overall Study||32
9839092|NCT00809354|10950520|FG005|COMPLETED|Overall Study||31
9839093|NCT00809354|10950521|FG006|COMPLETED|Overall Study||32
9839094|NCT00809354|10950522|FG007|COMPLETED|Overall Study||19
9839095|NCT00809354|10950523|FG008|COMPLETED|Overall Study||28
9839096|NCT00809354|10950524|FG009|COMPLETED|Overall Study||31
9839097|NCT00809354|10950515|FG000|NOT COMPLETED|Overall Study||255
9839098|NCT00809354|10950516|FG001|NOT COMPLETED|Overall Study||258
9839099|NCT00809354|10950517|FG002|NOT COMPLETED|Overall Study||254
9839100|NCT00809354|10950518|FG003|NOT COMPLETED|Overall Study||256
9839101|NCT00809354|10950519|FG004|NOT COMPLETED|Overall Study||256
9839102|NCT00809354|10950520|FG005|NOT COMPLETED|Overall Study||225
9839103|NCT00809354|10950521|FG006|NOT COMPLETED|Overall Study||223
9839104|NCT00809354|10950522|FG007|NOT COMPLETED|Overall Study||238
9839105|NCT00809354|10950523|FG008|NOT COMPLETED|Overall Study||228
9839106|NCT00809354|10950524|FG009|NOT COMPLETED|Overall Study||226
9959220|NCT01461551|11078688|FG000|COMPLETED|Overall Study||33
10021872|NCT01846871|11145351|FG000|NOT COMPLETED|Overall Study||0
10021873|NCT01846988|11145362|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
10021874|NCT01846988|11145363|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
10021875|NCT01846988|11145364|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
9959221|NCT01461551|11078689|FG001|COMPLETED|Overall Study||34
9959222|NCT01461551|11078690|FG002|COMPLETED|Overall Study||33
9959223|NCT01461551|11078688|FG000|NOT COMPLETED|Overall Study||2
9959224|NCT01461551|11078689|FG001|NOT COMPLETED|Overall Study||1
9959225|NCT01461551|11078690|FG002|NOT COMPLETED|Overall Study||2
9959226|NCT01461655|11078698|FG000|STARTED|Overall Study||40
9959227|NCT01461655|11078698|FG000|COMPLETED|Overall Study||40
9959228|NCT01461655|11078698|FG000|NOT COMPLETED|Overall Study||0
9959229|NCT01461668|11078705|FG000|STARTED|Overall Study||27
9959230|NCT01461668|11078706|FG001|STARTED|Overall Study||26
9959231|NCT01461668|11078705|FG000|COMPLETED|Overall Study||25
9959232|NCT01461668|11078706|FG001|COMPLETED|Overall Study||25
9959233|NCT01461668|11078705|FG000|NOT COMPLETED|Overall Study||2
9959234|NCT01461668|11078706|FG001|NOT COMPLETED|Overall Study||1
9959235|NCT01461707|11078714|FG000|STARTED|Overall Study||15
9959236|NCT01461707|11078715|FG001|STARTED|Overall Study||15
9959237|NCT01461707|11078714|FG000|COMPLETED|Overall Study||14
9959238|NCT01461707|11078715|FG001|COMPLETED|Overall Study||15
9959239|NCT01461707|11078714|FG000|NOT COMPLETED|Overall Study||1
9959240|NCT01461707|11078715|FG001|NOT COMPLETED|Overall Study||0
9959241|NCT01461733|11078723|FG000|STARTED|Overall Study||12
9959242|NCT01461733|11078724|FG001|STARTED|Overall Study||12
9959243|NCT01461733|11078723|FG000|COMPLETED|Overall Study||8
9959244|NCT01461733|11078724|FG001|COMPLETED|Overall Study||8
9959245|NCT01461733|11078723|FG000|NOT COMPLETED|Overall Study||4
9959246|NCT01461733|11078724|FG001|NOT COMPLETED|Overall Study||4
9959247|NCT01461811|11078732|FG000|STARTED|Overall Study||95
9959248|NCT01461811|11078733|FG001|STARTED|Overall Study||49
9959249|NCT01461811|11078732|FG000|COMPLETED|Overall Study||91
9959250|NCT01461811|11078733|FG001|COMPLETED|Overall Study||46
9959251|NCT01461811|11078732|FG000|NOT COMPLETED|Overall Study||4
9959252|NCT01461811|11078733|FG001|NOT COMPLETED|Overall Study||3
9959253|NCT01461824|11078742|FG000|STARTED|Overall Study||12
9959254|NCT01461824|11078743|FG001|STARTED|Overall Study||11
9959255|NCT01461824|11078744|FG002|STARTED|Overall Study||11
9959256|NCT01461824|11078742|FG000|COMPLETED|Overall Study||10
9959257|NCT01461824|11078743|FG001|COMPLETED|Overall Study||7
9959258|NCT01461824|11078744|FG002|COMPLETED|Overall Study||8
9839107|NCT00809445|10950554|FG000|STARTED|1 Month Follow-up||429
9839108|NCT00809445|10950555|FG001|STARTED|1 Month Follow-up||433
9839109|NCT00809445|10950556|FG002|STARTED|1 Month Follow-up||419
9839110|NCT00809445|10950554|FG000|COMPLETED|1 Month Follow-up||427
9839111|NCT00809445|10950555|FG001|COMPLETED|1 Month Follow-up||429
9839112|NCT00809445|10950556|FG002|COMPLETED|1 Month Follow-up||415
9839113|NCT00809445|10950554|FG000|NOT COMPLETED|1 Month Follow-up||2
9839114|NCT00809445|10950555|FG001|NOT COMPLETED|1 Month Follow-up||4
9839115|NCT00809445|10950556|FG002|NOT COMPLETED|1 Month Follow-up||4
9839116|NCT00809445|10950554|FG000|STARTED|6 Month Follow-up||429
9839117|NCT00809445|10950555|FG001|STARTED|6 Month Follow-up||433
9839118|NCT00809445|10950556|FG002|STARTED|6 Month Follow-up||419
9839119|NCT00809445|10950554|FG000|COMPLETED|6 Month Follow-up||405
9839120|NCT00809445|10950555|FG001|COMPLETED|6 Month Follow-up||410
9839121|NCT00809445|10950556|FG002|COMPLETED|6 Month Follow-up||395
9839122|NCT00809445|10950554|FG000|NOT COMPLETED|6 Month Follow-up||24
9839123|NCT00809445|10950555|FG001|NOT COMPLETED|6 Month Follow-up||23
9839124|NCT00809445|10950556|FG002|NOT COMPLETED|6 Month Follow-up||24
9839125|NCT00809471|10950567|FG000|STARTED|Overall Study||130
9839126|NCT00809471|10950568|FG001|STARTED|Overall Study||129
9839127|NCT00809471|10950569|FG002|STARTED|Overall Study||131
9839128|NCT00809471|10950567|FG000|COMPLETED|Overall Study||110
9839129|NCT00809471|10950568|FG001|COMPLETED|Overall Study||109
9839130|NCT00809471|10950569|FG002|COMPLETED|Overall Study||114
9839131|NCT00809471|10950567|FG000|NOT COMPLETED|Overall Study||20
9839132|NCT00809471|10950568|FG001|NOT COMPLETED|Overall Study||20
9839133|NCT00809471|10950569|FG002|NOT COMPLETED|Overall Study||17
9839134|NCT00809523|10950579|FG000|STARTED|Overall Study||54
9839135|NCT00809523|10950580|FG001|STARTED|Overall Study||52
9839136|NCT00809523|10950579|FG000|COMPLETED|Overall Study||47
9839137|NCT00809523|10950580|FG001|COMPLETED|Overall Study||48
9839138|NCT00809523|10950579|FG000|NOT COMPLETED|Overall Study||7
9839139|NCT00809523|10950580|FG001|NOT COMPLETED|Overall Study||4
9839140|NCT00809614|10950588|FG000|STARTED|Overall Study||28
9839141|NCT00809614|10950589|FG001|STARTED|Overall Study||14
9839142|NCT00809614|10950588|FG000|Pharmacokinetic Safety Set|Overall Study||27
9839143|NCT00809614|10950589|FG001|Pharmacokinetic Safety Set|Overall Study||14
9839144|NCT00809614|10950588|FG000|Pharmacodynamic (PD) Set|Overall Study||24
9839145|NCT00809614|10950589|FG001|Pharmacodynamic (PD) Set|Overall Study||13
9839146|NCT00809614|10950588|FG000|COMPLETED|Overall Study||25
9839147|NCT00809614|10950589|FG001|COMPLETED|Overall Study||10
9839148|NCT00809614|10950588|FG000|NOT COMPLETED|Overall Study||3
9839149|NCT00809614|10950589|FG001|NOT COMPLETED|Overall Study||4
9839150|NCT00809757|10950598|FG000|STARTED|Overall Study||68
9839151|NCT00809757|10950599|FG001|STARTED|Overall Study||65
9839152|NCT00809757|10950600|FG002|STARTED|Overall Study||64
9839153|NCT00809757|10950598|FG000|COMPLETED|Overall Study||62
9839154|NCT00809757|10950599|FG001|COMPLETED|Overall Study||60
9839155|NCT00809757|10950600|FG002|COMPLETED|Overall Study||53
9839156|NCT00809757|10950598|FG000|NOT COMPLETED|Overall Study||6
9839157|NCT00809757|10950599|FG001|NOT COMPLETED|Overall Study||5
9839158|NCT00809757|10950600|FG002|NOT COMPLETED|Overall Study||11
9839159|NCT00809783|10950617|FG000|STARTED|Overall Study||525
9839160|NCT00809783|10950618|FG001|STARTED|Overall Study||832
9959259|NCT01461824|11078742|FG000|NOT COMPLETED|Overall Study||2
9959260|NCT01461824|11078743|FG001|NOT COMPLETED|Overall Study||4
9959261|NCT01461824|11078744|FG002|NOT COMPLETED|Overall Study||3
9959262|NCT01461863|11078754|FG000|STARTED|Overall Study||48
9959263|NCT01461863|11078755|FG001|STARTED|Overall Study||48
9959264|NCT01461863|11078754|FG000|COMPLETED|Overall Study||48
9959265|NCT01461863|11078755|FG001|COMPLETED|Overall Study||48
9959266|NCT01461863|11078754|FG000|NOT COMPLETED|Overall Study||0
9839161|NCT00809783|10950619|FG002|STARTED|Overall Study||790
9839162|NCT00809783|10950617|FG000|Treated|Overall Study||522
9839163|NCT00809783|10950618|FG001|Treated|Overall Study||832
9839164|NCT00809783|10950619|FG002|Treated|Overall Study||788
9839165|NCT00809783|10950617|FG000|COMPLETED|Overall Study||0
9839166|NCT00809783|10950618|FG001|COMPLETED|Overall Study||0
9839167|NCT00809783|10950619|FG002|COMPLETED|Overall Study||0
9839168|NCT00809783|10950617|FG000|NOT COMPLETED|Overall Study||525
9839169|NCT00809783|10950618|FG001|NOT COMPLETED|Overall Study||832
9839170|NCT00809783|10950619|FG002|NOT COMPLETED|Overall Study||790
9839171|NCT00809809|10950629|FG000|STARTED|Overall Study||78
9839172|NCT00809809|10950630|FG001|STARTED|Overall Study||79
9959267|NCT01461863|11078755|FG001|NOT COMPLETED|Overall Study||0
9959268|NCT01461928|11078763|FG000|STARTED|Induction (up to 8 Months)||692
9959269|NCT01461928|11078764|FG001|STARTED|Induction (up to 8 Months)||0
9959270|NCT01461928|11078765|FG002|STARTED|Induction (up to 8 Months)||0
9839173|NCT00809809|10950629|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
9839174|NCT00809809|10950630|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
9839175|NCT00809809|10950629|FG000|NOT COMPLETED|Overall Study||3
9839176|NCT00809809|10950630|FG001|NOT COMPLETED|Overall Study||2
9839177|NCT00809835|10950640|FG000|STARTED|Overall Study||28
9839178|NCT00809835|10950641|FG001|STARTED|Overall Study||27
9839179|NCT00809835|10950642|FG002|STARTED|Overall Study||38
9839180|NCT00809835|10950643|FG003|STARTED|Overall Study||27
9839181|NCT00809835|10950640|FG000|COMPLETED|Overall Study||20
9839182|NCT00809835|10950641|FG001|COMPLETED|Overall Study||20
9839183|NCT00809835|10950642|FG002|COMPLETED|Overall Study||27
9839184|NCT00809835|10950643|FG003|COMPLETED|Overall Study||25
9839185|NCT00809835|10950640|FG000|NOT COMPLETED|Overall Study||8
9959271|NCT01461928|11078763|FG000|COMPLETED|Induction (up to 8 Months)||494
9959272|NCT01461928|11078764|FG001|COMPLETED|Induction (up to 8 Months)||0
10021876|NCT01846988|11145362|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
10021877|NCT01846988|11145363|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10021878|NCT01846988|11145364|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10021879|NCT01846988|11145362|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10021880|NCT01846988|11145363|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10021881|NCT01846988|11145364|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10021882|NCT01846988|11145362|FG000|STARTED|Intervention #1 - 4 Weeks||0
10021883|NCT01846988|11145363|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
10021884|NCT01846988|11145364|FG002|STARTED|Intervention #1 - 4 Weeks||5
10021885|NCT01846988|11145362|FG000|COMPLETED|Intervention #1 - 4 Weeks||0
10021886|NCT01846988|11145363|FG001|COMPLETED|Intervention #1 - 4 Weeks||5
10021887|NCT01846988|11145364|FG002|COMPLETED|Intervention #1 - 4 Weeks||5
10021888|NCT01846988|11145362|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0
10021889|NCT01846988|11145363|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0
10021890|NCT01846988|11145364|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0
10021891|NCT01846988|11145362|FG000|STARTED|Intervention #2 - 4 Weeks||0
10021892|NCT01846988|11145363|FG001|STARTED|Intervention #2 - 4 Weeks||5
10021893|NCT01846988|11145364|FG002|STARTED|Intervention #2 - 4 Weeks||5
10021894|NCT01846988|11145362|FG000|COMPLETED|Intervention #2 - 4 Weeks||0
10021895|NCT01846988|11145363|FG001|COMPLETED|Intervention #2 - 4 Weeks||5
10021896|NCT01846988|11145364|FG002|COMPLETED|Intervention #2 - 4 Weeks||5
10021897|NCT01846988|11145362|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0
10021898|NCT01846988|11145363|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0
10021899|NCT01846988|11145364|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0
10021900|NCT01847001|11145381|FG000|STARTED|Overall Study||10
10196042|NCT03358290|11324440|FG004|STARTED|Overall Study||2
10021901|NCT01847001|11145381|FG000|COMPLETED|Overall Study||10
10021902|NCT01847001|11145381|FG000|NOT COMPLETED|Overall Study||0
9721427|NCT00063999|10820934|FG000|COMPLETED|Overall Study||647
9721428|NCT00063999|10820935|FG001|COMPLETED|Overall Study||665
9721429|NCT00063999|10820934|FG000|NOT COMPLETED|Overall Study||45
9721430|NCT00063999|10820935|FG001|NOT COMPLETED|Overall Study||24
9721431|NCT00064025|10820948|FG000|STARTED|Overall Study||75
9721432|NCT00064025|10820948|FG000|COMPLETED|Overall Study||68
9721433|NCT00064025|10820948|FG000|NOT COMPLETED|Overall Study||7
9721434|NCT00064038|10820956|FG000|STARTED|Initial Randomization||100
9721435|NCT00064038|10820957|FG001|STARTED|Initial Randomization||98
9721436|NCT00064038|10820958|FG002|STARTED|Initial Randomization||0
9721437|NCT00064038|10820956|FG000|Eligible and Analyzable|Initial Randomization||97
9721438|NCT00064038|10820957|FG001|Eligible and Analyzable|Initial Randomization||95
9721439|NCT00064038|10820958|FG002|Eligible and Analyzable|Initial Randomization||0
9721440|NCT00064038|10820956|FG000|Safety Population|Initial Randomization||96
9721441|NCT00064038|10820957|FG001|Safety Population|Initial Randomization||94
9721442|NCT00064038|10820958|FG002|Safety Population|Initial Randomization||0
9721443|NCT00064038|10820956|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
9721444|NCT00064038|10820957|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
9721445|NCT00064038|10820958|FG002|COMPLETED|Initial Randomization||0
9721446|NCT00064038|10820956|FG000|NOT COMPLETED|Initial Randomization||100
9721447|NCT00064038|10820957|FG001|NOT COMPLETED|Initial Randomization||98
9721448|NCT00064038|10820958|FG002|NOT COMPLETED|Initial Randomization||0
9721449|NCT00064038|10820956|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0
9721450|NCT00064038|10820957|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
9721451|NCT00064038|10820958|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42
9721452|NCT00064038|10820956|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
9721453|NCT00064038|10820957|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
9721454|NCT00064038|10820958|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
9721455|NCT00064038|10820956|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
9721456|NCT00064038|10820957|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
9721457|NCT00064038|10820958|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
9721458|NCT00064038|10820956|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
9721459|NCT00064038|10820957|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
9721460|NCT00064038|10820958|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
9721461|NCT00064038|10820956|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
9721462|NCT00064038|10820957|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
9721463|NCT00064038|10820958|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
9721464|NCT00064077|10820971|FG000|STARTED|Overall Study||118
9721465|NCT00064077|10820972|FG001|STARTED|Overall Study||117
9721466|NCT00064077|10820973|FG002|STARTED|Overall Study||119
9721467|NCT00064077|10820974|FG003|STARTED|Overall Study||118
9721468|NCT00064077|10820971|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103
9721469|NCT00064077|10820972|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108
9721470|NCT00064077|10820973|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112
9721471|NCT00064077|10820974|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111
9721472|NCT00064077|10820971|FG000|NOT COMPLETED|Overall Study||15
9721473|NCT00064077|10820972|FG001|NOT COMPLETED|Overall Study||9
9721474|NCT00064077|10820973|FG002|NOT COMPLETED|Overall Study||7
9721475|NCT00064077|10820974|FG003|NOT COMPLETED|Overall Study||7
9721476|NCT00064259|10820984|FG000|STARTED|Overall Study||4
9721477|NCT00064259|10820985|FG001|STARTED|Overall Study||4
9721478|NCT00064259|10820986|FG002|STARTED|Overall Study||6
9721479|NCT00064259|10820987|FG003|STARTED|Overall Study||1
9721480|NCT00064259|10820984|FG000|COMPLETED|Overall Study||3
9721481|NCT00064259|10820985|FG001|COMPLETED|Overall Study||4
9721482|NCT00064259|10820986|FG002|COMPLETED|Overall Study||6
9721483|NCT00064259|10820987|FG003|COMPLETED|Overall Study||0
9721484|NCT00064259|10820984|FG000|NOT COMPLETED|Overall Study||1
9721485|NCT00064259|10820985|FG001|NOT COMPLETED|Overall Study||0
9721486|NCT00064259|10820986|FG002|NOT COMPLETED|Overall Study||0
9721487|NCT00064259|10820987|FG003|NOT COMPLETED|Overall Study||1
9721488|NCT00064298|10820994|FG000|STARTED|Overall Study||72
9721489|NCT00064298|10820995|FG001|STARTED|Overall Study||62
9721490|NCT00064298|10820994|FG000|COMPLETED|Overall Study||66
9721491|NCT00064298|10820995|FG001|COMPLETED|Overall Study||57
9721492|NCT00064298|10820994|FG000|NOT COMPLETED|Overall Study||6
9721493|NCT00064298|10820995|FG001|NOT COMPLETED|Overall Study||5
9721494|NCT00064337|10821001|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
9721495|NCT00064337|10821001|FG000|COMPLETED|PBSCC or Induction/PBSCC||73
9721496|NCT00064337|10821001|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20
9721497|NCT00064337|10821001|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
9721498|NCT00064337|10821001|FG000|COMPLETED|Transplant||46
9721499|NCT00064337|10821001|FG000|NOT COMPLETED|Transplant||21
9721500|NCT00064337|10821001|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
9721501|NCT00064337|10821001|FG000|COMPLETED|Maintenance||3
9721502|NCT00064337|10821001|FG000|NOT COMPLETED|Maintenance||10
9839186|NCT00809835|10950641|FG001|NOT COMPLETED|Overall Study||7
9839187|NCT00809835|10950642|FG002|NOT COMPLETED|Overall Study||11
9839188|NCT00809835|10950643|FG003|NOT COMPLETED|Overall Study||2
9839189|NCT00809848|10950658|FG000|STARTED|Overall Study||36
9839190|NCT00809848|10950659|FG001|STARTED|Overall Study||34
9839191|NCT00809848|10950660|FG002|STARTED|Overall Study||34
9839192|NCT00809848|10950661|FG003|STARTED|Overall Study||31
9839193|NCT00809848|10950662|FG004|STARTED|Overall Study||37
9839194|NCT00809848|10950658|FG000|COMPLETED|Overall Study||36
9839195|NCT00809848|10950659|FG001|COMPLETED|Overall Study||34
9721503|NCT00064350|10821011|FG000|STARTED|Induction Treatment||59
9721504|NCT00064350|10821012|FG001|STARTED|Induction Treatment||46
9721505|NCT00064350|10821013|FG002|STARTED|Induction Treatment||237
9721506|NCT00064350|10821011|FG000|Treated|Induction Treatment||59
9721507|NCT00064350|10821012|FG001|Treated|Induction Treatment||46
9721508|NCT00064350|10821013|FG002|Treated|Induction Treatment||228
9721509|NCT00064350|10821011|FG000|Eligible and Treated|Induction Treatment||59
9721510|NCT00064350|10821012|FG001|Eligible and Treated|Induction Treatment||46
9721511|NCT00064350|10821013|FG002|Eligible and Treated|Induction Treatment||194
9721512|NCT00064350|10821011|FG000|COMPLETED|Induction Treatment||51
9721513|NCT00064350|10821012|FG001|COMPLETED|Induction Treatment||37
9721514|NCT00064350|10821013|FG002|COMPLETED|Induction Treatment||1
9721515|NCT00064350|10821011|FG000|NOT COMPLETED|Induction Treatment||8
9721516|NCT00064350|10821012|FG001|NOT COMPLETED|Induction Treatment||9
9721517|NCT00064350|10821013|FG002|NOT COMPLETED|Induction Treatment||236
9721518|NCT00064350|10821011|FG000|STARTED|Randomization||59
9721519|NCT00064350|10821012|FG001|STARTED|Randomization||46
9721520|NCT00064350|10821013|FG002|STARTED|Randomization||0
9721521|NCT00064350|10821011|FG000|Treated|Randomization||55
9721522|NCT00064350|10821012|FG001|Treated|Randomization||40
9721523|NCT00064350|10821013|FG002|Treated|Randomization||0
9721524|NCT00064350|10821011|FG000|Eligible and Treated|Randomization||50
9721525|NCT00064350|10821012|FG001|Eligible and Treated|Randomization||31
9721526|NCT00064350|10821013|FG002|Eligible and Treated|Randomization||0
9721527|NCT00064350|10821011|FG000|COMPLETED|Randomization||33
9721528|NCT00064350|10821012|FG001|COMPLETED|Randomization||28
9721529|NCT00064350|10821013|FG002|COMPLETED|Randomization||0
9721530|NCT00064350|10821011|FG000|NOT COMPLETED|Randomization||26
9721531|NCT00064350|10821012|FG001|NOT COMPLETED|Randomization||18
9721532|NCT00064350|10821013|FG002|NOT COMPLETED|Randomization||0
9721533|NCT00064350|10821011|FG000|STARTED|Cross-Over||10
9721534|NCT00064350|10821012|FG001|STARTED|Cross-Over||27
9839196|NCT00809848|10950660|FG002|COMPLETED|Overall Study||34
9721535|NCT00064350|10821013|FG002|STARTED|Cross-Over||0
9721536|NCT00064350|10821011|FG000|Treated|Cross-Over||9
9721537|NCT00064350|10821012|FG001|Treated|Cross-Over||26
9721538|NCT00064350|10821013|FG002|Treated|Cross-Over||0
9839197|NCT00809848|10950661|FG003|COMPLETED|Overall Study||30
10021903|NCT01847014|11145386|FG000|STARTED|Baseline Extension Visit||4
10021904|NCT01847014|11145386|FG000|COMPLETED|Baseline Extension Visit||4
10021905|NCT01847014|11145386|FG000|NOT COMPLETED|Baseline Extension Visit||0
10021906|NCT01847014|11145386|FG000|STARTED|Completion of Extension Study||4
10021907|NCT01847014|11145386|FG000|COMPLETED|Completion of Extension Study||0
10021908|NCT01847014|11145386|FG000|NOT COMPLETED|Completion of Extension Study||4
9721539|NCT00064350|10821011|FG000|Eligible and Treated|Cross-Over||7
9721540|NCT00064350|10821012|FG001|Eligible and Treated|Cross-Over||21
9721541|NCT00064350|10821013|FG002|Eligible and Treated|Cross-Over||0
9721542|NCT00064350|10821011|FG000|COMPLETED|Cross-Over||4
9721543|NCT00064350|10821012|FG001|COMPLETED|Cross-Over||13
9721544|NCT00064350|10821013|FG002|COMPLETED|Cross-Over||0
9721545|NCT00064350|10821011|FG000|NOT COMPLETED|Cross-Over||6
9721546|NCT00064350|10821012|FG001|NOT COMPLETED|Cross-Over||14
9721547|NCT00064350|10821013|FG002|NOT COMPLETED|Cross-Over||0
9721548|NCT00064662|10821024|FG000|STARTED|Overall Study||329
9721549|NCT00064662|10821025|FG001|STARTED|Overall Study||326
9721550|NCT00064662|10821024|FG000|COMPLETED|Overall Study||255
9721551|NCT00064662|10821025|FG001|COMPLETED|Overall Study||265
9721552|NCT00064662|10821024|FG000|NOT COMPLETED|Overall Study||74
9721553|NCT00064662|10821025|FG001|NOT COMPLETED|Overall Study||61
9721554|NCT00064701|10821034|FG000|STARTED|One Year Post-transplant||219
9721555|NCT00064701|10821035|FG001|STARTED|One Year Post-transplant||226
9721556|NCT00064701|10821036|FG002|STARTED|One Year Post-transplant||223
9721557|NCT00064701|10821034|FG000|Received Study Drug|One Year Post-transplant||212
9721558|NCT00064701|10821035|FG001|Received Study Drug|One Year Post-transplant||214
9721559|NCT00064701|10821036|FG002|Received Study Drug|One Year Post-transplant||212
9721560|NCT00064701|10821034|FG000|COMPLETED|One Year Post-transplant||179
9721561|NCT00064701|10821035|FG001|COMPLETED|One Year Post-transplant||183
9721562|NCT00064701|10821036|FG002|COMPLETED|One Year Post-transplant||151
9721563|NCT00064701|10821034|FG000|NOT COMPLETED|One Year Post-transplant||40
9721564|NCT00064701|10821035|FG001|NOT COMPLETED|One Year Post-transplant||43
9721565|NCT00064701|10821036|FG002|NOT COMPLETED|One Year Post-transplant||72
9721566|NCT00064701|10821034|FG000|STARTED|Clinical Continuation Phase||179
9721567|NCT00064701|10821035|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
9721568|NCT00064701|10821036|FG002|STARTED|Clinical Continuation Phase||151
9721569|NCT00064701|10821034|FG000|COMPLETED|Clinical Continuation Phase||9
9721570|NCT00064701|10821035|FG001|COMPLETED|Clinical Continuation Phase||4
9721571|NCT00064701|10821036|FG002|COMPLETED|Clinical Continuation Phase||11
9721572|NCT00064701|10821034|FG000|NOT COMPLETED|Clinical Continuation Phase||170
9721573|NCT00064701|10821035|FG001|NOT COMPLETED|Clinical Continuation Phase||178
9721574|NCT00064701|10821036|FG002|NOT COMPLETED|Clinical Continuation Phase||140
9721575|NCT00064753|10821046|FG000|STARTED|Overall Study||2056
9721576|NCT00064753|10821047|FG001|STARTED|Overall Study||2054
9721577|NCT00064753|10821046|FG000|COMPLETED|Overall Study||1382
9721578|NCT00064753|10821047|FG001|COMPLETED|Overall Study||1406
9721579|NCT00064753|10821046|FG000|NOT COMPLETED|Overall Study||674
9721580|NCT00064753|10821047|FG001|NOT COMPLETED|Overall Study||648
9721581|NCT00064792|10821055|FG000|STARTED|Overall Study||13
9721582|NCT00064792|10821056|FG001|STARTED|Overall Study||10
9721583|NCT00064792|10821055|FG000|COMPLETED|Overall Study||8
9721584|NCT00064792|10821056|FG001|COMPLETED|Overall Study||10
9721585|NCT00064792|10821055|FG000|NOT COMPLETED|Overall Study||5
9721586|NCT00064792|10821056|FG001|NOT COMPLETED|Overall Study||0
9721587|NCT00064844|10821064|FG000|STARTED|Overall Study||45
9721588|NCT00064844|10821065|FG001|STARTED|Overall Study||51
9721589|NCT00064844|10821064|FG000|2 Week Follow-up|Overall Study||45
9721590|NCT00064844|10821065|FG001|2 Week Follow-up|Overall Study||51
9721591|NCT00064844|10821064|FG000|3 Month Follow-up|Overall Study||40
9721592|NCT00064844|10821065|FG001|3 Month Follow-up|Overall Study||47
9721593|NCT00064844|10821064|FG000|6 Month Follow-up|Overall Study||39
9721594|NCT00064844|10821065|FG001|6 Month Follow-up|Overall Study||40
9721595|NCT00064844|10821064|FG000|12 Month Follow-up|Overall Study||37
9721596|NCT00064844|10821065|FG001|12 Month Follow-up|Overall Study||32
10021909|NCT01847027|11145392|FG000|STARTED|Overall Study||11
10021910|NCT01847027|11145393|FG001|STARTED|Overall Study||12
10021911|NCT01847027|11145392|FG000|COMPLETED|Overall Study||10
10021912|NCT01847027|11145393|FG001|COMPLETED|Overall Study||10
10021913|NCT01847027|11145392|FG000|NOT COMPLETED|Overall Study||1
9721597|NCT00064844|10821064|FG000|COMPLETED|Overall Study||37
9721598|NCT00064844|10821065|FG001|COMPLETED|Overall Study||32
9721599|NCT00064844|10821064|FG000|NOT COMPLETED|Overall Study||8
9721600|NCT00064844|10821065|FG001|NOT COMPLETED|Overall Study||19
9721601|NCT00064987|10821073|FG000|STARTED|Overall Study||10
9721602|NCT00064987|10821074|FG001|STARTED|Overall Study||6
9721603|NCT00064987|10821073|FG000|COMPLETED|Overall Study||7
9721604|NCT00064987|10821074|FG001|COMPLETED|Overall Study||6
9721605|NCT00064987|10821073|FG000|NOT COMPLETED|Overall Study||3
9721606|NCT00064987|10821074|FG001|NOT COMPLETED|Overall Study||0
9721607|NCT00065065|10821082|FG000|STARTED|Overall Study||52
9721608|NCT00065065|10821083|FG001|STARTED|Overall Study||53
9721609|NCT00065065|10821082|FG000|COMPLETED|Overall Study||42
9721610|NCT00065065|10821083|FG001|COMPLETED|Overall Study||33
9721611|NCT00065065|10821082|FG000|NOT COMPLETED|Overall Study||10
10021914|NCT01847027|11145393|FG001|NOT COMPLETED|Overall Study||2
10021915|NCT01847092|11145401|FG000|STARTED|Overall Study||77
10021916|NCT01847092|11145402|FG001|STARTED|Overall Study||77
9839198|NCT00809848|10950662|FG004|COMPLETED|Overall Study||34
9839199|NCT00809848|10950658|FG000|NOT COMPLETED|Overall Study||0
9839200|NCT00809848|10950659|FG001|NOT COMPLETED|Overall Study||0
9839201|NCT00809848|10950660|FG002|NOT COMPLETED|Overall Study||0
9839202|NCT00809848|10950661|FG003|NOT COMPLETED|Overall Study||1
9839203|NCT00809848|10950662|FG004|NOT COMPLETED|Overall Study||3
9839204|NCT00809926|10950677|FG000|STARTED|Overall Study||232
9839205|NCT00809926|10950678|FG001|STARTED|Overall Study||219
9839206|NCT00809926|10950677|FG000|COMPLETED|Overall Study||201
9839207|NCT00809926|10950678|FG001|COMPLETED|Overall Study||196
9839208|NCT00809926|10950677|FG000|NOT COMPLETED|Overall Study||31
9839209|NCT00809926|10950678|FG001|NOT COMPLETED|Overall Study||23
9839210|NCT00809965|10950687|FG000|STARTED|Overall Study||5176
9839211|NCT00809965|10950688|FG001|STARTED|Overall Study||5174
9839212|NCT00809965|10950689|FG002|STARTED|Overall Study||5176
9839213|NCT00809965|10950687|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
9839214|NCT00809965|10950688|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
9839215|NCT00809965|10950689|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
9839216|NCT00809965|10950687|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
9839217|NCT00809965|10950688|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
9839218|NCT00809965|10950689|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
9839219|NCT00809965|10950687|FG000|COMPLETED|Overall Study||4393
9839220|NCT00809965|10950688|FG001|COMPLETED|Overall Study||4399
9839221|NCT00809965|10950689|FG002|COMPLETED|Overall Study||4332
9839222|NCT00809965|10950687|FG000|NOT COMPLETED|Overall Study||783
9839223|NCT00809965|10950688|FG001|NOT COMPLETED|Overall Study||775
9839224|NCT00809965|10950689|FG002|NOT COMPLETED|Overall Study||844
9839225|NCT00810043|10950699|FG000|STARTED|Overall Study||57
9839226|NCT00810043|10950700|FG001|STARTED|Overall Study||55
9839227|NCT00810043|10950701|FG002|STARTED|Overall Study||8
9839228|NCT00810043|10950699|FG000|COMPLETED|Overall Study||53
9839229|NCT00810043|10950700|FG001|COMPLETED|Overall Study||54
9839230|NCT00810043|10950701|FG002|COMPLETED|Overall Study||0
9839231|NCT00810043|10950699|FG000|NOT COMPLETED|Overall Study||4
9839232|NCT00810043|10950700|FG001|NOT COMPLETED|Overall Study||1
9839233|NCT00810043|10950701|FG002|NOT COMPLETED|Overall Study||8
9839234|NCT00810069|10950712|FG000|STARTED|Lead-in Period I||840
9839235|NCT00810069|10950713|FG001|STARTED|Lead-in Period I||0
9839236|NCT00810069|10950714|FG002|STARTED|Lead-in Period I||0
9839237|NCT00810069|10950712|FG000|COMPLETED|Lead-in Period I||566
9839238|NCT00810069|10950713|FG001|COMPLETED|Lead-in Period I||0
9839239|NCT00810069|10950714|FG002|COMPLETED|Lead-in Period I||0
9959273|NCT01461928|11078765|FG002|COMPLETED|Induction (up to 8 Months)||0
9959274|NCT01461928|11078763|FG000|NOT COMPLETED|Induction (up to 8 Months)||198
9959275|NCT01461928|11078764|FG001|NOT COMPLETED|Induction (up to 8 Months)||0
9959276|NCT01461928|11078765|FG002|NOT COMPLETED|Induction (up to 8 Months)||0
9959277|NCT01461928|11078763|FG000|STARTED|Maintenance I (24 Months)||494
9959278|NCT01461928|11078764|FG001|STARTED|Maintenance I (24 Months)||0
9839240|NCT00810069|10950712|FG000|NOT COMPLETED|Lead-in Period I||274
9839241|NCT00810069|10950713|FG001|NOT COMPLETED|Lead-in Period I||0
9839242|NCT00810069|10950714|FG002|NOT COMPLETED|Lead-in Period I||0
9839243|NCT00810069|10950712|FG000|STARTED|Double-Blind Period II||0
9839244|NCT00810069|10950713|FG001|STARTED|Double-Blind Period II||282
9839245|NCT00810069|10950714|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
9839246|NCT00810069|10950712|FG000|COMPLETED|Double-Blind Period II||0
9839247|NCT00810069|10950713|FG001|COMPLETED|Double-Blind Period II||226
9839248|NCT00810069|10950714|FG002|COMPLETED|Double-Blind Period II||212
9839249|NCT00810069|10950712|FG000|NOT COMPLETED|Double-Blind Period II||0
9839250|NCT00810069|10950713|FG001|NOT COMPLETED|Double-Blind Period II||56
9839251|NCT00810069|10950714|FG002|NOT COMPLETED|Double-Blind Period II||72
9839252|NCT00810082|10950725|FG000|STARTED|Overall Study||34
9839253|NCT00810082|10950726|FG001|STARTED|Overall Study||31
9959279|NCT01461928|11078765|FG002|STARTED|Maintenance I (24 Months)||0
10021917|NCT01847092|11145401|FG000|COMPLETED|Overall Study||51
10021918|NCT01847092|11145402|FG001|COMPLETED|Overall Study||66
10021919|NCT01847092|11145401|FG000|NOT COMPLETED|Overall Study||26
10021920|NCT01847092|11145402|FG001|NOT COMPLETED|Overall Study||11
10021921|NCT01847131|11145410|FG000|STARTED|Overall Study||25
10021922|NCT01847131|11145411|FG001|STARTED|Overall Study||25
10021923|NCT01847131|11145410|FG000|COMPLETED|Overall Study||25
10021924|NCT01847131|11145411|FG001|COMPLETED|Overall Study||25
10021925|NCT01847131|11145410|FG000|NOT COMPLETED|Overall Study||0
10021926|NCT01847131|11145411|FG001|NOT COMPLETED|Overall Study||0
10021927|NCT01847196|11145417|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
10021928|NCT01847196|11145417|FG000|COMPLETED|Overall Study||5
10021929|NCT01847196|11145417|FG000|NOT COMPLETED|Overall Study||0
10021930|NCT01847209|11145421|FG000|STARTED|Overall Study||25
10021931|NCT01847209|11145421|FG000|COMPLETED|Overall Study||23
10021932|NCT01847209|11145421|FG000|NOT COMPLETED|Overall Study||2
10021933|NCT01847313|11145427|FG000|STARTED|Overall Study||10
9721612|NCT00065065|10821083|FG001|NOT COMPLETED|Overall Study||20
9721613|NCT00065156|10821091|FG000|STARTED|Overall Study||148
9721614|NCT00065156|10821091|FG000|Modified Intent to Treat Population|Overall Study||94
9721615|NCT00065156|10821091|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
9721616|NCT00065156|10821091|FG000|NOT COMPLETED|Overall Study||124
9721617|NCT00065182|10821097|FG000|STARTED|Overall Study||202
9721618|NCT00065182|10821098|FG001|STARTED|Overall Study||197
9721619|NCT00065182|10821097|FG000|COMPLETED|Overall Study||154
9721620|NCT00065182|10821098|FG001|COMPLETED|Overall Study||160
9721621|NCT00065182|10821097|FG000|NOT COMPLETED|Overall Study||48
9721622|NCT00065182|10821098|FG001|NOT COMPLETED|Overall Study||37
9721623|NCT00065260|10821106|FG000|STARTED|Overall Study||27
9721624|NCT00065260|10821107|FG001|STARTED|Overall Study||27
9721625|NCT00065260|10821106|FG000|COMPLETED|Overall Study||27
9721626|NCT00065260|10821107|FG001|COMPLETED|Overall Study||26
9721627|NCT00065260|10821106|FG000|NOT COMPLETED|Overall Study||0
9721628|NCT00065260|10821107|FG001|NOT COMPLETED|Overall Study||1
9721629|NCT00065429|10821120|FG000|STARTED|Phase I - May 2001 - Oct 2002||4
9721630|NCT00065429|10821121|FG001|STARTED|Phase I - May 2001 - Oct 2002||3
9721631|NCT00065429|10821122|FG002|STARTED|Phase I - May 2001 - Oct 2002||4
9721632|NCT00065429|10821123|FG003|STARTED|Phase I - May 2001 - Oct 2002||4
9721633|NCT00065429|10821124|FG004|STARTED|Phase I - May 2001 - Oct 2002||9
9721634|NCT00065429|10821125|FG005|STARTED|Phase I - May 2001 - Oct 2002||4
9721635|NCT00065429|10821126|FG006|STARTED|Phase I - May 2001 - Oct 2002||4
9721636|NCT00065429|10821120|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3
9839254|NCT00810082|10950725|FG000|COMPLETED|Overall Study||34
9839255|NCT00810082|10950726|FG001|COMPLETED|Overall Study||27
9839256|NCT00810082|10950725|FG000|NOT COMPLETED|Overall Study||0
9839257|NCT00810082|10950726|FG001|NOT COMPLETED|Overall Study||4
9839258|NCT00810095|10950732|FG000|STARTED|Overall Study||40
9839259|NCT00810095|10950732|FG000|COMPLETED|Overall Study||40
9839260|NCT00810095|10950732|FG000|NOT COMPLETED|Overall Study||0
10021934|NCT01847313|11145428|FG001|STARTED|Overall Study||10
10021935|NCT01847313|11145427|FG000|COMPLETED|Overall Study||10
10021936|NCT01847313|11145428|FG001|COMPLETED|Overall Study||8
10021937|NCT01847313|11145427|FG000|NOT COMPLETED|Overall Study||0
10021938|NCT01847313|11145428|FG001|NOT COMPLETED|Overall Study||2
10081120|NCT02257970|11209577|FG003|STARTED|Part 2||0
10081121|NCT02257970|11209574|FG000|COMPLETED|Part 2||0
10081122|NCT02257970|11209575|FG001|COMPLETED|Part 2||16
10081123|NCT02257970|11209576|FG002|COMPLETED|Part 2||0
9721637|NCT00065429|10821121|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3
9721638|NCT00065429|10821122|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3
9721639|NCT00065429|10821123|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3
9721640|NCT00065429|10821124|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8
9721641|NCT00065429|10821125|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2
9721642|NCT00065429|10821126|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2
9721643|NCT00065429|10821120|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
9839261|NCT00810108|10950738|FG000|STARTED|Overall Study||6
9839262|NCT00810108|10950739|FG001|STARTED|Overall Study||7
10081124|NCT02257970|11209577|FG003|COMPLETED|Part 2||0
10081125|NCT02257970|11209574|FG000|NOT COMPLETED|Part 2||0
9839263|NCT00810108|10950738|FG000|COMPLETED|Overall Study||5
9839264|NCT00810108|10950739|FG001|COMPLETED|Overall Study||7
10081126|NCT02257970|11209575|FG001|NOT COMPLETED|Part 2||7
10081127|NCT02257970|11209576|FG002|NOT COMPLETED|Part 2||0
10081128|NCT02257970|11209577|FG003|NOT COMPLETED|Part 2||0
10081129|NCT02257970|11209574|FG000|STARTED|Part 3||0
10081130|NCT02257970|11209575|FG001|STARTED|Part 3||0
10081131|NCT02257970|11209576|FG002|STARTED|Part 3||23
9721644|NCT00065429|10821121|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
9721645|NCT00065429|10821122|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
9721646|NCT00065429|10821123|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
9721647|NCT00065429|10821124|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
9721648|NCT00065429|10821125|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
9721649|NCT00065429|10821126|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
9721650|NCT00065429|10821120|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
9721651|NCT00065429|10821121|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
9721652|NCT00065429|10821122|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
9721653|NCT00065429|10821123|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
9721654|NCT00065429|10821124|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
9839265|NCT00810108|10950738|FG000|NOT COMPLETED|Overall Study||1
9839266|NCT00810108|10950739|FG001|NOT COMPLETED|Overall Study||0
9839267|NCT00810199|10950746|FG000|STARTED|Overall Study||279
9839268|NCT00810199|10950747|FG001|STARTED|Overall Study||277
9839269|NCT00810199|10950746|FG000|Received Study Drug|Overall Study||277
9839270|NCT00810199|10950747|FG001|Received Study Drug|Overall Study||276
9839271|NCT00810199|10950746|FG000|Completed Week 24|Overall Study||259
9839272|NCT00810199|10950747|FG001|Completed Week 24|Overall Study||250
9839273|NCT00810199|10950746|FG000|Completed Week 52|Overall Study||243
9839274|NCT00810199|10950747|FG001|Completed Week 52|Overall Study||229
9839275|NCT00810199|10950746|FG000|Completed Week 104|Overall Study||222
9839276|NCT00810199|10950747|FG001|Completed Week 104|Overall Study||201
9839277|NCT00810199|10950746|FG000|COMPLETED|Overall Study||220
9839278|NCT00810199|10950747|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195
9839279|NCT00810199|10950746|FG000|NOT COMPLETED|Overall Study||59
9839280|NCT00810199|10950747|FG001|NOT COMPLETED|Overall Study||82
9839281|NCT00810264|10950759|FG000|STARTED|Overall Study||2499
9839282|NCT00810264|10950759|FG000|COMPLETED|Overall Study||946
9839283|NCT00810264|10950759|FG000|NOT COMPLETED|Overall Study||1553
9839284|NCT00810277|10950767|FG000|STARTED|Overall Study||14
9839285|NCT00810277|10950767|FG000|COMPLETED|Overall Study||13
9839286|NCT00810277|10950767|FG000|NOT COMPLETED|Overall Study||1
9839287|NCT00810303|10950771|FG000|STARTED|Efavirenz Alone - Day 1-5||12
9839288|NCT00810303|10950771|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12
9839289|NCT00810303|10950771|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
9839290|NCT00810303|10950771|FG000|STARTED|Ezetimibe Alone - Day 6-15||12
9839291|NCT00810303|10950771|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12
9839292|NCT00810303|10950771|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
9839293|NCT00810303|10950771|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
9839294|NCT00810303|10950771|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
9839295|NCT00810303|10950771|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
9839296|NCT00810303|10950771|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
9839297|NCT00810303|10950771|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
9839298|NCT00810303|10950771|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
9839299|NCT00810342|10950781|FG000|STARTED|Month 1 Follow-up||154
9839300|NCT00810342|10950782|FG001|STARTED|Month 1 Follow-up||157
9839301|NCT00810342|10950781|FG000|COMPLETED|Month 1 Follow-up||149
9839302|NCT00810342|10950782|FG001|COMPLETED|Month 1 Follow-up||155
9839303|NCT00810342|10950781|FG000|NOT COMPLETED|Month 1 Follow-up||5
9839304|NCT00810342|10950782|FG001|NOT COMPLETED|Month 1 Follow-up||2
9839305|NCT00810342|10950781|FG000|STARTED|6-month Follow-up||149
9839306|NCT00810342|10950782|FG001|STARTED|6-month Follow-up||155
9839307|NCT00810342|10950781|FG000|COMPLETED|6-month Follow-up||125
9839308|NCT00810342|10950782|FG001|COMPLETED|6-month Follow-up||147
9839309|NCT00810342|10950781|FG000|NOT COMPLETED|6-month Follow-up||24
9839310|NCT00810342|10950782|FG001|NOT COMPLETED|6-month Follow-up||8
9839311|NCT00810342|10950781|FG000|STARTED|12-month Followup||125
9959280|NCT01461928|11078763|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
9959281|NCT01461928|11078764|FG001|COMPLETED|Maintenance I (24 Months)||0
9839312|NCT00810342|10950782|FG001|STARTED|12-month Followup||147
9839313|NCT00810342|10950781|FG000|COMPLETED|12-month Followup||113
9839314|NCT00810342|10950782|FG001|COMPLETED|12-month Followup||136
9839315|NCT00810342|10950781|FG000|NOT COMPLETED|12-month Followup||12
9839316|NCT00810342|10950782|FG001|NOT COMPLETED|12-month Followup||11
9839317|NCT00810355|10950793|FG000|STARTED|Overall Study||25
9839318|NCT00810355|10950794|FG001|STARTED|Overall Study||25
9839319|NCT00810355|10950795|FG002|STARTED|Overall Study||25
9839320|NCT00810355|10950793|FG000|COMPLETED|Overall Study||11
9839321|NCT00810355|10950794|FG001|COMPLETED|Overall Study||8
9839322|NCT00810355|10950795|FG002|COMPLETED|Overall Study||14
9839323|NCT00810355|10950793|FG000|NOT COMPLETED|Overall Study||14
9839324|NCT00810355|10950794|FG001|NOT COMPLETED|Overall Study||17
9839325|NCT00810355|10950795|FG002|NOT COMPLETED|Overall Study||11
9839326|NCT00810368|10950805|FG000|STARTED|Overall Study||18
9839327|NCT00810368|10950806|FG001|STARTED|Overall Study||15
9839328|NCT00810368|10950805|FG000|COMPLETED|Overall Study||12
9839329|NCT00810368|10950806|FG001|COMPLETED|Overall Study||13
9839330|NCT00810368|10950805|FG000|NOT COMPLETED|Overall Study||6
9839331|NCT00810368|10950806|FG001|NOT COMPLETED|Overall Study||2
9839332|NCT00810394|10950814|FG000|STARTED|Overall Study||50
9839333|NCT00810394|10950814|FG000|Cycle 2 600mg Twice Daily|Overall Study||13
9839334|NCT00810394|10950814|FG000|Cycle 2 400mg Once Daily|Overall Study||22
9839335|NCT00810394|10950814|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4
9839336|NCT00810394|10950814|FG000|Cycle 3 400mg Twice Daily|Overall Study||5
9839337|NCT00810394|10950814|FG000|COMPLETED|Overall Study||47
9839338|NCT00810394|10950814|FG000|NOT COMPLETED|Overall Study||3
9839339|NCT00810407|10950818|FG000|STARTED|Overall Study||594
9839340|NCT00810407|10950818|FG000|COMPLETED|Overall Study||588
9839341|NCT00810407|10950818|FG000|NOT COMPLETED|Overall Study||6
9839342|NCT00810459|10950822|FG000|STARTED|Overall Study||4
9839343|NCT00810459|10950823|FG001|STARTED|Overall Study||2
9839344|NCT00810459|10950822|FG000|COMPLETED|Overall Study||4
9839345|NCT00810459|10950823|FG001|COMPLETED|Overall Study||2
9839346|NCT00810459|10950822|FG000|NOT COMPLETED|Overall Study||0
9839347|NCT00810459|10950823|FG001|NOT COMPLETED|Overall Study||0
9839348|NCT00810498|10950830|FG000|STARTED|Overall Study||6
9839349|NCT00810498|10950831|FG001|STARTED|Overall Study||5
9839350|NCT00810498|10950830|FG000|COMPLETED|Overall Study||6
9839351|NCT00810498|10950831|FG001|COMPLETED|Overall Study||5
9839352|NCT00810498|10950830|FG000|NOT COMPLETED|Overall Study||0
9839353|NCT00810498|10950831|FG001|NOT COMPLETED|Overall Study||0
9839354|NCT00810511|10950839|FG000|STARTED|Overall Study||107
9839355|NCT00810511|10950840|FG001|STARTED|Overall Study||106
9839356|NCT00810511|10950839|FG000|COMPLETED|Overall Study||97
9839357|NCT00810511|10950840|FG001|COMPLETED|Overall Study||102
9839358|NCT00810511|10950839|FG000|NOT COMPLETED|Overall Study||10
9839359|NCT00810511|10950840|FG001|NOT COMPLETED|Overall Study||4
9839360|NCT00810576|10950846|FG000|STARTED|Overall Study||1
9839361|NCT00810576|10950846|FG000|COMPLETED|Overall Study||1
9839362|NCT00810576|10950846|FG000|NOT COMPLETED|Overall Study||0
9839363|NCT00810602|10950850|FG000|STARTED|Overall Study||27
9839364|NCT00810602|10950851|FG001|STARTED|Overall Study||34
9839365|NCT00810602|10950850|FG000|COMPLETED|Overall Study||19
9839366|NCT00810602|10950851|FG001|COMPLETED|Overall Study||31
9839367|NCT00810602|10950850|FG000|NOT COMPLETED|Overall Study||8
9839368|NCT00810602|10950851|FG001|NOT COMPLETED|Overall Study||3
9839369|NCT00810615|10950857|FG000|STARTED|Overall Study||25
9839370|NCT00810615|10950858|FG001|STARTED|Overall Study||25
9839371|NCT00810615|10950857|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
9839372|NCT00810615|10950858|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
9839373|NCT00810615|10950857|FG000|NOT COMPLETED|Overall Study||1
9839374|NCT00810615|10950858|FG001|NOT COMPLETED|Overall Study||1
9839375|NCT00810641|10950879|FG000|STARTED|Overall Study||52
9839376|NCT00810641|10950880|FG001|STARTED|Overall Study||54
9839377|NCT00810641|10950881|FG002|STARTED|Overall Study||51
9839378|NCT00810641|10950879|FG000|COMPLETED|Overall Study||52
9839379|NCT00810641|10950880|FG001|COMPLETED|Overall Study||53
9839380|NCT00810641|10950881|FG002|COMPLETED|Overall Study||49
9839381|NCT00810641|10950879|FG000|NOT COMPLETED|Overall Study||0
9839382|NCT00810641|10950880|FG001|NOT COMPLETED|Overall Study||1
9839383|NCT00810641|10950881|FG002|NOT COMPLETED|Overall Study||2
9839384|NCT00810693|10950892|FG000|STARTED|Treatment Period||254
9839385|NCT00810693|10950893|FG001|STARTED|Treatment Period|1 randomized but not treated|64
9839386|NCT00810693|10950894|FG002|STARTED|Treatment Period|1 randomized but not treated|127
9839387|NCT00810693|10950892|FG000|Participants Received Treatment|Treatment Period||254
9839388|NCT00810693|10950893|FG001|Participants Received Treatment|Treatment Period||63
9839389|NCT00810693|10950894|FG002|Participants Received Treatment|Treatment Period||126
9839390|NCT00810693|10950892|FG000|COMPLETED|Treatment Period||237
9839391|NCT00810693|10950893|FG001|COMPLETED|Treatment Period||57
9839392|NCT00810693|10950894|FG002|COMPLETED|Treatment Period||111
9839393|NCT00810693|10950892|FG000|NOT COMPLETED|Treatment Period||17
9839394|NCT00810693|10950893|FG001|NOT COMPLETED|Treatment Period||7
9839395|NCT00810693|10950894|FG002|NOT COMPLETED|Treatment Period||16
9839396|NCT00810693|10950892|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
9839397|NCT00810693|10950893|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
9839398|NCT00810693|10950894|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
9721655|NCT00065429|10821125|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
9721656|NCT00065429|10821126|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
9721657|NCT00065429|10821120|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721658|NCT00065429|10821121|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721659|NCT00065429|10821122|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721660|NCT00065429|10821123|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721661|NCT00065429|10821124|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
9721662|NCT00065429|10821125|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721663|NCT00065429|10821126|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721664|NCT00065429|10821120|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721665|NCT00065429|10821121|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721666|NCT00065429|10821122|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721667|NCT00065429|10821123|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721668|NCT00065429|10821124|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
9721669|NCT00065429|10821125|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721670|NCT00065429|10821126|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
9721671|NCT00065442|10821139|FG000|STARTED|Overall Study||171
9721672|NCT00065442|10821140|FG001|STARTED|Overall Study||341
9721673|NCT00065442|10821139|FG000|COMPLETED|Overall Study||46
9721674|NCT00065442|10821140|FG001|COMPLETED|Overall Study||121
9721675|NCT00065442|10821139|FG000|NOT COMPLETED|Overall Study||125
9721676|NCT00065442|10821140|FG001|NOT COMPLETED|Overall Study||220
9721677|NCT00065468|10821149|FG000|STARTED|Overall Study||207
9721678|NCT00065468|10821150|FG001|STARTED|Overall Study||209
9721679|NCT00065468|10821151|FG002|STARTED|Overall Study||210
9721680|NCT00065468|10821149|FG000|Received Treatment|Overall Study||200
9721681|NCT00065468|10821150|FG001|Received Treatment|Overall Study||208
9721682|NCT00065468|10821151|FG002|Received Treatment|Overall Study||208
9721683|NCT00065468|10821149|FG000|COMPLETED|Overall Study||0
9721684|NCT00065468|10821150|FG001|COMPLETED|Overall Study||0
9721685|NCT00065468|10821151|FG002|COMPLETED|Overall Study||0
9721686|NCT00065468|10821149|FG000|NOT COMPLETED|Overall Study||207
9721687|NCT00065468|10821150|FG001|NOT COMPLETED|Overall Study||209
9721688|NCT00065468|10821151|FG002|NOT COMPLETED|Overall Study||210
9721689|NCT00065507|10821161|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
9721690|NCT00065507|10821162|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
9721691|NCT00065507|10821161|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
9721692|NCT00065507|10821162|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
9721693|NCT00065507|10821161|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
9721694|NCT00065507|10821162|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
9721695|NCT00065507|10821161|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
9721696|NCT00065507|10821162|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
9721697|NCT00065507|10821161|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25
9721698|NCT00065507|10821162|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28
9721699|NCT00065507|10821161|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
9721700|NCT00065507|10821162|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
9721701|NCT00065507|10821161|FG000|NOT COMPLETED|Overall Study||29
9721702|NCT00065507|10821162|FG001|NOT COMPLETED|Overall Study||29
9721703|NCT00065611|10821174|FG000|STARTED|Overall Study||4
9721704|NCT00065611|10821175|FG001|STARTED|Overall Study||4
9721705|NCT00065611|10821174|FG000|COMPLETED|Overall Study||4
9721706|NCT00065611|10821175|FG001|COMPLETED|Overall Study||3
9721707|NCT00065611|10821174|FG000|NOT COMPLETED|Overall Study||0
9721708|NCT00065611|10821175|FG001|NOT COMPLETED|Overall Study||1
9721709|NCT00065806|10821183|FG000|STARTED|Overall Study||113
9721710|NCT00065806|10821184|FG001|STARTED|Overall Study||108
9721711|NCT00065806|10821183|FG000|COMPLETED|Overall Study||93
9721712|NCT00065806|10821184|FG001|COMPLETED|Overall Study||89
9721713|NCT00065806|10821183|FG000|NOT COMPLETED|Overall Study||20
9721714|NCT00065806|10821184|FG001|NOT COMPLETED|Overall Study||19
9721715|NCT00066066|10821193|FG000|STARTED|Overall Study||27
9721716|NCT00066066|10821194|FG001|STARTED|Overall Study||22
9721717|NCT00066066|10821195|FG002|STARTED|Overall Study||30
9721718|NCT00066066|10821196|FG003|STARTED|Overall Study||20
9721719|NCT00066066|10821197|FG004|STARTED|Overall Study||27
9721720|NCT00066066|10821198|FG005|STARTED|Overall Study||20
9721721|NCT00066066|10821193|FG000|Baseline|Overall Study||27
9721722|NCT00066066|10821194|FG001|Baseline|Overall Study||22
9721723|NCT00066066|10821195|FG002|Baseline|Overall Study||30
9721724|NCT00066066|10821196|FG003|Baseline|Overall Study||20
9721725|NCT00066066|10821197|FG004|Baseline|Overall Study||27
9721726|NCT00066066|10821198|FG005|Baseline|Overall Study||20
9721727|NCT00066066|10821193|FG000|3 Month|Overall Study||21
9721728|NCT00066066|10821194|FG001|3 Month|Overall Study||17
9721729|NCT00066066|10821195|FG002|3 Month|Overall Study||23
10021939|NCT01847430|11145434|FG000|STARTED|Overall Study||302
9721730|NCT00066066|10821196|FG003|3 Month|Overall Study||16
9721731|NCT00066066|10821197|FG004|3 Month|Overall Study||22
9721732|NCT00066066|10821198|FG005|3 Month|Overall Study||15
9721733|NCT00066066|10821193|FG000|6 Month|Overall Study||19
9721734|NCT00066066|10821194|FG001|6 Month|Overall Study||13
9721735|NCT00066066|10821195|FG002|6 Month|Overall Study||23
9721736|NCT00066066|10821196|FG003|6 Month|Overall Study||13
9721737|NCT00066066|10821197|FG004|6 Month|Overall Study||21
9721738|NCT00066066|10821198|FG005|6 Month|Overall Study||14
9721739|NCT00066066|10821193|FG000|12 Month|Overall Study||18
9721740|NCT00066066|10821194|FG001|12 Month|Overall Study||11
9721741|NCT00066066|10821195|FG002|12 Month|Overall Study||21
9721742|NCT00066066|10821196|FG003|12 Month|Overall Study||11
9721743|NCT00066066|10821197|FG004|12 Month|Overall Study||19
9721744|NCT00066066|10821198|FG005|12 Month|Overall Study||9
9721745|NCT00066066|10821193|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
9721746|NCT00066066|10821194|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
9721747|NCT00066066|10821195|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
9721748|NCT00066066|10821196|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
9721749|NCT00066066|10821197|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
9721750|NCT00066066|10821198|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
9721751|NCT00066066|10821193|FG000|NOT COMPLETED|Overall Study||6
9721752|NCT00066066|10821194|FG001|NOT COMPLETED|Overall Study||4
9721753|NCT00066066|10821195|FG002|NOT COMPLETED|Overall Study||7
9721754|NCT00066066|10821196|FG003|NOT COMPLETED|Overall Study||4
9721755|NCT00066066|10821197|FG004|NOT COMPLETED|Overall Study||3
9721756|NCT00066066|10821198|FG005|NOT COMPLETED|Overall Study||5
9721757|NCT00066170|10821216|FG000|STARTED|Overall Study||56
9721758|NCT00066170|10821217|FG001|STARTED|Overall Study||55
9721759|NCT00066170|10821218|FG002|STARTED|Overall Study||63
9721760|NCT00066170|10821219|FG003|STARTED|Overall Study||57
9721761|NCT00066170|10821216|FG000|Intent to Treat|Overall Study||55
9721762|NCT00066170|10821217|FG001|Intent to Treat|Overall Study||50
9721763|NCT00066170|10821218|FG002|Intent to Treat|Overall Study||63
9721764|NCT00066170|10821219|FG003|Intent to Treat|Overall Study||54
9721765|NCT00066170|10821216|FG000|COMPLETED|Overall Study||49
9721766|NCT00066170|10821217|FG001|COMPLETED|Overall Study||45
9721767|NCT00066170|10821218|FG002|COMPLETED|Overall Study||59
9721768|NCT00066170|10821219|FG003|COMPLETED|Overall Study||48
9721769|NCT00066170|10821216|FG000|NOT COMPLETED|Overall Study||7
9721770|NCT00066170|10821217|FG001|NOT COMPLETED|Overall Study||10
9721771|NCT00066170|10821218|FG002|NOT COMPLETED|Overall Study||4
9721772|NCT00066170|10821219|FG003|NOT COMPLETED|Overall Study||9
9721773|NCT00066222|10821229|FG000|STARTED|Overall Study||72
9721774|NCT00066222|10821229|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
9721775|NCT00066222|10821229|FG000|NOT COMPLETED|Overall Study||1
9721776|NCT00066365|10821235|FG000|STARTED|Overall Study||31
9721777|NCT00066365|10821236|FG001|STARTED|Overall Study||18
9721778|NCT00066365|10821235|FG000|COMPLETED|Overall Study||8
9721779|NCT00066365|10821236|FG001|COMPLETED|Overall Study||4
9721780|NCT00066365|10821235|FG000|NOT COMPLETED|Overall Study||23
9721781|NCT00066365|10821236|FG001|NOT COMPLETED|Overall Study||14
9721782|NCT00066469|10821244|FG000|STARTED|Overall Study||55
9721783|NCT00066469|10821244|FG000|COMPLETED|Overall Study||39
9721784|NCT00066469|10821244|FG000|NOT COMPLETED|Overall Study||16
9721785|NCT00066573|10821250|FG000|STARTED|Overall Study||3789
9721786|NCT00066573|10821251|FG001|STARTED|Overall Study||3787
9721787|NCT00066573|10821250|FG000|COMPLETED|Overall Study||3761
9721788|NCT00066573|10821251|FG001|COMPLETED|Overall Study||3759
9721789|NCT00066573|10821250|FG000|NOT COMPLETED|Overall Study||28
9839399|NCT00810693|10950892|FG000|COMPLETED|Follow-up Period (FUP)||15
9839400|NCT00810693|10950893|FG001|COMPLETED|Follow-up Period (FUP)||4
9839401|NCT00810693|10950894|FG002|COMPLETED|Follow-up Period (FUP)||12
9839402|NCT00810693|10950892|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
9839403|NCT00810693|10950893|FG001|NOT COMPLETED|Follow-up Period (FUP)||3
9839404|NCT00810693|10950894|FG002|NOT COMPLETED|Follow-up Period (FUP)||4
9839405|NCT00810719|10950902|FG000|STARTED|Overall Study||30
9839406|NCT00810719|10950902|FG000|COMPLETED|Overall Study||30
9839407|NCT00810719|10950902|FG000|NOT COMPLETED|Overall Study||0
9839408|NCT00810771|10950909|FG000|STARTED|Overall Study||232
9839409|NCT00810771|10950910|FG001|STARTED|Overall Study||234
9839410|NCT00810771|10950911|FG002|STARTED|Overall Study||84
9839411|NCT00810771|10950909|FG000|COMPLETED|Overall Study||232
9839412|NCT00810771|10950910|FG001|COMPLETED|Overall Study||234
9839413|NCT00810771|10950911|FG002|COMPLETED|Overall Study||84
9839414|NCT00810771|10950909|FG000|NOT COMPLETED|Overall Study||0
9839415|NCT00810771|10950910|FG001|NOT COMPLETED|Overall Study||0
9839416|NCT00810771|10950911|FG002|NOT COMPLETED|Overall Study||0
9839417|NCT00810797|10950921|FG000|STARTED|Overall Study||36
9839418|NCT00810797|10950921|FG000|COMPLETED|Overall Study||36
9839419|NCT00810797|10950921|FG000|NOT COMPLETED|Overall Study||0
9839420|NCT00810810|10950929|FG000|STARTED|Overall Study||124
9839421|NCT00810810|10950930|FG001|STARTED|Overall Study||49
9839422|NCT00810810|10950931|FG002|STARTED|Overall Study||56
9839423|NCT00810810|10950932|FG003|STARTED|Overall Study||51
9839424|NCT00810810|10950929|FG000|COMPLETED|Overall Study||124
9839425|NCT00810810|10950930|FG001|COMPLETED|Overall Study||38
9839426|NCT00810810|10950931|FG002|COMPLETED|Overall Study||45
9839427|NCT00810810|10950932|FG003|COMPLETED|Overall Study||38
9839428|NCT00810810|10950929|FG000|NOT COMPLETED|Overall Study||0
9839429|NCT00810810|10950930|FG001|NOT COMPLETED|Overall Study||11
9839430|NCT00810810|10950931|FG002|NOT COMPLETED|Overall Study||11
9839431|NCT00810810|10950932|FG003|NOT COMPLETED|Overall Study||13
9839432|NCT00810888|10950945|FG000|STARTED|Overall Study||10
9839433|NCT00810888|10950946|FG001|STARTED|Overall Study||9
9839434|NCT00810888|10950947|FG002|STARTED|Overall Study||73
9839435|NCT00810888|10950945|FG000|COMPLETED|Overall Study||10
9839436|NCT00810888|10950946|FG001|COMPLETED|Overall Study||9
9839437|NCT00810888|10950947|FG002|COMPLETED|Overall Study||73
9839438|NCT00810888|10950945|FG000|NOT COMPLETED|Overall Study||0
9839439|NCT00810888|10950946|FG001|NOT COMPLETED|Overall Study||0
9839440|NCT00810888|10950947|FG002|NOT COMPLETED|Overall Study||0
9839441|NCT00810901|10950957|FG000|STARTED|Overall Study||253
9839442|NCT00810901|10950958|FG001|STARTED|Overall Study||176
9839443|NCT00810901|10950957|FG000|1-month Follow up|Overall Study||242
9839444|NCT00810901|10950958|FG001|1-month Follow up|Overall Study||146
9839445|NCT00810901|10950957|FG000|6-month Follow-up|Overall Study||181
9839446|NCT00810901|10950958|FG001|6-month Follow-up|Overall Study||122
9839447|NCT00810901|10950957|FG000|COMPLETED|Overall Study||165
9839448|NCT00810901|10950958|FG001|COMPLETED|Overall Study||118
9839449|NCT00810901|10950957|FG000|NOT COMPLETED|Overall Study||88
9839450|NCT00810901|10950958|FG001|NOT COMPLETED|Overall Study||58
9839451|NCT00811018|10950964|FG000|STARTED|Overall Study||1192
9839452|NCT00811018|10950964|FG000|COMPLETED|Overall Study||224
9839453|NCT00811018|10950964|FG000|NOT COMPLETED|Overall Study||968
9839454|NCT00811057|10950971|FG000|STARTED|Overall Study||90
9839455|NCT00811057|10950972|FG001|STARTED|Overall Study||114
9839456|NCT00811057|10950973|FG002|STARTED|Overall Study||97
9839457|NCT00811057|10950971|FG000|COMPLETED|Overall Study||85
9839458|NCT00811057|10950972|FG001|COMPLETED|Overall Study||104
9839459|NCT00811057|10950973|FG002|COMPLETED|Overall Study||87
9839460|NCT00811057|10950971|FG000|NOT COMPLETED|Overall Study||5
9839461|NCT00811057|10950972|FG001|NOT COMPLETED|Overall Study||10
9839462|NCT00811057|10950973|FG002|NOT COMPLETED|Overall Study||10
9839463|NCT00811070|10950987|FG000|STARTED|Overall Study||7
9839464|NCT00811070|10950988|FG001|STARTED|Overall Study||7
9839465|NCT00811070|10950989|FG002|STARTED|Overall Study||3
9839466|NCT00811070|10950990|FG003|STARTED|Overall Study||28
9839467|NCT00811070|10950991|FG004|STARTED|Overall Study||7
9959282|NCT01461928|11078765|FG002|COMPLETED|Maintenance I (24 Months)||0
9839468|NCT00811070|10950992|FG005|STARTED|Overall Study||11
9839469|NCT00811070|10950987|FG000|COMPLETED|Overall Study||6
9839470|NCT00811070|10950988|FG001|COMPLETED|Overall Study||6
9839471|NCT00811070|10950989|FG002|COMPLETED|Overall Study||3
9839472|NCT00811070|10950990|FG003|COMPLETED|Overall Study||26
9839473|NCT00811070|10950991|FG004|COMPLETED|Overall Study||2
9839474|NCT00811070|10950992|FG005|COMPLETED|Overall Study||10
9839475|NCT00811070|10950987|FG000|NOT COMPLETED|Overall Study||1
9839476|NCT00811070|10950988|FG001|NOT COMPLETED|Overall Study||1
9839477|NCT00811070|10950989|FG002|NOT COMPLETED|Overall Study||0
9839478|NCT00811070|10950990|FG003|NOT COMPLETED|Overall Study||2
9839479|NCT00811070|10950991|FG004|NOT COMPLETED|Overall Study||5
10021940|NCT01847430|11145434|FG000|COMPLETED|Overall Study||302
10021941|NCT01847430|11145434|FG000|NOT COMPLETED|Overall Study||0
10021942|NCT01847443|11145438|FG000|STARTED|Study Period 1||21
10021943|NCT01847443|11145439|FG001|STARTED|Study Period 1||21
9721790|NCT00066573|10821251|FG001|NOT COMPLETED|Overall Study||28
9721791|NCT00066677|10821259|FG000|STARTED|Overall Study||16
9721792|NCT00066677|10821260|FG001|STARTED|Overall Study||16
9721793|NCT00066677|10821259|FG000|COMPLETED|Overall Study||16
9721794|NCT00066677|10821260|FG001|COMPLETED|Overall Study||16
9721795|NCT00066677|10821259|FG000|NOT COMPLETED|Overall Study||0
9721796|NCT00066677|10821260|FG001|NOT COMPLETED|Overall Study||0
9721797|NCT00066690|10821269|FG000|STARTED|Overall Study||1021
9721798|NCT00066690|10821270|FG001|STARTED|Overall Study||1024
9721799|NCT00066690|10821271|FG002|STARTED|Overall Study||1021
9721800|NCT00066690|10821269|FG000|COMPLETED|Overall Study||423
10021944|NCT01847443|11145440|FG002|STARTED|Study Period 1||21
9839480|NCT00811070|10950992|FG005|NOT COMPLETED|Overall Study||1
9839481|NCT00811135|10951008|FG000|STARTED|Overall Study||88
9839482|NCT00811135|10951008|FG000|COMPLETED|Overall Study||0
9839483|NCT00811135|10951008|FG000|NOT COMPLETED|Overall Study||88
9839484|NCT00811174|10951012|FG000|STARTED|Overall Study||5
9839485|NCT00811174|10951012|FG000|COMPLETED|Overall Study||2
9839486|NCT00811174|10951012|FG000|NOT COMPLETED|Overall Study||3
9839487|NCT00811187|10951018|FG000|STARTED|Overall Study||40
9839488|NCT00811187|10951019|FG001|STARTED|Overall Study||40
9839489|NCT00811187|10951018|FG000|COMPLETED|Overall Study||37
9839490|NCT00811187|10951019|FG001|COMPLETED|Overall Study||37
9839491|NCT00811187|10951018|FG000|NOT COMPLETED|Overall Study||3
9839492|NCT00811187|10951019|FG001|NOT COMPLETED|Overall Study||3
9839493|NCT00811252|10951028|FG000|STARTED|Overall Study||145
9839494|NCT00811252|10951029|FG001|STARTED|Overall Study||156
9839495|NCT00811252|10951030|FG002|STARTED|Overall Study||151
9839496|NCT00811252|10951028|FG000|COMPLETED|Overall Study||128
9839497|NCT00811252|10951029|FG001|COMPLETED|Overall Study||136
9839498|NCT00811252|10951030|FG002|COMPLETED|Overall Study||128
9839499|NCT00811252|10951028|FG000|NOT COMPLETED|Overall Study||17
9839500|NCT00811252|10951029|FG001|NOT COMPLETED|Overall Study||20
9839501|NCT00811252|10951030|FG002|NOT COMPLETED|Overall Study||23
9839502|NCT00811317|10951038|FG000|STARTED|Overall Study||11
9839503|NCT00811317|10951038|FG000|COMPLETED|Overall Study||11
9839504|NCT00811317|10951038|FG000|NOT COMPLETED|Overall Study||0
9839505|NCT00811382|10951044|FG000|STARTED|Overall Study||88
9839506|NCT00811382|10951045|FG001|STARTED|Overall Study||75
9839507|NCT00811382|10951044|FG000|COMPLETED|Overall Study||88
9839508|NCT00811382|10951045|FG001|COMPLETED|Overall Study||75
9839509|NCT00811382|10951044|FG000|NOT COMPLETED|Overall Study||0
9839510|NCT00811382|10951045|FG001|NOT COMPLETED|Overall Study||0
9839511|NCT00811395|10951059|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
9839512|NCT00811395|10951060|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
9839513|NCT00811395|10951061|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
9839514|NCT00811395|10951062|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
9839515|NCT00811395|10951063|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
9839516|NCT00811395|10951064|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
9839517|NCT00811395|10951059|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
9839518|NCT00811395|10951060|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
9839519|NCT00811395|10951061|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
9839520|NCT00811395|10951062|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
9839521|NCT00811395|10951063|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
9839522|NCT00811395|10951064|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
9839523|NCT00811395|10951059|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
9839524|NCT00811395|10951060|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
9839525|NCT00811395|10951061|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
9839526|NCT00811395|10951062|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
9839527|NCT00811395|10951063|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
9839528|NCT00811395|10951064|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
9839529|NCT00811395|10951059|FG000|STARTED|Extension Treatment|continued initial treatment|31
9839530|NCT00811395|10951060|FG001|STARTED|Extension Treatment|continued initial treatment|28
9839531|NCT00811395|10951061|FG002|STARTED|Extension Treatment|continued initial treatment|27
9839532|NCT00811395|10951062|FG003|STARTED|Extension Treatment|continued initial treatment|37
9839533|NCT00811395|10951063|FG004|STARTED|Extension Treatment|continued initial treatment|30
9839534|NCT00811395|10951064|FG005|STARTED|Extension Treatment|continued initial treatment|29
9839535|NCT00811395|10951059|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29
9839536|NCT00811395|10951060|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22
9839537|NCT00811395|10951061|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24
9839538|NCT00811395|10951062|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34
9839539|NCT00811395|10951063|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30
9839540|NCT00811395|10951064|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27
9839541|NCT00811395|10951059|FG000|NOT COMPLETED|Extension Treatment||2
9839542|NCT00811395|10951060|FG001|NOT COMPLETED|Extension Treatment||6
9839543|NCT00811395|10951061|FG002|NOT COMPLETED|Extension Treatment||3
9839544|NCT00811395|10951062|FG003|NOT COMPLETED|Extension Treatment||3
9721801|NCT00066690|10821270|FG001|COMPLETED|Overall Study||502
9721802|NCT00066690|10821271|FG002|COMPLETED|Overall Study||457
9721803|NCT00066690|10821269|FG000|NOT COMPLETED|Overall Study||598
9721804|NCT00066690|10821270|FG001|NOT COMPLETED|Overall Study||522
9721805|NCT00066690|10821271|FG002|NOT COMPLETED|Overall Study||564
9721806|NCT00066703|10821284|FG000|STARTED|Overall Study||1334
9721807|NCT00066703|10821285|FG001|STARTED|Overall Study||1338
9721808|NCT00066703|10821284|FG000|COMPLETED|Overall Study||722
9721809|NCT00066703|10821285|FG001|COMPLETED|Overall Study||756
9721810|NCT00066703|10821284|FG000|NOT COMPLETED|Overall Study||612
9721811|NCT00066703|10821285|FG001|NOT COMPLETED|Overall Study||582
9721812|NCT00066729|10821291|FG000|STARTED|Overall Study||9
9721813|NCT00066729|10821291|FG000|COMPLETED|Overall Study||7
9721814|NCT00066729|10821291|FG000|NOT COMPLETED|Overall Study||2
9721815|NCT00066742|10821295|FG000|STARTED|Induction Chemoradiotherapy||72
9721816|NCT00066742|10821295|FG000|Eligible|Induction Chemoradiotherapy||69
9721817|NCT00066742|10821295|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68
9721818|NCT00066742|10821295|FG000|COMPLETED|Induction Chemoradiotherapy||43
9721819|NCT00066742|10821295|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29
9721820|NCT00066742|10821295|FG000|STARTED|Consolidation Chemotherapy||42
9721821|NCT00066742|10821295|FG000|Eligible|Consolidation Chemotherapy||40
9721822|NCT00066742|10821295|FG000|COMPLETED|Consolidation Chemotherapy||39
9721823|NCT00066742|10821295|FG000|NOT COMPLETED|Consolidation Chemotherapy||3
9721824|NCT00066781|10821303|FG000|STARTED|Overall Study||14
10021945|NCT01847443|11145441|FG003|STARTED|Study Period 1||21
10021946|NCT01847443|11145438|FG000|COMPLETED|Study Period 1||21
10021947|NCT01847443|11145439|FG001|COMPLETED|Study Period 1||20
10021948|NCT01847443|11145440|FG002|COMPLETED|Study Period 1||21
10021949|NCT01847443|11145441|FG003|COMPLETED|Study Period 1||21
10021950|NCT01847443|11145438|FG000|NOT COMPLETED|Study Period 1||0
10021951|NCT01847443|11145439|FG001|NOT COMPLETED|Study Period 1||1
10021952|NCT01847443|11145440|FG002|NOT COMPLETED|Study Period 1||0
10021953|NCT01847443|11145441|FG003|NOT COMPLETED|Study Period 1||0
9839545|NCT00811395|10951063|FG004|NOT COMPLETED|Extension Treatment||0
9839546|NCT00811395|10951064|FG005|NOT COMPLETED|Extension Treatment||2
10021954|NCT01847443|11145438|FG000|STARTED|Washout Period Before Study Period 2||21
10021955|NCT01847443|11145439|FG001|STARTED|Washout Period Before Study Period 2||20
9721825|NCT00066781|10821304|FG001|STARTED|Overall Study||17
9721826|NCT00066781|10821303|FG000|COMPLETED|Overall Study||14
9721827|NCT00066781|10821304|FG001|COMPLETED|Overall Study||17
9721828|NCT00066781|10821303|FG000|NOT COMPLETED|Overall Study||0
9721829|NCT00066781|10821304|FG001|NOT COMPLETED|Overall Study||0
9721830|NCT00066937|10821314|FG000|STARTED|Treatment Phase||41
9721831|NCT00066937|10821315|FG001|STARTED|Treatment Phase||38
9721832|NCT00066937|10821316|FG002|STARTED|Treatment Phase||37
9721833|NCT00066937|10821317|FG003|STARTED|Treatment Phase||24
9721834|NCT00066937|10821314|FG000|COMPLETED|Treatment Phase||38
9721835|NCT00066937|10821315|FG001|COMPLETED|Treatment Phase||33
9721836|NCT00066937|10821316|FG002|COMPLETED|Treatment Phase||26
9721837|NCT00066937|10821317|FG003|COMPLETED|Treatment Phase||19
9721838|NCT00066937|10821314|FG000|NOT COMPLETED|Treatment Phase||3
9839547|NCT00811434|10951081|FG000|STARTED|First Intervention||7
9839548|NCT00811434|10951082|FG001|STARTED|First Intervention||5
9839549|NCT00811434|10951081|FG000|COMPLETED|First Intervention||4
9839550|NCT00811434|10951082|FG001|COMPLETED|First Intervention||5
9839551|NCT00811434|10951081|FG000|NOT COMPLETED|First Intervention||3
9839552|NCT00811434|10951082|FG001|NOT COMPLETED|First Intervention||0
9839553|NCT00811434|10951081|FG000|STARTED|Washout (1 Month)||4
9839554|NCT00811434|10951082|FG001|STARTED|Washout (1 Month)||5
9839555|NCT00811434|10951081|FG000|COMPLETED|Washout (1 Month)||4
9839556|NCT00811434|10951082|FG001|COMPLETED|Washout (1 Month)||5
9839557|NCT00811434|10951081|FG000|NOT COMPLETED|Washout (1 Month)||0
9839558|NCT00811434|10951082|FG001|NOT COMPLETED|Washout (1 Month)||0
9839559|NCT00811434|10951081|FG000|STARTED|Second Intervention||4
9839560|NCT00811434|10951082|FG001|STARTED|Second Intervention||5
9839561|NCT00811434|10951081|FG000|COMPLETED|Second Intervention||4
9839562|NCT00811434|10951082|FG001|COMPLETED|Second Intervention||5
9839563|NCT00811434|10951081|FG000|NOT COMPLETED|Second Intervention||0
9839564|NCT00811434|10951082|FG001|NOT COMPLETED|Second Intervention||0
9839565|NCT00811473|10951091|FG000|STARTED|Overall Study||93
9839566|NCT00811473|10951092|FG001|STARTED|Overall Study||100
9839567|NCT00811473|10951091|FG000|COMPLETED|Overall Study||70
9839568|NCT00811473|10951092|FG001|COMPLETED|Overall Study||74
9839569|NCT00811473|10951091|FG000|NOT COMPLETED|Overall Study||23
9839570|NCT00811473|10951092|FG001|NOT COMPLETED|Overall Study||26
9839571|NCT00811564|10951100|FG000|STARTED|Overall Study||73
9839572|NCT00811564|10951101|FG001|STARTED|Overall Study||75
9839573|NCT00811564|10951100|FG000|COMPLETED|Overall Study||64
9839574|NCT00811564|10951101|FG001|COMPLETED|Overall Study||73
9839575|NCT00811564|10951100|FG000|NOT COMPLETED|Overall Study||9
9839576|NCT00811564|10951101|FG001|NOT COMPLETED|Overall Study||2
9839577|NCT00811577|10951109|FG000|STARTED|Overall Study||126
9839578|NCT00811577|10951110|FG001|STARTED|Overall Study||24
9839579|NCT00811577|10951109|FG000|COMPLETED|Overall Study||116
9839580|NCT00811577|10951110|FG001|COMPLETED|Overall Study||23
9839581|NCT00811577|10951109|FG000|NOT COMPLETED|Overall Study||10
9839582|NCT00811577|10951110|FG001|NOT COMPLETED|Overall Study||1
9839583|NCT00811642|10951159|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
9839584|NCT00811642|10951159|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
9839585|NCT00811642|10951159|FG000|NOT COMPLETED|Overall Study||15
9839586|NCT00811655|10951163|FG000|STARTED|Overall Study||6
9839587|NCT00811655|10951163|FG000|COMPLETED|Overall Study||5
9839588|NCT00811655|10951163|FG000|NOT COMPLETED|Overall Study||1
9839589|NCT00811720|10951169|FG000|STARTED|All Randomised Patients||298
9839590|NCT00811720|10951170|FG001|STARTED|All Randomised Patients||306
9839591|NCT00811720|10951169|FG000|COMPLETED|All Randomised Patients||296
9839592|NCT00811720|10951170|FG001|COMPLETED|All Randomised Patients||302
9839593|NCT00811720|10951169|FG000|NOT COMPLETED|All Randomised Patients||2
9839594|NCT00811720|10951170|FG001|NOT COMPLETED|All Randomised Patients||4
9839595|NCT00811720|10951169|FG000|STARTED|All Treated Patients||296
9839596|NCT00811720|10951170|FG001|STARTED|All Treated Patients||302
9839597|NCT00811720|10951169|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
9839598|NCT00811720|10951170|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
9839599|NCT00811720|10951169|FG000|NOT COMPLETED|All Treated Patients||96
9839600|NCT00811720|10951170|FG001|NOT COMPLETED|All Treated Patients||164
9839601|NCT00811733|10951178|FG000|STARTED|Overall Study||15
9839602|NCT00811733|10951179|FG001|STARTED|Overall Study||22
9839603|NCT00811733|10951178|FG000|COMPLETED|Overall Study||4
9839604|NCT00811733|10951179|FG001|COMPLETED|Overall Study||12
9839605|NCT00811733|10951178|FG000|NOT COMPLETED|Overall Study||11
9959283|NCT01461928|11078763|FG000|NOT COMPLETED|Maintenance I (24 Months)||218
9839606|NCT00811733|10951179|FG001|NOT COMPLETED|Overall Study||10
9839607|NCT00811798|10951185|FG000|STARTED|Overall Study||92
9839608|NCT00811798|10951185|FG000|COMPLETED|Overall Study||92
9959284|NCT01461928|11078764|FG001|NOT COMPLETED|Maintenance I (24 Months)||0
9959285|NCT01461928|11078765|FG002|NOT COMPLETED|Maintenance I (24 Months)||0
9959286|NCT01461928|11078763|FG000|STARTED|Maintenance II (15 Months)||0
9839609|NCT00811798|10951185|FG000|NOT COMPLETED|Overall Study||0
9839610|NCT00811850|10951189|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
9839611|NCT00811850|10951189|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
9839612|NCT00811850|10951189|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
9839613|NCT00811850|10951189|FG000|STARTED|Treatment Period 2: Wash Out||15
9839614|NCT00811850|10951189|FG000|COMPLETED|Treatment Period 2: Wash Out||15
9839615|NCT00811850|10951189|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0
9839616|NCT00811850|10951189|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
9839617|NCT00811850|10951189|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
9839618|NCT00811850|10951189|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
9839619|NCT00811928|10951197|FG000|STARTED|Overall Study||129
9839620|NCT00811928|10951198|FG001|STARTED|Overall Study||123
9839621|NCT00811928|10951197|FG000|COMPLETED|Overall Study||90
9839622|NCT00811928|10951198|FG001|COMPLETED|Overall Study||90
9839623|NCT00811928|10951197|FG000|NOT COMPLETED|Overall Study||39
9839624|NCT00811928|10951198|FG001|NOT COMPLETED|Overall Study||33
9839625|NCT00811941|10951206|FG000|STARTED|All Randomised Patients||166
9839626|NCT00811941|10951207|FG001|STARTED|All Randomised Patients||509
9839627|NCT00811941|10951206|FG000|COMPLETED|All Randomised Patients||164
9959287|NCT01461928|11078764|FG001|STARTED|Maintenance II (15 Months)||138
9959288|NCT01461928|11078765|FG002|STARTED|Maintenance II (15 Months)||138
9959289|NCT01461928|11078763|FG000|COMPLETED|Maintenance II (15 Months)||0
9959290|NCT01461928|11078764|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
9959291|NCT01461928|11078765|FG002|COMPLETED|Maintenance II (15 Months)||111
9959292|NCT01461928|11078763|FG000|NOT COMPLETED|Maintenance II (15 Months)||0
9959293|NCT01461928|11078764|FG001|NOT COMPLETED|Maintenance II (15 Months)||23
9959294|NCT01461928|11078765|FG002|NOT COMPLETED|Maintenance II (15 Months)||27
9721839|NCT00066937|10821315|FG001|NOT COMPLETED|Treatment Phase||5
9721840|NCT00066937|10821316|FG002|NOT COMPLETED|Treatment Phase||11
9721841|NCT00066937|10821317|FG003|NOT COMPLETED|Treatment Phase||5
9721842|NCT00066937|10821314|FG000|STARTED|3 Month Follow-up||38
9721843|NCT00066937|10821315|FG001|STARTED|3 Month Follow-up||33
9839628|NCT00811941|10951207|FG001|COMPLETED|All Randomised Patients||501
9839629|NCT00811941|10951206|FG000|NOT COMPLETED|All Randomised Patients||2
9721844|NCT00066937|10821316|FG002|STARTED|3 Month Follow-up||26
9721845|NCT00066937|10821317|FG003|STARTED|3 Month Follow-up||19
9721846|NCT00066937|10821314|FG000|COMPLETED|3 Month Follow-up||33
9721847|NCT00066937|10821315|FG001|COMPLETED|3 Month Follow-up||32
9721848|NCT00066937|10821316|FG002|COMPLETED|3 Month Follow-up||25
9721849|NCT00066937|10821317|FG003|COMPLETED|3 Month Follow-up||15
9721850|NCT00066937|10821314|FG000|NOT COMPLETED|3 Month Follow-up||5
9721851|NCT00066937|10821315|FG001|NOT COMPLETED|3 Month Follow-up||1
10021956|NCT01847443|11145440|FG002|STARTED|Washout Period Before Study Period 2||21
10021957|NCT01847443|11145441|FG003|STARTED|Washout Period Before Study Period 2||21
10021958|NCT01847443|11145438|FG000|COMPLETED|Washout Period Before Study Period 2||19
10021959|NCT01847443|11145439|FG001|COMPLETED|Washout Period Before Study Period 2||19
10021960|NCT01847443|11145440|FG002|COMPLETED|Washout Period Before Study Period 2||21
10021961|NCT01847443|11145441|FG003|COMPLETED|Washout Period Before Study Period 2||21
9839630|NCT00811941|10951207|FG001|NOT COMPLETED|All Randomised Patients||8
9839631|NCT00811941|10951206|FG000|STARTED|All Treated Patients||164
9839632|NCT00811941|10951207|FG001|STARTED|All Treated Patients||501
9839633|NCT00811941|10951206|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
9839634|NCT00811941|10951207|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
9839635|NCT00811941|10951206|FG000|NOT COMPLETED|All Treated Patients||52
9839636|NCT00811941|10951207|FG001|NOT COMPLETED|All Treated Patients||191
9839637|NCT00811954|10951216|FG000|STARTED|Overall Study||605
9839638|NCT00811954|10951217|FG001|STARTED|Overall Study||603
9839639|NCT00811954|10951218|FG002|STARTED|Overall Study||601
9839640|NCT00811954|10951216|FG000|COMPLETED|Overall Study||516
9839641|NCT00811954|10951217|FG001|COMPLETED|Overall Study||531
9839642|NCT00811954|10951218|FG002|COMPLETED|Overall Study||500
9839643|NCT00811954|10951216|FG000|NOT COMPLETED|Overall Study||89
9839644|NCT00811954|10951217|FG001|NOT COMPLETED|Overall Study||72
9839645|NCT00811954|10951218|FG002|NOT COMPLETED|Overall Study||101
9839646|NCT00812097|10951230|FG000|STARTED|Overall Study||572
9839647|NCT00812097|10951231|FG001|STARTED|Overall Study||190
9839648|NCT00812097|10951232|FG002|STARTED|Overall Study||124
9839649|NCT00812097|10951233|FG003|STARTED|Overall Study||69
9839650|NCT00812097|10951230|FG000|COMPLETED|Overall Study||327
9839651|NCT00812097|10951231|FG001|COMPLETED|Overall Study||101
9839652|NCT00812097|10951232|FG002|COMPLETED|Overall Study||67
9839653|NCT00812097|10951233|FG003|COMPLETED|Overall Study||34
9839654|NCT00812097|10951230|FG000|NOT COMPLETED|Overall Study||245
9839655|NCT00812097|10951231|FG001|NOT COMPLETED|Overall Study||89
9839656|NCT00812097|10951232|FG002|NOT COMPLETED|Overall Study||57
9839657|NCT00812097|10951233|FG003|NOT COMPLETED|Overall Study||35
9959295|NCT01461980|11078779|FG000|STARTED|Overall Study||888
9959296|NCT01461980|11078780|FG001|STARTED|Overall Study||878
9959297|NCT01461980|11078781|FG002|STARTED|Overall Study||882
9959298|NCT01461980|11078779|FG000|Vaccination 1|Overall Study||884
9959299|NCT01461980|11078780|FG001|Vaccination 1|Overall Study||870
9959300|NCT01461980|11078781|FG002|Vaccination 1|Overall Study||875
9959301|NCT01461980|11078779|FG000|Vaccination 2|Overall Study||802
9959302|NCT01461980|11078780|FG001|Vaccination 2|Overall Study||819
9959303|NCT01461980|11078781|FG002|Vaccination 2|Overall Study||799
9959304|NCT01461980|11078779|FG000|Vaccination 3|Overall Study||757
9959305|NCT01461980|11078780|FG001|Vaccination 3|Overall Study||777
9959306|NCT01461980|11078781|FG002|Vaccination 3|Overall Study||748
9959307|NCT01461980|11078779|FG000|COMPLETED|Overall Study||722
9959308|NCT01461980|11078780|FG001|COMPLETED|Overall Study||733
9959309|NCT01461980|11078781|FG002|COMPLETED|Overall Study||717
9959310|NCT01461980|11078779|FG000|NOT COMPLETED|Overall Study||166
9959311|NCT01461980|11078780|FG001|NOT COMPLETED|Overall Study||145
9959312|NCT01461980|11078781|FG002|NOT COMPLETED|Overall Study||165
9959313|NCT01461993|11078793|FG000|STARTED|Overall Study||999
9959314|NCT01461993|11078794|FG001|STARTED|Overall Study||998
9959315|NCT01461993|11078795|FG002|STARTED|Overall Study||502
9959316|NCT01461993|11078793|FG000|COMPLETED|Overall Study||848
9959317|NCT01461993|11078794|FG001|COMPLETED|Overall Study||841
9959318|NCT01461993|11078795|FG002|COMPLETED|Overall Study||438
9959319|NCT01461993|11078793|FG000|NOT COMPLETED|Overall Study||151
9839658|NCT00812110|10951243|FG000|STARTED|Overall Study||292
9839659|NCT00812110|10951243|FG000|COMPLETED|Overall Study||292
9839660|NCT00812110|10951243|FG000|NOT COMPLETED|Overall Study||0
9839661|NCT00812253|10951249|FG000|STARTED|Overall Study||32
9839662|NCT00812253|10951250|FG001|STARTED|Overall Study||42
9839663|NCT00812253|10951249|FG000|COMPLETED|Overall Study||26
9839664|NCT00812253|10951250|FG001|COMPLETED|Overall Study||39
9839665|NCT00812253|10951249|FG000|NOT COMPLETED|Overall Study||6
9839666|NCT00812253|10951250|FG001|NOT COMPLETED|Overall Study||3
9839667|NCT00812331|10951261|FG000|STARTED|Overall Study||6
9839668|NCT00812331|10951262|FG001|STARTED|Overall Study||8
9839669|NCT00812331|10951263|FG002|STARTED|Overall Study||8
9839670|NCT00812331|10951264|FG003|STARTED|Overall Study||7
9839671|NCT00812331|10951265|FG004|STARTED|Overall Study||8
9839672|NCT00812331|10951261|FG000|COMPLETED|Overall Study||5
9839673|NCT00812331|10951262|FG001|COMPLETED|Overall Study||8
9839674|NCT00812331|10951263|FG002|COMPLETED|Overall Study||8
9839675|NCT00812331|10951264|FG003|COMPLETED|Overall Study||7
9839676|NCT00812331|10951265|FG004|COMPLETED|Overall Study||8
9839677|NCT00812331|10951261|FG000|NOT COMPLETED|Overall Study||1
9839678|NCT00812331|10951262|FG001|NOT COMPLETED|Overall Study||0
9839679|NCT00812331|10951263|FG002|NOT COMPLETED|Overall Study||0
9839680|NCT00812331|10951264|FG003|NOT COMPLETED|Overall Study||0
9839681|NCT00812331|10951265|FG004|NOT COMPLETED|Overall Study||0
9839682|NCT00812461|10951275|FG000|STARTED|All Randomised Patients||360
9839683|NCT00812461|10951276|FG001|STARTED|All Randomised Patients||358
9839684|NCT00812461|10951275|FG000|COMPLETED|All Randomised Patients||337
9839685|NCT00812461|10951276|FG001|COMPLETED|All Randomised Patients||341
9839686|NCT00812461|10951275|FG000|NOT COMPLETED|All Randomised Patients||23
9839687|NCT00812461|10951276|FG001|NOT COMPLETED|All Randomised Patients||17
9839688|NCT00812461|10951275|FG000|STARTED|All Treated Patients||337
9839689|NCT00812461|10951276|FG001|STARTED|All Treated Patients||341
9839690|NCT00812461|10951275|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
9839691|NCT00812461|10951276|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
9839692|NCT00812461|10951275|FG000|NOT COMPLETED|All Treated Patients||132
9839693|NCT00812461|10951276|FG001|NOT COMPLETED|All Treated Patients||147
9839694|NCT00812487|10951284|FG000|STARTED|Overall Study||32
9839695|NCT00812487|10951285|FG001|STARTED|Overall Study||42
9839696|NCT00812487|10951284|FG000|COMPLETED|Overall Study||26
9839697|NCT00812487|10951285|FG001|COMPLETED|Overall Study||39
9839698|NCT00812487|10951284|FG000|NOT COMPLETED|Overall Study||6
9839699|NCT00812487|10951285|FG001|NOT COMPLETED|Overall Study||3
9839700|NCT00812565|10951299|FG000|STARTED|Overall Study||8
9839701|NCT00812565|10951300|FG001|STARTED|Overall Study||7
9839702|NCT00812565|10951301|FG002|STARTED|Overall Study||7
9839703|NCT00812565|10951302|FG003|STARTED|Overall Study||7
9839704|NCT00812565|10951303|FG004|STARTED|Overall Study||7
9839705|NCT00812565|10951304|FG005|STARTED|Overall Study||7
9839706|NCT00812565|10951305|FG006|STARTED|Overall Study||8
9839707|NCT00812565|10951306|FG007|STARTED|Overall Study||7
9839708|NCT00812565|10951299|FG000|COMPLETED|Overall Study||5
9839709|NCT00812565|10951300|FG001|COMPLETED|Overall Study||6
9839710|NCT00812565|10951301|FG002|COMPLETED|Overall Study||7
9839711|NCT00812565|10951302|FG003|COMPLETED|Overall Study||5
9839712|NCT00812565|10951303|FG004|COMPLETED|Overall Study||6
9839713|NCT00812565|10951304|FG005|COMPLETED|Overall Study||6
9839714|NCT00812565|10951305|FG006|COMPLETED|Overall Study||8
9839715|NCT00812565|10951306|FG007|COMPLETED|Overall Study||6
9839716|NCT00812565|10951299|FG000|NOT COMPLETED|Overall Study||3
9839717|NCT00812565|10951300|FG001|NOT COMPLETED|Overall Study||1
9839718|NCT00812565|10951301|FG002|NOT COMPLETED|Overall Study||0
9839719|NCT00812565|10951302|FG003|NOT COMPLETED|Overall Study||2
9839720|NCT00812565|10951303|FG004|NOT COMPLETED|Overall Study||1
9839721|NCT00812565|10951304|FG005|NOT COMPLETED|Overall Study||1
10021962|NCT01847443|11145438|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2
10021963|NCT01847443|11145439|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1
10021964|NCT01847443|11145440|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0
9839722|NCT00812565|10951305|FG006|NOT COMPLETED|Overall Study||0
9839723|NCT00812565|10951306|FG007|NOT COMPLETED|Overall Study||1
9839724|NCT00812604|10951326|FG000|STARTED|Overall Study||28
9839725|NCT00812604|10951327|FG001|STARTED|Overall Study||27
9839726|NCT00812604|10951326|FG000|COMPLETED|Overall Study||23
9839727|NCT00812604|10951327|FG001|COMPLETED|Overall Study||22
9839728|NCT00812604|10951326|FG000|NOT COMPLETED|Overall Study||5
10021965|NCT01847443|11145441|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0
10021966|NCT01847443|11145438|FG000|STARTED|Study Period 2||19
10021967|NCT01847443|11145439|FG001|STARTED|Study Period 2||19
10021968|NCT01847443|11145440|FG002|STARTED|Study Period 2||21
10021969|NCT01847443|11145441|FG003|STARTED|Study Period 2||21
10021970|NCT01847443|11145438|FG000|COMPLETED|Study Period 2||19
10021971|NCT01847443|11145439|FG001|COMPLETED|Study Period 2||19
10021972|NCT01847443|11145440|FG002|COMPLETED|Study Period 2||21
10021973|NCT01847443|11145441|FG003|COMPLETED|Study Period 2||21
10021974|NCT01847443|11145438|FG000|NOT COMPLETED|Study Period 2||0
10021975|NCT01847443|11145439|FG001|NOT COMPLETED|Study Period 2||0
10021976|NCT01847443|11145440|FG002|NOT COMPLETED|Study Period 2||0
10196043|NCT03358290|11324436|FG000|COMPLETED|Overall Study||2
10021977|NCT01847443|11145441|FG003|NOT COMPLETED|Study Period 2||0
10021978|NCT01847443|11145438|FG000|STARTED|Washout Period Before Study Period 3||19
9839729|NCT00812604|10951327|FG001|NOT COMPLETED|Overall Study||5
9839730|NCT00812812|10951335|FG000|STARTED|Overall Study||27
9839731|NCT00812812|10951336|FG001|STARTED|Overall Study||29
9839732|NCT00812812|10951335|FG000|COMPLETED|Overall Study||24
9839733|NCT00812812|10951336|FG001|COMPLETED|Overall Study||25
9839734|NCT00812812|10951335|FG000|NOT COMPLETED|Overall Study||3
9839735|NCT00812812|10951336|FG001|NOT COMPLETED|Overall Study||4
9839736|NCT00812838|10951346|FG000|STARTED|Treatment Period of 16 Weeks||6
9839737|NCT00812838|10951347|FG001|STARTED|Treatment Period of 16 Weeks||6
9839738|NCT00812838|10951346|FG000|COMPLETED|Treatment Period of 16 Weeks||6
9839739|NCT00812838|10951347|FG001|COMPLETED|Treatment Period of 16 Weeks||6
9839740|NCT00812838|10951346|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0
9839741|NCT00812838|10951347|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0
9839742|NCT00812838|10951346|FG000|STARTED|Optional Crossover of 16 Weeks||0
9959320|NCT01461993|11078794|FG001|NOT COMPLETED|Overall Study||157
10021979|NCT01847443|11145439|FG001|STARTED|Washout Period Before Study Period 3||19
10021980|NCT01847443|11145440|FG002|STARTED|Washout Period Before Study Period 3||21
10021981|NCT01847443|11145441|FG003|STARTED|Washout Period Before Study Period 3||21
10021982|NCT01847443|11145438|FG000|COMPLETED|Washout Period Before Study Period 3||18
10081132|NCT02257970|11209577|FG003|STARTED|Part 3||21
9839743|NCT00812838|10951347|FG001|STARTED|Optional Crossover of 16 Weeks||4
9959321|NCT01461993|11078795|FG002|NOT COMPLETED|Overall Study||64
10021983|NCT01847443|11145439|FG001|COMPLETED|Washout Period Before Study Period 3||19
10021984|NCT01847443|11145440|FG002|COMPLETED|Washout Period Before Study Period 3||21
10021985|NCT01847443|11145441|FG003|COMPLETED|Washout Period Before Study Period 3||21
9721852|NCT00066937|10821316|FG002|NOT COMPLETED|3 Month Follow-up||1
9721853|NCT00066937|10821317|FG003|NOT COMPLETED|3 Month Follow-up||4
9721854|NCT00066937|10821314|FG000|STARTED|6 Month Follow-up||33
9721855|NCT00066937|10821315|FG001|STARTED|6 Month Follow-up||32
9721856|NCT00066937|10821316|FG002|STARTED|6 Month Follow-up||25
9721857|NCT00066937|10821317|FG003|STARTED|6 Month Follow-up||15
9721858|NCT00066937|10821314|FG000|COMPLETED|6 Month Follow-up||26
9721859|NCT00066937|10821315|FG001|COMPLETED|6 Month Follow-up||29
9721860|NCT00066937|10821316|FG002|COMPLETED|6 Month Follow-up||22
9721861|NCT00066937|10821317|FG003|COMPLETED|6 Month Follow-up||14
9721862|NCT00066937|10821314|FG000|NOT COMPLETED|6 Month Follow-up||7
9721863|NCT00066937|10821315|FG001|NOT COMPLETED|6 Month Follow-up||3
9721864|NCT00066937|10821316|FG002|NOT COMPLETED|6 Month Follow-up||3
9721865|NCT00066937|10821317|FG003|NOT COMPLETED|6 Month Follow-up||1
9721866|NCT00067002|10821329|FG000|STARTED|Overall Study||52
9721867|NCT00067002|10821330|FG001|STARTED|Overall Study||53
9721868|NCT00067002|10821329|FG000|COMPLETED|Overall Study||45
9721869|NCT00067002|10821330|FG001|COMPLETED|Overall Study||44
9721870|NCT00067002|10821329|FG000|NOT COMPLETED|Overall Study||7
9721871|NCT00067002|10821330|FG001|NOT COMPLETED|Overall Study||9
9721872|NCT00067028|10821339|FG000|STARTED|Overall Study||17
9721873|NCT00067028|10821340|FG001|STARTED|Overall Study||36
9721874|NCT00067028|10821341|FG002|STARTED|Overall Study||63
9721875|NCT00067028|10821339|FG000|COMPLETED|Overall Study||17
9721876|NCT00067028|10821340|FG001|COMPLETED|Overall Study||36
9721877|NCT00067028|10821341|FG002|COMPLETED|Overall Study||63
9721878|NCT00067028|10821339|FG000|NOT COMPLETED|Overall Study||0
9721879|NCT00067028|10821340|FG001|NOT COMPLETED|Overall Study||0
9721880|NCT00067028|10821341|FG002|NOT COMPLETED|Overall Study||0
9721881|NCT00067236|10821353|FG000|STARTED|Overall Study||128
9721882|NCT00067236|10821354|FG001|STARTED|Overall Study||125
9721883|NCT00067236|10821353|FG000|COMPLETED|Overall Study||108
9721884|NCT00067236|10821354|FG001|COMPLETED|Overall Study||99
9721885|NCT00067236|10821353|FG000|NOT COMPLETED|Overall Study||20
9721886|NCT00067236|10821354|FG001|NOT COMPLETED|Overall Study||26
9721887|NCT00067470|10821362|FG000|STARTED|Overall Study||19
9721888|NCT00067470|10821363|FG001|STARTED|Overall Study||20
9721889|NCT00067470|10821362|FG000|COMPLETED|Overall Study||19
9721890|NCT00067470|10821363|FG001|COMPLETED|Overall Study||19
9721891|NCT00067470|10821362|FG000|NOT COMPLETED|Overall Study||0
9721892|NCT00067470|10821363|FG001|NOT COMPLETED|Overall Study||1
9721893|NCT00067808|10821372|FG000|STARTED|Overall Study||17
9721894|NCT00067808|10821373|FG001|STARTED|Overall Study||93
9721895|NCT00067808|10821374|FG002|STARTED|Overall Study||14
9721896|NCT00067808|10821372|FG000|COMPLETED|Overall Study||17
9721897|NCT00067808|10821373|FG001|COMPLETED|Overall Study||93
9721898|NCT00067808|10821374|FG002|COMPLETED|Overall Study||14
9721899|NCT00067808|10821372|FG000|NOT COMPLETED|Overall Study||0
9721900|NCT00067808|10821373|FG001|NOT COMPLETED|Overall Study||0
9721901|NCT00067808|10821374|FG002|NOT COMPLETED|Overall Study||0
9721902|NCT00067990|10821384|FG000|STARTED|Overall Study||77
9721903|NCT00067990|10821385|FG001|STARTED|Overall Study||76
9721904|NCT00067990|10821384|FG000|COMPLETED|Overall Study||67
9721905|NCT00067990|10821385|FG001|COMPLETED|Overall Study||54
9721906|NCT00067990|10821384|FG000|NOT COMPLETED|Overall Study||10
9721907|NCT00067990|10821385|FG001|NOT COMPLETED|Overall Study||22
9721908|NCT00068107|10821391|FG000|STARTED|Overall Study||12
9721909|NCT00068107|10821391|FG000|COMPLETED|Overall Study||3
9721910|NCT00068107|10821391|FG000|NOT COMPLETED|Overall Study||9
9721911|NCT00068237|10821398|FG000|STARTED|Overall Study||49
9721912|NCT00068237|10821398|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
9959322|NCT01462045|11078807|FG000|STARTED|Overall Study||11
9721913|NCT00068237|10821398|FG000|NOT COMPLETED|Overall Study||5
9721914|NCT00068250|10821405|FG000|STARTED|Phase I: Dose Level 1||6
9721915|NCT00068250|10821406|FG001|STARTED|Phase I: Dose Level 1||0
9721916|NCT00068250|10821407|FG002|STARTED|Phase I: Dose Level 1||0
9721917|NCT00068250|10821408|FG003|STARTED|Phase I: Dose Level 1||0
9721918|NCT00068250|10821405|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
9721919|NCT00068250|10821406|FG001|COMPLETED|Phase I: Dose Level 1||0
9721920|NCT00068250|10821407|FG002|COMPLETED|Phase I: Dose Level 1||0
9721921|NCT00068250|10821408|FG003|COMPLETED|Phase I: Dose Level 1||0
9721922|NCT00068250|10821405|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
10021986|NCT01847443|11145438|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1
10021987|NCT01847443|11145439|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0
10021988|NCT01847443|11145440|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0
10021989|NCT01847443|11145441|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0
9839744|NCT00812838|10951346|FG000|COMPLETED|Optional Crossover of 16 Weeks||0
9839745|NCT00812838|10951347|FG001|COMPLETED|Optional Crossover of 16 Weeks||4
9839746|NCT00812838|10951346|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0
9839747|NCT00812838|10951347|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0
9839748|NCT00812877|10951357|FG000|STARTED|Overall Study||195
9839749|NCT00812877|10951358|FG001|STARTED|Overall Study||181
9839750|NCT00812877|10951357|FG000|COMPLETED|Overall Study||158
9839751|NCT00812877|10951358|FG001|COMPLETED|Overall Study||130
9839752|NCT00812877|10951357|FG000|NOT COMPLETED|Overall Study||37
9839753|NCT00812877|10951358|FG001|NOT COMPLETED|Overall Study||51
9839754|NCT00812916|10951364|FG000|STARTED|Overall Study|206 enrolled (consented)|206
9839755|NCT00812916|10951364|FG000|Data Available|Overall Study||205
9839756|NCT00812916|10951364|FG000|CFAE - Guided Ablation|Overall Study||203
9839757|NCT00812916|10951364|FG000|COMPLETED|Overall Study||203
9839758|NCT00812916|10951364|FG000|NOT COMPLETED|Overall Study||3
9839759|NCT00812929|10951370|FG000|STARTED|Treatment Period 1||5
9839760|NCT00812929|10951371|FG001|STARTED|Treatment Period 1||4
10021990|NCT01847443|11145438|FG000|STARTED|Study Period 3||18
10021991|NCT01847443|11145439|FG001|STARTED|Study Period 3||19
10021992|NCT01847443|11145440|FG002|STARTED|Study Period 3||21
10021993|NCT01847443|11145441|FG003|STARTED|Study Period 3||21
10021994|NCT01847443|11145438|FG000|COMPLETED|Study Period 3||18
10021995|NCT01847443|11145439|FG001|COMPLETED|Study Period 3||19
10021996|NCT01847443|11145440|FG002|COMPLETED|Study Period 3||21
10021997|NCT01847443|11145441|FG003|COMPLETED|Study Period 3||21
10021998|NCT01847443|11145438|FG000|NOT COMPLETED|Study Period 3||0
10021999|NCT01847443|11145439|FG001|NOT COMPLETED|Study Period 3||0
9839761|NCT00812929|10951372|FG002|STARTED|Treatment Period 1||5
9839762|NCT00812929|10951373|FG003|STARTED|Treatment Period 1||4
9839763|NCT00812929|10951374|FG004|STARTED|Treatment Period 1||5
9839764|NCT00812929|10951375|FG005|STARTED|Treatment Period 1||5
9839765|NCT00812929|10951376|FG006|STARTED|Treatment Period 1||5
9839766|NCT00812929|10951377|FG007|STARTED|Treatment Period 1||5
9839767|NCT00812929|10951378|FG008|STARTED|Treatment Period 1||4
9839768|NCT00812929|10951379|FG009|STARTED|Treatment Period 1||5
9839769|NCT00812929|10951370|FG000|COMPLETED|Treatment Period 1||5
9839770|NCT00812929|10951371|FG001|COMPLETED|Treatment Period 1||4
9839771|NCT00812929|10951372|FG002|COMPLETED|Treatment Period 1||5
9839772|NCT00812929|10951373|FG003|COMPLETED|Treatment Period 1||4
9839773|NCT00812929|10951374|FG004|COMPLETED|Treatment Period 1||5
9839774|NCT00812929|10951375|FG005|COMPLETED|Treatment Period 1||5
9839775|NCT00812929|10951376|FG006|COMPLETED|Treatment Period 1||5
9839776|NCT00812929|10951377|FG007|COMPLETED|Treatment Period 1||5
10022000|NCT01847443|11145440|FG002|NOT COMPLETED|Study Period 3||0
10022001|NCT01847443|11145441|FG003|NOT COMPLETED|Study Period 3||0
10022002|NCT01847443|11145438|FG000|STARTED|Washout Period Before Study Period 4||18
10022003|NCT01847443|11145439|FG001|STARTED|Washout Period Before Study Period 4||19
10022004|NCT01847443|11145440|FG002|STARTED|Washout Period Before Study Period 4||21
10022005|NCT01847443|11145441|FG003|STARTED|Washout Period Before Study Period 4||21
10022006|NCT01847443|11145438|FG000|COMPLETED|Washout Period Before Study Period 4||16
10022007|NCT01847443|11145439|FG001|COMPLETED|Washout Period Before Study Period 4||19
10022008|NCT01847443|11145440|FG002|COMPLETED|Washout Period Before Study Period 4||21
10022009|NCT01847443|11145441|FG003|COMPLETED|Washout Period Before Study Period 4||21
9721923|NCT00068250|10821406|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
9839777|NCT00812929|10951378|FG008|COMPLETED|Treatment Period 1||4
9839778|NCT00812929|10951379|FG009|COMPLETED|Treatment Period 1||5
9839779|NCT00812929|10951370|FG000|NOT COMPLETED|Treatment Period 1||0
9839780|NCT00812929|10951371|FG001|NOT COMPLETED|Treatment Period 1||0
9839781|NCT00812929|10951372|FG002|NOT COMPLETED|Treatment Period 1||0
9839782|NCT00812929|10951373|FG003|NOT COMPLETED|Treatment Period 1||0
9839783|NCT00812929|10951374|FG004|NOT COMPLETED|Treatment Period 1||0
9839784|NCT00812929|10951375|FG005|NOT COMPLETED|Treatment Period 1||0
9959323|NCT01462045|11078808|FG001|STARTED|Overall Study||11
9959324|NCT01462045|11078809|FG002|STARTED|Overall Study||7
9959325|NCT01462045|11078807|FG000|COMPLETED|Overall Study||11
9959326|NCT01462045|11078808|FG001|COMPLETED|Overall Study||10
9959327|NCT01462045|11078809|FG002|COMPLETED|Overall Study||7
9959328|NCT01462045|11078807|FG000|NOT COMPLETED|Overall Study||0
9959329|NCT01462045|11078808|FG001|NOT COMPLETED|Overall Study||1
9959330|NCT01462045|11078809|FG002|NOT COMPLETED|Overall Study||0
9959331|NCT01462084|11078817|FG000|STARTED|Overall Study||11
9959332|NCT01462084|11078818|FG001|STARTED|Overall Study||10
9959333|NCT01462084|11078817|FG000|Included for Analysis|Overall Study||9
9959334|NCT01462084|11078818|FG001|Included for Analysis|Overall Study||9
9959335|NCT01462084|11078817|FG000|COMPLETED|Overall Study||9
9959336|NCT01462084|11078818|FG001|COMPLETED|Overall Study||9
10081133|NCT02257970|11209574|FG000|COMPLETED|Part 3||0
9839785|NCT00812929|10951376|FG006|NOT COMPLETED|Treatment Period 1||0
9839786|NCT00812929|10951377|FG007|NOT COMPLETED|Treatment Period 1||0
9839787|NCT00812929|10951378|FG008|NOT COMPLETED|Treatment Period 1||0
9839788|NCT00812929|10951379|FG009|NOT COMPLETED|Treatment Period 1||0
9839789|NCT00812929|10951370|FG000|STARTED|Washout Period 1 (7 Days)||5
9839790|NCT00812929|10951371|FG001|STARTED|Washout Period 1 (7 Days)||4
9839791|NCT00812929|10951372|FG002|STARTED|Washout Period 1 (7 Days)||5
9839792|NCT00812929|10951373|FG003|STARTED|Washout Period 1 (7 Days)||4
9839793|NCT00812929|10951374|FG004|STARTED|Washout Period 1 (7 Days)||5
9839794|NCT00812929|10951375|FG005|STARTED|Washout Period 1 (7 Days)||5
9839795|NCT00812929|10951376|FG006|STARTED|Washout Period 1 (7 Days)||5
9839796|NCT00812929|10951377|FG007|STARTED|Washout Period 1 (7 Days)||5
9839797|NCT00812929|10951378|FG008|STARTED|Washout Period 1 (7 Days)||4
9839798|NCT00812929|10951379|FG009|STARTED|Washout Period 1 (7 Days)||5
9839799|NCT00812929|10951370|FG000|COMPLETED|Washout Period 1 (7 Days)||5
9839800|NCT00812929|10951371|FG001|COMPLETED|Washout Period 1 (7 Days)||4
9839801|NCT00812929|10951372|FG002|COMPLETED|Washout Period 1 (7 Days)||4
9839802|NCT00812929|10951373|FG003|COMPLETED|Washout Period 1 (7 Days)||4
9839803|NCT00812929|10951374|FG004|COMPLETED|Washout Period 1 (7 Days)||5
9839804|NCT00812929|10951375|FG005|COMPLETED|Washout Period 1 (7 Days)||5
9839805|NCT00812929|10951376|FG006|COMPLETED|Washout Period 1 (7 Days)||5
9839806|NCT00812929|10951377|FG007|COMPLETED|Washout Period 1 (7 Days)||5
9839807|NCT00812929|10951378|FG008|COMPLETED|Washout Period 1 (7 Days)||4
9839808|NCT00812929|10951379|FG009|COMPLETED|Washout Period 1 (7 Days)||5
9839809|NCT00812929|10951370|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839810|NCT00812929|10951371|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839811|NCT00812929|10951372|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
9839812|NCT00812929|10951373|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839813|NCT00812929|10951374|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839814|NCT00812929|10951375|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839815|NCT00812929|10951376|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839816|NCT00812929|10951377|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
9721924|NCT00068250|10821407|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
9721925|NCT00068250|10821408|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
9721926|NCT00068250|10821405|FG000|STARTED|Phase I: Dose Level 2||0
9721927|NCT00068250|10821406|FG001|STARTED|Phase I: Dose Level 2||7
9721928|NCT00068250|10821407|FG002|STARTED|Phase I: Dose Level 2||0
9721929|NCT00068250|10821408|FG003|STARTED|Phase I: Dose Level 2||0
9721930|NCT00068250|10821405|FG000|COMPLETED|Phase I: Dose Level 2||0
9721931|NCT00068250|10821406|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
9721932|NCT00068250|10821407|FG002|COMPLETED|Phase I: Dose Level 2||0
9721933|NCT00068250|10821408|FG003|COMPLETED|Phase I: Dose Level 2||0
9721934|NCT00068250|10821405|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
9721935|NCT00068250|10821406|FG001|NOT COMPLETED|Phase I: Dose Level 2||1
9721936|NCT00068250|10821407|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
9721937|NCT00068250|10821408|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
9721938|NCT00068250|10821405|FG000|STARTED|Phase II: Dose Level 2||0
9721939|NCT00068250|10821406|FG001|STARTED|Phase II: Dose Level 2||0
9721940|NCT00068250|10821407|FG002|STARTED|Phase II: Dose Level 2||0
9721941|NCT00068250|10821408|FG003|STARTED|Phase II: Dose Level 2||47
9721942|NCT00068250|10821405|FG000|COMPLETED|Phase II: Dose Level 2||0
9721943|NCT00068250|10821406|FG001|COMPLETED|Phase II: Dose Level 2||0
9721944|NCT00068250|10821407|FG002|COMPLETED|Phase II: Dose Level 2||0
9721945|NCT00068250|10821408|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
9721946|NCT00068250|10821405|FG000|NOT COMPLETED|Phase II: Dose Level 2||0
9721947|NCT00068250|10821406|FG001|NOT COMPLETED|Phase II: Dose Level 2||0
9721948|NCT00068250|10821407|FG002|NOT COMPLETED|Phase II: Dose Level 2||0
9721949|NCT00068250|10821408|FG003|NOT COMPLETED|Phase II: Dose Level 2||0
9721950|NCT00068341|10821419|FG000|STARTED|Overall Study||15
9721951|NCT00068341|10821420|FG001|STARTED|Overall Study||15
9721952|NCT00068341|10821421|FG002|STARTED|Overall Study||44
9721953|NCT00068341|10821419|FG000|COMPLETED|Overall Study||15
9721954|NCT00068341|10821420|FG001|COMPLETED|Overall Study||15
9721955|NCT00068341|10821421|FG002|COMPLETED|Overall Study||44
9721956|NCT00068341|10821419|FG000|NOT COMPLETED|Overall Study||0
9721957|NCT00068341|10821420|FG001|NOT COMPLETED|Overall Study||0
9721958|NCT00068341|10821421|FG002|NOT COMPLETED|Overall Study||0
9721959|NCT00068367|10821442|FG000|STARTED|Overall Study||20
9721960|NCT00068367|10821442|FG000|COMPLETED|Overall Study||20
9721961|NCT00068367|10821442|FG000|NOT COMPLETED|Overall Study||0
9721962|NCT00068380|10821446|FG000|STARTED|Overall Study||17
9721963|NCT00068380|10821446|FG000|COMPLETED|Overall Study||12
9721964|NCT00068380|10821446|FG000|NOT COMPLETED|Overall Study||5
9721965|NCT00068393|10821450|FG000|STARTED|Overall Study||39
9721966|NCT00068393|10821450|FG000|Eligible and Treated|Overall Study||38
9721967|NCT00068393|10821450|FG000|COMPLETED|Overall Study||29
9721968|NCT00068393|10821450|FG000|NOT COMPLETED|Overall Study||10
9721969|NCT00068406|10821454|FG000|STARTED|Overall Study||61
9721970|NCT00068406|10821454|FG000|COMPLETED|Overall Study||58
9721971|NCT00068406|10821454|FG000|NOT COMPLETED|Overall Study||3
9721972|NCT00068419|10821458|FG000|STARTED|Overall Study||70
9721973|NCT00068419|10821458|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
9721974|NCT00068419|10821458|FG000|NOT COMPLETED|Overall Study||60
9721975|NCT00068445|10821464|FG000|STARTED|Randomization||65
9721976|NCT00068445|10821465|FG001|STARTED|Randomization||66
9721977|NCT00068445|10821464|FG000|COMPLETED|Randomization||63
9721978|NCT00068445|10821465|FG001|COMPLETED|Randomization||62
9721979|NCT00068445|10821464|FG000|NOT COMPLETED|Randomization||2
10022010|NCT01847443|11145438|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2
10081134|NCT02257970|11209575|FG001|COMPLETED|Part 3||0
9839817|NCT00812929|10951378|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839818|NCT00812929|10951379|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
9839819|NCT00812929|10951370|FG000|STARTED|Treatment Period 2||5
9839820|NCT00812929|10951371|FG001|STARTED|Treatment Period 2||4
9839821|NCT00812929|10951372|FG002|STARTED|Treatment Period 2||4
9839822|NCT00812929|10951373|FG003|STARTED|Treatment Period 2||4
9839823|NCT00812929|10951374|FG004|STARTED|Treatment Period 2||5
9839824|NCT00812929|10951375|FG005|STARTED|Treatment Period 2||5
9959337|NCT01462084|11078817|FG000|NOT COMPLETED|Overall Study||2
9959338|NCT01462084|11078818|FG001|NOT COMPLETED|Overall Study||1
9959339|NCT01462110|11078827|FG000|STARTED|Overall Study||44
9959340|NCT01462110|11078828|FG001|STARTED|Overall Study||43
9959341|NCT01462110|11078827|FG000|COMPLETED|Overall Study||43
9959342|NCT01462110|11078828|FG001|COMPLETED|Overall Study||43
9959343|NCT01462110|11078827|FG000|NOT COMPLETED|Overall Study||1
9959344|NCT01462110|11078828|FG001|NOT COMPLETED|Overall Study||0
9959345|NCT01462162|11078834|FG000|STARTED|Overall Study||120
9959346|NCT01462162|11078834|FG000|COMPLETED|Overall Study||108
9959347|NCT01462162|11078834|FG000|NOT COMPLETED|Overall Study||12
9959348|NCT01462227|11078841|FG000|STARTED|First Assignment||4
9839825|NCT00812929|10951376|FG006|STARTED|Treatment Period 2||5
9839826|NCT00812929|10951377|FG007|STARTED|Treatment Period 2||5
9959349|NCT01462227|11078842|FG001|STARTED|First Assignment||2
9959350|NCT01462227|11078843|FG002|STARTED|First Assignment||6
9959351|NCT01462227|11078844|FG003|STARTED|First Assignment||5
9721980|NCT00068445|10821465|FG001|NOT COMPLETED|Randomization||4
9721981|NCT00068445|10821464|FG000|STARTED|Treatment||63
9721982|NCT00068445|10821465|FG001|STARTED|Treatment||62
9721983|NCT00068445|10821464|FG000|COMPLETED|Treatment||34
9721984|NCT00068445|10821465|FG001|COMPLETED|Treatment||46
9721985|NCT00068445|10821464|FG000|NOT COMPLETED|Treatment||29
9721986|NCT00068445|10821465|FG001|NOT COMPLETED|Treatment||16
9721987|NCT00068575|10821471|FG000|STARTED|Overall Study||28
9721988|NCT00068575|10821471|FG000|COMPLETED|Overall Study||28
9721989|NCT00068575|10821471|FG000|NOT COMPLETED|Overall Study||0
9721990|NCT00068588|10821478|FG000|STARTED|Overall Study||0
9721991|NCT00068588|10821479|FG001|STARTED|Overall Study||3
9721992|NCT00068588|10821480|FG002|STARTED|Overall Study||21
9721993|NCT00068588|10821478|FG000|COMPLETED|Overall Study||0
9721994|NCT00068588|10821479|FG001|COMPLETED|Overall Study||3
9721995|NCT00068588|10821480|FG002|COMPLETED|Overall Study||17
9721996|NCT00068588|10821478|FG000|NOT COMPLETED|Overall Study||0
9721997|NCT00068588|10821479|FG001|NOT COMPLETED|Overall Study||0
9721998|NCT00068588|10821480|FG002|NOT COMPLETED|Overall Study||4
9721999|NCT00068601|10821489|FG000|STARTED|Overall Study||131
9722000|NCT00068601|10821490|FG001|STARTED|Overall Study||126
9722001|NCT00068601|10821489|FG000|COMPLETED|Overall Study||69
9722002|NCT00068601|10821490|FG001|COMPLETED|Overall Study||66
9722003|NCT00068601|10821489|FG000|NOT COMPLETED|Overall Study||62
9722004|NCT00068601|10821490|FG001|NOT COMPLETED|Overall Study||60
9722005|NCT00068692|10821499|FG000|STARTED|Step 1: Registration||128
9722006|NCT00068692|10821500|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
9722007|NCT00068692|10821501|FG002|STARTED|Step 1: Registration||0
9722008|NCT00068692|10821502|FG003|STARTED|Step 1: Registration||0
9722009|NCT00068692|10821503|FG004|STARTED|Step 1: Registration||0
9722010|NCT00068692|10821504|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
9722011|NCT00068692|10821505|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
9722012|NCT00068692|10821506|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
9722013|NCT00068692|10821499|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125
9722014|NCT00068692|10821500|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
9722015|NCT00068692|10821501|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0
9722016|NCT00068692|10821502|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0
9722017|NCT00068692|10821503|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0
9722018|NCT00068692|10821504|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0
9722019|NCT00068692|10821505|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0
9722020|NCT00068692|10821506|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0
9722021|NCT00068692|10821499|FG000|Reported AE Data|Step 1: Registration||123
9722022|NCT00068692|10821500|FG001|Reported AE Data|Step 1: Registration||0
9722023|NCT00068692|10821501|FG002|Reported AE Data|Step 1: Registration||0
9722024|NCT00068692|10821502|FG003|Reported AE Data|Step 1: Registration||0
9722025|NCT00068692|10821503|FG004|Reported AE Data|Step 1: Registration||0
9722026|NCT00068692|10821504|FG005|Reported AE Data|Step 1: Registration||0
9722027|NCT00068692|10821505|FG006|Reported AE Data|Step 1: Registration||0
9722028|NCT00068692|10821506|FG007|Reported AE Data|Step 1: Registration||0
9722029|NCT00068692|10821499|FG000|COMPLETED|Step 1: Registration||88
9722030|NCT00068692|10821500|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
9722031|NCT00068692|10821501|FG002|COMPLETED|Step 1: Registration||0
9722032|NCT00068692|10821502|FG003|COMPLETED|Step 1: Registration||0
9722033|NCT00068692|10821503|FG004|COMPLETED|Step 1: Registration||0
9722034|NCT00068692|10821504|FG005|COMPLETED|Step 1: Registration||0
9722035|NCT00068692|10821505|FG006|COMPLETED|Step 1: Registration||0
9722036|NCT00068692|10821506|FG007|COMPLETED|Step 1: Registration||0
9722037|NCT00068692|10821499|FG000|NOT COMPLETED|Step 1: Registration||40
9722038|NCT00068692|10821500|FG001|NOT COMPLETED|Step 1: Registration||1
9722039|NCT00068692|10821501|FG002|NOT COMPLETED|Step 1: Registration||0
9722040|NCT00068692|10821502|FG003|NOT COMPLETED|Step 1: Registration||0
9722041|NCT00068692|10821503|FG004|NOT COMPLETED|Step 1: Registration||0
9722042|NCT00068692|10821504|FG005|NOT COMPLETED|Step 1: Registration||0
9722043|NCT00068692|10821505|FG006|NOT COMPLETED|Step 1: Registration||0
9722044|NCT00068692|10821506|FG007|NOT COMPLETED|Step 1: Registration||0
9722045|NCT00068692|10821499|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
9722046|NCT00068692|10821500|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
10022011|NCT01847443|11145439|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0
10022012|NCT01847443|11145440|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0
10022013|NCT01847443|11145441|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0
10022014|NCT01847443|11145438|FG000|STARTED|Study Period 4||16
9722047|NCT00068692|10821501|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
9731566|NCT00132808|10831421|FG001|NOT COMPLETED|Stratum II||15
9731567|NCT00132808|10831422|FG002|NOT COMPLETED|Stratum II||9
9839827|NCT00812929|10951378|FG008|STARTED|Treatment Period 2||4
9839828|NCT00812929|10951379|FG009|STARTED|Treatment Period 2||5
9839829|NCT00812929|10951370|FG000|COMPLETED|Treatment Period 2||5
9839830|NCT00812929|10951371|FG001|COMPLETED|Treatment Period 2||4
9839831|NCT00812929|10951372|FG002|COMPLETED|Treatment Period 2||4
9839832|NCT00812929|10951373|FG003|COMPLETED|Treatment Period 2||4
9839833|NCT00812929|10951374|FG004|COMPLETED|Treatment Period 2||5
9839834|NCT00812929|10951375|FG005|COMPLETED|Treatment Period 2||5
9839835|NCT00812929|10951376|FG006|COMPLETED|Treatment Period 2||5
9839836|NCT00812929|10951377|FG007|COMPLETED|Treatment Period 2||5
9839837|NCT00812929|10951378|FG008|COMPLETED|Treatment Period 2||4
9839838|NCT00812929|10951379|FG009|COMPLETED|Treatment Period 2||5
9839839|NCT00812929|10951370|FG000|NOT COMPLETED|Treatment Period 2||0
9839840|NCT00812929|10951371|FG001|NOT COMPLETED|Treatment Period 2||0
9839841|NCT00812929|10951372|FG002|NOT COMPLETED|Treatment Period 2||0
9839842|NCT00812929|10951373|FG003|NOT COMPLETED|Treatment Period 2||0
9839843|NCT00812929|10951374|FG004|NOT COMPLETED|Treatment Period 2||0
9839844|NCT00812929|10951375|FG005|NOT COMPLETED|Treatment Period 2||0
9839845|NCT00812929|10951376|FG006|NOT COMPLETED|Treatment Period 2||0
9839846|NCT00812929|10951377|FG007|NOT COMPLETED|Treatment Period 2||0
9839847|NCT00812929|10951378|FG008|NOT COMPLETED|Treatment Period 2||0
9839848|NCT00812929|10951379|FG009|NOT COMPLETED|Treatment Period 2||0
9839849|NCT00812929|10951370|FG000|STARTED|Washout Period 2 (7 Days)||5
9839850|NCT00812929|10951371|FG001|STARTED|Washout Period 2 (7 Days)||4
9839851|NCT00812929|10951372|FG002|STARTED|Washout Period 2 (7 Days)||4
9839852|NCT00812929|10951373|FG003|STARTED|Washout Period 2 (7 Days)||4
9839853|NCT00812929|10951374|FG004|STARTED|Washout Period 2 (7 Days)||5
9839854|NCT00812929|10951375|FG005|STARTED|Washout Period 2 (7 Days)||5
9839855|NCT00812929|10951376|FG006|STARTED|Washout Period 2 (7 Days)||5
9839856|NCT00812929|10951377|FG007|STARTED|Washout Period 2 (7 Days)||5
9839857|NCT00812929|10951378|FG008|STARTED|Washout Period 2 (7 Days)||4
9839858|NCT00812929|10951379|FG009|STARTED|Washout Period 2 (7 Days)||5
9959352|NCT01462227|11078841|FG000|COMPLETED|First Assignment||4
9839859|NCT00812929|10951370|FG000|COMPLETED|Washout Period 2 (7 Days)||5
9839860|NCT00812929|10951371|FG001|COMPLETED|Washout Period 2 (7 Days)||4
9839861|NCT00812929|10951372|FG002|COMPLETED|Washout Period 2 (7 Days)||4
9839862|NCT00812929|10951373|FG003|COMPLETED|Washout Period 2 (7 Days)||4
9839863|NCT00812929|10951374|FG004|COMPLETED|Washout Period 2 (7 Days)||5
9839864|NCT00812929|10951375|FG005|COMPLETED|Washout Period 2 (7 Days)||5
9839865|NCT00812929|10951376|FG006|COMPLETED|Washout Period 2 (7 Days)||5
9839866|NCT00812929|10951377|FG007|COMPLETED|Washout Period 2 (7 Days)||5
9839867|NCT00812929|10951378|FG008|COMPLETED|Washout Period 2 (7 Days)||4
9839868|NCT00812929|10951379|FG009|COMPLETED|Washout Period 2 (7 Days)||4
9839869|NCT00812929|10951370|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839870|NCT00812929|10951371|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839871|NCT00812929|10951372|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839872|NCT00812929|10951373|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839873|NCT00812929|10951374|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839874|NCT00812929|10951375|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839875|NCT00812929|10951376|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839876|NCT00812929|10951377|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839877|NCT00812929|10951378|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
9839878|NCT00812929|10951379|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1
9839879|NCT00812929|10951370|FG000|STARTED|Treatment Period 3||5
9839880|NCT00812929|10951371|FG001|STARTED|Treatment Period 3||4
9839881|NCT00812929|10951372|FG002|STARTED|Treatment Period 3||4
9839882|NCT00812929|10951373|FG003|STARTED|Treatment Period 3||4
9839883|NCT00812929|10951374|FG004|STARTED|Treatment Period 3||5
9839884|NCT00812929|10951375|FG005|STARTED|Treatment Period 3||5
9839885|NCT00812929|10951376|FG006|STARTED|Treatment Period 3||5
9839886|NCT00812929|10951377|FG007|STARTED|Treatment Period 3||5
9839887|NCT00812929|10951378|FG008|STARTED|Treatment Period 3||4
9839888|NCT00812929|10951379|FG009|STARTED|Treatment Period 3||4
9839889|NCT00812929|10951370|FG000|COMPLETED|Treatment Period 3||5
9839890|NCT00812929|10951371|FG001|COMPLETED|Treatment Period 3||4
9839891|NCT00812929|10951372|FG002|COMPLETED|Treatment Period 3||4
9839892|NCT00812929|10951373|FG003|COMPLETED|Treatment Period 3||4
9839893|NCT00812929|10951374|FG004|COMPLETED|Treatment Period 3||5
9839894|NCT00812929|10951375|FG005|COMPLETED|Treatment Period 3||5
9839895|NCT00812929|10951376|FG006|COMPLETED|Treatment Period 3||5
9839896|NCT00812929|10951377|FG007|COMPLETED|Treatment Period 3||5
9959353|NCT01462227|11078842|FG001|COMPLETED|First Assignment||2
9959354|NCT01462227|11078843|FG002|COMPLETED|First Assignment||6
9959355|NCT01462227|11078844|FG003|COMPLETED|First Assignment||5
9959356|NCT01462227|11078841|FG000|NOT COMPLETED|First Assignment||0
9959357|NCT01462227|11078842|FG001|NOT COMPLETED|First Assignment||0
9959358|NCT01462227|11078843|FG002|NOT COMPLETED|First Assignment||0
9959359|NCT01462227|11078844|FG003|NOT COMPLETED|First Assignment||0
9959360|NCT01462227|11078841|FG000|STARTED|Second Assignment||4
9959361|NCT01462227|11078842|FG001|STARTED|Second Assignment||2
10022015|NCT01847443|11145439|FG001|STARTED|Study Period 4||19
10022016|NCT01847443|11145440|FG002|STARTED|Study Period 4||21
10022017|NCT01847443|11145441|FG003|STARTED|Study Period 4||21
10022018|NCT01847443|11145438|FG000|COMPLETED|Study Period 4||16
9959362|NCT01462227|11078843|FG002|STARTED|Second Assignment||6
9959363|NCT01462227|11078844|FG003|STARTED|Second Assignment||5
9959364|NCT01462227|11078841|FG000|COMPLETED|Second Assignment||3
9959365|NCT01462227|11078842|FG001|COMPLETED|Second Assignment||1
10022019|NCT01847443|11145439|FG001|COMPLETED|Study Period 4||19
10022020|NCT01847443|11145440|FG002|COMPLETED|Study Period 4||21
10022021|NCT01847443|11145441|FG003|COMPLETED|Study Period 4||21
10022022|NCT01847443|11145438|FG000|NOT COMPLETED|Study Period 4||0
9839897|NCT00812929|10951378|FG008|COMPLETED|Treatment Period 3||4
9839898|NCT00812929|10951379|FG009|COMPLETED|Treatment Period 3||4
9839899|NCT00812929|10951370|FG000|NOT COMPLETED|Treatment Period 3||0
9839900|NCT00812929|10951371|FG001|NOT COMPLETED|Treatment Period 3||0
10196044|NCT03358290|11324437|FG001|COMPLETED|Overall Study||2
9722048|NCT00068692|10821502|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
9722049|NCT00068692|10821503|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
9722050|NCT00068692|10821504|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
9722051|NCT00068692|10821505|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
9722052|NCT00068692|10821506|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
9722053|NCT00068692|10821499|FG000|Treated|Step 2: Randomization||0
9722054|NCT00068692|10821500|FG001|Treated|Step 2: Randomization||0
9722055|NCT00068692|10821501|FG002|Treated|Step 2: Randomization||27
9722056|NCT00068692|10821502|FG003|Treated|Step 2: Randomization||25
9722057|NCT00068692|10821503|FG004|Treated|Step 2: Randomization||29
9722058|NCT00068692|10821504|FG005|Treated|Step 2: Randomization||31
9722059|NCT00068692|10821505|FG006|Treated|Step 2: Randomization||33
9722060|NCT00068692|10821506|FG007|Treated|Step 2: Randomization||32
9722061|NCT00068692|10821499|FG000|Had Sphincter Preservation|Step 2: Randomization||0
9722062|NCT00068692|10821500|FG001|Had Sphincter Preservation|Step 2: Randomization||0
9722063|NCT00068692|10821501|FG002|Had Sphincter Preservation|Step 2: Randomization||28
9722064|NCT00068692|10821502|FG003|Had Sphincter Preservation|Step 2: Randomization||25
9722065|NCT00068692|10821503|FG004|Had Sphincter Preservation|Step 2: Randomization||28
9722066|NCT00068692|10821504|FG005|Had Sphincter Preservation|Step 2: Randomization||31
9722067|NCT00068692|10821505|FG006|Had Sphincter Preservation|Step 2: Randomization||33
9722068|NCT00068692|10821506|FG007|Had Sphincter Preservation|Step 2: Randomization||30
9722069|NCT00068692|10821499|FG000|Reported AE Data|Step 2: Randomization||0
9722070|NCT00068692|10821500|FG001|Reported AE Data|Step 2: Randomization||0
9722071|NCT00068692|10821501|FG002|Reported AE Data|Step 2: Randomization||27
9722072|NCT00068692|10821502|FG003|Reported AE Data|Step 2: Randomization||22
9722073|NCT00068692|10821503|FG004|Reported AE Data|Step 2: Randomization||28
9722074|NCT00068692|10821504|FG005|Reported AE Data|Step 2: Randomization||31
9722075|NCT00068692|10821505|FG006|Reported AE Data|Step 2: Randomization||33
9722076|NCT00068692|10821506|FG007|Reported AE Data|Step 2: Randomization||32
9722077|NCT00068692|10821499|FG000|COMPLETED|Step 2: Randomization||0
9722078|NCT00068692|10821500|FG001|COMPLETED|Step 2: Randomization||0
9722079|NCT00068692|10821501|FG002|COMPLETED|Step 2: Randomization||18
9722080|NCT00068692|10821502|FG003|COMPLETED|Step 2: Randomization||13
9722081|NCT00068692|10821503|FG004|COMPLETED|Step 2: Randomization||21
9722082|NCT00068692|10821504|FG005|COMPLETED|Step 2: Randomization||25
9722083|NCT00068692|10821505|FG006|COMPLETED|Step 2: Randomization||29
9722084|NCT00068692|10821506|FG007|COMPLETED|Step 2: Randomization||24
9722085|NCT00068692|10821499|FG000|NOT COMPLETED|Step 2: Randomization||0
9722086|NCT00068692|10821500|FG001|NOT COMPLETED|Step 2: Randomization||0
9722087|NCT00068692|10821501|FG002|NOT COMPLETED|Step 2: Randomization||10
9722088|NCT00068692|10821502|FG003|NOT COMPLETED|Step 2: Randomization||12
9722089|NCT00068692|10821503|FG004|NOT COMPLETED|Step 2: Randomization||9
9722090|NCT00068692|10821504|FG005|NOT COMPLETED|Step 2: Randomization||6
9722091|NCT00068692|10821505|FG006|NOT COMPLETED|Step 2: Randomization||4
9722092|NCT00068692|10821506|FG007|NOT COMPLETED|Step 2: Randomization||8
9722093|NCT00068718|10821519|FG000|STARTED|Overall Study||35
9722094|NCT00068718|10821519|FG000|COMPLETED|Overall Study||35
10022023|NCT01847443|11145439|FG001|NOT COMPLETED|Study Period 4||0
10022024|NCT01847443|11145440|FG002|NOT COMPLETED|Study Period 4||0
10022025|NCT01847443|11145441|FG003|NOT COMPLETED|Study Period 4||0
10022026|NCT01847469|11145455|FG000|STARTED|Overall Study||18
9722095|NCT00068718|10821519|FG000|NOT COMPLETED|Overall Study||0
9722096|NCT00068770|10821525|FG000|STARTED|Overall Study||13
9722097|NCT00068770|10821526|FG001|STARTED|Overall Study||22
9722098|NCT00068770|10821525|FG000|COMPLETED|Overall Study||13
9722099|NCT00068770|10821526|FG001|COMPLETED|Overall Study||22
9722100|NCT00068770|10821525|FG000|NOT COMPLETED|Overall Study||0
9722101|NCT00068770|10821526|FG001|NOT COMPLETED|Overall Study||0
9839901|NCT00812929|10951372|FG002|NOT COMPLETED|Treatment Period 3||0
9839902|NCT00812929|10951373|FG003|NOT COMPLETED|Treatment Period 3||0
9839903|NCT00812929|10951374|FG004|NOT COMPLETED|Treatment Period 3||0
9839904|NCT00812929|10951375|FG005|NOT COMPLETED|Treatment Period 3||0
9839905|NCT00812929|10951376|FG006|NOT COMPLETED|Treatment Period 3||0
9839906|NCT00812929|10951377|FG007|NOT COMPLETED|Treatment Period 3||0
9839907|NCT00812929|10951378|FG008|NOT COMPLETED|Treatment Period 3||0
9839908|NCT00812929|10951379|FG009|NOT COMPLETED|Treatment Period 3||0
9839909|NCT00812929|10951370|FG000|STARTED|Washout Period 3 (7 Days)||5
9839910|NCT00812929|10951371|FG001|STARTED|Washout Period 3 (7 Days)||4
9839911|NCT00812929|10951372|FG002|STARTED|Washout Period 3 (7 Days)||4
9839912|NCT00812929|10951373|FG003|STARTED|Washout Period 3 (7 Days)||4
9839913|NCT00812929|10951374|FG004|STARTED|Washout Period 3 (7 Days)||5
9839914|NCT00812929|10951375|FG005|STARTED|Washout Period 3 (7 Days)||5
9839915|NCT00812929|10951376|FG006|STARTED|Washout Period 3 (7 Days)||5
9839916|NCT00812929|10951377|FG007|STARTED|Washout Period 3 (7 Days)||5
9839917|NCT00812929|10951378|FG008|STARTED|Washout Period 3 (7 Days)||4
9839918|NCT00812929|10951379|FG009|STARTED|Washout Period 3 (7 Days)||4
9839919|NCT00812929|10951370|FG000|COMPLETED|Washout Period 3 (7 Days)||5
9839920|NCT00812929|10951371|FG001|COMPLETED|Washout Period 3 (7 Days)||4
9839921|NCT00812929|10951372|FG002|COMPLETED|Washout Period 3 (7 Days)||4
9839922|NCT00812929|10951373|FG003|COMPLETED|Washout Period 3 (7 Days)||4
9839923|NCT00812929|10951374|FG004|COMPLETED|Washout Period 3 (7 Days)||5
9839924|NCT00812929|10951375|FG005|COMPLETED|Washout Period 3 (7 Days)||4
9839925|NCT00812929|10951376|FG006|COMPLETED|Washout Period 3 (7 Days)||5
9839926|NCT00812929|10951377|FG007|COMPLETED|Washout Period 3 (7 Days)||5
9839927|NCT00812929|10951378|FG008|COMPLETED|Washout Period 3 (7 Days)||4
9839928|NCT00812929|10951379|FG009|COMPLETED|Washout Period 3 (7 Days)||4
9839929|NCT00812929|10951370|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839930|NCT00812929|10951371|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839931|NCT00812929|10951372|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839932|NCT00812929|10951373|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839933|NCT00812929|10951374|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839934|NCT00812929|10951375|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1
9839935|NCT00812929|10951376|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
10022027|NCT01847469|11145456|FG001|STARTED|Overall Study||6
10022028|NCT01847469|11145455|FG000|COMPLETED|Overall Study||9
10022029|NCT01847469|11145456|FG001|COMPLETED|Overall Study||3
10022030|NCT01847469|11145455|FG000|NOT COMPLETED|Overall Study||9
10022031|NCT01847469|11145456|FG001|NOT COMPLETED|Overall Study||3
10022032|NCT01847547|11145464|FG000|STARTED|Overall Study||2991
10022033|NCT01847547|11145465|FG001|STARTED|Overall Study||2991
10022034|NCT01847547|11145464|FG000|COMPLETED|Overall Study||2991
10022035|NCT01847547|11145465|FG001|COMPLETED|Overall Study||2991
10022036|NCT01847547|11145464|FG000|NOT COMPLETED|Overall Study||0
10022037|NCT01847547|11145465|FG001|NOT COMPLETED|Overall Study||0
10022038|NCT01847560|11145482|FG000|STARTED|Overall Study||13464
10022039|NCT01847560|11145483|FG001|STARTED|Overall Study||19955
10022040|NCT01847560|11145484|FG002|STARTED|Overall Study||9731
10022041|NCT01847560|11145485|FG003|STARTED|Overall Study||56655
10022042|NCT01847560|11145486|FG004|STARTED|Overall Study||27731
10022043|NCT01847560|11145487|FG005|STARTED|Overall Study||28343
10022044|NCT01847560|11145488|FG006|STARTED|Overall Study||40971
10022045|NCT01847560|11145489|FG007|STARTED|Overall Study||19829
10022046|NCT01847560|11145490|FG008|STARTED|Overall Study||77547
10022047|NCT01847560|11145491|FG009|STARTED|Overall Study||39438
9722102|NCT00068822|10821536|FG000|STARTED|First Randomized Intervention||68
9722103|NCT00068822|10821537|FG001|STARTED|First Randomized Intervention||63
9722104|NCT00068822|10821536|FG000|COMPLETED|First Randomized Intervention||67
9722105|NCT00068822|10821537|FG001|COMPLETED|First Randomized Intervention||61
9722106|NCT00068822|10821536|FG000|NOT COMPLETED|First Randomized Intervention||1
9722107|NCT00068822|10821537|FG001|NOT COMPLETED|First Randomized Intervention||2
9722108|NCT00068822|10821536|FG000|STARTED|Optional Crossover Intervention||9
9722109|NCT00068822|10821537|FG001|STARTED|Optional Crossover Intervention||29
9722110|NCT00068822|10821536|FG000|Crossover at Month 1|Optional Crossover Intervention||1
9722111|NCT00068822|10821537|FG001|Crossover at Month 1|Optional Crossover Intervention||2
9722112|NCT00068822|10821536|FG000|Crossover at Month 3|Optional Crossover Intervention||8
9722113|NCT00068822|10821537|FG001|Crossover at Month 3|Optional Crossover Intervention||27
9722114|NCT00068822|10821536|FG000|COMPLETED|Optional Crossover Intervention||9
9722115|NCT00068822|10821537|FG001|COMPLETED|Optional Crossover Intervention||29
9839936|NCT00812929|10951377|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839937|NCT00812929|10951378|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839938|NCT00812929|10951379|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
9839939|NCT00812929|10951370|FG000|STARTED|Treatment Period 4||5
9839940|NCT00812929|10951371|FG001|STARTED|Treatment Period 4||4
9839941|NCT00812929|10951372|FG002|STARTED|Treatment Period 4||4
10022048|NCT01847560|11145482|FG000|COMPLETED|Overall Study||13464
9722116|NCT00068822|10821536|FG000|NOT COMPLETED|Optional Crossover Intervention||0
9722117|NCT00068822|10821537|FG001|NOT COMPLETED|Optional Crossover Intervention||0
9722118|NCT00069095|10821549|FG000|STARTED|Primary Treatment Phase||317
9722119|NCT00069095|10821550|FG001|STARTED|Primary Treatment Phase||317
9722120|NCT00069095|10821551|FG002|STARTED|Primary Treatment Phase||350
9722121|NCT00069095|10821552|FG003|STARTED|Primary Treatment Phase||351
9722122|NCT00069095|10821553|FG004|STARTED|Primary Treatment Phase||350
9722123|NCT00069095|10821554|FG005|STARTED|Primary Treatment Phase||349
9722124|NCT00069095|10821549|FG000|COMPLETED|Primary Treatment Phase||22
9722125|NCT00069095|10821550|FG001|COMPLETED|Primary Treatment Phase||15
9722126|NCT00069095|10821551|FG002|COMPLETED|Primary Treatment Phase||36
9722127|NCT00069095|10821552|FG003|COMPLETED|Primary Treatment Phase||31
9722128|NCT00069095|10821553|FG004|COMPLETED|Primary Treatment Phase||48
9722129|NCT00069095|10821554|FG005|COMPLETED|Primary Treatment Phase||48
9722130|NCT00069095|10821549|FG000|NOT COMPLETED|Primary Treatment Phase||295
9722131|NCT00069095|10821550|FG001|NOT COMPLETED|Primary Treatment Phase||302
9722132|NCT00069095|10821551|FG002|NOT COMPLETED|Primary Treatment Phase||314
9722133|NCT00069095|10821552|FG003|NOT COMPLETED|Primary Treatment Phase||320
9722134|NCT00069095|10821553|FG004|NOT COMPLETED|Primary Treatment Phase||302
9722135|NCT00069095|10821554|FG005|NOT COMPLETED|Primary Treatment Phase||301
9722136|NCT00069095|10821549|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
9722137|NCT00069095|10821550|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
9722138|NCT00069095|10821551|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
9722139|NCT00069095|10821552|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
9722140|NCT00069095|10821553|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
9722141|NCT00069095|10821554|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
9722142|NCT00069095|10821549|FG000|COMPLETED|Post-study Treatment Phase||0
9722143|NCT00069095|10821550|FG001|COMPLETED|Post-study Treatment Phase||0
9722144|NCT00069095|10821551|FG002|COMPLETED|Post-study Treatment Phase||0
9722145|NCT00069095|10821552|FG003|COMPLETED|Post-study Treatment Phase||0
9722146|NCT00069095|10821553|FG004|COMPLETED|Post-study Treatment Phase||0
9722147|NCT00069095|10821554|FG005|COMPLETED|Post-study Treatment Phase||0
9722148|NCT00069095|10821549|FG000|NOT COMPLETED|Post-study Treatment Phase||8
9722149|NCT00069095|10821550|FG001|NOT COMPLETED|Post-study Treatment Phase||13
9722150|NCT00069095|10821551|FG002|NOT COMPLETED|Post-study Treatment Phase||21
9722151|NCT00069095|10821552|FG003|NOT COMPLETED|Post-study Treatment Phase||17
9722152|NCT00069095|10821553|FG004|NOT COMPLETED|Post-study Treatment Phase||36
9722153|NCT00069095|10821554|FG005|NOT COMPLETED|Post-study Treatment Phase||29
9722154|NCT00069095|10821549|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
9722155|NCT00069095|10821550|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
9722156|NCT00069095|10821551|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
9722157|NCT00069095|10821552|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
9722158|NCT00069095|10821553|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
9722159|NCT00069095|10821554|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
9722160|NCT00069095|10821549|FG000|COMPLETED|Follow-up Phase||110
9722161|NCT00069095|10821550|FG001|COMPLETED|Follow-up Phase||93
9722162|NCT00069095|10821551|FG002|COMPLETED|Follow-up Phase||178
9722163|NCT00069095|10821552|FG003|COMPLETED|Follow-up Phase||187
9722164|NCT00069095|10821553|FG004|COMPLETED|Follow-up Phase||186
9722165|NCT00069095|10821554|FG005|COMPLETED|Follow-up Phase||171
9722166|NCT00069095|10821549|FG000|NOT COMPLETED|Follow-up Phase||174
9722167|NCT00069095|10821550|FG001|NOT COMPLETED|Follow-up Phase||206
9722168|NCT00069095|10821551|FG002|NOT COMPLETED|Follow-up Phase||120
9722169|NCT00069095|10821552|FG003|NOT COMPLETED|Follow-up Phase||112
9722170|NCT00069095|10821553|FG004|NOT COMPLETED|Follow-up Phase||92
9722171|NCT00069095|10821554|FG005|NOT COMPLETED|Follow-up Phase||101
9722172|NCT00069108|10821568|FG000|STARTED|Overall Study||313
9722173|NCT00069108|10821569|FG001|STARTED|Overall Study||314
9722174|NCT00069108|10821568|FG000|COMPLETED|Overall Study||100
9839942|NCT00812929|10951373|FG003|STARTED|Treatment Period 4||4
9839943|NCT00812929|10951374|FG004|STARTED|Treatment Period 4||5
9839944|NCT00812929|10951375|FG005|STARTED|Treatment Period 4||4
9839945|NCT00812929|10951376|FG006|STARTED|Treatment Period 4||5
9839946|NCT00812929|10951377|FG007|STARTED|Treatment Period 4||5
9839947|NCT00812929|10951378|FG008|STARTED|Treatment Period 4||4
9839948|NCT00812929|10951379|FG009|STARTED|Treatment Period 4||4
9839949|NCT00812929|10951370|FG000|COMPLETED|Treatment Period 4||5
9839950|NCT00812929|10951371|FG001|COMPLETED|Treatment Period 4||4
9839951|NCT00812929|10951372|FG002|COMPLETED|Treatment Period 4||4
9839952|NCT00812929|10951373|FG003|COMPLETED|Treatment Period 4||4
9839953|NCT00812929|10951374|FG004|COMPLETED|Treatment Period 4||5
9839954|NCT00812929|10951375|FG005|COMPLETED|Treatment Period 4||4
9839955|NCT00812929|10951376|FG006|COMPLETED|Treatment Period 4||5
9839956|NCT00812929|10951377|FG007|COMPLETED|Treatment Period 4||5
9839957|NCT00812929|10951378|FG008|COMPLETED|Treatment Period 4||4
9839958|NCT00812929|10951379|FG009|COMPLETED|Treatment Period 4||4
9839959|NCT00812929|10951370|FG000|NOT COMPLETED|Treatment Period 4||0
9839960|NCT00812929|10951371|FG001|NOT COMPLETED|Treatment Period 4||0
9839961|NCT00812929|10951372|FG002|NOT COMPLETED|Treatment Period 4||0
9839962|NCT00812929|10951373|FG003|NOT COMPLETED|Treatment Period 4||0
9839963|NCT00812929|10951374|FG004|NOT COMPLETED|Treatment Period 4||0
9839964|NCT00812929|10951375|FG005|NOT COMPLETED|Treatment Period 4||0
9839965|NCT00812929|10951376|FG006|NOT COMPLETED|Treatment Period 4||0
9839966|NCT00812929|10951377|FG007|NOT COMPLETED|Treatment Period 4||0
9839967|NCT00812929|10951378|FG008|NOT COMPLETED|Treatment Period 4||0
9839968|NCT00812929|10951379|FG009|NOT COMPLETED|Treatment Period 4||0
9839969|NCT00812929|10951370|FG000|STARTED|Washout Period 4 (7 Days)||5
9839970|NCT00812929|10951371|FG001|STARTED|Washout Period 4 (7 Days)||4
9839971|NCT00812929|10951372|FG002|STARTED|Washout Period 4 (7 Days)||4
9839972|NCT00812929|10951373|FG003|STARTED|Washout Period 4 (7 Days)||4
9839973|NCT00812929|10951374|FG004|STARTED|Washout Period 4 (7 Days)||5
9839974|NCT00812929|10951375|FG005|STARTED|Washout Period 4 (7 Days)||4
9839975|NCT00812929|10951376|FG006|STARTED|Washout Period 4 (7 Days)||5
9839976|NCT00812929|10951377|FG007|STARTED|Washout Period 4 (7 Days)||5
9839977|NCT00812929|10951378|FG008|STARTED|Washout Period 4 (7 Days)||4
9839978|NCT00812929|10951379|FG009|STARTED|Washout Period 4 (7 Days)||4
9839979|NCT00812929|10951370|FG000|COMPLETED|Washout Period 4 (7 Days)||5
9839980|NCT00812929|10951371|FG001|COMPLETED|Washout Period 4 (7 Days)||4
9839981|NCT00812929|10951372|FG002|COMPLETED|Washout Period 4 (7 Days)||4
9839982|NCT00812929|10951373|FG003|COMPLETED|Washout Period 4 (7 Days)||4
9839983|NCT00812929|10951374|FG004|COMPLETED|Washout Period 4 (7 Days)||5
9839984|NCT00812929|10951375|FG005|COMPLETED|Washout Period 4 (7 Days)||4
9839985|NCT00812929|10951376|FG006|COMPLETED|Washout Period 4 (7 Days)||5
9839986|NCT00812929|10951377|FG007|COMPLETED|Washout Period 4 (7 Days)||5
9839987|NCT00812929|10951378|FG008|COMPLETED|Washout Period 4 (7 Days)||4
9839988|NCT00812929|10951379|FG009|COMPLETED|Washout Period 4 (7 Days)||4
9839989|NCT00812929|10951370|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
9959366|NCT01462227|11078843|FG002|COMPLETED|Second Assignment||5
9959367|NCT01462227|11078844|FG003|COMPLETED|Second Assignment||5
9959368|NCT01462227|11078841|FG000|NOT COMPLETED|Second Assignment||1
9959369|NCT01462227|11078842|FG001|NOT COMPLETED|Second Assignment||1
9959370|NCT01462227|11078843|FG002|NOT COMPLETED|Second Assignment||1
9839990|NCT00812929|10951371|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
9839991|NCT00812929|10951372|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
9959371|NCT01462227|11078844|FG003|NOT COMPLETED|Second Assignment||0
9839992|NCT00812929|10951373|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
9959372|NCT01462253|11078852|FG000|STARTED|Overall Study||35
9959373|NCT01462253|11078852|FG000|COMPLETED|Overall Study||27
10022049|NCT01847560|11145483|FG001|COMPLETED|Overall Study||19955
10022050|NCT01847560|11145484|FG002|COMPLETED|Overall Study||9731
10022051|NCT01847560|11145485|FG003|COMPLETED|Overall Study||56655
9722175|NCT00069108|10821569|FG001|COMPLETED|Overall Study||95
9722176|NCT00069108|10821568|FG000|NOT COMPLETED|Overall Study||213
9722177|NCT00069108|10821569|FG001|NOT COMPLETED|Overall Study||219
9722178|NCT00069121|10821578|FG000|STARTED|Overall Study||942
9722179|NCT00069121|10821579|FG001|STARTED|Overall Study||944
9722180|NCT00069121|10821578|FG000|Received Treatment|Overall Study|Safety Population|926
9722181|NCT00069121|10821579|FG001|Received Treatment|Overall Study|Safety Population|938
9722182|NCT00069121|10821578|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
9722183|NCT00069121|10821579|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
9722184|NCT00069121|10821578|FG000|NOT COMPLETED|Overall Study||367
9722185|NCT00069121|10821579|FG001|NOT COMPLETED|Overall Study||325
9722186|NCT00069160|10821591|FG000|STARTED|Overall Study||23
9722187|NCT00069160|10821592|FG001|STARTED|Overall Study||25
9722188|NCT00069160|10821591|FG000|COMPLETED|Overall Study||23
9722189|NCT00069160|10821592|FG001|COMPLETED|Overall Study||25
9722190|NCT00069160|10821591|FG000|NOT COMPLETED|Overall Study||0
9722191|NCT00069160|10821592|FG001|NOT COMPLETED|Overall Study||0
9722192|NCT00069264|10821601|FG000|STARTED|Overall Study||32
9722193|NCT00069264|10821601|FG000|COMPLETED|Overall Study||0
9722194|NCT00069264|10821601|FG000|NOT COMPLETED|Overall Study||32
9722195|NCT00069277|10821605|FG000|STARTED|Overall Study||21
9839993|NCT00812929|10951374|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
9839994|NCT00812929|10951375|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0
9839995|NCT00812929|10951376|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
9839996|NCT00812929|10951377|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0
9839997|NCT00812929|10951378|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
10022052|NCT01847560|11145486|FG004|COMPLETED|Overall Study||27731
10022053|NCT01847560|11145487|FG005|COMPLETED|Overall Study||28343
10022054|NCT01847560|11145488|FG006|COMPLETED|Overall Study||40971
10022055|NCT01847560|11145489|FG007|COMPLETED|Overall Study||19829
9839998|NCT00812929|10951379|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
10022056|NCT01847560|11145490|FG008|COMPLETED|Overall Study||77547
9722196|NCT00069277|10821605|FG000|COMPLETED|Overall Study||0
9722197|NCT00069277|10821605|FG000|NOT COMPLETED|Overall Study||21
9722198|NCT00069329|10821609|FG000|STARTED|Overall Study||43
9722199|NCT00069329|10821609|FG000|COMPLETED|Overall Study||41
9722200|NCT00069329|10821609|FG000|NOT COMPLETED|Overall Study||2
9722201|NCT00069576|10821615|FG000|STARTED|Original Trial||485
9722202|NCT00069576|10821616|FG001|STARTED|Original Trial||473
9722203|NCT00069576|10821615|FG000|COMPLETED|Original Trial||460
9722204|NCT00069576|10821616|FG001|COMPLETED|Original Trial||440
9722205|NCT00069576|10821615|FG000|NOT COMPLETED|Original Trial||25
9722206|NCT00069576|10821616|FG001|NOT COMPLETED|Original Trial||33
9722207|NCT00069576|10821615|FG000|STARTED|Follow-up Study at 5-10 Years||460
9722208|NCT00069576|10821616|FG001|STARTED|Follow-up Study at 5-10 Years||440
9722209|NCT00069576|10821615|FG000|COMPLETED|Follow-up Study at 5-10 Years||264
9722210|NCT00069576|10821616|FG001|COMPLETED|Follow-up Study at 5-10 Years||236
9722211|NCT00069576|10821615|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196
9722212|NCT00069576|10821616|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204
9722213|NCT00069641|10821625|FG000|STARTED|Overall Study||32
9722214|NCT00069641|10821626|FG001|STARTED|Overall Study||32
9722215|NCT00069641|10821627|FG002|STARTED|Overall Study||32
9722216|NCT00069641|10821625|FG000|COMPLETED|Overall Study||31
9722217|NCT00069641|10821626|FG001|COMPLETED|Overall Study||32
9722218|NCT00069641|10821627|FG002|COMPLETED|Overall Study||31
9722219|NCT00069641|10821625|FG000|NOT COMPLETED|Overall Study||1
9722220|NCT00069641|10821626|FG001|NOT COMPLETED|Overall Study||0
9722221|NCT00069641|10821627|FG002|NOT COMPLETED|Overall Study||1
9722222|NCT00069784|10821638|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
9722223|NCT00069784|10821639|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
9722224|NCT00069784|10821638|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
9722225|NCT00069784|10821639|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
9722226|NCT00069784|10821638|FG000|COMPLETED|Overall Study|completed study treatment|5052
9722227|NCT00069784|10821639|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273
9722228|NCT00069784|10821638|FG000|NOT COMPLETED|Overall Study||1212
9722229|NCT00069784|10821639|FG001|NOT COMPLETED|Overall Study||0
9722230|NCT00069823|10821647|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
9722231|NCT00069823|10821648|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
9722232|NCT00069823|10821647|FG000|COMPLETED|Overall Study||193
9722233|NCT00069823|10821648|FG001|COMPLETED|Overall Study||200
9722234|NCT00069823|10821647|FG000|NOT COMPLETED|Overall Study||6
9722235|NCT00069823|10821648|FG001|NOT COMPLETED|Overall Study||3
9722236|NCT00069953|10821654|FG000|STARTED|Overall Study||43
9722237|NCT00069953|10821654|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
9722238|NCT00069953|10821654|FG000|NOT COMPLETED|Overall Study||2
9722239|NCT00070070|10821662|FG000|STARTED|Overall Study||1
9722240|NCT00070070|10821663|FG001|STARTED|Overall Study||0
9722241|NCT00070070|10821664|FG002|STARTED|Overall Study||0
9722242|NCT00070070|10821665|FG003|STARTED|Overall Study||5
9722243|NCT00070070|10821662|FG000|COMPLETED|Overall Study||1
9722244|NCT00070070|10821663|FG001|COMPLETED|Overall Study||0
9722245|NCT00070070|10821664|FG002|COMPLETED|Overall Study||0
9722246|NCT00070070|10821665|FG003|COMPLETED|Overall Study||5
9722247|NCT00070070|10821662|FG000|NOT COMPLETED|Overall Study||0
9722248|NCT00070070|10821663|FG001|NOT COMPLETED|Overall Study||0
9722249|NCT00070070|10821664|FG002|NOT COMPLETED|Overall Study||0
9722250|NCT00070070|10821665|FG003|NOT COMPLETED|Overall Study||0
9731568|NCT00132873|10831430|FG000|STARTED|Overall Study||59
9731569|NCT00132873|10831430|FG000|COMPLETED|Overall Study||50
9731570|NCT00132873|10831430|FG000|NOT COMPLETED|Overall Study||9
9731571|NCT00132964|10831436|FG000|STARTED|Overall Study||54
9731572|NCT00132964|10831437|FG001|STARTED|Overall Study||57
9731573|NCT00132964|10831436|FG000|COMPLETED|Overall Study||50
9731574|NCT00132964|10831437|FG001|COMPLETED|Overall Study||54
9731575|NCT00132964|10831436|FG000|NOT COMPLETED|Overall Study||4
9731576|NCT00132964|10831437|FG001|NOT COMPLETED|Overall Study||3
9731577|NCT00133575|10831450|FG000|STARTED|Overall Study||10
9731578|NCT00133575|10831451|FG001|STARTED|Overall Study||10
9731579|NCT00133575|10831452|FG002|STARTED|Overall Study||10
9731580|NCT00133575|10831453|FG003|STARTED|Overall Study||10
9731581|NCT00133575|10831454|FG004|STARTED|Overall Study||10
9731582|NCT00133575|10831455|FG005|STARTED|Overall Study||10
9731583|NCT00133575|10831456|FG006|STARTED|Overall Study||12
9731584|NCT00133575|10831450|FG000|COMPLETED|Overall Study||10
9731585|NCT00133575|10831451|FG001|COMPLETED|Overall Study||10
9731586|NCT00133575|10831452|FG002|COMPLETED|Overall Study||8
9731587|NCT00133575|10831453|FG003|COMPLETED|Overall Study||9
9731588|NCT00133575|10831454|FG004|COMPLETED|Overall Study||6
9731589|NCT00133575|10831455|FG005|COMPLETED|Overall Study||9
9731590|NCT00133575|10831456|FG006|COMPLETED|Overall Study||9
9731591|NCT00133575|10831450|FG000|NOT COMPLETED|Overall Study||0
9731592|NCT00133575|10831451|FG001|NOT COMPLETED|Overall Study||0
9731593|NCT00133575|10831452|FG002|NOT COMPLETED|Overall Study||2
9731594|NCT00133575|10831453|FG003|NOT COMPLETED|Overall Study||1
9731595|NCT00133575|10831454|FG004|NOT COMPLETED|Overall Study||4
9731596|NCT00133575|10831455|FG005|NOT COMPLETED|Overall Study||1
9731597|NCT00133575|10831456|FG006|NOT COMPLETED|Overall Study||3
9731598|NCT00133705|10831474|FG000|STARTED|Overall Study||22
9731599|NCT00133705|10831475|FG001|STARTED|Overall Study||20
9731600|NCT00133705|10831474|FG000|COMPLETED|Overall Study||20
9731601|NCT00133705|10831475|FG001|COMPLETED|Overall Study||17
9731602|NCT00133705|10831474|FG000|NOT COMPLETED|Overall Study||2
9731603|NCT00133705|10831475|FG001|NOT COMPLETED|Overall Study||3
9731604|NCT00133809|10831481|FG000|STARTED|Overall Study||8
9731605|NCT00133809|10831481|FG000|COMPLETED|Overall Study||8
9731606|NCT00133809|10831481|FG000|NOT COMPLETED|Overall Study||0
9731607|NCT00133952|10831487|FG000|STARTED|Overall Study||157
9731608|NCT00133952|10831488|FG001|STARTED|Overall Study||152
9731609|NCT00133952|10831487|FG000|Received at Least One Dose of Study Drug|Overall Study||153
9731610|NCT00133952|10831488|FG001|Received at Least One Dose of Study Drug|Overall Study||149
9731611|NCT00133952|10831487|FG000|COMPLETED|Overall Study||115
9731612|NCT00133952|10831488|FG001|COMPLETED|Overall Study||124
9731613|NCT00133952|10831487|FG000|NOT COMPLETED|Overall Study||42
9731614|NCT00133952|10831488|FG001|NOT COMPLETED|Overall Study||28
9731615|NCT00133978|10831498|FG000|STARTED|Overall Study||303
9731616|NCT00133978|10831499|FG001|STARTED|Overall Study||308
9731617|NCT00133978|10831500|FG002|STARTED|Overall Study||310
9731618|NCT00133978|10831501|FG003|STARTED|Overall Study||302
9731619|NCT00133978|10831498|FG000|COMPLETED|Overall Study||301
9731620|NCT00133978|10831499|FG001|COMPLETED|Overall Study||307
9731621|NCT00133978|10831500|FG002|COMPLETED|Overall Study||310
9731622|NCT00133978|10831501|FG003|COMPLETED|Overall Study||300
9731623|NCT00133978|10831498|FG000|NOT COMPLETED|Overall Study||2
9731624|NCT00133978|10831499|FG001|NOT COMPLETED|Overall Study||1
9731625|NCT00133978|10831500|FG002|NOT COMPLETED|Overall Study||0
9731626|NCT00133978|10831501|FG003|NOT COMPLETED|Overall Study||2
9731627|NCT00133991|10831515|FG000|STARTED|Overall Study||21
9731628|NCT00133991|10831515|FG000|COMPLETED|Overall Study||17
9731629|NCT00133991|10831515|FG000|NOT COMPLETED|Overall Study||4
9731630|NCT00134004|10831519|FG000|STARTED|Overall Study||210
9959374|NCT01462253|11078852|FG000|NOT COMPLETED|Overall Study||8
9839999|NCT00812929|10951370|FG000|STARTED|Treatment Period 5||5
9840000|NCT00812929|10951371|FG001|STARTED|Treatment Period 5||4
9840001|NCT00812929|10951372|FG002|STARTED|Treatment Period 5||4
9840002|NCT00812929|10951373|FG003|STARTED|Treatment Period 5||4
9840003|NCT00812929|10951374|FG004|STARTED|Treatment Period 5||5
9840004|NCT00812929|10951375|FG005|STARTED|Treatment Period 5||4
9840005|NCT00812929|10951376|FG006|STARTED|Treatment Period 5||5
9840006|NCT00812929|10951377|FG007|STARTED|Treatment Period 5||5
9840007|NCT00812929|10951378|FG008|STARTED|Treatment Period 5||4
9840008|NCT00812929|10951379|FG009|STARTED|Treatment Period 5||4
9840009|NCT00812929|10951370|FG000|COMPLETED|Treatment Period 5||5
9840010|NCT00812929|10951371|FG001|COMPLETED|Treatment Period 5||4
9840011|NCT00812929|10951372|FG002|COMPLETED|Treatment Period 5||4
9840012|NCT00812929|10951373|FG003|COMPLETED|Treatment Period 5||4
9840013|NCT00812929|10951374|FG004|COMPLETED|Treatment Period 5||5
9840014|NCT00812929|10951375|FG005|COMPLETED|Treatment Period 5||4
9840015|NCT00812929|10951376|FG006|COMPLETED|Treatment Period 5||5
9840016|NCT00812929|10951377|FG007|COMPLETED|Treatment Period 5||5
9840017|NCT00812929|10951378|FG008|COMPLETED|Treatment Period 5||4
9840018|NCT00812929|10951379|FG009|COMPLETED|Treatment Period 5||4
9840019|NCT00812929|10951370|FG000|NOT COMPLETED|Treatment Period 5||0
9840020|NCT00812929|10951371|FG001|NOT COMPLETED|Treatment Period 5||0
9840021|NCT00812929|10951372|FG002|NOT COMPLETED|Treatment Period 5||0
9840022|NCT00812929|10951373|FG003|NOT COMPLETED|Treatment Period 5||0
9840023|NCT00812929|10951374|FG004|NOT COMPLETED|Treatment Period 5||0
9840024|NCT00812929|10951375|FG005|NOT COMPLETED|Treatment Period 5||0
9840025|NCT00812929|10951376|FG006|NOT COMPLETED|Treatment Period 5||0
9840026|NCT00812929|10951377|FG007|NOT COMPLETED|Treatment Period 5||0
9840027|NCT00812929|10951378|FG008|NOT COMPLETED|Treatment Period 5||0
9840028|NCT00812929|10951379|FG009|NOT COMPLETED|Treatment Period 5||0
9840029|NCT00812955|10951400|FG000|STARTED|Overall Study||119
9840030|NCT00812955|10951401|FG001|STARTED|Overall Study||118
9840031|NCT00812955|10951402|FG002|STARTED|Overall Study||119
9840032|NCT00812955|10951403|FG003|STARTED|Overall Study||118
9840033|NCT00812955|10951400|FG000|COMPLETED|Overall Study||109
9840034|NCT00812955|10951401|FG001|COMPLETED|Overall Study||111
9840035|NCT00812955|10951402|FG002|COMPLETED|Overall Study||113
9840036|NCT00812955|10951403|FG003|COMPLETED|Overall Study||110
9840037|NCT00812955|10951400|FG000|NOT COMPLETED|Overall Study||10
9840038|NCT00812955|10951401|FG001|NOT COMPLETED|Overall Study||7
9840039|NCT00812955|10951402|FG002|NOT COMPLETED|Overall Study||6
9840040|NCT00812955|10951403|FG003|NOT COMPLETED|Overall Study||8
9840041|NCT00812968|10951417|FG000|STARTED|Overall Study||11
10022057|NCT01847560|11145491|FG009|COMPLETED|Overall Study||39438
9840042|NCT00812968|10951417|FG000|COMPLETED|Overall Study||0
9840043|NCT00812968|10951417|FG000|NOT COMPLETED|Overall Study||11
9840044|NCT00812981|10951425|FG000|STARTED|Overall Study||160
9840045|NCT00812981|10951426|FG001|STARTED|Overall Study||160
9840046|NCT00812981|10951425|FG000|COMPLETED|Overall Study||160
9840047|NCT00812981|10951426|FG001|COMPLETED|Overall Study||159
9840048|NCT00812981|10951425|FG000|NOT COMPLETED|Overall Study||0
9840049|NCT00812981|10951426|FG001|NOT COMPLETED|Overall Study||1
9840050|NCT00813098|10951435|FG000|STARTED|Overall Study||49
9840051|NCT00813098|10951436|FG001|STARTED|Overall Study||54
9840052|NCT00813098|10951437|FG002|STARTED|Overall Study||52
9840053|NCT00813098|10951435|FG000|COMPLETED|Overall Study||46
9840054|NCT00813098|10951436|FG001|COMPLETED|Overall Study||46
9840055|NCT00813098|10951437|FG002|COMPLETED|Overall Study||50
9840056|NCT00813098|10951435|FG000|NOT COMPLETED|Overall Study||3
9840057|NCT00813098|10951436|FG001|NOT COMPLETED|Overall Study||8
9840058|NCT00813098|10951437|FG002|NOT COMPLETED|Overall Study||2
9840059|NCT00813111|10951447|FG000|STARTED|Overall Study||66
9840060|NCT00813111|10951448|FG001|STARTED|Overall Study||70
9840061|NCT00813111|10951447|FG000|COMPLETED|Overall Study||64
9840062|NCT00813111|10951448|FG001|COMPLETED|Overall Study||70
9840063|NCT00813111|10951447|FG000|NOT COMPLETED|Overall Study||2
9840064|NCT00813111|10951448|FG001|NOT COMPLETED|Overall Study||0
9840065|NCT00813124|10951454|FG000|STARTED|Overall Study||24
9840066|NCT00813124|10951454|FG000|COMPLETED|Overall Study||12
9840067|NCT00813124|10951454|FG000|NOT COMPLETED|Overall Study||12
9840068|NCT00813150|10951460|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46
9840069|NCT00813150|10951461|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47
9840070|NCT00813150|10951460|FG000|Intent-to-treat Participants|Treatment Period||43
9840071|NCT00813150|10951461|FG001|Intent-to-treat Participants|Treatment Period||47
9840072|NCT00813150|10951460|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
9840073|NCT00813150|10951461|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
9840074|NCT00813150|10951460|FG000|NOT COMPLETED|Treatment Period||32
9840075|NCT00813150|10951461|FG001|NOT COMPLETED|Treatment Period||32
9840076|NCT00813150|10951460|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
9840077|NCT00813150|10951461|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
9840078|NCT00813150|10951460|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
9840079|NCT00813150|10951461|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
9840080|NCT00813150|10951460|FG000|NOT COMPLETED|Long Term Follow-up||24
9840081|NCT00813150|10951461|FG001|NOT COMPLETED|Long Term Follow-up||31
9840082|NCT00813176|10951469|FG000|STARTED|Overall Study||25
9840083|NCT00813176|10951470|FG001|STARTED|Overall Study||25
9840084|NCT00813176|10951469|FG000|COMPLETED|Overall Study||25
9840085|NCT00813176|10951470|FG001|COMPLETED|Overall Study||25
9840086|NCT00813176|10951469|FG000|NOT COMPLETED|Overall Study||0
9840087|NCT00813176|10951470|FG001|NOT COMPLETED|Overall Study||0
9840088|NCT00813293|10951480|FG000|STARTED|Overall Study||10
9840089|NCT00813293|10951481|FG001|STARTED|Overall Study||10
9840090|NCT00813293|10951480|FG000|Started Treatment|Overall Study||9
9840091|NCT00813293|10951481|FG001|Started Treatment|Overall Study||10
9840092|NCT00813293|10951480|FG000|Evaluable RFA|Overall Study||7
9840093|NCT00813293|10951481|FG001|Evaluable RFA|Overall Study||8
9840094|NCT00813293|10951480|FG000|COMPLETED|Overall Study||9
9840095|NCT00813293|10951481|FG001|COMPLETED|Overall Study||9
9840096|NCT00813293|10951480|FG000|NOT COMPLETED|Overall Study||1
9840097|NCT00813293|10951481|FG001|NOT COMPLETED|Overall Study||1
9840098|NCT00813319|10951489|FG000|STARTED|Overall Study||108
9840099|NCT00813319|10951490|FG001|STARTED|Overall Study||108
9840100|NCT00813319|10951489|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
9840101|NCT00813319|10951490|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
9840102|NCT00813319|10951489|FG000|NOT COMPLETED|Overall Study||0
9840103|NCT00813319|10951490|FG001|NOT COMPLETED|Overall Study||0
9722251|NCT00070109|10821680|FG000|STARTED|Overall Study||8
9722252|NCT00070109|10821681|FG001|STARTED|Overall Study||6
9722253|NCT00070109|10821682|FG002|STARTED|Overall Study||8
9722254|NCT00070109|10821683|FG003|STARTED|Overall Study||20
9722255|NCT00070109|10821684|FG004|STARTED|Overall Study||8
9722256|NCT00070109|10821680|FG000|COMPLETED|Overall Study||0
9722257|NCT00070109|10821681|FG001|COMPLETED|Overall Study||0
9722258|NCT00070109|10821682|FG002|COMPLETED|Overall Study||0
9722259|NCT00070109|10821683|FG003|COMPLETED|Overall Study||0
9722260|NCT00070109|10821684|FG004|COMPLETED|Overall Study||0
9722261|NCT00070109|10821680|FG000|NOT COMPLETED|Overall Study||8
9722262|NCT00070109|10821681|FG001|NOT COMPLETED|Overall Study||6
9722263|NCT00070109|10821682|FG002|NOT COMPLETED|Overall Study||8
9722264|NCT00070109|10821683|FG003|NOT COMPLETED|Overall Study||20
9722265|NCT00070109|10821684|FG004|NOT COMPLETED|Overall Study||8
9722266|NCT00070135|10821703|FG000|STARTED|Overall Study||114
9722267|NCT00070135|10821703|FG000|COMPLETED|Overall Study||114
9722268|NCT00070135|10821703|FG000|NOT COMPLETED|Overall Study||0
9722269|NCT00070291|10821707|FG000|STARTED|Step 1||4
9722270|NCT00070291|10821707|FG000|Treated|Step 1||3
9722271|NCT00070291|10821707|FG000|COMPLETED|Step 1||2
9722272|NCT00070291|10821707|FG000|NOT COMPLETED|Step 1||2
9722273|NCT00070291|10821707|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
9722274|NCT00070291|10821707|FG000|COMPLETED|Step 2||0
9722275|NCT00070291|10821707|FG000|NOT COMPLETED|Step 2||1
9722276|NCT00070317|10821711|FG000|STARTED|Overall Study||102
9722277|NCT00070317|10821711|FG000|COMPLETED|Overall Study||89
9722278|NCT00070317|10821711|FG000|NOT COMPLETED|Overall Study||13
9722279|NCT00070941|10821718|FG000|STARTED|Overall Study||12
9722280|NCT00070941|10821719|FG001|STARTED|Overall Study||11
9722281|NCT00070941|10821720|FG002|STARTED|Overall Study||6
9722282|NCT00070941|10821718|FG000|COMPLETED|Overall Study||2
9722283|NCT00070941|10821719|FG001|COMPLETED|Overall Study||3
9722284|NCT00070941|10821720|FG002|COMPLETED|Overall Study||2
9722285|NCT00070941|10821718|FG000|NOT COMPLETED|Overall Study||10
9722286|NCT00070941|10821719|FG001|NOT COMPLETED|Overall Study||8
9722287|NCT00070941|10821720|FG002|NOT COMPLETED|Overall Study||4
9722288|NCT00071006|10821728|FG000|STARTED|Overall Study||12
9722289|NCT00071006|10821728|FG000|COMPLETED|Overall Study||0
9722290|NCT00071006|10821728|FG000|NOT COMPLETED|Overall Study||12
9722291|NCT00071032|10821734|FG000|STARTED|Overall Study||1007
9722292|NCT00071032|10821735|FG001|STARTED|Overall Study||1009
9722293|NCT00071032|10821734|FG000|COMPLETED|Overall Study||998
9722294|NCT00071032|10821735|FG001|COMPLETED|Overall Study||1001
9722295|NCT00071032|10821734|FG000|NOT COMPLETED|Overall Study||9
9722296|NCT00071032|10821735|FG001|NOT COMPLETED|Overall Study||8
9722297|NCT00071058|10821742|FG000|STARTED|Overall Study||50
9722298|NCT00071058|10821742|FG000|COMPLETED|Overall Study||49
9722299|NCT00071058|10821742|FG000|NOT COMPLETED|Overall Study||1
9722300|NCT00071110|10821749|FG000|STARTED|Overall Study||28
9722301|NCT00071110|10821750|FG001|STARTED|Overall Study||29
9722302|NCT00071110|10821749|FG000|COMPLETED|Overall Study||28
9722303|NCT00071110|10821750|FG001|COMPLETED|Overall Study||25
9840104|NCT00813358|10951496|FG000|STARTED|Overall Study||115
9840105|NCT00813358|10951496|FG000|COMPLETED|Overall Study||46
9840106|NCT00813358|10951496|FG000|NOT COMPLETED|Overall Study||69
9840107|NCT00813488|10951500|FG000|STARTED|Titration Period 1||107
9840108|NCT00813488|10951501|FG001|STARTED|Titration Period 1||106
9840109|NCT00813488|10951500|FG000|COMPLETED|Titration Period 1||80
9840110|NCT00813488|10951501|FG001|COMPLETED|Titration Period 1||89
9840111|NCT00813488|10951500|FG000|NOT COMPLETED|Titration Period 1||27
9840112|NCT00813488|10951501|FG001|NOT COMPLETED|Titration Period 1||17
9959375|NCT01462266|11078858|FG000|STARTED|Overall Study||330
9840113|NCT00813488|10951500|FG000|STARTED|Titration Period 2||80
9840114|NCT00813488|10951501|FG001|STARTED|Titration Period 2||89
9840115|NCT00813488|10951500|FG000|COMPLETED|Titration Period 2||64
9840116|NCT00813488|10951501|FG001|COMPLETED|Titration Period 2||79
9840117|NCT00813488|10951500|FG000|NOT COMPLETED|Titration Period 2||16
9840118|NCT00813488|10951501|FG001|NOT COMPLETED|Titration Period 2||10
9840119|NCT00813488|10951500|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
9840120|NCT00813488|10951501|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
9840121|NCT00813488|10951500|FG000|COMPLETED|Double-blind Treatment Period 1||71
9840122|NCT00813488|10951501|FG001|COMPLETED|Double-blind Treatment Period 1||66
9840123|NCT00813488|10951500|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
9840124|NCT00813488|10951501|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5
9840125|NCT00813488|10951500|FG000|STARTED|Double-blind Treatment Period 2||71
9840126|NCT00813488|10951501|FG001|STARTED|Double-blind Treatment Period 2||66
9840127|NCT00813488|10951500|FG000|COMPLETED|Double-blind Treatment Period 2||66
9840128|NCT00813488|10951501|FG001|COMPLETED|Double-blind Treatment Period 2||65
9840129|NCT00813488|10951500|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5
9840130|NCT00813488|10951501|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1
9840131|NCT00813488|10951500|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
9840132|NCT00813488|10951501|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
9840133|NCT00813488|10951500|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53
9840134|NCT00813488|10951501|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
9840135|NCT00813488|10951500|FG000|NOT COMPLETED|Open-label Extension||12
9959376|NCT01462266|11078859|FG001|STARTED|Overall Study||330
9959377|NCT01462266|11078858|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
9959378|NCT01462266|11078859|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
9959379|NCT01462266|11078858|FG000|COMPLETED|Overall Study||295
9959380|NCT01462266|11078859|FG001|COMPLETED|Overall Study||303
9959381|NCT01462266|11078858|FG000|NOT COMPLETED|Overall Study||35
9959382|NCT01462266|11078859|FG001|NOT COMPLETED|Overall Study||27
9959383|NCT01462279|11078865|FG000|STARTED|Overall Study||20
9959384|NCT01462279|11078865|FG000|COMPLETED|Overall Study||17
9959385|NCT01462279|11078865|FG000|NOT COMPLETED|Overall Study||3
9959386|NCT01462292|11078872|FG000|STARTED|Overall Study||16
9959387|NCT01462292|11078873|FG001|STARTED|Overall Study||17
9959388|NCT01462292|11078874|FG002|STARTED|Overall Study||18
9959389|NCT01462292|11078872|FG000|COMPLETED|Overall Study||16
9959390|NCT01462292|11078873|FG001|COMPLETED|Overall Study||17
9959391|NCT01462292|11078874|FG002|COMPLETED|Overall Study||18
9959392|NCT01462292|11078872|FG000|NOT COMPLETED|Overall Study||0
9959393|NCT01462292|11078873|FG001|NOT COMPLETED|Overall Study||0
9959394|NCT01462292|11078874|FG002|NOT COMPLETED|Overall Study||0
9959395|NCT01462305|11078887|FG000|STARTED|Overall Study||18
9959396|NCT01462305|11078888|FG001|STARTED|Overall Study||17
9959397|NCT01462305|11078887|FG000|COMPLETED|Overall Study||16
9959398|NCT01462305|11078888|FG001|COMPLETED|Overall Study||13
9959399|NCT01462305|11078887|FG000|NOT COMPLETED|Overall Study||2
9959400|NCT01462305|11078888|FG001|NOT COMPLETED|Overall Study||4
9959401|NCT01462318|11078896|FG000|STARTED|Main Study / TP-DI Study||113
9959402|NCT01462318|11078897|FG001|STARTED|Main Study / TP-DI Study||20
9959403|NCT01462318|11078898|FG002|STARTED|Main Study / TP-DI Study||0
9959404|NCT01462318|11078896|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
9959405|NCT01462318|11078897|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
9959406|NCT01462318|11078898|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
9959407|NCT01462318|11078896|FG000|COMPLETED|Main Study / TP-DI Study||105
9959408|NCT01462318|11078897|FG001|COMPLETED|Main Study / TP-DI Study||20
9959409|NCT01462318|11078898|FG002|COMPLETED|Main Study / TP-DI Study||0
9959410|NCT01462318|11078896|FG000|NOT COMPLETED|Main Study / TP-DI Study||8
9959411|NCT01462318|11078897|FG001|NOT COMPLETED|Main Study / TP-DI Study||0
9959412|NCT01462318|11078898|FG002|NOT COMPLETED|Main Study / TP-DI Study||0
9959413|NCT01462318|11078896|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
9959414|NCT01462318|11078897|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
9959415|NCT01462318|11078898|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
9959416|NCT01462318|11078896|FG000|COMPLETED|Extension Phase||0
9959417|NCT01462318|11078897|FG001|COMPLETED|Extension Phase||0
9959418|NCT01462318|11078898|FG002|COMPLETED|Extension Phase||70
9959419|NCT01462318|11078896|FG000|NOT COMPLETED|Extension Phase||0
9959420|NCT01462318|11078897|FG001|NOT COMPLETED|Extension Phase||0
9959421|NCT01462318|11078898|FG002|NOT COMPLETED|Extension Phase||45
9959422|NCT01462344|11078905|FG000|STARTED|Overall Study||3107
9959423|NCT01462344|11078906|FG001|STARTED|Overall Study||3101
9959424|NCT01462344|11078905|FG000|COMPLETED|Overall Study||2724
9959425|NCT01462344|11078906|FG001|COMPLETED|Overall Study||2751
9959426|NCT01462344|11078905|FG000|NOT COMPLETED|Overall Study||383
9722304|NCT00071110|10821749|FG000|NOT COMPLETED|Overall Study||0
9722305|NCT00071110|10821750|FG001|NOT COMPLETED|Overall Study||4
9722306|NCT00071396|10821756|FG000|STARTED|Overall Study||44
9722307|NCT00071396|10821756|FG000|COMPLETED|Overall Study|Evaluable for response.|41
9722308|NCT00071396|10821756|FG000|NOT COMPLETED|Overall Study||3
9722309|NCT00071487|10821764|FG000|STARTED|52-Week Double-Blind Period||113
9722310|NCT00071487|10821765|FG001|STARTED|52-Week Double-Blind Period||114
9722311|NCT00071487|10821766|FG002|STARTED|52-Week Double-Blind Period||111
9722312|NCT00071487|10821767|FG003|STARTED|52-Week Double-Blind Period||111
9722313|NCT00071487|10821764|FG000|COMPLETED|52-Week Double-Blind Period||93
9722314|NCT00071487|10821765|FG001|COMPLETED|52-Week Double-Blind Period||87
9722315|NCT00071487|10821766|FG002|COMPLETED|52-Week Double-Blind Period||94
9722316|NCT00071487|10821767|FG003|COMPLETED|52-Week Double-Blind Period||90
9722317|NCT00071487|10821764|FG000|NOT COMPLETED|52-Week Double-Blind Period||20
9722318|NCT00071487|10821765|FG001|NOT COMPLETED|52-Week Double-Blind Period||27
9722319|NCT00071487|10821766|FG002|NOT COMPLETED|52-Week Double-Blind Period||17
9722320|NCT00071487|10821767|FG003|NOT COMPLETED|52-Week Double-Blind Period||21
9722321|NCT00071487|10821764|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
9722322|NCT00071487|10821765|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
9722323|NCT00071487|10821766|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
9722324|NCT00071487|10821767|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
9722325|NCT00071487|10821764|FG000|COMPLETED|24-Week Open-Label Extension Period||0
9722326|NCT00071487|10821765|FG001|COMPLETED|24-Week Open-Label Extension Period||19
9722327|NCT00071487|10821766|FG002|COMPLETED|24-Week Open-Label Extension Period||23
9722328|NCT00071487|10821767|FG003|COMPLETED|24-Week Open-Label Extension Period||279
9722329|NCT00071487|10821764|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
9722330|NCT00071487|10821765|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
9722331|NCT00071487|10821766|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
9722332|NCT00071487|10821767|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23
9722333|NCT00071513|10821781|FG000|STARTED|Intervention Component||241
9722334|NCT00071513|10821782|FG001|STARTED|Intervention Component||256
9722335|NCT00071513|10821781|FG000|COMPLETED|Intervention Component||239
9722336|NCT00071513|10821782|FG001|COMPLETED|Intervention Component||253
9722337|NCT00071513|10821781|FG000|NOT COMPLETED|Intervention Component||2
9722338|NCT00071513|10821782|FG001|NOT COMPLETED|Intervention Component||3
9722339|NCT00071513|10821781|FG000|STARTED|Follow-up Assessment||239
9722340|NCT00071513|10821782|FG001|STARTED|Follow-up Assessment||253
9722341|NCT00071513|10821781|FG000|COMPLETED|Follow-up Assessment||233
9722342|NCT00071513|10821782|FG001|COMPLETED|Follow-up Assessment||247
9722343|NCT00071513|10821781|FG000|NOT COMPLETED|Follow-up Assessment||6
9722344|NCT00071513|10821782|FG001|NOT COMPLETED|Follow-up Assessment||6
9722345|NCT00071721|10821792|FG000|STARTED|Overall Study||153
9722346|NCT00071721|10821793|FG001|STARTED|Overall Study||160
9722347|NCT00071721|10821792|FG000|COMPLETED|Overall Study||81
9722348|NCT00071721|10821793|FG001|COMPLETED|Overall Study||69
9722349|NCT00071721|10821792|FG000|NOT COMPLETED|Overall Study||72
9722350|NCT00071721|10821793|FG001|NOT COMPLETED|Overall Study||91
9722351|NCT00071760|10821799|FG000|STARTED|Overall Study||54
9722352|NCT00071760|10821799|FG000|Ongoing|Overall Study||25
9722353|NCT00071760|10821799|FG000|COMPLETED|Overall Study||0
9722354|NCT00071760|10821799|FG000|NOT COMPLETED|Overall Study||54
9722355|NCT00071799|10821811|FG000|STARTED|Overall Study||179
9722356|NCT00071799|10821812|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
9722357|NCT00071799|10821811|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
9722358|NCT00071799|10821812|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
9722359|NCT00071799|10821811|FG000|NOT COMPLETED|Overall Study||70
9722360|NCT00071799|10821812|FG001|NOT COMPLETED|Overall Study||98
9722361|NCT00071812|10821828|FG000|STARTED|24-Week Double-Blind Period||69
9722362|NCT00071812|10821829|FG001|STARTED|24-Week Double-Blind Period||72
9722363|NCT00071812|10821830|FG002|STARTED|24-Week Double-Blind Period||71
10114152|NCT02514044|11244862|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
10114153|NCT02514044|11244862|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
9840136|NCT00813488|10951501|FG001|NOT COMPLETED|Open-label Extension||7
9840137|NCT00813592|10951511|FG000|STARTED|Overall Study||2
9840138|NCT00813592|10951511|FG000|Treated|Overall Study|Two patients were treated.|2
9840139|NCT00813592|10951511|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1
9840140|NCT00813592|10951511|FG000|COMPLETED|Overall Study||0
9840141|NCT00813592|10951511|FG000|NOT COMPLETED|Overall Study||2
9840142|NCT00813709|10951519|FG000|STARTED|Double Blind Period||84
9840143|NCT00813709|10951520|FG001|STARTED|Double Blind Period||117
9840144|NCT00813709|10951521|FG002|STARTED|Double Blind Period||99
9840145|NCT00813709|10951522|FG003|STARTED|Double Blind Period||0
9840146|NCT00813709|10951523|FG004|STARTED|Double Blind Period||0
9840147|NCT00813709|10951524|FG005|STARTED|Double Blind Period||0
9840148|NCT00813709|10951519|FG000|Treated|Double Blind Period||83
9840149|NCT00813709|10951520|FG001|Treated|Double Blind Period||114
9840150|NCT00813709|10951521|FG002|Treated|Double Blind Period||98
9840151|NCT00813709|10951522|FG003|Treated|Double Blind Period||0
9840152|NCT00813709|10951523|FG004|Treated|Double Blind Period||0
9840153|NCT00813709|10951524|FG005|Treated|Double Blind Period||0
9840154|NCT00813709|10951519|FG000|COMPLETED|Double Blind Period||53
9840155|NCT00813709|10951520|FG001|COMPLETED|Double Blind Period||76
9840156|NCT00813709|10951521|FG002|COMPLETED|Double Blind Period||68
9840157|NCT00813709|10951522|FG003|COMPLETED|Double Blind Period||0
9840158|NCT00813709|10951523|FG004|COMPLETED|Double Blind Period||0
9840159|NCT00813709|10951524|FG005|COMPLETED|Double Blind Period||0
9840160|NCT00813709|10951519|FG000|NOT COMPLETED|Double Blind Period||31
9840161|NCT00813709|10951520|FG001|NOT COMPLETED|Double Blind Period||41
9840162|NCT00813709|10951521|FG002|NOT COMPLETED|Double Blind Period||31
9840163|NCT00813709|10951522|FG003|NOT COMPLETED|Double Blind Period||0
9840164|NCT00813709|10951523|FG004|NOT COMPLETED|Double Blind Period||0
9840165|NCT00813709|10951524|FG005|NOT COMPLETED|Double Blind Period||0
9840166|NCT00813709|10951519|FG000|STARTED|Open Label Period||0
9840167|NCT00813709|10951520|FG001|STARTED|Open Label Period||0
9840168|NCT00813709|10951521|FG002|STARTED|Open Label Period||0
9840169|NCT00813709|10951522|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
9840170|NCT00813709|10951523|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
9840171|NCT00813709|10951524|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
9840172|NCT00813709|10951519|FG000|Treated|Open Label Period||0
9840173|NCT00813709|10951520|FG001|Treated|Open Label Period||0
9840174|NCT00813709|10951521|FG002|Treated|Open Label Period||0
9840175|NCT00813709|10951522|FG003|Treated|Open Label Period||57
9840176|NCT00813709|10951523|FG004|Treated|Open Label Period||51
9840177|NCT00813709|10951524|FG005|Treated|Open Label Period||45
9840178|NCT00813709|10951519|FG000|COMPLETED|Open Label Period||0
9840179|NCT00813709|10951520|FG001|COMPLETED|Open Label Period||0
9840180|NCT00813709|10951521|FG002|COMPLETED|Open Label Period||0
9840181|NCT00813709|10951522|FG003|COMPLETED|Open Label Period||38
9840182|NCT00813709|10951523|FG004|COMPLETED|Open Label Period||41
9840183|NCT00813709|10951524|FG005|COMPLETED|Open Label Period||35
9840184|NCT00813709|10951519|FG000|NOT COMPLETED|Open Label Period||0
9840185|NCT00813709|10951520|FG001|NOT COMPLETED|Open Label Period||0
9959427|NCT01462344|11078906|FG001|NOT COMPLETED|Overall Study||350
9959428|NCT01462357|11078915|FG000|STARTED|Overall Study||359
9959429|NCT01462357|11078916|FG001|STARTED|Overall Study||358
9959430|NCT01462357|11078917|FG002|STARTED|Overall Study||358
9959431|NCT01462357|11078915|FG000|COMPLETED|Overall Study||351
9959432|NCT01462357|11078916|FG001|COMPLETED|Overall Study||339
9959433|NCT01462357|11078917|FG002|COMPLETED|Overall Study||346
9959434|NCT01462357|11078915|FG000|NOT COMPLETED|Overall Study||8
10022058|NCT01847560|11145482|FG000|NOT COMPLETED|Overall Study||0
10022059|NCT01847560|11145483|FG001|NOT COMPLETED|Overall Study||0
10022060|NCT01847560|11145484|FG002|NOT COMPLETED|Overall Study||0
10022061|NCT01847560|11145485|FG003|NOT COMPLETED|Overall Study||0
10022062|NCT01847560|11145486|FG004|NOT COMPLETED|Overall Study||0
10022063|NCT01847560|11145487|FG005|NOT COMPLETED|Overall Study||0
10022064|NCT01847560|11145488|FG006|NOT COMPLETED|Overall Study||0
10022065|NCT01847560|11145489|FG007|NOT COMPLETED|Overall Study||0
10022066|NCT01847560|11145490|FG008|NOT COMPLETED|Overall Study||0
10022067|NCT01847560|11145491|FG009|NOT COMPLETED|Overall Study||0
10022068|NCT01847638|11145535|FG000|STARTED|Overall Study||25
10022069|NCT01847638|11145536|FG001|STARTED|Overall Study||25
9840186|NCT00813709|10951521|FG002|NOT COMPLETED|Open Label Period||0
9840187|NCT00813709|10951522|FG003|NOT COMPLETED|Open Label Period||20
9840188|NCT00813709|10951523|FG004|NOT COMPLETED|Open Label Period||10
9840189|NCT00813709|10951524|FG005|NOT COMPLETED|Open Label Period||11
9840190|NCT00813748|10951555|FG000|STARTED|Main Observational Study||30
9840191|NCT00813748|10951556|FG001|STARTED|Main Observational Study||88
9840192|NCT00813748|10951555|FG000|COMPLETED|Main Observational Study||30
9840193|NCT00813748|10951556|FG001|COMPLETED|Main Observational Study||88
9840194|NCT00813748|10951555|FG000|NOT COMPLETED|Main Observational Study||0
9840195|NCT00813748|10951556|FG001|NOT COMPLETED|Main Observational Study||0
9840196|NCT00813748|10951555|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
9840197|NCT00813748|10951556|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
9840198|NCT00813748|10951555|FG000|COMPLETED|Skin Test Substudy||3
9840199|NCT00813748|10951556|FG001|COMPLETED|Skin Test Substudy||7
9840200|NCT00813748|10951555|FG000|NOT COMPLETED|Skin Test Substudy||0
9840201|NCT00813748|10951556|FG001|NOT COMPLETED|Skin Test Substudy||1
9840202|NCT00813761|10951566|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121
9840203|NCT00813761|10951567|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103
9840204|NCT00813761|10951568|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115
9840205|NCT00813761|10951569|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107
9840206|NCT00813761|10951566|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
9840207|NCT00813761|10951567|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
9840208|NCT00813761|10951568|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
10022070|NCT01847638|11145535|FG000|COMPLETED|Overall Study||25
10022071|NCT01847638|11145536|FG001|COMPLETED|Overall Study||25
10022072|NCT01847638|11145535|FG000|NOT COMPLETED|Overall Study||0
10022073|NCT01847638|11145536|FG001|NOT COMPLETED|Overall Study||0
10022074|NCT01847755|11145542|FG000|STARTED|Overall Study||18
10022075|NCT01847755|11145542|FG000|COMPLETED|Overall Study||13
10022076|NCT01847755|11145542|FG000|NOT COMPLETED|Overall Study||5
10022077|NCT01847885|11145548|FG000|STARTED|Initial Enrollment (Consented)||88
10022078|NCT01847885|11145549|FG001|STARTED|Initial Enrollment (Consented)||0
9840209|NCT00813761|10951569|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
9840210|NCT00813761|10951566|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
9840211|NCT00813761|10951567|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
9840212|NCT00813761|10951568|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
9840213|NCT00813761|10951569|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
9840214|NCT00813761|10951566|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
9840215|NCT00813761|10951567|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
9840216|NCT00813761|10951568|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
9840217|NCT00813761|10951569|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
9840218|NCT00813761|10951566|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
9840219|NCT00813761|10951567|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
9840220|NCT00813761|10951568|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
9840221|NCT00813761|10951569|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
9840222|NCT00813761|10951566|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
9840223|NCT00813761|10951567|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
9840224|NCT00813761|10951568|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
9840225|NCT00813761|10951569|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
9840226|NCT00813800|10951585|FG000|STARTED|Overall Study||11
9840227|NCT00813800|10951585|FG000|COMPLETED|Overall Study||5
9840228|NCT00813800|10951585|FG000|NOT COMPLETED|Overall Study||6
9840229|NCT00813813|10951591|FG000|STARTED|Overall Study||7
9840230|NCT00813813|10951592|FG001|STARTED|Overall Study||25
9840231|NCT00813813|10951591|FG000|COMPLETED|Overall Study||4
10022079|NCT01847885|11145550|FG002|STARTED|Initial Enrollment (Consented)||0
9840232|NCT00813813|10951592|FG001|COMPLETED|Overall Study||16
9840233|NCT00813813|10951591|FG000|NOT COMPLETED|Overall Study||3
10022080|NCT01847885|11145548|FG000|Randomized|Initial Enrollment (Consented)||46
10022081|NCT01847885|11145549|FG001|Randomized|Initial Enrollment (Consented)||0
9840234|NCT00813813|10951592|FG001|NOT COMPLETED|Overall Study||9
9840235|NCT00813865|10951598|FG000|STARTED|Overall Study||8
9840236|NCT00813865|10951598|FG000|Safety Population|Overall Study||8
9840237|NCT00813865|10951598|FG000|Pharmacodynamic (PD) Population|Overall Study||8
9840238|NCT00813865|10951598|FG000|COMPLETED|Overall Study||1
9840239|NCT00813865|10951598|FG000|NOT COMPLETED|Overall Study||7
9840240|NCT00813904|10951602|FG000|STARTED|Overall Study||31
9840241|NCT00813904|10951602|FG000|COMPLETED|Overall Study||30
9840242|NCT00813904|10951602|FG000|NOT COMPLETED|Overall Study||1
9840243|NCT00813917|10951608|FG000|STARTED|Overall Study||38
9840244|NCT00813917|10951609|FG001|STARTED|Overall Study||38
9840245|NCT00813917|10951608|FG000|COMPLETED|Overall Study||32
9840246|NCT00813917|10951609|FG001|COMPLETED|Overall Study||32
9840247|NCT00813917|10951608|FG000|NOT COMPLETED|Overall Study||6
9840248|NCT00813917|10951609|FG001|NOT COMPLETED|Overall Study||6
9840249|NCT00813943|10951618|FG000|STARTED|Overall Study||88
9840250|NCT00813943|10951619|FG001|STARTED|Overall Study||88
9840251|NCT00813943|10951620|FG002|STARTED|Overall Study||89
9840252|NCT00813943|10951618|FG000|COMPLETED|Overall Study||83
9840253|NCT00813943|10951619|FG001|COMPLETED|Overall Study||83
9840254|NCT00813943|10951620|FG002|COMPLETED|Overall Study||86
9840255|NCT00813943|10951618|FG000|NOT COMPLETED|Overall Study||5
9840256|NCT00813943|10951619|FG001|NOT COMPLETED|Overall Study||5
9840257|NCT00813943|10951620|FG002|NOT COMPLETED|Overall Study||3
9840258|NCT00813982|10951629|FG000|STARTED|Overall Study||59
9840259|NCT00813982|10951629|FG000|COMPLETED|Overall Study||59
9840260|NCT00813982|10951629|FG000|NOT COMPLETED|Overall Study||0
9840261|NCT00813995|10951637|FG000|STARTED|Overall Study||197
9840262|NCT00813995|10951638|FG001|STARTED|Overall Study||198
9840263|NCT00813995|10951637|FG000|COMPLETED|Overall Study||174
9840264|NCT00813995|10951638|FG001|COMPLETED|Overall Study||182
9840265|NCT00813995|10951637|FG000|NOT COMPLETED|Overall Study||23
9840266|NCT00813995|10951638|FG001|NOT COMPLETED|Overall Study||16
9722364|NCT00071812|10821831|FG003|STARTED|24-Week Double-Blind Period||71
9722365|NCT00071812|10821828|FG000|COMPLETED|24-Week Double-Blind Period||59
9722366|NCT00071812|10821829|FG001|COMPLETED|24-Week Double-Blind Period||66
9722367|NCT00071812|10821830|FG002|COMPLETED|24-Week Double-Blind Period||63
9722368|NCT00071812|10821831|FG003|COMPLETED|24-Week Double-Blind Period||60
9722369|NCT00071812|10821828|FG000|NOT COMPLETED|24-Week Double-Blind Period||10
9722370|NCT00071812|10821829|FG001|NOT COMPLETED|24-Week Double-Blind Period||6
9722371|NCT00071812|10821830|FG002|NOT COMPLETED|24-Week Double-Blind Period||8
9722372|NCT00071812|10821831|FG003|NOT COMPLETED|24-Week Double-Blind Period||11
9722373|NCT00071812|10821828|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
9722374|NCT00071812|10821829|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
9722375|NCT00071812|10821830|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
9722376|NCT00071812|10821831|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
9722377|NCT00071812|10821828|FG000|COMPLETED|24-Week Open-Label Extension Period||0
9722378|NCT00071812|10821829|FG001|COMPLETED|24-Week Open-Label Extension Period||11
9722379|NCT00071812|10821830|FG002|COMPLETED|24-Week Open-Label Extension Period||7
9722380|NCT00071812|10821831|FG003|COMPLETED|24-Week Open-Label Extension Period||178
9722381|NCT00071812|10821828|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
9722382|NCT00071812|10821829|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
9722383|NCT00071812|10821830|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
9722384|NCT00071812|10821831|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40
9722385|NCT00071890|10821845|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81
9722386|NCT00071890|10821846|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67
9722387|NCT00071890|10821845|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
9722388|NCT00071890|10821846|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
9722389|NCT00071890|10821845|FG000|NOT COMPLETED|Overall Study||0
9722390|NCT00071890|10821846|FG001|NOT COMPLETED|Overall Study||0
9722391|NCT00071981|10821856|FG000|STARTED|Overall Study||47
9722392|NCT00071981|10821857|FG001|STARTED|Overall Study||43
9722393|NCT00071981|10821858|FG002|STARTED|Overall Study||37
10022082|NCT01847885|11145550|FG002|Randomized|Initial Enrollment (Consented)||0
10022083|NCT01847885|11145548|FG000|Full Analysis Set|Initial Enrollment (Consented)||43
10022084|NCT01847885|11145549|FG001|Full Analysis Set|Initial Enrollment (Consented)||0
10022085|NCT01847885|11145550|FG002|Full Analysis Set|Initial Enrollment (Consented)||0
9722394|NCT00071981|10821859|FG003|STARTED|Overall Study||48
9722395|NCT00071981|10821856|FG000|Eligible|Overall Study||43
10022086|NCT01847885|11145548|FG000|Safety Set|Initial Enrollment (Consented)||41
9722396|NCT00071981|10821857|FG001|Eligible|Overall Study||36
9722397|NCT00071981|10821858|FG002|Eligible|Overall Study||33
9722398|NCT00071981|10821859|FG003|Eligible|Overall Study||42
9722399|NCT00071981|10821856|FG000|Treated|Overall Study||45
9722400|NCT00071981|10821857|FG001|Treated|Overall Study||38
9722401|NCT00071981|10821858|FG002|Treated|Overall Study||36
9722402|NCT00071981|10821859|FG003|Treated|Overall Study||48
9722403|NCT00071981|10821856|FG000|Eligible and Treated|Overall Study||41
9722404|NCT00071981|10821857|FG001|Eligible and Treated|Overall Study||33
9840267|NCT00814138|10951650|FG000|STARTED|Overall Study||25
9840268|NCT00814138|10951651|FG001|STARTED|Overall Study||25
9840269|NCT00814138|10951650|FG000|COMPLETED|Overall Study||24
9840270|NCT00814138|10951651|FG001|COMPLETED|Overall Study||18
9840271|NCT00814138|10951650|FG000|NOT COMPLETED|Overall Study||1
9840272|NCT00814138|10951651|FG001|NOT COMPLETED|Overall Study||7
9840273|NCT00814164|10951659|FG000|STARTED|Overall Study||21
9840274|NCT00814164|10951659|FG000|COMPLETED|Overall Study||2
9840275|NCT00814164|10951659|FG000|NOT COMPLETED|Overall Study||19
9840276|NCT00814177|10951665|FG000|STARTED|Overall Study||80
9840277|NCT00814177|10951666|FG001|STARTED|Overall Study||80
9840278|NCT00814177|10951665|FG000|COMPLETED|Overall Study||80
9840279|NCT00814177|10951666|FG001|COMPLETED|Overall Study||80
9840280|NCT00814177|10951665|FG000|NOT COMPLETED|Overall Study||0
9840281|NCT00814177|10951666|FG001|NOT COMPLETED|Overall Study||0
9840282|NCT00814255|10951675|FG000|STARTED|Overall Study||8
9840283|NCT00814255|10951676|FG001|STARTED|Overall Study||7
9840284|NCT00814255|10951677|FG002|STARTED|Overall Study||8
9840285|NCT00814255|10951675|FG000|COMPLETED|Overall Study||7
9840286|NCT00814255|10951676|FG001|COMPLETED|Overall Study||7
9840287|NCT00814255|10951677|FG002|COMPLETED|Overall Study||7
9840288|NCT00814255|10951675|FG000|NOT COMPLETED|Overall Study||1
9840289|NCT00814255|10951676|FG001|NOT COMPLETED|Overall Study||0
9840290|NCT00814255|10951677|FG002|NOT COMPLETED|Overall Study||1
9840291|NCT00814307|10951692|FG000|STARTED|Overall Study||244
9840292|NCT00814307|10951693|FG001|STARTED|Overall Study||245
9840293|NCT00814307|10951694|FG002|STARTED|Overall Study||61
9840294|NCT00814307|10951695|FG003|STARTED|Overall Study||61
9840295|NCT00814307|10951692|FG000|Treated|Overall Study||243
9840296|NCT00814307|10951693|FG001|Treated|Overall Study||245
9840297|NCT00814307|10951694|FG002|Treated|Overall Study||61
9840298|NCT00814307|10951695|FG003|Treated|Overall Study||61
9840299|NCT00814307|10951692|FG000|COMPLETED|Overall Study||232
9840300|NCT00814307|10951693|FG001|COMPLETED|Overall Study||218
9840301|NCT00814307|10951694|FG002|COMPLETED|Overall Study||54
9840302|NCT00814307|10951695|FG003|COMPLETED|Overall Study||51
9840303|NCT00814307|10951692|FG000|NOT COMPLETED|Overall Study||12
9840304|NCT00814307|10951693|FG001|NOT COMPLETED|Overall Study||27
9840305|NCT00814307|10951694|FG002|NOT COMPLETED|Overall Study||7
9840306|NCT00814307|10951695|FG003|NOT COMPLETED|Overall Study||10
9840307|NCT00814320|10951709|FG000|STARTED|Epoch 1 (IV Treatment)||14
9840308|NCT00814320|10951710|FG001|STARTED|Epoch 1 (IV Treatment)||73
9840309|NCT00814320|10951709|FG000|COMPLETED|Epoch 1 (IV Treatment)||13
9840310|NCT00814320|10951710|FG001|COMPLETED|Epoch 1 (IV Treatment)||71
9840311|NCT00814320|10951709|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1
9840312|NCT00814320|10951710|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2
9840313|NCT00814320|10951709|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
9840314|NCT00814320|10951710|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
9840315|NCT00814320|10951709|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
9840316|NCT00814320|10951710|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
9840317|NCT00814320|10951709|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
9840318|NCT00814320|10951710|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
9840319|NCT00814320|10951709|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
9840320|NCT00814320|10951710|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
9840321|NCT00814320|10951709|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
9840322|NCT00814320|10951710|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
9840323|NCT00814320|10951709|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
9840324|NCT00814320|10951710|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
9840325|NCT00814320|10951709|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
9840326|NCT00814320|10951710|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
9840327|NCT00814320|10951709|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
9840328|NCT00814320|10951710|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
9840329|NCT00814320|10951709|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
9840330|NCT00814320|10951710|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
9840331|NCT00814346|10951735|FG000|STARTED|Double-blind Phase (4 Weeks)||23
9840332|NCT00814346|10951736|FG001|STARTED|Double-blind Phase (4 Weeks)||26
9840333|NCT00814346|10951735|FG000|CNE|Double-blind Phase (4 Weeks)||10
9840334|NCT00814346|10951736|FG001|CNE|Double-blind Phase (4 Weeks)||13
9840335|NCT00814346|10951735|FG000|MC|Double-blind Phase (4 Weeks)||10
9840336|NCT00814346|10951736|FG001|MC|Double-blind Phase (4 Weeks)||11
9840337|NCT00814346|10951735|FG000|AD|Double-blind Phase (4 Weeks)||3
9840338|NCT00814346|10951736|FG001|AD|Double-blind Phase (4 Weeks)||2
9840339|NCT00814346|10951735|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23
9840340|NCT00814346|10951736|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23
9840341|NCT00814346|10951735|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
9840342|NCT00814346|10951736|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
9959435|NCT01462357|11078916|FG001|NOT COMPLETED|Overall Study||19
9959436|NCT01462357|11078917|FG002|NOT COMPLETED|Overall Study||12
9959437|NCT01462435|11078929|FG000|STARTED|Overall Study||106
9959438|NCT01462435|11078930|FG001|STARTED|Overall Study||109
9959439|NCT01462435|11078931|FG002|STARTED|Overall Study||107
9959440|NCT01462435|11078932|FG003|STARTED|Overall Study||106
9959441|NCT01462435|11078929|FG000|COMPLETED|Overall Study||105
9959442|NCT01462435|11078930|FG001|COMPLETED|Overall Study||109
9959443|NCT01462435|11078931|FG002|COMPLETED|Overall Study||106
9959444|NCT01462435|11078932|FG003|COMPLETED|Overall Study||101
9840343|NCT00814346|10951735|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
9840344|NCT00814346|10951736|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
9959445|NCT01462435|11078929|FG000|NOT COMPLETED|Overall Study||1
9959446|NCT01462435|11078930|FG001|NOT COMPLETED|Overall Study||0
10114154|NCT02514044|11244862|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
10114155|NCT02514070|11244872|FG000|STARTED|Weeks 0 to Week 6||19
10114156|NCT02514070|11244873|FG001|STARTED|Weeks 0 to Week 6||20
10114157|NCT02514070|11244872|FG000|COMPLETED|Weeks 0 to Week 6||17
10114158|NCT02514070|11244873|FG001|COMPLETED|Weeks 0 to Week 6||16
9840345|NCT00814346|10951735|FG000|CNE|Open Phase (17 Months)||21
9840346|NCT00814346|10951736|FG001|CNE|Open Phase (17 Months)||0
9840347|NCT00814346|10951735|FG000|MC|Open Phase (17 Months)||20
9840348|NCT00814346|10951736|FG001|MC|Open Phase (17 Months)||0
9840349|NCT00814346|10951735|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
9840350|NCT00814346|10951736|FG001|AD|Open Phase (17 Months)||0
9840351|NCT00814346|10951735|FG000|COMPLETED|Open Phase (17 Months)||31
9840352|NCT00814346|10951736|FG001|COMPLETED|Open Phase (17 Months)||0
9840353|NCT00814346|10951735|FG000|NOT COMPLETED|Open Phase (17 Months)||10
9840354|NCT00814346|10951736|FG001|NOT COMPLETED|Open Phase (17 Months)||0
9840355|NCT00814463|10951755|FG000|STARTED|Overall Study||1
9840356|NCT00814463|10951755|FG000|COMPLETED|Overall Study||0
9840357|NCT00814463|10951755|FG000|NOT COMPLETED|Overall Study||1
9840358|NCT00814489|10951763|FG000|STARTED|Overall Study||15
9840359|NCT00814489|10951764|FG001|STARTED|Overall Study||17
9840360|NCT00814489|10951765|FG002|STARTED|Overall Study||8
9840361|NCT00814489|10951763|FG000|COMPLETED|Overall Study||13
9840362|NCT00814489|10951764|FG001|COMPLETED|Overall Study||17
9840363|NCT00814489|10951765|FG002|COMPLETED|Overall Study||7
9840364|NCT00814489|10951763|FG000|NOT COMPLETED|Overall Study||2
9840365|NCT00814489|10951764|FG001|NOT COMPLETED|Overall Study||0
9840366|NCT00814489|10951765|FG002|NOT COMPLETED|Overall Study||1
9840367|NCT00814502|10951777|FG000|STARTED|Overall Study||8
9840368|NCT00814502|10951778|FG001|STARTED|Overall Study||9
9840369|NCT00814502|10951777|FG000|COMPLETED|Overall Study||7
9840370|NCT00814502|10951778|FG001|COMPLETED|Overall Study||7
9840371|NCT00814502|10951777|FG000|NOT COMPLETED|Overall Study||1
9840372|NCT00814502|10951778|FG001|NOT COMPLETED|Overall Study||2
9840373|NCT00814580|10951788|FG000|STARTED|Overall Study||194
9840374|NCT00814580|10951789|FG001|STARTED|Overall Study||188
9840375|NCT00814580|10951788|FG000|COMPLETED|Overall Study||163
9840376|NCT00814580|10951789|FG001|COMPLETED|Overall Study||141
9840377|NCT00814580|10951788|FG000|NOT COMPLETED|Overall Study||31
9840378|NCT00814580|10951789|FG001|NOT COMPLETED|Overall Study||47
9840379|NCT00814632|10951807|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
9840380|NCT00814632|10951807|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
9840381|NCT00814632|10951807|FG000|NOT COMPLETED|Overall Study||2
9840382|NCT00814658|10951813|FG000|STARTED|Overall Study||9
9840383|NCT00814658|10951814|FG001|STARTED|Overall Study||12
9840384|NCT00814658|10951813|FG000|COMPLETED|Overall Study||5
9840385|NCT00814658|10951814|FG001|COMPLETED|Overall Study||8
9840386|NCT00814658|10951813|FG000|NOT COMPLETED|Overall Study||4
9840387|NCT00814658|10951814|FG001|NOT COMPLETED|Overall Study||4
9840388|NCT00814671|10951833|FG000|STARTED|Overall Study||54
9840389|NCT00814671|10951834|FG001|STARTED|Overall Study||48
9840390|NCT00814671|10951835|FG002|STARTED|Overall Study||51
9840391|NCT00814671|10951833|FG000|COMPLETED|Overall Study||47
9840392|NCT00814671|10951834|FG001|COMPLETED|Overall Study||44
9840393|NCT00814671|10951835|FG002|COMPLETED|Overall Study||49
9840394|NCT00814671|10951833|FG000|NOT COMPLETED|Overall Study||7
9840395|NCT00814671|10951834|FG001|NOT COMPLETED|Overall Study||4
9840396|NCT00814671|10951835|FG002|NOT COMPLETED|Overall Study||2
9840397|NCT00814697|10951847|FG000|STARTED|Overall Study||12
9840398|NCT00814697|10951847|FG000|COMPLETED|Overall Study||12
9840399|NCT00814697|10951847|FG000|NOT COMPLETED|Overall Study||0
9840400|NCT00814710|10951853|FG000|STARTED|Overall Study||240
9840401|NCT00814710|10951854|FG001|STARTED|Overall Study||120
10114159|NCT02514070|11244872|FG000|NOT COMPLETED|Weeks 0 to Week 6||2
10022087|NCT01847885|11145549|FG001|Safety Set|Initial Enrollment (Consented)||0
10022088|NCT01847885|11145550|FG002|Safety Set|Initial Enrollment (Consented)||0
10022089|NCT01847885|11145548|FG000|Per Protocol Set|Initial Enrollment (Consented)||40
10022090|NCT01847885|11145549|FG001|Per Protocol Set|Initial Enrollment (Consented)||0
10022091|NCT01847885|11145550|FG002|Per Protocol Set|Initial Enrollment (Consented)||0
10022092|NCT01847885|11145548|FG000|COMPLETED|Initial Enrollment (Consented)||40
10022093|NCT01847885|11145549|FG001|COMPLETED|Initial Enrollment (Consented)||0
10022094|NCT01847885|11145550|FG002|COMPLETED|Initial Enrollment (Consented)||0
10022095|NCT01847885|11145548|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48
10022096|NCT01847885|11145549|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0
10022097|NCT01847885|11145550|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0
10022098|NCT01847885|11145548|FG000|STARTED|Randomization||0
10022099|NCT01847885|11145549|FG001|STARTED|Randomization||31
10022100|NCT01847885|11145550|FG002|STARTED|Randomization||15
10022101|NCT01847885|11145548|FG000|Full Analysis Set|Randomization||0
10022102|NCT01847885|11145549|FG001|Full Analysis Set|Randomization||28
10022103|NCT01847885|11145550|FG002|Full Analysis Set|Randomization||15
9840402|NCT00814710|10951853|FG000|COMPLETED|Overall Study||232
9840403|NCT00814710|10951854|FG001|COMPLETED|Overall Study||117
9840404|NCT00814710|10951853|FG000|NOT COMPLETED|Overall Study||8
9840405|NCT00814710|10951854|FG001|NOT COMPLETED|Overall Study||3
9840406|NCT00814775|10951862|FG000|STARTED|Overall Study||23
9840407|NCT00814775|10951863|FG001|STARTED|Overall Study||20
9840408|NCT00814775|10951862|FG000|COMPLETED|Overall Study||23
9840409|NCT00814775|10951863|FG001|COMPLETED|Overall Study||20
9840410|NCT00814775|10951862|FG000|NOT COMPLETED|Overall Study||0
9840411|NCT00814775|10951863|FG001|NOT COMPLETED|Overall Study||0
9840412|NCT00814788|10951869|FG000|STARTED|Overall Study||24
9840413|NCT00814788|10951869|FG000|COMPLETED|Overall Study||24
9840414|NCT00814788|10951869|FG000|NOT COMPLETED|Overall Study||0
9840415|NCT00814801|10951878|FG000|STARTED|Overall Study||194
9840416|NCT00814801|10951879|FG001|STARTED|Overall Study||192
9840417|NCT00814801|10951880|FG002|STARTED|Overall Study||194
9840418|NCT00814801|10951878|FG000|COMPLETED|Overall Study||160
9840419|NCT00814801|10951879|FG001|COMPLETED|Overall Study||154
9840420|NCT00814801|10951880|FG002|COMPLETED|Overall Study||151
9840421|NCT00814801|10951878|FG000|NOT COMPLETED|Overall Study||34
9840422|NCT00814801|10951879|FG001|NOT COMPLETED|Overall Study||38
9840423|NCT00814801|10951880|FG002|NOT COMPLETED|Overall Study||43
9840424|NCT00814879|10951890|FG000|STARTED|By Week 24||28
9840425|NCT00814879|10951891|FG001|STARTED|By Week 24||30
9959447|NCT01462435|11078931|FG002|NOT COMPLETED|Overall Study||1
9959448|NCT01462435|11078932|FG003|NOT COMPLETED|Overall Study||5
9959449|NCT01462565|11078942|FG000|STARTED|Overall Study||16
9959450|NCT01462565|11078942|FG000|COMPLETED|Overall Study||16
9959451|NCT01462565|11078942|FG000|NOT COMPLETED|Overall Study||0
9959452|NCT01462695|11078948|FG000|STARTED|Overall Study||17
9959453|NCT01462695|11078949|FG001|STARTED|Overall Study||13
9959454|NCT01462695|11078948|FG000|COMPLETED|Overall Study||0
9959455|NCT01462695|11078949|FG001|COMPLETED|Overall Study||0
9959456|NCT01462695|11078948|FG000|NOT COMPLETED|Overall Study||17
9959457|NCT01462695|11078949|FG001|NOT COMPLETED|Overall Study||13
9959458|NCT01462773|11078955|FG000|STARTED|Overall Study||16
9959459|NCT01462773|11078955|FG000|COMPLETED|Overall Study||16
9959460|NCT01462773|11078955|FG000|NOT COMPLETED|Overall Study||0
9959461|NCT01462812|11078962|FG000|STARTED|Overall Study||111
9959462|NCT01462812|11078963|FG001|STARTED|Overall Study||112
9959463|NCT01462812|11078962|FG000|COMPLETED|Overall Study||111
9959464|NCT01462812|11078963|FG001|COMPLETED|Overall Study||111
9959465|NCT01462812|11078962|FG000|NOT COMPLETED|Overall Study||0
9959466|NCT01462812|11078963|FG001|NOT COMPLETED|Overall Study||1
9959467|NCT01462877|11078969|FG000|STARTED|Overall Study||506
9959468|NCT01462877|11078969|FG000|Safety Set|Overall Study||492
9959469|NCT01462877|11078969|FG000|Full Analysis Set|Overall Study||468
9959470|NCT01462877|11078969|FG000|Per-protocol Set|Overall Study||364
9959471|NCT01462877|11078969|FG000|COMPLETED|Overall Study||435
9959472|NCT01462877|11078969|FG000|NOT COMPLETED|Overall Study||71
9959473|NCT01462929|11078976|FG000|STARTED|Overall Study||171
9959474|NCT01462929|11078977|FG001|STARTED|Overall Study||158
9959475|NCT01462929|11078978|FG002|STARTED|Overall Study||85
9959476|NCT01462929|11078976|FG000|COMPLETED|Overall Study||166
9959477|NCT01462929|11078977|FG001|COMPLETED|Overall Study||154
9959478|NCT01462929|11078978|FG002|COMPLETED|Overall Study||80
9959479|NCT01462929|11078976|FG000|NOT COMPLETED|Overall Study||5
9959480|NCT01462929|11078977|FG001|NOT COMPLETED|Overall Study||4
9959481|NCT01462929|11078978|FG002|NOT COMPLETED|Overall Study||5
9959482|NCT01462942|11078991|FG000|STARTED|Overall Study||194
9959483|NCT01462942|11078992|FG001|STARTED|Overall Study||385
9959484|NCT01462942|11078993|FG002|STARTED|Overall Study||381
9959485|NCT01462942|11078994|FG003|STARTED|Overall Study||385
9959486|NCT01462942|11078995|FG004|STARTED|Overall Study||384
9959487|NCT01462942|11078991|FG000|COMPLETED|Overall Study||160
9959488|NCT01462942|11078992|FG001|COMPLETED|Overall Study||351
9959489|NCT01462942|11078993|FG002|COMPLETED|Overall Study||341
9959490|NCT01462942|11078994|FG003|COMPLETED|Overall Study||335
9959491|NCT01462942|11078995|FG004|COMPLETED|Overall Study||339
9959492|NCT01462942|11078991|FG000|NOT COMPLETED|Overall Study||34
9959493|NCT01462942|11078992|FG001|NOT COMPLETED|Overall Study||34
9959494|NCT01462942|11078993|FG002|NOT COMPLETED|Overall Study||40
9959495|NCT01462942|11078994|FG003|NOT COMPLETED|Overall Study||50
9959496|NCT01462942|11078995|FG004|NOT COMPLETED|Overall Study||45
9959497|NCT01463007|11079007|FG000|STARTED|Overall Study||41
9959498|NCT01463007|11079007|FG000|COMPLETED|Overall Study||40
9959499|NCT01463007|11079007|FG000|NOT COMPLETED|Overall Study||1
9959500|NCT01463033|11079014|FG000|STARTED|Overall Study||66
9840426|NCT00814879|10951890|FG000|COMPLETED|By Week 24||27
9959501|NCT01463033|11079015|FG001|STARTED|Overall Study||60
9959502|NCT01463033|11079014|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
9959503|NCT01463033|11079015|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
9959504|NCT01463033|11079014|FG000|NOT COMPLETED|Overall Study||7
9959505|NCT01463033|11079015|FG001|NOT COMPLETED|Overall Study||6
9959506|NCT01463098|11079036|FG000|STARTED|Part A (11 Days)||16
9959507|NCT01463098|11079037|FG001|STARTED|Part A (11 Days)||6
9959508|NCT01463098|11079038|FG002|STARTED|Part A (11 Days)||6
9959509|NCT01463098|11079039|FG003|STARTED|Part A (11 Days)||6
9959510|NCT01463098|11079040|FG004|STARTED|Part A (11 Days)||6
9959511|NCT01463098|11079041|FG005|STARTED|Part A (11 Days)||6
9959512|NCT01463098|11079042|FG006|STARTED|Part A (11 Days)||6
9959513|NCT01463098|11079043|FG007|STARTED|Part A (11 Days)||6
9959514|NCT01463098|11079044|FG008|STARTED|Part A (11 Days)||6
9959515|NCT01463098|11079045|FG009|STARTED|Part A (11 Days)||0
9959516|NCT01463098|11079046|FG010|STARTED|Part A (11 Days)||0
10022104|NCT01847885|11145548|FG000|Safety Set|Randomization||0
10022105|NCT01847885|11145549|FG001|Safety Set|Randomization||28
10022106|NCT01847885|11145550|FG002|Safety Set|Randomization||13
9959517|NCT01463098|11079047|FG011|STARTED|Part A (11 Days)||0
9959518|NCT01463098|11079048|FG012|STARTED|Part A (11 Days)||0
9959519|NCT01463098|11079049|FG013|STARTED|Part A (11 Days)||0
9959520|NCT01463098|11079036|FG000|COMPLETED|Part A (11 Days)||14
9959521|NCT01463098|11079037|FG001|COMPLETED|Part A (11 Days)||6
9959522|NCT01463098|11079038|FG002|COMPLETED|Part A (11 Days)||6
9959523|NCT01463098|11079039|FG003|COMPLETED|Part A (11 Days)||6
9959524|NCT01463098|11079040|FG004|COMPLETED|Part A (11 Days)||5
9959525|NCT01463098|11079041|FG005|COMPLETED|Part A (11 Days)||6
10022107|NCT01847885|11145548|FG000|Per Protocol Set|Randomization||0
9722405|NCT00071981|10821858|FG002|Eligible and Treated|Overall Study||32
9722406|NCT00071981|10821859|FG003|Eligible and Treated|Overall Study||42
9722407|NCT00071981|10821856|FG000|Have CTL Response Data|Overall Study||40
9722408|NCT00071981|10821857|FG001|Have CTL Response Data|Overall Study||30
9722409|NCT00071981|10821858|FG002|Have CTL Response Data|Overall Study||29
9722410|NCT00071981|10821859|FG003|Have CTL Response Data|Overall Study||41
9722411|NCT00071981|10821856|FG000|Have Helper T Cell Response Data|Overall Study||37
9722412|NCT00071981|10821857|FG001|Have Helper T Cell Response Data|Overall Study||27
9722413|NCT00071981|10821858|FG002|Have Helper T Cell Response Data|Overall Study||25
9722414|NCT00071981|10821859|FG003|Have Helper T Cell Response Data|Overall Study||39
9722415|NCT00071981|10821856|FG000|COMPLETED|Overall Study||1
9722416|NCT00071981|10821857|FG001|COMPLETED|Overall Study||2
9722417|NCT00071981|10821858|FG002|COMPLETED|Overall Study||0
9722418|NCT00071981|10821859|FG003|COMPLETED|Overall Study||3
9722419|NCT00071981|10821856|FG000|NOT COMPLETED|Overall Study||46
9722420|NCT00071981|10821857|FG001|NOT COMPLETED|Overall Study||41
9722421|NCT00071981|10821858|FG002|NOT COMPLETED|Overall Study||37
9722422|NCT00071981|10821859|FG003|NOT COMPLETED|Overall Study||45
9722423|NCT00072176|10821871|FG000|STARTED|Overall Study||34
9722424|NCT00072176|10821872|FG001|STARTED|Overall Study||28
9722425|NCT00072176|10821871|FG000|COMPLETED|Overall Study||33
9722426|NCT00072176|10821872|FG001|COMPLETED|Overall Study||27
9722427|NCT00072176|10821871|FG000|NOT COMPLETED|Overall Study||1
9722428|NCT00072176|10821872|FG001|NOT COMPLETED|Overall Study||1
9722429|NCT00072189|10821878|FG000|STARTED|Overall Study||17
9722430|NCT00072189|10821878|FG000|COMPLETED|Overall Study||16
9722431|NCT00072189|10821878|FG000|NOT COMPLETED|Overall Study||1
9722432|NCT00072280|10821884|FG000|STARTED|Treatment||3
9722433|NCT00072280|10821885|FG001|STARTED|Treatment||4
9722434|NCT00072280|10821884|FG000|COMPLETED|Treatment||2
9722435|NCT00072280|10821885|FG001|COMPLETED|Treatment||2
9722436|NCT00072280|10821884|FG000|NOT COMPLETED|Treatment||1
9722437|NCT00072280|10821885|FG001|NOT COMPLETED|Treatment||2
9722438|NCT00072280|10821884|FG000|STARTED|Follow-up||2
9722439|NCT00072280|10821885|FG001|STARTED|Follow-up||2
9722440|NCT00072280|10821884|FG000|COMPLETED|Follow-up||0
9722441|NCT00072280|10821885|FG001|COMPLETED|Follow-up||0
9722442|NCT00072280|10821884|FG000|NOT COMPLETED|Follow-up||2
9722443|NCT00072280|10821885|FG001|NOT COMPLETED|Follow-up||2
9722444|NCT00072293|10821892|FG000|STARTED|Overall Study||465
9722445|NCT00072293|10821893|FG001|STARTED|Overall Study||469
9722446|NCT00072293|10821892|FG000|COMPLETED|Overall Study||464
9722447|NCT00072293|10821893|FG001|COMPLETED|Overall Study||467
9722448|NCT00072293|10821892|FG000|NOT COMPLETED|Overall Study||1
9722449|NCT00072293|10821893|FG001|NOT COMPLETED|Overall Study||2
9722450|NCT00072384|10821899|FG000|STARTED|Overall Study||30
9722451|NCT00072384|10821899|FG000|COMPLETED|Overall Study||21
9722452|NCT00072384|10821899|FG000|NOT COMPLETED|Overall Study||9
9722453|NCT00072449|10821905|FG000|STARTED|Overall Study||12
9722454|NCT00072449|10821905|FG000|COMPLETED|Overall Study||12
9722455|NCT00072449|10821905|FG000|NOT COMPLETED|Overall Study||0
9722456|NCT00072475|10821909|FG000|STARTED|Overall Study||142
9722457|NCT00072475|10821909|FG000|COMPLETED|Overall Study||45
9722458|NCT00072475|10821909|FG000|NOT COMPLETED|Overall Study||97
9722459|NCT00072514|10821913|FG000|STARTED|Overall Study||55
9722460|NCT00072514|10821913|FG000|COMPLETED|Overall Study||51
9722461|NCT00072514|10821913|FG000|NOT COMPLETED|Overall Study||4
9722462|NCT00072566|10821917|FG000|STARTED|Overall Study||70
9722463|NCT00072566|10821917|FG000|COMPLETED|Overall Study||70
9722464|NCT00072566|10821917|FG000|NOT COMPLETED|Overall Study||0
9722465|NCT00072761|10821923|FG000|STARTED|Overall Study||99
9722466|NCT00072761|10821924|FG001|STARTED|Overall Study||97
9722467|NCT00072761|10821923|FG000|COMPLETED|Overall Study||90
9722468|NCT00072761|10821924|FG001|COMPLETED|Overall Study||95
9722469|NCT00072761|10821923|FG000|NOT COMPLETED|Overall Study||9
9722470|NCT00072761|10821924|FG001|NOT COMPLETED|Overall Study||2
9722471|NCT00073008|10821932|FG000|STARTED|Overall Study||65
9722472|NCT00073008|10821933|FG001|STARTED|Overall Study||66
9722473|NCT00073008|10821932|FG000|COMPLETED|Overall Study||3
9722474|NCT00073008|10821933|FG001|COMPLETED|Overall Study||3
9722475|NCT00073008|10821932|FG000|NOT COMPLETED|Overall Study||62
9722476|NCT00073008|10821933|FG001|NOT COMPLETED|Overall Study||63
9722477|NCT00073021|10821941|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
9722478|NCT00073021|10821942|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
9722479|NCT00073021|10821941|FG000|COMPLETED|Overall Study||113
9722480|NCT00073021|10821942|FG001|COMPLETED|Overall Study||113
10022108|NCT01847885|11145549|FG001|Per Protocol Set|Randomization||27
10022109|NCT01847885|11145550|FG002|Per Protocol Set|Randomization||13
10022110|NCT01847885|11145548|FG000|COMPLETED|Randomization||0
10022111|NCT01847885|11145549|FG001|COMPLETED|Randomization||27
9840427|NCT00814879|10951891|FG001|COMPLETED|By Week 24||29
9840428|NCT00814879|10951890|FG000|NOT COMPLETED|By Week 24||1
9840429|NCT00814879|10951891|FG001|NOT COMPLETED|By Week 24||1
9840430|NCT00814879|10951890|FG000|STARTED|By Week 48||27
10022112|NCT01847885|11145550|FG002|COMPLETED|Randomization||13
10022113|NCT01847885|11145548|FG000|NOT COMPLETED|Randomization||0
10022114|NCT01847885|11145549|FG001|NOT COMPLETED|Randomization||4
10022115|NCT01847885|11145550|FG002|NOT COMPLETED|Randomization||2
10022116|NCT01848041|11145565|FG000|STARTED|Overall Study||15
10022117|NCT01848041|11145566|FG001|STARTED|Overall Study||16
10022118|NCT01848041|11145567|FG002|STARTED|Overall Study||15
10022119|NCT01848041|11145565|FG000|COMPLETED|Overall Study||15
10022120|NCT01848041|11145566|FG001|COMPLETED|Overall Study||16
10022121|NCT01848041|11145567|FG002|COMPLETED|Overall Study||15
9840431|NCT00814879|10951891|FG001|STARTED|By Week 48||29
9840432|NCT00814879|10951890|FG000|COMPLETED|By Week 48||25
9840433|NCT00814879|10951891|FG001|COMPLETED|By Week 48||26
9840434|NCT00814879|10951890|FG000|NOT COMPLETED|By Week 48||2
9840435|NCT00814879|10951891|FG001|NOT COMPLETED|By Week 48||3
9840436|NCT00814970|10951898|FG000|STARTED|Overall Study||196
9840437|NCT00814970|10951898|FG000|COMPLETED|Overall Study||146
9840438|NCT00814970|10951898|FG000|NOT COMPLETED|Overall Study||50
9840439|NCT00815035|10951906|FG000|STARTED|Blinded Phase||10
9840440|NCT00815035|10951907|FG001|STARTED|Blinded Phase||6
9840441|NCT00815035|10951908|FG002|STARTED|Blinded Phase||0
9840442|NCT00815035|10951906|FG000|COMPLETED|Blinded Phase||9
9840443|NCT00815035|10951907|FG001|COMPLETED|Blinded Phase||6
9840444|NCT00815035|10951908|FG002|COMPLETED|Blinded Phase||0
9840445|NCT00815035|10951906|FG000|NOT COMPLETED|Blinded Phase||1
9840446|NCT00815035|10951907|FG001|NOT COMPLETED|Blinded Phase||0
9840447|NCT00815035|10951908|FG002|NOT COMPLETED|Blinded Phase||0
9840448|NCT00815035|10951906|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
10022122|NCT01848041|11145565|FG000|NOT COMPLETED|Overall Study||0
10022123|NCT01848041|11145566|FG001|NOT COMPLETED|Overall Study||0
9722481|NCT00073021|10821941|FG000|NOT COMPLETED|Overall Study||26
9722482|NCT00073021|10821942|FG001|NOT COMPLETED|Overall Study||16
9722483|NCT00073073|10821948|FG000|STARTED|Overall Study||46
9722484|NCT00073073|10821948|FG000|COMPLETED|Overall Study||42
9722485|NCT00073073|10821948|FG000|NOT COMPLETED|Overall Study||4
9722486|NCT00073307|10821954|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451
9722487|NCT00073307|10821955|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452
9722488|NCT00073307|10821956|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0
9722489|NCT00073307|10821954|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
9722490|NCT00073307|10821955|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
9722491|NCT00073307|10821956|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
9722492|NCT00073307|10821954|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
9722493|NCT00073307|10821955|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
9722494|NCT00073307|10821956|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
9840449|NCT00815035|10951907|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
9840450|NCT00815035|10951908|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
9840451|NCT00815035|10951906|FG000|COMPLETED|Open Label Extension Phase||0
9840452|NCT00815035|10951907|FG001|COMPLETED|Open Label Extension Phase||0
9840453|NCT00815035|10951908|FG002|COMPLETED|Open Label Extension Phase||9
9840454|NCT00815035|10951906|FG000|NOT COMPLETED|Open Label Extension Phase||0
9840455|NCT00815035|10951907|FG001|NOT COMPLETED|Open Label Extension Phase||0
9840456|NCT00815035|10951908|FG002|NOT COMPLETED|Open Label Extension Phase||6
9840457|NCT00815087|10951919|FG000|STARTED|Overall Study||10
9840458|NCT00815087|10951920|FG001|STARTED|Overall Study||10
9840459|NCT00815087|10951919|FG000|COMPLETED|Overall Study||10
9840460|NCT00815087|10951920|FG001|COMPLETED|Overall Study||10
9840461|NCT00815087|10951919|FG000|NOT COMPLETED|Overall Study||0
9840462|NCT00815087|10951920|FG001|NOT COMPLETED|Overall Study||0
9840463|NCT00815191|10951928|FG000|STARTED|Overall Study||38
9840464|NCT00815191|10951929|FG001|STARTED|Overall Study||35
9840465|NCT00815191|10951928|FG000|COMPLETED|Overall Study||37
9840466|NCT00815191|10951929|FG001|COMPLETED|Overall Study||34
9840467|NCT00815191|10951928|FG000|NOT COMPLETED|Overall Study||1
9840468|NCT00815191|10951929|FG001|NOT COMPLETED|Overall Study||1
9840469|NCT00815295|10951938|FG000|STARTED|Overall Study||8
9840470|NCT00815295|10951939|FG001|STARTED|Overall Study||8
9840471|NCT00815295|10951940|FG002|STARTED|Overall Study||12
9840472|NCT00815295|10951938|FG000|COMPLETED|Overall Study||8
9840473|NCT00815295|10951939|FG001|COMPLETED|Overall Study||7
9840474|NCT00815295|10951940|FG002|COMPLETED|Overall Study||9
9840475|NCT00815295|10951938|FG000|NOT COMPLETED|Overall Study||0
9840476|NCT00815295|10951939|FG001|NOT COMPLETED|Overall Study||1
9840477|NCT00815295|10951940|FG002|NOT COMPLETED|Overall Study||3
9840478|NCT00815308|10951948|FG000|STARTED|Overall Study||55
9840479|NCT00815308|10951948|FG000|COMPLETED|Overall Study||45
9840480|NCT00815308|10951948|FG000|NOT COMPLETED|Overall Study||10
9840481|NCT00815347|10951952|FG000|STARTED|Overall Study||11
9840482|NCT00815347|10951952|FG000|COMPLETED|Overall Study||7
9840483|NCT00815347|10951952|FG000|NOT COMPLETED|Overall Study||4
9840484|NCT00815360|10951960|FG000|STARTED|Overall Study||11
9840485|NCT00815360|10951961|FG001|STARTED|Overall Study||11
9840486|NCT00815360|10951960|FG000|COMPLETED|Overall Study||11
9840487|NCT00815360|10951961|FG001|COMPLETED|Overall Study||11
9840488|NCT00815360|10951960|FG000|NOT COMPLETED|Overall Study||0
9840489|NCT00815360|10951961|FG001|NOT COMPLETED|Overall Study||0
9840490|NCT00815490|10951969|FG000|STARTED|Overall Study||9
9840491|NCT00815490|10951970|FG001|STARTED|Overall Study||9
9840492|NCT00815490|10951969|FG000|COMPLETED|Overall Study||9
9840493|NCT00815490|10951970|FG001|COMPLETED|Overall Study||9
10022124|NCT01848041|11145567|FG002|NOT COMPLETED|Overall Study||0
10022125|NCT01848054|11145580|FG000|STARTED|Induction Phase||155
9840494|NCT00815490|10951969|FG000|NOT COMPLETED|Overall Study||0
9840495|NCT00815490|10951970|FG001|NOT COMPLETED|Overall Study||0
9840496|NCT00815516|10951978|FG000|STARTED|Overall Study||20
9840497|NCT00815516|10951979|FG001|STARTED|Overall Study||10
9840498|NCT00815516|10951978|FG000|COMPLETED|Overall Study||16
9840499|NCT00815516|10951979|FG001|COMPLETED|Overall Study||9
9840500|NCT00815516|10951978|FG000|NOT COMPLETED|Overall Study||4
9840501|NCT00815516|10951979|FG001|NOT COMPLETED|Overall Study||1
9840502|NCT00815659|10951985|FG000|STARTED|Overall Study||97
9840503|NCT00815659|10951985|FG000|COMPLETED|Overall Study||74
9840504|NCT00815659|10951985|FG000|NOT COMPLETED|Overall Study||23
9840505|NCT00815685|10951989|FG000|STARTED|Overall Study||36
9840506|NCT00815685|10951989|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
9840507|NCT00815685|10951989|FG000|NOT COMPLETED|Overall Study||22
9840508|NCT00815698|10951995|FG000|STARTED|Overall Study||163
9840509|NCT00815698|10951996|FG001|STARTED|Overall Study||171
9840510|NCT00815698|10951995|FG000|COMPLETED|Overall Study||163
9840511|NCT00815698|10951996|FG001|COMPLETED|Overall Study||171
9840512|NCT00815698|10951995|FG000|NOT COMPLETED|Overall Study||0
9840513|NCT00815698|10951996|FG001|NOT COMPLETED|Overall Study||0
9840514|NCT00815776|10952005|FG000|STARTED|Overall Study||60
9840515|NCT00815776|10952006|FG001|STARTED|Overall Study||64
9840516|NCT00815776|10952007|FG002|STARTED|Overall Study||28
9840517|NCT00815776|10952005|FG000|COMPLETED|Overall Study||52
9840518|NCT00815776|10952006|FG001|COMPLETED|Overall Study||56
9840519|NCT00815776|10952007|FG002|COMPLETED|Overall Study||22
9840520|NCT00815776|10952005|FG000|NOT COMPLETED|Overall Study||8
9840521|NCT00815776|10952006|FG001|NOT COMPLETED|Overall Study||8
9840522|NCT00815776|10952007|FG002|NOT COMPLETED|Overall Study||6
9840523|NCT00815919|10952018|FG000|STARTED|Overall Study||22
9840524|NCT00815919|10952018|FG000|COMPLETED|Overall Study||18
9840525|NCT00815919|10952018|FG000|NOT COMPLETED|Overall Study||4
9840526|NCT00815997|10952024|FG000|STARTED|Overall Study||80
9840527|NCT00815997|10952025|FG001|STARTED|Overall Study||80
9840528|NCT00815997|10952024|FG000|COMPLETED|Overall Study||80
9840529|NCT00815997|10952025|FG001|COMPLETED|Overall Study||80
9840530|NCT00815997|10952024|FG000|NOT COMPLETED|Overall Study||0
9840531|NCT00815997|10952025|FG001|NOT COMPLETED|Overall Study||0
9840532|NCT00816023|10952037|FG000|STARTED|Overall Study||71
9840533|NCT00816023|10952038|FG001|STARTED|Overall Study||62
9840534|NCT00816023|10952039|FG002|STARTED|Overall Study||69
9840535|NCT00816023|10952040|FG003|STARTED|Overall Study||74
9840536|NCT00816023|10952037|FG000|Completed Therapy|Overall Study||65
9840537|NCT00816023|10952038|FG001|Completed Therapy|Overall Study||59
9840538|NCT00816023|10952039|FG002|Completed Therapy|Overall Study||61
9840539|NCT00816023|10952040|FG003|Completed Therapy|Overall Study||63
9840540|NCT00816023|10952037|FG000|COMPLETED|Overall Study||62
9840541|NCT00816023|10952038|FG001|COMPLETED|Overall Study||56
9840542|NCT00816023|10952039|FG002|COMPLETED|Overall Study||60
9840543|NCT00816023|10952040|FG003|COMPLETED|Overall Study||62
9840544|NCT00816023|10952037|FG000|NOT COMPLETED|Overall Study||9
9840545|NCT00816023|10952038|FG001|NOT COMPLETED|Overall Study||6
9840546|NCT00816023|10952039|FG002|NOT COMPLETED|Overall Study||9
9840547|NCT00816023|10952040|FG003|NOT COMPLETED|Overall Study||12
10022126|NCT01848054|11145581|FG001|STARTED|Induction Phase||155
10022127|NCT01848054|11145580|FG000|COMPLETED|Induction Phase||132
10022128|NCT01848054|11145581|FG001|COMPLETED|Induction Phase||147
10022129|NCT01848054|11145580|FG000|NOT COMPLETED|Induction Phase||23
10022130|NCT01848054|11145581|FG001|NOT COMPLETED|Induction Phase||8
9840548|NCT00816036|10952052|FG000|STARTED|Overall Study||503
9840549|NCT00816036|10952053|FG001|STARTED|Overall Study||395
9840550|NCT00816036|10952052|FG000|COMPLETED|Overall Study||327
9840551|NCT00816036|10952053|FG001|COMPLETED|Overall Study||287
9840552|NCT00816036|10952052|FG000|NOT COMPLETED|Overall Study||176
9840553|NCT00816036|10952053|FG001|NOT COMPLETED|Overall Study||108
9840554|NCT00816062|10952059|FG000|STARTED|Overall Study||260
9840555|NCT00816062|10952059|FG000|COMPLETED|Overall Study||133
9840556|NCT00816062|10952059|FG000|NOT COMPLETED|Overall Study||127
9840557|NCT00816101|10952067|FG000|STARTED|Overall Study||13
9840558|NCT00816101|10952068|FG001|STARTED|Overall Study||8
9840559|NCT00816101|10952069|FG002|STARTED|Overall Study||5
9840560|NCT00816101|10952067|FG000|COMPLETED|Overall Study||13
9840561|NCT00816101|10952068|FG001|COMPLETED|Overall Study||8
9840562|NCT00816101|10952069|FG002|COMPLETED|Overall Study||5
9840563|NCT00816101|10952067|FG000|NOT COMPLETED|Overall Study||0
9840564|NCT00816101|10952068|FG001|NOT COMPLETED|Overall Study||0
9959526|NCT01463098|11079042|FG006|COMPLETED|Part A (11 Days)||6
9959527|NCT01463098|11079043|FG007|COMPLETED|Part A (11 Days)||6
9959528|NCT01463098|11079044|FG008|COMPLETED|Part A (11 Days)||5
9959529|NCT01463098|11079045|FG009|COMPLETED|Part A (11 Days)||0
9959530|NCT01463098|11079046|FG010|COMPLETED|Part A (11 Days)||0
9959531|NCT01463098|11079047|FG011|COMPLETED|Part A (11 Days)||0
9959532|NCT01463098|11079048|FG012|COMPLETED|Part A (11 Days)||0
9959533|NCT01463098|11079049|FG013|COMPLETED|Part A (11 Days)||0
9959534|NCT01463098|11079036|FG000|NOT COMPLETED|Part A (11 Days)||2
9959535|NCT01463098|11079037|FG001|NOT COMPLETED|Part A (11 Days)||0
9959536|NCT01463098|11079038|FG002|NOT COMPLETED|Part A (11 Days)||0
9959537|NCT01463098|11079039|FG003|NOT COMPLETED|Part A (11 Days)||0
9959538|NCT01463098|11079040|FG004|NOT COMPLETED|Part A (11 Days)||1
9959539|NCT01463098|11079041|FG005|NOT COMPLETED|Part A (11 Days)||0
9959540|NCT01463098|11079042|FG006|NOT COMPLETED|Part A (11 Days)||0
9959541|NCT01463098|11079043|FG007|NOT COMPLETED|Part A (11 Days)||0
9959542|NCT01463098|11079044|FG008|NOT COMPLETED|Part A (11 Days)||1
9959543|NCT01463098|11079045|FG009|NOT COMPLETED|Part A (11 Days)||0
9959544|NCT01463098|11079046|FG010|NOT COMPLETED|Part A (11 Days)||0
9959545|NCT01463098|11079047|FG011|NOT COMPLETED|Part A (11 Days)||0
9959546|NCT01463098|11079048|FG012|NOT COMPLETED|Part A (11 Days)||0
9959547|NCT01463098|11079049|FG013|NOT COMPLETED|Part A (11 Days)||0
9959548|NCT01463098|11079036|FG000|STARTED|Part B (11 Days)||0
9959549|NCT01463098|11079037|FG001|STARTED|Part B (11 Days)||0
9959550|NCT01463098|11079038|FG002|STARTED|Part B (11 Days)||0
9959551|NCT01463098|11079039|FG003|STARTED|Part B (11 Days)||0
9959552|NCT01463098|11079040|FG004|STARTED|Part B (11 Days)||0
9959553|NCT01463098|11079041|FG005|STARTED|Part B (11 Days)||0
9959554|NCT01463098|11079042|FG006|STARTED|Part B (11 Days)||0
9959555|NCT01463098|11079043|FG007|STARTED|Part B (11 Days)||0
9959556|NCT01463098|11079044|FG008|STARTED|Part B (11 Days)||0
9959557|NCT01463098|11079045|FG009|STARTED|Part B (11 Days)||12
9840565|NCT00816101|10952069|FG002|NOT COMPLETED|Overall Study||0
9959558|NCT01463098|11079046|FG010|STARTED|Part B (11 Days)||11
10022131|NCT01848054|11145580|FG000|STARTED|Stabilization/Maintenance||132
10022132|NCT01848054|11145581|FG001|STARTED|Stabilization/Maintenance||147
10022133|NCT01848054|11145580|FG000|COMPLETED|Stabilization/Maintenance||92
9959559|NCT01463098|11079047|FG011|STARTED|Part B (11 Days)||13
9959560|NCT01463098|11079048|FG012|STARTED|Part B (11 Days)||10
9959561|NCT01463098|11079049|FG013|STARTED|Part B (11 Days)||12
9959562|NCT01463098|11079036|FG000|COMPLETED|Part B (11 Days)||0
9840566|NCT00816166|10952079|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
9840567|NCT00816166|10952080|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
9840568|NCT00816166|10952079|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
9840569|NCT00816166|10952080|FG001|ITT Population (Met Eligibility)|Overall Study||53
9840570|NCT00816166|10952079|FG000|COMPLETED|Overall Study||49
9840571|NCT00816166|10952080|FG001|COMPLETED|Overall Study||41
9840572|NCT00816166|10952079|FG000|NOT COMPLETED|Overall Study||10
9840573|NCT00816166|10952080|FG001|NOT COMPLETED|Overall Study||12
9840574|NCT00816348|10952086|FG000|STARTED|Overall Study||15
9840575|NCT00816348|10952086|FG000|COMPLETED|Overall Study||15
9840576|NCT00816348|10952086|FG000|NOT COMPLETED|Overall Study||0
9840577|NCT00816361|10952097|FG000|STARTED|Overall Study||4
9840578|NCT00816361|10952098|FG001|STARTED|Overall Study||3
9840579|NCT00816361|10952099|FG002|STARTED|Overall Study||4
9840580|NCT00816361|10952100|FG003|STARTED|Overall Study||3
9840581|NCT00816361|10952101|FG004|STARTED|Overall Study||3
9840582|NCT00816361|10952102|FG005|STARTED|Overall Study||3
9840583|NCT00816361|10952103|FG006|STARTED|Overall Study||3
9840584|NCT00816361|10952104|FG007|STARTED|Overall Study||10
9840585|NCT00816361|10952105|FG008|STARTED|Overall Study||10
9840586|NCT00816361|10952097|FG000|COMPLETED|Overall Study||0
9840587|NCT00816361|10952098|FG001|COMPLETED|Overall Study||0
9840588|NCT00816361|10952099|FG002|COMPLETED|Overall Study||1
9840589|NCT00816361|10952100|FG003|COMPLETED|Overall Study||0
9840590|NCT00816361|10952101|FG004|COMPLETED|Overall Study||1
9840591|NCT00816361|10952102|FG005|COMPLETED|Overall Study||0
9840592|NCT00816361|10952103|FG006|COMPLETED|Overall Study||0
9840593|NCT00816361|10952104|FG007|COMPLETED|Overall Study||1
9840594|NCT00816361|10952105|FG008|COMPLETED|Overall Study||0
9840595|NCT00816361|10952097|FG000|NOT COMPLETED|Overall Study||4
9840596|NCT00816361|10952098|FG001|NOT COMPLETED|Overall Study||3
9840597|NCT00816361|10952099|FG002|NOT COMPLETED|Overall Study||3
9840598|NCT00816361|10952100|FG003|NOT COMPLETED|Overall Study||3
9840599|NCT00816361|10952101|FG004|NOT COMPLETED|Overall Study||2
9840600|NCT00816361|10952102|FG005|NOT COMPLETED|Overall Study||3
9840601|NCT00816361|10952103|FG006|NOT COMPLETED|Overall Study||3
9840602|NCT00816361|10952104|FG007|NOT COMPLETED|Overall Study||9
9840603|NCT00816361|10952105|FG008|NOT COMPLETED|Overall Study||10
9840604|NCT00816400|10952135|FG000|STARTED|Overall Study||3
9840605|NCT00816400|10952136|FG001|STARTED|Overall Study||3
9840606|NCT00816400|10952137|FG002|STARTED|Overall Study||5
10022134|NCT01848054|11145581|FG001|COMPLETED|Stabilization/Maintenance||107
9840607|NCT00816400|10952138|FG003|STARTED|Overall Study||3
9840608|NCT00816400|10952139|FG004|STARTED|Overall Study||3
9840609|NCT00816400|10952140|FG005|STARTED|Overall Study||3
9840610|NCT00816400|10952141|FG006|STARTED|Overall Study||3
9840611|NCT00816400|10952142|FG007|STARTED|Overall Study||6
9840612|NCT00816400|10952143|FG008|STARTED|Overall Study||6
9840613|NCT00816400|10952135|FG000|COMPLETED|Overall Study||1
9840614|NCT00816400|10952136|FG001|COMPLETED|Overall Study||0
9840615|NCT00816400|10952137|FG002|COMPLETED|Overall Study||0
9840616|NCT00816400|10952138|FG003|COMPLETED|Overall Study||0
9840617|NCT00816400|10952139|FG004|COMPLETED|Overall Study||1
9840618|NCT00816400|10952140|FG005|COMPLETED|Overall Study||0
9840619|NCT00816400|10952141|FG006|COMPLETED|Overall Study||1
9840620|NCT00816400|10952142|FG007|COMPLETED|Overall Study||1
9840621|NCT00816400|10952143|FG008|COMPLETED|Overall Study||0
9840622|NCT00816400|10952135|FG000|NOT COMPLETED|Overall Study||2
9840623|NCT00816400|10952136|FG001|NOT COMPLETED|Overall Study||3
9840624|NCT00816400|10952137|FG002|NOT COMPLETED|Overall Study||5
9840625|NCT00816400|10952138|FG003|NOT COMPLETED|Overall Study||3
9840626|NCT00816400|10952139|FG004|NOT COMPLETED|Overall Study||2
9840627|NCT00816400|10952140|FG005|NOT COMPLETED|Overall Study||3
9840628|NCT00816400|10952141|FG006|NOT COMPLETED|Overall Study||2
9840629|NCT00816400|10952142|FG007|NOT COMPLETED|Overall Study||5
9840630|NCT00816400|10952143|FG008|NOT COMPLETED|Overall Study||6
9840631|NCT00816556|10952167|FG000|STARTED|Overall Study||20
9840632|NCT00816556|10952168|FG001|STARTED|Overall Study||21
9840633|NCT00816556|10952169|FG002|STARTED|Overall Study||22
9840634|NCT00816556|10952167|FG000|COMPLETED|Overall Study||18
9840635|NCT00816556|10952168|FG001|COMPLETED|Overall Study||19
9840636|NCT00816556|10952169|FG002|COMPLETED|Overall Study||19
9840637|NCT00816556|10952167|FG000|NOT COMPLETED|Overall Study||2
9840638|NCT00816556|10952168|FG001|NOT COMPLETED|Overall Study||2
9840639|NCT00816556|10952169|FG002|NOT COMPLETED|Overall Study||3
9840640|NCT00816595|10952179|FG000|STARTED|Overall Study||35
9840641|NCT00816595|10952180|FG001|STARTED|Overall Study||33
9840642|NCT00816595|10952179|FG000|COMPLETED|Overall Study||33
10022135|NCT01848054|11145580|FG000|NOT COMPLETED|Stabilization/Maintenance||40
10022136|NCT01848054|11145581|FG001|NOT COMPLETED|Stabilization/Maintenance||40
9840643|NCT00816595|10952180|FG001|COMPLETED|Overall Study||33
9840644|NCT00816595|10952179|FG000|NOT COMPLETED|Overall Study||2
9840645|NCT00816595|10952180|FG001|NOT COMPLETED|Overall Study||0
9840646|NCT00816751|10952190|FG000|STARTED|Overall Study||45
9840647|NCT00816751|10952191|FG001|STARTED|Overall Study||44
9840648|NCT00816751|10952190|FG000|COMPLETED|Overall Study||45
9959563|NCT01463098|11079037|FG001|COMPLETED|Part B (11 Days)||0
9959564|NCT01463098|11079038|FG002|COMPLETED|Part B (11 Days)||0
9959565|NCT01463098|11079039|FG003|COMPLETED|Part B (11 Days)||0
9959566|NCT01463098|11079040|FG004|COMPLETED|Part B (11 Days)||0
9959567|NCT01463098|11079041|FG005|COMPLETED|Part B (11 Days)||0
9959568|NCT01463098|11079042|FG006|COMPLETED|Part B (11 Days)||0
9959569|NCT01463098|11079043|FG007|COMPLETED|Part B (11 Days)||0
9959570|NCT01463098|11079044|FG008|COMPLETED|Part B (11 Days)||0
9959571|NCT01463098|11079045|FG009|COMPLETED|Part B (11 Days)||12
9959572|NCT01463098|11079046|FG010|COMPLETED|Part B (11 Days)||11
10022137|NCT01848067|11145591|FG000|STARTED|Overall Study||9
10022138|NCT01848067|11145591|FG000|COMPLETED|Overall Study||9
10022139|NCT01848067|11145591|FG000|NOT COMPLETED|Overall Study||0
9959573|NCT01463098|11079047|FG011|COMPLETED|Part B (11 Days)||12
9959574|NCT01463098|11079048|FG012|COMPLETED|Part B (11 Days)||10
9959575|NCT01463098|11079049|FG013|COMPLETED|Part B (11 Days)||12
9959576|NCT01463098|11079036|FG000|NOT COMPLETED|Part B (11 Days)||0
9959577|NCT01463098|11079037|FG001|NOT COMPLETED|Part B (11 Days)||0
9840649|NCT00816751|10952191|FG001|COMPLETED|Overall Study||44
9840650|NCT00816751|10952190|FG000|NOT COMPLETED|Overall Study||0
9840651|NCT00816751|10952191|FG001|NOT COMPLETED|Overall Study||0
9840652|NCT00816829|10952199|FG000|STARTED|Overall Study||16
9840653|NCT00816829|10952200|FG001|STARTED|Overall Study||18
9840654|NCT00816829|10952199|FG000|COMPLETED|Overall Study||16
9840655|NCT00816829|10952200|FG001|COMPLETED|Overall Study||18
9840656|NCT00816829|10952199|FG000|NOT COMPLETED|Overall Study||0
9840657|NCT00816829|10952200|FG001|NOT COMPLETED|Overall Study||0
9840658|NCT00816907|10952208|FG000|STARTED|Overall Study||71
9840659|NCT00816907|10952209|FG001|STARTED|Overall Study||75
9840660|NCT00816907|10952208|FG000|COMPLETED|Overall Study||58
9840661|NCT00816907|10952209|FG001|COMPLETED|Overall Study||58
9840662|NCT00816907|10952208|FG000|NOT COMPLETED|Overall Study||13
9840663|NCT00816907|10952209|FG001|NOT COMPLETED|Overall Study||17
9840664|NCT00817063|10952219|FG000|STARTED|Overall Study||298
9840665|NCT00817063|10952220|FG001|STARTED|Overall Study||298
9840666|NCT00817063|10952219|FG000|COMPLETED|Overall Study||161
9840667|NCT00817063|10952220|FG001|COMPLETED|Overall Study||128
9840668|NCT00817063|10952219|FG000|NOT COMPLETED|Overall Study||137
9840669|NCT00817063|10952220|FG001|NOT COMPLETED|Overall Study||170
9840670|NCT00817089|10952230|FG000|STARTED|First Alcohol Challenge||6
9840671|NCT00817089|10952231|FG001|STARTED|First Alcohol Challenge||8
9840672|NCT00817089|10952232|FG002|STARTED|First Alcohol Challenge||4
9840673|NCT00817089|10952233|FG003|STARTED|First Alcohol Challenge||6
9840674|NCT00817089|10952230|FG000|COMPLETED|First Alcohol Challenge||6
9840675|NCT00817089|10952231|FG001|COMPLETED|First Alcohol Challenge||8
9840676|NCT00817089|10952232|FG002|COMPLETED|First Alcohol Challenge||4
9840677|NCT00817089|10952233|FG003|COMPLETED|First Alcohol Challenge||5
9840678|NCT00817089|10952230|FG000|NOT COMPLETED|First Alcohol Challenge||0
9840679|NCT00817089|10952231|FG001|NOT COMPLETED|First Alcohol Challenge||0
9840680|NCT00817089|10952232|FG002|NOT COMPLETED|First Alcohol Challenge||0
9840681|NCT00817089|10952233|FG003|NOT COMPLETED|First Alcohol Challenge||1
9840682|NCT00817089|10952230|FG000|STARTED|Second Alcohol Challenge||6
9840683|NCT00817089|10952231|FG001|STARTED|Second Alcohol Challenge||8
9840684|NCT00817089|10952232|FG002|STARTED|Second Alcohol Challenge||4
9840685|NCT00817089|10952233|FG003|STARTED|Second Alcohol Challenge||5
9840686|NCT00817089|10952230|FG000|COMPLETED|Second Alcohol Challenge||6
9840687|NCT00817089|10952231|FG001|COMPLETED|Second Alcohol Challenge||7
9840688|NCT00817089|10952232|FG002|COMPLETED|Second Alcohol Challenge||4
9840689|NCT00817089|10952233|FG003|COMPLETED|Second Alcohol Challenge||5
9840690|NCT00817089|10952230|FG000|NOT COMPLETED|Second Alcohol Challenge||0
9959578|NCT01463098|11079038|FG002|NOT COMPLETED|Part B (11 Days)||0
9840691|NCT00817089|10952231|FG001|NOT COMPLETED|Second Alcohol Challenge||1
9959579|NCT01463098|11079039|FG003|NOT COMPLETED|Part B (11 Days)||0
9959580|NCT01463098|11079040|FG004|NOT COMPLETED|Part B (11 Days)||0
9959581|NCT01463098|11079041|FG005|NOT COMPLETED|Part B (11 Days)||0
9959582|NCT01463098|11079042|FG006|NOT COMPLETED|Part B (11 Days)||0
9959583|NCT01463098|11079043|FG007|NOT COMPLETED|Part B (11 Days)||0
9959584|NCT01463098|11079044|FG008|NOT COMPLETED|Part B (11 Days)||0
9959585|NCT01463098|11079045|FG009|NOT COMPLETED|Part B (11 Days)||0
9959586|NCT01463098|11079046|FG010|NOT COMPLETED|Part B (11 Days)||0
9959587|NCT01463098|11079047|FG011|NOT COMPLETED|Part B (11 Days)||1
9959588|NCT01463098|11079048|FG012|NOT COMPLETED|Part B (11 Days)||0
9959589|NCT01463098|11079049|FG013|NOT COMPLETED|Part B (11 Days)||0
9959590|NCT01463111|11079098|FG000|STARTED|Overall Study||26
9959591|NCT01463111|11079098|FG000|COMPLETED|Overall Study||17
9959592|NCT01463111|11079098|FG000|NOT COMPLETED|Overall Study||9
9722495|NCT00073307|10821954|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
9722496|NCT00073307|10821955|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
9722497|NCT00073307|10821956|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
9722498|NCT00073307|10821954|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
9722499|NCT00073307|10821955|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
9722500|NCT00073307|10821956|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
9722501|NCT00073307|10821954|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
9722502|NCT00073307|10821955|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
9722503|NCT00073307|10821956|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
9722504|NCT00073307|10821954|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
9722505|NCT00073307|10821955|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
9722506|NCT00073307|10821956|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
9722507|NCT00073307|10821954|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
9722508|NCT00073307|10821955|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
9722509|NCT00073307|10821956|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
9722510|NCT00073333|10821968|FG000|STARTED|Overall Study||46
9959593|NCT01463202|11079104|FG000|STARTED|Overall Study||79
9959594|NCT01463202|11079105|FG001|STARTED|Overall Study||78
9959595|NCT01463202|11079104|FG000|COMPLETED|Overall Study||79
10022140|NCT01848145|11145595|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
10081135|NCT02257970|11209576|FG002|COMPLETED|Part 3||16
9959596|NCT01463202|11079105|FG001|COMPLETED|Overall Study||78
10081136|NCT02257970|11209577|FG003|COMPLETED|Part 3||14
9959597|NCT01463202|11079104|FG000|NOT COMPLETED|Overall Study||0
9840692|NCT00817089|10952232|FG002|NOT COMPLETED|Second Alcohol Challenge||0
9840693|NCT00817089|10952233|FG003|NOT COMPLETED|Second Alcohol Challenge||0
9840694|NCT00817206|10952249|FG000|STARTED|Overall Study||163
9840695|NCT00817206|10952250|FG001|STARTED|Overall Study||163
9840696|NCT00817206|10952249|FG000|COMPLETED|Overall Study||142
9840697|NCT00817206|10952250|FG001|COMPLETED|Overall Study||154
9840698|NCT00817206|10952249|FG000|NOT COMPLETED|Overall Study||21
9840699|NCT00817206|10952250|FG001|NOT COMPLETED|Overall Study||9
9959598|NCT01463202|11079105|FG001|NOT COMPLETED|Overall Study||0
9959599|NCT01463267|11079115|FG000|STARTED|Overall Study||15
9959600|NCT01463267|11079116|FG001|STARTED|Overall Study||15
9959601|NCT01463267|11079117|FG002|STARTED|Overall Study||15
9959602|NCT01463267|11079118|FG003|STARTED|Overall Study||15
9959603|NCT01463267|11079115|FG000|COMPLETED|Overall Study||14
9959604|NCT01463267|11079116|FG001|COMPLETED|Overall Study||15
9959605|NCT01463267|11079117|FG002|COMPLETED|Overall Study||13
9959606|NCT01463267|11079118|FG003|COMPLETED|Overall Study||13
9959607|NCT01463267|11079115|FG000|NOT COMPLETED|Overall Study||1
9959608|NCT01463267|11079116|FG001|NOT COMPLETED|Overall Study||0
9959609|NCT01463267|11079117|FG002|NOT COMPLETED|Overall Study||2
9959610|NCT01463267|11079118|FG003|NOT COMPLETED|Overall Study||2
9967709|NCT01515865|11088039|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
9967710|NCT01515865|11088040|FG001|STARTED|Part B (Open-label)||0
9967711|NCT01515865|11088041|FG002|STARTED|Part B (Open-label)||0
9967712|NCT01515865|11088039|FG000|COMPLETED|Part B (Open-label)||69
9967713|NCT01515865|11088040|FG001|COMPLETED|Part B (Open-label)||0
9967714|NCT01515865|11088041|FG002|COMPLETED|Part B (Open-label)||0
9967715|NCT01515865|11088039|FG000|NOT COMPLETED|Part B (Open-label)||2
9967716|NCT01515865|11088040|FG001|NOT COMPLETED|Part B (Open-label)||0
9967717|NCT01515865|11088041|FG002|NOT COMPLETED|Part B (Open-label)||0
9967718|NCT01515865|11088039|FG000|STARTED|Part C (Randomized)||0
9967719|NCT01515865|11088040|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
9967720|NCT01515865|11088041|FG002|STARTED|Part C (Randomized)||34
9967721|NCT01515865|11088039|FG000|COMPLETED|Part C (Randomized)||0
9967722|NCT01515865|11088040|FG001|COMPLETED|Part C (Randomized)||33
9967723|NCT01515865|11088041|FG002|COMPLETED|Part C (Randomized)||34
9967724|NCT01515865|11088039|FG000|NOT COMPLETED|Part C (Randomized)||0
9967725|NCT01515865|11088040|FG001|NOT COMPLETED|Part C (Randomized)||0
9967726|NCT01515865|11088041|FG002|NOT COMPLETED|Part C (Randomized)||0
9967727|NCT01515891|11088049|FG000|STARTED|Overall Study||4
9840700|NCT00817219|10952256|FG000|STARTED|Overall Study||33
9840701|NCT00817219|10952256|FG000|COMPLETED|Overall Study||33
9840702|NCT00817219|10952256|FG000|NOT COMPLETED|Overall Study||0
9840703|NCT00817336|10952262|FG000|STARTED|Overall Study||8
9840704|NCT00817336|10952263|FG001|STARTED|Overall Study||8
9840705|NCT00817336|10952262|FG000|COMPLETED|Overall Study||7
9959611|NCT01463306|11079131|FG000|STARTED|Overall Study||384
9959612|NCT01463306|11079132|FG001|STARTED|Overall Study||210
9959613|NCT01463306|11079133|FG002|STARTED|Overall Study||11
9959614|NCT01463306|11079131|FG000|COMPLETED|Overall Study||298
9959615|NCT01463306|11079132|FG001|COMPLETED|Overall Study||158
9959616|NCT01463306|11079133|FG002|COMPLETED|Overall Study||6
9959617|NCT01463306|11079131|FG000|NOT COMPLETED|Overall Study||86
9959618|NCT01463306|11079132|FG001|NOT COMPLETED|Overall Study||52
9959619|NCT01463306|11079133|FG002|NOT COMPLETED|Overall Study||5
9959620|NCT01463358|11079143|FG000|STARTED|Overall Study||49
9959621|NCT01463358|11079144|FG001|STARTED|Overall Study||52
9959622|NCT01463358|11079143|FG000|COMPLETED|Overall Study||46
9959623|NCT01463358|11079144|FG001|COMPLETED|Overall Study||47
10022141|NCT01848145|11145595|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
10022142|NCT01848145|11145595|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
10022143|NCT01848145|11145595|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
10022144|NCT01848145|11145595|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
10022145|NCT01848145|11145595|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
10022146|NCT01848145|11145595|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
10022147|NCT01848145|11145595|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
10022148|NCT01848145|11145595|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
10022149|NCT01848145|11145595|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
10022150|NCT01848145|11145595|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
10022151|NCT01848145|11145595|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
10022152|NCT01848145|11145595|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30
10022153|NCT01848145|11145595|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20
10022154|NCT01848145|11145595|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
10022155|NCT01848158|11145601|FG000|STARTED|Overall Study||10
10022156|NCT01848158|11145602|FG001|STARTED|Overall Study||7
10022157|NCT01848158|11145601|FG000|COMPLETED|Overall Study||10
10022158|NCT01848158|11145602|FG001|COMPLETED|Overall Study||7
10022159|NCT01848158|11145601|FG000|NOT COMPLETED|Overall Study||0
10022160|NCT01848158|11145602|FG001|NOT COMPLETED|Overall Study||0
10022161|NCT01848184|11145608|FG000|STARTED|Overall Study||126
10022162|NCT01848184|11145608|FG000|COMPLETED|Overall Study||100
10022163|NCT01848184|11145608|FG000|NOT COMPLETED|Overall Study||26
10022164|NCT01848210|11145620|FG000|STARTED|Overall Study||411
10022165|NCT01848210|11145621|FG001|STARTED|Overall Study||418
10022166|NCT01848210|11145620|FG000|Safety Population-Received Study Drug|Overall Study||394
10022167|NCT01848210|11145621|FG001|Safety Population-Received Study Drug|Overall Study||398
10022168|NCT01848210|11145620|FG000|Intent-to-Treat (ITT) Population|Overall Study||383
10022169|NCT01848210|11145621|FG001|Intent-to-Treat (ITT) Population|Overall Study||388
10022170|NCT01848210|11145620|FG000|Per Protocol Population|Overall Study||222
10022171|NCT01848210|11145621|FG001|Per Protocol Population|Overall Study||245
10022172|NCT01848210|11145620|FG000|COMPLETED|Overall Study||323
10022173|NCT01848210|11145621|FG001|COMPLETED|Overall Study||340
10022174|NCT01848210|11145620|FG000|NOT COMPLETED|Overall Study||88
10114160|NCT02514070|11244873|FG001|NOT COMPLETED|Weeks 0 to Week 6||4
10114161|NCT02514070|11244872|FG000|STARTED|Week 6 to Week 14 - Washout Period||17
10114162|NCT02514070|11244873|FG001|STARTED|Week 6 to Week 14 - Washout Period||16
10114163|NCT02514070|11244872|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17
9840706|NCT00817336|10952263|FG001|COMPLETED|Overall Study||7
10022175|NCT01848210|11145621|FG001|NOT COMPLETED|Overall Study||78
10022176|NCT01848288|11145627|FG000|STARTED|Overall Study||100
10022177|NCT01848288|11145627|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
10022178|NCT01848288|11145627|FG000|NOT COMPLETED|Overall Study||3
10022179|NCT01848353|11145636|FG000|STARTED|Phase 1||38
10114164|NCT02514070|11244873|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16
9840707|NCT00817336|10952262|FG000|NOT COMPLETED|Overall Study||1
9840708|NCT00817336|10952263|FG001|NOT COMPLETED|Overall Study||1
9840709|NCT00817414|10952273|FG000|STARTED|Overall Study||12
9840710|NCT00817414|10952274|FG001|STARTED|Overall Study||12
9959624|NCT01463358|11079143|FG000|NOT COMPLETED|Overall Study||3
9959625|NCT01463358|11079144|FG001|NOT COMPLETED|Overall Study||5
9959626|NCT01463384|11079150|FG000|STARTED|Overall Study||13
9959627|NCT01463384|11079150|FG000|COMPLETED|Overall Study||13
9840711|NCT00817414|10952275|FG002|STARTED|Overall Study||13
9959628|NCT01463384|11079150|FG000|NOT COMPLETED|Overall Study||0
9959629|NCT01463527|11079158|FG000|STARTED|Overall Study||83
9722511|NCT00073333|10821969|FG001|STARTED|Overall Study||41
9722512|NCT00073333|10821970|FG002|STARTED|Overall Study||19
9722513|NCT00073333|10821968|FG000|COMPLETED|Overall Study||32
9722514|NCT00073333|10821969|FG001|COMPLETED|Overall Study||27
9722515|NCT00073333|10821970|FG002|COMPLETED|Overall Study||19
9722516|NCT00073333|10821968|FG000|NOT COMPLETED|Overall Study||14
9722517|NCT00073333|10821969|FG001|NOT COMPLETED|Overall Study||14
9722518|NCT00073333|10821970|FG002|NOT COMPLETED|Overall Study||0
9722519|NCT00073528|10821980|FG000|STARTED|Overall Study||644
9722520|NCT00073528|10821981|FG001|STARTED|Overall Study||642
9722521|NCT00073528|10821980|FG000|COMPLETED|Overall Study||14
9722522|NCT00073528|10821981|FG001|COMPLETED|Overall Study||14
9722523|NCT00073528|10821980|FG000|NOT COMPLETED|Overall Study||630
9722524|NCT00073528|10821981|FG001|NOT COMPLETED|Overall Study||628
9722525|NCT00073749|10821994|FG000|STARTED|Overall Study||2
9722526|NCT00073749|10821995|FG001|STARTED|Overall Study||5
9722527|NCT00073749|10821996|FG002|STARTED|Overall Study||11
9722528|NCT00073749|10821997|FG003|STARTED|Overall Study||6
9722529|NCT00073749|10821998|FG004|STARTED|Overall Study||6
9722530|NCT00073749|10821999|FG005|STARTED|Overall Study||6
9722531|NCT00073749|10822000|FG006|STARTED|Overall Study||43
9722532|NCT00073749|10821994|FG000|COMPLETED|Overall Study||0
9722533|NCT00073749|10821995|FG001|COMPLETED|Overall Study||0
9722534|NCT00073749|10821996|FG002|COMPLETED|Overall Study||0
9722535|NCT00073749|10821997|FG003|COMPLETED|Overall Study||0
9722536|NCT00073749|10821998|FG004|COMPLETED|Overall Study||0
9722537|NCT00073749|10821999|FG005|COMPLETED|Overall Study||0
9722538|NCT00073749|10822000|FG006|COMPLETED|Overall Study||3
9722539|NCT00073749|10821994|FG000|NOT COMPLETED|Overall Study||2
9722540|NCT00073749|10821995|FG001|NOT COMPLETED|Overall Study||5
10022180|NCT01848353|11145637|FG001|STARTED|Phase 1||43
9722541|NCT00073749|10821996|FG002|NOT COMPLETED|Overall Study||11
9722542|NCT00073749|10821997|FG003|NOT COMPLETED|Overall Study||6
9722543|NCT00073749|10821998|FG004|NOT COMPLETED|Overall Study||6
9722544|NCT00073749|10821999|FG005|NOT COMPLETED|Overall Study||6
9722545|NCT00073749|10822000|FG006|NOT COMPLETED|Overall Study||40
9722546|NCT00073918|10822019|FG000|STARTED|Overall Study||111
9722547|NCT00073918|10822019|FG000|COMPLETED|Overall Study||107
9722548|NCT00073918|10822019|FG000|NOT COMPLETED|Overall Study||4
9722549|NCT00073957|10822023|FG000|STARTED|Overall Study||25
9722550|NCT00073957|10822023|FG000|COMPLETED|Overall Study||25
10022181|NCT01848353|11145638|FG002|STARTED|Phase 1||20
10022182|NCT01848353|11145639|FG003|STARTED|Phase 1||19
10022183|NCT01848353|11145636|FG000|COMPLETED|Phase 1||35
10022184|NCT01848353|11145637|FG001|COMPLETED|Phase 1||42
10022185|NCT01848353|11145638|FG002|COMPLETED|Phase 1||20
10022186|NCT01848353|11145639|FG003|COMPLETED|Phase 1||19
9722551|NCT00073957|10822023|FG000|NOT COMPLETED|Overall Study||0
9722552|NCT00073983|10822029|FG000|STARTED|Overall Study||54
9722553|NCT00073983|10822029|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
9722554|NCT00073983|10822029|FG000|NOT COMPLETED|Overall Study||1
9722555|NCT00074035|10822035|FG000|STARTED|Overall Study||38
9722556|NCT00074035|10822035|FG000|COMPLETED|Overall Study||38
9722557|NCT00074035|10822035|FG000|NOT COMPLETED|Overall Study||0
9722558|NCT00074152|10822041|FG000|STARTED|Overall Study||77
9722559|NCT00074152|10822042|FG001|STARTED|Overall Study||85
9722560|NCT00074152|10822041|FG000|COMPLETED|Overall Study||22
9722561|NCT00074152|10822042|FG001|COMPLETED|Overall Study||52
9722562|NCT00074152|10822041|FG000|NOT COMPLETED|Overall Study||55
9722563|NCT00074152|10822042|FG001|NOT COMPLETED|Overall Study||33
9722564|NCT00074165|10822049|FG000|STARTED|Overall Study||17
9722565|NCT00074165|10822049|FG000|COMPLETED|Overall Study||17
9722566|NCT00074165|10822049|FG000|NOT COMPLETED|Overall Study||0
9722567|NCT00074269|10822053|FG000|STARTED|Overall Study||5
9722568|NCT00074269|10822053|FG000|COMPLETED|Overall Study||5
9840712|NCT00817414|10952276|FG003|STARTED|Overall Study||13
9840713|NCT00817414|10952277|FG004|STARTED|Overall Study||13
9840714|NCT00817414|10952273|FG000|COMPLETED|Overall Study||10
9840715|NCT00817414|10952274|FG001|COMPLETED|Overall Study||9
9840716|NCT00817414|10952275|FG002|COMPLETED|Overall Study||9
9840717|NCT00817414|10952276|FG003|COMPLETED|Overall Study||1
9840718|NCT00817414|10952277|FG004|COMPLETED|Overall Study||11
9840719|NCT00817414|10952273|FG000|NOT COMPLETED|Overall Study||2
9840720|NCT00817414|10952274|FG001|NOT COMPLETED|Overall Study||3
9840721|NCT00817414|10952275|FG002|NOT COMPLETED|Overall Study||4
9840722|NCT00817414|10952276|FG003|NOT COMPLETED|Overall Study||12
9959630|NCT01463527|11079159|FG001|STARTED|Overall Study||84
10114165|NCT02514070|11244872|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
10114166|NCT02514070|11244873|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
9840723|NCT00817414|10952277|FG004|NOT COMPLETED|Overall Study||2
9840724|NCT00817479|10952296|FG000|STARTED|Overall Study||6
9840725|NCT00817479|10952297|FG001|STARTED|Overall Study||14
9722569|NCT00074269|10822053|FG000|NOT COMPLETED|Overall Study||0
9840726|NCT00817479|10952296|FG000|COMPLETED|Overall Study||5
9840727|NCT00817479|10952297|FG001|COMPLETED|Overall Study||13
9959631|NCT01463527|11079158|FG000|COMPLETED|Overall Study||77
9722570|NCT00074282|10822061|FG000|STARTED|Step 1||102
9722571|NCT00074282|10822062|FG001|STARTED|Step 1||0
9722572|NCT00074282|10822063|FG002|STARTED|Step 1||0
9722573|NCT00074282|10822061|FG000|Eligible|Step 1||98
9722574|NCT00074282|10822062|FG001|Eligible|Step 1||0
9722575|NCT00074282|10822063|FG002|Eligible|Step 1||0
10022187|NCT01848353|11145636|FG000|NOT COMPLETED|Phase 1||3
10022188|NCT01848353|11145637|FG001|NOT COMPLETED|Phase 1||1
10022189|NCT01848353|11145638|FG002|NOT COMPLETED|Phase 1||0
10022190|NCT01848353|11145639|FG003|NOT COMPLETED|Phase 1||0
10022191|NCT01848353|11145636|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
10022192|NCT01848353|11145637|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
10022193|NCT01848353|11145638|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
10081137|NCT02257970|11209574|FG000|NOT COMPLETED|Part 3||0
9722576|NCT00074282|10822061|FG000|Started Treatment|Step 1||96
9722577|NCT00074282|10822062|FG001|Started Treatment|Step 1||0
9722578|NCT00074282|10822063|FG002|Started Treatment|Step 1||0
9722579|NCT00074282|10822061|FG000|COMPLETED|Step 1||44
9722580|NCT00074282|10822062|FG001|COMPLETED|Step 1||0
9722581|NCT00074282|10822063|FG002|COMPLETED|Step 1||0
9722582|NCT00074282|10822061|FG000|NOT COMPLETED|Step 1||58
9722583|NCT00074282|10822062|FG001|NOT COMPLETED|Step 1||0
9722584|NCT00074282|10822063|FG002|NOT COMPLETED|Step 1||0
9722585|NCT00074282|10822061|FG000|STARTED|Step 2||0
9722586|NCT00074282|10822062|FG001|STARTED|Step 2||9
9722587|NCT00074282|10822063|FG002|STARTED|Step 2||31
9722588|NCT00074282|10822061|FG000|COMPLETED|Step 2||0
9722589|NCT00074282|10822062|FG001|COMPLETED|Step 2||7
9722590|NCT00074282|10822063|FG002|COMPLETED|Step 2||7
9722591|NCT00074282|10822061|FG000|NOT COMPLETED|Step 2||0
9722592|NCT00074282|10822062|FG001|NOT COMPLETED|Step 2||2
9722593|NCT00074282|10822063|FG002|NOT COMPLETED|Step 2||24
9722594|NCT00074308|10822073|FG000|STARTED|Overall Study||3
9722595|NCT00074308|10822074|FG001|STARTED|Overall Study||3
9722596|NCT00074308|10822075|FG002|STARTED|Overall Study||3
9722597|NCT00074308|10822076|FG003|STARTED|Overall Study||8
9722598|NCT00074308|10822077|FG004|STARTED|Overall Study||23
9722599|NCT00074308|10822073|FG000|COMPLETED|Overall Study||3
9722600|NCT00074308|10822074|FG001|COMPLETED|Overall Study||3
9722601|NCT00074308|10822075|FG002|COMPLETED|Overall Study||3
9722602|NCT00074308|10822076|FG003|COMPLETED|Overall Study||8
9722603|NCT00074308|10822077|FG004|COMPLETED|Overall Study||23
9722604|NCT00074308|10822073|FG000|NOT COMPLETED|Overall Study||0
9722605|NCT00074308|10822074|FG001|NOT COMPLETED|Overall Study||0
9722606|NCT00074308|10822075|FG002|NOT COMPLETED|Overall Study||0
9722607|NCT00074308|10822076|FG003|NOT COMPLETED|Overall Study||0
9722608|NCT00074308|10822077|FG004|NOT COMPLETED|Overall Study||0
9722609|NCT00074412|10822089|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
9722610|NCT00074412|10822090|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
9722611|NCT00074412|10822089|FG000|Week 8 Visit|Overall Study||759
9722612|NCT00074412|10822090|FG001|Week 8 Visit|Overall Study||759
9722613|NCT00074412|10822089|FG000|Month 3 Visit|Overall Study||759
9722614|NCT00074412|10822090|FG001|Month 3 Visit|Overall Study||755
9722615|NCT00074412|10822089|FG000|Month 4 Visit|Overall Study||758
9722616|NCT00074412|10822090|FG001|Month 4 Visit|Overall Study||752
9722617|NCT00074412|10822089|FG000|Month 5 Visit|Overall Study||756
9722618|NCT00074412|10822090|FG001|Month 5 Visit|Overall Study||750
9722619|NCT00074412|10822089|FG000|Month 6 Visit|Overall Study||748
9722620|NCT00074412|10822090|FG001|Month 6 Visit|Overall Study||748
9722621|NCT00074412|10822089|FG000|Month 9 Visit|Overall Study||741
9722622|NCT00074412|10822090|FG001|Month 9 Visit|Overall Study||741
9722623|NCT00074412|10822089|FG000|Month 12 Visit|Overall Study||733
9722624|NCT00074412|10822090|FG001|Month 12 Visit|Overall Study||735
9722625|NCT00074412|10822089|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
9722626|NCT00074412|10822090|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
9722627|NCT00074412|10822089|FG000|NOT COMPLETED|Overall Study||82
9722628|NCT00074412|10822090|FG001|NOT COMPLETED|Overall Study||84
9722629|NCT00074490|10822102|FG000|STARTED|Overall Study||1
9722630|NCT00074490|10822103|FG001|STARTED|Overall Study||34
9722631|NCT00074490|10822104|FG002|STARTED|Overall Study||40
9722632|NCT00074490|10822105|FG003|STARTED|Overall Study||44
9722633|NCT00074490|10822106|FG004|STARTED|Overall Study||45
9722634|NCT00074490|10822107|FG005|STARTED|Overall Study||221
9722635|NCT00074490|10822102|FG000|COMPLETED|Overall Study||1
9722636|NCT00074490|10822103|FG001|COMPLETED|Overall Study||27
9722637|NCT00074490|10822104|FG002|COMPLETED|Overall Study||40
9722638|NCT00074490|10822105|FG003|COMPLETED|Overall Study||44
9722639|NCT00074490|10822106|FG004|COMPLETED|Overall Study||42
9722640|NCT00074490|10822107|FG005|COMPLETED|Overall Study||221
9722641|NCT00074490|10822102|FG000|NOT COMPLETED|Overall Study||0
9722642|NCT00074490|10822103|FG001|NOT COMPLETED|Overall Study||7
9722643|NCT00074490|10822104|FG002|NOT COMPLETED|Overall Study||0
9722644|NCT00074490|10822105|FG003|NOT COMPLETED|Overall Study||0
9722645|NCT00074490|10822106|FG004|NOT COMPLETED|Overall Study||3
9722646|NCT00074490|10822107|FG005|NOT COMPLETED|Overall Study||0
9722647|NCT00074581|10822122|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
9722648|NCT00074581|10822123|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
9722649|NCT00074581|10822122|FG000|COMPLETED|Overall Study||1545
9722650|NCT00074581|10822123|FG001|COMPLETED|Overall Study||1541
9722651|NCT00074581|10822122|FG000|NOT COMPLETED|Overall Study||244
9722652|NCT00074581|10822123|FG001|NOT COMPLETED|Overall Study||226
9722653|NCT00074711|10822131|FG000|STARTED|Overall Study||120
9722654|NCT00074711|10822132|FG001|STARTED|Overall Study||121
9722655|NCT00074711|10822131|FG000|COMPLETED|Overall Study||105
9722656|NCT00074711|10822132|FG001|COMPLETED|Overall Study||106
9722657|NCT00074711|10822131|FG000|NOT COMPLETED|Overall Study||15
9722658|NCT00074711|10822132|FG001|NOT COMPLETED|Overall Study||15
9722659|NCT00074802|10822140|FG000|STARTED|Overall Study||29
9722660|NCT00074802|10822141|FG001|STARTED|Overall Study||32
9722661|NCT00074802|10822140|FG000|COMPLETED|Overall Study||20
9722662|NCT00074802|10822141|FG001|COMPLETED|Overall Study||25
9722663|NCT00074802|10822140|FG000|NOT COMPLETED|Overall Study||9
10022194|NCT01848353|11145639|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
10022195|NCT01848353|11145636|FG000|COMPLETED|Phase 2||20
10022196|NCT01848353|11145637|FG001|COMPLETED|Phase 2||26
10022197|NCT01848353|11145638|FG002|COMPLETED|Phase 2||0
10022198|NCT01848353|11145639|FG003|COMPLETED|Phase 2||0
10022199|NCT01848353|11145636|FG000|NOT COMPLETED|Phase 2||3
10022200|NCT01848353|11145637|FG001|NOT COMPLETED|Phase 2||2
10022201|NCT01848353|11145638|FG002|NOT COMPLETED|Phase 2||0
10022202|NCT01848353|11145639|FG003|NOT COMPLETED|Phase 2||0
10022203|NCT01848353|11145636|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
9840728|NCT00817479|10952296|FG000|NOT COMPLETED|Overall Study||1
9840729|NCT00817479|10952297|FG001|NOT COMPLETED|Overall Study||1
9840730|NCT00817531|10952303|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
9840731|NCT00817531|10952303|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
9840732|NCT00817531|10952303|FG000|NOT COMPLETED|Overall Study||2
9840733|NCT00817596|10952307|FG000|STARTED|Overall Study||110
9840734|NCT00817596|10952307|FG000|COMPLETED|Overall Study||62
9840735|NCT00817596|10952307|FG000|NOT COMPLETED|Overall Study||48
9840736|NCT00817635|10952316|FG000|STARTED|Overall Study||32
9840737|NCT00817635|10952317|FG001|STARTED|Overall Study||26
9840738|NCT00817635|10952318|FG002|STARTED|Overall Study||31
9840739|NCT00817635|10952319|FG003|STARTED|Overall Study||33
9840740|NCT00817635|10952320|FG004|STARTED|Overall Study||33
9840741|NCT00817635|10952316|FG000|COMPLETED|Overall Study||23
9840742|NCT00817635|10952317|FG001|COMPLETED|Overall Study||22
9840743|NCT00817635|10952318|FG002|COMPLETED|Overall Study||28
9840744|NCT00817635|10952319|FG003|COMPLETED|Overall Study||28
9840745|NCT00817635|10952320|FG004|COMPLETED|Overall Study||25
9840746|NCT00817635|10952316|FG000|NOT COMPLETED|Overall Study||9
9840747|NCT00817635|10952317|FG001|NOT COMPLETED|Overall Study||4
9840748|NCT00817635|10952318|FG002|NOT COMPLETED|Overall Study||3
9840749|NCT00817635|10952319|FG003|NOT COMPLETED|Overall Study||5
9840750|NCT00817635|10952320|FG004|NOT COMPLETED|Overall Study||8
9840751|NCT00817778|10952341|FG000|STARTED|Overall Study||19
9840752|NCT00817778|10952342|FG001|STARTED|Overall Study||8
9840753|NCT00817778|10952341|FG000|COMPLETED|Overall Study||16
9840754|NCT00817778|10952342|FG001|COMPLETED|Overall Study||5
9840755|NCT00817778|10952341|FG000|NOT COMPLETED|Overall Study||3
9840756|NCT00817778|10952342|FG001|NOT COMPLETED|Overall Study||3
9840757|NCT00817804|10952350|FG000|STARTED|Overall Study||1
9840758|NCT00817804|10952351|FG001|STARTED|Overall Study||2
9840759|NCT00817804|10952350|FG000|COMPLETED|Overall Study||1
9840760|NCT00817804|10952351|FG001|COMPLETED|Overall Study||2
9840761|NCT00817804|10952350|FG000|NOT COMPLETED|Overall Study||0
9840762|NCT00817804|10952351|FG001|NOT COMPLETED|Overall Study||0
9840763|NCT00817843|10952357|FG000|STARTED|First Period (6 Weeks)||50
9840764|NCT00817843|10952358|FG001|STARTED|First Period (6 Weeks)||50
9840765|NCT00817843|10952357|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
9840766|NCT00817843|10952358|FG001|COMPLETED|First Period (6 Weeks)||46
9840767|NCT00817843|10952357|FG000|NOT COMPLETED|First Period (6 Weeks)||8
9840768|NCT00817843|10952358|FG001|NOT COMPLETED|First Period (6 Weeks)||4
9840769|NCT00817843|10952357|FG000|STARTED|Washout Period (6 Weeks)||42
9840770|NCT00817843|10952358|FG001|STARTED|Washout Period (6 Weeks)||46
9840771|NCT00817843|10952357|FG000|COMPLETED|Washout Period (6 Weeks)||41
9840772|NCT00817843|10952358|FG001|COMPLETED|Washout Period (6 Weeks)||45
9840773|NCT00817843|10952357|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1
9840774|NCT00817843|10952358|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1
9840775|NCT00817843|10952357|FG000|STARTED|Second Period (6 Weeks)||41
9840776|NCT00817843|10952358|FG001|STARTED|Second Period (6 Weeks)||45
9840777|NCT00817843|10952357|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
9840778|NCT00817843|10952358|FG001|COMPLETED|Second Period (6 Weeks)||44
9840779|NCT00817843|10952357|FG000|NOT COMPLETED|Second Period (6 Weeks)||0
9840780|NCT00817843|10952358|FG001|NOT COMPLETED|Second Period (6 Weeks)||1
9840781|NCT00817999|10952365|FG000|STARTED|Grapefruit Juice||15
9840782|NCT00817999|10952366|FG001|STARTED|Grapefruit Juice||17
9840783|NCT00817999|10952365|FG000|COMPLETED|Grapefruit Juice||15
9840784|NCT00817999|10952366|FG001|COMPLETED|Grapefruit Juice||17
9840785|NCT00817999|10952365|FG000|NOT COMPLETED|Grapefruit Juice||0
9840786|NCT00817999|10952366|FG001|NOT COMPLETED|Grapefruit Juice||0
9840787|NCT00817999|10952365|FG000|STARTED|No Grapefruit Juice||15
9840788|NCT00817999|10952366|FG001|STARTED|No Grapefruit Juice||17
9840789|NCT00817999|10952365|FG000|COMPLETED|No Grapefruit Juice||15
9840790|NCT00817999|10952366|FG001|COMPLETED|No Grapefruit Juice||17
9840791|NCT00817999|10952365|FG000|NOT COMPLETED|No Grapefruit Juice||0
9840792|NCT00817999|10952366|FG001|NOT COMPLETED|No Grapefruit Juice||0
9840793|NCT00818116|10952374|FG000|STARTED|Overall Study||34
9840794|NCT00818116|10952374|FG000|COMPLETED|Overall Study||34
9840795|NCT00818116|10952374|FG000|NOT COMPLETED|Overall Study||0
9959632|NCT01463527|11079159|FG001|COMPLETED|Overall Study||77
9959633|NCT01463527|11079158|FG000|NOT COMPLETED|Overall Study||6
9959634|NCT01463527|11079159|FG001|NOT COMPLETED|Overall Study||7
9959635|NCT01463631|11079169|FG000|STARTED|Overall Study||3
9959636|NCT01463631|11079170|FG001|STARTED|Overall Study||4
9959637|NCT01463631|11079171|FG002|STARTED|Overall Study||5
9959638|NCT01463631|11079172|FG003|STARTED|Overall Study||15
9959639|NCT01463631|11079169|FG000|Received at Least One Dose of Study Drug|Overall Study||3
9959640|NCT01463631|11079170|FG001|Received at Least One Dose of Study Drug|Overall Study||4
9959641|NCT01463631|11079171|FG002|Received at Least One Dose of Study Drug|Overall Study||5
9840796|NCT00818168|10952378|FG000|STARTED|Overall Study||320
9840797|NCT00818168|10952378|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
9840798|NCT00818168|10952378|FG000|NOT COMPLETED|Overall Study||70
9840799|NCT00818207|10952384|FG000|STARTED|Overall Study||696
9840800|NCT00818207|10952385|FG001|STARTED|Overall Study||684
9840801|NCT00818207|10952384|FG000|COMPLETED|Overall Study||474
9840802|NCT00818207|10952385|FG001|COMPLETED|Overall Study||417
9840803|NCT00818207|10952384|FG000|NOT COMPLETED|Overall Study||222
9840804|NCT00818207|10952385|FG001|NOT COMPLETED|Overall Study||267
9840805|NCT00818246|10952391|FG000|STARTED|Overall Study||40
9840806|NCT00818246|10952391|FG000|COMPLETED|Overall Study|split-face study|35
9840807|NCT00818246|10952391|FG000|NOT COMPLETED|Overall Study||5
9840808|NCT00818259|10952402|FG000|STARTED|Randomization||12
9840809|NCT00818259|10952403|FG001|STARTED|Randomization||11
9840810|NCT00818259|10952404|FG002|STARTED|Randomization||19
9840811|NCT00818259|10952405|FG003|STARTED|Randomization||20
9840812|NCT00818259|10952406|FG004|STARTED|Randomization||19
9840813|NCT00818259|10952407|FG005|STARTED|Randomization||0
9840814|NCT00818259|10952408|FG006|STARTED|Randomization||5
9840815|NCT00818259|10952409|FG007|STARTED|Randomization||0
9840816|NCT00818259|10952410|FG008|STARTED|Randomization||6
9840817|NCT00818259|10952402|FG000|COMPLETED|Randomization||12
9840818|NCT00818259|10952403|FG001|COMPLETED|Randomization||11
9840819|NCT00818259|10952404|FG002|COMPLETED|Randomization||19
9840820|NCT00818259|10952405|FG003|COMPLETED|Randomization||20
9840821|NCT00818259|10952406|FG004|COMPLETED|Randomization||19
9840822|NCT00818259|10952407|FG005|COMPLETED|Randomization||0
9840823|NCT00818259|10952408|FG006|COMPLETED|Randomization||5
9840824|NCT00818259|10952409|FG007|COMPLETED|Randomization||0
9840825|NCT00818259|10952410|FG008|COMPLETED|Randomization||6
9722664|NCT00074802|10822141|FG001|NOT COMPLETED|Overall Study||7
9722665|NCT00074815|10822150|FG000|STARTED|Overall Study||42
9722666|NCT00074815|10822151|FG001|STARTED|Overall Study||40
9722667|NCT00074815|10822152|FG002|STARTED|Overall Study||42
9722668|NCT00074815|10822150|FG000|COMPLETED|Overall Study||37
9722669|NCT00074815|10822151|FG001|COMPLETED|Overall Study||34
9722670|NCT00074815|10822152|FG002|COMPLETED|Overall Study||30
9722671|NCT00074815|10822150|FG000|NOT COMPLETED|Overall Study||5
9722672|NCT00074815|10822151|FG001|NOT COMPLETED|Overall Study||6
9722673|NCT00074815|10822152|FG002|NOT COMPLETED|Overall Study||12
9722674|NCT00074958|10822160|FG000|STARTED|Overall Study||16
9722675|NCT00074958|10822160|FG000|COMPLETED|Overall Study||15
9722676|NCT00074958|10822160|FG000|NOT COMPLETED|Overall Study||1
9722677|NCT00074984|10822166|FG000|STARTED|Overall Study||31
9722678|NCT00074984|10822167|FG001|STARTED|Overall Study||51
9722679|NCT00074984|10822166|FG000|COMPLETED|Overall Study||28
9840826|NCT00818259|10952402|FG000|NOT COMPLETED|Randomization||0
9840827|NCT00818259|10952403|FG001|NOT COMPLETED|Randomization||0
9840828|NCT00818259|10952404|FG002|NOT COMPLETED|Randomization||0
9840829|NCT00818259|10952405|FG003|NOT COMPLETED|Randomization||0
9840830|NCT00818259|10952406|FG004|NOT COMPLETED|Randomization||0
9840831|NCT00818259|10952407|FG005|NOT COMPLETED|Randomization||0
9840832|NCT00818259|10952408|FG006|NOT COMPLETED|Randomization||0
9840833|NCT00818259|10952409|FG007|NOT COMPLETED|Randomization||0
9840834|NCT00818259|10952410|FG008|NOT COMPLETED|Randomization||0
9840835|NCT00818259|10952402|FG000|STARTED|Part I|Newly enrolled participants|12
9840836|NCT00818259|10952403|FG001|STARTED|Part I|Newly enrolled participants|11
9840837|NCT00818259|10952404|FG002|STARTED|Part I||0
9840838|NCT00818259|10952405|FG003|STARTED|Part I||0
9840839|NCT00818259|10952406|FG004|STARTED|Part I||0
9840840|NCT00818259|10952407|FG005|STARTED|Part I||0
9840841|NCT00818259|10952408|FG006|STARTED|Part I||0
9840842|NCT00818259|10952409|FG007|STARTED|Part I||0
9840843|NCT00818259|10952410|FG008|STARTED|Part I||0
9840844|NCT00818259|10952402|FG000|COMPLETED|Part I||11
9840845|NCT00818259|10952403|FG001|COMPLETED|Part I||11
9840846|NCT00818259|10952404|FG002|COMPLETED|Part I||0
9722680|NCT00074984|10822167|FG001|COMPLETED|Overall Study||43
9722681|NCT00074984|10822166|FG000|NOT COMPLETED|Overall Study||3
9722682|NCT00074984|10822167|FG001|NOT COMPLETED|Overall Study||8
9722683|NCT00075023|10822176|FG000|STARTED|Pilot Study||5
9722684|NCT00075023|10822177|FG001|STARTED|Pilot Study||5
9722685|NCT00075023|10822176|FG000|COMPLETED|Pilot Study||3
9722686|NCT00075023|10822177|FG001|COMPLETED|Pilot Study||3
9722687|NCT00075023|10822176|FG000|NOT COMPLETED|Pilot Study||2
9840847|NCT00818259|10952405|FG003|COMPLETED|Part I||0
9840848|NCT00818259|10952406|FG004|COMPLETED|Part I||0
9840849|NCT00818259|10952407|FG005|COMPLETED|Part I||0
9840850|NCT00818259|10952408|FG006|COMPLETED|Part I||0
9840851|NCT00818259|10952409|FG007|COMPLETED|Part I||0
9840852|NCT00818259|10952410|FG008|COMPLETED|Part I||0
9840853|NCT00818259|10952402|FG000|NOT COMPLETED|Part I||1
9840854|NCT00818259|10952403|FG001|NOT COMPLETED|Part I||0
9840855|NCT00818259|10952404|FG002|NOT COMPLETED|Part I||0
9840856|NCT00818259|10952405|FG003|NOT COMPLETED|Part I||0
9840857|NCT00818259|10952406|FG004|NOT COMPLETED|Part I||0
9840858|NCT00818259|10952407|FG005|NOT COMPLETED|Part I||0
9840859|NCT00818259|10952408|FG006|NOT COMPLETED|Part I||0
9840860|NCT00818259|10952409|FG007|NOT COMPLETED|Part I||0
9840861|NCT00818259|10952410|FG008|NOT COMPLETED|Part I||0
9840862|NCT00818259|10952402|FG000|STARTED|Part II||0
9840863|NCT00818259|10952403|FG001|STARTED|Part II||0
9840864|NCT00818259|10952404|FG002|STARTED|Part II|Newly enrolled participants|19
9840865|NCT00818259|10952405|FG003|STARTED|Part II|Newly enrolled participants|20
9840866|NCT00818259|10952406|FG004|STARTED|Part II||0
9840867|NCT00818259|10952407|FG005|STARTED|Part II||0
9840868|NCT00818259|10952408|FG006|STARTED|Part II||0
9840869|NCT00818259|10952409|FG007|STARTED|Part II||0
9840870|NCT00818259|10952410|FG008|STARTED|Part II||0
9840871|NCT00818259|10952402|FG000|Treated|Part II||0
9840872|NCT00818259|10952403|FG001|Treated|Part II||0
9840873|NCT00818259|10952404|FG002|Treated|Part II||19
9840874|NCT00818259|10952405|FG003|Treated|Part II||19
9840875|NCT00818259|10952406|FG004|Treated|Part II||0
9840876|NCT00818259|10952407|FG005|Treated|Part II||0
9840877|NCT00818259|10952408|FG006|Treated|Part II||0
9722688|NCT00075023|10822177|FG001|NOT COMPLETED|Pilot Study||2
9722689|NCT00075023|10822176|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
9722690|NCT00075023|10822177|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
9722691|NCT00075023|10822176|FG000|COMPLETED|Part Two||0
9722692|NCT00075023|10822177|FG001|COMPLETED|Part Two||0
9722693|NCT00075023|10822176|FG000|NOT COMPLETED|Part Two||0
9722694|NCT00075023|10822177|FG001|NOT COMPLETED|Part Two||0
9722695|NCT00075088|10822186|FG000|STARTED|Overall Study||403
9722696|NCT00075088|10822187|FG001|STARTED|Overall Study||391
9722697|NCT00075088|10822186|FG000|COMPLETED|Overall Study||403
9722698|NCT00075088|10822187|FG001|COMPLETED|Overall Study||391
9722699|NCT00075088|10822186|FG000|NOT COMPLETED|Overall Study||0
9722700|NCT00075088|10822187|FG001|NOT COMPLETED|Overall Study||0
9722701|NCT00075218|10822196|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
9722702|NCT00075218|10822197|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
9722703|NCT00075218|10822198|FG002|STARTED|Double-Blind Treatment||0
9722704|NCT00075218|10822196|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
9722705|NCT00075218|10822197|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
9722706|NCT00075218|10822198|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0
9722707|NCT00075218|10822196|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
9722708|NCT00075218|10822197|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
9722709|NCT00075218|10822198|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
9722710|NCT00075218|10822196|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
9722711|NCT00075218|10822197|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
9722712|NCT00075218|10822198|FG002|COMPLETED|Double-Blind Treatment||0
9722713|NCT00075218|10822196|FG000|NOT COMPLETED|Double-Blind Treatment||91
9722714|NCT00075218|10822197|FG001|NOT COMPLETED|Double-Blind Treatment||15
9722715|NCT00075218|10822198|FG002|NOT COMPLETED|Double-Blind Treatment||0
9722716|NCT00075218|10822196|FG000|STARTED|Open-Label Treatment||0
9722717|NCT00075218|10822197|FG001|STARTED|Open-Label Treatment||0
9722718|NCT00075218|10822198|FG002|STARTED|Open-Label Treatment||255
9722719|NCT00075218|10822196|FG000|COMPLETED|Open-Label Treatment||0
9722720|NCT00075218|10822197|FG001|COMPLETED|Open-Label Treatment||0
9722721|NCT00075218|10822198|FG002|COMPLETED|Open-Label Treatment||0
9722722|NCT00075218|10822196|FG000|NOT COMPLETED|Open-Label Treatment||0
9722723|NCT00075218|10822197|FG001|NOT COMPLETED|Open-Label Treatment||0
9722724|NCT00075218|10822198|FG002|NOT COMPLETED|Open-Label Treatment||255
9722725|NCT00075270|10822207|FG000|STARTED|Overall Study||291
9722726|NCT00075270|10822208|FG001|STARTED|Overall Study||288
9731631|NCT00134004|10831519|FG000|COMPLETED|Overall Study||210
9840878|NCT00818259|10952409|FG007|Treated|Part II||0
9959642|NCT01463631|11079172|FG003|Received at Least One Dose of Study Drug|Overall Study||15
9840879|NCT00818259|10952410|FG008|Treated|Part II||0
9840880|NCT00818259|10952402|FG000|COMPLETED|Part II||0
9840881|NCT00818259|10952403|FG001|COMPLETED|Part II||0
9840882|NCT00818259|10952404|FG002|COMPLETED|Part II||18
9840883|NCT00818259|10952405|FG003|COMPLETED|Part II||18
9840884|NCT00818259|10952406|FG004|COMPLETED|Part II||0
9840885|NCT00818259|10952407|FG005|COMPLETED|Part II||0
9840886|NCT00818259|10952408|FG006|COMPLETED|Part II||0
9840887|NCT00818259|10952409|FG007|COMPLETED|Part II||0
9840888|NCT00818259|10952410|FG008|COMPLETED|Part II||0
9840889|NCT00818259|10952402|FG000|NOT COMPLETED|Part II||0
9840890|NCT00818259|10952403|FG001|NOT COMPLETED|Part II||0
9840891|NCT00818259|10952404|FG002|NOT COMPLETED|Part II||1
9840892|NCT00818259|10952405|FG003|NOT COMPLETED|Part II||2
9840893|NCT00818259|10952406|FG004|NOT COMPLETED|Part II||0
9840894|NCT00818259|10952407|FG005|NOT COMPLETED|Part II||0
9840895|NCT00818259|10952408|FG006|NOT COMPLETED|Part II||0
9840896|NCT00818259|10952409|FG007|NOT COMPLETED|Part II||0
9840897|NCT00818259|10952410|FG008|NOT COMPLETED|Part II||0
9840898|NCT00818259|10952402|FG000|STARTED|Part III||0
9840899|NCT00818259|10952403|FG001|STARTED|Part III||0
9840900|NCT00818259|10952404|FG002|STARTED|Part III||0
9840901|NCT00818259|10952405|FG003|STARTED|Part III||0
9840902|NCT00818259|10952406|FG004|STARTED|Part III|Newly enrolled participants|19
9840903|NCT00818259|10952407|FG005|STARTED|Part III||0
9840904|NCT00818259|10952408|FG006|STARTED|Part III||0
9840905|NCT00818259|10952409|FG007|STARTED|Part III||0
9840906|NCT00818259|10952410|FG008|STARTED|Part III||0
9840907|NCT00818259|10952402|FG000|COMPLETED|Part III||0
9840908|NCT00818259|10952403|FG001|COMPLETED|Part III||0
9840909|NCT00818259|10952404|FG002|COMPLETED|Part III||0
9840910|NCT00818259|10952405|FG003|COMPLETED|Part III||0
9840911|NCT00818259|10952406|FG004|COMPLETED|Part III||19
9840912|NCT00818259|10952407|FG005|COMPLETED|Part III||0
9840913|NCT00818259|10952408|FG006|COMPLETED|Part III||0
9840914|NCT00818259|10952409|FG007|COMPLETED|Part III||0
9840915|NCT00818259|10952410|FG008|COMPLETED|Part III||0
9840916|NCT00818259|10952402|FG000|NOT COMPLETED|Part III||0
9840917|NCT00818259|10952403|FG001|NOT COMPLETED|Part III||0
9840918|NCT00818259|10952404|FG002|NOT COMPLETED|Part III||0
9840919|NCT00818259|10952405|FG003|NOT COMPLETED|Part III||0
9840920|NCT00818259|10952406|FG004|NOT COMPLETED|Part III||0
9840921|NCT00818259|10952407|FG005|NOT COMPLETED|Part III||0
9840922|NCT00818259|10952408|FG006|NOT COMPLETED|Part III||0
9840923|NCT00818259|10952409|FG007|NOT COMPLETED|Part III||0
9840924|NCT00818259|10952410|FG008|NOT COMPLETED|Part III||0
9840925|NCT00818259|10952402|FG000|STARTED|Part IV||0
9840926|NCT00818259|10952403|FG001|STARTED|Part IV||0
9840927|NCT00818259|10952404|FG002|STARTED|Part IV||0
9840928|NCT00818259|10952405|FG003|STARTED|Part IV||0
9840929|NCT00818259|10952406|FG004|STARTED|Part IV||0
9840930|NCT00818259|10952407|FG005|STARTED|Part IV|Participants continuing from Part III|15
9840931|NCT00818259|10952408|FG006|STARTED|Part IV|Newly enrolled participants|5
9840932|NCT00818259|10952409|FG007|STARTED|Part IV||0
9840933|NCT00818259|10952410|FG008|STARTED|Part IV||0
9840934|NCT00818259|10952402|FG000|COMPLETED|Part IV||0
9840935|NCT00818259|10952403|FG001|COMPLETED|Part IV||0
9840936|NCT00818259|10952404|FG002|COMPLETED|Part IV||0
9840937|NCT00818259|10952405|FG003|COMPLETED|Part IV||0
9840938|NCT00818259|10952406|FG004|COMPLETED|Part IV||0
9840939|NCT00818259|10952407|FG005|COMPLETED|Part IV||14
9840940|NCT00818259|10952408|FG006|COMPLETED|Part IV||5
9840941|NCT00818259|10952409|FG007|COMPLETED|Part IV||0
9840942|NCT00818259|10952410|FG008|COMPLETED|Part IV||0
9840943|NCT00818259|10952402|FG000|NOT COMPLETED|Part IV||0
9840944|NCT00818259|10952403|FG001|NOT COMPLETED|Part IV||0
9840945|NCT00818259|10952404|FG002|NOT COMPLETED|Part IV||0
9840946|NCT00818259|10952405|FG003|NOT COMPLETED|Part IV||0
9840947|NCT00818259|10952406|FG004|NOT COMPLETED|Part IV||0
9840948|NCT00818259|10952407|FG005|NOT COMPLETED|Part IV||1
9840949|NCT00818259|10952408|FG006|NOT COMPLETED|Part IV||0
9840950|NCT00818259|10952409|FG007|NOT COMPLETED|Part IV||0
9840951|NCT00818259|10952410|FG008|NOT COMPLETED|Part IV||0
9840952|NCT00818259|10952402|FG000|STARTED|Part V||0
9840953|NCT00818259|10952403|FG001|STARTED|Part V||0
9840954|NCT00818259|10952404|FG002|STARTED|Part V||0
9840955|NCT00818259|10952405|FG003|STARTED|Part V||0
9840956|NCT00818259|10952406|FG004|STARTED|Part V||0
10022204|NCT01848353|11145637|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
10022205|NCT01848353|11145638|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
10022206|NCT01848353|11145639|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
10022207|NCT01848353|11145636|FG000|COMPLETED|Phase 3||4
10022208|NCT01848353|11145637|FG001|COMPLETED|Phase 3||9
9840957|NCT00818259|10952407|FG005|STARTED|Part V||0
9840958|NCT00818259|10952408|FG006|STARTED|Part V||0
9840959|NCT00818259|10952409|FG007|STARTED|Part V|Participants continuing from Part IV|17
9840960|NCT00818259|10952410|FG008|STARTED|Part V|Newly enrolled participants|6
9840961|NCT00818259|10952402|FG000|COMPLETED|Part V||0
9840962|NCT00818259|10952403|FG001|COMPLETED|Part V||0
9840963|NCT00818259|10952404|FG002|COMPLETED|Part V||0
9840964|NCT00818259|10952405|FG003|COMPLETED|Part V||0
9840965|NCT00818259|10952406|FG004|COMPLETED|Part V||0
9840966|NCT00818259|10952407|FG005|COMPLETED|Part V||0
9840967|NCT00818259|10952408|FG006|COMPLETED|Part V||0
10022209|NCT01848353|11145638|FG002|COMPLETED|Phase 3||0
10022210|NCT01848353|11145639|FG003|COMPLETED|Phase 3||0
10022211|NCT01848353|11145636|FG000|NOT COMPLETED|Phase 3||1
10022212|NCT01848353|11145637|FG001|NOT COMPLETED|Phase 3||1
10022213|NCT01848353|11145638|FG002|NOT COMPLETED|Phase 3||0
10022214|NCT01848353|11145639|FG003|NOT COMPLETED|Phase 3||0
10022215|NCT01848366|11145657|FG000|STARTED|Overall Study||8
10022216|NCT01848366|11145657|FG000|COMPLETED|Overall Study||8
10022217|NCT01848366|11145657|FG000|NOT COMPLETED|Overall Study||0
10022218|NCT01848457|11145665|FG000|STARTED|Overall Study||4
10022219|NCT01848457|11145666|FG001|STARTED|Overall Study||3
10022220|NCT01848457|11145667|FG002|STARTED|Overall Study||3
10114167|NCT02514070|11244872|FG000|STARTED|Week 14 to Week 20||17
10114168|NCT02514070|11244873|FG001|STARTED|Week 14 to Week 20||16
10114169|NCT02514070|11244872|FG000|COMPLETED|Week 14 to Week 20||16
10114170|NCT02514070|11244873|FG001|COMPLETED|Week 14 to Week 20||14
10114171|NCT02514070|11244872|FG000|NOT COMPLETED|Week 14 to Week 20||1
10114172|NCT02514070|11244873|FG001|NOT COMPLETED|Week 14 to Week 20||2
10022221|NCT01848457|11145668|FG003|STARTED|Overall Study||3
10022222|NCT01848457|11145665|FG000|Baseline|Overall Study||4
10022223|NCT01848457|11145666|FG001|Baseline|Overall Study||3
9722727|NCT00075270|10822207|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
9722728|NCT00075270|10822208|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
9722729|NCT00075270|10822207|FG000|COMPLETED|Overall Study||5
9722730|NCT00075270|10822208|FG001|COMPLETED|Overall Study||4
9722731|NCT00075270|10822207|FG000|NOT COMPLETED|Overall Study||286
9722732|NCT00075270|10822208|FG001|NOT COMPLETED|Overall Study||284
9722733|NCT00075335|10822215|FG000|STARTED|Overall Study||8
9722734|NCT00075335|10822215|FG000|COMPLETED|Overall Study||8
9722735|NCT00075335|10822215|FG000|NOT COMPLETED|Overall Study||0
9722736|NCT00075400|10822219|FG000|STARTED|Overall Study||26
9722737|NCT00075400|10822219|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23
9722738|NCT00075400|10822219|FG000|NOT COMPLETED|Overall Study||3
9722739|NCT00075478|10822230|FG000|STARTED|Overall Study||42
9722740|NCT00075478|10822231|FG001|STARTED|Overall Study||45
9722741|NCT00075478|10822230|FG000|COMPLETED|Overall Study||41
9722742|NCT00075478|10822231|FG001|COMPLETED|Overall Study||44
9722743|NCT00075478|10822230|FG000|NOT COMPLETED|Overall Study||1
9722744|NCT00075478|10822231|FG001|NOT COMPLETED|Overall Study||1
9722745|NCT00075504|10822239|FG000|STARTED|Overall Study||23
9722746|NCT00075504|10822240|FG001|STARTED|Overall Study||10
9722747|NCT00075504|10822239|FG000|COMPLETED|Overall Study||14
9722748|NCT00075504|10822240|FG001|COMPLETED|Overall Study||3
9722749|NCT00075504|10822239|FG000|NOT COMPLETED|Overall Study||9
9722750|NCT00075504|10822240|FG001|NOT COMPLETED|Overall Study||7
9722751|NCT00075582|10822248|FG000|STARTED|Overall Study||305
9722752|NCT00075582|10822249|FG001|STARTED|Overall Study||85
9722753|NCT00075582|10822248|FG000|COMPLETED|Overall Study||255
9722754|NCT00075582|10822249|FG001|COMPLETED|Overall Study||50
9722755|NCT00075582|10822248|FG000|NOT COMPLETED|Overall Study||50
9722756|NCT00075582|10822249|FG001|NOT COMPLETED|Overall Study||35
9722757|NCT00075725|10822271|FG000|STARTED|Overall Study||246
9722758|NCT00075725|10822272|FG001|STARTED|Overall Study||106
9722759|NCT00075725|10822273|FG002|STARTED|Overall Study||296
9722760|NCT00075725|10822274|FG003|STARTED|Overall Study||246
9722761|NCT00075725|10822275|FG004|STARTED|Overall Study||232
9722762|NCT00075725|10822276|FG005|STARTED|Overall Study||710
9722763|NCT00075725|10822277|FG006|STARTED|Overall Study||246
9722764|NCT00075725|10822278|FG007|STARTED|Overall Study||696
9722765|NCT00075725|10822279|FG008|STARTED|Overall Study||302
9722766|NCT00075725|10822280|FG009|STARTED|Overall Study||34
9722767|NCT00075725|10822281|FG010|STARTED|Overall Study||12
9840968|NCT00818259|10952409|FG007|COMPLETED|Part V||16
9840969|NCT00818259|10952410|FG008|COMPLETED|Part V||6
9840970|NCT00818259|10952402|FG000|NOT COMPLETED|Part V||0
9840971|NCT00818259|10952403|FG001|NOT COMPLETED|Part V||0
9840972|NCT00818259|10952404|FG002|NOT COMPLETED|Part V||0
9840973|NCT00818259|10952405|FG003|NOT COMPLETED|Part V||0
9840974|NCT00818259|10952406|FG004|NOT COMPLETED|Part V||0
9840975|NCT00818259|10952407|FG005|NOT COMPLETED|Part V||0
9840976|NCT00818259|10952408|FG006|NOT COMPLETED|Part V||0
9840977|NCT00818259|10952409|FG007|NOT COMPLETED|Part V||1
9840978|NCT00818259|10952410|FG008|NOT COMPLETED|Part V||0
9840979|NCT00818272|10952426|FG000|STARTED|Overall Study||148
9840980|NCT00818272|10952426|FG000|COMPLETED|Overall Study||74
9840981|NCT00818272|10952426|FG000|NOT COMPLETED|Overall Study||74
9840982|NCT00818324|10952430|FG000|STARTED|Overall Study||154
9840983|NCT00818324|10952430|FG000|COMPLETED|Overall Study||127
9840984|NCT00818324|10952430|FG000|NOT COMPLETED|Overall Study||27
9840985|NCT00818337|10952434|FG000|STARTED|Overall Study||36
9840986|NCT00818337|10952434|FG000|COMPLETED|Overall Study||36
9840987|NCT00818337|10952434|FG000|NOT COMPLETED|Overall Study||0
9840988|NCT00818363|10952441|FG000|STARTED|Overall Study||40
9840989|NCT00818363|10952442|FG001|STARTED|Overall Study||20
9840990|NCT00818363|10952441|FG000|COMPLETED|Overall Study||40
9840991|NCT00818363|10952442|FG001|COMPLETED|Overall Study||19
9840992|NCT00818363|10952441|FG000|NOT COMPLETED|Overall Study||0
9840993|NCT00818363|10952442|FG001|NOT COMPLETED|Overall Study||1
9722768|NCT00075725|10822282|FG011|STARTED|Overall Study||28
9722769|NCT00075725|10822271|FG000|COMPLETED|Overall Study||172
9722770|NCT00075725|10822272|FG001|COMPLETED|Overall Study||57
9722771|NCT00075725|10822273|FG002|COMPLETED|Overall Study||175
9722772|NCT00075725|10822274|FG003|COMPLETED|Overall Study||168
9722773|NCT00075725|10822275|FG004|COMPLETED|Overall Study||166
9722774|NCT00075725|10822276|FG005|COMPLETED|Overall Study||397
9722775|NCT00075725|10822277|FG006|COMPLETED|Overall Study||171
9722776|NCT00075725|10822278|FG007|COMPLETED|Overall Study||401
9722777|NCT00075725|10822279|FG008|COMPLETED|Overall Study||185
9840994|NCT00818389|10952450|FG000|STARTED|Overall Study||40
9840995|NCT00818389|10952451|FG001|STARTED|Overall Study||44
9959643|NCT01463631|11079169|FG000|COMPLETED|Overall Study||3
9840996|NCT00818389|10952450|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
9840997|NCT00818389|10952451|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
9840998|NCT00818389|10952450|FG000|NOT COMPLETED|Overall Study||4
9722778|NCT00075725|10822280|FG009|COMPLETED|Overall Study||16
9722779|NCT00075725|10822281|FG010|COMPLETED|Overall Study||3
9722780|NCT00075725|10822282|FG011|COMPLETED|Overall Study||10
9722781|NCT00075725|10822271|FG000|NOT COMPLETED|Overall Study||74
9722782|NCT00075725|10822272|FG001|NOT COMPLETED|Overall Study||49
9722783|NCT00075725|10822273|FG002|NOT COMPLETED|Overall Study||121
9722784|NCT00075725|10822274|FG003|NOT COMPLETED|Overall Study||78
9722785|NCT00075725|10822275|FG004|NOT COMPLETED|Overall Study||66
9722786|NCT00075725|10822276|FG005|NOT COMPLETED|Overall Study||313
9722787|NCT00075725|10822277|FG006|NOT COMPLETED|Overall Study||75
9722788|NCT00075725|10822278|FG007|NOT COMPLETED|Overall Study||295
9722789|NCT00075725|10822279|FG008|NOT COMPLETED|Overall Study||117
9722790|NCT00075725|10822280|FG009|NOT COMPLETED|Overall Study||18
9722791|NCT00075725|10822281|FG010|NOT COMPLETED|Overall Study||9
9722792|NCT00075725|10822282|FG011|NOT COMPLETED|Overall Study||18
9722793|NCT00075764|10822315|FG000|STARTED|Overall Study||345
9722794|NCT00075764|10822316|FG001|STARTED|Overall Study||349
9722795|NCT00075764|10822315|FG000|COMPLETED|Overall Study||0
9722796|NCT00075764|10822316|FG001|COMPLETED|Overall Study||0
9722797|NCT00075764|10822315|FG000|NOT COMPLETED|Overall Study||345
9722798|NCT00075764|10822316|FG001|NOT COMPLETED|Overall Study||349
9722799|NCT00075803|10822326|FG000|STARTED|Overall Study||295
9722800|NCT00075803|10822327|FG001|STARTED|Overall Study||305
9722801|NCT00075803|10822326|FG000|COMPLETED|Overall Study||295
9722802|NCT00075803|10822327|FG001|COMPLETED|Overall Study||305
9722803|NCT00075803|10822326|FG000|NOT COMPLETED|Overall Study||0
9722804|NCT00075803|10822327|FG001|NOT COMPLETED|Overall Study||0
9722805|NCT00075816|10822335|FG000|STARTED|Overall Study||278
9722806|NCT00075816|10822336|FG001|STARTED|Overall Study||273
9722807|NCT00075816|10822335|FG000|COMPLETED|Overall Study||264
9722808|NCT00075816|10822336|FG001|COMPLETED|Overall Study||262
9722809|NCT00075816|10822335|FG000|NOT COMPLETED|Overall Study||14
9722810|NCT00075816|10822336|FG001|NOT COMPLETED|Overall Study||11
9722811|NCT00075829|10822348|FG000|STARTED|Overall Study||436
9722812|NCT00075829|10822349|FG001|STARTED|Overall Study||189
9722813|NCT00075829|10822350|FG002|STARTED|Overall Study||48
9722814|NCT00075829|10822351|FG003|STARTED|Overall Study||37
9722815|NCT00075829|10822348|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
9722816|NCT00075829|10822349|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
9722817|NCT00075829|10822350|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
9722818|NCT00075829|10822351|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
9722819|NCT00075829|10822348|FG000|NOT COMPLETED|Overall Study||258
9722820|NCT00075829|10822349|FG001|NOT COMPLETED|Overall Study||118
9722821|NCT00075829|10822350|FG002|NOT COMPLETED|Overall Study||34
9840999|NCT00818389|10952451|FG001|NOT COMPLETED|Overall Study||6
9841000|NCT00818441|10952459|FG000|STARTED|Overall Study||89
9841001|NCT00818441|10952460|FG001|STARTED|Overall Study||30
9841002|NCT00818441|10952459|FG000|COMPLETED|Overall Study||0
9841003|NCT00818441|10952460|FG001|COMPLETED|Overall Study||0
9841004|NCT00818441|10952459|FG000|NOT COMPLETED|Overall Study||89
9841005|NCT00818441|10952460|FG001|NOT COMPLETED|Overall Study||30
9841006|NCT00818454|10952467|FG000|STARTED|Treatment Period 1||115
9841007|NCT00818454|10952468|FG001|STARTED|Treatment Period 1||111
9841008|NCT00818454|10952469|FG002|STARTED|Treatment Period 1||0
9841009|NCT00818454|10952470|FG003|STARTED|Treatment Period 1||0
9841010|NCT00818454|10952467|FG000|COMPLETED|Treatment Period 1||112
9841011|NCT00818454|10952468|FG001|COMPLETED|Treatment Period 1||110
9841012|NCT00818454|10952469|FG002|COMPLETED|Treatment Period 1||0
9841013|NCT00818454|10952470|FG003|COMPLETED|Treatment Period 1||0
9959644|NCT01463631|11079170|FG001|COMPLETED|Overall Study||4
9959645|NCT01463631|11079171|FG002|COMPLETED|Overall Study||4
9959646|NCT01463631|11079172|FG003|COMPLETED|Overall Study||9
9959647|NCT01463631|11079169|FG000|NOT COMPLETED|Overall Study||0
9959648|NCT01463631|11079170|FG001|NOT COMPLETED|Overall Study||0
9959649|NCT01463631|11079171|FG002|NOT COMPLETED|Overall Study||1
9959650|NCT01463631|11079172|FG003|NOT COMPLETED|Overall Study||6
9959651|NCT01463683|11079187|FG000|STARTED|Overall Study||309
9959652|NCT01463683|11079188|FG001|STARTED|Overall Study||309
9959653|NCT01463683|11079189|FG002|STARTED|Overall Study||104
9959654|NCT01463683|11079187|FG000|Received Vaccination 1 (Day 1)|Overall Study||309
9959655|NCT01463683|11079188|FG001|Received Vaccination 1 (Day 1)|Overall Study||308
9841014|NCT00818454|10952467|FG000|NOT COMPLETED|Treatment Period 1||3
9841015|NCT00818454|10952468|FG001|NOT COMPLETED|Treatment Period 1||1
9841016|NCT00818454|10952469|FG002|NOT COMPLETED|Treatment Period 1||0
9959656|NCT01463683|11079189|FG002|Received Vaccination 1 (Day 1)|Overall Study||104
9959657|NCT01463683|11079187|FG000|Received Vaccination 2 (Month 1)|Overall Study||302
9722822|NCT00075829|10822351|FG003|NOT COMPLETED|Overall Study||24
9722823|NCT00075881|10822364|FG000|STARTED|Overall Study||44
9722824|NCT00075881|10822364|FG000|Eligible|Overall Study||43
9722825|NCT00075881|10822364|FG000|Treated|Overall Study||42
9722826|NCT00075881|10822364|FG000|Induction Treatment|Overall Study||42
9722827|NCT00075881|10822364|FG000|Maintenance Treatment|Overall Study||15
9722828|NCT00075881|10822364|FG000|Reinduction Treatment|Overall Study||7
9722829|NCT00075881|10822364|FG000|COMPLETED|Overall Study||1
9722830|NCT00075881|10822364|FG000|NOT COMPLETED|Overall Study||43
9722831|NCT00076011|10822370|FG000|STARTED|Overall Study||52
9722832|NCT00076011|10822370|FG000|COMPLETED|Overall Study||0
9722833|NCT00076011|10822370|FG000|NOT COMPLETED|Overall Study||52
9722834|NCT00076024|10822377|FG000|STARTED|Phase 1, Lead-in||6
9722835|NCT00076024|10822378|FG001|STARTED|Phase 1, Lead-in||0
9722836|NCT00076024|10822379|FG002|STARTED|Phase 1, Lead-in||0
9722837|NCT00076024|10822380|FG003|STARTED|Phase 1, Lead-in||0
9841017|NCT00818454|10952470|FG003|NOT COMPLETED|Treatment Period 1||0
9841018|NCT00818454|10952467|FG000|STARTED|Washout Period of 1 Week||112
9841019|NCT00818454|10952468|FG001|STARTED|Washout Period of 1 Week||110
9841020|NCT00818454|10952469|FG002|STARTED|Washout Period of 1 Week||0
9841021|NCT00818454|10952470|FG003|STARTED|Washout Period of 1 Week||0
9841022|NCT00818454|10952467|FG000|COMPLETED|Washout Period of 1 Week||108
9841023|NCT00818454|10952468|FG001|COMPLETED|Washout Period of 1 Week||107
9841024|NCT00818454|10952469|FG002|COMPLETED|Washout Period of 1 Week||0
9841025|NCT00818454|10952470|FG003|COMPLETED|Washout Period of 1 Week||0
9841026|NCT00818454|10952467|FG000|NOT COMPLETED|Washout Period of 1 Week||4
9841027|NCT00818454|10952468|FG001|NOT COMPLETED|Washout Period of 1 Week||3
9841028|NCT00818454|10952469|FG002|NOT COMPLETED|Washout Period of 1 Week||0
9841029|NCT00818454|10952470|FG003|NOT COMPLETED|Washout Period of 1 Week||0
9841030|NCT00818454|10952467|FG000|STARTED|Treatment Period 2||108
9841031|NCT00818454|10952468|FG001|STARTED|Treatment Period 2||107
9841032|NCT00818454|10952469|FG002|STARTED|Treatment Period 2||0
9841033|NCT00818454|10952470|FG003|STARTED|Treatment Period 2||0
9841034|NCT00818454|10952467|FG000|COMPLETED|Treatment Period 2||106
9841035|NCT00818454|10952468|FG001|COMPLETED|Treatment Period 2||106
9841036|NCT00818454|10952469|FG002|COMPLETED|Treatment Period 2||0
9841037|NCT00818454|10952470|FG003|COMPLETED|Treatment Period 2||0
9841038|NCT00818454|10952467|FG000|NOT COMPLETED|Treatment Period 2||2
9841039|NCT00818454|10952468|FG001|NOT COMPLETED|Treatment Period 2||1
9841040|NCT00818454|10952469|FG002|NOT COMPLETED|Treatment Period 2||0
9841041|NCT00818454|10952470|FG003|NOT COMPLETED|Treatment Period 2||0
9841042|NCT00818454|10952467|FG000|STARTED|Treatment Period 3||0
9841043|NCT00818454|10952468|FG001|STARTED|Treatment Period 3||0
9841044|NCT00818454|10952469|FG002|STARTED|Treatment Period 3||26
9841045|NCT00818454|10952470|FG003|STARTED|Treatment Period 3||139
9841046|NCT00818454|10952467|FG000|COMPLETED|Treatment Period 3||0
9841047|NCT00818454|10952468|FG001|COMPLETED|Treatment Period 3||0
9841048|NCT00818454|10952469|FG002|COMPLETED|Treatment Period 3||26
9841049|NCT00818454|10952470|FG003|COMPLETED|Treatment Period 3||138
9841050|NCT00818454|10952467|FG000|NOT COMPLETED|Treatment Period 3||0
9841051|NCT00818454|10952468|FG001|NOT COMPLETED|Treatment Period 3||0
9841052|NCT00818454|10952469|FG002|NOT COMPLETED|Treatment Period 3||0
9841053|NCT00818454|10952470|FG003|NOT COMPLETED|Treatment Period 3||1
9841054|NCT00818519|10952482|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
9841055|NCT00818519|10952483|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
9841056|NCT00818519|10952482|FG000|Participants Received Treatment|Overall Study|= Baseline|87
9841057|NCT00818519|10952483|FG001|Participants Received Treatment|Overall Study|= Baseline|86
9722838|NCT00076024|10822377|FG000|COMPLETED|Phase 1, Lead-in||0
9722839|NCT00076024|10822378|FG001|COMPLETED|Phase 1, Lead-in||0
9722840|NCT00076024|10822379|FG002|COMPLETED|Phase 1, Lead-in||0
9722841|NCT00076024|10822380|FG003|COMPLETED|Phase 1, Lead-in||0
9722842|NCT00076024|10822377|FG000|NOT COMPLETED|Phase 1, Lead-in||6
9722843|NCT00076024|10822378|FG001|NOT COMPLETED|Phase 1, Lead-in||0
9722844|NCT00076024|10822379|FG002|NOT COMPLETED|Phase 1, Lead-in||0
9722845|NCT00076024|10822380|FG003|NOT COMPLETED|Phase 1, Lead-in||0
9722846|NCT00076024|10822377|FG000|STARTED|Phase 2, Double-blind||0
9722847|NCT00076024|10822378|FG001|STARTED|Phase 2, Double-blind||112
9722848|NCT00076024|10822379|FG002|STARTED|Phase 2, Double-blind||56
9722849|NCT00076024|10822380|FG003|STARTED|Phase 2, Double-blind||0
9722850|NCT00076024|10822377|FG000|Treated|Phase 2, Double-blind||0
9722851|NCT00076024|10822378|FG001|Treated|Phase 2, Double-blind||111
9722852|NCT00076024|10822379|FG002|Treated|Phase 2, Double-blind||56
9722853|NCT00076024|10822380|FG003|Treated|Phase 2, Double-blind||0
9722854|NCT00076024|10822377|FG000|COMPLETED|Phase 2, Double-blind||0
9722855|NCT00076024|10822378|FG001|COMPLETED|Phase 2, Double-blind||0
9722856|NCT00076024|10822379|FG002|COMPLETED|Phase 2, Double-blind||0
9722857|NCT00076024|10822380|FG003|COMPLETED|Phase 2, Double-blind||0
9722858|NCT00076024|10822377|FG000|NOT COMPLETED|Phase 2, Double-blind||0
9722859|NCT00076024|10822378|FG001|NOT COMPLETED|Phase 2, Double-blind||112
9722860|NCT00076024|10822379|FG002|NOT COMPLETED|Phase 2, Double-blind||56
9722861|NCT00076024|10822380|FG003|NOT COMPLETED|Phase 2, Double-blind||0
9722862|NCT00076024|10822377|FG000|STARTED|Phase 2, Open-label||0
9722863|NCT00076024|10822378|FG001|STARTED|Phase 2, Open-label||0
9722864|NCT00076024|10822379|FG002|STARTED|Phase 2, Open-label||0
9722865|NCT00076024|10822380|FG003|STARTED|Phase 2, Open-label||16
9722866|NCT00076024|10822377|FG000|COMPLETED|Phase 2, Open-label||0
9722867|NCT00076024|10822378|FG001|COMPLETED|Phase 2, Open-label||0
9722868|NCT00076024|10822379|FG002|COMPLETED|Phase 2, Open-label||0
9722869|NCT00076024|10822380|FG003|COMPLETED|Phase 2, Open-label||0
9722870|NCT00076024|10822377|FG000|NOT COMPLETED|Phase 2, Open-label||0
9722871|NCT00076024|10822378|FG001|NOT COMPLETED|Phase 2, Open-label||0
9722872|NCT00076024|10822379|FG002|NOT COMPLETED|Phase 2, Open-label||0
9722873|NCT00076024|10822380|FG003|NOT COMPLETED|Phase 2, Open-label||16
9722874|NCT00076050|10822391|FG000|STARTED|Overall Study||122
9722875|NCT00076050|10822392|FG001|STARTED|Overall Study||126
9722876|NCT00076050|10822391|FG000|COMPLETED|Overall Study||99
9722877|NCT00076050|10822392|FG001|COMPLETED|Overall Study||83
9722878|NCT00076050|10822391|FG000|NOT COMPLETED|Overall Study||23
9722879|NCT00076050|10822392|FG001|NOT COMPLETED|Overall Study||43
9722880|NCT00076102|10822398|FG000|STARTED|Overall Study||36
9722881|NCT00076102|10822398|FG000|COMPLETED|Overall Study||31
9722882|NCT00076102|10822398|FG000|NOT COMPLETED|Overall Study||5
9722883|NCT00076219|10822406|FG000|STARTED|Overall Study||563
9722884|NCT00076219|10822407|FG001|STARTED|Overall Study||561
9722885|NCT00076219|10822406|FG000|COMPLETED|Overall Study||545
9722886|NCT00076219|10822407|FG001|COMPLETED|Overall Study||550
9722887|NCT00076219|10822406|FG000|NOT COMPLETED|Overall Study||18
9722888|NCT00076219|10822407|FG001|NOT COMPLETED|Overall Study||11
9722889|NCT00076245|10822417|FG000|STARTED|Overall Study||16
9722890|NCT00076245|10822418|FG001|STARTED|Overall Study||15
9722891|NCT00076245|10822419|FG002|STARTED|Overall Study||15
9722892|NCT00076245|10822420|FG003|STARTED|Overall Study||15
9722893|NCT00076245|10822417|FG000|COMPLETED|Overall Study||16
9722894|NCT00076245|10822418|FG001|COMPLETED|Overall Study||15
9722895|NCT00076245|10822419|FG002|COMPLETED|Overall Study||15
9722896|NCT00076245|10822420|FG003|COMPLETED|Overall Study||14
9722897|NCT00076245|10822417|FG000|NOT COMPLETED|Overall Study||0
10022224|NCT01848457|11145667|FG002|Baseline|Overall Study||3
10022225|NCT01848457|11145668|FG003|Baseline|Overall Study||3
10022226|NCT01848457|11145665|FG000|Cycle 1|Overall Study||4
10022227|NCT01848457|11145666|FG001|Cycle 1|Overall Study||3
10022228|NCT01848457|11145667|FG002|Cycle 1|Overall Study||3
10022229|NCT01848457|11145668|FG003|Cycle 1|Overall Study||3
10022230|NCT01848457|11145665|FG000|Cycle 2|Overall Study||3
10022231|NCT01848457|11145666|FG001|Cycle 2|Overall Study||3
10022232|NCT01848457|11145667|FG002|Cycle 2|Overall Study||3
10022233|NCT01848457|11145668|FG003|Cycle 2|Overall Study||3
9722898|NCT00076245|10822418|FG001|NOT COMPLETED|Overall Study||0
10022234|NCT01848457|11145665|FG000|Cycle 3|Overall Study||3
10022235|NCT01848457|11145666|FG001|Cycle 3|Overall Study||3
9722899|NCT00076245|10822419|FG002|NOT COMPLETED|Overall Study||0
9722900|NCT00076245|10822420|FG003|NOT COMPLETED|Overall Study||1
9722901|NCT00076258|10822432|FG000|STARTED|Overall Study||62
9722902|NCT00076258|10822433|FG001|STARTED|Overall Study||64
9722903|NCT00076258|10822432|FG000|COMPLETED|Overall Study||61
9722904|NCT00076258|10822433|FG001|COMPLETED|Overall Study||61
9722905|NCT00076258|10822432|FG000|NOT COMPLETED|Overall Study||1
9722906|NCT00076258|10822433|FG001|NOT COMPLETED|Overall Study||3
9722907|NCT00076336|10822441|FG000|STARTED|Overall Study||116
9722908|NCT00076336|10822442|FG001|STARTED|Overall Study||116
9722909|NCT00076336|10822441|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
9722910|NCT00076336|10822442|FG001|Safety Population|Overall Study||116
9722911|NCT00076336|10822441|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
9722912|NCT00076336|10822442|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
9722913|NCT00076336|10822441|FG000|Completed Week 52|Overall Study||97
9722914|NCT00076336|10822442|FG001|Completed Week 52|Overall Study||94
9722915|NCT00076336|10822441|FG000|Completed Week 104|Overall Study||70
9722916|NCT00076336|10822442|FG001|Completed Week 104|Overall Study||62
9722917|NCT00076336|10822441|FG000|COMPLETED|Overall Study||64
9722918|NCT00076336|10822442|FG001|COMPLETED|Overall Study||60
9722919|NCT00076336|10822441|FG000|NOT COMPLETED|Overall Study||52
9722920|NCT00076336|10822442|FG001|NOT COMPLETED|Overall Study||56
9722921|NCT00076570|10822450|FG000|STARTED|Overall Study||15
9722922|NCT00076570|10822451|FG001|STARTED|Overall Study||16
9722923|NCT00076570|10822450|FG000|COMPLETED|Overall Study||7
9722924|NCT00076570|10822451|FG001|COMPLETED|Overall Study||8
9722925|NCT00076570|10822450|FG000|NOT COMPLETED|Overall Study||8
9722926|NCT00076570|10822451|FG001|NOT COMPLETED|Overall Study||8
9722927|NCT00076622|10822461|FG000|STARTED|Overall Study||23
9722928|NCT00076622|10822462|FG001|STARTED|Overall Study||13
9722929|NCT00076622|10822463|FG002|STARTED|Overall Study||40
9722930|NCT00076622|10822464|FG003|STARTED|Overall Study||18
9722931|NCT00076622|10822461|FG000|COMPLETED|Overall Study||23
9722932|NCT00076622|10822462|FG001|COMPLETED|Overall Study||13
9722933|NCT00076622|10822463|FG002|COMPLETED|Overall Study||40
9722934|NCT00076622|10822464|FG003|COMPLETED|Overall Study||18
9722935|NCT00076622|10822461|FG000|NOT COMPLETED|Overall Study||0
9722936|NCT00076622|10822462|FG001|NOT COMPLETED|Overall Study||0
9722937|NCT00076622|10822463|FG002|NOT COMPLETED|Overall Study||0
9722938|NCT00076622|10822464|FG003|NOT COMPLETED|Overall Study||0
9722939|NCT00076687|10822481|FG000|STARTED|Overall Study||48
9841058|NCT00818519|10952482|FG000|COMPLETED|Overall Study||75
9841059|NCT00818519|10952483|FG001|COMPLETED|Overall Study||71
9841060|NCT00818519|10952482|FG000|NOT COMPLETED|Overall Study||14
9841061|NCT00818519|10952483|FG001|NOT COMPLETED|Overall Study||19
9841062|NCT00818623|10952497|FG000|STARTED|Overall Study||26
9841063|NCT00818623|10952498|FG001|STARTED|Overall Study||12
9841064|NCT00818623|10952499|FG002|STARTED|Overall Study||13
9841065|NCT00818623|10952500|FG003|STARTED|Overall Study||24
9841066|NCT00818623|10952501|FG004|STARTED|Overall Study||27
9841067|NCT00818623|10952502|FG005|STARTED|Overall Study||24
9841068|NCT00818623|10952503|FG006|STARTED|Overall Study||27
9841069|NCT00818623|10952504|FG007|STARTED|Overall Study||27
9841070|NCT00818623|10952497|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
9841071|NCT00818623|10952498|FG001|Intent-to-treat (ITT) Population|Overall Study||12
9841072|NCT00818623|10952499|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
9841073|NCT00818623|10952500|FG003|Intent-to-treat (ITT) Population|Overall Study||24
9841074|NCT00818623|10952501|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
9841075|NCT00818623|10952502|FG005|Intent-to-treat (ITT) Population|Overall Study||24
9841076|NCT00818623|10952503|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
9967728|NCT01515891|11088049|FG000|COMPLETED|Overall Study||4
9967729|NCT01515891|11088049|FG000|NOT COMPLETED|Overall Study||0
9967730|NCT01515943|11088056|FG000|STARTED|Overall Study||75
9722940|NCT00076687|10822482|FG001|STARTED|Overall Study||52
9722941|NCT00076687|10822483|FG002|STARTED|Overall Study||55
9722942|NCT00076687|10822481|FG000|COMPLETED|Overall Study||42
9722943|NCT00076687|10822482|FG001|COMPLETED|Overall Study||47
9722944|NCT00076687|10822483|FG002|COMPLETED|Overall Study||51
9722945|NCT00076687|10822481|FG000|NOT COMPLETED|Overall Study||6
9722946|NCT00076687|10822482|FG001|NOT COMPLETED|Overall Study||5
9841077|NCT00818623|10952504|FG007|Intent-to-treat (ITT) Population|Overall Study||27
9841078|NCT00818623|10952497|FG000|COMPLETED|Overall Study||24
9841079|NCT00818623|10952498|FG001|COMPLETED|Overall Study||8
9841080|NCT00818623|10952499|FG002|COMPLETED|Overall Study||9
9841081|NCT00818623|10952500|FG003|COMPLETED|Overall Study||19
9841082|NCT00818623|10952501|FG004|COMPLETED|Overall Study||23
9841083|NCT00818623|10952502|FG005|COMPLETED|Overall Study||21
9841084|NCT00818623|10952503|FG006|COMPLETED|Overall Study||23
9841085|NCT00818623|10952504|FG007|COMPLETED|Overall Study||26
9841086|NCT00818623|10952497|FG000|NOT COMPLETED|Overall Study||2
9841087|NCT00818623|10952498|FG001|NOT COMPLETED|Overall Study||4
9841088|NCT00818623|10952499|FG002|NOT COMPLETED|Overall Study||4
9841089|NCT00818623|10952500|FG003|NOT COMPLETED|Overall Study||5
9841090|NCT00818623|10952501|FG004|NOT COMPLETED|Overall Study||4
9841091|NCT00818623|10952502|FG005|NOT COMPLETED|Overall Study||3
9841092|NCT00818623|10952503|FG006|NOT COMPLETED|Overall Study||4
9841093|NCT00818623|10952504|FG007|NOT COMPLETED|Overall Study||1
9841094|NCT00818649|10952522|FG000|STARTED|Overall Study||16
9841095|NCT00818649|10952522|FG000|COMPLETED|Overall Study||12
9959658|NCT01463683|11079188|FG001|Received Vaccination 2 (Month 1)|Overall Study||300
9959659|NCT01463683|11079189|FG002|Received Vaccination 2 (Month 1)|Overall Study||103
9959660|NCT01463683|11079187|FG000|Received Vaccination 3 (Month 6)|Overall Study||290
9959661|NCT01463683|11079188|FG001|Received Vaccination 3 (Month 6)|Overall Study||281
9959662|NCT01463683|11079189|FG002|Received Vaccination 3 (Month 6)|Overall Study||93
9959663|NCT01463683|11079187|FG000|COMPLETED|Overall Study||290
9959664|NCT01463683|11079188|FG001|COMPLETED|Overall Study||278
9959665|NCT01463683|11079189|FG002|COMPLETED|Overall Study||93
9959666|NCT01463683|11079187|FG000|NOT COMPLETED|Overall Study||19
9959667|NCT01463683|11079188|FG001|NOT COMPLETED|Overall Study||31
10022236|NCT01848457|11145667|FG002|Cycle 3|Overall Study||3
9959668|NCT01463683|11079189|FG002|NOT COMPLETED|Overall Study||11
9959669|NCT01463696|11079205|FG000|STARTED|Overall Study||1
9959670|NCT01463696|11079206|FG001|STARTED|Overall Study||6
9959671|NCT01463696|11079207|FG002|STARTED|Overall Study||3
9959672|NCT01463696|11079208|FG003|STARTED|Overall Study||7
9959673|NCT01463696|11079209|FG004|STARTED|Overall Study||3
9959674|NCT01463696|11079210|FG005|STARTED|Overall Study||6
9959675|NCT01463696|11079211|FG006|STARTED|Overall Study||16
9959676|NCT01463696|11079212|FG007|STARTED|Overall Study||6
9959677|NCT01463696|11079205|FG000|Treated|Overall Study||1
9959678|NCT01463696|11079206|FG001|Treated|Overall Study||6
9959679|NCT01463696|11079207|FG002|Treated|Overall Study||3
9959680|NCT01463696|11079208|FG003|Treated|Overall Study||7
9959681|NCT01463696|11079209|FG004|Treated|Overall Study||3
9959682|NCT01463696|11079210|FG005|Treated|Overall Study||6
9959683|NCT01463696|11079211|FG006|Treated|Overall Study||15
9959684|NCT01463696|11079212|FG007|Treated|Overall Study||6
9959685|NCT01463696|11079205|FG000|COMPLETED|Overall Study||1
9959686|NCT01463696|11079206|FG001|COMPLETED|Overall Study||4
9959687|NCT01463696|11079207|FG002|COMPLETED|Overall Study||2
9959688|NCT01463696|11079208|FG003|COMPLETED|Overall Study||3
9959689|NCT01463696|11079209|FG004|COMPLETED|Overall Study||2
9959690|NCT01463696|11079210|FG005|COMPLETED|Overall Study||3
9959691|NCT01463696|11079211|FG006|COMPLETED|Overall Study||6
9959692|NCT01463696|11079212|FG007|COMPLETED|Overall Study||2
9959693|NCT01463696|11079205|FG000|NOT COMPLETED|Overall Study||0
9959694|NCT01463696|11079206|FG001|NOT COMPLETED|Overall Study||2
9959695|NCT01463696|11079207|FG002|NOT COMPLETED|Overall Study||1
10022237|NCT01848457|11145668|FG003|Cycle 3|Overall Study||3
9841096|NCT00818649|10952522|FG000|NOT COMPLETED|Overall Study||4
9841097|NCT00818662|10952531|FG000|STARTED|Overall Study||127
9841098|NCT00818662|10952532|FG001|STARTED|Overall Study||135
9841099|NCT00818662|10952533|FG002|STARTED|Overall Study||58
9841100|NCT00818662|10952534|FG003|STARTED|Overall Study||63
9841101|NCT00818662|10952531|FG000|COMPLETED|Overall Study||104
9959696|NCT01463696|11079208|FG003|NOT COMPLETED|Overall Study||4
9959697|NCT01463696|11079209|FG004|NOT COMPLETED|Overall Study||1
9959698|NCT01463696|11079210|FG005|NOT COMPLETED|Overall Study||3
9959699|NCT01463696|11079211|FG006|NOT COMPLETED|Overall Study||10
9959700|NCT01463696|11079212|FG007|NOT COMPLETED|Overall Study||4
10022238|NCT01848457|11145665|FG000|Cycle 4|Overall Study||3
9841102|NCT00818662|10952532|FG001|COMPLETED|Overall Study||102
9841103|NCT00818662|10952533|FG002|COMPLETED|Overall Study||49
9841104|NCT00818662|10952534|FG003|COMPLETED|Overall Study||47
9841105|NCT00818662|10952531|FG000|NOT COMPLETED|Overall Study||23
9841106|NCT00818662|10952532|FG001|NOT COMPLETED|Overall Study||33
9841107|NCT00818662|10952533|FG002|NOT COMPLETED|Overall Study||9
9841108|NCT00818662|10952534|FG003|NOT COMPLETED|Overall Study||16
9841109|NCT00818753|10952548|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
9841110|NCT00818753|10952549|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
9841111|NCT00818753|10952550|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
9841112|NCT00818753|10952548|FG000|COMPLETED|Overall Study||19
9841113|NCT00818753|10952549|FG001|COMPLETED|Overall Study||21
9841114|NCT00818753|10952550|FG002|COMPLETED|Overall Study||9
9841115|NCT00818753|10952548|FG000|NOT COMPLETED|Overall Study||3
9841116|NCT00818753|10952549|FG001|NOT COMPLETED|Overall Study||0
9841117|NCT00818753|10952550|FG002|NOT COMPLETED|Overall Study||1
9841118|NCT00818766|10952560|FG000|STARTED|Overall Study||125
9841119|NCT00818766|10952561|FG001|STARTED|Overall Study||126
9841120|NCT00818766|10952560|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
9841121|NCT00818766|10952561|FG001|Received Allocated Intervention|Overall Study||126
9841122|NCT00818766|10952560|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
9841123|NCT00818766|10952561|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
9841124|NCT00818766|10952560|FG000|COMPLETED|Overall Study||110
9841125|NCT00818766|10952561|FG001|COMPLETED|Overall Study||116
9841126|NCT00818766|10952560|FG000|NOT COMPLETED|Overall Study||15
9841127|NCT00818766|10952561|FG001|NOT COMPLETED|Overall Study||10
9841128|NCT00818779|10952569|FG000|STARTED|Overall Study||22
9841129|NCT00818779|10952570|FG001|STARTED|Overall Study||16
9841130|NCT00818779|10952569|FG000|COMPLETED|Overall Study||16
9841131|NCT00818779|10952570|FG001|COMPLETED|Overall Study||15
9841132|NCT00818779|10952569|FG000|NOT COMPLETED|Overall Study||6
9841133|NCT00818779|10952570|FG001|NOT COMPLETED|Overall Study||1
9841134|NCT00818805|10952576|FG000|STARTED|First Intervention||25
9841135|NCT00818805|10952577|FG001|STARTED|First Intervention||25
9841136|NCT00818805|10952576|FG000|COMPLETED|First Intervention||25
9841137|NCT00818805|10952577|FG001|COMPLETED|First Intervention||25
9841138|NCT00818805|10952576|FG000|NOT COMPLETED|First Intervention||0
9841139|NCT00818805|10952577|FG001|NOT COMPLETED|First Intervention||0
9841140|NCT00818805|10952576|FG000|STARTED|Second Intervention||25
9841141|NCT00818805|10952577|FG001|STARTED|Second Intervention||25
9841142|NCT00818805|10952576|FG000|COMPLETED|Second Intervention||25
9841143|NCT00818805|10952577|FG001|COMPLETED|Second Intervention||25
9841144|NCT00818805|10952576|FG000|NOT COMPLETED|Second Intervention||0
9841145|NCT00818805|10952577|FG001|NOT COMPLETED|Second Intervention||0
9841146|NCT00818883|10952589|FG000|STARTED|Overall Study||303
9841147|NCT00818883|10952590|FG001|STARTED|Overall Study||306
9841148|NCT00818883|10952589|FG000|COMPLETED|Overall Study||252
9841149|NCT00818883|10952590|FG001|COMPLETED|Overall Study||260
9841150|NCT00818883|10952589|FG000|NOT COMPLETED|Overall Study||51
9841151|NCT00818883|10952590|FG001|NOT COMPLETED|Overall Study||46
9841152|NCT00818961|10952596|FG000|STARTED|Overall Study||36
9841153|NCT00818961|10952596|FG000|COMPLETED|Overall Study||36
9841154|NCT00818961|10952596|FG000|NOT COMPLETED|Overall Study||0
9841155|NCT00819013|10952604|FG000|STARTED|Overall Study||22
9959701|NCT01463878|11079232|FG000|STARTED|Overall Study||9
9959702|NCT01463878|11079233|FG001|STARTED|Overall Study||9
9959703|NCT01463878|11079232|FG000|COMPLETED|Overall Study||7
9959704|NCT01463878|11079233|FG001|COMPLETED|Overall Study||7
9959705|NCT01463878|11079232|FG000|NOT COMPLETED|Overall Study||2
9722947|NCT00076687|10822483|FG002|NOT COMPLETED|Overall Study||4
9722948|NCT00076752|10822491|FG000|STARTED|Overall Study||9
9722949|NCT00076752|10822491|FG000|COMPLETED|Overall Study||6
9722950|NCT00076752|10822491|FG000|NOT COMPLETED|Overall Study||3
9722951|NCT00076804|10822498|FG000|STARTED|Overall Study||137
9722952|NCT00076804|10822499|FG001|STARTED|Overall Study||137
9722953|NCT00076804|10822498|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
9722954|NCT00076804|10822499|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
9722955|NCT00076804|10822498|FG000|NOT COMPLETED|Overall Study||60
9722956|NCT00076804|10822499|FG001|NOT COMPLETED|Overall Study||69
9722957|NCT00076999|10822509|FG000|STARTED|Overall Study||25
9722958|NCT00076999|10822510|FG001|STARTED|Overall Study||31
9722959|NCT00076999|10822511|FG002|STARTED|Overall Study||19
9722960|NCT00076999|10822512|FG003|STARTED|Overall Study||6
9722961|NCT00076999|10822513|FG004|STARTED|Overall Study||34
9722962|NCT00076999|10822509|FG000|COMPLETED|Overall Study||13
9722963|NCT00076999|10822510|FG001|COMPLETED|Overall Study||7
9722964|NCT00076999|10822511|FG002|COMPLETED|Overall Study||2
9722965|NCT00076999|10822512|FG003|COMPLETED|Overall Study||5
9722966|NCT00076999|10822513|FG004|COMPLETED|Overall Study||9
9722967|NCT00076999|10822509|FG000|NOT COMPLETED|Overall Study||12
9722968|NCT00076999|10822510|FG001|NOT COMPLETED|Overall Study||24
9722969|NCT00076999|10822511|FG002|NOT COMPLETED|Overall Study||17
9722970|NCT00076999|10822512|FG003|NOT COMPLETED|Overall Study||1
9722971|NCT00076999|10822513|FG004|NOT COMPLETED|Overall Study||25
9722972|NCT00077064|10822528|FG000|STARTED|Overall Study||17
9722973|NCT00077064|10822529|FG001|STARTED|Overall Study||16
9722974|NCT00077064|10822528|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
9722975|NCT00077064|10822529|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
9722976|NCT00077064|10822528|FG000|NOT COMPLETED|Overall Study||0
9722977|NCT00077064|10822529|FG001|NOT COMPLETED|Overall Study||6
9722978|NCT00077207|10822536|FG000|STARTED|Overall Study||66
9722979|NCT00077207|10822536|FG000|COMPLETED|Overall Study||36
9722980|NCT00077207|10822536|FG000|NOT COMPLETED|Overall Study||30
9722981|NCT00077376|10822541|FG000|STARTED|Overall Study||61
9722982|NCT00077376|10822541|FG000|Treated|Overall Study||59
9722983|NCT00077376|10822541|FG000|HER2+ in Central Testing|Overall Study||39
9722984|NCT00077376|10822541|FG000|COMPLETED|Overall Study||39
9722985|NCT00077376|10822541|FG000|NOT COMPLETED|Overall Study||22
9722986|NCT00077610|10822548|FG000|STARTED|Overall Study||223
9722987|NCT00077610|10822549|FG001|STARTED|Overall Study||224
9722988|NCT00077610|10822550|FG002|STARTED|Overall Study||226
9722989|NCT00077610|10822548|FG000|Started Treatment|Overall Study||221
9722990|NCT00077610|10822549|FG001|Started Treatment|Overall Study||220
9722991|NCT00077610|10822550|FG002|Started Treatment|Overall Study||225
9722992|NCT00077610|10822548|FG000|COMPLETED|Overall Study||169
9722993|NCT00077610|10822549|FG001|COMPLETED|Overall Study||168
9722994|NCT00077610|10822550|FG002|COMPLETED|Overall Study||180
9722995|NCT00077610|10822548|FG000|NOT COMPLETED|Overall Study||54
9722996|NCT00077610|10822549|FG001|NOT COMPLETED|Overall Study||56
9722997|NCT00077610|10822550|FG002|NOT COMPLETED|Overall Study||46
9722998|NCT00077623|10822566|FG000|STARTED|Overall Study||190
9722999|NCT00077623|10822567|FG001|STARTED|Overall Study||191
9723000|NCT00077623|10822568|FG002|STARTED|Overall Study||191
9723001|NCT00077623|10822566|FG000|COMPLETED|Overall Study||154
9723002|NCT00077623|10822567|FG001|COMPLETED|Overall Study||148
9723003|NCT00077623|10822568|FG002|COMPLETED|Overall Study||159
9723004|NCT00077623|10822566|FG000|NOT COMPLETED|Overall Study||36
9723005|NCT00077623|10822567|FG001|NOT COMPLETED|Overall Study||43
9723006|NCT00077623|10822568|FG002|NOT COMPLETED|Overall Study||32
9723007|NCT00077636|10822578|FG000|STARTED|Overall Study||736
9723008|NCT00077636|10822579|FG001|STARTED|Overall Study||733
9723009|NCT00077636|10822578|FG000|COMPLETED|Overall Study||692
9723010|NCT00077636|10822579|FG001|COMPLETED|Overall Study||641
9723011|NCT00077636|10822578|FG000|NOT COMPLETED|Overall Study||44
9723012|NCT00077636|10822579|FG001|NOT COMPLETED|Overall Study||92
9723013|NCT00077649|10822590|FG000|STARTED|Overall Study||47
9723014|NCT00077649|10822591|FG001|STARTED|Overall Study||47
9723015|NCT00077649|10822592|FG002|STARTED|Overall Study||47
9723016|NCT00077649|10822593|FG003|STARTED|Overall Study||47
9723017|NCT00077649|10822590|FG000|Completed 24 Weeks of Follow-up|Overall Study||36
9723018|NCT00077649|10822591|FG001|Completed 24 Weeks of Follow-up|Overall Study||40
9723019|NCT00077649|10822592|FG002|Completed 24 Weeks of Follow-up|Overall Study||36
9723020|NCT00077649|10822593|FG003|Completed 24 Weeks of Follow-up|Overall Study||31
9723021|NCT00077649|10822590|FG000|COMPLETED|Overall Study||33
9723022|NCT00077649|10822591|FG001|COMPLETED|Overall Study||38
9723023|NCT00077649|10822592|FG002|COMPLETED|Overall Study||32
9723024|NCT00077649|10822593|FG003|COMPLETED|Overall Study||30
10022239|NCT01848457|11145666|FG001|Cycle 4|Overall Study||3
10022240|NCT01848457|11145667|FG002|Cycle 4|Overall Study||3
10022241|NCT01848457|11145668|FG003|Cycle 4|Overall Study||3
10022242|NCT01848457|11145665|FG000|COMPLETED|Overall Study||3
10022243|NCT01848457|11145666|FG001|COMPLETED|Overall Study||3
10022244|NCT01848457|11145667|FG002|COMPLETED|Overall Study||3
10022245|NCT01848457|11145668|FG003|COMPLETED|Overall Study||3
10022246|NCT01848457|11145665|FG000|NOT COMPLETED|Overall Study||1
10022247|NCT01848457|11145666|FG001|NOT COMPLETED|Overall Study||0
10022248|NCT01848457|11145667|FG002|NOT COMPLETED|Overall Study||0
10022249|NCT01848457|11145668|FG003|NOT COMPLETED|Overall Study||0
10022250|NCT01848483|11145688|FG000|STARTED|Overall Study||61
9841156|NCT00819013|10952605|FG001|STARTED|Overall Study||23
10022251|NCT01848483|11145689|FG001|STARTED|Overall Study||60
10022252|NCT01848483|11145688|FG000|COMPLETED|Overall Study||50
9841157|NCT00819013|10952606|FG002|STARTED|Overall Study||21
10022253|NCT01848483|11145689|FG001|COMPLETED|Overall Study||49
10022254|NCT01848483|11145688|FG000|NOT COMPLETED|Overall Study||11
10114173|NCT02514122|11244885|FG000|STARTED|Overall Study||32
9723025|NCT00077649|10822590|FG000|NOT COMPLETED|Overall Study||14
9723026|NCT00077649|10822591|FG001|NOT COMPLETED|Overall Study||9
9723027|NCT00077649|10822592|FG002|NOT COMPLETED|Overall Study||15
9723028|NCT00077649|10822593|FG003|NOT COMPLETED|Overall Study||17
9723029|NCT00077675|10822609|FG000|STARTED|Overall Study||103
9723030|NCT00077675|10822610|FG001|STARTED|Overall Study||98
9723031|NCT00077675|10822609|FG000|COMPLETED|Overall Study||92
9723032|NCT00077675|10822610|FG001|COMPLETED|Overall Study||89
9723033|NCT00077675|10822609|FG000|NOT COMPLETED|Overall Study||11
9723034|NCT00077675|10822610|FG001|NOT COMPLETED|Overall Study||9
9723035|NCT00077766|10822618|FG000|STARTED|Overall Study||157
9723036|NCT00077766|10822619|FG001|STARTED|Overall Study||156
9723037|NCT00077766|10822618|FG000|COMPLETED|Overall Study||118
9723038|NCT00077766|10822619|FG001|COMPLETED|Overall Study||131
9723039|NCT00077766|10822618|FG000|NOT COMPLETED|Overall Study||39
9723040|NCT00077766|10822619|FG001|NOT COMPLETED|Overall Study||25
9723041|NCT00077857|10822628|FG000|STARTED|Overall Study||235
9723042|NCT00077857|10822629|FG001|STARTED|Overall Study||235
9723043|NCT00077857|10822628|FG000|Received Study Drug|Overall Study||231
9723044|NCT00077857|10822629|FG001|Received Study Drug|Overall Study||234
9723045|NCT00077857|10822628|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
9723046|NCT00077857|10822629|FG001|Safety Population: Actual Dose Received|Overall Study||248
9723047|NCT00077857|10822628|FG000|COMPLETED|Overall Study||34
9723048|NCT00077857|10822629|FG001|COMPLETED|Overall Study||31
9723049|NCT00077857|10822628|FG000|NOT COMPLETED|Overall Study||201
9723050|NCT00077857|10822629|FG001|NOT COMPLETED|Overall Study||204
9723051|NCT00077922|10822635|FG000|STARTED|Overall Study||15
9723052|NCT00077922|10822635|FG000|COMPLETED|Overall Study||15
9723053|NCT00077922|10822635|FG000|NOT COMPLETED|Overall Study||0
9723054|NCT00077974|10822639|FG000|STARTED|Overall Study||106
9723055|NCT00077974|10822639|FG000|COMPLETED|Overall Study||2
9723056|NCT00077974|10822639|FG000|NOT COMPLETED|Overall Study||104
9723057|NCT00078286|10822645|FG000|STARTED|Overall Study||234
9723058|NCT00078286|10822646|FG001|STARTED|Overall Study||235
9723059|NCT00078286|10822645|FG000|COMPLETED|Overall Study||138
9723060|NCT00078286|10822646|FG001|COMPLETED|Overall Study||152
9723061|NCT00078286|10822645|FG000|NOT COMPLETED|Overall Study||96
9723062|NCT00078286|10822646|FG001|NOT COMPLETED|Overall Study||83
9723063|NCT00078312|10822652|FG000|STARTED|Overall Study||328
9723064|NCT00078312|10822652|FG000|COMPLETED|Overall Study||151
9723065|NCT00078312|10822652|FG000|NOT COMPLETED|Overall Study||177
9723066|NCT00078325|10822659|FG000|STARTED|Overall Study||131
9723067|NCT00078325|10822660|FG001|STARTED|Overall Study||133
9723068|NCT00078325|10822661|FG002|STARTED|Overall Study||131
9723069|NCT00078325|10822659|FG000|COMPLETED|Overall Study||110
9723070|NCT00078325|10822660|FG001|COMPLETED|Overall Study||114
9723071|NCT00078325|10822661|FG002|COMPLETED|Overall Study||120
9723072|NCT00078325|10822659|FG000|NOT COMPLETED|Overall Study||21
9723073|NCT00078325|10822660|FG001|NOT COMPLETED|Overall Study||19
9723074|NCT00078325|10822661|FG002|NOT COMPLETED|Overall Study||11
9723075|NCT00078338|10822671|FG000|STARTED|Overall Study||386
9723076|NCT00078338|10822672|FG001|STARTED|Overall Study||378
9723077|NCT00078338|10822671|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
9723078|NCT00078338|10822672|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
9723079|NCT00078338|10822671|FG000|COMPLETED|Overall Study||301
9723080|NCT00078338|10822672|FG001|COMPLETED|Overall Study||324
9723081|NCT00078338|10822671|FG000|NOT COMPLETED|Overall Study||85
9723082|NCT00078338|10822672|FG001|NOT COMPLETED|Overall Study||54
9723083|NCT00078377|10822681|FG000|STARTED|Overall Study||67
9723084|NCT00078377|10822682|FG001|STARTED|Overall Study||65
9723085|NCT00078377|10822683|FG002|STARTED|Overall Study||64
9723086|NCT00078377|10822681|FG000|COMPLETED|Overall Study||56
9723087|NCT00078377|10822682|FG001|COMPLETED|Overall Study||49
9723088|NCT00078377|10822683|FG002|COMPLETED|Overall Study||55
9723089|NCT00078377|10822681|FG000|NOT COMPLETED|Overall Study||11
9723090|NCT00078377|10822682|FG001|NOT COMPLETED|Overall Study||16
9723091|NCT00078377|10822683|FG002|NOT COMPLETED|Overall Study||9
9959706|NCT01463878|11079233|FG001|NOT COMPLETED|Overall Study||2
9723092|NCT00078403|10822695|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
9723093|NCT00078403|10822696|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
9723094|NCT00078403|10822697|FG002|STARTED|Overall Study||169
9959707|NCT01463982|11079243|FG000|STARTED|Overall Study||3
9959708|NCT01463982|11079244|FG001|STARTED|Overall Study||8
10114174|NCT02514122|11244886|FG001|STARTED|Overall Study||29
9723095|NCT00078403|10822695|FG000|COMPLETED|Overall Study||26
9723096|NCT00078403|10822696|FG001|COMPLETED|Overall Study||26
9723097|NCT00078403|10822697|FG002|COMPLETED|Overall Study||141
9723098|NCT00078403|10822695|FG000|NOT COMPLETED|Overall Study||18
9723099|NCT00078403|10822696|FG001|NOT COMPLETED|Overall Study||16
9723100|NCT00078403|10822697|FG002|NOT COMPLETED|Overall Study||28
9723101|NCT00078559|10822706|FG000|STARTED|Overall Study||10
9723102|NCT00078559|10822706|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
9723103|NCT00078559|10822706|FG000|NOT COMPLETED|Overall Study||0
9731632|NCT00134004|10831519|FG000|NOT COMPLETED|Overall Study||0
9731633|NCT00134017|10831523|FG000|STARTED|Overall Study||142
9731634|NCT00134017|10831523|FG000|COMPLETED|Overall Study||142
9731635|NCT00134017|10831523|FG000|NOT COMPLETED|Overall Study||0
9731636|NCT00134043|10831529|FG000|STARTED|Overall Study||16
9731637|NCT00134043|10831530|FG001|STARTED|Overall Study||3
9731638|NCT00134043|10831529|FG000|COMPLETED|Overall Study||16
9731639|NCT00134043|10831530|FG001|COMPLETED|Overall Study||3
9731640|NCT00134043|10831529|FG000|NOT COMPLETED|Overall Study||0
9731641|NCT00134043|10831530|FG001|NOT COMPLETED|Overall Study||0
9731642|NCT00134056|10831537|FG000|STARTED|Randomization||518
9731643|NCT00134056|10831538|FG001|STARTED|Randomization||520
9731644|NCT00134056|10831537|FG000|COMPLETED|Randomization||496
9731645|NCT00134056|10831538|FG001|COMPLETED|Randomization||500
9731646|NCT00134056|10831537|FG000|NOT COMPLETED|Randomization||22
9731647|NCT00134056|10831538|FG001|NOT COMPLETED|Randomization||20
9731648|NCT00134056|10831537|FG000|STARTED|Eligible for Protocol Assigned Treatment||496
9731649|NCT00134056|10831538|FG001|STARTED|Eligible for Protocol Assigned Treatment||500
9731650|NCT00134056|10831537|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169
9731651|NCT00134056|10831538|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185
9731652|NCT00134056|10831537|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
9731653|NCT00134056|10831538|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
9731654|NCT00134082|10831547|FG000|STARTED|Overall Study||30
9731655|NCT00134082|10831547|FG000|COMPLETED|Overall Study||27
9731656|NCT00134082|10831547|FG000|NOT COMPLETED|Overall Study||3
9731657|NCT00134381|10831551|FG000|STARTED|Overall Study||1
9731658|NCT00134381|10831552|FG001|STARTED|Overall Study||2
9731659|NCT00134381|10831553|FG002|STARTED|Overall Study||1
9731660|NCT00134381|10831554|FG003|STARTED|Overall Study||2
9731661|NCT00134381|10831555|FG004|STARTED|Overall Study||31
9731662|NCT00134381|10831556|FG005|STARTED|Overall Study||31
9731663|NCT00134381|10831551|FG000|COMPLETED|Overall Study||1
9731664|NCT00134381|10831552|FG001|COMPLETED|Overall Study||2
9731665|NCT00134381|10831553|FG002|COMPLETED|Overall Study||1
9731666|NCT00134381|10831554|FG003|COMPLETED|Overall Study||2
9731667|NCT00134381|10831555|FG004|COMPLETED|Overall Study||31
9731668|NCT00134381|10831556|FG005|COMPLETED|Overall Study||29
9731669|NCT00134381|10831551|FG000|NOT COMPLETED|Overall Study||0
9731670|NCT00134381|10831552|FG001|NOT COMPLETED|Overall Study||0
9731671|NCT00134381|10831553|FG002|NOT COMPLETED|Overall Study||0
9731672|NCT00134381|10831554|FG003|NOT COMPLETED|Overall Study||0
9731673|NCT00134381|10831555|FG004|NOT COMPLETED|Overall Study||0
9731674|NCT00134381|10831556|FG005|NOT COMPLETED|Overall Study||2
9731675|NCT00134563|10831576|FG000|STARTED|Overall Study|Randomized|363
9731676|NCT00134563|10831577|FG001|STARTED|Overall Study|Randomized|366
9731677|NCT00134563|10831578|FG002|STARTED|Overall Study|Randomized|359
9731678|NCT00134563|10831576|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
9731679|NCT00134563|10831577|FG001|Treated|Overall Study||365
9731680|NCT00134563|10831578|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
9731681|NCT00134563|10831576|FG000|COMPLETED|Overall Study|completed treatment period|259
9731682|NCT00134563|10831577|FG001|COMPLETED|Overall Study|completed treatment period|274
9731683|NCT00134563|10831578|FG002|COMPLETED|Overall Study|completed treatment period|263
9731684|NCT00134563|10831576|FG000|NOT COMPLETED|Overall Study||104
9731685|NCT00134563|10831577|FG001|NOT COMPLETED|Overall Study||92
9731686|NCT00134563|10831578|FG002|NOT COMPLETED|Overall Study||96
9731961|NCT00138294|10831952|FG000|COMPLETED|Overall Study||29255
9731962|NCT00138294|10831952|FG000|NOT COMPLETED|Overall Study||0
9731963|NCT00138424|10831962|FG000|STARTED|Overall Study||9
9731964|NCT00138424|10831963|FG001|STARTED|Overall Study||5
9731965|NCT00138424|10831964|FG002|STARTED|Overall Study||5
9731966|NCT00138424|10831965|FG003|STARTED|Overall Study||3
9731967|NCT00138424|10831962|FG000|COMPLETED|Overall Study||9
9731968|NCT00138424|10831963|FG001|COMPLETED|Overall Study||4
9731969|NCT00138424|10831964|FG002|COMPLETED|Overall Study||5
9731970|NCT00138424|10831965|FG003|COMPLETED|Overall Study||3
9731971|NCT00138424|10831962|FG000|NOT COMPLETED|Overall Study||0
9731972|NCT00138424|10831963|FG001|NOT COMPLETED|Overall Study||1
9731973|NCT00138424|10831964|FG002|NOT COMPLETED|Overall Study||0
9731974|NCT00138424|10831965|FG003|NOT COMPLETED|Overall Study||0
9731975|NCT00138645|10831979|FG000|STARTED|Overall Study||30
9731976|NCT00138645|10831980|FG001|STARTED|Overall Study||30
9731977|NCT00138645|10831979|FG000|COMPLETED|Overall Study||24
9731978|NCT00138645|10831980|FG001|COMPLETED|Overall Study||23
9731979|NCT00138645|10831979|FG000|NOT COMPLETED|Overall Study||6
9731980|NCT00138645|10831980|FG001|NOT COMPLETED|Overall Study||7
9731981|NCT00138658|10831986|FG000|STARTED|Overall Study||81
9731982|NCT00138658|10831986|FG000|COMPLETED|Overall Study||20
9731983|NCT00138658|10831986|FG000|NOT COMPLETED|Overall Study||61
9731984|NCT00138671|10831994|FG000|STARTED|Overall Study||59
9723104|NCT00078715|10822713|FG000|STARTED|First Intervention||2
9723105|NCT00078715|10822714|FG001|STARTED|First Intervention||4
9723106|NCT00078715|10822713|FG000|COMPLETED|First Intervention||2
9723107|NCT00078715|10822714|FG001|COMPLETED|First Intervention||4
9723108|NCT00078715|10822713|FG000|NOT COMPLETED|First Intervention||0
9723109|NCT00078715|10822714|FG001|NOT COMPLETED|First Intervention||0
9723110|NCT00078715|10822713|FG000|STARTED|Second Intervention||2
9723111|NCT00078715|10822714|FG001|STARTED|Second Intervention||4
9723112|NCT00078715|10822713|FG000|COMPLETED|Second Intervention||2
9723113|NCT00078715|10822714|FG001|COMPLETED|Second Intervention||4
9723114|NCT00078715|10822713|FG000|NOT COMPLETED|Second Intervention||0
9723115|NCT00078715|10822714|FG001|NOT COMPLETED|Second Intervention||0
9723116|NCT00078728|10822722|FG000|STARTED|Overall Study||20
9723117|NCT00078728|10822723|FG001|STARTED|Overall Study||20
9723118|NCT00078728|10822722|FG000|COMPLETED|Overall Study||16
9723119|NCT00078728|10822723|FG001|COMPLETED|Overall Study||17
9723120|NCT00078728|10822722|FG000|NOT COMPLETED|Overall Study||4
9723121|NCT00078728|10822723|FG001|NOT COMPLETED|Overall Study||3
9723122|NCT00078754|10822733|FG000|STARTED|Overall Study||29
9723123|NCT00078754|10822734|FG001|STARTED|Overall Study||30
9723124|NCT00078754|10822735|FG002|STARTED|Overall Study||31
9723125|NCT00078754|10822733|FG000|COMPLETED|Overall Study||14
9723126|NCT00078754|10822734|FG001|COMPLETED|Overall Study||11
9723127|NCT00078754|10822735|FG002|COMPLETED|Overall Study||16
9723128|NCT00078754|10822733|FG000|NOT COMPLETED|Overall Study||15
9723129|NCT00078754|10822734|FG001|NOT COMPLETED|Overall Study||19
9723130|NCT00078754|10822735|FG002|NOT COMPLETED|Overall Study||15
9723131|NCT00078767|10822748|FG000|STARTED|Overall Study||12
9723132|NCT00078767|10822749|FG001|STARTED|Overall Study||12
9723133|NCT00078767|10822748|FG000|COMPLETED|Overall Study||11
9723134|NCT00078767|10822749|FG001|COMPLETED|Overall Study||11
9723135|NCT00078767|10822748|FG000|NOT COMPLETED|Overall Study||1
9723136|NCT00078767|10822749|FG001|NOT COMPLETED|Overall Study||1
9723137|NCT00078819|10822757|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105
9723138|NCT00078819|10822758|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106
9723139|NCT00078819|10822759|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0
9723140|NCT00078819|10822760|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0
9723141|NCT00078819|10822757|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27
9723142|NCT00078819|10822758|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5
9723143|NCT00078819|10822759|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0
9723144|NCT00078819|10822760|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0
9723145|NCT00078819|10822757|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104
9723146|NCT00078819|10822758|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105
9723147|NCT00078819|10822759|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0
9723148|NCT00078819|10822760|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0
9723149|NCT00078819|10822757|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
9723150|NCT00078819|10822758|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
9723151|NCT00078819|10822759|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
9723152|NCT00078819|10822760|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
9723153|NCT00078819|10822757|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
9723154|NCT00078819|10822758|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105
9841158|NCT00819013|10952607|FG003|STARTED|Overall Study||21
9841159|NCT00819013|10952604|FG000|COMPLETED|Overall Study||19
9841160|NCT00819013|10952605|FG001|COMPLETED|Overall Study||22
9841161|NCT00819013|10952606|FG002|COMPLETED|Overall Study||16
9841162|NCT00819013|10952607|FG003|COMPLETED|Overall Study||17
9841163|NCT00819013|10952604|FG000|NOT COMPLETED|Overall Study||3
9841164|NCT00819013|10952605|FG001|NOT COMPLETED|Overall Study||1
9841165|NCT00819013|10952606|FG002|NOT COMPLETED|Overall Study||5
9841166|NCT00819013|10952607|FG003|NOT COMPLETED|Overall Study||4
9841167|NCT00819039|10952620|FG000|STARTED|Overall Study||46
9841168|NCT00819039|10952621|FG001|STARTED|Overall Study||27
9841169|NCT00819039|10952622|FG002|STARTED|Overall Study||25
9841170|NCT00819039|10952620|FG000|COMPLETED|Overall Study||44
9841171|NCT00819039|10952621|FG001|COMPLETED|Overall Study||27
9841172|NCT00819039|10952622|FG002|COMPLETED|Overall Study||24
9841173|NCT00819039|10952620|FG000|NOT COMPLETED|Overall Study||2
9841174|NCT00819039|10952621|FG001|NOT COMPLETED|Overall Study||0
9841175|NCT00819039|10952622|FG002|NOT COMPLETED|Overall Study||1
9841176|NCT00819052|10952634|FG000|STARTED|Overall Study||148
9841177|NCT00819052|10952635|FG001|STARTED|Overall Study||295
9841178|NCT00819052|10952634|FG000|COMPLETED|Overall Study||142
9841179|NCT00819052|10952635|FG001|COMPLETED|Overall Study||281
9841180|NCT00819052|10952634|FG000|NOT COMPLETED|Overall Study||6
9841181|NCT00819052|10952635|FG001|NOT COMPLETED|Overall Study||14
9841182|NCT00819091|10952646|FG000|STARTED|Overall Study||84
9841183|NCT00819091|10952647|FG001|STARTED|Overall Study||161
9841184|NCT00819091|10952646|FG000|COMPLETED|Overall Study||77
9841185|NCT00819091|10952647|FG001|COMPLETED|Overall Study||151
9841186|NCT00819091|10952646|FG000|NOT COMPLETED|Overall Study||7
9841187|NCT00819091|10952647|FG001|NOT COMPLETED|Overall Study||10
9841188|NCT00819156|10952659|FG000|STARTED|Overall Study||30
9841189|NCT00819156|10952660|FG001|STARTED|Overall Study||33
9841190|NCT00819156|10952661|FG002|STARTED|Overall Study||32
9841191|NCT00819156|10952662|FG003|STARTED|Overall Study||30
9841192|NCT00819156|10952663|FG004|STARTED|Overall Study||33
9841193|NCT00819156|10952664|FG005|STARTED|Overall Study||31
9959709|NCT01463982|11079245|FG002|STARTED|Overall Study||4
9959710|NCT01463982|11079246|FG003|STARTED|Overall Study||6
9959711|NCT01463982|11079243|FG000|COMPLETED|Overall Study||3
9959712|NCT01463982|11079244|FG001|COMPLETED|Overall Study||7
9959713|NCT01463982|11079245|FG002|COMPLETED|Overall Study||2
9841194|NCT00819156|10952659|FG000|Randomised and Treated (ITT Population)|Overall Study||30
9841195|NCT00819156|10952660|FG001|Randomised and Treated (ITT Population)|Overall Study||32
9841196|NCT00819156|10952661|FG002|Randomised and Treated (ITT Population)|Overall Study||32
9841197|NCT00819156|10952662|FG003|Randomised and Treated (ITT Population)|Overall Study||30
9841198|NCT00819156|10952663|FG004|Randomised and Treated (ITT Population)|Overall Study||33
9841199|NCT00819156|10952664|FG005|Randomised and Treated (ITT Population)|Overall Study||30
9841200|NCT00819156|10952659|FG000|COMPLETED|Overall Study||20
9841201|NCT00819156|10952660|FG001|COMPLETED|Overall Study||23
9841202|NCT00819156|10952661|FG002|COMPLETED|Overall Study||26
9841203|NCT00819156|10952662|FG003|COMPLETED|Overall Study||28
9841204|NCT00819156|10952663|FG004|COMPLETED|Overall Study||27
9841205|NCT00819156|10952664|FG005|COMPLETED|Overall Study||23
9841206|NCT00819156|10952659|FG000|NOT COMPLETED|Overall Study||10
9841207|NCT00819156|10952660|FG001|NOT COMPLETED|Overall Study||10
9841208|NCT00819156|10952661|FG002|NOT COMPLETED|Overall Study||6
9841209|NCT00819156|10952662|FG003|NOT COMPLETED|Overall Study||2
9841210|NCT00819156|10952663|FG004|NOT COMPLETED|Overall Study||6
9841211|NCT00819156|10952664|FG005|NOT COMPLETED|Overall Study||8
9841212|NCT00819182|10952689|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88
9841213|NCT00819182|10952690|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86
9841214|NCT00819182|10952691|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44
9841215|NCT00819182|10952689|FG000|Week 16 Visit|Overall Study||75
9841216|NCT00819182|10952690|FG001|Week 16 Visit|Overall Study||78
9841217|NCT00819182|10952691|FG002|Week 16 Visit|Overall Study||43
9841218|NCT00819182|10952689|FG000|COMPLETED|Overall Study||75
9841219|NCT00819182|10952690|FG001|COMPLETED|Overall Study||78
9841220|NCT00819182|10952691|FG002|COMPLETED|Overall Study||43
9841221|NCT00819182|10952689|FG000|NOT COMPLETED|Overall Study||13
9841222|NCT00819182|10952690|FG001|NOT COMPLETED|Overall Study||8
9841223|NCT00819182|10952691|FG002|NOT COMPLETED|Overall Study||1
9841224|NCT00819234|10952699|FG000|STARTED|Overall Study||31
9841225|NCT00819234|10952700|FG001|STARTED|Overall Study||35
9841226|NCT00819234|10952701|FG002|STARTED|Overall Study||36
9841227|NCT00819234|10952702|FG003|STARTED|Overall Study||28
9841228|NCT00819234|10952703|FG004|STARTED|Overall Study||13
9841229|NCT00819234|10952704|FG005|STARTED|Overall Study||14
9841230|NCT00819234|10952705|FG006|STARTED|Overall Study||13
9841231|NCT00819234|10952706|FG007|STARTED|Overall Study||29
9841232|NCT00819234|10952707|FG008|STARTED|Overall Study||37
9841233|NCT00819234|10952708|FG009|STARTED|Overall Study||37
9841234|NCT00819234|10952699|FG000|COMPLETED|Overall Study||21
9841235|NCT00819234|10952700|FG001|COMPLETED|Overall Study||20
9841236|NCT00819234|10952701|FG002|COMPLETED|Overall Study||28
9841237|NCT00819234|10952702|FG003|COMPLETED|Overall Study||22
9841238|NCT00819234|10952703|FG004|COMPLETED|Overall Study||12
9841239|NCT00819234|10952704|FG005|COMPLETED|Overall Study||7
9841240|NCT00819234|10952705|FG006|COMPLETED|Overall Study||8
9841241|NCT00819234|10952706|FG007|COMPLETED|Overall Study||20
9841242|NCT00819234|10952707|FG008|COMPLETED|Overall Study||31
9841243|NCT00819234|10952708|FG009|COMPLETED|Overall Study||30
9841244|NCT00819234|10952699|FG000|NOT COMPLETED|Overall Study||10
9841245|NCT00819234|10952700|FG001|NOT COMPLETED|Overall Study||15
9841246|NCT00819234|10952701|FG002|NOT COMPLETED|Overall Study||8
9841247|NCT00819234|10952702|FG003|NOT COMPLETED|Overall Study||6
9841248|NCT00819234|10952703|FG004|NOT COMPLETED|Overall Study||1
9841249|NCT00819234|10952704|FG005|NOT COMPLETED|Overall Study||7
9841250|NCT00819234|10952705|FG006|NOT COMPLETED|Overall Study||5
9841251|NCT00819234|10952706|FG007|NOT COMPLETED|Overall Study||9
9841252|NCT00819234|10952707|FG008|NOT COMPLETED|Overall Study||6
9841253|NCT00819234|10952708|FG009|NOT COMPLETED|Overall Study||7
9841254|NCT00819247|10952766|FG000|STARTED|Overall Study||43
9841255|NCT00819247|10952767|FG001|STARTED|Overall Study||46
9841256|NCT00819247|10952768|FG002|STARTED|Overall Study||40
9841257|NCT00819247|10952766|FG000|Randomized|Overall Study||43
9841258|NCT00819247|10952767|FG001|Randomized|Overall Study||46
9841259|NCT00819247|10952768|FG002|Randomized|Overall Study||40
9841260|NCT00819247|10952766|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
10114175|NCT02514122|11244885|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
9841261|NCT00819247|10952767|FG001|Intent-to-treat Population|Overall Study||46
9841262|NCT00819247|10952768|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
9841263|NCT00819247|10952766|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
9841264|NCT00819247|10952767|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
9841265|NCT00819247|10952768|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
9841266|NCT00819247|10952766|FG000|COMPLETED|Overall Study||32
9841267|NCT00819247|10952767|FG001|COMPLETED|Overall Study||30
9841268|NCT00819247|10952768|FG002|COMPLETED|Overall Study||26
9841269|NCT00819247|10952766|FG000|NOT COMPLETED|Overall Study||11
9841270|NCT00819247|10952767|FG001|NOT COMPLETED|Overall Study||16
9841271|NCT00819247|10952768|FG002|NOT COMPLETED|Overall Study||14
9959714|NCT01463982|11079246|FG003|COMPLETED|Overall Study||6
9841272|NCT00819260|10952776|FG000|STARTED|Overall Study||31
9841273|NCT00819260|10952776|FG000|COMPLETED|Overall Study||31
9959715|NCT01463982|11079243|FG000|NOT COMPLETED|Overall Study||0
10022255|NCT01848483|11145689|FG001|NOT COMPLETED|Overall Study||11
10022256|NCT01848756|11145696|FG000|STARTED|Overall Study||15
10022257|NCT01848756|11145696|FG000|COMPLETED|Overall Study|Cycle 1|12
10022258|NCT01848756|11145696|FG000|NOT COMPLETED|Overall Study||3
10022259|NCT01848821|11145703|FG000|STARTED|Overall Study||7
10022260|NCT01848821|11145704|FG001|STARTED|Overall Study||7
10022261|NCT01848821|11145703|FG000|COMPLETED|Overall Study||7
10022262|NCT01848821|11145704|FG001|COMPLETED|Overall Study||7
10022263|NCT01848821|11145703|FG000|NOT COMPLETED|Overall Study||0
10022264|NCT01848821|11145704|FG001|NOT COMPLETED|Overall Study||0
10022265|NCT01848834|11145715|FG000|STARTED|Overall Study||32
10022266|NCT01848834|11145716|FG001|STARTED|Overall Study||61
10022267|NCT01848834|11145717|FG002|STARTED|Overall Study||33
10022268|NCT01848834|11145718|FG003|STARTED|Overall Study||39
10022269|NCT01848834|11145719|FG004|STARTED|Overall Study||132
10022270|NCT01848834|11145715|FG000|Treated|Overall Study||32
10022271|NCT01848834|11145716|FG001|Treated|Overall Study||60
10022272|NCT01848834|11145717|FG002|Treated|Overall Study||33
10022273|NCT01848834|11145718|FG003|Treated|Overall Study||39
10022274|NCT01848834|11145719|FG004|Treated|Overall Study||132
10022275|NCT01848834|11145715|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13
9841274|NCT00819260|10952776|FG000|NOT COMPLETED|Overall Study||0
9841275|NCT00819286|10952784|FG000|STARTED|Overall Study||70
9841276|NCT00819286|10952785|FG001|STARTED|Overall Study||70
9841277|NCT00819286|10952784|FG000|COMPLETED|Overall Study||56
9841278|NCT00819286|10952785|FG001|COMPLETED|Overall Study||45
9841279|NCT00819286|10952784|FG000|NOT COMPLETED|Overall Study||14
9841280|NCT00819286|10952785|FG001|NOT COMPLETED|Overall Study||25
9841281|NCT00819390|10952795|FG000|STARTED|Overall Study||16
9841282|NCT00819390|10952796|FG001|STARTED|Overall Study||17
9841283|NCT00819390|10952797|FG002|STARTED|Overall Study||18
9841284|NCT00819390|10952798|FG003|STARTED|Overall Study||19
9841285|NCT00819390|10952795|FG000|COMPLETED|Overall Study||13
9841286|NCT00819390|10952796|FG001|COMPLETED|Overall Study||16
9841287|NCT00819390|10952797|FG002|COMPLETED|Overall Study||17
9841288|NCT00819390|10952798|FG003|COMPLETED|Overall Study||19
9841289|NCT00819390|10952795|FG000|NOT COMPLETED|Overall Study||3
9841290|NCT00819390|10952796|FG001|NOT COMPLETED|Overall Study||1
9841291|NCT00819390|10952797|FG002|NOT COMPLETED|Overall Study||1
9841292|NCT00819390|10952798|FG003|NOT COMPLETED|Overall Study||0
9841293|NCT00819403|10952813|FG000|STARTED|First Intervention (6 Weeks)||7
9841294|NCT00819403|10952814|FG001|STARTED|First Intervention (6 Weeks)||8
9841295|NCT00819403|10952813|FG000|COMPLETED|First Intervention (6 Weeks)||7
9841296|NCT00819403|10952814|FG001|COMPLETED|First Intervention (6 Weeks)||8
9841297|NCT00819403|10952813|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
9841298|NCT00819403|10952814|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
9841299|NCT00819403|10952813|FG000|STARTED|Washout (14 Days)||7
9841300|NCT00819403|10952814|FG001|STARTED|Washout (14 Days)||8
9841301|NCT00819403|10952813|FG000|COMPLETED|Washout (14 Days)||7
9841302|NCT00819403|10952814|FG001|COMPLETED|Washout (14 Days)||8
9841303|NCT00819403|10952813|FG000|NOT COMPLETED|Washout (14 Days)||0
9841304|NCT00819403|10952814|FG001|NOT COMPLETED|Washout (14 Days)||0
9841305|NCT00819403|10952813|FG000|STARTED|Second Intervention (6 Weeks)||7
9841306|NCT00819403|10952814|FG001|STARTED|Second Intervention (6 Weeks)||8
9841307|NCT00819403|10952813|FG000|COMPLETED|Second Intervention (6 Weeks)||7
9841308|NCT00819403|10952814|FG001|COMPLETED|Second Intervention (6 Weeks)||8
9841309|NCT00819403|10952813|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9841310|NCT00819403|10952814|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9841311|NCT00819507|10952821|FG000|STARTED|Overall Study||25
9841312|NCT00819507|10952821|FG000|COMPLETED|Overall Study||25
9841313|NCT00819507|10952821|FG000|NOT COMPLETED|Overall Study||0
9959716|NCT01463982|11079244|FG001|NOT COMPLETED|Overall Study||1
10022276|NCT01848834|11145716|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13
10022277|NCT01848834|11145717|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9
10022278|NCT01848834|11145718|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13
10022279|NCT01848834|11145719|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38
9841314|NCT00819585|10952832|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
9841315|NCT00819585|10952833|FG001|STARTED|Core Study||54
9841316|NCT00819585|10952834|FG002|STARTED|Core Study||54
9841317|NCT00819585|10952835|FG003|STARTED|Core Study||54
9841318|NCT00819585|10952836|FG004|STARTED|Core Study||53
9841319|NCT00819585|10952837|FG005|STARTED|Core Study||54
9841320|NCT00819585|10952838|FG006|STARTED|Core Study||108
9841321|NCT00819585|10952839|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0
9841322|NCT00819585|10952840|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0
9841323|NCT00819585|10952841|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0
9841324|NCT00819585|10952842|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0
9841325|NCT00819585|10952832|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
9841326|NCT00819585|10952833|FG001|Received Study Medication|Core Study||54
9841327|NCT00819585|10952834|FG002|Received Study Medication|Core Study||54
9841328|NCT00819585|10952835|FG003|Received Study Medication|Core Study||54
9841329|NCT00819585|10952836|FG004|Received Study Medication|Core Study||53
9841330|NCT00819585|10952837|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
9841331|NCT00819585|10952838|FG006|Received Study Medication|Core Study||108
9841332|NCT00819585|10952839|FG007|Received Study Medication|Core Study||0
9841333|NCT00819585|10952840|FG008|Received Study Medication|Core Study||0
9841334|NCT00819585|10952841|FG009|Received Study Medication|Core Study||0
9841335|NCT00819585|10952842|FG010|Received Study Medication|Core Study||0
9841336|NCT00819585|10952832|FG000|COMPLETED|Core Study||49
9841337|NCT00819585|10952833|FG001|COMPLETED|Core Study||48
9841338|NCT00819585|10952834|FG002|COMPLETED|Core Study||48
9841339|NCT00819585|10952835|FG003|COMPLETED|Core Study||49
9841340|NCT00819585|10952836|FG004|COMPLETED|Core Study||50
9841341|NCT00819585|10952837|FG005|COMPLETED|Core Study||52
9841342|NCT00819585|10952838|FG006|COMPLETED|Core Study||95
9841343|NCT00819585|10952839|FG007|COMPLETED|Core Study||0
9841344|NCT00819585|10952840|FG008|COMPLETED|Core Study||0
9841345|NCT00819585|10952841|FG009|COMPLETED|Core Study||0
9841346|NCT00819585|10952842|FG010|COMPLETED|Core Study||0
9841347|NCT00819585|10952832|FG000|NOT COMPLETED|Core Study||6
9841348|NCT00819585|10952833|FG001|NOT COMPLETED|Core Study||6
9959717|NCT01463982|11079245|FG002|NOT COMPLETED|Overall Study||2
9959718|NCT01463982|11079246|FG003|NOT COMPLETED|Overall Study||0
9959719|NCT01464021|11079256|FG000|STARTED|Overall Study||26
9959720|NCT01464021|11079256|FG000|COMPLETED|Overall Study||0
9723155|NCT00078819|10822759|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0
9723156|NCT00078819|10822760|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0
9723157|NCT00078819|10822757|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
9723158|NCT00078819|10822758|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
9841349|NCT00819585|10952834|FG002|NOT COMPLETED|Core Study||6
9841350|NCT00819585|10952835|FG003|NOT COMPLETED|Core Study||5
9959721|NCT01464021|11079256|FG000|NOT COMPLETED|Overall Study||26
9723159|NCT00078819|10822759|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
9841351|NCT00819585|10952836|FG004|NOT COMPLETED|Core Study||3
9841352|NCT00819585|10952837|FG005|NOT COMPLETED|Core Study||2
9841353|NCT00819585|10952838|FG006|NOT COMPLETED|Core Study||13
9841354|NCT00819585|10952839|FG007|NOT COMPLETED|Core Study||0
9841355|NCT00819585|10952840|FG008|NOT COMPLETED|Core Study||0
9841356|NCT00819585|10952841|FG009|NOT COMPLETED|Core Study||0
9841357|NCT00819585|10952842|FG010|NOT COMPLETED|Core Study||0
9841358|NCT00819585|10952832|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
9841359|NCT00819585|10952833|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
9841360|NCT00819585|10952834|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
9841361|NCT00819585|10952835|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
9841362|NCT00819585|10952836|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
9841363|NCT00819585|10952837|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
9841364|NCT00819585|10952838|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
9841365|NCT00819585|10952839|FG007|STARTED|Extension Study||75
9841366|NCT00819585|10952840|FG008|STARTED|Extension Study||181
9841367|NCT00819585|10952841|FG009|STARTED|Extension Study||25
9841368|NCT00819585|10952842|FG010|STARTED|Extension Study||60
9841369|NCT00819585|10952832|FG000|COMPLETED|Extension Study||0
9959722|NCT01464190|11079262|FG000|STARTED|Overall Study||391
9959723|NCT01464190|11079263|FG001|STARTED|Overall Study||268
9959724|NCT01464190|11079262|FG000|COMPLETED|Overall Study||322
9959725|NCT01464190|11079263|FG001|COMPLETED|Overall Study||227
9959726|NCT01464190|11079262|FG000|NOT COMPLETED|Overall Study||69
9959727|NCT01464190|11079263|FG001|NOT COMPLETED|Overall Study||41
9959728|NCT01464229|11079271|FG000|STARTED|Overall Study||10
10022280|NCT01848834|11145715|FG000|NOT COMPLETED|Overall Study||19
9959729|NCT01464229|11079272|FG001|STARTED|Overall Study||10
10022281|NCT01848834|11145716|FG001|NOT COMPLETED|Overall Study||48
10022282|NCT01848834|11145717|FG002|NOT COMPLETED|Overall Study||24
10114176|NCT02514122|11244886|FG001|COMPLETED|Overall Study||29
10114177|NCT02514122|11244885|FG000|NOT COMPLETED|Overall Study||2
9841370|NCT00819585|10952833|FG001|COMPLETED|Extension Study||0
9841371|NCT00819585|10952834|FG002|COMPLETED|Extension Study||0
9959730|NCT01464229|11079271|FG000|COMPLETED|Overall Study||5
9959731|NCT01464229|11079272|FG001|COMPLETED|Overall Study||8
9959732|NCT01464229|11079271|FG000|NOT COMPLETED|Overall Study||5
9959733|NCT01464229|11079272|FG001|NOT COMPLETED|Overall Study||2
9959734|NCT01464255|11079280|FG000|STARTED|Overall Study||25
9959735|NCT01464255|11079281|FG001|STARTED|Overall Study||25
9959736|NCT01464255|11079280|FG000|COMPLETED|Overall Study||25
9959737|NCT01464255|11079281|FG001|COMPLETED|Overall Study||24
9959738|NCT01464255|11079280|FG000|NOT COMPLETED|Overall Study||0
9959739|NCT01464255|11079281|FG001|NOT COMPLETED|Overall Study||1
9959740|NCT01464307|11079290|FG000|STARTED|Main Period||144
9959741|NCT01464307|11079291|FG001|STARTED|Main Period||145
9959742|NCT01464307|11079290|FG000|Treated|Main Period||144
9959743|NCT01464307|11079291|FG001|Treated|Main Period||145
9959744|NCT01464307|11079290|FG000|COMPLETED|Main Period||129
9959745|NCT01464307|11079291|FG001|COMPLETED|Main Period||140
9959746|NCT01464307|11079290|FG000|NOT COMPLETED|Main Period||15
9959747|NCT01464307|11079291|FG001|NOT COMPLETED|Main Period||5
9959748|NCT01464307|11079290|FG000|STARTED|Open-Label Extension Period||269
9959749|NCT01464307|11079291|FG001|STARTED|Open-Label Extension Period||0
9959750|NCT01464307|11079290|FG000|Treated|Open-Label Extension Period||269
9959751|NCT01464307|11079291|FG001|Treated|Open-Label Extension Period||0
9959752|NCT01464307|11079290|FG000|COMPLETED|Open-Label Extension Period||218
10022283|NCT01848834|11145718|FG003|NOT COMPLETED|Overall Study||26
10022284|NCT01848834|11145719|FG004|NOT COMPLETED|Overall Study||94
10022285|NCT01848847|11145737|FG000|STARTED|Overall Study||51
10022286|NCT01848847|11145738|FG001|STARTED|Overall Study||51
9841372|NCT00819585|10952835|FG003|COMPLETED|Extension Study||0
9841373|NCT00819585|10952836|FG004|COMPLETED|Extension Study||0
9841374|NCT00819585|10952837|FG005|COMPLETED|Extension Study||0
9841375|NCT00819585|10952838|FG006|COMPLETED|Extension Study||0
9841376|NCT00819585|10952839|FG007|COMPLETED|Extension Study||75
9841377|NCT00819585|10952840|FG008|COMPLETED|Extension Study||173
9841378|NCT00819585|10952841|FG009|COMPLETED|Extension Study||24
9841379|NCT00819585|10952842|FG010|COMPLETED|Extension Study||58
9841380|NCT00819585|10952832|FG000|NOT COMPLETED|Extension Study||0
9841381|NCT00819585|10952833|FG001|NOT COMPLETED|Extension Study||0
9841382|NCT00819585|10952834|FG002|NOT COMPLETED|Extension Study||0
9841383|NCT00819585|10952835|FG003|NOT COMPLETED|Extension Study||0
9841384|NCT00819585|10952836|FG004|NOT COMPLETED|Extension Study||0
9841385|NCT00819585|10952837|FG005|NOT COMPLETED|Extension Study||0
9841386|NCT00819585|10952838|FG006|NOT COMPLETED|Extension Study||0
9841387|NCT00819585|10952839|FG007|NOT COMPLETED|Extension Study||0
9841388|NCT00819585|10952840|FG008|NOT COMPLETED|Extension Study||8
9841389|NCT00819585|10952841|FG009|NOT COMPLETED|Extension Study||1
9841390|NCT00819585|10952842|FG010|NOT COMPLETED|Extension Study||2
9841391|NCT00819637|10952873|FG000|STARTED|Overall Study||2
10022287|NCT01848847|11145737|FG000|COMPLETED|Overall Study||49
10022288|NCT01848847|11145738|FG001|COMPLETED|Overall Study||48
10022289|NCT01848847|11145737|FG000|NOT COMPLETED|Overall Study||2
10022290|NCT01848847|11145738|FG001|NOT COMPLETED|Overall Study||3
10022291|NCT01848899|11145746|FG000|STARTED|Overall Study||50
10022292|NCT01848899|11145747|FG001|STARTED|Overall Study||50
10022293|NCT01848899|11145746|FG000|COMPLETED|Overall Study||50
10022294|NCT01848899|11145747|FG001|COMPLETED|Overall Study||50
10022295|NCT01848899|11145746|FG000|NOT COMPLETED|Overall Study||0
10022296|NCT01848899|11145747|FG001|NOT COMPLETED|Overall Study||0
10022297|NCT01848938|11145755|FG000|STARTED|Overall Study||62
10022298|NCT01848938|11145756|FG001|STARTED|Overall Study||61
10022299|NCT01848938|11145755|FG000|COMPLETED|Overall Study||61
10022300|NCT01848938|11145756|FG001|COMPLETED|Overall Study||60
10022301|NCT01848938|11145755|FG000|NOT COMPLETED|Overall Study||1
10022302|NCT01848938|11145756|FG001|NOT COMPLETED|Overall Study||1
10022303|NCT01848977|11145762|FG000|STARTED|Overall Study||20
10022304|NCT01848977|11145762|FG000|COMPLETED|Overall Study||20
10022305|NCT01848977|11145762|FG000|NOT COMPLETED|Overall Study||0
10022306|NCT01848990|11145774|FG000|STARTED|Overall Study||227
10022307|NCT01848990|11145775|FG001|STARTED|Overall Study||115
10022308|NCT01848990|11145776|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
10022309|NCT01848990|11145774|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227
10022310|NCT01848990|11145775|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
10022311|NCT01848990|11145776|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113
10022312|NCT01848990|11145774|FG000|Completed Month 6|Overall Study||194
10022313|NCT01848990|11145775|FG001|Completed Month 6|Overall Study||106
10022314|NCT01848990|11145776|FG002|Completed Month 6|Overall Study||103
10022315|NCT01848990|11145774|FG000|COMPLETED|Overall Study||181
10022316|NCT01848990|11145775|FG001|COMPLETED|Overall Study||95
10022317|NCT01848990|11145776|FG002|COMPLETED|Overall Study||98
9723160|NCT00078819|10822760|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
9723161|NCT00078819|10822757|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
9723162|NCT00078819|10822758|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
9723163|NCT00078819|10822759|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
9723164|NCT00078819|10822760|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
9723165|NCT00078819|10822757|FG000|STARTED|Withdrawal Period: Weeks 37-48||0
9723166|NCT00078819|10822758|FG001|STARTED|Withdrawal Period: Weeks 37-48||0
9723167|NCT00078819|10822759|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
9723168|NCT00078819|10822760|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
9723169|NCT00078819|10822757|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0
9723170|NCT00078819|10822758|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0
9723171|NCT00078819|10822759|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69
9723172|NCT00078819|10822760|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68
9723173|NCT00078819|10822757|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0
9723174|NCT00078819|10822758|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0
9723175|NCT00078819|10822759|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
9723176|NCT00078819|10822760|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
9723177|NCT00078819|10822757|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
9723178|NCT00078819|10822758|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
9723179|NCT00078819|10822759|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
9723180|NCT00078819|10822760|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
9723181|NCT00078819|10822757|FG000|STARTED|Re-treatment Period||0
9723182|NCT00078819|10822758|FG001|STARTED|Re-treatment Period||0
9723183|NCT00078819|10822759|FG002|STARTED|Re-treatment Period||29
9723184|NCT00078819|10822760|FG003|STARTED|Re-treatment Period||13
9723185|NCT00078819|10822757|FG000|Received Study Drug|Re-treatment Period||0
9723186|NCT00078819|10822758|FG001|Received Study Drug|Re-treatment Period||0
9723187|NCT00078819|10822759|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
9723188|NCT00078819|10822760|FG003|Received Study Drug|Re-treatment Period||12
9723189|NCT00078819|10822757|FG000|COMPLETED|Re-treatment Period||0
9723190|NCT00078819|10822758|FG001|COMPLETED|Re-treatment Period||0
9723191|NCT00078819|10822759|FG002|COMPLETED|Re-treatment Period||29
9723192|NCT00078819|10822760|FG003|COMPLETED|Re-treatment Period||13
9723193|NCT00078819|10822757|FG000|NOT COMPLETED|Re-treatment Period||0
9723194|NCT00078819|10822758|FG001|NOT COMPLETED|Re-treatment Period||0
9723195|NCT00078819|10822759|FG002|NOT COMPLETED|Re-treatment Period||0
9723196|NCT00078819|10822760|FG003|NOT COMPLETED|Re-treatment Period||0
9723197|NCT00078897|10822779|FG000|STARTED|Overall Study||809
9723198|NCT00078897|10822780|FG001|STARTED|Overall Study||812
9723199|NCT00078897|10822779|FG000|COMPLETED|Overall Study||685
9723200|NCT00078897|10822780|FG001|COMPLETED|Overall Study||689
9723201|NCT00078897|10822779|FG000|NOT COMPLETED|Overall Study||124
9723202|NCT00078897|10822780|FG001|NOT COMPLETED|Overall Study||123
9723203|NCT00078949|10822790|FG000|STARTED|Overall Study||310
9723204|NCT00078949|10822791|FG001|STARTED|Overall Study||309
9723205|NCT00078949|10822792|FG002|STARTED|Overall Study||115
9723206|NCT00078949|10822793|FG003|STARTED|Overall Study||115
9723207|NCT00078949|10822790|FG000|COMPLETED|Overall Study||306
9723208|NCT00078949|10822791|FG001|COMPLETED|Overall Study||304
9723209|NCT00078949|10822792|FG002|COMPLETED|Overall Study||112
9723210|NCT00078949|10822793|FG003|COMPLETED|Overall Study||112
9723211|NCT00078949|10822790|FG000|NOT COMPLETED|Overall Study||4
9723212|NCT00078949|10822791|FG001|NOT COMPLETED|Overall Study||5
9723213|NCT00078949|10822792|FG002|NOT COMPLETED|Overall Study||3
9723214|NCT00078949|10822793|FG003|NOT COMPLETED|Overall Study||3
9723215|NCT00079001|10822807|FG000|STARTED|Overall Study||323
9723216|NCT00079001|10822808|FG001|STARTED|Overall Study||322
9723217|NCT00079001|10822807|FG000|COMPLETED|Overall Study||323
9723218|NCT00079001|10822808|FG001|COMPLETED|Overall Study||322
9723219|NCT00079001|10822807|FG000|NOT COMPLETED|Overall Study||0
9723220|NCT00079001|10822808|FG001|NOT COMPLETED|Overall Study||0
9723221|NCT00079040|10822814|FG000|STARTED|Overall Study||65
9841392|NCT00819637|10952874|FG001|STARTED|Overall Study||0
9841393|NCT00819637|10952875|FG002|STARTED|Overall Study||0
10022318|NCT01848990|11145774|FG000|NOT COMPLETED|Overall Study||46
10022319|NCT01848990|11145775|FG001|NOT COMPLETED|Overall Study||20
10022320|NCT01848990|11145776|FG002|NOT COMPLETED|Overall Study||16
10022321|NCT01849055|11145794|FG000|STARTED|Overall Study||8
10022322|NCT01849055|11145795|FG001|STARTED|Overall Study||8
10022323|NCT01849055|11145796|FG002|STARTED|Overall Study||8
9841394|NCT00819637|10952873|FG000|COMPLETED|Overall Study||2
9841395|NCT00819637|10952874|FG001|COMPLETED|Overall Study||0
9959753|NCT01464307|11079291|FG001|COMPLETED|Open-Label Extension Period||0
9959754|NCT01464307|11079290|FG000|NOT COMPLETED|Open-Label Extension Period||51
9959755|NCT01464307|11079291|FG001|NOT COMPLETED|Open-Label Extension Period||0
9959756|NCT01464333|11079298|FG000|STARTED|Overall Study||389
9959757|NCT01464333|11079298|FG000|COMPLETED|Overall Study||226
9959758|NCT01464333|11079298|FG000|NOT COMPLETED|Overall Study||163
9959759|NCT01464346|11079302|FG000|STARTED|Overall Study||29
9959760|NCT01464346|11079303|FG001|STARTED|Overall Study||32
9959761|NCT01464346|11079304|FG002|STARTED|Overall Study||29
9959762|NCT01464346|11079302|FG000|COMPLETED|Overall Study||29
9959763|NCT01464346|11079303|FG001|COMPLETED|Overall Study||32
9959764|NCT01464346|11079304|FG002|COMPLETED|Overall Study||28
9959765|NCT01464346|11079302|FG000|NOT COMPLETED|Overall Study||0
9959766|NCT01464346|11079303|FG001|NOT COMPLETED|Overall Study||0
9959767|NCT01464346|11079304|FG002|NOT COMPLETED|Overall Study||1
9959768|NCT01464359|11079312|FG000|STARTED|Overall Study||3
9959769|NCT01464359|11079312|FG000|COMPLETED|Overall Study||3
9959770|NCT01464359|11079312|FG000|NOT COMPLETED|Overall Study||0
9959771|NCT01464424|11079316|FG000|STARTED|Period 1, First 6 Weeks||42
9959772|NCT01464424|11079317|FG001|STARTED|Period 1, First 6 Weeks||42
9959773|NCT01464424|11079316|FG000|COMPLETED|Period 1, First 6 Weeks||42
9959774|NCT01464424|11079317|FG001|COMPLETED|Period 1, First 6 Weeks||41
9959775|NCT01464424|11079316|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0
9959776|NCT01464424|11079317|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1
9959777|NCT01464424|11079316|FG000|STARTED|Period 2, Second 6 Weeks||42
9959778|NCT01464424|11079317|FG001|STARTED|Period 2, Second 6 Weeks||41
9959779|NCT01464424|11079316|FG000|COMPLETED|Period 2, Second 6 Weeks||42
9959780|NCT01464424|11079317|FG001|COMPLETED|Period 2, Second 6 Weeks||41
9959781|NCT01464424|11079316|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
9959782|NCT01464424|11079317|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
9959783|NCT01464619|11079325|FG000|STARTED|Overall Study||32
9959784|NCT01464619|11079326|FG001|STARTED|Overall Study||29
9959785|NCT01464619|11079325|FG000|COMPLETED|Overall Study||29
9959786|NCT01464619|11079326|FG001|COMPLETED|Overall Study||25
9959787|NCT01464619|11079325|FG000|NOT COMPLETED|Overall Study||3
9959788|NCT01464619|11079326|FG001|NOT COMPLETED|Overall Study||4
9959789|NCT01464697|11079336|FG000|STARTED|Overall Study||93
9959790|NCT01464697|11079337|FG001|STARTED|Overall Study||96
9959791|NCT01464697|11079336|FG000|COMPLETED|Overall Study||90
9959792|NCT01464697|11079337|FG001|COMPLETED|Overall Study||86
9959793|NCT01464697|11079336|FG000|NOT COMPLETED|Overall Study||3
9959794|NCT01464697|11079337|FG001|NOT COMPLETED|Overall Study||10
9959795|NCT01464775|11079345|FG000|STARTED|Overall Study||123
9959796|NCT01464775|11079346|FG001|STARTED|Overall Study||44
10022324|NCT01849055|11145797|FG003|STARTED|Overall Study||8
10022325|NCT01849055|11145798|FG004|STARTED|Overall Study||8
9841396|NCT00819637|10952875|FG002|COMPLETED|Overall Study||0
9841397|NCT00819637|10952873|FG000|NOT COMPLETED|Overall Study||0
9841398|NCT00819637|10952874|FG001|NOT COMPLETED|Overall Study||0
9841399|NCT00819637|10952875|FG002|NOT COMPLETED|Overall Study||0
9841400|NCT00819741|10952885|FG000|STARTED|Overall Study||218
9841401|NCT00819741|10952886|FG001|STARTED|Overall Study||215
9841402|NCT00819741|10952885|FG000|Exposed to Drug|Overall Study||218
9841403|NCT00819741|10952886|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
9841404|NCT00819741|10952885|FG000|COMPLETED|Overall Study||196
9841405|NCT00819741|10952886|FG001|COMPLETED|Overall Study||201
9841406|NCT00819741|10952885|FG000|NOT COMPLETED|Overall Study||22
9841407|NCT00819741|10952886|FG001|NOT COMPLETED|Overall Study||14
9841408|NCT00819767|10952894|FG000|STARTED|Overall Study||33
9959797|NCT01464775|11079345|FG000|COMPLETED|Overall Study||112
10022326|NCT01849055|11145799|FG005|STARTED|Overall Study||8
9841409|NCT00819767|10952895|FG001|STARTED|Overall Study||35
9841410|NCT00819767|10952894|FG000|COMPLETED|Overall Study||32
9841411|NCT00819767|10952895|FG001|COMPLETED|Overall Study||33
9841412|NCT00819767|10952894|FG000|NOT COMPLETED|Overall Study||1
9841413|NCT00819767|10952895|FG001|NOT COMPLETED|Overall Study||2
9841414|NCT00819780|10952903|FG000|STARTED|Overall Study||142
9841415|NCT00819780|10952904|FG001|STARTED|Overall Study||143
9841416|NCT00819780|10952903|FG000|Received Study Treatment|Overall Study||139
9841417|NCT00819780|10952904|FG001|Received Study Treatment|Overall Study||139
9841418|NCT00819780|10952903|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
9841419|NCT00819780|10952904|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
9841420|NCT00819780|10952903|FG000|NOT COMPLETED|Overall Study||28
9841421|NCT00819780|10952904|FG001|NOT COMPLETED|Overall Study||21
9841425|NCT00819910|10952919|FG000|STARTED|Overall Study||10
9841426|NCT00819910|10952920|FG001|STARTED|Overall Study||10
9841427|NCT00819910|10952921|FG002|STARTED|Overall Study||10
9841428|NCT00819910|10952922|FG003|STARTED|Overall Study||11
9841429|NCT00819910|10952919|FG000|COMPLETED|Overall Study||8
9841430|NCT00819910|10952920|FG001|COMPLETED|Overall Study||9
9841431|NCT00819910|10952921|FG002|COMPLETED|Overall Study||7
9841432|NCT00819910|10952922|FG003|COMPLETED|Overall Study||10
9841433|NCT00819910|10952919|FG000|NOT COMPLETED|Overall Study||2
9841434|NCT00819910|10952920|FG001|NOT COMPLETED|Overall Study||1
9841435|NCT00819910|10952921|FG002|NOT COMPLETED|Overall Study||3
9841436|NCT00819910|10952922|FG003|NOT COMPLETED|Overall Study||1
9841437|NCT00820040|10952934|FG000|STARTED|Overall Study||10
9841438|NCT00820040|10952934|FG000|Safety Evaluable Population|Overall Study||8
9841439|NCT00820040|10952934|FG000|Full Analysis Set|Overall Study||8
9841440|NCT00820040|10952934|FG000|COMPLETED|Overall Study||7
9841441|NCT00820040|10952934|FG000|NOT COMPLETED|Overall Study||3
9841442|NCT00820170|10952943|FG000|STARTED|Overall Study||3
9841443|NCT00820170|10952944|FG001|STARTED|Overall Study||5
9841444|NCT00820170|10952945|FG002|STARTED|Overall Study||3
9841445|NCT00820170|10952946|FG003|STARTED|Overall Study||40
9841446|NCT00820170|10952947|FG004|STARTED|Overall Study||4
9841447|NCT00820170|10952943|FG000|COMPLETED|Overall Study||3
9841448|NCT00820170|10952944|FG001|COMPLETED|Overall Study||5
9841449|NCT00820170|10952945|FG002|COMPLETED|Overall Study||3
9841450|NCT00820170|10952946|FG003|COMPLETED|Overall Study||40
9841451|NCT00820170|10952947|FG004|COMPLETED|Overall Study||0
9841452|NCT00820170|10952943|FG000|NOT COMPLETED|Overall Study||0
9841453|NCT00820170|10952944|FG001|NOT COMPLETED|Overall Study||0
9841454|NCT00820170|10952945|FG002|NOT COMPLETED|Overall Study||0
9841455|NCT00820170|10952946|FG003|NOT COMPLETED|Overall Study||0
9841456|NCT00820170|10952947|FG004|NOT COMPLETED|Overall Study||4
9841457|NCT00820222|10952966|FG000|STARTED|Overall Study||271
9841458|NCT00820222|10952967|FG001|STARTED|Overall Study||269
9841459|NCT00820222|10952966|FG000|COMPLETED|Overall Study||95
9841460|NCT00820222|10952967|FG001|COMPLETED|Overall Study||79
9841461|NCT00820222|10952966|FG000|NOT COMPLETED|Overall Study||176
9841462|NCT00820222|10952967|FG001|NOT COMPLETED|Overall Study||190
9841463|NCT00820235|10952976|FG000|STARTED|Overall Study||48
9841464|NCT00820235|10952977|FG001|STARTED|Overall Study||49
9841465|NCT00820235|10952978|FG002|STARTED|Overall Study||44
9841466|NCT00820235|10952976|FG000|COMPLETED|Overall Study||33
9841467|NCT00820235|10952977|FG001|COMPLETED|Overall Study||28
9841468|NCT00820235|10952978|FG002|COMPLETED|Overall Study||27
9841469|NCT00820235|10952976|FG000|NOT COMPLETED|Overall Study||15
9841470|NCT00820235|10952977|FG001|NOT COMPLETED|Overall Study||21
9841471|NCT00820235|10952978|FG002|NOT COMPLETED|Overall Study||17
9841472|NCT00820248|10952988|FG000|STARTED|Overall Study||160
9841473|NCT00820248|10952989|FG001|STARTED|Overall Study||160
9841474|NCT00820248|10952988|FG000|Received Protocol Treatment|Overall Study||156
9841475|NCT00820248|10952989|FG001|Received Protocol Treatment|Overall Study||159
9841476|NCT00820248|10952988|FG000|COMPLETED|Overall Study||156
9841477|NCT00820248|10952989|FG001|COMPLETED|Overall Study||159
9841478|NCT00820248|10952988|FG000|NOT COMPLETED|Overall Study||4
9841479|NCT00820248|10952989|FG001|NOT COMPLETED|Overall Study||1
9841480|NCT00820443|10952995|FG000|STARTED|Pre-Op||253
9841481|NCT00820443|10952995|FG000|COMPLETED|Pre-Op||253
9841482|NCT00820443|10952995|FG000|NOT COMPLETED|Pre-Op||0
9841483|NCT00820443|10952995|FG000|STARTED|Op||253
9841484|NCT00820443|10952995|FG000|COMPLETED|Op||253
9841485|NCT00820443|10952995|FG000|NOT COMPLETED|Op||0
9841486|NCT00820443|10952995|FG000|STARTED|Immediately||253
9841487|NCT00820443|10952995|FG000|COMPLETED|Immediately||248
9723222|NCT00079040|10822814|FG000|COMPLETED|Overall Study||63
9723223|NCT00079040|10822814|FG000|NOT COMPLETED|Overall Study||2
9723224|NCT00079183|10822818|FG000|STARTED|Overall Study||44
9723225|NCT00079183|10822818|FG000|Drop Outs|Overall Study||7
9723226|NCT00079183|10822818|FG000|COMPLETED|Overall Study||37
9723227|NCT00079183|10822818|FG000|NOT COMPLETED|Overall Study||7
9723228|NCT00079274|10822830|FG000|STARTED|Overall Study||1402
9723229|NCT00079274|10822831|FG001|STARTED|Overall Study||111
9723230|NCT00079274|10822832|FG002|STARTED|Overall Study||111
9723231|NCT00079274|10822833|FG003|STARTED|Overall Study||1350
9723232|NCT00079274|10822834|FG004|STARTED|Overall Study||45
9723233|NCT00079274|10822835|FG005|STARTED|Overall Study||46
9723234|NCT00079274|10822836|FG006|STARTED|Overall Study||332
9723235|NCT00079274|10822830|FG000|COMPLETED|Overall Study||1081
9723236|NCT00079274|10822831|FG001|COMPLETED|Overall Study||84
9723237|NCT00079274|10822832|FG002|COMPLETED|Overall Study||84
9723238|NCT00079274|10822833|FG003|COMPLETED|Overall Study||906
9723239|NCT00079274|10822834|FG004|COMPLETED|Overall Study||30
9723240|NCT00079274|10822835|FG005|COMPLETED|Overall Study||26
9723241|NCT00079274|10822836|FG006|COMPLETED|Overall Study||332
9723242|NCT00079274|10822830|FG000|NOT COMPLETED|Overall Study||321
9723243|NCT00079274|10822831|FG001|NOT COMPLETED|Overall Study||27
9723244|NCT00079274|10822832|FG002|NOT COMPLETED|Overall Study||27
9723245|NCT00079274|10822833|FG003|NOT COMPLETED|Overall Study||444
9723246|NCT00079274|10822834|FG004|NOT COMPLETED|Overall Study||15
9723247|NCT00079274|10822835|FG005|NOT COMPLETED|Overall Study||20
9723248|NCT00079274|10822836|FG006|NOT COMPLETED|Overall Study||0
9723249|NCT00079326|10822851|FG000|STARTED|Overall Study||15
9723250|NCT00079326|10822852|FG001|STARTED|Overall Study||24
9723251|NCT00079326|10822851|FG000|COMPLETED|Overall Study||15
9723252|NCT00079326|10822852|FG001|COMPLETED|Overall Study||24
9723253|NCT00079326|10822851|FG000|NOT COMPLETED|Overall Study||0
9723254|NCT00079326|10822852|FG001|NOT COMPLETED|Overall Study||0
9723255|NCT00079339|10822860|FG000|STARTED|Overall Study||5
9723256|NCT00079339|10822861|FG001|STARTED|Overall Study||40
9723257|NCT00079339|10822862|FG002|STARTED|Overall Study||6
9723258|NCT00079339|10822860|FG000|Enrolled in Phase I|Overall Study||5
9841488|NCT00820443|10952995|FG000|NOT COMPLETED|Immediately||5
9841489|NCT00820443|10952995|FG000|STARTED|3 Month||253
9841490|NCT00820443|10952995|FG000|COMPLETED|3 Month||244
9841491|NCT00820443|10952995|FG000|NOT COMPLETED|3 Month||9
9841492|NCT00820443|10952995|FG000|STARTED|6 Month||253
9841493|NCT00820443|10952995|FG000|COMPLETED|6 Month||233
9841494|NCT00820443|10952995|FG000|NOT COMPLETED|6 Month||20
9841495|NCT00820443|10952995|FG000|STARTED|12 Month||250
9841496|NCT00820443|10952995|FG000|COMPLETED|12 Month||226
9841497|NCT00820443|10952995|FG000|NOT COMPLETED|12 Month||24
9841498|NCT00820443|10952995|FG000|STARTED|24 Month||245
9841499|NCT00820443|10952995|FG000|COMPLETED|24 Month||202
9841500|NCT00820443|10952995|FG000|NOT COMPLETED|24 Month||43
9841501|NCT00820534|10953002|FG000|STARTED|Overall Study||64
9841502|NCT00820534|10953003|FG001|STARTED|Overall Study||62
9841503|NCT00820534|10953002|FG000|COMPLETED|Overall Study||64
9841504|NCT00820534|10953003|FG001|COMPLETED|Overall Study||62
9841505|NCT00820534|10953002|FG000|NOT COMPLETED|Overall Study||0
9841506|NCT00820534|10953003|FG001|NOT COMPLETED|Overall Study||0
9841507|NCT00820573|10953013|FG000|STARTED|Overall Study||4
9841508|NCT00820573|10953014|FG001|STARTED|Overall Study||4
9841509|NCT00820573|10953015|FG002|STARTED|Overall Study||4
9841510|NCT00820573|10953016|FG003|STARTED|Overall Study||4
9841511|NCT00820573|10953013|FG000|COMPLETED|Overall Study||4
9841512|NCT00820573|10953014|FG001|COMPLETED|Overall Study||4
9841513|NCT00820573|10953015|FG002|COMPLETED|Overall Study||4
9841514|NCT00820573|10953016|FG003|COMPLETED|Overall Study||4
9841515|NCT00820573|10953013|FG000|NOT COMPLETED|Overall Study||0
9841516|NCT00820573|10953014|FG001|NOT COMPLETED|Overall Study||0
9841517|NCT00820573|10953015|FG002|NOT COMPLETED|Overall Study||0
9723259|NCT00079339|10822861|FG001|Enrolled in Phase I|Overall Study||6
9723260|NCT00079339|10822862|FG002|Enrolled in Phase I|Overall Study||6
9723261|NCT00079339|10822860|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
9841518|NCT00820573|10953016|FG003|NOT COMPLETED|Overall Study||0
9841519|NCT00820599|10953035|FG000|STARTED|Overall Study||211
9841520|NCT00820599|10953035|FG000|COMPLETED|Overall Study||80
9841521|NCT00820599|10953035|FG000|NOT COMPLETED|Overall Study||131
9841522|NCT00820612|10953041|FG000|STARTED|Overall Study||307
10022327|NCT01849055|11145794|FG000|COMPLETED|Overall Study||8
10022328|NCT01849055|11145795|FG001|COMPLETED|Overall Study||8
10022329|NCT01849055|11145796|FG002|COMPLETED|Overall Study||7
10022330|NCT01849055|11145797|FG003|COMPLETED|Overall Study||8
9841523|NCT00820612|10953042|FG001|STARTED|Overall Study||295
9841524|NCT00820612|10953041|FG000|COMPLETED|Overall Study||307
9841525|NCT00820612|10953042|FG001|COMPLETED|Overall Study||295
9841526|NCT00820612|10953041|FG000|NOT COMPLETED|Overall Study||0
9841527|NCT00820612|10953042|FG001|NOT COMPLETED|Overall Study||0
9841528|NCT00820664|10953051|FG000|STARTED|Overall Study||9
9841529|NCT00820664|10953052|FG001|STARTED|Overall Study||11
9841530|NCT00820664|10953053|FG002|STARTED|Overall Study||9
9841531|NCT00820664|10953051|FG000|COMPLETED|Overall Study||9
9841532|NCT00820664|10953052|FG001|COMPLETED|Overall Study||11
9841533|NCT00820664|10953053|FG002|COMPLETED|Overall Study||9
9841534|NCT00820664|10953051|FG000|NOT COMPLETED|Overall Study||0
9841535|NCT00820664|10953052|FG001|NOT COMPLETED|Overall Study||0
9841536|NCT00820664|10953053|FG002|NOT COMPLETED|Overall Study||0
9841537|NCT00820755|10953061|FG000|STARTED|Period 1: Combination Therapy Phase||583
9841538|NCT00820755|10953062|FG001|STARTED|Period 1: Combination Therapy Phase||0
9841539|NCT00820755|10953063|FG002|STARTED|Period 1: Combination Therapy Phase||0
9841540|NCT00820755|10953061|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
9841541|NCT00820755|10953062|FG001|COMPLETED|Period 1: Combination Therapy Phase||0
9841542|NCT00820755|10953063|FG002|COMPLETED|Period 1: Combination Therapy Phase||0
9841543|NCT00820755|10953061|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270
9841544|NCT00820755|10953062|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0
9841545|NCT00820755|10953063|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0
9841546|NCT00820755|10953061|FG000|STARTED|Period 2: Maintenance Therapy Phase||0
9841547|NCT00820755|10953062|FG001|STARTED|Period 2: Maintenance Therapy Phase||157
9841548|NCT00820755|10953063|FG002|STARTED|Period 2: Maintenance Therapy Phase||154
9841549|NCT00820755|10953061|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0
9841550|NCT00820755|10953062|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112
9841551|NCT00820755|10953063|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109
9841552|NCT00820755|10953061|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
9841553|NCT00820755|10953062|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
9841554|NCT00820755|10953063|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
9841555|NCT00820872|10953071|FG000|STARTED|Overall Study||30
9841556|NCT00820872|10953071|FG000|COMPLETED|Overall Study||30
9841557|NCT00820872|10953071|FG000|NOT COMPLETED|Overall Study||0
9841558|NCT00820898|10953075|FG000|STARTED|Overall Study||24
9841559|NCT00820898|10953075|FG000|COMPLETED|Overall Study||23
9841560|NCT00820898|10953075|FG000|NOT COMPLETED|Overall Study||1
9841561|NCT00821015|10953085|FG000|STARTED|Overall Study||27
9841562|NCT00821015|10953085|FG000|COMPLETED|Overall Study||15
9841563|NCT00821015|10953085|FG000|NOT COMPLETED|Overall Study||12
9841564|NCT00821041|10953091|FG000|STARTED|Overall Study||59
9841565|NCT00821041|10953092|FG001|STARTED|Overall Study||59
9723262|NCT00079339|10822861|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
9723263|NCT00079339|10822862|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
9723264|NCT00079339|10822860|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
9723265|NCT00079339|10822861|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
9723266|NCT00079339|10822862|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
9723267|NCT00079339|10822860|FG000|COMPLETED|Overall Study||0
9723268|NCT00079339|10822861|FG001|COMPLETED|Overall Study||1
9723269|NCT00079339|10822862|FG002|COMPLETED|Overall Study||0
9723270|NCT00079339|10822860|FG000|NOT COMPLETED|Overall Study||5
9723271|NCT00079339|10822861|FG001|NOT COMPLETED|Overall Study||39
9723272|NCT00079339|10822862|FG002|NOT COMPLETED|Overall Study||6
9723273|NCT00079391|10822875|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50
9841566|NCT00821041|10953091|FG000|COMPLETED|Overall Study||59
9841567|NCT00821041|10953092|FG001|COMPLETED|Overall Study||59
9841568|NCT00821041|10953091|FG000|NOT COMPLETED|Overall Study||0
9841569|NCT00821041|10953092|FG001|NOT COMPLETED|Overall Study||0
9841570|NCT00821093|10953100|FG000|STARTED|Overall Study||560
9841571|NCT00821093|10953101|FG001|STARTED|Overall Study||563
9841572|NCT00821093|10953100|FG000|Exposed to Drug|Overall Study||559
9841573|NCT00821093|10953101|FG001|Exposed to Drug|Overall Study||562
9841574|NCT00821093|10953100|FG000|COMPLETED|Overall Study||511
9723274|NCT00079391|10822875|FG000|COMPLETED|Overall Study||49
9723275|NCT00079391|10822875|FG000|NOT COMPLETED|Overall Study||1
9841575|NCT00821093|10953101|FG001|COMPLETED|Overall Study||523
9841576|NCT00821093|10953100|FG000|NOT COMPLETED|Overall Study||49
9841577|NCT00821093|10953101|FG001|NOT COMPLETED|Overall Study||40
9841578|NCT00821119|10953109|FG000|STARTED|Overall Study||100
9841579|NCT00821119|10953110|FG001|STARTED|Overall Study||100
9841580|NCT00821119|10953109|FG000|COMPLETED|Overall Study||100
9841581|NCT00821119|10953110|FG001|COMPLETED|Overall Study||100
9841582|NCT00821119|10953109|FG000|NOT COMPLETED|Overall Study||0
9841583|NCT00821119|10953110|FG001|NOT COMPLETED|Overall Study||0
9841584|NCT00821184|10953120|FG000|STARTED|Overall Study||6
9841585|NCT00821184|10953121|FG001|STARTED|Overall Study||6
9959798|NCT01464775|11079346|FG001|COMPLETED|Overall Study||38
9959799|NCT01464775|11079345|FG000|NOT COMPLETED|Overall Study||11
9959800|NCT01464775|11079346|FG001|NOT COMPLETED|Overall Study||6
9959801|NCT01464788|11079357|FG000|STARTED|Overall Study||30
9959802|NCT01464788|11079358|FG001|STARTED|Overall Study||31
9959803|NCT01464788|11079359|FG002|STARTED|Overall Study||29
9723276|NCT00079417|10822881|FG000|STARTED|Overall Study||28
9723277|NCT00079417|10822881|FG000|COMPLETED|Overall Study||19
9723278|NCT00079417|10822881|FG000|NOT COMPLETED|Overall Study||9
9723279|NCT00079677|10822887|FG000|STARTED|Overall Study||131
9723280|NCT00079677|10822888|FG001|STARTED|Overall Study||132
9723281|NCT00079677|10822887|FG000|COMPLETED|Overall Study||111
9723282|NCT00079677|10822888|FG001|COMPLETED|Overall Study||118
9841586|NCT00821184|10953120|FG000|COMPLETED|Overall Study||6
9841587|NCT00821184|10953121|FG001|COMPLETED|Overall Study||6
9959804|NCT01464788|11079357|FG000|COMPLETED|Overall Study||30
9959805|NCT01464788|11079358|FG001|COMPLETED|Overall Study||29
9959806|NCT01464788|11079359|FG002|COMPLETED|Overall Study||29
9841588|NCT00821184|10953120|FG000|NOT COMPLETED|Overall Study||0
9841589|NCT00821184|10953121|FG001|NOT COMPLETED|Overall Study||0
9959807|NCT01464788|11079357|FG000|NOT COMPLETED|Overall Study||0
9723283|NCT00079677|10822887|FG000|NOT COMPLETED|Overall Study||20
9723284|NCT00079677|10822888|FG001|NOT COMPLETED|Overall Study||14
9723285|NCT00079781|10822897|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
9723286|NCT00079781|10822898|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
9723287|NCT00079781|10822899|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
9723288|NCT00079781|10822897|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
9723289|NCT00079781|10822898|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
9723290|NCT00079781|10822899|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
9723291|NCT00079781|10822897|FG000|NOT COMPLETED|Pre-implant Period||3
9723292|NCT00079781|10822898|FG001|NOT COMPLETED|Pre-implant Period||1
9723293|NCT00079781|10822899|FG002|NOT COMPLETED|Pre-implant Period||1
9723294|NCT00079781|10822897|FG000|STARTED|Evaluation Period||42
9723295|NCT00079781|10822898|FG001|STARTED|Evaluation Period||9
9723296|NCT00079781|10822899|FG002|STARTED|Evaluation Period||14
9723297|NCT00079781|10822897|FG000|COMPLETED|Evaluation Period||42
9723298|NCT00079781|10822898|FG001|COMPLETED|Evaluation Period||9
9723299|NCT00079781|10822899|FG002|COMPLETED|Evaluation Period||14
9723300|NCT00079781|10822897|FG000|NOT COMPLETED|Evaluation Period||0
9723301|NCT00079781|10822898|FG001|NOT COMPLETED|Evaluation Period||0
9723302|NCT00079781|10822899|FG002|NOT COMPLETED|Evaluation Period||0
9723303|NCT00079781|10822897|FG000|STARTED|Follow-up Period||42
9723304|NCT00079781|10822898|FG001|STARTED|Follow-up Period||9
9723305|NCT00079781|10822899|FG002|STARTED|Follow-up Period||14
9723306|NCT00079781|10822897|FG000|COMPLETED|Follow-up Period||38
9723307|NCT00079781|10822898|FG001|COMPLETED|Follow-up Period||9
9723308|NCT00079781|10822899|FG002|COMPLETED|Follow-up Period||12
9841590|NCT04187989|10953131|FG000|STARTED|Overall Study - 3-Month Follow-Up||76
9841591|NCT04187989|10953132|FG001|STARTED|Overall Study - 3-Month Follow-Up||73
9841592|NCT04187989|10953131|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70
9841593|NCT04187989|10953132|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65
9841594|NCT04187989|10953131|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6
9841595|NCT04187989|10953132|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8
9841596|NCT04187989|10953131|FG000|STARTED|Overall Study - 6-Month Follow-Up||76
9841597|NCT04187989|10953132|FG001|STARTED|Overall Study - 6-Month Follow-Up||73
9841598|NCT04187989|10953131|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68
9841599|NCT04187989|10953132|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65
9841600|NCT04187989|10953131|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
9841601|NCT04187989|10953132|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
9959808|NCT01464788|11079358|FG001|NOT COMPLETED|Overall Study||2
9959809|NCT01464788|11079359|FG002|NOT COMPLETED|Overall Study||0
9959810|NCT01464827|11079383|FG000|STARTED|Overall Study||80
9959811|NCT01464827|11079384|FG001|STARTED|Overall Study||43
9959812|NCT01464827|11079385|FG002|STARTED|Overall Study||39
9959813|NCT01464827|11079386|FG003|STARTED|Overall Study||40
9959814|NCT01464827|11079387|FG004|STARTED|Overall Study||80
9959815|NCT01464827|11079388|FG005|STARTED|Overall Study||39
9959816|NCT01464827|11079389|FG006|STARTED|Overall Study||41
9959817|NCT01464827|11079390|FG007|STARTED|Overall Study||40
9959818|NCT01464827|11079391|FG008|STARTED|Overall Study||40
9959819|NCT01464827|11079392|FG009|STARTED|Overall Study||47
9959820|NCT01464827|11079393|FG010|STARTED|Overall Study||23
9959821|NCT01464827|11079394|FG011|STARTED|Overall Study||23
10022331|NCT01849055|11145798|FG004|COMPLETED|Overall Study||8
10022332|NCT01849055|11145799|FG005|COMPLETED|Overall Study||8
10022333|NCT01849055|11145794|FG000|NOT COMPLETED|Overall Study||0
10022334|NCT01849055|11145795|FG001|NOT COMPLETED|Overall Study||0
10022335|NCT01849055|11145796|FG002|NOT COMPLETED|Overall Study||1
10022336|NCT01849055|11145797|FG003|NOT COMPLETED|Overall Study||0
10022337|NCT01849055|11145798|FG004|NOT COMPLETED|Overall Study||0
10022338|NCT01849055|11145799|FG005|NOT COMPLETED|Overall Study||0
10022339|NCT01849068|11145819|FG000|STARTED|Overall Study||10
10022340|NCT01849068|11145820|FG001|STARTED|Overall Study||10
10022341|NCT01849068|11145819|FG000|COMPLETED|Overall Study||10
10022342|NCT01849068|11145820|FG001|COMPLETED|Overall Study||10
10022343|NCT01849068|11145819|FG000|NOT COMPLETED|Overall Study||0
10022344|NCT01849068|11145820|FG001|NOT COMPLETED|Overall Study||0
10022345|NCT01849172|11145828|FG000|STARTED|Overall Study||180
10022346|NCT01849172|11145829|FG001|STARTED|Overall Study||180
10022347|NCT01849172|11145828|FG000|COMPLETED|Overall Study||173
10022348|NCT01849172|11145829|FG001|COMPLETED|Overall Study||174
10022349|NCT01849172|11145828|FG000|NOT COMPLETED|Overall Study||7
10022350|NCT01849172|11145829|FG001|NOT COMPLETED|Overall Study||6
10022351|NCT01849276|11145835|FG000|STARTED|Registered to the Study||2
10022352|NCT01849276|11145835|FG000|COMPLETED|Registered to the Study||2
10022353|NCT01849276|11145835|FG000|NOT COMPLETED|Registered to the Study||0
10022354|NCT01849276|11145835|FG000|STARTED|Completed Treatment||2
10022355|NCT01849276|11145835|FG000|COMPLETED|Completed Treatment||2
10022356|NCT01849276|11145835|FG000|NOT COMPLETED|Completed Treatment||0
10022357|NCT01849276|11145835|FG000|STARTED|Followed for Survival for 5 Years||2
10022358|NCT01849276|11145835|FG000|COMPLETED|Followed for Survival for 5 Years||0
10022359|NCT01849276|11145835|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2
10022360|NCT01849289|11145841|FG000|STARTED|Overall Study||555
10022361|NCT01849289|11145842|FG001|STARTED|Overall Study||278
10022362|NCT01849289|11145841|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
10022363|NCT01849289|11145842|FG001|Exposed|Overall Study||278
10022364|NCT01849289|11145841|FG000|COMPLETED|Overall Study||523
10022365|NCT01849289|11145842|FG001|COMPLETED|Overall Study||254
10022366|NCT01849289|11145841|FG000|NOT COMPLETED|Overall Study||32
10022367|NCT01849289|11145842|FG001|NOT COMPLETED|Overall Study||24
10022368|NCT01849419|11145848|FG000|STARTED|Overall Study||65
10022369|NCT01849419|11145848|FG000|COMPLETED|Overall Study||65
10022370|NCT01849419|11145848|FG000|NOT COMPLETED|Overall Study||0
10022371|NCT01849458|11145853|FG000|STARTED|Overall Study||50
10022372|NCT01849458|11145853|FG000|6 Months Follow-up|Overall Study||50
10022373|NCT01849458|11145853|FG000|COMPLETED|Overall Study||46
10022374|NCT01849458|11145853|FG000|NOT COMPLETED|Overall Study||4
9841602|NCT04109118|10953138|FG000|STARTED|Overall Study||4
9959822|NCT01464827|11079395|FG012|STARTED|Overall Study||23
10022375|NCT01849497|11145859|FG000|STARTED|Overall Study||75
10022376|NCT01849497|11145860|FG001|STARTED|Overall Study||74
10022377|NCT01849497|11145859|FG000|Received Treatment|Overall Study||75
9959823|NCT01464827|11079396|FG013|STARTED|Overall Study||22
10022378|NCT01849497|11145860|FG001|Received Treatment|Overall Study||74
10022379|NCT01849497|11145859|FG000|COMPLETED|Overall Study||74
10022380|NCT01849497|11145860|FG001|COMPLETED|Overall Study||70
10022381|NCT01849497|11145859|FG000|NOT COMPLETED|Overall Study||1
10022382|NCT01849497|11145860|FG001|NOT COMPLETED|Overall Study||4
10022383|NCT01849562|11145869|FG000|STARTED|Overall Study||10
10022384|NCT01849562|11145870|FG001|STARTED|Overall Study||10
10022385|NCT01849562|11145871|FG002|STARTED|Overall Study||10
10022386|NCT01849562|11145869|FG000|COMPLETED|Overall Study||8
10022387|NCT01849562|11145870|FG001|COMPLETED|Overall Study||10
10022388|NCT01849562|11145871|FG002|COMPLETED|Overall Study||10
10022389|NCT01849562|11145869|FG000|NOT COMPLETED|Overall Study||2
10022390|NCT01849562|11145870|FG001|NOT COMPLETED|Overall Study||0
10022391|NCT01849562|11145871|FG002|NOT COMPLETED|Overall Study||0
10022392|NCT01849575|11145882|FG000|STARTED|Overall Study||1749
9723309|NCT00079781|10822897|FG000|NOT COMPLETED|Follow-up Period||4
9723310|NCT00079781|10822898|FG001|NOT COMPLETED|Follow-up Period||0
9723311|NCT00079781|10822899|FG002|NOT COMPLETED|Follow-up Period||2
9723312|NCT00079937|10822907|FG000|STARTED|Overall Study||421
9723313|NCT00079937|10822908|FG001|STARTED|Overall Study||207
9723314|NCT00079937|10822907|FG000|COMPLETED|Overall Study||352
9723315|NCT00079937|10822908|FG001|COMPLETED|Overall Study||175
9723316|NCT00079937|10822907|FG000|NOT COMPLETED|Overall Study||69
9723317|NCT00079937|10822908|FG001|NOT COMPLETED|Overall Study||32
9723318|NCT00080119|10822918|FG000|STARTED|Overall Study||403
9723319|NCT00080119|10822919|FG001|STARTED|Overall Study||401
9723320|NCT00080119|10822920|FG002|STARTED|Overall Study||273
9723321|NCT00080119|10822921|FG003|STARTED|Overall Study||274
10022393|NCT01849575|11145883|FG001|STARTED|Overall Study||1783
10022394|NCT01849575|11145882|FG000|COMPLETED|Overall Study||1599
10022395|NCT01849575|11145883|FG001|COMPLETED|Overall Study||1576
10022396|NCT01849575|11145882|FG000|NOT COMPLETED|Overall Study||150
10022397|NCT01849575|11145883|FG001|NOT COMPLETED|Overall Study||207
10022398|NCT01849588|11145891|FG000|STARTED|Overall Study||3
9841603|NCT04109118|10953138|FG000|COMPLETED|Overall Study||1
9841604|NCT04109118|10953138|FG000|NOT COMPLETED|Overall Study||3
9841605|NCT04045132|10953145|FG000|STARTED|Overall Study||37
9841606|NCT04045132|10953146|FG001|STARTED|Overall Study||38
9841607|NCT04045132|10953145|FG000|COMPLETED|Overall Study||34
9841608|NCT04045132|10953146|FG001|COMPLETED|Overall Study||31
9841609|NCT04045132|10953145|FG000|NOT COMPLETED|Overall Study||3
9841610|NCT04045132|10953146|FG001|NOT COMPLETED|Overall Study||7
9841611|NCT03846219|10953157|FG000|STARTED|Overall Study||72
9841612|NCT03846219|10953158|FG001|STARTED|Overall Study||69
9841613|NCT03846219|10953159|FG002|STARTED|Overall Study||69
9841614|NCT03846219|10953157|FG000|Patients Treated|Overall Study||71
9841615|NCT03846219|10953158|FG001|Patients Treated|Overall Study||69
9841616|NCT03846219|10953159|FG002|Patients Treated|Overall Study||69
9841617|NCT03846219|10953157|FG000|COMPLETED|Overall Study||69
9841618|NCT03846219|10953158|FG001|COMPLETED|Overall Study||65
9841619|NCT03846219|10953159|FG002|COMPLETED|Overall Study||64
9841620|NCT03846219|10953157|FG000|NOT COMPLETED|Overall Study||3
9841621|NCT03846219|10953158|FG001|NOT COMPLETED|Overall Study||4
9841622|NCT03846219|10953159|FG002|NOT COMPLETED|Overall Study||5
9959824|NCT01464827|11079383|FG000|Treated|Overall Study||80
9959825|NCT01464827|11079384|FG001|Treated|Overall Study||41
9959826|NCT01464827|11079385|FG002|Treated|Overall Study||39
9959827|NCT01464827|11079386|FG003|Treated|Overall Study||40
9959828|NCT01464827|11079387|FG004|Treated|Overall Study||79
9959829|NCT01464827|11079388|FG005|Treated|Overall Study||39
9959830|NCT01464827|11079389|FG006|Treated|Overall Study||40
9959831|NCT01464827|11079390|FG007|Treated|Overall Study||40
9959832|NCT01464827|11079391|FG008|Treated|Overall Study||40
9959833|NCT01464827|11079392|FG009|Treated|Overall Study||45
9959834|NCT01464827|11079393|FG010|Treated|Overall Study||23
9959835|NCT01464827|11079394|FG011|Treated|Overall Study||22
9959836|NCT01464827|11079395|FG012|Treated|Overall Study||23
9959837|NCT01464827|11079396|FG013|Treated|Overall Study||20
9959838|NCT01464827|11079383|FG000|COMPLETED|Overall Study||77
9959839|NCT01464827|11079384|FG001|COMPLETED|Overall Study||36
9959840|NCT01464827|11079385|FG002|COMPLETED|Overall Study||39
9959841|NCT01464827|11079386|FG003|COMPLETED|Overall Study||36
9959842|NCT01464827|11079387|FG004|COMPLETED|Overall Study||72
9959843|NCT01464827|11079388|FG005|COMPLETED|Overall Study||38
9959844|NCT01464827|11079389|FG006|COMPLETED|Overall Study||37
9959845|NCT01464827|11079390|FG007|COMPLETED|Overall Study||37
9959846|NCT01464827|11079391|FG008|COMPLETED|Overall Study||37
9959847|NCT01464827|11079392|FG009|COMPLETED|Overall Study||44
9959848|NCT01464827|11079393|FG010|COMPLETED|Overall Study||21
9959849|NCT01464827|11079394|FG011|COMPLETED|Overall Study||21
9959850|NCT01464827|11079395|FG012|COMPLETED|Overall Study||21
9959851|NCT01464827|11079396|FG013|COMPLETED|Overall Study||19
9959852|NCT01464827|11079383|FG000|NOT COMPLETED|Overall Study||3
9959853|NCT01464827|11079384|FG001|NOT COMPLETED|Overall Study||7
9959854|NCT01464827|11079385|FG002|NOT COMPLETED|Overall Study||0
9959855|NCT01464827|11079386|FG003|NOT COMPLETED|Overall Study||4
9959856|NCT01464827|11079387|FG004|NOT COMPLETED|Overall Study||8
9959857|NCT01464827|11079388|FG005|NOT COMPLETED|Overall Study||1
9959858|NCT01464827|11079389|FG006|NOT COMPLETED|Overall Study||4
9959859|NCT01464827|11079390|FG007|NOT COMPLETED|Overall Study||3
9959860|NCT01464827|11079391|FG008|NOT COMPLETED|Overall Study||3
9959861|NCT01464827|11079392|FG009|NOT COMPLETED|Overall Study||3
9959862|NCT01464827|11079393|FG010|NOT COMPLETED|Overall Study||2
9959863|NCT01464827|11079394|FG011|NOT COMPLETED|Overall Study||2
9959864|NCT01464827|11079395|FG012|NOT COMPLETED|Overall Study||2
9959865|NCT01464827|11079396|FG013|NOT COMPLETED|Overall Study||3
9959866|NCT01464840|11079440|FG000|STARTED|Overall Study||10
9959867|NCT01464840|11079441|FG001|STARTED|Overall Study||10
9959868|NCT01464840|11079442|FG002|STARTED|Overall Study||10
9959869|NCT01464840|11079440|FG000|COMPLETED|Overall Study||10
9959870|NCT01464840|11079441|FG001|COMPLETED|Overall Study||10
9841623|NCT03758404|10953178|FG000|STARTED|Overall Study||3
9841624|NCT03758404|10953179|FG001|STARTED|Overall Study||3
9841625|NCT03758404|10953180|FG002|STARTED|Overall Study||5
9841626|NCT03758404|10953178|FG000|COMPLETED|Overall Study||3
9841627|NCT03758404|10953179|FG001|COMPLETED|Overall Study||3
9841628|NCT03758404|10953180|FG002|COMPLETED|Overall Study||5
9841629|NCT03758404|10953178|FG000|NOT COMPLETED|Overall Study||0
9841630|NCT03758404|10953179|FG001|NOT COMPLETED|Overall Study||0
9841631|NCT03758404|10953180|FG002|NOT COMPLETED|Overall Study||0
9841632|NCT03698708|10953190|FG000|STARTED|Overall Study||17
9841633|NCT03698708|10953191|FG001|STARTED|Overall Study||20
9841634|NCT03698708|10953190|FG000|COMPLETED|Overall Study||13
9841635|NCT03698708|10953191|FG001|COMPLETED|Overall Study||16
9841636|NCT03698708|10953190|FG000|NOT COMPLETED|Overall Study||4
9959871|NCT01464840|11079442|FG002|COMPLETED|Overall Study||10
9959872|NCT01464840|11079440|FG000|NOT COMPLETED|Overall Study||0
9959873|NCT01464840|11079441|FG001|NOT COMPLETED|Overall Study||0
9959874|NCT01464840|11079442|FG002|NOT COMPLETED|Overall Study||0
9959875|NCT01464879|11079450|FG000|STARTED|Overall Study||20
9959876|NCT01464879|11079450|FG000|Hand Application (2.50 mL)|Overall Study||20
9959877|NCT01464879|11079450|FG000|Washout Period|Overall Study||20
9959878|NCT01464879|11079450|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
9959879|NCT01464879|11079450|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
9959880|NCT01464879|11079450|FG000|Applicator Application (3.75 mL)|Overall Study||18
9959881|NCT01464879|11079450|FG000|COMPLETED|Overall Study||18
9841637|NCT03698708|10953191|FG001|NOT COMPLETED|Overall Study||4
9841638|NCT03608696|10953197|FG000|STARTED|Overall Study||10
9841639|NCT03608696|10953197|FG000|COMPLETED|Overall Study||10
9841640|NCT03608696|10953197|FG000|NOT COMPLETED|Overall Study||0
9841641|NCT03606668|10953201|FG000|STARTED|Overall Study||20
9841642|NCT03606668|10953201|FG000|COMPLETED|Overall Study||18
9841643|NCT03606668|10953201|FG000|NOT COMPLETED|Overall Study||2
9841644|NCT03575897|10953207|FG000|STARTED|Overall Study||25
9841645|NCT03575897|10953208|FG001|STARTED|Overall Study||25
9841646|NCT03575897|10953207|FG000|COMPLETED|Overall Study||13
9841647|NCT03575897|10953208|FG001|COMPLETED|Overall Study||12
9841648|NCT03575897|10953207|FG000|NOT COMPLETED|Overall Study||12
9723322|NCT00080119|10822918|FG000|COMPLETED|Overall Study||347
9723323|NCT00080119|10822919|FG001|COMPLETED|Overall Study||339
9723324|NCT00080119|10822920|FG002|COMPLETED|Overall Study||108
9723325|NCT00080119|10822921|FG003|COMPLETED|Overall Study||111
9723326|NCT00080119|10822918|FG000|NOT COMPLETED|Overall Study||56
9723327|NCT00080119|10822919|FG001|NOT COMPLETED|Overall Study||62
9723328|NCT00080119|10822920|FG002|NOT COMPLETED|Overall Study||165
9723329|NCT00080119|10822921|FG003|NOT COMPLETED|Overall Study||163
9723330|NCT00080223|10822933|FG000|STARTED|Overall Study||83
9723331|NCT00080223|10822933|FG000|COMPLETED|Overall Study||7
9723332|NCT00080223|10822933|FG000|NOT COMPLETED|Overall Study||76
9841649|NCT03575897|10953208|FG001|NOT COMPLETED|Overall Study||13
9841650|NCT03343626|10953222|FG000|STARTED|Overall Study||31
9841651|NCT03343626|10953223|FG001|STARTED|Overall Study||31
9841652|NCT03343626|10953224|FG002|STARTED|Overall Study||31
9841653|NCT03343626|10953225|FG003|STARTED|Overall Study||32
9841654|NCT03343626|10953226|FG004|STARTED|Overall Study||36
9841655|NCT03343626|10953227|FG005|STARTED|Overall Study||37
9841656|NCT03343626|10953228|FG006|STARTED|Overall Study||37
9841657|NCT03343626|10953229|FG007|STARTED|Overall Study||36
9841658|NCT03343626|10953222|FG000|Safety Analysis Set|Overall Study||31
9841659|NCT03343626|10953223|FG001|Safety Analysis Set|Overall Study||31
9841660|NCT03343626|10953224|FG002|Safety Analysis Set|Overall Study||31
9959882|NCT01464879|11079450|FG000|NOT COMPLETED|Overall Study||2
9959883|NCT01464931|11079462|FG000|STARTED|Overall Study||16
9959884|NCT01464931|11079463|FG001|STARTED|Overall Study||16
9723333|NCT00080288|10822939|FG000|STARTED|Overall Study||127
9723334|NCT00080288|10822940|FG001|STARTED|Overall Study||127
9723335|NCT00080288|10822939|FG000|COMPLETED|Overall Study||97
9723336|NCT00080288|10822940|FG001|COMPLETED|Overall Study||89
9723337|NCT00080288|10822939|FG000|NOT COMPLETED|Overall Study||30
9723338|NCT00080288|10822940|FG001|NOT COMPLETED|Overall Study||38
9723339|NCT00080301|10822948|FG000|STARTED|Overall Study||375
9723340|NCT00080301|10822949|FG001|STARTED|Overall Study||377
9723341|NCT00080301|10822948|FG000|Never Treated|Overall Study||5
9723342|NCT00080301|10822949|FG001|Never Treated|Overall Study||10
9723343|NCT00080301|10822948|FG000|Still on Treatment|Overall Study||0
9723344|NCT00080301|10822949|FG001|Still on Treatment|Overall Study||1
9723345|NCT00080301|10822948|FG000|COMPLETED|Overall Study|Participants who are off treatment|370
9731687|NCT00134719|10831589|FG000|STARTED|Primary Vaccination Phase||661
9841661|NCT03343626|10953225|FG003|Safety Analysis Set|Overall Study||32
9841662|NCT03343626|10953226|FG004|Safety Analysis Set|Overall Study||36
9841663|NCT03343626|10953227|FG005|Safety Analysis Set|Overall Study||37
9841664|NCT03343626|10953228|FG006|Safety Analysis Set|Overall Study||37
9959885|NCT01464931|11079462|FG000|COMPLETED|Overall Study||15
9959886|NCT01464931|11079463|FG001|COMPLETED|Overall Study||16
9959887|NCT01464931|11079462|FG000|NOT COMPLETED|Overall Study||1
9959888|NCT01464931|11079463|FG001|NOT COMPLETED|Overall Study||0
9959889|NCT01464996|11079476|FG000|STARTED|Overall Study||24
9959890|NCT01464996|11079476|FG000|OptiBond XTR|Overall Study||23
9959891|NCT01464996|11079476|FG000|OptiBond FL|Overall Study||24
9959892|NCT01464996|11079476|FG000|COMPLETED|Overall Study||24
9841665|NCT03343626|10953229|FG007|Safety Analysis Set|Overall Study||36
10022399|NCT01849588|11145891|FG000|COMPLETED|Overall Study||0
9841666|NCT03343626|10953222|FG000|Full Analysis Set|Overall Study||30
10022400|NCT01849588|11145891|FG000|NOT COMPLETED|Overall Study||3
9841667|NCT03343626|10953223|FG001|Full Analysis Set|Overall Study||28
9841668|NCT03343626|10953224|FG002|Full Analysis Set|Overall Study||31
9841669|NCT03343626|10953225|FG003|Full Analysis Set|Overall Study||30
9841670|NCT03343626|10953226|FG004|Full Analysis Set|Overall Study||34
9841671|NCT03343626|10953227|FG005|Full Analysis Set|Overall Study||34
9841672|NCT03343626|10953228|FG006|Full Analysis Set|Overall Study||34
9841673|NCT03343626|10953229|FG007|Full Analysis Set|Overall Study||34
9841674|NCT03343626|10953222|FG000|Per Protocol Set|Overall Study||28
9841675|NCT03343626|10953223|FG001|Per Protocol Set|Overall Study||25
9841676|NCT03343626|10953224|FG002|Per Protocol Set|Overall Study||29
9841677|NCT03343626|10953225|FG003|Per Protocol Set|Overall Study||30
9841678|NCT03343626|10953226|FG004|Per Protocol Set|Overall Study||34
9841679|NCT03343626|10953227|FG005|Per Protocol Set|Overall Study||33
9841680|NCT03343626|10953228|FG006|Per Protocol Set|Overall Study||34
9841681|NCT03343626|10953229|FG007|Per Protocol Set|Overall Study||33
9841682|NCT03343626|10953222|FG000|COMPLETED|Overall Study||25
9841683|NCT03343626|10953223|FG001|COMPLETED|Overall Study||26
9841684|NCT03343626|10953224|FG002|COMPLETED|Overall Study||29
9841685|NCT03343626|10953225|FG003|COMPLETED|Overall Study||24
9841686|NCT03343626|10953226|FG004|COMPLETED|Overall Study||29
9841687|NCT03343626|10953227|FG005|COMPLETED|Overall Study||32
9841688|NCT03343626|10953228|FG006|COMPLETED|Overall Study||32
9841689|NCT03343626|10953229|FG007|COMPLETED|Overall Study||25
9841690|NCT03343626|10953222|FG000|NOT COMPLETED|Overall Study||6
9841691|NCT03343626|10953223|FG001|NOT COMPLETED|Overall Study||5
9841692|NCT03343626|10953224|FG002|NOT COMPLETED|Overall Study||2
9841693|NCT03343626|10953225|FG003|NOT COMPLETED|Overall Study||8
9841694|NCT03343626|10953226|FG004|NOT COMPLETED|Overall Study||7
9841695|NCT03343626|10953227|FG005|NOT COMPLETED|Overall Study||5
9841696|NCT03343626|10953228|FG006|NOT COMPLETED|Overall Study||5
9841697|NCT03343626|10953229|FG007|NOT COMPLETED|Overall Study||11
9841698|NCT03088930|10953250|FG000|STARTED|Overall Study||3
9841699|NCT03088930|10953250|FG000|COMPLETED|Overall Study||3
9959893|NCT01464996|11079476|FG000|NOT COMPLETED|Overall Study||0
9841700|NCT03088930|10953250|FG000|NOT COMPLETED|Overall Study||0
9841701|NCT02960204|10953258|FG000|STARTED|Overall Study||65
9841702|NCT02960204|10953259|FG001|STARTED|Overall Study||65
9841703|NCT02960204|10953260|FG002|STARTED|Overall Study||66
9841704|NCT02960204|10953261|FG003|STARTED|Overall Study||67
9841705|NCT02960204|10953258|FG000|Randomized|Overall Study||65
9841706|NCT02960204|10953259|FG001|Randomized|Overall Study||65
9841707|NCT02960204|10953260|FG002|Randomized|Overall Study||66
9841708|NCT02960204|10953261|FG003|Randomized|Overall Study||67
9841709|NCT02960204|10953258|FG000|Completed Week 24 of Study|Overall Study||62
9841710|NCT02960204|10953259|FG001|Completed Week 24 of Study|Overall Study||62
9841711|NCT02960204|10953260|FG002|Completed Week 24 of Study|Overall Study||60
9841712|NCT02960204|10953261|FG003|Completed Week 24 of Study|Overall Study||66
9841713|NCT02960204|10953258|FG000|Completed Week 48 of Study|Overall Study||55
9841714|NCT02960204|10953259|FG001|Completed Week 48 of Study|Overall Study||55
9841715|NCT02960204|10953260|FG002|Completed Week 48 of Study|Overall Study||50
9841716|NCT02960204|10953261|FG003|Completed Week 48 of Study|Overall Study||59
9841717|NCT02960204|10953258|FG000|COMPLETED|Overall Study||36
9841718|NCT02960204|10953259|FG001|COMPLETED|Overall Study||44
9841719|NCT02960204|10953260|FG002|COMPLETED|Overall Study||37
9841720|NCT02960204|10953261|FG003|COMPLETED|Overall Study||38
9841721|NCT02960204|10953258|FG000|NOT COMPLETED|Overall Study||29
9841722|NCT02960204|10953259|FG001|NOT COMPLETED|Overall Study||21
9841723|NCT02960204|10953260|FG002|NOT COMPLETED|Overall Study||29
9723346|NCT00080301|10822949|FG001|COMPLETED|Overall Study|Participants who are off treatment|366
9723347|NCT00080301|10822948|FG000|NOT COMPLETED|Overall Study||5
9723348|NCT00080301|10822949|FG001|NOT COMPLETED|Overall Study||11
9723349|NCT00080470|10822958|FG000|STARTED|Overall Study||45
9723350|NCT00080470|10822959|FG001|STARTED|Overall Study||42
9723351|NCT00080470|10822958|FG000|COMPLETED|Overall Study||11
9723352|NCT00080470|10822959|FG001|COMPLETED|Overall Study||14
9723353|NCT00080470|10822958|FG000|NOT COMPLETED|Overall Study||34
9723354|NCT00080470|10822959|FG001|NOT COMPLETED|Overall Study||28
9723355|NCT00080483|10822969|FG000|STARTED|Overall Study||17
9723356|NCT00080483|10822970|FG001|STARTED|Overall Study||18
9723357|NCT00080483|10822969|FG000|COMPLETED|Overall Study||15
9723358|NCT00080483|10822970|FG001|COMPLETED|Overall Study||16
9723359|NCT00080483|10822969|FG000|NOT COMPLETED|Overall Study||2
9723360|NCT00080483|10822970|FG001|NOT COMPLETED|Overall Study||2
9723361|NCT00080535|10822976|FG000|STARTED|Overall Study||10
9723362|NCT00080535|10822976|FG000|COMPLETED|Overall Study||10
9723363|NCT00080535|10822976|FG000|NOT COMPLETED|Overall Study||0
9723364|NCT00080899|10822980|FG000|STARTED|Overall Study||23
9723365|NCT00080899|10822980|FG000|COMPLETED|Overall Study||22
9723366|NCT00080899|10822980|FG000|NOT COMPLETED|Overall Study||1
9723367|NCT00080912|10822986|FG000|STARTED|Overall Study||425
9723368|NCT00080912|10822987|FG001|STARTED|Overall Study||425
9723369|NCT00080912|10822986|FG000|COMPLETED|Overall Study||425
9723370|NCT00080912|10822987|FG001|COMPLETED|Overall Study||425
9723371|NCT00080912|10822986|FG000|NOT COMPLETED|Overall Study||0
9723372|NCT00080912|10822987|FG001|NOT COMPLETED|Overall Study||0
9723373|NCT00080938|10822993|FG000|STARTED|Overall Study||26
9723374|NCT00080938|10822993|FG000|Began Protocol Therapy|Overall Study||25
9723375|NCT00080938|10822993|FG000|Eligible and Treated|Overall Study||21
9723376|NCT00080938|10822993|FG000|COMPLETED|Overall Study||2
9723377|NCT00080938|10822993|FG000|NOT COMPLETED|Overall Study||24
9723378|NCT00081159|10822999|FG000|STARTED|Overall Study||39
9723379|NCT00081159|10823000|FG001|STARTED|Overall Study||40
10022401|NCT01849692|11145897|FG000|STARTED|Overall Study||10
10022402|NCT01849692|11145898|FG001|STARTED|Overall Study||3
10022403|NCT01849692|11145899|FG002|STARTED|Overall Study||10
10022404|NCT01849692|11145900|FG003|STARTED|Overall Study||3
10022405|NCT01849692|11145901|FG004|STARTED|Overall Study||10
10022406|NCT01849692|11145902|FG005|STARTED|Overall Study||3
10022407|NCT01849692|11145903|FG006|STARTED|Overall Study||10
9723380|NCT00081159|10822999|FG000|COMPLETED|Overall Study||37
9723381|NCT00081159|10823000|FG001|COMPLETED|Overall Study||35
9723382|NCT00081159|10822999|FG000|NOT COMPLETED|Overall Study||2
9723383|NCT00081159|10823000|FG001|NOT COMPLETED|Overall Study||5
9723384|NCT00081263|10823008|FG000|STARTED|Overall Study||67
9723385|NCT00081263|10823009|FG001|STARTED|Overall Study||63
9723386|NCT00081263|10823008|FG000|COMPLETED|Overall Study||50
9723387|NCT00081263|10823009|FG001|COMPLETED|Overall Study||41
9723388|NCT00081263|10823008|FG000|NOT COMPLETED|Overall Study||17
9723389|NCT00081263|10823009|FG001|NOT COMPLETED|Overall Study||22
9723390|NCT00081289|10823017|FG000|STARTED|Overall Study||73
9723391|NCT00081289|10823018|FG001|STARTED|Overall Study||73
9723392|NCT00081289|10823017|FG000|Primary Endpoint Population|Overall Study||48
9723393|NCT00081289|10823018|FG001|Primary Endpoint Population|Overall Study||48
9723394|NCT00081289|10823017|FG000|General Analysis Population|Overall Study||52
9723395|NCT00081289|10823018|FG001|General Analysis Population|Overall Study||52
9723396|NCT00081289|10823017|FG000|Full AE Population|Overall Study||70
9723397|NCT00081289|10823018|FG001|Full AE Population|Overall Study||68
9723398|NCT00081289|10823017|FG000|Surgery|Overall Study||47
9723399|NCT00081289|10823018|FG001|Surgery|Overall Study||51
9723400|NCT00081289|10823017|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
9723401|NCT00081289|10823018|FG001|Global Health Status Score at End of CR|Overall Study||32
9723402|NCT00081289|10823017|FG000|GHS at End of Post-op CT|Overall Study||20
9723403|NCT00081289|10823018|FG001|GHS at End of Post-op CT|Overall Study||28
9723404|NCT00081289|10823017|FG000|GHS at Two Years|Overall Study||21
10022408|NCT01849692|11145904|FG007|STARTED|Overall Study||3
9723405|NCT00081289|10823018|FG001|GHS at Two Years|Overall Study||20
9723406|NCT00081289|10823017|FG000|GI Symptom Score at End of CR|Overall Study||34
9723407|NCT00081289|10823018|FG001|GI Symptom Score at End of CR|Overall Study||33
9723408|NCT00081289|10823017|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22
9723409|NCT00081289|10823018|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27
9723410|NCT00081289|10823017|FG000|GI Symptom Score at Two Years|Overall Study||21
9723411|NCT00081289|10823018|FG001|GI Symptom Score at Two Years|Overall Study||20
9723412|NCT00081289|10823017|FG000|Defecation Symptom Score at End of CR|Overall Study||32
9723413|NCT00081289|10823018|FG001|Defecation Symptom Score at End of CR|Overall Study||32
9723414|NCT00081289|10823017|FG000|DS Score at End of Post-op CT|Overall Study||12
9723415|NCT00081289|10823018|FG001|DS Score at End of Post-op CT|Overall Study||14
10022409|NCT01849692|11145897|FG000|COMPLETED|Overall Study||10
10022410|NCT01849692|11145898|FG001|COMPLETED|Overall Study||3
10022411|NCT01849692|11145899|FG002|COMPLETED|Overall Study||10
9841724|NCT02960204|10953261|FG003|NOT COMPLETED|Overall Study||29
9841725|NCT02856269|10953273|FG000|STARTED|Overall Study||25
9841726|NCT02856269|10953274|FG001|STARTED|Overall Study||27
9841727|NCT02856269|10953273|FG000|COMPLETED|Overall Study||24
9841728|NCT02856269|10953274|FG001|COMPLETED|Overall Study||24
9841729|NCT02856269|10953273|FG000|NOT COMPLETED|Overall Study||1
9841730|NCT02856269|10953274|FG001|NOT COMPLETED|Overall Study||3
9841731|NCT02807363|10953284|FG000|STARTED|Dosing Period||9
9841732|NCT02807363|10953285|FG001|STARTED|Dosing Period||9
9841733|NCT02807363|10953286|FG002|STARTED|Dosing Period||5
9959894|NCT01465022|11079485|FG000|STARTED|Overall Study||64
9959895|NCT01465022|11079486|FG001|STARTED|Overall Study||63
9959896|NCT01465022|11079487|FG002|STARTED|Overall Study||70
9959897|NCT01465022|11079485|FG000|COMPLETED|Overall Study||41
9959898|NCT01465022|11079486|FG001|COMPLETED|Overall Study||40
9959899|NCT01465022|11079487|FG002|COMPLETED|Overall Study||0
9959900|NCT01465022|11079485|FG000|NOT COMPLETED|Overall Study||23
9959901|NCT01465022|11079486|FG001|NOT COMPLETED|Overall Study||23
9959902|NCT01465022|11079487|FG002|NOT COMPLETED|Overall Study||70
9959903|NCT01465048|11079496|FG000|STARTED|Overall Study||6
9959904|NCT01465048|11079497|FG001|STARTED|Overall Study||6
9959905|NCT01465048|11079498|FG002|STARTED|Overall Study||6
9959906|NCT01465048|11079496|FG000|COMPLETED|Overall Study||6
9959907|NCT01465048|11079497|FG001|COMPLETED|Overall Study||6
9959908|NCT01465048|11079498|FG002|COMPLETED|Overall Study||6
9959909|NCT01465048|11079496|FG000|NOT COMPLETED|Overall Study||0
9959910|NCT01465048|11079497|FG001|NOT COMPLETED|Overall Study||0
9959911|NCT01465048|11079498|FG002|NOT COMPLETED|Overall Study||0
9959912|NCT01465178|11079508|FG000|STARTED|Overall Study||31
9959913|NCT01465178|11079509|FG001|STARTED|Overall Study||31
9959914|NCT01465178|11079508|FG000|COMPLETED|Overall Study||30
9959915|NCT01465178|11079509|FG001|COMPLETED|Overall Study||31
9959916|NCT01465178|11079508|FG000|NOT COMPLETED|Overall Study||1
9959917|NCT01465178|11079509|FG001|NOT COMPLETED|Overall Study||0
9959918|NCT01465191|11079518|FG000|STARTED|Overall Study||56
9959919|NCT01465191|11079519|FG001|STARTED|Overall Study||63
9959920|NCT01465191|11079520|FG002|STARTED|Overall Study||50
9959921|NCT01465191|11079518|FG000|COMPLETED|Overall Study||47
9959922|NCT01465191|11079519|FG001|COMPLETED|Overall Study||54
9959923|NCT01465191|11079520|FG002|COMPLETED|Overall Study||43
9959924|NCT01465191|11079518|FG000|NOT COMPLETED|Overall Study||9
10114178|NCT02514122|11244886|FG001|NOT COMPLETED|Overall Study||0
10114179|NCT02514174|11244892|FG000|STARTED|Overall Study||25
10114180|NCT02514174|11244892|FG000|COMPLETED|Overall Study||0
10114181|NCT02514174|11244892|FG000|NOT COMPLETED|Overall Study||25
10114182|NCT02514473|11244898|FG000|STARTED|Overall Study||101
10114183|NCT02514473|11244899|FG001|STARTED|Overall Study||103
10114184|NCT02514473|11244898|FG000|COMPLETED|Overall Study||98
10114185|NCT02514473|11244899|FG001|COMPLETED|Overall Study||98
10114186|NCT02514473|11244898|FG000|NOT COMPLETED|Overall Study||3
10114187|NCT02514473|11244899|FG001|NOT COMPLETED|Overall Study||5
10114188|NCT02514551|11244908|FG000|STARTED|Overall Study||123
10114189|NCT02514551|11244909|FG001|STARTED|Overall Study||122
9841734|NCT02807363|10953287|FG003|STARTED|Dosing Period||12
9841735|NCT02807363|10953284|FG000|COMPLETED|Dosing Period||9
9841736|NCT02807363|10953285|FG001|COMPLETED|Dosing Period||8
9841737|NCT02807363|10953286|FG002|COMPLETED|Dosing Period||5
9841738|NCT02807363|10953287|FG003|COMPLETED|Dosing Period||12
9841739|NCT02807363|10953284|FG000|NOT COMPLETED|Dosing Period||0
9841740|NCT02807363|10953285|FG001|NOT COMPLETED|Dosing Period||1
9841741|NCT02807363|10953286|FG002|NOT COMPLETED|Dosing Period||0
9959925|NCT01465191|11079519|FG001|NOT COMPLETED|Overall Study||9
9959926|NCT01465191|11079520|FG002|NOT COMPLETED|Overall Study||7
9959927|NCT01465347|11079531|FG000|STARTED|Overall Study||3
9959928|NCT01465347|11079532|FG001|STARTED|Overall Study||56
9959929|NCT01465347|11079531|FG000|COMPLETED|Overall Study||2
9841742|NCT02807363|10953287|FG003|NOT COMPLETED|Dosing Period||0
9841743|NCT02807363|10953284|FG000|STARTED|Post- Dosing Period||9
9841744|NCT02807363|10953285|FG001|STARTED|Post- Dosing Period||8
9841745|NCT02807363|10953286|FG002|STARTED|Post- Dosing Period||5
9959930|NCT01465347|11079532|FG001|COMPLETED|Overall Study||53
9959931|NCT01465347|11079531|FG000|NOT COMPLETED|Overall Study||1
9959932|NCT01465347|11079532|FG001|NOT COMPLETED|Overall Study||3
9959933|NCT01465386|11079541|FG000|STARTED|Overall Study||6
9959934|NCT01465386|11079541|FG000|COMPLETED|Overall Study||2
9959935|NCT01465386|11079541|FG000|NOT COMPLETED|Overall Study||4
9959936|NCT01465412|11079549|FG000|STARTED|Overall Study||12
9959937|NCT01465412|11079550|FG001|STARTED|Overall Study||12
9959938|NCT01465412|11079551|FG002|STARTED|Overall Study||9
9959939|NCT01465412|11079552|FG003|STARTED|Overall Study||9
9959940|NCT01465412|11079549|FG000|COMPLETED|Overall Study||12
9959941|NCT01465412|11079550|FG001|COMPLETED|Overall Study||12
9959942|NCT01465412|11079551|FG002|COMPLETED|Overall Study||9
9959943|NCT01465412|11079552|FG003|COMPLETED|Overall Study||9
10022412|NCT01849692|11145900|FG003|COMPLETED|Overall Study||3
10022413|NCT01849692|11145901|FG004|COMPLETED|Overall Study||10
10022414|NCT01849692|11145902|FG005|COMPLETED|Overall Study||3
10022415|NCT01849692|11145903|FG006|COMPLETED|Overall Study||10
10022416|NCT01849692|11145904|FG007|COMPLETED|Overall Study||3
10022417|NCT01849692|11145897|FG000|NOT COMPLETED|Overall Study||0
10022418|NCT01849692|11145898|FG001|NOT COMPLETED|Overall Study||0
10022419|NCT01849692|11145899|FG002|NOT COMPLETED|Overall Study||0
10022420|NCT01849692|11145900|FG003|NOT COMPLETED|Overall Study||0
10022421|NCT01849692|11145901|FG004|NOT COMPLETED|Overall Study||0
10022422|NCT01849692|11145902|FG005|NOT COMPLETED|Overall Study||0
10022423|NCT01849692|11145903|FG006|NOT COMPLETED|Overall Study||0
10022424|NCT01849692|11145904|FG007|NOT COMPLETED|Overall Study||0
10022425|NCT01849770|11145928|FG000|STARTED|Overall Study||20
10022426|NCT01849770|11145929|FG001|STARTED|Overall Study||19
10022427|NCT01849770|11145930|FG002|STARTED|Overall Study||20
10022428|NCT01849770|11145928|FG000|COMPLETED|Overall Study||20
10022429|NCT01849770|11145929|FG001|COMPLETED|Overall Study||15
10022430|NCT01849770|11145930|FG002|COMPLETED|Overall Study||19
10022431|NCT01849770|11145928|FG000|NOT COMPLETED|Overall Study||0
10022432|NCT01849770|11145929|FG001|NOT COMPLETED|Overall Study||4
10022433|NCT01849770|11145930|FG002|NOT COMPLETED|Overall Study||1
10022434|NCT01849822|11145940|FG000|STARTED|Overall Study||1
10022435|NCT01849822|11145940|FG000|COMPLETED|Overall Study||1
10022436|NCT01849822|11145940|FG000|NOT COMPLETED|Overall Study||0
10022437|NCT01849848|11145944|FG000|STARTED|Overall Study||17
10022438|NCT01849848|11145944|FG000|COMPLETED|Overall Study||13
10022439|NCT01849848|11145944|FG000|NOT COMPLETED|Overall Study||4
10022440|NCT01850030|11145950|FG000|STARTED|Overall Study||520
10022441|NCT01850030|11145951|FG001|STARTED|Overall Study||511
10022442|NCT01850030|11145950|FG000|COMPLETED|Overall Study||173
10022443|NCT01850030|11145951|FG001|COMPLETED|Overall Study||142
10022444|NCT01850030|11145950|FG000|NOT COMPLETED|Overall Study||347
10022445|NCT01850030|11145951|FG001|NOT COMPLETED|Overall Study||369
10022446|NCT01850394|11145960|FG000|STARTED|Overall Study||45
10022447|NCT01850394|11145961|FG001|STARTED|Overall Study||45
10022448|NCT01850394|11145962|FG002|STARTED|Overall Study||45
10022449|NCT01850394|11145960|FG000|COMPLETED|Overall Study||45
10022450|NCT01850394|11145961|FG001|COMPLETED|Overall Study||45
10022451|NCT01850394|11145962|FG002|COMPLETED|Overall Study||45
10022452|NCT01850394|11145960|FG000|NOT COMPLETED|Overall Study||0
10022453|NCT01850394|11145961|FG001|NOT COMPLETED|Overall Study||0
10022454|NCT01850394|11145962|FG002|NOT COMPLETED|Overall Study||0
10022455|NCT01850446|11145972|FG000|STARTED|Overall Study||92
10022456|NCT01850446|11145973|FG001|STARTED|Overall Study||92
10022457|NCT01850446|11145972|FG000|COMPLETED|Overall Study||87
9841746|NCT02807363|10953287|FG003|STARTED|Post- Dosing Period||12
9841747|NCT02807363|10953284|FG000|COMPLETED|Post- Dosing Period||9
9841748|NCT02807363|10953285|FG001|COMPLETED|Post- Dosing Period||8
9841749|NCT02807363|10953286|FG002|COMPLETED|Post- Dosing Period||5
9841750|NCT02807363|10953287|FG003|COMPLETED|Post- Dosing Period||12
9841751|NCT02807363|10953284|FG000|NOT COMPLETED|Post- Dosing Period||0
9841752|NCT02807363|10953285|FG001|NOT COMPLETED|Post- Dosing Period||0
9959944|NCT01465412|11079549|FG000|NOT COMPLETED|Overall Study||0
9959945|NCT01465412|11079550|FG001|NOT COMPLETED|Overall Study||0
10022458|NCT01850446|11145973|FG001|COMPLETED|Overall Study||90
10022459|NCT01850446|11145972|FG000|NOT COMPLETED|Overall Study||5
10022460|NCT01850446|11145973|FG001|NOT COMPLETED|Overall Study||2
9841753|NCT02807363|10953286|FG002|NOT COMPLETED|Post- Dosing Period||0
9841754|NCT02807363|10953287|FG003|NOT COMPLETED|Post- Dosing Period||0
9841755|NCT02756403|10953303|FG000|STARTED|Overall Study||46
9841756|NCT02756403|10953304|FG001|STARTED|Overall Study||45
9841757|NCT02756403|10953305|FG002|STARTED|Overall Study||43
9841758|NCT02756403|10953306|FG003|STARTED|Overall Study||47
9841759|NCT02756403|10953303|FG000|COMPLETED|Overall Study||46
9841760|NCT02756403|10953304|FG001|COMPLETED|Overall Study||42
9959946|NCT01465412|11079551|FG002|NOT COMPLETED|Overall Study||0
10022461|NCT01850485|11145981|FG000|STARTED|Overall Study||9
10022462|NCT01850485|11145982|FG001|STARTED|Overall Study||13
10022463|NCT01850485|11145981|FG000|COMPLETED|Overall Study||9
10022464|NCT01850485|11145982|FG001|COMPLETED|Overall Study||13
9723416|NCT00081289|10823017|FG000|Defecation Symptom Score at Two Years|Overall Study||13
9723417|NCT00081289|10823018|FG001|Defecation Symptom Score at Two Years|Overall Study||15
9723418|NCT00081289|10823017|FG000|COMPLETED|Overall Study||52
9723419|NCT00081289|10823018|FG001|COMPLETED|Overall Study||52
9723420|NCT00081289|10823017|FG000|NOT COMPLETED|Overall Study||21
9723421|NCT00081289|10823018|FG001|NOT COMPLETED|Overall Study||21
9723422|NCT00081328|10823028|FG000|STARTED|Overall Study||232
9723423|NCT00081328|10823029|FG001|STARTED|Overall Study||233
9723424|NCT00081328|10823030|FG002|STARTED|Overall Study||234
9723425|NCT00081328|10823028|FG000|COMPLETED|Overall Study||232
9723426|NCT00081328|10823029|FG001|COMPLETED|Overall Study||233
9723427|NCT00081328|10823030|FG002|COMPLETED|Overall Study||234
9723428|NCT00081328|10823028|FG000|NOT COMPLETED|Overall Study||0
9723429|NCT00081328|10823029|FG001|NOT COMPLETED|Overall Study||0
9723430|NCT00081328|10823030|FG002|NOT COMPLETED|Overall Study||0
9723431|NCT00081458|10823042|FG000|STARTED|Overall Study||16
9723432|NCT00081458|10823043|FG001|STARTED|Overall Study||35
9723433|NCT00081458|10823044|FG002|STARTED|Overall Study||33
9723434|NCT00081458|10823042|FG000|Received Treatment|Overall Study||16
9723435|NCT00081458|10823043|FG001|Received Treatment|Overall Study||35
9723436|NCT00081458|10823044|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
9723437|NCT00081458|10823042|FG000|COMPLETED|Overall Study||15
9723438|NCT00081458|10823043|FG001|COMPLETED|Overall Study||27
9723439|NCT00081458|10823044|FG002|COMPLETED|Overall Study||29
9723440|NCT00081458|10823042|FG000|NOT COMPLETED|Overall Study||1
9723441|NCT00081458|10823043|FG001|NOT COMPLETED|Overall Study||8
9723442|NCT00081458|10823044|FG002|NOT COMPLETED|Overall Study||4
9723443|NCT00081497|10823055|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
9723444|NCT00081497|10823056|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
9841761|NCT02756403|10953305|FG002|COMPLETED|Overall Study||41
9841762|NCT02756403|10953306|FG003|COMPLETED|Overall Study||45
9841763|NCT02756403|10953303|FG000|NOT COMPLETED|Overall Study||0
9841764|NCT02756403|10953304|FG001|NOT COMPLETED|Overall Study||3
9841765|NCT02756403|10953305|FG002|NOT COMPLETED|Overall Study||2
9841766|NCT02756403|10953306|FG003|NOT COMPLETED|Overall Study||2
9841767|NCT02751502|10953316|FG000|STARTED|Overall Study||4
9841768|NCT02751502|10953316|FG000|COMPLETED|Overall Study||0
9841769|NCT02751502|10953316|FG000|NOT COMPLETED|Overall Study||4
9959947|NCT01465412|11079552|FG003|NOT COMPLETED|Overall Study||0
9959948|NCT01465464|11079564|FG000|STARTED|Overall Study||444
9959949|NCT01465464|11079565|FG001|STARTED|Overall Study||444
9959950|NCT01465464|11079564|FG000|COMPLETED|Overall Study||0
9959951|NCT01465464|11079565|FG001|COMPLETED|Overall Study||0
9959952|NCT01465464|11079564|FG000|NOT COMPLETED|Overall Study||444
9959953|NCT01465464|11079565|FG001|NOT COMPLETED|Overall Study||444
9959954|NCT01465659|11079575|FG000|STARTED|Completed 1 Cycle of Treatment||7
9959955|NCT01465659|11079576|FG001|STARTED|Completed 1 Cycle of Treatment||5
9959956|NCT01465659|11079577|FG002|STARTED|Completed 1 Cycle of Treatment||6
9959957|NCT01465659|11079578|FG003|STARTED|Completed 1 Cycle of Treatment||11
9959958|NCT01465659|11079575|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
9959959|NCT01465659|11079576|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
9959960|NCT01465659|11079577|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
9959961|NCT01465659|11079578|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
9959962|NCT01465659|11079575|FG000|COMPLETED|Completed 1 Cycle of Treatment||7
9959963|NCT01465659|11079576|FG001|COMPLETED|Completed 1 Cycle of Treatment||4
9959964|NCT01465659|11079577|FG002|COMPLETED|Completed 1 Cycle of Treatment||6
9959965|NCT01465659|11079578|FG003|COMPLETED|Completed 1 Cycle of Treatment||10
9959966|NCT01465659|11079575|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0
9959967|NCT01465659|11079576|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1
9959968|NCT01465659|11079577|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0
9959969|NCT01465659|11079578|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1
9959970|NCT01465659|11079575|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7
9959971|NCT01465659|11079576|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4
9959972|NCT01465659|11079577|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6
9959973|NCT01465659|11079578|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10
10114190|NCT02514551|11244908|FG000|Received at Least One Dose of Study Drug|Overall Study||123
10114191|NCT02514551|11244909|FG001|Received at Least One Dose of Study Drug|Overall Study||120
10114192|NCT02514551|11244908|FG000|COMPLETED|Overall Study||123
10114193|NCT02514551|11244909|FG001|COMPLETED|Overall Study||119
9959974|NCT01465659|11079575|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
9959975|NCT01465659|11079576|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
9959976|NCT01465659|11079577|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
9959977|NCT01465659|11079578|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
9959978|NCT01465659|11079575|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
9959979|NCT01465659|11079576|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
9959980|NCT01465659|11079577|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
9959981|NCT01465659|11079578|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
9959982|NCT01465659|11079575|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
9959983|NCT01465659|11079576|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
9959984|NCT01465659|11079577|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
9959985|NCT01465659|11079578|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
9959986|NCT01465659|11079575|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
9959987|NCT01465659|11079576|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
9959988|NCT01465659|11079577|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
9959989|NCT01465659|11079578|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
9959990|NCT01465659|11079575|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
9959991|NCT01465659|11079576|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
9959992|NCT01465659|11079577|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
9959993|NCT01465659|11079578|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
9959994|NCT01465659|11079575|FG000|STARTED|Went on to Cycle 3 and Beyond||5
9959995|NCT01465659|11079576|FG001|STARTED|Went on to Cycle 3 and Beyond||4
9959996|NCT01465659|11079577|FG002|STARTED|Went on to Cycle 3 and Beyond||4
9841770|NCT02487797|10953322|FG000|STARTED|Overall Study||502
9841771|NCT02487797|10953323|FG001|STARTED|Overall Study||501
9841772|NCT02487797|10953322|FG000|COMPLETED|Overall Study||502
9841773|NCT02487797|10953323|FG001|COMPLETED|Overall Study||501
9841774|NCT02487797|10953322|FG000|NOT COMPLETED|Overall Study||0
9841775|NCT02487797|10953323|FG001|NOT COMPLETED|Overall Study||0
9841776|NCT02348359|10953333|FG000|STARTED|Overall Study||40
9841777|NCT02348359|10953334|FG001|STARTED|Overall Study||39
9841778|NCT02348359|10953335|FG002|STARTED|Overall Study||39
9841779|NCT02348359|10953336|FG003|STARTED|Overall Study||39
9841780|NCT02348359|10953333|FG000|COMPLETED|Overall Study||29
9841781|NCT02348359|10953334|FG001|COMPLETED|Overall Study||22
9841782|NCT02348359|10953335|FG002|COMPLETED|Overall Study||25
9841783|NCT02348359|10953336|FG003|COMPLETED|Overall Study||27
9841784|NCT02348359|10953333|FG000|NOT COMPLETED|Overall Study||11
9841785|NCT02348359|10953334|FG001|NOT COMPLETED|Overall Study||17
9841786|NCT02348359|10953335|FG002|NOT COMPLETED|Overall Study||14
9841787|NCT02348359|10953336|FG003|NOT COMPLETED|Overall Study||12
9841788|NCT02285062|10953348|FG000|STARTED|Overall Study||285
9841789|NCT02285062|10953349|FG001|STARTED|Overall Study||285
9841790|NCT02285062|10953348|FG000|Received Study Treatment|Overall Study||283
9841791|NCT02285062|10953349|FG001|Received Study Treatment|Overall Study||284
9841792|NCT02285062|10953348|FG000|Ongoing Study Treatment|Overall Study||0
9841793|NCT02285062|10953349|FG001|Ongoing Study Treatment|Overall Study||0
9841794|NCT02285062|10953348|FG000|COMPLETED|Overall Study||207
9841795|NCT02285062|10953349|FG001|COMPLETED|Overall Study||201
9841796|NCT02285062|10953348|FG000|NOT COMPLETED|Overall Study||78
9841797|NCT02285062|10953349|FG001|NOT COMPLETED|Overall Study||84
9841801|NCT01981096|10953361|FG000|STARTED|Overall Study||20
9841802|NCT01981096|10953362|FG001|STARTED|Overall Study||20
9841803|NCT01981096|10953361|FG000|Post-treatment|Overall Study||17
9841804|NCT01981096|10953362|FG001|Post-treatment|Overall Study||19
9841805|NCT01981096|10953361|FG000|COMPLETED|Overall Study||17
9841806|NCT01981096|10953362|FG001|COMPLETED|Overall Study||19
9841807|NCT01981096|10953361|FG000|NOT COMPLETED|Overall Study||3
9841808|NCT01981096|10953362|FG001|NOT COMPLETED|Overall Study||1
9841809|NCT01935336|10953372|FG000|STARTED|Overall Study|Only one subject was treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|6
9841810|NCT01935336|10953373|FG001|STARTED|Overall Study|no subjects were treated in this arm|3
9841811|NCT01935336|10953374|FG002|STARTED|Overall Study|Only three subjects were treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|47
9841812|NCT01935336|10953375|FG003|STARTED|Overall Study|No subjects were treated in this arm|66
9841813|NCT01935336|10953372|FG000|Started Treatment|Overall Study||1
9841814|NCT01935336|10953373|FG001|Started Treatment|Overall Study||0
9841815|NCT01935336|10953374|FG002|Started Treatment|Overall Study||3
9841816|NCT01935336|10953375|FG003|Started Treatment|Overall Study||0
9841817|NCT01935336|10953372|FG000|COMPLETED|Overall Study||0
9841818|NCT01935336|10953373|FG001|COMPLETED|Overall Study||0
9841819|NCT01935336|10953374|FG002|COMPLETED|Overall Study||0
9841820|NCT01935336|10953375|FG003|COMPLETED|Overall Study||0
9841821|NCT01935336|10953372|FG000|NOT COMPLETED|Overall Study||6
9841822|NCT01935336|10953373|FG001|NOT COMPLETED|Overall Study||3
9841823|NCT01935336|10953374|FG002|NOT COMPLETED|Overall Study||47
9841824|NCT01935336|10953375|FG003|NOT COMPLETED|Overall Study||66
9841825|NCT01712490|10953393|FG000|STARTED|Overall Study||664
9841826|NCT01712490|10953394|FG001|STARTED|Overall Study||670
9841827|NCT01712490|10953393|FG000|Treated|Overall Study||662
9841828|NCT01712490|10953394|FG001|Treated|Overall Study||659
9841829|NCT01712490|10953393|FG000|COMPLETED|Overall Study||0
9841830|NCT01712490|10953394|FG001|COMPLETED|Overall Study||0
9841831|NCT01712490|10953393|FG000|NOT COMPLETED|Overall Study||664
9841832|NCT01712490|10953394|FG001|NOT COMPLETED|Overall Study||670
9841833|NCT01702805|10953402|FG000|STARTED|Overall Study||911
9841834|NCT01702805|10953403|FG001|STARTED|Overall Study||913
9841835|NCT01702805|10953402|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699
9841836|NCT01702805|10953403|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712
9841837|NCT01702805|10953402|FG000|Died After Discharge|Overall Study||19
9841838|NCT01702805|10953403|FG001|Died After Discharge|Overall Study||10
9841839|NCT01702805|10953402|FG000|Died Before Discharge|Overall Study||127
9841840|NCT01702805|10953403|FG001|Died Before Discharge|Overall Study||125
9841841|NCT01702805|10953402|FG000|Survived to Discharge|Overall Study||781
9841842|NCT01702805|10953403|FG001|Survived to Discharge|Overall Study||781
9841843|NCT01702805|10953402|FG000|COMPLETED|Overall Study||845
9841844|NCT01702805|10953403|FG001|COMPLETED|Overall Study||847
9841845|NCT01702805|10953402|FG000|NOT COMPLETED|Overall Study||66
9841846|NCT01702805|10953403|FG001|NOT COMPLETED|Overall Study||66
9841847|NCT01499160|10953409|FG000|STARTED|Overall Study||7
9841848|NCT01499160|10953409|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
9841849|NCT01499160|10953409|FG000|NOT COMPLETED|Overall Study||2
9841850|NCT01333436|10953416|FG000|STARTED|Overall Study||43
9841851|NCT01333436|10953417|FG001|STARTED|Overall Study||50
9841852|NCT01333436|10953416|FG000|COMPLETED|Overall Study||43
9841853|NCT01333436|10953417|FG001|COMPLETED|Overall Study||50
9841854|NCT01333436|10953416|FG000|NOT COMPLETED|Overall Study||0
9841855|NCT01333436|10953417|FG001|NOT COMPLETED|Overall Study||0
9959997|NCT01465659|11079578|FG003|STARTED|Went on to Cycle 3 and Beyond||9
9959998|NCT01465659|11079575|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5
9959999|NCT01465659|11079576|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4
9960000|NCT01465659|11079577|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4
9960001|NCT01465659|11079578|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9
9841856|NCT01307631|10953423|FG000|STARTED|Overall Study||9
9841857|NCT01307631|10953424|FG001|STARTED|Overall Study||28
9841858|NCT01307631|10953423|FG000|COMPLETED|Overall Study||9
9841859|NCT01307631|10953424|FG001|COMPLETED|Overall Study||28
9841860|NCT01307631|10953423|FG000|NOT COMPLETED|Overall Study||0
9841861|NCT01307631|10953424|FG001|NOT COMPLETED|Overall Study||0
9841862|NCT01256086|10953434|FG000|STARTED|Treatment Day 1||11
9841863|NCT01256086|10953435|FG001|STARTED|Treatment Day 1||11
9841864|NCT01256086|10953436|FG002|STARTED|Treatment Day 1||11
9841865|NCT01256086|10953437|FG003|STARTED|Treatment Day 1||11
9723445|NCT00081497|10823055|FG000|COMPLETED|Overall Study||25
9723446|NCT00081497|10823056|FG001|COMPLETED|Overall Study||37
9723447|NCT00081497|10823055|FG000|NOT COMPLETED|Overall Study||3
9723448|NCT00081497|10823056|FG001|NOT COMPLETED|Overall Study||2
9723449|NCT00081653|10823070|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
9723450|NCT00081653|10823071|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
9723451|NCT00081653|10823070|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311
9723452|NCT00081653|10823071|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324
9723453|NCT00081653|10823070|FG000|NOT COMPLETED|Overall Study||47
9723454|NCT00081653|10823071|FG001|NOT COMPLETED|Overall Study||37
9723455|NCT00081731|10823080|FG000|STARTED|Overall Study||480
9723456|NCT00081731|10823081|FG001|STARTED|Overall Study||467
9723457|NCT00081731|10823080|FG000|COMPLETED|Overall Study||472
9723458|NCT00081731|10823081|FG001|COMPLETED|Overall Study||459
9723459|NCT00081731|10823080|FG000|NOT COMPLETED|Overall Study||8
9723460|NCT00081731|10823081|FG001|NOT COMPLETED|Overall Study||8
9723461|NCT00081770|10823090|FG000|STARTED|Overall Study||1019
9723462|NCT00081770|10823091|FG001|STARTED|Overall Study||1016
9723463|NCT00081770|10823092|FG002|STARTED|Overall Study||1035
9723464|NCT00081770|10823090|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
9723465|NCT00081770|10823091|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
9723466|NCT00081770|10823092|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
9723467|NCT00081770|10823090|FG000|NOT COMPLETED|Overall Study||502
9723468|NCT00081770|10823091|FG001|NOT COMPLETED|Overall Study||546
9723469|NCT00081770|10823092|FG002|NOT COMPLETED|Overall Study||456
9723470|NCT00081861|10823100|FG000|STARTED|Overall Study||13
9723471|NCT00081861|10823100|FG000|COMPLETED|Overall Study||13
9723472|NCT00081861|10823100|FG000|NOT COMPLETED|Overall Study||0
9723473|NCT00081939|10823104|FG000|STARTED|Overall Study||303
9723474|NCT00081939|10823104|FG000|COMPLETED|Overall Study||303
9723475|NCT00081939|10823104|FG000|NOT COMPLETED|Overall Study||0
9723476|NCT00082017|10823108|FG000|STARTED|Overall Study||11
9723477|NCT00082017|10823109|FG001|STARTED|Overall Study||9
9723478|NCT00082017|10823108|FG000|COMPLETED|Overall Study||11
9723479|NCT00082017|10823109|FG001|COMPLETED|Overall Study||9
9723480|NCT00082017|10823108|FG000|NOT COMPLETED|Overall Study||0
9723481|NCT00082017|10823109|FG001|NOT COMPLETED|Overall Study||0
9723482|NCT00082173|10823117|FG000|STARTED|Overall Study||74
9723483|NCT00082173|10823118|FG001|STARTED|Overall Study||72
9723484|NCT00082173|10823117|FG000|COMPLETED|Overall Study||64
9723485|NCT00082173|10823118|FG001|COMPLETED|Overall Study||61
9723486|NCT00082173|10823117|FG000|NOT COMPLETED|Overall Study||10
9723487|NCT00082173|10823118|FG001|NOT COMPLETED|Overall Study||11
9723488|NCT00082329|10823124|FG000|STARTED|Overall Study||9
9723489|NCT00082329|10823124|FG000|COMPLETED|Overall Study||9
9723490|NCT00082329|10823124|FG000|NOT COMPLETED|Overall Study||0
9723491|NCT00082342|10823130|FG000|STARTED|Overall Study||13
9723492|NCT00082342|10823131|FG001|STARTED|Overall Study||12
10022465|NCT01850485|11145981|FG000|NOT COMPLETED|Overall Study||0
10022466|NCT01850485|11145982|FG001|NOT COMPLETED|Overall Study||0
10022467|NCT01850550|11145990|FG000|STARTED|Overall Study||40
10022468|NCT01850550|11145991|FG001|STARTED|Overall Study||40
10022469|NCT01850550|11145990|FG000|COMPLETED|Overall Study||40
10022470|NCT01850550|11145991|FG001|COMPLETED|Overall Study||37
10022471|NCT01850550|11145990|FG000|NOT COMPLETED|Overall Study||0
10022472|NCT01850550|11145991|FG001|NOT COMPLETED|Overall Study||3
10022473|NCT01850589|11145999|FG000|STARTED|Overall Study||22
10022474|NCT01850589|11146000|FG001|STARTED|Overall Study||22
10022475|NCT01850589|11145999|FG000|COMPLETED|Overall Study||14
10022476|NCT01850589|11146000|FG001|COMPLETED|Overall Study||22
9841866|NCT01256086|10953434|FG000|COMPLETED|Treatment Day 1||11
9841867|NCT01256086|10953435|FG001|COMPLETED|Treatment Day 1||11
9841868|NCT01256086|10953436|FG002|COMPLETED|Treatment Day 1||11
9841869|NCT01256086|10953437|FG003|COMPLETED|Treatment Day 1||11
9841870|NCT01256086|10953434|FG000|NOT COMPLETED|Treatment Day 1||0
9841871|NCT01256086|10953435|FG001|NOT COMPLETED|Treatment Day 1||0
9841872|NCT01256086|10953436|FG002|NOT COMPLETED|Treatment Day 1||0
9841873|NCT01256086|10953437|FG003|NOT COMPLETED|Treatment Day 1||0
9841874|NCT01256086|10953434|FG000|STARTED|Treatment Day 2||11
9841875|NCT01256086|10953435|FG001|STARTED|Treatment Day 2||10
9841876|NCT01256086|10953436|FG002|STARTED|Treatment Day 2||9
9841877|NCT01256086|10953437|FG003|STARTED|Treatment Day 2||11
9841878|NCT01256086|10953434|FG000|COMPLETED|Treatment Day 2||11
9841879|NCT01256086|10953435|FG001|COMPLETED|Treatment Day 2||10
9960002|NCT01465659|11079575|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
10022477|NCT01850589|11145999|FG000|NOT COMPLETED|Overall Study||8
9723493|NCT00082342|10823130|FG000|COMPLETED|Overall Study||13
9841880|NCT01256086|10953436|FG002|COMPLETED|Treatment Day 2||9
9841881|NCT01256086|10953437|FG003|COMPLETED|Treatment Day 2||11
9841882|NCT01256086|10953434|FG000|NOT COMPLETED|Treatment Day 2||0
9841883|NCT01256086|10953435|FG001|NOT COMPLETED|Treatment Day 2||0
9841884|NCT01256086|10953436|FG002|NOT COMPLETED|Treatment Day 2||0
9841885|NCT01256086|10953437|FG003|NOT COMPLETED|Treatment Day 2||0
9841886|NCT01256086|10953434|FG000|STARTED|Treatment Day 3||11
9841887|NCT01256086|10953435|FG001|STARTED|Treatment Day 3||10
9841888|NCT01256086|10953436|FG002|STARTED|Treatment Day 3||9
9841889|NCT01256086|10953437|FG003|STARTED|Treatment Day 3||11
9960003|NCT01465659|11079576|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
9960004|NCT01465659|11079577|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
9960005|NCT01465659|11079578|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
9960006|NCT01465659|11079575|FG000|STARTED|Completed Follow for 1 Year||7
9960007|NCT01465659|11079576|FG001|STARTED|Completed Follow for 1 Year||4
9960008|NCT01465659|11079577|FG002|STARTED|Completed Follow for 1 Year||6
9960009|NCT01465659|11079578|FG003|STARTED|Completed Follow for 1 Year||11
9960010|NCT01465659|11079575|FG000|COMPLETED|Completed Follow for 1 Year||1
9960011|NCT01465659|11079576|FG001|COMPLETED|Completed Follow for 1 Year||1
9960012|NCT01465659|11079577|FG002|COMPLETED|Completed Follow for 1 Year||4
9960013|NCT01465659|11079578|FG003|COMPLETED|Completed Follow for 1 Year||7
9960014|NCT01465659|11079575|FG000|NOT COMPLETED|Completed Follow for 1 Year||6
9960015|NCT01465659|11079576|FG001|NOT COMPLETED|Completed Follow for 1 Year||3
10022478|NCT01850589|11146000|FG001|NOT COMPLETED|Overall Study||0
10022479|NCT01850602|11146008|FG000|STARTED|Overall Study||108
10022480|NCT01850602|11146009|FG001|STARTED|Overall Study||105
10022481|NCT01850602|11146008|FG000|COMPLETED|Overall Study||94
10022482|NCT01850602|11146009|FG001|COMPLETED|Overall Study||87
10022483|NCT01850602|11146008|FG000|NOT COMPLETED|Overall Study||14
10022484|NCT01850602|11146009|FG001|NOT COMPLETED|Overall Study||18
10022485|NCT01850615|11146017|FG000|STARTED|Overall Study||116
10022486|NCT01850615|11146018|FG001|STARTED|Overall Study||120
10022487|NCT01850615|11146017|FG000|Exposed|Overall Study||115
10022488|NCT01850615|11146018|FG001|Exposed|Overall Study||120
10022489|NCT01850615|11146017|FG000|COMPLETED|Overall Study||107
10022490|NCT01850615|11146018|FG001|COMPLETED|Overall Study||115
10022491|NCT01850615|11146017|FG000|NOT COMPLETED|Overall Study||9
10022492|NCT01850615|11146018|FG001|NOT COMPLETED|Overall Study||5
10022493|NCT01850641|11146024|FG000|STARTED|Overall Study||35
10022494|NCT01850641|11146024|FG000|COMPLETED|Overall Study||30
10022495|NCT01850641|11146024|FG000|NOT COMPLETED|Overall Study||5
9841890|NCT01256086|10953434|FG000|COMPLETED|Treatment Day 3||11
9841891|NCT01256086|10953435|FG001|COMPLETED|Treatment Day 3||10
9841892|NCT01256086|10953436|FG002|COMPLETED|Treatment Day 3||9
9960016|NCT01465659|11079577|FG002|NOT COMPLETED|Completed Follow for 1 Year||2
10022496|NCT01850745|11146031|FG000|STARTED|Overall Study||147
10022497|NCT01850745|11146032|FG001|STARTED|Overall Study||169
10022498|NCT01850745|11146033|FG002|STARTED|Overall Study||131
10022499|NCT01850745|11146031|FG000|COMPLETED|Overall Study||147
10022500|NCT01850745|11146032|FG001|COMPLETED|Overall Study||169
10022501|NCT01850745|11146033|FG002|COMPLETED|Overall Study||131
10022502|NCT01850745|11146031|FG000|NOT COMPLETED|Overall Study||0
10022503|NCT01850745|11146032|FG001|NOT COMPLETED|Overall Study||0
10022504|NCT01850745|11146033|FG002|NOT COMPLETED|Overall Study||0
10022505|NCT01850823|11146044|FG000|STARTED|Overall Study||175
10022506|NCT01850823|11146045|FG001|STARTED|Overall Study||350
10022507|NCT01850823|11146046|FG002|STARTED|Overall Study||355
10022508|NCT01850823|11146044|FG000|COMPLETED|Overall Study||172
10022509|NCT01850823|11146045|FG001|COMPLETED|Overall Study||347
10022510|NCT01850823|11146046|FG002|COMPLETED|Overall Study||345
10022511|NCT01850823|11146044|FG000|NOT COMPLETED|Overall Study||3
9841893|NCT01256086|10953437|FG003|COMPLETED|Treatment Day 3||11
9841894|NCT01256086|10953434|FG000|NOT COMPLETED|Treatment Day 3||0
9841895|NCT01256086|10953435|FG001|NOT COMPLETED|Treatment Day 3||0
9841896|NCT01256086|10953436|FG002|NOT COMPLETED|Treatment Day 3||0
9841897|NCT01256086|10953437|FG003|NOT COMPLETED|Treatment Day 3||0
9841898|NCT01256086|10953434|FG000|STARTED|Treatment Day 4||11
9841899|NCT01256086|10953435|FG001|STARTED|Treatment Day 4||10
9841900|NCT01256086|10953436|FG002|STARTED|Treatment Day 4||9
9841901|NCT01256086|10953437|FG003|STARTED|Treatment Day 4||11
9841902|NCT01256086|10953434|FG000|COMPLETED|Treatment Day 4||11
9841903|NCT01256086|10953435|FG001|COMPLETED|Treatment Day 4||10
9841904|NCT01256086|10953436|FG002|COMPLETED|Treatment Day 4||9
9841905|NCT01256086|10953437|FG003|COMPLETED|Treatment Day 4||11
9841906|NCT01256086|10953434|FG000|NOT COMPLETED|Treatment Day 4||0
9841907|NCT01256086|10953435|FG001|NOT COMPLETED|Treatment Day 4||0
9841908|NCT01256086|10953436|FG002|NOT COMPLETED|Treatment Day 4||0
9841909|NCT01256086|10953437|FG003|NOT COMPLETED|Treatment Day 4||0
9841910|NCT01061151|10953451|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
9841911|NCT01061151|10953452|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
9841912|NCT01061151|10953453|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
9841913|NCT01061151|10953454|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
9841914|NCT01061151|10953451|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
9841915|NCT01061151|10953452|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
9841916|NCT01061151|10953453|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
9841917|NCT01061151|10953454|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
9841918|NCT01061151|10953451|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
9841919|NCT01061151|10953452|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
9841920|NCT01061151|10953453|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
9841921|NCT01061151|10953454|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
9841922|NCT01061151|10953451|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
9841923|NCT01061151|10953452|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
9960017|NCT01465659|11079578|FG003|NOT COMPLETED|Completed Follow for 1 Year||4
10022512|NCT01850823|11146045|FG001|NOT COMPLETED|Overall Study||3
10022513|NCT01850823|11146046|FG002|NOT COMPLETED|Overall Study||10
10022514|NCT01851330|11146059|FG000|STARTED|Overall Study||215
10022515|NCT01851330|11146060|FG001|STARTED|Overall Study||216
10022516|NCT01851330|11146061|FG002|STARTED|Overall Study||216
10022517|NCT01851330|11146059|FG000|COMPLETED|Overall Study||202
10022518|NCT01851330|11146060|FG001|COMPLETED|Overall Study||200
10022519|NCT01851330|11146061|FG002|COMPLETED|Overall Study||204
10022520|NCT01851330|11146059|FG000|NOT COMPLETED|Overall Study||13
9841924|NCT01061151|10953453|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
9841925|NCT01061151|10953454|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
9841926|NCT01061151|10953451|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
9841927|NCT01061151|10953452|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
9841928|NCT01061151|10953453|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
9841929|NCT01061151|10953454|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
9841930|NCT01061151|10953451|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
9841931|NCT01061151|10953452|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
9723494|NCT00082342|10823131|FG001|COMPLETED|Overall Study||12
9723495|NCT00082342|10823130|FG000|NOT COMPLETED|Overall Study||0
9723496|NCT00082342|10823131|FG001|NOT COMPLETED|Overall Study||0
9723497|NCT00082355|10823151|FG000|STARTED|Initial Results of Thrombolytic Therapy||30
9723498|NCT00082355|10823151|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28
9723499|NCT00082355|10823151|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
9723500|NCT00082355|10823151|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28
9723501|NCT00082355|10823151|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
9723502|NCT00082355|10823151|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
9723503|NCT00082368|10823155|FG000|STARTED|Overall Study||12
9723504|NCT00082368|10823155|FG000|COMPLETED|Overall Study||11
9723505|NCT00082368|10823155|FG000|NOT COMPLETED|Overall Study||1
9723506|NCT00082381|10823161|FG000|STARTED|Overall Study||283
9723507|NCT00082381|10823162|FG001|STARTED|Overall Study||268
9723508|NCT00082381|10823161|FG000|Received Treatment (Intent to Treat)|Overall Study||282
10114194|NCT02514551|11244908|FG000|NOT COMPLETED|Overall Study||0
10114195|NCT02514551|11244909|FG001|NOT COMPLETED|Overall Study||3
10114196|NCT02514577|11244918|FG000|STARTED|Overall Study||143
10114197|NCT02514577|11244919|FG001|STARTED|Overall Study||74
10114198|NCT02514577|11244918|FG000|Intent-to-Treat (ITT) Population|Overall Study||143
10022521|NCT01851330|11146060|FG001|NOT COMPLETED|Overall Study||16
10022522|NCT01851330|11146061|FG002|NOT COMPLETED|Overall Study||12
10022523|NCT01851590|11146072|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
10022524|NCT01851590|11146073|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
10022525|NCT01851590|11146074|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
10022526|NCT01851590|11146072|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
10022527|NCT01851590|11146073|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
10022528|NCT01851590|11146074|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
10022529|NCT01851590|11146072|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
9841932|NCT01061151|10953453|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
9841933|NCT01061151|10953454|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
9841934|NCT01061151|10953451|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
9841935|NCT01061151|10953452|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
9841936|NCT01061151|10953453|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
9841937|NCT01061151|10953454|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
9841938|NCT01061151|10953451|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
9841939|NCT01061151|10953452|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
9841940|NCT01061151|10953453|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
9841941|NCT01061151|10953454|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
9841942|NCT00981058|10953476|FG000|STARTED|Overall Study||545
9841943|NCT00981058|10953477|FG001|STARTED|Overall Study||548
9841944|NCT00981058|10953476|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538
9841945|NCT00981058|10953477|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541
9841946|NCT00981058|10953476|FG000|Death Due to Any Cause|Overall Study||418
9841947|NCT00981058|10953477|FG001|Death Due to Any Cause|Overall Study||442
9841948|NCT00981058|10953476|FG000|COMPLETED|Overall Study||425
9841949|NCT00981058|10953477|FG001|COMPLETED|Overall Study||451
9841950|NCT00981058|10953476|FG000|NOT COMPLETED|Overall Study||120
9841951|NCT00981058|10953477|FG001|NOT COMPLETED|Overall Study||97
9841952|NCT00885495|10953485|FG000|STARTED|Overall Study||8
9841953|NCT00885495|10953486|FG001|STARTED|Overall Study||9
9841954|NCT00885495|10953485|FG000|COMPLETED|Overall Study||6
9841955|NCT00885495|10953486|FG001|COMPLETED|Overall Study||6
9841956|NCT00885495|10953485|FG000|NOT COMPLETED|Overall Study||2
9841957|NCT00885495|10953486|FG001|NOT COMPLETED|Overall Study||3
9841958|NCT00084799|10953499|FG000|STARTED|Overall Study||5
9841959|NCT00084799|10953500|FG001|STARTED|Overall Study||5
9960018|NCT01465763|11079594|FG000|STARTED|Overall Study||476
9960019|NCT01465763|11079595|FG001|STARTED|Overall Study||16
9960020|NCT01465763|11079596|FG002|STARTED|Overall Study||122
9960021|NCT01465763|11079594|FG000|COMPLETED|Overall Study||445
9960022|NCT01465763|11079595|FG001|COMPLETED|Overall Study||15
9960023|NCT01465763|11079596|FG002|COMPLETED|Overall Study||118
9960024|NCT01465763|11079594|FG000|NOT COMPLETED|Overall Study||31
9960025|NCT01465763|11079595|FG001|NOT COMPLETED|Overall Study||1
9960026|NCT01465763|11079596|FG002|NOT COMPLETED|Overall Study||4
9960027|NCT01465802|11079608|FG000|STARTED|Overall Study||66
9960028|NCT01465802|11079609|FG001|STARTED|Overall Study||66
9960029|NCT01465802|11079610|FG002|STARTED|Overall Study||7
9960030|NCT01465802|11079611|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
9960031|NCT01465802|11079612|FG004|STARTED|Overall Study||25
9960032|NCT01465802|11079608|FG000|COMPLETED|Overall Study||33
9960033|NCT01465802|11079609|FG001|COMPLETED|Overall Study||42
9960034|NCT01465802|11079610|FG002|COMPLETED|Overall Study||7
9960035|NCT01465802|11079611|FG003|COMPLETED|Overall Study||38
9960036|NCT01465802|11079612|FG004|COMPLETED|Overall Study||13
9960037|NCT01465802|11079608|FG000|NOT COMPLETED|Overall Study||33
9960038|NCT01465802|11079609|FG001|NOT COMPLETED|Overall Study||24
9960039|NCT01465802|11079610|FG002|NOT COMPLETED|Overall Study||0
9841960|NCT00084799|10953499|FG000|COMPLETED|Overall Study||4
9723509|NCT00082381|10823162|FG001|Received Treatment (Intent to Treat)|Overall Study||267
9723510|NCT00082381|10823161|FG000|COMPLETED|Overall Study||228
9723511|NCT00082381|10823162|FG001|COMPLETED|Overall Study||242
9723512|NCT00082381|10823161|FG000|NOT COMPLETED|Overall Study||55
9723513|NCT00082381|10823162|FG001|NOT COMPLETED|Overall Study||26
9723514|NCT00082407|10823170|FG000|STARTED|Overall Study||255
9723515|NCT00082407|10823171|FG001|STARTED|Overall Study||250
9723516|NCT00082407|10823170|FG000|Received Treatment (Intent to Treat)|Overall Study||253
9723517|NCT00082407|10823171|FG001|Received Treatment (Intent to Treat)|Overall Study||248
9723518|NCT00082407|10823170|FG000|COMPLETED|Overall Study||199
9723519|NCT00082407|10823171|FG001|COMPLETED|Overall Study||223
9723520|NCT00082407|10823170|FG000|NOT COMPLETED|Overall Study||56
9723521|NCT00082407|10823171|FG001|NOT COMPLETED|Overall Study||27
9723522|NCT00082433|10823179|FG000|STARTED|Overall Study||609
9723523|NCT00082433|10823180|FG001|STARTED|Overall Study||612
9723524|NCT00082433|10823179|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
9723525|NCT00082433|10823180|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
9723526|NCT00082433|10823179|FG000|NOT COMPLETED|Overall Study||594
9723527|NCT00082433|10823180|FG001|NOT COMPLETED|Overall Study||597
9723528|NCT00082628|10823188|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81
9723529|NCT00082628|10823189|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245
9723530|NCT00082628|10823190|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0
9723531|NCT00082628|10823191|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0
9723532|NCT00082628|10823192|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0
9723533|NCT00082628|10823188|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
9723534|NCT00082628|10823189|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
9723535|NCT00082628|10823190|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
9723536|NCT00082628|10823191|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
9723537|NCT00082628|10823192|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
9723538|NCT00082628|10823188|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
9841961|NCT00084799|10953500|FG001|COMPLETED|Overall Study||5
9723539|NCT00082628|10823189|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
9723540|NCT00082628|10823190|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
9723541|NCT00082628|10823191|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
9723542|NCT00082628|10823192|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
9723543|NCT00082628|10823188|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0
9723544|NCT00082628|10823189|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0
9723545|NCT00082628|10823190|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93
9723546|NCT00082628|10823191|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92
9723547|NCT00082628|10823192|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73
9723548|NCT00082628|10823188|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0
9723549|NCT00082628|10823189|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0
9723550|NCT00082628|10823190|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78
9723551|NCT00082628|10823191|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76
9723552|NCT00082628|10823192|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55
9723553|NCT00082628|10823188|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
10022530|NCT01851590|11146073|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
10022531|NCT01851590|11146074|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
10081138|NCT02257970|11209575|FG001|NOT COMPLETED|Part 3||0
10081139|NCT02257970|11209576|FG002|NOT COMPLETED|Part 3||7
9841962|NCT00084799|10953499|FG000|NOT COMPLETED|Overall Study||1
9841963|NCT00084799|10953500|FG001|NOT COMPLETED|Overall Study||0
9841964|NCT00821236|10953509|FG000|STARTED|Overall Study||40
9841965|NCT00821236|10953509|FG000|COMPLETED|Overall Study||37
9841966|NCT00821236|10953509|FG000|NOT COMPLETED|Overall Study||3
9841967|NCT00821327|10953517|FG000|STARTED|Overall Study||36
9841968|NCT00821327|10953517|FG000|COMPLETED|Overall Study||1
9841969|NCT00821327|10953517|FG000|NOT COMPLETED|Overall Study||35
9841970|NCT00821431|10953523|FG000|STARTED|Overall Study||38
9841971|NCT00821431|10953524|FG001|STARTED|Overall Study||52
9841972|NCT00821431|10953523|FG000|COMPLETED|Overall Study||23
9841973|NCT00821431|10953524|FG001|COMPLETED|Overall Study||47
9841974|NCT00821431|10953523|FG000|NOT COMPLETED|Overall Study||15
9841975|NCT00821431|10953524|FG001|NOT COMPLETED|Overall Study||5
9841976|NCT00821509|10953533|FG000|STARTED|Overall Study||257
9841977|NCT00821509|10953534|FG001|STARTED|Overall Study||202
9841978|NCT00821509|10953535|FG002|STARTED|Overall Study||224
9841979|NCT00821509|10953533|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
9841980|NCT00821509|10953534|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
9960040|NCT01465802|11079611|FG003|NOT COMPLETED|Overall Study||29
9841981|NCT00821509|10953535|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
9841982|NCT00821509|10953533|FG000|NOT COMPLETED|Overall Study||12
9841983|NCT00821509|10953534|FG001|NOT COMPLETED|Overall Study||11
9841984|NCT00821509|10953535|FG002|NOT COMPLETED|Overall Study||34
9841985|NCT00821626|10953545|FG000|STARTED|Overall Study||60
9841986|NCT00821626|10953546|FG001|STARTED|Overall Study||33
9841987|NCT00821626|10953545|FG000|COMPLETED|Overall Study||60
9841988|NCT00821626|10953546|FG001|COMPLETED|Overall Study||33
9841989|NCT00821626|10953545|FG000|NOT COMPLETED|Overall Study||0
9841990|NCT00821626|10953546|FG001|NOT COMPLETED|Overall Study||0
9841991|NCT00821678|10953556|FG000|STARTED|Overall Study||133
9841992|NCT00821678|10953557|FG001|STARTED|Overall Study||132
9841993|NCT00821678|10953556|FG000|COMPLETED|Overall Study||112
9841994|NCT00821678|10953557|FG001|COMPLETED|Overall Study||118
9841995|NCT00821678|10953556|FG000|NOT COMPLETED|Overall Study||21
9841996|NCT00821678|10953557|FG001|NOT COMPLETED|Overall Study||14
10022532|NCT01851590|11146072|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
10022533|NCT01851590|11146073|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
10081140|NCT02257970|11209577|FG003|NOT COMPLETED|Part 3||7
9841997|NCT00821795|10953567|FG000|STARTED|Overall Study||50
9841998|NCT00821795|10953568|FG001|STARTED|Overall Study||64
9841999|NCT00821795|10953567|FG000|COMPLETED|Overall Study||44
9842000|NCT00821795|10953568|FG001|COMPLETED|Overall Study||60
9842001|NCT00821795|10953567|FG000|NOT COMPLETED|Overall Study||6
9842002|NCT00821795|10953568|FG001|NOT COMPLETED|Overall Study||4
9842003|NCT00821821|10953577|FG000|STARTED|Overall Study||12
9842004|NCT00821821|10953578|FG001|STARTED|Overall Study||13
9842005|NCT00821821|10953579|FG002|STARTED|Overall Study||11
9842006|NCT00821821|10953577|FG000|COMPLETED|Overall Study||12
9842007|NCT00821821|10953578|FG001|COMPLETED|Overall Study||13
9842008|NCT00821821|10953579|FG002|COMPLETED|Overall Study||11
9842009|NCT00821821|10953577|FG000|NOT COMPLETED|Overall Study||0
9960041|NCT01465802|11079612|FG004|NOT COMPLETED|Overall Study||12
9960042|NCT01465841|11079626|FG000|STARTED|Overall Study||517
9960043|NCT01465841|11079626|FG000|COMPLETED|Overall Study||449
9960044|NCT01465841|11079626|FG000|NOT COMPLETED|Overall Study||68
10081141|NCT02258074|11209600|FG000|STARTED|Overall Study||53
9960045|NCT01465958|11079630|FG000|STARTED|Run-in Phase||11
9960046|NCT01465958|11079631|FG001|STARTED|Run-in Phase||0
9960047|NCT01465958|11079630|FG000|COMPLETED|Run-in Phase||10
9960048|NCT01465958|11079631|FG001|COMPLETED|Run-in Phase||0
9960049|NCT01465958|11079630|FG000|NOT COMPLETED|Run-in Phase||1
9960050|NCT01465958|11079631|FG001|NOT COMPLETED|Run-in Phase||0
9960051|NCT01465958|11079630|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
9960052|NCT01465958|11079631|FG001|STARTED|Intravenous (IV) Phase||0
9842010|NCT00821821|10953578|FG001|NOT COMPLETED|Overall Study||0
9842011|NCT00821821|10953579|FG002|NOT COMPLETED|Overall Study||0
9842012|NCT00821873|10953589|FG000|STARTED|Overall Study||9
9842013|NCT00821873|10953589|FG000|COMPLETED|Overall Study||5
9842014|NCT00821873|10953589|FG000|NOT COMPLETED|Overall Study||4
9960053|NCT01465958|11079630|FG000|COMPLETED|Intravenous (IV) Phase||11
10022534|NCT01851590|11146074|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
9960054|NCT01465958|11079631|FG001|COMPLETED|Intravenous (IV) Phase||0
9960055|NCT01465958|11079630|FG000|NOT COMPLETED|Intravenous (IV) Phase||0
9960056|NCT01465958|11079631|FG001|NOT COMPLETED|Intravenous (IV) Phase||0
9960057|NCT01465958|11079630|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
9960058|NCT01465958|11079631|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
9960059|NCT01465958|11079630|FG000|COMPLETED|Subcutaneous (SC) Phase||0
9960060|NCT01465958|11079631|FG001|COMPLETED|Subcutaneous (SC) Phase||10
9960061|NCT01465958|11079630|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0
9960062|NCT01465958|11079631|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1
9960063|NCT01465997|11079640|FG000|STARTED|Overall Study||279
9960064|NCT01465997|11079641|FG001|STARTED|Overall Study||269
9960065|NCT01465997|11079640|FG000|COMPLETED|Overall Study||211
9960066|NCT01465997|11079641|FG001|COMPLETED|Overall Study||180
9960067|NCT01465997|11079640|FG000|NOT COMPLETED|Overall Study||68
10022535|NCT01851590|11146072|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
10022536|NCT01851590|11146073|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
10022537|NCT01851590|11146074|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
10022538|NCT01851590|11146072|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
10022539|NCT01851590|11146073|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
10022540|NCT01851590|11146074|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
10022541|NCT01851590|11146072|FG000|NOT COMPLETED|Overall Study||0
10022542|NCT01851590|11146073|FG001|NOT COMPLETED|Overall Study||1
10022543|NCT01851590|11146074|FG002|NOT COMPLETED|Overall Study||3
10022544|NCT01851655|11146088|FG000|STARTED|Overall Study||12
10022545|NCT01851655|11146089|FG001|STARTED|Overall Study||12
10022546|NCT01851655|11146088|FG000|COMPLETED|Overall Study||12
9842015|NCT00821886|10953593|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
9842016|NCT00821886|10953593|FG000|COMPLETED|Overall Study||49
9842017|NCT00821886|10953593|FG000|NOT COMPLETED|Overall Study||9
9842018|NCT00821951|10953597|FG000|STARTED|Overall Study||17
9842019|NCT00821951|10953597|FG000|COMPLETED|Overall Study||12
9842020|NCT00821951|10953597|FG000|NOT COMPLETED|Overall Study||5
9842021|NCT00821964|10953601|FG000|STARTED|Overall Study||15
9842022|NCT00821964|10953601|FG000|Evaluable for Clinical Response|Overall Study||14
9842023|NCT00821964|10953601|FG000|Evaluable for Pathologic Response|Overall Study||7
9842024|NCT00821964|10953601|FG000|COMPLETED|Overall Study||9
9842025|NCT00821964|10953601|FG000|NOT COMPLETED|Overall Study||6
9842026|NCT00822094|10953610|FG000|STARTED|Overall Study||81
9842027|NCT00822094|10953611|FG001|STARTED|Overall Study||45
9842028|NCT00822094|10953610|FG000|COMPLETED|Overall Study||37
9842029|NCT00822094|10953611|FG001|COMPLETED|Overall Study||20
9842030|NCT00822094|10953610|FG000|NOT COMPLETED|Overall Study||44
9842031|NCT00822094|10953611|FG001|NOT COMPLETED|Overall Study||25
9842032|NCT00822107|10953617|FG000|STARTED|Overall Study||5
9842033|NCT00822107|10953617|FG000|COMPLETED|Overall Study||5
9842034|NCT00822107|10953617|FG000|NOT COMPLETED|Overall Study||0
9842035|NCT00822172|10953623|FG000|STARTED|Overall Study||80
9842036|NCT00822172|10953624|FG001|STARTED|Overall Study||83
9842037|NCT00822172|10953623|FG000|COMPLETED|Overall Study||65
9842038|NCT00822172|10953624|FG001|COMPLETED|Overall Study||64
9842039|NCT00822172|10953623|FG000|NOT COMPLETED|Overall Study||15
9842040|NCT00822172|10953624|FG001|NOT COMPLETED|Overall Study||19
9842041|NCT00822185|10953635|FG000|STARTED|Overall Study||6
9842042|NCT00822185|10953636|FG001|STARTED|Overall Study||6
9842043|NCT00822185|10953637|FG002|STARTED|Overall Study||6
9842044|NCT00822185|10953638|FG003|STARTED|Overall Study||6
9842045|NCT00822185|10953639|FG004|STARTED|Overall Study||8
9842046|NCT00822185|10953635|FG000|COMPLETED|Overall Study||6
9842047|NCT00822185|10953636|FG001|COMPLETED|Overall Study||6
9842048|NCT00822185|10953637|FG002|COMPLETED|Overall Study||6
9842049|NCT00822185|10953638|FG003|COMPLETED|Overall Study||6
9960068|NCT01465997|11079641|FG001|NOT COMPLETED|Overall Study||89
9960069|NCT01466062|11079649|FG000|STARTED|Overall Study||28
9960070|NCT01466062|11079649|FG000|COMPLETED|Overall Study||26
9960071|NCT01466062|11079649|FG000|NOT COMPLETED|Overall Study||2
9960072|NCT01466075|11079653|FG000|STARTED|Overall Study||207
9960073|NCT01466075|11079653|FG000|COMPLETED|Overall Study||207
9960074|NCT01466075|11079653|FG000|NOT COMPLETED|Overall Study||0
9960075|NCT01466127|11079659|FG000|STARTED|Overall Study||30
9960076|NCT01466127|11079660|FG001|STARTED|Overall Study||30
9960077|NCT01466127|11079659|FG000|COMPLETED|Overall Study||16
9960078|NCT01466127|11079660|FG001|COMPLETED|Overall Study||14
9960079|NCT01466127|11079659|FG000|NOT COMPLETED|Overall Study||14
9960080|NCT01466127|11079660|FG001|NOT COMPLETED|Overall Study||16
9842050|NCT00822185|10953639|FG004|COMPLETED|Overall Study||8
9842051|NCT00822185|10953635|FG000|NOT COMPLETED|Overall Study||0
9960081|NCT01466153|11079669|FG000|STARTED|Overall Study||62
9960082|NCT01466153|11079670|FG001|STARTED|Overall Study||36
9842052|NCT00822185|10953636|FG001|NOT COMPLETED|Overall Study||0
9842053|NCT00822185|10953637|FG002|NOT COMPLETED|Overall Study||0
9723554|NCT00082628|10823189|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
9723555|NCT00082628|10823190|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
9723556|NCT00082628|10823191|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
9723557|NCT00082628|10823192|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
9723558|NCT00082641|10823206|FG000|STARTED|Overall Study||11
9723559|NCT00082641|10823207|FG001|STARTED|Overall Study||12
9723560|NCT00082641|10823206|FG000|COMPLETED|Overall Study||11
9723561|NCT00082641|10823207|FG001|COMPLETED|Overall Study||12
9723562|NCT00082641|10823206|FG000|NOT COMPLETED|Overall Study||0
9723563|NCT00082641|10823207|FG001|NOT COMPLETED|Overall Study||0
9723564|NCT00082758|10823217|FG000|STARTED|Overall Study||15
9723565|NCT00082758|10823218|FG001|STARTED|Overall Study||24
9723566|NCT00082758|10823219|FG002|STARTED|Overall Study||0
9723567|NCT00082758|10823217|FG000|COMPLETED|Overall Study||0
9723568|NCT00082758|10823218|FG001|COMPLETED|Overall Study||7
9723569|NCT00082758|10823219|FG002|COMPLETED|Overall Study||0
9723570|NCT00082758|10823217|FG000|NOT COMPLETED|Overall Study||15
9723571|NCT00082758|10823218|FG001|NOT COMPLETED|Overall Study||17
9723572|NCT00082758|10823219|FG002|NOT COMPLETED|Overall Study||0
9723573|NCT00082810|10823227|FG000|STARTED|Overall Study||33
9723574|NCT00082810|10823227|FG000|COMPLETED|Overall Study||2
9723575|NCT00082810|10823227|FG000|NOT COMPLETED|Overall Study||31
9723576|NCT00082888|10823235|FG000|STARTED|Overall Study||42
9723577|NCT00082888|10823236|FG001|STARTED|Overall Study||15
9723578|NCT00082888|10823237|FG002|STARTED|Overall Study||36
9723579|NCT00082888|10823235|FG000|COMPLETED|Overall Study||41
9723580|NCT00082888|10823236|FG001|COMPLETED|Overall Study||15
9723581|NCT00082888|10823237|FG002|COMPLETED|Overall Study||36
9723582|NCT00082888|10823235|FG000|NOT COMPLETED|Overall Study||1
9723583|NCT00082888|10823236|FG001|NOT COMPLETED|Overall Study||0
9723584|NCT00082888|10823237|FG002|NOT COMPLETED|Overall Study||0
9723585|NCT00083122|10823248|FG000|STARTED|Overall Study||40
9723586|NCT00083122|10823249|FG001|STARTED|Overall Study||5
9723587|NCT00083122|10823248|FG000|COMPLETED|Overall Study||40
9723588|NCT00083122|10823249|FG001|COMPLETED|Overall Study||5
9723589|NCT00083122|10823248|FG000|NOT COMPLETED|Overall Study||0
9723590|NCT00083122|10823249|FG001|NOT COMPLETED|Overall Study||0
9731688|NCT00134719|10831590|FG001|STARTED|Primary Vaccination Phase||221
9731689|NCT00134719|10831591|FG002|STARTED|Primary Vaccination Phase||221
9731690|NCT00134719|10831589|FG000|COMPLETED|Primary Vaccination Phase||647
9731691|NCT00134719|10831590|FG001|COMPLETED|Primary Vaccination Phase||215
9731692|NCT00134719|10831591|FG002|COMPLETED|Primary Vaccination Phase||216
9731693|NCT00134719|10831589|FG000|NOT COMPLETED|Primary Vaccination Phase||14
9731694|NCT00134719|10831590|FG001|NOT COMPLETED|Primary Vaccination Phase||6
9731695|NCT00134719|10831591|FG002|NOT COMPLETED|Primary Vaccination Phase||5
9731696|NCT00134719|10831589|FG000|STARTED|Fourth Dose Vaccination Phase||625
9731697|NCT00134719|10831590|FG001|STARTED|Fourth Dose Vaccination Phase||206
9731698|NCT00134719|10831591|FG002|STARTED|Fourth Dose Vaccination Phase||204
9731699|NCT00134719|10831589|FG000|COMPLETED|Fourth Dose Vaccination Phase||623
9731700|NCT00134719|10831590|FG001|COMPLETED|Fourth Dose Vaccination Phase||203
9731701|NCT00134719|10831591|FG002|COMPLETED|Fourth Dose Vaccination Phase||203
9731702|NCT00134719|10831589|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2
9731703|NCT00134719|10831590|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3
9731704|NCT00134719|10831591|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1
9731705|NCT00134784|10831603|FG000|STARTED|Overall Study||29
9731706|NCT00134784|10831604|FG001|STARTED|Overall Study||38
9731707|NCT00134784|10831605|FG002|STARTED|Overall Study||37
9731708|NCT00134784|10831606|FG003|STARTED|Overall Study||38
9731709|NCT00134784|10831603|FG000|COMPLETED|Overall Study||27
9731710|NCT00134784|10831604|FG001|COMPLETED|Overall Study||36
9731711|NCT00134784|10831605|FG002|COMPLETED|Overall Study||35
9731712|NCT00134784|10831606|FG003|COMPLETED|Overall Study||37
9731713|NCT00134784|10831603|FG000|NOT COMPLETED|Overall Study||2
9731714|NCT00134784|10831604|FG001|NOT COMPLETED|Overall Study||2
9731715|NCT00134784|10831605|FG002|NOT COMPLETED|Overall Study||2
9731716|NCT00134784|10831606|FG003|NOT COMPLETED|Overall Study||1
10022547|NCT01851655|11146089|FG001|COMPLETED|Overall Study||12
10022548|NCT01851655|11146088|FG000|NOT COMPLETED|Overall Study||0
10022549|NCT01851655|11146089|FG001|NOT COMPLETED|Overall Study||0
10022550|NCT01851720|11146097|FG000|STARTED|Overall Study||0
10022551|NCT01851720|11146098|FG001|STARTED|Overall Study||1
10022552|NCT01851720|11146097|FG000|COMPLETED|Overall Study||0
10022553|NCT01851720|11146098|FG001|COMPLETED|Overall Study||0
10022554|NCT01851720|11146097|FG000|NOT COMPLETED|Overall Study||0
10022555|NCT01851720|11146098|FG001|NOT COMPLETED|Overall Study||1
10022556|NCT01851772|11146104|FG000|STARTED|Overall Study||3
10022557|NCT01851772|11146104|FG000|COMPLETED|Overall Study||3
10022558|NCT01851772|11146104|FG000|NOT COMPLETED|Overall Study||0
10022559|NCT01851863|11146112|FG000|STARTED|Overall Study||65
10022560|NCT01851863|11146113|FG001|STARTED|Overall Study||66
10022561|NCT01851863|11146114|FG002|STARTED|Overall Study||65
10022562|NCT01851863|11146115|FG003|STARTED|Overall Study||66
10022563|NCT01851863|11146112|FG000|COMPLETED|Overall Study||60
10114199|NCT02514577|11244919|FG001|Intent-to-Treat (ITT) Population|Overall Study||74
10114200|NCT02514577|11244918|FG000|Safety Population|Overall Study||142
10114201|NCT02514577|11244919|FG001|Safety Population|Overall Study||72
10114202|NCT02514577|11244918|FG000|COMPLETED|Overall Study||129
10114203|NCT02514577|11244919|FG001|COMPLETED|Overall Study||61
9723591|NCT00083174|10823257|FG000|STARTED|Randomization Period||2285
9723592|NCT00083174|10823258|FG001|STARTED|Randomization Period||2275
9723593|NCT00083174|10823259|FG002|STARTED|Randomization Period||0
9723594|NCT00083174|10823257|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
9723595|NCT00083174|10823258|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
9723596|NCT00083174|10823259|FG002|COMPLETED|Randomization Period||0
9723597|NCT00083174|10823257|FG000|NOT COMPLETED|Randomization Period||0
9842054|NCT00822185|10953638|FG003|NOT COMPLETED|Overall Study||0
9842055|NCT00822185|10953639|FG004|NOT COMPLETED|Overall Study||0
9842056|NCT00822237|10953653|FG000|STARTED|Dose 1 Vaccination|Number randomized|299
9842057|NCT00822237|10953654|FG001|STARTED|Dose 1 Vaccination|Number randomized|299
9842058|NCT00822237|10953653|FG000|COMPLETED|Dose 1 Vaccination||274
9842059|NCT00822237|10953654|FG001|COMPLETED|Dose 1 Vaccination||273
9842060|NCT00822237|10953653|FG000|NOT COMPLETED|Dose 1 Vaccination||25
9842061|NCT00822237|10953654|FG001|NOT COMPLETED|Dose 1 Vaccination||26
9842062|NCT00822237|10953653|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274
9842063|NCT00822237|10953654|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273
9842064|NCT00822237|10953653|FG000|COMPLETED|Dose 2 Vaccination||270
9842065|NCT00822237|10953654|FG001|COMPLETED|Dose 2 Vaccination||262
9842066|NCT00822237|10953653|FG000|NOT COMPLETED|Dose 2 Vaccination||4
9842067|NCT00822237|10953654|FG001|NOT COMPLETED|Dose 2 Vaccination||11
9842068|NCT00822328|10953661|FG000|STARTED|Overall Study||12
9842069|NCT00822328|10953662|FG001|STARTED|Overall Study||12
9842070|NCT00822328|10953661|FG000|COMPLETED|Overall Study||12
9842071|NCT00822328|10953662|FG001|COMPLETED|Overall Study||12
9842072|NCT00822328|10953661|FG000|NOT COMPLETED|Overall Study||0
9842073|NCT00822328|10953662|FG001|NOT COMPLETED|Overall Study||0
9842074|NCT00822354|10953670|FG000|STARTED|First Intervention (28 Days)||5
10114204|NCT02514577|11244918|FG000|NOT COMPLETED|Overall Study||14
9723598|NCT00083174|10823258|FG001|NOT COMPLETED|Randomization Period||0
9842075|NCT00822354|10953671|FG001|STARTED|First Intervention (28 Days)||5
10022564|NCT01851863|11146113|FG001|COMPLETED|Overall Study||57
10022565|NCT01851863|11146114|FG002|COMPLETED|Overall Study||60
10022566|NCT01851863|11146115|FG003|COMPLETED|Overall Study||63
9842076|NCT00822354|10953670|FG000|COMPLETED|First Intervention (28 Days)||4
9842077|NCT00822354|10953671|FG001|COMPLETED|First Intervention (28 Days)||5
10022567|NCT01851863|11146112|FG000|NOT COMPLETED|Overall Study||5
10022568|NCT01851863|11146113|FG001|NOT COMPLETED|Overall Study||9
10022569|NCT01851863|11146114|FG002|NOT COMPLETED|Overall Study||5
10022570|NCT01851863|11146115|FG003|NOT COMPLETED|Overall Study||3
9842078|NCT00822354|10953670|FG000|NOT COMPLETED|First Intervention (28 Days)||1
9842079|NCT00822354|10953671|FG001|NOT COMPLETED|First Intervention (28 Days)||0
9842080|NCT00822354|10953670|FG000|STARTED|Washout (7 Days)||4
9842081|NCT00822354|10953671|FG001|STARTED|Washout (7 Days)||5
10022571|NCT01851876|11146130|FG000|STARTED|Overall Study||56
9842082|NCT00822354|10953670|FG000|COMPLETED|Washout (7 Days)||4
9842083|NCT00822354|10953671|FG001|COMPLETED|Washout (7 Days)||5
9842084|NCT00822354|10953670|FG000|NOT COMPLETED|Washout (7 Days)||0
9842085|NCT00822354|10953671|FG001|NOT COMPLETED|Washout (7 Days)||0
9842086|NCT00822354|10953670|FG000|STARTED|Second Intervention (28 Days)||4
9842087|NCT00822354|10953671|FG001|STARTED|Second Intervention (28 Days)||5
10022572|NCT01851876|11146131|FG001|STARTED|Overall Study||62
10022573|NCT01851876|11146130|FG000|COMPLETED|Overall Study||56
9842088|NCT00822354|10953670|FG000|COMPLETED|Second Intervention (28 Days)||3
9842089|NCT00822354|10953671|FG001|COMPLETED|Second Intervention (28 Days)||5
9842090|NCT00822354|10953670|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
9842091|NCT00822354|10953671|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
9842092|NCT00822510|10953681|FG000|STARTED|Overall Study||38
9842093|NCT00822510|10953682|FG001|STARTED|Overall Study||41
9842094|NCT00822510|10953681|FG000|COMPLETED|Overall Study||35
9842095|NCT00822510|10953682|FG001|COMPLETED|Overall Study||36
9842096|NCT00822510|10953681|FG000|NOT COMPLETED|Overall Study||3
9842097|NCT00822510|10953682|FG001|NOT COMPLETED|Overall Study||5
9842098|NCT00822523|10953693|FG000|STARTED|Overall Study||5
9842099|NCT00822523|10953694|FG001|STARTED|Overall Study||4
9842100|NCT00822523|10953695|FG002|STARTED|Overall Study||4
9842101|NCT00822523|10953693|FG000|COMPLETED|Overall Study||5
9842102|NCT00822523|10953694|FG001|COMPLETED|Overall Study||4
9842103|NCT00822523|10953695|FG002|COMPLETED|Overall Study||4
9842104|NCT00822523|10953693|FG000|NOT COMPLETED|Overall Study||0
9842105|NCT00822523|10953694|FG001|NOT COMPLETED|Overall Study||0
9842106|NCT00822523|10953695|FG002|NOT COMPLETED|Overall Study||0
9842107|NCT00822588|10953713|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
9842108|NCT00822588|10953714|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
9842109|NCT00822588|10953713|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106
9842110|NCT00822588|10953714|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110
9842111|NCT00822588|10953713|FG000|NOT COMPLETED|Overall Study||7
9842112|NCT00822588|10953714|FG001|NOT COMPLETED|Overall Study||4
9842113|NCT00822692|10953722|FG000|STARTED|Overall Study|July 1, 2008|63
9842114|NCT00822692|10953723|FG001|STARTED|Overall Study|July 1, 2008|76
9842115|NCT00822692|10953722|FG000|COMPLETED|Overall Study|June 1, 2009|46
9842116|NCT00822692|10953723|FG001|COMPLETED|Overall Study|June 1 , 2009|51
9842117|NCT00822692|10953722|FG000|NOT COMPLETED|Overall Study||17
9842118|NCT00822692|10953723|FG001|NOT COMPLETED|Overall Study||25
9842119|NCT00822757|10953731|FG000|STARTED|Overall Study||41
9842120|NCT00822757|10953732|FG001|STARTED|Overall Study||10
9842121|NCT00822757|10953731|FG000|COMPLETED|Overall Study||41
9842122|NCT00822757|10953732|FG001|COMPLETED|Overall Study||10
9842123|NCT00822757|10953731|FG000|NOT COMPLETED|Overall Study||0
9842124|NCT00822757|10953732|FG001|NOT COMPLETED|Overall Study||0
9842125|NCT00822770|10953740|FG000|STARTED|Overall Study||18
9842126|NCT00822770|10953741|FG001|STARTED|Overall Study||29
9842127|NCT00822770|10953740|FG000|COMPLETED|Overall Study||15
9842128|NCT00822770|10953741|FG001|COMPLETED|Overall Study||28
9842129|NCT00822770|10953740|FG000|NOT COMPLETED|Overall Study||3
9842130|NCT00822770|10953741|FG001|NOT COMPLETED|Overall Study||1
9842131|NCT00822900|10953749|FG000|STARTED|Overall Study||442
9842132|NCT00822900|10953750|FG001|STARTED|Overall Study||440
9842133|NCT00822900|10953749|FG000|COMPLETED|Overall Study||334
9842134|NCT00822900|10953750|FG001|COMPLETED|Overall Study||347
9842135|NCT00822900|10953749|FG000|NOT COMPLETED|Overall Study||108
9842136|NCT00822900|10953750|FG001|NOT COMPLETED|Overall Study||93
9842137|NCT00822926|10953758|FG000|STARTED|First Injection Visit||2
9842138|NCT00822926|10953759|FG001|STARTED|First Injection Visit||3
9842139|NCT00822926|10953758|FG000|COMPLETED|First Injection Visit||2
9842140|NCT00822926|10953759|FG001|COMPLETED|First Injection Visit||3
9842141|NCT00822926|10953758|FG000|NOT COMPLETED|First Injection Visit||0
9842142|NCT00822926|10953759|FG001|NOT COMPLETED|First Injection Visit||0
9842143|NCT00822926|10953758|FG000|STARTED|Washout (Varies Based on Scheduling)||2
10022574|NCT01851876|11146131|FG001|COMPLETED|Overall Study||62
10022575|NCT01851876|11146130|FG000|NOT COMPLETED|Overall Study||0
10022576|NCT01851876|11146131|FG001|NOT COMPLETED|Overall Study||0
10022577|NCT01852019|11146139|FG000|STARTED|Day 1||3
10022578|NCT01852019|11146140|FG001|STARTED|Day 1||3
10022579|NCT01852019|11146141|FG002|STARTED|Day 1||6
10022580|NCT01852019|11146142|FG003|STARTED|Day 1||0
10022581|NCT01852019|11146143|FG004|STARTED|Day 1||0
10022582|NCT01852019|11146139|FG000|COMPLETED|Day 1||3
10022583|NCT01852019|11146140|FG001|COMPLETED|Day 1||3
10022584|NCT01852019|11146141|FG002|COMPLETED|Day 1||6
10022585|NCT01852019|11146142|FG003|COMPLETED|Day 1||0
10022586|NCT01852019|11146143|FG004|COMPLETED|Day 1||0
10022587|NCT01852019|11146139|FG000|NOT COMPLETED|Day 1||0
10022588|NCT01852019|11146140|FG001|NOT COMPLETED|Day 1||0
10022589|NCT01852019|11146141|FG002|NOT COMPLETED|Day 1||0
10022590|NCT01852019|11146142|FG003|NOT COMPLETED|Day 1||0
10022591|NCT01852019|11146143|FG004|NOT COMPLETED|Day 1||0
10022592|NCT01852019|11146139|FG000|STARTED|Day 8||0
10022593|NCT01852019|11146140|FG001|STARTED|Day 8||0
10022594|NCT01852019|11146141|FG002|STARTED|Day 8||0
10022595|NCT01852019|11146142|FG003|STARTED|Day 8||6
10022596|NCT01852019|11146143|FG004|STARTED|Day 8||6
10022597|NCT01852019|11146139|FG000|COMPLETED|Day 8||0
10022598|NCT01852019|11146140|FG001|COMPLETED|Day 8||0
10022599|NCT01852019|11146141|FG002|COMPLETED|Day 8||0
10022600|NCT01852019|11146142|FG003|COMPLETED|Day 8||6
10022601|NCT01852019|11146143|FG004|COMPLETED|Day 8||6
10022602|NCT01852019|11146139|FG000|NOT COMPLETED|Day 8||0
10022603|NCT01852019|11146140|FG001|NOT COMPLETED|Day 8||0
10022604|NCT01852019|11146141|FG002|NOT COMPLETED|Day 8||0
10022605|NCT01852019|11146142|FG003|NOT COMPLETED|Day 8||0
10022606|NCT01852019|11146143|FG004|NOT COMPLETED|Day 8||0
10022607|NCT01852032|11146156|FG000|STARTED|Overall Study||23
10022608|NCT01852032|11146156|FG000|COMPLETED|Overall Study||23
10022609|NCT01852032|11146156|FG000|NOT COMPLETED|Overall Study||0
10022610|NCT01852045|11146163|FG000|STARTED|Overall Study||39
10022611|NCT01852045|11146164|FG001|STARTED|Overall Study||45
10022612|NCT01852045|11146165|FG002|STARTED|Overall Study||30
10022613|NCT01852045|11146163|FG000|mITT Population|Overall Study||38
10022614|NCT01852045|11146164|FG001|mITT Population|Overall Study||45
10022615|NCT01852045|11146165|FG002|mITT Population|Overall Study||30
10022616|NCT01852045|11146163|FG000|Safety Population|Overall Study||38
10022617|NCT01852045|11146164|FG001|Safety Population|Overall Study||45
10022618|NCT01852045|11146165|FG002|Safety Population|Overall Study||30
10022619|NCT01852045|11146163|FG000|COMPLETED|Overall Study||33
10022620|NCT01852045|11146164|FG001|COMPLETED|Overall Study||41
10022621|NCT01852045|11146165|FG002|COMPLETED|Overall Study||26
10022622|NCT01852045|11146163|FG000|NOT COMPLETED|Overall Study||6
10022623|NCT01852045|11146164|FG001|NOT COMPLETED|Overall Study||4
10022624|NCT01852045|11146165|FG002|NOT COMPLETED|Overall Study||4
10022625|NCT01852058|11146176|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31
10022626|NCT01852058|11146177|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39
9842144|NCT00822926|10953759|FG001|STARTED|Washout (Varies Based on Scheduling)||3
9842145|NCT00822926|10953758|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2
9842146|NCT00822926|10953759|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3
10022627|NCT01852058|11146178|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25
10022628|NCT01852058|11146179|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022629|NCT01852058|11146180|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022630|NCT01852058|11146181|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022631|NCT01852058|11146182|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022632|NCT01852058|11146183|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022633|NCT01852058|11146184|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022634|NCT01852058|11146185|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022635|NCT01852058|11146186|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022636|NCT01852058|11146187|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10022637|NCT01852058|11146176|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
10022638|NCT01852058|11146177|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
10022639|NCT01852058|11146178|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
10022640|NCT01852058|11146179|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
9723599|NCT00083174|10823259|FG002|NOT COMPLETED|Randomization Period||0
9723600|NCT00083174|10823257|FG000|STARTED|Open-label Extension||0
9723601|NCT00083174|10823258|FG001|STARTED|Open-label Extension||0
9723602|NCT00083174|10823259|FG002|STARTED|Open-label Extension||2831
9723603|NCT00083174|10823257|FG000|COMPLETED|Open-label Extension||0
9723604|NCT00083174|10823258|FG001|COMPLETED|Open-label Extension||0
9723605|NCT00083174|10823259|FG002|COMPLETED|Open-label Extension||2831
9723606|NCT00083174|10823257|FG000|NOT COMPLETED|Open-label Extension||0
9723607|NCT00083174|10823258|FG001|NOT COMPLETED|Open-label Extension||0
9723608|NCT00083174|10823259|FG002|NOT COMPLETED|Open-label Extension||0
9723609|NCT00083226|10823269|FG000|STARTED|Overall Study||42
9723610|NCT00083226|10823269|FG000|COMPLETED|Overall Study||0
9723611|NCT00083226|10823269|FG000|NOT COMPLETED|Overall Study||42
9723612|NCT00083382|10823273|FG000|STARTED|Overall Study||83
9723613|NCT00083382|10823273|FG000|COMPLETED|Overall Study||83
9723614|NCT00083382|10823273|FG000|NOT COMPLETED|Overall Study||0
9723615|NCT00083551|10823279|FG000|STARTED|Overall Study||323
9723616|NCT00083551|10823280|FG001|STARTED|Overall Study||345
9723617|NCT00083551|10823279|FG000|COMPLETED|Overall Study||323
9723618|NCT00083551|10823280|FG001|COMPLETED|Overall Study||345
9723619|NCT00083551|10823279|FG000|NOT COMPLETED|Overall Study||0
9723620|NCT00083551|10823280|FG001|NOT COMPLETED|Overall Study||0
9723621|NCT00083616|10823286|FG000|STARTED|Overall Study||185
9723622|NCT00083616|10823286|FG000|Received Study Medication|Overall Study||182
9723623|NCT00083616|10823286|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
9723624|NCT00083616|10823286|FG000|NOT COMPLETED|Overall Study||31
9723625|NCT00083720|10823290|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
9723626|NCT00083720|10823290|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
9723627|NCT00083720|10823290|FG000|NOT COMPLETED|Overall Study||0
9723628|NCT00083889|10823296|FG000|STARTED|Overall Study||375
9723629|NCT00083889|10823297|FG001|STARTED|Overall Study||375
10081142|NCT02258074|11209601|FG001|STARTED|Overall Study||50
10022641|NCT01852058|11146180|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022642|NCT01852058|11146181|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
9842147|NCT00822926|10953758|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
9842148|NCT00822926|10953759|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
9842149|NCT00822926|10953758|FG000|STARTED|Second Injection Visit||2
9842150|NCT00822926|10953759|FG001|STARTED|Second Injection Visit||3
9842151|NCT00822926|10953758|FG000|COMPLETED|Second Injection Visit||1
9842152|NCT00822926|10953759|FG001|COMPLETED|Second Injection Visit||2
9842153|NCT00822926|10953758|FG000|NOT COMPLETED|Second Injection Visit||1
9842154|NCT00822926|10953759|FG001|NOT COMPLETED|Second Injection Visit||1
9842155|NCT00823043|10953768|FG000|STARTED|Overall Study||64
9842156|NCT00823043|10953769|FG001|STARTED|Overall Study||39
9842157|NCT00823043|10953768|FG000|COMPLETED|Overall Study||64
9842158|NCT00823043|10953769|FG001|COMPLETED|Overall Study||39
9842159|NCT00823043|10953768|FG000|NOT COMPLETED|Overall Study||0
9842160|NCT00823043|10953769|FG001|NOT COMPLETED|Overall Study||0
9842161|NCT00823069|10953774|FG000|STARTED|Overall Study||60
9842162|NCT00823069|10953774|FG000|COMPLETED|Overall Study||60
9842163|NCT00823069|10953774|FG000|NOT COMPLETED|Overall Study||0
9842164|NCT00823082|10953783|FG000|STARTED|Overall Study||100
9842165|NCT00823082|10953784|FG001|STARTED|Overall Study||100
9842166|NCT00823082|10953783|FG000|Safety Population|Overall Study||100
9842167|NCT00823082|10953784|FG001|Safety Population|Overall Study||99
9842168|NCT00823082|10953783|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100
9842169|NCT00823082|10953784|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94
9842170|NCT00823082|10953783|FG000|COMPLETED|Overall Study||100
9842171|NCT00823082|10953784|FG001|COMPLETED|Overall Study||99
9842172|NCT00823082|10953783|FG000|NOT COMPLETED|Overall Study||0
9842173|NCT00823082|10953784|FG001|NOT COMPLETED|Overall Study||1
9842174|NCT00823134|10953790|FG000|STARTED|Overall Study||23
9842175|NCT00823134|10953790|FG000|COMPLETED|Overall Study||22
9842176|NCT00823134|10953790|FG000|NOT COMPLETED|Overall Study||1
9842177|NCT00823199|10953795|FG000|STARTED|Overall Study||10
9842178|NCT00823199|10953795|FG000|COMPLETED|Overall Study||8
9842179|NCT00823199|10953795|FG000|NOT COMPLETED|Overall Study||2
9842180|NCT00823212|10953802|FG000|STARTED|Overall Study||762
9842181|NCT00823212|10953803|FG001|STARTED|Overall Study||768
9842182|NCT00823212|10953802|FG000|COMPLETED|Overall Study|12-month follow-up|727
9842183|NCT00823212|10953803|FG001|COMPLETED|Overall Study|12-month follow-up|735
9960083|NCT01466153|11079671|FG002|STARTED|Overall Study||61
9960084|NCT01466153|11079669|FG000|COMPLETED|Overall Study||33
9960085|NCT01466153|11079670|FG001|COMPLETED|Overall Study||12
9960086|NCT01466153|11079671|FG002|COMPLETED|Overall Study||36
9960087|NCT01466153|11079669|FG000|NOT COMPLETED|Overall Study||29
9960088|NCT01466153|11079670|FG001|NOT COMPLETED|Overall Study||24
9960089|NCT01466153|11079671|FG002|NOT COMPLETED|Overall Study||25
9960090|NCT01466166|11079681|FG000|STARTED|Overall Study||188
9960091|NCT01466166|11079681|FG000|Received Treatment|Overall Study||188
9960092|NCT01466166|11079681|FG000|Completed 24 Weeks of Treatment|Overall Study||55
9960093|NCT01466166|11079681|FG000|COMPLETED|Overall Study||25
9960094|NCT01466166|11079681|FG000|NOT COMPLETED|Overall Study||163
9960095|NCT01466179|11079685|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
9960096|NCT01466179|11079685|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
9960097|NCT01466179|11079685|FG000|NOT COMPLETED|Overall Study||179
9960098|NCT01466192|11079692|FG000|STARTED|Overall Study||108
9960099|NCT01466192|11079692|FG000|COMPLETED|Overall Study||104
9960100|NCT01466192|11079692|FG000|NOT COMPLETED|Overall Study||4
9960101|NCT01466270|11079698|FG000|STARTED|Overall Study||31
9842184|NCT00823212|10953802|FG000|NOT COMPLETED|Overall Study||35
9842185|NCT00823212|10953803|FG001|NOT COMPLETED|Overall Study||33
9842186|NCT00823264|10953813|FG000|STARTED|Overall Study||10
9842187|NCT00823264|10953814|FG001|STARTED|Overall Study||7
9842188|NCT00823264|10953813|FG000|COMPLETED|Overall Study||8
9842189|NCT00823264|10953814|FG001|COMPLETED|Overall Study||7
9960102|NCT01466270|11079699|FG001|STARTED|Overall Study||31
10081143|NCT02258074|11209602|FG002|STARTED|Overall Study||51
9842190|NCT00823264|10953813|FG000|NOT COMPLETED|Overall Study||2
9842191|NCT00823264|10953814|FG001|NOT COMPLETED|Overall Study||0
9960103|NCT01466270|11079698|FG000|COMPLETED|Overall Study||19
9960104|NCT01466270|11079699|FG001|COMPLETED|Overall Study||25
9960105|NCT01466270|11079698|FG000|NOT COMPLETED|Overall Study||12
9960106|NCT01466270|11079699|FG001|NOT COMPLETED|Overall Study||6
9960107|NCT01466348|11079707|FG000|STARTED|Period I - First Intervention||36
9960108|NCT01466348|11079708|FG001|STARTED|Period I - First Intervention||36
9960109|NCT01466348|11079707|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36
9960110|NCT01466348|11079708|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
9960111|NCT01466348|11079707|FG000|COMPLETED|Period I - First Intervention||36
9960112|NCT01466348|11079708|FG001|COMPLETED|Period I - First Intervention||35
9960113|NCT01466348|11079707|FG000|NOT COMPLETED|Period I - First Intervention||0
9960114|NCT01466348|11079708|FG001|NOT COMPLETED|Period I - First Intervention||1
9960115|NCT01466348|11079707|FG000|STARTED|Period II - Second Intervention||35
9960116|NCT01466348|11079708|FG001|STARTED|Period II - Second Intervention||36
9960117|NCT01466348|11079707|FG000|COMPLETED|Period II - Second Intervention||35
9960118|NCT01466348|11079708|FG001|COMPLETED|Period II - Second Intervention||36
9960119|NCT01466348|11079707|FG000|NOT COMPLETED|Period II - Second Intervention||0
9960120|NCT01466348|11079708|FG001|NOT COMPLETED|Period II - Second Intervention||0
9960121|NCT01466361|11079720|FG000|STARTED|Overall Study||52
9960122|NCT01466361|11079721|FG001|STARTED|Overall Study||34
9960123|NCT01466361|11079722|FG002|STARTED|Overall Study||60
9960124|NCT01466361|11079723|FG003|STARTED|Overall Study||41
9960125|NCT01466361|11079720|FG000|COMPLETED|Overall Study||52
9960126|NCT01466361|11079721|FG001|COMPLETED|Overall Study||34
9960127|NCT01466361|11079722|FG002|COMPLETED|Overall Study||60
9960128|NCT01466361|11079723|FG003|COMPLETED|Overall Study||41
9960129|NCT01466361|11079720|FG000|NOT COMPLETED|Overall Study||0
9960130|NCT01466361|11079721|FG001|NOT COMPLETED|Overall Study||0
9960131|NCT01466361|11079722|FG002|NOT COMPLETED|Overall Study||0
9960132|NCT01466361|11079723|FG003|NOT COMPLETED|Overall Study||0
9960133|NCT01466387|11079744|FG000|STARTED|Overall Study||101
9960134|NCT01466387|11079745|FG001|STARTED|Overall Study||100
9960135|NCT01466387|11079746|FG002|STARTED|Overall Study||99
9960136|NCT01466387|11079747|FG003|STARTED|Overall Study||101
9960137|NCT01466387|11079748|FG004|STARTED|Overall Study||51
9960138|NCT01466387|11079749|FG005|STARTED|Overall Study||100
9960139|NCT01466387|11079744|FG000|COMPLETED|Overall Study||100
9960140|NCT01466387|11079745|FG001|COMPLETED|Overall Study||100
9960141|NCT01466387|11079746|FG002|COMPLETED|Overall Study||98
9960142|NCT01466387|11079747|FG003|COMPLETED|Overall Study||99
9960143|NCT01466387|11079748|FG004|COMPLETED|Overall Study||51
9960144|NCT01466387|11079749|FG005|COMPLETED|Overall Study||99
9960145|NCT01466387|11079744|FG000|NOT COMPLETED|Overall Study||1
9960146|NCT01466387|11079745|FG001|NOT COMPLETED|Overall Study||0
9960147|NCT01466387|11079746|FG002|NOT COMPLETED|Overall Study||1
9960148|NCT01466387|11079747|FG003|NOT COMPLETED|Overall Study||2
9960149|NCT01466387|11079748|FG004|NOT COMPLETED|Overall Study||0
9960150|NCT01466387|11079749|FG005|NOT COMPLETED|Overall Study||1
9960151|NCT01466491|11079776|FG000|STARTED|Overall Study||83
9960152|NCT01466491|11079777|FG001|STARTED|Overall Study||83
9960153|NCT01466491|11079778|FG002|STARTED|Overall Study||83
9960154|NCT01466491|11079779|FG003|STARTED|Overall Study||83
9960155|NCT01466491|11079776|FG000|COMPLETED|Overall Study||83
9960156|NCT01466491|11079777|FG001|COMPLETED|Overall Study||80
9960157|NCT01466491|11079778|FG002|COMPLETED|Overall Study||80
9960158|NCT01466491|11079779|FG003|COMPLETED|Overall Study||83
9960159|NCT01466491|11079776|FG000|NOT COMPLETED|Overall Study||0
9960160|NCT01466491|11079777|FG001|NOT COMPLETED|Overall Study||3
9960161|NCT01466491|11079778|FG002|NOT COMPLETED|Overall Study||3
9960162|NCT01466491|11079779|FG003|NOT COMPLETED|Overall Study||0
9960163|NCT01466595|11079791|FG000|STARTED|Overall Study||49
9960164|NCT01466595|11079792|FG001|STARTED|Overall Study||24
9960165|NCT01466595|11079791|FG000|COMPLETED|Overall Study||49
9960166|NCT01466595|11079792|FG001|COMPLETED|Overall Study||23
9960167|NCT01466595|11079791|FG000|NOT COMPLETED|Overall Study||0
9960168|NCT01466595|11079792|FG001|NOT COMPLETED|Overall Study||1
9960169|NCT01466660|11079800|FG000|STARTED|Overall Study||160
9960170|NCT01466660|11079801|FG001|STARTED|Overall Study||159
9960171|NCT01466660|11079800|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
9960172|NCT01466660|11079801|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
9960173|NCT01466660|11079800|FG000|NOT COMPLETED|Overall Study||160
9960174|NCT01466660|11079801|FG001|NOT COMPLETED|Overall Study||159
9842192|NCT00823303|10953822|FG000|STARTED|Overall Study||54
9842193|NCT00823303|10953823|FG001|STARTED|Overall Study||56
9723630|NCT00083889|10823296|FG000|Received Treatment|Overall Study||375
9723631|NCT00083889|10823297|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
9723632|NCT00083889|10823296|FG000|COMPLETED|Overall Study||0
9723633|NCT00083889|10823297|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
9723634|NCT00083889|10823296|FG000|NOT COMPLETED|Overall Study||375
9723635|NCT00083889|10823297|FG001|NOT COMPLETED|Overall Study||375
9723636|NCT00084084|10823306|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17
9723637|NCT00084084|10823306|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
9723638|NCT00084084|10823306|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
9723639|NCT00084084|10823306|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
9723640|NCT00084084|10823306|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10
9723641|NCT00084084|10823306|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
9723642|NCT00084136|10823314|FG000|STARTED|PI Comparison||519
9723643|NCT00084136|10823315|FG001|STARTED|PI Comparison||526
9723644|NCT00084136|10823316|FG002|STARTED|PI Comparison||0
9723645|NCT00084136|10823314|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
9731717|NCT00134901|10831615|FG000|STARTED|Overall Study||39
9842194|NCT00823303|10953822|FG000|COMPLETED|Overall Study||45
9842195|NCT00823303|10953823|FG001|COMPLETED|Overall Study||45
9842196|NCT00823303|10953822|FG000|NOT COMPLETED|Overall Study||9
9842197|NCT00823303|10953823|FG001|NOT COMPLETED|Overall Study||11
9842198|NCT00823459|10953829|FG000|STARTED|Overall Study||58
9723646|NCT00084136|10823315|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
9723647|NCT00084136|10823316|FG002|COMPLETED|PI Comparison||0
9723648|NCT00084136|10823314|FG000|NOT COMPLETED|PI Comparison||55
9723649|NCT00084136|10823315|FG001|NOT COMPLETED|PI Comparison||47
9723650|NCT00084136|10823316|FG002|NOT COMPLETED|PI Comparison||0
9723651|NCT00084136|10823314|FG000|STARTED|NRTI Comparison||519
9723652|NCT00084136|10823315|FG001|STARTED|NRTI Comparison||0
9723653|NCT00084136|10823316|FG002|STARTED|NRTI Comparison||526
9723654|NCT00084136|10823314|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
9723655|NCT00084136|10823315|FG001|COMPLETED|NRTI Comparison||0
9723656|NCT00084136|10823316|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
9723657|NCT00084136|10823314|FG000|NOT COMPLETED|NRTI Comparison||101
9723658|NCT00084136|10823315|FG001|NOT COMPLETED|NRTI Comparison||0
9723659|NCT00084136|10823316|FG002|NOT COMPLETED|NRTI Comparison||82
9723660|NCT00084149|10823327|FG000|STARTED|Overall Study||36
9723661|NCT00084149|10823328|FG001|STARTED|Overall Study||18
9723662|NCT00084149|10823327|FG000|COMPLETED|Overall Study||28
9723663|NCT00084149|10823328|FG001|COMPLETED|Overall Study||13
9723664|NCT00084149|10823327|FG000|NOT COMPLETED|Overall Study||8
9723665|NCT00084149|10823328|FG001|NOT COMPLETED|Overall Study||5
9723666|NCT00084266|10823340|FG000|STARTED|Overall Study||618
9723667|NCT00084266|10823341|FG001|STARTED|Overall Study||607
9723668|NCT00084266|10823340|FG000|Treated|Overall Study||597
9723669|NCT00084266|10823341|FG001|Treated|Overall Study||587
9723670|NCT00084266|10823340|FG000|COMPLETED|Overall Study||177
9723671|NCT00084266|10823341|FG001|COMPLETED|Overall Study||184
9723672|NCT00084266|10823340|FG000|NOT COMPLETED|Overall Study||441
9723673|NCT00084266|10823341|FG001|NOT COMPLETED|Overall Study||423
9723674|NCT00084318|10823349|FG000|STARTED|Overall Study||119
9723675|NCT00084318|10823350|FG001|STARTED|Overall Study||119
9723676|NCT00084318|10823349|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
9723677|NCT00084318|10823350|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
9723678|NCT00084318|10823349|FG000|NOT COMPLETED|Overall Study||22
9723679|NCT00084318|10823350|FG001|NOT COMPLETED|Overall Study||13
9723680|NCT00084383|10823358|FG000|STARTED|Overall Study||60
9723681|NCT00084383|10823358|FG000|COMPLETED|Overall Study||13
9723682|NCT00084383|10823358|FG000|NOT COMPLETED|Overall Study||47
9723683|NCT00084409|10823364|FG000|STARTED|Overall Study|40 Current, 35 former|75
9723684|NCT00084409|10823365|FG001|STARTED|Overall Study|41 current, 36 former|77
9723685|NCT00084409|10823364|FG000|COMPLETED|Overall Study|9 current, 6 former|60
9723686|NCT00084409|10823365|FG001|COMPLETED|Overall Study|4 Current, 8 former|65
9723687|NCT00084409|10823364|FG000|NOT COMPLETED|Overall Study||15
9723688|NCT00084409|10823365|FG001|NOT COMPLETED|Overall Study||12
9723689|NCT00084487|10823373|FG000|STARTED|Overall Study||21
9723690|NCT00084487|10823373|FG000|COMPLETED|Overall Study||20
9723691|NCT00084487|10823373|FG000|NOT COMPLETED|Overall Study||1
9723692|NCT00084552|10823379|FG000|STARTED|Overall Study||54
9723693|NCT00084552|10823380|FG001|STARTED|Overall Study||62
9723694|NCT00084552|10823379|FG000|COMPLETED|Overall Study||54
9723695|NCT00084552|10823380|FG001|COMPLETED|Overall Study||62
10022643|NCT01852058|11146182|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022644|NCT01852058|11146183|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022645|NCT01852058|11146184|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022646|NCT01852058|11146185|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022647|NCT01852058|11146186|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022648|NCT01852058|11146187|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
9842199|NCT00823459|10953829|FG000|COMPLETED|Overall Study||58
9842200|NCT00823459|10953829|FG000|NOT COMPLETED|Overall Study||0
9723696|NCT00084552|10823379|FG000|NOT COMPLETED|Overall Study||0
9723697|NCT00084552|10823380|FG001|NOT COMPLETED|Overall Study||0
9723698|NCT00084617|10823386|FG000|STARTED|Overall Study||39
9723699|NCT00084617|10823386|FG000|COMPLETED|Overall Study||30
9723700|NCT00084617|10823386|FG000|NOT COMPLETED|Overall Study||9
9723701|NCT00084682|10823390|FG000|STARTED|Overall Study||14
9723702|NCT00084682|10823390|FG000|COMPLETED|Overall Study||13
9842201|NCT00823472|10953836|FG000|STARTED|Overall Study||80
9842202|NCT00823472|10953837|FG001|STARTED|Overall Study||67
9842203|NCT00823472|10953836|FG000|COMPLETED|Overall Study||56
9842204|NCT00823472|10953837|FG001|COMPLETED|Overall Study||39
9842205|NCT00823472|10953836|FG000|NOT COMPLETED|Overall Study||24
9842206|NCT00823472|10953837|FG001|NOT COMPLETED|Overall Study||28
9842207|NCT00823615|10953843|FG000|STARTED|Period 1||19
9842208|NCT00823615|10953844|FG001|STARTED|Period 1||19
9842209|NCT00823615|10953843|FG000|COMPLETED|Period 1||19
9842210|NCT00823615|10953844|FG001|COMPLETED|Period 1||19
9842211|NCT00823615|10953843|FG000|NOT COMPLETED|Period 1||0
9842212|NCT00823615|10953844|FG001|NOT COMPLETED|Period 1||0
9842213|NCT00823615|10953843|FG000|STARTED|Period 2||19
9842214|NCT00823615|10953844|FG001|STARTED|Period 2||19
9842215|NCT00823615|10953843|FG000|COMPLETED|Period 2||16
9842216|NCT00823615|10953844|FG001|COMPLETED|Period 2||17
9842217|NCT00823615|10953843|FG000|NOT COMPLETED|Period 2||3
9842218|NCT00823615|10953844|FG001|NOT COMPLETED|Period 2||2
9842219|NCT00823719|10953852|FG000|STARTED|Overall Study||26
9842220|NCT00823719|10953853|FG001|STARTED|Overall Study||35
9842221|NCT00823719|10953852|FG000|COMPLETED|Overall Study||20
9842222|NCT00823719|10953853|FG001|COMPLETED|Overall Study||24
9842223|NCT00823719|10953852|FG000|NOT COMPLETED|Overall Study||6
9842224|NCT00823719|10953853|FG001|NOT COMPLETED|Overall Study||11
9842225|NCT00823797|10953863|FG000|STARTED|Overall Study||29
9842226|NCT00823797|10953864|FG001|STARTED|Overall Study||16
9842227|NCT00823797|10953863|FG000|COMPLETED|Overall Study||29
9842228|NCT00823797|10953864|FG001|COMPLETED|Overall Study||16
9842229|NCT00823797|10953863|FG000|NOT COMPLETED|Overall Study||0
9842230|NCT00823797|10953864|FG001|NOT COMPLETED|Overall Study||0
9842231|NCT00823823|10953871|FG000|STARTED|Overall Study||109
9842232|NCT00823823|10953872|FG001|STARTED|Overall Study||107
9842233|NCT00823823|10953871|FG000|COMPLETED|Overall Study||101
9842234|NCT00823823|10953872|FG001|COMPLETED|Overall Study||101
9842235|NCT00823823|10953871|FG000|NOT COMPLETED|Overall Study||8
9842236|NCT00823823|10953872|FG001|NOT COMPLETED|Overall Study||6
9842237|NCT00823836|10953880|FG000|STARTED|NV and PR/XR Switching Phases||156
9842238|NCT00823836|10953881|FG001|STARTED|NV and PR/XR Switching Phases||146
9842239|NCT00823836|10953880|FG000|COMPLETED|NV and PR/XR Switching Phases||124
9842240|NCT00823836|10953881|FG001|COMPLETED|NV and PR/XR Switching Phases||117
9842241|NCT00823836|10953880|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32
9842242|NCT00823836|10953881|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29
9842243|NCT00823836|10953880|FG000|STARTED|Long-term Phase||73
9842244|NCT00823836|10953881|FG001|STARTED|Long-term Phase||84
9842245|NCT00823836|10953880|FG000|COMPLETED|Long-term Phase||68
9842246|NCT00823836|10953881|FG001|COMPLETED|Long-term Phase||79
9842247|NCT00823836|10953880|FG000|NOT COMPLETED|Long-term Phase||5
9842248|NCT00823836|10953881|FG001|NOT COMPLETED|Long-term Phase||5
9842249|NCT00823901|10953892|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
9842250|NCT00823901|10953893|FG001|STARTED|Overall Study|Randomized to placebo gel|40
9842251|NCT00823901|10953892|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
9723703|NCT00084682|10823390|FG000|NOT COMPLETED|Overall Study||1
9723704|NCT00084747|10823395|FG000|STARTED|Overall Study||30
9723705|NCT00084747|10823395|FG000|COMPLETED|Overall Study||17
9723706|NCT00084747|10823395|FG000|NOT COMPLETED|Overall Study||13
9723707|NCT00084838|10823400|FG000|STARTED|Overall Study||25
9723708|NCT00084838|10823400|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
9723709|NCT00084838|10823400|FG000|COMPLETED|Overall Study||12
9723710|NCT00084838|10823400|FG000|NOT COMPLETED|Overall Study||13
9723711|NCT00084864|10823410|FG000|STARTED|Overall Study||10
9723712|NCT00084864|10823411|FG001|STARTED|Overall Study||7
9723713|NCT00084864|10823412|FG002|STARTED|Overall Study||4
9723714|NCT00084864|10823413|FG003|STARTED|Overall Study||4
9723715|NCT00084864|10823410|FG000|COMPLETED|Overall Study||9
9723716|NCT00084864|10823411|FG001|COMPLETED|Overall Study||7
9723717|NCT00084864|10823412|FG002|COMPLETED|Overall Study||4
9723718|NCT00084864|10823413|FG003|COMPLETED|Overall Study||4
9723719|NCT00084864|10823410|FG000|NOT COMPLETED|Overall Study||1
9723720|NCT00084864|10823411|FG001|NOT COMPLETED|Overall Study||0
9723721|NCT00084864|10823412|FG002|NOT COMPLETED|Overall Study||0
9723722|NCT00084864|10823413|FG003|NOT COMPLETED|Overall Study||0
9723723|NCT00084929|10823423|FG000|STARTED|Overall Study||2600
9723724|NCT00084929|10823423|FG000|COMPLETED|Overall Study||2531
9723725|NCT00084929|10823423|FG000|NOT COMPLETED|Overall Study||69
9723726|NCT00085098|10823433|FG000|STARTED|Overall Study||11
10022649|NCT01852058|11146176|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
10022650|NCT01852058|11146177|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022651|NCT01852058|11146178|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
9723727|NCT00085098|10823434|FG001|STARTED|Overall Study||13
9723728|NCT00085098|10823433|FG000|COMPLETED|Overall Study||10
9723729|NCT00085098|10823434|FG001|COMPLETED|Overall Study||11
9723730|NCT00085098|10823433|FG000|NOT COMPLETED|Overall Study||1
9723731|NCT00085098|10823434|FG001|NOT COMPLETED|Overall Study||2
9723732|NCT00085254|10823446|FG000|STARTED|Overall Study||18
9723733|NCT00085254|10823447|FG001|STARTED|Overall Study||46
9723734|NCT00085254|10823448|FG002|STARTED|Overall Study||48
9723735|NCT00085254|10823446|FG000|COMPLETED|Overall Study||18
9723736|NCT00085254|10823447|FG001|COMPLETED|Overall Study||46
9723737|NCT00085254|10823448|FG002|COMPLETED|Overall Study||48
9723738|NCT00085254|10823446|FG000|NOT COMPLETED|Overall Study||0
9723739|NCT00085254|10823447|FG001|NOT COMPLETED|Overall Study||0
9723740|NCT00085254|10823448|FG002|NOT COMPLETED|Overall Study||0
9723741|NCT00085293|10823462|FG000|STARTED|Overall Study||12
9723742|NCT00085293|10823462|FG000|COMPLETED|Overall Study||12
9723743|NCT00085293|10823462|FG000|NOT COMPLETED|Overall Study||0
9723744|NCT00085410|10823466|FG000|STARTED|Overall Study||20
9723745|NCT00085410|10823466|FG000|COMPLETED|Overall Study||20
9723746|NCT00085410|10823466|FG000|NOT COMPLETED|Overall Study||0
9723747|NCT00085423|10823471|FG000|STARTED|Overall Study||20
9723748|NCT00085423|10823471|FG000|COMPLETED|Overall Study||18
9723749|NCT00085423|10823471|FG000|NOT COMPLETED|Overall Study||2
9723750|NCT00085436|10823475|FG000|STARTED|Overall Study||18
9723751|NCT00085436|10823475|FG000|COMPLETED|Overall Study||18
9723752|NCT00085436|10823475|FG000|NOT COMPLETED|Overall Study||0
9723753|NCT00085540|10823482|FG000|STARTED|Overall Study||8
9723754|NCT00085540|10823483|FG001|STARTED|Overall Study||42
9723755|NCT00085540|10823482|FG000|COMPLETED|Overall Study||8
9723756|NCT00085540|10823483|FG001|COMPLETED|Overall Study||40
9723757|NCT00085540|10823482|FG000|NOT COMPLETED|Overall Study||0
9723758|NCT00085540|10823483|FG001|NOT COMPLETED|Overall Study||2
9723759|NCT00085566|10823492|FG000|STARTED|Overall Study||3
9723760|NCT00085566|10823493|FG001|STARTED|Overall Study||3
9723761|NCT00085566|10823494|FG002|STARTED|Overall Study||57
9723762|NCT00085566|10823492|FG000|COMPLETED|Overall Study||3
9723763|NCT00085566|10823493|FG001|COMPLETED|Overall Study||3
9723764|NCT00085566|10823494|FG002|COMPLETED|Overall Study||43
9723765|NCT00085566|10823492|FG000|NOT COMPLETED|Overall Study||0
9723766|NCT00085566|10823493|FG001|NOT COMPLETED|Overall Study||0
9723767|NCT00085566|10823494|FG002|NOT COMPLETED|Overall Study||14
9723768|NCT00085644|10823504|FG000|STARTED|Double-Blind Period||208
9723769|NCT00085644|10823505|FG001|STARTED|Double-Blind Period||107
9723770|NCT00085644|10823506|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
9723771|NCT00085644|10823504|FG000|COMPLETED|Double-Blind Period||195
9723772|NCT00085644|10823505|FG001|COMPLETED|Double-Blind Period||101
9723773|NCT00085644|10823506|FG002|COMPLETED|Double-Blind Period||0
9723774|NCT00085644|10823504|FG000|NOT COMPLETED|Double-Blind Period||13
9960175|NCT01466673|11079809|FG000|STARTED|Overall Study||100
9723775|NCT00085644|10823505|FG001|NOT COMPLETED|Double-Blind Period||6
9723776|NCT00085644|10823506|FG002|NOT COMPLETED|Double-Blind Period||0
10022652|NCT01852058|11146179|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022653|NCT01852058|11146180|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
9842252|NCT00823901|10953893|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
9842253|NCT00823901|10953892|FG000|NOT COMPLETED|Overall Study||4
9842254|NCT00823901|10953893|FG001|NOT COMPLETED|Overall Study||2
9842255|NCT00823966|10953899|FG000|STARTED|Overall Study||3
9842256|NCT00823966|10953899|FG000|COMPLETED|Overall Study||3
9842257|NCT00823966|10953899|FG000|NOT COMPLETED|Overall Study||0
9842258|NCT00823979|10953906|FG000|STARTED|Overall Study||35
9842259|NCT00823979|10953907|FG001|STARTED|Overall Study||35
9842260|NCT00823979|10953908|FG002|STARTED|Overall Study||35
9842261|NCT00823979|10953906|FG000|Treated|Overall Study||31
9842262|NCT00823979|10953907|FG001|Treated|Overall Study||32
9842263|NCT00823979|10953908|FG002|Treated|Overall Study||34
9842264|NCT00823979|10953906|FG000|COMPLETED|Overall Study||6
9842265|NCT00823979|10953907|FG001|COMPLETED|Overall Study||3
9842266|NCT00823979|10953908|FG002|COMPLETED|Overall Study||11
9842267|NCT00823979|10953906|FG000|NOT COMPLETED|Overall Study||29
9842268|NCT00823979|10953907|FG001|NOT COMPLETED|Overall Study||32
9842269|NCT00823979|10953908|FG002|NOT COMPLETED|Overall Study||24
9842270|NCT00824005|10953918|FG000|STARTED|Overall Study||31
9842271|NCT00824005|10953919|FG001|STARTED|Overall Study||61
9842272|NCT00824005|10953918|FG000|COMPLETED|Overall Study||31
9842273|NCT00824005|10953919|FG001|COMPLETED|Overall Study||59
9960176|NCT01466673|11079810|FG001|STARTED|Overall Study||101
9960177|NCT01466673|11079809|FG000|COMPLETED|Overall Study||93
9960178|NCT01466673|11079810|FG001|COMPLETED|Overall Study||95
9960179|NCT01466673|11079809|FG000|NOT COMPLETED|Overall Study||7
9960180|NCT01466673|11079810|FG001|NOT COMPLETED|Overall Study||6
9960181|NCT01466751|11079818|FG000|STARTED|Overall Study||14
9960182|NCT01466751|11079819|FG001|STARTED|Overall Study||14
9960183|NCT01466751|11079818|FG000|COMPLETED|Overall Study||13
9960184|NCT01466751|11079819|FG001|COMPLETED|Overall Study||14
9960185|NCT01466751|11079818|FG000|NOT COMPLETED|Overall Study||1
9960186|NCT01466751|11079819|FG001|NOT COMPLETED|Overall Study||0
9960187|NCT01466764|11079829|FG000|STARTED|Overall Study||5
9960188|NCT01466764|11079830|FG001|STARTED|Overall Study||5
9960189|NCT01466764|11079829|FG000|COMPLETED|Overall Study||5
9960190|NCT01466764|11079830|FG001|COMPLETED|Overall Study||5
9960191|NCT01466764|11079829|FG000|NOT COMPLETED|Overall Study||0
9960192|NCT01466764|11079830|FG001|NOT COMPLETED|Overall Study||0
9960193|NCT01466790|11079844|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
9960194|NCT01466790|11079845|FG001|STARTED|Overall Study||15
9842274|NCT00824005|10953918|FG000|NOT COMPLETED|Overall Study||0
9842275|NCT00824005|10953919|FG001|NOT COMPLETED|Overall Study||2
9842276|NCT00824044|10953927|FG000|STARTED|Overall Study||23
9842277|NCT00824044|10953928|FG001|STARTED|Overall Study||16
9960195|NCT01466790|11079846|FG002|STARTED|Overall Study||27
9960196|NCT01466790|11079847|FG003|STARTED|Overall Study||14
9960197|NCT01466790|11079848|FG004|STARTED|Overall Study||30
9960198|NCT01466790|11079849|FG005|STARTED|Overall Study||16
9723777|NCT00085644|10823504|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
9723778|NCT00085644|10823505|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
9723779|NCT00085644|10823506|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
9723780|NCT00085644|10823504|FG000|COMPLETED|Open-Label Period||0
9723781|NCT00085644|10823505|FG001|COMPLETED|Open-Label Period||0
9723782|NCT00085644|10823506|FG002|COMPLETED|Open-Label Period||202
9723783|NCT00085644|10823504|FG000|NOT COMPLETED|Open-Label Period||0
9723784|NCT00085644|10823505|FG001|NOT COMPLETED|Open-Label Period||0
9723785|NCT00085644|10823506|FG002|NOT COMPLETED|Open-Label Period||109
9723786|NCT00085709|10823515|FG000|STARTED|Overall Study||317
9723787|NCT00085709|10823516|FG001|STARTED|Overall Study||320
9723788|NCT00085709|10823515|FG000|Eligible|Overall Study||298
9723789|NCT00085709|10823516|FG001|Eligible|Overall Study||301
9723790|NCT00085709|10823515|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296
9723791|NCT00085709|10823516|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300
9723792|NCT00085709|10823515|FG000|COMPLETED|Overall Study||264
9723793|NCT00085709|10823516|FG001|COMPLETED|Overall Study||270
9723794|NCT00085709|10823515|FG000|NOT COMPLETED|Overall Study||53
9723795|NCT00085709|10823516|FG001|NOT COMPLETED|Overall Study||50
9723796|NCT00085839|10823532|FG000|STARTED|Overall Study||52
9723797|NCT00085839|10823533|FG001|STARTED|Overall Study||51
9960199|NCT01466790|11079850|FG006|STARTED|Overall Study||27
9960200|NCT01466790|11079851|FG007|STARTED|Overall Study||14
9960201|NCT01466790|11079844|FG000|COMPLETED|Overall Study||20
9960202|NCT01466790|11079845|FG001|COMPLETED|Overall Study||14
9960203|NCT01466790|11079846|FG002|COMPLETED|Overall Study||27
9960204|NCT01466790|11079847|FG003|COMPLETED|Overall Study||14
9960205|NCT01466790|11079848|FG004|COMPLETED|Overall Study||27
9960206|NCT01466790|11079849|FG005|COMPLETED|Overall Study||16
9960207|NCT01466790|11079850|FG006|COMPLETED|Overall Study||26
9960208|NCT01466790|11079851|FG007|COMPLETED|Overall Study||13
9960209|NCT01466790|11079844|FG000|NOT COMPLETED|Overall Study||4
9960210|NCT01466790|11079845|FG001|NOT COMPLETED|Overall Study||1
9960211|NCT01466790|11079846|FG002|NOT COMPLETED|Overall Study||0
10022654|NCT01852058|11146181|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022655|NCT01852058|11146182|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022656|NCT01852058|11146183|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10081144|NCT02258074|11209603|FG003|STARTED|Overall Study||51
9723798|NCT00085839|10823532|FG000|COMPLETED|Overall Study||52
9723799|NCT00085839|10823533|FG001|COMPLETED|Overall Study||51
9723800|NCT00085839|10823532|FG000|NOT COMPLETED|Overall Study||0
9723801|NCT00085839|10823533|FG001|NOT COMPLETED|Overall Study||0
9723802|NCT00085917|10823541|FG000|STARTED|Overall Study||15
9723803|NCT00085917|10823542|FG001|STARTED|Overall Study||14
9723804|NCT00085917|10823541|FG000|COMPLETED|Overall Study||11
9723805|NCT00085917|10823542|FG001|COMPLETED|Overall Study||11
9723806|NCT00085917|10823541|FG000|NOT COMPLETED|Overall Study||4
9723807|NCT00085917|10823542|FG001|NOT COMPLETED|Overall Study||3
9723808|NCT00086047|10823550|FG000|STARTED|Overall Study||57
9723809|NCT00086047|10823551|FG001|STARTED|Overall Study||57
9723810|NCT00086047|10823550|FG000|COMPLETED|Overall Study||50
9723811|NCT00086047|10823551|FG001|COMPLETED|Overall Study||50
9723812|NCT00086047|10823550|FG000|NOT COMPLETED|Overall Study||7
9723813|NCT00086047|10823551|FG001|NOT COMPLETED|Overall Study||7
9723814|NCT00086138|10823559|FG000|STARTED|Overall Study||64
9723815|NCT00086138|10823560|FG001|STARTED|Overall Study||67
9723816|NCT00086138|10823559|FG000|COMPLETED|Overall Study||60
9723817|NCT00086138|10823560|FG001|COMPLETED|Overall Study||64
9723818|NCT00086138|10823559|FG000|NOT COMPLETED|Overall Study||4
9723819|NCT00086138|10823560|FG001|NOT COMPLETED|Overall Study||3
9723820|NCT00086190|10823569|FG000|STARTED|Overall Study||42
9723821|NCT00086190|10823570|FG001|STARTED|Overall Study||34
9723822|NCT00086190|10823571|FG002|STARTED|Overall Study||39
9723823|NCT00086190|10823569|FG000|COMPLETED|Overall Study||34
9723824|NCT00086190|10823570|FG001|COMPLETED|Overall Study||30
9723825|NCT00086190|10823571|FG002|COMPLETED|Overall Study||33
9723826|NCT00086190|10823569|FG000|NOT COMPLETED|Overall Study||8
9723827|NCT00086190|10823570|FG001|NOT COMPLETED|Overall Study||4
9723828|NCT00086190|10823571|FG002|NOT COMPLETED|Overall Study||6
9723829|NCT00086281|10823594|FG000|STARTED|Phase 1||11
9723830|NCT00086281|10823595|FG001|STARTED|Phase 1||12
9723831|NCT00086281|10823596|FG002|STARTED|Phase 1||8
9842278|NCT00824044|10953927|FG000|COMPLETED|Overall Study||14
9842279|NCT00824044|10953928|FG001|COMPLETED|Overall Study||10
9842280|NCT00824044|10953927|FG000|NOT COMPLETED|Overall Study||9
9842281|NCT00824044|10953928|FG001|NOT COMPLETED|Overall Study||6
9842282|NCT00824070|10953941|FG000|STARTED|Overall Study||34
9960212|NCT01466790|11079847|FG003|NOT COMPLETED|Overall Study||0
9960213|NCT01466790|11079848|FG004|NOT COMPLETED|Overall Study||3
9960214|NCT01466790|11079849|FG005|NOT COMPLETED|Overall Study||0
9960215|NCT01466790|11079850|FG006|NOT COMPLETED|Overall Study||1
9842283|NCT00824070|10953942|FG001|STARTED|Overall Study||35
9960216|NCT01466790|11079851|FG007|NOT COMPLETED|Overall Study||1
9960217|NCT01466881|11079865|FG000|STARTED|Overall Study||42
9960218|NCT01466881|11079865|FG000|Eligible and Treated|Overall Study||37
9960219|NCT01466881|11079865|FG000|COMPLETED|Overall Study||2
9723832|NCT00086281|10823597|FG003|STARTED|Phase 1||11
9723833|NCT00086281|10823598|FG004|STARTED|Phase 1||1
9723834|NCT00086281|10823599|FG005|STARTED|Phase 1||3
9723835|NCT00086281|10823600|FG006|STARTED|Phase 1||1
9723836|NCT00086281|10823601|FG007|STARTED|Phase 1||1
9723837|NCT00086281|10823602|FG008|STARTED|Phase 1||2
9723838|NCT00086281|10823603|FG009|STARTED|Phase 1||1
9960220|NCT01466881|11079865|FG000|NOT COMPLETED|Overall Study||40
9960221|NCT01466972|11079871|FG000|STARTED|Overall Study||30
9842284|NCT00824070|10953943|FG002|STARTED|Overall Study||36
9842285|NCT00824070|10953941|FG000|COMPLETED|Overall Study||34
9842286|NCT00824070|10953942|FG001|COMPLETED|Overall Study||35
9842287|NCT00824070|10953943|FG002|COMPLETED|Overall Study||36
9842288|NCT00824070|10953941|FG000|NOT COMPLETED|Overall Study||0
9842289|NCT00824070|10953942|FG001|NOT COMPLETED|Overall Study||0
9842290|NCT00824070|10953943|FG002|NOT COMPLETED|Overall Study||0
9842291|NCT00824161|10953951|FG000|STARTED|Overall Study||28
9842292|NCT00824161|10953951|FG000|COMPLETED|Overall Study||26
9842293|NCT00824161|10953951|FG000|NOT COMPLETED|Overall Study||2
9842294|NCT00824265|10953958|FG000|STARTED|Treatment Phase||183
9842295|NCT00824265|10953959|FG001|STARTED|Treatment Phase||182
9842296|NCT00824265|10953958|FG000|COMPLETED|Treatment Phase||119
9842297|NCT00824265|10953959|FG001|COMPLETED|Treatment Phase||102
9842298|NCT00824265|10953958|FG000|NOT COMPLETED|Treatment Phase||64
9842299|NCT00824265|10953959|FG001|NOT COMPLETED|Treatment Phase||80
9842300|NCT00824265|10953958|FG000|STARTED|Follow-up Phase||172
9842301|NCT00824265|10953959|FG001|STARTED|Follow-up Phase||160
9842302|NCT00824265|10953958|FG000|COMPLETED|Follow-up Phase||154
9842303|NCT00824265|10953959|FG001|COMPLETED|Follow-up Phase||129
9842304|NCT00824265|10953958|FG000|NOT COMPLETED|Follow-up Phase||18
9960222|NCT01466972|11079871|FG000|COMPLETED|Overall Study||30
9960223|NCT01466972|11079871|FG000|NOT COMPLETED|Overall Study||0
9723839|NCT00086281|10823604|FG010|STARTED|Phase 1||3
9842305|NCT00824265|10953959|FG001|NOT COMPLETED|Follow-up Phase||31
9842306|NCT00824265|10953958|FG000|STARTED|Survival Follow-up Phase||96
9842307|NCT00824265|10953959|FG001|STARTED|Survival Follow-up Phase||89
9842308|NCT00824265|10953958|FG000|COMPLETED|Survival Follow-up Phase||87
9723840|NCT00086281|10823605|FG011|STARTED|Phase 1||1
9960224|NCT01466985|11079878|FG000|STARTED|Overall Study||6
9842309|NCT00824265|10953959|FG001|COMPLETED|Survival Follow-up Phase||73
9842310|NCT00824265|10953958|FG000|NOT COMPLETED|Survival Follow-up Phase||9
9842311|NCT00824265|10953959|FG001|NOT COMPLETED|Survival Follow-up Phase||16
9842312|NCT00824291|10953971|FG000|STARTED|Overall Study||285
9842313|NCT00824291|10953972|FG001|STARTED|Overall Study||142
9842314|NCT00824291|10953971|FG000|COMPLETED|Overall Study||231
9842315|NCT00824291|10953972|FG001|COMPLETED|Overall Study||107
9842316|NCT00824291|10953971|FG000|NOT COMPLETED|Overall Study||54
9842317|NCT00824291|10953972|FG001|NOT COMPLETED|Overall Study||35
9842318|NCT00824369|10953984|FG000|STARTED|Overall Study||5
9842319|NCT00824369|10953985|FG001|STARTED|Overall Study||4
9842320|NCT00824369|10953986|FG002|STARTED|Overall Study||3
9842321|NCT00824369|10953987|FG003|STARTED|Overall Study||11
9842322|NCT00824369|10953988|FG004|STARTED|Overall Study||12
9842323|NCT00824369|10953989|FG005|STARTED|Overall Study||17
9842324|NCT00824369|10953984|FG000|COMPLETED|Overall Study||4
9842325|NCT00824369|10953985|FG001|COMPLETED|Overall Study||4
9842326|NCT00824369|10953986|FG002|COMPLETED|Overall Study||2
9842327|NCT00824369|10953987|FG003|COMPLETED|Overall Study||9
9842328|NCT00824369|10953988|FG004|COMPLETED|Overall Study||11
9842329|NCT00824369|10953989|FG005|COMPLETED|Overall Study||16
9842330|NCT00824369|10953984|FG000|NOT COMPLETED|Overall Study||1
9842331|NCT00824369|10953985|FG001|NOT COMPLETED|Overall Study||0
9842332|NCT00824369|10953986|FG002|NOT COMPLETED|Overall Study||1
9842333|NCT00824369|10953987|FG003|NOT COMPLETED|Overall Study||2
9842334|NCT00824369|10953988|FG004|NOT COMPLETED|Overall Study||1
9842335|NCT00824369|10953989|FG005|NOT COMPLETED|Overall Study||1
9842336|NCT00824382|10954007|FG000|STARTED|Overall Study||79
9842337|NCT00824382|10954008|FG001|STARTED|Overall Study||84
9842338|NCT00824382|10954009|FG002|STARTED|Overall Study||79
9842339|NCT00824382|10954010|FG003|STARTED|Overall Study||86
9842340|NCT00824382|10954007|FG000|COMPLETED|Overall Study||74
9842341|NCT00824382|10954008|FG001|COMPLETED|Overall Study||82
9842342|NCT00824382|10954009|FG002|COMPLETED|Overall Study||76
9842343|NCT00824382|10954010|FG003|COMPLETED|Overall Study||81
9842344|NCT00824382|10954007|FG000|NOT COMPLETED|Overall Study||5
9842345|NCT00824382|10954008|FG001|NOT COMPLETED|Overall Study||2
9842346|NCT00824382|10954009|FG002|NOT COMPLETED|Overall Study||3
9842347|NCT00824382|10954010|FG003|NOT COMPLETED|Overall Study||5
9842348|NCT00824408|10954027|FG000|STARTED|Run-in Phase||6
9842349|NCT00824408|10954028|FG001|STARTED|Run-in Phase||6
9842350|NCT00824408|10954029|FG002|STARTED|Run-in Phase||0
9842351|NCT00824408|10954030|FG003|STARTED|Run-in Phase||0
9842352|NCT00824408|10954031|FG004|STARTED|Run-in Phase||0
9842353|NCT00824408|10954027|FG000|COMPLETED|Run-in Phase||0
9842354|NCT00824408|10954028|FG001|COMPLETED|Run-in Phase||0
9842355|NCT00824408|10954029|FG002|COMPLETED|Run-in Phase||0
9842356|NCT00824408|10954030|FG003|COMPLETED|Run-in Phase||0
9842357|NCT00824408|10954031|FG004|COMPLETED|Run-in Phase||0
9842358|NCT00824408|10954027|FG000|NOT COMPLETED|Run-in Phase||6
9842359|NCT00824408|10954028|FG001|NOT COMPLETED|Run-in Phase||6
9842360|NCT00824408|10954029|FG002|NOT COMPLETED|Run-in Phase||0
9842361|NCT00824408|10954030|FG003|NOT COMPLETED|Run-in Phase||0
9842362|NCT00824408|10954031|FG004|NOT COMPLETED|Run-in Phase||0
9842363|NCT00824408|10954027|FG000|STARTED|Randomized Phase||0
9842364|NCT00824408|10954028|FG001|STARTED|Randomized Phase||0
9842365|NCT00824408|10954029|FG002|STARTED|Randomized Phase||37
9842366|NCT00824408|10954030|FG003|STARTED|Randomized Phase||47
9842367|NCT00824408|10954031|FG004|STARTED|Randomized Phase||47
9842368|NCT00824408|10954027|FG000|COMPLETED|Randomized Phase||0
9842369|NCT00824408|10954028|FG001|COMPLETED|Randomized Phase||0
9842370|NCT00824408|10954029|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
10022657|NCT01852058|11146184|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
9960225|NCT01466985|11079879|FG001|STARTED|Overall Study||6
9960226|NCT01466985|11079880|FG002|STARTED|Overall Study||6
9960227|NCT01466985|11079878|FG000|COMPLETED|Overall Study||6
9960228|NCT01466985|11079879|FG001|COMPLETED|Overall Study||6
9960229|NCT01466985|11079880|FG002|COMPLETED|Overall Study||6
9960230|NCT01466985|11079878|FG000|NOT COMPLETED|Overall Study||0
9723841|NCT00086281|10823606|FG012|STARTED|Phase 1||1
9723842|NCT00086281|10823607|FG013|STARTED|Phase 1||1
9723843|NCT00086281|10823608|FG014|STARTED|Phase 1||3
9723844|NCT00086281|10823594|FG000|COMPLETED|Phase 1||11
9842371|NCT00824408|10954030|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
9842372|NCT00824408|10954031|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
9842373|NCT00824408|10954027|FG000|NOT COMPLETED|Randomized Phase||0
9842374|NCT00824408|10954028|FG001|NOT COMPLETED|Randomized Phase||0
9842375|NCT00824408|10954029|FG002|NOT COMPLETED|Randomized Phase||36
9842376|NCT00824408|10954030|FG003|NOT COMPLETED|Randomized Phase||46
9842377|NCT00824408|10954031|FG004|NOT COMPLETED|Randomized Phase||46
9842378|NCT00824421|10954052|FG000|STARTED|Overall Study||66
9842379|NCT00824421|10954053|FG001|STARTED|Overall Study||66
9842380|NCT00824421|10954054|FG002|STARTED|Overall Study||63
9842381|NCT00824421|10954052|FG000|Treated|Overall Study||65
9842382|NCT00824421|10954053|FG001|Treated|Overall Study||65
9723845|NCT00086281|10823595|FG001|COMPLETED|Phase 1||12
9723846|NCT00086281|10823596|FG002|COMPLETED|Phase 1||8
9723847|NCT00086281|10823597|FG003|COMPLETED|Phase 1||11
9842383|NCT00824421|10954054|FG002|Treated|Overall Study||63
9960231|NCT01466985|11079879|FG001|NOT COMPLETED|Overall Study||0
9960232|NCT01466985|11079880|FG002|NOT COMPLETED|Overall Study||0
9960233|NCT01467037|11079891|FG000|STARTED|Overall Study||374
9960234|NCT01467037|11079891|FG000|COMPLETED|Overall Study||374
9960235|NCT01467037|11079891|FG000|NOT COMPLETED|Overall Study||0
9960236|NCT01467063|11079898|FG000|STARTED|Overall Study||6
9960237|NCT01467063|11079899|FG001|STARTED|Overall Study||7
9960238|NCT01467063|11079898|FG000|COMPLETED|Overall Study||5
9960239|NCT01467063|11079899|FG001|COMPLETED|Overall Study||7
10022658|NCT01852058|11146185|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022659|NCT01852058|11146186|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022660|NCT01852058|11146187|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10022661|NCT01852058|11146176|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022662|NCT01852058|11146177|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022663|NCT01852058|11146178|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022664|NCT01852058|11146179|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
10022665|NCT01852058|11146180|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
10022666|NCT01852058|11146181|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
10022667|NCT01852058|11146182|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022668|NCT01852058|11146183|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022669|NCT01852058|11146184|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022670|NCT01852058|11146185|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022671|NCT01852058|11146186|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022672|NCT01852058|11146187|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10022673|NCT01852058|11146176|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022674|NCT01852058|11146177|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022675|NCT01852058|11146178|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022676|NCT01852058|11146179|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
10022677|NCT01852058|11146180|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
10114205|NCT02514577|11244919|FG001|NOT COMPLETED|Overall Study||13
10114206|NCT02514746|11244927|FG000|STARTED|Overall Study||437
10114207|NCT02514746|11244928|FG001|STARTED|Overall Study||124
10114208|NCT02514746|11244927|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437
10114209|NCT02514746|11244928|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123
10114210|NCT02514746|11244927|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424
10114211|NCT02514746|11244928|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109
9842384|NCT00824421|10954052|FG000|COMPLETED|Overall Study||49
9842385|NCT00824421|10954053|FG001|COMPLETED|Overall Study||44
9842386|NCT00824421|10954054|FG002|COMPLETED|Overall Study||49
9842387|NCT00824421|10954052|FG000|NOT COMPLETED|Overall Study||17
9842388|NCT00824421|10954053|FG001|NOT COMPLETED|Overall Study||22
9842389|NCT00824421|10954054|FG002|NOT COMPLETED|Overall Study||14
9842390|NCT00824434|10954064|FG000|STARTED|Overall Study||100
9842391|NCT00824434|10954064|FG000|COMPLETED|Overall Study||100
9842392|NCT00824434|10954064|FG000|NOT COMPLETED|Overall Study||0
9842393|NCT00824460|10954074|FG000|STARTED|Overall Study||26
9842394|NCT00824460|10954075|FG001|STARTED|Overall Study||26
9842395|NCT00824460|10954076|FG002|STARTED|Overall Study||25
9842396|NCT00824460|10954077|FG003|STARTED|Overall Study||27
10114212|NCT02514746|11244927|FG000|Received CD-JEV Booster Vaccine|Overall Study||424
10114213|NCT02514746|11244928|FG001|Received CD-JEV Booster Vaccine|Overall Study||109
10114214|NCT02514746|11244927|FG000|COMPLETED|Overall Study||415
10114215|NCT02514746|11244928|FG001|COMPLETED|Overall Study||109
9842397|NCT00824460|10954078|FG004|STARTED|Overall Study||24
9842398|NCT00824460|10954079|FG005|STARTED|Overall Study||26
9842399|NCT00824460|10954074|FG000|COMPLETED|Overall Study||18
9723848|NCT00086281|10823598|FG004|COMPLETED|Phase 1||1
9723849|NCT00086281|10823599|FG005|COMPLETED|Phase 1||3
9723850|NCT00086281|10823600|FG006|COMPLETED|Phase 1||1
9723851|NCT00086281|10823601|FG007|COMPLETED|Phase 1||1
9723852|NCT00086281|10823602|FG008|COMPLETED|Phase 1||2
9723853|NCT00086281|10823603|FG009|COMPLETED|Phase 1||0
9723854|NCT00086281|10823604|FG010|COMPLETED|Phase 1||0
9723855|NCT00086281|10823605|FG011|COMPLETED|Phase 1||0
9723856|NCT00086281|10823606|FG012|COMPLETED|Phase 1||0
9723857|NCT00086281|10823607|FG013|COMPLETED|Phase 1||0
9723858|NCT00086281|10823608|FG014|COMPLETED|Phase 1||0
9723859|NCT00086281|10823594|FG000|NOT COMPLETED|Phase 1||0
9723860|NCT00086281|10823595|FG001|NOT COMPLETED|Phase 1||0
9723861|NCT00086281|10823596|FG002|NOT COMPLETED|Phase 1||0
9723862|NCT00086281|10823597|FG003|NOT COMPLETED|Phase 1||0
9723863|NCT00086281|10823598|FG004|NOT COMPLETED|Phase 1||0
9723864|NCT00086281|10823599|FG005|NOT COMPLETED|Phase 1||0
9723865|NCT00086281|10823600|FG006|NOT COMPLETED|Phase 1||0
10022678|NCT01852058|11146181|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
10022679|NCT01852058|11146182|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022680|NCT01852058|11146183|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
9723866|NCT00086281|10823601|FG007|NOT COMPLETED|Phase 1||0
9723867|NCT00086281|10823602|FG008|NOT COMPLETED|Phase 1||0
9842400|NCT00824460|10954075|FG001|COMPLETED|Overall Study||17
9723868|NCT00086281|10823603|FG009|NOT COMPLETED|Phase 1||1
9723869|NCT00086281|10823604|FG010|NOT COMPLETED|Phase 1||3
9723870|NCT00086281|10823605|FG011|NOT COMPLETED|Phase 1||1
9723871|NCT00086281|10823606|FG012|NOT COMPLETED|Phase 1||1
9723872|NCT00086281|10823607|FG013|NOT COMPLETED|Phase 1||1
9723873|NCT00086281|10823608|FG014|NOT COMPLETED|Phase 1||3
9842401|NCT00824460|10954076|FG002|COMPLETED|Overall Study||20
9723874|NCT00086281|10823594|FG000|STARTED|Phase 2||0
9723875|NCT00086281|10823595|FG001|STARTED|Phase 2||0
9723876|NCT00086281|10823596|FG002|STARTED|Phase 2||0
9723877|NCT00086281|10823597|FG003|STARTED|Phase 2||0
9842402|NCT00824460|10954077|FG003|COMPLETED|Overall Study||15
9723878|NCT00086281|10823598|FG004|STARTED|Phase 2||0
9723879|NCT00086281|10823599|FG005|STARTED|Phase 2||0
9723880|NCT00086281|10823600|FG006|STARTED|Phase 2||0
9723881|NCT00086281|10823601|FG007|STARTED|Phase 2||0
9723882|NCT00086281|10823602|FG008|STARTED|Phase 2||0
9842403|NCT00824460|10954078|FG004|COMPLETED|Overall Study||15
9842404|NCT00824460|10954079|FG005|COMPLETED|Overall Study||18
9842405|NCT00824460|10954074|FG000|NOT COMPLETED|Overall Study||8
9842406|NCT00824460|10954075|FG001|NOT COMPLETED|Overall Study||9
9842407|NCT00824460|10954076|FG002|NOT COMPLETED|Overall Study||5
9842408|NCT00824460|10954077|FG003|NOT COMPLETED|Overall Study||12
9842409|NCT00824460|10954078|FG004|NOT COMPLETED|Overall Study||9
9842410|NCT00824460|10954079|FG005|NOT COMPLETED|Overall Study||8
9842411|NCT00824473|10954103|FG000|STARTED|Overall Study|1 subject was randomized in error|255
9842412|NCT00824473|10954104|FG001|STARTED|Overall Study||251
9842413|NCT00824473|10954103|FG000|COMPLETED|Overall Study||240
9842414|NCT00824473|10954104|FG001|COMPLETED|Overall Study||238
9842415|NCT00824473|10954103|FG000|NOT COMPLETED|Overall Study||15
9842416|NCT00824473|10954104|FG001|NOT COMPLETED|Overall Study||13
9842417|NCT00824512|10954112|FG000|STARTED|Overall Study||11
9842418|NCT00824512|10954113|FG001|STARTED|Overall Study||11
9842419|NCT00824512|10954112|FG000|COMPLETED|Overall Study||11
9842420|NCT00824512|10954113|FG001|COMPLETED|Overall Study||11
9842421|NCT00824512|10954112|FG000|NOT COMPLETED|Overall Study||0
9842422|NCT00824512|10954113|FG001|NOT COMPLETED|Overall Study||0
9842423|NCT00824538|10954119|FG000|STARTED|Overall Study|13 patients entered the study|13
9842424|NCT00824538|10954119|FG000|COMPLETED|Overall Study||11
9842425|NCT00824538|10954119|FG000|NOT COMPLETED|Overall Study||2
9842426|NCT00824564|10954126|FG000|STARTED|Overall Study||42
9842427|NCT00824564|10954127|FG001|STARTED|Overall Study||40
9842428|NCT00824564|10954126|FG000|Treated|Overall Study||41
9842429|NCT00824564|10954127|FG001|Treated|Overall Study||40
9842430|NCT00824564|10954126|FG000|COMPLETED|Overall Study||34
9842431|NCT00824564|10954127|FG001|COMPLETED|Overall Study||30
9842432|NCT00824564|10954126|FG000|NOT COMPLETED|Overall Study||8
9842433|NCT00824564|10954127|FG001|NOT COMPLETED|Overall Study||10
9842434|NCT00824616|10954135|FG000|STARTED|Overall Study||34
9842435|NCT00824616|10954136|FG001|STARTED|Overall Study||34
9842436|NCT00824616|10954135|FG000|COMPLETED|Overall Study||28
9842437|NCT00824616|10954136|FG001|COMPLETED|Overall Study||27
9842438|NCT00824616|10954135|FG000|NOT COMPLETED|Overall Study||6
9842439|NCT00824616|10954136|FG001|NOT COMPLETED|Overall Study||7
9842440|NCT00824655|10954144|FG000|STARTED|Infant Series (5 Months of Age)||118
9960240|NCT01467063|11079898|FG000|NOT COMPLETED|Overall Study||1
9960241|NCT01467063|11079899|FG001|NOT COMPLETED|Overall Study||0
9960242|NCT01467076|11079908|FG000|STARTED|Overall Study||3
9960243|NCT01467076|11079909|FG001|STARTED|Overall Study||2
9960244|NCT01467076|11079910|FG002|STARTED|Overall Study||2
9960245|NCT01467076|11079908|FG000|COMPLETED|Overall Study||2
9960246|NCT01467076|11079909|FG001|COMPLETED|Overall Study||2
9960247|NCT01467076|11079910|FG002|COMPLETED|Overall Study||2
9960248|NCT01467076|11079908|FG000|NOT COMPLETED|Overall Study||1
9960249|NCT01467076|11079909|FG001|NOT COMPLETED|Overall Study||0
9960250|NCT01467076|11079910|FG002|NOT COMPLETED|Overall Study||0
9960251|NCT01467271|11079918|FG000|STARTED|Overall Study||540
9960252|NCT01467271|11079918|FG000|COMPLETED|Overall Study||338
9960253|NCT01467271|11079918|FG000|NOT COMPLETED|Overall Study||202
9960254|NCT01467427|11079924|FG000|STARTED|Overall Study||12
9960255|NCT01467427|11079925|FG001|STARTED|Overall Study||13
9960256|NCT01467427|11079924|FG000|Completed Main Phase|Overall Study||11
9960257|NCT01467427|11079925|FG001|Completed Main Phase|Overall Study||13
9960258|NCT01467427|11079924|FG000|COMPLETED|Overall Study||0
9960259|NCT01467427|11079925|FG001|COMPLETED|Overall Study||0
9960260|NCT01467427|11079924|FG000|NOT COMPLETED|Overall Study||12
10022681|NCT01852058|11146184|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10081145|NCT02258074|11209600|FG000|COMPLETED|Overall Study||52
9723883|NCT00086281|10823603|FG009|STARTED|Phase 2||0
9723884|NCT00086281|10823604|FG010|STARTED|Phase 2||0
9723885|NCT00086281|10823605|FG011|STARTED|Phase 2||0
9723886|NCT00086281|10823606|FG012|STARTED|Phase 2||23
9723887|NCT00086281|10823607|FG013|STARTED|Phase 2||27
9723888|NCT00086281|10823608|FG014|STARTED|Phase 2||0
9723889|NCT00086281|10823594|FG000|COMPLETED|Phase 2||0
9723890|NCT00086281|10823595|FG001|COMPLETED|Phase 2||0
9723891|NCT00086281|10823596|FG002|COMPLETED|Phase 2||0
9723892|NCT00086281|10823597|FG003|COMPLETED|Phase 2||0
9723893|NCT00086281|10823598|FG004|COMPLETED|Phase 2||0
9723894|NCT00086281|10823599|FG005|COMPLETED|Phase 2||0
9723895|NCT00086281|10823600|FG006|COMPLETED|Phase 2||0
9723896|NCT00086281|10823601|FG007|COMPLETED|Phase 2||0
9723897|NCT00086281|10823602|FG008|COMPLETED|Phase 2||0
9723898|NCT00086281|10823603|FG009|COMPLETED|Phase 2||0
9723899|NCT00086281|10823604|FG010|COMPLETED|Phase 2||0
9723900|NCT00086281|10823605|FG011|COMPLETED|Phase 2||0
9723901|NCT00086281|10823606|FG012|COMPLETED|Phase 2||22
9723902|NCT00086281|10823607|FG013|COMPLETED|Phase 2||26
9723903|NCT00086281|10823608|FG014|COMPLETED|Phase 2||0
9723904|NCT00086281|10823594|FG000|NOT COMPLETED|Phase 2||0
9723905|NCT00086281|10823595|FG001|NOT COMPLETED|Phase 2||0
9723906|NCT00086281|10823596|FG002|NOT COMPLETED|Phase 2||0
9723907|NCT00086281|10823597|FG003|NOT COMPLETED|Phase 2||0
9723908|NCT00086281|10823598|FG004|NOT COMPLETED|Phase 2||0
9723909|NCT00086281|10823599|FG005|NOT COMPLETED|Phase 2||0
9723910|NCT00086281|10823600|FG006|NOT COMPLETED|Phase 2||0
9723911|NCT00086281|10823601|FG007|NOT COMPLETED|Phase 2||0
9723912|NCT00086281|10823602|FG008|NOT COMPLETED|Phase 2||0
9723913|NCT00086281|10823603|FG009|NOT COMPLETED|Phase 2||0
9723914|NCT00086281|10823604|FG010|NOT COMPLETED|Phase 2||0
9723915|NCT00086281|10823605|FG011|NOT COMPLETED|Phase 2||0
9723916|NCT00086281|10823606|FG012|NOT COMPLETED|Phase 2||1
9723917|NCT00086281|10823607|FG013|NOT COMPLETED|Phase 2||1
9723918|NCT00086281|10823608|FG014|NOT COMPLETED|Phase 2||0
9723919|NCT00086307|10823621|FG000|STARTED|Overall Study||13
9723920|NCT00086307|10823622|FG001|STARTED|Overall Study||13
9723921|NCT00086307|10823623|FG002|STARTED|Overall Study||13
9723922|NCT00086307|10823621|FG000|COMPLETED|Overall Study||11
9723923|NCT00086307|10823622|FG001|COMPLETED|Overall Study||12
9723924|NCT00086307|10823623|FG002|COMPLETED|Overall Study||5
9723925|NCT00086307|10823621|FG000|NOT COMPLETED|Overall Study||2
9723926|NCT00086307|10823622|FG001|NOT COMPLETED|Overall Study||1
9723927|NCT00086307|10823623|FG002|NOT COMPLETED|Overall Study||8
9723928|NCT00086346|10823633|FG000|STARTED|Randomization||393
9723929|NCT00086346|10823634|FG001|STARTED|Randomization||214
9723930|NCT00086346|10823633|FG000|COMPLETED|Randomization||389
9723931|NCT00086346|10823634|FG001|COMPLETED|Randomization||210
9723932|NCT00086346|10823633|FG000|NOT COMPLETED|Randomization||4
9723933|NCT00086346|10823634|FG001|NOT COMPLETED|Randomization||4
9723934|NCT00086346|10823633|FG000|STARTED|Patients Dosed With Test Article||389
9723935|NCT00086346|10823634|FG001|STARTED|Patients Dosed With Test Article||210
9723936|NCT00086346|10823633|FG000|COMPLETED|Patients Dosed With Test Article||249
9723937|NCT00086346|10823634|FG001|COMPLETED|Patients Dosed With Test Article||187
9723938|NCT00086346|10823633|FG000|NOT COMPLETED|Patients Dosed With Test Article||140
9723939|NCT00086346|10823634|FG001|NOT COMPLETED|Patients Dosed With Test Article||23
9723940|NCT00086385|10823644|FG000|STARTED|Overall Study||100
9723941|NCT00086385|10823645|FG001|STARTED|Overall Study||99
9723942|NCT00086385|10823646|FG002|STARTED|Overall Study||104
9723943|NCT00086385|10823647|FG003|STARTED|Overall Study||99
9723944|NCT00086385|10823644|FG000|COMPLETED|Overall Study||98
9723945|NCT00086385|10823645|FG001|COMPLETED|Overall Study||97
9723946|NCT00086385|10823646|FG002|COMPLETED|Overall Study||103
9723947|NCT00086385|10823647|FG003|COMPLETED|Overall Study||98
9723948|NCT00086385|10823644|FG000|NOT COMPLETED|Overall Study||2
9723949|NCT00086385|10823645|FG001|NOT COMPLETED|Overall Study||2
9723950|NCT00086385|10823646|FG002|NOT COMPLETED|Overall Study||1
9723951|NCT00086385|10823647|FG003|NOT COMPLETED|Overall Study||1
9723952|NCT00086411|10823661|FG000|STARTED|Overall Study||70
9723953|NCT00086411|10823662|FG001|STARTED|Overall Study||63
9723954|NCT00086411|10823663|FG002|STARTED|Overall Study||62
9723955|NCT00086411|10823664|FG003|STARTED|Overall Study||65
9723956|NCT00086411|10823661|FG000|COMPLETED|Overall Study||59
9723957|NCT00086411|10823662|FG001|COMPLETED|Overall Study||52
9723958|NCT00086411|10823663|FG002|COMPLETED|Overall Study||49
9723959|NCT00086411|10823664|FG003|COMPLETED|Overall Study||53
9723960|NCT00086411|10823661|FG000|NOT COMPLETED|Overall Study||11
9723961|NCT00086411|10823662|FG001|NOT COMPLETED|Overall Study||11
9723962|NCT00086411|10823663|FG002|NOT COMPLETED|Overall Study||13
9723963|NCT00086411|10823664|FG003|NOT COMPLETED|Overall Study||12
9723964|NCT00086450|10823677|FG000|STARTED|Overall Study||953
10114216|NCT02514746|11244927|FG000|NOT COMPLETED|Overall Study||22
10114217|NCT02514746|11244928|FG001|NOT COMPLETED|Overall Study||15
10114218|NCT02514772|11244938|FG000|STARTED|Overall Study||53
10114219|NCT02514772|11244939|FG001|STARTED|Overall Study||54
10114220|NCT02514772|11244938|FG000|COMPLETED|Overall Study||50
10114221|NCT02514772|11244939|FG001|COMPLETED|Overall Study||52
9723965|NCT00086450|10823678|FG001|STARTED|Overall Study||947
9723966|NCT00086450|10823677|FG000|COMPLETED|Overall Study||953
9723967|NCT00086450|10823678|FG001|COMPLETED|Overall Study||947
9723968|NCT00086450|10823677|FG000|NOT COMPLETED|Overall Study||0
9723969|NCT00086450|10823678|FG001|NOT COMPLETED|Overall Study||0
9723970|NCT00086502|10823686|FG000|STARTED|Overall Study||175
9723971|NCT00086502|10823687|FG001|STARTED|Overall Study||178
9723972|NCT00086502|10823686|FG000|COMPLETED|Overall Study||149
10114222|NCT02514772|11244938|FG000|NOT COMPLETED|Overall Study||3
9723973|NCT00086502|10823687|FG001|COMPLETED|Overall Study||158
9677338|NCT04884191|10776538|FG000|STARTED|Overall Study||55
9677339|NCT04884191|10776539|FG001|STARTED|Overall Study||55
9677340|NCT04884191|10776540|FG002|STARTED|Overall Study||55
9677341|NCT04884191|10776538|FG000|COMPLETED|Overall Study||52
9677342|NCT04884191|10776539|FG001|COMPLETED|Overall Study||55
9677343|NCT04884191|10776540|FG002|COMPLETED|Overall Study||54
9677344|NCT04884191|10776538|FG000|NOT COMPLETED|Overall Study||3
9677345|NCT04884191|10776539|FG001|NOT COMPLETED|Overall Study||0
9677346|NCT04884191|10776540|FG002|NOT COMPLETED|Overall Study||1
9677347|NCT04881175|10776548|FG000|STARTED|Overall Study||3
9677348|NCT04881175|10776548|FG000|COMPLETED|Overall Study||3
9677349|NCT04881175|10776548|FG000|NOT COMPLETED|Overall Study||0
9677350|NCT04881149|10776552|FG000|STARTED|Overall Study||7
9677351|NCT04881149|10776552|FG000|Control Biopsy|Overall Study||7
9677352|NCT04881149|10776552|FG000|Treatment Biopsy|Overall Study||7
9677353|NCT04881149|10776552|FG000|COMPLETED|Overall Study||7
9677354|NCT04881149|10776552|FG000|NOT COMPLETED|Overall Study||0
9677355|NCT04600076|10776557|FG000|STARTED|Overall Study||22
9677356|NCT04600076|10776557|FG000|COMPLETED|Overall Study||19
9677357|NCT04600076|10776557|FG000|NOT COMPLETED|Overall Study||3
9677358|NCT04375397|10776563|FG000|STARTED|Overall Study||22
9677359|NCT04375397|10776564|FG001|STARTED|Overall Study||24
9677360|NCT04375397|10776563|FG000|COMPLETED|Overall Study||13
9677361|NCT04375397|10776564|FG001|COMPLETED|Overall Study||18
9677362|NCT04375397|10776563|FG000|NOT COMPLETED|Overall Study||9
9677363|NCT04375397|10776564|FG001|NOT COMPLETED|Overall Study||6
9842441|NCT00824655|10954145|FG001|STARTED|Infant Series (5 Months of Age)||0
9842442|NCT00824655|10954144|FG000|COMPLETED|Infant Series (5 Months of Age)||118
9677367|NCT04327518|10776574|FG000|STARTED|Overall Study||125
9677368|NCT04327518|10776574|FG000|COMPLETED|Overall Study||124
9677369|NCT04327518|10776574|FG000|NOT COMPLETED|Overall Study||1
9677370|NCT04273737|10776578|FG000|STARTED|Overall Study||11
9677371|NCT04273737|10776578|FG000|COMPLETED|Overall Study||11
9677372|NCT04273737|10776578|FG000|NOT COMPLETED|Overall Study||0
9677373|NCT04267276|10776582|FG000|STARTED|Overall Study||7
9677374|NCT04267276|10776582|FG000|Treated|Overall Study||7
9677375|NCT04267276|10776582|FG000|COMPLETED|Overall Study||7
9677376|NCT04267276|10776582|FG000|NOT COMPLETED|Overall Study||0
9677377|NCT04255381|10776586|FG000|STARTED|Overall Study||20
9677378|NCT04255381|10776586|FG000|COMPLETED|Overall Study||20
9677379|NCT04255381|10776586|FG000|NOT COMPLETED|Overall Study||0
9677380|NCT04075734|10776593|FG000|STARTED|Overall Study||25
9677381|NCT04075734|10776594|FG001|STARTED|Overall Study||25
9677382|NCT04075734|10776595|FG002|STARTED|Overall Study||10
9677383|NCT04075734|10776593|FG000|COMPLETED|Overall Study||21
9677384|NCT04075734|10776594|FG001|COMPLETED|Overall Study||24
9677385|NCT04075734|10776595|FG002|COMPLETED|Overall Study||10
9677386|NCT04075734|10776593|FG000|NOT COMPLETED|Overall Study||4
9677387|NCT04075734|10776594|FG001|NOT COMPLETED|Overall Study||1
9677388|NCT04075734|10776595|FG002|NOT COMPLETED|Overall Study||0
9677389|NCT04064684|10776606|FG000|STARTED|Overall Study||1
9677390|NCT04064684|10776607|FG001|STARTED|Overall Study||1
9677391|NCT04064684|10776606|FG000|COMPLETED|Overall Study||1
9677392|NCT04064684|10776607|FG001|COMPLETED|Overall Study||1
9677393|NCT04064684|10776606|FG000|NOT COMPLETED|Overall Study||0
9677394|NCT04064684|10776607|FG001|NOT COMPLETED|Overall Study||0
9677395|NCT04048343|10776613|FG000|STARTED|Overall Study||65
9677396|NCT04048343|10776613|FG000|COMPLETED|Overall Study||65
9677397|NCT04048343|10776613|FG000|NOT COMPLETED|Overall Study||0
9677398|NCT04019561|10776620|FG000|STARTED|Overall Study||25
9677399|NCT04019561|10776621|FG001|STARTED|Overall Study||25
9677400|NCT04019561|10776622|FG002|STARTED|Overall Study||24
9677401|NCT04019561|10776620|FG000|COMPLETED|Overall Study||21
9677402|NCT04019561|10776621|FG001|COMPLETED|Overall Study||23
9677403|NCT04019561|10776622|FG002|COMPLETED|Overall Study||19
9677404|NCT04019561|10776620|FG000|NOT COMPLETED|Overall Study||4
9677405|NCT04019561|10776621|FG001|NOT COMPLETED|Overall Study||2
9677406|NCT04019561|10776622|FG002|NOT COMPLETED|Overall Study||5
9677407|NCT03915470|10776632|FG000|STARTED|Overall Study||63
9677408|NCT03915470|10776633|FG001|STARTED|Overall Study||61
9677409|NCT03915470|10776632|FG000|COMPLETED|Overall Study|63 - 6 (discontinued intervention)|57
9677410|NCT03915470|10776633|FG001|COMPLETED|Overall Study|61-2 (discontinued intervention)|59
9677411|NCT03915470|10776632|FG000|NOT COMPLETED|Overall Study||6
9677412|NCT03915470|10776633|FG001|NOT COMPLETED|Overall Study||2
9677413|NCT03892642|10776639|FG000|STARTED|Overall Study||18
9677414|NCT03892642|10776639|FG000|COMPLETED|Overall Study||18
9677415|NCT03892642|10776639|FG000|NOT COMPLETED|Overall Study||0
9677416|NCT03881553|10776646|FG000|STARTED|Overall Study||11
9677417|NCT03881553|10776647|FG001|STARTED|Overall Study||2
9677418|NCT03881553|10776648|FG002|STARTED|Overall Study||4
9677419|NCT03881553|10776646|FG000|COMPLETED|Overall Study||10
9677420|NCT03881553|10776647|FG001|COMPLETED|Overall Study||1
9677421|NCT03881553|10776648|FG002|COMPLETED|Overall Study||3
9677422|NCT03881553|10776646|FG000|NOT COMPLETED|Overall Study||1
9677423|NCT03881553|10776647|FG001|NOT COMPLETED|Overall Study||1
9677424|NCT03881553|10776648|FG002|NOT COMPLETED|Overall Study||1
9677425|NCT03874325|10776656|FG000|STARTED|Overall Study||17
9677426|NCT03874325|10776657|FG001|STARTED|Overall Study||0
9677427|NCT03874325|10776656|FG000|COMPLETED|Overall Study||17
9677428|NCT03874325|10776657|FG001|COMPLETED|Overall Study||0
9677429|NCT03874325|10776656|FG000|NOT COMPLETED|Overall Study||0
9677430|NCT03874325|10776657|FG001|NOT COMPLETED|Overall Study||0
9677431|NCT03861611|10776664|FG000|STARTED|Overall Study||66
9677432|NCT03861611|10776665|FG001|STARTED|Overall Study||66
9677433|NCT03861611|10776666|FG002|STARTED|Overall Study||66
9677434|NCT03861611|10776664|FG000|COMPLETED|Overall Study||59
9677435|NCT03861611|10776665|FG001|COMPLETED|Overall Study||61
9677436|NCT03861611|10776666|FG002|COMPLETED|Overall Study||62
9677437|NCT03861611|10776664|FG000|NOT COMPLETED|Overall Study||7
9677438|NCT03861611|10776665|FG001|NOT COMPLETED|Overall Study||5
9677439|NCT03861611|10776666|FG002|NOT COMPLETED|Overall Study||4
9677440|NCT03860311|10776679|FG000|STARTED|Overall Study||22
9677441|NCT03860311|10776680|FG001|STARTED|Overall Study||23
9677442|NCT03860311|10776679|FG000|COMPLETED|Overall Study||22
9677443|NCT03860311|10776680|FG001|COMPLETED|Overall Study||23
9677444|NCT03860311|10776679|FG000|NOT COMPLETED|Overall Study||0
9677445|NCT03860311|10776680|FG001|NOT COMPLETED|Overall Study||0
9723974|NCT00086502|10823686|FG000|NOT COMPLETED|Overall Study||26
9723975|NCT00086502|10823687|FG001|NOT COMPLETED|Overall Study||20
9723976|NCT00086515|10823695|FG000|STARTED|Phase A (Weeks 0-24)||464
9723977|NCT00086515|10823696|FG001|STARTED|Phase A (Weeks 0-24)||237
9723978|NCT00086515|10823695|FG000|COMPLETED|Phase A (Weeks 0-24)||415
9723979|NCT00086515|10823696|FG001|COMPLETED|Phase A (Weeks 0-24)||192
9723980|NCT00086515|10823695|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49
9723981|NCT00086515|10823696|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45
9723982|NCT00086515|10823695|FG000|STARTED|Phase A to Phase B Transition Period||415
9723983|NCT00086515|10823696|FG001|STARTED|Phase A to Phase B Transition Period||192
9723984|NCT00086515|10823695|FG000|COMPLETED|Phase A to Phase B Transition Period||391
9723985|NCT00086515|10823696|FG001|COMPLETED|Phase A to Phase B Transition Period||164
9723986|NCT00086515|10823695|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24
9723987|NCT00086515|10823696|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28
9842443|NCT00824655|10954145|FG001|COMPLETED|Infant Series (5 Months of Age)||0
9842444|NCT00824655|10954144|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0
9842445|NCT00824655|10954145|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0
9842446|NCT00824655|10954144|FG000|STARTED|After Infant Dose (6 Months of Age)||118
9842447|NCT00824655|10954145|FG001|STARTED|After Infant Dose (6 Months of Age)||0
9842448|NCT00824655|10954144|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118
9842449|NCT00824655|10954145|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0
9842450|NCT00824655|10954144|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
9842451|NCT00824655|10954145|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
9842452|NCT00824655|10954144|FG000|STARTED|Toddler Dose (12 Months of Age)||118
9842453|NCT00824655|10954145|FG001|STARTED|Toddler Dose (12 Months of Age)||116
9842454|NCT00824655|10954144|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116
9842455|NCT00824655|10954145|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116
9842456|NCT00824655|10954144|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
9842457|NCT00824655|10954145|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
9842458|NCT00824720|10954156|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
9842459|NCT00824720|10954157|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
9842460|NCT00824720|10954158|FG002|STARTED|Overall Study||20
9842461|NCT00824720|10954156|FG000|COMPLETED|Overall Study||16
9842462|NCT00824720|10954157|FG001|COMPLETED|Overall Study||15
9842463|NCT00824720|10954158|FG002|COMPLETED|Overall Study||19
9842464|NCT00824720|10954156|FG000|NOT COMPLETED|Overall Study||3
9842465|NCT00824720|10954157|FG001|NOT COMPLETED|Overall Study||1
9842466|NCT00824720|10954158|FG002|NOT COMPLETED|Overall Study||1
9842467|NCT00824733|10954166|FG000|STARTED|Overall Study||6
9842468|NCT00824733|10954166|FG000|COMPLETED|Overall Study||6
9842469|NCT00824733|10954166|FG000|NOT COMPLETED|Overall Study||0
9842470|NCT00824746|10954170|FG000|STARTED|Overall Study||23
9842471|NCT00824746|10954170|FG000|COMPLETED|Overall Study||23
9842472|NCT00824746|10954170|FG000|NOT COMPLETED|Overall Study||0
9723988|NCT00086515|10823695|FG000|STARTED|Phase B (Weeks 24-104)||391
9723989|NCT00086515|10823696|FG001|STARTED|Phase B (Weeks 24-104)||164
9677446|NCT03795116|10776689|FG000|STARTED|Overall Study||10
9677447|NCT03795116|10776690|FG001|STARTED|Overall Study||10
9677448|NCT03795116|10776691|FG002|STARTED|Overall Study||10
9677449|NCT03795116|10776692|FG003|STARTED|Overall Study||10
9677450|NCT03795116|10776693|FG004|STARTED|Overall Study||10
9677451|NCT03795116|10776694|FG005|STARTED|Overall Study||10
9677452|NCT03795116|10776689|FG000|COMPLETED|Overall Study||6
9677453|NCT03795116|10776690|FG001|COMPLETED|Overall Study||6
9677454|NCT03795116|10776691|FG002|COMPLETED|Overall Study||9
9677455|NCT03795116|10776692|FG003|COMPLETED|Overall Study||9
9677456|NCT03795116|10776693|FG004|COMPLETED|Overall Study||9
9677457|NCT03795116|10776694|FG005|COMPLETED|Overall Study||9
9677458|NCT03795116|10776689|FG000|NOT COMPLETED|Overall Study||4
9677459|NCT03795116|10776690|FG001|NOT COMPLETED|Overall Study||4
9677460|NCT03795116|10776691|FG002|NOT COMPLETED|Overall Study||1
9677461|NCT03795116|10776692|FG003|NOT COMPLETED|Overall Study||1
9677462|NCT03795116|10776693|FG004|NOT COMPLETED|Overall Study||1
9677463|NCT03795116|10776694|FG005|NOT COMPLETED|Overall Study||1
9677464|NCT03750292|10776715|FG000|STARTED|First Intervention (Baseline to 8 Weeks)||5
9677465|NCT03750292|10776716|FG001|STARTED|First Intervention (Baseline to 8 Weeks)||4
9677466|NCT03750292|10776715|FG000|COMPLETED|First Intervention (Baseline to 8 Weeks)||5
9677467|NCT03750292|10776716|FG001|COMPLETED|First Intervention (Baseline to 8 Weeks)||4
9677468|NCT03750292|10776715|FG000|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0
9677469|NCT03750292|10776716|FG001|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0
9677470|NCT03750292|10776715|FG000|STARTED|Washout (3 Weeks)||5
9677471|NCT03750292|10776716|FG001|STARTED|Washout (3 Weeks)||4
9677472|NCT03750292|10776715|FG000|COMPLETED|Washout (3 Weeks)||5
9677473|NCT03750292|10776716|FG001|COMPLETED|Washout (3 Weeks)||4
9677474|NCT03750292|10776715|FG000|NOT COMPLETED|Washout (3 Weeks)||0
9677475|NCT03750292|10776716|FG001|NOT COMPLETED|Washout (3 Weeks)||0
9677476|NCT03750292|10776715|FG000|STARTED|Second Intervention (11 to 19 Weeks)||5
9677477|NCT03750292|10776716|FG001|STARTED|Second Intervention (11 to 19 Weeks)||4
9677478|NCT03750292|10776715|FG000|COMPLETED|Second Intervention (11 to 19 Weeks)||5
9677479|NCT03750292|10776716|FG001|COMPLETED|Second Intervention (11 to 19 Weeks)||4
9677480|NCT03750292|10776715|FG000|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0
9677481|NCT03750292|10776716|FG001|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0
9677482|NCT03749252|10776725|FG000|STARTED|Overall Study||26
9677483|NCT03749252|10776726|FG001|STARTED|Overall Study||23
9677484|NCT03749252|10776727|FG002|STARTED|Overall Study||31
9677485|NCT03749252|10776725|FG000|COMPLETED|Overall Study||26
9677486|NCT03749252|10776726|FG001|COMPLETED|Overall Study||23
9677487|NCT03749252|10776727|FG002|COMPLETED|Overall Study||31
9677488|NCT03749252|10776725|FG000|NOT COMPLETED|Overall Study||0
9677489|NCT03749252|10776726|FG001|NOT COMPLETED|Overall Study||0
9677490|NCT03749252|10776727|FG002|NOT COMPLETED|Overall Study||0
9677491|NCT03718000|10776737|FG000|STARTED|Overall Study||55
9677492|NCT03718000|10776738|FG001|STARTED|Overall Study||56
9677493|NCT03718000|10776737|FG000|COMPLETED|Overall Study||53
9677494|NCT03718000|10776738|FG001|COMPLETED|Overall Study||51
9677495|NCT03718000|10776737|FG000|NOT COMPLETED|Overall Study||2
9677496|NCT03718000|10776738|FG001|NOT COMPLETED|Overall Study||5
9677497|NCT03703466|10776748|FG000|STARTED|Overall Study||24
9677498|NCT03703466|10776749|FG001|STARTED|Overall Study||24
9677499|NCT03703466|10776750|FG002|STARTED|Overall Study||24
9677500|NCT03703466|10776748|FG000|Received at Least One Dose of Study Drug|Overall Study||24
9677501|NCT03703466|10776749|FG001|Received at Least One Dose of Study Drug|Overall Study||23
9677502|NCT03703466|10776750|FG002|Received at Least One Dose of Study Drug|Overall Study||24
9677503|NCT03703466|10776748|FG000|COMPLETED|Overall Study||20
9677504|NCT03703466|10776749|FG001|COMPLETED|Overall Study||18
9677505|NCT03703466|10776750|FG002|COMPLETED|Overall Study||22
9677506|NCT03703466|10776748|FG000|NOT COMPLETED|Overall Study||4
9677507|NCT03703466|10776749|FG001|NOT COMPLETED|Overall Study||6
9677508|NCT03703466|10776750|FG002|NOT COMPLETED|Overall Study||2
9842473|NCT00824772|10954176|FG000|STARTED|Overall Study||204
9677509|NCT03700047|10776762|FG000|STARTED|Overall Study||142
9677510|NCT03700047|10776763|FG001|STARTED|Overall Study||60
9677511|NCT03700047|10776764|FG002|STARTED|Overall Study||68
9677512|NCT03700047|10776762|FG000|COMPLETED|Overall Study||126
9677513|NCT03700047|10776763|FG001|COMPLETED|Overall Study||50
9677514|NCT03700047|10776764|FG002|COMPLETED|Overall Study||58
9677515|NCT03700047|10776762|FG000|NOT COMPLETED|Overall Study||16
9677516|NCT03700047|10776763|FG001|NOT COMPLETED|Overall Study||10
9677517|NCT03700047|10776764|FG002|NOT COMPLETED|Overall Study||10
9677518|NCT03698409|10776774|FG000|STARTED|Overall Study||39
9677519|NCT03698409|10776775|FG001|STARTED|Overall Study||29
9677520|NCT03698409|10776774|FG000|COMPLETED|Overall Study||39
9677521|NCT03698409|10776775|FG001|COMPLETED|Overall Study||29
9677522|NCT03698409|10776774|FG000|NOT COMPLETED|Overall Study||0
9677523|NCT03698409|10776775|FG001|NOT COMPLETED|Overall Study||0
9677524|NCT03654651|10776783|FG000|STARTED|First Intervention (6 Weeks)||26
9677525|NCT03654651|10776784|FG001|STARTED|First Intervention (6 Weeks)||25
9677526|NCT03654651|10776783|FG000|COMPLETED|First Intervention (6 Weeks)||25
9677527|NCT03654651|10776784|FG001|COMPLETED|First Intervention (6 Weeks)||25
9677528|NCT03654651|10776783|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
9677529|NCT03654651|10776784|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10022682|NCT01852058|11146185|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022683|NCT01852058|11146186|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022684|NCT01852058|11146187|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022685|NCT01852058|11146176|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022686|NCT01852058|11146177|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022687|NCT01852058|11146178|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
9677530|NCT03654651|10776783|FG000|STARTED|Washout Period (2-weeks)||25
10022688|NCT01852058|11146179|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
10022689|NCT01852058|11146180|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
9677531|NCT03654651|10776784|FG001|STARTED|Washout Period (2-weeks)||25
9677532|NCT03654651|10776783|FG000|COMPLETED|Washout Period (2-weeks)||25
9677533|NCT03654651|10776784|FG001|COMPLETED|Washout Period (2-weeks)||25
9677534|NCT03654651|10776783|FG000|NOT COMPLETED|Washout Period (2-weeks)||0
9677535|NCT03654651|10776784|FG001|NOT COMPLETED|Washout Period (2-weeks)||0
9677536|NCT03654651|10776783|FG000|STARTED|Second Intervention (6 Weeks)||25
9677537|NCT03654651|10776784|FG001|STARTED|Second Intervention (6 Weeks)||25
9677538|NCT03654651|10776783|FG000|COMPLETED|Second Intervention (6 Weeks)||25
9677539|NCT03654651|10776784|FG001|COMPLETED|Second Intervention (6 Weeks)||25
9677540|NCT03654651|10776783|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9677541|NCT03654651|10776784|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9677542|NCT03633396|10776793|FG000|STARTED|Overall Study||29
9677543|NCT03633396|10776794|FG001|STARTED|Overall Study||30
9677544|NCT03633396|10776793|FG000|COMPLETED|Overall Study||23
9677545|NCT03633396|10776794|FG001|COMPLETED|Overall Study||24
9677546|NCT03633396|10776793|FG000|NOT COMPLETED|Overall Study||6
9677547|NCT03633396|10776794|FG001|NOT COMPLETED|Overall Study||6
9677548|NCT03612856|10776803|FG000|STARTED|Pre-dose Period||8
9677549|NCT03612856|10776804|FG001|STARTED|Pre-dose Period||10
9677550|NCT03612856|10776805|FG002|STARTED|Pre-dose Period||9
9677551|NCT03612856|10776803|FG000|COMPLETED|Pre-dose Period||8
9677552|NCT03612856|10776804|FG001|COMPLETED|Pre-dose Period||8
9677553|NCT03612856|10776805|FG002|COMPLETED|Pre-dose Period||8
9677554|NCT03612856|10776803|FG000|NOT COMPLETED|Pre-dose Period||0
9677555|NCT03612856|10776804|FG001|NOT COMPLETED|Pre-dose Period||2
9677556|NCT03612856|10776805|FG002|NOT COMPLETED|Pre-dose Period||1
9677557|NCT03612856|10776803|FG000|STARTED|Post-dose Period||8
9677558|NCT03612856|10776804|FG001|STARTED|Post-dose Period||8
9677559|NCT03612856|10776805|FG002|STARTED|Post-dose Period||8
9677560|NCT03612856|10776803|FG000|COMPLETED|Post-dose Period||8
9677561|NCT03612856|10776804|FG001|COMPLETED|Post-dose Period||8
9677562|NCT03612856|10776805|FG002|COMPLETED|Post-dose Period||8
9677563|NCT03612856|10776803|FG000|NOT COMPLETED|Post-dose Period||0
10022690|NCT01852058|11146181|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
10022691|NCT01852058|11146182|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022692|NCT01852058|11146183|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022693|NCT01852058|11146184|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022694|NCT01852058|11146185|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022695|NCT01852058|11146186|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022696|NCT01852058|11146187|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10022697|NCT01852058|11146176|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022698|NCT01852058|11146177|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022699|NCT01852058|11146178|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022700|NCT01852058|11146179|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022701|NCT01852058|11146180|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022702|NCT01852058|11146181|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022703|NCT01852058|11146182|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
10022704|NCT01852058|11146183|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
10022705|NCT01852058|11146184|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
10022706|NCT01852058|11146185|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022707|NCT01852058|11146186|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022708|NCT01852058|11146187|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10022709|NCT01852058|11146176|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10081146|NCT02258074|11209601|FG001|COMPLETED|Overall Study||50
9677564|NCT03612856|10776804|FG001|NOT COMPLETED|Post-dose Period||0
9677565|NCT03612856|10776805|FG002|NOT COMPLETED|Post-dose Period||0
9677566|NCT03607994|10776815|FG000|STARTED|Overall Study||10
9677567|NCT03607994|10776816|FG001|STARTED|Overall Study||12
9677568|NCT03607994|10776815|FG000|COMPLETED|Overall Study||9
9677569|NCT03607994|10776816|FG001|COMPLETED|Overall Study||11
9677570|NCT03607994|10776815|FG000|NOT COMPLETED|Overall Study||1
9677571|NCT03607994|10776816|FG001|NOT COMPLETED|Overall Study||1
9677572|NCT03602560|10776825|FG000|STARTED|Overall Study||89
10022710|NCT01852058|11146177|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022711|NCT01852058|11146178|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022712|NCT01852058|11146179|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022713|NCT01852058|11146180|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022714|NCT01852058|11146181|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022715|NCT01852058|11146182|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
10022716|NCT01852058|11146183|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
10022717|NCT01852058|11146184|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
10022718|NCT01852058|11146185|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022719|NCT01852058|11146186|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022720|NCT01852058|11146187|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022721|NCT01852058|11146176|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022722|NCT01852058|11146177|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022723|NCT01852058|11146178|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022724|NCT01852058|11146179|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022725|NCT01852058|11146180|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022726|NCT01852058|11146181|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022727|NCT01852058|11146182|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022728|NCT01852058|11146183|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
10022729|NCT01852058|11146184|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
10022730|NCT01852058|11146185|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022731|NCT01852058|11146186|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022732|NCT01852058|11146187|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10022733|NCT01852058|11146176|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022734|NCT01852058|11146177|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022735|NCT01852058|11146178|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022736|NCT01852058|11146179|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022737|NCT01852058|11146180|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022738|NCT01852058|11146181|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022739|NCT01852058|11146182|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022740|NCT01852058|11146183|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022741|NCT01852058|11146184|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10022742|NCT01852058|11146185|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
10022743|NCT01852058|11146186|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
10022744|NCT01852058|11146187|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
10022745|NCT01852058|11146176|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022746|NCT01852058|11146177|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022747|NCT01852058|11146178|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022748|NCT01852058|11146179|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022749|NCT01852058|11146180|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022750|NCT01852058|11146181|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022751|NCT01852058|11146182|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022752|NCT01852058|11146183|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022753|NCT01852058|11146184|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022754|NCT01852058|11146185|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
10022755|NCT01852058|11146186|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
10022756|NCT01852058|11146187|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
10022757|NCT01852058|11146176|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022758|NCT01852058|11146177|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022759|NCT01852058|11146178|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022760|NCT01852058|11146179|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022761|NCT01852058|11146180|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022762|NCT01852058|11146181|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022763|NCT01852058|11146182|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022764|NCT01852058|11146183|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022765|NCT01852058|11146184|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022766|NCT01852058|11146185|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022767|NCT01852058|11146186|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022768|NCT01852058|11146187|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10022769|NCT01852071|11146224|FG000|STARTED|Overall Study||20
10022770|NCT01852071|11146225|FG001|STARTED|Overall Study||26
10022771|NCT01852071|11146224|FG000|COMPLETED|Overall Study||20
10022772|NCT01852071|11146225|FG001|COMPLETED|Overall Study||26
10022773|NCT01852071|11146224|FG000|NOT COMPLETED|Overall Study||0
10114223|NCT02514772|11244939|FG001|NOT COMPLETED|Overall Study||2
10022774|NCT01852071|11146225|FG001|NOT COMPLETED|Overall Study||0
10022775|NCT01852084|11146241|FG000|STARTED|Overall Study||79
10022776|NCT01852084|11146242|FG001|STARTED|Overall Study||80
10022777|NCT01852084|11146243|FG002|STARTED|Overall Study||20
10022778|NCT01852084|11146244|FG003|STARTED|Overall Study||12
10022779|NCT01852084|11146241|FG000|COMPLETED|Overall Study||79
10022780|NCT01852084|11146242|FG001|COMPLETED|Overall Study||80
10022781|NCT01852084|11146243|FG002|COMPLETED|Overall Study||18
10022782|NCT01852084|11146244|FG003|COMPLETED|Overall Study||12
9677573|NCT03602560|10776826|FG001|STARTED|Overall Study||89
9677574|NCT03602560|10776827|FG002|STARTED|Overall Study||87
9677575|NCT03602560|10776825|FG000|COMPLETED|Overall Study||1
9677576|NCT03602560|10776826|FG001|COMPLETED|Overall Study||1
9677577|NCT03602560|10776827|FG002|COMPLETED|Overall Study||1
9677578|NCT03602560|10776825|FG000|NOT COMPLETED|Overall Study||88
9677579|NCT03602560|10776826|FG001|NOT COMPLETED|Overall Study||88
9677580|NCT03602560|10776827|FG002|NOT COMPLETED|Overall Study||86
9677581|NCT03589469|10776835|FG000|STARTED|Overall Study||145
9677582|NCT03589469|10776835|FG000|Received Treatment|Overall Study||145
10022783|NCT01852084|11146241|FG000|NOT COMPLETED|Overall Study||0
10022784|NCT01852084|11146242|FG001|NOT COMPLETED|Overall Study||0
10022785|NCT01852084|11146243|FG002|NOT COMPLETED|Overall Study||2
10022786|NCT01852084|11146244|FG003|NOT COMPLETED|Overall Study||0
10022787|NCT01852110|11146256|FG000|STARTED|Overall Study||120
10022788|NCT01852110|11146257|FG001|STARTED|Overall Study||120
10022789|NCT01852110|11146258|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022790|NCT01852110|11146259|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022791|NCT01852110|11146260|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022792|NCT01852110|11146261|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022793|NCT01852110|11146256|FG000|Treated|Overall Study||119
10022794|NCT01852110|11146257|FG001|Treated|Overall Study||120
10022795|NCT01852110|11146258|FG002|Treated|Overall Study||0
10022796|NCT01852110|11146259|FG003|Treated|Overall Study||0
10022797|NCT01852110|11146260|FG004|Treated|Overall Study||0
10022798|NCT01852110|11146261|FG005|Treated|Overall Study||0
10022799|NCT01852110|11146256|FG000|COMPLETED|Overall Study||70
10022800|NCT01852110|11146257|FG001|COMPLETED|Overall Study||74
10022801|NCT01852110|11146258|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022802|NCT01852110|11146259|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022803|NCT01852110|11146260|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022804|NCT01852110|11146261|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10022805|NCT01852110|11146256|FG000|NOT COMPLETED|Overall Study||50
10022806|NCT01852110|11146257|FG001|NOT COMPLETED|Overall Study||46
10022807|NCT01852110|11146258|FG002|NOT COMPLETED|Overall Study||0
10022808|NCT01852110|11146259|FG003|NOT COMPLETED|Overall Study||0
10022809|NCT01852110|11146260|FG004|NOT COMPLETED|Overall Study||0
10022810|NCT01852110|11146261|FG005|NOT COMPLETED|Overall Study||0
10022811|NCT01852162|11146277|FG000|STARTED|Overall Study||18
10022812|NCT01852162|11146278|FG001|STARTED|Overall Study||17
10022813|NCT01852162|11146277|FG000|COMPLETED|Overall Study||14
10022814|NCT01852162|11146278|FG001|COMPLETED|Overall Study||16
10022815|NCT01852162|11146277|FG000|NOT COMPLETED|Overall Study||4
10022816|NCT01852162|11146278|FG001|NOT COMPLETED|Overall Study||1
10022817|NCT01852175|11146286|FG000|STARTED|Overall Study||55
10022818|NCT01852175|11146287|FG001|STARTED|Overall Study||55
10022819|NCT01852175|11146286|FG000|COMPLETED|Overall Study||55
10022820|NCT01852175|11146287|FG001|COMPLETED|Overall Study||55
10022821|NCT01852175|11146286|FG000|NOT COMPLETED|Overall Study||0
10022822|NCT01852175|11146287|FG001|NOT COMPLETED|Overall Study||0
10022823|NCT01852201|11146295|FG000|STARTED|Overall Study||21
10022824|NCT01852201|11146296|FG001|STARTED|Overall Study||12
10022825|NCT01852201|11146295|FG000|COMPLETED|Overall Study||21
10022826|NCT01852201|11146296|FG001|COMPLETED|Overall Study||12
10022827|NCT01852201|11146295|FG000|NOT COMPLETED|Overall Study||0
10022828|NCT01852201|11146296|FG001|NOT COMPLETED|Overall Study||0
10022829|NCT01852214|11146303|FG000|STARTED|Period 1||26
10022830|NCT01852214|11146304|FG001|STARTED|Period 1||24
10022831|NCT01852214|11146303|FG000|COMPLETED|Period 1||25
10022832|NCT01852214|11146304|FG001|COMPLETED|Period 1||21
10022833|NCT01852214|11146303|FG000|NOT COMPLETED|Period 1||1
10022834|NCT01852214|11146304|FG001|NOT COMPLETED|Period 1||3
10022835|NCT01852214|11146303|FG000|STARTED|Washout Period||25
10022836|NCT01852214|11146304|FG001|STARTED|Washout Period||21
9677583|NCT03589469|10776835|FG000|COMPLETED|Overall Study||0
9677584|NCT03589469|10776835|FG000|NOT COMPLETED|Overall Study||145
9723990|NCT00086515|10823695|FG000|COMPLETED|Phase B (Weeks 24-104)||201
9723991|NCT00086515|10823696|FG001|COMPLETED|Phase B (Weeks 24-104)||109
10022837|NCT01852214|11146303|FG000|COMPLETED|Washout Period||25
10022838|NCT01852214|11146304|FG001|COMPLETED|Washout Period||20
10022839|NCT01852214|11146303|FG000|NOT COMPLETED|Washout Period||0
10022840|NCT01852214|11146304|FG001|NOT COMPLETED|Washout Period||1
9723992|NCT00086515|10823695|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190
9723993|NCT00086515|10823696|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55
10022841|NCT01852214|11146303|FG000|STARTED|Period 2||25
10022842|NCT01852214|11146304|FG001|STARTED|Period 2||20
10022843|NCT01852214|11146303|FG000|COMPLETED|Period 2||25
10022844|NCT01852214|11146304|FG001|COMPLETED|Period 2||20
10022845|NCT01852214|11146303|FG000|NOT COMPLETED|Period 2||0
9677585|NCT03563716|10776841|FG000|STARTED|Overall Study||68
9677586|NCT03563716|10776842|FG001|STARTED|Overall Study||67
9677587|NCT03563716|10776841|FG000|COMPLETED|Overall Study||0
9677588|NCT03563716|10776842|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
9677589|NCT03563716|10776841|FG000|NOT COMPLETED|Overall Study||68
9677590|NCT03563716|10776842|FG001|NOT COMPLETED|Overall Study||67
9677591|NCT03505671|10776850|FG000|STARTED|Overall Study||11
9677592|NCT03505671|10776851|FG001|STARTED|Overall Study||12
9677593|NCT03505671|10776850|FG000|COMPLETED|Overall Study||8
9677594|NCT03505671|10776851|FG001|COMPLETED|Overall Study||11
9677595|NCT03505671|10776850|FG000|NOT COMPLETED|Overall Study||3
9677596|NCT03505671|10776851|FG001|NOT COMPLETED|Overall Study||1
9677597|NCT03469999|10776857|FG000|STARTED|Overall Study||12
9677598|NCT03469999|10776857|FG000|COMPLETED|Overall Study||10
9677599|NCT03469999|10776857|FG000|NOT COMPLETED|Overall Study||2
9677600|NCT03463993|10776864|FG000|STARTED|Overall Study||253
9677601|NCT03463993|10776865|FG001|STARTED|Overall Study||253
9677602|NCT03463993|10776864|FG000|COMPLETED|Overall Study||224
10022846|NCT01852214|11146304|FG001|NOT COMPLETED|Period 2||0
10022847|NCT01852292|11146313|FG000|STARTED|Overall Study||79
10022848|NCT01852292|11146314|FG001|STARTED|Overall Study||79
10022849|NCT01852292|11146313|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
10022850|NCT01852292|11146314|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
10022851|NCT01852292|11146313|FG000|NOT COMPLETED|Overall Study||79
10022852|NCT01852292|11146314|FG001|NOT COMPLETED|Overall Study||79
10022853|NCT01852344|11146324|FG000|STARTED|Overall Study||27
10022854|NCT01852344|11146325|FG001|STARTED|Overall Study||27
10022855|NCT01852344|11146326|FG002|STARTED|Overall Study||27
10022856|NCT01852344|11146327|FG003|STARTED|Overall Study||27
10022857|NCT01852344|11146324|FG000|Actual Participation in First Assignment|Overall Study||27
10022858|NCT01852344|11146325|FG001|Actual Participation in First Assignment|Overall Study||27
10022859|NCT01852344|11146326|FG002|Actual Participation in First Assignment|Overall Study||27
10022860|NCT01852344|11146327|FG003|Actual Participation in First Assignment|Overall Study||27
10022861|NCT01852344|11146324|FG000|COMPLETED|Overall Study||27
10022862|NCT01852344|11146325|FG001|COMPLETED|Overall Study||27
10022863|NCT01852344|11146326|FG002|COMPLETED|Overall Study||27
10022864|NCT01852344|11146327|FG003|COMPLETED|Overall Study||27
10022865|NCT01852344|11146324|FG000|NOT COMPLETED|Overall Study||0
10022866|NCT01852344|11146325|FG001|NOT COMPLETED|Overall Study||0
10022867|NCT01852344|11146326|FG002|NOT COMPLETED|Overall Study||0
10022868|NCT01852344|11146327|FG003|NOT COMPLETED|Overall Study||0
10022869|NCT01852383|11146338|FG000|STARTED|Overall Study||30
10022870|NCT01852383|11146338|FG000|COMPLETED|Overall Study||19
10022871|NCT01852383|11146338|FG000|NOT COMPLETED|Overall Study||11
10022872|NCT01852513|11146345|FG000|STARTED|Overall Study||20
10022873|NCT01852513|11146346|FG001|STARTED|Overall Study||19
10022874|NCT01852513|11146345|FG000|COMPLETED|Overall Study||20
10022875|NCT01852513|11146346|FG001|COMPLETED|Overall Study||19
10022876|NCT01852513|11146345|FG000|NOT COMPLETED|Overall Study||0
10022877|NCT01852513|11146346|FG001|NOT COMPLETED|Overall Study||0
10022878|NCT01852591|11146352|FG000|STARTED|Overall Study||8
10022879|NCT01852591|11146352|FG000|COMPLETED|Overall Study||5
10022880|NCT01852591|11146352|FG000|NOT COMPLETED|Overall Study||3
10022881|NCT01852669|11146358|FG000|STARTED|Overall Study||71
10022882|NCT01852669|11146359|FG001|STARTED|Overall Study||69
10022883|NCT01852669|11146358|FG000|COMPLETED|Overall Study||71
10022884|NCT01852669|11146359|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
10022885|NCT01852669|11146358|FG000|NOT COMPLETED|Overall Study||0
10022886|NCT01852669|11146359|FG001|NOT COMPLETED|Overall Study||1
10022887|NCT01852799|11146365|FG000|STARTED|Overall Study||18
10022888|NCT01852799|11146365|FG000|COMPLETED|Overall Study||0
10022889|NCT01852799|11146365|FG000|NOT COMPLETED|Overall Study||18
10022890|NCT01852825|11146372|FG000|STARTED|Overall Study||16
10022891|NCT01852825|11146373|FG001|STARTED|Overall Study||7
10022892|NCT01852825|11146374|FG002|STARTED|Overall Study||3
10022893|NCT01852825|11146372|FG000|COMPLETED|Overall Study||14
10022894|NCT01852825|11146373|FG001|COMPLETED|Overall Study||7
10022895|NCT01852825|11146374|FG002|COMPLETED|Overall Study||3
10022896|NCT01852825|11146372|FG000|NOT COMPLETED|Overall Study||2
10022897|NCT01852825|11146373|FG001|NOT COMPLETED|Overall Study||0
10022898|NCT01852825|11146374|FG002|NOT COMPLETED|Overall Study||0
10022899|NCT01852942|11146384|FG000|STARTED|Overall Study||25
10022900|NCT01852942|11146385|FG001|STARTED|Overall Study||27
10022901|NCT01852942|11146384|FG000|COMPLETED|Overall Study||20
10022902|NCT01852942|11146385|FG001|COMPLETED|Overall Study||21
10022903|NCT01852942|11146384|FG000|NOT COMPLETED|Overall Study||5
10022904|NCT01852942|11146385|FG001|NOT COMPLETED|Overall Study||6
10022905|NCT01852955|11146394|FG000|STARTED|Overall Study||35
10022906|NCT01852955|11146395|FG001|STARTED|Overall Study||35
9677603|NCT03463993|10776865|FG001|COMPLETED|Overall Study||227
9677604|NCT03463993|10776864|FG000|NOT COMPLETED|Overall Study||29
9677605|NCT03463993|10776865|FG001|NOT COMPLETED|Overall Study||26
9677606|NCT03390101|10776874|FG000|STARTED|Weeks 0-12||85
9677607|NCT03390101|10776875|FG001|STARTED|Weeks 0-12||84
9677608|NCT03390101|10776876|FG002|STARTED|Weeks 0-12||44
9677609|NCT03390101|10776874|FG000|COMPLETED|Weeks 0-12||85
10022907|NCT01852955|11146394|FG000|COMPLETED|Overall Study||33
10022908|NCT01852955|11146395|FG001|COMPLETED|Overall Study||32
9677610|NCT03390101|10776875|FG001|COMPLETED|Weeks 0-12||82
9677611|NCT03390101|10776876|FG002|COMPLETED|Weeks 0-12||43
9677612|NCT03390101|10776874|FG000|NOT COMPLETED|Weeks 0-12||0
9677613|NCT03390101|10776875|FG001|NOT COMPLETED|Weeks 0-12||2
9677614|NCT03390101|10776876|FG002|NOT COMPLETED|Weeks 0-12||1
9677615|NCT03390101|10776874|FG000|STARTED|Weeks 12-54||85
9677616|NCT03390101|10776875|FG001|STARTED|Weeks 12-54||82
9677617|NCT03390101|10776876|FG002|STARTED|Weeks 12-54||43
9677618|NCT03390101|10776874|FG000|COMPLETED|Weeks 12-54||82
9677619|NCT03390101|10776875|FG001|COMPLETED|Weeks 12-54||78
9677620|NCT03390101|10776876|FG002|COMPLETED|Weeks 12-54||41
9677621|NCT03390101|10776874|FG000|NOT COMPLETED|Weeks 12-54||3
9677622|NCT03390101|10776875|FG001|NOT COMPLETED|Weeks 12-54||4
9677623|NCT03390101|10776876|FG002|NOT COMPLETED|Weeks 12-54||2
9842474|NCT00824772|10954176|FG000|COMPLETED|Overall Study||196
9842475|NCT00824772|10954176|FG000|NOT COMPLETED|Overall Study||8
9842476|NCT00824824|10954182|FG000|STARTED|Overall Study||4
9842477|NCT00824824|10954183|FG001|STARTED|Overall Study||3
9842478|NCT00824824|10954182|FG000|COMPLETED|Overall Study||4
9842479|NCT00824824|10954183|FG001|COMPLETED|Overall Study||3
9842480|NCT00824824|10954182|FG000|NOT COMPLETED|Overall Study||0
9842481|NCT00824824|10954183|FG001|NOT COMPLETED|Overall Study||0
9677632|NCT03213158|10776893|FG000|STARTED|Overall Study||10
9677633|NCT03213158|10776893|FG000|COMPLETED|Overall Study||7
9677634|NCT03213158|10776893|FG000|NOT COMPLETED|Overall Study||3
9677635|NCT03194646|10776901|FG000|STARTED|Overall Study||363
9677636|NCT03194646|10776902|FG001|STARTED|Overall Study||361
9677637|NCT03194646|10776903|FG002|STARTED|Overall Study||183
9677638|NCT03194646|10776904|FG003|STARTED|Overall Study||365
9677639|NCT03194646|10776901|FG000|Treated|Overall Study||349
9677640|NCT03194646|10776902|FG001|Treated|Overall Study||347
9677641|NCT03194646|10776903|FG002|Treated|Overall Study||177
9677642|NCT03194646|10776904|FG003|Treated|Overall Study||365
9677643|NCT03194646|10776901|FG000|COMPLETED|Overall Study||61
9677644|NCT03194646|10776902|FG001|COMPLETED|Overall Study||93
9842482|NCT00824850|10954191|FG000|STARTED|Overall Study||38
10022909|NCT01852955|11146394|FG000|NOT COMPLETED|Overall Study||2
10022910|NCT01852955|11146395|FG001|NOT COMPLETED|Overall Study||3
10022911|NCT01853046|11146403|FG000|STARTED|Overall Study||18
10022912|NCT01853046|11146404|FG001|STARTED|Overall Study||6
10022913|NCT01853046|11146403|FG000|Received Treatment|Overall Study||18
10022914|NCT01853046|11146404|FG001|Received Treatment|Overall Study||6
10022915|NCT01853046|11146403|FG000|COMPLETED|Overall Study||0
10022916|NCT01853046|11146404|FG001|COMPLETED|Overall Study||0
10022917|NCT01853046|11146403|FG000|NOT COMPLETED|Overall Study||18
10022918|NCT01853046|11146404|FG001|NOT COMPLETED|Overall Study||6
10022919|NCT01853072|11146413|FG000|STARTED|Overall Study||308
10022920|NCT01853072|11146414|FG001|STARTED|Overall Study||307
10022921|NCT01853072|11146413|FG000|Randomized|Overall Study||308
10022922|NCT01853072|11146414|FG001|Randomized|Overall Study||307
10022923|NCT01853072|11146413|FG000|Treated (Safety Analysis Set)|Overall Study||301
10022924|NCT01853072|11146414|FG001|Treated (Safety Analysis Set)|Overall Study||302
10022925|NCT01853072|11146413|FG000|Full Analysis Set|Overall Study||298
10022926|NCT01853072|11146414|FG001|Full Analysis Set|Overall Study||300
10022927|NCT01853072|11146413|FG000|COMPLETED|Overall Study||296
10022928|NCT01853072|11146414|FG001|COMPLETED|Overall Study||286
10022929|NCT01853072|11146413|FG000|NOT COMPLETED|Overall Study||12
10022930|NCT01853072|11146414|FG001|NOT COMPLETED|Overall Study||21
10114224|NCT02514824|11244949|FG000|STARTED|Overall Study||4
10114225|NCT02514824|11244950|FG001|STARTED|Overall Study||5
10114226|NCT02514824|11244951|FG002|STARTED|Overall Study||0
10114227|NCT02514824|11244952|FG003|STARTED|Overall Study||0
10114228|NCT02514824|11244949|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3
10114229|NCT02514824|11244950|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5
10114230|NCT02514824|11244951|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0
10114231|NCT02514824|11244952|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0
9677645|NCT03194646|10776903|FG002|COMPLETED|Overall Study||44
9677646|NCT03194646|10776904|FG003|COMPLETED|Overall Study||85
10022931|NCT01853085|11146422|FG000|STARTED|Overall Study||1830
10022932|NCT01853085|11146422|FG000|COMPLETED|Overall Study||1595
10022933|NCT01853085|11146422|FG000|NOT COMPLETED|Overall Study||235
10022934|NCT01853137|11146428|FG000|STARTED|Overall Study||25
10022935|NCT01853137|11146429|FG001|STARTED|Overall Study||18
9677647|NCT03194646|10776901|FG000|NOT COMPLETED|Overall Study||302
9677648|NCT03194646|10776902|FG001|NOT COMPLETED|Overall Study||268
9677649|NCT03194646|10776903|FG002|NOT COMPLETED|Overall Study||139
9677650|NCT03194646|10776904|FG003|NOT COMPLETED|Overall Study||280
9677651|NCT03179605|10776919|FG000|STARTED|Overall Study||22
9677652|NCT03179605|10776919|FG000|COMPLETED|Overall Study||21
9677653|NCT03179605|10776919|FG000|NOT COMPLETED|Overall Study||1
10022936|NCT01853137|11146428|FG000|COMPLETED|Overall Study||21
10022937|NCT01853137|11146429|FG001|COMPLETED|Overall Study||17
10022938|NCT01853137|11146428|FG000|NOT COMPLETED|Overall Study||4
10022939|NCT01853137|11146429|FG001|NOT COMPLETED|Overall Study||1
10022940|NCT01853215|11146436|FG000|STARTED|Overall Study||24
9677654|NCT03159195|10776925|FG000|STARTED|Overall Study||360
9677655|NCT03159195|10776926|FG001|STARTED|Overall Study||292
9677656|NCT03159195|10776925|FG000|COMPLETED|Overall Study||360
9842483|NCT00824850|10954192|FG001|STARTED|Overall Study||37
9842484|NCT00824850|10954191|FG000|Received Vaccination 13vPnC|Overall Study||38
10022941|NCT01853215|11146436|FG000|COMPLETED|Overall Study||24
10114232|NCT02514824|11244949|FG000|COMPLETED|Overall Study||3
9677657|NCT03159195|10776926|FG001|COMPLETED|Overall Study||292
9677658|NCT03159195|10776925|FG000|NOT COMPLETED|Overall Study||0
9677659|NCT03159195|10776926|FG001|NOT COMPLETED|Overall Study||0
9723994|NCT00086580|10823704|FG000|STARTED|Treatment Period||168
9723995|NCT00086580|10823705|FG001|STARTED|Treatment Period||167
9723996|NCT00086580|10823704|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164
9723997|NCT00086580|10823705|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165
9723998|NCT00086580|10823704|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
9723999|NCT00086580|10823705|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
9724000|NCT00086580|10823704|FG000|NOT COMPLETED|Treatment Period||65
9724001|NCT00086580|10823705|FG001|NOT COMPLETED|Treatment Period||60
9724002|NCT00086580|10823704|FG000|STARTED|Follow-up Period||141
9724003|NCT00086580|10823705|FG001|STARTED|Follow-up Period||137
9724004|NCT00086580|10823704|FG000|COMPLETED|Follow-up Period||37
9724005|NCT00086580|10823705|FG001|COMPLETED|Follow-up Period||18
9724006|NCT00086580|10823704|FG000|NOT COMPLETED|Follow-up Period||104
9724007|NCT00086580|10823705|FG001|NOT COMPLETED|Follow-up Period||119
9724008|NCT00086580|10823704|FG000|STARTED|Observation Period||95
9724009|NCT00086580|10823705|FG001|STARTED|Observation Period||121
9724010|NCT00086580|10823704|FG000|COMPLETED|Observation Period||49
9724011|NCT00086580|10823705|FG001|COMPLETED|Observation Period||56
9724012|NCT00086580|10823704|FG000|NOT COMPLETED|Observation Period||46
9724013|NCT00086580|10823705|FG001|NOT COMPLETED|Observation Period||65
9731718|NCT00134901|10831616|FG001|STARTED|Overall Study||42
9731719|NCT00134901|10831615|FG000|COMPLETED|Overall Study||22
9731720|NCT00134901|10831616|FG001|COMPLETED|Overall Study||27
9731721|NCT00134901|10831615|FG000|NOT COMPLETED|Overall Study||17
9731722|NCT00134901|10831616|FG001|NOT COMPLETED|Overall Study||15
9842485|NCT00824850|10954192|FG001|Received Vaccination 13vPnC|Overall Study||36
10022942|NCT01853215|11146436|FG000|NOT COMPLETED|Overall Study||0
10022943|NCT01853228|11146441|FG000|STARTED|Phase 1||9
10022944|NCT01853228|11146442|FG001|STARTED|Phase 1||7
10022945|NCT01853228|11146441|FG000|COMPLETED|Phase 1||0
10022946|NCT01853228|11146442|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
10022947|NCT01853228|11146441|FG000|NOT COMPLETED|Phase 1||9
10022948|NCT01853228|11146442|FG001|NOT COMPLETED|Phase 1||0
10022949|NCT01853228|11146441|FG000|STARTED|Phase 2||0
10022950|NCT01853228|11146442|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
10022951|NCT01853228|11146441|FG000|COMPLETED|Phase 2||0
10022952|NCT01853228|11146442|FG001|COMPLETED|Phase 2||0
10022953|NCT01853228|11146441|FG000|NOT COMPLETED|Phase 2||0
10022954|NCT01853228|11146442|FG001|NOT COMPLETED|Phase 2||8
10022955|NCT01853254|11146447|FG000|STARTED|Overall Study||272
10022956|NCT01853254|11146447|FG000|COMPLETED|Overall Study||168
10022957|NCT01853254|11146447|FG000|NOT COMPLETED|Overall Study||104
10022958|NCT01853280|11146453|FG000|STARTED|Overall Study||22
10022959|NCT01853280|11146454|FG001|STARTED|Overall Study||22
10022960|NCT01853280|11146453|FG000|COMPLETED|Overall Study||20
10022961|NCT01853280|11146454|FG001|COMPLETED|Overall Study||16
10022962|NCT01853280|11146453|FG000|NOT COMPLETED|Overall Study||2
10022963|NCT01853280|11146454|FG001|NOT COMPLETED|Overall Study||6
10022964|NCT01853332|11146460|FG000|STARTED|Overall Study||210
10022965|NCT01853332|11146460|FG000|COMPLETED|Overall Study||151
10022966|NCT01853332|11146460|FG000|NOT COMPLETED|Overall Study||59
10022967|NCT01853371|11146467|FG000|STARTED|Overall Study||10
10022968|NCT01853371|11146468|FG001|STARTED|Overall Study||10
10022969|NCT01853371|11146467|FG000|COMPLETED|Overall Study||10
10022970|NCT01853371|11146468|FG001|COMPLETED|Overall Study||8
10022971|NCT01853371|11146467|FG000|NOT COMPLETED|Overall Study||0
10022972|NCT01853371|11146468|FG001|NOT COMPLETED|Overall Study||2
10022973|NCT01853384|11146476|FG000|STARTED|Randomized||131
10022974|NCT01853384|11146477|FG001|STARTED|Randomized||121
10022975|NCT01853384|11146476|FG000|COMPLETED|Randomized||69
10022976|NCT01853384|11146477|FG001|COMPLETED|Randomized||75
10022977|NCT01853384|11146476|FG000|NOT COMPLETED|Randomized||62
10022978|NCT01853384|11146477|FG001|NOT COMPLETED|Randomized||46
10022979|NCT01853384|11146476|FG000|STARTED|Enrolled in Follow up Period||96
10022980|NCT01853384|11146477|FG001|STARTED|Enrolled in Follow up Period||94
10022981|NCT01853384|11146476|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
10022982|NCT01853384|11146477|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
10022983|NCT01853384|11146476|FG000|COMPLETED|Enrolled in Follow up Period||96
10022984|NCT01853384|11146477|FG001|COMPLETED|Enrolled in Follow up Period||94
10022985|NCT01853384|11146476|FG000|NOT COMPLETED|Enrolled in Follow up Period||0
10022986|NCT01853384|11146477|FG001|NOT COMPLETED|Enrolled in Follow up Period||0
9731723|NCT00135226|10831628|FG000|STARTED|Overall Study||3870
9731724|NCT00135226|10831629|FG001|STARTED|Overall Study||3870
9731725|NCT00135226|10831630|FG002|STARTED|Overall Study||3870
9731726|NCT00135226|10831631|FG003|STARTED|Overall Study||3870
9731727|NCT00135226|10831628|FG000|COMPLETED|Overall Study||3836
9731728|NCT00135226|10831629|FG001|COMPLETED|Overall Study||3835
9731729|NCT00135226|10831630|FG002|COMPLETED|Overall Study||3836
9842486|NCT00824850|10954191|FG000|COMPLETED|Overall Study||38
9842487|NCT00824850|10954192|FG001|COMPLETED|Overall Study||36
10022987|NCT01853384|11146476|FG000|STARTED|Completed Follow up Visit 1||96
10022988|NCT01853384|11146477|FG001|STARTED|Completed Follow up Visit 1||94
10022989|NCT01853384|11146476|FG000|COMPLETED|Completed Follow up Visit 1||82
10022990|NCT01853384|11146477|FG001|COMPLETED|Completed Follow up Visit 1||85
10022991|NCT01853384|11146476|FG000|NOT COMPLETED|Completed Follow up Visit 1||14
9677660|NCT03150862|10776940|FG000|STARTED|Overall Study||3
9677661|NCT03150862|10776941|FG001|STARTED|Overall Study||8
9677662|NCT03150862|10776942|FG002|STARTED|Overall Study||9
9677663|NCT03150862|10776943|FG003|STARTED|Overall Study||40
9677664|NCT03150862|10776944|FG004|STARTED|Overall Study||9
9677665|NCT03150862|10776945|FG005|STARTED|Overall Study||9
9677666|NCT03150862|10776946|FG006|STARTED|Overall Study||8
9677667|NCT03150862|10776947|FG007|STARTED|Overall Study||30
9677668|NCT03150862|10776940|FG000|COMPLETED|Overall Study||0
9842488|NCT00824850|10954191|FG000|NOT COMPLETED|Overall Study||0
9842489|NCT00824850|10954192|FG001|NOT COMPLETED|Overall Study||1
9842490|NCT00824993|10954206|FG000|STARTED|Overall Study||39
9842491|NCT00824993|10954207|FG001|STARTED|Overall Study||39
9842492|NCT00824993|10954206|FG000|6 Month Follow up|Overall Study||33
10022992|NCT01853384|11146477|FG001|NOT COMPLETED|Completed Follow up Visit 1||9
10022993|NCT01853384|11146476|FG000|STARTED|Completed Follow up Visit 2||96
10022994|NCT01853384|11146477|FG001|STARTED|Completed Follow up Visit 2||94
10022995|NCT01853384|11146476|FG000|COMPLETED|Completed Follow up Visit 2||93
10022996|NCT01853384|11146477|FG001|COMPLETED|Completed Follow up Visit 2||91
10022997|NCT01853384|11146476|FG000|NOT COMPLETED|Completed Follow up Visit 2||3
10022998|NCT01853384|11146477|FG001|NOT COMPLETED|Completed Follow up Visit 2||3
10022999|NCT01853397|11146487|FG000|STARTED|Overall Study||18
10023000|NCT01853397|11146488|FG001|STARTED|Overall Study||20
10023001|NCT01853397|11146489|FG002|STARTED|Overall Study||17
10023002|NCT01853397|11146490|FG003|STARTED|Overall Study||17
10023003|NCT01853397|11146487|FG000|COMPLETED|Overall Study||18
10023004|NCT01853397|11146488|FG001|COMPLETED|Overall Study||20
10023005|NCT01853397|11146489|FG002|COMPLETED|Overall Study||17
10023006|NCT01853397|11146490|FG003|COMPLETED|Overall Study||15
10023007|NCT01853397|11146487|FG000|NOT COMPLETED|Overall Study||0
10023008|NCT01853397|11146488|FG001|NOT COMPLETED|Overall Study||0
10023009|NCT01853397|11146489|FG002|NOT COMPLETED|Overall Study||0
10023010|NCT01853397|11146490|FG003|NOT COMPLETED|Overall Study||2
10023011|NCT01853462|11146502|FG000|STARTED|Overall Study||11
10023012|NCT01853462|11146503|FG001|STARTED|Overall Study||11
10023013|NCT01853462|11146502|FG000|COMPLETED|Overall Study||10
10023014|NCT01853462|11146503|FG001|COMPLETED|Overall Study||10
10023015|NCT01853462|11146502|FG000|NOT COMPLETED|Overall Study||1
10023016|NCT01853462|11146503|FG001|NOT COMPLETED|Overall Study||1
10023017|NCT01853475|11146514|FG000|STARTED|Overall Study||8
10023018|NCT01853475|11146515|FG001|STARTED|Overall Study||8
9677669|NCT03150862|10776941|FG001|COMPLETED|Overall Study||0
9677670|NCT03150862|10776942|FG002|COMPLETED|Overall Study||0
9842493|NCT00824993|10954207|FG001|6 Month Follow up|Overall Study||27
9842494|NCT00824993|10954206|FG000|COMPLETED|Overall Study||25
10023019|NCT01853475|11146516|FG002|STARTED|Overall Study||8
10023020|NCT01853475|11146514|FG000|COMPLETED|Overall Study||8
10023021|NCT01853475|11146515|FG001|COMPLETED|Overall Study||7
10023022|NCT01853475|11146516|FG002|COMPLETED|Overall Study||8
10023023|NCT01853475|11146514|FG000|NOT COMPLETED|Overall Study||0
10023024|NCT01853475|11146515|FG001|NOT COMPLETED|Overall Study||1
9677671|NCT03150862|10776943|FG003|COMPLETED|Overall Study||0
9677672|NCT03150862|10776944|FG004|COMPLETED|Overall Study||0
9677673|NCT03150862|10776945|FG005|COMPLETED|Overall Study||0
9677674|NCT03150862|10776946|FG006|COMPLETED|Overall Study||0
9677675|NCT03150862|10776947|FG007|COMPLETED|Overall Study||0
9677676|NCT03150862|10776940|FG000|NOT COMPLETED|Overall Study||3
9677677|NCT03150862|10776941|FG001|NOT COMPLETED|Overall Study||8
9677678|NCT03150862|10776942|FG002|NOT COMPLETED|Overall Study||9
9677679|NCT03150862|10776943|FG003|NOT COMPLETED|Overall Study||40
9677680|NCT03150862|10776944|FG004|NOT COMPLETED|Overall Study||9
9677681|NCT03150862|10776945|FG005|NOT COMPLETED|Overall Study||9
9677682|NCT03150862|10776946|FG006|NOT COMPLETED|Overall Study||8
9677683|NCT03150862|10776947|FG007|NOT COMPLETED|Overall Study||30
9677684|NCT03074695|10776976|FG000|STARTED|Overall Study||70
9677685|NCT03074695|10776977|FG001|STARTED|Overall Study||71
9677686|NCT03074695|10776976|FG000|COMPLETED|Overall Study||66
9677687|NCT03074695|10776977|FG001|COMPLETED|Overall Study||66
9677688|NCT03074695|10776976|FG000|NOT COMPLETED|Overall Study||4
9677689|NCT03074695|10776977|FG001|NOT COMPLETED|Overall Study||5
9677690|NCT03052608|10776985|FG000|STARTED|Treatment Phase||149
9677691|NCT03052608|10776986|FG001|STARTED|Treatment Phase||147
9677692|NCT03052608|10776985|FG000|COMPLETED|Treatment Phase||26
9677693|NCT03052608|10776986|FG001|COMPLETED|Treatment Phase||83
9677694|NCT03052608|10776985|FG000|NOT COMPLETED|Treatment Phase||123
9677695|NCT03052608|10776986|FG001|NOT COMPLETED|Treatment Phase||64
9842495|NCT00824993|10954207|FG001|COMPLETED|Overall Study||22
9842496|NCT00824993|10954206|FG000|NOT COMPLETED|Overall Study||14
9842497|NCT00824993|10954207|FG001|NOT COMPLETED|Overall Study||17
9842498|NCT00825162|10954216|FG000|STARTED|Overall Study||710
9842499|NCT00825162|10954217|FG001|STARTED|Overall Study||880
9842500|NCT00825162|10954218|FG002|STARTED|Overall Study||402
9842501|NCT00825162|10954216|FG000|COMPLETED|Overall Study||682
9842502|NCT00825162|10954217|FG001|COMPLETED|Overall Study||859
9842503|NCT00825162|10954218|FG002|COMPLETED|Overall Study||396
9960261|NCT01467427|11079925|FG001|NOT COMPLETED|Overall Study||13
9960262|NCT01467466|11079935|FG000|STARTED|Overall Study||1300
9960263|NCT01467466|11079936|FG001|STARTED|Overall Study||1292
9842504|NCT00825162|10954216|FG000|NOT COMPLETED|Overall Study||28
9842505|NCT00825162|10954217|FG001|NOT COMPLETED|Overall Study||21
9842506|NCT00825162|10954218|FG002|NOT COMPLETED|Overall Study||6
9842507|NCT00825175|10954233|FG000|STARTED|Overall Study||10
9842508|NCT00825175|10954234|FG001|STARTED|Overall Study||12
9842509|NCT00825175|10954233|FG000|COMPLETED|Overall Study||10
9842510|NCT00825175|10954234|FG001|COMPLETED|Overall Study||7
9842511|NCT00825175|10954233|FG000|NOT COMPLETED|Overall Study||0
9842512|NCT00825175|10954234|FG001|NOT COMPLETED|Overall Study||5
9842513|NCT00825266|10954242|FG000|STARTED|Overall Study||1
9842514|NCT00825266|10954243|FG001|STARTED|Overall Study||1
9842515|NCT00825266|10954242|FG000|COMPLETED|Overall Study||1
9960264|NCT01467466|11079937|FG002|STARTED|Overall Study||1294
9960265|NCT01467466|11079938|FG003|STARTED|Overall Study||1291
9960266|NCT01467466|11079935|FG000|COMPLETED|Overall Study||1191
9960267|NCT01467466|11079936|FG001|COMPLETED|Overall Study||1188
9842516|NCT00825266|10954243|FG001|COMPLETED|Overall Study||1
9842517|NCT00825266|10954242|FG000|NOT COMPLETED|Overall Study||0
9842518|NCT00825266|10954243|FG001|NOT COMPLETED|Overall Study||0
9842519|NCT00825305|10954251|FG000|STARTED|Overall Study||550
9842520|NCT00825305|10954252|FG001|STARTED|Overall Study||275
9677696|NCT03052608|10776985|FG000|STARTED|Long-Term Follow-up Phase||149
9677697|NCT03052608|10776986|FG001|STARTED|Long-Term Follow-up Phase||147
9677698|NCT03052608|10776985|FG000|COMPLETED|Long-Term Follow-up Phase||0
9677699|NCT03052608|10776986|FG001|COMPLETED|Long-Term Follow-up Phase||0
9677700|NCT03052608|10776985|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149
9677701|NCT03052608|10776986|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147
9677702|NCT02944071|10776992|FG000|STARTED|Overall Study||123
9677703|NCT02944071|10776992|FG000|COMPLETED|Overall Study||113
9677704|NCT02944071|10776992|FG000|NOT COMPLETED|Overall Study||10
9677705|NCT02938520|10776998|FG000|STARTED|Overall Study||283
9677706|NCT02938520|10776999|FG001|STARTED|Overall Study||283
9677707|NCT02938520|10776998|FG000|COMPLETED|Overall Study||0
9677708|NCT02938520|10776999|FG001|COMPLETED|Overall Study||0
9677709|NCT02938520|10776998|FG000|NOT COMPLETED|Overall Study||283
9677710|NCT02938520|10776999|FG001|NOT COMPLETED|Overall Study||283
9677711|NCT02922725|10777011|FG000|STARTED|Overall Study||12
9677712|NCT02922725|10777012|FG001|STARTED|Overall Study||12
9677713|NCT02922725|10777013|FG002|STARTED|Overall Study||8
9677714|NCT02922725|10777011|FG000|COMPLETED|Overall Study||11
9677715|NCT02922725|10777012|FG001|COMPLETED|Overall Study||12
9677716|NCT02922725|10777013|FG002|COMPLETED|Overall Study||8
9677717|NCT02922725|10777011|FG000|NOT COMPLETED|Overall Study||1
9677718|NCT02922725|10777012|FG001|NOT COMPLETED|Overall Study||0
9677719|NCT02922725|10777013|FG002|NOT COMPLETED|Overall Study||0
9677720|NCT02886572|10777020|FG000|STARTED|Overall Study||40
9677721|NCT02886572|10777020|FG000|Survival Analysis Population|Overall Study||40
9677722|NCT02886572|10777020|FG000|Distant Brain Recurrence|Overall Study||32
9677723|NCT02886572|10777020|FG000|Local Recurrence|Overall Study||32
9677724|NCT02886572|10777020|FG000|Time to Neurologic Death|Overall Study||32
9677725|NCT02886572|10777020|FG000|SRS Related Adverse Events|Overall Study||32
9677726|NCT02886572|10777020|FG000|COMPLETED|Overall Study||32
9677727|NCT02886572|10777020|FG000|NOT COMPLETED|Overall Study||8
9677728|NCT02831673|10777026|FG000|STARTED|Overall Study||356
9677729|NCT02831673|10777027|FG001|STARTED|Overall Study||358
9677730|NCT02831673|10777026|FG000|COMPLETED|Overall Study||0
9677731|NCT02831673|10777027|FG001|COMPLETED|Overall Study||0
9677732|NCT02831673|10777026|FG000|NOT COMPLETED|Overall Study||356
9677733|NCT02831673|10777027|FG001|NOT COMPLETED|Overall Study||358
9677734|NCT02805257|10777035|FG000|STARTED|Overall Study||60
9677735|NCT02805257|10777036|FG001|STARTED|Overall Study||59
9677736|NCT02805257|10777035|FG000|COMPLETED|Overall Study||53
9677737|NCT02805257|10777036|FG001|COMPLETED|Overall Study||52
9677738|NCT02805257|10777035|FG000|NOT COMPLETED|Overall Study||7
9677739|NCT02805257|10777036|FG001|NOT COMPLETED|Overall Study||7
9677740|NCT02780609|10777046|FG000|STARTED|Overall Study||3
9677741|NCT02780609|10777047|FG001|STARTED|Overall Study||3
9677742|NCT02780609|10777048|FG002|STARTED|Overall Study||6
9677743|NCT02780609|10777049|FG003|STARTED|Overall Study||10
9677744|NCT02780609|10777046|FG000|COMPLETED|Overall Study||3
9677745|NCT02780609|10777047|FG001|COMPLETED|Overall Study||3
9677746|NCT02780609|10777048|FG002|COMPLETED|Overall Study||6
9677747|NCT02780609|10777049|FG003|COMPLETED|Overall Study||10
9677748|NCT02780609|10777046|FG000|NOT COMPLETED|Overall Study||0
9677749|NCT02780609|10777047|FG001|NOT COMPLETED|Overall Study||0
9677750|NCT02780609|10777048|FG002|NOT COMPLETED|Overall Study||0
9677751|NCT02780609|10777049|FG003|NOT COMPLETED|Overall Study||0
9677752|NCT02747433|10777063|FG000|STARTED|Overall Study||5
9677753|NCT02747433|10777064|FG001|STARTED|Overall Study||5
9677754|NCT02747433|10777063|FG000|COMPLETED|Overall Study||5
9677755|NCT02747433|10777064|FG001|COMPLETED|Overall Study||5
9677756|NCT02747433|10777063|FG000|NOT COMPLETED|Overall Study||0
9677757|NCT02747433|10777064|FG001|NOT COMPLETED|Overall Study||0
9677758|NCT02696564|10777075|FG000|STARTED|Overall Study||108
9677759|NCT02696564|10777076|FG001|STARTED|Overall Study||112
9677760|NCT02696564|10777075|FG000|COMPLETED|Overall Study||94
9677761|NCT02696564|10777076|FG001|COMPLETED|Overall Study||99
9677762|NCT02696564|10777075|FG000|NOT COMPLETED|Overall Study||14
9677763|NCT02696564|10777076|FG001|NOT COMPLETED|Overall Study||13
9960268|NCT01467466|11079937|FG002|COMPLETED|Overall Study||1190
9677770|NCT02685826|10777097|FG000|STARTED|Overall Study||25
9677771|NCT02685826|10777098|FG001|STARTED|Overall Study||10
9677772|NCT02685826|10777099|FG002|STARTED|Overall Study||21
9677773|NCT02685826|10777097|FG000|COMPLETED|Overall Study||0
9677774|NCT02685826|10777098|FG001|COMPLETED|Overall Study||0
9677775|NCT02685826|10777099|FG002|COMPLETED|Overall Study||0
9677776|NCT02685826|10777097|FG000|NOT COMPLETED|Overall Study||25
9960269|NCT01467466|11079938|FG003|COMPLETED|Overall Study||1203
9677777|NCT02685826|10777098|FG001|NOT COMPLETED|Overall Study||10
9677778|NCT02685826|10777099|FG002|NOT COMPLETED|Overall Study||21
9842521|NCT00825305|10954251|FG000|COMPLETED|Overall Study||533
9842522|NCT00825305|10954252|FG001|COMPLETED|Overall Study||252
9842523|NCT00825305|10954251|FG000|NOT COMPLETED|Overall Study||17
9842524|NCT00825305|10954252|FG001|NOT COMPLETED|Overall Study||23
9842525|NCT00825318|10954258|FG000|STARTED|Overall Study||13
9842526|NCT00825318|10954258|FG000|COMPLETED|Overall Study||12
9842527|NCT00825318|10954258|FG000|NOT COMPLETED|Overall Study||1
9842528|NCT00825344|10954268|FG000|STARTED|Overall Study||34
9842529|NCT00825344|10954269|FG001|STARTED|Overall Study||43
9842530|NCT00825344|10954268|FG000|COMPLETED|Overall Study||33
9842531|NCT00825344|10954269|FG001|COMPLETED|Overall Study||42
9842532|NCT00825344|10954268|FG000|NOT COMPLETED|Overall Study||1
9842533|NCT00825344|10954269|FG001|NOT COMPLETED|Overall Study||1
9842534|NCT00825370|10954277|FG000|STARTED|Overall Study||175
9677793|NCT02663622|10777121|FG000|STARTED|Overall Study||6
9842535|NCT00825370|10954278|FG001|STARTED|Overall Study||175
9677794|NCT02663622|10777122|FG001|STARTED|Overall Study||6
9677795|NCT02663622|10777123|FG002|STARTED|Overall Study||6
9842536|NCT00825370|10954277|FG000|COMPLETED|Overall Study||175
9842537|NCT00825370|10954278|FG001|COMPLETED|Overall Study||175
9842538|NCT00825370|10954277|FG000|NOT COMPLETED|Overall Study||0
9842539|NCT00825370|10954278|FG001|NOT COMPLETED|Overall Study||0
9842540|NCT00825500|10954287|FG000|STARTED|Overall Study||125
9842541|NCT00825500|10954288|FG001|STARTED|Overall Study||121
9677796|NCT02663622|10777124|FG003|STARTED|Overall Study||26
9677797|NCT02663622|10777121|FG000|COMPLETED|Overall Study||3
9677798|NCT02663622|10777122|FG001|COMPLETED|Overall Study||5
9677799|NCT02663622|10777123|FG002|COMPLETED|Overall Study||5
9677800|NCT02663622|10777124|FG003|COMPLETED|Overall Study||17
9677801|NCT02663622|10777121|FG000|NOT COMPLETED|Overall Study||3
9677802|NCT02663622|10777122|FG001|NOT COMPLETED|Overall Study||1
9677803|NCT02663622|10777123|FG002|NOT COMPLETED|Overall Study||1
9677804|NCT02663622|10777124|FG003|NOT COMPLETED|Overall Study||9
9842542|NCT00825500|10954289|FG002|STARTED|Overall Study||120
9842543|NCT00825500|10954287|FG000|COMPLETED|Overall Study||125
10023025|NCT01853475|11146516|FG002|NOT COMPLETED|Overall Study||0
10023026|NCT01853553|11146526|FG000|STARTED|Overall Study||29
10023027|NCT01853553|11146527|FG001|STARTED|Overall Study||32
10023028|NCT01853553|11146526|FG000|COMPLETED|Overall Study||28
10023029|NCT01853553|11146527|FG001|COMPLETED|Overall Study||32
10023030|NCT01853553|11146526|FG000|NOT COMPLETED|Overall Study||1
10023031|NCT01853553|11146527|FG001|NOT COMPLETED|Overall Study||0
10023032|NCT01853605|11146537|FG000|STARTED|Overall Study||1939
9842544|NCT00825500|10954288|FG001|COMPLETED|Overall Study||121
9842545|NCT00825500|10954289|FG002|COMPLETED|Overall Study||120
10023033|NCT01853605|11146538|FG001|STARTED|Overall Study||693
10023034|NCT01853605|11146539|FG002|STARTED|Overall Study||751
10023035|NCT01853605|11146540|FG003|STARTED|Overall Study||428
10023036|NCT01853605|11146537|FG000|COMPLETED|Overall Study||1939
9842546|NCT00825500|10954287|FG000|NOT COMPLETED|Overall Study||0
9842547|NCT00825500|10954288|FG001|NOT COMPLETED|Overall Study||0
9842548|NCT00825500|10954289|FG002|NOT COMPLETED|Overall Study||0
9842549|NCT00825565|10954297|FG000|STARTED|Overall Study||8
9842550|NCT00825565|10954297|FG000|COMPLETED|Overall Study||8
9842551|NCT00825565|10954297|FG000|NOT COMPLETED|Overall Study||0
9842552|NCT00825630|10954311|FG000|STARTED|Overall Study||29
9842553|NCT00825630|10954312|FG001|STARTED|Overall Study||62
9677817|NCT02640950|10777152|FG000|STARTED|Overall Study||31
9677818|NCT02640950|10777152|FG000|COMPLETED|Overall Study||29
9677819|NCT02640950|10777152|FG000|NOT COMPLETED|Overall Study||2
9677820|NCT02639065|10777156|FG000|STARTED|Study Treatment||37
9677821|NCT02639065|10777156|FG000|COMPLETED|Study Treatment||17
9677822|NCT02639065|10777156|FG000|NOT COMPLETED|Study Treatment||20
9677823|NCT02639065|10777156|FG000|STARTED|Follow up||37
9677824|NCT02639065|10777156|FG000|COMPLETED|Follow up||28
9677825|NCT02639065|10777156|FG000|NOT COMPLETED|Follow up||9
9724014|NCT00086619|10823713|FG000|STARTED|Overall Study||40
9724015|NCT00086619|10823714|FG001|STARTED|Overall Study||40
9724016|NCT00086619|10823713|FG000|Completed Baseline Visit|Overall Study||34
9724017|NCT00086619|10823714|FG001|Completed Baseline Visit|Overall Study||36
9724018|NCT00086619|10823713|FG000|Completed 12 Month Visit|Overall Study||26
9724019|NCT00086619|10823714|FG001|Completed 12 Month Visit|Overall Study||26
9724020|NCT00086619|10823713|FG000|COMPLETED|Overall Study||25
9724021|NCT00086619|10823714|FG001|COMPLETED|Overall Study||23
9724022|NCT00086619|10823713|FG000|NOT COMPLETED|Overall Study||15
9724023|NCT00086619|10823714|FG001|NOT COMPLETED|Overall Study||17
9724024|NCT00086684|10823723|FG000|STARTED|Overall Study||118
9724025|NCT00086684|10823724|FG001|STARTED|Overall Study||129
9724026|NCT00086684|10823725|FG002|STARTED|Overall Study||122
9724027|NCT00086684|10823723|FG000|COMPLETED|Overall Study||63
9724028|NCT00086684|10823724|FG001|COMPLETED|Overall Study||74
9724029|NCT00086684|10823725|FG002|COMPLETED|Overall Study||69
9724030|NCT00086684|10823723|FG000|NOT COMPLETED|Overall Study||55
9724031|NCT00086684|10823724|FG001|NOT COMPLETED|Overall Study||55
9724032|NCT00086684|10823725|FG002|NOT COMPLETED|Overall Study||53
10023037|NCT01853605|11146538|FG001|COMPLETED|Overall Study||693
10023038|NCT01853605|11146539|FG002|COMPLETED|Overall Study||751
9724033|NCT00086957|10823733|FG000|STARTED|Overall Study||2
9724034|NCT00086957|10823734|FG001|STARTED|Overall Study||7
9724035|NCT00086957|10823735|FG002|STARTED|Overall Study||22
9724036|NCT00086957|10823733|FG000|COMPLETED|Overall Study||2
9724037|NCT00086957|10823734|FG001|COMPLETED|Overall Study||7
9724038|NCT00086957|10823735|FG002|COMPLETED|Overall Study||22
9724039|NCT00086957|10823733|FG000|NOT COMPLETED|Overall Study||0
9724040|NCT00086957|10823734|FG001|NOT COMPLETED|Overall Study||0
9724041|NCT00086957|10823735|FG002|NOT COMPLETED|Overall Study||0
9724042|NCT00086996|10823744|FG000|STARTED|Overall Study||98
9724043|NCT00086996|10823744|FG000|Eligible|Overall Study||93
9724044|NCT00086996|10823744|FG000|Eligible and Began Protocol Therapy|Overall Study||93
9724045|NCT00086996|10823744|FG000|COMPLETED|Overall Study||34
9724046|NCT00086996|10823744|FG000|NOT COMPLETED|Overall Study||64
9724047|NCT00087022|10823750|FG000|STARTED|Overall Study||433
9724048|NCT00087022|10823751|FG001|STARTED|Overall Study||431
9724049|NCT00087022|10823750|FG000|Treated (Safety Population)|Overall Study||431
9677826|NCT02564263|10777162|FG000|STARTED|Overall Study||314
9677827|NCT02564263|10777163|FG001|STARTED|Overall Study||314
9677828|NCT02564263|10777162|FG000|Treated|Overall Study||314
9677829|NCT02564263|10777163|FG001|Treated|Overall Study||296
9677830|NCT02564263|10777162|FG000|COMPLETED|Overall Study||0
9677831|NCT02564263|10777163|FG001|COMPLETED|Overall Study||0
9677832|NCT02564263|10777162|FG000|NOT COMPLETED|Overall Study||314
9677833|NCT02564263|10777163|FG001|NOT COMPLETED|Overall Study||314
9677834|NCT02422615|10777171|FG000|STARTED|Overall Study||484
9677835|NCT02422615|10777172|FG001|STARTED|Overall Study||242
9677836|NCT02422615|10777171|FG000|Untreated|Overall Study||1
9677837|NCT02422615|10777172|FG001|Untreated|Overall Study||1
9677838|NCT02422615|10777171|FG000|COMPLETED|Overall Study||204
9677839|NCT02422615|10777172|FG001|COMPLETED|Overall Study||76
10023039|NCT01853605|11146540|FG003|COMPLETED|Overall Study||428
10023040|NCT01853605|11146537|FG000|NOT COMPLETED|Overall Study||0
9677840|NCT02422615|10777171|FG000|NOT COMPLETED|Overall Study||280
9677841|NCT02422615|10777172|FG001|NOT COMPLETED|Overall Study||166
9677842|NCT02372136|10777180|FG000|STARTED|Overall Study||62
9677843|NCT02372136|10777181|FG001|STARTED|Overall Study||58
9677844|NCT02372136|10777180|FG000|COMPLETED|Overall Study||59
9677845|NCT02372136|10777181|FG001|COMPLETED|Overall Study||57
9677846|NCT02372136|10777180|FG000|NOT COMPLETED|Overall Study||3
9677847|NCT02372136|10777181|FG001|NOT COMPLETED|Overall Study||1
9677848|NCT02367456|10777192|FG000|STARTED|Overall Study||12
9677849|NCT02367456|10777193|FG001|STARTED|Overall Study||30
9677850|NCT02367456|10777194|FG002|STARTED|Overall Study||30
9677851|NCT02367456|10777192|FG000|COMPLETED|Overall Study||0
9677852|NCT02367456|10777193|FG001|COMPLETED|Overall Study||0
9677853|NCT02367456|10777194|FG002|COMPLETED|Overall Study||0
9677854|NCT02367456|10777192|FG000|NOT COMPLETED|Overall Study||12
9677855|NCT02367456|10777193|FG001|NOT COMPLETED|Overall Study||30
9677856|NCT02367456|10777194|FG002|NOT COMPLETED|Overall Study||30
9677857|NCT02091960|10777207|FG000|STARTED|Overall Study||103
9677858|NCT02091960|10777207|FG000|Received Treatment|Overall Study||103
9677859|NCT02091960|10777207|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
9677860|NCT02091960|10777207|FG000|NOT COMPLETED|Overall Study||51
9677861|NCT02022033|10777211|FG000|STARTED|Overall Study||25
9677862|NCT02022033|10777211|FG000|COMPLETED|Overall Study||24
9842554|NCT00825630|10954313|FG002|STARTED|Overall Study||19
10023041|NCT01853605|11146538|FG001|NOT COMPLETED|Overall Study||0
10023042|NCT01853605|11146539|FG002|NOT COMPLETED|Overall Study||0
10023043|NCT01853605|11146540|FG003|NOT COMPLETED|Overall Study||0
10023044|NCT01853618|11146555|FG000|STARTED|Overall Study||8
10023045|NCT01853618|11146556|FG001|STARTED|Overall Study||12
10023046|NCT01853618|11146557|FG002|STARTED|Overall Study||12
10023047|NCT01853618|11146558|FG003|STARTED|Overall Study||9
10023048|NCT01853618|11146559|FG004|STARTED|Overall Study||20
10023049|NCT01853618|11146555|FG000|COMPLETED|Overall Study||6
9677863|NCT02022033|10777211|FG000|NOT COMPLETED|Overall Study||1
9677864|NCT01942135|10777217|FG000|STARTED|Overall Study||347
9677865|NCT01942135|10777218|FG001|STARTED|Overall Study||174
9677866|NCT01942135|10777217|FG000|COMPLETED|Overall Study||0
9842555|NCT00825630|10954314|FG003|STARTED|Overall Study||13
9677867|NCT01942135|10777218|FG001|COMPLETED|Overall Study||0
9677868|NCT01942135|10777217|FG000|NOT COMPLETED|Overall Study||347
9677869|NCT01942135|10777218|FG001|NOT COMPLETED|Overall Study||174
9677870|NCT01434602|10777229|FG000|STARTED|Phase I Dose Escalation||6
9677871|NCT01434602|10777230|FG001|STARTED|Phase I Dose Escalation||7
9677872|NCT01434602|10777231|FG002|STARTED|Phase I Dose Escalation||0
9677873|NCT01434602|10777232|FG003|STARTED|Phase I Dose Escalation||0
10023050|NCT01853618|11146556|FG001|COMPLETED|Overall Study||10
10023051|NCT01853618|11146557|FG002|COMPLETED|Overall Study||10
10023052|NCT01853618|11146558|FG003|COMPLETED|Overall Study||8
9842556|NCT00825630|10954311|FG000|COMPLETED|Overall Study||29
9677874|NCT01434602|10777233|FG004|STARTED|Phase I Dose Escalation||0
9677875|NCT01434602|10777229|FG000|COMPLETED|Phase I Dose Escalation||6
9677876|NCT01434602|10777230|FG001|COMPLETED|Phase I Dose Escalation||6
9677877|NCT01434602|10777231|FG002|COMPLETED|Phase I Dose Escalation||0
10023053|NCT01853618|11146559|FG004|COMPLETED|Overall Study||17
9677878|NCT01434602|10777232|FG003|COMPLETED|Phase I Dose Escalation||0
9677879|NCT01434602|10777233|FG004|COMPLETED|Phase I Dose Escalation||0
9677880|NCT01434602|10777229|FG000|NOT COMPLETED|Phase I Dose Escalation||0
9677881|NCT01434602|10777230|FG001|NOT COMPLETED|Phase I Dose Escalation||1
9677882|NCT01434602|10777231|FG002|NOT COMPLETED|Phase I Dose Escalation||0
9677883|NCT01434602|10777232|FG003|NOT COMPLETED|Phase I Dose Escalation||0
9677884|NCT01434602|10777233|FG004|NOT COMPLETED|Phase I Dose Escalation||0
9677885|NCT01434602|10777229|FG000|STARTED|Phase II Recommended Phase 2 Dose||0
9677886|NCT01434602|10777230|FG001|STARTED|Phase II Recommended Phase 2 Dose||0
9677887|NCT01434602|10777231|FG002|STARTED|Phase II Recommended Phase 2 Dose||12
9677888|NCT01434602|10777232|FG003|STARTED|Phase II Recommended Phase 2 Dose||40
9677889|NCT01434602|10777233|FG004|STARTED|Phase II Recommended Phase 2 Dose||21
9677890|NCT01434602|10777229|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0
9677891|NCT01434602|10777230|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0
9677892|NCT01434602|10777231|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12
9677893|NCT01434602|10777232|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31
9677894|NCT01434602|10777233|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19
9677895|NCT01434602|10777229|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10023054|NCT01853618|11146555|FG000|NOT COMPLETED|Overall Study||2
9677896|NCT01434602|10777230|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10023055|NCT01853618|11146556|FG001|NOT COMPLETED|Overall Study||2
9677897|NCT01434602|10777231|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
9677898|NCT01434602|10777232|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9
9677899|NCT01434602|10777233|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2
9677900|NCT01358877|10777257|FG000|STARTED|Overall Study||2400
9677901|NCT01358877|10777258|FG001|STARTED|Overall Study||2404
9677902|NCT01358877|10777257|FG000|Did Not Receive Study Drug|Overall Study||22
9677903|NCT01358877|10777258|FG001|Did Not Receive Study Drug|Overall Study||13
9677904|NCT01358877|10777257|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
9677905|NCT01358877|10777258|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
9677906|NCT01358877|10777257|FG000|COMPLETED|Overall Study||0
9677907|NCT01358877|10777258|FG001|COMPLETED|Overall Study||0
9677908|NCT01358877|10777257|FG000|NOT COMPLETED|Overall Study||2400
9677909|NCT01358877|10777258|FG001|NOT COMPLETED|Overall Study||2404
9677916|NCT01239797|10777275|FG000|STARTED|Randomized Participants||321
9677917|NCT01239797|10777276|FG001|STARTED|Randomized Participants||325
9677918|NCT01239797|10777275|FG000|COMPLETED|Randomized Participants||319
9677919|NCT01239797|10777276|FG001|COMPLETED|Randomized Participants||316
9677920|NCT01239797|10777275|FG000|NOT COMPLETED|Randomized Participants||2
9677921|NCT01239797|10777276|FG001|NOT COMPLETED|Randomized Participants||9
9677922|NCT01239797|10777275|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
9677923|NCT01239797|10777276|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
9677924|NCT01239797|10777275|FG000|COMPLETED|Treated Participants||0
9677925|NCT01239797|10777276|FG001|COMPLETED|Treated Participants||0
9677926|NCT01239797|10777275|FG000|NOT COMPLETED|Treated Participants||318
9677927|NCT01239797|10777276|FG001|NOT COMPLETED|Treated Participants||317
9677928|NCT01236521|10777284|FG000|STARTED|Overall Study||131
9677929|NCT01236521|10777285|FG001|STARTED|Overall Study||130
9677930|NCT01236521|10777284|FG000|3-month Completed|Overall Study||122
9677931|NCT01236521|10777285|FG001|3-month Completed|Overall Study||118
9677932|NCT01236521|10777284|FG000|6-month Completed|Overall Study||121
9677933|NCT01236521|10777285|FG001|6-month Completed|Overall Study||114
9677934|NCT01236521|10777284|FG000|9-month Completed|Overall Study||105
9677935|NCT01236521|10777285|FG001|9-month Completed|Overall Study||98
9677936|NCT01236521|10777284|FG000|12-moth Completed|Overall Study||108
9677937|NCT01236521|10777285|FG001|12-moth Completed|Overall Study||105
9677938|NCT01236521|10777284|FG000|COMPLETED|Overall Study||108
9677939|NCT01236521|10777285|FG001|COMPLETED|Overall Study||105
9677940|NCT01236521|10777284|FG000|NOT COMPLETED|Overall Study||23
9677941|NCT01236521|10777285|FG001|NOT COMPLETED|Overall Study||25
9677942|NCT01103349|10777294|FG000|STARTED|Overall Study||95
9677943|NCT01103349|10777295|FG001|STARTED|Overall Study||81
9677944|NCT01103349|10777296|FG002|STARTED|Overall Study||67
9677945|NCT01103349|10777294|FG000|COMPLETED|Overall Study||84
9677946|NCT01103349|10777295|FG001|COMPLETED|Overall Study||74
9677947|NCT01103349|10777296|FG002|COMPLETED|Overall Study||63
9677948|NCT01103349|10777294|FG000|NOT COMPLETED|Overall Study||11
9677949|NCT01103349|10777295|FG001|NOT COMPLETED|Overall Study||7
9677950|NCT01103349|10777296|FG002|NOT COMPLETED|Overall Study||4
9677951|NCT01092143|10777309|FG000|STARTED|Overall Study||78
9677952|NCT01092143|10777310|FG001|STARTED|Overall Study||77
9960270|NCT01467466|11079935|FG000|NOT COMPLETED|Overall Study||109
9960271|NCT01467466|11079936|FG001|NOT COMPLETED|Overall Study||104
9677953|NCT01092143|10777311|FG002|STARTED|Overall Study||84
9677954|NCT01092143|10777312|FG003|STARTED|Overall Study||79
9677955|NCT01092143|10777313|FG004|STARTED|Overall Study||71
9677956|NCT01092143|10777309|FG000|Treated|Overall Study||78
9677957|NCT01092143|10777310|FG001|Treated|Overall Study||77
9677958|NCT01092143|10777311|FG002|Treated|Overall Study||83
9677959|NCT01092143|10777312|FG003|Treated|Overall Study||79
9677960|NCT01092143|10777313|FG004|Treated|Overall Study||71
9677961|NCT01092143|10777309|FG000|COMPLETED|Overall Study||63
9677962|NCT01092143|10777310|FG001|COMPLETED|Overall Study||70
9677963|NCT01092143|10777311|FG002|COMPLETED|Overall Study||80
9677964|NCT01092143|10777312|FG003|COMPLETED|Overall Study||72
9677965|NCT01092143|10777313|FG004|COMPLETED|Overall Study||63
9677966|NCT01092143|10777309|FG000|NOT COMPLETED|Overall Study||15
9677967|NCT01092143|10777310|FG001|NOT COMPLETED|Overall Study||7
9677968|NCT01092143|10777311|FG002|NOT COMPLETED|Overall Study||4
9677969|NCT01092143|10777312|FG003|NOT COMPLETED|Overall Study||7
9677970|NCT01092143|10777313|FG004|NOT COMPLETED|Overall Study||8
9724050|NCT00087022|10823751|FG001|Treated (Safety Population)|Overall Study||424
9724051|NCT00087022|10823750|FG000|COMPLETED|Overall Study||379
9724052|NCT00087022|10823751|FG001|COMPLETED|Overall Study||376
9724053|NCT00087022|10823750|FG000|NOT COMPLETED|Overall Study||54
9724054|NCT00087022|10823751|FG001|NOT COMPLETED|Overall Study||55
9724055|NCT00087126|10823757|FG000|STARTED|Overall Study||27
9724056|NCT00087126|10823757|FG000|COMPLETED|Overall Study||25
9724057|NCT00087126|10823757|FG000|NOT COMPLETED|Overall Study||2
9724058|NCT00087139|10823769|FG000|STARTED|Overall Study||39
9724059|NCT00087139|10823770|FG001|STARTED|Overall Study||49
9724060|NCT00087139|10823771|FG002|STARTED|Overall Study||36
9724061|NCT00087139|10823769|FG000|Treated|Overall Study||39
9724062|NCT00087139|10823770|FG001|Treated|Overall Study||48
9724063|NCT00087139|10823771|FG002|Treated|Overall Study||36
9724064|NCT00087139|10823769|FG000|Eligible and Treated|Overall Study||35
9724065|NCT00087139|10823770|FG001|Eligible and Treated|Overall Study||42
9724066|NCT00087139|10823771|FG002|Eligible and Treated|Overall Study||32
9724067|NCT00087139|10823769|FG000|Patients for the Analysis of PSA Respons|Overall Study||30
9724068|NCT00087139|10823770|FG001|Patients for the Analysis of PSA Respons|Overall Study||34
9724069|NCT00087139|10823771|FG002|Patients for the Analysis of PSA Respons|Overall Study||22
9724070|NCT00087139|10823769|FG000|Patients With Measurable Disease|Overall Study||22
9724071|NCT00087139|10823770|FG001|Patients With Measurable Disease|Overall Study||25
9724072|NCT00087139|10823771|FG002|Patients With Measurable Disease|Overall Study||24
9724073|NCT00087139|10823769|FG000|Patients With PSA Response|Overall Study||10
9724074|NCT00087139|10823770|FG001|Patients With PSA Response|Overall Study||8
9724075|NCT00087139|10823771|FG002|Patients With PSA Response|Overall Study||4
9724076|NCT00087139|10823769|FG000|Patients w/ Measurable Disease Response|Overall Study||5
9724077|NCT00087139|10823770|FG001|Patients w/ Measurable Disease Response|Overall Study||2
9724078|NCT00087139|10823771|FG002|Patients w/ Measurable Disease Response|Overall Study||0
9724079|NCT00087139|10823769|FG000|COMPLETED|Overall Study||0
9724080|NCT00087139|10823770|FG001|COMPLETED|Overall Study||0
9724081|NCT00087139|10823771|FG002|COMPLETED|Overall Study||0
9724082|NCT00087139|10823769|FG000|NOT COMPLETED|Overall Study||39
9724083|NCT00087139|10823770|FG001|NOT COMPLETED|Overall Study||49
9724084|NCT00087139|10823771|FG002|NOT COMPLETED|Overall Study||36
9724085|NCT00087152|10823777|FG000|STARTED|Overall Study||27
9724086|NCT00087152|10823777|FG000|COMPLETED|Overall Study||21
9724087|NCT00087152|10823777|FG000|NOT COMPLETED|Overall Study||6
9724088|NCT00087438|10823782|FG000|STARTED|Overall Study||59
9724089|NCT00087438|10823782|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
9724090|NCT00087438|10823782|FG000|NOT COMPLETED|Overall Study||4
9724091|NCT00087490|10823790|FG000|STARTED|Overall Study||544
9724092|NCT00087490|10823791|FG001|STARTED|Overall Study||533
9724093|NCT00087490|10823790|FG000|Treated|Overall Study||537
9724094|NCT00087490|10823791|FG001|Treated|Overall Study||515
9724095|NCT00087490|10823790|FG000|COMPLETED|Overall Study||286
9724096|NCT00087490|10823791|FG001|COMPLETED|Overall Study||264
9724097|NCT00087490|10823790|FG000|NOT COMPLETED|Overall Study||258
9724098|NCT00087490|10823791|FG001|NOT COMPLETED|Overall Study||269
9724099|NCT00087516|10823800|FG000|STARTED|Overall Study||238
9724100|NCT00087516|10823801|FG001|STARTED|Overall Study||250
9678007|NCT01004029|10777346|FG000|STARTED|Overall Study||578
9678008|NCT01004029|10777347|FG001|STARTED|Overall Study||1130
9678009|NCT01004029|10777346|FG000|Safety Population|Overall Study||578
9678010|NCT01004029|10777347|FG001|Safety Population|Overall Study||1128
9678011|NCT01004029|10777346|FG000|COMPLETED|Overall Study||530
9678012|NCT01004029|10777347|FG001|COMPLETED|Overall Study||1057
9678013|NCT01004029|10777346|FG000|NOT COMPLETED|Overall Study||48
9678014|NCT01004029|10777347|FG001|NOT COMPLETED|Overall Study||73
9678015|NCT00640133|10777356|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15
9678016|NCT00640133|10777357|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12
9678017|NCT00640133|10777356|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15
9678018|NCT00640133|10777357|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12
9678019|NCT00640133|10777356|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
9678020|NCT00640133|10777357|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
9678021|NCT00640133|10777356|FG000|STARTED|Open Label Phase (Month 4-12)||27
9678022|NCT00640133|10777357|FG001|STARTED|Open Label Phase (Month 4-12)||0
9678023|NCT00640133|10777356|FG000|COMPLETED|Open Label Phase (Month 4-12)||24
9678024|NCT00640133|10777357|FG001|COMPLETED|Open Label Phase (Month 4-12)||0
9678025|NCT00640133|10777356|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3
9678026|NCT00640133|10777357|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0
9678027|NCT00593567|10777367|FG000|STARTED|Overall Study||48
9678028|NCT00593567|10777368|FG001|STARTED|Overall Study||22
9678029|NCT00593567|10777367|FG000|COMPLETED|Overall Study||28
9678030|NCT00593567|10777368|FG001|COMPLETED|Overall Study||12
9678031|NCT00593567|10777367|FG000|NOT COMPLETED|Overall Study||20
9678032|NCT00593567|10777368|FG001|NOT COMPLETED|Overall Study||10
9678033|NCT00588770|10777376|FG000|STARTED|Overall Study||200
9678034|NCT00588770|10777377|FG001|STARTED|Overall Study||203
9678035|NCT00588770|10777376|FG000|Eligible|Overall Study||188
9678036|NCT00588770|10777377|FG001|Eligible|Overall Study||183
9678037|NCT00588770|10777376|FG000|Start Protocol Therapy|Overall Study||200
9678038|NCT00588770|10777377|FG001|Start Protocol Therapy|Overall Study||194
9678039|NCT00588770|10777376|FG000|COMPLETED|Overall Study||41
9678040|NCT00588770|10777377|FG001|COMPLETED|Overall Study||3
9678041|NCT00588770|10777376|FG000|NOT COMPLETED|Overall Study||159
9678042|NCT00588770|10777377|FG001|NOT COMPLETED|Overall Study||200
9842557|NCT00825630|10954312|FG001|COMPLETED|Overall Study||62
9842558|NCT00825630|10954313|FG002|COMPLETED|Overall Study||19
9842559|NCT00825630|10954314|FG003|COMPLETED|Overall Study||13
9678046|NCT02983617|10777389|FG000|STARTED|Overall Study||6
9678047|NCT02983617|10777390|FG001|STARTED|Overall Study||30
9678048|NCT02983617|10777389|FG000|COMPLETED|Overall Study||6
9678049|NCT02983617|10777390|FG001|COMPLETED|Overall Study||21
9678050|NCT02983617|10777389|FG000|NOT COMPLETED|Overall Study||0
9678051|NCT02983617|10777390|FG001|NOT COMPLETED|Overall Study||9
9678052|NCT02964377|10777399|FG000|STARTED|Overall Study||5
9678053|NCT02964377|10777400|FG001|STARTED|Overall Study||5
9678054|NCT02964377|10777401|FG002|STARTED|Overall Study||5
9678055|NCT02964377|10777399|FG000|COMPLETED|Overall Study||5
9678056|NCT02964377|10777400|FG001|COMPLETED|Overall Study||5
9678057|NCT02964377|10777401|FG002|COMPLETED|Overall Study||5
9678058|NCT02964377|10777399|FG000|NOT COMPLETED|Overall Study||0
9678059|NCT02964377|10777400|FG001|NOT COMPLETED|Overall Study||0
9678060|NCT02964377|10777401|FG002|NOT COMPLETED|Overall Study||0
9678061|NCT02790034|10777412|FG000|STARTED|Overall Study||33
9678062|NCT02790034|10777413|FG001|STARTED|Overall Study||56
9678063|NCT02790034|10777414|FG002|STARTED|Overall Study||40
9678064|NCT02790034|10777412|FG000|COMPLETED|Overall Study||27
9678065|NCT02790034|10777413|FG001|COMPLETED|Overall Study||46
9678066|NCT02790034|10777414|FG002|COMPLETED|Overall Study||36
9678067|NCT02790034|10777412|FG000|NOT COMPLETED|Overall Study||6
9678068|NCT02790034|10777413|FG001|NOT COMPLETED|Overall Study||10
9678069|NCT02790034|10777414|FG002|NOT COMPLETED|Overall Study||4
9678070|NCT02649946|10777424|FG000|STARTED|Overall Study||142
9678071|NCT02649946|10777425|FG001|STARTED|Overall Study||138
9678072|NCT02649946|10777424|FG000|COMPLETED|Overall Study||130
9678073|NCT02649946|10777425|FG001|COMPLETED|Overall Study||123
9678074|NCT02649946|10777424|FG000|NOT COMPLETED|Overall Study||12
9678075|NCT02649946|10777425|FG001|NOT COMPLETED|Overall Study||15
9678076|NCT02431247|10777433|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362
9678077|NCT02431247|10777434|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363
9678078|NCT02431247|10777435|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0
9678079|NCT02431247|10777433|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296
9678080|NCT02431247|10777434|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322
9678081|NCT02431247|10777435|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0
9678082|NCT02431247|10777433|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66
9678083|NCT02431247|10777434|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41
9678084|NCT02431247|10777435|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0
9678085|NCT02431247|10777433|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
9678086|NCT02431247|10777434|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0
9678087|NCT02431247|10777435|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322
9678088|NCT02431247|10777433|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9678089|NCT02431247|10777434|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9678090|NCT02431247|10777435|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289
9678091|NCT02431247|10777433|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9678092|NCT02431247|10777434|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9678093|NCT02431247|10777435|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33
9678094|NCT02345850|10777450|FG000|STARTED|Overall Study||114
9678095|NCT02345850|10777451|FG001|STARTED|Overall Study||114
9678096|NCT02345850|10777452|FG002|STARTED|Overall Study||118
9678097|NCT02345850|10777450|FG000|COMPLETED|Overall Study||101
9678098|NCT02345850|10777451|FG001|COMPLETED|Overall Study||106
9678099|NCT02345850|10777452|FG002|COMPLETED|Overall Study||112
9678100|NCT02345850|10777450|FG000|NOT COMPLETED|Overall Study||13
9678101|NCT02345850|10777451|FG001|NOT COMPLETED|Overall Study||8
9678102|NCT02345850|10777452|FG002|NOT COMPLETED|Overall Study||6
9678103|NCT02343302|10777462|FG000|STARTED|Overall Study||1
9678104|NCT02343302|10777463|FG001|STARTED|Overall Study||1
9678105|NCT02343302|10777462|FG000|COMPLETED|Overall Study||0
9842560|NCT00825630|10954311|FG000|NOT COMPLETED|Overall Study||0
9842561|NCT00825630|10954312|FG001|NOT COMPLETED|Overall Study||0
9842562|NCT00825630|10954313|FG002|NOT COMPLETED|Overall Study||0
9842563|NCT00825630|10954314|FG003|NOT COMPLETED|Overall Study||0
9842564|NCT00825682|10954326|FG000|STARTED|Overall Study||47
9842565|NCT00825682|10954327|FG001|STARTED|Overall Study||25
9842566|NCT00825682|10954326|FG000|COMPLETED|Overall Study||34
9842567|NCT00825682|10954327|FG001|COMPLETED|Overall Study||20
9842568|NCT00825682|10954326|FG000|NOT COMPLETED|Overall Study||13
9842569|NCT00825682|10954327|FG001|NOT COMPLETED|Overall Study||5
9842570|NCT00825734|10954334|FG000|STARTED|Phase I||4
9842571|NCT00825734|10954335|FG001|STARTED|Phase I||3
9842572|NCT00825734|10954336|FG002|STARTED|Phase I||3
9842573|NCT00825734|10954334|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
9842574|NCT00825734|10954335|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
9842575|NCT00825734|10954336|FG002|COMPLETED|Phase I||3
9842576|NCT00825734|10954334|FG000|NOT COMPLETED|Phase I||4
9842577|NCT00825734|10954335|FG001|NOT COMPLETED|Phase I||3
9842578|NCT00825734|10954336|FG002|NOT COMPLETED|Phase I||0
9842579|NCT00825734|10954334|FG000|STARTED|Phase II||0
9842580|NCT00825734|10954335|FG001|STARTED|Phase II||0
9842581|NCT00825734|10954336|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
9842582|NCT00825734|10954334|FG000|COMPLETED|Phase II||0
9842583|NCT00825734|10954335|FG001|COMPLETED|Phase II||0
9842584|NCT00825734|10954336|FG002|COMPLETED|Phase II||0
9842585|NCT00825734|10954334|FG000|NOT COMPLETED|Phase II||0
9842586|NCT00825734|10954335|FG001|NOT COMPLETED|Phase II||0
9842587|NCT00825734|10954336|FG002|NOT COMPLETED|Phase II||76
9842588|NCT00825786|10954343|FG000|STARTED|Overall Study||52
9842589|NCT00825786|10954344|FG001|STARTED|Overall Study||51
9842590|NCT00825786|10954343|FG000|COMPLETED|Overall Study||52
9842591|NCT00825786|10954344|FG001|COMPLETED|Overall Study||51
9842592|NCT00825786|10954343|FG000|NOT COMPLETED|Overall Study||0
9842593|NCT00825786|10954344|FG001|NOT COMPLETED|Overall Study||0
9842594|NCT00825812|10954354|FG000|STARTED|Overall Study||29
9842595|NCT00825812|10954355|FG001|STARTED|Overall Study||32
9842596|NCT00825812|10954356|FG002|STARTED|Overall Study||126
9842597|NCT00825812|10954357|FG003|STARTED|Overall Study||121
9842598|NCT00825812|10954354|FG000|TREATED|Overall Study||29
9842599|NCT00825812|10954355|FG001|TREATED|Overall Study||31
9842600|NCT00825812|10954356|FG002|TREATED|Overall Study||120
9842601|NCT00825812|10954357|FG003|TREATED|Overall Study||111
9842602|NCT00825812|10954354|FG000|COMPLETED|Overall Study||29
9842603|NCT00825812|10954355|FG001|COMPLETED|Overall Study||31
9842604|NCT00825812|10954356|FG002|COMPLETED|Overall Study||120
9842605|NCT00825812|10954357|FG003|COMPLETED|Overall Study||111
9842606|NCT00825812|10954354|FG000|NOT COMPLETED|Overall Study||0
9842607|NCT00825812|10954355|FG001|NOT COMPLETED|Overall Study||1
9842608|NCT00825812|10954356|FG002|NOT COMPLETED|Overall Study||6
9842609|NCT00825812|10954357|FG003|NOT COMPLETED|Overall Study||10
9842610|NCT00825825|10954367|FG000|STARTED|First Medication Period (14 Days)||6
9842611|NCT00825825|10954368|FG001|STARTED|First Medication Period (14 Days)||4
9842612|NCT00825825|10954369|FG002|STARTED|First Medication Period (14 Days)||3
9842613|NCT00825825|10954370|FG003|STARTED|First Medication Period (14 Days)||5
9842614|NCT00825825|10954371|FG004|STARTED|First Medication Period (14 Days)||4
9842615|NCT00825825|10954372|FG005|STARTED|First Medication Period (14 Days)||5
9842616|NCT00825825|10954367|FG000|COMPLETED|First Medication Period (14 Days)||3
9842617|NCT00825825|10954368|FG001|COMPLETED|First Medication Period (14 Days)||4
9842618|NCT00825825|10954369|FG002|COMPLETED|First Medication Period (14 Days)||2
9842619|NCT00825825|10954370|FG003|COMPLETED|First Medication Period (14 Days)||5
9842620|NCT00825825|10954371|FG004|COMPLETED|First Medication Period (14 Days)||4
9842621|NCT00825825|10954372|FG005|COMPLETED|First Medication Period (14 Days)||3
9842622|NCT00825825|10954367|FG000|NOT COMPLETED|First Medication Period (14 Days)||3
9842623|NCT00825825|10954368|FG001|NOT COMPLETED|First Medication Period (14 Days)||0
9842624|NCT00825825|10954369|FG002|NOT COMPLETED|First Medication Period (14 Days)||1
9842625|NCT00825825|10954370|FG003|NOT COMPLETED|First Medication Period (14 Days)||0
9678106|NCT02343302|10777463|FG001|COMPLETED|Overall Study||0
9678107|NCT02343302|10777462|FG000|NOT COMPLETED|Overall Study||1
9678108|NCT02343302|10777463|FG001|NOT COMPLETED|Overall Study||1
9678121|NCT02053584|10777486|FG000|STARTED|Overall Study||230
9678122|NCT02053584|10777486|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230
9678123|NCT02053584|10777486|FG000|NOT COMPLETED|Overall Study||0
9678124|NCT01962792|10777497|FG000|STARTED|Overall Study||3
9678125|NCT01962792|10777498|FG001|STARTED|Overall Study||5
9678126|NCT01962792|10777499|FG002|STARTED|Overall Study||17
9678127|NCT01962792|10777500|FG003|STARTED|Overall Study||59
9678128|NCT01962792|10777497|FG000|COMPLETED|Overall Study||3
9678129|NCT01962792|10777498|FG001|COMPLETED|Overall Study||5
9678130|NCT01962792|10777499|FG002|COMPLETED|Overall Study||17
9678131|NCT01962792|10777500|FG003|COMPLETED|Overall Study||59
9678132|NCT01962792|10777497|FG000|NOT COMPLETED|Overall Study||0
9678133|NCT01962792|10777498|FG001|NOT COMPLETED|Overall Study||0
9678134|NCT01962792|10777499|FG002|NOT COMPLETED|Overall Study||0
9678135|NCT01962792|10777500|FG003|NOT COMPLETED|Overall Study||0
9678136|NCT01878500|10777511|FG000|STARTED|Overall Study||47
9678137|NCT01878500|10777511|FG000|COMPLETED|Overall Study||47
9678138|NCT01878500|10777511|FG000|NOT COMPLETED|Overall Study||0
9678139|NCT01464164|10777522|FG000|STARTED|Overall Study||3
9678140|NCT01464164|10777523|FG001|STARTED|Overall Study||4
9678141|NCT01464164|10777524|FG002|STARTED|Overall Study||4
9678142|NCT01464164|10777525|FG003|STARTED|Overall Study||2
9678143|NCT01464164|10777526|FG004|STARTED|Overall Study||3
9678144|NCT01464164|10777527|FG005|STARTED|Overall Study||0
9678145|NCT01464164|10777528|FG006|STARTED|Overall Study||3
9678146|NCT01464164|10777522|FG000|COMPLETED|Overall Study||3
9678147|NCT01464164|10777523|FG001|COMPLETED|Overall Study||3
9678148|NCT01464164|10777524|FG002|COMPLETED|Overall Study||2
9678149|NCT01464164|10777525|FG003|COMPLETED|Overall Study||2
9678150|NCT01464164|10777526|FG004|COMPLETED|Overall Study||3
9678151|NCT01464164|10777527|FG005|COMPLETED|Overall Study||0
9678152|NCT01464164|10777528|FG006|COMPLETED|Overall Study||1
9678153|NCT01464164|10777522|FG000|NOT COMPLETED|Overall Study||0
9678154|NCT01464164|10777523|FG001|NOT COMPLETED|Overall Study||1
9678155|NCT01464164|10777524|FG002|NOT COMPLETED|Overall Study||2
9678156|NCT01464164|10777525|FG003|NOT COMPLETED|Overall Study||0
9678157|NCT01464164|10777526|FG004|NOT COMPLETED|Overall Study||0
9678158|NCT01464164|10777527|FG005|NOT COMPLETED|Overall Study||0
9678159|NCT01464164|10777528|FG006|NOT COMPLETED|Overall Study||2
9678160|NCT01318317|10777547|FG000|STARTED|Overall Study||1
9678161|NCT01318317|10777548|FG001|STARTED|Overall Study||4
9678162|NCT01318317|10777549|FG002|STARTED|Overall Study||3
9678163|NCT01318317|10777547|FG000|COMPLETED|Overall Study||1
9678164|NCT01318317|10777548|FG001|COMPLETED|Overall Study||4
9678165|NCT01318317|10777549|FG002|COMPLETED|Overall Study||3
9678166|NCT01318317|10777547|FG000|NOT COMPLETED|Overall Study||0
9678167|NCT01318317|10777548|FG001|NOT COMPLETED|Overall Study||0
9678168|NCT01318317|10777549|FG002|NOT COMPLETED|Overall Study||0
9678169|NCT01111565|10777558|FG000|STARTED|Phase B (Weeks 0 to 8)||137
9678170|NCT01111565|10777559|FG001|STARTED|Phase B (Weeks 0 to 8)||0
9678171|NCT01111565|10777560|FG002|STARTED|Phase B (Weeks 0 to 8)||0
9678172|NCT01111565|10777561|FG003|STARTED|Phase B (Weeks 0 to 8)||0
9842626|NCT00825825|10954371|FG004|NOT COMPLETED|First Medication Period (14 Days)||0
9842627|NCT00825825|10954372|FG005|NOT COMPLETED|First Medication Period (14 Days)||2
9842628|NCT00825825|10954367|FG000|STARTED|First Washout Period (14 Days)||3
9842629|NCT00825825|10954368|FG001|STARTED|First Washout Period (14 Days)||4
9842630|NCT00825825|10954369|FG002|STARTED|First Washout Period (14 Days)||2
9842631|NCT00825825|10954370|FG003|STARTED|First Washout Period (14 Days)||5
9842632|NCT00825825|10954371|FG004|STARTED|First Washout Period (14 Days)||4
9842633|NCT00825825|10954372|FG005|STARTED|First Washout Period (14 Days)||3
9842634|NCT00825825|10954367|FG000|COMPLETED|First Washout Period (14 Days)||3
9842635|NCT00825825|10954368|FG001|COMPLETED|First Washout Period (14 Days)||4
9842636|NCT00825825|10954369|FG002|COMPLETED|First Washout Period (14 Days)||2
9842637|NCT00825825|10954370|FG003|COMPLETED|First Washout Period (14 Days)||5
9842638|NCT00825825|10954371|FG004|COMPLETED|First Washout Period (14 Days)||4
9842639|NCT00825825|10954372|FG005|COMPLETED|First Washout Period (14 Days)||3
9842640|NCT00825825|10954367|FG000|NOT COMPLETED|First Washout Period (14 Days)||0
9842641|NCT00825825|10954368|FG001|NOT COMPLETED|First Washout Period (14 Days)||0
9842642|NCT00825825|10954369|FG002|NOT COMPLETED|First Washout Period (14 Days)||0
9842643|NCT00825825|10954370|FG003|NOT COMPLETED|First Washout Period (14 Days)||0
9842644|NCT00825825|10954371|FG004|NOT COMPLETED|First Washout Period (14 Days)||0
9842645|NCT00825825|10954372|FG005|NOT COMPLETED|First Washout Period (14 Days)||0
9678173|NCT01111565|10777562|FG004|STARTED|Phase B (Weeks 0 to 8)||0
9678174|NCT01111565|10777558|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71
9678175|NCT01111565|10777559|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0
9678176|NCT01111565|10777560|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0
9678177|NCT01111565|10777561|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0
9678178|NCT01111565|10777562|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0
9842646|NCT00825825|10954367|FG000|STARTED|Second Medication Period (14 Days)||3
9678179|NCT01111565|10777558|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66
9678180|NCT01111565|10777559|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
9678181|NCT01111565|10777560|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
9678182|NCT01111565|10777561|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
9678183|NCT01111565|10777562|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
9678184|NCT01111565|10777558|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0
9678185|NCT01111565|10777559|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26
9678186|NCT01111565|10777560|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16
9678187|NCT01111565|10777561|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14
9678188|NCT01111565|10777562|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15
9678189|NCT01111565|10777558|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
9678190|NCT01111565|10777559|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19
9678191|NCT01111565|10777560|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
9678192|NCT01111565|10777561|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10
9678193|NCT01111565|10777562|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
9678194|NCT01111565|10777558|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
9678195|NCT01111565|10777559|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7
9678196|NCT01111565|10777560|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5
9678197|NCT01111565|10777561|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
9678198|NCT01111565|10777562|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
9678199|NCT01092117|10777572|FG000|STARTED|Index Procedure to 1 Month||161
9678200|NCT01092117|10777572|FG000|COMPLETED|Index Procedure to 1 Month||160
9678201|NCT01092117|10777572|FG000|NOT COMPLETED|Index Procedure to 1 Month||1
9678202|NCT01092117|10777572|FG000|STARTED|1 Month||160
9678203|NCT01092117|10777572|FG000|COMPLETED|1 Month||157
9678204|NCT01092117|10777572|FG000|NOT COMPLETED|1 Month||3
9678205|NCT01092117|10777572|FG000|STARTED|6 Months||157
9678206|NCT01092117|10777572|FG000|COMPLETED|6 Months||152
9678207|NCT01092117|10777572|FG000|NOT COMPLETED|6 Months||5
9678208|NCT01092117|10777572|FG000|STARTED|12 Month||152
9678209|NCT01092117|10777572|FG000|COMPLETED|12 Month||138
9678210|NCT01092117|10777572|FG000|NOT COMPLETED|12 Month||14
10023056|NCT01853618|11146557|FG002|NOT COMPLETED|Overall Study||2
10023057|NCT01853618|11146558|FG003|NOT COMPLETED|Overall Study||1
10023058|NCT01853618|11146559|FG004|NOT COMPLETED|Overall Study||3
9678211|NCT01092117|10777572|FG000|STARTED|Year 2||138
9678212|NCT01092117|10777572|FG000|COMPLETED|Year 2||128
9678213|NCT01092117|10777572|FG000|NOT COMPLETED|Year 2||10
9678214|NCT01092117|10777572|FG000|STARTED|Year 3||128
9678215|NCT01092117|10777572|FG000|COMPLETED|Year 3||109
9678216|NCT01092117|10777572|FG000|NOT COMPLETED|Year 3||19
9678217|NCT01092117|10777572|FG000|STARTED|Year 4||109
9678218|NCT01092117|10777572|FG000|COMPLETED|Year 4||93
9678219|NCT01092117|10777572|FG000|NOT COMPLETED|Year 4||16
9678220|NCT00950989|10777580|FG000|STARTED|Overall Study||63
9678221|NCT00950989|10777581|FG001|STARTED|Overall Study||63
9678222|NCT00950989|10777582|FG002|STARTED|Overall Study||63
9678223|NCT00950989|10777583|FG003|STARTED|Overall Study||63
9678224|NCT00950989|10777580|FG000|COMPLETED|Overall Study||59
9678225|NCT00950989|10777581|FG001|COMPLETED|Overall Study||60
9678226|NCT00950989|10777582|FG002|COMPLETED|Overall Study||60
9678227|NCT00950989|10777583|FG003|COMPLETED|Overall Study||63
9678228|NCT00950989|10777580|FG000|NOT COMPLETED|Overall Study||4
9678229|NCT00950989|10777581|FG001|NOT COMPLETED|Overall Study||3
9678230|NCT00950989|10777582|FG002|NOT COMPLETED|Overall Study||3
9678231|NCT00950989|10777583|FG003|NOT COMPLETED|Overall Study||0
9678232|NCT00489307|10777598|FG000|STARTED|Overall Study||67
9678233|NCT00489307|10777599|FG001|STARTED|Overall Study||65
9678234|NCT00489307|10777598|FG000|COMPLETED|Overall Study||43
9678235|NCT00489307|10777599|FG001|COMPLETED|Overall Study||41
9678236|NCT00489307|10777598|FG000|NOT COMPLETED|Overall Study||24
9678237|NCT00489307|10777599|FG001|NOT COMPLETED|Overall Study||24
9678238|NCT00072410|10777607|FG000|STARTED|Overall Study||3
9678239|NCT00072410|10777608|FG001|STARTED|Overall Study||4
9678240|NCT00072410|10777607|FG000|COMPLETED|Overall Study||3
9678241|NCT00072410|10777608|FG001|COMPLETED|Overall Study||1
9678242|NCT00072410|10777607|FG000|NOT COMPLETED|Overall Study||0
9842647|NCT00825825|10954368|FG001|STARTED|Second Medication Period (14 Days)||4
9842648|NCT00825825|10954369|FG002|STARTED|Second Medication Period (14 Days)||2
9842649|NCT00825825|10954370|FG003|STARTED|Second Medication Period (14 Days)||5
9842650|NCT00825825|10954371|FG004|STARTED|Second Medication Period (14 Days)||4
9842651|NCT00825825|10954372|FG005|STARTED|Second Medication Period (14 Days)||3
10023059|NCT01853644|11146572|FG000|STARTED|Registration and Treatment Start||31
9678243|NCT00072410|10777608|FG001|NOT COMPLETED|Overall Study||3
9724101|NCT00087516|10823802|FG002|STARTED|Overall Study||130
9724102|NCT00087516|10823803|FG003|STARTED|Overall Study||123
9724103|NCT00087516|10823800|FG000|COMPLETED|Overall Study||77
9724104|NCT00087516|10823801|FG001|COMPLETED|Overall Study||81
9724105|NCT00087516|10823802|FG002|COMPLETED|Overall Study||33
9724106|NCT00087516|10823803|FG003|COMPLETED|Overall Study||38
9724107|NCT00087516|10823800|FG000|NOT COMPLETED|Overall Study||161
9724108|NCT00087516|10823801|FG001|NOT COMPLETED|Overall Study||169
9724109|NCT00087516|10823802|FG002|NOT COMPLETED|Overall Study||97
9724110|NCT00087516|10823803|FG003|NOT COMPLETED|Overall Study||85
9724111|NCT00087529|10823819|FG000|STARTED|Overall Study||147
9724112|NCT00087529|10823820|FG001|STARTED|Overall Study||292
9724113|NCT00087529|10823819|FG000|COMPLETED|Overall Study||116
9724114|NCT00087529|10823820|FG001|COMPLETED|Overall Study||224
9678244|NCT05057923|10777614|FG000|STARTED|Overall Study||6
9678245|NCT05057923|10777614|FG000|COMPLETED|Overall Study||6
9678246|NCT05057923|10777614|FG000|NOT COMPLETED|Overall Study||0
9678247|NCT04632706|10777622|FG000|STARTED|Overall Study||6
9678248|NCT04632706|10777623|FG001|STARTED|Overall Study||6
9678249|NCT04632706|10777624|FG002|STARTED|Overall Study||6
9678250|NCT04632706|10777625|FG003|STARTED|Overall Study||6
9678251|NCT04632706|10777622|FG000|COMPLETED|Overall Study||6
9678252|NCT04632706|10777623|FG001|COMPLETED|Overall Study||6
9678253|NCT04632706|10777624|FG002|COMPLETED|Overall Study||5
9678254|NCT04632706|10777625|FG003|COMPLETED|Overall Study||6
9678255|NCT04632706|10777622|FG000|NOT COMPLETED|Overall Study||0
9678256|NCT04632706|10777623|FG001|NOT COMPLETED|Overall Study||0
9842652|NCT00825825|10954367|FG000|COMPLETED|Second Medication Period (14 Days)||1
9842653|NCT00825825|10954368|FG001|COMPLETED|Second Medication Period (14 Days)||4
9842654|NCT00825825|10954369|FG002|COMPLETED|Second Medication Period (14 Days)||2
9842655|NCT00825825|10954370|FG003|COMPLETED|Second Medication Period (14 Days)||3
9842656|NCT00825825|10954371|FG004|COMPLETED|Second Medication Period (14 Days)||3
9842657|NCT00825825|10954372|FG005|COMPLETED|Second Medication Period (14 Days)||3
9842658|NCT00825825|10954367|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2
9842659|NCT00825825|10954368|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0
9842660|NCT00825825|10954369|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0
9842661|NCT00825825|10954370|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2
9842662|NCT00825825|10954371|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1
9842663|NCT00825825|10954372|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0
9842664|NCT00825825|10954367|FG000|STARTED|Second Washout Period (14 Days)||1
9842665|NCT00825825|10954368|FG001|STARTED|Second Washout Period (14 Days)||4
9842666|NCT00825825|10954369|FG002|STARTED|Second Washout Period (14 Days)||2
9842667|NCT00825825|10954370|FG003|STARTED|Second Washout Period (14 Days)||3
9842668|NCT00825825|10954371|FG004|STARTED|Second Washout Period (14 Days)||3
9842669|NCT00825825|10954372|FG005|STARTED|Second Washout Period (14 Days)||3
9842670|NCT00825825|10954367|FG000|COMPLETED|Second Washout Period (14 Days)||1
9842671|NCT00825825|10954368|FG001|COMPLETED|Second Washout Period (14 Days)||4
9842672|NCT00825825|10954369|FG002|COMPLETED|Second Washout Period (14 Days)||2
9842673|NCT00825825|10954370|FG003|COMPLETED|Second Washout Period (14 Days)||3
9842674|NCT00825825|10954371|FG004|COMPLETED|Second Washout Period (14 Days)||3
9842675|NCT00825825|10954372|FG005|COMPLETED|Second Washout Period (14 Days)||3
9842676|NCT00825825|10954367|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0
9842677|NCT00825825|10954368|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0
9842678|NCT00825825|10954369|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0
9842679|NCT00825825|10954370|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0
9842680|NCT00825825|10954371|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0
9842681|NCT00825825|10954372|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0
9842682|NCT00825825|10954367|FG000|STARTED|Third Medication Period (14 Days)||1
9842683|NCT00825825|10954368|FG001|STARTED|Third Medication Period (14 Days)||4
9842684|NCT00825825|10954369|FG002|STARTED|Third Medication Period (14 Days)||2
9842685|NCT00825825|10954370|FG003|STARTED|Third Medication Period (14 Days)||3
9842686|NCT00825825|10954371|FG004|STARTED|Third Medication Period (14 Days)||3
9842687|NCT00825825|10954372|FG005|STARTED|Third Medication Period (14 Days)||3
9842688|NCT00825825|10954367|FG000|COMPLETED|Third Medication Period (14 Days)||1
9842689|NCT00825825|10954368|FG001|COMPLETED|Third Medication Period (14 Days)||2
9842690|NCT00825825|10954369|FG002|COMPLETED|Third Medication Period (14 Days)||2
9842691|NCT00825825|10954370|FG003|COMPLETED|Third Medication Period (14 Days)||3
9842692|NCT00825825|10954371|FG004|COMPLETED|Third Medication Period (14 Days)||3
9842693|NCT00825825|10954372|FG005|COMPLETED|Third Medication Period (14 Days)||1
9842694|NCT00825825|10954367|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0
9842695|NCT00825825|10954368|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2
9842696|NCT00825825|10954369|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0
9842697|NCT00825825|10954370|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0
9842698|NCT00825825|10954371|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0
9842699|NCT00825825|10954372|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2
9842700|NCT00825916|10954382|FG000|STARTED|Overall Study||19
9842701|NCT00825916|10954383|FG001|STARTED|Overall Study||20
9842702|NCT00825916|10954384|FG002|STARTED|Overall Study||20
9842703|NCT00825916|10954382|FG000|COMPLETED|Overall Study||15
9842704|NCT00825916|10954383|FG001|COMPLETED|Overall Study||18
9842705|NCT00825916|10954384|FG002|COMPLETED|Overall Study||19
9842706|NCT00825916|10954382|FG000|NOT COMPLETED|Overall Study||4
9842707|NCT00825916|10954383|FG001|NOT COMPLETED|Overall Study||2
9842708|NCT00825916|10954384|FG002|NOT COMPLETED|Overall Study||1
9842709|NCT00825994|10954425|FG000|STARTED|Overall Study||24
9842710|NCT00825994|10954425|FG000|COMPLETED|Overall Study||19
9842711|NCT00825994|10954425|FG000|NOT COMPLETED|Overall Study||5
9842712|NCT00826007|10954431|FG000|STARTED|Overall Study|Retrospective review|308
9842713|NCT00826007|10954432|FG001|STARTED|Overall Study||279
9842714|NCT00826007|10954431|FG000|COMPLETED|Overall Study|Retrospective review|308
9842715|NCT00826007|10954432|FG001|COMPLETED|Overall Study||279
9842716|NCT00826007|10954431|FG000|NOT COMPLETED|Overall Study||0
9842717|NCT00826007|10954432|FG001|NOT COMPLETED|Overall Study||0
9842718|NCT00826020|10954437|FG000|STARTED|Overall Study||72
9842719|NCT00826020|10954437|FG000|COMPLETED|Overall Study||72
9842720|NCT00826020|10954437|FG000|NOT COMPLETED|Overall Study||0
9842721|NCT00826111|10954443|FG000|STARTED|Overall Study||14
9678257|NCT04632706|10777624|FG002|NOT COMPLETED|Overall Study||1
9678258|NCT04632706|10777625|FG003|NOT COMPLETED|Overall Study||0
9678259|NCT04544358|10777639|FG000|STARTED|Overall Study||12
9678260|NCT04544358|10777640|FG001|STARTED|Overall Study||10
9678261|NCT04544358|10777639|FG000|COMPLETED|Overall Study||12
9678262|NCT04544358|10777640|FG001|COMPLETED|Overall Study||10
9678263|NCT04544358|10777639|FG000|NOT COMPLETED|Overall Study||0
9678264|NCT04544358|10777640|FG001|NOT COMPLETED|Overall Study||0
9724115|NCT00087529|10823819|FG000|NOT COMPLETED|Overall Study||31
9724116|NCT00087529|10823820|FG001|NOT COMPLETED|Overall Study||68
9724117|NCT00087555|10823829|FG000|STARTED|Overall Study||66
9724118|NCT00087555|10823830|FG001|STARTED|Overall Study||62
9724119|NCT00087555|10823831|FG002|STARTED|Overall Study||67
9724120|NCT00087555|10823829|FG000|Treated|Overall Study||65
9724121|NCT00087555|10823830|FG001|Treated|Overall Study||60
9724122|NCT00087555|10823831|FG002|Treated|Overall Study||67
9724123|NCT00087555|10823829|FG000|COMPLETED|Overall Study||54
9724124|NCT00087555|10823830|FG001|COMPLETED|Overall Study||51
9724125|NCT00087555|10823831|FG002|COMPLETED|Overall Study||46
9724126|NCT00087555|10823829|FG000|NOT COMPLETED|Overall Study||12
9724127|NCT00087555|10823830|FG001|NOT COMPLETED|Overall Study||11
9724128|NCT00087555|10823831|FG002|NOT COMPLETED|Overall Study||21
9724129|NCT00087568|10823841|FG000|STARTED|Overall Study||32
9724130|NCT00087568|10823842|FG001|STARTED|Overall Study||25
9724131|NCT00087568|10823841|FG000|COMPLETED|Overall Study||2
9724132|NCT00087568|10823842|FG001|COMPLETED|Overall Study||23
9724133|NCT00087568|10823841|FG000|NOT COMPLETED|Overall Study||30
9724134|NCT00087568|10823842|FG001|NOT COMPLETED|Overall Study||2
9724135|NCT00087594|10823850|FG000|STARTED|Overall Study||24
9724136|NCT00087594|10823851|FG001|STARTED|Overall Study||24
9724137|NCT00087594|10823850|FG000|COMPLETED|Overall Study||16
9724138|NCT00087594|10823851|FG001|COMPLETED|Overall Study||12
9724139|NCT00087594|10823850|FG000|NOT COMPLETED|Overall Study||8
9724140|NCT00087594|10823851|FG001|NOT COMPLETED|Overall Study||12
9724141|NCT00087607|10823859|FG000|STARTED|Overall Study||192
9724142|NCT00087607|10823860|FG001|STARTED|Overall Study||193
9724143|NCT00087607|10823859|FG000|COMPLETED|Overall Study||70
9724144|NCT00087607|10823860|FG001|COMPLETED|Overall Study||71
9724145|NCT00087607|10823859|FG000|NOT COMPLETED|Overall Study||122
9724146|NCT00087607|10823860|FG001|NOT COMPLETED|Overall Study||122
9724147|NCT00087633|10823872|FG000|STARTED|Overall Study|Randomized|55
9724148|NCT00087633|10823873|FG001|STARTED|Overall Study|Randomized|60
9724149|NCT00087633|10823872|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
9842722|NCT00826111|10954444|FG001|STARTED|Overall Study||5
9842723|NCT00826111|10954443|FG000|COMPLETED|Overall Study||7
9842724|NCT00826111|10954444|FG001|COMPLETED|Overall Study||3
9842725|NCT00826111|10954443|FG000|NOT COMPLETED|Overall Study||7
10023060|NCT01853644|11146572|FG000|Registered|Registration and Treatment Start||31
10023061|NCT01853644|11146572|FG000|Started Treatment|Registration and Treatment Start||30
10023062|NCT01853644|11146572|FG000|COMPLETED|Registration and Treatment Start||30
10023063|NCT01853644|11146572|FG000|NOT COMPLETED|Registration and Treatment Start||1
9842726|NCT00826111|10954444|FG001|NOT COMPLETED|Overall Study||2
9842727|NCT00826150|10954456|FG000|STARTED|Overall Study||8
9842728|NCT00826150|10954457|FG001|STARTED|Overall Study||3
9842729|NCT00826150|10954458|FG002|STARTED|Overall Study||3
9842730|NCT00826150|10954456|FG000|COMPLETED|Overall Study||2
9842731|NCT00826150|10954457|FG001|COMPLETED|Overall Study||1
9842732|NCT00826150|10954458|FG002|COMPLETED|Overall Study||0
9842733|NCT00826150|10954456|FG000|NOT COMPLETED|Overall Study||6
9842734|NCT00826150|10954457|FG001|NOT COMPLETED|Overall Study||2
9842735|NCT00826150|10954458|FG002|NOT COMPLETED|Overall Study||3
9842736|NCT00826176|10954470|FG000|STARTED|Overall Study|enrolled|128
9842737|NCT00826176|10954471|FG001|STARTED|Overall Study|enrolled|36
9842738|NCT00826176|10954470|FG000|COMPLETED|Overall Study|treated and completed|115
9842739|NCT00826176|10954471|FG001|COMPLETED|Overall Study|treated and completed|36
9842740|NCT00826176|10954470|FG000|NOT COMPLETED|Overall Study||13
9842741|NCT00826176|10954471|FG001|NOT COMPLETED|Overall Study||0
9842742|NCT00826202|10954479|FG000|STARTED|Overall Study||20
9842743|NCT00826202|10954480|FG001|STARTED|Overall Study||24
9842744|NCT00826202|10954479|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
9842745|NCT00826202|10954480|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
9842746|NCT00826202|10954479|FG000|COMPLETED|Overall Study||10
9842747|NCT00826202|10954480|FG001|COMPLETED|Overall Study||11
9842748|NCT00826202|10954479|FG000|NOT COMPLETED|Overall Study||10
9842749|NCT00826202|10954480|FG001|NOT COMPLETED|Overall Study||13
10081147|NCT02258074|11209602|FG002|COMPLETED|Overall Study||51
9724150|NCT00087633|10823873|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
9724151|NCT00087633|10823872|FG000|NOT COMPLETED|Overall Study||24
9724152|NCT00087633|10823873|FG001|NOT COMPLETED|Overall Study||17
9724153|NCT00087646|10823883|FG000|STARTED|Overall Study||317
9724154|NCT00087646|10823884|FG001|STARTED|Overall Study||156
9724155|NCT00087646|10823885|FG002|STARTED|Overall Study||156
9724156|NCT00087646|10823886|FG003|STARTED|Overall Study||313
9842750|NCT00826228|10954486|FG000|STARTED|Overall Study||12
9842751|NCT00826228|10954486|FG000|COMPLETED|Overall Study||11
9842752|NCT00826228|10954486|FG000|NOT COMPLETED|Overall Study||1
9842753|NCT00826241|10954491|FG000|STARTED|Overall Study||58
9842754|NCT00826241|10954491|FG000|COMPLETED|Overall Study||31
9842755|NCT00826241|10954491|FG000|NOT COMPLETED|Overall Study||27
9842756|NCT00826267|10954498|FG000|STARTED|Overall Study||10
9678265|NCT04498247|10777655|FG000|STARTED|Overall Study||21
9678266|NCT04498247|10777656|FG001|STARTED|Overall Study||80
9678267|NCT04498247|10777657|FG002|STARTED|Overall Study||4
9678268|NCT04498247|10777658|FG003|STARTED|Overall Study||81
9678269|NCT04498247|10777659|FG004|STARTED|Overall Study||4
9678270|NCT04498247|10777660|FG005|STARTED|Overall Study||20
9678271|NCT04498247|10777661|FG006|STARTED|Overall Study||51
9678272|NCT04498247|10777662|FG007|STARTED|Overall Study||2
9678273|NCT04498247|10777655|FG000|Vaccination 1|Overall Study||20
9678274|NCT04498247|10777656|FG001|Vaccination 1|Overall Study||80
9678275|NCT04498247|10777657|FG002|Vaccination 1|Overall Study||4
9678276|NCT04498247|10777658|FG003|Vaccination 1|Overall Study||81
9678277|NCT04498247|10777659|FG004|Vaccination 1|Overall Study||4
9678278|NCT04498247|10777660|FG005|Vaccination 1|Overall Study||20
9678279|NCT04498247|10777661|FG006|Vaccination 1|Overall Study||51
9678280|NCT04498247|10777662|FG007|Vaccination 1|Overall Study||2
9678281|NCT04498247|10777655|FG000|Vaccination 2|Overall Study||0
9678282|NCT04498247|10777656|FG001|Vaccination 2|Overall Study||0
9678283|NCT04498247|10777657|FG002|Vaccination 2|Overall Study||4
9678284|NCT04498247|10777658|FG003|Vaccination 2|Overall Study||0
9678285|NCT04498247|10777659|FG004|Vaccination 2|Overall Study||4
9678286|NCT04498247|10777660|FG005|Vaccination 2|Overall Study||0
9678287|NCT04498247|10777661|FG006|Vaccination 2|Overall Study||0
9678288|NCT04498247|10777662|FG007|Vaccination 2|Overall Study||2
9678289|NCT04498247|10777655|FG000|COMPLETED|Overall Study||20
9678290|NCT04498247|10777656|FG001|COMPLETED|Overall Study||68
9842757|NCT00826267|10954499|FG001|STARTED|Overall Study||8
9842758|NCT00826267|10954500|FG002|STARTED|Overall Study||11
9842759|NCT00826267|10954498|FG000|COMPLETED|Overall Study||9
9842760|NCT00826267|10954499|FG001|COMPLETED|Overall Study||8
9842761|NCT00826267|10954500|FG002|COMPLETED|Overall Study||11
9842762|NCT00826267|10954498|FG000|NOT COMPLETED|Overall Study||1
9842763|NCT00826267|10954499|FG001|NOT COMPLETED|Overall Study||0
9842764|NCT00826267|10954500|FG002|NOT COMPLETED|Overall Study||0
9842765|NCT00826280|10954512|FG000|STARTED|Overall Study||114
9842766|NCT00826280|10954513|FG001|STARTED|Overall Study||116
9842767|NCT00826280|10954514|FG002|STARTED|Overall Study||117
9842768|NCT00826280|10954512|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
9842769|NCT00826280|10954513|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
9842770|NCT00826280|10954514|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
9842771|NCT00826280|10954512|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
9842772|NCT00826280|10954513|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
9842773|NCT00826280|10954514|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
9842774|NCT00826280|10954512|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
9842775|NCT00826280|10954513|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
9842776|NCT00826280|10954514|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
9842777|NCT00826280|10954512|FG000|NOT COMPLETED|Overall Study||48
9842778|NCT00826280|10954513|FG001|NOT COMPLETED|Overall Study||46
9842779|NCT00826280|10954514|FG002|NOT COMPLETED|Overall Study||46
9842780|NCT00826449|10954524|FG000|STARTED|Overall Study||47
9842781|NCT00826449|10954524|FG000|Phase I|Overall Study||12
9842782|NCT00826449|10954524|FG000|Phase II|Overall Study||35
9842783|NCT00826449|10954524|FG000|COMPLETED|Overall Study||42
9842784|NCT00826449|10954524|FG000|NOT COMPLETED|Overall Study||5
9842785|NCT00826514|10954531|FG000|STARTED|Overall Study||30
9842786|NCT00826514|10954532|FG001|STARTED|Overall Study||32
9842787|NCT00826514|10954531|FG000|COMPLETED|Overall Study||27
9842788|NCT00826514|10954532|FG001|COMPLETED|Overall Study||27
9842789|NCT00826514|10954531|FG000|NOT COMPLETED|Overall Study||3
9842790|NCT00826514|10954532|FG001|NOT COMPLETED|Overall Study||5
9842791|NCT00826540|10954538|FG000|STARTED|Overall Study||83
9842792|NCT00826540|10954538|FG000|COMPLETED|Overall Study||79
9842793|NCT00826540|10954538|FG000|NOT COMPLETED|Overall Study||4
9842794|NCT00826618|10954542|FG000|STARTED|Overall Study||6
9842795|NCT00826618|10954542|FG000|COMPLETED|Overall Study||5
9842796|NCT00826618|10954542|FG000|NOT COMPLETED|Overall Study||1
9842797|NCT00826748|10954549|FG000|STARTED|Overall Study||6
9842798|NCT00826748|10954550|FG001|STARTED|Overall Study||4
9842799|NCT00826748|10954551|FG002|STARTED|Overall Study||12
9842800|NCT00826748|10954549|FG000|COMPLETED|Overall Study||6
9842801|NCT00826748|10954550|FG001|COMPLETED|Overall Study||4
10023064|NCT01853644|11146572|FG000|STARTED|Reached First Response/Complete 2 Cycles||30
9678291|NCT04498247|10777657|FG002|COMPLETED|Overall Study||4
9842802|NCT00826748|10954551|FG002|COMPLETED|Overall Study||8
9842803|NCT00826748|10954549|FG000|NOT COMPLETED|Overall Study||0
10023065|NCT01853644|11146572|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24
10023066|NCT01853644|11146572|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
9678292|NCT04498247|10777658|FG003|COMPLETED|Overall Study||70
9678293|NCT04498247|10777659|FG004|COMPLETED|Overall Study||4
9678294|NCT04498247|10777660|FG005|COMPLETED|Overall Study||20
9678295|NCT04498247|10777661|FG006|COMPLETED|Overall Study||43
9678296|NCT04498247|10777662|FG007|COMPLETED|Overall Study||2
9678297|NCT04498247|10777655|FG000|NOT COMPLETED|Overall Study||1
9678298|NCT04498247|10777656|FG001|NOT COMPLETED|Overall Study||12
9678299|NCT04498247|10777657|FG002|NOT COMPLETED|Overall Study||0
9678300|NCT04498247|10777658|FG003|NOT COMPLETED|Overall Study||11
9678301|NCT04498247|10777659|FG004|NOT COMPLETED|Overall Study||0
9678302|NCT04498247|10777660|FG005|NOT COMPLETED|Overall Study||0
9678303|NCT04498247|10777661|FG006|NOT COMPLETED|Overall Study||8
9678304|NCT04498247|10777662|FG007|NOT COMPLETED|Overall Study||0
9678305|NCT04472650|10777679|FG000|STARTED|Period 1 (Up to 15 Days)||13
9678306|NCT04472650|10777680|FG001|STARTED|Period 1 (Up to 15 Days)||13
9678307|NCT04472650|10777679|FG000|COMPLETED|Period 1 (Up to 15 Days)||13
9678308|NCT04472650|10777680|FG001|COMPLETED|Period 1 (Up to 15 Days)||13
9678309|NCT04472650|10777679|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0
9678310|NCT04472650|10777680|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0
9678311|NCT04472650|10777679|FG000|STARTED|Washout Period (Minimum 14 Days)||13
9678312|NCT04472650|10777680|FG001|STARTED|Washout Period (Minimum 14 Days)||13
9678313|NCT04472650|10777679|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12
9678314|NCT04472650|10777680|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13
9678315|NCT04472650|10777679|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1
9678316|NCT04472650|10777680|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0
9678317|NCT04472650|10777679|FG000|STARTED|Period 2 (Up to 15 Days)||12
9678318|NCT04472650|10777680|FG001|STARTED|Period 2 (Up to 15 Days)||13
9678319|NCT04472650|10777679|FG000|COMPLETED|Period 2 (Up to 15 Days)||12
9678320|NCT04472650|10777680|FG001|COMPLETED|Period 2 (Up to 15 Days)||13
9678321|NCT04472650|10777679|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0
9678322|NCT04472650|10777680|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0
9678323|NCT04359797|10777690|FG000|STARTED|Overall Study||243
9678324|NCT04359797|10777691|FG001|STARTED|Overall Study||258
9678325|NCT04359797|10777690|FG000|COMPLETED|Overall Study||243
9678326|NCT04359797|10777691|FG001|COMPLETED|Overall Study||258
9678327|NCT04359797|10777690|FG000|NOT COMPLETED|Overall Study||0
9678328|NCT04359797|10777691|FG001|NOT COMPLETED|Overall Study||0
9678329|NCT04151290|10777697|FG000|STARTED|Overall Study||711
9678330|NCT04151290|10777697|FG000|COMPLETED|Overall Study||425
9678331|NCT04151290|10777697|FG000|NOT COMPLETED|Overall Study||286
9724157|NCT00087646|10823883|FG000|COMPLETED|Overall Study||182
9724158|NCT00087646|10823884|FG001|COMPLETED|Overall Study||114
9724159|NCT00087646|10823885|FG002|COMPLETED|Overall Study||91
9724160|NCT00087646|10823886|FG003|COMPLETED|Overall Study||229
9724161|NCT00087646|10823883|FG000|NOT COMPLETED|Overall Study||135
9724162|NCT00087646|10823884|FG001|NOT COMPLETED|Overall Study||42
9724163|NCT00087646|10823885|FG002|NOT COMPLETED|Overall Study||65
9724164|NCT00087646|10823886|FG003|NOT COMPLETED|Overall Study||84
9724165|NCT00087672|10823901|FG000|STARTED|Overall Study||41
9724166|NCT00087672|10823901|FG000|COMPLETED|Overall Study||41
9724167|NCT00087672|10823901|FG000|NOT COMPLETED|Overall Study||0
9724168|NCT00087685|10823905|FG000|STARTED|Overall Study||35
9724169|NCT00087685|10823905|FG000|COMPLETED|Overall Study||21
9724170|NCT00087685|10823905|FG000|NOT COMPLETED|Overall Study||14
9724171|NCT00087698|10823909|FG000|STARTED|Overall Study||77
9724172|NCT00087698|10823909|FG000|COMPLETED|Overall Study||41
9724173|NCT00087698|10823909|FG000|NOT COMPLETED|Overall Study||36
9724174|NCT00088153|10823915|FG000|STARTED|Overall Study||55
9724175|NCT00088153|10823916|FG001|STARTED|Overall Study||55
9724176|NCT00088153|10823915|FG000|COMPLETED|Overall Study||31
9724177|NCT00088153|10823916|FG001|COMPLETED|Overall Study||30
9724178|NCT00088153|10823915|FG000|NOT COMPLETED|Overall Study||24
9724179|NCT00088153|10823916|FG001|NOT COMPLETED|Overall Study||25
9724180|NCT00088166|10823924|FG000|STARTED|Overall Study||100
9724181|NCT00088166|10823925|FG001|STARTED|Overall Study||100
9724182|NCT00088166|10823924|FG000|COMPLETED|Overall Study||47
9724183|NCT00088166|10823925|FG001|COMPLETED|Overall Study||39
9724184|NCT00088166|10823924|FG000|NOT COMPLETED|Overall Study||53
9724185|NCT00088166|10823925|FG001|NOT COMPLETED|Overall Study||61
9724186|NCT00088205|10823931|FG000|STARTED|Overall Study||60
9724187|NCT00088205|10823931|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60
9724188|NCT00088205|10823931|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
9724189|NCT00088205|10823931|FG000|COMPLETED|Overall Study||0
10023067|NCT01853644|11146572|FG000|STARTED|Continued Treatment After First Response||24
10023068|NCT01853644|11146572|FG000|COMPLETED|Continued Treatment After First Response||12
10023069|NCT01853644|11146572|FG000|NOT COMPLETED|Continued Treatment After First Response||12
9724190|NCT00088205|10823931|FG000|NOT COMPLETED|Overall Study||60
9724191|NCT00088218|10823937|FG000|STARTED|Overall Study||16
9724192|NCT00088218|10823938|FG001|STARTED|Overall Study||79
9724193|NCT00088218|10823937|FG000|COMPLETED|Overall Study||16
9724194|NCT00088218|10823938|FG001|COMPLETED|Overall Study||79
9724195|NCT00088218|10823937|FG000|NOT COMPLETED|Overall Study||0
9724196|NCT00088218|10823938|FG001|NOT COMPLETED|Overall Study||0
9724197|NCT00088374|10823944|FG000|STARTED|Overall Study||9
9724198|NCT00088374|10823944|FG000|COMPLETED|Overall Study||7
9724199|NCT00088374|10823944|FG000|NOT COMPLETED|Overall Study||2
9724200|NCT00088413|10823952|FG000|STARTED|Overall Study||10
9724201|NCT00088413|10823953|FG001|STARTED|Overall Study||15
9724202|NCT00088413|10823954|FG002|STARTED|Overall Study||12
10023070|NCT01853644|11146572|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30
9724203|NCT00088413|10823955|FG003|STARTED|Overall Study||14
9724204|NCT00088413|10823952|FG000|COMPLETED|Overall Study||0
9678332|NCT04038385|10777703|FG000|STARTED|Overall Study||160
9678333|NCT04038385|10777704|FG001|STARTED|Overall Study||137
9678334|NCT04038385|10777703|FG000|COMPLETED|Overall Study||143
9678335|NCT04038385|10777704|FG001|COMPLETED|Overall Study||130
9678336|NCT04038385|10777703|FG000|NOT COMPLETED|Overall Study||17
9678337|NCT04038385|10777704|FG001|NOT COMPLETED|Overall Study||7
9678338|NCT03923738|10777710|FG000|STARTED|Period 1||24
9842804|NCT00826748|10954550|FG001|NOT COMPLETED|Overall Study||0
9842805|NCT00826748|10954551|FG002|NOT COMPLETED|Overall Study||4
9842806|NCT00826800|10954559|FG000|STARTED|Overall Study||2
9842807|NCT00826800|10954559|FG000|COMPLETED|Overall Study||2
9842808|NCT00826800|10954559|FG000|NOT COMPLETED|Overall Study||0
9842809|NCT00826943|10954563|FG000|STARTED|Overall Study||6
9842810|NCT00826943|10954564|FG001|STARTED|Overall Study||6
9842811|NCT00826943|10954565|FG002|STARTED|Overall Study||4
9842812|NCT00826943|10954566|FG003|STARTED|Overall Study||5
9842813|NCT00826943|10954567|FG004|STARTED|Overall Study||7
9842814|NCT00826943|10954568|FG005|STARTED|Overall Study||2
9842815|NCT00826943|10954563|FG000|COMPLETED|Overall Study||6
9842816|NCT00826943|10954564|FG001|COMPLETED|Overall Study||6
9842817|NCT00826943|10954565|FG002|COMPLETED|Overall Study||4
9842818|NCT00826943|10954566|FG003|COMPLETED|Overall Study||5
9842819|NCT00826943|10954567|FG004|COMPLETED|Overall Study||6
9842820|NCT00826943|10954568|FG005|COMPLETED|Overall Study||2
9842821|NCT00826943|10954563|FG000|NOT COMPLETED|Overall Study||0
9842822|NCT00826943|10954564|FG001|NOT COMPLETED|Overall Study||0
9842823|NCT00826943|10954565|FG002|NOT COMPLETED|Overall Study||0
9842824|NCT00826943|10954566|FG003|NOT COMPLETED|Overall Study||0
9842825|NCT00826943|10954567|FG004|NOT COMPLETED|Overall Study||1
9842826|NCT00826943|10954568|FG005|NOT COMPLETED|Overall Study||0
9842827|NCT00827073|10954578|FG000|STARTED|Overall Study||20
9842828|NCT00827073|10954579|FG001|STARTED|Overall Study||20
9842829|NCT00827073|10954578|FG000|COMPLETED|Overall Study||20
9842830|NCT00827073|10954579|FG001|COMPLETED|Overall Study||20
9842831|NCT00827073|10954578|FG000|NOT COMPLETED|Overall Study||0
9842832|NCT00827073|10954579|FG001|NOT COMPLETED|Overall Study||0
9842833|NCT00827099|10954585|FG000|STARTED|Overall Study||5
9842834|NCT00827099|10954585|FG000|COMPLETED|Overall Study||5
9842835|NCT00827099|10954585|FG000|NOT COMPLETED|Overall Study||0
9842836|NCT00827112|10954591|FG000|STARTED|Overall Study||65
9842837|NCT00827112|10954592|FG001|STARTED|Overall Study||64
9842838|NCT00827112|10954591|FG000|Treated|Overall Study||60
9842839|NCT00827112|10954592|FG001|Treated|Overall Study||61
9842840|NCT00827112|10954591|FG000|COMPLETED|Overall Study||50
9842841|NCT00827112|10954592|FG001|COMPLETED|Overall Study||52
9842842|NCT00827112|10954591|FG000|NOT COMPLETED|Overall Study||15
9842843|NCT00827112|10954592|FG001|NOT COMPLETED|Overall Study||12
9842844|NCT00827242|10954600|FG000|STARTED|Overall Study||161
9842845|NCT00827242|10954601|FG001|STARTED|Overall Study||164
9842846|NCT00827242|10954600|FG000|COMPLETED|Overall Study||148
9842847|NCT00827242|10954601|FG001|COMPLETED|Overall Study||152
9842848|NCT00827242|10954600|FG000|NOT COMPLETED|Overall Study||13
9960272|NCT01467466|11079937|FG002|NOT COMPLETED|Overall Study||104
9960273|NCT01467466|11079938|FG003|NOT COMPLETED|Overall Study||88
9960274|NCT01467479|11079951|FG000|STARTED|Overall Study||55
9960275|NCT01467479|11079952|FG001|STARTED|Overall Study||69
9960276|NCT01467479|11079953|FG002|STARTED|Overall Study||61
9960277|NCT01467479|11079951|FG000|Treated|Overall Study||54
9960278|NCT01467479|11079952|FG001|Treated|Overall Study||69
9960279|NCT01467479|11079953|FG002|Treated|Overall Study||59
9960280|NCT01467479|11079951|FG000|COMPLETED|Overall Study||46
9960281|NCT01467479|11079952|FG001|COMPLETED|Overall Study||52
9960282|NCT01467479|11079953|FG002|COMPLETED|Overall Study||45
9960283|NCT01467479|11079951|FG000|NOT COMPLETED|Overall Study||9
9960284|NCT01467479|11079952|FG001|NOT COMPLETED|Overall Study||17
9960285|NCT01467479|11079953|FG002|NOT COMPLETED|Overall Study||16
9960286|NCT01467492|11079964|FG000|STARTED|Overall Study||83
9960287|NCT01467492|11079965|FG001|STARTED|Overall Study||38
9960288|NCT01467492|11079964|FG000|COMPLETED|Overall Study||61
9960289|NCT01467492|11079965|FG001|COMPLETED|Overall Study||25
9960290|NCT01467492|11079964|FG000|NOT COMPLETED|Overall Study||22
9960291|NCT01467492|11079965|FG001|NOT COMPLETED|Overall Study||13
9678339|NCT03923738|10777710|FG000|COMPLETED|Period 1||22
9678340|NCT03923738|10777710|FG000|NOT COMPLETED|Period 1||2
9960292|NCT01467505|11079974|FG000|STARTED|Overall Study||51
9960293|NCT01467505|11079975|FG001|STARTED|Overall Study||10
9960294|NCT01467505|11079974|FG000|COMPLETED|Overall Study||18
9678341|NCT03923738|10777710|FG000|STARTED|Period 2||22
9842849|NCT00827242|10954601|FG001|NOT COMPLETED|Overall Study||12
9842850|NCT00827255|10954607|FG000|STARTED|Overall Study||35
9842851|NCT00827255|10954607|FG000|COMPLETED|Overall Study||35
9842852|NCT00827255|10954607|FG000|NOT COMPLETED|Overall Study||0
9842853|NCT00827359|10954611|FG000|STARTED|Overall Study||25
9842854|NCT00827359|10954611|FG000|Treated|Overall Study||24
9842855|NCT00827359|10954611|FG000|COMPLETED|Overall Study||0
9842856|NCT00827359|10954611|FG000|NOT COMPLETED|Overall Study||25
9842857|NCT00827372|10954615|FG000|STARTED|Overall Study||10
9842858|NCT00827372|10954615|FG000|COMPLETED|Overall Study||2
9842859|NCT00827372|10954615|FG000|NOT COMPLETED|Overall Study||8
9842860|NCT00827502|10954620|FG000|STARTED|Overall Study||421
9960295|NCT01467505|11079975|FG001|COMPLETED|Overall Study||7
9960296|NCT01467505|11079974|FG000|NOT COMPLETED|Overall Study||33
9960297|NCT01467505|11079975|FG001|NOT COMPLETED|Overall Study||3
9960298|NCT01467557|11079983|FG000|STARTED|Overall Study||601
9678342|NCT03923738|10777710|FG000|COMPLETED|Period 2||22
9678343|NCT03923738|10777710|FG000|NOT COMPLETED|Period 2||0
9678344|NCT03887117|10777720|FG000|STARTED|Overall Study||25
9678345|NCT03887117|10777721|FG001|STARTED|Overall Study||15
9678346|NCT03887117|10777722|FG002|STARTED|Overall Study||26
9678347|NCT03887117|10777723|FG003|STARTED|Overall Study||27
9678348|NCT03887117|10777720|FG000|COMPLETED|Overall Study||25
9678349|NCT03887117|10777721|FG001|COMPLETED|Overall Study||14
9678350|NCT03887117|10777722|FG002|COMPLETED|Overall Study||25
9678351|NCT03887117|10777723|FG003|COMPLETED|Overall Study||25
9678352|NCT03887117|10777720|FG000|NOT COMPLETED|Overall Study||0
9678353|NCT03887117|10777721|FG001|NOT COMPLETED|Overall Study||1
9678354|NCT03887117|10777722|FG002|NOT COMPLETED|Overall Study||1
9678355|NCT03887117|10777723|FG003|NOT COMPLETED|Overall Study||2
9678356|NCT03858634|10777744|FG000|STARTED|Overall Study||39
9678357|NCT03858634|10777745|FG001|STARTED|Overall Study||19
9678358|NCT03858634|10777744|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4
9678359|NCT03858634|10777745|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2
9678360|NCT03858634|10777744|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14
9678361|NCT03858634|10777745|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9
9678362|NCT03858634|10777744|FG000|Participants With Lichen Planus (LP)|Overall Study||3
9678363|NCT03858634|10777745|FG001|Participants With Lichen Planus (LP)|Overall Study||0
9678364|NCT03858634|10777744|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4
9678365|NCT03858634|10777745|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1
9678366|NCT03858634|10777744|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14
9678367|NCT03858634|10777745|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7
9678368|NCT03858634|10777744|FG000|COMPLETED|Overall Study||36
9678369|NCT03858634|10777745|FG001|COMPLETED|Overall Study||17
9678370|NCT03858634|10777744|FG000|NOT COMPLETED|Overall Study||3
9678371|NCT03858634|10777745|FG001|NOT COMPLETED|Overall Study||2
9678372|NCT03819114|10777763|FG000|STARTED|Overall Study||17
9678373|NCT03819114|10777764|FG001|STARTED|Overall Study||36
9678374|NCT03819114|10777765|FG002|STARTED|Overall Study||35
9678375|NCT03819114|10777766|FG003|STARTED|Overall Study||34
9678376|NCT03819114|10777763|FG000|Received LNG Treatment|Overall Study||17
9678377|NCT03819114|10777764|FG001|Received LNG Treatment|Overall Study||36
9678378|NCT03819114|10777765|FG002|Received LNG Treatment|Overall Study||35
9678379|NCT03819114|10777766|FG003|Received LNG Treatment|Overall Study||34
9678380|NCT03819114|10777763|FG000|COMPLETED|Overall Study||17
9678381|NCT03819114|10777764|FG001|COMPLETED|Overall Study||35
9678382|NCT03819114|10777765|FG002|COMPLETED|Overall Study||33
9678383|NCT03819114|10777766|FG003|COMPLETED|Overall Study||34
9678384|NCT03819114|10777763|FG000|NOT COMPLETED|Overall Study||0
9678385|NCT03819114|10777764|FG001|NOT COMPLETED|Overall Study||1
9678386|NCT03819114|10777765|FG002|NOT COMPLETED|Overall Study||2
9678387|NCT03819114|10777766|FG003|NOT COMPLETED|Overall Study||0
9678388|NCT03804268|10777780|FG000|STARTED|Overall Study||160
9678389|NCT03804268|10777781|FG001|STARTED|Overall Study||163
9678390|NCT03804268|10777780|FG000|COMPLETED|Overall Study||153
9678391|NCT03804268|10777781|FG001|COMPLETED|Overall Study||161
9678392|NCT03804268|10777780|FG000|NOT COMPLETED|Overall Study||7
9678393|NCT03804268|10777781|FG001|NOT COMPLETED|Overall Study||2
9724205|NCT00088413|10823953|FG001|COMPLETED|Overall Study||0
9724206|NCT00088413|10823954|FG002|COMPLETED|Overall Study||0
9724207|NCT00088413|10823955|FG003|COMPLETED|Overall Study||0
9724208|NCT00088413|10823952|FG000|NOT COMPLETED|Overall Study||10
9724209|NCT00088413|10823953|FG001|NOT COMPLETED|Overall Study||15
9724210|NCT00088413|10823954|FG002|NOT COMPLETED|Overall Study||12
9724211|NCT00088413|10823955|FG003|NOT COMPLETED|Overall Study||14
9724212|NCT00088452|10823970|FG000|STARTED|Overall Study||156
9724213|NCT00088452|10823971|FG001|STARTED|Overall Study||149
9724214|NCT00088452|10823972|FG002|STARTED|Overall Study||148
9842861|NCT00827502|10954620|FG000|Received Treatment (Number Treated)|Overall Study||410
9842862|NCT00827502|10954620|FG000|COMPLETED|Overall Study||400
9842863|NCT00827502|10954620|FG000|NOT COMPLETED|Overall Study||21
9842864|NCT00827541|10954626|FG000|STARTED|Overall Study||19
9842865|NCT00827541|10954627|FG001|STARTED|Overall Study||96
9842866|NCT00827541|10954626|FG000|COMPLETED|Overall Study||15
9842867|NCT00827541|10954627|FG001|COMPLETED|Overall Study||85
9842868|NCT00827541|10954626|FG000|NOT COMPLETED|Overall Study||4
9724215|NCT00088452|10823970|FG000|COMPLETED|Overall Study||155
9724216|NCT00088452|10823971|FG001|COMPLETED|Overall Study||149
9724217|NCT00088452|10823972|FG002|COMPLETED|Overall Study||147
9724218|NCT00088452|10823970|FG000|NOT COMPLETED|Overall Study||1
9724219|NCT00088452|10823971|FG001|NOT COMPLETED|Overall Study||0
9724220|NCT00088452|10823972|FG002|NOT COMPLETED|Overall Study||1
9724221|NCT00088465|10823980|FG000|STARTED|Overall Study||931
9724222|NCT00088465|10823980|FG000|COMPLETED|Overall Study||370
9724223|NCT00088465|10823980|FG000|NOT COMPLETED|Overall Study||561
9724224|NCT00088530|10823986|FG000|STARTED|Overall Study||70
9724225|NCT00088530|10823987|FG001|STARTED|Overall Study||70
9724226|NCT00088530|10823986|FG000|COMPLETED|Overall Study||20
9724227|NCT00088530|10823987|FG001|COMPLETED|Overall Study||16
9724228|NCT00088530|10823986|FG000|NOT COMPLETED|Overall Study||50
9724229|NCT00088530|10823987|FG001|NOT COMPLETED|Overall Study||54
9724230|NCT00088595|10823993|FG000|STARTED|Overall Study||45
9842869|NCT00827541|10954627|FG001|NOT COMPLETED|Overall Study||11
9842870|NCT00827606|10954635|FG000|STARTED|Overall Study||139
9678394|NCT04435808|10777790|FG000|STARTED|Overall Study||0
9678395|NCT04435808|10777791|FG001|STARTED|Overall Study||1
9678396|NCT04435808|10777790|FG000|COMPLETED|Overall Study||0
9678397|NCT04435808|10777791|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
9678398|NCT04435808|10777790|FG000|NOT COMPLETED|Overall Study||0
9678399|NCT04435808|10777791|FG001|NOT COMPLETED|Overall Study||1
9678400|NCT04409262|10777799|FG000|STARTED|Overall Study||215
9678401|NCT04409262|10777800|FG001|STARTED|Overall Study||434
9678402|NCT04409262|10777799|FG000|COMPLETED|Overall Study||140
10023071|NCT01853644|11146572|FG000|COMPLETED|Follow up for 3 Years or Until Death||30
10023072|NCT01853644|11146572|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0
10081148|NCT02258074|11209603|FG003|COMPLETED|Overall Study||51
10081149|NCT02258074|11209600|FG000|NOT COMPLETED|Overall Study||1
10081150|NCT02258074|11209601|FG001|NOT COMPLETED|Overall Study||0
10081151|NCT02258074|11209602|FG002|NOT COMPLETED|Overall Study||0
10081152|NCT02258074|11209603|FG003|NOT COMPLETED|Overall Study||0
10081153|NCT02258139|11209613|FG000|STARTED|Overall Study||38
10081154|NCT02258139|11209613|FG000|COMPLETED|Overall Study||30
10081155|NCT02258139|11209613|FG000|NOT COMPLETED|Overall Study||8
10081156|NCT02258152|11209621|FG000|STARTED|Overall Study||44
10081157|NCT02258152|11209622|FG001|STARTED|Overall Study||38
9678403|NCT04409262|10777800|FG001|COMPLETED|Overall Study||300
9678404|NCT04409262|10777799|FG000|NOT COMPLETED|Overall Study||75
9678405|NCT04409262|10777800|FG001|NOT COMPLETED|Overall Study||134
9678406|NCT04305912|10777809|FG000|STARTED|First Intervention||26
9678407|NCT04305912|10777810|FG001|STARTED|First Intervention||25
9678408|NCT04305912|10777809|FG000|COMPLETED|First Intervention||24
10081158|NCT02258152|11209621|FG000|COMPLETED|Overall Study||38
10081159|NCT02258152|11209622|FG001|COMPLETED|Overall Study||34
10081160|NCT02258152|11209621|FG000|NOT COMPLETED|Overall Study||6
10081161|NCT02258152|11209622|FG001|NOT COMPLETED|Overall Study||4
10081162|NCT02258217|11209628|FG000|STARTED|Overall Study||30
10081163|NCT02258217|11209628|FG000|COMPLETED|Overall Study||30
10081164|NCT02258217|11209628|FG000|NOT COMPLETED|Overall Study||0
10081165|NCT02258256|11209632|FG000|STARTED|Overall Study||11
10081166|NCT02258256|11209632|FG000|COMPLETED|Overall Study||11
9678409|NCT04305912|10777810|FG001|COMPLETED|First Intervention||24
9678410|NCT04305912|10777809|FG000|NOT COMPLETED|First Intervention||2
9678411|NCT04305912|10777810|FG001|NOT COMPLETED|First Intervention||1
9678412|NCT04305912|10777809|FG000|STARTED|Second Intervention||24
9678413|NCT04305912|10777810|FG001|STARTED|Second Intervention||24
9678414|NCT04305912|10777809|FG000|COMPLETED|Second Intervention||24
9678415|NCT04305912|10777810|FG001|COMPLETED|Second Intervention||23
9678416|NCT04305912|10777809|FG000|NOT COMPLETED|Second Intervention||0
9678417|NCT04305912|10777810|FG001|NOT COMPLETED|Second Intervention||1
9678503|NCT03410693|10777909|FG000|COMPLETED|Overall Study|Completed treatment|0
9678504|NCT03410693|10777910|FG001|COMPLETED|Overall Study|Completed treatment|0
9678505|NCT03410693|10777909|FG000|NOT COMPLETED|Overall Study||87
10081167|NCT02258256|11209632|FG000|NOT COMPLETED|Overall Study||0
9678506|NCT03410693|10777910|FG001|NOT COMPLETED|Overall Study||88
9678507|NCT03359356|10777924|FG000|STARTED|Overall Study||20
9678508|NCT03359356|10777925|FG001|STARTED|Overall Study||40
9678509|NCT03359356|10777924|FG000|COMPLETED|Overall Study||20
9678510|NCT03359356|10777925|FG001|COMPLETED|Overall Study||40
9678511|NCT03359356|10777924|FG000|NOT COMPLETED|Overall Study||0
9678512|NCT03359356|10777925|FG001|NOT COMPLETED|Overall Study||0
9678513|NCT03252925|10777937|FG000|STARTED|Overall Study||80
9678514|NCT03252925|10777938|FG001|STARTED|Overall Study||80
9678515|NCT03252925|10777937|FG000|COMPLETED|Overall Study||66
9678516|NCT03252925|10777938|FG001|COMPLETED|Overall Study||74
9678517|NCT03252925|10777937|FG000|NOT COMPLETED|Overall Study||14
9678518|NCT03252925|10777938|FG001|NOT COMPLETED|Overall Study||6
9678519|NCT03185832|10777948|FG000|STARTED|Overall Study||69
9678520|NCT03185832|10777949|FG001|STARTED|Overall Study||102
9678521|NCT03185832|10777950|FG002|STARTED|Overall Study||68
9678522|NCT03185832|10777951|FG003|STARTED|Overall Study||115
9678523|NCT03185832|10777948|FG000|COMPLETED|Overall Study||60
9678524|NCT03185832|10777949|FG001|COMPLETED|Overall Study||87
9678525|NCT03185832|10777950|FG002|COMPLETED|Overall Study||58
9678526|NCT03185832|10777951|FG003|COMPLETED|Overall Study||104
9678527|NCT03185832|10777948|FG000|NOT COMPLETED|Overall Study||9
9678528|NCT03185832|10777949|FG001|NOT COMPLETED|Overall Study||15
9678529|NCT03185832|10777950|FG002|NOT COMPLETED|Overall Study||10
9678530|NCT03185832|10777951|FG003|NOT COMPLETED|Overall Study||11
9724231|NCT00088595|10823993|FG000|COMPLETED|Overall Study||17
9724232|NCT00088595|10823993|FG000|NOT COMPLETED|Overall Study||28
9724233|NCT00088621|10824007|FG000|STARTED|Overall Study||61
9724234|NCT00088621|10824007|FG000|COMPLETED|Overall Study||7
10081168|NCT02258334|11209640|FG000|STARTED|Overall Study||50
10081169|NCT02258334|11209641|FG001|STARTED|Overall Study||54
10081170|NCT02258334|11209642|FG002|STARTED|Overall Study||52
10081171|NCT02258334|11209643|FG003|STARTED|Overall Study||52
10081172|NCT02258334|11209640|FG000|COMPLETED|Overall Study||49
9724235|NCT00088621|10824007|FG000|NOT COMPLETED|Overall Study||54
9724236|NCT00088634|10824013|FG000|STARTED|Overall Study||90
9724237|NCT00088634|10824014|FG001|STARTED|Overall Study||90
9724238|NCT00088634|10824013|FG000|COMPLETED|Overall Study||52
9724239|NCT00088634|10824014|FG001|COMPLETED|Overall Study||47
9724240|NCT00088634|10824013|FG000|NOT COMPLETED|Overall Study||38
9724241|NCT00088634|10824014|FG001|NOT COMPLETED|Overall Study||43
10081173|NCT02258334|11209641|FG001|COMPLETED|Overall Study||54
9678418|NCT04030416|10777816|FG000|STARTED|Overall Study||120
9678419|NCT04030416|10777816|FG000|COMPLETED|Overall Study||119
9678420|NCT04030416|10777816|FG000|NOT COMPLETED|Overall Study||1
9678421|NCT04028648|10777820|FG000|STARTED|Overall Study||150
9678422|NCT04028648|10777820|FG000|COMPLETED|Overall Study||150
9678423|NCT04028648|10777820|FG000|NOT COMPLETED|Overall Study||0
9678424|NCT03987919|10777829|FG000|STARTED|Overall Study||471
9678425|NCT03987919|10777830|FG001|STARTED|Overall Study||469
9678426|NCT03987919|10777831|FG002|STARTED|Overall Study||470
9678427|NCT03987919|10777832|FG003|STARTED|Overall Study||469
9678428|NCT03987919|10777829|FG000|Received at Least One Dose of Study Drug|Overall Study||470
9678429|NCT03987919|10777830|FG001|Received at Least One Dose of Study Drug|Overall Study||469
9678430|NCT03987919|10777831|FG002|Received at Least One Dose of Study Drug|Overall Study||470
9678431|NCT03987919|10777832|FG003|Received at Least One Dose of Study Drug|Overall Study||469
9678432|NCT03987919|10777829|FG000|COMPLETED|Overall Study||452
9678433|NCT03987919|10777830|FG001|COMPLETED|Overall Study||442
9678434|NCT03987919|10777831|FG002|COMPLETED|Overall Study||446
9678435|NCT03987919|10777832|FG003|COMPLETED|Overall Study||443
9678436|NCT03987919|10777829|FG000|NOT COMPLETED|Overall Study||19
9678437|NCT03987919|10777830|FG001|NOT COMPLETED|Overall Study||27
9678438|NCT03987919|10777831|FG002|NOT COMPLETED|Overall Study||24
9678439|NCT03987919|10777832|FG003|NOT COMPLETED|Overall Study||26
9678440|NCT03980145|10777849|FG000|STARTED|Overall Study||7
9678441|NCT03980145|10777850|FG001|STARTED|Overall Study||8
9678442|NCT03980145|10777849|FG000|COMPLETED|Overall Study||7
9678443|NCT03980145|10777850|FG001|COMPLETED|Overall Study||8
9678444|NCT03980145|10777849|FG000|NOT COMPLETED|Overall Study||0
9678445|NCT03980145|10777850|FG001|NOT COMPLETED|Overall Study||0
9678446|NCT03861039|10777861|FG000|STARTED|Overall Study||148
9678447|NCT03861039|10777862|FG001|STARTED|Overall Study||147
9678448|NCT03861039|10777863|FG002|STARTED|Overall Study||148
9678449|NCT03861039|10777861|FG000|Received at Least One Dose of Study Drug|Overall Study||148
9678450|NCT03861039|10777862|FG001|Received at Least One Dose of Study Drug|Overall Study||147
9678451|NCT03861039|10777863|FG002|Received at Least One Dose of Study Drug|Overall Study||148
9678452|NCT03861039|10777861|FG000|COMPLETED|Overall Study||145
9678453|NCT03861039|10777862|FG001|COMPLETED|Overall Study||139
9678454|NCT03861039|10777863|FG002|COMPLETED|Overall Study||133
9678455|NCT03861039|10777861|FG000|NOT COMPLETED|Overall Study||3
9678456|NCT03861039|10777862|FG001|NOT COMPLETED|Overall Study||8
9678457|NCT03861039|10777863|FG002|NOT COMPLETED|Overall Study||15
9678458|NCT03759587|10777873|FG000|STARTED|Overall Study||19
9678459|NCT03759587|10777873|FG000|COMPLETED|Overall Study||0
9678460|NCT03759587|10777873|FG000|NOT COMPLETED|Overall Study||19
9678461|NCT03730662|10777881|FG000|STARTED|Treatment Period (52 Weeks)||329
9678462|NCT03730662|10777882|FG001|STARTED|Treatment Period (52 Weeks)||330
9678463|NCT03730662|10777883|FG002|STARTED|Treatment Period (52 Weeks)||338
9678464|NCT03730662|10777884|FG003|STARTED|Treatment Period (52 Weeks)||1005
9678465|NCT03730662|10777881|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329
9678466|NCT03730662|10777882|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328
9678467|NCT03730662|10777883|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338
9678468|NCT03730662|10777884|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000
9678469|NCT03730662|10777881|FG000|COMPLETED|Treatment Period (52 Weeks)||308
9678470|NCT03730662|10777882|FG001|COMPLETED|Treatment Period (52 Weeks)||319
9678471|NCT03730662|10777883|FG002|COMPLETED|Treatment Period (52 Weeks)||329
9678472|NCT03730662|10777884|FG003|COMPLETED|Treatment Period (52 Weeks)||953
9678473|NCT03730662|10777881|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21
9678474|NCT03730662|10777882|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11
9678475|NCT03730662|10777883|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9
9678476|NCT03730662|10777884|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52
9678477|NCT03730662|10777881|FG000|STARTED|Variable Treatment Period||308
9678478|NCT03730662|10777882|FG001|STARTED|Variable Treatment Period||319
9678479|NCT03730662|10777883|FG002|STARTED|Variable Treatment Period||329
9678480|NCT03730662|10777884|FG003|STARTED|Variable Treatment Period||953
9678481|NCT03730662|10777881|FG000|COMPLETED|Variable Treatment Period||294
9678482|NCT03730662|10777882|FG001|COMPLETED|Variable Treatment Period||312
9678483|NCT03730662|10777883|FG002|COMPLETED|Variable Treatment Period||313
9678484|NCT03730662|10777884|FG003|COMPLETED|Variable Treatment Period||882
9678485|NCT03730662|10777881|FG000|NOT COMPLETED|Variable Treatment Period||14
9678486|NCT03730662|10777882|FG001|NOT COMPLETED|Variable Treatment Period||7
9678487|NCT03730662|10777883|FG002|NOT COMPLETED|Variable Treatment Period||16
9678488|NCT03730662|10777884|FG003|NOT COMPLETED|Variable Treatment Period||71
9678489|NCT03538444|10777900|FG000|STARTED|Overall Study||4
9678490|NCT03538444|10777901|FG001|STARTED|Overall Study||3
9678491|NCT03538444|10777900|FG000|COMPLETED|Overall Study||3
9678492|NCT03538444|10777901|FG001|COMPLETED|Overall Study||3
9678493|NCT03538444|10777900|FG000|NOT COMPLETED|Overall Study||1
9678494|NCT03538444|10777901|FG001|NOT COMPLETED|Overall Study||0
9678495|NCT03410693|10777909|FG000|STARTED|Overall Study||87
9678496|NCT03410693|10777910|FG001|STARTED|Overall Study||88
9678497|NCT03410693|10777909|FG000|Started Treatment|Overall Study||86
9678498|NCT03410693|10777910|FG001|Started Treatment|Overall Study||82
9678499|NCT03410693|10777909|FG000|Active Follow-up Performed|Overall Study||61
9678500|NCT03410693|10777910|FG001|Active Follow-up Performed|Overall Study||56
9678501|NCT03410693|10777909|FG000|Entered Long Term Follow-up|Overall Study||56
9678502|NCT03410693|10777910|FG001|Entered Long Term Follow-up|Overall Study||69
9678531|NCT02963714|10777961|FG000|STARTED|Overall Study||176
9678532|NCT02963714|10777962|FG001|STARTED|Overall Study||176
9678533|NCT02963714|10777961|FG000|COMPLETED|Overall Study||126
9678534|NCT02963714|10777962|FG001|COMPLETED|Overall Study||126
9678535|NCT02963714|10777961|FG000|NOT COMPLETED|Overall Study||50
9678536|NCT02963714|10777962|FG001|NOT COMPLETED|Overall Study||50
9678537|NCT02959918|10777982|FG000|STARTED|Overall Study||3
9678538|NCT02959918|10777983|FG001|STARTED|Overall Study||3
9678539|NCT02959918|10777984|FG002|STARTED|Overall Study||9
9678540|NCT02959918|10777985|FG003|STARTED|Overall Study||10
9678541|NCT02959918|10777986|FG004|STARTED|Overall Study||6
9678542|NCT02959918|10777987|FG005|STARTED|Overall Study||11
9678543|NCT02959918|10777988|FG006|STARTED|Overall Study||11
9678544|NCT02959918|10777989|FG007|STARTED|Overall Study||12
9678545|NCT02959918|10777990|FG008|STARTED|Overall Study||14
9678546|NCT02959918|10777991|FG009|STARTED|Overall Study||13
9678547|NCT02959918|10777992|FG010|STARTED|Overall Study||14
9678548|NCT02959918|10777993|FG011|STARTED|Overall Study||23
9678549|NCT02959918|10777994|FG012|STARTED|Overall Study||11
9678550|NCT02959918|10777995|FG013|STARTED|Overall Study||12
9678551|NCT02959918|10777982|FG000|COMPLETED|Overall Study||0
9678552|NCT02959918|10777983|FG001|COMPLETED|Overall Study||0
9678553|NCT02959918|10777984|FG002|COMPLETED|Overall Study||1
9678554|NCT02959918|10777985|FG003|COMPLETED|Overall Study||1
9678555|NCT02959918|10777986|FG004|COMPLETED|Overall Study||1
9678556|NCT02959918|10777987|FG005|COMPLETED|Overall Study||5
9678557|NCT02959918|10777988|FG006|COMPLETED|Overall Study||6
9678558|NCT02959918|10777989|FG007|COMPLETED|Overall Study||6
9678559|NCT02959918|10777990|FG008|COMPLETED|Overall Study||7
9678560|NCT02959918|10777991|FG009|COMPLETED|Overall Study||7
9678561|NCT02959918|10777992|FG010|COMPLETED|Overall Study||8
9678562|NCT02959918|10777993|FG011|COMPLETED|Overall Study||11
9678563|NCT02959918|10777994|FG012|COMPLETED|Overall Study||4
9678564|NCT02959918|10777995|FG013|COMPLETED|Overall Study||6
9678565|NCT02959918|10777982|FG000|NOT COMPLETED|Overall Study||3
9678566|NCT02959918|10777983|FG001|NOT COMPLETED|Overall Study||3
9678567|NCT02959918|10777984|FG002|NOT COMPLETED|Overall Study||8
9678568|NCT02959918|10777985|FG003|NOT COMPLETED|Overall Study||9
9678569|NCT02959918|10777986|FG004|NOT COMPLETED|Overall Study||5
9678570|NCT02959918|10777987|FG005|NOT COMPLETED|Overall Study||6
9678571|NCT02959918|10777988|FG006|NOT COMPLETED|Overall Study||5
9678572|NCT02959918|10777989|FG007|NOT COMPLETED|Overall Study||6
9678573|NCT02959918|10777990|FG008|NOT COMPLETED|Overall Study||7
9678574|NCT02959918|10777991|FG009|NOT COMPLETED|Overall Study||6
9678575|NCT02959918|10777992|FG010|NOT COMPLETED|Overall Study||6
9678576|NCT02959918|10777993|FG011|NOT COMPLETED|Overall Study||12
9678577|NCT02959918|10777994|FG012|NOT COMPLETED|Overall Study||7
9678578|NCT02959918|10777995|FG013|NOT COMPLETED|Overall Study||6
9678579|NCT02472964|10778030|FG000|STARTED|Part 1 (up to Week 24)||246
9678580|NCT02472964|10778031|FG001|STARTED|Part 1 (up to Week 24)||247
9678581|NCT02472964|10778030|FG000|COMPLETED|Part 1 (up to Week 24)||171
9678582|NCT02472964|10778031|FG001|COMPLETED|Part 1 (up to Week 24)||185
9678583|NCT02472964|10778030|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75
9678584|NCT02472964|10778031|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62
9678585|NCT02472964|10778030|FG000|STARTED|Part 2 (Week 24-week 48)||163
9678586|NCT02472964|10778031|FG001|STARTED|Part 2 (Week 24-week 48)||179
9678587|NCT02472964|10778030|FG000|COMPLETED|Part 2 (Week 24-week 48)||98
9678588|NCT02472964|10778031|FG001|COMPLETED|Part 2 (Week 24-week 48)||116
9678589|NCT02472964|10778030|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65
9678590|NCT02472964|10778031|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63
9678591|NCT02178722|10778042|FG000|STARTED|Overall Study||4
9678592|NCT02178722|10778043|FG001|STARTED|Overall Study||20
9678593|NCT02178722|10778044|FG002|STARTED|Overall Study||18
9678594|NCT02178722|10778045|FG003|STARTED|Overall Study||20
9678595|NCT02178722|10778046|FG004|STARTED|Overall Study||382
9678596|NCT02178722|10778042|FG000|COMPLETED|Overall Study||0
9678597|NCT02178722|10778043|FG001|COMPLETED|Overall Study||0
9678598|NCT02178722|10778044|FG002|COMPLETED|Overall Study||0
9678599|NCT02178722|10778045|FG003|COMPLETED|Overall Study||0
9678600|NCT02178722|10778046|FG004|COMPLETED|Overall Study||0
9678601|NCT02178722|10778042|FG000|NOT COMPLETED|Overall Study||4
9678602|NCT02178722|10778043|FG001|NOT COMPLETED|Overall Study||20
9678603|NCT02178722|10778044|FG002|NOT COMPLETED|Overall Study||18
9678604|NCT02178722|10778045|FG003|NOT COMPLETED|Overall Study||20
9678605|NCT02178722|10778046|FG004|NOT COMPLETED|Overall Study||382
9678606|NCT01258803|10778061|FG000|STARTED|Treatment Period 1 (1 Dose)||15
9678607|NCT01258803|10778062|FG001|STARTED|Treatment Period 1 (1 Dose)||16
9678608|NCT01258803|10778063|FG002|STARTED|Treatment Period 1 (1 Dose)||15
9678609|NCT01258803|10778064|FG003|STARTED|Treatment Period 1 (1 Dose)||15
9678610|NCT01258803|10778065|FG004|STARTED|Treatment Period 1 (1 Dose)||15
9678611|NCT01258803|10778066|FG005|STARTED|Treatment Period 1 (1 Dose)||16
9678612|NCT01258803|10778061|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15
9678613|NCT01258803|10778062|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16
9678614|NCT01258803|10778063|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15
9678615|NCT01258803|10778064|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15
9678616|NCT01258803|10778065|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15
9678617|NCT01258803|10778066|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16
9678618|NCT01258803|10778061|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
9678619|NCT01258803|10778062|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
9678620|NCT01258803|10778063|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
9678621|NCT01258803|10778064|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
9678622|NCT01258803|10778065|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
9678623|NCT01258803|10778066|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
9678624|NCT01258803|10778061|FG000|STARTED|Treatment Period 2 (1 Dose)||15
9678625|NCT01258803|10778062|FG001|STARTED|Treatment Period 2 (1 Dose)||16
9678626|NCT01258803|10778063|FG002|STARTED|Treatment Period 2 (1 Dose)||15
9678627|NCT01258803|10778064|FG003|STARTED|Treatment Period 2 (1 Dose)||15
9678628|NCT01258803|10778065|FG004|STARTED|Treatment Period 2 (1 Dose)||15
9678629|NCT01258803|10778066|FG005|STARTED|Treatment Period 2 (1 Dose)||16
9678630|NCT01258803|10778061|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14
9678631|NCT01258803|10778062|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14
9678632|NCT01258803|10778063|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15
9678633|NCT01258803|10778064|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15
9678634|NCT01258803|10778065|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15
9678635|NCT01258803|10778066|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15
9678636|NCT01258803|10778061|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
9678637|NCT01258803|10778062|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
9678638|NCT01258803|10778063|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
9678639|NCT01258803|10778064|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
9678640|NCT01258803|10778065|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
9678641|NCT01258803|10778066|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
9678642|NCT01258803|10778061|FG000|STARTED|Treatment Period 3 (1 Dose)||14
9678643|NCT01258803|10778062|FG001|STARTED|Treatment Period 3 (1 Dose)||14
9678644|NCT01258803|10778063|FG002|STARTED|Treatment Period 3 (1 Dose)||15
9678645|NCT01258803|10778064|FG003|STARTED|Treatment Period 3 (1 Dose)||15
9678646|NCT01258803|10778065|FG004|STARTED|Treatment Period 3 (1 Dose)||15
9678647|NCT01258803|10778066|FG005|STARTED|Treatment Period 3 (1 Dose)||15
9678648|NCT01258803|10778061|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14
9678649|NCT01258803|10778062|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14
9678650|NCT01258803|10778063|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14
9678651|NCT01258803|10778064|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15
9678652|NCT01258803|10778065|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15
9678653|NCT01258803|10778066|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15
9678654|NCT01258803|10778061|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
9678655|NCT01258803|10778062|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
9678656|NCT01258803|10778063|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
9678657|NCT01258803|10778064|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
9678658|NCT01258803|10778065|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
9678659|NCT01258803|10778066|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
9678660|NCT01258803|10778061|FG000|STARTED|Treatment Period 4 (1 Dose)||14
9678661|NCT01258803|10778062|FG001|STARTED|Treatment Period 4 (1 Dose)||14
9678662|NCT01258803|10778063|FG002|STARTED|Treatment Period 4 (1 Dose)||14
9678663|NCT01258803|10778064|FG003|STARTED|Treatment Period 4 (1 Dose)||15
9678664|NCT01258803|10778065|FG004|STARTED|Treatment Period 4 (1 Dose)||15
9678665|NCT01258803|10778066|FG005|STARTED|Treatment Period 4 (1 Dose)||15
9678666|NCT01258803|10778061|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14
9678667|NCT01258803|10778062|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14
9678668|NCT01258803|10778063|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14
9678669|NCT01258803|10778064|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15
9678670|NCT01258803|10778065|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15
9678671|NCT01258803|10778066|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15
9678672|NCT01258803|10778061|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
9678673|NCT01258803|10778062|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
9678674|NCT01258803|10778063|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
9678675|NCT01258803|10778064|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
9678676|NCT01258803|10778065|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
9678677|NCT01258803|10778066|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
9678678|NCT01104922|10778080|FG000|STARTED|Overall Study||48
9678679|NCT01104922|10778080|FG000|COMPLETED|Overall Study||48
9678680|NCT01104922|10778080|FG000|NOT COMPLETED|Overall Study||0
9678681|NCT00862251|10778087|FG000|STARTED|Overall Study||322
9678682|NCT00862251|10778088|FG001|STARTED|Overall Study||162
9678683|NCT00862251|10778089|FG002|STARTED|Overall Study||324
9678684|NCT00862251|10778087|FG000|COMPLETED|Overall Study||303
9678685|NCT00862251|10778088|FG001|COMPLETED|Overall Study||157
9678686|NCT00862251|10778089|FG002|COMPLETED|Overall Study||315
9678687|NCT00862251|10778087|FG000|NOT COMPLETED|Overall Study||19
9678688|NCT00862251|10778088|FG001|NOT COMPLETED|Overall Study||5
9678689|NCT00862251|10778089|FG002|NOT COMPLETED|Overall Study||9
9678690|NCT00783263|10778104|FG000|STARTED|Overall Study||99
9678691|NCT00783263|10778105|FG001|STARTED|Overall Study||98
9678692|NCT00783263|10778106|FG002|STARTED|Overall Study||122
9678693|NCT00783263|10778107|FG003|STARTED|Overall Study||121
9678694|NCT00783263|10778104|FG000|COMPLETED|Overall Study||95
9678695|NCT00783263|10778105|FG001|COMPLETED|Overall Study||96
9678696|NCT00783263|10778106|FG002|COMPLETED|Overall Study||119
9678697|NCT00783263|10778107|FG003|COMPLETED|Overall Study||118
9678698|NCT00783263|10778104|FG000|NOT COMPLETED|Overall Study||4
9678699|NCT00783263|10778105|FG001|NOT COMPLETED|Overall Study||2
9678700|NCT00783263|10778106|FG002|NOT COMPLETED|Overall Study||3
9678701|NCT00783263|10778107|FG003|NOT COMPLETED|Overall Study||3
9678702|NCT00782184|10778132|FG000|STARTED|Overall Study||120
9678703|NCT00782184|10778133|FG001|STARTED|Overall Study||130
9678704|NCT00782184|10778132|FG000|COMPLETED|Overall Study||116
9678705|NCT00782184|10778133|FG001|COMPLETED|Overall Study||125
9678706|NCT00782184|10778132|FG000|NOT COMPLETED|Overall Study||4
9678707|NCT00782184|10778133|FG001|NOT COMPLETED|Overall Study||5
9678708|NCT00635882|10778146|FG000|STARTED|Overall Study||20
9678709|NCT00635882|10778147|FG001|STARTED|Overall Study||17
9678710|NCT00635882|10778148|FG002|STARTED|Overall Study||12
9678711|NCT00635882|10778149|FG003|STARTED|Overall Study||15
9678712|NCT00635882|10778150|FG004|STARTED|Overall Study||16
9678713|NCT00635882|10778151|FG005|STARTED|Overall Study||13
9678714|NCT00635882|10778146|FG000|COMPLETED|Overall Study||19
9678715|NCT00635882|10778147|FG001|COMPLETED|Overall Study||17
9678716|NCT00635882|10778148|FG002|COMPLETED|Overall Study||12
9678717|NCT00635882|10778149|FG003|COMPLETED|Overall Study||15
9678718|NCT00635882|10778150|FG004|COMPLETED|Overall Study||16
9678719|NCT00635882|10778151|FG005|COMPLETED|Overall Study||13
9678720|NCT00635882|10778146|FG000|NOT COMPLETED|Overall Study||1
9678721|NCT00635882|10778147|FG001|NOT COMPLETED|Overall Study||0
9678722|NCT00635882|10778148|FG002|NOT COMPLETED|Overall Study||0
9678723|NCT00635882|10778149|FG003|NOT COMPLETED|Overall Study||0
9678724|NCT00635882|10778150|FG004|NOT COMPLETED|Overall Study||0
9678725|NCT00635882|10778151|FG005|NOT COMPLETED|Overall Study||0
9678726|NCT00594620|10778167|FG000|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
9678727|NCT00594620|10778168|FG001|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
9678728|NCT00594620|10778167|FG000|COMPLETED|Overall Study||0
9678729|NCT00594620|10778168|FG001|COMPLETED|Overall Study||0
9678730|NCT00594620|10778167|FG000|NOT COMPLETED|Overall Study||0
9678731|NCT00594620|10778168|FG001|NOT COMPLETED|Overall Study||0
9678732|NCT00535405|10778179|FG000|STARTED|Overall Study||257
9678733|NCT00535405|10778180|FG001|STARTED|Overall Study||259
9678734|NCT00535405|10778181|FG002|STARTED|Overall Study||259
9678735|NCT00535405|10778182|FG003|STARTED|Overall Study||257
9678736|NCT00535405|10778183|FG004|STARTED|Overall Study||257
9678737|NCT00535405|10778179|FG000|COMPLETED|Overall Study||240
9678738|NCT00535405|10778180|FG001|COMPLETED|Overall Study||233
10023073|NCT01853696|11146578|FG000|STARTED|Overall Study||84
10023074|NCT01853696|11146579|FG001|STARTED|Overall Study||83
10023075|NCT01853696|11146578|FG000|COMPLETED|Overall Study||78
10023076|NCT01853696|11146579|FG001|COMPLETED|Overall Study||78
10023077|NCT01853696|11146578|FG000|NOT COMPLETED|Overall Study||6
10023078|NCT01853696|11146579|FG001|NOT COMPLETED|Overall Study||5
10023079|NCT01853774|11146587|FG000|STARTED|Overall Study||257
10023080|NCT01853774|11146588|FG001|STARTED|Overall Study||162
10023081|NCT01853774|11146587|FG000|COMPLETED|Overall Study||211
10023082|NCT01853774|11146588|FG001|COMPLETED|Overall Study||134
10023083|NCT01853774|11146587|FG000|NOT COMPLETED|Overall Study||46
10023084|NCT01853774|11146588|FG001|NOT COMPLETED|Overall Study||28
10023085|NCT01853839|11146596|FG000|STARTED|Overall Study||2092
10023086|NCT01853839|11146596|FG000|COMPLETED|Overall Study||1663
10023087|NCT01853839|11146596|FG000|NOT COMPLETED|Overall Study||429
10023088|NCT01853878|11146606|FG000|STARTED|Overall Study||86
10023089|NCT01853878|11146607|FG001|STARTED|Overall Study||47
10023090|NCT01853878|11146606|FG000|COMPLETED|Overall Study||23
10023091|NCT01853878|11146607|FG001|COMPLETED|Overall Study||3
10023092|NCT01853878|11146606|FG000|NOT COMPLETED|Overall Study||63
10023093|NCT01853878|11146607|FG001|NOT COMPLETED|Overall Study||44
10023094|NCT01853930|11146615|FG000|STARTED|Overall Study||25
10023095|NCT01853930|11146616|FG001|STARTED|Overall Study||8
10023096|NCT01853930|11146615|FG000|COMPLETED|Overall Study||25
9678739|NCT00535405|10778181|FG002|COMPLETED|Overall Study||241
9678740|NCT00535405|10778182|FG003|COMPLETED|Overall Study||235
9678741|NCT00535405|10778183|FG004|COMPLETED|Overall Study||241
9678742|NCT00535405|10778179|FG000|NOT COMPLETED|Overall Study||17
9678743|NCT00535405|10778180|FG001|NOT COMPLETED|Overall Study||26
9678744|NCT00535405|10778181|FG002|NOT COMPLETED|Overall Study||18
9678745|NCT00535405|10778182|FG003|NOT COMPLETED|Overall Study||22
9678746|NCT00535405|10778183|FG004|NOT COMPLETED|Overall Study||16
9678747|NCT00496730|10778197|FG000|STARTED|Overall Study||130
10023097|NCT01853930|11146616|FG001|COMPLETED|Overall Study||8
10023098|NCT01853930|11146615|FG000|NOT COMPLETED|Overall Study||0
10023099|NCT01853930|11146616|FG001|NOT COMPLETED|Overall Study||0
10023100|NCT01854034|11146622|FG000|STARTED|Overall Study||29
9678748|NCT00496730|10778198|FG001|STARTED|Overall Study||126
9678749|NCT00496730|10778197|FG000|COMPLETED|Overall Study||124
9678750|NCT00496730|10778198|FG001|COMPLETED|Overall Study||121
9678751|NCT00496730|10778197|FG000|NOT COMPLETED|Overall Study||6
9678752|NCT00496730|10778198|FG001|NOT COMPLETED|Overall Study||5
9678753|NCT00462748|10778207|FG000|STARTED|Overall Study||261
9678754|NCT00462748|10778208|FG001|STARTED|Overall Study||263
9678755|NCT00462748|10778209|FG002|STARTED|Overall Study||262
10023101|NCT01854034|11146622|FG000|COMPLETED|Overall Study||29
10023102|NCT01854034|11146622|FG000|NOT COMPLETED|Overall Study||0
10023103|NCT01854047|11146631|FG000|STARTED|Overall Study||158
10023104|NCT01854047|11146632|FG001|STARTED|Overall Study||157
9678756|NCT00462748|10778207|FG000|COMPLETED|Overall Study||249
9678757|NCT00462748|10778208|FG001|COMPLETED|Overall Study||252
9678758|NCT00462748|10778209|FG002|COMPLETED|Overall Study||251
9678759|NCT00462748|10778207|FG000|NOT COMPLETED|Overall Study||12
9678760|NCT00462748|10778208|FG001|NOT COMPLETED|Overall Study||11
9678761|NCT00462748|10778209|FG002|NOT COMPLETED|Overall Study||11
9678762|NCT00418834|10778219|FG000|STARTED|Overall Study||526
9678763|NCT00418834|10778220|FG001|STARTED|Overall Study||527
10023105|NCT01854047|11146633|FG002|STARTED|Overall Study||150
9678764|NCT00418834|10778219|FG000|COMPLETED|Overall Study||503
9678765|NCT00418834|10778220|FG001|COMPLETED|Overall Study||507
9678766|NCT00418834|10778219|FG000|NOT COMPLETED|Overall Study||23
9678767|NCT00418834|10778220|FG001|NOT COMPLETED|Overall Study||20
9678768|NCT00409773|10778231|FG000|STARTED|Overall Study||229
9678769|NCT00409773|10778232|FG001|STARTED|Overall Study||229
9678770|NCT00409773|10778233|FG002|STARTED|Overall Study||229
9678771|NCT00409773|10778234|FG003|STARTED|Overall Study||228
9678772|NCT00409773|10778235|FG004|STARTED|Overall Study||228
9678773|NCT00409773|10778231|FG000|COMPLETED|Overall Study||220
9678774|NCT00409773|10778232|FG001|COMPLETED|Overall Study||222
9678775|NCT00409773|10778233|FG002|COMPLETED|Overall Study||220
9678776|NCT00409773|10778234|FG003|COMPLETED|Overall Study||216
9678777|NCT00409773|10778235|FG004|COMPLETED|Overall Study||218
9678778|NCT00409773|10778231|FG000|NOT COMPLETED|Overall Study||9
9678779|NCT00409773|10778232|FG001|NOT COMPLETED|Overall Study||7
9678780|NCT00409773|10778233|FG002|NOT COMPLETED|Overall Study||9
9678781|NCT00409773|10778234|FG003|NOT COMPLETED|Overall Study||12
9678782|NCT00409773|10778235|FG004|NOT COMPLETED|Overall Study||10
9678783|NCT00276484|10778249|FG000|STARTED|Overall Study||288
9678784|NCT00276484|10778250|FG001|STARTED|Overall Study||291
9678785|NCT00276484|10778249|FG000|COMPLETED|Overall Study||279
9678786|NCT00276484|10778250|FG001|COMPLETED|Overall Study||278
9678787|NCT00276484|10778249|FG000|NOT COMPLETED|Overall Study||9
9678788|NCT00276484|10778250|FG001|NOT COMPLETED|Overall Study||13
9678789|NCT00276458|10778258|FG000|STARTED|Overall Study||98
9678790|NCT00276458|10778259|FG001|STARTED|Overall Study||98
9678791|NCT00276458|10778258|FG000|COMPLETED|Overall Study||92
9678792|NCT00276458|10778259|FG001|COMPLETED|Overall Study||91
9678793|NCT00276458|10778258|FG000|NOT COMPLETED|Overall Study||6
9678794|NCT00276458|10778259|FG001|NOT COMPLETED|Overall Study||7
9678795|NCT00271817|10778268|FG000|STARTED|Part 1||272
9678796|NCT00271817|10778269|FG001|STARTED|Part 1||272
9678797|NCT00271817|10778270|FG002|STARTED|Part 1||676
9678798|NCT00271817|10778268|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
9678799|NCT00271817|10778269|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
9678800|NCT00271817|10778270|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
9678801|NCT00271817|10778268|FG000|NOT COMPLETED|Part 1||106
9678802|NCT00271817|10778269|FG001|NOT COMPLETED|Part 1||59
9678803|NCT00271817|10778270|FG002|NOT COMPLETED|Part 1||285
9678804|NCT00271817|10778268|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
9678805|NCT00271817|10778269|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
9678806|NCT00271817|10778270|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
9678807|NCT00271817|10778268|FG000|COMPLETED|Part 2||0
9678808|NCT00271817|10778269|FG001|COMPLETED|Part 2||234
9678809|NCT00271817|10778270|FG002|COMPLETED|Part 2||401
9678810|NCT00271817|10778268|FG000|NOT COMPLETED|Part 2||0
9678811|NCT00271817|10778269|FG001|NOT COMPLETED|Part 2||32
9678812|NCT00271817|10778270|FG002|NOT COMPLETED|Part 2||84
9724242|NCT00088699|10824022|FG000|STARTED|Infusion 1||23
9724243|NCT00088699|10824023|FG001|STARTED|Infusion 1||19
9724244|NCT00088699|10824024|FG002|STARTED|Infusion 1||13
9724245|NCT00088699|10824025|FG003|STARTED|Infusion 1||12
9724246|NCT00088699|10824022|FG000|COMPLETED|Infusion 1||22
9724247|NCT00088699|10824023|FG001|COMPLETED|Infusion 1||19
9724248|NCT00088699|10824024|FG002|COMPLETED|Infusion 1||12
9724249|NCT00088699|10824025|FG003|COMPLETED|Infusion 1||10
9724250|NCT00088699|10824022|FG000|NOT COMPLETED|Infusion 1||1
9724251|NCT00088699|10824023|FG001|NOT COMPLETED|Infusion 1||0
9724252|NCT00088699|10824024|FG002|NOT COMPLETED|Infusion 1||1
9724253|NCT00088699|10824025|FG003|NOT COMPLETED|Infusion 1||2
9724254|NCT00088699|10824022|FG000|STARTED|Infusion 2||19
9724255|NCT00088699|10824023|FG001|STARTED|Infusion 2||18
9724256|NCT00088699|10824024|FG002|STARTED|Infusion 2||11
9724257|NCT00088699|10824025|FG003|STARTED|Infusion 2||11
9724258|NCT00088699|10824022|FG000|COMPLETED|Infusion 2||19
9724259|NCT00088699|10824023|FG001|COMPLETED|Infusion 2||18
9724260|NCT00088699|10824024|FG002|COMPLETED|Infusion 2||11
9724261|NCT00088699|10824025|FG003|COMPLETED|Infusion 2||10
9724262|NCT00088699|10824022|FG000|NOT COMPLETED|Infusion 2||0
9724263|NCT00088699|10824023|FG001|NOT COMPLETED|Infusion 2||0
9724264|NCT00088699|10824024|FG002|NOT COMPLETED|Infusion 2||0
9724265|NCT00088699|10824025|FG003|NOT COMPLETED|Infusion 2||1
9724266|NCT00088881|10824035|FG000|STARTED|Step 1 - R-CHOP||62
9724267|NCT00088881|10824035|FG000|Eligible and Treated|Step 1 - R-CHOP||53
9724268|NCT00088881|10824035|FG000|COMPLETED|Step 1 - R-CHOP||48
9724269|NCT00088881|10824035|FG000|NOT COMPLETED|Step 1 - R-CHOP||14
9724270|NCT00088881|10824035|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
9731730|NCT00135226|10831631|FG003|COMPLETED|Overall Study||3834
10114233|NCT02514824|11244950|FG001|COMPLETED|Overall Study||4
10114234|NCT02514824|11244951|FG002|COMPLETED|Overall Study||0
10114235|NCT02514824|11244952|FG003|COMPLETED|Overall Study||0
10114236|NCT02514824|11244949|FG000|NOT COMPLETED|Overall Study||1
10114237|NCT02514824|11244950|FG001|NOT COMPLETED|Overall Study||1
9678813|NCT03660865|10778284|FG000|STARTED|Overall Study||105
9678814|NCT03660865|10778285|FG001|STARTED|Overall Study||105
9678815|NCT03660865|10778284|FG000|COMPLETED|Overall Study||105
9678816|NCT03660865|10778285|FG001|COMPLETED|Overall Study||105
9678817|NCT03660865|10778284|FG000|NOT COMPLETED|Overall Study||0
9678818|NCT03660865|10778285|FG001|NOT COMPLETED|Overall Study||0
9678819|NCT03493126|10778293|FG000|STARTED|Overall Study||31
9678820|NCT03493126|10778294|FG001|STARTED|Overall Study||28
9678821|NCT03493126|10778293|FG000|COMPLETED|Overall Study||28
9678822|NCT03493126|10778294|FG001|COMPLETED|Overall Study||28
9678823|NCT03493126|10778293|FG000|NOT COMPLETED|Overall Study||3
9678824|NCT03493126|10778294|FG001|NOT COMPLETED|Overall Study||0
9678825|NCT03420781|10778302|FG000|STARTED|Treatment Period (40 Weeks)||236
9678826|NCT03420781|10778303|FG001|STARTED|Treatment Period (40 Weeks)||231
9678827|NCT03420781|10778304|FG002|STARTED|Treatment Period (40 Weeks)||0
9678828|NCT03420781|10778305|FG003|STARTED|Treatment Period (40 Weeks)||0
9678829|NCT03420781|10778306|FG004|STARTED|Treatment Period (40 Weeks)||0
9678830|NCT03420781|10778302|FG000|Safety Population|Treatment Period (40 Weeks)||235
9678831|NCT03420781|10778303|FG001|Safety Population|Treatment Period (40 Weeks)||231
9678832|NCT03420781|10778304|FG002|Safety Population|Treatment Period (40 Weeks)||0
9678833|NCT03420781|10778305|FG003|Safety Population|Treatment Period (40 Weeks)||0
9678834|NCT03420781|10778306|FG004|Safety Population|Treatment Period (40 Weeks)||0
9678835|NCT03420781|10778302|FG000|COMPLETED|Treatment Period (40 Weeks)||92
9678836|NCT03420781|10778303|FG001|COMPLETED|Treatment Period (40 Weeks)||105
9678837|NCT03420781|10778304|FG002|COMPLETED|Treatment Period (40 Weeks)||0
9678838|NCT03420781|10778305|FG003|COMPLETED|Treatment Period (40 Weeks)||0
9678839|NCT03420781|10778306|FG004|COMPLETED|Treatment Period (40 Weeks)||0
9678840|NCT03420781|10778302|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144
9678841|NCT03420781|10778303|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126
9678842|NCT03420781|10778304|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0
9678843|NCT03420781|10778305|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0
9678844|NCT03420781|10778306|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0
9678845|NCT03420781|10778302|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
9678846|NCT03420781|10778303|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
9678847|NCT03420781|10778304|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91
9678848|NCT03420781|10778305|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59
9678849|NCT03420781|10778306|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43
9678850|NCT03420781|10778302|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
9678851|NCT03420781|10778303|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
9678852|NCT03420781|10778304|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85
9678853|NCT03420781|10778305|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54
9678854|NCT03420781|10778306|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38
9678855|NCT03420781|10778302|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
9678856|NCT03420781|10778303|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
9678857|NCT03420781|10778304|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6
9678858|NCT03420781|10778305|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
9678859|NCT03420781|10778306|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
9678860|NCT03316586|10778322|FG000|STARTED|Overall Study||18
9678861|NCT03316586|10778322|FG000|COMPLETED|Overall Study||0
9678862|NCT03316586|10778322|FG000|NOT COMPLETED|Overall Study||18
9678863|NCT03277066|10778329|FG000|STARTED|Overall Study||71
9678864|NCT03277066|10778330|FG001|STARTED|Overall Study||72
9678865|NCT03277066|10778331|FG002|STARTED|Overall Study||146
9678866|NCT03277066|10778329|FG000|COMPLETED|Overall Study||69
9678867|NCT03277066|10778330|FG001|COMPLETED|Overall Study||71
9678868|NCT03277066|10778331|FG002|COMPLETED|Overall Study||143
9678869|NCT03277066|10778329|FG000|NOT COMPLETED|Overall Study||2
9678870|NCT03277066|10778330|FG001|NOT COMPLETED|Overall Study||1
9678871|NCT03277066|10778331|FG002|NOT COMPLETED|Overall Study||3
9678872|NCT03269695|10778341|FG000|STARTED|Overall Study||10
10114238|NCT02514824|11244951|FG002|NOT COMPLETED|Overall Study||0
10114239|NCT02514824|11244952|FG003|NOT COMPLETED|Overall Study||0
9678873|NCT03269695|10778342|FG001|STARTED|Overall Study||10
9678874|NCT03269695|10778341|FG000|Treated|Overall Study||10
9678875|NCT03269695|10778342|FG001|Treated|Overall Study||10
9678876|NCT03269695|10778341|FG000|COMPLETED|Overall Study||8
9678877|NCT03269695|10778342|FG001|COMPLETED|Overall Study||7
9678878|NCT03269695|10778341|FG000|NOT COMPLETED|Overall Study||2
9678879|NCT03269695|10778342|FG001|NOT COMPLETED|Overall Study||3
9678880|NCT03268811|10778351|FG000|STARTED|Overall Study||7
9678881|NCT03268811|10778352|FG001|STARTED|Overall Study||2
9678882|NCT03268811|10778351|FG000|COMPLETED|Overall Study||7
9678883|NCT03268811|10778352|FG001|COMPLETED|Overall Study||1
9678884|NCT03268811|10778351|FG000|NOT COMPLETED|Overall Study||0
9678885|NCT03268811|10778352|FG001|NOT COMPLETED|Overall Study||1
9678886|NCT03227757|10778359|FG000|STARTED|Overall Study||85
9678887|NCT03227757|10778359|FG000|COMPLETED|Overall Study||69
9678888|NCT03227757|10778359|FG000|NOT COMPLETED|Overall Study||16
9678889|NCT03222128|10778363|FG000|STARTED|Overall Study||1074
10114240|NCT02514889|11244961|FG000|STARTED|Randomization/Allocation to Condition||131
9678890|NCT03222128|10778363|FG000|Valve-Implanted|Overall Study||1069
9678891|NCT03222128|10778363|FG000|COMPLETED|Overall Study||968
9678892|NCT03222128|10778363|FG000|NOT COMPLETED|Overall Study||106
9678893|NCT03142334|10778369|FG000|STARTED|Overall Study||496
9678894|NCT03142334|10778370|FG001|STARTED|Overall Study||498
9678895|NCT03142334|10778369|FG000|Treated|Overall Study||488
9678896|NCT03142334|10778370|FG001|Treated|Overall Study||496
9678897|NCT03142334|10778369|FG000|Continuing Study Treatment|Overall Study||0
9678898|NCT03142334|10778370|FG001|Continuing Study Treatment|Overall Study||1
9678899|NCT03142334|10778369|FG000|Completed Study Treatment|Overall Study||298
9678900|NCT03142334|10778370|FG001|Completed Study Treatment|Overall Study||365
9678901|NCT03142334|10778369|FG000|Discontinued Study Treatment|Overall Study||190
9678902|NCT03142334|10778370|FG001|Discontinued Study Treatment|Overall Study||130
9678903|NCT03142334|10778369|FG000|COMPLETED|Overall Study||0
9678904|NCT03142334|10778370|FG001|COMPLETED|Overall Study||0
9678905|NCT03142334|10778369|FG000|NOT COMPLETED|Overall Study||496
9678906|NCT03142334|10778370|FG001|NOT COMPLETED|Overall Study||498
9678907|NCT03093701|10778379|FG000|STARTED|Overall Study||10
9678908|NCT03093701|10778380|FG001|STARTED|Overall Study||10
9678909|NCT03093701|10778381|FG002|STARTED|Overall Study||11
9678910|NCT03093701|10778382|FG003|STARTED|Overall Study||0
9678911|NCT03093701|10778379|FG000|COMPLETED|Overall Study||10
9678912|NCT03093701|10778380|FG001|COMPLETED|Overall Study||7
9678913|NCT03093701|10778381|FG002|COMPLETED|Overall Study||11
9678914|NCT03093701|10778382|FG003|COMPLETED|Overall Study||0
9678915|NCT03093701|10778379|FG000|NOT COMPLETED|Overall Study||0
9678916|NCT03093701|10778380|FG001|NOT COMPLETED|Overall Study||3
9678917|NCT03093701|10778381|FG002|NOT COMPLETED|Overall Study||0
9678918|NCT03093701|10778382|FG003|NOT COMPLETED|Overall Study||0
9678919|NCT03093246|10778392|FG000|STARTED|Overall Study||19
9678920|NCT03093246|10778393|FG001|STARTED|Overall Study||19
9678921|NCT03093246|10778392|FG000|COMPLETED|Overall Study||19
9678922|NCT03093246|10778393|FG001|COMPLETED|Overall Study||19
9678923|NCT03093246|10778392|FG000|NOT COMPLETED|Overall Study||0
9678924|NCT03093246|10778393|FG001|NOT COMPLETED|Overall Study||0
9724271|NCT00088881|10824035|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
9724272|NCT00088881|10824035|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
9724273|NCT00088881|10824035|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
9724274|NCT00088881|10824035|FG000|STARTED|Step 3 - Radiation Therapy||1
9724275|NCT00088881|10824035|FG000|COMPLETED|Step 3 - Radiation Therapy||1
9724276|NCT00088881|10824035|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0
9724277|NCT00088907|10824043|FG000|STARTED|Randomized Study (Step 1)||136
9724278|NCT00088907|10824044|FG001|STARTED|Randomized Study (Step 1)||134
9724279|NCT00088907|10824043|FG000|Treated|Randomized Study (Step 1)||129
9724280|NCT00088907|10824044|FG001|Treated|Randomized Study (Step 1)||124
9724281|NCT00088907|10824043|FG000|Eligible|Randomized Study (Step 1)||117
9724282|NCT00088907|10824044|FG001|Eligible|Randomized Study (Step 1)||122
9724283|NCT00088907|10824043|FG000|Eligible and Treated|Randomized Study (Step 1)||117
9724284|NCT00088907|10824044|FG001|Eligible and Treated|Randomized Study (Step 1)||122
9724285|NCT00088907|10824043|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
9724286|NCT00088907|10824044|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
9724287|NCT00088907|10824043|FG000|NOT COMPLETED|Randomized Study (Step 1)||136
9724288|NCT00088907|10824044|FG001|NOT COMPLETED|Randomized Study (Step 1)||134
9724289|NCT00088907|10824043|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
9724290|NCT00088907|10824044|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
9724291|NCT00088907|10824043|FG000|Treated|Single Gefitinib Treatment (Step 2)||19
9724292|NCT00088907|10824044|FG001|Treated|Single Gefitinib Treatment (Step 2)||0
9724293|NCT00088907|10824043|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0
9724294|NCT00088907|10824044|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0
9724295|NCT00088907|10824043|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
9724296|NCT00088907|10824044|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
9724297|NCT00088985|10824051|FG000|STARTED|Overall Study||7
9724298|NCT00088985|10824051|FG000|COMPLETED|Overall Study||4
9724299|NCT00088985|10824051|FG000|NOT COMPLETED|Overall Study||3
9724300|NCT00089011|10824057|FG000|STARTED|Overall Study||100
9724301|NCT00089011|10824058|FG001|STARTED|Overall Study||50
9724302|NCT00089011|10824057|FG000|COMPLETED|Overall Study||100
9724303|NCT00089011|10824058|FG001|COMPLETED|Overall Study||50
9724304|NCT00089011|10824057|FG000|NOT COMPLETED|Overall Study||0
9724305|NCT00089011|10824058|FG001|NOT COMPLETED|Overall Study||0
9724306|NCT00089024|10824064|FG000|STARTED|Overall Study||29
9724307|NCT00089024|10824064|FG000|Treated Subjects|Overall Study||29
9724308|NCT00089024|10824064|FG000|COMPLETED|Overall Study||24
9724309|NCT00089024|10824064|FG000|NOT COMPLETED|Overall Study||5
9724310|NCT00089076|10824068|FG000|STARTED|Overall Study||18
9724311|NCT00089076|10824068|FG000|COMPLETED|Overall Study||8
9724312|NCT00089076|10824068|FG000|NOT COMPLETED|Overall Study||10
9724313|NCT00089102|10824072|FG000|STARTED|Overall Study||9
9724314|NCT00089102|10824072|FG000|COMPLETED|Overall Study||9
9724315|NCT00089102|10824072|FG000|NOT COMPLETED|Overall Study||0
9724316|NCT00089284|10824081|FG000|STARTED|Overall Study||7
9724317|NCT00089284|10824082|FG001|STARTED|Overall Study||3
9724318|NCT00089284|10824083|FG002|STARTED|Overall Study||6
9678925|NCT02991599|10778401|FG000|STARTED|Overall Study||98
9678926|NCT02991599|10778402|FG001|STARTED|Overall Study||98
9678927|NCT02991599|10778401|FG000|COMPLETED|Overall Study||60
9678928|NCT02991599|10778402|FG001|COMPLETED|Overall Study||61
9678929|NCT02991599|10778401|FG000|NOT COMPLETED|Overall Study||38
9678930|NCT02991599|10778402|FG001|NOT COMPLETED|Overall Study||37
9678931|NCT02976129|10778410|FG000|STARTED|Overall Study||82
9678932|NCT02976129|10778411|FG001|STARTED|Overall Study||43
9678933|NCT02976129|10778410|FG000|COMPLETED|Overall Study||77
9678934|NCT02976129|10778411|FG001|COMPLETED|Overall Study||41
9678935|NCT02976129|10778410|FG000|NOT COMPLETED|Overall Study||5
9678936|NCT02976129|10778411|FG001|NOT COMPLETED|Overall Study||2
9678937|NCT02970136|10778419|FG000|STARTED|Overall Study||377
9678938|NCT02970136|10778420|FG001|STARTED|Overall Study||377
9678939|NCT02970136|10778419|FG000|COMPLETED|Overall Study||297
9678940|NCT02970136|10778420|FG001|COMPLETED|Overall Study||282
9678941|NCT02970136|10778419|FG000|NOT COMPLETED|Overall Study||80
9678942|NCT02970136|10778420|FG001|NOT COMPLETED|Overall Study||95
9678943|NCT02969928|10778428|FG000|STARTED|Overall Study||23
9678944|NCT02969928|10778429|FG001|STARTED|Overall Study||23
9678945|NCT02969928|10778428|FG000|COMPLETED|Overall Study||23
9678946|NCT02969928|10778429|FG001|COMPLETED|Overall Study||23
9678947|NCT02969928|10778428|FG000|NOT COMPLETED|Overall Study||0
9678948|NCT02969928|10778429|FG001|NOT COMPLETED|Overall Study||0
9678949|NCT02949297|10778435|FG000|STARTED|1 Month||75
9678950|NCT02949297|10778435|FG000|COMPLETED|1 Month||75
9678951|NCT02949297|10778435|FG000|NOT COMPLETED|1 Month||0
9678952|NCT02949297|10778435|FG000|STARTED|6 Months||75
9678953|NCT02949297|10778435|FG000|COMPLETED|6 Months||72
9678954|NCT02949297|10778435|FG000|NOT COMPLETED|6 Months||3
9678955|NCT02949297|10778435|FG000|STARTED|12 Months||72
9678956|NCT02949297|10778435|FG000|COMPLETED|12 Months||67
9678957|NCT02949297|10778435|FG000|NOT COMPLETED|12 Months||5
9678958|NCT02945787|10778441|FG000|STARTED|Overall Study||714
9678959|NCT02945787|10778442|FG001|STARTED|Overall Study||703
9678960|NCT02945787|10778441|FG000|COMPLETED|Overall Study||714
9678961|NCT02945787|10778442|FG001|COMPLETED|Overall Study||703
9678962|NCT02945787|10778441|FG000|NOT COMPLETED|Overall Study||0
9678963|NCT02945787|10778442|FG001|NOT COMPLETED|Overall Study||0
9678964|NCT02857426|10778450|FG000|STARTED|Overall Study||47
9678965|NCT02857426|10778451|FG001|STARTED|Overall Study||19
9678966|NCT02857426|10778450|FG000|COMPLETED|Overall Study||0
9678967|NCT02857426|10778451|FG001|COMPLETED|Overall Study||0
9678968|NCT02857426|10778450|FG000|NOT COMPLETED|Overall Study||47
9678969|NCT02857426|10778451|FG001|NOT COMPLETED|Overall Study||19
9678970|NCT02855125|10778459|FG000|STARTED|Overall Study||64
9678971|NCT02855125|10778460|FG001|STARTED|Overall Study||64
9678972|NCT02855125|10778459|FG000|Treated|Overall Study||64
9678973|NCT02855125|10778460|FG001|Treated|Overall Study||63
9678974|NCT02855125|10778459|FG000|COMPLETED|Overall Study||0
9678975|NCT02855125|10778460|FG001|COMPLETED|Overall Study||0
9678976|NCT02855125|10778459|FG000|NOT COMPLETED|Overall Study||64
9678977|NCT02855125|10778460|FG001|NOT COMPLETED|Overall Study||64
9678978|NCT02836236|10778468|FG000|STARTED|Overall Study||105
9678979|NCT02836236|10778469|FG001|STARTED|Overall Study||50
9678980|NCT02836236|10778468|FG000|COMPLETED|Overall Study||0
9678981|NCT02836236|10778469|FG001|COMPLETED|Overall Study||0
9678982|NCT02836236|10778468|FG000|NOT COMPLETED|Overall Study||105
9678983|NCT02836236|10778469|FG001|NOT COMPLETED|Overall Study||50
9678984|NCT02728752|10778477|FG000|STARTED|First Period||48
9678985|NCT02728752|10778478|FG001|STARTED|First Period||47
9678986|NCT02728752|10778477|FG000|COMPLETED|First Period||46
9678987|NCT02728752|10778478|FG001|COMPLETED|First Period||45
9678988|NCT02728752|10778477|FG000|NOT COMPLETED|First Period||2
9678989|NCT02728752|10778478|FG001|NOT COMPLETED|First Period||2
9678990|NCT02728752|10778477|FG000|STARTED|Extension Period||46
9678991|NCT02728752|10778478|FG001|STARTED|Extension Period||45
9678992|NCT02728752|10778477|FG000|COMPLETED|Extension Period||35
9678993|NCT02728752|10778478|FG001|COMPLETED|Extension Period||34
9678994|NCT02728752|10778477|FG000|NOT COMPLETED|Extension Period||11
9678995|NCT02728752|10778478|FG001|NOT COMPLETED|Extension Period||11
9678996|NCT02680587|10778487|FG000|STARTED|Overall Study||18
9678997|NCT02680587|10778488|FG001|STARTED|Overall Study||36
9678998|NCT02680587|10778487|FG000|COMPLETED|Overall Study||17
9678999|NCT02680587|10778488|FG001|COMPLETED|Overall Study||36
9679000|NCT02680587|10778487|FG000|NOT COMPLETED|Overall Study||1
9679001|NCT02680587|10778488|FG001|NOT COMPLETED|Overall Study||0
9679002|NCT02667639|10778500|FG000|STARTED|Overall Study||25
9679003|NCT02667639|10778501|FG001|STARTED|Overall Study||10
9679004|NCT02667639|10778500|FG000|COMPLETED|Overall Study||25
9679005|NCT02667639|10778501|FG001|COMPLETED|Overall Study||10
9679006|NCT02667639|10778500|FG000|NOT COMPLETED|Overall Study||0
9679007|NCT02667639|10778501|FG001|NOT COMPLETED|Overall Study||0
9842871|NCT00827606|10954636|FG001|STARTED|Overall Study||132
9842872|NCT00827606|10954635|FG000|COMPLETED|Overall Study||112
9842873|NCT00827606|10954636|FG001|COMPLETED|Overall Study||94
9842874|NCT00827606|10954635|FG000|NOT COMPLETED|Overall Study||27
9842875|NCT00827606|10954636|FG001|NOT COMPLETED|Overall Study||38
9842876|NCT00827632|10954650|FG000|STARTED|Overall Study||128
9842877|NCT00827632|10954651|FG001|STARTED|Overall Study||98
9842878|NCT00827632|10954650|FG000|COMPLETED|Overall Study||106
9679016|NCT02527798|10778524|FG000|STARTED|Overall Study||32
9679017|NCT02527798|10778525|FG001|STARTED|Overall Study||10
9679018|NCT02527798|10778526|FG002|STARTED|Overall Study||30
9679019|NCT02527798|10778527|FG003|STARTED|Overall Study||10
9679020|NCT02527798|10778528|FG004|STARTED|Overall Study||0
9679021|NCT02527798|10778529|FG005|STARTED|Overall Study||0
9679022|NCT02527798|10778524|FG000|Randomized, Not Dosed|Overall Study||31
9679023|NCT02527798|10778525|FG001|Randomized, Not Dosed|Overall Study||9
9679024|NCT02527798|10778526|FG002|Randomized, Not Dosed|Overall Study||30
9679025|NCT02527798|10778527|FG003|Randomized, Not Dosed|Overall Study||10
9679026|NCT02527798|10778528|FG004|Randomized, Not Dosed|Overall Study||0
9679027|NCT02527798|10778529|FG005|Randomized, Not Dosed|Overall Study||0
9679028|NCT02527798|10778524|FG000|Pharmacokinetic (PK) Population|Overall Study||20
9679029|NCT02527798|10778525|FG001|Pharmacokinetic (PK) Population|Overall Study||0
9679030|NCT02527798|10778526|FG002|Pharmacokinetic (PK) Population|Overall Study||19
9679031|NCT02527798|10778527|FG003|Pharmacokinetic (PK) Population|Overall Study||0
9679032|NCT02527798|10778528|FG004|Pharmacokinetic (PK) Population|Overall Study||0
9679033|NCT02527798|10778529|FG005|Pharmacokinetic (PK) Population|Overall Study||0
9679034|NCT02527798|10778524|FG000|COMPLETED|Overall Study||29
9679035|NCT02527798|10778525|FG001|COMPLETED|Overall Study||8
9679036|NCT02527798|10778526|FG002|COMPLETED|Overall Study||25
9679037|NCT02527798|10778527|FG003|COMPLETED|Overall Study||9
9679038|NCT02527798|10778528|FG004|COMPLETED|Overall Study||0
9679039|NCT02527798|10778529|FG005|COMPLETED|Overall Study||0
9679040|NCT02527798|10778524|FG000|NOT COMPLETED|Overall Study||3
9679041|NCT02527798|10778525|FG001|NOT COMPLETED|Overall Study||2
9679042|NCT02527798|10778526|FG002|NOT COMPLETED|Overall Study||5
9679043|NCT02527798|10778527|FG003|NOT COMPLETED|Overall Study||1
9679044|NCT02527798|10778528|FG004|NOT COMPLETED|Overall Study||0
9679045|NCT02527798|10778529|FG005|NOT COMPLETED|Overall Study||0
9679046|NCT02416492|10778560|FG000|STARTED|Overall Study||15
9679047|NCT02416492|10778561|FG001|STARTED|Overall Study||15
9679048|NCT02416492|10778562|FG002|STARTED|Overall Study||16
9679049|NCT02416492|10778563|FG003|STARTED|Overall Study||15
9679050|NCT02416492|10778560|FG000|COMPLETED|Overall Study||15
9679051|NCT02416492|10778561|FG001|COMPLETED|Overall Study||15
9679052|NCT02416492|10778562|FG002|COMPLETED|Overall Study||16
9679053|NCT02416492|10778563|FG003|COMPLETED|Overall Study||15
9679054|NCT02416492|10778560|FG000|NOT COMPLETED|Overall Study||0
9679055|NCT02416492|10778561|FG001|NOT COMPLETED|Overall Study||0
9679056|NCT02416492|10778562|FG002|NOT COMPLETED|Overall Study||0
9679057|NCT02416492|10778563|FG003|NOT COMPLETED|Overall Study||0
9679058|NCT02324816|10778576|FG000|STARTED|Overall Study||19
9679059|NCT02324816|10778576|FG000|COMPLETED|Overall Study||19
9679060|NCT02324816|10778576|FG000|NOT COMPLETED|Overall Study||0
9679061|NCT02279745|10778580|FG000|STARTED|Overall Study||45
9679062|NCT02279745|10778580|FG000|COMPLETED|Overall Study||25
9679063|NCT02279745|10778580|FG000|NOT COMPLETED|Overall Study||20
9679064|NCT02067975|10778586|FG000|STARTED|Overall Study||20
9679065|NCT02067975|10778587|FG001|STARTED|Overall Study||18
9679066|NCT02067975|10778588|FG002|STARTED|Overall Study||21
9679067|NCT02067975|10778589|FG003|STARTED|Overall Study||18
9679068|NCT02067975|10778590|FG004|STARTED|Overall Study||8
9679069|NCT02067975|10778591|FG005|STARTED|Overall Study||8
9679070|NCT02067975|10778586|FG000|COMPLETED|Overall Study||16
9679071|NCT02067975|10778587|FG001|COMPLETED|Overall Study||16
9842879|NCT00827632|10954651|FG001|COMPLETED|Overall Study||75
9842880|NCT00827632|10954650|FG000|NOT COMPLETED|Overall Study||22
9842881|NCT00827632|10954651|FG001|NOT COMPLETED|Overall Study||23
9842882|NCT00827775|10954659|FG000|STARTED|Overall Study||25
9842883|NCT00827775|10954660|FG001|STARTED|Overall Study||30
9842884|NCT00827775|10954659|FG000|COMPLETED|Overall Study||25
9842885|NCT00827775|10954660|FG001|COMPLETED|Overall Study||25
9842886|NCT00827775|10954659|FG000|NOT COMPLETED|Overall Study||0
9842887|NCT00827775|10954660|FG001|NOT COMPLETED|Overall Study||5
9842888|NCT00827827|10954668|FG000|STARTED|Overall Study||22
9842889|NCT00827827|10954669|FG001|STARTED|Overall Study||16
9842890|NCT00827827|10954668|FG000|COMPLETED|Overall Study||14
9842891|NCT00827827|10954669|FG001|COMPLETED|Overall Study||16
9842892|NCT00827827|10954668|FG000|NOT COMPLETED|Overall Study||8
9842893|NCT00827827|10954669|FG001|NOT COMPLETED|Overall Study||0
9842894|NCT00827918|10954679|FG000|STARTED|Overall Study||86
9842895|NCT00827918|10954680|FG001|STARTED|Overall Study||47
9842896|NCT00827918|10954681|FG002|STARTED|Overall Study||83
9842897|NCT00827918|10954679|FG000|COMPLETED|Overall Study||58
9842898|NCT00827918|10954680|FG001|COMPLETED|Overall Study||38
9842899|NCT00827918|10954681|FG002|COMPLETED|Overall Study||62
9679072|NCT02067975|10778588|FG002|COMPLETED|Overall Study||19
9679073|NCT02067975|10778589|FG003|COMPLETED|Overall Study||14
9842900|NCT00827918|10954679|FG000|NOT COMPLETED|Overall Study||28
9842901|NCT00827918|10954680|FG001|NOT COMPLETED|Overall Study||9
9842902|NCT00827918|10954681|FG002|NOT COMPLETED|Overall Study||21
9842903|NCT00827931|10954691|FG000|STARTED|Overall Study||49
9842904|NCT00827931|10954692|FG001|STARTED|Overall Study||45
9842905|NCT00827931|10954691|FG000|COMPLETED|Overall Study||43
9842906|NCT00827931|10954692|FG001|COMPLETED|Overall Study||39
9842907|NCT00827931|10954691|FG000|NOT COMPLETED|Overall Study||6
9842908|NCT00827931|10954692|FG001|NOT COMPLETED|Overall Study||6
9679074|NCT02067975|10778590|FG004|COMPLETED|Overall Study||0
9842909|NCT00827944|10954700|FG000|STARTED|Overall Study||304
9842910|NCT00827944|10954701|FG001|STARTED|Overall Study||299
9842911|NCT00827944|10954700|FG000|COMPLETED|Overall Study||241
9842912|NCT00827944|10954701|FG001|COMPLETED|Overall Study||240
9842913|NCT00827944|10954700|FG000|NOT COMPLETED|Overall Study||63
9679075|NCT02067975|10778591|FG005|COMPLETED|Overall Study||0
9679076|NCT02067975|10778586|FG000|NOT COMPLETED|Overall Study||4
9679077|NCT02067975|10778587|FG001|NOT COMPLETED|Overall Study||2
9679078|NCT02067975|10778588|FG002|NOT COMPLETED|Overall Study||2
9679079|NCT02067975|10778589|FG003|NOT COMPLETED|Overall Study||4
9679080|NCT02067975|10778590|FG004|NOT COMPLETED|Overall Study||8
9679081|NCT02067975|10778591|FG005|NOT COMPLETED|Overall Study||8
9679082|NCT02030938|10778603|FG000|STARTED|Overall Study||34
9679083|NCT02030938|10778603|FG000|COMPLETED|Overall Study||29
9679084|NCT02030938|10778603|FG000|NOT COMPLETED|Overall Study||5
9679085|NCT02006147|10778615|FG000|STARTED|Overall Study||5
9679086|NCT02006147|10778616|FG001|STARTED|Overall Study||9
9679087|NCT02006147|10778617|FG002|STARTED|Overall Study||0
9679088|NCT02006147|10778618|FG003|STARTED|Overall Study||0
9679089|NCT02006147|10778615|FG000|COMPLETED|Overall Study||3
9679090|NCT02006147|10778616|FG001|COMPLETED|Overall Study||7
9679091|NCT02006147|10778617|FG002|COMPLETED|Overall Study||0
9679092|NCT02006147|10778618|FG003|COMPLETED|Overall Study||0
9679093|NCT02006147|10778615|FG000|NOT COMPLETED|Overall Study||2
9679094|NCT02006147|10778616|FG001|NOT COMPLETED|Overall Study||2
9679095|NCT02006147|10778617|FG002|NOT COMPLETED|Overall Study||0
9679096|NCT02006147|10778618|FG003|NOT COMPLETED|Overall Study||0
9679097|NCT01940341|10778626|FG000|STARTED|Double-Blind Phase||285
9679098|NCT01940341|10778627|FG001|STARTED|Double-Blind Phase||141
9679099|NCT01940341|10778626|FG000|COMPLETED|Double-Blind Phase||4
9679100|NCT01940341|10778627|FG001|COMPLETED|Double-Blind Phase||1
9679101|NCT01940341|10778626|FG000|NOT COMPLETED|Double-Blind Phase||281
9679102|NCT01940341|10778627|FG001|NOT COMPLETED|Double-Blind Phase||140
9679103|NCT01940341|10778626|FG000|STARTED|Open-label Extension Phase||4
9679104|NCT01940341|10778627|FG001|STARTED|Open-label Extension Phase||1
9679105|NCT01940341|10778626|FG000|COMPLETED|Open-label Extension Phase||0
9679106|NCT01940341|10778627|FG001|COMPLETED|Open-label Extension Phase||0
9679107|NCT01940341|10778626|FG000|NOT COMPLETED|Open-label Extension Phase||4
9679108|NCT01940341|10778627|FG001|NOT COMPLETED|Open-label Extension Phase||1
9679109|NCT01925794|10778635|FG000|STARTED|30 Days||296
9679110|NCT01925794|10778635|FG000|COMPLETED|30 Days||296
9679111|NCT01925794|10778635|FG000|NOT COMPLETED|30 Days||0
9679112|NCT01925794|10778635|FG000|STARTED|180 Days||296
9679113|NCT01925794|10778635|FG000|COMPLETED|180 Days||292
9679114|NCT01925794|10778635|FG000|NOT COMPLETED|180 Days||4
9679115|NCT01925794|10778635|FG000|STARTED|270 Days||292
9679116|NCT01925794|10778635|FG000|COMPLETED|270 Days||287
9679117|NCT01925794|10778635|FG000|NOT COMPLETED|270 Days||5
9724319|NCT00089284|10824084|FG003|STARTED|Overall Study||6
9724320|NCT00089284|10824085|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
9724321|NCT00089284|10824086|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
9724322|NCT00089284|10824087|FG006|STARTED|Overall Study||8
9724323|NCT00089284|10824081|FG000|COMPLETED|Overall Study||7
9724324|NCT00089284|10824082|FG001|COMPLETED|Overall Study||3
9724325|NCT00089284|10824083|FG002|COMPLETED|Overall Study||6
9724326|NCT00089284|10824084|FG003|COMPLETED|Overall Study||6
9724327|NCT00089284|10824085|FG004|COMPLETED|Overall Study||0
9724328|NCT00089284|10824086|FG005|COMPLETED|Overall Study||0
9724329|NCT00089284|10824087|FG006|COMPLETED|Overall Study||7
9724330|NCT00089284|10824081|FG000|NOT COMPLETED|Overall Study||0
9724331|NCT00089284|10824082|FG001|NOT COMPLETED|Overall Study||0
9724332|NCT00089284|10824083|FG002|NOT COMPLETED|Overall Study||0
9724333|NCT00089284|10824084|FG003|NOT COMPLETED|Overall Study||0
9724334|NCT00089284|10824085|FG004|NOT COMPLETED|Overall Study||0
9724335|NCT00089284|10824086|FG005|NOT COMPLETED|Overall Study||0
9724336|NCT00089284|10824087|FG006|NOT COMPLETED|Overall Study||1
9724337|NCT00089297|10824109|FG000|STARTED|Overall Study||74
9724338|NCT00089297|10824109|FG000|Treated|Overall Study||70
9724339|NCT00089297|10824109|FG000|Eligible|Overall Study||63
9724340|NCT00089297|10824109|FG000|COMPLETED|Overall Study||36
9724341|NCT00089297|10824109|FG000|NOT COMPLETED|Overall Study||38
9724342|NCT00089479|10824115|FG000|STARTED|Overall Study||1304
9724343|NCT00089479|10824116|FG001|STARTED|Overall Study||1307
9724344|NCT00089479|10824115|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
9724345|NCT00089479|10824116|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
9842914|NCT00827944|10954701|FG001|NOT COMPLETED|Overall Study||59
9724346|NCT00089479|10824115|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
9724347|NCT00089479|10824116|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
9724348|NCT00089479|10824115|FG000|NOT COMPLETED|Overall Study||331
9724349|NCT00089479|10824116|FG001|NOT COMPLETED|Overall Study||289
9724350|NCT00089505|10824126|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
9724351|NCT00089505|10824127|FG001|STARTED|Overall Study||120
9724352|NCT00089505|10824128|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
9724353|NCT00089505|10824129|FG003|STARTED|Overall Study||251
9724354|NCT00089505|10824126|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
9724355|NCT00089505|10824127|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
9724356|NCT00089505|10824128|FG002|COMPLETED|Overall Study||228
9724357|NCT00089505|10824129|FG003|COMPLETED|Overall Study||230
9679118|NCT01907360|10778645|FG000|STARTED|Overall Study||18
9679119|NCT01907360|10778646|FG001|STARTED|Overall Study||11
9679120|NCT01907360|10778645|FG000|COMPLETED|Overall Study||18
9842915|NCT00827983|10954709|FG000|STARTED|Overall Study|All randomised patients|339
9842916|NCT00827983|10954710|FG001|STARTED|Overall Study|all randomised patients|344
9842917|NCT00827983|10954709|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321
9842918|NCT00827983|10954710|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328
9842919|NCT00827983|10954709|FG000|NOT COMPLETED|Overall Study||18
9842920|NCT00827983|10954710|FG001|NOT COMPLETED|Overall Study||16
9842921|NCT00828009|10954716|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
9842922|NCT00828009|10954716|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
9842923|NCT00828009|10954716|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
9842924|NCT00828009|10954716|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
9842925|NCT00828009|10954716|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
9842926|NCT00828009|10954716|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
9842927|NCT00828009|10954716|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33
9842928|NCT00828061|10954721|FG000|STARTED|Period 1||4
9842929|NCT00828061|10954722|FG001|STARTED|Period 1||3
9842930|NCT00828061|10954723|FG002|STARTED|Period 1||3
9842931|NCT00828061|10954724|FG003|STARTED|Period 1||3
9842932|NCT00828061|10954725|FG004|STARTED|Period 1||3
9842933|NCT00828061|10954726|FG005|STARTED|Period 1||3
9842934|NCT00828061|10954721|FG000|COMPLETED|Period 1||4
9842935|NCT00828061|10954722|FG001|COMPLETED|Period 1||3
9842936|NCT00828061|10954723|FG002|COMPLETED|Period 1||3
9842937|NCT00828061|10954724|FG003|COMPLETED|Period 1||3
9842938|NCT00828061|10954725|FG004|COMPLETED|Period 1||3
9842939|NCT00828061|10954726|FG005|COMPLETED|Period 1||3
9842940|NCT00828061|10954721|FG000|NOT COMPLETED|Period 1||0
9842941|NCT00828061|10954722|FG001|NOT COMPLETED|Period 1||0
9842942|NCT00828061|10954723|FG002|NOT COMPLETED|Period 1||0
9842943|NCT00828061|10954724|FG003|NOT COMPLETED|Period 1||0
9842944|NCT00828061|10954725|FG004|NOT COMPLETED|Period 1||0
9842945|NCT00828061|10954726|FG005|NOT COMPLETED|Period 1||0
9842946|NCT00828061|10954721|FG000|STARTED|Period 2||4
9842947|NCT00828061|10954722|FG001|STARTED|Period 2||3
9842948|NCT00828061|10954723|FG002|STARTED|Period 2||3
9842949|NCT00828061|10954724|FG003|STARTED|Period 2||3
9842950|NCT00828061|10954725|FG004|STARTED|Period 2||3
9842951|NCT00828061|10954726|FG005|STARTED|Period 2||3
9842952|NCT00828061|10954721|FG000|COMPLETED|Period 2||4
9842953|NCT00828061|10954722|FG001|COMPLETED|Period 2||3
9842954|NCT00828061|10954723|FG002|COMPLETED|Period 2||3
9842955|NCT00828061|10954724|FG003|COMPLETED|Period 2||3
9842956|NCT00828061|10954725|FG004|COMPLETED|Period 2||3
9842957|NCT00828061|10954726|FG005|COMPLETED|Period 2||3
9842958|NCT00828061|10954721|FG000|NOT COMPLETED|Period 2||0
9842959|NCT00828061|10954722|FG001|NOT COMPLETED|Period 2||0
9842960|NCT00828061|10954723|FG002|NOT COMPLETED|Period 2||0
9842961|NCT00828061|10954724|FG003|NOT COMPLETED|Period 2||0
9842962|NCT00828061|10954725|FG004|NOT COMPLETED|Period 2||0
9842963|NCT00828061|10954726|FG005|NOT COMPLETED|Period 2||0
9842964|NCT00828061|10954721|FG000|STARTED|Period 3||4
9842965|NCT00828061|10954722|FG001|STARTED|Period 3||3
9842966|NCT00828061|10954723|FG002|STARTED|Period 3||3
9842967|NCT00828061|10954724|FG003|STARTED|Period 3||3
9842968|NCT00828061|10954725|FG004|STARTED|Period 3||3
9842969|NCT00828061|10954726|FG005|STARTED|Period 3||3
9842970|NCT00828061|10954721|FG000|COMPLETED|Period 3||4
9842971|NCT00828061|10954722|FG001|COMPLETED|Period 3||3
9679121|NCT01907360|10778646|FG001|COMPLETED|Overall Study||11
9679122|NCT01907360|10778645|FG000|NOT COMPLETED|Overall Study||0
9679123|NCT01907360|10778646|FG001|NOT COMPLETED|Overall Study||0
9679124|NCT01856868|10778652|FG000|STARTED|Overall Study||7
9679125|NCT01856868|10778652|FG000|COMPLETED|Overall Study||7
9679126|NCT01856868|10778652|FG000|NOT COMPLETED|Overall Study||0
9679127|NCT01849250|10778658|FG000|STARTED|Overall Study||32
9679128|NCT01849250|10778659|FG001|STARTED|Overall Study||32
9679129|NCT01849250|10778658|FG000|COMPLETED|Overall Study||25
9679130|NCT01849250|10778659|FG001|COMPLETED|Overall Study||29
9679131|NCT01849250|10778658|FG000|NOT COMPLETED|Overall Study||7
9679132|NCT01849250|10778659|FG001|NOT COMPLETED|Overall Study||3
9679133|NCT01592643|10778666|FG000|STARTED|Overall Study||30
9679134|NCT01592643|10778666|FG000|COMPLETED|Overall Study||30
9679135|NCT01592643|10778666|FG000|NOT COMPLETED|Overall Study||0
9679136|NCT01441115|10778670|FG000|STARTED|Overall Study||2
9842972|NCT00828061|10954723|FG002|COMPLETED|Period 3||3
9842973|NCT00828061|10954724|FG003|COMPLETED|Period 3||3
9679137|NCT01441115|10778670|FG000|COMPLETED|Overall Study||1
9679138|NCT01441115|10778670|FG000|NOT COMPLETED|Overall Study||1
9679139|NCT01199302|10778681|FG000|STARTED|Overall Study||20
9679140|NCT01199302|10778682|FG001|STARTED|Overall Study||16
9679141|NCT01199302|10778683|FG002|STARTED|Overall Study||20
9679142|NCT01199302|10778684|FG003|STARTED|Overall Study||11
9842974|NCT00828061|10954725|FG004|COMPLETED|Period 3||3
9842975|NCT00828061|10954726|FG005|COMPLETED|Period 3||3
9842976|NCT00828061|10954721|FG000|NOT COMPLETED|Period 3||0
9842977|NCT00828061|10954722|FG001|NOT COMPLETED|Period 3||0
9842978|NCT00828061|10954723|FG002|NOT COMPLETED|Period 3||0
9842979|NCT00828061|10954724|FG003|NOT COMPLETED|Period 3||0
9842980|NCT00828061|10954725|FG004|NOT COMPLETED|Period 3||0
9679143|NCT01199302|10778681|FG000|COMPLETED|Overall Study||0
9679144|NCT01199302|10778682|FG001|COMPLETED|Overall Study||0
9679145|NCT01199302|10778683|FG002|COMPLETED|Overall Study||0
9679146|NCT01199302|10778684|FG003|COMPLETED|Overall Study||0
9679147|NCT01199302|10778681|FG000|NOT COMPLETED|Overall Study||20
9679148|NCT01199302|10778682|FG001|NOT COMPLETED|Overall Study||16
9679149|NCT01199302|10778683|FG002|NOT COMPLETED|Overall Study||20
9679150|NCT01199302|10778684|FG003|NOT COMPLETED|Overall Study||11
9679151|NCT01123707|10778695|FG000|STARTED|Overall Study||44
9679152|NCT01123707|10778696|FG001|STARTED|Overall Study||41
9679153|NCT01123707|10778697|FG002|STARTED|Overall Study||38
9679154|NCT01123707|10778698|FG003|STARTED|Overall Study||50
9679155|NCT01123707|10778695|FG000|Safety Sample|Overall Study||44
9679156|NCT01123707|10778696|FG001|Safety Sample|Overall Study||41
9679157|NCT01123707|10778697|FG002|Safety Sample|Overall Study||36
9679158|NCT01123707|10778698|FG003|Safety Sample|Overall Study||49
9679159|NCT01123707|10778695|FG000|COMPLETED|Overall Study||0
9679160|NCT01123707|10778696|FG001|COMPLETED|Overall Study||0
9679161|NCT01123707|10778697|FG002|COMPLETED|Overall Study||0
9679162|NCT01123707|10778698|FG003|COMPLETED|Overall Study||0
9679163|NCT01123707|10778695|FG000|NOT COMPLETED|Overall Study||44
9679164|NCT01123707|10778696|FG001|NOT COMPLETED|Overall Study||41
9679165|NCT01123707|10778697|FG002|NOT COMPLETED|Overall Study||38
9679166|NCT01123707|10778698|FG003|NOT COMPLETED|Overall Study||50
9679167|NCT00894244|10778708|FG000|STARTED|Overall Study||25
9679168|NCT00894244|10778708|FG000|COMPLETED|Overall Study||24
9679169|NCT00894244|10778708|FG000|NOT COMPLETED|Overall Study||1
9679170|NCT00462943|10778715|FG000|STARTED|Overall Study||46
9679171|NCT00462943|10778716|FG001|STARTED|Overall Study||31
9679172|NCT00462943|10778717|FG002|STARTED|Overall Study||23
9679173|NCT00462943|10778715|FG000|COMPLETED|Overall Study||1
9679174|NCT00462943|10778716|FG001|COMPLETED|Overall Study||1
9679175|NCT00462943|10778717|FG002|COMPLETED|Overall Study||0
9679176|NCT00462943|10778715|FG000|NOT COMPLETED|Overall Study||45
9679177|NCT00462943|10778716|FG001|NOT COMPLETED|Overall Study||30
9679178|NCT00462943|10778717|FG002|NOT COMPLETED|Overall Study||23
9679179|NCT00248287|10778727|FG000|STARTED|Overall Study||75
9679180|NCT00248287|10778728|FG001|STARTED|Overall Study||79
9679181|NCT00248287|10778727|FG000|COMPLETED|Overall Study||51
9679182|NCT00248287|10778728|FG001|COMPLETED|Overall Study||60
9679183|NCT00248287|10778727|FG000|NOT COMPLETED|Overall Study||24
9679184|NCT00248287|10778728|FG001|NOT COMPLETED|Overall Study||19
9679185|NCT00182728|10778734|FG000|STARTED|Overall Study||71
9679186|NCT00182728|10778734|FG000|COMPLETED|Overall Study||71
9679187|NCT00182728|10778734|FG000|NOT COMPLETED|Overall Study||0
9679188|NCT00105560|10778738|FG000|STARTED|Overall Study||59
9679189|NCT00105560|10778738|FG000|COMPLETED|Overall Study||58
9679190|NCT00105560|10778738|FG000|NOT COMPLETED|Overall Study||1
9679191|NCT00038727|10778754|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
9679192|NCT00038727|10778755|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
9679193|NCT00038727|10778756|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
9679194|NCT00038727|10778754|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
9679195|NCT00038727|10778755|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
9679196|NCT00038727|10778756|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
9679197|NCT00038727|10778754|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
9679198|NCT00038727|10778755|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
9679199|NCT00038727|10778756|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
9679200|NCT00038727|10778754|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
9679201|NCT00038727|10778755|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
9679202|NCT00038727|10778756|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
9679203|NCT00038727|10778754|FG000|DPPOS Phase 3 Enrolled|Overall Study||916
9679204|NCT00038727|10778755|FG001|DPPOS Phase 3 Enrolled|Overall Study||927
9679205|NCT00038727|10778756|FG002|DPPOS Phase 3 Enrolled|Overall Study||936
9679206|NCT00038727|10778754|FG000|COMPLETED|Overall Study||916
9679207|NCT00038727|10778755|FG001|COMPLETED|Overall Study||927
9679208|NCT00038727|10778756|FG002|COMPLETED|Overall Study||936
9679209|NCT00038727|10778754|FG000|NOT COMPLETED|Overall Study||0
9679210|NCT00038727|10778755|FG001|NOT COMPLETED|Overall Study||0
9842981|NCT00828061|10954726|FG005|NOT COMPLETED|Period 3||0
9842982|NCT00828074|10954736|FG000|STARTED|Overall Study||6
9842983|NCT00828074|10954737|FG001|STARTED|Overall Study||5
9842984|NCT00828074|10954738|FG002|STARTED|Overall Study||35
9842985|NCT00828074|10954736|FG000|COMPLETED|Overall Study||6
9842986|NCT00828074|10954737|FG001|COMPLETED|Overall Study||5
9842987|NCT00828074|10954738|FG002|COMPLETED|Overall Study||35
9842988|NCT00828074|10954736|FG000|NOT COMPLETED|Overall Study||0
9842989|NCT00828074|10954737|FG001|NOT COMPLETED|Overall Study||0
9842990|NCT00828074|10954738|FG002|NOT COMPLETED|Overall Study||0
9842991|NCT00828113|10954750|FG000|STARTED|Overall Study||50
9842992|NCT00828113|10954751|FG001|STARTED|Overall Study||51
9842993|NCT00828113|10954750|FG000|COMPLETED|Overall Study||20
9842994|NCT00828113|10954751|FG001|COMPLETED|Overall Study||20
9842995|NCT00828113|10954750|FG000|NOT COMPLETED|Overall Study||30
9842996|NCT00828113|10954751|FG001|NOT COMPLETED|Overall Study||31
9842997|NCT00828139|10954761|FG000|STARTED|Overall Study||42
9679211|NCT00038727|10778756|FG002|NOT COMPLETED|Overall Study||0
9724358|NCT00089505|10824126|FG000|NOT COMPLETED|Overall Study||9
9724359|NCT00089505|10824127|FG001|NOT COMPLETED|Overall Study||2
9724360|NCT00089505|10824128|FG002|NOT COMPLETED|Overall Study||21
9724361|NCT00089505|10824129|FG003|NOT COMPLETED|Overall Study||21
9724362|NCT00089544|10824141|FG000|STARTED|Overall Study||16
9724363|NCT00089544|10824142|FG001|STARTED|Overall Study||7
9724364|NCT00089544|10824141|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
9724365|NCT00089544|10824142|FG001|COMPLETED|Overall Study||7
9724366|NCT00089544|10824141|FG000|NOT COMPLETED|Overall Study||1
9724367|NCT00089544|10824142|FG001|NOT COMPLETED|Overall Study||0
9724368|NCT00089583|10824150|FG000|STARTED|Overall Study||20
9724369|NCT00089583|10824151|FG001|STARTED|Overall Study||89
9724370|NCT00089583|10824150|FG000|COMPLETED|Overall Study||13
9724371|NCT00089583|10824151|FG001|COMPLETED|Overall Study||51
9724372|NCT00089583|10824150|FG000|NOT COMPLETED|Overall Study||7
9724373|NCT00089583|10824151|FG001|NOT COMPLETED|Overall Study||38
9724374|NCT00089609|10824165|FG000|STARTED|Overall Study||60
9724375|NCT00089609|10824166|FG001|STARTED|Overall Study||13
9724376|NCT00089609|10824165|FG000|COMPLETED|Overall Study||57
9724377|NCT00089609|10824166|FG001|COMPLETED|Overall Study||12
9724378|NCT00089609|10824165|FG000|NOT COMPLETED|Overall Study||3
9724379|NCT00089609|10824166|FG001|NOT COMPLETED|Overall Study||1
9724380|NCT00089635|10824175|FG000|STARTED|Overall Study||203
9724381|NCT00089635|10824175|FG000|COMPLETED|Overall Study||160
9724382|NCT00089635|10824175|FG000|NOT COMPLETED|Overall Study||43
9724383|NCT00089648|10824179|FG000|STARTED|Overall Study||61
9724384|NCT00089648|10824179|FG000|COMPLETED|Overall Study||20
9842998|NCT00828139|10954762|FG001|STARTED|Overall Study||41
9842999|NCT00828139|10954763|FG002|STARTED|Overall Study||55
9843000|NCT00828139|10954764|FG003|STARTED|Overall Study||51
9843001|NCT00828139|10954761|FG000|COMPLETED|Overall Study||1
9843002|NCT00828139|10954762|FG001|COMPLETED|Overall Study||0
9843003|NCT00828139|10954763|FG002|COMPLETED|Overall Study||0
9843004|NCT00828139|10954764|FG003|COMPLETED|Overall Study||0
9843005|NCT00828139|10954761|FG000|NOT COMPLETED|Overall Study||41
9843006|NCT00828139|10954762|FG001|NOT COMPLETED|Overall Study||41
9843007|NCT00828139|10954763|FG002|NOT COMPLETED|Overall Study||55
9843008|NCT00828139|10954764|FG003|NOT COMPLETED|Overall Study||51
9843009|NCT00828178|10954776|FG000|STARTED|Overall Study||42
9843010|NCT00828178|10954777|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45
9843011|NCT00828178|10954776|FG000|COMPLETED|Overall Study||42
9843012|NCT00828178|10954777|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43
9843013|NCT00828178|10954776|FG000|NOT COMPLETED|Overall Study||0
9843014|NCT00828178|10954777|FG001|NOT COMPLETED|Overall Study||2
9843015|NCT00828191|10954787|FG000|STARTED|Overall Study|Randomized patients|400
9843016|NCT00828191|10954788|FG001|STARTED|Overall Study|Randomized patients|400
9843017|NCT00828191|10954787|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
9843018|NCT00828191|10954788|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
9843019|NCT00828191|10954787|FG000|NOT COMPLETED|Overall Study||8
9843020|NCT00828191|10954788|FG001|NOT COMPLETED|Overall Study||10
9843021|NCT00828204|10954796|FG000|STARTED|Main Study: Prior to Study Suspension||21
9843022|NCT00828204|10954797|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
9843023|NCT00828204|10954796|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21
9843024|NCT00828204|10954797|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0
9843025|NCT00828204|10954796|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
9843026|NCT00828204|10954797|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
9843027|NCT00828204|10954796|FG000|COMPLETED|Main Study: Prior to Study Suspension||7
9843028|NCT00828204|10954797|FG001|COMPLETED|Main Study: Prior to Study Suspension||0
9960299|NCT01467557|11079984|FG001|STARTED|Overall Study||570
9960300|NCT01467557|11079983|FG000|2 Week Survey Completed|Overall Study||551
9960301|NCT01467557|11079984|FG001|2 Week Survey Completed|Overall Study||522
9960302|NCT01467557|11079983|FG000|4 Month Survey Completed|Overall Study||533
9960303|NCT01467557|11079984|FG001|4 Month Survey Completed|Overall Study||493
9960304|NCT01467557|11079983|FG000|12 Month Survey Completed|Overall Study||502
9960305|NCT01467557|11079984|FG001|12 Month Survey Completed|Overall Study||463
9960306|NCT01467557|11079983|FG000|COMPLETED|Overall Study||502
9960307|NCT01467557|11079984|FG001|COMPLETED|Overall Study||463
9960308|NCT01467557|11079983|FG000|NOT COMPLETED|Overall Study||99
9960309|NCT01467557|11079984|FG001|NOT COMPLETED|Overall Study||107
9960310|NCT01467570|11079992|FG000|STARTED|Overall Study||75
9960311|NCT01467570|11079993|FG001|STARTED|Overall Study||72
9960312|NCT01467570|11079992|FG000|COMPLETED|Overall Study||67
9960313|NCT01467570|11079993|FG001|COMPLETED|Overall Study||63
9960314|NCT01467570|11079992|FG000|NOT COMPLETED|Overall Study||8
9960315|NCT01467570|11079993|FG001|NOT COMPLETED|Overall Study||9
9724385|NCT00089648|10824179|FG000|NOT COMPLETED|Overall Study||41
9724386|NCT00089661|10824185|FG000|STARTED|Overall Study||127
9724387|NCT00089661|10824186|FG001|STARTED|Overall Study||125
9724388|NCT00089661|10824185|FG000|COMPLETED|Overall Study||106
9724389|NCT00089661|10824186|FG001|COMPLETED|Overall Study||99
9843029|NCT00828204|10954796|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14
9960316|NCT01467583|11080004|FG000|STARTED|Overall Study||16
9960317|NCT01467583|11080005|FG001|STARTED|Overall Study||4
9679212|NCT04569786|10778772|FG000|STARTED|Overall Study||39
9679213|NCT04569786|10778773|FG001|STARTED|Overall Study||39
9679214|NCT04569786|10778774|FG002|STARTED|Overall Study||42
9679215|NCT04569786|10778775|FG003|STARTED|Overall Study||56
9679216|NCT04569786|10778776|FG004|STARTED|Overall Study||56
9679217|NCT04569786|10778772|FG000|COMPLETED|Overall Study||38
9679218|NCT04569786|10778773|FG001|COMPLETED|Overall Study||39
9679219|NCT04569786|10778774|FG002|COMPLETED|Overall Study||38
9679220|NCT04569786|10778775|FG003|COMPLETED|Overall Study||49
9679221|NCT04569786|10778776|FG004|COMPLETED|Overall Study||55
9679222|NCT04569786|10778772|FG000|NOT COMPLETED|Overall Study||1
9679223|NCT04569786|10778773|FG001|NOT COMPLETED|Overall Study||0
9679224|NCT04569786|10778774|FG002|NOT COMPLETED|Overall Study||4
9679225|NCT04569786|10778775|FG003|NOT COMPLETED|Overall Study||7
9679226|NCT04569786|10778776|FG004|NOT COMPLETED|Overall Study||1
9679227|NCT04409041|10778788|FG000|STARTED|Overall Study||43
9679228|NCT04409041|10778788|FG000|COMPLETED|Overall Study||26
9679229|NCT04409041|10778788|FG000|NOT COMPLETED|Overall Study||17
9679230|NCT04129944|10778797|FG000|STARTED|Overall Study||46
9679231|NCT04129944|10778798|FG001|STARTED|Overall Study||45
9679232|NCT04129944|10778799|FG002|STARTED|Overall Study||46
9679233|NCT04129944|10778800|FG003|STARTED|Overall Study||46
9679234|NCT04129944|10778797|FG000|COMPLETED|Overall Study||44
9679235|NCT04129944|10778798|FG001|COMPLETED|Overall Study||45
9679236|NCT04129944|10778799|FG002|COMPLETED|Overall Study||45
9679237|NCT04129944|10778800|FG003|COMPLETED|Overall Study||43
9679238|NCT04129944|10778797|FG000|NOT COMPLETED|Overall Study||2
9679239|NCT04129944|10778798|FG001|NOT COMPLETED|Overall Study||0
9679240|NCT04129944|10778799|FG002|NOT COMPLETED|Overall Study||1
9679241|NCT04129944|10778800|FG003|NOT COMPLETED|Overall Study||3
9679242|NCT03861728|10778812|FG000|STARTED|Overall Study||6
9679243|NCT03861728|10778813|FG001|STARTED|Overall Study||5
9679244|NCT03861728|10778812|FG000|COMPLETED|Overall Study||6
9679245|NCT03861728|10778813|FG001|COMPLETED|Overall Study||5
9679246|NCT03861728|10778812|FG000|NOT COMPLETED|Overall Study||0
9679247|NCT03861728|10778813|FG001|NOT COMPLETED|Overall Study||0
9679248|NCT03857542|10778821|FG000|STARTED|Overall Study||215
9679249|NCT03857542|10778822|FG001|STARTED|Overall Study||212
9679250|NCT03857542|10778821|FG000|COMPLETED|Overall Study||209
9679251|NCT03857542|10778822|FG001|COMPLETED|Overall Study||207
9679252|NCT03857542|10778821|FG000|NOT COMPLETED|Overall Study||6
9679253|NCT03857542|10778822|FG001|NOT COMPLETED|Overall Study||5
9679254|NCT03848832|10778832|FG000|STARTED|Overall Study||10
9679255|NCT03848832|10778833|FG001|STARTED|Overall Study||9
9679256|NCT03848832|10778834|FG002|STARTED|Overall Study||10
9679257|NCT03848832|10778832|FG000|COMPLETED|Overall Study||7
9679258|NCT03848832|10778833|FG001|COMPLETED|Overall Study||6
9679259|NCT03848832|10778834|FG002|COMPLETED|Overall Study||4
9679260|NCT03848832|10778832|FG000|NOT COMPLETED|Overall Study||3
9679261|NCT03848832|10778833|FG001|NOT COMPLETED|Overall Study||3
9679262|NCT03848832|10778834|FG002|NOT COMPLETED|Overall Study||6
9679263|NCT03688802|10778846|FG000|STARTED|Overall Study||12
9679264|NCT03688802|10778847|FG001|STARTED|Overall Study||6
9679265|NCT03688802|10778846|FG000|COMPLETED|Overall Study||11
9679266|NCT03688802|10778847|FG001|COMPLETED|Overall Study||6
9679267|NCT03688802|10778846|FG000|NOT COMPLETED|Overall Study||1
9679268|NCT03688802|10778847|FG001|NOT COMPLETED|Overall Study||0
9679269|NCT03656744|10778856|FG000|STARTED|Overall Study||34
9679270|NCT03656744|10778857|FG001|STARTED|Overall Study||34
9679271|NCT03656744|10778858|FG002|STARTED|Overall Study||33
9679272|NCT03656744|10778856|FG000|COMPLETED|Overall Study||29
9679273|NCT03656744|10778857|FG001|COMPLETED|Overall Study||27
9679274|NCT03656744|10778858|FG002|COMPLETED|Overall Study||32
9679275|NCT03656744|10778856|FG000|NOT COMPLETED|Overall Study||5
9679276|NCT03656744|10778857|FG001|NOT COMPLETED|Overall Study||7
9679277|NCT03656744|10778858|FG002|NOT COMPLETED|Overall Study||1
9679278|NCT03510598|10778866|FG000|STARTED|Overall Study||16
9679279|NCT03510598|10778866|FG000|COMPLETED|Overall Study||15
9679280|NCT03510598|10778866|FG000|NOT COMPLETED|Overall Study||1
9679281|NCT03487796|10778874|FG000|STARTED|Overall Study||41
9679282|NCT03487796|10778875|FG001|STARTED|Overall Study||31
9679283|NCT03487796|10778874|FG000|2 Month Follow-up|Overall Study||24
9679284|NCT03487796|10778875|FG001|2 Month Follow-up|Overall Study||26
9679285|NCT03487796|10778874|FG000|COMPLETED|Overall Study||23
9679286|NCT03487796|10778875|FG001|COMPLETED|Overall Study||25
9679287|NCT03487796|10778874|FG000|NOT COMPLETED|Overall Study||18
9679288|NCT03487796|10778875|FG001|NOT COMPLETED|Overall Study||6
9679289|NCT03446612|10778889|FG000|STARTED|Overall Study||2
9679290|NCT03446612|10778890|FG001|STARTED|Overall Study||3
9679291|NCT03446612|10778889|FG000|COMPLETED|Overall Study||2
9679292|NCT03446612|10778890|FG001|COMPLETED|Overall Study||2
9679293|NCT03446612|10778889|FG000|NOT COMPLETED|Overall Study||0
9679294|NCT03446612|10778890|FG001|NOT COMPLETED|Overall Study||1
9679295|NCT03436433|10778901|FG000|STARTED|Overall Study||1
9679296|NCT03436433|10778902|FG001|STARTED|Overall Study||2
9679297|NCT03436433|10778903|FG002|STARTED|Overall Study||1
9679298|NCT03436433|10778901|FG000|COMPLETED|Overall Study||1
9679299|NCT03436433|10778902|FG001|COMPLETED|Overall Study||2
9679300|NCT03436433|10778903|FG002|COMPLETED|Overall Study||1
9679301|NCT03436433|10778901|FG000|NOT COMPLETED|Overall Study||0
9679302|NCT03436433|10778902|FG001|NOT COMPLETED|Overall Study||0
9679303|NCT03436433|10778903|FG002|NOT COMPLETED|Overall Study||0
9679304|NCT03370120|10778911|FG000|STARTED|Overall Study||406
9679305|NCT03370120|10778911|FG000|COMPLETED|Overall Study||0
9679306|NCT03370120|10778911|FG000|NOT COMPLETED|Overall Study||406
9679307|NCT03367429|10778920|FG000|STARTED|Overall Study||0
9679308|NCT03367429|10778921|FG001|STARTED|Overall Study||1
9679309|NCT03367429|10778922|FG002|STARTED|Overall Study||2
9679310|NCT03367429|10778920|FG000|COMPLETED|Overall Study||0
9679311|NCT03367429|10778921|FG001|COMPLETED|Overall Study||1
9679312|NCT03367429|10778922|FG002|COMPLETED|Overall Study||2
9679313|NCT03367429|10778920|FG000|NOT COMPLETED|Overall Study||0
9679314|NCT03367429|10778921|FG001|NOT COMPLETED|Overall Study||0
9679315|NCT03367429|10778922|FG002|NOT COMPLETED|Overall Study||0
9679316|NCT03143829|10778934|FG000|STARTED|Overall Study||38
9679317|NCT03143829|10778935|FG001|STARTED|Overall Study||42
9679318|NCT03143829|10778934|FG000|COMPLETED|Overall Study||33
9679319|NCT03143829|10778935|FG001|COMPLETED|Overall Study||32
9679320|NCT03143829|10778934|FG000|NOT COMPLETED|Overall Study||5
9679321|NCT03143829|10778935|FG001|NOT COMPLETED|Overall Study||10
9679322|NCT03099863|10778943|FG000|STARTED|Overall Study||121
9679323|NCT03099863|10778944|FG001|STARTED|Overall Study||121
9679324|NCT03099863|10778943|FG000|COMPLETED|Overall Study||111
9679325|NCT03099863|10778944|FG001|COMPLETED|Overall Study||105
9679326|NCT03099863|10778943|FG000|NOT COMPLETED|Overall Study||10
9679327|NCT03099863|10778944|FG001|NOT COMPLETED|Overall Study||16
9679328|NCT02963610|10778950|FG000|STARTED|Overall Study||3
9679329|NCT02963610|10778950|FG000|COMPLETED|Overall Study||0
9679330|NCT02963610|10778950|FG000|NOT COMPLETED|Overall Study||3
9679331|NCT02766335|10778957|FG000|STARTED|Initial Registration||68
9679332|NCT02766335|10778958|FG001|STARTED|Initial Registration||30
9679333|NCT02766335|10778959|FG002|STARTED|Initial Registration||0
9679334|NCT02766335|10778957|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32
9843030|NCT00828204|10954797|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0
9843031|NCT00828204|10954796|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
9843032|NCT00828204|10954797|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
9843033|NCT00828204|10954796|FG000|Completed Manual Injection|Main Study: After Study Restart||0
9843034|NCT00828204|10954797|FG001|Completed Manual Injection|Main Study: After Study Restart||74
9843035|NCT00828204|10954796|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0
9843036|NCT00828204|10954797|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72
9843037|NCT00828204|10954796|FG000|COMPLETED|Main Study: After Study Restart||0
9843038|NCT00828204|10954797|FG001|COMPLETED|Main Study: After Study Restart||71
9843039|NCT00828204|10954796|FG000|NOT COMPLETED|Main Study: After Study Restart||0
9843040|NCT00828204|10954797|FG001|NOT COMPLETED|Main Study: After Study Restart||3
9843041|NCT00828204|10954796|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
9843042|NCT00828204|10954797|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
9843043|NCT00828204|10954796|FG000|COMPLETED|Extension Study||0
9843044|NCT00828204|10954797|FG001|COMPLETED|Extension Study||61
9843045|NCT00828204|10954796|FG000|NOT COMPLETED|Extension Study||0
9843046|NCT00828204|10954797|FG001|NOT COMPLETED|Extension Study||3
9843047|NCT00828295|10954806|FG000|STARTED|Overall Study||75
9843048|NCT00828295|10954807|FG001|STARTED|Overall Study||75
9843049|NCT00828295|10954806|FG000|COMPLETED|Overall Study||75
9843050|NCT00828295|10954807|FG001|COMPLETED|Overall Study||75
9843051|NCT00828295|10954806|FG000|NOT COMPLETED|Overall Study||0
9843052|NCT00828295|10954807|FG001|NOT COMPLETED|Overall Study||0
9843053|NCT00828347|10954815|FG000|STARTED|Overall Study||12
9843054|NCT00828347|10954816|FG001|STARTED|Overall Study||11
9843055|NCT00828347|10954815|FG000|COMPLETED|Overall Study||12
9843056|NCT00828347|10954816|FG001|COMPLETED|Overall Study||11
9843057|NCT00828347|10954815|FG000|NOT COMPLETED|Overall Study||0
9843058|NCT00828347|10954816|FG001|NOT COMPLETED|Overall Study||0
9843059|NCT00828412|10954824|FG000|STARTED|Overall Study||50
9843060|NCT00828412|10954825|FG001|STARTED|Overall Study||50
9843061|NCT00828412|10954824|FG000|COMPLETED|Overall Study||41
9843062|NCT00828412|10954825|FG001|COMPLETED|Overall Study||48
9843063|NCT00828412|10954824|FG000|NOT COMPLETED|Overall Study||9
9843064|NCT00828412|10954825|FG001|NOT COMPLETED|Overall Study||2
9843065|NCT00828451|10954831|FG000|STARTED|Overall Study||29
9843066|NCT00828451|10954831|FG000|COMPLETED|Overall Study||18
9843067|NCT00828451|10954831|FG000|NOT COMPLETED|Overall Study||11
9843068|NCT00828464|10954835|FG000|STARTED|Overall Study||30
9843069|NCT00828464|10954835|FG000|COMPLETED|Overall Study||29
9843070|NCT00828464|10954835|FG000|NOT COMPLETED|Overall Study||1
9960318|NCT01467583|11080006|FG002|STARTED|Overall Study||12
9960319|NCT01467583|11080004|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
9960320|NCT01467583|11080005|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
9960321|NCT01467583|11080006|FG002|COMPLETED|Overall Study||10
9960322|NCT01467583|11080004|FG000|NOT COMPLETED|Overall Study||2
9960323|NCT01467583|11080005|FG001|NOT COMPLETED|Overall Study||1
9960324|NCT01467583|11080006|FG002|NOT COMPLETED|Overall Study||2
9679335|NCT02766335|10778958|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30
9679336|NCT02766335|10778959|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0
9679337|NCT02766335|10778957|FG000|COMPLETED|Initial Registration||10
9679338|NCT02766335|10778958|FG001|COMPLETED|Initial Registration||0
9679339|NCT02766335|10778959|FG002|COMPLETED|Initial Registration||0
9679340|NCT02766335|10778957|FG000|NOT COMPLETED|Initial Registration||58
9679341|NCT02766335|10778958|FG001|NOT COMPLETED|Initial Registration||30
9679342|NCT02766335|10778959|FG002|NOT COMPLETED|Initial Registration||0
9679343|NCT02766335|10778957|FG000|STARTED|Re-registration of Arm I to MEDI4738||0
9679344|NCT02766335|10778958|FG001|STARTED|Re-registration of Arm I to MEDI4738||0
9679345|NCT02766335|10778959|FG002|STARTED|Re-registration of Arm I to MEDI4738||4
9679346|NCT02766335|10778957|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0
9679347|NCT02766335|10778958|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0
9679348|NCT02766335|10778959|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2
9679349|NCT02766335|10778957|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
9679350|NCT02766335|10778958|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
9679351|NCT02766335|10778959|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2
9724390|NCT00089661|10824185|FG000|NOT COMPLETED|Overall Study||21
9724391|NCT00089661|10824186|FG001|NOT COMPLETED|Overall Study||26
9724392|NCT00089674|10824194|FG000|STARTED|Overall Study||734
9724393|NCT00089674|10824195|FG001|STARTED|Overall Study||734
9724394|NCT00089674|10824194|FG000|Received Study Drug|Overall Study||730
9724395|NCT00089674|10824195|FG001|Received Study Drug|Overall Study||726
9724396|NCT00089674|10824194|FG000|COMPLETED|Overall Study||445
9724397|NCT00089674|10824195|FG001|COMPLETED|Overall Study||467
9724398|NCT00089674|10824194|FG000|NOT COMPLETED|Overall Study||289
9724399|NCT00089674|10824195|FG001|NOT COMPLETED|Overall Study||267
9724400|NCT00089752|10824203|FG000|STARTED|Overall Study||141
9724401|NCT00089752|10824204|FG001|STARTED|Overall Study||140
9724402|NCT00089752|10824203|FG000|COMPLETED|Overall Study||121
9724403|NCT00089752|10824204|FG001|COMPLETED|Overall Study||118
9724404|NCT00089752|10824203|FG000|NOT COMPLETED|Overall Study||20
9724405|NCT00089752|10824204|FG001|NOT COMPLETED|Overall Study||22
9724406|NCT00089778|10824215|FG000|STARTED|Overall Study||2
9724407|NCT00089778|10824216|FG001|STARTED|Overall Study||1
9724408|NCT00089778|10824217|FG002|STARTED|Overall Study||8
9724409|NCT00089778|10824215|FG000|COMPLETED|Overall Study||2
9724410|NCT00089778|10824216|FG001|COMPLETED|Overall Study||1
9724411|NCT00089778|10824217|FG002|COMPLETED|Overall Study||7
9724412|NCT00089778|10824215|FG000|NOT COMPLETED|Overall Study||0
9724413|NCT00089778|10824216|FG001|NOT COMPLETED|Overall Study||0
9724414|NCT00089778|10824217|FG002|NOT COMPLETED|Overall Study||1
9724415|NCT00089843|10824231|FG000|STARTED|Overall Study||19
9724416|NCT00089843|10824232|FG001|STARTED|Overall Study||20
9724417|NCT00089843|10824233|FG002|STARTED|Overall Study||20
9724418|NCT00089843|10824234|FG003|STARTED|Overall Study||18
9724419|NCT00089843|10824231|FG000|COMPLETED|Overall Study||17
9724420|NCT00089843|10824232|FG001|COMPLETED|Overall Study||16
9724421|NCT00089843|10824233|FG002|COMPLETED|Overall Study||15
9724422|NCT00089843|10824234|FG003|COMPLETED|Overall Study||11
9724423|NCT00089843|10824231|FG000|NOT COMPLETED|Overall Study||2
9724424|NCT00089843|10824232|FG001|NOT COMPLETED|Overall Study||4
9724425|NCT00089843|10824233|FG002|NOT COMPLETED|Overall Study||5
9724426|NCT00089843|10824234|FG003|NOT COMPLETED|Overall Study||7
9724427|NCT00089973|10824244|FG000|STARTED|Overall Study||50
9724428|NCT00089973|10824244|FG000|COMPLETED|Overall Study||0
9724429|NCT00089973|10824244|FG000|NOT COMPLETED|Overall Study||50
9724430|NCT00089986|10824251|FG000|STARTED|Overall Study||599
9724431|NCT00089986|10824252|FG001|STARTED|Overall Study||598
9724432|NCT00089986|10824253|FG002|STARTED|Overall Study||182
9724433|NCT00089986|10824251|FG000|COMPLETED|Overall Study||584
9724434|NCT00089986|10824252|FG001|COMPLETED|Overall Study||574
9724435|NCT00089986|10824253|FG002|COMPLETED|Overall Study||172
9724436|NCT00089986|10824251|FG000|NOT COMPLETED|Overall Study||15
9724437|NCT00089986|10824252|FG001|NOT COMPLETED|Overall Study||24
9724438|NCT00089986|10824253|FG002|NOT COMPLETED|Overall Study||10
9724439|NCT00089999|10824263|FG000|STARTED|Overall Study||69
9724440|NCT00089999|10824264|FG001|STARTED|Overall Study||69
9724441|NCT00089999|10824263|FG000|COMPLETED|Overall Study||0
9724442|NCT00089999|10824264|FG001|COMPLETED|Overall Study||0
9724443|NCT00089999|10824263|FG000|NOT COMPLETED|Overall Study||69
9724444|NCT00089999|10824264|FG001|NOT COMPLETED|Overall Study||69
9724445|NCT00090051|10824273|FG000|STARTED|Overall Study||276
9724446|NCT00090051|10824274|FG001|STARTED|Overall Study||276
9724447|NCT00090051|10824273|FG000|Safety Population; Received Study Drug|Overall Study||272
9724448|NCT00090051|10824274|FG001|Safety Population; Received Study Drug|Overall Study||274
9724449|NCT00090051|10824273|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
9724450|NCT00090051|10824274|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
9724451|NCT00090051|10824273|FG000|NOT COMPLETED|Overall Study||109
9724452|NCT00090051|10824274|FG001|NOT COMPLETED|Overall Study||95
9724453|NCT00090064|10824282|FG000|STARTED|Overall Study||15
9724454|NCT00090064|10824283|FG001|STARTED|Overall Study||8
9724455|NCT00090064|10824282|FG000|COMPLETED|Overall Study||12
9724456|NCT00090064|10824283|FG001|COMPLETED|Overall Study||8
9724457|NCT00090064|10824282|FG000|NOT COMPLETED|Overall Study||3
9724458|NCT00090064|10824283|FG001|NOT COMPLETED|Overall Study||0
9724459|NCT00090103|10824295|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610
9724460|NCT00090103|10824296|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623
9724461|NCT00090103|10824297|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611
9724462|NCT00090103|10824295|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113
9724463|NCT00090103|10824296|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093
9679352|NCT02606136|10778965|FG000|STARTED|Overall Study||21
9679353|NCT02606136|10778965|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
9679354|NCT02606136|10778965|FG000|COMPLETED|Overall Study||15
9679355|NCT02606136|10778965|FG000|NOT COMPLETED|Overall Study||6
9679356|NCT02228382|10778974|FG000|STARTED|Overall Study||46
9679357|NCT02228382|10778975|FG001|STARTED|Overall Study||61
9679358|NCT02228382|10778976|FG002|STARTED|Overall Study||49
9679359|NCT02228382|10778977|FG003|STARTED|Overall Study||4
10023106|NCT01854047|11146634|FG003|STARTED|Overall Study||157
10023107|NCT01854047|11146635|FG004|STARTED|Overall Study||154
10023108|NCT01854047|11146631|FG000|Treated|Overall Study||158
10023109|NCT01854047|11146632|FG001|Treated|Overall Study||156
10023110|NCT01854047|11146633|FG002|Treated|Overall Study||148
10023111|NCT01854047|11146634|FG003|Treated|Overall Study||157
9679360|NCT02228382|10778978|FG004|STARTED|Overall Study||3
9679361|NCT02228382|10778974|FG000|COMPLETED|Overall Study||36
9679362|NCT02228382|10778975|FG001|COMPLETED|Overall Study||43
9679363|NCT02228382|10778976|FG002|COMPLETED|Overall Study||28
9679364|NCT02228382|10778977|FG003|COMPLETED|Overall Study||2
9679365|NCT02228382|10778978|FG004|COMPLETED|Overall Study||1
9679366|NCT02228382|10778974|FG000|NOT COMPLETED|Overall Study||10
9679367|NCT02228382|10778975|FG001|NOT COMPLETED|Overall Study||18
9679368|NCT02228382|10778976|FG002|NOT COMPLETED|Overall Study||21
10023112|NCT01854047|11146635|FG004|Treated|Overall Study||150
10023113|NCT01854047|11146631|FG000|Completed 12-week Study Treatment|Overall Study||153
9679369|NCT02228382|10778977|FG003|NOT COMPLETED|Overall Study||2
9679370|NCT02228382|10778978|FG004|NOT COMPLETED|Overall Study||2
9679371|NCT02090998|10778997|FG000|STARTED|Overall Study||2
9679372|NCT02090998|10778998|FG001|STARTED|Overall Study||8
9679373|NCT02090998|10778997|FG000|COMPLETED|Overall Study||2
9679374|NCT02090998|10778998|FG001|COMPLETED|Overall Study||8
9679375|NCT02090998|10778997|FG000|NOT COMPLETED|Overall Study||0
9679376|NCT02090998|10778998|FG001|NOT COMPLETED|Overall Study||0
9679377|NCT02051309|10779006|FG000|STARTED|Overall Study||58
9679378|NCT02051309|10779007|FG001|STARTED|Overall Study||63
9679379|NCT02051309|10779006|FG000|COMPLETED|Overall Study||26
9679380|NCT02051309|10779007|FG001|COMPLETED|Overall Study||35
9679381|NCT02051309|10779006|FG000|NOT COMPLETED|Overall Study||32
9679382|NCT02051309|10779007|FG001|NOT COMPLETED|Overall Study||28
9679383|NCT02001623|10779028|FG000|STARTED|Overall Study||3
9679384|NCT02001623|10779029|FG001|STARTED|Overall Study||3
9679385|NCT02001623|10779030|FG002|STARTED|Overall Study||3
9679386|NCT02001623|10779031|FG003|STARTED|Overall Study||3
9679387|NCT02001623|10779032|FG004|STARTED|Overall Study||3
9679388|NCT02001623|10779033|FG005|STARTED|Overall Study||3
9679389|NCT02001623|10779034|FG006|STARTED|Overall Study||3
9679390|NCT02001623|10779035|FG007|STARTED|Overall Study||6
9679391|NCT02001623|10779036|FG008|STARTED|Overall Study||15
9679392|NCT02001623|10779037|FG009|STARTED|Overall Study||55
9679393|NCT02001623|10779038|FG010|STARTED|Overall Study||14
9679394|NCT02001623|10779039|FG011|STARTED|Overall Study||15
9679395|NCT02001623|10779040|FG012|STARTED|Overall Study||15
9679396|NCT02001623|10779041|FG013|STARTED|Overall Study||36
9679397|NCT02001623|10779042|FG014|STARTED|Overall Study||18
9679398|NCT02001623|10779028|FG000|Completed 4 Cycles of Treatment|Overall Study||0
9679399|NCT02001623|10779029|FG001|Completed 4 Cycles of Treatment|Overall Study||1
9679400|NCT02001623|10779030|FG002|Completed 4 Cycles of Treatment|Overall Study||1
9679401|NCT02001623|10779031|FG003|Completed 4 Cycles of Treatment|Overall Study||2
9679402|NCT02001623|10779032|FG004|Completed 4 Cycles of Treatment|Overall Study||0
9679403|NCT02001623|10779033|FG005|Completed 4 Cycles of Treatment|Overall Study||2
9679404|NCT02001623|10779034|FG006|Completed 4 Cycles of Treatment|Overall Study||2
9679405|NCT02001623|10779035|FG007|Completed 4 Cycles of Treatment|Overall Study||1
9679406|NCT02001623|10779036|FG008|Completed 4 Cycles of Treatment|Overall Study||5
9679407|NCT02001623|10779037|FG009|Completed 4 Cycles of Treatment|Overall Study||31
9679408|NCT02001623|10779038|FG010|Completed 4 Cycles of Treatment|Overall Study||6
9679409|NCT02001623|10779039|FG011|Completed 4 Cycles of Treatment|Overall Study||4
9679410|NCT02001623|10779040|FG012|Completed 4 Cycles of Treatment|Overall Study||6
9679411|NCT02001623|10779041|FG013|Completed 4 Cycles of Treatment|Overall Study||22
9679412|NCT02001623|10779042|FG014|Completed 4 Cycles of Treatment|Overall Study||7
9679413|NCT02001623|10779028|FG000|Completed 12 Cycles of Treatment|Overall Study||0
9679414|NCT02001623|10779029|FG001|Completed 12 Cycles of Treatment|Overall Study||1
9679415|NCT02001623|10779030|FG002|Completed 12 Cycles of Treatment|Overall Study||0
9679416|NCT02001623|10779031|FG003|Completed 12 Cycles of Treatment|Overall Study||1
9679417|NCT02001623|10779032|FG004|Completed 12 Cycles of Treatment|Overall Study||0
9679418|NCT02001623|10779033|FG005|Completed 12 Cycles of Treatment|Overall Study||0
9679419|NCT02001623|10779034|FG006|Completed 12 Cycles of Treatment|Overall Study||0
9679420|NCT02001623|10779035|FG007|Completed 12 Cycles of Treatment|Overall Study||0
9679421|NCT02001623|10779036|FG008|Completed 12 Cycles of Treatment|Overall Study||0
9679422|NCT02001623|10779037|FG009|Completed 12 Cycles of Treatment|Overall Study||3
9679423|NCT02001623|10779038|FG010|Completed 12 Cycles of Treatment|Overall Study||0
9679424|NCT02001623|10779039|FG011|Completed 12 Cycles of Treatment|Overall Study||0
9679425|NCT02001623|10779040|FG012|Completed 12 Cycles of Treatment|Overall Study||1
9679426|NCT02001623|10779041|FG013|Completed 12 Cycles of Treatment|Overall Study||1
9679427|NCT02001623|10779042|FG014|Completed 12 Cycles of Treatment|Overall Study||0
10023114|NCT01854047|11146632|FG001|Completed 12-week Study Treatment|Overall Study||149
10023115|NCT01854047|11146633|FG002|Completed 12-week Study Treatment|Overall Study||141
9679428|NCT02001623|10779028|FG000|COMPLETED|Overall Study||0
9679429|NCT02001623|10779029|FG001|COMPLETED|Overall Study||0
9679430|NCT02001623|10779030|FG002|COMPLETED|Overall Study||0
9679431|NCT02001623|10779031|FG003|COMPLETED|Overall Study||1
9679432|NCT02001623|10779032|FG004|COMPLETED|Overall Study||0
9679433|NCT02001623|10779033|FG005|COMPLETED|Overall Study||0
9679434|NCT02001623|10779034|FG006|COMPLETED|Overall Study||0
9679435|NCT02001623|10779035|FG007|COMPLETED|Overall Study||0
9679436|NCT02001623|10779036|FG008|COMPLETED|Overall Study||0
9679437|NCT02001623|10779037|FG009|COMPLETED|Overall Study||2
9679438|NCT02001623|10779038|FG010|COMPLETED|Overall Study||0
9679439|NCT02001623|10779039|FG011|COMPLETED|Overall Study||0
9679440|NCT02001623|10779040|FG012|COMPLETED|Overall Study||1
9679441|NCT02001623|10779041|FG013|COMPLETED|Overall Study||1
9679442|NCT02001623|10779042|FG014|COMPLETED|Overall Study||0
9679443|NCT02001623|10779028|FG000|NOT COMPLETED|Overall Study||3
9679444|NCT02001623|10779029|FG001|NOT COMPLETED|Overall Study||3
9679445|NCT02001623|10779030|FG002|NOT COMPLETED|Overall Study||3
9679446|NCT02001623|10779031|FG003|NOT COMPLETED|Overall Study||2
9679447|NCT02001623|10779032|FG004|NOT COMPLETED|Overall Study||3
9679448|NCT02001623|10779033|FG005|NOT COMPLETED|Overall Study||3
9679449|NCT02001623|10779034|FG006|NOT COMPLETED|Overall Study||3
9679450|NCT02001623|10779035|FG007|NOT COMPLETED|Overall Study||6
9679451|NCT02001623|10779036|FG008|NOT COMPLETED|Overall Study||15
9679452|NCT02001623|10779037|FG009|NOT COMPLETED|Overall Study||53
9679453|NCT02001623|10779038|FG010|NOT COMPLETED|Overall Study||14
9679454|NCT02001623|10779039|FG011|NOT COMPLETED|Overall Study||15
9679455|NCT02001623|10779040|FG012|NOT COMPLETED|Overall Study||14
9679456|NCT02001623|10779041|FG013|NOT COMPLETED|Overall Study||35
9679457|NCT02001623|10779042|FG014|NOT COMPLETED|Overall Study||18
9679458|NCT01900002|10779091|FG000|STARTED|Overall Study||40
9679459|NCT01900002|10779091|FG000|COMPLETED|Overall Study||34
9679460|NCT01900002|10779091|FG000|NOT COMPLETED|Overall Study||6
9679461|NCT01595061|10779095|FG000|STARTED|Overall Study||57
9679462|NCT01595061|10779095|FG000|COMPLETED|Overall Study||53
9679463|NCT01595061|10779095|FG000|NOT COMPLETED|Overall Study||4
9724464|NCT00090103|10824297|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989
9724465|NCT00090103|10824295|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
9724466|NCT00090103|10824296|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
9843071|NCT00828516|10954839|FG000|STARTED|Clinical Phase: Series 1||35
9843072|NCT00828516|10954839|FG000|COMPLETED|Clinical Phase: Series 1||33
9843073|NCT00828516|10954839|FG000|NOT COMPLETED|Clinical Phase: Series 1||2
9843074|NCT00828516|10954839|FG000|STARTED|Clinical Phase: Series 2||30
9843075|NCT00828516|10954839|FG000|COMPLETED|Clinical Phase: Series 2||30
9843076|NCT00828516|10954839|FG000|NOT COMPLETED|Clinical Phase: Series 2||0
9843077|NCT00828542|10954845|FG000|STARTED|Overall Study||23
9960325|NCT01467661|11080017|FG000|STARTED|Overall Study||53
9960326|NCT01467661|11080017|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42
9960327|NCT01467661|11080017|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41
9960328|NCT01467661|11080017|FG000|Started Post Marketing Trial|Overall Study||33
9960329|NCT01467661|11080017|FG000|COMPLETED|Overall Study||32
9960330|NCT01467661|11080017|FG000|NOT COMPLETED|Overall Study||21
9960331|NCT01467700|11080027|FG000|STARTED|Overall Study||115
9960332|NCT01467700|11080028|FG001|STARTED|Overall Study||128
9960333|NCT01467700|11080029|FG002|STARTED|Overall Study||124
9960334|NCT01467700|11080030|FG003|STARTED|Overall Study||123
9960335|NCT01467700|11080027|FG000|Safety Set - Received Treatment|Overall Study||115
9960336|NCT01467700|11080028|FG001|Safety Set - Received Treatment|Overall Study||127
9960337|NCT01467700|11080029|FG002|Safety Set - Received Treatment|Overall Study||124
9960338|NCT01467700|11080030|FG003|Safety Set - Received Treatment|Overall Study||123
9960339|NCT01467700|11080027|FG000|COMPLETED|Overall Study||86
9960340|NCT01467700|11080028|FG001|COMPLETED|Overall Study||100
9960341|NCT01467700|11080029|FG002|COMPLETED|Overall Study||97
9960342|NCT01467700|11080030|FG003|COMPLETED|Overall Study||96
9960343|NCT01467700|11080027|FG000|NOT COMPLETED|Overall Study||29
10023116|NCT01854047|11146634|FG003|Completed 12-week Study Treatment|Overall Study||146
9843078|NCT00828542|10954846|FG001|STARTED|Overall Study||23
9960344|NCT01467700|11080028|FG001|NOT COMPLETED|Overall Study||28
9960345|NCT01467700|11080029|FG002|NOT COMPLETED|Overall Study||27
9960346|NCT01467700|11080030|FG003|NOT COMPLETED|Overall Study||27
9960347|NCT01467713|11080044|FG000|STARTED|Overall Study||164
9960348|NCT01467713|11080045|FG001|STARTED|Overall Study||164
9960349|NCT01467713|11080046|FG002|STARTED|Overall Study||160
9960350|NCT01467713|11080047|FG003|STARTED|Overall Study||154
9960351|NCT01467713|11080044|FG000|Safety Analysis Set: Received Treatment|Overall Study||163
10023117|NCT01854047|11146635|FG004|Completed 12-week Study Treatment|Overall Study||143
9960352|NCT01467713|11080045|FG001|Safety Analysis Set: Received Treatment|Overall Study||164
9724467|NCT00090103|10824297|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
9724468|NCT00090103|10824295|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
9724469|NCT00090103|10824296|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
9843079|NCT00828542|10954845|FG000|COMPLETED|Overall Study||20
9960353|NCT01467713|11080046|FG002|Safety Analysis Set: Received Treatment|Overall Study||159
9960354|NCT01467713|11080047|FG003|Safety Analysis Set: Received Treatment|Overall Study||154
9960355|NCT01467713|11080044|FG000|COMPLETED|Overall Study||62
9960356|NCT01467713|11080045|FG001|COMPLETED|Overall Study||60
9679464|NCT04502212|10779099|FG000|STARTED|Overall Study||16
9843080|NCT00828542|10954846|FG001|COMPLETED|Overall Study||20
9843081|NCT00828542|10954845|FG000|NOT COMPLETED|Overall Study||3
9843082|NCT00828542|10954846|FG001|NOT COMPLETED|Overall Study||3
9843083|NCT00828568|10954855|FG000|STARTED|Randomized||184
9843084|NCT00828568|10954856|FG001|STARTED|Randomized||179
9843085|NCT00828568|10954857|FG002|STARTED|Randomized||62
9843086|NCT00828568|10954855|FG000|COMPLETED|Randomized||183
9843087|NCT00828568|10954856|FG001|COMPLETED|Randomized||179
9843088|NCT00828568|10954857|FG002|COMPLETED|Randomized||60
9843089|NCT00828568|10954855|FG000|NOT COMPLETED|Randomized||1
9843090|NCT00828568|10954856|FG001|NOT COMPLETED|Randomized||0
9843091|NCT00828568|10954857|FG002|NOT COMPLETED|Randomized||2
9843092|NCT00828568|10954855|FG000|STARTED|Treated - Received at Least One Dose||183
9843093|NCT00828568|10954856|FG001|STARTED|Treated - Received at Least One Dose||179
9843094|NCT00828568|10954857|FG002|STARTED|Treated - Received at Least One Dose||60
9843095|NCT00828568|10954855|FG000|COMPLETED|Treated - Received at Least One Dose||153
9843096|NCT00828568|10954856|FG001|COMPLETED|Treated - Received at Least One Dose||150
9843097|NCT00828568|10954857|FG002|COMPLETED|Treated - Received at Least One Dose||55
9843098|NCT00828568|10954855|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30
9843099|NCT00828568|10954856|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29
9843100|NCT00828568|10954857|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5
9843101|NCT00828672|10954868|FG000|STARTED|Pre-treatment (Baseline)||43
9843102|NCT00828672|10954869|FG001|STARTED|Pre-treatment (Baseline)||41
9843103|NCT00828672|10954868|FG000|COMPLETED|Pre-treatment (Baseline)||43
9843104|NCT00828672|10954869|FG001|COMPLETED|Pre-treatment (Baseline)||41
9843105|NCT00828672|10954868|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0
9843106|NCT00828672|10954869|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0
9843107|NCT00828672|10954868|FG000|STARTED|Study Treatment||43
9843108|NCT00828672|10954869|FG001|STARTED|Study Treatment||41
9843109|NCT00828672|10954868|FG000|COMPLETED|Study Treatment||41
9843110|NCT00828672|10954869|FG001|COMPLETED|Study Treatment||39
9843111|NCT00828672|10954868|FG000|NOT COMPLETED|Study Treatment||2
9843112|NCT00828672|10954869|FG001|NOT COMPLETED|Study Treatment||2
9843113|NCT00828672|10954868|FG000|STARTED|Post-surgery (<30 Days)||41
9843114|NCT00828672|10954869|FG001|STARTED|Post-surgery (<30 Days)||39
9843115|NCT00828672|10954868|FG000|COMPLETED|Post-surgery (<30 Days)||41
9843116|NCT00828672|10954869|FG001|COMPLETED|Post-surgery (<30 Days)||38
9843117|NCT00828672|10954868|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0
9843118|NCT00828672|10954869|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1
9843119|NCT00828672|10954868|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
9843120|NCT00828672|10954869|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
9843121|NCT00828672|10954868|FG000|COMPLETED|Follow-up||42
9843122|NCT00828672|10954869|FG001|COMPLETED|Follow-up||41
9843123|NCT00828672|10954868|FG000|NOT COMPLETED|Follow-up||0
9843124|NCT00828672|10954869|FG001|NOT COMPLETED|Follow-up||0
9843125|NCT00828711|10954878|FG000|STARTED|Overall Study||118
9843126|NCT00828711|10954879|FG001|STARTED|Overall Study||125
9843127|NCT00828711|10954880|FG002|STARTED|Overall Study||131
9843128|NCT00828711|10954878|FG000|COMPLETED|Overall Study||117
9843129|NCT00828711|10954879|FG001|COMPLETED|Overall Study||125
9843130|NCT00828711|10954880|FG002|COMPLETED|Overall Study||131
9843131|NCT00828711|10954878|FG000|NOT COMPLETED|Overall Study||1
9843132|NCT00828711|10954879|FG001|NOT COMPLETED|Overall Study||0
9843133|NCT00828711|10954880|FG002|NOT COMPLETED|Overall Study||0
9843134|NCT00828750|10954888|FG000|STARTED|Overall Study||19
9843135|NCT00828750|10954888|FG000|COMPLETED|Overall Study||15
9843136|NCT00828750|10954888|FG000|NOT COMPLETED|Overall Study||4
9843137|NCT00828841|10954896|FG000|STARTED|Overall Study||235
9843138|NCT00828841|10954897|FG001|STARTED|Overall Study||236
9843139|NCT00828841|10954898|FG002|STARTED|Overall Study||130
9843140|NCT00828841|10954896|FG000|COMPLETED|Overall Study||231
9843141|NCT00828841|10954897|FG001|COMPLETED|Overall Study||232
9843142|NCT00828841|10954898|FG002|COMPLETED|Overall Study||126
9843143|NCT00828841|10954896|FG000|NOT COMPLETED|Overall Study||4
9843144|NCT00828841|10954897|FG001|NOT COMPLETED|Overall Study||4
9843145|NCT00828841|10954898|FG002|NOT COMPLETED|Overall Study||4
9843146|NCT00828945|10954908|FG000|STARTED|Overall Study||257
9843147|NCT00828945|10954908|FG000|COMPLETED|Overall Study||216
9843148|NCT00828945|10954908|FG000|NOT COMPLETED|Overall Study||41
9843149|NCT00828984|10954915|FG000|STARTED|Overall Study||28
9843150|NCT00828984|10954916|FG001|STARTED|Overall Study||31
9843151|NCT00828984|10954917|FG002|STARTED|Overall Study||28
9843152|NCT00828984|10954915|FG000|Randomization|Overall Study||28
9843153|NCT00828984|10954916|FG001|Randomization|Overall Study||31
9843154|NCT00828984|10954917|FG002|Randomization|Overall Study||28
9960357|NCT01467713|11080046|FG002|COMPLETED|Overall Study||58
9843155|NCT00828984|10954915|FG000|Treatment|Overall Study||24
9843156|NCT00828984|10954916|FG001|Treatment|Overall Study||26
9843157|NCT00828984|10954917|FG002|Treatment|Overall Study||24
9843158|NCT00828984|10954915|FG000|Flexible Sigmoidoscopy|Overall Study||20
9843159|NCT00828984|10954916|FG001|Flexible Sigmoidoscopy|Overall Study||19
9843160|NCT00828984|10954917|FG002|Flexible Sigmoidoscopy|Overall Study||19
9843161|NCT00828984|10954915|FG000|Post Intervention Follow-Up|Overall Study||15
9843162|NCT00828984|10954916|FG001|Post Intervention Follow-Up|Overall Study||16
9843163|NCT00828984|10954917|FG002|Post Intervention Follow-Up|Overall Study||19
9843164|NCT00828984|10954915|FG000|COMPLETED|Overall Study||14
10023118|NCT01854047|11146631|FG000|COMPLETED|Overall Study||146
10023119|NCT01854047|11146632|FG001|COMPLETED|Overall Study||149
10023120|NCT01854047|11146633|FG002|COMPLETED|Overall Study||137
10023121|NCT01854047|11146634|FG003|COMPLETED|Overall Study||142
10023122|NCT01854047|11146635|FG004|COMPLETED|Overall Study||135
10023123|NCT01854047|11146631|FG000|NOT COMPLETED|Overall Study||12
10023124|NCT01854047|11146632|FG001|NOT COMPLETED|Overall Study||8
10023125|NCT01854047|11146633|FG002|NOT COMPLETED|Overall Study||13
10023126|NCT01854047|11146634|FG003|NOT COMPLETED|Overall Study||15
9679465|NCT04502212|10779099|FG000|COMPLETED|Overall Study||14
9679466|NCT04502212|10779099|FG000|NOT COMPLETED|Overall Study||2
9724470|NCT00090103|10824297|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
9724471|NCT00090103|10824295|FG000|COMPLETED|16-Week Safety Follow-up Period||1224
9724472|NCT00090103|10824296|FG001|COMPLETED|16-Week Safety Follow-up Period||1205
9724473|NCT00090103|10824297|FG002|COMPLETED|16-Week Safety Follow-up Period||1143
9724474|NCT00090103|10824295|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374
9724475|NCT00090103|10824296|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410
9724476|NCT00090103|10824297|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457
9724477|NCT00090220|10824307|FG000|STARTED|Base Study Vaccination Period||1911
9724478|NCT00090220|10824308|FG001|STARTED|Base Study Vaccination Period||1908
9724479|NCT00090220|10824309|FG002|STARTED|Base Study Vaccination Period||0
9724480|NCT00090220|10824310|FG003|STARTED|Base Study Vaccination Period||0
9724481|NCT00090220|10824311|FG004|STARTED|Base Study Vaccination Period||0
9724482|NCT00090220|10824312|FG005|STARTED|Base Study Vaccination Period||0
9724483|NCT00090220|10824307|FG000|Vaccinated|Base Study Vaccination Period||1910
9724484|NCT00090220|10824308|FG001|Vaccinated|Base Study Vaccination Period||1907
9724485|NCT00090220|10824309|FG002|Vaccinated|Base Study Vaccination Period||0
9724486|NCT00090220|10824310|FG003|Vaccinated|Base Study Vaccination Period||0
9724487|NCT00090220|10824311|FG004|Vaccinated|Base Study Vaccination Period||0
9724488|NCT00090220|10824312|FG005|Vaccinated|Base Study Vaccination Period||0
10023127|NCT01854047|11146635|FG004|NOT COMPLETED|Overall Study||19
10023128|NCT01854138|11146649|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
10023129|NCT01854138|11146650|FG001|STARTED|Overall Study||248
10023130|NCT01854138|11146649|FG000|COMPLETED|Overall Study||400
9724489|NCT00090220|10824307|FG000|COMPLETED|Base Study Vaccination Period||1847
9724490|NCT00090220|10824308|FG001|COMPLETED|Base Study Vaccination Period||1845
9724491|NCT00090220|10824309|FG002|COMPLETED|Base Study Vaccination Period||0
9724492|NCT00090220|10824310|FG003|COMPLETED|Base Study Vaccination Period||0
9724493|NCT00090220|10824311|FG004|COMPLETED|Base Study Vaccination Period||0
9724494|NCT00090220|10824312|FG005|COMPLETED|Base Study Vaccination Period||0
9724495|NCT00090220|10824307|FG000|NOT COMPLETED|Base Study Vaccination Period||64
9724496|NCT00090220|10824308|FG001|NOT COMPLETED|Base Study Vaccination Period||63
9724497|NCT00090220|10824309|FG002|NOT COMPLETED|Base Study Vaccination Period||0
9724498|NCT00090220|10824310|FG003|NOT COMPLETED|Base Study Vaccination Period||0
9724499|NCT00090220|10824311|FG004|NOT COMPLETED|Base Study Vaccination Period||0
9724500|NCT00090220|10824312|FG005|NOT COMPLETED|Base Study Vaccination Period||0
9724501|NCT00090220|10824307|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
9724502|NCT00090220|10824308|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
9724503|NCT00090220|10824309|FG002|STARTED|Base Study Follow-up Period||0
9724504|NCT00090220|10824310|FG003|STARTED|Base Study Follow-up Period||0
9724505|NCT00090220|10824311|FG004|STARTED|Base Study Follow-up Period||0
9724506|NCT00090220|10824312|FG005|STARTED|Base Study Follow-up Period||0
9724507|NCT00090220|10824307|FG000|COMPLETED|Base Study Follow-up Period||1695
10023131|NCT01854138|11146650|FG001|COMPLETED|Overall Study||196
9679467|NCT04442230|10779106|FG000|STARTED|Overall Study||23
9679468|NCT04442230|10779107|FG001|STARTED|Overall Study||25
9679469|NCT04442230|10779106|FG000|COMPLETED|Overall Study||23
9679470|NCT04442230|10779107|FG001|COMPLETED|Overall Study||24
9679471|NCT04442230|10779106|FG000|NOT COMPLETED|Overall Study||0
9679472|NCT04442230|10779107|FG001|NOT COMPLETED|Overall Study||1
9679473|NCT04794803|10779115|FG000|STARTED|Overall Study||37
9679474|NCT04794803|10779116|FG001|STARTED|Overall Study||19
9679475|NCT04794803|10779115|FG000|FAS Population|Overall Study||36
9679476|NCT04794803|10779116|FG001|FAS Population|Overall Study||19
9679477|NCT04794803|10779115|FG000|Safety Set|Overall Study||36
9679478|NCT04794803|10779116|FG001|Safety Set|Overall Study||19
9679479|NCT04794803|10779115|FG000|Per Protocol Set|Overall Study||17
9679480|NCT04794803|10779116|FG001|Per Protocol Set|Overall Study||11
9679481|NCT04794803|10779115|FG000|COMPLETED|Overall Study||27
9679482|NCT04794803|10779116|FG001|COMPLETED|Overall Study||11
9679483|NCT04794803|10779115|FG000|NOT COMPLETED|Overall Study||10
9679484|NCT04794803|10779116|FG001|NOT COMPLETED|Overall Study||8
9679485|NCT04706403|10779127|FG000|STARTED|Overall Study||172
9679486|NCT04706403|10779128|FG001|STARTED|Overall Study||121
9679487|NCT04706403|10779129|FG002|STARTED|Overall Study||165
9679488|NCT04706403|10779130|FG003|STARTED|Overall Study||146
10023132|NCT01854138|11146649|FG000|NOT COMPLETED|Overall Study||0
10023133|NCT01854138|11146650|FG001|NOT COMPLETED|Overall Study||52
10023134|NCT01854177|11146657|FG000|STARTED|Overall Study||10
10023135|NCT01854177|11146657|FG000|COMPLETED|Overall Study||10
10023136|NCT01854177|11146657|FG000|NOT COMPLETED|Overall Study||0
9679489|NCT04706403|10779131|FG004|STARTED|Overall Study||152
9679490|NCT04706403|10779127|FG000|COMPLETED|Overall Study||172
9679491|NCT04706403|10779128|FG001|COMPLETED|Overall Study||121
9679492|NCT04706403|10779129|FG002|COMPLETED|Overall Study||164
9679493|NCT04706403|10779130|FG003|COMPLETED|Overall Study||145
9679494|NCT04706403|10779131|FG004|COMPLETED|Overall Study||150
9679495|NCT04706403|10779127|FG000|NOT COMPLETED|Overall Study||0
9679496|NCT04706403|10779128|FG001|NOT COMPLETED|Overall Study||0
9679497|NCT04706403|10779129|FG002|NOT COMPLETED|Overall Study||1
9679498|NCT04706403|10779130|FG003|NOT COMPLETED|Overall Study||1
9679499|NCT04706403|10779131|FG004|NOT COMPLETED|Overall Study||2
9679500|NCT04440449|10779145|FG000|STARTED|Overall Study||20
9679501|NCT04440449|10779146|FG001|STARTED|Overall Study||0
9679502|NCT04440449|10779145|FG000|COMPLETED|Overall Study||18
9679503|NCT04440449|10779146|FG001|COMPLETED|Overall Study||0
9679504|NCT04440449|10779145|FG000|NOT COMPLETED|Overall Study||2
9679505|NCT04440449|10779146|FG001|NOT COMPLETED|Overall Study||0
9679506|NCT04369469|10779155|FG000|STARTED|Overall Study||135
9679507|NCT04369469|10779156|FG001|STARTED|Overall Study||67
9679508|NCT04369469|10779155|FG000|Intent to Treat (ITT) Population|Overall Study||135
9679509|NCT04369469|10779156|FG001|Intent to Treat (ITT) Population|Overall Study||66
9679510|NCT04369469|10779155|FG000|Pharmacokinetic (PK)|Overall Study||127
9679511|NCT04369469|10779156|FG001|Pharmacokinetic (PK)|Overall Study||52
9679512|NCT04369469|10779155|FG000|Safety Population|Overall Study||127
9679513|NCT04369469|10779156|FG001|Safety Population|Overall Study||67
9679514|NCT04369469|10779155|FG000|COMPLETED|Overall Study||125
9679515|NCT04369469|10779156|FG001|COMPLETED|Overall Study||58
9679516|NCT04369469|10779155|FG000|NOT COMPLETED|Overall Study||10
9679517|NCT04369469|10779156|FG001|NOT COMPLETED|Overall Study||9
9843165|NCT00828984|10954916|FG001|COMPLETED|Overall Study||15
9843166|NCT00828984|10954917|FG002|COMPLETED|Overall Study||19
9843167|NCT00828984|10954915|FG000|NOT COMPLETED|Overall Study||14
9843168|NCT00828984|10954916|FG001|NOT COMPLETED|Overall Study||16
9843169|NCT00828984|10954917|FG002|NOT COMPLETED|Overall Study||9
9843170|NCT00829010|10954930|FG000|STARTED|Overall Study||83
9843171|NCT00829010|10954931|FG001|STARTED|Overall Study||101
9843172|NCT00829010|10954932|FG002|STARTED|Overall Study||100
9843173|NCT00829010|10954933|FG003|STARTED|Overall Study||100
9843174|NCT00829010|10954934|FG004|STARTED|Overall Study||100
9679528|NCT04036799|10779171|FG000|STARTED|Overall Study||572
9679529|NCT04036799|10779171|FG000|COMPLETED|Overall Study||572
9679530|NCT04036799|10779171|FG000|NOT COMPLETED|Overall Study||0
9679531|NCT03965962|10779179|FG000|STARTED|Overall Study||320
9679532|NCT03965962|10779180|FG001|STARTED|Overall Study||107
9679533|NCT03965962|10779181|FG002|STARTED|Overall Study||107
9679534|NCT03965962|10779182|FG003|STARTED|Overall Study||106
9679535|NCT03965962|10779179|FG000|Vaccination 1 (Day 0)|Overall Study||318
9679536|NCT03965962|10779180|FG001|Vaccination 1 (Day 0)|Overall Study||107
9679537|NCT03965962|10779181|FG002|Vaccination 1 (Day 0)|Overall Study||107
9679538|NCT03965962|10779182|FG003|Vaccination 1 (Day 0)|Overall Study||106
9679539|NCT03965962|10779179|FG000|Vaccination 2 (Day 3)|Overall Study||317
9679540|NCT03965962|10779180|FG001|Vaccination 2 (Day 3)|Overall Study||104
9679541|NCT03965962|10779181|FG002|Vaccination 2 (Day 3)|Overall Study||107
9679542|NCT03965962|10779182|FG003|Vaccination 2 (Day 3)|Overall Study||106
9679543|NCT03965962|10779179|FG000|Vaccination 3 (Day 7)|Overall Study||311
9679544|NCT03965962|10779180|FG001|Vaccination 3 (Day 7)|Overall Study||103
9679545|NCT03965962|10779181|FG002|Vaccination 3 (Day 7)|Overall Study||105
10023137|NCT01854242|11146663|FG000|STARTED|Overall Study||50
9679546|NCT03965962|10779182|FG003|Vaccination 3 (Day 7)|Overall Study||105
9679547|NCT03965962|10779179|FG000|Vaccination 4 (Day 14)|Overall Study||301
9679548|NCT03965962|10779180|FG001|Vaccination 4 (Day 14)|Overall Study||101
9679549|NCT03965962|10779181|FG002|Vaccination 4 (Day 14)|Overall Study||101
9843175|NCT00829010|10954930|FG000|COMPLETED|Overall Study||73
9679550|NCT03965962|10779182|FG003|Vaccination 4 (Day 14)|Overall Study||103
9679551|NCT03965962|10779179|FG000|Vaccination 5 (Day 28)|Overall Study||294
9679552|NCT03965962|10779180|FG001|Vaccination 5 (Day 28)|Overall Study||98
9679553|NCT03965962|10779181|FG002|Vaccination 5 (Day 28)|Overall Study||97
9679554|NCT03965962|10779182|FG003|Vaccination 5 (Day 28)|Overall Study||98
9679555|NCT03965962|10779179|FG000|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|320
9679556|NCT03965962|10779180|FG001|Safety Analysis Set (SafAS)|Overall Study||107
9679557|NCT03965962|10779181|FG002|Safety Analysis Set (SafAS)|Overall Study||107
9679558|NCT03965962|10779182|FG003|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|104
9679559|NCT03965962|10779179|FG000|COMPLETED|Overall Study||295
9679560|NCT03965962|10779180|FG001|COMPLETED|Overall Study||102
9679561|NCT03965962|10779181|FG002|COMPLETED|Overall Study||97
9679562|NCT03965962|10779182|FG003|COMPLETED|Overall Study||100
9679563|NCT03965962|10779179|FG000|NOT COMPLETED|Overall Study||25
9679564|NCT03965962|10779180|FG001|NOT COMPLETED|Overall Study||5
9679565|NCT03965962|10779181|FG002|NOT COMPLETED|Overall Study||10
9679566|NCT03965962|10779182|FG003|NOT COMPLETED|Overall Study||6
9679567|NCT03772574|10779195|FG000|STARTED|Overall Study||42
9679568|NCT03772574|10779196|FG001|STARTED|Overall Study||25
9679569|NCT03772574|10779197|FG002|STARTED|Overall Study||24
9679570|NCT03772574|10779195|FG000|COMPLETED|Overall Study||40
9679571|NCT03772574|10779196|FG001|COMPLETED|Overall Study||20
9679572|NCT03772574|10779197|FG002|COMPLETED|Overall Study||20
9679573|NCT03772574|10779195|FG000|NOT COMPLETED|Overall Study||2
9679574|NCT03772574|10779196|FG001|NOT COMPLETED|Overall Study||5
9679575|NCT03772574|10779197|FG002|NOT COMPLETED|Overall Study||4
9679576|NCT03694522|10779207|FG000|STARTED|Overall Study||77
9843176|NCT00829010|10954931|FG001|COMPLETED|Overall Study||92
9843177|NCT00829010|10954932|FG002|COMPLETED|Overall Study||97
9843178|NCT00829010|10954933|FG003|COMPLETED|Overall Study||92
10023138|NCT01854242|11146663|FG000|COMPLETED|Overall Study||50
10023139|NCT01854242|11146663|FG000|NOT COMPLETED|Overall Study||0
10023140|NCT01854281|11146671|FG000|STARTED|Overall Study||15
10023141|NCT01854281|11146672|FG001|STARTED|Overall Study||19
9679577|NCT03694522|10779208|FG001|STARTED|Overall Study||78
9843179|NCT00829010|10954934|FG004|COMPLETED|Overall Study||98
9843180|NCT00829010|10954930|FG000|NOT COMPLETED|Overall Study||10
9843181|NCT00829010|10954931|FG001|NOT COMPLETED|Overall Study||9
9843182|NCT00829010|10954932|FG002|NOT COMPLETED|Overall Study||3
9843183|NCT00829010|10954933|FG003|NOT COMPLETED|Overall Study||8
9843184|NCT00829010|10954934|FG004|NOT COMPLETED|Overall Study||2
9843185|NCT00829036|10954946|FG000|STARTED|Overall Study||24
9843186|NCT00829036|10954946|FG000|COMPLETED|Overall Study||24
9843187|NCT00829036|10954946|FG000|NOT COMPLETED|Overall Study||0
9843188|NCT00829049|10954952|FG000|STARTED|Overall Study||77
9843189|NCT00829049|10954953|FG001|STARTED|Overall Study||88
9843190|NCT00829049|10954952|FG000|COMPLETED|Overall Study||60
9843191|NCT00829049|10954953|FG001|COMPLETED|Overall Study||68
9843192|NCT00829049|10954952|FG000|NOT COMPLETED|Overall Study||17
10023142|NCT01854281|11146673|FG002|STARTED|Overall Study||5
10023143|NCT01854281|11146674|FG003|STARTED|Overall Study||8
9679578|NCT03694522|10779207|FG000|Received Any Study Treatment|Overall Study||76
9679579|NCT03694522|10779208|FG001|Received Any Study Treatment|Overall Study||77
9679580|NCT03694522|10779207|FG000|COMPLETED|Overall Study||0
9679581|NCT03694522|10779208|FG001|COMPLETED|Overall Study||0
9679582|NCT03694522|10779207|FG000|NOT COMPLETED|Overall Study||77
9679583|NCT03694522|10779208|FG001|NOT COMPLETED|Overall Study||78
9724508|NCT00090220|10824308|FG001|COMPLETED|Base Study Follow-up Period||1687
9724509|NCT00090220|10824309|FG002|COMPLETED|Base Study Follow-up Period||0
9724510|NCT00090220|10824310|FG003|COMPLETED|Base Study Follow-up Period||0
9724511|NCT00090220|10824311|FG004|COMPLETED|Base Study Follow-up Period||0
9724512|NCT00090220|10824312|FG005|COMPLETED|Base Study Follow-up Period||0
9724513|NCT00090220|10824307|FG000|NOT COMPLETED|Base Study Follow-up Period||160
9724514|NCT00090220|10824308|FG001|NOT COMPLETED|Base Study Follow-up Period||164
9724515|NCT00090220|10824309|FG002|NOT COMPLETED|Base Study Follow-up Period||0
9724516|NCT00090220|10824310|FG003|NOT COMPLETED|Base Study Follow-up Period||0
9724517|NCT00090220|10824311|FG004|NOT COMPLETED|Base Study Follow-up Period||0
9724518|NCT00090220|10824312|FG005|NOT COMPLETED|Base Study Follow-up Period||0
9724519|NCT00090220|10824307|FG000|STARTED|Extension 1 (EXT1)||0
9724520|NCT00090220|10824308|FG001|STARTED|Extension 1 (EXT1)||0
9724521|NCT00090220|10824309|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
9724522|NCT00090220|10824310|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
9724523|NCT00090220|10824311|FG004|STARTED|Extension 1 (EXT1)||0
9724524|NCT00090220|10824312|FG005|STARTED|Extension 1 (EXT1)||0
9724525|NCT00090220|10824307|FG000|Vaccinated|Extension 1 (EXT1)||0
9724526|NCT00090220|10824308|FG001|Vaccinated|Extension 1 (EXT1)||0
9724527|NCT00090220|10824309|FG002|Vaccinated|Extension 1 (EXT1)||1321
9724528|NCT00090220|10824310|FG003|Vaccinated|Extension 1 (EXT1)||7
9724529|NCT00090220|10824311|FG004|Vaccinated|Extension 1 (EXT1)||0
9843193|NCT00829049|10954953|FG001|NOT COMPLETED|Overall Study||20
9843194|NCT00829166|10954961|FG000|STARTED|Overall Study||495
9843195|NCT00829166|10954962|FG001|STARTED|Overall Study||496
9843196|NCT00829166|10954961|FG000|Treated|Overall Study||490
9843197|NCT00829166|10954962|FG001|Treated|Overall Study||488
9843198|NCT00829166|10954961|FG000|COMPLETED|Overall Study||0
9843199|NCT00829166|10954962|FG001|COMPLETED|Overall Study||0
9843200|NCT00829166|10954961|FG000|NOT COMPLETED|Overall Study||495
9843201|NCT00829166|10954962|FG001|NOT COMPLETED|Overall Study||496
9843202|NCT00829179|10954969|FG000|STARTED|Overall Study||20
9843203|NCT00829179|10954969|FG000|COMPLETED|Overall Study||19
9843204|NCT00829179|10954969|FG000|NOT COMPLETED|Overall Study||1
9843205|NCT00829244|10954975|FG000|STARTED|Overall Study||96
9843206|NCT00829244|10954976|FG001|STARTED|Overall Study||104
9843207|NCT00829244|10954975|FG000|COMPLETED|Overall Study||82
9843208|NCT00829244|10954976|FG001|COMPLETED|Overall Study||83
9843209|NCT00829244|10954975|FG000|NOT COMPLETED|Overall Study||14
9843210|NCT00829244|10954976|FG001|NOT COMPLETED|Overall Study||21
9843211|NCT00829283|10954984|FG000|STARTED|Overall Study||39
9843212|NCT00829283|10954985|FG001|STARTED|Overall Study||152
9843213|NCT00829283|10954984|FG000|COMPLETED|Overall Study||32
9843214|NCT00829283|10954985|FG001|COMPLETED|Overall Study||127
9843215|NCT00829283|10954984|FG000|NOT COMPLETED|Overall Study||7
9843216|NCT00829283|10954985|FG001|NOT COMPLETED|Overall Study||25
9843217|NCT00829296|10954993|FG000|STARTED|Overall Study||34
9843218|NCT00829296|10954994|FG001|STARTED|Overall Study||36
9960358|NCT01467713|11080047|FG003|COMPLETED|Overall Study||45
9960359|NCT01467713|11080044|FG000|NOT COMPLETED|Overall Study||102
9960360|NCT01467713|11080045|FG001|NOT COMPLETED|Overall Study||104
9960361|NCT01467713|11080046|FG002|NOT COMPLETED|Overall Study||102
9960362|NCT01467713|11080047|FG003|NOT COMPLETED|Overall Study||109
9960363|NCT01467882|11080057|FG000|STARTED|Overall Study||44
9960364|NCT01467882|11080057|FG000|COMPLETED|Overall Study||44
9960365|NCT01467882|11080057|FG000|NOT COMPLETED|Overall Study||0
9960366|NCT01467934|11080071|FG000|STARTED|Overall Study||208
9960367|NCT01467934|11080072|FG001|STARTED|Overall Study||212
9960368|NCT01467934|11080073|FG002|STARTED|Overall Study||110
9960369|NCT01467934|11080071|FG000|COMPLETED|Overall Study||208
9960370|NCT01467934|11080072|FG001|COMPLETED|Overall Study||212
9960371|NCT01467934|11080073|FG002|COMPLETED|Overall Study||110
9960372|NCT01467934|11080071|FG000|NOT COMPLETED|Overall Study||0
9960373|NCT01467934|11080072|FG001|NOT COMPLETED|Overall Study||0
9960374|NCT01467934|11080073|FG002|NOT COMPLETED|Overall Study||0
9960375|NCT01467947|11080081|FG000|STARTED|Overall Study||46
9960376|NCT01467947|11080081|FG000|COMPLETED|Overall Study||46
9960377|NCT01467947|11080081|FG000|NOT COMPLETED|Overall Study||0
9960378|NCT01467960|11080091|FG000|STARTED|Overall Study||30
9960379|NCT01467960|11080092|FG001|STARTED|Overall Study||30
9960380|NCT01467960|11080093|FG002|STARTED|Overall Study||30
9960381|NCT01467960|11080094|FG003|STARTED|Overall Study||30
9960382|NCT01467960|11080095|FG004|STARTED|Overall Study||30
9960383|NCT01467960|11080096|FG005|STARTED|Overall Study||30
9960384|NCT01467960|11080091|FG000|COMPLETED|Overall Study||30
9960385|NCT01467960|11080092|FG001|COMPLETED|Overall Study||30
9960386|NCT01467960|11080093|FG002|COMPLETED|Overall Study||30
9960387|NCT01467960|11080094|FG003|COMPLETED|Overall Study||0
9960388|NCT01467960|11080095|FG004|COMPLETED|Overall Study||0
9960389|NCT01467960|11080096|FG005|COMPLETED|Overall Study||0
9960390|NCT01467960|11080091|FG000|NOT COMPLETED|Overall Study||0
9960391|NCT01467960|11080092|FG001|NOT COMPLETED|Overall Study||0
9960392|NCT01467960|11080093|FG002|NOT COMPLETED|Overall Study||0
9960393|NCT01467960|11080094|FG003|NOT COMPLETED|Overall Study||30
9960394|NCT01467960|11080095|FG004|NOT COMPLETED|Overall Study||30
9960395|NCT01467960|11080096|FG005|NOT COMPLETED|Overall Study||30
9960396|NCT01467999|11080110|FG000|STARTED|Overall Study||22
9960397|NCT01467999|11080110|FG000|COMPLETED|Overall Study||9
9960398|NCT01467999|11080110|FG000|NOT COMPLETED|Overall Study||13
9960399|NCT01468012|11080117|FG000|STARTED|Overall Study||9
9960400|NCT01468012|11080118|FG001|STARTED|Overall Study||10
9960401|NCT01468012|11080119|FG002|STARTED|Overall Study||4
9960402|NCT01468012|11080117|FG000|COMPLETED|Overall Study||7
9960403|NCT01468012|11080118|FG001|COMPLETED|Overall Study||9
9960404|NCT01468012|11080119|FG002|COMPLETED|Overall Study||0
9960405|NCT01468012|11080117|FG000|NOT COMPLETED|Overall Study||2
9960406|NCT01468012|11080118|FG001|NOT COMPLETED|Overall Study||1
9960407|NCT01468012|11080119|FG002|NOT COMPLETED|Overall Study||4
9960408|NCT01468077|11080130|FG000|STARTED|Overall Study||22
9960409|NCT01468077|11080131|FG001|STARTED|Overall Study||25
9960410|NCT01468077|11080130|FG000|COMPLETED|Overall Study||18
9960411|NCT01468077|11080131|FG001|COMPLETED|Overall Study||22
9960412|NCT01468077|11080130|FG000|NOT COMPLETED|Overall Study||4
9960413|NCT01468077|11080131|FG001|NOT COMPLETED|Overall Study||3
9960414|NCT01468181|11080142|FG000|STARTED|Overall Study||131
9960415|NCT01468181|11080143|FG001|STARTED|Overall Study||61
9960416|NCT01468181|11080144|FG002|STARTED|Overall Study||65
9843219|NCT00829296|10954993|FG000|COMPLETED|Overall Study||29
9843220|NCT00829296|10954994|FG001|COMPLETED|Overall Study||32
9843221|NCT00829296|10954993|FG000|NOT COMPLETED|Overall Study||5
9843222|NCT00829296|10954994|FG001|NOT COMPLETED|Overall Study||4
9843223|NCT00829387|10955002|FG000|STARTED|Overall Study||23
9843224|NCT00829387|10955003|FG001|STARTED|Overall Study||24
9960417|NCT01468181|11080145|FG003|STARTED|Overall Study||66
9960418|NCT01468181|11080146|FG004|STARTED|Overall Study||71
9960419|NCT01468181|11080142|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131
9960420|NCT01468181|11080143|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61
9960421|NCT01468181|11080144|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
9843225|NCT00829387|10955002|FG000|COMPLETED|Overall Study||20
9843226|NCT00829387|10955003|FG001|COMPLETED|Overall Study||21
9843227|NCT00829387|10955002|FG000|NOT COMPLETED|Overall Study||3
9843228|NCT00829387|10955003|FG001|NOT COMPLETED|Overall Study||3
9843229|NCT00829413|10955009|FG000|STARTED|Overall Study||353
9843230|NCT00829413|10955009|FG000|COMPLETED|Overall Study||259
9679590|NCT03594955|10779223|FG000|STARTED|Overall Study||7
9679591|NCT03594955|10779223|FG000|COMPLETED|Overall Study||0
9679592|NCT03594955|10779223|FG000|NOT COMPLETED|Overall Study||7
9679593|NCT03548220|10779231|FG000|STARTED|Overall Study||40
9679594|NCT03548220|10779232|FG001|STARTED|Overall Study||2
9679595|NCT03548220|10779233|FG002|STARTED|Overall Study||3
9679596|NCT03548220|10779234|FG003|STARTED|Overall Study||35
9679597|NCT03548220|10779231|FG000|COMPLETED|Overall Study||39
9679598|NCT03548220|10779232|FG001|COMPLETED|Overall Study||2
9679599|NCT03548220|10779233|FG002|COMPLETED|Overall Study||3
9679600|NCT03548220|10779234|FG003|COMPLETED|Overall Study||35
9679601|NCT03548220|10779231|FG000|NOT COMPLETED|Overall Study||1
9679602|NCT03548220|10779232|FG001|NOT COMPLETED|Overall Study||0
9679603|NCT03548220|10779233|FG002|NOT COMPLETED|Overall Study||0
9679604|NCT03548220|10779234|FG003|NOT COMPLETED|Overall Study||0
9843231|NCT00829413|10955009|FG000|NOT COMPLETED|Overall Study||94
9843232|NCT00829439|10955020|FG000|STARTED|Overall Study||3
9843233|NCT00829439|10955021|FG001|STARTED|Overall Study||3
9843234|NCT00829439|10955022|FG002|STARTED|Overall Study||6
9843235|NCT00829439|10955023|FG003|STARTED|Overall Study||4
9843236|NCT00829439|10955020|FG000|COMPLETED|Overall Study||3
9843237|NCT00829439|10955021|FG001|COMPLETED|Overall Study||3
9843238|NCT00829439|10955022|FG002|COMPLETED|Overall Study||5
9679613|NCT03453684|10779263|FG000|STARTED|Overall Study||60
9679614|NCT03453684|10779263|FG000|COMPLETED|Overall Study||60
9679615|NCT03453684|10779263|FG000|NOT COMPLETED|Overall Study||0
9679616|NCT03434041|10779269|FG000|STARTED|Double Blind Treatment Phase (4 Weeks)||126
9679617|NCT03434041|10779270|FG001|STARTED|Double Blind Treatment Phase (4 Weeks)||126
9679618|NCT03434041|10779269|FG000|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||124
9679619|NCT03434041|10779270|FG001|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||126
9679620|NCT03434041|10779269|FG000|COMPLETED|Double Blind Treatment Phase (4 Weeks)||108
9679621|NCT03434041|10779270|FG001|COMPLETED|Double Blind Treatment Phase (4 Weeks)||106
9679622|NCT03434041|10779269|FG000|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||18
9679623|NCT03434041|10779270|FG001|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||20
9679624|NCT03434041|10779269|FG000|STARTED|Follow-up Phase (Up to 8 Weeks)||106
9679625|NCT03434041|10779270|FG001|STARTED|Follow-up Phase (Up to 8 Weeks)||103
9679626|NCT03434041|10779269|FG000|COMPLETED|Follow-up Phase (Up to 8 Weeks)||99
9679627|NCT03434041|10779270|FG001|COMPLETED|Follow-up Phase (Up to 8 Weeks)||100
9679628|NCT03434041|10779269|FG000|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||7
9679629|NCT03434041|10779270|FG001|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||3
9679630|NCT03420222|10779280|FG000|STARTED|Overall Study||8
9679631|NCT03420222|10779281|FG001|STARTED|Overall Study||2
9679632|NCT03420222|10779280|FG000|COMPLETED|Overall Study||3
9679633|NCT03420222|10779281|FG001|COMPLETED|Overall Study||1
9679634|NCT03420222|10779280|FG000|NOT COMPLETED|Overall Study||5
9679635|NCT03420222|10779281|FG001|NOT COMPLETED|Overall Study||1
9679636|NCT03409796|10779289|FG000|STARTED|Overall Study||9
9679637|NCT03409796|10779290|FG001|STARTED|Overall Study||7
9679638|NCT03409796|10779289|FG000|COMPLETED|Overall Study||7
9679639|NCT03409796|10779290|FG001|COMPLETED|Overall Study||6
9679640|NCT03409796|10779289|FG000|NOT COMPLETED|Overall Study||2
9679641|NCT03409796|10779290|FG001|NOT COMPLETED|Overall Study||1
9679642|NCT03215706|10779298|FG000|STARTED|Randomization||361
9679643|NCT03215706|10779299|FG001|STARTED|Randomization||358
9679644|NCT03215706|10779298|FG000|COMPLETED|Randomization||358
9679645|NCT03215706|10779299|FG001|COMPLETED|Randomization||349
9679646|NCT03215706|10779298|FG000|NOT COMPLETED|Randomization||3
9679647|NCT03215706|10779299|FG001|NOT COMPLETED|Randomization||9
9679648|NCT03215706|10779298|FG000|STARTED|Treatment Period||358
9679649|NCT03215706|10779299|FG001|STARTED|Treatment Period||349
9679650|NCT03215706|10779298|FG000|COMPLETED|Treatment Period||16
9679651|NCT03215706|10779299|FG001|COMPLETED|Treatment Period||103
9679652|NCT03215706|10779298|FG000|NOT COMPLETED|Treatment Period||342
9679653|NCT03215706|10779299|FG001|NOT COMPLETED|Treatment Period||246
9679654|NCT03189563|10779308|FG000|STARTED|Overall Study||20
9679655|NCT03189563|10779309|FG001|STARTED|Overall Study||21
9679656|NCT03189563|10779310|FG002|STARTED|Overall Study||20
10023144|NCT01854281|11146671|FG000|COMPLETED|Overall Study||15
10023145|NCT01854281|11146672|FG001|COMPLETED|Overall Study||19
9679657|NCT03189563|10779308|FG000|ITT Population|Overall Study||20
9679658|NCT03189563|10779309|FG001|ITT Population|Overall Study||21
9679659|NCT03189563|10779310|FG002|ITT Population|Overall Study||19
9679660|NCT03189563|10779308|FG000|Safety Population|Overall Study||20
9679661|NCT03189563|10779309|FG001|Safety Population|Overall Study||21
9679662|NCT03189563|10779310|FG002|Safety Population|Overall Study||19
9679663|NCT03189563|10779308|FG000|COMPLETED|Overall Study||19
9679664|NCT03189563|10779309|FG001|COMPLETED|Overall Study||20
9679665|NCT03189563|10779310|FG002|COMPLETED|Overall Study||18
9679666|NCT03189563|10779308|FG000|NOT COMPLETED|Overall Study||1
9679667|NCT03189563|10779309|FG001|NOT COMPLETED|Overall Study||1
9679668|NCT03189563|10779310|FG002|NOT COMPLETED|Overall Study||2
9679669|NCT03144674|10779322|FG000|STARTED|Overall Study||4
9843239|NCT00829439|10955023|FG003|COMPLETED|Overall Study||4
9843240|NCT00829439|10955020|FG000|NOT COMPLETED|Overall Study||0
9679670|NCT03144674|10779323|FG001|STARTED|Overall Study||6
9679671|NCT03144674|10779324|FG002|STARTED|Overall Study||28
9679672|NCT03144674|10779325|FG003|STARTED|Overall Study||72
9679673|NCT03144674|10779322|FG000|COMPLETED|Overall Study||0
9679674|NCT03144674|10779323|FG001|COMPLETED|Overall Study||0
9679675|NCT03144674|10779324|FG002|COMPLETED|Overall Study||0
9679676|NCT03144674|10779325|FG003|COMPLETED|Overall Study||0
9679677|NCT03144674|10779322|FG000|NOT COMPLETED|Overall Study||4
9679678|NCT03144674|10779323|FG001|NOT COMPLETED|Overall Study||6
9679679|NCT03144674|10779324|FG002|NOT COMPLETED|Overall Study||28
9679680|NCT03144674|10779325|FG003|NOT COMPLETED|Overall Study||72
9843241|NCT00829439|10955021|FG001|NOT COMPLETED|Overall Study||0
9843242|NCT00829439|10955022|FG002|NOT COMPLETED|Overall Study||1
9843243|NCT00829439|10955023|FG003|NOT COMPLETED|Overall Study||0
9843244|NCT00829621|10955029|FG000|STARTED|Overall Study||8
9843245|NCT00829621|10955030|FG001|STARTED|Overall Study||12
9843246|NCT00829621|10955029|FG000|COMPLETED|Overall Study||4
9843247|NCT00829621|10955030|FG001|COMPLETED|Overall Study||8
9843248|NCT00829621|10955029|FG000|NOT COMPLETED|Overall Study||4
9843249|NCT00829621|10955030|FG001|NOT COMPLETED|Overall Study||4
9843250|NCT00829738|10955036|FG000|STARTED|Overall Study||4188
9843251|NCT00829738|10955036|FG000|COMPLETED|Overall Study||4180
9843252|NCT00829738|10955036|FG000|NOT COMPLETED|Overall Study||8
9843253|NCT00829829|10955044|FG000|STARTED|Overall Study||80
9843254|NCT00829829|10955045|FG001|STARTED|Overall Study||80
9843255|NCT00829829|10955046|FG002|STARTED|Overall Study||81
9843256|NCT00829829|10955044|FG000|Treated|Overall Study||79
9843257|NCT00829829|10955045|FG001|Treated|Overall Study||80
10023146|NCT01854281|11146673|FG002|COMPLETED|Overall Study||5
9679699|NCT03093350|10779353|FG000|STARTED|Overall Study||12
9679700|NCT03093350|10779353|FG000|Started Treatment|Overall Study||10
9679701|NCT03093350|10779353|FG000|COMPLETED|Overall Study||10
9679702|NCT03093350|10779353|FG000|NOT COMPLETED|Overall Study||2
9679703|NCT03070236|10779359|FG000|STARTED|Overall Study||912
9679704|NCT03070236|10779359|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538
10023147|NCT01854281|11146674|FG003|COMPLETED|Overall Study||8
10023148|NCT01854281|11146671|FG000|NOT COMPLETED|Overall Study||0
10023149|NCT01854281|11146672|FG001|NOT COMPLETED|Overall Study||0
10023150|NCT01854281|11146673|FG002|NOT COMPLETED|Overall Study||0
9679705|NCT03070236|10779359|FG000|Active Surveillance (AS) Arm|Overall Study||374
9679706|NCT03070236|10779359|FG000|COMPLETED|Overall Study||912
9679707|NCT03070236|10779359|FG000|NOT COMPLETED|Overall Study||0
9679708|NCT02999854|10779366|FG000|STARTED|Active Study Phase (up to 18 Months)||32
9679709|NCT02999854|10779367|FG001|STARTED|Active Study Phase (up to 18 Months)||31
9679710|NCT02999854|10779366|FG000|COMPLETED|Active Study Phase (up to 18 Months)||8
9679711|NCT02999854|10779367|FG001|COMPLETED|Active Study Phase (up to 18 Months)||22
9679712|NCT02999854|10779366|FG000|NOT COMPLETED|Active Study Phase (up to 18 Months)||24
9679713|NCT02999854|10779367|FG001|NOT COMPLETED|Active Study Phase (up to 18 Months)||9
9679714|NCT02999854|10779366|FG000|STARTED|Long Term Safety FU (up to 24 Months)||8
9679715|NCT02999854|10779367|FG001|STARTED|Long Term Safety FU (up to 24 Months)||22
9679716|NCT02999854|10779366|FG000|COMPLETED|Long Term Safety FU (up to 24 Months)||5
9679717|NCT02999854|10779367|FG001|COMPLETED|Long Term Safety FU (up to 24 Months)||19
9679718|NCT02999854|10779366|FG000|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
9679719|NCT02999854|10779367|FG001|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
9679720|NCT02960763|10779378|FG000|STARTED|Step 1||211
9679721|NCT02960763|10779379|FG001|STARTED|Step 1||206
9679722|NCT02960763|10779380|FG002|STARTED|Step 1||202
9679723|NCT02960763|10779381|FG003|STARTED|Step 1||0
9679724|NCT02960763|10779382|FG004|STARTED|Step 1||0
9679725|NCT02960763|10779378|FG000|COMPLETED|Step 1||192
9679726|NCT02960763|10779379|FG001|COMPLETED|Step 1||188
9679727|NCT02960763|10779380|FG002|COMPLETED|Step 1||174
9679728|NCT02960763|10779381|FG003|COMPLETED|Step 1||0
9679729|NCT02960763|10779382|FG004|COMPLETED|Step 1||0
9679730|NCT02960763|10779378|FG000|NOT COMPLETED|Step 1||19
9679731|NCT02960763|10779379|FG001|NOT COMPLETED|Step 1||18
9679732|NCT02960763|10779380|FG002|NOT COMPLETED|Step 1||28
9679733|NCT02960763|10779381|FG003|NOT COMPLETED|Step 1||0
9679734|NCT02960763|10779382|FG004|NOT COMPLETED|Step 1||0
9679735|NCT02960763|10779378|FG000|STARTED|Step 2||0
9679736|NCT02960763|10779379|FG001|STARTED|Step 2||0
9679737|NCT02960763|10779380|FG002|STARTED|Step 2||0
9679738|NCT02960763|10779381|FG003|STARTED|Step 2||127
9679739|NCT02960763|10779382|FG004|STARTED|Step 2||121
9679740|NCT02960763|10779378|FG000|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||43
9679741|NCT02960763|10779379|FG001|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||44
9679742|NCT02960763|10779380|FG002|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||38
9679743|NCT02960763|10779381|FG003|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
9679744|NCT02960763|10779382|FG004|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
9679745|NCT02960763|10779378|FG000|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
9679746|NCT02960763|10779379|FG001|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
9679747|NCT02960763|10779380|FG002|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
9679748|NCT02960763|10779381|FG003|People Who Began Step 2 Without Having Participated in Step 1|Step 2||63
9679749|NCT02960763|10779382|FG004|People Who Began Step 2 Without Having Participated in Step 1|Step 2||60
9679750|NCT02960763|10779378|FG000|COMPLETED|Step 2||0
9679751|NCT02960763|10779379|FG001|COMPLETED|Step 2||0
9679752|NCT02960763|10779380|FG002|COMPLETED|Step 2||0
9679753|NCT02960763|10779381|FG003|COMPLETED|Step 2||116
9679754|NCT02960763|10779382|FG004|COMPLETED|Step 2||116
9679755|NCT02960763|10779378|FG000|NOT COMPLETED|Step 2||0
9679756|NCT02960763|10779379|FG001|NOT COMPLETED|Step 2||0
9679757|NCT02960763|10779380|FG002|NOT COMPLETED|Step 2||0
9679758|NCT02960763|10779381|FG003|NOT COMPLETED|Step 2||11
9679759|NCT02960763|10779382|FG004|NOT COMPLETED|Step 2||5
9679760|NCT02839343|10779396|FG000|STARTED|Overall Study||70
9679761|NCT02839343|10779397|FG001|STARTED|Overall Study||56
9679762|NCT02839343|10779396|FG000|COMPLETED|Overall Study||65
9679763|NCT02839343|10779397|FG001|COMPLETED|Overall Study||55
9679764|NCT02839343|10779396|FG000|NOT COMPLETED|Overall Study||5
9679765|NCT02839343|10779397|FG001|NOT COMPLETED|Overall Study||1
9679766|NCT02819479|10779403|FG000|STARTED|Overall Study||10
9679767|NCT02819479|10779403|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
9679768|NCT02819479|10779403|FG000|NOT COMPLETED|Overall Study||2
9724530|NCT00090220|10824312|FG005|Vaccinated|Extension 1 (EXT1)||0
9724531|NCT00090220|10824307|FG000|COMPLETED|Extension 1 (EXT1)||0
9724532|NCT00090220|10824308|FG001|COMPLETED|Extension 1 (EXT1)||0
9724533|NCT00090220|10824309|FG002|COMPLETED|Extension 1 (EXT1)||1267
9724534|NCT00090220|10824310|FG003|COMPLETED|Extension 1 (EXT1)||5
9724535|NCT00090220|10824311|FG004|COMPLETED|Extension 1 (EXT1)||0
9724536|NCT00090220|10824312|FG005|COMPLETED|Extension 1 (EXT1)||0
9724537|NCT00090220|10824307|FG000|NOT COMPLETED|Extension 1 (EXT1)||0
9724538|NCT00090220|10824308|FG001|NOT COMPLETED|Extension 1 (EXT1)||0
9724539|NCT00090220|10824309|FG002|NOT COMPLETED|Extension 1 (EXT1)||55
9724540|NCT00090220|10824310|FG003|NOT COMPLETED|Extension 1 (EXT1)||2
9724541|NCT00090220|10824311|FG004|NOT COMPLETED|Extension 1 (EXT1)||0
9724542|NCT00090220|10824312|FG005|NOT COMPLETED|Extension 1 (EXT1)||0
9724543|NCT00090220|10824307|FG000|STARTED|Long-term Follow-up (EXT2)||0
9724544|NCT00090220|10824308|FG001|STARTED|Long-term Follow-up (EXT2)||0
9724545|NCT00090220|10824309|FG002|STARTED|Long-term Follow-up (EXT2)||0
9724546|NCT00090220|10824310|FG003|STARTED|Long-term Follow-up (EXT2)||0
9724547|NCT00090220|10824311|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
9724548|NCT00090220|10824312|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
9724549|NCT00090220|10824307|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
9724550|NCT00090220|10824308|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
9724551|NCT00090220|10824309|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
9724552|NCT00090220|10824310|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
9724553|NCT00090220|10824311|FG004|COMPLETED|Long-term Follow-up (EXT2)||641
9724554|NCT00090220|10824312|FG005|COMPLETED|Long-term Follow-up (EXT2)||623
9724555|NCT00090220|10824307|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724556|NCT00090220|10824308|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724557|NCT00090220|10824309|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724558|NCT00090220|10824310|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724559|NCT00090220|10824311|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44
9724560|NCT00090220|10824312|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28
9724561|NCT00090233|10824331|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
9724562|NCT00090233|10824332|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
9724563|NCT00090233|10824331|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
9724564|NCT00090233|10824332|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
9724565|NCT00090233|10824331|FG000|Vaccinated at Visit 2|Overall Study||31052
9724566|NCT00090233|10824332|FG001|Vaccinated at Visit 2|Overall Study||31066
9724567|NCT00090233|10824331|FG000|Vaccinated at Visit 3|Overall Study||29667
9724568|NCT00090233|10824332|FG001|Vaccinated at Visit 3|Overall Study||29598
9724569|NCT00090233|10824331|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
9724570|NCT00090233|10824332|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
9724571|NCT00090233|10824331|FG000|NOT COMPLETED|Overall Study||4999
9724572|NCT00090233|10824332|FG001|NOT COMPLETED|Overall Study||5065
9724573|NCT00090285|10824344|FG000|STARTED|Base Study Vaccination Period||2032
9724574|NCT00090285|10824345|FG001|STARTED|Base Study Vaccination Period||2033
9843258|NCT00829829|10955046|FG002|Treated|Overall Study||81
9843259|NCT00829829|10955044|FG000|COMPLETED|Overall Study||58
9843260|NCT00829829|10955045|FG001|COMPLETED|Overall Study||64
9843261|NCT00829829|10955046|FG002|COMPLETED|Overall Study||70
9843262|NCT00829829|10955044|FG000|NOT COMPLETED|Overall Study||22
9843263|NCT00829829|10955045|FG001|NOT COMPLETED|Overall Study||16
9843264|NCT00829829|10955046|FG002|NOT COMPLETED|Overall Study||11
9843265|NCT00829933|10955059|FG000|STARTED|Overall Study||135
9843266|NCT00829933|10955060|FG001|STARTED|Overall Study||135
9843267|NCT00829933|10955061|FG002|STARTED|Overall Study||132
9843268|NCT00829933|10955062|FG003|STARTED|Overall Study||134
9843269|NCT00829933|10955059|FG000|Baseline Analysis Population|Overall Study||131
9843270|NCT00829933|10955060|FG001|Baseline Analysis Population|Overall Study||134
9843271|NCT00829933|10955061|FG002|Baseline Analysis Population|Overall Study||131
9843272|NCT00829933|10955062|FG003|Baseline Analysis Population|Overall Study||129
9843273|NCT00829933|10955059|FG000|COMPLETED|Overall Study||121
9843274|NCT00829933|10955060|FG001|COMPLETED|Overall Study||122
9843275|NCT00829933|10955061|FG002|COMPLETED|Overall Study||119
9679769|NCT02601313|10779411|FG000|STARTED|Overall Study||14
9679770|NCT02601313|10779412|FG001|STARTED|Overall Study||74
9679771|NCT02601313|10779413|FG002|STARTED|Overall Study||17
9679772|NCT02601313|10779411|FG000|COMPLETED|Overall Study||8
9679773|NCT02601313|10779412|FG001|COMPLETED|Overall Study||0
9679774|NCT02601313|10779413|FG002|COMPLETED|Overall Study||0
9679775|NCT02601313|10779411|FG000|NOT COMPLETED|Overall Study||6
9679776|NCT02601313|10779412|FG001|NOT COMPLETED|Overall Study||74
9679777|NCT02601313|10779413|FG002|NOT COMPLETED|Overall Study||17
9679781|NCT02542293|10779427|FG000|STARTED|Overall Study||474
9679782|NCT02542293|10779428|FG001|STARTED|Overall Study||479
9679783|NCT02542293|10779427|FG000|Randomized in Global Cohort|Overall Study||410
9679784|NCT02542293|10779428|FG001|Randomized in Global Cohort|Overall Study||413
9679785|NCT02542293|10779427|FG000|Received Treatment in Global Cohort|Overall Study||410
9679786|NCT02542293|10779428|FG001|Received Treatment in Global Cohort|Overall Study||399
9679787|NCT02542293|10779427|FG000|Randomized in China Cohort|Overall Study||78
9679788|NCT02542293|10779428|FG001|Randomized in China Cohort|Overall Study||82
9679789|NCT02542293|10779427|FG000|Received Treatment in China Cohort|Overall Study||77
9679790|NCT02542293|10779428|FG001|Received Treatment in China Cohort|Overall Study||78
9679791|NCT02542293|10779427|FG000|Included in Both Cohorts (Global and China)|Overall Study||14
9679792|NCT02542293|10779428|FG001|Included in Both Cohorts (Global and China)|Overall Study||16
9679793|NCT02542293|10779427|FG000|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||75
9679794|NCT02542293|10779428|FG001|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||67
9679795|NCT02542293|10779427|FG000|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||27
9679796|NCT02542293|10779428|FG001|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||18
9679797|NCT02542293|10779427|FG000|COMPLETED|Overall Study||99
9679798|NCT02542293|10779428|FG001|COMPLETED|Overall Study||83
9679799|NCT02542293|10779427|FG000|NOT COMPLETED|Overall Study||375
9679800|NCT02542293|10779428|FG001|NOT COMPLETED|Overall Study||396
9679801|NCT02484430|10779441|FG000|STARTED|Overall Study||16
9679802|NCT02484430|10779441|FG000|COMPLETED|Overall Study||16
9679803|NCT02484430|10779441|FG000|NOT COMPLETED|Overall Study||0
9679804|NCT02438722|10779447|FG000|STARTED|Overall Study||83
9679805|NCT02438722|10779448|FG001|STARTED|Overall Study||85
9679806|NCT02438722|10779447|FG000|Participants Evaluable for Adverse Events|Overall Study||78
9679807|NCT02438722|10779448|FG001|Participants Evaluable for Adverse Events|Overall Study||85
9679808|NCT02438722|10779447|FG000|COMPLETED|Overall Study||0
9679809|NCT02438722|10779448|FG001|COMPLETED|Overall Study||0
9679810|NCT02438722|10779447|FG000|NOT COMPLETED|Overall Study||83
9679811|NCT02438722|10779448|FG001|NOT COMPLETED|Overall Study||85
9679812|NCT02425306|10779458|FG000|STARTED|Overall Study||3
10023151|NCT01854281|11146674|FG003|NOT COMPLETED|Overall Study||0
10023152|NCT01854359|11146686|FG000|STARTED|Overall Study||31
10023153|NCT01854359|11146687|FG001|STARTED|Overall Study||30
10023154|NCT01854359|11146686|FG000|COMPLETED|Overall Study||26
10023155|NCT01854359|11146687|FG001|COMPLETED|Overall Study||22
9679813|NCT02425306|10779459|FG001|STARTED|Overall Study||7
9679814|NCT02425306|10779460|FG002|STARTED|Overall Study||6
9679815|NCT02425306|10779461|FG003|STARTED|Overall Study||32
9679816|NCT02425306|10779458|FG000|COMPLETED|Overall Study||3
9679817|NCT02425306|10779459|FG001|COMPLETED|Overall Study||6
9679818|NCT02425306|10779460|FG002|COMPLETED|Overall Study||5
9679819|NCT02425306|10779461|FG003|COMPLETED|Overall Study||18
9679820|NCT02425306|10779458|FG000|NOT COMPLETED|Overall Study||0
9679821|NCT02425306|10779459|FG001|NOT COMPLETED|Overall Study||1
9679822|NCT02425306|10779460|FG002|NOT COMPLETED|Overall Study||1
9679823|NCT02425306|10779461|FG003|NOT COMPLETED|Overall Study||14
9843276|NCT00829933|10955062|FG003|COMPLETED|Overall Study||120
9843277|NCT00829933|10955059|FG000|NOT COMPLETED|Overall Study||14
9843278|NCT00829933|10955060|FG001|NOT COMPLETED|Overall Study||13
9843279|NCT00829933|10955061|FG002|NOT COMPLETED|Overall Study||13
10023156|NCT01854359|11146686|FG000|NOT COMPLETED|Overall Study||5
10023157|NCT01854359|11146687|FG001|NOT COMPLETED|Overall Study||8
10023158|NCT01854528|11146703|FG000|STARTED|Overall Study||101
10023159|NCT01854528|11146704|FG001|STARTED|Overall Study||47
9843280|NCT00829933|10955062|FG003|NOT COMPLETED|Overall Study||14
9679836|NCT02120352|10779491|FG000|STARTED|Induction Period (20 Weeks)||309
9679837|NCT02120352|10779492|FG001|STARTED|Induction Period (20 Weeks)||0
9679838|NCT02120352|10779493|FG002|STARTED|Induction Period (20 Weeks)||0
9679839|NCT02120352|10779494|FG003|STARTED|Induction Period (20 Weeks)||0
9679840|NCT02120352|10779491|FG000|COMPLETED|Induction Period (20 Weeks)||288
9679841|NCT02120352|10779492|FG001|COMPLETED|Induction Period (20 Weeks)||0
9679842|NCT02120352|10779493|FG002|COMPLETED|Induction Period (20 Weeks)||0
9679843|NCT02120352|10779494|FG003|COMPLETED|Induction Period (20 Weeks)||0
9679844|NCT02120352|10779491|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21
9679845|NCT02120352|10779492|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0
9679846|NCT02120352|10779493|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0
9679847|NCT02120352|10779494|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0
9679848|NCT02120352|10779491|FG000|STARTED|Maintenance Period (32 Weeks)||0
9679849|NCT02120352|10779492|FG001|STARTED|Maintenance Period (32 Weeks)||115
9679850|NCT02120352|10779493|FG002|STARTED|Maintenance Period (32 Weeks)||115
9679851|NCT02120352|10779494|FG003|STARTED|Maintenance Period (32 Weeks)||56
9679852|NCT02120352|10779491|FG000|COMPLETED|Maintenance Period (32 Weeks)||0
10023160|NCT01854528|11146703|FG000|COMPLETED|Overall Study||101
10023161|NCT01854528|11146704|FG001|COMPLETED|Overall Study||32
10023162|NCT01854528|11146703|FG000|NOT COMPLETED|Overall Study||0
10023163|NCT01854528|11146704|FG001|NOT COMPLETED|Overall Study||15
10023164|NCT01854593|11146712|FG000|STARTED|Overall Study||34
10023165|NCT01854593|11146713|FG001|STARTED|Overall Study||35
9679853|NCT02120352|10779492|FG001|COMPLETED|Maintenance Period (32 Weeks)||0
9679854|NCT02120352|10779493|FG002|COMPLETED|Maintenance Period (32 Weeks)||0
9679855|NCT02120352|10779494|FG003|COMPLETED|Maintenance Period (32 Weeks)||0
9679856|NCT02120352|10779491|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0
9679857|NCT02120352|10779492|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115
9679858|NCT02120352|10779493|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115
9679859|NCT02120352|10779494|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56
9679860|NCT02114814|10779510|FG000|STARTED|Overall Study||103
9679861|NCT02114814|10779511|FG001|STARTED|Overall Study||83
9679862|NCT02114814|10779510|FG000|COMPLETED|Overall Study||88
9679863|NCT02114814|10779511|FG001|COMPLETED|Overall Study||74
9679864|NCT02114814|10779510|FG000|NOT COMPLETED|Overall Study||15
9679865|NCT02114814|10779511|FG001|NOT COMPLETED|Overall Study||9
9679866|NCT02067819|10779523|FG000|STARTED|Overall Study||11
9679867|NCT02067819|10779524|FG001|STARTED|Overall Study||10
9679868|NCT02067819|10779523|FG000|COMPLETED|Overall Study||6
9679869|NCT02067819|10779524|FG001|COMPLETED|Overall Study||7
9679870|NCT02067819|10779523|FG000|NOT COMPLETED|Overall Study||5
9679871|NCT02067819|10779524|FG001|NOT COMPLETED|Overall Study||3
9679872|NCT02004691|10779532|FG000|STARTED|PAP: Up to 52 Weeks||18
9679873|NCT02004691|10779533|FG001|STARTED|PAP: Up to 52 Weeks||18
9679874|NCT02004691|10779532|FG000|COMPLETED|PAP: Up to 52 Weeks||17
9679875|NCT02004691|10779533|FG001|COMPLETED|PAP: Up to 52 Weeks||18
9679876|NCT02004691|10779532|FG000|NOT COMPLETED|PAP: Up to 52 Weeks||1
9679877|NCT02004691|10779533|FG001|NOT COMPLETED|PAP: Up to 52 Weeks||0
9679878|NCT02004691|10779532|FG000|STARTED|ETP: Ongoing From Week 52||17
9679879|NCT02004691|10779533|FG001|STARTED|ETP: Ongoing From Week 52||18
9679880|NCT02004691|10779532|FG000|COMPLETED|ETP: Ongoing From Week 52||0
9679881|NCT02004691|10779533|FG001|COMPLETED|ETP: Ongoing From Week 52||0
9679882|NCT02004691|10779532|FG000|NOT COMPLETED|ETP: Ongoing From Week 52||17
9679883|NCT02004691|10779533|FG001|NOT COMPLETED|ETP: Ongoing From Week 52||18
9679908|NCT01802632|10779570|FG000|STARTED|Overall Study||201
9679909|NCT01802632|10779571|FG001|STARTED|Overall Study||31
9679910|NCT01802632|10779572|FG002|STARTED|Overall Study||271
9679911|NCT01802632|10779573|FG003|STARTED|Overall Study||60
9679912|NCT01802632|10779574|FG004|STARTED|Overall Study||12
9679913|NCT01802632|10779575|FG005|STARTED|Overall Study||28
9679914|NCT01802632|10779570|FG000|COMPLETED|Overall Study||0
9679915|NCT01802632|10779571|FG001|COMPLETED|Overall Study||0
9679916|NCT01802632|10779572|FG002|COMPLETED|Overall Study||0
9679917|NCT01802632|10779573|FG003|COMPLETED|Overall Study||0
9679918|NCT01802632|10779574|FG004|COMPLETED|Overall Study||0
9679919|NCT01802632|10779575|FG005|COMPLETED|Overall Study||0
9679920|NCT01802632|10779570|FG000|NOT COMPLETED|Overall Study||201
10023166|NCT01854593|11146712|FG000|COMPLETED|Overall Study||32
10023167|NCT01854593|11146713|FG001|COMPLETED|Overall Study||34
9679921|NCT01802632|10779571|FG001|NOT COMPLETED|Overall Study||31
9679922|NCT01802632|10779572|FG002|NOT COMPLETED|Overall Study||271
9679923|NCT01802632|10779573|FG003|NOT COMPLETED|Overall Study||60
9679924|NCT01802632|10779574|FG004|NOT COMPLETED|Overall Study||12
9679925|NCT01802632|10779575|FG005|NOT COMPLETED|Overall Study||28
9679926|NCT01668719|10779590|FG000|STARTED|Phase I||6
10023168|NCT01854593|11146712|FG000|NOT COMPLETED|Overall Study||2
9679927|NCT01668719|10779591|FG001|STARTED|Phase I||0
9679928|NCT01668719|10779592|FG002|STARTED|Phase I||0
9679929|NCT01668719|10779590|FG000|COMPLETED|Phase I||0
9679930|NCT01668719|10779591|FG001|COMPLETED|Phase I||0
9679931|NCT01668719|10779592|FG002|COMPLETED|Phase I||0
9679932|NCT01668719|10779590|FG000|NOT COMPLETED|Phase I||6
9679933|NCT01668719|10779591|FG001|NOT COMPLETED|Phase I||0
9679934|NCT01668719|10779592|FG002|NOT COMPLETED|Phase I||0
9679935|NCT01668719|10779590|FG000|STARTED|Phase II||0
9679936|NCT01668719|10779591|FG001|STARTED|Phase II||52
9679937|NCT01668719|10779592|FG002|STARTED|Phase II||48
9679938|NCT01668719|10779590|FG000|COMPLETED|Phase II||0
9679939|NCT01668719|10779591|FG001|COMPLETED|Phase II||0
9679940|NCT01668719|10779592|FG002|COMPLETED|Phase II||0
9679941|NCT01668719|10779590|FG000|NOT COMPLETED|Phase II||0
9679942|NCT01668719|10779591|FG001|NOT COMPLETED|Phase II||52
9679943|NCT01668719|10779592|FG002|NOT COMPLETED|Phase II||48
9679944|NCT01625286|10779609|FG000|STARTED|Overall Study||12
9679945|NCT01625286|10779610|FG001|STARTED|Overall Study||8
9679946|NCT01625286|10779611|FG002|STARTED|Overall Study||5
9679947|NCT01625286|10779612|FG003|STARTED|Overall Study||7
9679948|NCT01625286|10779613|FG004|STARTED|Overall Study||6
9679949|NCT01625286|10779614|FG005|STARTED|Overall Study||54
9679950|NCT01625286|10779615|FG006|STARTED|Overall Study||56
9679951|NCT01625286|10779609|FG000|Received AZD5363/Placebo Treatment|Overall Study||12
9679952|NCT01625286|10779610|FG001|Received AZD5363/Placebo Treatment|Overall Study||8
9679953|NCT01625286|10779611|FG002|Received AZD5363/Placebo Treatment|Overall Study||5
9679954|NCT01625286|10779612|FG003|Received AZD5363/Placebo Treatment|Overall Study||7
9679955|NCT01625286|10779613|FG004|Received AZD5363/Placebo Treatment|Overall Study||6
9679956|NCT01625286|10779614|FG005|Received AZD5363/Placebo Treatment|Overall Study||54
9679957|NCT01625286|10779615|FG006|Received AZD5363/Placebo Treatment|Overall Study||55
9679958|NCT01625286|10779609|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
9679959|NCT01625286|10779610|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
9679960|NCT01625286|10779611|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
9679961|NCT01625286|10779612|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
9679962|NCT01625286|10779613|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
9679963|NCT01625286|10779614|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
9679964|NCT01625286|10779615|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
9679965|NCT01625286|10779609|FG000|COMPLETED|Overall Study||0
9679966|NCT01625286|10779610|FG001|COMPLETED|Overall Study||0
9679967|NCT01625286|10779611|FG002|COMPLETED|Overall Study||0
9679968|NCT01625286|10779612|FG003|COMPLETED|Overall Study||0
9679969|NCT01625286|10779613|FG004|COMPLETED|Overall Study||0
9679970|NCT01625286|10779614|FG005|COMPLETED|Overall Study||0
9679971|NCT01625286|10779615|FG006|COMPLETED|Overall Study||0
9679972|NCT01625286|10779609|FG000|NOT COMPLETED|Overall Study||12
9679973|NCT01625286|10779610|FG001|NOT COMPLETED|Overall Study||8
9679974|NCT01625286|10779611|FG002|NOT COMPLETED|Overall Study||5
9679975|NCT01625286|10779612|FG003|NOT COMPLETED|Overall Study||7
9679976|NCT01625286|10779613|FG004|NOT COMPLETED|Overall Study||6
9679977|NCT01625286|10779614|FG005|NOT COMPLETED|Overall Study||54
9679978|NCT01625286|10779615|FG006|NOT COMPLETED|Overall Study||56
9679979|NCT01515748|10779633|FG000|STARTED|Overall Study||264
9679980|NCT01515748|10779634|FG001|STARTED|Overall Study||266
9679981|NCT01515748|10779633|FG000|Treated|Overall Study||195
9679982|NCT01515748|10779634|FG001|Treated|Overall Study||241
9679983|NCT01515748|10779633|FG000|COMPLETED|Overall Study||144
9679984|NCT01515748|10779634|FG001|COMPLETED|Overall Study||131
9679985|NCT01515748|10779633|FG000|NOT COMPLETED|Overall Study||120
9679986|NCT01515748|10779634|FG001|NOT COMPLETED|Overall Study||135
9679987|NCT01261247|10779641|FG000|STARTED|Overall Study||41
9679988|NCT01261247|10779641|FG000|COMPLETED|Overall Study||39
9679989|NCT01261247|10779641|FG000|NOT COMPLETED|Overall Study||2
9679990|NCT01169259|10779649|FG000|STARTED|Overall Study||6463
9679991|NCT01169259|10779650|FG001|STARTED|Overall Study||6464
10023169|NCT01854593|11146713|FG001|NOT COMPLETED|Overall Study||1
10023170|NCT01854632|11146722|FG000|STARTED|Overall Study||1174
10023171|NCT01854632|11146723|FG001|STARTED|Overall Study||587
10023172|NCT01854632|11146722|FG000|COMPLETED|Overall Study||1148
10023173|NCT01854632|11146723|FG001|COMPLETED|Overall Study||574
10023174|NCT01854632|11146722|FG000|NOT COMPLETED|Overall Study||26
10023175|NCT01854632|11146723|FG001|NOT COMPLETED|Overall Study||13
10023176|NCT01854645|11146734|FG000|STARTED|Overall Study||527
10023177|NCT01854645|11146735|FG001|STARTED|Overall Study||451
10023178|NCT01854645|11146736|FG002|STARTED|Overall Study||452
10023179|NCT01854645|11146737|FG003|STARTED|Overall Study||453
10023180|NCT01854645|11146738|FG004|STARTED|Overall Study||220
9679992|NCT01169259|10779651|FG002|STARTED|Overall Study||6470
9679993|NCT01169259|10779652|FG003|STARTED|Overall Study||6474
10023181|NCT01854645|11146734|FG000|COMPLETED|Overall Study||429
10023182|NCT01854645|11146735|FG001|COMPLETED|Overall Study||345
9679994|NCT01169259|10779649|FG000|COMPLETED|Overall Study||6463
9679995|NCT01169259|10779650|FG001|COMPLETED|Overall Study||6464
9679996|NCT01169259|10779651|FG002|COMPLETED|Overall Study||6470
9679997|NCT01169259|10779652|FG003|COMPLETED|Overall Study||6474
9679998|NCT01169259|10779649|FG000|NOT COMPLETED|Overall Study||0
9679999|NCT01169259|10779650|FG001|NOT COMPLETED|Overall Study||0
9680000|NCT01169259|10779651|FG002|NOT COMPLETED|Overall Study||0
9680001|NCT01169259|10779652|FG003|NOT COMPLETED|Overall Study||0
9680002|NCT00790933|10779673|FG000|STARTED|Overall Study||675
10023183|NCT01854645|11146736|FG002|COMPLETED|Overall Study||370
10023184|NCT01854645|11146737|FG003|COMPLETED|Overall Study||391
9680003|NCT00790933|10779674|FG001|STARTED|Overall Study||726
9680004|NCT00790933|10779675|FG002|STARTED|Overall Study||384
9680005|NCT00790933|10779676|FG003|STARTED|Overall Study||37
9680006|NCT00790933|10779677|FG004|STARTED|Overall Study||421
9680007|NCT00790933|10779673|FG000|COMPLETED|Overall Study||237
9680008|NCT00790933|10779674|FG001|COMPLETED|Overall Study||246
9680009|NCT00790933|10779675|FG002|COMPLETED|Overall Study||115
9680010|NCT00790933|10779676|FG003|COMPLETED|Overall Study||23
9680011|NCT00790933|10779677|FG004|COMPLETED|Overall Study||145
9680012|NCT00790933|10779673|FG000|NOT COMPLETED|Overall Study||438
9680013|NCT00790933|10779674|FG001|NOT COMPLETED|Overall Study||480
9680014|NCT00790933|10779675|FG002|NOT COMPLETED|Overall Study||269
9680015|NCT00790933|10779676|FG003|NOT COMPLETED|Overall Study||14
9680016|NCT00790933|10779677|FG004|NOT COMPLETED|Overall Study||276
9680017|NCT00624234|10779699|FG000|STARTED|Overall Study||8
9680018|NCT00624234|10779700|FG001|STARTED|Overall Study||9
9680019|NCT00624234|10779701|FG002|STARTED|Overall Study||26
9680020|NCT00624234|10779702|FG003|STARTED|Overall Study||14
9680021|NCT00624234|10779703|FG004|STARTED|Overall Study||18
9680022|NCT00624234|10779704|FG005|STARTED|Overall Study||14
9680023|NCT00624234|10779699|FG000|COMPLETED|Overall Study||8
9680024|NCT00624234|10779700|FG001|COMPLETED|Overall Study||9
9680025|NCT00624234|10779701|FG002|COMPLETED|Overall Study||26
9680026|NCT00624234|10779702|FG003|COMPLETED|Overall Study||14
9680027|NCT00624234|10779703|FG004|COMPLETED|Overall Study||18
9680028|NCT00624234|10779704|FG005|COMPLETED|Overall Study||14
9680029|NCT00624234|10779699|FG000|NOT COMPLETED|Overall Study||0
9680030|NCT00624234|10779700|FG001|NOT COMPLETED|Overall Study||0
9680031|NCT00624234|10779701|FG002|NOT COMPLETED|Overall Study||0
9680032|NCT00624234|10779702|FG003|NOT COMPLETED|Overall Study||0
9680033|NCT00624234|10779703|FG004|NOT COMPLETED|Overall Study||0
9680034|NCT00624234|10779704|FG005|NOT COMPLETED|Overall Study||0
9680059|NCT00127673|10779745|FG000|STARTED|Overall Study||48
9680060|NCT00127673|10779746|FG001|STARTED|Overall Study||61
9680061|NCT00127673|10779747|FG002|STARTED|Overall Study||55
9680062|NCT00127673|10779748|FG003|STARTED|Overall Study||36
9680063|NCT00127673|10779745|FG000|COMPLETED|Overall Study||23
9680064|NCT00127673|10779746|FG001|COMPLETED|Overall Study||44
9680065|NCT00127673|10779747|FG002|COMPLETED|Overall Study||35
10023185|NCT01854645|11146738|FG004|COMPLETED|Overall Study||160
10023186|NCT01854645|11146734|FG000|NOT COMPLETED|Overall Study||98
10023187|NCT01854645|11146735|FG001|NOT COMPLETED|Overall Study||106
10023188|NCT01854645|11146736|FG002|NOT COMPLETED|Overall Study||82
10023189|NCT01854645|11146737|FG003|NOT COMPLETED|Overall Study||62
10023190|NCT01854645|11146738|FG004|NOT COMPLETED|Overall Study||60
10023191|NCT01854658|11146754|FG000|STARTED|Overall Study||439
10023192|NCT01854658|11146755|FG001|STARTED|Overall Study||440
9680066|NCT00127673|10779748|FG003|COMPLETED|Overall Study||25
9680067|NCT00127673|10779745|FG000|NOT COMPLETED|Overall Study||25
9680068|NCT00127673|10779746|FG001|NOT COMPLETED|Overall Study||17
9680069|NCT00127673|10779747|FG002|NOT COMPLETED|Overall Study||20
9680070|NCT00127673|10779748|FG003|NOT COMPLETED|Overall Study||11
10023193|NCT01854658|11146756|FG002|STARTED|Overall Study||512
9724575|NCT00090285|10824346|FG002|STARTED|Base Study Vaccination Period||0
9724576|NCT00090285|10824347|FG003|STARTED|Base Study Vaccination Period||0
9724577|NCT00090285|10824348|FG004|STARTED|Base Study Vaccination Period||0
9724578|NCT00090285|10824349|FG005|STARTED|Base Study Vaccination Period||0
9724579|NCT00090285|10824344|FG000|Vaccinated|Base Study Vaccination Period||2025
9724580|NCT00090285|10824345|FG001|Vaccinated|Base Study Vaccination Period||2030
10023194|NCT01854658|11146757|FG003|STARTED|Overall Study||224
10023195|NCT01854658|11146754|FG000|COMPLETED|Overall Study||346
9680071|NCT04388527|10779762|FG000|STARTED|Overall Study||32
9680072|NCT04388527|10779762|FG000|COMPLETED|Overall Study||15
9680073|NCT04388527|10779762|FG000|NOT COMPLETED|Overall Study||17
9680074|NCT04369833|10779766|FG000|STARTED|Overall Study||130
9680075|NCT04369833|10779766|FG000|COMPLETED|Overall Study||129
9680076|NCT04369833|10779766|FG000|NOT COMPLETED|Overall Study||1
9680077|NCT04280081|10779770|FG000|STARTED|Overall Study||77
9680078|NCT04280081|10779770|FG000|Enrolled: All NSCLC|Overall Study||47
9680079|NCT04280081|10779770|FG000|Enrolled: All TC|Overall Study||1
9680080|NCT04280081|10779770|FG000|Enrolled: All MTC|Overall Study||29
9680081|NCT04280081|10779770|FG000|PAS: RET Fusion Positive NSCLC|Overall Study||26
9680082|NCT04280081|10779770|FG000|PAS: RET Fusion Positive TC|Overall Study||1
9680083|NCT04280081|10779770|FG000|PAS: Advance RET-mutant MTC|Overall Study||26
9680084|NCT04280081|10779770|FG000|COMPLETED|Overall Study||65
9680085|NCT04280081|10779770|FG000|NOT COMPLETED|Overall Study||12
9680086|NCT04238429|10779785|FG000|STARTED|Overall Study||43
9680087|NCT04238429|10779786|FG001|STARTED|Overall Study||43
9680088|NCT04238429|10779785|FG000|COMPLETED|Overall Study||40
9680089|NCT04238429|10779786|FG001|COMPLETED|Overall Study||41
9680090|NCT04238429|10779785|FG000|NOT COMPLETED|Overall Study||3
9680091|NCT04238429|10779786|FG001|NOT COMPLETED|Overall Study||2
9843281|NCT00829985|10955074|FG000|STARTED|Overall Study||28
9843282|NCT00829985|10955075|FG001|STARTED|Overall Study||26
9843283|NCT00829985|10955074|FG000|COMPLETED|Overall Study||19
9843284|NCT00829985|10955075|FG001|COMPLETED|Overall Study||22
9843285|NCT00829985|10955074|FG000|NOT COMPLETED|Overall Study||9
9843286|NCT00829985|10955075|FG001|NOT COMPLETED|Overall Study||4
9843287|NCT00830037|10955083|FG000|STARTED|Overall Study||67
9843288|NCT00830037|10955084|FG001|STARTED|Overall Study||69
9960422|NCT01468181|11080145|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66
9960423|NCT01468181|11080146|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71
9960424|NCT01468181|11080142|FG000|COMPLETED|Overall Study||121
9960425|NCT01468181|11080143|FG001|COMPLETED|Overall Study||59
9960426|NCT01468181|11080144|FG002|COMPLETED|Overall Study||57
9960427|NCT01468181|11080145|FG003|COMPLETED|Overall Study||63
9960428|NCT01468181|11080146|FG004|COMPLETED|Overall Study||66
9960429|NCT01468181|11080142|FG000|NOT COMPLETED|Overall Study||10
9960430|NCT01468181|11080143|FG001|NOT COMPLETED|Overall Study||2
9960431|NCT01468181|11080144|FG002|NOT COMPLETED|Overall Study||8
9960432|NCT01468181|11080145|FG003|NOT COMPLETED|Overall Study||3
9960433|NCT01468181|11080146|FG004|NOT COMPLETED|Overall Study||5
9960434|NCT01468207|11080160|FG000|STARTED|Treatment Period 1||154
9960435|NCT01468207|11080161|FG001|STARTED|Treatment Period 1||153
9960436|NCT01468207|11080162|FG002|STARTED|Treatment Period 1||0
9960437|NCT01468207|11080163|FG003|STARTED|Treatment Period 1||0
9960438|NCT01468207|11080164|FG004|STARTED|Treatment Period 1||0
9960439|NCT01468207|11080165|FG005|STARTED|Treatment Period 1||0
9960440|NCT01468207|11080160|FG000|Received Study Drug|Treatment Period 1||152
9960441|NCT01468207|11080161|FG001|Received Study Drug|Treatment Period 1||153
9960442|NCT01468207|11080162|FG002|Received Study Drug|Treatment Period 1||0
9960443|NCT01468207|11080163|FG003|Received Study Drug|Treatment Period 1||0
9960444|NCT01468207|11080164|FG004|Received Study Drug|Treatment Period 1||0
9960445|NCT01468207|11080165|FG005|Received Study Drug|Treatment Period 1||0
9960446|NCT01468207|11080160|FG000|COMPLETED|Treatment Period 1||145
9960447|NCT01468207|11080161|FG001|COMPLETED|Treatment Period 1||145
9960448|NCT01468207|11080162|FG002|COMPLETED|Treatment Period 1||0
9960449|NCT01468207|11080163|FG003|COMPLETED|Treatment Period 1||0
9960450|NCT01468207|11080164|FG004|COMPLETED|Treatment Period 1||0
9960451|NCT01468207|11080165|FG005|COMPLETED|Treatment Period 1||0
9960452|NCT01468207|11080160|FG000|NOT COMPLETED|Treatment Period 1||9
9960453|NCT01468207|11080161|FG001|NOT COMPLETED|Treatment Period 1||8
9680171|NCT02725593|10779941|FG001|STARTED|Blinded Treatment Period||33
9680172|NCT02725593|10779940|FG000|Received Treatment|Blinded Treatment Period||39
9680173|NCT02725593|10779941|FG001|Received Treatment|Blinded Treatment Period||33
9680174|NCT02725593|10779940|FG000|COMPLETED|Blinded Treatment Period||34
9843289|NCT00830037|10955083|FG000|COMPLETED|Overall Study||49
9843290|NCT00830037|10955084|FG001|COMPLETED|Overall Study||50
9843291|NCT00830037|10955083|FG000|NOT COMPLETED|Overall Study||18
9680175|NCT02725593|10779941|FG001|COMPLETED|Blinded Treatment Period||27
9680176|NCT02725593|10779940|FG000|NOT COMPLETED|Blinded Treatment Period||5
9960454|NCT01468207|11080162|FG002|NOT COMPLETED|Treatment Period 1||0
9960455|NCT01468207|11080163|FG003|NOT COMPLETED|Treatment Period 1||0
9960456|NCT01468207|11080164|FG004|NOT COMPLETED|Treatment Period 1||0
9960457|NCT01468207|11080165|FG005|NOT COMPLETED|Treatment Period 1||0
9960458|NCT01468207|11080160|FG000|STARTED|Treatment Period 2||0
9960459|NCT01468207|11080161|FG001|STARTED|Treatment Period 2||0
9960460|NCT01468207|11080162|FG002|STARTED|Treatment Period 2||145
9960461|NCT01468207|11080163|FG003|STARTED|Treatment Period 2||49
9960462|NCT01468207|11080164|FG004|STARTED|Treatment Period 2||48
9960463|NCT01468207|11080165|FG005|STARTED|Treatment Period 2||48
9960464|NCT01468207|11080160|FG000|COMPLETED|Treatment Period 2||0
9960465|NCT01468207|11080161|FG001|COMPLETED|Treatment Period 2||0
9960466|NCT01468207|11080162|FG002|COMPLETED|Treatment Period 2||93
9960467|NCT01468207|11080163|FG003|COMPLETED|Treatment Period 2||22
9680177|NCT02725593|10779941|FG001|NOT COMPLETED|Blinded Treatment Period||6
9843292|NCT00830037|10955084|FG001|NOT COMPLETED|Overall Study||19
9960468|NCT01468207|11080164|FG004|COMPLETED|Treatment Period 2||27
9960469|NCT01468207|11080165|FG005|COMPLETED|Treatment Period 2||28
9680092|NCT04126083|10779792|FG000|STARTED|Overall Study||6
9680093|NCT04126083|10779792|FG000|COMPLETED|Overall Study||5
9680094|NCT04126083|10779792|FG000|NOT COMPLETED|Overall Study||1
9680095|NCT03901300|10779798|FG000|STARTED|Overall Study|Children were enrolled study participants. Parents were not study participants.|35
9680096|NCT03901300|10779799|FG001|STARTED|Overall Study||37
9680097|NCT03901300|10779798|FG000|COMPLETED|Overall Study||32
9680098|NCT03901300|10779799|FG001|COMPLETED|Overall Study||37
9680099|NCT03901300|10779798|FG000|NOT COMPLETED|Overall Study||3
9680100|NCT03901300|10779799|FG001|NOT COMPLETED|Overall Study||0
9680101|NCT03744637|10779815|FG000|STARTED|Overall Study||2
9680102|NCT03744637|10779816|FG001|STARTED|Overall Study||2
9680103|NCT03744637|10779817|FG002|STARTED|Overall Study||2
9680104|NCT03744637|10779818|FG003|STARTED|Overall Study||1
9680105|NCT03744637|10779819|FG004|STARTED|Overall Study||1
9680106|NCT03744637|10779820|FG005|STARTED|Overall Study||1
9680107|NCT03744637|10779821|FG006|STARTED|Overall Study||8
9680108|NCT03744637|10779822|FG007|STARTED|Overall Study||4
9680109|NCT03744637|10779823|FG008|STARTED|Overall Study||3
9680110|NCT03744637|10779824|FG009|STARTED|Overall Study||1
9680111|NCT03744637|10779815|FG000|COMPLETED|Overall Study||2
9680112|NCT03744637|10779816|FG001|COMPLETED|Overall Study||2
9680113|NCT03744637|10779817|FG002|COMPLETED|Overall Study||2
9680114|NCT03744637|10779818|FG003|COMPLETED|Overall Study||1
9680115|NCT03744637|10779819|FG004|COMPLETED|Overall Study|Participant did not receive MK-5475 240 ug in Part 2 as planned.|1
9680116|NCT03744637|10779820|FG005|COMPLETED|Overall Study|Participant received 165 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|1
9680117|NCT03744637|10779821|FG006|COMPLETED|Overall Study||8
9680118|NCT03744637|10779822|FG007|COMPLETED|Overall Study|Participants received 120 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|4
9680119|NCT03744637|10779823|FG008|COMPLETED|Overall Study||3
9680120|NCT03744637|10779824|FG009|COMPLETED|Overall Study|Participant did not receive 120 ug in Part 2 Period 3 as planned.|1
9680121|NCT03744637|10779815|FG000|NOT COMPLETED|Overall Study||0
9680122|NCT03744637|10779816|FG001|NOT COMPLETED|Overall Study||0
9680123|NCT03744637|10779817|FG002|NOT COMPLETED|Overall Study||0
9680124|NCT03744637|10779818|FG003|NOT COMPLETED|Overall Study||0
9680125|NCT03744637|10779819|FG004|NOT COMPLETED|Overall Study||0
9680126|NCT03744637|10779820|FG005|NOT COMPLETED|Overall Study||0
9680127|NCT03744637|10779821|FG006|NOT COMPLETED|Overall Study||0
9680128|NCT03744637|10779822|FG007|NOT COMPLETED|Overall Study||0
9680129|NCT03744637|10779823|FG008|NOT COMPLETED|Overall Study||0
9680130|NCT03744637|10779824|FG009|NOT COMPLETED|Overall Study||0
9680131|NCT03576144|10779891|FG000|STARTED|Overall Study||10
9680132|NCT03576144|10779892|FG001|STARTED|Overall Study||8
9680133|NCT03576144|10779893|FG002|STARTED|Overall Study||8
9680134|NCT03576144|10779894|FG003|STARTED|Overall Study||8
9680135|NCT03576144|10779895|FG004|STARTED|Overall Study||8
9680136|NCT03576144|10779896|FG005|STARTED|Overall Study||8
9680137|NCT03576144|10779891|FG000|COMPLETED|Overall Study||10
9680138|NCT03576144|10779892|FG001|COMPLETED|Overall Study||8
9680139|NCT03576144|10779893|FG002|COMPLETED|Overall Study||8
9680140|NCT03576144|10779894|FG003|COMPLETED|Overall Study||8
9680141|NCT03576144|10779895|FG004|COMPLETED|Overall Study||8
9680142|NCT03576144|10779896|FG005|COMPLETED|Overall Study||8
9680143|NCT03576144|10779891|FG000|NOT COMPLETED|Overall Study||0
9680144|NCT03576144|10779892|FG001|NOT COMPLETED|Overall Study||0
9680145|NCT03576144|10779893|FG002|NOT COMPLETED|Overall Study||0
9680146|NCT03576144|10779894|FG003|NOT COMPLETED|Overall Study||0
9680147|NCT03576144|10779895|FG004|NOT COMPLETED|Overall Study||0
9680148|NCT03576144|10779896|FG005|NOT COMPLETED|Overall Study||0
9680149|NCT03444038|10779915|FG000|STARTED|Overall Study||85
9680150|NCT03444038|10779915|FG000|COMPLETED|Overall Study||56
9680151|NCT03444038|10779915|FG000|NOT COMPLETED|Overall Study||29
9680152|NCT03432897|10779919|FG000|STARTED|Overall Study||1
9680153|NCT03432897|10779919|FG000|COMPLETED|Overall Study||1
9680154|NCT03432897|10779919|FG000|NOT COMPLETED|Overall Study||0
9680155|NCT03265665|10779925|FG000|STARTED|24-week Data Collection||25
9680156|NCT03265665|10779926|FG001|STARTED|24-week Data Collection||28
9680157|NCT03265665|10779925|FG000|COMPLETED|24-week Data Collection||19
9680158|NCT03265665|10779926|FG001|COMPLETED|24-week Data Collection||21
9680159|NCT03265665|10779925|FG000|NOT COMPLETED|24-week Data Collection||6
9680160|NCT03265665|10779926|FG001|NOT COMPLETED|24-week Data Collection||7
9680161|NCT03265665|10779925|FG000|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|23
9680162|NCT03265665|10779926|FG001|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|26
9680163|NCT03265665|10779925|FG000|COMPLETED|36-week Data Collection||17
9680164|NCT03265665|10779926|FG001|COMPLETED|36-week Data Collection||18
9680165|NCT03265665|10779925|FG000|NOT COMPLETED|36-week Data Collection||6
9680166|NCT03265665|10779926|FG001|NOT COMPLETED|36-week Data Collection||8
9680167|NCT03196180|10779934|FG000|STARTED|Overall Study||13
9680168|NCT03196180|10779934|FG000|COMPLETED|Overall Study||11
9680169|NCT03196180|10779934|FG000|NOT COMPLETED|Overall Study||2
9680170|NCT02725593|10779940|FG000|STARTED|Blinded Treatment Period||39
10023196|NCT01854658|11146755|FG001|COMPLETED|Overall Study||365
9680178|NCT02725593|10779940|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
9680179|NCT02725593|10779941|FG001|STARTED|Long Term Extension||27
9680180|NCT02725593|10779940|FG000|COMPLETED|Long Term Extension||32
9680181|NCT02725593|10779941|FG001|COMPLETED|Long Term Extension||24
9680182|NCT02725593|10779940|FG000|NOT COMPLETED|Long Term Extension||1
9680183|NCT02725593|10779941|FG001|NOT COMPLETED|Long Term Extension||3
9680184|NCT02716675|10779950|FG000|STARTED|Overall Study||903
9680185|NCT02716675|10779951|FG001|STARTED|Overall Study||899
9680186|NCT02716675|10779952|FG002|STARTED|Overall Study||897
9680187|NCT02716675|10779950|FG000|Modified Intent-to-treat Population|Overall Study||898
9680188|NCT02716675|10779951|FG001|Modified Intent-to-treat Population|Overall Study||895
9680189|NCT02716675|10779952|FG002|Modified Intent-to-treat Population|Overall Study||894
9680190|NCT02716675|10779950|FG000|COMPLETED|Overall Study||703
9680191|NCT02716675|10779951|FG001|COMPLETED|Overall Study||702
9680192|NCT02716675|10779952|FG002|COMPLETED|Overall Study||686
9680193|NCT02716675|10779950|FG000|NOT COMPLETED|Overall Study||200
9680194|NCT02716675|10779951|FG001|NOT COMPLETED|Overall Study||197
9680195|NCT02716675|10779952|FG002|NOT COMPLETED|Overall Study||211
9680196|NCT02636946|10779967|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72
9680197|NCT02636946|10779968|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72
9680198|NCT02636946|10779967|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72
9680199|NCT02636946|10779968|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70
9680200|NCT02636946|10779967|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71
9680201|NCT02636946|10779968|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67
9680202|NCT02636946|10779967|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1
9680203|NCT02636946|10779968|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5
9680204|NCT02636946|10779967|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65
9680205|NCT02636946|10779968|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62
9680206|NCT02636946|10779967|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63
9680207|NCT02636946|10779968|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61
9680208|NCT02636946|10779967|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2
9680209|NCT02636946|10779968|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1
9680210|NCT02636946|10779967|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17
9680211|NCT02636946|10779968|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16
9680212|NCT02636946|10779967|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17
9680213|NCT02636946|10779968|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16
9680214|NCT02636946|10779967|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
9680215|NCT02636946|10779968|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
9680216|NCT02631941|10779984|FG000|STARTED|Overall Study||9
9680217|NCT02631941|10779985|FG001|STARTED|Overall Study||10
9680218|NCT02631941|10779986|FG002|STARTED|Overall Study||9
9680219|NCT02631941|10779987|FG003|STARTED|Overall Study||9
9680220|NCT02631941|10779988|FG004|STARTED|Overall Study||9
9680221|NCT02631941|10779989|FG005|STARTED|Overall Study||8
9680222|NCT02631941|10779990|FG006|STARTED|Overall Study||9
9680223|NCT02631941|10779991|FG007|STARTED|Overall Study||9
9680224|NCT02631941|10779992|FG008|STARTED|Overall Study||10
9680225|NCT02631941|10779993|FG009|STARTED|Overall Study||9
9680226|NCT02631941|10779984|FG000|A|Overall Study||9
9680227|NCT02631941|10779985|FG001|A|Overall Study||8
9680228|NCT02631941|10779986|FG002|A|Overall Study||9
9680229|NCT02631941|10779987|FG003|A|Overall Study||9
9680230|NCT02631941|10779988|FG004|A|Overall Study||9
9680231|NCT02631941|10779989|FG005|A|Overall Study||8
9680232|NCT02631941|10779990|FG006|A|Overall Study||9
9680233|NCT02631941|10779991|FG007|A|Overall Study||9
9680234|NCT02631941|10779992|FG008|A|Overall Study||9
9680235|NCT02631941|10779993|FG009|A|Overall Study||9
9680236|NCT02631941|10779984|FG000|B1|Overall Study||9
9680237|NCT02631941|10779985|FG001|B1|Overall Study||10
9680238|NCT02631941|10779986|FG002|B1|Overall Study||9
9680239|NCT02631941|10779987|FG003|B1|Overall Study||9
9680240|NCT02631941|10779988|FG004|B1|Overall Study||8
9680241|NCT02631941|10779989|FG005|B1|Overall Study||8
9680242|NCT02631941|10779990|FG006|B1|Overall Study||9
9680243|NCT02631941|10779991|FG007|B1|Overall Study||9
9680244|NCT02631941|10779992|FG008|B1|Overall Study||10
9680245|NCT02631941|10779993|FG009|B1|Overall Study||9
9680246|NCT02631941|10779984|FG000|B2|Overall Study||9
9843293|NCT00830063|10955094|FG000|STARTED|Overall Study||208
9843294|NCT00830063|10955095|FG001|STARTED|Overall Study||208
9843295|NCT00830063|10955096|FG002|STARTED|Overall Study||208
9843296|NCT00830063|10955097|FG003|STARTED|Overall Study||208
9843297|NCT00830063|10955094|FG000|Treated|Overall Study||208
9843298|NCT00830063|10955095|FG001|Treated|Overall Study||206
9843299|NCT00830063|10955096|FG002|Treated|Overall Study||208
10023197|NCT01854658|11146756|FG002|COMPLETED|Overall Study||432
9680247|NCT02631941|10779985|FG001|B2|Overall Study||8
9680248|NCT02631941|10779986|FG002|B2|Overall Study||9
9680249|NCT02631941|10779987|FG003|B2|Overall Study||9
9680250|NCT02631941|10779988|FG004|B2|Overall Study||9
9680251|NCT02631941|10779989|FG005|B2|Overall Study||8
9680252|NCT02631941|10779990|FG006|B2|Overall Study||9
9680253|NCT02631941|10779991|FG007|B2|Overall Study||9
9680254|NCT02631941|10779992|FG008|B2|Overall Study||9
9680255|NCT02631941|10779993|FG009|B2|Overall Study||9
9680256|NCT02631941|10779984|FG000|C|Overall Study||9
9680257|NCT02631941|10779985|FG001|C|Overall Study||8
9680258|NCT02631941|10779986|FG002|C|Overall Study||9
9680259|NCT02631941|10779987|FG003|C|Overall Study||9
9680260|NCT02631941|10779988|FG004|C|Overall Study||8
9843300|NCT00830063|10955097|FG003|Treated|Overall Study||206
9680261|NCT02631941|10779989|FG005|C|Overall Study||8
9680262|NCT02631941|10779990|FG006|C|Overall Study||9
9680263|NCT02631941|10779991|FG007|C|Overall Study||8
9680264|NCT02631941|10779992|FG008|C|Overall Study||9
9680265|NCT02631941|10779993|FG009|C|Overall Study||9
9680266|NCT02631941|10779984|FG000|D|Overall Study||9
9680267|NCT02631941|10779985|FG001|D|Overall Study||8
9680268|NCT02631941|10779986|FG002|D|Overall Study||9
9680269|NCT02631941|10779987|FG003|D|Overall Study||9
9680270|NCT02631941|10779988|FG004|D|Overall Study||8
9680271|NCT02631941|10779989|FG005|D|Overall Study||8
9680272|NCT02631941|10779990|FG006|D|Overall Study||9
9680273|NCT02631941|10779991|FG007|D|Overall Study||9
9680274|NCT02631941|10779992|FG008|D|Overall Study||9
9680275|NCT02631941|10779993|FG009|D|Overall Study||9
9680276|NCT02631941|10779984|FG000|COMPLETED|Overall Study||9
9680277|NCT02631941|10779985|FG001|COMPLETED|Overall Study||8
9680278|NCT02631941|10779986|FG002|COMPLETED|Overall Study||9
9680279|NCT02631941|10779987|FG003|COMPLETED|Overall Study||9
9680280|NCT02631941|10779988|FG004|COMPLETED|Overall Study||8
9680281|NCT02631941|10779989|FG005|COMPLETED|Overall Study||8
9680282|NCT02631941|10779990|FG006|COMPLETED|Overall Study||9
9680283|NCT02631941|10779991|FG007|COMPLETED|Overall Study||8
9680284|NCT02631941|10779992|FG008|COMPLETED|Overall Study||9
9680285|NCT02631941|10779993|FG009|COMPLETED|Overall Study||9
9680286|NCT02631941|10779984|FG000|NOT COMPLETED|Overall Study||0
9680287|NCT02631941|10779985|FG001|NOT COMPLETED|Overall Study||2
9680288|NCT02631941|10779986|FG002|NOT COMPLETED|Overall Study||0
9680289|NCT02631941|10779987|FG003|NOT COMPLETED|Overall Study||0
9680290|NCT02631941|10779988|FG004|NOT COMPLETED|Overall Study||1
9680291|NCT02631941|10779989|FG005|NOT COMPLETED|Overall Study||0
9680292|NCT02631941|10779990|FG006|NOT COMPLETED|Overall Study||0
9680293|NCT02631941|10779991|FG007|NOT COMPLETED|Overall Study||1
9680294|NCT02631941|10779992|FG008|NOT COMPLETED|Overall Study||1
9680295|NCT02631941|10779993|FG009|NOT COMPLETED|Overall Study||0
9680296|NCT02568215|10780006|FG000|STARTED|Overall Study||637
9680297|NCT02568215|10780007|FG001|STARTED|Overall Study||642
9680298|NCT02568215|10780008|FG002|STARTED|Overall Study||645
9680299|NCT02568215|10780006|FG000|Modified Intent-to-treat Population|Overall Study||637
9680300|NCT02568215|10780007|FG001|Modified Intent-to-treat Population|Overall Study||642
9680301|NCT02568215|10780008|FG002|Modified Intent-to-treat Population|Overall Study||645
9680302|NCT02568215|10780006|FG000|COMPLETED|Overall Study||558
9680303|NCT02568215|10780007|FG001|COMPLETED|Overall Study||562
9680304|NCT02568215|10780008|FG002|COMPLETED|Overall Study||555
9680305|NCT02568215|10780006|FG000|NOT COMPLETED|Overall Study||79
9680306|NCT02568215|10780007|FG001|NOT COMPLETED|Overall Study||80
9680307|NCT02568215|10780008|FG002|NOT COMPLETED|Overall Study||90
9680308|NCT02562378|10780024|FG000|STARTED|Overall Study||3
9680309|NCT02562378|10780025|FG001|STARTED|Overall Study||3
9680310|NCT02562378|10780026|FG002|STARTED|Overall Study||9
9680311|NCT02562378|10780024|FG000|COMPLETED|Overall Study||3
9680312|NCT02562378|10780025|FG001|COMPLETED|Overall Study||3
9680313|NCT02562378|10780026|FG002|COMPLETED|Overall Study||9
9680314|NCT02562378|10780024|FG000|NOT COMPLETED|Overall Study||0
9680315|NCT02562378|10780025|FG001|NOT COMPLETED|Overall Study||0
9680316|NCT02562378|10780026|FG002|NOT COMPLETED|Overall Study||0
9680317|NCT02528643|10780036|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55
9680318|NCT02528643|10780037|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110
9680319|NCT02528643|10780036|FG000|Treated|DB (Median Duration up to 14.65 Months)||55
9680320|NCT02528643|10780037|FG001|Treated|DB (Median Duration up to 14.65 Months)||107
9680321|NCT02528643|10780036|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0
9680322|NCT02528643|10780037|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0
9680323|NCT02528643|10780036|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55
9680324|NCT02528643|10780037|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110
9680325|NCT02528643|10780036|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0
9680326|NCT02528643|10780037|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1
9680327|NCT02528643|10780036|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0
9680328|NCT02528643|10780037|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0
9680329|NCT02528643|10780036|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0
9680330|NCT02528643|10780037|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1
9680331|NCT02416011|10780048|FG000|STARTED|Overall Study||575
9680332|NCT02416011|10780049|FG001|STARTED|Overall Study||1154
9680333|NCT02416011|10780050|FG002|STARTED|Overall Study||1167
9680334|NCT02416011|10780048|FG000|COMPLETED|Overall Study||561
9680335|NCT02416011|10780049|FG001|COMPLETED|Overall Study||1101
9680336|NCT02416011|10780050|FG002|COMPLETED|Overall Study||1114
9680337|NCT02416011|10780048|FG000|NOT COMPLETED|Overall Study||14
9680338|NCT02416011|10780049|FG001|NOT COMPLETED|Overall Study||53
9680339|NCT02416011|10780050|FG002|NOT COMPLETED|Overall Study||53
9680340|NCT02237508|10780081|FG000|STARTED|Overall Study||9
9680341|NCT02237508|10780082|FG001|STARTED|Overall Study||9
9680342|NCT02237508|10780083|FG002|STARTED|Overall Study||9
9680343|NCT02237508|10780084|FG003|STARTED|Overall Study||9
9680344|NCT02237508|10780085|FG004|STARTED|Overall Study||9
9680345|NCT02237508|10780086|FG005|STARTED|Overall Study||9
9680346|NCT02237508|10780087|FG006|STARTED|Overall Study||9
9680347|NCT02237508|10780088|FG007|STARTED|Overall Study||9
9680348|NCT02237508|10780089|FG008|STARTED|Overall Study||9
9680349|NCT02237508|10780090|FG009|STARTED|Overall Study||9
9680350|NCT02237508|10780081|FG000|A|Overall Study||9
9680351|NCT02237508|10780082|FG001|A|Overall Study||6
9680352|NCT02237508|10780083|FG002|A|Overall Study||8
9680353|NCT02237508|10780084|FG003|A|Overall Study||8
9680354|NCT02237508|10780085|FG004|A|Overall Study||9
9680355|NCT02237508|10780086|FG005|A|Overall Study||8
9680356|NCT02237508|10780087|FG006|A|Overall Study||8
9680357|NCT02237508|10780088|FG007|A|Overall Study||9
9680358|NCT02237508|10780089|FG008|A|Overall Study||9
9680359|NCT02237508|10780090|FG009|A|Overall Study||9
9680360|NCT02237508|10780081|FG000|B1|Overall Study||9
9680361|NCT02237508|10780082|FG001|B1|Overall Study||9
9680362|NCT02237508|10780083|FG002|B1|Overall Study||9
9680363|NCT02237508|10780084|FG003|B1|Overall Study||8
9680364|NCT02237508|10780085|FG004|B1|Overall Study||9
9680365|NCT02237508|10780086|FG005|B1|Overall Study||9
9680366|NCT02237508|10780087|FG006|B1|Overall Study||9
9680367|NCT02237508|10780088|FG007|B1|Overall Study||9
9680368|NCT02237508|10780089|FG008|B1|Overall Study||9
9680369|NCT02237508|10780090|FG009|B1|Overall Study||9
9680370|NCT02237508|10780081|FG000|B2|Overall Study||9
9680371|NCT02237508|10780082|FG001|B2|Overall Study||6
9680372|NCT02237508|10780083|FG002|B2|Overall Study||9
9680373|NCT02237508|10780084|FG003|B2|Overall Study||9
9680374|NCT02237508|10780085|FG004|B2|Overall Study||9
9680375|NCT02237508|10780086|FG005|B2|Overall Study||9
9680376|NCT02237508|10780087|FG006|B2|Overall Study||9
9680377|NCT02237508|10780088|FG007|B2|Overall Study||9
9680378|NCT02237508|10780089|FG008|B2|Overall Study||8
9680379|NCT02237508|10780090|FG009|B2|Overall Study||9
9680380|NCT02237508|10780081|FG000|C|Overall Study||9
9680381|NCT02237508|10780082|FG001|C|Overall Study||8
9680382|NCT02237508|10780083|FG002|C|Overall Study||9
9680383|NCT02237508|10780084|FG003|C|Overall Study||8
9680384|NCT02237508|10780085|FG004|C|Overall Study||9
9680385|NCT02237508|10780086|FG005|C|Overall Study||9
9680386|NCT02237508|10780087|FG006|C|Overall Study||9
9680387|NCT02237508|10780088|FG007|C|Overall Study||9
9680388|NCT02237508|10780089|FG008|C|Overall Study||9
9680389|NCT02237508|10780090|FG009|C|Overall Study||9
9680390|NCT02237508|10780081|FG000|D|Overall Study||9
9680391|NCT02237508|10780082|FG001|D|Overall Study||6
9680392|NCT02237508|10780083|FG002|D|Overall Study||9
9680393|NCT02237508|10780084|FG003|D|Overall Study||9
9680394|NCT02237508|10780085|FG004|D|Overall Study||9
9680395|NCT02237508|10780086|FG005|D|Overall Study||9
9680396|NCT02237508|10780087|FG006|D|Overall Study||9
9680397|NCT02237508|10780088|FG007|D|Overall Study||9
9680398|NCT02237508|10780089|FG008|D|Overall Study||8
9680399|NCT02237508|10780090|FG009|D|Overall Study||9
9680400|NCT02237508|10780081|FG000|COMPLETED|Overall Study||9
9680401|NCT02237508|10780082|FG001|COMPLETED|Overall Study||6
9680402|NCT02237508|10780083|FG002|COMPLETED|Overall Study||8
9680403|NCT02237508|10780084|FG003|COMPLETED|Overall Study||8
9680404|NCT02237508|10780085|FG004|COMPLETED|Overall Study||9
9680405|NCT02237508|10780086|FG005|COMPLETED|Overall Study||8
9680406|NCT02237508|10780087|FG006|COMPLETED|Overall Study||8
9680407|NCT02237508|10780088|FG007|COMPLETED|Overall Study||9
9680408|NCT02237508|10780089|FG008|COMPLETED|Overall Study||8
9680409|NCT02237508|10780090|FG009|COMPLETED|Overall Study||9
9680410|NCT02237508|10780081|FG000|NOT COMPLETED|Overall Study||0
9680411|NCT02237508|10780082|FG001|NOT COMPLETED|Overall Study||3
9680412|NCT02237508|10780083|FG002|NOT COMPLETED|Overall Study||1
9680413|NCT02237508|10780084|FG003|NOT COMPLETED|Overall Study||1
9680414|NCT02237508|10780085|FG004|NOT COMPLETED|Overall Study||0
9680415|NCT02237508|10780086|FG005|NOT COMPLETED|Overall Study||1
9680416|NCT02237508|10780087|FG006|NOT COMPLETED|Overall Study||1
9680417|NCT02237508|10780088|FG007|NOT COMPLETED|Overall Study||0
9680418|NCT02237508|10780089|FG008|NOT COMPLETED|Overall Study||1
9680419|NCT02237508|10780090|FG009|NOT COMPLETED|Overall Study||0
9843301|NCT00830063|10955094|FG000|COMPLETED|Overall Study||8
9843302|NCT00830063|10955095|FG001|COMPLETED|Overall Study||16
9843303|NCT00830063|10955096|FG002|COMPLETED|Overall Study||10
9843304|NCT00830063|10955097|FG003|COMPLETED|Overall Study||13
9843305|NCT00830063|10955094|FG000|NOT COMPLETED|Overall Study||200
9843306|NCT00830063|10955095|FG001|NOT COMPLETED|Overall Study||192
9843307|NCT00830063|10955096|FG002|NOT COMPLETED|Overall Study||198
9843308|NCT00830063|10955097|FG003|NOT COMPLETED|Overall Study||195
9843309|NCT00830076|10955109|FG000|STARTED|Sitagliptin + Placebo Metformin||18
9843310|NCT00830076|10955109|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18
9843311|NCT00830076|10955109|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
9843312|NCT00830076|10955109|FG000|STARTED|7-day Washout||18
9843313|NCT00830076|10955109|FG000|COMPLETED|7-day Washout||18
9843314|NCT00830076|10955109|FG000|NOT COMPLETED|7-day Washout||0
9843315|NCT00830076|10955109|FG000|STARTED|Metformin + Placebo Sitagliptin||18
9843316|NCT00830076|10955109|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18
9843317|NCT00830076|10955109|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
9843318|NCT00830076|10955109|FG000|STARTED|7-day Washout||18
9843319|NCT00830076|10955109|FG000|COMPLETED|7-day Washout||18
9843320|NCT00830076|10955109|FG000|NOT COMPLETED|7-day Washout||0
9843321|NCT00830076|10955109|FG000|STARTED|Sitagliptin + Metformin||18
9843322|NCT00830076|10955109|FG000|COMPLETED|Sitagliptin + Metformin||18
9843323|NCT00830076|10955109|FG000|NOT COMPLETED|Sitagliptin + Metformin||0
9843324|NCT00830076|10955109|FG000|STARTED|7-day Washout||18
9843325|NCT00830076|10955109|FG000|COMPLETED|7-day Washout||18
9843326|NCT00830076|10955109|FG000|NOT COMPLETED|7-day Washout||0
9843327|NCT00830076|10955109|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18
9843328|NCT00830076|10955109|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
9843329|NCT00830076|10955109|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
9843330|NCT00830115|10955116|FG000|STARTED|Overall Study||1045
9843331|NCT00830115|10955116|FG000|COMPLETED|Overall Study||1042
9843332|NCT00830115|10955116|FG000|NOT COMPLETED|Overall Study||3
9843333|NCT00830128|10955122|FG000|STARTED|Overall Study||106
9843334|NCT00830128|10955122|FG000|COMPLETED|Overall Study||87
9843335|NCT00830128|10955122|FG000|NOT COMPLETED|Overall Study||19
9843336|NCT00830167|10955128|FG000|STARTED|Overall Study|Treated|248
9843337|NCT00830167|10955129|FG001|STARTED|Overall Study|Treated|250
9843338|NCT00830167|10955128|FG000|COMPLETED|Overall Study||208
9843339|NCT00830167|10955129|FG001|COMPLETED|Overall Study||207
9843340|NCT00830167|10955128|FG000|NOT COMPLETED|Overall Study||40
9843341|NCT00830167|10955129|FG001|NOT COMPLETED|Overall Study||43
9843342|NCT00830180|10955135|FG000|STARTED|Overall Study||41
9843343|NCT00830180|10955135|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19
9843344|NCT00830180|10955135|FG000|Received Placebo in Parent Study A4091003|Overall Study||22
9724581|NCT00090285|10824346|FG002|Vaccinated|Base Study Vaccination Period||0
9724582|NCT00090285|10824347|FG003|Vaccinated|Base Study Vaccination Period||0
9724583|NCT00090285|10824348|FG004|Vaccinated|Base Study Vaccination Period||0
9724584|NCT00090285|10824349|FG005|Vaccinated|Base Study Vaccination Period||0
9724585|NCT00090285|10824344|FG000|COMPLETED|Base Study Vaccination Period||1818
9724586|NCT00090285|10824345|FG001|COMPLETED|Base Study Vaccination Period||1814
9724587|NCT00090285|10824346|FG002|COMPLETED|Base Study Vaccination Period||0
9724588|NCT00090285|10824347|FG003|COMPLETED|Base Study Vaccination Period||0
9724589|NCT00090285|10824348|FG004|COMPLETED|Base Study Vaccination Period||0
9724590|NCT00090285|10824349|FG005|COMPLETED|Base Study Vaccination Period||0
9724591|NCT00090285|10824344|FG000|NOT COMPLETED|Base Study Vaccination Period||214
9843345|NCT00830180|10955135|FG000|COMPLETED|Overall Study||15
10023198|NCT01854658|11146757|FG003|COMPLETED|Overall Study||165
9843346|NCT00830180|10955135|FG000|NOT COMPLETED|Overall Study||26
9843347|NCT00830232|10955143|FG000|STARTED|Overall Study||20
9843348|NCT00830232|10955144|FG001|STARTED|Overall Study||20
9843349|NCT00830232|10955143|FG000|COMPLETED|Overall Study||20
9843350|NCT00830232|10955144|FG001|COMPLETED|Overall Study||20
9843351|NCT00830232|10955143|FG000|NOT COMPLETED|Overall Study||0
9843352|NCT00830232|10955144|FG001|NOT COMPLETED|Overall Study||0
9843353|NCT00830284|10955150|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
9843354|NCT00830284|10955150|FG000|COMPLETED|Overall Study||10
9843355|NCT00830284|10955150|FG000|NOT COMPLETED|Overall Study||2
9843356|NCT00830310|10955154|FG000|STARTED|Overall Study||43
9843357|NCT00830310|10955154|FG000|COMPLETED|Overall Study||30
9843358|NCT00830310|10955154|FG000|NOT COMPLETED|Overall Study||13
9843359|NCT00830362|10955160|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
9843360|NCT00830362|10955161|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
9843361|NCT00830362|10955160|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
9843362|NCT00830362|10955161|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
9843363|NCT00830362|10955160|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
9843364|NCT00830362|10955161|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
9843365|NCT00830362|10955160|FG000|NOT COMPLETED|Overall Study||4
9843366|NCT00830362|10955161|FG001|NOT COMPLETED|Overall Study||4
9843367|NCT00830375|10955167|FG000|STARTED|Overall Study||10
9843368|NCT00830375|10955167|FG000|COMPLETED|Overall Study||9
9843369|NCT00830375|10955167|FG000|NOT COMPLETED|Overall Study||1
9843370|NCT00830388|10955171|FG000|STARTED|Overall Study||11
9843371|NCT00830388|10955171|FG000|COMPLETED|Overall Study||11
9843372|NCT00830388|10955171|FG000|NOT COMPLETED|Overall Study||0
9843373|NCT00830440|10955177|FG000|STARTED|Overall Study||32
9843374|NCT00830440|10955178|FG001|STARTED|Overall Study||11
9843375|NCT00830440|10955177|FG000|Received Device|Overall Study||26
9843376|NCT00830440|10955178|FG001|Received Device|Overall Study||0
9843377|NCT00830440|10955177|FG000|Completed 12 Week Follow up|Overall Study||24
9843378|NCT00830440|10955178|FG001|Completed 12 Week Follow up|Overall Study||11
9843379|NCT00830440|10955177|FG000|Completed 16 Week Follow up|Overall Study||4
9843380|NCT00830440|10955178|FG001|Completed 16 Week Follow up|Overall Study||0
9843381|NCT00830440|10955177|FG000|Completed 24 Week Follow up|Overall Study||3
9843382|NCT00830440|10955178|FG001|Completed 24 Week Follow up|Overall Study||0
9960470|NCT01468207|11080160|FG000|NOT COMPLETED|Treatment Period 2||0
9960471|NCT01468207|11080161|FG001|NOT COMPLETED|Treatment Period 2||0
9960472|NCT01468207|11080162|FG002|NOT COMPLETED|Treatment Period 2||52
9960473|NCT01468207|11080163|FG003|NOT COMPLETED|Treatment Period 2||27
9960474|NCT01468207|11080164|FG004|NOT COMPLETED|Treatment Period 2||21
9960475|NCT01468207|11080165|FG005|NOT COMPLETED|Treatment Period 2||20
9960476|NCT01468233|11080185|FG000|STARTED|Treatment Period 1||163
9960477|NCT01468233|11080186|FG001|STARTED|Treatment Period 1||163
9960478|NCT01468233|11080187|FG002|STARTED|Treatment Period 1||0
9960479|NCT01468233|11080188|FG003|STARTED|Treatment Period 1||0
9960480|NCT01468233|11080189|FG004|STARTED|Treatment Period 1||0
9960481|NCT01468233|11080190|FG005|STARTED|Treatment Period 1||0
9960482|NCT01468233|11080185|FG000|COMPLETED|Treatment Period 1||151
9960483|NCT01468233|11080186|FG001|COMPLETED|Treatment Period 1||155
9960484|NCT01468233|11080187|FG002|COMPLETED|Treatment Period 1||0
9960485|NCT01468233|11080188|FG003|COMPLETED|Treatment Period 1||0
9843383|NCT00830440|10955177|FG000|COMPLETED|Overall Study||24
9843384|NCT00830440|10955178|FG001|COMPLETED|Overall Study||11
9843385|NCT00830440|10955177|FG000|NOT COMPLETED|Overall Study||8
9843386|NCT00830440|10955178|FG001|NOT COMPLETED|Overall Study||0
9843387|NCT00830518|10955187|FG000|STARTED|Overall Study||46
9843388|NCT00830518|10955188|FG001|STARTED|Overall Study||11
9843389|NCT00830518|10955187|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
9843390|NCT00830518|10955188|FG001|COMPLETED|Overall Study||0
9843391|NCT00830518|10955187|FG000|NOT COMPLETED|Overall Study||46
9680468|NCT01706705|10780133|FG000|STARTED|Overall Study||57
9680469|NCT01706705|10780133|FG000|COMPLETED|Overall Study||37
9680470|NCT01706705|10780133|FG000|NOT COMPLETED|Overall Study||20
9680471|NCT01609842|10780142|FG000|STARTED|Pre-Intervention Control||0
9680472|NCT01609842|10780143|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
9680473|NCT01609842|10780142|FG000|COMPLETED|Pre-Intervention Control||0
9680474|NCT01609842|10780143|FG001|COMPLETED|Pre-Intervention Control||6081
9843392|NCT00830518|10955188|FG001|NOT COMPLETED|Overall Study||11
9843393|NCT00830596|10955198|FG000|STARTED|Overall Study||74
9843394|NCT00830596|10955199|FG001|STARTED|Overall Study||74
9843395|NCT00830596|10955200|FG002|STARTED|Overall Study||73
9843396|NCT00830596|10955198|FG000|COMPLETED|Overall Study||72
9843397|NCT00830596|10955199|FG001|COMPLETED|Overall Study||72
9843398|NCT00830596|10955200|FG002|COMPLETED|Overall Study||67
9843399|NCT00830596|10955198|FG000|NOT COMPLETED|Overall Study||2
9843400|NCT00830596|10955199|FG001|NOT COMPLETED|Overall Study||2
9843401|NCT00830596|10955200|FG002|NOT COMPLETED|Overall Study||6
9843402|NCT00830765|10955210|FG000|STARTED|Overall Study||73
9843403|NCT00830765|10955211|FG001|STARTED|Overall Study||71
9843404|NCT00830765|10955210|FG000|COMPLETED|Overall Study||70
9960486|NCT01468233|11080189|FG004|COMPLETED|Treatment Period 1||0
9960487|NCT01468233|11080190|FG005|COMPLETED|Treatment Period 1||0
9960488|NCT01468233|11080185|FG000|NOT COMPLETED|Treatment Period 1||12
9960489|NCT01468233|11080186|FG001|NOT COMPLETED|Treatment Period 1||8
9960490|NCT01468233|11080187|FG002|NOT COMPLETED|Treatment Period 1||0
9960491|NCT01468233|11080188|FG003|NOT COMPLETED|Treatment Period 1||0
9960492|NCT01468233|11080189|FG004|NOT COMPLETED|Treatment Period 1||0
9960493|NCT01468233|11080190|FG005|NOT COMPLETED|Treatment Period 1||0
9960494|NCT01468233|11080185|FG000|STARTED|Treatment Period 2||0
9960495|NCT01468233|11080186|FG001|STARTED|Treatment Period 2||0
9960496|NCT01468233|11080187|FG002|STARTED|Treatment Period 2||151
9960497|NCT01468233|11080188|FG003|STARTED|Treatment Period 2||51
9960498|NCT01468233|11080189|FG004|STARTED|Treatment Period 2||53
9960499|NCT01468233|11080190|FG005|STARTED|Treatment Period 2||51
9960500|NCT01468233|11080185|FG000|COMPLETED|Treatment Period 2||0
9960501|NCT01468233|11080186|FG001|COMPLETED|Treatment Period 2||0
9960502|NCT01468233|11080187|FG002|COMPLETED|Treatment Period 2||40
9960503|NCT01468233|11080188|FG003|COMPLETED|Treatment Period 2||23
9960504|NCT01468233|11080189|FG004|COMPLETED|Treatment Period 2||25
9960505|NCT01468233|11080190|FG005|COMPLETED|Treatment Period 2||28
9960506|NCT01468233|11080185|FG000|NOT COMPLETED|Treatment Period 2||0
9960507|NCT01468233|11080186|FG001|NOT COMPLETED|Treatment Period 2||0
9960508|NCT01468233|11080187|FG002|NOT COMPLETED|Treatment Period 2||111
9960509|NCT01468233|11080188|FG003|NOT COMPLETED|Treatment Period 2||28
9960510|NCT01468233|11080189|FG004|NOT COMPLETED|Treatment Period 2||28
9960511|NCT01468233|11080190|FG005|NOT COMPLETED|Treatment Period 2||23
9960512|NCT01468311|11080208|FG000|STARTED|Overall Study||6
9960513|NCT01468311|11080208|FG000|COMPLETED|Overall Study||4
9960514|NCT01468311|11080208|FG000|NOT COMPLETED|Overall Study||2
9960515|NCT01468337|11080212|FG000|STARTED|Overall Study||5
9960516|NCT01468337|11080212|FG000|Week 2|Overall Study||5
9960517|NCT01468337|11080212|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
9960518|NCT01468337|11080212|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
9960519|NCT01468337|11080212|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
9960520|NCT01468337|11080212|FG000|COMPLETED|Overall Study||5
9960521|NCT01468337|11080212|FG000|NOT COMPLETED|Overall Study||0
9960522|NCT01468350|11080220|FG000|STARTED|(PART A) Day 1, Day 3||6
9960523|NCT01468350|11080221|FG001|STARTED|(PART A) Day 1, Day 3||5
9960524|NCT01468350|11080222|FG002|STARTED|(PART A) Day 1, Day 3||0
9960525|NCT01468350|11080223|FG003|STARTED|(PART A) Day 1, Day 3||0
9960526|NCT01468350|11080220|FG000|COMPLETED|(PART A) Day 1, Day 3||6
9960527|NCT01468350|11080221|FG001|COMPLETED|(PART A) Day 1, Day 3||5
9960528|NCT01468350|11080222|FG002|COMPLETED|(PART A) Day 1, Day 3||0
9960529|NCT01468350|11080223|FG003|COMPLETED|(PART A) Day 1, Day 3||0
9960530|NCT01468350|11080220|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0
9960531|NCT01468350|11080221|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0
9960532|NCT01468350|11080222|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0
9960533|NCT01468350|11080223|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0
9960534|NCT01468350|11080220|FG000|STARTED|(PART B) Day 1, Day 15||0
9843405|NCT00830765|10955211|FG001|COMPLETED|Overall Study||69
9843406|NCT00830765|10955210|FG000|NOT COMPLETED|Overall Study||3
9843407|NCT00830765|10955211|FG001|NOT COMPLETED|Overall Study||2
9960535|NCT01468350|11080221|FG001|STARTED|(PART B) Day 1, Day 15||0
9960536|NCT01468350|11080222|FG002|STARTED|(PART B) Day 1, Day 15||12
9960537|NCT01468350|11080223|FG003|STARTED|(PART B) Day 1, Day 15||12
9960538|NCT01468350|11080220|FG000|COMPLETED|(PART B) Day 1, Day 15||0
9680475|NCT01609842|10780142|FG000|NOT COMPLETED|Pre-Intervention Control||0
9680476|NCT01609842|10780143|FG001|NOT COMPLETED|Pre-Intervention Control||0
9680477|NCT01609842|10780142|FG000|STARTED|Post-Intervention Control||0
9680478|NCT01609842|10780143|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
9680479|NCT01609842|10780142|FG000|COMPLETED|Post-Intervention Control||0
9680480|NCT01609842|10780143|FG001|COMPLETED|Post-Intervention Control||2917
9680481|NCT01609842|10780142|FG000|NOT COMPLETED|Post-Intervention Control||0
9680482|NCT01609842|10780143|FG001|NOT COMPLETED|Post-Intervention Control||0
9680483|NCT01609842|10780142|FG000|STARTED|Concurrent Intervention Control||708
9680484|NCT01609842|10780143|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
9680485|NCT01609842|10780142|FG000|COMPLETED|Concurrent Intervention Control||706
9680486|NCT01609842|10780143|FG001|COMPLETED|Concurrent Intervention Control||4869
9680487|NCT01609842|10780142|FG000|NOT COMPLETED|Concurrent Intervention Control||2
9680488|NCT01609842|10780143|FG001|NOT COMPLETED|Concurrent Intervention Control||0
9680489|NCT01341600|10780156|FG000|STARTED|Clopidogrel 75 mg||6
9680490|NCT01341600|10780157|FG001|STARTED|Clopidogrel 75 mg||6
9680491|NCT01341600|10780158|FG002|STARTED|Clopidogrel 75 mg||6
9680492|NCT01341600|10780156|FG000|COMPLETED|Clopidogrel 75 mg||6
9680493|NCT01341600|10780157|FG001|COMPLETED|Clopidogrel 75 mg||6
9680494|NCT01341600|10780158|FG002|COMPLETED|Clopidogrel 75 mg||6
9680495|NCT01341600|10780156|FG000|NOT COMPLETED|Clopidogrel 75 mg||0
9680496|NCT01341600|10780157|FG001|NOT COMPLETED|Clopidogrel 75 mg||0
9680497|NCT01341600|10780158|FG002|NOT COMPLETED|Clopidogrel 75 mg||0
9680498|NCT01341600|10780156|FG000|STARTED|Clopidogrel 150 mg||6
9680499|NCT01341600|10780157|FG001|STARTED|Clopidogrel 150 mg||6
9680500|NCT01341600|10780158|FG002|STARTED|Clopidogrel 150 mg||6
9680501|NCT01341600|10780156|FG000|COMPLETED|Clopidogrel 150 mg||6
9680502|NCT01341600|10780157|FG001|COMPLETED|Clopidogrel 150 mg||6
9680503|NCT01341600|10780158|FG002|COMPLETED|Clopidogrel 150 mg||6
9680504|NCT01341600|10780156|FG000|NOT COMPLETED|Clopidogrel 150 mg||0
9680505|NCT01341600|10780157|FG001|NOT COMPLETED|Clopidogrel 150 mg||0
9680506|NCT01341600|10780158|FG002|NOT COMPLETED|Clopidogrel 150 mg||0
9680507|NCT01341600|10780156|FG000|STARTED|Clopidogrel 225 mg||6
9680508|NCT01341600|10780157|FG001|STARTED|Clopidogrel 225 mg||6
9680509|NCT01341600|10780158|FG002|STARTED|Clopidogrel 225 mg||6
9680510|NCT01341600|10780156|FG000|COMPLETED|Clopidogrel 225 mg||6
9680511|NCT01341600|10780157|FG001|COMPLETED|Clopidogrel 225 mg||6
9680512|NCT01341600|10780158|FG002|COMPLETED|Clopidogrel 225 mg||6
9680513|NCT01341600|10780156|FG000|NOT COMPLETED|Clopidogrel 225 mg||0
9680514|NCT01341600|10780157|FG001|NOT COMPLETED|Clopidogrel 225 mg||0
9680515|NCT01341600|10780158|FG002|NOT COMPLETED|Clopidogrel 225 mg||0
9680516|NCT01341600|10780156|FG000|STARTED|Clopidogrel Plus Omeprazole||5
9680517|NCT01341600|10780157|FG001|STARTED|Clopidogrel Plus Omeprazole||5
9680518|NCT01341600|10780158|FG002|STARTED|Clopidogrel Plus Omeprazole||4
9680519|NCT01341600|10780156|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5
9680520|NCT01341600|10780157|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5
9680521|NCT01341600|10780158|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4
9680522|NCT01341600|10780156|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
9680523|NCT01341600|10780157|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
9680524|NCT01341600|10780158|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
9680525|NCT01044901|10780168|FG000|STARTED|Overall Study||38
9680526|NCT01044901|10780169|FG001|STARTED|Overall Study||13
9680527|NCT01044901|10780168|FG000|COMPLETED|Overall Study||38
9680528|NCT01044901|10780169|FG001|COMPLETED|Overall Study||13
10023199|NCT01854658|11146754|FG000|NOT COMPLETED|Overall Study||93
10023200|NCT01854658|11146755|FG001|NOT COMPLETED|Overall Study||75
9680529|NCT01044901|10780168|FG000|NOT COMPLETED|Overall Study||0
9680530|NCT01044901|10780169|FG001|NOT COMPLETED|Overall Study||0
9843408|NCT00830791|10955223|FG000|STARTED|Overall Study||8
9843409|NCT00830791|10955224|FG001|STARTED|Overall Study||8
9843410|NCT00830791|10955225|FG002|STARTED|Overall Study||8
9843411|NCT00830791|10955226|FG003|STARTED|Overall Study||8
9843412|NCT00830791|10955227|FG004|STARTED|Overall Study||0
9843413|NCT00830791|10955228|FG005|STARTED|Overall Study||0
9843414|NCT00830791|10955223|FG000|COMPLETED|Overall Study||8
9843415|NCT00830791|10955224|FG001|COMPLETED|Overall Study||8
10023201|NCT01854658|11146756|FG002|NOT COMPLETED|Overall Study||80
10023202|NCT01854658|11146757|FG003|NOT COMPLETED|Overall Study||59
9680543|NCT00003479|10780193|FG000|STARTED|Overall Study||9
9680544|NCT00003479|10780193|FG000|COMPLETED|Overall Study||6
9680545|NCT00003479|10780193|FG000|NOT COMPLETED|Overall Study||3
9724592|NCT00090285|10824345|FG001|NOT COMPLETED|Base Study Vaccination Period||219
9724593|NCT00090285|10824346|FG002|NOT COMPLETED|Base Study Vaccination Period||0
9724594|NCT00090285|10824347|FG003|NOT COMPLETED|Base Study Vaccination Period||0
9724595|NCT00090285|10824348|FG004|NOT COMPLETED|Base Study Vaccination Period||0
9724596|NCT00090285|10824349|FG005|NOT COMPLETED|Base Study Vaccination Period||0
9724597|NCT00090285|10824344|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
9724598|NCT00090285|10824345|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
9724599|NCT00090285|10824346|FG002|STARTED|Base Study Follow-up Period||0
9724600|NCT00090285|10824347|FG003|STARTED|Base Study Follow-up Period||0
9724601|NCT00090285|10824348|FG004|STARTED|Base Study Follow-up Period||0
9724602|NCT00090285|10824349|FG005|STARTED|Base Study Follow-up Period||0
9680546|NCT04160195|10780199|FG000|STARTED|Overall Study||2
9680547|NCT04160195|10780200|FG001|STARTED|Overall Study||0
9680548|NCT04160195|10780199|FG000|COMPLETED|Overall Study||1
9680549|NCT04160195|10780200|FG001|COMPLETED|Overall Study||0
9680550|NCT04160195|10780199|FG000|NOT COMPLETED|Overall Study||1
9680551|NCT04160195|10780200|FG001|NOT COMPLETED|Overall Study||0
9680552|NCT04159701|10780210|FG000|STARTED|Period 1: Treatment Period||39
9680553|NCT04159701|10780211|FG001|STARTED|Period 1: Treatment Period||13
9680554|NCT04159701|10780210|FG000|Received at Least One Dose of Study Drug|Period 1: Treatment Period||39
9680555|NCT04159701|10780211|FG001|Received at Least One Dose of Study Drug|Period 1: Treatment Period||13
9680556|NCT04159701|10780210|FG000|COMPLETED|Period 1: Treatment Period||31
9680557|NCT04159701|10780211|FG001|COMPLETED|Period 1: Treatment Period||12
9680558|NCT04159701|10780210|FG000|NOT COMPLETED|Period 1: Treatment Period||8
9680559|NCT04159701|10780211|FG001|NOT COMPLETED|Period 1: Treatment Period||1
9680560|NCT04159701|10780210|FG000|STARTED|Washout Period||31
9680561|NCT04159701|10780211|FG001|STARTED|Washout Period||12
9680562|NCT04159701|10780210|FG000|COMPLETED|Washout Period||18
9680563|NCT04159701|10780211|FG001|COMPLETED|Washout Period||8
9680564|NCT04159701|10780210|FG000|NOT COMPLETED|Washout Period||13
9680565|NCT04159701|10780211|FG001|NOT COMPLETED|Washout Period||4
9680566|NCT04159701|10780210|FG000|STARTED|Period 2: Treatment Period (Crossover)||18
9680567|NCT04159701|10780211|FG001|STARTED|Period 2: Treatment Period (Crossover)||8
9680568|NCT04159701|10780210|FG000|COMPLETED|Period 2: Treatment Period (Crossover)||18
9680569|NCT04159701|10780211|FG001|COMPLETED|Period 2: Treatment Period (Crossover)||5
9680570|NCT04159701|10780210|FG000|NOT COMPLETED|Period 2: Treatment Period (Crossover)||0
9680571|NCT04159701|10780211|FG001|NOT COMPLETED|Period 2: Treatment Period (Crossover)||3
9680572|NCT04159701|10780210|FG000|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|29
9680573|NCT04159701|10780211|FG001|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|9
9680574|NCT04159701|10780210|FG000|COMPLETED|Post-treatment Follow-up||19
9680575|NCT04159701|10780211|FG001|COMPLETED|Post-treatment Follow-up||6
9680576|NCT04159701|10780210|FG000|NOT COMPLETED|Post-treatment Follow-up||10
9680577|NCT04159701|10780211|FG001|NOT COMPLETED|Post-treatment Follow-up||3
9680578|NCT04152447|10780223|FG000|STARTED|Overall Study||16
9680579|NCT04152447|10780224|FG001|STARTED|Overall Study||19
9680580|NCT04152447|10780223|FG000|COMPLETED|Overall Study||13
9680581|NCT04152447|10780224|FG001|COMPLETED|Overall Study||14
9680582|NCT04152447|10780223|FG000|NOT COMPLETED|Overall Study||3
9680583|NCT04152447|10780224|FG001|NOT COMPLETED|Overall Study||5
9843416|NCT00830791|10955225|FG002|COMPLETED|Overall Study||8
9843417|NCT00830791|10955226|FG003|COMPLETED|Overall Study||8
9843418|NCT00830791|10955227|FG004|COMPLETED|Overall Study||0
9843419|NCT00830791|10955228|FG005|COMPLETED|Overall Study||0
9843420|NCT00830791|10955223|FG000|NOT COMPLETED|Overall Study||0
9843421|NCT00830791|10955224|FG001|NOT COMPLETED|Overall Study||0
9843422|NCT00830791|10955225|FG002|NOT COMPLETED|Overall Study||0
9843423|NCT00830791|10955226|FG003|NOT COMPLETED|Overall Study||0
9843424|NCT00830791|10955227|FG004|NOT COMPLETED|Overall Study||0
9843425|NCT00830791|10955228|FG005|NOT COMPLETED|Overall Study||0
9843426|NCT00830804|10955241|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
9843427|NCT00830804|10955241|FG000|COMPLETED|Overall Study||97
9843428|NCT00830804|10955241|FG000|NOT COMPLETED|Overall Study||15
9843429|NCT00830869|10955258|FG000|STARTED|Period 1: Part 1||1
9843430|NCT00830869|10955259|FG001|STARTED|Period 1: Part 1||1
9680623|NCT04460183|10780269|FG000|STARTED|Overall Study||14
9680624|NCT04460183|10780270|FG001|STARTED|Overall Study||5
9680625|NCT04460183|10780269|FG000|COMPLETED|Overall Study||10
9680626|NCT04460183|10780270|FG001|COMPLETED|Overall Study||4
9680627|NCT04460183|10780269|FG000|NOT COMPLETED|Overall Study||4
9680628|NCT04460183|10780270|FG001|NOT COMPLETED|Overall Study||1
9680629|NCT04421027|10780278|FG000|STARTED|Overall Study||761
9680630|NCT04421027|10780279|FG001|STARTED|Overall Study||764
9680631|NCT04421027|10780278|FG000|Received at Least One Dose of Study Drug|Overall Study||752
9680632|NCT04421027|10780279|FG001|Received at Least One Dose of Study Drug|Overall Study||750
9680633|NCT04421027|10780278|FG000|COMPLETED|Overall Study||604
9680634|NCT04421027|10780279|FG001|COMPLETED|Overall Study||644
9680635|NCT04421027|10780278|FG000|NOT COMPLETED|Overall Study||157
9680636|NCT04421027|10780279|FG001|NOT COMPLETED|Overall Study||120
9843431|NCT00830869|10955260|FG002|STARTED|Period 1: Part 1||1
9843432|NCT00830869|10955261|FG003|STARTED|Period 1: Part 1||7
9680640|NCT03831360|10780293|FG000|STARTED|Overall Study||15
9680641|NCT03831360|10780294|FG001|STARTED|Overall Study||15
9680642|NCT03831360|10780293|FG000|COMPLETED|Overall Study||12
9680643|NCT03831360|10780294|FG001|COMPLETED|Overall Study||14
9680644|NCT03831360|10780293|FG000|NOT COMPLETED|Overall Study||3
9680645|NCT03831360|10780294|FG001|NOT COMPLETED|Overall Study||1
9680646|NCT03829332|10780302|FG000|STARTED|Overall Study||309
9680647|NCT03829332|10780303|FG001|STARTED|Overall Study||314
9680648|NCT03829332|10780302|FG000|Treated|Overall Study||309
9680649|NCT03829332|10780303|FG001|Treated|Overall Study||312
9680584|NCT04150107|10780232|FG000|STARTED|Period 1- Placebo run-in (All Patients)||14
9680585|NCT04150107|10780233|FG001|STARTED|Period 1- Placebo run-in (All Patients)||16
9680586|NCT04150107|10780232|FG000|COMPLETED|Period 1- Placebo run-in (All Patients)||14
9680587|NCT04150107|10780233|FG001|COMPLETED|Period 1- Placebo run-in (All Patients)||16
9680588|NCT04150107|10780232|FG000|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0
9680589|NCT04150107|10780233|FG001|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0
9680590|NCT04150107|10780232|FG000|STARTED|Period 2- Either Treatment A or B||14
9680591|NCT04150107|10780233|FG001|STARTED|Period 2- Either Treatment A or B||16
9680592|NCT04150107|10780232|FG000|COMPLETED|Period 2- Either Treatment A or B||14
9680593|NCT04150107|10780233|FG001|COMPLETED|Period 2- Either Treatment A or B||16
9680594|NCT04150107|10780232|FG000|NOT COMPLETED|Period 2- Either Treatment A or B||0
9680595|NCT04150107|10780233|FG001|NOT COMPLETED|Period 2- Either Treatment A or B||0
9680596|NCT04150107|10780232|FG000|STARTED|Period 3 Crossover-Treatment B or A||14
9680597|NCT04150107|10780233|FG001|STARTED|Period 3 Crossover-Treatment B or A||16
9680598|NCT04150107|10780232|FG000|COMPLETED|Period 3 Crossover-Treatment B or A||12
9680599|NCT04150107|10780233|FG001|COMPLETED|Period 3 Crossover-Treatment B or A||15
9680600|NCT04150107|10780232|FG000|NOT COMPLETED|Period 3 Crossover-Treatment B or A||2
9680601|NCT04150107|10780233|FG001|NOT COMPLETED|Period 3 Crossover-Treatment B or A||1
9680650|NCT03829332|10780302|FG000|COMPLETED|Overall Study||0
9680651|NCT03829332|10780303|FG001|COMPLETED|Overall Study||0
9680652|NCT03829332|10780302|FG000|NOT COMPLETED|Overall Study||309
9680653|NCT03829332|10780303|FG001|NOT COMPLETED|Overall Study||314
9680654|NCT03813121|10780311|FG000|STARTED|Overall Study||4
9680655|NCT03813121|10780312|FG001|STARTED|Overall Study||6
9680656|NCT03813121|10780311|FG000|COMPLETED|Overall Study||4
9680657|NCT03813121|10780312|FG001|COMPLETED|Overall Study||6
9680658|NCT03813121|10780311|FG000|NOT COMPLETED|Overall Study||0
9680659|NCT03813121|10780312|FG001|NOT COMPLETED|Overall Study||0
9724603|NCT00090285|10824344|FG000|COMPLETED|Base Study Follow-up Period||1487
9724604|NCT00090285|10824345|FG001|COMPLETED|Base Study Follow-up Period||1479
9724605|NCT00090285|10824346|FG002|COMPLETED|Base Study Follow-up Period||0
9724606|NCT00090285|10824347|FG003|COMPLETED|Base Study Follow-up Period||0
9724607|NCT00090285|10824348|FG004|COMPLETED|Base Study Follow-up Period||0
9724608|NCT00090285|10824349|FG005|COMPLETED|Base Study Follow-up Period||0
9960539|NCT01468350|11080221|FG001|COMPLETED|(PART B) Day 1, Day 15||0
9960540|NCT01468350|11080222|FG002|COMPLETED|(PART B) Day 1, Day 15||12
9960541|NCT01468350|11080223|FG003|COMPLETED|(PART B) Day 1, Day 15||12
9960542|NCT01468350|11080220|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0
9960543|NCT01468350|11080221|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0
9960544|NCT01468350|11080222|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0
9960545|NCT01468350|11080223|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0
9960546|NCT01468454|11080233|FG000|STARTED|Overall Study||128
9960547|NCT01468454|11080233|FG000|PETs Completed|Overall Study||128
9960548|NCT01468454|11080233|FG000|Had Both PET and Surgery|Overall Study||119
9960549|NCT01468454|11080233|FG000|COMPLETED|Overall Study||119
9960550|NCT01468454|11080233|FG000|NOT COMPLETED|Overall Study||9
9960551|NCT01468532|11080238|FG000|STARTED|Overall Study||18
9960552|NCT01468532|11080238|FG000|COMPLETED|Overall Study||18
10023203|NCT01854697|11146772|FG000|STARTED|Overall Study||69
9680678|NCT03635099|10780335|FG000|STARTED|Period 1||20
9680679|NCT03635099|10780336|FG001|STARTED|Period 1||40
9680680|NCT03635099|10780337|FG002|STARTED|Period 1||39
9680681|NCT03635099|10780338|FG003|STARTED|Period 1||39
9680682|NCT03635099|10780339|FG004|STARTED|Period 1||40
9680683|NCT03635099|10780340|FG005|STARTED|Period 1||10
9680684|NCT03635099|10780341|FG006|STARTED|Period 1||44
9680685|NCT03635099|10780342|FG007|STARTED|Period 1||42
9680686|NCT03635099|10780335|FG000|Full Analysis Set (FAS)|Period 1||20
9680687|NCT03635099|10780336|FG001|Full Analysis Set (FAS)|Period 1||40
9680688|NCT03635099|10780337|FG002|Full Analysis Set (FAS)|Period 1||39
9680689|NCT03635099|10780338|FG003|Full Analysis Set (FAS)|Period 1||39
9680690|NCT03635099|10780339|FG004|Full Analysis Set (FAS)|Period 1||40
9680691|NCT03635099|10780340|FG005|Full Analysis Set (FAS)|Period 1||10
9680692|NCT03635099|10780341|FG006|Full Analysis Set (FAS)|Period 1||43
9680693|NCT03635099|10780342|FG007|Full Analysis Set (FAS)|Period 1||42
9680694|NCT03635099|10780335|FG000|COMPLETED|Period 1||16
9680695|NCT03635099|10780336|FG001|COMPLETED|Period 1||37
9680696|NCT03635099|10780337|FG002|COMPLETED|Period 1||31
9680697|NCT03635099|10780338|FG003|COMPLETED|Period 1||34
9680698|NCT03635099|10780339|FG004|COMPLETED|Period 1||37
9680699|NCT03635099|10780340|FG005|COMPLETED|Period 1||9
9680700|NCT03635099|10780341|FG006|COMPLETED|Period 1||40
9680701|NCT03635099|10780342|FG007|COMPLETED|Period 1||40
9680702|NCT03635099|10780335|FG000|NOT COMPLETED|Period 1||4
9680703|NCT03635099|10780336|FG001|NOT COMPLETED|Period 1||3
9680704|NCT03635099|10780337|FG002|NOT COMPLETED|Period 1||8
9680705|NCT03635099|10780338|FG003|NOT COMPLETED|Period 1||5
9680706|NCT03635099|10780339|FG004|NOT COMPLETED|Period 1||3
9680707|NCT03635099|10780340|FG005|NOT COMPLETED|Period 1||1
9680708|NCT03635099|10780341|FG006|NOT COMPLETED|Period 1||4
9680709|NCT03635099|10780342|FG007|NOT COMPLETED|Period 1||2
9680710|NCT03635099|10780335|FG000|STARTED|Not Eligible for Period 2||16
9680711|NCT03635099|10780336|FG001|STARTED|Not Eligible for Period 2||37
9680712|NCT03635099|10780337|FG002|STARTED|Not Eligible for Period 2||31
9680713|NCT03635099|10780338|FG003|STARTED|Not Eligible for Period 2||34
9680714|NCT03635099|10780339|FG004|STARTED|Not Eligible for Period 2||37
9680715|NCT03635099|10780340|FG005|STARTED|Not Eligible for Period 2||9
9680716|NCT03635099|10780341|FG006|STARTED|Not Eligible for Period 2||40
9680717|NCT03635099|10780342|FG007|STARTED|Not Eligible for Period 2||40
9680718|NCT03635099|10780335|FG000|COMPLETED|Not Eligible for Period 2||15
9680719|NCT03635099|10780336|FG001|COMPLETED|Not Eligible for Period 2||37
9680720|NCT03635099|10780337|FG002|COMPLETED|Not Eligible for Period 2||31
9680721|NCT03635099|10780338|FG003|COMPLETED|Not Eligible for Period 2||33
9680722|NCT03635099|10780339|FG004|COMPLETED|Not Eligible for Period 2||37
9680723|NCT03635099|10780340|FG005|COMPLETED|Not Eligible for Period 2||0
9680724|NCT03635099|10780341|FG006|COMPLETED|Not Eligible for Period 2||0
9680725|NCT03635099|10780342|FG007|COMPLETED|Not Eligible for Period 2||0
9680726|NCT03635099|10780335|FG000|NOT COMPLETED|Not Eligible for Period 2||1
10023204|NCT01854697|11146773|FG001|STARTED|Overall Study||34
10023205|NCT01854697|11146774|FG002|STARTED|Overall Study||84
10023206|NCT01854697|11146775|FG003|STARTED|Overall Study||83
10023207|NCT01854697|11146776|FG004|STARTED|Overall Study||41
9680727|NCT03635099|10780336|FG001|NOT COMPLETED|Not Eligible for Period 2||0
9680728|NCT03635099|10780337|FG002|NOT COMPLETED|Not Eligible for Period 2||0
9680729|NCT03635099|10780338|FG003|NOT COMPLETED|Not Eligible for Period 2||1
9680730|NCT03635099|10780339|FG004|NOT COMPLETED|Not Eligible for Period 2||0
9680731|NCT03635099|10780340|FG005|NOT COMPLETED|Not Eligible for Period 2||9
9680732|NCT03635099|10780341|FG006|NOT COMPLETED|Not Eligible for Period 2||40
9843433|NCT00830869|10955262|FG004|STARTED|Period 1: Part 1||4
9843434|NCT00830869|10955263|FG005|STARTED|Period 1: Part 1||6
9843435|NCT00830869|10955264|FG006|STARTED|Period 1: Part 1||3
10023208|NCT01854697|11146772|FG000|COMPLETED|Overall Study||63
9680733|NCT03635099|10780342|FG007|NOT COMPLETED|Not Eligible for Period 2||40
9680734|NCT03635099|10780335|FG000|STARTED|Eligible for Period 2||15
9680735|NCT03635099|10780336|FG001|STARTED|Eligible for Period 2||37
9680736|NCT03635099|10780337|FG002|STARTED|Eligible for Period 2||31
9680737|NCT03635099|10780338|FG003|STARTED|Eligible for Period 2||33
9680738|NCT03635099|10780339|FG004|STARTED|Eligible for Period 2||37
10023209|NCT01854697|11146773|FG001|COMPLETED|Overall Study||31
10023210|NCT01854697|11146774|FG002|COMPLETED|Overall Study||82
9680739|NCT03635099|10780340|FG005|STARTED|Eligible for Period 2||0
9843436|NCT00830869|10955265|FG007|STARTED|Period 1: Part 1||0
9680740|NCT03635099|10780341|FG006|STARTED|Eligible for Period 2||0
9680741|NCT03635099|10780342|FG007|STARTED|Eligible for Period 2||0
9680742|NCT03635099|10780335|FG000|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|15
9680743|NCT03635099|10780336|FG001|Switching Patients|Eligible for Period 2|Switched to the 'BI 50 mg' dose group.|35
9680744|NCT03635099|10780337|FG002|Switching Patients|Eligible for Period 2|Switched to the 'BI 100 mg' dose group.|21
9680745|NCT03635099|10780338|FG003|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|25
9680746|NCT03635099|10780339|FG004|Switching Patients|Eligible for Period 2||0
9680747|NCT03635099|10780340|FG005|Switching Patients|Eligible for Period 2||0
9680748|NCT03635099|10780341|FG006|Switching Patients|Eligible for Period 2||0
9680749|NCT03635099|10780342|FG007|Switching Patients|Eligible for Period 2||0
9680750|NCT03635099|10780335|FG000|Non Switching Patients|Eligible for Period 2||0
9680751|NCT03635099|10780336|FG001|Non Switching Patients|Eligible for Period 2||2
9680752|NCT03635099|10780337|FG002|Non Switching Patients|Eligible for Period 2||10
9680753|NCT03635099|10780338|FG003|Non Switching Patients|Eligible for Period 2||8
9843437|NCT00830869|10955266|FG008|STARTED|Period 1: Part 1||0
9843438|NCT00830869|10955267|FG009|STARTED|Period 1: Part 1||0
9843439|NCT00830869|10955268|FG010|STARTED|Period 1: Part 1||0
9843440|NCT00830869|10955269|FG011|STARTED|Period 1: Part 1||0
9843441|NCT00830869|10955258|FG000|COMPLETED|Period 1: Part 1||0
9843442|NCT00830869|10955259|FG001|COMPLETED|Period 1: Part 1||0
9843443|NCT00830869|10955260|FG002|COMPLETED|Period 1: Part 1||0
9843444|NCT00830869|10955261|FG003|COMPLETED|Period 1: Part 1||0
9843445|NCT00830869|10955262|FG004|COMPLETED|Period 1: Part 1||0
9843446|NCT00830869|10955263|FG005|COMPLETED|Period 1: Part 1||0
9843447|NCT00830869|10955264|FG006|COMPLETED|Period 1: Part 1||0
9843448|NCT00830869|10955265|FG007|COMPLETED|Period 1: Part 1||0
9843449|NCT00830869|10955266|FG008|COMPLETED|Period 1: Part 1||0
9843450|NCT00830869|10955267|FG009|COMPLETED|Period 1: Part 1||0
9843451|NCT00830869|10955268|FG010|COMPLETED|Period 1: Part 1||0
9843452|NCT00830869|10955269|FG011|COMPLETED|Period 1: Part 1||0
9960553|NCT01468532|11080238|FG000|NOT COMPLETED|Overall Study||0
9960554|NCT01468558|11080242|FG000|STARTED|Overall Study||24
9960555|NCT01468558|11080242|FG000|COMPLETED|Overall Study||22
9960556|NCT01468558|11080242|FG000|NOT COMPLETED|Overall Study||2
9960557|NCT01468584|11080250|FG000|STARTED|Overall Study||10
9960558|NCT01468584|11080250|FG000|COMPLETED|Overall Study||10
9960559|NCT01468584|11080250|FG000|NOT COMPLETED|Overall Study||0
9960560|NCT01468597|11080254|FG000|STARTED|Overall Study||184
9960561|NCT01468597|11080254|FG000|COMPLETED|Overall Study||149
9960562|NCT01468597|11080254|FG000|NOT COMPLETED|Overall Study||35
9960563|NCT01468675|11080260|FG000|STARTED|Overall Study||2699
9960564|NCT01468675|11080261|FG001|STARTED|Overall Study||3376
9960565|NCT01468675|11080260|FG000|COMPLETED|Overall Study||1699
9960566|NCT01468675|11080261|FG001|COMPLETED|Overall Study||2004
9960567|NCT01468675|11080260|FG000|NOT COMPLETED|Overall Study||1000
9960568|NCT01468675|11080261|FG001|NOT COMPLETED|Overall Study||1372
9960569|NCT01468701|11080284|FG000|STARTED|Overall Study||4964
9960570|NCT01468701|11080285|FG001|STARTED|Overall Study||5103
9960571|NCT01468701|11080286|FG002|STARTED|Overall Study||1784
9960572|NCT01468701|11080287|FG003|STARTED|Overall Study||715
9960573|NCT01468701|11080288|FG004|STARTED|Overall Study||1736
9960574|NCT01468701|11080289|FG005|STARTED|Overall Study||128
9960575|NCT01468701|11080290|FG006|STARTED|Overall Study||1209
9960576|NCT01468701|11080291|FG007|STARTED|Overall Study||5
9960577|NCT01468701|11080292|FG008|STARTED|Overall Study||3879
9960578|NCT01468701|11080293|FG009|STARTED|Overall Study||4962
9960579|NCT01468701|11080294|FG010|STARTED|Overall Study||4054
9960580|NCT01468701|11080295|FG011|STARTED|Overall Study||4538
9960581|NCT01468701|11080296|FG012|STARTED|Overall Study||333
9960582|NCT01468701|11080297|FG013|STARTED|Overall Study||2182
9960583|NCT01468701|11080298|FG014|STARTED|Overall Study||214
9960584|NCT01468701|11080299|FG015|STARTED|Overall Study||1418
9960585|NCT01468701|11080300|FG016|STARTED|Overall Study||11
9960586|NCT01468701|11080284|FG000|All Eligible Patient|Overall Study||4873
9960587|NCT01468701|11080285|FG001|All Eligible Patient|Overall Study||4963
9960588|NCT01468701|11080286|FG002|All Eligible Patient|Overall Study||1755
9960589|NCT01468701|11080287|FG003|All Eligible Patient|Overall Study||703
9960590|NCT01468701|11080288|FG004|All Eligible Patient|Overall Study||1714
9960591|NCT01468701|11080289|FG005|All Eligible Patient|Overall Study||126
9680754|NCT03635099|10780339|FG004|Non Switching Patients|Eligible for Period 2||37
9680755|NCT03635099|10780340|FG005|Non Switching Patients|Eligible for Period 2||0
9843453|NCT00830869|10955258|FG000|NOT COMPLETED|Period 1: Part 1||1
9843454|NCT00830869|10955259|FG001|NOT COMPLETED|Period 1: Part 1||1
9960592|NCT01468701|11080290|FG006|All Eligible Patient|Overall Study||1170
9960593|NCT01468701|11080291|FG007|All Eligible Patient|Overall Study||4
9960594|NCT01468701|11080292|FG008|All Eligible Patient|Overall Study||3839
9843455|NCT00830869|10955260|FG002|NOT COMPLETED|Period 1: Part 1||1
9843456|NCT00830869|10955261|FG003|NOT COMPLETED|Period 1: Part 1||7
9960595|NCT01468701|11080293|FG009|All Eligible Patient|Overall Study||4836
9960596|NCT01468701|11080294|FG010|All Eligible Patient|Overall Study||4015
9960597|NCT01468701|11080295|FG011|All Eligible Patient|Overall Study||4505
9960598|NCT01468701|11080296|FG012|All Eligible Patient|Overall Study||332
9960599|NCT01468701|11080297|FG013|All Eligible Patient|Overall Study||2163
9960600|NCT01468701|11080298|FG014|All Eligible Patient|Overall Study||213
9960601|NCT01468701|11080299|FG015|All Eligible Patient|Overall Study||1386
9680756|NCT03635099|10780341|FG006|Non Switching Patients|Eligible for Period 2||0
9680757|NCT03635099|10780342|FG007|Non Switching Patients|Eligible for Period 2||0
9680758|NCT03635099|10780335|FG000|COMPLETED|Eligible for Period 2||0
9680759|NCT03635099|10780336|FG001|COMPLETED|Eligible for Period 2||2
9680760|NCT03635099|10780337|FG002|COMPLETED|Eligible for Period 2||10
9680761|NCT03635099|10780338|FG003|COMPLETED|Eligible for Period 2||8
9680762|NCT03635099|10780339|FG004|COMPLETED|Eligible for Period 2||37
9680763|NCT03635099|10780340|FG005|COMPLETED|Eligible for Period 2||0
9680764|NCT03635099|10780341|FG006|COMPLETED|Eligible for Period 2||0
9680765|NCT03635099|10780342|FG007|COMPLETED|Eligible for Period 2||0
9680766|NCT03635099|10780335|FG000|NOT COMPLETED|Eligible for Period 2||15
9680767|NCT03635099|10780336|FG001|NOT COMPLETED|Eligible for Period 2||35
9680768|NCT03635099|10780337|FG002|NOT COMPLETED|Eligible for Period 2||21
9680769|NCT03635099|10780338|FG003|NOT COMPLETED|Eligible for Period 2||25
9680770|NCT03635099|10780339|FG004|NOT COMPLETED|Eligible for Period 2||0
9680771|NCT03635099|10780340|FG005|NOT COMPLETED|Eligible for Period 2||0
9680772|NCT03635099|10780341|FG006|NOT COMPLETED|Eligible for Period 2||0
9680773|NCT03635099|10780342|FG007|NOT COMPLETED|Eligible for Period 2||0
9680774|NCT03635099|10780335|FG000|STARTED|Period 2||0
9680775|NCT03635099|10780336|FG001|STARTED|Period 2||2
9680776|NCT03635099|10780337|FG002|STARTED|Period 2|"Combination of period 1 dose groups: BI 50 mg and switched patients from dose Group BI 25 mg"|45
9680777|NCT03635099|10780338|FG003|STARTED|Period 2|"Combination of period 1 dose groups: BI 100 mg and switched patients from dose Group BI 50 mg"|29
9680778|NCT03635099|10780339|FG004|STARTED|Period 2|"Combination of period 1: BI 200mg, switched patients from dose Group BI 100 mg and Placebo."|77
9680779|NCT03635099|10780340|FG005|STARTED|Period 2||0
9680780|NCT03635099|10780341|FG006|STARTED|Period 2||0
9680781|NCT03635099|10780342|FG007|STARTED|Period 2||0
9680782|NCT03635099|10780335|FG000|COMPLETED|Period 2||0
9680783|NCT03635099|10780336|FG001|COMPLETED|Period 2||2
9680784|NCT03635099|10780337|FG002|COMPLETED|Period 2||36
9680785|NCT03635099|10780338|FG003|COMPLETED|Period 2||25
9680786|NCT03635099|10780339|FG004|COMPLETED|Period 2||65
9680787|NCT03635099|10780340|FG005|COMPLETED|Period 2||0
9680788|NCT03635099|10780341|FG006|COMPLETED|Period 2||0
9680789|NCT03635099|10780342|FG007|COMPLETED|Period 2||0
9680790|NCT03635099|10780335|FG000|NOT COMPLETED|Period 2||0
9680791|NCT03635099|10780336|FG001|NOT COMPLETED|Period 2||0
9680792|NCT03635099|10780337|FG002|NOT COMPLETED|Period 2||9
9680793|NCT03635099|10780338|FG003|NOT COMPLETED|Period 2||4
9680794|NCT03635099|10780339|FG004|NOT COMPLETED|Period 2||12
9680795|NCT03635099|10780340|FG005|NOT COMPLETED|Period 2||0
9680796|NCT03635099|10780341|FG006|NOT COMPLETED|Period 2||0
9680797|NCT03635099|10780342|FG007|NOT COMPLETED|Period 2||0
9680798|NCT03543046|10780370|FG000|STARTED|Overall Study||14
9680799|NCT03543046|10780371|FG001|STARTED|Overall Study||13
9680800|NCT03543046|10780370|FG000|COMPLETED|Overall Study||11
9680801|NCT03543046|10780371|FG001|COMPLETED|Overall Study||11
9680802|NCT03543046|10780370|FG000|NOT COMPLETED|Overall Study||3
9680803|NCT03543046|10780371|FG001|NOT COMPLETED|Overall Study||2
9680804|NCT03542877|10780377|FG000|STARTED|Overall Study||44
9680805|NCT03542877|10780377|FG000|COMPLETED|Overall Study||23
9680806|NCT03542877|10780377|FG000|NOT COMPLETED|Overall Study||21
9680807|NCT03530800|10780387|FG000|STARTED|Overall Study||25
9680808|NCT03530800|10780388|FG001|STARTED|Overall Study||25
9680809|NCT03530800|10780387|FG000|COMPLETED|Overall Study||14
9680810|NCT03530800|10780388|FG001|COMPLETED|Overall Study||16
9680811|NCT03530800|10780387|FG000|NOT COMPLETED|Overall Study||11
9680812|NCT03530800|10780388|FG001|NOT COMPLETED|Overall Study||9
9680813|NCT03270462|10780394|FG000|STARTED|Overall Study||20
9680814|NCT03270462|10780394|FG000|COMPLETED|Overall Study||20
9680815|NCT03270462|10780394|FG000|NOT COMPLETED|Overall Study||0
9843457|NCT00830869|10955262|FG004|NOT COMPLETED|Period 1: Part 1||4
9843458|NCT00830869|10955263|FG005|NOT COMPLETED|Period 1: Part 1||6
9843459|NCT00830869|10955264|FG006|NOT COMPLETED|Period 1: Part 1||3
9680819|NCT03100149|10780405|FG000|STARTED|Overall Study||105
9680820|NCT03100149|10780406|FG001|STARTED|Overall Study||105
9680821|NCT03100149|10780407|FG002|STARTED|Overall Study||106
9680822|NCT03100149|10780405|FG000|COMPLETED|Overall Study||105
9680823|NCT03100149|10780406|FG001|COMPLETED|Overall Study||101
9680824|NCT03100149|10780407|FG002|COMPLETED|Overall Study||104
9680825|NCT03100149|10780405|FG000|NOT COMPLETED|Overall Study||0
9680826|NCT03100149|10780406|FG001|NOT COMPLETED|Overall Study||4
9680827|NCT03100149|10780407|FG002|NOT COMPLETED|Overall Study||2
9680828|NCT03090412|10780417|FG000|STARTED|Overall Study||1
9680829|NCT03090412|10780418|FG001|STARTED|Overall Study||1
9680830|NCT03090412|10780417|FG000|COMPLETED|Overall Study||1
9680831|NCT03090412|10780418|FG001|COMPLETED|Overall Study||1
9680832|NCT03090412|10780417|FG000|NOT COMPLETED|Overall Study||0
9680833|NCT03090412|10780418|FG001|NOT COMPLETED|Overall Study||0
9680834|NCT03065517|10780426|FG000|STARTED|Overall Study||110
9680835|NCT03065517|10780427|FG001|STARTED|Overall Study||106
9680836|NCT03065517|10780426|FG000|COMPLETED|Overall Study||84
9680837|NCT03065517|10780427|FG001|COMPLETED|Overall Study||90
9680838|NCT03065517|10780426|FG000|NOT COMPLETED|Overall Study||26
9680839|NCT03065517|10780427|FG001|NOT COMPLETED|Overall Study||16
9680840|NCT03063203|10780433|FG000|STARTED|Overall Study||17
9680841|NCT03063203|10780433|FG000|COMPLETED|Overall Study||3
9680842|NCT03063203|10780433|FG000|NOT COMPLETED|Overall Study||14
9680843|NCT02831764|10780446|FG000|STARTED|Overall Study||360
9680844|NCT02831764|10780447|FG001|STARTED|Overall Study||359
9680845|NCT02831764|10780446|FG000|COMPLETED|Overall Study||0
9680846|NCT02831764|10780447|FG001|COMPLETED|Overall Study||0
9680847|NCT02831764|10780446|FG000|NOT COMPLETED|Overall Study||360
9680848|NCT02831764|10780447|FG001|NOT COMPLETED|Overall Study||359
9680849|NCT02722941|10780455|FG000|STARTED|Overall Study||15
9680850|NCT02722941|10780456|FG001|STARTED|Overall Study||15
9680851|NCT02722941|10780455|FG000|COMPLETED|Overall Study||15
9680852|NCT02722941|10780456|FG001|COMPLETED|Overall Study||15
9680853|NCT02722941|10780455|FG000|NOT COMPLETED|Overall Study||0
9680854|NCT02722941|10780456|FG001|NOT COMPLETED|Overall Study||0
9680855|NCT02655692|10780465|FG000|STARTED|Overall Study||55
9680856|NCT02655692|10780466|FG001|STARTED|Overall Study||55
9680857|NCT02655692|10780467|FG002|STARTED|Overall Study||53
9680858|NCT02655692|10780465|FG000|COMPLETED|Overall Study||36
9680859|NCT02655692|10780466|FG001|COMPLETED|Overall Study||41
9680860|NCT02655692|10780467|FG002|COMPLETED|Overall Study||40
9680861|NCT02655692|10780465|FG000|NOT COMPLETED|Overall Study||19
9680862|NCT02655692|10780466|FG001|NOT COMPLETED|Overall Study||14
9680863|NCT02655692|10780467|FG002|NOT COMPLETED|Overall Study||13
10023211|NCT01854697|11146775|FG003|COMPLETED|Overall Study||80
10023212|NCT01854697|11146776|FG004|COMPLETED|Overall Study||39
10023213|NCT01854697|11146772|FG000|NOT COMPLETED|Overall Study||6
10023214|NCT01854697|11146773|FG001|NOT COMPLETED|Overall Study||3
10023215|NCT01854697|11146774|FG002|NOT COMPLETED|Overall Study||2
10023216|NCT01854697|11146775|FG003|NOT COMPLETED|Overall Study||3
10023217|NCT01854697|11146776|FG004|NOT COMPLETED|Overall Study||2
10023218|NCT01854710|11146786|FG000|STARTED|Overall Study||10
9680864|NCT02623205|10780477|FG000|STARTED|Overall Study||42
9680865|NCT02623205|10780478|FG001|STARTED|Overall Study||43
9680866|NCT02623205|10780477|FG000|COMPLETED|Overall Study||38
9680867|NCT02623205|10780478|FG001|COMPLETED|Overall Study||40
9680868|NCT02623205|10780477|FG000|NOT COMPLETED|Overall Study||4
9680869|NCT02623205|10780478|FG001|NOT COMPLETED|Overall Study||3
9680870|NCT02574481|10780488|FG000|STARTED|Overall Study||309
9680871|NCT02574481|10780489|FG001|STARTED|Overall Study||156
9680872|NCT02574481|10780490|FG002|STARTED|Overall Study||50
9680873|NCT02574481|10780491|FG003|STARTED|Overall Study||13
9680874|NCT02574481|10780488|FG000|COMPLETED|Overall Study||282
9680875|NCT02574481|10780489|FG001|COMPLETED|Overall Study||142
10023219|NCT01854710|11146787|FG001|STARTED|Overall Study||10
10023220|NCT01854710|11146788|FG002|STARTED|Overall Study||10
10023221|NCT01854710|11146789|FG003|STARTED|Overall Study||10
10023222|NCT01854710|11146790|FG004|STARTED|Overall Study||10
10023223|NCT01854710|11146791|FG005|STARTED|Overall Study||10
10023224|NCT01854710|11146786|FG000|COMPLETED|Overall Study||6
9680876|NCT02574481|10780490|FG002|COMPLETED|Overall Study||47
9680877|NCT02574481|10780491|FG003|COMPLETED|Overall Study||13
9680878|NCT02574481|10780488|FG000|NOT COMPLETED|Overall Study||27
9680879|NCT02574481|10780489|FG001|NOT COMPLETED|Overall Study||14
9680880|NCT02574481|10780490|FG002|NOT COMPLETED|Overall Study||3
9680881|NCT02574481|10780491|FG003|NOT COMPLETED|Overall Study||0
9843460|NCT00830869|10955265|FG007|NOT COMPLETED|Period 1: Part 1||0
9843461|NCT00830869|10955266|FG008|NOT COMPLETED|Period 1: Part 1||0
9843462|NCT00830869|10955267|FG009|NOT COMPLETED|Period 1: Part 1||0
9843463|NCT00830869|10955268|FG010|NOT COMPLETED|Period 1: Part 1||0
9843464|NCT00830869|10955269|FG011|NOT COMPLETED|Period 1: Part 1||0
9843465|NCT00830869|10955258|FG000|STARTED|Period 2: Part 2||0
9843466|NCT00830869|10955259|FG001|STARTED|Period 2: Part 2||0
9843467|NCT00830869|10955260|FG002|STARTED|Period 2: Part 2||0
9843468|NCT00830869|10955261|FG003|STARTED|Period 2: Part 2||0
9843469|NCT00830869|10955262|FG004|STARTED|Period 2: Part 2||0
9843470|NCT00830869|10955263|FG005|STARTED|Period 2: Part 2||0
9843471|NCT00830869|10955264|FG006|STARTED|Period 2: Part 2||0
9724609|NCT00090285|10824344|FG000|NOT COMPLETED|Base Study Follow-up Period||335
9724610|NCT00090285|10824345|FG001|NOT COMPLETED|Base Study Follow-up Period||342
9724611|NCT00090285|10824346|FG002|NOT COMPLETED|Base Study Follow-up Period||0
9724612|NCT00090285|10824347|FG003|NOT COMPLETED|Base Study Follow-up Period||0
9724613|NCT00090285|10824348|FG004|NOT COMPLETED|Base Study Follow-up Period||0
9724614|NCT00090285|10824349|FG005|NOT COMPLETED|Base Study Follow-up Period||0
9724615|NCT00090285|10824344|FG000|STARTED|Extension 1||0
9724616|NCT00090285|10824345|FG001|STARTED|Extension 1||0
9724617|NCT00090285|10824346|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
9724618|NCT00090285|10824347|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
9724619|NCT00090285|10824348|FG004|STARTED|Extension 1||0
9724620|NCT00090285|10824349|FG005|STARTED|Extension 1||0
9724621|NCT00090285|10824344|FG000|COMPLETED|Extension 1||0
9724622|NCT00090285|10824345|FG001|COMPLETED|Extension 1||0
9724623|NCT00090285|10824346|FG002|COMPLETED|Extension 1||1041
9724624|NCT00090285|10824347|FG003|COMPLETED|Extension 1||15
9724625|NCT00090285|10824348|FG004|COMPLETED|Extension 1||0
9724626|NCT00090285|10824349|FG005|COMPLETED|Extension 1||0
9724627|NCT00090285|10824344|FG000|NOT COMPLETED|Extension 1||0
10023225|NCT01854710|11146787|FG001|COMPLETED|Overall Study||7
10023226|NCT01854710|11146788|FG002|COMPLETED|Overall Study||8
9724628|NCT00090285|10824345|FG001|NOT COMPLETED|Extension 1||0
9724629|NCT00090285|10824346|FG002|NOT COMPLETED|Extension 1||57
9724630|NCT00090285|10824347|FG003|NOT COMPLETED|Extension 1||1
9724631|NCT00090285|10824348|FG004|NOT COMPLETED|Extension 1||0
9724632|NCT00090285|10824349|FG005|NOT COMPLETED|Extension 1||0
9724633|NCT00090285|10824344|FG000|STARTED|Long-term Follow-up (EXT2)||0
10023227|NCT01854710|11146789|FG003|COMPLETED|Overall Study||8
9680894|NCT02445456|10780537|FG000|STARTED|Overall Study||13
9680895|NCT02445456|10780538|FG001|STARTED|Overall Study||2
9680896|NCT02445456|10780537|FG000|COMPLETED|Overall Study||13
9680897|NCT02445456|10780538|FG001|COMPLETED|Overall Study||2
9680898|NCT02445456|10780537|FG000|NOT COMPLETED|Overall Study||0
9680899|NCT02445456|10780538|FG001|NOT COMPLETED|Overall Study||0
9680900|NCT02348203|10780546|FG000|STARTED|Overall Study||31
9680901|NCT02348203|10780547|FG001|STARTED|Overall Study||32
9680902|NCT02348203|10780546|FG000|COMPLETED|Overall Study||21
9680903|NCT02348203|10780547|FG001|COMPLETED|Overall Study||22
9680904|NCT02348203|10780546|FG000|NOT COMPLETED|Overall Study||10
9680905|NCT02348203|10780547|FG001|NOT COMPLETED|Overall Study||10
9843472|NCT00830869|10955265|FG007|STARTED|Period 2: Part 2||20
9843473|NCT00830869|10955266|FG008|STARTED|Period 2: Part 2||22
9843474|NCT00830869|10955267|FG009|STARTED|Period 2: Part 2||20
9843475|NCT00830869|10955268|FG010|STARTED|Period 2: Part 2||11
9843476|NCT00830869|10955269|FG011|STARTED|Period 2: Part 2||20
9843477|NCT00830869|10955258|FG000|COMPLETED|Period 2: Part 2||0
9843478|NCT00830869|10955259|FG001|COMPLETED|Period 2: Part 2||0
9843479|NCT00830869|10955260|FG002|COMPLETED|Period 2: Part 2||0
9843480|NCT00830869|10955261|FG003|COMPLETED|Period 2: Part 2||0
9843481|NCT00830869|10955262|FG004|COMPLETED|Period 2: Part 2||0
9843482|NCT00830869|10955263|FG005|COMPLETED|Period 2: Part 2||0
9843483|NCT00830869|10955264|FG006|COMPLETED|Period 2: Part 2||0
9843484|NCT00830869|10955265|FG007|COMPLETED|Period 2: Part 2||0
9843485|NCT00830869|10955266|FG008|COMPLETED|Period 2: Part 2||0
9843486|NCT00830869|10955267|FG009|COMPLETED|Period 2: Part 2||0
9843487|NCT00830869|10955268|FG010|COMPLETED|Period 2: Part 2||0
9843488|NCT00830869|10955269|FG011|COMPLETED|Period 2: Part 2||0
9843489|NCT00830869|10955258|FG000|NOT COMPLETED|Period 2: Part 2||0
9843490|NCT00830869|10955259|FG001|NOT COMPLETED|Period 2: Part 2||0
9843491|NCT00830869|10955260|FG002|NOT COMPLETED|Period 2: Part 2||0
9843492|NCT00830869|10955261|FG003|NOT COMPLETED|Period 2: Part 2||0
9843493|NCT00830869|10955262|FG004|NOT COMPLETED|Period 2: Part 2||0
9843494|NCT00830869|10955263|FG005|NOT COMPLETED|Period 2: Part 2||0
9843495|NCT00830869|10955264|FG006|NOT COMPLETED|Period 2: Part 2||0
9843496|NCT00830869|10955265|FG007|NOT COMPLETED|Period 2: Part 2||20
9843497|NCT00830869|10955266|FG008|NOT COMPLETED|Period 2: Part 2||22
9843498|NCT00830869|10955267|FG009|NOT COMPLETED|Period 2: Part 2||20
9843499|NCT00830869|10955268|FG010|NOT COMPLETED|Period 2: Part 2||11
9843500|NCT00830869|10955269|FG011|NOT COMPLETED|Period 2: Part 2||20
9843501|NCT00830947|10955298|FG000|STARTED|Overall Study||23
9843502|NCT00830947|10955299|FG001|STARTED|Overall Study||22
9843503|NCT00830947|10955298|FG000|COMPLETED|Overall Study||19
9843504|NCT00830947|10955299|FG001|COMPLETED|Overall Study||18
9843505|NCT00830947|10955298|FG000|NOT COMPLETED|Overall Study||4
9843506|NCT00830947|10955299|FG001|NOT COMPLETED|Overall Study||4
9843507|NCT00830960|10955311|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
9843508|NCT00830960|10955312|FG001|STARTED|Overall Study||124
9843509|NCT00830960|10955313|FG002|STARTED|Overall Study||137
9843510|NCT00830960|10955314|FG003|STARTED|Overall Study||138
9843511|NCT00830960|10955315|FG004|STARTED|Overall Study||96
9843512|NCT00830960|10955316|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
9843513|NCT00830960|10955311|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
9843514|NCT00830960|10955312|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122
9843515|NCT00830960|10955313|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133
9843516|NCT00830960|10955314|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135
9843517|NCT00830960|10955315|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91
9843518|NCT00830960|10955316|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93
9843519|NCT00830960|10955311|FG000|COMPLETED|Overall Study||91
9843520|NCT00830960|10955312|FG001|COMPLETED|Overall Study||96
9843521|NCT00830960|10955313|FG002|COMPLETED|Overall Study||108
9843522|NCT00830960|10955314|FG003|COMPLETED|Overall Study||106
9843523|NCT00830960|10955315|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
9843524|NCT00830960|10955316|FG005|COMPLETED|Overall Study||63
9843525|NCT00830960|10955311|FG000|NOT COMPLETED|Overall Study||33
9843526|NCT00830960|10955312|FG001|NOT COMPLETED|Overall Study||28
9843527|NCT00830960|10955313|FG002|NOT COMPLETED|Overall Study||29
9843528|NCT00830960|10955314|FG003|NOT COMPLETED|Overall Study||32
9843529|NCT00830960|10955315|FG004|NOT COMPLETED|Overall Study||32
9843530|NCT00830960|10955316|FG005|NOT COMPLETED|Overall Study||37
9843531|NCT00831129|10955355|FG000|STARTED|Overall Study||20
9843532|NCT00831129|10955356|FG001|STARTED|Overall Study||33
9843533|NCT00831129|10955355|FG000|COMPLETED|Overall Study||20
9843534|NCT00831129|10955356|FG001|COMPLETED|Overall Study||23
9843535|NCT00831129|10955355|FG000|NOT COMPLETED|Overall Study||0
9843536|NCT00831129|10955356|FG001|NOT COMPLETED|Overall Study||10
9843537|NCT00831181|10955362|FG000|STARTED|Overall Study||27
9843538|NCT00831181|10955362|FG000|COMPLETED|Overall Study||15
9843539|NCT00831181|10955362|FG000|NOT COMPLETED|Overall Study||12
9843540|NCT00831233|10955369|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
9843541|NCT00831233|10955370|FG001|STARTED|Overall Study|ITT population.|13
9843542|NCT00831233|10955369|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
9843543|NCT00831233|10955370|FG001|Full Analysis Set (FAS)|Overall Study||13
9843544|NCT00831233|10955369|FG000|Per Protocol (PP) Analysis Set|Overall Study||26
9680923|NCT01892722|10780578|FG000|STARTED|Overall Study||107
9680924|NCT01892722|10780579|FG001|STARTED|Overall Study||108
9680925|NCT01892722|10780578|FG000|Full Analysis Set|Overall Study||107
9680926|NCT01892722|10780579|FG001|Full Analysis Set|Overall Study||107
9680927|NCT01892722|10780578|FG000|COMPLETED|Overall Study||100
9680928|NCT01892722|10780579|FG001|COMPLETED|Overall Study||88
9680929|NCT01892722|10780578|FG000|NOT COMPLETED|Overall Study||7
9680930|NCT01892722|10780579|FG001|NOT COMPLETED|Overall Study||20
9680931|NCT01723774|10780588|FG000|STARTED|Neoadjuvant||34
9680932|NCT01723774|10780589|FG001|STARTED|Neoadjuvant||16
9680933|NCT01723774|10780590|FG002|STARTED|Neoadjuvant||34
9680934|NCT01723774|10780591|FG003|STARTED|Neoadjuvant||0
9680935|NCT01723774|10780588|FG000|COMPLETED|Neoadjuvant||27
9680936|NCT01723774|10780589|FG001|COMPLETED|Neoadjuvant||12
9680937|NCT01723774|10780590|FG002|COMPLETED|Neoadjuvant||21
9680938|NCT01723774|10780591|FG003|COMPLETED|Neoadjuvant||0
9680939|NCT01723774|10780588|FG000|NOT COMPLETED|Neoadjuvant||7
9680940|NCT01723774|10780589|FG001|NOT COMPLETED|Neoadjuvant||4
9680941|NCT01723774|10780590|FG002|NOT COMPLETED|Neoadjuvant||13
9680942|NCT01723774|10780591|FG003|NOT COMPLETED|Neoadjuvant||0
9680943|NCT01723774|10780588|FG000|STARTED|Adjuvant||0
9680944|NCT01723774|10780589|FG001|STARTED|Adjuvant||0
9680945|NCT01723774|10780590|FG002|STARTED|Adjuvant||0
9680946|NCT01723774|10780591|FG003|STARTED|Adjuvant||7
9680947|NCT01723774|10780588|FG000|COMPLETED|Adjuvant||0
9680948|NCT01723774|10780589|FG001|COMPLETED|Adjuvant||0
9680949|NCT01723774|10780590|FG002|COMPLETED|Adjuvant||0
9680950|NCT01723774|10780591|FG003|COMPLETED|Adjuvant||6
9680951|NCT01723774|10780588|FG000|NOT COMPLETED|Adjuvant||0
9680952|NCT01723774|10780589|FG001|NOT COMPLETED|Adjuvant||0
9680953|NCT01723774|10780590|FG002|NOT COMPLETED|Adjuvant||0
9680954|NCT01723774|10780591|FG003|NOT COMPLETED|Adjuvant||1
9680955|NCT01560637|10780600|FG000|STARTED|Overall Study|471 subjects from the parent study (TDE-PH-310) consented to participate in TDE-PH-311. However, one subject withdrew consent prior to receiving oral treprostinil in TDE-PH-311. This subject was not included in the data summary.|470
9680956|NCT01560637|10780600|FG000|COMPLETED|Overall Study||272
9680957|NCT01560637|10780600|FG000|NOT COMPLETED|Overall Study||198
9680958|NCT00999804|10780606|FG000|STARTED|Overall Study||85
9680959|NCT00999804|10780607|FG001|STARTED|Overall Study||43
9680960|NCT00999804|10780606|FG000|COMPLETED|Overall Study||64
9680961|NCT00999804|10780607|FG001|COMPLETED|Overall Study||38
9680962|NCT00999804|10780606|FG000|NOT COMPLETED|Overall Study||21
9680963|NCT00999804|10780607|FG001|NOT COMPLETED|Overall Study||5
9680964|NCT00458003|10780615|FG000|STARTED|Overall Study||55
9680965|NCT00458003|10780616|FG001|STARTED|Overall Study||55
9680966|NCT00458003|10780615|FG000|COMPLETED|Overall Study||54
9680967|NCT00458003|10780616|FG001|COMPLETED|Overall Study||54
9680968|NCT00458003|10780615|FG000|NOT COMPLETED|Overall Study||1
9680969|NCT00458003|10780616|FG001|NOT COMPLETED|Overall Study||1
9724634|NCT00090285|10824345|FG001|STARTED|Long-term Follow-up (EXT2)||0
9724635|NCT00090285|10824346|FG002|STARTED|Long-term Follow-up (EXT2)||0
9724636|NCT00090285|10824347|FG003|STARTED|Long-term Follow-up (EXT2)||0
9724637|NCT00090285|10824348|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
9724638|NCT00090285|10824349|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
9724639|NCT00090285|10824344|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
9724640|NCT00090285|10824345|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
9724641|NCT00090285|10824346|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
9724642|NCT00090285|10824347|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
9724643|NCT00090285|10824348|FG004|COMPLETED|Long-term Follow-up (EXT2)||709
9724644|NCT00090285|10824349|FG005|COMPLETED|Long-term Follow-up (EXT2)||664
9724645|NCT00090285|10824344|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724646|NCT00090285|10824345|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724647|NCT00090285|10824346|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724648|NCT00090285|10824347|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
9724649|NCT00090285|10824348|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227
9724650|NCT00090285|10824349|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203
9724651|NCT00090363|10824367|FG000|STARTED|Overall Study||107
9724652|NCT00090363|10824368|FG001|STARTED|Overall Study||107
9724653|NCT00090363|10824369|FG002|STARTED|Overall Study||98
9724654|NCT00090363|10824367|FG000|Received Study Treatment.|Overall Study||107
9724655|NCT00090363|10824368|FG001|Received Study Treatment.|Overall Study||107
9724656|NCT00090363|10824369|FG002|Received Study Treatment.|Overall Study||98
9724657|NCT00090363|10824367|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
9724658|NCT00090363|10824368|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
9731731|NCT00135226|10831628|FG000|NOT COMPLETED|Overall Study||34
9731732|NCT00135226|10831629|FG001|NOT COMPLETED|Overall Study||35
9731733|NCT00135226|10831630|FG002|NOT COMPLETED|Overall Study||34
9731734|NCT00135226|10831631|FG003|NOT COMPLETED|Overall Study||36
9731735|NCT00135330|10831646|FG000|STARTED|Overall Study||45
9731736|NCT00135330|10831647|FG001|STARTED|Overall Study||47
9731737|NCT00135330|10831648|FG002|STARTED|Overall Study||45
9731738|NCT00135330|10831646|FG000|COMPLETED|Overall Study||33
9731739|NCT00135330|10831647|FG001|COMPLETED|Overall Study||34
9731740|NCT00135330|10831648|FG002|COMPLETED|Overall Study||34
9731741|NCT00135330|10831646|FG000|NOT COMPLETED|Overall Study||12
9731742|NCT00135330|10831647|FG001|NOT COMPLETED|Overall Study||13
9680970|NCT03882788|10780626|FG000|STARTED|Overall Study||44
9680971|NCT03882788|10780627|FG001|STARTED|Overall Study||45
9680972|NCT03882788|10780626|FG000|COMPLETED|Overall Study||44
9680973|NCT03882788|10780627|FG001|COMPLETED|Overall Study||45
9680974|NCT03882788|10780626|FG000|NOT COMPLETED|Overall Study||0
9680975|NCT03882788|10780627|FG001|NOT COMPLETED|Overall Study||0
9680976|NCT03834974|10780635|FG000|STARTED|Overall Study||34
9680977|NCT03834974|10780636|FG001|STARTED|Overall Study||32
9680978|NCT03834974|10780635|FG000|COMPLETED|Overall Study||34
9680979|NCT03834974|10780636|FG001|COMPLETED|Overall Study||32
9680980|NCT03834974|10780635|FG000|NOT COMPLETED|Overall Study||0
9680981|NCT03834974|10780636|FG001|NOT COMPLETED|Overall Study||0
9680982|NCT03821675|10780645|FG000|STARTED|Overall Study||19
9680983|NCT03821675|10780646|FG001|STARTED|Overall Study||19
9680984|NCT03821675|10780645|FG000|COMPLETED|Overall Study||16
9680985|NCT03821675|10780646|FG001|COMPLETED|Overall Study||17
9680986|NCT03821675|10780645|FG000|NOT COMPLETED|Overall Study||3
9680987|NCT03821675|10780646|FG001|NOT COMPLETED|Overall Study||2
9680988|NCT03794544|10780658|FG000|STARTED|Overall Study||27
9680989|NCT03794544|10780659|FG001|STARTED|Overall Study||21
9680990|NCT03794544|10780660|FG002|STARTED|Overall Study||20
9680991|NCT03794544|10780661|FG003|STARTED|Overall Study||16
9680992|NCT03794544|10780658|FG000|Treated|Overall Study||26
9680993|NCT03794544|10780659|FG001|Treated|Overall Study||21
9680994|NCT03794544|10780660|FG002|Treated|Overall Study||20
9680995|NCT03794544|10780661|FG003|Treated|Overall Study||16
9680996|NCT03794544|10780658|FG000|COMPLETED|Overall Study||26
9680997|NCT03794544|10780659|FG001|COMPLETED|Overall Study||18
9680998|NCT03794544|10780660|FG002|COMPLETED|Overall Study||19
9680999|NCT03794544|10780661|FG003|COMPLETED|Overall Study||15
9681000|NCT03794544|10780658|FG000|NOT COMPLETED|Overall Study||1
9681001|NCT03794544|10780659|FG001|NOT COMPLETED|Overall Study||3
9681002|NCT03794544|10780660|FG002|NOT COMPLETED|Overall Study||1
9681003|NCT03794544|10780661|FG003|NOT COMPLETED|Overall Study||1
9681004|NCT03732807|10780678|FG000|STARTED|Treatment Period (up to Week 24)||132
9681005|NCT03732807|10780679|FG001|STARTED|Treatment Period (up to Week 24)||130
9681006|NCT03732807|10780680|FG002|STARTED|Treatment Period (up to Week 24)||130
9681007|NCT03732807|10780681|FG003|STARTED|Treatment Period (up to Week 24)||132
9681008|NCT03732807|10780682|FG004|STARTED|Treatment Period (up to Week 24)||63
9681009|NCT03732807|10780683|FG005|STARTED|Treatment Period (up to Week 24)||65
9681010|NCT03732807|10780684|FG006|STARTED|Treatment Period (up to Week 24)||66
9681011|NCT03732807|10780678|FG000|COMPLETED|Treatment Period (up to Week 24)||122
9681012|NCT03732807|10780679|FG001|COMPLETED|Treatment Period (up to Week 24)||124
9681013|NCT03732807|10780680|FG002|COMPLETED|Treatment Period (up to Week 24)||121
9681014|NCT03732807|10780681|FG003|COMPLETED|Treatment Period (up to Week 24)||117
9681015|NCT03732807|10780682|FG004|COMPLETED|Treatment Period (up to Week 24)||58
9681016|NCT03732807|10780683|FG005|COMPLETED|Treatment Period (up to Week 24)||63
9681017|NCT03732807|10780684|FG006|COMPLETED|Treatment Period (up to Week 24)||61
9681018|NCT03732807|10780678|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10
9681019|NCT03732807|10780679|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
9681020|NCT03732807|10780680|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
9681021|NCT03732807|10780681|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15
9681022|NCT03732807|10780682|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5
9681023|NCT03732807|10780683|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2
9681024|NCT03732807|10780684|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5
9681025|NCT03732807|10780678|FG000|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|113
9681026|NCT03732807|10780679|FG001|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|111
9681027|NCT03732807|10780680|FG002|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|108
9681028|NCT03732807|10780681|FG003|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|106
9681029|NCT03732807|10780682|FG004|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|49
9681030|NCT03732807|10780683|FG005|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|59
9681031|NCT03732807|10780684|FG006|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|57
9681032|NCT03732807|10780678|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107
9681033|NCT03732807|10780679|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100
9681034|NCT03732807|10780680|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103
9681035|NCT03732807|10780681|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97
9681036|NCT03732807|10780682|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44
9681037|NCT03732807|10780683|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56
9681038|NCT03732807|10780684|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53
9681039|NCT03732807|10780678|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6
9681040|NCT03732807|10780679|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11
9681041|NCT03732807|10780680|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
9681042|NCT03732807|10780681|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9
9681043|NCT03732807|10780682|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
9681044|NCT03732807|10780683|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3
9681045|NCT03732807|10780684|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4
9724659|NCT00090363|10824369|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
9724660|NCT00090363|10824367|FG000|NOT COMPLETED|Overall Study||106
9724661|NCT00090363|10824368|FG001|NOT COMPLETED|Overall Study||107
9724662|NCT00090363|10824369|FG002|NOT COMPLETED|Overall Study||96
9724663|NCT00090402|10824380|FG000|STARTED|Overall Study||13
9724664|NCT00090402|10824381|FG001|STARTED|Overall Study||13
9724665|NCT00090402|10824382|FG002|STARTED|Overall Study||13
9724666|NCT00090402|10824380|FG000|COMPLETED|Overall Study||11
9724667|NCT00090402|10824381|FG001|COMPLETED|Overall Study||11
9724668|NCT00090402|10824382|FG002|COMPLETED|Overall Study||12
9724669|NCT00090402|10824380|FG000|NOT COMPLETED|Overall Study||2
9724670|NCT00090402|10824381|FG001|NOT COMPLETED|Overall Study||2
9724671|NCT00090402|10824382|FG002|NOT COMPLETED|Overall Study||1
9724672|NCT00090493|10824393|FG000|STARTED|Overall Study||4
9724673|NCT00090493|10824393|FG000|COMPLETED|Overall Study||2
9724674|NCT00090493|10824393|FG000|NOT COMPLETED|Overall Study||2
9724675|NCT00090519|10824399|FG000|STARTED|Overall Study||371
9724676|NCT00090519|10824400|FG001|STARTED|Overall Study||360
9724677|NCT00090519|10824399|FG000|COMPLETED|Overall Study||298
9724678|NCT00090519|10824400|FG001|COMPLETED|Overall Study||285
9724679|NCT00090519|10824399|FG000|NOT COMPLETED|Overall Study||73
9724680|NCT00090519|10824400|FG001|NOT COMPLETED|Overall Study||75
9724681|NCT00090545|10824408|FG000|STARTED|Overall Study||22
9724682|NCT00090545|10824409|FG001|STARTED|Overall Study||24
9724683|NCT00090545|10824408|FG000|COMPLETED|Overall Study||0
9724684|NCT00090545|10824409|FG001|COMPLETED|Overall Study||0
9724685|NCT00090545|10824408|FG000|NOT COMPLETED|Overall Study||22
9724686|NCT00090545|10824409|FG001|NOT COMPLETED|Overall Study||24
9724687|NCT00090584|10824419|FG000|STARTED|Baseline to 10 Weeks||154
10023228|NCT01854710|11146790|FG004|COMPLETED|Overall Study||8
10023229|NCT01854710|11146791|FG005|COMPLETED|Overall Study||8
10023230|NCT01854710|11146786|FG000|NOT COMPLETED|Overall Study||4
10023231|NCT01854710|11146787|FG001|NOT COMPLETED|Overall Study||3
9724688|NCT00090584|10824420|FG001|STARTED|Baseline to 10 Weeks||153
9724689|NCT00090584|10824419|FG000|COMPLETED|Baseline to 10 Weeks||139
9724690|NCT00090584|10824420|FG001|COMPLETED|Baseline to 10 Weeks||141
9724691|NCT00090584|10824419|FG000|NOT COMPLETED|Baseline to 10 Weeks||15
9724692|NCT00090584|10824420|FG001|NOT COMPLETED|Baseline to 10 Weeks||12
9724693|NCT00090584|10824419|FG000|STARTED|Baseline to 8 Months||154
9724694|NCT00090584|10824420|FG001|STARTED|Baseline to 8 Months||153
9724695|NCT00090584|10824419|FG000|COMPLETED|Baseline to 8 Months||110
9724696|NCT00090584|10824420|FG001|COMPLETED|Baseline to 8 Months||112
9724697|NCT00090584|10824419|FG000|NOT COMPLETED|Baseline to 8 Months||44
9724698|NCT00090584|10824420|FG001|NOT COMPLETED|Baseline to 8 Months||41
9724699|NCT00090610|10824436|FG000|STARTED|Overall Study||75
9724700|NCT00090610|10824437|FG001|STARTED|Overall Study||75
9724701|NCT00090610|10824436|FG000|COMPLETED|Overall Study||74
9724702|NCT00090610|10824437|FG001|COMPLETED|Overall Study||74
9724703|NCT00090610|10824436|FG000|NOT COMPLETED|Overall Study||1
9724704|NCT00090610|10824437|FG001|NOT COMPLETED|Overall Study||1
9724705|NCT00090753|10824445|FG000|STARTED|First Treatment Period||748
9724706|NCT00090753|10824446|FG001|STARTED|First Treatment Period||480
9724707|NCT00090753|10824445|FG000|COMPLETED|First Treatment Period||492
9724708|NCT00090753|10824446|FG001|COMPLETED|First Treatment Period||302
9724709|NCT00090753|10824445|FG000|NOT COMPLETED|First Treatment Period||256
9724710|NCT00090753|10824446|FG001|NOT COMPLETED|First Treatment Period||178
9724711|NCT00090753|10824445|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
9724712|NCT00090753|10824446|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
9724713|NCT00090753|10824445|FG000|COMPLETED|Extended Treatment Period||94
9724714|NCT00090753|10824446|FG001|COMPLETED|Extended Treatment Period||59
9724715|NCT00090753|10824445|FG000|NOT COMPLETED|Extended Treatment Period||359
9724716|NCT00090753|10824446|FG001|NOT COMPLETED|Extended Treatment Period||191
9724717|NCT00090766|10824455|FG000|STARTED|Overall Study||17
9724718|NCT00090766|10824456|FG001|STARTED|Overall Study||21
9724719|NCT00090766|10824457|FG002|STARTED|Overall Study||25
9724720|NCT00090766|10824455|FG000|COMPLETED|Overall Study||14
9724721|NCT00090766|10824456|FG001|COMPLETED|Overall Study||19
9724722|NCT00090766|10824457|FG002|COMPLETED|Overall Study||22
9724723|NCT00090766|10824455|FG000|NOT COMPLETED|Overall Study||3
9724724|NCT00090766|10824456|FG001|NOT COMPLETED|Overall Study||2
9724725|NCT00090766|10824457|FG002|NOT COMPLETED|Overall Study||3
9724726|NCT00090779|10824469|FG000|STARTED|Step 1||66
9724727|NCT00090779|10824470|FG001|STARTED|Step 1||64
9724728|NCT00090779|10824469|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
10023232|NCT01854710|11146788|FG002|NOT COMPLETED|Overall Study||2
9724729|NCT00090779|10824470|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
9724730|NCT00090779|10824469|FG000|NOT COMPLETED|Step 1||11
9724731|NCT00090779|10824470|FG001|NOT COMPLETED|Step 1||15
9724732|NCT00090779|10824469|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
9724733|NCT00090779|10824470|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
10023233|NCT01854710|11146789|FG003|NOT COMPLETED|Overall Study||2
10023234|NCT01854710|11146790|FG004|NOT COMPLETED|Overall Study||2
9843545|NCT00831233|10955370|FG001|Per Protocol (PP) Analysis Set|Overall Study||11
9843546|NCT00831233|10955369|FG000|COMPLETED|Overall Study||26
9843547|NCT00831233|10955370|FG001|COMPLETED|Overall Study||12
9843548|NCT00831233|10955369|FG000|NOT COMPLETED|Overall Study||3
9843549|NCT00831233|10955370|FG001|NOT COMPLETED|Overall Study||1
9843550|NCT00831272|10955380|FG000|STARTED|Overall Study||38
9843551|NCT00831272|10955381|FG001|STARTED|Overall Study||44
9843552|NCT00831272|10955382|FG002|STARTED|Overall Study||73
9843553|NCT00831272|10955383|FG003|STARTED|Overall Study||66
9843554|NCT00831272|10955380|FG000|COMPLETED|Overall Study||30
9843555|NCT00831272|10955381|FG001|COMPLETED|Overall Study||37
9843556|NCT00831272|10955382|FG002|COMPLETED|Overall Study||63
9843557|NCT00831272|10955383|FG003|COMPLETED|Overall Study||56
9843558|NCT00831272|10955380|FG000|NOT COMPLETED|Overall Study||8
9843559|NCT00831272|10955381|FG001|NOT COMPLETED|Overall Study||7
9843560|NCT00831272|10955382|FG002|NOT COMPLETED|Overall Study||10
9843561|NCT00831272|10955383|FG003|NOT COMPLETED|Overall Study||10
9843562|NCT00831311|10955395|FG000|STARTED|Overall Study||312
9843563|NCT00831311|10955396|FG001|STARTED|Overall Study||312
9843564|NCT00831311|10955395|FG000|COMPLETED|Overall Study||300
9843565|NCT00831311|10955396|FG001|COMPLETED|Overall Study||304
9843566|NCT00831311|10955395|FG000|NOT COMPLETED|Overall Study||12
9843567|NCT00831311|10955396|FG001|NOT COMPLETED|Overall Study||8
9843568|NCT00831389|10955405|FG000|STARTED|Overall Study||6
9843569|NCT00831389|10955406|FG001|STARTED|Overall Study||7
9843570|NCT00831389|10955405|FG000|COMPLETED|Overall Study||6
9843571|NCT00831389|10955406|FG001|COMPLETED|Overall Study||6
9843572|NCT00831389|10955405|FG000|NOT COMPLETED|Overall Study||0
9843573|NCT00831389|10955406|FG001|NOT COMPLETED|Overall Study||1
9843574|NCT00831415|10955412|FG000|STARTED|Overall Study||304
9843575|NCT00831415|10955412|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
10023235|NCT01854710|11146791|FG005|NOT COMPLETED|Overall Study||2
9843576|NCT00831415|10955412|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
9843577|NCT00831415|10955412|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
9681046|NCT03731364|10780706|FG000|STARTED|Overall Study||9
9681047|NCT03731364|10780707|FG001|STARTED|Overall Study||9
9681048|NCT03731364|10780708|FG002|STARTED|Overall Study||13
9681049|NCT03731364|10780709|FG003|STARTED|Overall Study||13
9681050|NCT03731364|10780710|FG004|STARTED|Overall Study||11
9681051|NCT03731364|10780706|FG000|COMPLETED|Overall Study||9
9681052|NCT03731364|10780707|FG001|COMPLETED|Overall Study||9
9681053|NCT03731364|10780708|FG002|COMPLETED|Overall Study||12
9681054|NCT03731364|10780709|FG003|COMPLETED|Overall Study||11
9681055|NCT03731364|10780710|FG004|COMPLETED|Overall Study||10
9681056|NCT03731364|10780706|FG000|NOT COMPLETED|Overall Study||0
9681057|NCT03731364|10780707|FG001|NOT COMPLETED|Overall Study||0
9681058|NCT03731364|10780708|FG002|NOT COMPLETED|Overall Study||1
9681059|NCT03731364|10780709|FG003|NOT COMPLETED|Overall Study||2
9681060|NCT03731364|10780710|FG004|NOT COMPLETED|Overall Study||1
9724734|NCT00090779|10824469|FG000|COMPLETED|Step 2||0
9724735|NCT00090779|10824470|FG001|COMPLETED|Step 2||1
9724736|NCT00090779|10824469|FG000|NOT COMPLETED|Step 2||6
9724737|NCT00090779|10824470|FG001|NOT COMPLETED|Step 2||18
9724738|NCT00090779|10824469|FG000|STARTED|Step 3||7
9724739|NCT00090779|10824470|FG001|STARTED|Step 3||5
9724740|NCT00090779|10824469|FG000|COMPLETED|Step 3||0
9724741|NCT00090779|10824470|FG001|COMPLETED|Step 3||0
9724742|NCT00090779|10824469|FG000|NOT COMPLETED|Step 3||7
9724743|NCT00090779|10824470|FG001|NOT COMPLETED|Step 3||5
9724744|NCT00090844|10824478|FG000|STARTED|Overall Study||27
9724745|NCT00090844|10824479|FG001|STARTED|Overall Study||22
9724746|NCT00090844|10824478|FG000|COMPLETED|Overall Study||26
9724747|NCT00090844|10824479|FG001|COMPLETED|Overall Study||21
9724748|NCT00090844|10824478|FG000|NOT COMPLETED|Overall Study||1
9724749|NCT00090844|10824479|FG001|NOT COMPLETED|Overall Study||1
9724750|NCT00090857|10824488|FG000|STARTED|Overall Study||33
9724751|NCT00090857|10824489|FG001|STARTED|Overall Study||16
9724752|NCT00090857|10824488|FG000|COMPLETED|Overall Study||29
9724753|NCT00090857|10824489|FG001|COMPLETED|Overall Study||13
9724754|NCT00090857|10824488|FG000|NOT COMPLETED|Overall Study||4
9724755|NCT00090857|10824489|FG001|NOT COMPLETED|Overall Study||3
9724756|NCT00090987|10824495|FG000|STARTED|Overall Study||30
9724757|NCT00090987|10824495|FG000|COMPLETED|Overall Study||9
9724758|NCT00090987|10824495|FG000|NOT COMPLETED|Overall Study||21
9724759|NCT00091026|10824501|FG000|STARTED|Overall Study||72
9724760|NCT00091026|10824502|FG001|STARTED|Overall Study||71
9724761|NCT00091026|10824501|FG000|COMPLETED|Overall Study||71
9724762|NCT00091026|10824502|FG001|COMPLETED|Overall Study||68
9724763|NCT00091026|10824501|FG000|NOT COMPLETED|Overall Study||1
9724764|NCT00091026|10824502|FG001|NOT COMPLETED|Overall Study||3
9724765|NCT00091169|10824510|FG000|STARTED|Overall Study||189
9724766|NCT00091169|10824511|FG001|STARTED|Overall Study||187
9724767|NCT00091169|10824510|FG000|Treated|Overall Study||163
9724768|NCT00091169|10824511|FG001|Treated|Overall Study||170
9724769|NCT00091169|10824510|FG000|COMPLETED|Overall Study||132
9724770|NCT00091169|10824511|FG001|COMPLETED|Overall Study||134
9724771|NCT00091169|10824510|FG000|NOT COMPLETED|Overall Study||57
9724772|NCT00091169|10824511|FG001|NOT COMPLETED|Overall Study||53
9724773|NCT00091260|10824519|FG000|STARTED|Overall Study||82
9724774|NCT00091260|10824519|FG000|COMPLETED|Overall Study||82
9724775|NCT00091260|10824519|FG000|NOT COMPLETED|Overall Study||0
9724776|NCT00091273|10824524|FG000|STARTED|Overall Study||9
9724777|NCT00091273|10824524|FG000|COMPLETED|Overall Study||9
9724778|NCT00091273|10824524|FG000|NOT COMPLETED|Overall Study||0
9724779|NCT00091390|10824528|FG000|STARTED|Overall Study||129
9724780|NCT00091390|10824528|FG000|Eligible and Started Study Treatment|Overall Study||125
9724781|NCT00091390|10824528|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115
9724782|NCT00091390|10824528|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
9724783|NCT00091390|10824528|FG000|NOT COMPLETED|Overall Study||4
9724784|NCT00091442|10824534|FG000|STARTED|Overall Study||373
9724785|NCT00091442|10824535|FG001|STARTED|Overall Study||378
9724786|NCT00091442|10824534|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
9724787|NCT00091442|10824535|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
9724788|NCT00091442|10824534|FG000|NOT COMPLETED|Overall Study||369
9724789|NCT00091442|10824535|FG001|NOT COMPLETED|Overall Study||373
9724790|NCT00091507|10824543|FG000|STARTED|Overall Study||432
9724791|NCT00091507|10824544|FG001|STARTED|Overall Study||479
9724792|NCT00091507|10824543|FG000|COMPLETED|Overall Study||411
9724793|NCT00091507|10824544|FG001|COMPLETED|Overall Study||460
9724794|NCT00091507|10824543|FG000|NOT COMPLETED|Overall Study||21
9724795|NCT00091507|10824544|FG001|NOT COMPLETED|Overall Study||19
9724796|NCT00091572|10824552|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
10023254|NCT01854827|11146814|FG000|STARTED|Overall Study||30
10023255|NCT01854827|11146814|FG000|COMPLETED|Overall Study||29
9724797|NCT00091572|10824553|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
9724798|NCT00091572|10824552|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
9724799|NCT00091572|10824553|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
9681061|NCT03728153|10780722|FG000|STARTED|Overall Study||34
9681062|NCT03728153|10780722|FG000|COMPLETED|Overall Study||32
9681063|NCT03728153|10780722|FG000|NOT COMPLETED|Overall Study||2
9724800|NCT00091572|10824552|FG000|NOT COMPLETED|Overall Study||95
9724801|NCT00091572|10824553|FG001|NOT COMPLETED|Overall Study||82
9724802|NCT00091793|10824561|FG000|STARTED|Overall Study||166
9724803|NCT00091793|10824562|FG001|STARTED|Overall Study||166
9724804|NCT00091793|10824561|FG000|COMPLETED|Overall Study||142
9724805|NCT00091793|10824562|FG001|COMPLETED|Overall Study||144
9724806|NCT00091793|10824561|FG000|NOT COMPLETED|Overall Study||24
9724807|NCT00091793|10824562|FG001|NOT COMPLETED|Overall Study||22
9724808|NCT00091819|10824570|FG000|STARTED|Overall Study||429
9724809|NCT00091819|10824571|FG001|STARTED|Overall Study||433
9724810|NCT00091819|10824570|FG000|COMPLETED|Overall Study||387
9724811|NCT00091819|10824571|FG001|COMPLETED|Overall Study||387
9724812|NCT00091819|10824570|FG000|NOT COMPLETED|Overall Study||42
9724813|NCT00091819|10824571|FG001|NOT COMPLETED|Overall Study||46
9724814|NCT00091832|10824583|FG000|STARTED|Overall Study||43
9724815|NCT00091832|10824584|FG001|STARTED|Overall Study||42
9724816|NCT00091832|10824585|FG002|STARTED|Overall Study||42
9724817|NCT00091832|10824586|FG003|STARTED|Overall Study||43
9724818|NCT00091832|10824587|FG004|STARTED|Overall Study||42
9724819|NCT00091832|10824588|FG005|STARTED|Overall Study||43
9724820|NCT00091832|10824583|FG000|Received Study Medication|Overall Study||43
9724821|NCT00091832|10824584|FG001|Received Study Medication|Overall Study||42
9724822|NCT00091832|10824585|FG002|Received Study Medication|Overall Study||41
9724823|NCT00091832|10824586|FG003|Received Study Medication|Overall Study||43
9724824|NCT00091832|10824587|FG004|Received Study Medication|Overall Study||42
9724825|NCT00091832|10824588|FG005|Received Study Medication|Overall Study||43
9724826|NCT00091832|10824583|FG000|COMPLETED|Overall Study||29
9724827|NCT00091832|10824584|FG001|COMPLETED|Overall Study||31
9724828|NCT00091832|10824585|FG002|COMPLETED|Overall Study||30
9724829|NCT00091832|10824586|FG003|COMPLETED|Overall Study||29
9724830|NCT00091832|10824587|FG004|COMPLETED|Overall Study||27
9724831|NCT00091832|10824588|FG005|COMPLETED|Overall Study||32
9724832|NCT00091832|10824583|FG000|NOT COMPLETED|Overall Study||14
9724833|NCT00091832|10824584|FG001|NOT COMPLETED|Overall Study||11
9724834|NCT00091832|10824585|FG002|NOT COMPLETED|Overall Study||12
9724835|NCT00091832|10824586|FG003|NOT COMPLETED|Overall Study||14
9724836|NCT00091832|10824587|FG004|NOT COMPLETED|Overall Study||15
9724837|NCT00091832|10824588|FG005|NOT COMPLETED|Overall Study||11
9724838|NCT00091949|10824604|FG000|STARTED|Overall Study||1939
9724839|NCT00091949|10824605|FG001|STARTED|Overall Study||1937
9724840|NCT00091949|10824604|FG000|COMPLETED|Overall Study||1764
9724841|NCT00091949|10824605|FG001|COMPLETED|Overall Study||1786
9724842|NCT00091949|10824604|FG000|NOT COMPLETED|Overall Study||175
9724843|NCT00091949|10824605|FG001|NOT COMPLETED|Overall Study||151
9724844|NCT00091962|10824614|FG000|STARTED|Overall Study||150
9724845|NCT00091962|10824615|FG001|STARTED|Overall Study||152
9724846|NCT00091962|10824616|FG002|STARTED|Overall Study||151
9724847|NCT00091962|10824614|FG000|COMPLETED|Overall Study||150
9724848|NCT00091962|10824615|FG001|COMPLETED|Overall Study||152
9843578|NCT00831415|10955412|FG000|NOT COMPLETED|Overall Study||75
9843579|NCT00831428|10955416|FG000|STARTED|Overall Study||97
9843580|NCT00831428|10955416|FG000|COMPLETED|Overall Study||97
9843581|NCT00831428|10955416|FG000|NOT COMPLETED|Overall Study||0
9843582|NCT00831441|10955422|FG000|STARTED|Randomized||3687
9843583|NCT00831441|10955423|FG001|STARTED|Randomized||3705
9843584|NCT00831441|10955422|FG000|Treated|Randomized||3643
9843585|NCT00831441|10955423|FG001|Treated|Randomized||3672
9960602|NCT01468701|11080300|FG016|All Eligible Patient|Overall Study||11
9960603|NCT01468701|11080284|FG000|COMPLETED|Overall Study||3965
9960604|NCT01468701|11080285|FG001|COMPLETED|Overall Study||0
9960605|NCT01468701|11080286|FG002|COMPLETED|Overall Study||0
9960606|NCT01468701|11080287|FG003|COMPLETED|Overall Study||0
9960607|NCT01468701|11080288|FG004|COMPLETED|Overall Study||0
9960608|NCT01468701|11080289|FG005|COMPLETED|Overall Study||0
9843586|NCT00831441|10955422|FG000|COMPLETED|Randomized||0
9843587|NCT00831441|10955423|FG001|COMPLETED|Randomized||0
9843588|NCT00831441|10955422|FG000|NOT COMPLETED|Randomized||3687
9843589|NCT00831441|10955423|FG001|NOT COMPLETED|Randomized||3705
9843590|NCT00831441|10955422|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
9843591|NCT00831441|10955423|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
9843592|NCT00831441|10955422|FG000|COMPLETED|Follow Up (30 Days)||3375
9843593|NCT00831441|10955423|FG001|COMPLETED|Follow Up (30 Days)||3355
9843594|NCT00831441|10955422|FG000|NOT COMPLETED|Follow Up (30 Days)||133
9960609|NCT01468701|11080290|FG006|COMPLETED|Overall Study||0
9960610|NCT01468701|11080291|FG007|COMPLETED|Overall Study||0
9960611|NCT01468701|11080292|FG008|COMPLETED|Overall Study||3219
9724849|NCT00091962|10824616|FG002|COMPLETED|Overall Study||151
9724850|NCT00091962|10824614|FG000|NOT COMPLETED|Overall Study||0
9724851|NCT00091962|10824615|FG001|NOT COMPLETED|Overall Study||0
9960612|NCT01468701|11080293|FG009|COMPLETED|Overall Study||3780
9724852|NCT00091962|10824616|FG002|NOT COMPLETED|Overall Study||0
9960613|NCT01468701|11080294|FG010|COMPLETED|Overall Study||3256
9724853|NCT00092417|10824629|FG000|STARTED|Overall Study|Started Period Group 1|464
9724854|NCT00092417|10824630|FG001|STARTED|Overall Study|Started Period Group 2|234
9960614|NCT01468701|11080295|FG011|COMPLETED|Overall Study||3672
9724855|NCT00092417|10824629|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
9724856|NCT00092417|10824630|FG001|Vaccinated|Overall Study||234
9681064|NCT03724422|10780728|FG000|STARTED|Overall Study||1
9681065|NCT03724422|10780729|FG001|STARTED|Overall Study||2
9681066|NCT03724422|10780728|FG000|COMPLETED|Overall Study||1
9681067|NCT03724422|10780729|FG001|COMPLETED|Overall Study|Patients had interval healing then lost follow up|0
9681068|NCT03724422|10780728|FG000|NOT COMPLETED|Overall Study||0
9681069|NCT03724422|10780729|FG001|NOT COMPLETED|Overall Study||2
9724857|NCT00092417|10824629|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
9724858|NCT00092417|10824630|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
9724859|NCT00092417|10824629|FG000|NOT COMPLETED|Overall Study||5
9724860|NCT00092417|10824630|FG001|NOT COMPLETED|Overall Study||1
9724861|NCT00092443|10824638|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
9724862|NCT00092443|10824639|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
9724863|NCT00092443|10824638|FG000|Vaccinated at Visit 1|Overall Study||650
9724864|NCT00092443|10824639|FG001|Vaccinated at Visit 1|Overall Study||660
9724865|NCT00092443|10824638|FG000|Vaccinated at Visit 2|Overall Study||618
9724866|NCT00092443|10824639|FG001|Vaccinated at Visit 2|Overall Study||627
9724867|NCT00092443|10824638|FG000|Vaccinated at Visit 3|Overall Study||593
9724868|NCT00092443|10824639|FG001|Vaccinated at Visit 3|Overall Study||608
9724869|NCT00092443|10824638|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
9724870|NCT00092443|10824639|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
9724871|NCT00092443|10824638|FG000|NOT COMPLETED|Overall Study||58
9724872|NCT00092443|10824639|FG001|NOT COMPLETED|Overall Study||54
9724873|NCT00092456|10824659|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
9724874|NCT00092456|10824660|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
9724875|NCT00092456|10824661|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
9724876|NCT00092456|10824662|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
9724877|NCT00092456|10824659|FG000|Vaccinated at Visit 1|Overall Study||226
9724878|NCT00092456|10824660|FG001|Vaccinated at Visit 1|Overall Study||225
9724879|NCT00092456|10824661|FG002|Vaccinated at Visit 1|Overall Study||229
9724880|NCT00092456|10824662|FG003|Vaccinated at Visit 1|Overall Study||113
9724881|NCT00092456|10824659|FG000|Vaccinated at Visit 2|Overall Study||208
9724882|NCT00092456|10824660|FG001|Vaccinated at Visit 2|Overall Study||217
9724883|NCT00092456|10824661|FG002|Vaccinated at Visit 2|Overall Study||210
9724884|NCT00092456|10824662|FG003|Vaccinated at Visit 2|Overall Study||104
9724885|NCT00092456|10824659|FG000|Vaccinated at Visit 3|Overall Study||202
9724886|NCT00092456|10824660|FG001|Vaccinated at Visit 3|Overall Study||210
9724887|NCT00092456|10824661|FG002|Vaccinated at Visit 3|Overall Study||200
9843595|NCT00831441|10955423|FG001|NOT COMPLETED|Follow Up (30 Days)||174
9843596|NCT00831480|10955430|FG000|STARTED|Overall Study||9
9843597|NCT00831480|10955430|FG000|COMPLETED|Overall Study||7
9843598|NCT00831480|10955430|FG000|NOT COMPLETED|Overall Study||2
9843599|NCT00831493|10955434|FG000|STARTED|Overall Study||3
9843600|NCT00831493|10955434|FG000|COMPLETED|Overall Study||2
9843601|NCT00831493|10955434|FG000|NOT COMPLETED|Overall Study||1
9843602|NCT00831675|10955440|FG000|STARTED|Overall Study||12
9843603|NCT00831675|10955441|FG001|STARTED|Overall Study||18
9843604|NCT00831675|10955440|FG000|COMPLETED|Overall Study||12
9843605|NCT00831675|10955441|FG001|COMPLETED|Overall Study||18
9843606|NCT00831675|10955440|FG000|NOT COMPLETED|Overall Study||0
9843607|NCT00831675|10955441|FG001|NOT COMPLETED|Overall Study||0
9843608|NCT00831701|10955449|FG000|STARTED|Overall Study||50
9843609|NCT00831701|10955450|FG001|STARTED|Overall Study||50
9843610|NCT00831701|10955449|FG000|COMPLETED|Overall Study||45
9843611|NCT00831701|10955450|FG001|COMPLETED|Overall Study||45
9960615|NCT01468701|11080296|FG012|COMPLETED|Overall Study||284
9960616|NCT01468701|11080297|FG013|COMPLETED|Overall Study||1712
9960617|NCT01468701|11080298|FG014|COMPLETED|Overall Study||151
9960618|NCT01468701|11080299|FG015|COMPLETED|Overall Study||1056
9960619|NCT01468701|11080300|FG016|COMPLETED|Overall Study||10
9960620|NCT01468701|11080284|FG000|NOT COMPLETED|Overall Study||999
9960621|NCT01468701|11080285|FG001|NOT COMPLETED|Overall Study||5103
9960622|NCT01468701|11080286|FG002|NOT COMPLETED|Overall Study||1784
9960623|NCT01468701|11080287|FG003|NOT COMPLETED|Overall Study||715
9960624|NCT01468701|11080288|FG004|NOT COMPLETED|Overall Study||1736
9960625|NCT01468701|11080289|FG005|NOT COMPLETED|Overall Study||128
9960626|NCT01468701|11080290|FG006|NOT COMPLETED|Overall Study||1209
9960627|NCT01468701|11080291|FG007|NOT COMPLETED|Overall Study||5
9960628|NCT01468701|11080292|FG008|NOT COMPLETED|Overall Study||660
9960629|NCT01468701|11080293|FG009|NOT COMPLETED|Overall Study||1182
9960630|NCT01468701|11080294|FG010|NOT COMPLETED|Overall Study||798
9960631|NCT01468701|11080295|FG011|NOT COMPLETED|Overall Study||866
9960632|NCT01468701|11080296|FG012|NOT COMPLETED|Overall Study||49
9960633|NCT01468701|11080297|FG013|NOT COMPLETED|Overall Study||470
9960634|NCT01468701|11080298|FG014|NOT COMPLETED|Overall Study||63
9960635|NCT01468701|11080299|FG015|NOT COMPLETED|Overall Study||362
9960636|NCT01468701|11080300|FG016|NOT COMPLETED|Overall Study||1
9960637|NCT01468818|11080313|FG000|STARTED|Overall Study||18
9960638|NCT01468818|11080313|FG000|COMPLETED|Overall Study||16
9960639|NCT01468818|11080313|FG000|NOT COMPLETED|Overall Study||2
10023256|NCT01854827|11146814|FG000|NOT COMPLETED|Overall Study||1
9681070|NCT03720899|10780737|FG000|STARTED|Overall Study||21
9681071|NCT03720899|10780738|FG001|STARTED|Overall Study||24
9681072|NCT03720899|10780737|FG000|COMPLETED|Overall Study||13
9681073|NCT03720899|10780738|FG001|COMPLETED|Overall Study||13
9681074|NCT03720899|10780737|FG000|NOT COMPLETED|Overall Study||8
9681075|NCT03720899|10780738|FG001|NOT COMPLETED|Overall Study||11
9681076|NCT03716869|10780746|FG000|STARTED|Overall Study||6436
9681077|NCT03716869|10780747|FG001|STARTED|Overall Study||6473
9843612|NCT00831701|10955449|FG000|NOT COMPLETED|Overall Study||5
9843613|NCT00831701|10955450|FG001|NOT COMPLETED|Overall Study||5
9843614|NCT00831753|10955458|FG000|STARTED|Overall Study||132
9843615|NCT00831753|10955459|FG001|STARTED|Overall Study||131
9843616|NCT00831753|10955458|FG000|COMPLETED|Overall Study||132
9843617|NCT00831753|10955459|FG001|COMPLETED|Overall Study||131
9843618|NCT00831753|10955458|FG000|NOT COMPLETED|Overall Study||0
9843619|NCT00831753|10955459|FG001|NOT COMPLETED|Overall Study||0
9843620|NCT00831766|10955467|FG000|STARTED|Overall Study||23
9843621|NCT00831766|10955468|FG001|STARTED|Overall Study||28
9843622|NCT00831766|10955467|FG000|COMPLETED|Overall Study||23
9843623|NCT00831766|10955468|FG001|COMPLETED|Overall Study||28
9843624|NCT00831766|10955467|FG000|NOT COMPLETED|Overall Study||0
9843625|NCT00831766|10955468|FG001|NOT COMPLETED|Overall Study||0
9843626|NCT00831779|10955477|FG000|STARTED|Overall Study||21
9843627|NCT00831779|10955478|FG001|STARTED|Overall Study||23
9843628|NCT00831779|10955477|FG000|COMPLETED|Overall Study||20
9843629|NCT00831779|10955478|FG001|COMPLETED|Overall Study||22
9843630|NCT00831779|10955477|FG000|NOT COMPLETED|Overall Study||1
9843631|NCT00831779|10955478|FG001|NOT COMPLETED|Overall Study||1
9843632|NCT00831792|10955484|FG000|STARTED|Overall Study||46
9843633|NCT00831792|10955484|FG000|COMPLETED|Overall Study||40
9843634|NCT00831792|10955484|FG000|NOT COMPLETED|Overall Study||6
9843635|NCT00831844|10955498|FG000|STARTED|Overall Study||10
9843636|NCT00831844|10955499|FG001|STARTED|Overall Study||12
9843637|NCT00831844|10955500|FG002|STARTED|Overall Study||21
9843638|NCT00831844|10955501|FG003|STARTED|Overall Study||10
9843639|NCT00831844|10955502|FG004|STARTED|Overall Study||14
9843640|NCT00831844|10955503|FG005|STARTED|Overall Study||20
9843641|NCT00831844|10955504|FG006|STARTED|Overall Study||10
9843642|NCT00831844|10955505|FG007|STARTED|Overall Study||10
9843643|NCT00831844|10955506|FG008|STARTED|Overall Study||9
9843644|NCT00831844|10955507|FG009|STARTED|Overall Study||0
9843645|NCT00831844|10955498|FG000|COMPLETED|Overall Study||0
9843646|NCT00831844|10955499|FG001|COMPLETED|Overall Study||0
9843647|NCT00831844|10955500|FG002|COMPLETED|Overall Study||1
9843648|NCT00831844|10955501|FG003|COMPLETED|Overall Study||0
9843649|NCT00831844|10955502|FG004|COMPLETED|Overall Study||0
9843650|NCT00831844|10955503|FG005|COMPLETED|Overall Study||1
9843651|NCT00831844|10955504|FG006|COMPLETED|Overall Study||0
9843652|NCT00831844|10955505|FG007|COMPLETED|Overall Study||0
9843653|NCT00831844|10955506|FG008|COMPLETED|Overall Study||0
9843654|NCT00831844|10955507|FG009|COMPLETED|Overall Study||0
9843655|NCT00831844|10955498|FG000|NOT COMPLETED|Overall Study||10
9843656|NCT00831844|10955499|FG001|NOT COMPLETED|Overall Study||12
9843657|NCT00831844|10955500|FG002|NOT COMPLETED|Overall Study||20
9843658|NCT00831844|10955501|FG003|NOT COMPLETED|Overall Study||10
9843659|NCT00831844|10955502|FG004|NOT COMPLETED|Overall Study||14
9843660|NCT00831844|10955503|FG005|NOT COMPLETED|Overall Study||19
9843661|NCT00831844|10955504|FG006|NOT COMPLETED|Overall Study||10
9843662|NCT00831844|10955505|FG007|NOT COMPLETED|Overall Study||10
9843663|NCT00831844|10955506|FG008|NOT COMPLETED|Overall Study||9
9681078|NCT03716869|10780746|FG000|COMPLETED|Overall Study||6436
9681079|NCT03716869|10780747|FG001|COMPLETED|Overall Study||6473
9681080|NCT03716869|10780746|FG000|NOT COMPLETED|Overall Study||0
9681081|NCT03716869|10780747|FG001|NOT COMPLETED|Overall Study||0
9681088|NCT04598152|10780762|FG000|STARTED|Overall Study||3
9681089|NCT04598152|10780763|FG001|STARTED|Overall Study||1
9681090|NCT04598152|10780762|FG000|COMPLETED|Overall Study||3
9681091|NCT04598152|10780763|FG001|COMPLETED|Overall Study||0
9681092|NCT04598152|10780762|FG000|NOT COMPLETED|Overall Study||0
9681093|NCT04598152|10780763|FG001|NOT COMPLETED|Overall Study||1
9681094|NCT04353271|10780771|FG000|STARTED|Overall Study||1
9681095|NCT04353271|10780772|FG001|STARTED|Overall Study||2
9681096|NCT04353271|10780771|FG000|COMPLETED|Overall Study||1
9681097|NCT04353271|10780772|FG001|COMPLETED|Overall Study||1
9681098|NCT04353271|10780771|FG000|NOT COMPLETED|Overall Study||0
9681099|NCT04353271|10780772|FG001|NOT COMPLETED|Overall Study||1
9681100|NCT05166824|10780782|FG000|STARTED|Overall Study||1
9681101|NCT05166824|10780783|FG001|STARTED|Overall Study||10
9681102|NCT05166824|10780784|FG002|STARTED|Overall Study||68
9681103|NCT05166824|10780785|FG003|STARTED|Overall Study||10
9681104|NCT05166824|10780782|FG000|COMPLETED|Overall Study||1
9681105|NCT05166824|10780783|FG001|COMPLETED|Overall Study||10
9681106|NCT05166824|10780784|FG002|COMPLETED|Overall Study||59
9681107|NCT05166824|10780785|FG003|COMPLETED|Overall Study||10
9681108|NCT05166824|10780782|FG000|NOT COMPLETED|Overall Study||0
9681109|NCT05166824|10780783|FG001|NOT COMPLETED|Overall Study||0
9843664|NCT00831844|10955507|FG009|NOT COMPLETED|Overall Study||0
9843665|NCT00831987|10955531|FG000|STARTED|Overall Study||60
9843666|NCT00831987|10955532|FG001|STARTED|Overall Study||60
9843667|NCT00831987|10955531|FG000|COMPLETED|Overall Study||60
9843668|NCT00831987|10955532|FG001|COMPLETED|Overall Study||60
9843669|NCT00831987|10955531|FG000|NOT COMPLETED|Overall Study||0
9843670|NCT00831987|10955532|FG001|NOT COMPLETED|Overall Study||0
9681082|NCT03713957|10780755|FG000|STARTED|Overall Study||53
9681083|NCT03713957|10780756|FG001|STARTED|Overall Study||26
9681084|NCT03713957|10780755|FG000|COMPLETED|Overall Study||35
9681085|NCT03713957|10780756|FG001|COMPLETED|Overall Study||16
9681086|NCT03713957|10780755|FG000|NOT COMPLETED|Overall Study||18
9681087|NCT03713957|10780756|FG001|NOT COMPLETED|Overall Study||10
10023257|NCT01854879|11146818|FG000|STARTED|Overall Study|97 consented|97
10023258|NCT01854879|11146818|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92
10023259|NCT01854879|11146818|FG000|NOT COMPLETED|Overall Study||5
10023260|NCT01854905|11146822|FG000|STARTED|Overall Study||400
10023261|NCT01854905|11146822|FG000|COMPLETED|Overall Study||400
10023262|NCT01854905|11146822|FG000|NOT COMPLETED|Overall Study||0
9681110|NCT05166824|10780784|FG002|NOT COMPLETED|Overall Study||9
9681111|NCT05166824|10780785|FG003|NOT COMPLETED|Overall Study||0
9724888|NCT00092456|10824662|FG003|Vaccinated at Visit 3|Overall Study||98
10023263|NCT01854918|11146828|FG000|STARTED|SOC-controlled Period (Year 1)||1227
10023264|NCT01854918|11146829|FG001|STARTED|SOC-controlled Period (Year 1)||2454
10023265|NCT01854918|11146828|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
10023266|NCT01854918|11146829|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452
9724889|NCT00092456|10824659|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
9724890|NCT00092456|10824660|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
9724891|NCT00092456|10824661|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
9724892|NCT00092456|10824662|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
9724893|NCT00092456|10824659|FG000|NOT COMPLETED|Overall Study||25
9724894|NCT00092456|10824660|FG001|NOT COMPLETED|Overall Study||17
9724895|NCT00092456|10824661|FG002|NOT COMPLETED|Overall Study||29
9724896|NCT00092456|10824662|FG003|NOT COMPLETED|Overall Study||16
9724897|NCT00092495|10824676|FG000|STARTED|Base Study Vaccination Period||504
9724898|NCT00092495|10824677|FG001|STARTED|Base Study Vaccination Period||514
9724899|NCT00092495|10824678|FG002|STARTED|Base Study Vaccination Period||508
9724900|NCT00092495|10824679|FG003|STARTED|Base Study Vaccination Period||1529
9724901|NCT00092495|10824680|FG004|STARTED|Base Study Vaccination Period||0
9724902|NCT00092495|10824676|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
9724903|NCT00092495|10824677|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
9724904|NCT00092495|10824678|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
9724905|NCT00092495|10824679|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
9724906|NCT00092495|10824680|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0
9724907|NCT00092495|10824676|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
9724908|NCT00092495|10824677|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
9724909|NCT00092495|10824678|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
9724910|NCT00092495|10824679|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
9724911|NCT00092495|10824680|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0
9724912|NCT00092495|10824676|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
9724913|NCT00092495|10824677|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
9724914|NCT00092495|10824678|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
9724915|NCT00092495|10824679|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
9724916|NCT00092495|10824680|FG004|COMPLETED|Base Study Vaccination Period||0
9724917|NCT00092495|10824676|FG000|NOT COMPLETED|Base Study Vaccination Period||37
9724918|NCT00092495|10824677|FG001|NOT COMPLETED|Base Study Vaccination Period||22
9724919|NCT00092495|10824678|FG002|NOT COMPLETED|Base Study Vaccination Period||34
9724920|NCT00092495|10824679|FG003|NOT COMPLETED|Base Study Vaccination Period||88
9724921|NCT00092495|10824680|FG004|NOT COMPLETED|Base Study Vaccination Period||0
9724922|NCT00092495|10824676|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
9724923|NCT00092495|10824677|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
9724924|NCT00092495|10824678|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
9724925|NCT00092495|10824679|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
9724926|NCT00092495|10824680|FG004|STARTED|Base Study Follow-up Period||0
10023267|NCT01854918|11146828|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197
10023268|NCT01854918|11146829|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391
10081174|NCT02258334|11209642|FG002|COMPLETED|Overall Study||52
9681112|NCT04570670|10780797|FG000|STARTED|Overall Study||25
9681113|NCT04570670|10780798|FG001|STARTED|Overall Study||25
9681114|NCT04570670|10780797|FG000|COMPLETED|Overall Study||24
9681115|NCT04570670|10780798|FG001|COMPLETED|Overall Study||25
9681116|NCT04570670|10780797|FG000|NOT COMPLETED|Overall Study||1
9681117|NCT04570670|10780798|FG001|NOT COMPLETED|Overall Study||0
9681118|NCT04552704|10780807|FG000|STARTED|Overall Study||3
9681119|NCT04552704|10780807|FG000|COMPLETED|Overall Study||3
9681120|NCT04552704|10780807|FG000|NOT COMPLETED|Overall Study||0
9681121|NCT04546581|10780814|FG000|STARTED|Overall Study||301
9681122|NCT04546581|10780815|FG001|STARTED|Overall Study||292
9681123|NCT04546581|10780814|FG000|COMPLETED|Overall Study||288
9681124|NCT04546581|10780815|FG001|COMPLETED|Overall Study||279
9681125|NCT04546581|10780814|FG000|NOT COMPLETED|Overall Study||13
9681126|NCT04546581|10780815|FG001|NOT COMPLETED|Overall Study||13
9681127|NCT04236245|10780821|FG000|STARTED|Overall Study||25
9681128|NCT04236245|10780821|FG000|COMPLETED|Overall Study||25
9681129|NCT04236245|10780821|FG000|NOT COMPLETED|Overall Study||0
9681130|NCT03915626|10780825|FG000|STARTED|Overall Study||7
9843671|NCT00832000|10955538|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
9843672|NCT00832000|10955539|FG001|STARTED|Overall Study|Placebo|30
9843673|NCT00832000|10955538|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
9843674|NCT00832000|10955539|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
9843675|NCT00832000|10955538|FG000|COMPLETED|Overall Study||23
9843676|NCT00832000|10955539|FG001|COMPLETED|Overall Study||29
9843677|NCT00832000|10955538|FG000|NOT COMPLETED|Overall Study||6
9843678|NCT00832000|10955539|FG001|NOT COMPLETED|Overall Study||1
9843679|NCT00832078|10955574|FG000|STARTED|Test Day 1- 1 Period||13
9843680|NCT00832078|10955575|FG001|STARTED|Test Day 1- 1 Period||12
9843681|NCT00832078|10955574|FG000|COMPLETED|Test Day 1- 1 Period||13
9843682|NCT00832078|10955575|FG001|COMPLETED|Test Day 1- 1 Period||12
9843683|NCT00832078|10955574|FG000|NOT COMPLETED|Test Day 1- 1 Period||0
9843684|NCT00832078|10955575|FG001|NOT COMPLETED|Test Day 1- 1 Period||0
9843685|NCT00832078|10955574|FG000|STARTED|Test Day 1-2 Period||13
9843686|NCT00832078|10955575|FG001|STARTED|Test Day 1-2 Period||12
9843687|NCT00832078|10955574|FG000|COMPLETED|Test Day 1-2 Period||13
9843688|NCT00832078|10955575|FG001|COMPLETED|Test Day 1-2 Period||10
9843689|NCT00832078|10955574|FG000|NOT COMPLETED|Test Day 1-2 Period||0
9843690|NCT00832078|10955575|FG001|NOT COMPLETED|Test Day 1-2 Period||2
9843691|NCT00832078|10955574|FG000|STARTED|Test Day 2 - 1 Period||13
9843692|NCT00832078|10955575|FG001|STARTED|Test Day 2 - 1 Period||10
9843693|NCT00832078|10955574|FG000|COMPLETED|Test Day 2 - 1 Period||13
9843694|NCT00832078|10955575|FG001|COMPLETED|Test Day 2 - 1 Period||10
9843695|NCT00832078|10955574|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0
9843696|NCT00832078|10955575|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0
9843697|NCT00832078|10955574|FG000|STARTED|Test Day 2 - 2 Period||13
9843698|NCT00832078|10955575|FG001|STARTED|Test Day 2 - 2 Period||10
9843699|NCT00832078|10955574|FG000|COMPLETED|Test Day 2 - 2 Period||12
9843700|NCT00832078|10955575|FG001|COMPLETED|Test Day 2 - 2 Period||10
9843701|NCT00832078|10955574|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1
9843702|NCT00832078|10955575|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0
9843703|NCT00832091|10955583|FG000|STARTED|Overall Study||17
9843704|NCT00832091|10955584|FG001|STARTED|Overall Study||55
9843705|NCT00832091|10955583|FG000|COMPLETED|Overall Study||12
9843706|NCT00832091|10955584|FG001|COMPLETED|Overall Study||53
9843707|NCT00832091|10955583|FG000|NOT COMPLETED|Overall Study||5
9843708|NCT00832091|10955584|FG001|NOT COMPLETED|Overall Study||2
9843709|NCT00832117|10955592|FG000|STARTED|Overall Study||29
9843710|NCT00832117|10955592|FG000|COMPLETED|Overall Study||17
9843711|NCT00832117|10955592|FG000|NOT COMPLETED|Overall Study||12
9843712|NCT00832130|10955601|FG000|STARTED|Overall Study||69
9843713|NCT00832130|10955602|FG001|STARTED|Overall Study||70
9843714|NCT00832130|10955601|FG000|COMPLETED|Overall Study||69
9681131|NCT03915626|10780825|FG000|COMPLETED|Overall Study||6
9681132|NCT03915626|10780825|FG000|NOT COMPLETED|Overall Study||1
9960640|NCT01468844|11080319|FG000|STARTED|Overall Study||4
9960641|NCT01468844|11080320|FG001|STARTED|Overall Study||2
9960642|NCT01468844|11080319|FG000|COMPLETED|Overall Study||2
9681133|NCT03698279|10780841|FG000|STARTED|Overall Study||124
9681134|NCT03698279|10780842|FG001|STARTED|Overall Study||122
9843715|NCT00832130|10955602|FG001|COMPLETED|Overall Study||70
9843716|NCT00832130|10955601|FG000|NOT COMPLETED|Overall Study||0
9843717|NCT00832130|10955602|FG001|NOT COMPLETED|Overall Study||0
9960643|NCT01468844|11080320|FG001|COMPLETED|Overall Study||2
9960644|NCT01468844|11080319|FG000|NOT COMPLETED|Overall Study||2
9681135|NCT03698279|10780843|FG002|STARTED|Overall Study||159
9681136|NCT03698279|10780844|FG003|STARTED|Overall Study||234
9681137|NCT03698279|10780845|FG004|STARTED|Overall Study||13
9681138|NCT03698279|10780846|FG005|STARTED|Overall Study||13
9681139|NCT03698279|10780841|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122
9681140|NCT03698279|10780842|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121
9681141|NCT03698279|10780843|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158
9681142|NCT03698279|10780844|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234
9681143|NCT03698279|10780845|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13
9681144|NCT03698279|10780846|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13
9681145|NCT03698279|10780841|FG000|COMPLETED|Overall Study||119
9681146|NCT03698279|10780842|FG001|COMPLETED|Overall Study||120
9681147|NCT03698279|10780843|FG002|COMPLETED|Overall Study||152
9681148|NCT03698279|10780844|FG003|COMPLETED|Overall Study||228
9681149|NCT03698279|10780845|FG004|COMPLETED|Overall Study||13
9681150|NCT03698279|10780846|FG005|COMPLETED|Overall Study||13
9681151|NCT03698279|10780841|FG000|NOT COMPLETED|Overall Study||5
9681152|NCT03698279|10780842|FG001|NOT COMPLETED|Overall Study||2
9681153|NCT03698279|10780843|FG002|NOT COMPLETED|Overall Study||7
9681154|NCT03698279|10780844|FG003|NOT COMPLETED|Overall Study||6
9681155|NCT03698279|10780845|FG004|NOT COMPLETED|Overall Study||0
9681156|NCT03698279|10780846|FG005|NOT COMPLETED|Overall Study||0
9681157|NCT03559010|10780865|FG000|STARTED|Overall Study|The number of participants to start a period is not equal to the number who completed previous period|189
9681158|NCT03559010|10780865|FG000|Purchaser Population|Overall Study||113
9681159|NCT03559010|10780865|FG000|Use Phase Norgestrel 0.075 mg|Overall Study||109
9681160|NCT03559010|10780865|FG000|COMPLETED|Overall Study||189
9681161|NCT03559010|10780865|FG000|NOT COMPLETED|Overall Study||0
9681162|NCT03478930|10780876|FG000|STARTED|Overall Study||126
9681163|NCT03478930|10780877|FG001|STARTED|Overall Study||123
9681164|NCT03478930|10780876|FG000|COMPLETED|Overall Study||117
9681165|NCT03478930|10780877|FG001|COMPLETED|Overall Study||114
9681166|NCT03478930|10780876|FG000|NOT COMPLETED|Overall Study||9
9681167|NCT03478930|10780877|FG001|NOT COMPLETED|Overall Study||9
9681168|NCT03434353|10780888|FG000|STARTED|Overall Study||30
9681169|NCT03434353|10780889|FG001|STARTED|Overall Study||12
9681170|NCT03434353|10780890|FG002|STARTED|Overall Study||30
9681171|NCT03434353|10780891|FG003|STARTED|Overall Study||21
9681172|NCT03434353|10780892|FG004|STARTED|Overall Study||30
9681173|NCT03434353|10780888|FG000|COMPLETED|Overall Study||16
9681174|NCT03434353|10780889|FG001|COMPLETED|Overall Study||9
9681175|NCT03434353|10780890|FG002|COMPLETED|Overall Study||16
9681176|NCT03434353|10780891|FG003|COMPLETED|Overall Study||18
9681177|NCT03434353|10780892|FG004|COMPLETED|Overall Study||12
9681178|NCT03434353|10780888|FG000|NOT COMPLETED|Overall Study||14
9681179|NCT03434353|10780889|FG001|NOT COMPLETED|Overall Study||3
9681180|NCT03434353|10780890|FG002|NOT COMPLETED|Overall Study||14
9681181|NCT03434353|10780891|FG003|NOT COMPLETED|Overall Study||3
9681182|NCT03434353|10780892|FG004|NOT COMPLETED|Overall Study||18
9681183|NCT03415022|10780906|FG000|STARTED|Overall Study||21
9681184|NCT03415022|10780907|FG001|STARTED|Overall Study||20
9681185|NCT03415022|10780906|FG000|COMPLETED|Overall Study||16
9681186|NCT03415022|10780907|FG001|COMPLETED|Overall Study||15
9681187|NCT03415022|10780906|FG000|NOT COMPLETED|Overall Study||5
9681188|NCT03415022|10780907|FG001|NOT COMPLETED|Overall Study||5
9681189|NCT03283670|10780913|FG000|STARTED|Placebo Gas||24
9681190|NCT03283670|10780913|FG000|COMPLETED|Placebo Gas||22
9681191|NCT03283670|10780913|FG000|NOT COMPLETED|Placebo Gas||2
9681192|NCT03283670|10780913|FG000|STARTED|25% Nitrous Oxide||24
9681193|NCT03283670|10780913|FG000|COMPLETED|25% Nitrous Oxide||20
9681194|NCT03283670|10780913|FG000|NOT COMPLETED|25% Nitrous Oxide||4
9681195|NCT03283670|10780913|FG000|STARTED|50% Nitrous Oxide||24
9681196|NCT03283670|10780913|FG000|COMPLETED|50% Nitrous Oxide||23
9681197|NCT03283670|10780913|FG000|NOT COMPLETED|50% Nitrous Oxide||1
9681198|NCT03233217|10780926|FG000|STARTED|Overall Study||5
9681199|NCT03233217|10780927|FG001|STARTED|Overall Study||5
9681200|NCT03233217|10780928|FG002|STARTED|Overall Study||55
9681201|NCT03233217|10780929|FG003|STARTED|Overall Study||55
9681202|NCT03233217|10780930|FG004|STARTED|Overall Study||55
9681203|NCT03233217|10780926|FG000|Safety Analysis Set (SafAS)|Overall Study||5
9681204|NCT03233217|10780927|FG001|Safety Analysis Set (SafAS)|Overall Study||5
9681205|NCT03233217|10780928|FG002|Safety Analysis Set (SafAS)|Overall Study||55
9681206|NCT03233217|10780929|FG003|Safety Analysis Set (SafAS)|Overall Study||55
9681207|NCT03233217|10780930|FG004|Safety Analysis Set (SafAS)|Overall Study||55
9681208|NCT03233217|10780926|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5
9681209|NCT03233217|10780927|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5
9681210|NCT03233217|10780928|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55
9681211|NCT03233217|10780929|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55
9681212|NCT03233217|10780930|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54
9681213|NCT03233217|10780926|FG000|COMPLETED|Overall Study||5
9681214|NCT03233217|10780927|FG001|COMPLETED|Overall Study||5
9681215|NCT03233217|10780928|FG002|COMPLETED|Overall Study||55
9681216|NCT03233217|10780929|FG003|COMPLETED|Overall Study||55
9681217|NCT03233217|10780930|FG004|COMPLETED|Overall Study||55
9681218|NCT03233217|10780926|FG000|NOT COMPLETED|Overall Study||0
9681219|NCT03233217|10780927|FG001|NOT COMPLETED|Overall Study||0
9681220|NCT03233217|10780928|FG002|NOT COMPLETED|Overall Study||0
9681221|NCT03233217|10780929|FG003|NOT COMPLETED|Overall Study||0
9681222|NCT03233217|10780930|FG004|NOT COMPLETED|Overall Study||0
9681223|NCT03219567|10780944|FG000|STARTED|Overall Study||18
9681224|NCT03219567|10780945|FG001|STARTED|Overall Study||64
9681225|NCT03219567|10780944|FG000|COMPLETED|Overall Study||18
9681226|NCT03219567|10780945|FG001|COMPLETED|Overall Study||63
9681227|NCT03219567|10780944|FG000|NOT COMPLETED|Overall Study||0
9681228|NCT03219567|10780945|FG001|NOT COMPLETED|Overall Study||1
9681229|NCT03205358|10780954|FG000|STARTED|Overall Study||94
9681230|NCT03205358|10780955|FG001|STARTED|Overall Study||94
9681231|NCT03205358|10780954|FG000|COMPLETED|Overall Study||94
9681232|NCT03205358|10780955|FG001|COMPLETED|Overall Study||94
9681233|NCT03205358|10780954|FG000|NOT COMPLETED|Overall Study||0
9681234|NCT03205358|10780955|FG001|NOT COMPLETED|Overall Study||0
9681235|NCT03153111|10780963|FG000|STARTED|Overall Study||71
9681236|NCT03153111|10780964|FG001|STARTED|Overall Study||71
9681237|NCT03153111|10780963|FG000|COMPLETED|Overall Study||60
9681238|NCT03153111|10780964|FG001|COMPLETED|Overall Study||62
9681239|NCT03153111|10780963|FG000|NOT COMPLETED|Overall Study||11
9681240|NCT03153111|10780964|FG001|NOT COMPLETED|Overall Study||9
9681241|NCT03073733|10780973|FG000|STARTED|Overall Study||29
9681242|NCT03073733|10780974|FG001|STARTED|Overall Study||27
9681243|NCT03073733|10780975|FG002|STARTED|Overall Study||27
9681244|NCT03073733|10780973|FG000|COMPLETED|Overall Study||28
9681245|NCT03073733|10780974|FG001|COMPLETED|Overall Study||26
9681246|NCT03073733|10780975|FG002|COMPLETED|Overall Study||26
9681247|NCT03073733|10780973|FG000|NOT COMPLETED|Overall Study||1
9681248|NCT03073733|10780974|FG001|NOT COMPLETED|Overall Study||1
9681249|NCT03073733|10780975|FG002|NOT COMPLETED|Overall Study||1
9681250|NCT02821000|10780985|FG000|STARTED|Overall Study||103
9681251|NCT02821000|10780985|FG000|Treated|Overall Study||103
9681252|NCT02821000|10780985|FG000|COMPLETED|Overall Study||0
9681253|NCT02821000|10780985|FG000|NOT COMPLETED|Overall Study||103
9681254|NCT02749968|10780991|FG000|STARTED|Overall Study||50
9681255|NCT02749968|10780992|FG001|STARTED|Overall Study||50
9681256|NCT02749968|10780991|FG000|Interim Analysis|Overall Study||25
9681257|NCT02749968|10780992|FG001|Interim Analysis|Overall Study||25
9681258|NCT02749968|10780991|FG000|COMPLETED|Overall Study||50
9681259|NCT02749968|10780992|FG001|COMPLETED|Overall Study||50
9681260|NCT02749968|10780991|FG000|NOT COMPLETED|Overall Study||0
9681261|NCT02749968|10780992|FG001|NOT COMPLETED|Overall Study||0
9681262|NCT02738255|10781000|FG000|STARTED|Overall Study||11
9681263|NCT02738255|10781001|FG001|STARTED|Overall Study||15
9681264|NCT02738255|10781000|FG000|COMPLETED|Overall Study||11
9681265|NCT02738255|10781001|FG001|COMPLETED|Overall Study||14
9681266|NCT02738255|10781000|FG000|NOT COMPLETED|Overall Study||0
9681267|NCT02738255|10781001|FG001|NOT COMPLETED|Overall Study||1
9681268|NCT02702414|10781013|FG000|STARTED|Overall Study||105
9681269|NCT02702414|10781014|FG001|STARTED|Overall Study||51
9681270|NCT02702414|10781013|FG000|Treated|Overall Study||104
9681271|NCT02702414|10781014|FG001|Treated|Overall Study||51
9681272|NCT02702414|10781013|FG000|COMPLETED|Overall Study||0
9681273|NCT02702414|10781014|FG001|COMPLETED|Overall Study||0
9681274|NCT02702414|10781013|FG000|NOT COMPLETED|Overall Study||105
9681275|NCT02702414|10781014|FG001|NOT COMPLETED|Overall Study||51
9724927|NCT00092495|10824676|FG000|COMPLETED|Base Study Follow-up Period||112
9724928|NCT00092495|10824677|FG001|COMPLETED|Base Study Follow-up Period||122
9724929|NCT00092495|10824678|FG002|COMPLETED|Base Study Follow-up Period||126
9724930|NCT00092495|10824679|FG003|COMPLETED|Base Study Follow-up Period||446
9724931|NCT00092495|10824680|FG004|COMPLETED|Base Study Follow-up Period||0
9724932|NCT00092495|10824676|FG000|NOT COMPLETED|Base Study Follow-up Period||3
9724933|NCT00092495|10824677|FG001|NOT COMPLETED|Base Study Follow-up Period||3
9724934|NCT00092495|10824678|FG002|NOT COMPLETED|Base Study Follow-up Period||4
9724935|NCT00092495|10824679|FG003|NOT COMPLETED|Base Study Follow-up Period||14
9724936|NCT00092495|10824680|FG004|NOT COMPLETED|Base Study Follow-up Period||0
9724937|NCT00092495|10824676|FG000|STARTED|Extension Study||0
9724938|NCT00092495|10824677|FG001|STARTED|Extension Study||0
9724939|NCT00092495|10824678|FG002|STARTED|Extension Study||0
9724940|NCT00092495|10824679|FG003|STARTED|Extension Study||0
9724941|NCT00092495|10824680|FG004|STARTED|Extension Study||12
9724942|NCT00092495|10824676|FG000|COMPLETED|Extension Study||0
9724943|NCT00092495|10824677|FG001|COMPLETED|Extension Study||0
9724944|NCT00092495|10824678|FG002|COMPLETED|Extension Study||0
9724945|NCT00092495|10824679|FG003|COMPLETED|Extension Study||0
9724946|NCT00092495|10824680|FG004|COMPLETED|Extension Study||12
9724947|NCT00092495|10824676|FG000|NOT COMPLETED|Extension Study||0
9724948|NCT00092495|10824677|FG001|NOT COMPLETED|Extension Study||0
9724949|NCT00092495|10824678|FG002|NOT COMPLETED|Extension Study||0
9724950|NCT00092495|10824679|FG003|NOT COMPLETED|Extension Study||0
9724951|NCT00092495|10824680|FG004|NOT COMPLETED|Extension Study||0
9724952|NCT00092521|10824696|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723
9724953|NCT00092521|10824697|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304
9724954|NCT00092521|10824698|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732
9724955|NCT00092521|10824699|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0
9724956|NCT00092521|10824696|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
9724957|NCT00092521|10824697|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290
9724958|NCT00092521|10824698|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
9724959|NCT00092521|10824699|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0
9724960|NCT00092521|10824696|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
9724961|NCT00092521|10824697|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
9724962|NCT00092521|10824698|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
9681276|NCT02605616|10781024|FG000|STARTED|Overall Study||46
9681277|NCT02605616|10781025|FG001|STARTED|Overall Study||47
9681278|NCT02605616|10781024|FG000|COMPLETED|Overall Study||42
9681279|NCT02605616|10781025|FG001|COMPLETED|Overall Study||43
9681280|NCT02605616|10781024|FG000|NOT COMPLETED|Overall Study||4
9681281|NCT02605616|10781025|FG001|NOT COMPLETED|Overall Study||4
9681282|NCT02573233|10781033|FG000|STARTED|Overall Study||22
9681283|NCT02573233|10781034|FG001|STARTED|Overall Study||20
9681284|NCT02573233|10781033|FG000|COMPLETED|Overall Study||22
9681285|NCT02573233|10781034|FG001|COMPLETED|Overall Study||20
9681286|NCT02573233|10781033|FG000|NOT COMPLETED|Overall Study||0
9681287|NCT02573233|10781034|FG001|NOT COMPLETED|Overall Study||0
9681288|NCT02425904|10781043|FG000|STARTED|Overall Study||20
9681289|NCT02425904|10781044|FG001|STARTED|Overall Study||5
9681290|NCT02425904|10781043|FG000|Efficacy Analysis|Overall Study||20
9681291|NCT02425904|10781044|FG001|Efficacy Analysis|Overall Study|1 patient was incorrectly assigned to LCH-related disorders cohort but it is actually LCH patients, so excluded from efficacy analysis.|4
9681292|NCT02425904|10781043|FG000|COMPLETED|Overall Study||17
9681293|NCT02425904|10781044|FG001|COMPLETED|Overall Study||2
9681294|NCT02425904|10781043|FG000|NOT COMPLETED|Overall Study||3
9681295|NCT02425904|10781044|FG001|NOT COMPLETED|Overall Study||3
9681296|NCT02420795|10781054|FG000|STARTED|Overall Study||4
9681297|NCT02420795|10781055|FG001|STARTED|Overall Study||2
9681298|NCT02420795|10781056|FG002|STARTED|Overall Study||5
9681299|NCT02420795|10781054|FG000|COMPLETED|Overall Study||0
9681300|NCT02420795|10781055|FG001|COMPLETED|Overall Study||0
9681301|NCT02420795|10781056|FG002|COMPLETED|Overall Study||0
9681302|NCT02420795|10781054|FG000|NOT COMPLETED|Overall Study||4
9681303|NCT02420795|10781055|FG001|NOT COMPLETED|Overall Study||2
9681304|NCT02420795|10781056|FG002|NOT COMPLETED|Overall Study||5
9681305|NCT02240485|10781068|FG000|STARTED|3 Months Post-admission||44
9681306|NCT02240485|10781069|FG001|STARTED|3 Months Post-admission||36
9681307|NCT02240485|10781068|FG000|COMPLETED|3 Months Post-admission|Couple modality: 1 couple refused and one gambler refused but his partner continued|41
9681308|NCT02240485|10781069|FG001|COMPLETED|3 Months Post-admission||30
9681309|NCT02240485|10781068|FG000|NOT COMPLETED|3 Months Post-admission||3
9681310|NCT02240485|10781069|FG001|NOT COMPLETED|3 Months Post-admission||6
9681311|NCT02240485|10781068|FG000|STARTED|9 Months Post-admission||41
9843718|NCT00832260|10955608|FG000|STARTED|Overall Study||70
9843719|NCT00832260|10955608|FG000|COMPLETED|Overall Study||70
9843720|NCT00832260|10955608|FG000|NOT COMPLETED|Overall Study||0
9843721|NCT00832338|10955612|FG000|STARTED|Overall Study||23
9843722|NCT00832338|10955612|FG000|COMPLETED|Overall Study||23
9843723|NCT00832338|10955612|FG000|NOT COMPLETED|Overall Study||0
9843724|NCT00832377|10955616|FG000|STARTED|Overall Study||37
9843725|NCT00832377|10955616|FG000|COMPLETED|Overall Study||36
9843726|NCT00832377|10955616|FG000|NOT COMPLETED|Overall Study||1
9843727|NCT00832390|10955623|FG000|STARTED|Overall Study||12
9843728|NCT00832390|10955624|FG001|STARTED|Overall Study||16
9843729|NCT00832390|10955625|FG002|STARTED|Overall Study||1
9843730|NCT00832390|10955623|FG000|COMPLETED|Overall Study||12
9843731|NCT00832390|10955624|FG001|COMPLETED|Overall Study||16
9843732|NCT00832390|10955625|FG002|COMPLETED|Overall Study||1
9843733|NCT00832390|10955623|FG000|NOT COMPLETED|Overall Study||0
9843734|NCT00832390|10955624|FG001|NOT COMPLETED|Overall Study||0
9843735|NCT00832390|10955625|FG002|NOT COMPLETED|Overall Study||0
9960645|NCT01468844|11080320|FG001|NOT COMPLETED|Overall Study||0
9960646|NCT01468909|11080331|FG000|STARTED|Overall Study||52
9960647|NCT01468909|11080332|FG001|STARTED|Overall Study||54
9960648|NCT01468909|11080331|FG000|COMPLETED|Overall Study||50
9960649|NCT01468909|11080332|FG001|COMPLETED|Overall Study||52
9960650|NCT01468909|11080331|FG000|NOT COMPLETED|Overall Study||2
9960651|NCT01468909|11080332|FG001|NOT COMPLETED|Overall Study||2
9967731|NCT01515943|11088057|FG001|STARTED|Overall Study||85
9967732|NCT01515943|11088058|FG002|STARTED|Overall Study||44
9967733|NCT01515943|11088056|FG000|COMPLETED|Overall Study||69
9967734|NCT01515943|11088057|FG001|COMPLETED|Overall Study||69
9967735|NCT01515943|11088058|FG002|COMPLETED|Overall Study||31
9967736|NCT01515943|11088056|FG000|NOT COMPLETED|Overall Study||6
9967737|NCT01515943|11088057|FG001|NOT COMPLETED|Overall Study||16
9967738|NCT01515943|11088058|FG002|NOT COMPLETED|Overall Study||13
9967739|NCT01515956|11088068|FG000|STARTED|Overall Study||15
9967740|NCT01515956|11088068|FG000|COMPLETED|Overall Study||15
9843736|NCT00832416|10955637|FG000|STARTED|Overall Study||110
9843737|NCT00832416|10955638|FG001|STARTED|Overall Study||113
9843738|NCT00832416|10955639|FG002|STARTED|Overall Study||115
9843739|NCT00832416|10955640|FG003|STARTED|Overall Study||227
9967741|NCT01515956|11088068|FG000|NOT COMPLETED|Overall Study||0
9967742|NCT01515995|11088075|FG000|STARTED|Overall Study||25
9967743|NCT01515995|11088076|FG001|STARTED|Overall Study||25
9967744|NCT01515995|11088075|FG000|COMPLETED|Overall Study||22
9967745|NCT01515995|11088076|FG001|COMPLETED|Overall Study||21
9843740|NCT00832416|10955637|FG000|COMPLETED|Overall Study||64
9843741|NCT00832416|10955638|FG001|COMPLETED|Overall Study||60
9967746|NCT01515995|11088075|FG000|NOT COMPLETED|Overall Study||3
9967747|NCT01515995|11088076|FG001|NOT COMPLETED|Overall Study||4
9967748|NCT01516008|11088085|FG000|STARTED|Overall Study||114
9681312|NCT02240485|10781069|FG001|STARTED|9 Months Post-admission||30
9681313|NCT02240485|10781068|FG000|COMPLETED|9 Months Post-admission||38
9681314|NCT02240485|10781069|FG001|COMPLETED|9 Months Post-admission|26 couples completed + 1 individual (partner lost)|26
9967749|NCT01516008|11088086|FG001|STARTED|Overall Study||121
9681315|NCT02240485|10781068|FG000|NOT COMPLETED|9 Months Post-admission||3
9681316|NCT02240485|10781069|FG001|NOT COMPLETED|9 Months Post-admission||4
9681317|NCT02240485|10781068|FG000|STARTED|18 Months Post-admission||38
9681318|NCT02240485|10781069|FG001|STARTED|18 Months Post-admission||26
9681319|NCT02240485|10781068|FG000|COMPLETED|18 Months Post-admission||35
9681320|NCT02240485|10781069|FG001|COMPLETED|18 Months Post-admission||21
9681321|NCT02240485|10781068|FG000|NOT COMPLETED|18 Months Post-admission||3
9681322|NCT02240485|10781069|FG001|NOT COMPLETED|18 Months Post-admission||5
9681323|NCT02227147|10781081|FG000|STARTED|Controlled Treatment Period||24
9681324|NCT02227147|10781082|FG001|STARTED|Controlled Treatment Period||24
9681325|NCT02227147|10781081|FG000|COMPLETED|Controlled Treatment Period||18
9681326|NCT02227147|10781082|FG001|COMPLETED|Controlled Treatment Period||21
9681327|NCT02227147|10781081|FG000|NOT COMPLETED|Controlled Treatment Period||6
9681328|NCT02227147|10781082|FG001|NOT COMPLETED|Controlled Treatment Period||3
9681329|NCT02227147|10781081|FG000|STARTED|Follow-up Period||18
9681330|NCT02227147|10781082|FG001|STARTED|Follow-up Period||21
9681331|NCT02227147|10781081|FG000|COMPLETED|Follow-up Period||15
9681332|NCT02227147|10781082|FG001|COMPLETED|Follow-up Period||16
9681333|NCT02227147|10781081|FG000|NOT COMPLETED|Follow-up Period||3
9681334|NCT02227147|10781082|FG001|NOT COMPLETED|Follow-up Period||5
9681335|NCT02199691|10781096|FG000|STARTED|Overall Study||505
9681336|NCT02199691|10781097|FG001|STARTED|Overall Study||507
9681337|NCT02199691|10781098|FG002|STARTED|Overall Study||403
9681338|NCT02199691|10781099|FG003|STARTED|Overall Study||300
9681339|NCT02199691|10781096|FG000|Safety Analysis Set (SafAS)|Overall Study||503
9681340|NCT02199691|10781097|FG001|Safety Analysis Set (SafAS)|Overall Study||501
9681341|NCT02199691|10781098|FG002|Safety Analysis Set (SafAS)|Overall Study||392
9681342|NCT02199691|10781099|FG003|Safety Analysis Set (SafAS)|Overall Study||296
9681343|NCT02199691|10781096|FG000|COMPLETED|Overall Study||495
9681344|NCT02199691|10781097|FG001|COMPLETED|Overall Study||500
9681345|NCT02199691|10781098|FG002|COMPLETED|Overall Study||376
9681346|NCT02199691|10781099|FG003|COMPLETED|Overall Study||270
9681347|NCT02199691|10781096|FG000|NOT COMPLETED|Overall Study||10
9681348|NCT02199691|10781097|FG001|NOT COMPLETED|Overall Study||7
9681349|NCT02199691|10781098|FG002|NOT COMPLETED|Overall Study||27
9681350|NCT02199691|10781099|FG003|NOT COMPLETED|Overall Study||30
9843742|NCT00832416|10955639|FG002|COMPLETED|Overall Study||54
9843743|NCT00832416|10955640|FG003|COMPLETED|Overall Study||144
9843744|NCT00832416|10955637|FG000|NOT COMPLETED|Overall Study||46
9843745|NCT00832416|10955638|FG001|NOT COMPLETED|Overall Study||53
9843746|NCT00832416|10955639|FG002|NOT COMPLETED|Overall Study||61
9843747|NCT00832416|10955640|FG003|NOT COMPLETED|Overall Study||83
9681357|NCT02143726|10781122|FG000|STARTED|Overall Study||18
9681358|NCT02143726|10781123|FG001|STARTED|Overall Study||17
9681359|NCT02143726|10781122|FG000|Received Everolimus After Disease Progression|Overall Study||11
9681360|NCT02143726|10781123|FG001|Received Everolimus After Disease Progression|Overall Study||0
9681361|NCT02143726|10781122|FG000|COMPLETED|Overall Study||16
9681362|NCT02143726|10781123|FG001|COMPLETED|Overall Study||17
9681363|NCT02143726|10781122|FG000|NOT COMPLETED|Overall Study||2
9681364|NCT02143726|10781123|FG001|NOT COMPLETED|Overall Study||0
9681365|NCT02046512|10781131|FG000|STARTED|Overall Study||45
9681366|NCT02046512|10781132|FG001|STARTED|Overall Study||44
9681367|NCT02046512|10781131|FG000|COMPLETED|Overall Study||44
9681368|NCT02046512|10781132|FG001|COMPLETED|Overall Study||44
9681369|NCT02046512|10781131|FG000|NOT COMPLETED|Overall Study||1
9681370|NCT02046512|10781132|FG001|NOT COMPLETED|Overall Study||0
9681371|NCT01958593|10781140|FG000|STARTED|Overall Study||2
9681372|NCT01958593|10781141|FG001|STARTED|Overall Study||4
9681373|NCT01958593|10781140|FG000|COMPLETED|Overall Study||2
9681374|NCT01958593|10781141|FG001|COMPLETED|Overall Study||4
9681375|NCT01958593|10781140|FG000|NOT COMPLETED|Overall Study||0
9681376|NCT01958593|10781141|FG001|NOT COMPLETED|Overall Study||0
9681377|NCT01842035|10781148|FG000|STARTED|Overall Study||90
9681378|NCT01842035|10781148|FG000|COMPLETED|Overall Study||90
9681379|NCT01842035|10781148|FG000|NOT COMPLETED|Overall Study||0
9681380|NCT01751984|10781155|FG000|STARTED|Overall Study||37
9681381|NCT01751984|10781156|FG001|STARTED|Overall Study||19
9681382|NCT01751984|10781155|FG000|COMPLETED|Overall Study||31
9681383|NCT01751984|10781156|FG001|COMPLETED|Overall Study||15
9681384|NCT01751984|10781155|FG000|NOT COMPLETED|Overall Study||6
9681385|NCT01751984|10781156|FG001|NOT COMPLETED|Overall Study||4
9681386|NCT01732627|10781164|FG000|STARTED|Overall Study||201
9681387|NCT01732627|10781165|FG001|STARTED|Overall Study||100
9681388|NCT01732627|10781164|FG000|Safety Analysis Set (SafAS)|Overall Study||199
9681389|NCT01732627|10781165|FG001|Safety Analysis Set (SafAS)|Overall Study||100
9681390|NCT01732627|10781164|FG000|COMPLETED|Overall Study||200
9681391|NCT01732627|10781165|FG001|COMPLETED|Overall Study||100
9681392|NCT01732627|10781164|FG000|NOT COMPLETED|Overall Study||1
9681393|NCT01732627|10781165|FG001|NOT COMPLETED|Overall Study||0
9681394|NCT01702571|10781173|FG000|STARTED|Overall Study||2003
9681395|NCT01702571|10781174|FG001|STARTED|Overall Study||182
9681396|NCT01702571|10781173|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
9681397|NCT01702571|10781174|FG001|COMPLETED|Overall Study||65
9681398|NCT01702571|10781173|FG000|NOT COMPLETED|Overall Study||1509
9681399|NCT01702571|10781174|FG001|NOT COMPLETED|Overall Study||117
9681400|NCT01578239|10781182|FG000|STARTED|Treatment Period||117
9681401|NCT01578239|10781183|FG001|STARTED|Treatment Period||114
9681402|NCT01578239|10781182|FG000|Full Analysis Set (FAS)|Treatment Period||117
9681403|NCT01578239|10781183|FG001|Full Analysis Set (FAS)|Treatment Period||114
9681404|NCT01578239|10781182|FG000|Safety Analysis Set (SAF)|Treatment Period||111
9681405|NCT01578239|10781183|FG001|Safety Analysis Set (SAF)|Treatment Period||112
9681406|NCT01578239|10781182|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101
9681407|NCT01578239|10781183|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99
9681408|NCT01578239|10781182|FG000|COMPLETED|Treatment Period||50
9681409|NCT01578239|10781183|FG001|COMPLETED|Treatment Period||13
9681410|NCT01578239|10781182|FG000|NOT COMPLETED|Treatment Period||67
9681411|NCT01578239|10781183|FG001|NOT COMPLETED|Treatment Period||101
9681412|NCT01578239|10781182|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101
9681413|NCT01578239|10781183|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99
9681414|NCT01578239|10781182|FG000|COMPLETED|Long-term Follow-Up Period||24
9681415|NCT01578239|10781183|FG001|COMPLETED|Long-term Follow-Up Period||19
9681416|NCT01578239|10781182|FG000|NOT COMPLETED|Long-term Follow-Up Period||77
9681417|NCT01578239|10781183|FG001|NOT COMPLETED|Long-term Follow-Up Period||80
9681418|NCT01458340|10781192|FG000|STARTED|Overall Study||97
9681419|NCT01458340|10781193|FG001|STARTED|Overall Study||99
9681420|NCT01458340|10781194|FG002|STARTED|Overall Study||99
9681421|NCT01458340|10781192|FG000|Received Study Treatment|Overall Study||97
9681422|NCT01458340|10781193|FG001|Received Study Treatment|Overall Study||98
9681423|NCT01458340|10781194|FG002|Received Study Treatment|Overall Study||98
9681424|NCT01458340|10781192|FG000|COMPLETED|Overall Study||70
9681425|NCT01458340|10781193|FG001|COMPLETED|Overall Study||78
9681426|NCT01458340|10781194|FG002|COMPLETED|Overall Study||76
9681427|NCT01458340|10781192|FG000|NOT COMPLETED|Overall Study||27
9681428|NCT01458340|10781193|FG001|NOT COMPLETED|Overall Study||21
9681429|NCT01458340|10781194|FG002|NOT COMPLETED|Overall Study||23
9681430|NCT01411267|10781212|FG000|STARTED|Overall Study||0
9681431|NCT01411267|10781213|FG001|STARTED|Overall Study||3
9681432|NCT01411267|10781214|FG002|STARTED|Overall Study||2
9681433|NCT01411267|10781215|FG003|STARTED|Overall Study||5
9681434|NCT01411267|10781216|FG004|STARTED|Overall Study||2
9681435|NCT01411267|10781217|FG005|STARTED|Overall Study||12
9681436|NCT01411267|10781218|FG006|STARTED|Overall Study||0
9681437|NCT01411267|10781219|FG007|STARTED|Overall Study||0
9681438|NCT01411267|10781220|FG008|STARTED|Overall Study||0
9681439|NCT01411267|10781221|FG009|STARTED|Overall Study||0
9681440|NCT01411267|10781212|FG000|COMPLETED|Overall Study||0
9681441|NCT01411267|10781213|FG001|COMPLETED|Overall Study||3
9681442|NCT01411267|10781214|FG002|COMPLETED|Overall Study||2
9681443|NCT01411267|10781215|FG003|COMPLETED|Overall Study||4
9681444|NCT01411267|10781216|FG004|COMPLETED|Overall Study||0
9681445|NCT01411267|10781217|FG005|COMPLETED|Overall Study||10
9681446|NCT01411267|10781218|FG006|COMPLETED|Overall Study||0
9681447|NCT01411267|10781219|FG007|COMPLETED|Overall Study||0
9681448|NCT01411267|10781220|FG008|COMPLETED|Overall Study||0
9681449|NCT01411267|10781221|FG009|COMPLETED|Overall Study||0
9681450|NCT01411267|10781212|FG000|NOT COMPLETED|Overall Study||0
9681451|NCT01411267|10781213|FG001|NOT COMPLETED|Overall Study||0
9681452|NCT01411267|10781214|FG002|NOT COMPLETED|Overall Study||0
9681453|NCT01411267|10781215|FG003|NOT COMPLETED|Overall Study||1
9681454|NCT01411267|10781216|FG004|NOT COMPLETED|Overall Study||2
9681455|NCT01411267|10781217|FG005|NOT COMPLETED|Overall Study||2
9681456|NCT01411267|10781218|FG006|NOT COMPLETED|Overall Study||0
9681457|NCT01411267|10781219|FG007|NOT COMPLETED|Overall Study||0
9681458|NCT01411267|10781220|FG008|NOT COMPLETED|Overall Study||0
9681459|NCT01411267|10781221|FG009|NOT COMPLETED|Overall Study||0
9681460|NCT01336634|10781242|FG000|STARTED|Overall Study||84
9681461|NCT01336634|10781243|FG001|STARTED|Overall Study||57
9681462|NCT01336634|10781244|FG002|STARTED|Overall Study|includes 34 subjects from Cohort C and 2 subjects enrolled as protocol deviations from Cohort B.|36
9681463|NCT01336634|10781242|FG000|2nd Line Plus All Treated|Overall Study||78
9681464|NCT01336634|10781243|FG001|2nd Line Plus All Treated|Overall Study||57
9681465|NCT01336634|10781244|FG002|2nd Line Plus All Treated|Overall Study||0
9681466|NCT01336634|10781242|FG000|1st Line All Treated|Overall Study||6
9681467|NCT01336634|10781243|FG001|1st Line All Treated|Overall Study||2
9681468|NCT01336634|10781244|FG002|1st Line All Treated|Overall Study||34
9681469|NCT01336634|10781242|FG000|Crossover|Overall Study||20
9681470|NCT01336634|10781243|FG001|Crossover|Overall Study||0
9681471|NCT01336634|10781244|FG002|Crossover|Overall Study||0
9843748|NCT00832585|10955650|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
9681472|NCT01336634|10781242|FG000|COMPLETED|Overall Study||70
9681473|NCT01336634|10781243|FG001|COMPLETED|Overall Study||49
9681474|NCT01336634|10781244|FG002|COMPLETED|Overall Study||27
9681475|NCT01336634|10781242|FG000|NOT COMPLETED|Overall Study||14
9681476|NCT01336634|10781243|FG001|NOT COMPLETED|Overall Study||8
9681477|NCT01336634|10781244|FG002|NOT COMPLETED|Overall Study||9
9681478|NCT01155375|10781257|FG000|STARTED|Overall Study||8
9681479|NCT01155375|10781258|FG001|STARTED|Overall Study||6
9681480|NCT01155375|10781257|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9681481|NCT01155375|10781258|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9681482|NCT01155375|10781257|FG000|COMPLETED|Overall Study||7
9681483|NCT01155375|10781258|FG001|COMPLETED|Overall Study||6
9681484|NCT01155375|10781257|FG000|NOT COMPLETED|Overall Study||1
9681485|NCT01155375|10781258|FG001|NOT COMPLETED|Overall Study||0
9681486|NCT00785798|10781265|FG000|STARTED|Overall Study||17
10023269|NCT01854918|11146828|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30
10023270|NCT01854918|11146829|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63
10023271|NCT01854918|11146828|FG000|STARTED|All-IP Period (Years 2 and 3)||1197
10023272|NCT01854918|11146829|FG001|STARTED|All-IP Period (Years 2 and 3)||2391
9681487|NCT00785798|10781265|FG000|COMPLETED|Overall Study||16
9681488|NCT00785798|10781265|FG000|NOT COMPLETED|Overall Study||1
9681489|NCT00628095|10781271|FG000|STARTED|Overall Study||53
9681490|NCT00628095|10781272|FG001|STARTED|Overall Study||47
9681491|NCT00628095|10781271|FG000|COMPLETED|Overall Study||46
9681492|NCT00628095|10781272|FG001|COMPLETED|Overall Study||40
9681493|NCT00628095|10781271|FG000|NOT COMPLETED|Overall Study||7
9681494|NCT00628095|10781272|FG001|NOT COMPLETED|Overall Study||7
9681495|NCT04246021|10781280|FG000|STARTED|Overall Study||84
9681496|NCT04246021|10781280|FG000|COMPLETED|Overall Study||84
9681497|NCT04246021|10781280|FG000|NOT COMPLETED|Overall Study||0
9724963|NCT00092521|10824699|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
9724964|NCT00092521|10824696|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
9724965|NCT00092521|10824697|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
9724966|NCT00092521|10824698|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
9724967|NCT00092521|10824699|FG003|STARTED|Follow-Up (After Month 7)||0
9724968|NCT00092521|10824696|FG000|COMPLETED|Follow-Up (After Month 7)||2353
9724969|NCT00092521|10824697|FG001|COMPLETED|Follow-Up (After Month 7)||155
9724970|NCT00092521|10824698|FG002|COMPLETED|Follow-Up (After Month 7)||1959
9724971|NCT00092521|10824699|FG003|COMPLETED|Follow-Up (After Month 7)||0
9724972|NCT00092521|10824696|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246
9724973|NCT00092521|10824697|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136
9724974|NCT00092521|10824698|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648
9724975|NCT00092521|10824699|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0
9724976|NCT00092521|10824696|FG000|STARTED|Extension Study (Group 4)||0
9724977|NCT00092521|10824697|FG001|STARTED|Extension Study (Group 4)||0
9724978|NCT00092521|10824698|FG002|STARTED|Extension Study (Group 4)||0
9724979|NCT00092521|10824699|FG003|STARTED|Extension Study (Group 4)||844
9724980|NCT00092521|10824696|FG000|Initiated Extension Study|Extension Study (Group 4)||0
9724981|NCT00092521|10824697|FG001|Initiated Extension Study|Extension Study (Group 4)||0
9724982|NCT00092521|10824698|FG002|Initiated Extension Study|Extension Study (Group 4)||0
9724983|NCT00092521|10824699|FG003|Initiated Extension Study|Extension Study (Group 4)||829
9724984|NCT00092521|10824696|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
9724985|NCT00092521|10824697|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
9724986|NCT00092521|10824698|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
9724987|NCT00092521|10824699|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
9724988|NCT00092521|10824696|FG000|COMPLETED|Extension Study (Group 4)||0
9724989|NCT00092521|10824697|FG001|COMPLETED|Extension Study (Group 4)||0
9724990|NCT00092521|10824698|FG002|COMPLETED|Extension Study (Group 4)||0
9724991|NCT00092521|10824699|FG003|COMPLETED|Extension Study (Group 4)||635
9724992|NCT00092521|10824696|FG000|NOT COMPLETED|Extension Study (Group 4)||0
9724993|NCT00092521|10824697|FG001|NOT COMPLETED|Extension Study (Group 4)||0
9724994|NCT00092521|10824698|FG002|NOT COMPLETED|Extension Study (Group 4)||0
9724995|NCT00092521|10824699|FG003|NOT COMPLETED|Extension Study (Group 4)||209
9724996|NCT00092534|10824709|FG000|STARTED|Base Study Vaccination Period||6087
9724997|NCT00092534|10824710|FG001|STARTED|Base Study Vaccination Period||6080
9724998|NCT00092534|10824711|FG002|STARTED|Base Study Vaccination Period||0
9724999|NCT00092534|10824712|FG003|STARTED|Base Study Vaccination Period||0
9725000|NCT00092534|10824713|FG004|STARTED|Base Study Vaccination Period||0
9725001|NCT00092534|10824709|FG000|COMPLETED|Base Study Vaccination Period||5916
9725002|NCT00092534|10824710|FG001|COMPLETED|Base Study Vaccination Period||5954
9725003|NCT00092534|10824711|FG002|COMPLETED|Base Study Vaccination Period||0
9725004|NCT00092534|10824712|FG003|COMPLETED|Base Study Vaccination Period||0
9725005|NCT00092534|10824713|FG004|COMPLETED|Base Study Vaccination Period||0
9725006|NCT00092534|10824709|FG000|NOT COMPLETED|Base Study Vaccination Period||171
9725007|NCT00092534|10824710|FG001|NOT COMPLETED|Base Study Vaccination Period||126
9725008|NCT00092534|10824711|FG002|NOT COMPLETED|Base Study Vaccination Period||0
9725009|NCT00092534|10824712|FG003|NOT COMPLETED|Base Study Vaccination Period||0
9725010|NCT00092534|10824713|FG004|NOT COMPLETED|Base Study Vaccination Period||0
9725011|NCT00092534|10824709|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
9725012|NCT00092534|10824710|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
9725013|NCT00092534|10824711|FG002|STARTED|Base Study Follow-Up Period||0
9725014|NCT00092534|10824712|FG003|STARTED|Base Study Follow-Up Period||0
9725015|NCT00092534|10824713|FG004|STARTED|Base Study Follow-Up Period||0
9725016|NCT00092534|10824709|FG000|COMPLETED|Base Study Follow-Up Period||5626
9725017|NCT00092534|10824710|FG001|COMPLETED|Base Study Follow-Up Period||5277
10023273|NCT01854918|11146828|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
10023274|NCT01854918|11146829|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
9725018|NCT00092534|10824711|FG002|COMPLETED|Base Study Follow-Up Period||0
9725019|NCT00092534|10824712|FG003|COMPLETED|Base Study Follow-Up Period||0
9681498|NCT04098497|10781294|FG000|STARTED|Overall Study||30
9681499|NCT04098497|10781294|FG000|Initial Interview|Overall Study||30
9681500|NCT04098497|10781294|FG000|Set Up Study App|Overall Study||29
9681501|NCT04098497|10781294|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26
9681502|NCT04098497|10781294|FG000|Linked Fitbit to Study Database|Overall Study||27
9681503|NCT04098497|10781294|FG000|Used Fitbit|Overall Study||24
9681504|NCT04098497|10781294|FG000|Exit Interview|Overall Study||29
9681505|NCT04098497|10781294|FG000|COMPLETED|Overall Study||30
9681506|NCT04098497|10781294|FG000|NOT COMPLETED|Overall Study||0
9681507|NCT03945825|10781304|FG000|STARTED|Overall Study||41
9681508|NCT03945825|10781305|FG001|STARTED|Overall Study||37
9681509|NCT03945825|10781306|FG002|STARTED|Overall Study||40
9681510|NCT03945825|10781307|FG003|STARTED|Overall Study||41
9681511|NCT03945825|10781308|FG004|STARTED|Overall Study||39
9681512|NCT03945825|10781309|FG005|STARTED|Overall Study||43
9681513|NCT03945825|10781304|FG000|COMPLETED|Overall Study||39
9681514|NCT03945825|10781305|FG001|COMPLETED|Overall Study||32
9681515|NCT03945825|10781306|FG002|COMPLETED|Overall Study||39
9681516|NCT03945825|10781307|FG003|COMPLETED|Overall Study||39
9681517|NCT03945825|10781308|FG004|COMPLETED|Overall Study||36
9681518|NCT03945825|10781309|FG005|COMPLETED|Overall Study||40
9681519|NCT03945825|10781304|FG000|NOT COMPLETED|Overall Study||2
9681520|NCT03945825|10781305|FG001|NOT COMPLETED|Overall Study||5
9681521|NCT03945825|10781306|FG002|NOT COMPLETED|Overall Study||1
9681522|NCT03945825|10781307|FG003|NOT COMPLETED|Overall Study||2
9681523|NCT03945825|10781308|FG004|NOT COMPLETED|Overall Study||3
9681524|NCT03945825|10781309|FG005|NOT COMPLETED|Overall Study||3
9681525|NCT03937141|10781332|FG000|STARTED|Overall Study||16
9681526|NCT03937141|10781332|FG000|COMPLETED|Overall Study||16
9681527|NCT03937141|10781332|FG000|NOT COMPLETED|Overall Study||0
9681528|NCT03678402|10781336|FG000|STARTED|Overall Study||521
9681529|NCT03678402|10781336|FG000|COMPLETED|Overall Study||521
9681530|NCT03678402|10781336|FG000|NOT COMPLETED|Overall Study||0
9681531|NCT03641937|10781340|FG000|STARTED|Overall Study||10
9681532|NCT03641937|10781340|FG000|COMPLETED|Overall Study||10
9681533|NCT03641937|10781340|FG000|NOT COMPLETED|Overall Study||0
9681534|NCT03572244|10781346|FG000|STARTED|Overall Study||6
9681535|NCT03572244|10781347|FG001|STARTED|Overall Study||6
9681536|NCT03572244|10781346|FG000|COMPLETED|Overall Study||6
9681537|NCT03572244|10781347|FG001|COMPLETED|Overall Study||6
9681538|NCT03572244|10781346|FG000|NOT COMPLETED|Overall Study||0
9681539|NCT03572244|10781347|FG001|NOT COMPLETED|Overall Study||0
9681540|NCT03562767|10781356|FG000|STARTED|Overall Study||10
9681541|NCT03562767|10781357|FG001|STARTED|Overall Study||10
9681542|NCT03562767|10781358|FG002|STARTED|Overall Study||0
9681543|NCT03562767|10781356|FG000|COMPLETED|Overall Study||7
10023275|NCT01854918|11146828|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079
9681544|NCT03562767|10781357|FG001|COMPLETED|Overall Study||7
9681545|NCT03562767|10781358|FG002|COMPLETED|Overall Study||0
9681546|NCT03562767|10781356|FG000|NOT COMPLETED|Overall Study||3
9681547|NCT03562767|10781357|FG001|NOT COMPLETED|Overall Study||3
9681548|NCT03562767|10781358|FG002|NOT COMPLETED|Overall Study||0
9681549|NCT03559699|10781370|FG000|STARTED|Overall Study||27
9681550|NCT03559699|10781370|FG000|COMPLETED|Overall Study||20
9681551|NCT03559699|10781370|FG000|NOT COMPLETED|Overall Study||7
9681552|NCT03333057|10781377|FG000|STARTED|Overall Study||111
9681553|NCT03333057|10781378|FG001|STARTED|Overall Study||114
9681554|NCT03333057|10781379|FG002|STARTED|Overall Study||111
9681555|NCT03333057|10781377|FG000|COMPLETED|Overall Study||105
9681556|NCT03333057|10781378|FG001|COMPLETED|Overall Study||110
9681557|NCT03333057|10781379|FG002|COMPLETED|Overall Study||108
9681558|NCT03333057|10781377|FG000|NOT COMPLETED|Overall Study||6
9681559|NCT03333057|10781378|FG001|NOT COMPLETED|Overall Study||4
9681560|NCT03333057|10781379|FG002|NOT COMPLETED|Overall Study||3
9681561|NCT03305016|10781387|FG000|STARTED|Overall Study||146
9681562|NCT03305016|10781387|FG000|COMPLETED|Overall Study||144
9681563|NCT03305016|10781387|FG000|NOT COMPLETED|Overall Study||2
9681564|NCT03300336|10781393|FG000|STARTED|Overall Study||7267
9681565|NCT03300336|10781394|FG001|STARTED|Overall Study||6859
9681566|NCT03300336|10781393|FG000|COMPLETED|Overall Study||7267
9681567|NCT03300336|10781394|FG001|COMPLETED|Overall Study||6859
9681568|NCT03300336|10781393|FG000|NOT COMPLETED|Overall Study||0
9681569|NCT03300336|10781394|FG001|NOT COMPLETED|Overall Study||0
9681570|NCT03291067|10781404|FG000|STARTED|Overall Study||94
9681571|NCT03291067|10781405|FG001|STARTED|Overall Study||92
9681572|NCT03291067|10781406|FG002|STARTED|Overall Study||94
9681573|NCT03291067|10781407|FG003|STARTED|Overall Study||94
9681574|NCT03291067|10781404|FG000|Treated|Overall Study||95
9681575|NCT03291067|10781405|FG001|Treated|Overall Study||90
9681576|NCT03291067|10781406|FG002|Treated|Overall Study||93
9681577|NCT03291067|10781407|FG003|Treated|Overall Study||90
9681578|NCT03291067|10781404|FG000|COMPLETED|Overall Study||84
9681579|NCT03291067|10781405|FG001|COMPLETED|Overall Study||78
9681580|NCT03291067|10781406|FG002|COMPLETED|Overall Study||61
9681581|NCT03291067|10781407|FG003|COMPLETED|Overall Study||77
9681582|NCT03291067|10781404|FG000|NOT COMPLETED|Overall Study||10
9681583|NCT03291067|10781405|FG001|NOT COMPLETED|Overall Study||14
9681584|NCT03291067|10781406|FG002|NOT COMPLETED|Overall Study||33
9681585|NCT03291067|10781407|FG003|NOT COMPLETED|Overall Study||17
9681586|NCT03271047|10781421|FG000|STARTED|Phase 1b: Dose Finding Period||10
9681587|NCT03271047|10781422|FG001|STARTED|Phase 1b: Dose Finding Period||11
9681588|NCT03271047|10781423|FG002|STARTED|Phase 1b: Dose Finding Period||0
9681589|NCT03271047|10781424|FG003|STARTED|Phase 1b: Dose Finding Period||0
9681590|NCT03271047|10781421|FG000|COMPLETED|Phase 1b: Dose Finding Period||0
9681591|NCT03271047|10781422|FG001|COMPLETED|Phase 1b: Dose Finding Period||0
9681592|NCT03271047|10781423|FG002|COMPLETED|Phase 1b: Dose Finding Period||0
9681593|NCT03271047|10781424|FG003|COMPLETED|Phase 1b: Dose Finding Period||0
9681594|NCT03271047|10781421|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10
9681595|NCT03271047|10781422|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11
9681596|NCT03271047|10781423|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0
9681597|NCT03271047|10781424|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0
9681598|NCT03271047|10781421|FG000|STARTED|Randomized Phase 2 Period||0
9681599|NCT03271047|10781422|FG001|STARTED|Randomized Phase 2 Period||0
9681600|NCT03271047|10781423|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
10023276|NCT01854918|11146829|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196
10023277|NCT01854918|11146828|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
10023278|NCT01854918|11146829|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
10023279|NCT01854944|11146845|FG000|STARTED|Overall Study||4
10023280|NCT01854944|11146846|FG001|STARTED|Overall Study||4
10023281|NCT01854944|11146847|FG002|STARTED|Overall Study||4
10023282|NCT01854944|11146845|FG000|COMPLETED|Overall Study||4
10023283|NCT01854944|11146846|FG001|COMPLETED|Overall Study||4
10023284|NCT01854944|11146847|FG002|COMPLETED|Overall Study||3
10023285|NCT01854944|11146845|FG000|NOT COMPLETED|Overall Study||0
10023286|NCT01854944|11146846|FG001|NOT COMPLETED|Overall Study||0
10023287|NCT01854944|11146847|FG002|NOT COMPLETED|Overall Study||1
10023288|NCT01855048|11146875|FG000|STARTED|Overall Study||9
10023289|NCT01855048|11146876|FG001|STARTED|Overall Study||3
10023290|NCT01855048|11146877|FG002|STARTED|Overall Study||6
10023291|NCT01855048|11146878|FG003|STARTED|Overall Study||6
9681601|NCT03271047|10781424|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
9681602|NCT03271047|10781421|FG000|COMPLETED|Randomized Phase 2 Period||0
9681603|NCT03271047|10781422|FG001|COMPLETED|Randomized Phase 2 Period||0
9681604|NCT03271047|10781423|FG002|COMPLETED|Randomized Phase 2 Period||0
9681605|NCT03271047|10781424|FG003|COMPLETED|Randomized Phase 2 Period||0
9681606|NCT03271047|10781421|FG000|NOT COMPLETED|Randomized Phase 2 Period||0
9681607|NCT03271047|10781422|FG001|NOT COMPLETED|Randomized Phase 2 Period||0
9681608|NCT03271047|10781423|FG002|NOT COMPLETED|Randomized Phase 2 Period||27
9681609|NCT03271047|10781424|FG003|NOT COMPLETED|Randomized Phase 2 Period||27
9725020|NCT00092534|10824713|FG004|COMPLETED|Base Study Follow-Up Period||0
9725021|NCT00092534|10824709|FG000|NOT COMPLETED|Base Study Follow-Up Period||316
9725022|NCT00092534|10824710|FG001|NOT COMPLETED|Base Study Follow-Up Period||694
9725023|NCT00092534|10824711|FG002|NOT COMPLETED|Base Study Follow-Up Period||0
9725024|NCT00092534|10824712|FG003|NOT COMPLETED|Base Study Follow-Up Period||0
9725025|NCT00092534|10824713|FG004|NOT COMPLETED|Base Study Follow-Up Period||0
9725026|NCT00092534|10824709|FG000|STARTED|Base Study EXT||0
9725027|NCT00092534|10824710|FG001|STARTED|Base Study EXT||0
9725028|NCT00092534|10824711|FG002|STARTED|Base Study EXT||594
9725029|NCT00092534|10824712|FG003|STARTED|Base Study EXT||0
9725030|NCT00092534|10824713|FG004|STARTED|Base Study EXT||0
9725031|NCT00092534|10824709|FG000|COMPLETED|Base Study EXT||0
9725032|NCT00092534|10824710|FG001|COMPLETED|Base Study EXT||0
9725033|NCT00092534|10824711|FG002|COMPLETED|Base Study EXT||449
9725034|NCT00092534|10824712|FG003|COMPLETED|Base Study EXT||0
9843749|NCT00832585|10955650|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
9843750|NCT00832585|10955650|FG000|NOT COMPLETED|Overall Study||2
9843751|NCT00832637|10955654|FG000|STARTED|Overall Study||33
9843752|NCT00832637|10955654|FG000|COMPLETED|Overall Study||33
9843753|NCT00832637|10955654|FG000|NOT COMPLETED|Overall Study||0
9843754|NCT00832650|10955661|FG000|STARTED|Overall Study||25
9843755|NCT00832650|10955662|FG001|STARTED|Overall Study||12
9843756|NCT00832650|10955663|FG002|STARTED|Overall Study||23
9843757|NCT00832650|10955661|FG000|Treated|Overall Study||25
9843758|NCT00832650|10955662|FG001|Treated|Overall Study||12
9843759|NCT00832650|10955663|FG002|Treated|Overall Study||22
9843760|NCT00832650|10955661|FG000|COMPLETED|Overall Study||25
9843761|NCT00832650|10955662|FG001|COMPLETED|Overall Study||12
9843762|NCT00832650|10955663|FG002|COMPLETED|Overall Study||22
9843763|NCT00832650|10955661|FG000|NOT COMPLETED|Overall Study||0
9843764|NCT00832650|10955662|FG001|NOT COMPLETED|Overall Study||0
9843765|NCT00832650|10955663|FG002|NOT COMPLETED|Overall Study||1
9843766|NCT00832767|10955673|FG000|STARTED|Overall Study||121
9843767|NCT00832767|10955674|FG001|STARTED|Overall Study||81
9843768|NCT00832767|10955673|FG000|COMPLETED|Overall Study||99
9843769|NCT00832767|10955674|FG001|COMPLETED|Overall Study||63
9843770|NCT00832767|10955673|FG000|NOT COMPLETED|Overall Study||22
9843771|NCT00832767|10955674|FG001|NOT COMPLETED|Overall Study||18
9843772|NCT00832780|10955682|FG000|STARTED|Overall Study||44
9843773|NCT00832780|10955682|FG000|COMPLETED|Overall Study||19
9843774|NCT00832780|10955682|FG000|NOT COMPLETED|Overall Study||25
9843775|NCT00832819|10955689|FG000|STARTED|Overall Study||6
9843776|NCT00832819|10955690|FG001|STARTED|Overall Study||6
9843777|NCT00832819|10955691|FG002|STARTED|Overall Study||16
9843778|NCT00832819|10955689|FG000|COMPLETED|Overall Study||6
9843779|NCT00832819|10955690|FG001|COMPLETED|Overall Study||5
9843780|NCT00832819|10955691|FG002|COMPLETED|Overall Study||15
9843781|NCT00832819|10955689|FG000|NOT COMPLETED|Overall Study||0
9843782|NCT00832819|10955690|FG001|NOT COMPLETED|Overall Study||1
9843783|NCT00832819|10955691|FG002|NOT COMPLETED|Overall Study||1
9843784|NCT00832871|10955697|FG000|STARTED|Overall Study||4
9843785|NCT00832871|10955697|FG000|COMPLETED|Overall Study||4
9843786|NCT00832871|10955697|FG000|NOT COMPLETED|Overall Study||0
9843787|NCT00832975|10955701|FG000|STARTED|Overall Study||157
9843788|NCT00832975|10955701|FG000|COMPLETED|Overall Study||118
9843789|NCT00832975|10955701|FG000|NOT COMPLETED|Overall Study||39
9843790|NCT00833027|10955705|FG000|STARTED|Overall Study||608
10023292|NCT01855048|11146879|FG004|STARTED|Overall Study||6
10023293|NCT01855048|11146880|FG005|STARTED|Overall Study||6
10023294|NCT01855048|11146875|FG000|COMPLETED|Overall Study||9
10023295|NCT01855048|11146876|FG001|COMPLETED|Overall Study||2
9843791|NCT00833027|10955705|FG000|COMPLETED|Overall Study||397
9843792|NCT00833027|10955705|FG000|NOT COMPLETED|Overall Study||211
9843793|NCT00833040|10955709|FG000|STARTED|Overall Study||6
9843794|NCT00833040|10955710|FG001|STARTED|Overall Study||6
9843795|NCT00833040|10955711|FG002|STARTED|Overall Study||6
9843796|NCT00833040|10955712|FG003|STARTED|Overall Study||6
9843797|NCT00833040|10955713|FG004|STARTED|Overall Study||5
9843798|NCT00833040|10955714|FG005|STARTED|Overall Study||5
9843799|NCT00833040|10955709|FG000|COMPLETED|Overall Study||6
9843800|NCT00833040|10955710|FG001|COMPLETED|Overall Study||6
9843801|NCT00833040|10955711|FG002|COMPLETED|Overall Study||6
9843802|NCT00833040|10955712|FG003|COMPLETED|Overall Study||6
9725035|NCT00092534|10824713|FG004|COMPLETED|Base Study EXT||0
9725036|NCT00092534|10824709|FG000|NOT COMPLETED|Base Study EXT||0
9725037|NCT00092534|10824710|FG001|NOT COMPLETED|Base Study EXT||0
9725038|NCT00092534|10824711|FG002|NOT COMPLETED|Base Study EXT||145
9843803|NCT00833040|10955713|FG004|COMPLETED|Overall Study||5
9843804|NCT00833040|10955714|FG005|COMPLETED|Overall Study||4
9843805|NCT00833040|10955709|FG000|NOT COMPLETED|Overall Study||0
9843806|NCT00833040|10955710|FG001|NOT COMPLETED|Overall Study||0
9681610|NCT03257436|10781436|FG000|STARTED|Overall Study||584
9681611|NCT03257436|10781436|FG000|COMPLETED|Overall Study||489
9681612|NCT03257436|10781436|FG000|NOT COMPLETED|Overall Study||95
9681613|NCT03171480|10781442|FG000|STARTED|Overall Study||89
9681614|NCT03171480|10781443|FG001|STARTED|Overall Study||87
9681615|NCT03171480|10781442|FG000|COMPLETED|Overall Study||89
9681616|NCT03171480|10781443|FG001|COMPLETED|Overall Study||87
9681617|NCT03171480|10781442|FG000|NOT COMPLETED|Overall Study||0
10023296|NCT01855048|11146877|FG002|COMPLETED|Overall Study||6
10023297|NCT01855048|11146878|FG003|COMPLETED|Overall Study||6
10023298|NCT01855048|11146879|FG004|COMPLETED|Overall Study||5
10023299|NCT01855048|11146880|FG005|COMPLETED|Overall Study||6
10023300|NCT01855048|11146875|FG000|NOT COMPLETED|Overall Study||0
9681618|NCT03171480|10781443|FG001|NOT COMPLETED|Overall Study||0
9681619|NCT03158285|10781453|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246
9681620|NCT03158285|10781454|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248
9681621|NCT03158285|10781455|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245
9681622|NCT03158285|10781453|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
9681623|NCT03158285|10781454|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
9681624|NCT03158285|10781455|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
9681625|NCT03158285|10781453|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
9681626|NCT03158285|10781454|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
9681627|NCT03158285|10781455|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
9681628|NCT03158285|10781453|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
9681629|NCT03158285|10781454|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
9681630|NCT03158285|10781455|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
9681631|NCT03158285|10781453|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
9681632|NCT03158285|10781454|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
9681633|NCT03158285|10781455|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
9681634|NCT03158285|10781453|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238
9681635|NCT03158285|10781454|FG001|STARTED|Active Treatment Period: Week 24 - 52||240
9681636|NCT03158285|10781455|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234
9681637|NCT03158285|10781453|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228
9681638|NCT03158285|10781454|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234
9681639|NCT03158285|10781455|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227
9681640|NCT03158285|10781453|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
9681641|NCT03158285|10781454|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
9681642|NCT03158285|10781455|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
9681643|NCT03158285|10781453|FG000|STARTED|Active Treatment Period: Week 52-100||228
9681644|NCT03158285|10781454|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232
9681645|NCT03158285|10781455|FG002|STARTED|Active Treatment Period: Week 52-100||227
9681646|NCT03158285|10781453|FG000|COMPLETED|Active Treatment Period: Week 52-100||210
9681647|NCT03158285|10781454|FG001|COMPLETED|Active Treatment Period: Week 52-100||223
9681648|NCT03158285|10781455|FG002|COMPLETED|Active Treatment Period: Week 52-100||219
9681649|NCT03158285|10781453|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18
9681650|NCT03158285|10781454|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9
9681651|NCT03158285|10781455|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8
9725039|NCT00092534|10824712|FG003|NOT COMPLETED|Base Study EXT||0
9725040|NCT00092534|10824713|FG004|NOT COMPLETED|Base Study EXT||0
9725041|NCT00092534|10824709|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0
9725042|NCT00092534|10824710|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0
9725043|NCT00092534|10824711|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0
9725044|NCT00092534|10824712|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
9725045|NCT00092534|10824713|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
9725046|NCT00092534|10824709|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
9725047|NCT00092534|10824710|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
9725048|NCT00092534|10824711|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
9725049|NCT00092534|10824712|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
9725050|NCT00092534|10824713|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
9725051|NCT00092534|10824709|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
9725052|NCT00092534|10824710|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
9725053|NCT00092534|10824711|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
9725054|NCT00092534|10824712|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
9725055|NCT00092534|10824713|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
10023301|NCT01855048|11146876|FG001|NOT COMPLETED|Overall Study||1
10023302|NCT01855048|11146877|FG002|NOT COMPLETED|Overall Study||0
10023303|NCT01855048|11146878|FG003|NOT COMPLETED|Overall Study||0
9681652|NCT04723173|10781468|FG000|STARTED|Measure of Detection Threshold (in dB)||10
9681653|NCT04723173|10781468|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10
9681654|NCT04723173|10781468|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10
9681655|NCT04723173|10781468|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10
9681656|NCT04723173|10781468|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0
10023304|NCT01855048|11146879|FG004|NOT COMPLETED|Overall Study||1
10023305|NCT01855048|11146880|FG005|NOT COMPLETED|Overall Study||0
10023306|NCT01855074|11146904|FG000|STARTED|Overall Study||80
9681657|NCT04723173|10781468|FG000|STARTED|Subjective Listening Effort Scaling|The test in this test period is independent (also temporally) from the previous test period. That is the reason, why the number of participants, who started this test period is lesser than the number of participants, who completed the previous period.|9
9681658|NCT04723173|10781468|FG000|DNC on|Subjective Listening Effort Scaling||9
9681659|NCT04723173|10781468|FG000|DNC Off|Subjective Listening Effort Scaling||9
9681660|NCT04723173|10781468|FG000|COMPLETED|Subjective Listening Effort Scaling||8
9681661|NCT04723173|10781468|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1
9681662|NCT04723173|10781468|FG000|STARTED|Subjective Ratings of Sound Samples|The test in this test period is independent (also temporal) from the previous test period. That is the reason, why the number of participants, who started this test period is greater than the number of participants, who completed the previous period.|9
9681663|NCT04723173|10781468|FG000|DNC on|Subjective Ratings of Sound Samples||9
9681664|NCT04723173|10781468|FG000|DNC Off|Subjective Ratings of Sound Samples||9
9681665|NCT04723173|10781468|FG000|COMPLETED|Subjective Ratings of Sound Samples|"All participants completed this study period, but just the results of 8 participants could be used.~This was because technical issues limited the reliability of the measures made for one participant.~N.B. this test was independent from the other tests in the study. Therefore the results are not influenced by other test periods. The number of people included in the analysis described here relates only to this test."|9
9681666|NCT04723173|10781468|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0
9843807|NCT00833040|10955711|FG002|NOT COMPLETED|Overall Study||0
9843808|NCT00833040|10955712|FG003|NOT COMPLETED|Overall Study||0
9843809|NCT00833040|10955713|FG004|NOT COMPLETED|Overall Study||0
9843810|NCT00833040|10955714|FG005|NOT COMPLETED|Overall Study||1
9843811|NCT00833053|10955721|FG000|STARTED|Overall Study||19
9843812|NCT00833053|10955722|FG001|STARTED|Overall Study||20
9843813|NCT00833053|10955721|FG000|COMPLETED|Overall Study||10
9843814|NCT00833053|10955722|FG001|COMPLETED|Overall Study||17
9843815|NCT00833053|10955721|FG000|NOT COMPLETED|Overall Study||9
9843816|NCT00833053|10955722|FG001|NOT COMPLETED|Overall Study||3
9843817|NCT00833092|10955730|FG000|STARTED|Overall Study||54
9843818|NCT00833092|10955731|FG001|STARTED|Overall Study||57
9843819|NCT00833092|10955730|FG000|COMPLETED|Overall Study||50
9843820|NCT00833092|10955731|FG001|COMPLETED|Overall Study||50
9843821|NCT00833092|10955730|FG000|NOT COMPLETED|Overall Study||4
9843822|NCT00833092|10955731|FG001|NOT COMPLETED|Overall Study||7
9843823|NCT00833105|10955737|FG000|STARTED|Overall Study||13
9843824|NCT00833105|10955737|FG000|COMPLETED|Overall Study||10
9843825|NCT00833105|10955737|FG000|NOT COMPLETED|Overall Study||3
9843826|NCT00833248|10955745|FG000|STARTED|Overall Study||181
9843827|NCT00833248|10955746|FG001|STARTED|Overall Study||65
9843828|NCT00833248|10955745|FG000|Full Analysis Set (FAS)|Overall Study||180
9960652|NCT01468974|11080338|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
9960653|NCT01468974|11080338|FG000|COMPLETED|1 Month Follow-up||34
9960654|NCT01468974|11080338|FG000|NOT COMPLETED|1 Month Follow-up||1
9960655|NCT01468974|11080338|FG000|STARTED|6 Months Follow-up||34
9960656|NCT01468974|11080338|FG000|COMPLETED|6 Months Follow-up||34
9960657|NCT01468974|11080338|FG000|NOT COMPLETED|6 Months Follow-up||0
9960658|NCT01468974|11080338|FG000|STARTED|1 Year Follow-up||34
9960659|NCT01468974|11080338|FG000|COMPLETED|1 Year Follow-up||34
9960660|NCT01468974|11080338|FG000|NOT COMPLETED|1 Year Follow-up||0
9960661|NCT01468974|11080338|FG000|STARTED|2 Years Follow-up||34
9960662|NCT01468974|11080338|FG000|COMPLETED|2 Years Follow-up||32
9960663|NCT01468974|11080338|FG000|NOT COMPLETED|2 Years Follow-up||2
9960664|NCT01468974|11080338|FG000|STARTED|3 Years Follow-up||32
9960665|NCT01468974|11080338|FG000|COMPLETED|3 Years Follow-up||26
9960666|NCT01468974|11080338|FG000|NOT COMPLETED|3 Years Follow-up||6
9960667|NCT01468987|11080344|FG000|STARTED|Overall Study||691
10023307|NCT01855074|11146904|FG000|Treated|Overall Study||79
9960668|NCT01468987|11080345|FG001|STARTED|Overall Study||678
9960669|NCT01468987|11080344|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691
9960670|NCT01468987|11080345|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677
10023308|NCT01855074|11146904|FG000|COMPLETED|Overall Study||66
10023309|NCT01855074|11146904|FG000|NOT COMPLETED|Overall Study||14
10023310|NCT01855126|11146910|FG000|STARTED|First Intervention (8 Weeks)||24
10023311|NCT01855126|11146911|FG001|STARTED|First Intervention (8 Weeks)||22
10023312|NCT01855126|11146910|FG000|COMPLETED|First Intervention (8 Weeks)||20
9681667|NCT04552470|10781484|FG000|STARTED|Overall Study||9
9681668|NCT04552470|10781485|FG001|STARTED|Overall Study||10
9681669|NCT04552470|10781486|FG002|STARTED|Overall Study||9
9681670|NCT04552470|10781487|FG003|STARTED|Overall Study||9
9681671|NCT04552470|10781484|FG000|COMPLETED|Overall Study||9
9681672|NCT04552470|10781485|FG001|COMPLETED|Overall Study||10
9681673|NCT04552470|10781486|FG002|COMPLETED|Overall Study||9
9681674|NCT04552470|10781487|FG003|COMPLETED|Overall Study||9
9681675|NCT04552470|10781484|FG000|NOT COMPLETED|Overall Study||0
9681676|NCT04552470|10781485|FG001|NOT COMPLETED|Overall Study||0
9681677|NCT04552470|10781486|FG002|NOT COMPLETED|Overall Study||0
9681678|NCT04552470|10781487|FG003|NOT COMPLETED|Overall Study||0
9725056|NCT00092534|10824709|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
9725057|NCT00092534|10824710|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
9725058|NCT00092534|10824711|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
9725059|NCT00092534|10824712|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
9725060|NCT00092534|10824713|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
9725061|NCT00092534|10824709|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
9725062|NCT00092534|10824710|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
9725063|NCT00092534|10824711|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
9725064|NCT00092534|10824712|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
9725065|NCT00092534|10824713|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
9725066|NCT00092534|10824709|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
9725067|NCT00092534|10824710|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
9725068|NCT00092534|10824711|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
9725069|NCT00092534|10824712|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
9725070|NCT00092534|10824713|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
9725071|NCT00092547|10824725|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
9725072|NCT00092547|10824726|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
9725073|NCT00092547|10824727|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
9725074|NCT00092547|10824725|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
9725075|NCT00092547|10824726|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
9725076|NCT00092547|10824727|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
9725077|NCT00092547|10824725|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
9725078|NCT00092547|10824726|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
9725079|NCT00092547|10824727|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
9725080|NCT00092547|10824725|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
9725081|NCT00092547|10824726|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
9725082|NCT00092547|10824727|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
9725083|NCT00092547|10824725|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
9725084|NCT00092547|10824726|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
9725085|NCT00092547|10824727|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0
9725086|NCT00092547|10824725|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
9725087|NCT00092547|10824726|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
9725088|NCT00092547|10824727|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
9725089|NCT00092547|10824725|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
9725090|NCT00092547|10824726|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
9725091|NCT00092547|10824727|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
9725092|NCT00092547|10824725|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
9725093|NCT00092547|10824726|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
9725094|NCT00092547|10824727|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0
9725095|NCT00092547|10824725|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
9725096|NCT00092547|10824726|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
9725097|NCT00092547|10824727|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
9725098|NCT00092547|10824725|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
9725099|NCT00092547|10824726|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
9725100|NCT00092547|10824727|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
9731743|NCT00135330|10831648|FG002|NOT COMPLETED|Overall Study||11
9843829|NCT00833248|10955746|FG001|Full Analysis Set (FAS)|Overall Study||64
9843830|NCT00833248|10955745|FG000|Per Protocol (PP) Analysis Set|Overall Study||164
9843831|NCT00833248|10955746|FG001|Per Protocol (PP) Analysis Set|Overall Study||57
9843832|NCT00833248|10955745|FG000|Safety Analysis Set|Overall Study||181
9843833|NCT00833248|10955746|FG001|Safety Analysis Set|Overall Study||64
9843834|NCT00833248|10955745|FG000|COMPLETED|Overall Study||177
9843835|NCT00833248|10955746|FG001|COMPLETED|Overall Study||62
9960671|NCT01468987|11080344|FG000|COMPLETED|Overall Study||620
9843836|NCT00833248|10955745|FG000|NOT COMPLETED|Overall Study||4
9843837|NCT00833248|10955746|FG001|NOT COMPLETED|Overall Study||3
9843838|NCT00833261|10955752|FG000|STARTED|Overall Study||37
9960672|NCT01468987|11080345|FG001|COMPLETED|Overall Study||618
9960673|NCT01468987|11080344|FG000|NOT COMPLETED|Overall Study||71
9960674|NCT01468987|11080345|FG001|NOT COMPLETED|Overall Study||60
9960675|NCT01469000|11080355|FG000|STARTED|Overall Study||129
9960676|NCT01469000|11080356|FG001|STARTED|Overall Study||66
9960677|NCT01469000|11080355|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126
9681679|NCT04251884|10781502|FG000|STARTED|Overall Study||23
9681680|NCT04251884|10781503|FG001|STARTED|Overall Study||26
9681681|NCT04251884|10781502|FG000|COMPLETED|Overall Study||23
9681682|NCT04251884|10781503|FG001|COMPLETED|Overall Study||26
9681683|NCT04251884|10781502|FG000|NOT COMPLETED|Overall Study||0
9681684|NCT04251884|10781503|FG001|NOT COMPLETED|Overall Study||0
9681685|NCT03683823|10781512|FG000|STARTED|Post-treatment Assessment||11
9681686|NCT03683823|10781513|FG001|STARTED|Post-treatment Assessment||10
9681687|NCT03683823|10781512|FG000|COMPLETED|Post-treatment Assessment||10
10023313|NCT01855126|11146911|FG001|COMPLETED|First Intervention (8 Weeks)||16
10023314|NCT01855126|11146910|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4
10023315|NCT01855126|11146911|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6
10023316|NCT01855126|11146910|FG000|STARTED|Washout Period (2 Weeks)||20
9681688|NCT03683823|10781513|FG001|COMPLETED|Post-treatment Assessment||8
9681689|NCT03683823|10781512|FG000|NOT COMPLETED|Post-treatment Assessment||1
9681690|NCT03683823|10781513|FG001|NOT COMPLETED|Post-treatment Assessment||2
9681691|NCT03683823|10781512|FG000|STARTED|1-week Follow-up||10
9681692|NCT03683823|10781513|FG001|STARTED|1-week Follow-up||8
9681693|NCT03683823|10781512|FG000|COMPLETED|1-week Follow-up||9
9681694|NCT03683823|10781513|FG001|COMPLETED|1-week Follow-up||7
9681695|NCT03683823|10781512|FG000|NOT COMPLETED|1-week Follow-up||1
9681696|NCT03683823|10781513|FG001|NOT COMPLETED|1-week Follow-up||1
9681697|NCT03546439|10781522|FG000|STARTED|Overall Study||203
9681698|NCT03546439|10781523|FG001|STARTED|Overall Study||156
9681699|NCT03546439|10781524|FG002|STARTED|Overall Study||75
9681700|NCT03546439|10781522|FG000|COMPLETED|Overall Study||203
9681701|NCT03546439|10781523|FG001|COMPLETED|Overall Study||156
9681702|NCT03546439|10781524|FG002|COMPLETED|Overall Study||75
9681703|NCT03546439|10781522|FG000|NOT COMPLETED|Overall Study||0
9681704|NCT03546439|10781523|FG001|NOT COMPLETED|Overall Study||0
9681705|NCT03546439|10781524|FG002|NOT COMPLETED|Overall Study||0
9681706|NCT03515551|10781539|FG000|STARTED|Overall Study||4
9681707|NCT03515551|10781540|FG001|STARTED|Overall Study||3
9681708|NCT03515551|10781541|FG002|STARTED|Overall Study||5
9681709|NCT03515551|10781542|FG003|STARTED|Overall Study||3
9681710|NCT03515551|10781543|FG004|STARTED|Overall Study|1 participant from the 10 mcg cohort was sequentially enrolled in the 30-100 mcg cohort and is counted as starting in both columns; reason for study discontinuation recorded as part of 30-100 mcg cohort.|5
9681711|NCT03515551|10781544|FG005|STARTED|Overall Study||4
9681712|NCT03515551|10781545|FG006|STARTED|Overall Study||5
9681713|NCT03515551|10781539|FG000|COMPLETED|Overall Study||0
9681714|NCT03515551|10781540|FG001|COMPLETED|Overall Study||0
9681715|NCT03515551|10781541|FG002|COMPLETED|Overall Study||0
9681716|NCT03515551|10781542|FG003|COMPLETED|Overall Study||0
9843839|NCT00833261|10955752|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
9843840|NCT00833261|10955752|FG000|NOT COMPLETED|Overall Study||4
9843841|NCT00833365|10955758|FG000|STARTED|Overall Study||9
9843842|NCT00833365|10955759|FG001|STARTED|Overall Study||6
9843843|NCT00833365|10955758|FG000|COMPLETED|Overall Study||9
9843844|NCT00833365|10955759|FG001|COMPLETED|Overall Study||6
9843845|NCT00833365|10955758|FG000|NOT COMPLETED|Overall Study||0
9843846|NCT00833365|10955759|FG001|NOT COMPLETED|Overall Study||0
9843847|NCT00833417|10955767|FG000|STARTED|Overall Study||33
9843848|NCT00833417|10955768|FG001|STARTED|Overall Study||71
9843849|NCT00833417|10955767|FG000|COMPLETED|Overall Study||0
9843850|NCT00833417|10955768|FG001|COMPLETED|Overall Study||0
9843851|NCT00833417|10955767|FG000|NOT COMPLETED|Overall Study||33
9843852|NCT00833417|10955768|FG001|NOT COMPLETED|Overall Study||71
9843853|NCT00833443|10955777|FG000|STARTED|Overall Study||41
9843854|NCT00833443|10955778|FG001|STARTED|Overall Study||43
9843855|NCT00833443|10955777|FG000|COMPLETED|Overall Study||21
9843856|NCT00833443|10955778|FG001|COMPLETED|Overall Study||15
9843857|NCT00833443|10955777|FG000|NOT COMPLETED|Overall Study||20
9843858|NCT00833443|10955778|FG001|NOT COMPLETED|Overall Study||28
9843859|NCT00833469|10955786|FG000|STARTED|Overall Study||5
9843860|NCT00833469|10955786|FG000|COMPLETED|Overall Study||3
9843861|NCT00833469|10955786|FG000|NOT COMPLETED|Overall Study||2
9843862|NCT00833482|10955792|FG000|STARTED|Days 1-3|Participants who received treatment|24
9843863|NCT00833482|10955793|FG001|STARTED|Days 1-3|Participants who received treatment|0
9843864|NCT00833482|10955794|FG002|STARTED|Days 1-3||0
9843865|NCT00833482|10955795|FG003|STARTED|Days 1-3||8
9843866|NCT00833482|10955796|FG004|STARTED|Days 1-3||0
9843867|NCT00833482|10955797|FG005|STARTED|Days 1-3||0
9843868|NCT00833482|10955792|FG000|COMPLETED|Days 1-3||24
9843869|NCT00833482|10955793|FG001|COMPLETED|Days 1-3||0
10023317|NCT01855126|11146911|FG001|STARTED|Washout Period (2 Weeks)||16
10023318|NCT01855126|11146910|FG000|COMPLETED|Washout Period (2 Weeks)||20
9843870|NCT00833482|10955794|FG002|COMPLETED|Days 1-3||0
9843871|NCT00833482|10955795|FG003|COMPLETED|Days 1-3||8
9681717|NCT03515551|10781543|FG004|COMPLETED|Overall Study||0
9681718|NCT03515551|10781544|FG005|COMPLETED|Overall Study||0
9681719|NCT03515551|10781545|FG006|COMPLETED|Overall Study||0
9681720|NCT03515551|10781539|FG000|NOT COMPLETED|Overall Study||4
9681721|NCT03515551|10781540|FG001|NOT COMPLETED|Overall Study||3
9681722|NCT03515551|10781541|FG002|NOT COMPLETED|Overall Study||5
9681723|NCT03515551|10781542|FG003|NOT COMPLETED|Overall Study||3
9681724|NCT03515551|10781543|FG004|NOT COMPLETED|Overall Study||5
9843872|NCT00833482|10955796|FG004|COMPLETED|Days 1-3||0
10023319|NCT01855126|11146911|FG001|COMPLETED|Washout Period (2 Weeks)||16
9843873|NCT00833482|10955797|FG005|COMPLETED|Days 1-3||0
9681725|NCT03515551|10781544|FG005|NOT COMPLETED|Overall Study||4
9681726|NCT03515551|10781545|FG006|NOT COMPLETED|Overall Study||5
9681727|NCT03385265|10781570|FG000|STARTED|Overall Study||20
9681728|NCT03385265|10781571|FG001|STARTED|Overall Study||11
9681729|NCT03385265|10781572|FG002|STARTED|Overall Study||20
9681730|NCT03385265|10781573|FG003|STARTED|Overall Study||11
9681731|NCT03385265|10781570|FG000|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
9681732|NCT03385265|10781571|FG001|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
9681733|NCT03385265|10781572|FG002|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
9681734|NCT03385265|10781573|FG003|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
9681735|NCT03385265|10781570|FG000|NOT COMPLETED|Overall Study||5
9681736|NCT03385265|10781571|FG001|NOT COMPLETED|Overall Study||2
9681737|NCT03385265|10781572|FG002|NOT COMPLETED|Overall Study||5
9681738|NCT03385265|10781573|FG003|NOT COMPLETED|Overall Study||2
9681739|NCT03316807|10781587|FG000|STARTED|Overall Study||91
9681740|NCT03316807|10781588|FG001|STARTED|Overall Study||91
9681741|NCT03316807|10781587|FG000|COMPLETED|Overall Study||60
9681742|NCT03316807|10781588|FG001|COMPLETED|Overall Study||65
9681743|NCT03316807|10781587|FG000|NOT COMPLETED|Overall Study||31
9681744|NCT03316807|10781588|FG001|NOT COMPLETED|Overall Study||26
9681745|NCT03138538|10781600|FG000|STARTED|Overall Study||3
9681746|NCT03138538|10781601|FG001|STARTED|Overall Study||3
9681747|NCT03138538|10781602|FG002|STARTED|Overall Study||3
9681748|NCT03138538|10781603|FG003|STARTED|Overall Study||8
9681749|NCT03138538|10781604|FG004|STARTED|Overall Study||7
9681750|NCT03138538|10781605|FG005|STARTED|Overall Study||3
9681751|NCT03138538|10781600|FG000|COMPLETED|Overall Study||3
9681752|NCT03138538|10781601|FG001|COMPLETED|Overall Study||3
9681753|NCT03138538|10781602|FG002|COMPLETED|Overall Study||3
9681754|NCT03138538|10781603|FG003|COMPLETED|Overall Study||8
9681755|NCT03138538|10781604|FG004|COMPLETED|Overall Study||7
9681756|NCT03138538|10781605|FG005|COMPLETED|Overall Study||3
9681757|NCT03138538|10781600|FG000|NOT COMPLETED|Overall Study||0
9681758|NCT03138538|10781601|FG001|NOT COMPLETED|Overall Study||0
9681759|NCT03138538|10781602|FG002|NOT COMPLETED|Overall Study||0
9681760|NCT03138538|10781603|FG003|NOT COMPLETED|Overall Study||0
9681761|NCT03138538|10781604|FG004|NOT COMPLETED|Overall Study||0
9681762|NCT03138538|10781605|FG005|NOT COMPLETED|Overall Study||0
9725101|NCT00092547|10824725|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
9725102|NCT00092547|10824726|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
9725103|NCT00092547|10824727|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
9725104|NCT00092547|10824725|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
9725105|NCT00092547|10824726|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
9725106|NCT00092547|10824727|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
9725107|NCT00092547|10824725|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
9725108|NCT00092547|10824726|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
9725109|NCT00092547|10824727|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
9725110|NCT00092547|10824725|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
9725111|NCT00092547|10824726|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
9725112|NCT00092547|10824727|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
9725113|NCT00092547|10824725|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
9725114|NCT00092547|10824726|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0
9725115|NCT00092547|10824727|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
9725116|NCT00092547|10824725|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
9725117|NCT00092547|10824726|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
9725118|NCT00092547|10824727|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
9725119|NCT00092547|10824725|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
9725120|NCT00092547|10824726|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
9725121|NCT00092547|10824727|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
9725122|NCT00092547|10824725|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
9725123|NCT00092547|10824726|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0
9725124|NCT00092547|10824727|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
9725125|NCT00092547|10824725|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
9725126|NCT00092547|10824726|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
9725127|NCT00092547|10824727|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
9725128|NCT00092547|10824725|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
9725129|NCT00092547|10824726|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
9725130|NCT00092547|10824727|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
9731744|NCT00135356|10831658|FG000|STARTED|Overall Study|Number randomized and treated|131
9843874|NCT00833482|10955792|FG000|NOT COMPLETED|Days 1-3||0
9843875|NCT00833482|10955793|FG001|NOT COMPLETED|Days 1-3||0
10023320|NCT01855126|11146910|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10023321|NCT01855126|11146911|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10023322|NCT01855126|11146910|FG000|STARTED|Second Intervention (8 Weeks)||20
9843876|NCT00833482|10955794|FG002|NOT COMPLETED|Days 1-3||0
9843877|NCT00833482|10955795|FG003|NOT COMPLETED|Days 1-3||0
9843878|NCT00833482|10955796|FG004|NOT COMPLETED|Days 1-3||0
9843879|NCT00833482|10955797|FG005|NOT COMPLETED|Days 1-3||0
9843880|NCT00833482|10955792|FG000|STARTED|Days 11-20||0
9843881|NCT00833482|10955793|FG001|STARTED|Days 11-20|Participants who received treatment.|24
9843882|NCT00833482|10955794|FG002|STARTED|Days 11-20||0
9843883|NCT00833482|10955795|FG003|STARTED|Days 11-20||0
9843884|NCT00833482|10955796|FG004|STARTED|Days 11-20||0
9843885|NCT00833482|10955797|FG005|STARTED|Days 11-20|Participants who received treatment.|8
9843886|NCT00833482|10955792|FG000|COMPLETED|Days 11-20||0
9843887|NCT00833482|10955793|FG001|COMPLETED|Days 11-20||21
9681775|NCT02919306|10781639|FG000|STARTED|Overall Study||18
9681776|NCT02919306|10781640|FG001|STARTED|Overall Study||9
9681777|NCT02919306|10781639|FG000|COMPLETED|Overall Study||16
9681778|NCT02919306|10781640|FG001|COMPLETED|Overall Study||9
9681779|NCT02919306|10781639|FG000|NOT COMPLETED|Overall Study||2
9681780|NCT02919306|10781640|FG001|NOT COMPLETED|Overall Study||0
9681781|NCT02763189|10781648|FG000|STARTED|Overall Study||4
9681782|NCT02763189|10781649|FG001|STARTED|Overall Study||4
9681783|NCT02763189|10781648|FG000|COMPLETED|Overall Study||4
9681784|NCT02763189|10781649|FG001|COMPLETED|Overall Study||2
9681785|NCT02763189|10781648|FG000|NOT COMPLETED|Overall Study||0
9681786|NCT02763189|10781649|FG001|NOT COMPLETED|Overall Study||2
9681787|NCT02700945|10781657|FG000|STARTED|Overall Study||242
9681788|NCT02700945|10781658|FG001|STARTED|Overall Study||250
9681789|NCT02700945|10781657|FG000|COMPLETED|Overall Study||210
9681790|NCT02700945|10781658|FG001|COMPLETED|Overall Study||207
9681791|NCT02700945|10781657|FG000|NOT COMPLETED|Overall Study||32
9681792|NCT02700945|10781658|FG001|NOT COMPLETED|Overall Study||43
9681793|NCT02659514|10781666|FG000|STARTED|Overall Study||33
9681794|NCT02659514|10781667|FG001|STARTED|Overall Study||34
9681795|NCT02659514|10781666|FG000|Safety Population|Overall Study||33
9681796|NCT02659514|10781667|FG001|Safety Population|Overall Study||34
9681797|NCT02659514|10781666|FG000|Evaluable Population|Overall Study||30
9681798|NCT02659514|10781667|FG001|Evaluable Population|Overall Study||27
9681799|NCT02659514|10781666|FG000|COMPLETED|Overall Study||1
9681800|NCT02659514|10781667|FG001|COMPLETED|Overall Study||0
9681801|NCT02659514|10781666|FG000|NOT COMPLETED|Overall Study||32
9681802|NCT02659514|10781667|FG001|NOT COMPLETED|Overall Study||34
9681803|NCT02435173|10781676|FG000|STARTED|Overall Study||6
9681804|NCT02435173|10781677|FG001|STARTED|Overall Study||21
9681805|NCT02435173|10781678|FG002|STARTED|Overall Study||10
9681806|NCT02435173|10781676|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||6
9681807|NCT02435173|10781677|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||19
9681808|NCT02435173|10781678|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
9681809|NCT02435173|10781676|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
9681810|NCT02435173|10781677|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||19
9681811|NCT02435173|10781678|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||8
9681812|NCT02435173|10781676|FG000|COMPLETED|Overall Study||6
9681813|NCT02435173|10781677|FG001|COMPLETED|Overall Study||21
9681814|NCT02435173|10781678|FG002|COMPLETED|Overall Study||10
9681815|NCT02435173|10781676|FG000|NOT COMPLETED|Overall Study||0
9681816|NCT02435173|10781677|FG001|NOT COMPLETED|Overall Study||0
9681817|NCT02435173|10781678|FG002|NOT COMPLETED|Overall Study||0
9681818|NCT02390245|10781692|FG000|STARTED|Phase I. Telemedicine Screening||906
9681819|NCT02390245|10781693|FG001|STARTED|Phase I. Telemedicine Screening||0
9681820|NCT02390245|10781694|FG002|STARTED|Phase I. Telemedicine Screening||0
9681821|NCT02390245|10781692|FG000|COMPLETED|Phase I. Telemedicine Screening||906
9681822|NCT02390245|10781693|FG001|COMPLETED|Phase I. Telemedicine Screening||0
9681823|NCT02390245|10781694|FG002|COMPLETED|Phase I. Telemedicine Screening||0
9681824|NCT02390245|10781692|FG000|NOT COMPLETED|Phase I. Telemedicine Screening||0
9681825|NCT02390245|10781693|FG001|NOT COMPLETED|Phase I. Telemedicine Screening||0
9681826|NCT02390245|10781694|FG002|NOT COMPLETED|Phase I. Telemedicine Screening||0
9681827|NCT02390245|10781692|FG000|STARTED|Phase 2. Randomization Into 2 Groups|Remaining 355 participants from Phase I Telemedicine Screening had normal eye examinations requiring no further follow-up.|0
9681828|NCT02390245|10781693|FG001|STARTED|Phase 2. Randomization Into 2 Groups||275
9681829|NCT02390245|10781694|FG002|STARTED|Phase 2. Randomization Into 2 Groups||276
9681830|NCT02390245|10781692|FG000|COMPLETED|Phase 2. Randomization Into 2 Groups||0
9681831|NCT02390245|10781693|FG001|COMPLETED|Phase 2. Randomization Into 2 Groups||171
9681832|NCT02390245|10781694|FG002|COMPLETED|Phase 2. Randomization Into 2 Groups||171
9843888|NCT00833482|10955794|FG002|COMPLETED|Days 11-20||0
9843889|NCT00833482|10955795|FG003|COMPLETED|Days 11-20||0
9843890|NCT00833482|10955796|FG004|COMPLETED|Days 11-20||0
9843891|NCT00833482|10955797|FG005|COMPLETED|Days 11-20||8
9843892|NCT00833482|10955792|FG000|NOT COMPLETED|Days 11-20||0
9843893|NCT00833482|10955793|FG001|NOT COMPLETED|Days 11-20||3
9843894|NCT00833482|10955794|FG002|NOT COMPLETED|Days 11-20||0
9843895|NCT00833482|10955795|FG003|NOT COMPLETED|Days 11-20||0
9843896|NCT00833482|10955796|FG004|NOT COMPLETED|Days 11-20||0
9843897|NCT00833482|10955797|FG005|NOT COMPLETED|Days 11-20||0
9843898|NCT00833482|10955792|FG000|STARTED|Days 21-30||0
9843899|NCT00833482|10955793|FG001|STARTED|Days 21-30||0
9843900|NCT00833482|10955794|FG002|STARTED|Days 21-30||21
9843901|NCT00833482|10955795|FG003|STARTED|Days 21-30||0
9681833|NCT02390245|10781692|FG000|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||0
9843902|NCT00833482|10955796|FG004|STARTED|Days 21-30||8
9843903|NCT00833482|10955797|FG005|STARTED|Days 21-30||0
9681834|NCT02390245|10781693|FG001|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||104
9681835|NCT02390245|10781694|FG002|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||105
9681836|NCT02390245|10781692|FG000|STARTED|Phase 3. Ophthalmic Follow-up Adherence||0
9681837|NCT02390245|10781693|FG001|STARTED|Phase 3. Ophthalmic Follow-up Adherence||171
9681838|NCT02390245|10781694|FG002|STARTED|Phase 3. Ophthalmic Follow-up Adherence||171
9681839|NCT02390245|10781692|FG000|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
10023323|NCT01855126|11146911|FG001|STARTED|Second Intervention (8 Weeks)||16
10023324|NCT01855126|11146910|FG000|COMPLETED|Second Intervention (8 Weeks)||18
10023325|NCT01855126|11146911|FG001|COMPLETED|Second Intervention (8 Weeks)||14
9681840|NCT02390245|10781693|FG001|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||77
9681841|NCT02390245|10781694|FG002|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||66
9681842|NCT02390245|10781692|FG000|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
9681843|NCT02390245|10781693|FG001|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||94
9681844|NCT02390245|10781694|FG002|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||105
9681845|NCT02254278|10781703|FG000|STARTED|Overall Study||158
9681846|NCT02254278|10781704|FG001|STARTED|Overall Study||150
9681847|NCT02254278|10781703|FG000|Eligible|Overall Study||157
9681848|NCT02254278|10781704|FG001|Eligible|Overall Study||149
9681849|NCT02254278|10781703|FG000|Started Study Treatment|Overall Study||152
9681850|NCT02254278|10781704|FG001|Started Study Treatment|Overall Study||147
9681851|NCT02254278|10781703|FG000|Negative Post-treatment PET|Overall Study||58
9681852|NCT02254278|10781704|FG001|Negative Post-treatment PET|Overall Study||57
9681853|NCT02254278|10781703|FG000|COMPLETED|Overall Study||157
9681854|NCT02254278|10781704|FG001|COMPLETED|Overall Study||149
9681855|NCT02254278|10781703|FG000|NOT COMPLETED|Overall Study||1
9681856|NCT02254278|10781704|FG001|NOT COMPLETED|Overall Study||1
9843904|NCT00833482|10955792|FG000|COMPLETED|Days 21-30||0
9843905|NCT00833482|10955793|FG001|COMPLETED|Days 21-30||0
9843906|NCT00833482|10955794|FG002|COMPLETED|Days 21-30||20
9843907|NCT00833482|10955795|FG003|COMPLETED|Days 21-30||0
9843908|NCT00833482|10955796|FG004|COMPLETED|Days 21-30||7
9843909|NCT00833482|10955797|FG005|COMPLETED|Days 21-30||0
9843910|NCT00833482|10955792|FG000|NOT COMPLETED|Days 21-30||0
9843911|NCT00833482|10955793|FG001|NOT COMPLETED|Days 21-30||0
9843912|NCT00833482|10955794|FG002|NOT COMPLETED|Days 21-30||1
9843913|NCT00833482|10955795|FG003|NOT COMPLETED|Days 21-30||0
9843914|NCT00833482|10955796|FG004|NOT COMPLETED|Days 21-30||1
9843915|NCT00833482|10955797|FG005|NOT COMPLETED|Days 21-30||0
9843916|NCT00833547|10955821|FG000|STARTED|Overall Study||13
9843917|NCT00833547|10955822|FG001|STARTED|Overall Study||12
9843918|NCT00833547|10955821|FG000|COMPLETED|Overall Study||11
9843919|NCT00833547|10955822|FG001|COMPLETED|Overall Study||10
9681873|NCT01673867|10781726|FG000|STARTED|Randomization||292
9681874|NCT01673867|10781727|FG001|STARTED|Randomization||290
9681875|NCT01673867|10781726|FG000|COMPLETED|Randomization||287
9681876|NCT01673867|10781727|FG001|COMPLETED|Randomization||268
9681877|NCT01673867|10781726|FG000|NOT COMPLETED|Randomization||5
9681878|NCT01673867|10781727|FG001|NOT COMPLETED|Randomization||22
9681879|NCT01673867|10781726|FG000|STARTED|Treatment||287
9681880|NCT01673867|10781727|FG001|STARTED|Treatment||268
9681881|NCT01673867|10781726|FG000|COMPLETED|Treatment||43
9681882|NCT01673867|10781727|FG001|COMPLETED|Treatment||0
9681883|NCT01673867|10781726|FG000|NOT COMPLETED|Treatment||244
9681884|NCT01673867|10781727|FG001|NOT COMPLETED|Treatment||268
9681885|NCT01182727|10781733|FG000|STARTED|Overall Study||10
9681886|NCT01182727|10781733|FG000|COMPLETED|Overall Study||10
9681887|NCT01182727|10781733|FG000|NOT COMPLETED|Overall Study||0
9681888|NCT00335777|10781737|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
9681889|NCT00335777|10781737|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35
9681890|NCT00335777|10781737|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
9681891|NCT00335777|10781737|FG000|STARTED|Treated 2 Headaches Per Protocol||35
9681892|NCT00335777|10781737|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22
9681893|NCT00335777|10781737|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
9681894|NCT00159588|10781745|FG000|STARTED|5 Month Follow-up||19
9681895|NCT00159588|10781746|FG001|STARTED|5 Month Follow-up||22
9681896|NCT00159588|10781747|FG002|STARTED|5 Month Follow-up||20
9681897|NCT00159588|10781745|FG000|COMPLETED|5 Month Follow-up||17
9681898|NCT00159588|10781746|FG001|COMPLETED|5 Month Follow-up||18
9681899|NCT00159588|10781747|FG002|COMPLETED|5 Month Follow-up||18
9681900|NCT00159588|10781745|FG000|NOT COMPLETED|5 Month Follow-up||2
9681901|NCT00159588|10781746|FG001|NOT COMPLETED|5 Month Follow-up||4
9681902|NCT00159588|10781747|FG002|NOT COMPLETED|5 Month Follow-up||2
10023326|NCT01855126|11146910|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
9681903|NCT00159588|10781745|FG000|STARTED|1-year Follow-up for Group 1 and 2||17
9681904|NCT00159588|10781746|FG001|STARTED|1-year Follow-up for Group 1 and 2||18
9681905|NCT00159588|10781747|FG002|STARTED|1-year Follow-up for Group 1 and 2||18
9681906|NCT00159588|10781745|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16
9681907|NCT00159588|10781746|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14
9681908|NCT00159588|10781747|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18
9843920|NCT00833547|10955821|FG000|NOT COMPLETED|Overall Study||2
9843921|NCT00833547|10955822|FG001|NOT COMPLETED|Overall Study||2
9843922|NCT00833560|10955828|FG000|STARTED|Overall Study||395
9843923|NCT00833560|10955828|FG000|COMPLETED|Overall Study||353
9843924|NCT00833560|10955828|FG000|NOT COMPLETED|Overall Study||42
9843925|NCT00833638|10955835|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121
9681909|NCT00159588|10781745|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1
9681910|NCT00159588|10781746|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4
9681911|NCT00159588|10781747|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0
9681912|NCT03051217|10781761|FG000|STARTED|Initial Period (Week 0 to Week 16)||26
9681913|NCT03051217|10781762|FG001|STARTED|Initial Period (Week 0 to Week 16)||48
9681914|NCT03051217|10781763|FG002|STARTED|Initial Period (Week 0 to Week 16)||53
9681915|NCT03051217|10781764|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
9681916|NCT03051217|10781765|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
9681917|NCT03051217|10781766|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
9681918|NCT03051217|10781767|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
9681919|NCT03051217|10781761|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23
9681920|NCT03051217|10781762|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46
9681921|NCT03051217|10781763|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51
9681922|NCT03051217|10781764|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
9681923|NCT03051217|10781765|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
9681924|NCT03051217|10781766|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
9681925|NCT03051217|10781767|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
9681926|NCT03051217|10781761|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
9681927|NCT03051217|10781762|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
9681928|NCT03051217|10781763|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
9681929|NCT03051217|10781764|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
9681930|NCT03051217|10781765|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
9681931|NCT03051217|10781766|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
9681932|NCT03051217|10781767|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
9681933|NCT03051217|10781761|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0
9681934|NCT03051217|10781762|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0
9681935|NCT03051217|10781763|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0
9681936|NCT03051217|10781764|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23
9681937|NCT03051217|10781765|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51
9681938|NCT03051217|10781766|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26
9681939|NCT03051217|10781767|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20
9681940|NCT03051217|10781761|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
9681941|NCT03051217|10781762|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
9681942|NCT03051217|10781763|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
9681943|NCT03051217|10781764|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
9681944|NCT03051217|10781765|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
9681945|NCT03051217|10781766|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
9681946|NCT03051217|10781767|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
9681947|NCT03051217|10781761|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
9681948|NCT03051217|10781762|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
9681949|NCT03051217|10781763|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
9681950|NCT03051217|10781764|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
9681951|NCT03051217|10781765|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
9681952|NCT03051217|10781766|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
9681953|NCT03051217|10781767|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
9681954|NCT03051217|10781761|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
9681955|NCT03051217|10781762|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
9681956|NCT03051217|10781763|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
9681957|NCT03051217|10781764|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
9681958|NCT03051217|10781765|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
9681959|NCT03051217|10781766|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
9681960|NCT03051217|10781767|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
9681961|NCT03025542|10781783|FG000|STARTED|Overall Study||32
9681962|NCT03025542|10781784|FG001|STARTED|Overall Study||17
9681963|NCT03025542|10781783|FG000|COMPLETED|Overall Study||30
9681964|NCT03025542|10781784|FG001|COMPLETED|Overall Study||15
9681965|NCT03025542|10781783|FG000|NOT COMPLETED|Overall Study||2
9681966|NCT03025542|10781784|FG001|NOT COMPLETED|Overall Study||2
9681967|NCT02958319|10781796|FG000|STARTED|Overall Study||145
9681968|NCT02958319|10781797|FG001|STARTED|Overall Study||133
9681969|NCT02958319|10781796|FG000|COMPLETED|Overall Study||145
9681970|NCT02958319|10781797|FG001|COMPLETED|Overall Study||133
9681971|NCT02958319|10781796|FG000|NOT COMPLETED|Overall Study||0
9843926|NCT00833638|10955836|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118
9843927|NCT00833638|10955837|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133
9843928|NCT00833638|10955835|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111
9843929|NCT00833638|10955836|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108
9843930|NCT00833638|10955837|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124
9843931|NCT00833638|10955835|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
9843932|NCT00833638|10955836|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
9843933|NCT00833638|10955837|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
9843934|NCT00833638|10955835|FG000|STARTED|Phase 3: Open-label Extension Phase||111
9843935|NCT00833638|10955836|FG001|STARTED|Phase 3: Open-label Extension Phase||108
9843936|NCT00833638|10955837|FG002|STARTED|Phase 3: Open-label Extension Phase||124
9843937|NCT00833638|10955835|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110
9681972|NCT02958319|10781797|FG001|NOT COMPLETED|Overall Study||0
9681973|NCT02929069|10781806|FG000|STARTED|Overall Study||100
9681974|NCT02929069|10781807|FG001|STARTED|Overall Study||102
9681975|NCT02929069|10781808|FG002|STARTED|Overall Study||52
9681976|NCT02929069|10781806|FG000|Completed 4 Month Follow Up|Overall Study||83
9681977|NCT02929069|10781807|FG001|Completed 4 Month Follow Up|Overall Study||76
9681978|NCT02929069|10781808|FG002|Completed 4 Month Follow Up|Overall Study||43
9681979|NCT02929069|10781806|FG000|Completed 8 Month Follow Up|Overall Study||82
9681980|NCT02929069|10781807|FG001|Completed 8 Month Follow Up|Overall Study||77
9681981|NCT02929069|10781808|FG002|Completed 8 Month Follow Up|Overall Study||36
9681982|NCT02929069|10781806|FG000|Assessed STI 12 Month|Overall Study||74
9681983|NCT02929069|10781807|FG001|Assessed STI 12 Month|Overall Study||75
9681984|NCT02929069|10781808|FG002|Assessed STI 12 Month|Overall Study||38
9681985|NCT02929069|10781806|FG000|Assessed HIV 12 Month|Overall Study||76
9681986|NCT02929069|10781807|FG001|Assessed HIV 12 Month|Overall Study||76
9681987|NCT02929069|10781808|FG002|Assessed HIV 12 Month|Overall Study||39
9681988|NCT02929069|10781806|FG000|Complete 12 Month Follow Up|Overall Study||81
9681989|NCT02929069|10781807|FG001|Complete 12 Month Follow Up|Overall Study||81
9681990|NCT02929069|10781808|FG002|Complete 12 Month Follow Up|Overall Study||42
9681991|NCT02929069|10781806|FG000|COMPLETED|Overall Study||81
9681992|NCT02929069|10781807|FG001|COMPLETED|Overall Study||81
9681993|NCT02929069|10781808|FG002|COMPLETED|Overall Study||42
9681994|NCT02929069|10781806|FG000|NOT COMPLETED|Overall Study||19
9681995|NCT02929069|10781807|FG001|NOT COMPLETED|Overall Study||21
9681996|NCT02929069|10781808|FG002|NOT COMPLETED|Overall Study||10
9681997|NCT02889809|10781820|FG000|STARTED|Overall Study||239
9681998|NCT02889809|10781821|FG001|STARTED|Overall Study||238
9681999|NCT02889809|10781820|FG000|COMPLETED|Overall Study||196
9682000|NCT02889809|10781821|FG001|COMPLETED|Overall Study||205
9682001|NCT02889809|10781820|FG000|NOT COMPLETED|Overall Study||43
9682002|NCT02889809|10781821|FG001|NOT COMPLETED|Overall Study||33
9682003|NCT02849587|10781830|FG000|STARTED|Overall Study||65
9682004|NCT02849587|10781831|FG001|STARTED|Overall Study||70
9682005|NCT02849587|10781832|FG002|STARTED|Overall Study||64
9682006|NCT02849587|10781830|FG000|COMPLETED|Overall Study||63
9682007|NCT02849587|10781831|FG001|COMPLETED|Overall Study||66
9682008|NCT02849587|10781832|FG002|COMPLETED|Overall Study||62
9682009|NCT02849587|10781830|FG000|NOT COMPLETED|Overall Study||2
9682010|NCT02849587|10781831|FG001|NOT COMPLETED|Overall Study||4
9682011|NCT02849587|10781832|FG002|NOT COMPLETED|Overall Study||2
9682012|NCT02815540|10781844|FG000|STARTED|Overall Study||2
9682013|NCT02815540|10781844|FG000|COMPLETED|Overall Study||0
9682014|NCT02815540|10781844|FG000|NOT COMPLETED|Overall Study||2
9682015|NCT02814708|10781855|FG000|STARTED|Overall Study||20
9682016|NCT02814708|10781856|FG001|STARTED|Overall Study||20
9682017|NCT02814708|10781857|FG002|STARTED|Overall Study||20
9682018|NCT02814708|10781858|FG003|STARTED|Overall Study||20
9682019|NCT02814708|10781859|FG004|STARTED|Overall Study||20
9682020|NCT02814708|10781860|FG005|STARTED|Overall Study||20
9682021|NCT02814708|10781861|FG006|STARTED|Overall Study||20
9682022|NCT02814708|10781855|FG000|COMPLETED|Overall Study||18
9682023|NCT02814708|10781856|FG001|COMPLETED|Overall Study||17
9682024|NCT02814708|10781857|FG002|COMPLETED|Overall Study||19
9682025|NCT02814708|10781858|FG003|COMPLETED|Overall Study||20
9682026|NCT02814708|10781859|FG004|COMPLETED|Overall Study||17
9682027|NCT02814708|10781860|FG005|COMPLETED|Overall Study||16
9682028|NCT02814708|10781861|FG006|COMPLETED|Overall Study||19
9682029|NCT02814708|10781855|FG000|NOT COMPLETED|Overall Study||2
9682030|NCT02814708|10781856|FG001|NOT COMPLETED|Overall Study||3
9682031|NCT02814708|10781857|FG002|NOT COMPLETED|Overall Study||1
9682032|NCT02814708|10781858|FG003|NOT COMPLETED|Overall Study||0
9682033|NCT02814708|10781859|FG004|NOT COMPLETED|Overall Study||3
9682034|NCT02814708|10781860|FG005|NOT COMPLETED|Overall Study||4
9682035|NCT02814708|10781861|FG006|NOT COMPLETED|Overall Study||1
9682036|NCT02781727|10781879|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106
9682037|NCT02781727|10781880|FG001|STARTED|Pre-dosing Period||56
9682038|NCT02781727|10781879|FG000|COMPLETED|Pre-dosing Period||105
9682039|NCT02781727|10781880|FG001|COMPLETED|Pre-dosing Period||56
9682040|NCT02781727|10781879|FG000|NOT COMPLETED|Pre-dosing Period||1
9682041|NCT02781727|10781880|FG001|NOT COMPLETED|Pre-dosing Period||0
9682042|NCT02781727|10781879|FG000|STARTED|Treatment Period||105
9682043|NCT02781727|10781880|FG001|STARTED|Treatment Period||56
9682044|NCT02781727|10781879|FG000|COMPLETED|Treatment Period||104
9682045|NCT02781727|10781880|FG001|COMPLETED|Treatment Period||55
9682046|NCT02781727|10781879|FG000|NOT COMPLETED|Treatment Period||1
9682047|NCT02781727|10781880|FG001|NOT COMPLETED|Treatment Period||1
9682048|NCT02778204|10781890|FG000|STARTED|Overall Study||8
9682049|NCT02778204|10781891|FG001|STARTED|Overall Study||7
9682050|NCT02778204|10781892|FG002|STARTED|Overall Study||16
9682051|NCT02778204|10781893|FG003|STARTED|Overall Study||16
9682052|NCT02778204|10781890|FG000|COMPLETED|Overall Study||6
9682053|NCT02778204|10781891|FG001|COMPLETED|Overall Study||7
9682054|NCT02778204|10781892|FG002|COMPLETED|Overall Study||12
9682055|NCT02778204|10781893|FG003|COMPLETED|Overall Study||12
9682056|NCT02778204|10781890|FG000|NOT COMPLETED|Overall Study||2
9682057|NCT02778204|10781891|FG001|NOT COMPLETED|Overall Study||0
9682058|NCT02778204|10781892|FG002|NOT COMPLETED|Overall Study||4
9682059|NCT02778204|10781893|FG003|NOT COMPLETED|Overall Study||4
9725131|NCT00092547|10824725|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
9725132|NCT00092547|10824726|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0
9725133|NCT00092547|10824727|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
10114241|NCT02514889|11244962|FG001|STARTED|Randomization/Allocation to Condition||130
10114242|NCT02514889|11244961|FG000|COMPLETED|Randomization/Allocation to Condition||111
9725134|NCT00092547|10824725|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
10023327|NCT01855126|11146911|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2
10023328|NCT01855243|11146924|FG000|STARTED|Overall Study||20
10023329|NCT01855243|11146925|FG001|STARTED|Overall Study||21
10023330|NCT01855243|11146926|FG002|STARTED|Overall Study||22
10023331|NCT01855243|11146924|FG000|COMPLETED|Overall Study||19
10023332|NCT01855243|11146925|FG001|COMPLETED|Overall Study||21
10023333|NCT01855243|11146926|FG002|COMPLETED|Overall Study||22
10023334|NCT01855243|11146924|FG000|NOT COMPLETED|Overall Study||1
10023335|NCT01855243|11146925|FG001|NOT COMPLETED|Overall Study||0
10023336|NCT01855243|11146926|FG002|NOT COMPLETED|Overall Study||0
10023337|NCT01855360|11146934|FG000|STARTED|Overall Study||40
10023338|NCT01855360|11146934|FG000|COMPLETED|Overall Study||30
9725135|NCT00092547|10824726|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
9725136|NCT00092547|10824727|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
9725137|NCT00092547|10824725|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10023339|NCT01855360|11146934|FG000|NOT COMPLETED|Overall Study||10
10023340|NCT01855399|11146940|FG000|STARTED|6 Month||146
10023341|NCT01855399|11146941|FG001|STARTED|6 Month||144
10023342|NCT01855399|11146940|FG000|COMPLETED|6 Month||126
9725138|NCT00092547|10824726|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
9725139|NCT00092547|10824727|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
9725140|NCT00092547|10824725|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454
9725141|NCT00092547|10824726|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0
9725142|NCT00092547|10824727|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211
9725143|NCT00092547|10824725|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
9725144|NCT00092547|10824726|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
9725145|NCT00092547|10824727|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
9725146|NCT00092547|10824725|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
9725147|NCT00092547|10824726|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
9725148|NCT00092547|10824727|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
9725149|NCT00093015|10824740|FG000|STARTED|Overall Study||2026
9843938|NCT00833638|10955836|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105
9843939|NCT00833638|10955837|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122
9843940|NCT00833638|10955835|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
9843941|NCT00833638|10955836|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
9843942|NCT00833638|10955837|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
9843943|NCT00833690|10955856|FG000|STARTED|Overall Study||25
9843944|NCT00833690|10955857|FG001|STARTED|Overall Study||24
9843945|NCT00833690|10955858|FG002|STARTED|Overall Study||26
9843946|NCT00833690|10955856|FG000|COMPLETED|Overall Study||21
9843947|NCT00833690|10955857|FG001|COMPLETED|Overall Study||22
9843948|NCT00833690|10955858|FG002|COMPLETED|Overall Study||26
9843949|NCT00833690|10955856|FG000|NOT COMPLETED|Overall Study||4
9843950|NCT00833690|10955857|FG001|NOT COMPLETED|Overall Study||2
9843951|NCT00833690|10955858|FG002|NOT COMPLETED|Overall Study||0
9960678|NCT01469000|11080356|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
9960679|NCT01469000|11080355|FG000|COMPLETED|Overall Study||109
9960680|NCT01469000|11080356|FG001|COMPLETED|Overall Study||62
9960681|NCT01469000|11080355|FG000|NOT COMPLETED|Overall Study||20
9960682|NCT01469000|11080356|FG001|NOT COMPLETED|Overall Study||4
9960683|NCT01469013|11080367|FG000|STARTED|Part A (Treatment Period)||24
9960684|NCT01469013|11080368|FG001|STARTED|Part A (Treatment Period)||24
9960685|NCT01469013|11080369|FG002|STARTED|Part A (Treatment Period)||24
9960686|NCT01469013|11080370|FG003|STARTED|Part A (Treatment Period)||24
9960687|NCT01469013|11080371|FG004|STARTED|Part A (Treatment Period)||49
9960688|NCT01469013|11080372|FG005|STARTED|Part A (Treatment Period)||0
9960689|NCT01469013|11080373|FG006|STARTED|Part A (Treatment Period)||0
9960690|NCT01469013|11080374|FG007|STARTED|Part A (Treatment Period)||0
9960691|NCT01469013|11080375|FG008|STARTED|Part A (Treatment Period)||0
9960692|NCT01469013|11080376|FG009|STARTED|Part A (Treatment Period)||0
9960693|NCT01469013|11080377|FG010|STARTED|Part A (Treatment Period)||0
10023343|NCT01855399|11146941|FG001|COMPLETED|6 Month||129
10023344|NCT01855399|11146940|FG000|NOT COMPLETED|6 Month||20
10023345|NCT01855399|11146941|FG001|NOT COMPLETED|6 Month||15
9725150|NCT00093015|10824741|FG001|STARTED|Overall Study||2012
9725151|NCT00093015|10824740|FG000|Received Study Medication|Overall Study||2019
9960694|NCT01469013|11080378|FG011|STARTED|Part A (Treatment Period)||0
10023346|NCT01855399|11146940|FG000|STARTED|12 Month||126
9682060|NCT02743364|10781907|FG000|STARTED|Overall Study||6
9682061|NCT02743364|10781908|FG001|STARTED|Overall Study||2
9682062|NCT02743364|10781907|FG000|COMPLETED|Overall Study||6
9682063|NCT02743364|10781908|FG001|COMPLETED|Overall Study||2
9682064|NCT02743364|10781907|FG000|NOT COMPLETED|Overall Study||0
9682065|NCT02743364|10781908|FG001|NOT COMPLETED|Overall Study||0
9682066|NCT02496611|10781916|FG000|STARTED|Overall Study||33
9682067|NCT02496611|10781917|FG001|STARTED|Overall Study||33
9682068|NCT02496611|10781916|FG000|COMPLETED|Overall Study||26
9682069|NCT02496611|10781917|FG001|COMPLETED|Overall Study||30
9682070|NCT02496611|10781916|FG000|NOT COMPLETED|Overall Study||7
9682071|NCT02496611|10781917|FG001|NOT COMPLETED|Overall Study||3
9682072|NCT02245308|10781926|FG000|STARTED|Overall Study||63
9682073|NCT02245308|10781927|FG001|STARTED|Overall Study||64
9682074|NCT02245308|10781926|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
9682075|NCT02245308|10781927|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
9682076|NCT02245308|10781926|FG000|NOT COMPLETED|Overall Study||0
9682077|NCT02245308|10781927|FG001|NOT COMPLETED|Overall Study||0
10023347|NCT01855399|11146941|FG001|STARTED|12 Month||129
10023348|NCT01855399|11146940|FG000|COMPLETED|12 Month||119
10023349|NCT01855399|11146941|FG001|COMPLETED|12 Month||118
10023350|NCT01855399|11146940|FG000|NOT COMPLETED|12 Month||7
10023351|NCT01855399|11146941|FG001|NOT COMPLETED|12 Month||11
9682087|NCT02177695|10781952|FG000|STARTED|ITT Analysis||120
9682088|NCT02177695|10781953|FG001|STARTED|ITT Analysis||117
9682089|NCT02177695|10781952|FG000|COMPLETED|ITT Analysis||115
9682090|NCT02177695|10781953|FG001|COMPLETED|ITT Analysis||112
9682091|NCT02177695|10781952|FG000|NOT COMPLETED|ITT Analysis||5
9682092|NCT02177695|10781953|FG001|NOT COMPLETED|ITT Analysis||5
9682093|NCT02177695|10781952|FG000|STARTED|Primary COXEN Analysis||115
9682094|NCT02177695|10781953|FG001|STARTED|Primary COXEN Analysis||112
9682095|NCT02177695|10781952|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33
9682096|NCT02177695|10781953|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27
9682097|NCT02177695|10781952|FG000|COMPLETED|Primary COXEN Analysis||82
9682098|NCT02177695|10781953|FG001|COMPLETED|Primary COXEN Analysis||85
9682099|NCT02177695|10781952|FG000|NOT COMPLETED|Primary COXEN Analysis||33
9682100|NCT02177695|10781953|FG001|NOT COMPLETED|Primary COXEN Analysis||27
9682101|NCT02145403|10781965|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
9682102|NCT02145403|10781966|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682103|NCT02145403|10781967|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682104|NCT02145403|10781968|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682105|NCT02145403|10781965|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
9682106|NCT02145403|10781966|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682107|NCT02145403|10781967|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682108|NCT02145403|10781968|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682109|NCT02145403|10781965|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682110|NCT02145403|10781966|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682111|NCT02145403|10781967|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682112|NCT02145403|10781968|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
9682113|NCT02145403|10781965|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682114|NCT02145403|10781966|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
9682115|NCT02145403|10781967|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682116|NCT02145403|10781968|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682117|NCT02145403|10781965|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682118|NCT02145403|10781966|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
9682119|NCT02145403|10781967|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682120|NCT02145403|10781968|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682121|NCT02145403|10781965|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682122|NCT02145403|10781966|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682123|NCT02145403|10781967|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682124|NCT02145403|10781968|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
9682125|NCT02145403|10781965|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682126|NCT02145403|10781966|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682127|NCT02145403|10781967|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
9682128|NCT02145403|10781968|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682129|NCT02145403|10781965|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682130|NCT02145403|10781966|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682131|NCT02145403|10781967|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
9682132|NCT02145403|10781968|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682133|NCT02145403|10781965|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682134|NCT02145403|10781966|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9725152|NCT00093015|10824741|FG001|Received Study Medication|Overall Study||2004
9682135|NCT02145403|10781967|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
10023352|NCT01855425|11146947|FG000|STARTED|Overall Study||96
10023353|NCT01855425|11146947|FG000|COMPLETED|Overall Study||76
10023354|NCT01855425|11146947|FG000|NOT COMPLETED|Overall Study||20
9682136|NCT02145403|10781968|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
9682137|NCT02145403|10781965|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682138|NCT02145403|10781966|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682139|NCT02145403|10781967|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682140|NCT02145403|10781968|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
9682141|NCT02145403|10781965|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10023355|NCT01855750|11146953|FG000|STARTED|Overall Study||419
10023356|NCT01855750|11146954|FG001|STARTED|Overall Study||419
10023357|NCT01855750|11146953|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
10023358|NCT01855750|11146954|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418
10023359|NCT01855750|11146953|FG000|COMPLETED|Overall Study||0
10023360|NCT01855750|11146954|FG001|COMPLETED|Overall Study||0
9682142|NCT02145403|10781966|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682143|NCT02145403|10781967|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682144|NCT02145403|10781968|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
9682145|NCT02145403|10781965|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682146|NCT02145403|10781966|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682147|NCT02145403|10781967|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
9682148|NCT02145403|10781968|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
9682149|NCT02145403|10781965|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682150|NCT02145403|10781966|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682151|NCT02145403|10781967|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
9682152|NCT02145403|10781968|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682153|NCT02145403|10781965|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682154|NCT02145403|10781966|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10023361|NCT01855750|11146953|FG000|NOT COMPLETED|Overall Study||419
9682155|NCT02145403|10781967|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
9682156|NCT02145403|10781968|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682157|NCT02145403|10781965|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682158|NCT02145403|10781966|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682159|NCT02145403|10781967|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
9682160|NCT02145403|10781968|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
9682161|NCT02105636|10781983|FG000|STARTED|Overall Study||236
9682162|NCT02105636|10781984|FG001|STARTED|Overall Study||111
9682163|NCT02105636|10781983|FG000|COMPLETED|Overall Study|Completed=Still on Treatment|41
9682164|NCT02105636|10781984|FG001|COMPLETED|Overall Study|Completed=Still on Treatment|3
9682165|NCT02105636|10781983|FG000|NOT COMPLETED|Overall Study||195
9682166|NCT02105636|10781984|FG001|NOT COMPLETED|Overall Study||108
9682167|NCT02038946|10781991|FG000|STARTED|Overall Study||92
9682168|NCT02038946|10781991|FG000|COMPLETED|Overall Study||80
9682169|NCT02038946|10781991|FG000|NOT COMPLETED|Overall Study||12
9682170|NCT01988571|10781997|FG000|STARTED|Overall Study||139
9682171|NCT01988571|10781998|FG001|STARTED|Overall Study||140
9682172|NCT01988571|10781997|FG000|Completed Baseline|Overall Study||136
9682173|NCT01988571|10781998|FG001|Completed Baseline|Overall Study||139
9682174|NCT01988571|10781997|FG000|Completed 6 Month Visit|Overall Study||122
9682175|NCT01988571|10781998|FG001|Completed 6 Month Visit|Overall Study||126
9682176|NCT01988571|10781997|FG000|COMPLETED|Overall Study||100
9682177|NCT01988571|10781998|FG001|COMPLETED|Overall Study||105
9682178|NCT01988571|10781997|FG000|NOT COMPLETED|Overall Study||39
9682179|NCT01988571|10781998|FG001|NOT COMPLETED|Overall Study||35
9682183|NCT01332266|10782013|FG000|STARTED|Phase 1b||4
9682184|NCT01332266|10782014|FG001|STARTED|Phase 1b||5
9682185|NCT01332266|10782015|FG002|STARTED|Phase 1b||3
9682186|NCT01332266|10782016|FG003|STARTED|Phase 1b||0
9682187|NCT01332266|10782017|FG004|STARTED|Phase 1b||0
9682188|NCT01332266|10782013|FG000|COMPLETED|Phase 1b||0
9682189|NCT01332266|10782014|FG001|COMPLETED|Phase 1b||0
9682190|NCT01332266|10782015|FG002|COMPLETED|Phase 1b||0
9682191|NCT01332266|10782016|FG003|COMPLETED|Phase 1b||0
9682192|NCT01332266|10782017|FG004|COMPLETED|Phase 1b||0
9682193|NCT01332266|10782013|FG000|NOT COMPLETED|Phase 1b||4
9682194|NCT01332266|10782014|FG001|NOT COMPLETED|Phase 1b||5
9682195|NCT01332266|10782015|FG002|NOT COMPLETED|Phase 1b||3
9682196|NCT01332266|10782016|FG003|NOT COMPLETED|Phase 1b||0
9682197|NCT01332266|10782017|FG004|NOT COMPLETED|Phase 1b||0
9682198|NCT01332266|10782013|FG000|STARTED|Phase 2||0
9682199|NCT01332266|10782014|FG001|STARTED|Phase 2||0
9682200|NCT01332266|10782015|FG002|STARTED|Phase 2||0
9682201|NCT01332266|10782016|FG003|STARTED|Phase 2||42
9682202|NCT01332266|10782017|FG004|STARTED|Phase 2||41
9682203|NCT01332266|10782013|FG000|COMPLETED|Phase 2||0
9682204|NCT01332266|10782014|FG001|COMPLETED|Phase 2||0
9682205|NCT01332266|10782015|FG002|COMPLETED|Phase 2||0
9682206|NCT01332266|10782016|FG003|COMPLETED|Phase 2||0
9682207|NCT01332266|10782017|FG004|COMPLETED|Phase 2||0
9682208|NCT01332266|10782013|FG000|NOT COMPLETED|Phase 2||0
9682209|NCT01332266|10782014|FG001|NOT COMPLETED|Phase 2||0
9682210|NCT01332266|10782015|FG002|NOT COMPLETED|Phase 2||0
9682211|NCT01332266|10782016|FG003|NOT COMPLETED|Phase 2||42
9682212|NCT01332266|10782017|FG004|NOT COMPLETED|Phase 2||41
9682213|NCT01150890|10782034|FG000|STARTED|Overall Study||32
9682214|NCT01150890|10782035|FG001|STARTED|Overall Study||32
9682215|NCT01150890|10782036|FG002|STARTED|Overall Study||33
9682216|NCT01150890|10782037|FG003|STARTED|Overall Study||33
9682217|NCT01150890|10782034|FG000|Received Study Drug|Overall Study||32
9682218|NCT01150890|10782035|FG001|Received Study Drug|Overall Study||31
9682219|NCT01150890|10782036|FG002|Received Study Drug|Overall Study||32
9682220|NCT01150890|10782037|FG003|Received Study Drug|Overall Study||33
9682221|NCT01150890|10782034|FG000|COMPLETED|Overall Study||28
9682222|NCT01150890|10782035|FG001|COMPLETED|Overall Study||19
9682223|NCT01150890|10782036|FG002|COMPLETED|Overall Study||21
9682224|NCT01150890|10782037|FG003|COMPLETED|Overall Study||16
9682225|NCT01150890|10782034|FG000|NOT COMPLETED|Overall Study||4
9682226|NCT01150890|10782035|FG001|NOT COMPLETED|Overall Study||13
9682227|NCT01150890|10782036|FG002|NOT COMPLETED|Overall Study||12
9682228|NCT01150890|10782037|FG003|NOT COMPLETED|Overall Study||17
9682229|NCT01140867|10782050|FG000|STARTED|Overall Study||121
9682230|NCT01140867|10782050|FG000|COMPLETED|Overall Study||88
9682231|NCT01140867|10782050|FG000|NOT COMPLETED|Overall Study||33
9682232|NCT01137773|10782056|FG000|STARTED|Overall Study||33
9682233|NCT01137773|10782057|FG001|STARTED|Overall Study||23
9682234|NCT01137773|10782056|FG000|COMPLETED|Overall Study||24
9682235|NCT01137773|10782057|FG001|COMPLETED|Overall Study||20
9682236|NCT01137773|10782056|FG000|NOT COMPLETED|Overall Study||9
9682237|NCT01137773|10782057|FG001|NOT COMPLETED|Overall Study||3
9682238|NCT01127256|10782067|FG000|STARTED|Overall Study||96
9682239|NCT01127256|10782068|FG001|STARTED|Overall Study||104
9682240|NCT01127256|10782067|FG000|COMPLETED|Overall Study||57
9682241|NCT01127256|10782068|FG001|COMPLETED|Overall Study||65
9682242|NCT01127256|10782067|FG000|NOT COMPLETED|Overall Study||39
9682243|NCT01127256|10782068|FG001|NOT COMPLETED|Overall Study||39
9682244|NCT01004861|10782087|FG000|STARTED|Overall Study||3
9682245|NCT01004861|10782088|FG001|STARTED|Overall Study||6
9682246|NCT01004861|10782089|FG002|STARTED|Overall Study||6
9682247|NCT01004861|10782090|FG003|STARTED|Overall Study||6
9682248|NCT01004861|10782091|FG004|STARTED|Overall Study||7
9682249|NCT01004861|10782092|FG005|STARTED|Overall Study||6
9682250|NCT01004861|10782093|FG006|STARTED|Overall Study||7
9682251|NCT01004861|10782094|FG007|STARTED|Overall Study||4
9682252|NCT01004861|10782095|FG008|STARTED|Overall Study||39
9682253|NCT01004861|10782096|FG009|STARTED|Overall Study||11
9682254|NCT01004861|10782097|FG010|STARTED|Overall Study||9
9682255|NCT01004861|10782098|FG011|STARTED|Overall Study||8
9682256|NCT01004861|10782099|FG012|STARTED|Overall Study||20
9682257|NCT01004861|10782087|FG000|COMPLETED|Overall Study||0
9682258|NCT01004861|10782088|FG001|COMPLETED|Overall Study||0
9682259|NCT01004861|10782089|FG002|COMPLETED|Overall Study||0
9682260|NCT01004861|10782090|FG003|COMPLETED|Overall Study||0
9682261|NCT01004861|10782091|FG004|COMPLETED|Overall Study||0
9682262|NCT01004861|10782092|FG005|COMPLETED|Overall Study||0
9682263|NCT01004861|10782093|FG006|COMPLETED|Overall Study||0
9682264|NCT01004861|10782094|FG007|COMPLETED|Overall Study||0
9682265|NCT01004861|10782095|FG008|COMPLETED|Overall Study||0
9682266|NCT01004861|10782096|FG009|COMPLETED|Overall Study||0
9682267|NCT01004861|10782097|FG010|COMPLETED|Overall Study||0
9682268|NCT01004861|10782098|FG011|COMPLETED|Overall Study||0
9682269|NCT01004861|10782099|FG012|COMPLETED|Overall Study||0
9682270|NCT01004861|10782087|FG000|NOT COMPLETED|Overall Study||3
9682271|NCT01004861|10782088|FG001|NOT COMPLETED|Overall Study||6
9682272|NCT01004861|10782089|FG002|NOT COMPLETED|Overall Study||6
9682273|NCT01004861|10782090|FG003|NOT COMPLETED|Overall Study||6
9682274|NCT01004861|10782091|FG004|NOT COMPLETED|Overall Study||7
9682275|NCT01004861|10782092|FG005|NOT COMPLETED|Overall Study||6
9682276|NCT01004861|10782093|FG006|NOT COMPLETED|Overall Study||7
9682277|NCT01004861|10782094|FG007|NOT COMPLETED|Overall Study||4
9682278|NCT01004861|10782095|FG008|NOT COMPLETED|Overall Study||39
9682279|NCT01004861|10782096|FG009|NOT COMPLETED|Overall Study||11
9682280|NCT01004861|10782097|FG010|NOT COMPLETED|Overall Study||9
9682281|NCT01004861|10782098|FG011|NOT COMPLETED|Overall Study||8
9682282|NCT01004861|10782099|FG012|NOT COMPLETED|Overall Study||20
9682283|NCT00912223|10782131|FG000|STARTED|Overall Study||65
9682284|NCT00912223|10782131|FG000|COMPLETED|Overall Study||62
9682285|NCT00912223|10782131|FG000|NOT COMPLETED|Overall Study||3
9682286|NCT00381381|10782135|FG000|STARTED|Overall Study||199
9682287|NCT00381381|10782135|FG000|COMPLETED|Overall Study||135
9682288|NCT00381381|10782135|FG000|NOT COMPLETED|Overall Study||64
9682289|NCT00038675|10782139|FG000|STARTED|Overall Study||125
9682290|NCT00038675|10782139|FG000|COMPLETED|Overall Study||125
9682291|NCT00038675|10782139|FG000|NOT COMPLETED|Overall Study||0
9725153|NCT00093015|10824740|FG000|COMPLETED|Overall Study||1361
9725154|NCT00093015|10824741|FG001|COMPLETED|Overall Study||1348
9725155|NCT00093015|10824740|FG000|NOT COMPLETED|Overall Study||665
9725156|NCT00093015|10824741|FG001|NOT COMPLETED|Overall Study||664
9725157|NCT00093041|10824753|FG000|STARTED|Overall Study||4
9725158|NCT00093041|10824754|FG001|STARTED|Overall Study||4
9725159|NCT00093041|10824755|FG002|STARTED|Overall Study||5
9725160|NCT00093041|10824756|FG003|STARTED|Overall Study||4
9725161|NCT00093041|10824757|FG004|STARTED|Overall Study||4
9725162|NCT00093041|10824758|FG005|STARTED|Overall Study||7
9731985|NCT00138671|10831995|FG001|STARTED|Overall Study||46
9682292|NCT04389333|10782145|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
9682293|NCT04389333|10782146|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
9682294|NCT04389333|10782145|FG000|COMPLETED|Overall Study||20
9682295|NCT04389333|10782146|FG001|COMPLETED|Overall Study||20
9682296|NCT04389333|10782145|FG000|NOT COMPLETED|Overall Study||0
9682297|NCT04389333|10782146|FG001|NOT COMPLETED|Overall Study||0
9682298|NCT03712124|10782155|FG000|STARTED|Overall Study||10
9682299|NCT03712124|10782156|FG001|STARTED|Overall Study||11
9682300|NCT03712124|10782155|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
9682301|NCT03712124|10782156|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11
9682302|NCT03712124|10782155|FG000|COMPLETED|Overall Study||9
9682303|NCT03712124|10782156|FG001|COMPLETED|Overall Study||11
9682304|NCT03712124|10782155|FG000|NOT COMPLETED|Overall Study||1
9682305|NCT03712124|10782156|FG001|NOT COMPLETED|Overall Study||0
9682306|NCT03689582|10782162|FG000|STARTED|Overall Study||11
9682307|NCT03689582|10782162|FG000|COMPLETED|Overall Study||11
9682308|NCT03689582|10782162|FG000|NOT COMPLETED|Overall Study||0
9682309|NCT03535740|10782168|FG000|STARTED|Overall Study||103
9682310|NCT03535740|10782168|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13
9682311|NCT03535740|10782168|FG000|COMPLETED|Overall Study||0
9682312|NCT03535740|10782168|FG000|NOT COMPLETED|Overall Study||103
9682313|NCT02986789|10782175|FG000|STARTED|Overall Study||43
9682314|NCT02986789|10782176|FG001|STARTED|Overall Study||0
9682315|NCT02986789|10782175|FG000|COMPLETED|Overall Study||43
9682316|NCT02986789|10782176|FG001|COMPLETED|Overall Study||0
9682317|NCT02986789|10782175|FG000|NOT COMPLETED|Overall Study||0
9682318|NCT02986789|10782176|FG001|NOT COMPLETED|Overall Study||0
9682319|NCT02974907|10782184|FG000|STARTED|Overall Study||299
9682320|NCT02974907|10782185|FG001|STARTED|Overall Study||302
9682321|NCT02974907|10782184|FG000|COMPLETED|Overall Study||286
9682322|NCT02974907|10782185|FG001|COMPLETED|Overall Study||292
9682323|NCT02974907|10782184|FG000|NOT COMPLETED|Overall Study||13
9682324|NCT02974907|10782185|FG001|NOT COMPLETED|Overall Study||10
9843952|NCT00833703|10955868|FG000|STARTED|Overall Study|Included|23
9843953|NCT00833703|10955869|FG001|STARTED|Overall Study|Included|26
9843954|NCT00833703|10955868|FG000|Treated|Overall Study||23
9843955|NCT00833703|10955869|FG001|Treated|Overall Study||26
9843956|NCT00833703|10955868|FG000|Completed Treatment|Overall Study||22
9843957|NCT00833703|10955869|FG001|Completed Treatment|Overall Study||24
9843958|NCT00833703|10955868|FG000|COMPLETED|Overall Study|Completed follow-up|23
9843959|NCT00833703|10955869|FG001|COMPLETED|Overall Study|Completed follow-up|25
9682333|NCT02918500|10782202|FG000|STARTED|Overall Study||2
9682334|NCT02918500|10782203|FG001|STARTED|Overall Study||2
9682335|NCT02918500|10782202|FG000|COMPLETED|Overall Study||2
9682336|NCT02918500|10782203|FG001|COMPLETED|Overall Study||2
9682337|NCT02918500|10782202|FG000|NOT COMPLETED|Overall Study||0
9682338|NCT02918500|10782203|FG001|NOT COMPLETED|Overall Study||0
9682339|NCT02896257|10782214|FG000|STARTED|Providers||88
9682340|NCT02896257|10782215|FG001|STARTED|Providers||93
9682341|NCT02896257|10782214|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68
9682342|NCT02896257|10782215|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79
9682343|NCT02896257|10782214|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18
9682344|NCT02896257|10782215|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12
9682345|NCT02896257|10782214|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1
9682346|NCT02896257|10782215|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2
9682347|NCT02896257|10782214|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1
9682348|NCT02896257|10782215|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0
9682349|NCT02896257|10782214|FG000|COMPLETED|Providers||67
9682350|NCT02896257|10782215|FG001|COMPLETED|Providers||65
9682351|NCT02896257|10782214|FG000|NOT COMPLETED|Providers||21
9682352|NCT02896257|10782215|FG001|NOT COMPLETED|Providers||28
9682353|NCT02896257|10782214|FG000|STARTED|Patients|Eligible patient participants assigned to a usual care PCP=344|344
9682354|NCT02896257|10782215|FG001|STARTED|Patients|Eligible patient participants assigned to an intervention PCP=342|342
9682355|NCT02896257|10782214|FG000|COMPLETED|Patients|Patients with an eligible primary care appointment with a usual care PCP who were assigned an index date=281|281
9682356|NCT02896257|10782215|FG001|COMPLETED|Patients|Patients with an eligible primary care appointment with an intervention PCP who were assigned an index date=269|269
9682357|NCT02896257|10782214|FG000|NOT COMPLETED|Patients||63
9682358|NCT02896257|10782215|FG001|NOT COMPLETED|Patients||73
9682359|NCT02774265|10782224|FG000|STARTED|Overall Study||164
9682360|NCT02774265|10782225|FG001|STARTED|Overall Study||165
9682361|NCT02774265|10782224|FG000|COMPLETED|Overall Study||151
9682362|NCT02774265|10782225|FG001|COMPLETED|Overall Study||159
9682363|NCT02774265|10782224|FG000|NOT COMPLETED|Overall Study||13
9682364|NCT02774265|10782225|FG001|NOT COMPLETED|Overall Study||6
9682365|NCT02736617|10782231|FG000|STARTED|Treatment||10
9682366|NCT02736617|10782231|FG000|COMPLETED|Treatment||7
9682367|NCT02736617|10782231|FG000|NOT COMPLETED|Treatment||3
9682368|NCT02736617|10782231|FG000|STARTED|Maintenance||7
9682369|NCT02736617|10782231|FG000|COMPLETED|Maintenance||2
9682370|NCT02736617|10782231|FG000|NOT COMPLETED|Maintenance||5
9682371|NCT02652468|10782236|FG000|STARTED|Overall Study||11
9682372|NCT02652468|10782236|FG000|COMPLETED|Overall Study||11
9682373|NCT02652468|10782236|FG000|NOT COMPLETED|Overall Study||0
9682374|NCT02579265|10782242|FG000|STARTED|Overall Study||83
9682375|NCT02579265|10782243|FG001|STARTED|Overall Study||78
9682376|NCT02579265|10782242|FG000|COMPLETED|Overall Study||33
9682377|NCT02579265|10782243|FG001|COMPLETED|Overall Study||33
9682378|NCT02579265|10782242|FG000|NOT COMPLETED|Overall Study||50
9682379|NCT02579265|10782243|FG001|NOT COMPLETED|Overall Study||45
9682380|NCT02013167|10782251|FG000|STARTED|Overall Study||134
9682381|NCT02013167|10782252|FG001|STARTED|Overall Study||271
9682382|NCT02013167|10782251|FG000|Received Treatment|Overall Study||109
9682383|NCT02013167|10782252|FG001|Received Treatment|Overall Study||267
9682384|NCT02013167|10782251|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
9682385|NCT02013167|10782252|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
9682386|NCT02013167|10782251|FG000|NOT COMPLETED|Overall Study||101
9682387|NCT02013167|10782252|FG001|NOT COMPLETED|Overall Study||178
9682388|NCT02004522|10782261|FG000|STARTED|Overall Study||160
9682389|NCT02004522|10782262|FG001|STARTED|Overall Study||159
9682390|NCT02004522|10782261|FG000|Number of Subjects Treated|Overall Study||158
9682391|NCT02004522|10782262|FG001|Number of Subjects Treated|Overall Study||155
9682392|NCT02004522|10782261|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
9682393|NCT02004522|10782262|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
9682394|NCT02004522|10782261|FG000|NOT COMPLETED|Overall Study||126
9682395|NCT02004522|10782262|FG001|NOT COMPLETED|Overall Study||159
9682396|NCT02000427|10782268|FG000|STARTED|Overall Study||45
9682397|NCT02000427|10782268|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
9682398|NCT02000427|10782268|FG000|NOT COMPLETED|Overall Study||22
9682399|NCT01981850|10782279|FG000|STARTED|Main Phase Stage 1||8
9682400|NCT01981850|10782280|FG001|STARTED|Main Phase Stage 1||7
9682401|NCT01981850|10782281|FG002|STARTED|Main Phase Stage 1||6
9682402|NCT01981850|10782282|FG003|STARTED|Main Phase Stage 1||6
9682403|NCT01981850|10782283|FG004|STARTED|Main Phase Stage 1||0
9682404|NCT01981850|10782284|FG005|STARTED|Main Phase Stage 1||0
9682405|NCT01981850|10782285|FG006|STARTED|Main Phase Stage 1||0
9682406|NCT01981850|10782286|FG007|STARTED|Main Phase Stage 1||0
9682407|NCT01981850|10782287|FG008|STARTED|Main Phase Stage 1||0
9682408|NCT01981850|10782288|FG009|STARTED|Main Phase Stage 1||0
9682409|NCT01981850|10782279|FG000|COMPLETED|Main Phase Stage 1||5
9682410|NCT01981850|10782280|FG001|COMPLETED|Main Phase Stage 1||5
9682411|NCT01981850|10782281|FG002|COMPLETED|Main Phase Stage 1||4
9682412|NCT01981850|10782282|FG003|COMPLETED|Main Phase Stage 1||6
9682413|NCT01981850|10782283|FG004|COMPLETED|Main Phase Stage 1||0
9682414|NCT01981850|10782284|FG005|COMPLETED|Main Phase Stage 1||0
9682415|NCT01981850|10782285|FG006|COMPLETED|Main Phase Stage 1||0
9682416|NCT01981850|10782286|FG007|COMPLETED|Main Phase Stage 1||0
9682417|NCT01981850|10782287|FG008|COMPLETED|Main Phase Stage 1||0
9682418|NCT01981850|10782288|FG009|COMPLETED|Main Phase Stage 1||0
9682419|NCT01981850|10782279|FG000|NOT COMPLETED|Main Phase Stage 1||3
9682420|NCT01981850|10782280|FG001|NOT COMPLETED|Main Phase Stage 1||2
9682421|NCT01981850|10782281|FG002|NOT COMPLETED|Main Phase Stage 1||2
9682422|NCT01981850|10782282|FG003|NOT COMPLETED|Main Phase Stage 1||0
9682423|NCT01981850|10782283|FG004|NOT COMPLETED|Main Phase Stage 1||0
9682424|NCT01981850|10782284|FG005|NOT COMPLETED|Main Phase Stage 1||0
9682425|NCT01981850|10782285|FG006|NOT COMPLETED|Main Phase Stage 1||0
9682426|NCT01981850|10782286|FG007|NOT COMPLETED|Main Phase Stage 1||0
9843960|NCT00833703|10955868|FG000|NOT COMPLETED|Overall Study||0
9843961|NCT00833703|10955869|FG001|NOT COMPLETED|Overall Study||1
9843962|NCT00833755|10955879|FG000|STARTED|Overall Study||16
9843963|NCT00833755|10955880|FG001|STARTED|Overall Study||18
9843964|NCT00833755|10955881|FG002|STARTED|Overall Study||22
9843965|NCT00833755|10955882|FG003|STARTED|Overall Study||23
9843966|NCT00833755|10955879|FG000|COMPLETED|Overall Study||12
9843967|NCT00833755|10955880|FG001|COMPLETED|Overall Study||13
9843968|NCT00833755|10955881|FG002|COMPLETED|Overall Study||20
9843969|NCT00833755|10955882|FG003|COMPLETED|Overall Study||17
9843970|NCT00833755|10955879|FG000|NOT COMPLETED|Overall Study||4
9843971|NCT00833755|10955880|FG001|NOT COMPLETED|Overall Study||5
9843972|NCT00833755|10955881|FG002|NOT COMPLETED|Overall Study||2
9843973|NCT00833755|10955882|FG003|NOT COMPLETED|Overall Study||6
9843974|NCT00833781|10955895|FG000|STARTED|Overall Study||10
9843975|NCT00833781|10955896|FG001|STARTED|Overall Study||5
9843976|NCT00833781|10955895|FG000|COMPLETED|Overall Study||10
9843977|NCT00833781|10955896|FG001|COMPLETED|Overall Study||5
9843978|NCT00833781|10955895|FG000|NOT COMPLETED|Overall Study||0
9843979|NCT00833781|10955896|FG001|NOT COMPLETED|Overall Study||0
9843980|NCT00833794|10955903|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
9682427|NCT01981850|10782287|FG008|NOT COMPLETED|Main Phase Stage 1||0
9682428|NCT01981850|10782288|FG009|NOT COMPLETED|Main Phase Stage 1||0
9682429|NCT01981850|10782279|FG000|STARTED|Main Phase Stage 2||0
9682430|NCT01981850|10782280|FG001|STARTED|Main Phase Stage 2||0
9682431|NCT01981850|10782281|FG002|STARTED|Main Phase Stage 2||0
9682432|NCT01981850|10782282|FG003|STARTED|Main Phase Stage 2||0
9682433|NCT01981850|10782283|FG004|STARTED|Main Phase Stage 2||33
9843981|NCT00833794|10955904|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
9843982|NCT00833794|10955903|FG000|Entered run-in Period|Open-label Phase||1027
9843983|NCT00833794|10955904|FG001|Entered run-in Period|Open-label Phase||0
9843984|NCT00833794|10955903|FG000|Received Open-Label Treatment|Open-label Phase||1023
9682434|NCT01981850|10782284|FG005|STARTED|Main Phase Stage 2||32
9682435|NCT01981850|10782285|FG006|STARTED|Main Phase Stage 2||32
9682436|NCT01981850|10782286|FG007|STARTED|Main Phase Stage 2||0
9682437|NCT01981850|10782287|FG008|STARTED|Main Phase Stage 2||0
9682438|NCT01981850|10782288|FG009|STARTED|Main Phase Stage 2||0
9682439|NCT01981850|10782279|FG000|COMPLETED|Main Phase Stage 2||0
9682440|NCT01981850|10782280|FG001|COMPLETED|Main Phase Stage 2||0
9682441|NCT01981850|10782281|FG002|COMPLETED|Main Phase Stage 2||0
9682442|NCT01981850|10782282|FG003|COMPLETED|Main Phase Stage 2||0
9682443|NCT01981850|10782283|FG004|COMPLETED|Main Phase Stage 2||20
9682444|NCT01981850|10782284|FG005|COMPLETED|Main Phase Stage 2||16
9682445|NCT01981850|10782285|FG006|COMPLETED|Main Phase Stage 2||15
9682446|NCT01981850|10782286|FG007|COMPLETED|Main Phase Stage 2||0
9682447|NCT01981850|10782287|FG008|COMPLETED|Main Phase Stage 2||0
9682448|NCT01981850|10782288|FG009|COMPLETED|Main Phase Stage 2||0
9682449|NCT01981850|10782279|FG000|NOT COMPLETED|Main Phase Stage 2||0
9682450|NCT01981850|10782280|FG001|NOT COMPLETED|Main Phase Stage 2||0
9682451|NCT01981850|10782281|FG002|NOT COMPLETED|Main Phase Stage 2||0
9682452|NCT01981850|10782282|FG003|NOT COMPLETED|Main Phase Stage 2||0
9682453|NCT01981850|10782283|FG004|NOT COMPLETED|Main Phase Stage 2||13
9682454|NCT01981850|10782284|FG005|NOT COMPLETED|Main Phase Stage 2||16
9682455|NCT01981850|10782285|FG006|NOT COMPLETED|Main Phase Stage 2||17
9682456|NCT01981850|10782286|FG007|NOT COMPLETED|Main Phase Stage 2||0
9682457|NCT01981850|10782287|FG008|NOT COMPLETED|Main Phase Stage 2||0
9682458|NCT01981850|10782288|FG009|NOT COMPLETED|Main Phase Stage 2||0
9682459|NCT01981850|10782279|FG000|STARTED|Open Label Extension (OLE)||0
9682460|NCT01981850|10782280|FG001|STARTED|Open Label Extension (OLE)||0
9682461|NCT01981850|10782281|FG002|STARTED|Open Label Extension (OLE)||0
9682462|NCT01981850|10782282|FG003|STARTED|Open Label Extension (OLE)||0
9682463|NCT01981850|10782283|FG004|STARTED|Open Label Extension (OLE)||0
9682464|NCT01981850|10782284|FG005|STARTED|Open Label Extension (OLE)||0
9682465|NCT01981850|10782285|FG006|STARTED|Open Label Extension (OLE)||0
9682466|NCT01981850|10782286|FG007|STARTED|Open Label Extension (OLE)||13
9682467|NCT01981850|10782287|FG008|STARTED|Open Label Extension (OLE)||5
9682468|NCT01981850|10782288|FG009|STARTED|Open Label Extension (OLE)||48
9682469|NCT01981850|10782279|FG000|COMPLETED|Open Label Extension (OLE)||0
9682470|NCT01981850|10782280|FG001|COMPLETED|Open Label Extension (OLE)||0
9682471|NCT01981850|10782281|FG002|COMPLETED|Open Label Extension (OLE)||0
9682472|NCT01981850|10782282|FG003|COMPLETED|Open Label Extension (OLE)||0
9682473|NCT01981850|10782283|FG004|COMPLETED|Open Label Extension (OLE)||0
9682474|NCT01981850|10782284|FG005|COMPLETED|Open Label Extension (OLE)||0
9682475|NCT01981850|10782285|FG006|COMPLETED|Open Label Extension (OLE)||0
9682476|NCT01981850|10782286|FG007|COMPLETED|Open Label Extension (OLE)||1
9682477|NCT01981850|10782287|FG008|COMPLETED|Open Label Extension (OLE)||0
9682478|NCT01981850|10782288|FG009|COMPLETED|Open Label Extension (OLE)||0
9682479|NCT01981850|10782279|FG000|NOT COMPLETED|Open Label Extension (OLE)||0
9682480|NCT01981850|10782280|FG001|NOT COMPLETED|Open Label Extension (OLE)||0
9682481|NCT01981850|10782281|FG002|NOT COMPLETED|Open Label Extension (OLE)||0
9682482|NCT01981850|10782282|FG003|NOT COMPLETED|Open Label Extension (OLE)||0
9682483|NCT01981850|10782283|FG004|NOT COMPLETED|Open Label Extension (OLE)||0
9682484|NCT01981850|10782284|FG005|NOT COMPLETED|Open Label Extension (OLE)||0
9682485|NCT01981850|10782285|FG006|NOT COMPLETED|Open Label Extension (OLE)||0
9682486|NCT01981850|10782286|FG007|NOT COMPLETED|Open Label Extension (OLE)||12
9682487|NCT01981850|10782287|FG008|NOT COMPLETED|Open Label Extension (OLE)||5
9682488|NCT01981850|10782288|FG009|NOT COMPLETED|Open Label Extension (OLE)||48
9682489|NCT01804816|10782320|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14
9682490|NCT01804816|10782320|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
9682491|NCT01804816|10782320|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
9682492|NCT01804816|10782320|FG000|STARTED|Acupuncture (Second 5 Weeks)||11
9682493|NCT01804816|10782320|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10
9682494|NCT01804816|10782320|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
9725163|NCT00093041|10824753|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
9725164|NCT00093041|10824754|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1
9725165|NCT00093041|10824755|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3
9725166|NCT00093041|10824756|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3
9843985|NCT00833794|10955904|FG001|Received Open-Label Treatment|Open-label Phase||0
9725167|NCT00093041|10824757|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3
9725168|NCT00093041|10824758|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
9725169|NCT00093041|10824753|FG000|NOT COMPLETED|Overall Study||2
9725170|NCT00093041|10824754|FG001|NOT COMPLETED|Overall Study||3
9725171|NCT00093041|10824755|FG002|NOT COMPLETED|Overall Study||2
9725172|NCT00093041|10824756|FG003|NOT COMPLETED|Overall Study||1
9725173|NCT00093041|10824757|FG004|NOT COMPLETED|Overall Study||1
9725174|NCT00093041|10824758|FG005|NOT COMPLETED|Overall Study||3
9725175|NCT00093145|10824772|FG000|STARTED|Overall Study||32
9725176|NCT00093145|10824772|FG000|At Least One Response Assessment|Overall Study||31
9725177|NCT00093145|10824772|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
9960695|NCT01469013|11080379|FG012|STARTED|Part A (Treatment Period)||0
9725178|NCT00093145|10824772|FG000|NOT COMPLETED|Overall Study||17
9731745|NCT00135356|10831659|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
9682495|NCT01572207|10782329|FG000|STARTED|Overall Study||14
9682496|NCT01572207|10782330|FG001|STARTED|Overall Study||16
9682497|NCT01572207|10782329|FG000|COMPLETED|Overall Study||12
9682498|NCT01572207|10782330|FG001|COMPLETED|Overall Study||13
9682499|NCT01572207|10782329|FG000|NOT COMPLETED|Overall Study||2
9682500|NCT01572207|10782330|FG001|NOT COMPLETED|Overall Study||3
9682501|NCT01550315|10782338|FG000|STARTED|Overall Study||7
9682502|NCT01550315|10782339|FG001|STARTED|Overall Study||7
9682503|NCT01550315|10782340|FG002|STARTED|Overall Study||6
9682504|NCT01550315|10782341|FG003|STARTED|Overall Study||7
9682505|NCT01550315|10782338|FG000|COMPLETED|Overall Study||7
9682506|NCT01550315|10782339|FG001|COMPLETED|Overall Study||7
9682507|NCT01550315|10782340|FG002|COMPLETED|Overall Study||6
9682508|NCT01550315|10782341|FG003|COMPLETED|Overall Study||7
9682509|NCT01550315|10782338|FG000|NOT COMPLETED|Overall Study||0
9682510|NCT01550315|10782339|FG001|NOT COMPLETED|Overall Study||0
9682511|NCT01550315|10782340|FG002|NOT COMPLETED|Overall Study||0
9682512|NCT01550315|10782341|FG003|NOT COMPLETED|Overall Study||0
9682513|NCT01519960|10782354|FG000|STARTED|Overall Study||101
9682514|NCT01519960|10782355|FG001|STARTED|Overall Study||50
9682515|NCT01519960|10782356|FG002|STARTED|Overall Study||10
9682516|NCT01519960|10782354|FG000|Completed Week 48|Overall Study||99
9682517|NCT01519960|10782355|FG001|Completed Week 48|Overall Study||47
9682518|NCT01519960|10782356|FG002|Completed Week 48|Overall Study||10
9682519|NCT01519960|10782354|FG000|Completed Follow-Up (FU) Week 12|Overall Study||101
9682520|NCT01519960|10782355|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26
9682521|NCT01519960|10782356|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10
9682522|NCT01519960|10782354|FG000|Completed FU Week 24|Overall Study||101
9682523|NCT01519960|10782355|FG001|Completed FU Week 24|Overall Study||15
9682524|NCT01519960|10782356|FG002|Completed FU Week 24|Overall Study||10
9682525|NCT01519960|10782354|FG000|COMPLETED|Overall Study||0
9682526|NCT01519960|10782355|FG001|COMPLETED|Overall Study||0
9682527|NCT01519960|10782356|FG002|COMPLETED|Overall Study||0
9682528|NCT01519960|10782354|FG000|NOT COMPLETED|Overall Study||101
9843986|NCT00833794|10955903|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
9843987|NCT00833794|10955904|FG001|COMPLETED|Open-label Phase||0
9843988|NCT00833794|10955903|FG000|NOT COMPLETED|Open-label Phase||382
9843989|NCT00833794|10955904|FG001|NOT COMPLETED|Open-label Phase||0
9843990|NCT00833794|10955903|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
9843991|NCT00833794|10955904|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
9843992|NCT00833794|10955903|FG000|COMPLETED|Double-blind Phase||326
9960696|NCT01469013|11080367|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
9960697|NCT01469013|11080368|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
9960698|NCT01469013|11080369|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
9960699|NCT01469013|11080370|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
9960700|NCT01469013|11080371|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
9960701|NCT01469013|11080372|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960702|NCT01469013|11080373|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960703|NCT01469013|11080374|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960704|NCT01469013|11080375|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960705|NCT01469013|11080376|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960706|NCT01469013|11080377|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960707|NCT01469013|11080378|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960708|NCT01469013|11080379|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
9960709|NCT01469013|11080367|FG000|COMPLETED|Part A (Treatment Period)||23
9960710|NCT01469013|11080368|FG001|COMPLETED|Part A (Treatment Period)||24
9960711|NCT01469013|11080369|FG002|COMPLETED|Part A (Treatment Period)||23
9960712|NCT01469013|11080370|FG003|COMPLETED|Part A (Treatment Period)||24
9960713|NCT01469013|11080371|FG004|COMPLETED|Part A (Treatment Period)||48
9960714|NCT01469013|11080372|FG005|COMPLETED|Part A (Treatment Period)||0
9682529|NCT01519960|10782355|FG001|NOT COMPLETED|Overall Study||50
9682530|NCT01519960|10782356|FG002|NOT COMPLETED|Overall Study||10
9682531|NCT00688376|10782369|FG000|STARTED|Double-Blind Phase||40
9682532|NCT00688376|10782370|FG001|STARTED|Double-Blind Phase||32
9682533|NCT00688376|10782369|FG000|Safety Population|Double-Blind Phase||40
9682534|NCT00688376|10782370|FG001|Safety Population|Double-Blind Phase||31
9682535|NCT00688376|10782369|FG000|COMPLETED|Double-Blind Phase||34
9843993|NCT00833794|10955904|FG001|COMPLETED|Double-blind Phase||165
9843994|NCT00833794|10955903|FG000|NOT COMPLETED|Double-blind Phase||106
9843995|NCT00833794|10955904|FG001|NOT COMPLETED|Double-blind Phase||49
9843996|NCT00833833|10955918|FG000|STARTED|Phase 1 (as of 01 April 2011)||6
9843997|NCT00833833|10955919|FG001|STARTED|Phase 1 (as of 01 April 2011)||8
9843998|NCT00833833|10955920|FG002|STARTED|Phase 1 (as of 01 April 2011)||14
9843999|NCT00833833|10955921|FG003|STARTED|Phase 1 (as of 01 April 2011)||10
9844000|NCT00833833|10955922|FG004|STARTED|Phase 1 (as of 01 April 2011)||0
9844001|NCT00833833|10955923|FG005|STARTED|Phase 1 (as of 01 April 2011)||0
9844002|NCT00833833|10955918|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
9844003|NCT00833833|10955919|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
9844004|NCT00833833|10955920|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
9682536|NCT00688376|10782370|FG001|COMPLETED|Double-Blind Phase||25
9682537|NCT00688376|10782369|FG000|NOT COMPLETED|Double-Blind Phase||6
9682538|NCT00688376|10782370|FG001|NOT COMPLETED|Double-Blind Phase||7
9682539|NCT00688376|10782369|FG000|STARTED|Blinded Extension Phase||34
9682540|NCT00688376|10782370|FG001|STARTED|Blinded Extension Phase||25
9682541|NCT00688376|10782369|FG000|COMPLETED|Blinded Extension Phase||29
9682542|NCT00688376|10782370|FG001|COMPLETED|Blinded Extension Phase||20
9682543|NCT00688376|10782369|FG000|NOT COMPLETED|Blinded Extension Phase||5
9682544|NCT00688376|10782370|FG001|NOT COMPLETED|Blinded Extension Phase||5
9682545|NCT00604201|10782378|FG000|STARTED|Overall Study||31
9682546|NCT00604201|10782378|FG000|COMPLETED|Overall Study||21
9682547|NCT00604201|10782378|FG000|NOT COMPLETED|Overall Study||10
9682548|NCT00492349|10782384|FG000|STARTED|Overall Study||35
9682549|NCT00492349|10782385|FG001|STARTED|Overall Study||34
9682550|NCT00492349|10782384|FG000|Week 2|Overall Study||32
9682551|NCT00492349|10782385|FG001|Week 2|Overall Study||33
9682552|NCT00492349|10782384|FG000|Week 8|Overall Study||32
9682553|NCT00492349|10782385|FG001|Week 8|Overall Study||27
9682554|NCT00492349|10782384|FG000|COMPLETED|Overall Study||32
9682555|NCT00492349|10782385|FG001|COMPLETED|Overall Study||27
9682556|NCT00492349|10782384|FG000|NOT COMPLETED|Overall Study||3
9682557|NCT00492349|10782385|FG001|NOT COMPLETED|Overall Study||7
9682558|NCT00121108|10782397|FG000|STARTED|Overall Study||710
9682559|NCT00121108|10782398|FG001|STARTED|Overall Study||1417
9682560|NCT00121108|10782397|FG000|COMPLETED|Overall Study||589
9682561|NCT00121108|10782398|FG001|COMPLETED|Overall Study||1192
9682562|NCT00121108|10782397|FG000|NOT COMPLETED|Overall Study||121
9682563|NCT00121108|10782398|FG001|NOT COMPLETED|Overall Study||225
9682564|NCT00003102|10782408|FG000|STARTED|Overall Study||3
9682565|NCT00003102|10782409|FG001|STARTED|Overall Study||9
9682566|NCT00003102|10782410|FG002|STARTED|Overall Study||3
9682567|NCT00003102|10782408|FG000|COMPLETED|Overall Study||2
9682568|NCT00003102|10782409|FG001|COMPLETED|Overall Study||6
9682569|NCT00003102|10782410|FG002|COMPLETED|Overall Study||1
9682570|NCT00003102|10782408|FG000|NOT COMPLETED|Overall Study||1
9682571|NCT00003102|10782409|FG001|NOT COMPLETED|Overall Study||3
9682572|NCT00003102|10782410|FG002|NOT COMPLETED|Overall Study||2
9725179|NCT00093379|10824776|FG000|STARTED|Overall Study||20
9725180|NCT00093379|10824776|FG000|COMPLETED|Overall Study||20
9725181|NCT00093379|10824776|FG000|NOT COMPLETED|Overall Study||0
9725182|NCT00093470|10824782|FG000|STARTED|Overall Study||73
9725183|NCT00093470|10824783|FG001|STARTED|Overall Study||71
9725184|NCT00093470|10824782|FG000|Treated|Overall Study||72
9725185|NCT00093470|10824783|FG001|Treated|Overall Study||71
9725186|NCT00093470|10824782|FG000|Patients With Toxicity Assessment|Overall Study||72
9725187|NCT00093470|10824783|FG001|Patients With Toxicity Assessment|Overall Study||69
9725188|NCT00093470|10824782|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
9725189|NCT00093470|10824783|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71
9844005|NCT00833833|10955921|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
9844006|NCT00833833|10955922|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0
9844007|NCT00833833|10955923|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0
9844008|NCT00833833|10955918|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
9844009|NCT00833833|10955919|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
9844010|NCT00833833|10955920|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
9844011|NCT00833833|10955921|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
9844012|NCT00833833|10955922|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
9844013|NCT00833833|10955923|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
9844014|NCT00833833|10955918|FG000|STARTED|Phase 2 (as of 01 April 2011)||0
9844015|NCT00833833|10955919|FG001|STARTED|Phase 2 (as of 01 April 2011)||0
9844016|NCT00833833|10955920|FG002|STARTED|Phase 2 (as of 01 April 2011)||0
9844017|NCT00833833|10955921|FG003|STARTED|Phase 2 (as of 01 April 2011)||0
9844018|NCT00833833|10955922|FG004|STARTED|Phase 2 (as of 01 April 2011)||113
9844019|NCT00833833|10955923|FG005|STARTED|Phase 2 (as of 01 April 2011)||108
9844020|NCT00833833|10955918|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0
9844021|NCT00833833|10955919|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0
9844022|NCT00833833|10955920|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0
9844023|NCT00833833|10955921|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0
9844024|NCT00833833|10955922|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112
9844025|NCT00833833|10955923|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107
9844026|NCT00833833|10955918|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0
9844027|NCT00833833|10955919|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0
9844028|NCT00833833|10955920|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0
9844029|NCT00833833|10955921|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0
9844030|NCT00833833|10955922|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
9844031|NCT00833833|10955923|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
9844032|NCT00833833|10955918|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
9844033|NCT00833833|10955919|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
9844034|NCT00833833|10955920|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
9844035|NCT00833833|10955921|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
9844036|NCT00833833|10955922|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
9725190|NCT00093470|10824782|FG000|NOT COMPLETED|Overall Study||73
9725191|NCT00093470|10824783|FG001|NOT COMPLETED|Overall Study||0
9844037|NCT00833833|10955923|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
9682573|NCT04633837|10782420|FG000|STARTED|Overall Study||5
9682574|NCT04633837|10782421|FG001|STARTED|Overall Study||0
9682575|NCT04633837|10782420|FG000|COMPLETED|Overall Study||0
9682576|NCT04633837|10782421|FG001|COMPLETED|Overall Study||0
9682577|NCT04633837|10782420|FG000|NOT COMPLETED|Overall Study||5
9682578|NCT04633837|10782421|FG001|NOT COMPLETED|Overall Study||0
9682579|NCT04057937|10782429|FG000|STARTED|Placebo-controlled Phase||44
9682580|NCT04057937|10782430|FG001|STARTED|Placebo-controlled Phase||46
9682581|NCT04057937|10782429|FG000|COMPLETED|Placebo-controlled Phase||41
9844038|NCT00833898|10955945|FG000|STARTED|Overall Study||74
9844039|NCT00833898|10955946|FG001|STARTED|Overall Study||74
9844040|NCT00833898|10955945|FG000|Month 1 (Post Transplantation)|Overall Study||72
9844041|NCT00833898|10955946|FG001|Month 1 (Post Transplantation)|Overall Study||74
9844042|NCT00833898|10955945|FG000|Month 3 (Post Transplantation)|Overall Study||66
9844043|NCT00833898|10955946|FG001|Month 3 (Post Transplantation)|Overall Study||64
9844044|NCT00833898|10955945|FG000|Month 6 (Post Transplantation)|Overall Study||59
9844045|NCT00833898|10955946|FG001|Month 6 (Post Transplantation)|Overall Study||54
9844046|NCT00833898|10955945|FG000|Month 12 (Post Transplantation)|Overall Study||50
9844047|NCT00833898|10955946|FG001|Month 12 (Post Transplantation)|Overall Study||50
9844048|NCT00833898|10955945|FG000|COMPLETED|Overall Study||34
9844049|NCT00833898|10955946|FG001|COMPLETED|Overall Study||38
9844050|NCT00833898|10955945|FG000|NOT COMPLETED|Overall Study||40
9844051|NCT00833898|10955946|FG001|NOT COMPLETED|Overall Study||36
9844052|NCT00833911|10955952|FG000|STARTED|Titration||392
9844053|NCT00833911|10955952|FG000|COMPLETED|Titration||371
9844054|NCT00833911|10955952|FG000|NOT COMPLETED|Titration||21
9844055|NCT00833911|10955952|FG000|STARTED|Maintenance Phase I||371
9844056|NCT00833911|10955952|FG000|COMPLETED|Maintenance Phase I||273
9844057|NCT00833911|10955952|FG000|NOT COMPLETED|Maintenance Phase I||98
9844058|NCT00833911|10955952|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
9844059|NCT00833911|10955952|FG000|COMPLETED|Maintenance Phase II||166
9844060|NCT00833911|10955952|FG000|NOT COMPLETED|Maintenance Phase II||10
9844061|NCT00833924|10955960|FG000|STARTED|Overall Study||120
9844062|NCT00833924|10955960|FG000|30-day|Overall Study||120
9844063|NCT00833924|10955960|FG000|12-month|Overall Study||113
9844064|NCT00833924|10955960|FG000|COMPLETED|Overall Study||11
9844065|NCT00833924|10955960|FG000|NOT COMPLETED|Overall Study||109
9844066|NCT00833976|10955964|FG000|STARTED|Overall Study||65
9844067|NCT00833976|10955964|FG000|COMPLETED|Overall Study||14
9844068|NCT00833976|10955964|FG000|NOT COMPLETED|Overall Study||51
9844069|NCT00833989|10955972|FG000|STARTED|Overall Study||17
9844070|NCT00833989|10955973|FG001|STARTED|Overall Study||8
9844071|NCT00833989|10955974|FG002|STARTED|Overall Study||9
9844072|NCT00833989|10955975|FG003|STARTED|Overall Study||8
9844073|NCT00833989|10955972|FG000|COMPLETED|Overall Study||14
9844074|NCT00833989|10955973|FG001|COMPLETED|Overall Study||8
9844075|NCT00833989|10955974|FG002|COMPLETED|Overall Study||8
9844076|NCT00833989|10955975|FG003|COMPLETED|Overall Study||6
9844077|NCT00833989|10955972|FG000|NOT COMPLETED|Overall Study||3
9844078|NCT00833989|10955973|FG001|NOT COMPLETED|Overall Study||0
9844079|NCT00833989|10955974|FG002|NOT COMPLETED|Overall Study||1
9844080|NCT00833989|10955975|FG003|NOT COMPLETED|Overall Study||2
9844081|NCT00834041|10955990|FG000|STARTED|Overall Study||19
9844082|NCT00834041|10955991|FG001|STARTED|Overall Study||20
9844083|NCT00834041|10955990|FG000|COMPLETED|Overall Study||18
9844084|NCT00834041|10955991|FG001|COMPLETED|Overall Study||19
9844085|NCT00834041|10955990|FG000|NOT COMPLETED|Overall Study||1
9844086|NCT00834041|10955991|FG001|NOT COMPLETED|Overall Study||1
9844087|NCT00834080|10955997|FG000|STARTED|Overall Study||38
10023362|NCT01855750|11146954|FG001|NOT COMPLETED|Overall Study||419
10023363|NCT01855789|11146960|FG000|STARTED|1) Baseline up to Week 24||718
10023364|NCT01855789|11146961|FG001|STARTED|1) Baseline up to Week 24||0
10023365|NCT01855789|11146962|FG002|STARTED|1) Baseline up to Week 24||0
10023366|NCT01855789|11146963|FG003|STARTED|1) Baseline up to Week 24||0
9844088|NCT00834080|10955997|FG000|COMPLETED|Overall Study||15
9844089|NCT00834080|10955997|FG000|NOT COMPLETED|Overall Study||23
9844090|NCT00834106|10956003|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
9844091|NCT00834106|10956004|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
9844092|NCT00834106|10956003|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503
9844093|NCT00834106|10956004|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503
9844094|NCT00834106|10956003|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
9682582|NCT04057937|10782430|FG001|COMPLETED|Placebo-controlled Phase||46
9844095|NCT00834106|10956004|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
9844096|NCT00834106|10956003|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
9844097|NCT00834106|10956004|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
9844098|NCT00834106|10956003|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
9844099|NCT00834106|10956004|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
9844100|NCT00834106|10956003|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
9844101|NCT00834106|10956004|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
9844102|NCT00834106|10956003|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308
10023367|NCT01855789|11146960|FG000|COMPLETED|1) Baseline up to Week 24||602
9844103|NCT00834106|10956004|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294
9844104|NCT00834106|10956003|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
9682583|NCT04057937|10782429|FG000|NOT COMPLETED|Placebo-controlled Phase||3
9682584|NCT04057937|10782430|FG001|NOT COMPLETED|Placebo-controlled Phase||0
9682585|NCT04057937|10782429|FG000|STARTED|Active-treatment Phase||41
9682586|NCT04057937|10782430|FG001|STARTED|Active-treatment Phase||46
9682587|NCT04057937|10782429|FG000|COMPLETED|Active-treatment Phase||40
9682588|NCT04057937|10782430|FG001|COMPLETED|Active-treatment Phase||44
9682589|NCT04057937|10782429|FG000|NOT COMPLETED|Active-treatment Phase||1
9682590|NCT04057937|10782430|FG001|NOT COMPLETED|Active-treatment Phase||2
9725192|NCT00093496|10824791|FG000|STARTED|Overall Study||15
9725193|NCT00093496|10824792|FG001|STARTED|Overall Study||14
9725194|NCT00093496|10824791|FG000|COMPLETED|Overall Study||14
9725195|NCT00093496|10824792|FG001|COMPLETED|Overall Study||11
9725196|NCT00093496|10824791|FG000|NOT COMPLETED|Overall Study||1
9725197|NCT00093496|10824792|FG001|NOT COMPLETED|Overall Study||3
9725198|NCT00093756|10824799|FG000|STARTED|Overall Study||27
9725199|NCT00093756|10824800|FG001|STARTED|Overall Study||21
9725200|NCT00093756|10824799|FG000|COMPLETED|Overall Study||27
9725201|NCT00093756|10824800|FG001|COMPLETED|Overall Study||21
9725202|NCT00093756|10824799|FG000|NOT COMPLETED|Overall Study||0
9725203|NCT00093756|10824800|FG001|NOT COMPLETED|Overall Study||0
9725204|NCT00093782|10824808|FG000|STARTED|Overall Study||36
9725205|NCT00093782|10824808|FG000|COMPLETED|Overall Study||36
9725206|NCT00093782|10824808|FG000|NOT COMPLETED|Overall Study||0
9725207|NCT00093795|10824815|FG000|STARTED|Overall Study||1630
9725208|NCT00093795|10824816|FG001|STARTED|Overall Study||1634
9725209|NCT00093795|10824817|FG002|STARTED|Overall Study||1630
9725210|NCT00093795|10824815|FG000|COMPLETED|Overall Study||1610
9725211|NCT00093795|10824816|FG001|COMPLETED|Overall Study||1618
9725212|NCT00093795|10824817|FG002|COMPLETED|Overall Study||1613
9725213|NCT00093795|10824815|FG000|NOT COMPLETED|Overall Study||20
9725214|NCT00093795|10824816|FG001|NOT COMPLETED|Overall Study||16
9725215|NCT00093795|10824817|FG002|NOT COMPLETED|Overall Study||17
9725216|NCT00093808|10824825|FG000|STARTED|Overall Study||47
9725217|NCT00093808|10824825|FG000|COMPLETED|Overall Study||45
9725218|NCT00093808|10824825|FG000|NOT COMPLETED|Overall Study||2
9725219|NCT00093847|10824831|FG000|STARTED|Overall Study||39
9725220|NCT00093847|10824832|FG001|STARTED|Overall Study||34
9725221|NCT00093847|10824831|FG000|COMPLETED|Overall Study||31
9725222|NCT00093847|10824832|FG001|COMPLETED|Overall Study||24
9725223|NCT00093847|10824831|FG000|NOT COMPLETED|Overall Study||8
9725224|NCT00093847|10824832|FG001|NOT COMPLETED|Overall Study||10
9725225|NCT00093964|10824840|FG000|STARTED|Overall Study||41
9725226|NCT00093964|10824841|FG001|STARTED|Overall Study||40
9725227|NCT00093964|10824840|FG000|COMPLETED|Overall Study||41
9725228|NCT00093964|10824841|FG001|COMPLETED|Overall Study||40
9725229|NCT00093964|10824840|FG000|NOT COMPLETED|Overall Study||0
9725230|NCT00093964|10824841|FG001|NOT COMPLETED|Overall Study||0
9725231|NCT00094055|10824849|FG000|STARTED|Overall Study||60
9725232|NCT00094055|10824849|FG000|COMPLETED|Overall Study||0
9725233|NCT00094055|10824849|FG000|NOT COMPLETED|Overall Study||60
9725234|NCT00094094|10824853|FG000|STARTED|Overall Study||32
9725235|NCT00094094|10824853|FG000|COMPLETED|Overall Study||0
9725236|NCT00094094|10824853|FG000|NOT COMPLETED|Overall Study||32
9725237|NCT00094107|10824857|FG000|STARTED|Overall Study||32
9725238|NCT00094107|10824857|FG000|COMPLETED|Overall Study||0
9725239|NCT00094107|10824857|FG000|NOT COMPLETED|Overall Study||32
9725240|NCT00094172|10824863|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
9725241|NCT00094172|10824864|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
9725242|NCT00094172|10824863|FG000|COMPLETED|Overall Study||36
9725243|NCT00094172|10824864|FG001|COMPLETED|Overall Study||25
9725244|NCT00094172|10824863|FG000|NOT COMPLETED|Overall Study||14
9725245|NCT00094172|10824864|FG001|NOT COMPLETED|Overall Study||7
9725246|NCT00094211|10824874|FG000|STARTED|Overall Study||221
9725247|NCT00094211|10824875|FG001|STARTED|Overall Study||259
9725248|NCT00094211|10824876|FG002|STARTED|Overall Study||230
9725249|NCT00094211|10824877|FG003|STARTED|Overall Study||186
9725250|NCT00094211|10824874|FG000|COMPLETED|Overall Study||212
9725251|NCT00094211|10824875|FG001|COMPLETED|Overall Study||251
9725252|NCT00094211|10824876|FG002|COMPLETED|Overall Study||220
9725253|NCT00094211|10824877|FG003|COMPLETED|Overall Study||179
9725254|NCT00094211|10824874|FG000|NOT COMPLETED|Overall Study||9
9725255|NCT00094211|10824875|FG001|NOT COMPLETED|Overall Study||8
9725256|NCT00094211|10824876|FG002|NOT COMPLETED|Overall Study||10
9725257|NCT00094211|10824877|FG003|NOT COMPLETED|Overall Study||7
9725258|NCT00094302|10824893|FG000|STARTED|Overall Study||1723
9725259|NCT00094302|10824894|FG001|STARTED|Overall Study||1722
9725260|NCT00094302|10824893|FG000|COMPLETED|Overall Study||1306
9725261|NCT00094302|10824894|FG001|COMPLETED|Overall Study||1316
9725262|NCT00094302|10824893|FG000|NOT COMPLETED|Overall Study||417
9725263|NCT00094302|10824894|FG001|NOT COMPLETED|Overall Study||406
9725264|NCT00094328|10824900|FG000|STARTED|Overall Study|Received treatment|14
9725265|NCT00094328|10824900|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13
9725266|NCT00094328|10824900|FG000|NOT COMPLETED|Overall Study||1
9725267|NCT00094445|10824904|FG000|STARTED|Overall Study||50
9725268|NCT00094445|10824904|FG000|COMPLETED|Overall Study||44
9725269|NCT00094445|10824904|FG000|NOT COMPLETED|Overall Study||6
9725270|NCT00094458|10824911|FG000|STARTED|Main Study: Through Week 30||170
9725271|NCT00094458|10824912|FG001|STARTED|Main Study: Through Week 30||169
9725272|NCT00094458|10824913|FG002|STARTED|Main Study: Through Week 30||169
9725273|NCT00094458|10824914|FG003|STARTED|Main Study: Through Week 30||0
9682591|NCT03566732|10782437|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914
9682592|NCT03566732|10782437|FG000|COMPLETED|Overall Study|914 completed questionnaires|914
9682593|NCT03566732|10782437|FG000|NOT COMPLETED|Overall Study||0
9682594|NCT03032510|10782443|FG000|STARTED|Overall Study||603
9682595|NCT03032510|10782444|FG001|STARTED|Overall Study||602
9682596|NCT03032510|10782443|FG000|COMPLETED|Overall Study||576
9682597|NCT03032510|10782444|FG001|COMPLETED|Overall Study||584
9682598|NCT03032510|10782443|FG000|NOT COMPLETED|Overall Study||27
9682599|NCT03032510|10782444|FG001|NOT COMPLETED|Overall Study||18
9682600|NCT03029000|10782454|FG000|STARTED|Overall Study||1
9682601|NCT03029000|10782454|FG000|COMPLETED|Overall Study||1
9682602|NCT03029000|10782454|FG000|NOT COMPLETED|Overall Study||0
9682603|NCT03022292|10782458|FG000|STARTED|Overall Study||26
9682604|NCT03022292|10782458|FG000|COMPLETED|Overall Study||24
9682605|NCT03022292|10782458|FG000|NOT COMPLETED|Overall Study||2
9682606|NCT02968602|10782464|FG000|STARTED|Overall Study||16
9682607|NCT02968602|10782465|FG001|STARTED|Overall Study||16
9682608|NCT02968602|10782464|FG000|COMPLETED|Overall Study||16
9682609|NCT02968602|10782465|FG001|COMPLETED|Overall Study||16
9682610|NCT02968602|10782464|FG000|NOT COMPLETED|Overall Study||0
9682611|NCT02968602|10782465|FG001|NOT COMPLETED|Overall Study||0
9682612|NCT02946047|10782475|FG000|STARTED|Overall Study||4
9682613|NCT02946047|10782476|FG001|STARTED|Overall Study||3
9682614|NCT02946047|10782477|FG002|STARTED|Overall Study||3
9682615|NCT02946047|10782478|FG003|STARTED|Overall Study||7
9682616|NCT02946047|10782475|FG000|COMPLETED|Overall Study||3
9682617|NCT02946047|10782476|FG001|COMPLETED|Overall Study||3
9682618|NCT02946047|10782477|FG002|COMPLETED|Overall Study||3
9682619|NCT02946047|10782478|FG003|COMPLETED|Overall Study||7
9682620|NCT02946047|10782475|FG000|NOT COMPLETED|Overall Study||1
9682621|NCT02946047|10782476|FG001|NOT COMPLETED|Overall Study||0
9682622|NCT02946047|10782477|FG002|NOT COMPLETED|Overall Study||0
9682623|NCT02946047|10782478|FG003|NOT COMPLETED|Overall Study||0
9682624|NCT02830165|10782488|FG000|STARTED|Overall Study||11
9682625|NCT02830165|10782488|FG000|COMPLETED|Overall Study||11
9682626|NCT02830165|10782488|FG000|NOT COMPLETED|Overall Study||0
9682627|NCT02784704|10782496|FG000|STARTED|Overall Study||250
9682628|NCT02784704|10782497|FG001|STARTED|Overall Study||250
9682629|NCT02784704|10782496|FG000|Treated|Overall Study||250
9682630|NCT02784704|10782497|FG001|Treated|Overall Study||249
10023368|NCT01855789|11146961|FG001|COMPLETED|1) Baseline up to Week 24||0
10023369|NCT01855789|11146962|FG002|COMPLETED|1) Baseline up to Week 24||0
10023370|NCT01855789|11146963|FG003|COMPLETED|1) Baseline up to Week 24||0
10023371|NCT01855789|11146960|FG000|NOT COMPLETED|1) Baseline up to Week 24||116
10023372|NCT01855789|11146961|FG001|NOT COMPLETED|1) Baseline up to Week 24||0
9682631|NCT02784704|10782496|FG000|COMPLETED|Overall Study||237
9682632|NCT02784704|10782497|FG001|COMPLETED|Overall Study||241
9682633|NCT02784704|10782496|FG000|NOT COMPLETED|Overall Study||13
9682634|NCT02784704|10782497|FG001|NOT COMPLETED|Overall Study||9
9725274|NCT00094458|10824915|FG004|STARTED|Main Study: Through Week 30||0
9844105|NCT00834106|10956004|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
9844106|NCT00834171|10956012|FG000|STARTED|Overall Study||43
9844107|NCT00834171|10956013|FG001|STARTED|Overall Study||7
9844108|NCT00834171|10956012|FG000|COMPLETED|Overall Study||43
9844109|NCT00834171|10956013|FG001|COMPLETED|Overall Study||7
9844110|NCT00834171|10956012|FG000|NOT COMPLETED|Overall Study||0
9844111|NCT00834171|10956013|FG001|NOT COMPLETED|Overall Study||0
9960715|NCT01469013|11080373|FG006|COMPLETED|Part A (Treatment Period)||0
9960716|NCT01469013|11080374|FG007|COMPLETED|Part A (Treatment Period)||0
9960717|NCT01469013|11080375|FG008|COMPLETED|Part A (Treatment Period)||0
9960718|NCT01469013|11080376|FG009|COMPLETED|Part A (Treatment Period)||0
9960719|NCT01469013|11080377|FG010|COMPLETED|Part A (Treatment Period)||0
9960720|NCT01469013|11080378|FG011|COMPLETED|Part A (Treatment Period)||0
9960721|NCT01469013|11080379|FG012|COMPLETED|Part A (Treatment Period)||0
9960722|NCT01469013|11080367|FG000|NOT COMPLETED|Part A (Treatment Period)||1
9960723|NCT01469013|11080368|FG001|NOT COMPLETED|Part A (Treatment Period)||0
9960724|NCT01469013|11080369|FG002|NOT COMPLETED|Part A (Treatment Period)||1
9960725|NCT01469013|11080370|FG003|NOT COMPLETED|Part A (Treatment Period)||0
9960726|NCT01469013|11080371|FG004|NOT COMPLETED|Part A (Treatment Period)||1
9960727|NCT01469013|11080372|FG005|NOT COMPLETED|Part A (Treatment Period)||0
9960728|NCT01469013|11080373|FG006|NOT COMPLETED|Part A (Treatment Period)||0
9960729|NCT01469013|11080374|FG007|NOT COMPLETED|Part A (Treatment Period)||0
9960730|NCT01469013|11080375|FG008|NOT COMPLETED|Part A (Treatment Period)||0
9960731|NCT01469013|11080376|FG009|NOT COMPLETED|Part A (Treatment Period)||0
10023373|NCT01855789|11146962|FG002|NOT COMPLETED|1) Baseline up to Week 24||0
10023374|NCT01855789|11146963|FG003|NOT COMPLETED|1) Baseline up to Week 24||0
9725275|NCT00094458|10824916|FG005|STARTED|Main Study: Through Week 30||0
9725276|NCT00094458|10824911|FG000|COMPLETED|Main Study: Through Week 30||86
9725277|NCT00094458|10824912|FG001|COMPLETED|Main Study: Through Week 30||111
9725278|NCT00094458|10824913|FG002|COMPLETED|Main Study: Through Week 30||121
9725279|NCT00094458|10824914|FG003|COMPLETED|Main Study: Through Week 30||0
9844112|NCT00834210|10956021|FG000|STARTED|Overall Study||86
9844113|NCT00834210|10956022|FG001|STARTED|Overall Study||85
9844114|NCT00834210|10956021|FG000|COMPLETED|Overall Study||83
9844115|NCT00834210|10956022|FG001|COMPLETED|Overall Study||77
9960732|NCT01469013|11080377|FG010|NOT COMPLETED|Part A (Treatment Period)||0
9960733|NCT01469013|11080378|FG011|NOT COMPLETED|Part A (Treatment Period)||0
9682635|NCT04831515|10782505|FG000|STARTED|First Intervention||24
9682636|NCT04831515|10782506|FG001|STARTED|First Intervention||24
9682637|NCT04831515|10782505|FG000|COMPLETED|First Intervention||24
9682638|NCT04831515|10782506|FG001|COMPLETED|First Intervention||23
9682639|NCT04831515|10782505|FG000|NOT COMPLETED|First Intervention||0
9682640|NCT04831515|10782506|FG001|NOT COMPLETED|First Intervention||1
9682641|NCT04831515|10782505|FG000|STARTED|Second Intervention||24
9682642|NCT04831515|10782506|FG001|STARTED|Second Intervention||23
9682643|NCT04831515|10782505|FG000|COMPLETED|Second Intervention||24
9682644|NCT04831515|10782506|FG001|COMPLETED|Second Intervention||23
9682645|NCT04831515|10782505|FG000|NOT COMPLETED|Second Intervention||0
9682646|NCT04831515|10782506|FG001|NOT COMPLETED|Second Intervention||0
9844116|NCT00834210|10956021|FG000|NOT COMPLETED|Overall Study||3
9844117|NCT00834210|10956022|FG001|NOT COMPLETED|Overall Study||8
9844118|NCT00834236|10956030|FG000|STARTED|Overall Study||29
9844119|NCT00834236|10956031|FG001|STARTED|Overall Study||47
9844120|NCT00834236|10956030|FG000|COMPLETED|Overall Study||29
9844121|NCT00834236|10956031|FG001|COMPLETED|Overall Study||47
9844122|NCT00834236|10956030|FG000|NOT COMPLETED|Overall Study||0
9844123|NCT00834236|10956031|FG001|NOT COMPLETED|Overall Study||0
9844124|NCT00834288|10956039|FG000|STARTED|Treatment Phase I||13
9682656|NCT04253834|10782527|FG000|STARTED|Overall Study||10
9682657|NCT04253834|10782528|FG001|STARTED|Overall Study||10
9682658|NCT04253834|10782527|FG000|COMPLETED|Overall Study||10
9682659|NCT04253834|10782528|FG001|COMPLETED|Overall Study||10
9682660|NCT04253834|10782527|FG000|NOT COMPLETED|Overall Study||0
9682661|NCT04253834|10782528|FG001|NOT COMPLETED|Overall Study||0
9682662|NCT03881059|10782537|FG000|STARTED|Treatment Period - Part A||66
9682663|NCT03881059|10782538|FG001|STARTED|Treatment Period - Part A||70
9682664|NCT03881059|10782539|FG002|STARTED|Treatment Period - Part A||67
9682665|NCT03881059|10782537|FG000|COMPLETED|Treatment Period - Part A||58
9682666|NCT03881059|10782538|FG001|COMPLETED|Treatment Period - Part A||63
9682667|NCT03881059|10782539|FG002|COMPLETED|Treatment Period - Part A||59
9682668|NCT03881059|10782537|FG000|NOT COMPLETED|Treatment Period - Part A||8
9682669|NCT03881059|10782538|FG001|NOT COMPLETED|Treatment Period - Part A||7
9682670|NCT03881059|10782539|FG002|NOT COMPLETED|Treatment Period - Part A||8
9682671|NCT03881059|10782537|FG000|STARTED|Treatment Period - Part B||55
9682672|NCT03881059|10782538|FG001|STARTED|Treatment Period - Part B||60
9682673|NCT03881059|10782539|FG002|STARTED|Treatment Period - Part B||58
9682674|NCT03881059|10782537|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0
9682675|NCT03881059|10782538|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13
9682676|NCT03881059|10782539|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16
9682677|NCT03881059|10782537|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55
9682678|NCT03881059|10782538|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47
9682679|NCT03881059|10782539|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42
9682680|NCT03881059|10782537|FG000|COMPLETED|Treatment Period - Part B||47
9682681|NCT03881059|10782538|FG001|COMPLETED|Treatment Period - Part B||54
9682682|NCT03881059|10782539|FG002|COMPLETED|Treatment Period - Part B||47
9682683|NCT03881059|10782537|FG000|NOT COMPLETED|Treatment Period - Part B||8
9682684|NCT03881059|10782538|FG001|NOT COMPLETED|Treatment Period - Part B||6
9682685|NCT03881059|10782539|FG002|NOT COMPLETED|Treatment Period - Part B||11
9682686|NCT03878277|10782552|FG000|STARTED|Overall Study||10
9682687|NCT03878277|10782552|FG000|COMPLETED|Overall Study||10
9682688|NCT03878277|10782552|FG000|NOT COMPLETED|Overall Study||0
9682689|NCT03450629|10782558|FG000|STARTED|Overall Study||341
9682690|NCT03450629|10782559|FG001|STARTED|Overall Study||341
9682691|NCT03450629|10782558|FG000|COMPLETED|Overall Study||293
9682692|NCT03450629|10782559|FG001|COMPLETED|Overall Study||307
9682693|NCT03450629|10782558|FG000|NOT COMPLETED|Overall Study||48
9682694|NCT03450629|10782559|FG001|NOT COMPLETED|Overall Study||34
9682695|NCT03367403|10782568|FG000|STARTED|Overall Study||131
9682696|NCT03367403|10782569|FG001|STARTED|Overall Study||126
9682697|NCT03367403|10782570|FG002|STARTED|Overall Study||15
9682698|NCT03367403|10782568|FG000|Received at Least One Dose of Study Drug|Overall Study||131
9682699|NCT03367403|10782569|FG001|Received at Least One Dose of Study Drug|Overall Study||125
9682700|NCT03367403|10782570|FG002|Received at Least One Dose of Study Drug|Overall Study||15
9682701|NCT03367403|10782568|FG000|COMPLETED|Overall Study||94
9682702|NCT03367403|10782569|FG001|COMPLETED|Overall Study||93
9682703|NCT03367403|10782570|FG002|COMPLETED|Overall Study||12
9682704|NCT03367403|10782568|FG000|NOT COMPLETED|Overall Study||37
9682705|NCT03367403|10782569|FG001|NOT COMPLETED|Overall Study||33
9682706|NCT03367403|10782570|FG002|NOT COMPLETED|Overall Study||3
9682707|NCT03286426|10782578|FG000|STARTED|Overall Study||3
9682708|NCT03286426|10782578|FG000|COMPLETED|Overall Study||0
9682709|NCT03286426|10782578|FG000|NOT COMPLETED|Overall Study||3
9682710|NCT03135249|10782582|FG000|STARTED|Overall Study|Nine patient entered the study|9
9682711|NCT03135249|10782582|FG000|COMPLETED|Overall Study|Eight patient completed the study.|7
9682712|NCT03135249|10782582|FG000|NOT COMPLETED|Overall Study||2
9682713|NCT02818582|10782588|FG000|STARTED|Overall Study||20
9682714|NCT02818582|10782589|FG001|STARTED|Overall Study||18
9682715|NCT02818582|10782588|FG000|COMPLETED|Overall Study||20
9682716|NCT02818582|10782589|FG001|COMPLETED|Overall Study||18
9682717|NCT02818582|10782588|FG000|NOT COMPLETED|Overall Study||0
9682718|NCT02818582|10782589|FG001|NOT COMPLETED|Overall Study||0
9682719|NCT02809677|10782595|FG000|STARTED|Overall Study||205
9682720|NCT02809677|10782595|FG000|COMPLETED|Overall Study||197
9682721|NCT02809677|10782595|FG000|NOT COMPLETED|Overall Study||8
9682722|NCT02728258|10782600|FG000|STARTED|Overall Study||11
9682723|NCT02728258|10782600|FG000|COMPLETED|Overall Study||11
9682724|NCT02728258|10782600|FG000|NOT COMPLETED|Overall Study||0
9682725|NCT02554253|10782606|FG000|STARTED|Overall Study||26
9682726|NCT02554253|10782607|FG001|STARTED|Overall Study||26
9682727|NCT02554253|10782606|FG000|COMPLETED|Overall Study||25
9682728|NCT02554253|10782607|FG001|COMPLETED|Overall Study||24
9682729|NCT02554253|10782606|FG000|NOT COMPLETED|Overall Study||1
9682730|NCT02554253|10782607|FG001|NOT COMPLETED|Overall Study||2
9725280|NCT00094458|10824915|FG004|COMPLETED|Main Study: Through Week 30||0
9725281|NCT00094458|10824916|FG005|COMPLETED|Main Study: Through Week 30||0
9725282|NCT00094458|10824911|FG000|NOT COMPLETED|Main Study: Through Week 30||84
9725283|NCT00094458|10824912|FG001|NOT COMPLETED|Main Study: Through Week 30||58
9725284|NCT00094458|10824913|FG002|NOT COMPLETED|Main Study: Through Week 30||48
9725285|NCT00094458|10824914|FG003|NOT COMPLETED|Main Study: Through Week 30||0
9725286|NCT00094458|10824915|FG004|NOT COMPLETED|Main Study: Through Week 30||0
9725287|NCT00094458|10824916|FG005|NOT COMPLETED|Main Study: Through Week 30||0
9725288|NCT00094458|10824911|FG000|STARTED|Study Extension: Week 30 Through Week 50||75
9725289|NCT00094458|10824912|FG001|STARTED|Study Extension: Week 30 Through Week 50||97
9725290|NCT00094458|10824913|FG002|STARTED|Study Extension: Week 30 Through Week 50||108
9725291|NCT00094458|10824914|FG003|STARTED|Study Extension: Week 30 Through Week 50||0
9725292|NCT00094458|10824915|FG004|STARTED|Study Extension: Week 30 Through Week 50||0
9725293|NCT00094458|10824916|FG005|STARTED|Study Extension: Week 30 Through Week 50||0
9725294|NCT00094458|10824911|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67
9725295|NCT00094458|10824912|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85
9725296|NCT00094458|10824913|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90
9725297|NCT00094458|10824914|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0
9725298|NCT00094458|10824915|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0
9725299|NCT00094458|10824916|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0
9725300|NCT00094458|10824911|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
9725301|NCT00094458|10824912|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
9725302|NCT00094458|10824913|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
9725303|NCT00094458|10824914|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
9725304|NCT00094458|10824915|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
9725305|NCT00094458|10824916|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
10023375|NCT01855789|11146960|FG000|STARTED|2) Week 24 up to End of Study||0
10023376|NCT01855789|11146961|FG001|STARTED|2) Week 24 up to End of Study||147
10023377|NCT01855789|11146962|FG002|STARTED|2) Week 24 up to End of Study||147
10023378|NCT01855789|11146963|FG003|STARTED|2) Week 24 up to End of Study||308
10023379|NCT01855789|11146960|FG000|COMPLETED|2) Week 24 up to End of Study||0
10023380|NCT01855789|11146961|FG001|COMPLETED|2) Week 24 up to End of Study||132
10023381|NCT01855789|11146962|FG002|COMPLETED|2) Week 24 up to End of Study||129
10023382|NCT01855789|11146963|FG003|COMPLETED|2) Week 24 up to End of Study||250
10023383|NCT01855789|11146960|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0
9725306|NCT00094458|10824911|FG000|STARTED|OLE: Open-Label Extension||0
9725307|NCT00094458|10824912|FG001|STARTED|OLE: Open-Label Extension||0
9725308|NCT00094458|10824913|FG002|STARTED|OLE: Open-Label Extension||0
9725309|NCT00094458|10824914|FG003|STARTED|OLE: Open-Label Extension||8
9725310|NCT00094458|10824915|FG004|STARTED|OLE: Open-Label Extension||18
9725311|NCT00094458|10824916|FG005|STARTED|OLE: Open-Label Extension||17
9725312|NCT00094458|10824911|FG000|COMPLETED|OLE: Open-Label Extension||0
9725313|NCT00094458|10824912|FG001|COMPLETED|OLE: Open-Label Extension||0
9725314|NCT00094458|10824913|FG002|COMPLETED|OLE: Open-Label Extension||0
9725315|NCT00094458|10824914|FG003|COMPLETED|OLE: Open-Label Extension||7
9725316|NCT00094458|10824915|FG004|COMPLETED|OLE: Open-Label Extension||13
9725317|NCT00094458|10824916|FG005|COMPLETED|OLE: Open-Label Extension||13
9725318|NCT00094458|10824911|FG000|NOT COMPLETED|OLE: Open-Label Extension||0
9725319|NCT00094458|10824912|FG001|NOT COMPLETED|OLE: Open-Label Extension||0
9725320|NCT00094458|10824913|FG002|NOT COMPLETED|OLE: Open-Label Extension||0
9725321|NCT00094458|10824914|FG003|NOT COMPLETED|OLE: Open-Label Extension||1
9725322|NCT00094458|10824915|FG004|NOT COMPLETED|OLE: Open-Label Extension||5
9725323|NCT00094458|10824916|FG005|NOT COMPLETED|OLE: Open-Label Extension||4
9725324|NCT00094497|10824932|FG000|STARTED|Overall Study||151
9725325|NCT00094497|10824933|FG001|STARTED|Overall Study||153
9725326|NCT00094497|10824932|FG000|Treated|Overall Study||148
9725327|NCT00094497|10824933|FG001|Treated|Overall Study||149
9725328|NCT00094497|10824932|FG000|Received Second Line Therapy|Overall Study||84
9725329|NCT00094497|10824933|FG001|Received Second Line Therapy|Overall Study||101
9725330|NCT00094497|10824932|FG000|COMPLETED|Overall Study||151
9725331|NCT00094497|10824933|FG001|COMPLETED|Overall Study||153
9725332|NCT00094497|10824932|FG000|NOT COMPLETED|Overall Study||0
9725333|NCT00094497|10824933|FG001|NOT COMPLETED|Overall Study||0
9725334|NCT00094536|10824939|FG000|STARTED|Inclusion Exclusion Evaluation||106
9844125|NCT00834288|10956040|FG001|STARTED|Treatment Phase I||13
9844126|NCT00834288|10956039|FG000|COMPLETED|Treatment Phase I||13
9844127|NCT00834288|10956040|FG001|COMPLETED|Treatment Phase I||13
9725335|NCT00094536|10824939|FG000|COMPLETED|Inclusion Exclusion Evaluation||82
10023384|NCT01855789|11146961|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15
9725336|NCT00094536|10824939|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24
9682731|NCT01524536|10782614|FG000|STARTED|Overall Study||23
9682732|NCT01524536|10782614|FG000|COMPLETED|Overall Study||23
9682733|NCT01524536|10782614|FG000|NOT COMPLETED|Overall Study||0
9682734|NCT01307046|10782626|FG000|STARTED|Overall Study||166
9682735|NCT01307046|10782627|FG001|STARTED|Overall Study||170
9682736|NCT01307046|10782626|FG000|COMPLETED|Overall Study||154
9682737|NCT01307046|10782627|FG001|COMPLETED|Overall Study||159
9682738|NCT01307046|10782626|FG000|NOT COMPLETED|Overall Study||12
9682739|NCT01307046|10782627|FG001|NOT COMPLETED|Overall Study||11
9682740|NCT01307033|10782635|FG000|STARTED|8-week Double-blind Period||144
9682741|NCT01307033|10782636|FG001|STARTED|8-week Double-blind Period||134
9682742|NCT01307033|10782637|FG002|STARTED|8-week Double-blind Period||0
9682743|NCT01307033|10782638|FG003|STARTED|8-week Double-blind Period||0
9682744|NCT01307033|10782635|FG000|COMPLETED|8-week Double-blind Period||131
9682745|NCT01307033|10782636|FG001|COMPLETED|8-week Double-blind Period||127
9682746|NCT01307033|10782637|FG002|COMPLETED|8-week Double-blind Period||0
9682747|NCT01307033|10782638|FG003|COMPLETED|8-week Double-blind Period||0
9682748|NCT01307033|10782635|FG000|NOT COMPLETED|8-week Double-blind Period||13
9682749|NCT01307033|10782636|FG001|NOT COMPLETED|8-week Double-blind Period||7
9682750|NCT01307033|10782637|FG002|NOT COMPLETED|8-week Double-blind Period||0
9682751|NCT01307033|10782638|FG003|NOT COMPLETED|8-week Double-blind Period||0
9682752|NCT01307033|10782635|FG000|STARTED|44-week Open-label Extension||0
9682753|NCT01307033|10782636|FG001|STARTED|44-week Open-label Extension||0
9682754|NCT01307033|10782637|FG002|STARTED|44-week Open-label Extension||131
9682755|NCT01307033|10782638|FG003|STARTED|44-week Open-label Extension||127
9682756|NCT01307033|10782635|FG000|COMPLETED|44-week Open-label Extension||0
9682757|NCT01307033|10782636|FG001|COMPLETED|44-week Open-label Extension||0
9682758|NCT01307033|10782637|FG002|COMPLETED|44-week Open-label Extension||120
9682759|NCT01307033|10782638|FG003|COMPLETED|44-week Open-label Extension||115
9682760|NCT01307033|10782635|FG000|NOT COMPLETED|44-week Open-label Extension||0
9682761|NCT01307033|10782636|FG001|NOT COMPLETED|44-week Open-label Extension||0
9682762|NCT01307033|10782637|FG002|NOT COMPLETED|44-week Open-label Extension||11
9682763|NCT01307033|10782638|FG003|NOT COMPLETED|44-week Open-label Extension||12
9682764|NCT00739674|10782652|FG000|STARTED|Overall Study||535
9682765|NCT00739674|10782653|FG001|STARTED|Overall Study||457
9682766|NCT00739674|10782652|FG000|Screening Failures|Overall Study||19
9682767|NCT00739674|10782653|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
9682768|NCT00739674|10782652|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
9682769|NCT00739674|10782653|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
9682770|NCT00739674|10782652|FG000|No Follow-up Data|Overall Study||33
9682771|NCT00739674|10782653|FG001|No Follow-up Data|Overall Study||18
9682772|NCT00739674|10782652|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
9682773|NCT00739674|10782653|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
9682774|NCT00739674|10782652|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
9682775|NCT00739674|10782653|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
9682776|NCT00739674|10782652|FG000|COMPLETED|Overall Study||354
9682777|NCT00739674|10782653|FG001|COMPLETED|Overall Study||335
9682778|NCT00739674|10782652|FG000|NOT COMPLETED|Overall Study||181
9682779|NCT00739674|10782653|FG001|NOT COMPLETED|Overall Study||122
9682780|NCT00546754|10782661|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425
9682781|NCT00546754|10782662|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383
9682782|NCT00546754|10782661|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
9682783|NCT00546754|10782662|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
9682784|NCT00546754|10782661|FG000|Week 6|Overall Study||396
9682785|NCT00546754|10782662|FG001|Week 6|Overall Study||347
9682786|NCT00546754|10782661|FG000|Week 12|Overall Study||375
9682787|NCT00546754|10782662|FG001|Week 12|Overall Study||334
9682788|NCT00546754|10782661|FG000|COMPLETED|Overall Study||375
9682789|NCT00546754|10782662|FG001|COMPLETED|Overall Study||334
9682790|NCT00546754|10782661|FG000|NOT COMPLETED|Overall Study||50
9682791|NCT00546754|10782662|FG001|NOT COMPLETED|Overall Study||49
9682792|NCT00479713|10782670|FG000|STARTED|Overall Study||314
9682793|NCT00479713|10782671|FG001|STARTED|Overall Study||304
9682794|NCT00479713|10782670|FG000|COMPLETED|Overall Study||301
9682795|NCT00479713|10782671|FG001|COMPLETED|Overall Study||295
9682796|NCT00479713|10782670|FG000|NOT COMPLETED|Overall Study||13
9682797|NCT00479713|10782671|FG001|NOT COMPLETED|Overall Study||9
9682798|NCT00406783|10782679|FG000|STARTED|Overall Study||276
9682799|NCT00406783|10782680|FG001|STARTED|Overall Study||271
9682800|NCT00406783|10782679|FG000|COMPLETED|Overall Study||262
9682801|NCT00406783|10782680|FG001|COMPLETED|Overall Study||256
9682802|NCT00406783|10782679|FG000|NOT COMPLETED|Overall Study||14
9682803|NCT00406783|10782680|FG001|NOT COMPLETED|Overall Study||15
9682804|NCT00405964|10782688|FG000|STARTED|Overall Study||360
9682805|NCT00405964|10782689|FG001|STARTED|Overall Study||356
9682806|NCT00405964|10782688|FG000|COMPLETED|Overall Study||301
9844128|NCT00834288|10956039|FG000|NOT COMPLETED|Treatment Phase I||0
9682807|NCT00405964|10782689|FG001|COMPLETED|Overall Study||261
9682808|NCT00405964|10782688|FG000|NOT COMPLETED|Overall Study||59
9682809|NCT00405964|10782689|FG001|NOT COMPLETED|Overall Study||95
9682810|NCT00383721|10782700|FG000|STARTED|26-Week Double-Blind Treatment Period||225
9682811|NCT00383721|10782701|FG001|STARTED|26-Week Double-Blind Treatment Period||239
9682812|NCT00383721|10782702|FG002|STARTED|26-Week Double-Blind Treatment Period||253
9682813|NCT00383721|10782703|FG003|STARTED|26-Week Double-Blind Treatment Period||243
9682814|NCT00383721|10782704|FG004|STARTED|26-Week Double-Blind Treatment Period||236
9682815|NCT00383721|10782700|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
9682816|NCT00383721|10782701|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202
9682817|NCT00383721|10782702|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202
9682818|NCT00383721|10782703|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193
9682819|NCT00383721|10782704|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169
9682820|NCT00383721|10782700|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
9682821|NCT00383721|10782701|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
9682822|NCT00383721|10782702|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
9682823|NCT00383721|10782703|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
9682824|NCT00383721|10782704|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
9682825|NCT00383721|10782700|FG000|STARTED|26-Week Treatment Safety Extension||145
9682826|NCT00383721|10782701|FG001|STARTED|26-Week Treatment Safety Extension||153
9682827|NCT00383721|10782702|FG002|STARTED|26-Week Treatment Safety Extension||149
9682828|NCT00383721|10782703|FG003|STARTED|26-Week Treatment Safety Extension||148
9682829|NCT00383721|10782704|FG004|STARTED|26-Week Treatment Safety Extension||8
9682830|NCT00383721|10782700|FG000|COMPLETED|26-Week Treatment Safety Extension||126
9682831|NCT00383721|10782701|FG001|COMPLETED|26-Week Treatment Safety Extension||136
9682832|NCT00383721|10782702|FG002|COMPLETED|26-Week Treatment Safety Extension||126
9682833|NCT00383721|10782703|FG003|COMPLETED|26-Week Treatment Safety Extension||131
9682834|NCT00383721|10782704|FG004|COMPLETED|26-Week Treatment Safety Extension||8
9682835|NCT00383721|10782700|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19
9682836|NCT00383721|10782701|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17
9682837|NCT00383721|10782702|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23
10023385|NCT01855789|11146962|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18
10023386|NCT01855789|11146963|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58
10023387|NCT01855828|11146969|FG000|STARTED|Overall Study||50
10023388|NCT01855828|11146969|FG000|COMPLETED|Overall Study||48
9682838|NCT00383721|10782703|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17
9682839|NCT00383721|10782704|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0
9682840|NCT00383552|10782720|FG000|STARTED|Overall Study||182
9682841|NCT00383552|10782721|FG001|STARTED|Overall Study||188
9682842|NCT00383552|10782722|FG002|STARTED|Overall Study||188
9682843|NCT00383552|10782723|FG003|STARTED|Overall Study||188
9682844|NCT00383552|10782720|FG000|COMPLETED|Overall Study||146
9682845|NCT00383552|10782721|FG001|COMPLETED|Overall Study||147
9682846|NCT00383552|10782722|FG002|COMPLETED|Overall Study||127
9682847|NCT00383552|10782723|FG003|COMPLETED|Overall Study||116
9682848|NCT00383552|10782720|FG000|NOT COMPLETED|Overall Study||36
9682849|NCT00383552|10782721|FG001|NOT COMPLETED|Overall Study||41
9682850|NCT00383552|10782722|FG002|NOT COMPLETED|Overall Study||61
9682851|NCT00383552|10782723|FG003|NOT COMPLETED|Overall Study||72
9682852|NCT00383435|10782743|FG000|STARTED|26-Week Double-Blind Treatment Period||217
9731986|NCT00138671|10831994|FG000|COMPLETED|Overall Study||46
9731987|NCT00138671|10831995|FG001|COMPLETED|Overall Study||30
9731988|NCT00138671|10831994|FG000|NOT COMPLETED|Overall Study||13
9731989|NCT00138671|10831995|FG001|NOT COMPLETED|Overall Study||16
9731990|NCT00139399|10832005|FG000|STARTED|Overall Study||60
9731991|NCT00139399|10832006|FG001|STARTED|Overall Study||82
9731992|NCT00139399|10832005|FG000|COMPLETED|Overall Study||44
9731993|NCT00139399|10832006|FG001|COMPLETED|Overall Study||59
9731994|NCT00139399|10832005|FG000|NOT COMPLETED|Overall Study||16
9731995|NCT00139399|10832006|FG001|NOT COMPLETED|Overall Study||23
9731996|NCT00139477|10832014|FG000|STARTED|First Intervention -Baseline to 6Months||31
9731997|NCT00139477|10832015|FG001|STARTED|First Intervention -Baseline to 6Months||35
9731998|NCT00139477|10832014|FG000|COMPLETED|First Intervention -Baseline to 6Months||19
9731999|NCT00139477|10832015|FG001|COMPLETED|First Intervention -Baseline to 6Months||23
9732000|NCT00139477|10832014|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12
9682853|NCT00383435|10782744|FG001|STARTED|26-Week Double-Blind Treatment Period||207
9682854|NCT00383435|10782745|FG002|STARTED|26-Week Double-Blind Treatment Period||210
9682855|NCT00383435|10782746|FG003|STARTED|26-Week Double-Blind Treatment Period||209
9682856|NCT00383435|10782747|FG004|STARTED|26-Week Double-Blind Treatment Period||212
9682857|NCT00383435|10782743|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176
9682858|NCT00383435|10782744|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169
9682859|NCT00383435|10782745|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164
9682860|NCT00383435|10782746|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172
9682861|NCT00383435|10782747|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159
9682862|NCT00383435|10782743|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
9682863|NCT00383435|10782744|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
9682864|NCT00383435|10782745|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
9682865|NCT00383435|10782746|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
9682866|NCT00383435|10782747|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
9682867|NCT00383435|10782743|FG000|STARTED|26-Week Treatment Safety Extension||131
9682868|NCT00383435|10782744|FG001|STARTED|26-Week Treatment Safety Extension||130
9682869|NCT00383435|10782745|FG002|STARTED|26-Week Treatment Safety Extension||124
9682870|NCT00383435|10782746|FG003|STARTED|26-Week Treatment Safety Extension||131
9682871|NCT00383435|10782747|FG004|STARTED|26-Week Treatment Safety Extension||13
9682872|NCT00383435|10782743|FG000|COMPLETED|26-Week Treatment Safety Extension||117
9682873|NCT00383435|10782744|FG001|COMPLETED|26-Week Treatment Safety Extension||121
9682874|NCT00383435|10782745|FG002|COMPLETED|26-Week Treatment Safety Extension||108
9682875|NCT00383435|10782746|FG003|COMPLETED|26-Week Treatment Safety Extension||116
9682876|NCT00383435|10782747|FG004|COMPLETED|26-Week Treatment Safety Extension||10
9682877|NCT00383435|10782743|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14
9682878|NCT00383435|10782744|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9
9682879|NCT00383435|10782745|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16
9682880|NCT00383435|10782746|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15
9682881|NCT00383435|10782747|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3
9682882|NCT00381485|10782762|FG000|STARTED|Open-Label Run-In Period||834
9682883|NCT00381485|10782763|FG001|STARTED|Open-Label Run-In Period||0
9682884|NCT00381485|10782764|FG002|STARTED|Open-Label Run-In Period||0
9682885|NCT00381485|10782765|FG003|STARTED|Open-Label Run-In Period||0
9682886|NCT00381485|10782762|FG000|COMPLETED|Open-Label Run-In Period||728
9682887|NCT00381485|10782763|FG001|COMPLETED|Open-Label Run-In Period||0
9682888|NCT00381485|10782764|FG002|COMPLETED|Open-Label Run-In Period||0
9682889|NCT00381485|10782765|FG003|COMPLETED|Open-Label Run-In Period||0
9682890|NCT00381485|10782762|FG000|NOT COMPLETED|Open-Label Run-In Period||106
9682891|NCT00381485|10782763|FG001|NOT COMPLETED|Open-Label Run-In Period||0
9682892|NCT00381485|10782764|FG002|NOT COMPLETED|Open-Label Run-In Period||0
9682893|NCT00381485|10782765|FG003|NOT COMPLETED|Open-Label Run-In Period||0
10023389|NCT01855828|11146969|FG000|NOT COMPLETED|Overall Study||2
10023390|NCT01855919|11146980|FG000|STARTED|Overall Study||232
10023391|NCT01855919|11146981|FG001|STARTED|Overall Study||226
10023392|NCT01855919|11146980|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232
10023393|NCT01855919|11146981|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226
10023394|NCT01855919|11146980|FG000|COMPLETED|Overall Study||209
9682894|NCT00381485|10782762|FG000|STARTED|Double-Blind Treatment Period||0
9682895|NCT00381485|10782763|FG001|STARTED|Double-Blind Treatment Period||255
9682896|NCT00381485|10782764|FG002|STARTED|Double-Blind Treatment Period||233
9682897|NCT00381485|10782765|FG003|STARTED|Double-Blind Treatment Period||240
9682898|NCT00381485|10782762|FG000|COMPLETED|Double-Blind Treatment Period||0
9682899|NCT00381485|10782763|FG001|COMPLETED|Double-Blind Treatment Period||228
9682900|NCT00381485|10782764|FG002|COMPLETED|Double-Blind Treatment Period||208
9682901|NCT00381485|10782765|FG003|COMPLETED|Double-Blind Treatment Period||207
9682902|NCT00381485|10782762|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
9844129|NCT00834288|10956040|FG001|NOT COMPLETED|Treatment Phase I||0
9844130|NCT00834288|10956039|FG000|STARTED|Treatment Phase II||13
9844131|NCT00834288|10956040|FG001|STARTED|Treatment Phase II||13
9844132|NCT00834288|10956039|FG000|COMPLETED|Treatment Phase II||13
9844133|NCT00834288|10956040|FG001|COMPLETED|Treatment Phase II||13
9844134|NCT00834288|10956039|FG000|NOT COMPLETED|Treatment Phase II||0
9844135|NCT00834288|10956040|FG001|NOT COMPLETED|Treatment Phase II||0
9844136|NCT00834366|10956048|FG000|STARTED|Treatment Period 1||13
9844137|NCT00834366|10956049|FG001|STARTED|Treatment Period 1||13
9844138|NCT00834366|10956048|FG000|COMPLETED|Treatment Period 1||12
9844139|NCT00834366|10956049|FG001|COMPLETED|Treatment Period 1||12
9844140|NCT00834366|10956048|FG000|NOT COMPLETED|Treatment Period 1||1
9844141|NCT00834366|10956049|FG001|NOT COMPLETED|Treatment Period 1||1
9844142|NCT00834366|10956048|FG000|STARTED|Treatment Period 2||12
9844143|NCT00834366|10956049|FG001|STARTED|Treatment Period 2||12
9844144|NCT00834366|10956048|FG000|COMPLETED|Treatment Period 2||12
10023395|NCT01855919|11146981|FG001|COMPLETED|Overall Study||200
10023396|NCT01855919|11146980|FG000|NOT COMPLETED|Overall Study||23
9682903|NCT00381485|10782763|FG001|NOT COMPLETED|Double-Blind Treatment Period||27
9682904|NCT00381485|10782764|FG002|NOT COMPLETED|Double-Blind Treatment Period||25
9844145|NCT00834366|10956049|FG001|COMPLETED|Treatment Period 2||12
9844146|NCT00834366|10956048|FG000|NOT COMPLETED|Treatment Period 2||0
10023397|NCT01855919|11146981|FG001|NOT COMPLETED|Overall Study||26
10023398|NCT01855945|11147000|FG000|STARTED|Overall Study||54
9682905|NCT00381485|10782765|FG003|NOT COMPLETED|Double-Blind Treatment Period||33
9682906|NCT00379288|10782778|FG000|STARTED|Overall Study||141
9682907|NCT00379288|10782779|FG001|STARTED|Overall Study||130
9682908|NCT00379288|10782780|FG002|STARTED|Overall Study||68
9682909|NCT00379288|10782781|FG003|STARTED|Overall Study||65
9682910|NCT00379288|10782778|FG000|COMPLETED|Overall Study||122
9682911|NCT00379288|10782779|FG001|COMPLETED|Overall Study||108
9682912|NCT00379288|10782780|FG002|COMPLETED|Overall Study||58
9682913|NCT00379288|10782781|FG003|COMPLETED|Overall Study||57
9682914|NCT00379288|10782778|FG000|NOT COMPLETED|Overall Study||19
9682915|NCT00379288|10782779|FG001|NOT COMPLETED|Overall Study||22
9682916|NCT00379288|10782780|FG002|NOT COMPLETED|Overall Study||10
9682917|NCT00379288|10782781|FG003|NOT COMPLETED|Overall Study||8
9682918|NCT00378378|10782794|FG000|STARTED|Overall Study||51
9682919|NCT00378378|10782795|FG001|STARTED|Overall Study||50
9682920|NCT00378378|10782796|FG002|STARTED|Overall Study||26
9682921|NCT00378378|10782794|FG000|COMPLETED|Overall Study||51
9682922|NCT00378378|10782795|FG001|COMPLETED|Overall Study||49
9682923|NCT00378378|10782796|FG002|COMPLETED|Overall Study||24
9682924|NCT00378378|10782794|FG000|NOT COMPLETED|Overall Study||0
9682925|NCT00378378|10782795|FG001|NOT COMPLETED|Overall Study||1
9682926|NCT00378378|10782796|FG002|NOT COMPLETED|Overall Study||2
9682927|NCT00089895|10782806|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
9682928|NCT00089895|10782807|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
9682929|NCT00089895|10782806|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687
9682930|NCT00089895|10782807|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642
9682931|NCT00089895|10782806|FG000|NOT COMPLETED|Overall Study||35
9682932|NCT00089895|10782807|FG001|NOT COMPLETED|Overall Study||42
9682933|NCT02577354|10782815|FG000|STARTED|Overall Study||102
9682934|NCT02577354|10782816|FG001|STARTED|Overall Study||102
9682935|NCT02577354|10782815|FG000|120 Day Primary Endpoint|Overall Study||100
9682936|NCT02577354|10782816|FG001|120 Day Primary Endpoint|Overall Study||101
9682937|NCT02577354|10782815|FG000|COMPLETED|Overall Study||87
9682938|NCT02577354|10782816|FG001|COMPLETED|Overall Study||89
9682939|NCT02577354|10782815|FG000|NOT COMPLETED|Overall Study||15
9682940|NCT02577354|10782816|FG001|NOT COMPLETED|Overall Study||13
9682944|NCT02471807|10782836|FG000|STARTED|Overall Study||34
9682945|NCT02471807|10782836|FG000|COMPLETED|Overall Study||11
9682946|NCT02471807|10782836|FG000|NOT COMPLETED|Overall Study||23
9682947|NCT02321514|10782840|FG000|STARTED|Overall Study||191
9682948|NCT02321514|10782840|FG000|COMPLETED|Overall Study||166
9682949|NCT02321514|10782840|FG000|NOT COMPLETED|Overall Study||25
9682950|NCT02118610|10782846|FG000|STARTED|Overall Study||30
9682951|NCT02118610|10782847|FG001|STARTED|Overall Study||33
9682952|NCT02118610|10782846|FG000|COMPLETED|Overall Study||29
9682953|NCT02118610|10782847|FG001|COMPLETED|Overall Study||32
9682954|NCT02118610|10782846|FG000|NOT COMPLETED|Overall Study||1
9682955|NCT02118610|10782847|FG001|NOT COMPLETED|Overall Study||1
9725337|NCT00094536|10824939|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
9725338|NCT00094536|10824939|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
9725339|NCT00094536|10824939|FG000|24 Month Follow-up|Treatment and Follow-up||53
9725340|NCT00094536|10824939|FG000|36 Month Follow-up|Treatment and Follow-up||51
9725341|NCT00094536|10824939|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
9725342|NCT00094536|10824939|FG000|NOT COMPLETED|Treatment and Follow-up||31
9725343|NCT00094575|10824945|FG000|STARTED|Overall Study||444
9725344|NCT00094575|10824946|FG001|STARTED|Overall Study||437
9725345|NCT00094575|10824945|FG000|COMPLETED|Overall Study||298
9725346|NCT00094575|10824946|FG001|COMPLETED|Overall Study||291
9725347|NCT00094575|10824945|FG000|NOT COMPLETED|Overall Study||146
9725348|NCT00094575|10824946|FG001|NOT COMPLETED|Overall Study||146
9725349|NCT00094653|10824957|FG000|STARTED|Overall Study||403
9725350|NCT00094653|10824958|FG001|STARTED|Overall Study||137
9725351|NCT00094653|10824959|FG002|STARTED|Overall Study||136
9725352|NCT00094653|10824957|FG000|Treated|Overall Study||381
9725353|NCT00094653|10824958|FG001|Treated|Overall Study||131
9725354|NCT00094653|10824959|FG002|Treated|Overall Study||131
9725355|NCT00094653|10824957|FG000|COMPLETED|Overall Study||82
9725356|NCT00094653|10824958|FG001|COMPLETED|Overall Study||31
9725357|NCT00094653|10824959|FG002|COMPLETED|Overall Study||10
9725358|NCT00094653|10824957|FG000|NOT COMPLETED|Overall Study||321
9725359|NCT00094653|10824958|FG001|NOT COMPLETED|Overall Study||106
9725360|NCT00094653|10824959|FG002|NOT COMPLETED|Overall Study||126
9725361|NCT00094757|10824971|FG000|STARTED|Overall Study||205
9725362|NCT00094757|10824972|FG001|STARTED|Overall Study||206
9725363|NCT00094757|10824973|FG002|STARTED|Overall Study||110
9725364|NCT00094757|10824971|FG000|COMPLETED|Overall Study||152
9725365|NCT00094757|10824972|FG001|COMPLETED|Overall Study||144
9725366|NCT00094757|10824973|FG002|COMPLETED|Overall Study||80
9725367|NCT00094757|10824971|FG000|NOT COMPLETED|Overall Study||53
9725368|NCT00094757|10824972|FG001|NOT COMPLETED|Overall Study||62
9725369|NCT00094757|10824973|FG002|NOT COMPLETED|Overall Study||30
9725370|NCT00094770|10824983|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588
9725371|NCT00094770|10824984|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584
9731746|NCT00135356|10831658|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16
9682956|NCT01909570|10782855|FG000|STARTED|Overall Study||84
9682957|NCT01909570|10782856|FG001|STARTED|Overall Study||91
9682958|NCT01909570|10782855|FG000|COMPLETED|Overall Study||57
9682959|NCT01909570|10782856|FG001|COMPLETED|Overall Study||64
9682960|NCT01909570|10782855|FG000|NOT COMPLETED|Overall Study||27
9682961|NCT01909570|10782856|FG001|NOT COMPLETED|Overall Study||27
9682962|NCT01453946|10782862|FG000|STARTED|Overall Study||50
9682963|NCT01453946|10782862|FG000|COMPLETED|Overall Study||41
9682964|NCT01453946|10782862|FG000|NOT COMPLETED|Overall Study||9
9682965|NCT01444092|10782866|FG000|STARTED|Overall Study||108
9682966|NCT01444092|10782866|FG000|INFORMED CONSENT OBTAINED|Overall Study||108
9682967|NCT01444092|10782866|FG000|COMPLETED|Overall Study||91
9682968|NCT01444092|10782866|FG000|NOT COMPLETED|Overall Study||17
9682969|NCT01265784|10782873|FG000|STARTED|Overall Study||56
9682970|NCT01265784|10782874|FG001|STARTED|Overall Study||57
9682971|NCT01265784|10782875|FG002|STARTED|Overall Study||30
9682972|NCT01265784|10782873|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
9682973|NCT01265784|10782874|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
9682974|NCT01265784|10782875|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29
9682975|NCT01265784|10782873|FG000|COMPLETED|Overall Study||44
9682976|NCT01265784|10782874|FG001|COMPLETED|Overall Study||49
9682977|NCT01265784|10782875|FG002|COMPLETED|Overall Study||26
9682978|NCT01265784|10782873|FG000|NOT COMPLETED|Overall Study||12
9682979|NCT01265784|10782874|FG001|NOT COMPLETED|Overall Study||8
9682980|NCT01265784|10782875|FG002|NOT COMPLETED|Overall Study||4
9682981|NCT00577577|10782885|FG000|STARTED|Overall Study||34
9682982|NCT00577577|10782886|FG001|STARTED|Overall Study||35
9682983|NCT00577577|10782885|FG000|Received Treatment|Overall Study||34
9682984|NCT00577577|10782886|FG001|Received Treatment|Overall Study||35
9682985|NCT00577577|10782885|FG000|COMPLETED|Overall Study||29
10023399|NCT01855945|11147001|FG001|STARTED|Overall Study||55
10023400|NCT01855945|11147002|FG002|STARTED|Overall Study||51
10023401|NCT01855945|11147003|FG003|STARTED|Overall Study||53
9682986|NCT00577577|10782886|FG001|COMPLETED|Overall Study||30
9682987|NCT00577577|10782885|FG000|NOT COMPLETED|Overall Study||5
9682988|NCT00577577|10782886|FG001|NOT COMPLETED|Overall Study||5
9682989|NCT00392327|10782900|FG000|STARTED|Overall Study||87
9682990|NCT00392327|10782901|FG001|STARTED|Overall Study||93
9682991|NCT00392327|10782902|FG002|STARTED|Overall Study||56
9682992|NCT00392327|10782903|FG003|STARTED|Overall Study||58
9682993|NCT00392327|10782904|FG004|STARTED|Overall Study||23
9682994|NCT00392327|10782905|FG005|STARTED|Overall Study||19
10023402|NCT01855945|11147004|FG004|STARTED|Overall Study||51
10023403|NCT01855945|11147005|FG005|STARTED|Overall Study||53
10023404|NCT01855945|11147006|FG006|STARTED|Overall Study||53
9682995|NCT00392327|10782906|FG006|STARTED|Overall Study||21
9682996|NCT00392327|10782907|FG007|STARTED|Overall Study||22
9682997|NCT00392327|10782900|FG000|COMPLETED|Overall Study||72
9682998|NCT00392327|10782901|FG001|COMPLETED|Overall Study||74
9682999|NCT00392327|10782902|FG002|COMPLETED|Overall Study||36
9683000|NCT00392327|10782903|FG003|COMPLETED|Overall Study||42
9683001|NCT00392327|10782904|FG004|COMPLETED|Overall Study||20
9683002|NCT00392327|10782905|FG005|COMPLETED|Overall Study||14
9683003|NCT00392327|10782906|FG006|COMPLETED|Overall Study||12
9683004|NCT00392327|10782907|FG007|COMPLETED|Overall Study||11
9683005|NCT00392327|10782900|FG000|NOT COMPLETED|Overall Study||15
9683006|NCT00392327|10782901|FG001|NOT COMPLETED|Overall Study||19
9683007|NCT00392327|10782902|FG002|NOT COMPLETED|Overall Study||20
9683008|NCT00392327|10782903|FG003|NOT COMPLETED|Overall Study||16
9683009|NCT00392327|10782904|FG004|NOT COMPLETED|Overall Study||3
9683010|NCT00392327|10782905|FG005|NOT COMPLETED|Overall Study||5
9683011|NCT00392327|10782906|FG006|NOT COMPLETED|Overall Study||9
9683012|NCT00392327|10782907|FG007|NOT COMPLETED|Overall Study||11
9683013|NCT00085202|10782927|FG000|STARTED|Overall Study||269
9683014|NCT00085202|10782928|FG001|STARTED|Overall Study||144
9683015|NCT00085202|10782927|FG000|COMPLETED|Overall Study||251
9683016|NCT00085202|10782928|FG001|COMPLETED|Overall Study||120
9683017|NCT00085202|10782927|FG000|NOT COMPLETED|Overall Study||18
9683018|NCT00085202|10782928|FG001|NOT COMPLETED|Overall Study||24
9725372|NCT00094770|10824983|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
9725373|NCT00094770|10824984|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
9725374|NCT00094770|10824983|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
9725375|NCT00094770|10824984|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
9725376|NCT00094770|10824983|FG000|STARTED|Year 2 (Week 0 to Week 104)||588
9725377|NCT00094770|10824984|FG001|STARTED|Year 2 (Week 0 to Week 104)||584
9725378|NCT00094770|10824983|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255
9725379|NCT00094770|10824984|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264
9725380|NCT00094770|10824983|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
9725381|NCT00094770|10824984|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
9725382|NCT00094809|10824992|FG000|STARTED|Overall Study||126
9725383|NCT00094809|10824993|FG001|STARTED|Overall Study||126
9725384|NCT00094809|10824992|FG000|Received Study Drug|Overall Study||124
9725385|NCT00094809|10824993|FG001|Received Study Drug|Overall Study||118
9725386|NCT00094809|10824992|FG000|Properly Consented; Received Study Drug|Overall Study||123
9725387|NCT00094809|10824993|FG001|Properly Consented; Received Study Drug|Overall Study||118
9725388|NCT00094809|10824992|FG000|Completed All 4 Cycles of Treatment|Overall Study||98
10023405|NCT01855945|11147007|FG007|STARTED|Overall Study||55
9683019|NCT05007639|10782947|FG000|STARTED|Overall Study||274
9683020|NCT05007639|10782947|FG000|COMPLETED|Overall Study||274
9683021|NCT05007639|10782947|FG000|NOT COMPLETED|Overall Study||0
9683022|NCT04739735|10782953|FG000|STARTED|Overall Study||25
9683023|NCT04739735|10782954|FG001|STARTED|Overall Study||25
9683024|NCT04739735|10782953|FG000|COMPLETED|Overall Study||25
9683025|NCT04739735|10782954|FG001|COMPLETED|Overall Study||25
9683026|NCT04739735|10782953|FG000|NOT COMPLETED|Overall Study||0
9683027|NCT04739735|10782954|FG001|NOT COMPLETED|Overall Study||0
9683028|NCT04552535|10782962|FG000|STARTED|Overall Study||99
9683029|NCT04552535|10782963|FG001|STARTED|Overall Study||101
9683030|NCT04552535|10782962|FG000|COMPLETED|Overall Study||99
9683031|NCT04552535|10782963|FG001|COMPLETED|Overall Study||101
9683032|NCT04552535|10782962|FG000|NOT COMPLETED|Overall Study||0
9683033|NCT04552535|10782963|FG001|NOT COMPLETED|Overall Study||0
9683106|NCT04296942|10783064|FG000|STARTED|Overall Study||1
9683107|NCT04296942|10783065|FG001|STARTED|Overall Study||0
9683108|NCT04296942|10783066|FG002|STARTED|Overall Study||0
9683109|NCT04296942|10783064|FG000|COMPLETED|Overall Study||0
9683110|NCT04296942|10783065|FG001|COMPLETED|Overall Study||0
9683111|NCT04296942|10783066|FG002|COMPLETED|Overall Study||0
9683112|NCT04296942|10783064|FG000|NOT COMPLETED|Overall Study||1
9683113|NCT04296942|10783065|FG001|NOT COMPLETED|Overall Study||0
9683114|NCT04296942|10783066|FG002|NOT COMPLETED|Overall Study||0
9683115|NCT04278872|10783078|FG000|STARTED|Overall Study||7
9683116|NCT04278872|10783079|FG001|STARTED|Overall Study||6
9683117|NCT04278872|10783078|FG000|COMPLETED|Overall Study||4
9683118|NCT04278872|10783079|FG001|COMPLETED|Overall Study||5
9683119|NCT04278872|10783078|FG000|NOT COMPLETED|Overall Study||3
9683120|NCT04278872|10783079|FG001|NOT COMPLETED|Overall Study||1
9683121|NCT04213807|10783088|FG000|STARTED|Overall Study||5
9683122|NCT04213807|10783089|FG001|STARTED|Overall Study||6
9683123|NCT04213807|10783090|FG002|STARTED|Overall Study||7
9683124|NCT04213807|10783088|FG000|COMPLETED|Overall Study||5
9683125|NCT04213807|10783089|FG001|COMPLETED|Overall Study||6
9683126|NCT04213807|10783090|FG002|COMPLETED|Overall Study||6
9683127|NCT04213807|10783088|FG000|NOT COMPLETED|Overall Study||0
9683128|NCT04213807|10783089|FG001|NOT COMPLETED|Overall Study||0
9683129|NCT04213807|10783090|FG002|NOT COMPLETED|Overall Study||1
9683130|NCT04172467|10783100|FG000|STARTED|Overall Study||1086
9683131|NCT04172467|10783100|FG000|COMPLETED|Overall Study||1086
9683132|NCT04172467|10783100|FG000|NOT COMPLETED|Overall Study||0
9683133|NCT04132804|10783107|FG000|STARTED|Overall Study||31
9683134|NCT04132804|10783107|FG000|COMPLETED|Overall Study||20
9683135|NCT04132804|10783107|FG000|NOT COMPLETED|Overall Study||11
9683136|NCT03963011|10783113|FG000|STARTED|Overall Study||8
9683137|NCT03963011|10783114|FG001|STARTED|Overall Study||6
9683138|NCT03963011|10783113|FG000|COMPLETED|Overall Study||8
9683139|NCT03963011|10783114|FG001|COMPLETED|Overall Study||6
9683140|NCT03963011|10783113|FG000|NOT COMPLETED|Overall Study||0
9683141|NCT03963011|10783114|FG001|NOT COMPLETED|Overall Study||0
9683142|NCT03894501|10783122|FG000|STARTED|Overall Study||15
9683143|NCT03894501|10783123|FG001|STARTED|Overall Study||15
9683144|NCT03894501|10783122|FG000|COMPLETED|Overall Study||15
9683145|NCT03894501|10783123|FG001|COMPLETED|Overall Study||15
9844147|NCT00834366|10956049|FG001|NOT COMPLETED|Treatment Period 2||0
9844148|NCT00834483|10956057|FG000|STARTED|Overall Study||31
9844149|NCT00834483|10956058|FG001|STARTED|Overall Study||29
10023406|NCT01855945|11147008|FG008|STARTED|Overall Study||48
10023407|NCT01855945|11147009|FG009|STARTED|Overall Study||51
10023408|NCT01855945|11147010|FG010|STARTED|Overall Study||51
10023409|NCT01855945|11147011|FG011|STARTED|Overall Study||52
10023410|NCT01855945|11147000|FG000|COMPLETED|Overall Study||38
10023411|NCT01855945|11147001|FG001|COMPLETED|Overall Study||44
10023412|NCT01855945|11147002|FG002|COMPLETED|Overall Study||39
10023413|NCT01855945|11147003|FG003|COMPLETED|Overall Study||49
10023414|NCT01855945|11147004|FG004|COMPLETED|Overall Study||50
9844150|NCT00834483|10956057|FG000|COMPLETED|Overall Study||31
9844151|NCT00834483|10956058|FG001|COMPLETED|Overall Study||29
9844152|NCT00834483|10956057|FG000|NOT COMPLETED|Overall Study||0
9844153|NCT00834483|10956058|FG001|NOT COMPLETED|Overall Study||0
9844154|NCT00834626|10956064|FG000|STARTED|Overall Study||30
9844155|NCT00834626|10956064|FG000|1 Year Follow-up|Overall Study||30
9844156|NCT00834626|10956064|FG000|COMPLETED|Overall Study||30
9844157|NCT00834626|10956064|FG000|NOT COMPLETED|Overall Study||0
9844158|NCT00834652|10956071|FG000|STARTED|Overall Study||104
9844159|NCT00834652|10956072|FG001|STARTED|Overall Study||102
9844160|NCT00834652|10956071|FG000|COMPLETED|Overall Study||66
9844161|NCT00834652|10956072|FG001|COMPLETED|Overall Study||62
9844162|NCT00834652|10956071|FG000|NOT COMPLETED|Overall Study||38
9844163|NCT00834652|10956072|FG001|NOT COMPLETED|Overall Study||40
9844164|NCT00834678|10956078|FG000|STARTED|Overall Study||11
10023415|NCT01855945|11147005|FG005|COMPLETED|Overall Study||50
9960734|NCT01469013|11080379|FG012|NOT COMPLETED|Part A (Treatment Period)||0
9683146|NCT03894501|10783122|FG000|NOT COMPLETED|Overall Study||0
9683147|NCT03894501|10783123|FG001|NOT COMPLETED|Overall Study||0
9683148|NCT03837184|10783144|FG000|STARTED|Overall Study||2
9844165|NCT00834678|10956078|FG000|COMPLETED|Overall Study||11
9844166|NCT00834678|10956078|FG000|NOT COMPLETED|Overall Study||0
9844167|NCT00834808|10956087|FG000|STARTED|Treatment Period 1 (Day 1)||9
9844168|NCT00834808|10956088|FG001|STARTED|Treatment Period 1 (Day 1)||9
10023416|NCT01855945|11147006|FG006|COMPLETED|Overall Study||43
10023417|NCT01855945|11147007|FG007|COMPLETED|Overall Study||47
10023418|NCT01855945|11147008|FG008|COMPLETED|Overall Study||46
9683034|NCT04502472|10782974|FG000|STARTED|Overall Study||61
9683035|NCT04502472|10782975|FG001|STARTED|Overall Study||48
9683036|NCT04502472|10782974|FG000|COMPLETED|Overall Study||58
9683037|NCT04502472|10782975|FG001|COMPLETED|Overall Study||45
9683038|NCT04502472|10782974|FG000|NOT COMPLETED|Overall Study||3
9683039|NCT04502472|10782975|FG001|NOT COMPLETED|Overall Study||3
9683040|NCT04495166|10782984|FG000|STARTED|Overall Study||37
9683041|NCT04495166|10782985|FG001|STARTED|Overall Study||44
9683042|NCT04495166|10782984|FG000|COMPLETED|Overall Study||30
9683043|NCT04495166|10782985|FG001|COMPLETED|Overall Study||41
9683044|NCT04495166|10782984|FG000|NOT COMPLETED|Overall Study||7
9683045|NCT04495166|10782985|FG001|NOT COMPLETED|Overall Study||3
9683046|NCT04461483|10782997|FG000|STARTED|Part 1 (Day 1)||6
9683047|NCT04461483|10782998|FG001|STARTED|Part 1 (Day 1)||6
9683048|NCT04461483|10782999|FG002|STARTED|Part 1 (Day 1)||6
9683049|NCT04461483|10783000|FG003|STARTED|Part 1 (Day 1)||6
9683050|NCT04461483|10783001|FG004|STARTED|Part 1 (Day 1)||0
9683051|NCT04461483|10783002|FG005|STARTED|Part 1 (Day 1)||0
9683052|NCT04461483|10782997|FG000|COMPLETED|Part 1 (Day 1)||6
9683053|NCT04461483|10782998|FG001|COMPLETED|Part 1 (Day 1)||6
9683054|NCT04461483|10782999|FG002|COMPLETED|Part 1 (Day 1)||6
9683055|NCT04461483|10783000|FG003|COMPLETED|Part 1 (Day 1)||6
9683056|NCT04461483|10783001|FG004|COMPLETED|Part 1 (Day 1)||0
9683057|NCT04461483|10783002|FG005|COMPLETED|Part 1 (Day 1)||0
9683058|NCT04461483|10782997|FG000|NOT COMPLETED|Part 1 (Day 1)||0
9683059|NCT04461483|10782998|FG001|NOT COMPLETED|Part 1 (Day 1)||0
9683060|NCT04461483|10782999|FG002|NOT COMPLETED|Part 1 (Day 1)||0
9683061|NCT04461483|10783000|FG003|NOT COMPLETED|Part 1 (Day 1)||0
9683062|NCT04461483|10783001|FG004|NOT COMPLETED|Part 1 (Day 1)||0
9683063|NCT04461483|10783002|FG005|NOT COMPLETED|Part 1 (Day 1)||0
9683064|NCT04461483|10782997|FG000|STARTED|Part 2 (Day 1 to 21)||0
9683065|NCT04461483|10782998|FG001|STARTED|Part 2 (Day 1 to 21)||0
9683066|NCT04461483|10782999|FG002|STARTED|Part 2 (Day 1 to 21)||0
9683067|NCT04461483|10783000|FG003|STARTED|Part 2 (Day 1 to 21)||0
9683068|NCT04461483|10783001|FG004|STARTED|Part 2 (Day 1 to 21)||3
9683069|NCT04461483|10783002|FG005|STARTED|Part 2 (Day 1 to 21)||6
9683070|NCT04461483|10782997|FG000|COMPLETED|Part 2 (Day 1 to 21)||0
9683071|NCT04461483|10782998|FG001|COMPLETED|Part 2 (Day 1 to 21)||0
9683072|NCT04461483|10782999|FG002|COMPLETED|Part 2 (Day 1 to 21)||0
9683073|NCT04461483|10783000|FG003|COMPLETED|Part 2 (Day 1 to 21)||0
9683074|NCT04461483|10783001|FG004|COMPLETED|Part 2 (Day 1 to 21)||3
9683075|NCT04461483|10783002|FG005|COMPLETED|Part 2 (Day 1 to 21)||6
9683076|NCT04461483|10782997|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0
9683077|NCT04461483|10782998|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0
9683078|NCT04461483|10782999|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0
9683079|NCT04461483|10783000|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0
9683080|NCT04461483|10783001|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0
9683081|NCT04461483|10783002|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0
9683082|NCT04386616|10783029|FG000|STARTED|Overall Study||134
9683083|NCT04386616|10783030|FG001|STARTED|Overall Study||130
9683084|NCT04386616|10783031|FG002|STARTED|Overall Study||132
9683085|NCT04386616|10783029|FG000|Received at Least One Dose of Study Drug|Overall Study|In this arm, 68 and 66 participants received MSTT1041A-matched placebo and UTTR1147A-matched placebo, respectively.|134
9683086|NCT04386616|10783030|FG001|Received at Least One Dose of Study Drug|Overall Study||130
9683087|NCT04386616|10783031|FG002|Received at Least One Dose of Study Drug|Overall Study||132
9683088|NCT04386616|10783029|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31
9683089|NCT04386616|10783030|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27
9683090|NCT04386616|10783031|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25
9683091|NCT04386616|10783029|FG000|COMPLETED|Overall Study||104
9683092|NCT04386616|10783030|FG001|COMPLETED|Overall Study||95
9683093|NCT04386616|10783031|FG002|COMPLETED|Overall Study||104
9683094|NCT04386616|10783029|FG000|NOT COMPLETED|Overall Study||30
9683095|NCT04386616|10783030|FG001|NOT COMPLETED|Overall Study||35
9683096|NCT04386616|10783031|FG002|NOT COMPLETED|Overall Study||28
9683097|NCT04377711|10783050|FG000|STARTED|Overall Study||197
9683098|NCT04377711|10783051|FG001|STARTED|Overall Study||203
9683099|NCT04377711|10783050|FG000|COMPLETED|Overall Study||178
9683100|NCT04377711|10783051|FG001|COMPLETED|Overall Study||181
9683101|NCT04377711|10783050|FG000|NOT COMPLETED|Overall Study||19
9683102|NCT04377711|10783051|FG001|NOT COMPLETED|Overall Study||22
9683103|NCT04347408|10783057|FG000|STARTED|Overall Study||992
9683104|NCT04347408|10783057|FG000|COMPLETED|Overall Study||992
9683105|NCT04347408|10783057|FG000|NOT COMPLETED|Overall Study||0
9683149|NCT03837184|10783144|FG000|COMPLETED|Overall Study||2
9683150|NCT03837184|10783144|FG000|NOT COMPLETED|Overall Study||0
9725389|NCT00094809|10824993|FG001|Completed All 4 Cycles of Treatment|Overall Study||90
9725390|NCT00094809|10824992|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
9725391|NCT00094809|10824993|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
9725392|NCT00094809|10824992|FG000|NOT COMPLETED|Overall Study||52
9725393|NCT00094809|10824993|FG001|NOT COMPLETED|Overall Study||65
9725394|NCT00094835|10825006|FG000|STARTED|Overall Study||9
9725395|NCT00094835|10825007|FG001|STARTED|Overall Study||11
9725396|NCT00094835|10825008|FG002|STARTED|Overall Study||7
9725397|NCT00094835|10825009|FG003|STARTED|Overall Study||5
9725398|NCT00094835|10825010|FG004|STARTED|Overall Study||7
9725399|NCT00094835|10825011|FG005|STARTED|Overall Study||6
9725400|NCT00094835|10825012|FG006|STARTED|Overall Study||6
9683151|NCT03735420|10783150|FG000|STARTED|Overall Study||16
9683152|NCT03735420|10783151|FG001|STARTED|Overall Study||14
9683153|NCT03735420|10783150|FG000|COMPLETED|Overall Study||16
9683154|NCT03735420|10783151|FG001|COMPLETED|Overall Study||14
9683155|NCT03735420|10783150|FG000|NOT COMPLETED|Overall Study||0
9683156|NCT03735420|10783151|FG001|NOT COMPLETED|Overall Study||0
9683157|NCT03721328|10783159|FG000|STARTED|Overall Study||15
9683158|NCT03721328|10783159|FG000|COMPLETED|Overall Study||15
9683159|NCT03721328|10783159|FG000|NOT COMPLETED|Overall Study||0
9683160|NCT03721107|10783167|FG000|STARTED|Overall Study||80
9683161|NCT03721107|10783168|FG001|STARTED|Overall Study||84
9683162|NCT03721107|10783169|FG002|STARTED|Overall Study||98
9683163|NCT03721107|10783170|FG003|STARTED|Overall Study||104
9683164|NCT03721107|10783167|FG000|Treated|Overall Study||80
9683165|NCT03721107|10783168|FG001|Treated|Overall Study||84
9683166|NCT03721107|10783169|FG002|Treated|Overall Study||97
9683167|NCT03721107|10783170|FG003|Treated|Overall Study||104
9683168|NCT03721107|10783167|FG000|COMPLETED|Overall Study||75
9683169|NCT03721107|10783168|FG001|COMPLETED|Overall Study||81
9683170|NCT03721107|10783169|FG002|COMPLETED|Overall Study||83
9683171|NCT03721107|10783170|FG003|COMPLETED|Overall Study||92
9683172|NCT03721107|10783167|FG000|NOT COMPLETED|Overall Study||5
9683173|NCT03721107|10783168|FG001|NOT COMPLETED|Overall Study||3
9683174|NCT03721107|10783169|FG002|NOT COMPLETED|Overall Study||15
9683175|NCT03721107|10783170|FG003|NOT COMPLETED|Overall Study||12
9683176|NCT03691727|10783182|FG000|STARTED|Overall Study||18
9683177|NCT03691727|10783183|FG001|STARTED|Overall Study||12
9683178|NCT03691727|10783182|FG000|COMPLETED|Overall Study||16
9683179|NCT03691727|10783183|FG001|COMPLETED|Overall Study||11
9683180|NCT03691727|10783182|FG000|NOT COMPLETED|Overall Study||2
9683181|NCT03691727|10783183|FG001|NOT COMPLETED|Overall Study||1
9683182|NCT03689920|10783191|FG000|STARTED|Overall Study||47
9683183|NCT03689920|10783192|FG001|STARTED|Overall Study||52
9683184|NCT03689920|10783191|FG000|COMPLETED|Overall Study||41
9683185|NCT03689920|10783192|FG001|COMPLETED|Overall Study||48
9683186|NCT03689920|10783191|FG000|NOT COMPLETED|Overall Study||6
9683187|NCT03689920|10783192|FG001|NOT COMPLETED|Overall Study||4
9683188|NCT03672227|10783200|FG000|STARTED|Overall Study||112
9683189|NCT03672227|10783201|FG001|STARTED|Overall Study||52
9844169|NCT00834808|10956089|FG002|STARTED|Treatment Period 1 (Day 1)||9
9844170|NCT00834808|10956087|FG000|COMPLETED|Treatment Period 1 (Day 1)||9
9844171|NCT00834808|10956088|FG001|COMPLETED|Treatment Period 1 (Day 1)||9
9844172|NCT00834808|10956089|FG002|COMPLETED|Treatment Period 1 (Day 1)||9
9844173|NCT00834808|10956087|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9844174|NCT00834808|10956088|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9844175|NCT00834808|10956089|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9960735|NCT01469013|11080367|FG000|STARTED|Part B (Extension Period)||0
9960736|NCT01469013|11080368|FG001|STARTED|Part B (Extension Period)||0
9960737|NCT01469013|11080369|FG002|STARTED|Part B (Extension Period)||0
9960738|NCT01469013|11080370|FG003|STARTED|Part B (Extension Period)||0
9960739|NCT01469013|11080371|FG004|STARTED|Part B (Extension Period)||0
9960740|NCT01469013|11080372|FG005|STARTED|Part B (Extension Period)||12
9960741|NCT01469013|11080373|FG006|STARTED|Part B (Extension Period)||12
9960742|NCT01469013|11080374|FG007|STARTED|Part B (Extension Period)||23
9960743|NCT01469013|11080375|FG008|STARTED|Part B (Extension Period)||24
9960744|NCT01469013|11080376|FG009|STARTED|Part B (Extension Period)||11
9960745|NCT01469013|11080377|FG010|STARTED|Part B (Extension Period)||12
9960746|NCT01469013|11080378|FG011|STARTED|Part B (Extension Period)||24
9960747|NCT01469013|11080379|FG012|STARTED|Part B (Extension Period)||24
9960748|NCT01469013|11080367|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
9960749|NCT01469013|11080368|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
9960750|NCT01469013|11080369|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
9960751|NCT01469013|11080370|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
9960752|NCT01469013|11080371|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
9960753|NCT01469013|11080372|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
9960754|NCT01469013|11080373|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
9960755|NCT01469013|11080374|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
9960756|NCT01469013|11080375|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
9960757|NCT01469013|11080376|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
9960758|NCT01469013|11080377|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
9683190|NCT03672227|10783200|FG000|Teachers Started|Overall Study||8
9683191|NCT03672227|10783201|FG001|Teachers Started|Overall Study||6
9683192|NCT03672227|10783200|FG000|Children Started|Overall Study||52
9683193|NCT03672227|10783201|FG001|Children Started|Overall Study||23
9683194|NCT03672227|10783200|FG000|Parents Started|Overall Study||52
9844176|NCT00834808|10956087|FG000|STARTED|Treatment Period 2 (Day 8)||9
9844177|NCT00834808|10956088|FG001|STARTED|Treatment Period 2 (Day 8)||9
9683195|NCT03672227|10783201|FG001|Parents Started|Overall Study||23
9683196|NCT03672227|10783200|FG000|COMPLETED|Overall Study||105
9844178|NCT00834808|10956089|FG002|STARTED|Treatment Period 2 (Day 8)||9
9844179|NCT00834808|10956087|FG000|COMPLETED|Treatment Period 2 (Day 8)||9
9683197|NCT03672227|10783201|FG001|COMPLETED|Overall Study||52
9683198|NCT03672227|10783200|FG000|NOT COMPLETED|Overall Study||7
9683199|NCT03672227|10783201|FG001|NOT COMPLETED|Overall Study||0
9683200|NCT03644849|10783210|FG000|STARTED|Overall Study||24
9844180|NCT00834808|10956088|FG001|COMPLETED|Treatment Period 2 (Day 8)||9
10023419|NCT01855945|11147009|FG009|COMPLETED|Overall Study||49
10023420|NCT01855945|11147010|FG010|COMPLETED|Overall Study||46
9683201|NCT03644849|10783211|FG001|STARTED|Overall Study||24
9683202|NCT03644849|10783210|FG000|COMPLETED|Overall Study||23
9683203|NCT03644849|10783211|FG001|COMPLETED|Overall Study||21
9683204|NCT03644849|10783210|FG000|NOT COMPLETED|Overall Study||1
9683205|NCT03644849|10783211|FG001|NOT COMPLETED|Overall Study||3
9683206|NCT03604159|10783219|FG000|STARTED|Overall Study||26
9683207|NCT03604159|10783220|FG001|STARTED|Overall Study||26
9683208|NCT03604159|10783219|FG000|COMPLETED|Overall Study||20
9683209|NCT03604159|10783220|FG001|COMPLETED|Overall Study||19
9683210|NCT03604159|10783219|FG000|NOT COMPLETED|Overall Study||6
9683211|NCT03604159|10783220|FG001|NOT COMPLETED|Overall Study||7
9683212|NCT03602885|10783228|FG000|STARTED|Overall Study||5
9683213|NCT03602885|10783229|FG001|STARTED|Overall Study||5
9683214|NCT03602885|10783228|FG000|COMPLETED|Overall Study||2
9683215|NCT03602885|10783229|FG001|COMPLETED|Overall Study||5
9683216|NCT03602885|10783228|FG000|NOT COMPLETED|Overall Study||3
9683217|NCT03602885|10783229|FG001|NOT COMPLETED|Overall Study||0
9683218|NCT03539601|10783239|FG000|STARTED|Overall Study||60
9683219|NCT03539601|10783240|FG001|STARTED|Overall Study||59
9683220|NCT03539601|10783241|FG002|STARTED|Overall Study||71
9683221|NCT03539601|10783242|FG003|STARTED|Overall Study||47
9683222|NCT03539601|10783239|FG000|Treated|Overall Study||59
9683223|NCT03539601|10783240|FG001|Treated|Overall Study||58
9683224|NCT03539601|10783241|FG002|Treated|Overall Study||71
10023421|NCT01855945|11147011|FG011|COMPLETED|Overall Study||49
10023422|NCT01855945|11147000|FG000|NOT COMPLETED|Overall Study||16
10023423|NCT01855945|11147001|FG001|NOT COMPLETED|Overall Study||11
10023424|NCT01855945|11147002|FG002|NOT COMPLETED|Overall Study||12
10023425|NCT01855945|11147003|FG003|NOT COMPLETED|Overall Study||4
10023426|NCT01855945|11147004|FG004|NOT COMPLETED|Overall Study||1
10023427|NCT01855945|11147005|FG005|NOT COMPLETED|Overall Study||3
10023428|NCT01855945|11147006|FG006|NOT COMPLETED|Overall Study||10
9683225|NCT03539601|10783242|FG003|Treated|Overall Study||47
9683226|NCT03539601|10783239|FG000|COMPLETED|Overall Study||54
9683227|NCT03539601|10783240|FG001|COMPLETED|Overall Study||52
9683228|NCT03539601|10783241|FG002|COMPLETED|Overall Study||65
9683229|NCT03539601|10783242|FG003|COMPLETED|Overall Study||46
9683230|NCT03539601|10783239|FG000|NOT COMPLETED|Overall Study||6
9683231|NCT03539601|10783240|FG001|NOT COMPLETED|Overall Study||7
9683232|NCT03539601|10783241|FG002|NOT COMPLETED|Overall Study||6
9683233|NCT03539601|10783242|FG003|NOT COMPLETED|Overall Study||1
9683234|NCT03539458|10783260|FG000|STARTED|Overall Study||11
9683235|NCT03539458|10783260|FG000|COMPLETED|Overall Study||10
9683236|NCT03539458|10783260|FG000|NOT COMPLETED|Overall Study||1
9683237|NCT03532451|10783266|FG000|STARTED|Overall Study||13
9683238|NCT03532451|10783267|FG001|STARTED|Overall Study||30
9683239|NCT03532451|10783266|FG000|COMPLETED|Overall Study||12
9683240|NCT03532451|10783267|FG001|COMPLETED|Overall Study||29
9683241|NCT03532451|10783266|FG000|NOT COMPLETED|Overall Study||1
9683242|NCT03532451|10783267|FG001|NOT COMPLETED|Overall Study||1
9725401|NCT00094835|10825006|FG000|Treated With Motesanib|Overall Study||6
9725402|NCT00094835|10825007|FG001|Treated With Motesanib|Overall Study||11
9725403|NCT00094835|10825008|FG002|Treated With Motesanib|Overall Study||6
9725404|NCT00094835|10825009|FG003|Treated With Motesanib|Overall Study||4
9725405|NCT00094835|10825010|FG004|Treated With Motesanib|Overall Study||7
9725406|NCT00094835|10825011|FG005|Treated With Motesanib|Overall Study||5
9725407|NCT00094835|10825012|FG006|Treated With Motesanib|Overall Study||6
9725408|NCT00094835|10825006|FG000|COMPLETED|Overall Study||5
9725409|NCT00094835|10825007|FG001|COMPLETED|Overall Study||8
9725410|NCT00094835|10825008|FG002|COMPLETED|Overall Study||4
9725411|NCT00094835|10825009|FG003|COMPLETED|Overall Study||4
9725412|NCT00094835|10825010|FG004|COMPLETED|Overall Study||3
9725413|NCT00094835|10825011|FG005|COMPLETED|Overall Study||3
9725414|NCT00094835|10825012|FG006|COMPLETED|Overall Study||4
9725415|NCT00094835|10825006|FG000|NOT COMPLETED|Overall Study||4
9725416|NCT00094835|10825007|FG001|NOT COMPLETED|Overall Study||3
9725417|NCT00094835|10825008|FG002|NOT COMPLETED|Overall Study||3
9725418|NCT00094835|10825009|FG003|NOT COMPLETED|Overall Study||1
9725419|NCT00094835|10825010|FG004|NOT COMPLETED|Overall Study||4
9725420|NCT00094835|10825011|FG005|NOT COMPLETED|Overall Study||3
10023429|NCT01855945|11147007|FG007|NOT COMPLETED|Overall Study||8
10023430|NCT01855945|11147008|FG008|NOT COMPLETED|Overall Study||2
10023431|NCT01855945|11147009|FG009|NOT COMPLETED|Overall Study||2
10023432|NCT01855945|11147010|FG010|NOT COMPLETED|Overall Study||5
9725421|NCT00094835|10825012|FG006|NOT COMPLETED|Overall Study||2
9725422|NCT00094861|10825035|FG000|STARTED|Overall Study||46
9725423|NCT00094861|10825036|FG001|STARTED|Overall Study||49
9725424|NCT00094861|10825035|FG000|Participants Treated|Overall Study||46
9725425|NCT00094861|10825036|FG001|Participants Treated|Overall Study||48
9725426|NCT00094861|10825035|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
9725427|NCT00094861|10825036|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
9725428|NCT00094861|10825035|FG000|NOT COMPLETED|Overall Study||18
9725429|NCT00094861|10825036|FG001|NOT COMPLETED|Overall Study||9
9725430|NCT00094887|10825044|FG000|STARTED|Overall Study||75
9725431|NCT00094887|10825045|FG001|STARTED|Overall Study||75
9725432|NCT00094887|10825044|FG000|Safety Population|Overall Study||75
9725433|NCT00094887|10825045|FG001|Safety Population|Overall Study||75
9725434|NCT00094887|10825044|FG000|Intent to Treat Population|Overall Study||75
9683243|NCT03505099|10783275|FG000|STARTED|Overall Study||14
9683244|NCT03505099|10783276|FG001|STARTED|Overall Study||15
9683245|NCT03505099|10783275|FG000|Received AVXS-101|Overall Study||14
9683246|NCT03505099|10783276|FG001|Received AVXS-101|Overall Study||15
9683247|NCT03505099|10783275|FG000|COMPLETED|Overall Study||14
9683248|NCT03505099|10783276|FG001|COMPLETED|Overall Study||15
9683249|NCT03505099|10783275|FG000|NOT COMPLETED|Overall Study||0
9683250|NCT03505099|10783276|FG001|NOT COMPLETED|Overall Study||0
9683251|NCT03494647|10783284|FG000|STARTED|Overall Study||21
9683252|NCT03494647|10783285|FG001|STARTED|Overall Study||22
9683253|NCT03494647|10783284|FG000|COMPLETED|Overall Study||16
9683254|NCT03494647|10783285|FG001|COMPLETED|Overall Study||16
9683255|NCT03494647|10783284|FG000|NOT COMPLETED|Overall Study||5
9683256|NCT03494647|10783285|FG001|NOT COMPLETED|Overall Study||6
9844181|NCT00834808|10956089|FG002|COMPLETED|Treatment Period 2 (Day 8)||9
9844182|NCT00834808|10956087|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0
9844183|NCT00834808|10956088|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0
9844184|NCT00834808|10956089|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0
9844185|NCT00834808|10956087|FG000|STARTED|Treatment Period 3 (Day 15)||9
9844186|NCT00834808|10956088|FG001|STARTED|Treatment Period 3 (Day 15)||9
9683263|NCT03439657|10783302|FG000|STARTED|Overall Study||449
9683264|NCT03439657|10783303|FG001|STARTED|Overall Study||463
9683265|NCT03439657|10783302|FG000|COMPLETED|Overall Study||442
9683266|NCT03439657|10783303|FG001|COMPLETED|Overall Study||459
9683267|NCT03439657|10783302|FG000|NOT COMPLETED|Overall Study||7
9683268|NCT03439657|10783303|FG001|NOT COMPLETED|Overall Study||4
9844187|NCT00834808|10956089|FG002|STARTED|Treatment Period 3 (Day 15)||9
9844188|NCT00834808|10956087|FG000|COMPLETED|Treatment Period 3 (Day 15)||9
9844189|NCT00834808|10956088|FG001|COMPLETED|Treatment Period 3 (Day 15)||9
9844190|NCT00834808|10956089|FG002|COMPLETED|Treatment Period 3 (Day 15)||9
9844191|NCT00834808|10956087|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0
9844192|NCT00834808|10956088|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0
9844193|NCT00834808|10956089|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0
9844194|NCT00834834|10956099|FG000|STARTED|Overall Study||42
9844195|NCT00834834|10956100|FG001|STARTED|Overall Study||42
9844196|NCT00834834|10956099|FG000|COMPLETED|Overall Study||38
9844197|NCT00834834|10956100|FG001|COMPLETED|Overall Study||39
9844198|NCT00834834|10956099|FG000|NOT COMPLETED|Overall Study||4
9844199|NCT00834834|10956100|FG001|NOT COMPLETED|Overall Study||3
9844200|NCT00834886|10956110|FG000|STARTED|Overall Study||10
9844201|NCT00834886|10956111|FG001|STARTED|Overall Study||10
9844202|NCT00834886|10956112|FG002|STARTED|Overall Study||10
9844203|NCT00834886|10956113|FG003|STARTED|Overall Study||10
9844204|NCT00834886|10956110|FG000|COMPLETED|Overall Study||10
9844205|NCT00834886|10956111|FG001|COMPLETED|Overall Study||9
9844206|NCT00834886|10956112|FG002|COMPLETED|Overall Study||9
9844207|NCT00834886|10956113|FG003|COMPLETED|Overall Study||10
9844208|NCT00834886|10956110|FG000|NOT COMPLETED|Overall Study||0
9844209|NCT00834886|10956111|FG001|NOT COMPLETED|Overall Study||1
9844210|NCT00834886|10956112|FG002|NOT COMPLETED|Overall Study||1
9844211|NCT00834886|10956113|FG003|NOT COMPLETED|Overall Study||0
9844212|NCT00834899|10956125|FG000|STARTED|Overall Study||9
9844213|NCT00834899|10956126|FG001|STARTED|Overall Study||4
9844214|NCT00834899|10956125|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
9844215|NCT00834899|10956126|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
9844216|NCT00834899|10956125|FG000|NOT COMPLETED|Overall Study||1
9844217|NCT00834899|10956126|FG001|NOT COMPLETED|Overall Study||1
9844218|NCT00834912|10956138|FG000|STARTED|Treatment Period 1||6
9844219|NCT00834912|10956139|FG001|STARTED|Treatment Period 1||6
9844220|NCT00834912|10956140|FG002|STARTED|Treatment Period 1||6
9844221|NCT00834912|10956141|FG003|STARTED|Treatment Period 1||6
9844222|NCT00834912|10956142|FG004|STARTED|Treatment Period 1||6
9844223|NCT00834912|10956143|FG005|STARTED|Treatment Period 1||6
9844224|NCT00834912|10956138|FG000|COMPLETED|Treatment Period 1||6
9844225|NCT00834912|10956139|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
9844226|NCT00834912|10956140|FG002|COMPLETED|Treatment Period 1||6
9844227|NCT00834912|10956141|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
9844228|NCT00834912|10956142|FG004|COMPLETED|Treatment Period 1||6
9844229|NCT00834912|10956143|FG005|COMPLETED|Treatment Period 1||6
9844230|NCT00834912|10956138|FG000|NOT COMPLETED|Treatment Period 1||0
9844231|NCT00834912|10956139|FG001|NOT COMPLETED|Treatment Period 1||1
9844232|NCT00834912|10956140|FG002|NOT COMPLETED|Treatment Period 1||0
9844233|NCT00834912|10956141|FG003|NOT COMPLETED|Treatment Period 1||1
9683269|NCT03377790|10783313|FG000|STARTED|Overall Study||160
9683270|NCT03377790|10783314|FG001|STARTED|Overall Study||106
9683271|NCT03377790|10783313|FG000|COMPLETED|Overall Study||150
9683272|NCT03377790|10783314|FG001|COMPLETED|Overall Study||100
9683273|NCT03377790|10783313|FG000|NOT COMPLETED|Overall Study||10
9683274|NCT03377790|10783314|FG001|NOT COMPLETED|Overall Study||6
9844234|NCT00834912|10956142|FG004|NOT COMPLETED|Treatment Period 1||0
9844235|NCT00834912|10956143|FG005|NOT COMPLETED|Treatment Period 1||0
9844236|NCT00834912|10956138|FG000|STARTED|Treatment Period 2||6
9844237|NCT00834912|10956139|FG001|STARTED|Treatment Period 2||5
9844238|NCT00834912|10956140|FG002|STARTED|Treatment Period 2||6
9844239|NCT00834912|10956141|FG003|STARTED|Treatment Period 2||5
9844240|NCT00834912|10956142|FG004|STARTED|Treatment Period 2||6
9683275|NCT03353675|10783320|FG000|STARTED|Overall Study||44
9683276|NCT03353675|10783320|FG000|COMPLETED|Overall Study||40
9683277|NCT03353675|10783320|FG000|NOT COMPLETED|Overall Study||4
9683278|NCT03294109|10783326|FG000|STARTED|Overall Study||46
9683279|NCT03294109|10783327|FG001|STARTED|Overall Study||57
9683280|NCT03294109|10783326|FG000|Underwent Surgery|Overall Study||40
9683281|NCT03294109|10783327|FG001|Underwent Surgery|Overall Study||52
9683282|NCT03294109|10783326|FG000|COMPLETED|Overall Study||40
9683283|NCT03294109|10783327|FG001|COMPLETED|Overall Study||52
9683284|NCT03294109|10783326|FG000|NOT COMPLETED|Overall Study||6
9683285|NCT03294109|10783327|FG001|NOT COMPLETED|Overall Study||5
9683286|NCT03268005|10783336|FG000|STARTED|Overall Study||546
9683287|NCT03268005|10783337|FG001|STARTED|Overall Study||545
9683288|NCT03268005|10783336|FG000|Full Analysis Set|Overall Study||546
9683289|NCT03268005|10783337|FG001|Full Analysis Set|Overall Study||545
9683290|NCT03268005|10783336|FG000|Safety Analysis Set|Overall Study||544
9683291|NCT03268005|10783337|FG001|Safety Analysis Set|Overall Study||544
9683292|NCT03268005|10783336|FG000|COMPLETED|Overall Study||531
9683293|NCT03268005|10783337|FG001|COMPLETED|Overall Study||531
9683294|NCT03268005|10783336|FG000|NOT COMPLETED|Overall Study||15
9683295|NCT03268005|10783337|FG001|NOT COMPLETED|Overall Study||14
9683296|NCT03225170|10783346|FG000|STARTED|Overall Study||23
9683297|NCT03225170|10783347|FG001|STARTED|Overall Study||22
9683298|NCT03225170|10783348|FG002|STARTED|Overall Study||2
9683299|NCT03225170|10783346|FG000|COMPLETED|Overall Study||19
9683300|NCT03225170|10783347|FG001|COMPLETED|Overall Study||17
9683301|NCT03225170|10783348|FG002|COMPLETED|Overall Study||2
9683302|NCT03225170|10783346|FG000|NOT COMPLETED|Overall Study||4
9683303|NCT03225170|10783347|FG001|NOT COMPLETED|Overall Study||5
9683304|NCT03225170|10783348|FG002|NOT COMPLETED|Overall Study||0
9683305|NCT03220854|10783357|FG000|STARTED|Overall Study||4
9683306|NCT03220854|10783358|FG001|STARTED|Overall Study||0
9683307|NCT03220854|10783359|FG002|STARTED|Overall Study||1
9683308|NCT03220854|10783357|FG000|COMPLETED|Overall Study||4
9683309|NCT03220854|10783358|FG001|COMPLETED|Overall Study||0
9683310|NCT03220854|10783359|FG002|COMPLETED|Overall Study||1
9683311|NCT03220854|10783357|FG000|NOT COMPLETED|Overall Study||0
9683312|NCT03220854|10783358|FG001|NOT COMPLETED|Overall Study||0
9683313|NCT03220854|10783359|FG002|NOT COMPLETED|Overall Study||0
9683314|NCT03219034|10783372|FG000|STARTED|Overall Study||31
9683315|NCT03219034|10783373|FG001|STARTED|Overall Study||31
9683316|NCT03219034|10783372|FG000|COMPLETED|Overall Study||20
9683317|NCT03219034|10783373|FG001|COMPLETED|Overall Study||16
9683318|NCT03219034|10783372|FG000|NOT COMPLETED|Overall Study||11
9683319|NCT03219034|10783373|FG001|NOT COMPLETED|Overall Study||15
9683320|NCT03168438|10783383|FG000|STARTED|Overall Study||3
9683321|NCT03168438|10783384|FG001|STARTED|Overall Study||3
9683322|NCT03168438|10783383|FG000|COMPLETED|Overall Study||3
9683323|NCT03168438|10783384|FG001|COMPLETED|Overall Study||2
9683324|NCT03168438|10783383|FG000|NOT COMPLETED|Overall Study||0
9683325|NCT03168438|10783384|FG001|NOT COMPLETED|Overall Study||1
9683326|NCT03110380|10783393|FG000|STARTED|Double-Blind Treatment Phase||284
9683327|NCT03110380|10783394|FG001|STARTED|Double-Blind Treatment Phase||283
9683328|NCT03110380|10783395|FG002|STARTED|Double-Blind Treatment Phase||0
9683329|NCT03110380|10783396|FG003|STARTED|Double-Blind Treatment Phase||0
9683330|NCT03110380|10783393|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284
9683331|NCT03110380|10783394|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281
9683332|NCT03110380|10783395|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0
9683333|NCT03110380|10783396|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0
9683334|NCT03110380|10783393|FG000|COMPLETED|Double-Blind Treatment Phase||263
9683335|NCT03110380|10783394|FG001|COMPLETED|Double-Blind Treatment Phase||253
9683336|NCT03110380|10783395|FG002|COMPLETED|Double-Blind Treatment Phase||0
9683337|NCT03110380|10783396|FG003|COMPLETED|Double-Blind Treatment Phase||0
9683338|NCT03110380|10783393|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21
9683339|NCT03110380|10783394|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30
9683340|NCT03110380|10783395|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
9683341|NCT03110380|10783396|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
9683342|NCT03110380|10783393|FG000|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
9683343|NCT03110380|10783394|FG001|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
9683344|NCT03110380|10783395|FG002|STARTED|Open-label B/F/TAF Extension Phase|138 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|125
9683345|NCT03110380|10783396|FG003|STARTED|Open-label B/F/TAF Extension Phase|137 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|116
9683346|NCT03110380|10783393|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0
9683347|NCT03110380|10783394|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0
9683348|NCT03110380|10783395|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121
9683349|NCT03110380|10783396|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113
9683350|NCT03110380|10783393|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
9683351|NCT03110380|10783394|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
9683352|NCT03110380|10783395|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4
9683353|NCT03110380|10783396|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3
9683354|NCT03109262|10783404|FG000|STARTED|Overall Study||42
9683355|NCT03109262|10783404|FG000|COMPLETED|Overall Study||42
9683356|NCT03109262|10783404|FG000|NOT COMPLETED|Overall Study||0
9683357|NCT03078478|10783412|FG000|STARTED|Titration Period (16 Weeks)||805
9683358|NCT03078478|10783413|FG001|STARTED|Titration Period (16 Weeks)||804
9683359|NCT03078478|10783412|FG000|Full Analysis Set|Titration Period (16 Weeks)||805
9683360|NCT03078478|10783413|FG001|Full Analysis Set|Titration Period (16 Weeks)||804
9683361|NCT03078478|10783412|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802
9683362|NCT03078478|10783413|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798
9683363|NCT03078478|10783412|FG000|COMPLETED|Titration Period (16 Weeks)||805
9683364|NCT03078478|10783413|FG001|COMPLETED|Titration Period (16 Weeks)||804
9683365|NCT03078478|10783412|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0
9683366|NCT03078478|10783413|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0
9683367|NCT03078478|10783412|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805
9683368|NCT03078478|10783413|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804
9683369|NCT03078478|10783412|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758
9683370|NCT03078478|10783413|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761
9683371|NCT03078478|10783412|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
9683372|NCT03078478|10783413|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
9683373|NCT03078478|10783412|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758
9683374|NCT03078478|10783413|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761
9683375|NCT03078478|10783412|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733
9683376|NCT03078478|10783413|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734
9683377|NCT03078478|10783412|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
9683378|NCT03078478|10783413|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
9683379|NCT03040661|10783421|FG000|STARTED|Overall Study||35
9683380|NCT03040661|10783422|FG001|STARTED|Overall Study||35
9683381|NCT03040661|10783421|FG000|COMPLETED|Overall Study||35
9683382|NCT03040661|10783422|FG001|COMPLETED|Overall Study||35
9683383|NCT03040661|10783421|FG000|NOT COMPLETED|Overall Study||0
9683384|NCT03040661|10783422|FG001|NOT COMPLETED|Overall Study||0
9683385|NCT02993263|10783428|FG000|STARTED|Overall Study||323
9683386|NCT02993263|10783428|FG000|COMPLETED|Overall Study||0
9683387|NCT02993263|10783428|FG000|NOT COMPLETED|Overall Study||323
9683388|NCT02985684|10783432|FG000|STARTED|6-Month Clinical Success Evaluation||125
9683389|NCT02985684|10783432|FG000|COMPLETED|6-Month Clinical Success Evaluation||120
9683390|NCT02985684|10783432|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5
9683391|NCT02985684|10783432|FG000|STARTED|6-Month Closure Success Evaluation||120
9683392|NCT02985684|10783432|FG000|COMPLETED|6-Month Closure Success Evaluation||112
9683393|NCT02985684|10783432|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8
9683394|NCT02964897|10783438|FG000|STARTED|Overall Study||43
9683395|NCT02964897|10783439|FG001|STARTED|Overall Study||36
9683396|NCT02964897|10783438|FG000|COMPLETED|Overall Study||43
9683397|NCT02964897|10783439|FG001|COMPLETED|Overall Study||36
9683398|NCT02964897|10783438|FG000|NOT COMPLETED|Overall Study||0
9683399|NCT02964897|10783439|FG001|NOT COMPLETED|Overall Study||0
9683400|NCT02873195|10783447|FG000|STARTED|Overall Study||87
9683401|NCT02873195|10783448|FG001|STARTED|Overall Study||46
9683402|NCT02873195|10783447|FG000|Never Began Treatment (Cancel)|Overall Study||1
9683403|NCT02873195|10783448|FG001|Never Began Treatment (Cancel)|Overall Study||0
9683404|NCT02873195|10783447|FG000|COMPLETED|Overall Study||82
9683405|NCT02873195|10783448|FG001|COMPLETED|Overall Study||46
9683406|NCT02873195|10783447|FG000|NOT COMPLETED|Overall Study||5
9683407|NCT02873195|10783448|FG001|NOT COMPLETED|Overall Study||0
9683408|NCT02809131|10783456|FG000|STARTED|Overall Study||505
9683409|NCT02809131|10783457|FG001|STARTED|Overall Study||505
9683410|NCT02809131|10783456|FG000|COMPLETED|Overall Study||445
9683411|NCT02809131|10783457|FG001|COMPLETED|Overall Study||445
9683412|NCT02809131|10783456|FG000|NOT COMPLETED|Overall Study||60
9683413|NCT02809131|10783457|FG001|NOT COMPLETED|Overall Study||60
9844241|NCT00834912|10956143|FG005|STARTED|Treatment Period 2||6
9844242|NCT00834912|10956138|FG000|COMPLETED|Treatment Period 2||6
9844243|NCT00834912|10956139|FG001|COMPLETED|Treatment Period 2||5
9844244|NCT00834912|10956140|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
9844245|NCT00834912|10956141|FG003|COMPLETED|Treatment Period 2||5
9844246|NCT00834912|10956142|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
9844247|NCT00834912|10956143|FG005|COMPLETED|Treatment Period 2||6
9844248|NCT00834912|10956138|FG000|NOT COMPLETED|Treatment Period 2||0
9844249|NCT00834912|10956139|FG001|NOT COMPLETED|Treatment Period 2||0
9844250|NCT00834912|10956140|FG002|NOT COMPLETED|Treatment Period 2||1
9844251|NCT00834912|10956141|FG003|NOT COMPLETED|Treatment Period 2||0
9844252|NCT00834912|10956142|FG004|NOT COMPLETED|Treatment Period 2||1
9844253|NCT00834912|10956143|FG005|NOT COMPLETED|Treatment Period 2||0
9844254|NCT00834912|10956138|FG000|STARTED|Treatment Period 3||6
9844255|NCT00834912|10956139|FG001|STARTED|Treatment Period 3||5
9844256|NCT00834912|10956140|FG002|STARTED|Treatment Period 3||5
9844257|NCT00834912|10956141|FG003|STARTED|Treatment Period 3||5
9844258|NCT00834912|10956142|FG004|STARTED|Treatment Period 3||5
9844259|NCT00834912|10956143|FG005|STARTED|Treatment Period 3||6
9683414|NCT02785952|10783465|FG000|STARTED|Overall Study||125
9844260|NCT00834912|10956138|FG000|COMPLETED|Treatment Period 3||6
9844261|NCT00834912|10956139|FG001|COMPLETED|Treatment Period 3||5
9683415|NCT02785952|10783466|FG001|STARTED|Overall Study||127
9683416|NCT02785952|10783465|FG000|COMPLETED|Overall Study||0
9683417|NCT02785952|10783466|FG001|COMPLETED|Overall Study||0
9683418|NCT02785952|10783465|FG000|NOT COMPLETED|Overall Study||125
9683419|NCT02785952|10783466|FG001|NOT COMPLETED|Overall Study||127
9683420|NCT02758717|10783474|FG000|STARTED|Overall Study||46
9683421|NCT02758717|10783474|FG000|COMPLETED|Overall Study||46
9683422|NCT02758717|10783474|FG000|NOT COMPLETED|Overall Study||0
9683423|NCT02748616|10783478|FG000|STARTED|Overall Study||9
9683424|NCT02748616|10783478|FG000|COMPLETED|Overall Study||2
9683425|NCT02748616|10783478|FG000|NOT COMPLETED|Overall Study||7
9683426|NCT02719522|10783482|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
9683427|NCT02719522|10783482|FG000|COMPLETED|Overall Study||193
9683428|NCT02719522|10783482|FG000|NOT COMPLETED|Overall Study||11
9683429|NCT02664181|10783488|FG000|STARTED|Overall Study||8
9683430|NCT02664181|10783489|FG001|STARTED|Overall Study||5
9683431|NCT02664181|10783488|FG000|COMPLETED|Overall Study||8
9683432|NCT02664181|10783489|FG001|COMPLETED|Overall Study||5
9683433|NCT02664181|10783488|FG000|NOT COMPLETED|Overall Study||0
9683434|NCT02664181|10783489|FG001|NOT COMPLETED|Overall Study||0
9683435|NCT02633241|10783495|FG000|STARTED|Overall Study||30
9683436|NCT02633241|10783495|FG000|COMPLETED|Overall Study||27
9683437|NCT02633241|10783495|FG000|NOT COMPLETED|Overall Study||3
9683438|NCT02585232|10783503|FG000|STARTED|Overall Study||40
9683439|NCT02585232|10783504|FG001|STARTED|Overall Study||42
9683440|NCT02585232|10783503|FG000|COMPLETED|Overall Study||28
9683441|NCT02585232|10783504|FG001|COMPLETED|Overall Study||26
9683442|NCT02585232|10783503|FG000|NOT COMPLETED|Overall Study||12
9683443|NCT02585232|10783504|FG001|NOT COMPLETED|Overall Study||16
9683444|NCT02583269|10783515|FG000|STARTED|Overall Study||3
9683445|NCT02583269|10783516|FG001|STARTED|Overall Study||7
9683446|NCT02583269|10783517|FG002|STARTED|Overall Study||3
9683447|NCT02583269|10783518|FG003|STARTED|Overall Study||5
9683448|NCT02583269|10783519|FG004|STARTED|Overall Study||6
9683449|NCT02583269|10783515|FG000|COMPLETED|Overall Study||2
9683450|NCT02583269|10783516|FG001|COMPLETED|Overall Study||7
9683451|NCT02583269|10783517|FG002|COMPLETED|Overall Study||3
9683452|NCT02583269|10783518|FG003|COMPLETED|Overall Study||5
9683453|NCT02583269|10783519|FG004|COMPLETED|Overall Study||6
9683454|NCT02583269|10783515|FG000|NOT COMPLETED|Overall Study||1
9683455|NCT02583269|10783516|FG001|NOT COMPLETED|Overall Study||0
9683456|NCT02583269|10783517|FG002|NOT COMPLETED|Overall Study||0
9683457|NCT02583269|10783518|FG003|NOT COMPLETED|Overall Study||0
9683458|NCT02583269|10783519|FG004|NOT COMPLETED|Overall Study||0
9683459|NCT02556606|10783536|FG000|STARTED|Overall Study||4
9683460|NCT02556606|10783537|FG001|STARTED|Overall Study||5
9683461|NCT02556606|10783538|FG002|STARTED|Overall Study||11
9683462|NCT02556606|10783539|FG003|STARTED|Overall Study||13
9683463|NCT02556606|10783536|FG000|COMPLETED|Overall Study||4
9683464|NCT02556606|10783537|FG001|COMPLETED|Overall Study||5
9683465|NCT02556606|10783538|FG002|COMPLETED|Overall Study||11
9683466|NCT02556606|10783539|FG003|COMPLETED|Overall Study||13
9683467|NCT02556606|10783536|FG000|NOT COMPLETED|Overall Study||0
9683468|NCT02556606|10783537|FG001|NOT COMPLETED|Overall Study||0
9683469|NCT02556606|10783538|FG002|NOT COMPLETED|Overall Study||0
9683470|NCT02556606|10783539|FG003|NOT COMPLETED|Overall Study||0
9683471|NCT02545283|10783555|FG000|STARTED|Overall Study||149
9683472|NCT02545283|10783556|FG001|STARTED|Overall Study||298
9683473|NCT02545283|10783555|FG000|Received Treatment|Overall Study||149
9683474|NCT02545283|10783556|FG001|Received Treatment|Overall Study||292
9683475|NCT02545283|10783555|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149
9683476|NCT02545283|10783556|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292
9683477|NCT02545283|10783555|FG000|COMPLETED|Overall Study||0
9683478|NCT02545283|10783556|FG001|COMPLETED|Overall Study||0
9683479|NCT02545283|10783555|FG000|NOT COMPLETED|Overall Study||149
9683480|NCT02545283|10783556|FG001|NOT COMPLETED|Overall Study||298
9725435|NCT00094887|10825045|FG001|Intent to Treat Population|Overall Study||75
9725436|NCT00094887|10825044|FG000|Per Protocol Analysis Set|Overall Study||71
9725437|NCT00094887|10825045|FG001|Per Protocol Analysis Set|Overall Study||71
9725438|NCT00094887|10825044|FG000|Primary Efficacy Population|Overall Study||65
9725439|NCT00094887|10825045|FG001|Primary Efficacy Population|Overall Study||64
9725440|NCT00094887|10825044|FG000|COMPLETED|Overall Study||71
9725441|NCT00094887|10825045|FG001|COMPLETED|Overall Study||71
9725442|NCT00094887|10825044|FG000|NOT COMPLETED|Overall Study||4
9725443|NCT00094887|10825045|FG001|NOT COMPLETED|Overall Study||4
9725444|NCT00094900|10825051|FG000|STARTED|Overall Study||11
9725445|NCT00094900|10825051|FG000|COMPLETED|Overall Study||10
9725446|NCT00094900|10825051|FG000|NOT COMPLETED|Overall Study||1
9725447|NCT00095056|10825057|FG000|STARTED|Phase A (Weeks 0-12)||65
9725448|NCT00095056|10825058|FG001|STARTED|Phase A (Weeks 0-12)||26
9725449|NCT00095056|10825057|FG000|COMPLETED|Phase A (Weeks 0-12)||58
9725450|NCT00095056|10825058|FG001|COMPLETED|Phase A (Weeks 0-12)||25
9725451|NCT00095056|10825057|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7
9725452|NCT00095056|10825058|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1
9725453|NCT00095056|10825057|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
9725454|NCT00095056|10825058|FG001|STARTED|Phase B (Weeks 12-54)||25
9725455|NCT00095056|10825057|FG000|COMPLETED|Phase B (Weeks 12-54)||46
9725456|NCT00095056|10825058|FG001|COMPLETED|Phase B (Weeks 12-54)||20
9725457|NCT00095056|10825057|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10
9683481|NCT02524171|10783566|FG000|STARTED|6-month Follow-up||172
9683482|NCT02524171|10783567|FG001|STARTED|6-month Follow-up||169
9683483|NCT02524171|10783566|FG000|COMPLETED|6-month Follow-up||119
9683484|NCT02524171|10783567|FG001|COMPLETED|6-month Follow-up||124
9683485|NCT02524171|10783566|FG000|NOT COMPLETED|6-month Follow-up||53
9683486|NCT02524171|10783567|FG001|NOT COMPLETED|6-month Follow-up||45
9683487|NCT02524171|10783566|FG000|STARTED|12-month Follow-up Interview||172
9683488|NCT02524171|10783567|FG001|STARTED|12-month Follow-up Interview||169
9683489|NCT02524171|10783566|FG000|COMPLETED|12-month Follow-up Interview||127
9683490|NCT02524171|10783567|FG001|COMPLETED|12-month Follow-up Interview||128
9683491|NCT02524171|10783566|FG000|NOT COMPLETED|12-month Follow-up Interview||45
9683492|NCT02524171|10783567|FG001|NOT COMPLETED|12-month Follow-up Interview||41
9683493|NCT02489422|10783575|FG000|STARTED|Overall Study||23
9683494|NCT02489422|10783576|FG001|STARTED|Overall Study||21
9683495|NCT02489422|10783575|FG000|COMPLETED|Overall Study||23
9683496|NCT02489422|10783576|FG001|COMPLETED|Overall Study||21
9683497|NCT02489422|10783575|FG000|NOT COMPLETED|Overall Study||0
9683498|NCT02489422|10783576|FG001|NOT COMPLETED|Overall Study||0
9683499|NCT02487251|10783587|FG000|STARTED|Overall Study||434
9683500|NCT02487251|10783588|FG001|STARTED|Overall Study||65
9683501|NCT02487251|10783589|FG002|STARTED|Overall Study||152
9683502|NCT02487251|10783590|FG003|STARTED|Overall Study||159
9683503|NCT02487251|10783587|FG000|COMPLETED|Overall Study||366
9683504|NCT02487251|10783588|FG001|COMPLETED|Overall Study||55
9683505|NCT02487251|10783589|FG002|COMPLETED|Overall Study||125
9683506|NCT02487251|10783590|FG003|COMPLETED|Overall Study||134
9683507|NCT02487251|10783587|FG000|NOT COMPLETED|Overall Study||68
9683508|NCT02487251|10783588|FG001|NOT COMPLETED|Overall Study||10
9683509|NCT02487251|10783589|FG002|NOT COMPLETED|Overall Study||27
9683510|NCT02487251|10783590|FG003|NOT COMPLETED|Overall Study||25
9683511|NCT02476968|10783603|FG000|STARTED|Overall Study||145
9683512|NCT02476968|10783604|FG001|STARTED|Overall Study||33
9683513|NCT02476968|10783605|FG002|STARTED|Overall Study||3
9683514|NCT02476968|10783603|FG000|Received Treatment|Overall Study||143
9683515|NCT02476968|10783604|FG001|Received Treatment|Overall Study||32
9683516|NCT02476968|10783605|FG002|Received Treatment|Overall Study||2
9683517|NCT02476968|10783603|FG000|COMPLETED|Overall Study||71
9683518|NCT02476968|10783604|FG001|COMPLETED|Overall Study||18
9683519|NCT02476968|10783605|FG002|COMPLETED|Overall Study||1
9683520|NCT02476968|10783603|FG000|NOT COMPLETED|Overall Study||74
9683521|NCT02476968|10783604|FG001|NOT COMPLETED|Overall Study||15
9683522|NCT02476968|10783605|FG002|NOT COMPLETED|Overall Study||2
9683523|NCT02306122|10783622|FG000|STARTED|Initial Physician Randomization||0
9683524|NCT02306122|10783623|FG001|STARTED|Initial Physician Randomization||0
9683525|NCT02306122|10783624|FG002|STARTED|Initial Physician Randomization||0
9683526|NCT02306122|10783625|FG003|STARTED|Initial Physician Randomization||0
9683527|NCT02306122|10783626|FG004|STARTED|Initial Physician Randomization||0
9683528|NCT02306122|10783627|FG005|STARTED|Initial Physician Randomization||0
9683529|NCT02306122|10783628|FG006|STARTED|Initial Physician Randomization||0
9683530|NCT02306122|10783629|FG007|STARTED|Initial Physician Randomization||0
9683531|NCT02306122|10783630|FG008|STARTED|Initial Physician Randomization||29
9683532|NCT02306122|10783631|FG009|STARTED|Initial Physician Randomization||31
9683533|NCT02306122|10783632|FG010|STARTED|Initial Physician Randomization||31
9683534|NCT02306122|10783622|FG000|COMPLETED|Initial Physician Randomization||0
9683535|NCT02306122|10783623|FG001|COMPLETED|Initial Physician Randomization||0
9683536|NCT02306122|10783624|FG002|COMPLETED|Initial Physician Randomization||0
9683537|NCT02306122|10783625|FG003|COMPLETED|Initial Physician Randomization||0
9683538|NCT02306122|10783626|FG004|COMPLETED|Initial Physician Randomization||0
9683539|NCT02306122|10783627|FG005|COMPLETED|Initial Physician Randomization||0
9683540|NCT02306122|10783628|FG006|COMPLETED|Initial Physician Randomization||0
9683541|NCT02306122|10783629|FG007|COMPLETED|Initial Physician Randomization||0
9683542|NCT02306122|10783630|FG008|COMPLETED|Initial Physician Randomization||28
9683543|NCT02306122|10783631|FG009|COMPLETED|Initial Physician Randomization||31
9683544|NCT02306122|10783632|FG010|COMPLETED|Initial Physician Randomization||31
9683545|NCT02306122|10783622|FG000|NOT COMPLETED|Initial Physician Randomization||0
9683546|NCT02306122|10783623|FG001|NOT COMPLETED|Initial Physician Randomization||0
9683547|NCT02306122|10783624|FG002|NOT COMPLETED|Initial Physician Randomization||0
9683548|NCT02306122|10783625|FG003|NOT COMPLETED|Initial Physician Randomization||0
9683549|NCT02306122|10783626|FG004|NOT COMPLETED|Initial Physician Randomization||0
9683550|NCT02306122|10783627|FG005|NOT COMPLETED|Initial Physician Randomization||0
9683551|NCT02306122|10783628|FG006|NOT COMPLETED|Initial Physician Randomization||0
9683552|NCT02306122|10783629|FG007|NOT COMPLETED|Initial Physician Randomization||0
9683553|NCT02306122|10783630|FG008|NOT COMPLETED|Initial Physician Randomization||1
9683554|NCT02306122|10783631|FG009|NOT COMPLETED|Initial Physician Randomization||0
9683555|NCT02306122|10783632|FG010|NOT COMPLETED|Initial Physician Randomization||0
9683556|NCT02306122|10783622|FG000|STARTED|Post Nonadherence Subgroup Randomization||244
9683557|NCT02306122|10783623|FG001|STARTED|Post Nonadherence Subgroup Randomization||123
9683558|NCT02306122|10783624|FG002|STARTED|Post Nonadherence Subgroup Randomization||121
9683559|NCT02306122|10783625|FG003|STARTED|Post Nonadherence Subgroup Randomization||274
9683560|NCT02306122|10783626|FG004|STARTED|Post Nonadherence Subgroup Randomization||134
9683561|NCT02306122|10783627|FG005|STARTED|Post Nonadherence Subgroup Randomization||137
9683562|NCT02306122|10783628|FG006|STARTED|Post Nonadherence Subgroup Randomization||220
9683563|NCT02306122|10783629|FG007|STARTED|Post Nonadherence Subgroup Randomization||221
9683564|NCT02306122|10783630|FG008|STARTED|Post Nonadherence Subgroup Randomization||28
9683565|NCT02306122|10783631|FG009|STARTED|Post Nonadherence Subgroup Randomization||31
9844262|NCT00834912|10956140|FG002|COMPLETED|Treatment Period 3||5
9844263|NCT00834912|10956141|FG003|COMPLETED|Treatment Period 3||5
9844264|NCT00834912|10956142|FG004|COMPLETED|Treatment Period 3||5
9844265|NCT00834912|10956143|FG005|COMPLETED|Treatment Period 3||6
9844266|NCT00834912|10956138|FG000|NOT COMPLETED|Treatment Period 3||0
9844267|NCT00834912|10956139|FG001|NOT COMPLETED|Treatment Period 3||0
9844268|NCT00834912|10956140|FG002|NOT COMPLETED|Treatment Period 3||0
9844269|NCT00834912|10956141|FG003|NOT COMPLETED|Treatment Period 3||0
9844270|NCT00834912|10956142|FG004|NOT COMPLETED|Treatment Period 3||0
9844271|NCT00834912|10956143|FG005|NOT COMPLETED|Treatment Period 3||0
9844272|NCT00835003|10956153|FG000|STARTED|Overall Study||636
9844273|NCT00835003|10956154|FG001|STARTED|Overall Study||638
9844274|NCT00835003|10956153|FG000|COMPLETED|Overall Study||636
9844275|NCT00835003|10956154|FG001|COMPLETED|Overall Study||638
9844276|NCT00835003|10956153|FG000|NOT COMPLETED|Overall Study||0
9844277|NCT00835003|10956154|FG001|NOT COMPLETED|Overall Study||0
9844278|NCT00835068|10956162|FG000|STARTED|Overall Study||57
9844279|NCT00835068|10956163|FG001|STARTED|Overall Study||1
9844280|NCT00835068|10956162|FG000|COMPLETED|Overall Study||47
9844281|NCT00835068|10956163|FG001|COMPLETED|Overall Study||0
9844282|NCT00835068|10956162|FG000|NOT COMPLETED|Overall Study||10
9844283|NCT00835068|10956163|FG001|NOT COMPLETED|Overall Study||1
9844284|NCT00835120|10956169|FG000|STARTED|Overall Study||34
9844285|NCT00835120|10956169|FG000|COMPLETED|Overall Study||26
9844286|NCT00835120|10956169|FG000|NOT COMPLETED|Overall Study||8
9844287|NCT00835159|10956175|FG000|STARTED|Overall Study||11
9844288|NCT00835159|10956176|FG001|STARTED|Overall Study||17
9844289|NCT00835159|10956175|FG000|COMPLETED|Overall Study||11
9844290|NCT00835159|10956176|FG001|COMPLETED|Overall Study||17
9844291|NCT00835159|10956175|FG000|NOT COMPLETED|Overall Study||0
9844292|NCT00835159|10956176|FG001|NOT COMPLETED|Overall Study||0
9844293|NCT00835185|10956182|FG000|STARTED|Overall Study||44
9844294|NCT00835185|10956182|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44
9844295|NCT00835185|10956182|FG000|COMPLETED|Overall Study||44
9844296|NCT00835185|10956182|FG000|NOT COMPLETED|Overall Study||0
9844297|NCT00835198|10956189|FG000|STARTED|Overall Study||82
9844298|NCT00835198|10956190|FG001|STARTED|Overall Study||81
9844299|NCT00835198|10956189|FG000|COMPLETED|Overall Study||74
9844300|NCT00835198|10956190|FG001|COMPLETED|Overall Study||74
9844301|NCT00835198|10956189|FG000|NOT COMPLETED|Overall Study||8
9844302|NCT00835198|10956190|FG001|NOT COMPLETED|Overall Study||7
9844303|NCT00835224|10956196|FG000|STARTED|Overall Study||34
9844304|NCT00835224|10956196|FG000|COMPLETED|Overall Study||24
9844305|NCT00835224|10956196|FG000|NOT COMPLETED|Overall Study||10
9844306|NCT00835237|10956212|FG000|STARTED|Overall Study||887
9844307|NCT00835237|10956213|FG001|STARTED|Overall Study||445
9844308|NCT00835237|10956212|FG000|COMPLETED|Overall Study||881
9844309|NCT00835237|10956213|FG001|COMPLETED|Overall Study||445
9844310|NCT00835237|10956212|FG000|NOT COMPLETED|Overall Study||6
9844311|NCT00835237|10956213|FG001|NOT COMPLETED|Overall Study||0
9844312|NCT00835341|10956221|FG000|STARTED|Overall Study||35
9844313|NCT00835341|10956222|FG001|STARTED|Overall Study||58
9844314|NCT00835341|10956221|FG000|COMPLETED|Overall Study||32
9844315|NCT00835341|10956222|FG001|COMPLETED|Overall Study||46
9844316|NCT00835341|10956221|FG000|NOT COMPLETED|Overall Study||3
9844317|NCT00835341|10956222|FG001|NOT COMPLETED|Overall Study||12
9844318|NCT00835380|10956228|FG000|STARTED|Overall Study||80
9844319|NCT00835380|10956228|FG000|COMPLETED|Overall Study||78
9844320|NCT00835380|10956228|FG000|NOT COMPLETED|Overall Study||2
9844321|NCT00835510|10956235|FG000|STARTED|Overall Study||219
9844322|NCT00835510|10956236|FG001|STARTED|Overall Study||221
9844323|NCT00835510|10956237|FG002|STARTED|Overall Study||108
9844324|NCT00835510|10956235|FG000|Positive Fungal Culture|Overall Study||149
9844325|NCT00835510|10956236|FG001|Positive Fungal Culture|Overall Study||155
9844326|NCT00835510|10956237|FG002|Positive Fungal Culture|Overall Study||71
9844327|NCT00835510|10956235|FG000|COMPLETED|Overall Study||143
9844328|NCT00835510|10956236|FG001|COMPLETED|Overall Study||152
9844329|NCT00835510|10956237|FG002|COMPLETED|Overall Study||70
9844330|NCT00835510|10956235|FG000|NOT COMPLETED|Overall Study||76
9844331|NCT00835510|10956236|FG001|NOT COMPLETED|Overall Study||69
9844332|NCT00835510|10956237|FG002|NOT COMPLETED|Overall Study||38
9683566|NCT02306122|10783632|FG010|STARTED|Post Nonadherence Subgroup Randomization||31
9844333|NCT00835731|10956247|FG000|STARTED|Overall Study||64
9844334|NCT00835731|10956248|FG001|STARTED|Overall Study||61
9844335|NCT00835731|10956247|FG000|COMPLETED|Overall Study||62
9844336|NCT00835731|10956248|FG001|COMPLETED|Overall Study||60
9844337|NCT00835731|10956247|FG000|NOT COMPLETED|Overall Study||2
9844338|NCT00835731|10956248|FG001|NOT COMPLETED|Overall Study||1
9844339|NCT00835770|10956256|FG000|STARTED|Overall Study||868
9844340|NCT00835770|10956257|FG001|STARTED|Overall Study||868
9844341|NCT00835770|10956256|FG000|COMPLETED|Overall Study||384
9844342|NCT00835770|10956257|FG001|COMPLETED|Overall Study||375
9844343|NCT00835770|10956256|FG000|NOT COMPLETED|Overall Study||484
9844344|NCT00835770|10956257|FG001|NOT COMPLETED|Overall Study||493
9844345|NCT00835861|10956271|FG000|STARTED|Overall Study||15
9844346|NCT00835861|10956272|FG001|STARTED|Overall Study||16
9844347|NCT00835861|10956271|FG000|COMPLETED|Overall Study||14
9844348|NCT00835861|10956272|FG001|COMPLETED|Overall Study||14
9844349|NCT00835861|10956271|FG000|NOT COMPLETED|Overall Study||1
9844350|NCT00835861|10956272|FG001|NOT COMPLETED|Overall Study||2
9844351|NCT00835900|10956280|FG000|STARTED|Overall Study||32
9683567|NCT02306122|10783622|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244
9683568|NCT02306122|10783623|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123
9683569|NCT02306122|10783624|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121
9683570|NCT02306122|10783625|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274
9683571|NCT02306122|10783626|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134
9683572|NCT02306122|10783627|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137
9683573|NCT02306122|10783628|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220
9683574|NCT02306122|10783629|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221
9683575|NCT02306122|10783630|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28
9683576|NCT02306122|10783631|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31
9683577|NCT02306122|10783632|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31
9683578|NCT02306122|10783622|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683579|NCT02306122|10783623|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683580|NCT02306122|10783624|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683581|NCT02306122|10783625|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683582|NCT02306122|10783626|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683583|NCT02306122|10783627|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683584|NCT02306122|10783628|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683585|NCT02306122|10783629|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683586|NCT02306122|10783630|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683587|NCT02306122|10783631|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683588|NCT02306122|10783632|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
9683589|NCT02304991|10783652|FG000|STARTED|Overall Study||25
9683590|NCT02304991|10783653|FG001|STARTED|Overall Study||25
9683591|NCT02304991|10783652|FG000|COMPLETED|Overall Study||18
9683592|NCT02304991|10783653|FG001|COMPLETED|Overall Study||15
9683593|NCT02304991|10783652|FG000|NOT COMPLETED|Overall Study||7
9683594|NCT02304991|10783653|FG001|NOT COMPLETED|Overall Study||10
9683595|NCT02223520|10783661|FG000|STARTED|Overall Study||147
9683596|NCT02223520|10783662|FG001|STARTED|Overall Study||160
9683597|NCT02223520|10783661|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
9683598|NCT02223520|10783662|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
9683599|NCT02223520|10783661|FG000|NOT COMPLETED|Overall Study||0
9683600|NCT02223520|10783662|FG001|NOT COMPLETED|Overall Study||0
9683601|NCT02147184|10783670|FG000|STARTED|Overall Study||127
9683602|NCT02147184|10783671|FG001|STARTED|Overall Study||137
9683603|NCT02147184|10783670|FG000|COMPLETED|Overall Study||78
9683604|NCT02147184|10783671|FG001|COMPLETED|Overall Study||110
9683605|NCT02147184|10783670|FG000|NOT COMPLETED|Overall Study||49
9683606|NCT02147184|10783671|FG001|NOT COMPLETED|Overall Study||27
9683607|NCT02122198|10783679|FG000|STARTED|Overall Study||5
9683608|NCT02122198|10783680|FG001|STARTED|Overall Study||12
9683609|NCT02122198|10783679|FG000|COMPLETED|Overall Study||3
9683610|NCT02122198|10783680|FG001|COMPLETED|Overall Study||10
9683611|NCT02122198|10783679|FG000|NOT COMPLETED|Overall Study||2
9683612|NCT02122198|10783680|FG001|NOT COMPLETED|Overall Study||2
9683613|NCT02055053|10783689|FG000|STARTED|Overall Study||35
9683614|NCT02055053|10783690|FG001|STARTED|Overall Study||35
9683615|NCT02055053|10783689|FG000|COMPLETED|Overall Study||35
9683616|NCT02055053|10783690|FG001|COMPLETED|Overall Study||35
9683617|NCT02055053|10783689|FG000|NOT COMPLETED|Overall Study||0
9683618|NCT02055053|10783690|FG001|NOT COMPLETED|Overall Study||0
9683619|NCT02000219|10783696|FG000|STARTED|14-Week Study Period||12
9683620|NCT02000219|10783696|FG000|COMPLETED|14-Week Study Period||9
9683621|NCT02000219|10783696|FG000|NOT COMPLETED|14-Week Study Period||3
9683622|NCT02000219|10783696|FG000|STARTED|Continuation Period||8
9683623|NCT02000219|10783696|FG000|COMPLETED|Continuation Period||3
9683624|NCT02000219|10783696|FG000|NOT COMPLETED|Continuation Period||5
9683625|NCT01978938|10783702|FG000|STARTED|Overall Study||455
9683626|NCT01978938|10783703|FG001|STARTED|Overall Study||453
9683627|NCT01978938|10783702|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454
9683628|NCT01978938|10783703|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451
9683629|NCT01978938|10783702|FG000|COMPLETED|Overall Study||432
9683630|NCT01978938|10783703|FG001|COMPLETED|Overall Study||439
9683631|NCT01978938|10783702|FG000|NOT COMPLETED|Overall Study||23
9683632|NCT01978938|10783703|FG001|NOT COMPLETED|Overall Study||14
9683633|NCT01854385|10783709|FG000|STARTED|Pre-Treatment||40
9683634|NCT01854385|10783709|FG000|COMPLETED|Pre-Treatment||17
9683635|NCT01854385|10783709|FG000|NOT COMPLETED|Pre-Treatment||23
9683636|NCT01854385|10783709|FG000|STARTED|Treatment||17
9683637|NCT01854385|10783709|FG000|COMPLETED|Treatment||16
9683638|NCT01854385|10783709|FG000|NOT COMPLETED|Treatment||1
9683639|NCT01844856|10783715|FG000|STARTED|Overall Study||270
9683640|NCT01844856|10783716|FG001|STARTED|Overall Study||271
9683641|NCT01844856|10783715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270
9683642|NCT01844856|10783716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268
9683643|NCT01844856|10783715|FG000|COMPLETED|Overall Study||246
9683644|NCT01844856|10783716|FG001|COMPLETED|Overall Study||255
9683645|NCT01844856|10783715|FG000|NOT COMPLETED|Overall Study||24
9683646|NCT01844856|10783716|FG001|NOT COMPLETED|Overall Study||16
9683647|NCT01788306|10783724|FG000|STARTED|Overall Study||125
9683648|NCT01788306|10783725|FG001|STARTED|Overall Study||131
9683649|NCT01788306|10783724|FG000|COMPLETED|Overall Study||115
9683650|NCT01788306|10783725|FG001|COMPLETED|Overall Study||126
9683651|NCT01788306|10783724|FG000|NOT COMPLETED|Overall Study||10
9683652|NCT01788306|10783725|FG001|NOT COMPLETED|Overall Study||5
9683653|NCT01744041|10783739|FG000|STARTED|Overall Study||21
9683654|NCT01744041|10783740|FG001|STARTED|Overall Study||21
9683655|NCT01744041|10783739|FG000|COMPLETED|Overall Study||15
9683656|NCT01744041|10783740|FG001|COMPLETED|Overall Study||13
9683657|NCT01744041|10783739|FG000|NOT COMPLETED|Overall Study||6
9683658|NCT01744041|10783740|FG001|NOT COMPLETED|Overall Study||8
9683659|NCT01733147|10783748|FG000|STARTED|Overall Study||30
9683660|NCT01733147|10783749|FG001|STARTED|Overall Study||30
9683661|NCT01733147|10783748|FG000|COMPLETED|Overall Study||30
9683662|NCT01733147|10783749|FG001|COMPLETED|Overall Study||30
9683663|NCT01733147|10783748|FG000|NOT COMPLETED|Overall Study||0
9683664|NCT01733147|10783749|FG001|NOT COMPLETED|Overall Study||0
9683665|NCT01712789|10783755|FG000|STARTED|Overall Study||682
9683666|NCT01712789|10783755|FG000|Received Study Treatment|Overall Study||676
9683667|NCT01712789|10783755|FG000|COMPLETED|Overall Study||0
9683668|NCT01712789|10783755|FG000|NOT COMPLETED|Overall Study||682
9683669|NCT01651403|10783761|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60
9683670|NCT01651403|10783762|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30
9683671|NCT01651403|10783761|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56
9683672|NCT01651403|10783762|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25
9683673|NCT01651403|10783761|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
9683674|NCT01651403|10783762|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
9683675|NCT01651403|10783761|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56
9683676|NCT01651403|10783762|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25
9683677|NCT01651403|10783761|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
9683678|NCT01651403|10783762|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
9683679|NCT01651403|10783761|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
9683680|NCT01651403|10783762|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
9725458|NCT00095056|10825058|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5
9725459|NCT00095121|10825066|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
9725460|NCT00095121|10825067|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
9725461|NCT00095121|10825066|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
9725462|NCT00095121|10825067|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
9725463|NCT00095121|10825066|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
9683681|NCT01543633|10783773|FG000|STARTED|Overall Study||36
9683682|NCT01543633|10783773|FG000|COMPLETED|Overall Study||17
9683683|NCT01543633|10783773|FG000|NOT COMPLETED|Overall Study||19
9683684|NCT01542736|10783777|FG000|STARTED|Overall Study||8
9683685|NCT01542736|10783777|FG000|COMPLETED|Overall Study||7
9683686|NCT01542736|10783777|FG000|NOT COMPLETED|Overall Study||1
9683687|NCT01535807|10783783|FG000|STARTED|Overall Study||22
9683688|NCT01535807|10783784|FG001|STARTED|Overall Study||22
9683689|NCT01535807|10783783|FG000|COMPLETED|Overall Study||20
9683690|NCT01535807|10783784|FG001|COMPLETED|Overall Study||20
9683691|NCT01535807|10783783|FG000|NOT COMPLETED|Overall Study||2
9683692|NCT01535807|10783784|FG001|NOT COMPLETED|Overall Study||2
9683693|NCT01147666|10783805|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12
9683694|NCT01147666|10783806|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12
9683695|NCT01147666|10783807|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12
9683696|NCT01147666|10783808|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12
9683697|NCT01147666|10783809|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12
9683698|NCT01147666|10783810|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12
9683699|NCT01147666|10783811|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12
9683700|NCT01147666|10783812|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12
9683701|NCT01147666|10783813|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2
9683702|NCT01147666|10783814|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10
9683703|NCT01147666|10783815|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36
9683704|NCT01147666|10783816|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4
9683705|NCT01147666|10783817|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5
9683706|NCT01147666|10783818|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4
9683707|NCT01147666|10783819|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4
9683708|NCT01147666|10783805|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683709|NCT01147666|10783806|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683710|NCT01147666|10783807|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683711|NCT01147666|10783808|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683712|NCT01147666|10783809|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683713|NCT01147666|10783810|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683714|NCT01147666|10783811|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683715|NCT01147666|10783812|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
9683716|NCT01147666|10783813|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2
9683717|NCT01147666|10783814|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10
9683718|NCT01147666|10783815|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36
9683719|NCT01147666|10783816|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
9683720|NCT01147666|10783817|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5
9683721|NCT01147666|10783818|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
9683722|NCT01147666|10783819|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
9683723|NCT01147666|10783805|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
9683724|NCT01147666|10783806|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
9683725|NCT01147666|10783807|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
9683726|NCT01147666|10783808|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
9683727|NCT01147666|10783809|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
9683728|NCT01147666|10783810|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
9683729|NCT01147666|10783811|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
9683730|NCT01147666|10783812|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
9683731|NCT01147666|10783813|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2
9683732|NCT01147666|10783814|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
9683733|NCT01147666|10783815|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31
9683734|NCT01147666|10783816|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1
9683735|NCT01147666|10783817|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
9683736|NCT01147666|10783818|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4
9683737|NCT01147666|10783819|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
10023433|NCT01855945|11147011|FG011|NOT COMPLETED|Overall Study||3
10023434|NCT01855958|11147076|FG000|STARTED|Overall Study||13
10023435|NCT01855958|11147077|FG001|STARTED|Overall Study||13
10023436|NCT01855958|11147076|FG000|COMPLETED|Overall Study||12
10023437|NCT01855958|11147077|FG001|COMPLETED|Overall Study||13
10023438|NCT01855958|11147076|FG000|NOT COMPLETED|Overall Study||1
10023439|NCT01855958|11147077|FG001|NOT COMPLETED|Overall Study||0
10023440|NCT01855997|11147085|FG000|STARTED|Overall Study||1669
10023441|NCT01855997|11147085|FG000|COMPLETED|Overall Study||1669
9683738|NCT01147666|10783805|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10
9683739|NCT01147666|10783806|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10
9683740|NCT01147666|10783807|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11
9683741|NCT01147666|10783808|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10
9683742|NCT01147666|10783809|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7
9683743|NCT01147666|10783810|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9
10023442|NCT01855997|11147085|FG000|NOT COMPLETED|Overall Study||0
9683744|NCT01147666|10783811|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9
9683745|NCT01147666|10783812|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9
9683746|NCT01147666|10783813|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2
9683747|NCT01147666|10783814|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8
9683748|NCT01147666|10783815|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33
9683749|NCT01147666|10783816|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2
9683750|NCT01147666|10783817|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1
9683751|NCT01147666|10783818|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3
9683752|NCT01147666|10783819|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0
9683753|NCT01147666|10783805|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
9683754|NCT01147666|10783806|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
9683755|NCT01147666|10783807|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
9683756|NCT01147666|10783808|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
9960759|NCT01469013|11080378|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
9960760|NCT01469013|11080379|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
9960761|NCT01469013|11080367|FG000|COMPLETED|Part B (Extension Period)||0
9960762|NCT01469013|11080368|FG001|COMPLETED|Part B (Extension Period)||0
9960763|NCT01469013|11080369|FG002|COMPLETED|Part B (Extension Period)||0
10023443|NCT01856114|11147099|FG000|STARTED|Overall Study||11
10023444|NCT01856114|11147100|FG001|STARTED|Overall Study||11
10023445|NCT01856114|11147099|FG000|COMPLETED|Overall Study||9
10023446|NCT01856114|11147100|FG001|COMPLETED|Overall Study||11
9683757|NCT01147666|10783809|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5
9683758|NCT01147666|10783810|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
9683759|NCT01147666|10783811|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
9683760|NCT01147666|10783812|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
9683761|NCT01147666|10783813|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0
9683762|NCT01147666|10783814|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
9683763|NCT01147666|10783815|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
9683764|NCT01147666|10783816|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
9683765|NCT01147666|10783817|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
9683766|NCT01147666|10783818|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
9683767|NCT01147666|10783819|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
9683768|NCT01147666|10783805|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0
9683769|NCT01147666|10783806|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0
9683770|NCT01147666|10783807|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0
9683771|NCT01147666|10783808|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7
9683772|NCT01147666|10783809|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12
9683773|NCT01147666|10783810|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12
9683774|NCT01147666|10783811|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12
9683775|NCT01147666|10783812|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12
9683776|NCT01147666|10783813|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2
9683777|NCT01147666|10783814|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10
9683778|NCT01147666|10783815|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23
9683779|NCT01147666|10783816|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0
9683780|NCT01147666|10783817|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5
9683781|NCT01147666|10783818|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3
9683782|NCT01147666|10783819|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3
9683783|NCT01147666|10783805|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
9683784|NCT01147666|10783806|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
9683785|NCT01147666|10783807|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
9683786|NCT01147666|10783808|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7
9683787|NCT01147666|10783809|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
9683788|NCT01147666|10783810|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
9683789|NCT01147666|10783811|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
9683790|NCT01147666|10783812|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
9683791|NCT01147666|10783813|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2
9683792|NCT01147666|10783814|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10
9683793|NCT01147666|10783815|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23
9683794|NCT01147666|10783816|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
9683795|NCT01147666|10783817|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5
9683796|NCT01147666|10783818|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
9683797|NCT01147666|10783819|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
9683798|NCT01147666|10783805|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
9683799|NCT01147666|10783806|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
9683800|NCT01147666|10783807|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
9683801|NCT01147666|10783808|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6
9683802|NCT01147666|10783809|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
9683803|NCT01147666|10783810|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
9683804|NCT01147666|10783811|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
9683805|NCT01147666|10783812|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
9683806|NCT01147666|10783813|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
9683807|NCT01147666|10783814|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
9683808|NCT01147666|10783815|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22
9683809|NCT01147666|10783816|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
9683810|NCT01147666|10783817|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
9683811|NCT01147666|10783818|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
9683812|NCT01147666|10783819|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
9683813|NCT01147666|10783805|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683814|NCT01147666|10783806|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683815|NCT01147666|10783807|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683816|NCT01147666|10783808|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5
9683817|NCT01147666|10783809|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7
9683818|NCT01147666|10783810|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9
9683819|NCT01147666|10783811|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9
9683820|NCT01147666|10783812|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9
9683821|NCT01147666|10783813|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2
9683822|NCT01147666|10783814|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8
9683823|NCT01147666|10783815|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21
9683824|NCT01147666|10783816|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683825|NCT01147666|10783817|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1
9683826|NCT01147666|10783818|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2
9683827|NCT01147666|10783819|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683828|NCT01147666|10783805|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683829|NCT01147666|10783806|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683830|NCT01147666|10783807|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683831|NCT01147666|10783808|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
9683832|NCT01147666|10783809|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5
9683833|NCT01147666|10783810|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
9683834|NCT01147666|10783811|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
9683835|NCT01147666|10783812|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
9683836|NCT01147666|10783813|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683837|NCT01147666|10783814|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
9683838|NCT01147666|10783815|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
9683839|NCT01147666|10783816|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
9683840|NCT01147666|10783817|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4
9683841|NCT01147666|10783818|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1
9683842|NCT01147666|10783819|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
9844352|NCT00835900|10956281|FG001|STARTED|Overall Study||28
9844353|NCT00835900|10956280|FG000|COMPLETED|Overall Study||27
9844354|NCT00835900|10956281|FG001|COMPLETED|Overall Study||22
9844355|NCT00835900|10956280|FG000|NOT COMPLETED|Overall Study||5
9844356|NCT00835900|10956281|FG001|NOT COMPLETED|Overall Study||6
9844357|NCT00835926|10956289|FG000|STARTED|Overall Study||61
9844358|NCT00835926|10956290|FG001|STARTED|Overall Study||60
9844359|NCT00835926|10956289|FG000|COMPLETED|Overall Study||61
9844360|NCT00835926|10956290|FG001|COMPLETED|Overall Study||60
9844361|NCT00835926|10956289|FG000|NOT COMPLETED|Overall Study||0
9844362|NCT00835926|10956290|FG001|NOT COMPLETED|Overall Study||0
9844363|NCT00835978|10956300|FG000|STARTED|Overall Study||56
9844364|NCT00835978|10956301|FG001|STARTED|Overall Study||56
9844365|NCT00835978|10956302|FG002|STARTED|Overall Study||91
9844366|NCT00835978|10956303|FG003|STARTED|Overall Study||10
9844367|NCT00835978|10956300|FG000|Treated|Overall Study||56
9844368|NCT00835978|10956301|FG001|Treated|Overall Study||56
9844369|NCT00835978|10956302|FG002|Treated|Overall Study||91
9844370|NCT00835978|10956303|FG003|Treated|Overall Study||10
9844371|NCT00835978|10956300|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
9844372|NCT00835978|10956301|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
9844373|NCT00835978|10956302|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
9844374|NCT00835978|10956303|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
9844375|NCT00835978|10956300|FG000|NOT COMPLETED|Overall Study||56
9844376|NCT00835978|10956301|FG001|NOT COMPLETED|Overall Study||56
9844377|NCT00835978|10956302|FG002|NOT COMPLETED|Overall Study||91
9844378|NCT00835978|10956303|FG003|NOT COMPLETED|Overall Study||10
9844379|NCT00836017|10956318|FG000|STARTED|Overall Study||1046
9844380|NCT00836017|10956318|FG000|COMPLETED|Overall Study||502
9844381|NCT00836017|10956318|FG000|NOT COMPLETED|Overall Study||544
9844382|NCT00836095|10956324|FG000|STARTED|Overall Study||22
9844383|NCT00836095|10956325|FG001|STARTED|Overall Study||30
9844384|NCT00836095|10956324|FG000|COMPLETED|Overall Study||22
9844385|NCT00836095|10956325|FG001|COMPLETED|Overall Study||27
9844386|NCT00836095|10956324|FG000|NOT COMPLETED|Overall Study||0
9844387|NCT00836095|10956325|FG001|NOT COMPLETED|Overall Study||3
9844388|NCT00836186|10956331|FG000|STARTED|Overall Study||82
9844389|NCT00836186|10956331|FG000|COMPLETED|Overall Study||81
9844390|NCT00836186|10956331|FG000|NOT COMPLETED|Overall Study||1
9844391|NCT00836277|10956336|FG000|STARTED|Overall Study||24
9844392|NCT00836277|10956336|FG000|COMPLETED|Overall Study||18
9844393|NCT00836277|10956336|FG000|NOT COMPLETED|Overall Study||6
9844394|NCT00836342|10956343|FG000|STARTED|Overall Study||22
9844395|NCT00836342|10956344|FG001|STARTED|Overall Study||23
9844396|NCT00836342|10956345|FG002|STARTED|Overall Study||36
9844397|NCT00836342|10956343|FG000|COMPLETED|Overall Study||22
9844398|NCT00836342|10956344|FG001|COMPLETED|Overall Study||23
9844399|NCT00836342|10956345|FG002|COMPLETED|Overall Study||36
9844400|NCT00836342|10956343|FG000|NOT COMPLETED|Overall Study||0
9844401|NCT00836342|10956344|FG001|NOT COMPLETED|Overall Study||0
9844402|NCT00836342|10956345|FG002|NOT COMPLETED|Overall Study||0
9844403|NCT00836407|10956357|FG000|STARTED|Overall Study||15
9844404|NCT00836407|10956358|FG001|STARTED|Overall Study||15
9844405|NCT00836407|10956357|FG000|COMPLETED|Overall Study||4
9844406|NCT00836407|10956358|FG001|COMPLETED|Overall Study||7
9844407|NCT00836407|10956357|FG000|NOT COMPLETED|Overall Study||11
9844408|NCT00836407|10956358|FG001|NOT COMPLETED|Overall Study||8
9844409|NCT00836433|10956366|FG000|STARTED|Overall Study||361
9844410|NCT00836433|10956367|FG001|STARTED|Overall Study||328
9844411|NCT00836433|10956366|FG000|COMPLETED|Overall Study||349
9844412|NCT00836433|10956367|FG001|COMPLETED|Overall Study||321
9844413|NCT00836433|10956366|FG000|NOT COMPLETED|Overall Study||12
9844414|NCT00836433|10956367|FG001|NOT COMPLETED|Overall Study||7
9844415|NCT00836498|10956377|FG000|STARTED|Overall Study||44
9844416|NCT00836498|10956378|FG001|STARTED|Overall Study||22
9683843|NCT00982111|10783883|FG000|STARTED|Overall Study||315
9683844|NCT00982111|10783884|FG001|STARTED|Overall Study||318
9683845|NCT00982111|10783883|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
9683846|NCT00982111|10783884|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312
9683847|NCT00982111|10783883|FG000|Death Due to Any Cause|Overall Study||236
9683848|NCT00982111|10783884|FG001|Death Due to Any Cause|Overall Study||246
9683849|NCT00982111|10783883|FG000|COMPLETED|Overall Study||236
9683850|NCT00982111|10783884|FG001|COMPLETED|Overall Study||246
9683851|NCT00982111|10783883|FG000|NOT COMPLETED|Overall Study||79
9683852|NCT00982111|10783884|FG001|NOT COMPLETED|Overall Study||72
9683853|NCT00193219|10783891|FG000|STARTED|Overall Study||36
9683854|NCT00193219|10783891|FG000|COMPLETED|Overall Study||6
9683855|NCT00193219|10783891|FG000|NOT COMPLETED|Overall Study||30
9683856|NCT00116142|10783898|FG000|STARTED|Overall Study||175
9683857|NCT00116142|10783899|FG001|STARTED|Overall Study||175
9683858|NCT00116142|10783898|FG000|Treated|Overall Study||174
9683859|NCT00116142|10783899|FG001|Treated|Overall Study||171
9683860|NCT00116142|10783898|FG000|COMPLETED|Overall Study||156
9683861|NCT00116142|10783899|FG001|COMPLETED|Overall Study||155
9683862|NCT00116142|10783898|FG000|NOT COMPLETED|Overall Study||19
9683863|NCT00116142|10783899|FG001|NOT COMPLETED|Overall Study||20
9683864|NCT00070018|10783908|FG000|STARTED|Overall Study||46
9683865|NCT00070018|10783908|FG000|Eligible|Overall Study||46
9683866|NCT00070018|10783908|FG000|Eligible and Began Protocol Therapy|Overall Study||46
9683867|NCT00070018|10783908|FG000|COMPLETED|Overall Study||42
9683868|NCT00070018|10783908|FG000|NOT COMPLETED|Overall Study||4
9725464|NCT00095121|10825067|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
9725465|NCT00095121|10825066|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108
9725466|NCT00095121|10825067|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54
9725467|NCT00095121|10825066|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
9725468|NCT00095121|10825067|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
9725469|NCT00095121|10825066|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
9725470|NCT00095121|10825067|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
9725471|NCT00095121|10825066|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
9725472|NCT00095121|10825067|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
9725473|NCT00095147|10825086|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156
9725474|NCT00095147|10825087|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165
9725475|NCT00095147|10825088|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110
9725476|NCT00095147|10825089|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0
9725477|NCT00095147|10825090|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0
9725478|NCT00095147|10825086|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147
9725479|NCT00095147|10825087|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152
9725480|NCT00095147|10825088|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107
9725481|NCT00095147|10825089|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0
9725482|NCT00095147|10825090|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0
9725483|NCT00095147|10825086|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
9725484|NCT00095147|10825087|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
9725485|NCT00095147|10825088|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
9725486|NCT00095147|10825089|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
9725487|NCT00095147|10825090|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
9725488|NCT00095147|10825086|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147
9725489|NCT00095147|10825087|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152
9725490|NCT00095147|10825088|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0
9725491|NCT00095147|10825089|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107
9725492|NCT00095147|10825090|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0
9725493|NCT00095147|10825086|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139
9725494|NCT00095147|10825087|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141
9725495|NCT00095147|10825088|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0
9725496|NCT00095147|10825089|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104
9725497|NCT00095147|10825090|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0
9725498|NCT00095147|10825086|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
9725499|NCT00095147|10825087|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
9725500|NCT00095147|10825088|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
9725501|NCT00095147|10825089|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
9725502|NCT00095147|10825090|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
9725503|NCT00095147|10825086|FG000|STARTED|Long-term Extension Period||0
9725504|NCT00095147|10825087|FG001|STARTED|Long-term Extension Period||0
9725505|NCT00095147|10825088|FG002|STARTED|Long-term Extension Period||0
9725506|NCT00095147|10825089|FG003|STARTED|Long-term Extension Period||0
9725507|NCT00095147|10825090|FG004|STARTED|Long-term Extension Period||372
9725508|NCT00095147|10825086|FG000|COMPLETED|Long-term Extension Period||0
9725509|NCT00095147|10825087|FG001|COMPLETED|Long-term Extension Period||0
9725510|NCT00095147|10825088|FG002|COMPLETED|Long-term Extension Period||0
9725511|NCT00095147|10825089|FG003|COMPLETED|Long-term Extension Period||0
9725512|NCT00095147|10825090|FG004|COMPLETED|Long-term Extension Period||327
9725513|NCT00095147|10825086|FG000|NOT COMPLETED|Long-term Extension Period||0
9725514|NCT00095147|10825087|FG001|NOT COMPLETED|Long-term Extension Period||0
9683869|NCT04631796|10783912|FG000|STARTED|Overall Study||35
9683870|NCT04631796|10783912|FG000|COMPLETED|Overall Study||35
9683871|NCT04631796|10783912|FG000|NOT COMPLETED|Overall Study||0
9683872|NCT04447287|10783921|FG000|STARTED|Period 1: Run-in Period||23
9683873|NCT04447287|10783922|FG001|STARTED|Period 1: Run-in Period||0
9683874|NCT04447287|10783923|FG002|STARTED|Period 1: Run-in Period||0
9683875|NCT04447287|10783921|FG000|COMPLETED|Period 1: Run-in Period||19
9683876|NCT04447287|10783922|FG001|COMPLETED|Period 1: Run-in Period||0
9683877|NCT04447287|10783923|FG002|COMPLETED|Period 1: Run-in Period||0
9683878|NCT04447287|10783921|FG000|NOT COMPLETED|Period 1: Run-in Period||4
9683879|NCT04447287|10783922|FG001|NOT COMPLETED|Period 1: Run-in Period||0
9683880|NCT04447287|10783923|FG002|NOT COMPLETED|Period 1: Run-in Period||0
9683881|NCT04447287|10783921|FG000|STARTED|Period 2: Investigational Period||1
9683882|NCT04447287|10783922|FG001|STARTED|Period 2: Investigational Period||12
9683883|NCT04447287|10783923|FG002|STARTED|Period 2: Investigational Period||6
9683884|NCT04447287|10783921|FG000|COMPLETED|Period 2: Investigational Period||0
9683885|NCT04447287|10783922|FG001|COMPLETED|Period 2: Investigational Period||12
9683886|NCT04447287|10783923|FG002|COMPLETED|Period 2: Investigational Period||6
9683887|NCT04447287|10783921|FG000|NOT COMPLETED|Period 2: Investigational Period||1
9683888|NCT04447287|10783922|FG001|NOT COMPLETED|Period 2: Investigational Period||0
9683889|NCT04447287|10783923|FG002|NOT COMPLETED|Period 2: Investigational Period||0
9683890|NCT04447287|10783921|FG000|STARTED|Period 3: Down-Titration Period||0
9683891|NCT04447287|10783922|FG001|STARTED|Period 3: Down-Titration Period||12
9683892|NCT04447287|10783923|FG002|STARTED|Period 3: Down-Titration Period||6
9683893|NCT04447287|10783921|FG000|COMPLETED|Period 3: Down-Titration Period||0
9683894|NCT04447287|10783922|FG001|COMPLETED|Period 3: Down-Titration Period||12
9683895|NCT04447287|10783923|FG002|COMPLETED|Period 3: Down-Titration Period||6
9683896|NCT04447287|10783921|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0
9683897|NCT04447287|10783922|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0
9683898|NCT04447287|10783923|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0
9683899|NCT04203537|10783946|FG000|STARTED|Overall Study||6
9683900|NCT04203537|10783947|FG001|STARTED|Overall Study||6
9683901|NCT04203537|10783948|FG002|STARTED|Overall Study||6
9683902|NCT04203537|10783949|FG003|STARTED|Overall Study||6
9683903|NCT04203537|10783950|FG004|STARTED|Overall Study||54
9683904|NCT04203537|10783951|FG005|STARTED|Overall Study||55
9683905|NCT04203537|10783952|FG006|STARTED|Overall Study||60
9683906|NCT04203537|10783946|FG000|COMPLETED|Overall Study||6
9683907|NCT04203537|10783947|FG001|COMPLETED|Overall Study||6
9683908|NCT04203537|10783948|FG002|COMPLETED|Overall Study||6
9683909|NCT04203537|10783949|FG003|COMPLETED|Overall Study||6
9683910|NCT04203537|10783950|FG004|COMPLETED|Overall Study||54
9683911|NCT04203537|10783951|FG005|COMPLETED|Overall Study||55
9683912|NCT04203537|10783952|FG006|COMPLETED|Overall Study||60
9683913|NCT04203537|10783946|FG000|NOT COMPLETED|Overall Study||0
9683914|NCT04203537|10783947|FG001|NOT COMPLETED|Overall Study||0
9683915|NCT04203537|10783948|FG002|NOT COMPLETED|Overall Study||0
9683916|NCT04203537|10783949|FG003|NOT COMPLETED|Overall Study||0
9683917|NCT04203537|10783950|FG004|NOT COMPLETED|Overall Study||0
9683918|NCT04203537|10783951|FG005|NOT COMPLETED|Overall Study||0
9683919|NCT04203537|10783952|FG006|NOT COMPLETED|Overall Study||0
9683920|NCT04125745|10783962|FG000|STARTED|Overall Study||1
9683921|NCT04125745|10783962|FG000|COMPLETED|Overall Study||1
9683922|NCT04125745|10783962|FG000|NOT COMPLETED|Overall Study||0
9683923|NCT04074928|10783968|FG000|STARTED|Overall Study||1605
9683924|NCT04074928|10783969|FG001|STARTED|Overall Study||809
9683925|NCT04074928|10783968|FG000|Received Study Vaccine|Overall Study||1597
9683926|NCT04074928|10783969|FG001|Received Study Vaccine|Overall Study||805
9683927|NCT04074928|10783968|FG000|COMPLETED|Overall Study||1370
9683928|NCT04074928|10783969|FG001|COMPLETED|Overall Study||710
9683929|NCT04074928|10783968|FG000|NOT COMPLETED|Overall Study||235
9683930|NCT04074928|10783969|FG001|NOT COMPLETED|Overall Study||99
9683931|NCT04039503|10783979|FG000|STARTED|Overall Study||116
9683932|NCT04039503|10783980|FG001|STARTED|Overall Study||119
9683933|NCT04039503|10783981|FG002|STARTED|Overall Study||120
9683934|NCT04039503|10783982|FG003|STARTED|Overall Study||120
9683935|NCT04039503|10783979|FG000|Received at Least One Dose of Study Drug|Overall Study||116
9683936|NCT04039503|10783980|FG001|Received at Least One Dose of Study Drug|Overall Study||119
9683937|NCT04039503|10783981|FG002|Received at Least One Dose of Study Drug|Overall Study||120
9683938|NCT04039503|10783982|FG003|Received at Least One Dose of Study Drug|Overall Study||120
9683939|NCT04039503|10783979|FG000|COMPLETED|Overall Study||109
9683940|NCT04039503|10783980|FG001|COMPLETED|Overall Study||115
9683941|NCT04039503|10783981|FG002|COMPLETED|Overall Study||110
9683942|NCT04039503|10783982|FG003|COMPLETED|Overall Study||117
9683943|NCT04039503|10783979|FG000|NOT COMPLETED|Overall Study||7
9683944|NCT04039503|10783980|FG001|NOT COMPLETED|Overall Study||4
9683945|NCT04039503|10783981|FG002|NOT COMPLETED|Overall Study||10
9683946|NCT04039503|10783982|FG003|NOT COMPLETED|Overall Study||3
9683947|NCT03695172|10784000|FG000|STARTED|Overall Study||5
9683948|NCT03695172|10784001|FG001|STARTED|Overall Study||4
9683949|NCT03695172|10784002|FG002|STARTED|Overall Study||3
9683950|NCT03695172|10784000|FG000|COMPLETED|Overall Study||4
9683951|NCT03695172|10784001|FG001|COMPLETED|Overall Study||3
9683952|NCT03695172|10784002|FG002|COMPLETED|Overall Study||3
9683953|NCT03695172|10784000|FG000|NOT COMPLETED|Overall Study||1
9683954|NCT03695172|10784001|FG001|NOT COMPLETED|Overall Study||1
9683955|NCT03695172|10784002|FG002|NOT COMPLETED|Overall Study||0
9683956|NCT03433040|10784013|FG000|STARTED|Overall Study||19
9683957|NCT03433040|10784014|FG001|STARTED|Overall Study||16
9683958|NCT03433040|10784015|FG002|STARTED|Overall Study||9
9683959|NCT03433040|10784013|FG000|COMPLETED|Overall Study||17
9683960|NCT03433040|10784014|FG001|COMPLETED|Overall Study||8
9683961|NCT03433040|10784015|FG002|COMPLETED|Overall Study||5
9683962|NCT03433040|10784013|FG000|NOT COMPLETED|Overall Study||2
9683963|NCT03433040|10784014|FG001|NOT COMPLETED|Overall Study||8
9683964|NCT03433040|10784015|FG002|NOT COMPLETED|Overall Study||4
9683965|NCT03394027|10784026|FG000|STARTED|Overall Study||10
9683966|NCT03394027|10784027|FG001|STARTED|Overall Study||6
9683967|NCT03394027|10784028|FG002|STARTED|Overall Study||14
9683968|NCT03394027|10784026|FG000|COMPLETED|Overall Study||7
9683969|NCT03394027|10784027|FG001|COMPLETED|Overall Study||5
9683970|NCT03394027|10784028|FG002|COMPLETED|Overall Study||10
9683971|NCT03394027|10784026|FG000|NOT COMPLETED|Overall Study||3
9683972|NCT03394027|10784027|FG001|NOT COMPLETED|Overall Study||1
9683973|NCT03394027|10784028|FG002|NOT COMPLETED|Overall Study||4
9683974|NCT03357952|10784056|FG000|STARTED|Overall Study||9
9683975|NCT03357952|10784057|FG001|STARTED|Overall Study||1
9683976|NCT03357952|10784056|FG000|COMPLETED|Overall Study||0
9683977|NCT03357952|10784057|FG001|COMPLETED|Overall Study||0
9683978|NCT03357952|10784056|FG000|NOT COMPLETED|Overall Study||9
9683979|NCT03357952|10784057|FG001|NOT COMPLETED|Overall Study||1
9683980|NCT03237234|10784065|FG000|STARTED|Overall Study||14
9683981|NCT03237234|10784066|FG001|STARTED|Overall Study||11
9683982|NCT03237234|10784065|FG000|COMPLETED|Overall Study||14
9683983|NCT03237234|10784066|FG001|COMPLETED|Overall Study||11
9683984|NCT03237234|10784065|FG000|NOT COMPLETED|Overall Study||0
9683985|NCT03237234|10784066|FG001|NOT COMPLETED|Overall Study||0
9683986|NCT03170869|10784072|FG000|STARTED|Overall Study||11
9683987|NCT03170869|10784072|FG000|COMPLETED|Overall Study||3
9683988|NCT03170869|10784072|FG000|NOT COMPLETED|Overall Study||8
9683989|NCT03066622|10784079|FG000|STARTED|Overall Study||61
9683990|NCT03066622|10784080|FG001|STARTED|Overall Study||61
9683991|NCT03066622|10784079|FG000|COMPLETED|Overall Study||35
9844417|NCT00836498|10956377|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
9844418|NCT00836498|10956378|FG001|COMPLETED|Overall Study||21
9844419|NCT00836498|10956377|FG000|NOT COMPLETED|Overall Study||4
9844420|NCT00836498|10956378|FG001|NOT COMPLETED|Overall Study||1
9844421|NCT00836589|10956385|FG000|STARTED|Overall Study||1997
9844422|NCT00836589|10956385|FG000|COMPLETED|Overall Study||731
9844423|NCT00836589|10956385|FG000|NOT COMPLETED|Overall Study||1266
9844424|NCT00836641|10956399|FG000|STARTED|Overall Study||36
9844425|NCT00836641|10956400|FG001|STARTED|Overall Study||34
9844426|NCT00836641|10956399|FG000|COMPLETED|Overall Study||36
9844427|NCT00836641|10956400|FG001|COMPLETED|Overall Study||34
9844428|NCT00836641|10956399|FG000|NOT COMPLETED|Overall Study||0
9844429|NCT00836641|10956400|FG001|NOT COMPLETED|Overall Study||0
9844430|NCT00836693|10956407|FG000|STARTED|Overall Study||147
9960764|NCT01469013|11080370|FG003|COMPLETED|Part B (Extension Period)||0
9960765|NCT01469013|11080371|FG004|COMPLETED|Part B (Extension Period)||0
9960766|NCT01469013|11080372|FG005|COMPLETED|Part B (Extension Period)||10
9960767|NCT01469013|11080373|FG006|COMPLETED|Part B (Extension Period)||7
9960768|NCT01469013|11080374|FG007|COMPLETED|Part B (Extension Period)||18
9960769|NCT01469013|11080375|FG008|COMPLETED|Part B (Extension Period)||20
9960770|NCT01469013|11080376|FG009|COMPLETED|Part B (Extension Period)||8
9960771|NCT01469013|11080377|FG010|COMPLETED|Part B (Extension Period)||10
9960772|NCT01469013|11080378|FG011|COMPLETED|Part B (Extension Period)||18
9960773|NCT01469013|11080379|FG012|COMPLETED|Part B (Extension Period)||18
9960774|NCT01469013|11080367|FG000|NOT COMPLETED|Part B (Extension Period)||0
9960775|NCT01469013|11080368|FG001|NOT COMPLETED|Part B (Extension Period)||0
9960776|NCT01469013|11080369|FG002|NOT COMPLETED|Part B (Extension Period)||0
9960777|NCT01469013|11080370|FG003|NOT COMPLETED|Part B (Extension Period)||0
9960778|NCT01469013|11080371|FG004|NOT COMPLETED|Part B (Extension Period)||0
9960779|NCT01469013|11080372|FG005|NOT COMPLETED|Part B (Extension Period)||2
9960780|NCT01469013|11080373|FG006|NOT COMPLETED|Part B (Extension Period)||5
9960781|NCT01469013|11080374|FG007|NOT COMPLETED|Part B (Extension Period)||5
9960782|NCT01469013|11080375|FG008|NOT COMPLETED|Part B (Extension Period)||4
9960783|NCT01469013|11080376|FG009|NOT COMPLETED|Part B (Extension Period)||3
9960784|NCT01469013|11080377|FG010|NOT COMPLETED|Part B (Extension Period)||2
9960785|NCT01469013|11080378|FG011|NOT COMPLETED|Part B (Extension Period)||6
9960786|NCT01469013|11080379|FG012|NOT COMPLETED|Part B (Extension Period)||6
9960787|NCT01469039|11080409|FG000|STARTED|Overall Study||207
9960788|NCT01469039|11080410|FG001|STARTED|Overall Study||208
9960789|NCT01469039|11080411|FG002|STARTED|Overall Study||208
10114243|NCT02514889|11244962|FG001|COMPLETED|Randomization/Allocation to Condition||106
9683992|NCT03066622|10784080|FG001|COMPLETED|Overall Study||35
9683993|NCT03066622|10784079|FG000|NOT COMPLETED|Overall Study||26
9844431|NCT00836693|10956408|FG001|STARTED|Overall Study||70
9683994|NCT03066622|10784080|FG001|NOT COMPLETED|Overall Study||26
9844432|NCT00836693|10956407|FG000|COMPLETED|Overall Study||130
9844433|NCT00836693|10956408|FG001|COMPLETED|Overall Study||64
9960790|NCT01469039|11080409|FG000|COMPLETED|Overall Study||130
9960791|NCT01469039|11080410|FG001|COMPLETED|Overall Study||135
9960792|NCT01469039|11080411|FG002|COMPLETED|Overall Study||95
9960793|NCT01469039|11080409|FG000|NOT COMPLETED|Overall Study||77
9683995|NCT03052920|10784086|FG000|STARTED|Overall Study||40
9683996|NCT03052920|10784086|FG000|COMPLETED|Overall Study||39
9683997|NCT03052920|10784086|FG000|NOT COMPLETED|Overall Study||1
9683998|NCT03029104|10784093|FG000|STARTED|Overall Study||745
9683999|NCT03029104|10784094|FG001|STARTED|Overall Study||735
9684000|NCT03029104|10784095|FG002|STARTED|Overall Study||748
9684001|NCT03029104|10784093|FG000|COMPLETED|Overall Study||612
9684002|NCT03029104|10784094|FG001|COMPLETED|Overall Study||597
9684003|NCT03029104|10784095|FG002|COMPLETED|Overall Study||623
9684004|NCT03029104|10784093|FG000|NOT COMPLETED|Overall Study||133
9684005|NCT03029104|10784094|FG001|NOT COMPLETED|Overall Study||138
9684006|NCT03029104|10784095|FG002|NOT COMPLETED|Overall Study||125
9684007|NCT03016312|10784105|FG000|STARTED|Overall Study||391
9684008|NCT03016312|10784106|FG001|STARTED|Overall Study||380
9684009|NCT03016312|10784105|FG000|COMPLETED|Overall Study||150
9684010|NCT03016312|10784106|FG001|COMPLETED|Overall Study||162
9684011|NCT03016312|10784105|FG000|NOT COMPLETED|Overall Study||241
9684012|NCT03016312|10784106|FG001|NOT COMPLETED|Overall Study||218
9684013|NCT02876172|10784114|FG000|STARTED|Overall Study||6
9684014|NCT02876172|10784115|FG001|STARTED|Overall Study||6
9684015|NCT02876172|10784114|FG000|COMPLETED|Overall Study||6
9684016|NCT02876172|10784115|FG001|COMPLETED|Overall Study||6
9684017|NCT02876172|10784114|FG000|NOT COMPLETED|Overall Study||0
9684018|NCT02876172|10784115|FG001|NOT COMPLETED|Overall Study||0
9684019|NCT02722434|10784124|FG000|STARTED|Overall Study||25
9684020|NCT02722434|10784125|FG001|STARTED|Overall Study||25
9684021|NCT02722434|10784124|FG000|Started Treatment|Overall Study||24
9684022|NCT02722434|10784125|FG001|Started Treatment|Overall Study||25
9684023|NCT02722434|10784124|FG000|COMPLETED|Overall Study||24
9684024|NCT02722434|10784125|FG001|COMPLETED|Overall Study||22
9684025|NCT02722434|10784124|FG000|NOT COMPLETED|Overall Study||1
9684026|NCT02722434|10784125|FG001|NOT COMPLETED|Overall Study||3
9684027|NCT02721979|10784131|FG000|STARTED|Overall Study||23
9684028|NCT02721979|10784131|FG000|COMPLETED|Overall Study||22
9684029|NCT02721979|10784131|FG000|NOT COMPLETED|Overall Study||1
9684030|NCT02604511|10784135|FG000|STARTED|Overall Study||31
9684031|NCT02604511|10784135|FG000|COMPLETED|Overall Study||19
9684032|NCT02604511|10784135|FG000|NOT COMPLETED|Overall Study||12
9684033|NCT02369536|10784141|FG000|STARTED|Overall Study||62
9684034|NCT02369536|10784142|FG001|STARTED|Overall Study||64
9844434|NCT00836693|10956407|FG000|NOT COMPLETED|Overall Study||17
9844435|NCT00836693|10956408|FG001|NOT COMPLETED|Overall Study||6
9844436|NCT00836719|10956414|FG000|STARTED|Overall Study||10
9844437|NCT00836719|10956414|FG000|COMPLETED|Overall Study||10
9844438|NCT00836719|10956414|FG000|NOT COMPLETED|Overall Study||0
9844439|NCT00836745|10956418|FG000|STARTED|Overall Study||36
9844440|NCT00836745|10956418|FG000|COMPLETED|Overall Study||15
9844441|NCT00836745|10956418|FG000|NOT COMPLETED|Overall Study||21
9844442|NCT00836758|10956422|FG000|STARTED|Overall Study||115
9844443|NCT00836758|10956422|FG000|COMPLETED|Overall Study||115
9844444|NCT00836758|10956422|FG000|NOT COMPLETED|Overall Study||0
9844445|NCT00836810|10956430|FG000|STARTED|Overall Study||5
9844446|NCT00836810|10956431|FG001|STARTED|Overall Study||6
9844447|NCT00836810|10956430|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
9844448|NCT00836810|10956431|FG001|COMPLETED|Overall Study||6
9844449|NCT00836810|10956430|FG000|NOT COMPLETED|Overall Study||1
9844450|NCT00836810|10956431|FG001|NOT COMPLETED|Overall Study||0
9844451|NCT00836875|10956439|FG000|STARTED|Overall Study||11
9844452|NCT00836875|10956440|FG001|STARTED|Overall Study||20
9844453|NCT00836875|10956439|FG000|COMPLETED|Overall Study||8
9844454|NCT00836875|10956440|FG001|COMPLETED|Overall Study||17
9844455|NCT00836875|10956439|FG000|NOT COMPLETED|Overall Study||3
9844456|NCT00836875|10956440|FG001|NOT COMPLETED|Overall Study||3
10023447|NCT01856114|11147099|FG000|NOT COMPLETED|Overall Study||2
10023448|NCT01856114|11147100|FG001|NOT COMPLETED|Overall Study||0
9844457|NCT00836888|10956450|FG000|STARTED|Overall Study||3
9844458|NCT00836888|10956451|FG001|STARTED|Overall Study||5
9844459|NCT00836888|10956452|FG002|STARTED|Overall Study||6
9844460|NCT00836888|10956453|FG003|STARTED|Overall Study||3
9844461|NCT00836888|10956450|FG000|COMPLETED|Overall Study||0
9844462|NCT00836888|10956451|FG001|COMPLETED|Overall Study||2
9844463|NCT00836888|10956452|FG002|COMPLETED|Overall Study||0
9844464|NCT00836888|10956453|FG003|COMPLETED|Overall Study||0
9844465|NCT00836888|10956450|FG000|NOT COMPLETED|Overall Study||3
9844466|NCT00836888|10956451|FG001|NOT COMPLETED|Overall Study||3
9684035|NCT02369536|10784141|FG000|COMPLETED|Overall Study||55
9684036|NCT02369536|10784142|FG001|COMPLETED|Overall Study||58
9684037|NCT02369536|10784141|FG000|NOT COMPLETED|Overall Study||7
9684038|NCT02369536|10784142|FG001|NOT COMPLETED|Overall Study||6
9684039|NCT02358681|10784152|FG000|STARTED|Overall Study||29
9684040|NCT02358681|10784153|FG001|STARTED|Overall Study||30
9684041|NCT02358681|10784152|FG000|COMPLETED|Overall Study||27
9684042|NCT02358681|10784153|FG001|COMPLETED|Overall Study||29
9684043|NCT02358681|10784152|FG000|NOT COMPLETED|Overall Study||2
9844467|NCT00836888|10956452|FG002|NOT COMPLETED|Overall Study||6
9844468|NCT00836888|10956453|FG003|NOT COMPLETED|Overall Study||3
9844469|NCT00836927|10956468|FG000|STARTED|Overall Study||3
10023449|NCT01856218|11147106|FG000|STARTED|First Phase||3
10023450|NCT01856218|11147106|FG000|COMPLETED|First Phase||3
10023451|NCT01856218|11147106|FG000|NOT COMPLETED|First Phase||0
9684044|NCT02358681|10784153|FG001|NOT COMPLETED|Overall Study||1
9684045|NCT02101788|10784161|FG000|STARTED|Overall Study||130
9844470|NCT00836927|10956469|FG001|STARTED|Overall Study||1
9960794|NCT01469039|11080410|FG001|NOT COMPLETED|Overall Study||73
9684046|NCT02101788|10784162|FG001|STARTED|Overall Study||130
9684047|NCT02101788|10784161|FG000|Crossover From Arm A to Arm B|Overall Study||88
9684048|NCT02101788|10784162|FG001|Crossover From Arm A to Arm B|Overall Study||0
9684049|NCT02101788|10784161|FG000|COMPLETED|Overall Study||120
9684050|NCT02101788|10784162|FG001|COMPLETED|Overall Study||116
9684051|NCT02101788|10784161|FG000|NOT COMPLETED|Overall Study||10
9684052|NCT02101788|10784162|FG001|NOT COMPLETED|Overall Study||14
9684053|NCT01963728|10784177|FG000|STARTED|Overall Study||0
9684054|NCT01963728|10784178|FG001|STARTED|Overall Study||1
9684055|NCT01963728|10784177|FG000|COMPLETED|Overall Study|study terminated early|0
9684056|NCT01963728|10784178|FG001|COMPLETED|Overall Study|study terminated early|0
9684057|NCT01963728|10784177|FG000|NOT COMPLETED|Overall Study||0
9684058|NCT01963728|10784178|FG001|NOT COMPLETED|Overall Study||1
9725515|NCT00095147|10825088|FG002|NOT COMPLETED|Long-term Extension Period||0
9725516|NCT00095147|10825089|FG003|NOT COMPLETED|Long-term Extension Period||0
9725517|NCT00095147|10825090|FG004|NOT COMPLETED|Long-term Extension Period||45
9725518|NCT00095173|10825108|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190
9725519|NCT00095173|10825109|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0
9725520|NCT00095173|10825110|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0
9725521|NCT00095173|10825111|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0
9725522|NCT00095173|10825112|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0
9725523|NCT00095173|10825113|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0
9725524|NCT00095173|10825108|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170
9725525|NCT00095173|10825109|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725526|NCT00095173|10825110|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725527|NCT00095173|10825111|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725528|NCT00095173|10825112|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725529|NCT00095173|10825113|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725530|NCT00095173|10825108|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
9725531|NCT00095173|10825109|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725532|NCT00095173|10825110|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725533|NCT00095173|10825111|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725534|NCT00095173|10825112|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725535|NCT00095173|10825113|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
9725536|NCT00095173|10825108|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
9725537|NCT00095173|10825109|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
9725538|NCT00095173|10825110|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
9725539|NCT00095173|10825111|FG003|STARTED|Double-Blind Phase (Period B)||0
9725540|NCT00095173|10825112|FG004|STARTED|Double-Blind Phase (Period B)||0
9725541|NCT00095173|10825113|FG005|STARTED|Double-Blind Phase (Period B)||0
9725542|NCT00095173|10825108|FG000|COMPLETED|Double-Blind Phase (Period B)||0
9725543|NCT00095173|10825109|FG001|COMPLETED|Double-Blind Phase (Period B)||49
9725544|NCT00095173|10825110|FG002|COMPLETED|Double-Blind Phase (Period B)||31
9725545|NCT00095173|10825111|FG003|COMPLETED|Double-Blind Phase (Period B)||0
9725546|NCT00095173|10825112|FG004|COMPLETED|Double-Blind Phase (Period B)||0
9725547|NCT00095173|10825113|FG005|COMPLETED|Double-Blind Phase (Period B)||0
9725548|NCT00095173|10825108|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0
9725549|NCT00095173|10825109|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11
9725550|NCT00095173|10825110|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31
9725551|NCT00095173|10825111|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0
9725552|NCT00095173|10825112|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0
9725553|NCT00095173|10825113|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0
9725554|NCT00095173|10825108|FG000|STARTED|Open-Label Extension Phase (Period C)||0
9725555|NCT00095173|10825109|FG001|STARTED|Open-Label Extension Phase (Period C)||0
9725556|NCT00095173|10825110|FG002|STARTED|Open-Label Extension Phase (Period C)||0
9725557|NCT00095173|10825111|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
9725558|NCT00095173|10825112|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
9725559|NCT00095173|10825113|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
9725560|NCT00095173|10825108|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0
9725561|NCT00095173|10825109|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0
9725562|NCT00095173|10825110|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0
9725563|NCT00095173|10825111|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13
9725564|NCT00095173|10825112|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29
9725565|NCT00095173|10825113|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27
9725566|NCT00095173|10825108|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
9725567|NCT00095173|10825109|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
9725568|NCT00095173|10825110|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
9725569|NCT00095173|10825111|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
9725570|NCT00095173|10825112|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
9725571|NCT00095173|10825113|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
9725572|NCT00095199|10825131|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
9684059|NCT01248247|10784188|FG000|STARTED|Overall Study||22
9684060|NCT01248247|10784189|FG001|STARTED|Overall Study||42
9684061|NCT01248247|10784190|FG002|STARTED|Overall Study||75
9684062|NCT01248247|10784191|FG003|STARTED|Overall Study||61
9684063|NCT01248247|10784188|FG000|COMPLETED|Overall Study||0
9684064|NCT01248247|10784189|FG001|COMPLETED|Overall Study||0
9684065|NCT01248247|10784190|FG002|COMPLETED|Overall Study||0
9684066|NCT01248247|10784191|FG003|COMPLETED|Overall Study||0
9684067|NCT01248247|10784188|FG000|NOT COMPLETED|Overall Study||22
9684068|NCT01248247|10784189|FG001|NOT COMPLETED|Overall Study||42
9684069|NCT01248247|10784190|FG002|NOT COMPLETED|Overall Study||75
9684070|NCT01248247|10784191|FG003|NOT COMPLETED|Overall Study||61
9684071|NCT01164228|10784203|FG000|STARTED|Overall Study||47
9684072|NCT01164228|10784204|FG001|STARTED|Overall Study||40
9684073|NCT01164228|10784203|FG000|Receipt of Protocol Therapy|Overall Study||46
9684074|NCT01164228|10784204|FG001|Receipt of Protocol Therapy|Overall Study||37
9684075|NCT01164228|10784203|FG000|Treated and Eligible Patients|Overall Study||45
9684076|NCT01164228|10784204|FG001|Treated and Eligible Patients|Overall Study||37
9684077|NCT01164228|10784203|FG000|COMPLETED|Overall Study||3
9684078|NCT01164228|10784204|FG001|COMPLETED|Overall Study||2
9684079|NCT01164228|10784203|FG000|NOT COMPLETED|Overall Study||44
9684080|NCT01164228|10784204|FG001|NOT COMPLETED|Overall Study||38
9684081|NCT01012167|10784213|FG000|STARTED|Overall Study||17
9684082|NCT01012167|10784214|FG001|STARTED|Overall Study||20
9684083|NCT01012167|10784215|FG002|STARTED|Overall Study||21
9684084|NCT01012167|10784213|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1
9684085|NCT01012167|10784214|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0
9684086|NCT01012167|10784215|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1
9684087|NCT01012167|10784213|FG000|Exposed to Study Drug|Overall Study||16
9684088|NCT01012167|10784214|FG001|Exposed to Study Drug|Overall Study||20
9684089|NCT01012167|10784215|FG002|Exposed to Study Drug|Overall Study||20
9684090|NCT01012167|10784213|FG000|COMPLETED|Overall Study||15
9684091|NCT01012167|10784214|FG001|COMPLETED|Overall Study||18
9684092|NCT01012167|10784215|FG002|COMPLETED|Overall Study||17
9684093|NCT01012167|10784213|FG000|NOT COMPLETED|Overall Study||2
9684094|NCT01012167|10784214|FG001|NOT COMPLETED|Overall Study||2
9684095|NCT01012167|10784215|FG002|NOT COMPLETED|Overall Study||4
9684096|NCT00924326|10784239|FG000|STARTED|Dose Administration||8
9684097|NCT00924326|10784240|FG001|STARTED|Dose Administration||2
9684098|NCT00924326|10784241|FG002|STARTED|Dose Administration||5
9684099|NCT00924326|10784242|FG003|STARTED|Dose Administration||6
9684100|NCT00924326|10784243|FG004|STARTED|Dose Administration||7
9684101|NCT00924326|10784244|FG005|STARTED|Dose Administration||10
9684102|NCT00924326|10784245|FG006|STARTED|Dose Administration||1
9684103|NCT00924326|10784246|FG007|STARTED|Dose Administration||2
9684104|NCT00924326|10784247|FG008|STARTED|Dose Administration||2
9684105|NCT00924326|10784239|FG000|COMPLETED|Dose Administration||8
9684106|NCT00924326|10784240|FG001|COMPLETED|Dose Administration||2
9684107|NCT00924326|10784241|FG002|COMPLETED|Dose Administration||5
9684108|NCT00924326|10784242|FG003|COMPLETED|Dose Administration||6
9684109|NCT00924326|10784243|FG004|COMPLETED|Dose Administration||7
9684110|NCT00924326|10784244|FG005|COMPLETED|Dose Administration||10
9684111|NCT00924326|10784245|FG006|COMPLETED|Dose Administration||1
9684112|NCT00924326|10784246|FG007|COMPLETED|Dose Administration||2
9684113|NCT00924326|10784247|FG008|COMPLETED|Dose Administration||2
9684114|NCT00924326|10784239|FG000|NOT COMPLETED|Dose Administration||0
9684115|NCT00924326|10784240|FG001|NOT COMPLETED|Dose Administration||0
9684116|NCT00924326|10784241|FG002|NOT COMPLETED|Dose Administration||0
9684117|NCT00924326|10784242|FG003|NOT COMPLETED|Dose Administration||0
9684118|NCT00924326|10784243|FG004|NOT COMPLETED|Dose Administration||0
9684119|NCT00924326|10784244|FG005|NOT COMPLETED|Dose Administration||0
9684120|NCT00924326|10784245|FG006|NOT COMPLETED|Dose Administration||0
9684121|NCT00924326|10784246|FG007|NOT COMPLETED|Dose Administration||0
9684122|NCT00924326|10784247|FG008|NOT COMPLETED|Dose Administration||0
9684123|NCT00924326|10784239|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
9684124|NCT00924326|10784240|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9960795|NCT01469039|11080411|FG002|NOT COMPLETED|Overall Study||113
9684125|NCT00924326|10784241|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9684126|NCT00924326|10784242|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9684127|NCT00924326|10784243|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9684128|NCT00924326|10784244|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9684129|NCT00924326|10784245|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9684130|NCT00924326|10784246|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9684131|NCT00924326|10784247|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
9684132|NCT00924326|10784239|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
9684133|NCT00924326|10784240|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684134|NCT00924326|10784241|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9960796|NCT01469052|11080425|FG000|STARTED|Overall Study||6
9960797|NCT01469052|11080426|FG001|STARTED|Overall Study||4
9960798|NCT01469052|11080427|FG002|STARTED|Overall Study||6
9960799|NCT01469052|11080428|FG003|STARTED|Overall Study||6
9960800|NCT01469052|11080429|FG004|STARTED|Overall Study||8
9960801|NCT01469052|11080430|FG005|STARTED|Overall Study||6
9960802|NCT01469052|11080425|FG000|COMPLETED|Overall Study||0
9960803|NCT01469052|11080426|FG001|COMPLETED|Overall Study||0
9960804|NCT01469052|11080427|FG002|COMPLETED|Overall Study||0
9684135|NCT00924326|10784242|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684136|NCT00924326|10784243|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684137|NCT00924326|10784244|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684138|NCT00924326|10784245|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684139|NCT00924326|10784246|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684140|NCT00924326|10784247|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684141|NCT00924326|10784239|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684142|NCT00924326|10784240|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684143|NCT00924326|10784241|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684144|NCT00924326|10784242|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684145|NCT00924326|10784243|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684146|NCT00924326|10784244|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684147|NCT00924326|10784245|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684148|NCT00924326|10784246|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9684149|NCT00924326|10784247|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
9844471|NCT00836927|10956470|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
9844472|NCT00836927|10956471|FG003|STARTED|Overall Study||1
9844473|NCT00836927|10956472|FG004|STARTED|Overall Study||1
9844474|NCT00836927|10956468|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0
9844475|NCT00836927|10956469|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
9844476|NCT00836927|10956470|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
9844477|NCT00836927|10956471|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0
9844478|NCT00836927|10956472|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0
9844479|NCT00836927|10956468|FG000|COMPLETED|Overall Study||0
9844480|NCT00836927|10956469|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
9844481|NCT00836927|10956470|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
9844482|NCT00836927|10956471|FG003|COMPLETED|Overall Study||0
9844483|NCT00836927|10956472|FG004|COMPLETED|Overall Study||0
9844484|NCT00836927|10956468|FG000|NOT COMPLETED|Overall Study||3
10114244|NCT02514889|11244961|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20
9844485|NCT00836927|10956469|FG001|NOT COMPLETED|Overall Study||0
9844486|NCT00836927|10956470|FG002|NOT COMPLETED|Overall Study||0
9844487|NCT00836927|10956471|FG003|NOT COMPLETED|Overall Study||1
9844488|NCT00836927|10956472|FG004|NOT COMPLETED|Overall Study||1
9844489|NCT00836953|10956486|FG000|STARTED|Overall Study||33
9844490|NCT00836953|10956486|FG000|COMPLETED|Overall Study||31
9844491|NCT00836953|10956486|FG000|NOT COMPLETED|Overall Study||2
9844492|NCT00837031|10956490|FG000|STARTED|Overall Study||72
9844493|NCT00837031|10956490|FG000|COMPLETED|Overall Study||72
9844494|NCT00837031|10956490|FG000|NOT COMPLETED|Overall Study||0
9844495|NCT00837096|10956496|FG000|STARTED|Overall Study||10
9844496|NCT00837096|10956497|FG001|STARTED|Overall Study||9
9844497|NCT00837096|10956496|FG000|COMPLETED|Overall Study||0
9844498|NCT00837096|10956497|FG001|COMPLETED|Overall Study||0
9844499|NCT00837096|10956496|FG000|NOT COMPLETED|Overall Study||10
9844500|NCT00837096|10956497|FG001|NOT COMPLETED|Overall Study||9
9844501|NCT00837148|10956503|FG000|STARTED|Overall Study||37
9844502|NCT00837148|10956503|FG000|COMPLETED|Overall Study||35
9844503|NCT00837148|10956503|FG000|NOT COMPLETED|Overall Study||2
9844504|NCT00837161|10956507|FG000|STARTED|Overall Study||11
9844505|NCT00837161|10956507|FG000|COMPLETED|Overall Study||9
9844506|NCT00837161|10956507|FG000|NOT COMPLETED|Overall Study||2
9844507|NCT00837200|10956511|FG000|STARTED|Overall Study||13
9844508|NCT00837200|10956511|FG000|COMPLETED|Overall Study||13
9844509|NCT00837200|10956511|FG000|NOT COMPLETED|Overall Study||0
9844510|NCT00837213|10956517|FG000|STARTED|Overall Study||16
9844511|NCT00837213|10956518|FG001|STARTED|Overall Study||17
9844512|NCT00837213|10956517|FG000|COMPLETED|Overall Study||10
10023452|NCT01856218|11147106|FG000|STARTED|Long-Term Extension Phase||3
10023453|NCT01856218|11147106|FG000|COMPLETED|Long-Term Extension Phase||3
9844513|NCT00837213|10956518|FG001|COMPLETED|Overall Study||12
9844514|NCT00837213|10956517|FG000|NOT COMPLETED|Overall Study||6
9844515|NCT00837213|10956518|FG001|NOT COMPLETED|Overall Study||5
9844516|NCT00837252|10956524|FG000|STARTED|Overall Study||5
9844517|NCT00837252|10956524|FG000|COMPLETED|Overall Study||5
9844518|NCT00837252|10956524|FG000|NOT COMPLETED|Overall Study||0
9844519|NCT00837330|10956530|FG000|STARTED|Overall Study||10
9844520|NCT00837330|10956531|FG001|STARTED|Overall Study||10
9844521|NCT00837330|10956530|FG000|COMPLETED|Overall Study||9
9844522|NCT00837330|10956531|FG001|COMPLETED|Overall Study||7
9844523|NCT00837330|10956530|FG000|NOT COMPLETED|Overall Study||1
9844524|NCT00837330|10956531|FG001|NOT COMPLETED|Overall Study||3
10023454|NCT01856218|11147106|FG000|NOT COMPLETED|Long-Term Extension Phase||0
10023455|NCT01856257|11147113|FG000|STARTED|Overall Study||29
10023456|NCT01856257|11147114|FG001|STARTED|Overall Study||29
10023457|NCT01856257|11147115|FG002|STARTED|Overall Study||11
10023458|NCT01856257|11147116|FG003|STARTED|Overall Study||2
10023459|NCT01856257|11147113|FG000|COMPLETED|Overall Study||26
10023460|NCT01856257|11147114|FG001|COMPLETED|Overall Study||28
10023461|NCT01856257|11147115|FG002|COMPLETED|Overall Study||11
10023462|NCT01856257|11147116|FG003|COMPLETED|Overall Study||0
10023463|NCT01856257|11147113|FG000|NOT COMPLETED|Overall Study||3
10023464|NCT01856257|11147114|FG001|NOT COMPLETED|Overall Study||1
10023465|NCT01856257|11147115|FG002|NOT COMPLETED|Overall Study||0
10023466|NCT01856257|11147116|FG003|NOT COMPLETED|Overall Study||2
10023467|NCT01856309|11147129|FG000|STARTED|Overall Study||305
10023468|NCT01856309|11147130|FG001|STARTED|Overall Study||291
10023469|NCT01856309|11147131|FG002|STARTED|Overall Study||606
10023470|NCT01856309|11147132|FG003|STARTED|Overall Study||618
10023471|NCT01856309|11147129|FG000|Participants From Study CNTO136ARA3002|Overall Study||197
10023472|NCT01856309|11147130|FG001|Participants From Study CNTO136ARA3002|Overall Study||187
9684150|NCT00591318|10784271|FG000|STARTED|Overall Study||5
9684151|NCT00591318|10784272|FG001|STARTED|Overall Study||5
9684152|NCT00591318|10784271|FG000|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant, regardless of whether the participant completed the study treatments.|1
9684153|NCT00591318|10784272|FG001|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant regardless of whether the participant completed the study treatments..|5
9684154|NCT00591318|10784271|FG000|NOT COMPLETED|Overall Study||4
9684155|NCT00591318|10784272|FG001|NOT COMPLETED|Overall Study||0
9684156|NCT00321100|10784284|FG000|STARTED|Overall Study||12
9684157|NCT00321100|10784285|FG001|STARTED|Overall Study||11
9684158|NCT00321100|10784284|FG000|COMPLETED|Overall Study||12
9684159|NCT00321100|10784285|FG001|COMPLETED|Overall Study||11
9684160|NCT00321100|10784284|FG000|NOT COMPLETED|Overall Study||0
9684161|NCT00321100|10784285|FG001|NOT COMPLETED|Overall Study||0
9725573|NCT00095199|10825132|FG001|STARTED|Overall Study||304
9725574|NCT00095199|10825133|FG002|STARTED|Overall Study||167
9725575|NCT00095199|10825134|FG003|STARTED|Overall Study||166
9725576|NCT00095199|10825131|FG000|COMPLETED|Overall Study||6
9725577|NCT00095199|10825132|FG001|COMPLETED|Overall Study||62
9725578|NCT00095199|10825133|FG002|COMPLETED|Overall Study||7
10023473|NCT01856309|11147131|FG002|Participants From Study CNTO136ARA3002|Overall Study||405
10023474|NCT01856309|11147132|FG003|Participants From Study CNTO136ARA3002|Overall Study||412
10023475|NCT01856309|11147129|FG000|Participants From Study CNTO136ARA3003|Overall Study||108
9725579|NCT00095199|10825134|FG003|COMPLETED|Overall Study||23
9725580|NCT00095199|10825131|FG000|NOT COMPLETED|Overall Study||296
9725581|NCT00095199|10825132|FG001|NOT COMPLETED|Overall Study||242
9725582|NCT00095199|10825133|FG002|NOT COMPLETED|Overall Study||160
9725583|NCT00095199|10825134|FG003|NOT COMPLETED|Overall Study||143
9725584|NCT00095212|10825151|FG000|STARTED|Overall Study||13
9725585|NCT00095212|10825152|FG001|STARTED|Overall Study||12
9725586|NCT00095212|10825151|FG000|COMPLETED|Overall Study||12
9725587|NCT00095212|10825152|FG001|COMPLETED|Overall Study||9
9725588|NCT00095212|10825151|FG000|NOT COMPLETED|Overall Study||1
9725589|NCT00095212|10825152|FG001|NOT COMPLETED|Overall Study||3
9725590|NCT00095238|10825160|FG000|STARTED|Overall Study|number randomized|2067
9725591|NCT00095238|10825161|FG001|STARTED|Overall Study|number randomized|2061
9725592|NCT00095238|10825160|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
9725593|NCT00095238|10825161|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
9725594|NCT00095238|10825160|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210
9725595|NCT00095238|10825161|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209
9725596|NCT00095238|10825160|FG000|NOT COMPLETED|Overall Study||857
9725597|NCT00095238|10825161|FG001|NOT COMPLETED|Overall Study||852
9725598|NCT00095303|10825201|FG000|STARTED|Main Study||245
9725599|NCT00095303|10825202|FG001|STARTED|Main Study||235
9725600|NCT00095303|10825201|FG000|COMPLETED|Main Study||154
9725601|NCT00095303|10825202|FG001|COMPLETED|Main Study||148
9725602|NCT00095303|10825201|FG000|NOT COMPLETED|Main Study||91
9725603|NCT00095303|10825202|FG001|NOT COMPLETED|Main Study||87
9725604|NCT00095303|10825201|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
9725605|NCT00095303|10825202|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
9725606|NCT00095303|10825201|FG000|COMPLETED|Follow Up Study||140
10023476|NCT01856309|11147130|FG001|Participants From Study CNTO136ARA3003|Overall Study||104
10023477|NCT01856309|11147131|FG002|Participants From Study CNTO136ARA3003|Overall Study||201
10081175|NCT02258334|11209643|FG003|COMPLETED|Overall Study||52
9844525|NCT00837434|10956539|FG000|STARTED|Overall Study||43
9844526|NCT00837434|10956540|FG001|STARTED|Overall Study||20
9844527|NCT00837434|10956539|FG000|COMPLETED|Overall Study||34
9844528|NCT00837434|10956540|FG001|COMPLETED|Overall Study||19
9844529|NCT00837434|10956539|FG000|NOT COMPLETED|Overall Study||9
9844530|NCT00837434|10956540|FG001|NOT COMPLETED|Overall Study||1
9844531|NCT00837447|10956546|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
9844532|NCT00837447|10956546|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
9844533|NCT00837447|10956546|FG000|NOT COMPLETED|Overall Study||0
9844534|NCT00837473|10956551|FG000|STARTED|Overall Study||15
9844535|NCT00837473|10956551|FG000|COMPLETED|Overall Study||12
9844536|NCT00837473|10956551|FG000|NOT COMPLETED|Overall Study||3
9844537|NCT00837486|10956557|FG000|STARTED|Blinded-treatment Phase||16
9960805|NCT01469052|11080428|FG003|COMPLETED|Overall Study||1
9960806|NCT01469052|11080429|FG004|COMPLETED|Overall Study||0
9960807|NCT01469052|11080430|FG005|COMPLETED|Overall Study||0
9960808|NCT01469052|11080425|FG000|NOT COMPLETED|Overall Study||6
9960809|NCT01469052|11080426|FG001|NOT COMPLETED|Overall Study||4
9960810|NCT01469052|11080427|FG002|NOT COMPLETED|Overall Study||6
9960811|NCT01469052|11080428|FG003|NOT COMPLETED|Overall Study||5
9960812|NCT01469052|11080429|FG004|NOT COMPLETED|Overall Study||8
9960813|NCT01469052|11080430|FG005|NOT COMPLETED|Overall Study||6
9684162|NCT04534517|10784293|FG000|STARTED|Overall Study||114
9684163|NCT04534517|10784293|FG000|COMPLETED|Overall Study||110
9684164|NCT04534517|10784293|FG000|NOT COMPLETED|Overall Study||4
9684165|NCT04494646|10784299|FG000|STARTED|Overall Study||21
9684166|NCT04494646|10784300|FG001|STARTED|Overall Study||19
9684167|NCT04494646|10784299|FG000|COMPLETED|Overall Study||21
9684168|NCT04494646|10784300|FG001|COMPLETED|Overall Study||17
9684169|NCT04494646|10784299|FG000|NOT COMPLETED|Overall Study||0
9684170|NCT04494646|10784300|FG001|NOT COMPLETED|Overall Study||2
9684171|NCT04258020|10784308|FG000|STARTED|Overall Study||4
9684172|NCT04258020|10784309|FG001|STARTED|Overall Study||0
9684173|NCT04258020|10784308|FG000|COMPLETED|Overall Study||3
9684174|NCT04258020|10784309|FG001|COMPLETED|Overall Study||0
9844538|NCT00837486|10956558|FG001|STARTED|Blinded-treatment Phase||14
9844539|NCT00837486|10956557|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
9844540|NCT00837486|10956558|FG001|COMPLETED|Blinded-treatment Phase||14
9844541|NCT00837486|10956557|FG000|NOT COMPLETED|Blinded-treatment Phase||1
9844542|NCT00837486|10956558|FG001|NOT COMPLETED|Blinded-treatment Phase||0
9844543|NCT00837486|10956557|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
9844544|NCT00837486|10956558|FG001|STARTED|Long-term Follow-up Phase - Open Label||0
9844545|NCT00837486|10956557|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24
9844546|NCT00837486|10956558|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0
9844547|NCT00837486|10956557|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
9844548|NCT00837486|10956558|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
9844549|NCT00837512|10956566|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8
9844550|NCT00837512|10956567|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8
9844551|NCT00837512|10956566|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
9844552|NCT00837512|10956567|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
9844553|NCT00837512|10956566|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
9960814|NCT01469065|11080447|FG000|STARTED|Overall Study||16
9960815|NCT01469065|11080448|FG001|STARTED|Overall Study||17
9960816|NCT01469065|11080449|FG002|STARTED|Overall Study||16
9960817|NCT01469065|11080450|FG003|STARTED|Overall Study||16
9960818|NCT01469065|11080451|FG004|STARTED|Overall Study||17
9960819|NCT01469065|11080447|FG000|COMPLETED|Overall Study||16
9960820|NCT01469065|11080448|FG001|COMPLETED|Overall Study||16
9960821|NCT01469065|11080449|FG002|COMPLETED|Overall Study||16
9960822|NCT01469065|11080450|FG003|COMPLETED|Overall Study||16
9960823|NCT01469065|11080451|FG004|COMPLETED|Overall Study||16
9960824|NCT01469065|11080447|FG000|NOT COMPLETED|Overall Study||0
9960825|NCT01469065|11080448|FG001|NOT COMPLETED|Overall Study||1
9960826|NCT01469065|11080449|FG002|NOT COMPLETED|Overall Study||0
9960827|NCT01469065|11080450|FG003|NOT COMPLETED|Overall Study||0
9960828|NCT01469065|11080451|FG004|NOT COMPLETED|Overall Study||1
9960829|NCT01469182|11080469|FG000|STARTED|Overall Study||610
9960830|NCT01469182|11080470|FG001|STARTED|Overall Study||304
9960831|NCT01469182|11080469|FG000|Treated|Overall Study||609
9960832|NCT01469182|11080470|FG001|Treated|Overall Study||304
9960833|NCT01469182|11080469|FG000|COMPLETED|Overall Study||575
9960834|NCT01469182|11080470|FG001|COMPLETED|Overall Study||298
9960835|NCT01469182|11080469|FG000|NOT COMPLETED|Overall Study||35
9960836|NCT01469182|11080470|FG001|NOT COMPLETED|Overall Study||6
9960837|NCT01469221|11080478|FG000|STARTED|Open Label Phase||0
9960838|NCT01469221|11080479|FG001|STARTED|Open Label Phase||0
9960839|NCT01469221|11080480|FG002|STARTED|Open Label Phase||47
9960840|NCT01469221|11080478|FG000|COMPLETED|Open Label Phase||0
9960841|NCT01469221|11080479|FG001|COMPLETED|Open Label Phase||0
9960842|NCT01469221|11080480|FG002|COMPLETED|Open Label Phase||44
9960843|NCT01469221|11080478|FG000|NOT COMPLETED|Open Label Phase||0
9960844|NCT01469221|11080479|FG001|NOT COMPLETED|Open Label Phase||0
9960845|NCT01469221|11080480|FG002|NOT COMPLETED|Open Label Phase||3
9960846|NCT01469221|11080478|FG000|STARTED|Double Blind Phase||14
9960847|NCT01469221|11080479|FG001|STARTED|Double Blind Phase||17
9960848|NCT01469221|11080480|FG002|STARTED|Double Blind Phase||0
10023478|NCT01856309|11147132|FG003|Participants From Study CNTO136ARA3003|Overall Study||206
10023479|NCT01856309|11147129|FG000|Treated Partcipants|Overall Study||305
10023480|NCT01856309|11147130|FG001|Treated Partcipants|Overall Study||290
10023481|NCT01856309|11147131|FG002|Treated Partcipants|Overall Study||605
10023482|NCT01856309|11147132|FG003|Treated Partcipants|Overall Study||618
10023483|NCT01856309|11147129|FG000|COMPLETED|Overall Study||6
10023484|NCT01856309|11147130|FG001|COMPLETED|Overall Study||3
10023485|NCT01856309|11147131|FG002|COMPLETED|Overall Study||11
10023486|NCT01856309|11147132|FG003|COMPLETED|Overall Study||9
9684175|NCT04258020|10784308|FG000|NOT COMPLETED|Overall Study||1
10023487|NCT01856309|11147129|FG000|NOT COMPLETED|Overall Study||299
10023488|NCT01856309|11147130|FG001|NOT COMPLETED|Overall Study||288
10023489|NCT01856309|11147131|FG002|NOT COMPLETED|Overall Study||595
10023490|NCT01856309|11147132|FG003|NOT COMPLETED|Overall Study||609
10023491|NCT01856491|11147142|FG000|STARTED|Overall Study||167
10023492|NCT01856491|11147142|FG000|COMPLETED|Overall Study||152
10023493|NCT01856491|11147142|FG000|NOT COMPLETED|Overall Study||15
10023494|NCT01856530|11147148|FG000|STARTED|Overall Study||27
9684176|NCT04258020|10784309|FG001|NOT COMPLETED|Overall Study||0
9684177|NCT04234464|10784317|FG000|STARTED|Period 1 (First Treatment Intervention)||29
9960849|NCT01469221|11080478|FG000|COMPLETED|Double Blind Phase||0
9960850|NCT01469221|11080479|FG001|COMPLETED|Double Blind Phase||0
10023495|NCT01856530|11147149|FG001|STARTED|Overall Study||27
9684178|NCT04234464|10784318|FG001|STARTED|Period 1 (First Treatment Intervention)||31
9684179|NCT04234464|10784317|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29
9684180|NCT04234464|10784318|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31
9684181|NCT04234464|10784317|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
9684182|NCT04234464|10784318|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
9684183|NCT04234464|10784317|FG000|STARTED|Period 2 (Second Treatment Intervention)||29
9684184|NCT04234464|10784318|FG001|STARTED|Period 2 (Second Treatment Intervention)||31
9684185|NCT04234464|10784317|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28
9684186|NCT04234464|10784318|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31
9684187|NCT04234464|10784317|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
9684188|NCT04234464|10784318|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
9684189|NCT03852316|10784324|FG000|STARTED|Overall Study||1585
9684190|NCT03852316|10784324|FG000|COMPLETED|Overall Study||1581
9684191|NCT03852316|10784324|FG000|NOT COMPLETED|Overall Study||4
9684192|NCT03789318|10784333|FG000|STARTED|Overall Study||9
9684193|NCT03789318|10784334|FG001|STARTED|Overall Study||9
9684194|NCT03789318|10784335|FG002|STARTED|Overall Study||12
9684195|NCT03789318|10784336|FG003|STARTED|Overall Study||12
9684196|NCT03789318|10784337|FG004|STARTED|Overall Study||12
9684197|NCT03789318|10784333|FG000|COMPLETED|Overall Study||9
9684198|NCT03789318|10784334|FG001|COMPLETED|Overall Study||9
9684199|NCT03789318|10784335|FG002|COMPLETED|Overall Study||9
9684200|NCT03789318|10784336|FG003|COMPLETED|Overall Study||11
9684201|NCT03789318|10784337|FG004|COMPLETED|Overall Study||12
9684202|NCT03789318|10784333|FG000|NOT COMPLETED|Overall Study||0
9684203|NCT03789318|10784334|FG001|NOT COMPLETED|Overall Study||0
9684204|NCT03789318|10784335|FG002|NOT COMPLETED|Overall Study||3
9684205|NCT03789318|10784336|FG003|NOT COMPLETED|Overall Study||1
9684206|NCT03789318|10784337|FG004|NOT COMPLETED|Overall Study||0
9684207|NCT03774875|10784351|FG000|STARTED|Overall Study||92
9684208|NCT03774875|10784352|FG001|STARTED|Overall Study||185
9684209|NCT03774875|10784351|FG000|Received Study Drug|Overall Study||91
9684210|NCT03774875|10784352|FG001|Received Study Drug|Overall Study||185
9684211|NCT03774875|10784351|FG000|COMPLETED|Overall Study||69
9684212|NCT03774875|10784352|FG001|COMPLETED|Overall Study||152
9684213|NCT03774875|10784351|FG000|NOT COMPLETED|Overall Study||23
9684214|NCT03774875|10784352|FG001|NOT COMPLETED|Overall Study||33
9725607|NCT00095303|10825202|FG001|COMPLETED|Follow Up Study||121
9725608|NCT00095303|10825201|FG000|NOT COMPLETED|Follow Up Study||59
9725609|NCT00095303|10825202|FG001|NOT COMPLETED|Follow Up Study||58
9725610|NCT00095498|10825211|FG000|STARTED|Overall Study||76
9725611|NCT00095498|10825212|FG001|STARTED|Overall Study||73
9725612|NCT00095498|10825213|FG002|STARTED|Overall Study||78
9725613|NCT00095498|10825211|FG000|Received Investigational Product|Overall Study||72
9725614|NCT00095498|10825212|FG001|Received Investigational Product|Overall Study||71
9725615|NCT00095498|10825213|FG002|Received Investigational Product|Overall Study||75
10023496|NCT01856530|11147148|FG000|COMPLETED|Overall Study||27
9725616|NCT00095498|10825211|FG000|COMPLETED|Overall Study||39
9725617|NCT00095498|10825212|FG001|COMPLETED|Overall Study||38
9725618|NCT00095498|10825213|FG002|COMPLETED|Overall Study||39
9725619|NCT00095498|10825211|FG000|NOT COMPLETED|Overall Study||37
9725620|NCT00095498|10825212|FG001|NOT COMPLETED|Overall Study||35
9725621|NCT00095498|10825213|FG002|NOT COMPLETED|Overall Study||39
9725622|NCT00095563|10825221|FG000|STARTED|Overall Study||39
9725623|NCT00095563|10825221|FG000|COMPLETED|Overall Study||39
9725624|NCT00095563|10825221|FG000|NOT COMPLETED|Overall Study||0
9725625|NCT00095576|10825227|FG000|STARTED|Overall Study||1484
9725626|NCT00095576|10825228|FG001|STARTED|Overall Study||1495
9725627|NCT00095576|10825227|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
9725628|NCT00095576|10825228|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
9725629|NCT00095576|10825227|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
9725630|NCT00095576|10825228|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
9725631|NCT00095576|10825227|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
9725632|NCT00095576|10825228|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
9725633|NCT00095576|10825227|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
9725634|NCT00095576|10825228|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
9725635|NCT00095576|10825227|FG000|NOT COMPLETED|Overall Study||1475
9725636|NCT00095576|10825228|FG001|NOT COMPLETED|Overall Study||1481
9725637|NCT00095628|10825234|FG000|STARTED|Overall Study||21
9725638|NCT00095628|10825234|FG000|COMPLETED|Overall Study||20
9725639|NCT00095628|10825234|FG000|NOT COMPLETED|Overall Study||1
9725640|NCT00095836|10825238|FG000|STARTED|Overall Study||27
9725641|NCT00095836|10825238|FG000|COMPLETED|Overall Study||23
9725642|NCT00095836|10825238|FG000|NOT COMPLETED|Overall Study||4
9725643|NCT00095875|10825244|FG000|STARTED|Overall Study||70
10023497|NCT01856530|11147149|FG001|COMPLETED|Overall Study||27
10023498|NCT01856530|11147148|FG000|NOT COMPLETED|Overall Study||0
9725644|NCT00095875|10825245|FG001|STARTED|Overall Study||75
9725645|NCT00095875|10825244|FG000|COMPLETED|Overall Study||56
9725646|NCT00095875|10825245|FG001|COMPLETED|Overall Study||66
9725647|NCT00095875|10825244|FG000|NOT COMPLETED|Overall Study||14
9725648|NCT00095875|10825245|FG001|NOT COMPLETED|Overall Study||9
9725649|NCT00095940|10825258|FG000|STARTED|Molecular Biology Phase||2
9725650|NCT00095940|10825259|FG001|STARTED|Molecular Biology Phase||2
9732176|NCT00141219|10832197|FG001|STARTED|Overall Study||78
9684215|NCT03613662|10784358|FG000|STARTED|Overall Study||19
9684216|NCT03613662|10784358|FG000|COMPLETED|Overall Study||19
9684217|NCT03613662|10784358|FG000|NOT COMPLETED|Overall Study||0
9684218|NCT03232736|10784364|FG000|STARTED|Overall Study||9
9684219|NCT03232736|10784365|FG001|STARTED|Overall Study||13
9684220|NCT03232736|10784364|FG000|COMPLETED|Overall Study||9
9684221|NCT03232736|10784365|FG001|COMPLETED|Overall Study||13
9684222|NCT03232736|10784364|FG000|NOT COMPLETED|Overall Study||0
9684223|NCT03232736|10784365|FG001|NOT COMPLETED|Overall Study||0
9684224|NCT03208530|10784375|FG000|STARTED|Overall Study||75
9684225|NCT03208530|10784375|FG000|COMPLETED|Overall Study||48
9684226|NCT03208530|10784375|FG000|NOT COMPLETED|Overall Study||27
9684227|NCT03158688|10784381|FG000|STARTED|Overall Study||154
9684228|NCT03158688|10784382|FG001|STARTED|Overall Study||312
9684229|NCT03158688|10784381|FG000|Treated|Overall Study||153
9684230|NCT03158688|10784382|FG001|Treated|Overall Study||308
9684231|NCT03158688|10784381|FG000|COMPLETED|Overall Study||0
9684232|NCT03158688|10784382|FG001|COMPLETED|Overall Study||0
9684233|NCT03158688|10784381|FG000|NOT COMPLETED|Overall Study||154
9684234|NCT03158688|10784382|FG001|NOT COMPLETED|Overall Study||312
9684235|NCT03103321|10784392|FG000|STARTED|Overall Study||25
9684236|NCT03103321|10784393|FG001|STARTED|Overall Study||39
9684237|NCT03103321|10784394|FG002|STARTED|Overall Study||44
9684238|NCT03103321|10784395|FG003|STARTED|Overall Study||50
9684239|NCT03103321|10784392|FG000|COMPLETED|Overall Study||24
9684240|NCT03103321|10784393|FG001|COMPLETED|Overall Study||38
9684241|NCT03103321|10784394|FG002|COMPLETED|Overall Study||43
9684242|NCT03103321|10784395|FG003|COMPLETED|Overall Study||50
9684243|NCT03103321|10784392|FG000|NOT COMPLETED|Overall Study||1
9684244|NCT03103321|10784393|FG001|NOT COMPLETED|Overall Study||1
9684245|NCT03103321|10784394|FG002|NOT COMPLETED|Overall Study||1
9684246|NCT03103321|10784395|FG003|NOT COMPLETED|Overall Study||0
9684247|NCT03079869|10784407|FG000|STARTED|Overall Study||28
9684248|NCT03079869|10784408|FG001|STARTED|Overall Study||27
9684249|NCT03079869|10784407|FG000|COMPLETED|Overall Study||15
9684250|NCT03079869|10784408|FG001|COMPLETED|Overall Study||16
9684251|NCT03079869|10784407|FG000|NOT COMPLETED|Overall Study||13
9684252|NCT03079869|10784408|FG001|NOT COMPLETED|Overall Study||11
9684253|NCT03033875|10784417|FG000|STARTED|Overall Study||96
9684254|NCT03033875|10784418|FG001|STARTED|Overall Study||111
9684255|NCT03033875|10784419|FG002|STARTED|Overall Study||54
9684256|NCT03033875|10784417|FG000|Completed Month 3 Assessment|Overall Study||71
9684257|NCT03033875|10784418|FG001|Completed Month 3 Assessment|Overall Study||83
9684258|NCT03033875|10784419|FG002|Completed Month 3 Assessment|Overall Study||43
9684259|NCT03033875|10784417|FG000|Completed Month 6 Assessment|Overall Study||73
9684260|NCT03033875|10784418|FG001|Completed Month 6 Assessment|Overall Study||81
9684261|NCT03033875|10784419|FG002|Completed Month 6 Assessment|Overall Study||46
9684262|NCT03033875|10784417|FG000|COMPLETED|Overall Study||77
9684263|NCT03033875|10784418|FG001|COMPLETED|Overall Study||87
9684264|NCT03033875|10784419|FG002|COMPLETED|Overall Study||42
9684265|NCT03033875|10784417|FG000|NOT COMPLETED|Overall Study||19
9684266|NCT03033875|10784418|FG001|NOT COMPLETED|Overall Study||24
9684267|NCT03033875|10784419|FG002|NOT COMPLETED|Overall Study||12
9684268|NCT02935595|10784427|FG000|STARTED|Overall Study||5
9684269|NCT02935595|10784427|FG000|COMPLETED|Overall Study||4
9684270|NCT02935595|10784427|FG000|NOT COMPLETED|Overall Study||1
9684271|NCT02887248|10784431|FG000|STARTED|Overall Study||3
9684272|NCT02887248|10784431|FG000|COMPLETED|Overall Study||0
9684273|NCT02887248|10784431|FG000|NOT COMPLETED|Overall Study||3
9684274|NCT02849990|10784435|FG000|STARTED|Overall Study||22
9684275|NCT02849990|10784435|FG000|COMPLETED|Overall Study||20
9684276|NCT02849990|10784435|FG000|NOT COMPLETED|Overall Study||2
9684277|NCT02673151|10784439|FG000|STARTED|Overall Study||61
9684278|NCT02673151|10784439|FG000|COMPLETED|Overall Study||61
9684279|NCT02673151|10784439|FG000|NOT COMPLETED|Overall Study||0
9684280|NCT02523274|10784451|FG000|STARTED|Overall Study||20
9684281|NCT02523274|10784452|FG001|STARTED|Overall Study||20
9684282|NCT02523274|10784453|FG002|STARTED|Overall Study||20
9684283|NCT02523274|10784451|FG000|COMPLETED|Overall Study||19
9684284|NCT02523274|10784452|FG001|COMPLETED|Overall Study||18
9684285|NCT02523274|10784453|FG002|COMPLETED|Overall Study||18
9684286|NCT02523274|10784451|FG000|NOT COMPLETED|Overall Study||1
9684287|NCT02523274|10784452|FG001|NOT COMPLETED|Overall Study||2
9684288|NCT02523274|10784453|FG002|NOT COMPLETED|Overall Study||2
9684289|NCT02467270|10784468|FG000|STARTED|Overall Study||94
9684290|NCT02467270|10784469|FG001|STARTED|Overall Study||95
9684291|NCT02467270|10784470|FG002|STARTED|Overall Study||94
9684292|NCT02467270|10784468|FG000|Treated (Safety Population)|Overall Study||94
9684293|NCT02467270|10784469|FG001|Treated (Safety Population)|Overall Study||94
9684294|NCT02467270|10784470|FG002|Treated (Safety Population)|Overall Study||94
9684295|NCT02467270|10784468|FG000|COMPLETED|Overall Study||0
9684296|NCT02467270|10784469|FG001|COMPLETED|Overall Study||0
9684297|NCT02467270|10784470|FG002|COMPLETED|Overall Study||0
9684298|NCT02467270|10784468|FG000|NOT COMPLETED|Overall Study||94
9684299|NCT02467270|10784469|FG001|NOT COMPLETED|Overall Study||95
9684300|NCT02467270|10784470|FG002|NOT COMPLETED|Overall Study||94
9684301|NCT02452554|10784484|FG000|STARTED|Overall Study||17
9684302|NCT02452554|10784485|FG001|STARTED|Overall Study||17
9684303|NCT02452554|10784486|FG002|STARTED|Overall Study||12
9684304|NCT02452554|10784487|FG003|STARTED|Overall Study||1
9684305|NCT02452554|10784488|FG004|STARTED|Overall Study||5
9684306|NCT02452554|10784489|FG005|STARTED|Overall Study||10
9684307|NCT02452554|10784484|FG000|COMPLETED|Overall Study||0
9684308|NCT02452554|10784485|FG001|COMPLETED|Overall Study||0
9684309|NCT02452554|10784486|FG002|COMPLETED|Overall Study||1
9684310|NCT02452554|10784487|FG003|COMPLETED|Overall Study||0
9684311|NCT02452554|10784488|FG004|COMPLETED|Overall Study||0
9684312|NCT02452554|10784489|FG005|COMPLETED|Overall Study||1
9684313|NCT02452554|10784484|FG000|NOT COMPLETED|Overall Study||17
9684314|NCT02452554|10784485|FG001|NOT COMPLETED|Overall Study||17
9684315|NCT02452554|10784486|FG002|NOT COMPLETED|Overall Study||11
9684316|NCT02452554|10784487|FG003|NOT COMPLETED|Overall Study||1
9684317|NCT02452554|10784488|FG004|NOT COMPLETED|Overall Study||5
9684318|NCT02452554|10784489|FG005|NOT COMPLETED|Overall Study||9
9684319|NCT02427568|10784506|FG000|STARTED|Overall Study||5
9684320|NCT02427568|10784507|FG001|STARTED|Overall Study||13
9684321|NCT02427568|10784506|FG000|COMPLETED|Overall Study||5
9684322|NCT02427568|10784507|FG001|COMPLETED|Overall Study||13
9684323|NCT02427568|10784506|FG000|NOT COMPLETED|Overall Study||0
9684324|NCT02427568|10784507|FG001|NOT COMPLETED|Overall Study||0
9684325|NCT02318277|10784525|FG000|STARTED|Overall Study||6
9684326|NCT02318277|10784526|FG001|STARTED|Overall Study||3
9684327|NCT02318277|10784527|FG002|STARTED|Overall Study||4
9684328|NCT02318277|10784528|FG003|STARTED|Overall Study||4
9684329|NCT02318277|10784529|FG004|STARTED|Overall Study||8
9684330|NCT02318277|10784530|FG005|STARTED|Overall Study||9
9684331|NCT02318277|10784531|FG006|STARTED|Overall Study||49
9684332|NCT02318277|10784532|FG007|STARTED|Overall Study||93
9684333|NCT02318277|10784525|FG000|COMPLETED|Overall Study||0
9684334|NCT02318277|10784526|FG001|COMPLETED|Overall Study||0
9684335|NCT02318277|10784527|FG002|COMPLETED|Overall Study||0
9684336|NCT02318277|10784528|FG003|COMPLETED|Overall Study||0
9684337|NCT02318277|10784529|FG004|COMPLETED|Overall Study||0
9684338|NCT02318277|10784530|FG005|COMPLETED|Overall Study||0
9684339|NCT02318277|10784531|FG006|COMPLETED|Overall Study||0
9684340|NCT02318277|10784532|FG007|COMPLETED|Overall Study||0
9684341|NCT02318277|10784525|FG000|NOT COMPLETED|Overall Study||6
9684342|NCT02318277|10784526|FG001|NOT COMPLETED|Overall Study||3
9684343|NCT02318277|10784527|FG002|NOT COMPLETED|Overall Study||4
9684344|NCT02318277|10784528|FG003|NOT COMPLETED|Overall Study||4
9684345|NCT02318277|10784529|FG004|NOT COMPLETED|Overall Study||8
9684346|NCT02318277|10784530|FG005|NOT COMPLETED|Overall Study||9
9684347|NCT02318277|10784531|FG006|NOT COMPLETED|Overall Study||49
9684348|NCT02318277|10784532|FG007|NOT COMPLETED|Overall Study||93
9684349|NCT02296801|10784568|FG000|STARTED|Overall Study||103
9684350|NCT02296801|10784569|FG001|STARTED|Overall Study||68
9684351|NCT02296801|10784570|FG002|STARTED|Overall Study||69
9684352|NCT02296801|10784571|FG003|STARTED|Overall Study||67
9684353|NCT02296801|10784568|FG000|COMPLETED|Overall Study||83
9684354|NCT02296801|10784569|FG001|COMPLETED|Overall Study||53
9684355|NCT02296801|10784570|FG002|COMPLETED|Overall Study||50
9684356|NCT02296801|10784571|FG003|COMPLETED|Overall Study||58
9684357|NCT02296801|10784568|FG000|NOT COMPLETED|Overall Study||20
9684358|NCT02296801|10784569|FG001|NOT COMPLETED|Overall Study||15
9684359|NCT02296801|10784570|FG002|NOT COMPLETED|Overall Study||19
9684360|NCT02296801|10784571|FG003|NOT COMPLETED|Overall Study||9
9684361|NCT02143063|10784588|FG000|STARTED|Overall Study||61
9684362|NCT02143063|10784589|FG001|STARTED|Overall Study||105
9684363|NCT02143063|10784590|FG002|STARTED|Overall Study||108
9684364|NCT02143063|10784588|FG000|COMPLETED|Overall Study||45
9684365|NCT02143063|10784589|FG001|COMPLETED|Overall Study||75
9684366|NCT02143063|10784590|FG002|COMPLETED|Overall Study||78
9684367|NCT02143063|10784588|FG000|NOT COMPLETED|Overall Study||16
9684368|NCT02143063|10784589|FG001|NOT COMPLETED|Overall Study||30
9684369|NCT02143063|10784590|FG002|NOT COMPLETED|Overall Study||30
9684370|NCT02017964|10784598|FG000|STARTED|Overall Study||26
9684371|NCT02017964|10784598|FG000|COMPLETED|Overall Study||25
9684372|NCT02017964|10784598|FG000|NOT COMPLETED|Overall Study||1
9684373|NCT01968785|10784604|FG000|STARTED|Overall Study||2
9684374|NCT01968785|10784605|FG001|STARTED|Overall Study||0
9684375|NCT01968785|10784604|FG000|COMPLETED|Overall Study||1
9684376|NCT01968785|10784605|FG001|COMPLETED|Overall Study||0
9684377|NCT01968785|10784604|FG000|NOT COMPLETED|Overall Study||1
9684378|NCT01968785|10784605|FG001|NOT COMPLETED|Overall Study||0
9684379|NCT01956110|10784613|FG000|STARTED|Overall Study||665
9684380|NCT01956110|10784614|FG001|STARTED|Overall Study||661
9684381|NCT01956110|10784613|FG000|COMPLETED|Overall Study||630
9684382|NCT01956110|10784614|FG001|COMPLETED|Overall Study||639
9684383|NCT01956110|10784613|FG000|NOT COMPLETED|Overall Study||35
9684384|NCT01956110|10784614|FG001|NOT COMPLETED|Overall Study||22
9684385|NCT01648023|10784623|FG000|STARTED|Overall Study||25
9684386|NCT01648023|10784624|FG001|STARTED|Overall Study||24
9684387|NCT01648023|10784623|FG000|COMPLETED|Overall Study||24
9684388|NCT01648023|10784624|FG001|COMPLETED|Overall Study||22
9684389|NCT01648023|10784623|FG000|NOT COMPLETED|Overall Study||1
9684390|NCT01648023|10784624|FG001|NOT COMPLETED|Overall Study||2
9684391|NCT01335581|10784632|FG000|STARTED|Overall Study||9
9684392|NCT01335581|10784633|FG001|STARTED|Overall Study||9
9684393|NCT01335581|10784632|FG000|COMPLETED|Overall Study||5
9684394|NCT01335581|10784633|FG001|COMPLETED|Overall Study||3
9684395|NCT01335581|10784632|FG000|NOT COMPLETED|Overall Study||4
9684396|NCT01335581|10784633|FG001|NOT COMPLETED|Overall Study||6
9684397|NCT01209923|10784639|FG000|STARTED|Overall Study||362
9684398|NCT01209923|10784639|FG000|COMPLETED|Overall Study||362
9684399|NCT01209923|10784639|FG000|NOT COMPLETED|Overall Study||0
9684400|NCT01083433|10784647|FG000|STARTED|Overall Study||22
9684401|NCT01083433|10784648|FG001|STARTED|Overall Study||23
9684402|NCT01083433|10784649|FG002|STARTED|Overall Study||23
9684403|NCT01083433|10784647|FG000|COMPLETED|Overall Study||20
9684404|NCT01083433|10784648|FG001|COMPLETED|Overall Study||17
9684405|NCT01083433|10784649|FG002|COMPLETED|Overall Study||18
9684406|NCT01083433|10784647|FG000|NOT COMPLETED|Overall Study||2
9684407|NCT01083433|10784648|FG001|NOT COMPLETED|Overall Study||6
9684408|NCT01083433|10784649|FG002|NOT COMPLETED|Overall Study||5
9684409|NCT00787176|10784665|FG000|STARTED|Overall Study||69
9684410|NCT00787176|10784666|FG001|STARTED|Overall Study||62
9684411|NCT00787176|10784667|FG002|STARTED|Overall Study||60
9684412|NCT00787176|10784668|FG003|STARTED|Overall Study||60
9684413|NCT00787176|10784665|FG000|COMPLETED|Overall Study||62
9684414|NCT00787176|10784666|FG001|COMPLETED|Overall Study||59
9684415|NCT00787176|10784667|FG002|COMPLETED|Overall Study||54
9684416|NCT00787176|10784668|FG003|COMPLETED|Overall Study||55
9684417|NCT00787176|10784665|FG000|NOT COMPLETED|Overall Study||7
9684418|NCT00787176|10784666|FG001|NOT COMPLETED|Overall Study||3
9684419|NCT00787176|10784667|FG002|NOT COMPLETED|Overall Study||6
9684420|NCT00787176|10784668|FG003|NOT COMPLETED|Overall Study||5
9725651|NCT00095940|10825260|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
9725652|NCT00095940|10825261|FG003|STARTED|Molecular Biology Phase||0
9725653|NCT00095940|10825262|FG004|STARTED|Molecular Biology Phase||0
9725654|NCT00095940|10825263|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
9725655|NCT00095940|10825264|FG006|STARTED|Molecular Biology Phase||2
9725656|NCT00095940|10825265|FG007|STARTED|Molecular Biology Phase||2
9725657|NCT00095940|10825266|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
9725658|NCT00095940|10825258|FG000|COMPLETED|Molecular Biology Phase||2
9725659|NCT00095940|10825259|FG001|COMPLETED|Molecular Biology Phase||2
9725660|NCT00095940|10825260|FG002|COMPLETED|Molecular Biology Phase||0
9725661|NCT00095940|10825261|FG003|COMPLETED|Molecular Biology Phase||0
9725662|NCT00095940|10825262|FG004|COMPLETED|Molecular Biology Phase||0
9725663|NCT00095940|10825263|FG005|COMPLETED|Molecular Biology Phase||0
9725664|NCT00095940|10825264|FG006|COMPLETED|Molecular Biology Phase||2
9725665|NCT00095940|10825265|FG007|COMPLETED|Molecular Biology Phase||2
9725666|NCT00095940|10825266|FG008|COMPLETED|Molecular Biology Phase||0
9725667|NCT00095940|10825258|FG000|NOT COMPLETED|Molecular Biology Phase||0
9725668|NCT00095940|10825259|FG001|NOT COMPLETED|Molecular Biology Phase||0
9725669|NCT00095940|10825260|FG002|NOT COMPLETED|Molecular Biology Phase||0
9725670|NCT00095940|10825261|FG003|NOT COMPLETED|Molecular Biology Phase||0
9725671|NCT00095940|10825262|FG004|NOT COMPLETED|Molecular Biology Phase||0
9725672|NCT00095940|10825263|FG005|NOT COMPLETED|Molecular Biology Phase||0
9725673|NCT00095940|10825264|FG006|NOT COMPLETED|Molecular Biology Phase||0
9725674|NCT00095940|10825265|FG007|NOT COMPLETED|Molecular Biology Phase||0
9725675|NCT00095940|10825266|FG008|NOT COMPLETED|Molecular Biology Phase||0
9725676|NCT00095940|10825258|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
9725677|NCT00095940|10825259|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
9725678|NCT00095940|10825260|FG002|STARTED|Lapatinib Continuation/Phase II||17
9725679|NCT00095940|10825261|FG003|STARTED|Lapatinib Continuation/Phase II||0
9725680|NCT00095940|10825262|FG004|STARTED|Lapatinib Continuation/Phase II||0
9725681|NCT00095940|10825263|FG005|STARTED|Lapatinib Continuation/Phase II||13
9725682|NCT00095940|10825264|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
9725683|NCT00095940|10825265|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
9725684|NCT00095940|10825266|FG008|STARTED|Lapatinib Continuation/Phase II||14
9725685|NCT00095940|10825258|FG000|COMPLETED|Lapatinib Continuation/Phase II||0
9725686|NCT00095940|10825259|FG001|COMPLETED|Lapatinib Continuation/Phase II||0
9725687|NCT00095940|10825260|FG002|COMPLETED|Lapatinib Continuation/Phase II||1
9725688|NCT00095940|10825261|FG003|COMPLETED|Lapatinib Continuation/Phase II||0
9725689|NCT00095940|10825262|FG004|COMPLETED|Lapatinib Continuation/Phase II||0
9725690|NCT00095940|10825263|FG005|COMPLETED|Lapatinib Continuation/Phase II||0
9725691|NCT00095940|10825264|FG006|COMPLETED|Lapatinib Continuation/Phase II||0
9725692|NCT00095940|10825265|FG007|COMPLETED|Lapatinib Continuation/Phase II||0
9725693|NCT00095940|10825266|FG008|COMPLETED|Lapatinib Continuation/Phase II||1
9725694|NCT00095940|10825258|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2
9725695|NCT00095940|10825259|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2
9725696|NCT00095940|10825260|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16
9725697|NCT00095940|10825261|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0
9725698|NCT00095940|10825262|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0
9725699|NCT00095940|10825263|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13
9725700|NCT00095940|10825264|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2
9725701|NCT00095940|10825265|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2
9725702|NCT00095940|10825266|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13
9725703|NCT00095979|10825284|FG000|STARTED|Overall Study||52
9725704|NCT00095979|10825284|FG000|COMPLETED|Overall Study||50
9725705|NCT00095979|10825284|FG000|NOT COMPLETED|Overall Study||2
9725706|NCT00096018|10825295|FG000|STARTED|Overall Study||13
9725707|NCT00096018|10825296|FG001|STARTED|Overall Study||30
9725708|NCT00096018|10825295|FG000|Treated With Study Therapy|Overall Study||13
9684421|NCT00352534|10784681|FG000|STARTED|Initial Staging||211
9684422|NCT00352534|10784682|FG001|STARTED|Initial Staging||597
9684423|NCT00352534|10784683|FG002|STARTED|Initial Staging||0
9684424|NCT00352534|10784684|FG003|STARTED|Initial Staging||0
9684425|NCT00352534|10784685|FG004|STARTED|Initial Staging||0
9684426|NCT00352534|10784686|FG005|STARTED|Initial Staging||0
9684427|NCT00352534|10784687|FG006|STARTED|Initial Staging||0
9684428|NCT00352534|10784681|FG000|COMPLETED|Initial Staging||203
9684429|NCT00352534|10784682|FG001|COMPLETED|Initial Staging||588
9684430|NCT00352534|10784683|FG002|COMPLETED|Initial Staging||0
9684431|NCT00352534|10784684|FG003|COMPLETED|Initial Staging||0
9684432|NCT00352534|10784685|FG004|COMPLETED|Initial Staging||0
9684433|NCT00352534|10784686|FG005|COMPLETED|Initial Staging||0
9684434|NCT00352534|10784687|FG006|COMPLETED|Initial Staging||0
9684435|NCT00352534|10784681|FG000|NOT COMPLETED|Initial Staging||8
9684436|NCT00352534|10784682|FG001|NOT COMPLETED|Initial Staging||9
9684437|NCT00352534|10784683|FG002|NOT COMPLETED|Initial Staging||0
9684438|NCT00352534|10784684|FG003|NOT COMPLETED|Initial Staging||0
9684439|NCT00352534|10784685|FG004|NOT COMPLETED|Initial Staging||0
9684440|NCT00352534|10784686|FG005|NOT COMPLETED|Initial Staging||0
9684441|NCT00352534|10784687|FG006|NOT COMPLETED|Initial Staging||0
9684442|NCT00352534|10784681|FG000|STARTED|Final Risk Group Assignment||0
9684443|NCT00352534|10784682|FG001|STARTED|Final Risk Group Assignment||0
9684444|NCT00352534|10784683|FG002|STARTED|Final Risk Group Assignment||119
9684445|NCT00352534|10784684|FG003|STARTED|Final Risk Group Assignment||52
9684446|NCT00352534|10784685|FG004|STARTED|Final Risk Group Assignment||32
9684447|NCT00352534|10784686|FG005|STARTED|Final Risk Group Assignment||548
9684448|NCT00352534|10784687|FG006|STARTED|Final Risk Group Assignment||40
9684449|NCT00352534|10784681|FG000|COMPLETED|Final Risk Group Assignment||0
9684450|NCT00352534|10784682|FG001|COMPLETED|Final Risk Group Assignment||0
9684451|NCT00352534|10784683|FG002|COMPLETED|Final Risk Group Assignment||116
9684452|NCT00352534|10784684|FG003|COMPLETED|Final Risk Group Assignment||49
9684453|NCT00352534|10784685|FG004|COMPLETED|Final Risk Group Assignment||31
9684454|NCT00352534|10784686|FG005|COMPLETED|Final Risk Group Assignment||503
9684455|NCT00352534|10784687|FG006|COMPLETED|Final Risk Group Assignment||1
9684456|NCT00352534|10784681|FG000|NOT COMPLETED|Final Risk Group Assignment||0
9684457|NCT00352534|10784682|FG001|NOT COMPLETED|Final Risk Group Assignment||0
9684458|NCT00352534|10784683|FG002|NOT COMPLETED|Final Risk Group Assignment||3
9684459|NCT00352534|10784684|FG003|NOT COMPLETED|Final Risk Group Assignment||3
9684460|NCT00352534|10784685|FG004|NOT COMPLETED|Final Risk Group Assignment||1
9684461|NCT00352534|10784686|FG005|NOT COMPLETED|Final Risk Group Assignment||45
9684462|NCT00352534|10784687|FG006|NOT COMPLETED|Final Risk Group Assignment||39
9684463|NCT00033293|10784699|FG000|STARTED|Overall Study||26
9684464|NCT00033293|10784700|FG001|STARTED|Overall Study||27
9684465|NCT00033293|10784699|FG000|COMPLETED|Overall Study||16
9684466|NCT00033293|10784700|FG001|COMPLETED|Overall Study||9
9684467|NCT00033293|10784699|FG000|NOT COMPLETED|Overall Study||10
9684468|NCT00033293|10784700|FG001|NOT COMPLETED|Overall Study||18
9725709|NCT00096018|10825296|FG001|Treated With Study Therapy|Overall Study||25
9725710|NCT00096018|10825295|FG000|COMPLETED|Overall Study||11
9725711|NCT00096018|10825296|FG001|COMPLETED|Overall Study||16
9725712|NCT00096018|10825295|FG000|NOT COMPLETED|Overall Study||2
9725713|NCT00096018|10825296|FG001|NOT COMPLETED|Overall Study||14
9725714|NCT00096031|10825302|FG000|STARTED|Overall Study||63
9725715|NCT00096031|10825302|FG000|Eligible|Overall Study||57
9725716|NCT00096031|10825302|FG000|Eligible and Began Protocol Therapy|Overall Study||55
9725717|NCT00096031|10825302|FG000|COMPLETED|Overall Study||0
9725718|NCT00096031|10825302|FG000|NOT COMPLETED|Overall Study||63
9725719|NCT00096044|10825306|FG000|STARTED|Overall Study||45
9725720|NCT00096044|10825306|FG000|COMPLETED|Overall Study||11
9725721|NCT00096044|10825306|FG000|NOT COMPLETED|Overall Study||34
9725722|NCT00096109|10825310|FG000|STARTED|Overall Study||11
9725723|NCT00096109|10825310|FG000|COMPLETED|Overall Study||11
9725724|NCT00096109|10825310|FG000|NOT COMPLETED|Overall Study||0
9725725|NCT00096122|10825314|FG000|STARTED|Overall Study||95
9725726|NCT00096122|10825314|FG000|COMPLETED|Overall Study||95
9725727|NCT00096122|10825314|FG000|NOT COMPLETED|Overall Study||0
9725728|NCT00096135|10825320|FG000|STARTED|Overall Study||126
9725729|NCT00096135|10825321|FG001|STARTED|Overall Study||42
9725730|NCT00096135|10825320|FG000|COMPLETED|Overall Study||63
9725731|NCT00096135|10825321|FG001|COMPLETED|Overall Study||27
9725732|NCT00096135|10825320|FG000|NOT COMPLETED|Overall Study||63
9725733|NCT00096135|10825321|FG001|NOT COMPLETED|Overall Study||15
9725734|NCT00096161|10825331|FG000|STARTED|Overall Study||20
9725735|NCT00096161|10825332|FG001|STARTED|Overall Study||10
9725736|NCT00096161|10825333|FG002|STARTED|Overall Study||6
9725737|NCT00096161|10825334|FG003|STARTED|Overall Study||0
9725738|NCT00096161|10825331|FG000|COMPLETED|Overall Study||20
9725739|NCT00096161|10825332|FG001|COMPLETED|Overall Study||10
9725740|NCT00096161|10825333|FG002|COMPLETED|Overall Study||6
9725741|NCT00096161|10825334|FG003|COMPLETED|Overall Study||0
9725742|NCT00096161|10825331|FG000|NOT COMPLETED|Overall Study||0
9725743|NCT00096161|10825332|FG001|NOT COMPLETED|Overall Study||0
9725744|NCT00096161|10825333|FG002|NOT COMPLETED|Overall Study||0
9725745|NCT00096161|10825334|FG003|NOT COMPLETED|Overall Study||0
9725746|NCT00096174|10825344|FG000|STARTED|Overall Study||69
9725747|NCT00096174|10825344|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
9725748|NCT00096174|10825344|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
9725749|NCT00096174|10825344|FG000|COMPLETED|Overall Study||7
9725750|NCT00096174|10825344|FG000|NOT COMPLETED|Overall Study||62
9725751|NCT00096226|10825348|FG000|STARTED|Overall Study||60
9725752|NCT00096226|10825348|FG000|Eligible|Overall Study||57
9725753|NCT00096226|10825348|FG000|Eligible and Underwent Surgery|Overall Study||37
9725754|NCT00096226|10825348|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
9725755|NCT00096226|10825348|FG000|NOT COMPLETED|Overall Study||3
9725756|NCT00096265|10825355|FG000|STARTED|Overall Study||45
9725757|NCT00096265|10825356|FG001|STARTED|Overall Study||40
9725758|NCT00096265|10825357|FG002|STARTED|Overall Study||41
9725759|NCT00096265|10825355|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
9725760|NCT00096265|10825356|FG001|COMPLETED|Overall Study||40
9725761|NCT00096265|10825357|FG002|COMPLETED|Overall Study||41
9725762|NCT00096265|10825355|FG000|NOT COMPLETED|Overall Study||1
9725763|NCT00096265|10825356|FG001|NOT COMPLETED|Overall Study||0
9725764|NCT00096265|10825357|FG002|NOT COMPLETED|Overall Study||0
9725765|NCT00096278|10825368|FG000|STARTED|Overall Study||1356
9725766|NCT00096278|10825369|FG001|STARTED|Overall Study||1354
9725767|NCT00096278|10825368|FG000|COMPLETED|Overall Study||1338
9725768|NCT00096278|10825369|FG001|COMPLETED|Overall Study||1334
9725769|NCT00096278|10825368|FG000|NOT COMPLETED|Overall Study||18
9725770|NCT00096278|10825369|FG001|NOT COMPLETED|Overall Study||20
9725771|NCT00096356|10825379|FG000|STARTED|Overall Study||122
9725772|NCT00096356|10825380|FG001|STARTED|Overall Study||114
9725773|NCT00096356|10825379|FG000|COMPLETED|Overall Study||78
9725774|NCT00096356|10825380|FG001|COMPLETED|Overall Study||61
9684469|NCT04497415|10784710|FG000|STARTED|Overall Study||229
9684470|NCT04497415|10784711|FG001|STARTED|Overall Study||121
9684471|NCT04497415|10784710|FG000|Post-intervention Assessment (Day 1)|Overall Study||229
9684472|NCT04497415|10784711|FG001|Post-intervention Assessment (Day 1)|Overall Study||121
9684473|NCT04497415|10784710|FG000|First Follow-up Assessment (Day 14)|Overall Study||195
9684474|NCT04497415|10784711|FG001|First Follow-up Assessment (Day 14)|Overall Study||102
9684475|NCT04497415|10784710|FG000|COMPLETED|Overall Study||186
9684476|NCT04497415|10784711|FG001|COMPLETED|Overall Study||94
9684477|NCT04497415|10784710|FG000|NOT COMPLETED|Overall Study||43
9684478|NCT04497415|10784711|FG001|NOT COMPLETED|Overall Study||27
9684494|NCT04975321|10784742|FG000|STARTED|Overall Study||25
9684495|NCT04975321|10784743|FG001|STARTED|Overall Study||26
9684496|NCT04975321|10784744|FG002|STARTED|Overall Study||25
9684497|NCT04975321|10784742|FG000|COMPLETED|Overall Study||15
9684498|NCT04975321|10784743|FG001|COMPLETED|Overall Study||15
9684499|NCT04975321|10784744|FG002|COMPLETED|Overall Study||17
9684500|NCT04975321|10784742|FG000|NOT COMPLETED|Overall Study||10
9684501|NCT04975321|10784743|FG001|NOT COMPLETED|Overall Study||11
9684502|NCT04975321|10784744|FG002|NOT COMPLETED|Overall Study||8
9684503|NCT04594759|10784752|FG000|STARTED|Overall Study||22
9684504|NCT04594759|10784752|FG000|COMPLETED|Overall Study||19
9684505|NCT04594759|10784752|FG000|NOT COMPLETED|Overall Study||3
9684506|NCT04463069|10784758|FG000|STARTED|Overall Study||41
9684507|NCT04463069|10784759|FG001|STARTED|Overall Study||45
9684508|NCT04463069|10784758|FG000|COMPLETED|Overall Study||39
9684509|NCT04463069|10784759|FG001|COMPLETED|Overall Study||22
9684510|NCT04463069|10784758|FG000|NOT COMPLETED|Overall Study||2
9684511|NCT04463069|10784759|FG001|NOT COMPLETED|Overall Study||23
9684512|NCT04250337|10784767|FG000|STARTED|Overall Study||75
9684513|NCT04250337|10784768|FG001|STARTED|Overall Study||153
9684514|NCT04250337|10784767|FG000|Received at Least One Dose of Study Drug|Overall Study||75
9684515|NCT04250337|10784768|FG001|Received at Least One Dose of Study Drug|Overall Study||153
9684516|NCT04250337|10784767|FG000|COMPLETED|Overall Study||67
9684517|NCT04250337|10784768|FG001|COMPLETED|Overall Study||142
9684518|NCT04250337|10784767|FG000|NOT COMPLETED|Overall Study||8
9844554|NCT00837512|10956567|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
9844555|NCT00837512|10956566|FG000|STARTED|Both Arms: Washout (7-28 Days)||8
9844556|NCT00837512|10956567|FG001|STARTED|Both Arms: Washout (7-28 Days)||8
9844557|NCT00837512|10956566|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8
9844558|NCT00837512|10956567|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8
9844559|NCT00837512|10956566|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
9844560|NCT00837512|10956567|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
9844561|NCT00837512|10956566|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
9844562|NCT00837512|10956567|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
9844563|NCT00837512|10956566|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
9844564|NCT00837512|10956567|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
9844565|NCT00837512|10956566|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
9844566|NCT00837512|10956567|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
9844567|NCT00837577|10956575|FG000|STARTED|Double-blind Period||70
9844568|NCT00837577|10956576|FG001|STARTED|Double-blind Period||63
9844569|NCT00837577|10956575|FG000|COMPLETED|Double-blind Period||68
9844570|NCT00837577|10956576|FG001|COMPLETED|Double-blind Period||63
9844571|NCT00837577|10956575|FG000|NOT COMPLETED|Double-blind Period||2
9844572|NCT00837577|10956576|FG001|NOT COMPLETED|Double-blind Period||0
9844573|NCT00837577|10956575|FG000|STARTED|Open-label Period||68
9844574|NCT00837577|10956576|FG001|STARTED|Open-label Period||63
9844575|NCT00837577|10956575|FG000|COMPLETED|Open-label Period||60
9844576|NCT00837577|10956576|FG001|COMPLETED|Open-label Period||54
9844577|NCT00837577|10956575|FG000|NOT COMPLETED|Open-label Period||8
9844578|NCT00837577|10956576|FG001|NOT COMPLETED|Open-label Period||9
9844579|NCT00837590|10956586|FG000|STARTED|Overall Study||6
9844580|NCT00837590|10956587|FG001|STARTED|Overall Study||5
9844581|NCT00837590|10956588|FG002|STARTED|Overall Study||5
9844582|NCT00837590|10956586|FG000|COMPLETED|Overall Study||6
9844583|NCT00837590|10956587|FG001|COMPLETED|Overall Study||4
9844584|NCT00837590|10956588|FG002|COMPLETED|Overall Study||4
9844585|NCT00837590|10956586|FG000|NOT COMPLETED|Overall Study||0
9844586|NCT00837590|10956587|FG001|NOT COMPLETED|Overall Study||1
9844587|NCT00837590|10956588|FG002|NOT COMPLETED|Overall Study||1
9844588|NCT00837616|10956598|FG000|STARTED|Overall Study||20
9844589|NCT00837616|10956599|FG001|STARTED|Overall Study||21
9844590|NCT00837616|10956598|FG000|COMPLETED|Overall Study||20
9960851|NCT01469221|11080480|FG002|COMPLETED|Double Blind Phase||0
9960852|NCT01469221|11080478|FG000|NOT COMPLETED|Double Blind Phase||14
9960853|NCT01469221|11080479|FG001|NOT COMPLETED|Double Blind Phase||17
9960854|NCT01469221|11080480|FG002|NOT COMPLETED|Double Blind Phase||0
9684519|NCT04250337|10784768|FG001|NOT COMPLETED|Overall Study||11
9684520|NCT04126733|10784775|FG000|STARTED|Treatment Period||70
9684521|NCT04126733|10784775|FG000|COMPLETED|Treatment Period||0
9684522|NCT04126733|10784775|FG000|NOT COMPLETED|Treatment Period||70
9684523|NCT04126733|10784775|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|34
9844591|NCT00837616|10956599|FG001|COMPLETED|Overall Study||20
9844592|NCT00837616|10956598|FG000|NOT COMPLETED|Overall Study||0
9844593|NCT00837616|10956599|FG001|NOT COMPLETED|Overall Study||1
9844594|NCT00837694|10956611|FG000|STARTED|Overall Study||10
9844595|NCT00837694|10956612|FG001|STARTED|Overall Study||11
9684479|NCT04231396|10784717|FG000|STARTED|Overall Study||27
9684480|NCT04231396|10784717|FG000|COMPLETED|Overall Study||27
9684481|NCT04231396|10784717|FG000|NOT COMPLETED|Overall Study||0
9684482|NCT04118348|10784726|FG000|STARTED|Overall Study||3445
9684483|NCT04118348|10784727|FG001|STARTED|Overall Study||3312
9684484|NCT04118348|10784728|FG002|STARTED|Overall Study||3461
9684485|NCT04118348|10784729|FG003|STARTED|Overall Study||3262
9684486|NCT04118348|10784726|FG000|COMPLETED|Overall Study||3445
9684487|NCT04118348|10784727|FG001|COMPLETED|Overall Study||3312
9684488|NCT04118348|10784728|FG002|COMPLETED|Overall Study||3461
9684489|NCT04118348|10784729|FG003|COMPLETED|Overall Study||3262
9684490|NCT04118348|10784726|FG000|NOT COMPLETED|Overall Study||0
9684491|NCT04118348|10784727|FG001|NOT COMPLETED|Overall Study||0
9684492|NCT04118348|10784728|FG002|NOT COMPLETED|Overall Study||0
9684493|NCT04118348|10784729|FG003|NOT COMPLETED|Overall Study||0
9684524|NCT04126733|10784775|FG000|COMPLETED|Active Follow-up Period||14
9684525|NCT04126733|10784775|FG000|NOT COMPLETED|Active Follow-up Period||20
9684526|NCT04126733|10784775|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|6
9684527|NCT04126733|10784775|FG000|COMPLETED|Long-term Follow-up Period||0
9684528|NCT04126733|10784775|FG000|NOT COMPLETED|Long-term Follow-up Period||6
9725775|NCT00096356|10825379|FG000|NOT COMPLETED|Overall Study||44
9725776|NCT00096356|10825380|FG001|NOT COMPLETED|Overall Study||53
9725777|NCT00096382|10825389|FG000|STARTED|Overall Study||23
9725778|NCT00096382|10825390|FG001|STARTED|Overall Study||3
9725779|NCT00096382|10825389|FG000|COMPLETED|Overall Study||21
9725780|NCT00096382|10825390|FG001|COMPLETED|Overall Study||3
9725781|NCT00096382|10825389|FG000|NOT COMPLETED|Overall Study||2
9725782|NCT00096382|10825390|FG001|NOT COMPLETED|Overall Study||0
9725783|NCT00096447|10825396|FG000|STARTED|Overall Study||31
9725784|NCT00096447|10825396|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30
9725785|NCT00096447|10825396|FG000|NOT COMPLETED|Overall Study||1
9725786|NCT00096460|10825407|FG000|STARTED|Overall Study||22
9725787|NCT00096460|10825408|FG001|STARTED|Overall Study||8
9725788|NCT00096460|10825407|FG000|COMPLETED|Overall Study||15
9725789|NCT00096460|10825408|FG001|COMPLETED|Overall Study||7
9725790|NCT00096460|10825407|FG000|NOT COMPLETED|Overall Study||7
9725791|NCT00096460|10825408|FG001|NOT COMPLETED|Overall Study||1
9725792|NCT00096486|10825418|FG000|STARTED|Overall Study||4
9725793|NCT00096486|10825419|FG001|STARTED|Overall Study||6
9725794|NCT00096486|10825420|FG002|STARTED|Overall Study||26
9725795|NCT00096486|10825421|FG003|STARTED|Overall Study||38
9725796|NCT00096486|10825418|FG000|COMPLETED|Overall Study||4
9725797|NCT00096486|10825419|FG001|COMPLETED|Overall Study||6
9725798|NCT00096486|10825420|FG002|COMPLETED|Overall Study||24
9725799|NCT00096486|10825421|FG003|COMPLETED|Overall Study||36
9725800|NCT00096486|10825418|FG000|NOT COMPLETED|Overall Study||0
9725801|NCT00096486|10825419|FG001|NOT COMPLETED|Overall Study||0
9725802|NCT00096486|10825420|FG002|NOT COMPLETED|Overall Study||2
9725803|NCT00096486|10825421|FG003|NOT COMPLETED|Overall Study||2
9725804|NCT00096538|10825431|FG000|STARTED|Overall Study||6
9725805|NCT00096538|10825431|FG000|COMPLETED|Overall Study||5
9725806|NCT00096538|10825431|FG000|NOT COMPLETED|Overall Study||1
9725807|NCT00096681|10825435|FG000|STARTED|Overall Study||762
9725808|NCT00096681|10825435|FG000|COMPLETED|Overall Study||762
9725809|NCT00096681|10825435|FG000|NOT COMPLETED|Overall Study||0
9725810|NCT00096785|10825441|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
9725811|NCT00096785|10825442|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
9725812|NCT00096785|10825441|FG000|As-Randomized Population|Overall Study||35
9725813|NCT00096785|10825442|FG001|As-Randomized Population|Overall Study||34
9725814|NCT00096785|10825441|FG000|As-Treated Population|Overall Study||36
9725815|NCT00096785|10825442|FG001|As-Treated Population|Overall Study||33
9725816|NCT00096785|10825441|FG000|COMPLETED|Overall Study|As randomized cohort|33
9725817|NCT00096785|10825442|FG001|COMPLETED|Overall Study|As randomized cohort|33
9725818|NCT00096785|10825441|FG000|NOT COMPLETED|Overall Study||2
9725819|NCT00096785|10825442|FG001|NOT COMPLETED|Overall Study||1
9725820|NCT00096941|10825448|FG000|STARTED|Overall Study||3
9725821|NCT00096941|10825448|FG000|COMPLETED|Overall Study||0
9725822|NCT00096941|10825448|FG000|NOT COMPLETED|Overall Study||3
9725823|NCT00096954|10825454|FG000|STARTED|Overall Study||159
9725824|NCT00096954|10825455|FG001|STARTED|Overall Study||174
9725825|NCT00096954|10825454|FG000|Received Study Drug|Overall Study||157
9725826|NCT00096954|10825455|FG001|Received Study Drug|Overall Study||171
9725827|NCT00096954|10825454|FG000|COMPLETED|Overall Study||135
9725828|NCT00096954|10825455|FG001|COMPLETED|Overall Study||154
9725829|NCT00096954|10825454|FG000|NOT COMPLETED|Overall Study||24
9725830|NCT00096954|10825455|FG001|NOT COMPLETED|Overall Study||20
9725831|NCT00096993|10825463|FG000|STARTED|Overall Study||66
9725832|NCT00096993|10825464|FG001|STARTED|Overall Study||65
9725833|NCT00096993|10825463|FG000|COMPLETED|Overall Study||1
9725834|NCT00096993|10825464|FG001|COMPLETED|Overall Study||0
9725835|NCT00096993|10825463|FG000|NOT COMPLETED|Overall Study||65
9725836|NCT00096993|10825464|FG001|NOT COMPLETED|Overall Study||65
9725837|NCT00097253|10825470|FG000|STARTED|Lavender||56
9725838|NCT00097253|10825470|FG000|COMPLETED|Lavender||56
9725839|NCT00097253|10825470|FG000|NOT COMPLETED|Lavender||0
9725840|NCT00097253|10825470|FG000|STARTED|Lemon||56
9725841|NCT00097253|10825470|FG000|COMPLETED|Lemon||56
9725842|NCT00097253|10825470|FG000|NOT COMPLETED|Lemon||0
9725843|NCT00097253|10825470|FG000|STARTED|Water (Control)||56
9684529|NCT03909178|10784781|FG000|STARTED|Overall Study||46
9684530|NCT03909178|10784782|FG001|STARTED|Overall Study||44
9684531|NCT03909178|10784781|FG000|COMPLETED|Overall Study||42
9684532|NCT03909178|10784782|FG001|COMPLETED|Overall Study||39
9684533|NCT03909178|10784781|FG000|NOT COMPLETED|Overall Study||4
10023499|NCT01856530|11147149|FG001|NOT COMPLETED|Overall Study||0
10023500|NCT01856543|11147157|FG000|STARTED|Overall Study||73
9684534|NCT03909178|10784782|FG001|NOT COMPLETED|Overall Study||5
9684535|NCT03662659|10784792|FG000|STARTED|Pre-treatment||138
9684536|NCT03662659|10784793|FG001|STARTED|Pre-treatment||136
9684537|NCT03662659|10784792|FG000|COMPLETED|Pre-treatment||136
9684538|NCT03662659|10784793|FG001|COMPLETED|Pre-treatment||135
9684539|NCT03662659|10784792|FG000|NOT COMPLETED|Pre-treatment||2
9684540|NCT03662659|10784793|FG001|NOT COMPLETED|Pre-treatment||1
9684541|NCT03662659|10784792|FG000|STARTED|Treatment||136
9684542|NCT03662659|10784793|FG001|STARTED|Treatment||135
9684543|NCT03662659|10784792|FG000|COMPLETED|Treatment||21
9684544|NCT03662659|10784793|FG001|COMPLETED|Treatment||29
9684545|NCT03662659|10784792|FG000|NOT COMPLETED|Treatment||115
9684546|NCT03662659|10784793|FG001|NOT COMPLETED|Treatment||106
9684547|NCT03631472|10784799|FG000|STARTED|Overall Study||21
9684548|NCT03631472|10784799|FG000|COMPLETED|Overall Study||21
9684549|NCT03631472|10784799|FG000|NOT COMPLETED|Overall Study||0
9684550|NCT03575572|10784805|FG000|STARTED|Overall Study||9
9684551|NCT03575572|10784805|FG000|COMPLETED|Overall Study||5
9684552|NCT03575572|10784805|FG000|NOT COMPLETED|Overall Study||4
9684553|NCT03521687|10784818|FG000|STARTED|Overall Study||20
9684554|NCT03521687|10784818|FG000|COMPLETED|Overall Study||15
9684555|NCT03521687|10784818|FG000|NOT COMPLETED|Overall Study||5
9684556|NCT03511664|10784824|FG000|STARTED|Overall Study||551
9684557|NCT03511664|10784825|FG001|STARTED|Overall Study||280
9684558|NCT03511664|10784824|FG000|FAS Safety Analysis Set|Overall Study||529
9684559|NCT03511664|10784825|FG001|FAS Safety Analysis Set|Overall Study||205
9684560|NCT03511664|10784824|FG000|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||385
9684561|NCT03511664|10784825|FG001|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||196
9684562|NCT03511664|10784824|FG000|Response Evaluable Analysis Set|Overall Study||319
9684563|NCT03511664|10784825|FG001|Response Evaluable Analysis Set|Overall Study||120
9684564|NCT03511664|10784824|FG000|COMPLETED|Overall Study||329
9684565|NCT03511664|10784825|FG001|COMPLETED|Overall Study||167
9684566|NCT03511664|10784824|FG000|NOT COMPLETED|Overall Study||222
9684567|NCT03511664|10784825|FG001|NOT COMPLETED|Overall Study||113
9684568|NCT03461289|10784831|FG000|STARTED|Overall Study||33
9684569|NCT03461289|10784831|FG000|COMPLETED|Overall Study||32
9684570|NCT03461289|10784831|FG000|NOT COMPLETED|Overall Study||1
9684571|NCT03406507|10784837|FG000|STARTED|Primary Evaluation Period||5
9684572|NCT03406507|10784838|FG001|STARTED|Primary Evaluation Period||8
9684573|NCT03406507|10784837|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||5
9684574|NCT03406507|10784838|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||8
9684575|NCT03406507|10784837|FG000|COMPLETED|Primary Evaluation Period||5
9684576|NCT03406507|10784838|FG001|COMPLETED|Primary Evaluation Period||8
9684577|NCT03406507|10784837|FG000|NOT COMPLETED|Primary Evaluation Period||0
9684578|NCT03406507|10784838|FG001|NOT COMPLETED|Primary Evaluation Period||0
9684579|NCT03406507|10784837|FG000|STARTED|Extension Period||5
9684580|NCT03406507|10784838|FG001|STARTED|Extension Period||8
9684581|NCT03406507|10784837|FG000|Received at Least 1 Dose of Study Drug|Extension Period||5
9684582|NCT03406507|10784838|FG001|Received at Least 1 Dose of Study Drug|Extension Period||8
9684583|NCT03406507|10784837|FG000|COMPLETED|Extension Period||0
9684584|NCT03406507|10784838|FG001|COMPLETED|Extension Period||2
9684585|NCT03406507|10784837|FG000|NOT COMPLETED|Extension Period||5
9684586|NCT03406507|10784838|FG001|NOT COMPLETED|Extension Period||6
9684587|NCT03256045|10784844|FG000|STARTED|Overall Study||9
9684588|NCT03256045|10784844|FG000|COMPLETED|Overall Study||9
9684589|NCT03256045|10784844|FG000|NOT COMPLETED|Overall Study||0
9684590|NCT03216499|10784848|FG000|STARTED|Overall Study||24
9684591|NCT03216499|10784848|FG000|COMPLETED|Overall Study||24
9684592|NCT03216499|10784848|FG000|NOT COMPLETED|Overall Study||0
9684593|NCT03046836|10784854|FG000|STARTED|Overall Study||100
9684594|NCT03046836|10784855|FG001|STARTED|Overall Study||100
9684595|NCT03046836|10784854|FG000|COMPLETED|Overall Study||100
9684596|NCT03046836|10784855|FG001|COMPLETED|Overall Study||100
9684597|NCT03046836|10784854|FG000|NOT COMPLETED|Overall Study||0
9684598|NCT03046836|10784855|FG001|NOT COMPLETED|Overall Study||0
9684599|NCT02966301|10784862|FG000|STARTED|Overall Study||21
9684600|NCT02966301|10784862|FG000|Full Analysis Set (FAS)|Overall Study|All patients who entered the study, completed their first cycle of ATO (11 infusions) and for whom the response at Week 6 after diagnosis of chronic GvHD has been evaluated.|20
10023501|NCT01856543|11147158|FG001|STARTED|Overall Study||70
9684601|NCT02966301|10784862|FG000|Safety Analysis (SA)|Overall Study|All patients included in the study for whom received at least one ATO infusion. One patient received 2 infusions and then exited the study due to SAE (reversible liver toxicity).|21
9684602|NCT02966301|10784862|FG000|COMPLETED|Overall Study||18
9684603|NCT02966301|10784862|FG000|NOT COMPLETED|Overall Study||3
9684604|NCT02941926|10784866|FG000|STARTED|Overall Study||3246
9684605|NCT02941926|10784866|FG000|Canadian Sub-study|Overall Study||88
9684606|NCT02941926|10784866|FG000|COMPLETED|Overall Study||1301
9684607|NCT02941926|10784866|FG000|NOT COMPLETED|Overall Study||1945
9684608|NCT02893514|10784874|FG000|STARTED|Overall Study||42
9684609|NCT02893514|10784875|FG001|STARTED|Overall Study||37
9684610|NCT02893514|10784874|FG000|COMPLETED|Overall Study||42
9684611|NCT02893514|10784875|FG001|COMPLETED|Overall Study||37
9684612|NCT02893514|10784874|FG000|NOT COMPLETED|Overall Study||0
9684613|NCT02893514|10784875|FG001|NOT COMPLETED|Overall Study||0
9684614|NCT02832167|10784881|FG000|STARTED|Treatment Period 1||239
9684615|NCT02832167|10784881|FG000|COMPLETED|Treatment Period 1||110
9684616|NCT02832167|10784881|FG000|NOT COMPLETED|Treatment Period 1||129
9844596|NCT00837694|10956613|FG002|STARTED|Overall Study||10
9844597|NCT00837694|10956614|FG003|STARTED|Overall Study||11
9844598|NCT00837694|10956615|FG004|STARTED|Overall Study||12
9844599|NCT00837694|10956616|FG005|STARTED|Overall Study||11
9844600|NCT00837694|10956611|FG000|COMPLETED|Overall Study||8
9844601|NCT00837694|10956612|FG001|COMPLETED|Overall Study||11
9844602|NCT00837694|10956613|FG002|COMPLETED|Overall Study||8
9844603|NCT00837694|10956614|FG003|COMPLETED|Overall Study||10
9844604|NCT00837694|10956615|FG004|COMPLETED|Overall Study||11
9844605|NCT00837694|10956616|FG005|COMPLETED|Overall Study||10
9844606|NCT00837694|10956611|FG000|NOT COMPLETED|Overall Study||2
9844607|NCT00837694|10956612|FG001|NOT COMPLETED|Overall Study||0
9844608|NCT00837694|10956613|FG002|NOT COMPLETED|Overall Study||2
9844609|NCT00837694|10956614|FG003|NOT COMPLETED|Overall Study||1
9844610|NCT00837694|10956615|FG004|NOT COMPLETED|Overall Study||1
9844611|NCT00837694|10956616|FG005|NOT COMPLETED|Overall Study||1
9844612|NCT00837759|10956630|FG000|STARTED|Overall Study||7
9844613|NCT00837759|10956630|FG000|COMPLETED|Overall Study||3
9844614|NCT00837759|10956630|FG000|NOT COMPLETED|Overall Study||4
9844615|NCT00837811|10956637|FG000|STARTED|Overall Study||60
9844616|NCT00837811|10956638|FG001|STARTED|Overall Study||121
9844617|NCT00837811|10956639|FG002|STARTED|Overall Study||1
9844618|NCT00837811|10956637|FG000|Received Any Amount of Study Drug|Overall Study||60
9844619|NCT00837811|10956638|FG001|Received Any Amount of Study Drug|Overall Study||121
9844620|NCT00837811|10956639|FG002|Received Any Amount of Study Drug|Overall Study||1
9844621|NCT00837811|10956637|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59
9844622|NCT00837811|10956638|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121
9844623|NCT00837811|10956639|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1
9844624|NCT00837811|10956637|FG000|Included in Efficacy Analyses|Overall Study||59
9844625|NCT00837811|10956638|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
9844626|NCT00837811|10956639|FG002|Included in Efficacy Analyses|Overall Study||1
9844627|NCT00837811|10956637|FG000|COMPLETED|Overall Study||53
9844628|NCT00837811|10956638|FG001|COMPLETED|Overall Study||87
9844629|NCT00837811|10956639|FG002|COMPLETED|Overall Study||0
9844630|NCT00837811|10956637|FG000|NOT COMPLETED|Overall Study||7
9844631|NCT00837811|10956638|FG001|NOT COMPLETED|Overall Study||34
9844632|NCT00837811|10956639|FG002|NOT COMPLETED|Overall Study||1
9844633|NCT00837824|10956658|FG000|STARTED|Overall Study||11
9844634|NCT00837824|10956659|FG001|STARTED|Overall Study||9
9844635|NCT00837824|10956658|FG000|COMPLETED|Overall Study||11
9844636|NCT00837824|10956659|FG001|COMPLETED|Overall Study||9
9844637|NCT00837824|10956658|FG000|NOT COMPLETED|Overall Study||0
9844638|NCT00837824|10956659|FG001|NOT COMPLETED|Overall Study||0
9844639|NCT00837876|10956666|FG000|STARTED|Overall Study||37
9844640|NCT00837876|10956666|FG000|COMPLETED|Overall Study||0
9844641|NCT00837876|10956666|FG000|NOT COMPLETED|Overall Study||37
9844642|NCT00837902|10956672|FG000|STARTED|Overall Study||85
9844643|NCT00837902|10956673|FG001|STARTED|Overall Study||69
9844644|NCT00837902|10956672|FG000|COMPLETED|Overall Study||85
9844645|NCT00837902|10956673|FG001|COMPLETED|Overall Study||69
9844646|NCT00837902|10956672|FG000|NOT COMPLETED|Overall Study||0
9844647|NCT00837902|10956673|FG001|NOT COMPLETED|Overall Study||0
9844648|NCT00837967|10956680|FG000|STARTED|First Intervention||13
9844649|NCT00837967|10956681|FG001|STARTED|First Intervention||12
9844650|NCT00837967|10956680|FG000|COMPLETED|First Intervention||13
9844651|NCT00837967|10956681|FG001|COMPLETED|First Intervention||12
9844652|NCT00837967|10956680|FG000|NOT COMPLETED|First Intervention||0
9844653|NCT00837967|10956681|FG001|NOT COMPLETED|First Intervention||0
9960855|NCT01469234|11080490|FG000|STARTED|Overall Study||85
9960856|NCT01469234|11080491|FG001|STARTED|Overall Study||85
9960857|NCT01469234|11080492|FG002|STARTED|Overall Study||85
9960858|NCT01469234|11080490|FG000|COMPLETED|Overall Study||85
9960859|NCT01469234|11080491|FG001|COMPLETED|Overall Study||85
9960860|NCT01469234|11080492|FG002|COMPLETED|Overall Study||85
9960861|NCT01469234|11080490|FG000|NOT COMPLETED|Overall Study||0
9960862|NCT01469234|11080491|FG001|NOT COMPLETED|Overall Study||0
9684617|NCT02832167|10784881|FG000|STARTED|Transition From Period 1 to Period 2||110
9684618|NCT02832167|10784881|FG000|COMPLETED|Transition From Period 1 to Period 2||103
9684619|NCT02832167|10784881|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7
9684620|NCT02832167|10784881|FG000|STARTED|Treatment Period 2||103
9684621|NCT02832167|10784881|FG000|COMPLETED|Treatment Period 2||19
9684622|NCT02832167|10784881|FG000|NOT COMPLETED|Treatment Period 2||84
9684623|NCT02699554|10784885|FG000|STARTED|Overall Study||55
9684624|NCT02699554|10784885|FG000|COMPLETED|Overall Study||46
9684625|NCT02699554|10784885|FG000|NOT COMPLETED|Overall Study||9
9684626|NCT02659020|10784896|FG000|STARTED|Overall Study||21
9684627|NCT02659020|10784897|FG001|STARTED|Overall Study||18
9684628|NCT02659020|10784898|FG002|STARTED|Overall Study||15
9684629|NCT02659020|10784899|FG003|STARTED|Overall Study||81
9684630|NCT02659020|10784900|FG004|STARTED|Overall Study||46
9684631|NCT02659020|10784901|FG005|STARTED|Overall Study||86
9844654|NCT00837967|10956680|FG000|STARTED|Washout Period of 7 - 14 Days||13
9684632|NCT02659020|10784902|FG006|STARTED|Overall Study||43
9684633|NCT02659020|10784896|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
9684634|NCT02659020|10784897|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
9684635|NCT02659020|10784898|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
9684636|NCT02659020|10784899|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
9684637|NCT02659020|10784900|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45
9684638|NCT02659020|10784901|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86
9684639|NCT02659020|10784902|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43
9684640|NCT02659020|10784896|FG000|COMPLETED|Overall Study||18
9684641|NCT02659020|10784897|FG001|COMPLETED|Overall Study||15
9684642|NCT02659020|10784898|FG002|COMPLETED|Overall Study||14
9684643|NCT02659020|10784899|FG003|COMPLETED|Overall Study||65
9684644|NCT02659020|10784900|FG004|COMPLETED|Overall Study||40
9684645|NCT02659020|10784901|FG005|COMPLETED|Overall Study||75
9684646|NCT02659020|10784902|FG006|COMPLETED|Overall Study||35
9684647|NCT02659020|10784896|FG000|NOT COMPLETED|Overall Study||3
9684648|NCT02659020|10784897|FG001|NOT COMPLETED|Overall Study||3
9684649|NCT02659020|10784898|FG002|NOT COMPLETED|Overall Study||1
9684650|NCT02659020|10784899|FG003|NOT COMPLETED|Overall Study||16
9684651|NCT02659020|10784900|FG004|NOT COMPLETED|Overall Study||6
9684652|NCT02659020|10784901|FG005|NOT COMPLETED|Overall Study||11
9684653|NCT02659020|10784902|FG006|NOT COMPLETED|Overall Study||8
9684654|NCT02626949|10784927|FG000|STARTED|Randomization, Pre-Enrollment||56
9684655|NCT02626949|10784928|FG001|STARTED|Randomization, Pre-Enrollment||58
9684656|NCT02626949|10784927|FG000|COMPLETED|Randomization, Pre-Enrollment||40
9684657|NCT02626949|10784928|FG001|COMPLETED|Randomization, Pre-Enrollment||44
9684658|NCT02626949|10784927|FG000|NOT COMPLETED|Randomization, Pre-Enrollment||16
9684659|NCT02626949|10784928|FG001|NOT COMPLETED|Randomization, Pre-Enrollment||14
9684660|NCT02626949|10784927|FG000|STARTED|Enrolled||40
9684661|NCT02626949|10784928|FG001|STARTED|Enrolled||44
9684662|NCT02626949|10784927|FG000|COMPLETED|Enrolled||30
9684663|NCT02626949|10784928|FG001|COMPLETED|Enrolled||36
9684664|NCT02626949|10784927|FG000|NOT COMPLETED|Enrolled||10
9684665|NCT02626949|10784928|FG001|NOT COMPLETED|Enrolled||8
9684666|NCT02625766|10784936|FG000|STARTED|Overall Study||47
9684667|NCT02625766|10784937|FG001|STARTED|Overall Study||48
9844655|NCT00837967|10956681|FG001|STARTED|Washout Period of 7 - 14 Days||12
9844656|NCT00837967|10956680|FG000|COMPLETED|Washout Period of 7 - 14 Days||11
9960863|NCT01469234|11080492|FG002|NOT COMPLETED|Overall Study||0
9960864|NCT01469364|11080500|FG000|STARTED|Overall Study||30
9960865|NCT01469364|11080500|FG000|COMPLETED|Overall Study||28
9960866|NCT01469364|11080500|FG000|NOT COMPLETED|Overall Study||2
9960867|NCT01469377|11080507|FG000|STARTED|Overall Study||269
9960868|NCT01469377|11080508|FG001|STARTED|Overall Study||274
9960869|NCT01469377|11080509|FG002|STARTED|Overall Study||276
9960870|NCT01469377|11080507|FG000|COMPLETED|Overall Study||234
10023502|NCT01856543|11147157|FG000|COMPLETED|Overall Study||60
10023503|NCT01856543|11147158|FG001|COMPLETED|Overall Study||64
10023504|NCT01856543|11147157|FG000|NOT COMPLETED|Overall Study||13
10023505|NCT01856543|11147158|FG001|NOT COMPLETED|Overall Study||6
10023506|NCT01856569|11147165|FG000|STARTED|Overall Study||152
10023507|NCT01856569|11147165|FG000|Full Analysis Set|Overall Study||144
10023508|NCT01856569|11147165|FG000|COMPLETED|Overall Study||139
10023509|NCT01856569|11147165|FG000|NOT COMPLETED|Overall Study||13
10023510|NCT01856582|11147169|FG000|STARTED|Overall Study||23
10023511|NCT01856582|11147169|FG000|COMPLETED|Overall Study||22
10023512|NCT01856582|11147169|FG000|NOT COMPLETED|Overall Study||1
10023513|NCT01856595|11147182|FG000|STARTED|Overall Study||18
10023514|NCT01856595|11147183|FG001|STARTED|Overall Study||12
10023515|NCT01856595|11147184|FG002|STARTED|Overall Study||12
9684668|NCT02625766|10784936|FG000|COMPLETED|Overall Study||47
9684669|NCT02625766|10784937|FG001|COMPLETED|Overall Study||48
9684670|NCT02625766|10784936|FG000|NOT COMPLETED|Overall Study||0
9684671|NCT02625766|10784937|FG001|NOT COMPLETED|Overall Study||0
9684672|NCT02565914|10784943|FG000|STARTED|Overall Study||1044
9684673|NCT02565914|10784943|FG000|Safety Set|Overall Study||1042
9684674|NCT02565914|10784943|FG000|COMPLETED|Overall Study||951
9844657|NCT00837967|10956681|FG001|COMPLETED|Washout Period of 7 - 14 Days||12
9844658|NCT00837967|10956680|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2
9844659|NCT00837967|10956681|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0
9844660|NCT00837967|10956680|FG000|STARTED|Second Intervention||11
9844661|NCT00837967|10956681|FG001|STARTED|Second Intervention||12
9844662|NCT00837967|10956680|FG000|COMPLETED|Second Intervention||11
10023516|NCT01856595|11147185|FG003|STARTED|Overall Study||12
10023517|NCT01856595|11147186|FG004|STARTED|Overall Study||14
10023518|NCT01856595|11147187|FG005|STARTED|Overall Study||12
10023519|NCT01856595|11147188|FG006|STARTED|Overall Study||13
10023520|NCT01856595|11147189|FG007|STARTED|Overall Study||10
9684675|NCT02565914|10784943|FG000|NOT COMPLETED|Overall Study||93
9844663|NCT00837967|10956681|FG001|COMPLETED|Second Intervention||12
9960871|NCT01469377|11080508|FG001|COMPLETED|Overall Study||226
9960872|NCT01469377|11080509|FG002|COMPLETED|Overall Study||210
9960873|NCT01469377|11080507|FG000|NOT COMPLETED|Overall Study||35
10023521|NCT01856595|11147190|FG008|STARTED|Overall Study||14
9684682|NCT02385045|10784964|FG000|STARTED|Overall Study||157
9684683|NCT02385045|10784964|FG000|COMPLETED|Overall Study|4 patients could not complete endoscopy as planned|153
9684684|NCT02385045|10784964|FG000|NOT COMPLETED|Overall Study||4
9684685|NCT02373241|10784970|FG000|STARTED|Overall Study||0
9684686|NCT02373241|10784971|FG001|STARTED|Overall Study||1
9684687|NCT02373241|10784970|FG000|COMPLETED|Overall Study||0
9684688|NCT02373241|10784971|FG001|COMPLETED|Overall Study||1
9684689|NCT02373241|10784970|FG000|NOT COMPLETED|Overall Study||0
9684690|NCT02373241|10784971|FG001|NOT COMPLETED|Overall Study||0
9684691|NCT01845649|10784979|FG000|STARTED|Overall Study||273
9684692|NCT01845649|10784980|FG001|STARTED|Overall Study||277
9684693|NCT01845649|10784979|FG000|Safety Population|Overall Study||271
9684694|NCT01845649|10784980|FG001|Safety Population|Overall Study||277
9684695|NCT01845649|10784979|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||233
9684696|NCT01845649|10784980|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||239
9684697|NCT01845649|10784979|FG000|COMPLETED|Overall Study||242
9684698|NCT01845649|10784980|FG001|COMPLETED|Overall Study||255
9684699|NCT01845649|10784979|FG000|NOT COMPLETED|Overall Study||31
9684700|NCT01845649|10784980|FG001|NOT COMPLETED|Overall Study||22
9684701|NCT01844986|10784988|FG000|STARTED|Overall Study||260
9684702|NCT01844986|10784989|FG001|STARTED|Overall Study||131
9684703|NCT01844986|10784988|FG000|COMPLETED|Overall Study||183
9684704|NCT01844986|10784989|FG001|COMPLETED|Overall Study||91
9844664|NCT00837967|10956680|FG000|NOT COMPLETED|Second Intervention||0
9844665|NCT00837967|10956681|FG001|NOT COMPLETED|Second Intervention||0
9844666|NCT00838006|10956690|FG000|STARTED|Overall Study||102
9844667|NCT00838006|10956691|FG001|STARTED|Overall Study||98
9844668|NCT00838006|10956692|FG002|STARTED|Overall Study||142
9844669|NCT00838006|10956690|FG000|3-month Post-deployment Follow-up|Overall Study||92
9684705|NCT01844986|10784988|FG000|NOT COMPLETED|Overall Study||77
9684706|NCT01844986|10784989|FG001|NOT COMPLETED|Overall Study||40
9684707|NCT01816139|10784997|FG000|STARTED|Overall Study||289
9684708|NCT01816139|10784998|FG001|STARTED|Overall Study||287
9844670|NCT00838006|10956691|FG001|3-month Post-deployment Follow-up|Overall Study||80
9844671|NCT00838006|10956692|FG002|3-month Post-deployment Follow-up|Overall Study||135
10023522|NCT01856595|11147182|FG000|COMPLETED|Overall Study||18
9684709|NCT01816139|10784997|FG000|Safety Population|Overall Study||287
9684710|NCT01816139|10784998|FG001|Safety Population|Overall Study||286
9684711|NCT01816139|10784997|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||240
9684712|NCT01816139|10784998|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||248
9684713|NCT01816139|10784997|FG000|COMPLETED|Overall Study||261
9684714|NCT01816139|10784998|FG001|COMPLETED|Overall Study||265
9684715|NCT01816139|10784997|FG000|NOT COMPLETED|Overall Study||28
9684716|NCT01816139|10784998|FG001|NOT COMPLETED|Overall Study||22
9725844|NCT00097253|10825470|FG000|COMPLETED|Water (Control)||56
9725845|NCT00097253|10825470|FG000|NOT COMPLETED|Water (Control)||0
9725846|NCT00097370|10825478|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37
9725847|NCT00097370|10825478|FG000|COMPLETED|Stage 1||31
9725848|NCT00097370|10825478|FG000|NOT COMPLETED|Stage 1||6
9725849|NCT00097370|10825478|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
9725850|NCT00097370|10825478|FG000|COMPLETED|Stage 2||59
9725851|NCT00097370|10825478|FG000|NOT COMPLETED|Stage 2||13
9725852|NCT00097370|10825478|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59
9725853|NCT00097370|10825478|FG000|COMPLETED|Stage 3||0
9725854|NCT00097370|10825478|FG000|NOT COMPLETED|Stage 3||59
9725855|NCT00097448|10825484|FG000|STARTED|Overall Study||125
9725856|NCT00097448|10825485|FG001|STARTED|Overall Study||130
9725857|NCT00097448|10825484|FG000|COMPLETED|Overall Study||121
9725858|NCT00097448|10825485|FG001|COMPLETED|Overall Study||129
9725859|NCT00097448|10825484|FG000|NOT COMPLETED|Overall Study||4
9725860|NCT00097448|10825485|FG001|NOT COMPLETED|Overall Study||1
9725861|NCT00097500|10825493|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36
9725862|NCT00097500|10825494|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33
9725863|NCT00097500|10825493|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
9725864|NCT00097500|10825494|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
9725865|NCT00097500|10825493|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
9725866|NCT00097500|10825494|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
9725867|NCT00097500|10825493|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
9844672|NCT00838006|10956690|FG000|COMPLETED|Overall Study||68
9844673|NCT00838006|10956691|FG001|COMPLETED|Overall Study||72
9844674|NCT00838006|10956692|FG002|COMPLETED|Overall Study||94
9844675|NCT00838006|10956690|FG000|NOT COMPLETED|Overall Study||34
9844676|NCT00838006|10956691|FG001|NOT COMPLETED|Overall Study||26
9844677|NCT00838006|10956692|FG002|NOT COMPLETED|Overall Study||48
9844678|NCT00838097|10956702|FG000|STARTED|Overall Study||321
9844679|NCT00838097|10956702|FG000|Received Darbepoetin Alfa|Overall Study||319
9725868|NCT00097500|10825494|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
9725869|NCT00097500|10825493|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
9844680|NCT00838097|10956702|FG000|COMPLETED|Overall Study||145
9844681|NCT00838097|10956702|FG000|NOT COMPLETED|Overall Study||176
9844682|NCT00838110|10956708|FG000|STARTED|Overall Study||127
10023523|NCT01856595|11147183|FG001|COMPLETED|Overall Study||11
9684717|NCT01455597|10785004|FG000|STARTED|Overall Study||101
9684718|NCT01455597|10785005|FG001|STARTED|Overall Study||56
9684719|NCT01455597|10785006|FG002|STARTED|Overall Study||100
9684720|NCT01455597|10785007|FG003|STARTED|Overall Study||52
9684721|NCT01455597|10785004|FG000|All-Participants-Treated Population|Overall Study||101
9684722|NCT01455597|10785005|FG001|All-Participants-Treated Population|Overall Study||56
9684723|NCT01455597|10785006|FG002|All-Participants-Treated Population|Overall Study||99
9684724|NCT01455597|10785007|FG003|All-Participants-Treated Population|Overall Study||52
9684725|NCT01455597|10785004|FG000|COMPLETED|Overall Study||84
9684726|NCT01455597|10785005|FG001|COMPLETED|Overall Study||48
9684727|NCT01455597|10785006|FG002|COMPLETED|Overall Study||80
9684728|NCT01455597|10785007|FG003|COMPLETED|Overall Study||42
9684729|NCT01455597|10785004|FG000|NOT COMPLETED|Overall Study||17
9684730|NCT01455597|10785005|FG001|NOT COMPLETED|Overall Study||8
9684731|NCT01455597|10785006|FG002|NOT COMPLETED|Overall Study||20
9684732|NCT01455597|10785007|FG003|NOT COMPLETED|Overall Study||10
9684733|NCT01400776|10785023|FG000|STARTED|Overall Study||238
9684734|NCT01400776|10785024|FG001|STARTED|Overall Study||124
9684735|NCT01400776|10785025|FG002|STARTED|Overall Study||237
9684736|NCT01400776|10785026|FG003|STARTED|Overall Study||123
9684737|NCT01400776|10785023|FG000|COMPLETED|Overall Study||217
9684738|NCT01400776|10785024|FG001|COMPLETED|Overall Study||119
9684739|NCT01400776|10785025|FG002|COMPLETED|Overall Study||209
9684740|NCT01400776|10785026|FG003|COMPLETED|Overall Study||114
9684741|NCT01400776|10785023|FG000|NOT COMPLETED|Overall Study||21
9684742|NCT01400776|10785024|FG001|NOT COMPLETED|Overall Study||5
9684743|NCT01400776|10785025|FG002|NOT COMPLETED|Overall Study||28
9684744|NCT01400776|10785026|FG003|NOT COMPLETED|Overall Study||9
9684745|NCT01194570|10785038|FG000|STARTED|Overall Study||244
9684746|NCT01194570|10785039|FG001|STARTED|Overall Study||488
9684747|NCT01194570|10785038|FG000|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
9684748|NCT01194570|10785039|FG001|COMPLETED|Overall Study||0
9684749|NCT01194570|10785038|FG000|NOT COMPLETED|Overall Study||244
9684750|NCT01194570|10785039|FG001|NOT COMPLETED|Overall Study||488
9684751|NCT00511134|10785047|FG000|STARTED|Overall Study||1
9684752|NCT00511134|10785048|FG001|STARTED|Overall Study||3
9684753|NCT00511134|10785047|FG000|COMPLETED|Overall Study||1
9684754|NCT00511134|10785048|FG001|COMPLETED|Overall Study||1
9684755|NCT00511134|10785047|FG000|NOT COMPLETED|Overall Study||0
9684756|NCT00511134|10785048|FG001|NOT COMPLETED|Overall Study||2
9684757|NCT00349466|10785056|FG000|STARTED|Overall Study||42
9684758|NCT00349466|10785057|FG001|STARTED|Overall Study||38
9684759|NCT00349466|10785056|FG000|COMPLETED|Overall Study||33
9684760|NCT00349466|10785057|FG001|COMPLETED|Overall Study||35
9684761|NCT00349466|10785056|FG000|NOT COMPLETED|Overall Study||9
9684762|NCT00349466|10785057|FG001|NOT COMPLETED|Overall Study||3
9844683|NCT00838110|10956709|FG001|STARTED|Overall Study||128
9844684|NCT00838110|10956710|FG002|STARTED|Overall Study||243
9844685|NCT00838110|10956711|FG003|STARTED|Overall Study||244
9844686|NCT00838110|10956708|FG000|Treated|Overall Study||127
9844687|NCT00838110|10956709|FG001|Treated|Overall Study||127
9844688|NCT00838110|10956710|FG002|Treated|Overall Study||243
9684769|NCT03894540|10785080|FG000|STARTED|Overall Study||1
9684770|NCT03894540|10785081|FG001|STARTED|Overall Study||1
10023524|NCT01856595|11147184|FG002|COMPLETED|Overall Study||12
9684771|NCT03894540|10785082|FG002|STARTED|Overall Study||1
9684772|NCT03894540|10785083|FG003|STARTED|Overall Study||4
9684773|NCT03894540|10785084|FG004|STARTED|Overall Study||11
9684774|NCT03894540|10785085|FG005|STARTED|Overall Study||4
9684775|NCT03894540|10785080|FG000|COMPLETED|Overall Study||0
9684776|NCT03894540|10785081|FG001|COMPLETED|Overall Study||0
9684777|NCT03894540|10785082|FG002|COMPLETED|Overall Study||0
9684778|NCT03894540|10785083|FG003|COMPLETED|Overall Study||0
9684779|NCT03894540|10785084|FG004|COMPLETED|Overall Study||0
9684780|NCT03894540|10785085|FG005|COMPLETED|Overall Study||0
9684781|NCT03894540|10785080|FG000|NOT COMPLETED|Overall Study||1
9684782|NCT03894540|10785081|FG001|NOT COMPLETED|Overall Study||1
9684783|NCT03894540|10785082|FG002|NOT COMPLETED|Overall Study||1
9684784|NCT03894540|10785083|FG003|NOT COMPLETED|Overall Study||4
9684785|NCT03894540|10785084|FG004|NOT COMPLETED|Overall Study||11
9684786|NCT03894540|10785085|FG005|NOT COMPLETED|Overall Study||4
9684787|NCT03816202|10785103|FG000|STARTED|Overall Study||100
9684788|NCT03816202|10785103|FG000|COMPLETED|Overall Study||100
9684789|NCT03816202|10785103|FG000|NOT COMPLETED|Overall Study||0
9684790|NCT03725293|10785109|FG000|STARTED|Overall Study||106
9684791|NCT03725293|10785110|FG001|STARTED|Overall Study||106
9684792|NCT03725293|10785109|FG000|COMPLETED|Overall Study||94
9684793|NCT03725293|10785110|FG001|COMPLETED|Overall Study||97
9684794|NCT03725293|10785109|FG000|NOT COMPLETED|Overall Study||12
9684795|NCT03725293|10785110|FG001|NOT COMPLETED|Overall Study||9
9684796|NCT03702231|10785119|FG000|STARTED|Overall Study||59
9684797|NCT03702231|10785120|FG001|STARTED|Overall Study||29
9684798|NCT03702231|10785121|FG002|STARTED|Overall Study||28
9684799|NCT03702231|10785119|FG000|COMPLETED|Overall Study||55
9684800|NCT03702231|10785120|FG001|COMPLETED|Overall Study||25
9684801|NCT03702231|10785121|FG002|COMPLETED|Overall Study||26
9684802|NCT03702231|10785119|FG000|NOT COMPLETED|Overall Study||4
9684803|NCT03702231|10785120|FG001|NOT COMPLETED|Overall Study||4
9684804|NCT03702231|10785121|FG002|NOT COMPLETED|Overall Study||2
9684805|NCT03690284|10785131|FG000|STARTED|Overall Study||25
10023525|NCT01856595|11147185|FG003|COMPLETED|Overall Study||12
9684806|NCT03690284|10785132|FG001|STARTED|Overall Study||25
9684807|NCT03690284|10785131|FG000|COMPLETED|Overall Study||25
9684808|NCT03690284|10785132|FG001|COMPLETED|Overall Study||25
9684809|NCT03690284|10785131|FG000|NOT COMPLETED|Overall Study||0
9684810|NCT03690284|10785132|FG001|NOT COMPLETED|Overall Study||0
9684811|NCT03670277|10785140|FG000|STARTED|Overall Study||20
9684812|NCT03670277|10785141|FG001|STARTED|Overall Study||8
9684813|NCT03670277|10785140|FG000|COMPLETED|Overall Study||20
9684814|NCT03670277|10785141|FG001|COMPLETED|Overall Study||8
9684815|NCT03670277|10785140|FG000|NOT COMPLETED|Overall Study||0
9684816|NCT03670277|10785141|FG001|NOT COMPLETED|Overall Study||0
9684817|NCT03556358|10785152|FG000|STARTED|Overall Study||404
9684818|NCT03556358|10785153|FG001|STARTED|Overall Study||405
9684819|NCT03556358|10785152|FG000|Subjects Treated|Overall Study||401
9684820|NCT03556358|10785153|FG001|Subjects Treated|Overall Study||405
9684821|NCT03556358|10785152|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394
9684822|NCT03556358|10785153|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400
9684823|NCT03556358|10785152|FG000|COMPLETED|Overall Study||393
9684824|NCT03556358|10785153|FG001|COMPLETED|Overall Study||393
9684825|NCT03556358|10785152|FG000|NOT COMPLETED|Overall Study||11
9684826|NCT03556358|10785153|FG001|NOT COMPLETED|Overall Study||12
9684827|NCT03290781|10785166|FG000|STARTED|Overall Study||73
9684828|NCT03290781|10785167|FG001|STARTED|Overall Study||71
9684829|NCT03290781|10785168|FG002|STARTED|Overall Study||86
9684830|NCT03290781|10785169|FG003|STARTED|Overall Study||82
9684831|NCT03290781|10785170|FG004|STARTED|Overall Study||11
9684832|NCT03290781|10785171|FG005|STARTED|Overall Study||22
9844689|NCT00838110|10956711|FG003|Treated|Overall Study||244
9844690|NCT00838110|10956708|FG000|COMPLETED|Overall Study||105
9844691|NCT00838110|10956709|FG001|COMPLETED|Overall Study||106
9844692|NCT00838110|10956710|FG002|COMPLETED|Overall Study||226
9844693|NCT00838110|10956711|FG003|COMPLETED|Overall Study||226
9844694|NCT00838110|10956708|FG000|NOT COMPLETED|Overall Study||22
9844695|NCT00838110|10956709|FG001|NOT COMPLETED|Overall Study||22
9844696|NCT00838110|10956710|FG002|NOT COMPLETED|Overall Study||17
9844697|NCT00838110|10956711|FG003|NOT COMPLETED|Overall Study||18
9844698|NCT00838162|10956725|FG000|STARTED|Overall Study||9
9844699|NCT00838162|10956726|FG001|STARTED|Overall Study||8
9844700|NCT00838162|10956727|FG002|STARTED|Overall Study||8
9844701|NCT00838162|10956728|FG003|STARTED|Overall Study||8
9844702|NCT00838162|10956725|FG000|COMPLETED|Overall Study||9
9844703|NCT00838162|10956726|FG001|COMPLETED|Overall Study||8
9844704|NCT00838162|10956727|FG002|COMPLETED|Overall Study||8
9844705|NCT00838162|10956728|FG003|COMPLETED|Overall Study||8
9844706|NCT00838162|10956725|FG000|NOT COMPLETED|Overall Study||0
9844707|NCT00838162|10956726|FG001|NOT COMPLETED|Overall Study||0
9844708|NCT00838162|10956727|FG002|NOT COMPLETED|Overall Study||0
9960874|NCT01469377|11080508|FG001|NOT COMPLETED|Overall Study||48
9960875|NCT01469377|11080509|FG002|NOT COMPLETED|Overall Study||66
9960876|NCT01469546|11080517|FG000|STARTED|Received 5 mg Dose||42
10023526|NCT01856595|11147186|FG004|COMPLETED|Overall Study||14
10023527|NCT01856595|11147187|FG005|COMPLETED|Overall Study||12
9960877|NCT01469546|11080517|FG000|Completed First Cycle|Received 5 mg Dose||30
9960878|NCT01469546|11080517|FG000|COMPLETED|Received 5 mg Dose||19
9960879|NCT01469546|11080517|FG000|NOT COMPLETED|Received 5 mg Dose||23
9960880|NCT01469546|11080517|FG000|STARTED|Dose Escalation to 10 mg||19
9960881|NCT01469546|11080517|FG000|COMPLETED|Dose Escalation to 10 mg||19
9960882|NCT01469546|11080517|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0
9960883|NCT01469585|11080523|FG000|STARTED|Overall Study||11
9960884|NCT01469585|11080524|FG001|STARTED|Overall Study||9
9960885|NCT01469585|11080523|FG000|COMPLETED|Overall Study||4
9960886|NCT01469585|11080524|FG001|COMPLETED|Overall Study||6
9960887|NCT01469585|11080523|FG000|NOT COMPLETED|Overall Study||7
9960888|NCT01469585|11080524|FG001|NOT COMPLETED|Overall Study||3
9960889|NCT01469637|11080534|FG000|STARTED|First Intervention||22
10023528|NCT01856595|11147188|FG006|COMPLETED|Overall Study||12
10114245|NCT02514889|11244962|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24
9684833|NCT03290781|10785172|FG006|STARTED|Overall Study||21
9684834|NCT03290781|10785166|FG000|COMPLETED|Overall Study||24
9684835|NCT03290781|10785167|FG001|COMPLETED|Overall Study||53
9684836|NCT03290781|10785168|FG002|COMPLETED|Overall Study||30
9684837|NCT03290781|10785169|FG003|COMPLETED|Overall Study||59
9684838|NCT03290781|10785170|FG004|COMPLETED|Overall Study||6
9684839|NCT03290781|10785171|FG005|COMPLETED|Overall Study||19
9684840|NCT03290781|10785172|FG006|COMPLETED|Overall Study||17
9684841|NCT03290781|10785166|FG000|NOT COMPLETED|Overall Study||49
9684842|NCT03290781|10785167|FG001|NOT COMPLETED|Overall Study||18
9684843|NCT03290781|10785168|FG002|NOT COMPLETED|Overall Study||56
9684844|NCT03290781|10785169|FG003|NOT COMPLETED|Overall Study||23
9844709|NCT00838162|10956728|FG003|NOT COMPLETED|Overall Study||0
9844710|NCT00838201|10956740|FG000|STARTED|Overall Study||186
9844711|NCT00838201|10956741|FG001|STARTED|Overall Study||198
9844712|NCT00838201|10956740|FG000|COMPLETED|Overall Study||144
9684845|NCT03290781|10785170|FG004|NOT COMPLETED|Overall Study||5
9684846|NCT03290781|10785171|FG005|NOT COMPLETED|Overall Study||3
9684847|NCT03290781|10785172|FG006|NOT COMPLETED|Overall Study||4
9844713|NCT00838201|10956741|FG001|COMPLETED|Overall Study||145
9844714|NCT00838201|10956740|FG000|NOT COMPLETED|Overall Study||42
9844715|NCT00838201|10956741|FG001|NOT COMPLETED|Overall Study||53
9844716|NCT00838331|10956747|FG000|STARTED|Fresh Blood Transfusion||17
9960890|NCT01469637|11080535|FG001|STARTED|First Intervention||22
9684848|NCT03263195|10785199|FG000|STARTED|Overall Study||174
9684849|NCT03263195|10785200|FG001|STARTED|Overall Study||0
9684850|NCT03263195|10785201|FG002|STARTED|Overall Study||0
9684851|NCT03263195|10785202|FG003|STARTED|Overall Study||26
9684852|NCT03263195|10785203|FG004|STARTED|Overall Study||170
9684853|NCT03263195|10785204|FG005|STARTED|Overall Study||0
9684854|NCT03263195|10785205|FG006|STARTED|Overall Study||0
9684855|NCT03263195|10785206|FG007|STARTED|Overall Study||25
9684856|NCT03263195|10785199|FG000|COMPLETED|Overall Study||168
9684857|NCT03263195|10785200|FG001|COMPLETED|Overall Study||0
9684858|NCT03263195|10785201|FG002|COMPLETED|Overall Study||0
9684859|NCT03263195|10785202|FG003|COMPLETED|Overall Study||23
9684860|NCT03263195|10785203|FG004|COMPLETED|Overall Study||155
9684861|NCT03263195|10785204|FG005|COMPLETED|Overall Study||0
9684862|NCT03263195|10785205|FG006|COMPLETED|Overall Study||0
9684863|NCT03263195|10785206|FG007|COMPLETED|Overall Study||19
9684864|NCT03263195|10785199|FG000|NOT COMPLETED|Overall Study||6
9684865|NCT03263195|10785200|FG001|NOT COMPLETED|Overall Study||0
9684866|NCT03263195|10785201|FG002|NOT COMPLETED|Overall Study||0
9684867|NCT03263195|10785202|FG003|NOT COMPLETED|Overall Study||3
9684868|NCT03263195|10785203|FG004|NOT COMPLETED|Overall Study||15
9684869|NCT03263195|10785204|FG005|NOT COMPLETED|Overall Study||0
9684870|NCT03263195|10785205|FG006|NOT COMPLETED|Overall Study||0
9684871|NCT03263195|10785206|FG007|NOT COMPLETED|Overall Study||6
9684872|NCT03228680|10785231|FG000|STARTED|Overall Study||170
9684873|NCT03228680|10785232|FG001|STARTED|Overall Study||178
9684874|NCT03228680|10785231|FG000|COMPLETED|Overall Study||147
9684875|NCT03228680|10785232|FG001|COMPLETED|Overall Study||143
9684876|NCT03228680|10785231|FG000|NOT COMPLETED|Overall Study||23
9684877|NCT03228680|10785232|FG001|NOT COMPLETED|Overall Study||35
9684878|NCT03196167|10785241|FG000|STARTED|Overall Study||45
9684879|NCT03196167|10785242|FG001|STARTED|Overall Study||45
9684880|NCT03196167|10785241|FG000|COMPLETED|Overall Study||40
9684881|NCT03196167|10785242|FG001|COMPLETED|Overall Study||43
9684882|NCT03196167|10785241|FG000|NOT COMPLETED|Overall Study||5
9684883|NCT03196167|10785242|FG001|NOT COMPLETED|Overall Study||2
9725870|NCT00097500|10825494|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
9844717|NCT00838331|10956747|FG000|COMPLETED|Fresh Blood Transfusion||17
9844718|NCT00838331|10956747|FG000|NOT COMPLETED|Fresh Blood Transfusion||0
9844719|NCT00838331|10956747|FG000|STARTED|Aged Blood Transfusion||17
9844720|NCT00838331|10956747|FG000|COMPLETED|Aged Blood Transfusion||8
9844721|NCT00838331|10956747|FG000|NOT COMPLETED|Aged Blood Transfusion||9
9844722|NCT00838435|10956751|FG000|STARTED|Part 1 (4 Weeks)||95
9844723|NCT00838435|10956751|FG000|COMPLETED|Part 1 (4 Weeks)||95
9844724|NCT00838435|10956751|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0
9844725|NCT00838435|10956751|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
9844726|NCT00838435|10956751|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
9844727|NCT00838435|10956751|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
9844728|NCT00838435|10956751|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
9844729|NCT00838435|10956751|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
9844730|NCT00838435|10956751|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
9844731|NCT00838435|10956751|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
9844732|NCT00838435|10956751|FG000|COMPLETED|Part 2 (7 Years)||49
9844733|NCT00838435|10956751|FG000|NOT COMPLETED|Part 2 (7 Years)||16
9844734|NCT00838513|10956758|FG000|STARTED|Screening Period||23
9844735|NCT00838513|10956758|FG000|COMPLETED|Screening Period||20
9844736|NCT00838513|10956758|FG000|NOT COMPLETED|Screening Period||3
9844737|NCT00838513|10956758|FG000|STARTED|Observation Period (8 Weeks)||20
9844738|NCT00838513|10956758|FG000|COMPLETED|Observation Period (8 Weeks)||20
9844739|NCT00838513|10956758|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
9844740|NCT00838513|10956758|FG000|STARTED|Treatment Period (26 Weeks)||20
9844741|NCT00838513|10956758|FG000|COMPLETED|Treatment Period (26 Weeks)||20
9844742|NCT00838513|10956758|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
9844743|NCT00838513|10956758|FG000|STARTED|Extension Treatment Period||19
9844744|NCT00838513|10956758|FG000|COMPLETED|Extension Treatment Period||18
9844745|NCT00838513|10956758|FG000|NOT COMPLETED|Extension Treatment Period||1
9844746|NCT00838513|10956758|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
9844747|NCT00838513|10956758|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
9844748|NCT00838513|10956758|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
9844749|NCT00838539|10956774|FG000|STARTED|Overall Study||3
9844750|NCT00838539|10956775|FG001|STARTED|Overall Study||6
9844751|NCT00838539|10956776|FG002|STARTED|Overall Study||5
9844752|NCT00838539|10956777|FG003|STARTED|Overall Study||4
9844753|NCT00838539|10956778|FG004|STARTED|Overall Study||6
9844754|NCT00838539|10956779|FG005|STARTED|Overall Study||4
9844755|NCT00838539|10956780|FG006|STARTED|Overall Study||7
9844756|NCT00838539|10956781|FG007|STARTED|Overall Study||6
9844757|NCT00838539|10956782|FG008|STARTED|Overall Study||5
9844758|NCT00838539|10956783|FG009|STARTED|Overall Study||8
9844759|NCT00838539|10956784|FG010|STARTED|Overall Study||5
9844760|NCT00838539|10956785|FG011|STARTED|Overall Study||4
9844761|NCT00838539|10956774|FG000|Received Treatment|Overall Study||3
9844762|NCT00838539|10956775|FG001|Received Treatment|Overall Study||5
9844763|NCT00838539|10956776|FG002|Received Treatment|Overall Study||5
9844764|NCT00838539|10956777|FG003|Received Treatment|Overall Study||4
9844765|NCT00838539|10956778|FG004|Received Treatment|Overall Study||4
9684884|NCT03077204|10785252|FG000|STARTED|Overall Study||20
9684885|NCT03077204|10785252|FG000|COMPLETED|Overall Study||20
9684886|NCT03077204|10785252|FG000|NOT COMPLETED|Overall Study||0
9684887|NCT03029611|10785257|FG000|STARTED|Overall Study|We had 11 patients sign consent with 2 patients deciding not to continue to receive treatment.|9
9684888|NCT03029611|10785257|FG000|COMPLETED|Overall Study|Please note that we did not fully enroll this study due to lack of funding. The complete date here relates to the last treatment administration.|9
9684889|NCT03029611|10785257|FG000|NOT COMPLETED|Overall Study||0
9684890|NCT02891798|10785263|FG000|STARTED|Overall Study||62
9684891|NCT02891798|10785264|FG001|STARTED|Overall Study||16
9684892|NCT02891798|10785263|FG000|COMPLETED|Overall Study||62
9684893|NCT02891798|10785264|FG001|COMPLETED|Overall Study||16
9684894|NCT02891798|10785263|FG000|NOT COMPLETED|Overall Study||0
9684895|NCT02891798|10785264|FG001|NOT COMPLETED|Overall Study||0
9684896|NCT02679781|10785272|FG000|STARTED|Overall Study||37
9684897|NCT02679781|10785273|FG001|STARTED|Overall Study||33
9684898|NCT02679781|10785272|FG000|COMPLETED|Overall Study||30
9684899|NCT02679781|10785273|FG001|COMPLETED|Overall Study||30
9684900|NCT02679781|10785272|FG000|NOT COMPLETED|Overall Study||7
9684901|NCT02679781|10785273|FG001|NOT COMPLETED|Overall Study||3
9684902|NCT02624869|10785282|FG000|STARTED|Overall Study||49
9684903|NCT02624869|10785283|FG001|STARTED|Overall Study||101
9684904|NCT02624869|10785284|FG002|STARTED|Overall Study||13
9684905|NCT02624869|10785282|FG000|Received Study Drug|Overall Study||49
9684906|NCT02624869|10785283|FG001|Received Study Drug|Overall Study||101
9684907|NCT02624869|10785284|FG002|Received Study Drug|Overall Study||12
9684908|NCT02624869|10785282|FG000|COMPLETED|Overall Study||48
9684909|NCT02624869|10785283|FG001|COMPLETED|Overall Study||98
9684910|NCT02624869|10785284|FG002|COMPLETED|Overall Study||11
9684911|NCT02624869|10785282|FG000|NOT COMPLETED|Overall Study||1
9684912|NCT02624869|10785283|FG001|NOT COMPLETED|Overall Study||3
9684913|NCT02624869|10785284|FG002|NOT COMPLETED|Overall Study||2
9684914|NCT02614690|10785296|FG000|STARTED|Overall Study||20
9684915|NCT02614690|10785297|FG001|STARTED|Overall Study||20
9684916|NCT02614690|10785298|FG002|STARTED|Overall Study||20
9684917|NCT02614690|10785296|FG000|COMPLETED|Overall Study||20
9684918|NCT02614690|10785297|FG001|COMPLETED|Overall Study||20
9684919|NCT02614690|10785298|FG002|COMPLETED|Overall Study||20
9684920|NCT02614690|10785296|FG000|NOT COMPLETED|Overall Study||0
9684921|NCT02614690|10785297|FG001|NOT COMPLETED|Overall Study||0
9684922|NCT02614690|10785298|FG002|NOT COMPLETED|Overall Study||0
9684923|NCT02569242|10785308|FG000|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|210
9684924|NCT02569242|10785309|FG001|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|209
9684925|NCT02569242|10785308|FG000|COMPLETED|Overall Study|Analysed for safety|209
9684926|NCT02569242|10785309|FG001|COMPLETED|Overall Study|Analysed for safety|208
9684927|NCT02569242|10785308|FG000|NOT COMPLETED|Overall Study||1
9684928|NCT02569242|10785309|FG001|NOT COMPLETED|Overall Study||1
9684929|NCT02516969|10785317|FG000|STARTED|Overall Study||3
9684930|NCT02516969|10785318|FG001|STARTED|Overall Study||4
9684931|NCT02516969|10785317|FG000|COMPLETED|Overall Study||3
9684932|NCT02516969|10785318|FG001|COMPLETED|Overall Study||4
9684933|NCT02516969|10785317|FG000|NOT COMPLETED|Overall Study||0
9684934|NCT02516969|10785318|FG001|NOT COMPLETED|Overall Study||0
9684935|NCT02507960|10785326|FG000|STARTED|Overall Study||17
9684936|NCT02507960|10785326|FG000|COMPLETED|Overall Study||17
9684937|NCT02507960|10785326|FG000|NOT COMPLETED|Overall Study||0
9684938|NCT02435433|10785332|FG000|STARTED|Overall Study||197
9684939|NCT02435433|10785333|FG001|STARTED|Overall Study||95
9684940|NCT02435433|10785334|FG002|STARTED|Overall Study||0
9684941|NCT02435433|10785335|FG003|STARTED|Overall Study||0
9684942|NCT02435433|10785336|FG004|STARTED|Overall Study||0
9684943|NCT02435433|10785332|FG000|Participants Who Received Study Drug|Overall Study||197
9684944|NCT02435433|10785333|FG001|Participants Who Received Study Drug|Overall Study||95
9684945|NCT02435433|10785334|FG002|Participants Who Received Study Drug|Overall Study||0
9684946|NCT02435433|10785335|FG003|Participants Who Received Study Drug|Overall Study||0
9684947|NCT02435433|10785336|FG004|Participants Who Received Study Drug|Overall Study||0
9684948|NCT02435433|10785332|FG000|COMPLETED|Overall Study||182
9684949|NCT02435433|10785333|FG001|COMPLETED|Overall Study||90
9684950|NCT02435433|10785334|FG002|COMPLETED|Overall Study||0
9684951|NCT02435433|10785335|FG003|COMPLETED|Overall Study||0
9684952|NCT02435433|10785336|FG004|COMPLETED|Overall Study||0
9684953|NCT02435433|10785332|FG000|NOT COMPLETED|Overall Study||15
9684954|NCT02435433|10785333|FG001|NOT COMPLETED|Overall Study||5
9684955|NCT02435433|10785334|FG002|NOT COMPLETED|Overall Study||0
9684956|NCT02435433|10785335|FG003|NOT COMPLETED|Overall Study||0
9844766|NCT00838539|10956779|FG005|Received Treatment|Overall Study||4
9844767|NCT00838539|10956780|FG006|Received Treatment|Overall Study||7
9844768|NCT00838539|10956781|FG007|Received Treatment|Overall Study||6
9844769|NCT00838539|10956782|FG008|Received Treatment|Overall Study||5
9844770|NCT00838539|10956783|FG009|Received Treatment|Overall Study||8
9684957|NCT02435433|10785336|FG004|NOT COMPLETED|Overall Study||0
9684958|NCT02426125|10785346|FG000|STARTED|Overall Study||263
9684959|NCT02426125|10785347|FG001|STARTED|Overall Study||267
9844771|NCT00838539|10956784|FG010|Received Treatment|Overall Study||5
9684960|NCT02426125|10785346|FG000|Received at Least One Dose of Study Drug|Overall Study||258
9684961|NCT02426125|10785347|FG001|Received at Least One Dose of Study Drug|Overall Study||265
9844772|NCT00838539|10956785|FG011|Received Treatment|Overall Study||4
9684962|NCT02426125|10785346|FG000|First Randomized Participants|Overall Study||216
9684963|NCT02426125|10785347|FG001|First Randomized Participants|Overall Study||221
9684964|NCT02426125|10785346|FG000|COMPLETED|Overall Study||234
9684965|NCT02426125|10785347|FG001|COMPLETED|Overall Study||241
9684966|NCT02426125|10785346|FG000|NOT COMPLETED|Overall Study||29
9684967|NCT02426125|10785347|FG001|NOT COMPLETED|Overall Study||26
9684968|NCT02417142|10785357|FG000|STARTED|Overall Study||35
9684969|NCT02417142|10785358|FG001|STARTED|Overall Study||35
9684970|NCT02417142|10785357|FG000|COMPLETED|Overall Study||19
9684971|NCT02417142|10785358|FG001|COMPLETED|Overall Study||22
9684972|NCT02417142|10785357|FG000|NOT COMPLETED|Overall Study||16
9684973|NCT02417142|10785358|FG001|NOT COMPLETED|Overall Study||13
9684974|NCT02368886|10785368|FG000|STARTED|Overall Study||29
9684975|NCT02368886|10785369|FG001|STARTED|Overall Study||27
9684976|NCT02368886|10785370|FG002|STARTED|Overall Study||34
9684977|NCT02368886|10785371|FG003|STARTED|Overall Study||33
9684978|NCT02368886|10785368|FG000|COMPLETED|Overall Study||28
9684979|NCT02368886|10785369|FG001|COMPLETED|Overall Study||26
9684980|NCT02368886|10785370|FG002|COMPLETED|Overall Study||33
9684981|NCT02368886|10785371|FG003|COMPLETED|Overall Study||29
9684982|NCT02368886|10785368|FG000|NOT COMPLETED|Overall Study||1
9684983|NCT02368886|10785369|FG001|NOT COMPLETED|Overall Study||1
9684984|NCT02368886|10785370|FG002|NOT COMPLETED|Overall Study||1
9684985|NCT02368886|10785371|FG003|NOT COMPLETED|Overall Study||4
9684986|NCT02354703|10785383|FG000|STARTED|Overall Study||12
9684987|NCT02354703|10785384|FG001|STARTED|Overall Study||34
9684988|NCT02354703|10785385|FG002|STARTED|Overall Study||39
9684989|NCT02354703|10785386|FG003|STARTED|Overall Study||10
9684990|NCT02354703|10785383|FG000|COMPLETED|Overall Study||9
9684991|NCT02354703|10785384|FG001|COMPLETED|Overall Study||26
9684992|NCT02354703|10785385|FG002|COMPLETED|Overall Study||28
9684993|NCT02354703|10785386|FG003|COMPLETED|Overall Study||7
9684994|NCT02354703|10785383|FG000|NOT COMPLETED|Overall Study||3
9684995|NCT02354703|10785384|FG001|NOT COMPLETED|Overall Study||8
9684996|NCT02354703|10785385|FG002|NOT COMPLETED|Overall Study||11
9684997|NCT02354703|10785386|FG003|NOT COMPLETED|Overall Study||3
9684998|NCT01981551|10785398|FG000|STARTED|Overall Study||17
9684999|NCT01981551|10785398|FG000|COMPLETED|Overall Study||8
9685000|NCT01981551|10785398|FG000|NOT COMPLETED|Overall Study||9
9685001|NCT00740181|10785402|FG000|STARTED|Overall Study||9
9685002|NCT00740181|10785402|FG000|COMPLETED|Overall Study||9
9685003|NCT00740181|10785402|FG000|NOT COMPLETED|Overall Study||0
9685004|NCT00468130|10785408|FG000|STARTED|Overall Study||7
9685005|NCT00468130|10785409|FG001|STARTED|Overall Study||6
9685006|NCT00468130|10785408|FG000|COMPLETED|Overall Study||5
9685007|NCT00468130|10785409|FG001|COMPLETED|Overall Study||4
9685008|NCT00468130|10785408|FG000|NOT COMPLETED|Overall Study||2
9685009|NCT00468130|10785409|FG001|NOT COMPLETED|Overall Study||2
9685010|NCT00384111|10785417|FG000|STARTED|Overall Study||26
9685011|NCT00384111|10785417|FG000|COMPLETED|Overall Study||0
9685012|NCT00384111|10785417|FG000|NOT COMPLETED|Overall Study||26
9725871|NCT00097500|10825493|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
9725872|NCT00097500|10825494|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
9725873|NCT00097539|10825507|FG000|STARTED|Overall Study||27286
9725874|NCT00097539|10825508|FG001|STARTED|Overall Study||9356
9725875|NCT00097539|10825509|FG002|STARTED|Overall Study||12519
9725876|NCT00097539|10825510|FG003|STARTED|Overall Study||5651
9725877|NCT00097539|10825511|FG004|STARTED|Overall Study||2144
9725878|NCT00097539|10825512|FG005|STARTED|Overall Study||8010
9725879|NCT00097539|10825513|FG006|STARTED|Overall Study||239
9725880|NCT00097539|10825507|FG000|COMPLETED|Overall Study||8220
9725881|NCT00097539|10825508|FG001|COMPLETED|Overall Study||2825
9725882|NCT00097539|10825509|FG002|COMPLETED|Overall Study||3411
9725883|NCT00097539|10825510|FG003|COMPLETED|Overall Study||2066
9725884|NCT00097539|10825511|FG004|COMPLETED|Overall Study||386
9725885|NCT00097539|10825512|FG005|COMPLETED|Overall Study||2118
9725886|NCT00097539|10825513|FG006|COMPLETED|Overall Study||68
9725887|NCT00097539|10825507|FG000|NOT COMPLETED|Overall Study||19066
9725888|NCT00097539|10825508|FG001|NOT COMPLETED|Overall Study||6531
9725889|NCT00097539|10825509|FG002|NOT COMPLETED|Overall Study||9108
9725890|NCT00097539|10825510|FG003|NOT COMPLETED|Overall Study||3585
9725891|NCT00097539|10825511|FG004|NOT COMPLETED|Overall Study||1758
9725892|NCT00097539|10825512|FG005|NOT COMPLETED|Overall Study||5892
9725893|NCT00097539|10825513|FG006|NOT COMPLETED|Overall Study||171
9725894|NCT00097591|10825531|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
9960891|NCT01469637|11080534|FG000|COMPLETED|First Intervention||22
9725895|NCT00097591|10825532|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
9725896|NCT00097591|10825531|FG000|COMPLETED|Overall Study||6403
9725897|NCT00097591|10825532|FG001|COMPLETED|Overall Study||6401
9725898|NCT00097591|10825531|FG000|NOT COMPLETED|Overall Study||410
9725899|NCT00097591|10825532|FG001|NOT COMPLETED|Overall Study||394
9725900|NCT00097669|10825540|FG000|STARTED|Overall Study||4089
9725901|NCT00097669|10825541|FG001|STARTED|Overall Study||4075
9960892|NCT01469637|11080535|FG001|COMPLETED|First Intervention||21
9960893|NCT01469637|11080534|FG000|NOT COMPLETED|First Intervention||0
9960894|NCT01469637|11080535|FG001|NOT COMPLETED|First Intervention||1
9960895|NCT01469637|11080534|FG000|STARTED|Second Intervention||22
9960896|NCT01469637|11080535|FG001|STARTED|Second Intervention||21
9725902|NCT00097669|10825540|FG000|COMPLETED|Overall Study||4089
9960897|NCT01469637|11080534|FG000|COMPLETED|Second Intervention||21
9685013|NCT04854642|10785421|FG000|STARTED|Overall Study||18
9685014|NCT04854642|10785422|FG001|STARTED|Overall Study||18
9685015|NCT04854642|10785421|FG000|Safety Set|Overall Study||18
9685016|NCT04854642|10785422|FG001|Safety Set|Overall Study||18
9685017|NCT04854642|10785421|FG000|PK Set 1|Overall Study||18
9685018|NCT04854642|10785422|FG001|PK Set 1|Overall Study||18
9685019|NCT04854642|10785421|FG000|PK Set 2|Overall Study||18
9685020|NCT04854642|10785422|FG001|PK Set 2|Overall Study||18
9685021|NCT04854642|10785421|FG000|COMPLETED|Overall Study||17
9685022|NCT04854642|10785422|FG001|COMPLETED|Overall Study||15
9685023|NCT04854642|10785421|FG000|NOT COMPLETED|Overall Study||1
9685024|NCT04854642|10785422|FG001|NOT COMPLETED|Overall Study||3
9844773|NCT00838539|10956774|FG000|COMPLETED|Overall Study||0
9844774|NCT00838539|10956775|FG001|COMPLETED|Overall Study||0
9844775|NCT00838539|10956776|FG002|COMPLETED|Overall Study||0
9844776|NCT00838539|10956777|FG003|COMPLETED|Overall Study||0
9844777|NCT00838539|10956778|FG004|COMPLETED|Overall Study||0
9844778|NCT00838539|10956779|FG005|COMPLETED|Overall Study||0
9844779|NCT00838539|10956780|FG006|COMPLETED|Overall Study||2
9844780|NCT00838539|10956781|FG007|COMPLETED|Overall Study||0
9844781|NCT00838539|10956782|FG008|COMPLETED|Overall Study||0
9844782|NCT00838539|10956783|FG009|COMPLETED|Overall Study||0
9844783|NCT00838539|10956784|FG010|COMPLETED|Overall Study||0
9844784|NCT00838539|10956785|FG011|COMPLETED|Overall Study||0
9685037|NCT04583592|10785449|FG000|STARTED|Overall Study||194
9685038|NCT04583592|10785450|FG001|STARTED|Overall Study||101
9685039|NCT04583592|10785449|FG000|COMPLETED|Overall Study||194
9685040|NCT04583592|10785450|FG001|COMPLETED|Overall Study||100
9685041|NCT04583592|10785449|FG000|NOT COMPLETED|Overall Study||0
9685042|NCT04583592|10785450|FG001|NOT COMPLETED|Overall Study||1
9685043|NCT04572399|10785456|FG000|STARTED|Overall Study||5
9685044|NCT04572399|10785456|FG000|COMPLETED|Overall Study||5
9685045|NCT04572399|10785456|FG000|NOT COMPLETED|Overall Study||0
9685046|NCT04388787|10785460|FG000|STARTED|Blinded Period||16
9685047|NCT04388787|10785460|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
9685048|NCT04388787|10785460|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
9685049|NCT04388787|10785460|FG000|COMPLETED|Blinded Period||15
9685050|NCT04388787|10785460|FG000|NOT COMPLETED|Blinded Period||1
9685051|NCT04388787|10785460|FG000|STARTED|Unblinded Period||15
9685052|NCT04388787|10785460|FG000|COMPLETED|Unblinded Period||6
9685053|NCT04388787|10785460|FG000|NOT COMPLETED|Unblinded Period||9
9685054|NCT04380090|10785470|FG000|STARTED|Overall Study||76
9685055|NCT04380090|10785471|FG001|STARTED|Overall Study||78
9685056|NCT04380090|10785470|FG000|COMPLETED|Overall Study||60
9685057|NCT04380090|10785471|FG001|COMPLETED|Overall Study||58
9685058|NCT04380090|10785470|FG000|NOT COMPLETED|Overall Study||16
9685059|NCT04380090|10785471|FG001|NOT COMPLETED|Overall Study||20
9685060|NCT04377620|10785484|FG000|STARTED|Overall Study||77
9685061|NCT04377620|10785485|FG001|STARTED|Overall Study||87
9685062|NCT04377620|10785486|FG002|STARTED|Overall Study||47
9685063|NCT04377620|10785484|FG000|COMPLETED|Overall Study||35
9685064|NCT04377620|10785485|FG001|COMPLETED|Overall Study||37
9685065|NCT04377620|10785486|FG002|COMPLETED|Overall Study||11
9685066|NCT04377620|10785484|FG000|NOT COMPLETED|Overall Study||42
9685067|NCT04377620|10785485|FG001|NOT COMPLETED|Overall Study||50
9685068|NCT04377620|10785486|FG002|NOT COMPLETED|Overall Study||36
9685069|NCT04355169|10785499|FG000|STARTED|Overall Study||0
9685070|NCT04355169|10785500|FG001|STARTED|Overall Study||0
9685071|NCT04355169|10785501|FG002|STARTED|Overall Study||0
9685072|NCT04355169|10785502|FG003|STARTED|Overall Study||0
9685073|NCT04355169|10785499|FG000|COMPLETED|Overall Study||0
9685074|NCT04355169|10785500|FG001|COMPLETED|Overall Study||0
9685075|NCT04355169|10785501|FG002|COMPLETED|Overall Study||0
9685076|NCT04355169|10785502|FG003|COMPLETED|Overall Study||0
9685077|NCT04355169|10785499|FG000|NOT COMPLETED|Overall Study||0
9685078|NCT04355169|10785500|FG001|NOT COMPLETED|Overall Study||0
9685079|NCT04355169|10785501|FG002|NOT COMPLETED|Overall Study||0
9685080|NCT04355169|10785502|FG003|NOT COMPLETED|Overall Study||0
9685081|NCT04338971|10785512|FG000|STARTED|Overall Study||24
9685082|NCT04338971|10785512|FG000|COMPLETED|Overall Study||17
9685083|NCT04338971|10785512|FG000|NOT COMPLETED|Overall Study||7
9685084|NCT04310566|10785517|FG000|STARTED|Period 1||31
9685085|NCT04310566|10785518|FG001|STARTED|Period 1||34
9685086|NCT04310566|10785517|FG000|COMPLETED|Period 1||15
9685087|NCT04310566|10785518|FG001|COMPLETED|Period 1||14
9685088|NCT04310566|10785517|FG000|NOT COMPLETED|Period 1||16
9685089|NCT04310566|10785518|FG001|NOT COMPLETED|Period 1||20
9685090|NCT04310566|10785517|FG000|STARTED|Period 2||15
9685091|NCT04310566|10785518|FG001|STARTED|Period 2||14
9685092|NCT04310566|10785517|FG000|COMPLETED|Period 2||8
9685093|NCT04310566|10785518|FG001|COMPLETED|Period 2||9
9685094|NCT04310566|10785517|FG000|NOT COMPLETED|Period 2||7
9685095|NCT04310566|10785518|FG001|NOT COMPLETED|Period 2||5
9685096|NCT04206020|10785526|FG000|STARTED|Overall Study||306
9685097|NCT04206020|10785527|FG001|STARTED|Overall Study||304
9685098|NCT04206020|10785526|FG000|COMPLETED|Overall Study||298
9685099|NCT04206020|10785527|FG001|COMPLETED|Overall Study||297
9685100|NCT04206020|10785526|FG000|NOT COMPLETED|Overall Study||8
9685101|NCT04206020|10785527|FG001|NOT COMPLETED|Overall Study||7
9844785|NCT00838539|10956774|FG000|NOT COMPLETED|Overall Study||3
9844786|NCT00838539|10956775|FG001|NOT COMPLETED|Overall Study||6
9844787|NCT00838539|10956776|FG002|NOT COMPLETED|Overall Study||5
9844788|NCT00838539|10956777|FG003|NOT COMPLETED|Overall Study||4
9685102|NCT04097301|10785533|FG000|STARTED|Overall Study|Enrolled patients. Overall, 8 patients were enrolled in the study and underwent the screening phase to evaluate the compliance to the clinical inclusion / exclusion criteria as well as the CD44v6 expression by tumor cells.|8
9685103|NCT04097301|10785533|FG000|Treated Patients|Overall Study|Of the 8 enrolled patients, 2 were treated with MLM-CAR44.1 T-cell at the first dose level.|2
9685104|NCT04097301|10785533|FG000|COMPLETED|Overall Study||1
9685105|NCT04097301|10785533|FG000|NOT COMPLETED|Overall Study||7
9685106|NCT04054375|10785539|FG000|STARTED|Overall Study||20
9685107|NCT04054375|10785539|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
9685108|NCT04054375|10785539|FG000|NOT COMPLETED|Overall Study||0
9685109|NCT03953079|10785546|FG000|STARTED|Core Study||21
9685110|NCT03953079|10785547|FG001|STARTED|Core Study||22
9685111|NCT03953079|10785548|FG002|STARTED|Core Study||13
9685112|NCT03953079|10785546|FG000|COMPLETED|Core Study||20
9685113|NCT03953079|10785547|FG001|COMPLETED|Core Study||18
9685114|NCT03953079|10785548|FG002|COMPLETED|Core Study||12
9685115|NCT03953079|10785546|FG000|NOT COMPLETED|Core Study||1
9685116|NCT03953079|10785547|FG001|NOT COMPLETED|Core Study||4
9685117|NCT03953079|10785548|FG002|NOT COMPLETED|Core Study||1
9685118|NCT03953079|10785546|FG000|STARTED|Extension Study||12
9685119|NCT03953079|10785547|FG001|STARTED|Extension Study||10
9685120|NCT03953079|10785548|FG002|STARTED|Extension Study||6
9685121|NCT03953079|10785546|FG000|COMPLETED|Extension Study||6
9685122|NCT03953079|10785547|FG001|COMPLETED|Extension Study||4
9685123|NCT03953079|10785548|FG002|COMPLETED|Extension Study||1
9685124|NCT03953079|10785546|FG000|NOT COMPLETED|Extension Study||6
9685125|NCT03953079|10785547|FG001|NOT COMPLETED|Extension Study||6
9685126|NCT03953079|10785548|FG002|NOT COMPLETED|Extension Study||5
9685127|NCT03922750|10785560|FG000|STARTED|Overall Study||50
9685128|NCT03922750|10785561|FG001|STARTED|Overall Study||54
9685129|NCT03922750|10785562|FG002|STARTED|Overall Study||50
9685130|NCT03922750|10785560|FG000|Full Analysis Set (FAS)|Overall Study||50
9685131|NCT03922750|10785561|FG001|Full Analysis Set (FAS)|Overall Study||54
9685132|NCT03922750|10785562|FG002|Full Analysis Set (FAS)|Overall Study||50
9685133|NCT03922750|10785560|FG000|Safety Analysis Set (SAS)|Overall Study||50
9685134|NCT03922750|10785561|FG001|Safety Analysis Set (SAS)|Overall Study||54
9685135|NCT03922750|10785562|FG002|Safety Analysis Set (SAS)|Overall Study||50
9685136|NCT03922750|10785560|FG000|COMPLETED|Overall Study||50
9685137|NCT03922750|10785561|FG001|COMPLETED|Overall Study||53
9685138|NCT03922750|10785562|FG002|COMPLETED|Overall Study||49
9685139|NCT03922750|10785560|FG000|NOT COMPLETED|Overall Study||0
9685140|NCT03922750|10785561|FG001|NOT COMPLETED|Overall Study||1
9685141|NCT03922750|10785562|FG002|NOT COMPLETED|Overall Study||1
9685142|NCT03910673|10785575|FG000|STARTED|Overall Study||7
9685143|NCT03910673|10785576|FG001|STARTED|Overall Study||6
9685144|NCT03910673|10785577|FG002|STARTED|Overall Study||7
9685145|NCT03910673|10785578|FG003|STARTED|Overall Study||13
9685146|NCT03910673|10785579|FG004|STARTED|Overall Study||6
9685147|NCT03910673|10785575|FG000|Enrolled and Randomized|Overall Study||6
9685148|NCT03910673|10785576|FG001|Enrolled and Randomized|Overall Study||6
9685149|NCT03910673|10785577|FG002|Enrolled and Randomized|Overall Study||6
9685150|NCT03910673|10785578|FG003|Enrolled and Randomized|Overall Study||6
9685151|NCT03910673|10785579|FG004|Enrolled and Randomized|Overall Study||6
9685152|NCT03910673|10785575|FG000|Enrolled as Replacement|Overall Study||1
9685153|NCT03910673|10785576|FG001|Enrolled as Replacement|Overall Study||0
9685154|NCT03910673|10785577|FG002|Enrolled as Replacement|Overall Study||1
9685155|NCT03910673|10785578|FG003|Enrolled as Replacement|Overall Study||7
9685156|NCT03910673|10785579|FG004|Enrolled as Replacement|Overall Study||0
9685157|NCT03910673|10785575|FG000|Began Infusion of Dose 1|Overall Study||7
9685158|NCT03910673|10785576|FG001|Began Infusion of Dose 1|Overall Study||6
9685159|NCT03910673|10785577|FG002|Began Infusion of Dose 1|Overall Study||7
9685160|NCT03910673|10785578|FG003|Began Infusion of Dose 1|Overall Study||13
9685161|NCT03910673|10785579|FG004|Began Infusion of Dose 1|Overall Study||6
9685162|NCT03910673|10785575|FG000|Completed Dose 1|Overall Study||7
9685163|NCT03910673|10785576|FG001|Completed Dose 1|Overall Study||6
9685164|NCT03910673|10785577|FG002|Completed Dose 1|Overall Study||7
9685165|NCT03910673|10785578|FG003|Completed Dose 1|Overall Study||13
9685166|NCT03910673|10785579|FG004|Completed Dose 1|Overall Study||6
9685167|NCT03910673|10785575|FG000|Completed Dose 2|Overall Study||7
9685168|NCT03910673|10785576|FG001|Completed Dose 2|Overall Study||6
9685169|NCT03910673|10785577|FG002|Completed Dose 2|Overall Study||7
9685170|NCT03910673|10785578|FG003|Completed Dose 2|Overall Study||13
9685171|NCT03910673|10785579|FG004|Completed Dose 2|Overall Study||6
9685172|NCT03910673|10785575|FG000|Completed Dose 3|Overall Study||6
9685173|NCT03910673|10785576|FG001|Completed Dose 3|Overall Study||6
9685174|NCT03910673|10785577|FG002|Completed Dose 3|Overall Study||7
9685175|NCT03910673|10785578|FG003|Completed Dose 3|Overall Study||12
9685176|NCT03910673|10785579|FG004|Completed Dose 3|Overall Study||6
9685177|NCT03910673|10785575|FG000|Completed All Scheduled Treatment|Overall Study||6
9685178|NCT03910673|10785576|FG001|Completed All Scheduled Treatment|Overall Study||6
9685179|NCT03910673|10785577|FG002|Completed All Scheduled Treatment|Overall Study||7
9685180|NCT03910673|10785578|FG003|Completed All Scheduled Treatment|Overall Study||12
9685181|NCT03910673|10785579|FG004|Completed All Scheduled Treatment|Overall Study||6
9685182|NCT03910673|10785575|FG000|Completed All PK Blood Draws|Overall Study||6
9685183|NCT03910673|10785576|FG001|Completed All PK Blood Draws|Overall Study||6
9685184|NCT03910673|10785577|FG002|Completed All PK Blood Draws|Overall Study||6
9685185|NCT03910673|10785578|FG003|Completed All PK Blood Draws|Overall Study||6
9685186|NCT03910673|10785579|FG004|Completed All PK Blood Draws|Overall Study||6
9685187|NCT03910673|10785575|FG000|Completed Bronchoscopy With BAL|Overall Study||6
9685188|NCT03910673|10785576|FG001|Completed Bronchoscopy With BAL|Overall Study||6
9685189|NCT03910673|10785577|FG002|Completed Bronchoscopy With BAL|Overall Study||6
9685190|NCT03910673|10785578|FG003|Completed Bronchoscopy With BAL|Overall Study||6
9685191|NCT03910673|10785579|FG004|Completed Bronchoscopy With BAL|Overall Study||6
9685192|NCT03910673|10785575|FG000|Completed All Plasma Urea Samples|Overall Study||6
9685193|NCT03910673|10785576|FG001|Completed All Plasma Urea Samples|Overall Study||6
9685194|NCT03910673|10785577|FG002|Completed All Plasma Urea Samples|Overall Study||6
9685195|NCT03910673|10785578|FG003|Completed All Plasma Urea Samples|Overall Study||6
9685196|NCT03910673|10785579|FG004|Completed All Plasma Urea Samples|Overall Study||6
9685197|NCT03910673|10785575|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
9685198|NCT03910673|10785576|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
9685199|NCT03910673|10785577|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
9685200|NCT03910673|10785578|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
9685201|NCT03910673|10785579|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
9685202|NCT03910673|10785575|FG000|COMPLETED|Overall Study||7
9685203|NCT03910673|10785576|FG001|COMPLETED|Overall Study||6
9685204|NCT03910673|10785577|FG002|COMPLETED|Overall Study||7
9685205|NCT03910673|10785578|FG003|COMPLETED|Overall Study||11
9685206|NCT03910673|10785579|FG004|COMPLETED|Overall Study||6
9685207|NCT03910673|10785575|FG000|NOT COMPLETED|Overall Study||0
9685208|NCT03910673|10785576|FG001|NOT COMPLETED|Overall Study||0
9685209|NCT03910673|10785577|FG002|NOT COMPLETED|Overall Study||0
9685210|NCT03910673|10785578|FG003|NOT COMPLETED|Overall Study||2
9685211|NCT03910673|10785579|FG004|NOT COMPLETED|Overall Study||0
9685212|NCT03885999|10785583|FG000|STARTED|Overall Study||12
9685213|NCT03885999|10785583|FG000|COMPLETED|Overall Study||11
9685214|NCT03885999|10785583|FG000|NOT COMPLETED|Overall Study||1
9685215|NCT03882970|10785591|FG000|STARTED|Overall Study||359
9685216|NCT03882970|10785592|FG001|STARTED|Overall Study||361
9685217|NCT03882970|10785593|FG002|STARTED|Overall Study||359
9685218|NCT03882970|10785594|FG003|STARTED|Overall Study||365
9685219|NCT03882970|10785591|FG000|Received at Least One Dose of Study Drug|Overall Study||358
9685220|NCT03882970|10785592|FG001|Received at Least One Dose of Study Drug|Overall Study||360
9685221|NCT03882970|10785593|FG002|Received at Least One Dose of Study Drug|Overall Study||359
9685222|NCT03882970|10785594|FG003|Received at Least One Dose of Study Drug|Overall Study||360
9685223|NCT03882970|10785591|FG000|COMPLETED|Overall Study||333
9685224|NCT03882970|10785592|FG001|COMPLETED|Overall Study||321
9685225|NCT03882970|10785593|FG002|COMPLETED|Overall Study||340
9685226|NCT03882970|10785594|FG003|COMPLETED|Overall Study||331
9685227|NCT03882970|10785591|FG000|NOT COMPLETED|Overall Study||26
9685228|NCT03882970|10785592|FG001|NOT COMPLETED|Overall Study||40
9685229|NCT03882970|10785593|FG002|NOT COMPLETED|Overall Study||19
9685230|NCT03882970|10785594|FG003|NOT COMPLETED|Overall Study||34
10114246|NCT02514889|11244961|FG000|STARTED|Intervention Participation||111
10114247|NCT02514889|11244962|FG001|STARTED|Intervention Participation||106
10114248|NCT02514889|11244961|FG000|COMPLETED|Intervention Participation||102
10114249|NCT02514889|11244962|FG001|COMPLETED|Intervention Participation||98
9685231|NCT03879525|10785610|FG000|STARTED|Overall Study||15
9685232|NCT03879525|10785611|FG001|STARTED|Overall Study||15
9685233|NCT03879525|10785610|FG000|COMPLETED|Overall Study||15
9685234|NCT03879525|10785611|FG001|COMPLETED|Overall Study||15
9685235|NCT03879525|10785610|FG000|NOT COMPLETED|Overall Study||0
9685236|NCT03879525|10785611|FG001|NOT COMPLETED|Overall Study||0
9685237|NCT03867734|10785618|FG000|STARTED|Overall Study||32
9685238|NCT03867734|10785618|FG000|COMPLETED|Overall Study||30
9685239|NCT03867734|10785618|FG000|NOT COMPLETED|Overall Study||2
9725903|NCT00097669|10825541|FG001|COMPLETED|Overall Study||4075
9725904|NCT00097669|10825540|FG000|NOT COMPLETED|Overall Study||0
9725905|NCT00097669|10825541|FG001|NOT COMPLETED|Overall Study||0
9725906|NCT00097695|10825551|FG000|STARTED|The Controlled Phase||27
9725907|NCT00097695|10825552|FG001|STARTED|The Controlled Phase||29
9725908|NCT00097695|10825553|FG002|STARTED|The Controlled Phase||8
9725909|NCT00097695|10825554|FG003|STARTED|The Controlled Phase||20
9725910|NCT00097695|10825551|FG000|COMPLETED|The Controlled Phase||23
9725911|NCT00097695|10825552|FG001|COMPLETED|The Controlled Phase||26
9725912|NCT00097695|10825553|FG002|COMPLETED|The Controlled Phase||3
9725913|NCT00097695|10825554|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
9725914|NCT00097695|10825551|FG000|NOT COMPLETED|The Controlled Phase||4
9725915|NCT00097695|10825552|FG001|NOT COMPLETED|The Controlled Phase||3
10114250|NCT02514889|11244961|FG000|NOT COMPLETED|Intervention Participation||9
10114251|NCT02514889|11244962|FG001|NOT COMPLETED|Intervention Participation||8
10114252|NCT02514889|11244961|FG000|STARTED|Follow-up Assessment Participation||102
9725916|NCT00097695|10825553|FG002|NOT COMPLETED|The Controlled Phase||5
9725917|NCT00097695|10825554|FG003|NOT COMPLETED|The Controlled Phase||20
9725918|NCT00097695|10825551|FG000|STARTED|The Open Label Extension (OLE) Phase||23
10196045|NCT03358290|11324438|FG002|COMPLETED|Overall Study||1
9685240|NCT03781778|10785628|FG000|STARTED|Overall Study||4
9685241|NCT03781778|10785629|FG001|STARTED|Overall Study||6
9685242|NCT03781778|10785628|FG000|Started Intervention|Overall Study||3
9685243|NCT03781778|10785629|FG001|Started Intervention|Overall Study||4
9685244|NCT03781778|10785628|FG000|COMPLETED|Overall Study||2
9685245|NCT03781778|10785629|FG001|COMPLETED|Overall Study||4
9685246|NCT03781778|10785628|FG000|NOT COMPLETED|Overall Study||2
9685247|NCT03781778|10785629|FG001|NOT COMPLETED|Overall Study||2
9844789|NCT00838539|10956778|FG004|NOT COMPLETED|Overall Study||6
9844790|NCT00838539|10956779|FG005|NOT COMPLETED|Overall Study||4
9844791|NCT00838539|10956780|FG006|NOT COMPLETED|Overall Study||5
9844792|NCT00838539|10956781|FG007|NOT COMPLETED|Overall Study||6
9844793|NCT00838539|10956782|FG008|NOT COMPLETED|Overall Study||5
9844794|NCT00838539|10956783|FG009|NOT COMPLETED|Overall Study||8
9844795|NCT00838539|10956784|FG010|NOT COMPLETED|Overall Study||5
9844796|NCT00838539|10956785|FG011|NOT COMPLETED|Overall Study||4
9844797|NCT00838565|10956831|FG000|STARTED|Overall Study||9
9844798|NCT00838565|10956832|FG001|STARTED|Overall Study||7
9844799|NCT00838565|10956833|FG002|STARTED|Overall Study||6
9844800|NCT00838565|10956834|FG003|STARTED|Overall Study||6
9844801|NCT00838565|10956835|FG004|STARTED|Overall Study||6
10023529|NCT01856595|11147189|FG007|COMPLETED|Overall Study||10
10023530|NCT01856595|11147190|FG008|COMPLETED|Overall Study||14
10023531|NCT01856595|11147182|FG000|NOT COMPLETED|Overall Study||0
10023532|NCT01856595|11147183|FG001|NOT COMPLETED|Overall Study||1
10023533|NCT01856595|11147184|FG002|NOT COMPLETED|Overall Study||0
10023534|NCT01856595|11147185|FG003|NOT COMPLETED|Overall Study||0
10023535|NCT01856595|11147186|FG004|NOT COMPLETED|Overall Study||0
10023536|NCT01856595|11147187|FG005|NOT COMPLETED|Overall Study||0
10023537|NCT01856595|11147188|FG006|NOT COMPLETED|Overall Study||1
10023538|NCT01856595|11147189|FG007|NOT COMPLETED|Overall Study||0
10023539|NCT01856595|11147190|FG008|NOT COMPLETED|Overall Study||0
10023540|NCT01856673|11147228|FG000|STARTED|Overall Study||175
10023541|NCT01856673|11147229|FG001|STARTED|Overall Study||175
10023542|NCT01856673|11147230|FG002|STARTED|Overall Study||171
10023543|NCT01856673|11147228|FG000|Buenaventura Participants|Overall Study||92
10023544|NCT01856673|11147229|FG001|Buenaventura Participants|Overall Study||89
10023545|NCT01856673|11147230|FG002|Buenaventura Participants|Overall Study||88
10023546|NCT01856673|11147228|FG000|Quibdó Participants|Overall Study||83
10023547|NCT01856673|11147229|FG001|Quibdó Participants|Overall Study||86
10023548|NCT01856673|11147230|FG002|Quibdó Participants|Overall Study||83
10023549|NCT01856673|11147228|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
10023550|NCT01856673|11147229|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
10023551|NCT01856673|11147230|FG002|COMPLETED|Overall Study||137
10023552|NCT01856673|11147228|FG000|NOT COMPLETED|Overall Study||95
10023553|NCT01856673|11147229|FG001|NOT COMPLETED|Overall Study||85
10023554|NCT01856673|11147230|FG002|NOT COMPLETED|Overall Study||34
10023555|NCT01856686|11147240|FG000|STARTED|Overall Study||31
10023556|NCT01856686|11147241|FG001|STARTED|Overall Study||33
10023557|NCT01856686|11147240|FG000|COMPLETED|Overall Study||26
10023558|NCT01856686|11147241|FG001|COMPLETED|Overall Study||22
10023559|NCT01856686|11147240|FG000|NOT COMPLETED|Overall Study||5
10023560|NCT01856686|11147241|FG001|NOT COMPLETED|Overall Study||11
10023561|NCT01856712|11147249|FG000|STARTED|Overall Study||23
10023562|NCT01856712|11147250|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22
10023563|NCT01856712|11147249|FG000|Lost to 14 Day Follow up|Overall Study||6
10023564|NCT01856712|11147250|FG001|Lost to 14 Day Follow up|Overall Study||2
10023565|NCT01856712|11147249|FG000|Lost to 45 Day Follow up|Overall Study||1
10023566|NCT01856712|11147250|FG001|Lost to 45 Day Follow up|Overall Study||1
10023567|NCT01856712|11147249|FG000|COMPLETED|Overall Study||16
10023568|NCT01856712|11147250|FG001|COMPLETED|Overall Study||19
10023569|NCT01856712|11147249|FG000|NOT COMPLETED|Overall Study||7
10023570|NCT01856712|11147250|FG001|NOT COMPLETED|Overall Study||3
10023571|NCT01856764|11147262|FG000|STARTED|Overall Study||20
10023572|NCT01856764|11147263|FG001|STARTED|Overall Study||20
10023573|NCT01856764|11147262|FG000|COMPLETED|Overall Study||20
10023574|NCT01856764|11147263|FG001|COMPLETED|Overall Study||20
10023575|NCT01856764|11147262|FG000|NOT COMPLETED|Overall Study||0
10023576|NCT01856764|11147263|FG001|NOT COMPLETED|Overall Study||0
10023577|NCT01856790|11147269|FG000|STARTED|Closed Loop Control||15
10023578|NCT01856790|11147269|FG000|COMPLETED|Closed Loop Control||13
10023579|NCT01856790|11147269|FG000|NOT COMPLETED|Closed Loop Control||2
10023580|NCT01856790|11147269|FG000|STARTED|Closed Loop Control + Liraglutide||13
10023581|NCT01856790|11147269|FG000|COMPLETED|Closed Loop Control + Liraglutide||11
9685248|NCT03764735|10785638|FG000|STARTED|Overall Study||151
9685249|NCT03764735|10785639|FG001|STARTED|Overall Study||150
9685250|NCT03764735|10785640|FG002|STARTED|Overall Study||151
9685251|NCT03764735|10785638|FG000|COMPLETED|Overall Study||147
9685252|NCT03764735|10785639|FG001|COMPLETED|Overall Study||144
9685253|NCT03764735|10785640|FG002|COMPLETED|Overall Study||147
9685254|NCT03764735|10785638|FG000|NOT COMPLETED|Overall Study||4
9685255|NCT03764735|10785639|FG001|NOT COMPLETED|Overall Study||6
9685256|NCT03764735|10785640|FG002|NOT COMPLETED|Overall Study||4
9685257|NCT03730480|10785648|FG000|STARTED|Overall Study||372
10023582|NCT01856790|11147269|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2
10023583|NCT01856907|11147283|FG000|STARTED|Overall Study||12
9844802|NCT00838565|10956836|FG005|STARTED|Overall Study||7
9844803|NCT00838565|10956831|FG000|Treated|Overall Study||9
9685258|NCT03730480|10785648|FG000|COMPLETED|Overall Study||371
9685259|NCT03730480|10785648|FG000|NOT COMPLETED|Overall Study||1
9685260|NCT03713073|10785653|FG000|STARTED|Overall Study||19
9685261|NCT03713073|10785653|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19
9685262|NCT03713073|10785653|FG000|Collagen Dressing|Overall Study||19
9685263|NCT03713073|10785653|FG000|COMPLETED|Overall Study||19
9685264|NCT03713073|10785653|FG000|NOT COMPLETED|Overall Study||0
9685265|NCT03713034|10785661|FG000|STARTED|Overall Study||150
9685266|NCT03713034|10785662|FG001|STARTED|Overall Study||146
9685267|NCT03713034|10785661|FG000|COMPLETED|Overall Study||145
9685268|NCT03713034|10785662|FG001|COMPLETED|Overall Study||142
9685269|NCT03713034|10785661|FG000|NOT COMPLETED|Overall Study||5
9685270|NCT03713034|10785662|FG001|NOT COMPLETED|Overall Study||4
9685271|NCT03654404|10785670|FG000|STARTED|Overall Study||20
9685272|NCT03654404|10785670|FG000|COMPLETED|Overall Study||12
9685273|NCT03654404|10785670|FG000|NOT COMPLETED|Overall Study||8
9685274|NCT03567057|10785677|FG000|STARTED|Overall Study||159
9685275|NCT03567057|10785678|FG001|STARTED|Overall Study||151
9685276|NCT03567057|10785679|FG002|STARTED|Overall Study||114
9685277|NCT03567057|10785677|FG000|COMPLETED|Overall Study||64
9685278|NCT03567057|10785678|FG001|COMPLETED|Overall Study||64
9685279|NCT03567057|10785679|FG002|COMPLETED|Overall Study||68
9685280|NCT03567057|10785677|FG000|NOT COMPLETED|Overall Study||95
9685281|NCT03567057|10785678|FG001|NOT COMPLETED|Overall Study||87
9685282|NCT03567057|10785679|FG002|NOT COMPLETED|Overall Study||46
9685283|NCT03548987|10785689|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902
9685284|NCT03548987|10785690|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0
9685285|NCT03548987|10785689|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
9685286|NCT03548987|10785690|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
9685287|NCT03548987|10785689|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803
9685288|NCT03548987|10785690|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0
9685289|NCT03548987|10785689|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
9685290|NCT03548987|10785690|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
9685291|NCT03548987|10785689|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535
9685292|NCT03548987|10785690|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268
9685293|NCT03548987|10785689|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
9685294|NCT03548987|10785690|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
9685295|NCT03548987|10785689|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
9685296|NCT03548987|10785690|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
9685297|NCT03548987|10785689|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
9685298|NCT03548987|10785690|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
9685299|NCT03548064|10785705|FG000|STARTED|Overall Study||12
9685300|NCT03548064|10785706|FG001|STARTED|Overall Study||12
9844804|NCT00838565|10956832|FG001|Treated|Overall Study||6
9844805|NCT00838565|10956833|FG002|Treated|Overall Study||6
9844806|NCT00838565|10956834|FG003|Treated|Overall Study||6
9844807|NCT00838565|10956835|FG004|Treated|Overall Study||6
9844808|NCT00838565|10956836|FG005|Treated|Overall Study||7
9844809|NCT00838565|10956831|FG000|COMPLETED|Overall Study||9
9844810|NCT00838565|10956832|FG001|COMPLETED|Overall Study||4
9844811|NCT00838565|10956833|FG002|COMPLETED|Overall Study||5
9844812|NCT00838565|10956834|FG003|COMPLETED|Overall Study||6
9844813|NCT00838565|10956835|FG004|COMPLETED|Overall Study||6
9844814|NCT00838565|10956836|FG005|COMPLETED|Overall Study||5
9844815|NCT00838565|10956831|FG000|NOT COMPLETED|Overall Study||0
9844816|NCT00838565|10956832|FG001|NOT COMPLETED|Overall Study||3
9844817|NCT00838565|10956833|FG002|NOT COMPLETED|Overall Study||1
9844818|NCT00838565|10956834|FG003|NOT COMPLETED|Overall Study||0
9844819|NCT00838565|10956835|FG004|NOT COMPLETED|Overall Study||0
9844820|NCT00838565|10956836|FG005|NOT COMPLETED|Overall Study||2
9844821|NCT00838578|10956855|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
9844822|NCT00838578|10956855|FG000|COMPLETED|Overall Study||63
9844823|NCT00838578|10956855|FG000|NOT COMPLETED|Overall Study||2
9844824|NCT00838682|10956865|FG000|STARTED|Overall Study||54
9844825|NCT00838682|10956866|FG001|STARTED|Overall Study||52
9960898|NCT01469637|11080535|FG001|COMPLETED|Second Intervention||21
9960899|NCT01469637|11080534|FG000|NOT COMPLETED|Second Intervention||1
9960900|NCT01469637|11080535|FG001|NOT COMPLETED|Second Intervention||0
9960901|NCT01469715|11080541|FG000|STARTED|Overall Study||16
9960902|NCT01469715|11080541|FG000|COMPLETED|Overall Study||16
9960903|NCT01469715|11080541|FG000|NOT COMPLETED|Overall Study||0
9960904|NCT01469767|11080545|FG000|STARTED|Overall Study||10
9960905|NCT01469767|11080545|FG000|COMPLETED|Overall Study||10
9960906|NCT01469767|11080545|FG000|NOT COMPLETED|Overall Study||0
9960907|NCT01469819|11080549|FG000|STARTED|Overall Study||37
9960908|NCT01469819|11080549|FG000|COMPLETED|Overall Study||29
9685301|NCT03548064|10785707|FG002|STARTED|Overall Study||6
9685302|NCT03548064|10785708|FG003|STARTED|Overall Study||12
9685303|NCT03548064|10785709|FG004|STARTED|Overall Study||12
9685304|NCT03548064|10785710|FG005|STARTED|Overall Study||6
9685305|NCT03548064|10785711|FG006|STARTED|Overall Study||12
9844826|NCT00838682|10956865|FG000|COMPLETED|Overall Study||29
9844827|NCT00838682|10956866|FG001|COMPLETED|Overall Study||33
9844828|NCT00838682|10956865|FG000|NOT COMPLETED|Overall Study||25
9844829|NCT00838682|10956866|FG001|NOT COMPLETED|Overall Study||19
9960909|NCT01469819|11080549|FG000|NOT COMPLETED|Overall Study||8
9960910|NCT01470001|11080561|FG000|STARTED|Overall Study||58
9685306|NCT03548064|10785712|FG007|STARTED|Overall Study||3
9685307|NCT03548064|10785705|FG000|COMPLETED|Overall Study||12
9685308|NCT03548064|10785706|FG001|COMPLETED|Overall Study||12
9685309|NCT03548064|10785707|FG002|COMPLETED|Overall Study||6
9685310|NCT03548064|10785708|FG003|COMPLETED|Overall Study||11
9685311|NCT03548064|10785709|FG004|COMPLETED|Overall Study||0
9685312|NCT03548064|10785710|FG005|COMPLETED|Overall Study||3
9685313|NCT03548064|10785711|FG006|COMPLETED|Overall Study||12
9685314|NCT03548064|10785712|FG007|COMPLETED|Overall Study||3
9685315|NCT03548064|10785705|FG000|NOT COMPLETED|Overall Study||0
9685316|NCT03548064|10785706|FG001|NOT COMPLETED|Overall Study||0
9685317|NCT03548064|10785707|FG002|NOT COMPLETED|Overall Study||0
9685318|NCT03548064|10785708|FG003|NOT COMPLETED|Overall Study||1
9685319|NCT03548064|10785709|FG004|NOT COMPLETED|Overall Study||12
9685320|NCT03548064|10785710|FG005|NOT COMPLETED|Overall Study||3
9685321|NCT03548064|10785711|FG006|NOT COMPLETED|Overall Study||0
9685322|NCT03548064|10785712|FG007|NOT COMPLETED|Overall Study||0
9685323|NCT03446456|10785738|FG000|STARTED|Overall Study||20
9685324|NCT03446456|10785739|FG001|STARTED|Overall Study||20
9685325|NCT03446456|10785738|FG000|COMPLETED|Overall Study||16
9685326|NCT03446456|10785739|FG001|COMPLETED|Overall Study||16
9685327|NCT03446456|10785738|FG000|NOT COMPLETED|Overall Study||4
9685328|NCT03446456|10785739|FG001|NOT COMPLETED|Overall Study||4
9685329|NCT03382834|10785747|FG000|STARTED|Overall Study||21
9685330|NCT03382834|10785748|FG001|STARTED|Overall Study||10
9685331|NCT03382834|10785747|FG000|COMPLETED|Overall Study||20
9685332|NCT03382834|10785748|FG001|COMPLETED|Overall Study||9
9685333|NCT03382834|10785747|FG000|NOT COMPLETED|Overall Study||1
9685334|NCT03382834|10785748|FG001|NOT COMPLETED|Overall Study||1
9685335|NCT03371823|10785756|FG000|STARTED|Overall Study||8
9685336|NCT03371823|10785757|FG001|STARTED|Overall Study|We had trouble enrolling naive to therapy women with high blood pressure|0
9685337|NCT03371823|10785756|FG000|COMPLETED|Overall Study||7
9685338|NCT03371823|10785757|FG001|COMPLETED|Overall Study||0
9685339|NCT03371823|10785756|FG000|NOT COMPLETED|Overall Study||1
9685340|NCT03371823|10785757|FG001|NOT COMPLETED|Overall Study||0
9685341|NCT03353350|10785767|FG000|STARTED|30-week Core Treatment Period||102
9685342|NCT03353350|10785768|FG001|STARTED|30-week Core Treatment Period||100
9685343|NCT03353350|10785769|FG002|STARTED|30-week Core Treatment Period||101
9685344|NCT03353350|10785770|FG003|STARTED|30-week Core Treatment Period||103
9685345|NCT03353350|10785767|FG000|COMPLETED|30-week Core Treatment Period||80
9685346|NCT03353350|10785768|FG001|COMPLETED|30-week Core Treatment Period||81
9685347|NCT03353350|10785769|FG002|COMPLETED|30-week Core Treatment Period||77
9685348|NCT03353350|10785770|FG003|COMPLETED|30-week Core Treatment Period||81
9685349|NCT03353350|10785767|FG000|NOT COMPLETED|30-week Core Treatment Period||22
9685350|NCT03353350|10785768|FG001|NOT COMPLETED|30-week Core Treatment Period||19
9685351|NCT03353350|10785769|FG002|NOT COMPLETED|30-week Core Treatment Period||24
9685352|NCT03353350|10785770|FG003|NOT COMPLETED|30-week Core Treatment Period||22
9685353|NCT03353350|10785767|FG000|STARTED|26-week Treatment Extension Period||80
9685354|NCT03353350|10785768|FG001|STARTED|26-week Treatment Extension Period||81
9685355|NCT03353350|10785769|FG002|STARTED|26-week Treatment Extension Period||77
9685356|NCT03353350|10785770|FG003|STARTED|26-week Treatment Extension Period||81
9685357|NCT03353350|10785767|FG000|COMPLETED|26-week Treatment Extension Period||75
9685358|NCT03353350|10785768|FG001|COMPLETED|26-week Treatment Extension Period||78
9685359|NCT03353350|10785769|FG002|COMPLETED|26-week Treatment Extension Period||73
9685360|NCT03353350|10785770|FG003|COMPLETED|26-week Treatment Extension Period||67
9685361|NCT03353350|10785767|FG000|NOT COMPLETED|26-week Treatment Extension Period||5
9685362|NCT03353350|10785768|FG001|NOT COMPLETED|26-week Treatment Extension Period||3
9685363|NCT03353350|10785769|FG002|NOT COMPLETED|26-week Treatment Extension Period||4
9685364|NCT03353350|10785770|FG003|NOT COMPLETED|26-week Treatment Extension Period||14
9685365|NCT03350503|10785780|FG000|STARTED|Overall Study||121
9685366|NCT03350503|10785780|FG000|COMPLETED|Overall Study||116
9685367|NCT03350503|10785780|FG000|NOT COMPLETED|Overall Study||5
9685368|NCT03326193|10785784|FG000|STARTED|Overall Study||105
9685369|NCT03326193|10785784|FG000|COMPLETED|Overall Study||52
9685370|NCT03326193|10785784|FG000|NOT COMPLETED|Overall Study||53
9685371|NCT03287687|10785790|FG000|STARTED|Overall Study||88
9685372|NCT03287687|10785791|FG001|STARTED|Overall Study||90
9685373|NCT03287687|10785790|FG000|Procedures|Overall Study||88
9685374|NCT03287687|10785791|FG001|Procedures|Overall Study||90
10023584|NCT01856907|11147284|FG001|STARTED|Overall Study||12
10023585|NCT01856907|11147285|FG002|STARTED|Overall Study||12
10023586|NCT01856907|11147283|FG000|COMPLETED|Overall Study||12
10023587|NCT01856907|11147284|FG001|COMPLETED|Overall Study||9
10023588|NCT01856907|11147285|FG002|COMPLETED|Overall Study||12
9685375|NCT03287687|10785790|FG000|COMPLETED|Overall Study||88
9685376|NCT03287687|10785791|FG001|COMPLETED|Overall Study||90
10023589|NCT01856907|11147283|FG000|NOT COMPLETED|Overall Study||0
10023590|NCT01856907|11147284|FG001|NOT COMPLETED|Overall Study||3
9685377|NCT03287687|10785790|FG000|NOT COMPLETED|Overall Study||0
9685378|NCT03287687|10785791|FG001|NOT COMPLETED|Overall Study||0
9685379|NCT03282565|10785800|FG000|STARTED|Overall Study||10
9685380|NCT03282565|10785801|FG001|STARTED|Overall Study||10
9685381|NCT03282565|10785802|FG002|STARTED|Overall Study||10
9685382|NCT03282565|10785800|FG000|COMPLETED|Overall Study||10
9685383|NCT03282565|10785801|FG001|COMPLETED|Overall Study||8
9685384|NCT03282565|10785802|FG002|COMPLETED|Overall Study||8
9685385|NCT03282565|10785800|FG000|NOT COMPLETED|Overall Study||0
9685386|NCT03282565|10785801|FG001|NOT COMPLETED|Overall Study||2
9685387|NCT03282565|10785802|FG002|NOT COMPLETED|Overall Study||2
10023591|NCT01856907|11147285|FG002|NOT COMPLETED|Overall Study||0
10023592|NCT01856933|11147296|FG000|STARTED|Overall Study||6
10023593|NCT01856933|11147296|FG000|COMPLETED|Overall Study||6
9725919|NCT00097695|10825552|FG001|STARTED|The Open Label Extension (OLE) Phase||26
9725920|NCT00097695|10825553|FG002|STARTED|The Open Label Extension (OLE) Phase||3
9725921|NCT00097695|10825554|FG003|STARTED|The Open Label Extension (OLE) Phase||20
9725922|NCT00097695|10825551|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10
9725923|NCT00097695|10825552|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11
9725924|NCT00097695|10825553|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1
9725925|NCT00097695|10825554|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15
9725926|NCT00097695|10825551|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
9725927|NCT00097695|10825552|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
9725928|NCT00097695|10825553|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
9725929|NCT00097695|10825554|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
9725930|NCT00097708|10825569|FG000|STARTED|Overall Study||173
9725931|NCT00097708|10825570|FG001|STARTED|Overall Study||176
9725932|NCT00097708|10825571|FG002|STARTED|Overall Study||162
9725933|NCT00097708|10825569|FG000|Intent-to-Treat (ITT)|Overall Study||165
9725934|NCT00097708|10825570|FG001|Intent-to-Treat (ITT)|Overall Study||169
9725935|NCT00097708|10825571|FG002|Intent-to-Treat (ITT)|Overall Study||149
9725936|NCT00097708|10825569|FG000|Treated|Overall Study||171
9725937|NCT00097708|10825570|FG001|Treated|Overall Study||176
9725938|NCT00097708|10825571|FG002|Treated|Overall Study||160
9725939|NCT00097708|10825569|FG000|COMPLETED|Overall Study||109
9725940|NCT00097708|10825570|FG001|COMPLETED|Overall Study||120
9725941|NCT00097708|10825571|FG002|COMPLETED|Overall Study||97
9725942|NCT00097708|10825569|FG000|NOT COMPLETED|Overall Study||64
9725943|NCT00097708|10825570|FG001|NOT COMPLETED|Overall Study||56
9725944|NCT00097708|10825571|FG002|NOT COMPLETED|Overall Study||65
9725945|NCT00097721|10825581|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
9725946|NCT00097721|10825582|FG001|STARTED|Overall Study||33
9725947|NCT00097721|10825581|FG000|COMPLETED|Overall Study||0
9725948|NCT00097721|10825582|FG001|COMPLETED|Overall Study||0
9725949|NCT00097721|10825581|FG000|NOT COMPLETED|Overall Study||71
9725950|NCT00097721|10825582|FG001|NOT COMPLETED|Overall Study||33
9725951|NCT00097773|10825592|FG000|STARTED|Overall Study||76
9725952|NCT00097773|10825593|FG001|STARTED|Overall Study||76
9725953|NCT00097773|10825594|FG002|STARTED|Overall Study||76
9725954|NCT00097773|10825595|FG003|STARTED|Overall Study||76
9725955|NCT00097773|10825592|FG000|COMPLETED|Overall Study||68
9725956|NCT00097773|10825593|FG001|COMPLETED|Overall Study||68
9725957|NCT00097773|10825594|FG002|COMPLETED|Overall Study||68
9725958|NCT00097773|10825595|FG003|COMPLETED|Overall Study||73
9725959|NCT00097773|10825592|FG000|NOT COMPLETED|Overall Study||8
9725960|NCT00097773|10825593|FG001|NOT COMPLETED|Overall Study||8
9725961|NCT00097773|10825594|FG002|NOT COMPLETED|Overall Study||8
9725962|NCT00097773|10825595|FG003|NOT COMPLETED|Overall Study||3
9725963|NCT00097786|10825614|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
9725964|NCT00097786|10825615|FG001|STARTED|Overall Study||2315
9725965|NCT00097786|10825616|FG002|STARTED|Overall Study||2329
9725966|NCT00097786|10825617|FG003|STARTED|Overall Study||2346
9725967|NCT00097786|10825614|FG000|Complete FU for Progression to Diabetes|Overall Study||1709
9725968|NCT00097786|10825615|FG001|Complete FU for Progression to Diabetes|Overall Study||1712
9725969|NCT00097786|10825616|FG002|Complete FU for Progression to Diabetes|Overall Study||1734
9725970|NCT00097786|10825617|FG003|Complete FU for Progression to Diabetes|Overall Study||1762
9725971|NCT00097786|10825614|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969
9725972|NCT00097786|10825615|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985
9725973|NCT00097786|10825616|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987
9725974|NCT00097786|10825617|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015
9725975|NCT00097786|10825614|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948
9725976|NCT00097786|10825615|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963
9725977|NCT00097786|10825616|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966
9725978|NCT00097786|10825617|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988
9725979|NCT00097786|10825614|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
9725980|NCT00097786|10825615|FG001|COMPLETED|Overall Study||2023
9725981|NCT00097786|10825616|FG002|COMPLETED|Overall Study||2016
9725982|NCT00097786|10825617|FG003|COMPLETED|Overall Study||2036
9725983|NCT00097786|10825614|FG000|NOT COMPLETED|Overall Study||296
9725984|NCT00097786|10825615|FG001|NOT COMPLETED|Overall Study||292
9725985|NCT00097786|10825616|FG002|NOT COMPLETED|Overall Study||313
9725986|NCT00097786|10825617|FG003|NOT COMPLETED|Overall Study||310
9725987|NCT00097981|10825629|FG000|STARTED|Overall Study|Enrollment at randomization|113
9725988|NCT00097981|10825630|FG001|STARTED|Overall Study|Enrollment at randomization|112
9725989|NCT00097981|10825629|FG000|Received Study Medication|Overall Study||110
9725990|NCT00097981|10825630|FG001|Received Study Medication|Overall Study||106
9725991|NCT00097981|10825629|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
9725992|NCT00097981|10825630|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
9725993|NCT00097981|10825629|FG000|NOT COMPLETED|Overall Study||106
10023594|NCT01856933|11147296|FG000|NOT COMPLETED|Overall Study||0
10023595|NCT01857102|11147300|FG000|STARTED|Period 1||58
10023596|NCT01857102|11147301|FG001|STARTED|Period 1||56
10023597|NCT01857102|11147300|FG000|Habitual Users|Period 1||51
10023598|NCT01857102|11147301|FG001|Habitual Users|Period 1||52
10023599|NCT01857102|11147300|FG000|Neophtyes|Period 1||7
9685388|NCT03276936|10785812|FG000|STARTED|Overall Study||332
9685389|NCT03276936|10785813|FG001|STARTED|Overall Study||172
9685390|NCT03276936|10785812|FG000|COMPLETED|Overall Study||276
9685391|NCT03276936|10785813|FG001|COMPLETED|Overall Study||134
9685392|NCT03276936|10785812|FG000|NOT COMPLETED|Overall Study||56
9685393|NCT03276936|10785813|FG001|NOT COMPLETED|Overall Study||38
9685394|NCT03271021|10785821|FG000|STARTED|Overall Study||738
9685395|NCT03271021|10785822|FG001|STARTED|Overall Study||750
9685396|NCT03271021|10785821|FG000|COMPLETED|Overall Study||649
9685397|NCT03271021|10785822|FG001|COMPLETED|Overall Study||644
9685398|NCT03271021|10785821|FG000|NOT COMPLETED|Overall Study||89
9685399|NCT03271021|10785822|FG001|NOT COMPLETED|Overall Study||106
9685400|NCT03255083|10785832|FG000|STARTED|Overall Study||6
9685401|NCT03255083|10785833|FG001|STARTED|Overall Study||3
9685402|NCT03255083|10785834|FG002|STARTED|Overall Study||3
9685403|NCT03255083|10785835|FG003|STARTED|Overall Study||1
9685404|NCT03255083|10785832|FG000|COMPLETED|Overall Study||0
9685405|NCT03255083|10785833|FG001|COMPLETED|Overall Study||0
9685406|NCT03255083|10785834|FG002|COMPLETED|Overall Study||0
9685407|NCT03255083|10785835|FG003|COMPLETED|Overall Study||0
9685408|NCT03255083|10785832|FG000|NOT COMPLETED|Overall Study||6
9685409|NCT03255083|10785833|FG001|NOT COMPLETED|Overall Study||3
9685410|NCT03255083|10785834|FG002|NOT COMPLETED|Overall Study||3
9685411|NCT03255083|10785835|FG003|NOT COMPLETED|Overall Study||1
9685412|NCT03227471|10785860|FG000|STARTED|Overall Study||9
9685413|NCT03227471|10785861|FG001|STARTED|Overall Study||30
9685414|NCT03227471|10785862|FG002|STARTED|Overall Study||8
9685415|NCT03227471|10785863|FG003|STARTED|Overall Study||7
9685416|NCT03227471|10785864|FG004|STARTED|Overall Study||25
9685417|NCT03227471|10785865|FG005|STARTED|Overall Study||6
9685418|NCT03227471|10785866|FG006|STARTED|Overall Study||17
9685419|NCT03227471|10785867|FG007|STARTED|Overall Study||12
9685420|NCT03227471|10785868|FG008|STARTED|Overall Study||10
9685421|NCT03227471|10785869|FG009|STARTED|Overall Study||22
9685422|NCT03227471|10785870|FG010|STARTED|Overall Study||21
9685423|NCT03227471|10785871|FG011|STARTED|Overall Study||7
9685424|NCT03227471|10785872|FG012|STARTED|Overall Study||21
9685425|NCT03227471|10785873|FG013|STARTED|Overall Study||8
9685426|NCT03227471|10785874|FG014|STARTED|Overall Study||22
9685427|NCT03227471|10785860|FG000|Safety Set|Overall Study||9
9685428|NCT03227471|10785861|FG001|Safety Set|Overall Study||30
9685429|NCT03227471|10785862|FG002|Safety Set|Overall Study||8
9685430|NCT03227471|10785863|FG003|Safety Set|Overall Study||7
9685431|NCT03227471|10785864|FG004|Safety Set|Overall Study||25
9685432|NCT03227471|10785865|FG005|Safety Set|Overall Study||6
9685433|NCT03227471|10785866|FG006|Safety Set|Overall Study||17
9685434|NCT03227471|10785867|FG007|Safety Set|Overall Study||12
9685435|NCT03227471|10785868|FG008|Safety Set|Overall Study||10
9685436|NCT03227471|10785869|FG009|Safety Set|Overall Study||22
9685437|NCT03227471|10785870|FG010|Safety Set|Overall Study||21
9685438|NCT03227471|10785871|FG011|Safety Set|Overall Study||7
9685439|NCT03227471|10785872|FG012|Safety Set|Overall Study||21
9685440|NCT03227471|10785873|FG013|Safety Set|Overall Study||8
9685441|NCT03227471|10785874|FG014|Safety Set|Overall Study||21
9685442|NCT03227471|10785860|FG000|COMPLETED|Overall Study||9
9685443|NCT03227471|10785861|FG001|COMPLETED|Overall Study||30
9685444|NCT03227471|10785862|FG002|COMPLETED|Overall Study||8
9685445|NCT03227471|10785863|FG003|COMPLETED|Overall Study||7
9685446|NCT03227471|10785864|FG004|COMPLETED|Overall Study||24
9685447|NCT03227471|10785865|FG005|COMPLETED|Overall Study||6
9685448|NCT03227471|10785866|FG006|COMPLETED|Overall Study||17
9685449|NCT03227471|10785867|FG007|COMPLETED|Overall Study||12
9685450|NCT03227471|10785868|FG008|COMPLETED|Overall Study||10
9685451|NCT03227471|10785869|FG009|COMPLETED|Overall Study||22
9685452|NCT03227471|10785870|FG010|COMPLETED|Overall Study||21
9685453|NCT03227471|10785871|FG011|COMPLETED|Overall Study||7
9685454|NCT03227471|10785872|FG012|COMPLETED|Overall Study||20
9685455|NCT03227471|10785873|FG013|COMPLETED|Overall Study||8
9685456|NCT03227471|10785874|FG014|COMPLETED|Overall Study||21
9685457|NCT03227471|10785860|FG000|NOT COMPLETED|Overall Study||0
9685458|NCT03227471|10785861|FG001|NOT COMPLETED|Overall Study||0
9685459|NCT03227471|10785862|FG002|NOT COMPLETED|Overall Study||0
9685460|NCT03227471|10785863|FG003|NOT COMPLETED|Overall Study||0
9685461|NCT03227471|10785864|FG004|NOT COMPLETED|Overall Study||1
9685462|NCT03227471|10785865|FG005|NOT COMPLETED|Overall Study||0
9685463|NCT03227471|10785866|FG006|NOT COMPLETED|Overall Study||0
9685464|NCT03227471|10785867|FG007|NOT COMPLETED|Overall Study||0
9685465|NCT03227471|10785868|FG008|NOT COMPLETED|Overall Study||0
9685466|NCT03227471|10785869|FG009|NOT COMPLETED|Overall Study||0
9685467|NCT03227471|10785870|FG010|NOT COMPLETED|Overall Study||0
9685468|NCT03227471|10785871|FG011|NOT COMPLETED|Overall Study||0
9685469|NCT03227471|10785872|FG012|NOT COMPLETED|Overall Study||1
9685470|NCT03227471|10785873|FG013|NOT COMPLETED|Overall Study||0
9685471|NCT03227471|10785874|FG014|NOT COMPLETED|Overall Study||1
9685472|NCT03221842|10785935|FG000|STARTED|Period 1 (Open-label)||63
9685473|NCT03221842|10785936|FG001|STARTED|Period 1 (Open-label)||0
10023600|NCT01857102|11147301|FG001|Neophtyes|Period 1||4
10023601|NCT01857102|11147300|FG000|COMPLETED|Period 1||55
9685474|NCT03221842|10785935|FG000|COMPLETED|Period 1 (Open-label)||53
9685475|NCT03221842|10785936|FG001|COMPLETED|Period 1 (Open-label)||0
9685476|NCT03221842|10785935|FG000|NOT COMPLETED|Period 1 (Open-label)||10
9685477|NCT03221842|10785936|FG001|NOT COMPLETED|Period 1 (Open-label)||0
9685478|NCT03221842|10785935|FG000|STARTED|Period 2 (Randomized, Blinded)||7
9685479|NCT03221842|10785936|FG001|STARTED|Period 2 (Randomized, Blinded)||6
9685480|NCT03221842|10785935|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6
9685481|NCT03221842|10785936|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5
9685482|NCT03221842|10785935|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
9685483|NCT03221842|10785936|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
9685484|NCT03194321|10785946|FG000|STARTED|Overall Study||20
9685485|NCT03194321|10785946|FG000|COMPLETED|Overall Study||17
9685486|NCT03194321|10785946|FG000|NOT COMPLETED|Overall Study||3
9685487|NCT03085095|10785952|FG000|STARTED|Overall Study||624
9685488|NCT03085095|10785953|FG001|STARTED|Overall Study||310
9685489|NCT03085095|10785952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622
9685490|NCT03085095|10785953|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308
9685491|NCT03085095|10785952|FG000|COMPLETED|Overall Study||563
9685492|NCT03085095|10785953|FG001|COMPLETED|Overall Study||276
9685493|NCT03085095|10785952|FG000|NOT COMPLETED|Overall Study||61
9685494|NCT03085095|10785953|FG001|NOT COMPLETED|Overall Study||34
9685495|NCT03048422|10785965|FG000|STARTED|Overall Study||217
9685496|NCT03048422|10785966|FG001|STARTED|Overall Study||215
9685497|NCT03048422|10785967|FG002|STARTED|Overall Study||211
9685498|NCT03048422|10785965|FG000|COMPLETED|Overall Study||200
9685499|NCT03048422|10785966|FG001|COMPLETED|Overall Study||205
9685500|NCT03048422|10785967|FG002|COMPLETED|Overall Study||202
9685501|NCT03048422|10785965|FG000|NOT COMPLETED|Overall Study||17
9685502|NCT03048422|10785966|FG001|NOT COMPLETED|Overall Study||10
9685503|NCT03048422|10785967|FG002|NOT COMPLETED|Overall Study||9
9685504|NCT03032068|10785985|FG000|STARTED|Overall Study||10
9685505|NCT03032068|10785985|FG000|Preoperative Visit|Overall Study||10
9685506|NCT03032068|10785985|FG000|Postoperative Home Care Visit 1|Overall Study||10
9844830|NCT00838695|10956874|FG000|STARTED|Overall Study||42
9844831|NCT00838695|10956875|FG001|STARTED|Overall Study||64
9844832|NCT00838695|10956874|FG000|COMPLETED|Overall Study||42
9844833|NCT00838695|10956875|FG001|COMPLETED|Overall Study||64
9844834|NCT00838695|10956874|FG000|NOT COMPLETED|Overall Study||0
9844835|NCT00838695|10956875|FG001|NOT COMPLETED|Overall Study||0
9844836|NCT00838903|10956885|FG000|STARTED|Treatment Period (156 Weeks)||101
9844837|NCT00838903|10956886|FG001|STARTED|Treatment Period (156 Weeks)||302
10023602|NCT01857102|11147301|FG001|COMPLETED|Period 1||51
10023603|NCT01857102|11147300|FG000|NOT COMPLETED|Period 1||3
10023604|NCT01857102|11147301|FG001|NOT COMPLETED|Period 1||5
9844838|NCT00838903|10956887|FG002|STARTED|Treatment Period (156 Weeks)||307
9844839|NCT00838903|10956888|FG003|STARTED|Treatment Period (156 Weeks)||302
9844840|NCT00838903|10956885|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
9844841|NCT00838903|10956886|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
9844842|NCT00838903|10956887|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
9844843|NCT00838903|10956888|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
9844844|NCT00838903|10956885|FG000|COMPLETED|Treatment Period (156 Weeks)||55
9844845|NCT00838903|10956886|FG001|COMPLETED|Treatment Period (156 Weeks)||190
9844846|NCT00838903|10956887|FG002|COMPLETED|Treatment Period (156 Weeks)||191
9844847|NCT00838903|10956888|FG003|COMPLETED|Treatment Period (156 Weeks)||192
9844848|NCT00838903|10956885|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46
9844849|NCT00838903|10956886|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112
9844850|NCT00838903|10956887|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116
9844851|NCT00838903|10956888|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110
9844852|NCT00838903|10956885|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
9844853|NCT00838903|10956886|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
9844854|NCT00838903|10956887|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
9844855|NCT00838903|10956888|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
9844856|NCT00838903|10956885|FG000|COMPLETED|Follow-up Period (8 Weeks)||75
9844857|NCT00838903|10956886|FG001|COMPLETED|Follow-up Period (8 Weeks)||237
9844858|NCT00838903|10956887|FG002|COMPLETED|Follow-up Period (8 Weeks)||243
9844859|NCT00838903|10956888|FG003|COMPLETED|Follow-up Period (8 Weeks)||244
9844860|NCT00838903|10956885|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26
9844861|NCT00838903|10956886|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65
9844862|NCT00838903|10956887|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64
9844863|NCT00838903|10956888|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58
9960911|NCT01470001|11080562|FG001|STARTED|Overall Study||60
9960912|NCT01470001|11080561|FG000|COMPLETED|Overall Study||53
9960913|NCT01470001|11080562|FG001|COMPLETED|Overall Study||58
10023605|NCT01857102|11147300|FG000|STARTED|Period 2||55
10023606|NCT01857102|11147301|FG001|STARTED|Period 2||51
9685507|NCT03032068|10785985|FG000|Postoperative Home Care Visit 2|Overall Study||10
9685508|NCT03032068|10785985|FG000|Postoperative Home Care Visit 3|Overall Study||10
9685509|NCT03032068|10785985|FG000|4 Weeks Postoperative Visit|Overall Study||9
9685510|NCT03032068|10785985|FG000|8 Weeks Postoperative Visit|Overall Study||9
9685511|NCT03032068|10785985|FG000|12 Weeks Postoperative Visit|Overall Study||9
9685512|NCT03032068|10785985|FG000|COMPLETED|Overall Study||9
9685513|NCT03032068|10785985|FG000|NOT COMPLETED|Overall Study||1
9844864|NCT00838916|10956900|FG000|STARTED|Treatment Period (156 Weeks)||504
9844865|NCT00838916|10956901|FG001|STARTED|Treatment Period (156 Weeks)||241
9844866|NCT00838916|10956900|FG000|COMPLETED|Treatment Period (156 Weeks)||308
9844867|NCT00838916|10956901|FG001|COMPLETED|Treatment Period (156 Weeks)||164
9844868|NCT00838916|10956900|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196
9844869|NCT00838916|10956901|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77
9844870|NCT00838916|10956900|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
9844871|NCT00838916|10956901|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
9844872|NCT00838916|10956900|FG000|COMPLETED|Follow-up Period (8 Weeks)||408
9844873|NCT00838916|10956901|FG001|COMPLETED|Follow-up Period (8 Weeks)||190
9844874|NCT00838916|10956900|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96
9844875|NCT00838916|10956901|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51
9844876|NCT00838929|10956910|FG000|STARTED|Overall Study||3
9844877|NCT00838929|10956911|FG001|STARTED|Overall Study||8
9844878|NCT00838929|10956912|FG002|STARTED|Overall Study||6
9844879|NCT00838929|10956910|FG000|COMPLETED|Overall Study||3
9844880|NCT00838929|10956911|FG001|COMPLETED|Overall Study||5
9844881|NCT00838929|10956912|FG002|COMPLETED|Overall Study||5
9844882|NCT00838929|10956910|FG000|NOT COMPLETED|Overall Study||0
9844883|NCT00838929|10956911|FG001|NOT COMPLETED|Overall Study||3
9844884|NCT00838929|10956912|FG002|NOT COMPLETED|Overall Study||1
9844885|NCT00839072|10956918|FG000|STARTED|First Intervention Period||12
9844886|NCT00839072|10956919|FG001|STARTED|First Intervention Period||12
9844887|NCT00839072|10956918|FG000|COMPLETED|First Intervention Period||10
9844888|NCT00839072|10956919|FG001|COMPLETED|First Intervention Period||11
9844889|NCT00839072|10956918|FG000|NOT COMPLETED|First Intervention Period||2
9844890|NCT00839072|10956919|FG001|NOT COMPLETED|First Intervention Period||1
9844891|NCT00839072|10956918|FG000|STARTED|Washout Period of 7 Days||10
9844892|NCT00839072|10956919|FG001|STARTED|Washout Period of 7 Days||11
9844893|NCT00839072|10956918|FG000|COMPLETED|Washout Period of 7 Days||10
9844894|NCT00839072|10956919|FG001|COMPLETED|Washout Period of 7 Days||11
9844895|NCT00839072|10956918|FG000|NOT COMPLETED|Washout Period of 7 Days||0
9844896|NCT00839072|10956919|FG001|NOT COMPLETED|Washout Period of 7 Days||0
9844897|NCT00839072|10956918|FG000|STARTED|Second Intervention Period||10
9844898|NCT00839072|10956919|FG001|STARTED|Second Intervention Period||11
9844899|NCT00839072|10956918|FG000|COMPLETED|Second Intervention Period||9
9844900|NCT00839072|10956919|FG001|COMPLETED|Second Intervention Period||11
9844901|NCT00839072|10956918|FG000|NOT COMPLETED|Second Intervention Period||1
9844902|NCT00839072|10956919|FG001|NOT COMPLETED|Second Intervention Period||0
9844903|NCT00839098|10956928|FG000|STARTED|Overall Study||3
9844904|NCT00839098|10956929|FG001|STARTED|Overall Study||12
9844905|NCT00839098|10956930|FG002|STARTED|Overall Study||13
9844906|NCT00839098|10956928|FG000|COMPLETED|Overall Study||1
9844907|NCT00839098|10956929|FG001|COMPLETED|Overall Study||11
9844908|NCT00839098|10956930|FG002|COMPLETED|Overall Study||6
9844909|NCT00839098|10956928|FG000|NOT COMPLETED|Overall Study||2
9844910|NCT00839098|10956929|FG001|NOT COMPLETED|Overall Study||1
9844911|NCT00839098|10956930|FG002|NOT COMPLETED|Overall Study||7
9844912|NCT00839241|10956940|FG000|STARTED|Overall Study||20
9844913|NCT00839241|10956941|FG001|STARTED|Overall Study||25
9844914|NCT00839241|10956940|FG000|COMPLETED|Overall Study||15
9844915|NCT00839241|10956941|FG001|COMPLETED|Overall Study||8
9844916|NCT00839241|10956940|FG000|NOT COMPLETED|Overall Study||5
9844917|NCT00839241|10956941|FG001|NOT COMPLETED|Overall Study||17
9844918|NCT00839254|10956955|FG000|STARTED|Overall Study||1849
9844919|NCT00839254|10956956|FG001|STARTED|Overall Study||1316
9844920|NCT00839254|10956957|FG002|STARTED|Overall Study||1069
9844921|NCT00839254|10956958|FG003|STARTED|Overall Study||859
9844922|NCT00839254|10956959|FG004|STARTED|Overall Study||241
9844923|NCT00839254|10956960|FG005|STARTED|Overall Study||204
9844924|NCT00839254|10956961|FG006|STARTED|Overall Study||368
9844925|NCT00839254|10956962|FG007|STARTED|Overall Study||271
9844926|NCT00839254|10956955|FG000|COMPLETED|Overall Study||1696
9844927|NCT00839254|10956956|FG001|COMPLETED|Overall Study||1224
9844928|NCT00839254|10956957|FG002|COMPLETED|Overall Study||979
9844929|NCT00839254|10956958|FG003|COMPLETED|Overall Study||797
9844930|NCT00839254|10956959|FG004|COMPLETED|Overall Study||204
9844931|NCT00839254|10956960|FG005|COMPLETED|Overall Study||178
9844932|NCT00839254|10956961|FG006|COMPLETED|Overall Study||340
9844933|NCT00839254|10956962|FG007|COMPLETED|Overall Study||256
9844934|NCT00839254|10956955|FG000|NOT COMPLETED|Overall Study||153
9844935|NCT00839254|10956956|FG001|NOT COMPLETED|Overall Study||92
9844936|NCT00839254|10956957|FG002|NOT COMPLETED|Overall Study||90
9844937|NCT00839254|10956958|FG003|NOT COMPLETED|Overall Study||62
9844938|NCT00839254|10956959|FG004|NOT COMPLETED|Overall Study||37
9844939|NCT00839254|10956960|FG005|NOT COMPLETED|Overall Study||26
9844940|NCT00839254|10956961|FG006|NOT COMPLETED|Overall Study||28
9844941|NCT00839254|10956962|FG007|NOT COMPLETED|Overall Study||15
9685514|NCT02965729|10785992|FG000|STARTED|Overall Study||24
9685515|NCT02965729|10785993|FG001|STARTED|Overall Study||25
9685516|NCT02965729|10785994|FG002|STARTED|Overall Study||56
9685517|NCT02965729|10785992|FG000|COMPLETED|Overall Study||17
9685518|NCT02965729|10785993|FG001|COMPLETED|Overall Study||22
9685519|NCT02965729|10785994|FG002|COMPLETED|Overall Study||45
9685520|NCT02965729|10785992|FG000|NOT COMPLETED|Overall Study||7
9685521|NCT02965729|10785993|FG001|NOT COMPLETED|Overall Study||3
9685522|NCT02965729|10785994|FG002|NOT COMPLETED|Overall Study||11
9685523|NCT02835690|10786005|FG000|STARTED|Overall Study||14
9685524|NCT02835690|10786006|FG001|STARTED|Overall Study||15
9685525|NCT02835690|10786007|FG002|STARTED|Overall Study||15
9685526|NCT02835690|10786005|FG000|Treated|Overall Study||14
9685527|NCT02835690|10786006|FG001|Treated|Overall Study||13
9685528|NCT02835690|10786007|FG002|Treated|Overall Study||15
9685529|NCT02835690|10786005|FG000|COMPLETED|Overall Study||0
9685530|NCT02835690|10786006|FG001|COMPLETED|Overall Study||0
9685531|NCT02835690|10786007|FG002|COMPLETED|Overall Study||0
9685532|NCT02835690|10786005|FG000|NOT COMPLETED|Overall Study||14
9685533|NCT02835690|10786006|FG001|NOT COMPLETED|Overall Study||15
9685534|NCT02835690|10786007|FG002|NOT COMPLETED|Overall Study||15
9685535|NCT02828982|10786015|FG000|STARTED|First Intervention (3 Weeks)||5
9685536|NCT02828982|10786016|FG001|STARTED|First Intervention (3 Weeks)||7
9685537|NCT02828982|10786015|FG000|Received Intervention|First Intervention (3 Weeks)||5
9685538|NCT02828982|10786016|FG001|Received Intervention|First Intervention (3 Weeks)||7
9685539|NCT02828982|10786015|FG000|COMPLETED|First Intervention (3 Weeks)||4
9685540|NCT02828982|10786016|FG001|COMPLETED|First Intervention (3 Weeks)||6
9685541|NCT02828982|10786015|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
9685542|NCT02828982|10786016|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
9685543|NCT02828982|10786015|FG000|STARTED|Second Intervention (3 Weeks)||4
9685544|NCT02828982|10786016|FG001|STARTED|Second Intervention (3 Weeks)||6
9685545|NCT02828982|10786015|FG000|Received Intervention|Second Intervention (3 Weeks)||4
9685546|NCT02828982|10786016|FG001|Received Intervention|Second Intervention (3 Weeks)||6
9685547|NCT02828982|10786015|FG000|COMPLETED|Second Intervention (3 Weeks)||4
9685548|NCT02828982|10786016|FG001|COMPLETED|Second Intervention (3 Weeks)||6
9685549|NCT02828982|10786015|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
9685550|NCT02828982|10786016|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9685551|NCT02823457|10786024|FG000|STARTED|Overall Study||20
9685552|NCT02823457|10786024|FG000|COMPLETED|Overall Study||15
9685553|NCT02823457|10786024|FG000|NOT COMPLETED|Overall Study||5
9685554|NCT02815280|10786030|FG000|STARTED|Double-Blind Phase||333
9685555|NCT02815280|10786031|FG001|STARTED|Double-Blind Phase||162
9685556|NCT02815280|10786030|FG000|COMPLETED|Double-Blind Phase||297
9685557|NCT02815280|10786031|FG001|COMPLETED|Double-Blind Phase||137
9685558|NCT02815280|10786030|FG000|NOT COMPLETED|Double-Blind Phase||36
9685559|NCT02815280|10786031|FG001|NOT COMPLETED|Double-Blind Phase||25
9685560|NCT02815280|10786030|FG000|STARTED|Open-Label Phase||256
9685561|NCT02815280|10786031|FG001|STARTED|Open-Label Phase||117
9685562|NCT02815280|10786030|FG000|COMPLETED|Open-Label Phase||169
9685563|NCT02815280|10786031|FG001|COMPLETED|Open-Label Phase||73
9685564|NCT02815280|10786030|FG000|NOT COMPLETED|Open-Label Phase||87
9685565|NCT02815280|10786031|FG001|NOT COMPLETED|Open-Label Phase||44
9685566|NCT02815267|10786043|FG000|STARTED|Double-Blind Phase||307
9685567|NCT02815267|10786044|FG001|STARTED|Double-Blind Phase||159
9685568|NCT02815267|10786043|FG000|COMPLETED|Double-Blind Phase||274
9685569|NCT02815267|10786044|FG001|COMPLETED|Double-Blind Phase||128
9685570|NCT02815267|10786043|FG000|NOT COMPLETED|Double-Blind Phase||33
9685571|NCT02815267|10786044|FG001|NOT COMPLETED|Double-Blind Phase||31
9685572|NCT02815267|10786043|FG000|STARTED|Open-Label Phase||193
9685573|NCT02815267|10786044|FG001|STARTED|Open-Label Phase||91
9685574|NCT02815267|10786043|FG000|COMPLETED|Open-Label Phase||122
9685575|NCT02815267|10786044|FG001|COMPLETED|Open-Label Phase||50
9685576|NCT02815267|10786043|FG000|NOT COMPLETED|Open-Label Phase||71
9685577|NCT02815267|10786044|FG001|NOT COMPLETED|Open-Label Phase||41
9685578|NCT02802228|10786056|FG000|STARTED|Overall Study||20
9685579|NCT02802228|10786057|FG001|STARTED|Overall Study||10
9685580|NCT02802228|10786056|FG000|COMPLETED|Overall Study||15
9685581|NCT02802228|10786057|FG001|COMPLETED|Overall Study||10
9685582|NCT02802228|10786056|FG000|NOT COMPLETED|Overall Study||5
9685583|NCT02802228|10786057|FG001|NOT COMPLETED|Overall Study||0
9685584|NCT02719691|10786068|FG000|STARTED|Overall Study||3
9685585|NCT02719691|10786069|FG001|STARTED|Overall Study||4
9685586|NCT02719691|10786070|FG002|STARTED|Overall Study||6
9685587|NCT02719691|10786071|FG003|STARTED|Overall Study||2
9685588|NCT02719691|10786072|FG004|STARTED|Overall Study||31
9685589|NCT02719691|10786068|FG000|COMPLETED|Overall Study||3
9685590|NCT02719691|10786069|FG001|COMPLETED|Overall Study||4
9685591|NCT02719691|10786070|FG002|COMPLETED|Overall Study||6
9685592|NCT02719691|10786071|FG003|COMPLETED|Overall Study||2
9685593|NCT02719691|10786072|FG004|COMPLETED|Overall Study||31
9685594|NCT02719691|10786068|FG000|NOT COMPLETED|Overall Study||0
9685595|NCT02719691|10786069|FG001|NOT COMPLETED|Overall Study||0
9685596|NCT02719691|10786070|FG002|NOT COMPLETED|Overall Study||0
9685597|NCT02719691|10786071|FG003|NOT COMPLETED|Overall Study||0
9685598|NCT02719691|10786072|FG004|NOT COMPLETED|Overall Study||0
9685599|NCT02674516|10786088|FG000|STARTED|Overall Study||17
9685600|NCT02674516|10786089|FG001|STARTED|Overall Study||15
9685601|NCT02674516|10786088|FG000|COMPLETED|Overall Study||13
9685602|NCT02674516|10786089|FG001|COMPLETED|Overall Study||11
9685603|NCT02674516|10786088|FG000|NOT COMPLETED|Overall Study||4
9685604|NCT02674516|10786089|FG001|NOT COMPLETED|Overall Study||4
9685605|NCT02655016|10786097|FG000|STARTED|Overall Study||246
9685606|NCT02655016|10786098|FG001|STARTED|Overall Study||487
9685607|NCT02655016|10786097|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
9725994|NCT00097981|10825630|FG001|NOT COMPLETED|Overall Study||100
9685608|NCT02655016|10786098|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
9685609|NCT02655016|10786097|FG000|Ongoing With Treatment in the Study|Overall Study||69
9844942|NCT00839306|10957013|FG000|STARTED|Overall Study|Treated|60
9844943|NCT00839306|10957014|FG001|STARTED|Overall Study|Treated|177
9844944|NCT00839306|10957013|FG000|COMPLETED|Overall Study||35
9844945|NCT00839306|10957014|FG001|COMPLETED|Overall Study||134
9844946|NCT00839306|10957013|FG000|NOT COMPLETED|Overall Study||25
9960914|NCT01470001|11080561|FG000|NOT COMPLETED|Overall Study||5
9960915|NCT01470001|11080562|FG001|NOT COMPLETED|Overall Study||2
9960916|NCT01470027|11080574|FG000|STARTED|Overall Study||16
9960917|NCT01470027|11080575|FG001|STARTED|Overall Study||15
9960918|NCT01470027|11080576|FG002|STARTED|Overall Study||16
9960919|NCT01470027|11080574|FG000|COMPLETED|Overall Study||15
9960920|NCT01470027|11080575|FG001|COMPLETED|Overall Study||14
9960921|NCT01470027|11080576|FG002|COMPLETED|Overall Study||15
9960922|NCT01470027|11080574|FG000|NOT COMPLETED|Overall Study||1
9960923|NCT01470027|11080575|FG001|NOT COMPLETED|Overall Study||1
9960924|NCT01470027|11080576|FG002|NOT COMPLETED|Overall Study||1
9960925|NCT01470118|11080593|FG000|STARTED|Overall Study||43
9960926|NCT01470118|11080594|FG001|STARTED|Overall Study||43
9960927|NCT01470118|11080595|FG002|STARTED|Overall Study||41
9960928|NCT01470118|11080593|FG000|COMPLETED|Overall Study||38
9960929|NCT01470118|11080594|FG001|COMPLETED|Overall Study||38
9960930|NCT01470118|11080595|FG002|COMPLETED|Overall Study||39
9960931|NCT01470118|11080593|FG000|NOT COMPLETED|Overall Study||5
9960932|NCT01470118|11080594|FG001|NOT COMPLETED|Overall Study||5
9960933|NCT01470118|11080595|FG002|NOT COMPLETED|Overall Study||2
9960934|NCT01470144|11080603|FG000|STARTED|Overall Study||41
9960935|NCT01470144|11080603|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
9960936|NCT01470144|11080603|FG000|NOT COMPLETED|Overall Study||10
9960937|NCT01470170|11080612|FG000|STARTED|Overall Study||34
9960938|NCT01470170|11080613|FG001|STARTED|Overall Study||35
9960939|NCT01470170|11080614|FG002|STARTED|Overall Study||34
9960940|NCT01470170|11080615|FG003|STARTED|Overall Study||36
9960941|NCT01470170|11080616|FG004|STARTED|Overall Study||34
9960942|NCT01470170|11080612|FG000|COMPLETED|Overall Study||34
9960943|NCT01470170|11080613|FG001|COMPLETED|Overall Study||35
9960944|NCT01470170|11080614|FG002|COMPLETED|Overall Study||34
9960945|NCT01470170|11080615|FG003|COMPLETED|Overall Study||36
9960946|NCT01470170|11080616|FG004|COMPLETED|Overall Study||34
9960947|NCT01470170|11080612|FG000|NOT COMPLETED|Overall Study||0
9960948|NCT01470170|11080613|FG001|NOT COMPLETED|Overall Study||0
9960949|NCT01470170|11080614|FG002|NOT COMPLETED|Overall Study||0
9960950|NCT01470170|11080615|FG003|NOT COMPLETED|Overall Study||0
9960951|NCT01470170|11080616|FG004|NOT COMPLETED|Overall Study||0
9960952|NCT01470196|11080628|FG000|STARTED|Overall Study||31
9960953|NCT01470196|11080628|FG000|COMPLETED|Overall Study||31
9960954|NCT01470196|11080628|FG000|NOT COMPLETED|Overall Study||0
9960955|NCT01470248|11080632|FG000|STARTED|Overall Study||20
9960956|NCT01470248|11080632|FG000|COMPLETED|Overall Study||19
9960957|NCT01470248|11080632|FG000|NOT COMPLETED|Overall Study||1
9960958|NCT01470417|11080638|FG000|STARTED|Overall Study||3
9960959|NCT01470417|11080639|FG001|STARTED|Overall Study||7
9960960|NCT01470417|11080638|FG000|COMPLETED|Overall Study||3
9960961|NCT01470417|11080639|FG001|COMPLETED|Overall Study||5
9960962|NCT01470417|11080638|FG000|NOT COMPLETED|Overall Study||0
9960963|NCT01470417|11080639|FG001|NOT COMPLETED|Overall Study||2
9960964|NCT01470469|11080647|FG000|STARTED|Overall Study||21
9960965|NCT01470469|11080648|FG001|STARTED|Overall Study||62
9960966|NCT01470469|11080647|FG000|COMPLETED|Overall Study||11
9960967|NCT01470469|11080648|FG001|COMPLETED|Overall Study||38
9960968|NCT01470469|11080647|FG000|NOT COMPLETED|Overall Study||10
9960969|NCT01470469|11080648|FG001|NOT COMPLETED|Overall Study||24
9960970|NCT01470599|11080656|FG000|STARTED|Overall Study||62
9960971|NCT01470599|11080657|FG001|STARTED|Overall Study||88
9960972|NCT01470599|11080656|FG000|COMPLETED|Overall Study||43
9960973|NCT01470599|11080657|FG001|COMPLETED|Overall Study||45
9844947|NCT00839306|10957014|FG001|NOT COMPLETED|Overall Study||43
9844948|NCT00839319|10957026|FG000|STARTED|Overall Study||8
9844949|NCT00839319|10957027|FG001|STARTED|Overall Study||8
9844950|NCT00839319|10957028|FG002|STARTED|Overall Study||8
9844951|NCT00839319|10957029|FG003|STARTED|Overall Study||8
9844952|NCT00839319|10957030|FG004|STARTED|Overall Study||8
9844953|NCT00839319|10957026|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
9844954|NCT00839319|10957027|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
9844955|NCT00839319|10957028|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
9844956|NCT00839319|10957029|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
9844957|NCT00839319|10957030|FG004|COMPLETED|Overall Study||8
9844958|NCT00839319|10957026|FG000|NOT COMPLETED|Overall Study||2
9844959|NCT00839319|10957027|FG001|NOT COMPLETED|Overall Study||1
9844960|NCT00839319|10957028|FG002|NOT COMPLETED|Overall Study||3
9844961|NCT00839319|10957029|FG003|NOT COMPLETED|Overall Study||3
9844962|NCT00839319|10957030|FG004|NOT COMPLETED|Overall Study||0
9844963|NCT00839332|10957045|FG000|STARTED|Phase 1||50
9844964|NCT00839332|10957046|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
9844965|NCT00839332|10957047|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
9685610|NCT02655016|10786098|FG001|Ongoing With Treatment in the Study|Overall Study||177
9685611|NCT02655016|10786097|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
9685612|NCT02655016|10786098|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
9685613|NCT02655016|10786097|FG000|NOT COMPLETED|Overall Study||55
9685614|NCT02655016|10786098|FG001|NOT COMPLETED|Overall Study||90
9685615|NCT02607046|10786107|FG000|STARTED|Overall Study||22
9685616|NCT02607046|10786108|FG001|STARTED|Overall Study||13
9685617|NCT02607046|10786107|FG000|COMPLETED|Overall Study||14
9685618|NCT02607046|10786108|FG001|COMPLETED|Overall Study||10
9685619|NCT02607046|10786107|FG000|NOT COMPLETED|Overall Study||8
9685620|NCT02607046|10786108|FG001|NOT COMPLETED|Overall Study||3
9685621|NCT02505425|10786118|FG000|STARTED|Overall Study||208
9685622|NCT02505425|10786119|FG001|STARTED|Overall Study||207
9685623|NCT02505425|10786120|FG002|STARTED|Overall Study||82
9685624|NCT02505425|10786121|FG003|STARTED|Overall Study||76
9685625|NCT02505425|10786118|FG000|COMPLETED|Overall Study||120
9685626|NCT02505425|10786119|FG001|COMPLETED|Overall Study||125
9685627|NCT02505425|10786120|FG002|COMPLETED|Overall Study||32
9685628|NCT02505425|10786121|FG003|COMPLETED|Overall Study||50
9685629|NCT02505425|10786118|FG000|NOT COMPLETED|Overall Study||88
9685630|NCT02505425|10786119|FG001|NOT COMPLETED|Overall Study||82
9685631|NCT02505425|10786120|FG002|NOT COMPLETED|Overall Study||50
9685632|NCT02505425|10786121|FG003|NOT COMPLETED|Overall Study||26
9685633|NCT02487979|10786131|FG000|STARTED|Overall Study||22
9685634|NCT02487979|10786131|FG000|COMPLETED|Overall Study||1
9685635|NCT02487979|10786131|FG000|NOT COMPLETED|Overall Study||21
9685636|NCT02463448|10786135|FG000|STARTED|Enrollment Through 6 Months||23
9685637|NCT02463448|10786135|FG000|COMPLETED|Enrollment Through 6 Months||20
9685638|NCT02463448|10786135|FG000|NOT COMPLETED|Enrollment Through 6 Months||3
9685639|NCT02463448|10786135|FG000|STARTED|6 Months Through 12 Months||20
9685640|NCT02463448|10786135|FG000|COMPLETED|6 Months Through 12 Months||18
9685641|NCT02463448|10786135|FG000|NOT COMPLETED|6 Months Through 12 Months||2
9685642|NCT02463448|10786135|FG000|STARTED|12 Months Through End of Study||18
9685643|NCT02463448|10786135|FG000|COMPLETED|12 Months Through End of Study||17
9685644|NCT02463448|10786135|FG000|NOT COMPLETED|12 Months Through End of Study||1
9725995|NCT00098020|10825636|FG000|STARTED|Overall Study||12
9725996|NCT00098020|10825636|FG000|Started Isotretinoin|Overall Study||8
9725997|NCT00098020|10825636|FG000|COMPLETED|Overall Study||6
9725998|NCT00098020|10825636|FG000|NOT COMPLETED|Overall Study||6
9725999|NCT00098059|10825642|FG000|STARTED|Overall Study||27
9726000|NCT00098059|10825643|FG001|STARTED|Overall Study||47
9726001|NCT00098059|10825642|FG000|COMPLETED|Overall Study||27
9726002|NCT00098059|10825643|FG001|COMPLETED|Overall Study||46
9726003|NCT00098059|10825642|FG000|NOT COMPLETED|Overall Study||0
9726004|NCT00098059|10825643|FG001|NOT COMPLETED|Overall Study||1
9726005|NCT00098254|10825654|FG000|STARTED|Overall Study||37
9726006|NCT00098254|10825654|FG000|COMPLETED|Overall Study||34
9726007|NCT00098254|10825654|FG000|NOT COMPLETED|Overall Study||3
9726008|NCT00098293|10825661|FG000|STARTED|Double-blind (DB) Phase||177
9726009|NCT00098293|10825662|FG001|STARTED|Double-blind (DB) Phase||368
9726010|NCT00098293|10825663|FG002|STARTED|Double-blind (DB) Phase||372
9726011|NCT00098293|10825664|FG003|STARTED|Double-blind (DB) Phase||0
9726012|NCT00098293|10825665|FG004|STARTED|Double-blind (DB) Phase||0
9726013|NCT00098293|10825661|FG000|Treated|Double-blind (DB) Phase||174
9726014|NCT00098293|10825662|FG001|Treated|Double-blind (DB) Phase||360
9726015|NCT00098293|10825663|FG002|Treated|Double-blind (DB) Phase||361
9726016|NCT00098293|10825664|FG003|Treated|Double-blind (DB) Phase||0
9726017|NCT00098293|10825665|FG004|Treated|Double-blind (DB) Phase||0
9726018|NCT00098293|10825661|FG000|COMPLETED|Double-blind (DB) Phase||0
9726019|NCT00098293|10825662|FG001|COMPLETED|Double-blind (DB) Phase||202
9726020|NCT00098293|10825663|FG002|COMPLETED|Double-blind (DB) Phase||202
9726021|NCT00098293|10825664|FG003|COMPLETED|Double-blind (DB) Phase||0
9726022|NCT00098293|10825665|FG004|COMPLETED|Double-blind (DB) Phase||0
9726023|NCT00098293|10825661|FG000|NOT COMPLETED|Double-blind (DB) Phase||177
9726024|NCT00098293|10825662|FG001|NOT COMPLETED|Double-blind (DB) Phase||166
9726025|NCT00098293|10825663|FG002|NOT COMPLETED|Double-blind (DB) Phase||170
9726026|NCT00098293|10825664|FG003|NOT COMPLETED|Double-blind (DB) Phase||0
9726027|NCT00098293|10825665|FG004|NOT COMPLETED|Double-blind (DB) Phase||0
9726028|NCT00098293|10825661|FG000|STARTED|Between DB and OL Phase||0
9726029|NCT00098293|10825662|FG001|STARTED|Between DB and OL Phase||202
9726030|NCT00098293|10825663|FG002|STARTED|Between DB and OL Phase||202
9726031|NCT00098293|10825664|FG003|STARTED|Between DB and OL Phase||0
9726032|NCT00098293|10825665|FG004|STARTED|Between DB and OL Phase||0
9726033|NCT00098293|10825661|FG000|COMPLETED|Between DB and OL Phase||0
9726034|NCT00098293|10825662|FG001|COMPLETED|Between DB and OL Phase||202
9726035|NCT00098293|10825663|FG002|COMPLETED|Between DB and OL Phase||199
9726036|NCT00098293|10825664|FG003|COMPLETED|Between DB and OL Phase||0
9726037|NCT00098293|10825665|FG004|COMPLETED|Between DB and OL Phase||0
9726038|NCT00098293|10825661|FG000|NOT COMPLETED|Between DB and OL Phase||0
9726039|NCT00098293|10825662|FG001|NOT COMPLETED|Between DB and OL Phase||0
9726040|NCT00098293|10825663|FG002|NOT COMPLETED|Between DB and OL Phase||3
9726041|NCT00098293|10825664|FG003|NOT COMPLETED|Between DB and OL Phase||0
9726042|NCT00098293|10825665|FG004|NOT COMPLETED|Between DB and OL Phase||0
9726043|NCT00098293|10825661|FG000|STARTED|Open-label (OL) Phase||0
9726044|NCT00098293|10825662|FG001|STARTED|Open-label (OL) Phase||202
9726045|NCT00098293|10825663|FG002|STARTED|Open-label (OL) Phase||199
9726046|NCT00098293|10825664|FG003|STARTED|Open-label (OL) Phase||130
9685645|NCT02288897|10786141|FG000|STARTED|Overall Study||12
9685646|NCT02288897|10786142|FG001|STARTED|Overall Study||8
9685647|NCT02288897|10786141|FG000|COMPLETED|Overall Study||12
9685648|NCT02288897|10786142|FG001|COMPLETED|Overall Study||8
9685649|NCT02288897|10786141|FG000|NOT COMPLETED|Overall Study||0
9685650|NCT02288897|10786142|FG001|NOT COMPLETED|Overall Study||0
9685651|NCT02276547|10786148|FG000|STARTED|Overall Study||27
9685652|NCT02276547|10786148|FG000|COMPLETED|Overall Study||23
9685653|NCT02276547|10786148|FG000|NOT COMPLETED|Overall Study||4
9685654|NCT02263885|10786152|FG000|STARTED|Overall Study||20
9685655|NCT02263885|10786152|FG000|COMPLETED|Overall Study||10
9685656|NCT02263885|10786152|FG000|NOT COMPLETED|Overall Study||10
9685657|NCT02213926|10786157|FG000|STARTED|Overall Study||124
9685658|NCT02213926|10786157|FG000|COMPLETED|Overall Study||0
9685659|NCT02213926|10786157|FG000|NOT COMPLETED|Overall Study||124
9685660|NCT02008396|10786163|FG000|STARTED|Overall Study||4
9685661|NCT02008396|10786164|FG001|STARTED|Overall Study||8
9685662|NCT02008396|10786163|FG000|COMPLETED|Overall Study||4
9685663|NCT02008396|10786164|FG001|COMPLETED|Overall Study||7
9685664|NCT02008396|10786163|FG000|NOT COMPLETED|Overall Study||0
9685665|NCT02008396|10786164|FG001|NOT COMPLETED|Overall Study||1
9685666|NCT01995175|10786171|FG000|STARTED|Overall Study||2401
9685667|NCT01995175|10786171|FG000|COMPLETED|Overall Study||2148
9685668|NCT01995175|10786171|FG000|NOT COMPLETED|Overall Study||253
9685669|NCT01883804|10786175|FG000|STARTED|Overall Study||25
9685670|NCT01883804|10786175|FG000|COMPLETED|Overall Study||20
9685671|NCT01883804|10786175|FG000|NOT COMPLETED|Overall Study||5
9685672|NCT01804296|10786179|FG000|STARTED|Overall Study||4
9685673|NCT01804296|10786179|FG000|COMPLETED|Overall Study||4
9685674|NCT01804296|10786179|FG000|NOT COMPLETED|Overall Study||0
9685675|NCT01804270|10786185|FG000|STARTED|Overall Study||2
9685676|NCT01804270|10786186|FG001|STARTED|Overall Study||4
9685677|NCT01804270|10786185|FG000|COMPLETED|Overall Study||1
9685678|NCT01804270|10786186|FG001|COMPLETED|Overall Study||3
10023607|NCT01857102|11147300|FG000|Habitual Users|Period 2||48
10023608|NCT01857102|11147301|FG001|Habitual Users|Period 2||47
9685679|NCT01804270|10786185|FG000|NOT COMPLETED|Overall Study||1
9685680|NCT01804270|10786186|FG001|NOT COMPLETED|Overall Study||1
10023609|NCT01857102|11147300|FG000|Neophytes|Period 2||7
10023610|NCT01857102|11147301|FG001|Neophytes|Period 2||4
9685690|NCT01338636|10786205|FG000|STARTED|Overall Study||30
9685691|NCT01338636|10786205|FG000|COMPLETED|Overall Study||22
9685692|NCT01338636|10786205|FG000|NOT COMPLETED|Overall Study||8
9685693|NCT01208974|10786209|FG000|STARTED|NAC-Sparing Mastectomy||21
9685694|NCT01208974|10786210|FG001|STARTED|NAC-Sparing Mastectomy||0
9685695|NCT01208974|10786211|FG002|STARTED|NAC-Sparing Mastectomy||0
9685696|NCT01208974|10786212|FG003|STARTED|NAC-Sparing Mastectomy||0
9685697|NCT01208974|10786209|FG000|COMPLETED|NAC-Sparing Mastectomy||21
9685698|NCT01208974|10786210|FG001|COMPLETED|NAC-Sparing Mastectomy||0
9685699|NCT01208974|10786211|FG002|COMPLETED|NAC-Sparing Mastectomy||0
9685700|NCT01208974|10786212|FG003|COMPLETED|NAC-Sparing Mastectomy||0
9685701|NCT01208974|10786209|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0
9685702|NCT01208974|10786210|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0
9685703|NCT01208974|10786211|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0
9685704|NCT01208974|10786212|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0
9685705|NCT01208974|10786209|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21
9685706|NCT01208974|10786210|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685707|NCT01208974|10786211|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685708|NCT01208974|10786212|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685709|NCT01208974|10786209|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18
9685710|NCT01208974|10786210|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685711|NCT01208974|10786211|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685712|NCT01208974|10786212|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685713|NCT01208974|10786209|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3
9685714|NCT01208974|10786210|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685715|NCT01208974|10786211|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685716|NCT01208974|10786212|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
9685717|NCT01208974|10786209|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0
9685718|NCT01208974|10786210|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
9685719|NCT01208974|10786211|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
9685720|NCT01208974|10786212|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
9685721|NCT01208974|10786209|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
9685722|NCT01208974|10786210|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6
9685723|NCT01208974|10786211|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
9685724|NCT01208974|10786212|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
9685725|NCT01208974|10786209|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
9726047|NCT00098293|10825665|FG004|STARTED|Open-label (OL) Phase||0
9726048|NCT00098293|10825661|FG000|COMPLETED|Open-label (OL) Phase||0
9726049|NCT00098293|10825662|FG001|COMPLETED|Open-label (OL) Phase||177
9726050|NCT00098293|10825663|FG002|COMPLETED|Open-label (OL) Phase||158
9726051|NCT00098293|10825664|FG003|COMPLETED|Open-label (OL) Phase||65
9726052|NCT00098293|10825665|FG004|COMPLETED|Open-label (OL) Phase||0
9726053|NCT00098293|10825661|FG000|NOT COMPLETED|Open-label (OL) Phase||0
9726054|NCT00098293|10825662|FG001|NOT COMPLETED|Open-label (OL) Phase||25
9726055|NCT00098293|10825663|FG002|NOT COMPLETED|Open-label (OL) Phase||41
9685726|NCT01208974|10786210|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
9685727|NCT01208974|10786211|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
9685728|NCT01208974|10786212|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
9685729|NCT01208974|10786209|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
9685730|NCT01208974|10786210|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
9685731|NCT01208974|10786211|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
9685732|NCT01208974|10786212|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
9685733|NCT01208974|10786209|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
9685734|NCT01208974|10786210|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
9685735|NCT01208974|10786211|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
9685736|NCT01208974|10786212|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
9685737|NCT01208974|10786209|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
9685738|NCT01208974|10786210|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
9685739|NCT01208974|10786211|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
9685740|NCT01208974|10786212|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
9685741|NCT00938912|10786219|FG000|STARTED|Overall Study||365
9685742|NCT00938912|10786219|FG000|COMPLETED|Overall Study||254
9685743|NCT00938912|10786219|FG000|NOT COMPLETED|Overall Study||111
9685744|NCT00925652|10786230|FG000|STARTED|Overall Study||13
9685745|NCT00925652|10786231|FG001|STARTED|Overall Study||13
9685746|NCT00925652|10786232|FG002|STARTED|Overall Study||11
9685747|NCT00925652|10786233|FG003|STARTED|Overall Study||13
9685748|NCT00925652|10786230|FG000|Withdraw|Overall Study||6
9685749|NCT00925652|10786231|FG001|Withdraw|Overall Study||5
9685750|NCT00925652|10786232|FG002|Withdraw|Overall Study||3
9685751|NCT00925652|10786233|FG003|Withdraw|Overall Study||1
9685752|NCT00925652|10786230|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0
9685753|NCT00925652|10786231|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0
9685754|NCT00925652|10786232|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2
9685755|NCT00925652|10786233|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3
9685756|NCT00925652|10786230|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1
9685757|NCT00925652|10786231|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3
9685758|NCT00925652|10786232|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0
9685759|NCT00925652|10786233|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0
9685760|NCT00925652|10786230|FG000|Lost of Follow-up|Overall Study||0
9685761|NCT00925652|10786231|FG001|Lost of Follow-up|Overall Study||1
9685762|NCT00925652|10786232|FG002|Lost of Follow-up|Overall Study||0
9685763|NCT00925652|10786233|FG003|Lost of Follow-up|Overall Study||0
9685764|NCT00925652|10786230|FG000|Death|Overall Study||0
9685765|NCT00925652|10786231|FG001|Death|Overall Study||0
9685766|NCT00925652|10786232|FG002|Death|Overall Study||0
9685767|NCT00925652|10786233|FG003|Death|Overall Study||3
9685768|NCT00925652|10786230|FG000|COMPLETED|Overall Study||6
9685769|NCT00925652|10786231|FG001|COMPLETED|Overall Study||4
9685770|NCT00925652|10786232|FG002|COMPLETED|Overall Study||6
9685771|NCT00925652|10786233|FG003|COMPLETED|Overall Study||6
9685772|NCT00925652|10786230|FG000|NOT COMPLETED|Overall Study||7
9685773|NCT00925652|10786231|FG001|NOT COMPLETED|Overall Study||9
9685774|NCT00925652|10786232|FG002|NOT COMPLETED|Overall Study||5
9685775|NCT00925652|10786233|FG003|NOT COMPLETED|Overall Study||7
9685776|NCT00676715|10786255|FG000|STARTED|Overall Study||54
9685777|NCT00676715|10786256|FG001|STARTED|Overall Study||55
9685778|NCT00676715|10786257|FG002|STARTED|Overall Study||55
9685779|NCT00676715|10786258|FG003|STARTED|Overall Study||54
9685780|NCT00676715|10786255|FG000|COMPLETED|Overall Study||14
9685781|NCT00676715|10786256|FG001|COMPLETED|Overall Study||8
9685782|NCT00676715|10786257|FG002|COMPLETED|Overall Study||14
9685783|NCT00676715|10786258|FG003|COMPLETED|Overall Study||14
9685784|NCT00676715|10786255|FG000|NOT COMPLETED|Overall Study||40
9685785|NCT00676715|10786256|FG001|NOT COMPLETED|Overall Study||47
9685786|NCT00676715|10786257|FG002|NOT COMPLETED|Overall Study||41
9685787|NCT00676715|10786258|FG003|NOT COMPLETED|Overall Study||40
9685788|NCT00579826|10786270|FG000|STARTED|Overall Study||29
9685789|NCT00579826|10786271|FG001|STARTED|Overall Study||26
9685790|NCT00579826|10786270|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
9685791|NCT00579826|10786271|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
9685792|NCT00579826|10786270|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
9685793|NCT00579826|10786271|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
9685794|NCT00579826|10786270|FG000|NOT COMPLETED|Overall Study||5
9685795|NCT00579826|10786271|FG001|NOT COMPLETED|Overall Study||3
9685796|NCT00322218|10786279|FG000|STARTED|Overall Study||34
9685797|NCT00322218|10786280|FG001|STARTED|Overall Study||34
9685798|NCT00322218|10786279|FG000|Per-Protocol Set|Overall Study||33
9685799|NCT00322218|10786280|FG001|Per-Protocol Set|Overall Study||32
9685800|NCT00322218|10786279|FG000|COMPLETED|Overall Study||31
9685801|NCT00322218|10786280|FG001|COMPLETED|Overall Study||28
9685802|NCT00322218|10786279|FG000|NOT COMPLETED|Overall Study||3
9685803|NCT00322218|10786280|FG001|NOT COMPLETED|Overall Study||6
9685804|NCT00186888|10786289|FG000|STARTED|Overall Study||23
9685805|NCT00186888|10786290|FG001|STARTED|Overall Study||27
9685806|NCT00186888|10786291|FG002|STARTED|Overall Study||55
9685807|NCT00186888|10786289|FG000|Window Therapy|Overall Study||0
9685808|NCT00186888|10786290|FG001|Window Therapy|Overall Study||27
9685809|NCT00186888|10786291|FG002|Window Therapy|Overall Study||0
9685810|NCT00186888|10786289|FG000|COMPLETED|Overall Study||19
9685811|NCT00186888|10786290|FG001|COMPLETED|Overall Study||24
9685812|NCT00186888|10786291|FG002|COMPLETED|Overall Study||55
10023611|NCT01857102|11147300|FG000|COMPLETED|Period 2||53
10023612|NCT01857102|11147301|FG001|COMPLETED|Period 2||51
9685813|NCT00186888|10786289|FG000|NOT COMPLETED|Overall Study||4
9685814|NCT00186888|10786290|FG001|NOT COMPLETED|Overall Study||3
9685815|NCT00186888|10786291|FG002|NOT COMPLETED|Overall Study||0
9726056|NCT00098293|10825664|FG003|NOT COMPLETED|Open-label (OL) Phase||65
9726057|NCT00098293|10825665|FG004|NOT COMPLETED|Open-label (OL) Phase||0
9726058|NCT00098293|10825661|FG000|STARTED|Supplemental Phase (SP)||0
9726059|NCT00098293|10825662|FG001|STARTED|Supplemental Phase (SP)||0
9726060|NCT00098293|10825663|FG002|STARTED|Supplemental Phase (SP)||0
9726061|NCT00098293|10825664|FG003|STARTED|Supplemental Phase (SP)||0
9726062|NCT00098293|10825665|FG004|STARTED|Supplemental Phase (SP)||127
9726063|NCT00098293|10825661|FG000|COMPLETED|Supplemental Phase (SP)||0
9726064|NCT00098293|10825662|FG001|COMPLETED|Supplemental Phase (SP)||0
9726065|NCT00098293|10825663|FG002|COMPLETED|Supplemental Phase (SP)||0
9726066|NCT00098293|10825664|FG003|COMPLETED|Supplemental Phase (SP)||0
9726067|NCT00098293|10825665|FG004|COMPLETED|Supplemental Phase (SP)||94
9726068|NCT00098293|10825661|FG000|NOT COMPLETED|Supplemental Phase (SP)||0
9726069|NCT00098293|10825662|FG001|NOT COMPLETED|Supplemental Phase (SP)||0
9726070|NCT00098293|10825663|FG002|NOT COMPLETED|Supplemental Phase (SP)||0
9726071|NCT00098293|10825664|FG003|NOT COMPLETED|Supplemental Phase (SP)||0
9726072|NCT00098293|10825665|FG004|NOT COMPLETED|Supplemental Phase (SP)||33
9726073|NCT00098306|10825679|FG000|STARTED|Double Blind||241
9726074|NCT00098306|10825680|FG001|STARTED|Double Blind||240
9726075|NCT00098306|10825681|FG002|STARTED|Double Blind||120
9726076|NCT00098306|10825682|FG003|STARTED|Double Blind||0
9726077|NCT00098306|10825683|FG004|STARTED|Double Blind||0
9726078|NCT00098306|10825684|FG005|STARTED|Double Blind||0
9726079|NCT00098306|10825685|FG006|STARTED|Double Blind||0
9726080|NCT00098306|10825679|FG000|Treated|Double Blind||232
9726081|NCT00098306|10825680|FG001|Treated|Double Blind||235
9726082|NCT00098306|10825681|FG002|Treated|Double Blind||118
9726083|NCT00098306|10825682|FG003|Treated|Double Blind||0
9726084|NCT00098306|10825683|FG004|Treated|Double Blind||0
9726085|NCT00098306|10825684|FG005|Treated|Double Blind||0
9726086|NCT00098306|10825685|FG006|Treated|Double Blind||0
9726087|NCT00098306|10825679|FG000|COMPLETED|Double Blind||0
9726088|NCT00098306|10825680|FG001|COMPLETED|Double Blind||0
9726089|NCT00098306|10825681|FG002|COMPLETED|Double Blind||0
9726090|NCT00098306|10825682|FG003|COMPLETED|Double Blind||0
9726091|NCT00098306|10825683|FG004|COMPLETED|Double Blind||0
9726092|NCT00098306|10825684|FG005|COMPLETED|Double Blind||0
9726093|NCT00098306|10825685|FG006|COMPLETED|Double Blind||0
9726094|NCT00098306|10825679|FG000|NOT COMPLETED|Double Blind||241
9726095|NCT00098306|10825680|FG001|NOT COMPLETED|Double Blind||240
9726096|NCT00098306|10825681|FG002|NOT COMPLETED|Double Blind||120
9726097|NCT00098306|10825682|FG003|NOT COMPLETED|Double Blind||0
9726098|NCT00098306|10825683|FG004|NOT COMPLETED|Double Blind||0
9726099|NCT00098306|10825684|FG005|NOT COMPLETED|Double Blind||0
9726100|NCT00098306|10825685|FG006|NOT COMPLETED|Double Blind||0
9726101|NCT00098306|10825679|FG000|STARTED|Open Label||0
9726102|NCT00098306|10825680|FG001|STARTED|Open Label||0
9726103|NCT00098306|10825681|FG002|STARTED|Open Label||0
9726104|NCT00098306|10825682|FG003|STARTED|Open Label||327
9726105|NCT00098306|10825683|FG004|STARTED|Open Label||62
9726106|NCT00098306|10825684|FG005|STARTED|Open Label||0
9726107|NCT00098306|10825685|FG006|STARTED|Open Label||0
9726108|NCT00098306|10825679|FG000|COMPLETED|Open Label||0
9726109|NCT00098306|10825680|FG001|COMPLETED|Open Label||0
9726110|NCT00098306|10825681|FG002|COMPLETED|Open Label||0
9960974|NCT01470599|11080656|FG000|NOT COMPLETED|Overall Study||19
9960975|NCT01470599|11080657|FG001|NOT COMPLETED|Overall Study||43
9960976|NCT01470612|11080665|FG000|STARTED|Overall Study||175
9960977|NCT01470612|11080666|FG001|STARTED|Overall Study||769
9960978|NCT01470612|11080665|FG000|COMPLETED|Overall Study||91
9960979|NCT01470612|11080666|FG001|COMPLETED|Overall Study||104
9960980|NCT01470612|11080665|FG000|NOT COMPLETED|Overall Study||84
9960981|NCT01470612|11080666|FG001|NOT COMPLETED|Overall Study||665
9960982|NCT01470651|11080674|FG000|STARTED|Overall Study||13
9726111|NCT00098306|10825682|FG003|COMPLETED|Open Label||0
9726112|NCT00098306|10825683|FG004|COMPLETED|Open Label||0
9726113|NCT00098306|10825684|FG005|COMPLETED|Open Label||0
9726114|NCT00098306|10825685|FG006|COMPLETED|Open Label||0
9726115|NCT00098306|10825679|FG000|NOT COMPLETED|Open Label||0
9726116|NCT00098306|10825680|FG001|NOT COMPLETED|Open Label||0
9685816|NCT04579549|10786326|FG000|STARTED|Overall Study||464
9685817|NCT04579549|10786326|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11
9685818|NCT04579549|10786326|FG000|COMPLETED|Overall Study||464
9685819|NCT04579549|10786326|FG000|NOT COMPLETED|Overall Study||0
9685820|NCT04622709|10786330|FG000|STARTED|Period 1 (First 6 Weeks)||39
9685821|NCT04622709|10786330|FG000|COMPLETED|Period 1 (First 6 Weeks)||36
9685822|NCT04622709|10786330|FG000|NOT COMPLETED|Period 1 (First 6 Weeks)||3
9685823|NCT04622709|10786330|FG000|STARTED|Period 2 (Subsequent 12 Weeks)||36
9685824|NCT04622709|10786330|FG000|COMPLETED|Period 2 (Subsequent 12 Weeks)||32
9685825|NCT04622709|10786330|FG000|NOT COMPLETED|Period 2 (Subsequent 12 Weeks)||4
9685826|NCT04314284|10786336|FG000|STARTED|Overall Study||69
9685827|NCT04314284|10786337|FG001|STARTED|Overall Study||81
9685828|NCT04314284|10786336|FG000|COMPLETED|Overall Study||65
9685829|NCT04314284|10786337|FG001|COMPLETED|Overall Study||68
9685830|NCT04314284|10786336|FG000|NOT COMPLETED|Overall Study||4
9685831|NCT04314284|10786337|FG001|NOT COMPLETED|Overall Study||13
9685832|NCT04066491|10786346|FG000|STARTED|Overall Study||12
9685833|NCT04066491|10786347|FG001|STARTED|Overall Study||149
9685834|NCT04066491|10786348|FG002|STARTED|Overall Study||148
9685835|NCT04066491|10786346|FG000|Treated|Overall Study||12
9685836|NCT04066491|10786347|FG001|Treated|Overall Study||149
9685837|NCT04066491|10786348|FG002|Treated|Overall Study||146
9685838|NCT04066491|10786346|FG000|COMPLETED|Overall Study||8
9685839|NCT04066491|10786347|FG001|COMPLETED|Overall Study||38
9685840|NCT04066491|10786348|FG002|COMPLETED|Overall Study||39
9685841|NCT04066491|10786346|FG000|NOT COMPLETED|Overall Study||4
9685842|NCT04066491|10786347|FG001|NOT COMPLETED|Overall Study||111
9685843|NCT04066491|10786348|FG002|NOT COMPLETED|Overall Study||109
9685844|NCT03259425|10786357|FG000|STARTED|Overall Study||7
9685845|NCT03259425|10786357|FG000|Surgery|Overall Study||6
9685846|NCT03259425|10786357|FG000|COMPLETED|Overall Study||6
9685847|NCT03259425|10786357|FG000|NOT COMPLETED|Overall Study||1
9685848|NCT03129100|10786366|FG000|STARTED|Lead-In Period (Period 1)||350
9685849|NCT03129100|10786367|FG001|STARTED|Lead-In Period (Period 1)||423
9685850|NCT03129100|10786368|FG002|STARTED|Lead-In Period (Period 1)||0
9685851|NCT03129100|10786369|FG003|STARTED|Lead-In Period (Period 1)||0
9685852|NCT03129100|10786370|FG004|STARTED|Lead-In Period (Period 1)||0
9685853|NCT03129100|10786371|FG005|STARTED|Lead-In Period (Period 1)||0
9685854|NCT03129100|10786372|FG006|STARTED|Lead-In Period (Period 1)||0
9685855|NCT03129100|10786373|FG007|STARTED|Lead-In Period (Period 1)||0
9685856|NCT03129100|10786374|FG008|STARTED|Lead-In Period (Period 1)||0
9685857|NCT03129100|10786375|FG009|STARTED|Lead-In Period (Period 1)||0
9685858|NCT03129100|10786376|FG010|STARTED|Lead-In Period (Period 1)||0
9685859|NCT03129100|10786377|FG011|STARTED|Lead-In Period (Period 1)||0
9685860|NCT03129100|10786378|FG012|STARTED|Lead-In Period (Period 1)||0
9685861|NCT03129100|10786379|FG013|STARTED|Lead-In Period (Period 1)||0
9685862|NCT03129100|10786380|FG014|STARTED|Lead-In Period (Period 1)||0
9685863|NCT03129100|10786381|FG015|STARTED|Lead-In Period (Period 1)||0
9685864|NCT03129100|10786382|FG016|STARTED|Lead-In Period (Period 1)||0
9685865|NCT03129100|10786383|FG017|STARTED|Lead-In Period (Period 1)||0
9685866|NCT03129100|10786384|FG018|STARTED|Lead-In Period (Period 1)||0
9685867|NCT03129100|10786385|FG019|STARTED|Lead-In Period (Period 1)||0
9685868|NCT03129100|10786386|FG020|STARTED|Lead-In Period (Period 1)||0
9685869|NCT03129100|10786387|FG021|STARTED|Lead-In Period (Period 1)||0
9685870|NCT03129100|10786388|FG022|STARTED|Lead-In Period (Period 1)||0
9685871|NCT03129100|10786389|FG023|STARTED|Lead-In Period (Period 1)||0
9685872|NCT03129100|10786390|FG024|STARTED|Lead-In Period (Period 1)||0
9685873|NCT03129100|10786391|FG025|STARTED|Lead-In Period (Period 1)||0
9685874|NCT03129100|10786366|FG000|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||348
9685875|NCT03129100|10786367|FG001|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||423
9685876|NCT03129100|10786368|FG002|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685877|NCT03129100|10786369|FG003|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685878|NCT03129100|10786370|FG004|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685879|NCT03129100|10786371|FG005|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685880|NCT03129100|10786372|FG006|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685881|NCT03129100|10786373|FG007|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685882|NCT03129100|10786374|FG008|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685883|NCT03129100|10786375|FG009|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685884|NCT03129100|10786376|FG010|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9726117|NCT00098306|10825681|FG002|NOT COMPLETED|Open Label||0
9685885|NCT03129100|10786377|FG011|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685886|NCT03129100|10786378|FG012|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685887|NCT03129100|10786379|FG013|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685888|NCT03129100|10786380|FG014|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685889|NCT03129100|10786381|FG015|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685890|NCT03129100|10786382|FG016|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685891|NCT03129100|10786383|FG017|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685892|NCT03129100|10786384|FG018|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685893|NCT03129100|10786385|FG019|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685894|NCT03129100|10786386|FG020|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685895|NCT03129100|10786387|FG021|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685896|NCT03129100|10786388|FG022|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685897|NCT03129100|10786389|FG023|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685898|NCT03129100|10786390|FG024|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685899|NCT03129100|10786391|FG025|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
9685900|NCT03129100|10786366|FG000|COMPLETED|Lead-In Period (Period 1)||335
9685901|NCT03129100|10786367|FG001|COMPLETED|Lead-In Period (Period 1)||406
9685902|NCT03129100|10786368|FG002|COMPLETED|Lead-In Period (Period 1)||0
9685903|NCT03129100|10786369|FG003|COMPLETED|Lead-In Period (Period 1)||0
9685904|NCT03129100|10786370|FG004|COMPLETED|Lead-In Period (Period 1)||0
9685905|NCT03129100|10786371|FG005|COMPLETED|Lead-In Period (Period 1)||0
9685906|NCT03129100|10786372|FG006|COMPLETED|Lead-In Period (Period 1)||0
9685907|NCT03129100|10786373|FG007|COMPLETED|Lead-In Period (Period 1)||0
9685908|NCT03129100|10786374|FG008|COMPLETED|Lead-In Period (Period 1)||0
9685909|NCT03129100|10786375|FG009|COMPLETED|Lead-In Period (Period 1)||0
9685910|NCT03129100|10786376|FG010|COMPLETED|Lead-In Period (Period 1)||0
9685911|NCT03129100|10786377|FG011|COMPLETED|Lead-In Period (Period 1)||0
9685912|NCT03129100|10786378|FG012|COMPLETED|Lead-In Period (Period 1)||0
9685913|NCT03129100|10786379|FG013|COMPLETED|Lead-In Period (Period 1)||0
9685914|NCT03129100|10786380|FG014|COMPLETED|Lead-In Period (Period 1)||0
9685915|NCT03129100|10786381|FG015|COMPLETED|Lead-In Period (Period 1)||0
9685916|NCT03129100|10786382|FG016|COMPLETED|Lead-In Period (Period 1)||0
9685917|NCT03129100|10786383|FG017|COMPLETED|Lead-In Period (Period 1)||0
9685918|NCT03129100|10786384|FG018|COMPLETED|Lead-In Period (Period 1)||0
9685919|NCT03129100|10786385|FG019|COMPLETED|Lead-In Period (Period 1)||0
9685920|NCT03129100|10786386|FG020|COMPLETED|Lead-In Period (Period 1)||0
9685921|NCT03129100|10786387|FG021|COMPLETED|Lead-In Period (Period 1)||0
9685922|NCT03129100|10786388|FG022|COMPLETED|Lead-In Period (Period 1)||0
9685923|NCT03129100|10786389|FG023|COMPLETED|Lead-In Period (Period 1)||0
9685924|NCT03129100|10786390|FG024|COMPLETED|Lead-In Period (Period 1)||0
9685925|NCT03129100|10786391|FG025|COMPLETED|Lead-In Period (Period 1)||0
9685926|NCT03129100|10786366|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15
9685927|NCT03129100|10786367|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17
9685928|NCT03129100|10786368|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0
9685929|NCT03129100|10786369|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0
9685930|NCT03129100|10786370|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0
9685931|NCT03129100|10786371|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0
9685932|NCT03129100|10786372|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0
9685933|NCT03129100|10786373|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0
9685934|NCT03129100|10786374|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0
9685935|NCT03129100|10786375|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0
9685936|NCT03129100|10786376|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0
9685937|NCT03129100|10786377|FG011|NOT COMPLETED|Lead-In Period (Period 1)||0
9685938|NCT03129100|10786378|FG012|NOT COMPLETED|Lead-In Period (Period 1)||0
9685939|NCT03129100|10786379|FG013|NOT COMPLETED|Lead-In Period (Period 1)||0
9685940|NCT03129100|10786380|FG014|NOT COMPLETED|Lead-In Period (Period 1)||0
9685941|NCT03129100|10786381|FG015|NOT COMPLETED|Lead-In Period (Period 1)||0
9685942|NCT03129100|10786382|FG016|NOT COMPLETED|Lead-In Period (Period 1)||0
9685943|NCT03129100|10786383|FG017|NOT COMPLETED|Lead-In Period (Period 1)||0
9685944|NCT03129100|10786384|FG018|NOT COMPLETED|Lead-In Period (Period 1)||0
9685945|NCT03129100|10786385|FG019|NOT COMPLETED|Lead-In Period (Period 1)||0
9685946|NCT03129100|10786386|FG020|NOT COMPLETED|Lead-In Period (Period 1)||0
9685947|NCT03129100|10786387|FG021|NOT COMPLETED|Lead-In Period (Period 1)||0
9685948|NCT03129100|10786388|FG022|NOT COMPLETED|Lead-In Period (Period 1)||0
9685949|NCT03129100|10786389|FG023|NOT COMPLETED|Lead-In Period (Period 1)||0
9685950|NCT03129100|10786390|FG024|NOT COMPLETED|Lead-In Period (Period 1)||0
9685951|NCT03129100|10786391|FG025|NOT COMPLETED|Lead-In Period (Period 1)||0
9685952|NCT03129100|10786366|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
9685953|NCT03129100|10786367|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
9685954|NCT03129100|10786368|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
9685955|NCT03129100|10786369|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
9685956|NCT03129100|10786370|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
9685957|NCT03129100|10786371|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
9685958|NCT03129100|10786372|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
9685959|NCT03129100|10786373|FG007|STARTED|Period2 Extension Period (Group A and B)||0
9685960|NCT03129100|10786374|FG008|STARTED|Period2 Extension Period (Group A and B)||0
9685961|NCT03129100|10786375|FG009|STARTED|Period2 Extension Period (Group A and B)||0
9685962|NCT03129100|10786376|FG010|STARTED|Period2 Extension Period (Group A and B)||0
9685963|NCT03129100|10786377|FG011|STARTED|Period2 Extension Period (Group A and B)||0
9685964|NCT03129100|10786378|FG012|STARTED|Period2 Extension Period (Group A and B)||0
9685965|NCT03129100|10786379|FG013|STARTED|Period2 Extension Period (Group A and B)||0
9685966|NCT03129100|10786380|FG014|STARTED|Period2 Extension Period (Group A and B)||0
9685967|NCT03129100|10786381|FG015|STARTED|Period2 Extension Period (Group A and B)||0
9685968|NCT03129100|10786382|FG016|STARTED|Period2 Extension Period (Group A and B)||0
9685969|NCT03129100|10786383|FG017|STARTED|Period2 Extension Period (Group A and B)||0
9685970|NCT03129100|10786384|FG018|STARTED|Period2 Extension Period (Group A and B)||0
9685971|NCT03129100|10786385|FG019|STARTED|Period2 Extension Period (Group A and B)||0
9685972|NCT03129100|10786386|FG020|STARTED|Period2 Extension Period (Group A and B)||0
9685973|NCT03129100|10786387|FG021|STARTED|Period2 Extension Period (Group A and B)||0
9685974|NCT03129100|10786388|FG022|STARTED|Period2 Extension Period (Group A and B)||0
9685975|NCT03129100|10786389|FG023|STARTED|Period2 Extension Period (Group A and B)||0
9685976|NCT03129100|10786390|FG024|STARTED|Period2 Extension Period (Group A and B)||0
9844966|NCT00839332|10957045|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50
9844967|NCT00839332|10957046|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0
9844968|NCT00839332|10957047|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0
9844969|NCT00839332|10957045|FG000|COMPLETED|Phase 1||0
9844970|NCT00839332|10957046|FG001|COMPLETED|Phase 1||0
9844971|NCT00839332|10957047|FG002|COMPLETED|Phase 1||0
9844972|NCT00839332|10957045|FG000|NOT COMPLETED|Phase 1||50
9844973|NCT00839332|10957046|FG001|NOT COMPLETED|Phase 1||0
9844974|NCT00839332|10957047|FG002|NOT COMPLETED|Phase 1||0
9844975|NCT00839332|10957045|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
9844976|NCT00839332|10957046|FG001|STARTED|Phase 2||68
9844977|NCT00839332|10957047|FG002|STARTED|Phase 2||39
9844978|NCT00839332|10957045|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0
9844979|NCT00839332|10957046|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65
9844980|NCT00839332|10957047|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34
9844981|NCT00839332|10957045|FG000|COMPLETED|Phase 2||0
9844982|NCT00839332|10957046|FG001|COMPLETED|Phase 2||0
9844983|NCT00839332|10957047|FG002|COMPLETED|Phase 2||0
9844984|NCT00839332|10957045|FG000|NOT COMPLETED|Phase 2||0
9844985|NCT00839332|10957046|FG001|NOT COMPLETED|Phase 2||68
9844986|NCT00839332|10957047|FG002|NOT COMPLETED|Phase 2||39
9844987|NCT00839423|10957060|FG000|STARTED|Overall Study||105
9844988|NCT00839423|10957061|FG001|STARTED|Overall Study||108
9844989|NCT00839423|10957062|FG002|STARTED|Overall Study||100
9844990|NCT00839423|10957063|FG003|STARTED|Overall Study||113
9844991|NCT00839423|10957060|FG000|COMPLETED|Overall Study||87
9844992|NCT00839423|10957061|FG001|COMPLETED|Overall Study||98
9844993|NCT00839423|10957062|FG002|COMPLETED|Overall Study||82
9844994|NCT00839423|10957063|FG003|COMPLETED|Overall Study||93
9844995|NCT00839423|10957060|FG000|NOT COMPLETED|Overall Study||18
9844996|NCT00839423|10957061|FG001|NOT COMPLETED|Overall Study||10
9844997|NCT00839423|10957062|FG002|NOT COMPLETED|Overall Study||18
9844998|NCT00839423|10957063|FG003|NOT COMPLETED|Overall Study||20
9844999|NCT00839436|10957076|FG000|STARTED|Overall Study||3
9845000|NCT00839436|10957077|FG001|STARTED|Overall Study||5
9845001|NCT00839436|10957078|FG002|STARTED|Overall Study||1
9845002|NCT00839436|10957076|FG000|COMPLETED|Overall Study||2
9845003|NCT00839436|10957077|FG001|COMPLETED|Overall Study||4
9845004|NCT00839436|10957078|FG002|COMPLETED|Overall Study||0
9845005|NCT00839436|10957076|FG000|NOT COMPLETED|Overall Study||1
9845006|NCT00839436|10957077|FG001|NOT COMPLETED|Overall Study||1
9845007|NCT00839436|10957078|FG002|NOT COMPLETED|Overall Study||1
9845008|NCT00839527|10957089|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115
9845009|NCT00839527|10957090|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277
9845010|NCT00839527|10957091|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271
9845011|NCT00839527|10957089|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55
9845012|NCT00839527|10957090|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159
9845013|NCT00839527|10957091|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152
9845014|NCT00839527|10957089|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
9845015|NCT00839527|10957090|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
9845016|NCT00839527|10957091|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
9845017|NCT00839527|10957089|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
9845018|NCT00839527|10957090|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
9845019|NCT00839527|10957091|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
9845020|NCT00839527|10957089|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
9845021|NCT00839527|10957090|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
9845022|NCT00839527|10957091|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
9845023|NCT00839527|10957089|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
9845024|NCT00839527|10957090|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
9685977|NCT03129100|10786391|FG025|STARTED|Period2 Extension Period (Group A and B)||0
9685978|NCT03129100|10786366|FG000|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9845025|NCT00839527|10957091|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
9845026|NCT00839540|10957104|FG000|STARTED|Overall Study||8
9845027|NCT00839540|10957105|FG001|STARTED|Overall Study||8
9845028|NCT00839540|10957106|FG002|STARTED|Overall Study||5
9845029|NCT00839540|10957104|FG000|COMPLETED|Overall Study||8
9845030|NCT00839540|10957105|FG001|COMPLETED|Overall Study||8
9845031|NCT00839540|10957106|FG002|COMPLETED|Overall Study||5
9845032|NCT00839540|10957104|FG000|NOT COMPLETED|Overall Study||0
9845033|NCT00839540|10957105|FG001|NOT COMPLETED|Overall Study||0
9845034|NCT00839540|10957106|FG002|NOT COMPLETED|Overall Study||0
9845035|NCT00839800|10957116|FG000|STARTED|Overall Study||1049
9845036|NCT00839800|10957117|FG001|STARTED|Overall Study||1042
9845037|NCT00839800|10957116|FG000|COMPLETED|Overall Study||956
9845038|NCT00839800|10957117|FG001|COMPLETED|Overall Study||932
9845039|NCT00839800|10957116|FG000|NOT COMPLETED|Overall Study||93
9845040|NCT00839800|10957117|FG001|NOT COMPLETED|Overall Study||110
9845041|NCT00839852|10957123|FG000|STARTED|Overall Study||93
9845042|NCT00839852|10957123|FG000|COMPLETED|Overall Study||46
9845043|NCT00839852|10957123|FG000|NOT COMPLETED|Overall Study||47
9845044|NCT00839917|10957129|FG000|STARTED|Overall Study||13
9845045|NCT00839917|10957130|FG001|STARTED|Overall Study||17
9845046|NCT00839917|10957129|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
9845047|NCT00839917|10957130|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
9845048|NCT00839917|10957129|FG000|NOT COMPLETED|Overall Study||1
9845049|NCT00839917|10957130|FG001|NOT COMPLETED|Overall Study||1
9845050|NCT00839956|10957136|FG000|STARTED|Overall Study||31
9845051|NCT00839956|10957136|FG000|COMPLETED|Overall Study||19
9845052|NCT00839956|10957136|FG000|NOT COMPLETED|Overall Study||12
9845053|NCT00839982|10957140|FG000|STARTED|Overall Study||4
9845054|NCT00839982|10957141|FG001|STARTED|Overall Study||26
9845055|NCT00839982|10957142|FG002|STARTED|Overall Study||2
9845056|NCT00839982|10957143|FG003|STARTED|Overall Study||3
9845057|NCT00839982|10957140|FG000|COMPLETED|Overall Study||4
9845058|NCT00839982|10957141|FG001|COMPLETED|Overall Study||26
9845059|NCT00839982|10957142|FG002|COMPLETED|Overall Study||2
9845060|NCT00839982|10957143|FG003|COMPLETED|Overall Study||3
9845061|NCT00839982|10957140|FG000|NOT COMPLETED|Overall Study||0
9845062|NCT00839982|10957141|FG001|NOT COMPLETED|Overall Study||0
9845063|NCT00839982|10957142|FG002|NOT COMPLETED|Overall Study||0
9845064|NCT00839982|10957143|FG003|NOT COMPLETED|Overall Study||0
9845065|NCT00840034|10957153|FG000|STARTED|Acute Treatment Phase||111
9845066|NCT00840034|10957154|FG001|STARTED|Acute Treatment Phase||116
9845067|NCT00840034|10957153|FG000|COMPLETED|Acute Treatment Phase||90
9845068|NCT00840034|10957154|FG001|COMPLETED|Acute Treatment Phase||80
9845069|NCT00840034|10957153|FG000|NOT COMPLETED|Acute Treatment Phase||21
9845070|NCT00840034|10957154|FG001|NOT COMPLETED|Acute Treatment Phase||36
9845071|NCT00840034|10957153|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
9845072|NCT00840034|10957154|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
9845073|NCT00840034|10957153|FG000|COMPLETED|Taper Phase||87
9845074|NCT00840034|10957154|FG001|COMPLETED|Taper Phase||80
9845075|NCT00840034|10957153|FG000|NOT COMPLETED|Taper Phase||3
9845076|NCT00840034|10957154|FG001|NOT COMPLETED|Taper Phase||2
9845077|NCT00840060|10957164|FG000|STARTED|Overall Study||20
9845078|NCT00840060|10957165|FG001|STARTED|Overall Study||20
9845079|NCT00840060|10957164|FG000|COMPLETED|Overall Study||19
9845080|NCT00840060|10957165|FG001|COMPLETED|Overall Study||19
9845081|NCT00840060|10957164|FG000|NOT COMPLETED|Overall Study||1
9845082|NCT00840060|10957165|FG001|NOT COMPLETED|Overall Study||1
9845083|NCT00840086|10957171|FG000|STARTED|Overall Study||150
9845084|NCT00840086|10957171|FG000|COMPLETED|Overall Study||146
9845085|NCT00840086|10957171|FG000|NOT COMPLETED|Overall Study||4
9845086|NCT00840294|10957180|FG000|STARTED|Overall Study||42
9845087|NCT00840294|10957181|FG001|STARTED|Overall Study||43
9845088|NCT00840294|10957180|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
9845089|NCT00840294|10957181|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
9845090|NCT00840294|10957180|FG000|NOT COMPLETED|Overall Study||3
9845091|NCT00840294|10957181|FG001|NOT COMPLETED|Overall Study||5
9845092|NCT00840307|10957187|FG000|STARTED|Overall Study||20
9845093|NCT00840307|10957187|FG000|COMPLETED|Overall Study||16
9845094|NCT00840307|10957187|FG000|NOT COMPLETED|Overall Study||4
9845095|NCT00840450|10957191|FG000|STARTED|Overall Study||12
9685979|NCT03129100|10786367|FG001|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685980|NCT03129100|10786368|FG002|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||255
9685981|NCT03129100|10786369|FG003|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||318
9685982|NCT03129100|10786370|FG004|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||47
9685983|NCT03129100|10786371|FG005|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||54
9685984|NCT03129100|10786372|FG006|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||53
9685985|NCT03129100|10786373|FG007|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685986|NCT03129100|10786374|FG008|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685987|NCT03129100|10786375|FG009|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685988|NCT03129100|10786376|FG010|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685989|NCT03129100|10786377|FG011|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685990|NCT03129100|10786378|FG012|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685991|NCT03129100|10786379|FG013|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685992|NCT03129100|10786380|FG014|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685993|NCT03129100|10786381|FG015|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685994|NCT03129100|10786382|FG016|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685995|NCT03129100|10786383|FG017|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685996|NCT03129100|10786384|FG018|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685997|NCT03129100|10786385|FG019|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685998|NCT03129100|10786386|FG020|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9685999|NCT03129100|10786387|FG021|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9686000|NCT03129100|10786388|FG022|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9686001|NCT03129100|10786389|FG023|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9686002|NCT03129100|10786390|FG024|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9686003|NCT03129100|10786391|FG025|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
9686004|NCT03129100|10786366|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0
9686005|NCT03129100|10786367|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0
9686006|NCT03129100|10786368|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234
9686007|NCT03129100|10786369|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312
9686008|NCT03129100|10786370|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42
9686009|NCT03129100|10786371|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45
9686010|NCT03129100|10786372|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32
9686011|NCT03129100|10786373|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0
9686012|NCT03129100|10786374|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0
9686013|NCT03129100|10786375|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0
9686014|NCT03129100|10786376|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0
9686015|NCT03129100|10786377|FG011|COMPLETED|Period2 Extension Period (Group A and B)||0
9686016|NCT03129100|10786378|FG012|COMPLETED|Period2 Extension Period (Group A and B)||0
9686017|NCT03129100|10786379|FG013|COMPLETED|Period2 Extension Period (Group A and B)||0
9686018|NCT03129100|10786380|FG014|COMPLETED|Period2 Extension Period (Group A and B)||0
9686019|NCT03129100|10786381|FG015|COMPLETED|Period2 Extension Period (Group A and B)||0
9686020|NCT03129100|10786382|FG016|COMPLETED|Period2 Extension Period (Group A and B)||0
9686021|NCT03129100|10786383|FG017|COMPLETED|Period2 Extension Period (Group A and B)||0
9686022|NCT03129100|10786384|FG018|COMPLETED|Period2 Extension Period (Group A and B)||0
9686023|NCT03129100|10786385|FG019|COMPLETED|Period2 Extension Period (Group A and B)||0
9686024|NCT03129100|10786386|FG020|COMPLETED|Period2 Extension Period (Group A and B)||0
9686025|NCT03129100|10786387|FG021|COMPLETED|Period2 Extension Period (Group A and B)||0
9686026|NCT03129100|10786388|FG022|COMPLETED|Period2 Extension Period (Group A and B)||0
9686027|NCT03129100|10786389|FG023|COMPLETED|Period2 Extension Period (Group A and B)||0
9686028|NCT03129100|10786390|FG024|COMPLETED|Period2 Extension Period (Group A and B)||0
9686029|NCT03129100|10786391|FG025|COMPLETED|Period2 Extension Period (Group A and B)||0
9686030|NCT03129100|10786366|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686031|NCT03129100|10786367|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686032|NCT03129100|10786368|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
9686033|NCT03129100|10786369|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
9686034|NCT03129100|10786370|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
9686035|NCT03129100|10786371|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
9686036|NCT03129100|10786372|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
9686037|NCT03129100|10786373|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9726118|NCT00098306|10825682|FG003|NOT COMPLETED|Open Label||327
9845096|NCT00840450|10957191|FG000|COMPLETED|Overall Study||9
9845097|NCT00840450|10957191|FG000|NOT COMPLETED|Overall Study||3
9845098|NCT00840463|10957197|FG000|STARTED|Overall Study||3
9845099|NCT00840463|10957198|FG001|STARTED|Overall Study||1
9845100|NCT00840463|10957197|FG000|COMPLETED|Overall Study||2
9960983|NCT01470651|11080675|FG001|STARTED|Overall Study||13
10023613|NCT01857102|11147300|FG000|NOT COMPLETED|Period 2||2
10023614|NCT01857102|11147301|FG001|NOT COMPLETED|Period 2||0
10023615|NCT01857206|11147311|FG000|STARTED|Overall Study||1372
10023616|NCT01857206|11147312|FG001|STARTED|Overall Study||683
10023617|NCT01857206|11147311|FG000|COMPLETED|Overall Study||1359
10023618|NCT01857206|11147312|FG001|COMPLETED|Overall Study||673
10023619|NCT01857206|11147311|FG000|NOT COMPLETED|Overall Study||13
10023620|NCT01857206|11147312|FG001|NOT COMPLETED|Overall Study||10
10023621|NCT01857232|11147327|FG000|STARTED|Overall Study||69
10023622|NCT01857232|11147328|FG001|STARTED|Overall Study||67
10023623|NCT01857232|11147329|FG002|STARTED|Overall Study||67
10023624|NCT01857232|11147330|FG003|STARTED|Overall Study||70
9686038|NCT03129100|10786374|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686039|NCT03129100|10786375|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686040|NCT03129100|10786376|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686041|NCT03129100|10786377|FG011|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686042|NCT03129100|10786378|FG012|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686043|NCT03129100|10786379|FG013|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686044|NCT03129100|10786380|FG014|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686045|NCT03129100|10786381|FG015|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686046|NCT03129100|10786382|FG016|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686047|NCT03129100|10786383|FG017|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686048|NCT03129100|10786384|FG018|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686049|NCT03129100|10786385|FG019|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686050|NCT03129100|10786386|FG020|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686051|NCT03129100|10786387|FG021|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686052|NCT03129100|10786388|FG022|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686053|NCT03129100|10786389|FG023|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686054|NCT03129100|10786390|FG024|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686055|NCT03129100|10786391|FG025|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9686056|NCT03129100|10786366|FG000|STARTED|Period 2 (Retreatment Extension Period)||0
9686057|NCT03129100|10786367|FG001|STARTED|Period 2 (Retreatment Extension Period)||0
9686058|NCT03129100|10786368|FG002|STARTED|Period 2 (Retreatment Extension Period)||0
9686059|NCT03129100|10786369|FG003|STARTED|Period 2 (Retreatment Extension Period)||0
9686060|NCT03129100|10786370|FG004|STARTED|Period 2 (Retreatment Extension Period)||0
9686061|NCT03129100|10786371|FG005|STARTED|Period 2 (Retreatment Extension Period)||0
9686062|NCT03129100|10786372|FG006|STARTED|Period 2 (Retreatment Extension Period)||0
9686063|NCT03129100|10786373|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
9686064|NCT03129100|10786374|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
9686065|NCT03129100|10786375|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
9686066|NCT03129100|10786376|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
9686067|NCT03129100|10786377|FG011|STARTED|Period 2 (Retreatment Extension Period)||0
9686068|NCT03129100|10786378|FG012|STARTED|Period 2 (Retreatment Extension Period)||0
9686069|NCT03129100|10786379|FG013|STARTED|Period 2 (Retreatment Extension Period)||0
9686070|NCT03129100|10786380|FG014|STARTED|Period 2 (Retreatment Extension Period)||0
9686071|NCT03129100|10786381|FG015|STARTED|Period 2 (Retreatment Extension Period)||0
9686072|NCT03129100|10786382|FG016|STARTED|Period 2 (Retreatment Extension Period)||0
9686073|NCT03129100|10786383|FG017|STARTED|Period 2 (Retreatment Extension Period)||0
9686074|NCT03129100|10786384|FG018|STARTED|Period 2 (Retreatment Extension Period)||0
9686075|NCT03129100|10786385|FG019|STARTED|Period 2 (Retreatment Extension Period)||0
9686076|NCT03129100|10786386|FG020|STARTED|Period 2 (Retreatment Extension Period)||0
9686077|NCT03129100|10786387|FG021|STARTED|Period 2 (Retreatment Extension Period)||0
9686078|NCT03129100|10786388|FG022|STARTED|Period 2 (Retreatment Extension Period)||0
9686079|NCT03129100|10786389|FG023|STARTED|Period 2 (Retreatment Extension Period)||0
9686080|NCT03129100|10786390|FG024|STARTED|Period 2 (Retreatment Extension Period)||0
9686081|NCT03129100|10786391|FG025|STARTED|Period 2 (Retreatment Extension Period)||0
9686082|NCT03129100|10786366|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686083|NCT03129100|10786367|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686084|NCT03129100|10786368|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686085|NCT03129100|10786369|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686086|NCT03129100|10786370|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686087|NCT03129100|10786371|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0
10023625|NCT01857232|11147331|FG004|STARTED|Overall Study||69
9686088|NCT03129100|10786372|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686089|NCT03129100|10786373|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6
9686090|NCT03129100|10786374|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5
9686091|NCT03129100|10786375|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8
9686092|NCT03129100|10786376|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10
9686093|NCT03129100|10786377|FG011|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686094|NCT03129100|10786378|FG012|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686095|NCT03129100|10786379|FG013|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686096|NCT03129100|10786380|FG014|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686097|NCT03129100|10786381|FG015|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686098|NCT03129100|10786382|FG016|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686099|NCT03129100|10786383|FG017|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686100|NCT03129100|10786384|FG018|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686101|NCT03129100|10786385|FG019|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686102|NCT03129100|10786386|FG020|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686103|NCT03129100|10786387|FG021|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686104|NCT03129100|10786388|FG022|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686105|NCT03129100|10786389|FG023|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686106|NCT03129100|10786390|FG024|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686107|NCT03129100|10786391|FG025|COMPLETED|Period 2 (Retreatment Extension Period)||0
9686108|NCT03129100|10786366|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686109|NCT03129100|10786367|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686110|NCT03129100|10786368|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686111|NCT03129100|10786369|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686112|NCT03129100|10786370|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686113|NCT03129100|10786371|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686114|NCT03129100|10786372|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686115|NCT03129100|10786373|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686116|NCT03129100|10786374|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686117|NCT03129100|10786375|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
9686118|NCT03129100|10786376|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686119|NCT03129100|10786377|FG011|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686120|NCT03129100|10786378|FG012|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686121|NCT03129100|10786379|FG013|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686122|NCT03129100|10786380|FG014|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686123|NCT03129100|10786381|FG015|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686124|NCT03129100|10786382|FG016|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686125|NCT03129100|10786383|FG017|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686126|NCT03129100|10786384|FG018|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686127|NCT03129100|10786385|FG019|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686128|NCT03129100|10786386|FG020|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686129|NCT03129100|10786387|FG021|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686130|NCT03129100|10786388|FG022|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686131|NCT03129100|10786389|FG023|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686132|NCT03129100|10786390|FG024|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9845101|NCT00840463|10957198|FG001|COMPLETED|Overall Study||1
9845102|NCT00840463|10957197|FG000|NOT COMPLETED|Overall Study||1
9845103|NCT00840463|10957198|FG001|NOT COMPLETED|Overall Study||0
9845104|NCT00840658|10957208|FG000|STARTED|Overall Study||144
9845105|NCT00840658|10957209|FG001|STARTED|Overall Study||146
9845106|NCT00840658|10957210|FG002|STARTED|Overall Study||148
9845107|NCT00840658|10957211|FG003|STARTED|Overall Study||146
9845108|NCT00840658|10957208|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
9845109|NCT00840658|10957209|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
9845110|NCT00840658|10957210|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
9845111|NCT00840658|10957211|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
9845112|NCT00840658|10957208|FG000|NOT COMPLETED|Overall Study||5
9845113|NCT00840658|10957209|FG001|NOT COMPLETED|Overall Study||3
9845114|NCT00840658|10957210|FG002|NOT COMPLETED|Overall Study||5
9845115|NCT00840658|10957211|FG003|NOT COMPLETED|Overall Study||4
9845116|NCT00840749|10957227|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
9845117|NCT00840749|10957228|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
9845118|NCT00840749|10957227|FG000|Treatment|Overall Study||20
9845119|NCT00840749|10957228|FG001|Treatment|Overall Study||16
9845120|NCT00840749|10957227|FG000|1 Month Post tx|Overall Study||19
9845121|NCT00840749|10957228|FG001|1 Month Post tx|Overall Study||15
9845122|NCT00840749|10957227|FG000|6 Months Post tx|Overall Study||16
9845123|NCT00840749|10957228|FG001|6 Months Post tx|Overall Study||10
9845124|NCT00840749|10957227|FG000|12 Months Post tx|Overall Study||14
9845125|NCT00840749|10957228|FG001|12 Months Post tx|Overall Study||7
9845126|NCT00840749|10957227|FG000|18 Months Post tx|Overall Study||12
9845127|NCT00840749|10957228|FG001|18 Months Post tx|Overall Study||6
9845128|NCT00840749|10957227|FG000|24 Months Post tx|Overall Study||9
9845129|NCT00840749|10957228|FG001|24 Months Post tx|Overall Study||3
9845130|NCT00840749|10957227|FG000|36 Months Post tx|Overall Study||1
9845131|NCT00840749|10957228|FG001|36 Months Post tx|Overall Study||0
9845132|NCT00840749|10957227|FG000|COMPLETED|Overall Study||0
9845133|NCT00840749|10957228|FG001|COMPLETED|Overall Study||0
9845134|NCT00840749|10957227|FG000|NOT COMPLETED|Overall Study||31
9845135|NCT00840749|10957228|FG001|NOT COMPLETED|Overall Study||27
9845136|NCT00840970|10957234|FG000|STARTED|Overall Study||7
9845137|NCT00840970|10957235|FG001|STARTED|Overall Study||38
9845138|NCT00840970|10957236|FG002|STARTED|Overall Study||5
9845139|NCT00840970|10957234|FG000|COMPLETED|Overall Study||7
9845140|NCT00840970|10957235|FG001|COMPLETED|Overall Study||38
9845141|NCT00840970|10957236|FG002|COMPLETED|Overall Study||4
9845142|NCT00840970|10957234|FG000|NOT COMPLETED|Overall Study||0
9845143|NCT00840970|10957235|FG001|NOT COMPLETED|Overall Study||0
9845144|NCT00840970|10957236|FG002|NOT COMPLETED|Overall Study||1
9845145|NCT00840996|10957248|FG000|STARTED|Overall Study||58
9845146|NCT00840996|10957249|FG001|STARTED|Overall Study||58
9845147|NCT00840996|10957248|FG000|COMPLETED|Overall Study||57
9845148|NCT00840996|10957249|FG001|COMPLETED|Overall Study||58
9960984|NCT01470651|11080674|FG000|COMPLETED|Overall Study||6
9960985|NCT01470651|11080675|FG001|COMPLETED|Overall Study||10
9960986|NCT01470651|11080674|FG000|NOT COMPLETED|Overall Study||7
9960987|NCT01470651|11080675|FG001|NOT COMPLETED|Overall Study||3
9960988|NCT01470781|11080683|FG000|STARTED|Overall Study||39
9960989|NCT01470781|11080684|FG001|STARTED|Overall Study||33
9686133|NCT03129100|10786391|FG025|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9686134|NCT03129100|10786366|FG000|STARTED|Period3-Long-Term Extension Period A & B||0
9686135|NCT03129100|10786367|FG001|STARTED|Period3-Long-Term Extension Period A & B||0
9686136|NCT03129100|10786368|FG002|STARTED|Period3-Long-Term Extension Period A & B||0
9686137|NCT03129100|10786369|FG003|STARTED|Period3-Long-Term Extension Period A & B||0
9686138|NCT03129100|10786370|FG004|STARTED|Period3-Long-Term Extension Period A & B||0
9686139|NCT03129100|10786371|FG005|STARTED|Period3-Long-Term Extension Period A & B||0
9686140|NCT03129100|10786372|FG006|STARTED|Period3-Long-Term Extension Period A & B||0
9686141|NCT03129100|10786373|FG007|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
9686142|NCT03129100|10786374|FG008|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
9686143|NCT03129100|10786375|FG009|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
9686144|NCT03129100|10786376|FG010|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
9686145|NCT03129100|10786377|FG011|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|306
9686146|NCT03129100|10786378|FG012|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|177
9686147|NCT03129100|10786379|FG013|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|45
9686148|NCT03129100|10786380|FG014|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|42
9686149|NCT03129100|10786381|FG015|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|30
9686150|NCT03129100|10786382|FG016|STARTED|Period3-Long-Term Extension Period A & B||0
9686151|NCT03129100|10786383|FG017|STARTED|Period3-Long-Term Extension Period A & B||0
9686152|NCT03129100|10786384|FG018|STARTED|Period3-Long-Term Extension Period A & B||0
9686153|NCT03129100|10786385|FG019|STARTED|Period3-Long-Term Extension Period A & B||0
9686154|NCT03129100|10786386|FG020|STARTED|Period3-Long-Term Extension Period A & B||0
9686155|NCT03129100|10786387|FG021|STARTED|Period3-Long-Term Extension Period A & B||0
9686156|NCT03129100|10786388|FG022|STARTED|Period3-Long-Term Extension Period A & B||0
9686157|NCT03129100|10786389|FG023|STARTED|Period3-Long-Term Extension Period A & B||0
9686158|NCT03129100|10786390|FG024|STARTED|Period3-Long-Term Extension Period A & B||0
9686159|NCT03129100|10786391|FG025|STARTED|Period3-Long-Term Extension Period A & B||0
9686160|NCT03129100|10786366|FG000|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686161|NCT03129100|10786367|FG001|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686162|NCT03129100|10786368|FG002|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686163|NCT03129100|10786369|FG003|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686164|NCT03129100|10786370|FG004|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686165|NCT03129100|10786371|FG005|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686166|NCT03129100|10786372|FG006|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686167|NCT03129100|10786373|FG007|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686168|NCT03129100|10786374|FG008|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686169|NCT03129100|10786375|FG009|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686170|NCT03129100|10786376|FG010|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686171|NCT03129100|10786377|FG011|COMPLETED|Period3-Long-Term Extension Period A & B||287
9686172|NCT03129100|10786378|FG012|COMPLETED|Period3-Long-Term Extension Period A & B||146
9686173|NCT03129100|10786379|FG013|COMPLETED|Period3-Long-Term Extension Period A & B||40
9686174|NCT03129100|10786380|FG014|COMPLETED|Period3-Long-Term Extension Period A & B||37
9686175|NCT03129100|10786381|FG015|COMPLETED|Period3-Long-Term Extension Period A & B||21
9686176|NCT03129100|10786382|FG016|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686177|NCT03129100|10786383|FG017|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686178|NCT03129100|10786384|FG018|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686179|NCT03129100|10786385|FG019|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686180|NCT03129100|10786386|FG020|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686181|NCT03129100|10786387|FG021|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686182|NCT03129100|10786388|FG022|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686183|NCT03129100|10786389|FG023|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686184|NCT03129100|10786390|FG024|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686185|NCT03129100|10786391|FG025|COMPLETED|Period3-Long-Term Extension Period A & B||0
9686186|NCT03129100|10786366|FG000|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686187|NCT03129100|10786367|FG001|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686188|NCT03129100|10786368|FG002|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686189|NCT03129100|10786369|FG003|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686190|NCT03129100|10786370|FG004|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686191|NCT03129100|10786371|FG005|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9726119|NCT00098306|10825683|FG004|NOT COMPLETED|Open Label||62
9845149|NCT00840996|10957248|FG000|NOT COMPLETED|Overall Study||1
9845150|NCT00840996|10957249|FG001|NOT COMPLETED|Overall Study||0
9845151|NCT00841087|10957257|FG000|STARTED|Overall Study||33
9845152|NCT00841087|10957258|FG001|STARTED|Overall Study||32
9845153|NCT00841087|10957257|FG000|COMPLETED|Overall Study||33
9845154|NCT00841087|10957258|FG001|COMPLETED|Overall Study||32
9845155|NCT00841087|10957257|FG000|NOT COMPLETED|Overall Study||0
9845156|NCT00841087|10957258|FG001|NOT COMPLETED|Overall Study||0
9686192|NCT03129100|10786372|FG006|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686193|NCT03129100|10786373|FG007|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686194|NCT03129100|10786374|FG008|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686195|NCT03129100|10786375|FG009|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686196|NCT03129100|10786376|FG010|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686197|NCT03129100|10786377|FG011|NOT COMPLETED|Period3-Long-Term Extension Period A & B||19
9686198|NCT03129100|10786378|FG012|NOT COMPLETED|Period3-Long-Term Extension Period A & B||31
9686199|NCT03129100|10786379|FG013|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5
9686200|NCT03129100|10786380|FG014|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5
9686201|NCT03129100|10786381|FG015|NOT COMPLETED|Period3-Long-Term Extension Period A & B||9
9686202|NCT03129100|10786382|FG016|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686203|NCT03129100|10786383|FG017|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686204|NCT03129100|10786384|FG018|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686205|NCT03129100|10786385|FG019|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686206|NCT03129100|10786386|FG020|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686207|NCT03129100|10786387|FG021|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686208|NCT03129100|10786388|FG022|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686209|NCT03129100|10786389|FG023|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686210|NCT03129100|10786390|FG024|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686211|NCT03129100|10786391|FG025|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
9686212|NCT03129100|10786366|FG000|STARTED|Period 3 (Flare)||0
9686213|NCT03129100|10786367|FG001|STARTED|Period 3 (Flare)||0
9686214|NCT03129100|10786368|FG002|STARTED|Period 3 (Flare)||0
9686215|NCT03129100|10786369|FG003|STARTED|Period 3 (Flare)||0
9686216|NCT03129100|10786370|FG004|STARTED|Period 3 (Flare)||0
9686217|NCT03129100|10786371|FG005|STARTED|Period 3 (Flare)||0
9686218|NCT03129100|10786372|FG006|STARTED|Period 3 (Flare)||0
9686219|NCT03129100|10786373|FG007|STARTED|Period 3 (Flare)||0
9686220|NCT03129100|10786374|FG008|STARTED|Period 3 (Flare)||0
9686221|NCT03129100|10786375|FG009|STARTED|Period 3 (Flare)||0
9686222|NCT03129100|10786376|FG010|STARTED|Period 3 (Flare)||0
9686223|NCT03129100|10786377|FG011|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
9686224|NCT03129100|10786378|FG012|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
9686225|NCT03129100|10786379|FG013|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
9686226|NCT03129100|10786380|FG014|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
9686227|NCT03129100|10786381|FG015|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
9686228|NCT03129100|10786382|FG016|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|6
9686229|NCT03129100|10786383|FG017|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|4
9686230|NCT03129100|10786384|FG018|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|11
9686231|NCT03129100|10786385|FG019|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|15
9686232|NCT03129100|10786386|FG020|STARTED|Period 3 (Flare)||0
9686233|NCT03129100|10786387|FG021|STARTED|Period 3 (Flare)||0
9686234|NCT03129100|10786388|FG022|STARTED|Period 3 (Flare)||0
9686235|NCT03129100|10786389|FG023|STARTED|Period 3 (Flare)||0
9686236|NCT03129100|10786390|FG024|STARTED|Period 3 (Flare)||0
9686237|NCT03129100|10786391|FG025|STARTED|Period 3 (Flare)||0
9686238|NCT03129100|10786366|FG000|COMPLETED|Period 3 (Flare)||0
9686239|NCT03129100|10786367|FG001|COMPLETED|Period 3 (Flare)||0
9686240|NCT03129100|10786368|FG002|COMPLETED|Period 3 (Flare)||0
9686241|NCT03129100|10786369|FG003|COMPLETED|Period 3 (Flare)||0
9686242|NCT03129100|10786370|FG004|COMPLETED|Period 3 (Flare)||0
9686243|NCT03129100|10786371|FG005|COMPLETED|Period 3 (Flare)||0
9686244|NCT03129100|10786372|FG006|COMPLETED|Period 3 (Flare)||0
9686245|NCT03129100|10786373|FG007|COMPLETED|Period 3 (Flare)||0
10023626|NCT01857232|11147327|FG000|Evaluable ITT|Overall Study||66
10023627|NCT01857232|11147328|FG001|Evaluable ITT|Overall Study||66
9686246|NCT03129100|10786374|FG008|COMPLETED|Period 3 (Flare)||0
9686247|NCT03129100|10786375|FG009|COMPLETED|Period 3 (Flare)||0
9686248|NCT03129100|10786376|FG010|COMPLETED|Period 3 (Flare)||0
9686249|NCT03129100|10786377|FG011|COMPLETED|Period 3 (Flare)||0
9686250|NCT03129100|10786378|FG012|COMPLETED|Period 3 (Flare)||0
9686251|NCT03129100|10786379|FG013|COMPLETED|Period 3 (Flare)||0
9686252|NCT03129100|10786380|FG014|COMPLETED|Period 3 (Flare)||0
9686253|NCT03129100|10786381|FG015|COMPLETED|Period 3 (Flare)||0
9686254|NCT03129100|10786382|FG016|COMPLETED|Period 3 (Flare)||6
9686255|NCT03129100|10786383|FG017|COMPLETED|Period 3 (Flare)||2
9686256|NCT03129100|10786384|FG018|COMPLETED|Period 3 (Flare)||11
9686257|NCT03129100|10786385|FG019|COMPLETED|Period 3 (Flare)||12
9686258|NCT03129100|10786386|FG020|COMPLETED|Period 3 (Flare)||0
9686259|NCT03129100|10786387|FG021|COMPLETED|Period 3 (Flare)||0
9686260|NCT03129100|10786388|FG022|COMPLETED|Period 3 (Flare)||0
9686261|NCT03129100|10786389|FG023|COMPLETED|Period 3 (Flare)||0
9686262|NCT03129100|10786390|FG024|COMPLETED|Period 3 (Flare)||0
9686263|NCT03129100|10786391|FG025|COMPLETED|Period 3 (Flare)||0
9686264|NCT03129100|10786366|FG000|NOT COMPLETED|Period 3 (Flare)||0
9686265|NCT03129100|10786367|FG001|NOT COMPLETED|Period 3 (Flare)||0
10023628|NCT01857232|11147329|FG002|Evaluable ITT|Overall Study||63
9686266|NCT03129100|10786368|FG002|NOT COMPLETED|Period 3 (Flare)||0
9686267|NCT03129100|10786369|FG003|NOT COMPLETED|Period 3 (Flare)||0
9686268|NCT03129100|10786370|FG004|NOT COMPLETED|Period 3 (Flare)||0
9686269|NCT03129100|10786371|FG005|NOT COMPLETED|Period 3 (Flare)||0
9686270|NCT03129100|10786372|FG006|NOT COMPLETED|Period 3 (Flare)||0
9686271|NCT03129100|10786373|FG007|NOT COMPLETED|Period 3 (Flare)||0
9686272|NCT03129100|10786374|FG008|NOT COMPLETED|Period 3 (Flare)||0
9686273|NCT03129100|10786375|FG009|NOT COMPLETED|Period 3 (Flare)||0
9686274|NCT03129100|10786376|FG010|NOT COMPLETED|Period 3 (Flare)||0
9686275|NCT03129100|10786377|FG011|NOT COMPLETED|Period 3 (Flare)||0
9686276|NCT03129100|10786378|FG012|NOT COMPLETED|Period 3 (Flare)||0
9686277|NCT03129100|10786379|FG013|NOT COMPLETED|Period 3 (Flare)||0
9686278|NCT03129100|10786380|FG014|NOT COMPLETED|Period 3 (Flare)||0
9686279|NCT03129100|10786381|FG015|NOT COMPLETED|Period 3 (Flare)||0
9686280|NCT03129100|10786382|FG016|NOT COMPLETED|Period 3 (Flare)||0
9686281|NCT03129100|10786383|FG017|NOT COMPLETED|Period 3 (Flare)||2
9686282|NCT03129100|10786384|FG018|NOT COMPLETED|Period 3 (Flare)||0
9686283|NCT03129100|10786385|FG019|NOT COMPLETED|Period 3 (Flare)||3
9686284|NCT03129100|10786386|FG020|NOT COMPLETED|Period 3 (Flare)||0
9686285|NCT03129100|10786387|FG021|NOT COMPLETED|Period 3 (Flare)||0
9686286|NCT03129100|10786388|FG022|NOT COMPLETED|Period 3 (Flare)||0
9686287|NCT03129100|10786389|FG023|NOT COMPLETED|Period 3 (Flare)||0
9686288|NCT03129100|10786390|FG024|NOT COMPLETED|Period 3 (Flare)||0
9686289|NCT03129100|10786391|FG025|NOT COMPLETED|Period 3 (Flare)||0
9686290|NCT03129100|10786366|FG000|STARTED|Period 3 (Dose Escalation)||0
9686291|NCT03129100|10786367|FG001|STARTED|Period 3 (Dose Escalation)||0
9686292|NCT03129100|10786368|FG002|STARTED|Period 3 (Dose Escalation)||0
9686293|NCT03129100|10786369|FG003|STARTED|Period 3 (Dose Escalation)||0
9686294|NCT03129100|10786370|FG004|STARTED|Period 3 (Dose Escalation)||0
9686295|NCT03129100|10786371|FG005|STARTED|Period 3 (Dose Escalation)||0
9686296|NCT03129100|10786372|FG006|STARTED|Period 3 (Dose Escalation)||0
9686297|NCT03129100|10786373|FG007|STARTED|Period 3 (Dose Escalation)||0
9686298|NCT03129100|10786374|FG008|STARTED|Period 3 (Dose Escalation)||0
9686299|NCT03129100|10786375|FG009|STARTED|Period 3 (Dose Escalation)||0
9686300|NCT03129100|10786376|FG010|STARTED|Period 3 (Dose Escalation)||0
9686301|NCT03129100|10786377|FG011|STARTED|Period 3 (Dose Escalation)||0
9686302|NCT03129100|10786378|FG012|STARTED|Period 3 (Dose Escalation)||0
9686303|NCT03129100|10786379|FG013|STARTED|Period 3 (Dose Escalation)||0
9686304|NCT03129100|10786380|FG014|STARTED|Period 3 (Dose Escalation)||0
9686305|NCT03129100|10786381|FG015|STARTED|Period 3 (Dose Escalation)||0
9686306|NCT03129100|10786382|FG016|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
9686307|NCT03129100|10786383|FG017|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
9686308|NCT03129100|10786384|FG018|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
9686309|NCT03129100|10786385|FG019|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
9686310|NCT03129100|10786386|FG020|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|77
9686311|NCT03129100|10786387|FG021|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|5
9686312|NCT03129100|10786388|FG022|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|4
9686313|NCT03129100|10786389|FG023|STARTED|Period 3 (Dose Escalation)||0
9686314|NCT03129100|10786390|FG024|STARTED|Period 3 (Dose Escalation)||0
9686315|NCT03129100|10786391|FG025|STARTED|Period 3 (Dose Escalation)||0
9686316|NCT03129100|10786366|FG000|COMPLETED|Period 3 (Dose Escalation)||0
9686317|NCT03129100|10786367|FG001|COMPLETED|Period 3 (Dose Escalation)||0
9686318|NCT03129100|10786368|FG002|COMPLETED|Period 3 (Dose Escalation)||0
9686319|NCT03129100|10786369|FG003|COMPLETED|Period 3 (Dose Escalation)||0
9686320|NCT03129100|10786370|FG004|COMPLETED|Period 3 (Dose Escalation)||0
9686321|NCT03129100|10786371|FG005|COMPLETED|Period 3 (Dose Escalation)||0
9686322|NCT03129100|10786372|FG006|COMPLETED|Period 3 (Dose Escalation)||0
9686323|NCT03129100|10786373|FG007|COMPLETED|Period 3 (Dose Escalation)||0
9686324|NCT03129100|10786374|FG008|COMPLETED|Period 3 (Dose Escalation)||0
9686325|NCT03129100|10786375|FG009|COMPLETED|Period 3 (Dose Escalation)||0
9686326|NCT03129100|10786376|FG010|COMPLETED|Period 3 (Dose Escalation)||0
9686327|NCT03129100|10786377|FG011|COMPLETED|Period 3 (Dose Escalation)||0
9686328|NCT03129100|10786378|FG012|COMPLETED|Period 3 (Dose Escalation)||0
9686329|NCT03129100|10786379|FG013|COMPLETED|Period 3 (Dose Escalation)||0
9686330|NCT03129100|10786380|FG014|COMPLETED|Period 3 (Dose Escalation)||0
9686331|NCT03129100|10786381|FG015|COMPLETED|Period 3 (Dose Escalation)||0
9686332|NCT03129100|10786382|FG016|COMPLETED|Period 3 (Dose Escalation)||0
9686333|NCT03129100|10786383|FG017|COMPLETED|Period 3 (Dose Escalation)||0
9686334|NCT03129100|10786384|FG018|COMPLETED|Period 3 (Dose Escalation)||0
9686335|NCT03129100|10786385|FG019|COMPLETED|Period 3 (Dose Escalation)||0
9686336|NCT03129100|10786386|FG020|COMPLETED|Period 3 (Dose Escalation)||73
9686337|NCT03129100|10786387|FG021|COMPLETED|Period 3 (Dose Escalation)||5
9686338|NCT03129100|10786388|FG022|COMPLETED|Period 3 (Dose Escalation)||4
9686339|NCT03129100|10786389|FG023|COMPLETED|Period 3 (Dose Escalation)||0
9686340|NCT03129100|10786390|FG024|COMPLETED|Period 3 (Dose Escalation)||0
9686341|NCT03129100|10786391|FG025|COMPLETED|Period 3 (Dose Escalation)||0
9686342|NCT03129100|10786366|FG000|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686343|NCT03129100|10786367|FG001|NOT COMPLETED|Period 3 (Dose Escalation)||0
9845157|NCT00841100|10957264|FG000|STARTED|Acute Component (24 Hours)||21
9686344|NCT03129100|10786368|FG002|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686345|NCT03129100|10786369|FG003|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686346|NCT03129100|10786370|FG004|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686347|NCT03129100|10786371|FG005|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686348|NCT03129100|10786372|FG006|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686349|NCT03129100|10786373|FG007|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686350|NCT03129100|10786374|FG008|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686351|NCT03129100|10786375|FG009|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686352|NCT03129100|10786376|FG010|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686353|NCT03129100|10786377|FG011|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686354|NCT03129100|10786378|FG012|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686355|NCT03129100|10786379|FG013|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686356|NCT03129100|10786380|FG014|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686357|NCT03129100|10786381|FG015|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686358|NCT03129100|10786382|FG016|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686359|NCT03129100|10786383|FG017|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686360|NCT03129100|10786384|FG018|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686361|NCT03129100|10786385|FG019|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686362|NCT03129100|10786386|FG020|NOT COMPLETED|Period 3 (Dose Escalation)||4
9686363|NCT03129100|10786387|FG021|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686364|NCT03129100|10786388|FG022|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686365|NCT03129100|10786389|FG023|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686366|NCT03129100|10786390|FG024|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686367|NCT03129100|10786391|FG025|NOT COMPLETED|Period 3 (Dose Escalation)||0
9686368|NCT03129100|10786366|FG000|STARTED|Period 4 (Post Treatment Follow-up)||0
9686369|NCT03129100|10786367|FG001|STARTED|Period 4 (Post Treatment Follow-up)||0
9686370|NCT03129100|10786368|FG002|STARTED|Period 4 (Post Treatment Follow-up)||0
9686371|NCT03129100|10786369|FG003|STARTED|Period 4 (Post Treatment Follow-up)||0
9686372|NCT03129100|10786370|FG004|STARTED|Period 4 (Post Treatment Follow-up)||0
9686373|NCT03129100|10786371|FG005|STARTED|Period 4 (Post Treatment Follow-up)||0
9686374|NCT03129100|10786372|FG006|STARTED|Period 4 (Post Treatment Follow-up)||0
9686375|NCT03129100|10786373|FG007|STARTED|Period 4 (Post Treatment Follow-up)||0
9686376|NCT03129100|10786374|FG008|STARTED|Period 4 (Post Treatment Follow-up)||0
9686377|NCT03129100|10786375|FG009|STARTED|Period 4 (Post Treatment Follow-up)||0
9686378|NCT03129100|10786376|FG010|STARTED|Period 4 (Post Treatment Follow-up)||0
9686379|NCT03129100|10786377|FG011|STARTED|Period 4 (Post Treatment Follow-up)||0
9686380|NCT03129100|10786378|FG012|STARTED|Period 4 (Post Treatment Follow-up)||0
9686381|NCT03129100|10786379|FG013|STARTED|Period 4 (Post Treatment Follow-up)||0
9686382|NCT03129100|10786380|FG014|STARTED|Period 4 (Post Treatment Follow-up)||0
9686383|NCT03129100|10786381|FG015|STARTED|Period 4 (Post Treatment Follow-up)||0
9686384|NCT03129100|10786382|FG016|STARTED|Period 4 (Post Treatment Follow-up)||0
9686385|NCT03129100|10786383|FG017|STARTED|Period 4 (Post Treatment Follow-up)||0
9686386|NCT03129100|10786384|FG018|STARTED|Period 4 (Post Treatment Follow-up)||0
9686387|NCT03129100|10786385|FG019|STARTED|Period 4 (Post Treatment Follow-up)||0
9686388|NCT03129100|10786386|FG020|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
9686389|NCT03129100|10786387|FG021|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
9686390|NCT03129100|10786388|FG022|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
9686391|NCT03129100|10786389|FG023|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|25
9686392|NCT03129100|10786390|FG024|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|223
9686393|NCT03129100|10786391|FG025|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|453
9686394|NCT03129100|10786366|FG000|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686395|NCT03129100|10786367|FG001|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686396|NCT03129100|10786368|FG002|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686397|NCT03129100|10786369|FG003|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686398|NCT03129100|10786370|FG004|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686399|NCT03129100|10786371|FG005|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686400|NCT03129100|10786372|FG006|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686401|NCT03129100|10786373|FG007|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686402|NCT03129100|10786374|FG008|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686403|NCT03129100|10786375|FG009|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686404|NCT03129100|10786376|FG010|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686405|NCT03129100|10786377|FG011|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686406|NCT03129100|10786378|FG012|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686407|NCT03129100|10786379|FG013|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686408|NCT03129100|10786380|FG014|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686409|NCT03129100|10786381|FG015|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686410|NCT03129100|10786382|FG016|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686411|NCT03129100|10786383|FG017|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686412|NCT03129100|10786384|FG018|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686413|NCT03129100|10786385|FG019|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686414|NCT03129100|10786386|FG020|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686415|NCT03129100|10786387|FG021|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686416|NCT03129100|10786388|FG022|COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686417|NCT03129100|10786389|FG023|COMPLETED|Period 4 (Post Treatment Follow-up)||22
9686418|NCT03129100|10786390|FG024|COMPLETED|Period 4 (Post Treatment Follow-up)||198
9686419|NCT03129100|10786391|FG025|COMPLETED|Period 4 (Post Treatment Follow-up)||411
9686420|NCT03129100|10786366|FG000|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9845158|NCT00841100|10957264|FG000|COMPLETED|Acute Component (24 Hours)||21
9845159|NCT00841100|10957264|FG000|NOT COMPLETED|Acute Component (24 Hours)||0
9845160|NCT00841100|10957264|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
9845161|NCT00841100|10957264|FG000|COMPLETED|Phase 1 (28 Days)||15
9845162|NCT00841100|10957264|FG000|NOT COMPLETED|Phase 1 (28 Days)||3
9845163|NCT00841100|10957264|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
9845164|NCT00841100|10957264|FG000|COMPLETED|Phase 2 (2 Weeks)||5
9845165|NCT00841100|10957264|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0
9845166|NCT00841100|10957264|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
9845167|NCT00841100|10957264|FG000|COMPLETED|Phase 3 (28 Days)||4
9845168|NCT00841100|10957264|FG000|NOT COMPLETED|Phase 3 (28 Days)||0
9845169|NCT00841204|10957270|FG000|STARTED|Overall Study||25
9845170|NCT00841204|10957271|FG001|STARTED|Overall Study||25
9845171|NCT00841204|10957270|FG000|COMPLETED|Overall Study||25
9845172|NCT00841204|10957271|FG001|COMPLETED|Overall Study||25
9845173|NCT00841204|10957270|FG000|NOT COMPLETED|Overall Study||0
9845174|NCT00841204|10957271|FG001|NOT COMPLETED|Overall Study||0
9845175|NCT00841269|10957281|FG000|STARTED|Overall Study||20
9845176|NCT00841269|10957282|FG001|STARTED|Overall Study||22
9845177|NCT00841269|10957281|FG000|COMPLETED|Overall Study||12
9845178|NCT00841269|10957282|FG001|COMPLETED|Overall Study||13
9845179|NCT00841269|10957281|FG000|NOT COMPLETED|Overall Study||8
9845180|NCT00841269|10957282|FG001|NOT COMPLETED|Overall Study||9
9845181|NCT00841321|10957289|FG000|STARTED|Overall Study||59
9845182|NCT00841321|10957290|FG001|STARTED|Overall Study||61
9845183|NCT00841321|10957289|FG000|COMPLETED|Overall Study||58
9845184|NCT00841321|10957290|FG001|COMPLETED|Overall Study||58
9845185|NCT00841321|10957289|FG000|NOT COMPLETED|Overall Study||1
9845186|NCT00841321|10957290|FG001|NOT COMPLETED|Overall Study||3
9845187|NCT00841412|10957298|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
9845188|NCT00841412|10957299|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
9845189|NCT00841412|10957298|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
9845190|NCT00841412|10957299|FG001|COMPLETED|Overall Study||50
9845191|NCT00841412|10957298|FG000|NOT COMPLETED|Overall Study||40
9845192|NCT00841412|10957299|FG001|NOT COMPLETED|Overall Study||30
9845193|NCT00841555|10957306|FG000|STARTED|Overall Study||3
9845194|NCT00841555|10957307|FG001|STARTED|Overall Study||3
9845195|NCT00841555|10957308|FG002|STARTED|Overall Study||3
9845196|NCT00841555|10957306|FG000|COMPLETED|Overall Study||3
9845197|NCT00841555|10957307|FG001|COMPLETED|Overall Study||3
9845198|NCT00841555|10957308|FG002|COMPLETED|Overall Study||3
9845199|NCT00841555|10957306|FG000|NOT COMPLETED|Overall Study||0
9845200|NCT00841555|10957307|FG001|NOT COMPLETED|Overall Study||0
9845201|NCT00841555|10957308|FG002|NOT COMPLETED|Overall Study||0
9845202|NCT00841568|10957314|FG000|STARTED|Overall Study||17
9845203|NCT00841568|10957314|FG000|COMPLETED|Overall Study||12
9845204|NCT00841568|10957314|FG000|NOT COMPLETED|Overall Study||5
9845205|NCT00841672|10957324|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
9845206|NCT00841672|10957325|FG001|STARTED|Overall Study||241
9845207|NCT00841672|10957324|FG000|COMPLETED|Overall Study||224
9845208|NCT00841672|10957325|FG001|COMPLETED|Overall Study||209
9845209|NCT00841672|10957324|FG000|NOT COMPLETED|Overall Study||20
9845210|NCT00841672|10957325|FG001|NOT COMPLETED|Overall Study||32
9845211|NCT00841763|10957333|FG000|STARTED|Overall Study||2691
9845212|NCT00841763|10957334|FG001|STARTED|Overall Study||681
9845213|NCT00841763|10957335|FG002|STARTED|Overall Study||219
9845214|NCT00841763|10957336|FG003|STARTED|Overall Study||56
9845215|NCT00841763|10957333|FG000|COMPLETED|Overall Study||2529
9845216|NCT00841763|10957334|FG001|COMPLETED|Overall Study||624
9686421|NCT03129100|10786367|FG001|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686422|NCT03129100|10786368|FG002|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686423|NCT03129100|10786369|FG003|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686424|NCT03129100|10786370|FG004|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686425|NCT03129100|10786371|FG005|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686426|NCT03129100|10786372|FG006|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686427|NCT03129100|10786373|FG007|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686428|NCT03129100|10786374|FG008|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686429|NCT03129100|10786375|FG009|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686430|NCT03129100|10786376|FG010|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686431|NCT03129100|10786377|FG011|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686432|NCT03129100|10786378|FG012|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686433|NCT03129100|10786379|FG013|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686434|NCT03129100|10786380|FG014|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686435|NCT03129100|10786381|FG015|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686436|NCT03129100|10786382|FG016|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9845217|NCT00841763|10957335|FG002|COMPLETED|Overall Study||211
9686437|NCT03129100|10786383|FG017|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686438|NCT03129100|10786384|FG018|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686439|NCT03129100|10786385|FG019|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686440|NCT03129100|10786386|FG020|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686441|NCT03129100|10786387|FG021|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686442|NCT03129100|10786388|FG022|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
9686443|NCT03129100|10786389|FG023|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||3
9686444|NCT03129100|10786390|FG024|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||25
9686445|NCT03129100|10786391|FG025|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||42
9686446|NCT02921763|10786428|FG000|STARTED|Overall Study||60
9686447|NCT02921763|10786428|FG000|COMPLETED|Overall Study||42
9686448|NCT02921763|10786428|FG000|NOT COMPLETED|Overall Study||18
9686449|NCT02831257|10786446|FG000|STARTED|Overall Study||18
9686450|NCT02831257|10786446|FG000|COMPLETED|Overall Study||6
9686451|NCT02831257|10786446|FG000|NOT COMPLETED|Overall Study||12
9686452|NCT02775903|10786454|FG000|STARTED|Overall Study||42
9686453|NCT02775903|10786455|FG001|STARTED|Overall Study||42
9686454|NCT02775903|10786456|FG002|STARTED|Overall Study||64
9686455|NCT02775903|10786457|FG003|STARTED|Overall Study||65
9686456|NCT02775903|10786454|FG000|Received Study Treatment|Overall Study||38
9686457|NCT02775903|10786455|FG001|Received Study Treatment|Overall Study||41
9686458|NCT02775903|10786456|FG002|Received Study Treatment|Overall Study||64
9686459|NCT02775903|10786457|FG003|Received Study Treatment|Overall Study||62
9686460|NCT02775903|10786454|FG000|COMPLETED|Overall Study||0
9686461|NCT02775903|10786455|FG001|COMPLETED|Overall Study||1
9686462|NCT02775903|10786456|FG002|COMPLETED|Overall Study||0
9686463|NCT02775903|10786457|FG003|COMPLETED|Overall Study||0
9686464|NCT02775903|10786454|FG000|NOT COMPLETED|Overall Study||42
9686465|NCT02775903|10786455|FG001|NOT COMPLETED|Overall Study||41
9686466|NCT02775903|10786456|FG002|NOT COMPLETED|Overall Study||64
9686467|NCT02775903|10786457|FG003|NOT COMPLETED|Overall Study||65
9686468|NCT02476916|10786473|FG000|STARTED|Core Period||27
9686469|NCT02476916|10786474|FG001|STARTED|Core Period||25
9686470|NCT02476916|10786473|FG000|COMPLETED|Core Period||21
9686471|NCT02476916|10786474|FG001|COMPLETED|Core Period||22
9686472|NCT02476916|10786473|FG000|NOT COMPLETED|Core Period||6
9686473|NCT02476916|10786474|FG001|NOT COMPLETED|Core Period||3
9686474|NCT02476916|10786473|FG000|STARTED|Extension Period||18
9686475|NCT02476916|10786474|FG001|STARTED|Extension Period||18
10023629|NCT01857232|11147330|FG003|Evaluable ITT|Overall Study||68
10023630|NCT01857232|11147331|FG004|Evaluable ITT|Overall Study||65
10023631|NCT01857232|11147327|FG000|COMPLETED|Overall Study||61
10023632|NCT01857232|11147328|FG001|COMPLETED|Overall Study||65
9686476|NCT02476916|10786473|FG000|COMPLETED|Extension Period||0
9686477|NCT02476916|10786474|FG001|COMPLETED|Extension Period||0
9686478|NCT02476916|10786473|FG000|NOT COMPLETED|Extension Period||18
9686479|NCT02476916|10786474|FG001|NOT COMPLETED|Extension Period||18
9686480|NCT02406027|10786484|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35
9686481|NCT02406027|10786485|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29
9686482|NCT02406027|10786486|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26
9686483|NCT02406027|10786487|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0
9686484|NCT02406027|10786488|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0
9686485|NCT02406027|10786489|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0
9686486|NCT02406027|10786490|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0
9686487|NCT02406027|10786484|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
10023633|NCT01857232|11147329|FG002|COMPLETED|Overall Study||63
10023634|NCT01857232|11147330|FG003|COMPLETED|Overall Study||68
9686488|NCT02406027|10786485|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
9686489|NCT02406027|10786486|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
9686490|NCT02406027|10786487|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
9686491|NCT02406027|10786488|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
9686492|NCT02406027|10786489|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
9686493|NCT02406027|10786490|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
9686494|NCT02406027|10786484|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29
9686495|NCT02406027|10786485|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21
9686496|NCT02406027|10786486|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20
9686497|NCT02406027|10786487|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0
9686498|NCT02406027|10786488|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0
9686499|NCT02406027|10786489|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0
9686500|NCT02406027|10786490|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0
9686501|NCT02406027|10786484|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29
9686502|NCT02406027|10786485|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26
9686503|NCT02406027|10786486|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22
9686504|NCT02406027|10786487|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686505|NCT02406027|10786488|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686506|NCT02406027|10786489|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686507|NCT02406027|10786490|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686508|NCT02406027|10786484|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
9686509|NCT02406027|10786485|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
9686510|NCT02406027|10786486|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
9686511|NCT02406027|10786487|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686512|NCT02406027|10786488|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686513|NCT02406027|10786489|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686514|NCT02406027|10786490|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
9686515|NCT02406027|10786484|FG000|STARTED|Open-label Phase (Period 2)||0
9686516|NCT02406027|10786485|FG001|STARTED|Open-label Phase (Period 2)||0
9686517|NCT02406027|10786486|FG002|STARTED|Open-label Phase (Period 2)||0
9686518|NCT02406027|10786487|FG003|STARTED|Open-label Phase (Period 2)||15
9686519|NCT02406027|10786488|FG004|STARTED|Open-label Phase (Period 2)||14
9686520|NCT02406027|10786489|FG005|STARTED|Open-label Phase (Period 2)||26
9686521|NCT02406027|10786490|FG006|STARTED|Open-label Phase (Period 2)||22
9686522|NCT02406027|10786484|FG000|COMPLETED|Open-label Phase (Period 2)||0
9686523|NCT02406027|10786485|FG001|COMPLETED|Open-label Phase (Period 2)||0
9686524|NCT02406027|10786486|FG002|COMPLETED|Open-label Phase (Period 2)||0
9686525|NCT02406027|10786487|FG003|COMPLETED|Open-label Phase (Period 2)||0
9686526|NCT02406027|10786488|FG004|COMPLETED|Open-label Phase (Period 2)||0
9686527|NCT02406027|10786489|FG005|COMPLETED|Open-label Phase (Period 2)||0
9686528|NCT02406027|10786490|FG006|COMPLETED|Open-label Phase (Period 2)||0
9686529|NCT02406027|10786484|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0
9686530|NCT02406027|10786485|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0
9686531|NCT02406027|10786486|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0
9686532|NCT02406027|10786487|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15
9686533|NCT02406027|10786488|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14
9686534|NCT02406027|10786489|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26
9686535|NCT02406027|10786490|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22
9686536|NCT02374814|10786512|FG000|STARTED|Overall Study||12
9686537|NCT02374814|10786513|FG001|STARTED|Overall Study||12
9686538|NCT02374814|10786514|FG002|STARTED|Overall Study||12
9686539|NCT02374814|10786515|FG003|STARTED|Overall Study||11
9686540|NCT02374814|10786516|FG004|STARTED|Overall Study||6
9686541|NCT02374814|10786517|FG005|STARTED|Overall Study||6
9686542|NCT02374814|10786512|FG000|COMPLETED|Overall Study||11
9686543|NCT02374814|10786513|FG001|COMPLETED|Overall Study||11
9686544|NCT02374814|10786514|FG002|COMPLETED|Overall Study||11
9686545|NCT02374814|10786515|FG003|COMPLETED|Overall Study||9
9686546|NCT02374814|10786516|FG004|COMPLETED|Overall Study||6
9686547|NCT02374814|10786517|FG005|COMPLETED|Overall Study||6
9686548|NCT02374814|10786512|FG000|NOT COMPLETED|Overall Study||1
9686549|NCT02374814|10786513|FG001|NOT COMPLETED|Overall Study||1
9686550|NCT02374814|10786514|FG002|NOT COMPLETED|Overall Study||1
9686551|NCT02374814|10786515|FG003|NOT COMPLETED|Overall Study||2
9686552|NCT02374814|10786516|FG004|NOT COMPLETED|Overall Study||0
9686553|NCT02374814|10786517|FG005|NOT COMPLETED|Overall Study||0
9686554|NCT02142738|10786541|FG000|STARTED|Overall Study||154
9686555|NCT02142738|10786542|FG001|STARTED|Overall Study||151
9686556|NCT02142738|10786541|FG000|Treated|Overall Study||154
9686557|NCT02142738|10786542|FG001|Treated|Overall Study||150
9686558|NCT02142738|10786541|FG000|Chemotherapy Switch to Pembrolizumab|Overall Study||0
9686559|NCT02142738|10786542|FG001|Chemotherapy Switch to Pembrolizumab|Overall Study||83
9686560|NCT02142738|10786541|FG000|Second Course Pembrolizumab|Overall Study||12
9686561|NCT02142738|10786542|FG001|Second Course Pembrolizumab|Overall Study||1
9686562|NCT02142738|10786541|FG000|COMPLETED|Overall Study||0
9686563|NCT02142738|10786542|FG001|COMPLETED|Overall Study||0
9686564|NCT02142738|10786541|FG000|NOT COMPLETED|Overall Study||154
9686565|NCT02142738|10786542|FG001|NOT COMPLETED|Overall Study||151
9686566|NCT02032823|10786553|FG000|STARTED|Overall Study||921
9686567|NCT02032823|10786554|FG001|STARTED|Overall Study||915
9686568|NCT02032823|10786553|FG000|COMPLETED|Overall Study||0
9686569|NCT02032823|10786554|FG001|COMPLETED|Overall Study||0
9686570|NCT02032823|10786553|FG000|NOT COMPLETED|Overall Study||921
9686571|NCT02032823|10786554|FG001|NOT COMPLETED|Overall Study||915
9686572|NCT02005172|10786560|FG000|STARTED|Overall Study||33
9686573|NCT02005172|10786560|FG000|ITT|Overall Study||38
9686574|NCT02005172|10786560|FG000|COMPLETED|Overall Study||33
9686575|NCT02005172|10786560|FG000|NOT COMPLETED|Overall Study||0
9686576|NCT01931709|10786565|FG000|STARTED|Overall Study||35
9686577|NCT01931709|10786565|FG000|COMPLETED|Overall Study||35
9686578|NCT01931709|10786565|FG000|NOT COMPLETED|Overall Study||0
9686579|NCT01667133|10786583|FG000|STARTED|Phase 1: Dose-escalation||1
9686580|NCT01667133|10786584|FG001|STARTED|Phase 1: Dose-escalation||1
9686581|NCT01667133|10786585|FG002|STARTED|Phase 1: Dose-escalation||4
9686582|NCT01667133|10786586|FG003|STARTED|Phase 1: Dose-escalation||3
9686583|NCT01667133|10786587|FG004|STARTED|Phase 1: Dose-escalation||1
9686584|NCT01667133|10786588|FG005|STARTED|Phase 1: Dose-escalation||1
9686585|NCT01667133|10786589|FG006|STARTED|Phase 1: Dose-escalation||1
9686586|NCT01667133|10786590|FG007|STARTED|Phase 1: Dose-escalation||0
9686587|NCT01667133|10786591|FG008|STARTED|Phase 1: Dose-escalation||0
9686588|NCT01667133|10786592|FG009|STARTED|Phase 1: Dose-escalation||0
9686589|NCT01667133|10786593|FG010|STARTED|Phase 1: Dose-escalation||0
9686590|NCT01667133|10786594|FG011|STARTED|Phase 1: Dose-escalation||0
9686591|NCT01667133|10786583|FG000|COMPLETED|Phase 1: Dose-escalation||1
9686592|NCT01667133|10786584|FG001|COMPLETED|Phase 1: Dose-escalation||0
9686593|NCT01667133|10786585|FG002|COMPLETED|Phase 1: Dose-escalation||0
9686594|NCT01667133|10786586|FG003|COMPLETED|Phase 1: Dose-escalation||2
9686595|NCT01667133|10786587|FG004|COMPLETED|Phase 1: Dose-escalation||0
9686596|NCT01667133|10786588|FG005|COMPLETED|Phase 1: Dose-escalation||0
9686597|NCT01667133|10786589|FG006|COMPLETED|Phase 1: Dose-escalation||0
9686598|NCT01667133|10786590|FG007|COMPLETED|Phase 1: Dose-escalation||0
9686599|NCT01667133|10786591|FG008|COMPLETED|Phase 1: Dose-escalation||0
9845218|NCT00841763|10957336|FG003|COMPLETED|Overall Study||53
9845219|NCT00841763|10957333|FG000|NOT COMPLETED|Overall Study||162
9845220|NCT00841763|10957334|FG001|NOT COMPLETED|Overall Study||57
9845221|NCT00841763|10957335|FG002|NOT COMPLETED|Overall Study||8
9845222|NCT00841763|10957336|FG003|NOT COMPLETED|Overall Study||3
9845223|NCT00841776|10957383|FG000|STARTED|Overall Study||27
9845224|NCT00841776|10957384|FG001|STARTED|Overall Study||27
9845225|NCT00841776|10957383|FG000|COMPLETED|Overall Study||25
9845226|NCT00841776|10957384|FG001|COMPLETED|Overall Study||24
9845227|NCT00841776|10957383|FG000|NOT COMPLETED|Overall Study||2
9845228|NCT00841776|10957384|FG001|NOT COMPLETED|Overall Study||3
9845229|NCT00841828|10957392|FG000|STARTED|Overall Study||52
9845230|NCT00841828|10957393|FG001|STARTED|Overall Study||50
9845231|NCT00841828|10957392|FG000|COMPLETED|Overall Study||42
9845232|NCT00841828|10957393|FG001|COMPLETED|Overall Study||48
9845233|NCT00841828|10957392|FG000|NOT COMPLETED|Overall Study||10
9845234|NCT00841828|10957393|FG001|NOT COMPLETED|Overall Study||2
9845235|NCT00841906|10957403|FG000|STARTED|Overall Study||18
9845236|NCT00841906|10957404|FG001|STARTED|Overall Study||14
9845237|NCT00841906|10957403|FG000|COMPLETED|Overall Study||16
9845238|NCT00841906|10957404|FG001|COMPLETED|Overall Study||14
9845239|NCT00841906|10957403|FG000|NOT COMPLETED|Overall Study||2
9845240|NCT00841906|10957404|FG001|NOT COMPLETED|Overall Study||0
9845241|NCT00841971|10957414|FG000|STARTED|Overall Study||100
9845242|NCT00841971|10957415|FG001|STARTED|Overall Study||100
9845243|NCT00841971|10957414|FG000|COMPLETED|Overall Study||98
9960990|NCT01470781|11080683|FG000|Midpoint Assessment|Overall Study||30
9960991|NCT01470781|11080684|FG001|Midpoint Assessment|Overall Study||30
9960992|NCT01470781|11080683|FG000|Post-Treatment Assessment|Overall Study||22
9960993|NCT01470781|11080684|FG001|Post-Treatment Assessment|Overall Study||23
9960994|NCT01470781|11080683|FG000|COMPLETED|Overall Study||21
9960995|NCT01470781|11080684|FG001|COMPLETED|Overall Study||21
9960996|NCT01470781|11080683|FG000|NOT COMPLETED|Overall Study||18
9960997|NCT01470781|11080684|FG001|NOT COMPLETED|Overall Study||12
9960998|NCT01470859|11080693|FG000|STARTED|Overall Study||15
9960999|NCT01470859|11080694|FG001|STARTED|Overall Study||15
9961000|NCT01470859|11080693|FG000|COMPLETED|Overall Study||14
9961001|NCT01470859|11080694|FG001|COMPLETED|Overall Study||15
9961002|NCT01470859|11080693|FG000|NOT COMPLETED|Overall Study||1
9961003|NCT01470859|11080694|FG001|NOT COMPLETED|Overall Study||0
9686600|NCT01667133|10786592|FG009|COMPLETED|Phase 1: Dose-escalation||0
9686601|NCT01667133|10786593|FG010|COMPLETED|Phase 1: Dose-escalation||0
9686602|NCT01667133|10786594|FG011|COMPLETED|Phase 1: Dose-escalation||0
9686603|NCT01667133|10786583|FG000|NOT COMPLETED|Phase 1: Dose-escalation||0
9686604|NCT01667133|10786584|FG001|NOT COMPLETED|Phase 1: Dose-escalation||1
9686605|NCT01667133|10786585|FG002|NOT COMPLETED|Phase 1: Dose-escalation||4
9686606|NCT01667133|10786586|FG003|NOT COMPLETED|Phase 1: Dose-escalation||1
9686607|NCT01667133|10786587|FG004|NOT COMPLETED|Phase 1: Dose-escalation||1
9686608|NCT01667133|10786588|FG005|NOT COMPLETED|Phase 1: Dose-escalation||1
9961004|NCT01470989|11080702|FG000|STARTED|Overall Study||227
9686609|NCT01667133|10786589|FG006|NOT COMPLETED|Phase 1: Dose-escalation||1
9686610|NCT01667133|10786590|FG007|NOT COMPLETED|Phase 1: Dose-escalation||0
9845244|NCT00841971|10957415|FG001|COMPLETED|Overall Study||99
9845245|NCT00841971|10957414|FG000|NOT COMPLETED|Overall Study||2
9845246|NCT00841971|10957415|FG001|NOT COMPLETED|Overall Study||1
9845247|NCT00842023|10957423|FG000|STARTED|Overall Study||45
9961005|NCT01470989|11080703|FG001|STARTED|Overall Study||229
9961006|NCT01470989|11080702|FG000|Completed Core Study|Overall Study||208
9686611|NCT01667133|10786591|FG008|NOT COMPLETED|Phase 1: Dose-escalation||0
9686612|NCT01667133|10786592|FG009|NOT COMPLETED|Phase 1: Dose-escalation||0
9686613|NCT01667133|10786593|FG010|NOT COMPLETED|Phase 1: Dose-escalation||0
9686614|NCT01667133|10786594|FG011|NOT COMPLETED|Phase 1: Dose-escalation||0
9686615|NCT01667133|10786583|FG000|STARTED|Phase 2: Dose-expansion||0
9686616|NCT01667133|10786584|FG001|STARTED|Phase 2: Dose-expansion||0
9686617|NCT01667133|10786585|FG002|STARTED|Phase 2: Dose-expansion||0
9686618|NCT01667133|10786586|FG003|STARTED|Phase 2: Dose-expansion||0
9686619|NCT01667133|10786587|FG004|STARTED|Phase 2: Dose-expansion||0
9686620|NCT01667133|10786588|FG005|STARTED|Phase 2: Dose-expansion||0
9686621|NCT01667133|10786589|FG006|STARTED|Phase 2: Dose-expansion||0
9686622|NCT01667133|10786590|FG007|STARTED|Phase 2: Dose-expansion||2
9686623|NCT01667133|10786591|FG008|STARTED|Phase 2: Dose-expansion||1
9686624|NCT01667133|10786592|FG009|STARTED|Phase 2: Dose-expansion||11
9686625|NCT01667133|10786593|FG010|STARTED|Phase 2: Dose-expansion||3
9686626|NCT01667133|10786594|FG011|STARTED|Phase 2: Dose-expansion||6
9686627|NCT01667133|10786583|FG000|COMPLETED|Phase 2: Dose-expansion||0
9686628|NCT01667133|10786584|FG001|COMPLETED|Phase 2: Dose-expansion||0
9686629|NCT01667133|10786585|FG002|COMPLETED|Phase 2: Dose-expansion||0
9686630|NCT01667133|10786586|FG003|COMPLETED|Phase 2: Dose-expansion||0
9686631|NCT01667133|10786587|FG004|COMPLETED|Phase 2: Dose-expansion||0
9686632|NCT01667133|10786588|FG005|COMPLETED|Phase 2: Dose-expansion||0
9686633|NCT01667133|10786589|FG006|COMPLETED|Phase 2: Dose-expansion||0
9686634|NCT01667133|10786590|FG007|COMPLETED|Phase 2: Dose-expansion||0
9686635|NCT01667133|10786591|FG008|COMPLETED|Phase 2: Dose-expansion||0
9686636|NCT01667133|10786592|FG009|COMPLETED|Phase 2: Dose-expansion||5
9686637|NCT01667133|10786593|FG010|COMPLETED|Phase 2: Dose-expansion||0
9686638|NCT01667133|10786594|FG011|COMPLETED|Phase 2: Dose-expansion||0
9686639|NCT01667133|10786583|FG000|NOT COMPLETED|Phase 2: Dose-expansion||0
9686640|NCT01667133|10786584|FG001|NOT COMPLETED|Phase 2: Dose-expansion||0
9686641|NCT01667133|10786585|FG002|NOT COMPLETED|Phase 2: Dose-expansion||0
9686642|NCT01667133|10786586|FG003|NOT COMPLETED|Phase 2: Dose-expansion||0
9686643|NCT01667133|10786587|FG004|NOT COMPLETED|Phase 2: Dose-expansion||0
9686644|NCT01667133|10786588|FG005|NOT COMPLETED|Phase 2: Dose-expansion||0
9686645|NCT01667133|10786589|FG006|NOT COMPLETED|Phase 2: Dose-expansion||0
9686646|NCT01667133|10786590|FG007|NOT COMPLETED|Phase 2: Dose-expansion||2
9686647|NCT01667133|10786591|FG008|NOT COMPLETED|Phase 2: Dose-expansion||1
9686648|NCT01667133|10786592|FG009|NOT COMPLETED|Phase 2: Dose-expansion||6
9686649|NCT01667133|10786593|FG010|NOT COMPLETED|Phase 2: Dose-expansion||3
9686650|NCT01667133|10786594|FG011|NOT COMPLETED|Phase 2: Dose-expansion||6
9686651|NCT01585103|10786655|FG000|STARTED|Overall Study||86
9686652|NCT01585103|10786655|FG000|COMPLETED|Overall Study||80
9686653|NCT01585103|10786655|FG000|NOT COMPLETED|Overall Study||6
9686654|NCT01427725|10786659|FG000|STARTED|Overall Study||579
9686655|NCT01427725|10786659|FG000|Collected CRFs|Overall Study|Not collected Case Report Forms (CRFs) of 17 patients.|562
9686656|NCT01427725|10786659|FG000|Safety Analysis Set|Overall Study|Analysis of safety data. 9 patients dropped out, could not confirm existence of Adverse Events.|553
9686657|NCT01427725|10786659|FG000|COMPLETED|Overall Study|Among the patients in the safety analysis set, 175 patients discontinued the survey.|378
9686658|NCT01427725|10786659|FG000|NOT COMPLETED|Overall Study||201
9686659|NCT00921115|10786664|FG000|STARTED|Overall Study||42
9686660|NCT00921115|10786664|FG000|COMPLETED|Overall Study||42
9686661|NCT00921115|10786664|FG000|NOT COMPLETED|Overall Study||0
9726120|NCT00098306|10825684|FG005|NOT COMPLETED|Open Label||0
9726121|NCT00098306|10825685|FG006|NOT COMPLETED|Open Label||0
9726122|NCT00098306|10825679|FG000|STARTED|Observational Phase||0
9726123|NCT00098306|10825680|FG001|STARTED|Observational Phase||0
9726124|NCT00098306|10825681|FG002|STARTED|Observational Phase||0
9726125|NCT00098306|10825682|FG003|STARTED|Observational Phase||0
10023635|NCT01857232|11147331|FG004|COMPLETED|Overall Study||63
10023636|NCT01857232|11147327|FG000|NOT COMPLETED|Overall Study||8
9726126|NCT00098306|10825683|FG004|STARTED|Observational Phase||0
9726127|NCT00098306|10825684|FG005|STARTED|Observational Phase||250
9726128|NCT00098306|10825685|FG006|STARTED|Observational Phase||81
9726129|NCT00098306|10825679|FG000|COMPLETED|Observational Phase||0
9726130|NCT00098306|10825680|FG001|COMPLETED|Observational Phase||0
9726131|NCT00098306|10825681|FG002|COMPLETED|Observational Phase||0
9726132|NCT00098306|10825682|FG003|COMPLETED|Observational Phase||0
9726133|NCT00098306|10825683|FG004|COMPLETED|Observational Phase||0
9726134|NCT00098306|10825684|FG005|COMPLETED|Observational Phase||204
9726135|NCT00098306|10825685|FG006|COMPLETED|Observational Phase||55
9726136|NCT00098306|10825679|FG000|NOT COMPLETED|Observational Phase||0
9726137|NCT00098306|10825680|FG001|NOT COMPLETED|Observational Phase||0
9726138|NCT00098306|10825681|FG002|NOT COMPLETED|Observational Phase||0
9726139|NCT00098306|10825682|FG003|NOT COMPLETED|Observational Phase||0
10023637|NCT01857232|11147328|FG001|NOT COMPLETED|Overall Study||2
9686662|NCT04608344|10786670|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14
9686663|NCT04608344|10786671|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13
9686664|NCT04608344|10786670|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13
9686665|NCT04608344|10786671|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12
9686666|NCT04608344|10786670|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
9686667|NCT04608344|10786671|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
9686668|NCT04608344|10786670|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13
9686669|NCT04608344|10786671|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12
9686670|NCT04608344|10786670|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13
9686671|NCT04608344|10786671|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12
9686672|NCT04608344|10786670|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
9686673|NCT04608344|10786671|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
9686674|NCT04569253|10786685|FG000|STARTED|Overall Study||65
9686675|NCT04569253|10786685|FG000|Control Flanks|Overall Study||65
9686676|NCT04569253|10786685|FG000|Treatment Flanks|Overall Study||65
9686677|NCT04569253|10786685|FG000|COMPLETED|Overall Study||57
9686678|NCT04569253|10786685|FG000|NOT COMPLETED|Overall Study||8
9686679|NCT04350372|10786690|FG000|STARTED|Overall Study||16
9686680|NCT04350372|10786690|FG000|COMPLETED|Overall Study||15
9686681|NCT04350372|10786690|FG000|NOT COMPLETED|Overall Study||1
9686682|NCT04343989|10786697|FG000|STARTED|Overall Study||78
9686683|NCT04343989|10786698|FG001|STARTED|Overall Study||26
9686684|NCT04343989|10786699|FG002|STARTED|Overall Study||74
9686685|NCT04343989|10786697|FG000|COMPLETED|Overall Study||78
9686686|NCT04343989|10786698|FG001|COMPLETED|Overall Study||26
9686687|NCT04343989|10786699|FG002|COMPLETED|Overall Study||74
9686688|NCT04343989|10786697|FG000|NOT COMPLETED|Overall Study||0
9686689|NCT04343989|10786698|FG001|NOT COMPLETED|Overall Study||0
9686690|NCT04343989|10786699|FG002|NOT COMPLETED|Overall Study||0
9686691|NCT04328077|10786711|FG000|STARTED|Overall Study||26
9686692|NCT04328077|10786712|FG001|STARTED|Overall Study||25
9686693|NCT04328077|10786713|FG002|STARTED|Overall Study||26
9686694|NCT04328077|10786714|FG003|STARTED|Overall Study||24
9845248|NCT00842023|10957424|FG001|STARTED|Overall Study||44
9845249|NCT00842023|10957423|FG000|COMPLETED|Overall Study||45
9845250|NCT00842023|10957424|FG001|COMPLETED|Overall Study||44
9845251|NCT00842023|10957423|FG000|NOT COMPLETED|Overall Study||0
9845252|NCT00842023|10957424|FG001|NOT COMPLETED|Overall Study||0
9845253|NCT00842075|10957435|FG000|STARTED|Overall Study||5
10114253|NCT02514889|11244962|FG001|STARTED|Follow-up Assessment Participation||98
10114254|NCT02514889|11244961|FG000|COMPLETED|Follow-up Assessment Participation||92
10114255|NCT02514889|11244962|FG001|COMPLETED|Follow-up Assessment Participation||86
10114256|NCT02514889|11244961|FG000|NOT COMPLETED|Follow-up Assessment Participation||10
10114257|NCT02514889|11244962|FG001|NOT COMPLETED|Follow-up Assessment Participation||12
10114258|NCT02515045|11244970|FG000|STARTED|Overall Study||29
10114259|NCT02515045|11244971|FG001|STARTED|Overall Study||30
10114260|NCT02515045|11244972|FG002|STARTED|Overall Study||59
10114261|NCT02515045|11244970|FG000|COMPLETED|Overall Study||29
10114262|NCT02515045|11244971|FG001|COMPLETED|Overall Study||26
10114263|NCT02515045|11244972|FG002|COMPLETED|Overall Study||55
9686695|NCT04328077|10786711|FG000|COMPLETED|Overall Study||26
9845254|NCT00842075|10957436|FG001|STARTED|Overall Study||5
9845255|NCT00842075|10957435|FG000|COMPLETED|Overall Study||5
9845256|NCT00842075|10957436|FG001|COMPLETED|Overall Study||5
9845257|NCT00842075|10957435|FG000|NOT COMPLETED|Overall Study||0
9845258|NCT00842075|10957436|FG001|NOT COMPLETED|Overall Study||0
9845259|NCT00842153|10957444|FG000|STARTED|Overall Study||28
9845260|NCT00842153|10957445|FG001|STARTED|Overall Study||30
9845261|NCT00842153|10957444|FG000|COMPLETED|Overall Study||27
9845262|NCT00842153|10957445|FG001|COMPLETED|Overall Study||27
10114264|NCT02515045|11244970|FG000|NOT COMPLETED|Overall Study||0
10114265|NCT02515045|11244971|FG001|NOT COMPLETED|Overall Study||4
9686696|NCT04328077|10786712|FG001|COMPLETED|Overall Study||23
9686697|NCT04328077|10786713|FG002|COMPLETED|Overall Study||25
9686698|NCT04328077|10786714|FG003|COMPLETED|Overall Study||21
9686699|NCT04328077|10786711|FG000|NOT COMPLETED|Overall Study||0
9686700|NCT04328077|10786712|FG001|NOT COMPLETED|Overall Study||2
9686701|NCT04328077|10786713|FG002|NOT COMPLETED|Overall Study||1
9686702|NCT04328077|10786714|FG003|NOT COMPLETED|Overall Study||3
9686703|NCT04249310|10786732|FG000|STARTED|Overall Study||1436
9686704|NCT04249310|10786733|FG001|STARTED|Overall Study||5352
9686705|NCT04249310|10786732|FG000|PS-matched Cohort|Overall Study||1412
9686706|NCT04249310|10786733|FG001|PS-matched Cohort|Overall Study||1412
9686707|NCT04249310|10786732|FG000|hdPS-matched Cohort|Overall Study||1302
9686708|NCT04249310|10786733|FG001|hdPS-matched Cohort|Overall Study||1302
9686709|NCT04249310|10786732|FG000|COMPLETED|Overall Study||1436
9686710|NCT04249310|10786733|FG001|COMPLETED|Overall Study||5352
9686711|NCT04249310|10786732|FG000|NOT COMPLETED|Overall Study||0
9686712|NCT04249310|10786733|FG001|NOT COMPLETED|Overall Study||0
9686713|NCT04234984|10786741|FG000|STARTED|Follow-up at 6 Weeks||61
9686714|NCT04234984|10786741|FG000|COMPLETED|Follow-up at 6 Weeks||59
9686715|NCT04234984|10786741|FG000|NOT COMPLETED|Follow-up at 6 Weeks||2
9686716|NCT04234984|10786741|FG000|STARTED|Follow-up at the Second Time Point||19
9686717|NCT04234984|10786741|FG000|COMPLETED|Follow-up at the Second Time Point||17
9845263|NCT00842153|10957444|FG000|NOT COMPLETED|Overall Study||1
9845264|NCT00842153|10957445|FG001|NOT COMPLETED|Overall Study||3
9845265|NCT00842231|10957451|FG000|STARTED|Overall Study||40
9845266|NCT00842231|10957451|FG000|COMPLETED|Overall Study||40
9686718|NCT04234984|10786741|FG000|NOT COMPLETED|Follow-up at the Second Time Point||2
9686719|NCT04227197|10786749|FG000|STARTED|Randomization||117
9686720|NCT04227197|10786750|FG001|STARTED|Randomization||113
9686721|NCT04227197|10786749|FG000|COMPLETED|Randomization||115
9686722|NCT04227197|10786750|FG001|COMPLETED|Randomization||113
9686723|NCT04227197|10786749|FG000|NOT COMPLETED|Randomization||2
9686724|NCT04227197|10786750|FG001|NOT COMPLETED|Randomization||0
9686725|NCT04227197|10786749|FG000|STARTED|Primary Care Provider (PCP) Visit||115
9686726|NCT04227197|10786750|FG001|STARTED|Primary Care Provider (PCP) Visit||113
9686727|NCT04227197|10786749|FG000|COMPLETED|Primary Care Provider (PCP) Visit||113
9686728|NCT04227197|10786750|FG001|COMPLETED|Primary Care Provider (PCP) Visit||113
9686729|NCT04227197|10786749|FG000|NOT COMPLETED|Primary Care Provider (PCP) Visit||2
9686730|NCT04227197|10786750|FG001|NOT COMPLETED|Primary Care Provider (PCP) Visit||0
9686731|NCT04227197|10786749|FG000|STARTED|2-week Follow-up Survey for Caregivers||113
9686732|NCT04227197|10786750|FG001|STARTED|2-week Follow-up Survey for Caregivers||113
9686733|NCT04227197|10786749|FG000|COMPLETED|2-week Follow-up Survey for Caregivers||101
9686734|NCT04227197|10786750|FG001|COMPLETED|2-week Follow-up Survey for Caregivers||108
9686735|NCT04227197|10786749|FG000|NOT COMPLETED|2-week Follow-up Survey for Caregivers||12
9686736|NCT04227197|10786750|FG001|NOT COMPLETED|2-week Follow-up Survey for Caregivers||5
9686737|NCT04227197|10786749|FG000|STARTED|2-week Follow-up Survey for PCP's||114
9686738|NCT04227197|10786750|FG001|STARTED|2-week Follow-up Survey for PCP's||113
9686739|NCT04227197|10786749|FG000|COMPLETED|2-week Follow-up Survey for PCP's||94
9845267|NCT00842231|10957451|FG000|NOT COMPLETED|Overall Study||0
9845268|NCT00842244|10957455|FG000|STARTED|Overall Study||22
9845269|NCT00842244|10957455|FG000|COMPLETED|Overall Study||1
9845270|NCT00842244|10957455|FG000|NOT COMPLETED|Overall Study||21
9845271|NCT00842257|10957462|FG000|STARTED|Overall Study||20
9845272|NCT00842257|10957462|FG000|COMPLETED|Overall Study||19
9845273|NCT00842257|10957462|FG000|NOT COMPLETED|Overall Study||1
9845274|NCT00842296|10957466|FG000|STARTED|Overall Study||326
9845275|NCT00842296|10957466|FG000|COMPLETED|Overall Study||326
9845276|NCT00842296|10957466|FG000|NOT COMPLETED|Overall Study||0
9845277|NCT00842309|10957472|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
9845278|NCT00842309|10957473|FG001|STARTED|Overall Study||14
9845279|NCT00842309|10957472|FG000|COMPLETED|Overall Study||11
9845280|NCT00842309|10957473|FG001|COMPLETED|Overall Study||13
9845281|NCT00842309|10957472|FG000|NOT COMPLETED|Overall Study||3
9845282|NCT00842309|10957473|FG001|NOT COMPLETED|Overall Study||1
9845283|NCT00842335|10957479|FG000|STARTED|Overall Study||18
9845284|NCT00842335|10957479|FG000|COMPLETED|Overall Study||18
9845285|NCT00842335|10957479|FG000|NOT COMPLETED|Overall Study||0
9845286|NCT00842348|10957487|FG000|STARTED|Patients Randomised in Study 726||101
9845287|NCT00842348|10957488|FG001|STARTED|Patients Randomised in Study 726||103
9845288|NCT00842348|10957487|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
9845289|NCT00842348|10957488|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
9845290|NCT00842348|10957487|FG000|NOT COMPLETED|Patients Randomised in Study 726||59
9845291|NCT00842348|10957488|FG001|NOT COMPLETED|Patients Randomised in Study 726||56
9845292|NCT00842348|10957487|FG000|STARTED|Study 729||42
9845293|NCT00842348|10957488|FG001|STARTED|Study 729||47
9845294|NCT00842348|10957487|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
9845295|NCT00842348|10957488|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
9845296|NCT00842348|10957487|FG000|NOT COMPLETED|Study 729||26
9845297|NCT00842348|10957488|FG001|NOT COMPLETED|Study 729||38
9845298|NCT00842361|10957500|FG000|STARTED|Overall Study||33
9845299|NCT00842361|10957501|FG001|STARTED|Overall Study||33
9845300|NCT00842361|10957500|FG000|Exposed|Overall Study||33
9845301|NCT00842361|10957501|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
9845302|NCT00842361|10957500|FG000|COMPLETED|Overall Study||32
9845303|NCT00842361|10957501|FG001|COMPLETED|Overall Study||31
9845304|NCT00842361|10957500|FG000|NOT COMPLETED|Overall Study||1
9845305|NCT00842361|10957501|FG001|NOT COMPLETED|Overall Study||2
9845306|NCT00842543|10957511|FG000|STARTED|Overall Study||13
9845307|NCT00842543|10957512|FG001|STARTED|Overall Study||5
9845308|NCT00842543|10957513|FG002|STARTED|Overall Study||13
9845309|NCT00842543|10957514|FG003|STARTED|Overall Study||8
9845310|NCT00842543|10957511|FG000|COMPLETED|Overall Study||11
9845311|NCT00842543|10957512|FG001|COMPLETED|Overall Study||5
9845312|NCT00842543|10957513|FG002|COMPLETED|Overall Study||10
9845313|NCT00842543|10957514|FG003|COMPLETED|Overall Study||4
9845314|NCT00842543|10957511|FG000|NOT COMPLETED|Overall Study||2
9845315|NCT00842543|10957512|FG001|NOT COMPLETED|Overall Study||0
9686740|NCT04227197|10786750|FG001|COMPLETED|2-week Follow-up Survey for PCP's||88
9686741|NCT04227197|10786749|FG000|NOT COMPLETED|2-week Follow-up Survey for PCP's||20
9686742|NCT04227197|10786750|FG001|NOT COMPLETED|2-week Follow-up Survey for PCP's||25
9686743|NCT04227197|10786749|FG000|STARTED|7-month Follow-up Survey for Caregivers||114
9686744|NCT04227197|10786750|FG001|STARTED|7-month Follow-up Survey for Caregivers||113
9686745|NCT04227197|10786749|FG000|COMPLETED|7-month Follow-up Survey for Caregivers||103
9686746|NCT04227197|10786750|FG001|COMPLETED|7-month Follow-up Survey for Caregivers||110
9686747|NCT04227197|10786749|FG000|NOT COMPLETED|7-month Follow-up Survey for Caregivers||11
9686748|NCT04227197|10786750|FG001|NOT COMPLETED|7-month Follow-up Survey for Caregivers||3
9686749|NCT04105725|10786761|FG000|STARTED|Primary Intervention||37
9686750|NCT04105725|10786762|FG001|STARTED|Primary Intervention||29
9686751|NCT04105725|10786761|FG000|COMPLETED|Primary Intervention||37
9686752|NCT04105725|10786762|FG001|COMPLETED|Primary Intervention||26
9686753|NCT04105725|10786761|FG000|NOT COMPLETED|Primary Intervention||0
9686754|NCT04105725|10786762|FG001|NOT COMPLETED|Primary Intervention||3
9686755|NCT04105725|10786761|FG000|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
9686756|NCT04105725|10786762|FG001|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
9686757|NCT04105725|10786761|FG000|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 1|36
9686758|NCT04105725|10786762|FG001|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 1|25
9686759|NCT04105725|10786761|FG000|NOT COMPLETED|Mini-Session Week 1||1
9686760|NCT04105725|10786762|FG001|NOT COMPLETED|Mini-Session Week 1||1
9686761|NCT04105725|10786761|FG000|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
9686762|NCT04105725|10786762|FG001|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
9686763|NCT04105725|10786761|FG000|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 2|34
9686764|NCT04105725|10786762|FG001|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 2|22
9686765|NCT04105725|10786761|FG000|NOT COMPLETED|Mini-Session Week 2||3
9686766|NCT04105725|10786762|FG001|NOT COMPLETED|Mini-Session Week 2||4
9686767|NCT04105725|10786761|FG000|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
9686768|NCT04105725|10786762|FG001|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
9686769|NCT04105725|10786761|FG000|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 3|34
9686770|NCT04105725|10786762|FG001|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 3|22
9686771|NCT04105725|10786761|FG000|NOT COMPLETED|Mini-Session Week 3||3
9686772|NCT04105725|10786762|FG001|NOT COMPLETED|Mini-Session Week 3||4
9686773|NCT04105725|10786761|FG000|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
9686774|NCT04105725|10786762|FG001|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
9686775|NCT04105725|10786761|FG000|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 4|35
9686776|NCT04105725|10786762|FG001|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 4|21
9686777|NCT04105725|10786761|FG000|NOT COMPLETED|Mini-Session Week 4||2
9686778|NCT04105725|10786762|FG001|NOT COMPLETED|Mini-Session Week 4||5
9686779|NCT04105725|10786761|FG000|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
9686780|NCT04105725|10786762|FG001|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
9686781|NCT04105725|10786761|FG000|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the Post-Intervention Survey|33
9726140|NCT00098306|10825683|FG004|NOT COMPLETED|Observational Phase||0
9686782|NCT04105725|10786762|FG001|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the Post-Intervention Survey|18
9686783|NCT04105725|10786761|FG000|NOT COMPLETED|Post-Intervention Survey||4
9686784|NCT04105725|10786762|FG001|NOT COMPLETED|Post-Intervention Survey||8
9686785|NCT04105725|10786761|FG000|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
9686786|NCT04105725|10786762|FG001|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
9686787|NCT04105725|10786761|FG000|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the 3-Month Follow-up Survey|33
9686788|NCT04105725|10786762|FG001|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the 3-Month Follow-up Survey|22
9686789|NCT04105725|10786761|FG000|NOT COMPLETED|3-Month Follow-up Survey||4
9686790|NCT04105725|10786762|FG001|NOT COMPLETED|3-Month Follow-up Survey||4
9686791|NCT04066023|10786771|FG000|STARTED|Overall Study||12
9686792|NCT04066023|10786772|FG001|STARTED|Overall Study||17
9686793|NCT04066023|10786773|FG002|STARTED|Overall Study||13
9686794|NCT04066023|10786771|FG000|COMPLETED|Overall Study||9
9686795|NCT04066023|10786772|FG001|COMPLETED|Overall Study||9
9686796|NCT04066023|10786773|FG002|COMPLETED|Overall Study||7
9686797|NCT04066023|10786771|FG000|NOT COMPLETED|Overall Study||3
9686798|NCT04066023|10786772|FG001|NOT COMPLETED|Overall Study||8
9686799|NCT04066023|10786773|FG002|NOT COMPLETED|Overall Study||6
9686800|NCT04011475|10786784|FG000|STARTED|Overall Study||239
9686801|NCT04011475|10786785|FG001|STARTED|Overall Study||937
9686802|NCT04011475|10786786|FG002|STARTED|Overall Study||441
9686803|NCT04011475|10786784|FG000|Propensity Score Matched Cohort|Overall Study||114
9686804|NCT04011475|10786785|FG001|Propensity Score Matched Cohort|Overall Study||114
9686805|NCT04011475|10786786|FG002|Propensity Score Matched Cohort|Overall Study||114
9686806|NCT04011475|10786784|FG000|COMPLETED|Overall Study||239
9686807|NCT04011475|10786785|FG001|COMPLETED|Overall Study||937
9686808|NCT04011475|10786786|FG002|COMPLETED|Overall Study||441
9686809|NCT04011475|10786784|FG000|NOT COMPLETED|Overall Study||0
9686810|NCT04011475|10786785|FG001|NOT COMPLETED|Overall Study||0
9686811|NCT04011475|10786786|FG002|NOT COMPLETED|Overall Study||0
9686812|NCT03994120|10786796|FG000|STARTED|Overall Study||7
9686813|NCT03994120|10786797|FG001|STARTED|Overall Study||6
9686814|NCT03994120|10786796|FG000|COMPLETED|Overall Study||4
9686815|NCT03994120|10786797|FG001|COMPLETED|Overall Study||5
9686816|NCT03994120|10786796|FG000|NOT COMPLETED|Overall Study||3
9686817|NCT03994120|10786797|FG001|NOT COMPLETED|Overall Study||1
9686818|NCT03882957|10786803|FG000|STARTED|Overall Study||92
9686819|NCT03882957|10786803|FG000|Participant Flow 1|Overall Study|participant flow sequence: video --> media multitask --> sustained attention|17
10023638|NCT01857232|11147329|FG002|NOT COMPLETED|Overall Study||4
10023639|NCT01857232|11147330|FG003|NOT COMPLETED|Overall Study||2
10023640|NCT01857232|11147331|FG004|NOT COMPLETED|Overall Study||6
10023641|NCT01857258|11147346|FG000|STARTED|First Intervention (3 h Postprandially)||8
10023642|NCT01857258|11147347|FG001|STARTED|First Intervention (3 h Postprandially)||7
10023643|NCT01857258|11147346|FG000|COMPLETED|First Intervention (3 h Postprandially)||8
10023644|NCT01857258|11147347|FG001|COMPLETED|First Intervention (3 h Postprandially)||7
10023645|NCT01857258|11147346|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0
10023646|NCT01857258|11147347|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0
9686820|NCT03882957|10786803|FG000|Participant Flow 2|Overall Study|participant flow sequence: video --> sustained attention -- media multitask|16
9686821|NCT03882957|10786803|FG000|Participant Flow 3|Overall Study|participant flow sequence: media multitask --> video --> sustained attention|13
9726141|NCT00098306|10825684|FG005|NOT COMPLETED|Observational Phase||46
9686822|NCT03882957|10786803|FG000|Participant Flow 4|Overall Study|participant flow sequence: sustained attention --> video -- media multitask|15
9686823|NCT03882957|10786803|FG000|Participant Flow 5|Overall Study|participant flow sequence: sustained attention --> media multitask --> video|16
9686824|NCT03882957|10786803|FG000|Participant Flow 6|Overall Study|participant flow 6: media multitask --> sustained attention --> video|14
9686825|NCT03882957|10786803|FG000|COMPLETED|Overall Study||91
9686826|NCT03882957|10786803|FG000|NOT COMPLETED|Overall Study||1
9686827|NCT03711500|10786816|FG000|STARTED|Overall Study||12
9686828|NCT03711500|10786817|FG001|STARTED|Overall Study||12
9686829|NCT03711500|10786818|FG002|STARTED|Overall Study||12
9686830|NCT03711500|10786819|FG003|STARTED|Overall Study||9
9686831|NCT03711500|10786816|FG000|COMPLETED|Overall Study||12
9686832|NCT03711500|10786817|FG001|COMPLETED|Overall Study|One subject completed 2 of three treatment sessions, with LOCF carried forward for analysis|11
9686833|NCT03711500|10786818|FG002|COMPLETED|Overall Study||12
9686834|NCT03711500|10786819|FG003|COMPLETED|Overall Study||9
9686835|NCT03711500|10786816|FG000|NOT COMPLETED|Overall Study||0
9686836|NCT03711500|10786817|FG001|NOT COMPLETED|Overall Study||1
9686837|NCT03711500|10786818|FG002|NOT COMPLETED|Overall Study||0
9686838|NCT03711500|10786819|FG003|NOT COMPLETED|Overall Study||0
9686839|NCT03639558|10786831|FG000|STARTED|Overall Study||52
9686840|NCT03639558|10786832|FG001|STARTED|Overall Study||48
9686841|NCT03639558|10786831|FG000|COMPLETED|Overall Study||51
9686842|NCT03639558|10786832|FG001|COMPLETED|Overall Study||43
9686843|NCT03639558|10786831|FG000|NOT COMPLETED|Overall Study||1
9686844|NCT03639558|10786832|FG001|NOT COMPLETED|Overall Study||5
9686845|NCT03630770|10786840|FG000|STARTED|Overall Study||4
9686846|NCT03630770|10786841|FG001|STARTED|Overall Study||8
9686847|NCT03630770|10786840|FG000|COMPLETED|Overall Study||4
9686848|NCT03630770|10786841|FG001|COMPLETED|Overall Study||8
9686849|NCT03630770|10786840|FG000|NOT COMPLETED|Overall Study||0
9686850|NCT03630770|10786841|FG001|NOT COMPLETED|Overall Study||0
9845316|NCT00842543|10957513|FG002|NOT COMPLETED|Overall Study||3
9845317|NCT00842543|10957514|FG003|NOT COMPLETED|Overall Study||4
9845318|NCT00842608|10957530|FG000|STARTED|Overall Study||174
9845319|NCT00842608|10957531|FG001|STARTED|Overall Study||177
9845320|NCT00842608|10957532|FG002|STARTED|Overall Study||99
9845321|NCT00842608|10957533|FG003|STARTED|Overall Study||101
9845322|NCT00842608|10957530|FG000|COMPLETED|Overall Study||170
9845323|NCT00842608|10957531|FG001|COMPLETED|Overall Study||176
9686859|NCT03387852|10786860|FG000|STARTED|Overall Study||74
9686860|NCT03387852|10786861|FG001|STARTED|Overall Study||73
9686861|NCT03387852|10786862|FG002|STARTED|Overall Study||74
9686862|NCT03387852|10786863|FG003|STARTED|Overall Study||75
9686863|NCT03387852|10786860|FG000|Treated|Overall Study||74
9686864|NCT03387852|10786861|FG001|Treated|Overall Study||73
9686865|NCT03387852|10786862|FG002|Treated|Overall Study||74
9686866|NCT03387852|10786863|FG003|Treated|Overall Study||74
9686867|NCT03387852|10786860|FG000|COMPLETED|Overall Study||41
9686868|NCT03387852|10786861|FG001|COMPLETED|Overall Study||55
9686869|NCT03387852|10786862|FG002|COMPLETED|Overall Study||47
9686870|NCT03387852|10786863|FG003|COMPLETED|Overall Study||56
9686871|NCT03387852|10786860|FG000|NOT COMPLETED|Overall Study||33
9686872|NCT03387852|10786861|FG001|NOT COMPLETED|Overall Study||18
9686873|NCT03387852|10786862|FG002|NOT COMPLETED|Overall Study||27
9686874|NCT03387852|10786863|FG003|NOT COMPLETED|Overall Study||19
9686875|NCT03382574|10786874|FG000|STARTED|Overall Study||0
9686876|NCT03382574|10786874|FG000|COMPLETED|Overall Study||0
9686877|NCT03382574|10786874|FG000|NOT COMPLETED|Overall Study||0
9686878|NCT03364673|10786880|FG000|STARTED|Overall Study||29
9686879|NCT03364673|10786880|FG000|COMPLETED|Overall Study||24
9686880|NCT03364673|10786880|FG000|NOT COMPLETED|Overall Study||5
9686881|NCT03343704|10786886|FG000|STARTED|Overall Study||13
9686882|NCT03343704|10786887|FG001|STARTED|Overall Study||6
10023647|NCT01857258|11147346|FG000|STARTED|Wash-out Period (7 Days)||8
10023648|NCT01857258|11147347|FG001|STARTED|Wash-out Period (7 Days)||7
10023649|NCT01857258|11147346|FG000|COMPLETED|Wash-out Period (7 Days)||8
10023650|NCT01857258|11147347|FG001|COMPLETED|Wash-out Period (7 Days)||7
10023651|NCT01857258|11147346|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
9686883|NCT03343704|10786886|FG000|COMPLETED|Overall Study||12
9686884|NCT03343704|10786887|FG001|COMPLETED|Overall Study||4
9686885|NCT03343704|10786886|FG000|NOT COMPLETED|Overall Study||1
9686886|NCT03343704|10786887|FG001|NOT COMPLETED|Overall Study||2
9686887|NCT03265145|10786897|FG000|STARTED|Overall Study||356
9686888|NCT03265145|10786898|FG001|STARTED|Overall Study||358
9686889|NCT03265145|10786897|FG000|COMPLETED|Overall Study||285
9686890|NCT03265145|10786898|FG001|COMPLETED|Overall Study||302
9686891|NCT03265145|10786897|FG000|NOT COMPLETED|Overall Study||71
9686892|NCT03265145|10786898|FG001|NOT COMPLETED|Overall Study||56
9686893|NCT03219164|10786907|FG000|STARTED|Overall Study||74
9686894|NCT03219164|10786908|FG001|STARTED|Overall Study||75
9686895|NCT03219164|10786907|FG000|COMPLETED|Overall Study||49
9686896|NCT03219164|10786908|FG001|COMPLETED|Overall Study||57
9686897|NCT03219164|10786907|FG000|NOT COMPLETED|Overall Study||25
9686898|NCT03219164|10786908|FG001|NOT COMPLETED|Overall Study||18
9686899|NCT03143153|10786917|FG000|STARTED|Pre-Treatment||325
9686900|NCT03143153|10786918|FG001|STARTED|Pre-Treatment||321
9686901|NCT03143153|10786919|FG002|STARTED|Pre-Treatment||324
9686902|NCT03143153|10786917|FG000|COMPLETED|Pre-Treatment||322
9686903|NCT03143153|10786918|FG001|COMPLETED|Pre-Treatment||310
9845324|NCT00842608|10957532|FG002|COMPLETED|Overall Study||99
9845325|NCT00842608|10957533|FG003|COMPLETED|Overall Study||100
9686904|NCT03143153|10786919|FG002|COMPLETED|Pre-Treatment||304
9686905|NCT03143153|10786917|FG000|NOT COMPLETED|Pre-Treatment||3
9686906|NCT03143153|10786918|FG001|NOT COMPLETED|Pre-Treatment||11
9686907|NCT03143153|10786919|FG002|NOT COMPLETED|Pre-Treatment||20
9686908|NCT03143153|10786917|FG000|STARTED|Treatment||322
9686909|NCT03143153|10786918|FG001|STARTED|Treatment||310
9686910|NCT03143153|10786919|FG002|STARTED|Treatment||304
9686911|NCT03143153|10786917|FG000|COMPLETED|Treatment||21
9686912|NCT03143153|10786918|FG001|COMPLETED|Treatment||25
9686913|NCT03143153|10786919|FG002|COMPLETED|Treatment||4
9686914|NCT03143153|10786917|FG000|NOT COMPLETED|Treatment||301
9686915|NCT03143153|10786918|FG001|NOT COMPLETED|Treatment||285
9686916|NCT03143153|10786919|FG002|NOT COMPLETED|Treatment||300
9686917|NCT03104413|10786930|FG000|STARTED|Induction Period 1||207
9686918|NCT03104413|10786931|FG001|STARTED|Induction Period 1||206
9686919|NCT03104413|10786932|FG002|STARTED|Induction Period 1||205
9686920|NCT03104413|10786933|FG003|STARTED|Induction Period 1||0
9686921|NCT03104413|10786934|FG004|STARTED|Induction Period 1||0
9686922|NCT03104413|10786935|FG005|STARTED|Induction Period 1||0
9686923|NCT03104413|10786936|FG006|STARTED|Induction Period 1||0
9686924|NCT03104413|10786930|FG000|COMPLETED|Induction Period 1||186
9686925|NCT03104413|10786931|FG001|COMPLETED|Induction Period 1||202
9686926|NCT03104413|10786932|FG002|COMPLETED|Induction Period 1||199
9686927|NCT03104413|10786933|FG003|COMPLETED|Induction Period 1||0
9686928|NCT03104413|10786934|FG004|COMPLETED|Induction Period 1||0
9686929|NCT03104413|10786935|FG005|COMPLETED|Induction Period 1||0
9686930|NCT03104413|10786936|FG006|COMPLETED|Induction Period 1||0
9686931|NCT03104413|10786930|FG000|NOT COMPLETED|Induction Period 1||21
9686932|NCT03104413|10786931|FG001|NOT COMPLETED|Induction Period 1||4
9686933|NCT03104413|10786932|FG002|NOT COMPLETED|Induction Period 1||6
9686934|NCT03104413|10786933|FG003|NOT COMPLETED|Induction Period 1||0
9686935|NCT03104413|10786934|FG004|NOT COMPLETED|Induction Period 1||0
9686936|NCT03104413|10786935|FG005|NOT COMPLETED|Induction Period 1||0
9686937|NCT03104413|10786936|FG006|NOT COMPLETED|Induction Period 1||0
9686938|NCT03104413|10786930|FG000|STARTED|Induction Period 2||0
9686939|NCT03104413|10786931|FG001|STARTED|Induction Period 2||0
9686940|NCT03104413|10786932|FG002|STARTED|Induction Period 2||0
9686941|NCT03104413|10786933|FG003|STARTED|Induction Period 2||41
9686942|NCT03104413|10786934|FG004|STARTED|Induction Period 2||42
9686943|NCT03104413|10786935|FG005|STARTED|Induction Period 2||42
9686944|NCT03104413|10786936|FG006|STARTED|Induction Period 2||86
9686945|NCT03104413|10786930|FG000|COMPLETED|Induction Period 2||0
9686946|NCT03104413|10786931|FG001|COMPLETED|Induction Period 2||0
9686947|NCT03104413|10786932|FG002|COMPLETED|Induction Period 2||0
9686948|NCT03104413|10786933|FG003|COMPLETED|Induction Period 2||39
9686949|NCT03104413|10786934|FG004|COMPLETED|Induction Period 2||39
9686950|NCT03104413|10786935|FG005|COMPLETED|Induction Period 2||38
9686951|NCT03104413|10786936|FG006|COMPLETED|Induction Period 2||76
9686952|NCT03104413|10786930|FG000|NOT COMPLETED|Induction Period 2||0
9686953|NCT03104413|10786931|FG001|NOT COMPLETED|Induction Period 2||0
9686954|NCT03104413|10786932|FG002|NOT COMPLETED|Induction Period 2||0
9686955|NCT03104413|10786933|FG003|NOT COMPLETED|Induction Period 2||2
9686956|NCT03104413|10786934|FG004|NOT COMPLETED|Induction Period 2||3
9686957|NCT03104413|10786935|FG005|NOT COMPLETED|Induction Period 2||4
9686958|NCT03104413|10786936|FG006|NOT COMPLETED|Induction Period 2||10
9686959|NCT02930590|10786950|FG000|STARTED|First Intervention (2 Hours)||3
9686960|NCT02930590|10786951|FG001|STARTED|First Intervention (2 Hours)||3
9686961|NCT02930590|10786952|FG002|STARTED|First Intervention (2 Hours)||3
9686962|NCT02930590|10786953|FG003|STARTED|First Intervention (2 Hours)||2
9686963|NCT02930590|10786954|FG004|STARTED|First Intervention (2 Hours)||2
9686964|NCT02930590|10786955|FG005|STARTED|First Intervention (2 Hours)||2
9686965|NCT02930590|10786950|FG000|COMPLETED|First Intervention (2 Hours)||3
9686966|NCT02930590|10786951|FG001|COMPLETED|First Intervention (2 Hours)||3
9686967|NCT02930590|10786952|FG002|COMPLETED|First Intervention (2 Hours)||3
9686968|NCT02930590|10786953|FG003|COMPLETED|First Intervention (2 Hours)||2
9686969|NCT02930590|10786954|FG004|COMPLETED|First Intervention (2 Hours)||2
9686970|NCT02930590|10786955|FG005|COMPLETED|First Intervention (2 Hours)||2
10023652|NCT01857258|11147347|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
10023653|NCT01857258|11147346|FG000|STARTED|Second Intervention (3 h Postprandially)||8
9686971|NCT02930590|10786950|FG000|NOT COMPLETED|First Intervention (2 Hours)||0
9686972|NCT02930590|10786951|FG001|NOT COMPLETED|First Intervention (2 Hours)||0
9686973|NCT02930590|10786952|FG002|NOT COMPLETED|First Intervention (2 Hours)||0
10023654|NCT01857258|11147347|FG001|STARTED|Second Intervention (3 h Postprandially)||7
9686974|NCT02930590|10786953|FG003|NOT COMPLETED|First Intervention (2 Hours)||0
9686975|NCT02930590|10786954|FG004|NOT COMPLETED|First Intervention (2 Hours)||0
9686976|NCT02930590|10786955|FG005|NOT COMPLETED|First Intervention (2 Hours)||0
9686977|NCT02930590|10786950|FG000|STARTED|Second Intervention (2 Hours)||3
9686978|NCT02930590|10786951|FG001|STARTED|Second Intervention (2 Hours)||3
9686979|NCT02930590|10786952|FG002|STARTED|Second Intervention (2 Hours)||3
9686980|NCT02930590|10786953|FG003|STARTED|Second Intervention (2 Hours)||2
9686981|NCT02930590|10786954|FG004|STARTED|Second Intervention (2 Hours)||2
9686982|NCT02930590|10786955|FG005|STARTED|Second Intervention (2 Hours)||2
9686983|NCT02930590|10786950|FG000|COMPLETED|Second Intervention (2 Hours)||3
9686984|NCT02930590|10786951|FG001|COMPLETED|Second Intervention (2 Hours)||3
9686985|NCT02930590|10786952|FG002|COMPLETED|Second Intervention (2 Hours)||3
10081176|NCT02258334|11209640|FG000|NOT COMPLETED|Overall Study||1
9686986|NCT02930590|10786953|FG003|COMPLETED|Second Intervention (2 Hours)||2
9686987|NCT02930590|10786954|FG004|COMPLETED|Second Intervention (2 Hours)||2
9686988|NCT02930590|10786955|FG005|COMPLETED|Second Intervention (2 Hours)||2
9686989|NCT02930590|10786950|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
9686990|NCT02930590|10786951|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0
9686991|NCT02930590|10786952|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0
9686992|NCT02930590|10786953|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0
9686993|NCT02930590|10786954|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0
9686994|NCT02930590|10786955|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0
9686995|NCT02930590|10786950|FG000|STARTED|Third Intervention (2 Hours)||3
9686996|NCT02930590|10786951|FG001|STARTED|Third Intervention (2 Hours)||3
9686997|NCT02930590|10786952|FG002|STARTED|Third Intervention (2 Hours)||3
9686998|NCT02930590|10786953|FG003|STARTED|Third Intervention (2 Hours)||2
9686999|NCT02930590|10786954|FG004|STARTED|Third Intervention (2 Hours)||2
9687000|NCT02930590|10786955|FG005|STARTED|Third Intervention (2 Hours)||2
9687001|NCT02930590|10786950|FG000|COMPLETED|Third Intervention (2 Hours)||3
9687002|NCT02930590|10786951|FG001|COMPLETED|Third Intervention (2 Hours)||3
10023655|NCT01857258|11147346|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8
10023656|NCT01857258|11147347|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7
10023657|NCT01857258|11147346|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
10023658|NCT01857258|11147347|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
10023659|NCT01857297|11147357|FG000|STARTED|Overall Study||60
10023660|NCT01857297|11147358|FG001|STARTED|Overall Study||60
10023661|NCT01857297|11147357|FG000|COMPLETED|Overall Study||60
10023662|NCT01857297|11147358|FG001|COMPLETED|Overall Study||60
10023663|NCT01857297|11147357|FG000|NOT COMPLETED|Overall Study||0
10023664|NCT01857297|11147358|FG001|NOT COMPLETED|Overall Study||0
10023665|NCT01857310|11147366|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185
10023666|NCT01857310|11147367|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185
10023667|NCT01857310|11147366|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
10023668|NCT01857310|11147367|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
10023669|NCT01857310|11147366|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0
10023670|NCT01857310|11147367|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0
10023671|NCT01857310|11147366|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
10023672|NCT01857310|11147367|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
9687003|NCT02930590|10786952|FG002|COMPLETED|Third Intervention (2 Hours)||3
9687004|NCT02930590|10786953|FG003|COMPLETED|Third Intervention (2 Hours)||2
9687005|NCT02930590|10786954|FG004|COMPLETED|Third Intervention (2 Hours)||2
9687006|NCT02930590|10786955|FG005|COMPLETED|Third Intervention (2 Hours)||2
9687007|NCT02930590|10786950|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0
9687008|NCT02930590|10786951|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0
9687009|NCT02930590|10786952|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0
9687010|NCT02930590|10786953|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0
9687011|NCT02930590|10786954|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0
9687012|NCT02930590|10786955|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0
9687013|NCT02921789|10786967|FG000|STARTED|Overall Study||34
9687014|NCT02921789|10786968|FG001|STARTED|Overall Study||29
9687015|NCT02921789|10786967|FG000|Randomized and Took Study Drug|Overall Study||34
9687016|NCT02921789|10786968|FG001|Randomized and Took Study Drug|Overall Study||29
9687017|NCT02921789|10786967|FG000|COMPLETED|Overall Study||26
9687018|NCT02921789|10786968|FG001|COMPLETED|Overall Study||25
9687019|NCT02921789|10786967|FG000|NOT COMPLETED|Overall Study||8
9845326|NCT00842608|10957530|FG000|NOT COMPLETED|Overall Study||4
9845327|NCT00842608|10957531|FG001|NOT COMPLETED|Overall Study||1
9845328|NCT00842608|10957532|FG002|NOT COMPLETED|Overall Study||0
9845329|NCT00842608|10957533|FG003|NOT COMPLETED|Overall Study||1
9845330|NCT00842712|10957550|FG000|STARTED|Safety Run-in Part||3
9845331|NCT00842712|10957551|FG001|STARTED|Safety Run-in Part||3
9845332|NCT00842712|10957552|FG002|STARTED|Safety Run-in Part||3
9845333|NCT00842712|10957553|FG003|STARTED|Safety Run-in Part||3
9845334|NCT00842712|10957554|FG004|STARTED|Safety Run-in Part||0
9845335|NCT00842712|10957555|FG005|STARTED|Safety Run-in Part||0
9845336|NCT00842712|10957556|FG006|STARTED|Safety Run-in Part||0
9961007|NCT01470989|11080703|FG001|Completed Core Study|Overall Study||208
9961008|NCT01470989|11080702|FG000|Entered Extension 1 Study|Overall Study||174
9961009|NCT01470989|11080703|FG001|Entered Extension 1 Study|Overall Study||161
9961010|NCT01470989|11080702|FG000|Completed Extension 1 Study|Overall Study||165
9961011|NCT01470989|11080703|FG001|Completed Extension 1 Study|Overall Study||152
9961012|NCT01470989|11080702|FG000|Entered Extension 2 Study|Overall Study||141
9961013|NCT01470989|11080703|FG001|Entered Extension 2 Study|Overall Study||131
10081177|NCT02258334|11209641|FG001|NOT COMPLETED|Overall Study||0
10081178|NCT02258334|11209642|FG002|NOT COMPLETED|Overall Study||0
9687020|NCT02921789|10786968|FG001|NOT COMPLETED|Overall Study||4
9687021|NCT02898077|10786976|FG000|STARTED|Overall Study||294
9687022|NCT02898077|10786977|FG001|STARTED|Overall Study||146
9687023|NCT02898077|10786976|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293
9687024|NCT02898077|10786977|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145
9845337|NCT00842712|10957550|FG000|COMPLETED|Safety Run-in Part||0
9961014|NCT01470989|11080702|FG000|Completed Extension 2 Study|Overall Study||132
9961015|NCT01470989|11080703|FG001|Completed Extension 2 Study|Overall Study||117
9687025|NCT02898077|10786976|FG000|COMPLETED|Overall Study||246
9687026|NCT02898077|10786977|FG001|COMPLETED|Overall Study||123
9687027|NCT02898077|10786976|FG000|NOT COMPLETED|Overall Study||48
9687028|NCT02898077|10786977|FG001|NOT COMPLETED|Overall Study||23
9687029|NCT02702271|10786985|FG000|STARTED|Overall Study||400
9687030|NCT02702271|10786986|FG001|STARTED|Overall Study||58
9687031|NCT02702271|10786985|FG000|COMPLETED|Overall Study||337
9687032|NCT02702271|10786986|FG001|COMPLETED|Overall Study||49
9687033|NCT02702271|10786985|FG000|NOT COMPLETED|Overall Study||63
9687034|NCT02702271|10786986|FG001|NOT COMPLETED|Overall Study||9
9687035|NCT02658136|10786992|FG000|STARTED|Overall Study|Approved to start in year 2016. Goal was to reach 15 participants (1 day study).|15
9687036|NCT02658136|10786992|FG000|COMPLETED|Overall Study|Date of end of study: June 2017, N=15|15
9687037|NCT02658136|10786992|FG000|NOT COMPLETED|Overall Study||0
9687038|NCT02558634|10786997|FG000|STARTED|Blinded: First Intervention (3 Months)||4
9687039|NCT02558634|10786998|FG001|STARTED|Blinded: First Intervention (3 Months)||2
9687040|NCT02558634|10786997|FG000|COMPLETED|Blinded: First Intervention (3 Months)||4
9687041|NCT02558634|10786998|FG001|COMPLETED|Blinded: First Intervention (3 Months)||2
9687042|NCT02558634|10786997|FG000|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
9687043|NCT02558634|10786998|FG001|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
9687044|NCT02558634|10786997|FG000|STARTED|Blinded: Second Intervention (3 Months)||4
9687045|NCT02558634|10786998|FG001|STARTED|Blinded: Second Intervention (3 Months)||2
9687046|NCT02558634|10786997|FG000|COMPLETED|Blinded: Second Intervention (3 Months)|Assessed after 2 weeks - 1 participant requested to have their DBS 'on'|3
9687047|NCT02558634|10786998|FG001|COMPLETED|Blinded: Second Intervention (3 Months)||2
9687048|NCT02558634|10786997|FG000|NOT COMPLETED|Blinded: Second Intervention (3 Months)||1
9687049|NCT02558634|10786998|FG001|NOT COMPLETED|Blinded: Second Intervention (3 Months)||0
9687050|NCT02558634|10786997|FG000|STARTED|Unblinded: DBS on (6 Months)||4
9687051|NCT02558634|10786998|FG001|STARTED|Unblinded: DBS on (6 Months)||2
9687052|NCT02558634|10786997|FG000|COMPLETED|Unblinded: DBS on (6 Months)||4
9687053|NCT02558634|10786998|FG001|COMPLETED|Unblinded: DBS on (6 Months)||2
9687054|NCT02558634|10786997|FG000|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
9687055|NCT02558634|10786998|FG001|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
9687056|NCT02471339|10787010|FG000|STARTED|Overall Study||32
9687057|NCT02471339|10787011|FG001|STARTED|Overall Study||34
9687058|NCT02471339|10787010|FG000|COMPLETED|Overall Study||30
9687059|NCT02471339|10787011|FG001|COMPLETED|Overall Study||34
9687060|NCT02471339|10787010|FG000|NOT COMPLETED|Overall Study||2
9687061|NCT02471339|10787011|FG001|NOT COMPLETED|Overall Study||0
9687062|NCT02470585|10787020|FG000|STARTED|Overall Study||375
9687063|NCT02470585|10787021|FG001|STARTED|Overall Study||383
9687064|NCT02470585|10787022|FG002|STARTED|Overall Study||382
9687065|NCT02470585|10787020|FG000|Received Study Drug|Overall Study||371
9687066|NCT02470585|10787021|FG001|Received Study Drug|Overall Study||376
9687067|NCT02470585|10787022|FG002|Received Study Drug|Overall Study||377
9687068|NCT02470585|10787020|FG000|COMPLETED|Overall Study||268
9687069|NCT02470585|10787021|FG001|COMPLETED|Overall Study||266
9687070|NCT02470585|10787022|FG002|COMPLETED|Overall Study||257
9687071|NCT02470585|10787020|FG000|NOT COMPLETED|Overall Study||107
9687072|NCT02470585|10787021|FG001|NOT COMPLETED|Overall Study||117
9687073|NCT02470585|10787022|FG002|NOT COMPLETED|Overall Study||125
9687074|NCT02426749|10787032|FG000|STARTED|Overall Study||12
9687075|NCT02426749|10787033|FG001|STARTED|Overall Study||10
9687076|NCT02426749|10787032|FG000|COMPLETED|Overall Study||9
9687077|NCT02426749|10787033|FG001|COMPLETED|Overall Study||9
9687078|NCT02426749|10787032|FG000|NOT COMPLETED|Overall Study||3
9687079|NCT02426749|10787033|FG001|NOT COMPLETED|Overall Study||1
10023673|NCT01857310|11147366|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
9687080|NCT02318264|10787043|FG000|STARTED|Overall Study||8
9687081|NCT02318264|10787044|FG001|STARTED|Overall Study||7
9687082|NCT02318264|10787043|FG000|COMPLETED|Overall Study||8
9687083|NCT02318264|10787044|FG001|COMPLETED|Overall Study||7
9687084|NCT02318264|10787043|FG000|NOT COMPLETED|Overall Study||0
10023674|NCT01857310|11147367|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
10023675|NCT01857310|11147366|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
9687085|NCT02318264|10787044|FG001|NOT COMPLETED|Overall Study||0
9687086|NCT02163694|10787053|FG000|STARTED|Overall Study||172
9687087|NCT02163694|10787054|FG001|STARTED|Overall Study||337
9687088|NCT02163694|10787053|FG000|COMPLETED|Overall Study||18
9687089|NCT02163694|10787054|FG001|COMPLETED|Overall Study||70
9687090|NCT02163694|10787053|FG000|NOT COMPLETED|Overall Study||154
9687091|NCT02163694|10787054|FG001|NOT COMPLETED|Overall Study||267
9687092|NCT01966471|10787062|FG000|STARTED|Overall Study||918
9687093|NCT01966471|10787063|FG001|STARTED|Overall Study||928
9687094|NCT01966471|10787062|FG000|COMPLETED|Overall Study||0
9687095|NCT01966471|10787063|FG001|COMPLETED|Overall Study|There is a difference in the death count displayed here and in the All-Cause Mortality section under Adverse Events. The difference relates to a participant that died and who was randomized to the AC-KP arm, but never received trastuzumab emtansine. Consequently they were assigned to the AC-THP for safety analyses. This death counts in the AC-KP arm when summary is based on the ITT population, but counts in the AC-THP arm when the summary on the safety population.|0
9687096|NCT01966471|10787062|FG000|NOT COMPLETED|Overall Study||918
9687097|NCT01966471|10787063|FG001|NOT COMPLETED|Overall Study||928
9687098|NCT01871220|10787071|FG000|STARTED|Overall Study||29
9687099|NCT01871220|10787072|FG001|STARTED|Overall Study||32
9687100|NCT01871220|10787071|FG000|COMPLETED|Overall Study||25
9687101|NCT01871220|10787072|FG001|COMPLETED|Overall Study||29
9687102|NCT01871220|10787071|FG000|NOT COMPLETED|Overall Study||4
9687103|NCT01871220|10787072|FG001|NOT COMPLETED|Overall Study||3
9687104|NCT01825187|10787080|FG000|STARTED|Overall Study||25
9687105|NCT01825187|10787081|FG001|STARTED|Overall Study||25
9687106|NCT01825187|10787082|FG002|STARTED|Overall Study||25
9687107|NCT01825187|10787080|FG000|COMPLETED|Overall Study||24
9687108|NCT01825187|10787081|FG001|COMPLETED|Overall Study||24
9687109|NCT01825187|10787082|FG002|COMPLETED|Overall Study||24
9687110|NCT01825187|10787080|FG000|NOT COMPLETED|Overall Study||1
9687111|NCT01825187|10787081|FG001|NOT COMPLETED|Overall Study||1
9687112|NCT01825187|10787082|FG002|NOT COMPLETED|Overall Study||1
9845338|NCT00842712|10957551|FG001|COMPLETED|Safety Run-in Part||1
9845339|NCT00842712|10957552|FG002|COMPLETED|Safety Run-in Part||3
9845340|NCT00842712|10957553|FG003|COMPLETED|Safety Run-in Part||2
9845341|NCT00842712|10957554|FG004|COMPLETED|Safety Run-in Part||0
9845342|NCT00842712|10957555|FG005|COMPLETED|Safety Run-in Part||0
9845343|NCT00842712|10957556|FG006|COMPLETED|Safety Run-in Part||0
9845344|NCT00842712|10957550|FG000|NOT COMPLETED|Safety Run-in Part||3
10023676|NCT01857310|11147367|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
9687124|NCT01465334|10787106|FG000|STARTED|Overall Study||15
9687125|NCT01465334|10787107|FG001|STARTED|Overall Study||15
9687126|NCT01465334|10787106|FG000|Complete Part A Induction|Overall Study||12
9687127|NCT01465334|10787107|FG001|Complete Part A Induction|Overall Study||15
9687128|NCT01465334|10787106|FG000|Complete Part B Induction|Overall Study||7
9687129|NCT01465334|10787107|FG001|Complete Part B Induction|Overall Study||15
9687130|NCT01465334|10787106|FG000|Eligible for Allogeneic Transplant|Overall Study||9
9687131|NCT01465334|10787107|FG001|Eligible for Allogeneic Transplant|Overall Study||9
9687132|NCT01465334|10787106|FG000|COMPLETED|Overall Study||13
9687133|NCT01465334|10787107|FG001|COMPLETED|Overall Study||9
9687134|NCT01465334|10787106|FG000|NOT COMPLETED|Overall Study||2
9687135|NCT01465334|10787107|FG001|NOT COMPLETED|Overall Study||6
9687136|NCT01307423|10787116|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
9687137|NCT01307423|10787117|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
9687138|NCT01307423|10787118|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
9687139|NCT01307423|10787119|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9687140|NCT01307423|10787120|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9687141|NCT01307423|10787121|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9687142|NCT01307423|10787122|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9687143|NCT01307423|10787123|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9687144|NCT01307423|10787124|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
9687145|NCT01307423|10787116|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
9687146|NCT01307423|10787117|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
9687147|NCT01307423|10787118|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
9687148|NCT01307423|10787119|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10081179|NCT02258334|11209643|FG003|NOT COMPLETED|Overall Study||0
9687149|NCT01307423|10787120|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9687150|NCT01307423|10787121|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9687151|NCT01307423|10787122|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9687152|NCT01307423|10787123|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9687153|NCT01307423|10787124|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
9687154|NCT01307423|10787116|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
9687155|NCT01307423|10787117|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
9687156|NCT01307423|10787118|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
9687157|NCT01307423|10787119|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687158|NCT01307423|10787120|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687159|NCT01307423|10787121|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687160|NCT01307423|10787122|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687161|NCT01307423|10787123|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687162|NCT01307423|10787124|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687163|NCT01307423|10787116|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
9687164|NCT01307423|10787117|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
9687165|NCT01307423|10787118|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
9687166|NCT01307423|10787119|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687167|NCT01307423|10787120|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687168|NCT01307423|10787121|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687169|NCT01307423|10787122|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687170|NCT01307423|10787123|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687171|NCT01307423|10787124|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
9687172|NCT01307423|10787116|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
9687173|NCT01307423|10787117|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
9687174|NCT01307423|10787118|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
9687175|NCT01307423|10787119|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687176|NCT01307423|10787120|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687177|NCT01307423|10787121|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687178|NCT01307423|10787122|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687179|NCT01307423|10787123|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687180|NCT01307423|10787124|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687181|NCT01307423|10787116|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
9687182|NCT01307423|10787117|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
9687183|NCT01307423|10787118|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
9687184|NCT01307423|10787119|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687185|NCT01307423|10787120|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687186|NCT01307423|10787121|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687187|NCT01307423|10787122|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687188|NCT01307423|10787123|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687189|NCT01307423|10787124|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
9687190|NCT01307423|10787116|FG000|STARTED|Active Treatment Phase (Week 25-52)||0
9687191|NCT01307423|10787117|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
9687192|NCT01307423|10787118|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
9687193|NCT01307423|10787119|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
9687194|NCT01307423|10787120|FG004|STARTED|Active Treatment Phase (Week 25-52)||26
9687195|NCT01307423|10787121|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
9687196|NCT01307423|10787122|FG006|STARTED|Active Treatment Phase (Week 25-52)||26
9687197|NCT01307423|10787123|FG007|STARTED|Active Treatment Phase (Week 25-52)||0
9845345|NCT00842712|10957551|FG001|NOT COMPLETED|Safety Run-in Part||2
9845346|NCT00842712|10957552|FG002|NOT COMPLETED|Safety Run-in Part||0
9845347|NCT00842712|10957553|FG003|NOT COMPLETED|Safety Run-in Part||1
9961016|NCT01470989|11080702|FG000|Entered Extension 3|Overall Study||87
10081180|NCT02258373|11209657|FG000|STARTED|Overall Study||149
9845348|NCT00842712|10957554|FG004|NOT COMPLETED|Safety Run-in Part||0
9845349|NCT00842712|10957555|FG005|NOT COMPLETED|Safety Run-in Part||0
9845350|NCT00842712|10957556|FG006|NOT COMPLETED|Safety Run-in Part||0
9845351|NCT00842712|10957550|FG000|STARTED|Randomized Part||0
9845352|NCT00842712|10957551|FG001|STARTED|Randomized Part||0
9845353|NCT00842712|10957552|FG002|STARTED|Randomized Part||0
9845354|NCT00842712|10957553|FG003|STARTED|Randomized Part||0
9961017|NCT01470989|11080703|FG001|Entered Extension 3|Overall Study||49
9687198|NCT01307423|10787124|FG008|STARTED|Active Treatment Phase (Week 25-52)||0
9687199|NCT01307423|10787116|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0
9687200|NCT01307423|10787117|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132
9687201|NCT01307423|10787118|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141
9687202|NCT01307423|10787119|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38
9687203|NCT01307423|10787120|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23
9687204|NCT01307423|10787121|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43
9687205|NCT01307423|10787122|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25
10023677|NCT01857323|11147373|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
10023678|NCT01857323|11147373|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
10023679|NCT01857323|11147373|FG000|COMPLETED|Overall Study||253
9687206|NCT01307423|10787123|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0
9687207|NCT01307423|10787124|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0
9961018|NCT01470989|11080702|FG000|COMPLETED|Overall Study||79
9961019|NCT01470989|11080703|FG001|COMPLETED|Overall Study||43
9961020|NCT01470989|11080702|FG000|NOT COMPLETED|Overall Study||148
9961021|NCT01470989|11080703|FG001|NOT COMPLETED|Overall Study||186
9961022|NCT01471015|11080714|FG000|STARTED|Overall Study||10
9961023|NCT01471015|11080715|FG001|STARTED|Overall Study||10
9687208|NCT01307423|10787116|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
9687209|NCT01307423|10787117|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
9687210|NCT01307423|10787118|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
9687211|NCT01307423|10787119|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
9687212|NCT01307423|10787120|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
9687213|NCT01307423|10787121|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
9687214|NCT01307423|10787122|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
9687215|NCT01307423|10787123|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
9687216|NCT01307423|10787124|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
9687217|NCT01307423|10787116|FG000|STARTED|Long-term Safety Phase (Year 2)||0
9687218|NCT01307423|10787117|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
9687219|NCT01307423|10787118|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
9687220|NCT01307423|10787119|FG003|STARTED|Long-term Safety Phase (Year 2)||0
9687221|NCT01307423|10787120|FG004|STARTED|Long-term Safety Phase (Year 2)||0
9687222|NCT01307423|10787121|FG005|STARTED|Long-term Safety Phase (Year 2)||0
9687223|NCT01307423|10787122|FG006|STARTED|Long-term Safety Phase (Year 2)||0
9687224|NCT01307423|10787123|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
9687225|NCT01307423|10787124|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
9687226|NCT01307423|10787116|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
9687227|NCT01307423|10787117|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99
9687228|NCT01307423|10787118|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109
9687229|NCT01307423|10787119|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
10023680|NCT01857323|11147373|FG000|NOT COMPLETED|Overall Study||64
10023681|NCT01857362|11147377|FG000|STARTED|Overall Study||6
9961024|NCT01471015|11080716|FG002|STARTED|Overall Study||10
9961025|NCT01471015|11080714|FG000|COMPLETED|Overall Study||10
9961026|NCT01471015|11080715|FG001|COMPLETED|Overall Study||9
9961027|NCT01471015|11080716|FG002|COMPLETED|Overall Study||9
9961028|NCT01471015|11080714|FG000|NOT COMPLETED|Overall Study||0
9961029|NCT01471015|11080715|FG001|NOT COMPLETED|Overall Study||1
10023682|NCT01857362|11147378|FG001|STARTED|Overall Study||6
10023683|NCT01857362|11147377|FG000|COMPLETED|Overall Study||6
10023684|NCT01857362|11147378|FG001|COMPLETED|Overall Study||6
9687230|NCT01307423|10787120|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
9687231|NCT01307423|10787121|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
9687232|NCT01307423|10787122|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
9687233|NCT01307423|10787123|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48
9687234|NCT01307423|10787124|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60
9687235|NCT01307423|10787116|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9687236|NCT01307423|10787117|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
9687237|NCT01307423|10787118|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
9687238|NCT01307423|10787119|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9687239|NCT01307423|10787120|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9687240|NCT01307423|10787121|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10023685|NCT01857362|11147377|FG000|NOT COMPLETED|Overall Study||0
10023686|NCT01857362|11147378|FG001|NOT COMPLETED|Overall Study||0
10023687|NCT01857531|11147384|FG000|STARTED|Overall Study||16
10023688|NCT01857531|11147384|FG000|COMPLETED|Overall Study||12
10023689|NCT01857531|11147384|FG000|NOT COMPLETED|Overall Study||4
10023690|NCT01857583|11147392|FG000|STARTED|Overall Study||30
10023691|NCT01857583|11147393|FG001|STARTED|Overall Study||7
10023692|NCT01857583|11147394|FG002|STARTED|Overall Study||22
10023693|NCT01857583|11147395|FG003|STARTED|Overall Study||21
9687241|NCT01307423|10787122|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
9687242|NCT01307423|10787123|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
9687243|NCT01307423|10787124|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
9687244|NCT01307423|10787116|FG000|STARTED|Long-term Safety Phase (Year 3)||0
9687245|NCT01307423|10787117|FG001|STARTED|Long-term Safety Phase (Year 3)||99
9687246|NCT01307423|10787118|FG002|STARTED|Long-term Safety Phase (Year 3)||109
9687247|NCT01307423|10787119|FG003|STARTED|Long-term Safety Phase (Year 3)||0
9687248|NCT01307423|10787120|FG004|STARTED|Long-term Safety Phase (Year 3)||0
9687249|NCT01307423|10787121|FG005|STARTED|Long-term Safety Phase (Year 3)||0
9687250|NCT01307423|10787122|FG006|STARTED|Long-term Safety Phase (Year 3)||0
9687251|NCT01307423|10787123|FG007|STARTED|Long-term Safety Phase (Year 3)||48
9687252|NCT01307423|10787124|FG008|STARTED|Long-term Safety Phase (Year 3)||60
9687253|NCT01307423|10787116|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
9687254|NCT01307423|10787117|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90
10023694|NCT01857583|11147392|FG000|Safety Analysis Population|Overall Study||30
10023695|NCT01857583|11147393|FG001|Safety Analysis Population|Overall Study||7
10023696|NCT01857583|11147394|FG002|Safety Analysis Population|Overall Study||22
9687255|NCT01307423|10787118|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91
9687256|NCT01307423|10787119|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
9687257|NCT01307423|10787120|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
9687258|NCT01307423|10787121|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
9687259|NCT01307423|10787122|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
9687260|NCT01307423|10787123|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40
9687261|NCT01307423|10787124|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49
9687262|NCT01307423|10787116|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9687263|NCT01307423|10787117|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
9687264|NCT01307423|10787118|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
9687265|NCT01307423|10787119|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9687266|NCT01307423|10787120|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9687267|NCT01307423|10787121|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9687268|NCT01307423|10787122|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
9687269|NCT01307423|10787123|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
9687270|NCT01307423|10787124|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
9687271|NCT01307423|10787116|FG000|STARTED|Long-term Safety Phase (Year 4)||0
9687272|NCT01307423|10787117|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
9687273|NCT01307423|10787118|FG002|STARTED|Long-term Safety Phase (Year 4)||91
9687274|NCT01307423|10787119|FG003|STARTED|Long-term Safety Phase (Year 4)||0
9687275|NCT01307423|10787120|FG004|STARTED|Long-term Safety Phase (Year 4)||0
9687276|NCT01307423|10787121|FG005|STARTED|Long-term Safety Phase (Year 4)||0
9687277|NCT01307423|10787122|FG006|STARTED|Long-term Safety Phase (Year 4)||0
9687278|NCT01307423|10787123|FG007|STARTED|Long-term Safety Phase (Year 4)||40
9687279|NCT01307423|10787124|FG008|STARTED|Long-term Safety Phase (Year 4)||49
9687280|NCT01307423|10787116|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
9687281|NCT01307423|10787117|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81
9687282|NCT01307423|10787118|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86
9687283|NCT01307423|10787119|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
9687284|NCT01307423|10787120|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
9687285|NCT01307423|10787121|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
9687286|NCT01307423|10787122|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
9687287|NCT01307423|10787123|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38
9687288|NCT01307423|10787124|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44
9687289|NCT01307423|10787116|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9687290|NCT01307423|10787117|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
9687291|NCT01307423|10787118|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
9687292|NCT01307423|10787119|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9687293|NCT01307423|10787120|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9687294|NCT01307423|10787121|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9687295|NCT01307423|10787122|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9687296|NCT01307423|10787123|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
9687297|NCT01307423|10787124|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
9687298|NCT01307423|10787116|FG000|STARTED|Long-term Safety Phase (Year 5)||0
9687299|NCT01307423|10787117|FG001|STARTED|Long-term Safety Phase (Year 5)||81
9687300|NCT01307423|10787118|FG002|STARTED|Long-term Safety Phase (Year 5)||86
9687301|NCT01307423|10787119|FG003|STARTED|Long-term Safety Phase (Year 5)||0
9687302|NCT01307423|10787120|FG004|STARTED|Long-term Safety Phase (Year 5)||0
9687303|NCT01307423|10787121|FG005|STARTED|Long-term Safety Phase (Year 5)||0
9687304|NCT01307423|10787122|FG006|STARTED|Long-term Safety Phase (Year 5)||0
9687305|NCT01307423|10787123|FG007|STARTED|Long-term Safety Phase (Year 5)||38
9687306|NCT01307423|10787124|FG008|STARTED|Long-term Safety Phase (Year 5)||44
9687307|NCT01307423|10787116|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
9687308|NCT01307423|10787117|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71
9687309|NCT01307423|10787118|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80
9687310|NCT01307423|10787119|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
9687311|NCT01307423|10787120|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
9687312|NCT01307423|10787121|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
9687313|NCT01307423|10787122|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
9687314|NCT01307423|10787123|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37
9687315|NCT01307423|10787124|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
9687316|NCT01307423|10787116|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9687317|NCT01307423|10787117|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
9687318|NCT01307423|10787118|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
9687319|NCT01307423|10787119|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9687320|NCT01307423|10787120|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9687321|NCT01307423|10787121|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9687322|NCT01307423|10787122|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
9687323|NCT01307423|10787123|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
9687324|NCT01307423|10787124|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
9687325|NCT01030575|10787160|FG000|STARTED|Overall Study||29
9687326|NCT01030575|10787161|FG001|STARTED|Overall Study||30
9687327|NCT01030575|10787162|FG002|STARTED|Overall Study||28
9687328|NCT01030575|10787163|FG003|STARTED|Overall Study||35
9687329|NCT01030575|10787160|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
9687330|NCT01030575|10787161|FG001|COMPLETED|Overall Study||30
9687331|NCT01030575|10787162|FG002|COMPLETED|Overall Study||28
9687332|NCT01030575|10787163|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
9687333|NCT01030575|10787160|FG000|NOT COMPLETED|Overall Study||0
9687334|NCT01030575|10787161|FG001|NOT COMPLETED|Overall Study||0
9687335|NCT01030575|10787162|FG002|NOT COMPLETED|Overall Study||0
9687336|NCT01030575|10787163|FG003|NOT COMPLETED|Overall Study||0
9687337|NCT00911183|10787176|FG000|STARTED|Overall Study||47
9687338|NCT00911183|10787177|FG001|STARTED|Overall Study||20
9687339|NCT00911183|10787176|FG000|COMPLETED|Overall Study||47
9687340|NCT00911183|10787177|FG001|COMPLETED|Overall Study||20
9687341|NCT00911183|10787176|FG000|NOT COMPLETED|Overall Study||0
9687342|NCT00911183|10787177|FG001|NOT COMPLETED|Overall Study||0
9687343|NCT00655876|10787185|FG000|STARTED|Overall Study||168
9687344|NCT00655876|10787186|FG001|STARTED|Overall Study||176
9687345|NCT00655876|10787185|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
9687346|NCT00655876|10787186|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
9687347|NCT00655876|10787185|FG000|NOT COMPLETED|Overall Study||9
9687348|NCT00655876|10787186|FG001|NOT COMPLETED|Overall Study||7
9687349|NCT00602576|10787196|FG000|STARTED|Overall Study||38
9687350|NCT00602576|10787197|FG001|STARTED|Overall Study||40
9687351|NCT00602576|10787198|FG002|STARTED|Overall Study||38
9687352|NCT00602576|10787199|FG003|STARTED|Overall Study||53
9687353|NCT00602576|10787196|FG000|COMPLETED|Overall Study||38
9687354|NCT00602576|10787197|FG001|COMPLETED|Overall Study||40
9687355|NCT00602576|10787198|FG002|COMPLETED|Overall Study||38
9687356|NCT00602576|10787199|FG003|COMPLETED|Overall Study||53
9687357|NCT00602576|10787196|FG000|NOT COMPLETED|Overall Study||0
9687358|NCT00602576|10787197|FG001|NOT COMPLETED|Overall Study||0
9687359|NCT00602576|10787198|FG002|NOT COMPLETED|Overall Study||0
9687360|NCT00602576|10787199|FG003|NOT COMPLETED|Overall Study||0
9687361|NCT00265941|10787211|FG000|STARTED|Overall Study||470
9687362|NCT00265941|10787212|FG001|STARTED|Overall Study||470
9687363|NCT00265941|10787211|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
9687364|NCT00265941|10787212|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
9687365|NCT00265941|10787211|FG000|NOT COMPLETED|Overall Study||23
9687366|NCT00265941|10787212|FG001|NOT COMPLETED|Overall Study||26
9961030|NCT01471015|11080716|FG002|NOT COMPLETED|Overall Study||1
9961031|NCT01471028|11080726|FG000|STARTED|VTI-208||96
9961032|NCT01471028|11080727|FG001|STARTED|VTI-208||107
9961033|NCT01471028|11080726|FG000|COMPLETED|VTI-208||56
9961034|NCT01471028|11080727|FG001|COMPLETED|VTI-208||63
9961035|NCT01471028|11080726|FG000|NOT COMPLETED|VTI-208||40
9961036|NCT01471028|11080727|FG001|NOT COMPLETED|VTI-208||44
9961037|NCT01471028|11080726|FG000|STARTED|VTI-208E||56
9961038|NCT01471028|11080727|FG001|STARTED|VTI-208E||63
9961039|NCT01471028|11080726|FG000|Database Lock, 31 July 2015|VTI-208E||56
9961040|NCT01471028|11080727|FG001|Database Lock, 31 July 2015|VTI-208E||63
9961041|NCT01471028|11080726|FG000|COMPLETED|VTI-208E||48
9961042|NCT01471028|11080727|FG001|COMPLETED|VTI-208E||51
9687367|NCT00114140|10787226|FG000|STARTED|Overall Study||136
9687368|NCT00114140|10787226|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
9687369|NCT00114140|10787226|FG000|NOT COMPLETED|Overall Study||7
9687370|NCT00047008|10787239|FG000|STARTED|Overall Study||372
9687371|NCT00047008|10787240|FG001|STARTED|Overall Study||371
9687372|NCT00047008|10787239|FG000|COMPLETED|Overall Study||361
9687373|NCT00047008|10787240|FG001|COMPLETED|Overall Study||360
9687374|NCT00047008|10787239|FG000|NOT COMPLETED|Overall Study||11
9687375|NCT00047008|10787240|FG001|NOT COMPLETED|Overall Study||11
9726142|NCT00098306|10825685|FG006|NOT COMPLETED|Observational Phase||26
9726143|NCT00098345|10825698|FG000|STARTED|Overall Study||30
9726144|NCT00098345|10825698|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
9726145|NCT00098345|10825698|FG000|NOT COMPLETED|Overall Study||13
9726146|NCT00098371|10825702|FG000|STARTED|Overall Study||64
9726147|NCT00098371|10825702|FG000|COMPLETED|Overall Study||64
9726148|NCT00098371|10825702|FG000|NOT COMPLETED|Overall Study||0
9726149|NCT00098670|10825717|FG000|STARTED|Overall Study||102
9726150|NCT00098670|10825717|FG000|COMPLETED|Overall Study||102
9726151|NCT00098670|10825717|FG000|NOT COMPLETED|Overall Study||0
9726152|NCT00098722|10825725|FG000|STARTED|Double Blind Phase||186
9726153|NCT00098722|10825726|FG001|STARTED|Double Blind Phase||194
10023697|NCT01857583|11147395|FG003|Safety Analysis Population|Overall Study||20
10023698|NCT01857583|11147392|FG000|COMPLETED|Overall Study||29
10023699|NCT01857583|11147393|FG001|COMPLETED|Overall Study||6
10023700|NCT01857583|11147394|FG002|COMPLETED|Overall Study||19
9726154|NCT00098722|10825727|FG002|STARTED|Double Blind Phase||94
9726155|NCT00098722|10825728|FG003|STARTED|Double Blind Phase||0
9726156|NCT00098722|10825729|FG004|STARTED|Double Blind Phase||0
9726157|NCT00098722|10825730|FG005|STARTED|Double Blind Phase||0
9726158|NCT00098722|10825731|FG006|STARTED|Double Blind Phase||0
9726159|NCT00098722|10825725|FG000|Treated|Double Blind Phase||182
9726160|NCT00098722|10825726|FG001|Treated|Double Blind Phase||191
9726161|NCT00098722|10825727|FG002|Treated|Double Blind Phase||91
9726162|NCT00098722|10825728|FG003|Treated|Double Blind Phase||0
9726163|NCT00098722|10825729|FG004|Treated|Double Blind Phase||0
9726164|NCT00098722|10825730|FG005|Treated|Double Blind Phase||0
9726165|NCT00098722|10825731|FG006|Treated|Double Blind Phase||0
9726166|NCT00098722|10825725|FG000|COMPLETED|Double Blind Phase||0
9726167|NCT00098722|10825726|FG001|COMPLETED|Double Blind Phase||0
9726168|NCT00098722|10825727|FG002|COMPLETED|Double Blind Phase||0
9726169|NCT00098722|10825728|FG003|COMPLETED|Double Blind Phase||0
9726170|NCT00098722|10825729|FG004|COMPLETED|Double Blind Phase||0
9726171|NCT00098722|10825730|FG005|COMPLETED|Double Blind Phase||0
9726172|NCT00098722|10825731|FG006|COMPLETED|Double Blind Phase||0
9726173|NCT00098722|10825725|FG000|NOT COMPLETED|Double Blind Phase||186
9726174|NCT00098722|10825726|FG001|NOT COMPLETED|Double Blind Phase||194
9726175|NCT00098722|10825727|FG002|NOT COMPLETED|Double Blind Phase||94
10023701|NCT01857583|11147395|FG003|COMPLETED|Overall Study||17
9726176|NCT00098722|10825728|FG003|NOT COMPLETED|Double Blind Phase||0
10023702|NCT01857583|11147392|FG000|NOT COMPLETED|Overall Study||1
9687376|NCT04701138|10787246|FG000|STARTED|Overall Study||24
9687377|NCT04701138|10787246|FG000|COMPLETED|Overall Study||23
9687378|NCT04701138|10787246|FG000|NOT COMPLETED|Overall Study||1
9687379|NCT04392583|10787250|FG000|STARTED|Overall Study||40
9687380|NCT04392583|10787250|FG000|COMPLETED|Overall Study||39
9687381|NCT04392583|10787250|FG000|NOT COMPLETED|Overall Study||1
9687382|NCT04332640|10787254|FG000|STARTED|Overall Study||79
9687383|NCT04332640|10787254|FG000|COMPLETED|Overall Study||79
9687384|NCT04332640|10787254|FG000|NOT COMPLETED|Overall Study||0
9687385|NCT04326439|10787260|FG000|STARTED|Overall Study||5
9687386|NCT04326439|10787261|FG001|STARTED|Overall Study||3
9687387|NCT04326439|10787260|FG000|COMPLETED|Overall Study||3
9845355|NCT00842712|10957554|FG004|STARTED|Randomized Part||85
9845356|NCT00842712|10957555|FG005|STARTED|Randomized Part||51
9845357|NCT00842712|10957556|FG006|STARTED|Randomized Part||84
9845358|NCT00842712|10957550|FG000|Treated|Randomized Part||0
9845359|NCT00842712|10957551|FG001|Treated|Randomized Part||0
9845360|NCT00842712|10957552|FG002|Treated|Randomized Part||0
9845361|NCT00842712|10957553|FG003|Treated|Randomized Part||0
9845362|NCT00842712|10957554|FG004|Treated|Randomized Part||85
9845363|NCT00842712|10957555|FG005|Treated|Randomized Part||50
9845364|NCT00842712|10957556|FG006|Treated|Randomized Part||80
9845365|NCT00842712|10957550|FG000|COMPLETED|Randomized Part||0
9845366|NCT00842712|10957551|FG001|COMPLETED|Randomized Part||0
9845367|NCT00842712|10957552|FG002|COMPLETED|Randomized Part||0
9845368|NCT00842712|10957553|FG003|COMPLETED|Randomized Part||0
9845369|NCT00842712|10957554|FG004|COMPLETED|Randomized Part||85
9961043|NCT01471028|11080726|FG000|NOT COMPLETED|VTI-208E||8
9961044|NCT01471028|11080727|FG001|NOT COMPLETED|VTI-208E||12
9961045|NCT01471041|11080736|FG000|STARTED|Overall Study||54
9961046|NCT01471041|11080736|FG000|COMPLETED|Overall Study||47
9961047|NCT01471041|11080736|FG000|NOT COMPLETED|Overall Study||7
9961048|NCT01471054|11080742|FG000|STARTED|Overall Study||5
9961049|NCT01471054|11080743|FG001|STARTED|Overall Study||1
9961050|NCT01471054|11080742|FG000|COMPLETED|Overall Study||1
9961051|NCT01471054|11080743|FG001|COMPLETED|Overall Study||1
9961052|NCT01471054|11080742|FG000|NOT COMPLETED|Overall Study||4
9961053|NCT01471054|11080743|FG001|NOT COMPLETED|Overall Study||0
9961054|NCT01471093|11080761|FG000|STARTED|Overall Study||25
9961055|NCT01471093|11080762|FG001|STARTED|Overall Study||25
9961056|NCT01471093|11080763|FG002|STARTED|Overall Study||25
9961057|NCT01471093|11080764|FG003|STARTED|Overall Study||25
9961058|NCT01471093|11080761|FG000|COMPLETED|Overall Study||24
9961059|NCT01471093|11080762|FG001|COMPLETED|Overall Study||25
9961060|NCT01471093|11080763|FG002|COMPLETED|Overall Study||25
9961061|NCT01471093|11080764|FG003|COMPLETED|Overall Study||25
9961062|NCT01471093|11080761|FG000|NOT COMPLETED|Overall Study||1
9961063|NCT01471093|11080762|FG001|NOT COMPLETED|Overall Study||0
9961064|NCT01471093|11080763|FG002|NOT COMPLETED|Overall Study||0
9961065|NCT01471093|11080764|FG003|NOT COMPLETED|Overall Study||0
9961066|NCT01471171|11080770|FG000|STARTED|Treatment Period 1||57
9961067|NCT01471171|11080771|FG001|STARTED|Treatment Period 1||55
9961068|NCT01471171|11080770|FG000|COMPLETED|Treatment Period 1||53
9961069|NCT01471171|11080771|FG001|COMPLETED|Treatment Period 1||54
9961070|NCT01471171|11080770|FG000|NOT COMPLETED|Treatment Period 1||4
9961071|NCT01471171|11080771|FG001|NOT COMPLETED|Treatment Period 1||1
9961072|NCT01471171|11080770|FG000|STARTED|Treatment Period 2||53
9961073|NCT01471171|11080771|FG001|STARTED|Treatment Period 2||54
9961074|NCT01471171|11080770|FG000|COMPLETED|Treatment Period 2||52
9961075|NCT01471171|11080771|FG001|COMPLETED|Treatment Period 2||54
9961076|NCT01471171|11080770|FG000|NOT COMPLETED|Treatment Period 2||1
9961077|NCT01471171|11080771|FG001|NOT COMPLETED|Treatment Period 2||0
9961078|NCT01471197|11080779|FG000|STARTED|Overall Study||6
9961079|NCT01471197|11080780|FG001|STARTED|Overall Study||2
9961080|NCT01471197|11080779|FG000|COMPLETED|Overall Study||0
9961081|NCT01471197|11080780|FG001|COMPLETED|Overall Study||0
9961082|NCT01471197|11080779|FG000|NOT COMPLETED|Overall Study||6
9961083|NCT01471197|11080780|FG001|NOT COMPLETED|Overall Study||2
9961084|NCT01471353|11080786|FG000|STARTED|Overall Study||42
9961085|NCT01471353|11080786|FG000|COMPLETED|Overall Study||39
9961086|NCT01471353|11080786|FG000|NOT COMPLETED|Overall Study||3
9961087|NCT01471379|11080793|FG000|STARTED|Overall Study||1
9961088|NCT01471379|11080794|FG001|STARTED|Overall Study||1
9961089|NCT01471379|11080795|FG002|STARTED|Overall Study||0
9961090|NCT01471379|11080793|FG000|COMPLETED|Overall Study||0
9961091|NCT01471379|11080794|FG001|COMPLETED|Overall Study||0
9961092|NCT01471379|11080795|FG002|COMPLETED|Overall Study||0
9961093|NCT01471379|11080793|FG000|NOT COMPLETED|Overall Study||1
9961094|NCT01471379|11080794|FG001|NOT COMPLETED|Overall Study||1
9961095|NCT01471379|11080795|FG002|NOT COMPLETED|Overall Study||0
9961096|NCT01471457|11080806|FG000|STARTED|Overall Study||92
9961097|NCT01471457|11080807|FG001|STARTED|Overall Study||92
9961098|NCT01471457|11080806|FG000|COMPLETED|Overall Study||73
9687388|NCT04326439|10787261|FG001|COMPLETED|Overall Study||0
9687389|NCT04326439|10787260|FG000|NOT COMPLETED|Overall Study||2
9961099|NCT01471457|11080807|FG001|COMPLETED|Overall Study||74
9961100|NCT01471457|11080806|FG000|NOT COMPLETED|Overall Study||19
9961101|NCT01471457|11080807|FG001|NOT COMPLETED|Overall Study||18
9961102|NCT01471522|11080815|FG000|STARTED|Overall Study||2588
9687390|NCT04326439|10787261|FG001|NOT COMPLETED|Overall Study||3
9687391|NCT04188730|10787273|FG000|STARTED|Overall Study||4
9845370|NCT00842712|10957555|FG005|COMPLETED|Randomized Part||50
9845371|NCT00842712|10957556|FG006|COMPLETED|Randomized Part||78
9961103|NCT01471522|11080816|FG001|STARTED|Overall Study||2591
9687392|NCT04188730|10787274|FG001|STARTED|Overall Study||4
10023703|NCT01857583|11147393|FG001|NOT COMPLETED|Overall Study||1
10023704|NCT01857583|11147394|FG002|NOT COMPLETED|Overall Study||3
10023705|NCT01857583|11147395|FG003|NOT COMPLETED|Overall Study||4
10023706|NCT01857622|11147408|FG000|STARTED|Overall Study||50
10023707|NCT01857622|11147409|FG001|STARTED|Overall Study||22
10023708|NCT01857622|11147410|FG002|STARTED|Overall Study||21
9687393|NCT04188730|10787275|FG002|STARTED|Overall Study||4
9687394|NCT04188730|10787276|FG003|STARTED|Overall Study||4
9687395|NCT04188730|10787273|FG000|Period 1|Overall Study||4
9687396|NCT04188730|10787274|FG001|Period 1|Overall Study||4
9687397|NCT04188730|10787275|FG002|Period 1|Overall Study||4
9687398|NCT04188730|10787276|FG003|Period 1|Overall Study||4
9687399|NCT04188730|10787273|FG000|Period 2|Overall Study||3
9687400|NCT04188730|10787274|FG001|Period 2|Overall Study||4
9687401|NCT04188730|10787275|FG002|Period 2|Overall Study||4
9687402|NCT04188730|10787276|FG003|Period 2|Overall Study||4
9687403|NCT04188730|10787273|FG000|Period 3|Overall Study||3
9687404|NCT04188730|10787274|FG001|Period 3|Overall Study||4
9687405|NCT04188730|10787275|FG002|Period 3|Overall Study||4
9687406|NCT04188730|10787276|FG003|Period 3|Overall Study||4
9687407|NCT04188730|10787273|FG000|COMPLETED|Overall Study||3
9687408|NCT04188730|10787274|FG001|COMPLETED|Overall Study||4
9687409|NCT04188730|10787275|FG002|COMPLETED|Overall Study||4
9687410|NCT04188730|10787276|FG003|COMPLETED|Overall Study||4
9687411|NCT04188730|10787273|FG000|NOT COMPLETED|Overall Study||1
9687412|NCT04188730|10787274|FG001|NOT COMPLETED|Overall Study||0
9687413|NCT04188730|10787275|FG002|NOT COMPLETED|Overall Study||0
9687414|NCT04188730|10787276|FG003|NOT COMPLETED|Overall Study||0
9687415|NCT04003142|10787290|FG000|STARTED|Double-blind Period (12 Weeks)||168
9687416|NCT04003142|10787291|FG001|STARTED|Double-blind Period (12 Weeks)||166
9687417|NCT04003142|10787292|FG002|STARTED|Double-blind Period (12 Weeks)||167
9687418|NCT04003142|10787293|FG003|STARTED|Double-blind Period (12 Weeks)||0
9687419|NCT04003142|10787294|FG004|STARTED|Double-blind Period (12 Weeks)||0
9687420|NCT04003142|10787290|FG000|Treated|Double-blind Period (12 Weeks)||167
9687421|NCT04003142|10787291|FG001|Treated|Double-blind Period (12 Weeks)||166
9687422|NCT04003142|10787292|FG002|Treated|Double-blind Period (12 Weeks)||167
9687423|NCT04003142|10787293|FG003|Treated|Double-blind Period (12 Weeks)||0
9687424|NCT04003142|10787294|FG004|Treated|Double-blind Period (12 Weeks)||0
9687425|NCT04003142|10787290|FG000|COMPLETED|Double-blind Period (12 Weeks)||151
9687426|NCT04003142|10787291|FG001|COMPLETED|Double-blind Period (12 Weeks)||152
9687427|NCT04003142|10787292|FG002|COMPLETED|Double-blind Period (12 Weeks)||155
9687428|NCT04003142|10787293|FG003|COMPLETED|Double-blind Period (12 Weeks)||0
9687429|NCT04003142|10787294|FG004|COMPLETED|Double-blind Period (12 Weeks)||0
9687430|NCT04003142|10787290|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||17
9687431|NCT04003142|10787291|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
9687432|NCT04003142|10787292|FG002|NOT COMPLETED|Double-blind Period (12 Weeks)||12
9687433|NCT04003142|10787293|FG003|NOT COMPLETED|Double-blind Period (12 Weeks)||0
9687434|NCT04003142|10787294|FG004|NOT COMPLETED|Double-blind Period (12 Weeks)||0
9687435|NCT04003142|10787290|FG000|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were moved to fezolinetant 30/45 mg arms in extension treatment period|0
9687436|NCT04003142|10787291|FG001|STARTED|Extension Period (40 Weeks)||152
9687437|NCT04003142|10787292|FG002|STARTED|Extension Period (40 Weeks)|One participant who completed double-blind period discontinued the study before entering the extension treatment period.|154
10023709|NCT01857622|11147408|FG000|COMPLETED|Overall Study||39
10023710|NCT01857622|11147409|FG001|COMPLETED|Overall Study||21
10023711|NCT01857622|11147410|FG002|COMPLETED|Overall Study||19
10023712|NCT01857622|11147408|FG000|NOT COMPLETED|Overall Study||11
10114266|NCT02515045|11244972|FG002|NOT COMPLETED|Overall Study||4
10114267|NCT02515058|11244982|FG000|STARTED|Overall Study||21
9687438|NCT04003142|10787293|FG003|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 30 mg arms|76
9687439|NCT04003142|10787294|FG004|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 45 mg arms|75
9687440|NCT04003142|10787290|FG000|COMPLETED|Extension Period (40 Weeks)||0
9687441|NCT04003142|10787291|FG001|COMPLETED|Extension Period (40 Weeks)||125
9687442|NCT04003142|10787292|FG002|COMPLETED|Extension Period (40 Weeks)||132
9687443|NCT04003142|10787293|FG003|COMPLETED|Extension Period (40 Weeks)||63
9687444|NCT04003142|10787294|FG004|COMPLETED|Extension Period (40 Weeks)||63
9687445|NCT04003142|10787290|FG000|NOT COMPLETED|Extension Period (40 Weeks)||0
9687446|NCT04003142|10787291|FG001|NOT COMPLETED|Extension Period (40 Weeks)||27
9687447|NCT04003142|10787292|FG002|NOT COMPLETED|Extension Period (40 Weeks)||22
9687448|NCT04003142|10787293|FG003|NOT COMPLETED|Extension Period (40 Weeks)||13
9687449|NCT04003142|10787294|FG004|NOT COMPLETED|Extension Period (40 Weeks)||12
9687450|NCT03909607|10787315|FG000|STARTED|Overall Study||40
9687451|NCT03909607|10787316|FG001|STARTED|Overall Study||40
9687452|NCT03909607|10787317|FG002|STARTED|Overall Study||40
9687453|NCT03909607|10787315|FG000|COMPLETED|Overall Study||35
9687454|NCT03909607|10787316|FG001|COMPLETED|Overall Study||36
9687455|NCT03909607|10787317|FG002|COMPLETED|Overall Study||38
9687456|NCT03909607|10787315|FG000|NOT COMPLETED|Overall Study||5
9687457|NCT03909607|10787316|FG001|NOT COMPLETED|Overall Study||4
9687458|NCT03909607|10787317|FG002|NOT COMPLETED|Overall Study||2
9687459|NCT03586050|10787325|FG000|STARTED|Overall Study||33
9687460|NCT03586050|10787325|FG000|COMPLETED|Overall Study||33
9687461|NCT03586050|10787325|FG000|NOT COMPLETED|Overall Study||0
9687462|NCT03430531|10787329|FG000|STARTED|Overall Study||6
9687463|NCT03430531|10787329|FG000|COMPLETED|Overall Study||6
9687464|NCT03430531|10787329|FG000|NOT COMPLETED|Overall Study||0
9687465|NCT03402841|10787333|FG000|STARTED|Overall Study||279
9687466|NCT03402841|10787333|FG000|COMPLETED|Overall Study||187
9687467|NCT03402841|10787333|FG000|NOT COMPLETED|Overall Study||92
9687468|NCT03383666|10787337|FG000|STARTED|Overall Study||21
9687469|NCT03383666|10787337|FG000|Implanted With Pulse Rider|Overall Study||18
9687470|NCT03383666|10787337|FG000|Attempted But Unsuccessful Implantation|Overall Study||3
9687471|NCT03383666|10787337|FG000|COMPLETED|Overall Study||17
9687472|NCT03383666|10787337|FG000|NOT COMPLETED|Overall Study||4
9687473|NCT03299049|10787343|FG000|STARTED|Overall Study||522
9687474|NCT03299049|10787344|FG001|STARTED|Overall Study||523
9687475|NCT03299049|10787343|FG000|COMPLETED|Overall Study||0
9687476|NCT03299049|10787344|FG001|COMPLETED|Overall Study||0
9687477|NCT03299049|10787343|FG000|NOT COMPLETED|Overall Study||522
9687478|NCT03299049|10787344|FG001|NOT COMPLETED|Overall Study||523
9687479|NCT03219333|10787359|FG000|STARTED|Overall Study||128
9687480|NCT03219333|10787360|FG001|STARTED|Overall Study||91
9687481|NCT03219333|10787359|FG000|Treated|Overall Study||125
9687482|NCT03219333|10787360|FG001|Treated|Overall Study||89
9687483|NCT03219333|10787359|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23
9687484|NCT03219333|10787360|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42
9687485|NCT03219333|10787359|FG000|NOT COMPLETED|Overall Study||105
9687486|NCT03219333|10787360|FG001|NOT COMPLETED|Overall Study||49
9687487|NCT02987543|10787370|FG000|STARTED|Overall Study||162
9687488|NCT02987543|10787371|FG001|STARTED|Overall Study||83
9687489|NCT02987543|10787372|FG002|STARTED|Overall Study||94
9687490|NCT02987543|10787373|FG003|STARTED|Overall Study||48
9687491|NCT02987543|10787370|FG000|COMPLETED|Overall Study||0
9687492|NCT02987543|10787371|FG001|COMPLETED|Overall Study||0
9687493|NCT02987543|10787372|FG002|COMPLETED|Overall Study||0
9687494|NCT02987543|10787373|FG003|COMPLETED|Overall Study||0
9687495|NCT02987543|10787370|FG000|NOT COMPLETED|Overall Study||162
9687496|NCT02987543|10787371|FG001|NOT COMPLETED|Overall Study||83
9687497|NCT02987543|10787372|FG002|NOT COMPLETED|Overall Study||94
9687498|NCT02987543|10787373|FG003|NOT COMPLETED|Overall Study||48
9687499|NCT02908685|10787391|FG000|STARTED|Part 1 Exploratory||7
9687500|NCT02908685|10787392|FG001|STARTED|Part 1 Exploratory||7
9687501|NCT02908685|10787393|FG002|STARTED|Part 1 Exploratory||3
9687502|NCT02908685|10787394|FG003|STARTED|Part 1 Exploratory||3
9687503|NCT02908685|10787395|FG004|STARTED|Part 1 Exploratory||7
9687504|NCT02908685|10787396|FG005|STARTED|Part 1 Exploratory||7
9687505|NCT02908685|10787397|FG006|STARTED|Part 1 Exploratory||7
9687506|NCT02908685|10787398|FG007|STARTED|Part 1 Exploratory||3
9687507|NCT02908685|10787399|FG008|STARTED|Part 1 Exploratory||4
9687508|NCT02908685|10787400|FG009|STARTED|Part 1 Exploratory||3
9687509|NCT02908685|10787401|FG010|STARTED|Part 1 Exploratory||0
9687510|NCT02908685|10787402|FG011|STARTED|Part 1 Exploratory||0
9687511|NCT02908685|10787391|FG000|COMPLETED|Part 1 Exploratory||7
9687512|NCT02908685|10787392|FG001|COMPLETED|Part 1 Exploratory||6
9687513|NCT02908685|10787393|FG002|COMPLETED|Part 1 Exploratory||3
9687514|NCT02908685|10787394|FG003|COMPLETED|Part 1 Exploratory||3
9687515|NCT02908685|10787395|FG004|COMPLETED|Part 1 Exploratory||7
9687516|NCT02908685|10787396|FG005|COMPLETED|Part 1 Exploratory||7
9687517|NCT02908685|10787397|FG006|COMPLETED|Part 1 Exploratory||7
9687518|NCT02908685|10787398|FG007|COMPLETED|Part 1 Exploratory||3
9687519|NCT02908685|10787399|FG008|COMPLETED|Part 1 Exploratory||4
9687520|NCT02908685|10787400|FG009|COMPLETED|Part 1 Exploratory||3
9687521|NCT02908685|10787401|FG010|COMPLETED|Part 1 Exploratory||0
9687522|NCT02908685|10787402|FG011|COMPLETED|Part 1 Exploratory||0
9687523|NCT02908685|10787391|FG000|NOT COMPLETED|Part 1 Exploratory||0
9687524|NCT02908685|10787392|FG001|NOT COMPLETED|Part 1 Exploratory||1
9687525|NCT02908685|10787393|FG002|NOT COMPLETED|Part 1 Exploratory||0
9687526|NCT02908685|10787394|FG003|NOT COMPLETED|Part 1 Exploratory||0
9687527|NCT02908685|10787395|FG004|NOT COMPLETED|Part 1 Exploratory||0
9687528|NCT02908685|10787396|FG005|NOT COMPLETED|Part 1 Exploratory||0
9687529|NCT02908685|10787397|FG006|NOT COMPLETED|Part 1 Exploratory||0
9687530|NCT02908685|10787398|FG007|NOT COMPLETED|Part 1 Exploratory||0
9687531|NCT02908685|10787399|FG008|NOT COMPLETED|Part 1 Exploratory||0
9687532|NCT02908685|10787400|FG009|NOT COMPLETED|Part 1 Exploratory||0
9687533|NCT02908685|10787401|FG010|NOT COMPLETED|Part 1 Exploratory||0
9687534|NCT02908685|10787402|FG011|NOT COMPLETED|Part 1 Exploratory||0
9687535|NCT02908685|10787391|FG000|STARTED|Part 2 Confirmatory||0
9687536|NCT02908685|10787392|FG001|STARTED|Part 2 Confirmatory||0
9687537|NCT02908685|10787393|FG002|STARTED|Part 2 Confirmatory||0
9687538|NCT02908685|10787394|FG003|STARTED|Part 2 Confirmatory||0
9687539|NCT02908685|10787395|FG004|STARTED|Part 2 Confirmatory||0
9687540|NCT02908685|10787396|FG005|STARTED|Part 2 Confirmatory||0
9687541|NCT02908685|10787397|FG006|STARTED|Part 2 Confirmatory||0
9687542|NCT02908685|10787398|FG007|STARTED|Part 2 Confirmatory||0
9687543|NCT02908685|10787399|FG008|STARTED|Part 2 Confirmatory||0
9687544|NCT02908685|10787400|FG009|STARTED|Part 2 Confirmatory||0
9687545|NCT02908685|10787401|FG010|STARTED|Part 2 Confirmatory||120
9687546|NCT02908685|10787402|FG011|STARTED|Part 2 Confirmatory||60
9687547|NCT02908685|10787391|FG000|COMPLETED|Part 2 Confirmatory||0
9687548|NCT02908685|10787392|FG001|COMPLETED|Part 2 Confirmatory||0
9687549|NCT02908685|10787393|FG002|COMPLETED|Part 2 Confirmatory||0
9687550|NCT02908685|10787394|FG003|COMPLETED|Part 2 Confirmatory||0
9687551|NCT02908685|10787395|FG004|COMPLETED|Part 2 Confirmatory||0
9687552|NCT02908685|10787396|FG005|COMPLETED|Part 2 Confirmatory||0
9687553|NCT02908685|10787397|FG006|COMPLETED|Part 2 Confirmatory||0
9687554|NCT02908685|10787398|FG007|COMPLETED|Part 2 Confirmatory||0
9687555|NCT02908685|10787399|FG008|COMPLETED|Part 2 Confirmatory||0
9687556|NCT02908685|10787400|FG009|COMPLETED|Part 2 Confirmatory||0
9687557|NCT02908685|10787401|FG010|COMPLETED|Part 2 Confirmatory||117
9687558|NCT02908685|10787402|FG011|COMPLETED|Part 2 Confirmatory||59
9687559|NCT02908685|10787391|FG000|NOT COMPLETED|Part 2 Confirmatory||0
9687560|NCT02908685|10787392|FG001|NOT COMPLETED|Part 2 Confirmatory||0
9687561|NCT02908685|10787393|FG002|NOT COMPLETED|Part 2 Confirmatory||0
9687562|NCT02908685|10787394|FG003|NOT COMPLETED|Part 2 Confirmatory||0
9687563|NCT02908685|10787395|FG004|NOT COMPLETED|Part 2 Confirmatory||0
9687564|NCT02908685|10787396|FG005|NOT COMPLETED|Part 2 Confirmatory||0
9687565|NCT02908685|10787397|FG006|NOT COMPLETED|Part 2 Confirmatory||0
9687566|NCT02908685|10787398|FG007|NOT COMPLETED|Part 2 Confirmatory||0
9687567|NCT02908685|10787399|FG008|NOT COMPLETED|Part 2 Confirmatory||0
9687568|NCT02908685|10787400|FG009|NOT COMPLETED|Part 2 Confirmatory||0
9687569|NCT02908685|10787401|FG010|NOT COMPLETED|Part 2 Confirmatory||3
9687570|NCT02908685|10787402|FG011|NOT COMPLETED|Part 2 Confirmatory||1
9687571|NCT02881957|10787421|FG000|STARTED|Overall Study||136
9687572|NCT02881957|10787422|FG001|STARTED|Overall Study||138
9687573|NCT02881957|10787421|FG000|COMPLETED|Overall Study||133
9687574|NCT02881957|10787422|FG001|COMPLETED|Overall Study||134
9687575|NCT02881957|10787421|FG000|NOT COMPLETED|Overall Study||3
9687576|NCT02881957|10787422|FG001|NOT COMPLETED|Overall Study||4
9687577|NCT02880189|10787428|FG000|STARTED|Overall Study||21
9687578|NCT02880189|10787428|FG000|COMPLETED|Overall Study||21
9687579|NCT02880189|10787428|FG000|NOT COMPLETED|Overall Study||0
9687580|NCT02761694|10787444|FG000|STARTED|Overall Study||4
9687581|NCT02761694|10787445|FG001|STARTED|Overall Study||4
9687582|NCT02761694|10787446|FG002|STARTED|Overall Study||1
10023713|NCT01857622|11147409|FG001|NOT COMPLETED|Overall Study||1
9687583|NCT02761694|10787447|FG003|STARTED|Overall Study||3
10023714|NCT01857622|11147410|FG002|NOT COMPLETED|Overall Study||2
9687584|NCT02761694|10787448|FG004|STARTED|Overall Study||3
9687585|NCT02761694|10787449|FG005|STARTED|Overall Study||3
9687586|NCT02761694|10787450|FG006|STARTED|Overall Study||33
9687587|NCT02761694|10787451|FG007|STARTED|Overall Study||8
9687588|NCT02761694|10787452|FG008|STARTED|Overall Study||5
9687589|NCT02761694|10787453|FG009|STARTED|Overall Study||5
9687590|NCT02761694|10787454|FG010|STARTED|Overall Study||3
9687591|NCT02761694|10787455|FG011|STARTED|Overall Study||6
9687592|NCT02761694|10787444|FG000|Treated|Overall Study||4
9687593|NCT02761694|10787445|FG001|Treated|Overall Study||4
9687594|NCT02761694|10787446|FG002|Treated|Overall Study||1
9687595|NCT02761694|10787447|FG003|Treated|Overall Study||3
9687596|NCT02761694|10787448|FG004|Treated|Overall Study||3
9687597|NCT02761694|10787449|FG005|Treated|Overall Study||3
9687598|NCT02761694|10787450|FG006|Treated|Overall Study||32
9687599|NCT02761694|10787451|FG007|Treated|Overall Study||8
9687600|NCT02761694|10787452|FG008|Treated|Overall Study||5
9687601|NCT02761694|10787453|FG009|Treated|Overall Study||5
9687602|NCT02761694|10787454|FG010|Treated|Overall Study||3
9687603|NCT02761694|10787455|FG011|Treated|Overall Study||6
9687604|NCT02761694|10787444|FG000|COMPLETED|Overall Study||0
9687605|NCT02761694|10787445|FG001|COMPLETED|Overall Study||0
9687606|NCT02761694|10787446|FG002|COMPLETED|Overall Study||0
9687607|NCT02761694|10787447|FG003|COMPLETED|Overall Study||0
9687608|NCT02761694|10787448|FG004|COMPLETED|Overall Study||0
9687609|NCT02761694|10787449|FG005|COMPLETED|Overall Study||0
9687610|NCT02761694|10787450|FG006|COMPLETED|Overall Study||0
9687611|NCT02761694|10787451|FG007|COMPLETED|Overall Study||0
9687612|NCT02761694|10787452|FG008|COMPLETED|Overall Study||0
9687613|NCT02761694|10787453|FG009|COMPLETED|Overall Study||0
9687614|NCT02761694|10787454|FG010|COMPLETED|Overall Study||0
9687615|NCT02761694|10787455|FG011|COMPLETED|Overall Study||0
9687616|NCT02761694|10787444|FG000|NOT COMPLETED|Overall Study||4
9687617|NCT02761694|10787445|FG001|NOT COMPLETED|Overall Study||4
9687618|NCT02761694|10787446|FG002|NOT COMPLETED|Overall Study||1
9687619|NCT02761694|10787447|FG003|NOT COMPLETED|Overall Study||3
9687620|NCT02761694|10787448|FG004|NOT COMPLETED|Overall Study||3
9687621|NCT02761694|10787449|FG005|NOT COMPLETED|Overall Study||3
9687622|NCT02761694|10787450|FG006|NOT COMPLETED|Overall Study||33
9687623|NCT02761694|10787451|FG007|NOT COMPLETED|Overall Study||8
9687624|NCT02761694|10787452|FG008|NOT COMPLETED|Overall Study||5
9687625|NCT02761694|10787453|FG009|NOT COMPLETED|Overall Study||5
9687626|NCT02761694|10787454|FG010|NOT COMPLETED|Overall Study||3
9687627|NCT02761694|10787455|FG011|NOT COMPLETED|Overall Study||6
9687628|NCT02611960|10787484|FG000|STARTED|Overall Study||117
9687629|NCT02611960|10787485|FG001|STARTED|Overall Study||116
9687630|NCT02611960|10787484|FG000|Treated|Overall Study||116
9687631|NCT02611960|10787485|FG001|Treated|Overall Study||112
9687632|NCT02611960|10787484|FG000|COMPLETED|Overall Study||0
9687633|NCT02611960|10787485|FG001|COMPLETED|Overall Study||0
9687634|NCT02611960|10787484|FG000|NOT COMPLETED|Overall Study||117
9687635|NCT02611960|10787485|FG001|NOT COMPLETED|Overall Study||116
9687636|NCT02574455|10787494|FG000|STARTED|Overall Study||267
9687637|NCT02574455|10787495|FG001|STARTED|Overall Study||262
9687638|NCT02574455|10787494|FG000|Enrolled and Treated|Overall Study||258
9687639|NCT02574455|10787495|FG001|Enrolled and Treated|Overall Study||224
9687640|NCT02574455|10787494|FG000|COMPLETED|Overall Study||0
9845372|NCT00842712|10957550|FG000|NOT COMPLETED|Randomized Part||0
9845373|NCT00842712|10957551|FG001|NOT COMPLETED|Randomized Part||0
9845374|NCT00842712|10957552|FG002|NOT COMPLETED|Randomized Part||0
9845375|NCT00842712|10957553|FG003|NOT COMPLETED|Randomized Part||0
9845376|NCT00842712|10957554|FG004|NOT COMPLETED|Randomized Part||0
9845377|NCT00842712|10957555|FG005|NOT COMPLETED|Randomized Part||1
9845378|NCT00842712|10957556|FG006|NOT COMPLETED|Randomized Part||6
9845379|NCT00842751|10957572|FG000|STARTED|Overall Study||11
9845380|NCT00842751|10957572|FG000|COMPLETED|Overall Study||11
9845381|NCT00842751|10957572|FG000|NOT COMPLETED|Overall Study||0
9845382|NCT00842764|10957585|FG000|STARTED|Overall Study||7
9845383|NCT00842764|10957585|FG000|COMPLETED|Overall Study||5
9845384|NCT00842764|10957585|FG000|NOT COMPLETED|Overall Study||2
9845385|NCT00842829|10957591|FG000|STARTED|Dose Titration Period||156
9845386|NCT00842829|10957592|FG001|STARTED|Dose Titration Period||174
9845387|NCT00842829|10957593|FG002|STARTED|Dose Titration Period||0
9845388|NCT00842829|10957591|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
9845389|NCT00842829|10957592|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
9845390|NCT00842829|10957593|FG002|Titration Safety Analysis Set|Dose Titration Period||0
9845391|NCT00842829|10957591|FG000|COMPLETED|Dose Titration Period||130
9687641|NCT02574455|10787495|FG001|COMPLETED|Overall Study||0
9687642|NCT02574455|10787494|FG000|NOT COMPLETED|Overall Study||267
9687643|NCT02574455|10787495|FG001|NOT COMPLETED|Overall Study||262
9687644|NCT02493660|10787503|FG000|STARTED|Overall Study|ITT|93
9687645|NCT02493660|10787504|FG001|STARTED|Overall Study|ITT|91
9687646|NCT02493660|10787503|FG000|COMPLETED|Overall Study||83
9687647|NCT02493660|10787504|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|79
9687648|NCT02493660|10787503|FG000|NOT COMPLETED|Overall Study||10
9687649|NCT02493660|10787504|FG001|NOT COMPLETED|Overall Study||12
9687650|NCT02232087|10787512|FG000|STARTED|Overall Study||9
9687651|NCT02232087|10787513|FG001|STARTED|Overall Study||10
9687652|NCT02232087|10787514|FG002|STARTED|Overall Study||8
9687653|NCT02232087|10787515|FG003|STARTED|Overall Study||8
9845392|NCT00842829|10957592|FG001|COMPLETED|Dose Titration Period||151
9845393|NCT00842829|10957593|FG002|COMPLETED|Dose Titration Period||0
9845394|NCT00842829|10957591|FG000|NOT COMPLETED|Dose Titration Period||26
9845395|NCT00842829|10957592|FG001|NOT COMPLETED|Dose Titration Period||23
9845396|NCT00842829|10957593|FG002|NOT COMPLETED|Dose Titration Period||0
9845397|NCT00842829|10957591|FG000|STARTED|Treatment Period||0
9845398|NCT00842829|10957592|FG001|STARTED|Treatment Period||0
9845399|NCT00842829|10957593|FG002|STARTED|Treatment Period||281
9845400|NCT00842829|10957591|FG000|Safety Analysis Set|Treatment Period||0
9845401|NCT00842829|10957592|FG001|Safety Analysis Set|Treatment Period||0
9845402|NCT00842829|10957593|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
9845403|NCT00842829|10957591|FG000|COMPLETED|Treatment Period||0
9845404|NCT00842829|10957592|FG001|COMPLETED|Treatment Period||0
9845405|NCT00842829|10957593|FG002|COMPLETED|Treatment Period||218
9845406|NCT00842829|10957591|FG000|NOT COMPLETED|Treatment Period||0
9845407|NCT00842829|10957592|FG001|NOT COMPLETED|Treatment Period||0
9845408|NCT00842829|10957593|FG002|NOT COMPLETED|Treatment Period||63
9845409|NCT00842829|10957591|FG000|STARTED|Continuation Period||0
9845410|NCT00842829|10957592|FG001|STARTED|Continuation Period||0
9845411|NCT00842829|10957593|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88
9845412|NCT00842829|10957591|FG000|Continuation Safety Analysis Set|Continuation Period||0
9845413|NCT00842829|10957592|FG001|Continuation Safety Analysis Set|Continuation Period||0
9845414|NCT00842829|10957593|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
9845415|NCT00842829|10957591|FG000|COMPLETED|Continuation Period||0
9845416|NCT00842829|10957592|FG001|COMPLETED|Continuation Period||0
9845417|NCT00842829|10957593|FG002|COMPLETED|Continuation Period||27
9845418|NCT00842829|10957591|FG000|NOT COMPLETED|Continuation Period||0
9845419|NCT00842829|10957592|FG001|NOT COMPLETED|Continuation Period||0
9845420|NCT00842829|10957593|FG002|NOT COMPLETED|Continuation Period||61
9845421|NCT00842946|10957607|FG000|STARTED|Overall Study||21
9845422|NCT00842946|10957608|FG001|STARTED|Overall Study||24
9845423|NCT00842946|10957607|FG000|COMPLETED|Overall Study||16
9845424|NCT00842946|10957608|FG001|COMPLETED|Overall Study||19
9845425|NCT00842946|10957607|FG000|NOT COMPLETED|Overall Study||5
9845426|NCT00842946|10957608|FG001|NOT COMPLETED|Overall Study||5
9845427|NCT00842985|10957614|FG000|STARTED|Screening||53
9845428|NCT00842985|10957614|FG000|COMPLETED|Screening||26
9961104|NCT01471522|11080815|FG000|COMPLETED|Overall Study||2524
9961105|NCT01471522|11080816|FG001|COMPLETED|Overall Study||2543
9961106|NCT01471522|11080815|FG000|NOT COMPLETED|Overall Study||64
9961107|NCT01471522|11080816|FG001|NOT COMPLETED|Overall Study||48
9961108|NCT01471574|11080827|FG000|STARTED|Treatment Period||132
9961109|NCT01471574|11080828|FG001|STARTED|Treatment Period||39
9961110|NCT01471574|11080829|FG002|STARTED|Treatment Period||106
9961111|NCT01471574|11080830|FG003|STARTED|Treatment Period||24
9961112|NCT01471574|11080827|FG000|COMPLETED|Treatment Period||101
9961113|NCT01471574|11080828|FG001|COMPLETED|Treatment Period||29
9961114|NCT01471574|11080829|FG002|COMPLETED|Treatment Period||82
9961115|NCT01471574|11080830|FG003|COMPLETED|Treatment Period||21
9961116|NCT01471574|11080827|FG000|NOT COMPLETED|Treatment Period||31
9961117|NCT01471574|11080828|FG001|NOT COMPLETED|Treatment Period||10
9961118|NCT01471574|11080829|FG002|NOT COMPLETED|Treatment Period||24
9687654|NCT02232087|10787516|FG004|STARTED|Overall Study||8
9845429|NCT00842985|10957614|FG000|NOT COMPLETED|Screening||27
9845430|NCT00842985|10957614|FG000|STARTED|First Intervention|Signed Consent|26
9845431|NCT00842985|10957614|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20
9845432|NCT00842985|10957614|FG000|NOT COMPLETED|First Intervention||6
9845433|NCT00842985|10957614|FG000|STARTED|Washout Period of GE 4 Days||20
9845434|NCT00842985|10957614|FG000|COMPLETED|Washout Period of GE 4 Days||18
9845435|NCT00842985|10957614|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
9961119|NCT01471574|11080830|FG003|NOT COMPLETED|Treatment Period||3
9961120|NCT01471574|11080827|FG000|STARTED|Follow-up Period||121
9687655|NCT02232087|10787517|FG005|STARTED|Overall Study||9
9687656|NCT02232087|10787512|FG000|COMPLETED|Overall Study||7
9687657|NCT02232087|10787513|FG001|COMPLETED|Overall Study||8
9687658|NCT02232087|10787514|FG002|COMPLETED|Overall Study||8
9687659|NCT02232087|10787515|FG003|COMPLETED|Overall Study||7
9687660|NCT02232087|10787516|FG004|COMPLETED|Overall Study||7
9687661|NCT02232087|10787517|FG005|COMPLETED|Overall Study||6
9687662|NCT02232087|10787512|FG000|NOT COMPLETED|Overall Study||2
9687663|NCT02232087|10787513|FG001|NOT COMPLETED|Overall Study||2
9687664|NCT02232087|10787514|FG002|NOT COMPLETED|Overall Study||0
9687665|NCT02232087|10787515|FG003|NOT COMPLETED|Overall Study||1
9687666|NCT02232087|10787516|FG004|NOT COMPLETED|Overall Study||1
9687667|NCT02232087|10787517|FG005|NOT COMPLETED|Overall Study||3
9687668|NCT02065154|10787536|FG000|STARTED|Overall Study||39
9687669|NCT02065154|10787536|FG000|COMPLETED|Overall Study||39
9687670|NCT02065154|10787536|FG000|NOT COMPLETED|Overall Study||0
9687671|NCT01952847|10787544|FG000|STARTED|Overall Study||27
9687672|NCT01952847|10787545|FG001|STARTED|Overall Study||26
9687673|NCT01952847|10787546|FG002|STARTED|Overall Study||7
9687674|NCT01952847|10787547|FG003|STARTED|Overall Study||7
9687675|NCT01952847|10787544|FG000|COMPLETED|Overall Study||25
9687676|NCT01952847|10787545|FG001|COMPLETED|Overall Study||24
9687677|NCT01952847|10787546|FG002|COMPLETED|Overall Study||7
9687678|NCT01952847|10787547|FG003|COMPLETED|Overall Study||6
9687679|NCT01952847|10787544|FG000|NOT COMPLETED|Overall Study||2
9687680|NCT01952847|10787545|FG001|NOT COMPLETED|Overall Study||2
9687681|NCT01952847|10787546|FG002|NOT COMPLETED|Overall Study||0
9687682|NCT01952847|10787547|FG003|NOT COMPLETED|Overall Study||1
9845436|NCT00842985|10957614|FG000|STARTED|Second Intervention||18
9845437|NCT00842985|10957614|FG000|COMPLETED|Second Intervention||17
9845438|NCT00842985|10957614|FG000|NOT COMPLETED|Second Intervention||1
9845439|NCT00842985|10957614|FG000|STARTED|Washout Period of GE 4 Days||17
9845440|NCT00842985|10957614|FG000|COMPLETED|Washout Period of GE 4 Days||15
9845441|NCT00842985|10957614|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
9845442|NCT00842985|10957614|FG000|STARTED|Third Intervention||15
9845443|NCT00842985|10957614|FG000|COMPLETED|Third Intervention||15
9845444|NCT00842985|10957614|FG000|NOT COMPLETED|Third Intervention||0
9845445|NCT00842985|10957614|FG000|STARTED|Washout Period of GE 4 Days||15
9845446|NCT00842985|10957614|FG000|COMPLETED|Washout Period of GE 4 Days||15
9845447|NCT00842985|10957614|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0
9845448|NCT00842985|10957614|FG000|STARTED|Fourth Intervention||15
9845449|NCT00842985|10957614|FG000|COMPLETED|Fourth Intervention||15
9845450|NCT00842985|10957614|FG000|NOT COMPLETED|Fourth Intervention||0
9845451|NCT00843024|10957625|FG000|STARTED|Single-blind Placebo Run-In Phase||408
9845452|NCT00843024|10957626|FG001|STARTED|Single-blind Placebo Run-In Phase||457
9845453|NCT00843024|10957627|FG002|STARTED|Single-blind Placebo Run-In Phase||0
9845454|NCT00843024|10957628|FG003|STARTED|Single-blind Placebo Run-In Phase||0
9845455|NCT00843024|10957629|FG004|STARTED|Single-blind Placebo Run-In Phase||0
9845456|NCT00843024|10957630|FG005|STARTED|Single-blind Placebo Run-In Phase||0
9845457|NCT00843024|10957625|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268
9845458|NCT00843024|10957626|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321
9845459|NCT00843024|10957627|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0
9845460|NCT00843024|10957628|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0
9845461|NCT00843024|10957629|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0
9845462|NCT00843024|10957630|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0
9845463|NCT00843024|10957625|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
9845464|NCT00843024|10957626|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
9845465|NCT00843024|10957627|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
9845466|NCT00843024|10957628|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
9845467|NCT00843024|10957629|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
9687683|NCT01889238|10787559|FG000|STARTED|Overall Study||118
9687684|NCT01889238|10787559|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
9687685|NCT01889238|10787559|FG000|NOT COMPLETED|Overall Study||9
9687686|NCT01740427|10787565|FG000|STARTED|Overall Study||444
9687687|NCT01740427|10787566|FG001|STARTED|Overall Study||222
9687688|NCT01740427|10787565|FG000|COMPLETED|Overall Study||0
9687689|NCT01740427|10787566|FG001|COMPLETED|Overall Study||0
9687690|NCT01740427|10787565|FG000|NOT COMPLETED|Overall Study||444
9687691|NCT01740427|10787566|FG001|NOT COMPLETED|Overall Study||222
9687692|NCT01672892|10787574|FG000|STARTED|Overall Study||137
9687693|NCT01672892|10787575|FG001|STARTED|Overall Study||152
9687694|NCT01672892|10787574|FG000|Eligible Population|Overall Study||130
9687695|NCT01672892|10787575|FG001|Eligible Population|Overall Study||149
9687696|NCT01672892|10787574|FG000|Adverse Event Population|Overall Study||125
9687697|NCT01672892|10787575|FG001|Adverse Event Population|Overall Study||144
9687698|NCT01672892|10787574|FG000|COMPLETED|Overall Study||130
9687699|NCT01672892|10787575|FG001|COMPLETED|Overall Study||149
9687700|NCT01672892|10787574|FG000|NOT COMPLETED|Overall Study||7
9687701|NCT01672892|10787575|FG001|NOT COMPLETED|Overall Study||3
9687702|NCT01560585|10787584|FG000|STARTED|Overall Study||3
9687703|NCT01560585|10787584|FG000|Screened|Overall Study|3 subjects screend and started treatment in open label|3
9687704|NCT01560585|10787584|FG000|COMPLETED|Overall Study|Study stopped due to adverse events One subject had transient loss of consciousness - possibly related to treatment One subject declined rapidly and found to have glioblastoma- not rrelated to treatment|0
9687705|NCT01560585|10787584|FG000|NOT COMPLETED|Overall Study||3
9687706|NCT00979212|10787591|FG000|STARTED|Overall Study||24
9687707|NCT00979212|10787592|FG001|STARTED|Overall Study||47
9687708|NCT00979212|10787591|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
9687709|NCT00979212|10787592|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
9687710|NCT00979212|10787591|FG000|NOT COMPLETED|Overall Study||2
9687711|NCT00979212|10787592|FG001|NOT COMPLETED|Overall Study||8
9687712|NCT00777491|10787600|FG000|STARTED|Overall Study||35
9687713|NCT00777491|10787601|FG001|STARTED|Overall Study||35
9687714|NCT00777491|10787600|FG000|Eligible|Overall Study||33
9687715|NCT00777491|10787601|FG001|Eligible|Overall Study||33
9687716|NCT00777491|10787600|FG000|Has 3-year Efficacy Data|Overall Study||27
9687717|NCT00777491|10787601|FG001|Has 3-year Efficacy Data|Overall Study||25
9687718|NCT00777491|10787600|FG000|Started Induction Therapy|Overall Study||33
9687719|NCT00777491|10787601|FG001|Started Induction Therapy|Overall Study||33
9687720|NCT00777491|10787600|FG000|Started Consolidation Therapy|Overall Study||29
9687721|NCT00777491|10787601|FG001|Started Consolidation Therapy|Overall Study||25
9687722|NCT00777491|10787600|FG000|Started Adjuvant Therapy|Overall Study||32
9687723|NCT00777491|10787601|FG001|Started Adjuvant Therapy|Overall Study||31
9687724|NCT00777491|10787600|FG000|Has Adverse Event Data (Treatment)|Overall Study||33
9687725|NCT00777491|10787601|FG001|Has Adverse Event Data (Treatment)|Overall Study||33
9687726|NCT00777491|10787600|FG000|Has Adverse Event Data (Late)|Overall Study||32
9687727|NCT00777491|10787601|FG001|Has Adverse Event Data (Late)|Overall Study||31
9687728|NCT00777491|10787600|FG000|Has 3 Year AUASI Data|Overall Study||6
9687729|NCT00777491|10787601|FG001|Has 3 Year AUASI Data|Overall Study||6
9687730|NCT00777491|10787600|FG000|COMPLETED|Overall Study||33
9687731|NCT00777491|10787601|FG001|COMPLETED|Overall Study||33
9687732|NCT00777491|10787600|FG000|NOT COMPLETED|Overall Study||2
9687733|NCT00777491|10787601|FG001|NOT COMPLETED|Overall Study||2
9687734|NCT00759655|10787607|FG000|STARTED|Overall Study||1
9687735|NCT00759655|10787607|FG000|COMPLETED|Overall Study||0
9687736|NCT00759655|10787607|FG000|NOT COMPLETED|Overall Study||1
9687737|NCT00145795|10787613|FG000|STARTED|Overall Study||10
9687738|NCT00145795|10787614|FG001|STARTED|Overall Study||10
9687739|NCT00145795|10787613|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
9687740|NCT00145795|10787614|FG001|COMPLETED|Overall Study||10
9687741|NCT00145795|10787613|FG000|NOT COMPLETED|Overall Study||1
9687742|NCT00145795|10787614|FG001|NOT COMPLETED|Overall Study||0
9687743|NCT00005044|10787622|FG000|STARTED|Overall Study||790
9687744|NCT00005044|10787623|FG001|STARTED|Overall Study||789
9687745|NCT00005044|10787622|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
9687746|NCT00005044|10787623|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
9687747|NCT00005044|10787622|FG000|NOT COMPLETED|Overall Study||38
9687748|NCT00005044|10787623|FG001|NOT COMPLETED|Overall Study||52
9687749|NCT00002874|10787631|FG000|STARTED|Overall Study||421
9687750|NCT00002874|10787632|FG001|STARTED|Overall Study||419
9687751|NCT00002874|10787631|FG000|COMPLETED|Overall Study||376
9687752|NCT00002874|10787632|FG001|COMPLETED|Overall Study||384
9687753|NCT00002874|10787631|FG000|NOT COMPLETED|Overall Study||45
9687754|NCT00002874|10787632|FG001|NOT COMPLETED|Overall Study||35
9726177|NCT00098722|10825729|FG004|NOT COMPLETED|Double Blind Phase||0
9726178|NCT00098722|10825730|FG005|NOT COMPLETED|Double Blind Phase||0
9726179|NCT00098722|10825731|FG006|NOT COMPLETED|Double Blind Phase||0
9726180|NCT00098722|10825725|FG000|STARTED|Open Label Phase||0
9726181|NCT00098722|10825726|FG001|STARTED|Open Label Phase||0
9726182|NCT00098722|10825727|FG002|STARTED|Open Label Phase||0
9726183|NCT00098722|10825728|FG003|STARTED|Open Label Phase||272
9726184|NCT00098722|10825729|FG004|STARTED|Open Label Phase||50
9726185|NCT00098722|10825730|FG005|STARTED|Open Label Phase||0
9726186|NCT00098722|10825731|FG006|STARTED|Open Label Phase||0
9726187|NCT00098722|10825725|FG000|COMPLETED|Open Label Phase||0
9726188|NCT00098722|10825726|FG001|COMPLETED|Open Label Phase||0
9726189|NCT00098722|10825727|FG002|COMPLETED|Open Label Phase||0
9726190|NCT00098722|10825728|FG003|COMPLETED|Open Label Phase||0
9726191|NCT00098722|10825729|FG004|COMPLETED|Open Label Phase||0
9726192|NCT00098722|10825730|FG005|COMPLETED|Open Label Phase||0
9726193|NCT00098722|10825731|FG006|COMPLETED|Open Label Phase||0
9726194|NCT00098722|10825725|FG000|NOT COMPLETED|Open Label Phase||0
9726195|NCT00098722|10825726|FG001|NOT COMPLETED|Open Label Phase||0
9726196|NCT00098722|10825727|FG002|NOT COMPLETED|Open Label Phase||0
9726197|NCT00098722|10825728|FG003|NOT COMPLETED|Open Label Phase||272
9726198|NCT00098722|10825729|FG004|NOT COMPLETED|Open Label Phase||50
9726199|NCT00098722|10825730|FG005|NOT COMPLETED|Open Label Phase||0
9726200|NCT00098722|10825731|FG006|NOT COMPLETED|Open Label Phase||0
9726201|NCT00098722|10825725|FG000|STARTED|Observation Phase||0
9726202|NCT00098722|10825726|FG001|STARTED|Observation Phase||0
9726203|NCT00098722|10825727|FG002|STARTED|Observation Phase||0
9726204|NCT00098722|10825728|FG003|STARTED|Observation Phase||0
9726205|NCT00098722|10825729|FG004|STARTED|Observation Phase||0
9726206|NCT00098722|10825730|FG005|STARTED|Observation Phase||205
9726207|NCT00098722|10825731|FG006|STARTED|Observation Phase||65
9726208|NCT00098722|10825725|FG000|COMPLETED|Observation Phase||0
9726209|NCT00098722|10825726|FG001|COMPLETED|Observation Phase||0
9726210|NCT00098722|10825727|FG002|COMPLETED|Observation Phase||0
9726211|NCT00098722|10825728|FG003|COMPLETED|Observation Phase||0
9726212|NCT00098722|10825729|FG004|COMPLETED|Observation Phase||0
9726213|NCT00098722|10825730|FG005|COMPLETED|Observation Phase||160
9726214|NCT00098722|10825731|FG006|COMPLETED|Observation Phase||48
9726215|NCT00098722|10825725|FG000|NOT COMPLETED|Observation Phase||0
9726216|NCT00098722|10825726|FG001|NOT COMPLETED|Observation Phase||0
9726217|NCT00098722|10825727|FG002|NOT COMPLETED|Observation Phase||0
9726218|NCT00098722|10825728|FG003|NOT COMPLETED|Observation Phase||0
9726219|NCT00098722|10825729|FG004|NOT COMPLETED|Observation Phase||0
9726220|NCT00098722|10825730|FG005|NOT COMPLETED|Observation Phase||45
9726221|NCT00098722|10825731|FG006|NOT COMPLETED|Observation Phase||17
9726222|NCT00098748|10825746|FG000|STARTED|Assigned to Study Treatment||63
9726223|NCT00098748|10825747|FG001|STARTED|Assigned to Study Treatment||63
9726224|NCT00098748|10825748|FG002|STARTED|Assigned to Study Treatment||64
9726225|NCT00098748|10825746|FG000|COMPLETED|Assigned to Study Treatment||63
9726226|NCT00098748|10825747|FG001|COMPLETED|Assigned to Study Treatment||61
9726227|NCT00098748|10825748|FG002|COMPLETED|Assigned to Study Treatment||62
9726228|NCT00098748|10825746|FG000|NOT COMPLETED|Assigned to Study Treatment||0
9726229|NCT00098748|10825747|FG001|NOT COMPLETED|Assigned to Study Treatment||2
9726230|NCT00098748|10825748|FG002|NOT COMPLETED|Assigned to Study Treatment||2
9726231|NCT00098748|10825746|FG000|STARTED|Received Study Treatment||63
9726232|NCT00098748|10825747|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
9726233|NCT00098748|10825748|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
9687755|NCT04391894|10787643|FG000|STARTED|Overall Study||111
9687756|NCT04391894|10787644|FG001|STARTED|Overall Study||112
9687757|NCT04391894|10787645|FG002|STARTED|Overall Study||112
9687758|NCT04391894|10787646|FG003|STARTED|Overall Study||109
9687759|NCT04391894|10787647|FG004|STARTED|Overall Study||114
9687760|NCT04391894|10787643|FG000|COMPLETED|Overall Study||107
9687761|NCT04391894|10787644|FG001|COMPLETED|Overall Study||111
9687762|NCT04391894|10787645|FG002|COMPLETED|Overall Study||108
9687763|NCT04391894|10787646|FG003|COMPLETED|Overall Study||107
10023715|NCT01857713|11147418|FG000|STARTED|Overall Study||95
10023716|NCT01857713|11147418|FG000|COMPLETED|Overall Study||89
10023717|NCT01857713|11147418|FG000|NOT COMPLETED|Overall Study||6
10023718|NCT01857869|11147434|FG000|STARTED|Primary/Challenge Phase||34
10023719|NCT01857869|11147435|FG001|STARTED|Primary/Challenge Phase||17
9687764|NCT04391894|10787647|FG004|COMPLETED|Overall Study||111
9687765|NCT04391894|10787643|FG000|NOT COMPLETED|Overall Study||4
9687766|NCT04391894|10787644|FG001|NOT COMPLETED|Overall Study||1
9687767|NCT04391894|10787645|FG002|NOT COMPLETED|Overall Study||4
9845468|NCT00843024|10957630|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
9845469|NCT00843024|10957625|FG000|STARTED|Double-blind Treatment Phase||0
9845470|NCT00843024|10957626|FG001|STARTED|Double-blind Treatment Phase||0
9845471|NCT00843024|10957627|FG002|STARTED|Double-blind Treatment Phase||176
9845472|NCT00843024|10957628|FG003|STARTED|Double-blind Treatment Phase||119
9845473|NCT00843024|10957629|FG004|STARTED|Double-blind Treatment Phase||117
9845474|NCT00843024|10957630|FG005|STARTED|Double-blind Treatment Phase||177
10023720|NCT01857869|11147436|FG002|STARTED|Primary/Challenge Phase||12
10023721|NCT01857869|11147437|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
9687768|NCT04391894|10787646|FG003|NOT COMPLETED|Overall Study||2
9687769|NCT04391894|10787647|FG004|NOT COMPLETED|Overall Study||3
9687770|NCT04151628|10787661|FG000|STARTED|Overall Study||8
9687771|NCT04151628|10787662|FG001|STARTED|Overall Study||64
9687772|NCT04151628|10787661|FG000|COMPLETED|Overall Study||8
9687773|NCT04151628|10787662|FG001|COMPLETED|Overall Study||64
9687774|NCT04151628|10787661|FG000|NOT COMPLETED|Overall Study||0
9687775|NCT04151628|10787662|FG001|NOT COMPLETED|Overall Study||0
9687776|NCT04097925|10787669|FG000|STARTED|Overall Study||30
9687777|NCT04097925|10787669|FG000|COMPLETED|Overall Study||29
9687778|NCT04097925|10787669|FG000|NOT COMPLETED|Overall Study||1
9687779|NCT03614663|10787675|FG000|STARTED|Overall Study||110
9687780|NCT03614663|10787676|FG001|STARTED|Overall Study||102
9687781|NCT03614663|10787675|FG000|COMPLETED|Overall Study||106
9687782|NCT03614663|10787676|FG001|COMPLETED|Overall Study||99
9687783|NCT03614663|10787675|FG000|NOT COMPLETED|Overall Study||4
9687784|NCT03614663|10787676|FG001|NOT COMPLETED|Overall Study||3
9687785|NCT03501966|10787687|FG000|STARTED|Overall Study||2
9687786|NCT03501966|10787688|FG001|STARTED|Overall Study||2
9687787|NCT03501966|10787689|FG002|STARTED|Overall Study||3
9687788|NCT03501966|10787687|FG000|COMPLETED|Overall Study||0
9687789|NCT03501966|10787688|FG001|COMPLETED|Overall Study||0
9687790|NCT03501966|10787689|FG002|COMPLETED|Overall Study||0
9687791|NCT03501966|10787687|FG000|NOT COMPLETED|Overall Study||2
9687792|NCT03501966|10787688|FG001|NOT COMPLETED|Overall Study||2
9687793|NCT03501966|10787689|FG002|NOT COMPLETED|Overall Study||3
9687794|NCT03489291|10787697|FG000|STARTED|Overall Study||3
9687795|NCT03489291|10787697|FG000|COMPLETED|Overall Study||3
9687796|NCT03489291|10787697|FG000|NOT COMPLETED|Overall Study||0
9687797|NCT03428100|10787705|FG000|STARTED|Overall Study||93
9687798|NCT03428100|10787706|FG001|STARTED|Overall Study||93
9687799|NCT03428100|10787707|FG002|STARTED|Overall Study||185
9687800|NCT03428100|10787708|FG003|STARTED|Overall Study||92
9687801|NCT03428100|10787705|FG000|Received at Least One Dose of Study Drug|Overall Study||93
9687802|NCT03428100|10787706|FG001|Received at Least One Dose of Study Drug|Overall Study||93
9687803|NCT03428100|10787707|FG002|Received at Least One Dose of Study Drug|Overall Study||184
9687804|NCT03428100|10787708|FG003|Received at Least One Dose of Study Drug|Overall Study||92
9687805|NCT03428100|10787705|FG000|COMPLETED|Overall Study||72
9687806|NCT03428100|10787706|FG001|COMPLETED|Overall Study||80
9687807|NCT03428100|10787707|FG002|COMPLETED|Overall Study||173
9687808|NCT03428100|10787708|FG003|COMPLETED|Overall Study||85
10081181|NCT02258373|11209658|FG001|STARTED|Overall Study||77
9687809|NCT03428100|10787705|FG000|NOT COMPLETED|Overall Study||21
9687810|NCT03428100|10787706|FG001|NOT COMPLETED|Overall Study||13
9687811|NCT03428100|10787707|FG002|NOT COMPLETED|Overall Study||12
9687812|NCT03428100|10787708|FG003|NOT COMPLETED|Overall Study||7
9687813|NCT03341936|10787728|FG000|STARTED|Overall Study||29
9687814|NCT03341936|10787728|FG000|Treated|Overall Study||28
9687815|NCT03341936|10787728|FG000|COMPLETED|Overall Study||18
9687816|NCT03341936|10787728|FG000|NOT COMPLETED|Overall Study||11
9687817|NCT03174353|10787732|FG000|STARTED|Overall Study||114
9687818|NCT03174353|10787732|FG000|COMPLETED|Overall Study||98
9687819|NCT03174353|10787732|FG000|NOT COMPLETED|Overall Study||16
9687820|NCT03144687|10787738|FG000|STARTED|Overall Study||13
9687821|NCT03144687|10787739|FG001|STARTED|Overall Study||10
9687822|NCT03144687|10787738|FG000|COMPLETED|Overall Study||10
9687823|NCT03144687|10787739|FG001|COMPLETED|Overall Study||3
9687824|NCT03144687|10787738|FG000|NOT COMPLETED|Overall Study||3
9687825|NCT03144687|10787739|FG001|NOT COMPLETED|Overall Study||7
9687826|NCT03090737|10787749|FG000|STARTED|Overall Study||129
9687827|NCT03090737|10787749|FG000|COMPLETED|Overall Study||98
9687828|NCT03090737|10787749|FG000|NOT COMPLETED|Overall Study||31
9687829|NCT02947646|10787755|FG000|STARTED|Overall Study||10
9687830|NCT02947646|10787756|FG001|STARTED|Overall Study||10
9687831|NCT02947646|10787755|FG000|COMPLETED|Overall Study||10
9687832|NCT02947646|10787756|FG001|COMPLETED|Overall Study||9
9687833|NCT02947646|10787755|FG000|NOT COMPLETED|Overall Study||0
9687834|NCT02947646|10787756|FG001|NOT COMPLETED|Overall Study||1
9687835|NCT02880371|10787772|FG000|STARTED|Phase 1b||6
9687836|NCT02880371|10787773|FG001|STARTED|Phase 1b||7
9687837|NCT02880371|10787774|FG002|STARTED|Phase 1b||7
9687838|NCT02880371|10787775|FG003|STARTED|Phase 1b||1
9687839|NCT02880371|10787776|FG004|STARTED|Phase 1b||0
9687840|NCT02880371|10787777|FG005|STARTED|Phase 1b||0
9687841|NCT02880371|10787778|FG006|STARTED|Phase 1b||0
9687842|NCT02880371|10787779|FG007|STARTED|Phase 1b||0
9687843|NCT02880371|10787772|FG000|Treated|Phase 1b||6
9687844|NCT02880371|10787773|FG001|Treated|Phase 1b||6
9687845|NCT02880371|10787774|FG002|Treated|Phase 1b||7
9687846|NCT02880371|10787775|FG003|Treated|Phase 1b||1
9687847|NCT02880371|10787776|FG004|Treated|Phase 1b||0
9687848|NCT02880371|10787777|FG005|Treated|Phase 1b||0
9687849|NCT02880371|10787778|FG006|Treated|Phase 1b||0
9687850|NCT02880371|10787779|FG007|Treated|Phase 1b||0
9687851|NCT02880371|10787772|FG000|COMPLETED|Phase 1b||0
9687852|NCT02880371|10787773|FG001|COMPLETED|Phase 1b||0
9687853|NCT02880371|10787774|FG002|COMPLETED|Phase 1b||1
9687854|NCT02880371|10787775|FG003|COMPLETED|Phase 1b||0
9687855|NCT02880371|10787776|FG004|COMPLETED|Phase 1b||0
9687856|NCT02880371|10787777|FG005|COMPLETED|Phase 1b||0
9687857|NCT02880371|10787778|FG006|COMPLETED|Phase 1b||0
9687858|NCT02880371|10787779|FG007|COMPLETED|Phase 1b||0
9687859|NCT02880371|10787772|FG000|NOT COMPLETED|Phase 1b||6
9687860|NCT02880371|10787773|FG001|NOT COMPLETED|Phase 1b||7
9687861|NCT02880371|10787774|FG002|NOT COMPLETED|Phase 1b||6
9687862|NCT02880371|10787775|FG003|NOT COMPLETED|Phase 1b||1
9687863|NCT02880371|10787776|FG004|NOT COMPLETED|Phase 1b||0
9687864|NCT02880371|10787777|FG005|NOT COMPLETED|Phase 1b||0
9687865|NCT02880371|10787778|FG006|NOT COMPLETED|Phase 1b||0
9687866|NCT02880371|10787779|FG007|NOT COMPLETED|Phase 1b||0
9687867|NCT02880371|10787772|FG000|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
9687868|NCT02880371|10787773|FG001|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
9687869|NCT02880371|10787774|FG002|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
9687870|NCT02880371|10787775|FG003|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
9687871|NCT02880371|10787776|FG004|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|2
9687872|NCT02880371|10787777|FG005|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|20
9687873|NCT02880371|10787778|FG006|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|28
9687874|NCT02880371|10787779|FG007|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|11
9687875|NCT02880371|10787772|FG000|Treated|Phase 2||0
9687876|NCT02880371|10787773|FG001|Treated|Phase 2||0
9687877|NCT02880371|10787774|FG002|Treated|Phase 2||0
9687878|NCT02880371|10787775|FG003|Treated|Phase 2||0
9687879|NCT02880371|10787776|FG004|Treated|Phase 2||2
9687880|NCT02880371|10787777|FG005|Treated|Phase 2||19
9687881|NCT02880371|10787778|FG006|Treated|Phase 2||27
9687882|NCT02880371|10787779|FG007|Treated|Phase 2||11
9687883|NCT02880371|10787772|FG000|COMPLETED|Phase 2||0
9687884|NCT02880371|10787773|FG001|COMPLETED|Phase 2||0
9687885|NCT02880371|10787774|FG002|COMPLETED|Phase 2||0
9687886|NCT02880371|10787775|FG003|COMPLETED|Phase 2||0
9687887|NCT02880371|10787776|FG004|COMPLETED|Phase 2||0
9687888|NCT02880371|10787777|FG005|COMPLETED|Phase 2||0
9687889|NCT02880371|10787778|FG006|COMPLETED|Phase 2||0
9687890|NCT02880371|10787779|FG007|COMPLETED|Phase 2||0
9687891|NCT02880371|10787772|FG000|NOT COMPLETED|Phase 2||0
9687892|NCT02880371|10787773|FG001|NOT COMPLETED|Phase 2||0
9687893|NCT02880371|10787774|FG002|NOT COMPLETED|Phase 2||0
9687894|NCT02880371|10787775|FG003|NOT COMPLETED|Phase 2||0
9687895|NCT02880371|10787776|FG004|NOT COMPLETED|Phase 2||2
9687896|NCT02880371|10787777|FG005|NOT COMPLETED|Phase 2||20
9687897|NCT02880371|10787778|FG006|NOT COMPLETED|Phase 2||28
9687898|NCT02880371|10787779|FG007|NOT COMPLETED|Phase 2||11
9687899|NCT02562235|10787799|FG000|STARTED|Overall Study||24
9687900|NCT02562235|10787799|FG000|COMPLETED|Overall Study||21
9687901|NCT02562235|10787799|FG000|NOT COMPLETED|Overall Study||3
9687902|NCT02477696|10787810|FG000|STARTED|Overall Study|3 patients withdrew after being randomized but prior to receiving Acalabrutinib treatment.|268
9687903|NCT02477696|10787811|FG001|STARTED|Overall Study|1 patient withdrew after being randomized but prior to receiving Ibrutinib treatment.|265
9687904|NCT02477696|10787810|FG000|COMPLETED|Overall Study||127
9687905|NCT02477696|10787811|FG001|COMPLETED|Overall Study||110
9687906|NCT02477696|10787810|FG000|NOT COMPLETED|Overall Study||141
9687907|NCT02477696|10787811|FG001|NOT COMPLETED|Overall Study||155
9687908|NCT02434354|10787817|FG000|STARTED|Overall Study|Consented|33
9687909|NCT02434354|10787817|FG000|Post Consent Screening|Overall Study||30
9687910|NCT02434354|10787817|FG000|COMPLETED|Overall Study||30
9687911|NCT02434354|10787817|FG000|NOT COMPLETED|Overall Study||3
9687912|NCT02419417|10787832|FG000|STARTED|Overall Study||5
9687913|NCT02419417|10787833|FG001|STARTED|Overall Study||4
9687914|NCT02419417|10787834|FG002|STARTED|Overall Study||13
9687915|NCT02419417|10787835|FG003|STARTED|Overall Study||10
9687916|NCT02419417|10787836|FG004|STARTED|Overall Study||13
9687917|NCT02419417|10787837|FG005|STARTED|Overall Study||4
9687918|NCT02419417|10787838|FG006|STARTED|Overall Study||4
9687919|NCT02419417|10787839|FG007|STARTED|Overall Study||6
9687920|NCT02419417|10787840|FG008|STARTED|Overall Study||13
9687921|NCT02419417|10787841|FG009|STARTED|Overall Study||10
9687922|NCT02419417|10787842|FG010|STARTED|Overall Study||1
9687923|NCT02419417|10787832|FG000|COMPLETED|Overall Study||0
9687924|NCT02419417|10787833|FG001|COMPLETED|Overall Study||0
9687925|NCT02419417|10787834|FG002|COMPLETED|Overall Study||0
9687926|NCT02419417|10787835|FG003|COMPLETED|Overall Study||0
9687927|NCT02419417|10787836|FG004|COMPLETED|Overall Study||0
9687928|NCT02419417|10787837|FG005|COMPLETED|Overall Study||0
9687929|NCT02419417|10787838|FG006|COMPLETED|Overall Study||0
9687930|NCT02419417|10787839|FG007|COMPLETED|Overall Study||0
9845475|NCT00843024|10957625|FG000|COMPLETED|Double-blind Treatment Phase||0
9845476|NCT00843024|10957626|FG001|COMPLETED|Double-blind Treatment Phase||0
9845477|NCT00843024|10957627|FG002|COMPLETED|Double-blind Treatment Phase||145
9845478|NCT00843024|10957628|FG003|COMPLETED|Double-blind Treatment Phase||96
9845479|NCT00843024|10957629|FG004|COMPLETED|Double-blind Treatment Phase||97
9845480|NCT00843024|10957630|FG005|COMPLETED|Double-blind Treatment Phase||152
9845481|NCT00843024|10957625|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
9845482|NCT00843024|10957626|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
9845483|NCT00843024|10957627|FG002|NOT COMPLETED|Double-blind Treatment Phase||31
9845484|NCT00843024|10957628|FG003|NOT COMPLETED|Double-blind Treatment Phase||23
9845485|NCT00843024|10957629|FG004|NOT COMPLETED|Double-blind Treatment Phase||20
9845486|NCT00843024|10957630|FG005|NOT COMPLETED|Double-blind Treatment Phase||25
9845487|NCT00843115|10957643|FG000|STARTED|Overall Study||370
9845488|NCT00843115|10957643|FG000|COMPLETED|Overall Study||304
9845489|NCT00843115|10957643|FG000|NOT COMPLETED|Overall Study||66
9845490|NCT00843167|10957649|FG000|STARTED|Treatment Period||27
9845491|NCT00843167|10957650|FG001|STARTED|Treatment Period||27
9845492|NCT00843167|10957649|FG000|COMPLETED|Treatment Period||24
9845493|NCT00843167|10957650|FG001|COMPLETED|Treatment Period||19
9845494|NCT00843167|10957649|FG000|NOT COMPLETED|Treatment Period||3
9845495|NCT00843167|10957650|FG001|NOT COMPLETED|Treatment Period||8
9845496|NCT00843167|10957649|FG000|STARTED|Follow-up||24
9845497|NCT00843167|10957650|FG001|STARTED|Follow-up||24
9845498|NCT00843167|10957649|FG000|Completed Final Visit|Follow-up||24
9845499|NCT00843167|10957650|FG001|Completed Final Visit|Follow-up||24
9845500|NCT00843167|10957649|FG000|COMPLETED|Follow-up||24
9845501|NCT00843167|10957650|FG001|COMPLETED|Follow-up||24
9845502|NCT00843167|10957649|FG000|NOT COMPLETED|Follow-up||0
9845503|NCT00843167|10957650|FG001|NOT COMPLETED|Follow-up||0
9845504|NCT00843180|10957662|FG000|STARTED|Overall Study||16
9845505|NCT00843180|10957663|FG001|STARTED|Overall Study||7
9845506|NCT00843180|10957662|FG000|COMPLETED|Overall Study||16
9845507|NCT00843180|10957663|FG001|COMPLETED|Overall Study||7
9845508|NCT00843180|10957662|FG000|NOT COMPLETED|Overall Study||0
9845509|NCT00843180|10957663|FG001|NOT COMPLETED|Overall Study||0
9845510|NCT00843193|10957671|FG000|STARTED|Overall Study||99
9961121|NCT01471574|11080828|FG001|STARTED|Follow-up Period||34
9961122|NCT01471574|11080829|FG002|STARTED|Follow-up Period||102
9961123|NCT01471574|11080830|FG003|STARTED|Follow-up Period||24
9961124|NCT01471574|11080827|FG000|COMPLETED|Follow-up Period||114
9961125|NCT01471574|11080828|FG001|COMPLETED|Follow-up Period||32
9961126|NCT01471574|11080829|FG002|COMPLETED|Follow-up Period||95
9961127|NCT01471574|11080830|FG003|COMPLETED|Follow-up Period||21
9961128|NCT01471574|11080827|FG000|NOT COMPLETED|Follow-up Period||7
9961129|NCT01471574|11080828|FG001|NOT COMPLETED|Follow-up Period||2
9961130|NCT01471574|11080829|FG002|NOT COMPLETED|Follow-up Period||7
9961131|NCT01471574|11080830|FG003|NOT COMPLETED|Follow-up Period||3
9961132|NCT01471626|11080846|FG000|STARTED|Overall Study||21
9961133|NCT01471626|11080846|FG000|COMPLETED|Overall Study||21
9961134|NCT01471626|11080846|FG000|NOT COMPLETED|Overall Study||0
9961135|NCT01471639|11080850|FG000|STARTED|Overall Study||37
9961136|NCT01471639|11080850|FG000|COMPLETED|Overall Study||37
9961137|NCT01471639|11080850|FG000|NOT COMPLETED|Overall Study||0
9845511|NCT00843193|10957672|FG001|STARTED|Overall Study||99
9961138|NCT01471691|11080856|FG000|STARTED|Overall Study||8
9961139|NCT01471691|11080857|FG001|STARTED|Overall Study||6
9961140|NCT01471691|11080856|FG000|COMPLETED|Overall Study||8
9961141|NCT01471691|11080857|FG001|COMPLETED|Overall Study||5
9687931|NCT02419417|10787840|FG008|COMPLETED|Overall Study||0
9687932|NCT02419417|10787841|FG009|COMPLETED|Overall Study||0
9687933|NCT02419417|10787842|FG010|COMPLETED|Overall Study||0
9687934|NCT02419417|10787832|FG000|NOT COMPLETED|Overall Study||5
9687935|NCT02419417|10787833|FG001|NOT COMPLETED|Overall Study||4
9687936|NCT02419417|10787834|FG002|NOT COMPLETED|Overall Study||13
9845512|NCT00843193|10957671|FG000|COMPLETED|Overall Study||91
9845513|NCT00843193|10957672|FG001|COMPLETED|Overall Study||88
9845514|NCT00843193|10957671|FG000|NOT COMPLETED|Overall Study||8
9845515|NCT00843193|10957672|FG001|NOT COMPLETED|Overall Study||11
9961142|NCT01471691|11080856|FG000|NOT COMPLETED|Overall Study||0
9961143|NCT01471691|11080857|FG001|NOT COMPLETED|Overall Study||1
9687937|NCT02419417|10787835|FG003|NOT COMPLETED|Overall Study||10
9687938|NCT02419417|10787836|FG004|NOT COMPLETED|Overall Study||13
9687939|NCT02419417|10787837|FG005|NOT COMPLETED|Overall Study||4
9687940|NCT02419417|10787838|FG006|NOT COMPLETED|Overall Study||4
9687941|NCT02419417|10787839|FG007|NOT COMPLETED|Overall Study||6
9687942|NCT02419417|10787840|FG008|NOT COMPLETED|Overall Study||13
9687943|NCT02419417|10787841|FG009|NOT COMPLETED|Overall Study||10
9687944|NCT02419417|10787842|FG010|NOT COMPLETED|Overall Study||1
9687945|NCT02395120|10787876|FG000|STARTED|Overall Study|Caregivers and Children|400
9687946|NCT02395120|10787877|FG001|STARTED|Overall Study|Caregivers and Children|398
9687947|NCT02395120|10787878|FG002|STARTED|Overall Study|Caregivers and Children|43
9687948|NCT02395120|10787879|FG003|STARTED|Overall Study|Caregivers and Children|63
9687949|NCT02395120|10787880|FG004|STARTED|Overall Study|Caregivers and Children|401
9687950|NCT02395120|10787876|FG000|Started-Caregivers|Overall Study||188
9687951|NCT02395120|10787877|FG001|Started-Caregivers|Overall Study||188
9687952|NCT02395120|10787878|FG002|Started-Caregivers|Overall Study||20
9687953|NCT02395120|10787879|FG003|Started-Caregivers|Overall Study||28
9687954|NCT02395120|10787880|FG004|Started-Caregivers|Overall Study||187
9687955|NCT02395120|10787876|FG000|Started-Children|Overall Study||212
9687956|NCT02395120|10787877|FG001|Started-Children|Overall Study||210
9687957|NCT02395120|10787878|FG002|Started-Children|Overall Study||23
9687958|NCT02395120|10787879|FG003|Started-Children|Overall Study||35
9687959|NCT02395120|10787880|FG004|Started-Children|Overall Study||214
9687960|NCT02395120|10787876|FG000|Completed-Caregivers|Overall Study||161
9687961|NCT02395120|10787877|FG001|Completed-Caregivers|Overall Study||159
9687962|NCT02395120|10787878|FG002|Completed-Caregivers|Overall Study||17
9687963|NCT02395120|10787879|FG003|Completed-Caregivers|Overall Study||25
9687964|NCT02395120|10787880|FG004|Completed-Caregivers|Overall Study||164
9687965|NCT02395120|10787876|FG000|Completed-Children|Overall Study||182
9687966|NCT02395120|10787877|FG001|Completed-Children|Overall Study||177
9687967|NCT02395120|10787878|FG002|Completed-Children|Overall Study||20
9687968|NCT02395120|10787879|FG003|Completed-Children|Overall Study||32
9687969|NCT02395120|10787880|FG004|Completed-Children|Overall Study||186
9687970|NCT02395120|10787876|FG000|COMPLETED|Overall Study|Caregivers and Children|343
9687971|NCT02395120|10787877|FG001|COMPLETED|Overall Study|Caregivers and Children|336
9687972|NCT02395120|10787878|FG002|COMPLETED|Overall Study|Caregivers and Children|37
9687973|NCT02395120|10787879|FG003|COMPLETED|Overall Study|Caregivers and Children|57
9687974|NCT02395120|10787880|FG004|COMPLETED|Overall Study|Caregivers and Children|350
9687975|NCT02395120|10787876|FG000|NOT COMPLETED|Overall Study||57
9687976|NCT02395120|10787877|FG001|NOT COMPLETED|Overall Study||62
9687977|NCT02395120|10787878|FG002|NOT COMPLETED|Overall Study||6
9687978|NCT02395120|10787879|FG003|NOT COMPLETED|Overall Study||6
9687979|NCT02395120|10787880|FG004|NOT COMPLETED|Overall Study||51
9687980|NCT02342275|10787894|FG000|STARTED|Overall Study||190
9687981|NCT02342275|10787895|FG001|STARTED|Overall Study||187
9687982|NCT02342275|10787894|FG000|COMPLETED|Overall Study||184
9687983|NCT02342275|10787895|FG001|COMPLETED|Overall Study||182
9687984|NCT02342275|10787894|FG000|NOT COMPLETED|Overall Study||6
9687985|NCT02342275|10787895|FG001|NOT COMPLETED|Overall Study||5
9687986|NCT02075840|10787904|FG000|STARTED|Overall Study||152
9687987|NCT02075840|10787905|FG001|STARTED|Overall Study||151
9687988|NCT02075840|10787904|FG000|COMPLETED|Overall Study||0
9687989|NCT02075840|10787905|FG001|COMPLETED|Overall Study||0
9687990|NCT02075840|10787904|FG000|NOT COMPLETED|Overall Study||152
9687991|NCT02075840|10787905|FG001|NOT COMPLETED|Overall Study||151
9845516|NCT00843284|10957679|FG000|STARTED|Overall Study||691
9845517|NCT00843284|10957679|FG000|COMPLETED|Overall Study||619
9845518|NCT00843284|10957679|FG000|NOT COMPLETED|Overall Study||72
9845519|NCT00843349|10957687|FG000|STARTED|Overall Study||11
9845520|NCT00843349|10957688|FG001|STARTED|Overall Study||11
9845521|NCT00843349|10957689|FG002|STARTED|Overall Study||10
9845522|NCT00843349|10957690|FG003|STARTED|Overall Study||11
9845523|NCT00843349|10957687|FG000|COMPLETED|Overall Study||8
9845524|NCT00843349|10957688|FG001|COMPLETED|Overall Study||11
9845525|NCT00843349|10957689|FG002|COMPLETED|Overall Study||10
9845526|NCT00843349|10957690|FG003|COMPLETED|Overall Study||10
9845527|NCT00843349|10957687|FG000|NOT COMPLETED|Overall Study||3
9845528|NCT00843349|10957688|FG001|NOT COMPLETED|Overall Study||0
9687992|NCT02051608|10787915|FG000|STARTED|Part 1: Double Blind Treatment||195
9687993|NCT02051608|10787916|FG001|STARTED|Part 1: Double Blind Treatment||192
9687994|NCT02051608|10787917|FG002|STARTED|Part 1: Double Blind Treatment||0
9687995|NCT02051608|10787918|FG003|STARTED|Part 1: Double Blind Treatment||0
9687996|NCT02051608|10787915|FG000|COMPLETED|Part 1: Double Blind Treatment||134
9687997|NCT02051608|10787916|FG001|COMPLETED|Part 1: Double Blind Treatment||136
9845529|NCT00843349|10957689|FG002|NOT COMPLETED|Overall Study||0
9845530|NCT00843349|10957690|FG003|NOT COMPLETED|Overall Study||1
9845531|NCT00843466|10957702|FG000|STARTED|Overall Study||24
9845532|NCT00843466|10957703|FG001|STARTED|Overall Study||18
9687998|NCT02051608|10787917|FG002|COMPLETED|Part 1: Double Blind Treatment||0
9687999|NCT02051608|10787918|FG003|COMPLETED|Part 1: Double Blind Treatment||0
9688000|NCT02051608|10787915|FG000|NOT COMPLETED|Part 1: Double Blind Treatment||61
9688001|NCT02051608|10787916|FG001|NOT COMPLETED|Part 1: Double Blind Treatment||56
9688002|NCT02051608|10787917|FG002|NOT COMPLETED|Part 1: Double Blind Treatment||0
9688003|NCT02051608|10787918|FG003|NOT COMPLETED|Part 1: Double Blind Treatment||0
9688004|NCT02051608|10787915|FG000|STARTED|Part 2: Open-label Extension||0
9688005|NCT02051608|10787916|FG001|STARTED|Part 2: Open-label Extension||0
9688006|NCT02051608|10787917|FG002|STARTED|Part 2: Open-label Extension||119
9688007|NCT02051608|10787918|FG003|STARTED|Part 2: Open-label Extension||111
9688008|NCT02051608|10787915|FG000|COMPLETED|Part 2: Open-label Extension||0
9688009|NCT02051608|10787916|FG001|COMPLETED|Part 2: Open-label Extension||0
9688010|NCT02051608|10787917|FG002|COMPLETED|Part 2: Open-label Extension||49
9688011|NCT02051608|10787918|FG003|COMPLETED|Part 2: Open-label Extension||50
9688012|NCT02051608|10787915|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
9688013|NCT02051608|10787916|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
9688014|NCT02051608|10787917|FG002|NOT COMPLETED|Part 2: Open-label Extension||70
9688015|NCT02051608|10787918|FG003|NOT COMPLETED|Part 2: Open-label Extension||61
9688016|NCT02015832|10787931|FG000|STARTED|Overall Study||454
9688017|NCT02015832|10787931|FG000|COMPLETED|Overall Study||443
9688018|NCT02015832|10787931|FG000|NOT COMPLETED|Overall Study||11
9688019|NCT01850524|10787942|FG000|STARTED|Overall Study||354
9688020|NCT01850524|10787943|FG001|STARTED|Overall Study||351
9688021|NCT01850524|10787942|FG000|Intent-to-Treat (ITT) Population|Overall Study||354
9688022|NCT01850524|10787943|FG001|Intent-to-Treat (ITT) Population|Overall Study||351
9688023|NCT01850524|10787942|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
9688024|NCT01850524|10787943|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
9688025|NCT01850524|10787942|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||270
9688026|NCT01850524|10787943|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||264
9688027|NCT01850524|10787942|FG000|Per Protocol (PP) Population|Overall Study||295
9688028|NCT01850524|10787943|FG001|Per Protocol (PP) Population|Overall Study||298
9688029|NCT01850524|10787942|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
9688030|NCT01850524|10787943|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
9688031|NCT01850524|10787942|FG000|COMPLETED|Overall Study||0
9688032|NCT01850524|10787943|FG001|COMPLETED|Overall Study||0
9688033|NCT01850524|10787942|FG000|NOT COMPLETED|Overall Study||354
9688034|NCT01850524|10787943|FG001|NOT COMPLETED|Overall Study||351
9688035|NCT01700673|10787954|FG000|STARTED|Overall Study||1
9688036|NCT01700673|10787955|FG001|STARTED|Overall Study||23
9688037|NCT01700673|10787956|FG002|STARTED|Overall Study||1
9688038|NCT01700673|10787954|FG000|COMPLETED|Overall Study||1
9688039|NCT01700673|10787955|FG001|COMPLETED|Overall Study||17
9688040|NCT01700673|10787956|FG002|COMPLETED|Overall Study||1
9688041|NCT01700673|10787954|FG000|NOT COMPLETED|Overall Study||0
9688042|NCT01700673|10787955|FG001|NOT COMPLETED|Overall Study||6
9688043|NCT01700673|10787956|FG002|NOT COMPLETED|Overall Study||0
9688044|NCT01531374|10787968|FG000|STARTED|Overall Study||1285
9688045|NCT01531374|10787969|FG001|STARTED|Overall Study||373
9688046|NCT01531374|10787970|FG002|STARTED|Overall Study||1119
9688047|NCT01531374|10787968|FG000|COMPLETED|Overall Study||921
10023722|NCT01857869|11147438|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023723|NCT01857869|11147439|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
9688048|NCT01531374|10787969|FG001|COMPLETED|Overall Study||231
9688049|NCT01531374|10787970|FG002|COMPLETED|Overall Study||836
9688050|NCT01531374|10787968|FG000|NOT COMPLETED|Overall Study||364
9688051|NCT01531374|10787969|FG001|NOT COMPLETED|Overall Study||142
9688052|NCT01531374|10787970|FG002|NOT COMPLETED|Overall Study||283
9688053|NCT01240902|10787984|FG000|STARTED|Overall Study||500
9688054|NCT01240902|10787985|FG001|STARTED|Overall Study||156
9688055|NCT01240902|10787986|FG002|STARTED|Overall Study||395
9688056|NCT01240902|10787987|FG003|STARTED|Overall Study||402
9688057|NCT01240902|10787984|FG000|COMPLETED|Overall Study||289
9688058|NCT01240902|10787985|FG001|COMPLETED|Overall Study||77
9688059|NCT01240902|10787986|FG002|COMPLETED|Overall Study||295
9688060|NCT01240902|10787987|FG003|COMPLETED|Overall Study||237
9688061|NCT01240902|10787984|FG000|NOT COMPLETED|Overall Study||211
9688062|NCT01240902|10787985|FG001|NOT COMPLETED|Overall Study||79
9688063|NCT01240902|10787986|FG002|NOT COMPLETED|Overall Study||100
9688064|NCT01240902|10787987|FG003|NOT COMPLETED|Overall Study||165
9688065|NCT00726596|10787999|FG000|STARTED|Overall Study||36
9688066|NCT00726596|10788000|FG001|STARTED|Overall Study||28
9688067|NCT00726596|10787999|FG000|COMPLETED|Overall Study||31
9688068|NCT00726596|10788000|FG001|COMPLETED|Overall Study||24
9688069|NCT00726596|10787999|FG000|NOT COMPLETED|Overall Study||5
9688070|NCT00726596|10788000|FG001|NOT COMPLETED|Overall Study||4
9688071|NCT00489827|10788008|FG000|STARTED|Overall Study||430
9688072|NCT00489827|10788009|FG001|STARTED|Overall Study||435
9688073|NCT00489827|10788008|FG000|COMPLETED|Overall Study||428
9688074|NCT00489827|10788009|FG001|COMPLETED|Overall Study||433
9688075|NCT00489827|10788008|FG000|NOT COMPLETED|Overall Study||2
9688076|NCT00489827|10788009|FG001|NOT COMPLETED|Overall Study||2
9688077|NCT00278915|10788015|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
9688078|NCT00278915|10788015|FG000|COMPLETED|Overall Study||29
9688079|NCT00278915|10788015|FG000|NOT COMPLETED|Overall Study||1
9726234|NCT00098748|10825746|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
9726235|NCT00098748|10825747|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
9726236|NCT00098748|10825748|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
9726237|NCT00098748|10825746|FG000|COMPLETED|Received Study Treatment||15
9726238|NCT00098748|10825747|FG001|COMPLETED|Received Study Treatment||25
9726239|NCT00098748|10825748|FG002|COMPLETED|Received Study Treatment||18
9726240|NCT00098748|10825746|FG000|NOT COMPLETED|Received Study Treatment||48
9726241|NCT00098748|10825747|FG001|NOT COMPLETED|Received Study Treatment||36
9726242|NCT00098748|10825748|FG002|NOT COMPLETED|Received Study Treatment||44
9726243|NCT00098748|10825746|FG000|STARTED|Continued on Open-Label Treatment||15
9726244|NCT00098748|10825747|FG001|STARTED|Continued on Open-Label Treatment||25
9726245|NCT00098748|10825748|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
9726246|NCT00098748|10825746|FG000|COMPLETED|Continued on Open-Label Treatment||7
9726247|NCT00098748|10825747|FG001|COMPLETED|Continued on Open-Label Treatment||10
9726248|NCT00098748|10825748|FG002|COMPLETED|Continued on Open-Label Treatment||0
9726249|NCT00098748|10825746|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8
9726250|NCT00098748|10825747|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15
9726251|NCT00098748|10825748|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0
9726252|NCT00098774|10825756|FG000|STARTED|Overall Study||44
9726253|NCT00098774|10825756|FG000|COMPLETED|Overall Study||26
9726254|NCT00098774|10825756|FG000|NOT COMPLETED|Overall Study||18
9726255|NCT00098787|10825763|FG000|STARTED|Overall Study||73
9726256|NCT00098787|10825764|FG001|STARTED|Overall Study||75
9726257|NCT00098787|10825765|FG002|STARTED|Overall Study||63
9726258|NCT00098787|10825763|FG000|Treated|Overall Study||70
9726259|NCT00098787|10825764|FG001|Treated|Overall Study||73
9726260|NCT00098787|10825765|FG002|Treated|Overall Study||62
9726261|NCT00098787|10825763|FG000|Eligible and Treated|Overall Study||61
9726262|NCT00098787|10825764|FG001|Eligible and Treated|Overall Study||66
9726263|NCT00098787|10825765|FG002|Eligible and Treated|Overall Study||59
9688080|NCT04505722|10788021|FG000|STARTED|Overall Study||22174
9688081|NCT04505722|10788022|FG001|STARTED|Overall Study||22150
9688082|NCT04505722|10788021|FG000|Vaccinated|Overall Study||21898
9688083|NCT04505722|10788022|FG001|Vaccinated|Overall Study||21890
9688084|NCT04505722|10788021|FG000|Participants in Entire Double Blind Phase|Overall Study||21894
9688085|NCT04505722|10788022|FG001|Participants in Entire Double Blind Phase|Overall Study||21882
9688086|NCT04505722|10788021|FG000|COMPLETED|Overall Study||0
9688087|NCT04505722|10788022|FG001|COMPLETED|Overall Study||0
9688088|NCT04505722|10788021|FG000|NOT COMPLETED|Overall Study||22174
9688089|NCT04505722|10788022|FG001|NOT COMPLETED|Overall Study||22150
9845533|NCT00843466|10957702|FG000|COMPLETED|Overall Study||24
9845534|NCT00843466|10957703|FG001|COMPLETED|Overall Study||18
9845535|NCT00843466|10957702|FG000|NOT COMPLETED|Overall Study||0
9845536|NCT00843466|10957703|FG001|NOT COMPLETED|Overall Study||0
9845537|NCT00843479|10957711|FG000|STARTED|Overall Study||12
9845538|NCT00843479|10957712|FG001|STARTED|Overall Study||12
9845539|NCT00843479|10957711|FG000|COMPLETED|Overall Study||12
9845540|NCT00843479|10957712|FG001|COMPLETED|Overall Study||12
9845541|NCT00843479|10957711|FG000|NOT COMPLETED|Overall Study||0
9845542|NCT00843479|10957712|FG001|NOT COMPLETED|Overall Study||0
9845543|NCT00843492|10957722|FG000|STARTED|Overall Study||622
9845544|NCT00843492|10957723|FG001|STARTED|Overall Study||621
9845545|NCT00843492|10957722|FG000|COMPLETED|Overall Study||614
9845546|NCT00843492|10957723|FG001|COMPLETED|Overall Study||607
9845547|NCT00843492|10957722|FG000|NOT COMPLETED|Overall Study||8
9845548|NCT00843492|10957723|FG001|NOT COMPLETED|Overall Study||14
9845549|NCT00843518|10957731|FG000|STARTED|Period 2 (Double-blind Treatment)||63
9845550|NCT00843518|10957732|FG001|STARTED|Period 2 (Double-blind Treatment)||69
9845551|NCT00843518|10957731|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43
9845552|NCT00843518|10957732|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49
9845553|NCT00843518|10957731|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
9845554|NCT00843518|10957732|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
9845555|NCT00843518|10957731|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
9845556|NCT00843518|10957732|FG001|STARTED|Period 3 (Single-blind Washout)||49
9845557|NCT00843518|10957731|FG000|COMPLETED|Period 3 (Single-blind Washout)||42
9845558|NCT00843518|10957732|FG001|COMPLETED|Period 3 (Single-blind Washout)||49
9845559|NCT00843518|10957731|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0
9845560|NCT00843518|10957732|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0
9845561|NCT00843531|10957742|FG000|STARTED|Overall Study||17
9845562|NCT00843531|10957742|FG000|COMPLETED|Overall Study||17
9845563|NCT00843531|10957742|FG000|NOT COMPLETED|Overall Study||0
9845564|NCT00843622|10957752|FG000|STARTED|Overall Study||125
9845565|NCT00843622|10957753|FG001|STARTED|Overall Study||125
9845566|NCT00843622|10957752|FG000|COMPLETED|Overall Study||82
9845567|NCT00843622|10957753|FG001|COMPLETED|Overall Study||70
9845568|NCT00843622|10957752|FG000|NOT COMPLETED|Overall Study||43
9845569|NCT00843622|10957753|FG001|NOT COMPLETED|Overall Study||55
9845570|NCT00843635|10957762|FG000|STARTED|Overall Study||15
9845571|NCT00843635|10957763|FG001|STARTED|Overall Study||15
9845572|NCT00843635|10957764|FG002|STARTED|Overall Study||5
9845573|NCT00843635|10957762|FG000|COMPLETED|Overall Study||13
9845574|NCT00843635|10957763|FG001|COMPLETED|Overall Study||13
9845575|NCT00843635|10957764|FG002|COMPLETED|Overall Study||5
9845576|NCT00843635|10957762|FG000|NOT COMPLETED|Overall Study||2
9845577|NCT00843635|10957763|FG001|NOT COMPLETED|Overall Study||2
9845578|NCT00843635|10957764|FG002|NOT COMPLETED|Overall Study||0
9845579|NCT00843713|10957778|FG000|STARTED|Overall Study||30
9845580|NCT00843713|10957779|FG001|STARTED|Overall Study||26
9845581|NCT00843713|10957778|FG000|COMPLETED|Overall Study||30
9845582|NCT00843713|10957779|FG001|COMPLETED|Overall Study||26
9845583|NCT00843713|10957778|FG000|NOT COMPLETED|Overall Study||0
9845584|NCT00843713|10957779|FG001|NOT COMPLETED|Overall Study||0
9845585|NCT00843726|10957787|FG000|STARTED|Overall Study||49
9845586|NCT00843726|10957788|FG001|STARTED|Overall Study||49
9845587|NCT00843726|10957787|FG000|COMPLETED|Overall Study||48
9845588|NCT00843726|10957788|FG001|COMPLETED|Overall Study||48
9845589|NCT00843726|10957787|FG000|NOT COMPLETED|Overall Study||1
9845590|NCT00843726|10957788|FG001|NOT COMPLETED|Overall Study||1
9845591|NCT00843778|10957795|FG000|STARTED|Overall Study||131
9845592|NCT00843778|10957795|FG000|COMPLETED|Overall Study||96
9845593|NCT00843778|10957795|FG000|NOT COMPLETED|Overall Study||35
9845594|NCT00843843|10957801|FG000|STARTED|Overall Study||8
9845595|NCT00843843|10957802|FG001|STARTED|Overall Study||8
9845596|NCT00843843|10957801|FG000|COMPLETED|Overall Study||6
9845597|NCT00843843|10957802|FG001|COMPLETED|Overall Study||6
9845598|NCT00843843|10957801|FG000|NOT COMPLETED|Overall Study||2
9845599|NCT00843843|10957802|FG001|NOT COMPLETED|Overall Study||2
9845600|NCT00843856|10957810|FG000|STARTED|Overall Study||20
9845601|NCT00843856|10957811|FG001|STARTED|Overall Study||20
9845602|NCT00843856|10957810|FG000|COMPLETED|Overall Study||19
9845603|NCT00843856|10957811|FG001|COMPLETED|Overall Study||18
9845604|NCT00843856|10957810|FG000|NOT COMPLETED|Overall Study||1
9845605|NCT00843856|10957811|FG001|NOT COMPLETED|Overall Study||2
9845606|NCT00844051|10957819|FG000|STARTED|Overall Study||2087
9845607|NCT00844051|10957820|FG001|STARTED|Overall Study||2368
9845608|NCT00844051|10957819|FG000|COMPLETED|Overall Study||2087
9845609|NCT00844051|10957820|FG001|COMPLETED|Overall Study||2368
9845610|NCT00844051|10957819|FG000|NOT COMPLETED|Overall Study||0
9845611|NCT00844051|10957820|FG001|NOT COMPLETED|Overall Study||0
9845612|NCT00844090|10957828|FG000|STARTED|Overall Study||52
10023724|NCT01857869|11147440|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10081182|NCT02258373|11209657|FG000|COMPLETED|Overall Study||142
9845613|NCT00844090|10957829|FG001|STARTED|Overall Study||54
9845614|NCT00844090|10957828|FG000|COMPLETED|Overall Study||46
9845615|NCT00844090|10957829|FG001|COMPLETED|Overall Study||46
9845616|NCT00844090|10957828|FG000|NOT COMPLETED|Overall Study||6
9845617|NCT00844090|10957829|FG001|NOT COMPLETED|Overall Study||8
9845618|NCT00844194|10957837|FG000|STARTED|Overall Study||78
9845619|NCT00844194|10957838|FG001|STARTED|Overall Study||30
9845620|NCT00844194|10957837|FG000|COMPLETED|Overall Study||53
9845621|NCT00844194|10957838|FG001|COMPLETED|Overall Study||22
9845622|NCT00844194|10957837|FG000|NOT COMPLETED|Overall Study||25
9845623|NCT00844194|10957838|FG001|NOT COMPLETED|Overall Study||8
9845624|NCT00844298|10957848|FG000|STARTED|Overall Study||91
9845625|NCT00844298|10957848|FG000|COMPLETED|Overall Study||91
9845626|NCT00844298|10957848|FG000|NOT COMPLETED|Overall Study||0
9845627|NCT00844376|10957852|FG000|STARTED|Period 1: First Intervention||6
9845628|NCT00844376|10957853|FG001|STARTED|Period 1: First Intervention||6
9845629|NCT00844376|10957852|FG000|COMPLETED|Period 1: First Intervention||5
9845630|NCT00844376|10957853|FG001|COMPLETED|Period 1: First Intervention||6
9845631|NCT00844376|10957852|FG000|NOT COMPLETED|Period 1: First Intervention||1
9845632|NCT00844376|10957853|FG001|NOT COMPLETED|Period 1: First Intervention||0
9845633|NCT00844376|10957852|FG000|STARTED|Period 2: Second Intervention||5
9845634|NCT00844376|10957853|FG001|STARTED|Period 2: Second Intervention||6
9845635|NCT00844376|10957852|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
9845636|NCT00844376|10957853|FG001|COMPLETED|Period 2: Second Intervention||6
9845637|NCT00844376|10957852|FG000|NOT COMPLETED|Period 2: Second Intervention||0
9845638|NCT00844376|10957853|FG001|NOT COMPLETED|Period 2: Second Intervention||0
9845639|NCT00844415|10957859|FG000|STARTED|Overall Study|Entered and treated.|9
9845640|NCT00844415|10957859|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3
9845641|NCT00844415|10957859|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3
9845642|NCT00844415|10957859|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2
9845643|NCT00844415|10957859|FG000|Pat. Received Single Dose 75mg|Overall Study||1
9845644|NCT00844415|10957859|FG000|COMPLETED|Overall Study|Completed.|8
9845645|NCT00844415|10957859|FG000|NOT COMPLETED|Overall Study||1
9845646|NCT00844428|10957864|FG000|STARTED|Screening Period||23
9845647|NCT00844428|10957864|FG000|COMPLETED|Screening Period||20
9845648|NCT00844428|10957864|FG000|NOT COMPLETED|Screening Period||3
9845649|NCT00844428|10957864|FG000|STARTED|Observation Period (8 Weeks)||20
9845650|NCT00844428|10957864|FG000|COMPLETED|Observation Period (8 Weeks)||20
9845651|NCT00844428|10957864|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
9845652|NCT00844428|10957864|FG000|STARTED|Treatment Period (26 Weeks)||20
9845653|NCT00844428|10957864|FG000|COMPLETED|Treatment Period (26 Weeks)||20
9845654|NCT00844428|10957864|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
9845655|NCT00844428|10957864|FG000|STARTED|Extension Treatment Period||19
9845656|NCT00844428|10957864|FG000|COMPLETED|Extension Treatment Period||18
9845657|NCT00844428|10957864|FG000|NOT COMPLETED|Extension Treatment Period||1
9845658|NCT00844428|10957864|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
9845659|NCT00844428|10957864|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
9845660|NCT00844428|10957864|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
9845661|NCT00844519|10957870|FG000|STARTED|Overall Study||26
9845662|NCT00844519|10957871|FG001|STARTED|Overall Study||26
9845663|NCT00844519|10957870|FG000|COMPLETED|Overall Study||24
9845664|NCT00844519|10957871|FG001|COMPLETED|Overall Study||25
9845665|NCT00844519|10957870|FG000|NOT COMPLETED|Overall Study||2
9845666|NCT00844519|10957871|FG001|NOT COMPLETED|Overall Study||1
9845667|NCT00844532|10957877|FG000|STARTED|Overall Study||151
9845668|NCT00844532|10957877|FG000|COMPLETED|Overall Study||112
9845669|NCT00844532|10957877|FG000|NOT COMPLETED|Overall Study||39
9845670|NCT00844545|10957881|FG000|STARTED|Screening Period||17
9845671|NCT00844545|10957881|FG000|COMPLETED|Screening Period||17
9845672|NCT00844545|10957881|FG000|NOT COMPLETED|Screening Period||0
9845673|NCT00844545|10957881|FG000|STARTED|Treatment Period (26 Weeks)||17
9845674|NCT00844545|10957881|FG000|COMPLETED|Treatment Period (26 Weeks)||15
9845675|NCT00844545|10957881|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
9845676|NCT00844545|10957881|FG000|STARTED|Extension Treatment Period||13
9845677|NCT00844545|10957881|FG000|COMPLETED|Extension Treatment Period||11
9845678|NCT00844545|10957881|FG000|NOT COMPLETED|Extension Treatment Period||2
9845679|NCT00844545|10957881|FG000|STARTED|Post Treatment Period||6
9845680|NCT00844545|10957881|FG000|COMPLETED|Post Treatment Period||5
9845681|NCT00844545|10957881|FG000|NOT COMPLETED|Post Treatment Period||1
9961144|NCT01471782|11080869|FG000|STARTED|Overall Study||5
9961145|NCT01471782|11080870|FG001|STARTED|Overall Study||7
9961146|NCT01471782|11080871|FG002|STARTED|Overall Study||5
9961147|NCT01471782|11080872|FG003|STARTED|Overall Study||6
9961148|NCT01471782|11080873|FG004|STARTED|Overall Study||26
9961149|NCT01471782|11080874|FG005|STARTED|Overall Study||44
9961150|NCT01471782|11080869|FG000|COMPLETED|Overall Study|Completed 5 cycles|0
9961151|NCT01471782|11080870|FG001|COMPLETED|Overall Study|Completed 5 cycles|1
9961152|NCT01471782|11080871|FG002|COMPLETED|Overall Study|Completed 5 cycles|0
9961153|NCT01471782|11080872|FG003|COMPLETED|Overall Study|Completed 5 cycles|1
9845682|NCT00844558|10957888|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
9845683|NCT00844558|10957889|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
9845684|NCT00844558|10957888|FG000|Received Allocated Intervention|Overall Study||33
9845685|NCT00844558|10957889|FG001|Received Allocated Intervention|Overall Study||21
9845686|NCT00844558|10957888|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
9845687|NCT00844558|10957889|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
9961154|NCT01471782|11080873|FG004|COMPLETED|Overall Study|Completed 5 cycles|0
9961155|NCT01471782|11080874|FG005|COMPLETED|Overall Study|Completed 5 cycles|3
9961156|NCT01471782|11080869|FG000|NOT COMPLETED|Overall Study||5
9845688|NCT00844558|10957888|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
9845689|NCT00844558|10957889|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
9845690|NCT00844558|10957888|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
9845691|NCT00844558|10957889|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
9845692|NCT00844558|10957888|FG000|COMPLETED|Overall Study||24
9845693|NCT00844558|10957889|FG001|COMPLETED|Overall Study||18
9845694|NCT00844558|10957888|FG000|NOT COMPLETED|Overall Study||12
9845695|NCT00844558|10957889|FG001|NOT COMPLETED|Overall Study||4
9845696|NCT00844597|10957906|FG000|STARTED|Overall Study||4
9845697|NCT00844597|10957907|FG001|STARTED|Overall Study||2
9845698|NCT00844597|10957908|FG002|STARTED|Overall Study||2
9845699|NCT00844597|10957909|FG003|STARTED|Overall Study||3
9845700|NCT00844597|10957910|FG004|STARTED|Overall Study||4
9845701|NCT00844597|10957911|FG005|STARTED|Overall Study||4
9845702|NCT00844597|10957906|FG000|COMPLETED|Overall Study||4
9845703|NCT00844597|10957907|FG001|COMPLETED|Overall Study||2
9845704|NCT00844597|10957908|FG002|COMPLETED|Overall Study||2
9845705|NCT00844597|10957909|FG003|COMPLETED|Overall Study||2
9845706|NCT00844597|10957910|FG004|COMPLETED|Overall Study||4
9845707|NCT00844597|10957911|FG005|COMPLETED|Overall Study||4
9845708|NCT00844597|10957906|FG000|NOT COMPLETED|Overall Study||0
9845709|NCT00844597|10957907|FG001|NOT COMPLETED|Overall Study||0
9845710|NCT00844597|10957908|FG002|NOT COMPLETED|Overall Study||0
9845711|NCT00844597|10957909|FG003|NOT COMPLETED|Overall Study||1
9845712|NCT00844597|10957910|FG004|NOT COMPLETED|Overall Study||0
9845713|NCT00844597|10957911|FG005|NOT COMPLETED|Overall Study||0
9845714|NCT00844649|10957929|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
9845715|NCT00844649|10957930|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
9845716|NCT00844649|10957929|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
9845717|NCT00844649|10957930|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
9845718|NCT00844649|10957929|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
9845719|NCT00844649|10957930|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
9845720|NCT00844649|10957929|FG000|NOT COMPLETED|Overall Study||405
9845721|NCT00844649|10957930|FG001|NOT COMPLETED|Overall Study||418
9845722|NCT00844714|10957938|FG000|STARTED|Overall Study||20
9845723|NCT00844714|10957938|FG000|COMPLETED|Overall Study||20
9845724|NCT00844714|10957938|FG000|NOT COMPLETED|Overall Study||0
9845725|NCT00844753|10957946|FG000|STARTED|Overall Study||32
9845726|NCT00844753|10957947|FG001|STARTED|Overall Study||32
9845727|NCT00844753|10957948|FG002|STARTED|Overall Study||32
9845728|NCT00844753|10957949|FG003|STARTED|Overall Study||32
9845729|NCT00844753|10957946|FG000|COMPLETED|Overall Study||24
9845730|NCT00844753|10957947|FG001|COMPLETED|Overall Study||29
9845731|NCT00844753|10957948|FG002|COMPLETED|Overall Study||25
9845732|NCT00844753|10957949|FG003|COMPLETED|Overall Study||21
9845733|NCT00844753|10957946|FG000|NOT COMPLETED|Overall Study||8
9845734|NCT00844753|10957947|FG001|NOT COMPLETED|Overall Study||3
9845735|NCT00844753|10957948|FG002|NOT COMPLETED|Overall Study||7
9845736|NCT00844753|10957949|FG003|NOT COMPLETED|Overall Study||11
9845737|NCT00844805|10957959|FG000|STARTED|Treatment Phase||106
9845738|NCT00844805|10957960|FG001|STARTED|Treatment Phase||52
9845739|NCT00844805|10957961|FG002|STARTED|Treatment Phase||0
9845740|NCT00844805|10957962|FG003|STARTED|Treatment Phase||0
9845741|NCT00844805|10957959|FG000|COMPLETED|Treatment Phase||96
9845742|NCT00844805|10957960|FG001|COMPLETED|Treatment Phase||45
9845743|NCT00844805|10957961|FG002|COMPLETED|Treatment Phase||0
10023725|NCT01857869|11147441|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
9845744|NCT00844805|10957962|FG003|COMPLETED|Treatment Phase||0
9845745|NCT00844805|10957959|FG000|NOT COMPLETED|Treatment Phase||10
9845746|NCT00844805|10957960|FG001|NOT COMPLETED|Treatment Phase||7
9845747|NCT00844805|10957961|FG002|NOT COMPLETED|Treatment Phase||0
9845748|NCT00844805|10957962|FG003|NOT COMPLETED|Treatment Phase||0
9845749|NCT00844805|10957959|FG000|STARTED|Follow-Up Phase||0
9845750|NCT00844805|10957960|FG001|STARTED|Follow-Up Phase||0
9845751|NCT00844805|10957961|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
9845752|NCT00844805|10957962|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
9845753|NCT00844805|10957959|FG000|COMPLETED|Follow-Up Phase||0
9845754|NCT00844805|10957960|FG001|COMPLETED|Follow-Up Phase||0
9845755|NCT00844805|10957961|FG002|COMPLETED|Follow-Up Phase||32
9845756|NCT00844805|10957962|FG003|COMPLETED|Follow-Up Phase||32
9845757|NCT00844805|10957959|FG000|NOT COMPLETED|Follow-Up Phase||0
9845758|NCT00844805|10957960|FG001|NOT COMPLETED|Follow-Up Phase||0
9845759|NCT00844805|10957961|FG002|NOT COMPLETED|Follow-Up Phase||9
9845760|NCT00844805|10957962|FG003|NOT COMPLETED|Follow-Up Phase||9
9845761|NCT00844831|10957973|FG000|STARTED|Overall Study||25
9845762|NCT00844831|10957973|FG000|COMPLETED|Overall Study||19
9845763|NCT00844831|10957973|FG000|NOT COMPLETED|Overall Study||6
9845764|NCT00844844|10957981|FG000|STARTED|Screening Period||17
9845765|NCT00844844|10957981|FG000|COMPLETED|Screening Period||17
9845766|NCT00844844|10957981|FG000|NOT COMPLETED|Screening Period||0
9845767|NCT00844844|10957981|FG000|STARTED|Treatment Period (26 Weeks)||17
9845768|NCT00844844|10957981|FG000|COMPLETED|Treatment Period (26 Weeks)||15
9845769|NCT00844844|10957981|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
9845770|NCT00844844|10957981|FG000|STARTED|Extension Treatment Period||13
10023726|NCT01857869|11147442|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023727|NCT01857869|11147443|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023728|NCT01857869|11147434|FG000|COMPLETED|Primary/Challenge Phase||29
10023729|NCT01857869|11147435|FG001|COMPLETED|Primary/Challenge Phase||16
10023730|NCT01857869|11147436|FG002|COMPLETED|Primary/Challenge Phase||12
10023731|NCT01857869|11147437|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
9845771|NCT00844844|10957981|FG000|COMPLETED|Extension Treatment Period||11
9845772|NCT00844844|10957981|FG000|NOT COMPLETED|Extension Treatment Period||2
9845773|NCT00844844|10957981|FG000|STARTED|Post Treatment Period||6
9845774|NCT00844844|10957981|FG000|COMPLETED|Post Treatment Period||5
9845775|NCT00844844|10957981|FG000|NOT COMPLETED|Post Treatment Period||1
9845776|NCT00844857|10957987|FG000|STARTED|Overall Study||194
9845777|NCT00844857|10957988|FG001|STARTED|Overall Study||97
9845778|NCT00844857|10957987|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
9845779|NCT00844857|10957988|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
9845780|NCT00844857|10957987|FG000|COMPLETED|Overall Study||116
9845781|NCT00844857|10957988|FG001|COMPLETED|Overall Study||60
9845782|NCT00844857|10957987|FG000|NOT COMPLETED|Overall Study||78
9845783|NCT00844857|10957988|FG001|NOT COMPLETED|Overall Study||37
9961157|NCT01471782|11080870|FG001|NOT COMPLETED|Overall Study||6
9961158|NCT01471782|11080871|FG002|NOT COMPLETED|Overall Study||5
9961159|NCT01471782|11080872|FG003|NOT COMPLETED|Overall Study||5
9961160|NCT01471782|11080873|FG004|NOT COMPLETED|Overall Study||26
9961161|NCT01471782|11080874|FG005|NOT COMPLETED|Overall Study||41
9961162|NCT01472185|11080901|FG000|STARTED|Overall Study||232
9961163|NCT01472185|11080902|FG001|STARTED|Overall Study||233
9961164|NCT01472185|11080901|FG000|COMPLETED|Overall Study||198
9961165|NCT01472185|11080902|FG001|COMPLETED|Overall Study||199
9961166|NCT01472185|11080901|FG000|NOT COMPLETED|Overall Study||34
9961167|NCT01472185|11080902|FG001|NOT COMPLETED|Overall Study||34
9961168|NCT01472289|11080908|FG000|STARTED|Overall Study||17
9961169|NCT01472289|11080908|FG000|COMPLETED|Overall Study||15
9961170|NCT01472289|11080908|FG000|NOT COMPLETED|Overall Study||2
9961171|NCT01472341|11080912|FG000|STARTED|Overall Study||507
9961172|NCT01472341|11080912|FG000|COMPLETED|Overall Study||235
9961173|NCT01472341|11080912|FG000|NOT COMPLETED|Overall Study||272
9961174|NCT01472380|11080916|FG000|STARTED|Efavirenz Alone||30
9961175|NCT01472380|11080916|FG000|COMPLETED|Efavirenz Alone||29
10081183|NCT02258373|11209658|FG001|COMPLETED|Overall Study||75
9961176|NCT01472380|11080916|FG000|NOT COMPLETED|Efavirenz Alone||1
9961177|NCT01472380|11080916|FG000|STARTED|Fenofibric Acid (FFA) Alone||29
9961178|NCT01472380|11080916|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29
9961179|NCT01472380|11080916|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
9961180|NCT01472380|11080916|FG000|STARTED|1 Day Period Between Dosing||29
9961181|NCT01472380|11080916|FG000|COMPLETED|1 Day Period Between Dosing||28
9961182|NCT01472380|11080916|FG000|NOT COMPLETED|1 Day Period Between Dosing||1
9961183|NCT01472380|11080916|FG000|STARTED|Efavirenz and FFA||28
9961184|NCT01472380|11080916|FG000|COMPLETED|Efavirenz and FFA||28
9961185|NCT01472380|11080916|FG000|NOT COMPLETED|Efavirenz and FFA||0
9961186|NCT01472432|11080925|FG000|STARTED|Overall Study||53
9961187|NCT01472432|11080926|FG001|STARTED|Overall Study||53
9961188|NCT01472432|11080925|FG000|Ulcer Reduction|Overall Study||13
9961189|NCT01472432|11080926|FG001|Ulcer Reduction|Overall Study||33
9961190|NCT01472432|11080925|FG000|COMPLETED|Overall Study||53
9961191|NCT01472432|11080926|FG001|COMPLETED|Overall Study||53
9961192|NCT01472432|11080925|FG000|NOT COMPLETED|Overall Study||0
9961193|NCT01472432|11080926|FG001|NOT COMPLETED|Overall Study||0
9961194|NCT01472445|11080936|FG000|STARTED|Overall Study||25
9961195|NCT01472445|11080937|FG001|STARTED|Overall Study||16
9961196|NCT01472445|11080936|FG000|COMPLETED|Overall Study||25
9961197|NCT01472445|11080937|FG001|COMPLETED|Overall Study||16
9961198|NCT01472445|11080936|FG000|NOT COMPLETED|Overall Study||0
9961199|NCT01472445|11080937|FG001|NOT COMPLETED|Overall Study||0
9961200|NCT01472549|11080947|FG000|STARTED|Overall Study||572
9961201|NCT01472549|11080948|FG001|STARTED|Overall Study||575
9961202|NCT01472549|11080947|FG000|COMPLETED|Overall Study||572
9961203|NCT01472549|11080948|FG001|COMPLETED|Overall Study||575
9961204|NCT01472549|11080947|FG000|NOT COMPLETED|Overall Study||0
9961205|NCT01472549|11080948|FG001|NOT COMPLETED|Overall Study||0
9961206|NCT01472718|11080956|FG000|STARTED|Overall Study||104
9961207|NCT01472718|11080957|FG001|STARTED|Overall Study||104
9961208|NCT01472718|11080956|FG000|COMPLETED|Overall Study||98
9961209|NCT01472718|11080957|FG001|COMPLETED|Overall Study||97
9961210|NCT01472718|11080956|FG000|NOT COMPLETED|Overall Study||6
9961211|NCT01472718|11080957|FG001|NOT COMPLETED|Overall Study||7
9961212|NCT01472757|11080967|FG000|STARTED|Overall Study||91
9961213|NCT01472757|11080968|FG001|STARTED|Overall Study||93
9961214|NCT01472757|11080969|FG002|STARTED|Overall Study||95
9961215|NCT01472757|11080970|FG003|STARTED|Overall Study||94
9845784|NCT00844883|10957997|FG000|STARTED|Overall Study||50
9845785|NCT00844883|10957997|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
9845786|NCT00844883|10957997|FG000|COMPLETED|Overall Study||46
9845787|NCT00844883|10957997|FG000|NOT COMPLETED|Overall Study||4
9845788|NCT00844896|10958003|FG000|STARTED|Overall Study||29
9845789|NCT00844896|10958004|FG001|STARTED|Overall Study||28
9845790|NCT00844896|10958003|FG000|COMPLETED|Overall Study||17
9845791|NCT00844896|10958004|FG001|COMPLETED|Overall Study||11
9845792|NCT00844896|10958003|FG000|NOT COMPLETED|Overall Study||12
9845793|NCT00844896|10958004|FG001|NOT COMPLETED|Overall Study||17
9845794|NCT00845000|10958017|FG000|STARTED|Period 1||2
9845795|NCT00845000|10958018|FG001|STARTED|Period 1||2
9845796|NCT00845000|10958019|FG002|STARTED|Period 1||2
9845797|NCT00845000|10958020|FG003|STARTED|Period 1||2
9845798|NCT00845000|10958021|FG004|STARTED|Period 1||2
9845799|NCT00845000|10958022|FG005|STARTED|Period 1||2
9845800|NCT00845000|10958017|FG000|COMPLETED|Period 1||2
9845801|NCT00845000|10958018|FG001|COMPLETED|Period 1||2
9845802|NCT00845000|10958019|FG002|COMPLETED|Period 1||2
9845803|NCT00845000|10958020|FG003|COMPLETED|Period 1||2
9845804|NCT00845000|10958021|FG004|COMPLETED|Period 1||2
10081184|NCT02258373|11209657|FG000|NOT COMPLETED|Overall Study||7
9845805|NCT00845000|10958022|FG005|COMPLETED|Period 1||2
9845806|NCT00845000|10958017|FG000|NOT COMPLETED|Period 1||0
9845807|NCT00845000|10958018|FG001|NOT COMPLETED|Period 1||0
9845808|NCT00845000|10958019|FG002|NOT COMPLETED|Period 1||0
9845809|NCT00845000|10958020|FG003|NOT COMPLETED|Period 1||0
9845810|NCT00845000|10958021|FG004|NOT COMPLETED|Period 1||0
9845811|NCT00845000|10958022|FG005|NOT COMPLETED|Period 1||0
10081185|NCT02258373|11209658|FG001|NOT COMPLETED|Overall Study||2
9845812|NCT00845000|10958017|FG000|STARTED|Period 2||2
9845813|NCT00845000|10958018|FG001|STARTED|Period 2||2
9845814|NCT00845000|10958019|FG002|STARTED|Period 2||2
9845815|NCT00845000|10958020|FG003|STARTED|Period 2||2
9845816|NCT00845000|10958021|FG004|STARTED|Period 2||2
9845817|NCT00845000|10958022|FG005|STARTED|Period 2||2
9845818|NCT00845000|10958017|FG000|COMPLETED|Period 2||2
9845819|NCT00845000|10958018|FG001|COMPLETED|Period 2||2
9845820|NCT00845000|10958019|FG002|COMPLETED|Period 2||2
9845821|NCT00845000|10958020|FG003|COMPLETED|Period 2||2
9845822|NCT00845000|10958021|FG004|COMPLETED|Period 2||2
9845823|NCT00845000|10958022|FG005|COMPLETED|Period 2||2
9845824|NCT00845000|10958017|FG000|NOT COMPLETED|Period 2||0
9845825|NCT00845000|10958018|FG001|NOT COMPLETED|Period 2||0
9845826|NCT00845000|10958019|FG002|NOT COMPLETED|Period 2||0
9845827|NCT00845000|10958020|FG003|NOT COMPLETED|Period 2||0
9845828|NCT00845000|10958021|FG004|NOT COMPLETED|Period 2||0
9845829|NCT00845000|10958022|FG005|NOT COMPLETED|Period 2||0
9845830|NCT00845000|10958017|FG000|STARTED|Period 3||2
9845831|NCT00845000|10958018|FG001|STARTED|Period 3||2
9845832|NCT00845000|10958019|FG002|STARTED|Period 3||2
9845833|NCT00845000|10958020|FG003|STARTED|Period 3||2
9845834|NCT00845000|10958021|FG004|STARTED|Period 3||2
9845835|NCT00845000|10958022|FG005|STARTED|Period 3||2
9845836|NCT00845000|10958017|FG000|COMPLETED|Period 3||2
9845837|NCT00845000|10958018|FG001|COMPLETED|Period 3||2
9845838|NCT00845000|10958019|FG002|COMPLETED|Period 3||2
9845839|NCT00845000|10958020|FG003|COMPLETED|Period 3||2
9845840|NCT00845000|10958021|FG004|COMPLETED|Period 3||2
9845841|NCT00845000|10958022|FG005|COMPLETED|Period 3||2
9845842|NCT00845000|10958017|FG000|NOT COMPLETED|Period 3||0
9845843|NCT00845000|10958018|FG001|NOT COMPLETED|Period 3||0
9845844|NCT00845000|10958019|FG002|NOT COMPLETED|Period 3||0
9845845|NCT00845000|10958020|FG003|NOT COMPLETED|Period 3||0
9845846|NCT00845000|10958021|FG004|NOT COMPLETED|Period 3||0
9845847|NCT00845000|10958022|FG005|NOT COMPLETED|Period 3||0
9845848|NCT00845039|10958032|FG000|STARTED|Overall Study||2
9845849|NCT00845039|10958033|FG001|STARTED|Overall Study||2
9845850|NCT00845039|10958032|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
9845851|NCT00845039|10958033|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
9845852|NCT00845039|10958032|FG000|COMPLETED|Overall Study||2
9845853|NCT00845039|10958033|FG001|COMPLETED|Overall Study||2
9845854|NCT00845039|10958032|FG000|NOT COMPLETED|Overall Study||0
9845855|NCT00845039|10958033|FG001|NOT COMPLETED|Overall Study||0
9845856|NCT00845065|10958043|FG000|STARTED|Overall Study||67
9845857|NCT00845065|10958044|FG001|STARTED|Overall Study||134
9845858|NCT00845065|10958043|FG000|COMPLETED|Overall Study||20
9845859|NCT00845065|10958044|FG001|COMPLETED|Overall Study||79
9845860|NCT00845065|10958043|FG000|NOT COMPLETED|Overall Study||47
9845861|NCT00845065|10958044|FG001|NOT COMPLETED|Overall Study||55
9845862|NCT00845130|10958052|FG000|STARTED|Overall Study||20
9845863|NCT00845130|10958053|FG001|STARTED|Overall Study||22
9845864|NCT00845130|10958052|FG000|COMPLETED|Overall Study||16
9845865|NCT00845130|10958053|FG001|COMPLETED|Overall Study||19
9845866|NCT00845130|10958052|FG000|NOT COMPLETED|Overall Study||4
9845867|NCT00845130|10958053|FG001|NOT COMPLETED|Overall Study||3
9845868|NCT00845182|10958064|FG000|STARTED|Overall Study||13
9845869|NCT00845182|10958065|FG001|STARTED|Overall Study||15
9845870|NCT00845182|10958066|FG002|STARTED|Overall Study||15
9845871|NCT00845182|10958064|FG000|COMPLETED|Overall Study||10
9845872|NCT00845182|10958065|FG001|COMPLETED|Overall Study||11
9845873|NCT00845182|10958066|FG002|COMPLETED|Overall Study||9
9845874|NCT00845182|10958064|FG000|NOT COMPLETED|Overall Study||3
9845875|NCT00845182|10958065|FG001|NOT COMPLETED|Overall Study||4
9845876|NCT00845182|10958066|FG002|NOT COMPLETED|Overall Study||6
9845877|NCT00845195|10958080|FG000|STARTED|Overall Study||75
9845878|NCT00845195|10958081|FG001|STARTED|Overall Study||75
9845879|NCT00845195|10958080|FG000|COMPLETED|Overall Study||75
9845880|NCT00845195|10958081|FG001|COMPLETED|Overall Study||75
9845881|NCT00845195|10958080|FG000|NOT COMPLETED|Overall Study||0
9845882|NCT00845195|10958081|FG001|NOT COMPLETED|Overall Study||0
9845883|NCT00845429|10958090|FG000|STARTED|Overall Study||244
9845884|NCT00845429|10958091|FG001|STARTED|Overall Study||241
9845885|NCT00845429|10958092|FG002|STARTED|Overall Study||244
9845886|NCT00845429|10958090|FG000|COMPLETED|Overall Study||230
9845887|NCT00845429|10958091|FG001|COMPLETED|Overall Study||226
9845888|NCT00845429|10958092|FG002|COMPLETED|Overall Study||224
9845889|NCT00845429|10958090|FG000|NOT COMPLETED|Overall Study||14
9845890|NCT00845429|10958091|FG001|NOT COMPLETED|Overall Study||15
9845891|NCT00845429|10958092|FG002|NOT COMPLETED|Overall Study||20
9845892|NCT00845481|10958100|FG000|STARTED|Overall Study||24
9845893|NCT00845481|10958100|FG000|COMPLETED|Overall Study||24
9845894|NCT00845481|10958100|FG000|NOT COMPLETED|Overall Study||0
9845895|NCT00845507|10958111|FG000|STARTED|Overall Study||24
9845896|NCT00845507|10958112|FG001|STARTED|Overall Study||30
9845897|NCT00845507|10958111|FG000|COMPLETED|Overall Study||22
9845898|NCT00845507|10958112|FG001|COMPLETED|Overall Study||29
9845899|NCT00845507|10958111|FG000|NOT COMPLETED|Overall Study||2
9845900|NCT00845507|10958112|FG001|NOT COMPLETED|Overall Study||1
9845901|NCT00845520|10958121|FG000|STARTED|Overall Study||25
9845902|NCT00845520|10958122|FG001|STARTED|Overall Study||25
9845903|NCT00845520|10958123|FG002|STARTED|Overall Study||24
9845904|NCT00845520|10958121|FG000|COMPLETED|Overall Study||23
9845905|NCT00845520|10958122|FG001|COMPLETED|Overall Study||23
9845906|NCT00845520|10958123|FG002|COMPLETED|Overall Study||23
9845907|NCT00845520|10958121|FG000|NOT COMPLETED|Overall Study||2
9845908|NCT00845520|10958122|FG001|NOT COMPLETED|Overall Study||2
9845909|NCT00845520|10958123|FG002|NOT COMPLETED|Overall Study||1
9845910|NCT00845650|10958143|FG000|STARTED|Overall Study|1 subject not dosed|31
9845911|NCT00845650|10958144|FG001|STARTED|Overall Study||5
9845912|NCT00845650|10958145|FG002|STARTED|Overall Study||31
9845913|NCT00845650|10958146|FG003|STARTED|Overall Study||14
9845914|NCT00845650|10958147|FG004|STARTED|Overall Study|2 subjects not dosed|31
9845915|NCT00845650|10958148|FG005|STARTED|Overall Study|1 subject not dosed|17
9845916|NCT00845650|10958143|FG000|COMPLETED|Overall Study||30
9845917|NCT00845650|10958144|FG001|COMPLETED|Overall Study||5
9845918|NCT00845650|10958145|FG002|COMPLETED|Overall Study||28
9845919|NCT00845650|10958146|FG003|COMPLETED|Overall Study||13
9845920|NCT00845650|10958147|FG004|COMPLETED|Overall Study||28
9845921|NCT00845650|10958148|FG005|COMPLETED|Overall Study||15
9845922|NCT00845650|10958143|FG000|NOT COMPLETED|Overall Study||1
9845923|NCT00845650|10958144|FG001|NOT COMPLETED|Overall Study||0
9845924|NCT00845650|10958145|FG002|NOT COMPLETED|Overall Study||3
9845925|NCT00845650|10958146|FG003|NOT COMPLETED|Overall Study||1
9845926|NCT00845650|10958147|FG004|NOT COMPLETED|Overall Study||3
9845927|NCT00845650|10958148|FG005|NOT COMPLETED|Overall Study||2
9845928|NCT00845663|10958166|FG000|STARTED|Overall Study||49
9845929|NCT00845663|10958167|FG001|STARTED|Overall Study||49
9845930|NCT00845663|10958166|FG000|COMPLETED|Overall Study||49
9845931|NCT00845663|10958167|FG001|COMPLETED|Overall Study||49
9845932|NCT00845663|10958166|FG000|NOT COMPLETED|Overall Study||0
9845933|NCT00845663|10958167|FG001|NOT COMPLETED|Overall Study||0
9845934|NCT00845676|10958173|FG000|STARTED|Overall Study||21
9845935|NCT00845676|10958173|FG000|COMPLETED|Overall Study||19
9845936|NCT00845676|10958173|FG000|NOT COMPLETED|Overall Study||2
9845937|NCT00845728|10958180|FG000|STARTED|Overall Study||1723
9845938|NCT00845728|10958181|FG001|STARTED|Overall Study||1721
9845939|NCT00845728|10958180|FG000|Exposed|Overall Study||1721
9845940|NCT00845728|10958181|FG001|Exposed|Overall Study||1718
9845941|NCT00845728|10958180|FG000|COMPLETED|Overall Study||1337
9845942|NCT00845728|10958181|FG001|COMPLETED|Overall Study||1379
9845943|NCT00845728|10958180|FG000|NOT COMPLETED|Overall Study||386
9845944|NCT00845728|10958181|FG001|NOT COMPLETED|Overall Study||342
9845945|NCT00845832|10958190|FG000|STARTED|Treatment Period||4
9845946|NCT00845832|10958191|FG001|STARTED|Treatment Period||10
9845947|NCT00845832|10958192|FG002|STARTED|Treatment Period||10
9845948|NCT00845832|10958190|FG000|COMPLETED|Treatment Period||3
9845949|NCT00845832|10958191|FG001|COMPLETED|Treatment Period||7
9845950|NCT00845832|10958192|FG002|COMPLETED|Treatment Period||10
9845951|NCT00845832|10958190|FG000|NOT COMPLETED|Treatment Period||1
9845952|NCT00845832|10958191|FG001|NOT COMPLETED|Treatment Period||3
9845953|NCT00845832|10958192|FG002|NOT COMPLETED|Treatment Period||0
9845954|NCT00845832|10958190|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
9845955|NCT00845832|10958191|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
9845956|NCT00845832|10958192|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
10081186|NCT02258412|11209667|FG000|STARTED|Overall Study||26
10023732|NCT01857869|11147438|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023733|NCT01857869|11147439|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023734|NCT01857869|11147440|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023735|NCT01857869|11147441|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023736|NCT01857869|11147442|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
9845957|NCT00845832|10958190|FG000|COMPLETED|Safety Follow-Up||2
9845958|NCT00845832|10958191|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
9845959|NCT00845832|10958192|FG002|COMPLETED|Safety Follow-Up||12
9845960|NCT00845832|10958190|FG000|NOT COMPLETED|Safety Follow-Up||1
9845961|NCT00845832|10958191|FG001|NOT COMPLETED|Safety Follow-Up||0
9845962|NCT00845832|10958192|FG002|NOT COMPLETED|Safety Follow-Up||0
9845963|NCT00845832|10958190|FG000|STARTED|Extended Safety Follow-Up||2
9845964|NCT00845832|10958191|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
9845965|NCT00845832|10958192|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
9845966|NCT00845832|10958190|FG000|COMPLETED|Extended Safety Follow-Up||2
9845967|NCT00845832|10958191|FG001|COMPLETED|Extended Safety Follow-Up||5
9845968|NCT00845832|10958192|FG002|COMPLETED|Extended Safety Follow-Up||0
10023737|NCT01857869|11147443|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10023738|NCT01857869|11147434|FG000|NOT COMPLETED|Primary/Challenge Phase||5
9845969|NCT00845832|10958190|FG000|NOT COMPLETED|Extended Safety Follow-Up||0
9845970|NCT00845832|10958191|FG001|NOT COMPLETED|Extended Safety Follow-Up||0
9845971|NCT00845832|10958192|FG002|NOT COMPLETED|Extended Safety Follow-Up||7
9845972|NCT00845858|10958203|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
9845973|NCT00845858|10958204|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
9845974|NCT00845858|10958205|FG002|STARTED|Overall Study||95
9845975|NCT00845858|10958203|FG000|COMPLETED|Overall Study||88
9845976|NCT00845858|10958204|FG001|COMPLETED|Overall Study||84
9845977|NCT00845858|10958205|FG002|COMPLETED|Overall Study||87
9845978|NCT00845858|10958203|FG000|NOT COMPLETED|Overall Study||8
9845979|NCT00845858|10958204|FG001|NOT COMPLETED|Overall Study||12
9845980|NCT00845858|10958205|FG002|NOT COMPLETED|Overall Study||8
9845981|NCT00845871|10958216|FG000|STARTED|Run-in Period||65
9845982|NCT00845871|10958216|FG000|COMPLETED|Run-in Period||65
9845983|NCT00845871|10958216|FG000|NOT COMPLETED|Run-in Period||0
9845984|NCT00845871|10958216|FG000|STARTED|Assessment Period||65
9845985|NCT00845871|10958216|FG000|COMPLETED|Assessment Period||58
9845986|NCT00845871|10958216|FG000|NOT COMPLETED|Assessment Period||7
9845987|NCT00845897|10958243|FG000|STARTED|Overall Study||5
9845988|NCT00845897|10958244|FG001|STARTED|Overall Study||7
9845989|NCT00845897|10958245|FG002|STARTED|Overall Study||5
9845990|NCT00845897|10958243|FG000|COMPLETED|Overall Study||3
9845991|NCT00845897|10958244|FG001|COMPLETED|Overall Study||2
9845992|NCT00845897|10958245|FG002|COMPLETED|Overall Study||2
9845993|NCT00845897|10958243|FG000|NOT COMPLETED|Overall Study||2
9845994|NCT00845897|10958244|FG001|NOT COMPLETED|Overall Study||5
9845995|NCT00845897|10958245|FG002|NOT COMPLETED|Overall Study||3
9845996|NCT00845975|10958255|FG000|STARTED|Overall Study||9
9845997|NCT00845975|10958256|FG001|STARTED|Overall Study||9
9845998|NCT00845975|10958255|FG000|COMPLETED|Overall Study||9
9845999|NCT00845975|10958256|FG001|COMPLETED|Overall Study||9
9846000|NCT00845975|10958255|FG000|NOT COMPLETED|Overall Study||0
9846001|NCT00845975|10958256|FG001|NOT COMPLETED|Overall Study||0
9846002|NCT00846027|10958262|FG000|STARTED|Overall Study||90
9846003|NCT00846027|10958262|FG000|Received Treatment|Overall Study||83
9846004|NCT00846027|10958262|FG000|COMPLETED|Overall Study||0
9846005|NCT00846027|10958262|FG000|NOT COMPLETED|Overall Study||90
9846006|NCT00846040|10958269|FG000|STARTED|Baseline: Days 1-5||10
9846007|NCT00846040|10958270|FG001|STARTED|Baseline: Days 1-5||10
9846008|NCT00846040|10958271|FG002|STARTED|Baseline: Days 1-5||23
9846009|NCT00846040|10958269|FG000|COMPLETED|Baseline: Days 1-5||9
9846010|NCT00846040|10958270|FG001|COMPLETED|Baseline: Days 1-5||10
10023739|NCT01857869|11147435|FG001|NOT COMPLETED|Primary/Challenge Phase||1
10023740|NCT01857869|11147436|FG002|NOT COMPLETED|Primary/Challenge Phase||0
10023741|NCT01857869|11147437|FG003|NOT COMPLETED|Primary/Challenge Phase||0
10023742|NCT01857869|11147438|FG004|NOT COMPLETED|Primary/Challenge Phase||0
10023743|NCT01857869|11147439|FG005|NOT COMPLETED|Primary/Challenge Phase||0
10023744|NCT01857869|11147440|FG006|NOT COMPLETED|Primary/Challenge Phase||0
10023745|NCT01857869|11147441|FG007|NOT COMPLETED|Primary/Challenge Phase||0
10023746|NCT01857869|11147442|FG008|NOT COMPLETED|Primary/Challenge Phase||0
10023747|NCT01857869|11147443|FG009|NOT COMPLETED|Primary/Challenge Phase||0
10023748|NCT01857869|11147434|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10081187|NCT02258412|11209668|FG001|STARTED|Overall Study||25
9846011|NCT00846040|10958271|FG002|COMPLETED|Baseline: Days 1-5||23
9846012|NCT00846040|10958269|FG000|NOT COMPLETED|Baseline: Days 1-5||1
9846013|NCT00846040|10958270|FG001|NOT COMPLETED|Baseline: Days 1-5||0
9846014|NCT00846040|10958271|FG002|NOT COMPLETED|Baseline: Days 1-5||0
9846015|NCT00846040|10958269|FG000|STARTED|First Treatment Period: Days 6-14||9
9846016|NCT00846040|10958270|FG001|STARTED|First Treatment Period: Days 6-14||10
9846017|NCT00846040|10958271|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
9846018|NCT00846040|10958269|FG000|COMPLETED|First Treatment Period: Days 6-14||9
9846019|NCT00846040|10958270|FG001|COMPLETED|First Treatment Period: Days 6-14||10
9846020|NCT00846040|10958271|FG002|COMPLETED|First Treatment Period: Days 6-14||0
9846021|NCT00846040|10958269|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0
9846022|NCT00846040|10958270|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0
9846023|NCT00846040|10958271|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0
9846024|NCT00846040|10958269|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9
9846025|NCT00846040|10958270|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10
9846026|NCT00846040|10958271|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0
9846027|NCT00846040|10958269|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
9846028|NCT00846040|10958270|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
9846029|NCT00846040|10958271|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
9846030|NCT00846040|10958269|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
9846031|NCT00846040|10958270|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
9846032|NCT00846040|10958271|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
9846033|NCT00846040|10958269|FG000|STARTED|Second Treatment: After Washout, 14 Day||9
9846034|NCT00846040|10958270|FG001|STARTED|Second Treatment: After Washout, 14 Day||8
9846035|NCT00846040|10958271|FG002|STARTED|Second Treatment: After Washout, 14 Day||0
10081188|NCT02258412|11209669|FG002|STARTED|Overall Study||61
10081189|NCT02258412|11209667|FG000|COMPLETED|Overall Study||26
9846036|NCT00846040|10958269|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9
9846037|NCT00846040|10958270|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8
9846038|NCT00846040|10958271|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0
9846039|NCT00846040|10958269|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
9846040|NCT00846040|10958270|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
9846041|NCT00846040|10958271|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
9846042|NCT00846053|10958282|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
9846043|NCT00846053|10958283|FG001|STARTED|Overall Study||8
9846044|NCT00846053|10958282|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
9846045|NCT00846053|10958283|FG001|COMPLETED|Overall Study||8
9846046|NCT00846053|10958282|FG000|NOT COMPLETED|Overall Study||3
9846047|NCT00846053|10958283|FG001|NOT COMPLETED|Overall Study||0
9846048|NCT00846066|10958293|FG000|STARTED|Overall Study||27
9846049|NCT00846066|10958294|FG001|STARTED|Overall Study||29
9846050|NCT00846066|10958293|FG000|COMPLETED|Overall Study||27
9846051|NCT00846066|10958294|FG001|COMPLETED|Overall Study||29
9846052|NCT00846066|10958293|FG000|NOT COMPLETED|Overall Study||0
9846053|NCT00846066|10958294|FG001|NOT COMPLETED|Overall Study||0
9846054|NCT00846287|10958303|FG000|STARTED|Overall Study||16
9846055|NCT00846287|10958304|FG001|STARTED|Overall Study||15
9846056|NCT00846287|10958303|FG000|COMPLETED|Overall Study||6
9846057|NCT00846287|10958304|FG001|COMPLETED|Overall Study||10
9846058|NCT00846287|10958303|FG000|NOT COMPLETED|Overall Study||10
9846059|NCT00846287|10958304|FG001|NOT COMPLETED|Overall Study||5
9846060|NCT00846365|10958313|FG000|STARTED|Overall Study||372
9846061|NCT00846365|10958314|FG001|STARTED|Overall Study||357
9846062|NCT00846365|10958315|FG002|STARTED|Overall Study||356
9846063|NCT00846365|10958313|FG000|COMPLETED|Overall Study||317
9846064|NCT00846365|10958314|FG001|COMPLETED|Overall Study||308
9846065|NCT00846365|10958315|FG002|COMPLETED|Overall Study||323
9846066|NCT00846365|10958313|FG000|NOT COMPLETED|Overall Study||55
9846067|NCT00846365|10958314|FG001|NOT COMPLETED|Overall Study||49
9846068|NCT00846365|10958315|FG002|NOT COMPLETED|Overall Study||33
9846069|NCT00846391|10958326|FG000|STARTED|Overall Study||4
9846070|NCT00846391|10958327|FG001|STARTED|Overall Study||4
9846071|NCT00846391|10958328|FG002|STARTED|Overall Study||6
9846072|NCT00846391|10958326|FG000|COMPLETED|Overall Study||3
9846073|NCT00846391|10958327|FG001|COMPLETED|Overall Study||2
9846074|NCT00846391|10958328|FG002|COMPLETED|Overall Study||3
9846075|NCT00846391|10958326|FG000|NOT COMPLETED|Overall Study||1
9846076|NCT00846391|10958327|FG001|NOT COMPLETED|Overall Study||2
9846077|NCT00846391|10958328|FG002|NOT COMPLETED|Overall Study||3
9846078|NCT00846482|10958336|FG000|STARTED|Overall Study||64
9846079|NCT00846482|10958336|FG000|COMPLETED|Overall Study||54
9846080|NCT00846482|10958336|FG000|NOT COMPLETED|Overall Study||10
9846081|NCT00846495|10958343|FG000|STARTED|Overall Study||28
9846082|NCT00846495|10958344|FG001|STARTED|Overall Study||27
9846083|NCT00846495|10958343|FG000|COMPLETED|Overall Study||20
9846084|NCT00846495|10958344|FG001|COMPLETED|Overall Study||24
9846085|NCT00846495|10958343|FG000|NOT COMPLETED|Overall Study||8
9846086|NCT00846495|10958344|FG001|NOT COMPLETED|Overall Study||3
9846087|NCT00846521|10958350|FG000|STARTED|Overall Study||23
9846088|NCT00846521|10958350|FG000|COMPLETED|Overall Study||12
9846089|NCT00846521|10958350|FG000|NOT COMPLETED|Overall Study||11
9846090|NCT00846547|10958354|FG000|STARTED|Overall Study||32
9846091|NCT00846547|10958354|FG000|COMPLETED|Overall Study||25
9846092|NCT00846547|10958354|FG000|NOT COMPLETED|Overall Study||7
9846093|NCT00846573|10958361|FG000|STARTED|Overall Study||5
9846094|NCT00846573|10958362|FG001|STARTED|Overall Study||2
9846095|NCT00846573|10958363|FG002|STARTED|Overall Study||7
9846096|NCT00846573|10958364|FG003|STARTED|Overall Study||0
9846097|NCT00846573|10958361|FG000|COMPLETED|Overall Study||5
9846098|NCT00846573|10958362|FG001|COMPLETED|Overall Study||2
9846099|NCT00846573|10958363|FG002|COMPLETED|Overall Study||7
9846100|NCT00846573|10958364|FG003|COMPLETED|Overall Study||0
9846101|NCT00846573|10958361|FG000|NOT COMPLETED|Overall Study||0
9846102|NCT00846573|10958362|FG001|NOT COMPLETED|Overall Study||0
9846103|NCT00846573|10958363|FG002|NOT COMPLETED|Overall Study||0
9846104|NCT00846573|10958364|FG003|NOT COMPLETED|Overall Study||0
9846105|NCT00846586|10958374|FG000|STARTED|Overall Study||570
9846106|NCT00846586|10958375|FG001|STARTED|Overall Study||564
9846107|NCT00846586|10958374|FG000|Received Study Drug|Overall Study||570
9846108|NCT00846586|10958375|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
9846109|NCT00846586|10958374|FG000|COMPLETED|Overall Study||531
9846110|NCT00846586|10958375|FG001|COMPLETED|Overall Study||529
9846111|NCT00846586|10958374|FG000|NOT COMPLETED|Overall Study||39
9846112|NCT00846586|10958375|FG001|NOT COMPLETED|Overall Study||35
9846113|NCT00846651|10958383|FG000|STARTED|Overall Study||41
9846114|NCT00846651|10958384|FG001|STARTED|Overall Study||41
9846115|NCT00846651|10958383|FG000|COMPLETED|Overall Study||37
10023749|NCT01857869|11147435|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10023750|NCT01857869|11147436|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10023751|NCT01857869|11147437|FG003|STARTED|Booster/Rechallenge Phase||9
10023752|NCT01857869|11147438|FG004|STARTED|Booster/Rechallenge Phase||10
10023753|NCT01857869|11147439|FG005|STARTED|Booster/Rechallenge Phase||2
10023754|NCT01857869|11147440|FG006|STARTED|Booster/Rechallenge Phase||5
9846116|NCT00846651|10958384|FG001|COMPLETED|Overall Study||37
9846117|NCT00846651|10958383|FG000|NOT COMPLETED|Overall Study||4
9846118|NCT00846651|10958384|FG001|NOT COMPLETED|Overall Study||4
9846119|NCT00846768|10958392|FG000|STARTED|Overall Study||11
9846120|NCT00846768|10958393|FG001|STARTED|Overall Study||12
9846121|NCT00846768|10958394|FG002|STARTED|Overall Study||12
9846122|NCT00846768|10958395|FG003|STARTED|Overall Study||12
9846123|NCT00846768|10958392|FG000|COMPLETED|Overall Study||11
9846124|NCT00846768|10958393|FG001|COMPLETED|Overall Study||11
9846125|NCT00846768|10958394|FG002|COMPLETED|Overall Study||12
9846126|NCT00846768|10958395|FG003|COMPLETED|Overall Study||12
9846127|NCT00846768|10958392|FG000|NOT COMPLETED|Overall Study||0
9846128|NCT00846768|10958393|FG001|NOT COMPLETED|Overall Study||1
9846129|NCT00846768|10958394|FG002|NOT COMPLETED|Overall Study||0
9846130|NCT00846768|10958395|FG003|NOT COMPLETED|Overall Study||0
9846131|NCT00846807|10958405|FG000|STARTED|Overall Study|Entered and treated.|5292
9846132|NCT00846807|10958405|FG000|COMPLETED|Overall Study|Completed treatment.|4660
9846133|NCT00846807|10958405|FG000|NOT COMPLETED|Overall Study||632
9846134|NCT00846846|10958409|FG000|STARTED|Overall Study||1018
9846135|NCT00846846|10958409|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
9846136|NCT00846846|10958409|FG000|NOT COMPLETED|Overall Study||75
9846137|NCT00847015|10958413|FG000|STARTED|Overall Study||18
9846138|NCT00847015|10958413|FG000|COMPLETED|Overall Study||15
9846139|NCT00847015|10958413|FG000|NOT COMPLETED|Overall Study||3
9846140|NCT00847132|10958419|FG000|STARTED|Overall Study||90
9846141|NCT00847132|10958420|FG001|STARTED|Overall Study||85
9846142|NCT00847132|10958419|FG000|COMPLETED|Overall Study||89
9846143|NCT00847132|10958420|FG001|COMPLETED|Overall Study||84
9846144|NCT00847132|10958419|FG000|NOT COMPLETED|Overall Study||1
9846145|NCT00847132|10958420|FG001|NOT COMPLETED|Overall Study||1
9846146|NCT00847145|10958434|FG000|STARTED|Overall Study||629
9846147|NCT00847145|10958435|FG001|STARTED|Overall Study||633
9846148|NCT00847145|10958436|FG002|STARTED|Overall Study||285
9846149|NCT00847145|10958437|FG003|STARTED|Overall Study||117
9846150|NCT00847145|10958438|FG004|STARTED|Overall Study||137
9846151|NCT00847145|10958439|FG005|STARTED|Overall Study||156
9846152|NCT00847145|10958440|FG006|STARTED|Overall Study||152
9846153|NCT00847145|10958441|FG007|STARTED|Overall Study||140
9846154|NCT00847145|10958434|FG000|COMPLETED|Overall Study||623
9846155|NCT00847145|10958435|FG001|COMPLETED|Overall Study||627
9846156|NCT00847145|10958436|FG002|COMPLETED|Overall Study||274
9846157|NCT00847145|10958437|FG003|COMPLETED|Overall Study||116
9846158|NCT00847145|10958438|FG004|COMPLETED|Overall Study||131
9846159|NCT00847145|10958439|FG005|COMPLETED|Overall Study||152
9846160|NCT00847145|10958440|FG006|COMPLETED|Overall Study||143
9846161|NCT00847145|10958441|FG007|COMPLETED|Overall Study||136
9846162|NCT00847145|10958434|FG000|NOT COMPLETED|Overall Study||6
9846163|NCT00847145|10958435|FG001|NOT COMPLETED|Overall Study||6
9846164|NCT00847145|10958436|FG002|NOT COMPLETED|Overall Study||11
9846165|NCT00847145|10958437|FG003|NOT COMPLETED|Overall Study||1
9846166|NCT00847145|10958438|FG004|NOT COMPLETED|Overall Study||6
9846167|NCT00847145|10958439|FG005|NOT COMPLETED|Overall Study||4
9846168|NCT00847145|10958440|FG006|NOT COMPLETED|Overall Study||9
9846169|NCT00847145|10958441|FG007|NOT COMPLETED|Overall Study||4
9846170|NCT00847171|10958468|FG000|STARTED|Overall Study||20
9846171|NCT00847171|10958468|FG000|COMPLETED|Overall Study||20
9846172|NCT00847171|10958468|FG000|NOT COMPLETED|Overall Study||0
9846173|NCT00847197|10958475|FG000|STARTED|Overall Study||116
9846174|NCT00847197|10958476|FG001|STARTED|Overall Study||75
9846175|NCT00847197|10958475|FG000|COMPLETED|Overall Study||92
9846176|NCT00847197|10958476|FG001|COMPLETED|Overall Study||70
9846177|NCT00847197|10958475|FG000|NOT COMPLETED|Overall Study||24
9846178|NCT00847197|10958476|FG001|NOT COMPLETED|Overall Study||5
9846179|NCT00847210|10958484|FG000|STARTED|Overall Study||18
9846180|NCT00847210|10958485|FG001|STARTED|Overall Study||18
9846181|NCT00847210|10958484|FG000|COMPLETED|Overall Study||18
9846182|NCT00847210|10958485|FG001|COMPLETED|Overall Study||18
9846183|NCT00847210|10958484|FG000|NOT COMPLETED|Overall Study||0
9846184|NCT00847210|10958485|FG001|NOT COMPLETED|Overall Study||0
9846185|NCT00847288|10958493|FG000|STARTED|Overall Study||841
9846186|NCT00847288|10958494|FG001|STARTED|Overall Study||827
9846187|NCT00847288|10958493|FG000|COMPLETED|Overall Study||811
9846188|NCT00847288|10958494|FG001|COMPLETED|Overall Study||780
9846189|NCT00847288|10958493|FG000|NOT COMPLETED|Overall Study||30
9846190|NCT00847288|10958494|FG001|NOT COMPLETED|Overall Study||47
9846191|NCT00847301|10958500|FG000|STARTED|Overall Study||428
9846192|NCT00847301|10958500|FG000|COMPLETED|Overall Study||374
9846193|NCT00847301|10958500|FG000|NOT COMPLETED|Overall Study||54
9846194|NCT00847379|10958507|FG000|STARTED|Overall Study||59
9846195|NCT00847379|10958508|FG001|STARTED|Overall Study||57
9846196|NCT00847379|10958509|FG002|STARTED|Overall Study||57
9846197|NCT00847379|10958507|FG000|As-treated Population|Overall Study||59
9846198|NCT00847379|10958508|FG001|As-treated Population|Overall Study||57
9846199|NCT00847379|10958509|FG002|As-treated Population|Overall Study||57
9846200|NCT00847379|10958507|FG000|COMPLETED|Overall Study||0
9846201|NCT00847379|10958508|FG001|COMPLETED|Overall Study||0
9846202|NCT00847379|10958509|FG002|COMPLETED|Overall Study||0
9846203|NCT00847379|10958507|FG000|NOT COMPLETED|Overall Study||59
9846204|NCT00847379|10958508|FG001|NOT COMPLETED|Overall Study||57
9846205|NCT00847379|10958509|FG002|NOT COMPLETED|Overall Study||57
9846206|NCT00847522|10958519|FG000|STARTED|Overall Study||90
9846207|NCT00847522|10958519|FG000|Phase I|Overall Study||10
9846208|NCT00847522|10958519|FG000|Phase II|Overall Study||80
9846209|NCT00847522|10958519|FG000|COMPLETED|Overall Study||90
9846210|NCT00847522|10958519|FG000|NOT COMPLETED|Overall Study||0
9846211|NCT00847535|10958523|FG000|STARTED|Overall Study||24
9846212|NCT00847535|10958524|FG001|STARTED|Overall Study||24
9846213|NCT00847535|10958525|FG002|STARTED|Overall Study||16
9846214|NCT00847535|10958523|FG000|10 Million AMDC|Overall Study||8
9846215|NCT00847535|10958524|FG001|10 Million AMDC|Overall Study||8
9846216|NCT00847535|10958525|FG002|10 Million AMDC|Overall Study||0
9846217|NCT00847535|10958523|FG000|50 Million AMDC|Overall Study||8
9846218|NCT00847535|10958524|FG001|50 Million AMDC|Overall Study||8
9846219|NCT00847535|10958525|FG002|50 Million AMDC|Overall Study||0
9846220|NCT00847535|10958523|FG000|100 Million AMDC|Overall Study||8
9846221|NCT00847535|10958524|FG001|100 Million AMDC|Overall Study||8
9846222|NCT00847535|10958525|FG002|100 Million AMDC|Overall Study||8
9846223|NCT00847535|10958523|FG000|200 Million AMDC|Overall Study||0
9846224|NCT00847535|10958524|FG001|200 Million AMDC|Overall Study||0
9846225|NCT00847535|10958525|FG002|200 Million AMDC|Overall Study||8
9846226|NCT00847535|10958523|FG000|COMPLETED|Overall Study||22
9846227|NCT00847535|10958524|FG001|COMPLETED|Overall Study||22
9846228|NCT00847535|10958525|FG002|COMPLETED|Overall Study||15
9846229|NCT00847535|10958523|FG000|NOT COMPLETED|Overall Study||2
9846230|NCT00847535|10958524|FG001|NOT COMPLETED|Overall Study||2
9846231|NCT00847535|10958525|FG002|NOT COMPLETED|Overall Study||1
9846232|NCT00847561|10958532|FG000|STARTED|Overall Study||70
9846233|NCT00847561|10958533|FG001|STARTED|Overall Study||66
9846234|NCT00847561|10958532|FG000|COMPLETED|Overall Study||57
9846235|NCT00847561|10958533|FG001|COMPLETED|Overall Study||62
9846236|NCT00847561|10958532|FG000|NOT COMPLETED|Overall Study||13
9846237|NCT00847561|10958533|FG001|NOT COMPLETED|Overall Study||4
9846238|NCT00847587|10958541|FG000|STARTED|Overall Study||35
9846239|NCT00847587|10958542|FG001|STARTED|Overall Study||34
9846240|NCT00847587|10958541|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34
9846241|NCT00847587|10958542|FG001|COMPLETED|Overall Study||34
10023755|NCT01857869|11147441|FG007|STARTED|Booster/Rechallenge Phase||4
10023756|NCT01857869|11147442|FG008|STARTED|Booster/Rechallenge Phase||3
10023757|NCT01857869|11147443|FG009|STARTED|Booster/Rechallenge Phase||6
10023758|NCT01857869|11147434|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10081190|NCT02258412|11209668|FG001|COMPLETED|Overall Study||25
9846242|NCT00847587|10958541|FG000|NOT COMPLETED|Overall Study||1
9846243|NCT00847587|10958542|FG001|NOT COMPLETED|Overall Study||0
9846244|NCT00847613|10958552|FG000|STARTED|Overall Study||321
9846245|NCT00847613|10958553|FG001|STARTED|Overall Study||319
9846246|NCT00847613|10958554|FG002|STARTED|Overall Study||81
9846247|NCT00847613|10958555|FG003|STARTED|Overall Study||79
9846248|NCT00847613|10958552|FG000|Treated|Overall Study||321
9846249|NCT00847613|10958553|FG001|Treated|Overall Study||316
9846250|NCT00847613|10958554|FG002|Treated|Overall Study||81
9846251|NCT00847613|10958555|FG003|Treated|Overall Study||79
9846252|NCT00847613|10958552|FG000|COMPLETED|Overall Study||0
9846253|NCT00847613|10958553|FG001|COMPLETED|Overall Study||0
9846254|NCT00847613|10958554|FG002|COMPLETED|Overall Study||0
9846255|NCT00847613|10958555|FG003|COMPLETED|Overall Study||0
9846256|NCT00847613|10958552|FG000|NOT COMPLETED|Overall Study||321
9846257|NCT00847613|10958553|FG001|NOT COMPLETED|Overall Study||319
10023759|NCT01857869|11147435|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10023760|NCT01857869|11147436|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10023761|NCT01857869|11147437|FG003|COMPLETED|Booster/Rechallenge Phase||7
10023762|NCT01857869|11147438|FG004|COMPLETED|Booster/Rechallenge Phase||10
10023763|NCT01857869|11147439|FG005|COMPLETED|Booster/Rechallenge Phase||2
10023764|NCT01857869|11147440|FG006|COMPLETED|Booster/Rechallenge Phase||5
10023765|NCT01857869|11147441|FG007|COMPLETED|Booster/Rechallenge Phase||4
10023766|NCT01857869|11147442|FG008|COMPLETED|Booster/Rechallenge Phase||3
10023767|NCT01857869|11147443|FG009|COMPLETED|Booster/Rechallenge Phase||6
10023768|NCT01857869|11147434|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0
10023769|NCT01857869|11147435|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0
10023770|NCT01857869|11147436|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0
10023771|NCT01857869|11147437|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2
10023772|NCT01857869|11147438|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0
10023773|NCT01857869|11147439|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0
10023774|NCT01857869|11147440|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0
10023775|NCT01857869|11147441|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0
10023776|NCT01857869|11147442|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0
10023777|NCT01857869|11147443|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0
10023778|NCT01857882|11147468|FG000|STARTED|Overall Study||21
10114268|NCT02515058|11244983|FG001|STARTED|Overall Study||22
9846258|NCT00847613|10958554|FG002|NOT COMPLETED|Overall Study||81
9846259|NCT00847613|10958555|FG003|NOT COMPLETED|Overall Study||79
9846260|NCT00847626|10958583|FG000|STARTED|Overall Study||156
9846261|NCT00847626|10958584|FG001|STARTED|Overall Study||154
9846262|NCT00847626|10958585|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
9846263|NCT00847626|10958586|FG003|STARTED|Overall Study||156
9846264|NCT00847626|10958587|FG004|STARTED|Overall Study||153
9846265|NCT00847626|10958588|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
9846266|NCT00847626|10958589|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
9846267|NCT00847626|10958590|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
9846268|NCT00847626|10958591|FG008|STARTED|Overall Study||155
9846269|NCT00847626|10958592|FG009|STARTED|Overall Study||153
9846270|NCT00847626|10958593|FG010|STARTED|Overall Study||162
10023779|NCT01857882|11147469|FG001|STARTED|Overall Study||20
10023780|NCT01857882|11147468|FG000|COMPLETED|Overall Study||21
10114269|NCT02515058|11244982|FG000|COMPLETED|Overall Study||18
9846271|NCT00847626|10958583|FG000|COMPLETED|Overall Study||135
9846272|NCT00847626|10958584|FG001|COMPLETED|Overall Study||131
9846273|NCT00847626|10958585|FG002|COMPLETED|Overall Study||131
9846274|NCT00847626|10958586|FG003|COMPLETED|Overall Study||125
9846275|NCT00847626|10958587|FG004|COMPLETED|Overall Study||125
9846276|NCT00847626|10958588|FG005|COMPLETED|Overall Study||125
9846277|NCT00847626|10958589|FG006|COMPLETED|Overall Study||135
9846278|NCT00847626|10958590|FG007|COMPLETED|Overall Study||141
9846279|NCT00847626|10958591|FG008|COMPLETED|Overall Study||141
9846280|NCT00847626|10958592|FG009|COMPLETED|Overall Study||139
9846281|NCT00847626|10958593|FG010|COMPLETED|Overall Study||142
9846282|NCT00847626|10958583|FG000|NOT COMPLETED|Overall Study||21
9846283|NCT00847626|10958584|FG001|NOT COMPLETED|Overall Study||23
10023781|NCT01857882|11147469|FG001|COMPLETED|Overall Study||20
10023782|NCT01857882|11147468|FG000|NOT COMPLETED|Overall Study||0
10023783|NCT01857882|11147469|FG001|NOT COMPLETED|Overall Study||0
9846284|NCT00847626|10958585|FG002|NOT COMPLETED|Overall Study||16
9846285|NCT00847626|10958586|FG003|NOT COMPLETED|Overall Study||31
9846286|NCT00847626|10958587|FG004|NOT COMPLETED|Overall Study||28
9846287|NCT00847626|10958588|FG005|NOT COMPLETED|Overall Study||37
9846288|NCT00847626|10958589|FG006|NOT COMPLETED|Overall Study||22
9846289|NCT00847626|10958590|FG007|NOT COMPLETED|Overall Study||19
9846290|NCT00847626|10958591|FG008|NOT COMPLETED|Overall Study||14
9846291|NCT00847626|10958592|FG009|NOT COMPLETED|Overall Study||14
9846292|NCT00847626|10958593|FG010|NOT COMPLETED|Overall Study||20
9846293|NCT00847665|10958622|FG000|STARTED|Overall Study||165
9846294|NCT00847665|10958623|FG001|STARTED|Overall Study||165
9846295|NCT00847665|10958622|FG000|COMPLETED|Overall Study||164
9846296|NCT00847665|10958623|FG001|COMPLETED|Overall Study||165
9846297|NCT00847665|10958622|FG000|NOT COMPLETED|Overall Study||1
9846298|NCT00847665|10958623|FG001|NOT COMPLETED|Overall Study||0
9846299|NCT00847704|10958629|FG000|STARTED|Overall Study||3
9846300|NCT00847704|10958629|FG000|COMPLETED|Overall Study||2
9846301|NCT00847704|10958629|FG000|NOT COMPLETED|Overall Study||1
9846302|NCT00847730|10958633|FG000|STARTED|Overall Study||33
9846303|NCT00847730|10958633|FG000|COMPLETED|Overall Study||25
9846304|NCT00847730|10958633|FG000|NOT COMPLETED|Overall Study||8
9846305|NCT00847808|10958637|FG000|STARTED|Overall Study||178
9846306|NCT00847808|10958637|FG000|COMPLETED|Overall Study||163
9846307|NCT00847808|10958637|FG000|NOT COMPLETED|Overall Study||15
9846308|NCT00847886|10958643|FG000|STARTED|Overall Study||12
9846309|NCT00847886|10958644|FG001|STARTED|Overall Study||4
9846310|NCT00847886|10958643|FG000|COMPLETED|Overall Study||12
9846311|NCT00847886|10958644|FG001|COMPLETED|Overall Study||3
9846312|NCT00847886|10958643|FG000|NOT COMPLETED|Overall Study||0
9846313|NCT00847886|10958644|FG001|NOT COMPLETED|Overall Study||1
9846314|NCT00847912|10958652|FG000|STARTED|Overall Study||477
9846315|NCT00847912|10958653|FG001|STARTED|Overall Study||477
9846316|NCT00847912|10958652|FG000|COMPLETED|Overall Study||468
9846317|NCT00847912|10958653|FG001|COMPLETED|Overall Study||464
9846318|NCT00847912|10958652|FG000|NOT COMPLETED|Overall Study||9
9846319|NCT00847912|10958653|FG001|NOT COMPLETED|Overall Study||13
9846320|NCT00847938|10958664|FG000|STARTED|Overall Study||16
9846321|NCT00847938|10958665|FG001|STARTED|Overall Study||15
9846322|NCT00847938|10958666|FG002|STARTED|Overall Study||16
9846323|NCT00847938|10958667|FG003|STARTED|Overall Study||15
9846324|NCT00847938|10958664|FG000|COMPLETED|Overall Study||16
9846325|NCT00847938|10958665|FG001|COMPLETED|Overall Study||14
10023784|NCT01857973|11147475|FG000|STARTED|Overall Study||78
9846326|NCT00847938|10958666|FG002|COMPLETED|Overall Study||15
9846327|NCT00847938|10958667|FG003|COMPLETED|Overall Study||15
9846328|NCT00847938|10958664|FG000|NOT COMPLETED|Overall Study||0
10023785|NCT01857973|11147475|FG000|Exploratory A Phase|Overall Study||9
10023786|NCT01857973|11147475|FG000|Xploratory B Phase|Overall Study||9
9846329|NCT00847938|10958665|FG001|NOT COMPLETED|Overall Study||1
9846330|NCT00847938|10958666|FG002|NOT COMPLETED|Overall Study||1
9846331|NCT00847938|10958667|FG003|NOT COMPLETED|Overall Study||0
9846332|NCT00848016|10958677|FG000|STARTED|Overall Study||29
9846333|NCT00848016|10958677|FG000|COMPLETED|Overall Study||29
9846334|NCT00848016|10958677|FG000|NOT COMPLETED|Overall Study||0
9846335|NCT00848042|10958684|FG000|STARTED|Overall Study||5
9846336|NCT00848042|10958685|FG001|STARTED|Overall Study||5
9846337|NCT00848042|10958686|FG002|STARTED|Overall Study||1
9846338|NCT00848042|10958684|FG000|Day 1|Overall Study||5
9846339|NCT00848042|10958685|FG001|Day 1|Overall Study||5
9846340|NCT00848042|10958686|FG002|Day 1|Overall Study||1
9846341|NCT00848042|10958684|FG000|Day 2|Overall Study||5
9846342|NCT00848042|10958685|FG001|Day 2|Overall Study||5
9846343|NCT00848042|10958686|FG002|Day 2|Overall Study||1
9846344|NCT00848042|10958684|FG000|Day 3|Overall Study||5
9846345|NCT00848042|10958685|FG001|Day 3|Overall Study||5
9846346|NCT00848042|10958686|FG002|Day 3|Overall Study||1
9846347|NCT00848042|10958684|FG000|Day 8|Overall Study||5
9846348|NCT00848042|10958685|FG001|Day 8|Overall Study||5
10023787|NCT01857973|11147475|FG000|Phase 1|Overall Study||17
10023788|NCT01857973|11147475|FG000|Phase 2|Overall Study||14
9846349|NCT00848042|10958686|FG002|Day 8|Overall Study||1
9846350|NCT00848042|10958684|FG000|Day 15|Overall Study||4
9846351|NCT00848042|10958685|FG001|Day 15|Overall Study||5
9846352|NCT00848042|10958686|FG002|Day 15|Overall Study||1
9846353|NCT00848042|10958684|FG000|Month 1|Overall Study||4
10023789|NCT01857973|11147475|FG000|Phase 3|Overall Study||10
10023790|NCT01857973|11147475|FG000|Phase 4|Overall Study||10
10023791|NCT01857973|11147475|FG000|Phase 6|Overall Study||4
10023792|NCT01857973|11147475|FG000|Phase 7|Overall Study||4
10023793|NCT01857973|11147475|FG000|COMPLETED|Overall Study||73
9726264|NCT00098787|10825763|FG000|COMPLETED|Overall Study||0
9726265|NCT00098787|10825764|FG001|COMPLETED|Overall Study||0
9726266|NCT00098787|10825765|FG002|COMPLETED|Overall Study||0
9726267|NCT00098787|10825763|FG000|NOT COMPLETED|Overall Study||73
9726268|NCT00098787|10825764|FG001|NOT COMPLETED|Overall Study||75
9726269|NCT00098787|10825765|FG002|NOT COMPLETED|Overall Study||63
9726270|NCT00098813|10825773|FG000|STARTED|Overall Study||20
9726271|NCT00098813|10825773|FG000|COMPLETED|Overall Study||1
9726272|NCT00098813|10825773|FG000|NOT COMPLETED|Overall Study||19
9726273|NCT00098839|10825779|FG000|STARTED|Overall Study||56
9726274|NCT00098839|10825780|FG001|STARTED|Overall Study||60
9726275|NCT00098839|10825779|FG000|COMPLETED|Overall Study||24
9726276|NCT00098839|10825780|FG001|COMPLETED|Overall Study||27
9726277|NCT00098839|10825779|FG000|NOT COMPLETED|Overall Study||32
9726278|NCT00098839|10825780|FG001|NOT COMPLETED|Overall Study||33
9726279|NCT00098865|10825787|FG000|STARTED|Overall Study||15
9726280|NCT00098865|10825787|FG000|COMPLETED|Overall Study||6
9726281|NCT00098865|10825787|FG000|NOT COMPLETED|Overall Study||9
10114270|NCT02515058|11244983|FG001|COMPLETED|Overall Study||20
10114271|NCT02515058|11244982|FG000|NOT COMPLETED|Overall Study||3
10023794|NCT01857973|11147475|FG000|NOT COMPLETED|Overall Study||5
10023795|NCT01857986|11147481|FG000|STARTED|Overall Study||39
10023796|NCT01857986|11147482|FG001|STARTED|Overall Study||37
10023797|NCT01857986|11147481|FG000|COMPLETED|Overall Study||34
10023798|NCT01857986|11147482|FG001|COMPLETED|Overall Study||30
10023799|NCT01857986|11147481|FG000|NOT COMPLETED|Overall Study||5
10023800|NCT01857986|11147482|FG001|NOT COMPLETED|Overall Study||7
10023801|NCT01858194|11147490|FG000|STARTED|Overall Study||8
10023802|NCT01858194|11147491|FG001|STARTED|Overall Study||9
10023803|NCT01858194|11147490|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8
10023804|NCT01858194|11147491|FG001|COMPLETED|Overall Study||7
10023805|NCT01858194|11147490|FG000|NOT COMPLETED|Overall Study||0
10023806|NCT01858194|11147491|FG001|NOT COMPLETED|Overall Study||2
10114272|NCT02515058|11244983|FG001|NOT COMPLETED|Overall Study||2
10114273|NCT02515097|11244991|FG000|STARTED|Overall Study||142
10114274|NCT02515097|11244992|FG001|STARTED|Overall Study||71
10114275|NCT02515097|11244991|FG000|Intent-to-Treat (ITT) Population|Overall Study||142
9688789|NCT04460690|10788863|FG000|STARTED|Overall Study||93
9688790|NCT04460690|10788863|FG000|Community Participants|Overall Study||83
9688791|NCT04460690|10788863|FG000|Investigator Participants|Overall Study||10
9688792|NCT04460690|10788863|FG000|COMPLETED|Overall Study||93
9688793|NCT04460690|10788863|FG000|NOT COMPLETED|Overall Study||0
9688794|NCT04374019|10788874|FG000|STARTED|Overall Study||1
9688795|NCT04374019|10788875|FG001|STARTED|Overall Study||1
9688796|NCT04374019|10788876|FG002|STARTED|Overall Study||6
9688797|NCT04374019|10788877|FG003|STARTED|Overall Study||5
9688798|NCT04374019|10788874|FG000|COMPLETED|Overall Study||1
9688799|NCT04374019|10788875|FG001|COMPLETED|Overall Study||1
9688800|NCT04374019|10788876|FG002|COMPLETED|Overall Study||5
9688801|NCT04374019|10788877|FG003|COMPLETED|Overall Study||5
9688802|NCT04374019|10788874|FG000|NOT COMPLETED|Overall Study||0
9688803|NCT04374019|10788875|FG001|NOT COMPLETED|Overall Study||0
9688804|NCT04374019|10788876|FG002|NOT COMPLETED|Overall Study||1
9688805|NCT04374019|10788877|FG003|NOT COMPLETED|Overall Study||0
9688806|NCT04357730|10788891|FG000|STARTED|Phase 1||17
9688807|NCT04357730|10788892|FG001|STARTED|Phase 1||19
9688808|NCT04357730|10788893|FG002|STARTED|Phase 1||0
9688809|NCT04357730|10788891|FG000|COMPLETED|Phase 1||17
9688810|NCT04357730|10788892|FG001|COMPLETED|Phase 1||19
9688811|NCT04357730|10788893|FG002|COMPLETED|Phase 1||0
9688812|NCT04357730|10788891|FG000|NOT COMPLETED|Phase 1||0
9688813|NCT04357730|10788892|FG001|NOT COMPLETED|Phase 1||0
9688814|NCT04357730|10788893|FG002|NOT COMPLETED|Phase 1||0
9688815|NCT04357730|10788891|FG000|STARTED|Phase 2||8
9688816|NCT04357730|10788892|FG001|STARTED|Phase 2||0
9688817|NCT04357730|10788893|FG002|STARTED|Phase 2||6
9688818|NCT04357730|10788891|FG000|COMPLETED|Phase 2||8
9688819|NCT04357730|10788892|FG001|COMPLETED|Phase 2||0
9688820|NCT04357730|10788893|FG002|COMPLETED|Phase 2||6
9688821|NCT04357730|10788891|FG000|NOT COMPLETED|Phase 2||0
9688822|NCT04357730|10788892|FG001|NOT COMPLETED|Phase 2||0
9688823|NCT04357730|10788893|FG002|NOT COMPLETED|Phase 2||0
9688824|NCT04311463|10788907|FG000|STARTED|Period 1 (Up to Day 3)||19
9688825|NCT04311463|10788908|FG001|STARTED|Period 1 (Up to Day 3)||19
9688826|NCT04311463|10788907|FG000|COMPLETED|Period 1 (Up to Day 3)||18
9688827|NCT04311463|10788908|FG001|COMPLETED|Period 1 (Up to Day 3)||19
9688828|NCT04311463|10788907|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1
9688829|NCT04311463|10788908|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0
9688830|NCT04311463|10788907|FG000|STARTED|Washout Period (Up to Day 7)||18
9688831|NCT04311463|10788908|FG001|STARTED|Washout Period (Up to Day 7)||19
9688832|NCT04311463|10788907|FG000|COMPLETED|Washout Period (Up to Day 7)||17
9688833|NCT04311463|10788908|FG001|COMPLETED|Washout Period (Up to Day 7)||18
9688834|NCT04311463|10788907|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1
9688835|NCT04311463|10788908|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1
9688836|NCT04311463|10788907|FG000|STARTED|Period 2 (Up to Day 3)||17
9688837|NCT04311463|10788908|FG001|STARTED|Period 2 (Up to Day 3)||18
9688838|NCT04311463|10788907|FG000|COMPLETED|Period 2 (Up to Day 3)||15
9688839|NCT04311463|10788908|FG001|COMPLETED|Period 2 (Up to Day 3)||17
9688840|NCT04311463|10788907|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2
9688841|NCT04311463|10788908|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1
9688842|NCT04175509|10788917|FG000|STARTED|Overall Study||19
9688843|NCT04175509|10788918|FG001|STARTED|Overall Study||21
9688844|NCT04175509|10788917|FG000|COMPLETED|Overall Study||17
9688845|NCT04175509|10788918|FG001|COMPLETED|Overall Study||19
9688846|NCT04175509|10788917|FG000|NOT COMPLETED|Overall Study||2
9688847|NCT04175509|10788918|FG001|NOT COMPLETED|Overall Study||2
9688848|NCT03930186|10788924|FG000|STARTED|Weeks 0 to 16||152
9688849|NCT03930186|10788924|FG000|Received Study Drug|Weeks 0 to 16||152
9688850|NCT03930186|10788924|FG000|COMPLETED|Weeks 0 to 16||140
9688851|NCT03930186|10788924|FG000|NOT COMPLETED|Weeks 0 to 16||12
9688852|NCT03930186|10788924|FG000|STARTED|Weeks 16 to 32||140
9688853|NCT03930186|10788924|FG000|COMPLETED|Weeks 16 to 32||136
9688854|NCT03930186|10788924|FG000|NOT COMPLETED|Weeks 16 to 32||4
9688855|NCT03740100|10788928|FG000|STARTED|Overall Study|Note: Ten patients were consented, but two died before starting therapy.|8
9688856|NCT03740100|10788928|FG000|Confirmed Partial Response|Overall Study|"Using a Simon's optimal two-stage design, we planned to enroll up to 10 evaluable patients in the first stage.~Two of eight treated patients were not evaluable for response based on toxicity.~We did not reach this milestone."|1
9688857|NCT03740100|10788928|FG000|COMPLETED|Overall Study||6
9688858|NCT03740100|10788928|FG000|NOT COMPLETED|Overall Study||2
9688859|NCT03597295|10788932|FG000|STARTED|Overall Study||94
9688860|NCT03597295|10788932|FG000|COMPLETED|Overall Study||0
9688861|NCT03597295|10788932|FG000|NOT COMPLETED|Overall Study||94
9961216|NCT01472757|11080967|FG000|Full Analysis Set|Overall Study||91
9688882|NCT03053362|10788962|FG000|STARTED|Overall Study||100
9688883|NCT03053362|10788963|FG001|STARTED|Overall Study||58
9688884|NCT03053362|10788962|FG000|COMPLETED|Overall Study||83
9688885|NCT03053362|10788963|FG001|COMPLETED|Overall Study||50
9688886|NCT03053362|10788962|FG000|NOT COMPLETED|Overall Study||17
9688887|NCT03053362|10788963|FG001|NOT COMPLETED|Overall Study||8
9688888|NCT02849626|10788972|FG000|STARTED|Core Phase (up to 23 Weeks)||149
9688889|NCT02849626|10788973|FG001|STARTED|Core Phase (up to 23 Weeks)||31
9688890|NCT02849626|10788972|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122
9688891|NCT02849626|10788973|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24
9688892|NCT02849626|10788972|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
9688893|NCT02849626|10788973|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
9688894|NCT02849626|10788972|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116
9688895|NCT02849626|10788973|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20
9688896|NCT02849626|10788972|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105
9688897|NCT02849626|10788973|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17
9688898|NCT02849626|10788972|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
9688899|NCT02849626|10788973|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
9846354|NCT00848042|10958685|FG001|Month 1|Overall Study||5
9846355|NCT00848042|10958686|FG002|Month 1|Overall Study||1
9846356|NCT00848042|10958684|FG000|Month 2|Overall Study||1
9846357|NCT00848042|10958685|FG001|Month 2|Overall Study||5
9846358|NCT00848042|10958686|FG002|Month 2|Overall Study||1
9846359|NCT00848042|10958684|FG000|Month 3|Overall Study||1
9846360|NCT00848042|10958685|FG001|Month 3|Overall Study||4
9846361|NCT00848042|10958686|FG002|Month 3|Overall Study||1
9846362|NCT00848042|10958684|FG000|Month 4|Overall Study||1
9688909|NCT02654132|10789005|FG000|STARTED|Overall Study||60
9688910|NCT02654132|10789006|FG001|STARTED|Overall Study||57
9688911|NCT02654132|10789005|FG000|COMPLETED|Overall Study||24
9688912|NCT02654132|10789006|FG001|COMPLETED|Overall Study||11
9688913|NCT02654132|10789005|FG000|NOT COMPLETED|Overall Study||36
9688914|NCT02654132|10789006|FG001|NOT COMPLETED|Overall Study||46
9688915|NCT02603432|10789015|FG000|STARTED|Overall Study||350
9688916|NCT02603432|10789016|FG001|STARTED|Overall Study||350
9688917|NCT02603432|10789015|FG000|COMPLETED|Overall Study||0
9688918|NCT02603432|10789016|FG001|COMPLETED|Overall Study||0
9688919|NCT02603432|10789015|FG000|NOT COMPLETED|Overall Study||350
9688920|NCT02603432|10789016|FG001|NOT COMPLETED|Overall Study||350
9688921|NCT02600923|10789022|FG000|STARTED|Overall Study||131
9688922|NCT02600923|10789022|FG000|Treated|Overall Study||130
9688923|NCT02600923|10789022|FG000|COMPLETED|Overall Study||0
9688924|NCT02600923|10789022|FG000|NOT COMPLETED|Overall Study||131
9688925|NCT02597790|10789028|FG000|STARTED|Overall Study||45
9688926|NCT02597790|10789029|FG001|STARTED|Overall Study||41
9688927|NCT02597790|10789028|FG000|COMPLETED|Overall Study||36
9688928|NCT02597790|10789029|FG001|COMPLETED|Overall Study||29
9688929|NCT02597790|10789028|FG000|NOT COMPLETED|Overall Study||9
9688930|NCT02597790|10789029|FG001|NOT COMPLETED|Overall Study||12
9688931|NCT02484664|10789040|FG000|STARTED|Overall Study||12
9688932|NCT02484664|10789040|FG000|COMPLETED|Overall Study||9
9688933|NCT02484664|10789040|FG000|NOT COMPLETED|Overall Study||3
9688934|NCT02412735|10789047|FG000|STARTED|Overall Study||143
9688935|NCT02412735|10789048|FG001|STARTED|Overall Study||129
9688936|NCT02412735|10789049|FG002|STARTED|Overall Study||132
9688937|NCT02412735|10789047|FG000|Received Treatment|Overall Study||140
9688938|NCT02412735|10789048|FG001|Received Treatment|Overall Study||128
9688939|NCT02412735|10789049|FG002|Received Treatment|Overall Study||130
9688940|NCT02412735|10789047|FG000|COMPLETED|Overall Study||97
9688941|NCT02412735|10789048|FG001|COMPLETED|Overall Study||85
9688942|NCT02412735|10789049|FG002|COMPLETED|Overall Study||86
9688943|NCT02412735|10789047|FG000|NOT COMPLETED|Overall Study||46
9688944|NCT02412735|10789048|FG001|NOT COMPLETED|Overall Study||44
9688945|NCT02412735|10789049|FG002|NOT COMPLETED|Overall Study||46
9688946|NCT02371889|10789059|FG000|STARTED|Overall Study||85
9688947|NCT02371889|10789060|FG001|STARTED|Overall Study||85
9688948|NCT02371889|10789059|FG000|COMPLETED|Overall Study||66
9688949|NCT02371889|10789060|FG001|COMPLETED|Overall Study||71
9688950|NCT02371889|10789059|FG000|NOT COMPLETED|Overall Study||19
9688951|NCT02371889|10789060|FG001|NOT COMPLETED|Overall Study||14
9846363|NCT00848042|10958685|FG001|Month 4|Overall Study||4
9846364|NCT00848042|10958686|FG002|Month 4|Overall Study||1
9846365|NCT00848042|10958684|FG000|Month 5|Overall Study||1
9961217|NCT01472757|11080968|FG001|Full Analysis Set|Overall Study||93
10114276|NCT02515097|11244992|FG001|Intent-to-Treat (ITT) Population|Overall Study||71
10114277|NCT02515097|11244991|FG000|Safety Population|Overall Study||142
9846366|NCT00848042|10958685|FG001|Month 5|Overall Study||3
9846367|NCT00848042|10958686|FG002|Month 5|Overall Study||1
10023807|NCT01858363|11147501|FG000|STARTED|Overall Study||222
10023808|NCT01858363|11147502|FG001|STARTED|Overall Study||72
10023809|NCT01858363|11147501|FG000|Pre-discharge Visit|Overall Study||219
10023810|NCT01858363|11147502|FG001|Pre-discharge Visit|Overall Study||72
10023811|NCT01858363|11147501|FG000|1-month Visit|Overall Study||214
10023812|NCT01858363|11147502|FG001|1-month Visit|Overall Study||68
10023813|NCT01858363|11147501|FG000|6-month Visit|Overall Study||208
10023814|NCT01858363|11147502|FG001|6-month Visit|Overall Study||64
10023815|NCT01858363|11147501|FG000|12-month Vist|Overall Study||205
10023816|NCT01858363|11147502|FG001|12-month Vist|Overall Study||61
10023817|NCT01858363|11147501|FG000|24-month Visit|Overall Study||184
10023818|NCT01858363|11147502|FG001|24-month Visit|Overall Study||58
10023819|NCT01858363|11147501|FG000|36-month Visit|Overall Study||169
10023820|NCT01858363|11147502|FG001|36-month Visit|Overall Study||53
10023821|NCT01858363|11147501|FG000|48-month Visit|Overall Study||157
10023822|NCT01858363|11147502|FG001|48-month Visit|Overall Study||53
10023823|NCT01858363|11147501|FG000|COMPLETED|Overall Study||146
10023824|NCT01858363|11147502|FG001|COMPLETED|Overall Study||46
10023825|NCT01858363|11147501|FG000|NOT COMPLETED|Overall Study||76
10023826|NCT01858363|11147502|FG001|NOT COMPLETED|Overall Study||26
10023827|NCT01858376|11147508|FG000|STARTED|Overall Study||24
10023828|NCT01858376|11147508|FG000|COMPLETED|Overall Study||20
10023829|NCT01858376|11147508|FG000|NOT COMPLETED|Overall Study||4
10023830|NCT01858389|11147514|FG000|STARTED|Overall Study|Enrolled|16
10023831|NCT01858389|11147515|FG001|STARTED|Overall Study|Enrolled|25
10023832|NCT01858389|11147514|FG000|Received Treatment|Overall Study||16
10023833|NCT01858389|11147515|FG001|Received Treatment|Overall Study||22
10023834|NCT01858389|11147514|FG000|COMPLETED|Overall Study||0
10023835|NCT01858389|11147515|FG001|COMPLETED|Overall Study||0
10023836|NCT01858389|11147514|FG000|NOT COMPLETED|Overall Study||16
10023837|NCT01858389|11147515|FG001|NOT COMPLETED|Overall Study||25
10023838|NCT01858428|11147525|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
10023839|NCT01858428|11147526|FG001|STARTED|Overall Study||200
10023840|NCT01858428|11147525|FG000|COMPLETED|Overall Study||99
10023841|NCT01858428|11147526|FG001|COMPLETED|Overall Study||190
9846368|NCT00848042|10958684|FG000|Month 6|Overall Study||1
9846369|NCT00848042|10958685|FG001|Month 6|Overall Study||3
9846370|NCT00848042|10958686|FG002|Month 6|Overall Study||1
9846371|NCT00848042|10958684|FG000|COMPLETED|Overall Study||1
9846372|NCT00848042|10958685|FG001|COMPLETED|Overall Study||3
9846373|NCT00848042|10958686|FG002|COMPLETED|Overall Study||1
9846374|NCT00848042|10958684|FG000|NOT COMPLETED|Overall Study||4
9846375|NCT00848042|10958685|FG001|NOT COMPLETED|Overall Study||2
9846376|NCT00848042|10958686|FG002|NOT COMPLETED|Overall Study||0
9846377|NCT00848081|10958696|FG000|STARTED|Overall Study||160
9846378|NCT00848081|10958697|FG001|STARTED|Overall Study||158
9846379|NCT00848081|10958696|FG000|COMPLETED|Overall Study||140
9846380|NCT00848081|10958697|FG001|COMPLETED|Overall Study||140
9846381|NCT00848081|10958696|FG000|NOT COMPLETED|Overall Study||20
9846382|NCT00848081|10958697|FG001|NOT COMPLETED|Overall Study||18
9846383|NCT00848107|10958703|FG000|STARTED|Overall Study||115
9846384|NCT00848107|10958703|FG000|COMPLETED|Overall Study||94
9846385|NCT00848107|10958703|FG000|NOT COMPLETED|Overall Study||21
9846386|NCT00848120|10958707|FG000|STARTED|Overall Study||29
9846387|NCT00848120|10958707|FG000|COMPLETED|Overall Study||28
9846388|NCT00848120|10958707|FG000|NOT COMPLETED|Overall Study||1
9846389|NCT00848172|10958713|FG000|STARTED|Visit 2 - Drug Administration||10
9846390|NCT00848172|10958714|FG001|STARTED|Visit 2 - Drug Administration||9
9846391|NCT00848172|10958713|FG000|COMPLETED|Visit 2 - Drug Administration||10
9846392|NCT00848172|10958714|FG001|COMPLETED|Visit 2 - Drug Administration||8
9846393|NCT00848172|10958713|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0
9846394|NCT00848172|10958714|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1
9846395|NCT00848172|10958713|FG000|STARTED|Visit 3 - Follow Up||10
9961218|NCT01472757|11080969|FG002|Full Analysis Set|Overall Study||92
9961219|NCT01472757|11080970|FG003|Full Analysis Set|Overall Study||92
9846396|NCT00848172|10958714|FG001|STARTED|Visit 3 - Follow Up||8
9846397|NCT00848172|10958713|FG000|COMPLETED|Visit 3 - Follow Up||10
9846398|NCT00848172|10958714|FG001|COMPLETED|Visit 3 - Follow Up||8
9846399|NCT00848172|10958713|FG000|NOT COMPLETED|Visit 3 - Follow Up||0
9846400|NCT00848172|10958714|FG001|NOT COMPLETED|Visit 3 - Follow Up||0
9846401|NCT00848185|10958726|FG000|STARTED|Overall Study||32
9846402|NCT00848185|10958727|FG001|STARTED|Overall Study||32
9846403|NCT00848185|10958728|FG002|STARTED|Overall Study||32
9846404|NCT00848185|10958726|FG000|COMPLETED|Overall Study||32
9688994|NCT02121158|10789095|FG000|STARTED|Overall Study||85
9688995|NCT02121158|10789096|FG001|STARTED|Overall Study||82
9688996|NCT02121158|10789095|FG000|COMPLETED|Overall Study||85
9688997|NCT02121158|10789096|FG001|COMPLETED|Overall Study||82
9688998|NCT02121158|10789095|FG000|NOT COMPLETED|Overall Study||0
9688999|NCT02121158|10789096|FG001|NOT COMPLETED|Overall Study||0
9689000|NCT02100722|10789104|FG000|STARTED|Overall Study||757
9689001|NCT02100722|10789105|FG001|STARTED|Overall Study||743
9689002|NCT02100722|10789104|FG000|Underwent Alternate Procedure|Overall Study||11
9689003|NCT02100722|10789105|FG001|Underwent Alternate Procedure|Overall Study||37
9689004|NCT02100722|10789104|FG000|COMPLETED|Overall Study||0
9689005|NCT02100722|10789105|FG001|COMPLETED|Overall Study||0
9689006|NCT02100722|10789104|FG000|NOT COMPLETED|Overall Study||757
9689007|NCT02100722|10789105|FG001|NOT COMPLETED|Overall Study||743
9689008|NCT02046096|10789114|FG000|STARTED|Overall Study||149
9689009|NCT02046096|10789115|FG001|STARTED|Overall Study||324
9689010|NCT02046096|10789114|FG000|COMPLETED|Overall Study||105
9689011|NCT02046096|10789115|FG001|COMPLETED|Overall Study||223
9689012|NCT02046096|10789114|FG000|NOT COMPLETED|Overall Study||44
9689013|NCT02046096|10789115|FG001|NOT COMPLETED|Overall Study||101
9689014|NCT01945775|10789125|FG000|STARTED|Overall Study||287
9689015|NCT01945775|10789126|FG001|STARTED|Overall Study||144
9689016|NCT01945775|10789125|FG000|Treated|Overall Study||286
9689017|NCT01945775|10789126|FG001|Treated|Overall Study||126
9689018|NCT01945775|10789125|FG000|COMPLETED|Overall Study||0
9689019|NCT01945775|10789126|FG001|COMPLETED|Overall Study||0
9689020|NCT01945775|10789125|FG000|NOT COMPLETED|Overall Study||287
9689021|NCT01945775|10789126|FG001|NOT COMPLETED|Overall Study||144
10023842|NCT01858428|11147525|FG000|NOT COMPLETED|Overall Study||1
10023843|NCT01858428|11147526|FG001|NOT COMPLETED|Overall Study||10
9689022|NCT01781637|10789134|FG000|STARTED|Overall Study||28
9689023|NCT01781637|10789135|FG001|STARTED|Overall Study||8
9689024|NCT01781637|10789134|FG000|COMPLETED|Overall Study||24
9689025|NCT01781637|10789135|FG001|COMPLETED|Overall Study||2
9689026|NCT01781637|10789134|FG000|NOT COMPLETED|Overall Study||4
9689027|NCT01781637|10789135|FG001|NOT COMPLETED|Overall Study||6
10023844|NCT01858532|11147536|FG000|STARTED|Overall Study||1325
9689043|NCT01670539|10789167|FG000|STARTED|Overall Study||26
9689044|NCT01670539|10789168|FG001|STARTED|Overall Study||21
9689045|NCT01670539|10789167|FG000|COMPLETED|Overall Study||20
9689046|NCT01670539|10789168|FG001|COMPLETED|Overall Study||16
9846405|NCT00848185|10958727|FG001|COMPLETED|Overall Study||32
10023845|NCT01858532|11147537|FG001|STARTED|Overall Study||1323
10023846|NCT01858532|11147538|FG002|STARTED|Overall Study||509
10023847|NCT01858532|11147539|FG003|STARTED|Overall Study||511
10023848|NCT01858532|11147536|FG000|COMPLETED|Overall Study||1144
10023849|NCT01858532|11147537|FG001|COMPLETED|Overall Study||1131
10023850|NCT01858532|11147538|FG002|COMPLETED|Overall Study||411
10023851|NCT01858532|11147539|FG003|COMPLETED|Overall Study||418
10023852|NCT01858532|11147536|FG000|NOT COMPLETED|Overall Study||181
10023853|NCT01858532|11147537|FG001|NOT COMPLETED|Overall Study||192
10023854|NCT01858532|11147538|FG002|NOT COMPLETED|Overall Study||98
10023855|NCT01858532|11147539|FG003|NOT COMPLETED|Overall Study||93
10023856|NCT01858545|11147551|FG000|STARTED|Overall Study||27
10023857|NCT01858545|11147552|FG001|STARTED|Overall Study||29
10023858|NCT01858545|11147551|FG000|COMPLETED|Overall Study||23
10023859|NCT01858545|11147552|FG001|COMPLETED|Overall Study||23
10023860|NCT01858545|11147551|FG000|NOT COMPLETED|Overall Study||4
10023861|NCT01858545|11147552|FG001|NOT COMPLETED|Overall Study||6
10023862|NCT01858558|11147560|FG000|STARTED|Overall Study||70
10023863|NCT01858558|11147561|FG001|STARTED|Overall Study||31
9689047|NCT01670539|10789167|FG000|NOT COMPLETED|Overall Study||6
10023864|NCT01858558|11147560|FG000|COMPLETED|Overall Study||61
10023865|NCT01858558|11147561|FG001|COMPLETED|Overall Study||29
10023866|NCT01858558|11147560|FG000|NOT COMPLETED|Overall Study||9
10023867|NCT01858558|11147561|FG001|NOT COMPLETED|Overall Study||2
10023868|NCT01858636|11147567|FG000|STARTED|Overall Study|Subjects consented|235
9689048|NCT01670539|10789168|FG001|NOT COMPLETED|Overall Study||5
9726282|NCT00098956|10825791|FG000|STARTED|Overall Study||19
9726283|NCT00098956|10825791|FG000|COMPLETED|Overall Study||19
9726284|NCT00098956|10825791|FG000|NOT COMPLETED|Overall Study||0
9726285|NCT00099021|10825795|FG000|STARTED|Overall Study||21
9726286|NCT00099021|10825795|FG000|COMPLETED|Overall Study||21
9726287|NCT00099021|10825795|FG000|NOT COMPLETED|Overall Study||0
9726288|NCT00099047|10825801|FG000|STARTED|Overall Study||11
9726289|NCT00099047|10825802|FG001|STARTED|Overall Study||12
9726290|NCT00099047|10825801|FG000|COMPLETED|Overall Study||11
9726291|NCT00099047|10825802|FG001|COMPLETED|Overall Study||12
9726292|NCT00099047|10825801|FG000|NOT COMPLETED|Overall Study||0
9726293|NCT00099047|10825802|FG001|NOT COMPLETED|Overall Study||0
9726294|NCT00099268|10825810|FG000|STARTED|Overall Study||374
9726295|NCT00099268|10825811|FG001|STARTED|Overall Study||373
9726296|NCT00099268|10825810|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
9726297|NCT00099268|10825811|FG001|Intent-to-Treat|Overall Study||372
9726298|NCT00099268|10825810|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
9846406|NCT00848185|10958728|FG002|COMPLETED|Overall Study||32
9846407|NCT00848185|10958726|FG000|NOT COMPLETED|Overall Study||0
9846408|NCT00848185|10958727|FG001|NOT COMPLETED|Overall Study||0
9846409|NCT00848185|10958728|FG002|NOT COMPLETED|Overall Study||0
9846410|NCT00848198|10958736|FG000|STARTED|Overall Study||314
9846411|NCT00848198|10958736|FG000|COMPLETED|Overall Study||299
9846412|NCT00848198|10958736|FG000|NOT COMPLETED|Overall Study||15
9846413|NCT00848211|10958748|FG000|STARTED|Overall Study||6
9846414|NCT00848211|10958749|FG001|STARTED|Overall Study||7
9846415|NCT00848211|10958750|FG002|STARTED|Overall Study||6
9846416|NCT00848211|10958751|FG003|STARTED|Overall Study||5
9846417|NCT00848211|10958748|FG000|COMPLETED|Overall Study||6
9846418|NCT00848211|10958749|FG001|COMPLETED|Overall Study||6
9846419|NCT00848211|10958750|FG002|COMPLETED|Overall Study||5
9846420|NCT00848211|10958751|FG003|COMPLETED|Overall Study||5
9846421|NCT00848211|10958748|FG000|NOT COMPLETED|Overall Study||0
9846422|NCT00848211|10958749|FG001|NOT COMPLETED|Overall Study||1
9846423|NCT00848211|10958750|FG002|NOT COMPLETED|Overall Study||1
9846424|NCT00848211|10958751|FG003|NOT COMPLETED|Overall Study||0
9846425|NCT00848237|10958761|FG000|STARTED|Overall Study||5521
9846426|NCT00848237|10958761|FG000|COMPLETED|Overall Study||4982
9846427|NCT00848237|10958761|FG000|NOT COMPLETED|Overall Study||539
9846428|NCT00848250|10958767|FG000|STARTED|Overall Study||11
9846429|NCT00848250|10958768|FG001|STARTED|Overall Study||10
9846430|NCT00848250|10958767|FG000|COMPLETED|Overall Study||11
9846431|NCT00848250|10958768|FG001|COMPLETED|Overall Study||9
9846432|NCT00848250|10958767|FG000|NOT COMPLETED|Overall Study||0
9846433|NCT00848250|10958768|FG001|NOT COMPLETED|Overall Study||1
9846434|NCT00848354|10958777|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
9846435|NCT00848354|10958778|FG001|STARTED|Phase 1||143
9846436|NCT00848354|10958777|FG000|COMPLETED|Phase 1||269
9846437|NCT00848354|10958778|FG001|COMPLETED|Phase 1||129
9846438|NCT00848354|10958777|FG000|NOT COMPLETED|Phase 1||12
9846439|NCT00848354|10958778|FG001|NOT COMPLETED|Phase 1||14
9846440|NCT00848354|10958777|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
9846441|NCT00848354|10958778|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
9846442|NCT00848354|10958777|FG000|COMPLETED|Phase 2 Year 1||242
9726299|NCT00099268|10825811|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
9726300|NCT00099268|10825810|FG000|NOT COMPLETED|Overall Study||92
9846443|NCT00848354|10958778|FG001|COMPLETED|Phase 2 Year 1||120
9689049|NCT00407602|10789175|FG000|STARTED|Overall Study||30
9689050|NCT00407602|10789175|FG000|COMPLETED|Overall Study||23
9689051|NCT00407602|10789175|FG000|NOT COMPLETED|Overall Study||7
9689052|NCT05143541|10789182|FG000|STARTED|Overall Study||80
9689053|NCT05143541|10789182|FG000|COMPLETED|Overall Study||80
9689054|NCT05143541|10789182|FG000|NOT COMPLETED|Overall Study||0
9689055|NCT04685213|10789188|FG000|STARTED|Overall Study||9
9689056|NCT04685213|10789189|FG001|STARTED|Overall Study||10
9689057|NCT04685213|10789188|FG000|COMPLETED|Overall Study||8
9689058|NCT04685213|10789189|FG001|COMPLETED|Overall Study||7
9689059|NCT04685213|10789188|FG000|NOT COMPLETED|Overall Study||1
9689060|NCT04685213|10789189|FG001|NOT COMPLETED|Overall Study||3
9689061|NCT04567186|10789195|FG000|STARTED|Period 1||38
9689062|NCT04567186|10789196|FG001|STARTED|Period 1||40
9689063|NCT04567186|10789195|FG000|COMPLETED|Period 1||37
9689064|NCT04567186|10789196|FG001|COMPLETED|Period 1||37
9689065|NCT04567186|10789195|FG000|NOT COMPLETED|Period 1||1
9689066|NCT04567186|10789196|FG001|NOT COMPLETED|Period 1||3
9689067|NCT04567186|10789195|FG000|STARTED|Period 2||37
9689068|NCT04567186|10789196|FG001|STARTED|Period 2||37
9689069|NCT04567186|10789195|FG000|COMPLETED|Period 2||37
9689070|NCT04567186|10789196|FG001|COMPLETED|Period 2||34
10023869|NCT01858636|11147567|FG000|Device Deployment|Overall Study||211
10023870|NCT01858636|11147567|FG000|COMPLETED|Overall Study||207
10023871|NCT01858636|11147567|FG000|NOT COMPLETED|Overall Study||28
10023872|NCT01858701|11147572|FG000|STARTED|Period 1, First 30 Days of Wear||20
10023873|NCT01858701|11147573|FG001|STARTED|Period 1, First 30 Days of Wear||20
10023874|NCT01858701|11147572|FG000|COMPLETED|Period 1, First 30 Days of Wear||20
10023875|NCT01858701|11147573|FG001|COMPLETED|Period 1, First 30 Days of Wear||19
10023876|NCT01858701|11147572|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10023877|NCT01858701|11147573|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
10023878|NCT01858701|11147572|FG000|STARTED|Washout Period, 1-13 Days||20
10023879|NCT01858701|11147573|FG001|STARTED|Washout Period, 1-13 Days||19
10023880|NCT01858701|11147572|FG000|COMPLETED|Washout Period, 1-13 Days||18
10023881|NCT01858701|11147573|FG001|COMPLETED|Washout Period, 1-13 Days||17
10023882|NCT01858701|11147572|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2
10023883|NCT01858701|11147573|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2
10023884|NCT01858701|11147572|FG000|STARTED|Period 2, Second 30 Days of Wear||18
10023885|NCT01858701|11147573|FG001|STARTED|Period 2, Second 30 Days of Wear||17
10023886|NCT01858701|11147572|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18
10023887|NCT01858701|11147573|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16
10023888|NCT01858701|11147572|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
10023889|NCT01858701|11147573|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10023890|NCT01858753|11147581|FG000|STARTED|Overall Study||5
10023891|NCT01858753|11147582|FG001|STARTED|Overall Study||0
10023892|NCT01858753|11147581|FG000|COMPLETED|Overall Study||0
10023893|NCT01858753|11147582|FG001|COMPLETED|Overall Study||0
10023894|NCT01858753|11147581|FG000|NOT COMPLETED|Overall Study||5
9846444|NCT00848354|10958777|FG000|NOT COMPLETED|Phase 2 Year 1||18
9846445|NCT00848354|10958778|FG001|NOT COMPLETED|Phase 2 Year 1||6
10023895|NCT01858753|11147582|FG001|NOT COMPLETED|Overall Study||0
10023896|NCT01858766|11147607|FG000|STARTED|Overall Study||27
10023897|NCT01858766|11147608|FG001|STARTED|Overall Study||28
10023898|NCT01858766|11147609|FG002|STARTED|Overall Study||11
10023899|NCT01858766|11147610|FG003|STARTED|Overall Study||10
10023900|NCT01858766|11147611|FG004|STARTED|Overall Study||27
10023901|NCT01858766|11147612|FG005|STARTED|Overall Study||28
10023902|NCT01858766|11147613|FG006|STARTED|Overall Study||7
10023903|NCT01858766|11147614|FG007|STARTED|Overall Study||7
10023904|NCT01858766|11147615|FG008|STARTED|Overall Study||1
10023905|NCT01858766|11147616|FG009|STARTED|Overall Study||4
10023906|NCT01858766|11147617|FG010|STARTED|Overall Study||5
10023907|NCT01858766|11147618|FG011|STARTED|Overall Study||30
10023908|NCT01858766|11147619|FG012|STARTED|Overall Study||30
10023909|NCT01858766|11147620|FG013|STARTED|Overall Study||29
10023910|NCT01858766|11147621|FG014|STARTED|Overall Study||31
10023911|NCT01858766|11147622|FG015|STARTED|Overall Study||26
10023912|NCT01858766|11147623|FG016|STARTED|Overall Study||25
10023913|NCT01858766|11147624|FG017|STARTED|Overall Study||27
10023914|NCT01858766|11147625|FG018|STARTED|Overall Study||26
10023915|NCT01858766|11147607|FG000|COMPLETED|Overall Study||26
10023916|NCT01858766|11147608|FG001|COMPLETED|Overall Study||28
10023917|NCT01858766|11147609|FG002|COMPLETED|Overall Study||10
10023918|NCT01858766|11147610|FG003|COMPLETED|Overall Study||10
9846446|NCT00848354|10958777|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
9846447|NCT00848354|10958778|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
10023919|NCT01858766|11147611|FG004|COMPLETED|Overall Study||26
10023920|NCT01858766|11147612|FG005|COMPLETED|Overall Study||24
10023921|NCT01858766|11147613|FG006|COMPLETED|Overall Study||7
10023922|NCT01858766|11147614|FG007|COMPLETED|Overall Study||5
10023923|NCT01858766|11147615|FG008|COMPLETED|Overall Study||1
10023924|NCT01858766|11147616|FG009|COMPLETED|Overall Study||4
10023925|NCT01858766|11147617|FG010|COMPLETED|Overall Study||5
10023926|NCT01858766|11147618|FG011|COMPLETED|Overall Study||25
10023927|NCT01858766|11147619|FG012|COMPLETED|Overall Study||25
10023928|NCT01858766|11147620|FG013|COMPLETED|Overall Study||26
10023929|NCT01858766|11147621|FG014|COMPLETED|Overall Study||23
10023930|NCT01858766|11147622|FG015|COMPLETED|Overall Study||20
10023931|NCT01858766|11147623|FG016|COMPLETED|Overall Study||22
10023932|NCT01858766|11147624|FG017|COMPLETED|Overall Study||23
10023933|NCT01858766|11147625|FG018|COMPLETED|Overall Study||22
10023934|NCT01858766|11147607|FG000|NOT COMPLETED|Overall Study||1
10023935|NCT01858766|11147608|FG001|NOT COMPLETED|Overall Study||0
10023936|NCT01858766|11147609|FG002|NOT COMPLETED|Overall Study||1
10023937|NCT01858766|11147610|FG003|NOT COMPLETED|Overall Study||0
10023938|NCT01858766|11147611|FG004|NOT COMPLETED|Overall Study||1
10023939|NCT01858766|11147612|FG005|NOT COMPLETED|Overall Study||4
9689071|NCT04567186|10789195|FG000|NOT COMPLETED|Period 2||0
9689072|NCT04567186|10789196|FG001|NOT COMPLETED|Period 2||3
9689073|NCT04567186|10789195|FG000|STARTED|Period 3||37
9689074|NCT04567186|10789196|FG001|STARTED|Period 3||34
9689075|NCT04567186|10789195|FG000|COMPLETED|Period 3||36
9689076|NCT04567186|10789196|FG001|COMPLETED|Period 3||34
9689077|NCT04567186|10789195|FG000|NOT COMPLETED|Period 3||1
9689078|NCT04567186|10789196|FG001|NOT COMPLETED|Period 3||0
9726301|NCT00099268|10825811|FG001|NOT COMPLETED|Overall Study||82
9726302|NCT00099359|10825820|FG000|STARTED|Overall Study||581
9726303|NCT00099359|10825821|FG001|STARTED|Overall Study||580
9726304|NCT00099359|10825822|FG002|STARTED|Overall Study||574
9726305|NCT00099359|10825820|FG000|COMPLETED|Overall Study||527
9726306|NCT00099359|10825821|FG001|COMPLETED|Overall Study||515
9726307|NCT00099359|10825822|FG002|COMPLETED|Overall Study||506
9726308|NCT00099359|10825820|FG000|NOT COMPLETED|Overall Study||54
9726309|NCT00099359|10825821|FG001|NOT COMPLETED|Overall Study||65
9726310|NCT00099359|10825822|FG002|NOT COMPLETED|Overall Study||68
9731747|NCT00135356|10831659|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9
9731748|NCT00135356|10831658|FG000|Discontinued on or After Week 96 Visit|Overall Study||1
9731749|NCT00135356|10831659|FG001|Discontinued on or After Week 96 Visit|Overall Study||0
9731750|NCT00135356|10831658|FG000|COMPLETED|Overall Study||114
9731751|NCT00135356|10831659|FG001|COMPLETED|Overall Study||60
9731752|NCT00135356|10831658|FG000|NOT COMPLETED|Overall Study||17
9731753|NCT00135356|10831659|FG001|NOT COMPLETED|Overall Study||9
9731754|NCT00135512|10831665|FG000|STARTED|Overall Study||234
9731755|NCT00135512|10831665|FG000|COMPLETED|Overall Study||111
9731756|NCT00135512|10831665|FG000|NOT COMPLETED|Overall Study||123
9731757|NCT00135694|10831672|FG000|STARTED|Overall Study||180
9731758|NCT00135694|10831673|FG001|STARTED|Overall Study||77
9731759|NCT00135694|10831674|FG002|STARTED|Overall Study||18
9731760|NCT00135694|10831672|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
9731761|NCT00135694|10831673|FG001|COMPLETED|Overall Study||56
9731762|NCT00135694|10831674|FG002|COMPLETED|Overall Study||11
9731763|NCT00135694|10831672|FG000|NOT COMPLETED|Overall Study||180
9731764|NCT00135694|10831673|FG001|NOT COMPLETED|Overall Study||21
9731765|NCT00135694|10831674|FG002|NOT COMPLETED|Overall Study||7
9731766|NCT00135707|10831684|FG000|STARTED|Overall Study||5088
9731767|NCT00135707|10831685|FG001|STARTED|Overall Study||5066
9731768|NCT00135707|10831684|FG000|COMPLETED|Overall Study||4993
9731769|NCT00135707|10831685|FG001|COMPLETED|Overall Study||4976
9731770|NCT00135707|10831684|FG000|NOT COMPLETED|Overall Study||95
9731771|NCT00135707|10831685|FG001|NOT COMPLETED|Overall Study||90
9731772|NCT00135798|10831698|FG000|STARTED|Overall Study||16
9731773|NCT00135798|10831699|FG001|STARTED|Overall Study||31
9731774|NCT00135798|10831700|FG002|STARTED|Overall Study||32
9731775|NCT00135798|10831698|FG000|COMPLETED|Overall Study||16
9731776|NCT00135798|10831699|FG001|COMPLETED|Overall Study||31
9731777|NCT00135798|10831700|FG002|COMPLETED|Overall Study||32
9731778|NCT00135798|10831698|FG000|NOT COMPLETED|Overall Study||0
9731779|NCT00135798|10831699|FG001|NOT COMPLETED|Overall Study||0
9731780|NCT00135798|10831700|FG002|NOT COMPLETED|Overall Study||0
9731781|NCT00136084|10831709|FG000|STARTED|Overall Study||109
9731782|NCT00136084|10831710|FG001|STARTED|Overall Study||114
9731783|NCT00136084|10831709|FG000|COMPLETED|Overall Study||61
9731784|NCT00136084|10831710|FG001|COMPLETED|Overall Study||72
9731785|NCT00136084|10831709|FG000|NOT COMPLETED|Overall Study||48
9731786|NCT00136084|10831710|FG001|NOT COMPLETED|Overall Study||42
9731787|NCT00136214|10831724|FG000|STARTED|Overall Study||15
9731788|NCT00136214|10831725|FG001|STARTED|Overall Study||7
9731789|NCT00136214|10831724|FG000|COMPLETED|Overall Study||15
9731790|NCT00136214|10831725|FG001|COMPLETED|Overall Study||7
9731791|NCT00136214|10831724|FG000|NOT COMPLETED|Overall Study||0
9731792|NCT00136214|10831725|FG001|NOT COMPLETED|Overall Study||0
9731793|NCT00136318|10831735|FG000|STARTED|Overall Study|Took first dose of study medication|90
9731794|NCT00136318|10831736|FG001|STARTED|Overall Study|Took first dose of study medication|91
9731795|NCT00136318|10831735|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
9731796|NCT00136318|10831736|FG001|COMPLETED|Overall Study||84
9731797|NCT00136318|10831735|FG000|NOT COMPLETED|Overall Study||7
9731798|NCT00136318|10831736|FG001|NOT COMPLETED|Overall Study||7
9731799|NCT00136357|10831745|FG000|STARTED|Overall Study||41
9731800|NCT00136357|10831746|FG001|STARTED|Overall Study||41
9731801|NCT00136357|10831745|FG000|COMPLETED|Overall Study||38
9731802|NCT00136357|10831746|FG001|COMPLETED|Overall Study||39
9731803|NCT00136357|10831745|FG000|NOT COMPLETED|Overall Study||3
9731804|NCT00136357|10831746|FG001|NOT COMPLETED|Overall Study||2
9731805|NCT00136604|10831757|FG000|STARTED|Overall Study||249
9731806|NCT00136604|10831758|FG001|STARTED|Overall Study||123
9731807|NCT00136604|10831759|FG002|STARTED|Overall Study||79
9731808|NCT00136604|10831760|FG003|STARTED|Overall Study||41
9731809|NCT00136604|10831761|FG004|STARTED|Overall Study||125
9731810|NCT00136604|10831757|FG000|COMPLETED|Overall Study||248
9731811|NCT00136604|10831758|FG001|COMPLETED|Overall Study||122
9731812|NCT00136604|10831759|FG002|COMPLETED|Overall Study||79
9731813|NCT00136604|10831760|FG003|COMPLETED|Overall Study||41
9731814|NCT00136604|10831761|FG004|COMPLETED|Overall Study||124
9731815|NCT00136604|10831757|FG000|NOT COMPLETED|Overall Study||1
9731816|NCT00136604|10831758|FG001|NOT COMPLETED|Overall Study||1
9731817|NCT00136604|10831759|FG002|NOT COMPLETED|Overall Study||0
9846448|NCT00848354|10958777|FG000|COMPLETED|Phase 2 Year 2||218
9846449|NCT00848354|10958778|FG001|COMPLETED|Phase 2 Year 2||113
9846450|NCT00848354|10958777|FG000|NOT COMPLETED|Phase 2 Year 2||23
9689079|NCT04065074|10789202|FG000|STARTED|Overall Study||16
9689080|NCT04065074|10789202|FG000|COMPLETED|Overall Study||14
9689081|NCT04065074|10789202|FG000|NOT COMPLETED|Overall Study||2
9689082|NCT03980730|10789208|FG000|STARTED|Overall Study||21
9689083|NCT03980730|10789209|FG001|STARTED|Overall Study||22
9689084|NCT03980730|10789208|FG000|COMPLETED|Overall Study||19
9689085|NCT03980730|10789209|FG001|COMPLETED|Overall Study||18
9689086|NCT03980730|10789208|FG000|NOT COMPLETED|Overall Study||2
9689087|NCT03980730|10789209|FG001|NOT COMPLETED|Overall Study||4
9689088|NCT03793010|10789217|FG000|STARTED|Overall Study||35
9689089|NCT03793010|10789218|FG001|STARTED|Overall Study||35
9689090|NCT03793010|10789217|FG000|Randomized But Not Dosed|Overall Study||2
9689091|NCT03793010|10789218|FG001|Randomized But Not Dosed|Overall Study||0
9689092|NCT03793010|10789217|FG000|COMPLETED|Overall Study||7
9689093|NCT03793010|10789218|FG001|COMPLETED|Overall Study||8
9689094|NCT03793010|10789217|FG000|NOT COMPLETED|Overall Study||28
9689095|NCT03793010|10789218|FG001|NOT COMPLETED|Overall Study||27
9689096|NCT03644017|10789224|FG000|STARTED|Overall Study||46
9689097|NCT03644017|10789224|FG000|COMPLETED|Overall Study||39
9689098|NCT03644017|10789224|FG000|NOT COMPLETED|Overall Study||7
9689099|NCT03592186|10789230|FG000|STARTED|Overall Study||60
9689100|NCT03592186|10789231|FG001|STARTED|Overall Study||62
9689101|NCT03592186|10789230|FG000|6-week Follow-up|Overall Study||49
9689102|NCT03592186|10789231|FG001|6-week Follow-up|Overall Study||56
9689103|NCT03592186|10789230|FG000|12-week Follow-up|Overall Study||47
9689104|NCT03592186|10789231|FG001|12-week Follow-up|Overall Study||51
9689105|NCT03592186|10789230|FG000|COMPLETED|Overall Study||43
9689106|NCT03592186|10789231|FG001|COMPLETED|Overall Study||51
9689107|NCT03592186|10789230|FG000|NOT COMPLETED|Overall Study||17
9689108|NCT03592186|10789231|FG001|NOT COMPLETED|Overall Study||11
9689109|NCT03529942|10789237|FG000|STARTED|Overall Study||129
9689110|NCT03529942|10789237|FG000|Reached Week 6 With Paired MRI|Overall Study||108
9689111|NCT03529942|10789237|FG000|COMPLETED|Overall Study||106
9689112|NCT03529942|10789237|FG000|NOT COMPLETED|Overall Study||23
9689113|NCT03349775|10789246|FG000|STARTED|Overall Study||10
9689114|NCT03349775|10789247|FG001|STARTED|Overall Study||11
9689115|NCT03349775|10789246|FG000|COMPLETED|Overall Study||8
9689116|NCT03349775|10789247|FG001|COMPLETED|Overall Study||7
9689117|NCT03349775|10789246|FG000|NOT COMPLETED|Overall Study||2
9689118|NCT03349775|10789247|FG001|NOT COMPLETED|Overall Study||4
9689119|NCT03292471|10789255|FG000|STARTED|Overall Study||8
9689120|NCT03292471|10789256|FG001|STARTED|Overall Study||8
9689121|NCT03292471|10789255|FG000|COMPLETED|Overall Study||8
9689122|NCT03292471|10789256|FG001|COMPLETED|Overall Study||8
9689123|NCT03292471|10789255|FG000|NOT COMPLETED|Overall Study||0
9689124|NCT03292471|10789256|FG001|NOT COMPLETED|Overall Study||0
9689125|NCT03256344|10789264|FG000|STARTED|Overall Study||11
9689126|NCT03256344|10789265|FG001|STARTED|Overall Study||25
9689127|NCT03256344|10789264|FG000|Received Talimogene Laherparepvec|Overall Study||8
9846451|NCT00848354|10958778|FG001|NOT COMPLETED|Phase 2 Year 2||7
9846452|NCT00848367|10958790|FG000|STARTED|Overall Study||52
9846453|NCT00848367|10958791|FG001|STARTED|Overall Study||50
9846454|NCT00848367|10958790|FG000|COMPLETED|Overall Study||43
9846455|NCT00848367|10958791|FG001|COMPLETED|Overall Study||41
9846456|NCT00848367|10958790|FG000|NOT COMPLETED|Overall Study||9
9689128|NCT03256344|10789265|FG001|Received Talimogene Laherparepvec|Overall Study||23
9689129|NCT03256344|10789264|FG000|Received Atezolizumab|Overall Study||10
9689130|NCT03256344|10789265|FG001|Received Atezolizumab|Overall Study||24
9689131|NCT03256344|10789264|FG000|COMPLETED|Overall Study||0
9689132|NCT03256344|10789265|FG001|COMPLETED|Overall Study||0
9689133|NCT03256344|10789264|FG000|NOT COMPLETED|Overall Study||11
9689134|NCT03256344|10789265|FG001|NOT COMPLETED|Overall Study||25
9689135|NCT03207815|10789273|FG000|STARTED|Overall Study||38
9689136|NCT03207815|10789274|FG001|STARTED|Overall Study||36
9689137|NCT03207815|10789273|FG000|COMPLETED|Overall Study||30
9689138|NCT03207815|10789274|FG001|COMPLETED|Overall Study||29
9689139|NCT03207815|10789273|FG000|NOT COMPLETED|Overall Study||8
9689140|NCT03207815|10789274|FG001|NOT COMPLETED|Overall Study||7
9689141|NCT03077737|10789282|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97
9689142|NCT03077737|10789283|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93
9689143|NCT03077737|10789282|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89
9689144|NCT03077737|10789283|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79
9689145|NCT03077737|10789282|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8
9689146|NCT03077737|10789283|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14
9689147|NCT03077737|10789282|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97
9689148|NCT03077737|10789283|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93
9689149|NCT03077737|10789282|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83
9689150|NCT03077737|10789283|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76
9689151|NCT03077737|10789282|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14
9689152|NCT03077737|10789283|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17
9689153|NCT03077737|10789282|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49
9689154|NCT03077737|10789283|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47
9689155|NCT03077737|10789282|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39
9689156|NCT03077737|10789283|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40
9689157|NCT03077737|10789282|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10
9689158|NCT03077737|10789283|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7
9689159|NCT02991937|10789291|FG000|STARTED|Overall Study||20
9689160|NCT02991937|10789292|FG001|STARTED|Overall Study||19
9689161|NCT02991937|10789291|FG000|COMPLETED|Overall Study||20
9689162|NCT02991937|10789292|FG001|COMPLETED|Overall Study||19
9689163|NCT02991937|10789291|FG000|NOT COMPLETED|Overall Study||0
9689164|NCT02991937|10789292|FG001|NOT COMPLETED|Overall Study||0
9689165|NCT02968563|10789300|FG000|STARTED|Overall Study||5
9689166|NCT02968563|10789301|FG001|STARTED|Overall Study||30
9689167|NCT02968563|10789300|FG000|COMPLETED|Overall Study||4
9689168|NCT02968563|10789301|FG001|COMPLETED|Overall Study||22
9689169|NCT02968563|10789300|FG000|NOT COMPLETED|Overall Study||1
9689170|NCT02968563|10789301|FG001|NOT COMPLETED|Overall Study||8
9689171|NCT02915783|10789307|FG000|STARTED|Overall Study||31
9689172|NCT02915783|10789307|FG000|COMPLETED|Overall Study||17
9689173|NCT02915783|10789307|FG000|NOT COMPLETED|Overall Study||14
9689174|NCT02913482|10789314|FG000|STARTED|Overall Study||4
9689175|NCT02913482|10789315|FG001|STARTED|Overall Study||17
9689176|NCT02913482|10789316|FG002|STARTED|Overall Study||41
9689177|NCT02913482|10789314|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|3
9689178|NCT02913482|10789315|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|14
9689179|NCT02913482|10789316|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|38
9689180|NCT02913482|10789314|FG000|NOT COMPLETED|Overall Study||1
9689181|NCT02913482|10789315|FG001|NOT COMPLETED|Overall Study||3
9846457|NCT00848367|10958791|FG001|NOT COMPLETED|Overall Study||9
9846458|NCT00848393|10958802|FG000|STARTED|Overall Study||17
9846459|NCT00848393|10958803|FG001|STARTED|Overall Study||16
9846460|NCT00848393|10958804|FG002|STARTED|Overall Study||18
9846461|NCT00848393|10958802|FG000|COMPLETED|Overall Study||17
9846462|NCT00848393|10958803|FG001|COMPLETED|Overall Study||16
9846463|NCT00848393|10958804|FG002|COMPLETED|Overall Study||15
9846464|NCT00848393|10958802|FG000|NOT COMPLETED|Overall Study||0
9689182|NCT02913482|10789316|FG002|NOT COMPLETED|Overall Study||3
9689183|NCT02787044|10789328|FG000|STARTED|Overall Study||2630
9689184|NCT02787044|10789329|FG001|STARTED|Overall Study||2630
9689185|NCT02787044|10789328|FG000|COMPLETED|Overall Study||2615
9689186|NCT02787044|10789329|FG001|COMPLETED|Overall Study||2611
9689187|NCT02787044|10789328|FG000|NOT COMPLETED|Overall Study||15
9689188|NCT02787044|10789329|FG001|NOT COMPLETED|Overall Study||19
9689189|NCT02698163|10789341|FG000|STARTED|Overall Study||1
9689190|NCT02698163|10789342|FG001|STARTED|Overall Study||3
9689191|NCT02698163|10789341|FG000|COMPLETED|Overall Study||1
9689192|NCT02698163|10789342|FG001|COMPLETED|Overall Study||2
9689193|NCT02698163|10789341|FG000|NOT COMPLETED|Overall Study||0
9689194|NCT02698163|10789342|FG001|NOT COMPLETED|Overall Study||1
9689195|NCT02586675|10789348|FG000|STARTED|Overall Study||7
9689196|NCT02586675|10789348|FG000|COMPLETED|Overall Study||7
9689197|NCT02586675|10789348|FG000|NOT COMPLETED|Overall Study||0
9689198|NCT02367105|10789354|FG000|STARTED|Overall Study||41
9689199|NCT02367105|10789355|FG001|STARTED|Overall Study||42
9689200|NCT02367105|10789354|FG000|COMPLETED|Overall Study||36
9689201|NCT02367105|10789355|FG001|COMPLETED|Overall Study||34
9689202|NCT02367105|10789354|FG000|NOT COMPLETED|Overall Study||5
9689203|NCT02367105|10789355|FG001|NOT COMPLETED|Overall Study||8
9846465|NCT00848393|10958803|FG001|NOT COMPLETED|Overall Study||0
9846466|NCT00848393|10958804|FG002|NOT COMPLETED|Overall Study||3
9961220|NCT01472757|11080967|FG000|COMPLETED|Overall Study||61
9726311|NCT00099372|10825842|FG000|STARTED|Enrolled in Extended CARE Trial||104
9726312|NCT00099372|10825843|FG001|STARTED|Enrolled in Extended CARE Trial||111
9726313|NCT00099372|10825842|FG000|COMPLETED|Enrolled in Extended CARE Trial||104
9689204|NCT01816165|10789369|FG000|STARTED|Overall Study||5
9846467|NCT00848484|10958818|FG000|STARTED|First Intervention (Treatment Period 1)||27
9846468|NCT00848484|10958819|FG001|STARTED|First Intervention (Treatment Period 1)||27
9846469|NCT00848484|10958818|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
9846470|NCT00848484|10958819|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
9846471|NCT00848484|10958818|FG000|COMPLETED|First Intervention (Treatment Period 1)||25
9846472|NCT00848484|10958819|FG001|COMPLETED|First Intervention (Treatment Period 1)||24
9846473|NCT00848484|10958818|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2
9846474|NCT00848484|10958819|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3
9846475|NCT00848484|10958818|FG000|STARTED|Washout Period of Two Weeks||25
9846476|NCT00848484|10958819|FG001|STARTED|Washout Period of Two Weeks||24
9846477|NCT00848484|10958818|FG000|COMPLETED|Washout Period of Two Weeks||25
9846478|NCT00848484|10958819|FG001|COMPLETED|Washout Period of Two Weeks||21
9846479|NCT00848484|10958818|FG000|NOT COMPLETED|Washout Period of Two Weeks||0
9846480|NCT00848484|10958819|FG001|NOT COMPLETED|Washout Period of Two Weeks||3
9846481|NCT00848484|10958818|FG000|STARTED|Second Intervention (Treatment Period 2)||25
9846482|NCT00848484|10958819|FG001|STARTED|Second Intervention (Treatment Period 2)||21
9846483|NCT00848484|10958818|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
9846484|NCT00848484|10958819|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
9846485|NCT00848484|10958818|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25
9846486|NCT00848484|10958819|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20
9846487|NCT00848484|10958818|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
9846488|NCT00848484|10958819|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
9846489|NCT00848497|10958827|FG000|STARTED|Overall Study||2
9846490|NCT00848497|10958828|FG001|STARTED|Overall Study|Completed Visit 4|1
9846491|NCT00848497|10958827|FG000|COMPLETED|Overall Study||0
9846492|NCT00848497|10958828|FG001|COMPLETED|Overall Study||0
9846493|NCT00848497|10958827|FG000|NOT COMPLETED|Overall Study||2
9846494|NCT00848497|10958828|FG001|NOT COMPLETED|Overall Study||1
9846495|NCT00848510|10958840|FG000|STARTED|Overall Study||10
9846496|NCT00848510|10958841|FG001|STARTED|Overall Study||13
9846497|NCT00848510|10958842|FG002|STARTED|Overall Study||8
9846498|NCT00848510|10958843|FG003|STARTED|Overall Study||10
9846499|NCT00848510|10958840|FG000|COMPLETED|Overall Study||10
9846500|NCT00848510|10958841|FG001|COMPLETED|Overall Study||13
9846501|NCT00848510|10958842|FG002|COMPLETED|Overall Study||8
9846502|NCT00848510|10958843|FG003|COMPLETED|Overall Study||10
9846503|NCT00848510|10958840|FG000|NOT COMPLETED|Overall Study||0
9846504|NCT00848510|10958841|FG001|NOT COMPLETED|Overall Study||0
9846505|NCT00848510|10958842|FG002|NOT COMPLETED|Overall Study||0
9846506|NCT00848510|10958843|FG003|NOT COMPLETED|Overall Study||0
10114278|NCT02515097|11244992|FG001|Safety Population|Overall Study||70
10114279|NCT02515097|11244991|FG000|COMPLETED|Overall Study||135
10114280|NCT02515097|11244992|FG001|COMPLETED|Overall Study||65
9846507|NCT00848536|10958855|FG000|STARTED|Overall Study||185
9846508|NCT00848536|10958856|FG001|STARTED|Overall Study||186
9846509|NCT00848536|10958855|FG000|COMPLETED|Overall Study||181
9846510|NCT00848536|10958856|FG001|COMPLETED|Overall Study||179
9846511|NCT00848536|10958855|FG000|NOT COMPLETED|Overall Study||4
9846512|NCT00848536|10958856|FG001|NOT COMPLETED|Overall Study||7
9846513|NCT00848549|10958864|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282
9846514|NCT00848549|10958865|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301
9846515|NCT00848549|10958864|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
9846516|NCT00848549|10958865|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
9846517|NCT00848549|10958864|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
9846518|NCT00848549|10958865|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
9846519|NCT00848549|10958864|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161
9846520|NCT00848549|10958865|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192
9846521|NCT00848549|10958864|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137
9846522|NCT00848549|10958865|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158
10114281|NCT02515097|11244991|FG000|NOT COMPLETED|Overall Study||7
10023940|NCT01858766|11147613|FG006|NOT COMPLETED|Overall Study||0
10023941|NCT01858766|11147614|FG007|NOT COMPLETED|Overall Study||2
10023942|NCT01858766|11147615|FG008|NOT COMPLETED|Overall Study||0
10023943|NCT01858766|11147616|FG009|NOT COMPLETED|Overall Study||0
10023944|NCT01858766|11147617|FG010|NOT COMPLETED|Overall Study||0
10023945|NCT01858766|11147618|FG011|NOT COMPLETED|Overall Study||5
10023946|NCT01858766|11147619|FG012|NOT COMPLETED|Overall Study||5
10023947|NCT01858766|11147620|FG013|NOT COMPLETED|Overall Study||3
10023948|NCT01858766|11147621|FG014|NOT COMPLETED|Overall Study||8
10023949|NCT01858766|11147622|FG015|NOT COMPLETED|Overall Study||6
10023950|NCT01858766|11147623|FG016|NOT COMPLETED|Overall Study||3
9689205|NCT01816165|10789370|FG001|STARTED|Overall Study||4
9689206|NCT01816165|10789371|FG002|STARTED|Overall Study||5
9689207|NCT01816165|10789372|FG003|STARTED|Overall Study||4
10023951|NCT01858766|11147624|FG017|NOT COMPLETED|Overall Study||4
10023952|NCT01858766|11147625|FG018|NOT COMPLETED|Overall Study||4
9689208|NCT01816165|10789369|FG000|Completed Intervention 1|Overall Study||4
9689209|NCT01816165|10789370|FG001|Completed Intervention 1|Overall Study||4
9689210|NCT01816165|10789371|FG002|Completed Intervention 1|Overall Study||5
9689211|NCT01816165|10789372|FG003|Completed Intervention 1|Overall Study||4
9689212|NCT01816165|10789369|FG000|Completed ~2 Week Washout|Overall Study||4
9689213|NCT01816165|10789370|FG001|Completed ~2 Week Washout|Overall Study||4
9689214|NCT01816165|10789371|FG002|Completed ~2 Week Washout|Overall Study||5
9689215|NCT01816165|10789372|FG003|Completed ~2 Week Washout|Overall Study||4
9689216|NCT01816165|10789369|FG000|Started Second Intervention|Overall Study||4
9689217|NCT01816165|10789370|FG001|Started Second Intervention|Overall Study||4
9689218|NCT01816165|10789371|FG002|Started Second Intervention|Overall Study||5
9689219|NCT01816165|10789372|FG003|Started Second Intervention|Overall Study||4
9689220|NCT01816165|10789369|FG000|COMPLETED|Overall Study||4
9689221|NCT01816165|10789370|FG001|COMPLETED|Overall Study||4
9689222|NCT01816165|10789371|FG002|COMPLETED|Overall Study||5
9689223|NCT01816165|10789372|FG003|COMPLETED|Overall Study||4
9689224|NCT01816165|10789369|FG000|NOT COMPLETED|Overall Study||1
9689225|NCT01816165|10789370|FG001|NOT COMPLETED|Overall Study||0
9689226|NCT01816165|10789371|FG002|NOT COMPLETED|Overall Study||0
9689227|NCT01816165|10789372|FG003|NOT COMPLETED|Overall Study||0
9689228|NCT01813929|10789394|FG000|STARTED|Overall Study||5
9689229|NCT01813929|10789395|FG001|STARTED|Overall Study||12
9689230|NCT01813929|10789394|FG000|Completed Intervention 1|Overall Study||5
9689231|NCT01813929|10789395|FG001|Completed Intervention 1|Overall Study||12
9689232|NCT01813929|10789394|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5
9689233|NCT01813929|10789395|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11
9689234|NCT01813929|10789394|FG000|Started Intervention 2|Overall Study||5
9689235|NCT01813929|10789395|FG001|Started Intervention 2|Overall Study||11
9689236|NCT01813929|10789394|FG000|COMPLETED|Overall Study||5
9689237|NCT01813929|10789395|FG001|COMPLETED|Overall Study||11
9689238|NCT01813929|10789394|FG000|NOT COMPLETED|Overall Study||0
9689239|NCT01813929|10789395|FG001|NOT COMPLETED|Overall Study||1
9689240|NCT01502085|10789401|FG000|STARTED|Overall Study||25
9689241|NCT01502085|10789401|FG000|COMPLETED|Overall Study||25
9689242|NCT01502085|10789401|FG000|NOT COMPLETED|Overall Study||0
9689243|NCT01178814|10789405|FG000|STARTED|Overall Study||57
9689244|NCT01178814|10789405|FG000|COMPLETED|Overall Study||57
9689245|NCT01178814|10789405|FG000|NOT COMPLETED|Overall Study||0
9689246|NCT01125176|10789409|FG000|STARTED|Treatment Phase||14
9689247|NCT01125176|10789409|FG000|COMPLETED|Treatment Phase||13
9689248|NCT01125176|10789409|FG000|NOT COMPLETED|Treatment Phase||1
9689249|NCT01125176|10789409|FG000|STARTED|Post-treatment Follow-up Phase||13
9689250|NCT01125176|10789409|FG000|COMPLETED|Post-treatment Follow-up Phase||2
9689251|NCT01125176|10789409|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11
9689252|NCT00882050|10789416|FG000|STARTED|Overall Study||32
9689253|NCT00882050|10789417|FG001|STARTED|Overall Study||33
10023953|NCT01859013|11147660|FG000|STARTED|Overall Study||16
10023954|NCT01859013|11147661|FG001|STARTED|Overall Study||14
10023955|NCT01859013|11147660|FG000|COMPLETED|Overall Study||12
10023956|NCT01859013|11147661|FG001|COMPLETED|Overall Study||9
10023957|NCT01859013|11147660|FG000|NOT COMPLETED|Overall Study||4
9689254|NCT00882050|10789418|FG002|STARTED|Overall Study||39
9689255|NCT00882050|10789416|FG000|COMPLETED|Overall Study||31
9689256|NCT00882050|10789417|FG001|COMPLETED|Overall Study||33
9689257|NCT00882050|10789418|FG002|COMPLETED|Overall Study||39
9689258|NCT00882050|10789416|FG000|NOT COMPLETED|Overall Study||1
9689259|NCT00882050|10789417|FG001|NOT COMPLETED|Overall Study||0
9689260|NCT00882050|10789418|FG002|NOT COMPLETED|Overall Study||0
9689261|NCT00070564|10789432|FG000|STARTED|Overall Study||678
9689262|NCT00070564|10789433|FG001|STARTED|Overall Study||693
9689263|NCT00070564|10789434|FG002|STARTED|Overall Study||697
9689264|NCT00070564|10789435|FG003|STARTED|Overall Study||648
9689265|NCT00070564|10789436|FG004|STARTED|Overall Study||282
9689266|NCT00070564|10789437|FG005|STARTED|Overall Study||296
9689267|NCT00070564|10789432|FG000|COMPLETED|Overall Study||478
9689268|NCT00070564|10789433|FG001|COMPLETED|Overall Study||490
9689269|NCT00070564|10789434|FG002|COMPLETED|Overall Study||526
9689270|NCT00070564|10789435|FG003|COMPLETED|Overall Study||481
9689271|NCT00070564|10789436|FG004|COMPLETED|Overall Study||203
9689272|NCT00070564|10789437|FG005|COMPLETED|Overall Study||244
9689273|NCT00070564|10789432|FG000|NOT COMPLETED|Overall Study||200
9689274|NCT00070564|10789433|FG001|NOT COMPLETED|Overall Study||203
9689275|NCT00070564|10789434|FG002|NOT COMPLETED|Overall Study||171
9689276|NCT00070564|10789435|FG003|NOT COMPLETED|Overall Study||167
9689277|NCT00070564|10789436|FG004|NOT COMPLETED|Overall Study||79
9689278|NCT00070564|10789437|FG005|NOT COMPLETED|Overall Study||52
9726314|NCT00099372|10825843|FG001|COMPLETED|Enrolled in Extended CARE Trial||111
9726315|NCT00099372|10825842|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0
9726316|NCT00099372|10825843|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0
9726317|NCT00099372|10825842|FG000|STARTED|Followed up 5 Years After Index Surgery||104
9726318|NCT00099372|10825843|FG001|STARTED|Followed up 5 Years After Index Surgery||111
9726319|NCT00099372|10825842|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89
9726320|NCT00099372|10825843|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92
9731818|NCT00136604|10831760|FG003|NOT COMPLETED|Overall Study||0
10023958|NCT01859013|11147661|FG001|NOT COMPLETED|Overall Study||5
10023959|NCT01859078|11147667|FG000|STARTED|Overall Study||28
10023960|NCT01859078|11147667|FG000|COMPLETED|Overall Study||28
10023961|NCT01859078|11147667|FG000|NOT COMPLETED|Overall Study||0
10023962|NCT01859143|11147675|FG000|STARTED|Overall Study||240
9689279|NCT05167370|10789457|FG000|STARTED|Overall Study||2
9689280|NCT05167370|10789457|FG000|COMPLETED|Overall Study||2
10023963|NCT01859143|11147676|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
10114282|NCT02515097|11244992|FG001|NOT COMPLETED|Overall Study||6
10114283|NCT02515253|11245000|FG000|STARTED|Overall Study||17
10114284|NCT02515253|11245001|FG001|STARTED|Overall Study||16
10114285|NCT02515253|11245000|FG000|COMPLETED|Overall Study||10
10114286|NCT02515253|11245001|FG001|COMPLETED|Overall Study||8
10114287|NCT02515253|11245000|FG000|NOT COMPLETED|Overall Study||7
10114288|NCT02515253|11245001|FG001|NOT COMPLETED|Overall Study||8
10023964|NCT01859143|11147675|FG000|COMPLETED|Overall Study||238
10023965|NCT01859143|11147676|FG001|COMPLETED|Overall Study||60
10023966|NCT01859143|11147675|FG000|NOT COMPLETED|Overall Study||2
9689281|NCT05167370|10789457|FG000|NOT COMPLETED|Overall Study||0
9726321|NCT00099372|10825842|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
9726322|NCT00099372|10825843|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
10023967|NCT01859143|11147676|FG001|NOT COMPLETED|Overall Study||0
10023968|NCT01859195|11147685|FG000|STARTED|Overall Study||24
10023969|NCT01859195|11147686|FG001|STARTED|Overall Study||12
9726323|NCT00099372|10825842|FG000|STARTED|Followed up 7 Years After Index Surgery||89
9726324|NCT00099372|10825843|FG001|STARTED|Followed up 7 Years After Index Surgery||92
9726325|NCT00099372|10825842|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66
9726326|NCT00099372|10825843|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60
9726327|NCT00099372|10825842|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
9726328|NCT00099372|10825843|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
9726329|NCT00099632|10825857|FG000|STARTED|Overall Study||73
9726330|NCT00099632|10825858|FG001|STARTED|Overall Study||68
9726331|NCT00099632|10825859|FG002|STARTED|Overall Study||75
9726332|NCT00099632|10825860|FG003|STARTED|Overall Study||67
9726333|NCT00099632|10825861|FG004|STARTED|Overall Study||71
9726334|NCT00099632|10825862|FG005|STARTED|Overall Study||68
9726335|NCT00099632|10825857|FG000|COMPLETED|Overall Study||72
9726336|NCT00099632|10825858|FG001|COMPLETED|Overall Study||67
9726337|NCT00099632|10825859|FG002|COMPLETED|Overall Study||72
9726338|NCT00099632|10825860|FG003|COMPLETED|Overall Study||66
9726339|NCT00099632|10825861|FG004|COMPLETED|Overall Study||70
9726340|NCT00099632|10825862|FG005|COMPLETED|Overall Study||66
9726341|NCT00099632|10825857|FG000|NOT COMPLETED|Overall Study||1
9726342|NCT00099632|10825858|FG001|NOT COMPLETED|Overall Study||1
9726343|NCT00099632|10825859|FG002|NOT COMPLETED|Overall Study||3
9726344|NCT00099632|10825860|FG003|NOT COMPLETED|Overall Study||1
9726345|NCT00099632|10825861|FG004|NOT COMPLETED|Overall Study||1
9726346|NCT00099632|10825862|FG005|NOT COMPLETED|Overall Study||2
9726347|NCT00099983|10825878|FG000|STARTED|Overall Study||147
9726348|NCT00099983|10825879|FG001|STARTED|Overall Study||149
9726349|NCT00099983|10825878|FG000|COMPLETED|Overall Study||123
9726350|NCT00099983|10825879|FG001|COMPLETED|Overall Study||124
9726351|NCT00099983|10825878|FG000|NOT COMPLETED|Overall Study||24
10023970|NCT01859195|11147685|FG000|COMPLETED|Overall Study||24
10023971|NCT01859195|11147686|FG001|COMPLETED|Overall Study||12
9726352|NCT00099983|10825879|FG001|NOT COMPLETED|Overall Study||25
9726353|NCT00100048|10825890|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7
9726354|NCT00100048|10825891|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7
9726355|NCT00100048|10825892|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6
9726356|NCT00100048|10825893|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8
10023972|NCT01859195|11147685|FG000|NOT COMPLETED|Overall Study||0
10023973|NCT01859195|11147686|FG001|NOT COMPLETED|Overall Study||0
10023974|NCT01859247|11147702|FG000|STARTED|Overall Study||1
10023975|NCT01859247|11147703|FG001|STARTED|Overall Study||1
10023976|NCT01859247|11147704|FG002|STARTED|Overall Study||1
10023977|NCT01859247|11147705|FG003|STARTED|Overall Study||1
10023978|NCT01859247|11147706|FG004|STARTED|Overall Study||1
10023979|NCT01859247|11147707|FG005|STARTED|Overall Study||1
10023980|NCT01859247|11147708|FG006|STARTED|Overall Study||1
10023981|NCT01859247|11147709|FG007|STARTED|Overall Study||1
10023982|NCT01859247|11147702|FG000|COMPLETED|Overall Study||1
10023983|NCT01859247|11147703|FG001|COMPLETED|Overall Study||1
10023984|NCT01859247|11147704|FG002|COMPLETED|Overall Study||1
10023985|NCT01859247|11147705|FG003|COMPLETED|Overall Study||1
10023986|NCT01859247|11147706|FG004|COMPLETED|Overall Study||1
10114289|NCT02515279|11245007|FG000|STARTED|Overall Study||463
10114290|NCT02515279|11245007|FG000|COMPLETED|Overall Study||359
10114291|NCT02515279|11245007|FG000|NOT COMPLETED|Overall Study||104
10114292|NCT02515305|11245014|FG000|STARTED|Overall Study||385
10114293|NCT02515305|11245015|FG001|STARTED|Overall Study||378
10114294|NCT02515305|11245016|FG002|STARTED|Overall Study||127
10114295|NCT02515305|11245014|FG000|COMPLETED|Overall Study||356
10114296|NCT02515305|11245015|FG001|COMPLETED|Overall Study||343
10114297|NCT02515305|11245016|FG002|COMPLETED|Overall Study||113
10114298|NCT02515305|11245014|FG000|NOT COMPLETED|Overall Study||29
10114299|NCT02515305|11245015|FG001|NOT COMPLETED|Overall Study||35
10114300|NCT02515305|11245016|FG002|NOT COMPLETED|Overall Study||14
10114301|NCT02515331|11245027|FG000|STARTED|Overall Study||17
10114302|NCT02515331|11245028|FG001|STARTED|Overall Study||15
10114303|NCT02515331|11245029|FG002|STARTED|Overall Study||32
10114304|NCT02515331|11245027|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15
10114305|NCT02515331|11245028|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14
10114306|NCT02515331|11245029|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29
10114307|NCT02515331|11245027|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17
10114308|NCT02515331|11245028|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15
10114309|NCT02515331|11245029|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10114310|NCT02515331|11245027|FG000|COMPLETED|Overall Study||15
10114311|NCT02515331|11245028|FG001|COMPLETED|Overall Study||15
10114312|NCT02515331|11245029|FG002|COMPLETED|Overall Study||28
10114313|NCT02515331|11245027|FG000|NOT COMPLETED|Overall Study||2
10114314|NCT02515331|11245028|FG001|NOT COMPLETED|Overall Study||0
10114315|NCT02515331|11245029|FG002|NOT COMPLETED|Overall Study||4
10114316|NCT02515630|11245039|FG000|STARTED|Overall Study||41
10114317|NCT02515630|11245039|FG000|COMPLETED|Overall Study||25
10114318|NCT02515630|11245039|FG000|NOT COMPLETED|Overall Study||16
10114319|NCT02515656|11245048|FG000|STARTED|Overall Study||326
10114320|NCT02515656|11245049|FG001|STARTED|Overall Study||332
10114321|NCT02515656|11245048|FG000|Full Analysis Set (FAS)|Overall Study||302
10114322|NCT02515656|11245049|FG001|Full Analysis Set (FAS)|Overall Study||309
10114323|NCT02515656|11245048|FG000|Per Protocol Set (PPS)|Overall Study||277
10114324|NCT02515656|11245049|FG001|Per Protocol Set (PPS)|Overall Study||275
10114325|NCT02515656|11245048|FG000|Safety Population|Overall Study||325
10114326|NCT02515656|11245049|FG001|Safety Population|Overall Study||328
9846523|NCT00848549|10958864|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
9846524|NCT00848549|10958865|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
9846525|NCT00848549|10958864|FG000|STARTED|E2090-E044-314 (Extension Study)||137
9846526|NCT00848549|10958865|FG001|STARTED|E2090-E044-314 (Extension Study)||158
9846527|NCT00848549|10958864|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120
9846528|NCT00848549|10958865|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134
9846529|NCT00848549|10958864|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
9961221|NCT01472757|11080968|FG001|COMPLETED|Overall Study||80
10023987|NCT01859247|11147707|FG005|COMPLETED|Overall Study||1
10114327|NCT02515656|11245048|FG000|COMPLETED|Overall Study||270
10114328|NCT02515656|11245049|FG001|COMPLETED|Overall Study||261
10114329|NCT02515656|11245048|FG000|NOT COMPLETED|Overall Study||56
10114330|NCT02515656|11245049|FG001|NOT COMPLETED|Overall Study||71
10114331|NCT02515669|11245059|FG000|STARTED|24 Week Double-Blind Phase||11
10114332|NCT02515669|11245060|FG001|STARTED|24 Week Double-Blind Phase||7
10114333|NCT02515669|11245061|FG002|STARTED|24 Week Double-Blind Phase||6
10114334|NCT02515669|11245062|FG003|STARTED|24 Week Double-Blind Phase||19
10114335|NCT02515669|11245059|FG000|COMPLETED|24 Week Double-Blind Phase||11
10114336|NCT02515669|11245060|FG001|COMPLETED|24 Week Double-Blind Phase||7
10114337|NCT02515669|11245061|FG002|COMPLETED|24 Week Double-Blind Phase||6
10114338|NCT02515669|11245062|FG003|COMPLETED|24 Week Double-Blind Phase||19
10114339|NCT02515669|11245059|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0
10023988|NCT01859247|11147708|FG006|COMPLETED|Overall Study||1
10023989|NCT01859247|11147709|FG007|COMPLETED|Overall Study||1
10023990|NCT01859247|11147702|FG000|NOT COMPLETED|Overall Study||0
10023991|NCT01859247|11147703|FG001|NOT COMPLETED|Overall Study||0
10023992|NCT01859247|11147704|FG002|NOT COMPLETED|Overall Study||0
10023993|NCT01859247|11147705|FG003|NOT COMPLETED|Overall Study||0
9689282|NCT04500821|10789461|FG000|STARTED|Overall Study||44
9689283|NCT04500821|10789461|FG000|COMPLETED|Overall Study||44
9689284|NCT04500821|10789461|FG000|NOT COMPLETED|Overall Study||0
9689285|NCT04425720|10789468|FG000|STARTED|Overall Study||150
9689286|NCT04425720|10789469|FG001|STARTED|Overall Study||150
9689287|NCT04425720|10789468|FG000|COMPLETED|Overall Study||150
9689288|NCT04425720|10789469|FG001|COMPLETED|Overall Study||130
9689289|NCT04425720|10789468|FG000|NOT COMPLETED|Overall Study||0
9689290|NCT04425720|10789469|FG001|NOT COMPLETED|Overall Study||20
9689291|NCT04409509|10789478|FG000|STARTED|Overall Study||61
9689292|NCT04409509|10789479|FG001|STARTED|Overall Study||63
9689293|NCT04409509|10789478|FG000|COMPLETED|Overall Study||48
9689294|NCT04409509|10789479|FG001|COMPLETED|Overall Study||43
9689295|NCT04409509|10789478|FG000|NOT COMPLETED|Overall Study||13
9689296|NCT04409509|10789479|FG001|NOT COMPLETED|Overall Study||20
9689297|NCT04380519|10789489|FG000|STARTED|Overall Study||124
9689298|NCT04380519|10789490|FG001|STARTED|Overall Study||124
9689299|NCT04380519|10789491|FG002|STARTED|Overall Study||124
9689300|NCT04380519|10789489|FG000|Intent-to-Treat (ITT)|Overall Study||124
9689301|NCT04380519|10789490|FG001|Intent-to-Treat (ITT)|Overall Study||124
9689302|NCT04380519|10789491|FG002|Intent-to-Treat (ITT)|Overall Study||124
9689303|NCT04380519|10789489|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115
9689304|NCT04380519|10789490|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119
9689305|NCT04380519|10789491|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118
9689306|NCT04380519|10789489|FG000|Safety Population|Overall Study||123
9689307|NCT04380519|10789490|FG001|Safety Population|Overall Study||124
9689308|NCT04380519|10789491|FG002|Safety Population|Overall Study||124
9689309|NCT04380519|10789489|FG000|COMPLETED|Overall Study||106
9689310|NCT04380519|10789490|FG001|COMPLETED|Overall Study||113
9689311|NCT04380519|10789491|FG002|COMPLETED|Overall Study||117
9689312|NCT04380519|10789489|FG000|NOT COMPLETED|Overall Study||18
9689313|NCT04380519|10789490|FG001|NOT COMPLETED|Overall Study||11
9846530|NCT00848549|10958865|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
9846531|NCT00848718|10958886|FG000|STARTED|Overall Study||7
9689314|NCT04380519|10789491|FG002|NOT COMPLETED|Overall Study||7
9726357|NCT00100048|10825894|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7
9726358|NCT00100048|10825895|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
9726359|NCT00100048|10825890|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7
9726360|NCT00100048|10825891|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7
9731819|NCT00136604|10831761|FG004|NOT COMPLETED|Overall Study||1
9731820|NCT00136695|10831779|FG000|STARTED|Overall Study||45
9731821|NCT00136695|10831780|FG001|STARTED|Overall Study||43
9731822|NCT00136695|10831779|FG000|COMPLETED|Overall Study||34
9731823|NCT00136695|10831780|FG001|COMPLETED|Overall Study||35
9731824|NCT00136695|10831779|FG000|NOT COMPLETED|Overall Study||11
9731825|NCT00136695|10831780|FG001|NOT COMPLETED|Overall Study||8
9731826|NCT00136760|10831790|FG000|STARTED|Overall Study||12
9731827|NCT00136760|10831791|FG001|STARTED|Overall Study||16
9731828|NCT00136760|10831792|FG002|STARTED|Overall Study||11
9731829|NCT00136760|10831793|FG003|STARTED|Overall Study||13
9731830|NCT00136760|10831790|FG000|COMPLETED|Overall Study||12
9731831|NCT00136760|10831791|FG001|COMPLETED|Overall Study||16
9731832|NCT00136760|10831792|FG002|COMPLETED|Overall Study||11
9731833|NCT00136760|10831793|FG003|COMPLETED|Overall Study||13
9731834|NCT00136760|10831790|FG000|NOT COMPLETED|Overall Study||0
9731835|NCT00136760|10831791|FG001|NOT COMPLETED|Overall Study||0
9731836|NCT00136760|10831792|FG002|NOT COMPLETED|Overall Study||0
9731837|NCT00136760|10831793|FG003|NOT COMPLETED|Overall Study||0
9731838|NCT00136812|10831805|FG000|STARTED|Overall Study||111
9689315|NCT04362813|10789501|FG000|STARTED|Overall Study||227
9689316|NCT04362813|10789502|FG001|STARTED|Overall Study||227
9689317|NCT04362813|10789501|FG000|Safety Set|Overall Study||225
9689318|NCT04362813|10789502|FG001|Safety Set|Overall Study||223
9689319|NCT04362813|10789501|FG000|Completed Day 29|Overall Study||211
9689320|NCT04362813|10789502|FG001|Completed Day 29|Overall Study||206
9689321|NCT04362813|10789501|FG000|COMPLETED|Overall Study||209
9689322|NCT04362813|10789502|FG001|COMPLETED|Overall Study||202
9689323|NCT04362813|10789501|FG000|NOT COMPLETED|Overall Study||18
9689324|NCT04362813|10789502|FG001|NOT COMPLETED|Overall Study||25
9689325|NCT04231409|10789510|FG000|STARTED|Overall Study||5
9689326|NCT04231409|10789511|FG001|STARTED|Overall Study||4
9689327|NCT04231409|10789510|FG000|COMPLETED|Overall Study||0
9689328|NCT04231409|10789511|FG001|COMPLETED|Overall Study||0
9689329|NCT04231409|10789510|FG000|NOT COMPLETED|Overall Study||5
9689330|NCT04231409|10789511|FG001|NOT COMPLETED|Overall Study||4
9689331|NCT04136548|10789517|FG000|STARTED|Enrolled & Randomized||19
9689332|NCT04136548|10789518|FG001|STARTED|Enrolled & Randomized||19
9689333|NCT04136548|10789517|FG000|COMPLETED|Enrolled & Randomized||13
9689334|NCT04136548|10789518|FG001|COMPLETED|Enrolled & Randomized||15
9689335|NCT04136548|10789517|FG000|NOT COMPLETED|Enrolled & Randomized||6
9689336|NCT04136548|10789518|FG001|NOT COMPLETED|Enrolled & Randomized||4
9689337|NCT04136548|10789517|FG000|STARTED|First Visit||13
9689338|NCT04136548|10789518|FG001|STARTED|First Visit||15
9689339|NCT04136548|10789517|FG000|COMPLETED|First Visit||13
9689340|NCT04136548|10789518|FG001|COMPLETED|First Visit||15
9689341|NCT04136548|10789517|FG000|NOT COMPLETED|First Visit||0
9689342|NCT04136548|10789518|FG001|NOT COMPLETED|First Visit||0
9689343|NCT04136548|10789517|FG000|STARTED|Washout (at Least 48 Hours)||13
9689344|NCT04136548|10789518|FG001|STARTED|Washout (at Least 48 Hours)||15
9689345|NCT04136548|10789517|FG000|COMPLETED|Washout (at Least 48 Hours)||13
9689346|NCT04136548|10789518|FG001|COMPLETED|Washout (at Least 48 Hours)||15
9689347|NCT04136548|10789517|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
9689348|NCT04136548|10789518|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
9689349|NCT04136548|10789517|FG000|STARTED|Second Visit||13
9689350|NCT04136548|10789518|FG001|STARTED|Second Visit||15
9689351|NCT04136548|10789517|FG000|COMPLETED|Second Visit||13
9689352|NCT04136548|10789518|FG001|COMPLETED|Second Visit||15
9689353|NCT04136548|10789517|FG000|NOT COMPLETED|Second Visit||0
9689354|NCT04136548|10789518|FG001|NOT COMPLETED|Second Visit||0
9689355|NCT04126057|10789526|FG000|STARTED|Overall Study||50
9689356|NCT04126057|10789527|FG001|STARTED|Overall Study||50
9689357|NCT04126057|10789526|FG000|COMPLETED|Overall Study||47
9689358|NCT04126057|10789527|FG001|COMPLETED|Overall Study||46
9689359|NCT04126057|10789526|FG000|NOT COMPLETED|Overall Study||3
9689360|NCT04126057|10789527|FG001|NOT COMPLETED|Overall Study||4
9689361|NCT04087395|10789533|FG000|STARTED|Overall Study||30
9689362|NCT04087395|10789533|FG000|COMPLETED|Overall Study||30
9689363|NCT04087395|10789533|FG000|NOT COMPLETED|Overall Study||0
9689364|NCT04072432|10789544|FG000|STARTED|Overall Study||6
9689365|NCT04072432|10789545|FG001|STARTED|Overall Study||6
9689366|NCT04072432|10789546|FG002|STARTED|Overall Study||6
9689367|NCT04072432|10789544|FG000|COMPLETED|Overall Study||6
9689368|NCT04072432|10789545|FG001|COMPLETED|Overall Study||6
9689369|NCT04072432|10789546|FG002|COMPLETED|Overall Study||6
9689370|NCT04072432|10789544|FG000|NOT COMPLETED|Overall Study||0
9689371|NCT04072432|10789545|FG001|NOT COMPLETED|Overall Study||0
9689372|NCT04072432|10789546|FG002|NOT COMPLETED|Overall Study||0
9689373|NCT04069585|10789554|FG000|STARTED|Overall Study||30
9689374|NCT04069585|10789554|FG000|COMPLETED|Overall Study||30
9846532|NCT00848718|10958887|FG001|STARTED|Overall Study||9
9689375|NCT04069585|10789554|FG000|NOT COMPLETED|Overall Study||0
9726361|NCT00100048|10825892|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6
9726362|NCT00100048|10825893|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8
9726363|NCT00100048|10825894|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7
9726364|NCT00100048|10825895|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0
9726365|NCT00100048|10825890|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
9726366|NCT00100048|10825891|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
9726367|NCT00100048|10825892|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
9689376|NCT03922321|10789560|FG000|STARTED|Overall Study||7
9689377|NCT03922321|10789560|FG000|COMPLETED|Overall Study||5
9689378|NCT03922321|10789560|FG000|NOT COMPLETED|Overall Study||2
9689379|NCT03911713|10789569|FG000|STARTED|Overall Study||12
9689380|NCT03911713|10789570|FG001|STARTED|Overall Study||6
9689381|NCT03911713|10789571|FG002|STARTED|Overall Study||11
9689382|NCT03911713|10789572|FG003|STARTED|Overall Study||24
9689383|NCT03911713|10789573|FG004|STARTED|Overall Study||24
9689384|NCT03911713|10789569|FG000|Full Analysis Set|Overall Study||11
9689385|NCT03911713|10789570|FG001|Full Analysis Set|Overall Study||6
9689386|NCT03911713|10789571|FG002|Full Analysis Set|Overall Study||11
9689387|NCT03911713|10789572|FG003|Full Analysis Set|Overall Study||23
9689388|NCT03911713|10789573|FG004|Full Analysis Set|Overall Study||24
9689389|NCT03911713|10789569|FG000|COMPLETED|Overall Study||11
9689390|NCT03911713|10789570|FG001|COMPLETED|Overall Study||4
9689391|NCT03911713|10789571|FG002|COMPLETED|Overall Study||11
9689392|NCT03911713|10789572|FG003|COMPLETED|Overall Study||22
9689393|NCT03911713|10789573|FG004|COMPLETED|Overall Study||24
9689394|NCT03911713|10789569|FG000|NOT COMPLETED|Overall Study||1
9689395|NCT03911713|10789570|FG001|NOT COMPLETED|Overall Study||2
9689396|NCT03911713|10789571|FG002|NOT COMPLETED|Overall Study||0
9689397|NCT03911713|10789572|FG003|NOT COMPLETED|Overall Study||2
9689398|NCT03911713|10789573|FG004|NOT COMPLETED|Overall Study||0
9689399|NCT03879642|10789589|FG000|STARTED|Overall Study||22
9689400|NCT03879642|10789590|FG001|STARTED|Overall Study||21
9689401|NCT03879642|10789589|FG000|COMPLETED|Overall Study||19
9689402|NCT03879642|10789590|FG001|COMPLETED|Overall Study||18
9689403|NCT03879642|10789589|FG000|NOT COMPLETED|Overall Study||3
9689404|NCT03879642|10789590|FG001|NOT COMPLETED|Overall Study||3
9689405|NCT03852459|10789598|FG000|STARTED|Overall Study||126
9961222|NCT01472757|11080969|FG002|COMPLETED|Overall Study||76
9689406|NCT03852459|10789599|FG001|STARTED|Overall Study||125
9689407|NCT03852459|10789598|FG000|COMPLETED|Overall Study||123
9689408|NCT03852459|10789599|FG001|COMPLETED|Overall Study||122
9689409|NCT03852459|10789598|FG000|NOT COMPLETED|Overall Study||3
9689410|NCT03852459|10789599|FG001|NOT COMPLETED|Overall Study||3
9689411|NCT03740919|10789608|FG000|STARTED|Lead-in Period||751
9689412|NCT03740919|10789609|FG001|STARTED|Lead-in Period||0
9689413|NCT03740919|10789610|FG002|STARTED|Lead-in Period||0
9689414|NCT03740919|10789611|FG003|STARTED|Lead-in Period||0
9689415|NCT03740919|10789608|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751
9689416|NCT03740919|10789609|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0
9689417|NCT03740919|10789610|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0
9689418|NCT03740919|10789611|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0
9689419|NCT03740919|10789608|FG000|COMPLETED|Lead-in Period||716
9689420|NCT03740919|10789609|FG001|COMPLETED|Lead-in Period||0
9689421|NCT03740919|10789610|FG002|COMPLETED|Lead-in Period||0
9689422|NCT03740919|10789611|FG003|COMPLETED|Lead-in Period||0
9689423|NCT03740919|10789608|FG000|NOT COMPLETED|Lead-in Period||35
9689424|NCT03740919|10789609|FG001|NOT COMPLETED|Lead-in Period||0
9689425|NCT03740919|10789610|FG002|NOT COMPLETED|Lead-in Period||0
9689426|NCT03740919|10789611|FG003|NOT COMPLETED|Lead-in Period||0
9689427|NCT03740919|10789608|FG000|STARTED|Treatment Period||0
9689428|NCT03740919|10789609|FG001|STARTED|Treatment Period|Participants were randomized from Lead-in Period to Insulin Lispro (Humalog).|298
9689429|NCT03740919|10789610|FG002|STARTED|Treatment Period|Participants were randomized from Lead-in Period to LY900014.|280
9689430|NCT03740919|10789611|FG003|STARTED|Treatment Period|Participants were randomized from Lead-in Period to open-label LY900014.|138
9689431|NCT03740919|10789608|FG000|Received at Least One Dose of Study Drug|Treatment Period||0
9689432|NCT03740919|10789609|FG001|Received at Least One Dose of Study Drug|Treatment Period||298
9689433|NCT03740919|10789610|FG002|Received at Least One Dose of Study Drug|Treatment Period||280
9689434|NCT03740919|10789611|FG003|Received at Least One Dose of Study Drug|Treatment Period||138
9689435|NCT03740919|10789608|FG000|COMPLETED|Treatment Period||0
9689436|NCT03740919|10789609|FG001|COMPLETED|Treatment Period||288
9689437|NCT03740919|10789610|FG002|COMPLETED|Treatment Period||266
9689438|NCT03740919|10789611|FG003|COMPLETED|Treatment Period||135
9689439|NCT03740919|10789608|FG000|NOT COMPLETED|Treatment Period||0
9689440|NCT03740919|10789609|FG001|NOT COMPLETED|Treatment Period||10
9689441|NCT03740919|10789610|FG002|NOT COMPLETED|Treatment Period||14
9689442|NCT03740919|10789611|FG003|NOT COMPLETED|Treatment Period||3
9689443|NCT03700970|10789624|FG000|STARTED|Overall Study||30
9689444|NCT03700970|10789625|FG001|STARTED|Overall Study||30
9689445|NCT03700970|10789624|FG000|COMPLETED|Overall Study||21
9689446|NCT03700970|10789625|FG001|COMPLETED|Overall Study||19
9689447|NCT03700970|10789624|FG000|NOT COMPLETED|Overall Study||9
9689448|NCT03700970|10789625|FG001|NOT COMPLETED|Overall Study||11
9689449|NCT03652454|10789635|FG000|STARTED|Overall Study||14
9689450|NCT03652454|10789636|FG001|STARTED|Overall Study||14
9689451|NCT03652454|10789635|FG000|COMPLETED|Overall Study||14
9689452|NCT03652454|10789636|FG001|COMPLETED|Overall Study||14
9689453|NCT03652454|10789635|FG000|NOT COMPLETED|Overall Study||0
9689454|NCT03652454|10789636|FG001|NOT COMPLETED|Overall Study||0
9689455|NCT03647488|10789645|FG000|STARTED|Overall Study||18
9689456|NCT03647488|10789646|FG001|STARTED|Overall Study|Randomized part was not opened|0
9689457|NCT03647488|10789647|FG002|STARTED|Overall Study|Randomized part was not opened|0
9689458|NCT03647488|10789645|FG000|COMPLETED|Overall Study||0
9689459|NCT03647488|10789646|FG001|COMPLETED|Overall Study||0
10023994|NCT01859247|11147706|FG004|NOT COMPLETED|Overall Study||0
10023995|NCT01859247|11147707|FG005|NOT COMPLETED|Overall Study||0
10023996|NCT01859247|11147708|FG006|NOT COMPLETED|Overall Study||0
10023997|NCT01859247|11147709|FG007|NOT COMPLETED|Overall Study||0
10023998|NCT01859312|11147728|FG000|STARTED|Overall Study||8
10023999|NCT01859312|11147728|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
10024000|NCT01859312|11147728|FG000|NOT COMPLETED|Overall Study||0
10024001|NCT01859325|11147735|FG000|STARTED|Overall Study||15
9689460|NCT03647488|10789647|FG002|COMPLETED|Overall Study||0
9689461|NCT03647488|10789645|FG000|NOT COMPLETED|Overall Study||18
9689462|NCT03647488|10789646|FG001|NOT COMPLETED|Overall Study||0
10024002|NCT01859325|11147736|FG001|STARTED|Overall Study||16
10024003|NCT01859325|11147737|FG002|STARTED|Overall Study||2
10024004|NCT01859325|11147735|FG000|COMPLETED|Overall Study||12
9689463|NCT03647488|10789647|FG002|NOT COMPLETED|Overall Study||0
9689464|NCT03614923|10789656|FG000|STARTED|Overall Study||35
9689465|NCT03614923|10789657|FG001|STARTED|Overall Study||35
9689466|NCT03614923|10789658|FG002|STARTED|Overall Study||35
9689467|NCT03614923|10789656|FG000|COMPLETED|Overall Study||30
9689468|NCT03614923|10789657|FG001|COMPLETED|Overall Study||30
9689469|NCT03614923|10789658|FG002|COMPLETED|Overall Study||30
9689470|NCT03614923|10789656|FG000|NOT COMPLETED|Overall Study||5
9689471|NCT03614923|10789657|FG001|NOT COMPLETED|Overall Study||5
9689472|NCT03614923|10789658|FG002|NOT COMPLETED|Overall Study||5
9689473|NCT03502187|10789669|FG000|STARTED|Overall Study||43
9689474|NCT03502187|10789670|FG001|STARTED|Overall Study||43
9689475|NCT03502187|10789671|FG002|STARTED|Overall Study||42
9689476|NCT03502187|10789669|FG000|COMPLETED|Overall Study||34
9689477|NCT03502187|10789670|FG001|COMPLETED|Overall Study||36
9689478|NCT03502187|10789671|FG002|COMPLETED|Overall Study||34
9689479|NCT03502187|10789669|FG000|NOT COMPLETED|Overall Study||9
9689480|NCT03502187|10789670|FG001|NOT COMPLETED|Overall Study||7
9689481|NCT03502187|10789671|FG002|NOT COMPLETED|Overall Study||8
9726368|NCT00100048|10825893|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
9726369|NCT00100048|10825894|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
10024005|NCT01859325|11147736|FG001|COMPLETED|Overall Study||12
9726370|NCT00100048|10825895|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
9726371|NCT00100048|10825890|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
9726372|NCT00100048|10825891|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10024006|NCT01859325|11147737|FG002|COMPLETED|Overall Study||2
9689482|NCT03447262|10789679|FG000|STARTED|Overall Study||481
9689483|NCT03447262|10789679|FG000|COMPLETED|Overall Study||2
9689484|NCT03447262|10789679|FG000|NOT COMPLETED|Overall Study||479
9689485|NCT03432819|10789688|FG000|STARTED|Overall Study||38
9689486|NCT03432819|10789689|FG001|STARTED|Overall Study||38
9689487|NCT03432819|10789688|FG000|COMPLETED|Overall Study||31
9689488|NCT03432819|10789689|FG001|COMPLETED|Overall Study||33
9689489|NCT03432819|10789688|FG000|NOT COMPLETED|Overall Study||7
9689490|NCT03432819|10789689|FG001|NOT COMPLETED|Overall Study||5
9689491|NCT03323749|10789697|FG000|STARTED|Double-blind Period||109
10024007|NCT01859325|11147735|FG000|NOT COMPLETED|Overall Study||3
10024008|NCT01859325|11147736|FG001|NOT COMPLETED|Overall Study||4
9846533|NCT00848718|10958888|FG002|STARTED|Overall Study||6
9846534|NCT00848718|10958889|FG003|STARTED|Overall Study||5
9846535|NCT00848718|10958890|FG004|STARTED|Overall Study||6
9846536|NCT00848718|10958891|FG005|STARTED|Overall Study||5
9846537|NCT00848718|10958892|FG006|STARTED|Overall Study||3
10024009|NCT01859325|11147737|FG002|NOT COMPLETED|Overall Study||0
9846538|NCT00848718|10958893|FG007|STARTED|Overall Study||5
9846539|NCT00848718|10958894|FG008|STARTED|Overall Study||4
9846540|NCT00848718|10958895|FG009|STARTED|Overall Study||9
9846541|NCT00848718|10958896|FG010|STARTED|Overall Study||4
10114340|NCT02515669|11245060|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0
10114341|NCT02515669|11245061|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0
10024010|NCT01859390|11147745|FG000|STARTED|Overall Study||36
10024011|NCT01859390|11147746|FG001|STARTED|Overall Study||37
10024012|NCT01859390|11147745|FG000|Withdrawals|Overall Study||2
10024013|NCT01859390|11147746|FG001|Withdrawals|Overall Study||2
10024014|NCT01859390|11147745|FG000|COMPLETED|Overall Study||35
10024015|NCT01859390|11147746|FG001|COMPLETED|Overall Study||30
10024016|NCT01859390|11147745|FG000|NOT COMPLETED|Overall Study||1
9689492|NCT03323749|10789698|FG001|STARTED|Double-blind Period||109
9689493|NCT03323749|10789697|FG000|COMPLETED|Double-blind Period||102
9689494|NCT03323749|10789698|FG001|COMPLETED|Double-blind Period||103
9689495|NCT03323749|10789697|FG000|NOT COMPLETED|Double-blind Period||7
9689496|NCT03323749|10789698|FG001|NOT COMPLETED|Double-blind Period||6
9689497|NCT03323749|10789697|FG000|STARTED|Open-Label Period||93
9689498|NCT03323749|10789698|FG001|STARTED|Open-Label Period||103
9689499|NCT03323749|10789697|FG000|COMPLETED|Open-Label Period||0
9689500|NCT03323749|10789698|FG001|COMPLETED|Open-Label Period||0
9689501|NCT03323749|10789697|FG000|NOT COMPLETED|Open-Label Period||93
9689502|NCT03323749|10789698|FG001|NOT COMPLETED|Open-Label Period||103
9689503|NCT03322566|10789711|FG000|STARTED|Overall Study||91
9689504|NCT03322566|10789712|FG001|STARTED|Overall Study||87
9689505|NCT03322566|10789713|FG002|STARTED|Overall Study||55
9689506|NCT03322566|10789711|FG000|COMPLETED|Overall Study||46
9689507|NCT03322566|10789712|FG001|COMPLETED|Overall Study||42
10024017|NCT01859390|11147746|FG001|NOT COMPLETED|Overall Study||7
9689508|NCT03322566|10789713|FG002|COMPLETED|Overall Study||22
9689509|NCT03322566|10789711|FG000|NOT COMPLETED|Overall Study||45
10114342|NCT02515669|11245062|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0
9689510|NCT03322566|10789712|FG001|NOT COMPLETED|Overall Study||45
9846542|NCT00848718|10958897|FG011|STARTED|Overall Study||6
10024018|NCT01859403|11147754|FG000|STARTED|Primary Endpoint Measure||21
10024019|NCT01859403|11147755|FG001|STARTED|Primary Endpoint Measure||30
9689511|NCT03322566|10789713|FG002|NOT COMPLETED|Overall Study||33
9689512|NCT03322540|10789723|FG000|STARTED|Overall Study||77
9689513|NCT03322540|10789724|FG001|STARTED|Overall Study||77
9689514|NCT03322540|10789723|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75
9689515|NCT03322540|10789724|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77
9689516|NCT03322540|10789723|FG000|COMPLETED|Overall Study||46
9689517|NCT03322540|10789724|FG001|COMPLETED|Overall Study||40
9689518|NCT03322540|10789723|FG000|NOT COMPLETED|Overall Study||31
9689519|NCT03322540|10789724|FG001|NOT COMPLETED|Overall Study||37
9689520|NCT03240601|10789734|FG000|STARTED|Overall Study||9
9689521|NCT03240601|10789735|FG001|STARTED|Overall Study||9
9689522|NCT03240601|10789734|FG000|COMPLETED|Overall Study||8
9689523|NCT03240601|10789735|FG001|COMPLETED|Overall Study||8
9689524|NCT03240601|10789734|FG000|NOT COMPLETED|Overall Study||1
9689525|NCT03240601|10789735|FG001|NOT COMPLETED|Overall Study||1
9689526|NCT03189719|10789743|FG000|STARTED|Overall Study||373
9689527|NCT03189719|10789744|FG001|STARTED|Overall Study||376
9689528|NCT03189719|10789743|FG000|Treated|Overall Study||370
9689529|NCT03189719|10789744|FG001|Treated|Overall Study||370
9689530|NCT03189719|10789743|FG000|COMPLETED|Overall Study||0
9689531|NCT03189719|10789744|FG001|COMPLETED|Overall Study||0
9689532|NCT03189719|10789743|FG000|NOT COMPLETED|Overall Study||373
9689533|NCT03189719|10789744|FG001|NOT COMPLETED|Overall Study||376
9689534|NCT03155997|10789752|FG000|STARTED|Overall Study||2808
9689535|NCT03155997|10789753|FG001|STARTED|Overall Study||2829
9689536|NCT03155997|10789752|FG000|Received at Least One Dose of Study Drug|Overall Study||2791
9689537|NCT03155997|10789753|FG001|Received at Least One Dose of Study Drug|Overall Study||2800
9689538|NCT03155997|10789752|FG000|COMPLETED|Overall Study||650
9689539|NCT03155997|10789753|FG001|COMPLETED|Overall Study||607
9689540|NCT03155997|10789752|FG000|NOT COMPLETED|Overall Study||2158
9689541|NCT03155997|10789753|FG001|NOT COMPLETED|Overall Study||2222
10024020|NCT01859403|11147754|FG000|COMPLETED|Primary Endpoint Measure||20
10024021|NCT01859403|11147755|FG001|COMPLETED|Primary Endpoint Measure||26
10024022|NCT01859403|11147754|FG000|NOT COMPLETED|Primary Endpoint Measure||1
9689542|NCT03104400|10789763|FG000|STARTED|Overall Study||211
9689543|NCT03104400|10789764|FG001|STARTED|Overall Study||212
9689544|NCT03104400|10789765|FG002|STARTED|Overall Study||429
9689545|NCT03104400|10789766|FG003|STARTED|Overall Study||430
9689546|NCT03104400|10789767|FG004|STARTED|Overall Study||423
9689547|NCT03104400|10789763|FG000|Received Study Drug|Overall Study||211
9689548|NCT03104400|10789764|FG001|Received Study Drug|Overall Study||212
9689549|NCT03104400|10789765|FG002|Received Study Drug|Overall Study||429
9689550|NCT03104400|10789766|FG003|Received Study Drug|Overall Study||429
9689551|NCT03104400|10789767|FG004|Received Study Drug|Overall Study||423
9689552|NCT03104400|10789763|FG000|Completed Week 24|Overall Study||190
9689553|NCT03104400|10789764|FG001|Completed Week 24|Overall Study||193
9689554|NCT03104400|10789765|FG002|Completed Week 24|Overall Study||404
9689555|NCT03104400|10789766|FG003|Completed Week 24|Overall Study||408
9689556|NCT03104400|10789767|FG004|Completed Week 24|Overall Study||394
9689557|NCT03104400|10789763|FG000|COMPLETED|Overall Study||177
9689558|NCT03104400|10789764|FG001|COMPLETED|Overall Study||178
9689559|NCT03104400|10789765|FG002|COMPLETED|Overall Study||370
9689560|NCT03104400|10789766|FG003|COMPLETED|Overall Study||379
9689561|NCT03104400|10789767|FG004|COMPLETED|Overall Study||366
9689562|NCT03104400|10789763|FG000|NOT COMPLETED|Overall Study||34
9689563|NCT03104400|10789764|FG001|NOT COMPLETED|Overall Study||34
9689564|NCT03104400|10789765|FG002|NOT COMPLETED|Overall Study||59
9689565|NCT03104400|10789766|FG003|NOT COMPLETED|Overall Study||51
9689566|NCT03104400|10789767|FG004|NOT COMPLETED|Overall Study||57
9689567|NCT03104374|10789784|FG000|STARTED|Overall Study||106
9689568|NCT03104374|10789785|FG001|STARTED|Overall Study||106
10024023|NCT01859403|11147755|FG001|NOT COMPLETED|Primary Endpoint Measure||4
10024024|NCT01859403|11147754|FG000|STARTED|Secondary Endpoint Measure||20
10024025|NCT01859403|11147755|FG001|STARTED|Secondary Endpoint Measure||26
9689569|NCT03104374|10789786|FG002|STARTED|Overall Study||211
9689570|NCT03104374|10789787|FG003|STARTED|Overall Study||219
9689571|NCT03104374|10789784|FG000|Received Study Drug|Overall Study||106
9689572|NCT03104374|10789785|FG001|Received Study Drug|Overall Study||106
9689573|NCT03104374|10789786|FG002|Received Study Drug|Overall Study||211
9689574|NCT03104374|10789787|FG003|Received Study Drug|Overall Study||218
9689575|NCT03104374|10789784|FG000|Completed Week 24|Overall Study||81
9689576|NCT03104374|10789785|FG001|Completed Week 24|Overall Study||92
9689577|NCT03104374|10789786|FG002|Completed Week 24|Overall Study||192
9689578|NCT03104374|10789787|FG003|Completed Week 24|Overall Study||195
9689579|NCT03104374|10789784|FG000|COMPLETED|Overall Study||69
9689580|NCT03104374|10789785|FG001|COMPLETED|Overall Study||77
9689581|NCT03104374|10789786|FG002|COMPLETED|Overall Study||167
9689582|NCT03104374|10789787|FG003|COMPLETED|Overall Study||166
9689583|NCT03104374|10789784|FG000|NOT COMPLETED|Overall Study||37
10024026|NCT01859403|11147754|FG000|COMPLETED|Secondary Endpoint Measure||14
10196046|NCT03358290|11324439|FG003|COMPLETED|Overall Study||1
10196047|NCT03358290|11324440|FG004|COMPLETED|Overall Study||1
10196048|NCT03358290|11324436|FG000|NOT COMPLETED|Overall Study||0
10196049|NCT03358290|11324437|FG001|NOT COMPLETED|Overall Study||1
10196050|NCT03358290|11324438|FG002|NOT COMPLETED|Overall Study||2
10196051|NCT03358290|11324439|FG003|NOT COMPLETED|Overall Study||2
10196052|NCT03358290|11324440|FG004|NOT COMPLETED|Overall Study||1
10196053|NCT03358329|11324452|FG000|STARTED|Overall Study||50
10196054|NCT03358329|11324452|FG000|COMPLETED|Overall Study||46
10196055|NCT03358329|11324452|FG000|NOT COMPLETED|Overall Study||4
9689584|NCT03104374|10789785|FG001|NOT COMPLETED|Overall Study||29
9689585|NCT03104374|10789786|FG002|NOT COMPLETED|Overall Study||44
9689586|NCT03104374|10789787|FG003|NOT COMPLETED|Overall Study||53
9689587|NCT03072043|10789800|FG000|STARTED|Overall Study||3
9689588|NCT03072043|10789801|FG001|STARTED|Overall Study||3
9689589|NCT03072043|10789802|FG002|STARTED|Overall Study||49
9689590|NCT03072043|10789800|FG000|COMPLETED|Overall Study||3
9689591|NCT03072043|10789801|FG001|COMPLETED|Overall Study||3
9689592|NCT03072043|10789802|FG002|COMPLETED|Overall Study||40
9689593|NCT03072043|10789800|FG000|NOT COMPLETED|Overall Study||0
9689594|NCT03072043|10789801|FG001|NOT COMPLETED|Overall Study||0
9689595|NCT03072043|10789802|FG002|NOT COMPLETED|Overall Study||9
9689596|NCT02970981|10789814|FG000|STARTED|Overall Study||16
9689597|NCT02970981|10789814|FG000|COMPLETED|Overall Study||16
9689598|NCT02970981|10789814|FG000|NOT COMPLETED|Overall Study||0
9689599|NCT02946853|10789820|FG000|STARTED|Overall Study||13
9689600|NCT02946853|10789821|FG001|STARTED|Overall Study||13
9689601|NCT02946853|10789820|FG000|COMPLETED|Overall Study||12
9961223|NCT01472757|11080970|FG003|COMPLETED|Overall Study||75
9961224|NCT01472757|11080967|FG000|NOT COMPLETED|Overall Study||30
9961225|NCT01472757|11080968|FG001|NOT COMPLETED|Overall Study||13
9961226|NCT01472757|11080969|FG002|NOT COMPLETED|Overall Study||19
9961227|NCT01472757|11080970|FG003|NOT COMPLETED|Overall Study||19
9689602|NCT02946853|10789821|FG001|COMPLETED|Overall Study||13
9961228|NCT01472822|11080982|FG000|STARTED|Overall Study||30
9689603|NCT02946853|10789820|FG000|NOT COMPLETED|Overall Study||1
9689604|NCT02946853|10789821|FG001|NOT COMPLETED|Overall Study||0
9961229|NCT01472822|11080983|FG001|STARTED|Overall Study||30
9961230|NCT01472822|11080982|FG000|COMPLETED|Overall Study||28
9961231|NCT01472822|11080983|FG001|COMPLETED|Overall Study||28
9961232|NCT01472822|11080982|FG000|NOT COMPLETED|Overall Study||2
9689605|NCT02905032|10789830|FG000|STARTED|Overall Study||467
9689606|NCT02905032|10789831|FG001|STARTED|Overall Study||475
9689607|NCT02905032|10789832|FG002|STARTED|Overall Study||244
9689608|NCT02905032|10789830|FG000|COMPLETED|Overall Study||459
9689609|NCT02905032|10789831|FG001|COMPLETED|Overall Study||463
9689610|NCT02905032|10789832|FG002|COMPLETED|Overall Study||244
9689611|NCT02905032|10789830|FG000|NOT COMPLETED|Overall Study||8
9689612|NCT02905032|10789831|FG001|NOT COMPLETED|Overall Study||12
9689613|NCT02905032|10789832|FG002|NOT COMPLETED|Overall Study||0
9689614|NCT02837029|10789842|FG000|STARTED|Screening||15
9689615|NCT02837029|10789843|FG001|STARTED|Screening||12
9689616|NCT02837029|10789844|FG002|STARTED|Screening||0
9689617|NCT02837029|10789842|FG000|COMPLETED|Screening||8
9689618|NCT02837029|10789843|FG001|COMPLETED|Screening||9
9689619|NCT02837029|10789844|FG002|COMPLETED|Screening||0
9689620|NCT02837029|10789842|FG000|NOT COMPLETED|Screening||7
9689621|NCT02837029|10789843|FG001|NOT COMPLETED|Screening||3
10024027|NCT01859403|11147755|FG001|COMPLETED|Secondary Endpoint Measure||18
10024028|NCT01859403|11147754|FG000|NOT COMPLETED|Secondary Endpoint Measure||6
10024029|NCT01859403|11147755|FG001|NOT COMPLETED|Secondary Endpoint Measure||8
10024030|NCT01859494|11147761|FG000|STARTED|Overall Study||219
10024031|NCT01859494|11147761|FG000|COMPLETED|Overall Study||218
10024032|NCT01859494|11147761|FG000|NOT COMPLETED|Overall Study||1
9689622|NCT02837029|10789844|FG002|NOT COMPLETED|Screening||0
10024033|NCT01859507|11147765|FG000|STARTED|Overall Study||32
10024034|NCT01859507|11147765|FG000|COMPLETED|Overall Study||28
10024035|NCT01859507|11147765|FG000|NOT COMPLETED|Overall Study||4
10024036|NCT01859598|11147770|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
10024037|NCT01859598|11147770|FG000|COMPLETED|Visit 2 at 3 Months||17253
10024038|NCT01859598|11147770|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742
10024039|NCT01859598|11147770|FG000|STARTED|Visit 3 at 6 Months||17253
10024040|NCT01859598|11147770|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
9689623|NCT02837029|10789842|FG000|STARTED|Induction Treatment With Y90||8
9689624|NCT02837029|10789843|FG001|STARTED|Induction Treatment With Y90||9
9689625|NCT02837029|10789844|FG002|STARTED|Induction Treatment With Y90||0
9689626|NCT02837029|10789842|FG000|COMPLETED|Induction Treatment With Y90||8
9689627|NCT02837029|10789843|FG001|COMPLETED|Induction Treatment With Y90||9
9689628|NCT02837029|10789844|FG002|COMPLETED|Induction Treatment With Y90||0
9689629|NCT02837029|10789842|FG000|NOT COMPLETED|Induction Treatment With Y90||0
10024041|NCT01859598|11147770|FG000|NOT COMPLETED|Visit 3 at 6 Months||912
10024042|NCT01859611|11147776|FG000|STARTED|Overall Study||51
10024043|NCT01859611|11147776|FG000|COMPLETED|Overall Study||43
10024044|NCT01859611|11147776|FG000|NOT COMPLETED|Overall Study||8
10024045|NCT01859637|11147780|FG000|STARTED|Overall Study||6
10024046|NCT01859637|11147780|FG000|COMPLETED|Overall Study||6
10024047|NCT01859637|11147780|FG000|NOT COMPLETED|Overall Study||0
10024048|NCT01859702|11147784|FG000|STARTED|Overall Study||36
10024049|NCT01859702|11147784|FG000|COMPLETED|Overall Study||31
10024050|NCT01859702|11147784|FG000|NOT COMPLETED|Overall Study||5
10024051|NCT01859715|11147791|FG000|STARTED|Overall Study||141
10024052|NCT01859715|11147792|FG001|STARTED|Overall Study||91
10024053|NCT01859715|11147793|FG002|STARTED|Overall Study||116
10024054|NCT01859715|11147791|FG000|COMPLETED|Overall Study||125
10024055|NCT01859715|11147792|FG001|COMPLETED|Overall Study||83
10024056|NCT01859715|11147793|FG002|COMPLETED|Overall Study||93
10024057|NCT01859715|11147791|FG000|NOT COMPLETED|Overall Study||16
10024058|NCT01859715|11147792|FG001|NOT COMPLETED|Overall Study||8
10024059|NCT01859715|11147793|FG002|NOT COMPLETED|Overall Study||23
10081191|NCT02258412|11209669|FG002|COMPLETED|Overall Study||61
10081192|NCT02258412|11209667|FG000|NOT COMPLETED|Overall Study||0
10081193|NCT02258412|11209668|FG001|NOT COMPLETED|Overall Study||0
10081194|NCT02258412|11209669|FG002|NOT COMPLETED|Overall Study||0
10081195|NCT02258464|11209678|FG000|STARTED|Overall Study||49
10081196|NCT02258464|11209679|FG001|STARTED|Overall Study||50
10081197|NCT02258464|11209678|FG000|COMPLETED|Overall Study||32
10081198|NCT02258464|11209679|FG001|COMPLETED|Overall Study||25
10081199|NCT02258464|11209678|FG000|NOT COMPLETED|Overall Study||17
10081200|NCT02258464|11209679|FG001|NOT COMPLETED|Overall Study||25
10081201|NCT02258477|11209685|FG000|STARTED|First Intervention (1 Week)||10
10081202|NCT02258477|11209686|FG001|STARTED|First Intervention (1 Week)||9
10081203|NCT02258477|11209687|FG002|STARTED|First Intervention (1 Week)||9
10081204|NCT02258477|11209688|FG003|STARTED|First Intervention (1 Week)||9
9689630|NCT02837029|10789843|FG001|NOT COMPLETED|Induction Treatment With Y90||0
9689631|NCT02837029|10789844|FG002|NOT COMPLETED|Induction Treatment With Y90||0
9689632|NCT02837029|10789842|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8
9689633|NCT02837029|10789843|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9
9689634|NCT02837029|10789844|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0
9689635|NCT02837029|10789842|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
9689636|NCT02837029|10789843|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
9689637|NCT02837029|10789844|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
9689638|NCT02837029|10789842|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
9689639|NCT02837029|10789843|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
9689640|NCT02837029|10789844|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
9689641|NCT02837029|10789842|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
9689642|NCT02837029|10789843|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
9689643|NCT02837029|10789844|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
9689644|NCT02837029|10789842|FG000|STARTED|Cycle 2 and Beyond||6
9689645|NCT02837029|10789843|FG001|STARTED|Cycle 2 and Beyond||6
9689646|NCT02837029|10789844|FG002|STARTED|Cycle 2 and Beyond||0
9689647|NCT02837029|10789842|FG000|COMPLETED|Cycle 2 and Beyond||5
9689648|NCT02837029|10789843|FG001|COMPLETED|Cycle 2 and Beyond||6
9689649|NCT02837029|10789844|FG002|COMPLETED|Cycle 2 and Beyond||0
9689650|NCT02837029|10789842|FG000|NOT COMPLETED|Cycle 2 and Beyond||1
9689651|NCT02837029|10789843|FG001|NOT COMPLETED|Cycle 2 and Beyond||0
9689652|NCT02837029|10789844|FG002|NOT COMPLETED|Cycle 2 and Beyond||0
9689653|NCT02837029|10789842|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
9689654|NCT02837029|10789843|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
9689655|NCT02837029|10789844|FG002|STARTED|2 Year Follow-up||0
9689656|NCT02837029|10789842|FG000|COMPLETED|2 Year Follow-up||0
9689657|NCT02837029|10789843|FG001|COMPLETED|2 Year Follow-up||0
9689658|NCT02837029|10789844|FG002|COMPLETED|2 Year Follow-up||0
9689659|NCT02837029|10789842|FG000|NOT COMPLETED|2 Year Follow-up||6
9689660|NCT02837029|10789843|FG001|NOT COMPLETED|2 Year Follow-up||7
9689661|NCT02837029|10789844|FG002|NOT COMPLETED|2 Year Follow-up||0
9689662|NCT02740127|10789855|FG000|STARTED|Overall Study||24
9689663|NCT02740127|10789856|FG001|STARTED|Overall Study||28
9689664|NCT02740127|10789855|FG000|COMPLETED|Overall Study||24
9689665|NCT02740127|10789856|FG001|COMPLETED|Overall Study||28
9689666|NCT02740127|10789855|FG000|NOT COMPLETED|Overall Study||0
9689667|NCT02740127|10789856|FG001|NOT COMPLETED|Overall Study||0
9689668|NCT02737553|10789864|FG000|STARTED|Overall Study||49
9689669|NCT02737553|10789865|FG001|STARTED|Overall Study||48
9689670|NCT02737553|10789864|FG000|COMPLETED|Overall Study||49
9689671|NCT02737553|10789865|FG001|COMPLETED|Overall Study||48
9689672|NCT02737553|10789864|FG000|NOT COMPLETED|Overall Study||0
9689673|NCT02737553|10789865|FG001|NOT COMPLETED|Overall Study||0
9689674|NCT02737475|10789899|FG000|STARTED|Overall Study||4
9689675|NCT02737475|10789900|FG001|STARTED|Overall Study||4
9689676|NCT02737475|10789901|FG002|STARTED|Overall Study||4
9689677|NCT02737475|10789902|FG003|STARTED|Overall Study||4
10024060|NCT01859741|11147811|FG000|STARTED|Overall Study||3
10024061|NCT01859741|11147812|FG001|STARTED|Overall Study||3
10024062|NCT01859741|11147813|FG002|STARTED|Overall Study||6
10024063|NCT01859741|11147814|FG003|STARTED|Overall Study||3
10024064|NCT01859741|11147815|FG004|STARTED|Overall Study||6
10024065|NCT01859741|11147816|FG005|STARTED|Overall Study||6
10024066|NCT01859741|11147817|FG006|STARTED|Overall Study||72
10024067|NCT01859741|11147818|FG007|STARTED|Overall Study||73
10024068|NCT01859741|11147811|FG000|COMPLETED|Overall Study||0
10024069|NCT01859741|11147812|FG001|COMPLETED|Overall Study||0
10024070|NCT01859741|11147813|FG002|COMPLETED|Overall Study||0
10024071|NCT01859741|11147814|FG003|COMPLETED|Overall Study||0
10024072|NCT01859741|11147815|FG004|COMPLETED|Overall Study||0
10024073|NCT01859741|11147816|FG005|COMPLETED|Overall Study||0
10024074|NCT01859741|11147817|FG006|COMPLETED|Overall Study||2
10024075|NCT01859741|11147818|FG007|COMPLETED|Overall Study||3
10024076|NCT01859741|11147811|FG000|NOT COMPLETED|Overall Study||3
10024077|NCT01859741|11147812|FG001|NOT COMPLETED|Overall Study||3
10024078|NCT01859741|11147813|FG002|NOT COMPLETED|Overall Study||6
10024079|NCT01859741|11147814|FG003|NOT COMPLETED|Overall Study||3
10024080|NCT01859741|11147815|FG004|NOT COMPLETED|Overall Study||6
10024081|NCT01859741|11147816|FG005|NOT COMPLETED|Overall Study||6
10024082|NCT01859741|11147817|FG006|NOT COMPLETED|Overall Study||70
10024083|NCT01859741|11147818|FG007|NOT COMPLETED|Overall Study||70
10024084|NCT01859793|11147838|FG000|STARTED|First Intervention (8 Weeks)||20
10024085|NCT01859793|11147839|FG001|STARTED|First Intervention (8 Weeks)||18
9689678|NCT02737475|10789903|FG004|STARTED|Overall Study||4
9689679|NCT02737475|10789904|FG005|STARTED|Overall Study||7
9689680|NCT02737475|10789905|FG006|STARTED|Overall Study||8
9689681|NCT02737475|10789906|FG007|STARTED|Overall Study||12
10024086|NCT01859793|11147838|FG000|COMPLETED|First Intervention (8 Weeks)||15
10024087|NCT01859793|11147839|FG001|COMPLETED|First Intervention (8 Weeks)||17
10024088|NCT01859793|11147838|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5
10024089|NCT01859793|11147839|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
10024090|NCT01859793|11147838|FG000|STARTED|Washout Period (4 Weeks)||15
10024091|NCT01859793|11147839|FG001|STARTED|Washout Period (4 Weeks)||17
10024092|NCT01859793|11147838|FG000|COMPLETED|Washout Period (4 Weeks)||14
10024093|NCT01859793|11147839|FG001|COMPLETED|Washout Period (4 Weeks)||16
10024094|NCT01859793|11147838|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1
10024095|NCT01859793|11147839|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1
10024096|NCT01859793|11147838|FG000|STARTED|2nd Intervention Period||14
10024097|NCT01859793|11147839|FG001|STARTED|2nd Intervention Period||16
10024098|NCT01859793|11147838|FG000|COMPLETED|2nd Intervention Period||14
10024099|NCT01859793|11147839|FG001|COMPLETED|2nd Intervention Period||16
10024100|NCT01859793|11147838|FG000|NOT COMPLETED|2nd Intervention Period||0
10024101|NCT01859793|11147839|FG001|NOT COMPLETED|2nd Intervention Period||0
10024102|NCT01859923|11147849|FG000|STARTED|Overall Study||7
10024103|NCT01859923|11147850|FG001|STARTED|Overall Study||6
10024104|NCT01859923|11147851|FG002|STARTED|Overall Study||12
10024105|NCT01859923|11147852|FG003|STARTED|Overall Study||12
10024106|NCT01859923|11147849|FG000|COMPLETED|Overall Study||7
10024107|NCT01859923|11147850|FG001|COMPLETED|Overall Study||6
10024108|NCT01859923|11147851|FG002|COMPLETED|Overall Study||11
10024109|NCT01859923|11147852|FG003|COMPLETED|Overall Study||11
10024110|NCT01859923|11147849|FG000|NOT COMPLETED|Overall Study||0
9689682|NCT02737475|10789907|FG008|STARTED|Overall Study||8
9689683|NCT02737475|10789908|FG009|STARTED|Overall Study||8
9689684|NCT02737475|10789909|FG010|STARTED|Overall Study||4
9689685|NCT02737475|10789910|FG011|STARTED|Overall Study||10
9689686|NCT02737475|10789911|FG012|STARTED|Overall Study||7
9689687|NCT02737475|10789912|FG013|STARTED|Overall Study||8
9689688|NCT02737475|10789913|FG014|STARTED|Overall Study||6
9689689|NCT02737475|10789914|FG015|STARTED|Overall Study||18
9689690|NCT02737475|10789915|FG016|STARTED|Overall Study||12
9689691|NCT02737475|10789916|FG017|STARTED|Overall Study||6
9689692|NCT02737475|10789917|FG018|STARTED|Overall Study||7
10024111|NCT01859923|11147850|FG001|NOT COMPLETED|Overall Study||0
10024112|NCT01859923|11147851|FG002|NOT COMPLETED|Overall Study||1
10024113|NCT01859923|11147852|FG003|NOT COMPLETED|Overall Study||1
10024114|NCT01859949|11147867|FG000|STARTED|Overall Study|Treated participants|29
9689693|NCT02737475|10789918|FG019|STARTED|Overall Study||1
9689694|NCT02737475|10789919|FG020|STARTED|Overall Study||6
9689695|NCT02737475|10789920|FG021|STARTED|Overall Study||9
9689696|NCT02737475|10789921|FG022|STARTED|Overall Study||2
9689697|NCT02737475|10789922|FG023|STARTED|Overall Study||2
9689698|NCT02737475|10789923|FG024|STARTED|Overall Study||2
9689699|NCT02737475|10789924|FG025|STARTED|Overall Study||2
9689700|NCT02737475|10789925|FG026|STARTED|Overall Study||1
9689701|NCT02737475|10789899|FG000|COMPLETED|Overall Study||3
9689702|NCT02737475|10789900|FG001|COMPLETED|Overall Study||4
9689703|NCT02737475|10789901|FG002|COMPLETED|Overall Study||4
9689704|NCT02737475|10789902|FG003|COMPLETED|Overall Study||3
9689705|NCT02737475|10789903|FG004|COMPLETED|Overall Study||3
9689706|NCT02737475|10789904|FG005|COMPLETED|Overall Study||4
9689707|NCT02737475|10789905|FG006|COMPLETED|Overall Study||8
9689708|NCT02737475|10789906|FG007|COMPLETED|Overall Study||10
9689709|NCT02737475|10789907|FG008|COMPLETED|Overall Study||7
9689710|NCT02737475|10789908|FG009|COMPLETED|Overall Study||8
9689711|NCT02737475|10789909|FG010|COMPLETED|Overall Study||3
10024115|NCT01859949|11147868|FG001|STARTED|Overall Study|Treated participants|32
9689712|NCT02737475|10789910|FG011|COMPLETED|Overall Study||6
9689713|NCT02737475|10789911|FG012|COMPLETED|Overall Study||5
9689714|NCT02737475|10789912|FG013|COMPLETED|Overall Study||6
9689715|NCT02737475|10789913|FG014|COMPLETED|Overall Study||5
9689716|NCT02737475|10789914|FG015|COMPLETED|Overall Study||15
9689717|NCT02737475|10789915|FG016|COMPLETED|Overall Study||10
9689718|NCT02737475|10789916|FG017|COMPLETED|Overall Study||2
9689719|NCT02737475|10789917|FG018|COMPLETED|Overall Study||5
9689720|NCT02737475|10789918|FG019|COMPLETED|Overall Study||1
9689721|NCT02737475|10789919|FG020|COMPLETED|Overall Study||4
9689722|NCT02737475|10789920|FG021|COMPLETED|Overall Study||8
9689723|NCT02737475|10789921|FG022|COMPLETED|Overall Study||2
9689724|NCT02737475|10789922|FG023|COMPLETED|Overall Study||1
9689725|NCT02737475|10789923|FG024|COMPLETED|Overall Study||1
9689726|NCT02737475|10789924|FG025|COMPLETED|Overall Study||1
9689727|NCT02737475|10789925|FG026|COMPLETED|Overall Study||0
9689728|NCT02737475|10789899|FG000|NOT COMPLETED|Overall Study||1
9689729|NCT02737475|10789900|FG001|NOT COMPLETED|Overall Study||0
9689730|NCT02737475|10789901|FG002|NOT COMPLETED|Overall Study||0
9689731|NCT02737475|10789902|FG003|NOT COMPLETED|Overall Study||1
9689732|NCT02737475|10789903|FG004|NOT COMPLETED|Overall Study||1
9689733|NCT02737475|10789904|FG005|NOT COMPLETED|Overall Study||3
9689734|NCT02737475|10789905|FG006|NOT COMPLETED|Overall Study||0
9689735|NCT02737475|10789906|FG007|NOT COMPLETED|Overall Study||2
9689736|NCT02737475|10789907|FG008|NOT COMPLETED|Overall Study||1
9689737|NCT02737475|10789908|FG009|NOT COMPLETED|Overall Study||0
9689738|NCT02737475|10789909|FG010|NOT COMPLETED|Overall Study||1
9689739|NCT02737475|10789910|FG011|NOT COMPLETED|Overall Study||4
9689740|NCT02737475|10789911|FG012|NOT COMPLETED|Overall Study||2
9689741|NCT02737475|10789912|FG013|NOT COMPLETED|Overall Study||2
9689742|NCT02737475|10789913|FG014|NOT COMPLETED|Overall Study||1
9689743|NCT02737475|10789914|FG015|NOT COMPLETED|Overall Study||3
9689744|NCT02737475|10789915|FG016|NOT COMPLETED|Overall Study||2
9689745|NCT02737475|10789916|FG017|NOT COMPLETED|Overall Study||4
9689746|NCT02737475|10789917|FG018|NOT COMPLETED|Overall Study||2
9689747|NCT02737475|10789918|FG019|NOT COMPLETED|Overall Study||0
9689748|NCT02737475|10789919|FG020|NOT COMPLETED|Overall Study||2
9689749|NCT02737475|10789920|FG021|NOT COMPLETED|Overall Study||1
9689750|NCT02737475|10789921|FG022|NOT COMPLETED|Overall Study||0
9689751|NCT02737475|10789922|FG023|NOT COMPLETED|Overall Study||1
9689752|NCT02737475|10789923|FG024|NOT COMPLETED|Overall Study||1
9689753|NCT02737475|10789924|FG025|NOT COMPLETED|Overall Study||1
9689754|NCT02737475|10789925|FG026|NOT COMPLETED|Overall Study||1
9689755|NCT02703714|10790013|FG000|STARTED|Overall Study||42
9689756|NCT02703714|10790013|FG000|COMPLETED|Overall Study||42
9689757|NCT02703714|10790013|FG000|NOT COMPLETED|Overall Study||0
9689758|NCT02642965|10790017|FG000|STARTED|Overall Study||38
9689759|NCT02642965|10790017|FG000|COMPLETED|Overall Study||25
9689760|NCT02642965|10790017|FG000|NOT COMPLETED|Overall Study||13
9726373|NCT00100048|10825892|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
9726374|NCT00100048|10825893|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
9726375|NCT00100048|10825894|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
9726376|NCT00100048|10825895|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
9726377|NCT00100048|10825890|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
9726378|NCT00100048|10825891|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
9726379|NCT00100048|10825892|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
9726380|NCT00100048|10825893|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
9726381|NCT00100048|10825894|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
9726382|NCT00100048|10825895|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
9726383|NCT00100048|10825890|FG000|Treated|Cohort I & II-Combination Therapy Phase||39
9726384|NCT00100048|10825891|FG001|Treated|Cohort I & II-Combination Therapy Phase||40
9726385|NCT00100048|10825892|FG002|Treated|Cohort I & II-Combination Therapy Phase||41
9726386|NCT00100048|10825893|FG003|Treated|Cohort I & II-Combination Therapy Phase||40
9726387|NCT00100048|10825894|FG004|Treated|Cohort I & II-Combination Therapy Phase||0
9726388|NCT00100048|10825895|FG005|Treated|Cohort I & II-Combination Therapy Phase||38
9726389|NCT00100048|10825890|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
9726390|NCT00100048|10825891|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0
9726391|NCT00100048|10825892|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0
9726392|NCT00100048|10825893|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0
9726393|NCT00100048|10825894|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0
9726394|NCT00100048|10825895|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
9726395|NCT00100048|10825890|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27
9726396|NCT00100048|10825891|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31
9726397|NCT00100048|10825892|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28
9689761|NCT02629159|10790024|FG000|STARTED|Overall Study||651
9689762|NCT02629159|10790025|FG001|STARTED|Overall Study||327
9689763|NCT02629159|10790026|FG002|STARTED|Overall Study||651
9689764|NCT02629159|10790024|FG000|Received Assigned Study Drug|Overall Study||651
9689765|NCT02629159|10790025|FG001|Received Assigned Study Drug|Overall Study||327
9689766|NCT02629159|10790026|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
9689767|NCT02629159|10790024|FG000|Completed Week 14 on Study Drug|Overall Study||620
9689768|NCT02629159|10790025|FG001|Completed Week 14 on Study Drug|Overall Study||300
9689769|NCT02629159|10790026|FG002|Completed Week 14 on Study Drug|Overall Study||620
9689770|NCT02629159|10790024|FG000|Rescued at Week 14|Overall Study||231
9689771|NCT02629159|10790025|FG001|Rescued at Week 14|Overall Study||56
9689772|NCT02629159|10790026|FG002|Rescued at Week 14|Overall Study||78
9689773|NCT02629159|10790024|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
9689774|NCT02629159|10790025|FG001|Rescued at Week 18|Overall Study||14
9689775|NCT02629159|10790026|FG002|Rescued at Week 18|Overall Study||29
9689776|NCT02629159|10790024|FG000|Rescued at Week 22|Overall Study||26
9689777|NCT02629159|10790025|FG001|Rescued at Week 22|Overall Study||7
9689778|NCT02629159|10790026|FG002|Rescued at Week 22|Overall Study||18
9689779|NCT02629159|10790024|FG000|COMPLETED|Overall Study||595
9689780|NCT02629159|10790025|FG001|COMPLETED|Overall Study||288
9689781|NCT02629159|10790026|FG002|COMPLETED|Overall Study||600
9689782|NCT02629159|10790024|FG000|NOT COMPLETED|Overall Study||56
9689783|NCT02629159|10790025|FG001|NOT COMPLETED|Overall Study||39
9689784|NCT02629159|10790026|FG002|NOT COMPLETED|Overall Study||51
9689785|NCT02604433|10790039|FG000|STARTED|Overall Study||224
9689786|NCT02604433|10790040|FG001|STARTED|Overall Study||112
9689787|NCT02604433|10790039|FG000|Participants Treated|Overall Study||223
9689788|NCT02604433|10790040|FG001|Participants Treated|Overall Study||109
9689789|NCT02604433|10790039|FG000|Completed 24 Weeks of Treatment|Overall Study||211
9689790|NCT02604433|10790040|FG001|Completed 24 Weeks of Treatment|Overall Study||102
9689791|NCT02604433|10790039|FG000|Completed 48 Weeks of Treatment|Overall Study||202
9689792|NCT02604433|10790040|FG001|Completed 48 Weeks of Treatment|Overall Study||96
9689793|NCT02604433|10790039|FG000|Completed 96 Weeks of Treatment|Overall Study||155
9689794|NCT02604433|10790040|FG001|Completed 96 Weeks of Treatment|Overall Study||3
9689795|NCT02604433|10790039|FG000|Completed 144 Weeks of Treatment|Overall Study||125
9689796|NCT02604433|10790040|FG001|Completed 144 Weeks of Treatment|Overall Study||0
9689797|NCT02604433|10790039|FG000|Completed 192 Weeks of Treatment|Overall Study||6
9689798|NCT02604433|10790040|FG001|Completed 192 Weeks of Treatment|Overall Study||0
9689799|NCT02604433|10790039|FG000|COMPLETED|Overall Study||6
9689800|NCT02604433|10790040|FG001|COMPLETED|Overall Study||6
9689801|NCT02604433|10790039|FG000|NOT COMPLETED|Overall Study||218
9689802|NCT02604433|10790040|FG001|NOT COMPLETED|Overall Study||106
9689803|NCT02519738|10790049|FG000|STARTED|Overall Study||20
9689804|NCT02519738|10790050|FG001|STARTED|Overall Study||17
9689805|NCT02519738|10790051|FG002|STARTED|Overall Study||15
9689806|NCT02519738|10790049|FG000|COMPLETED|Overall Study||6
9689807|NCT02519738|10790050|FG001|COMPLETED|Overall Study||4
9689808|NCT02519738|10790051|FG002|COMPLETED|Overall Study||3
9689809|NCT02519738|10790049|FG000|NOT COMPLETED|Overall Study||14
9689810|NCT02519738|10790050|FG001|NOT COMPLETED|Overall Study||13
9689811|NCT02519738|10790051|FG002|NOT COMPLETED|Overall Study||12
9689812|NCT02502071|10790059|FG000|STARTED|Overall Study||45
9689813|NCT02502071|10790059|FG000|COMPLETED|Overall Study||45
9689814|NCT02502071|10790059|FG000|NOT COMPLETED|Overall Study||0
9689815|NCT02420821|10790065|FG000|STARTED|Overall Study||461
9689816|NCT02420821|10790066|FG001|STARTED|Overall Study||454
9689817|NCT02420821|10790065|FG000|COMPLETED|Overall Study||293
9689818|NCT02420821|10790066|FG001|COMPLETED|Overall Study||317
9689819|NCT02420821|10790065|FG000|NOT COMPLETED|Overall Study||168
9689820|NCT02420821|10790066|FG001|NOT COMPLETED|Overall Study||137
9689821|NCT02412670|10790075|FG000|STARTED|Overall Study||30
9689822|NCT02412670|10790076|FG001|STARTED|Overall Study||6
9689823|NCT02412670|10790075|FG000|Eligible and Treated|Overall Study||29
9689824|NCT02412670|10790076|FG001|Eligible and Treated|Overall Study||6
9689825|NCT02412670|10790075|FG000|COMPLETED|Overall Study||23
9689826|NCT02412670|10790076|FG001|COMPLETED|Overall Study||5
9689827|NCT02412670|10790075|FG000|NOT COMPLETED|Overall Study||7
10024116|NCT01859949|11147867|FG000|COMPLETED|Overall Study||15
9689828|NCT02412670|10790076|FG001|NOT COMPLETED|Overall Study||1
9689829|NCT02410343|10790084|FG000|STARTED|Core Period (24 Weeks)||6
9689830|NCT02410343|10790085|FG001|STARTED|Core Period (24 Weeks)||8
9689831|NCT02410343|10790084|FG000|COMPLETED|Core Period (24 Weeks)||1
9689832|NCT02410343|10790085|FG001|COMPLETED|Core Period (24 Weeks)||1
10024117|NCT01859949|11147868|FG001|COMPLETED|Overall Study||15
9689833|NCT02410343|10790084|FG000|NOT COMPLETED|Core Period (24 Weeks)||5
9689834|NCT02410343|10790085|FG001|NOT COMPLETED|Core Period (24 Weeks)||7
9689835|NCT02410343|10790084|FG000|STARTED|Extension Period (12 Months)||1
9689836|NCT02410343|10790085|FG001|STARTED|Extension Period (12 Months)||1
9689837|NCT02410343|10790084|FG000|COMPLETED|Extension Period (12 Months)||0
9689838|NCT02410343|10790085|FG001|COMPLETED|Extension Period (12 Months)||0
9689839|NCT02410343|10790084|FG000|NOT COMPLETED|Extension Period (12 Months)||1
9689840|NCT02410343|10790085|FG001|NOT COMPLETED|Extension Period (12 Months)||1
9689841|NCT02343224|10790092|FG000|STARTED|Overall Study||9
9689842|NCT02343224|10790092|FG000|COMPLETED|Overall Study||0
9689843|NCT02343224|10790092|FG000|NOT COMPLETED|Overall Study||9
9689844|NCT02339740|10790098|FG000|STARTED|Overall Study||101
9689845|NCT02339740|10790099|FG001|STARTED|Overall Study||57
9689846|NCT02339740|10790098|FG000|COMPLETED|Overall Study||92
9689847|NCT02339740|10790099|FG001|COMPLETED|Overall Study||53
9689848|NCT02339740|10790098|FG000|NOT COMPLETED|Overall Study||9
9689849|NCT02339740|10790099|FG001|NOT COMPLETED|Overall Study||4
9689850|NCT02291445|10790107|FG000|STARTED|Overall Study||4
9689851|NCT02291445|10790108|FG001|STARTED|Overall Study||4
9689852|NCT02291445|10790107|FG000|COMPLETED|Overall Study||4
9689853|NCT02291445|10790108|FG001|COMPLETED|Overall Study||4
9689854|NCT02291445|10790107|FG000|NOT COMPLETED|Overall Study||0
9689855|NCT02291445|10790108|FG001|NOT COMPLETED|Overall Study||0
10024118|NCT01859949|11147867|FG000|NOT COMPLETED|Overall Study||14
10024119|NCT01859949|11147868|FG001|NOT COMPLETED|Overall Study||17
9689856|NCT02248688|10790116|FG000|STARTED|Overall Study||5
9689857|NCT02248688|10790116|FG000|COMPLETED|Overall Study||5
9689858|NCT02248688|10790116|FG000|NOT COMPLETED|Overall Study||0
9689859|NCT02045303|10790122|FG000|STARTED|Overall Study||6
9689860|NCT02045303|10790123|FG001|STARTED|Overall Study||3
9689861|NCT02045303|10790124|FG002|STARTED|Overall Study||2
9689862|NCT02045303|10790122|FG000|COMPLETED|Overall Study||4
9689863|NCT02045303|10790123|FG001|COMPLETED|Overall Study||0
9689864|NCT02045303|10790124|FG002|COMPLETED|Overall Study||2
9689865|NCT02045303|10790122|FG000|NOT COMPLETED|Overall Study||2
9689866|NCT02045303|10790123|FG001|NOT COMPLETED|Overall Study||3
9689867|NCT02045303|10790124|FG002|NOT COMPLETED|Overall Study||0
9689868|NCT02025556|10790136|FG000|STARTED|Overall Study||104
9689869|NCT02025556|10790137|FG001|STARTED|Overall Study||96
9689870|NCT02025556|10790138|FG002|STARTED|Overall Study||97
9689871|NCT02025556|10790136|FG000|Safety Analysis Set|Overall Study||104
9689872|NCT02025556|10790137|FG001|Safety Analysis Set|Overall Study||96
9689873|NCT02025556|10790138|FG002|Safety Analysis Set|Overall Study||96
9689874|NCT02025556|10790136|FG000|Intent-to-treat (ITT) Set|Overall Study||104
9689875|NCT02025556|10790137|FG001|Intent-to-treat (ITT) Set|Overall Study||95
9689876|NCT02025556|10790138|FG002|Intent-to-treat (ITT) Set|Overall Study||96
9689877|NCT02025556|10790136|FG000|COMPLETED|Overall Study||98
9689878|NCT02025556|10790137|FG001|COMPLETED|Overall Study||83
9689879|NCT02025556|10790138|FG002|COMPLETED|Overall Study||88
10024120|NCT01859988|11147880|FG000|STARTED|Overall Study||63
9689880|NCT02025556|10790136|FG000|NOT COMPLETED|Overall Study||6
9689881|NCT02025556|10790137|FG001|NOT COMPLETED|Overall Study||13
9689882|NCT02025556|10790138|FG002|NOT COMPLETED|Overall Study||9
9689883|NCT01986933|10790151|FG000|STARTED|Placebo-controlled (Part A)||53
9689884|NCT01986933|10790152|FG001|STARTED|Placebo-controlled (Part A)||53
9689885|NCT01986933|10790153|FG002|STARTED|Placebo-controlled (Part A)||54
9689886|NCT01986933|10790154|FG003|STARTED|Placebo-controlled (Part A)||52
9689887|NCT01986933|10790155|FG004|STARTED|Placebo-controlled (Part A)||52
9689888|NCT01986933|10790151|FG000|COMPLETED|Placebo-controlled (Part A)||44
9689889|NCT01986933|10790152|FG001|COMPLETED|Placebo-controlled (Part A)||44
9689890|NCT01986933|10790153|FG002|COMPLETED|Placebo-controlled (Part A)||45
9689891|NCT01986933|10790154|FG003|COMPLETED|Placebo-controlled (Part A)||45
9689892|NCT01986933|10790155|FG004|COMPLETED|Placebo-controlled (Part A)||38
9689893|NCT01986933|10790151|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9
9689894|NCT01986933|10790152|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9
9689895|NCT01986933|10790153|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9
9689896|NCT01986933|10790154|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7
9689897|NCT01986933|10790155|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14
9689898|NCT01986933|10790151|FG000|STARTED|Active-to-active (Part B)||0
9689899|NCT01986933|10790152|FG001|STARTED|Active-to-active (Part B)||41
9689900|NCT01986933|10790153|FG002|STARTED|Active-to-active (Part B)||38
9689901|NCT01986933|10790154|FG003|STARTED|Active-to-active (Part B)||39
9689902|NCT01986933|10790155|FG004|STARTED|Active-to-active (Part B)||35
9689903|NCT01986933|10790151|FG000|COMPLETED|Active-to-active (Part B)||0
9689904|NCT01986933|10790152|FG001|COMPLETED|Active-to-active (Part B)||31
9689905|NCT01986933|10790153|FG002|COMPLETED|Active-to-active (Part B)||28
9689906|NCT01986933|10790154|FG003|COMPLETED|Active-to-active (Part B)||30
9689907|NCT01986933|10790155|FG004|COMPLETED|Active-to-active (Part B)||19
9689908|NCT01986933|10790151|FG000|NOT COMPLETED|Active-to-active (Part B)||0
9689909|NCT01986933|10790152|FG001|NOT COMPLETED|Active-to-active (Part B)||10
9689910|NCT01986933|10790153|FG002|NOT COMPLETED|Active-to-active (Part B)||10
9689911|NCT01986933|10790154|FG003|NOT COMPLETED|Active-to-active (Part B)||9
9689912|NCT01986933|10790155|FG004|NOT COMPLETED|Active-to-active (Part B)||16
9689913|NCT01986933|10790151|FG000|STARTED|Placebo-to-active (Part B)||0
9689914|NCT01986933|10790152|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
9689915|NCT01986933|10790153|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12
9689916|NCT01986933|10790154|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
9689917|NCT01986933|10790155|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0
9689918|NCT01986933|10790151|FG000|COMPLETED|Placebo-to-active (Part B)||0
9689919|NCT01986933|10790152|FG001|COMPLETED|Placebo-to-active (Part B)||8
9689920|NCT01986933|10790153|FG002|COMPLETED|Placebo-to-active (Part B)||7
9689921|NCT01986933|10790154|FG003|COMPLETED|Placebo-to-active (Part B)||8
9689922|NCT01986933|10790155|FG004|COMPLETED|Placebo-to-active (Part B)||0
9689923|NCT01986933|10790151|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0
9689924|NCT01986933|10790152|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5
9689925|NCT01986933|10790153|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5
9689926|NCT01986933|10790154|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5
9689927|NCT01986933|10790155|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0
9689928|NCT01986075|10790177|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0
9689929|NCT01986075|10790178|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0
9689930|NCT01986075|10790179|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145
9689931|NCT01986075|10790177|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0
9689932|NCT01986075|10790178|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0
9689933|NCT01986075|10790179|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86
9689934|NCT01986075|10790177|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
9689935|NCT01986075|10790178|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
9689936|NCT01986075|10790179|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59
9689937|NCT01986075|10790177|FG000|STARTED|Randomized Intervention||45
9689938|NCT01986075|10790178|FG001|STARTED|Randomized Intervention||41
10024121|NCT01859988|11147881|FG001|STARTED|Overall Study||64
10024122|NCT01859988|11147882|FG002|STARTED|Overall Study||62
10024123|NCT01859988|11147883|FG003|STARTED|Overall Study||65
10024124|NCT01859988|11147884|FG004|STARTED|Overall Study||65
10024125|NCT01859988|11147885|FG005|STARTED|Overall Study||61
9689939|NCT01986075|10790179|FG002|STARTED|Randomized Intervention||0
9689940|NCT01986075|10790177|FG000|COMPLETED|Randomized Intervention||30
9689941|NCT01986075|10790178|FG001|COMPLETED|Randomized Intervention||27
9689942|NCT01986075|10790179|FG002|COMPLETED|Randomized Intervention||0
10024126|NCT01859988|11147880|FG000|Treated|Overall Study||63
9689943|NCT01986075|10790177|FG000|NOT COMPLETED|Randomized Intervention||15
9689944|NCT01986075|10790178|FG001|NOT COMPLETED|Randomized Intervention||14
9689945|NCT01986075|10790179|FG002|NOT COMPLETED|Randomized Intervention||0
9689946|NCT01841333|10790186|FG000|STARTED|Overall Study||31
9689947|NCT01841333|10790186|FG000|COMPLETED|Overall Study||31
9689948|NCT01841333|10790186|FG000|NOT COMPLETED|Overall Study||0
9689949|NCT01802788|10790192|FG000|STARTED|Overall Study||941
9689950|NCT01802788|10790193|FG001|STARTED|Overall Study||59
9689951|NCT01802788|10790192|FG000|COMPLETED|Overall Study||755
9689952|NCT01802788|10790193|FG001|COMPLETED|Overall Study||59
9689953|NCT01802788|10790192|FG000|NOT COMPLETED|Overall Study||186
10024127|NCT01859988|11147881|FG001|Treated|Overall Study||64
10024128|NCT01859988|11147882|FG002|Treated|Overall Study||61
10024129|NCT01859988|11147883|FG003|Treated|Overall Study||65
9689954|NCT01802788|10790193|FG001|NOT COMPLETED|Overall Study||0
9846543|NCT00848718|10958898|FG012|STARTED|Overall Study||8
9846544|NCT00848718|10958886|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
10024130|NCT01859988|11147884|FG004|Treated|Overall Study||65
9689958|NCT01563107|10790205|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12
9689959|NCT01563107|10790206|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5
9689960|NCT01563107|10790207|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10
9689961|NCT01563107|10790208|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11
9689962|NCT01563107|10790205|FG000|Phase 1 Baseline Labs|Overall Study||12
9689963|NCT01563107|10790206|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
9689964|NCT01563107|10790207|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
9689965|NCT01563107|10790208|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
9689966|NCT01563107|10790205|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
9689967|NCT01563107|10790206|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
9689968|NCT01563107|10790207|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
9689969|NCT01563107|10790208|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
9689970|NCT01563107|10790205|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
9689971|NCT01563107|10790206|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
9689972|NCT01563107|10790207|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
9689973|NCT01563107|10790208|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
9689974|NCT01563107|10790205|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
9689975|NCT01563107|10790206|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.|2
9689976|NCT01563107|10790207|FG002|Phase 1-finish|Overall Study||8
9689977|NCT01563107|10790208|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
9689978|NCT01563107|10790205|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
9689979|NCT01563107|10790206|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
9689980|NCT01563107|10790207|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
9689981|NCT01563107|10790208|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
9689982|NCT01563107|10790205|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
9689983|NCT01563107|10790206|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
10024131|NCT01859988|11147885|FG005|Treated|Overall Study||61
10024132|NCT01859988|11147880|FG000|COMPLETED|Overall Study||52
10024133|NCT01859988|11147881|FG001|COMPLETED|Overall Study||52
10024134|NCT01859988|11147882|FG002|COMPLETED|Overall Study||34
10024135|NCT01859988|11147883|FG003|COMPLETED|Overall Study||55
9689984|NCT01563107|10790207|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
9689985|NCT01563107|10790208|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
9689986|NCT01563107|10790205|FG000|Phase 2-finish|Overall Study||11
9689987|NCT01563107|10790206|FG001|Phase 2-finish|Overall Study||2
9689988|NCT01563107|10790207|FG002|Phase 2-finish|Overall Study||8
9689989|NCT01563107|10790208|FG003|Phase 2-finish|Overall Study||6
9689990|NCT01563107|10790205|FG000|COMPLETED|Overall Study||11
9689991|NCT01563107|10790206|FG001|COMPLETED|Overall Study||2
9689992|NCT01563107|10790207|FG002|COMPLETED|Overall Study||8
9689993|NCT01563107|10790208|FG003|COMPLETED|Overall Study||6
9689994|NCT01563107|10790205|FG000|NOT COMPLETED|Overall Study||1
9689995|NCT01563107|10790206|FG001|NOT COMPLETED|Overall Study||3
9689996|NCT01563107|10790207|FG002|NOT COMPLETED|Overall Study||2
9689997|NCT01563107|10790208|FG003|NOT COMPLETED|Overall Study||5
10024136|NCT01859988|11147884|FG004|COMPLETED|Overall Study||42
10024137|NCT01859988|11147885|FG005|COMPLETED|Overall Study||42
10024138|NCT01859988|11147880|FG000|NOT COMPLETED|Overall Study||11
10024139|NCT01859988|11147881|FG001|NOT COMPLETED|Overall Study||12
10024140|NCT01859988|11147882|FG002|NOT COMPLETED|Overall Study||28
10024141|NCT01859988|11147883|FG003|NOT COMPLETED|Overall Study||10
10024142|NCT01859988|11147884|FG004|NOT COMPLETED|Overall Study||23
10024143|NCT01859988|11147885|FG005|NOT COMPLETED|Overall Study||19
10024144|NCT01860079|11147901|FG000|STARTED|Overall Study||384
10024145|NCT01860079|11147902|FG001|STARTED|Overall Study||385
10024146|NCT01860079|11147901|FG000|COMPLETED|Overall Study||370
10024147|NCT01860079|11147902|FG001|COMPLETED|Overall Study||363
10024148|NCT01860079|11147901|FG000|NOT COMPLETED|Overall Study||14
10024149|NCT01860079|11147902|FG001|NOT COMPLETED|Overall Study||22
9689998|NCT01320072|10790270|FG000|STARTED|Overall Study||16
9689999|NCT01320072|10790271|FG001|STARTED|Overall Study||13
9690000|NCT01320072|10790270|FG000|COMPLETED|Overall Study||16
9690001|NCT01320072|10790271|FG001|COMPLETED|Overall Study||13
9690002|NCT01320072|10790270|FG000|NOT COMPLETED|Overall Study||0
9690003|NCT01320072|10790271|FG001|NOT COMPLETED|Overall Study||0
9690004|NCT01064479|10790280|FG000|STARTED|Overall Study||60
9690005|NCT01064479|10790281|FG001|STARTED|Overall Study||59
9690006|NCT01064479|10790280|FG000|COMPLETED|Overall Study||45
9690007|NCT01064479|10790281|FG001|COMPLETED|Overall Study||42
9690008|NCT01064479|10790280|FG000|NOT COMPLETED|Overall Study||15
9690009|NCT01064479|10790281|FG001|NOT COMPLETED|Overall Study||17
9690010|NCT01042522|10790289|FG000|STARTED|Overall Study||31
9690011|NCT01042522|10790290|FG001|STARTED|Overall Study||32
9690012|NCT01042522|10790289|FG000|COMPLETED|Overall Study|Completed 6 cycles of protocol regimen|23
9690013|NCT01042522|10790290|FG001|COMPLETED|Overall Study|Completed 4 cycles of protocol regimen|26
9690014|NCT01042522|10790289|FG000|NOT COMPLETED|Overall Study||8
9690015|NCT01042522|10790290|FG001|NOT COMPLETED|Overall Study||6
9690016|NCT00944528|10790299|FG000|STARTED|Overall Study||9
9690017|NCT00944528|10790300|FG001|STARTED|Overall Study||10
9690018|NCT00944528|10790301|FG002|STARTED|Overall Study||16
9690019|NCT00944528|10790299|FG000|COMPLETED|Overall Study||8
9690020|NCT00944528|10790300|FG001|COMPLETED|Overall Study||8
9690021|NCT00944528|10790301|FG002|COMPLETED|Overall Study||16
9690022|NCT00944528|10790299|FG000|NOT COMPLETED|Overall Study||1
9690023|NCT00944528|10790300|FG001|NOT COMPLETED|Overall Study||2
9690024|NCT00944528|10790301|FG002|NOT COMPLETED|Overall Study||0
9690025|NCT00941915|10790310|FG000|STARTED|Overall Study||60
9690026|NCT00941915|10790310|FG000|COMPLETED|Overall Study||60
9690027|NCT00941915|10790310|FG000|NOT COMPLETED|Overall Study||0
9690028|NCT00826462|10790317|FG000|STARTED|Overall Study||59
9690029|NCT00826462|10790318|FG001|STARTED|Overall Study||58
9690030|NCT00826462|10790319|FG002|STARTED|Overall Study||60
9690031|NCT00826462|10790317|FG000|COMPLETED|Overall Study||52
9690032|NCT00826462|10790318|FG001|COMPLETED|Overall Study||53
9690033|NCT00826462|10790319|FG002|COMPLETED|Overall Study||52
9690034|NCT00826462|10790317|FG000|NOT COMPLETED|Overall Study||7
9690035|NCT00826462|10790318|FG001|NOT COMPLETED|Overall Study||5
9690036|NCT00826462|10790319|FG002|NOT COMPLETED|Overall Study||8
9690037|NCT00710970|10790329|FG000|STARTED|Overall Study||28
9690038|NCT00710970|10790329|FG000|COMPLETED|Overall Study||25
9690039|NCT00710970|10790329|FG000|NOT COMPLETED|Overall Study||3
9690040|NCT00685919|10790337|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8
9690041|NCT00685919|10790338|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9
9690042|NCT00685919|10790339|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8
10024150|NCT01860170|11147911|FG000|STARTED|Overall Study||3
10024151|NCT01860170|11147912|FG001|STARTED|Overall Study||3
9690043|NCT00685919|10790340|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3
9690044|NCT00685919|10790337|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8
9690045|NCT00685919|10790338|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9
9690046|NCT00685919|10790339|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8
9690047|NCT00685919|10790340|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3
9726398|NCT00100048|10825893|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30
9726399|NCT00100048|10825894|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0
9846545|NCT00848718|10958887|FG001|Treated|Overall Study||9
9846546|NCT00848718|10958888|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
9846547|NCT00848718|10958889|FG003|Treated|Overall Study||5
9846548|NCT00848718|10958890|FG004|Treated|Overall Study||6
9846549|NCT00848718|10958891|FG005|Treated|Overall Study||5
9846550|NCT00848718|10958892|FG006|Treated|Overall Study||3
9846551|NCT00848718|10958893|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
9846552|NCT00848718|10958894|FG008|Treated|Overall Study||4
9846553|NCT00848718|10958895|FG009|Treated|Overall Study||9
9846554|NCT00848718|10958896|FG010|Treated|Overall Study||4
9846555|NCT00848718|10958897|FG011|Treated|Overall Study||6
9846556|NCT00848718|10958898|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
9846557|NCT00848718|10958886|FG000|COMPLETED|Overall Study||0
9846558|NCT00848718|10958887|FG001|COMPLETED|Overall Study||0
9846559|NCT00848718|10958888|FG002|COMPLETED|Overall Study||0
9846560|NCT00848718|10958889|FG003|COMPLETED|Overall Study||0
9846561|NCT00848718|10958890|FG004|COMPLETED|Overall Study||0
9846562|NCT00848718|10958891|FG005|COMPLETED|Overall Study||0
9846563|NCT00848718|10958892|FG006|COMPLETED|Overall Study||0
9846564|NCT00848718|10958893|FG007|COMPLETED|Overall Study||0
9846565|NCT00848718|10958894|FG008|COMPLETED|Overall Study||0
9961233|NCT01472822|11080983|FG001|NOT COMPLETED|Overall Study||2
9846566|NCT00848718|10958895|FG009|COMPLETED|Overall Study||0
9846567|NCT00848718|10958896|FG010|COMPLETED|Overall Study||0
9846568|NCT00848718|10958897|FG011|COMPLETED|Overall Study||0
9846569|NCT00848718|10958898|FG012|COMPLETED|Overall Study||0
9846570|NCT00848718|10958886|FG000|NOT COMPLETED|Overall Study||7
9846571|NCT00848718|10958887|FG001|NOT COMPLETED|Overall Study||9
9846572|NCT00848718|10958888|FG002|NOT COMPLETED|Overall Study||6
9846573|NCT00848718|10958889|FG003|NOT COMPLETED|Overall Study||5
9846574|NCT00848718|10958890|FG004|NOT COMPLETED|Overall Study||6
9846575|NCT00848718|10958891|FG005|NOT COMPLETED|Overall Study||5
9846576|NCT00848718|10958892|FG006|NOT COMPLETED|Overall Study||3
9846577|NCT00848718|10958893|FG007|NOT COMPLETED|Overall Study||5
9846578|NCT00848718|10958894|FG008|NOT COMPLETED|Overall Study||4
9846579|NCT00848718|10958895|FG009|NOT COMPLETED|Overall Study||9
9846580|NCT00848718|10958896|FG010|NOT COMPLETED|Overall Study||4
9846581|NCT00848718|10958897|FG011|NOT COMPLETED|Overall Study||6
9846582|NCT00848718|10958898|FG012|NOT COMPLETED|Overall Study||8
9961234|NCT01472835|11080991|FG000|STARTED|Overall Study||37
9690048|NCT00685919|10790337|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
9690049|NCT00685919|10790338|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
9690050|NCT00685919|10790339|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8
9690051|NCT00685919|10790340|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
9690052|NCT00685919|10790337|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
9690053|NCT00685919|10790338|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9
9690054|NCT00685919|10790339|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
9731839|NCT00136812|10831806|FG001|STARTED|Overall Study||113
10024152|NCT01860170|11147913|FG002|STARTED|Overall Study||22
10024153|NCT01860170|11147911|FG000|COMPLETED|Overall Study||3
10024154|NCT01860170|11147912|FG001|COMPLETED|Overall Study||3
10024155|NCT01860170|11147913|FG002|COMPLETED|Overall Study||22
10024156|NCT01860170|11147911|FG000|NOT COMPLETED|Overall Study||0
10024157|NCT01860170|11147912|FG001|NOT COMPLETED|Overall Study||0
10024158|NCT01860170|11147913|FG002|NOT COMPLETED|Overall Study||0
10024159|NCT01860287|11147924|FG000|STARTED|Overall Study||18
10024160|NCT01860287|11147925|FG001|STARTED|Overall Study||15
10024161|NCT01860287|11147926|FG002|STARTED|Overall Study||15
10024162|NCT01860287|11147924|FG000|COMPLETED|Overall Study||18
10024163|NCT01860287|11147925|FG001|COMPLETED|Overall Study||15
10024164|NCT01860287|11147926|FG002|COMPLETED|Overall Study||15
10024165|NCT01860287|11147924|FG000|NOT COMPLETED|Overall Study||0
10024166|NCT01860287|11147925|FG001|NOT COMPLETED|Overall Study||0
10024167|NCT01860287|11147926|FG002|NOT COMPLETED|Overall Study||0
10024168|NCT01860521|11147936|FG000|STARTED|Overall Study|September 2011|52
10024169|NCT01860521|11147937|FG001|STARTED|Overall Study|September 2011|52
10024170|NCT01860521|11147936|FG000|COMPLETED|Overall Study|June 2013|52
10024171|NCT01860521|11147937|FG001|COMPLETED|Overall Study|June 2013|52
10024172|NCT01860521|11147936|FG000|NOT COMPLETED|Overall Study||0
10024173|NCT01860521|11147937|FG001|NOT COMPLETED|Overall Study||0
10024174|NCT01860534|11147945|FG000|STARTED|ROP #1||14
10024175|NCT01860534|11147946|FG001|STARTED|ROP #1||14
10024176|NCT01860534|11147945|FG000|COMPLETED|ROP #1||14
10024177|NCT01860534|11147946|FG001|COMPLETED|ROP #1||13
10024178|NCT01860534|11147945|FG000|NOT COMPLETED|ROP #1||0
10024179|NCT01860534|11147946|FG001|NOT COMPLETED|ROP #1||1
10024180|NCT01860534|11147945|FG000|STARTED|ROP #2||14
10024181|NCT01860534|11147946|FG001|STARTED|ROP #2||13
10024182|NCT01860534|11147945|FG000|COMPLETED|ROP #2||13
9690055|NCT00685919|10790340|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3
9690056|NCT00685919|10790337|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
9690057|NCT00685919|10790338|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9
9690058|NCT00685919|10790339|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
9690059|NCT00685919|10790340|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3
9690060|NCT00685919|10790337|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
9690061|NCT00685919|10790338|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
9690062|NCT00685919|10790339|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
9690063|NCT00685919|10790340|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
9690064|NCT00685919|10790337|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
9690065|NCT00685919|10790338|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9
9690066|NCT00685919|10790339|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
9731840|NCT00136812|10831805|FG000|COMPLETED|Overall Study||111
9846583|NCT00848744|10958932|FG000|STARTED|Overall Study||10
9846584|NCT00848744|10958932|FG000|COMPLETED|Overall Study||10
9846585|NCT00848744|10958932|FG000|NOT COMPLETED|Overall Study||0
9846586|NCT00848783|10958940|FG000|STARTED|Overall Study||4
9846587|NCT00848783|10958941|FG001|STARTED|Overall Study||3
9846588|NCT00848783|10958942|FG002|STARTED|Overall Study||1
9846589|NCT00848783|10958940|FG000|COMPLETED|Overall Study||1
9846590|NCT00848783|10958941|FG001|COMPLETED|Overall Study||1
10114343|NCT02515669|11245059|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
10114344|NCT02515669|11245060|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
10114345|NCT02515669|11245061|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
10024183|NCT01860534|11147946|FG001|COMPLETED|ROP #2||13
10024184|NCT01860534|11147945|FG000|NOT COMPLETED|ROP #2||1
10024185|NCT01860534|11147946|FG001|NOT COMPLETED|ROP #2||0
10024186|NCT01860573|11147956|FG000|STARTED|Overall Study||83
10024187|NCT01860573|11147957|FG001|STARTED|Overall Study||85
10114346|NCT02515669|11245062|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
10114347|NCT02515669|11245059|FG000|COMPLETED|228 Week Open-Label Phase||0
10114348|NCT02515669|11245060|FG001|COMPLETED|228 Week Open-Label Phase||0
10114349|NCT02515669|11245061|FG002|COMPLETED|228 Week Open-Label Phase||0
10114350|NCT02515669|11245062|FG003|COMPLETED|228 Week Open-Label Phase||0
10114351|NCT02515669|11245059|FG000|NOT COMPLETED|228 Week Open-Label Phase||0
10024188|NCT01860573|11147956|FG000|COMPLETED|Overall Study||83
10024189|NCT01860573|11147957|FG001|COMPLETED|Overall Study||85
10024190|NCT01860573|11147956|FG000|NOT COMPLETED|Overall Study||0
10024191|NCT01860573|11147957|FG001|NOT COMPLETED|Overall Study||0
10114352|NCT02515669|11245060|FG001|NOT COMPLETED|228 Week Open-Label Phase||9
10024192|NCT01860586|11147963|FG000|STARTED|Overall Study||20
10024193|NCT01860586|11147963|FG000|COMPLETED|Overall Study||20
10024194|NCT01860586|11147963|FG000|NOT COMPLETED|Overall Study||0
10024195|NCT01860651|11147970|FG000|STARTED|Overall Study||56
10114353|NCT02515669|11245061|FG002|NOT COMPLETED|228 Week Open-Label Phase||8
10114354|NCT02515669|11245062|FG003|NOT COMPLETED|228 Week Open-Label Phase||26
10114355|NCT02515825|11245094|FG000|STARTED|Overall Study||70
10114356|NCT02515825|11245095|FG001|STARTED|Overall Study||31
10114357|NCT02515825|11245094|FG000|COMPLETED|Overall Study||70
10114358|NCT02515825|11245095|FG001|COMPLETED|Overall Study||31
10114359|NCT02515825|11245094|FG000|NOT COMPLETED|Overall Study||0
10114360|NCT02515825|11245095|FG001|NOT COMPLETED|Overall Study||0
10114361|NCT02515890|11245107|FG000|STARTED|Overall Study||7
10114362|NCT02515890|11245108|FG001|STARTED|Overall Study||4
10114363|NCT02515890|11245109|FG002|STARTED|Overall Study||5
10114364|NCT02515890|11245110|FG003|STARTED|Overall Study||8
10114365|NCT02515890|11245111|FG004|STARTED|Overall Study||8
10114366|NCT02515890|11245107|FG000|COMPLETED|Overall Study||7
9690067|NCT00685919|10790340|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3
9690068|NCT00685919|10790337|FG000|COMPLETED|Overall Study||7
9690069|NCT00685919|10790338|FG001|COMPLETED|Overall Study||9
9690070|NCT00685919|10790339|FG002|COMPLETED|Overall Study||7
9690071|NCT00685919|10790340|FG003|COMPLETED|Overall Study||3
9690072|NCT00685919|10790337|FG000|NOT COMPLETED|Overall Study||1
9690073|NCT00685919|10790338|FG001|NOT COMPLETED|Overall Study||0
9690074|NCT00685919|10790339|FG002|NOT COMPLETED|Overall Study||1
9690075|NCT00685919|10790340|FG003|NOT COMPLETED|Overall Study||0
9690076|NCT00344487|10790350|FG000|STARTED|Overall Study||3
9690077|NCT00344487|10790350|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
9690078|NCT00344487|10790350|FG000|NOT COMPLETED|Overall Study||1
9690079|NCT00281658|10790358|FG000|STARTED|Double-blind, Randomized Phase||222
9690080|NCT00281658|10790359|FG001|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
9690081|NCT00281658|10790360|FG002|STARTED|Double-blind, Randomized Phase||0
9690082|NCT00281658|10790358|FG000|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
9690083|NCT00281658|10790359|FG001|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
9690084|NCT00281658|10790360|FG002|COMPLETED|Double-blind, Randomized Phase||0
9690085|NCT00281658|10790358|FG000|NOT COMPLETED|Double-blind, Randomized Phase||137
9846591|NCT00848783|10958942|FG002|COMPLETED|Overall Study||1
9846592|NCT00848783|10958940|FG000|NOT COMPLETED|Overall Study||3
9846593|NCT00848783|10958941|FG001|NOT COMPLETED|Overall Study||2
10024196|NCT01860651|11147971|FG001|STARTED|Overall Study||47
10024197|NCT01860651|11147970|FG000|COMPLETED|Overall Study||31
10024198|NCT01860651|11147971|FG001|COMPLETED|Overall Study||39
10024199|NCT01860651|11147970|FG000|NOT COMPLETED|Overall Study||25
10024200|NCT01860651|11147971|FG001|NOT COMPLETED|Overall Study||8
10024201|NCT01860677|11147983|FG000|STARTED|First Intervention (1 Day)||8
10024202|NCT01860677|11147984|FG001|STARTED|First Intervention (1 Day)||0
10024203|NCT01860677|11147983|FG000|COMPLETED|First Intervention (1 Day)||8
10024204|NCT01860677|11147984|FG001|COMPLETED|First Intervention (1 Day)||0
10024205|NCT01860677|11147983|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10114367|NCT02515890|11245108|FG001|COMPLETED|Overall Study||4
10114368|NCT02515890|11245109|FG002|COMPLETED|Overall Study||5
10114369|NCT02515890|11245110|FG003|COMPLETED|Overall Study||8
10114370|NCT02515890|11245111|FG004|COMPLETED|Overall Study||8
10114371|NCT02515890|11245107|FG000|NOT COMPLETED|Overall Study||0
9690086|NCT00281658|10790359|FG001|NOT COMPLETED|Double-blind, Randomized Phase||54
9690087|NCT00281658|10790360|FG002|NOT COMPLETED|Double-blind, Randomized Phase||0
9690088|NCT00281658|10790358|FG000|STARTED|Open-label Monotherapy Extension Phase||0
9690089|NCT00281658|10790359|FG001|STARTED|Open-label Monotherapy Extension Phase||0
9690090|NCT00281658|10790360|FG002|STARTED|Open-label Monotherapy Extension Phase||149
9690091|NCT00281658|10790358|FG000|COMPLETED|Open-label Monotherapy Extension Phase||0
9690092|NCT00281658|10790359|FG001|COMPLETED|Open-label Monotherapy Extension Phase||0
9690093|NCT00281658|10790360|FG002|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
9690094|NCT00281658|10790358|FG000|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
9690095|NCT00281658|10790359|FG001|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
9690096|NCT00281658|10790360|FG002|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
9726400|NCT00100048|10825895|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26
9726401|NCT00100048|10825890|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
9726402|NCT00100048|10825891|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
9726403|NCT00100048|10825892|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
9726404|NCT00100048|10825893|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
9726405|NCT00100048|10825894|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
9726406|NCT00100048|10825895|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
9726407|NCT00100165|10825923|FG000|STARTED|Baseline||10
9726408|NCT00100165|10825924|FG001|STARTED|Baseline||10
9726409|NCT00100165|10825925|FG002|STARTED|Baseline||9
9726410|NCT00100165|10825923|FG000|COMPLETED|Baseline||10
9726411|NCT00100165|10825924|FG001|COMPLETED|Baseline||10
9726412|NCT00100165|10825925|FG002|COMPLETED|Baseline||9
9726413|NCT00100165|10825923|FG000|NOT COMPLETED|Baseline||0
9726414|NCT00100165|10825924|FG001|NOT COMPLETED|Baseline||0
9726415|NCT00100165|10825925|FG002|NOT COMPLETED|Baseline||0
9726416|NCT00100165|10825923|FG000|STARTED|First Intervention (4 Weeks)||10
9690097|NCT04368910|10790369|FG000|STARTED|Overall Study||15
9690098|NCT04368910|10790370|FG001|STARTED|Overall Study||15
9690099|NCT04368910|10790369|FG000|COMPLETED|Overall Study||15
9690100|NCT04368910|10790370|FG001|COMPLETED|Overall Study||15
9690101|NCT04368910|10790369|FG000|NOT COMPLETED|Overall Study||0
9690102|NCT04368910|10790370|FG001|NOT COMPLETED|Overall Study||0
9690103|NCT04365985|10790379|FG000|STARTED|Overall Study||9
9846594|NCT00848783|10958942|FG002|NOT COMPLETED|Overall Study||0
9846595|NCT00848926|10958949|FG000|STARTED|Treatment Period||102
9846596|NCT00848926|10958949|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
9846597|NCT00848926|10958949|FG000|NOT COMPLETED|Treatment Period||84
9846598|NCT00848926|10958949|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102
9846599|NCT00848926|10958949|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
9846600|NCT00848926|10958949|FG000|NOT COMPLETED|Follow-up Period||12
9846601|NCT00848965|10958953|FG000|STARTED|Overall Study||59
9846602|NCT00848965|10958953|FG000|COMPLETED|Overall Study||57
9846603|NCT00848965|10958953|FG000|NOT COMPLETED|Overall Study||2
9846604|NCT00849017|10958968|FG000|STARTED|Treatment Period (156 Weeks)||101
9846605|NCT00849017|10958969|FG001|STARTED|Treatment Period (156 Weeks)||101
9846606|NCT00849017|10958970|FG002|STARTED|Treatment Period (156 Weeks)||99
9846607|NCT00849017|10958968|FG000|COMPLETED|Treatment Period (156 Weeks)||58
9846608|NCT00849017|10958969|FG001|COMPLETED|Treatment Period (156 Weeks)||68
9846609|NCT00849017|10958970|FG002|COMPLETED|Treatment Period (156 Weeks)||57
9846610|NCT00849017|10958968|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43
9846611|NCT00849017|10958969|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33
9846612|NCT00849017|10958970|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42
9846613|NCT00849017|10958968|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
9846614|NCT00849017|10958969|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
9846615|NCT00849017|10958970|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
9846616|NCT00849017|10958968|FG000|COMPLETED|Follow-up Period (8 Weeks)||76
9846617|NCT00849017|10958969|FG001|COMPLETED|Follow-up Period (8 Weeks)||83
9846618|NCT00849017|10958970|FG002|COMPLETED|Follow-up Period (8 Weeks)||74
9846619|NCT00849017|10958968|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25
9846620|NCT00849017|10958969|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18
9846621|NCT00849017|10958970|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25
9846622|NCT00849056|10958984|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151
9846623|NCT00849056|10958985|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150
9846624|NCT00849056|10958984|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88
9846625|NCT00849056|10958985|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100
9846626|NCT00849056|10958984|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
9846627|NCT00849056|10958985|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
9846628|NCT00849056|10958984|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
9961235|NCT01472835|11080992|FG001|STARTED|Overall Study||36
9961236|NCT01472835|11080991|FG000|COMPLETED|Overall Study||35
9690104|NCT04365985|10790380|FG001|STARTED|Overall Study||9
9690105|NCT04365985|10790381|FG002|STARTED|Overall Study||52
9690106|NCT04365985|10790379|FG000|COMPLETED|Overall Study||9
10024206|NCT01860677|11147984|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10024207|NCT01860677|11147983|FG000|STARTED|Second Intervention (1 Day)||8
10024208|NCT01860677|11147984|FG001|STARTED|Second Intervention (1 Day)||0
10024209|NCT01860677|11147983|FG000|COMPLETED|Second Intervention (1 Day)||1
10024210|NCT01860677|11147984|FG001|COMPLETED|Second Intervention (1 Day)||0
9690107|NCT04365985|10790380|FG001|COMPLETED|Overall Study||9
9690108|NCT04365985|10790381|FG002|COMPLETED|Overall Study||52
9690109|NCT04365985|10790379|FG000|NOT COMPLETED|Overall Study||0
9690110|NCT04365985|10790380|FG001|NOT COMPLETED|Overall Study||0
9690111|NCT04365985|10790381|FG002|NOT COMPLETED|Overall Study||0
10024211|NCT01860677|11147983|FG000|NOT COMPLETED|Second Intervention (1 Day)||7
10024212|NCT01860677|11147984|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10024213|NCT01860703|11147991|FG000|STARTED|Overall Study||13
10024214|NCT01860703|11147992|FG001|STARTED|Overall Study||13
10024215|NCT01860703|11147993|FG002|STARTED|Overall Study||12
10024216|NCT01860703|11147994|FG003|STARTED|Overall Study||12
10024217|NCT01860703|11147991|FG000|COMPLETED|Overall Study||11
10024218|NCT01860703|11147992|FG001|COMPLETED|Overall Study||8
10024219|NCT01860703|11147993|FG002|COMPLETED|Overall Study||11
10024220|NCT01860703|11147994|FG003|COMPLETED|Overall Study||10
10024221|NCT01860703|11147991|FG000|NOT COMPLETED|Overall Study||2
10024222|NCT01860703|11147992|FG001|NOT COMPLETED|Overall Study||5
10024223|NCT01860703|11147993|FG002|NOT COMPLETED|Overall Study||1
10024224|NCT01860703|11147994|FG003|NOT COMPLETED|Overall Study||2
10024225|NCT01860807|11148012|FG000|STARTED|Overall Study||64
10024226|NCT01860807|11148013|FG001|STARTED|Overall Study||61
10024227|NCT01860807|11148012|FG000|COMPLETED|Overall Study||34
9690112|NCT04034355|10790391|FG000|STARTED|Overall Study||151
9690113|NCT04034355|10790392|FG001|STARTED|Overall Study||150
9690114|NCT04034355|10790391|FG000|Treated|Overall Study||147
9690115|NCT04034355|10790392|FG001|Treated|Overall Study||150
9690116|NCT04034355|10790391|FG000|COMPLETED|Overall Study||117
9690117|NCT04034355|10790392|FG001|COMPLETED|Overall Study||115
9690118|NCT04034355|10790391|FG000|NOT COMPLETED|Overall Study||34
9690119|NCT04034355|10790392|FG001|NOT COMPLETED|Overall Study||35
9690120|NCT03781726|10790398|FG000|STARTED|Overall Study||30
9690121|NCT03781726|10790398|FG000|COMPLETED|Overall Study||28
9690122|NCT03781726|10790398|FG000|NOT COMPLETED|Overall Study||2
9690123|NCT03721276|10790404|FG000|STARTED|Overall Study||30
9690124|NCT03721276|10790405|FG001|STARTED|Overall Study||30
9690125|NCT03721276|10790404|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0
9690126|NCT03721276|10790405|FG001|Three-month Pre-intervention|Overall Study||30
9690127|NCT03721276|10790404|FG000|Immediate Pre-intervention|Overall Study||30
9690128|NCT03721276|10790405|FG001|Immediate Pre-intervention|Overall Study||29
9690129|NCT03721276|10790404|FG000|Post-intervention|Overall Study||25
9690130|NCT03721276|10790405|FG001|Post-intervention|Overall Study||26
9690131|NCT03721276|10790404|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25
9690132|NCT03721276|10790405|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0
9690133|NCT03721276|10790404|FG000|COMPLETED|Overall Study||25
9690134|NCT03721276|10790405|FG001|COMPLETED|Overall Study||26
9690135|NCT03721276|10790404|FG000|NOT COMPLETED|Overall Study||5
9690136|NCT03721276|10790405|FG001|NOT COMPLETED|Overall Study||4
9690137|NCT03700658|10790411|FG000|STARTED|Overall Study||27
10024228|NCT01860807|11148013|FG001|COMPLETED|Overall Study||32
10024229|NCT01860807|11148012|FG000|NOT COMPLETED|Overall Study||30
10024230|NCT01860807|11148013|FG001|NOT COMPLETED|Overall Study||29
10024231|NCT01860846|11148019|FG000|STARTED|Overall Study||106
10024232|NCT01860846|11148019|FG000|Month 1|Overall Study||97
10024233|NCT01860846|11148019|FG000|Month 2|Overall Study||83
10024234|NCT01860846|11148019|FG000|Month 4|Overall Study||82
10024235|NCT01860846|11148019|FG000|Month 6|Overall Study||85
10024236|NCT01860846|11148019|FG000|Month 12|Overall Study||73
10024237|NCT01860846|11148019|FG000|COMPLETED|Overall Study||73
10024238|NCT01860846|11148019|FG000|NOT COMPLETED|Overall Study||33
10024239|NCT01860950|11148029|FG000|STARTED|Overall Study||14
9846629|NCT00849056|10958985|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
9846630|NCT00849056|10958984|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
9846631|NCT00849056|10958985|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
10024240|NCT01860950|11148030|FG001|STARTED|Overall Study||15
10024241|NCT01860950|11148031|FG002|STARTED|Overall Study||10
10024242|NCT01860950|11148032|FG003|STARTED|Overall Study||13
10024243|NCT01860950|11148033|FG004|STARTED|Overall Study||14
10114372|NCT02515890|11245108|FG001|NOT COMPLETED|Overall Study||0
10024244|NCT01860950|11148034|FG005|STARTED|Overall Study||13
10024245|NCT01860950|11148029|FG000|COMPLETED|Overall Study||14
10024246|NCT01860950|11148030|FG001|COMPLETED|Overall Study||15
10024247|NCT01860950|11148031|FG002|COMPLETED|Overall Study||10
9690138|NCT03700658|10790411|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
9690139|NCT03700658|10790411|FG000|COMPLETED|Overall Study||27
9690140|NCT03700658|10790411|FG000|NOT COMPLETED|Overall Study||0
9726417|NCT00100165|10825924|FG001|STARTED|First Intervention (4 Weeks)||10
9726418|NCT00100165|10825925|FG002|STARTED|First Intervention (4 Weeks)||9
9726419|NCT00100165|10825923|FG000|COMPLETED|First Intervention (4 Weeks)||10
9726420|NCT00100165|10825924|FG001|COMPLETED|First Intervention (4 Weeks)||10
9726421|NCT00100165|10825925|FG002|COMPLETED|First Intervention (4 Weeks)||9
9726422|NCT00100165|10825923|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
9726423|NCT00100165|10825924|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
9726424|NCT00100165|10825925|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0
9726425|NCT00100165|10825923|FG000|STARTED|Washout (1 Week)||10
9726426|NCT00100165|10825924|FG001|STARTED|Washout (1 Week)||10
9726427|NCT00100165|10825925|FG002|STARTED|Washout (1 Week)||9
9726428|NCT00100165|10825923|FG000|COMPLETED|Washout (1 Week)||10
9726429|NCT00100165|10825924|FG001|COMPLETED|Washout (1 Week)||10
9726430|NCT00100165|10825925|FG002|COMPLETED|Washout (1 Week)||9
9726431|NCT00100165|10825923|FG000|NOT COMPLETED|Washout (1 Week)||0
9726432|NCT00100165|10825924|FG001|NOT COMPLETED|Washout (1 Week)||0
9726433|NCT00100165|10825925|FG002|NOT COMPLETED|Washout (1 Week)||0
9726434|NCT00100165|10825923|FG000|STARTED|Second Intervention (4 Weeks)||10
9726435|NCT00100165|10825924|FG001|STARTED|Second Intervention (4 Weeks)||10
9726436|NCT00100165|10825925|FG002|STARTED|Second Intervention (4 Weeks)||9
9726437|NCT00100165|10825923|FG000|COMPLETED|Second Intervention (4 Weeks)||10
9726438|NCT00100165|10825924|FG001|COMPLETED|Second Intervention (4 Weeks)||10
9726439|NCT00100165|10825925|FG002|COMPLETED|Second Intervention (4 Weeks)||9
9726440|NCT00100165|10825923|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
9726441|NCT00100165|10825924|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
9726442|NCT00100165|10825925|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0
9726443|NCT00100165|10825923|FG000|STARTED|Washout (1 Week)||10
9726444|NCT00100165|10825924|FG001|STARTED|Washout (1 Week)||10
9726445|NCT00100165|10825925|FG002|STARTED|Washout (1 Week)||9
9726446|NCT00100165|10825923|FG000|COMPLETED|Washout (1 Week)||10
9726447|NCT00100165|10825924|FG001|COMPLETED|Washout (1 Week)||10
9726448|NCT00100165|10825925|FG002|COMPLETED|Washout (1 Week)||9
9726449|NCT00100165|10825923|FG000|NOT COMPLETED|Washout (1 Week)||0
10024248|NCT01860950|11148032|FG003|COMPLETED|Overall Study||13
10024249|NCT01860950|11148033|FG004|COMPLETED|Overall Study||14
10024250|NCT01860950|11148034|FG005|COMPLETED|Overall Study||13
9961237|NCT01472835|11080992|FG001|COMPLETED|Overall Study||36
9961238|NCT01472835|11080991|FG000|NOT COMPLETED|Overall Study||2
9961239|NCT01472835|11080992|FG001|NOT COMPLETED|Overall Study||0
9961240|NCT01472874|11081001|FG000|STARTED|Overall Study||8
9961241|NCT01472874|11081001|FG000|COMPLETED|Overall Study||8
9961242|NCT01472874|11081001|FG000|NOT COMPLETED|Overall Study||0
9961243|NCT01472939|11081009|FG000|STARTED|Overall Study||123
9961244|NCT01472939|11081010|FG001|STARTED|Overall Study||119
9961245|NCT01472939|11081011|FG002|STARTED|Overall Study||119
9961246|NCT01472939|11081012|FG003|STARTED|Overall Study||119
9961247|NCT01472939|11081009|FG000|COMPLETED|Overall Study||103
9961248|NCT01472939|11081010|FG001|COMPLETED|Overall Study||105
10024251|NCT01860950|11148029|FG000|NOT COMPLETED|Overall Study||0
10024252|NCT01860950|11148030|FG001|NOT COMPLETED|Overall Study||0
10024253|NCT01860950|11148031|FG002|NOT COMPLETED|Overall Study||0
10024254|NCT01860950|11148032|FG003|NOT COMPLETED|Overall Study||0
9961249|NCT01472939|11081011|FG002|COMPLETED|Overall Study||108
9961250|NCT01472939|11081012|FG003|COMPLETED|Overall Study||99
10024255|NCT01860950|11148033|FG004|NOT COMPLETED|Overall Study||0
10024256|NCT01860950|11148034|FG005|NOT COMPLETED|Overall Study||0
10024257|NCT01860989|11148049|FG000|STARTED|Overall Study||11
10024258|NCT01860989|11148049|FG000|COMPLETED|Overall Study||6
10024259|NCT01860989|11148049|FG000|NOT COMPLETED|Overall Study||5
9690141|NCT03637491|10790428|FG000|STARTED|Overall Study||10
9690142|NCT03637491|10790429|FG001|STARTED|Overall Study||12
9690143|NCT03637491|10790430|FG002|STARTED|Overall Study||7
9690144|NCT03637491|10790431|FG003|STARTED|Overall Study||6
9690145|NCT03637491|10790428|FG000|Received Treatment|Overall Study||10
9690146|NCT03637491|10790429|FG001|Received Treatment|Overall Study||12
9690147|NCT03637491|10790430|FG002|Received Treatment|Overall Study||7
9690148|NCT03637491|10790431|FG003|Received Treatment|Overall Study||6
9690149|NCT03637491|10790428|FG000|COMPLETED|Overall Study||0
9690150|NCT03637491|10790429|FG001|COMPLETED|Overall Study||0
9690151|NCT03637491|10790430|FG002|COMPLETED|Overall Study||0
9690152|NCT03637491|10790431|FG003|COMPLETED|Overall Study||0
9690153|NCT03637491|10790428|FG000|NOT COMPLETED|Overall Study||10
9690154|NCT03637491|10790429|FG001|NOT COMPLETED|Overall Study||12
9690155|NCT03637491|10790430|FG002|NOT COMPLETED|Overall Study||7
9690156|NCT03637491|10790431|FG003|NOT COMPLETED|Overall Study||6
9690157|NCT03610334|10790455|FG000|STARTED|Period 1: 2.5mg (1 Day)||6
9690158|NCT03610334|10790456|FG001|STARTED|Period 1: 2.5mg (1 Day)||2
9690159|NCT03610334|10790457|FG002|STARTED|Period 1: 2.5mg (1 Day)||0
9690160|NCT03610334|10790458|FG003|STARTED|Period 1: 2.5mg (1 Day)||0
9690161|NCT03610334|10790459|FG004|STARTED|Period 1: 2.5mg (1 Day)||0
9690162|NCT03610334|10790460|FG005|STARTED|Period 1: 2.5mg (1 Day)||0
9690163|NCT03610334|10790461|FG006|STARTED|Period 1: 2.5mg (1 Day)||0
9690164|NCT03610334|10790462|FG007|STARTED|Period 1: 2.5mg (1 Day)||0
9690165|NCT03610334|10790463|FG008|STARTED|Period 1: 2.5mg (1 Day)||0
9690166|NCT03610334|10790464|FG009|STARTED|Period 1: 2.5mg (1 Day)||0
9690167|NCT03610334|10790465|FG010|STARTED|Period 1: 2.5mg (1 Day)||0
9690168|NCT03610334|10790466|FG011|STARTED|Period 1: 2.5mg (1 Day)||0
9690169|NCT03610334|10790467|FG012|STARTED|Period 1: 2.5mg (1 Day)||0
9690170|NCT03610334|10790468|FG013|STARTED|Period 1: 2.5mg (1 Day)||0
9690171|NCT03610334|10790469|FG014|STARTED|Period 1: 2.5mg (1 Day)||0
9690172|NCT03610334|10790470|FG015|STARTED|Period 1: 2.5mg (1 Day)||0
9690173|NCT03610334|10790471|FG016|STARTED|Period 1: 2.5mg (1 Day)||0
9690174|NCT03610334|10790472|FG017|STARTED|Period 1: 2.5mg (1 Day)||0
9690175|NCT03610334|10790455|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6
9690176|NCT03610334|10790456|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2
9690177|NCT03610334|10790457|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690178|NCT03610334|10790458|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690179|NCT03610334|10790459|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690180|NCT03610334|10790460|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690181|NCT03610334|10790461|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690182|NCT03610334|10790462|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690183|NCT03610334|10790463|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690184|NCT03610334|10790464|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690185|NCT03610334|10790465|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690186|NCT03610334|10790466|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690187|NCT03610334|10790467|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690188|NCT03610334|10790468|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690189|NCT03610334|10790469|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690190|NCT03610334|10790470|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690191|NCT03610334|10790471|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690192|NCT03610334|10790472|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0
9690193|NCT03610334|10790455|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690194|NCT03610334|10790456|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690195|NCT03610334|10790457|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10024260|NCT01861002|11148053|FG000|STARTED|Overall Study||15
10024261|NCT01861002|11148053|FG000|COMPLETED|Overall Study||14
10024262|NCT01861002|11148053|FG000|NOT COMPLETED|Overall Study||1
10024263|NCT01861028|11148061|FG000|STARTED|Overall Study||44
10024264|NCT01861028|11148061|FG000|COMPLETED|Overall Study||44
10024265|NCT01861028|11148061|FG000|NOT COMPLETED|Overall Study||0
10024266|NCT01861054|11148068|FG000|STARTED|Overall Study||18
10024267|NCT01861054|11148069|FG001|STARTED|Overall Study||2
10024268|NCT01861054|11148068|FG000|Safety Population|Overall Study||18
10024269|NCT01861054|11148069|FG001|Safety Population|Overall Study||2
10024270|NCT01861054|11148068|FG000|PK Population|Overall Study||4
10024271|NCT01861054|11148069|FG001|PK Population|Overall Study||2
9690196|NCT03610334|10790458|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690197|NCT03610334|10790459|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690198|NCT03610334|10790460|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690199|NCT03610334|10790461|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690200|NCT03610334|10790462|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690201|NCT03610334|10790463|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690202|NCT03610334|10790464|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690203|NCT03610334|10790465|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9961251|NCT01472939|11081009|FG000|NOT COMPLETED|Overall Study||20
10024272|NCT01861054|11148068|FG000|COMPLETED|Overall Study||18
10024273|NCT01861054|11148069|FG001|COMPLETED|Overall Study||2
10024274|NCT01861054|11148068|FG000|NOT COMPLETED|Overall Study||0
10024275|NCT01861054|11148069|FG001|NOT COMPLETED|Overall Study||0
10024276|NCT01861301|11148078|FG000|STARTED|Overall Study||18
10024277|NCT01861301|11148078|FG000|COMPLETED|Overall Study||18
10024278|NCT01861301|11148078|FG000|NOT COMPLETED|Overall Study||0
10024279|NCT01861457|11148085|FG000|STARTED|Overall Study||20
10024280|NCT01861457|11148086|FG001|STARTED|Overall Study||19
10024281|NCT01861457|11148085|FG000|COMPLETED|Overall Study||20
10114373|NCT02515890|11245109|FG002|NOT COMPLETED|Overall Study||0
10114374|NCT02515890|11245110|FG003|NOT COMPLETED|Overall Study||0
10114375|NCT02515890|11245111|FG004|NOT COMPLETED|Overall Study||0
10114376|NCT02515942|11245125|FG000|STARTED|Overall Study||36
10114377|NCT02515942|11245126|FG001|STARTED|Overall Study||39
10114378|NCT02515942|11245127|FG002|STARTED|Overall Study||39
10114379|NCT02515942|11245125|FG000|Safety Analysis Set|Overall Study||36
10114380|NCT02515942|11245126|FG001|Safety Analysis Set|Overall Study||39
10114381|NCT02515942|11245127|FG002|Safety Analysis Set|Overall Study||39
10114382|NCT02515942|11245125|FG000|Full Analysis Set (FAS)|Overall Study||35
10114383|NCT02515942|11245126|FG001|Full Analysis Set (FAS)|Overall Study||37
10114384|NCT02515942|11245127|FG002|Full Analysis Set (FAS)|Overall Study||38
10114385|NCT02515942|11245125|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30
10114386|NCT02515942|11245126|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35
10114387|NCT02515942|11245127|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34
10114388|NCT02515942|11245125|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36
10114389|NCT02515942|11245126|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39
10114390|NCT02515942|11245127|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10114391|NCT02515942|11245125|FG000|Completed Day 85|Overall Study||35
10114392|NCT02515942|11245126|FG001|Completed Day 85|Overall Study||38
10114393|NCT02515942|11245127|FG002|Completed Day 85|Overall Study||37
10024282|NCT01861457|11148086|FG001|COMPLETED|Overall Study||19
10024283|NCT01861457|11148085|FG000|NOT COMPLETED|Overall Study||0
10024284|NCT01861457|11148086|FG001|NOT COMPLETED|Overall Study||0
10024285|NCT01861522|11148094|FG000|STARTED|Overall Study||240
10024286|NCT01861522|11148095|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
10024287|NCT01861522|11148094|FG000|COMPLETED|Overall Study||237
10024288|NCT01861522|11148095|FG001|COMPLETED|Overall Study||232
10024289|NCT01861522|11148094|FG000|NOT COMPLETED|Overall Study||3
10024290|NCT01861522|11148095|FG001|NOT COMPLETED|Overall Study||0
10024291|NCT01861574|11148105|FG000|STARTED|Overall Study||28
10024292|NCT01861574|11148106|FG001|STARTED|Overall Study||25
10024293|NCT01861574|11148107|FG002|STARTED|Overall Study||27
10024294|NCT01861574|11148108|FG003|STARTED|Overall Study||28
10024295|NCT01861574|11148105|FG000|COMPLETED|Overall Study||28
10024296|NCT01861574|11148106|FG001|COMPLETED|Overall Study||25
10024297|NCT01861574|11148107|FG002|COMPLETED|Overall Study||27
10024298|NCT01861574|11148108|FG003|COMPLETED|Overall Study||28
10024299|NCT01861574|11148105|FG000|NOT COMPLETED|Overall Study||0
10024300|NCT01861574|11148106|FG001|NOT COMPLETED|Overall Study||0
10024301|NCT01861574|11148107|FG002|NOT COMPLETED|Overall Study||0
10024302|NCT01861574|11148108|FG003|NOT COMPLETED|Overall Study||0
10024303|NCT01861587|11148123|FG000|STARTED|Overall Study||14
10024304|NCT01861587|11148124|FG001|STARTED|Overall Study||13
10024305|NCT01861587|11148123|FG000|COMPLETED|Overall Study||14
10024306|NCT01861587|11148124|FG001|COMPLETED|Overall Study||13
10024307|NCT01861587|11148123|FG000|NOT COMPLETED|Overall Study||0
10024308|NCT01861587|11148124|FG001|NOT COMPLETED|Overall Study||0
10024309|NCT01861665|11148136|FG000|STARTED|Overall Study||10
10024310|NCT01861665|11148137|FG001|STARTED|Overall Study||17
10024311|NCT01861665|11148136|FG000|COMPLETED|Overall Study||10
10024312|NCT01861665|11148137|FG001|COMPLETED|Overall Study||17
10024313|NCT01861665|11148136|FG000|NOT COMPLETED|Overall Study||0
10024314|NCT01861665|11148137|FG001|NOT COMPLETED|Overall Study||0
10024315|NCT01861704|11148145|FG000|STARTED|Overall Study||70
10024316|NCT01861704|11148146|FG001|STARTED|Overall Study||107
10024317|NCT01861704|11148145|FG000|COMPLETED|Overall Study||67
10024318|NCT01861704|11148146|FG001|COMPLETED|Overall Study||104
10024319|NCT01861704|11148145|FG000|NOT COMPLETED|Overall Study||3
10024320|NCT01861704|11148146|FG001|NOT COMPLETED|Overall Study||3
10024321|NCT01861756|11148154|FG000|STARTED|Overall Study||101
10024322|NCT01861756|11148155|FG001|STARTED|Overall Study||103
10024323|NCT01861756|11148154|FG000|COMPLETED|Overall Study||88
10114394|NCT02515942|11245125|FG000|Completed Day 169|Overall Study||32
9690204|NCT03610334|10790466|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690205|NCT03610334|10790467|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690206|NCT03610334|10790468|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690207|NCT03610334|10790469|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690208|NCT03610334|10790470|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690209|NCT03610334|10790471|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690210|NCT03610334|10790472|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
9690211|NCT03610334|10790455|FG000|STARTED|Period 2: 5.0mg (1 Day)||6
9690212|NCT03610334|10790456|FG001|STARTED|Period 2: 5.0mg (1 Day)||2
9690213|NCT03610334|10790457|FG002|STARTED|Period 2: 5.0mg (1 Day)||6
9690214|NCT03610334|10790458|FG003|STARTED|Period 2: 5.0mg (1 Day)||2
9690215|NCT03610334|10790459|FG004|STARTED|Period 2: 5.0mg (1 Day)||0
9690216|NCT03610334|10790460|FG005|STARTED|Period 2: 5.0mg (1 Day)||0
9690217|NCT03610334|10790461|FG006|STARTED|Period 2: 5.0mg (1 Day)||0
9690218|NCT03610334|10790462|FG007|STARTED|Period 2: 5.0mg (1 Day)||0
9690219|NCT03610334|10790463|FG008|STARTED|Period 2: 5.0mg (1 Day)||0
9690220|NCT03610334|10790464|FG009|STARTED|Period 2: 5.0mg (1 Day)||0
9690221|NCT03610334|10790465|FG010|STARTED|Period 2: 5.0mg (1 Day)||0
9690222|NCT03610334|10790466|FG011|STARTED|Period 2: 5.0mg (1 Day)||0
9690223|NCT03610334|10790467|FG012|STARTED|Period 2: 5.0mg (1 Day)||0
9690224|NCT03610334|10790468|FG013|STARTED|Period 2: 5.0mg (1 Day)||0
9690225|NCT03610334|10790469|FG014|STARTED|Period 2: 5.0mg (1 Day)||0
9690226|NCT03610334|10790470|FG015|STARTED|Period 2: 5.0mg (1 Day)||0
9690227|NCT03610334|10790471|FG016|STARTED|Period 2: 5.0mg (1 Day)||0
9690228|NCT03610334|10790472|FG017|STARTED|Period 2: 5.0mg (1 Day)||0
9690229|NCT03610334|10790455|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6
10024324|NCT01861756|11148155|FG001|COMPLETED|Overall Study||85
10024325|NCT01861756|11148154|FG000|NOT COMPLETED|Overall Study||13
10024326|NCT01861756|11148155|FG001|NOT COMPLETED|Overall Study||18
10024327|NCT01861925|11148164|FG000|STARTED|Overall Study||34
10024328|NCT01861925|11148165|FG001|STARTED|Overall Study||8
10024329|NCT01861925|11148166|FG002|STARTED|Overall Study||8
9690230|NCT03610334|10790456|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2
9690231|NCT03610334|10790457|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6
9690232|NCT03610334|10790458|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2
9690233|NCT03610334|10790459|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690234|NCT03610334|10790460|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690235|NCT03610334|10790461|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690236|NCT03610334|10790462|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690237|NCT03610334|10790463|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690238|NCT03610334|10790464|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690239|NCT03610334|10790465|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690240|NCT03610334|10790466|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690241|NCT03610334|10790467|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690242|NCT03610334|10790468|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690243|NCT03610334|10790469|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690244|NCT03610334|10790470|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690245|NCT03610334|10790471|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690246|NCT03610334|10790472|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0
9690247|NCT03610334|10790455|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690248|NCT03610334|10790456|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690249|NCT03610334|10790457|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690250|NCT03610334|10790458|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690251|NCT03610334|10790459|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690252|NCT03610334|10790460|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690253|NCT03610334|10790461|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690254|NCT03610334|10790462|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690255|NCT03610334|10790463|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690256|NCT03610334|10790464|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690257|NCT03610334|10790465|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690258|NCT03610334|10790466|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690259|NCT03610334|10790467|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690260|NCT03610334|10790468|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690261|NCT03610334|10790469|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690262|NCT03610334|10790470|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690263|NCT03610334|10790471|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690264|NCT03610334|10790472|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
9690265|NCT03610334|10790455|FG000|STARTED|Period 3: 10.0mg (1 Day)||6
9690266|NCT03610334|10790456|FG001|STARTED|Period 3: 10.0mg (1 Day)||2
9690267|NCT03610334|10790457|FG002|STARTED|Period 3: 10.0mg (1 Day)||6
9690268|NCT03610334|10790458|FG003|STARTED|Period 3: 10.0mg (1 Day)||2
9690269|NCT03610334|10790459|FG004|STARTED|Period 3: 10.0mg (1 Day)||6
9690270|NCT03610334|10790460|FG005|STARTED|Period 3: 10.0mg (1 Day)||2
9690271|NCT03610334|10790461|FG006|STARTED|Period 3: 10.0mg (1 Day)||0
9690272|NCT03610334|10790462|FG007|STARTED|Period 3: 10.0mg (1 Day)||0
10024330|NCT01861925|11148164|FG000|COMPLETED|Overall Study||34
9690273|NCT03610334|10790463|FG008|STARTED|Period 3: 10.0mg (1 Day)||0
9690274|NCT03610334|10790464|FG009|STARTED|Period 3: 10.0mg (1 Day)||0
9690275|NCT03610334|10790465|FG010|STARTED|Period 3: 10.0mg (1 Day)||0
9690276|NCT03610334|10790466|FG011|STARTED|Period 3: 10.0mg (1 Day)||0
9690277|NCT03610334|10790467|FG012|STARTED|Period 3: 10.0mg (1 Day)||0
9690278|NCT03610334|10790468|FG013|STARTED|Period 3: 10.0mg (1 Day)||0
10024331|NCT01861925|11148165|FG001|COMPLETED|Overall Study||8
10024332|NCT01861925|11148166|FG002|COMPLETED|Overall Study||8
10024333|NCT01861925|11148164|FG000|NOT COMPLETED|Overall Study||0
10024334|NCT01861925|11148165|FG001|NOT COMPLETED|Overall Study||0
9690279|NCT03610334|10790469|FG014|STARTED|Period 3: 10.0mg (1 Day)||0
9690280|NCT03610334|10790470|FG015|STARTED|Period 3: 10.0mg (1 Day)||0
9690281|NCT03610334|10790471|FG016|STARTED|Period 3: 10.0mg (1 Day)||0
9690282|NCT03610334|10790472|FG017|STARTED|Period 3: 10.0mg (1 Day)||0
9690283|NCT03610334|10790455|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6
9690284|NCT03610334|10790456|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2
9690285|NCT03610334|10790457|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6
9690286|NCT03610334|10790458|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2
9690287|NCT03610334|10790459|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6
9690288|NCT03610334|10790460|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2
9690289|NCT03610334|10790461|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690290|NCT03610334|10790462|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690291|NCT03610334|10790463|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690292|NCT03610334|10790464|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690293|NCT03610334|10790465|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690294|NCT03610334|10790466|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690295|NCT03610334|10790467|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690296|NCT03610334|10790468|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690297|NCT03610334|10790469|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690298|NCT03610334|10790470|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690299|NCT03610334|10790471|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0
9690300|NCT03610334|10790472|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0
10024335|NCT01861925|11148166|FG002|NOT COMPLETED|Overall Study||0
10024336|NCT01862029|11148175|FG000|STARTED|Overall Study||9
10024337|NCT01862029|11148175|FG000|COMPLETED|Overall Study||8
10024338|NCT01862029|11148175|FG000|NOT COMPLETED|Overall Study||1
10024339|NCT01862133|11148180|FG000|STARTED|Overall Study||105
10024340|NCT01862133|11148181|FG001|STARTED|Overall Study||31
9690301|NCT03610334|10790455|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10024341|NCT01862133|11148180|FG000|Returned During 6 mo Study|Overall Study||92
10024342|NCT01862133|11148181|FG001|Returned During 6 mo Study|Overall Study||31
9846632|NCT00849056|10958984|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
9846633|NCT00849056|10958985|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
10024343|NCT01862133|11148180|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
10024344|NCT01862133|11148181|FG001|COMPLETED|Overall Study||31
10024345|NCT01862133|11148180|FG000|NOT COMPLETED|Overall Study||0
9690302|NCT03610334|10790456|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690303|NCT03610334|10790457|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690304|NCT03610334|10790458|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690305|NCT03610334|10790459|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690306|NCT03610334|10790460|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690307|NCT03610334|10790461|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690308|NCT03610334|10790462|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690309|NCT03610334|10790463|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690310|NCT03610334|10790464|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690311|NCT03610334|10790465|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690312|NCT03610334|10790466|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690313|NCT03610334|10790467|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690314|NCT03610334|10790468|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690315|NCT03610334|10790469|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690316|NCT03610334|10790470|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690317|NCT03610334|10790471|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690318|NCT03610334|10790472|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
9690319|NCT03610334|10790455|FG000|STARTED|Period 4: 20.0mg (1 Day)||6
9690320|NCT03610334|10790456|FG001|STARTED|Period 4: 20.0mg (1 Day)||2
9690321|NCT03610334|10790457|FG002|STARTED|Period 4: 20.0mg (1 Day)||6
9690322|NCT03610334|10790458|FG003|STARTED|Period 4: 20.0mg (1 Day)||2
9690323|NCT03610334|10790459|FG004|STARTED|Period 4: 20.0mg (1 Day)||6
9690324|NCT03610334|10790460|FG005|STARTED|Period 4: 20.0mg (1 Day)||2
9690325|NCT03610334|10790461|FG006|STARTED|Period 4: 20.0mg (1 Day)||6
9690326|NCT03610334|10790462|FG007|STARTED|Period 4: 20.0mg (1 Day)||2
9690327|NCT03610334|10790463|FG008|STARTED|Period 4: 20.0mg (1 Day)||0
10024346|NCT01862133|11148181|FG001|NOT COMPLETED|Overall Study||0
10024347|NCT01862159|11148187|FG000|STARTED|Overall Study||25038
10024348|NCT01862159|11148187|FG000|COMPLETED|Overall Study||25038
10024349|NCT01862159|11148187|FG000|NOT COMPLETED|Overall Study||0
10024350|NCT01862250|11148191|FG000|STARTED|Overall Study||12
10024351|NCT01862250|11148191|FG000|COMPLETED|Overall Study||8
10024352|NCT01862250|11148191|FG000|NOT COMPLETED|Overall Study||4
10024353|NCT01862328|11148202|FG000|STARTED|Overall Study||4
10024354|NCT01862328|11148203|FG001|STARTED|Overall Study||18
10114395|NCT02515942|11245126|FG001|Completed Day 169|Overall Study||37
10114396|NCT02515942|11245127|FG002|Completed Day 169|Overall Study||37
10114397|NCT02515942|11245125|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
10114398|NCT02515942|11245126|FG001|Completed Day 253|Overall Study||37
10114399|NCT02515942|11245127|FG002|Completed Day 253|Overall Study||36
10114400|NCT02515942|11245125|FG000|Completed Day 337|Overall Study||30
10114401|NCT02515942|11245126|FG001|Completed Day 337|Overall Study||36
10114402|NCT02515942|11245127|FG002|Completed Day 337|Overall Study||35
10114403|NCT02515942|11245125|FG000|COMPLETED|Overall Study||29
9690328|NCT03610334|10790464|FG009|STARTED|Period 4: 20.0mg (1 Day)||0
9690329|NCT03610334|10790465|FG010|STARTED|Period 4: 20.0mg (1 Day)||0
9690330|NCT03610334|10790466|FG011|STARTED|Period 4: 20.0mg (1 Day)||0
9690331|NCT03610334|10790467|FG012|STARTED|Period 4: 20.0mg (1 Day)||0
9690332|NCT03610334|10790468|FG013|STARTED|Period 4: 20.0mg (1 Day)||0
9690333|NCT03610334|10790469|FG014|STARTED|Period 4: 20.0mg (1 Day)||0
9690334|NCT03610334|10790470|FG015|STARTED|Period 4: 20.0mg (1 Day)||0
9690335|NCT03610334|10790471|FG016|STARTED|Period 4: 20.0mg (1 Day)||0
9690336|NCT03610334|10790472|FG017|STARTED|Period 4: 20.0mg (1 Day)||0
9690337|NCT03610334|10790455|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6
9690338|NCT03610334|10790456|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2
10024355|NCT01862328|11148204|FG002|STARTED|Overall Study||6
10024356|NCT01862328|11148205|FG003|STARTED|Overall Study||7
10024357|NCT01862328|11148206|FG004|STARTED|Overall Study||12
10024358|NCT01862328|11148207|FG005|STARTED|Overall Study||7
9690339|NCT03610334|10790457|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6
9690340|NCT03610334|10790458|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2
9690341|NCT03610334|10790459|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6
9690342|NCT03610334|10790460|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2
9690343|NCT03610334|10790461|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6
9690344|NCT03610334|10790462|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2
9690345|NCT03610334|10790463|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690346|NCT03610334|10790464|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690347|NCT03610334|10790465|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690348|NCT03610334|10790466|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690349|NCT03610334|10790467|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690350|NCT03610334|10790468|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690351|NCT03610334|10790469|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690352|NCT03610334|10790470|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690353|NCT03610334|10790471|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690354|NCT03610334|10790472|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0
9690355|NCT03610334|10790455|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690356|NCT03610334|10790456|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690357|NCT03610334|10790457|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690358|NCT03610334|10790458|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690359|NCT03610334|10790459|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690360|NCT03610334|10790460|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690361|NCT03610334|10790461|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690362|NCT03610334|10790462|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690363|NCT03610334|10790463|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690364|NCT03610334|10790464|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690365|NCT03610334|10790465|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690366|NCT03610334|10790466|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690367|NCT03610334|10790467|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690368|NCT03610334|10790468|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690369|NCT03610334|10790469|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690370|NCT03610334|10790470|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10024359|NCT01862328|11148208|FG006|STARTED|Overall Study||10
10024360|NCT01862328|11148202|FG000|COMPLETED|Overall Study||0
10024361|NCT01862328|11148203|FG001|COMPLETED|Overall Study||0
9690371|NCT03610334|10790471|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690372|NCT03610334|10790472|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
9690373|NCT03610334|10790455|FG000|STARTED|Period 5: 40.0mg (1 Day)||6
9690374|NCT03610334|10790456|FG001|STARTED|Period 5: 40.0mg (1 Day)||2
9690375|NCT03610334|10790457|FG002|STARTED|Period 5: 40.0mg (1 Day)||6
9690376|NCT03610334|10790458|FG003|STARTED|Period 5: 40.0mg (1 Day)||2
9690377|NCT03610334|10790459|FG004|STARTED|Period 5: 40.0mg (1 Day)||6
9690378|NCT03610334|10790460|FG005|STARTED|Period 5: 40.0mg (1 Day)||2
9690379|NCT03610334|10790461|FG006|STARTED|Period 5: 40.0mg (1 Day)||6
9690380|NCT03610334|10790462|FG007|STARTED|Period 5: 40.0mg (1 Day)||2
9690381|NCT03610334|10790463|FG008|STARTED|Period 5: 40.0mg (1 Day)||6
9690382|NCT03610334|10790464|FG009|STARTED|Period 5: 40.0mg (1 Day)||2
9690383|NCT03610334|10790465|FG010|STARTED|Period 5: 40.0mg (1 Day)||0
9690384|NCT03610334|10790466|FG011|STARTED|Period 5: 40.0mg (1 Day)||0
9690385|NCT03610334|10790467|FG012|STARTED|Period 5: 40.0mg (1 Day)||0
9690386|NCT03610334|10790468|FG013|STARTED|Period 5: 40.0mg (1 Day)||0
9690387|NCT03610334|10790469|FG014|STARTED|Period 5: 40.0mg (1 Day)||0
9690388|NCT03610334|10790470|FG015|STARTED|Period 5: 40.0mg (1 Day)||0
9690389|NCT03610334|10790471|FG016|STARTED|Period 5: 40.0mg (1 Day)||0
9690390|NCT03610334|10790472|FG017|STARTED|Period 5: 40.0mg (1 Day)||0
9690391|NCT03610334|10790455|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6
9690392|NCT03610334|10790456|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2
9690393|NCT03610334|10790457|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6
9690394|NCT03610334|10790458|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2
9690395|NCT03610334|10790459|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6
9690396|NCT03610334|10790460|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2
9690397|NCT03610334|10790461|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6
10024362|NCT01862328|11148204|FG002|COMPLETED|Overall Study||0
10024363|NCT01862328|11148205|FG003|COMPLETED|Overall Study||0
9690398|NCT03610334|10790462|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2
9690399|NCT03610334|10790463|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6
9690400|NCT03610334|10790464|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2
9690401|NCT03610334|10790465|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690402|NCT03610334|10790466|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690403|NCT03610334|10790467|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690404|NCT03610334|10790468|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690405|NCT03610334|10790469|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690406|NCT03610334|10790470|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690407|NCT03610334|10790471|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690408|NCT03610334|10790472|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0
9690409|NCT03610334|10790455|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690410|NCT03610334|10790456|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690411|NCT03610334|10790457|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690412|NCT03610334|10790458|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690413|NCT03610334|10790459|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690414|NCT03610334|10790460|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690415|NCT03610334|10790461|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690416|NCT03610334|10790462|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690417|NCT03610334|10790463|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690418|NCT03610334|10790464|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690419|NCT03610334|10790465|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690420|NCT03610334|10790466|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690421|NCT03610334|10790467|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690422|NCT03610334|10790468|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690423|NCT03610334|10790469|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690424|NCT03610334|10790470|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690425|NCT03610334|10790471|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690426|NCT03610334|10790472|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
9690427|NCT03610334|10790455|FG000|STARTED|Period 6: 60.0mg (1 Day)||6
10024364|NCT01862328|11148206|FG004|COMPLETED|Overall Study||0
10024365|NCT01862328|11148207|FG005|COMPLETED|Overall Study||0
10024366|NCT01862328|11148208|FG006|COMPLETED|Overall Study||0
10024367|NCT01862328|11148202|FG000|NOT COMPLETED|Overall Study||4
10024368|NCT01862328|11148203|FG001|NOT COMPLETED|Overall Study||18
10024369|NCT01862328|11148204|FG002|NOT COMPLETED|Overall Study||6
10024370|NCT01862328|11148205|FG003|NOT COMPLETED|Overall Study||7
10024371|NCT01862328|11148206|FG004|NOT COMPLETED|Overall Study||12
10024372|NCT01862328|11148207|FG005|NOT COMPLETED|Overall Study||7
10024373|NCT01862328|11148208|FG006|NOT COMPLETED|Overall Study||10
10024374|NCT01862419|11148232|FG000|STARTED|Overall Study||1201
10024375|NCT01862419|11148233|FG001|STARTED|Overall Study||1192
10024376|NCT01862419|11148232|FG000|COMPLETED|Overall Study||1201
10024377|NCT01862419|11148233|FG001|COMPLETED|Overall Study||1192
10024378|NCT01862419|11148232|FG000|NOT COMPLETED|Overall Study||0
10024379|NCT01862419|11148233|FG001|NOT COMPLETED|Overall Study||0
10024380|NCT01862484|11148241|FG000|STARTED|Overall Study||15
10024381|NCT01862484|11148242|FG001|STARTED|Overall Study||14
10024382|NCT01862484|11148241|FG000|COMPLETED|Overall Study||13
10024383|NCT01862484|11148242|FG001|COMPLETED|Overall Study||6
10024384|NCT01862484|11148241|FG000|NOT COMPLETED|Overall Study||2
10024385|NCT01862484|11148242|FG001|NOT COMPLETED|Overall Study||8
10024386|NCT01862536|11148250|FG000|STARTED|Overall Study||13
10024387|NCT01862536|11148251|FG001|STARTED|Overall Study||23
10024388|NCT01862536|11148250|FG000|COMPLETED|Overall Study||10
10024389|NCT01862536|11148251|FG001|COMPLETED|Overall Study||16
10024390|NCT01862536|11148250|FG000|NOT COMPLETED|Overall Study||3
10024391|NCT01862536|11148251|FG001|NOT COMPLETED|Overall Study||7
10024392|NCT01862614|11148259|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40
10024393|NCT01862614|11148260|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
10024394|NCT01862614|11148259|FG000|COMPLETED|First Appointment.||40
10024395|NCT01862614|11148260|FG001|COMPLETED|First Appointment.||40
10024396|NCT01862614|11148259|FG000|NOT COMPLETED|First Appointment.||0
10024397|NCT01862614|11148260|FG001|NOT COMPLETED|First Appointment.||0
10024398|NCT01862614|11148259|FG000|STARTED|2 Week Washout Period.||40
10024399|NCT01862614|11148260|FG001|STARTED|2 Week Washout Period.||40
10024400|NCT01862614|11148259|FG000|COMPLETED|2 Week Washout Period.||40
10024401|NCT01862614|11148260|FG001|COMPLETED|2 Week Washout Period.||40
10024402|NCT01862614|11148259|FG000|NOT COMPLETED|2 Week Washout Period.||0
10024403|NCT01862614|11148260|FG001|NOT COMPLETED|2 Week Washout Period.||0
10024404|NCT01862614|11148259|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
10024405|NCT01862614|11148260|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40
10024406|NCT01862614|11148259|FG000|COMPLETED|Second Appointment.||40
10024407|NCT01862614|11148260|FG001|COMPLETED|Second Appointment.||40
10024408|NCT01862614|11148259|FG000|NOT COMPLETED|Second Appointment.||0
10024409|NCT01862614|11148260|FG001|NOT COMPLETED|Second Appointment.||0
10024410|NCT01862640|11148270|FG000|STARTED|Overall Study||20
9846634|NCT00849108|10958994|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
9846635|NCT00849108|10958995|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
9846636|NCT00849108|10958994|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
9846637|NCT00849108|10958995|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
9846638|NCT00849108|10958994|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
9846639|NCT00849108|10958995|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
9846640|NCT00849108|10958994|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
9846641|NCT00849108|10958995|FG001|STARTED|Cohort 2 Efficacy||143
9846642|NCT00849108|10958994|FG000|COMPLETED|Cohort 2 Efficacy||0
9846643|NCT00849108|10958995|FG001|COMPLETED|Cohort 2 Efficacy||133
9846644|NCT00849108|10958994|FG000|NOT COMPLETED|Cohort 2 Efficacy||0
9846645|NCT00849108|10958995|FG001|NOT COMPLETED|Cohort 2 Efficacy||10
9846646|NCT00849121|10959005|FG000|STARTED|Overall Study||8
9846647|NCT00849121|10959006|FG001|STARTED|Overall Study||9
9846648|NCT00849121|10959005|FG000|COMPLETED|Overall Study||8
9846649|NCT00849121|10959006|FG001|COMPLETED|Overall Study||9
9846650|NCT00849121|10959005|FG000|NOT COMPLETED|Overall Study||0
9846651|NCT00849121|10959006|FG001|NOT COMPLETED|Overall Study||0
9846652|NCT00849147|10959012|FG000|STARTED|Overall Study||55
9846653|NCT00849147|10959012|FG000|COMPLETED|Overall Study||50
9846654|NCT00849147|10959012|FG000|NOT COMPLETED|Overall Study||5
9846655|NCT00849186|10959016|FG000|STARTED|Overall Study||26
9846656|NCT00849186|10959016|FG000|COMPLETED|Overall Study||16
9846657|NCT00849186|10959016|FG000|NOT COMPLETED|Overall Study||10
9961252|NCT01472939|11081010|FG001|NOT COMPLETED|Overall Study||14
9961253|NCT01472939|11081011|FG002|NOT COMPLETED|Overall Study||11
9961254|NCT01472939|11081012|FG003|NOT COMPLETED|Overall Study||20
9961255|NCT01472965|11081027|FG000|STARTED|Overall Study||49
9961256|NCT01472965|11081028|FG001|STARTED|Overall Study||46
9961257|NCT01472965|11081027|FG000|COMPLETED|Overall Study||48
9961258|NCT01472965|11081028|FG001|COMPLETED|Overall Study||46
9961259|NCT01472965|11081027|FG000|NOT COMPLETED|Overall Study||1
9961260|NCT01472965|11081028|FG001|NOT COMPLETED|Overall Study||0
9961261|NCT01473160|11081034|FG000|STARTED|Overall Study||9
9961262|NCT01473160|11081034|FG000|COMPLETED|Overall Study||9
9961263|NCT01473160|11081034|FG000|NOT COMPLETED|Overall Study||0
9961264|NCT01473355|11081040|FG000|STARTED|Overall Study||45
9961265|NCT01473355|11081040|FG000|COMPLETED|Overall Study||39
9961266|NCT01473355|11081040|FG000|NOT COMPLETED|Overall Study||6
9961267|NCT01473368|11081048|FG000|STARTED|Overall Study||14
9846658|NCT00849212|10959021|FG000|STARTED|Overall Study||30
9846659|NCT00849212|10959021|FG000|COMPLETED|Overall Study||23
9846660|NCT00849212|10959021|FG000|NOT COMPLETED|Overall Study||7
9846661|NCT00849251|10959025|FG000|STARTED|Overall Study||6
9846662|NCT00849251|10959026|FG001|STARTED|Overall Study||25
9846663|NCT00849251|10959025|FG000|COMPLETED|Overall Study||5
9846664|NCT00849251|10959026|FG001|COMPLETED|Overall Study||24
9846665|NCT00849251|10959025|FG000|NOT COMPLETED|Overall Study||1
9846666|NCT00849251|10959026|FG001|NOT COMPLETED|Overall Study||1
9846667|NCT00849290|10959032|FG000|STARTED|Overall Study||113
9846668|NCT00849290|10959032|FG000|COMPLETED|Overall Study||58
9846669|NCT00849290|10959032|FG000|NOT COMPLETED|Overall Study||55
9846670|NCT00849381|10959036|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
9846671|NCT00849381|10959036|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
9846672|NCT00849381|10959036|FG000|NOT COMPLETED|Overall Study||145
9846673|NCT00849472|10959040|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
9846674|NCT00849472|10959040|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
9846675|NCT00849472|10959040|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
9846676|NCT00849472|10959040|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
9846677|NCT00849472|10959040|FG000|COMPLETED|Weekly Paclitaxel||78
9846678|NCT00849472|10959040|FG000|NOT COMPLETED|Weekly Paclitaxel||16
9846679|NCT00849472|10959040|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94
9846680|NCT00849472|10959040|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
9846681|NCT00849472|10959040|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
9846682|NCT00849472|10959040|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
9846683|NCT00849472|10959040|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16
9846684|NCT00849472|10959040|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
9846685|NCT00849680|10959053|FG000|STARTED|Overall Study||27
9846686|NCT00849680|10959054|FG001|STARTED|Overall Study||13
9846687|NCT00849680|10959055|FG002|STARTED|Overall Study||42
9846688|NCT00849680|10959056|FG003|STARTED|Overall Study||42
9690428|NCT03610334|10790456|FG001|STARTED|Period 6: 60.0mg (1 Day)||2
9690429|NCT03610334|10790457|FG002|STARTED|Period 6: 60.0mg (1 Day)||6
9690430|NCT03610334|10790458|FG003|STARTED|Period 6: 60.0mg (1 Day)||2
9690431|NCT03610334|10790459|FG004|STARTED|Period 6: 60.0mg (1 Day)||6
9690432|NCT03610334|10790460|FG005|STARTED|Period 6: 60.0mg (1 Day)||2
9690433|NCT03610334|10790461|FG006|STARTED|Period 6: 60.0mg (1 Day)||6
9690434|NCT03610334|10790462|FG007|STARTED|Period 6: 60.0mg (1 Day)||2
9690435|NCT03610334|10790463|FG008|STARTED|Period 6: 60.0mg (1 Day)||6
9690436|NCT03610334|10790464|FG009|STARTED|Period 6: 60.0mg (1 Day)||2
9690437|NCT03610334|10790465|FG010|STARTED|Period 6: 60.0mg (1 Day)||6
9690438|NCT03610334|10790466|FG011|STARTED|Period 6: 60.0mg (1 Day)||2
9690439|NCT03610334|10790467|FG012|STARTED|Period 6: 60.0mg (1 Day)||0
9690440|NCT03610334|10790468|FG013|STARTED|Period 6: 60.0mg (1 Day)||0
9690441|NCT03610334|10790469|FG014|STARTED|Period 6: 60.0mg (1 Day)||0
9690442|NCT03610334|10790470|FG015|STARTED|Period 6: 60.0mg (1 Day)||0
9690443|NCT03610334|10790471|FG016|STARTED|Period 6: 60.0mg (1 Day)||0
9690444|NCT03610334|10790472|FG017|STARTED|Period 6: 60.0mg (1 Day)||0
9690445|NCT03610334|10790455|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6
9690446|NCT03610334|10790456|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2
9690447|NCT03610334|10790457|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6
9690448|NCT03610334|10790458|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2
9690449|NCT03610334|10790459|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6
9690450|NCT03610334|10790460|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2
9690451|NCT03610334|10790461|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6
9690452|NCT03610334|10790462|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2
9690453|NCT03610334|10790463|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6
9690454|NCT03610334|10790464|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2
9690455|NCT03610334|10790465|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6
9690456|NCT03610334|10790466|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2
9690457|NCT03610334|10790467|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0
9690458|NCT03610334|10790468|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0
9690459|NCT03610334|10790469|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0
9690460|NCT03610334|10790470|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0
9690461|NCT03610334|10790471|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0
9690462|NCT03610334|10790472|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0
9690463|NCT03610334|10790455|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690464|NCT03610334|10790456|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690465|NCT03610334|10790457|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690466|NCT03610334|10790458|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690467|NCT03610334|10790459|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690468|NCT03610334|10790460|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690469|NCT03610334|10790461|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690470|NCT03610334|10790462|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690471|NCT03610334|10790463|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690472|NCT03610334|10790464|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690473|NCT03610334|10790465|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690474|NCT03610334|10790466|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690475|NCT03610334|10790467|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690476|NCT03610334|10790468|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690477|NCT03610334|10790469|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690478|NCT03610334|10790470|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690479|NCT03610334|10790471|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690480|NCT03610334|10790472|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
9690481|NCT03610334|10790455|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
9690482|NCT03610334|10790456|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
9690483|NCT03610334|10790457|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
9690484|NCT03610334|10790458|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
9690485|NCT03610334|10790459|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
9690486|NCT03610334|10790460|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
9690487|NCT03610334|10790461|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
9690488|NCT03610334|10790462|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
9690489|NCT03610334|10790463|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
9690490|NCT03610334|10790464|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
9690491|NCT03610334|10790465|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
9690492|NCT03610334|10790466|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
9690493|NCT03610334|10790467|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
9690494|NCT03610334|10790468|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
9690495|NCT03610334|10790469|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
9690496|NCT03610334|10790470|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
9690497|NCT03610334|10790471|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
9690498|NCT03610334|10790472|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
9690499|NCT03610334|10790455|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
9690500|NCT03610334|10790456|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
9690501|NCT03610334|10790457|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
9690502|NCT03610334|10790458|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
9690503|NCT03610334|10790459|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
9690504|NCT03610334|10790460|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
9690505|NCT03610334|10790461|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
9690506|NCT03610334|10790462|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
9690507|NCT03610334|10790463|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
9690508|NCT03610334|10790464|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
9690509|NCT03610334|10790465|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
9690510|NCT03610334|10790466|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
9690511|NCT03610334|10790467|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
9690512|NCT03610334|10790468|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
9690513|NCT03610334|10790469|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690514|NCT03610334|10790470|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690515|NCT03610334|10790471|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690516|NCT03610334|10790472|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690517|NCT03610334|10790455|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10024411|NCT01862640|11148271|FG001|STARTED|Overall Study||137
10024412|NCT01862640|11148272|FG002|STARTED|Overall Study||140
9690518|NCT03610334|10790456|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690519|NCT03610334|10790457|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690520|NCT03610334|10790458|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690521|NCT03610334|10790459|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690522|NCT03610334|10790460|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690523|NCT03610334|10790461|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690524|NCT03610334|10790462|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690525|NCT03610334|10790463|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690526|NCT03610334|10790464|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690527|NCT03610334|10790465|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690528|NCT03610334|10790466|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690529|NCT03610334|10790467|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690530|NCT03610334|10790468|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690531|NCT03610334|10790469|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690532|NCT03610334|10790470|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690533|NCT03610334|10790471|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690534|NCT03610334|10790472|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
9690535|NCT03610334|10790455|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690536|NCT03610334|10790456|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690537|NCT03610334|10790457|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690538|NCT03610334|10790458|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690539|NCT03610334|10790459|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690540|NCT03610334|10790460|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690541|NCT03610334|10790461|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690542|NCT03610334|10790462|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690543|NCT03610334|10790463|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690544|NCT03610334|10790464|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690545|NCT03610334|10790465|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690546|NCT03610334|10790466|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690547|NCT03610334|10790467|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690548|NCT03610334|10790468|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690549|NCT03610334|10790469|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
9690550|NCT03610334|10790470|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
9690551|NCT03610334|10790471|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
9690552|NCT03610334|10790472|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
9690553|NCT03610334|10790455|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690554|NCT03610334|10790456|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690555|NCT03610334|10790457|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690556|NCT03610334|10790458|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690557|NCT03610334|10790459|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690558|NCT03610334|10790460|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690559|NCT03610334|10790461|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690560|NCT03610334|10790462|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690561|NCT03610334|10790463|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690562|NCT03610334|10790464|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690563|NCT03610334|10790465|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690564|NCT03610334|10790466|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690565|NCT03610334|10790467|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690566|NCT03610334|10790468|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690567|NCT03610334|10790469|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
9690568|NCT03610334|10790470|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
9690569|NCT03610334|10790471|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690570|NCT03610334|10790472|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690571|NCT03610334|10790455|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690572|NCT03610334|10790456|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690573|NCT03610334|10790457|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690574|NCT03610334|10790458|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690575|NCT03610334|10790459|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690576|NCT03610334|10790460|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690577|NCT03610334|10790461|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690578|NCT03610334|10790462|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690579|NCT03610334|10790463|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690580|NCT03610334|10790464|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690581|NCT03610334|10790465|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10024413|NCT01862640|11148273|FG003|STARTED|Overall Study||136
10024414|NCT01862640|11148270|FG000|COMPLETED|Overall Study||13
9690582|NCT03610334|10790466|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690583|NCT03610334|10790467|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690584|NCT03610334|10790468|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690585|NCT03610334|10790469|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690586|NCT03610334|10790470|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690587|NCT03610334|10790471|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690588|NCT03610334|10790472|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
9690589|NCT03610334|10790455|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690590|NCT03610334|10790456|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690591|NCT03610334|10790457|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10024415|NCT01862640|11148271|FG001|COMPLETED|Overall Study||121
10024416|NCT01862640|11148272|FG002|COMPLETED|Overall Study||122
9690592|NCT03610334|10790458|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690593|NCT03610334|10790459|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690594|NCT03610334|10790460|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690595|NCT03610334|10790461|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690596|NCT03610334|10790462|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690597|NCT03610334|10790463|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690598|NCT03610334|10790464|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690599|NCT03610334|10790465|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690600|NCT03610334|10790466|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690601|NCT03610334|10790467|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690602|NCT03610334|10790468|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690603|NCT03610334|10790469|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690604|NCT03610334|10790470|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
9690605|NCT03610334|10790471|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
9690606|NCT03610334|10790472|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10024417|NCT01862640|11148273|FG003|COMPLETED|Overall Study||121
10024418|NCT01862640|11148270|FG000|NOT COMPLETED|Overall Study||7
10024419|NCT01862640|11148271|FG001|NOT COMPLETED|Overall Study||16
10024420|NCT01862640|11148272|FG002|NOT COMPLETED|Overall Study||18
10024421|NCT01862640|11148273|FG003|NOT COMPLETED|Overall Study||15
10024422|NCT01862796|11148285|FG000|STARTED|Overall Study||19
10024423|NCT01862796|11148286|FG001|STARTED|Overall Study||18
10024424|NCT01862796|11148287|FG002|STARTED|Overall Study||24
10024425|NCT01862796|11148285|FG000|COMPLETED|Overall Study||19
10024426|NCT01862796|11148286|FG001|COMPLETED|Overall Study||18
10024427|NCT01862796|11148287|FG002|COMPLETED|Overall Study||23
10024428|NCT01862796|11148285|FG000|NOT COMPLETED|Overall Study||0
10024429|NCT01862796|11148286|FG001|NOT COMPLETED|Overall Study||0
10024430|NCT01862796|11148287|FG002|NOT COMPLETED|Overall Study||1
10024431|NCT01862874|11148297|FG000|STARTED|Overall Study|Randomized participants|562
10024432|NCT01862874|11148298|FG001|STARTED|Overall Study|Randomized participants|562
10024433|NCT01862874|11148297|FG000|Vaccination 1|Overall Study||561
10024434|NCT01862874|11148298|FG001|Vaccination 1|Overall Study||562
10024435|NCT01862874|11148297|FG000|Vaccination 2|Overall Study||539
10024436|NCT01862874|11148298|FG001|Vaccination 2|Overall Study||542
10024437|NCT01862874|11148297|FG000|Vaccination 3|Overall Study||530
10024438|NCT01862874|11148298|FG001|Vaccination 3|Overall Study||532
10024439|NCT01862874|11148297|FG000|COMPLETED|Overall Study||483
10024440|NCT01862874|11148298|FG001|COMPLETED|Overall Study||485
10024441|NCT01862874|11148297|FG000|NOT COMPLETED|Overall Study||79
10024442|NCT01862874|11148298|FG001|NOT COMPLETED|Overall Study||77
10024443|NCT01862991|11148307|FG000|STARTED|Overall Study||24
10024444|NCT01862991|11148308|FG001|STARTED|Overall Study||28
10024445|NCT01862991|11148309|FG002|STARTED|Overall Study||28
10024446|NCT01862991|11148307|FG000|COMPLETED|Overall Study||21
10024447|NCT01862991|11148308|FG001|COMPLETED|Overall Study||27
10024448|NCT01862991|11148309|FG002|COMPLETED|Overall Study||27
10024449|NCT01862991|11148307|FG000|NOT COMPLETED|Overall Study||3
10024450|NCT01862991|11148308|FG001|NOT COMPLETED|Overall Study||1
10024451|NCT01862991|11148309|FG002|NOT COMPLETED|Overall Study||1
10024452|NCT01863017|11148319|FG000|STARTED|Overall Study||12
9690607|NCT03610334|10790455|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690608|NCT03610334|10790456|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690609|NCT03610334|10790457|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690610|NCT03610334|10790458|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690611|NCT03610334|10790459|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690612|NCT03610334|10790460|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690613|NCT03610334|10790461|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690614|NCT03610334|10790462|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690615|NCT03610334|10790463|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690616|NCT03610334|10790464|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690617|NCT03610334|10790465|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690618|NCT03610334|10790466|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690619|NCT03610334|10790467|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690620|NCT03610334|10790468|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690621|NCT03610334|10790469|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690622|NCT03610334|10790470|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690623|NCT03610334|10790471|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
9690624|NCT03610334|10790472|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
9690625|NCT03610334|10790455|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690626|NCT03610334|10790456|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690627|NCT03610334|10790457|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690628|NCT03610334|10790458|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690629|NCT03610334|10790459|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690630|NCT03610334|10790460|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690631|NCT03610334|10790461|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690632|NCT03610334|10790462|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690633|NCT03610334|10790463|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690634|NCT03610334|10790464|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9726450|NCT00100165|10825924|FG001|NOT COMPLETED|Washout (1 Week)||0
9690635|NCT03610334|10790465|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690636|NCT03610334|10790466|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690637|NCT03610334|10790467|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690638|NCT03610334|10790468|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690639|NCT03610334|10790469|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690640|NCT03610334|10790470|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690641|NCT03610334|10790471|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690642|NCT03610334|10790472|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
9690643|NCT03334539|10790522|FG000|STARTED|Overall Study||50
9690644|NCT03334539|10790523|FG001|STARTED|Overall Study||50
9690645|NCT03334539|10790524|FG002|STARTED|Overall Study||50
9690646|NCT03334539|10790522|FG000|COMPLETED|Overall Study||46
9690647|NCT03334539|10790523|FG001|COMPLETED|Overall Study||43
9690648|NCT03334539|10790524|FG002|COMPLETED|Overall Study||49
9690649|NCT03334539|10790522|FG000|NOT COMPLETED|Overall Study||4
9690650|NCT03334539|10790523|FG001|NOT COMPLETED|Overall Study||7
9690651|NCT03334539|10790524|FG002|NOT COMPLETED|Overall Study||1
9690652|NCT03311854|10790537|FG000|STARTED|Overall Study||14
9690653|NCT03311854|10790537|FG000|COMPLETED|Overall Study||14
9690654|NCT03311854|10790537|FG000|NOT COMPLETED|Overall Study||0
9690655|NCT03269344|10790546|FG000|STARTED|Overall Study||33
9690656|NCT03269344|10790547|FG001|STARTED|Overall Study||32
9690657|NCT03269344|10790546|FG000|COMPLETED|Overall Study||29
9690658|NCT03269344|10790547|FG001|COMPLETED|Overall Study||29
9690659|NCT03269344|10790546|FG000|NOT COMPLETED|Overall Study||4
9690660|NCT03269344|10790547|FG001|NOT COMPLETED|Overall Study||3
9690661|NCT03079284|10790553|FG000|STARTED|Overall Study||10
9690662|NCT03079284|10790553|FG000|COMPLETED|Overall Study||10
9690663|NCT03079284|10790553|FG000|NOT COMPLETED|Overall Study||0
9690664|NCT03076775|10790561|FG000|STARTED|Overall Study||44
9690665|NCT03076775|10790562|FG001|STARTED|Overall Study||42
9690666|NCT03076775|10790561|FG000|Neonates Born During Study|Overall Study||43
9690667|NCT03076775|10790562|FG001|Neonates Born During Study|Overall Study||42
9690668|NCT03076775|10790561|FG000|Umbilical Cord Blood Collected|Overall Study||33
9690669|NCT03076775|10790562|FG001|Umbilical Cord Blood Collected|Overall Study||38
9690670|NCT03076775|10790561|FG000|COMPLETED|Overall Study||43
9690671|NCT03076775|10790562|FG001|COMPLETED|Overall Study||42
9690672|NCT03076775|10790561|FG000|NOT COMPLETED|Overall Study||1
9690673|NCT03076775|10790562|FG001|NOT COMPLETED|Overall Study||0
9690674|NCT02933944|10790572|FG000|STARTED|Overall Study||6
9690675|NCT02933944|10790572|FG000|COMPLETED|Overall Study||6
9690676|NCT02933944|10790572|FG000|NOT COMPLETED|Overall Study||0
9690677|NCT02921997|10790581|FG000|STARTED|Overall Study||10
10024453|NCT01863017|11148320|FG001|STARTED|Overall Study||19
10024454|NCT01863017|11148319|FG000|Normal Weight Participants|Overall Study||5
10024455|NCT01863017|11148320|FG001|Normal Weight Participants|Overall Study||5
10024456|NCT01863017|11148319|FG000|Obese Participants|Overall Study||4
10024457|NCT01863017|11148320|FG001|Obese Participants|Overall Study||7
10024458|NCT01863017|11148319|FG000|Participants With PWS|Overall Study||3
10024459|NCT01863017|11148320|FG001|Participants With PWS|Overall Study||7
10024460|NCT01863017|11148319|FG000|COMPLETED|Overall Study||12
10024461|NCT01863017|11148320|FG001|COMPLETED|Overall Study||19
9846689|NCT00849680|10959057|FG004|STARTED|Overall Study||42
9846690|NCT00849680|10959058|FG005|STARTED|Overall Study||42
9846691|NCT00849680|10959059|FG006|STARTED|Overall Study||78
9846692|NCT00849680|10959060|FG007|STARTED|Overall Study||31
9846693|NCT00849680|10959053|FG000|COMPLETED|Overall Study||16
9846694|NCT00849680|10959054|FG001|COMPLETED|Overall Study||10
9846695|NCT00849680|10959055|FG002|COMPLETED|Overall Study||27
9846696|NCT00849680|10959056|FG003|COMPLETED|Overall Study||28
9846697|NCT00849680|10959057|FG004|COMPLETED|Overall Study||32
9846698|NCT00849680|10959058|FG005|COMPLETED|Overall Study||27
9846699|NCT00849680|10959059|FG006|COMPLETED|Overall Study||61
9846700|NCT00849680|10959060|FG007|COMPLETED|Overall Study||23
9846701|NCT00849680|10959053|FG000|NOT COMPLETED|Overall Study||11
9846702|NCT00849680|10959054|FG001|NOT COMPLETED|Overall Study||3
9846703|NCT00849680|10959055|FG002|NOT COMPLETED|Overall Study||15
9846704|NCT00849680|10959056|FG003|NOT COMPLETED|Overall Study||14
10114404|NCT02515942|11245126|FG001|COMPLETED|Overall Study||36
10114405|NCT02515942|11245127|FG002|COMPLETED|Overall Study||35
10114406|NCT02515942|11245125|FG000|NOT COMPLETED|Overall Study||7
10114407|NCT02515942|11245126|FG001|NOT COMPLETED|Overall Study||3
10114408|NCT02515942|11245127|FG002|NOT COMPLETED|Overall Study||4
10114409|NCT02515994|11245139|FG000|STARTED|Overall Study||109
10024462|NCT01863017|11148319|FG000|NOT COMPLETED|Overall Study||0
10024463|NCT01863017|11148320|FG001|NOT COMPLETED|Overall Study||0
10024464|NCT01863030|11148326|FG000|STARTED|Baseline||31
10024465|NCT01863030|11148326|FG000|COMPLETED|Baseline||31
10114410|NCT02515994|11245140|FG001|STARTED|Overall Study||112
9846705|NCT00849680|10959057|FG004|NOT COMPLETED|Overall Study||10
9846706|NCT00849680|10959058|FG005|NOT COMPLETED|Overall Study||15
9846707|NCT00849680|10959059|FG006|NOT COMPLETED|Overall Study||17
10024466|NCT01863030|11148326|FG000|NOT COMPLETED|Baseline||0
10024467|NCT01863030|11148326|FG000|STARTED|Follow up||31
10114411|NCT02515994|11245139|FG000|COMPLETED|Overall Study||99
10024468|NCT01863030|11148326|FG000|2 Weeks|Follow up||31
10024469|NCT01863030|11148326|FG000|3 Months|Follow up||28
10024470|NCT01863030|11148326|FG000|6 Months|Follow up||29
10024471|NCT01863030|11148326|FG000|12 Months|Follow up||26
10024472|NCT01863030|11148326|FG000|24 Months|Follow up||13
10024473|NCT01863030|11148326|FG000|COMPLETED|Follow up||13
10024474|NCT01863030|11148326|FG000|NOT COMPLETED|Follow up||18
10024475|NCT01863134|11148333|FG000|STARTED|Overall Study||72
10024476|NCT01863134|11148334|FG001|STARTED|Overall Study||68
10024477|NCT01863134|11148333|FG000|COMPLETED|Overall Study||72
10024478|NCT01863134|11148334|FG001|COMPLETED|Overall Study||68
10024479|NCT01863134|11148333|FG000|NOT COMPLETED|Overall Study||0
10024480|NCT01863134|11148334|FG001|NOT COMPLETED|Overall Study||0
10024481|NCT01863368|11148342|FG000|STARTED|Phase I, Day 0 to Day 35||46
10024482|NCT01863368|11148343|FG001|STARTED|Phase I, Day 0 to Day 35||48
10024483|NCT01863368|11148342|FG000|Treated|Phase I, Day 0 to Day 35||46
10024484|NCT01863368|11148343|FG001|Treated|Phase I, Day 0 to Day 35||47
10024485|NCT01863368|11148342|FG000|COMPLETED|Phase I, Day 0 to Day 35||43
10024486|NCT01863368|11148343|FG001|COMPLETED|Phase I, Day 0 to Day 35||41
10024487|NCT01863368|11148342|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3
10024488|NCT01863368|11148343|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7
10024489|NCT01863368|11148342|FG000|STARTED|Phase II, Day 35 to Day 90||43
10024490|NCT01863368|11148343|FG001|STARTED|Phase II, Day 35 to Day 90||41
10114412|NCT02515994|11245140|FG001|COMPLETED|Overall Study||105
10114413|NCT02515994|11245139|FG000|NOT COMPLETED|Overall Study||10
10114414|NCT02515994|11245140|FG001|NOT COMPLETED|Overall Study||7
10114415|NCT02516046|11245146|FG000|STARTED|Overall Study|Total number of subjects scanned|156
10114416|NCT02516046|11245146|FG000|Died While on Study|Overall Study||73
10114417|NCT02516046|11245146|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
10114418|NCT02516046|11245146|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
10114419|NCT02516046|11245146|FG000|NOT COMPLETED|Overall Study||92
10114420|NCT02516098|11245162|FG000|STARTED|Period 1||28
10114421|NCT02516098|11245163|FG001|STARTED|Period 1||28
10114422|NCT02516098|11245162|FG000|COMPLETED|Period 1||27
10114423|NCT02516098|11245163|FG001|COMPLETED|Period 1||28
10114424|NCT02516098|11245162|FG000|NOT COMPLETED|Period 1||1
10114425|NCT02516098|11245163|FG001|NOT COMPLETED|Period 1||0
10114426|NCT02516098|11245162|FG000|STARTED|Washout After Period 1||27
10114427|NCT02516098|11245163|FG001|STARTED|Washout After Period 1||28
10114428|NCT02516098|11245162|FG000|COMPLETED|Washout After Period 1||27
10114429|NCT02516098|11245163|FG001|COMPLETED|Washout After Period 1||27
10114430|NCT02516098|11245162|FG000|NOT COMPLETED|Washout After Period 1||0
10114431|NCT02516098|11245163|FG001|NOT COMPLETED|Washout After Period 1||1
10114432|NCT02516098|11245162|FG000|STARTED|Period 2||27
10114433|NCT02516098|11245163|FG001|STARTED|Period 2||27
10114434|NCT02516098|11245162|FG000|COMPLETED|Period 2||27
10114435|NCT02516098|11245163|FG001|COMPLETED|Period 2||26
10114436|NCT02516098|11245162|FG000|NOT COMPLETED|Period 2||0
10114437|NCT02516098|11245163|FG001|NOT COMPLETED|Period 2||1
10114438|NCT02516098|11245162|FG000|STARTED|Washout After Period 2||27
10114439|NCT02516098|11245163|FG001|STARTED|Washout After Period 2||26
10114440|NCT02516098|11245162|FG000|COMPLETED|Washout After Period 2||27
10114441|NCT02516098|11245163|FG001|COMPLETED|Washout After Period 2||26
10114442|NCT02516098|11245162|FG000|NOT COMPLETED|Washout After Period 2||0
10114443|NCT02516098|11245163|FG001|NOT COMPLETED|Washout After Period 2||0
10114444|NCT02516150|11245169|FG000|STARTED|Overall Study||15
10114445|NCT02516150|11245169|FG000|COMPLETED|Overall Study||15
10114446|NCT02516150|11245169|FG000|NOT COMPLETED|Overall Study||0
10114447|NCT02516163|11245175|FG000|STARTED|Overall Study||52
10114448|NCT02516163|11245175|FG000|COMPLETED|Overall Study||24
10114449|NCT02516163|11245175|FG000|NOT COMPLETED|Overall Study||28
10114450|NCT02516202|11245182|FG000|STARTED|Overall Study||102
10114451|NCT02516202|11245183|FG001|STARTED|Overall Study||100
10114452|NCT02516202|11245184|FG002|STARTED|Overall Study||100
10114453|NCT02516202|11245182|FG000|COMPLETED|Overall Study||100
10114454|NCT02516202|11245183|FG001|COMPLETED|Overall Study||99
10024491|NCT01863368|11148342|FG000|COMPLETED|Phase II, Day 35 to Day 90||41
10114455|NCT02516202|11245184|FG002|COMPLETED|Overall Study||97
10114456|NCT02516202|11245182|FG000|NOT COMPLETED|Overall Study||2
10114457|NCT02516202|11245183|FG001|NOT COMPLETED|Overall Study||1
10114458|NCT02516202|11245184|FG002|NOT COMPLETED|Overall Study||3
10024492|NCT01863368|11148343|FG001|COMPLETED|Phase II, Day 35 to Day 90||41
10024493|NCT01863368|11148342|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2
10024494|NCT01863368|11148343|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0
10024495|NCT01863433|11148350|FG000|STARTED|Overall Study||120
10024496|NCT01863433|11148350|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
10114459|NCT02516306|11245194|FG000|STARTED|Period 1: Day 1 - 7||50
10114460|NCT02516306|11245195|FG001|STARTED|Period 1: Day 1 - 7||25
10114461|NCT02516306|11245194|FG000|COMPLETED|Period 1: Day 1 - 7||50
10114462|NCT02516306|11245195|FG001|COMPLETED|Period 1: Day 1 - 7||25
10114463|NCT02516306|11245194|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0
9690678|NCT02921997|10790582|FG001|STARTED|Overall Study||10
9690679|NCT02921997|10790583|FG002|STARTED|Overall Study||10
9690680|NCT02921997|10790581|FG000|COMPLETED|Overall Study||10
9690681|NCT02921997|10790582|FG001|COMPLETED|Overall Study||10
9690682|NCT02921997|10790583|FG002|COMPLETED|Overall Study||10
9690683|NCT02921997|10790581|FG000|NOT COMPLETED|Overall Study||0
9690684|NCT02921997|10790582|FG001|NOT COMPLETED|Overall Study||0
9690685|NCT02921997|10790583|FG002|NOT COMPLETED|Overall Study||0
9690686|NCT02833935|10790595|FG000|STARTED|Overall Study||12
9690687|NCT02833935|10790596|FG001|STARTED|Overall Study||12
9690688|NCT02833935|10790595|FG000|COMPLETED|Overall Study||10
9690689|NCT02833935|10790596|FG001|COMPLETED|Overall Study||12
9690690|NCT02833935|10790595|FG000|NOT COMPLETED|Overall Study||2
9690691|NCT02833935|10790596|FG001|NOT COMPLETED|Overall Study||0
9690692|NCT02660827|10790602|FG000|STARTED|From Study to End of Continued Access||151
9690693|NCT02660827|10790602|FG000|COMPLETED|From Study to End of Continued Access||120
9690694|NCT02660827|10790602|FG000|NOT COMPLETED|From Study to End of Continued Access||31
9690695|NCT02660827|10790602|FG000|STARTED|Period 1: Study Period||151
10024497|NCT01863433|11148350|FG000|NOT COMPLETED|Overall Study||1
10024498|NCT01863498|11148356|FG000|STARTED|Overall Study||33
10024499|NCT01863498|11148357|FG001|STARTED|Overall Study||32
10024500|NCT01863498|11148356|FG000|COMPLETED|Overall Study||33
10024501|NCT01863498|11148357|FG001|COMPLETED|Overall Study||32
9961268|NCT01473368|11081049|FG001|STARTED|Overall Study||12
10024502|NCT01863498|11148356|FG000|NOT COMPLETED|Overall Study||0
9961269|NCT01473368|11081050|FG002|STARTED|Overall Study||15
9690696|NCT02660827|10790602|FG000|COMPLETED|Period 1: Study Period||150
9690697|NCT02660827|10790602|FG000|NOT COMPLETED|Period 1: Study Period||1
9690698|NCT02660827|10790602|FG000|STARTED|Period 2: Continued Access Period||145
9690699|NCT02660827|10790602|FG000|COMPLETED|Period 2: Continued Access Period||120
9690700|NCT02660827|10790602|FG000|NOT COMPLETED|Period 2: Continued Access Period||25
9690701|NCT02627963|10790611|FG000|STARTED|Overall Study||175
9690702|NCT02627963|10790612|FG001|STARTED|Overall Study||175
9690703|NCT02627963|10790611|FG000|COMPLETED|Overall Study||139
10024503|NCT01863498|11148357|FG001|NOT COMPLETED|Overall Study||0
10024504|NCT01863563|11148363|FG000|STARTED|Overall Study||100
9690704|NCT02627963|10790612|FG001|COMPLETED|Overall Study||161
9690705|NCT02627963|10790611|FG000|NOT COMPLETED|Overall Study||36
9690706|NCT02627963|10790612|FG001|NOT COMPLETED|Overall Study||14
9690707|NCT02425644|10790620|FG000|STARTED|Overall Study||567
9690708|NCT02425644|10790621|FG001|STARTED|Overall Study||566
9690709|NCT02425644|10790620|FG000|Treated|Overall Study||565
9690710|NCT02425644|10790621|FG001|Treated|Overall Study||566
9690711|NCT02425644|10790620|FG000|COMPLETED|Overall Study||490
9690712|NCT02425644|10790621|FG001|COMPLETED|Overall Study||495
9690713|NCT02425644|10790620|FG000|NOT COMPLETED|Overall Study||77
9690714|NCT02425644|10790621|FG001|NOT COMPLETED|Overall Study||71
9690715|NCT02395614|10790627|FG000|STARTED|Overall Study||88
9690716|NCT02395614|10790627|FG000|Chlorhexidine Irrigation|Overall Study||88
9690717|NCT02395614|10790627|FG000|Triple Antibiotic Irrigation|Overall Study||88
9690718|NCT02395614|10790627|FG000|COMPLETED|Overall Study||88
9690719|NCT02395614|10790627|FG000|NOT COMPLETED|Overall Study||0
9690720|NCT02340221|10790634|FG000|STARTED|Overall Study||214
9690721|NCT02340221|10790635|FG001|STARTED|Overall Study||417
9690722|NCT02340221|10790634|FG000|COMPLETED|Overall Study||0
9690723|NCT02340221|10790635|FG001|COMPLETED|Overall Study||0
9690724|NCT02340221|10790634|FG000|NOT COMPLETED|Overall Study||214
9690725|NCT02340221|10790635|FG001|NOT COMPLETED|Overall Study||417
9690726|NCT02270957|10790644|FG000|STARTED|Overall Study||31
9690727|NCT02270957|10790645|FG001|STARTED|Overall Study||35
9690728|NCT02270957|10790644|FG000|COMPLETED|Overall Study||27
9690729|NCT02270957|10790645|FG001|COMPLETED|Overall Study||31
9690730|NCT02270957|10790644|FG000|NOT COMPLETED|Overall Study||4
9690731|NCT02270957|10790645|FG001|NOT COMPLETED|Overall Study||4
9690732|NCT02134925|10790654|FG000|STARTED|Overall Study||54
9690733|NCT02134925|10790655|FG001|STARTED|Overall Study||56
9690734|NCT02134925|10790654|FG000|Received at Least One Dose of Treatment|Overall Study||53
9690735|NCT02134925|10790655|FG001|Received at Least One Dose of Treatment|Overall Study||50
9690736|NCT02134925|10790654|FG000|COMPLETED|Overall Study||52
9690737|NCT02134925|10790655|FG001|COMPLETED|Overall Study||50
9690738|NCT02134925|10790654|FG000|NOT COMPLETED|Overall Study||2
9690739|NCT02134925|10790655|FG001|NOT COMPLETED|Overall Study||6
9690740|NCT02054104|10790663|FG000|STARTED|Overall Study||10
9690741|NCT02054104|10790664|FG001|STARTED|Overall Study||11
9690742|NCT02054104|10790663|FG000|COMPLETED|Overall Study||2
9690743|NCT02054104|10790664|FG001|COMPLETED|Overall Study||2
9690744|NCT02054104|10790663|FG000|NOT COMPLETED|Overall Study||8
9690745|NCT02054104|10790664|FG001|NOT COMPLETED|Overall Study||9
9690746|NCT01899144|10790670|FG000|STARTED|Treatment Period 1||61
9690747|NCT01899144|10790670|FG000|COMPLETED|Treatment Period 1||61
9690748|NCT01899144|10790670|FG000|NOT COMPLETED|Treatment Period 1||0
9690749|NCT01899144|10790670|FG000|STARTED|Treatment Period 2||61
9690750|NCT01899144|10790670|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
9690751|NCT01899144|10790670|FG000|NOT COMPLETED|Treatment Period 2||1
9690752|NCT01899144|10790670|FG000|STARTED|Treatment Period 3||60
9690753|NCT01899144|10790670|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
9690754|NCT01899144|10790670|FG000|NOT COMPLETED|Treatment Period 3||2
9690755|NCT01899144|10790670|FG000|STARTED|Treatment Period 4||58
10024505|NCT01863563|11148363|FG000|COMPLETED|Overall Study||100
9690756|NCT01899144|10790670|FG000|COMPLETED|Treatment Period 4||58
9690757|NCT01899144|10790670|FG000|NOT COMPLETED|Treatment Period 4||0
9690758|NCT01899144|10790670|FG000|STARTED|Treatment Period 5||58
9690759|NCT01899144|10790670|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
9690760|NCT01899144|10790670|FG000|NOT COMPLETED|Treatment Period 5||1
9690761|NCT01793610|10790685|FG000|STARTED|Overall Study||6
9690762|NCT01793610|10790686|FG001|STARTED|Overall Study||9
9690763|NCT01793610|10790687|FG002|STARTED|Overall Study||13
9690764|NCT01793610|10790685|FG000|COMPLETED|Overall Study||5
9690765|NCT01793610|10790686|FG001|COMPLETED|Overall Study||9
9690766|NCT01793610|10790687|FG002|COMPLETED|Overall Study||12
9690767|NCT01793610|10790685|FG000|NOT COMPLETED|Overall Study||1
9690768|NCT01793610|10790686|FG001|NOT COMPLETED|Overall Study||0
9690769|NCT01793610|10790687|FG002|NOT COMPLETED|Overall Study||1
9726451|NCT00100165|10825925|FG002|NOT COMPLETED|Washout (1 Week)||0
9726452|NCT00100165|10825923|FG000|STARTED|Third Intervention (4 Weeks)||10
10024506|NCT01863563|11148363|FG000|NOT COMPLETED|Overall Study||0
9846708|NCT00849680|10959060|FG007|NOT COMPLETED|Overall Study||8
9846709|NCT00849693|10959082|FG000|STARTED|Acute Treatment Phase||108
9846710|NCT00849693|10959083|FG001|STARTED|Acute Treatment Phase||116
9846711|NCT00849693|10959084|FG002|STARTED|Acute Treatment Phase||117
9846712|NCT00849693|10959085|FG003|STARTED|Acute Treatment Phase||122
9846713|NCT00849693|10959082|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
9690770|NCT01757665|10790701|FG000|STARTED|Overall Study||694
9690771|NCT01757665|10790702|FG001|STARTED|Overall Study||83
9690772|NCT01757665|10790701|FG000|Implanted With Device|Overall Study||689
9690773|NCT01757665|10790702|FG001|Implanted With Device|Overall Study||82
9690774|NCT01757665|10790701|FG000|COMPLETED|Overall Study||0
9690775|NCT01757665|10790702|FG001|COMPLETED|Overall Study||0
9690776|NCT01757665|10790701|FG000|NOT COMPLETED|Overall Study||694
9690777|NCT01757665|10790702|FG001|NOT COMPLETED|Overall Study||83
9690778|NCT01482195|10790723|FG000|STARTED|Overall Study||6
9690779|NCT01482195|10790723|FG000|One Year Results|Overall Study||6
9690780|NCT01482195|10790723|FG000|COMPLETED|Overall Study||6
9690781|NCT01482195|10790723|FG000|NOT COMPLETED|Overall Study||0
9690782|NCT01468831|10790730|FG000|STARTED|Overall Study||4
9690783|NCT01468831|10790731|FG001|STARTED|Overall Study||5
9690784|NCT01468831|10790730|FG000|Month 12 (Primary Outcome)|Overall Study||4
9690785|NCT01468831|10790731|FG001|Month 12 (Primary Outcome)|Overall Study||4
9690786|NCT01468831|10790730|FG000|COMPLETED|Overall Study||4
9690787|NCT01468831|10790731|FG001|COMPLETED|Overall Study||4
9690788|NCT01468831|10790730|FG000|NOT COMPLETED|Overall Study||0
9690789|NCT01468831|10790731|FG001|NOT COMPLETED|Overall Study||1
9690790|NCT01383109|10790737|FG000|STARTED|Overall Study||6
9690791|NCT01383109|10790737|FG000|COMPLETED|Overall Study||6
9690792|NCT01383109|10790737|FG000|NOT COMPLETED|Overall Study||0
9690793|NCT00822120|10790743|FG000|STARTED|Initial Registration||358
9690794|NCT00822120|10790744|FG001|STARTED|Initial Registration||13
9690795|NCT00822120|10790745|FG002|STARTED|Initial Registration||0
9690796|NCT00822120|10790746|FG003|STARTED|Initial Registration||0
9690797|NCT00822120|10790747|FG004|STARTED|Initial Registration||0
9690798|NCT00822120|10790748|FG005|STARTED|Initial Registration||0
9690799|NCT00822120|10790743|FG000|Eligible and Evaluable Patients|Initial Registration||336
9690800|NCT00822120|10790744|FG001|Eligible and Evaluable Patients|Initial Registration||12
9690801|NCT00822120|10790745|FG002|Eligible and Evaluable Patients|Initial Registration||0
9690802|NCT00822120|10790746|FG003|Eligible and Evaluable Patients|Initial Registration||0
9690803|NCT00822120|10790747|FG004|Eligible and Evaluable Patients|Initial Registration||0
9690804|NCT00822120|10790748|FG005|Eligible and Evaluable Patients|Initial Registration||0
9690805|NCT00822120|10790743|FG000|COMPLETED|Initial Registration||332
9690806|NCT00822120|10790744|FG001|COMPLETED|Initial Registration||12
9690807|NCT00822120|10790745|FG002|COMPLETED|Initial Registration||0
9690808|NCT00822120|10790746|FG003|COMPLETED|Initial Registration||0
9690809|NCT00822120|10790747|FG004|COMPLETED|Initial Registration||0
9690810|NCT00822120|10790748|FG005|COMPLETED|Initial Registration||0
9690811|NCT00822120|10790743|FG000|NOT COMPLETED|Initial Registration||26
9690812|NCT00822120|10790744|FG001|NOT COMPLETED|Initial Registration||1
9690813|NCT00822120|10790745|FG002|NOT COMPLETED|Initial Registration||0
9690814|NCT00822120|10790746|FG003|NOT COMPLETED|Initial Registration||0
9690815|NCT00822120|10790747|FG004|NOT COMPLETED|Initial Registration||0
9690816|NCT00822120|10790748|FG005|NOT COMPLETED|Initial Registration||0
9690817|NCT00822120|10790743|FG000|STARTED|PET-directed Therapy||0
9690818|NCT00822120|10790744|FG001|STARTED|PET-directed Therapy||0
9690819|NCT00822120|10790745|FG002|STARTED|PET-directed Therapy||270
9846714|NCT00849693|10959083|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
9846715|NCT00849693|10959084|FG002|COMPLETED|Acute Treatment Phase||84
9846716|NCT00849693|10959085|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
9846717|NCT00849693|10959082|FG000|NOT COMPLETED|Acute Treatment Phase||33
9846718|NCT00849693|10959083|FG001|NOT COMPLETED|Acute Treatment Phase||35
9846719|NCT00849693|10959084|FG002|NOT COMPLETED|Acute Treatment Phase||33
9846720|NCT00849693|10959085|FG003|NOT COMPLETED|Acute Treatment Phase||37
9846721|NCT00849693|10959082|FG000|STARTED|Extension Phase||73
9846722|NCT00849693|10959083|FG001|STARTED|Extension Phase||80
9846723|NCT00849693|10959084|FG002|STARTED|Extension Phase||84
9846724|NCT00849693|10959085|FG003|STARTED|Extension Phase||82
9846725|NCT00849693|10959082|FG000|COMPLETED|Extension Phase||43
9846726|NCT00849693|10959083|FG001|COMPLETED|Extension Phase||50
9846727|NCT00849693|10959084|FG002|COMPLETED|Extension Phase||49
9846728|NCT00849693|10959085|FG003|COMPLETED|Extension Phase||44
9846729|NCT00849693|10959082|FG000|NOT COMPLETED|Extension Phase||30
9846730|NCT00849693|10959083|FG001|NOT COMPLETED|Extension Phase||30
9846731|NCT00849693|10959084|FG002|NOT COMPLETED|Extension Phase||35
9846732|NCT00849693|10959085|FG003|NOT COMPLETED|Extension Phase||38
9846733|NCT00849810|10959107|FG000|STARTED|Overall Study||1
9846734|NCT00849810|10959107|FG000|COMPLETED|Overall Study||1
9690820|NCT00822120|10790746|FG003|STARTED|PET-directed Therapy||55
9846735|NCT00849810|10959107|FG000|NOT COMPLETED|Overall Study||0
9690821|NCT00822120|10790747|FG004|STARTED|PET-directed Therapy||10
9690822|NCT00822120|10790748|FG005|STARTED|PET-directed Therapy||1
10024507|NCT01863667|11148369|FG000|STARTED|Overall Study||33
10024508|NCT01863667|11148370|FG001|STARTED|Overall Study||32
10024509|NCT01863667|11148369|FG000|COMPLETED|Overall Study||0
10024510|NCT01863667|11148370|FG001|COMPLETED|Overall Study||0
10024511|NCT01863667|11148369|FG000|NOT COMPLETED|Overall Study||33
10024512|NCT01863667|11148370|FG001|NOT COMPLETED|Overall Study||32
10024513|NCT01863680|11148376|FG000|STARTED|Overall Study||178
10024514|NCT01863680|11148376|FG000|Subjects Started COS Treatment|Overall Study||169
9690823|NCT00822120|10790743|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0
9690824|NCT00822120|10790744|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0
9690825|NCT00822120|10790745|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270
9690826|NCT00822120|10790746|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55
9690827|NCT00822120|10790747|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10
9690828|NCT00822120|10790748|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1
9690829|NCT00822120|10790743|FG000|COMPLETED|PET-directed Therapy||0
9690830|NCT00822120|10790744|FG001|COMPLETED|PET-directed Therapy||0
9690831|NCT00822120|10790745|FG002|COMPLETED|PET-directed Therapy||270
9690832|NCT00822120|10790746|FG003|COMPLETED|PET-directed Therapy||45
9690833|NCT00822120|10790747|FG004|COMPLETED|PET-directed Therapy||10
9690834|NCT00822120|10790748|FG005|COMPLETED|PET-directed Therapy||1
9690835|NCT00822120|10790743|FG000|NOT COMPLETED|PET-directed Therapy||0
9690836|NCT00822120|10790744|FG001|NOT COMPLETED|PET-directed Therapy||0
9690837|NCT00822120|10790745|FG002|NOT COMPLETED|PET-directed Therapy||0
9690838|NCT00822120|10790746|FG003|NOT COMPLETED|PET-directed Therapy||10
9690839|NCT00822120|10790747|FG004|NOT COMPLETED|PET-directed Therapy||0
9690840|NCT00822120|10790748|FG005|NOT COMPLETED|PET-directed Therapy||0
9690841|NCT00603954|10790771|FG000|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|50
9690842|NCT00603954|10790772|FG001|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|47
9690843|NCT00603954|10790771|FG000|COMPLETED|Overall Study||49
9690844|NCT00603954|10790772|FG001|COMPLETED|Overall Study||45
9690845|NCT00603954|10790771|FG000|NOT COMPLETED|Overall Study||1
9690846|NCT00603954|10790772|FG001|NOT COMPLETED|Overall Study||2
9726453|NCT00100165|10825924|FG001|STARTED|Third Intervention (4 Weeks)||10
9726454|NCT00100165|10825925|FG002|STARTED|Third Intervention (4 Weeks)||9
9726455|NCT00100165|10825923|FG000|COMPLETED|Third Intervention (4 Weeks)||10
9726456|NCT00100165|10825924|FG001|COMPLETED|Third Intervention (4 Weeks)||10
9726457|NCT00100165|10825925|FG002|COMPLETED|Third Intervention (4 Weeks)||9
9726458|NCT00100165|10825923|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
9726459|NCT00100165|10825924|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0
9726460|NCT00100165|10825925|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0
9726461|NCT00100178|10825939|FG000|STARTED|Overall Study||41
9726462|NCT00100178|10825940|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
9726463|NCT00100178|10825941|FG002|STARTED|Overall Study||42
9726464|NCT00100178|10825939|FG000|COMPLETED|Overall Study||32
9726465|NCT00100178|10825940|FG001|COMPLETED|Overall Study||21
9726466|NCT00100178|10825941|FG002|COMPLETED|Overall Study||32
9726467|NCT00100178|10825939|FG000|NOT COMPLETED|Overall Study||9
9726468|NCT00100178|10825940|FG001|NOT COMPLETED|Overall Study||10
9726469|NCT00100178|10825941|FG002|NOT COMPLETED|Overall Study||10
9726470|NCT00100230|10825951|FG000|STARTED|Overall Study||41
9726471|NCT00100230|10825952|FG001|STARTED|Overall Study||37
9726472|NCT00100230|10825951|FG000|COMPLETED|Overall Study||29
9726473|NCT00100230|10825952|FG001|COMPLETED|Overall Study||22
9726474|NCT00100230|10825951|FG000|NOT COMPLETED|Overall Study||12
9726475|NCT00100230|10825952|FG001|NOT COMPLETED|Overall Study||15
9726476|NCT00100659|10825962|FG000|STARTED|Overall Study||55
9726477|NCT00100659|10825963|FG001|STARTED|Overall Study||59
9726478|NCT00100659|10825962|FG000|COMPLETED|Overall Study||52
9726479|NCT00100659|10825963|FG001|COMPLETED|Overall Study||57
9726480|NCT00100659|10825962|FG000|NOT COMPLETED|Overall Study||3
9726481|NCT00100659|10825963|FG001|NOT COMPLETED|Overall Study||2
9726482|NCT00100698|10825973|FG000|STARTED|Overall Study||27
9726483|NCT00100698|10825974|FG001|STARTED|Overall Study||29
9726484|NCT00100698|10825973|FG000|COMPLETED|Overall Study||21
9726485|NCT00100698|10825974|FG001|COMPLETED|Overall Study||27
9726486|NCT00100698|10825973|FG000|NOT COMPLETED|Overall Study||6
9726487|NCT00100698|10825974|FG001|NOT COMPLETED|Overall Study||2
9726488|NCT00100789|10825980|FG000|STARTED|Overall Study||67
9726489|NCT00100789|10825980|FG000|Eligible|Overall Study||64
9726490|NCT00100789|10825980|FG000|Eligible and Began Protocol Therapy|Overall Study||63
9726491|NCT00100789|10825980|FG000|COMPLETED|Overall Study||3
9726492|NCT00100789|10825980|FG000|NOT COMPLETED|Overall Study||64
9726493|NCT00100802|10825985|FG000|STARTED|Overall Study||118
9726494|NCT00100802|10825985|FG000|COMPLETED|Overall Study||38
9726495|NCT00100802|10825985|FG000|NOT COMPLETED|Overall Study||80
9726496|NCT00100815|10825989|FG000|STARTED|Overall Study||50
9726497|NCT00100815|10825989|FG000|COMPLETED|Overall Study||1
9726498|NCT00100815|10825989|FG000|NOT COMPLETED|Overall Study||49
9726499|NCT00100841|10825993|FG000|STARTED|Overall Study||66
9726500|NCT00100841|10825993|FG000|COMPLETED|Overall Study||66
9726501|NCT00100841|10825993|FG000|NOT COMPLETED|Overall Study||0
9726502|NCT00100932|10825999|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
9731841|NCT00136812|10831806|FG001|COMPLETED|Overall Study||113
9690847|NCT05087524|10790779|FG000|STARTED|Overall Study||65
9690848|NCT05087524|10790779|FG000|COMPLETED|Overall Study||65
9690849|NCT05087524|10790779|FG000|NOT COMPLETED|Overall Study||0
9690850|NCT04532294|10790786|FG000|STARTED|Overall Study||4
9690851|NCT04532294|10790787|FG001|STARTED|Overall Study||6
9690852|NCT04532294|10790788|FG002|STARTED|Overall Study||8
9690853|NCT04532294|10790786|FG000|COMPLETED|Overall Study||4
9690854|NCT04532294|10790787|FG001|COMPLETED|Overall Study||6
9690855|NCT04532294|10790788|FG002|COMPLETED|Overall Study||5
9690856|NCT04532294|10790786|FG000|NOT COMPLETED|Overall Study||0
9690857|NCT04532294|10790787|FG001|NOT COMPLETED|Overall Study||0
9690858|NCT04532294|10790788|FG002|NOT COMPLETED|Overall Study||3
9690859|NCT04250077|10790801|FG000|STARTED|Overall Study||15
9690860|NCT04250077|10790802|FG001|STARTED|Overall Study||15
9690861|NCT04250077|10790803|FG002|STARTED|Overall Study||15
9690862|NCT04250077|10790801|FG000|COMPLETED|Overall Study||13
9690863|NCT04250077|10790802|FG001|COMPLETED|Overall Study||11
9690864|NCT04250077|10790803|FG002|COMPLETED|Overall Study||15
9690865|NCT04250077|10790801|FG000|NOT COMPLETED|Overall Study||2
9690866|NCT04250077|10790802|FG001|NOT COMPLETED|Overall Study||4
9690867|NCT04250077|10790803|FG002|NOT COMPLETED|Overall Study||0
9690889|NCT03583931|10790847|FG000|STARTED|Overall Study||5
9690890|NCT03583931|10790848|FG001|STARTED|Overall Study||5
9690891|NCT03583931|10790847|FG000|COMPLETED|Overall Study||5
9690892|NCT03583931|10790848|FG001|COMPLETED|Overall Study||5
9690893|NCT03583931|10790847|FG000|NOT COMPLETED|Overall Study||0
9690894|NCT03583931|10790848|FG001|NOT COMPLETED|Overall Study||0
9690895|NCT03505710|10790857|FG000|STARTED|Overall Study||49
9690896|NCT03505710|10790858|FG001|STARTED|Overall Study||41
9690897|NCT03505710|10790859|FG002|STARTED|Overall Study||91
9690898|NCT03505710|10790857|FG000|COMPLETED|Overall Study||2
9690899|NCT03505710|10790858|FG001|COMPLETED|Overall Study||14
9690900|NCT03505710|10790859|FG002|COMPLETED|Overall Study||15
9690901|NCT03505710|10790857|FG000|NOT COMPLETED|Overall Study||47
9690902|NCT03505710|10790858|FG001|NOT COMPLETED|Overall Study||27
9690903|NCT03505710|10790859|FG002|NOT COMPLETED|Overall Study||76
9690904|NCT03296553|10790869|FG000|STARTED|Overall Study||20
9690905|NCT03296553|10790870|FG001|STARTED|Overall Study||20
9690906|NCT03296553|10790869|FG000|COMPLETED|Overall Study||18
9690907|NCT03296553|10790870|FG001|COMPLETED|Overall Study||19
9690908|NCT03296553|10790869|FG000|NOT COMPLETED|Overall Study||2
9690909|NCT03296553|10790870|FG001|NOT COMPLETED|Overall Study||1
9690910|NCT03148795|10790876|FG000|STARTED|Overall Study||128
9690911|NCT03148795|10790876|FG000|Treated|Overall Study||127
9690912|NCT03148795|10790876|FG000|COMPLETED|Overall Study||0
9690913|NCT03148795|10790876|FG000|NOT COMPLETED|Overall Study||128
9690914|NCT03049449|10790888|FG000|STARTED|Overall Study||0
9690915|NCT03049449|10790889|FG001|STARTED|Overall Study||3
9690916|NCT03049449|10790890|FG002|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|4
9690917|NCT03049449|10790891|FG003|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|8
9690918|NCT03049449|10790892|FG004|STARTED|Overall Study||5
9690919|NCT03049449|10790893|FG005|STARTED|Overall Study||0
9690920|NCT03049449|10790894|FG006|STARTED|Overall Study||3
9690921|NCT03049449|10790895|FG007|STARTED|Overall Study||1
9690922|NCT03049449|10790896|FG008|STARTED|Overall Study||1
9690923|NCT03049449|10790897|FG009|STARTED|Overall Study||1
9690924|NCT03049449|10790888|FG000|COMPLETED|Overall Study||0
9690925|NCT03049449|10790889|FG001|COMPLETED|Overall Study||3
9690926|NCT03049449|10790890|FG002|COMPLETED|Overall Study||3
9690927|NCT03049449|10790891|FG003|COMPLETED|Overall Study||7
9690928|NCT03049449|10790892|FG004|COMPLETED|Overall Study||5
9690929|NCT03049449|10790893|FG005|COMPLETED|Overall Study||0
9690930|NCT03049449|10790894|FG006|COMPLETED|Overall Study||3
9690931|NCT03049449|10790895|FG007|COMPLETED|Overall Study||0
9690932|NCT03049449|10790896|FG008|COMPLETED|Overall Study||0
9690933|NCT03049449|10790897|FG009|COMPLETED|Overall Study||0
9690934|NCT03049449|10790888|FG000|NOT COMPLETED|Overall Study||0
9690935|NCT03049449|10790889|FG001|NOT COMPLETED|Overall Study||0
9690936|NCT03049449|10790890|FG002|NOT COMPLETED|Overall Study||1
9690937|NCT03049449|10790891|FG003|NOT COMPLETED|Overall Study||1
9690938|NCT03049449|10790892|FG004|NOT COMPLETED|Overall Study||0
9690939|NCT03049449|10790893|FG005|NOT COMPLETED|Overall Study||0
9690940|NCT03049449|10790894|FG006|NOT COMPLETED|Overall Study||0
9690941|NCT03049449|10790895|FG007|NOT COMPLETED|Overall Study||1
9690942|NCT03049449|10790896|FG008|NOT COMPLETED|Overall Study||1
9690943|NCT03049449|10790897|FG009|NOT COMPLETED|Overall Study||1
9690944|NCT03000569|10790917|FG000|STARTED|Overall Study||15
9690945|NCT03000569|10790918|FG001|STARTED|Overall Study||14
9690946|NCT03000569|10790917|FG000|COMPLETED|Overall Study||14
9690868|NCT04068142|10790815|FG000|STARTED|Overall Study||17
9690869|NCT04068142|10790816|FG001|STARTED|Overall Study||20
9690870|NCT04068142|10790815|FG000|COMPLETED|Overall Study||15
9690871|NCT04068142|10790816|FG001|COMPLETED|Overall Study||16
9690872|NCT04068142|10790815|FG000|NOT COMPLETED|Overall Study||2
9690873|NCT04068142|10790816|FG001|NOT COMPLETED|Overall Study||4
9690874|NCT03961009|10790822|FG000|STARTED|Overall Study||47
9690875|NCT03961009|10790822|FG000|COMPLETED|Overall Study||47
9690876|NCT03961009|10790822|FG000|NOT COMPLETED|Overall Study||0
9690877|NCT03875495|10790826|FG000|STARTED|Overall Study||3
9690878|NCT03875495|10790826|FG000|COMPLETED|Overall Study||0
9690879|NCT03875495|10790826|FG000|NOT COMPLETED|Overall Study||3
9690880|NCT03702439|10790830|FG000|STARTED|Overall Study||408
9690881|NCT03702439|10790830|FG000|COMPLETED|Overall Study||408
9690882|NCT03702439|10790830|FG000|NOT COMPLETED|Overall Study||0
9690883|NCT03687190|10790838|FG000|STARTED|Overall Study||12
9690884|NCT03687190|10790839|FG001|STARTED|Overall Study||9
9690885|NCT03687190|10790838|FG000|COMPLETED|Overall Study||12
9690886|NCT03687190|10790839|FG001|COMPLETED|Overall Study||9
9690887|NCT03687190|10790838|FG000|NOT COMPLETED|Overall Study||0
9690888|NCT03687190|10790839|FG001|NOT COMPLETED|Overall Study||0
9690947|NCT03000569|10790918|FG001|COMPLETED|Overall Study||14
9690948|NCT03000569|10790917|FG000|NOT COMPLETED|Overall Study||1
9690949|NCT03000569|10790918|FG001|NOT COMPLETED|Overall Study||0
9690950|NCT03000530|10790935|FG000|STARTED|Overall Study||13
9690951|NCT03000530|10790936|FG001|STARTED|Overall Study||44
9690952|NCT03000530|10790937|FG002|STARTED|Overall Study||45
9690953|NCT03000530|10790935|FG000|COMPLETED|Overall Study||13
9690954|NCT03000530|10790936|FG001|COMPLETED|Overall Study||39
9690955|NCT03000530|10790937|FG002|COMPLETED|Overall Study||41
9690956|NCT03000530|10790935|FG000|NOT COMPLETED|Overall Study||0
9690957|NCT03000530|10790936|FG001|NOT COMPLETED|Overall Study||5
9690958|NCT03000530|10790937|FG002|NOT COMPLETED|Overall Study||4
9690959|NCT02978781|10790951|FG000|STARTED|Part A||2
9690960|NCT02978781|10790952|FG001|STARTED|Part A||14
9690961|NCT02978781|10790953|FG002|STARTED|Part A||0
9690962|NCT02978781|10790954|FG003|STARTED|Part A||0
9690963|NCT02978781|10790955|FG004|STARTED|Part A||0
9690964|NCT02978781|10790951|FG000|COMPLETED|Part A||1
9690965|NCT02978781|10790952|FG001|COMPLETED|Part A||12
9690966|NCT02978781|10790953|FG002|COMPLETED|Part A||0
9690967|NCT02978781|10790954|FG003|COMPLETED|Part A||0
9690968|NCT02978781|10790955|FG004|COMPLETED|Part A||0
9690969|NCT02978781|10790951|FG000|NOT COMPLETED|Part A||1
9690970|NCT02978781|10790952|FG001|NOT COMPLETED|Part A||2
9690971|NCT02978781|10790953|FG002|NOT COMPLETED|Part A||0
9690972|NCT02978781|10790954|FG003|NOT COMPLETED|Part A||0
9690973|NCT02978781|10790955|FG004|NOT COMPLETED|Part A||0
9690974|NCT02978781|10790951|FG000|STARTED|Part B||0
9690975|NCT02978781|10790952|FG001|STARTED|Part B||0
9690976|NCT02978781|10790953|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
9690977|NCT02978781|10790954|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
9690978|NCT02978781|10790955|FG004|STARTED|Part B||0
9690979|NCT02978781|10790951|FG000|COMPLETED|Part B||0
9690980|NCT02978781|10790952|FG001|COMPLETED|Part B||0
9690981|NCT02978781|10790953|FG002|COMPLETED|Part B||4
9690982|NCT02978781|10790954|FG003|COMPLETED|Part B||3
9690983|NCT02978781|10790955|FG004|COMPLETED|Part B||0
9690984|NCT02978781|10790951|FG000|NOT COMPLETED|Part B||0
9690985|NCT02978781|10790952|FG001|NOT COMPLETED|Part B||0
9690986|NCT02978781|10790953|FG002|NOT COMPLETED|Part B||0
9690987|NCT02978781|10790954|FG003|NOT COMPLETED|Part B||1
9690988|NCT02978781|10790955|FG004|NOT COMPLETED|Part B||0
9690989|NCT02978781|10790951|FG000|STARTED|Part C||0
9690990|NCT02978781|10790952|FG001|STARTED|Part C||0
9690991|NCT02978781|10790953|FG002|STARTED|Part C||0
9690992|NCT02978781|10790954|FG003|STARTED|Part C||0
10024515|NCT01863680|11148376|FG000|Subjects Received hCG Injection|Overall Study||162
10024516|NCT01863680|11148376|FG000|Subjects Received Study Drug|Overall Study||149
10024517|NCT01863680|11148376|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123
9690993|NCT02978781|10790955|FG004|STARTED|Part C||18
9690994|NCT02978781|10790951|FG000|COMPLETED|Part C||0
9690995|NCT02978781|10790952|FG001|COMPLETED|Part C||0
9690996|NCT02978781|10790953|FG002|COMPLETED|Part C||0
9690997|NCT02978781|10790954|FG003|COMPLETED|Part C||0
9690998|NCT02978781|10790955|FG004|COMPLETED|Part C||14
9690999|NCT02978781|10790951|FG000|NOT COMPLETED|Part C||0
10024518|NCT01863680|11148376|FG000|COMPLETED|Overall Study||121
9691000|NCT02978781|10790952|FG001|NOT COMPLETED|Part C||0
9691001|NCT02978781|10790953|FG002|NOT COMPLETED|Part C||0
9691002|NCT02978781|10790954|FG003|NOT COMPLETED|Part C||0
9691003|NCT02978781|10790955|FG004|NOT COMPLETED|Part C||4
9691004|NCT02964507|10790989|FG000|STARTED|Overall Study||33
9691005|NCT02964507|10790990|FG001|STARTED|Overall Study||12
9691006|NCT02964507|10790991|FG002|STARTED|Overall Study||42
9691007|NCT02964507|10790992|FG003|STARTED|Overall Study||7
9691008|NCT02964507|10790993|FG004|STARTED|Overall Study||18
9691009|NCT02964507|10790994|FG005|STARTED|Overall Study||11
9691010|NCT02964507|10790995|FG006|STARTED|Overall Study||0
9691011|NCT02964507|10790996|FG007|STARTED|Overall Study||0
9691012|NCT02964507|10790989|FG000|COMPLETED|Overall Study||7
9691013|NCT02964507|10790990|FG001|COMPLETED|Overall Study||1
9691014|NCT02964507|10790991|FG002|COMPLETED|Overall Study||17
9691015|NCT02964507|10790992|FG003|COMPLETED|Overall Study||1
9691016|NCT02964507|10790993|FG004|COMPLETED|Overall Study||2
9691017|NCT02964507|10790994|FG005|COMPLETED|Overall Study||3
9691018|NCT02964507|10790995|FG006|COMPLETED|Overall Study||0
9846736|NCT00849875|10959114|FG000|STARTED|Overall Study||48
9846737|NCT00849875|10959114|FG000|COMPLETED|Overall Study||1
9846738|NCT00849875|10959114|FG000|NOT COMPLETED|Overall Study||47
9846739|NCT00849901|10959128|FG000|STARTED|Acute Treatment Phase||117
9846740|NCT00849901|10959129|FG001|STARTED|Acute Treatment Phase||117
9846741|NCT00849901|10959130|FG002|STARTED|Acute Treatment Phase||103
9846742|NCT00849901|10959128|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
9846743|NCT00849901|10959129|FG001|COMPLETED|Acute Treatment Phase||91
9846744|NCT00849901|10959130|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
9846745|NCT00849901|10959128|FG000|NOT COMPLETED|Acute Treatment Phase||30
9846746|NCT00849901|10959129|FG001|NOT COMPLETED|Acute Treatment Phase||26
9846747|NCT00849901|10959130|FG002|NOT COMPLETED|Acute Treatment Phase||16
9846748|NCT00849901|10959128|FG000|STARTED|Extension Phase||83
9846749|NCT00849901|10959129|FG001|STARTED|Extension Phase||91
9846750|NCT00849901|10959130|FG002|STARTED|Extension Phase||86
9846751|NCT00849901|10959128|FG000|COMPLETED|Extension Phase||56
9846752|NCT00849901|10959129|FG001|COMPLETED|Extension Phase||65
9846753|NCT00849901|10959130|FG002|COMPLETED|Extension Phase||69
9846754|NCT00849901|10959128|FG000|NOT COMPLETED|Extension Phase||27
9846755|NCT00849901|10959129|FG001|NOT COMPLETED|Extension Phase||26
9846756|NCT00849901|10959130|FG002|NOT COMPLETED|Extension Phase||17
9961270|NCT01473368|11081051|FG003|STARTED|Overall Study||12
9961271|NCT01473368|11081048|FG000|COMPLETED|Overall Study||13
9961272|NCT01473368|11081049|FG001|COMPLETED|Overall Study||12
9961273|NCT01473368|11081050|FG002|COMPLETED|Overall Study||12
9961274|NCT01473368|11081051|FG003|COMPLETED|Overall Study||12
9961275|NCT01473368|11081048|FG000|NOT COMPLETED|Overall Study||1
9961276|NCT01473368|11081049|FG001|NOT COMPLETED|Overall Study||0
9961277|NCT01473368|11081050|FG002|NOT COMPLETED|Overall Study||3
9961278|NCT01473368|11081051|FG003|NOT COMPLETED|Overall Study||0
9961279|NCT01473381|11081081|FG000|STARTED|Overall Study||290
9961280|NCT01473381|11081082|FG001|STARTED|Overall Study||292
9961281|NCT01473381|11081083|FG002|STARTED|Overall Study||291
9961282|NCT01473381|11081084|FG003|STARTED|Overall Study||289
9961283|NCT01473381|11081081|FG000|Safety Population|Overall Study||281
9961284|NCT01473381|11081082|FG001|Safety Population|Overall Study||288
9961285|NCT01473381|11081083|FG002|Safety Population|Overall Study||287
9961286|NCT01473381|11081084|FG003|Safety Population|Overall Study||282
9961287|NCT01473381|11081081|FG000|COMPLETED|Overall Study||210
9961288|NCT01473381|11081082|FG001|COMPLETED|Overall Study||199
9961289|NCT01473381|11081083|FG002|COMPLETED|Overall Study||189
9961290|NCT01473381|11081084|FG003|COMPLETED|Overall Study||200
9961291|NCT01473381|11081081|FG000|NOT COMPLETED|Overall Study||80
9961292|NCT01473381|11081082|FG001|NOT COMPLETED|Overall Study||93
9961293|NCT01473381|11081083|FG002|NOT COMPLETED|Overall Study||102
9961294|NCT01473381|11081084|FG003|NOT COMPLETED|Overall Study||89
9961295|NCT01473394|11081097|FG000|STARTED|Overall Study||253
9961296|NCT01473394|11081098|FG001|STARTED|Overall Study||255
9961297|NCT01473394|11081097|FG000|COMPLETED|Overall Study||208
9961298|NCT01473394|11081098|FG001|COMPLETED|Overall Study||212
9961299|NCT01473394|11081097|FG000|NOT COMPLETED|Overall Study||45
9961300|NCT01473394|11081098|FG001|NOT COMPLETED|Overall Study||43
9961301|NCT01473407|11081106|FG000|STARTED|Overall Study||306
9961302|NCT01473407|11081107|FG001|STARTED|Overall Study||306
9961303|NCT01473407|11081106|FG000|COMPLETED|Overall Study||252
9961304|NCT01473407|11081107|FG001|COMPLETED|Overall Study||259
9961305|NCT01473407|11081106|FG000|NOT COMPLETED|Overall Study||54
9961306|NCT01473407|11081107|FG001|NOT COMPLETED|Overall Study||47
9961307|NCT01473420|11081115|FG000|STARTED|Titration Period (18 Weeks)||160
9961308|NCT01473420|11081116|FG001|STARTED|Titration Period (18 Weeks)||160
9961309|NCT01473420|11081115|FG000|Treated|Titration Period (18 Weeks)||80
9961310|NCT01473420|11081116|FG001|Treated|Titration Period (18 Weeks)||86
9961311|NCT01473420|11081115|FG000|COMPLETED|Titration Period (18 Weeks)||124
9961312|NCT01473420|11081116|FG001|COMPLETED|Titration Period (18 Weeks)||122
9961313|NCT01473420|11081115|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36
9961314|NCT01473420|11081116|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38
9961315|NCT01473420|11081115|FG000|STARTED|Maintenance Period (16 Weeks)||124
9961316|NCT01473420|11081116|FG001|STARTED|Maintenance Period (16 Weeks)||122
9961317|NCT01473420|11081115|FG000|COMPLETED|Maintenance Period (16 Weeks)||106
9961318|NCT01473420|11081116|FG001|COMPLETED|Maintenance Period (16 Weeks)||105
9961319|NCT01473420|11081115|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18
9961320|NCT01473420|11081116|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17
9961321|NCT01473524|11081131|FG000|STARTED|DB Phase||71
9961322|NCT01473524|11081132|FG001|STARTED|DB Phase||73
9961323|NCT01473524|11081133|FG002|STARTED|DB Phase||73
9961324|NCT01473524|11081134|FG003|STARTED|DB Phase||0
9961325|NCT01473524|11081135|FG004|STARTED|DB Phase||0
9961326|NCT01473524|11081136|FG005|STARTED|DB Phase||0
9961327|NCT01473524|11081131|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70
9961328|NCT01473524|11081132|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73
9961329|NCT01473524|11081133|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73
9961330|NCT01473524|11081134|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
9961331|NCT01473524|11081135|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0
9961332|NCT01473524|11081136|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0
9961333|NCT01473524|11081131|FG000|COMPLETED|DB Phase||64
9961334|NCT01473524|11081132|FG001|COMPLETED|DB Phase||64
9961335|NCT01473524|11081133|FG002|COMPLETED|DB Phase||70
9691019|NCT02964507|10790996|FG007|COMPLETED|Overall Study||0
9691020|NCT02964507|10790989|FG000|NOT COMPLETED|Overall Study||26
9691021|NCT02964507|10790990|FG001|NOT COMPLETED|Overall Study||11
9691022|NCT02964507|10790991|FG002|NOT COMPLETED|Overall Study||25
9691023|NCT02964507|10790992|FG003|NOT COMPLETED|Overall Study||6
9691024|NCT02964507|10790993|FG004|NOT COMPLETED|Overall Study||16
9691025|NCT02964507|10790994|FG005|NOT COMPLETED|Overall Study||8
9691026|NCT02964507|10790995|FG006|NOT COMPLETED|Overall Study||0
9691027|NCT02964507|10790996|FG007|NOT COMPLETED|Overall Study||0
9691028|NCT02942277|10791026|FG000|STARTED|Year 1||5
9691029|NCT02942277|10791027|FG001|STARTED|Year 1||10
9691030|NCT02942277|10791028|FG002|STARTED|Year 1||5
9691031|NCT02942277|10791029|FG003|STARTED|Year 1||10
9691032|NCT02942277|10791030|FG004|STARTED|Year 1||56
9691033|NCT02942277|10791031|FG005|STARTED|Year 1||61
9691034|NCT02942277|10791032|FG006|STARTED|Year 1||5
9691035|NCT02942277|10791033|FG007|STARTED|Year 1||10
9691036|NCT02942277|10791034|FG008|STARTED|Year 1||10
9691037|NCT02942277|10791035|FG009|STARTED|Year 1||10
9691038|NCT02942277|10791036|FG010|STARTED|Year 1||119
9691039|NCT02942277|10791026|FG000|COMPLETED|Year 1||5
9691040|NCT02942277|10791027|FG001|COMPLETED|Year 1||8
9691041|NCT02942277|10791028|FG002|COMPLETED|Year 1||5
9691042|NCT02942277|10791029|FG003|COMPLETED|Year 1||9
9691043|NCT02942277|10791030|FG004|COMPLETED|Year 1||49
9691044|NCT02942277|10791031|FG005|COMPLETED|Year 1||51
9691045|NCT02942277|10791032|FG006|COMPLETED|Year 1||5
9691046|NCT02942277|10791033|FG007|COMPLETED|Year 1||9
9691047|NCT02942277|10791034|FG008|COMPLETED|Year 1||10
9691048|NCT02942277|10791035|FG009|COMPLETED|Year 1||10
9691049|NCT02942277|10791036|FG010|COMPLETED|Year 1||104
9691050|NCT02942277|10791026|FG000|NOT COMPLETED|Year 1||0
9691051|NCT02942277|10791027|FG001|NOT COMPLETED|Year 1||2
9691052|NCT02942277|10791028|FG002|NOT COMPLETED|Year 1||0
9691053|NCT02942277|10791029|FG003|NOT COMPLETED|Year 1||1
9691054|NCT02942277|10791030|FG004|NOT COMPLETED|Year 1||7
9691055|NCT02942277|10791031|FG005|NOT COMPLETED|Year 1||10
9691056|NCT02942277|10791032|FG006|NOT COMPLETED|Year 1||0
9691057|NCT02942277|10791033|FG007|NOT COMPLETED|Year 1||1
9691058|NCT02942277|10791034|FG008|NOT COMPLETED|Year 1||0
9691059|NCT02942277|10791035|FG009|NOT COMPLETED|Year 1||0
9691060|NCT02942277|10791036|FG010|NOT COMPLETED|Year 1||15
9691061|NCT02942277|10791026|FG000|STARTED|Year 2||5
9691062|NCT02942277|10791027|FG001|STARTED|Year 2||8
9691063|NCT02942277|10791028|FG002|STARTED|Year 2||5
9691064|NCT02942277|10791029|FG003|STARTED|Year 2||9
9691065|NCT02942277|10791030|FG004|STARTED|Year 2||49
9691066|NCT02942277|10791031|FG005|STARTED|Year 2||51
9691067|NCT02942277|10791032|FG006|STARTED|Year 2||5
9691068|NCT02942277|10791033|FG007|STARTED|Year 2||9
9691069|NCT02942277|10791034|FG008|STARTED|Year 2||10
9691070|NCT02942277|10791035|FG009|STARTED|Year 2||10
9691071|NCT02942277|10791036|FG010|STARTED|Year 2||104
9691072|NCT02942277|10791026|FG000|COMPLETED|Year 2||5
9691073|NCT02942277|10791027|FG001|COMPLETED|Year 2||7
9691074|NCT02942277|10791028|FG002|COMPLETED|Year 2||4
9691075|NCT02942277|10791029|FG003|COMPLETED|Year 2||8
9691076|NCT02942277|10791030|FG004|COMPLETED|Year 2||36
9691077|NCT02942277|10791031|FG005|COMPLETED|Year 2||40
9691078|NCT02942277|10791032|FG006|COMPLETED|Year 2||4
9691079|NCT02942277|10791033|FG007|COMPLETED|Year 2||8
9691080|NCT02942277|10791034|FG008|COMPLETED|Year 2||10
9691081|NCT02942277|10791035|FG009|COMPLETED|Year 2||9
9691082|NCT02942277|10791036|FG010|COMPLETED|Year 2||79
9691083|NCT02942277|10791026|FG000|NOT COMPLETED|Year 2||0
9691084|NCT02942277|10791027|FG001|NOT COMPLETED|Year 2||1
9691085|NCT02942277|10791028|FG002|NOT COMPLETED|Year 2||1
9691086|NCT02942277|10791029|FG003|NOT COMPLETED|Year 2||1
9691087|NCT02942277|10791030|FG004|NOT COMPLETED|Year 2||13
9691088|NCT02942277|10791031|FG005|NOT COMPLETED|Year 2||11
9691089|NCT02942277|10791032|FG006|NOT COMPLETED|Year 2||1
9691090|NCT02942277|10791033|FG007|NOT COMPLETED|Year 2||1
9691091|NCT02942277|10791034|FG008|NOT COMPLETED|Year 2||0
9691092|NCT02942277|10791035|FG009|NOT COMPLETED|Year 2||1
9691093|NCT02942277|10791036|FG010|NOT COMPLETED|Year 2||25
9691094|NCT02942017|10791065|FG000|STARTED|Overall Study||54
9691095|NCT02942017|10791066|FG001|STARTED|Overall Study||54
9691096|NCT02942017|10791065|FG000|Treated|Overall Study||53
9691097|NCT02942017|10791066|FG001|Treated|Overall Study||51
9691098|NCT02942017|10791065|FG000|COMPLETED|Overall Study||52
9691099|NCT02942017|10791066|FG001|COMPLETED|Overall Study||48
9691100|NCT02942017|10791065|FG000|NOT COMPLETED|Overall Study||2
9691101|NCT02942017|10791066|FG001|NOT COMPLETED|Overall Study||6
9691102|NCT02942004|10791075|FG000|STARTED|Overall Study||46
9691103|NCT02942004|10791076|FG001|STARTED|Overall Study||47
9691104|NCT02942004|10791077|FG002|STARTED|Overall Study||45
9691105|NCT02942004|10791075|FG000|Participants Who Received Study Drug|Overall Study||43
9691106|NCT02942004|10791076|FG001|Participants Who Received Study Drug|Overall Study||38
9691107|NCT02942004|10791077|FG002|Participants Who Received Study Drug|Overall Study||41
9691108|NCT02942004|10791075|FG000|COMPLETED|Overall Study||42
9691109|NCT02942004|10791076|FG001|COMPLETED|Overall Study||35
9691110|NCT02942004|10791077|FG002|COMPLETED|Overall Study||36
9691111|NCT02942004|10791075|FG000|NOT COMPLETED|Overall Study||4
9691112|NCT02942004|10791076|FG001|NOT COMPLETED|Overall Study||12
9691113|NCT02942004|10791077|FG002|NOT COMPLETED|Overall Study||9
9691114|NCT02861014|10791085|FG000|STARTED|Primary Analysis||680
9691115|NCT02861014|10791085|FG000|COMPLETED|Primary Analysis||641
9691116|NCT02861014|10791085|FG000|NOT COMPLETED|Primary Analysis||39
9691117|NCT02861014|10791085|FG000|STARTED|Safety Follow-up||64
9691118|NCT02861014|10791085|FG000|COMPLETED|Safety Follow-up||14
9691119|NCT02861014|10791085|FG000|NOT COMPLETED|Safety Follow-up||50
9726503|NCT00100932|10826000|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
9726504|NCT00100932|10825999|FG000|COMPLETED|Overall Study||5
9726505|NCT00100932|10826000|FG001|COMPLETED|Overall Study||1
9726506|NCT00100932|10825999|FG000|NOT COMPLETED|Overall Study||73
9726507|NCT00100932|10826000|FG001|NOT COMPLETED|Overall Study||27
9726508|NCT00101010|10826006|FG000|STARTED|Overall Study||80
9726509|NCT00101010|10826006|FG000|COMPLETED|Overall Study||79
9726510|NCT00101010|10826006|FG000|NOT COMPLETED|Overall Study||1
9726511|NCT00101036|10826012|FG000|STARTED|Overall Study||17
9726512|NCT00101036|10826013|FG001|STARTED|Overall Study||40
9726513|NCT00101036|10826012|FG000|COMPLETED|Overall Study||17
9726514|NCT00101036|10826013|FG001|COMPLETED|Overall Study||40
9726515|NCT00101036|10826012|FG000|NOT COMPLETED|Overall Study||0
9726516|NCT00101036|10826013|FG001|NOT COMPLETED|Overall Study||0
9726517|NCT00101101|10826019|FG000|STARTED|Overall Study||43
9726518|NCT00101101|10826019|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
9726519|NCT00101101|10826019|FG000|NOT COMPLETED|Overall Study||20
9726520|NCT00101166|10826023|FG000|STARTED|Overall Study||28
9726521|NCT00101166|10826023|FG000|COMPLETED|Overall Study||18
9726522|NCT00101166|10826023|FG000|NOT COMPLETED|Overall Study||10
9726523|NCT00101192|10826027|FG000|STARTED|Overall Study||76
9726524|NCT00101192|10826027|FG000|COMPLETED|Overall Study||69
9726525|NCT00101192|10826027|FG000|NOT COMPLETED|Overall Study||7
9726526|NCT00101283|10826033|FG000|STARTED|Overall Study||16
9726527|NCT00101283|10826034|FG001|STARTED|Overall Study||16
9726528|NCT00101283|10826033|FG000|Began Treatment|Overall Study||16
9726529|NCT00101283|10826034|FG001|Began Treatment|Overall Study||13
9726530|NCT00101283|10826033|FG000|COMPLETED|Overall Study||16
9726531|NCT00101283|10826034|FG001|COMPLETED|Overall Study||13
9726532|NCT00101283|10826033|FG000|NOT COMPLETED|Overall Study||0
9726533|NCT00101283|10826034|FG001|NOT COMPLETED|Overall Study||3
9726534|NCT00101361|10826042|FG000|STARTED|Overall Study||108
9726535|NCT00101361|10826043|FG001|STARTED|Overall Study||104
9726536|NCT00101361|10826042|FG000|COMPLETED|Overall Study||108
9726537|NCT00101361|10826043|FG001|COMPLETED|Overall Study||104
9726538|NCT00101361|10826042|FG000|NOT COMPLETED|Overall Study||0
9726539|NCT00101361|10826043|FG001|NOT COMPLETED|Overall Study||0
9726540|NCT00101400|10826049|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
9726541|NCT00101400|10826049|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
9726542|NCT00101400|10826049|FG000|NOT COMPLETED|Treatment||0
9726543|NCT00101400|10826049|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
9726544|NCT00101400|10826049|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
9726545|NCT00101400|10826049|FG000|NOT COMPLETED|Survival Follow-Up||7
9726546|NCT00101413|10826053|FG000|STARTED|Overall Study||52
9726547|NCT00101413|10826053|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
9726548|NCT00101413|10826053|FG000|NOT COMPLETED|Overall Study||0
9726549|NCT00101452|10826060|FG000|STARTED|Overall Study||65
9726550|NCT00101452|10826061|FG001|STARTED|Overall Study||69
9726551|NCT00101452|10826062|FG002|STARTED|Overall Study||65
9726552|NCT00101452|10826060|FG000|COMPLETED|Overall Study||21
9726553|NCT00101452|10826061|FG001|COMPLETED|Overall Study||26
9726554|NCT00101452|10826062|FG002|COMPLETED|Overall Study||22
9726555|NCT00101452|10826060|FG000|NOT COMPLETED|Overall Study||44
9726556|NCT00101452|10826061|FG001|NOT COMPLETED|Overall Study||43
9726557|NCT00101452|10826062|FG002|NOT COMPLETED|Overall Study||43
9726558|NCT00101582|10826076|FG000|STARTED|Overall Study||94
9726559|NCT00101582|10826077|FG001|STARTED|Overall Study||94
9726560|NCT00101582|10826076|FG000|Received Study Drug|Overall Study||91
9726561|NCT00101582|10826077|FG001|Received Study Drug|Overall Study||94
9726562|NCT00101582|10826076|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
9726563|NCT00101582|10826077|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
9726564|NCT00101582|10826076|FG000|NOT COMPLETED|Overall Study||11
9726565|NCT00101582|10826077|FG001|NOT COMPLETED|Overall Study||15
9726566|NCT00101647|10826085|FG000|STARTED|Overall Study|Randomized|13
9726567|NCT00101647|10826086|FG001|STARTED|Overall Study|Randomized|161
9726568|NCT00101647|10826085|FG000|COMPLETED|Overall Study||13
9726569|NCT00101647|10826086|FG001|COMPLETED|Overall Study||161
9726570|NCT00101647|10826085|FG000|NOT COMPLETED|Overall Study||0
9726571|NCT00101647|10826086|FG001|NOT COMPLETED|Overall Study||0
9726572|NCT00101660|10826104|FG000|STARTED|Overall Study||99
9726573|NCT00101660|10826105|FG001|STARTED|Overall Study||288
9726574|NCT00101660|10826104|FG000|COMPLETED|Overall Study||99
9726575|NCT00101660|10826105|FG001|COMPLETED|Overall Study||288
9726576|NCT00101660|10826104|FG000|NOT COMPLETED|Overall Study||0
9726577|NCT00101660|10826105|FG001|NOT COMPLETED|Overall Study||0
9726578|NCT00101686|10826127|FG000|STARTED|Overall Study||71
9726579|NCT00101686|10826128|FG001|STARTED|Overall Study||73
9726580|NCT00101686|10826129|FG002|STARTED|Overall Study||69
9726581|NCT00101686|10826130|FG003|STARTED|Overall Study||72
9726582|NCT00101686|10826131|FG004|STARTED|Overall Study||73
9726583|NCT00101686|10826132|FG005|STARTED|Overall Study||72
9726584|NCT00101686|10826133|FG006|STARTED|Overall Study||27
9691120|NCT02775435|10791093|FG000|STARTED|Overall Study||278
9691121|NCT02775435|10791094|FG001|STARTED|Overall Study||281
9691122|NCT02775435|10791093|FG000|Treated|Overall Study||278
9691123|NCT02775435|10791094|FG001|Treated|Overall Study||280
9691124|NCT02775435|10791093|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
9691125|NCT02775435|10791094|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
9691126|NCT02775435|10791093|FG000|COMPLETED|Overall Study||0
9691127|NCT02775435|10791094|FG001|COMPLETED|Overall Study||0
9691128|NCT02775435|10791093|FG000|NOT COMPLETED|Overall Study||278
9691129|NCT02775435|10791094|FG001|NOT COMPLETED|Overall Study||281
9691130|NCT02767531|10791100|FG000|STARTED|Period 1|Orlistat therapy|1
9691131|NCT02767531|10791101|FG001|STARTED|Period 1|Off Orlistat|1
9691132|NCT02767531|10791100|FG000|COMPLETED|Period 1||1
9691133|NCT02767531|10791101|FG001|COMPLETED|Period 1||1
9691134|NCT02767531|10791100|FG000|NOT COMPLETED|Period 1||0
9691135|NCT02767531|10791101|FG001|NOT COMPLETED|Period 1||0
9691136|NCT02767531|10791100|FG000|STARTED|Period 2|Off Orlistat|1
9691137|NCT02767531|10791101|FG001|STARTED|Period 2|Orlistat Therapy|1
9691138|NCT02767531|10791100|FG000|COMPLETED|Period 2||1
9691139|NCT02767531|10791101|FG001|COMPLETED|Period 2||1
9691140|NCT02767531|10791100|FG000|NOT COMPLETED|Period 2||0
9691141|NCT02767531|10791101|FG001|NOT COMPLETED|Period 2||0
9691142|NCT02767531|10791100|FG000|STARTED|Period 3|Orlistat Therapy|1
9691143|NCT02767531|10791101|FG001|STARTED|Period 3|Off Orlistat|1
9691144|NCT02767531|10791100|FG000|COMPLETED|Period 3||1
9691145|NCT02767531|10791101|FG001|COMPLETED|Period 3||1
9691146|NCT02767531|10791100|FG000|NOT COMPLETED|Period 3||0
9691147|NCT02767531|10791101|FG001|NOT COMPLETED|Period 3||0
9691148|NCT02767531|10791100|FG000|STARTED|Period 4|Off Orlistat|1
9691149|NCT02767531|10791101|FG001|STARTED|Period 4|Orlistat Therapy|1
9691150|NCT02767531|10791100|FG000|COMPLETED|Period 4||1
9691151|NCT02767531|10791101|FG001|COMPLETED|Period 4||1
9691152|NCT02767531|10791100|FG000|NOT COMPLETED|Period 4||0
9691153|NCT02767531|10791101|FG001|NOT COMPLETED|Period 4||0
9691154|NCT02726880|10791109|FG000|STARTED|Overall Study||17
9691155|NCT02726880|10791110|FG001|STARTED|Overall Study||19
9691156|NCT02726880|10791109|FG000|COMPLETED|Overall Study||14
9691157|NCT02726880|10791110|FG001|COMPLETED|Overall Study||16
9691158|NCT02726880|10791109|FG000|NOT COMPLETED|Overall Study||3
9691159|NCT02726880|10791110|FG001|NOT COMPLETED|Overall Study||3
9691160|NCT02614547|10791119|FG000|STARTED|Overall Study||11
9691161|NCT02614547|10791120|FG001|STARTED|Overall Study||10
9691162|NCT02614547|10791119|FG000|COMPLETED|Overall Study||11
9691163|NCT02614547|10791120|FG001|COMPLETED|Overall Study||10
9691164|NCT02614547|10791119|FG000|NOT COMPLETED|Overall Study||0
9691165|NCT02614547|10791120|FG001|NOT COMPLETED|Overall Study||0
9691166|NCT02592551|10791132|FG000|STARTED|Overall Study||9
9691167|NCT02592551|10791133|FG001|STARTED|Overall Study||11
9691168|NCT02592551|10791134|FG002|STARTED|Overall Study||4
9691169|NCT02592551|10791132|FG000|COMPLETED|Overall Study|One participant completed all study procedures and got the tumor sample for analysis. However, the sample was too small to analyze in the lab and so that it was not evaluable for primary and secondary analysis.|8
9691170|NCT02592551|10791133|FG001|COMPLETED|Overall Study||8
9691171|NCT02592551|10791134|FG002|COMPLETED|Overall Study||4
9691172|NCT02592551|10791132|FG000|NOT COMPLETED|Overall Study||1
9691173|NCT02592551|10791133|FG001|NOT COMPLETED|Overall Study||3
9691174|NCT02592551|10791134|FG002|NOT COMPLETED|Overall Study||0
9691175|NCT02583048|10791146|FG000|STARTED|Overall Study||28
9691176|NCT02583048|10791147|FG001|STARTED|Overall Study||28
9961336|NCT01473524|11081134|FG003|COMPLETED|DB Phase||0
9961337|NCT01473524|11081135|FG004|COMPLETED|DB Phase||0
9961338|NCT01473524|11081136|FG005|COMPLETED|DB Phase||0
9961339|NCT01473524|11081131|FG000|NOT COMPLETED|DB Phase||7
9961340|NCT01473524|11081132|FG001|NOT COMPLETED|DB Phase||9
9691177|NCT02583048|10791148|FG002|STARTED|Overall Study||28
9691178|NCT02583048|10791146|FG000|COMPLETED|Overall Study||28
9691179|NCT02583048|10791147|FG001|COMPLETED|Overall Study||27
9691180|NCT02583048|10791148|FG002|COMPLETED|Overall Study||27
9691181|NCT02583048|10791146|FG000|NOT COMPLETED|Overall Study||0
9691182|NCT02583048|10791147|FG001|NOT COMPLETED|Overall Study||1
9691183|NCT02583048|10791148|FG002|NOT COMPLETED|Overall Study||1
9691184|NCT02546986|10791161|FG000|STARTED|Treatment Period||51
9691185|NCT02546986|10791162|FG001|STARTED|Treatment Period||49
9691186|NCT02546986|10791161|FG000|COMPLETED|Treatment Period||0
9691187|NCT02546986|10791162|FG001|COMPLETED|Treatment Period||0
9691188|NCT02546986|10791161|FG000|NOT COMPLETED|Treatment Period||51
9691189|NCT02546986|10791162|FG001|NOT COMPLETED|Treatment Period||49
9691190|NCT02546986|10791161|FG000|STARTED|Survival Follow-Up Phase||36
9691191|NCT02546986|10791162|FG001|STARTED|Survival Follow-Up Phase||35
9691192|NCT02546986|10791161|FG000|COMPLETED|Survival Follow-Up Phase||0
9691193|NCT02546986|10791162|FG001|COMPLETED|Survival Follow-Up Phase||0
9691194|NCT02546986|10791161|FG000|NOT COMPLETED|Survival Follow-Up Phase||36
9691195|NCT02546986|10791162|FG001|NOT COMPLETED|Survival Follow-Up Phase||35
9691196|NCT02539160|10791170|FG000|STARTED|Phase 1 Pre-crossover||24
9691197|NCT02539160|10791171|FG001|STARTED|Phase 1 Pre-crossover||24
9691198|NCT02539160|10791172|FG002|STARTED|Phase 1 Pre-crossover||22
9691199|NCT02539160|10791173|FG003|STARTED|Phase 1 Pre-crossover||22
9961341|NCT01473524|11081133|FG002|NOT COMPLETED|DB Phase||3
9961342|NCT01473524|11081134|FG003|NOT COMPLETED|DB Phase||0
9961343|NCT01473524|11081135|FG004|NOT COMPLETED|DB Phase||0
9961344|NCT01473524|11081136|FG005|NOT COMPLETED|DB Phase||0
9691200|NCT02539160|10791170|FG000|COMPLETED|Phase 1 Pre-crossover||19
9691201|NCT02539160|10791171|FG001|COMPLETED|Phase 1 Pre-crossover||20
9691202|NCT02539160|10791172|FG002|COMPLETED|Phase 1 Pre-crossover||19
9691203|NCT02539160|10791173|FG003|COMPLETED|Phase 1 Pre-crossover||19
9691204|NCT02539160|10791170|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5
9691205|NCT02539160|10791171|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4
9691206|NCT02539160|10791172|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3
9691207|NCT02539160|10791173|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3
9691208|NCT02539160|10791170|FG000|STARTED|Phase 2 Post-crossover||19
9691209|NCT02539160|10791171|FG001|STARTED|Phase 2 Post-crossover||20
9691210|NCT02539160|10791172|FG002|STARTED|Phase 2 Post-crossover||19
9691211|NCT02539160|10791173|FG003|STARTED|Phase 2 Post-crossover||19
9691212|NCT02539160|10791170|FG000|COMPLETED|Phase 2 Post-crossover||19
9691213|NCT02539160|10791171|FG001|COMPLETED|Phase 2 Post-crossover||20
9691214|NCT02539160|10791172|FG002|COMPLETED|Phase 2 Post-crossover||19
9691215|NCT02539160|10791173|FG003|COMPLETED|Phase 2 Post-crossover||19
9691216|NCT02539160|10791170|FG000|NOT COMPLETED|Phase 2 Post-crossover||0
9691217|NCT02539160|10791171|FG001|NOT COMPLETED|Phase 2 Post-crossover||0
9691218|NCT02539160|10791172|FG002|NOT COMPLETED|Phase 2 Post-crossover||0
9691219|NCT02539160|10791173|FG003|NOT COMPLETED|Phase 2 Post-crossover||0
9691220|NCT02507973|10791183|FG000|STARTED|Overall Study||8
9691221|NCT02507973|10791183|FG000|COMPLETED|Overall Study||7
9691222|NCT02507973|10791183|FG000|NOT COMPLETED|Overall Study||1
9691223|NCT02477618|10791191|FG000|STARTED|Overall Study||65
9691224|NCT02477618|10791192|FG001|STARTED|Overall Study||67
9691225|NCT02477618|10791191|FG000|Intent-to-Treat Analysis Set|Overall Study||66
9691226|NCT02477618|10791192|FG001|Intent-to-Treat Analysis Set|Overall Study||66
9691227|NCT02477618|10791191|FG000|COMPLETED|Overall Study||50
9691228|NCT02477618|10791192|FG001|COMPLETED|Overall Study||53
9691229|NCT02477618|10791191|FG000|NOT COMPLETED|Overall Study||15
9691230|NCT02477618|10791192|FG001|NOT COMPLETED|Overall Study||14
9691231|NCT02424851|10791200|FG000|STARTED|Overall Study||16
9691232|NCT02424851|10791201|FG001|STARTED|Overall Study||15
9691233|NCT02424851|10791200|FG000|COMPLETED|Overall Study||14
9691234|NCT02424851|10791201|FG001|COMPLETED|Overall Study||12
9691235|NCT02424851|10791200|FG000|NOT COMPLETED|Overall Study||2
9691236|NCT02424851|10791201|FG001|NOT COMPLETED|Overall Study||3
9691237|NCT02285504|10791207|FG000|STARTED|Overall Study||4
9691238|NCT02285504|10791207|FG000|COMPLETED|Overall Study||4
9691239|NCT02285504|10791207|FG000|NOT COMPLETED|Overall Study||0
9691240|NCT02227394|10791211|FG000|STARTED|Overall Study||10
9691241|NCT02227394|10791212|FG001|STARTED|Overall Study||10
9691242|NCT02227394|10791211|FG000|COMPLETED|Overall Study||10
9691243|NCT02227394|10791212|FG001|COMPLETED|Overall Study||10
9691244|NCT02227394|10791211|FG000|NOT COMPLETED|Overall Study||0
9691245|NCT02227394|10791212|FG001|NOT COMPLETED|Overall Study||0
9691246|NCT02073968|10791218|FG000|STARTED|Overall Study||35
9691247|NCT02073968|10791218|FG000|COMPLETED|Overall Study||35
9691248|NCT02073968|10791218|FG000|NOT COMPLETED|Overall Study||0
9691249|NCT02003924|10791224|FG000|STARTED|Double-blind Phase||933
9691250|NCT02003924|10791225|FG001|STARTED|Double-blind Phase||468
9691251|NCT02003924|10791226|FG002|STARTED|Double-blind Phase||0
9691252|NCT02003924|10791224|FG000|Treated|Double-blind Phase||930
9691253|NCT02003924|10791225|FG001|Treated|Double-blind Phase||465
9691254|NCT02003924|10791226|FG002|Treated|Double-blind Phase||0
9691255|NCT02003924|10791224|FG000|COMPLETED|Double-blind Phase||478
9691256|NCT02003924|10791225|FG001|COMPLETED|Double-blind Phase||87
9691257|NCT02003924|10791226|FG002|COMPLETED|Double-blind Phase||0
9691258|NCT02003924|10791224|FG000|NOT COMPLETED|Double-blind Phase||455
9691259|NCT02003924|10791225|FG001|NOT COMPLETED|Double-blind Phase||381
9691260|NCT02003924|10791226|FG002|NOT COMPLETED|Double-blind Phase||0
9691261|NCT02003924|10791224|FG000|STARTED|Open-label Phase||478
9691262|NCT02003924|10791225|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
9691263|NCT02003924|10791226|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
9691264|NCT02003924|10791224|FG000|Treated|Open-label Phase||478
9691265|NCT02003924|10791225|FG001|Treated|Open-label Phase||0
9691266|NCT02003924|10791226|FG002|Treated|Open-label Phase||87
9691267|NCT02003924|10791224|FG000|COMPLETED|Open-label Phase||378
9691268|NCT02003924|10791225|FG001|COMPLETED|Open-label Phase||0
9691269|NCT02003924|10791226|FG002|COMPLETED|Open-label Phase||70
9691270|NCT02003924|10791224|FG000|NOT COMPLETED|Open-label Phase||100
9691271|NCT02003924|10791225|FG001|NOT COMPLETED|Open-label Phase||0
9691272|NCT02003924|10791226|FG002|NOT COMPLETED|Open-label Phase||17
9691273|NCT02003924|10791224|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
9691274|NCT02003924|10791225|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
9691275|NCT02003924|10791226|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
9691276|NCT02003924|10791224|FG000|COMPLETED|Long-term Follow-up Phase||566
9691277|NCT02003924|10791225|FG001|COMPLETED|Long-term Follow-up Phase||144
9691278|NCT02003924|10791226|FG002|COMPLETED|Long-term Follow-up Phase||80
9691279|NCT02003924|10791224|FG000|NOT COMPLETED|Long-term Follow-up Phase||367
9691280|NCT02003924|10791225|FG001|NOT COMPLETED|Long-term Follow-up Phase||237
9691281|NCT02003924|10791226|FG002|NOT COMPLETED|Long-term Follow-up Phase||7
9691282|NCT01971970|10791235|FG000|STARTED|Baseline Until Week 6||24
9691283|NCT01971970|10791236|FG001|STARTED|Baseline Until Week 6||21
9691284|NCT01971970|10791235|FG000|Receiving Standard Therapy|Baseline Until Week 6||23
9691285|NCT01971970|10791236|FG001|Receiving Standard Therapy|Baseline Until Week 6||21
9691286|NCT01971970|10791235|FG000|Therapy Escalation|Baseline Until Week 6||1
9691287|NCT01971970|10791236|FG001|Therapy Escalation|Baseline Until Week 6||0
9691288|NCT01971970|10791235|FG000|COMPLETED|Baseline Until Week 6||23
9691289|NCT01971970|10791236|FG001|COMPLETED|Baseline Until Week 6||21
9691290|NCT01971970|10791235|FG000|NOT COMPLETED|Baseline Until Week 6||1
9691291|NCT01971970|10791236|FG001|NOT COMPLETED|Baseline Until Week 6||0
9691292|NCT01971970|10791235|FG000|STARTED|Week 6 Until Week 8||23
9691293|NCT01971970|10791236|FG001|STARTED|Week 6 Until Week 8||21
9691294|NCT01971970|10791235|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23
9691295|NCT01971970|10791236|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20
9691296|NCT01971970|10791235|FG000|COMPLETED|Week 6 Until Week 8||23
9691297|NCT01971970|10791236|FG001|COMPLETED|Week 6 Until Week 8||20
9691298|NCT01971970|10791235|FG000|NOT COMPLETED|Week 6 Until Week 8||0
9691299|NCT01971970|10791236|FG001|NOT COMPLETED|Week 6 Until Week 8||1
9691300|NCT01971970|10791235|FG000|STARTED|Week 8 Until Week 14||23
9691301|NCT01971970|10791236|FG001|STARTED|Week 8 Until Week 14||20
9691302|NCT01971970|10791235|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16
9691303|NCT01971970|10791236|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19
9691304|NCT01971970|10791235|FG000|Therapy Escalation|Week 8 Until Week 14||7
9691305|NCT01971970|10791236|FG001|Therapy Escalation|Week 8 Until Week 14||1
9691306|NCT01971970|10791235|FG000|COMPLETED|Week 8 Until Week 14||23
9691307|NCT01971970|10791236|FG001|COMPLETED|Week 8 Until Week 14||20
9691308|NCT01971970|10791235|FG000|NOT COMPLETED|Week 8 Until Week 14||0
9691309|NCT01971970|10791236|FG001|NOT COMPLETED|Week 8 Until Week 14||0
9691310|NCT01971970|10791235|FG000|STARTED|Week 14 Until Week 22||23
9691311|NCT01971970|10791236|FG001|STARTED|Week 14 Until Week 22||20
9691312|NCT01971970|10791235|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12
9691313|NCT01971970|10791236|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16
9691314|NCT01971970|10791235|FG000|Therapy Escalation|Week 14 Until Week 22||3
9691315|NCT01971970|10791236|FG001|Therapy Escalation|Week 14 Until Week 22||2
9691316|NCT01971970|10791235|FG000|COMPLETED|Week 14 Until Week 22||23
9691317|NCT01971970|10791236|FG001|COMPLETED|Week 14 Until Week 22||19
9691318|NCT01971970|10791235|FG000|NOT COMPLETED|Week 14 Until Week 22||0
9691319|NCT01971970|10791236|FG001|NOT COMPLETED|Week 14 Until Week 22||1
9691320|NCT01971970|10791235|FG000|STARTED|Week 22 Until Week 52||23
9691321|NCT01971970|10791236|FG001|STARTED|Week 22 Until Week 52||19
9691322|NCT01971970|10791235|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5
9691323|NCT01971970|10791236|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9
9691324|NCT01971970|10791235|FG000|Therapy Escalation|Week 22 Until Week 52||6
9691325|NCT01971970|10791236|FG001|Therapy Escalation|Week 22 Until Week 52||6
9691326|NCT01971970|10791235|FG000|COMPLETED|Week 22 Until Week 52||15
9691327|NCT01971970|10791236|FG001|COMPLETED|Week 22 Until Week 52||15
9691328|NCT01971970|10791235|FG000|NOT COMPLETED|Week 22 Until Week 52||8
9691329|NCT01971970|10791236|FG001|NOT COMPLETED|Week 22 Until Week 52||4
9691330|NCT01971970|10791235|FG000|STARTED|Week 52 Until Week 78||15
9691331|NCT01971970|10791236|FG001|STARTED|Week 52 Until Week 78||15
9691332|NCT01971970|10791235|FG000|COMPLETED|Week 52 Until Week 78||14
9691333|NCT01971970|10791236|FG001|COMPLETED|Week 52 Until Week 78||12
9691334|NCT01971970|10791235|FG000|NOT COMPLETED|Week 52 Until Week 78||1
9691335|NCT01971970|10791236|FG001|NOT COMPLETED|Week 52 Until Week 78||3
9691336|NCT01969409|10791249|FG000|STARTED|Overall Study||28
9691337|NCT01969409|10791250|FG001|STARTED|Overall Study||30
9691338|NCT01969409|10791249|FG000|COMPLETED|Overall Study||25
9691339|NCT01969409|10791250|FG001|COMPLETED|Overall Study||26
9691340|NCT01969409|10791249|FG000|NOT COMPLETED|Overall Study||3
9691341|NCT01969409|10791250|FG001|NOT COMPLETED|Overall Study||4
9691342|NCT01459497|10791258|FG000|STARTED|Overall Study||52
10024519|NCT01863680|11148376|FG000|NOT COMPLETED|Overall Study||57
9691343|NCT01459497|10791259|FG001|STARTED|Overall Study||51
9691344|NCT01459497|10791258|FG000|COMPLETED|Overall Study||50
9691345|NCT01459497|10791259|FG001|COMPLETED|Overall Study||46
9691346|NCT01459497|10791258|FG000|NOT COMPLETED|Overall Study||2
9691347|NCT01459497|10791259|FG001|NOT COMPLETED|Overall Study||5
9691348|NCT01307787|10791267|FG000|STARTED|Overall Study||19
9691349|NCT01307787|10791268|FG001|STARTED|Overall Study||15
9691350|NCT01307787|10791267|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18
9691351|NCT01307787|10791268|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15
9691352|NCT01307787|10791267|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17
9691353|NCT01307787|10791268|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15
9691354|NCT01307787|10791267|FG000|COMPLETED|Overall Study||17
9691355|NCT01307787|10791268|FG001|COMPLETED|Overall Study||15
9691356|NCT01307787|10791267|FG000|NOT COMPLETED|Overall Study||2
9691357|NCT01307787|10791268|FG001|NOT COMPLETED|Overall Study||0
9691358|NCT01250912|10791279|FG000|STARTED|Overall Study||20
9691359|NCT01250912|10791279|FG000|COMPLETED|Overall Study||19
9691360|NCT01250912|10791279|FG000|NOT COMPLETED|Overall Study||1
9691361|NCT01218555|10791286|FG000|STARTED|Overall Study||3
9691362|NCT01218555|10791287|FG001|STARTED|Overall Study||3
9691363|NCT01218555|10791288|FG002|STARTED|Overall Study||5
9691364|NCT01218555|10791289|FG003|STARTED|Overall Study||3
9691365|NCT01218555|10791290|FG004|STARTED|Overall Study||8
9691366|NCT01218555|10791291|FG005|STARTED|Overall Study||22
10024520|NCT01863732|11148384|FG000|STARTED|Overall Study||100
9691367|NCT01218555|10791286|FG000|COMPLETED|Overall Study||3
9691368|NCT01218555|10791287|FG001|COMPLETED|Overall Study||3
9691369|NCT01218555|10791288|FG002|COMPLETED|Overall Study||5
9691370|NCT01218555|10791289|FG003|COMPLETED|Overall Study||3
9691371|NCT01218555|10791290|FG004|COMPLETED|Overall Study||8
9691372|NCT01218555|10791291|FG005|COMPLETED|Overall Study||22
9691373|NCT01218555|10791286|FG000|NOT COMPLETED|Overall Study||0
9691374|NCT01218555|10791287|FG001|NOT COMPLETED|Overall Study||0
9691375|NCT01218555|10791288|FG002|NOT COMPLETED|Overall Study||0
9846757|NCT00849940|10959144|FG000|STARTED|Overall Study||72
9846758|NCT00849940|10959144|FG000|COMPLETED|Overall Study||68
9846759|NCT00849940|10959144|FG000|NOT COMPLETED|Overall Study||4
9846760|NCT00850031|10959148|FG000|STARTED|Overall Study||118
9846761|NCT00850031|10959148|FG000|COMPLETED|Overall Study||101
9846762|NCT00850031|10959148|FG000|NOT COMPLETED|Overall Study||17
9846763|NCT00850070|10959154|FG000|STARTED|Overall Study||23
9846764|NCT00850070|10959155|FG001|STARTED|Overall Study||23
9846765|NCT00850070|10959154|FG000|COMPLETED|Overall Study||20
9846766|NCT00850070|10959155|FG001|COMPLETED|Overall Study||22
9846767|NCT00850070|10959154|FG000|NOT COMPLETED|Overall Study||3
9846768|NCT00850070|10959155|FG001|NOT COMPLETED|Overall Study||1
9846769|NCT00850096|10959168|FG000|STARTED|Overall Study||47
9961345|NCT01473524|11081131|FG000|STARTED|LTSE Phase||0
9961346|NCT01473524|11081132|FG001|STARTED|LTSE Phase||0
9961347|NCT01473524|11081133|FG002|STARTED|LTSE Phase||0
9961348|NCT01473524|11081134|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
9961349|NCT01473524|11081135|FG004|STARTED|LTSE Phase||64
9961350|NCT01473524|11081136|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
9961351|NCT01473524|11081131|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
9961352|NCT01473524|11081132|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
9961353|NCT01473524|11081133|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
9961354|NCT01473524|11081134|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
9961355|NCT01473524|11081135|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
10024521|NCT01863732|11148385|FG001|STARTED|Overall Study||87
10024522|NCT01863732|11148386|FG002|STARTED|Overall Study||46
9961356|NCT01473524|11081136|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
9961357|NCT01473524|11081131|FG000|COMPLETED|LTSE Phase||0
9961358|NCT01473524|11081132|FG001|COMPLETED|LTSE Phase||0
9961359|NCT01473524|11081133|FG002|COMPLETED|LTSE Phase||0
9961360|NCT01473524|11081134|FG003|COMPLETED|LTSE Phase||54
9961361|NCT01473524|11081135|FG004|COMPLETED|LTSE Phase||47
9961362|NCT01473524|11081136|FG005|COMPLETED|LTSE Phase||45
9961363|NCT01473524|11081131|FG000|NOT COMPLETED|LTSE Phase||0
9961364|NCT01473524|11081132|FG001|NOT COMPLETED|LTSE Phase||0
9961365|NCT01473524|11081133|FG002|NOT COMPLETED|LTSE Phase||0
9961366|NCT01473524|11081134|FG003|NOT COMPLETED|LTSE Phase||9
9961367|NCT01473524|11081135|FG004|NOT COMPLETED|LTSE Phase||17
9961368|NCT01473524|11081136|FG005|NOT COMPLETED|LTSE Phase||21
9961369|NCT01473563|11081158|FG000|STARTED|Overall Study||52
9961370|NCT01473563|11081158|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52
9961371|NCT01473563|11081158|FG000|COMPLETED|Overall Study||51
9961372|NCT01473563|11081158|FG000|NOT COMPLETED|Overall Study||1
9961373|NCT01473589|11081164|FG000|STARTED|Overall Study||60
9961374|NCT01473589|11081165|FG001|STARTED|Overall Study||62
9961375|NCT01473589|11081164|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
9961376|NCT01473589|11081165|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
9961377|NCT01473589|11081164|FG000|Completed 6 Months|Overall Study||51
9961378|NCT01473589|11081165|FG001|Completed 6 Months|Overall Study||54
9961379|NCT01473589|11081164|FG000|Completed 12 Months|Overall Study||49
9961380|NCT01473589|11081165|FG001|Completed 12 Months|Overall Study||48
9961381|NCT01473589|11081164|FG000|COMPLETED|Overall Study||49
9961382|NCT01473589|11081165|FG001|COMPLETED|Overall Study||46
9961383|NCT01473589|11081164|FG000|NOT COMPLETED|Overall Study||11
9961384|NCT01473589|11081165|FG001|NOT COMPLETED|Overall Study||16
9961385|NCT01473602|11081175|FG000|STARTED|Overall Study||18
9961386|NCT01473602|11081176|FG001|STARTED|Overall Study||21
9961387|NCT01473602|11081175|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
9961388|NCT01473602|11081176|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
9961389|NCT01473602|11081175|FG000|Completed 6 Months|Overall Study||12
9961390|NCT01473602|11081176|FG001|Completed 6 Months|Overall Study||15
9961391|NCT01473602|11081175|FG000|Completed 12 Months|Overall Study||10
9961392|NCT01473602|11081176|FG001|Completed 12 Months|Overall Study||13
9961393|NCT01473602|11081175|FG000|COMPLETED|Overall Study||10
9961394|NCT01473602|11081176|FG001|COMPLETED|Overall Study||13
9961395|NCT01473602|11081175|FG000|NOT COMPLETED|Overall Study||8
9961396|NCT01473602|11081176|FG001|NOT COMPLETED|Overall Study||8
9961397|NCT01473745|11081186|FG000|STARTED|Overall Study||24
9961398|NCT01473745|11081187|FG001|STARTED|Overall Study||24
10024523|NCT01863732|11148387|FG003|STARTED|Overall Study||41
9961399|NCT01473745|11081186|FG000|COMPLETED|Overall Study||24
9961400|NCT01473745|11081187|FG001|COMPLETED|Overall Study||24
9961401|NCT01473745|11081186|FG000|NOT COMPLETED|Overall Study||0
9961402|NCT01473745|11081187|FG001|NOT COMPLETED|Overall Study||0
9961403|NCT01473758|11081195|FG000|STARTED|Cycle 1||38
10024524|NCT01863732|11148384|FG000|COMPLETED|Overall Study||87
9691376|NCT01218555|10791289|FG003|NOT COMPLETED|Overall Study||0
9846770|NCT00850096|10959169|FG001|STARTED|Overall Study||47
9691377|NCT01218555|10791290|FG004|NOT COMPLETED|Overall Study||0
9691378|NCT01218555|10791291|FG005|NOT COMPLETED|Overall Study||0
9691379|NCT01141712|10791295|FG000|STARTED|Overall Study||43
9691380|NCT01141712|10791295|FG000|COMPLETED|Overall Study||40
9691381|NCT01141712|10791295|FG000|NOT COMPLETED|Overall Study||3
9691382|NCT01111305|10791301|FG000|STARTED|Overall Study||4
9691383|NCT01111305|10791302|FG001|STARTED|Overall Study||4
9691384|NCT01111305|10791301|FG000|COMPLETED|Overall Study||4
10024525|NCT01863732|11148385|FG001|COMPLETED|Overall Study||75
10024526|NCT01863732|11148386|FG002|COMPLETED|Overall Study||35
10024527|NCT01863732|11148387|FG003|COMPLETED|Overall Study||33
10024528|NCT01863732|11148384|FG000|NOT COMPLETED|Overall Study||13
10024529|NCT01863732|11148385|FG001|NOT COMPLETED|Overall Study||12
10024530|NCT01863732|11148386|FG002|NOT COMPLETED|Overall Study||11
10024531|NCT01863732|11148387|FG003|NOT COMPLETED|Overall Study||8
10024532|NCT01863758|11148396|FG000|STARTED|Pharmacokinetic Assessment||66
10024533|NCT01863758|11148396|FG000|COMPLETED|Pharmacokinetic Assessment||66
10024534|NCT01863758|11148396|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0
10024535|NCT01863758|11148396|FG000|STARTED|Prophylactic Treatment-Phase I||66
10024536|NCT01863758|11148396|FG000|COMPLETED|Prophylactic Treatment-Phase I||66
10024537|NCT01863758|11148396|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0
10024538|NCT01863758|11148396|FG000|STARTED|Prophylactic Treatment-Phase II||66
10024539|NCT01863758|11148396|FG000|COMPLETED|Prophylactic Treatment-Phase II||64
10024540|NCT01863758|11148396|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2
10024541|NCT01863771|11148400|FG000|STARTED|Induction Phase||144
10024542|NCT01863771|11148401|FG001|STARTED|Induction Phase||0
10024543|NCT01863771|11148402|FG002|STARTED|Induction Phase||0
10024544|NCT01863771|11148403|FG003|STARTED|Induction Phase||0
10024545|NCT01863771|11148400|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
9691385|NCT01111305|10791302|FG001|COMPLETED|Overall Study||4
9691386|NCT01111305|10791301|FG000|NOT COMPLETED|Overall Study||0
9691387|NCT01111305|10791302|FG001|NOT COMPLETED|Overall Study||0
9726585|NCT00101686|10826134|FG007|STARTED|Overall Study||30
9726586|NCT00101686|10826135|FG008|STARTED|Overall Study||30
9726587|NCT00101686|10826136|FG009|STARTED|Overall Study||30
9726588|NCT00101686|10826127|FG000|Received Treatment|Overall Study||70
9726589|NCT00101686|10826128|FG001|Received Treatment|Overall Study||67
9726590|NCT00101686|10826129|FG002|Received Treatment|Overall Study||67
9726591|NCT00101686|10826130|FG003|Received Treatment|Overall Study||70
9726592|NCT00101686|10826131|FG004|Received Treatment|Overall Study||71
9726593|NCT00101686|10826132|FG005|Received Treatment|Overall Study||70
9726594|NCT00101686|10826133|FG006|Received Treatment|Overall Study||27
9726595|NCT00101686|10826134|FG007|Received Treatment|Overall Study||29
9726596|NCT00101686|10826135|FG008|Received Treatment|Overall Study||30
9726597|NCT00101686|10826136|FG009|Received Treatment|Overall Study||29
9726598|NCT00101686|10826127|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726599|NCT00101686|10826128|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726600|NCT00101686|10826129|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726601|NCT00101686|10826130|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726602|NCT00101686|10826131|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726603|NCT00101686|10826132|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726604|NCT00101686|10826133|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726605|NCT00101686|10826134|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726606|NCT00101686|10826135|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726607|NCT00101686|10826136|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0
9726608|NCT00101686|10826127|FG000|NOT COMPLETED|Overall Study||71
9726609|NCT00101686|10826128|FG001|NOT COMPLETED|Overall Study||73
9726610|NCT00101686|10826129|FG002|NOT COMPLETED|Overall Study||69
9726611|NCT00101686|10826130|FG003|NOT COMPLETED|Overall Study||72
9726612|NCT00101686|10826131|FG004|NOT COMPLETED|Overall Study||73
9726613|NCT00101686|10826132|FG005|NOT COMPLETED|Overall Study||72
9726614|NCT00101686|10826133|FG006|NOT COMPLETED|Overall Study||27
9726615|NCT00101686|10826134|FG007|NOT COMPLETED|Overall Study||30
9726616|NCT00101686|10826135|FG008|NOT COMPLETED|Overall Study||30
9726617|NCT00101686|10826136|FG009|NOT COMPLETED|Overall Study||30
9726618|NCT00101816|10826155|FG000|STARTED|Overall Study||10
9726619|NCT00101816|10826156|FG001|STARTED|Overall Study||99
9726620|NCT00101816|10826155|FG000|COMPLETED|Overall Study||10
9726621|NCT00101816|10826156|FG001|COMPLETED|Overall Study||99
9726622|NCT00101816|10826155|FG000|NOT COMPLETED|Overall Study||0
9726623|NCT00101816|10826156|FG001|NOT COMPLETED|Overall Study||0
9726624|NCT00101868|10826172|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
9726625|NCT00101868|10826173|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
9726626|NCT00101868|10826172|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
9726627|NCT00101868|10826173|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
9726628|NCT00101868|10826172|FG000|NOT COMPLETED|Overall Study||29
9726629|NCT00101868|10826173|FG001|NOT COMPLETED|Overall Study||32
9726630|NCT00101907|10826187|FG000|STARTED|Overall Study||8
9726631|NCT00101907|10826188|FG001|STARTED|Overall Study||8
9726632|NCT00101907|10826189|FG002|STARTED|Overall Study||6
9726633|NCT00101907|10826190|FG003|STARTED|Overall Study||6
9726634|NCT00101907|10826191|FG004|STARTED|Overall Study||11
9726635|NCT00101907|10826192|FG005|STARTED|Overall Study||2
9726636|NCT00101907|10826187|FG000|COMPLETED|Overall Study||6
9726637|NCT00101907|10826188|FG001|COMPLETED|Overall Study||7
9726638|NCT00101907|10826189|FG002|COMPLETED|Overall Study||5
9726639|NCT00101907|10826190|FG003|COMPLETED|Overall Study||5
9726640|NCT00101907|10826191|FG004|COMPLETED|Overall Study||6
9726641|NCT00101907|10826192|FG005|COMPLETED|Overall Study||2
9726642|NCT00101907|10826187|FG000|NOT COMPLETED|Overall Study||2
9726643|NCT00101907|10826188|FG001|NOT COMPLETED|Overall Study||1
9726644|NCT00101907|10826189|FG002|NOT COMPLETED|Overall Study||1
9846771|NCT00850096|10959168|FG000|COMPLETED|Overall Study||44
9846772|NCT00850096|10959169|FG001|COMPLETED|Overall Study||45
9961404|NCT01473758|11081196|FG001|STARTED|Cycle 1||43
9961405|NCT01473758|11081197|FG002|STARTED|Cycle 1||0
9961406|NCT01473758|11081198|FG003|STARTED|Cycle 1||0
9961407|NCT01473758|11081195|FG000|COMPLETED|Cycle 1||27
9726645|NCT00101907|10826190|FG003|NOT COMPLETED|Overall Study||1
9726646|NCT00101907|10826191|FG004|NOT COMPLETED|Overall Study||5
9726647|NCT00101907|10826192|FG005|NOT COMPLETED|Overall Study||0
9846773|NCT00850096|10959168|FG000|NOT COMPLETED|Overall Study||3
9846774|NCT00850096|10959169|FG001|NOT COMPLETED|Overall Study||2
9691388|NCT00659646|10791312|FG000|STARTED|Overall Study||38
9691389|NCT00659646|10791313|FG001|STARTED|Overall Study||18
9691390|NCT00659646|10791312|FG000|COMPLETED|Overall Study||23
9691391|NCT00659646|10791313|FG001|COMPLETED|Overall Study||10
9691392|NCT00659646|10791312|FG000|NOT COMPLETED|Overall Study||15
9691393|NCT00659646|10791313|FG001|NOT COMPLETED|Overall Study||8
9691409|NCT00477412|10791341|FG000|STARTED|Overall Study||4
9691410|NCT00477412|10791342|FG001|STARTED|Overall Study||3
9691411|NCT00477412|10791343|FG002|STARTED|Overall Study||5
9691412|NCT00477412|10791344|FG003|STARTED|Overall Study||95
9691413|NCT00477412|10791341|FG000|COMPLETED|Overall Study||3
9846775|NCT00850135|10959175|FG000|STARTED|Overall Study||57
9846776|NCT00850135|10959175|FG000|COMPLETED|Overall Study||56
9846777|NCT00850135|10959175|FG000|NOT COMPLETED|Overall Study||1
9846778|NCT00850200|10959181|FG000|STARTED|Overall Study||20
9846779|NCT00850200|10959181|FG000|COMPLETED|Overall Study||15
9846780|NCT00850200|10959181|FG000|NOT COMPLETED|Overall Study||5
9846781|NCT00850343|10959192|FG000|STARTED|Overall Study||110
9846782|NCT00850343|10959193|FG001|STARTED|Overall Study||12
9846783|NCT00850343|10959194|FG002|STARTED|Overall Study||43
9846784|NCT00850343|10959195|FG003|STARTED|Overall Study||43
9846785|NCT00850343|10959192|FG000|Completed Week 24|Overall Study||94
9846786|NCT00850343|10959193|FG001|Completed Week 24|Overall Study||12
9846787|NCT00850343|10959194|FG002|Completed Week 24|Overall Study||39
9846788|NCT00850343|10959195|FG003|Completed Week 24|Overall Study||39
9846789|NCT00850343|10959192|FG000|Completed Week 52|Overall Study||88
9846790|NCT00850343|10959193|FG001|Completed Week 52|Overall Study||11
9846791|NCT00850343|10959194|FG002|Completed Week 52|Overall Study||37
9961408|NCT01473758|11081196|FG001|COMPLETED|Cycle 1||40
9961409|NCT01473758|11081197|FG002|COMPLETED|Cycle 1||0
9961410|NCT01473758|11081198|FG003|COMPLETED|Cycle 1||0
9961411|NCT01473758|11081195|FG000|NOT COMPLETED|Cycle 1||11
9961412|NCT01473758|11081196|FG001|NOT COMPLETED|Cycle 1||3
9691414|NCT00477412|10791342|FG001|COMPLETED|Overall Study||3
9691415|NCT00477412|10791343|FG002|COMPLETED|Overall Study||4
9691416|NCT00477412|10791344|FG003|COMPLETED|Overall Study||87
9691417|NCT00477412|10791341|FG000|NOT COMPLETED|Overall Study||1
9691418|NCT00477412|10791342|FG001|NOT COMPLETED|Overall Study||0
9691419|NCT00477412|10791343|FG002|NOT COMPLETED|Overall Study||1
9691420|NCT00477412|10791344|FG003|NOT COMPLETED|Overall Study||8
9691421|NCT00369317|10791352|FG000|STARTED|Overall Study||205
9691422|NCT00369317|10791352|FG000|COMPLETED|Overall Study||185
9691423|NCT00369317|10791352|FG000|NOT COMPLETED|Overall Study||20
9691424|NCT00261807|10791357|FG000|STARTED|Overall Study||25
9691425|NCT00261807|10791357|FG000|COMPLETED|Overall Study||18
9691426|NCT00261807|10791357|FG000|NOT COMPLETED|Overall Study||7
9726648|NCT00101933|10826215|FG000|STARTED|Overall Study||54
9726649|NCT00101933|10826216|FG001|STARTED|Overall Study||55
9726650|NCT00101933|10826215|FG000|COMPLETED|Overall Study||54
9961413|NCT01473758|11081197|FG002|NOT COMPLETED|Cycle 1||0
9726651|NCT00101933|10826216|FG001|COMPLETED|Overall Study||55
9846792|NCT00850343|10959195|FG003|Completed Week 52|Overall Study||37
9846793|NCT00850343|10959192|FG000|COMPLETED|Overall Study||64
9846794|NCT00850343|10959193|FG001|COMPLETED|Overall Study||9
9961414|NCT01473758|11081198|FG003|NOT COMPLETED|Cycle 1||0
9726652|NCT00101933|10826215|FG000|NOT COMPLETED|Overall Study||0
9726653|NCT00101933|10826216|FG001|NOT COMPLETED|Overall Study||0
9726654|NCT00102063|10826226|FG000|STARTED|Overall Study||100
9846795|NCT00850343|10959194|FG002|COMPLETED|Overall Study||29
9961415|NCT01473758|11081195|FG000|STARTED|Cycle 2||0
10114464|NCT02516306|11245195|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0
10114465|NCT02516306|11245194|FG000|STARTED|Period 2: Day 8 - 91||50
10114466|NCT02516306|11245195|FG001|STARTED|Period 2: Day 8 - 91||25
9961416|NCT01473758|11081196|FG001|STARTED|Cycle 2||0
9961417|NCT01473758|11081197|FG002|STARTED|Cycle 2||10
9961418|NCT01473758|11081198|FG003|STARTED|Cycle 2||4
9961419|NCT01473758|11081195|FG000|COMPLETED|Cycle 2||0
9961420|NCT01473758|11081196|FG001|COMPLETED|Cycle 2||0
9961421|NCT01473758|11081197|FG002|COMPLETED|Cycle 2||5
9691427|NCT04964193|10791362|FG000|STARTED|1st Intervention||12
9691428|NCT04964193|10791363|FG001|STARTED|1st Intervention||12
9961422|NCT01473758|11081198|FG003|COMPLETED|Cycle 2||4
9691429|NCT04964193|10791362|FG000|COMPLETED|1st Intervention||12
9691430|NCT04964193|10791363|FG001|COMPLETED|1st Intervention||12
9961423|NCT01473758|11081195|FG000|NOT COMPLETED|Cycle 2||0
10114467|NCT02516306|11245194|FG000|COMPLETED|Period 2: Day 8 - 91||49
9691431|NCT04964193|10791362|FG000|NOT COMPLETED|1st Intervention||0
9691432|NCT04964193|10791363|FG001|NOT COMPLETED|1st Intervention||0
9691433|NCT04964193|10791362|FG000|STARTED|Washout = Three Weeks||12
9691434|NCT04964193|10791363|FG001|STARTED|Washout = Three Weeks||12
9691435|NCT04964193|10791362|FG000|COMPLETED|Washout = Three Weeks||12
9691436|NCT04964193|10791363|FG001|COMPLETED|Washout = Three Weeks||12
9691437|NCT04964193|10791362|FG000|NOT COMPLETED|Washout = Three Weeks||0
9691438|NCT04964193|10791363|FG001|NOT COMPLETED|Washout = Three Weeks||0
9691439|NCT04964193|10791362|FG000|STARTED|2nd Intervention||12
9691440|NCT04964193|10791363|FG001|STARTED|2nd Intervention||12
9691441|NCT04964193|10791362|FG000|COMPLETED|2nd Intervention||12
9691442|NCT04964193|10791363|FG001|COMPLETED|2nd Intervention||12
9691443|NCT04964193|10791362|FG000|NOT COMPLETED|2nd Intervention||0
9691444|NCT04964193|10791363|FG001|NOT COMPLETED|2nd Intervention||0
9691445|NCT04826731|10791371|FG000|STARTED|Overall Study||10
9691446|NCT04826731|10791372|FG001|STARTED|Overall Study||4
9691447|NCT04826731|10791371|FG000|COMPLETED|Overall Study|All patients were initially accepted as the study group per study design, with those unable to utilize respiratory exerciser (n=4) were later removed to standard care group.|10
10024546|NCT01863771|11148401|FG001|COMPLETED|Induction Phase||0
10024547|NCT01863771|11148402|FG002|COMPLETED|Induction Phase||0
10024548|NCT01863771|11148403|FG003|COMPLETED|Induction Phase||0
9691448|NCT04826731|10791372|FG001|COMPLETED|Overall Study|Patients who could not use the respiratory exerciser (n=2) or refused to do so (n=2) were accepted as the control group.|4
9691449|NCT04826731|10791371|FG000|NOT COMPLETED|Overall Study||0
9691450|NCT04826731|10791372|FG001|NOT COMPLETED|Overall Study||0
9691451|NCT04620798|10791380|FG000|STARTED|Overall Study||536
9691452|NCT04620798|10791381|FG001|STARTED|Overall Study||540
9691453|NCT04620798|10791380|FG000|Completed Behavioral Survey|Overall Study||477
9691454|NCT04620798|10791381|FG001|Completed Behavioral Survey|Overall Study||508
9691455|NCT04620798|10791380|FG000|COMPLETED|Overall Study||410
9691456|NCT04620798|10791381|FG001|COMPLETED|Overall Study||402
9691457|NCT04620798|10791380|FG000|NOT COMPLETED|Overall Study||126
9691458|NCT04620798|10791381|FG001|NOT COMPLETED|Overall Study||138
9691459|NCT04507321|10791387|FG000|STARTED|Treatment Period 1 (8 Days)||5
9691460|NCT04507321|10791387|FG000|COMPLETED|Treatment Period 1 (8 Days)||5
9691461|NCT04507321|10791387|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
9691462|NCT04507321|10791387|FG000|STARTED|Treatment Period 2 (8 Days)||5
9691463|NCT04507321|10791387|FG000|COMPLETED|Treatment Period 2 (8 Days)||5
9691464|NCT04507321|10791387|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9726655|NCT00102063|10826227|FG001|STARTED|Overall Study||102
9726656|NCT00102063|10826228|FG002|STARTED|Overall Study||100
9726657|NCT00102063|10826226|FG000|COMPLETED|Overall Study||84
9726658|NCT00102063|10826227|FG001|COMPLETED|Overall Study||84
9726659|NCT00102063|10826228|FG002|COMPLETED|Overall Study||90
9726660|NCT00102063|10826226|FG000|NOT COMPLETED|Overall Study||16
9726661|NCT00102063|10826227|FG001|NOT COMPLETED|Overall Study||18
9726662|NCT00102063|10826228|FG002|NOT COMPLETED|Overall Study||10
9726663|NCT00102440|10826239|FG000|STARTED|Overall Study||256
9726664|NCT00102440|10826240|FG001|STARTED|Overall Study||251
9726665|NCT00102440|10826241|FG002|STARTED|Overall Study||253
9726666|NCT00102440|10826239|FG000|COMPLETED|Overall Study||168
9726667|NCT00102440|10826240|FG001|COMPLETED|Overall Study||153
9726668|NCT00102440|10826241|FG002|COMPLETED|Overall Study||187
9726669|NCT00102440|10826239|FG000|NOT COMPLETED|Overall Study||88
9726670|NCT00102440|10826240|FG001|NOT COMPLETED|Overall Study||98
9726671|NCT00102440|10826241|FG002|NOT COMPLETED|Overall Study||66
9726672|NCT00102518|10826249|FG000|STARTED|Overall Study||325
9726673|NCT00102518|10826249|FG000|COMPLETED|Overall Study||238
9726674|NCT00102518|10826249|FG000|NOT COMPLETED|Overall Study||87
9726675|NCT00102531|10826255|FG000|STARTED|Overall Study||7
9726676|NCT00102531|10826256|FG001|STARTED|Overall Study||12
9726677|NCT00102531|10826255|FG000|COMPLETED|Overall Study||2
9726678|NCT00102531|10826256|FG001|COMPLETED|Overall Study||1
9726679|NCT00102531|10826255|FG000|NOT COMPLETED|Overall Study||5
9726680|NCT00102531|10826256|FG001|NOT COMPLETED|Overall Study||11
9726681|NCT00102596|10826262|FG000|STARTED|Part A||11
9726682|NCT00102596|10826263|FG001|STARTED|Part A||0
9726683|NCT00102596|10826262|FG000|Participants Assigned Treatment|Part A||5
9726684|NCT00102596|10826263|FG001|Participants Assigned Treatment|Part A||0
9726685|NCT00102596|10826262|FG000|COMPLETED|Part A||4
9726686|NCT00102596|10826263|FG001|COMPLETED|Part A||0
9726687|NCT00102596|10826262|FG000|NOT COMPLETED|Part A||7
9726688|NCT00102596|10826263|FG001|NOT COMPLETED|Part A||0
9726689|NCT00102596|10826262|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0
9726690|NCT00102596|10826263|FG001|STARTED|Part B||10
9726691|NCT00102596|10826262|FG000|COMPLETED|Part B||0
9726692|NCT00102596|10826263|FG001|COMPLETED|Part B||10
9726693|NCT00102596|10826262|FG000|NOT COMPLETED|Part B||0
9726694|NCT00102596|10826263|FG001|NOT COMPLETED|Part B||0
9726695|NCT00102596|10826262|FG000|STARTED|Part C||0
9726696|NCT00102596|10826263|FG001|STARTED|Part C|Only 2 patients participated in Part C|2
9726697|NCT00102596|10826262|FG000|COMPLETED|Part C||0
9726698|NCT00102596|10826263|FG001|COMPLETED|Part C||2
9726699|NCT00102596|10826262|FG000|NOT COMPLETED|Part C||0
9726700|NCT00102596|10826263|FG001|NOT COMPLETED|Part C||0
9726701|NCT00102687|10826273|FG000|STARTED|Initial Period||50
9726702|NCT00102687|10826274|FG001|STARTED|Initial Period||50
9726703|NCT00102687|10826275|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
9726704|NCT00102687|10826276|FG003|STARTED|Initial Period||0
9726705|NCT00102687|10826277|FG004|STARTED|Initial Period||0
9726706|NCT00102687|10826273|FG000|COMPLETED|Initial Period||32
9726707|NCT00102687|10826274|FG001|COMPLETED|Initial Period||22
9726708|NCT00102687|10826275|FG002|COMPLETED|Initial Period||25
9846796|NCT00850343|10959195|FG003|COMPLETED|Overall Study||30
10024549|NCT01863771|11148400|FG000|NOT COMPLETED|Induction Phase||21
10024550|NCT01863771|11148401|FG001|NOT COMPLETED|Induction Phase||0
9691465|NCT04256629|10791406|FG000|STARTED|Overall Study||4
9691466|NCT04256629|10791407|FG001|STARTED|Overall Study||4
9691467|NCT04256629|10791408|FG002|STARTED|Overall Study||4
9691468|NCT04256629|10791409|FG003|STARTED|Overall Study||4
9691469|NCT04256629|10791410|FG004|STARTED|Overall Study||4
9691470|NCT04256629|10791411|FG005|STARTED|Overall Study||4
9691471|NCT04256629|10791406|FG000|COMPLETED|Overall Study||4
9691472|NCT04256629|10791407|FG001|COMPLETED|Overall Study||3
9691473|NCT04256629|10791408|FG002|COMPLETED|Overall Study||4
9691474|NCT04256629|10791409|FG003|COMPLETED|Overall Study||4
9691475|NCT04256629|10791410|FG004|COMPLETED|Overall Study||4
9691476|NCT04256629|10791411|FG005|COMPLETED|Overall Study||3
9691477|NCT04256629|10791406|FG000|NOT COMPLETED|Overall Study||0
9691478|NCT04256629|10791407|FG001|NOT COMPLETED|Overall Study||1
9691479|NCT04256629|10791408|FG002|NOT COMPLETED|Overall Study||0
9691480|NCT04256629|10791409|FG003|NOT COMPLETED|Overall Study||0
9691481|NCT04256629|10791410|FG004|NOT COMPLETED|Overall Study||0
9691482|NCT04256629|10791411|FG005|NOT COMPLETED|Overall Study||1
9691483|NCT04174521|10791419|FG000|STARTED|Overall Study|A unit is defined as a mother-child pair; each unit was comprised of two participants: the mother and the child.|20670
9691484|NCT04174521|10791419|FG000|COMPLETED|Overall Study|This was a retrospective observational study so there really was no drop-out.|20670
9691485|NCT04174521|10791419|FG000|NOT COMPLETED|Overall Study||0
9691486|NCT04014075|10791423|FG000|STARTED|Overall Study||79
9691487|NCT04014075|10791423|FG000|COMPLETED|Overall Study||23
9691488|NCT04014075|10791423|FG000|NOT COMPLETED|Overall Study||56
9691489|NCT03284853|10791429|FG000|STARTED|Overall Study||218
9691490|NCT03284853|10791430|FG001|STARTED|Overall Study||212
9691491|NCT03284853|10791429|FG000|Intent-to-Treat Population|Overall Study||218
9691492|NCT03284853|10791430|FG001|Intent-to-Treat Population|Overall Study||212
9691493|NCT03284853|10791429|FG000|Per-Protocol Population|Overall Study||169
9691494|NCT03284853|10791430|FG001|Per-Protocol Population|Overall Study||170
9691495|NCT03284853|10791429|FG000|Safety Population|Overall Study||218
9691496|NCT03284853|10791430|FG001|Safety Population|Overall Study||212
9691497|NCT03284853|10791429|FG000|COMPLETED|Overall Study||163
9691498|NCT03284853|10791430|FG001|COMPLETED|Overall Study||199
9691499|NCT03284853|10791429|FG000|NOT COMPLETED|Overall Study||55
9691500|NCT03284853|10791430|FG001|NOT COMPLETED|Overall Study||13
9691501|NCT03032250|10791438|FG000|STARTED|Overall Study||17
9691502|NCT03032250|10791439|FG001|STARTED|Overall Study||18
9691503|NCT03032250|10791438|FG000|COMPLETED|Overall Study||17
9691504|NCT03032250|10791439|FG001|COMPLETED|Overall Study||18
9691505|NCT03032250|10791438|FG000|NOT COMPLETED|Overall Study||0
9691506|NCT03032250|10791439|FG001|NOT COMPLETED|Overall Study||0
9691507|NCT02942966|10791447|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233
9691508|NCT02942966|10791447|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205
9691509|NCT02942966|10791447|FG000|NOT COMPLETED|Overall Study||28
9691510|NCT02774889|10791453|FG000|STARTED|Overall Study||23
9691511|NCT02774889|10791454|FG001|STARTED|Overall Study||22
9691512|NCT02774889|10791453|FG000|COMPLETED|Overall Study||21
9691513|NCT02774889|10791454|FG001|COMPLETED|Overall Study||21
9691514|NCT02774889|10791453|FG000|NOT COMPLETED|Overall Study||2
9691515|NCT02774889|10791454|FG001|NOT COMPLETED|Overall Study||1
9691516|NCT02721069|10791462|FG000|STARTED|Overall Study||175
10114468|NCT02516306|11245195|FG001|COMPLETED|Period 2: Day 8 - 91||23
10114469|NCT02516306|11245194|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1
10114470|NCT02516306|11245195|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2
10114471|NCT02516332|11245204|FG000|STARTED|Overall Study||52
9961424|NCT01473758|11081196|FG001|NOT COMPLETED|Cycle 2||0
9961425|NCT01473758|11081197|FG002|NOT COMPLETED|Cycle 2||5
9961426|NCT01473758|11081198|FG003|NOT COMPLETED|Cycle 2||0
9961427|NCT01473836|11081206|FG000|STARTED|Overall Study||38
9961428|NCT01473836|11081206|FG000|COMPLETED|Overall Study||32
9961429|NCT01473836|11081206|FG000|NOT COMPLETED|Overall Study||6
9961430|NCT01473940|11081214|FG000|STARTED|Induction Therapy||3
10114472|NCT02516332|11245205|FG001|STARTED|Overall Study||53
9691517|NCT02721069|10791462|FG000|COMPLETED|Overall Study||117
9691518|NCT02721069|10791462|FG000|NOT COMPLETED|Overall Study||58
9691519|NCT02297438|10791474|FG000|STARTED|Overall Study||169
9691520|NCT02297438|10791475|FG001|STARTED|Overall Study||171
9691521|NCT02297438|10791474|FG000|Received Treatment|Overall Study||168
9691522|NCT02297438|10791475|FG001|Received Treatment|Overall Study||171
9691523|NCT02297438|10791474|FG000|COMPLETED|Overall Study||0
9691524|NCT02297438|10791475|FG001|COMPLETED|Overall Study||0
9691525|NCT02297438|10791474|FG000|NOT COMPLETED|Overall Study||169
9691526|NCT02297438|10791475|FG001|NOT COMPLETED|Overall Study||171
9691527|NCT02297412|10791483|FG000|STARTED|Overall Study||23
9691528|NCT02297412|10791484|FG001|STARTED|Overall Study||24
9691529|NCT02297412|10791483|FG000|COMPLETED|Overall Study||22
9691530|NCT02297412|10791484|FG001|COMPLETED|Overall Study||23
9691531|NCT02297412|10791483|FG000|NOT COMPLETED|Overall Study||1
9691532|NCT02297412|10791484|FG001|NOT COMPLETED|Overall Study||1
9691533|NCT02292758|10791492|FG000|STARTED|Overall Study||19
9691534|NCT02292758|10791493|FG001|STARTED|Overall Study||17
9691535|NCT02292758|10791492|FG000|COMPLETED|Overall Study||19
9691536|NCT02292758|10791493|FG001|COMPLETED|Overall Study||17
9691537|NCT02292758|10791492|FG000|NOT COMPLETED|Overall Study||0
9691538|NCT02292758|10791493|FG001|NOT COMPLETED|Overall Study||0
9691539|NCT02250326|10791502|FG000|STARTED|Treatment Period||81
9691540|NCT02250326|10791503|FG001|STARTED|Treatment Period||79
9691541|NCT02250326|10791504|FG002|STARTED|Treatment Period||80
9691542|NCT02250326|10791502|FG000|Treated Population|Treatment Period||79
9691543|NCT02250326|10791503|FG001|Treated Population|Treatment Period||78
9691544|NCT02250326|10791504|FG002|Treated Population|Treatment Period||79
9691545|NCT02250326|10791502|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
9691546|NCT02250326|10791503|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
9691547|NCT02250326|10791504|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
9691548|NCT02250326|10791502|FG000|NOT COMPLETED|Treatment Period||81
9691549|NCT02250326|10791503|FG001|NOT COMPLETED|Treatment Period||64
9691550|NCT02250326|10791504|FG002|NOT COMPLETED|Treatment Period||77
9691551|NCT02250326|10791502|FG000|STARTED|Follow-Up Period||67
9691552|NCT02250326|10791503|FG001|STARTED|Follow-Up Period||43
9691553|NCT02250326|10791504|FG002|STARTED|Follow-Up Period||64
9691554|NCT02250326|10791502|FG000|COMPLETED|Follow-Up Period||18
9691555|NCT02250326|10791503|FG001|COMPLETED|Follow-Up Period||13
9691556|NCT02250326|10791504|FG002|COMPLETED|Follow-Up Period||26
9691557|NCT02250326|10791502|FG000|NOT COMPLETED|Follow-Up Period||49
9691558|NCT02250326|10791503|FG001|NOT COMPLETED|Follow-Up Period||30
9691559|NCT02250326|10791504|FG002|NOT COMPLETED|Follow-Up Period||38
9691560|NCT01856270|10791515|FG000|STARTED|Overall Study||24
9691561|NCT01856270|10791516|FG001|STARTED|Overall Study||26
10114473|NCT02516332|11245206|FG002|STARTED|Overall Study||23
10114474|NCT02516332|11245204|FG000|COMPLETED|Overall Study||50
10024551|NCT01863771|11148402|FG002|NOT COMPLETED|Induction Phase||0
10024552|NCT01863771|11148403|FG003|NOT COMPLETED|Induction Phase||0
10024553|NCT01863771|11148400|FG000|STARTED|Maintenance Phase||0
10024554|NCT01863771|11148401|FG001|STARTED|Maintenance Phase||32
10024555|NCT01863771|11148402|FG002|STARTED|Maintenance Phase||31
10024556|NCT01863771|11148403|FG003|STARTED|Maintenance Phase||60
10024557|NCT01863771|11148400|FG000|COMPLETED|Maintenance Phase||0
9846797|NCT00850343|10959192|FG000|NOT COMPLETED|Overall Study||46
10024558|NCT01863771|11148401|FG001|COMPLETED|Maintenance Phase||27
10024559|NCT01863771|11148402|FG002|COMPLETED|Maintenance Phase||19
9846798|NCT00850343|10959193|FG001|NOT COMPLETED|Overall Study||3
10024560|NCT01863771|11148403|FG003|COMPLETED|Maintenance Phase||17
9691562|NCT01856270|10791515|FG000|COMPLETED|Overall Study||13
9691563|NCT01856270|10791516|FG001|COMPLETED|Overall Study||14
9691564|NCT01856270|10791515|FG000|NOT COMPLETED|Overall Study||11
9691565|NCT01856270|10791516|FG001|NOT COMPLETED|Overall Study||12
9691566|NCT01503515|10791526|FG000|STARTED|Overall Study||145
9691567|NCT01503515|10791527|FG001|STARTED|Overall Study||147
9691568|NCT01503515|10791526|FG000|COMPLETED|Overall Study||124
9691569|NCT01503515|10791527|FG001|COMPLETED|Overall Study||112
9691570|NCT01503515|10791526|FG000|NOT COMPLETED|Overall Study||21
9691571|NCT01503515|10791527|FG001|NOT COMPLETED|Overall Study||35
9691572|NCT01491893|10791533|FG000|STARTED|Overall Study||1
9691573|NCT01491893|10791534|FG001|STARTED|Overall Study||1
9691574|NCT01491893|10791535|FG002|STARTED|Overall Study||1
9691575|NCT01491893|10791536|FG003|STARTED|Overall Study||1
9691576|NCT01491893|10791537|FG004|STARTED|Overall Study||4
9691577|NCT01491893|10791538|FG005|STARTED|Overall Study||1
9691578|NCT01491893|10791539|FG006|STARTED|Overall Study||6
9691579|NCT01491893|10791540|FG007|STARTED|Overall Study||24
9691580|NCT01491893|10791541|FG008|STARTED|Overall Study||15
9691581|NCT01491893|10791542|FG009|STARTED|Overall Study||7
9691582|NCT01491893|10791533|FG000|COMPLETED|Overall Study||1
9691583|NCT01491893|10791534|FG001|COMPLETED|Overall Study||1
9691584|NCT01491893|10791535|FG002|COMPLETED|Overall Study||1
9691585|NCT01491893|10791536|FG003|COMPLETED|Overall Study||1
9691586|NCT01491893|10791537|FG004|COMPLETED|Overall Study||4
9691587|NCT01491893|10791538|FG005|COMPLETED|Overall Study||1
9691588|NCT01491893|10791539|FG006|COMPLETED|Overall Study||6
9691589|NCT01491893|10791540|FG007|COMPLETED|Overall Study||24
9691590|NCT01491893|10791541|FG008|COMPLETED|Overall Study||15
9691591|NCT01491893|10791542|FG009|COMPLETED|Overall Study||7
9691592|NCT01491893|10791533|FG000|NOT COMPLETED|Overall Study||0
9691593|NCT01491893|10791534|FG001|NOT COMPLETED|Overall Study||0
9691594|NCT01491893|10791535|FG002|NOT COMPLETED|Overall Study||0
9691595|NCT01491893|10791536|FG003|NOT COMPLETED|Overall Study||0
9691596|NCT01491893|10791537|FG004|NOT COMPLETED|Overall Study||0
9691597|NCT01491893|10791538|FG005|NOT COMPLETED|Overall Study||0
9691598|NCT01491893|10791539|FG006|NOT COMPLETED|Overall Study||0
9691599|NCT01491893|10791540|FG007|NOT COMPLETED|Overall Study||0
9691600|NCT01491893|10791541|FG008|NOT COMPLETED|Overall Study||0
9691601|NCT01491893|10791542|FG009|NOT COMPLETED|Overall Study||0
9691602|NCT00245960|10791560|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379
9691603|NCT00245960|10791561|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373
9691604|NCT00245960|10791560|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364
9691605|NCT00245960|10791561|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362
9691606|NCT00245960|10791560|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15
9691607|NCT00245960|10791561|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11
9691608|NCT00245960|10791560|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364
9691609|NCT00245960|10791561|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362
9691610|NCT00245960|10791560|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350
9691611|NCT00245960|10791561|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344
9691612|NCT00245960|10791560|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14
9691613|NCT00245960|10791561|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18
9726709|NCT00102687|10826276|FG003|COMPLETED|Initial Period||0
9726710|NCT00102687|10826277|FG004|COMPLETED|Initial Period||0
9726711|NCT00102687|10826273|FG000|NOT COMPLETED|Initial Period||18
9726712|NCT00102687|10826274|FG001|NOT COMPLETED|Initial Period||28
9726713|NCT00102687|10826275|FG002|NOT COMPLETED|Initial Period||26
9726714|NCT00102687|10826276|FG003|NOT COMPLETED|Initial Period||0
9726715|NCT00102687|10826277|FG004|NOT COMPLETED|Initial Period||0
9726716|NCT00102687|10826273|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
9726717|NCT00102687|10826274|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
9726718|NCT00102687|10826275|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
9726719|NCT00102687|10826276|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
9726720|NCT00102687|10826277|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
9726721|NCT00102687|10826273|FG000|COMPLETED|Maintenance Period||6
9726722|NCT00102687|10826274|FG001|COMPLETED|Maintenance Period||2
9726723|NCT00102687|10826275|FG002|COMPLETED|Maintenance Period||2
9726724|NCT00102687|10826276|FG003|COMPLETED|Maintenance Period||12
9726725|NCT00102687|10826277|FG004|COMPLETED|Maintenance Period||8
9726726|NCT00102687|10826273|FG000|NOT COMPLETED|Maintenance Period||7
9726727|NCT00102687|10826274|FG001|NOT COMPLETED|Maintenance Period||4
9726728|NCT00102687|10826275|FG002|NOT COMPLETED|Maintenance Period||6
9726729|NCT00102687|10826276|FG003|NOT COMPLETED|Maintenance Period||10
9726730|NCT00102687|10826277|FG004|NOT COMPLETED|Maintenance Period||13
9726731|NCT00102804|10826295|FG000|STARTED|Overall Study||441
9726732|NCT00102804|10826296|FG001|STARTED|Overall Study||222
9726733|NCT00102804|10826295|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434
9726734|NCT00102804|10826296|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
9726735|NCT00102804|10826295|FG000|COMPLETED|Overall Study||0
9726736|NCT00102804|10826296|FG001|COMPLETED|Overall Study||0
9726737|NCT00102804|10826295|FG000|NOT COMPLETED|Overall Study||441
9726738|NCT00102804|10826296|FG001|NOT COMPLETED|Overall Study||222
9726739|NCT00102960|10826305|FG000|STARTED|Overall Study||125
9726740|NCT00102960|10826306|FG001|STARTED|Overall Study||126
9726741|NCT00102960|10826307|FG002|STARTED|Overall Study||126
9726742|NCT00102960|10826305|FG000|COMPLETED|Overall Study||95
9726743|NCT00102960|10826306|FG001|COMPLETED|Overall Study||103
9726744|NCT00102960|10826307|FG002|COMPLETED|Overall Study||98
9726745|NCT00102960|10826305|FG000|NOT COMPLETED|Overall Study||30
9726746|NCT00102960|10826306|FG001|NOT COMPLETED|Overall Study||23
9726747|NCT00102960|10826307|FG002|NOT COMPLETED|Overall Study||28
9726748|NCT00103012|10826322|FG000|STARTED|Overall Study||17
9726749|NCT00103012|10826323|FG001|STARTED|Overall Study||14
9726750|NCT00103012|10826324|FG002|STARTED|Overall Study||16
9726751|NCT00103012|10826322|FG000|COMPLETED|Overall Study||14
9726752|NCT00103012|10826323|FG001|COMPLETED|Overall Study||13
9726753|NCT00103012|10826324|FG002|COMPLETED|Overall Study||12
9726754|NCT00103012|10826322|FG000|NOT COMPLETED|Overall Study||3
9726755|NCT00103012|10826323|FG001|NOT COMPLETED|Overall Study||1
9726756|NCT00103012|10826324|FG002|NOT COMPLETED|Overall Study||4
9726757|NCT00103116|10826332|FG000|STARTED|Overall Study||32
9726758|NCT00103116|10826332|FG000|COMPLETED|Overall Study||32
9726759|NCT00103116|10826332|FG000|NOT COMPLETED|Overall Study||0
9726760|NCT00103142|10826338|FG000|STARTED|Overall Study||36
9726761|NCT00103142|10826339|FG001|STARTED|Overall Study||37
9726762|NCT00103142|10826338|FG000|COMPLETED|Overall Study||33
9726763|NCT00103142|10826339|FG001|COMPLETED|Overall Study||36
9726764|NCT00103142|10826338|FG000|NOT COMPLETED|Overall Study||3
9726765|NCT00103142|10826339|FG001|NOT COMPLETED|Overall Study||1
9726766|NCT00103194|10826347|FG000|STARTED|Overall Study||49
9726767|NCT00103194|10826347|FG000|Treated|Overall Study||49
9726768|NCT00103194|10826347|FG000|Eligible|Overall Study||35
9726769|NCT00103194|10826347|FG000|Eligible and Treated|Overall Study||35
9726770|NCT00103194|10826347|FG000|COMPLETED|Overall Study||18
9726771|NCT00103194|10826347|FG000|NOT COMPLETED|Overall Study||31
9726772|NCT00103207|10826351|FG000|STARTED|Overall Study||72
9731842|NCT00136812|10831805|FG000|NOT COMPLETED|Overall Study||0
9691614|NCT04565353|10791587|FG000|STARTED|Overall Study||3742
9691615|NCT04565353|10791588|FG001|STARTED|Overall Study||3737
9691616|NCT04565353|10791589|FG002|STARTED|Overall Study||3709
9691617|NCT04565353|10791590|FG003|STARTED|Overall Study||3735
9691618|NCT04565353|10791591|FG004|STARTED|Overall Study||3758
9691619|NCT04565353|10791592|FG005|STARTED|Overall Study||3769
9691620|NCT04565353|10791593|FG006|STARTED|Overall Study||3719
9691621|NCT04565353|10791594|FG007|STARTED|Overall Study||3732
9691622|NCT04565353|10791595|FG008|STARTED|Overall Study||3728
9691623|NCT04565353|10791596|FG009|STARTED|Overall Study||3777
9691624|NCT04565353|10791597|FG010|STARTED|Overall Study||3672
9691625|NCT04565353|10791598|FG011|STARTED|Overall Study||3751
9691626|NCT04565353|10791599|FG012|STARTED|Overall Study||3737
9691627|NCT04565353|10791600|FG013|STARTED|Overall Study||3714
9691628|NCT04565353|10791601|FG014|STARTED|Overall Study||3773
9691629|NCT04565353|10791602|FG015|STARTED|Overall Study||3739
9691630|NCT04565353|10791603|FG016|STARTED|Overall Study||3776
9691631|NCT04565353|10791604|FG017|STARTED|Overall Study||3744
9691632|NCT04565353|10791605|FG018|STARTED|Overall Study||3741
9691633|NCT04565353|10791606|FG019|STARTED|Overall Study||3758
9691634|NCT04565353|10791587|FG000|COMPLETED|Overall Study||3742
9691635|NCT04565353|10791588|FG001|COMPLETED|Overall Study||3688
9691636|NCT04565353|10791589|FG002|COMPLETED|Overall Study||3670
9691637|NCT04565353|10791590|FG003|COMPLETED|Overall Study||3693
9691638|NCT04565353|10791591|FG004|COMPLETED|Overall Study||3717
9691639|NCT04565353|10791592|FG005|COMPLETED|Overall Study||3716
9691640|NCT04565353|10791593|FG006|COMPLETED|Overall Study||3665
9691641|NCT04565353|10791594|FG007|COMPLETED|Overall Study||3693
9691642|NCT04565353|10791595|FG008|COMPLETED|Overall Study||3662
9691643|NCT04565353|10791596|FG009|COMPLETED|Overall Study||3734
9691644|NCT04565353|10791597|FG010|COMPLETED|Overall Study||3623
9691645|NCT04565353|10791598|FG011|COMPLETED|Overall Study||3710
9691646|NCT04565353|10791599|FG012|COMPLETED|Overall Study||3685
9691647|NCT04565353|10791600|FG013|COMPLETED|Overall Study||3664
9691648|NCT04565353|10791601|FG014|COMPLETED|Overall Study||3736
9691649|NCT04565353|10791602|FG015|COMPLETED|Overall Study||3690
9691650|NCT04565353|10791603|FG016|COMPLETED|Overall Study||3734
9691651|NCT04565353|10791604|FG017|COMPLETED|Overall Study||3696
9691652|NCT04565353|10791605|FG018|COMPLETED|Overall Study||3698
9691653|NCT04565353|10791606|FG019|COMPLETED|Overall Study||3712
9691654|NCT04565353|10791587|FG000|NOT COMPLETED|Overall Study||0
9691655|NCT04565353|10791588|FG001|NOT COMPLETED|Overall Study||49
9691656|NCT04565353|10791589|FG002|NOT COMPLETED|Overall Study||39
9691657|NCT04565353|10791590|FG003|NOT COMPLETED|Overall Study||42
9691658|NCT04565353|10791591|FG004|NOT COMPLETED|Overall Study||41
9691659|NCT04565353|10791592|FG005|NOT COMPLETED|Overall Study||53
9691660|NCT04565353|10791593|FG006|NOT COMPLETED|Overall Study||54
9691661|NCT04565353|10791594|FG007|NOT COMPLETED|Overall Study||39
9691662|NCT04565353|10791595|FG008|NOT COMPLETED|Overall Study||66
9691663|NCT04565353|10791596|FG009|NOT COMPLETED|Overall Study||43
9691664|NCT04565353|10791597|FG010|NOT COMPLETED|Overall Study||49
9691665|NCT04565353|10791598|FG011|NOT COMPLETED|Overall Study||41
9691666|NCT04565353|10791599|FG012|NOT COMPLETED|Overall Study||52
9691667|NCT04565353|10791600|FG013|NOT COMPLETED|Overall Study||50
9691668|NCT04565353|10791601|FG014|NOT COMPLETED|Overall Study||37
9691669|NCT04565353|10791602|FG015|NOT COMPLETED|Overall Study||49
9691670|NCT04565353|10791603|FG016|NOT COMPLETED|Overall Study||42
9691671|NCT04565353|10791604|FG017|NOT COMPLETED|Overall Study||48
9691672|NCT04565353|10791605|FG018|NOT COMPLETED|Overall Study||43
9691673|NCT04565353|10791606|FG019|NOT COMPLETED|Overall Study||46
9691674|NCT04015336|10791648|FG000|STARTED|Overall Study||1
9691675|NCT04015336|10791648|FG000|COMPLETED|Overall Study||0
9691676|NCT04015336|10791648|FG000|NOT COMPLETED|Overall Study||1
9726773|NCT00103207|10826351|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
9726774|NCT00103207|10826351|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37
9726775|NCT00103207|10826351|FG000|COMPLETED|Overall Study||34
9726776|NCT00103207|10826351|FG000|NOT COMPLETED|Overall Study||38
9726777|NCT00103259|10826359|FG000|STARTED|Overall Study||27
9726778|NCT00103259|10826360|FG001|STARTED|Overall Study||44
9726779|NCT00103259|10826359|FG000|Eligible|Overall Study||27
9726780|NCT00103259|10826360|FG001|Eligible|Overall Study||41
9726781|NCT00103259|10826359|FG000|Treated|Overall Study||23
9726782|NCT00103259|10826360|FG001|Treated|Overall Study||41
9726783|NCT00103259|10826359|FG000|Eligible and Treated|Overall Study||23
9726784|NCT00103259|10826360|FG001|Eligible and Treated|Overall Study||38
9726785|NCT00103259|10826359|FG000|Cross Over to the Other Arm|Overall Study||0
9726786|NCT00103259|10826360|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
9726787|NCT00103259|10826359|FG000|Eligible Patients Who Cross Over|Overall Study||0
9726788|NCT00103259|10826360|FG001|Eligible Patients Who Cross Over|Overall Study||10
9726789|NCT00103259|10826359|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
9726790|NCT00103259|10826360|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
9726791|NCT00103259|10826359|FG000|NOT COMPLETED|Overall Study||12
9726792|NCT00103259|10826360|FG001|NOT COMPLETED|Overall Study||12
9726793|NCT00103285|10826368|FG000|STARTED|Induction||5377
9846799|NCT00850343|10959194|FG002|NOT COMPLETED|Overall Study||14
10024561|NCT01863771|11148400|FG000|NOT COMPLETED|Maintenance Phase||0
10024562|NCT01863771|11148401|FG001|NOT COMPLETED|Maintenance Phase||5
10024563|NCT01863771|11148402|FG002|NOT COMPLETED|Maintenance Phase||12
10024564|NCT01863771|11148403|FG003|NOT COMPLETED|Maintenance Phase||43
9846800|NCT00850343|10959195|FG003|NOT COMPLETED|Overall Study||13
9846801|NCT00850395|10959205|FG000|STARTED|Overall Study||79
9846802|NCT00850395|10959205|FG000|COMPLETED|Overall Study||69
9846803|NCT00850395|10959205|FG000|NOT COMPLETED|Overall Study||10
9846804|NCT00850460|10959211|FG000|STARTED|Overall Study||7
9846805|NCT00850460|10959212|FG001|STARTED|Overall Study||7
9846806|NCT00850460|10959211|FG000|Started - Week 0|Overall Study||7
9846807|NCT00850460|10959212|FG001|Started - Week 0|Overall Study||7
9846808|NCT00850460|10959211|FG000|Completion - Week 8|Overall Study||3
9846809|NCT00850460|10959212|FG001|Completion - Week 8|Overall Study||3
9846810|NCT00850460|10959211|FG000|COMPLETED|Overall Study||3
9846811|NCT00850460|10959212|FG001|COMPLETED|Overall Study||3
9846812|NCT00850460|10959211|FG000|NOT COMPLETED|Overall Study||4
9961431|NCT01473940|11081215|FG001|STARTED|Induction Therapy||4
9961432|NCT01473940|11081216|FG002|STARTED|Induction Therapy||6
9961433|NCT01473940|11081217|FG003|STARTED|Induction Therapy||8
9961434|NCT01473940|11081214|FG000|Started Treatment|Induction Therapy||3
9961435|NCT01473940|11081215|FG001|Started Treatment|Induction Therapy||4
9961436|NCT01473940|11081216|FG002|Started Treatment|Induction Therapy||6
9961437|NCT01473940|11081217|FG003|Started Treatment|Induction Therapy||8
9961438|NCT01473940|11081214|FG000|Completed Induction- 12 Weeks|Induction Therapy||3
9961439|NCT01473940|11081215|FG001|Completed Induction- 12 Weeks|Induction Therapy||3
9961440|NCT01473940|11081216|FG002|Completed Induction- 12 Weeks|Induction Therapy||4
9961441|NCT01473940|11081217|FG003|Completed Induction- 12 Weeks|Induction Therapy||7
9961442|NCT01473940|11081214|FG000|COMPLETED|Induction Therapy||3
9961443|NCT01473940|11081215|FG001|COMPLETED|Induction Therapy||3
9961444|NCT01473940|11081216|FG002|COMPLETED|Induction Therapy||4
9961445|NCT01473940|11081217|FG003|COMPLETED|Induction Therapy||7
9961446|NCT01473940|11081214|FG000|NOT COMPLETED|Induction Therapy||0
10024565|NCT01863849|11148413|FG000|STARTED|Overall Study||60
10024566|NCT01863849|11148414|FG001|STARTED|Overall Study||60
9846813|NCT00850460|10959212|FG001|NOT COMPLETED|Overall Study||4
9846814|NCT00850473|10959218|FG000|STARTED|Overall Study||3
10114475|NCT02516332|11245205|FG001|COMPLETED|Overall Study||52
10114476|NCT02516332|11245206|FG002|COMPLETED|Overall Study||21
10114477|NCT02516332|11245204|FG000|NOT COMPLETED|Overall Study||2
10114478|NCT02516332|11245205|FG001|NOT COMPLETED|Overall Study||1
9691677|NCT03972813|10791670|FG000|STARTED|Overall Study||85
9691678|NCT03972813|10791671|FG001|STARTED|Overall Study||49
9691679|NCT03972813|10791672|FG002|STARTED|Overall Study||58
9691680|NCT03972813|10791673|FG003|STARTED|Overall Study||55
9691681|NCT03972813|10791674|FG004|STARTED|Overall Study||52
9691682|NCT03972813|10791675|FG005|STARTED|Overall Study||51
9691683|NCT03972813|10791676|FG006|STARTED|Overall Study||53
9691684|NCT03972813|10791677|FG007|STARTED|Overall Study||55
9691685|NCT03972813|10791678|FG008|STARTED|Overall Study||58
9691686|NCT03972813|10791679|FG009|STARTED|Overall Study||60
9691687|NCT03972813|10791680|FG010|STARTED|Overall Study||62
9691688|NCT03972813|10791681|FG011|STARTED|Overall Study||55
9691689|NCT03972813|10791682|FG012|STARTED|Overall Study||58
9691690|NCT03972813|10791683|FG013|STARTED|Overall Study||55
9691691|NCT03972813|10791684|FG014|STARTED|Overall Study||58
9691692|NCT03972813|10791685|FG015|STARTED|Overall Study||56
9691693|NCT03972813|10791686|FG016|STARTED|Overall Study||51
9691694|NCT03972813|10791687|FG017|STARTED|Overall Study||50
9691695|NCT03972813|10791670|FG000|COMPLETED|Overall Study||79
9691696|NCT03972813|10791671|FG001|COMPLETED|Overall Study||45
9691697|NCT03972813|10791672|FG002|COMPLETED|Overall Study||52
9691698|NCT03972813|10791673|FG003|COMPLETED|Overall Study||51
9691699|NCT03972813|10791674|FG004|COMPLETED|Overall Study||48
9691700|NCT03972813|10791675|FG005|COMPLETED|Overall Study||49
9691701|NCT03972813|10791676|FG006|COMPLETED|Overall Study||49
9691702|NCT03972813|10791677|FG007|COMPLETED|Overall Study||52
9691703|NCT03972813|10791678|FG008|COMPLETED|Overall Study||53
10024567|NCT01863849|11148413|FG000|COMPLETED|Overall Study||59
10024568|NCT01863849|11148414|FG001|COMPLETED|Overall Study||60
10024569|NCT01863849|11148413|FG000|NOT COMPLETED|Overall Study||1
10024570|NCT01863849|11148414|FG001|NOT COMPLETED|Overall Study||0
10024571|NCT01863953|11148424|FG000|STARTED|Overall Study||38
10024572|NCT01863953|11148425|FG001|STARTED|Overall Study||36
10024573|NCT01863953|11148426|FG002|STARTED|Overall Study||38
10024574|NCT01863953|11148424|FG000|COMPLETED|Overall Study||38
10024575|NCT01863953|11148425|FG001|COMPLETED|Overall Study||36
10024576|NCT01863953|11148426|FG002|COMPLETED|Overall Study||37
10024577|NCT01863953|11148424|FG000|NOT COMPLETED|Overall Study||0
10024578|NCT01863953|11148425|FG001|NOT COMPLETED|Overall Study||0
10024579|NCT01863953|11148426|FG002|NOT COMPLETED|Overall Study||1
9691704|NCT03972813|10791679|FG009|COMPLETED|Overall Study||58
9691705|NCT03972813|10791680|FG010|COMPLETED|Overall Study||57
9691706|NCT03972813|10791681|FG011|COMPLETED|Overall Study||51
9691707|NCT03972813|10791682|FG012|COMPLETED|Overall Study||55
9691708|NCT03972813|10791683|FG013|COMPLETED|Overall Study||52
9691709|NCT03972813|10791684|FG014|COMPLETED|Overall Study||56
9691710|NCT03972813|10791685|FG015|COMPLETED|Overall Study||50
9691711|NCT03972813|10791686|FG016|COMPLETED|Overall Study||48
10024580|NCT01864005|11148436|FG000|STARTED|Overall Study||29
9691712|NCT03972813|10791687|FG017|COMPLETED|Overall Study||48
9691713|NCT03972813|10791670|FG000|NOT COMPLETED|Overall Study||6
9691714|NCT03972813|10791671|FG001|NOT COMPLETED|Overall Study||4
9691715|NCT03972813|10791672|FG002|NOT COMPLETED|Overall Study||6
9691716|NCT03972813|10791673|FG003|NOT COMPLETED|Overall Study||4
9691717|NCT03972813|10791674|FG004|NOT COMPLETED|Overall Study||4
10024581|NCT01864005|11148437|FG001|STARTED|Overall Study||31
10024582|NCT01864005|11148436|FG000|COMPLETED|Overall Study||26
10024583|NCT01864005|11148437|FG001|COMPLETED|Overall Study||25
9691718|NCT03972813|10791675|FG005|NOT COMPLETED|Overall Study||2
9691719|NCT03972813|10791676|FG006|NOT COMPLETED|Overall Study||4
9691720|NCT03972813|10791677|FG007|NOT COMPLETED|Overall Study||3
9691721|NCT03972813|10791678|FG008|NOT COMPLETED|Overall Study||5
9691722|NCT03972813|10791679|FG009|NOT COMPLETED|Overall Study||2
9691723|NCT03972813|10791680|FG010|NOT COMPLETED|Overall Study||5
9691724|NCT03972813|10791681|FG011|NOT COMPLETED|Overall Study||4
9691725|NCT03972813|10791682|FG012|NOT COMPLETED|Overall Study||3
9691726|NCT03972813|10791683|FG013|NOT COMPLETED|Overall Study||3
9691727|NCT03972813|10791684|FG014|NOT COMPLETED|Overall Study||2
9691728|NCT03972813|10791685|FG015|NOT COMPLETED|Overall Study||6
9691729|NCT03972813|10791686|FG016|NOT COMPLETED|Overall Study||3
9691730|NCT03972813|10791687|FG017|NOT COMPLETED|Overall Study||2
9691731|NCT03920280|10791727|FG000|STARTED|Overall Study||41
9691732|NCT03920280|10791728|FG001|STARTED|Overall Study||78
9691733|NCT03920280|10791727|FG000|COMPLETED|Overall Study||38
9691734|NCT03920280|10791728|FG001|COMPLETED|Overall Study||72
9691735|NCT03920280|10791727|FG000|NOT COMPLETED|Overall Study||3
9691736|NCT03920280|10791728|FG001|NOT COMPLETED|Overall Study||6
9691737|NCT03913091|10791739|FG000|STARTED|Overall Study||92
9691738|NCT03913091|10791740|FG001|STARTED|Overall Study||92
9691739|NCT03913091|10791739|FG000|COMPLETED|Overall Study||72
9691740|NCT03913091|10791740|FG001|COMPLETED|Overall Study||78
9691741|NCT03913091|10791739|FG000|NOT COMPLETED|Overall Study||20
9691742|NCT03913091|10791740|FG001|NOT COMPLETED|Overall Study||14
9691743|NCT03802565|10791751|FG000|STARTED|Overall Study||82
9691744|NCT03802565|10791752|FG001|STARTED|Overall Study||87
9691745|NCT03802565|10791753|FG002|STARTED|Overall Study||83
9691746|NCT03802565|10791754|FG003|STARTED|Overall Study||85
9691747|NCT03802565|10791755|FG004|STARTED|Overall Study||78
9691748|NCT03802565|10791751|FG000|COMPLETED|Overall Study||77
9691749|NCT03802565|10791752|FG001|COMPLETED|Overall Study||83
9691750|NCT03802565|10791753|FG002|COMPLETED|Overall Study||74
9691751|NCT03802565|10791754|FG003|COMPLETED|Overall Study||77
9691752|NCT03802565|10791755|FG004|COMPLETED|Overall Study||72
9691753|NCT03802565|10791751|FG000|NOT COMPLETED|Overall Study||5
9691754|NCT03802565|10791752|FG001|NOT COMPLETED|Overall Study||4
9691755|NCT03802565|10791753|FG002|NOT COMPLETED|Overall Study||9
9691756|NCT03802565|10791754|FG003|NOT COMPLETED|Overall Study||8
9691757|NCT03802565|10791755|FG004|NOT COMPLETED|Overall Study||6
9846815|NCT00850473|10959218|FG000|COMPLETED|Overall Study||3
9846816|NCT00850473|10959218|FG000|NOT COMPLETED|Overall Study||0
9846817|NCT00850499|10959224|FG000|STARTED|Overall Study||4
9846818|NCT00850499|10959225|FG001|STARTED|Overall Study||8
9846819|NCT00850499|10959224|FG000|COMPLETED|Overall Study||1
9846820|NCT00850499|10959225|FG001|COMPLETED|Overall Study||6
9846821|NCT00850499|10959224|FG000|NOT COMPLETED|Overall Study||3
9846822|NCT00850499|10959225|FG001|NOT COMPLETED|Overall Study||2
9846823|NCT00850538|10959231|FG000|STARTED|Overall Study||101
9846824|NCT00850538|10959231|FG000|COMPLETED|Overall Study||60
9846825|NCT00850538|10959231|FG000|NOT COMPLETED|Overall Study||41
9846826|NCT00850564|10959235|FG000|STARTED|Overall Study||15
9846827|NCT00850564|10959235|FG000|COMPLETED|Overall Study||13
9846828|NCT00850564|10959235|FG000|NOT COMPLETED|Overall Study||2
9846829|NCT00850603|10959244|FG000|STARTED|Overall Study||34
9846830|NCT00850603|10959245|FG001|STARTED|Overall Study||34
9961447|NCT01473940|11081215|FG001|NOT COMPLETED|Induction Therapy||1
9961448|NCT01473940|11081216|FG002|NOT COMPLETED|Induction Therapy||2
9961449|NCT01473940|11081217|FG003|NOT COMPLETED|Induction Therapy||1
9961450|NCT01473940|11081214|FG000|STARTED|Maintenance Therapy||3
9961451|NCT01473940|11081215|FG001|STARTED|Maintenance Therapy||3
9961452|NCT01473940|11081216|FG002|STARTED|Maintenance Therapy||4
9961453|NCT01473940|11081217|FG003|STARTED|Maintenance Therapy||7
9961454|NCT01473940|11081214|FG000|Evaluated for Response|Maintenance Therapy||3
9961455|NCT01473940|11081215|FG001|Evaluated for Response|Maintenance Therapy||3
9961456|NCT01473940|11081216|FG002|Evaluated for Response|Maintenance Therapy||4
9961457|NCT01473940|11081217|FG003|Evaluated for Response|Maintenance Therapy||7
9961458|NCT01473940|11081214|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2
9846831|NCT00850603|10959246|FG002|STARTED|Overall Study||34
9846832|NCT00850603|10959247|FG003|STARTED|Overall Study||34
9846833|NCT00850603|10959248|FG004|STARTED|Overall Study||34
9967750|NCT01516008|11088087|FG002|STARTED|Overall Study||117
10024584|NCT01864005|11148436|FG000|NOT COMPLETED|Overall Study||3
10024585|NCT01864005|11148437|FG001|NOT COMPLETED|Overall Study||6
10024586|NCT01864148|11148448|FG000|STARTED|Overall Study||93
10024587|NCT01864148|11148449|FG001|STARTED|Overall Study||45
9691758|NCT03769194|10791771|FG000|STARTED|Overall Study||29
9691759|NCT03769194|10791772|FG001|STARTED|Overall Study||214
9691760|NCT03769194|10791773|FG002|STARTED|Overall Study||205
9691761|NCT03769194|10791774|FG003|STARTED|Overall Study||124
9691762|NCT03769194|10791771|FG000|COMPLETED|Overall Study||25
9691763|NCT03769194|10791772|FG001|COMPLETED|Overall Study||196
9691764|NCT03769194|10791773|FG002|COMPLETED|Overall Study||197
9691765|NCT03769194|10791774|FG003|COMPLETED|Overall Study||115
9691766|NCT03769194|10791771|FG000|NOT COMPLETED|Overall Study||4
9691767|NCT03769194|10791772|FG001|NOT COMPLETED|Overall Study||18
9691768|NCT03769194|10791773|FG002|NOT COMPLETED|Overall Study||8
9691769|NCT03769194|10791774|FG003|NOT COMPLETED|Overall Study||9
9691770|NCT03738332|10791784|FG000|STARTED|Overall Study||12
9691771|NCT03738332|10791784|FG000|COMPLETED|Overall Study||11
9691772|NCT03738332|10791784|FG000|NOT COMPLETED|Overall Study||1
9691773|NCT03451786|10791789|FG000|STARTED|Overall Study||369
9691774|NCT03451786|10791789|FG000|COMPLETED|Overall Study||310
9691775|NCT03451786|10791789|FG000|NOT COMPLETED|Overall Study||59
9691776|NCT03416179|10791797|FG000|STARTED|Overall Study||201
9691777|NCT03416179|10791798|FG001|STARTED|Overall Study||203
9691778|NCT03416179|10791799|FG002|STARTED|Overall Study||163
9691779|NCT03416179|10791800|FG003|STARTED|Overall Study||162
9691780|NCT03416179|10791797|FG000|COMPLETED|Overall Study||0
9691781|NCT03416179|10791798|FG001|COMPLETED|Overall Study||0
9691782|NCT03416179|10791799|FG002|COMPLETED|Overall Study||0
9691783|NCT03416179|10791800|FG003|COMPLETED|Overall Study||0
9691784|NCT03416179|10791797|FG000|NOT COMPLETED|Overall Study||201
9691785|NCT03416179|10791798|FG001|NOT COMPLETED|Overall Study||203
9691786|NCT03416179|10791799|FG002|NOT COMPLETED|Overall Study||163
9691787|NCT03416179|10791800|FG003|NOT COMPLETED|Overall Study||162
9691788|NCT03353922|10791810|FG000|STARTED|Overall Study||6
9691789|NCT03353922|10791811|FG001|STARTED|Overall Study||6
9691790|NCT03353922|10791812|FG002|STARTED|Overall Study||6
9691791|NCT03353922|10791813|FG003|STARTED|Overall Study||6
9691792|NCT03353922|10791814|FG004|STARTED|Overall Study||5
9691793|NCT03353922|10791815|FG005|STARTED|Overall Study||6
9691794|NCT03353922|10791810|FG000|COMPLETED|Overall Study||5
9691795|NCT03353922|10791811|FG001|COMPLETED|Overall Study||5
9691796|NCT03353922|10791812|FG002|COMPLETED|Overall Study||5
9691797|NCT03353922|10791813|FG003|COMPLETED|Overall Study||5
9691798|NCT03353922|10791814|FG004|COMPLETED|Overall Study||5
9691799|NCT03353922|10791815|FG005|COMPLETED|Overall Study||6
9691800|NCT03353922|10791810|FG000|NOT COMPLETED|Overall Study||1
9691801|NCT03353922|10791811|FG001|NOT COMPLETED|Overall Study||1
9691802|NCT03353922|10791812|FG002|NOT COMPLETED|Overall Study||1
9691803|NCT03353922|10791813|FG003|NOT COMPLETED|Overall Study||1
9691804|NCT03353922|10791814|FG004|NOT COMPLETED|Overall Study||0
9691805|NCT03353922|10791815|FG005|NOT COMPLETED|Overall Study||0
9691806|NCT03322384|10791826|FG000|STARTED|Overall Study||20
9691807|NCT03322384|10791826|FG000|COMPLETED|Overall Study||14
9691808|NCT03322384|10791826|FG000|NOT COMPLETED|Overall Study||6
9691809|NCT03243071|10791832|FG000|STARTED|Overall Study||59
9691810|NCT03243071|10791833|FG001|STARTED|Overall Study||53
9691811|NCT03243071|10791832|FG000|COMPLETED|Overall Study||59
9691812|NCT03243071|10791833|FG001|COMPLETED|Overall Study||53
9691813|NCT03243071|10791832|FG000|NOT COMPLETED|Overall Study||0
9691814|NCT03243071|10791833|FG001|NOT COMPLETED|Overall Study||0
9691815|NCT03173456|10791850|FG000|STARTED|Baseline||120
9691816|NCT03173456|10791851|FG001|STARTED|Baseline||120
9691817|NCT03173456|10791852|FG002|STARTED|Baseline||120
9691818|NCT03173456|10791853|FG003|STARTED|Baseline||120
9691819|NCT03173456|10791854|FG004|STARTED|Baseline||120
10024588|NCT01864148|11148450|FG002|STARTED|Overall Study||95
10024589|NCT01864148|11148451|FG003|STARTED|Overall Study||94
10024590|NCT01864148|11148452|FG004|STARTED|Overall Study||92
10024591|NCT01864148|11148448|FG000|Randomized and Dosed|Overall Study||93
10024592|NCT01864148|11148449|FG001|Randomized and Dosed|Overall Study||45
10024593|NCT01864148|11148450|FG002|Randomized and Dosed|Overall Study||95
10024594|NCT01864148|11148451|FG003|Randomized and Dosed|Overall Study||93
10024595|NCT01864148|11148452|FG004|Randomized and Dosed|Overall Study||92
10024596|NCT01864148|11148448|FG000|COMPLETED|Overall Study||73
10024597|NCT01864148|11148449|FG001|COMPLETED|Overall Study||40
10024598|NCT01864148|11148450|FG002|COMPLETED|Overall Study||84
10024599|NCT01864148|11148451|FG003|COMPLETED|Overall Study||68
10024600|NCT01864148|11148452|FG004|COMPLETED|Overall Study||69
9691820|NCT03173456|10791850|FG000|COMPLETED|Baseline||120
9691821|NCT03173456|10791851|FG001|COMPLETED|Baseline||119
9691822|NCT03173456|10791852|FG002|COMPLETED|Baseline||120
9691823|NCT03173456|10791853|FG003|COMPLETED|Baseline||120
9691824|NCT03173456|10791854|FG004|COMPLETED|Baseline||118
9691825|NCT03173456|10791850|FG000|NOT COMPLETED|Baseline||0
9691826|NCT03173456|10791851|FG001|NOT COMPLETED|Baseline||1
9691827|NCT03173456|10791852|FG002|NOT COMPLETED|Baseline||0
9691828|NCT03173456|10791853|FG003|NOT COMPLETED|Baseline||0
9691829|NCT03173456|10791854|FG004|NOT COMPLETED|Baseline||2
9691830|NCT03173456|10791850|FG000|STARTED|2 Hour Follow-up||120
9691831|NCT03173456|10791851|FG001|STARTED|2 Hour Follow-up||119
9691832|NCT03173456|10791852|FG002|STARTED|2 Hour Follow-up||120
9691833|NCT03173456|10791853|FG003|STARTED|2 Hour Follow-up||120
9691834|NCT03173456|10791854|FG004|STARTED|2 Hour Follow-up||118
9691835|NCT03173456|10791850|FG000|COMPLETED|2 Hour Follow-up||120
9691836|NCT03173456|10791851|FG001|COMPLETED|2 Hour Follow-up||118
9691837|NCT03173456|10791852|FG002|COMPLETED|2 Hour Follow-up||119
9691838|NCT03173456|10791853|FG003|COMPLETED|2 Hour Follow-up||119
9691839|NCT03173456|10791854|FG004|COMPLETED|2 Hour Follow-up||116
9691840|NCT03173456|10791850|FG000|NOT COMPLETED|2 Hour Follow-up||0
9691841|NCT03173456|10791851|FG001|NOT COMPLETED|2 Hour Follow-up||1
9691842|NCT03173456|10791852|FG002|NOT COMPLETED|2 Hour Follow-up||1
9691843|NCT03173456|10791853|FG003|NOT COMPLETED|2 Hour Follow-up||1
9691844|NCT03173456|10791854|FG004|NOT COMPLETED|2 Hour Follow-up||2
9726794|NCT00103285|10826369|FG001|STARTED|Induction||0
9726795|NCT00103285|10826370|FG002|STARTED|Induction||0
9726796|NCT00103285|10826371|FG003|STARTED|Induction||0
9726797|NCT00103285|10826372|FG004|STARTED|Induction||0
9726798|NCT00103285|10826373|FG005|STARTED|Induction||0
9726799|NCT00103285|10826374|FG006|STARTED|Induction||0
9726800|NCT00103285|10826375|FG007|STARTED|Induction||0
9726801|NCT00103285|10826368|FG000|COMPLETED|Induction||4028
9726802|NCT00103285|10826369|FG001|COMPLETED|Induction||0
9726803|NCT00103285|10826370|FG002|COMPLETED|Induction||0
9726804|NCT00103285|10826371|FG003|COMPLETED|Induction||0
9726805|NCT00103285|10826372|FG004|COMPLETED|Induction||0
9726806|NCT00103285|10826373|FG005|COMPLETED|Induction||0
9726807|NCT00103285|10826374|FG006|COMPLETED|Induction||0
9726808|NCT00103285|10826375|FG007|COMPLETED|Induction||0
9726809|NCT00103285|10826368|FG000|NOT COMPLETED|Induction||1349
9726810|NCT00103285|10826369|FG001|NOT COMPLETED|Induction||0
9726811|NCT00103285|10826370|FG002|NOT COMPLETED|Induction||0
9726812|NCT00103285|10826371|FG003|NOT COMPLETED|Induction||0
9726813|NCT00103285|10826372|FG004|NOT COMPLETED|Induction||0
9726814|NCT00103285|10826373|FG005|NOT COMPLETED|Induction||0
9726815|NCT00103285|10826374|FG006|NOT COMPLETED|Induction||0
9726816|NCT00103285|10826375|FG007|NOT COMPLETED|Induction||0
9726817|NCT00103285|10826368|FG000|STARTED|Response Assignment||0
9726818|NCT00103285|10826369|FG001|STARTED|Response Assignment||939
9726819|NCT00103285|10826370|FG002|STARTED|Response Assignment||937
9726820|NCT00103285|10826371|FG003|STARTED|Response Assignment||503
9726821|NCT00103285|10826372|FG004|STARTED|Response Assignment||509
9726822|NCT00103285|10826373|FG005|STARTED|Response Assignment||249
9726823|NCT00103285|10826374|FG006|STARTED|Response Assignment||248
9726824|NCT00103285|10826375|FG007|STARTED|Response Assignment||643
9726825|NCT00103285|10826368|FG000|COMPLETED|Response Assignment||0
9726826|NCT00103285|10826369|FG001|COMPLETED|Response Assignment||807
9726827|NCT00103285|10826370|FG002|COMPLETED|Response Assignment||853
9726828|NCT00103285|10826371|FG003|COMPLETED|Response Assignment||441
9726829|NCT00103285|10826372|FG004|COMPLETED|Response Assignment||425
10114479|NCT02516332|11245206|FG002|NOT COMPLETED|Overall Study||2
9726830|NCT00103285|10826373|FG005|COMPLETED|Response Assignment||201
9726831|NCT00103285|10826374|FG006|COMPLETED|Response Assignment||199
9726832|NCT00103285|10826375|FG007|COMPLETED|Response Assignment||523
9726833|NCT00103285|10826368|FG000|NOT COMPLETED|Response Assignment||0
9726834|NCT00103285|10826369|FG001|NOT COMPLETED|Response Assignment||132
9726835|NCT00103285|10826370|FG002|NOT COMPLETED|Response Assignment||84
9726836|NCT00103285|10826371|FG003|NOT COMPLETED|Response Assignment||62
9726837|NCT00103285|10826372|FG004|NOT COMPLETED|Response Assignment||84
9726838|NCT00103285|10826373|FG005|NOT COMPLETED|Response Assignment||48
9726839|NCT00103285|10826374|FG006|NOT COMPLETED|Response Assignment||49
9726840|NCT00103285|10826375|FG007|NOT COMPLETED|Response Assignment||120
9726841|NCT00103311|10826402|FG000|STARTED|Overall Study||33
9726842|NCT00103311|10826403|FG001|STARTED|Overall Study||31
9726843|NCT00103311|10826402|FG000|COMPLETED|Overall Study||29
9726844|NCT00103311|10826403|FG001|COMPLETED|Overall Study||30
9726845|NCT00103311|10826402|FG000|NOT COMPLETED|Overall Study||4
9726846|NCT00103311|10826403|FG001|NOT COMPLETED|Overall Study||1
9691845|NCT03101566|10791868|FG000|STARTED|Overall Study||37
9691846|NCT03101566|10791869|FG001|STARTED|Overall Study||38
9691847|NCT03101566|10791868|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35
9691848|NCT03101566|10791869|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33
9691849|NCT03101566|10791868|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
9691850|NCT03101566|10791869|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
9691851|NCT03101566|10791868|FG000|COMPLETED|Overall Study||31
9691852|NCT03101566|10791869|FG001|COMPLETED|Overall Study||31
9691853|NCT03101566|10791868|FG000|NOT COMPLETED|Overall Study||6
9691854|NCT03101566|10791869|FG001|NOT COMPLETED|Overall Study||7
9691855|NCT03003520|10791877|FG000|STARTED|Induction||43
9691856|NCT03003520|10791878|FG001|STARTED|Induction||3
9691857|NCT03003520|10791877|FG000|Safety Population|Induction||43
9691858|NCT03003520|10791878|FG001|Safety Population|Induction||3
9691859|NCT03003520|10791877|FG000|Efficacy Evaluable Population|Induction||37
9691860|NCT03003520|10791878|FG001|Efficacy Evaluable Population|Induction||3
9691861|NCT03003520|10791877|FG000|COMPLETED|Induction||30
9691862|NCT03003520|10791878|FG001|COMPLETED|Induction||3
9691863|NCT03003520|10791877|FG000|NOT COMPLETED|Induction||13
9691864|NCT03003520|10791878|FG001|NOT COMPLETED|Induction||0
9691865|NCT03003520|10791877|FG000|STARTED|Consolidation||25
9691866|NCT03003520|10791878|FG001|STARTED|Consolidation||3
9691867|NCT03003520|10791877|FG000|COMPLETED|Consolidation||1
9691868|NCT03003520|10791878|FG001|COMPLETED|Consolidation||2
9691869|NCT03003520|10791877|FG000|NOT COMPLETED|Consolidation||24
9691870|NCT03003520|10791878|FG001|NOT COMPLETED|Consolidation||1
9691871|NCT03003520|10791877|FG000|STARTED|Follow-up||14
9691872|NCT03003520|10791878|FG001|STARTED|Follow-up||3
9691873|NCT03003520|10791877|FG000|COMPLETED|Follow-up||0
9691874|NCT03003520|10791878|FG001|COMPLETED|Follow-up||0
9691875|NCT03003520|10791877|FG000|NOT COMPLETED|Follow-up||14
9691876|NCT03003520|10791878|FG001|NOT COMPLETED|Follow-up||3
9691877|NCT02862457|10791899|FG000|STARTED|Overall Study||3
9691878|NCT02862457|10791900|FG001|STARTED|Overall Study||3
9691879|NCT02862457|10791901|FG002|STARTED|Overall Study||3
9691880|NCT02862457|10791902|FG003|STARTED|Overall Study||6
10024601|NCT01864148|11148448|FG000|NOT COMPLETED|Overall Study||20
10024602|NCT01864148|11148449|FG001|NOT COMPLETED|Overall Study||5
10024603|NCT01864148|11148450|FG002|NOT COMPLETED|Overall Study||11
9691881|NCT02862457|10791903|FG004|STARTED|Overall Study||7
9691882|NCT02862457|10791904|FG005|STARTED|Overall Study||6
9691883|NCT02862457|10791905|FG006|STARTED|Overall Study||6
9691884|NCT02862457|10791899|FG000|COMPLETED|Overall Study||1
9691885|NCT02862457|10791900|FG001|COMPLETED|Overall Study||0
9691886|NCT02862457|10791901|FG002|COMPLETED|Overall Study||0
9691887|NCT02862457|10791902|FG003|COMPLETED|Overall Study||2
9691888|NCT02862457|10791903|FG004|COMPLETED|Overall Study||7
9691889|NCT02862457|10791904|FG005|COMPLETED|Overall Study||3
9691890|NCT02862457|10791905|FG006|COMPLETED|Overall Study||5
9691891|NCT02862457|10791899|FG000|NOT COMPLETED|Overall Study||2
9691892|NCT02862457|10791900|FG001|NOT COMPLETED|Overall Study||3
9691893|NCT02862457|10791901|FG002|NOT COMPLETED|Overall Study||3
9691894|NCT02862457|10791902|FG003|NOT COMPLETED|Overall Study||4
9691895|NCT02862457|10791903|FG004|NOT COMPLETED|Overall Study||0
9691896|NCT02862457|10791904|FG005|NOT COMPLETED|Overall Study||3
9691897|NCT02862457|10791905|FG006|NOT COMPLETED|Overall Study||1
9691898|NCT02820753|10791931|FG000|STARTED|Baseline||256
10024604|NCT01864148|11148451|FG003|NOT COMPLETED|Overall Study||26
10024605|NCT01864148|11148452|FG004|NOT COMPLETED|Overall Study||23
10024606|NCT01864174|11148471|FG000|STARTED|Double Blind Treatment - All Treated||283
10024607|NCT01864174|11148472|FG001|STARTED|Double Blind Treatment - All Treated||285
10024608|NCT01864174|11148471|FG000|COMPLETED|Double Blind Treatment - All Treated||268
10024609|NCT01864174|11148472|FG001|COMPLETED|Double Blind Treatment - All Treated||271
10024610|NCT01864174|11148471|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15
10024611|NCT01864174|11148472|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14
10024612|NCT01864174|11148471|FG000|STARTED|Double Blind - Compliant Randomized||268
9691899|NCT02820753|10791932|FG001|STARTED|Baseline||421
9691900|NCT02820753|10791931|FG000|COMPLETED|Baseline||256
9691901|NCT02820753|10791932|FG001|COMPLETED|Baseline||421
9691902|NCT02820753|10791931|FG000|NOT COMPLETED|Baseline||0
9691903|NCT02820753|10791932|FG001|NOT COMPLETED|Baseline||0
9691904|NCT02820753|10791931|FG000|STARTED|2 Month||256
9691905|NCT02820753|10791932|FG001|STARTED|2 Month||421
9691906|NCT02820753|10791931|FG000|COMPLETED|2 Month||178
9691907|NCT02820753|10791932|FG001|COMPLETED|2 Month||379
9691908|NCT02820753|10791931|FG000|NOT COMPLETED|2 Month||78
9691909|NCT02820753|10791932|FG001|NOT COMPLETED|2 Month||42
9691910|NCT02820753|10791931|FG000|STARTED|6 Month||253
9691911|NCT02820753|10791932|FG001|STARTED|6 Month||418
9691912|NCT02820753|10791931|FG000|COMPLETED|6 Month||150
9691913|NCT02820753|10791932|FG001|COMPLETED|6 Month||307
9691914|NCT02820753|10791931|FG000|NOT COMPLETED|6 Month||103
9691915|NCT02820753|10791932|FG001|NOT COMPLETED|6 Month||111
9691916|NCT02733042|10791957|FG000|STARTED|Treatment Period||3
9691917|NCT02733042|10791958|FG001|STARTED|Treatment Period||3
9691918|NCT02733042|10791959|FG002|STARTED|Treatment Period||8
9691919|NCT02733042|10791960|FG003|STARTED|Treatment Period||3
9691920|NCT02733042|10791961|FG004|STARTED|Treatment Period||4
9691921|NCT02733042|10791962|FG005|STARTED|Treatment Period||3
9691922|NCT02733042|10791963|FG006|STARTED|Treatment Period||1
10024613|NCT01864174|11148472|FG001|STARTED|Double Blind - Compliant Randomized||271
10024614|NCT01864174|11148471|FG000|COMPLETED|Double Blind - Compliant Randomized||245
10024615|NCT01864174|11148472|FG001|COMPLETED|Double Blind - Compliant Randomized||245
10024616|NCT01864174|11148471|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23
10024617|NCT01864174|11148472|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26
10024618|NCT01864174|11148471|FG000|STARTED|Off Treatment Follow-Up||9
10024619|NCT01864174|11148472|FG001|STARTED|Off Treatment Follow-Up||1
10024620|NCT01864174|11148471|FG000|COMPLETED|Off Treatment Follow-Up||6
9691923|NCT02733042|10791964|FG007|STARTED|Treatment Period||4
9691924|NCT02733042|10791965|FG008|STARTED|Treatment Period||5
9691925|NCT02733042|10791966|FG009|STARTED|Treatment Period||10
9691926|NCT02733042|10791967|FG010|STARTED|Treatment Period||10
9691927|NCT02733042|10791968|FG011|STARTED|Treatment Period||10
9691928|NCT02733042|10791969|FG012|STARTED|Treatment Period||10
9691929|NCT02733042|10791970|FG013|STARTED|Treatment Period||5
9691930|NCT02733042|10791971|FG014|STARTED|Treatment Period||5
9691931|NCT02733042|10791972|FG015|STARTED|Treatment Period||10
9691932|NCT02733042|10791973|FG016|STARTED|Treatment Period||2
9691933|NCT02733042|10791974|FG017|STARTED|Treatment Period||5
9691934|NCT02733042|10791975|FG018|STARTED|Treatment Period||5
9691935|NCT02733042|10791957|FG000|COMPLETED|Treatment Period||0
9691936|NCT02733042|10791958|FG001|COMPLETED|Treatment Period||1
9691937|NCT02733042|10791959|FG002|COMPLETED|Treatment Period||1
9691938|NCT02733042|10791960|FG003|COMPLETED|Treatment Period||0
9691939|NCT02733042|10791961|FG004|COMPLETED|Treatment Period||0
9691940|NCT02733042|10791962|FG005|COMPLETED|Treatment Period||0
9691941|NCT02733042|10791963|FG006|COMPLETED|Treatment Period||0
9691942|NCT02733042|10791964|FG007|COMPLETED|Treatment Period||1
9691943|NCT02733042|10791965|FG008|COMPLETED|Treatment Period||0
9691944|NCT02733042|10791966|FG009|COMPLETED|Treatment Period||0
9691945|NCT02733042|10791967|FG010|COMPLETED|Treatment Period||0
9691946|NCT02733042|10791968|FG011|COMPLETED|Treatment Period||4
9691947|NCT02733042|10791969|FG012|COMPLETED|Treatment Period||1
9691948|NCT02733042|10791970|FG013|COMPLETED|Treatment Period||1
9691949|NCT02733042|10791971|FG014|COMPLETED|Treatment Period||0
9691950|NCT02733042|10791972|FG015|COMPLETED|Treatment Period||0
9691951|NCT02733042|10791973|FG016|COMPLETED|Treatment Period||0
9691952|NCT02733042|10791974|FG017|COMPLETED|Treatment Period||0
9691953|NCT02733042|10791975|FG018|COMPLETED|Treatment Period||0
9691954|NCT02733042|10791957|FG000|NOT COMPLETED|Treatment Period||3
9691955|NCT02733042|10791958|FG001|NOT COMPLETED|Treatment Period||2
9691956|NCT02733042|10791959|FG002|NOT COMPLETED|Treatment Period||7
9691957|NCT02733042|10791960|FG003|NOT COMPLETED|Treatment Period||3
9691958|NCT02733042|10791961|FG004|NOT COMPLETED|Treatment Period||4
9691959|NCT02733042|10791962|FG005|NOT COMPLETED|Treatment Period||3
9691960|NCT02733042|10791963|FG006|NOT COMPLETED|Treatment Period||1
9691961|NCT02733042|10791964|FG007|NOT COMPLETED|Treatment Period||3
9691962|NCT02733042|10791965|FG008|NOT COMPLETED|Treatment Period||5
9691963|NCT02733042|10791966|FG009|NOT COMPLETED|Treatment Period||10
9691964|NCT02733042|10791967|FG010|NOT COMPLETED|Treatment Period||10
9691965|NCT02733042|10791968|FG011|NOT COMPLETED|Treatment Period||6
9691966|NCT02733042|10791969|FG012|NOT COMPLETED|Treatment Period||9
9691967|NCT02733042|10791970|FG013|NOT COMPLETED|Treatment Period||4
9691968|NCT02733042|10791971|FG014|NOT COMPLETED|Treatment Period||5
9691969|NCT02733042|10791972|FG015|NOT COMPLETED|Treatment Period||10
9691970|NCT02733042|10791973|FG016|NOT COMPLETED|Treatment Period||2
9691971|NCT02733042|10791974|FG017|NOT COMPLETED|Treatment Period||5
9691972|NCT02733042|10791975|FG018|NOT COMPLETED|Treatment Period||5
9691973|NCT02733042|10791957|FG000|STARTED|Follow-up Period||3
9691974|NCT02733042|10791958|FG001|STARTED|Follow-up Period||3
9691975|NCT02733042|10791959|FG002|STARTED|Follow-up Period||6
9691976|NCT02733042|10791960|FG003|STARTED|Follow-up Period||3
9691977|NCT02733042|10791961|FG004|STARTED|Follow-up Period||1
9691978|NCT02733042|10791962|FG005|STARTED|Follow-up Period||2
9691979|NCT02733042|10791963|FG006|STARTED|Follow-up Period||0
9691980|NCT02733042|10791964|FG007|STARTED|Follow-up Period||4
9691981|NCT02733042|10791965|FG008|STARTED|Follow-up Period||4
9691982|NCT02733042|10791966|FG009|STARTED|Follow-up Period||2
9691983|NCT02733042|10791967|FG010|STARTED|Follow-up Period||5
9691984|NCT02733042|10791968|FG011|STARTED|Follow-up Period||9
10024621|NCT01864174|11148472|FG001|COMPLETED|Off Treatment Follow-Up||1
10024622|NCT01864174|11148471|FG000|NOT COMPLETED|Off Treatment Follow-Up||3
10024623|NCT01864174|11148472|FG001|NOT COMPLETED|Off Treatment Follow-Up||0
10024624|NCT01864200|11148480|FG000|STARTED|Overall Study||45
9691985|NCT02733042|10791969|FG012|STARTED|Follow-up Period||9
9691986|NCT02733042|10791970|FG013|STARTED|Follow-up Period||4
9691987|NCT02733042|10791971|FG014|STARTED|Follow-up Period||1
9691988|NCT02733042|10791972|FG015|STARTED|Follow-up Period||5
9691989|NCT02733042|10791973|FG016|STARTED|Follow-up Period||0
9691990|NCT02733042|10791974|FG017|STARTED|Follow-up Period||3
9691991|NCT02733042|10791975|FG018|STARTED|Follow-up Period||2
10024625|NCT01864200|11148481|FG001|STARTED|Overall Study||29
10024626|NCT01864200|11148480|FG000|COMPLETED|Overall Study||43
10024627|NCT01864200|11148481|FG001|COMPLETED|Overall Study||26
10024628|NCT01864200|11148480|FG000|NOT COMPLETED|Overall Study||2
9691992|NCT02733042|10791957|FG000|COMPLETED|Follow-up Period||0
10024629|NCT01864200|11148481|FG001|NOT COMPLETED|Overall Study||3
10024630|NCT01864291|11148487|FG000|STARTED|Overall Study||9
10024631|NCT01864291|11148487|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
10024632|NCT01864291|11148487|FG000|NOT COMPLETED|Overall Study||2
10024633|NCT01864434|11148493|FG000|STARTED|Overall Study||25
10024634|NCT01864434|11148494|FG001|STARTED|Overall Study||25
9691993|NCT02733042|10791958|FG001|COMPLETED|Follow-up Period||0
10024635|NCT01864434|11148493|FG000|COMPLETED|Overall Study||25
9691994|NCT02733042|10791959|FG002|COMPLETED|Follow-up Period||0
9691995|NCT02733042|10791960|FG003|COMPLETED|Follow-up Period||0
9691996|NCT02733042|10791961|FG004|COMPLETED|Follow-up Period||0
9691997|NCT02733042|10791962|FG005|COMPLETED|Follow-up Period||0
9691998|NCT02733042|10791963|FG006|COMPLETED|Follow-up Period||0
9691999|NCT02733042|10791964|FG007|COMPLETED|Follow-up Period||0
9692000|NCT02733042|10791965|FG008|COMPLETED|Follow-up Period||0
9692001|NCT02733042|10791966|FG009|COMPLETED|Follow-up Period||0
9692002|NCT02733042|10791967|FG010|COMPLETED|Follow-up Period||0
9692003|NCT02733042|10791968|FG011|COMPLETED|Follow-up Period||0
9692004|NCT02733042|10791969|FG012|COMPLETED|Follow-up Period||0
9692005|NCT02733042|10791970|FG013|COMPLETED|Follow-up Period||0
9692006|NCT02733042|10791971|FG014|COMPLETED|Follow-up Period||0
9692007|NCT02733042|10791972|FG015|COMPLETED|Follow-up Period||0
9692008|NCT02733042|10791973|FG016|COMPLETED|Follow-up Period||0
9692009|NCT02733042|10791974|FG017|COMPLETED|Follow-up Period||1
9692010|NCT02733042|10791975|FG018|COMPLETED|Follow-up Period||0
9692011|NCT02733042|10791957|FG000|NOT COMPLETED|Follow-up Period||3
9692012|NCT02733042|10791958|FG001|NOT COMPLETED|Follow-up Period||3
9692013|NCT02733042|10791959|FG002|NOT COMPLETED|Follow-up Period||6
9692014|NCT02733042|10791960|FG003|NOT COMPLETED|Follow-up Period||3
9692015|NCT02733042|10791961|FG004|NOT COMPLETED|Follow-up Period||1
9692016|NCT02733042|10791962|FG005|NOT COMPLETED|Follow-up Period||2
9692017|NCT02733042|10791963|FG006|NOT COMPLETED|Follow-up Period||0
9692018|NCT02733042|10791964|FG007|NOT COMPLETED|Follow-up Period||4
9846834|NCT00850603|10959244|FG000|COMPLETED|Overall Study||34
9846835|NCT00850603|10959245|FG001|COMPLETED|Overall Study||34
9846836|NCT00850603|10959246|FG002|COMPLETED|Overall Study||34
9846837|NCT00850603|10959247|FG003|COMPLETED|Overall Study||34
9846838|NCT00850603|10959248|FG004|COMPLETED|Overall Study||34
9846839|NCT00850603|10959244|FG000|NOT COMPLETED|Overall Study||0
9846840|NCT00850603|10959245|FG001|NOT COMPLETED|Overall Study||0
9846841|NCT00850603|10959246|FG002|NOT COMPLETED|Overall Study||0
9846842|NCT00850603|10959247|FG003|NOT COMPLETED|Overall Study||0
9846843|NCT00850603|10959248|FG004|NOT COMPLETED|Overall Study||0
9846844|NCT00850642|10959262|FG000|STARTED|Overall Study||3
9846845|NCT00850642|10959263|FG001|STARTED|Overall Study||4
9846846|NCT00850642|10959262|FG000|COMPLETED|Overall Study||3
9846847|NCT00850642|10959263|FG001|COMPLETED|Overall Study||4
9846848|NCT00850642|10959262|FG000|NOT COMPLETED|Overall Study||0
9846849|NCT00850642|10959263|FG001|NOT COMPLETED|Overall Study||0
9846850|NCT00850759|10959278|FG000|STARTED|Overall Study||59
9846851|NCT00850759|10959279|FG001|STARTED|Overall Study||57
9846852|NCT00850759|10959280|FG002|STARTED|Overall Study||57
9846853|NCT00850759|10959281|FG003|STARTED|Overall Study||58
9846854|NCT00850759|10959278|FG000|COMPLETED|Overall Study||52
9846855|NCT00850759|10959279|FG001|COMPLETED|Overall Study||52
9846856|NCT00850759|10959280|FG002|COMPLETED|Overall Study||52
9692019|NCT02733042|10791965|FG008|NOT COMPLETED|Follow-up Period||4
9692020|NCT02733042|10791966|FG009|NOT COMPLETED|Follow-up Period||2
9846857|NCT00850759|10959281|FG003|COMPLETED|Overall Study||55
9846858|NCT00850759|10959278|FG000|NOT COMPLETED|Overall Study||7
9846859|NCT00850759|10959279|FG001|NOT COMPLETED|Overall Study||5
9846860|NCT00850759|10959280|FG002|NOT COMPLETED|Overall Study||5
9692021|NCT02733042|10791967|FG010|NOT COMPLETED|Follow-up Period||5
9692022|NCT02733042|10791968|FG011|NOT COMPLETED|Follow-up Period||9
9692023|NCT02733042|10791969|FG012|NOT COMPLETED|Follow-up Period||9
9692024|NCT02733042|10791970|FG013|NOT COMPLETED|Follow-up Period||4
9692025|NCT02733042|10791971|FG014|NOT COMPLETED|Follow-up Period||1
9692026|NCT02733042|10791972|FG015|NOT COMPLETED|Follow-up Period||5
9692027|NCT02733042|10791973|FG016|NOT COMPLETED|Follow-up Period||0
9692028|NCT02733042|10791974|FG017|NOT COMPLETED|Follow-up Period||2
9692029|NCT02733042|10791975|FG018|NOT COMPLETED|Follow-up Period||2
9692030|NCT02668874|10792025|FG000|STARTED|Overall Study||104
9692031|NCT02668874|10792026|FG001|STARTED|Overall Study||104
9692032|NCT02668874|10792025|FG000|6 Months After Placement|Overall Study||59
9692033|NCT02668874|10792026|FG001|6 Months After Placement|Overall Study||59
9692034|NCT02668874|10792025|FG000|COMPLETED|Overall Study||47
9692035|NCT02668874|10792026|FG001|COMPLETED|Overall Study||47
9692036|NCT02668874|10792025|FG000|NOT COMPLETED|Overall Study||57
10024636|NCT01864434|11148494|FG001|COMPLETED|Overall Study||25
10024637|NCT01864434|11148493|FG000|NOT COMPLETED|Overall Study||0
10024638|NCT01864434|11148494|FG001|NOT COMPLETED|Overall Study||0
9692037|NCT02668874|10792026|FG001|NOT COMPLETED|Overall Study||57
9692038|NCT02609737|10792032|FG000|STARTED|Overall Study||20
9692039|NCT02609737|10792032|FG000|COMPLETED|Overall Study||20
9692040|NCT02609737|10792032|FG000|NOT COMPLETED|Overall Study||0
9692041|NCT02574286|10792036|FG000|STARTED|Overall Study||21
9692042|NCT02574286|10792036|FG000|COMPLETED|Overall Study||16
9692043|NCT02574286|10792036|FG000|NOT COMPLETED|Overall Study||5
9692044|NCT02471144|10792044|FG000|STARTED|Induction Period (Up to Week 12)||40
9692045|NCT02471144|10792045|FG001|STARTED|Induction Period (Up to Week 12)||40
9692046|NCT02471144|10792046|FG002|STARTED|Induction Period (Up to Week 12)||41
9692047|NCT02471144|10792047|FG003|STARTED|Induction Period (Up to Week 12)||41
9692048|NCT02471144|10792048|FG004|STARTED|Induction Period (Up to Week 12)||0
9692049|NCT02471144|10792049|FG005|STARTED|Induction Period (Up to Week 12)||0
9692050|NCT02471144|10792050|FG006|STARTED|Induction Period (Up to Week 12)||0
9692051|NCT02471144|10792051|FG007|STARTED|Induction Period (Up to Week 12)||0
9692052|NCT02471144|10792052|FG008|STARTED|Induction Period (Up to Week 12)||0
9692053|NCT02471144|10792053|FG009|STARTED|Induction Period (Up to Week 12)||0
9692054|NCT02471144|10792054|FG010|STARTED|Induction Period (Up to Week 12)||0
9692055|NCT02471144|10792044|FG000|COMPLETED|Induction Period (Up to Week 12)||39
9692056|NCT02471144|10792045|FG001|COMPLETED|Induction Period (Up to Week 12)||38
9692057|NCT02471144|10792046|FG002|COMPLETED|Induction Period (Up to Week 12)||39
9692058|NCT02471144|10792047|FG003|COMPLETED|Induction Period (Up to Week 12)||40
9692059|NCT02471144|10792048|FG004|COMPLETED|Induction Period (Up to Week 12)||0
9692060|NCT02471144|10792049|FG005|COMPLETED|Induction Period (Up to Week 12)||0
9692061|NCT02471144|10792050|FG006|COMPLETED|Induction Period (Up to Week 12)||0
9692062|NCT02471144|10792051|FG007|COMPLETED|Induction Period (Up to Week 12)||0
9692063|NCT02471144|10792052|FG008|COMPLETED|Induction Period (Up to Week 12)||0
9692064|NCT02471144|10792053|FG009|COMPLETED|Induction Period (Up to Week 12)||0
9692065|NCT02471144|10792054|FG010|COMPLETED|Induction Period (Up to Week 12)||0
9692066|NCT02471144|10792044|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1
9692067|NCT02471144|10792045|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2
9692068|NCT02471144|10792046|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2
9692069|NCT02471144|10792047|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1
9692070|NCT02471144|10792048|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0
9692071|NCT02471144|10792049|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0
9692072|NCT02471144|10792050|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0
9692073|NCT02471144|10792051|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0
9692074|NCT02471144|10792052|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0
9692075|NCT02471144|10792053|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0
9692076|NCT02471144|10792054|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0
9692077|NCT02471144|10792044|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0
9692078|NCT02471144|10792045|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0
10024639|NCT01864525|11148502|FG000|STARTED|Overall Study||10
10024640|NCT01864525|11148503|FG001|STARTED|Overall Study||7
10024641|NCT01864525|11148502|FG000|COMPLETED|Overall Study||9
10024642|NCT01864525|11148503|FG001|COMPLETED|Overall Study||7
10024643|NCT01864525|11148502|FG000|NOT COMPLETED|Overall Study||1
10024644|NCT01864525|11148503|FG001|NOT COMPLETED|Overall Study||0
10024645|NCT01864538|11148509|FG000|STARTED|Overall Study||11
10114480|NCT02516410|11245216|FG000|STARTED|Overall Study||85
10114481|NCT02516410|11245217|FG001|STARTED|Overall Study||83
9692079|NCT02471144|10792046|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0
9846861|NCT00850759|10959281|FG003|NOT COMPLETED|Overall Study||3
10024646|NCT01864538|11148509|FG000|COMPLETED|Overall Study||0
10114482|NCT02516410|11245216|FG000|COMPLETED|Overall Study||85
10114483|NCT02516410|11245217|FG001|COMPLETED|Overall Study||81
9692080|NCT02471144|10792047|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0
9692081|NCT02471144|10792048|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39
9692082|NCT02471144|10792049|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38
9692083|NCT02471144|10792050|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16
9692084|NCT02471144|10792051|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18
9692085|NCT02471144|10792052|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40
9692086|NCT02471144|10792053|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0
9692087|NCT02471144|10792054|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0
9692088|NCT02471144|10792044|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692089|NCT02471144|10792045|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692090|NCT02471144|10792046|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692091|NCT02471144|10792047|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692092|NCT02471144|10792048|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
9692093|NCT02471144|10792049|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
9692094|NCT02471144|10792050|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
9692095|NCT02471144|10792051|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
9692096|NCT02471144|10792052|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
9692097|NCT02471144|10792053|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692098|NCT02471144|10792054|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692099|NCT02471144|10792044|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692100|NCT02471144|10792045|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692101|NCT02471144|10792046|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692102|NCT02471144|10792047|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692103|NCT02471144|10792048|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
9692104|NCT02471144|10792049|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
9692105|NCT02471144|10792050|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
9692106|NCT02471144|10792051|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
9692107|NCT02471144|10792052|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
9692108|NCT02471144|10792053|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692109|NCT02471144|10792054|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
9692110|NCT02471144|10792044|FG000|STARTED|Extension Period (Week 52 to Week 236)||0
9692111|NCT02471144|10792045|FG001|STARTED|Extension Period (Week 52 to Week 236)||0
9692112|NCT02471144|10792046|FG002|STARTED|Extension Period (Week 52 to Week 236)||0
9692113|NCT02471144|10792047|FG003|STARTED|Extension Period (Week 52 to Week 236)||0
9692114|NCT02471144|10792048|FG004|STARTED|Extension Period (Week 52 to Week 236)||0
9692115|NCT02471144|10792049|FG005|STARTED|Extension Period (Week 52 to Week 236)||0
9692116|NCT02471144|10792050|FG006|STARTED|Extension Period (Week 52 to Week 236)||0
9692117|NCT02471144|10792051|FG007|STARTED|Extension Period (Week 52 to Week 236)||0
9692118|NCT02471144|10792052|FG008|STARTED|Extension Period (Week 52 to Week 236)||0
9692119|NCT02471144|10792053|FG009|STARTED|Extension Period (Week 52 to Week 236)||53
9692120|NCT02471144|10792054|FG010|STARTED|Extension Period (Week 52 to Week 236)||53
9692121|NCT02471144|10792044|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692122|NCT02471144|10792045|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692123|NCT02471144|10792046|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692124|NCT02471144|10792047|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692125|NCT02471144|10792048|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692126|NCT02471144|10792049|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692127|NCT02471144|10792050|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692128|NCT02471144|10792051|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692129|NCT02471144|10792052|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0
9692130|NCT02471144|10792053|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||46
9692131|NCT02471144|10792054|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||49
9692132|NCT02471144|10792044|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692133|NCT02471144|10792045|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692134|NCT02471144|10792046|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10024647|NCT01864538|11148509|FG000|NOT COMPLETED|Overall Study||11
10024648|NCT01864564|11148515|FG000|STARTED|Overall Study||480
10024649|NCT01864564|11148516|FG001|STARTED|Overall Study||482
10024650|NCT01864564|11148515|FG000|COMPLETED|Overall Study||443
10024651|NCT01864564|11148516|FG001|COMPLETED|Overall Study||387
10024652|NCT01864564|11148515|FG000|NOT COMPLETED|Overall Study||37
10024653|NCT01864564|11148516|FG001|NOT COMPLETED|Overall Study||95
10024654|NCT01865084|11148525|FG000|STARTED|Double Blind Period (DB)||116
10024655|NCT01865084|11148526|FG001|STARTED|Double Blind Period (DB)||102
10024656|NCT01865084|11148527|FG002|STARTED|Double Blind Period (DB)||113
10024657|NCT01865084|11148525|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
10024658|NCT01865084|11148526|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
10024659|NCT01865084|11148527|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
10024660|NCT01865084|11148525|FG000|COMPLETED|Double Blind Period (DB)||111
10024661|NCT01865084|11148526|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
10114484|NCT02516410|11245216|FG000|NOT COMPLETED|Overall Study||0
10114485|NCT02516410|11245217|FG001|NOT COMPLETED|Overall Study||2
10114486|NCT02516579|11245224|FG000|STARTED|Overall Study||1906
10114487|NCT02516579|11245224|FG000|COMPLETED|Overall Study||1906
10114488|NCT02516579|11245224|FG000|NOT COMPLETED|Overall Study||0
10114489|NCT02516592|11245230|FG000|STARTED|Overall Study||251
10114490|NCT02516592|11245231|FG001|STARTED|Overall Study||251
10114491|NCT02516592|11245230|FG000|Full Analysis Set|Overall Study||248
10114492|NCT02516592|11245231|FG001|Full Analysis Set|Overall Study||250
10114493|NCT02516592|11245230|FG000|COMPLETED|Overall Study||235
10114494|NCT02516592|11245231|FG001|COMPLETED|Overall Study||238
10114495|NCT02516592|11245230|FG000|NOT COMPLETED|Overall Study||16
10114496|NCT02516592|11245231|FG001|NOT COMPLETED|Overall Study||13
10114497|NCT02516605|11245242|FG000|STARTED|Overall Study||11
10114498|NCT02516605|11245243|FG001|STARTED|Overall Study||9
10114499|NCT02516605|11245244|FG002|STARTED|Overall Study||12
10114500|NCT02516605|11245245|FG003|STARTED|Overall Study||8
10114501|NCT02516605|11245246|FG004|STARTED|Overall Study||21
10114502|NCT02516605|11245242|FG000|COMPLETED|Overall Study||11
10114503|NCT02516605|11245243|FG001|COMPLETED|Overall Study||9
10114504|NCT02516605|11245244|FG002|COMPLETED|Overall Study||12
10114505|NCT02516605|11245245|FG003|COMPLETED|Overall Study||7
10114506|NCT02516605|11245246|FG004|COMPLETED|Overall Study||20
10114507|NCT02516605|11245242|FG000|NOT COMPLETED|Overall Study||0
10114508|NCT02516605|11245243|FG001|NOT COMPLETED|Overall Study||0
10114509|NCT02516605|11245244|FG002|NOT COMPLETED|Overall Study||0
10114510|NCT02516605|11245245|FG003|NOT COMPLETED|Overall Study||1
10114511|NCT02516605|11245246|FG004|NOT COMPLETED|Overall Study||1
10114512|NCT02516982|11245266|FG000|STARTED|Overall Study||305
10114513|NCT02516982|11245267|FG001|STARTED|Overall Study||292
10114514|NCT02516982|11245268|FG002|STARTED|Overall Study||174
10114515|NCT02516982|11245269|FG003|STARTED|Overall Study||175
10114516|NCT02516982|11245266|FG000|COMPLETED|Overall Study||273
10114517|NCT02516982|11245267|FG001|COMPLETED|Overall Study||257
10114518|NCT02516982|11245268|FG002|COMPLETED|Overall Study||126
10114519|NCT02516982|11245269|FG003|COMPLETED|Overall Study||125
10114520|NCT02516982|11245266|FG000|NOT COMPLETED|Overall Study||32
9692135|NCT02471144|10792047|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692136|NCT02471144|10792048|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692137|NCT02471144|10792049|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692138|NCT02471144|10792050|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692139|NCT02471144|10792051|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692140|NCT02471144|10792052|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
9692141|NCT02471144|10792053|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
9692142|NCT02471144|10792054|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
9692143|NCT02440464|10792072|FG000|STARTED|Overall Study||21
9692144|NCT02440464|10792073|FG001|STARTED|Overall Study||22
9692145|NCT02440464|10792072|FG000|COMPLETED|Overall Study||18
9692146|NCT02440464|10792073|FG001|COMPLETED|Overall Study||20
9692147|NCT02440464|10792072|FG000|NOT COMPLETED|Overall Study||3
9692148|NCT02440464|10792073|FG001|NOT COMPLETED|Overall Study||2
9692149|NCT02384421|10792080|FG000|STARTED|Overall Study||22
10114521|NCT02516982|11245267|FG001|NOT COMPLETED|Overall Study||35
9692150|NCT02384421|10792080|FG000|COMPLETED|Overall Study||22
9692151|NCT02384421|10792080|FG000|NOT COMPLETED|Overall Study||0
9692152|NCT02366728|10792090|FG000|STARTED|Overall Study||27
9692153|NCT02366728|10792091|FG001|STARTED|Overall Study||28
9692154|NCT02366728|10792092|FG002|STARTED|Overall Study||9
9692155|NCT02366728|10792090|FG000|Received at Least One ppp65 Vaccine|Overall Study||25
9692156|NCT02366728|10792091|FG001|Received at Least One ppp65 Vaccine|Overall Study||27
9692157|NCT02366728|10792092|FG002|Received at Least One ppp65 Vaccine|Overall Study||8
9692158|NCT02366728|10792090|FG000|COMPLETED|Overall Study||23
9692159|NCT02366728|10792091|FG001|COMPLETED|Overall Study||27
9692160|NCT02366728|10792092|FG002|COMPLETED|Overall Study||8
9692161|NCT02366728|10792090|FG000|NOT COMPLETED|Overall Study||4
9692162|NCT02366728|10792091|FG001|NOT COMPLETED|Overall Study||1
9692163|NCT02366728|10792092|FG002|NOT COMPLETED|Overall Study||1
9692164|NCT02236572|10792100|FG000|STARTED|Overall Study||17
9692165|NCT02236572|10792100|FG000|COMPLETED|Overall Study||14
9692166|NCT02236572|10792100|FG000|NOT COMPLETED|Overall Study||3
9692167|NCT02083354|10792104|FG000|STARTED|Overall Study||77
9692168|NCT02083354|10792104|FG000|COMPLETED|Overall Study||13
9692169|NCT02083354|10792104|FG000|NOT COMPLETED|Overall Study||64
9692170|NCT01775813|10792112|FG000|STARTED|Overall Study||47
9692171|NCT01775813|10792113|FG001|STARTED|Overall Study||13
9692172|NCT01775813|10792114|FG002|STARTED|Overall Study||24
9692173|NCT01775813|10792115|FG003|STARTED|Overall Study||20
9692174|NCT01775813|10792112|FG000|Study Visit 2 (Tanner 4)|Overall Study||36
9692175|NCT01775813|10792113|FG001|Study Visit 2 (Tanner 4)|Overall Study||4
9692176|NCT01775813|10792114|FG002|Study Visit 2 (Tanner 4)|Overall Study||11
9692177|NCT01775813|10792115|FG003|Study Visit 2 (Tanner 4)|Overall Study||11
9692178|NCT01775813|10792112|FG000|Study Visit 3 (Tanner 5)|Overall Study||34
10114522|NCT02516982|11245268|FG002|NOT COMPLETED|Overall Study||48
9692179|NCT01775813|10792113|FG001|Study Visit 3 (Tanner 5)|Overall Study||8
9692180|NCT01775813|10792114|FG002|Study Visit 3 (Tanner 5)|Overall Study||12
9692181|NCT01775813|10792115|FG003|Study Visit 3 (Tanner 5)|Overall Study||11
9692182|NCT01775813|10792112|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10
9692183|NCT01775813|10792113|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0
9692184|NCT01775813|10792114|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13
9692185|NCT01775813|10792115|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11
9692186|NCT01775813|10792112|FG000|COMPLETED|Overall Study||34
9692187|NCT01775813|10792113|FG001|COMPLETED|Overall Study||8
10024662|NCT01865084|11148527|FG002|COMPLETED|Double Blind Period (DB)||107
10024663|NCT01865084|11148525|FG000|NOT COMPLETED|Double Blind Period (DB)||5
10024664|NCT01865084|11148526|FG001|NOT COMPLETED|Double Blind Period (DB)||4
10024665|NCT01865084|11148527|FG002|NOT COMPLETED|Double Blind Period (DB)||6
10024666|NCT01865084|11148525|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
10024667|NCT01865084|11148526|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
10024668|NCT01865084|11148527|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
10024669|NCT01865084|11148525|FG000|COMPLETED|Open Label Extension (OLE) Period||0
10024670|NCT01865084|11148526|FG001|COMPLETED|Open Label Extension (OLE) Period||139
10024671|NCT01865084|11148527|FG002|COMPLETED|Open Label Extension (OLE) Period||158
10024672|NCT01865084|11148525|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
10024673|NCT01865084|11148526|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11
10024674|NCT01865084|11148527|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7
10024675|NCT01865448|11148541|FG000|STARTED|Overall Study||17
10024676|NCT01865448|11148542|FG001|STARTED|Overall Study||17
10024677|NCT01865448|11148541|FG000|COMPLETED|Overall Study||15
10024678|NCT01865448|11148542|FG001|COMPLETED|Overall Study||14
10024679|NCT01865448|11148541|FG000|NOT COMPLETED|Overall Study||2
10024680|NCT01865448|11148542|FG001|NOT COMPLETED|Overall Study||3
10024681|NCT01865487|11148555|FG000|STARTED|Overall Study||15
10024682|NCT01865487|11148556|FG001|STARTED|Overall Study||15
10024683|NCT01865487|11148557|FG002|STARTED|Overall Study||15
10024684|NCT01865487|11148558|FG003|STARTED|Overall Study||5
10024685|NCT01865487|11148559|FG004|STARTED|Overall Study||12
9692188|NCT01775813|10792114|FG002|COMPLETED|Overall Study||12
9692189|NCT01775813|10792115|FG003|COMPLETED|Overall Study||11
10024686|NCT01865487|11148560|FG005|STARTED|Overall Study||4
9692190|NCT01775813|10792112|FG000|NOT COMPLETED|Overall Study||13
9692191|NCT01775813|10792113|FG001|NOT COMPLETED|Overall Study||5
9692192|NCT01775813|10792114|FG002|NOT COMPLETED|Overall Study||12
9692193|NCT01775813|10792115|FG003|NOT COMPLETED|Overall Study||9
9692194|NCT01694069|10792132|FG000|STARTED|Overall Study||6
9692195|NCT01694069|10792132|FG000|COMPLETED|Overall Study||6
10024687|NCT01865487|11148561|FG006|STARTED|Overall Study||12
9692196|NCT01694069|10792132|FG000|NOT COMPLETED|Overall Study||0
9692197|NCT01446016|10792138|FG000|STARTED|Overall Study||38
9692198|NCT01446016|10792138|FG000|COMPLETED|Overall Study||31
9692199|NCT01446016|10792138|FG000|NOT COMPLETED|Overall Study||7
9692200|NCT01445327|10792145|FG000|STARTED|Overall Study||3
9692201|NCT01445327|10792146|FG001|STARTED|Overall Study||1
9692202|NCT01445327|10792147|FG002|STARTED|Overall Study||5
9692203|NCT01445327|10792145|FG000|COMPLETED|Overall Study||3
9692204|NCT01445327|10792146|FG001|COMPLETED|Overall Study||1
9692205|NCT01445327|10792147|FG002|COMPLETED|Overall Study||5
9692206|NCT01445327|10792145|FG000|NOT COMPLETED|Overall Study||0
9692207|NCT01445327|10792146|FG001|NOT COMPLETED|Overall Study||0
9692208|NCT01445327|10792147|FG002|NOT COMPLETED|Overall Study||0
9692209|NCT01411332|10792157|FG000|STARTED|Overall Study||10
9692210|NCT01411332|10792158|FG001|STARTED|Overall Study||9
9692211|NCT01411332|10792157|FG000|COMPLETED|Overall Study||8
9692212|NCT01411332|10792158|FG001|COMPLETED|Overall Study||7
9692213|NCT01411332|10792157|FG000|NOT COMPLETED|Overall Study||2
9692214|NCT01411332|10792158|FG001|NOT COMPLETED|Overall Study||2
9692215|NCT01399918|10792164|FG000|STARTED|Overall Study||57
9846862|NCT00850889|10959291|FG000|STARTED|Overall Study||32
9846863|NCT00850889|10959291|FG000|COMPLETED|Overall Study||32
9846864|NCT00850889|10959291|FG000|NOT COMPLETED|Overall Study||0
9846865|NCT00850993|10959302|FG000|STARTED|Overall Study||17
9846866|NCT00850993|10959303|FG001|STARTED|Overall Study||18
9846867|NCT00850993|10959304|FG002|STARTED|Overall Study||8
9846868|NCT00850993|10959305|FG003|STARTED|Overall Study||15
9846869|NCT00850993|10959302|FG000|Safety|Overall Study||17
9846870|NCT00850993|10959303|FG001|Safety|Overall Study||18
9846871|NCT00850993|10959304|FG002|Safety|Overall Study||8
9846872|NCT00850993|10959305|FG003|Safety|Overall Study||15
9846873|NCT00850993|10959302|FG000|Intent-to-treat|Overall Study||17
9846874|NCT00850993|10959303|FG001|Intent-to-treat|Overall Study||18
9846875|NCT00850993|10959304|FG002|Intent-to-treat|Overall Study||8
9846876|NCT00850993|10959305|FG003|Intent-to-treat|Overall Study||15
9846877|NCT00850993|10959302|FG000|Received Phototherapy|Overall Study||3
9846878|NCT00850993|10959303|FG001|Received Phototherapy|Overall Study||6
9846879|NCT00850993|10959304|FG002|Received Phototherapy|Overall Study||2
10024688|NCT01865487|11148562|FG007|STARTED|Overall Study||4
9692216|NCT01399918|10792164|FG000|COMPLETED|Overall Study||55
9692217|NCT01399918|10792164|FG000|NOT COMPLETED|Overall Study||2
9692218|NCT01377753|10792168|FG000|STARTED|Overall Study||15
9692219|NCT01377753|10792168|FG000|COMPLETED|Overall Study||15
9692220|NCT01377753|10792168|FG000|NOT COMPLETED|Overall Study||0
9692221|NCT01147653|10792174|FG000|STARTED|Year 1||32
9692222|NCT01147653|10792175|FG001|STARTED|Year 1||31
9692223|NCT01147653|10792174|FG000|COMPLETED|Year 1||32
9846880|NCT00850993|10959305|FG003|Received Phototherapy|Overall Study||8
9846881|NCT00850993|10959302|FG000|Per Protocol|Overall Study||10
9846882|NCT00850993|10959303|FG001|Per Protocol|Overall Study||13
10024689|NCT01865487|11148563|FG008|STARTED|Overall Study||12
10024690|NCT01865487|11148564|FG009|STARTED|Overall Study||4
10024691|NCT01865487|11148555|FG000|COMPLETED|Overall Study||15
10024692|NCT01865487|11148556|FG001|COMPLETED|Overall Study||15
10024693|NCT01865487|11148557|FG002|COMPLETED|Overall Study||15
9692224|NCT01147653|10792175|FG001|COMPLETED|Year 1||31
9692225|NCT01147653|10792174|FG000|NOT COMPLETED|Year 1||0
9692226|NCT01147653|10792175|FG001|NOT COMPLETED|Year 1||0
9692227|NCT01147653|10792174|FG000|STARTED|Year 2||32
9692228|NCT01147653|10792175|FG001|STARTED|Year 2||31
9692229|NCT01147653|10792174|FG000|COMPLETED|Year 2||30
9692230|NCT01147653|10792175|FG001|COMPLETED|Year 2||28
9692231|NCT01147653|10792174|FG000|NOT COMPLETED|Year 2||2
9692232|NCT01147653|10792175|FG001|NOT COMPLETED|Year 2||3
9692233|NCT01078454|10792195|FG000|STARTED|Overall Study||6
9692234|NCT01078454|10792196|FG001|STARTED|Overall Study||5
9692235|NCT01078454|10792195|FG000|COMPLETED|Overall Study||5
9692236|NCT01078454|10792196|FG001|COMPLETED|Overall Study||3
9692237|NCT01078454|10792195|FG000|NOT COMPLETED|Overall Study||1
9692238|NCT01078454|10792196|FG001|NOT COMPLETED|Overall Study||2
9692239|NCT00687596|10792204|FG000|STARTED|Overall Study||26
9692240|NCT00687596|10792205|FG001|STARTED|Overall Study||26
9692241|NCT00687596|10792204|FG000|COMPLETED|Overall Study||0
9692242|NCT00687596|10792205|FG001|COMPLETED|Overall Study||0
9692243|NCT00687596|10792204|FG000|NOT COMPLETED|Overall Study||26
9692244|NCT00687596|10792205|FG001|NOT COMPLETED|Overall Study||26
9692245|NCT00458536|10792211|FG000|STARTED|Overall Study||38
10024694|NCT01865487|11148558|FG003|COMPLETED|Overall Study||4
10024695|NCT01865487|11148559|FG004|COMPLETED|Overall Study||11
9692246|NCT00458536|10792211|FG000|COMPLETED|Overall Study||19
9692247|NCT00458536|10792211|FG000|NOT COMPLETED|Overall Study||19
9692248|NCT00112840|10792218|FG000|STARTED|Overall Study||8
9692249|NCT00112840|10792219|FG001|STARTED|Overall Study||6
10024696|NCT01865487|11148560|FG005|COMPLETED|Overall Study||4
9692250|NCT00112840|10792220|FG002|STARTED|Overall Study||46
9692251|NCT00112840|10792218|FG000|COMPLETED|Overall Study||6
9692252|NCT00112840|10792219|FG001|COMPLETED|Overall Study||6
9692253|NCT00112840|10792220|FG002|COMPLETED|Overall Study||40
9692254|NCT00112840|10792218|FG000|NOT COMPLETED|Overall Study||2
9692255|NCT00112840|10792219|FG001|NOT COMPLETED|Overall Study||0
9692256|NCT00112840|10792220|FG002|NOT COMPLETED|Overall Study||6
9726847|NCT00103376|10826412|FG000|STARTED|Overall Study||8
9726848|NCT00103376|10826413|FG001|STARTED|Overall Study||7
9726849|NCT00103376|10826414|FG002|STARTED|Overall Study||8
9726850|NCT00103376|10826412|FG000|COMPLETED|Overall Study||8
9726851|NCT00103376|10826413|FG001|COMPLETED|Overall Study||7
9726852|NCT00103376|10826414|FG002|COMPLETED|Overall Study||8
9726853|NCT00103376|10826412|FG000|NOT COMPLETED|Overall Study||0
9726854|NCT00103376|10826413|FG001|NOT COMPLETED|Overall Study||0
9726855|NCT00103376|10826414|FG002|NOT COMPLETED|Overall Study||0
9726856|NCT00103402|10826430|FG000|STARTED|Overall Study||138
9726857|NCT00103402|10826431|FG001|STARTED|Overall Study||134
9726858|NCT00103402|10826430|FG000|COMPLETED|Overall Study||116
9726859|NCT00103402|10826431|FG001|COMPLETED|Overall Study||117
9726860|NCT00103402|10826430|FG000|NOT COMPLETED|Overall Study||22
9726861|NCT00103402|10826431|FG001|NOT COMPLETED|Overall Study||17
9726862|NCT00103506|10826439|FG000|STARTED|Overall Study||322
9726863|NCT00103506|10826440|FG001|STARTED|Overall Study||324
9726864|NCT00103506|10826439|FG000|COMPLETED|Overall Study||0
9726865|NCT00103506|10826440|FG001|COMPLETED|Overall Study||0
9726866|NCT00103506|10826439|FG000|NOT COMPLETED|Overall Study||322
9726867|NCT00103506|10826440|FG001|NOT COMPLETED|Overall Study||324
9726868|NCT00103610|10826448|FG000|STARTED|Overall Study||150
9726869|NCT00103610|10826449|FG001|STARTED|Overall Study||148
9726870|NCT00103610|10826448|FG000|COMPLETED|Overall Study||112
9726871|NCT00103610|10826449|FG001|COMPLETED|Overall Study||68
9726872|NCT00103610|10826448|FG000|NOT COMPLETED|Overall Study||38
9726873|NCT00103610|10826449|FG001|NOT COMPLETED|Overall Study||80
9726874|NCT00103662|10826458|FG000|STARTED|Overall Study||148
9726875|NCT00103662|10826459|FG001|STARTED|Overall Study||154
9726876|NCT00103662|10826458|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
9726877|NCT00103662|10826459|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
9726878|NCT00103662|10826458|FG000|NOT COMPLETED|Overall Study||19
9726879|NCT00103662|10826459|FG001|NOT COMPLETED|Overall Study||33
9726880|NCT00103740|10826467|FG000|STARTED|Period 1 - Core||92
9726881|NCT00103740|10826468|FG001|STARTED|Period 1 - Core||93
9726882|NCT00103740|10826467|FG000|COMPLETED|Period 1 - Core||85
9726883|NCT00103740|10826468|FG001|COMPLETED|Period 1 - Core||89
9726884|NCT00103740|10826467|FG000|NOT COMPLETED|Period 1 - Core||7
9726885|NCT00103740|10826468|FG001|NOT COMPLETED|Period 1 - Core||4
9726886|NCT00103740|10826467|FG000|STARTED|Period 2 - Extended Observation Period||78
9726887|NCT00103740|10826468|FG001|STARTED|Period 2 - Extended Observation Period||63
9726888|NCT00103740|10826467|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
9726889|NCT00103740|10826468|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
9726890|NCT00103740|10826467|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69
9726891|NCT00103740|10826468|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36
9726892|NCT00103844|10826476|FG000|STARTED|Overall Study||101
9726893|NCT00103844|10826477|FG001|STARTED|Overall Study||49
10024697|NCT01865487|11148561|FG006|COMPLETED|Overall Study||11
10024698|NCT01865487|11148562|FG007|COMPLETED|Overall Study||4
10024699|NCT01865487|11148563|FG008|COMPLETED|Overall Study||12
10024700|NCT01865487|11148564|FG009|COMPLETED|Overall Study||4
10024701|NCT01865487|11148555|FG000|NOT COMPLETED|Overall Study||0
9692257|NCT04957732|10792235|FG000|STARTED|Overall Study||19
9692258|NCT04957732|10792236|FG001|STARTED|Overall Study||16
9692259|NCT04957732|10792235|FG000|COMPLETED|Overall Study||18
9692260|NCT04957732|10792236|FG001|COMPLETED|Overall Study||12
9692261|NCT04957732|10792235|FG000|NOT COMPLETED|Overall Study||1
9692262|NCT04957732|10792236|FG001|NOT COMPLETED|Overall Study||4
9692263|NCT04207749|10792249|FG000|STARTED|Overall Study||78
9692264|NCT04207749|10792250|FG001|STARTED|Overall Study||156
9692265|NCT04207749|10792249|FG000|COMPLETED|Overall Study||74
9692266|NCT04207749|10792250|FG001|COMPLETED|Overall Study||149
9692267|NCT04207749|10792249|FG000|NOT COMPLETED|Overall Study||4
9692268|NCT04207749|10792250|FG001|NOT COMPLETED|Overall Study||7
9726894|NCT00103844|10826476|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
9726895|NCT00103844|10826477|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
9726896|NCT00103844|10826476|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
9726897|NCT00103844|10826477|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
9726898|NCT00103844|10826476|FG000|NOT COMPLETED|Overall Study||0
9726899|NCT00103844|10826477|FG001|NOT COMPLETED|Overall Study||0
9726900|NCT00103857|10826490|FG000|STARTED|54-Week Base Study||179
9726901|NCT00103857|10826491|FG001|STARTED|54-Week Base Study||182
9726902|NCT00103857|10826492|FG002|STARTED|54-Week Base Study||182
9726903|NCT00103857|10826493|FG003|STARTED|54-Week Base Study||190
9726904|NCT00103857|10826494|FG004|STARTED|54-Week Base Study||182
9726905|NCT00103857|10826495|FG005|STARTED|54-Week Base Study||176
9846883|NCT00850993|10959304|FG002|Per Protocol|Overall Study||5
10024702|NCT01865487|11148556|FG001|NOT COMPLETED|Overall Study||0
9692269|NCT04167345|10792264|FG000|STARTED|Overall Study||10
9692270|NCT04167345|10792265|FG001|STARTED|Overall Study||4
9692271|NCT04167345|10792266|FG002|STARTED|Overall Study||3
9692272|NCT04167345|10792267|FG003|STARTED|Overall Study||13
9692273|NCT04167345|10792268|FG004|STARTED|Overall Study||18
9692274|NCT04167345|10792264|FG000|COMPLETED|Overall Study||9
10024703|NCT01865487|11148557|FG002|NOT COMPLETED|Overall Study||0
10024704|NCT01865487|11148558|FG003|NOT COMPLETED|Overall Study||1
10024705|NCT01865487|11148559|FG004|NOT COMPLETED|Overall Study||1
9692275|NCT04167345|10792265|FG001|COMPLETED|Overall Study||3
9692276|NCT04167345|10792266|FG002|COMPLETED|Overall Study||3
9692277|NCT04167345|10792267|FG003|COMPLETED|Overall Study||13
9692278|NCT04167345|10792268|FG004|COMPLETED|Overall Study||18
9692279|NCT04167345|10792264|FG000|NOT COMPLETED|Overall Study||1
9692280|NCT04167345|10792265|FG001|NOT COMPLETED|Overall Study||1
9692281|NCT04167345|10792266|FG002|NOT COMPLETED|Overall Study||0
9692282|NCT04167345|10792267|FG003|NOT COMPLETED|Overall Study||0
9692283|NCT04167345|10792268|FG004|NOT COMPLETED|Overall Study||0
9692284|NCT04042077|10792286|FG000|STARTED|Overall Study||134
9692285|NCT04042077|10792287|FG001|STARTED|Overall Study||132
9692286|NCT04042077|10792286|FG000|Vancomycin IV|Overall Study||0
9692287|NCT04042077|10792287|FG001|Vancomycin IV|Overall Study||2
9692288|NCT04042077|10792286|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0
9692289|NCT04042077|10792287|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8
9692290|NCT04042077|10792286|FG000|Piperacillin/Tazobactam IV|Overall Study||0
9692291|NCT04042077|10792287|FG001|Piperacillin/Tazobactam IV|Overall Study||68
9692292|NCT04042077|10792286|FG000|Tigecycline IV|Overall Study||0
9692293|NCT04042077|10792287|FG001|Tigecycline IV|Overall Study||54
10024706|NCT01865487|11148560|FG005|NOT COMPLETED|Overall Study||0
9692294|NCT04042077|10792286|FG000|COMPLETED|Overall Study||127
9692295|NCT04042077|10792287|FG001|COMPLETED|Overall Study||127
9692296|NCT04042077|10792286|FG000|NOT COMPLETED|Overall Study||7
9692297|NCT04042077|10792287|FG001|NOT COMPLETED|Overall Study||5
9692298|NCT04001803|10792299|FG000|STARTED|Overall Study||115
9692299|NCT04001803|10792299|FG000|COMPLETED|Overall Study||1
9692300|NCT04001803|10792299|FG000|NOT COMPLETED|Overall Study||114
9692301|NCT03936699|10792306|FG000|STARTED|Overall Study||83
9692302|NCT03936699|10792307|FG001|STARTED|Overall Study||78
9692303|NCT03936699|10792306|FG000|COMPLETED|Overall Study||61
9692304|NCT03936699|10792307|FG001|COMPLETED|Overall Study||55
9692305|NCT03936699|10792306|FG000|NOT COMPLETED|Overall Study||22
9692306|NCT03936699|10792307|FG001|NOT COMPLETED|Overall Study||23
9692307|NCT03925324|10792315|FG000|STARTED|Overall Study||2
9692308|NCT03925324|10792316|FG001|STARTED|Overall Study||2
9692309|NCT03925324|10792315|FG000|COMPLETED|Overall Study||1
9692310|NCT03925324|10792316|FG001|COMPLETED|Overall Study||1
9692311|NCT03925324|10792315|FG000|NOT COMPLETED|Overall Study||1
9692312|NCT03925324|10792316|FG001|NOT COMPLETED|Overall Study||1
9692313|NCT03875092|10792324|FG000|STARTED|Overall Study||65
9692314|NCT03875092|10792325|FG001|STARTED|Overall Study||60
9692315|NCT03875092|10792324|FG000|Treated|Overall Study||65
9692316|NCT03875092|10792325|FG001|Treated|Overall Study||60
9692317|NCT03875092|10792324|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
9692318|NCT03875092|10792325|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38
9692319|NCT03875092|10792324|FG000|COMPLETED|Overall Study||0
9692320|NCT03875092|10792325|FG001|COMPLETED|Overall Study||0
9692321|NCT03875092|10792324|FG000|NOT COMPLETED|Overall Study||65
9692322|NCT03875092|10792325|FG001|NOT COMPLETED|Overall Study||60
9692323|NCT03814382|10792331|FG000|STARTED|Overall Study||10
9692324|NCT03814382|10792331|FG000|COMPLETED|Overall Study||10
9692325|NCT03814382|10792331|FG000|NOT COMPLETED|Overall Study||0
9726906|NCT00103857|10826496|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
9726907|NCT00103857|10826490|FG000|COMPLETED|54-Week Base Study||122
9726908|NCT00103857|10826491|FG001|COMPLETED|54-Week Base Study||126
9726909|NCT00103857|10826492|FG002|COMPLETED|54-Week Base Study||135
9726910|NCT00103857|10826493|FG003|COMPLETED|54-Week Base Study||148
9726911|NCT00103857|10826494|FG004|COMPLETED|54-Week Base Study||141
9726912|NCT00103857|10826495|FG005|COMPLETED|54-Week Base Study||115
9726913|NCT00103857|10826496|FG006|COMPLETED|54-Week Base Study||79
9726914|NCT00103857|10826490|FG000|NOT COMPLETED|54-Week Base Study||57
9726915|NCT00103857|10826491|FG001|NOT COMPLETED|54-Week Base Study||56
9726916|NCT00103857|10826492|FG002|NOT COMPLETED|54-Week Base Study||47
9726917|NCT00103857|10826493|FG003|NOT COMPLETED|54-Week Base Study||42
9726918|NCT00103857|10826494|FG004|NOT COMPLETED|54-Week Base Study||41
9726919|NCT00103857|10826495|FG005|NOT COMPLETED|54-Week Base Study||61
9726920|NCT00103857|10826496|FG006|NOT COMPLETED|54-Week Base Study||38
9726921|NCT00103857|10826490|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
9726922|NCT00103857|10826491|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
9726923|NCT00103857|10826492|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
9726924|NCT00103857|10826493|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
9726925|NCT00103857|10826494|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
9726926|NCT00103857|10826495|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
9726927|NCT00103857|10826496|FG006|STARTED|50-Week Extension Study||0
9726928|NCT00103857|10826490|FG000|COMPLETED|50-Week Extension Study||65
9726929|NCT00103857|10826491|FG001|COMPLETED|50-Week Extension Study||80
9726930|NCT00103857|10826492|FG002|COMPLETED|50-Week Extension Study||95
9726931|NCT00103857|10826493|FG003|COMPLETED|50-Week Extension Study||98
9726932|NCT00103857|10826494|FG004|COMPLETED|50-Week Extension Study||101
9726933|NCT00103857|10826495|FG005|COMPLETED|50-Week Extension Study||78
9726934|NCT00103857|10826496|FG006|COMPLETED|50-Week Extension Study||0
9726935|NCT00103857|10826490|FG000|NOT COMPLETED|50-Week Extension Study||38
9726936|NCT00103857|10826491|FG001|NOT COMPLETED|50-Week Extension Study||27
9726937|NCT00103857|10826492|FG002|NOT COMPLETED|50-Week Extension Study||26
9726938|NCT00103857|10826493|FG003|NOT COMPLETED|50-Week Extension Study||36
9726939|NCT00103857|10826494|FG004|NOT COMPLETED|50-Week Extension Study||21
9726940|NCT00103857|10826495|FG005|NOT COMPLETED|50-Week Extension Study||20
10024707|NCT01865487|11148561|FG006|NOT COMPLETED|Overall Study||1
10024708|NCT01865487|11148562|FG007|NOT COMPLETED|Overall Study||0
9692326|NCT03740009|10792335|FG000|STARTED|Overall Study||20
9692327|NCT03740009|10792335|FG000|Consented|Overall Study||20
9692328|NCT03740009|10792335|FG000|Received Intervention|Overall Study||10
9692329|NCT03740009|10792335|FG000|COMPLETED|Overall Study||10
9692330|NCT03740009|10792335|FG000|NOT COMPLETED|Overall Study||10
9692331|NCT03738397|10792341|FG000|STARTED|Overall Study||344
9692332|NCT03738397|10792342|FG001|STARTED|Overall Study||348
9692333|NCT03738397|10792341|FG000|COMPLETED|Overall Study||320
9692334|NCT03738397|10792342|FG001|COMPLETED|Overall Study||318
9692335|NCT03738397|10792341|FG000|NOT COMPLETED|Overall Study||24
9692336|NCT03738397|10792342|FG001|NOT COMPLETED|Overall Study||30
9692337|NCT03666624|10792350|FG000|STARTED|Overall Study||15
9692338|NCT03666624|10792351|FG001|STARTED|Overall Study||15
9692339|NCT03666624|10792350|FG000|COMPLETED|Overall Study||14
9692340|NCT03666624|10792351|FG001|COMPLETED|Overall Study||15
9692341|NCT03666624|10792350|FG000|NOT COMPLETED|Overall Study||1
9692342|NCT03666624|10792351|FG001|NOT COMPLETED|Overall Study||0
9692343|NCT03649217|10792357|FG000|STARTED|Overall Study||23
9692344|NCT03649217|10792357|FG000|COMPLETED|Overall Study||21
9692345|NCT03649217|10792357|FG000|NOT COMPLETED|Overall Study||2
9692346|NCT03576976|10792363|FG000|STARTED|Overall Study||27
9692347|NCT03576976|10792364|FG001|STARTED|Overall Study||28
9692348|NCT03576976|10792363|FG000|COMPLETED|Overall Study||18
9692349|NCT03576976|10792364|FG001|COMPLETED|Overall Study||17
9692350|NCT03576976|10792363|FG000|NOT COMPLETED|Overall Study||9
9692351|NCT03576976|10792364|FG001|NOT COMPLETED|Overall Study||11
9692352|NCT03569293|10792376|FG000|STARTED|Overall Study||241
9692353|NCT03569293|10792377|FG001|STARTED|Overall Study||239
9692354|NCT03569293|10792378|FG002|STARTED|Overall Study||243
9692355|NCT03569293|10792379|FG003|STARTED|Overall Study||61
9692356|NCT03569293|10792380|FG004|STARTED|Overall Study||64
9692357|NCT03569293|10792381|FG005|STARTED|Overall Study||64
9692358|NCT03569293|10792376|FG000|Received Study Drug|Overall Study||241
9692359|NCT03569293|10792377|FG001|Received Study Drug|Overall Study||239
9692360|NCT03569293|10792378|FG002|Received Study Drug|Overall Study||243
9692361|NCT03569293|10792379|FG003|Received Study Drug|Overall Study||61
9692362|NCT03569293|10792380|FG004|Received Study Drug|Overall Study||64
9692363|NCT03569293|10792381|FG005|Received Study Drug|Overall Study||64
9692364|NCT03569293|10792376|FG000|COMPLETED|Overall Study||204
9692365|NCT03569293|10792377|FG001|COMPLETED|Overall Study||230
9692366|NCT03569293|10792378|FG002|COMPLETED|Overall Study||229
9692367|NCT03569293|10792379|FG003|COMPLETED|Overall Study||57
10024709|NCT01865487|11148563|FG008|NOT COMPLETED|Overall Study||0
10024710|NCT01865487|11148564|FG009|NOT COMPLETED|Overall Study||0
10024711|NCT01865552|11148598|FG000|STARTED|Period 1||23
10024712|NCT01865552|11148599|FG001|STARTED|Period 1||23
10024713|NCT01865552|11148600|FG002|STARTED|Period 1||23
9692368|NCT03569293|10792380|FG004|COMPLETED|Overall Study||64
9692369|NCT03569293|10792381|FG005|COMPLETED|Overall Study||64
10024714|NCT01865552|11148601|FG003|STARTED|Period 1||23
10024715|NCT01865552|11148602|FG004|STARTED|Period 1||23
10024716|NCT01865552|11148603|FG005|STARTED|Period 1||23
10024717|NCT01865552|11148598|FG000|Discontinued From Period 1|Period 1||1
9692370|NCT03569293|10792376|FG000|NOT COMPLETED|Overall Study||37
9692371|NCT03569293|10792377|FG001|NOT COMPLETED|Overall Study||9
9692372|NCT03569293|10792378|FG002|NOT COMPLETED|Overall Study||14
9692373|NCT03569293|10792379|FG003|NOT COMPLETED|Overall Study||4
9692374|NCT03569293|10792380|FG004|NOT COMPLETED|Overall Study||0
9692375|NCT03569293|10792381|FG005|NOT COMPLETED|Overall Study||0
9692376|NCT03564353|10792399|FG000|STARTED|Overall Study||10
9692377|NCT03564353|10792400|FG001|STARTED|Overall Study||10
9692378|NCT03564353|10792401|FG002|STARTED|Overall Study||10
9692379|NCT03564353|10792402|FG003|STARTED|Overall Study||10
9692380|NCT03564353|10792399|FG000|COMPLETED|Overall Study||10
9692381|NCT03564353|10792400|FG001|COMPLETED|Overall Study||10
9692382|NCT03564353|10792401|FG002|COMPLETED|Overall Study||10
9692383|NCT03564353|10792402|FG003|COMPLETED|Overall Study||10
9692384|NCT03564353|10792399|FG000|NOT COMPLETED|Overall Study||0
9692385|NCT03564353|10792400|FG001|NOT COMPLETED|Overall Study||0
9692386|NCT03564353|10792401|FG002|NOT COMPLETED|Overall Study||0
9692387|NCT03564353|10792402|FG003|NOT COMPLETED|Overall Study||0
9692388|NCT03541499|10792416|FG000|STARTED|Overall Study||15
9692389|NCT03541499|10792417|FG001|STARTED|Overall Study||15
9692390|NCT03541499|10792418|FG002|STARTED|Overall Study||5
9692391|NCT03541499|10792419|FG003|STARTED|Overall Study||15
9692392|NCT03541499|10792416|FG000|COMPLETED|Overall Study||15
9692393|NCT03541499|10792417|FG001|COMPLETED|Overall Study||15
9692394|NCT03541499|10792418|FG002|COMPLETED|Overall Study||5
9692395|NCT03541499|10792419|FG003|COMPLETED|Overall Study||15
9692396|NCT03541499|10792416|FG000|NOT COMPLETED|Overall Study||0
9692397|NCT03541499|10792417|FG001|NOT COMPLETED|Overall Study||0
10024718|NCT01865552|11148599|FG001|Discontinued From Period 1|Period 1||0
10024719|NCT01865552|11148600|FG002|Discontinued From Period 1|Period 1||0
9692398|NCT03541499|10792418|FG002|NOT COMPLETED|Overall Study||0
9692399|NCT03541499|10792419|FG003|NOT COMPLETED|Overall Study||0
9692400|NCT03473977|10792431|FG000|STARTED|Overall Study||13
9692401|NCT03473977|10792432|FG001|STARTED|Overall Study||13
9692402|NCT03473977|10792431|FG000|COMPLETED|Overall Study||13
9692403|NCT03473977|10792432|FG001|COMPLETED|Overall Study||13
9692404|NCT03473977|10792431|FG000|NOT COMPLETED|Overall Study||0
9692405|NCT03473977|10792432|FG001|NOT COMPLETED|Overall Study||0
9692406|NCT03373110|10792441|FG000|STARTED|Overall Study||133
10024720|NCT01865552|11148601|FG003|Discontinued From Period 1|Period 1||1
9692407|NCT03373110|10792442|FG001|STARTED|Overall Study||137
9692408|NCT03373110|10792443|FG002|STARTED|Overall Study||70
9692409|NCT03373110|10792441|FG000|Provided Fitbit Data|Overall Study||123
9692410|NCT03373110|10792442|FG001|Provided Fitbit Data|Overall Study||130
9692411|NCT03373110|10792443|FG002|Provided Fitbit Data|Overall Study||63
9692412|NCT03373110|10792441|FG000|COMPLETED|Overall Study||55
9692413|NCT03373110|10792442|FG001|COMPLETED|Overall Study||58
9692414|NCT03373110|10792443|FG002|COMPLETED|Overall Study||26
9692415|NCT03373110|10792441|FG000|NOT COMPLETED|Overall Study||78
9692416|NCT03373110|10792442|FG001|NOT COMPLETED|Overall Study||79
9692417|NCT03373110|10792443|FG002|NOT COMPLETED|Overall Study||44
9692418|NCT03365102|10792454|FG000|STARTED|Overall Study||22
9692419|NCT03365102|10792455|FG001|STARTED|Overall Study||22
9692420|NCT03365102|10792456|FG002|STARTED|Overall Study||20
9692421|NCT03365102|10792454|FG000|COMPLETED|Overall Study||18
9692422|NCT03365102|10792455|FG001|COMPLETED|Overall Study||21
9692423|NCT03365102|10792456|FG002|COMPLETED|Overall Study||19
10024721|NCT01865552|11148602|FG004|Discontinued From Period 1|Period 1||3
9692424|NCT03365102|10792454|FG000|NOT COMPLETED|Overall Study||4
9692425|NCT03365102|10792455|FG001|NOT COMPLETED|Overall Study||1
9692426|NCT03365102|10792456|FG002|NOT COMPLETED|Overall Study||1
9692427|NCT03318003|10792466|FG000|STARTED|Overall Study||21
9692428|NCT03318003|10792467|FG001|STARTED|Overall Study||22
9692429|NCT03318003|10792466|FG000|COMPLETED|Overall Study|completed means the presence of 3rd trimester ultrasound and delivery information.|20
9692430|NCT03318003|10792467|FG001|COMPLETED|Overall Study||20
9692431|NCT03318003|10792466|FG000|NOT COMPLETED|Overall Study||1
9692432|NCT03318003|10792467|FG001|NOT COMPLETED|Overall Study||2
9692433|NCT03309072|10792475|FG000|STARTED|Overall Study||15
9692434|NCT03309072|10792476|FG001|STARTED|Overall Study||15
9692435|NCT03309072|10792475|FG000|COMPLETED|Overall Study||15
9692436|NCT03309072|10792476|FG001|COMPLETED|Overall Study||15
9692437|NCT03309072|10792475|FG000|NOT COMPLETED|Overall Study||0
9692438|NCT03309072|10792476|FG001|NOT COMPLETED|Overall Study||0
9726941|NCT00103857|10826496|FG006|NOT COMPLETED|50-Week Extension Study||0
9726942|NCT00104052|10826511|FG000|STARTED|Overall Study||107
9726943|NCT00104052|10826511|FG000|COMPLETED|Overall Study||78
9726944|NCT00104052|10826511|FG000|NOT COMPLETED|Overall Study||29
9726945|NCT00104104|10826517|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
9726946|NCT00104104|10826518|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
9726947|NCT00104104|10826517|FG000|Safety Population (Including Site 74)|Overall Study||88
9726948|NCT00104104|10826518|FG001|Safety Population (Including Site 74)|Overall Study||88
9726949|NCT00104104|10826517|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
9726950|NCT00104104|10826518|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
10024722|NCT01865552|11148603|FG005|Discontinued From Period 1|Period 1||1
10024723|NCT01865552|11148598|FG000|COMPLETED|Period 1||22
10024724|NCT01865552|11148599|FG001|COMPLETED|Period 1||23
10024725|NCT01865552|11148600|FG002|COMPLETED|Period 1||23
10024726|NCT01865552|11148601|FG003|COMPLETED|Period 1||22
9726951|NCT00104104|10826517|FG000|COMPLETED|Overall Study||15
9726952|NCT00104104|10826518|FG001|COMPLETED|Overall Study||17
9726953|NCT00104104|10826517|FG000|NOT COMPLETED|Overall Study||75
9726954|NCT00104104|10826518|FG001|NOT COMPLETED|Overall Study||72
9726955|NCT00104234|10826526|FG000|STARTED|Overall Study||19
9726956|NCT00104234|10826527|FG001|STARTED|Overall Study||20
9726957|NCT00104234|10826526|FG000|COMPLETED|Overall Study||19
9726958|NCT00104234|10826527|FG001|COMPLETED|Overall Study||19
9726959|NCT00104234|10826526|FG000|NOT COMPLETED|Overall Study||0
9726960|NCT00104234|10826527|FG001|NOT COMPLETED|Overall Study||1
9726961|NCT00104247|10826535|FG000|STARTED|Overall Study||42
9726962|NCT00104247|10826536|FG001|STARTED|Overall Study||47
9726963|NCT00104247|10826535|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
9726964|NCT00104247|10826536|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
9726965|NCT00104247|10826535|FG000|NOT COMPLETED|Overall Study||1
9726966|NCT00104247|10826536|FG001|NOT COMPLETED|Overall Study||1
9726967|NCT00104299|10826544|FG000|STARTED|Overall Study||99
9726968|NCT00104299|10826545|FG001|STARTED|Overall Study||98
9726969|NCT00104299|10826544|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
9726970|NCT00104299|10826545|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
9726971|NCT00104299|10826544|FG000|NOT COMPLETED|Overall Study||9
9726972|NCT00104299|10826545|FG001|NOT COMPLETED|Overall Study||10
9726973|NCT00104416|10826553|FG000|STARTED|Double-Blind Phase||77
9726974|NCT00104416|10826554|FG001|STARTED|Double-Blind Phase||76
9726975|NCT00104416|10826555|FG002|STARTED|Double-Blind Phase||0
9726976|NCT00104416|10826556|FG003|STARTED|Double-Blind Phase||0
9726977|NCT00104416|10826557|FG004|STARTED|Double-Blind Phase||0
9726978|NCT00104416|10826553|FG000|COMPLETED|Double-Blind Phase||69
9726979|NCT00104416|10826554|FG001|COMPLETED|Double-Blind Phase||66
9726980|NCT00104416|10826555|FG002|COMPLETED|Double-Blind Phase||0
9726981|NCT00104416|10826556|FG003|COMPLETED|Double-Blind Phase||0
9726982|NCT00104416|10826557|FG004|COMPLETED|Double-Blind Phase||0
9726983|NCT00104416|10826553|FG000|NOT COMPLETED|Double-Blind Phase||8
9726984|NCT00104416|10826554|FG001|NOT COMPLETED|Double-Blind Phase||10
9726985|NCT00104416|10826555|FG002|NOT COMPLETED|Double-Blind Phase||0
10024727|NCT01865552|11148602|FG004|COMPLETED|Period 1||20
10024728|NCT01865552|11148603|FG005|COMPLETED|Period 1||22
9692439|NCT03138590|10792484|FG000|STARTED|Overall Study||10
9692440|NCT03138590|10792485|FG001|STARTED|Overall Study||10
9692441|NCT03138590|10792484|FG000|COMPLETED|Overall Study||10
9692442|NCT03138590|10792485|FG001|COMPLETED|Overall Study||10
9692443|NCT03138590|10792484|FG000|NOT COMPLETED|Overall Study||0
9692444|NCT03138590|10792485|FG001|NOT COMPLETED|Overall Study||0
9692445|NCT03132753|10792493|FG000|STARTED|Baseline - 6 Month Follow-Up||46
9692446|NCT03132753|10792494|FG001|STARTED|Baseline - 6 Month Follow-Up||54
9692447|NCT03132753|10792493|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19
9692448|NCT03132753|10792494|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22
9692449|NCT03132753|10792493|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
9692450|NCT03132753|10792494|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
9692451|NCT03132753|10792493|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
9692452|NCT03132753|10792494|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
9692453|NCT03132753|10792493|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
9692454|NCT03132753|10792494|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
9692455|NCT03132753|10792493|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
9692456|NCT03132753|10792494|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
9692457|NCT03085680|10792502|FG000|STARTED|Overall Study||9
9692458|NCT03085680|10792503|FG001|STARTED|Overall Study||8
9692459|NCT03085680|10792502|FG000|COMPLETED|Overall Study||9
9692460|NCT03085680|10792503|FG001|COMPLETED|Overall Study||8
9692461|NCT03085680|10792502|FG000|NOT COMPLETED|Overall Study||0
9692462|NCT03085680|10792503|FG001|NOT COMPLETED|Overall Study||0
9692463|NCT03067077|10792509|FG000|STARTED|Overall Study||44
9692464|NCT03067077|10792510|FG001|STARTED|Overall Study||44
9692465|NCT03067077|10792509|FG000|Received Surgery|Overall Study||40
9692466|NCT03067077|10792510|FG001|Received Surgery|Overall Study||39
9692467|NCT03067077|10792509|FG000|COMPLETED|Overall Study||37
9692468|NCT03067077|10792510|FG001|COMPLETED|Overall Study||37
9692469|NCT03067077|10792509|FG000|NOT COMPLETED|Overall Study||7
9692470|NCT03067077|10792510|FG001|NOT COMPLETED|Overall Study||7
9692471|NCT03059446|10792516|FG000|STARTED|Overall Study||167
9692472|NCT03059446|10792516|FG000|COMPLETED|Overall Study||0
9692473|NCT03059446|10792516|FG000|NOT COMPLETED|Overall Study||167
9692474|NCT03019575|10792520|FG000|STARTED|Overall Study||17
9692475|NCT03019575|10792520|FG000|COMPLETED|Overall Study||17
9692476|NCT03019575|10792520|FG000|NOT COMPLETED|Overall Study||0
9692477|NCT03011034|10792526|FG000|STARTED|Overall Study||1
9692478|NCT03011034|10792527|FG001|STARTED|Overall Study||33
9692479|NCT03011034|10792526|FG000|COMPLETED|Overall Study||0
9692480|NCT03011034|10792527|FG001|COMPLETED|Overall Study||33
9692481|NCT03011034|10792526|FG000|NOT COMPLETED|Overall Study||1
9692482|NCT03011034|10792527|FG001|NOT COMPLETED|Overall Study||0
9692483|NCT02980666|10792535|FG000|STARTED|Overall Study||8
9692484|NCT02980666|10792536|FG001|STARTED|Overall Study||2
9692485|NCT02980666|10792535|FG000|COMPLETED|Overall Study||8
9692486|NCT02980666|10792536|FG001|COMPLETED|Overall Study||2
9692487|NCT02980666|10792535|FG000|NOT COMPLETED|Overall Study||0
9692488|NCT02980666|10792536|FG001|NOT COMPLETED|Overall Study||0
9692489|NCT02962102|10792545|FG000|STARTED|Overall Study||51
9692490|NCT02962102|10792546|FG001|STARTED|Overall Study||50
9692491|NCT02962102|10792547|FG002|STARTED|Overall Study||49
9692492|NCT02962102|10792545|FG000|COMPLETED|Overall Study||51
9692493|NCT02962102|10792546|FG001|COMPLETED|Overall Study||50
9692494|NCT02962102|10792547|FG002|COMPLETED|Overall Study||49
9692495|NCT02962102|10792545|FG000|NOT COMPLETED|Overall Study||0
9692496|NCT02962102|10792546|FG001|NOT COMPLETED|Overall Study||0
9692497|NCT02962102|10792547|FG002|NOT COMPLETED|Overall Study||0
9692498|NCT02853331|10792557|FG000|STARTED|Overall Study||432
9692499|NCT02853331|10792558|FG001|STARTED|Overall Study||429
9692500|NCT02853331|10792557|FG000|Treated|Overall Study||429
9692501|NCT02853331|10792558|FG001|Treated|Overall Study||425
9692502|NCT02853331|10792557|FG000|COMPLETED|Overall Study||0
9692503|NCT02853331|10792558|FG001|COMPLETED|Overall Study||0
9692504|NCT02853331|10792557|FG000|NOT COMPLETED|Overall Study||432
9692505|NCT02853331|10792558|FG001|NOT COMPLETED|Overall Study||429
9692506|NCT02841644|10792566|FG000|STARTED|Overall Study||60
9692507|NCT02841644|10792567|FG001|STARTED|Overall Study||120
9692508|NCT02841644|10792566|FG000|COMPLETED|Overall Study||60
9692509|NCT02841644|10792567|FG001|COMPLETED|Overall Study||120
9692510|NCT02841644|10792566|FG000|NOT COMPLETED|Overall Study||0
9692511|NCT02841644|10792567|FG001|NOT COMPLETED|Overall Study||0
9692512|NCT02749045|10792573|FG000|STARTED|Overall Study||27
9692513|NCT02749045|10792573|FG000|COMPLETED|Overall Study||27
9692514|NCT02749045|10792573|FG000|NOT COMPLETED|Overall Study||0
9692515|NCT02659605|10792579|FG000|STARTED|Overall Study||40
9692516|NCT02659605|10792580|FG001|STARTED|Overall Study||34
9692517|NCT02659605|10792579|FG000|COMPLETED|Overall Study||31
9692518|NCT02659605|10792580|FG001|COMPLETED|Overall Study||30
9692519|NCT02659605|10792579|FG000|NOT COMPLETED|Overall Study||9
9692520|NCT02659605|10792580|FG001|NOT COMPLETED|Overall Study||4
9692521|NCT02601014|10792588|FG000|STARTED|Overall Study||15
9692522|NCT02601014|10792589|FG001|STARTED|Overall Study||15
9692523|NCT02601014|10792588|FG000|COMPLETED|Overall Study||5
9692524|NCT02601014|10792589|FG001|COMPLETED|Overall Study||3
9846884|NCT00850993|10959305|FG003|Per Protocol|Overall Study||13
9846885|NCT00850993|10959302|FG000|COMPLETED|Overall Study||16
9692525|NCT02601014|10792588|FG000|NOT COMPLETED|Overall Study||10
9692526|NCT02601014|10792589|FG001|NOT COMPLETED|Overall Study||12
9692527|NCT02579096|10792597|FG000|STARTED|Phase 1, Weeks 0 - 24||468
9692528|NCT02579096|10792598|FG001|STARTED|Phase 1, Weeks 0 - 24||472
9692529|NCT02579096|10792597|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411
9846886|NCT00850993|10959303|FG001|COMPLETED|Overall Study||18
9846887|NCT00850993|10959304|FG002|COMPLETED|Overall Study||8
10024729|NCT01865552|11148598|FG000|NOT COMPLETED|Period 1||1
10024730|NCT01865552|11148599|FG001|NOT COMPLETED|Period 1||0
9846888|NCT00850993|10959305|FG003|COMPLETED|Overall Study||14
9846889|NCT00850993|10959302|FG000|NOT COMPLETED|Overall Study||1
10024731|NCT01865552|11148600|FG002|NOT COMPLETED|Period 1||0
10024732|NCT01865552|11148601|FG003|NOT COMPLETED|Period 1||1
10024733|NCT01865552|11148602|FG004|NOT COMPLETED|Period 1||3
10024734|NCT01865552|11148603|FG005|NOT COMPLETED|Period 1||1
10024735|NCT01865552|11148598|FG000|STARTED|Period 2||22
10024736|NCT01865552|11148599|FG001|STARTED|Period 2||23
10024737|NCT01865552|11148600|FG002|STARTED|Period 2||23
10024738|NCT01865552|11148601|FG003|STARTED|Period 2||22
9692530|NCT02579096|10792598|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422
9692531|NCT02579096|10792597|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57
9692532|NCT02579096|10792598|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50
9692533|NCT02579096|10792597|FG000|STARTED|Phase 2, Weeks 25 - 48||411
9692534|NCT02579096|10792598|FG001|STARTED|Phase 2, Weeks 25 - 48||422
10024739|NCT01865552|11148602|FG004|STARTED|Period 2||20
10024740|NCT01865552|11148603|FG005|STARTED|Period 2||22
10024741|NCT01865552|11148598|FG000|COMPLETED|Period 2||22
10024742|NCT01865552|11148599|FG001|COMPLETED|Period 2||23
10024743|NCT01865552|11148600|FG002|COMPLETED|Period 2||23
10024744|NCT01865552|11148601|FG003|COMPLETED|Period 2||22
10024745|NCT01865552|11148602|FG004|COMPLETED|Period 2||20
10024746|NCT01865552|11148603|FG005|COMPLETED|Period 2||22
10024747|NCT01865552|11148598|FG000|NOT COMPLETED|Period 2||0
10024748|NCT01865552|11148599|FG001|NOT COMPLETED|Period 2||0
10024749|NCT01865552|11148600|FG002|NOT COMPLETED|Period 2||0
10024750|NCT01865552|11148601|FG003|NOT COMPLETED|Period 2||0
10024751|NCT01865552|11148602|FG004|NOT COMPLETED|Period 2||0
10024752|NCT01865552|11148603|FG005|NOT COMPLETED|Period 2||0
10024753|NCT01865708|11148617|FG000|STARTED|Overall Study||10
10024754|NCT01865708|11148617|FG000|COMPLETED|Overall Study||10
10024755|NCT01865708|11148617|FG000|NOT COMPLETED|Overall Study||0
9692535|NCT02579096|10792597|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389
9692536|NCT02579096|10792598|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391
9846890|NCT00850993|10959303|FG001|NOT COMPLETED|Overall Study||0
9692537|NCT02579096|10792597|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22
9692538|NCT02579096|10792598|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31
9692539|NCT02579096|10792597|FG000|STARTED|Phase 3, Weeks 49 - 72||389
9692540|NCT02579096|10792598|FG001|STARTED|Phase 3, Weeks 49 - 72||391
9692541|NCT02579096|10792597|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367
9692542|NCT02579096|10792598|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373
9692543|NCT02579096|10792597|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22
9692544|NCT02579096|10792598|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18
9692545|NCT02538666|10792607|FG000|STARTED|Overall Study||275
9692546|NCT02538666|10792608|FG001|STARTED|Overall Study||280
9692547|NCT02538666|10792609|FG002|STARTED|Overall Study||279
9692548|NCT02538666|10792607|FG000|COMPLETED|Overall Study||273
9692549|NCT02538666|10792608|FG001|COMPLETED|Overall Study||279
9692550|NCT02538666|10792609|FG002|COMPLETED|Overall Study||278
9692551|NCT02538666|10792607|FG000|NOT COMPLETED|Overall Study||2
9692552|NCT02538666|10792608|FG001|NOT COMPLETED|Overall Study||1
10024756|NCT01865747|11148623|FG000|STARTED|Overall Study (ITT)||330
10024757|NCT01865747|11148624|FG001|STARTED|Overall Study (ITT)||328
10024758|NCT01865747|11148623|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
9692553|NCT02538666|10792609|FG002|NOT COMPLETED|Overall Study||1
9692554|NCT02527200|10792622|FG000|STARTED|Overall Study||20
9692555|NCT02527200|10792623|FG001|STARTED|Overall Study||12
9692556|NCT02527200|10792624|FG002|STARTED|Overall Study||17
9692557|NCT02527200|10792625|FG003|STARTED|Overall Study||7
9692558|NCT02527200|10792622|FG000|Safety Analysis Set (SAS)|Overall Study||20
9692559|NCT02527200|10792623|FG001|Safety Analysis Set (SAS)|Overall Study||12
9692560|NCT02527200|10792624|FG002|Safety Analysis Set (SAS)|Overall Study||17
9692561|NCT02527200|10792625|FG003|Safety Analysis Set (SAS)|Overall Study||7
9692562|NCT02527200|10792622|FG000|Full Analysis Set (FAS)|Overall Study||19
9692563|NCT02527200|10792623|FG001|Full Analysis Set (FAS)|Overall Study||12
9692564|NCT02527200|10792624|FG002|Full Analysis Set (FAS)|Overall Study||17
9692565|NCT02527200|10792625|FG003|Full Analysis Set (FAS)|Overall Study||7
9692566|NCT02527200|10792622|FG000|COMPLETED|Overall Study||17
9692567|NCT02527200|10792623|FG001|COMPLETED|Overall Study||9
9692568|NCT02527200|10792624|FG002|COMPLETED|Overall Study||15
9692569|NCT02527200|10792625|FG003|COMPLETED|Overall Study||7
9692570|NCT02527200|10792622|FG000|NOT COMPLETED|Overall Study||3
9692571|NCT02527200|10792623|FG001|NOT COMPLETED|Overall Study||3
9692572|NCT02527200|10792624|FG002|NOT COMPLETED|Overall Study||2
9692573|NCT02527200|10792625|FG003|NOT COMPLETED|Overall Study||0
9692574|NCT02511106|10792641|FG000|STARTED|Overall Study||339
9692575|NCT02511106|10792642|FG001|STARTED|Overall Study||343
9692576|NCT02511106|10792641|FG000|Received Treatment|Overall Study||337
9692577|NCT02511106|10792642|FG001|Received Treatment|Overall Study||343
9692578|NCT02511106|10792641|FG000|COMPLETED|Overall Study||8
9692579|NCT02511106|10792642|FG001|COMPLETED|Overall Study||20
9692580|NCT02511106|10792641|FG000|NOT COMPLETED|Overall Study||331
9692581|NCT02511106|10792642|FG001|NOT COMPLETED|Overall Study||323
9692582|NCT02477358|10792652|FG000|STARTED|Overall Study||18
9692583|NCT02477358|10792653|FG001|STARTED|Overall Study||18
9692584|NCT02477358|10792652|FG000|COMPLETED|Overall Study||18
9692585|NCT02477358|10792653|FG001|COMPLETED|Overall Study||18
9692586|NCT02477358|10792652|FG000|NOT COMPLETED|Overall Study||0
9692587|NCT02477358|10792653|FG001|NOT COMPLETED|Overall Study||0
9692588|NCT02432209|10792663|FG000|STARTED|Overall Study||188
9692589|NCT02432209|10792664|FG001|STARTED|Overall Study||191
9692590|NCT02432209|10792663|FG000|COMPLETED|Overall Study||157
9692591|NCT02432209|10792664|FG001|COMPLETED|Overall Study||151
9692592|NCT02432209|10792663|FG000|NOT COMPLETED|Overall Study||31
9692593|NCT02432209|10792664|FG001|NOT COMPLETED|Overall Study||40
9692594|NCT02392637|10792672|FG000|STARTED|Overall Study||32
9692595|NCT02392637|10792673|FG001|STARTED|Overall Study||28
9692596|NCT02392637|10792672|FG000|COMPLETED|Overall Study||32
9692597|NCT02392637|10792673|FG001|COMPLETED|Overall Study||28
9692598|NCT02392637|10792672|FG000|NOT COMPLETED|Overall Study||0
9692599|NCT02392637|10792673|FG001|NOT COMPLETED|Overall Study||0
9726986|NCT00104416|10826556|FG003|NOT COMPLETED|Double-Blind Phase||0
9726987|NCT00104416|10826557|FG004|NOT COMPLETED|Double-Blind Phase||0
9726988|NCT00104416|10826553|FG000|STARTED|Continuation Phase||0
9726989|NCT00104416|10826554|FG001|STARTED|Continuation Phase||0
9726990|NCT00104416|10826555|FG002|STARTED|Continuation Phase||69
9726991|NCT00104416|10826556|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
9726992|NCT00104416|10826557|FG004|STARTED|Continuation Phase||32
9726993|NCT00104416|10826553|FG000|COMPLETED|Continuation Phase||0
9726994|NCT00104416|10826554|FG001|COMPLETED|Continuation Phase||0
9726995|NCT00104416|10826555|FG002|COMPLETED|Continuation Phase||63
9726996|NCT00104416|10826556|FG003|COMPLETED|Continuation Phase||65
9692600|NCT02253316|10792682|FG000|STARTED|Consolidation||236
9692601|NCT02253316|10792683|FG001|STARTED|Consolidation||0
9692602|NCT02253316|10792684|FG002|STARTED|Consolidation||0
9961459|NCT01473940|11081215|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1
10114523|NCT02516982|11245269|FG003|NOT COMPLETED|Overall Study||50
10024759|NCT01865747|11148624|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
10024760|NCT01865747|11148623|FG000|NOT COMPLETED|Overall Study (ITT)||198
10024761|NCT01865747|11148624|FG001|NOT COMPLETED|Overall Study (ITT)||255
10024762|NCT01865747|11148623|FG000|STARTED|Primary Intent to Treat (PITT)||187
10024763|NCT01865747|11148624|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
10024764|NCT01865747|11148623|FG000|COMPLETED|Primary Intent to Treat (PITT)||56
9692603|NCT02253316|10792682|FG000|COMPLETED|Consolidation||220
9692604|NCT02253316|10792683|FG001|COMPLETED|Consolidation||0
9692605|NCT02253316|10792684|FG002|COMPLETED|Consolidation||0
9692606|NCT02253316|10792682|FG000|NOT COMPLETED|Consolidation||16
9692607|NCT02253316|10792683|FG001|NOT COMPLETED|Consolidation||0
9692608|NCT02253316|10792684|FG002|NOT COMPLETED|Consolidation||0
9692609|NCT02253316|10792682|FG000|STARTED|Maintenance||0
9692610|NCT02253316|10792683|FG001|STARTED|Maintenance||99
9692611|NCT02253316|10792684|FG002|STARTED|Maintenance||116
9692612|NCT02253316|10792682|FG000|COMPLETED|Maintenance||0
10024765|NCT01865747|11148624|FG001|COMPLETED|Primary Intent to Treat (PITT)||36
10024766|NCT01865747|11148623|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131
10024767|NCT01865747|11148624|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152
10024768|NCT01865812|11148630|FG000|STARTED|Overall Study||26
10024769|NCT01865812|11148630|FG000|COMPLETED|Overall Study||24
9692613|NCT02253316|10792683|FG001|COMPLETED|Maintenance||53
9692614|NCT02253316|10792684|FG002|COMPLETED|Maintenance||49
9692615|NCT02253316|10792682|FG000|NOT COMPLETED|Maintenance||0
9692616|NCT02253316|10792683|FG001|NOT COMPLETED|Maintenance||46
9692617|NCT02253316|10792684|FG002|NOT COMPLETED|Maintenance||67
9692618|NCT02224573|10792694|FG000|STARTED|Treatment Phase||315
9692619|NCT02224573|10792695|FG001|STARTED|Treatment Phase||366
9692620|NCT02224573|10792694|FG000|COMPLETED|Treatment Phase||170
9692621|NCT02224573|10792695|FG001|COMPLETED|Treatment Phase||243
9692622|NCT02224573|10792694|FG000|NOT COMPLETED|Treatment Phase||145
9692623|NCT02224573|10792695|FG001|NOT COMPLETED|Treatment Phase||123
9692624|NCT02224573|10792694|FG000|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|79
9692625|NCT02224573|10792695|FG001|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|71
9692626|NCT02224573|10792694|FG000|COMPLETED|Taper Phase||76
9692627|NCT02224573|10792695|FG001|COMPLETED|Taper Phase||67
9692628|NCT02224573|10792694|FG000|NOT COMPLETED|Taper Phase||3
9692629|NCT02224573|10792695|FG001|NOT COMPLETED|Taper Phase||4
9692630|NCT01991067|10792704|FG000|STARTED|Overall Study||19
9692631|NCT01991067|10792705|FG001|STARTED|Overall Study||15
9692632|NCT01991067|10792704|FG000|COMPLETED|Overall Study||13
9692633|NCT01991067|10792705|FG001|COMPLETED|Overall Study||10
9692634|NCT01991067|10792704|FG000|NOT COMPLETED|Overall Study||6
9692635|NCT01991067|10792705|FG001|NOT COMPLETED|Overall Study||5
9692636|NCT01928732|10792713|FG000|STARTED|Overall Study||455
9692637|NCT01928732|10792714|FG001|STARTED|Overall Study||461
9692638|NCT01928732|10792713|FG000|COMPLETED|Overall Study||326
9692639|NCT01928732|10792714|FG001|COMPLETED|Overall Study||334
10024770|NCT01865812|11148630|FG000|NOT COMPLETED|Overall Study||2
10024771|NCT01866098|11148637|FG000|STARTED|Overall Study||51
10024772|NCT01866098|11148638|FG001|STARTED|Overall Study||47
10024773|NCT01866098|11148639|FG002|STARTED|Overall Study||46
9692640|NCT01928732|10792713|FG000|NOT COMPLETED|Overall Study||129
9692641|NCT01928732|10792714|FG001|NOT COMPLETED|Overall Study||127
9692642|NCT01925573|10792720|FG000|STARTED|Overall Study||7
9692643|NCT01925573|10792720|FG000|COMPLETED|Overall Study||0
9692644|NCT01925573|10792720|FG000|NOT COMPLETED|Overall Study||7
9692645|NCT01774721|10792726|FG000|STARTED|Overall Study||227
9692646|NCT01774721|10792727|FG001|STARTED|Overall Study||225
9692647|NCT01774721|10792726|FG000|Treated|Overall Study||227
9692648|NCT01774721|10792727|FG001|Treated|Overall Study||224
9692649|NCT01774721|10792726|FG000|COMPLETED|Overall Study||0
9692650|NCT01774721|10792727|FG001|COMPLETED|Overall Study||0
9692651|NCT01774721|10792726|FG000|NOT COMPLETED|Overall Study||227
9692652|NCT01774721|10792727|FG001|NOT COMPLETED|Overall Study||225
9692653|NCT01747447|10792737|FG000|STARTED|Overall Study||388
9692654|NCT01747447|10792738|FG001|STARTED|Overall Study||383
9692655|NCT01747447|10792737|FG000|COMPLETED|Overall Study||347
9692656|NCT01747447|10792738|FG001|COMPLETED|Overall Study||340
9692657|NCT01747447|10792737|FG000|NOT COMPLETED|Overall Study||41
9692658|NCT01747447|10792738|FG001|NOT COMPLETED|Overall Study||43
9692659|NCT01709331|10792744|FG000|STARTED|Overall Study||18
9692660|NCT01709331|10792744|FG000|COMPLETED|Overall Study||17
9692661|NCT01709331|10792744|FG000|NOT COMPLETED|Overall Study||1
9692662|NCT01689740|10792751|FG000|STARTED|Overall Study||2
9692663|NCT01689740|10792752|FG001|STARTED|Overall Study||3
9692664|NCT01689740|10792753|FG002|STARTED|Overall Study||5
9692665|NCT01689740|10792751|FG000|COMPLETED|Overall Study||2
9692666|NCT01689740|10792752|FG001|COMPLETED|Overall Study||3
9692667|NCT01689740|10792753|FG002|COMPLETED|Overall Study||5
9692668|NCT01689740|10792751|FG000|NOT COMPLETED|Overall Study||0
9692669|NCT01689740|10792752|FG001|NOT COMPLETED|Overall Study||0
9692670|NCT01689740|10792753|FG002|NOT COMPLETED|Overall Study||0
9692671|NCT01656434|10792765|FG000|STARTED|Overall Study||2553
9692672|NCT01656434|10792766|FG001|STARTED|Overall Study||620
9726997|NCT00104416|10826557|FG004|COMPLETED|Continuation Phase||27
9692673|NCT01656434|10792765|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
9692674|NCT01656434|10792766|FG001|Treated|Overall Study||604
9692675|NCT01656434|10792765|FG000|COMPLETED|Overall Study||152
9692676|NCT01656434|10792766|FG001|COMPLETED|Overall Study||40
9692677|NCT01656434|10792765|FG000|NOT COMPLETED|Overall Study||2401
9692678|NCT01656434|10792766|FG001|NOT COMPLETED|Overall Study||580
9692679|NCT01518517|10792775|FG000|STARTED|Overall Study||29
9692680|NCT01518517|10792776|FG001|STARTED|Overall Study||30
9692681|NCT01518517|10792777|FG002|STARTED|Overall Study||26
9692682|NCT01518517|10792775|FG000|COMPLETED|Overall Study||1
9692683|NCT01518517|10792776|FG001|COMPLETED|Overall Study||3
9692684|NCT01518517|10792777|FG002|COMPLETED|Overall Study||0
9692685|NCT01518517|10792775|FG000|NOT COMPLETED|Overall Study||28
9692686|NCT01518517|10792776|FG001|NOT COMPLETED|Overall Study||27
9692687|NCT01518517|10792777|FG002|NOT COMPLETED|Overall Study||26
9692688|NCT01496118|10792795|FG000|STARTED|Overall Study||4
9692689|NCT01496118|10792796|FG001|STARTED|Overall Study||3
9692690|NCT01496118|10792797|FG002|STARTED|Overall Study||3
9692691|NCT01496118|10792798|FG003|STARTED|Overall Study||3
9692692|NCT01496118|10792799|FG004|STARTED|Overall Study||3
9692693|NCT01496118|10792800|FG005|STARTED|Overall Study||3
9692694|NCT01496118|10792801|FG006|STARTED|Overall Study||31
9692695|NCT01496118|10792802|FG007|STARTED|Overall Study||30
9692696|NCT01496118|10792795|FG000|COMPLETED|Overall Study||0
9692697|NCT01496118|10792796|FG001|COMPLETED|Overall Study||0
9692698|NCT01496118|10792797|FG002|COMPLETED|Overall Study||0
9692699|NCT01496118|10792798|FG003|COMPLETED|Overall Study||0
9692700|NCT01496118|10792799|FG004|COMPLETED|Overall Study||0
9692701|NCT01496118|10792800|FG005|COMPLETED|Overall Study||0
9692702|NCT01496118|10792801|FG006|COMPLETED|Overall Study||0
9692703|NCT01496118|10792802|FG007|COMPLETED|Overall Study||0
9692704|NCT01496118|10792795|FG000|NOT COMPLETED|Overall Study||4
9692705|NCT01496118|10792796|FG001|NOT COMPLETED|Overall Study||3
9692706|NCT01496118|10792797|FG002|NOT COMPLETED|Overall Study||3
9692707|NCT01496118|10792798|FG003|NOT COMPLETED|Overall Study||3
9692708|NCT01496118|10792799|FG004|NOT COMPLETED|Overall Study||3
9692709|NCT01496118|10792800|FG005|NOT COMPLETED|Overall Study||3
9692710|NCT01496118|10792801|FG006|NOT COMPLETED|Overall Study||31
9692711|NCT01496118|10792802|FG007|NOT COMPLETED|Overall Study||30
9692712|NCT01350934|10792822|FG000|STARTED|Base Study||111
9692713|NCT01350934|10792823|FG001|STARTED|Base Study||108
9692714|NCT01350934|10792822|FG000|COMPLETED|Base Study||100
9692715|NCT01350934|10792823|FG001|COMPLETED|Base Study||105
9692716|NCT01350934|10792822|FG000|NOT COMPLETED|Base Study||11
9692717|NCT01350934|10792823|FG001|NOT COMPLETED|Base Study||3
9692718|NCT01350934|10792822|FG000|STARTED|Extension Study||100
9692719|NCT01350934|10792823|FG001|STARTED|Extension Study||105
9692720|NCT01350934|10792822|FG000|COMPLETED|Extension Study||95
9692721|NCT01350934|10792823|FG001|COMPLETED|Extension Study||101
9692722|NCT01350934|10792822|FG000|NOT COMPLETED|Extension Study||5
9692723|NCT01350934|10792823|FG001|NOT COMPLETED|Extension Study||4
9692724|NCT01286207|10792832|FG000|STARTED|Overall Study||751
9692725|NCT01286207|10792833|FG001|STARTED|Overall Study||857
9692726|NCT01286207|10792834|FG002|STARTED|Overall Study||351
9692727|NCT01286207|10792832|FG000|COMPLETED|Overall Study||453
9692728|NCT01286207|10792833|FG001|COMPLETED|Overall Study||609
9692729|NCT01286207|10792834|FG002|COMPLETED|Overall Study||261
9692730|NCT01286207|10792832|FG000|NOT COMPLETED|Overall Study||298
9692731|NCT01286207|10792833|FG001|NOT COMPLETED|Overall Study||248
9692732|NCT01286207|10792834|FG002|NOT COMPLETED|Overall Study||90
9692733|NCT01263769|10792842|FG000|STARTED|Overall Study||25
9692734|NCT01263769|10792842|FG000|COMPLETED|Overall Study||24
9692735|NCT01263769|10792842|FG000|NOT COMPLETED|Overall Study||1
9692736|NCT01227187|10792850|FG000|STARTED|Overall Study||1
9692737|NCT01227187|10792851|FG001|STARTED|Overall Study||3
9692738|NCT01227187|10792852|FG002|STARTED|Overall Study||3
9692739|NCT01227187|10792853|FG003|STARTED|Overall Study||5
9692740|NCT01227187|10792850|FG000|COMPLETED|Overall Study||1
9692741|NCT01227187|10792851|FG001|COMPLETED|Overall Study||3
9692742|NCT01227187|10792852|FG002|COMPLETED|Overall Study||3
9692743|NCT01227187|10792853|FG003|COMPLETED|Overall Study||4
9692744|NCT01227187|10792850|FG000|NOT COMPLETED|Overall Study||0
9692745|NCT01227187|10792851|FG001|NOT COMPLETED|Overall Study||0
9692746|NCT01227187|10792852|FG002|NOT COMPLETED|Overall Study||0
9692747|NCT01227187|10792853|FG003|NOT COMPLETED|Overall Study||1
9692748|NCT01222247|10792865|FG000|STARTED|Overall Study||1429
9692749|NCT01222247|10792866|FG001|STARTED|Overall Study||1402
9692750|NCT01222247|10792865|FG000|Received 2 Doses|Overall Study||860
9692751|NCT01222247|10792866|FG001|Received 2 Doses|Overall Study||826
9692752|NCT01222247|10792865|FG000|Received 1 Dose|Overall Study||568
9692753|NCT01222247|10792866|FG001|Received 1 Dose|Overall Study||571
9692754|NCT01222247|10792865|FG000|Did Not Receive Assigned Medication|Overall Study||1
9692755|NCT01222247|10792866|FG001|Did Not Receive Assigned Medication|Overall Study||5
9692756|NCT01222247|10792865|FG000|COMPLETED|Overall Study||1427
9692757|NCT01222247|10792866|FG001|COMPLETED|Overall Study||1400
9692758|NCT01222247|10792865|FG000|NOT COMPLETED|Overall Study||2
9692759|NCT01222247|10792866|FG001|NOT COMPLETED|Overall Study||2
9692760|NCT01211405|10792875|FG000|STARTED|Overall Study||7
9692761|NCT01211405|10792876|FG001|STARTED|Overall Study||7
9692762|NCT01211405|10792877|FG002|STARTED|Overall Study||12
9692763|NCT01211405|10792875|FG000|Completed Primary Endpoint|Overall Study||7
9692764|NCT01211405|10792876|FG001|Completed Primary Endpoint|Overall Study||7
9692765|NCT01211405|10792877|FG002|Completed Primary Endpoint|Overall Study||12
9692766|NCT01211405|10792875|FG000|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
9692767|NCT01211405|10792876|FG001|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
9692768|NCT01211405|10792877|FG002|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||12
9692769|NCT01211405|10792875|FG000|COMPLETED|Overall Study||6
9692770|NCT01211405|10792876|FG001|COMPLETED|Overall Study||7
9692771|NCT01211405|10792877|FG002|COMPLETED|Overall Study||11
9692772|NCT01211405|10792875|FG000|NOT COMPLETED|Overall Study||1
9692773|NCT01211405|10792876|FG001|NOT COMPLETED|Overall Study||0
9692774|NCT01211405|10792877|FG002|NOT COMPLETED|Overall Study||1
9692775|NCT01146418|10792887|FG000|STARTED|Base Study P06029 (NCT01144416)||694
9692776|NCT01146418|10792888|FG001|STARTED|Base Study P06029 (NCT01144416)||696
9692777|NCT01146418|10792889|FG002|STARTED|Base Study P06029 (NCT01144416)||0
9692778|NCT01146418|10792890|FG003|STARTED|Base Study P06029 (NCT01144416)||0
9692779|NCT01146418|10792887|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
9692780|NCT01146418|10792888|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
9692781|NCT01146418|10792889|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0
9692782|NCT01146418|10792890|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0
9692783|NCT01146418|10792887|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
9692784|NCT01146418|10792888|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
9692785|NCT01146418|10792889|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
9692786|NCT01146418|10792890|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
9692787|NCT01146418|10792887|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
9692788|NCT01146418|10792888|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
9692789|NCT01146418|10792889|FG002|STARTED|Women/Expectant Mother Follow Up||0
9692790|NCT01146418|10792890|FG003|STARTED|Women/Expectant Mother Follow Up||0
9692791|NCT01146418|10792887|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
9692792|NCT01146418|10792888|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
9692793|NCT01146418|10792889|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
9692794|NCT01146418|10792890|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
9692795|NCT01146418|10792887|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
9692796|NCT01146418|10792888|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
9692797|NCT01146418|10792889|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
9692798|NCT01146418|10792890|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
9692799|NCT01146418|10792887|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
9846891|NCT00850993|10959304|FG002|NOT COMPLETED|Overall Study||0
9846892|NCT00850993|10959305|FG003|NOT COMPLETED|Overall Study||1
9846893|NCT00851006|10959315|FG000|STARTED|Overall Study||7
9846894|NCT00851006|10959316|FG001|STARTED|Overall Study||6
9846895|NCT00851006|10959315|FG000|COMPLETED|Overall Study||7
9846896|NCT00851006|10959316|FG001|COMPLETED|Overall Study||6
9846897|NCT00851006|10959315|FG000|NOT COMPLETED|Overall Study||0
9692800|NCT01146418|10792888|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
9692801|NCT01146418|10792889|FG002|COMPLETED|Women/Expectant Mother Follow Up||0
9692802|NCT01146418|10792890|FG003|COMPLETED|Women/Expectant Mother Follow Up||0
9692803|NCT01146418|10792887|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44
9692804|NCT01146418|10792888|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40
9692805|NCT01146418|10792889|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0
9692806|NCT01146418|10792890|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0
9692807|NCT01146418|10792887|FG000|STARTED|Live-Born Infant Follow Up||0
9692808|NCT01146418|10792888|FG001|STARTED|Live-Born Infant Follow Up||0
9692809|NCT01146418|10792889|FG002|STARTED|Live-Born Infant Follow Up||61
9692810|NCT01146418|10792890|FG003|STARTED|Live-Born Infant Follow Up||56
9692811|NCT01146418|10792887|FG000|COMPLETED|Live-Born Infant Follow Up||0
9692812|NCT01146418|10792888|FG001|COMPLETED|Live-Born Infant Follow Up||0
9692813|NCT01146418|10792889|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
9692814|NCT01146418|10792890|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
9692815|NCT01146418|10792887|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0
9692816|NCT01146418|10792888|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0
9692817|NCT01146418|10792889|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6
9692818|NCT01146418|10792890|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5
9692819|NCT01144416|10792902|FG000|STARTED|Intervention Period||694
9692820|NCT01144416|10792903|FG001|STARTED|Intervention Period||696
9692821|NCT01144416|10792902|FG000|COMPLETED|Intervention Period||632
9692822|NCT01144416|10792903|FG001|COMPLETED|Intervention Period||647
9692823|NCT01144416|10792902|FG000|NOT COMPLETED|Intervention Period||62
9692824|NCT01144416|10792903|FG001|NOT COMPLETED|Intervention Period||49
9692825|NCT01144416|10792902|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
9692826|NCT01144416|10792903|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
9692827|NCT01144416|10792902|FG000|COMPLETED|Pregnancy Follow-up Period||146
9692828|NCT01144416|10792903|FG001|COMPLETED|Pregnancy Follow-up Period||157
9692829|NCT01144416|10792902|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8
9692830|NCT01144416|10792903|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10
9692831|NCT01140048|10792913|FG000|STARTED|Overall Study||343
9692832|NCT01140048|10792913|FG000|COMPLETED|Overall Study||298
9692833|NCT01140048|10792913|FG000|NOT COMPLETED|Overall Study||45
9692834|NCT01077817|10792917|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
9692835|NCT01077817|10792917|FG000|COMPLETED|Overall Study||684815
9692836|NCT01077817|10792917|FG000|NOT COMPLETED|Overall Study||0
9692837|NCT01065779|10792928|FG000|STARTED|Overall Study||880
9692838|NCT01065779|10792928|FG000|COMPLETED|Overall Study||798
9692839|NCT01065779|10792928|FG000|NOT COMPLETED|Overall Study||82
9692840|NCT00974571|10792935|FG000|STARTED|Overall Study||630
9692841|NCT00974571|10792936|FG001|STARTED|Overall Study||122
9692842|NCT00974571|10792937|FG002|STARTED|Overall Study||613
10024774|NCT01866098|11148637|FG000|COMPLETED|Overall Study||32
10024775|NCT01866098|11148638|FG001|COMPLETED|Overall Study||20
10024776|NCT01866098|11148639|FG002|COMPLETED|Overall Study||25
10024777|NCT01866098|11148637|FG000|NOT COMPLETED|Overall Study||19
10024778|NCT01866098|11148638|FG001|NOT COMPLETED|Overall Study||27
10024779|NCT01866098|11148639|FG002|NOT COMPLETED|Overall Study||21
10024780|NCT01866150|11148647|FG000|STARTED|Overall Study||450
10024781|NCT01866150|11148647|FG000|COMPLETED|Overall Study||450
10024782|NCT01866150|11148647|FG000|NOT COMPLETED|Overall Study||0
10024783|NCT01866163|11148656|FG000|STARTED|Overall Study||323
10024784|NCT01866163|11148657|FG001|STARTED|Overall Study||103
10024785|NCT01866163|11148656|FG000|COMPLETED|Overall Study||313
10024786|NCT01866163|11148657|FG001|COMPLETED|Overall Study||99
9692843|NCT00974571|10792935|FG000|COMPLETED|Overall Study||562
9692844|NCT00974571|10792936|FG001|COMPLETED|Overall Study||106
9692845|NCT00974571|10792937|FG002|COMPLETED|Overall Study||530
9692846|NCT00974571|10792935|FG000|NOT COMPLETED|Overall Study||68
9692847|NCT00974571|10792936|FG001|NOT COMPLETED|Overall Study||16
9692848|NCT00974571|10792937|FG002|NOT COMPLETED|Overall Study||83
9692849|NCT00972738|10792948|FG000|STARTED|Overall Study||522
9692850|NCT00972738|10792949|FG001|STARTED|Overall Study||171
9692851|NCT00972738|10792950|FG002|STARTED|Overall Study||521
9692852|NCT00972738|10792948|FG000|COMPLETED|Overall Study||501
9692853|NCT00972738|10792949|FG001|COMPLETED|Overall Study||165
9692854|NCT00972738|10792950|FG002|COMPLETED|Overall Study||492
9692855|NCT00972738|10792948|FG000|NOT COMPLETED|Overall Study||21
9692856|NCT00972738|10792949|FG001|NOT COMPLETED|Overall Study||6
9692857|NCT00972738|10792950|FG002|NOT COMPLETED|Overall Study||29
9692858|NCT00968201|10792960|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
9692859|NCT00968201|10792961|FG001|STARTED|Base Study - (Period II)||0
9692860|NCT00968201|10792962|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
9692861|NCT00968201|10792960|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
9692862|NCT00968201|10792961|FG001|COMPLETED|Base Study - (Period II)||0
9692863|NCT00968201|10792962|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
9692864|NCT00968201|10792960|FG000|NOT COMPLETED|Base Study - (Period II)||26
9692865|NCT00968201|10792961|FG001|NOT COMPLETED|Base Study - (Period II)||0
9692866|NCT00968201|10792962|FG002|NOT COMPLETED|Base Study - (Period II)||45
9692867|NCT00968201|10792960|FG000|STARTED|Extension Study - (Period III)||0
9692868|NCT00968201|10792961|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
9692869|NCT00968201|10792962|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
9692870|NCT00968201|10792960|FG000|COMPLETED|Extension Study - (Period III)||0
9692871|NCT00968201|10792961|FG001|COMPLETED|Extension Study - (Period III)||33
9692872|NCT00968201|10792962|FG002|COMPLETED|Extension Study - (Period III)||84
9692873|NCT00968201|10792960|FG000|NOT COMPLETED|Extension Study - (Period III)||0
10024787|NCT01866163|11148656|FG000|NOT COMPLETED|Overall Study||10
10024788|NCT01866163|11148657|FG001|NOT COMPLETED|Overall Study||4
10024789|NCT01866293|11148663|FG000|STARTED|Overall Study||11
10024790|NCT01866293|11148663|FG000|COMPLETED|Overall Study||9
9692874|NCT00968201|10792961|FG001|NOT COMPLETED|Extension Study - (Period III)||124
9692875|NCT00968201|10792962|FG002|NOT COMPLETED|Extension Study - (Period III)||280
9692876|NCT00968149|10792973|FG000|STARTED|Overall Study||280
9692877|NCT00968149|10792974|FG001|STARTED|Overall Study||133
9692878|NCT00968149|10792973|FG000|COMPLETED|Overall Study||269
9692879|NCT00968149|10792974|FG001|COMPLETED|Overall Study||127
9692880|NCT00968149|10792973|FG000|NOT COMPLETED|Overall Study||11
9692881|NCT00968149|10792974|FG001|NOT COMPLETED|Overall Study||6
9692882|NCT00963469|10792983|FG000|STARTED|Overall Study||451
9692883|NCT00963469|10792984|FG001|STARTED|Overall Study||448
9692884|NCT00963469|10792985|FG002|STARTED|Overall Study||180
9692885|NCT00963469|10792983|FG000|COMPLETED|Overall Study||410
9692886|NCT00963469|10792984|FG001|COMPLETED|Overall Study||420
9692887|NCT00963469|10792985|FG002|COMPLETED|Overall Study||170
9692888|NCT00963469|10792983|FG000|NOT COMPLETED|Overall Study||41
9692889|NCT00963469|10792984|FG001|NOT COMPLETED|Overall Study||28
9692890|NCT00963469|10792985|FG002|NOT COMPLETED|Overall Study||10
9692891|NCT00960141|10792996|FG000|STARTED|Overall Study||333
9692892|NCT00960141|10792997|FG001|STARTED|Overall Study||326
9692893|NCT00960141|10792998|FG002|STARTED|Overall Study||170
9692894|NCT00960141|10792996|FG000|COMPLETED|Overall Study||323
9692895|NCT00960141|10792997|FG001|COMPLETED|Overall Study||309
9692896|NCT00960141|10792998|FG002|COMPLETED|Overall Study||163
9692897|NCT00960141|10792996|FG000|NOT COMPLETED|Overall Study||10
9692898|NCT00960141|10792997|FG001|NOT COMPLETED|Overall Study||17
9692899|NCT00960141|10792998|FG002|NOT COMPLETED|Overall Study||7
9692900|NCT00943683|10793008|FG000|STARTED|Overall Study||81
9692901|NCT00943683|10793009|FG001|STARTED|Overall Study||175
9692902|NCT00943683|10793008|FG000|COMPLETED|Overall Study||74
9692903|NCT00943683|10793009|FG001|COMPLETED|Overall Study||169
9692904|NCT00943683|10793008|FG000|NOT COMPLETED|Overall Study||7
9692905|NCT00943683|10793009|FG001|NOT COMPLETED|Overall Study||6
9692906|NCT00943397|10793017|FG000|STARTED|Overall Study||32
9692907|NCT00943397|10793018|FG001|STARTED|Overall Study||158
9692908|NCT00943397|10793017|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
9692909|NCT00943397|10793018|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
9692910|NCT00943397|10793017|FG000|NOT COMPLETED|Overall Study||15
10024791|NCT01866293|11148663|FG000|NOT COMPLETED|Overall Study||2
10024792|NCT01866306|11148674|FG000|STARTED|Overall Study||6
10024793|NCT01866306|11148675|FG001|STARTED|Overall Study||6
10024794|NCT01866306|11148676|FG002|STARTED|Overall Study||6
10024795|NCT01866306|11148677|FG003|STARTED|Overall Study||6
10024796|NCT01866306|11148678|FG004|STARTED|Overall Study||6
10024797|NCT01866306|11148679|FG005|STARTED|Overall Study||6
10024798|NCT01866306|11148680|FG006|STARTED|Overall Study||23
10024799|NCT01866306|11148674|FG000|COMPLETED|Overall Study||6
10024800|NCT01866306|11148675|FG001|COMPLETED|Overall Study||6
10024801|NCT01866306|11148676|FG002|COMPLETED|Overall Study||6
10024802|NCT01866306|11148677|FG003|COMPLETED|Overall Study||6
10024803|NCT01866306|11148678|FG004|COMPLETED|Overall Study||6
10024804|NCT01866306|11148679|FG005|COMPLETED|Overall Study||6
10024805|NCT01866306|11148680|FG006|COMPLETED|Overall Study||23
10024806|NCT01866306|11148674|FG000|NOT COMPLETED|Overall Study||0
10024807|NCT01866306|11148675|FG001|NOT COMPLETED|Overall Study||0
10024808|NCT01866306|11148676|FG002|NOT COMPLETED|Overall Study||0
10024809|NCT01866306|11148677|FG003|NOT COMPLETED|Overall Study||0
10024810|NCT01866306|11148678|FG004|NOT COMPLETED|Overall Study||0
10024811|NCT01866306|11148679|FG005|NOT COMPLETED|Overall Study||0
10024812|NCT01866306|11148680|FG006|NOT COMPLETED|Overall Study||0
10024813|NCT01866319|11148699|FG000|STARTED|Overall Study||278
10024814|NCT01866319|11148700|FG001|STARTED|Overall Study||279
10024815|NCT01866319|11148701|FG002|STARTED|Overall Study||277
10024816|NCT01866319|11148699|FG000|Treated|Overall Study||256
10024817|NCT01866319|11148700|FG001|Treated|Overall Study||278
10024818|NCT01866319|11148701|FG002|Treated|Overall Study||277
10024819|NCT01866319|11148699|FG000|COMPLETED|Overall Study||71
10024820|NCT01866319|11148700|FG001|COMPLETED|Overall Study||101
10024821|NCT01866319|11148701|FG002|COMPLETED|Overall Study||97
10024822|NCT01866319|11148699|FG000|NOT COMPLETED|Overall Study||207
10024823|NCT01866319|11148700|FG001|NOT COMPLETED|Overall Study||178
10024824|NCT01866319|11148701|FG002|NOT COMPLETED|Overall Study||180
10024825|NCT01866410|11148709|FG000|STARTED|Overall Study||37
10024826|NCT01866410|11148709|FG000|COMPLETED|Overall Study||37
10024827|NCT01866410|11148709|FG000|NOT COMPLETED|Overall Study||0
10024828|NCT01866423|11148716|FG000|STARTED|Overall Study||4
10024829|NCT01866423|11148716|FG000|COMPLETED|Overall Study||0
10024830|NCT01866423|11148716|FG000|NOT COMPLETED|Overall Study||4
10024831|NCT01866592|11148720|FG000|STARTED|Overall Study||81
10024832|NCT01866592|11148720|FG000|COMPLETED|Overall Study||58
10024833|NCT01866592|11148720|FG000|NOT COMPLETED|Overall Study||23
10024834|NCT01866826|11148724|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23
10024835|NCT01866826|11148725|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23
10024836|NCT01866826|11148724|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
10024837|NCT01866826|11148725|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
10024838|NCT01866826|11148724|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
10024839|NCT01866826|11148725|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
10024840|NCT01866826|11148724|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22
10024841|NCT01866826|11148725|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23
10024842|NCT01866826|11148724|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
10024843|NCT01866826|11148725|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
10024844|NCT01866826|11148724|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
10024845|NCT01866826|11148725|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
10024846|NCT01866826|11148724|FG000|STARTED|Second Intervention - 4 Weeks||22
10024847|NCT01866826|11148725|FG001|STARTED|Second Intervention - 4 Weeks||20
10024848|NCT01866826|11148724|FG000|COMPLETED|Second Intervention - 4 Weeks||22
10024849|NCT01866826|11148725|FG001|COMPLETED|Second Intervention - 4 Weeks||20
10024850|NCT01866826|11148724|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0
10024851|NCT01866826|11148725|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0
10024852|NCT01866839|11148731|FG000|STARTED|Overall Study||40
10024853|NCT01866839|11148731|FG000|COMPLETED|Overall Study||30
10024854|NCT01866839|11148731|FG000|NOT COMPLETED|Overall Study||10
10024855|NCT01866917|11148737|FG000|STARTED|Overall Study||17
10024856|NCT01866917|11148738|FG001|STARTED|Overall Study||18
10024857|NCT01866917|11148737|FG000|COMPLETED|Overall Study||13
10024858|NCT01866917|11148738|FG001|COMPLETED|Overall Study||12
10024859|NCT01866917|11148737|FG000|NOT COMPLETED|Overall Study||4
10024860|NCT01866917|11148738|FG001|NOT COMPLETED|Overall Study||6
10024861|NCT01866943|11148746|FG000|STARTED|Overall Study||19
10024862|NCT01866943|11148747|FG001|STARTED|Overall Study||22
10024863|NCT01866943|11148746|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
10024864|NCT01866943|11148747|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
10024865|NCT01866943|11148746|FG000|NOT COMPLETED|Overall Study||19
10024866|NCT01866943|11148747|FG001|NOT COMPLETED|Overall Study||22
10024867|NCT01867008|11148756|FG000|STARTED|Overall Study||55
10024868|NCT01867008|11148756|FG000|COMPLETED|Overall Study||54
10024869|NCT01867008|11148756|FG000|NOT COMPLETED|Overall Study||1
10024870|NCT01867021|11148762|FG000|STARTED|Overall Study||1452
10024871|NCT01867021|11148763|FG001|STARTED|Overall Study||1450
10024872|NCT01867021|11148762|FG000|COMPLETED|Overall Study||1450
10024873|NCT01867021|11148763|FG001|COMPLETED|Overall Study||1440
10024874|NCT01867021|11148762|FG000|NOT COMPLETED|Overall Study||2
10024875|NCT01867021|11148763|FG001|NOT COMPLETED|Overall Study||10
10024876|NCT01867047|11148776|FG000|STARTED|Overall Study||31
10114524|NCT02517021|11245281|FG000|STARTED|Overall Study||203
10114525|NCT02517021|11245282|FG001|STARTED|Overall Study||202
10114526|NCT02517021|11245281|FG000|COMPLETED|Overall Study||120
10114527|NCT02517021|11245282|FG001|COMPLETED|Overall Study||117
10024877|NCT01867047|11148777|FG001|STARTED|Overall Study||28
10024878|NCT01867047|11148776|FG000|COMPLETED|Overall Study||23
10024879|NCT01867047|11148777|FG001|COMPLETED|Overall Study||23
10024880|NCT01867047|11148776|FG000|NOT COMPLETED|Overall Study||8
10114528|NCT02517021|11245281|FG000|NOT COMPLETED|Overall Study||83
9692911|NCT00943397|10793018|FG001|NOT COMPLETED|Overall Study||72
9692915|NCT00911547|10793033|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
9692916|NCT00911547|10793034|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
9692917|NCT00911547|10793035|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
9692918|NCT00911547|10793036|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
9692919|NCT00911547|10793033|FG000|COMPLETED|Overall Study||37
9692920|NCT00911547|10793034|FG001|COMPLETED|Overall Study||159
9692921|NCT00911547|10793035|FG002|COMPLETED|Overall Study||178
9692922|NCT00911547|10793036|FG003|COMPLETED|Overall Study||177
9692923|NCT00911547|10793033|FG000|NOT COMPLETED|Overall Study||11
9692924|NCT00911547|10793034|FG001|NOT COMPLETED|Overall Study||42
9692925|NCT00911547|10793035|FG002|NOT COMPLETED|Overall Study||22
9692926|NCT00911547|10793036|FG003|NOT COMPLETED|Overall Study||16
9692927|NCT00899379|10793051|FG000|STARTED|Overall Study|Patients who were allocated study drug|95
9692928|NCT00899379|10793052|FG001|STARTED|Overall Study|Patients who were allocated study drug|95
10024881|NCT01867047|11148777|FG001|NOT COMPLETED|Overall Study||5
10024882|NCT01867086|11148787|FG000|STARTED|Overall Study||1
10024883|NCT01867086|11148787|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
10024884|NCT01867086|11148787|FG000|NOT COMPLETED|Overall Study||1
10024885|NCT01867164|11148793|FG000|STARTED|Overall Study||81
10024886|NCT01867164|11148794|FG001|STARTED|Overall Study||79
10024887|NCT01867164|11148793|FG000|COMPLETED|Overall Study||81
10024888|NCT01867164|11148794|FG001|COMPLETED|Overall Study||79
10024889|NCT01867164|11148793|FG000|NOT COMPLETED|Overall Study||0
10024890|NCT01867164|11148794|FG001|NOT COMPLETED|Overall Study||0
10024891|NCT01867216|11148807|FG000|STARTED|Overall Study||16
10024892|NCT01867216|11148808|FG001|STARTED|Overall Study||8
10024893|NCT01867216|11148809|FG002|STARTED|Overall Study||8
10024894|NCT01867216|11148810|FG003|STARTED|Overall Study||8
10024895|NCT01867216|11148811|FG004|STARTED|Overall Study||9
10024896|NCT01867216|11148812|FG005|STARTED|Overall Study||8
10024897|NCT01867216|11148813|FG006|STARTED|Overall Study||9
10024898|NCT01867216|11148807|FG000|Received Study Drug|Overall Study||14
10024899|NCT01867216|11148808|FG001|Received Study Drug|Overall Study||8
10024900|NCT01867216|11148809|FG002|Received Study Drug|Overall Study||8
10024901|NCT01867216|11148810|FG003|Received Study Drug|Overall Study||8
10024902|NCT01867216|11148811|FG004|Received Study Drug|Overall Study||9
10024903|NCT01867216|11148812|FG005|Received Study Drug|Overall Study||8
10024904|NCT01867216|11148813|FG006|Received Study Drug|Overall Study||9
10024905|NCT01867216|11148807|FG000|COMPLETED|Overall Study||12
10114529|NCT02517021|11245282|FG001|NOT COMPLETED|Overall Study||85
9692929|NCT00899379|10793053|FG002|STARTED|Overall Study|Patients who were allocated study drug|95
9692930|NCT00899379|10793054|FG003|STARTED|Overall Study|Patients who were allocated study drug|94
9692931|NCT00899379|10793055|FG004|STARTED|Overall Study|Patients who were allocated study drug|94
9692932|NCT00899379|10793051|FG000|Patients Treated|Overall Study|Patients who took study drug|83
9692933|NCT00899379|10793052|FG001|Patients Treated|Overall Study|Patients who took study drug|82
9692934|NCT00899379|10793053|FG002|Patients Treated|Overall Study|Patients who took study drug|84
9692935|NCT00899379|10793054|FG003|Patients Treated|Overall Study|Patients who took study drug|77
9692936|NCT00899379|10793055|FG004|Patients Treated|Overall Study|Patients who took study drug|81
9692937|NCT00899379|10793051|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12
9692938|NCT00899379|10793052|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13
9692939|NCT00899379|10793053|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11
9692940|NCT00899379|10793054|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17
9692941|NCT00899379|10793055|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13
9692942|NCT00899379|10793051|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
9692943|NCT00899379|10793052|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
9692944|NCT00899379|10793053|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
9692945|NCT00899379|10793054|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
9692946|NCT00899379|10793055|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
9692947|NCT00899379|10793051|FG000|NOT COMPLETED|Overall Study||34
9692948|NCT00899379|10793052|FG001|NOT COMPLETED|Overall Study||29
9692949|NCT00899379|10793053|FG002|NOT COMPLETED|Overall Study||29
9692950|NCT00899379|10793054|FG003|NOT COMPLETED|Overall Study||37
10024906|NCT01867216|11148808|FG001|COMPLETED|Overall Study||8
10024907|NCT01867216|11148809|FG002|COMPLETED|Overall Study||8
10024908|NCT01867216|11148810|FG003|COMPLETED|Overall Study||8
10024909|NCT01867216|11148811|FG004|COMPLETED|Overall Study||8
10024910|NCT01867216|11148812|FG005|COMPLETED|Overall Study||8
10024911|NCT01867216|11148813|FG006|COMPLETED|Overall Study||8
9846898|NCT00851006|10959316|FG001|NOT COMPLETED|Overall Study||0
9846899|NCT00851084|10959325|FG000|STARTED|Overall Study||117
9846900|NCT00851084|10959326|FG001|STARTED|Overall Study||119
9846901|NCT00851084|10959325|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
9846902|NCT00851084|10959326|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
9846903|NCT00851084|10959325|FG000|NOT COMPLETED|Overall Study||117
9846904|NCT00851084|10959326|FG001|NOT COMPLETED|Overall Study||119
9846905|NCT00851253|10959336|FG000|STARTED|Overall Study||2
9846906|NCT00851253|10959337|FG001|STARTED|Overall Study||10
9846907|NCT00851253|10959336|FG000|COMPLETED|Overall Study||1
9846908|NCT00851253|10959337|FG001|COMPLETED|Overall Study||10
9846909|NCT00851253|10959336|FG000|NOT COMPLETED|Overall Study||1
9692951|NCT00899379|10793055|FG004|NOT COMPLETED|Overall Study||31
9692952|NCT00898677|10793065|FG000|STARTED|Overall Study||180
10024912|NCT01867216|11148807|FG000|NOT COMPLETED|Overall Study||4
10024913|NCT01867216|11148808|FG001|NOT COMPLETED|Overall Study||0
10024914|NCT01867216|11148809|FG002|NOT COMPLETED|Overall Study||0
10024915|NCT01867216|11148810|FG003|NOT COMPLETED|Overall Study||0
10024916|NCT01867216|11148811|FG004|NOT COMPLETED|Overall Study||1
10024917|NCT01867216|11148812|FG005|NOT COMPLETED|Overall Study||0
10024918|NCT01867216|11148813|FG006|NOT COMPLETED|Overall Study||1
9692953|NCT00898677|10793066|FG001|STARTED|Overall Study||455
10024919|NCT01867294|11148839|FG000|STARTED|Overall Study||9
10024920|NCT01867294|11148840|FG001|STARTED|Overall Study||10
10024921|NCT01867294|11148841|FG002|STARTED|Overall Study||0
10024922|NCT01867294|11148842|FG003|STARTED|Overall Study||0
9692954|NCT00898677|10793067|FG002|STARTED|Overall Study||455
9692955|NCT00898677|10793068|FG003|STARTED|Overall Study||178
9692956|NCT00898677|10793065|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164
9692957|NCT00898677|10793066|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387
9692958|NCT00898677|10793067|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388
9846910|NCT00851253|10959337|FG001|NOT COMPLETED|Overall Study||0
9846911|NCT00851279|10959343|FG000|STARTED|Overall Study||53
9961460|NCT01473940|11081216|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3
9961461|NCT01473940|11081217|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3
9692959|NCT00898677|10793068|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160
9692960|NCT00898677|10793065|FG000|COMPLETED|Overall Study||163
9692961|NCT00898677|10793066|FG001|COMPLETED|Overall Study||386
9692962|NCT00898677|10793067|FG002|COMPLETED|Overall Study||383
9692963|NCT00898677|10793068|FG003|COMPLETED|Overall Study||159
9692964|NCT00898677|10793065|FG000|NOT COMPLETED|Overall Study||17
9692965|NCT00898677|10793066|FG001|NOT COMPLETED|Overall Study||69
9692966|NCT00898677|10793067|FG002|NOT COMPLETED|Overall Study||72
9692967|NCT00898677|10793068|FG003|NOT COMPLETED|Overall Study||19
9692968|NCT00897949|10793081|FG000|STARTED|Overall Study|Patients who were allocated study drug|554
9692969|NCT00897949|10793082|FG001|STARTED|Overall Study|Patients who were allocated study drug|549
9692970|NCT00897949|10793083|FG002|STARTED|Overall Study|Patients who were allocated study drug|370
9692971|NCT00897949|10793081|FG000|Patients Treated|Overall Study|Patients who took study drug|458
9692972|NCT00897949|10793082|FG001|Patients Treated|Overall Study|Patients who took study drug|456
9692973|NCT00897949|10793083|FG002|Patients Treated|Overall Study|Patients who took study drug|304
9692974|NCT00897949|10793081|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
9692975|NCT00897949|10793082|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
9692976|NCT00897949|10793083|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
9692977|NCT00897949|10793081|FG000|NOT COMPLETED|Overall Study||104
9692978|NCT00897949|10793082|FG001|NOT COMPLETED|Overall Study||103
9692979|NCT00897949|10793083|FG002|NOT COMPLETED|Overall Study||69
9692980|NCT00897104|10793100|FG000|STARTED|Overall Study|Participants who were allocated study drug|418
9692981|NCT00897104|10793101|FG001|STARTED|Overall Study|Participants who were allocated study drug|428
9692982|NCT00897104|10793102|FG002|STARTED|Overall Study|Participants who were allocated study drug|87
9692983|NCT00897104|10793100|FG000|Participants Treated|Overall Study|Participants who took study drug|355
9692984|NCT00897104|10793101|FG001|Participants Treated|Overall Study|Participants who took study drug|357
9692985|NCT00897104|10793102|FG002|Participants Treated|Overall Study|Participants who took study drug|80
9692986|NCT00897104|10793100|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63
9846912|NCT00851279|10959343|FG000|COMPLETED|Overall Study||53
9846913|NCT00851279|10959343|FG000|NOT COMPLETED|Overall Study||0
9846914|NCT00851318|10959351|FG000|STARTED|Overall Study||81
9846915|NCT00851318|10959352|FG001|STARTED|Overall Study||19
9846916|NCT00851318|10959353|FG002|STARTED|Overall Study||93
9846917|NCT00851318|10959354|FG003|STARTED|Overall Study||92
9846918|NCT00851318|10959351|FG000|Completed Week 24|Overall Study||69
9846919|NCT00851318|10959352|FG001|Completed Week 24|Overall Study||17
9846920|NCT00851318|10959353|FG002|Completed Week 24|Overall Study||90
9846921|NCT00851318|10959354|FG003|Completed Week 24|Overall Study||87
9692987|NCT00897104|10793101|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71
9692988|NCT00897104|10793102|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7
9692989|NCT00897104|10793100|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
9692990|NCT00897104|10793101|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
9692991|NCT00897104|10793102|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
9692992|NCT00897104|10793100|FG000|NOT COMPLETED|Overall Study||64
9692993|NCT00897104|10793101|FG001|NOT COMPLETED|Overall Study||71
9692994|NCT00897104|10793102|FG002|NOT COMPLETED|Overall Study||8
9692995|NCT00803790|10793112|FG000|STARTED|Period 1||125
9692996|NCT00803790|10793113|FG001|STARTED|Period 1||126
9692997|NCT00803790|10793114|FG002|STARTED|Period 1||32
9692998|NCT00803790|10793115|FG003|STARTED|Period 1||35
9692999|NCT00803790|10793112|FG000|COMPLETED|Period 1||116
9693000|NCT00803790|10793113|FG001|COMPLETED|Period 1||114
9693001|NCT00803790|10793114|FG002|COMPLETED|Period 1||31
9693002|NCT00803790|10793115|FG003|COMPLETED|Period 1||31
9693003|NCT00803790|10793112|FG000|NOT COMPLETED|Period 1||9
9693004|NCT00803790|10793113|FG001|NOT COMPLETED|Period 1||12
9693005|NCT00803790|10793114|FG002|NOT COMPLETED|Period 1||1
9693006|NCT00803790|10793115|FG003|NOT COMPLETED|Period 1||4
9693007|NCT00803790|10793112|FG000|STARTED|Period 2||116
9846922|NCT00851318|10959351|FG000|Completed Week 52|Overall Study||64
9846923|NCT00851318|10959352|FG001|Completed Week 52|Overall Study||16
9846924|NCT00851318|10959353|FG002|Completed Week 52|Overall Study||87
9846925|NCT00851318|10959354|FG003|Completed Week 52|Overall Study||85
10024923|NCT01867294|11148839|FG000|COMPLETED|Overall Study||8
10024924|NCT01867294|11148840|FG001|COMPLETED|Overall Study||9
10024925|NCT01867294|11148841|FG002|COMPLETED|Overall Study||0
10024926|NCT01867294|11148842|FG003|COMPLETED|Overall Study||0
10024927|NCT01867294|11148839|FG000|NOT COMPLETED|Overall Study||1
9693008|NCT00803790|10793113|FG001|STARTED|Period 2||114
9693009|NCT00803790|10793114|FG002|STARTED|Period 2||31
9693010|NCT00803790|10793115|FG003|STARTED|Period 2||31
9693011|NCT00803790|10793112|FG000|COMPLETED|Period 2||114
9693012|NCT00803790|10793113|FG001|COMPLETED|Period 2||114
9693013|NCT00803790|10793114|FG002|COMPLETED|Period 2||30
9693014|NCT00803790|10793115|FG003|COMPLETED|Period 2||30
9693015|NCT00803790|10793112|FG000|NOT COMPLETED|Period 2||2
9693016|NCT00803790|10793113|FG001|NOT COMPLETED|Period 2||0
9693017|NCT00803790|10793114|FG002|NOT COMPLETED|Period 2||1
9693018|NCT00803790|10793115|FG003|NOT COMPLETED|Period 2||1
9693019|NCT00725491|10793128|FG000|STARTED|Overall Study|Intent-to-Treat Group|113
9693020|NCT00725491|10793129|FG001|STARTED|Overall Study|Intent-to-Treat Group|120
9693021|NCT00725491|10793128|FG000|COMPLETED|Overall Study||104
9693022|NCT00725491|10793129|FG001|COMPLETED|Overall Study||102
9693023|NCT00725491|10793128|FG000|NOT COMPLETED|Overall Study||9
9693024|NCT00725491|10793129|FG001|NOT COMPLETED|Overall Study||18
9726998|NCT00104416|10826553|FG000|NOT COMPLETED|Continuation Phase||0
9846926|NCT00851318|10959351|FG000|COMPLETED|Overall Study||51
9846927|NCT00851318|10959352|FG001|COMPLETED|Overall Study||14
9846928|NCT00851318|10959353|FG002|COMPLETED|Overall Study||72
9846929|NCT00851318|10959354|FG003|COMPLETED|Overall Study||73
9846930|NCT00851318|10959351|FG000|NOT COMPLETED|Overall Study||30
9846931|NCT00851318|10959352|FG001|NOT COMPLETED|Overall Study||5
9846932|NCT00851318|10959353|FG002|NOT COMPLETED|Overall Study||21
9846933|NCT00851318|10959354|FG003|NOT COMPLETED|Overall Study||19
9846934|NCT00851357|10959367|FG000|STARTED|Overall Study||1200
9846935|NCT00851357|10959368|FG001|STARTED|Overall Study||1201
9846936|NCT00851357|10959369|FG002|STARTED|Overall Study||1799
9846937|NCT00851357|10959367|FG000|COMPLETED|Overall Study||1200
9846938|NCT00851357|10959368|FG001|COMPLETED|Overall Study||1201
9846939|NCT00851357|10959369|FG002|COMPLETED|Overall Study||1799
9846940|NCT00851357|10959367|FG000|NOT COMPLETED|Overall Study||0
9846941|NCT00851357|10959368|FG001|NOT COMPLETED|Overall Study||0
9846942|NCT00851357|10959369|FG002|NOT COMPLETED|Overall Study||0
9846943|NCT00851409|10959377|FG000|STARTED|Overall Study||25
9846944|NCT00851409|10959377|FG000|COMPLETED|Overall Study||25
9846945|NCT00851409|10959377|FG000|NOT COMPLETED|Overall Study||0
9846946|NCT00851630|10959384|FG000|STARTED|Overall Study||35
9846947|NCT00851630|10959385|FG001|STARTED|Overall Study||35
9846948|NCT00851630|10959384|FG000|COMPLETED|Overall Study||33
9846949|NCT00851630|10959385|FG001|COMPLETED|Overall Study||33
9846950|NCT00851630|10959384|FG000|NOT COMPLETED|Overall Study||2
9846951|NCT00851630|10959385|FG001|NOT COMPLETED|Overall Study||2
9846952|NCT00851643|10959397|FG000|STARTED|Base Study (Up to 12 Months)||15
9846953|NCT00851643|10959398|FG001|STARTED|Base Study (Up to 12 Months)||30
9846954|NCT00851643|10959399|FG002|STARTED|Base Study (Up to 12 Months)||30
9846955|NCT00851643|10959400|FG003|STARTED|Base Study (Up to 12 Months)||15
9846956|NCT00851643|10959401|FG004|STARTED|Base Study (Up to 12 Months)||30
10024928|NCT01867294|11148840|FG001|NOT COMPLETED|Overall Study||1
9726999|NCT00104416|10826554|FG001|NOT COMPLETED|Continuation Phase||0
9727000|NCT00104416|10826555|FG002|NOT COMPLETED|Continuation Phase||6
9727001|NCT00104416|10826556|FG003|NOT COMPLETED|Continuation Phase||2
9727002|NCT00104416|10826557|FG004|NOT COMPLETED|Continuation Phase||5
9727003|NCT00104520|10826571|FG000|STARTED|Overall Study||76
9727004|NCT00104520|10826572|FG001|STARTED|Overall Study||135
9846957|NCT00851643|10959402|FG005|STARTED|Base Study (Up to 12 Months)||30
9846958|NCT00851643|10959397|FG000|COMPLETED|Base Study (Up to 12 Months)||14
9846959|NCT00851643|10959398|FG001|COMPLETED|Base Study (Up to 12 Months)||30
9846960|NCT00851643|10959399|FG002|COMPLETED|Base Study (Up to 12 Months)||30
9846961|NCT00851643|10959400|FG003|COMPLETED|Base Study (Up to 12 Months)||15
9846962|NCT00851643|10959401|FG004|COMPLETED|Base Study (Up to 12 Months)||30
10024929|NCT01867294|11148841|FG002|NOT COMPLETED|Overall Study||0
10024930|NCT01867294|11148842|FG003|NOT COMPLETED|Overall Study||0
10024931|NCT01867307|11148852|FG000|STARTED|Overall Study|Started are the treated patients|18
10024932|NCT01867307|11148853|FG001|STARTED|Overall Study|Started are the treated patients|19
10024933|NCT01867307|11148852|FG000|COMPLETED|Overall Study||15
10024934|NCT01867307|11148853|FG001|COMPLETED|Overall Study||16
10024935|NCT01867307|11148852|FG000|NOT COMPLETED|Overall Study||3
10024936|NCT01867307|11148853|FG001|NOT COMPLETED|Overall Study||3
10024937|NCT01867424|11148861|FG000|STARTED|Overall Study||12
10024938|NCT01867424|11148862|FG001|STARTED|Overall Study||12
10024939|NCT01867424|11148861|FG000|COMPLETED|Overall Study||10
9961462|NCT01473940|11081214|FG000|COMPLETED|Maintenance Therapy||2
9961463|NCT01473940|11081215|FG001|COMPLETED|Maintenance Therapy||1
9961464|NCT01473940|11081216|FG002|COMPLETED|Maintenance Therapy||3
9961465|NCT01473940|11081217|FG003|COMPLETED|Maintenance Therapy||3
9961466|NCT01473940|11081214|FG000|NOT COMPLETED|Maintenance Therapy||1
9961467|NCT01473940|11081215|FG001|NOT COMPLETED|Maintenance Therapy||2
9961468|NCT01473940|11081216|FG002|NOT COMPLETED|Maintenance Therapy||1
9961469|NCT01473940|11081217|FG003|NOT COMPLETED|Maintenance Therapy||4
9961470|NCT01473940|11081214|FG000|STARTED|Follow-up Until Death||3
9961471|NCT01473940|11081215|FG001|STARTED|Follow-up Until Death||4
10024940|NCT01867424|11148862|FG001|COMPLETED|Overall Study||11
10024941|NCT01867424|11148861|FG000|NOT COMPLETED|Overall Study||2
10024942|NCT01867424|11148862|FG001|NOT COMPLETED|Overall Study||1
9961472|NCT01473940|11081216|FG002|STARTED|Follow-up Until Death||5
9961473|NCT01473940|11081217|FG003|STARTED|Follow-up Until Death||7
9961474|NCT01473940|11081214|FG000|COMPLETED|Follow-up Until Death||3
10024943|NCT01867515|11148871|FG000|STARTED|Overall Study||13
10024944|NCT01867515|11148872|FG001|STARTED|Overall Study||12
9693025|NCT00703014|10793137|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
9693026|NCT00703014|10793138|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
9693027|NCT00703014|10793139|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
9693028|NCT00703014|10793140|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
9693029|NCT00703014|10793137|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
9693030|NCT00703014|10793138|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
9693031|NCT00703014|10793139|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0
9693032|NCT00703014|10793140|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0
9693033|NCT00703014|10793137|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
9693034|NCT00703014|10793138|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
9693035|NCT00703014|10793139|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
9693036|NCT00703014|10793140|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
9693037|NCT00703014|10793137|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
9693038|NCT00703014|10793138|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
9693039|NCT00703014|10793139|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
9693040|NCT00703014|10793140|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
9693041|NCT00703014|10793137|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
9693042|NCT00703014|10793138|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
9693043|NCT00703014|10793139|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
9693044|NCT00703014|10793140|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
9693045|NCT00703014|10793137|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
9727005|NCT00104520|10826571|FG000|COMPLETED|Overall Study||26
9693046|NCT00703014|10793138|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
9693047|NCT00703014|10793139|FG002|STARTED|Mothers Follow Up Trial P05712||0
9693048|NCT00703014|10793140|FG003|STARTED|Mothers Follow Up Trial P05712||0
9693049|NCT00703014|10793137|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
9693050|NCT00703014|10793138|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
9693051|NCT00703014|10793139|FG002|COMPLETED|Mothers Follow Up Trial P05712||0
9693052|NCT00703014|10793140|FG003|COMPLETED|Mothers Follow Up Trial P05712||0
9693053|NCT00703014|10793137|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33
9693054|NCT00703014|10793138|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32
9693055|NCT00703014|10793139|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0
9693056|NCT00703014|10793140|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0
9693057|NCT00703014|10793137|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0
9693058|NCT00703014|10793138|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0
9693059|NCT00703014|10793139|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
9693060|NCT00703014|10793140|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
9693061|NCT00703014|10793137|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
9693062|NCT00703014|10793138|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
9846963|NCT00851643|10959402|FG005|COMPLETED|Base Study (Up to 12 Months)||29
9846964|NCT00851643|10959397|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1
9846965|NCT00851643|10959398|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0
9846966|NCT00851643|10959399|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0
9846967|NCT00851643|10959400|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0
9846968|NCT00851643|10959401|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0
9846969|NCT00851643|10959402|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1
9846970|NCT00851643|10959397|FG000|STARTED|Extension Study (Up to 36 Months)||10
9846971|NCT00851643|10959398|FG001|STARTED|Extension Study (Up to 36 Months)||19
9846972|NCT00851643|10959399|FG002|STARTED|Extension Study (Up to 36 Months)||19
9846973|NCT00851643|10959400|FG003|STARTED|Extension Study (Up to 36 Months)||7
9846974|NCT00851643|10959401|FG004|STARTED|Extension Study (Up to 36 Months)||21
9846975|NCT00851643|10959402|FG005|STARTED|Extension Study (Up to 36 Months)||15
9846976|NCT00851643|10959397|FG000|COMPLETED|Extension Study (Up to 36 Months)||6
9846977|NCT00851643|10959398|FG001|COMPLETED|Extension Study (Up to 36 Months)||15
9846978|NCT00851643|10959399|FG002|COMPLETED|Extension Study (Up to 36 Months)||14
9846979|NCT00851643|10959400|FG003|COMPLETED|Extension Study (Up to 36 Months)||5
9846980|NCT00851643|10959401|FG004|COMPLETED|Extension Study (Up to 36 Months)||19
9846981|NCT00851643|10959402|FG005|COMPLETED|Extension Study (Up to 36 Months)||14
9846982|NCT00851643|10959397|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4
9846983|NCT00851643|10959398|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4
9846984|NCT00851643|10959399|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5
9693063|NCT00703014|10793139|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
9693064|NCT00703014|10793140|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
9693065|NCT00703014|10793137|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
9961475|NCT01473940|11081215|FG001|COMPLETED|Follow-up Until Death||4
9693066|NCT00703014|10793138|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
9693067|NCT00703014|10793139|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
9693068|NCT00703014|10793140|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
9693069|NCT00703014|10793137|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
9693070|NCT00703014|10793138|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
9693071|NCT00703014|10793139|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
9693072|NCT00703014|10793140|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
9693073|NCT00702845|10793152|FG000|STARTED|Overall Study||268
9693074|NCT00702845|10793153|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129
9693075|NCT00702845|10793152|FG000|Randomized|Overall Study||268
9693076|NCT00702845|10793153|FG001|Randomized|Overall Study||128
9693077|NCT00702845|10793152|FG000|COMPLETED|Overall Study||246
9693078|NCT00702845|10793153|FG001|COMPLETED|Overall Study||121
9693079|NCT00702845|10793152|FG000|NOT COMPLETED|Overall Study||22
9693080|NCT00702845|10793153|FG001|NOT COMPLETED|Overall Study||8
9693081|NCT00702624|10793161|FG000|STARTED|Base Study P05690 (NCT00702845)||268
9693082|NCT00702624|10793162|FG001|STARTED|Base Study P05690 (NCT00702845)||128
9693083|NCT00702624|10793163|FG002|STARTED|Base Study P05690 (NCT00702845)||0
9693084|NCT00702624|10793164|FG003|STARTED|Base Study P05690 (NCT00702845)||0
9693085|NCT00702624|10793161|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
9693086|NCT00702624|10793162|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
9693087|NCT00702624|10793163|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0
9693088|NCT00702624|10793164|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0
9693089|NCT00702624|10793161|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
9693090|NCT00702624|10793162|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
9846985|NCT00851643|10959400|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2
9846986|NCT00851643|10959401|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2
9846987|NCT00851643|10959402|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1
9846988|NCT00851721|10959417|FG000|STARTED|Overall Study||19
9846989|NCT00851721|10959418|FG001|STARTED|Overall Study||17
9846990|NCT00851721|10959417|FG000|COMPLETED|Overall Study||17
9846991|NCT00851721|10959418|FG001|COMPLETED|Overall Study||16
9693091|NCT00702624|10793163|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
9693092|NCT00702624|10793164|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
9693093|NCT00702624|10793161|FG000|STARTED|Expectant Mother Follow-up||68
9693094|NCT00702624|10793162|FG001|STARTED|Expectant Mother Follow-up||45
9693095|NCT00702624|10793163|FG002|STARTED|Expectant Mother Follow-up||0
9693096|NCT00702624|10793164|FG003|STARTED|Expectant Mother Follow-up||0
9693097|NCT00702624|10793161|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
9693098|NCT00702624|10793162|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
9693099|NCT00702624|10793163|FG002|COMPLETED|Expectant Mother Follow-up||0
9693100|NCT00702624|10793164|FG003|COMPLETED|Expectant Mother Follow-up||0
9693101|NCT00702624|10793161|FG000|NOT COMPLETED|Expectant Mother Follow-up||7
9693102|NCT00702624|10793162|FG001|NOT COMPLETED|Expectant Mother Follow-up||0
9693103|NCT00702624|10793163|FG002|NOT COMPLETED|Expectant Mother Follow-up||0
9693104|NCT00702624|10793164|FG003|NOT COMPLETED|Expectant Mother Follow-up||0
9693105|NCT00702624|10793161|FG000|STARTED|Fetuses/Infant Follow-up||0
9693106|NCT00702624|10793162|FG001|STARTED|Fetuses/Infant Follow-up||0
9693107|NCT00702624|10793163|FG002|STARTED|Fetuses/Infant Follow-up||88
9693108|NCT00702624|10793164|FG003|STARTED|Fetuses/Infant Follow-up||55
9693109|NCT00702624|10793161|FG000|Live Born Infants|Fetuses/Infant Follow-up||0
9693110|NCT00702624|10793162|FG001|Live Born Infants|Fetuses/Infant Follow-up||0
9693111|NCT00702624|10793163|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
9693112|NCT00702624|10793164|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
9693113|NCT00702624|10793161|FG000|COMPLETED|Fetuses/Infant Follow-up||0
9693114|NCT00702624|10793162|FG001|COMPLETED|Fetuses/Infant Follow-up||0
9693115|NCT00702624|10793163|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
9693116|NCT00702624|10793164|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
9693117|NCT00702624|10793161|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0
9693118|NCT00702624|10793162|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0
9693119|NCT00702624|10793163|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10
9693120|NCT00702624|10793164|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0
9693121|NCT00702546|10793179|FG000|STARTED|Base Study P05690 (NCT00702845)||268
9693122|NCT00702546|10793180|FG001|STARTED|Base Study P05690 (NCT00702845)||128
9693123|NCT00702546|10793179|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
9693124|NCT00702546|10793180|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
9693125|NCT00702546|10793179|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
9693126|NCT00702546|10793180|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
9693127|NCT00702546|10793179|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
9693128|NCT00702546|10793180|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
9693129|NCT00702546|10793179|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
9961476|NCT01473940|11081216|FG002|COMPLETED|Follow-up Until Death||5
9961477|NCT01473940|11081217|FG003|COMPLETED|Follow-up Until Death||7
10024945|NCT01867515|11148873|FG002|STARTED|Overall Study||25
10024946|NCT01867515|11148871|FG000|COMPLETED|Overall Study||13
10024947|NCT01867515|11148872|FG001|COMPLETED|Overall Study||11
10024948|NCT01867515|11148873|FG002|COMPLETED|Overall Study||14
10024949|NCT01867515|11148871|FG000|NOT COMPLETED|Overall Study||0
9961478|NCT01473940|11081214|FG000|NOT COMPLETED|Follow-up Until Death||0
9961479|NCT01473940|11081215|FG001|NOT COMPLETED|Follow-up Until Death||0
9961480|NCT01473940|11081216|FG002|NOT COMPLETED|Follow-up Until Death||0
9961481|NCT01473940|11081217|FG003|NOT COMPLETED|Follow-up Until Death||0
9961482|NCT01473953|11081235|FG000|STARTED|Overall Study||6
9961483|NCT01473953|11081236|FG001|STARTED|Overall Study||6
9961484|NCT01473953|11081237|FG002|STARTED|Overall Study||6
9961485|NCT01473953|11081238|FG003|STARTED|Overall Study||5
9961486|NCT01473953|11081239|FG004|STARTED|Overall Study||8
9961487|NCT01473953|11081235|FG000|COMPLETED|Overall Study||5
9961488|NCT01473953|11081236|FG001|COMPLETED|Overall Study||6
9961489|NCT01473953|11081237|FG002|COMPLETED|Overall Study||6
9961490|NCT01473953|11081238|FG003|COMPLETED|Overall Study||5
9961491|NCT01473953|11081239|FG004|COMPLETED|Overall Study||8
9961492|NCT01473953|11081235|FG000|NOT COMPLETED|Overall Study||1
10024950|NCT01867515|11148872|FG001|NOT COMPLETED|Overall Study||1
10024951|NCT01867515|11148873|FG002|NOT COMPLETED|Overall Study||11
10024952|NCT01867580|11148883|FG000|STARTED|Overall Study||93
10024953|NCT01867580|11148884|FG001|STARTED|Overall Study||88
10024954|NCT01867580|11148883|FG000|COMPLETED|Overall Study||65
10024955|NCT01867580|11148884|FG001|COMPLETED|Overall Study||64
10024956|NCT01867580|11148883|FG000|NOT COMPLETED|Overall Study||28
10024957|NCT01867580|11148884|FG001|NOT COMPLETED|Overall Study||24
10024958|NCT01867632|11148892|FG000|STARTED|Overall Study||65
10024959|NCT01867632|11148893|FG001|STARTED|Overall Study||66
10024960|NCT01867632|11148892|FG000|COMPLETED|Overall Study||65
10024961|NCT01867632|11148893|FG001|COMPLETED|Overall Study||66
10024962|NCT01867632|11148892|FG000|NOT COMPLETED|Overall Study||0
10024963|NCT01867632|11148893|FG001|NOT COMPLETED|Overall Study||0
10024964|NCT01867658|11148899|FG000|STARTED|Overall Study||112
10024965|NCT01867658|11148899|FG000|COMPLETED|Overall Study||103
10024966|NCT01867658|11148899|FG000|NOT COMPLETED|Overall Study||9
10081205|NCT02258477|11209685|FG000|COMPLETED|First Intervention (1 Week)||9
10081206|NCT02258477|11209686|FG001|COMPLETED|First Intervention (1 Week)||8
10081207|NCT02258477|11209687|FG002|COMPLETED|First Intervention (1 Week)||9
10081208|NCT02258477|11209688|FG003|COMPLETED|First Intervention (1 Week)||9
10081209|NCT02258477|11209685|FG000|NOT COMPLETED|First Intervention (1 Week)||1
10081210|NCT02258477|11209686|FG001|NOT COMPLETED|First Intervention (1 Week)||1
10081211|NCT02258477|11209687|FG002|NOT COMPLETED|First Intervention (1 Week)||0
10081212|NCT02258477|11209688|FG003|NOT COMPLETED|First Intervention (1 Week)||0
10081213|NCT02258477|11209685|FG000|STARTED|Second Intervention (1 Week)||9
10081214|NCT02258477|11209686|FG001|STARTED|Second Intervention (1 Week)||8
10081215|NCT02258477|11209687|FG002|STARTED|Second Intervention (1 Week)||9
10081216|NCT02258477|11209688|FG003|STARTED|Second Intervention (1 Week)||9
10081217|NCT02258477|11209685|FG000|COMPLETED|Second Intervention (1 Week)||9
10081218|NCT02258477|11209686|FG001|COMPLETED|Second Intervention (1 Week)||8
10081219|NCT02258477|11209687|FG002|COMPLETED|Second Intervention (1 Week)||8
10081220|NCT02258477|11209688|FG003|COMPLETED|Second Intervention (1 Week)||8
10081221|NCT02258477|11209685|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10081222|NCT02258477|11209686|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10081223|NCT02258477|11209687|FG002|NOT COMPLETED|Second Intervention (1 Week)||1
10081224|NCT02258477|11209688|FG003|NOT COMPLETED|Second Intervention (1 Week)||1
10081225|NCT02258477|11209685|FG000|STARTED|Third Intervention (1 Week)||9
10081226|NCT02258477|11209686|FG001|STARTED|Third Intervention (1 Week)||8
10081227|NCT02258477|11209687|FG002|STARTED|Third Intervention (1 Week)||8
10081228|NCT02258477|11209688|FG003|STARTED|Third Intervention (1 Week)||8
10081229|NCT02258477|11209685|FG000|COMPLETED|Third Intervention (1 Week)||9
10081230|NCT02258477|11209686|FG001|COMPLETED|Third Intervention (1 Week)||8
10081231|NCT02258477|11209687|FG002|COMPLETED|Third Intervention (1 Week)||8
10081232|NCT02258477|11209688|FG003|COMPLETED|Third Intervention (1 Week)||8
10081233|NCT02258477|11209685|FG000|NOT COMPLETED|Third Intervention (1 Week)||0
10081234|NCT02258477|11209686|FG001|NOT COMPLETED|Third Intervention (1 Week)||0
10081235|NCT02258477|11209687|FG002|NOT COMPLETED|Third Intervention (1 Week)||0
10081236|NCT02258477|11209688|FG003|NOT COMPLETED|Third Intervention (1 Week)||0
10081237|NCT02258477|11209685|FG000|STARTED|Fourth Intervention (1 Week)||9
10081238|NCT02258477|11209686|FG001|STARTED|Fourth Intervention (1 Week)||8
9693130|NCT00702546|10793180|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
9693131|NCT00702546|10793179|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
9693132|NCT00702546|10793180|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
10081239|NCT02258477|11209687|FG002|STARTED|Fourth Intervention (1 Week)||8
10081240|NCT02258477|11209688|FG003|STARTED|Fourth Intervention (1 Week)||8
10081241|NCT02258477|11209685|FG000|COMPLETED|Fourth Intervention (1 Week)||9
10081242|NCT02258477|11209686|FG001|COMPLETED|Fourth Intervention (1 Week)||8
10081243|NCT02258477|11209687|FG002|COMPLETED|Fourth Intervention (1 Week)||8
10081244|NCT02258477|11209688|FG003|COMPLETED|Fourth Intervention (1 Week)||8
10081245|NCT02258477|11209685|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0
9693133|NCT00702520|10793188|FG000|STARTED|Base Study P05788 - Assigned Treatment||25
9693134|NCT00702520|10793189|FG001|STARTED|Base Study P05788 - Assigned Treatment||25
9693135|NCT00702520|10793190|FG002|STARTED|Base Study P05788 - Assigned Treatment||0
9693136|NCT00702520|10793191|FG003|STARTED|Base Study P05788 - Assigned Treatment||0
9693137|NCT00702520|10793188|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
9693138|NCT00702520|10793189|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
9693139|NCT00702520|10793190|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
9693140|NCT00702520|10793191|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
9693141|NCT00702520|10793188|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
9693142|NCT00702520|10793189|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
9693143|NCT00702520|10793190|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
9693144|NCT00702520|10793191|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
9693145|NCT00702520|10793188|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25
9693146|NCT00702520|10793189|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24
9693147|NCT00702520|10793190|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0
9693148|NCT00702520|10793191|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0
9693149|NCT00702520|10793188|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
9693150|NCT00702520|10793189|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
9693151|NCT00702520|10793190|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
9693152|NCT00702520|10793191|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
9693153|NCT00702520|10793188|FG000|STARTED|Base Study P05788 - Embryo Transfer||25
9693154|NCT00702520|10793189|FG001|STARTED|Base Study P05788 - Embryo Transfer||24
9693155|NCT00702520|10793190|FG002|STARTED|Base Study P05788 - Embryo Transfer||0
9693156|NCT00702520|10793191|FG003|STARTED|Base Study P05788 - Embryo Transfer||0
9693157|NCT00702520|10793188|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
9693158|NCT00702520|10793189|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
9693159|NCT00702520|10793190|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
9693160|NCT00702520|10793191|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
9693161|NCT00702520|10793188|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22
9693162|NCT00702520|10793189|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18
9693163|NCT00702520|10793190|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0
9693164|NCT00702520|10793191|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0
9693165|NCT00702520|10793188|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
9693166|NCT00702520|10793189|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
9693167|NCT00702520|10793190|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
9693168|NCT00702520|10793191|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
9693169|NCT00702520|10793188|FG000|STARTED|Base Study P05788 - Follow-Up||22
9693170|NCT00702520|10793189|FG001|STARTED|Base Study P05788 - Follow-Up||18
9693171|NCT00702520|10793190|FG002|STARTED|Base Study P05788 - Follow-Up||0
9693172|NCT00702520|10793191|FG003|STARTED|Base Study P05788 - Follow-Up||0
9693173|NCT00702520|10793188|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
9693174|NCT00702520|10793189|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
9693175|NCT00702520|10793190|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
9693176|NCT00702520|10793191|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
9693177|NCT00702520|10793188|FG000|COMPLETED|Base Study P05788 - Follow-Up||7
9693178|NCT00702520|10793189|FG001|COMPLETED|Base Study P05788 - Follow-Up||8
9693179|NCT00702520|10793190|FG002|COMPLETED|Base Study P05788 - Follow-Up||0
9693180|NCT00702520|10793191|FG003|COMPLETED|Base Study P05788 - Follow-Up||0
9693181|NCT00702520|10793188|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15
9693182|NCT00702520|10793189|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10
9693183|NCT00702520|10793190|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0
9693184|NCT00702520|10793191|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0
9693185|NCT00702520|10793188|FG000|STARTED|Follow-up Study P05783||7
9693186|NCT00702520|10793189|FG001|STARTED|Follow-up Study P05783||8
9693187|NCT00702520|10793190|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
9693188|NCT00702520|10793191|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
9693189|NCT00702520|10793188|FG000|COMPLETED|Follow-up Study P05783||7
9846992|NCT00851721|10959417|FG000|NOT COMPLETED|Overall Study||2
9846993|NCT00851721|10959418|FG001|NOT COMPLETED|Overall Study||1
9961493|NCT01473953|11081236|FG001|NOT COMPLETED|Overall Study||0
9846994|NCT00851786|10959432|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
9846995|NCT00851786|10959433|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
9846996|NCT00851786|10959432|FG000|COMPLETED|Overall Study||291
10114530|NCT02517047|11245288|FG000|STARTED|Overall Study||26
10114531|NCT02517047|11245288|FG000|COMPLETED|Overall Study||24
10114532|NCT02517047|11245288|FG000|NOT COMPLETED|Overall Study||2
10114533|NCT02517268|11245295|FG000|STARTED|Overall Study||40
10114534|NCT02517268|11245296|FG001|STARTED|Overall Study||37
10114535|NCT02517268|11245295|FG000|COMPLETED|Overall Study||39
10114536|NCT02517268|11245296|FG001|COMPLETED|Overall Study||37
10114537|NCT02517268|11245295|FG000|NOT COMPLETED|Overall Study||1
10114538|NCT02517268|11245296|FG001|NOT COMPLETED|Overall Study||0
10114539|NCT02517463|11245304|FG000|STARTED|Overall Study||369
9693190|NCT00702520|10793189|FG001|COMPLETED|Follow-up Study P05783||8
9693191|NCT00702520|10793190|FG002|COMPLETED|Follow-up Study P05783||8
9846997|NCT00851786|10959433|FG001|COMPLETED|Overall Study||97
9846998|NCT00851786|10959432|FG000|NOT COMPLETED|Overall Study||5
9846999|NCT00851786|10959433|FG001|NOT COMPLETED|Overall Study||2
9847000|NCT00851799|10959442|FG000|STARTED|Overall Study||109
9847001|NCT00851799|10959443|FG001|STARTED|Overall Study||106
9847002|NCT00851799|10959444|FG002|STARTED|Overall Study||113
9847003|NCT00851799|10959442|FG000|COMPLETED|Overall Study||93
9847004|NCT00851799|10959443|FG001|COMPLETED|Overall Study||93
9847005|NCT00851799|10959444|FG002|COMPLETED|Overall Study||89
9847006|NCT00851799|10959442|FG000|NOT COMPLETED|Overall Study||16
9847007|NCT00851799|10959443|FG001|NOT COMPLETED|Overall Study||13
9847008|NCT00851799|10959444|FG002|NOT COMPLETED|Overall Study||24
9847009|NCT00851877|10959452|FG000|STARTED|Phase I-1||7
9847010|NCT00851877|10959453|FG001|STARTED|Phase I-1||0
9847011|NCT00851877|10959454|FG002|STARTED|Phase I-1||0
9847012|NCT00851877|10959452|FG000|COMPLETED|Phase I-1||6
9847013|NCT00851877|10959453|FG001|COMPLETED|Phase I-1||0
9847014|NCT00851877|10959454|FG002|COMPLETED|Phase I-1||0
9847015|NCT00851877|10959452|FG000|NOT COMPLETED|Phase I-1||1
9847016|NCT00851877|10959453|FG001|NOT COMPLETED|Phase I-1||0
9847017|NCT00851877|10959454|FG002|NOT COMPLETED|Phase I-1||0
9847018|NCT00851877|10959452|FG000|STARTED|Phase I-2||0
9847019|NCT00851877|10959453|FG001|STARTED|Phase I-2||5
9847020|NCT00851877|10959454|FG002|STARTED|Phase I-2||0
9847021|NCT00851877|10959452|FG000|COMPLETED|Phase I-2||0
9847022|NCT00851877|10959453|FG001|COMPLETED|Phase I-2||5
9847023|NCT00851877|10959454|FG002|COMPLETED|Phase I-2||0
9847024|NCT00851877|10959452|FG000|NOT COMPLETED|Phase I-2||0
9693192|NCT00702520|10793191|FG003|COMPLETED|Follow-up Study P05783||11
9693193|NCT00702520|10793188|FG000|NOT COMPLETED|Follow-up Study P05783||0
9693194|NCT00702520|10793189|FG001|NOT COMPLETED|Follow-up Study P05783||0
9693195|NCT00702520|10793190|FG002|NOT COMPLETED|Follow-up Study P05783||0
9693196|NCT00702520|10793191|FG003|NOT COMPLETED|Follow-up Study P05783||0
9693197|NCT00702338|10793201|FG000|STARTED|Base Study (NCT00697255)||5
9693198|NCT00702338|10793202|FG001|STARTED|Base Study (NCT00697255)||3
9693199|NCT00702338|10793203|FG002|STARTED|Base Study (NCT00697255)||0
9693200|NCT00702338|10793201|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
9693201|NCT00702338|10793202|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
9693202|NCT00702338|10793203|FG002|COMPLETED|Base Study (NCT00697255)||0
9693203|NCT00702338|10793201|FG000|NOT COMPLETED|Base Study (NCT00697255)||3
9693204|NCT00702338|10793202|FG001|NOT COMPLETED|Base Study (NCT00697255)||2
9693205|NCT00702338|10793203|FG002|NOT COMPLETED|Base Study (NCT00697255)||0
9693206|NCT00702338|10793201|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
9693207|NCT00702338|10793202|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
9693208|NCT00702338|10793203|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0
9693209|NCT00702338|10793201|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0
9693210|NCT00702338|10793202|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
9693211|NCT00702338|10793203|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0
9693212|NCT00702338|10793201|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
9693213|NCT00702338|10793202|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
9693214|NCT00702338|10793203|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
9693215|NCT00702338|10793201|FG000|STARTED|Follow-up Study: Infant FU||0
9693216|NCT00702338|10793202|FG001|STARTED|Follow-up Study: Infant FU||0
9693217|NCT00702338|10793203|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
9693218|NCT00702338|10793201|FG000|COMPLETED|Follow-up Study: Infant FU||0
9693219|NCT00702338|10793202|FG001|COMPLETED|Follow-up Study: Infant FU||0
9693220|NCT00702338|10793203|FG002|COMPLETED|Follow-up Study: Infant FU||0
9847025|NCT00851877|10959453|FG001|NOT COMPLETED|Phase I-2||0
9847026|NCT00851877|10959454|FG002|NOT COMPLETED|Phase I-2||0
9847027|NCT00851877|10959452|FG000|STARTED|Phase II||0
9847028|NCT00851877|10959453|FG001|STARTED|Phase II||0
9847029|NCT00851877|10959454|FG002|STARTED|Phase II||25
9847030|NCT00851877|10959452|FG000|COMPLETED|Phase II||0
9847031|NCT00851877|10959453|FG001|COMPLETED|Phase II||0
9693221|NCT00702338|10793201|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0
9693222|NCT00702338|10793202|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0
9693223|NCT00702338|10793203|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2
9693224|NCT00702273|10793213|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
9693225|NCT00702273|10793214|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
9693226|NCT00702273|10793213|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
9693227|NCT00702273|10793214|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
9693228|NCT00702273|10793213|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
9693229|NCT00702273|10793214|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
9693230|NCT00702273|10793213|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
9693231|NCT00702273|10793214|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
9693232|NCT00702273|10793213|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
9693233|NCT00702273|10793214|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
9693234|NCT00702273|10793213|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
9693235|NCT00702273|10793214|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
9693236|NCT00702273|10793213|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
9693237|NCT00702273|10793214|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
9693238|NCT00702234|10793220|FG000|STARTED|Base Study (NCT00696878)||682
9693239|NCT00702234|10793221|FG001|STARTED|Base Study (NCT00696878)||0
9693240|NCT00702234|10793220|FG000|COMPLETED|Base Study (NCT00696878)||178
9693241|NCT00702234|10793221|FG001|COMPLETED|Base Study (NCT00696878)||0
9693242|NCT00702234|10793220|FG000|NOT COMPLETED|Base Study (NCT00696878)||504
9693243|NCT00702234|10793221|FG001|NOT COMPLETED|Base Study (NCT00696878)||0
9693244|NCT00702234|10793220|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
9693245|NCT00702234|10793221|FG001|STARTED|Follow-up Study: Expectant Mothers||0
9693246|NCT00702234|10793220|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246
9693247|NCT00702234|10793221|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0
9693248|NCT00702234|10793220|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
9693249|NCT00702234|10793221|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
9693250|NCT00702234|10793220|FG000|STARTED|Follow-up Study: Fetuses/Infants||0
9693251|NCT00702234|10793221|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
9693252|NCT00702234|10793220|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0
9693253|NCT00702234|10793221|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
9693254|NCT00702234|10793220|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0
9693255|NCT00702234|10793221|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
9693256|NCT00702234|10793220|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
9693257|NCT00702234|10793221|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
9693258|NCT00697255|10793230|FG000|STARTED|Stage 1a||5
9693259|NCT00697255|10793231|FG001|STARTED|Stage 1a||0
9693260|NCT00697255|10793230|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
9693261|NCT00697255|10793231|FG001|COMPLETED|Stage 1a||0
9693262|NCT00697255|10793230|FG000|NOT COMPLETED|Stage 1a||3
9693263|NCT00697255|10793231|FG001|NOT COMPLETED|Stage 1a||0
9693264|NCT00697255|10793230|FG000|STARTED|Stage 1b||0
9693265|NCT00697255|10793231|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
9693266|NCT00697255|10793230|FG000|COMPLETED|Stage 1b||0
9693267|NCT00697255|10793231|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
9693268|NCT00697255|10793230|FG000|NOT COMPLETED|Stage 1b||0
9693269|NCT00697255|10793231|FG001|NOT COMPLETED|Stage 1b||2
9693270|NCT00696878|10793237|FG000|STARTED|Overall Study||682
9693271|NCT00696878|10793237|FG000|COMPLETED|Overall Study||178
9693272|NCT00696878|10793237|FG000|NOT COMPLETED|Overall Study||504
9693273|NCT00696800|10793243|FG000|STARTED|Overall Study||757
9693274|NCT00696800|10793244|FG001|STARTED|Overall Study||752
9693275|NCT00696800|10793243|FG000|Treated (ITT)|Overall Study|The ITT group|756
9847032|NCT00851877|10959454|FG002|COMPLETED|Phase II||22
9847033|NCT00851877|10959452|FG000|NOT COMPLETED|Phase II||0
9847034|NCT00851877|10959453|FG001|NOT COMPLETED|Phase II||0
9847035|NCT00851877|10959454|FG002|NOT COMPLETED|Phase II||3
9693276|NCT00696800|10793244|FG001|Treated (ITT)|Overall Study|The ITT group|750
9693277|NCT00696800|10793243|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672
9693278|NCT00696800|10793244|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704
9693279|NCT00696800|10793243|FG000|NOT COMPLETED|Overall Study||85
9693280|NCT00696800|10793244|FG001|NOT COMPLETED|Overall Study||48
9693281|NCT00616967|10793252|FG000|STARTED|Overall Study||6
9693282|NCT00616967|10793253|FG001|STARTED|Overall Study||31
9693283|NCT00616967|10793254|FG002|STARTED|Overall Study||31
9693284|NCT00616967|10793252|FG000|COMPLETED|Overall Study||6
9693285|NCT00616967|10793253|FG001|COMPLETED|Overall Study||31
9693286|NCT00616967|10793254|FG002|COMPLETED|Overall Study||30
9693287|NCT00616967|10793252|FG000|NOT COMPLETED|Overall Study||0
9693288|NCT00616967|10793253|FG001|NOT COMPLETED|Overall Study||0
9693289|NCT00616967|10793254|FG002|NOT COMPLETED|Overall Study||1
9693290|NCT00461032|10793274|FG000|STARTED|Overall Study||582
9693291|NCT00461032|10793275|FG001|STARTED|Overall Study||580
9693292|NCT00461032|10793274|FG000|COMPLETED|Overall Study||545
9693293|NCT00461032|10793275|FG001|COMPLETED|Overall Study||536
9693294|NCT00461032|10793274|FG000|NOT COMPLETED|Overall Study||37
9693295|NCT00461032|10793275|FG001|NOT COMPLETED|Overall Study||44
9693296|NCT00442338|10793284|FG000|STARTED|Overall Study||30
9693297|NCT00442338|10793285|FG001|STARTED|Overall Study||30
9693298|NCT00442338|10793286|FG002|STARTED|Overall Study||31
9693299|NCT00442338|10793284|FG000|COMPLETED|Overall Study||30
9693300|NCT00442338|10793285|FG001|COMPLETED|Overall Study||30
9693301|NCT00442338|10793286|FG002|COMPLETED|Overall Study||31
9693302|NCT00442338|10793284|FG000|NOT COMPLETED|Overall Study||0
9693303|NCT00442338|10793285|FG001|NOT COMPLETED|Overall Study||0
9693304|NCT00442338|10793286|FG002|NOT COMPLETED|Overall Study||0
9693305|NCT00289874|10793296|FG000|STARTED|Overall Study||203
9693306|NCT00289874|10793297|FG001|STARTED|Overall Study||218
9693307|NCT00289874|10793296|FG000|COMPLETED|Overall Study||197
9693308|NCT00289874|10793297|FG001|COMPLETED|Overall Study||210
9693309|NCT00289874|10793296|FG000|NOT COMPLETED|Overall Study||6
9693310|NCT00289874|10793297|FG001|NOT COMPLETED|Overall Study||8
9693311|NCT00250458|10793305|FG000|STARTED|Overall Study||232
9693312|NCT00250458|10793306|FG001|STARTED|Overall Study||114
9693313|NCT00250458|10793305|FG000|COMPLETED|Overall Study||200
9693314|NCT00250458|10793306|FG001|COMPLETED|Overall Study||97
9693315|NCT00250458|10793305|FG000|NOT COMPLETED|Overall Study||32
9693316|NCT00250458|10793306|FG001|NOT COMPLETED|Overall Study||17
9693317|NCT00245570|10793312|FG000|STARTED|Treatment Period II||7
9693318|NCT00245570|10793313|FG001|STARTED|Treatment Period II||8
9693319|NCT00245570|10793314|FG002|STARTED|Treatment Period II||8
9693320|NCT00245570|10793315|FG003|STARTED|Treatment Period II||8
9693321|NCT00245570|10793316|FG004|STARTED|Treatment Period II||8
9693322|NCT00245570|10793317|FG005|STARTED|Treatment Period II||8
9693323|NCT00245570|10793312|FG000|COMPLETED|Treatment Period II||7
9693324|NCT00245570|10793313|FG001|COMPLETED|Treatment Period II||8
9693325|NCT00245570|10793314|FG002|COMPLETED|Treatment Period II||8
9693326|NCT00245570|10793315|FG003|COMPLETED|Treatment Period II||8
9693327|NCT00245570|10793316|FG004|COMPLETED|Treatment Period II||8
9693328|NCT00245570|10793317|FG005|COMPLETED|Treatment Period II||8
9693329|NCT00245570|10793312|FG000|NOT COMPLETED|Treatment Period II||0
9693330|NCT00245570|10793313|FG001|NOT COMPLETED|Treatment Period II||0
9693331|NCT00245570|10793314|FG002|NOT COMPLETED|Treatment Period II||0
9693332|NCT00245570|10793315|FG003|NOT COMPLETED|Treatment Period II||0
9693333|NCT00245570|10793316|FG004|NOT COMPLETED|Treatment Period II||0
9693334|NCT00245570|10793317|FG005|NOT COMPLETED|Treatment Period II||0
9693335|NCT00245570|10793312|FG000|STARTED|Washout Between Periods II and III||7
9693336|NCT00245570|10793313|FG001|STARTED|Washout Between Periods II and III||8
9693337|NCT00245570|10793314|FG002|STARTED|Washout Between Periods II and III||8
9693338|NCT00245570|10793315|FG003|STARTED|Washout Between Periods II and III||8
9693339|NCT00245570|10793316|FG004|STARTED|Washout Between Periods II and III||8
9693340|NCT00245570|10793317|FG005|STARTED|Washout Between Periods II and III||8
9847036|NCT00851890|10959464|FG000|STARTED|Overall Study||8
9847037|NCT00851890|10959465|FG001|STARTED|Overall Study||8
9693341|NCT00245570|10793312|FG000|COMPLETED|Washout Between Periods II and III||7
9693342|NCT00245570|10793313|FG001|COMPLETED|Washout Between Periods II and III||8
9693343|NCT00245570|10793314|FG002|COMPLETED|Washout Between Periods II and III||8
9693344|NCT00245570|10793315|FG003|COMPLETED|Washout Between Periods II and III||8
9693345|NCT00245570|10793316|FG004|COMPLETED|Washout Between Periods II and III||8
9693346|NCT00245570|10793317|FG005|COMPLETED|Washout Between Periods II and III||8
9693347|NCT00245570|10793312|FG000|NOT COMPLETED|Washout Between Periods II and III||0
9693348|NCT00245570|10793313|FG001|NOT COMPLETED|Washout Between Periods II and III||0
9693349|NCT00245570|10793314|FG002|NOT COMPLETED|Washout Between Periods II and III||0
9693350|NCT00245570|10793315|FG003|NOT COMPLETED|Washout Between Periods II and III||0
9693351|NCT00245570|10793316|FG004|NOT COMPLETED|Washout Between Periods II and III||0
9693352|NCT00245570|10793317|FG005|NOT COMPLETED|Washout Between Periods II and III||0
9693353|NCT00245570|10793312|FG000|STARTED|Treatment Period III||7
9693354|NCT00245570|10793313|FG001|STARTED|Treatment Period III||8
9693355|NCT00245570|10793314|FG002|STARTED|Treatment Period III||8
9693356|NCT00245570|10793315|FG003|STARTED|Treatment Period III||8
9693357|NCT00245570|10793316|FG004|STARTED|Treatment Period III||8
9693358|NCT00245570|10793317|FG005|STARTED|Treatment Period III||8
9693359|NCT00245570|10793312|FG000|COMPLETED|Treatment Period III||7
9693360|NCT00245570|10793313|FG001|COMPLETED|Treatment Period III||8
9693361|NCT00245570|10793314|FG002|COMPLETED|Treatment Period III||8
9693362|NCT00245570|10793315|FG003|COMPLETED|Treatment Period III||8
9693363|NCT00245570|10793316|FG004|COMPLETED|Treatment Period III||8
9693364|NCT00245570|10793317|FG005|COMPLETED|Treatment Period III||8
9693365|NCT00245570|10793312|FG000|NOT COMPLETED|Treatment Period III||0
9693366|NCT00245570|10793313|FG001|NOT COMPLETED|Treatment Period III||0
9693367|NCT00245570|10793314|FG002|NOT COMPLETED|Treatment Period III||0
9693368|NCT00245570|10793315|FG003|NOT COMPLETED|Treatment Period III||0
9693369|NCT00245570|10793316|FG004|NOT COMPLETED|Treatment Period III||0
9693370|NCT00245570|10793317|FG005|NOT COMPLETED|Treatment Period III||0
9693371|NCT00245570|10793312|FG000|STARTED|Washout Between Periods III and IV||7
9693372|NCT00245570|10793313|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
9693373|NCT00245570|10793314|FG002|STARTED|Washout Between Periods III and IV||8
9693374|NCT00245570|10793315|FG003|STARTED|Washout Between Periods III and IV||8
9693375|NCT00245570|10793316|FG004|STARTED|Washout Between Periods III and IV||8
9693376|NCT00245570|10793317|FG005|STARTED|Washout Between Periods III and IV||8
9693377|NCT00245570|10793312|FG000|COMPLETED|Washout Between Periods III and IV||7
9693378|NCT00245570|10793313|FG001|COMPLETED|Washout Between Periods III and IV||7
9693379|NCT00245570|10793314|FG002|COMPLETED|Washout Between Periods III and IV||8
9693380|NCT00245570|10793315|FG003|COMPLETED|Washout Between Periods III and IV||8
9693381|NCT00245570|10793316|FG004|COMPLETED|Washout Between Periods III and IV||8
9693382|NCT00245570|10793317|FG005|COMPLETED|Washout Between Periods III and IV||8
9693383|NCT00245570|10793312|FG000|NOT COMPLETED|Washout Between Periods III and IV||0
9693384|NCT00245570|10793313|FG001|NOT COMPLETED|Washout Between Periods III and IV||1
9693385|NCT00245570|10793314|FG002|NOT COMPLETED|Washout Between Periods III and IV||0
9693386|NCT00245570|10793315|FG003|NOT COMPLETED|Washout Between Periods III and IV||0
9693387|NCT00245570|10793316|FG004|NOT COMPLETED|Washout Between Periods III and IV||0
10024967|NCT01867671|11148905|FG000|STARTED|Overall Study||96
10024968|NCT01867671|11148906|FG001|STARTED|Overall Study||50
10024969|NCT01867671|11148905|FG000|COMPLETED|Overall Study||67
10024970|NCT01867671|11148906|FG001|COMPLETED|Overall Study||22
10024971|NCT01867671|11148905|FG000|NOT COMPLETED|Overall Study||29
10024972|NCT01867671|11148906|FG001|NOT COMPLETED|Overall Study||28
10024973|NCT01867710|11148916|FG000|STARTED|Overall Study||41
9693388|NCT00245570|10793317|FG005|NOT COMPLETED|Washout Between Periods III and IV||0
9693389|NCT00245570|10793312|FG000|STARTED|Treatment Period IV||7
10024974|NCT01867710|11148917|FG001|STARTED|Overall Study||41
10024975|NCT01867710|11148918|FG002|STARTED|Overall Study||40
10024976|NCT01867710|11148919|FG003|STARTED|Overall Study||42
10024977|NCT01867710|11148916|FG000|Treated|Overall Study||41
10024978|NCT01867710|11148917|FG001|Treated|Overall Study||41
10024979|NCT01867710|11148918|FG002|Treated|Overall Study||39
9847038|NCT00851890|10959466|FG002|STARTED|Overall Study||8
10024980|NCT01867710|11148919|FG003|Treated|Overall Study||42
10024981|NCT01867710|11148916|FG000|COMPLETED|Overall Study||0
10024982|NCT01867710|11148917|FG001|COMPLETED|Overall Study||0
10024983|NCT01867710|11148918|FG002|COMPLETED|Overall Study||0
10024984|NCT01867710|11148919|FG003|COMPLETED|Overall Study||0
10024985|NCT01867710|11148916|FG000|NOT COMPLETED|Overall Study||41
10024986|NCT01867710|11148917|FG001|NOT COMPLETED|Overall Study||41
10024987|NCT01867710|11148918|FG002|NOT COMPLETED|Overall Study||40
10024988|NCT01867710|11148919|FG003|NOT COMPLETED|Overall Study||42
10024989|NCT01868009|11148929|FG000|STARTED|Period 1 (5-9 Days)||143
10024990|NCT01868009|11148930|FG001|STARTED|Period 1 (5-9 Days)||144
10024991|NCT01868009|11148929|FG000|COMPLETED|Period 1 (5-9 Days)||143
10024992|NCT01868009|11148930|FG001|COMPLETED|Period 1 (5-9 Days)||142
10024993|NCT01868009|11148929|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0
10114540|NCT02517463|11245305|FG001|STARTED|Overall Study||331
10114541|NCT02517463|11245304|FG000|COMPLETED|Overall Study||364
10114542|NCT02517463|11245305|FG001|COMPLETED|Overall Study||329
10114543|NCT02517463|11245304|FG000|NOT COMPLETED|Overall Study||5
10114544|NCT02517463|11245305|FG001|NOT COMPLETED|Overall Study||2
10114545|NCT02517515|11245313|FG000|STARTED|Overall Study||325
10114546|NCT02517515|11245314|FG001|STARTED|Overall Study||325
10114547|NCT02517515|11245313|FG000|COMPLETED|Overall Study||323
10114548|NCT02517515|11245314|FG001|COMPLETED|Overall Study||323
10114549|NCT02517515|11245313|FG000|NOT COMPLETED|Overall Study||2
10114550|NCT02517515|11245314|FG001|NOT COMPLETED|Overall Study||2
10114551|NCT02517528|11245321|FG000|STARTED|Overall Study||104
10114552|NCT02517528|11245321|FG000|COMPLETED|Overall Study||103
10114553|NCT02517528|11245321|FG000|NOT COMPLETED|Overall Study||1
10114554|NCT02517541|11245325|FG000|STARTED|Baseline Period (Own Product)||74
10114555|NCT02517541|11245325|FG000|COMPLETED|Baseline Period (Own Product)||73
10114556|NCT02517541|11245325|FG000|NOT COMPLETED|Baseline Period (Own Product)||1
10114557|NCT02517541|11245325|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73
10114558|NCT02517541|11245325|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
10114559|NCT02517541|11245325|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
10114560|NCT02517567|11245331|FG000|STARTED|First Exposure (8 Hours)||6
10114561|NCT02517567|11245332|FG001|STARTED|First Exposure (8 Hours)||8
10114562|NCT02517567|11245333|FG002|STARTED|First Exposure (8 Hours)||7
10114563|NCT02517567|11245334|FG003|STARTED|First Exposure (8 Hours)||8
10114564|NCT02517567|11245331|FG000|COMPLETED|First Exposure (8 Hours)||6
10024994|NCT01868009|11148930|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2
10024995|NCT01868009|11148929|FG000|STARTED|Period 2 (5-9 Days)||143
10024996|NCT01868009|11148930|FG001|STARTED|Period 2 (5-9 Days)||142
10024997|NCT01868009|11148929|FG000|COMPLETED|Period 2 (5-9 Days)||141
10024998|NCT01868009|11148930|FG001|COMPLETED|Period 2 (5-9 Days)||142
10024999|NCT01868009|11148929|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2
10114565|NCT02517567|11245332|FG001|COMPLETED|First Exposure (8 Hours)||8
9693390|NCT00245570|10793313|FG001|STARTED|Treatment Period IV||7
9693391|NCT00245570|10793314|FG002|STARTED|Treatment Period IV||8
9693392|NCT00245570|10793315|FG003|STARTED|Treatment Period IV||8
9693393|NCT00245570|10793316|FG004|STARTED|Treatment Period IV||8
9693394|NCT00245570|10793317|FG005|STARTED|Treatment Period IV||8
9693395|NCT00245570|10793312|FG000|COMPLETED|Treatment Period IV||7
9693396|NCT00245570|10793313|FG001|COMPLETED|Treatment Period IV||7
9693397|NCT00245570|10793314|FG002|COMPLETED|Treatment Period IV||8
9693398|NCT00245570|10793315|FG003|COMPLETED|Treatment Period IV||8
9693399|NCT00245570|10793316|FG004|COMPLETED|Treatment Period IV||8
9693400|NCT00245570|10793317|FG005|COMPLETED|Treatment Period IV||8
9693401|NCT00245570|10793312|FG000|NOT COMPLETED|Treatment Period IV||0
9693402|NCT00245570|10793313|FG001|NOT COMPLETED|Treatment Period IV||0
9693403|NCT00245570|10793314|FG002|NOT COMPLETED|Treatment Period IV||0
9693404|NCT00245570|10793315|FG003|NOT COMPLETED|Treatment Period IV||0
9693405|NCT00245570|10793316|FG004|NOT COMPLETED|Treatment Period IV||0
9693406|NCT00245570|10793317|FG005|NOT COMPLETED|Treatment Period IV||0
9693407|NCT00229970|10793331|FG000|STARTED|Overall Study||78
9693408|NCT00229970|10793332|FG001|STARTED|Overall Study||72
9693409|NCT00229970|10793333|FG002|STARTED|Overall Study||75
9693410|NCT00229970|10793331|FG000|COMPLETED|Overall Study||78
9693411|NCT00229970|10793332|FG001|COMPLETED|Overall Study||72
9693412|NCT00229970|10793333|FG002|COMPLETED|Overall Study||75
9693413|NCT00229970|10793331|FG000|NOT COMPLETED|Overall Study||0
9693414|NCT00229970|10793332|FG001|NOT COMPLETED|Overall Study||0
9693415|NCT00229970|10793333|FG002|NOT COMPLETED|Overall Study||0
9693416|NCT00092131|10793341|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
9693417|NCT00092131|10793342|FG001|STARTED|Treatment Period I||26
9693418|NCT00092131|10793341|FG000|COMPLETED|Treatment Period I||24
9693419|NCT00092131|10793342|FG001|COMPLETED|Treatment Period I||26
9693420|NCT00092131|10793341|FG000|NOT COMPLETED|Treatment Period I||1
9693421|NCT00092131|10793342|FG001|NOT COMPLETED|Treatment Period I||0
9693422|NCT00092131|10793341|FG000|STARTED|Treatment Period II||24
9693423|NCT00092131|10793342|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
9693424|NCT00092131|10793341|FG000|COMPLETED|Treatment Period II||24
9693425|NCT00092131|10793342|FG001|COMPLETED|Treatment Period II||25
9693426|NCT00092131|10793341|FG000|NOT COMPLETED|Treatment Period II||0
9693427|NCT00092131|10793342|FG001|NOT COMPLETED|Treatment Period II||1
9693428|NCT00092118|10793350|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
9693429|NCT00092118|10793351|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
9693430|NCT00092118|10793350|FG000|COMPLETED|Overall Study||906
9847039|NCT00851890|10959467|FG003|STARTED|Overall Study||6
9847040|NCT00851890|10959464|FG000|COMPLETED|Overall Study||8
9847041|NCT00851890|10959465|FG001|COMPLETED|Overall Study||7
9847042|NCT00851890|10959466|FG002|COMPLETED|Overall Study||8
10025000|NCT01868009|11148930|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0
10025001|NCT01868022|11148945|FG000|STARTED|Overall Study||3
10025002|NCT01868022|11148946|FG001|STARTED|Overall Study||3
10025003|NCT01868022|11148947|FG002|STARTED|Overall Study||14
10025004|NCT01868022|11148948|FG003|STARTED|Overall Study||3
10025005|NCT01868022|11148949|FG004|STARTED|Overall Study||3
10025006|NCT01868022|11148950|FG005|STARTED|Overall Study||3
10025007|NCT01868022|11148951|FG006|STARTED|Overall Study||3
10025008|NCT01868022|11148952|FG007|STARTED|Overall Study||25
10025009|NCT01868022|11148953|FG008|STARTED|Overall Study||8
10025010|NCT01868022|11148945|FG000|COMPLETED|Overall Study||3
10025011|NCT01868022|11148946|FG001|COMPLETED|Overall Study||3
10114566|NCT02517567|11245333|FG002|COMPLETED|First Exposure (8 Hours)||7
9847043|NCT00851890|10959467|FG003|COMPLETED|Overall Study||5
9847044|NCT00851890|10959464|FG000|NOT COMPLETED|Overall Study||0
9847045|NCT00851890|10959465|FG001|NOT COMPLETED|Overall Study||1
9847046|NCT00851890|10959466|FG002|NOT COMPLETED|Overall Study||0
9847047|NCT00851890|10959467|FG003|NOT COMPLETED|Overall Study||1
9847048|NCT00851903|10959477|FG000|STARTED|Overall Study||112
9847049|NCT00851903|10959477|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
10025012|NCT01868022|11148947|FG002|COMPLETED|Overall Study||13
10025013|NCT01868022|11148948|FG003|COMPLETED|Overall Study||2
10025014|NCT01868022|11148949|FG004|COMPLETED|Overall Study||1
10025015|NCT01868022|11148950|FG005|COMPLETED|Overall Study||2
10025016|NCT01868022|11148951|FG006|COMPLETED|Overall Study||3
10025017|NCT01868022|11148952|FG007|COMPLETED|Overall Study||16
10025018|NCT01868022|11148953|FG008|COMPLETED|Overall Study||6
10025019|NCT01868022|11148945|FG000|NOT COMPLETED|Overall Study||0
10025020|NCT01868022|11148946|FG001|NOT COMPLETED|Overall Study||0
10025021|NCT01868022|11148947|FG002|NOT COMPLETED|Overall Study||1
10025022|NCT01868022|11148948|FG003|NOT COMPLETED|Overall Study||1
10025023|NCT01868022|11148949|FG004|NOT COMPLETED|Overall Study||2
10025024|NCT01868022|11148950|FG005|NOT COMPLETED|Overall Study||1
10025025|NCT01868022|11148951|FG006|NOT COMPLETED|Overall Study||0
10025026|NCT01868022|11148952|FG007|NOT COMPLETED|Overall Study||9
10025027|NCT01868022|11148953|FG008|NOT COMPLETED|Overall Study||2
10025028|NCT01868035|11148979|FG000|STARTED|Overall Study||15
10025029|NCT01868035|11148979|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
10025030|NCT01868035|11148979|FG000|NOT COMPLETED|Overall Study||7
10025031|NCT01868074|11148985|FG000|STARTED|Overall Study||36
10025032|NCT01868074|11148986|FG001|STARTED|Overall Study||36
9693431|NCT00092118|10793351|FG001|COMPLETED|Overall Study||913
9693432|NCT00092118|10793350|FG000|NOT COMPLETED|Overall Study||84
9693433|NCT00092118|10793351|FG001|NOT COMPLETED|Overall Study||89
9693434|NCT00090142|10793357|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
9693435|NCT00090142|10793358|FG001|STARTED|Treatment Period I||31
9693436|NCT00090142|10793357|FG000|COMPLETED|Treatment Period I||26
9693437|NCT00090142|10793358|FG001|COMPLETED|Treatment Period I||28
9693438|NCT00090142|10793357|FG000|NOT COMPLETED|Treatment Period I||5
10025033|NCT01868074|11148985|FG000|COMPLETED|Overall Study||29
10025034|NCT01868074|11148986|FG001|COMPLETED|Overall Study||32
10025035|NCT01868074|11148985|FG000|NOT COMPLETED|Overall Study||7
10025036|NCT01868074|11148986|FG001|NOT COMPLETED|Overall Study||4
10025037|NCT01868165|11148992|FG000|STARTED|Overall Study||337
10025038|NCT01868165|11148992|FG000|COMPLETED|Overall Study||292
10025039|NCT01868165|11148992|FG000|NOT COMPLETED|Overall Study||45
10025040|NCT01868243|11148998|FG000|STARTED|Overall Study||15
9693439|NCT00090142|10793358|FG001|NOT COMPLETED|Treatment Period I||3
9693440|NCT00090142|10793357|FG000|STARTED|Treatment Period II||26
9693441|NCT00090142|10793358|FG001|STARTED|Treatment Period II||28
9693442|NCT00090142|10793357|FG000|COMPLETED|Treatment Period II||25
9693443|NCT00090142|10793358|FG001|COMPLETED|Treatment Period II||28
9693444|NCT00090142|10793357|FG000|NOT COMPLETED|Treatment Period II||1
9693445|NCT00090142|10793358|FG001|NOT COMPLETED|Treatment Period II||0
9693446|NCT00043108|10793364|FG000|STARTED|Overall Study||19
9693447|NCT00043108|10793364|FG000|COMPLETED|Overall Study||19
9693448|NCT00043108|10793364|FG000|NOT COMPLETED|Overall Study||0
9727006|NCT00104520|10826572|FG001|COMPLETED|Overall Study||64
9727007|NCT00104520|10826571|FG000|NOT COMPLETED|Overall Study||50
9727008|NCT00104520|10826572|FG001|NOT COMPLETED|Overall Study||71
9727009|NCT00104572|10826581|FG000|STARTED|Overall Study|These are the analysed subjects|13
9727010|NCT00104572|10826582|FG001|STARTED|Overall Study|These are the analysed subjects|13
9731843|NCT00136812|10831806|FG001|NOT COMPLETED|Overall Study||0
10025041|NCT01868243|11148999|FG001|STARTED|Overall Study||12
10025042|NCT01868243|11148998|FG000|COMPLETED|Overall Study||15
10025043|NCT01868243|11148999|FG001|COMPLETED|Overall Study||11
10025044|NCT01868243|11148998|FG000|NOT COMPLETED|Overall Study||0
10025045|NCT01868243|11148999|FG001|NOT COMPLETED|Overall Study||1
10025046|NCT01868334|11149009|FG000|STARTED|Year 1 RCCT Study||13186
10025047|NCT01868334|11149010|FG001|STARTED|Year 1 RCCT Study||17185
10025048|NCT01868334|11149011|FG002|STARTED|Year 1 RCCT Study||19274
10025049|NCT01868334|11149012|FG003|STARTED|Year 1 RCCT Study||20904
10025050|NCT01868334|11149009|FG000|COMPLETED|Year 1 RCCT Study||13186
10025051|NCT01868334|11149010|FG001|COMPLETED|Year 1 RCCT Study||17185
10025052|NCT01868334|11149011|FG002|COMPLETED|Year 1 RCCT Study||19274
10025053|NCT01868334|11149012|FG003|COMPLETED|Year 1 RCCT Study||20904
10025054|NCT01868334|11149009|FG000|NOT COMPLETED|Year 1 RCCT Study||0
10025055|NCT01868334|11149010|FG001|NOT COMPLETED|Year 1 RCCT Study||0
10025056|NCT01868334|11149011|FG002|NOT COMPLETED|Year 1 RCCT Study||0
10025057|NCT01868334|11149012|FG003|NOT COMPLETED|Year 1 RCCT Study||0
10025058|NCT01868334|11149009|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
10114567|NCT02517567|11245334|FG003|COMPLETED|First Exposure (8 Hours)||8
9693449|NCT04771013|10793370|FG000|STARTED|Overall Study||22
9693450|NCT04771013|10793371|FG001|STARTED|Overall Study||22
9693451|NCT04771013|10793370|FG000|COMPLETED|Overall Study||20
9693452|NCT04771013|10793371|FG001|COMPLETED|Overall Study||16
9693453|NCT04771013|10793370|FG000|NOT COMPLETED|Overall Study||2
9693454|NCT04771013|10793371|FG001|NOT COMPLETED|Overall Study||6
9693455|NCT04497987|10793379|FG000|STARTED|Overall Study||592
9693456|NCT04497987|10793380|FG001|STARTED|Overall Study||588
9693457|NCT04497987|10793379|FG000|Received at Least One Dose of Study Drug|Overall Study||587
9693458|NCT04497987|10793380|FG001|Received at Least One Dose of Study Drug|Overall Study||588
9693459|NCT04497987|10793379|FG000|Prevention Population|Overall Study||485
9693460|NCT04497987|10793380|FG001|Prevention Population|Overall Study||487
9693461|NCT04497987|10793379|FG000|Treatment Population|Overall Study||68
9693462|NCT04497987|10793380|FG001|Treatment Population|Overall Study||66
9693463|NCT04497987|10793379|FG000|Serology Positive|Overall Study||36
9693464|NCT04497987|10793380|FG001|Serology Positive|Overall Study||35
9693465|NCT04497987|10793379|FG000|COMPLETED|Overall Study||493
9693466|NCT04497987|10793380|FG001|COMPLETED|Overall Study||521
9693467|NCT04497987|10793379|FG000|NOT COMPLETED|Overall Study||99
9693468|NCT04497987|10793380|FG001|NOT COMPLETED|Overall Study||67
9693469|NCT04198584|10793389|FG000|STARTED|Overall Study||24
9693470|NCT04198584|10793390|FG001|STARTED|Overall Study||8
9693471|NCT04198584|10793389|FG000|Randomized to Wave 1|Overall Study||5
9693472|NCT04198584|10793390|FG001|Randomized to Wave 1|Overall Study||2
9693473|NCT04198584|10793389|FG000|Randomized to Wave 2|Overall Study||7
9693474|NCT04198584|10793390|FG001|Randomized to Wave 2|Overall Study||2
9693475|NCT04198584|10793389|FG000|Randomized to Wave 3|Overall Study||6
9693476|NCT04198584|10793390|FG001|Randomized to Wave 3|Overall Study||2
9693477|NCT04198584|10793389|FG000|Randomized to Wave 4|Overall Study||6
9693478|NCT04198584|10793390|FG001|Randomized to Wave 4|Overall Study||2
9693479|NCT04198584|10793389|FG000|Total Randomized|Overall Study||24
9693480|NCT04198584|10793390|FG001|Total Randomized|Overall Study||8
9693481|NCT04198584|10793389|FG000|Actually Received Treatment|Overall Study||21
9693482|NCT04198584|10793390|FG001|Actually Received Treatment|Overall Study||8
9693483|NCT04198584|10793389|FG000|COMPLETED|Overall Study||19
9693484|NCT04198584|10793390|FG001|COMPLETED|Overall Study||8
9693485|NCT04198584|10793389|FG000|NOT COMPLETED|Overall Study||5
9693486|NCT04198584|10793390|FG001|NOT COMPLETED|Overall Study||0
9693487|NCT04013932|10793403|FG000|STARTED|Overall Study||33
9693488|NCT04013932|10793404|FG001|STARTED|Overall Study||33
9693489|NCT04013932|10793403|FG000|COMPLETED|Overall Study||33
9693490|NCT04013932|10793404|FG001|COMPLETED|Overall Study||28
9693491|NCT04013932|10793403|FG000|NOT COMPLETED|Overall Study||0
9693492|NCT04013932|10793404|FG001|NOT COMPLETED|Overall Study||5
9693493|NCT03840616|10793414|FG000|STARTED|2-Week Induction Phase||147
9693494|NCT03840616|10793415|FG001|STARTED|2-Week Induction Phase||72
9693495|NCT03840616|10793414|FG000|COMPLETED|2-Week Induction Phase||123
9693496|NCT03840616|10793415|FG001|COMPLETED|2-Week Induction Phase||62
9693497|NCT03840616|10793414|FG000|NOT COMPLETED|2-Week Induction Phase||24
9693498|NCT03840616|10793415|FG001|NOT COMPLETED|2-Week Induction Phase||10
9693499|NCT03840616|10793414|FG000|STARTED|48-Week Maintenance Phase||123
9693500|NCT03840616|10793415|FG001|STARTED|48-Week Maintenance Phase||62
9693501|NCT03840616|10793414|FG000|COMPLETED|48-Week Maintenance Phase||112
9693502|NCT03840616|10793415|FG001|COMPLETED|48-Week Maintenance Phase||55
9693503|NCT03840616|10793414|FG000|NOT COMPLETED|48-Week Maintenance Phase||11
9693504|NCT03840616|10793415|FG001|NOT COMPLETED|48-Week Maintenance Phase||7
9693505|NCT03623373|10793423|FG000|STARTED|Overall Study||13
9693506|NCT03623373|10793423|FG000|COMPLETED|Overall Study||13
9693507|NCT03623373|10793423|FG000|NOT COMPLETED|Overall Study||0
9693508|NCT03581279|10793429|FG000|STARTED|Overall Study||18
9693509|NCT03581279|10793430|FG001|STARTED|Overall Study||0
9693510|NCT03581279|10793429|FG000|COMPLETED|Overall Study||16
9693511|NCT03581279|10793430|FG001|COMPLETED|Overall Study||0
9693512|NCT03581279|10793429|FG000|NOT COMPLETED|Overall Study||2
9693513|NCT03581279|10793430|FG001|NOT COMPLETED|Overall Study||0
9693514|NCT03512210|10793436|FG000|STARTED|Step 1: MINMON Intervention||400
9693515|NCT03512210|10793436|FG000|COMPLETED|Step 1: MINMON Intervention||396
9693516|NCT03512210|10793436|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4
9693517|NCT03512210|10793436|FG000|STARTED|Step 2:Post-MINMON||396
9693518|NCT03512210|10793436|FG000|COMPLETED|Step 2:Post-MINMON||362
9693519|NCT03512210|10793436|FG000|NOT COMPLETED|Step 2:Post-MINMON||34
9693520|NCT03506412|10793442|FG000|STARTED|Overall Study||18
9693521|NCT03506412|10793443|FG001|STARTED|Overall Study||19
9693522|NCT03506412|10793442|FG000|COMPLETED|Overall Study||18
9693523|NCT03506412|10793443|FG001|COMPLETED|Overall Study||19
9693524|NCT03506412|10793442|FG000|NOT COMPLETED|Overall Study||0
9693525|NCT03506412|10793443|FG001|NOT COMPLETED|Overall Study||0
9693526|NCT03420768|10793452|FG000|STARTED|Overall Study||18
9693527|NCT03420768|10793453|FG001|STARTED|Overall Study||28
9693528|NCT03420768|10793454|FG002|STARTED|Overall Study||15
9693529|NCT03420768|10793452|FG000|COMPLETED|Overall Study||18
9693530|NCT03420768|10793453|FG001|COMPLETED|Overall Study||28
9693531|NCT03420768|10793454|FG002|COMPLETED|Overall Study||15
9693532|NCT03420768|10793452|FG000|NOT COMPLETED|Overall Study||0
9693533|NCT03420768|10793453|FG001|NOT COMPLETED|Overall Study||0
9693534|NCT03420768|10793454|FG002|NOT COMPLETED|Overall Study||0
9693535|NCT03395288|10793465|FG000|STARTED|Overall Study||28
9693536|NCT03395288|10793466|FG001|STARTED|Overall Study||29
9693537|NCT03395288|10793467|FG002|STARTED|Overall Study||4
9693538|NCT03395288|10793465|FG000|COMPLETED|Overall Study||19
9693539|NCT03395288|10793466|FG001|COMPLETED|Overall Study||25
9693540|NCT03395288|10793467|FG002|COMPLETED|Overall Study||3
9693541|NCT03395288|10793465|FG000|NOT COMPLETED|Overall Study||9
9693542|NCT03395288|10793466|FG001|NOT COMPLETED|Overall Study||4
9693543|NCT03395288|10793467|FG002|NOT COMPLETED|Overall Study||1
9693544|NCT03180307|10793477|FG000|STARTED|Overall Study||134
9693545|NCT03180307|10793478|FG001|STARTED|Overall Study||6
9693546|NCT03180307|10793477|FG000|Safety Analysis Set|Overall Study||134
9693547|NCT03180307|10793478|FG001|Safety Analysis Set|Overall Study||16
9693548|NCT03180307|10793477|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134
9693549|NCT03180307|10793478|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0
9693550|NCT03180307|10793477|FG000|Per Protocol Analysis Set|Overall Study||106
9693551|NCT03180307|10793478|FG001|Per Protocol Analysis Set|Overall Study||0
9693552|NCT03180307|10793477|FG000|Pharmacokinetic Analysis Set|Overall Study||122
9693553|NCT03180307|10793478|FG001|Pharmacokinetic Analysis Set|Overall Study||6
9693554|NCT03180307|10793477|FG000|COMPLETED|Overall Study||128
9693555|NCT03180307|10793478|FG001|COMPLETED|Overall Study||6
9693556|NCT03180307|10793477|FG000|NOT COMPLETED|Overall Study||6
9693557|NCT03180307|10793478|FG001|NOT COMPLETED|Overall Study||0
9693558|NCT03151083|10793485|FG000|STARTED|Overall Study||27
9693559|NCT03151083|10793486|FG001|STARTED|Overall Study||20
9693560|NCT03151083|10793487|FG002|STARTED|Overall Study||30
9693561|NCT03151083|10793485|FG000|COMPLETED|Overall Study||25
9693562|NCT03151083|10793486|FG001|COMPLETED|Overall Study||19
9693563|NCT03151083|10793487|FG002|COMPLETED|Overall Study||26
9693564|NCT03151083|10793485|FG000|NOT COMPLETED|Overall Study||2
9693565|NCT03151083|10793486|FG001|NOT COMPLETED|Overall Study||1
9693566|NCT03151083|10793487|FG002|NOT COMPLETED|Overall Study||4
9693567|NCT02668822|10793497|FG000|STARTED|Overall Study||9
9693568|NCT02668822|10793498|FG001|STARTED|Overall Study||9
9693569|NCT02668822|10793497|FG000|COMPLETED|Overall Study||0
9693570|NCT02668822|10793498|FG001|COMPLETED|Overall Study||0
9693571|NCT02668822|10793497|FG000|NOT COMPLETED|Overall Study||9
9693572|NCT02668822|10793498|FG001|NOT COMPLETED|Overall Study||9
9693573|NCT02668783|10793506|FG000|STARTED|Overall Study||13
9693574|NCT02668783|10793507|FG001|STARTED|Overall Study||12
9693575|NCT02668783|10793506|FG000|Treated|Overall Study||13
9693576|NCT02668783|10793507|FG001|Treated|Overall Study||11
9693577|NCT02668783|10793506|FG000|COMPLETED|Overall Study||0
9693578|NCT02668783|10793507|FG001|COMPLETED|Overall Study||0
9693579|NCT02668783|10793506|FG000|NOT COMPLETED|Overall Study||13
9693580|NCT02668783|10793507|FG001|NOT COMPLETED|Overall Study||12
9693581|NCT02616146|10793515|FG000|STARTED|Overall Study||1512
9693582|NCT02616146|10793516|FG001|STARTED|Overall Study||504
9693583|NCT02616146|10793515|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
9693584|NCT02616146|10793516|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
9693585|NCT02616146|10793515|FG000|NOT COMPLETED|Overall Study||1512
9693586|NCT02616146|10793516|FG001|NOT COMPLETED|Overall Study||504
9693587|NCT02538510|10793524|FG000|STARTED|Overall Study||25
9693588|NCT02538510|10793525|FG001|STARTED|Overall Study||25
9693589|NCT02538510|10793524|FG000|COMPLETED|Overall Study||25
9693590|NCT02538510|10793525|FG001|COMPLETED|Overall Study||25
9693591|NCT02538510|10793524|FG000|NOT COMPLETED|Overall Study||0
9693592|NCT02538510|10793525|FG001|NOT COMPLETED|Overall Study||0
9693593|NCT02524288|10793535|FG000|STARTED|Overall Study||1941
9693594|NCT02524288|10793535|FG000|Treated|Overall Study||1936
9693595|NCT02524288|10793535|FG000|COMPLETED|Overall Study||0
9693596|NCT02524288|10793535|FG000|NOT COMPLETED|Overall Study||1941
9727011|NCT00104572|10826583|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
9727012|NCT00104572|10826581|FG000|COMPLETED|Overall Study||10
9847050|NCT00851903|10959477|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
9847051|NCT00851903|10959477|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
9847052|NCT00851903|10959477|FG000|COMPLETED|Overall Study||110
9847053|NCT00851903|10959477|FG000|NOT COMPLETED|Overall Study||2
9847054|NCT00852137|10959483|FG000|STARTED|Overall Study||13
9847055|NCT00852137|10959484|FG001|STARTED|Overall Study||3
9847056|NCT00852137|10959483|FG000|COMPLETED|Overall Study||13
9847057|NCT00852137|10959484|FG001|COMPLETED|Overall Study||3
9727013|NCT00104572|10826582|FG001|COMPLETED|Overall Study||10
9727014|NCT00104572|10826583|FG002|COMPLETED|Overall Study||9
9727015|NCT00104572|10826581|FG000|NOT COMPLETED|Overall Study||3
9727016|NCT00104572|10826582|FG001|NOT COMPLETED|Overall Study||3
9727017|NCT00104572|10826583|FG002|NOT COMPLETED|Overall Study||0
9727018|NCT00104637|10826591|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
9727019|NCT00104637|10826592|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
9727020|NCT00104637|10826591|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
9727021|NCT00104637|10826592|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
9693597|NCT02489942|10793539|FG000|STARTED|Overall Study||8145
9693598|NCT02489942|10793539|FG000|Case Report Form (CRF) Collected|Overall Study||8059
9693599|NCT02489942|10793539|FG000|Treated|Overall Study||8057
9693600|NCT02489942|10793539|FG000|COMPLETED|Overall Study||4729
9693601|NCT02489942|10793539|FG000|NOT COMPLETED|Overall Study||3416
9693602|NCT02409342|10793545|FG000|STARTED|Overall Study||287
9693603|NCT02409342|10793546|FG001|STARTED|Overall Study||285
9693604|NCT02409342|10793545|FG000|COMPLETED|Overall Study||0
9693605|NCT02409342|10793546|FG001|COMPLETED|Overall Study||0
9693606|NCT02409342|10793545|FG000|NOT COMPLETED|Overall Study||287
9693607|NCT02409342|10793546|FG001|NOT COMPLETED|Overall Study||285
9693608|NCT02293655|10793556|FG000|STARTED|Overall Study||92
9693609|NCT02293655|10793557|FG001|STARTED|Overall Study||17
9693610|NCT02293655|10793556|FG000|COMPLETED|Overall Study||85
9693611|NCT02293655|10793557|FG001|COMPLETED|Overall Study||15
9693612|NCT02293655|10793556|FG000|NOT COMPLETED|Overall Study||7
9693613|NCT02293655|10793557|FG001|NOT COMPLETED|Overall Study||2
9693614|NCT02275546|10793563|FG000|STARTED|Treatment Period 1||81
9693615|NCT02275546|10793564|FG001|STARTED|Treatment Period 1||83
9693616|NCT02275546|10793563|FG000|COMPLETED|Treatment Period 1||81
9693617|NCT02275546|10793564|FG001|COMPLETED|Treatment Period 1||83
9693618|NCT02275546|10793563|FG000|NOT COMPLETED|Treatment Period 1||0
9693619|NCT02275546|10793564|FG001|NOT COMPLETED|Treatment Period 1||0
9693620|NCT02275546|10793563|FG000|STARTED|Treatment Period 2||81
9693621|NCT02275546|10793564|FG001|STARTED|Treatment Period 2||83
9693622|NCT02275546|10793563|FG000|COMPLETED|Treatment Period 2||79
9693623|NCT02275546|10793564|FG001|COMPLETED|Treatment Period 2||81
9693624|NCT02275546|10793563|FG000|NOT COMPLETED|Treatment Period 2||2
9693625|NCT02275546|10793564|FG001|NOT COMPLETED|Treatment Period 2||2
9693626|NCT02077166|10793577|FG000|STARTED|Overall Study||12
9693627|NCT02077166|10793578|FG001|STARTED|Overall Study||7
9693628|NCT02077166|10793579|FG002|STARTED|Overall Study||9
9693629|NCT02077166|10793580|FG003|STARTED|Overall Study||9
9693630|NCT02077166|10793581|FG004|STARTED|Overall Study||8
9693631|NCT02077166|10793582|FG005|STARTED|Overall Study||55
9693632|NCT02077166|10793583|FG006|STARTED|Overall Study||34
9693633|NCT02077166|10793577|FG000|COMPLETED|Overall Study||0
9693634|NCT02077166|10793578|FG001|COMPLETED|Overall Study||0
9693635|NCT02077166|10793579|FG002|COMPLETED|Overall Study||0
9693636|NCT02077166|10793580|FG003|COMPLETED|Overall Study||0
9693637|NCT02077166|10793581|FG004|COMPLETED|Overall Study||0
9693638|NCT02077166|10793582|FG005|COMPLETED|Overall Study||0
9693639|NCT02077166|10793583|FG006|COMPLETED|Overall Study||0
9693640|NCT02077166|10793577|FG000|NOT COMPLETED|Overall Study||12
9693641|NCT02077166|10793578|FG001|NOT COMPLETED|Overall Study||7
9693642|NCT02077166|10793579|FG002|NOT COMPLETED|Overall Study||9
9693643|NCT02077166|10793580|FG003|NOT COMPLETED|Overall Study||9
9693644|NCT02077166|10793581|FG004|NOT COMPLETED|Overall Study||8
9693645|NCT02077166|10793582|FG005|NOT COMPLETED|Overall Study||55
9693646|NCT02077166|10793583|FG006|NOT COMPLETED|Overall Study||34
9693647|NCT01891344|10793608|FG000|STARTED|Overall Study||40
9693648|NCT01891344|10793609|FG001|STARTED|Overall Study||82
9693649|NCT01891344|10793610|FG002|STARTED|Overall Study||70
9693650|NCT01891344|10793611|FG003|STARTED|Overall Study||12
9693651|NCT01891344|10793612|FG004|STARTED|Overall Study||84
9693652|NCT01891344|10793613|FG005|STARTED|Overall Study||73
9693653|NCT01891344|10793614|FG006|STARTED|Overall Study||107
9693654|NCT01891344|10793615|FG007|STARTED|Overall Study||23
9693655|NCT01891344|10793608|FG000|COMPLETED|Overall Study||34
9693656|NCT01891344|10793609|FG001|COMPLETED|Overall Study||80
9693657|NCT01891344|10793610|FG002|COMPLETED|Overall Study||70
9693658|NCT01891344|10793611|FG003|COMPLETED|Overall Study||11
9693659|NCT01891344|10793612|FG004|COMPLETED|Overall Study||80
9693660|NCT01891344|10793613|FG005|COMPLETED|Overall Study||72
9961494|NCT01473953|11081237|FG002|NOT COMPLETED|Overall Study||0
9961495|NCT01473953|11081238|FG003|NOT COMPLETED|Overall Study||0
9961496|NCT01473953|11081239|FG004|NOT COMPLETED|Overall Study||0
10025059|NCT01868334|11149010|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
10025060|NCT01868334|11149011|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
10025061|NCT01868334|11149012|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
9693661|NCT01891344|10793614|FG006|COMPLETED|Overall Study||107
9693662|NCT01891344|10793615|FG007|COMPLETED|Overall Study||23
9693663|NCT01891344|10793608|FG000|NOT COMPLETED|Overall Study||6
9693664|NCT01891344|10793609|FG001|NOT COMPLETED|Overall Study||2
9693665|NCT01891344|10793610|FG002|NOT COMPLETED|Overall Study||0
9693666|NCT01891344|10793611|FG003|NOT COMPLETED|Overall Study||1
10025062|NCT01868334|11149009|FG000|COMPLETED|Year 2 Pre-post Study||22324
10025063|NCT01868334|11149010|FG001|COMPLETED|Year 2 Pre-post Study||8047
10025064|NCT01868334|11149011|FG002|COMPLETED|Year 2 Pre-post Study||20904
10025065|NCT01868334|11149012|FG003|COMPLETED|Year 2 Pre-post Study||19274
10025066|NCT01868334|11149009|FG000|NOT COMPLETED|Year 2 Pre-post Study||0
10025067|NCT01868334|11149010|FG001|NOT COMPLETED|Year 2 Pre-post Study||0
9693667|NCT01891344|10793612|FG004|NOT COMPLETED|Overall Study||4
9693668|NCT01891344|10793613|FG005|NOT COMPLETED|Overall Study||1
9693669|NCT01891344|10793614|FG006|NOT COMPLETED|Overall Study||0
9693670|NCT01891344|10793615|FG007|NOT COMPLETED|Overall Study||0
9693671|NCT01847274|10793637|FG000|STARTED|Overall Study||138
9961497|NCT01473992|11081253|FG000|STARTED|Overall Study||10
9961498|NCT01473992|11081254|FG001|STARTED|Overall Study||10
9961499|NCT01473992|11081255|FG002|STARTED|Overall Study||5
9961500|NCT01473992|11081253|FG000|COMPLETED|Overall Study||10
9961501|NCT01473992|11081254|FG001|COMPLETED|Overall Study||10
9961502|NCT01473992|11081255|FG002|COMPLETED|Overall Study||5
9961503|NCT01473992|11081253|FG000|NOT COMPLETED|Overall Study||0
9961504|NCT01473992|11081254|FG001|NOT COMPLETED|Overall Study||0
9693672|NCT01847274|10793638|FG001|STARTED|Overall Study||65
9693673|NCT01847274|10793639|FG002|STARTED|Overall Study||234
9693674|NCT01847274|10793640|FG003|STARTED|Overall Study||116
9693675|NCT01847274|10793637|FG000|COMPLETED|Overall Study||47
9693676|NCT01847274|10793638|FG001|COMPLETED|Overall Study||4
9693677|NCT01847274|10793639|FG002|COMPLETED|Overall Study||46
9693678|NCT01847274|10793640|FG003|COMPLETED|Overall Study||12
9693679|NCT01847274|10793637|FG000|NOT COMPLETED|Overall Study||91
9693680|NCT01847274|10793638|FG001|NOT COMPLETED|Overall Study||61
9693681|NCT01847274|10793639|FG002|NOT COMPLETED|Overall Study||188
9693682|NCT01847274|10793640|FG003|NOT COMPLETED|Overall Study||104
9693683|NCT01670656|10793655|FG000|STARTED|Overall Study||86
9693684|NCT01670656|10793656|FG001|STARTED|Overall Study||91
9693685|NCT01670656|10793657|FG002|STARTED|Overall Study||87
9693686|NCT01670656|10793658|FG003|STARTED|Overall Study||85
9693687|NCT01670656|10793659|FG004|STARTED|Overall Study||90
9693688|NCT01670656|10793655|FG000|Treated|Overall Study||86
9693689|NCT01670656|10793656|FG001|Treated|Overall Study||91
9693690|NCT01670656|10793657|FG002|Treated|Overall Study||86
9693691|NCT01670656|10793658|FG003|Treated|Overall Study||85
9693692|NCT01670656|10793659|FG004|Treated|Overall Study||90
9693693|NCT01670656|10793655|FG000|COMPLETED|Overall Study||83
9693694|NCT01670656|10793656|FG001|COMPLETED|Overall Study||84
9693695|NCT01670656|10793657|FG002|COMPLETED|Overall Study||79
9693696|NCT01670656|10793658|FG003|COMPLETED|Overall Study||79
9693697|NCT01670656|10793659|FG004|COMPLETED|Overall Study||79
9693698|NCT01670656|10793655|FG000|NOT COMPLETED|Overall Study||3
9693699|NCT01670656|10793656|FG001|NOT COMPLETED|Overall Study||7
9693700|NCT01670656|10793657|FG002|NOT COMPLETED|Overall Study||8
9693701|NCT01670656|10793658|FG003|NOT COMPLETED|Overall Study||6
9693702|NCT01670656|10793659|FG004|NOT COMPLETED|Overall Study||11
9693703|NCT01501955|10793673|FG000|STARTED|Overall Study||11
9693704|NCT01501955|10793674|FG001|STARTED|Overall Study||9
9693705|NCT01501955|10793673|FG000|Surgery|Overall Study||11
9693706|NCT01501955|10793674|FG001|Surgery|Overall Study||9
9693707|NCT01501955|10793673|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
9693708|NCT01501955|10793674|FG001|6 Weeks Postop|Overall Study||9
9693709|NCT01501955|10793673|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
9693710|NCT01501955|10793674|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
9693711|NCT01501955|10793673|FG000|2 Years Postop|Overall Study||9
9693712|NCT01501955|10793674|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
9693713|NCT01501955|10793673|FG000|COMPLETED|Overall Study||9
9693714|NCT01501955|10793674|FG001|COMPLETED|Overall Study||6
9693715|NCT01501955|10793673|FG000|NOT COMPLETED|Overall Study||2
9693716|NCT01501955|10793674|FG001|NOT COMPLETED|Overall Study||3
9693717|NCT01335399|10793682|FG000|STARTED|Pre-treatment Period||374
9693718|NCT01335399|10793683|FG001|STARTED|Pre-treatment Period||374
9693719|NCT01335399|10793682|FG000|COMPLETED|Pre-treatment Period||371
9693720|NCT01335399|10793683|FG001|COMPLETED|Pre-treatment Period||371
9693721|NCT01335399|10793682|FG000|NOT COMPLETED|Pre-treatment Period||3
9693722|NCT01335399|10793683|FG001|NOT COMPLETED|Pre-treatment Period||3
9693723|NCT01335399|10793682|FG000|STARTED|Treatment Period||371
9693724|NCT01335399|10793683|FG001|STARTED|Treatment Period||371
9693725|NCT01335399|10793682|FG000|COMPLETED|Treatment Period||38
9693726|NCT01335399|10793683|FG001|COMPLETED|Treatment Period||32
9693727|NCT01335399|10793682|FG000|NOT COMPLETED|Treatment Period||333
9693728|NCT01335399|10793683|FG001|NOT COMPLETED|Treatment Period||339
9693729|NCT01277211|10793691|FG000|STARTED|Overall Study||738
9693730|NCT01277211|10793692|FG001|STARTED|Overall Study||245
9693731|NCT01277211|10793691|FG000|Treated|Overall Study||714
9693732|NCT01277211|10793692|FG001|Treated|Overall Study||232
9693733|NCT01277211|10793691|FG000|COMPLETED|Overall Study||588
9693734|NCT01277211|10793692|FG001|COMPLETED|Overall Study||182
9693735|NCT01277211|10793691|FG000|NOT COMPLETED|Overall Study||150
9693736|NCT01277211|10793692|FG001|NOT COMPLETED|Overall Study||63
9693737|NCT01267812|10793698|FG000|STARTED|Overall Study||23
9693738|NCT01267812|10793698|FG000|COMPLETED|Overall Study||23
9693739|NCT01267812|10793698|FG000|NOT COMPLETED|Overall Study||0
9693740|NCT01244828|10793702|FG000|STARTED|Overall Study|Received study drug|157
9693741|NCT01244828|10793702|FG000|COMPLETED|Overall Study||79
9693742|NCT01244828|10793702|FG000|NOT COMPLETED|Overall Study||78
9693743|NCT01207492|10793706|FG000|STARTED|Overall Study||17
9693744|NCT01207492|10793706|FG000|COMPLETED|Overall Study||2
9693745|NCT01207492|10793706|FG000|NOT COMPLETED|Overall Study||15
9693746|NCT01181778|10793710|FG000|STARTED|Overall Study||1919
9693747|NCT01181778|10793710|FG000|COMPLETED|Overall Study||1871
9693748|NCT01181778|10793710|FG000|NOT COMPLETED|Overall Study||48
9693749|NCT01047540|10793721|FG000|STARTED|Overall Study||34
9693750|NCT01047540|10793722|FG001|STARTED|Overall Study||32
9693751|NCT01047540|10793723|FG002|STARTED|Overall Study||29
9693752|NCT01047540|10793724|FG003|STARTED|Overall Study||31
9693753|NCT01047540|10793725|FG004|STARTED|Overall Study||30
9693754|NCT01047540|10793721|FG000|COMPLETED|Overall Study||29
9693755|NCT01047540|10793722|FG001|COMPLETED|Overall Study||32
10025068|NCT01868334|11149011|FG002|NOT COMPLETED|Year 2 Pre-post Study||0
9693756|NCT01047540|10793723|FG002|COMPLETED|Overall Study||26
9693757|NCT01047540|10793724|FG003|COMPLETED|Overall Study||31
9693758|NCT01047540|10793725|FG004|COMPLETED|Overall Study||29
9693759|NCT01047540|10793721|FG000|NOT COMPLETED|Overall Study||5
9693760|NCT01047540|10793722|FG001|NOT COMPLETED|Overall Study||0
10025069|NCT01868334|11149012|FG003|NOT COMPLETED|Year 2 Pre-post Study||0
10025070|NCT01868425|11149052|FG000|STARTED|Overall Study||55
9693761|NCT01047540|10793723|FG002|NOT COMPLETED|Overall Study||3
9693762|NCT01047540|10793724|FG003|NOT COMPLETED|Overall Study||0
9693763|NCT01047540|10793725|FG004|NOT COMPLETED|Overall Study||1
9693764|NCT01044056|10793740|FG000|STARTED|Overall Study||8
9693765|NCT01044056|10793741|FG001|STARTED|Overall Study||8
9693766|NCT01044056|10793742|FG002|STARTED|Overall Study||8
9693767|NCT01044056|10793740|FG000|COMPLETED|Overall Study||8
9693768|NCT01044056|10793741|FG001|COMPLETED|Overall Study||8
9693769|NCT01044056|10793742|FG002|COMPLETED|Overall Study||8
9693770|NCT01044056|10793740|FG000|NOT COMPLETED|Overall Study||0
9693771|NCT01044056|10793741|FG001|NOT COMPLETED|Overall Study||0
9693772|NCT01044056|10793742|FG002|NOT COMPLETED|Overall Study||0
10025071|NCT01868425|11149053|FG001|STARTED|Overall Study||57
10025072|NCT01868425|11149052|FG000|COMPLETED|Overall Study||55
10025073|NCT01868425|11149053|FG001|COMPLETED|Overall Study||57
10025074|NCT01868425|11149052|FG000|NOT COMPLETED|Overall Study||0
10025075|NCT01868425|11149053|FG001|NOT COMPLETED|Overall Study||0
10025076|NCT01868477|11149061|FG000|STARTED|Overall Study||12
10025077|NCT01868477|11149062|FG001|STARTED|Overall Study||11
10025078|NCT01868477|11149061|FG000|Switched to EPO+DFX|Overall Study||5
10025079|NCT01868477|11149062|FG001|Switched to EPO+DFX|Overall Study||0
10025080|NCT01868477|11149061|FG000|Not Switched to EPO+DFX|Overall Study||7
10025081|NCT01868477|11149062|FG001|Not Switched to EPO+DFX|Overall Study||0
10025082|NCT01868477|11149061|FG000|COMPLETED|Overall Study||8
10025083|NCT01868477|11149062|FG001|COMPLETED|Overall Study||6
10025084|NCT01868477|11149061|FG000|NOT COMPLETED|Overall Study||4
10025085|NCT01868477|11149062|FG001|NOT COMPLETED|Overall Study||5
10025086|NCT01868503|11149075|FG000|STARTED|Overall Study||7
10025087|NCT01868503|11149075|FG000|COMPLETED|Overall Study||5
10025088|NCT01868503|11149075|FG000|NOT COMPLETED|Overall Study||2
10025089|NCT01868542|11149083|FG000|STARTED|Overall Study||23
10025090|NCT01868542|11149084|FG001|STARTED|Overall Study||23
10025091|NCT01868542|11149083|FG000|COMPLETED|Overall Study||23
10025092|NCT01868542|11149084|FG001|COMPLETED|Overall Study||21
10025093|NCT01868542|11149083|FG000|NOT COMPLETED|Overall Study||0
10025094|NCT01868542|11149084|FG001|NOT COMPLETED|Overall Study||2
10025095|NCT01868594|11149092|FG000|STARTED|Overall Study||76
10025096|NCT01868594|11149093|FG001|STARTED|Overall Study||75
10025097|NCT01868594|11149092|FG000|COMPLETED|Overall Study||72
10025098|NCT01868594|11149093|FG001|COMPLETED|Overall Study||72
10025099|NCT01868594|11149092|FG000|NOT COMPLETED|Overall Study||4
10025100|NCT01868594|11149093|FG001|NOT COMPLETED|Overall Study||3
10025101|NCT01868633|11149103|FG000|STARTED|Overall Study||26
10025102|NCT01868633|11149104|FG001|STARTED|Overall Study||26
10025103|NCT01868633|11149103|FG000|COMPLETED|Overall Study||26
10025104|NCT01868633|11149104|FG001|COMPLETED|Overall Study||26
10025105|NCT01868633|11149103|FG000|NOT COMPLETED|Overall Study||0
10025106|NCT01868633|11149104|FG001|NOT COMPLETED|Overall Study||0
10025107|NCT01868646|11149112|FG000|STARTED|Overall Study||76
10025108|NCT01868646|11149113|FG001|STARTED|Overall Study||72
10025109|NCT01868646|11149112|FG000|COMPLETED|Overall Study||73
10025110|NCT01868646|11149113|FG001|COMPLETED|Overall Study||67
10025111|NCT01868646|11149112|FG000|NOT COMPLETED|Overall Study||3
10025112|NCT01868646|11149113|FG001|NOT COMPLETED|Overall Study||5
10025113|NCT01868776|11149121|FG000|STARTED|Overall Study||50
10025114|NCT01868776|11149122|FG001|STARTED|Overall Study||50
10025115|NCT01868776|11149121|FG000|COMPLETED|Overall Study||50
10025116|NCT01868776|11149122|FG001|COMPLETED|Overall Study||50
10025117|NCT01868776|11149121|FG000|NOT COMPLETED|Overall Study||0
10025118|NCT01868776|11149122|FG001|NOT COMPLETED|Overall Study||0
10025119|NCT01868789|11149130|FG000|STARTED|Overall Study||9
10025120|NCT01868789|11149131|FG001|STARTED|Overall Study||14
10025121|NCT01868789|11149130|FG000|COMPLETED|Overall Study||7
10025122|NCT01868789|11149131|FG001|COMPLETED|Overall Study||12
10025123|NCT01868789|11149130|FG000|NOT COMPLETED|Overall Study||2
10025124|NCT01868789|11149131|FG001|NOT COMPLETED|Overall Study||2
10025125|NCT01868893|11149137|FG000|STARTED|Overall Study||20
10025126|NCT01868893|11149137|FG000|COMPLETED|Overall Study||0
10025127|NCT01868893|11149137|FG000|NOT COMPLETED|Overall Study||20
10025128|NCT01868997|11149145|FG000|STARTED|Overall Study|randomized and treated|45
10025129|NCT01868997|11149146|FG001|STARTED|Overall Study|randomized and treated|42
10025130|NCT01868997|11149145|FG000|COMPLETED|Overall Study||38
10025131|NCT01868997|11149146|FG001|COMPLETED|Overall Study||36
10025132|NCT01868997|11149145|FG000|NOT COMPLETED|Overall Study||7
10025133|NCT01868997|11149146|FG001|NOT COMPLETED|Overall Study||6
10025134|NCT01869075|11149158|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
10025135|NCT01869075|11149159|FG001|STARTED|Phase 0 (Baseline)||418
10025136|NCT01869075|11149160|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
10025137|NCT01869075|11149161|FG003|STARTED|Phase 0 (Baseline)||416
10025138|NCT01869075|11149162|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
10025139|NCT01869075|11149163|FG005|STARTED|Phase 0 (Baseline)||341
10025140|NCT01869075|11149158|FG000|COMPLETED|Phase 0 (Baseline)||0
10025141|NCT01869075|11149159|FG001|COMPLETED|Phase 0 (Baseline)||418
10025142|NCT01869075|11149160|FG002|COMPLETED|Phase 0 (Baseline)||0
10025143|NCT01869075|11149161|FG003|COMPLETED|Phase 0 (Baseline)||416
10025144|NCT01869075|11149162|FG004|COMPLETED|Phase 0 (Baseline)||0
10025145|NCT01869075|11149163|FG005|COMPLETED|Phase 0 (Baseline)||341
10025146|NCT01869075|11149158|FG000|NOT COMPLETED|Phase 0 (Baseline)||0
10025147|NCT01869075|11149159|FG001|NOT COMPLETED|Phase 0 (Baseline)||0
10025148|NCT01869075|11149160|FG002|NOT COMPLETED|Phase 0 (Baseline)||0
10025149|NCT01869075|11149161|FG003|NOT COMPLETED|Phase 0 (Baseline)||0
10025150|NCT01869075|11149162|FG004|NOT COMPLETED|Phase 0 (Baseline)||0
10025151|NCT01869075|11149163|FG005|NOT COMPLETED|Phase 0 (Baseline)||0
10114568|NCT02517567|11245331|FG000|NOT COMPLETED|First Exposure (8 Hours)||0
10114569|NCT02517567|11245332|FG001|NOT COMPLETED|First Exposure (8 Hours)||0
10114570|NCT02517567|11245333|FG002|NOT COMPLETED|First Exposure (8 Hours)||0
10114571|NCT02517567|11245334|FG003|NOT COMPLETED|First Exposure (8 Hours)||0
10114572|NCT02517567|11245331|FG000|STARTED|Second Exposure (8 Hours)||6
10114573|NCT02517567|11245332|FG001|STARTED|Second Exposure (8 Hours)||8
10114574|NCT02517567|11245333|FG002|STARTED|Second Exposure (8 Hours)||7
9693773|NCT00944216|10793750|FG000|STARTED|Overall Study||1
9693774|NCT00944216|10793750|FG000|COMPLETED|Overall Study||1
9693775|NCT00944216|10793750|FG000|NOT COMPLETED|Overall Study||0
10025152|NCT01869075|11149158|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
10114575|NCT02517567|11245334|FG003|STARTED|Second Exposure (8 Hours)||8
10114576|NCT02517567|11245331|FG000|COMPLETED|Second Exposure (8 Hours)||6
9693776|NCT00886691|10793757|FG000|STARTED|Overall Study||75
10025153|NCT01869075|11149159|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
10025154|NCT01869075|11149160|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
10025155|NCT01869075|11149161|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
10025156|NCT01869075|11149162|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
10114577|NCT02517567|11245332|FG001|COMPLETED|Second Exposure (8 Hours)||8
10114578|NCT02517567|11245333|FG002|COMPLETED|Second Exposure (8 Hours)||7
10114579|NCT02517567|11245334|FG003|COMPLETED|Second Exposure (8 Hours)||8
10114580|NCT02517567|11245331|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0
10114581|NCT02517567|11245332|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0
10114582|NCT02517567|11245333|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0
10114583|NCT02517567|11245334|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0
10114584|NCT02517567|11245331|FG000|STARTED|Third Exposure (8 Hours)||6
10114585|NCT02517567|11245332|FG001|STARTED|Third Exposure (8 Hours)||8
10114586|NCT02517567|11245333|FG002|STARTED|Third Exposure (8 Hours)||7
10025157|NCT01869075|11149163|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
10025158|NCT01869075|11149158|FG000|COMPLETED|Phase 1||45
10025159|NCT01869075|11149159|FG001|COMPLETED|Phase 1||75
10025160|NCT01869075|11149160|FG002|COMPLETED|Phase 1||45
10025161|NCT01869075|11149161|FG003|COMPLETED|Phase 1||75
10025162|NCT01869075|11149162|FG004|COMPLETED|Phase 1||30
10025163|NCT01869075|11149163|FG005|COMPLETED|Phase 1||90
10025164|NCT01869075|11149158|FG000|NOT COMPLETED|Phase 1||0
10025165|NCT01869075|11149159|FG001|NOT COMPLETED|Phase 1||0
10025166|NCT01869075|11149160|FG002|NOT COMPLETED|Phase 1||0
10025167|NCT01869075|11149161|FG003|NOT COMPLETED|Phase 1||0
10025168|NCT01869075|11149162|FG004|NOT COMPLETED|Phase 1||0
10025169|NCT01869075|11149163|FG005|NOT COMPLETED|Phase 1||0
10025170|NCT01869075|11149158|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
10025171|NCT01869075|11149159|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
10025172|NCT01869075|11149160|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
10025173|NCT01869075|11149161|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
10025174|NCT01869075|11149162|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
10025175|NCT01869075|11149163|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
10025176|NCT01869075|11149158|FG000|COMPLETED|Phase 2||90
10025177|NCT01869075|11149159|FG001|COMPLETED|Phase 2||30
10025178|NCT01869075|11149160|FG002|COMPLETED|Phase 2||75
10025179|NCT01869075|11149161|FG003|COMPLETED|Phase 2||45
10025180|NCT01869075|11149162|FG004|COMPLETED|Phase 2||75
10025181|NCT01869075|11149163|FG005|COMPLETED|Phase 2||45
10025182|NCT01869075|11149158|FG000|NOT COMPLETED|Phase 2||0
10025183|NCT01869075|11149159|FG001|NOT COMPLETED|Phase 2||0
10025184|NCT01869075|11149160|FG002|NOT COMPLETED|Phase 2||0
10025185|NCT01869075|11149161|FG003|NOT COMPLETED|Phase 2||0
10025186|NCT01869075|11149162|FG004|NOT COMPLETED|Phase 2||0
10025187|NCT01869075|11149163|FG005|NOT COMPLETED|Phase 2||0
10025188|NCT01869192|11149179|FG000|STARTED|Preoperative Chemotherapy to Surgery||37
10025189|NCT01869192|11149180|FG001|STARTED|Preoperative Chemotherapy to Surgery||35
10025190|NCT01869192|11149179|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35
10025191|NCT01869192|11149180|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
10025192|NCT01869192|11149179|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
10025193|NCT01869192|11149180|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
10025194|NCT01869192|11149179|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
10025195|NCT01869192|11149180|FG001|STARTED|Postoperative Chemotherapy||33
10025196|NCT01869192|11149179|FG000|COMPLETED|Postoperative Chemotherapy||32
10025197|NCT01869192|11149180|FG001|COMPLETED|Postoperative Chemotherapy||31
10025198|NCT01869192|11149179|FG000|NOT COMPLETED|Postoperative Chemotherapy||0
10025199|NCT01869192|11149180|FG001|NOT COMPLETED|Postoperative Chemotherapy||2
10025200|NCT01869348|11149188|FG000|STARTED|Overall Study||20
10025201|NCT01869348|11149189|FG001|STARTED|Overall Study||20
10025202|NCT01869348|11149188|FG000|COMPLETED|Overall Study||19
10025203|NCT01869348|11149189|FG001|COMPLETED|Overall Study||19
10025204|NCT01869348|11149188|FG000|NOT COMPLETED|Overall Study||1
10025205|NCT01869348|11149189|FG001|NOT COMPLETED|Overall Study||1
10025206|NCT01869374|11149197|FG000|STARTED|Overall Study||9
10025207|NCT01869374|11149198|FG001|STARTED|Overall Study||9
10025208|NCT01869374|11149197|FG000|COMPLETED|Overall Study||9
10025209|NCT01869374|11149198|FG001|COMPLETED|Overall Study||8
10025210|NCT01869374|11149197|FG000|NOT COMPLETED|Overall Study||0
10025211|NCT01869374|11149198|FG001|NOT COMPLETED|Overall Study||1
10025212|NCT01869439|11149204|FG000|STARTED|Overall Study||40
10025213|NCT01869439|11149204|FG000|COMPLETED|Overall Study||40
10025214|NCT01869439|11149204|FG000|NOT COMPLETED|Overall Study||0
10025215|NCT01869634|11149210|FG000|STARTED|Overall Study||20
10114587|NCT02517567|11245334|FG003|STARTED|Third Exposure (8 Hours)||8
10114588|NCT02517567|11245331|FG000|COMPLETED|Third Exposure (8 Hours)||6
10114589|NCT02517567|11245332|FG001|COMPLETED|Third Exposure (8 Hours)||8
10114590|NCT02517567|11245333|FG002|COMPLETED|Third Exposure (8 Hours)||7
10025216|NCT01869634|11149211|FG001|STARTED|Overall Study||17
10025217|NCT01869634|11149210|FG000|COMPLETED|Overall Study||18
10025218|NCT01869634|11149211|FG001|COMPLETED|Overall Study||17
10025219|NCT01869634|11149210|FG000|NOT COMPLETED|Overall Study||2
10025220|NCT01869634|11149211|FG001|NOT COMPLETED|Overall Study||0
10025221|NCT01869647|11149220|FG000|STARTED|Overall Study||66
10025222|NCT01869647|11149221|FG001|STARTED|Overall Study||136
10025223|NCT01869647|11149222|FG002|STARTED|Overall Study||62
10025224|NCT01869647|11149220|FG000|COMPLETED|Overall Study||65
10025225|NCT01869647|11149221|FG001|COMPLETED|Overall Study||130
10025226|NCT01869647|11149222|FG002|COMPLETED|Overall Study||62
10114591|NCT02517567|11245334|FG003|COMPLETED|Third Exposure (8 Hours)||8
10114592|NCT02517567|11245331|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0
10114593|NCT02517567|11245332|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0
10114594|NCT02517567|11245333|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0
10114595|NCT02517567|11245334|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0
10025227|NCT01869647|11149220|FG000|NOT COMPLETED|Overall Study||1
10025228|NCT01869647|11149221|FG001|NOT COMPLETED|Overall Study||6
10025229|NCT01869647|11149222|FG002|NOT COMPLETED|Overall Study||0
10025230|NCT01869686|11149230|FG000|STARTED|Overall Study||12
10025231|NCT01869686|11149230|FG000|COMPLETED|Overall Study||12
10025232|NCT01869686|11149230|FG000|NOT COMPLETED|Overall Study||0
10025233|NCT01869699|11149236|FG000|STARTED|Overall Study||21
10025234|NCT01869699|11149237|FG001|STARTED|Overall Study||20
10025235|NCT01869699|11149236|FG000|COMPLETED|Overall Study||20
10025236|NCT01869699|11149237|FG001|COMPLETED|Overall Study||20
10025237|NCT01869699|11149236|FG000|NOT COMPLETED|Overall Study||1
10025238|NCT01869699|11149237|FG001|NOT COMPLETED|Overall Study||0
10114596|NCT02517567|11245331|FG000|STARTED|Fourth Exposure (8 Hours)||6
10114597|NCT02517567|11245332|FG001|STARTED|Fourth Exposure (8 Hours)||8
10114598|NCT02517567|11245333|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
10114599|NCT02517567|11245334|FG003|STARTED|Fourth Exposure (8 Hours)||8
10114600|NCT02517567|11245331|FG000|COMPLETED|Fourth Exposure (8 Hours)||6
10114601|NCT02517567|11245332|FG001|COMPLETED|Fourth Exposure (8 Hours)||8
10114602|NCT02517567|11245333|FG002|COMPLETED|Fourth Exposure (8 Hours)||6
10114603|NCT02517567|11245334|FG003|COMPLETED|Fourth Exposure (8 Hours)||8
10114604|NCT02517567|11245331|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10114605|NCT02517567|11245332|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10114606|NCT02517567|11245333|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10114607|NCT02517567|11245334|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10114608|NCT02517580|11245343|FG000|STARTED|Overall Study||60
10114609|NCT02517580|11245343|FG000|COMPLETED|Overall Study||56
10114610|NCT02517580|11245343|FG000|NOT COMPLETED|Overall Study||4
10114611|NCT02517658|11245350|FG000|STARTED|Overall Study||33
10114612|NCT02517658|11245351|FG001|STARTED|Overall Study||33
9693777|NCT00886691|10793758|FG001|STARTED|Overall Study||75
9693778|NCT00886691|10793757|FG000|COMPLETED|Overall Study||75
9693779|NCT00886691|10793758|FG001|COMPLETED|Overall Study||75
9693780|NCT00886691|10793757|FG000|NOT COMPLETED|Overall Study||0
10025239|NCT01869725|11149243|FG000|STARTED|Overall Study||68
10025240|NCT01869725|11149243|FG000|COMPLETED|Overall Study||64
10025241|NCT01869725|11149243|FG000|NOT COMPLETED|Overall Study||4
10114613|NCT02517658|11245352|FG002|STARTED|Overall Study||33
10025242|NCT01869764|11149249|FG000|STARTED|Overall Study||28
9847058|NCT00852137|10959483|FG000|NOT COMPLETED|Overall Study||0
9847059|NCT00852137|10959484|FG001|NOT COMPLETED|Overall Study||0
9847060|NCT00852202|10959493|FG000|STARTED|Overall Study||77
9693781|NCT00886691|10793758|FG001|NOT COMPLETED|Overall Study||0
9693782|NCT00778999|10793770|FG000|STARTED|Overall Study||223
9693783|NCT00778999|10793771|FG001|STARTED|Overall Study||219
9693784|NCT00778999|10793770|FG000|COMPLETED|Overall Study||195
9693785|NCT00778999|10793771|FG001|COMPLETED|Overall Study||185
9693786|NCT00778999|10793770|FG000|NOT COMPLETED|Overall Study||28
9693787|NCT00778999|10793771|FG001|NOT COMPLETED|Overall Study||34
9693788|NCT00620464|10793779|FG000|STARTED|Overall Study||52
9693789|NCT00620464|10793780|FG001|STARTED|Overall Study||56
9693790|NCT00620464|10793779|FG000|COMPLETED|Overall Study||32
9693791|NCT00620464|10793780|FG001|COMPLETED|Overall Study||32
9693792|NCT00620464|10793779|FG000|NOT COMPLETED|Overall Study||20
9693793|NCT00620464|10793780|FG001|NOT COMPLETED|Overall Study||24
9693794|NCT00620035|10793786|FG000|STARTED|Overall Study||301
9693795|NCT00620035|10793786|FG000|COMPLETED|Overall Study||156
9693796|NCT00620035|10793786|FG000|NOT COMPLETED|Overall Study||145
9693797|NCT00210249|10793790|FG000|STARTED|Overall Study||364
9693798|NCT00210249|10793790|FG000|COMPLETED|Overall Study||348
9693799|NCT00210249|10793790|FG000|NOT COMPLETED|Overall Study||16
9727022|NCT00104637|10826591|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
9727023|NCT00104637|10826592|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
9727024|NCT00104637|10826591|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5
9727025|NCT00104637|10826592|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4
9727026|NCT00104637|10826591|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
9727027|NCT00104637|10826592|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
9727028|NCT00104637|10826591|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
9727029|NCT00104637|10826592|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
9727030|NCT00104637|10826591|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
9727031|NCT00104637|10826592|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
9727032|NCT00104637|10826591|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
9727033|NCT00104637|10826592|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
9727034|NCT00104637|10826591|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
9727035|NCT00104637|10826592|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
9727036|NCT00104650|10826604|FG000|STARTED|Treatment Period (25 Weeks)||37
9727037|NCT00104650|10826605|FG001|STARTED|Treatment Period (25 Weeks)||36
10025243|NCT01869764|11149250|FG001|STARTED|Overall Study||29
10025244|NCT01869764|11149249|FG000|COMPLETED|Overall Study||28
10025245|NCT01869764|11149250|FG001|COMPLETED|Overall Study||27
10025246|NCT01869764|11149249|FG000|NOT COMPLETED|Overall Study||0
10025247|NCT01869764|11149250|FG001|NOT COMPLETED|Overall Study||2
10025248|NCT01869777|11149256|FG000|STARTED|Overall Study||102
10025249|NCT01869777|11149256|FG000|COMPLETED|Overall Study||101
10025250|NCT01869777|11149256|FG000|NOT COMPLETED|Overall Study||1
10025251|NCT01869959|11149264|FG000|STARTED|Randomization Period||0
9693800|NCT03704142|10793798|FG000|STARTED|Overall Study||10
9693801|NCT03704142|10793799|FG001|STARTED|Overall Study||10
9693802|NCT03704142|10793800|FG002|STARTED|Overall Study||10
9693803|NCT03704142|10793801|FG003|STARTED|Overall Study||10
9693804|NCT03704142|10793798|FG000|COMPLETED|Overall Study||10
9693805|NCT03704142|10793799|FG001|COMPLETED|Overall Study||10
9693806|NCT03704142|10793800|FG002|COMPLETED|Overall Study||10
9693807|NCT03704142|10793801|FG003|COMPLETED|Overall Study||10
9693808|NCT03704142|10793798|FG000|NOT COMPLETED|Overall Study||0
9693809|NCT03704142|10793799|FG001|NOT COMPLETED|Overall Study||0
9693810|NCT03704142|10793800|FG002|NOT COMPLETED|Overall Study||0
9693811|NCT03704142|10793801|FG003|NOT COMPLETED|Overall Study||0
9727038|NCT00104650|10826606|FG002|STARTED|Treatment Period (25 Weeks)||38
9727039|NCT00104650|10826604|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35
9727040|NCT00104650|10826605|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35
9727041|NCT00104650|10826606|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38
9727042|NCT00104650|10826604|FG000|COMPLETED|Treatment Period (25 Weeks)||25
9727043|NCT00104650|10826605|FG001|COMPLETED|Treatment Period (25 Weeks)||25
9727044|NCT00104650|10826606|FG002|COMPLETED|Treatment Period (25 Weeks)||28
9727045|NCT00104650|10826604|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12
9727046|NCT00104650|10826605|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11
9727047|NCT00104650|10826606|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10
9727048|NCT00104650|10826604|FG000|STARTED|Follow-up Period||25
9727049|NCT00104650|10826605|FG001|STARTED|Follow-up Period||25
9727050|NCT00104650|10826606|FG002|STARTED|Follow-up Period||28
9727051|NCT00104650|10826604|FG000|COMPLETED|Follow-up Period||14
9727052|NCT00104650|10826605|FG001|COMPLETED|Follow-up Period||12
9727053|NCT00104650|10826606|FG002|COMPLETED|Follow-up Period||18
9727054|NCT00104650|10826604|FG000|NOT COMPLETED|Follow-up Period||11
9727055|NCT00104650|10826605|FG001|NOT COMPLETED|Follow-up Period||13
9727056|NCT00104650|10826606|FG002|NOT COMPLETED|Follow-up Period||10
9727057|NCT00104858|10826614|FG000|STARTED|Overall Study||52
9727058|NCT00104858|10826614|FG000|COMPLETED|Overall Study||52
9727059|NCT00104858|10826614|FG000|NOT COMPLETED|Overall Study||0
9727060|NCT00104871|10826620|FG000|STARTED|Overall Study||22
9727061|NCT00104871|10826620|FG000|COMPLETED|Overall Study||21
9727062|NCT00104871|10826620|FG000|NOT COMPLETED|Overall Study||1
9727063|NCT00104884|10826624|FG000|STARTED|Overall Study||4
9727064|NCT00104884|10826624|FG000|COMPLETED|Overall Study||0
9727065|NCT00104884|10826624|FG000|NOT COMPLETED|Overall Study||4
9727066|NCT00105001|10826631|FG000|STARTED|Overall Study||70
9727067|NCT00105001|10826632|FG001|STARTED|Overall Study||71
9727068|NCT00105001|10826633|FG002|STARTED|Overall Study||69
9727069|NCT00105001|10826631|FG000|COMPLETED|Overall Study||70
9727070|NCT00105001|10826632|FG001|COMPLETED|Overall Study||71
9727071|NCT00105001|10826633|FG002|COMPLETED|Overall Study||69
9727072|NCT00105001|10826631|FG000|NOT COMPLETED|Overall Study||0
9727073|NCT00105001|10826632|FG001|NOT COMPLETED|Overall Study||0
9727074|NCT00105001|10826633|FG002|NOT COMPLETED|Overall Study||0
9727075|NCT00105027|10826647|FG000|STARTED|Overall Study||88
9727076|NCT00105027|10826648|FG001|STARTED|Overall Study||92
9727077|NCT00105027|10826649|FG002|STARTED|Overall Study||91
9727078|NCT00105027|10826650|FG003|STARTED|Overall Study||137
9727079|NCT00105027|10826651|FG004|STARTED|Overall Study||136
9727080|NCT00105027|10826652|FG005|STARTED|Overall Study||138
9727081|NCT00105027|10826647|FG000|COMPLETED|Overall Study||73
9727082|NCT00105027|10826648|FG001|COMPLETED|Overall Study||83
9727083|NCT00105027|10826649|FG002|COMPLETED|Overall Study||82
9727084|NCT00105027|10826650|FG003|COMPLETED|Overall Study||121
9847061|NCT00852202|10959494|FG001|STARTED|Overall Study||75
9727085|NCT00105027|10826651|FG004|COMPLETED|Overall Study||121
9727086|NCT00105027|10826652|FG005|COMPLETED|Overall Study||125
9727087|NCT00105027|10826647|FG000|NOT COMPLETED|Overall Study||15
9727088|NCT00105027|10826648|FG001|NOT COMPLETED|Overall Study||9
9727089|NCT00105027|10826649|FG002|NOT COMPLETED|Overall Study||9
9727090|NCT00105027|10826650|FG003|NOT COMPLETED|Overall Study||16
9727091|NCT00105027|10826651|FG004|NOT COMPLETED|Overall Study||15
9727092|NCT00105027|10826652|FG005|NOT COMPLETED|Overall Study||13
9693812|NCT03692871|10793813|FG000|STARTED|Overall Study||1972
9693813|NCT03692871|10793814|FG001|STARTED|Overall Study||437
9693814|NCT03692871|10793813|FG000|COMPLETED|Overall Study||1847
9693815|NCT03692871|10793814|FG001|COMPLETED|Overall Study||400
9693816|NCT03692871|10793813|FG000|NOT COMPLETED|Overall Study||125
9693817|NCT03692871|10793814|FG001|NOT COMPLETED|Overall Study||37
9693818|NCT03626168|10793822|FG000|STARTED|First Intervention (4 Weeks)||9
9693819|NCT03626168|10793823|FG001|STARTED|First Intervention (4 Weeks)||12
9693820|NCT03626168|10793822|FG000|COMPLETED|First Intervention (4 Weeks)||8
9693821|NCT03626168|10793823|FG001|COMPLETED|First Intervention (4 Weeks)||11
9693822|NCT03626168|10793822|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1
9693823|NCT03626168|10793823|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
9693824|NCT03626168|10793822|FG000|STARTED|Washout (2 Weeks)||8
9693825|NCT03626168|10793823|FG001|STARTED|Washout (2 Weeks)||11
9693826|NCT03626168|10793822|FG000|COMPLETED|Washout (2 Weeks)||8
9693827|NCT03626168|10793823|FG001|COMPLETED|Washout (2 Weeks)||11
9693828|NCT03626168|10793822|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9693829|NCT03626168|10793823|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9693830|NCT03626168|10793822|FG000|STARTED|Second Intervention (4 Weeks)||8
9693831|NCT03626168|10793823|FG001|STARTED|Second Intervention (4 Weeks)||11
9693832|NCT03626168|10793822|FG000|COMPLETED|Second Intervention (4 Weeks)||8
9693833|NCT03626168|10793823|FG001|COMPLETED|Second Intervention (4 Weeks)||9
9693834|NCT03626168|10793822|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
9693835|NCT03626168|10793823|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
9693836|NCT03597035|10793829|FG000|STARTED|Overall Study||8
9693837|NCT03597035|10793829|FG000|COMPLETED|Overall Study||4
9693838|NCT03597035|10793829|FG000|NOT COMPLETED|Overall Study||4
9693839|NCT04823221|10793834|FG000|STARTED|Overall Study||22
9693840|NCT04823221|10793834|FG000|COMPLETED|Overall Study||22
9693841|NCT04823221|10793834|FG000|NOT COMPLETED|Overall Study||0
9693860|NCT04325906|10793868|FG000|STARTED|Overall Study||112
9693861|NCT04325906|10793869|FG001|STARTED|Overall Study||112
9693862|NCT04325906|10793868|FG000|COMPLETED|Overall Study||110
9693863|NCT04325906|10793869|FG001|COMPLETED|Overall Study||112
9693864|NCT04325906|10793868|FG000|NOT COMPLETED|Overall Study||2
9693865|NCT04325906|10793869|FG001|NOT COMPLETED|Overall Study||0
9693866|NCT04319445|10793875|FG000|STARTED|Overall Study||144
9693867|NCT04319445|10793875|FG000|COMPLETED|Overall Study||144
9693868|NCT04319445|10793875|FG000|NOT COMPLETED|Overall Study||0
9693869|NCT04203667|10793879|FG000|STARTED|Overall Study||66
9693870|NCT04203667|10793879|FG000|Per Protocol Population|Overall Study||45
9693871|NCT04203667|10793879|FG000|COMPLETED|Overall Study||62
9693872|NCT04203667|10793879|FG000|NOT COMPLETED|Overall Study||4
9693873|NCT03796637|10793884|FG000|STARTED|Overall Study||6
9693874|NCT03796637|10793884|FG000|COMPLETED|Overall Study||6
9693875|NCT03796637|10793884|FG000|NOT COMPLETED|Overall Study||0
9693876|NCT03679884|10793893|FG000|STARTED|Overall Study||142
9693877|NCT03679884|10793894|FG001|STARTED|Overall Study||268
9693878|NCT03679884|10793895|FG002|STARTED|Overall Study||137
9693879|NCT03679884|10793896|FG003|STARTED|Overall Study||128
9693880|NCT03679884|10793897|FG004|STARTED|Overall Study||126
9693881|NCT03679884|10793893|FG000|COMPLETED|Overall Study||99
9693882|NCT03679884|10793894|FG001|COMPLETED|Overall Study||190
9693883|NCT03679884|10793895|FG002|COMPLETED|Overall Study||93
9693884|NCT03679884|10793896|FG003|COMPLETED|Overall Study||78
9693885|NCT03679884|10793897|FG004|COMPLETED|Overall Study||90
9693886|NCT03679884|10793893|FG000|NOT COMPLETED|Overall Study||43
9693887|NCT03679884|10793894|FG001|NOT COMPLETED|Overall Study||78
9693888|NCT03679884|10793895|FG002|NOT COMPLETED|Overall Study||44
9693889|NCT03679884|10793896|FG003|NOT COMPLETED|Overall Study||50
9693890|NCT03679884|10793897|FG004|NOT COMPLETED|Overall Study||36
9693891|NCT03653026|10793911|FG000|STARTED|Part 1: Placebo-controlled Period||345
9693848|NCT04579393|10793849|FG000|STARTED|Overall Study||30
9693849|NCT04579393|10793850|FG001|STARTED|Overall Study||29
9693850|NCT04579393|10793849|FG000|COMPLETED|Overall Study||27
9693851|NCT04579393|10793850|FG001|COMPLETED|Overall Study||24
9693852|NCT04579393|10793849|FG000|NOT COMPLETED|Overall Study||3
9693853|NCT04579393|10793850|FG001|NOT COMPLETED|Overall Study||5
9693854|NCT04426656|10793859|FG000|STARTED|Overall Study||24
9693855|NCT04426656|10793860|FG001|STARTED|Overall Study||46
9693856|NCT04426656|10793859|FG000|COMPLETED|Overall Study||21
9693857|NCT04426656|10793860|FG001|COMPLETED|Overall Study||43
9693858|NCT04426656|10793859|FG000|NOT COMPLETED|Overall Study||3
9693859|NCT04426656|10793860|FG001|NOT COMPLETED|Overall Study||3
9693892|NCT03653026|10793912|FG001|STARTED|Part 1: Placebo-controlled Period||177
9693893|NCT03653026|10793913|FG002|STARTED|Part 1: Placebo-controlled Period||0
9693894|NCT03653026|10793914|FG003|STARTED|Part 1: Placebo-controlled Period||0
9693895|NCT03653026|10793911|FG000|Received Treatment|Part 1: Placebo-controlled Period||344
9693896|NCT03653026|10793912|FG001|Received Treatment|Part 1: Placebo-controlled Period||177
9693897|NCT03653026|10793913|FG002|Received Treatment|Part 1: Placebo-controlled Period||0
9693898|NCT03653026|10793914|FG003|Received Treatment|Part 1: Placebo-controlled Period||0
9693899|NCT03653026|10793911|FG000|COMPLETED|Part 1: Placebo-controlled Period||334
9693900|NCT03653026|10793912|FG001|COMPLETED|Part 1: Placebo-controlled Period||164
9693901|NCT03653026|10793913|FG002|COMPLETED|Part 1: Placebo-controlled Period||0
9693902|NCT03653026|10793914|FG003|COMPLETED|Part 1: Placebo-controlled Period||0
9693903|NCT03653026|10793911|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11
9693904|NCT03653026|10793912|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13
9693905|NCT03653026|10793913|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0
9693906|NCT03653026|10793914|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0
9693907|NCT03653026|10793911|FG000|STARTED|Part 2: Open-label Extension||0
9693908|NCT03653026|10793912|FG001|STARTED|Part 2: Open-label Extension||0
9693909|NCT03653026|10793913|FG002|STARTED|Part 2: Open-label Extension||68
9693910|NCT03653026|10793914|FG003|STARTED|Part 2: Open-label Extension||116
9693911|NCT03653026|10793911|FG000|COMPLETED|Part 2: Open-label Extension||0
9693912|NCT03653026|10793912|FG001|COMPLETED|Part 2: Open-label Extension||0
9693913|NCT03653026|10793913|FG002|COMPLETED|Part 2: Open-label Extension||65
9693914|NCT03653026|10793914|FG003|COMPLETED|Part 2: Open-label Extension||111
9693915|NCT03653026|10793911|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
9847062|NCT00852202|10959495|FG002|STARTED|Overall Study||75
9693916|NCT03653026|10793912|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
9847063|NCT00852202|10959493|FG000|COMPLETED|Overall Study||60
10025252|NCT01869959|11149265|FG001|STARTED|Randomization Period||0
10025253|NCT01869959|11149266|FG002|STARTED|Randomization Period||0
10025254|NCT01869959|11149267|FG003|STARTED|Randomization Period||0
10025255|NCT01869959|11149268|FG004|STARTED|Randomization Period||47
10025256|NCT01869959|11149264|FG000|COMPLETED|Randomization Period||0
10025257|NCT01869959|11149265|FG001|COMPLETED|Randomization Period||0
10025258|NCT01869959|11149266|FG002|COMPLETED|Randomization Period||0
10025259|NCT01869959|11149267|FG003|COMPLETED|Randomization Period||0
10025260|NCT01869959|11149268|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
9693917|NCT03653026|10793913|FG002|NOT COMPLETED|Part 2: Open-label Extension||3
9693918|NCT03653026|10793914|FG003|NOT COMPLETED|Part 2: Open-label Extension||5
9693919|NCT03648827|10793922|FG000|STARTED|Overall Study||20
9693920|NCT03648827|10793922|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10025261|NCT01869959|11149264|FG000|NOT COMPLETED|Randomization Period||0
10025262|NCT01869959|11149265|FG001|NOT COMPLETED|Randomization Period||0
10025263|NCT01869959|11149266|FG002|NOT COMPLETED|Randomization Period||0
10025264|NCT01869959|11149267|FG003|NOT COMPLETED|Randomization Period||0
10025265|NCT01869959|11149268|FG004|NOT COMPLETED|Randomization Period||1
10025266|NCT01869959|11149264|FG000|STARTED|Treatment Period||11
9693921|NCT03648827|10793922|FG000|COMPLETED|Overall Study||20
9693922|NCT03648827|10793922|FG000|NOT COMPLETED|Overall Study||0
9693923|NCT03553498|10793928|FG000|STARTED|Overall Study||81
9693924|NCT03553498|10793929|FG001|STARTED|Overall Study||81
9693925|NCT03553498|10793928|FG000|COMPLETED|Overall Study||80
9693926|NCT03553498|10793929|FG001|COMPLETED|Overall Study||79
9693927|NCT03553498|10793928|FG000|NOT COMPLETED|Overall Study||1
9693928|NCT03553498|10793929|FG001|NOT COMPLETED|Overall Study||2
9693929|NCT03530293|10793937|FG000|STARTED|Pre-randomization||81
9693930|NCT03530293|10793938|FG001|STARTED|Pre-randomization||0
9693931|NCT03530293|10793939|FG002|STARTED|Pre-randomization||0
9693932|NCT03530293|10793937|FG000|Safety Analysis Set|Pre-randomization||80
9693933|NCT03530293|10793938|FG001|Safety Analysis Set|Pre-randomization||0
9693934|NCT03530293|10793939|FG002|Safety Analysis Set|Pre-randomization||0
10025267|NCT01869959|11149265|FG001|STARTED|Treatment Period||10
9693935|NCT03530293|10793937|FG000|COMPLETED|Pre-randomization||57
9693936|NCT03530293|10793938|FG001|COMPLETED|Pre-randomization||0
9693937|NCT03530293|10793939|FG002|COMPLETED|Pre-randomization||0
9693938|NCT03530293|10793937|FG000|NOT COMPLETED|Pre-randomization||24
9693939|NCT03530293|10793938|FG001|NOT COMPLETED|Pre-randomization||0
9693940|NCT03530293|10793939|FG002|NOT COMPLETED|Pre-randomization||0
9693941|NCT03530293|10793937|FG000|STARTED|Randomized Withdrawal Period / Follow-up||0
9693942|NCT03530293|10793938|FG001|STARTED|Randomized Withdrawal Period / Follow-up||26
9693943|NCT03530293|10793939|FG002|STARTED|Randomized Withdrawal Period / Follow-up||26
9693944|NCT03530293|10793937|FG000|COMPLETED|Randomized Withdrawal Period / Follow-up||0
9693945|NCT03530293|10793938|FG001|COMPLETED|Randomized Withdrawal Period / Follow-up||9
9693946|NCT03530293|10793939|FG002|COMPLETED|Randomized Withdrawal Period / Follow-up||9
9693947|NCT03530293|10793937|FG000|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||0
9693948|NCT03530293|10793938|FG001|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
9693949|NCT03530293|10793939|FG002|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
9693950|NCT03505749|10793948|FG000|STARTED|Overall Study||38
9693951|NCT03505749|10793949|FG001|STARTED|Overall Study||45
9693952|NCT03505749|10793948|FG000|COMPLETED|Overall Study||22
9693953|NCT03505749|10793949|FG001|COMPLETED|Overall Study||28
9693954|NCT03505749|10793948|FG000|NOT COMPLETED|Overall Study||16
9693955|NCT03505749|10793949|FG001|NOT COMPLETED|Overall Study||17
9727093|NCT00105066|10826668|FG000|STARTED|Overall Study||27
9727094|NCT00105066|10826669|FG001|STARTED|Overall Study||50
9727095|NCT00105066|10826668|FG000|COMPLETED|Overall Study||25
9727096|NCT00105066|10826669|FG001|COMPLETED|Overall Study||45
9727097|NCT00105066|10826668|FG000|NOT COMPLETED|Overall Study||2
9727098|NCT00105066|10826669|FG001|NOT COMPLETED|Overall Study||5
9727099|NCT00105079|10826677|FG000|STARTED|Overall Study||167
9727100|NCT00105079|10826678|FG001|STARTED|Overall Study||170
10025268|NCT01869959|11149266|FG002|STARTED|Treatment Period||15
10025269|NCT01869959|11149267|FG003|STARTED|Treatment Period||10
10025270|NCT01869959|11149268|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
10025271|NCT01869959|11149264|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11
10025272|NCT01869959|11149265|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10
10025273|NCT01869959|11149266|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15
10025274|NCT01869959|11149267|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10
10114614|NCT02517658|11245350|FG000|COMPLETED|Overall Study||33
10114615|NCT02517658|11245351|FG001|COMPLETED|Overall Study||33
10025275|NCT01869959|11149268|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
10025276|NCT01869959|11149264|FG000|COMPLETED|Treatment Period||10
10025277|NCT01869959|11149265|FG001|COMPLETED|Treatment Period||8
10025278|NCT01869959|11149266|FG002|COMPLETED|Treatment Period||12
10025279|NCT01869959|11149267|FG003|COMPLETED|Treatment Period||8
10025280|NCT01869959|11149268|FG004|COMPLETED|Treatment Period||0
10025281|NCT01869959|11149264|FG000|NOT COMPLETED|Treatment Period||1
10025282|NCT01869959|11149265|FG001|NOT COMPLETED|Treatment Period||2
10025283|NCT01869959|11149266|FG002|NOT COMPLETED|Treatment Period||3
10025284|NCT01869959|11149267|FG003|NOT COMPLETED|Treatment Period||2
10025285|NCT01869959|11149268|FG004|NOT COMPLETED|Treatment Period||0
9847064|NCT00852202|10959494|FG001|COMPLETED|Overall Study||63
9847065|NCT00852202|10959495|FG002|COMPLETED|Overall Study||49
9847066|NCT00852202|10959493|FG000|NOT COMPLETED|Overall Study||17
9847067|NCT00852202|10959494|FG001|NOT COMPLETED|Overall Study||12
9847068|NCT00852202|10959495|FG002|NOT COMPLETED|Overall Study||26
9847069|NCT00852397|10959507|FG000|STARTED|Overall Study||52
9847070|NCT00852397|10959508|FG001|STARTED|Overall Study||49
10025286|NCT01870076|11149282|FG000|STARTED|Overall Study||10
10025287|NCT01870076|11149283|FG001|STARTED|Overall Study||12
10025288|NCT01870076|11149284|FG002|STARTED|Overall Study||8
9847071|NCT00852397|10959509|FG002|STARTED|Overall Study||50
9847072|NCT00852397|10959507|FG000|Treated Participants|Overall Study||51
9693956|NCT03472885|10793958|FG000|STARTED|Overall Study||12
9693957|NCT03472885|10793958|FG000|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
9693958|NCT03472885|10793958|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
9693959|NCT03472885|10793958|FG000|COMPLETED|Overall Study||11
9693960|NCT03472885|10793958|FG000|NOT COMPLETED|Overall Study||1
9693961|NCT03311269|10793964|FG000|STARTED|Overall Study||10
9693962|NCT03311269|10793965|FG001|STARTED|Overall Study||9
9693963|NCT03311269|10793964|FG000|COMPLETED|Overall Study||10
10025289|NCT01870076|11149285|FG003|STARTED|Overall Study||11
10025290|NCT01870076|11149282|FG000|COMPLETED|Overall Study||9
10025291|NCT01870076|11149283|FG001|COMPLETED|Overall Study||12
10025292|NCT01870076|11149284|FG002|COMPLETED|Overall Study||7
10025293|NCT01870076|11149285|FG003|COMPLETED|Overall Study||11
10025294|NCT01870076|11149282|FG000|NOT COMPLETED|Overall Study||1
10025295|NCT01870076|11149283|FG001|NOT COMPLETED|Overall Study||0
10025296|NCT01870076|11149284|FG002|NOT COMPLETED|Overall Study||1
10025297|NCT01870076|11149285|FG003|NOT COMPLETED|Overall Study||0
10025298|NCT01870297|11149302|FG000|STARTED|Overall Study||11
10025299|NCT01870297|11149303|FG001|STARTED|Overall Study||15
10025300|NCT01870297|11149304|FG002|STARTED|Overall Study||8
10114616|NCT02517658|11245352|FG002|COMPLETED|Overall Study||33
10114617|NCT02517658|11245350|FG000|NOT COMPLETED|Overall Study||0
10114618|NCT02517658|11245351|FG001|NOT COMPLETED|Overall Study||0
10114619|NCT02517658|11245352|FG002|NOT COMPLETED|Overall Study||0
10114620|NCT02517866|11245360|FG000|STARTED|Overall Study||289
10114621|NCT02517866|11245361|FG001|STARTED|Overall Study||90
10114622|NCT02517866|11245362|FG002|STARTED|Overall Study||1
10114623|NCT02517866|11245360|FG000|COMPLETED|Overall Study||269
10114624|NCT02517866|11245361|FG001|COMPLETED|Overall Study||84
10114625|NCT02517866|11245362|FG002|COMPLETED|Overall Study||1
10114626|NCT02517866|11245360|FG000|NOT COMPLETED|Overall Study||20
10114627|NCT02517866|11245361|FG001|NOT COMPLETED|Overall Study||6
10114628|NCT02517866|11245362|FG002|NOT COMPLETED|Overall Study||0
10114629|NCT02517905|11245374|FG000|STARTED|Overall Study||107
9693964|NCT03311269|10793965|FG001|COMPLETED|Overall Study||9
10114630|NCT02517905|11245375|FG001|STARTED|Overall Study||59
10114631|NCT02517905|11245374|FG000|COMPLETED|Overall Study||97
10114632|NCT02517905|11245375|FG001|COMPLETED|Overall Study||57
10114633|NCT02517905|11245374|FG000|NOT COMPLETED|Overall Study||10
10114634|NCT02517905|11245375|FG001|NOT COMPLETED|Overall Study||2
10114635|NCT02517996|11245383|FG000|STARTED|Overall Study||8
10114636|NCT02517996|11245384|FG001|STARTED|Overall Study||9
10114637|NCT02517996|11245383|FG000|COMPLETED|Overall Study||8
9693965|NCT03311269|10793964|FG000|NOT COMPLETED|Overall Study||0
9693966|NCT03311269|10793965|FG001|NOT COMPLETED|Overall Study||0
9693967|NCT03249376|10793973|FG000|STARTED|Overall Study|191 patients were randomized but only 188 patients received study drug. The number completed and discontinued is based on the 188 patients that received study drug.|188
9693968|NCT03249376|10793974|FG001|STARTED|Overall Study|190 patients were randomized but only 189 patients received study drug. The number completed and discontinued is based on the 189 patients that received study drug.|189
9693969|NCT03249376|10793973|FG000|COMPLETED|Overall Study||167
9693970|NCT03249376|10793974|FG001|COMPLETED|Overall Study||166
9693971|NCT03249376|10793973|FG000|NOT COMPLETED|Overall Study||21
9693972|NCT03249376|10793974|FG001|NOT COMPLETED|Overall Study||23
9727101|NCT00105079|10826677|FG000|Safety Population|Overall Study||163
9727102|NCT00105079|10826678|FG001|Safety Population|Overall Study||168
10114638|NCT02517996|11245384|FG001|COMPLETED|Overall Study||9
9693973|NCT03118570|10793985|FG000|STARTED|Overall Study||31
9693974|NCT03118570|10793986|FG001|STARTED|Overall Study||29
9693975|NCT03118570|10793987|FG002|STARTED|Overall Study||30
9693976|NCT03118570|10793988|FG003|STARTED|Overall Study||2
9693977|NCT03118570|10793989|FG004|STARTED|Overall Study||20
9693978|NCT03118570|10793985|FG000|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
9693979|NCT03118570|10793986|FG001|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
9693980|NCT03118570|10793987|FG002|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
9693981|NCT03118570|10793988|FG003|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
9693982|NCT03118570|10793989|FG004|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||19
9693983|NCT03118570|10793985|FG000|COMPLETED|Overall Study||26
9693984|NCT03118570|10793986|FG001|COMPLETED|Overall Study||22
9693985|NCT03118570|10793987|FG002|COMPLETED|Overall Study||25
9693986|NCT03118570|10793988|FG003|COMPLETED|Overall Study||2
9693987|NCT03118570|10793989|FG004|COMPLETED|Overall Study||15
9693988|NCT03118570|10793985|FG000|NOT COMPLETED|Overall Study||5
9693989|NCT03118570|10793986|FG001|NOT COMPLETED|Overall Study||7
9693990|NCT03118570|10793987|FG002|NOT COMPLETED|Overall Study||5
9693991|NCT03118570|10793988|FG003|NOT COMPLETED|Overall Study||0
9693992|NCT03118570|10793989|FG004|NOT COMPLETED|Overall Study||5
9693993|NCT03094416|10794002|FG000|STARTED|Run-in||66
9693994|NCT03094416|10794002|FG000|COMPLETED|Run-in||47
9693995|NCT03094416|10794002|FG000|NOT COMPLETED|Run-in||19
9693996|NCT03094416|10794002|FG000|STARTED|Treatment Period||47
9693997|NCT03094416|10794002|FG000|COMPLETED|Treatment Period||45
9693998|NCT03094416|10794002|FG000|NOT COMPLETED|Treatment Period||2
9693999|NCT02811861|10794010|FG000|STARTED|Overall Study||357
9694000|NCT02811861|10794011|FG001|STARTED|Overall Study||355
9694001|NCT02811861|10794012|FG002|STARTED|Overall Study||357
9694002|NCT02811861|10794010|FG000|Treated|Overall Study||355
9694003|NCT02811861|10794011|FG001|Treated|Overall Study||352
9694004|NCT02811861|10794012|FG002|Treated|Overall Study||340
9694005|NCT02811861|10794010|FG000|COMPLETED|Overall Study||0
9694006|NCT02811861|10794011|FG001|COMPLETED|Overall Study||0
9694007|NCT02811861|10794012|FG002|COMPLETED|Overall Study||0
9694008|NCT02811861|10794010|FG000|NOT COMPLETED|Overall Study||357
9694009|NCT02811861|10794011|FG001|NOT COMPLETED|Overall Study||355
9694010|NCT02811861|10794012|FG002|NOT COMPLETED|Overall Study||357
9694051|NCT02580058|10794056|FG000|STARTED|Overall Study||188
10025301|NCT01870297|11149305|FG003|STARTED|Overall Study||9
10025302|NCT01870297|11149306|FG004|STARTED|Overall Study||10
10025303|NCT01870297|11149307|FG005|STARTED|Overall Study||9
10025304|NCT01870297|11149308|FG006|STARTED|Overall Study||10
10025305|NCT01870297|11149302|FG000|COMPLETED|Overall Study||11
10025306|NCT01870297|11149303|FG001|COMPLETED|Overall Study||8
9694052|NCT02580058|10794057|FG001|STARTED|Overall Study||188
9694053|NCT02580058|10794058|FG002|STARTED|Overall Study||190
9694054|NCT02580058|10794056|FG000|Treated|Overall Study||187
9694055|NCT02580058|10794057|FG001|Treated|Overall Study||182
10025307|NCT01870297|11149304|FG002|COMPLETED|Overall Study||7
10025308|NCT01870297|11149305|FG003|COMPLETED|Overall Study||9
9694056|NCT02580058|10794058|FG002|Treated|Overall Study||177
9694057|NCT02580058|10794056|FG000|COMPLETED|Overall Study||109
9694058|NCT02580058|10794057|FG001|COMPLETED|Overall Study||102
9694059|NCT02580058|10794058|FG002|COMPLETED|Overall Study||104
9694060|NCT02580058|10794056|FG000|NOT COMPLETED|Overall Study||79
9694061|NCT02580058|10794057|FG001|NOT COMPLETED|Overall Study||86
9694062|NCT02580058|10794058|FG002|NOT COMPLETED|Overall Study||86
9694063|NCT02578680|10794068|FG000|STARTED|Overall Study||410
9694064|NCT02578680|10794069|FG001|STARTED|Overall Study||206
9694065|NCT02578680|10794068|FG000|Treated|Overall Study||405
9694066|NCT02578680|10794069|FG001|Treated|Overall Study||202
9694067|NCT02578680|10794068|FG000|Switched to Pembrolizumab|Overall Study||0
10025309|NCT01870297|11149306|FG004|COMPLETED|Overall Study||7
10025310|NCT01870297|11149307|FG005|COMPLETED|Overall Study||8
10025311|NCT01870297|11149308|FG006|COMPLETED|Overall Study||8
9694011|NCT02734667|10794022|FG000|STARTED|Overall Study||84
9694012|NCT02734667|10794023|FG001|STARTED|Overall Study||36
9694013|NCT02734667|10794022|FG000|Youth|Overall Study||42
9694014|NCT02734667|10794023|FG001|Youth|Overall Study||18
9694015|NCT02734667|10794022|FG000|Parent|Overall Study||42
9694016|NCT02734667|10794023|FG001|Parent|Overall Study||18
9694017|NCT02734667|10794022|FG000|COMPLETED|Overall Study||82
9694018|NCT02734667|10794023|FG001|COMPLETED|Overall Study||30
9694019|NCT02734667|10794022|FG000|NOT COMPLETED|Overall Study||2
9694020|NCT02734667|10794023|FG001|NOT COMPLETED|Overall Study||6
9694021|NCT02709317|10794031|FG000|STARTED|Overall Study||50
9694022|NCT02709317|10794032|FG001|STARTED|Overall Study||58
9694023|NCT02709317|10794031|FG000|COMPLETED|Overall Study||18
9694024|NCT02709317|10794032|FG001|COMPLETED|Overall Study||31
9694025|NCT02709317|10794031|FG000|NOT COMPLETED|Overall Study||32
9694026|NCT02709317|10794032|FG001|NOT COMPLETED|Overall Study||27
9694027|NCT02607930|10794040|FG000|STARTED|Double-Blinded Treatment Phase||316
9694028|NCT02607930|10794041|FG001|STARTED|Double-Blinded Treatment Phase||315
9694029|NCT02607930|10794042|FG002|STARTED|Double-Blinded Treatment Phase||0
9694030|NCT02607930|10794043|FG003|STARTED|Double-Blinded Treatment Phase||0
9694031|NCT02607930|10794040|FG000|COMPLETED|Double-Blinded Treatment Phase||262
9694032|NCT02607930|10794041|FG001|COMPLETED|Double-Blinded Treatment Phase||262
9694033|NCT02607930|10794042|FG002|COMPLETED|Double-Blinded Treatment Phase||0
9694034|NCT02607930|10794043|FG003|COMPLETED|Double-Blinded Treatment Phase||0
9694035|NCT02607930|10794040|FG000|NOT COMPLETED|Double-Blinded Treatment Phase||54
9694036|NCT02607930|10794041|FG001|NOT COMPLETED|Double-Blinded Treatment Phase||53
9694037|NCT02607930|10794042|FG002|NOT COMPLETED|Double-Blinded Treatment Phase||0
9694038|NCT02607930|10794043|FG003|NOT COMPLETED|Double-Blinded Treatment Phase||0
9694039|NCT02607930|10794040|FG000|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
9694040|NCT02607930|10794041|FG001|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
9694041|NCT02607930|10794042|FG002|STARTED|Open-Label B/F/TAF Extension Phase|10 participants from B/F/TAF arm did not enter the Open-Label Extension Phase.|252
9694042|NCT02607930|10794043|FG003|STARTED|Open-Label B/F/TAF Extension Phase|8 participants from the ABC/DTG/3TC arm did not enter the Open-Label Extension Phase.|254
9694043|NCT02607930|10794040|FG000|COMPLETED|Open-Label B/F/TAF Extension Phase||0
9694044|NCT02607930|10794041|FG001|COMPLETED|Open-Label B/F/TAF Extension Phase||0
9694045|NCT02607930|10794042|FG002|COMPLETED|Open-Label B/F/TAF Extension Phase||218
9694046|NCT02607930|10794043|FG003|COMPLETED|Open-Label B/F/TAF Extension Phase||221
9694047|NCT02607930|10794040|FG000|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
9694048|NCT02607930|10794041|FG001|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
9694049|NCT02607930|10794042|FG002|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||34
9694050|NCT02607930|10794043|FG003|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||33
9961505|NCT01473992|11081255|FG002|NOT COMPLETED|Overall Study||0
10025312|NCT01870297|11149302|FG000|NOT COMPLETED|Overall Study||0
10025313|NCT01870297|11149303|FG001|NOT COMPLETED|Overall Study||7
10025314|NCT01870297|11149304|FG002|NOT COMPLETED|Overall Study||1
10025315|NCT01870297|11149305|FG003|NOT COMPLETED|Overall Study||0
10114639|NCT02517996|11245383|FG000|NOT COMPLETED|Overall Study||0
10114640|NCT02517996|11245384|FG001|NOT COMPLETED|Overall Study||0
9694068|NCT02578680|10794069|FG001|Switched to Pembrolizumab|Overall Study||67
10025316|NCT01870297|11149306|FG004|NOT COMPLETED|Overall Study||3
10025317|NCT01870297|11149307|FG005|NOT COMPLETED|Overall Study||1
9847073|NCT00852397|10959508|FG001|Treated Participants|Overall Study||49
9847074|NCT00852397|10959509|FG002|Treated Participants|Overall Study||49
9847075|NCT00852397|10959507|FG000|COMPLETED|Overall Study||41
9847076|NCT00852397|10959508|FG001|COMPLETED|Overall Study||41
9847077|NCT00852397|10959509|FG002|COMPLETED|Overall Study||36
9847078|NCT00852397|10959507|FG000|NOT COMPLETED|Overall Study||11
9847079|NCT00852397|10959508|FG001|NOT COMPLETED|Overall Study||8
9847080|NCT00852397|10959509|FG002|NOT COMPLETED|Overall Study||14
9847081|NCT00852475|10959519|FG000|STARTED|Overall Study||26
9847082|NCT00852475|10959520|FG001|STARTED|Overall Study||20
9847083|NCT00852475|10959519|FG000|COMPLETED|Overall Study||23
9847084|NCT00852475|10959520|FG001|COMPLETED|Overall Study||16
9847085|NCT00852475|10959519|FG000|NOT COMPLETED|Overall Study||3
9847086|NCT00852475|10959520|FG001|NOT COMPLETED|Overall Study||4
9847087|NCT00852527|10959528|FG000|STARTED|Overall Study||196
9847088|NCT00852527|10959529|FG001|STARTED|Overall Study||242
9847089|NCT00852527|10959528|FG000|COMPLETED|Overall Study||196
9847090|NCT00852527|10959529|FG001|COMPLETED|Overall Study||242
9847091|NCT00852527|10959528|FG000|NOT COMPLETED|Overall Study||0
9847092|NCT00852527|10959529|FG001|NOT COMPLETED|Overall Study||0
9847093|NCT00852540|10959536|FG000|STARTED|Overall Study||270
9847094|NCT00852540|10959537|FG001|STARTED|Overall Study||140
9847095|NCT00852540|10959536|FG000|COMPLETED|Overall Study||234
9961506|NCT01474018|11081265|FG000|STARTED|Overall Study||5
9961507|NCT01474018|11081266|FG001|STARTED|Overall Study||10
9961508|NCT01474018|11081265|FG000|COMPLETED|Overall Study|Writing paper|5
9961509|NCT01474018|11081266|FG001|COMPLETED|Overall Study||7
9961510|NCT01474018|11081265|FG000|NOT COMPLETED|Overall Study||0
9961511|NCT01474018|11081266|FG001|NOT COMPLETED|Overall Study||3
9961512|NCT01474109|11081275|FG000|STARTED|Period 1: Baseline to Week 16||95
9961513|NCT01474109|11081276|FG001|STARTED|Period 1: Baseline to Week 16||97
9961514|NCT01474109|11081277|FG002|STARTED|Period 1: Baseline to Week 16||97
9961515|NCT01474109|11081275|FG000|COMPLETED|Period 1: Baseline to Week 16||88
9961516|NCT01474109|11081276|FG001|COMPLETED|Period 1: Baseline to Week 16||91
9961517|NCT01474109|11081277|FG002|COMPLETED|Period 1: Baseline to Week 16||95
9961518|NCT01474109|11081275|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7
9961519|NCT01474109|11081276|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6
9961520|NCT01474109|11081277|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2
9961521|NCT01474109|11081275|FG000|STARTED|Period 2: Week 16 to End of Study||88
9961522|NCT01474109|11081276|FG001|STARTED|Period 2: Week 16 to End of Study||91
9961523|NCT01474109|11081277|FG002|STARTED|Period 2: Week 16 to End of Study||95
9961524|NCT01474109|11081275|FG000|COMPLETED|Period 2: Week 16 to End of Study||70
9961525|NCT01474109|11081276|FG001|COMPLETED|Period 2: Week 16 to End of Study||73
9961526|NCT01474109|11081277|FG002|COMPLETED|Period 2: Week 16 to End of Study||83
9961527|NCT01474109|11081275|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18
9961528|NCT01474109|11081276|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18
9961529|NCT01474109|11081277|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12
9961530|NCT01474122|11081288|FG000|STARTED|Period 1: Baseline to Week 16||88
9961531|NCT01474122|11081289|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
9961532|NCT01474122|11081290|FG002|STARTED|Period 1: Baseline to Week 16||89
9961533|NCT01474122|11081288|FG000|COMPLETED|Period 1: Baseline to Week 16||87
9961534|NCT01474122|11081289|FG001|COMPLETED|Period 1: Baseline to Week 16||86
9847096|NCT00852540|10959537|FG001|COMPLETED|Overall Study||122
9847097|NCT00852540|10959536|FG000|NOT COMPLETED|Overall Study||36
9847098|NCT00852540|10959537|FG001|NOT COMPLETED|Overall Study||18
9847099|NCT00852592|10959546|FG000|STARTED|Overall Study||23
9847100|NCT00852592|10959547|FG001|STARTED|Overall Study||23
9847101|NCT00852592|10959546|FG000|COMPLETED|Overall Study||20
9847102|NCT00852592|10959547|FG001|COMPLETED|Overall Study||19
9961535|NCT01474122|11081290|FG002|COMPLETED|Period 1: Baseline to Week 16||88
9694069|NCT02578680|10794068|FG000|COMPLETED|Overall Study||0
9694070|NCT02578680|10794069|FG001|COMPLETED|Overall Study||0
9694071|NCT02578680|10794068|FG000|NOT COMPLETED|Overall Study||410
9694072|NCT02578680|10794069|FG001|NOT COMPLETED|Overall Study||206
9694073|NCT02513485|10794077|FG000|STARTED|Overall Study||28
9694074|NCT02513485|10794078|FG001|STARTED|Overall Study||29
9694075|NCT02513485|10794077|FG000|COMPLETED|Overall Study||27
9694076|NCT02513485|10794078|FG001|COMPLETED|Overall Study||29
9694077|NCT02513485|10794077|FG000|NOT COMPLETED|Overall Study||1
9694078|NCT02513485|10794078|FG001|NOT COMPLETED|Overall Study||0
9694079|NCT02476201|10794084|FG000|STARTED|Overall Study||105
9694080|NCT02476201|10794084|FG000|Implant Attempts|Overall Study||103
9694081|NCT02476201|10794084|FG000|Sucessful Implants|Overall Study||102
9694082|NCT02476201|10794084|FG000|6 Months Visit|Overall Study||82
9694083|NCT02476201|10794084|FG000|COMPLETED|Overall Study||79
9694084|NCT02476201|10794084|FG000|NOT COMPLETED|Overall Study||26
9847103|NCT00852592|10959546|FG000|NOT COMPLETED|Overall Study||3
9847104|NCT00852592|10959547|FG001|NOT COMPLETED|Overall Study||4
9847105|NCT00852631|10959553|FG000|STARTED|Overall Study||28
9847106|NCT00852631|10959553|FG000|COMPLETED|Overall Study||17
9847107|NCT00852631|10959553|FG000|NOT COMPLETED|Overall Study||11
9847108|NCT00852644|10959557|FG000|STARTED|Overall Study||3
9847109|NCT00852644|10959558|FG001|STARTED|Overall Study||3
9847110|NCT00852644|10959559|FG002|STARTED|Overall Study||0
10025318|NCT01870297|11149308|FG006|NOT COMPLETED|Overall Study||2
10025319|NCT01870388|11149335|FG000|STARTED|Overall Study||8
10025320|NCT01870388|11149336|FG001|STARTED|Overall Study||8
10025321|NCT01870388|11149335|FG000|Received 1 Dose of Study Drug|Overall Study||8
10025322|NCT01870388|11149336|FG001|Received 1 Dose of Study Drug|Overall Study||8
9694093|NCT01399658|10794269|FG000|STARTED|Overall Study||93
9694094|NCT01399658|10794269|FG000|COMPLETED|Overall Study||87
9847111|NCT00852644|10959560|FG003|STARTED|Overall Study||3
9847112|NCT00852644|10959561|FG004|STARTED|Overall Study||0
10025323|NCT01870388|11149335|FG000|COMPLETED|Overall Study||8
9694095|NCT01399658|10794269|FG000|NOT COMPLETED|Overall Study||6
9694096|NCT01397968|10794275|FG000|STARTED|Double-blind Period of Study YKP3089C013||113
9694097|NCT01397968|10794276|FG001|STARTED|Double-blind Period of Study YKP3089C013||109
9694098|NCT01397968|10794275|FG000|COMPLETED|Double-blind Period of Study YKP3089C013||102
9694099|NCT01397968|10794276|FG001|COMPLETED|Double-blind Period of Study YKP3089C013||99
9694100|NCT01397968|10794275|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C013||11
9694101|NCT01397968|10794276|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C013||10
9694102|NCT01397968|10794275|FG000|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|76
9694103|NCT01397968|10794276|FG001|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|73
9694104|NCT01397968|10794275|FG000|COMPLETED|Open-label Extension Study YKP3089C013||40
9694105|NCT01397968|10794276|FG001|COMPLETED|Open-label Extension Study YKP3089C013||37
9694106|NCT01397968|10794275|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
9694107|NCT01397968|10794276|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
9694108|NCT01365195|10794287|FG000|STARTED|Overall Study||6
9694109|NCT01365195|10794288|FG001|STARTED|Overall Study||8
9694110|NCT01365195|10794289|FG002|STARTED|Overall Study||7
9694111|NCT01365195|10794287|FG000|COMPLETED|Overall Study||6
9694112|NCT01365195|10794288|FG001|COMPLETED|Overall Study||8
9694113|NCT01365195|10794289|FG002|COMPLETED|Overall Study||7
9694114|NCT01365195|10794287|FG000|NOT COMPLETED|Overall Study||0
9694115|NCT01365195|10794288|FG001|NOT COMPLETED|Overall Study||0
9694116|NCT01365195|10794289|FG002|NOT COMPLETED|Overall Study||0
9727103|NCT00105079|10826677|FG000|COMPLETED|Overall Study||128
9727104|NCT00105079|10826678|FG001|COMPLETED|Overall Study||135
9727105|NCT00105079|10826677|FG000|NOT COMPLETED|Overall Study||39
9727106|NCT00105079|10826678|FG001|NOT COMPLETED|Overall Study||35
9727107|NCT00105157|10826688|FG000|STARTED|Double-Blind (DB)||44
9727108|NCT00105157|10826689|FG001|STARTED|Double-Blind (DB)||45
9727109|NCT00105157|10826690|FG002|STARTED|Double-Blind (DB)||45
9727110|NCT00105157|10826691|FG003|STARTED|Double-Blind (DB)||45
9727111|NCT00105157|10826688|FG000|Treated|Double-Blind (DB)||43
9727112|NCT00105157|10826689|FG001|Treated|Double-Blind (DB)||45
9727113|NCT00105157|10826690|FG002|Treated|Double-Blind (DB)||45
9727114|NCT00105157|10826691|FG003|Treated|Double-Blind (DB)||45
9727115|NCT00105157|10826688|FG000|COMPLETED|Double-Blind (DB)||30
9727116|NCT00105157|10826689|FG001|COMPLETED|Double-Blind (DB)||31
9727117|NCT00105157|10826690|FG002|COMPLETED|Double-Blind (DB)||33
9727118|NCT00105157|10826691|FG003|COMPLETED|Double-Blind (DB)||6
10025324|NCT01870388|11149336|FG001|COMPLETED|Overall Study||8
10025325|NCT01870388|11149335|FG000|NOT COMPLETED|Overall Study||0
10025326|NCT01870388|11149336|FG001|NOT COMPLETED|Overall Study||0
9727119|NCT00105157|10826688|FG000|NOT COMPLETED|Double-Blind (DB)||14
9727120|NCT00105157|10826689|FG001|NOT COMPLETED|Double-Blind (DB)||14
9727121|NCT00105157|10826690|FG002|NOT COMPLETED|Double-Blind (DB)||12
9727122|NCT00105157|10826691|FG003|NOT COMPLETED|Double-Blind (DB)||39
9727123|NCT00105157|10826688|FG000|STARTED|Open-Label Continuation of DB||30
9727124|NCT00105157|10826689|FG001|STARTED|Open-Label Continuation of DB||31
9727125|NCT00105157|10826690|FG002|STARTED|Open-Label Continuation of DB||33
10025327|NCT01870583|11149347|FG000|STARTED|Overall Study||467
10025328|NCT01870583|11149348|FG001|STARTED|Overall Study||474
9694117|NCT00966953|10794301|FG000|STARTED|1st Intervention||6
9694118|NCT00966953|10794302|FG001|STARTED|1st Intervention||6
9694119|NCT00966953|10794303|FG002|STARTED|1st Intervention||6
9694120|NCT00966953|10794304|FG003|STARTED|1st Intervention||7
9694121|NCT00966953|10794301|FG000|COMPLETED|1st Intervention||6
9694122|NCT00966953|10794302|FG001|COMPLETED|1st Intervention||6
9694123|NCT00966953|10794303|FG002|COMPLETED|1st Intervention||6
9694124|NCT00966953|10794304|FG003|COMPLETED|1st Intervention||7
9694125|NCT00966953|10794301|FG000|NOT COMPLETED|1st Intervention||0
9694126|NCT00966953|10794302|FG001|NOT COMPLETED|1st Intervention||0
9694127|NCT00966953|10794303|FG002|NOT COMPLETED|1st Intervention||0
9694128|NCT00966953|10794304|FG003|NOT COMPLETED|1st Intervention||0
9694129|NCT00966953|10794301|FG000|STARTED|1 Week Washout After 1st Intervention||6
9694130|NCT00966953|10794302|FG001|STARTED|1 Week Washout After 1st Intervention||6
9694131|NCT00966953|10794303|FG002|STARTED|1 Week Washout After 1st Intervention||6
9694132|NCT00966953|10794304|FG003|STARTED|1 Week Washout After 1st Intervention||7
9694133|NCT00966953|10794301|FG000|COMPLETED|1 Week Washout After 1st Intervention||6
9694134|NCT00966953|10794302|FG001|COMPLETED|1 Week Washout After 1st Intervention||6
9694135|NCT00966953|10794303|FG002|COMPLETED|1 Week Washout After 1st Intervention||6
9694136|NCT00966953|10794304|FG003|COMPLETED|1 Week Washout After 1st Intervention||7
9694137|NCT00966953|10794301|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0
9694138|NCT00966953|10794302|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0
9694139|NCT00966953|10794303|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0
9694140|NCT00966953|10794304|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0
9694141|NCT00966953|10794301|FG000|STARTED|2nd Intervention||6
9694142|NCT00966953|10794302|FG001|STARTED|2nd Intervention||6
9694143|NCT00966953|10794303|FG002|STARTED|2nd Intervention||6
9694144|NCT00966953|10794304|FG003|STARTED|2nd Intervention||7
9694145|NCT00966953|10794301|FG000|COMPLETED|2nd Intervention||6
9694146|NCT00966953|10794302|FG001|COMPLETED|2nd Intervention||6
9694147|NCT00966953|10794303|FG002|COMPLETED|2nd Intervention||6
9694148|NCT00966953|10794304|FG003|COMPLETED|2nd Intervention||7
9694149|NCT00966953|10794301|FG000|NOT COMPLETED|2nd Intervention||0
9694150|NCT00966953|10794302|FG001|NOT COMPLETED|2nd Intervention||0
9694151|NCT00966953|10794303|FG002|NOT COMPLETED|2nd Intervention||0
9694152|NCT00966953|10794304|FG003|NOT COMPLETED|2nd Intervention||0
9694153|NCT00966953|10794301|FG000|STARTED|1 Week Washout After 2nd Intervention||6
9694154|NCT00966953|10794302|FG001|STARTED|1 Week Washout After 2nd Intervention||6
9694155|NCT00966953|10794303|FG002|STARTED|1 Week Washout After 2nd Intervention||6
9694156|NCT00966953|10794304|FG003|STARTED|1 Week Washout After 2nd Intervention||7
9694157|NCT00966953|10794301|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6
9694158|NCT00966953|10794302|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6
9694159|NCT00966953|10794303|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6
9961536|NCT01474122|11081288|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1
9961537|NCT01474122|11081289|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2
9961538|NCT01474122|11081290|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1
9961539|NCT01474122|11081288|FG000|STARTED|Period 2: Week 16 to End of Study||87
9961540|NCT01474122|11081289|FG001|STARTED|Period 2: Week 16 to End of Study||86
9961541|NCT01474122|11081290|FG002|STARTED|Period 2: Week 16 to End of Study||88
9961542|NCT01474122|11081288|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
9961543|NCT01474122|11081289|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
9694160|NCT00966953|10794304|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7
9694161|NCT00966953|10794301|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
9694162|NCT00966953|10794302|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
9694163|NCT00966953|10794303|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
9694164|NCT00966953|10794304|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
9694165|NCT00966953|10794301|FG000|STARTED|3rd Intervention Order||6
9694166|NCT00966953|10794302|FG001|STARTED|3rd Intervention Order||6
9694167|NCT00966953|10794303|FG002|STARTED|3rd Intervention Order||6
9694168|NCT00966953|10794304|FG003|STARTED|3rd Intervention Order||7
9694169|NCT00966953|10794301|FG000|COMPLETED|3rd Intervention Order||6
9694170|NCT00966953|10794302|FG001|COMPLETED|3rd Intervention Order||6
9694171|NCT00966953|10794303|FG002|COMPLETED|3rd Intervention Order||6
9694172|NCT00966953|10794304|FG003|COMPLETED|3rd Intervention Order||7
9694173|NCT00966953|10794301|FG000|NOT COMPLETED|3rd Intervention Order||0
9694174|NCT00966953|10794302|FG001|NOT COMPLETED|3rd Intervention Order||0
9694175|NCT00966953|10794303|FG002|NOT COMPLETED|3rd Intervention Order||0
9694176|NCT00966953|10794304|FG003|NOT COMPLETED|3rd Intervention Order||0
9694177|NCT00966953|10794301|FG000|STARTED|1 Week Washout After 3rd Intervention||6
9694178|NCT00966953|10794302|FG001|STARTED|1 Week Washout After 3rd Intervention||6
9694179|NCT00966953|10794303|FG002|STARTED|1 Week Washout After 3rd Intervention||6
9694180|NCT00966953|10794304|FG003|STARTED|1 Week Washout After 3rd Intervention||7
9694181|NCT00966953|10794301|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6
9694182|NCT00966953|10794302|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6
9694183|NCT00966953|10794303|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6
9694184|NCT00966953|10794304|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7
9694185|NCT00966953|10794301|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
9694186|NCT00966953|10794302|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
9694187|NCT00966953|10794303|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
9694188|NCT00966953|10794304|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
9694189|NCT00966953|10794301|FG000|STARTED|4th Intervention Order||6
9694190|NCT00966953|10794302|FG001|STARTED|4th Intervention Order||6
9694191|NCT00966953|10794303|FG002|STARTED|4th Intervention Order||6
9694192|NCT00966953|10794304|FG003|STARTED|4th Intervention Order||7
9694193|NCT00966953|10794301|FG000|COMPLETED|4th Intervention Order||6
9694194|NCT00966953|10794302|FG001|COMPLETED|4th Intervention Order||6
9694195|NCT00966953|10794303|FG002|COMPLETED|4th Intervention Order||6
9694196|NCT00966953|10794304|FG003|COMPLETED|4th Intervention Order||7
9694197|NCT00966953|10794301|FG000|NOT COMPLETED|4th Intervention Order||0
9694198|NCT00966953|10794302|FG001|NOT COMPLETED|4th Intervention Order||0
9694199|NCT00966953|10794303|FG002|NOT COMPLETED|4th Intervention Order||0
9694200|NCT00966953|10794304|FG003|NOT COMPLETED|4th Intervention Order||0
9694201|NCT00961805|10794312|FG000|STARTED|Overall Study||40
9694202|NCT00961805|10794313|FG001|STARTED|Overall Study||40
9694203|NCT00961805|10794312|FG000|COMPLETED|Overall Study||40
9694204|NCT00961805|10794313|FG001|COMPLETED|Overall Study||40
9694205|NCT00961805|10794312|FG000|NOT COMPLETED|Overall Study||0
9694206|NCT00961805|10794313|FG001|NOT COMPLETED|Overall Study||0
9694207|NCT00950937|10794319|FG000|STARTED|Overall Study||14
9694208|NCT00950937|10794320|FG001|STARTED|Overall Study||14
9694209|NCT00950937|10794319|FG000|COMPLETED|Overall Study||14
9694210|NCT00950937|10794320|FG001|COMPLETED|Overall Study||14
9694211|NCT00950937|10794319|FG000|NOT COMPLETED|Overall Study||0
9694212|NCT00950937|10794320|FG001|NOT COMPLETED|Overall Study||0
9694213|NCT00948753|10794327|FG000|STARTED|Phase 1||7
9694214|NCT00948753|10794328|FG001|STARTED|Phase 1||6
9694215|NCT00948753|10794329|FG002|STARTED|Phase 1||0
9694216|NCT00948753|10794327|FG000|COMPLETED|Phase 1||7
9694217|NCT00948753|10794328|FG001|COMPLETED|Phase 1||6
9694218|NCT00948753|10794329|FG002|COMPLETED|Phase 1||0
9694219|NCT00948753|10794327|FG000|NOT COMPLETED|Phase 1||0
9694220|NCT00948753|10794328|FG001|NOT COMPLETED|Phase 1||0
9694221|NCT00948753|10794329|FG002|NOT COMPLETED|Phase 1||0
9694222|NCT00948753|10794327|FG000|STARTED|Phase 2||0
9694223|NCT00948753|10794328|FG001|STARTED|Phase 2||0
9694224|NCT00948753|10794329|FG002|STARTED|Phase 2||25
9694225|NCT00948753|10794327|FG000|COMPLETED|Phase 2||0
9694226|NCT00948753|10794328|FG001|COMPLETED|Phase 2||0
9694227|NCT00948753|10794329|FG002|COMPLETED|Phase 2||25
9694228|NCT00948753|10794327|FG000|NOT COMPLETED|Phase 2||0
9694229|NCT00948753|10794328|FG001|NOT COMPLETED|Phase 2||0
9694230|NCT00948753|10794329|FG002|NOT COMPLETED|Phase 2||0
9694231|NCT00947518|10794341|FG000|STARTED|Overall Study||20
9694232|NCT00947518|10794342|FG001|STARTED|Overall Study||20
9694233|NCT00947518|10794343|FG002|STARTED|Overall Study||20
9694234|NCT00947518|10794341|FG000|COMPLETED|Overall Study||20
9694235|NCT00947518|10794342|FG001|COMPLETED|Overall Study||20
9694236|NCT00947518|10794343|FG002|COMPLETED|Overall Study||20
9694237|NCT00947518|10794341|FG000|NOT COMPLETED|Overall Study||0
9694238|NCT00947518|10794342|FG001|NOT COMPLETED|Overall Study||0
9694239|NCT00947518|10794343|FG002|NOT COMPLETED|Overall Study||0
9694240|NCT00934921|10794350|FG000|STARTED|First Intervention||12
9694241|NCT00934921|10794351|FG001|STARTED|First Intervention||12
9694242|NCT00934921|10794350|FG000|COMPLETED|First Intervention||12
9694243|NCT00934921|10794351|FG001|COMPLETED|First Intervention||12
9694244|NCT00934921|10794350|FG000|NOT COMPLETED|First Intervention||0
9694245|NCT00934921|10794351|FG001|NOT COMPLETED|First Intervention||0
9694246|NCT00934921|10794350|FG000|STARTED|Second Intervention||12
9694247|NCT00934921|10794351|FG001|STARTED|Second Intervention||12
9694248|NCT00934921|10794350|FG000|COMPLETED|Second Intervention||12
9694249|NCT00934921|10794351|FG001|COMPLETED|Second Intervention||12
9694250|NCT00934921|10794350|FG000|NOT COMPLETED|Second Intervention||0
9694251|NCT00934921|10794351|FG001|NOT COMPLETED|Second Intervention||0
9694252|NCT00934180|10794357|FG000|STARTED|First Intervention||12
9694253|NCT00934180|10794358|FG001|STARTED|First Intervention||12
9694254|NCT00934180|10794357|FG000|COMPLETED|First Intervention||12
9694255|NCT00934180|10794358|FG001|COMPLETED|First Intervention||12
9694256|NCT00934180|10794357|FG000|NOT COMPLETED|First Intervention||0
9694257|NCT00934180|10794358|FG001|NOT COMPLETED|First Intervention||0
9694258|NCT00934180|10794357|FG000|STARTED|Second Intervention||12
9694259|NCT00934180|10794358|FG001|STARTED|Second Intervention||12
9694260|NCT00934180|10794357|FG000|COMPLETED|Second Intervention||12
9694261|NCT00934180|10794358|FG001|COMPLETED|Second Intervention||12
9847113|NCT00852644|10959562|FG005|STARTED|Overall Study||0
9847114|NCT00852644|10959557|FG000|COMPLETED|Overall Study||3
9847115|NCT00852644|10959558|FG001|COMPLETED|Overall Study||3
9847116|NCT00852644|10959559|FG002|COMPLETED|Overall Study||0
9847117|NCT00852644|10959560|FG003|COMPLETED|Overall Study||3
9847118|NCT00852644|10959561|FG004|COMPLETED|Overall Study||0
9847119|NCT00852644|10959562|FG005|COMPLETED|Overall Study||0
9847120|NCT00852644|10959557|FG000|NOT COMPLETED|Overall Study||0
9847121|NCT00852644|10959558|FG001|NOT COMPLETED|Overall Study||0
9847122|NCT00852644|10959559|FG002|NOT COMPLETED|Overall Study||0
9847123|NCT00852644|10959560|FG003|NOT COMPLETED|Overall Study||0
9847124|NCT00852644|10959561|FG004|NOT COMPLETED|Overall Study||0
9847125|NCT00852644|10959562|FG005|NOT COMPLETED|Overall Study||0
9847126|NCT00852761|10959579|FG000|STARTED|Overall Study||17
9847127|NCT00852761|10959580|FG001|STARTED|Overall Study||17
9847128|NCT00852761|10959579|FG000|COMPLETED|Overall Study||17
9847129|NCT00852761|10959580|FG001|COMPLETED|Overall Study||17
9847130|NCT00852761|10959579|FG000|NOT COMPLETED|Overall Study||0
9847131|NCT00852761|10959580|FG001|NOT COMPLETED|Overall Study||0
9847132|NCT00852917|10959590|FG000|STARTED|Overall Study||106
9847133|NCT00852917|10959591|FG001|STARTED|Overall Study||111
9847134|NCT00852917|10959592|FG002|STARTED|Overall Study||108
9847135|NCT00852917|10959593|FG003|STARTED|Overall Study||227
9847136|NCT00852917|10959590|FG000|COMPLETED|Overall Study||62
9847137|NCT00852917|10959591|FG001|COMPLETED|Overall Study||65
9847138|NCT00852917|10959592|FG002|COMPLETED|Overall Study||50
9847139|NCT00852917|10959593|FG003|COMPLETED|Overall Study||134
9847140|NCT00852917|10959590|FG000|NOT COMPLETED|Overall Study||44
9847141|NCT00852917|10959591|FG001|NOT COMPLETED|Overall Study||46
9847142|NCT00852917|10959592|FG002|NOT COMPLETED|Overall Study||58
9847143|NCT00852917|10959593|FG003|NOT COMPLETED|Overall Study||93
9847144|NCT00852930|10959606|FG000|STARTED|Overall Study||16
9694262|NCT00934180|10794357|FG000|NOT COMPLETED|Second Intervention||0
9694263|NCT00934180|10794358|FG001|NOT COMPLETED|Second Intervention||0
9694264|NCT00924833|10794365|FG000|STARTED|Overall Study||9
9694265|NCT00924833|10794366|FG001|STARTED|Overall Study||9
9694266|NCT00924833|10794367|FG002|STARTED|Overall Study||9
9847145|NCT00852930|10959607|FG001|STARTED|Overall Study||17
9847146|NCT00852930|10959608|FG002|STARTED|Overall Study||17
9847147|NCT00852930|10959606|FG000|COMPLETED|Overall Study||15
9847148|NCT00852930|10959607|FG001|COMPLETED|Overall Study||16
9847149|NCT00852930|10959608|FG002|COMPLETED|Overall Study||15
9847150|NCT00852930|10959606|FG000|NOT COMPLETED|Overall Study||1
9847151|NCT00852930|10959607|FG001|NOT COMPLETED|Overall Study||1
9847152|NCT00852930|10959608|FG002|NOT COMPLETED|Overall Study||2
9847153|NCT00852969|10959619|FG000|STARTED|Overall Study||15
9847154|NCT00852969|10959620|FG001|STARTED|Overall Study||15
9847155|NCT00852969|10959619|FG000|COMPLETED|Overall Study||15
9847156|NCT00852969|10959620|FG001|COMPLETED|Overall Study||13
9847157|NCT00852969|10959619|FG000|NOT COMPLETED|Overall Study||0
9694267|NCT00924833|10794365|FG000|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
9694268|NCT00924833|10794366|FG001|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
9694269|NCT00924833|10794367|FG002|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
9694270|NCT00924833|10794365|FG000|NOT COMPLETED|Overall Study||0
9694271|NCT00924833|10794366|FG001|NOT COMPLETED|Overall Study||0
9694272|NCT00924833|10794367|FG002|NOT COMPLETED|Overall Study||0
9694273|NCT00919893|10794374|FG000|STARTED|Overall Study||70
9694274|NCT00919893|10794375|FG001|STARTED|Overall Study||69
9694275|NCT00919893|10794374|FG000|COMPLETED|Overall Study||51
9694276|NCT00919893|10794375|FG001|COMPLETED|Overall Study||60
9694277|NCT00919893|10794374|FG000|NOT COMPLETED|Overall Study||19
9694278|NCT00919893|10794375|FG001|NOT COMPLETED|Overall Study||9
9694279|NCT00912158|10794382|FG000|STARTED|Overall Study||44
9694280|NCT00912158|10794383|FG001|STARTED|Overall Study||44
9694281|NCT00912158|10794384|FG002|STARTED|Overall Study||41
9694282|NCT00912158|10794382|FG000|COMPLETED|Overall Study||44
9694283|NCT00912158|10794383|FG001|COMPLETED|Overall Study||44
9694284|NCT00912158|10794384|FG002|COMPLETED|Overall Study||41
9694285|NCT00912158|10794382|FG000|NOT COMPLETED|Overall Study||0
9694286|NCT00912158|10794383|FG001|NOT COMPLETED|Overall Study||0
9694287|NCT00912158|10794384|FG002|NOT COMPLETED|Overall Study||0
9694288|NCT00911443|10794394|FG000|STARTED|Overall Study||97
9694289|NCT00911443|10794395|FG001|STARTED|Overall Study||97
9694290|NCT00911443|10794396|FG002|STARTED|Overall Study||98
9694291|NCT00911443|10794397|FG003|STARTED|Overall Study||99
9694292|NCT00911443|10794398|FG004|STARTED|Overall Study||97
9694293|NCT00911443|10794394|FG000|COMPLETED|Overall Study||97
9694294|NCT00911443|10794395|FG001|COMPLETED|Overall Study||97
9694295|NCT00911443|10794396|FG002|COMPLETED|Overall Study||98
9694296|NCT00911443|10794397|FG003|COMPLETED|Overall Study||99
9694297|NCT00911443|10794398|FG004|COMPLETED|Overall Study||97
9694298|NCT00911443|10794394|FG000|NOT COMPLETED|Overall Study||0
9694299|NCT00911443|10794395|FG001|NOT COMPLETED|Overall Study||0
9694300|NCT00911443|10794396|FG002|NOT COMPLETED|Overall Study||0
9694301|NCT00911443|10794397|FG003|NOT COMPLETED|Overall Study||0
10025329|NCT01870583|11149349|FG002|STARTED|Overall Study||463
10025330|NCT01870583|11149347|FG000|COMPLETED|Overall Study||456
10025331|NCT01870583|11149348|FG001|COMPLETED|Overall Study||456
10025332|NCT01870583|11149349|FG002|COMPLETED|Overall Study||455
10025333|NCT01870583|11149347|FG000|NOT COMPLETED|Overall Study||11
10025334|NCT01870583|11149348|FG001|NOT COMPLETED|Overall Study||18
10025335|NCT01870583|11149349|FG002|NOT COMPLETED|Overall Study||8
10025336|NCT01870596|11149359|FG000|STARTED|Overall Study||14
10025337|NCT01870596|11149360|FG001|STARTED|Overall Study||18
10025338|NCT01870596|11149359|FG000|COMPLETED|Overall Study||14
10025339|NCT01870596|11149360|FG001|COMPLETED|Overall Study||18
10025340|NCT01870596|11149359|FG000|NOT COMPLETED|Overall Study||0
10025341|NCT01870596|11149360|FG001|NOT COMPLETED|Overall Study||0
10025342|NCT01870726|11149373|FG000|STARTED|Overall Study||5
9694302|NCT00911443|10794398|FG004|NOT COMPLETED|Overall Study||0
9694303|NCT00911274|10794407|FG000|STARTED|Period 1||27
9694304|NCT00911274|10794408|FG001|STARTED|Period 1||26
9694305|NCT00911274|10794407|FG000|COMPLETED|Period 1||27
9694306|NCT00911274|10794408|FG001|COMPLETED|Period 1||26
9694307|NCT00911274|10794407|FG000|NOT COMPLETED|Period 1||0
9694308|NCT00911274|10794408|FG001|NOT COMPLETED|Period 1||0
9694309|NCT00911274|10794407|FG000|STARTED|Period 2||27
9694310|NCT00911274|10794408|FG001|STARTED|Period 2||26
9694311|NCT00911274|10794407|FG000|COMPLETED|Period 2||27
9694312|NCT00911274|10794408|FG001|COMPLETED|Period 2||26
9694313|NCT00911274|10794407|FG000|NOT COMPLETED|Period 2||0
9694314|NCT00911274|10794408|FG001|NOT COMPLETED|Period 2||0
9694315|NCT00909753|10794414|FG000|STARTED|Period: First Intervention||46
9694316|NCT00909753|10794415|FG001|STARTED|Period: First Intervention||46
9694317|NCT00909753|10794414|FG000|COMPLETED|Period: First Intervention||46
9694318|NCT00909753|10794415|FG001|COMPLETED|Period: First Intervention||46
9694319|NCT00909753|10794414|FG000|NOT COMPLETED|Period: First Intervention||0
9694320|NCT00909753|10794415|FG001|NOT COMPLETED|Period: First Intervention||0
9694321|NCT00909753|10794414|FG000|STARTED|Period: Washout of 28 Days||46
9694322|NCT00909753|10794415|FG001|STARTED|Period: Washout of 28 Days||46
9694323|NCT00909753|10794414|FG000|COMPLETED|Period: Washout of 28 Days||44
9694324|NCT00909753|10794415|FG001|COMPLETED|Period: Washout of 28 Days||43
9694325|NCT00909753|10794414|FG000|NOT COMPLETED|Period: Washout of 28 Days||2
9694326|NCT00909753|10794415|FG001|NOT COMPLETED|Period: Washout of 28 Days||3
9694327|NCT00909753|10794414|FG000|STARTED|Period: Second Intervention||44
9694328|NCT00909753|10794415|FG001|STARTED|Period: Second Intervention||43
9694329|NCT00909753|10794414|FG000|COMPLETED|Period: Second Intervention||43
9694330|NCT00909753|10794415|FG001|COMPLETED|Period: Second Intervention||43
10025343|NCT01870726|11149374|FG001|STARTED|Overall Study||6
10025344|NCT01870726|11149375|FG002|STARTED|Overall Study||4
9694331|NCT00909753|10794414|FG000|NOT COMPLETED|Period: Second Intervention||1
9847158|NCT00852969|10959620|FG001|NOT COMPLETED|Overall Study||2
9847159|NCT00852995|10959631|FG000|STARTED|Overall Study||46
9847160|NCT00852995|10959632|FG001|STARTED|Overall Study||43
9847161|NCT00852995|10959633|FG002|STARTED|Overall Study||44
9847162|NCT00852995|10959634|FG003|STARTED|Overall Study||45
9847163|NCT00852995|10959635|FG004|STARTED|Overall Study||50
9847164|NCT00852995|10959631|FG000|COMPLETED|Overall Study||38
9847165|NCT00852995|10959632|FG001|COMPLETED|Overall Study||42
9847166|NCT00852995|10959633|FG002|COMPLETED|Overall Study||39
9847167|NCT00852995|10959634|FG003|COMPLETED|Overall Study||40
9847168|NCT00852995|10959635|FG004|COMPLETED|Overall Study||46
9847169|NCT00852995|10959631|FG000|NOT COMPLETED|Overall Study||8
9847170|NCT00852995|10959632|FG001|NOT COMPLETED|Overall Study||1
9847171|NCT00852995|10959633|FG002|NOT COMPLETED|Overall Study||5
9847172|NCT00852995|10959634|FG003|NOT COMPLETED|Overall Study||5
9847173|NCT00852995|10959635|FG004|NOT COMPLETED|Overall Study||4
9847174|NCT00853021|10959652|FG000|STARTED|Overall Study||26
9847175|NCT00853021|10959652|FG000|COMPLETED|Overall Study||21
9847176|NCT00853021|10959652|FG000|NOT COMPLETED|Overall Study||5
9847177|NCT00853047|10959661|FG000|STARTED|Core Phase||5
9847178|NCT00853047|10959662|FG001|STARTED|Core Phase||3
9847179|NCT00853047|10959663|FG002|STARTED|Core Phase||3
9847180|NCT00853047|10959664|FG003|STARTED|Core Phase||3
9847181|NCT00853047|10959665|FG004|STARTED|Core Phase||9
9847182|NCT00853047|10959666|FG005|STARTED|Core Phase||0
9847183|NCT00853047|10959661|FG000|COMPLETED|Core Phase||5
9847184|NCT00853047|10959662|FG001|COMPLETED|Core Phase||3
9847185|NCT00853047|10959663|FG002|COMPLETED|Core Phase||3
9847186|NCT00853047|10959664|FG003|COMPLETED|Core Phase||2
9847187|NCT00853047|10959665|FG004|COMPLETED|Core Phase||9
9847188|NCT00853047|10959666|FG005|COMPLETED|Core Phase||0
9847189|NCT00853047|10959661|FG000|NOT COMPLETED|Core Phase||0
9847190|NCT00853047|10959662|FG001|NOT COMPLETED|Core Phase||0
9847191|NCT00853047|10959663|FG002|NOT COMPLETED|Core Phase||0
9847192|NCT00853047|10959664|FG003|NOT COMPLETED|Core Phase||1
9847193|NCT00853047|10959665|FG004|NOT COMPLETED|Core Phase||0
9847194|NCT00853047|10959666|FG005|NOT COMPLETED|Core Phase||0
9847195|NCT00853047|10959661|FG000|STARTED|Open-Label Extension Phase||0
9847196|NCT00853047|10959662|FG001|STARTED|Open-Label Extension Phase||0
9847197|NCT00853047|10959663|FG002|STARTED|Open-Label Extension Phase||0
9694332|NCT00909753|10794415|FG001|NOT COMPLETED|Period: Second Intervention||0
9694333|NCT00909649|10794421|FG000|STARTED|Overall Study||25
9694334|NCT00909649|10794422|FG001|STARTED|Overall Study||25
9694335|NCT00909649|10794421|FG000|COMPLETED|Overall Study||25
9694336|NCT00909649|10794422|FG001|COMPLETED|Overall Study||25
9694337|NCT00909649|10794421|FG000|NOT COMPLETED|Overall Study||0
9694338|NCT00909649|10794422|FG001|NOT COMPLETED|Overall Study||0
9694339|NCT00909610|10794428|FG000|STARTED|Period: First Intervention||40
9694340|NCT00909610|10794429|FG001|STARTED|Period: First Intervention||40
9694341|NCT00909610|10794428|FG000|COMPLETED|Period: First Intervention||40
9694342|NCT00909610|10794429|FG001|COMPLETED|Period: First Intervention||39
9694343|NCT00909610|10794428|FG000|NOT COMPLETED|Period: First Intervention||0
9694344|NCT00909610|10794429|FG001|NOT COMPLETED|Period: First Intervention||1
9694345|NCT00909610|10794428|FG000|STARTED|Period: Washout of 28 Days||40
9694346|NCT00909610|10794429|FG001|STARTED|Period: Washout of 28 Days||39
9694347|NCT00909610|10794428|FG000|COMPLETED|Period: Washout of 28 Days||37
9694348|NCT00909610|10794429|FG001|COMPLETED|Period: Washout of 28 Days||33
9694349|NCT00909610|10794428|FG000|NOT COMPLETED|Period: Washout of 28 Days||3
9694350|NCT00909610|10794429|FG001|NOT COMPLETED|Period: Washout of 28 Days||6
9694351|NCT00909610|10794428|FG000|STARTED|Period: Second Intervention||37
9694352|NCT00909610|10794429|FG001|STARTED|Period: Second Intervention||33
9694353|NCT00909610|10794428|FG000|COMPLETED|Period: Second Intervention||36
9694354|NCT00909610|10794429|FG001|COMPLETED|Period: Second Intervention||33
9847198|NCT00853047|10959664|FG003|STARTED|Open-Label Extension Phase||0
9847199|NCT00853047|10959665|FG004|STARTED|Open-Label Extension Phase||0
9847200|NCT00853047|10959666|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
9847201|NCT00853047|10959661|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0
9847202|NCT00853047|10959662|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0
9847203|NCT00853047|10959663|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0
9847204|NCT00853047|10959664|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0
9847205|NCT00853047|10959665|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0
9847206|NCT00853047|10959666|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16
9847207|NCT00853047|10959661|FG000|COMPLETED|Open-Label Extension Phase||0
9847208|NCT00853047|10959662|FG001|COMPLETED|Open-Label Extension Phase||0
9847209|NCT00853047|10959663|FG002|COMPLETED|Open-Label Extension Phase||0
9694355|NCT00909610|10794428|FG000|NOT COMPLETED|Period: Second Intervention||1
9694356|NCT00909610|10794429|FG001|NOT COMPLETED|Period: Second Intervention||0
10025345|NCT01870726|11149376|FG003|STARTED|Overall Study||6
10025346|NCT01870726|11149377|FG004|STARTED|Overall Study||7
10025347|NCT01870726|11149378|FG005|STARTED|Overall Study||5
9694357|NCT00908648|10794436|FG000|STARTED|Overall Study||108
9694358|NCT00908648|10794437|FG001|STARTED|Overall Study||103
9694359|NCT00908648|10794436|FG000|COMPLETED|Overall Study||108
9694360|NCT00908648|10794437|FG001|COMPLETED|Overall Study||103
9694361|NCT00908648|10794436|FG000|NOT COMPLETED|Overall Study||0
9694362|NCT00908648|10794437|FG001|NOT COMPLETED|Overall Study||0
9694363|NCT00908128|10794443|FG000|STARTED|Period 1||20
9694364|NCT00908128|10794444|FG001|STARTED|Period 1||20
9694365|NCT00908128|10794443|FG000|COMPLETED|Period 1||20
9694366|NCT00908128|10794444|FG001|COMPLETED|Period 1||20
9694367|NCT00908128|10794443|FG000|NOT COMPLETED|Period 1||0
9694368|NCT00908128|10794444|FG001|NOT COMPLETED|Period 1||0
9694369|NCT00908128|10794443|FG000|STARTED|Period 2||20
9694370|NCT00908128|10794444|FG001|STARTED|Period 2||20
9694371|NCT00908128|10794443|FG000|COMPLETED|Period 2||20
9694372|NCT00908128|10794444|FG001|COMPLETED|Period 2||20
9694373|NCT00908128|10794443|FG000|NOT COMPLETED|Period 2||0
9694374|NCT00908128|10794444|FG001|NOT COMPLETED|Period 2||0
9694375|NCT00908128|10794443|FG000|STARTED|Period 3||20
9694376|NCT00908128|10794444|FG001|STARTED|Period 3||20
9694377|NCT00908128|10794443|FG000|COMPLETED|Period 3||20
9694378|NCT00908128|10794444|FG001|COMPLETED|Period 3||20
9694379|NCT00908128|10794443|FG000|NOT COMPLETED|Period 3||0
9694380|NCT00908128|10794444|FG001|NOT COMPLETED|Period 3||0
9694381|NCT00908128|10794443|FG000|STARTED|Period 4||20
9694382|NCT00908128|10794444|FG001|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
9694383|NCT00908128|10794443|FG000|COMPLETED|Period 4||20
9694384|NCT00908128|10794444|FG001|COMPLETED|Period 4||19
9694385|NCT00908128|10794443|FG000|NOT COMPLETED|Period 4||0
9694386|NCT00908128|10794444|FG001|NOT COMPLETED|Period 4||0
9694387|NCT00907907|10794450|FG000|STARTED|Period 1||20
9694388|NCT00907907|10794451|FG001|STARTED|Period 1||20
9694389|NCT00907907|10794450|FG000|COMPLETED|Period 1||20
9694390|NCT00907907|10794451|FG001|COMPLETED|Period 1||20
9694391|NCT00907907|10794450|FG000|NOT COMPLETED|Period 1||0
9694392|NCT00907907|10794451|FG001|NOT COMPLETED|Period 1||0
9694393|NCT00907907|10794450|FG000|STARTED|Period 2||20
9694394|NCT00907907|10794451|FG001|STARTED|Period 2||20
9694395|NCT00907907|10794450|FG000|COMPLETED|Period 2||20
9694396|NCT00907907|10794451|FG001|COMPLETED|Period 2||20
9694397|NCT00907907|10794450|FG000|NOT COMPLETED|Period 2||0
9694398|NCT00907907|10794451|FG001|NOT COMPLETED|Period 2||0
9694399|NCT00907907|10794450|FG000|STARTED|Period 3||20
9694400|NCT00907907|10794451|FG001|STARTED|Period 3||20
9694401|NCT00907907|10794450|FG000|COMPLETED|Period 3||20
9694402|NCT00907907|10794451|FG001|COMPLETED|Period 3||20
9694403|NCT00907907|10794450|FG000|NOT COMPLETED|Period 3||0
9694404|NCT00907907|10794451|FG001|NOT COMPLETED|Period 3||0
9694405|NCT00907907|10794450|FG000|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
9694406|NCT00907907|10794451|FG001|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
9694407|NCT00907907|10794450|FG000|COMPLETED|Period 4||19
9694408|NCT00907907|10794451|FG001|COMPLETED|Period 4||18
9694409|NCT00907907|10794450|FG000|NOT COMPLETED|Period 4||0
9694410|NCT00907907|10794451|FG001|NOT COMPLETED|Period 4||0
9694411|NCT00905606|10794457|FG000|STARTED|Period 1||15
9694412|NCT00905606|10794458|FG001|STARTED|Period 1||15
9694413|NCT00905606|10794457|FG000|COMPLETED|Period 1||15
9694414|NCT00905606|10794458|FG001|COMPLETED|Period 1||14
9694415|NCT00905606|10794457|FG000|NOT COMPLETED|Period 1||0
9694416|NCT00905606|10794458|FG001|NOT COMPLETED|Period 1||1
9694417|NCT00905606|10794457|FG000|STARTED|Washout||15
9694418|NCT00905606|10794458|FG001|STARTED|Washout||14
9694419|NCT00905606|10794457|FG000|COMPLETED|Washout||14
9694420|NCT00905606|10794458|FG001|COMPLETED|Washout||14
9694421|NCT00905606|10794457|FG000|NOT COMPLETED|Washout||1
9694422|NCT00905606|10794458|FG001|NOT COMPLETED|Washout||0
9694423|NCT00905606|10794457|FG000|STARTED|Period 2||14
9694424|NCT00905606|10794458|FG001|STARTED|Period 2||14
10025348|NCT01870726|11149379|FG006|STARTED|Overall Study||10
10025349|NCT01870726|11149373|FG000|COMPLETED|Overall Study||0
10025350|NCT01870726|11149374|FG001|COMPLETED|Overall Study||0
10025351|NCT01870726|11149375|FG002|COMPLETED|Overall Study||0
10025352|NCT01870726|11149376|FG003|COMPLETED|Overall Study||0
10025353|NCT01870726|11149377|FG004|COMPLETED|Overall Study||0
9694425|NCT00905606|10794457|FG000|COMPLETED|Period 2||14
9694426|NCT00905606|10794458|FG001|COMPLETED|Period 2||14
9694427|NCT00905606|10794457|FG000|NOT COMPLETED|Period 2||0
9694428|NCT00905606|10794458|FG001|NOT COMPLETED|Period 2||0
9694429|NCT00905567|10794464|FG000|STARTED|Period 1||12
9694430|NCT00905567|10794465|FG001|STARTED|Period 1||12
10025354|NCT01870726|11149378|FG005|COMPLETED|Overall Study||0
10025355|NCT01870726|11149379|FG006|COMPLETED|Overall Study||0
10025356|NCT01870726|11149373|FG000|NOT COMPLETED|Overall Study||5
10025357|NCT01870726|11149374|FG001|NOT COMPLETED|Overall Study||6
10025358|NCT01870726|11149375|FG002|NOT COMPLETED|Overall Study||4
10025359|NCT01870726|11149376|FG003|NOT COMPLETED|Overall Study||6
10025360|NCT01870726|11149377|FG004|NOT COMPLETED|Overall Study||7
10025361|NCT01870726|11149378|FG005|NOT COMPLETED|Overall Study||5
10025362|NCT01870726|11149379|FG006|NOT COMPLETED|Overall Study||10
10025363|NCT01870739|11149406|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
10025364|NCT01870739|11149407|FG001|STARTED|Single Drug Treatment (12 Weeks)||57
10025365|NCT01870739|11149406|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
10025366|NCT01870739|11149407|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
10025367|NCT01870739|11149406|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
10025368|NCT01870739|11149407|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
9694431|NCT00905567|10794464|FG000|COMPLETED|Period 1||12
9694432|NCT00905567|10794465|FG001|COMPLETED|Period 1||12
9694433|NCT00905567|10794464|FG000|NOT COMPLETED|Period 1||0
9694434|NCT00905567|10794465|FG001|NOT COMPLETED|Period 1||0
9694435|NCT00905567|10794464|FG000|STARTED|Washout||12
9694436|NCT00905567|10794465|FG001|STARTED|Washout||12
9694437|NCT00905567|10794464|FG000|COMPLETED|Washout||12
9694438|NCT00905567|10794465|FG001|COMPLETED|Washout||11
9694439|NCT00905567|10794464|FG000|NOT COMPLETED|Washout||0
9694440|NCT00905567|10794465|FG001|NOT COMPLETED|Washout||1
9694441|NCT00905567|10794464|FG000|STARTED|Period 2||12
9694442|NCT00905567|10794465|FG001|STARTED|Period 2||11
9694443|NCT00905567|10794464|FG000|COMPLETED|Period 2||12
9694444|NCT00905567|10794465|FG001|COMPLETED|Period 2||11
9694445|NCT00905567|10794464|FG000|NOT COMPLETED|Period 2||0
9694446|NCT00905567|10794465|FG001|NOT COMPLETED|Period 2||0
9694447|NCT00905346|10794471|FG000|STARTED|Period 1||12
9694448|NCT00905346|10794472|FG001|STARTED|Period 1||12
9694449|NCT00905346|10794471|FG000|COMPLETED|Period 1||11
9694450|NCT00905346|10794472|FG001|COMPLETED|Period 1||12
9694451|NCT00905346|10794471|FG000|NOT COMPLETED|Period 1||1
9694452|NCT00905346|10794472|FG001|NOT COMPLETED|Period 1||0
9694453|NCT00905346|10794471|FG000|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
9694454|NCT00905346|10794472|FG001|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
9694455|NCT00905346|10794471|FG000|COMPLETED|Period 2||10
9694456|NCT00905346|10794472|FG001|COMPLETED|Period 2||11
9694457|NCT00905346|10794471|FG000|NOT COMPLETED|Period 2||0
9694458|NCT00905346|10794472|FG001|NOT COMPLETED|Period 2||0
9694459|NCT00905164|10794478|FG000|STARTED|Period 1||12
9694460|NCT00905164|10794479|FG001|STARTED|Period 1||12
9694461|NCT00905164|10794478|FG000|COMPLETED|Period 1||12
9694462|NCT00905164|10794479|FG001|COMPLETED|Period 1||11
9694463|NCT00905164|10794478|FG000|NOT COMPLETED|Period 1||0
9694464|NCT00905164|10794479|FG001|NOT COMPLETED|Period 1||1
9694465|NCT00905164|10794478|FG000|STARTED|Period 2||12
9694466|NCT00905164|10794479|FG001|STARTED|Period 2||11
9694467|NCT00905164|10794478|FG000|COMPLETED|Period 2||12
9694468|NCT00905164|10794479|FG001|COMPLETED|Period 2||11
9694469|NCT00905164|10794478|FG000|NOT COMPLETED|Period 2||0
9694470|NCT00905164|10794479|FG001|NOT COMPLETED|Period 2||0
9694471|NCT00904943|10794485|FG000|STARTED|Period 1||9
9694472|NCT00904943|10794486|FG001|STARTED|Period 1||9
9694473|NCT00904943|10794485|FG000|COMPLETED|Period 1||9
9694474|NCT00904943|10794486|FG001|COMPLETED|Period 1||9
9694475|NCT00904943|10794485|FG000|NOT COMPLETED|Period 1||0
9694476|NCT00904943|10794486|FG001|NOT COMPLETED|Period 1||0
9694477|NCT00904943|10794485|FG000|STARTED|Period 2||9
9694478|NCT00904943|10794486|FG001|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
9694479|NCT00904943|10794485|FG000|COMPLETED|Period 2||9
9694480|NCT00904943|10794486|FG001|COMPLETED|Period 2||8
9694481|NCT00904943|10794485|FG000|NOT COMPLETED|Period 2||0
9694482|NCT00904943|10794486|FG001|NOT COMPLETED|Period 2||0
9694483|NCT00890591|10794490|FG000|STARTED|Overall Study||144
9694484|NCT00890591|10794490|FG000|COMPLETED|Overall Study||124
9694485|NCT00890591|10794490|FG000|NOT COMPLETED|Overall Study||20
9847210|NCT00853047|10959664|FG003|COMPLETED|Open-Label Extension Phase||0
9847211|NCT00853047|10959665|FG004|COMPLETED|Open-Label Extension Phase||0
9847212|NCT00853047|10959666|FG005|COMPLETED|Open-Label Extension Phase||2
9847213|NCT00853047|10959661|FG000|NOT COMPLETED|Open-Label Extension Phase||0
9847214|NCT00853047|10959662|FG001|NOT COMPLETED|Open-Label Extension Phase||0
9847215|NCT00853047|10959663|FG002|NOT COMPLETED|Open-Label Extension Phase||0
9847216|NCT00853047|10959664|FG003|NOT COMPLETED|Open-Label Extension Phase||0
9961544|NCT01474122|11081290|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
9961545|NCT01474122|11081288|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17
9961546|NCT01474122|11081289|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13
9961547|NCT01474122|11081290|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15
9961548|NCT01474200|11081302|FG000|STARTED|Overall Study||110
9961549|NCT01474200|11081303|FG001|STARTED|Overall Study||114
9694486|NCT00890409|10794498|FG000|STARTED|Overall Study||116
9694487|NCT00890409|10794499|FG001|STARTED|Overall Study||140
9694488|NCT00890409|10794498|FG000|COMPLETED|Overall Study||96
9694489|NCT00890409|10794499|FG001|COMPLETED|Overall Study||119
9847217|NCT00853047|10959665|FG004|NOT COMPLETED|Open-Label Extension Phase||0
9694490|NCT00890409|10794498|FG000|NOT COMPLETED|Overall Study||20
9694491|NCT00890409|10794499|FG001|NOT COMPLETED|Overall Study||21
9847218|NCT00853047|10959666|FG005|NOT COMPLETED|Open-Label Extension Phase||17
10025369|NCT01870739|11149406|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
10025370|NCT01870739|11149407|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53
10025371|NCT01870739|11149406|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
10025372|NCT01870739|11149407|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
10025373|NCT01870739|11149406|FG000|STARTED|Add-on Period (40 Weeks)||54
10025374|NCT01870739|11149407|FG001|STARTED|Add-on Period (40 Weeks)||53
9694492|NCT00888355|10794507|FG000|STARTED|Overall Study||108
9694493|NCT00888355|10794508|FG001|STARTED|Overall Study||108
9694494|NCT00888355|10794509|FG002|STARTED|Overall Study||106
9694495|NCT00888355|10794510|FG003|STARTED|Overall Study||106
9694496|NCT00888355|10794507|FG000|COMPLETED|Overall Study||86
9694497|NCT00888355|10794508|FG001|COMPLETED|Overall Study||99
9694498|NCT00888355|10794509|FG002|COMPLETED|Overall Study||94
9694499|NCT00888355|10794510|FG003|COMPLETED|Overall Study||96
9694500|NCT00888355|10794507|FG000|NOT COMPLETED|Overall Study||22
9694501|NCT00888355|10794508|FG001|NOT COMPLETED|Overall Study||9
9694502|NCT00888355|10794509|FG002|NOT COMPLETED|Overall Study||12
9694503|NCT00888355|10794510|FG003|NOT COMPLETED|Overall Study||10
9694504|NCT00887250|10794519|FG000|STARTED|Overall Study||116
9694505|NCT00887250|10794520|FG001|STARTED|Overall Study||127
9694506|NCT00887250|10794521|FG002|STARTED|Overall Study||123
9694507|NCT00887250|10794519|FG000|COMPLETED|Overall Study||98
9694508|NCT00887250|10794520|FG001|COMPLETED|Overall Study||115
9694509|NCT00887250|10794521|FG002|COMPLETED|Overall Study||110
9694510|NCT00887250|10794519|FG000|NOT COMPLETED|Overall Study||18
9694511|NCT00887250|10794520|FG001|NOT COMPLETED|Overall Study||12
9694512|NCT00887250|10794521|FG002|NOT COMPLETED|Overall Study||13
9694513|NCT00886600|10794530|FG000|STARTED|Double-blind Monotherapy||32
9694514|NCT00886600|10794531|FG001|STARTED|Double-blind Monotherapy||29
9694515|NCT00886600|10794532|FG002|STARTED|Double-blind Monotherapy||30
9694516|NCT00886600|10794533|FG003|STARTED|Double-blind Monotherapy||31
9694517|NCT00886600|10794530|FG000|COMPLETED|Double-blind Monotherapy||30
9694518|NCT00886600|10794531|FG001|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
9694519|NCT00886600|10794532|FG002|COMPLETED|Double-blind Monotherapy||29
9694520|NCT00886600|10794533|FG003|COMPLETED|Double-blind Monotherapy||29
9694521|NCT00886600|10794530|FG000|NOT COMPLETED|Double-blind Monotherapy||2
9694522|NCT00886600|10794531|FG001|NOT COMPLETED|Double-blind Monotherapy||1
9694523|NCT00886600|10794532|FG002|NOT COMPLETED|Double-blind Monotherapy||1
9694524|NCT00886600|10794533|FG003|NOT COMPLETED|Double-blind Monotherapy||2
9694525|NCT00886600|10794530|FG000|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
9694526|NCT00886600|10794531|FG001|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
9727126|NCT00105157|10826691|FG003|STARTED|Open-Label Continuation of DB||6
10025375|NCT01870739|11149406|FG000|COMPLETED|Add-on Period (40 Weeks)||51
10025376|NCT01870739|11149407|FG001|COMPLETED|Add-on Period (40 Weeks)||51
10025377|NCT01870739|11149406|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3
10025378|NCT01870739|11149407|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2
9694527|NCT00886600|10794532|FG002|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
9694528|NCT00886600|10794533|FG003|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
9694529|NCT00886600|10794530|FG000|COMPLETED|Combination Therapy Period||28
9694530|NCT00886600|10794531|FG001|COMPLETED|Combination Therapy Period||21
9694531|NCT00886600|10794532|FG002|COMPLETED|Combination Therapy Period||19
9694532|NCT00886600|10794533|FG003|COMPLETED|Combination Therapy Period||23
9694533|NCT00886600|10794530|FG000|NOT COMPLETED|Combination Therapy Period||0
9694534|NCT00886600|10794531|FG001|NOT COMPLETED|Combination Therapy Period||0
9694535|NCT00886600|10794532|FG002|NOT COMPLETED|Combination Therapy Period||2
9694536|NCT00886600|10794533|FG003|NOT COMPLETED|Combination Therapy Period||0
9694537|NCT00882440|10794546|FG000|STARTED|Overall Study||78
9694538|NCT00882440|10794547|FG001|STARTED|Overall Study||80
9694539|NCT00882440|10794548|FG002|STARTED|Overall Study||82
9694540|NCT00882440|10794549|FG003|STARTED|Overall Study||79
9694541|NCT00882440|10794550|FG004|STARTED|Overall Study||90
9694542|NCT00882440|10794551|FG005|STARTED|Overall Study||84
9694543|NCT00882440|10794552|FG006|STARTED|Overall Study||83
9694544|NCT00882440|10794546|FG000|COMPLETED|Overall Study||67
9694545|NCT00882440|10794547|FG001|COMPLETED|Overall Study||72
9694546|NCT00882440|10794548|FG002|COMPLETED|Overall Study||75
9694547|NCT00882440|10794549|FG003|COMPLETED|Overall Study||76
9694548|NCT00882440|10794550|FG004|COMPLETED|Overall Study||80
9694549|NCT00882440|10794551|FG005|COMPLETED|Overall Study||77
9694550|NCT00882440|10794552|FG006|COMPLETED|Overall Study||79
9694551|NCT00882440|10794546|FG000|NOT COMPLETED|Overall Study||11
9694552|NCT00882440|10794547|FG001|NOT COMPLETED|Overall Study||8
9694553|NCT00882440|10794548|FG002|NOT COMPLETED|Overall Study||7
9694554|NCT00882440|10794549|FG003|NOT COMPLETED|Overall Study||3
9694555|NCT00882440|10794550|FG004|NOT COMPLETED|Overall Study||10
9694556|NCT00882440|10794551|FG005|NOT COMPLETED|Overall Study||7
9694557|NCT00882440|10794552|FG006|NOT COMPLETED|Overall Study||4
9727127|NCT00105157|10826688|FG000|COMPLETED|Open-Label Continuation of DB||23
9727128|NCT00105157|10826689|FG001|COMPLETED|Open-Label Continuation of DB||21
9727129|NCT00105157|10826690|FG002|COMPLETED|Open-Label Continuation of DB||24
9727130|NCT00105157|10826691|FG003|COMPLETED|Open-Label Continuation of DB||5
9727131|NCT00105157|10826688|FG000|NOT COMPLETED|Open-Label Continuation of DB||7
9727132|NCT00105157|10826689|FG001|NOT COMPLETED|Open-Label Continuation of DB||10
9727133|NCT00105157|10826690|FG002|NOT COMPLETED|Open-Label Continuation of DB||9
9727134|NCT00105157|10826691|FG003|NOT COMPLETED|Open-Label Continuation of DB||1
9727135|NCT00105157|10826688|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
9727136|NCT00105157|10826689|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
9727137|NCT00105157|10826690|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
9727138|NCT00105157|10826691|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
9847219|NCT00853073|10959683|FG000|STARTED|Overall Study||32
9847220|NCT00853073|10959684|FG001|STARTED|Overall Study||31
9847221|NCT00853073|10959683|FG000|COMPLETED|Overall Study||29
9847222|NCT00853073|10959684|FG001|COMPLETED|Overall Study||29
9847223|NCT00853073|10959683|FG000|NOT COMPLETED|Overall Study||3
9847224|NCT00853073|10959684|FG001|NOT COMPLETED|Overall Study||2
9847225|NCT00853099|10959693|FG000|STARTED|Double-blind Period||96
9847226|NCT00853099|10959694|FG001|STARTED|Double-blind Period||87
9847227|NCT00853099|10959695|FG002|STARTED|Double-blind Period||91
9847228|NCT00853099|10959696|FG003|STARTED|Double-blind Period||0
10025379|NCT01870778|11149425|FG000|STARTED|Overall Study||3274
10025380|NCT01870778|11149426|FG001|STARTED|Overall Study||3271
10025381|NCT01870778|11149425|FG000|Safety Set|Overall Study||3257
9847229|NCT00853099|10959693|FG000|Treated|Double-blind Period||96
9847230|NCT00853099|10959694|FG001|Treated|Double-blind Period||87
10025382|NCT01870778|11149426|FG001|Safety Set|Overall Study||3248
10025383|NCT01870778|11149425|FG000|Full Analysis Set|Overall Study||3274
9847231|NCT00853099|10959695|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
9847232|NCT00853099|10959696|FG003|Treated|Double-blind Period||0
9694558|NCT00872430|10794563|FG000|STARTED|First Intervention||10
9694559|NCT00872430|10794564|FG001|STARTED|First Intervention||10
9694560|NCT00872430|10794563|FG000|COMPLETED|First Intervention||10
9694561|NCT00872430|10794564|FG001|COMPLETED|First Intervention||10
9694562|NCT00872430|10794563|FG000|NOT COMPLETED|First Intervention||0
9694563|NCT00872430|10794564|FG001|NOT COMPLETED|First Intervention||0
9694564|NCT00872430|10794563|FG000|STARTED|Washout Period||10
9694565|NCT00872430|10794564|FG001|STARTED|Washout Period||10
9694566|NCT00872430|10794563|FG000|COMPLETED|Washout Period||10
9694567|NCT00872430|10794564|FG001|COMPLETED|Washout Period||10
9694568|NCT00872430|10794563|FG000|NOT COMPLETED|Washout Period||0
9694569|NCT00872430|10794564|FG001|NOT COMPLETED|Washout Period||0
9694570|NCT00872430|10794563|FG000|STARTED|Second Intervention||10
9694571|NCT00872430|10794564|FG001|STARTED|Second Intervention||10
9694572|NCT00872430|10794563|FG000|COMPLETED|Second Intervention||10
9694573|NCT00872430|10794564|FG001|COMPLETED|Second Intervention||10
9694574|NCT00872430|10794563|FG000|NOT COMPLETED|Second Intervention||0
9694575|NCT00872430|10794564|FG001|NOT COMPLETED|Second Intervention||0
9694576|NCT00870688|10794568|FG000|STARTED|Overall Study||82
9694577|NCT00870688|10794568|FG000|COMPLETED|Overall Study||78
9694578|NCT00870688|10794568|FG000|NOT COMPLETED|Overall Study||4
9694579|NCT00869128|10794571|FG000|STARTED|Overall Study||18
9694580|NCT00869128|10794572|FG001|STARTED|Overall Study||18
9694581|NCT00869128|10794571|FG000|COMPLETED|Overall Study||12
9694582|NCT00869128|10794572|FG001|COMPLETED|Overall Study||12
9694583|NCT00869128|10794571|FG000|NOT COMPLETED|Overall Study||6
9694584|NCT00869128|10794572|FG001|NOT COMPLETED|Overall Study||6
9694585|NCT00861705|10794580|FG000|STARTED|Overall Study||115
9694586|NCT00861705|10794581|FG001|STARTED|Overall Study||113
9694587|NCT00861705|10794582|FG002|STARTED|Overall Study||113
9694588|NCT00861705|10794583|FG003|STARTED|Overall Study||113
9694589|NCT00861705|10794580|FG000|COMPLETED|Overall Study||108
9694590|NCT00861705|10794581|FG001|COMPLETED|Overall Study||110
9694591|NCT00861705|10794582|FG002|COMPLETED|Overall Study||113
9694592|NCT00861705|10794583|FG003|COMPLETED|Overall Study||112
9694593|NCT00861705|10794580|FG000|NOT COMPLETED|Overall Study||7
9694594|NCT00861705|10794581|FG001|NOT COMPLETED|Overall Study||3
9694595|NCT00861705|10794582|FG002|NOT COMPLETED|Overall Study||0
9694596|NCT00861705|10794583|FG003|NOT COMPLETED|Overall Study||1
9694597|NCT00859521|10794603|FG000|STARTED|First Intervention||15
9694598|NCT00859521|10794604|FG001|STARTED|First Intervention||15
9694599|NCT00859521|10794603|FG000|COMPLETED|First Intervention||15
9694600|NCT00859521|10794604|FG001|COMPLETED|First Intervention||15
9694601|NCT00859521|10794603|FG000|NOT COMPLETED|First Intervention||0
9694602|NCT00859521|10794604|FG001|NOT COMPLETED|First Intervention||0
9694603|NCT00859521|10794603|FG000|STARTED|Washout||15
9694604|NCT00859521|10794604|FG001|STARTED|Washout||15
9694605|NCT00859521|10794603|FG000|COMPLETED|Washout||15
9694606|NCT00859521|10794604|FG001|COMPLETED|Washout||14
9694607|NCT00859521|10794603|FG000|NOT COMPLETED|Washout||0
9694608|NCT00859521|10794604|FG001|NOT COMPLETED|Washout||1
9694609|NCT00859521|10794603|FG000|STARTED|Second Intervention||15
9694610|NCT00859521|10794604|FG001|STARTED|Second Intervention||14
9694611|NCT00859521|10794603|FG000|COMPLETED|Second Intervention||15
9694612|NCT00859521|10794604|FG001|COMPLETED|Second Intervention||14
9694613|NCT00859521|10794603|FG000|NOT COMPLETED|Second Intervention||0
9694614|NCT00859521|10794604|FG001|NOT COMPLETED|Second Intervention||0
9694615|NCT00859430|10794610|FG000|STARTED|First Intervention||11
9694616|NCT00859430|10794611|FG001|STARTED|First Intervention||11
9694617|NCT00859430|10794610|FG000|COMPLETED|First Intervention||11
9694618|NCT00859430|10794611|FG001|COMPLETED|First Intervention||10
9694619|NCT00859430|10794610|FG000|NOT COMPLETED|First Intervention||0
9694620|NCT00859430|10794611|FG001|NOT COMPLETED|First Intervention||1
9694621|NCT00859430|10794610|FG000|STARTED|Second Intervention||11
9694622|NCT00859430|10794611|FG001|STARTED|Second Intervention||10
9694623|NCT00859430|10794610|FG000|COMPLETED|Second Intervention||11
9694624|NCT00859430|10794611|FG001|COMPLETED|Second Intervention||10
9694625|NCT00859430|10794610|FG000|NOT COMPLETED|Second Intervention||0
9694626|NCT00859430|10794611|FG001|NOT COMPLETED|Second Intervention||0
9694627|NCT00858702|10794617|FG000|STARTED|Overall Study||53
9694628|NCT00858702|10794618|FG001|STARTED|Overall Study||52
9694629|NCT00858702|10794617|FG000|COMPLETED|Overall Study||48
9694630|NCT00858702|10794618|FG001|COMPLETED|Overall Study||50
9694631|NCT00858702|10794617|FG000|NOT COMPLETED|Overall Study||5
9694632|NCT00858702|10794618|FG001|NOT COMPLETED|Overall Study||2
9694633|NCT00857285|10794626|FG000|STARTED|Overall Study||65
9694634|NCT00857285|10794627|FG001|STARTED|Overall Study||65
9694635|NCT00857285|10794626|FG000|COMPLETED|Overall Study||53
9694636|NCT00857285|10794627|FG001|COMPLETED|Overall Study||59
9694637|NCT00857285|10794626|FG000|NOT COMPLETED|Overall Study||12
9694638|NCT00857285|10794627|FG001|NOT COMPLETED|Overall Study||6
9694639|NCT00856934|10794634|FG000|STARTED|Overall Study||15
9694640|NCT00856934|10794635|FG001|STARTED|Overall Study||15
9694641|NCT00856934|10794636|FG002|STARTED|Overall Study||15
10025384|NCT01870778|11149426|FG001|Full Analysis Set|Overall Study||3271
10025385|NCT01870778|11149425|FG000|Biomarker Analysis Set|Overall Study||521
10025386|NCT01870778|11149426|FG001|Biomarker Analysis Set|Overall Study||510
10025387|NCT01870778|11149425|FG000|COMPLETED|Overall Study||3266
9694642|NCT00856934|10794634|FG000|COMPLETED|Overall Study||15
10025388|NCT01870778|11149426|FG001|COMPLETED|Overall Study||3262
10025389|NCT01870778|11149425|FG000|NOT COMPLETED|Overall Study||8
10025390|NCT01870778|11149426|FG001|NOT COMPLETED|Overall Study||9
9694643|NCT00856934|10794635|FG001|COMPLETED|Overall Study||15
9694644|NCT00856934|10794636|FG002|COMPLETED|Overall Study||15
9694645|NCT00856934|10794634|FG000|NOT COMPLETED|Overall Study||0
9847233|NCT00853099|10959693|FG000|Completed Week 8|Double-blind Period||92
9847234|NCT00853099|10959694|FG001|Completed Week 8|Double-blind Period||85
9847235|NCT00853099|10959695|FG002|Completed Week 8|Double-blind Period||86
9847236|NCT00853099|10959696|FG003|Completed Week 8|Double-blind Period||0
10025391|NCT01870843|11149432|FG000|STARTED|Overall Study||261
10025392|NCT01870843|11149432|FG000|COMPLETED|Overall Study||208
9694646|NCT00856934|10794635|FG001|NOT COMPLETED|Overall Study||0
9694647|NCT00856934|10794636|FG002|NOT COMPLETED|Overall Study||0
9694648|NCT00850174|10794643|FG000|STARTED|First Intervention||30
9694649|NCT00850174|10794644|FG001|STARTED|First Intervention||30
9694650|NCT00850174|10794643|FG000|COMPLETED|First Intervention||30
9694651|NCT00850174|10794644|FG001|COMPLETED|First Intervention||30
9694652|NCT00850174|10794643|FG000|NOT COMPLETED|First Intervention||0
9694653|NCT00850174|10794644|FG001|NOT COMPLETED|First Intervention||0
9694654|NCT00850174|10794643|FG000|STARTED|Washout: One Week||30
9694655|NCT00850174|10794644|FG001|STARTED|Washout: One Week||30
9694656|NCT00850174|10794643|FG000|COMPLETED|Washout: One Week||30
9694657|NCT00850174|10794644|FG001|COMPLETED|Washout: One Week||28
9694658|NCT00850174|10794643|FG000|NOT COMPLETED|Washout: One Week||0
9694659|NCT00850174|10794644|FG001|NOT COMPLETED|Washout: One Week||2
9694660|NCT00850174|10794643|FG000|STARTED|Second Intervention||30
9694661|NCT00850174|10794644|FG001|STARTED|Second Intervention||28
9694662|NCT00850174|10794643|FG000|COMPLETED|Second Intervention||29
9694663|NCT00850174|10794644|FG001|COMPLETED|Second Intervention||28
9694664|NCT00850174|10794643|FG000|NOT COMPLETED|Second Intervention||1
9694665|NCT00850174|10794644|FG001|NOT COMPLETED|Second Intervention||0
9694666|NCT00849862|10794650|FG000|STARTED|First Intervention||11
9694667|NCT00849862|10794651|FG001|STARTED|First Intervention||11
9694668|NCT00849862|10794650|FG000|COMPLETED|First Intervention||11
9694669|NCT00849862|10794651|FG001|COMPLETED|First Intervention||11
9694670|NCT00849862|10794650|FG000|NOT COMPLETED|First Intervention||0
9694671|NCT00849862|10794651|FG001|NOT COMPLETED|First Intervention||0
9694672|NCT00849862|10794650|FG000|STARTED|Washout: 7 Days||11
9694673|NCT00849862|10794651|FG001|STARTED|Washout: 7 Days||11
10025393|NCT01870843|11149432|FG000|NOT COMPLETED|Overall Study||53
10025394|NCT01870856|11149438|FG000|STARTED|Overall Study||25
9694674|NCT00849862|10794650|FG000|COMPLETED|Washout: 7 Days||11
9694675|NCT00849862|10794651|FG001|COMPLETED|Washout: 7 Days||11
9694676|NCT00849862|10794650|FG000|NOT COMPLETED|Washout: 7 Days||0
9694677|NCT00849862|10794651|FG001|NOT COMPLETED|Washout: 7 Days||0
9847237|NCT00853099|10959693|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
10025395|NCT01870856|11149439|FG001|STARTED|Overall Study||27
9694678|NCT00849862|10794650|FG000|STARTED|Second Intervention||11
9694679|NCT00849862|10794651|FG001|STARTED|Second Intervention||11
9694680|NCT00849862|10794650|FG000|COMPLETED|Second Intervention||11
9694681|NCT00849862|10794651|FG001|COMPLETED|Second Intervention||11
9694682|NCT00849862|10794650|FG000|NOT COMPLETED|Second Intervention||0
9694683|NCT00849862|10794651|FG001|NOT COMPLETED|Second Intervention||0
9694684|NCT00849797|10794657|FG000|STARTED|First Intervention||60
9694685|NCT00849797|10794658|FG001|STARTED|First Intervention||60
9847238|NCT00853099|10959694|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
9847239|NCT00853099|10959695|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
9847240|NCT00853099|10959696|FG003|COMPLETED|Double-blind Period||0
9847241|NCT00853099|10959693|FG000|NOT COMPLETED|Double-blind Period||23
9847242|NCT00853099|10959694|FG001|NOT COMPLETED|Double-blind Period||29
9847243|NCT00853099|10959695|FG002|NOT COMPLETED|Double-blind Period||31
9847244|NCT00853099|10959696|FG003|NOT COMPLETED|Double-blind Period||0
9847245|NCT00853099|10959693|FG000|STARTED|Double-blind + Open-label Periods||0
9847246|NCT00853099|10959694|FG001|STARTED|Double-blind + Open-label Periods||0
9847247|NCT00853099|10959695|FG002|STARTED|Double-blind + Open-label Periods||0
9847248|NCT00853099|10959696|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
9847249|NCT00853099|10959693|FG000|COMPLETED|Double-blind + Open-label Periods||0
9847250|NCT00853099|10959694|FG001|COMPLETED|Double-blind + Open-label Periods||0
9847251|NCT00853099|10959695|FG002|COMPLETED|Double-blind + Open-label Periods||0
9847252|NCT00853099|10959696|FG003|COMPLETED|Double-blind + Open-label Periods||119
9847253|NCT00853099|10959693|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0
9847254|NCT00853099|10959694|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0
9847255|NCT00853099|10959695|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0
9847256|NCT00853099|10959696|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147
9847257|NCT00853112|10959713|FG000|STARTED|Overall Study||6
9847258|NCT00853112|10959714|FG001|STARTED|Overall Study||7
9847259|NCT00853112|10959715|FG002|STARTED|Overall Study||7
9847260|NCT00853112|10959716|FG003|STARTED|Overall Study||8
9847261|NCT00853112|10959717|FG004|STARTED|Overall Study||6
9847262|NCT00853112|10959718|FG005|STARTED|Overall Study||7
9847263|NCT00853112|10959719|FG006|STARTED|Overall Study||7
9847264|NCT00853112|10959713|FG000|Treated|Overall Study||6
9847265|NCT00853112|10959714|FG001|Treated|Overall Study||6
9847266|NCT00853112|10959715|FG002|Treated|Overall Study||7
9847267|NCT00853112|10959716|FG003|Treated|Overall Study||6
9847268|NCT00853112|10959717|FG004|Treated|Overall Study||6
9961550|NCT01474200|11081302|FG000|COMPLETED|Overall Study||81
9961551|NCT01474200|11081303|FG001|COMPLETED|Overall Study||84
9961552|NCT01474200|11081302|FG000|NOT COMPLETED|Overall Study||29
9961553|NCT01474200|11081303|FG001|NOT COMPLETED|Overall Study||30
9961554|NCT01474213|11081311|FG000|STARTED|Overall Study||20
9961555|NCT01474213|11081312|FG001|STARTED|Overall Study||20
9961556|NCT01474213|11081311|FG000|COMPLETED|Overall Study||20
9961557|NCT01474213|11081312|FG001|COMPLETED|Overall Study||20
9961558|NCT01474213|11081311|FG000|NOT COMPLETED|Overall Study||0
9961559|NCT01474213|11081312|FG001|NOT COMPLETED|Overall Study||0
9961560|NCT01474239|11081324|FG000|STARTED|Overall Study||59
9961561|NCT01474239|11081325|FG001|STARTED|Overall Study||32
9961562|NCT01474239|11081324|FG000|COMPLETED|Overall Study||0
9961563|NCT01474239|11081325|FG001|COMPLETED|Overall Study||0
9961564|NCT01474239|11081324|FG000|NOT COMPLETED|Overall Study||59
9961565|NCT01474239|11081325|FG001|NOT COMPLETED|Overall Study||32
9961566|NCT01474291|11081333|FG000|STARTED|Overall Study||603
9961567|NCT01474291|11081333|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
9961568|NCT01474291|11081333|FG000|COMPLETED|Overall Study||383
9961569|NCT01474291|11081333|FG000|NOT COMPLETED|Overall Study||220
9961570|NCT01474317|11081340|FG000|STARTED|Overall Study||226
9961571|NCT01474317|11081340|FG000|COMPLETED|Overall Study||224
9961572|NCT01474317|11081340|FG000|NOT COMPLETED|Overall Study||2
9961573|NCT01474434|11081348|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
9961574|NCT01474434|11081349|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
9961575|NCT01474434|11081350|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
9961576|NCT01474434|11081351|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
9961577|NCT01474434|11081348|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
9961578|NCT01474434|11081349|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
9961579|NCT01474434|11081350|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
9961580|NCT01474434|11081351|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
9961581|NCT01474434|11081348|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
9961582|NCT01474434|11081349|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
9961583|NCT01474434|11081350|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
9961584|NCT01474434|11081351|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
9961585|NCT01474434|11081348|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
9961586|NCT01474434|11081349|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
9961587|NCT01474434|11081350|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
9961588|NCT01474434|11081351|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
9961589|NCT01474434|11081348|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
9961590|NCT01474434|11081349|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
9961591|NCT01474434|11081350|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
9961592|NCT01474434|11081351|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
9847269|NCT00853112|10959718|FG005|Treated|Overall Study||7
9847270|NCT00853112|10959719|FG006|Treated|Overall Study||6
9847271|NCT00853112|10959713|FG000|COMPLETED|Overall Study||6
9847272|NCT00853112|10959714|FG001|COMPLETED|Overall Study||6
9847273|NCT00853112|10959715|FG002|COMPLETED|Overall Study||7
9847274|NCT00853112|10959716|FG003|COMPLETED|Overall Study||6
9847275|NCT00853112|10959717|FG004|COMPLETED|Overall Study||6
9847276|NCT00853112|10959718|FG005|COMPLETED|Overall Study||7
9847277|NCT00853112|10959719|FG006|COMPLETED|Overall Study||6
9847278|NCT00853112|10959713|FG000|NOT COMPLETED|Overall Study||0
9847279|NCT00853112|10959714|FG001|NOT COMPLETED|Overall Study||1
9847280|NCT00853112|10959715|FG002|NOT COMPLETED|Overall Study||0
9847281|NCT00853112|10959716|FG003|NOT COMPLETED|Overall Study||2
9847282|NCT00853112|10959717|FG004|NOT COMPLETED|Overall Study||0
9847283|NCT00853112|10959718|FG005|NOT COMPLETED|Overall Study||0
9847284|NCT00853112|10959719|FG006|NOT COMPLETED|Overall Study||1
9847285|NCT00853125|10959735|FG000|STARTED|Overall Study||10
9847286|NCT00853125|10959735|FG000|COMPLETED|Overall Study||9
9847287|NCT00853125|10959735|FG000|NOT COMPLETED|Overall Study||1
9847288|NCT00853151|10959744|FG000|STARTED|Overall Study||38
9847289|NCT00853151|10959745|FG001|STARTED|Overall Study||37
9847290|NCT00853151|10959746|FG002|STARTED|Overall Study||38
9847291|NCT00853151|10959747|FG003|STARTED|Overall Study||18
9847292|NCT00853151|10959744|FG000|COMPLETED|Overall Study||28
9847293|NCT00853151|10959745|FG001|COMPLETED|Overall Study||24
9847294|NCT00853151|10959746|FG002|COMPLETED|Overall Study||30
9847295|NCT00853151|10959747|FG003|COMPLETED|Overall Study||15
9847296|NCT00853151|10959744|FG000|NOT COMPLETED|Overall Study||10
9847297|NCT00853151|10959745|FG001|NOT COMPLETED|Overall Study||13
9694686|NCT00849797|10794657|FG000|COMPLETED|First Intervention||59
9694687|NCT00849797|10794658|FG001|COMPLETED|First Intervention||59
9694688|NCT00849797|10794657|FG000|NOT COMPLETED|First Intervention||1
9694689|NCT00849797|10794658|FG001|NOT COMPLETED|First Intervention||1
9694690|NCT00849797|10794657|FG000|STARTED|Washout: One Week||59
9694691|NCT00849797|10794658|FG001|STARTED|Washout: One Week||59
9694692|NCT00849797|10794657|FG000|COMPLETED|Washout: One Week||59
9694693|NCT00849797|10794658|FG001|COMPLETED|Washout: One Week||57
9694694|NCT00849797|10794657|FG000|NOT COMPLETED|Washout: One Week||0
10025396|NCT01870856|11149438|FG000|COMPLETED|Overall Study||25
9694695|NCT00849797|10794658|FG001|NOT COMPLETED|Washout: One Week||2
9694696|NCT00849797|10794657|FG000|STARTED|Second Intervention||59
9694697|NCT00849797|10794658|FG001|STARTED|Second Intervention||57
10025397|NCT01870856|11149439|FG001|COMPLETED|Overall Study||27
10025398|NCT01870856|11149438|FG000|NOT COMPLETED|Overall Study||0
10025399|NCT01870856|11149439|FG001|NOT COMPLETED|Overall Study||0
10025400|NCT01870869|11149451|FG000|STARTED|Overall Study||288
10025401|NCT01870869|11149452|FG001|STARTED|Overall Study||206
9694698|NCT00849797|10794657|FG000|COMPLETED|Second Intervention||59
9694699|NCT00849797|10794658|FG001|COMPLETED|Second Intervention||57
9694700|NCT00849797|10794657|FG000|NOT COMPLETED|Second Intervention||0
9694701|NCT00849797|10794658|FG001|NOT COMPLETED|Second Intervention||0
9694702|NCT00849485|10794665|FG000|STARTED|First Intervention||11
9694703|NCT00849485|10794666|FG001|STARTED|First Intervention||11
9694704|NCT00849485|10794665|FG000|COMPLETED|First Intervention||11
9694705|NCT00849485|10794666|FG001|COMPLETED|First Intervention||11
9694706|NCT00849485|10794665|FG000|NOT COMPLETED|First Intervention||0
9694707|NCT00849485|10794666|FG001|NOT COMPLETED|First Intervention||0
9847298|NCT00853151|10959746|FG002|NOT COMPLETED|Overall Study||8
9847299|NCT00853151|10959747|FG003|NOT COMPLETED|Overall Study||3
9847300|NCT00853242|10959767|FG000|STARTED|Overall Study||50
9847301|NCT00853242|10959768|FG001|STARTED|Overall Study||50
9847302|NCT00853242|10959769|FG002|STARTED|Overall Study||49
9847303|NCT00853242|10959770|FG003|STARTED|Overall Study||50
9847304|NCT00853242|10959771|FG004|STARTED|Overall Study||50
9847305|NCT00853242|10959772|FG005|STARTED|Overall Study||51
9847306|NCT00853242|10959773|FG006|STARTED|Overall Study||49
9847307|NCT00853242|10959767|FG000|Treated|Overall Study||50
9847308|NCT00853242|10959768|FG001|Treated|Overall Study||49
9847309|NCT00853242|10959769|FG002|Treated|Overall Study||48
9847310|NCT00853242|10959770|FG003|Treated|Overall Study||50
9847311|NCT00853242|10959771|FG004|Treated|Overall Study||50
9847312|NCT00853242|10959772|FG005|Treated|Overall Study||51
9847313|NCT00853242|10959773|FG006|Treated|Overall Study||48
9847314|NCT00853242|10959767|FG000|COMPLETED|Overall Study||47
9847315|NCT00853242|10959768|FG001|COMPLETED|Overall Study||47
9847316|NCT00853242|10959769|FG002|COMPLETED|Overall Study||46
9847317|NCT00853242|10959770|FG003|COMPLETED|Overall Study||46
9847318|NCT00853242|10959771|FG004|COMPLETED|Overall Study||46
9847319|NCT00853242|10959772|FG005|COMPLETED|Overall Study||49
9847320|NCT00853242|10959773|FG006|COMPLETED|Overall Study||44
9847321|NCT00853242|10959767|FG000|NOT COMPLETED|Overall Study||3
9847322|NCT00853242|10959768|FG001|NOT COMPLETED|Overall Study||3
9847323|NCT00853242|10959769|FG002|NOT COMPLETED|Overall Study||3
9847324|NCT00853242|10959770|FG003|NOT COMPLETED|Overall Study||4
9847325|NCT00853242|10959771|FG004|NOT COMPLETED|Overall Study||4
9847326|NCT00853242|10959772|FG005|NOT COMPLETED|Overall Study||2
9847327|NCT00853242|10959773|FG006|NOT COMPLETED|Overall Study||5
9847328|NCT00853333|10959798|FG000|STARTED|Overall Study||28
9847329|NCT00853333|10959799|FG001|STARTED|Overall Study||27
9847330|NCT00853333|10959800|FG002|STARTED|Overall Study||31
9847331|NCT00853333|10959798|FG000|COMPLETED|Overall Study||28
9694708|NCT00849485|10794665|FG000|STARTED|Washout: 7 Days||11
9847332|NCT00853333|10959799|FG001|COMPLETED|Overall Study||27
9847333|NCT00853333|10959800|FG002|COMPLETED|Overall Study||31
9847334|NCT00853333|10959798|FG000|NOT COMPLETED|Overall Study||0
9847335|NCT00853333|10959799|FG001|NOT COMPLETED|Overall Study||0
9847336|NCT00853333|10959800|FG002|NOT COMPLETED|Overall Study||0
9847337|NCT00853372|10959810|FG000|STARTED|Overall Study||43
9847338|NCT00853372|10959811|FG001|STARTED|Overall Study||42
9847339|NCT00853372|10959810|FG000|COMPLETED|Overall Study||11
9847340|NCT00853372|10959811|FG001|COMPLETED|Overall Study||13
9847341|NCT00853372|10959810|FG000|NOT COMPLETED|Overall Study||32
9694709|NCT00849485|10794666|FG001|STARTED|Washout: 7 Days||11
9694710|NCT00849485|10794665|FG000|COMPLETED|Washout: 7 Days||11
9694711|NCT00849485|10794666|FG001|COMPLETED|Washout: 7 Days||11
9694712|NCT00849485|10794665|FG000|NOT COMPLETED|Washout: 7 Days||0
9694713|NCT00849485|10794666|FG001|NOT COMPLETED|Washout: 7 Days||0
9694714|NCT00849485|10794665|FG000|STARTED|Second Intervention||11
10025402|NCT01870869|11149453|FG002|STARTED|Overall Study||1222
10025403|NCT01870869|11149454|FG003|STARTED|Overall Study||235
10025404|NCT01870869|11149451|FG000|COMPLETED|Overall Study||260
10025405|NCT01870869|11149452|FG001|COMPLETED|Overall Study||192
10025406|NCT01870869|11149453|FG002|COMPLETED|Overall Study||1092
9694715|NCT00849485|10794666|FG001|STARTED|Second Intervention||11
9694716|NCT00849485|10794665|FG000|COMPLETED|Second Intervention||11
9694717|NCT00849485|10794666|FG001|COMPLETED|Second Intervention||11
9694718|NCT00849485|10794665|FG000|NOT COMPLETED|Second Intervention||0
9694719|NCT00849485|10794666|FG001|NOT COMPLETED|Second Intervention||0
9694720|NCT00847405|10794672|FG000|STARTED|First Intervention||14
9694721|NCT00847405|10794673|FG001|STARTED|First Intervention||14
9694722|NCT00847405|10794672|FG000|COMPLETED|First Intervention||14
9694723|NCT00847405|10794673|FG001|COMPLETED|First Intervention||13
9694724|NCT00847405|10794672|FG000|NOT COMPLETED|First Intervention||0
9694725|NCT00847405|10794673|FG001|NOT COMPLETED|First Intervention||1
9694726|NCT00847405|10794672|FG000|STARTED|Washout of 7 Days||14
9694727|NCT00847405|10794673|FG001|STARTED|Washout of 7 Days||13
9694728|NCT00847405|10794672|FG000|COMPLETED|Washout of 7 Days||13
9694729|NCT00847405|10794673|FG001|COMPLETED|Washout of 7 Days||13
9694730|NCT00847405|10794672|FG000|NOT COMPLETED|Washout of 7 Days||1
9694731|NCT00847405|10794673|FG001|NOT COMPLETED|Washout of 7 Days||0
9694732|NCT00847405|10794672|FG000|STARTED|Second Intervention||13
9694733|NCT00847405|10794673|FG001|STARTED|Second Intervention||13
9694734|NCT00847405|10794672|FG000|COMPLETED|Second Intervention||13
9694735|NCT00847405|10794673|FG001|COMPLETED|Second Intervention||13
9694736|NCT00847405|10794672|FG000|NOT COMPLETED|Second Intervention||0
9694737|NCT00847405|10794673|FG001|NOT COMPLETED|Second Intervention||0
9694738|NCT00846885|10794679|FG000|STARTED|First Intervention||14
9694739|NCT00846885|10794680|FG001|STARTED|First Intervention||14
9694740|NCT00846885|10794679|FG000|COMPLETED|First Intervention||14
9694741|NCT00846885|10794680|FG001|COMPLETED|First Intervention||14
9694742|NCT00846885|10794679|FG000|NOT COMPLETED|First Intervention||0
9694743|NCT00846885|10794680|FG001|NOT COMPLETED|First Intervention||0
9694744|NCT00846885|10794679|FG000|STARTED|Washout of 7 Days||14
9694745|NCT00846885|10794680|FG001|STARTED|Washout of 7 Days||14
9694746|NCT00846885|10794679|FG000|COMPLETED|Washout of 7 Days||14
9694747|NCT00846885|10794680|FG001|COMPLETED|Washout of 7 Days||14
9694748|NCT00846885|10794679|FG000|NOT COMPLETED|Washout of 7 Days||0
9694749|NCT00846885|10794680|FG001|NOT COMPLETED|Washout of 7 Days||0
10025407|NCT01870869|11149454|FG003|COMPLETED|Overall Study||205
10025408|NCT01870869|11149451|FG000|NOT COMPLETED|Overall Study||28
10025409|NCT01870869|11149452|FG001|NOT COMPLETED|Overall Study||14
10025410|NCT01870869|11149453|FG002|NOT COMPLETED|Overall Study||130
10025411|NCT01870869|11149454|FG003|NOT COMPLETED|Overall Study||30
10025412|NCT01870921|11149464|FG000|STARTED|Overall Study||2004
10025413|NCT01870921|11149464|FG000|COMPLETED|Overall Study||1914
10025414|NCT01870921|11149464|FG000|NOT COMPLETED|Overall Study||90
10025415|NCT01870973|11149470|FG000|STARTED|Overall Study||56
9694750|NCT00846885|10794679|FG000|STARTED|Second Intervention||14
9694751|NCT00846885|10794680|FG001|STARTED|Second Intervention||14
9694752|NCT00846885|10794679|FG000|COMPLETED|Second Intervention||14
9694753|NCT00846885|10794680|FG001|COMPLETED|Second Intervention||14
9694754|NCT00846885|10794679|FG000|NOT COMPLETED|Second Intervention||0
9694755|NCT00846885|10794680|FG001|NOT COMPLETED|Second Intervention||0
9694756|NCT00841815|10794686|FG000|STARTED|Period 1||14
9694757|NCT00841815|10794687|FG001|STARTED|Period 1||14
9694758|NCT00841815|10794686|FG000|COMPLETED|Period 1||14
9694759|NCT00841815|10794687|FG001|COMPLETED|Period 1||14
9694760|NCT00841815|10794686|FG000|NOT COMPLETED|Period 1||0
9694761|NCT00841815|10794687|FG001|NOT COMPLETED|Period 1||0
9694762|NCT00841815|10794686|FG000|STARTED|Washout||14
9694763|NCT00841815|10794687|FG001|STARTED|Washout||14
9694764|NCT00841815|10794686|FG000|COMPLETED|Washout||14
9694765|NCT00841815|10794687|FG001|COMPLETED|Washout||13
9694766|NCT00841815|10794686|FG000|NOT COMPLETED|Washout||0
9694767|NCT00841815|10794687|FG001|NOT COMPLETED|Washout||1
9694768|NCT00841815|10794686|FG000|STARTED|Period 2||14
9694769|NCT00841815|10794687|FG001|STARTED|Period 2||13
9694770|NCT00841815|10794686|FG000|COMPLETED|Period 2||14
9694771|NCT00841815|10794687|FG001|COMPLETED|Period 2||13
9694772|NCT00841815|10794686|FG000|NOT COMPLETED|Period 2||0
9694773|NCT00841815|10794687|FG001|NOT COMPLETED|Period 2||0
9694774|NCT00841698|10794694|FG000|STARTED|First Intervention||25
9694775|NCT00841698|10794695|FG001|STARTED|First Intervention||25
9694776|NCT00841698|10794694|FG000|COMPLETED|First Intervention||24
9694777|NCT00841698|10794695|FG001|COMPLETED|First Intervention||25
9694778|NCT00841698|10794694|FG000|NOT COMPLETED|First Intervention||1
9847342|NCT00853372|10959811|FG001|NOT COMPLETED|Overall Study||29
9847343|NCT00853385|10959822|FG000|STARTED|Overall Study||204
9847344|NCT00853385|10959823|FG001|STARTED|Overall Study||201
9847345|NCT00853385|10959824|FG002|STARTED|Overall Study||56
9847346|NCT00853385|10959825|FG003|STARTED|Overall Study||52
9847347|NCT00853385|10959826|FG004|STARTED|Overall Study||204
9847348|NCT00853385|10959822|FG000|COMPLETED|Overall Study||150
9847349|NCT00853385|10959823|FG001|COMPLETED|Overall Study||158
9847350|NCT00853385|10959824|FG002|COMPLETED|Overall Study||47
9847351|NCT00853385|10959825|FG003|COMPLETED|Overall Study||39
9847352|NCT00853385|10959826|FG004|COMPLETED|Overall Study||162
9847353|NCT00853385|10959822|FG000|NOT COMPLETED|Overall Study||54
9847354|NCT00853385|10959823|FG001|NOT COMPLETED|Overall Study||43
9847355|NCT00853385|10959824|FG002|NOT COMPLETED|Overall Study||9
9847356|NCT00853385|10959825|FG003|NOT COMPLETED|Overall Study||13
9847357|NCT00853385|10959826|FG004|NOT COMPLETED|Overall Study||42
9961593|NCT01474434|11081348|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
9961594|NCT01474434|11081349|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
10025416|NCT01870973|11149471|FG001|STARTED|Overall Study||52
9694779|NCT00841698|10794695|FG001|NOT COMPLETED|First Intervention||0
9694780|NCT00841698|10794694|FG000|STARTED|Washout: 2 Weeks||24
9694781|NCT00841698|10794695|FG001|STARTED|Washout: 2 Weeks||25
9694782|NCT00841698|10794694|FG000|COMPLETED|Washout: 2 Weeks||24
9694783|NCT00841698|10794695|FG001|COMPLETED|Washout: 2 Weeks||25
9694784|NCT00841698|10794694|FG000|NOT COMPLETED|Washout: 2 Weeks||0
9694785|NCT00841698|10794695|FG001|NOT COMPLETED|Washout: 2 Weeks||0
9694786|NCT00841698|10794694|FG000|STARTED|Second Intervention||24
9694787|NCT00841698|10794695|FG001|STARTED|Second Intervention||25
9694788|NCT00841698|10794694|FG000|COMPLETED|Second Intervention||24
9694789|NCT00841698|10794695|FG001|COMPLETED|Second Intervention||25
9694790|NCT00841698|10794694|FG000|NOT COMPLETED|Second Intervention||0
9694791|NCT00841698|10794695|FG001|NOT COMPLETED|Second Intervention||0
9694792|NCT00841659|10794701|FG000|STARTED|First Intervention||12
9694793|NCT00841659|10794702|FG001|STARTED|First Intervention||12
9694794|NCT00841659|10794701|FG000|COMPLETED|First Intervention||12
9694795|NCT00841659|10794702|FG001|COMPLETED|First Intervention||12
9694796|NCT00841659|10794701|FG000|NOT COMPLETED|First Intervention||0
9694797|NCT00841659|10794702|FG001|NOT COMPLETED|First Intervention||0
9847358|NCT00853489|10959850|FG000|STARTED|Overall Study||16
9847359|NCT00853489|10959851|FG001|STARTED|Overall Study||14
9694798|NCT00841659|10794701|FG000|STARTED|Washout: 2 Weeks||12
9847360|NCT00853489|10959850|FG000|COMPLETED|Overall Study||11
9847361|NCT00853489|10959851|FG001|COMPLETED|Overall Study||12
9847362|NCT00853489|10959850|FG000|NOT COMPLETED|Overall Study||5
9847363|NCT00853489|10959851|FG001|NOT COMPLETED|Overall Study||2
9961595|NCT01474434|11081350|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
9694799|NCT00841659|10794702|FG001|STARTED|Washout: 2 Weeks||12
9694800|NCT00841659|10794701|FG000|COMPLETED|Washout: 2 Weeks||11
9694801|NCT00841659|10794702|FG001|COMPLETED|Washout: 2 Weeks||12
9694802|NCT00841659|10794701|FG000|NOT COMPLETED|Washout: 2 Weeks||1
9694803|NCT00841659|10794702|FG001|NOT COMPLETED|Washout: 2 Weeks||0
9694804|NCT00841659|10794701|FG000|STARTED|Second Intervention||11
9694805|NCT00841659|10794702|FG001|STARTED|Second Intervention||12
9694806|NCT00841659|10794701|FG000|COMPLETED|Second Intervention||11
9694807|NCT00841659|10794702|FG001|COMPLETED|Second Intervention||12
9694808|NCT00841659|10794701|FG000|NOT COMPLETED|Second Intervention||0
9694809|NCT00841659|10794702|FG001|NOT COMPLETED|Second Intervention||0
9694810|NCT00841542|10794708|FG000|STARTED|Period 1||14
9694811|NCT00841542|10794709|FG001|STARTED|Period 1||14
9694812|NCT00841542|10794708|FG000|COMPLETED|Period 1||13
9694813|NCT00841542|10794709|FG001|COMPLETED|Period 1||14
9694814|NCT00841542|10794708|FG000|NOT COMPLETED|Period 1||1
9694815|NCT00841542|10794709|FG001|NOT COMPLETED|Period 1||0
9694816|NCT00841542|10794708|FG000|STARTED|Period 2||13
9694817|NCT00841542|10794709|FG001|STARTED|Period 2||14
9694818|NCT00841542|10794708|FG000|COMPLETED|Period 2||13
9694819|NCT00841542|10794709|FG001|COMPLETED|Period 2||14
9694820|NCT00841542|10794708|FG000|NOT COMPLETED|Period 2||0
9694821|NCT00841542|10794709|FG001|NOT COMPLETED|Period 2||0
9694822|NCT00840879|10794715|FG000|STARTED|First Intervention||14
9694823|NCT00840879|10794716|FG001|STARTED|First Intervention||14
9694824|NCT00840879|10794715|FG000|COMPLETED|First Intervention||14
9694825|NCT00840879|10794716|FG001|COMPLETED|First Intervention||14
9694826|NCT00840879|10794715|FG000|NOT COMPLETED|First Intervention||0
9694827|NCT00840879|10794716|FG001|NOT COMPLETED|First Intervention||0
9694828|NCT00840879|10794715|FG000|STARTED|Washout: 14 Days||14
9694829|NCT00840879|10794716|FG001|STARTED|Washout: 14 Days||14
9694830|NCT00840879|10794715|FG000|COMPLETED|Washout: 14 Days||14
9694831|NCT00840879|10794716|FG001|COMPLETED|Washout: 14 Days||14
9694832|NCT00840879|10794715|FG000|NOT COMPLETED|Washout: 14 Days||0
9694833|NCT00840879|10794716|FG001|NOT COMPLETED|Washout: 14 Days||0
9694834|NCT00840879|10794715|FG000|STARTED|Second Intervention||14
9694835|NCT00840879|10794716|FG001|STARTED|Second Intervention||14
9694836|NCT00840879|10794715|FG000|COMPLETED|Second Intervention||13
9694837|NCT00840879|10794716|FG001|COMPLETED|Second Intervention||14
9694838|NCT00840879|10794715|FG000|NOT COMPLETED|Second Intervention||1
9694839|NCT00840879|10794716|FG001|NOT COMPLETED|Second Intervention||0
9694840|NCT00840866|10794722|FG000|STARTED|First Intervention||20
9694841|NCT00840866|10794723|FG001|STARTED|First Intervention||19
9694842|NCT00840866|10794722|FG000|COMPLETED|First Intervention||20
9694843|NCT00840866|10794723|FG001|COMPLETED|First Intervention||19
9694844|NCT00840866|10794722|FG000|NOT COMPLETED|First Intervention||0
9694845|NCT00840866|10794723|FG001|NOT COMPLETED|First Intervention||0
9694846|NCT00840866|10794722|FG000|STARTED|Washout of 7 Days||20
9694847|NCT00840866|10794723|FG001|STARTED|Washout of 7 Days||19
9694848|NCT00840866|10794722|FG000|COMPLETED|Washout of 7 Days||20
9694849|NCT00840866|10794723|FG001|COMPLETED|Washout of 7 Days||19
9694850|NCT00840866|10794722|FG000|NOT COMPLETED|Washout of 7 Days||0
9694851|NCT00840866|10794723|FG001|NOT COMPLETED|Washout of 7 Days||0
9694852|NCT00840866|10794722|FG000|STARTED|Second Intervention||20
9694853|NCT00840866|10794723|FG001|STARTED|Second Intervention||19
9694854|NCT00840866|10794722|FG000|COMPLETED|Second Intervention||20
9694855|NCT00840866|10794723|FG001|COMPLETED|Second Intervention||19
9694856|NCT00840866|10794722|FG000|NOT COMPLETED|Second Intervention||0
9694857|NCT00840866|10794723|FG001|NOT COMPLETED|Second Intervention||0
9694858|NCT00840840|10794729|FG000|STARTED|Period 1||24
9694859|NCT00840840|10794730|FG001|STARTED|Period 1||24
9694860|NCT00840840|10794729|FG000|COMPLETED|Period 1||24
9694861|NCT00840840|10794730|FG001|COMPLETED|Period 1||24
9694862|NCT00840840|10794729|FG000|NOT COMPLETED|Period 1||0
9694863|NCT00840840|10794730|FG001|NOT COMPLETED|Period 1||0
9694864|NCT00840840|10794729|FG000|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
9694865|NCT00840840|10794730|FG001|STARTED|Period 2||24
9694866|NCT00840840|10794729|FG000|COMPLETED|Period 2||23
9694867|NCT00840840|10794730|FG001|COMPLETED|Period 2||24
9694868|NCT00840840|10794729|FG000|NOT COMPLETED|Period 2||0
9694869|NCT00840840|10794730|FG001|NOT COMPLETED|Period 2||0
9694870|NCT00840632|10794736|FG000|STARTED|First Intervention||20
9694871|NCT00840632|10794737|FG001|STARTED|First Intervention||20
9694872|NCT00840632|10794736|FG000|COMPLETED|First Intervention||20
9694873|NCT00840632|10794737|FG001|COMPLETED|First Intervention||19
9694874|NCT00840632|10794736|FG000|NOT COMPLETED|First Intervention||0
9694875|NCT00840632|10794737|FG001|NOT COMPLETED|First Intervention||1
9694876|NCT00840632|10794736|FG000|STARTED|Washout||20
9694877|NCT00840632|10794737|FG001|STARTED|Washout||19
9694878|NCT00840632|10794736|FG000|COMPLETED|Washout||19
9694879|NCT00840632|10794737|FG001|COMPLETED|Washout||18
9694880|NCT00840632|10794736|FG000|NOT COMPLETED|Washout||1
9694881|NCT00840632|10794737|FG001|NOT COMPLETED|Washout||1
9694882|NCT00840632|10794736|FG000|STARTED|Second Intervention||19
9694883|NCT00840632|10794737|FG001|STARTED|Second Intervention||18
9694884|NCT00840632|10794736|FG000|COMPLETED|Second Intervention||19
9694885|NCT00840632|10794737|FG001|COMPLETED|Second Intervention||18
9694886|NCT00840632|10794736|FG000|NOT COMPLETED|Second Intervention||0
9694887|NCT00840632|10794737|FG001|NOT COMPLETED|Second Intervention||0
9694888|NCT00840476|10794743|FG000|STARTED|First Intervention||14
9694889|NCT00840476|10794744|FG001|STARTED|First Intervention||14
9694890|NCT00840476|10794743|FG000|COMPLETED|First Intervention||14
9694891|NCT00840476|10794744|FG001|COMPLETED|First Intervention||14
9694892|NCT00840476|10794743|FG000|NOT COMPLETED|First Intervention||0
9694893|NCT00840476|10794744|FG001|NOT COMPLETED|First Intervention||0
9694894|NCT00840476|10794743|FG000|STARTED|Washout: 14 Days||14
9694895|NCT00840476|10794744|FG001|STARTED|Washout: 14 Days||14
9694896|NCT00840476|10794743|FG000|COMPLETED|Washout: 14 Days||14
9694897|NCT00840476|10794744|FG001|COMPLETED|Washout: 14 Days||14
9694898|NCT00840476|10794743|FG000|NOT COMPLETED|Washout: 14 Days||0
9694899|NCT00840476|10794744|FG001|NOT COMPLETED|Washout: 14 Days||0
9694900|NCT00840476|10794743|FG000|STARTED|Second Intervention||14
9694901|NCT00840476|10794744|FG001|STARTED|Second Intervention||14
9694902|NCT00840476|10794743|FG000|COMPLETED|Second Intervention||14
9694903|NCT00840476|10794744|FG001|COMPLETED|Second Intervention||14
9694904|NCT00840476|10794743|FG000|NOT COMPLETED|Second Intervention||0
9694905|NCT00840476|10794744|FG001|NOT COMPLETED|Second Intervention||0
9694906|NCT00840411|10794750|FG000|STARTED|First Intervention||33
9694907|NCT00840411|10794751|FG001|STARTED|First Intervention||33
9694908|NCT00840411|10794750|FG000|COMPLETED|First Intervention||32
9694909|NCT00840411|10794751|FG001|COMPLETED|First Intervention||33
9694910|NCT00840411|10794750|FG000|NOT COMPLETED|First Intervention||1
9694911|NCT00840411|10794751|FG001|NOT COMPLETED|First Intervention||0
9694912|NCT00840411|10794750|FG000|STARTED|Washout||32
9694913|NCT00840411|10794751|FG001|STARTED|Washout||33
9694914|NCT00840411|10794750|FG000|COMPLETED|Washout||31
9694915|NCT00840411|10794751|FG001|COMPLETED|Washout||33
9694916|NCT00840411|10794750|FG000|NOT COMPLETED|Washout||1
9694917|NCT00840411|10794751|FG001|NOT COMPLETED|Washout||0
9694918|NCT00840411|10794750|FG000|STARTED|Second Intervention||31
9694919|NCT00840411|10794751|FG001|STARTED|Second Intervention||33
9694920|NCT00840411|10794750|FG000|COMPLETED|Second Intervention||31
9694921|NCT00840411|10794751|FG001|COMPLETED|Second Intervention||33
9694922|NCT00840411|10794750|FG000|NOT COMPLETED|Second Intervention||0
9694923|NCT00840411|10794751|FG001|NOT COMPLETED|Second Intervention||0
9694924|NCT00840281|10794757|FG000|STARTED|First Intervention||19
9694925|NCT00840281|10794758|FG001|STARTED|First Intervention||19
9694926|NCT00840281|10794757|FG000|COMPLETED|First Intervention||19
9694927|NCT00840281|10794758|FG001|COMPLETED|First Intervention||19
9694928|NCT00840281|10794757|FG000|NOT COMPLETED|First Intervention||0
9694929|NCT00840281|10794758|FG001|NOT COMPLETED|First Intervention||0
9961596|NCT01474434|11081351|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
9961597|NCT01474486|11081365|FG000|STARTED|Overall Study||28
9961598|NCT01474486|11081365|FG000|Treated|Overall Study||22
9961599|NCT01474486|11081365|FG000|COMPLETED|Overall Study||20
9961600|NCT01474486|11081365|FG000|NOT COMPLETED|Overall Study||8
10025417|NCT01870973|11149470|FG000|COMPLETED|Overall Study||46
9694930|NCT00840281|10794757|FG000|STARTED|Washout of 7 Days||19
9694931|NCT00840281|10794758|FG001|STARTED|Washout of 7 Days||19
9961601|NCT01474512|11081376|FG000|STARTED|Induction Period||431
9961602|NCT01474512|11081377|FG001|STARTED|Induction Period||432
9961603|NCT01474512|11081378|FG002|STARTED|Induction Period||433
9961604|NCT01474512|11081379|FG003|STARTED|Induction Period||0
9961605|NCT01474512|11081380|FG004|STARTED|Induction Period||0
9961606|NCT01474512|11081381|FG005|STARTED|Induction Period||0
10025418|NCT01870973|11149471|FG001|COMPLETED|Overall Study||49
10025419|NCT01870973|11149470|FG000|NOT COMPLETED|Overall Study||10
10025420|NCT01870973|11149471|FG001|NOT COMPLETED|Overall Study||3
10025421|NCT01870999|11149480|FG000|STARTED|Overall Study||14
10025422|NCT01870999|11149481|FG001|STARTED|Overall Study||16
10025423|NCT01870999|11149482|FG002|STARTED|Overall Study||11
10025424|NCT01870999|11149480|FG000|Safety Population; Received Study Drug|Overall Study||14
10025425|NCT01870999|11149481|FG001|Safety Population; Received Study Drug|Overall Study||15
10025426|NCT01870999|11149482|FG002|Safety Population; Received Study Drug|Overall Study||10
10025427|NCT01870999|11149480|FG000|COMPLETED|Overall Study||10
10025428|NCT01870999|11149481|FG001|COMPLETED|Overall Study||8
10025429|NCT01870999|11149482|FG002|COMPLETED|Overall Study||4
10025430|NCT01870999|11149480|FG000|NOT COMPLETED|Overall Study||4
10025431|NCT01870999|11149481|FG001|NOT COMPLETED|Overall Study||8
10025432|NCT01870999|11149482|FG002|NOT COMPLETED|Overall Study||7
10025433|NCT01871077|11149490|FG000|STARTED|Overall Study||30
10025434|NCT01871077|11149490|FG000|COMPLETED|Overall Study||30
10025435|NCT01871077|11149490|FG000|NOT COMPLETED|Overall Study||0
10025436|NCT01871090|11149496|FG000|STARTED|Overall Study||35
10025437|NCT01871090|11149497|FG001|STARTED|Overall Study||48
10025438|NCT01871090|11149496|FG000|COMPLETED|Overall Study||33
9961607|NCT01474512|11081382|FG006|STARTED|Induction Period||0
10025439|NCT01871090|11149497|FG001|COMPLETED|Overall Study||25
10025440|NCT01871090|11149496|FG000|NOT COMPLETED|Overall Study||2
10025441|NCT01871090|11149497|FG001|NOT COMPLETED|Overall Study||23
10025442|NCT01871142|11149503|FG000|STARTED|Overall Study||12
10025443|NCT01871142|11149503|FG000|Received Placebo + Normoixa|Overall Study||11
9694932|NCT00840281|10794757|FG000|COMPLETED|Washout of 7 Days||19
9694933|NCT00840281|10794758|FG001|COMPLETED|Washout of 7 Days||19
9694934|NCT00840281|10794757|FG000|NOT COMPLETED|Washout of 7 Days||0
9694935|NCT00840281|10794758|FG001|NOT COMPLETED|Washout of 7 Days||0
9694936|NCT00840281|10794757|FG000|STARTED|Second Intervention||19
9694937|NCT00840281|10794758|FG001|STARTED|Second Intervention||19
9694938|NCT00840281|10794757|FG000|COMPLETED|Second Intervention||19
9694939|NCT00840281|10794758|FG001|COMPLETED|Second Intervention||19
9694940|NCT00840281|10794757|FG000|NOT COMPLETED|Second Intervention||0
9694941|NCT00840281|10794758|FG001|NOT COMPLETED|Second Intervention||0
9694942|NCT00840216|10794764|FG000|STARTED|First Intervention||11
9694943|NCT00840216|10794765|FG001|STARTED|First Intervention||11
9694944|NCT00840216|10794764|FG000|COMPLETED|First Intervention||11
9694945|NCT00840216|10794765|FG001|COMPLETED|First Intervention||11
9694946|NCT00840216|10794764|FG000|NOT COMPLETED|First Intervention||0
9694947|NCT00840216|10794765|FG001|NOT COMPLETED|First Intervention||0
9694948|NCT00840216|10794764|FG000|STARTED|Washout: 7 Days||11
9694949|NCT00840216|10794765|FG001|STARTED|Washout: 7 Days||11
9694950|NCT00840216|10794764|FG000|COMPLETED|Washout: 7 Days||10
9694951|NCT00840216|10794765|FG001|COMPLETED|Washout: 7 Days||11
9694952|NCT00840216|10794764|FG000|NOT COMPLETED|Washout: 7 Days||1
9694953|NCT00840216|10794765|FG001|NOT COMPLETED|Washout: 7 Days||0
9694954|NCT00840216|10794764|FG000|STARTED|Second Intervention||10
9694955|NCT00840216|10794765|FG001|STARTED|Second Intervention||11
9694956|NCT00840216|10794764|FG000|COMPLETED|Second Intervention||10
9694957|NCT00840216|10794765|FG001|COMPLETED|Second Intervention||11
9694958|NCT00840216|10794764|FG000|NOT COMPLETED|Second Intervention||0
9694959|NCT00840216|10794765|FG001|NOT COMPLETED|Second Intervention||0
9694960|NCT00840203|10794771|FG000|STARTED|First Intervention||37
9694961|NCT00840203|10794772|FG001|STARTED|First Intervention||35
9694962|NCT00840203|10794771|FG000|COMPLETED|First Intervention||36
9694963|NCT00840203|10794772|FG001|COMPLETED|First Intervention||34
9694964|NCT00840203|10794771|FG000|NOT COMPLETED|First Intervention||1
9694965|NCT00840203|10794772|FG001|NOT COMPLETED|First Intervention||1
9694966|NCT00840203|10794771|FG000|STARTED|Washout||36
9694967|NCT00840203|10794772|FG001|STARTED|Washout||34
9694968|NCT00840203|10794771|FG000|COMPLETED|Washout||35
9694969|NCT00840203|10794772|FG001|COMPLETED|Washout||34
9694970|NCT00840203|10794771|FG000|NOT COMPLETED|Washout||1
9694971|NCT00840203|10794772|FG001|NOT COMPLETED|Washout||0
9694972|NCT00840203|10794771|FG000|STARTED|Second Intervention||35
9694973|NCT00840203|10794772|FG001|STARTED|Second Intervention||34
9694974|NCT00840203|10794771|FG000|COMPLETED|Second Intervention||35
9694975|NCT00840203|10794772|FG001|COMPLETED|Second Intervention||34
9694976|NCT00840203|10794771|FG000|NOT COMPLETED|Second Intervention||0
9694977|NCT00840203|10794772|FG001|NOT COMPLETED|Second Intervention||0
9694978|NCT00840099|10794778|FG000|STARTED|Period 1||24
9694979|NCT00840099|10794779|FG001|STARTED|Period 1||24
9694980|NCT00840099|10794778|FG000|COMPLETED|Period 1||24
9694981|NCT00840099|10794779|FG001|COMPLETED|Period 1||24
9694982|NCT00840099|10794778|FG000|NOT COMPLETED|Period 1||0
9694983|NCT00840099|10794779|FG001|NOT COMPLETED|Period 1||0
9694984|NCT00840099|10794778|FG000|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
9694985|NCT00840099|10794779|FG001|STARTED|Period 2||24
9694986|NCT00840099|10794778|FG000|COMPLETED|Period 2||21
9694987|NCT00840099|10794779|FG001|COMPLETED|Period 2||24
9694988|NCT00840099|10794778|FG000|NOT COMPLETED|Period 2||0
9694989|NCT00840099|10794779|FG001|NOT COMPLETED|Period 2||0
9694990|NCT00840073|10794785|FG000|STARTED|First Intervention||25
9694991|NCT00840073|10794786|FG001|STARTED|First Intervention||25
9694992|NCT00840073|10794785|FG000|COMPLETED|First Intervention||25
9694993|NCT00840073|10794786|FG001|COMPLETED|First Intervention||25
9694994|NCT00840073|10794785|FG000|NOT COMPLETED|First Intervention||0
9694995|NCT00840073|10794786|FG001|NOT COMPLETED|First Intervention||0
9694996|NCT00840073|10794785|FG000|STARTED|Second Intervention||25
9694997|NCT00840073|10794786|FG001|STARTED|Second Intervention||25
10025444|NCT01871142|11149503|FG000|Received Placebo + Hypoxia|Overall Study||12
9694998|NCT00840073|10794785|FG000|COMPLETED|Second Intervention||24
9694999|NCT00840073|10794786|FG001|COMPLETED|Second Intervention||24
9695000|NCT00840073|10794785|FG000|NOT COMPLETED|Second Intervention||1
10025445|NCT01871142|11149503|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
10025446|NCT01871142|11149503|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
10025447|NCT01871142|11149503|FG000|COMPLETED|Overall Study||11
9695001|NCT00840073|10794786|FG001|NOT COMPLETED|Second Intervention||1
9695002|NCT00839930|10794792|FG000|STARTED|First Intervention||15
9695003|NCT00839930|10794793|FG001|STARTED|First Intervention||15
9695004|NCT00839930|10794792|FG000|COMPLETED|First Intervention||15
9695005|NCT00839930|10794793|FG001|COMPLETED|First Intervention||15
9695006|NCT00839930|10794792|FG000|NOT COMPLETED|First Intervention||0
10025448|NCT01871142|11149503|FG000|NOT COMPLETED|Overall Study||1
10025449|NCT01871285|11149519|FG000|STARTED|First Intervention (1 Day)||18
10025450|NCT01871285|11149520|FG001|STARTED|First Intervention (1 Day)||15
10025451|NCT01871285|11149521|FG002|STARTED|First Intervention (1 Day)||4
9695007|NCT00839930|10794793|FG001|NOT COMPLETED|First Intervention||0
9695008|NCT00839930|10794792|FG000|STARTED|Washout: 7 Days||15
9695009|NCT00839930|10794793|FG001|STARTED|Washout: 7 Days||15
9695010|NCT00839930|10794792|FG000|COMPLETED|Washout: 7 Days||15
9695011|NCT00839930|10794793|FG001|COMPLETED|Washout: 7 Days||15
9695012|NCT00839930|10794792|FG000|NOT COMPLETED|Washout: 7 Days||0
9695013|NCT00839930|10794793|FG001|NOT COMPLETED|Washout: 7 Days||0
9695014|NCT00839930|10794792|FG000|STARTED|Second Intervention||15
9695015|NCT00839930|10794793|FG001|STARTED|Second Intervention||15
9695016|NCT00839930|10794792|FG000|COMPLETED|Second Intervention||15
9695017|NCT00839930|10794793|FG001|COMPLETED|Second Intervention||15
9695018|NCT00839930|10794792|FG000|NOT COMPLETED|Second Intervention||0
9695019|NCT00839930|10794793|FG001|NOT COMPLETED|Second Intervention||0
9695020|NCT00838630|10794799|FG000|STARTED|First Intervention||18
9695021|NCT00838630|10794800|FG001|STARTED|First Intervention||18
9695022|NCT00838630|10794799|FG000|COMPLETED|First Intervention||17
9695023|NCT00838630|10794800|FG001|COMPLETED|First Intervention||18
9695024|NCT00838630|10794799|FG000|NOT COMPLETED|First Intervention||1
9695025|NCT00838630|10794800|FG001|NOT COMPLETED|First Intervention||0
9695026|NCT00838630|10794799|FG000|STARTED|Washout: 7 Days||17
9695027|NCT00838630|10794800|FG001|STARTED|Washout: 7 Days||18
9695028|NCT00838630|10794799|FG000|COMPLETED|Washout: 7 Days||16
9695029|NCT00838630|10794800|FG001|COMPLETED|Washout: 7 Days||18
9695030|NCT00838630|10794799|FG000|NOT COMPLETED|Washout: 7 Days||1
9695031|NCT00838630|10794800|FG001|NOT COMPLETED|Washout: 7 Days||0
9695032|NCT00838630|10794799|FG000|STARTED|Second Intervention||16
9695033|NCT00838630|10794800|FG001|STARTED|Second Intervention||18
9695034|NCT00838630|10794799|FG000|COMPLETED|Second Intervention||16
9695035|NCT00838630|10794800|FG001|COMPLETED|Second Intervention||18
9695036|NCT00838630|10794799|FG000|NOT COMPLETED|Second Intervention||0
9695037|NCT00838630|10794800|FG001|NOT COMPLETED|Second Intervention||0
9695038|NCT00838279|10794806|FG000|STARTED|First Intervention||16
9695039|NCT00838279|10794807|FG001|STARTED|First Intervention||16
9695040|NCT00838279|10794806|FG000|COMPLETED|First Intervention||16
9695041|NCT00838279|10794807|FG001|COMPLETED|First Intervention||16
9695042|NCT00838279|10794806|FG000|NOT COMPLETED|First Intervention||0
9695043|NCT00838279|10794807|FG001|NOT COMPLETED|First Intervention||0
9695044|NCT00838279|10794806|FG000|STARTED|Washout||16
9695045|NCT00838279|10794807|FG001|STARTED|Washout||16
9695046|NCT00838279|10794806|FG000|COMPLETED|Washout||15
9695047|NCT00838279|10794807|FG001|COMPLETED|Washout||15
9695048|NCT00838279|10794806|FG000|NOT COMPLETED|Washout||1
9695049|NCT00838279|10794807|FG001|NOT COMPLETED|Washout||1
9695050|NCT00838279|10794806|FG000|STARTED|Second Intervention||15
9695051|NCT00838279|10794807|FG001|STARTED|Second Intervention||15
9695052|NCT00838279|10794806|FG000|COMPLETED|Second Intervention||15
9695053|NCT00838279|10794807|FG001|COMPLETED|Second Intervention||15
9695054|NCT00838279|10794806|FG000|NOT COMPLETED|Second Intervention||0
9695055|NCT00838279|10794807|FG001|NOT COMPLETED|Second Intervention||0
9695056|NCT00838136|10794813|FG000|STARTED|First Intervention||16
9695057|NCT00838136|10794814|FG001|STARTED|First Intervention||16
9695058|NCT00838136|10794813|FG000|COMPLETED|First Intervention||16
9695059|NCT00838136|10794814|FG001|COMPLETED|First Intervention||16
9695060|NCT00838136|10794813|FG000|NOT COMPLETED|First Intervention||0
9695061|NCT00838136|10794814|FG001|NOT COMPLETED|First Intervention||0
9695062|NCT00838136|10794813|FG000|STARTED|Second Intervention||16
9695063|NCT00838136|10794814|FG001|STARTED|Second Intervention||16
9695064|NCT00838136|10794813|FG000|COMPLETED|Second Intervention||16
9695065|NCT00838136|10794814|FG001|COMPLETED|Second Intervention||15
9695066|NCT00838136|10794813|FG000|NOT COMPLETED|Second Intervention||0
9695067|NCT00838136|10794814|FG001|NOT COMPLETED|Second Intervention||1
9695068|NCT00836901|10794820|FG000|STARTED|First Intervention||24
9695069|NCT00836901|10794821|FG001|STARTED|First Intervention||28
9695070|NCT00836901|10794820|FG000|COMPLETED|First Intervention||23
9695071|NCT00836901|10794821|FG001|COMPLETED|First Intervention||28
9695072|NCT00836901|10794820|FG000|NOT COMPLETED|First Intervention||1
9695073|NCT00836901|10794821|FG001|NOT COMPLETED|First Intervention||0
9695074|NCT00836901|10794820|FG000|STARTED|Second Intervention||23
9695075|NCT00836901|10794821|FG001|STARTED|Second Intervention||28
9695076|NCT00836901|10794820|FG000|COMPLETED|Second Intervention||23
9695077|NCT00836901|10794821|FG001|COMPLETED|Second Intervention||28
9695078|NCT00836901|10794820|FG000|NOT COMPLETED|Second Intervention||0
9695079|NCT00836901|10794821|FG001|NOT COMPLETED|Second Intervention||0
9695080|NCT00836706|10794827|FG000|STARTED|First Intervention||11
9695081|NCT00836706|10794828|FG001|STARTED|First Intervention||12
9695082|NCT00836706|10794827|FG000|COMPLETED|First Intervention||11
9695083|NCT00836706|10794828|FG001|COMPLETED|First Intervention||12
9695084|NCT00836706|10794827|FG000|NOT COMPLETED|First Intervention||0
9695085|NCT00836706|10794828|FG001|NOT COMPLETED|First Intervention||0
9695086|NCT00836706|10794827|FG000|STARTED|Washout: 7 Days||11
9695087|NCT00836706|10794828|FG001|STARTED|Washout: 7 Days||12
9695088|NCT00836706|10794827|FG000|COMPLETED|Washout: 7 Days||11
9695089|NCT00836706|10794828|FG001|COMPLETED|Washout: 7 Days||11
9695090|NCT00836706|10794827|FG000|NOT COMPLETED|Washout: 7 Days||0
9695091|NCT00836706|10794828|FG001|NOT COMPLETED|Washout: 7 Days||1
9695092|NCT00836706|10794827|FG000|STARTED|Second Intervention||11
9695093|NCT00836706|10794828|FG001|STARTED|Second Intervention||11
9695094|NCT00836706|10794827|FG000|COMPLETED|Second Intervention||11
9695095|NCT00836706|10794828|FG001|COMPLETED|Second Intervention||11
9695096|NCT00836706|10794827|FG000|NOT COMPLETED|Second Intervention||0
9695097|NCT00836706|10794828|FG001|NOT COMPLETED|Second Intervention||0
9695098|NCT00836472|10794834|FG000|STARTED|First Intervention||30
9695099|NCT00836472|10794835|FG001|STARTED|First Intervention||30
9695100|NCT00836472|10794834|FG000|COMPLETED|First Intervention||30
9695101|NCT00836472|10794835|FG001|COMPLETED|First Intervention||30
9695102|NCT00836472|10794834|FG000|NOT COMPLETED|First Intervention||0
9695103|NCT00836472|10794835|FG001|NOT COMPLETED|First Intervention||0
9695104|NCT00836472|10794834|FG000|STARTED|Washout||30
9695105|NCT00836472|10794835|FG001|STARTED|Washout||30
9695106|NCT00836472|10794834|FG000|COMPLETED|Washout||28
9695107|NCT00836472|10794835|FG001|COMPLETED|Washout||27
9695108|NCT00836472|10794834|FG000|NOT COMPLETED|Washout||2
9695109|NCT00836472|10794835|FG001|NOT COMPLETED|Washout||3
9695110|NCT00836472|10794834|FG000|STARTED|Second Intervention||28
9695111|NCT00836472|10794835|FG001|STARTED|Second Intervention||27
9695112|NCT00836472|10794834|FG000|COMPLETED|Second Intervention||28
9695113|NCT00836472|10794835|FG001|COMPLETED|Second Intervention||27
9695114|NCT00836472|10794834|FG000|NOT COMPLETED|Second Intervention||0
9695115|NCT00836472|10794835|FG001|NOT COMPLETED|Second Intervention||0
9727139|NCT00105157|10826688|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
9727140|NCT00105157|10826689|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
9727141|NCT00105157|10826690|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
9727142|NCT00105157|10826691|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
9847364|NCT00853580|10959859|FG000|STARTED|Overall Study||74
9847365|NCT00853580|10959860|FG001|STARTED|Overall Study||72
9847366|NCT00853580|10959859|FG000|COMPLETED|Overall Study||67
10025452|NCT01871285|11149522|FG003|STARTED|First Intervention (1 Day)||2
10025453|NCT01871285|11149519|FG000|COMPLETED|First Intervention (1 Day)||17
10025454|NCT01871285|11149520|FG001|COMPLETED|First Intervention (1 Day)||14
9847367|NCT00853580|10959860|FG001|COMPLETED|Overall Study||56
9847368|NCT00853580|10959859|FG000|NOT COMPLETED|Overall Study||7
9847369|NCT00853580|10959860|FG001|NOT COMPLETED|Overall Study||16
9847370|NCT00853593|10959866|FG000|STARTED|Overall Study||197
9847371|NCT00853593|10959866|FG000|Implant Attempted|Overall Study||193
9695116|NCT00836056|10794841|FG000|STARTED|First Intervention||12
10025455|NCT01871285|11149521|FG002|COMPLETED|First Intervention (1 Day)||3
10025456|NCT01871285|11149522|FG003|COMPLETED|First Intervention (1 Day)||2
10025457|NCT01871285|11149519|FG000|NOT COMPLETED|First Intervention (1 Day)||1
10025458|NCT01871285|11149520|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10025459|NCT01871285|11149521|FG002|NOT COMPLETED|First Intervention (1 Day)||1
10025460|NCT01871285|11149522|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10025461|NCT01871285|11149519|FG000|STARTED|Second Intervention (1 Day)||17
10025462|NCT01871285|11149520|FG001|STARTED|Second Intervention (1 Day)||14
9695117|NCT00836056|10794842|FG001|STARTED|First Intervention||12
9695118|NCT00836056|10794841|FG000|COMPLETED|First Intervention||11
9695119|NCT00836056|10794842|FG001|COMPLETED|First Intervention||12
9695120|NCT00836056|10794841|FG000|NOT COMPLETED|First Intervention||1
9695121|NCT00836056|10794842|FG001|NOT COMPLETED|First Intervention||0
9695122|NCT00836056|10794841|FG000|STARTED|Washout: 7 Days||11
9695123|NCT00836056|10794842|FG001|STARTED|Washout: 7 Days||12
9695124|NCT00836056|10794841|FG000|COMPLETED|Washout: 7 Days||11
9695125|NCT00836056|10794842|FG001|COMPLETED|Washout: 7 Days||12
9695126|NCT00836056|10794841|FG000|NOT COMPLETED|Washout: 7 Days||0
9695127|NCT00836056|10794842|FG001|NOT COMPLETED|Washout: 7 Days||0
9695128|NCT00836056|10794841|FG000|STARTED|Second Intervention||11
9695129|NCT00836056|10794842|FG001|STARTED|Second Intervention||12
9695130|NCT00836056|10794841|FG000|COMPLETED|Second Intervention||11
9695131|NCT00836056|10794842|FG001|COMPLETED|Second Intervention||12
9695132|NCT00836056|10794841|FG000|NOT COMPLETED|Second Intervention||0
9695133|NCT00836056|10794842|FG001|NOT COMPLETED|Second Intervention||0
9695134|NCT00836004|10794848|FG000|STARTED|First Intervention||12
9695135|NCT00836004|10794849|FG001|STARTED|First Intervention||12
9695136|NCT00836004|10794848|FG000|COMPLETED|First Intervention||12
9695137|NCT00836004|10794849|FG001|COMPLETED|First Intervention||12
9695138|NCT00836004|10794848|FG000|NOT COMPLETED|First Intervention||0
9695139|NCT00836004|10794849|FG001|NOT COMPLETED|First Intervention||0
10025463|NCT01871285|11149521|FG002|STARTED|Second Intervention (1 Day)||3
10025464|NCT01871285|11149522|FG003|STARTED|Second Intervention (1 Day)||2
10025465|NCT01871285|11149519|FG000|COMPLETED|Second Intervention (1 Day)||17
10025466|NCT01871285|11149520|FG001|COMPLETED|Second Intervention (1 Day)||14
10025467|NCT01871285|11149521|FG002|COMPLETED|Second Intervention (1 Day)||3
9695140|NCT00836004|10794848|FG000|STARTED|Washout: 7 Days||12
9695141|NCT00836004|10794849|FG001|STARTED|Washout: 7 Days||12
9695142|NCT00836004|10794848|FG000|COMPLETED|Washout: 7 Days||12
10025468|NCT01871285|11149522|FG003|COMPLETED|Second Intervention (1 Day)||2
10025469|NCT01871285|11149519|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9695143|NCT00836004|10794849|FG001|COMPLETED|Washout: 7 Days||12
9695144|NCT00836004|10794848|FG000|NOT COMPLETED|Washout: 7 Days||0
9695145|NCT00836004|10794849|FG001|NOT COMPLETED|Washout: 7 Days||0
9695146|NCT00836004|10794848|FG000|STARTED|Second Intervention||12
9695147|NCT00836004|10794849|FG001|STARTED|Second Intervention||12
9695148|NCT00836004|10794848|FG000|COMPLETED|Second Intervention||12
9695149|NCT00836004|10794849|FG001|COMPLETED|Second Intervention||12
9695150|NCT00836004|10794848|FG000|NOT COMPLETED|Second Intervention||0
9695151|NCT00836004|10794849|FG001|NOT COMPLETED|Second Intervention||0
9695152|NCT00835991|10794855|FG000|STARTED|First Intervention||30
9695153|NCT00835991|10794856|FG001|STARTED|First Intervention||30
9695154|NCT00835991|10794855|FG000|COMPLETED|First Intervention||30
9695155|NCT00835991|10794856|FG001|COMPLETED|First Intervention||29
9695156|NCT00835991|10794855|FG000|NOT COMPLETED|First Intervention||0
9695157|NCT00835991|10794856|FG001|NOT COMPLETED|First Intervention||1
9695158|NCT00835991|10794855|FG000|STARTED|Washout||30
9695159|NCT00835991|10794856|FG001|STARTED|Washout||29
9695160|NCT00835991|10794855|FG000|COMPLETED|Washout||27
9695161|NCT00835991|10794856|FG001|COMPLETED|Washout||26
9695162|NCT00835991|10794855|FG000|NOT COMPLETED|Washout||3
9695163|NCT00835991|10794856|FG001|NOT COMPLETED|Washout||3
9695164|NCT00835991|10794855|FG000|STARTED|Second Intervention||27
9695165|NCT00835991|10794856|FG001|STARTED|Second Intervention||26
9695166|NCT00835991|10794855|FG000|COMPLETED|Second Intervention||27
9695167|NCT00835991|10794856|FG001|COMPLETED|Second Intervention||26
9695168|NCT00835991|10794855|FG000|NOT COMPLETED|Second Intervention||0
9695169|NCT00835991|10794856|FG001|NOT COMPLETED|Second Intervention||0
9695170|NCT00835796|10794862|FG000|STARTED|First Intervention||10
9695171|NCT00835796|10794863|FG001|STARTED|First Intervention||10
9695172|NCT00835796|10794862|FG000|COMPLETED|First Intervention||10
9695173|NCT00835796|10794863|FG001|COMPLETED|First Intervention||9
9695174|NCT00835796|10794862|FG000|NOT COMPLETED|First Intervention||0
9695175|NCT00835796|10794863|FG001|NOT COMPLETED|First Intervention||1
9695176|NCT00835796|10794862|FG000|STARTED|Washout||10
9695177|NCT00835796|10794863|FG001|STARTED|Washout||9
9695178|NCT00835796|10794862|FG000|COMPLETED|Washout||10
9695179|NCT00835796|10794863|FG001|COMPLETED|Washout||9
9961608|NCT01474512|11081383|FG007|STARTED|Induction Period||0
9695180|NCT00835796|10794862|FG000|NOT COMPLETED|Washout||0
9695181|NCT00835796|10794863|FG001|NOT COMPLETED|Washout||0
9695182|NCT00835796|10794862|FG000|STARTED|Second Intervention||10
9695183|NCT00835796|10794863|FG001|STARTED|Second Intervention||9
9695184|NCT00835796|10794862|FG000|COMPLETED|Second Intervention||10
9695185|NCT00835796|10794863|FG001|COMPLETED|Second Intervention||9
9695186|NCT00835796|10794862|FG000|NOT COMPLETED|Second Intervention||0
9695187|NCT00835796|10794863|FG001|NOT COMPLETED|Second Intervention||0
10025470|NCT01871285|11149520|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10025471|NCT01871285|11149521|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10025472|NCT01871285|11149522|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10114641|NCT02518048|11245390|FG000|STARTED|Overall Study||35
10114642|NCT02518048|11245390|FG000|COMPLETED|Overall Study||34
10114643|NCT02518048|11245390|FG000|NOT COMPLETED|Overall Study||1
10114644|NCT02518113|11245399|FG000|STARTED|Overall Study||6
10025473|NCT01871402|11149534|FG000|STARTED|Overall Study||110
10025474|NCT01871402|11149535|FG001|STARTED|Overall Study||111
10025475|NCT01871402|11149534|FG000|COMPLETED|Overall Study||109
10025476|NCT01871402|11149535|FG001|COMPLETED|Overall Study||108
10114645|NCT02518113|11245400|FG001|STARTED|Overall Study||12
10114646|NCT02518113|11245401|FG002|STARTED|Overall Study||15
10114647|NCT02518113|11245402|FG003|STARTED|Overall Study||3
10114648|NCT02518113|11245399|FG000|COMPLETED|Overall Study||3
10114649|NCT02518113|11245400|FG001|COMPLETED|Overall Study||7
10114650|NCT02518113|11245401|FG002|COMPLETED|Overall Study||11
10114651|NCT02518113|11245402|FG003|COMPLETED|Overall Study||3
10114652|NCT02518113|11245399|FG000|NOT COMPLETED|Overall Study||3
10114653|NCT02518113|11245400|FG001|NOT COMPLETED|Overall Study||5
10114654|NCT02518113|11245401|FG002|NOT COMPLETED|Overall Study||4
10114655|NCT02518113|11245402|FG003|NOT COMPLETED|Overall Study||0
10114656|NCT02518191|11245417|FG000|STARTED|Overall Study||171
10114657|NCT02518191|11245418|FG001|STARTED|Overall Study||174
10114658|NCT02518191|11245417|FG000|COMPLETED|Overall Study||165
10114659|NCT02518191|11245418|FG001|COMPLETED|Overall Study||165
10114660|NCT02518191|11245417|FG000|NOT COMPLETED|Overall Study||6
9695188|NCT00835705|10794869|FG000|STARTED|First Intervention||24
9695189|NCT00835705|10794870|FG001|STARTED|First Intervention||28
9695190|NCT00835705|10794869|FG000|COMPLETED|First Intervention||23
9695191|NCT00835705|10794870|FG001|COMPLETED|First Intervention||28
9695192|NCT00835705|10794869|FG000|NOT COMPLETED|First Intervention||1
9695193|NCT00835705|10794870|FG001|NOT COMPLETED|First Intervention||0
9695194|NCT00835705|10794869|FG000|STARTED|Second Intervention||23
9695195|NCT00835705|10794870|FG001|STARTED|Second Intervention||28
9695196|NCT00835705|10794869|FG000|COMPLETED|Second Intervention||22
9695197|NCT00835705|10794870|FG001|COMPLETED|Second Intervention||28
9695198|NCT00835705|10794869|FG000|NOT COMPLETED|Second Intervention||1
9695199|NCT00835705|10794870|FG001|NOT COMPLETED|Second Intervention||0
9695200|NCT00835692|10794876|FG000|STARTED|First Intervention||28
9695201|NCT00835692|10794877|FG001|STARTED|First Intervention||28
9695202|NCT00835692|10794876|FG000|COMPLETED|First Intervention||27
9695203|NCT00835692|10794877|FG001|COMPLETED|First Intervention||28
9695204|NCT00835692|10794876|FG000|NOT COMPLETED|First Intervention||1
9847372|NCT00853593|10959866|FG000|Model 4396 Lead Attempted|Overall Study||164
9847373|NCT00853593|10959866|FG000|COMPLETED|Overall Study||152
9847374|NCT00853593|10959866|FG000|NOT COMPLETED|Overall Study||45
10025477|NCT01871402|11149534|FG000|NOT COMPLETED|Overall Study||1
10025478|NCT01871402|11149535|FG001|NOT COMPLETED|Overall Study||3
10025479|NCT01871441|11149541|FG000|STARTED|Overall Study||4
9695205|NCT00835692|10794877|FG001|NOT COMPLETED|First Intervention||0
9695206|NCT00835692|10794876|FG000|STARTED|Washout||27
9695207|NCT00835692|10794877|FG001|STARTED|Washout||28
9695208|NCT00835692|10794876|FG000|COMPLETED|Washout||27
9695209|NCT00835692|10794877|FG001|COMPLETED|Washout||28
10025480|NCT01871441|11149541|FG000|COMPLETED|Overall Study||4
10114661|NCT02518191|11245418|FG001|NOT COMPLETED|Overall Study||9
10114662|NCT02518230|11245428|FG000|STARTED|Overall Study||11
10114663|NCT02518230|11245429|FG001|STARTED|Overall Study||11
9695210|NCT00835692|10794876|FG000|NOT COMPLETED|Washout||0
9847375|NCT00853606|10959887|FG000|STARTED|Overall Study||712
9847376|NCT00853606|10959887|FG000|COMPLETED|Overall Study||492
9847377|NCT00853606|10959887|FG000|NOT COMPLETED|Overall Study||220
9695211|NCT00835692|10794877|FG001|NOT COMPLETED|Washout||0
9695212|NCT00835692|10794876|FG000|STARTED|Second Intervention||27
9695213|NCT00835692|10794877|FG001|STARTED|Second Intervention||28
10025481|NCT01871441|11149541|FG000|NOT COMPLETED|Overall Study||0
10025482|NCT01871506|11149548|FG000|STARTED|Overall Study||150
9695214|NCT00835692|10794876|FG000|COMPLETED|Second Intervention||27
9695215|NCT00835692|10794877|FG001|COMPLETED|Second Intervention||28
9695216|NCT00835692|10794876|FG000|NOT COMPLETED|Second Intervention||0
9695217|NCT00835692|10794877|FG001|NOT COMPLETED|Second Intervention||0
9695218|NCT00835666|10794883|FG000|STARTED|First Intervention||16
9695219|NCT00835666|10794884|FG001|STARTED|First Intervention||16
9695220|NCT00835666|10794883|FG000|COMPLETED|First Intervention||16
9695221|NCT00835666|10794884|FG001|COMPLETED|First Intervention||16
9695222|NCT00835666|10794883|FG000|NOT COMPLETED|First Intervention||0
9695223|NCT00835666|10794884|FG001|NOT COMPLETED|First Intervention||0
9847378|NCT00853645|10959891|FG000|STARTED|Overall Study||6
9847379|NCT00853645|10959891|FG000|COMPLETED|Overall Study||6
9847380|NCT00853645|10959891|FG000|NOT COMPLETED|Overall Study||0
9847381|NCT00853658|10959898|FG000|STARTED|Overall Study||2354
9847382|NCT00853658|10959899|FG001|STARTED|Overall Study||2356
9847383|NCT00853658|10959900|FG002|STARTED|Overall Study||2354
9961609|NCT01474512|11081384|FG008|STARTED|Induction Period||0
9961610|NCT01474512|11081385|FG009|STARTED|Induction Period||0
9961611|NCT01474512|11081386|FG010|STARTED|Induction Period||0
9961612|NCT01474512|11081387|FG011|STARTED|Induction Period||0
9961613|NCT01474512|11081388|FG012|STARTED|Induction Period||0
9961614|NCT01474512|11081389|FG013|STARTED|Induction Period||0
9961615|NCT01474512|11081390|FG014|STARTED|Induction Period||0
9961616|NCT01474512|11081391|FG015|STARTED|Induction Period||0
9961617|NCT01474512|11081392|FG016|STARTED|Induction Period||0
9961618|NCT01474512|11081393|FG017|STARTED|Induction Period||0
9961619|NCT01474512|11081376|FG000|Received Study Drug|Induction Period||431
9961620|NCT01474512|11081377|FG001|Received Study Drug|Induction Period||432
9961621|NCT01474512|11081378|FG002|Received Study Drug|Induction Period||433
9961622|NCT01474512|11081379|FG003|Received Study Drug|Induction Period||0
9961623|NCT01474512|11081380|FG004|Received Study Drug|Induction Period||0
9961624|NCT01474512|11081381|FG005|Received Study Drug|Induction Period||0
9961625|NCT01474512|11081382|FG006|Received Study Drug|Induction Period||0
9961626|NCT01474512|11081383|FG007|Received Study Drug|Induction Period||0
9961627|NCT01474512|11081384|FG008|Received Study Drug|Induction Period||0
9961628|NCT01474512|11081385|FG009|Received Study Drug|Induction Period||0
9961629|NCT01474512|11081386|FG010|Received Study Drug|Induction Period||0
9961630|NCT01474512|11081387|FG011|Received Study Drug|Induction Period||0
9961631|NCT01474512|11081388|FG012|Received Study Drug|Induction Period||0
9961632|NCT01474512|11081389|FG013|Received Study Drug|Induction Period||0
9961633|NCT01474512|11081390|FG014|Received Study Drug|Induction Period||0
9961634|NCT01474512|11081391|FG015|Received Study Drug|Induction Period||0
9961635|NCT01474512|11081392|FG016|Received Study Drug|Induction Period||0
9961636|NCT01474512|11081393|FG017|Received Study Drug|Induction Period||0
9961637|NCT01474512|11081376|FG000|COMPLETED|Induction Period||407
9961638|NCT01474512|11081377|FG001|COMPLETED|Induction Period||408
9961639|NCT01474512|11081378|FG002|COMPLETED|Induction Period||415
9961640|NCT01474512|11081379|FG003|COMPLETED|Induction Period||0
9961641|NCT01474512|11081380|FG004|COMPLETED|Induction Period||0
9961642|NCT01474512|11081381|FG005|COMPLETED|Induction Period||0
9961643|NCT01474512|11081382|FG006|COMPLETED|Induction Period||0
9961644|NCT01474512|11081383|FG007|COMPLETED|Induction Period||0
9961645|NCT01474512|11081384|FG008|COMPLETED|Induction Period||0
9961646|NCT01474512|11081385|FG009|COMPLETED|Induction Period||0
9961647|NCT01474512|11081386|FG010|COMPLETED|Induction Period||0
9695224|NCT00835666|10794883|FG000|STARTED|Washout||16
9695225|NCT00835666|10794884|FG001|STARTED|Washout||16
9695226|NCT00835666|10794883|FG000|COMPLETED|Washout||14
9695227|NCT00835666|10794884|FG001|COMPLETED|Washout||16
9847384|NCT00853658|10959898|FG000|Full Analysis Set (FAS)|Overall Study||2340
9847385|NCT00853658|10959899|FG001|Full Analysis Set (FAS)|Overall Study||2340
9847386|NCT00853658|10959900|FG002|Full Analysis Set (FAS)|Overall Study||2336
9847387|NCT00853658|10959898|FG000|Safety Set|Overall Study||2347
9847388|NCT00853658|10959899|FG001|Safety Set|Overall Study||2348
9961648|NCT01474512|11081387|FG011|COMPLETED|Induction Period||0
9961649|NCT01474512|11081388|FG012|COMPLETED|Induction Period||0
9961650|NCT01474512|11081389|FG013|COMPLETED|Induction Period||0
9961651|NCT01474512|11081390|FG014|COMPLETED|Induction Period||0
9961652|NCT01474512|11081391|FG015|COMPLETED|Induction Period||0
9961653|NCT01474512|11081392|FG016|COMPLETED|Induction Period||0
9961654|NCT01474512|11081393|FG017|COMPLETED|Induction Period||0
9847389|NCT00853658|10959900|FG002|Safety Set|Overall Study||2345
9695228|NCT00835666|10794883|FG000|NOT COMPLETED|Washout||2
9695229|NCT00835666|10794884|FG001|NOT COMPLETED|Washout||0
10025483|NCT01871506|11149549|FG001|STARTED|Overall Study||153
10025484|NCT01871506|11149548|FG000|COMPLETED|Overall Study||150
10025485|NCT01871506|11149549|FG001|COMPLETED|Overall Study||153
10025486|NCT01871506|11149548|FG000|NOT COMPLETED|Overall Study||0
10025487|NCT01871506|11149549|FG001|NOT COMPLETED|Overall Study||0
10025488|NCT01871519|11149568|FG000|STARTED|Overall Study||350
10025489|NCT01871519|11149568|FG000|COMPLETED|Overall Study||260
10025490|NCT01871519|11149568|FG000|NOT COMPLETED|Overall Study||90
10025491|NCT01871532|11149575|FG000|STARTED|Overall Study||12
10025492|NCT01871532|11149576|FG001|STARTED|Overall Study||12
10025493|NCT01871532|11149575|FG000|Subjects Received hCG Treatment|Overall Study||11
10025494|NCT01871532|11149576|FG001|Subjects Received hCG Treatment|Overall Study||9
10025495|NCT01871532|11149575|FG000|COMPLETED|Overall Study||11
10025496|NCT01871532|11149576|FG001|COMPLETED|Overall Study||10
10025497|NCT01871532|11149575|FG000|NOT COMPLETED|Overall Study||1
9695230|NCT00835666|10794883|FG000|STARTED|Second Intervention||14
9695231|NCT00835666|10794884|FG001|STARTED|Second Intervention||16
9695232|NCT00835666|10794883|FG000|COMPLETED|Second Intervention||14
9695233|NCT00835666|10794884|FG001|COMPLETED|Second Intervention||16
9695234|NCT00835666|10794883|FG000|NOT COMPLETED|Second Intervention||0
9695235|NCT00835666|10794884|FG001|NOT COMPLETED|Second Intervention||0
9695236|NCT00835640|10794890|FG000|STARTED|First Intervention||12
9695237|NCT00835640|10794891|FG001|STARTED|First Intervention||12
9695238|NCT00835640|10794890|FG000|COMPLETED|First Intervention||12
9695239|NCT00835640|10794891|FG001|COMPLETED|First Intervention||12
9695240|NCT00835640|10794890|FG000|NOT COMPLETED|First Intervention||0
9695241|NCT00835640|10794891|FG001|NOT COMPLETED|First Intervention||0
9695242|NCT00835640|10794890|FG000|STARTED|Washout of 7 Days||12
9695243|NCT00835640|10794891|FG001|STARTED|Washout of 7 Days||12
9695244|NCT00835640|10794890|FG000|COMPLETED|Washout of 7 Days||12
10025498|NCT01871532|11149576|FG001|NOT COMPLETED|Overall Study||2
9695245|NCT00835640|10794891|FG001|COMPLETED|Washout of 7 Days||12
9695246|NCT00835640|10794890|FG000|NOT COMPLETED|Washout of 7 Days||0
10025499|NCT01871545|11149584|FG000|STARTED|Overall Study||73
10025500|NCT01871545|11149585|FG001|STARTED|Overall Study||11
10025501|NCT01871545|11149584|FG000|COMPLETED|Overall Study||56
9695247|NCT00835640|10794891|FG001|NOT COMPLETED|Washout of 7 Days||0
9695248|NCT00835640|10794890|FG000|STARTED|Second Intervention||12
9695249|NCT00835640|10794891|FG001|STARTED|Second Intervention||12
9695250|NCT00835640|10794890|FG000|COMPLETED|Second Intervention||11
9695251|NCT00835640|10794891|FG001|COMPLETED|Second Intervention||12
9695252|NCT00835640|10794890|FG000|NOT COMPLETED|Second Intervention||1
9695253|NCT00835640|10794891|FG001|NOT COMPLETED|Second Intervention||0
9695254|NCT00835614|10794897|FG000|STARTED|First Intervention||13
9695255|NCT00835614|10794898|FG001|STARTED|First Intervention||13
9695256|NCT00835614|10794897|FG000|COMPLETED|First Intervention||13
9695257|NCT00835614|10794898|FG001|COMPLETED|First Intervention||13
10025502|NCT01871545|11149585|FG001|COMPLETED|Overall Study||8
10025503|NCT01871545|11149584|FG000|NOT COMPLETED|Overall Study||17
10025504|NCT01871545|11149585|FG001|NOT COMPLETED|Overall Study||3
10025505|NCT01871558|11149596|FG000|STARTED|Overall Study||21
10025506|NCT01871558|11149597|FG001|STARTED|Overall Study||21
10025507|NCT01871558|11149596|FG000|COMPLETED|Overall Study||18
10025508|NCT01871558|11149597|FG001|COMPLETED|Overall Study||19
10025509|NCT01871558|11149596|FG000|NOT COMPLETED|Overall Study||3
10025510|NCT01871558|11149597|FG001|NOT COMPLETED|Overall Study||2
10025511|NCT01871805|11149609|FG000|STARTED|Phase I||7
10025512|NCT01871805|11149610|FG001|STARTED|Phase I||7
10025513|NCT01871805|11149611|FG002|STARTED|Phase I||13
9695258|NCT00835614|10794897|FG000|NOT COMPLETED|First Intervention||0
9695259|NCT00835614|10794898|FG001|NOT COMPLETED|First Intervention||0
9695260|NCT00835614|10794897|FG000|STARTED|Washout of 7 Days||13
9695261|NCT00835614|10794898|FG001|STARTED|Washout of 7 Days||13
9695262|NCT00835614|10794897|FG000|COMPLETED|Washout of 7 Days||13
9695263|NCT00835614|10794898|FG001|COMPLETED|Washout of 7 Days||13
9695264|NCT00835614|10794897|FG000|NOT COMPLETED|Washout of 7 Days||0
9695265|NCT00835614|10794898|FG001|NOT COMPLETED|Washout of 7 Days||0
9695266|NCT00835614|10794897|FG000|STARTED|Second Intervention||13
9695267|NCT00835614|10794898|FG001|STARTED|Second Intervention||13
9695268|NCT00835614|10794897|FG000|COMPLETED|Second Intervention||13
9695269|NCT00835614|10794898|FG001|COMPLETED|Second Intervention||13
9695270|NCT00835614|10794897|FG000|NOT COMPLETED|Second Intervention||0
9695271|NCT00835614|10794898|FG001|NOT COMPLETED|Second Intervention||0
9695272|NCT00835588|10794904|FG000|STARTED|First Intervention||50
9695273|NCT00835588|10794905|FG001|STARTED|First Intervention||50
9695274|NCT00835588|10794904|FG000|COMPLETED|First Intervention||50
9695275|NCT00835588|10794905|FG001|COMPLETED|First Intervention||50
9695276|NCT00835588|10794904|FG000|NOT COMPLETED|First Intervention||0
9695277|NCT00835588|10794905|FG001|NOT COMPLETED|First Intervention||0
9695278|NCT00835588|10794904|FG000|STARTED|Washout: 5 Days||50
9695279|NCT00835588|10794905|FG001|STARTED|Washout: 5 Days||50
9695280|NCT00835588|10794904|FG000|COMPLETED|Washout: 5 Days||50
9695281|NCT00835588|10794905|FG001|COMPLETED|Washout: 5 Days||50
9695282|NCT00835588|10794904|FG000|NOT COMPLETED|Washout: 5 Days||0
9695283|NCT00835588|10794905|FG001|NOT COMPLETED|Washout: 5 Days||0
9695284|NCT00835588|10794904|FG000|STARTED|Second Intervention||50
9695285|NCT00835588|10794905|FG001|STARTED|Second Intervention||50
9695286|NCT00835588|10794904|FG000|COMPLETED|Second Intervention||50
9695287|NCT00835588|10794905|FG001|COMPLETED|Second Intervention||50
9695288|NCT00835588|10794904|FG000|NOT COMPLETED|Second Intervention||0
9695289|NCT00835588|10794905|FG001|NOT COMPLETED|Second Intervention||0
9695290|NCT00835575|10794911|FG000|STARTED|First Intervention||16
9695291|NCT00835575|10794912|FG001|STARTED|First Intervention||16
9695292|NCT00835575|10794911|FG000|COMPLETED|First Intervention||16
9695293|NCT00835575|10794912|FG001|COMPLETED|First Intervention||16
9695294|NCT00835575|10794911|FG000|NOT COMPLETED|First Intervention||0
9695295|NCT00835575|10794912|FG001|NOT COMPLETED|First Intervention||0
9695296|NCT00835575|10794911|FG000|STARTED|Washout of 14 Days||16
9695297|NCT00835575|10794912|FG001|STARTED|Washout of 14 Days||16
10025514|NCT01871805|11149612|FG003|STARTED|Phase I||7
10025515|NCT01871805|11149613|FG004|STARTED|Phase I||13
10025516|NCT01871805|11149614|FG005|STARTED|Phase I||0
10025517|NCT01871805|11149609|FG000|COMPLETED|Phase I||0
9695298|NCT00835575|10794911|FG000|COMPLETED|Washout of 14 Days||15
9695299|NCT00835575|10794912|FG001|COMPLETED|Washout of 14 Days||16
9695300|NCT00835575|10794911|FG000|NOT COMPLETED|Washout of 14 Days||1
9695301|NCT00835575|10794912|FG001|NOT COMPLETED|Washout of 14 Days||0
10025518|NCT01871805|11149610|FG001|COMPLETED|Phase I||0
10025519|NCT01871805|11149611|FG002|COMPLETED|Phase I||0
10025520|NCT01871805|11149612|FG003|COMPLETED|Phase I||0
9847390|NCT00853658|10959898|FG000|COMPLETED|Overall Study||1567
9847391|NCT00853658|10959899|FG001|COMPLETED|Overall Study||1524
9847392|NCT00853658|10959900|FG002|COMPLETED|Overall Study||1539
9847393|NCT00853658|10959898|FG000|NOT COMPLETED|Overall Study||787
9847394|NCT00853658|10959899|FG001|NOT COMPLETED|Overall Study||832
9847395|NCT00853658|10959900|FG002|NOT COMPLETED|Overall Study||815
9847396|NCT00853671|10959908|FG000|STARTED|Overall Study||50
9847397|NCT00853671|10959908|FG000|COMPLETED|Overall Study||50
9847398|NCT00853671|10959908|FG000|NOT COMPLETED|Overall Study||0
9847399|NCT00853723|10959915|FG000|STARTED|Overall Study||35
9847400|NCT00853723|10959916|FG001|STARTED|Overall Study||35
9847401|NCT00853723|10959917|FG002|STARTED|Overall Study||35
10025521|NCT01871805|11149613|FG004|COMPLETED|Phase I||0
10025522|NCT01871805|11149614|FG005|COMPLETED|Phase I||0
10025523|NCT01871805|11149609|FG000|NOT COMPLETED|Phase I||7
9695302|NCT00835575|10794911|FG000|STARTED|Second Intervention||15
9695303|NCT00835575|10794912|FG001|STARTED|Second Intervention||16
9695304|NCT00835575|10794911|FG000|COMPLETED|Second Intervention||15
9695305|NCT00835575|10794912|FG001|COMPLETED|Second Intervention||16
9695306|NCT00835575|10794911|FG000|NOT COMPLETED|Second Intervention||0
9695307|NCT00835575|10794912|FG001|NOT COMPLETED|Second Intervention||0
9695308|NCT00835549|10794918|FG000|STARTED|First Intervention||16
9695309|NCT00835549|10794919|FG001|STARTED|First Intervention||16
9695310|NCT00835549|10794918|FG000|COMPLETED|First Intervention||16
9695311|NCT00835549|10794919|FG001|COMPLETED|First Intervention||16
9695312|NCT00835549|10794918|FG000|NOT COMPLETED|First Intervention||0
9695313|NCT00835549|10794919|FG001|NOT COMPLETED|First Intervention||0
9695314|NCT00835549|10794918|FG000|STARTED|Washout of 7 Days||16
9695315|NCT00835549|10794919|FG001|STARTED|Washout of 7 Days||16
9695316|NCT00835549|10794918|FG000|COMPLETED|Washout of 7 Days||14
9695317|NCT00835549|10794919|FG001|COMPLETED|Washout of 7 Days||16
9695318|NCT00835549|10794918|FG000|NOT COMPLETED|Washout of 7 Days||2
9695319|NCT00835549|10794919|FG001|NOT COMPLETED|Washout of 7 Days||0
9695320|NCT00835549|10794918|FG000|STARTED|Second Intervention||14
9695321|NCT00835549|10794919|FG001|STARTED|Second Intervention||16
9695322|NCT00835549|10794918|FG000|COMPLETED|Second Intervention||14
9695323|NCT00835549|10794919|FG001|COMPLETED|Second Intervention||16
9695324|NCT00835549|10794918|FG000|NOT COMPLETED|Second Intervention||0
9695325|NCT00835549|10794919|FG001|NOT COMPLETED|Second Intervention||0
9695326|NCT00835536|10794925|FG000|STARTED|First Intervention||13
9695327|NCT00835536|10794926|FG001|STARTED|First Intervention||14
9695328|NCT00835536|10794925|FG000|COMPLETED|First Intervention||13
9695329|NCT00835536|10794926|FG001|COMPLETED|First Intervention||14
9695330|NCT00835536|10794925|FG000|NOT COMPLETED|First Intervention||0
9695331|NCT00835536|10794926|FG001|NOT COMPLETED|First Intervention||0
9695332|NCT00835536|10794925|FG000|STARTED|Washout of 5 Weeks||13
9695333|NCT00835536|10794926|FG001|STARTED|Washout of 5 Weeks||14
9695334|NCT00835536|10794925|FG000|COMPLETED|Washout of 5 Weeks||12
9695335|NCT00835536|10794926|FG001|COMPLETED|Washout of 5 Weeks||14
9695336|NCT00835536|10794925|FG000|NOT COMPLETED|Washout of 5 Weeks||1
9695337|NCT00835536|10794926|FG001|NOT COMPLETED|Washout of 5 Weeks||0
9695338|NCT00835536|10794925|FG000|STARTED|Second Intervention||12
9695339|NCT00835536|10794926|FG001|STARTED|Second Intervention||14
9695340|NCT00835536|10794925|FG000|COMPLETED|Second Intervention||12
9695341|NCT00835536|10794926|FG001|COMPLETED|Second Intervention||14
9695342|NCT00835536|10794925|FG000|NOT COMPLETED|Second Intervention||0
9695343|NCT00835536|10794926|FG001|NOT COMPLETED|Second Intervention||0
9695344|NCT00835497|10794932|FG000|STARTED|First Intervention||20
9695345|NCT00835497|10794933|FG001|STARTED|First Intervention||20
9695346|NCT00835497|10794932|FG000|COMPLETED|First Intervention||20
9695347|NCT00835497|10794933|FG001|COMPLETED|First Intervention||20
9695348|NCT00835497|10794932|FG000|NOT COMPLETED|First Intervention||0
9695349|NCT00835497|10794933|FG001|NOT COMPLETED|First Intervention||0
9695350|NCT00835497|10794932|FG000|STARTED|Washout: 7 Days||20
9695351|NCT00835497|10794933|FG001|STARTED|Washout: 7 Days||20
9695352|NCT00835497|10794932|FG000|COMPLETED|Washout: 7 Days||20
9695353|NCT00835497|10794933|FG001|COMPLETED|Washout: 7 Days||20
9695354|NCT00835497|10794932|FG000|NOT COMPLETED|Washout: 7 Days||0
9695355|NCT00835497|10794933|FG001|NOT COMPLETED|Washout: 7 Days||0
10025524|NCT01871805|11149610|FG001|NOT COMPLETED|Phase I||7
9695356|NCT00835497|10794932|FG000|STARTED|Second Intervention||20
9695357|NCT00835497|10794933|FG001|STARTED|Second Intervention||20
9695358|NCT00835497|10794932|FG000|COMPLETED|Second Intervention||20
9695359|NCT00835497|10794933|FG001|COMPLETED|Second Intervention||20
9695360|NCT00835497|10794932|FG000|NOT COMPLETED|Second Intervention||0
9695361|NCT00835497|10794933|FG001|NOT COMPLETED|Second Intervention||0
9695362|NCT00835484|10794939|FG000|STARTED|First Intervention||16
9695363|NCT00835484|10794940|FG001|STARTED|First Intervention||16
9695364|NCT00835484|10794939|FG000|COMPLETED|First Intervention||16
9695365|NCT00835484|10794940|FG001|COMPLETED|First Intervention||16
10025525|NCT01871805|11149611|FG002|NOT COMPLETED|Phase I||13
10025526|NCT01871805|11149612|FG003|NOT COMPLETED|Phase I||7
9695366|NCT00835484|10794939|FG000|NOT COMPLETED|First Intervention||0
9695367|NCT00835484|10794940|FG001|NOT COMPLETED|First Intervention||0
9695368|NCT00835484|10794939|FG000|STARTED|Washout of 7 Days||16
9695369|NCT00835484|10794940|FG001|STARTED|Washout of 7 Days||16
9695370|NCT00835484|10794939|FG000|COMPLETED|Washout of 7 Days||16
9695371|NCT00835484|10794940|FG001|COMPLETED|Washout of 7 Days||16
9695372|NCT00835484|10794939|FG000|NOT COMPLETED|Washout of 7 Days||0
9695373|NCT00835484|10794940|FG001|NOT COMPLETED|Washout of 7 Days||0
9695374|NCT00835484|10794939|FG000|STARTED|Second Intervention||16
9695375|NCT00835484|10794940|FG001|STARTED|Second Intervention||16
9695376|NCT00835484|10794939|FG000|COMPLETED|Second Intervention||16
9695377|NCT00835484|10794940|FG001|COMPLETED|Second Intervention||16
9695378|NCT00835484|10794939|FG000|NOT COMPLETED|Second Intervention||0
9695379|NCT00835484|10794940|FG001|NOT COMPLETED|Second Intervention||0
9695380|NCT00835406|10794946|FG000|STARTED|Period: First Intervention||70
9695381|NCT00835406|10794947|FG001|STARTED|Period: First Intervention||70
9695382|NCT00835406|10794946|FG000|COMPLETED|Period: First Intervention||68
9695383|NCT00835406|10794947|FG001|COMPLETED|Period: First Intervention||69
9695384|NCT00835406|10794946|FG000|NOT COMPLETED|Period: First Intervention||2
9695385|NCT00835406|10794947|FG001|NOT COMPLETED|Period: First Intervention||1
9695386|NCT00835406|10794946|FG000|STARTED|Period: Washout of 7 Days||68
9695387|NCT00835406|10794947|FG001|STARTED|Period: Washout of 7 Days||69
9695388|NCT00835406|10794946|FG000|COMPLETED|Period: Washout of 7 Days||68
9695389|NCT00835406|10794947|FG001|COMPLETED|Period: Washout of 7 Days||67
9695390|NCT00835406|10794946|FG000|NOT COMPLETED|Period: Washout of 7 Days||0
9695391|NCT00835406|10794947|FG001|NOT COMPLETED|Period: Washout of 7 Days||2
9695392|NCT00835406|10794946|FG000|STARTED|Period: Second Intervention||68
9695393|NCT00835406|10794947|FG001|STARTED|Period: Second Intervention||67
9695394|NCT00835406|10794946|FG000|COMPLETED|Period: Second Intervention||68
9695395|NCT00835406|10794947|FG001|COMPLETED|Period: Second Intervention||67
9695396|NCT00835406|10794946|FG000|NOT COMPLETED|Period: Second Intervention||0
9695397|NCT00835406|10794947|FG001|NOT COMPLETED|Period: Second Intervention||0
9695398|NCT00835367|10794953|FG000|STARTED|First Intervention||34
10025527|NCT01871805|11149613|FG004|NOT COMPLETED|Phase I||13
10025528|NCT01871805|11149614|FG005|NOT COMPLETED|Phase I||0
10025529|NCT01871805|11149609|FG000|STARTED|Phase II||0
10025530|NCT01871805|11149610|FG001|STARTED|Phase II||0
9695399|NCT00835367|10794954|FG001|STARTED|First Intervention||34
9695400|NCT00835367|10794953|FG000|COMPLETED|First Intervention||34
9695401|NCT00835367|10794954|FG001|COMPLETED|First Intervention||34
9695402|NCT00835367|10794953|FG000|NOT COMPLETED|First Intervention||0
9695403|NCT00835367|10794954|FG001|NOT COMPLETED|First Intervention||0
9695404|NCT00835367|10794953|FG000|STARTED|Washout||34
9695405|NCT00835367|10794954|FG001|STARTED|Washout||34
9695406|NCT00835367|10794953|FG000|COMPLETED|Washout||31
9695407|NCT00835367|10794954|FG001|COMPLETED|Washout||34
9695408|NCT00835367|10794953|FG000|NOT COMPLETED|Washout||3
9695409|NCT00835367|10794954|FG001|NOT COMPLETED|Washout||0
9695410|NCT00835367|10794953|FG000|STARTED|Second Intervention||31
9695411|NCT00835367|10794954|FG001|STARTED|Second Intervention||34
9695412|NCT00835367|10794953|FG000|COMPLETED|Second Intervention||30
9695413|NCT00835367|10794954|FG001|COMPLETED|Second Intervention||33
9695414|NCT00835367|10794953|FG000|NOT COMPLETED|Second Intervention||1
9695415|NCT00835367|10794954|FG001|NOT COMPLETED|Second Intervention||1
9695416|NCT00835354|10794960|FG000|STARTED|First Intervention||13
9695417|NCT00835354|10794961|FG001|STARTED|First Intervention||13
9695418|NCT00835354|10794960|FG000|COMPLETED|First Intervention||13
9695419|NCT00835354|10794961|FG001|COMPLETED|First Intervention||12
9695420|NCT00835354|10794960|FG000|NOT COMPLETED|First Intervention||0
9695421|NCT00835354|10794961|FG001|NOT COMPLETED|First Intervention||1
9695422|NCT00835354|10794960|FG000|STARTED|Washout of 7 Days||13
9695423|NCT00835354|10794961|FG001|STARTED|Washout of 7 Days||12
9695424|NCT00835354|10794960|FG000|COMPLETED|Washout of 7 Days||13
9695425|NCT00835354|10794961|FG001|COMPLETED|Washout of 7 Days||12
9695426|NCT00835354|10794960|FG000|NOT COMPLETED|Washout of 7 Days||0
9695427|NCT00835354|10794961|FG001|NOT COMPLETED|Washout of 7 Days||0
9695428|NCT00835354|10794960|FG000|STARTED|Second Intervention||13
9695429|NCT00835354|10794961|FG001|STARTED|Second Intervention||12
9847402|NCT00853723|10959915|FG000|COMPLETED|Overall Study||29
9847403|NCT00853723|10959916|FG001|COMPLETED|Overall Study||28
9847404|NCT00853723|10959917|FG002|COMPLETED|Overall Study||33
10025531|NCT01871805|11149611|FG002|STARTED|Phase II||0
10025532|NCT01871805|11149612|FG003|STARTED|Phase II||0
10025533|NCT01871805|11149613|FG004|STARTED|Phase II||0
9695430|NCT00835354|10794960|FG000|COMPLETED|Second Intervention||13
9695431|NCT00835354|10794961|FG001|COMPLETED|Second Intervention||12
9695432|NCT00835354|10794960|FG000|NOT COMPLETED|Second Intervention||0
9847405|NCT00853723|10959915|FG000|NOT COMPLETED|Overall Study||6
9695433|NCT00835354|10794961|FG001|NOT COMPLETED|Second Intervention||0
9695434|NCT00835276|10794967|FG000|STARTED|First Intervention||24
9695435|NCT00835276|10794968|FG001|STARTED|First Intervention||24
9847406|NCT00853723|10959916|FG001|NOT COMPLETED|Overall Study||7
10025534|NCT01871805|11149614|FG005|STARTED|Phase II||87
10025535|NCT01871805|11149609|FG000|COMPLETED|Phase II||0
10025536|NCT01871805|11149610|FG001|COMPLETED|Phase II||0
10025537|NCT01871805|11149611|FG002|COMPLETED|Phase II||0
10025538|NCT01871805|11149612|FG003|COMPLETED|Phase II||0
10025539|NCT01871805|11149613|FG004|COMPLETED|Phase II||0
10025540|NCT01871805|11149614|FG005|COMPLETED|Phase II||0
10025541|NCT01871805|11149609|FG000|NOT COMPLETED|Phase II||0
10114664|NCT02518230|11245428|FG000|COMPLETED|Overall Study||11
10114665|NCT02518230|11245429|FG001|COMPLETED|Overall Study||11
10114666|NCT02518230|11245428|FG000|NOT COMPLETED|Overall Study||0
10114667|NCT02518230|11245429|FG001|NOT COMPLETED|Overall Study||0
10114668|NCT02518464|11245436|FG000|STARTED|Overall Study||40
10114669|NCT02518464|11245436|FG000|COMPLETED|Overall Study||38
10025542|NCT01871805|11149610|FG001|NOT COMPLETED|Phase II||0
10025543|NCT01871805|11149611|FG002|NOT COMPLETED|Phase II||0
10025544|NCT01871805|11149612|FG003|NOT COMPLETED|Phase II||0
10025545|NCT01871805|11149613|FG004|NOT COMPLETED|Phase II||0
10025546|NCT01871805|11149614|FG005|NOT COMPLETED|Phase II||87
10114670|NCT02518464|11245436|FG000|NOT COMPLETED|Overall Study||2
10114671|NCT02518490|11245440|FG000|STARTED|Overall Study||18
10114672|NCT02518490|11245441|FG001|STARTED|Overall Study||18
10114673|NCT02518490|11245440|FG000|COMPLETED|Overall Study||17
10114674|NCT02518490|11245441|FG001|COMPLETED|Overall Study||17
10114675|NCT02518490|11245440|FG000|NOT COMPLETED|Overall Study||1
10114676|NCT02518490|11245441|FG001|NOT COMPLETED|Overall Study||1
10196056|NCT03358355|11324458|FG000|STARTED|Overall Study||9
10196057|NCT03358355|11324458|FG000|COMPLETED|Overall Study||9
10196058|NCT03358355|11324458|FG000|NOT COMPLETED|Overall Study||0
10196059|NCT03358407|11324477|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196060|NCT03358407|11324478|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196061|NCT03358407|11324479|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196062|NCT03358407|11324480|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196063|NCT03358407|11324481|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196064|NCT03358407|11324482|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196065|NCT03358407|11324483|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196066|NCT03358407|11324484|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196067|NCT03358407|11324485|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196068|NCT03358407|11324486|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196069|NCT03358407|11324477|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196070|NCT03358407|11324478|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196071|NCT03358407|11324479|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196072|NCT03358407|11324480|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196073|NCT03358407|11324481|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10196074|NCT03358407|11324482|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196075|NCT03358407|11324483|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196076|NCT03358407|11324484|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196077|NCT03358407|11324485|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196078|NCT03358407|11324486|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196079|NCT03358407|11324477|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196080|NCT03358407|11324478|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196081|NCT03358407|11324479|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196082|NCT03358407|11324480|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196083|NCT03358407|11324481|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196084|NCT03358407|11324482|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196085|NCT03358407|11324483|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196086|NCT03358407|11324484|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196087|NCT03358407|11324485|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196088|NCT03358407|11324486|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10196089|NCT03358407|11324477|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196090|NCT03358407|11324478|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196091|NCT03358407|11324479|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9695436|NCT00835276|10794967|FG000|COMPLETED|First Intervention||24
9695437|NCT00835276|10794968|FG001|COMPLETED|First Intervention||24
9695438|NCT00835276|10794967|FG000|NOT COMPLETED|First Intervention||0
9695439|NCT00835276|10794968|FG001|NOT COMPLETED|First Intervention||0
9695440|NCT00835276|10794967|FG000|STARTED|Washout of 7 Days||24
9695441|NCT00835276|10794968|FG001|STARTED|Washout of 7 Days||24
9695442|NCT00835276|10794967|FG000|COMPLETED|Washout of 7 Days||24
9695443|NCT00835276|10794968|FG001|COMPLETED|Washout of 7 Days||24
9695444|NCT00835276|10794967|FG000|NOT COMPLETED|Washout of 7 Days||0
9695445|NCT00835276|10794968|FG001|NOT COMPLETED|Washout of 7 Days||0
9695446|NCT00835276|10794967|FG000|STARTED|Second Intervention||24
9695447|NCT00835276|10794968|FG001|STARTED|Second Intervention||24
9695448|NCT00835276|10794967|FG000|COMPLETED|Second Intervention||24
9695449|NCT00835276|10794968|FG001|COMPLETED|Second Intervention||24
9695450|NCT00835276|10794967|FG000|NOT COMPLETED|Second Intervention||0
9695451|NCT00835276|10794968|FG001|NOT COMPLETED|Second Intervention||0
9695452|NCT00835263|10794974|FG000|STARTED|First Intervention||16
9695453|NCT00835263|10794975|FG001|STARTED|First Intervention||16
9695454|NCT00835263|10794974|FG000|COMPLETED|First Intervention||16
9695455|NCT00835263|10794975|FG001|COMPLETED|First Intervention||16
9695456|NCT00835263|10794974|FG000|NOT COMPLETED|First Intervention||0
9695457|NCT00835263|10794975|FG001|NOT COMPLETED|First Intervention||0
9695458|NCT00835263|10794974|FG000|STARTED|Second Intervention||16
9695459|NCT00835263|10794975|FG001|STARTED|Second Intervention||16
9695460|NCT00835263|10794974|FG000|COMPLETED|Second Intervention||15
9695461|NCT00835263|10794975|FG001|COMPLETED|Second Intervention||16
9695462|NCT00835263|10794974|FG000|NOT COMPLETED|Second Intervention||1
9695463|NCT00835263|10794975|FG001|NOT COMPLETED|Second Intervention||0
9695464|NCT00835211|10794981|FG000|STARTED|First Intervention||24
9695465|NCT00835211|10794982|FG001|STARTED|First Intervention||24
9695466|NCT00835211|10794981|FG000|COMPLETED|First Intervention||24
9695467|NCT00835211|10794982|FG001|COMPLETED|First Intervention||23
9695468|NCT00835211|10794981|FG000|NOT COMPLETED|First Intervention||0
9695469|NCT00835211|10794982|FG001|NOT COMPLETED|First Intervention||1
9695470|NCT00835211|10794981|FG000|STARTED|Washout: 7 Days||24
9695471|NCT00835211|10794982|FG001|STARTED|Washout: 7 Days||23
9695472|NCT00835211|10794981|FG000|COMPLETED|Washout: 7 Days||21
9695473|NCT00835211|10794982|FG001|COMPLETED|Washout: 7 Days||22
9695474|NCT00835211|10794981|FG000|NOT COMPLETED|Washout: 7 Days||3
9695475|NCT00835211|10794982|FG001|NOT COMPLETED|Washout: 7 Days||1
9695476|NCT00835211|10794981|FG000|STARTED|Second Intervention||21
9695477|NCT00835211|10794982|FG001|STARTED|Second Intervention||22
9695478|NCT00835211|10794981|FG000|COMPLETED|Second Intervention||21
9695479|NCT00835211|10794982|FG001|COMPLETED|Second Intervention||22
9695480|NCT00835211|10794981|FG000|NOT COMPLETED|Second Intervention||0
9695481|NCT00835211|10794982|FG001|NOT COMPLETED|Second Intervention||0
9695482|NCT00835172|10794988|FG000|STARTED|First Intervention||16
9695483|NCT00835172|10794989|FG001|STARTED|First Intervention||16
9695484|NCT00835172|10794988|FG000|COMPLETED|First Intervention||16
9695485|NCT00835172|10794989|FG001|COMPLETED|First Intervention||16
9695486|NCT00835172|10794988|FG000|NOT COMPLETED|First Intervention||0
9695487|NCT00835172|10794989|FG001|NOT COMPLETED|First Intervention||0
9695488|NCT00835172|10794988|FG000|STARTED|Washout||16
9695489|NCT00835172|10794989|FG001|STARTED|Washout||16
9695490|NCT00835172|10794988|FG000|COMPLETED|Washout||16
9695491|NCT00835172|10794989|FG001|COMPLETED|Washout||15
9695492|NCT00835172|10794988|FG000|NOT COMPLETED|Washout||0
9695493|NCT00835172|10794989|FG001|NOT COMPLETED|Washout||1
9695494|NCT00835172|10794988|FG000|STARTED|Second Intervention||16
9695495|NCT00835172|10794989|FG001|STARTED|Second Intervention||15
9695496|NCT00835172|10794988|FG000|COMPLETED|Second Intervention||16
9695497|NCT00835172|10794989|FG001|COMPLETED|Second Intervention||15
9695498|NCT00835172|10794988|FG000|NOT COMPLETED|Second Intervention||0
9695499|NCT00835172|10794989|FG001|NOT COMPLETED|Second Intervention||0
9695500|NCT00835146|10794995|FG000|STARTED|First Intervention||14
9695501|NCT00835146|10794996|FG001|STARTED|First Intervention||14
9695502|NCT00835146|10794995|FG000|COMPLETED|First Intervention||14
9695503|NCT00835146|10794996|FG001|COMPLETED|First Intervention||14
9695504|NCT00835146|10794995|FG000|NOT COMPLETED|First Intervention||0
9695505|NCT00835146|10794996|FG001|NOT COMPLETED|First Intervention||0
9695506|NCT00835146|10794995|FG000|STARTED|Washout of 5 Weeks||14
9695507|NCT00835146|10794996|FG001|STARTED|Washout of 5 Weeks||14
9695508|NCT00835146|10794995|FG000|COMPLETED|Washout of 5 Weeks||14
9695509|NCT00835146|10794996|FG001|COMPLETED|Washout of 5 Weeks||14
9695510|NCT00835146|10794995|FG000|NOT COMPLETED|Washout of 5 Weeks||0
9695511|NCT00835146|10794996|FG001|NOT COMPLETED|Washout of 5 Weeks||0
9695512|NCT00835146|10794995|FG000|STARTED|Second Intervention||14
10025547|NCT01871870|11149645|FG000|STARTED|Overall Study||20
9695513|NCT00835146|10794996|FG001|STARTED|Second Intervention||14
9695514|NCT00835146|10794995|FG000|COMPLETED|Second Intervention||14
9695515|NCT00835146|10794996|FG001|COMPLETED|Second Intervention||14
9695516|NCT00835146|10794995|FG000|NOT COMPLETED|Second Intervention||0
9695517|NCT00835146|10794996|FG001|NOT COMPLETED|Second Intervention||0
9695518|NCT00835081|10795002|FG000|STARTED|First Intervention||13
9695519|NCT00835081|10795003|FG001|STARTED|First Intervention||13
9695520|NCT00835081|10795002|FG000|COMPLETED|First Intervention||13
9695521|NCT00835081|10795003|FG001|COMPLETED|First Intervention||13
9695522|NCT00835081|10795002|FG000|NOT COMPLETED|First Intervention||0
9695523|NCT00835081|10795003|FG001|NOT COMPLETED|First Intervention||0
9695524|NCT00835081|10795002|FG000|STARTED|Washout of 7 Days||13
9695525|NCT00835081|10795003|FG001|STARTED|Washout of 7 Days||13
9695526|NCT00835081|10795002|FG000|COMPLETED|Washout of 7 Days||12
9695527|NCT00835081|10795003|FG001|COMPLETED|Washout of 7 Days||13
9695528|NCT00835081|10795002|FG000|NOT COMPLETED|Washout of 7 Days||1
9695529|NCT00835081|10795003|FG001|NOT COMPLETED|Washout of 7 Days||0
9695530|NCT00835081|10795002|FG000|STARTED|Second Intervention||12
9695531|NCT00835081|10795003|FG001|STARTED|Second Intervention||13
9695532|NCT00835081|10795002|FG000|COMPLETED|Second Intervention||12
9695533|NCT00835081|10795003|FG001|COMPLETED|Second Intervention||13
9695534|NCT00835081|10795002|FG000|NOT COMPLETED|Second Intervention||0
9695535|NCT00835081|10795003|FG001|NOT COMPLETED|Second Intervention||0
9695536|NCT00835042|10795009|FG000|STARTED|First Intervention||30
9695537|NCT00835042|10795010|FG001|STARTED|First Intervention||28
9695538|NCT00835042|10795009|FG000|COMPLETED|First Intervention||26
9695539|NCT00835042|10795010|FG001|COMPLETED|First Intervention||26
9695540|NCT00835042|10795009|FG000|NOT COMPLETED|First Intervention||4
9695541|NCT00835042|10795010|FG001|NOT COMPLETED|First Intervention||2
9695542|NCT00835042|10795009|FG000|STARTED|Washout of 21 Days||26
9695543|NCT00835042|10795010|FG001|STARTED|Washout of 21 Days||26
9695544|NCT00835042|10795009|FG000|COMPLETED|Washout of 21 Days||26
9695545|NCT00835042|10795010|FG001|COMPLETED|Washout of 21 Days||24
9695546|NCT00835042|10795009|FG000|NOT COMPLETED|Washout of 21 Days||0
9695547|NCT00835042|10795010|FG001|NOT COMPLETED|Washout of 21 Days||2
9695548|NCT00835042|10795009|FG000|STARTED|Second Intervention||26
9695549|NCT00835042|10795010|FG001|STARTED|Second Intervention||24
9695550|NCT00835042|10795009|FG000|COMPLETED|Second Intervention||26
9695551|NCT00835042|10795010|FG001|COMPLETED|Second Intervention||24
9847407|NCT00853723|10959917|FG002|NOT COMPLETED|Overall Study||2
9847408|NCT00853749|10959930|FG000|STARTED|Overall Study||50
9847409|NCT00853749|10959931|FG001|STARTED|Overall Study||39
9847410|NCT00853749|10959930|FG000|Vaccinated|Overall Study||50
9847411|NCT00853749|10959931|FG001|Vaccinated|Overall Study||39
9847412|NCT00853749|10959930|FG000|COMPLETED|Overall Study||50
9847413|NCT00853749|10959931|FG001|COMPLETED|Overall Study||38
9847414|NCT00853749|10959930|FG000|NOT COMPLETED|Overall Study||0
9847415|NCT00853749|10959931|FG001|NOT COMPLETED|Overall Study||1
9847416|NCT00853762|10959941|FG000|STARTED|Overall Study||16
9847417|NCT00853762|10959942|FG001|STARTED|Overall Study||19
9847418|NCT00853762|10959943|FG002|STARTED|Overall Study||17
9847419|NCT00853762|10959944|FG003|STARTED|Overall Study||22
9847420|NCT00853762|10959941|FG000|COMPLETED|Overall Study||0
10025548|NCT01871870|11149645|FG000|COMPLETED|Overall Study||11
9847421|NCT00853762|10959942|FG001|COMPLETED|Overall Study||0
9847422|NCT00853762|10959943|FG002|COMPLETED|Overall Study||0
9847423|NCT00853762|10959944|FG003|COMPLETED|Overall Study||0
9847424|NCT00853762|10959941|FG000|NOT COMPLETED|Overall Study||16
9847425|NCT00853762|10959942|FG001|NOT COMPLETED|Overall Study||19
9847426|NCT00853762|10959943|FG002|NOT COMPLETED|Overall Study||17
10025549|NCT01871870|11149645|FG000|NOT COMPLETED|Overall Study||9
9847427|NCT00853762|10959944|FG003|NOT COMPLETED|Overall Study||22
9847428|NCT00853827|10959956|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
9847429|NCT00853827|10959957|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
10025550|NCT01872078|11149653|FG000|STARTED|Overall Study||16
9695552|NCT00835042|10795009|FG000|NOT COMPLETED|Second Intervention||0
10025551|NCT01872078|11149654|FG001|STARTED|Overall Study||15
10025552|NCT01872078|11149655|FG002|STARTED|Overall Study||17
10025553|NCT01872078|11149656|FG003|STARTED|Overall Study||17
10025554|NCT01872078|11149653|FG000|COMPLETED|Overall Study||16
10025555|NCT01872078|11149654|FG001|COMPLETED|Overall Study||15
10025556|NCT01872078|11149655|FG002|COMPLETED|Overall Study||14
10025557|NCT01872078|11149656|FG003|COMPLETED|Overall Study||15
10025558|NCT01872078|11149653|FG000|NOT COMPLETED|Overall Study||0
10025559|NCT01872078|11149654|FG001|NOT COMPLETED|Overall Study||0
9695553|NCT00835042|10795010|FG001|NOT COMPLETED|Second Intervention||0
9695554|NCT00834990|10795016|FG000|STARTED|First Intervention||12
9695555|NCT00834990|10795017|FG001|STARTED|First Intervention||11
9695556|NCT00834990|10795016|FG000|COMPLETED|First Intervention||12
9695557|NCT00834990|10795017|FG001|COMPLETED|First Intervention||11
9695558|NCT00834990|10795016|FG000|NOT COMPLETED|First Intervention||0
9695559|NCT00834990|10795017|FG001|NOT COMPLETED|First Intervention||0
9695560|NCT00834990|10795016|FG000|STARTED|Washout of 7 Days||12
9695561|NCT00834990|10795017|FG001|STARTED|Washout of 7 Days||11
9695562|NCT00834990|10795016|FG000|COMPLETED|Washout of 7 Days||12
9695563|NCT00834990|10795017|FG001|COMPLETED|Washout of 7 Days||11
9695564|NCT00834990|10795016|FG000|NOT COMPLETED|Washout of 7 Days||0
9695565|NCT00834990|10795017|FG001|NOT COMPLETED|Washout of 7 Days||0
9695566|NCT00834990|10795016|FG000|STARTED|Second Intervention||12
9695567|NCT00834990|10795017|FG001|STARTED|Second Intervention||11
9695568|NCT00834990|10795016|FG000|COMPLETED|Second Intervention||12
9695569|NCT00834990|10795017|FG001|COMPLETED|Second Intervention||11
9695570|NCT00834990|10795016|FG000|NOT COMPLETED|Second Intervention||0
9695571|NCT00834990|10795017|FG001|NOT COMPLETED|Second Intervention||0
9695572|NCT00834977|10795023|FG000|STARTED|First Intervention||24
9695573|NCT00834977|10795024|FG001|STARTED|First Intervention||24
9695574|NCT00834977|10795023|FG000|COMPLETED|First Intervention||24
9695575|NCT00834977|10795024|FG001|COMPLETED|First Intervention||24
9695576|NCT00834977|10795023|FG000|NOT COMPLETED|First Intervention||0
9695577|NCT00834977|10795024|FG001|NOT COMPLETED|First Intervention||0
9695578|NCT00834977|10795023|FG000|STARTED|Second Intervention||24
9695579|NCT00834977|10795024|FG001|STARTED|Second Intervention||24
9695580|NCT00834977|10795023|FG000|COMPLETED|Second Intervention||24
9695581|NCT00834977|10795024|FG001|COMPLETED|Second Intervention||24
9695582|NCT00834977|10795023|FG000|NOT COMPLETED|Second Intervention||0
9695583|NCT00834977|10795024|FG001|NOT COMPLETED|Second Intervention||0
9695584|NCT00834964|10795030|FG000|STARTED|First Intervention||15
9695585|NCT00834964|10795031|FG001|STARTED|First Intervention||15
9695586|NCT00834964|10795030|FG000|COMPLETED|First Intervention||15
9695587|NCT00834964|10795031|FG001|COMPLETED|First Intervention||15
9695588|NCT00834964|10795030|FG000|NOT COMPLETED|First Intervention||0
9695589|NCT00834964|10795031|FG001|NOT COMPLETED|First Intervention||0
9695590|NCT00834964|10795030|FG000|STARTED|Washout: 7 Days||15
9695591|NCT00834964|10795031|FG001|STARTED|Washout: 7 Days||15
9695592|NCT00834964|10795030|FG000|COMPLETED|Washout: 7 Days||15
9695593|NCT00834964|10795031|FG001|COMPLETED|Washout: 7 Days||15
9695594|NCT00834964|10795030|FG000|NOT COMPLETED|Washout: 7 Days||0
9695595|NCT00834964|10795031|FG001|NOT COMPLETED|Washout: 7 Days||0
9695596|NCT00834964|10795030|FG000|STARTED|Second Intervention||15
9695597|NCT00834964|10795031|FG001|STARTED|Second Intervention||15
9695598|NCT00834964|10795030|FG000|COMPLETED|Second Intervention||15
9695599|NCT00834964|10795031|FG001|COMPLETED|Second Intervention||15
9695600|NCT00834964|10795030|FG000|NOT COMPLETED|Second Intervention||0
9695601|NCT00834964|10795031|FG001|NOT COMPLETED|Second Intervention||0
9695602|NCT00834873|10795037|FG000|STARTED|First Intervention||12
9847430|NCT00853827|10959956|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
9695603|NCT00834873|10795038|FG001|STARTED|First Intervention||12
9695604|NCT00834873|10795037|FG000|COMPLETED|First Intervention||12
9695605|NCT00834873|10795038|FG001|COMPLETED|First Intervention||11
9695606|NCT00834873|10795037|FG000|NOT COMPLETED|First Intervention||0
9695607|NCT00834873|10795038|FG001|NOT COMPLETED|First Intervention||1
9695608|NCT00834873|10795037|FG000|STARTED|Washout: 7 Days||12
9695609|NCT00834873|10795038|FG001|STARTED|Washout: 7 Days||11
9695610|NCT00834873|10795037|FG000|COMPLETED|Washout: 7 Days||12
9695611|NCT00834873|10795038|FG001|COMPLETED|Washout: 7 Days||11
9695612|NCT00834873|10795037|FG000|NOT COMPLETED|Washout: 7 Days||0
9695613|NCT00834873|10795038|FG001|NOT COMPLETED|Washout: 7 Days||0
9695614|NCT00834873|10795037|FG000|STARTED|Second Intervention||12
9695615|NCT00834873|10795038|FG001|STARTED|Second Intervention||11
9695616|NCT00834873|10795037|FG000|COMPLETED|Second Intervention||12
9695617|NCT00834873|10795038|FG001|COMPLETED|Second Intervention||11
9695618|NCT00834873|10795037|FG000|NOT COMPLETED|Second Intervention||0
9695619|NCT00834873|10795038|FG001|NOT COMPLETED|Second Intervention||0
10025560|NCT01872078|11149655|FG002|NOT COMPLETED|Overall Study||3
10025561|NCT01872078|11149656|FG003|NOT COMPLETED|Overall Study||2
10025562|NCT01872325|11149668|FG000|STARTED|Overall Study||689
10025563|NCT01872325|11149669|FG001|STARTED|Overall Study||387
9695620|NCT00834795|10795044|FG000|STARTED|First Intervention||18
9695621|NCT00834795|10795045|FG001|STARTED|First Intervention||18
9695622|NCT00834795|10795044|FG000|COMPLETED|First Intervention||18
9695623|NCT00834795|10795045|FG001|COMPLETED|First Intervention||18
9695624|NCT00834795|10795044|FG000|NOT COMPLETED|First Intervention||0
9695625|NCT00834795|10795045|FG001|NOT COMPLETED|First Intervention||0
9695626|NCT00834795|10795044|FG000|STARTED|Washout: 7 Days||18
9695627|NCT00834795|10795045|FG001|STARTED|Washout: 7 Days||18
9695628|NCT00834795|10795044|FG000|COMPLETED|Washout: 7 Days||18
9695629|NCT00834795|10795045|FG001|COMPLETED|Washout: 7 Days||17
9695630|NCT00834795|10795044|FG000|NOT COMPLETED|Washout: 7 Days||0
9695631|NCT00834795|10795045|FG001|NOT COMPLETED|Washout: 7 Days||1
9695632|NCT00834795|10795044|FG000|STARTED|Second Intervention||18
9695633|NCT00834795|10795045|FG001|STARTED|Second Intervention||17
9695634|NCT00834795|10795044|FG000|COMPLETED|Second Intervention||17
9695635|NCT00834795|10795045|FG001|COMPLETED|Second Intervention||17
9695636|NCT00834795|10795044|FG000|NOT COMPLETED|Second Intervention||1
10025564|NCT01872325|11149668|FG000|COMPLETED|Overall Study||689
9695637|NCT00834795|10795045|FG001|NOT COMPLETED|Second Intervention||0
9695638|NCT00834756|10795051|FG000|STARTED|First Intervention||18
9695639|NCT00834756|10795052|FG001|STARTED|First Intervention||18
9695640|NCT00834756|10795051|FG000|COMPLETED|First Intervention||17
9695641|NCT00834756|10795052|FG001|COMPLETED|First Intervention||18
9695642|NCT00834756|10795051|FG000|NOT COMPLETED|First Intervention||1
9695643|NCT00834756|10795052|FG001|NOT COMPLETED|First Intervention||0
9695644|NCT00834756|10795051|FG000|STARTED|Washout: 21 Days||17
9695645|NCT00834756|10795052|FG001|STARTED|Washout: 21 Days||18
9961655|NCT01474512|11081376|FG000|NOT COMPLETED|Induction Period||24
9961656|NCT01474512|11081377|FG001|NOT COMPLETED|Induction Period||24
9961657|NCT01474512|11081378|FG002|NOT COMPLETED|Induction Period||18
9961658|NCT01474512|11081379|FG003|NOT COMPLETED|Induction Period||0
9961659|NCT01474512|11081380|FG004|NOT COMPLETED|Induction Period||0
9695646|NCT00834756|10795051|FG000|COMPLETED|Washout: 21 Days||16
9695647|NCT00834756|10795052|FG001|COMPLETED|Washout: 21 Days||18
9695648|NCT00834756|10795051|FG000|NOT COMPLETED|Washout: 21 Days||1
9695649|NCT00834756|10795052|FG001|NOT COMPLETED|Washout: 21 Days||0
9695650|NCT00834756|10795051|FG000|STARTED|Second Intervention||16
9695651|NCT00834756|10795052|FG001|STARTED|Second Intervention||18
9695652|NCT00834756|10795051|FG000|COMPLETED|Second Intervention||16
9695653|NCT00834756|10795052|FG001|COMPLETED|Second Intervention||18
9695654|NCT00834756|10795051|FG000|NOT COMPLETED|Second Intervention||0
9695655|NCT00834756|10795052|FG001|NOT COMPLETED|Second Intervention||0
9695656|NCT00834743|10795058|FG000|STARTED|First Intervention||16
9695657|NCT00834743|10795059|FG001|STARTED|First Intervention||16
9695658|NCT00834743|10795058|FG000|COMPLETED|First Intervention||16
9695659|NCT00834743|10795059|FG001|COMPLETED|First Intervention||16
9695660|NCT00834743|10795058|FG000|NOT COMPLETED|First Intervention||0
9695661|NCT00834743|10795059|FG001|NOT COMPLETED|First Intervention||0
9695662|NCT00834743|10795058|FG000|STARTED|Washout of 7 Days||16
9695663|NCT00834743|10795059|FG001|STARTED|Washout of 7 Days||16
9695664|NCT00834743|10795058|FG000|COMPLETED|Washout of 7 Days||16
9695665|NCT00834743|10795059|FG001|COMPLETED|Washout of 7 Days||16
9695666|NCT00834743|10795058|FG000|NOT COMPLETED|Washout of 7 Days||0
9695667|NCT00834743|10795059|FG001|NOT COMPLETED|Washout of 7 Days||0
9695668|NCT00834743|10795058|FG000|STARTED|Second Intervention||16
9695669|NCT00834743|10795059|FG001|STARTED|Second Intervention||16
9695670|NCT00834743|10795058|FG000|COMPLETED|Second Intervention||15
9695671|NCT00834743|10795059|FG001|COMPLETED|Second Intervention||16
9695672|NCT00834743|10795058|FG000|NOT COMPLETED|Second Intervention||1
9695673|NCT00834743|10795059|FG001|NOT COMPLETED|Second Intervention||0
9695674|NCT00834717|10795065|FG000|STARTED|First Intervention||20
9695675|NCT00834717|10795066|FG001|STARTED|First Intervention||20
9695676|NCT00834717|10795065|FG000|COMPLETED|First Intervention||19
9695677|NCT00834717|10795066|FG001|COMPLETED|First Intervention||19
9695678|NCT00834717|10795065|FG000|NOT COMPLETED|First Intervention||1
9695679|NCT00834717|10795066|FG001|NOT COMPLETED|First Intervention||1
9695680|NCT00834717|10795065|FG000|STARTED|Second Intervention||19
9695681|NCT00834717|10795066|FG001|STARTED|Second Intervention||19
9695682|NCT00834717|10795065|FG000|COMPLETED|Second Intervention||19
9695683|NCT00834717|10795066|FG001|COMPLETED|Second Intervention||19
9695684|NCT00834717|10795065|FG000|NOT COMPLETED|Second Intervention||0
9695685|NCT00834717|10795066|FG001|NOT COMPLETED|Second Intervention||0
9695686|NCT00834639|10795072|FG000|STARTED|First Intervention||12
9695687|NCT00834639|10795073|FG001|STARTED|First Intervention||12
9695688|NCT00834639|10795072|FG000|COMPLETED|First Intervention||12
9695689|NCT00834639|10795073|FG001|COMPLETED|First Intervention||12
9695690|NCT00834639|10795072|FG000|NOT COMPLETED|First Intervention||0
9695691|NCT00834639|10795073|FG001|NOT COMPLETED|First Intervention||0
9695692|NCT00834639|10795072|FG000|STARTED|Washout of 7 Days||12
9695693|NCT00834639|10795073|FG001|STARTED|Washout of 7 Days||12
9695694|NCT00834639|10795072|FG000|COMPLETED|Washout of 7 Days||12
9695695|NCT00834639|10795073|FG001|COMPLETED|Washout of 7 Days||12
9695696|NCT00834639|10795072|FG000|NOT COMPLETED|Washout of 7 Days||0
9695697|NCT00834639|10795073|FG001|NOT COMPLETED|Washout of 7 Days||0
9961660|NCT01474512|11081381|FG005|NOT COMPLETED|Induction Period||0
9961661|NCT01474512|11081382|FG006|NOT COMPLETED|Induction Period||0
9695698|NCT00834639|10795072|FG000|STARTED|Second Intervention||12
9695699|NCT00834639|10795073|FG001|STARTED|Second Intervention||12
9695700|NCT00834639|10795072|FG000|COMPLETED|Second Intervention||12
9695701|NCT00834639|10795073|FG001|COMPLETED|Second Intervention||10
9695702|NCT00834639|10795072|FG000|NOT COMPLETED|Second Intervention||0
9695703|NCT00834639|10795073|FG001|NOT COMPLETED|Second Intervention||2
9695704|NCT00834613|10795079|FG000|STARTED|First Intervention||16
9695705|NCT00834613|10795080|FG001|STARTED|First Intervention||16
9695706|NCT00834613|10795079|FG000|COMPLETED|First Intervention||15
9695707|NCT00834613|10795080|FG001|COMPLETED|First Intervention||16
9695708|NCT00834613|10795079|FG000|NOT COMPLETED|First Intervention||1
9695709|NCT00834613|10795080|FG001|NOT COMPLETED|First Intervention||0
9695710|NCT00834613|10795079|FG000|STARTED|Washout of 7 Days||15
9695711|NCT00834613|10795080|FG001|STARTED|Washout of 7 Days||16
9695712|NCT00834613|10795079|FG000|COMPLETED|Washout of 7 Days||15
9695713|NCT00834613|10795080|FG001|COMPLETED|Washout of 7 Days||16
9695714|NCT00834613|10795079|FG000|NOT COMPLETED|Washout of 7 Days||0
9695715|NCT00834613|10795080|FG001|NOT COMPLETED|Washout of 7 Days||0
9847431|NCT00853827|10959957|FG001|COMPLETED|Single Blind Period (1 Week)||0
9847432|NCT00853827|10959956|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39
9695716|NCT00834613|10795079|FG000|STARTED|Second Intervention||15
9695717|NCT00834613|10795080|FG001|STARTED|Second Intervention||16
9695718|NCT00834613|10795079|FG000|COMPLETED|Second Intervention||15
9695719|NCT00834613|10795080|FG001|COMPLETED|Second Intervention||16
9695720|NCT00834613|10795079|FG000|NOT COMPLETED|Second Intervention||0
9695721|NCT00834613|10795080|FG001|NOT COMPLETED|Second Intervention||0
9695722|NCT00834587|10795086|FG000|STARTED|First Intervention||20
9695723|NCT00834587|10795087|FG001|STARTED|First Intervention||20
9695724|NCT00834587|10795086|FG000|COMPLETED|First Intervention||20
9695725|NCT00834587|10795087|FG001|COMPLETED|First Intervention||20
9695726|NCT00834587|10795086|FG000|NOT COMPLETED|First Intervention||0
9695727|NCT00834587|10795087|FG001|NOT COMPLETED|First Intervention||0
9695728|NCT00834587|10795086|FG000|STARTED|Washout: 7 Days||20
9695729|NCT00834587|10795087|FG001|STARTED|Washout: 7 Days||20
9695730|NCT00834587|10795086|FG000|COMPLETED|Washout: 7 Days||19
9695731|NCT00834587|10795087|FG001|COMPLETED|Washout: 7 Days||20
9695732|NCT00834587|10795086|FG000|NOT COMPLETED|Washout: 7 Days||1
9695733|NCT00834587|10795087|FG001|NOT COMPLETED|Washout: 7 Days||0
9695734|NCT00834587|10795086|FG000|STARTED|Second Intervention||19
9695735|NCT00834587|10795087|FG001|STARTED|Second Intervention||20
9695736|NCT00834587|10795086|FG000|COMPLETED|Second Intervention||19
9695737|NCT00834587|10795087|FG001|COMPLETED|Second Intervention||20
9695738|NCT00834587|10795086|FG000|NOT COMPLETED|Second Intervention||0
9695739|NCT00834587|10795087|FG001|NOT COMPLETED|Second Intervention||0
9695740|NCT00834574|10795093|FG000|STARTED|First Intervention||16
9695741|NCT00834574|10795094|FG001|STARTED|First Intervention||16
9695742|NCT00834574|10795093|FG000|COMPLETED|First Intervention||16
9695743|NCT00834574|10795094|FG001|COMPLETED|First Intervention||16
9695744|NCT00834574|10795093|FG000|NOT COMPLETED|First Intervention||0
9695745|NCT00834574|10795094|FG001|NOT COMPLETED|First Intervention||0
9695746|NCT00834574|10795093|FG000|STARTED|Washout of 7 Days||16
9695747|NCT00834574|10795094|FG001|STARTED|Washout of 7 Days||16
9695748|NCT00834574|10795093|FG000|COMPLETED|Washout of 7 Days||16
9695749|NCT00834574|10795094|FG001|COMPLETED|Washout of 7 Days||16
9695750|NCT00834574|10795093|FG000|NOT COMPLETED|Washout of 7 Days||0
9695751|NCT00834574|10795094|FG001|NOT COMPLETED|Washout of 7 Days||0
9695752|NCT00834574|10795093|FG000|STARTED|Second Intervention||16
9695753|NCT00834574|10795094|FG001|STARTED|Second Intervention||16
9695754|NCT00834574|10795093|FG000|COMPLETED|Second Intervention||16
9695755|NCT00834574|10795094|FG001|COMPLETED|Second Intervention||16
9695756|NCT00834574|10795093|FG000|NOT COMPLETED|Second Intervention||0
9695757|NCT00834574|10795094|FG001|NOT COMPLETED|Second Intervention||0
9695758|NCT00834561|10795100|FG000|STARTED|First Intervention||16
9695759|NCT00834561|10795101|FG001|STARTED|First Intervention||16
9695760|NCT00834561|10795100|FG000|COMPLETED|First Intervention||16
9695761|NCT00834561|10795101|FG001|COMPLETED|First Intervention||16
9695762|NCT00834561|10795100|FG000|NOT COMPLETED|First Intervention||0
9695763|NCT00834561|10795101|FG001|NOT COMPLETED|First Intervention||0
9695764|NCT00834561|10795100|FG000|STARTED|Second Intervention||16
9695765|NCT00834561|10795101|FG001|STARTED|Second Intervention||16
9695766|NCT00834561|10795100|FG000|COMPLETED|Second Intervention||16
9695767|NCT00834561|10795101|FG001|COMPLETED|Second Intervention||16
9695768|NCT00834561|10795100|FG000|NOT COMPLETED|Second Intervention||0
9695769|NCT00834561|10795101|FG001|NOT COMPLETED|Second Intervention||0
9695770|NCT00834535|10795107|FG000|STARTED|First Intervention||16
9695771|NCT00834535|10795108|FG001|STARTED|First Intervention||16
9695772|NCT00834535|10795107|FG000|COMPLETED|First Intervention||16
9695773|NCT00834535|10795108|FG001|COMPLETED|First Intervention||16
9695774|NCT00834535|10795107|FG000|NOT COMPLETED|First Intervention||0
9695775|NCT00834535|10795108|FG001|NOT COMPLETED|First Intervention||0
9695776|NCT00834535|10795107|FG000|STARTED|Washout of 7 Days||16
9695777|NCT00834535|10795108|FG001|STARTED|Washout of 7 Days||16
9695778|NCT00834535|10795107|FG000|COMPLETED|Washout of 7 Days||16
9695779|NCT00834535|10795108|FG001|COMPLETED|Washout of 7 Days||16
9695780|NCT00834535|10795107|FG000|NOT COMPLETED|Washout of 7 Days||0
9695781|NCT00834535|10795108|FG001|NOT COMPLETED|Washout of 7 Days||0
9695782|NCT00834535|10795107|FG000|STARTED|Second Intervention||16
9695783|NCT00834535|10795108|FG001|STARTED|Second Intervention||16
9695784|NCT00834535|10795107|FG000|COMPLETED|Second Intervention||16
9695785|NCT00834535|10795108|FG001|COMPLETED|Second Intervention||16
9695786|NCT00834535|10795107|FG000|NOT COMPLETED|Second Intervention||0
10025565|NCT01872325|11149669|FG001|COMPLETED|Overall Study||387
9695787|NCT00834535|10795108|FG001|NOT COMPLETED|Second Intervention||0
9695788|NCT00834522|10795114|FG000|STARTED|First Intervention||40
9695789|NCT00834522|10795115|FG001|STARTED|First Intervention||40
9695790|NCT00834522|10795114|FG000|COMPLETED|First Intervention||40
9695791|NCT00834522|10795115|FG001|COMPLETED|First Intervention||40
9695792|NCT00834522|10795114|FG000|NOT COMPLETED|First Intervention||0
9695793|NCT00834522|10795115|FG001|NOT COMPLETED|First Intervention||0
9695794|NCT00834522|10795114|FG000|STARTED|Washout||40
9695795|NCT00834522|10795115|FG001|STARTED|Washout||40
9695796|NCT00834522|10795114|FG000|COMPLETED|Washout||37
9695797|NCT00834522|10795115|FG001|COMPLETED|Washout||39
9695798|NCT00834522|10795114|FG000|NOT COMPLETED|Washout||3
9695799|NCT00834522|10795115|FG001|NOT COMPLETED|Washout||1
9695800|NCT00834522|10795114|FG000|STARTED|Second Intervention||37
9695801|NCT00834522|10795115|FG001|STARTED|Second Intervention||39
9695802|NCT00834522|10795114|FG000|COMPLETED|Second Intervention||37
9695803|NCT00834522|10795115|FG001|COMPLETED|Second Intervention||39
9695804|NCT00834522|10795114|FG000|NOT COMPLETED|Second Intervention||0
9695805|NCT00834522|10795115|FG001|NOT COMPLETED|Second Intervention||0
9695806|NCT00834444|10795121|FG000|STARTED|First Intervention||18
9695807|NCT00834444|10795122|FG001|STARTED|First Intervention||18
10025566|NCT01872325|11149668|FG000|NOT COMPLETED|Overall Study||0
10025567|NCT01872325|11149669|FG001|NOT COMPLETED|Overall Study||0
10025568|NCT01872338|11149677|FG000|STARTED|Overall Study||66
9695808|NCT00834444|10795121|FG000|COMPLETED|First Intervention||17
9695809|NCT00834444|10795122|FG001|COMPLETED|First Intervention||17
9695810|NCT00834444|10795121|FG000|NOT COMPLETED|First Intervention||1
9695811|NCT00834444|10795122|FG001|NOT COMPLETED|First Intervention||1
9695812|NCT00834444|10795121|FG000|STARTED|Washout of 7 Days||17
9695813|NCT00834444|10795122|FG001|STARTED|Washout of 7 Days||17
9695814|NCT00834444|10795121|FG000|COMPLETED|Washout of 7 Days||17
9695815|NCT00834444|10795122|FG001|COMPLETED|Washout of 7 Days||16
9695816|NCT00834444|10795121|FG000|NOT COMPLETED|Washout of 7 Days||0
9695817|NCT00834444|10795122|FG001|NOT COMPLETED|Washout of 7 Days||1
9695818|NCT00834444|10795121|FG000|STARTED|Second Intervention||17
9695819|NCT00834444|10795122|FG001|STARTED|Second Intervention||16
9695820|NCT00834444|10795121|FG000|COMPLETED|Second Intervention||16
9695821|NCT00834444|10795122|FG001|COMPLETED|Second Intervention||16
9695822|NCT00834444|10795121|FG000|NOT COMPLETED|Second Intervention||1
9695823|NCT00834444|10795122|FG001|NOT COMPLETED|Second Intervention||0
9695824|NCT00834431|10795128|FG000|STARTED|First Intervention||18
9695825|NCT00834431|10795129|FG001|STARTED|First Intervention||18
9695826|NCT00834431|10795128|FG000|COMPLETED|First Intervention||18
9695827|NCT00834431|10795129|FG001|COMPLETED|First Intervention||17
9695828|NCT00834431|10795128|FG000|NOT COMPLETED|First Intervention||0
9695829|NCT00834431|10795129|FG001|NOT COMPLETED|First Intervention||1
9695830|NCT00834431|10795128|FG000|STARTED|Washout of 7 Days||18
9695831|NCT00834431|10795129|FG001|STARTED|Washout of 7 Days||17
9695832|NCT00834431|10795128|FG000|COMPLETED|Washout of 7 Days||18
9695833|NCT00834431|10795129|FG001|COMPLETED|Washout of 7 Days||16
9695834|NCT00834431|10795128|FG000|NOT COMPLETED|Washout of 7 Days||0
10025569|NCT01872338|11149678|FG001|STARTED|Overall Study||69
9695835|NCT00834431|10795129|FG001|NOT COMPLETED|Washout of 7 Days||1
9695836|NCT00834431|10795128|FG000|STARTED|Second Intervention||18
9695837|NCT00834431|10795129|FG001|STARTED|Second Intervention||16
9695838|NCT00834431|10795128|FG000|COMPLETED|Second Intervention||18
9695839|NCT00834431|10795129|FG001|COMPLETED|Second Intervention||16
9695840|NCT00834431|10795128|FG000|NOT COMPLETED|Second Intervention||0
9695841|NCT00834431|10795129|FG001|NOT COMPLETED|Second Intervention||0
9695842|NCT00834418|10795135|FG000|STARTED|Overall Study||42
9695843|NCT00834418|10795136|FG001|STARTED|Overall Study||42
9695844|NCT00834418|10795135|FG000|COMPLETED|Overall Study||42
9695845|NCT00834418|10795136|FG001|COMPLETED|Overall Study||40
9695846|NCT00834418|10795135|FG000|NOT COMPLETED|Overall Study||0
9695847|NCT00834418|10795136|FG001|NOT COMPLETED|Overall Study||2
9695848|NCT00834405|10795142|FG000|STARTED|Overall Study||20
9695849|NCT00834405|10795143|FG001|STARTED|Overall Study||17
9695850|NCT00834405|10795142|FG000|COMPLETED|Overall Study||20
9695851|NCT00834405|10795143|FG001|COMPLETED|Overall Study||17
9695852|NCT00834405|10795142|FG000|NOT COMPLETED|Overall Study||0
9695853|NCT00834405|10795143|FG001|NOT COMPLETED|Overall Study||0
9695854|NCT00834340|10795149|FG000|STARTED|First Intervention||16
9695855|NCT00834340|10795150|FG001|STARTED|First Intervention||16
9695856|NCT00834340|10795149|FG000|COMPLETED|First Intervention||16
9695857|NCT00834340|10795150|FG001|COMPLETED|First Intervention||16
9695858|NCT00834340|10795149|FG000|NOT COMPLETED|First Intervention||0
9695859|NCT00834340|10795150|FG001|NOT COMPLETED|First Intervention||0
9695860|NCT00834340|10795149|FG000|STARTED|Washout||16
9695861|NCT00834340|10795150|FG001|STARTED|Washout||16
9695862|NCT00834340|10795149|FG000|COMPLETED|Washout||14
9695863|NCT00834340|10795150|FG001|COMPLETED|Washout||16
9695864|NCT00834340|10795149|FG000|NOT COMPLETED|Washout||2
9695865|NCT00834340|10795150|FG001|NOT COMPLETED|Washout||0
9695866|NCT00834340|10795149|FG000|STARTED|Second Intervention||14
9695867|NCT00834340|10795150|FG001|STARTED|Second Intervention||16
9695868|NCT00834340|10795149|FG000|COMPLETED|Second Intervention||14
9695869|NCT00834340|10795150|FG001|COMPLETED|Second Intervention||16
9695870|NCT00834340|10795149|FG000|NOT COMPLETED|Second Intervention||0
9695871|NCT00834340|10795150|FG001|NOT COMPLETED|Second Intervention||0
9695872|NCT00834275|10795156|FG000|STARTED|First Intervention||13
9695873|NCT00834275|10795157|FG001|STARTED|First Intervention||13
9695874|NCT00834275|10795156|FG000|COMPLETED|First Intervention||13
9695875|NCT00834275|10795157|FG001|COMPLETED|First Intervention||13
9695876|NCT00834275|10795156|FG000|NOT COMPLETED|First Intervention||0
9695877|NCT00834275|10795157|FG001|NOT COMPLETED|First Intervention||0
9695878|NCT00834275|10795156|FG000|STARTED|Washout of 7 Days||13
9847433|NCT00853827|10959957|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0
9847434|NCT00853827|10959956|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
9847435|NCT00853827|10959957|FG001|STARTED|Double Blind Period (103 Weeks)||308
9847436|NCT00853827|10959956|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
9847437|NCT00853827|10959957|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
9847438|NCT00853827|10959956|FG000|COMPLETED|Double Blind Period (103 Weeks)||201
9847439|NCT00853827|10959957|FG001|COMPLETED|Double Blind Period (103 Weeks)||199
9847440|NCT00853827|10959956|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104
9847441|NCT00853827|10959957|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109
9847442|NCT00853840|10959963|FG000|STARTED|Period 1||9
9847443|NCT00853840|10959964|FG001|STARTED|Period 1||9
9847444|NCT00853840|10959963|FG000|Maraviroc (Days 1 - 4)|Period 1||9
9847445|NCT00853840|10959964|FG001|Maraviroc (Days 1 - 4)|Period 1||9
9847446|NCT00853840|10959963|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
9847447|NCT00853840|10959964|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
9847448|NCT00853840|10959963|FG000|COMPLETED|Period 1||9
9847449|NCT00853840|10959964|FG001|COMPLETED|Period 1||9
9847450|NCT00853840|10959963|FG000|NOT COMPLETED|Period 1||0
10025570|NCT01872338|11149677|FG000|COMPLETED|Overall Study||46
10025571|NCT01872338|11149678|FG001|COMPLETED|Overall Study||69
10025572|NCT01872338|11149677|FG000|NOT COMPLETED|Overall Study||20
9847451|NCT00853840|10959964|FG001|NOT COMPLETED|Period 1||0
9847452|NCT00853840|10959963|FG000|STARTED|Period 2||9
9847453|NCT00853840|10959964|FG001|STARTED|Period 2||9
9847454|NCT00853840|10959963|FG000|Maraviroc (Days 1 - 3)|Period 2||9
9847455|NCT00853840|10959964|FG001|Maraviroc (Days 1 - 3)|Period 2||9
10025573|NCT01872338|11149678|FG001|NOT COMPLETED|Overall Study||0
10025574|NCT01872611|11149686|FG000|STARTED|Overall Study||301
9695879|NCT00834275|10795157|FG001|STARTED|Washout of 7 Days||13
9695880|NCT00834275|10795156|FG000|COMPLETED|Washout of 7 Days||13
9695881|NCT00834275|10795157|FG001|COMPLETED|Washout of 7 Days||13
10025575|NCT01872611|11149687|FG001|STARTED|Overall Study||304
10025576|NCT01872611|11149686|FG000|Randomized|Overall Study||301
10025577|NCT01872611|11149687|FG001|Randomized|Overall Study||304
10025578|NCT01872611|11149686|FG000|Treated (Safety Analysis Set)|Overall Study||293
10025579|NCT01872611|11149687|FG001|Treated (Safety Analysis Set)|Overall Study||295
10025580|NCT01872611|11149686|FG000|Full Analysis Set|Overall Study||289
10025581|NCT01872611|11149687|FG001|Full Analysis Set|Overall Study||293
10025582|NCT01872611|11149686|FG000|COMPLETED|Overall Study||277
10025583|NCT01872611|11149687|FG001|COMPLETED|Overall Study||292
10025584|NCT01872611|11149686|FG000|NOT COMPLETED|Overall Study||24
10025585|NCT01872611|11149687|FG001|NOT COMPLETED|Overall Study||12
10025586|NCT01872689|11149699|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76
10025587|NCT01872689|11149700|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78
10025588|NCT01872689|11149701|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177
10025589|NCT01872689|11149702|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174
10025590|NCT01872689|11149699|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56
10025591|NCT01872689|11149700|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58
10025592|NCT01872689|11149701|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129
10025593|NCT01872689|11149702|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136
10025594|NCT01872689|11149699|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
10025595|NCT01872689|11149700|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
10025596|NCT01872689|11149701|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
10025597|NCT01872689|11149702|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
10025598|NCT01872689|11149699|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
10025599|NCT01872689|11149700|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
10025600|NCT01872689|11149701|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
10025601|NCT01872689|11149702|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
10025602|NCT01872689|11149699|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31
10025603|NCT01872689|11149700|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33
10025604|NCT01872689|11149701|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0
10025605|NCT01872689|11149702|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0
10025606|NCT01872689|11149699|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
10025607|NCT01872689|11149700|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
10025608|NCT01872689|11149701|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
10025609|NCT01872689|11149702|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
10025610|NCT01872715|11149715|FG000|STARTED|Overall Study||24
10025611|NCT01872715|11149715|FG000|COMPLETED|Overall Study||20
10025612|NCT01872715|11149715|FG000|NOT COMPLETED|Overall Study||4
10025613|NCT01872819|11149729|FG000|STARTED|Overall Study||14
10025614|NCT01872819|11149729|FG000|COMPLETED|Overall Study||14
10025615|NCT01872819|11149729|FG000|NOT COMPLETED|Overall Study||0
10025616|NCT01872910|11149740|FG000|STARTED|Overall Study||30
10025617|NCT01872910|11149741|FG001|STARTED|Overall Study||31
10025618|NCT01872910|11149742|FG002|STARTED|Overall Study||30
10025619|NCT01872910|11149743|FG003|STARTED|Overall Study||15
10025620|NCT01872910|11149744|FG004|STARTED|Overall Study||15
10025621|NCT01872910|11149745|FG005|STARTED|Overall Study||3
10025622|NCT01872910|11149740|FG000|Received Any Study Drug|Overall Study||30
10025623|NCT01872910|11149741|FG001|Received Any Study Drug|Overall Study||31
10025624|NCT01872910|11149742|FG002|Received Any Study Drug|Overall Study||30
10025625|NCT01872910|11149743|FG003|Received Any Study Drug|Overall Study||15
10025626|NCT01872910|11149744|FG004|Received Any Study Drug|Overall Study||15
10025627|NCT01872910|11149745|FG005|Received Any Study Drug|Overall Study||3
10025628|NCT01872910|11149740|FG000|COMPLETED|Overall Study||28
10025629|NCT01872910|11149741|FG001|COMPLETED|Overall Study||31
10025630|NCT01872910|11149742|FG002|COMPLETED|Overall Study||28
10025631|NCT01872910|11149743|FG003|COMPLETED|Overall Study||15
10025632|NCT01872910|11149744|FG004|COMPLETED|Overall Study||15
10025633|NCT01872910|11149745|FG005|COMPLETED|Overall Study||3
10025634|NCT01872910|11149740|FG000|NOT COMPLETED|Overall Study||2
10025635|NCT01872910|11149741|FG001|NOT COMPLETED|Overall Study||0
10025636|NCT01872910|11149742|FG002|NOT COMPLETED|Overall Study||2
10025637|NCT01872910|11149743|FG003|NOT COMPLETED|Overall Study||0
10025638|NCT01872910|11149744|FG004|NOT COMPLETED|Overall Study||0
10025639|NCT01872910|11149745|FG005|NOT COMPLETED|Overall Study||0
10025640|NCT01873287|11149760|FG000|STARTED|Overall Study||2006
10025641|NCT01873287|11149761|FG001|STARTED|Overall Study||1057
10025642|NCT01873287|11149760|FG000|COMPLETED|Overall Study||1701
10025643|NCT01873287|11149761|FG001|COMPLETED|Overall Study||883
10025644|NCT01873287|11149760|FG000|NOT COMPLETED|Overall Study||305
10025645|NCT01873287|11149761|FG001|NOT COMPLETED|Overall Study||174
10025646|NCT01873417|11149769|FG000|STARTED|Overall Study||237
10025647|NCT01873417|11149769|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
10025648|NCT01873417|11149769|FG000|COMPLETED|Overall Study||202
10025649|NCT01873417|11149769|FG000|NOT COMPLETED|Overall Study||35
10025650|NCT01873495|11149773|FG000|STARTED|Overall Study||7
10025651|NCT01873495|11149773|FG000|COMPLETED|Overall Study||0
10025652|NCT01873495|11149773|FG000|NOT COMPLETED|Overall Study||7
10025653|NCT01873586|11149777|FG000|STARTED|Overall Study||29
10025654|NCT01873586|11149777|FG000|COMPLETED|Overall Study||26
10025655|NCT01873586|11149777|FG000|NOT COMPLETED|Overall Study||3
10025656|NCT01873729|11149784|FG000|STARTED|Overall Study||3
10025657|NCT01873729|11149784|FG000|COMPLETED|Overall Study||2
10025658|NCT01873729|11149784|FG000|NOT COMPLETED|Overall Study||1
10025659|NCT01873742|11149790|FG000|STARTED|Overall Study||165
10025660|NCT01873742|11149791|FG001|STARTED|Overall Study||163
10025661|NCT01873742|11149790|FG000|COMPLETED|Overall Study||97
10025662|NCT01873742|11149791|FG001|COMPLETED|Overall Study||87
10025663|NCT01873742|11149790|FG000|NOT COMPLETED|Overall Study||68
10025664|NCT01873742|11149791|FG001|NOT COMPLETED|Overall Study||76
10025665|NCT01873846|11149797|FG000|STARTED|Overall Study||400
10025666|NCT01873846|11149797|FG000|Eligble Participants Dispensed Lenses|Overall Study||396
10025667|NCT01873846|11149797|FG000|COMPLETED|Overall Study||388
10025668|NCT01873846|11149797|FG000|NOT COMPLETED|Overall Study||12
10025669|NCT01873859|11149803|FG000|STARTED|Overall Study||83
10025670|NCT01873859|11149804|FG001|STARTED|Overall Study||83
10025671|NCT01873859|11149803|FG000|COMPLETED|Overall Study||83
10025672|NCT01873859|11149804|FG001|COMPLETED|Overall Study||79
10025673|NCT01873859|11149803|FG000|NOT COMPLETED|Overall Study||0
10025674|NCT01873859|11149804|FG001|NOT COMPLETED|Overall Study||4
10025675|NCT01873950|11149811|FG000|STARTED|Period 1||5
10025676|NCT01873950|11149812|FG001|STARTED|Period 1||4
10025677|NCT01873950|11149813|FG002|STARTED|Period 1||5
10025678|NCT01873950|11149814|FG003|STARTED|Period 1||4
10025679|NCT01873950|11149815|FG004|STARTED|Period 1||4
10025680|NCT01873950|11149811|FG000|COMPLETED|Period 1||5
10025681|NCT01873950|11149812|FG001|COMPLETED|Period 1||4
10025682|NCT01873950|11149813|FG002|COMPLETED|Period 1||5
10025683|NCT01873950|11149814|FG003|COMPLETED|Period 1||4
10025684|NCT01873950|11149815|FG004|COMPLETED|Period 1||4
10025685|NCT01873950|11149811|FG000|NOT COMPLETED|Period 1||0
10025686|NCT01873950|11149812|FG001|NOT COMPLETED|Period 1||0
10025687|NCT01873950|11149813|FG002|NOT COMPLETED|Period 1||0
10025688|NCT01873950|11149814|FG003|NOT COMPLETED|Period 1||0
10025689|NCT01873950|11149815|FG004|NOT COMPLETED|Period 1||0
10025690|NCT01873950|11149811|FG000|STARTED|Period 2||5
10025691|NCT01873950|11149812|FG001|STARTED|Period 2||4
10025692|NCT01873950|11149813|FG002|STARTED|Period 2||4
10025693|NCT01873950|11149814|FG003|STARTED|Period 2||4
10025694|NCT01873950|11149815|FG004|STARTED|Period 2||5
10025695|NCT01873950|11149811|FG000|COMPLETED|Period 2||5
10025696|NCT01873950|11149812|FG001|COMPLETED|Period 2||4
10025697|NCT01873950|11149813|FG002|COMPLETED|Period 2||4
10025698|NCT01873950|11149814|FG003|COMPLETED|Period 2||4
10025699|NCT01873950|11149815|FG004|COMPLETED|Period 2||5
10025700|NCT01873950|11149811|FG000|NOT COMPLETED|Period 2||0
10025701|NCT01873950|11149812|FG001|NOT COMPLETED|Period 2||0
10025702|NCT01873950|11149813|FG002|NOT COMPLETED|Period 2||0
10025703|NCT01873950|11149814|FG003|NOT COMPLETED|Period 2||0
10025704|NCT01873950|11149815|FG004|NOT COMPLETED|Period 2||0
10025705|NCT01873950|11149811|FG000|STARTED|Period 3||4
10025706|NCT01873950|11149812|FG001|STARTED|Period 3||4
10025707|NCT01873950|11149813|FG002|STARTED|Period 3||5
10025708|NCT01873950|11149814|FG003|STARTED|Period 3||5
10025709|NCT01873950|11149815|FG004|STARTED|Period 3||4
10025710|NCT01873950|11149811|FG000|COMPLETED|Period 3||4
10025711|NCT01873950|11149812|FG001|COMPLETED|Period 3||4
10025712|NCT01873950|11149813|FG002|COMPLETED|Period 3||5
10025713|NCT01873950|11149814|FG003|COMPLETED|Period 3||5
10025714|NCT01873950|11149815|FG004|COMPLETED|Period 3||4
10025715|NCT01873950|11149811|FG000|NOT COMPLETED|Period 3||0
10025716|NCT01873950|11149812|FG001|NOT COMPLETED|Period 3||0
10025717|NCT01873950|11149813|FG002|NOT COMPLETED|Period 3||0
10025718|NCT01873950|11149814|FG003|NOT COMPLETED|Period 3||0
10025719|NCT01873950|11149815|FG004|NOT COMPLETED|Period 3||0
10025720|NCT01873950|11149811|FG000|STARTED|Period 4||4
10025721|NCT01873950|11149812|FG001|STARTED|Period 4||5
10025722|NCT01873950|11149813|FG002|STARTED|Period 4||4
10025723|NCT01873950|11149814|FG003|STARTED|Period 4||4
10025724|NCT01873950|11149815|FG004|STARTED|Period 4||5
10025725|NCT01873950|11149811|FG000|COMPLETED|Period 4||4
10025726|NCT01873950|11149812|FG001|COMPLETED|Period 4||5
10025727|NCT01873950|11149813|FG002|COMPLETED|Period 4||4
10025728|NCT01873950|11149814|FG003|COMPLETED|Period 4||4
10025729|NCT01873950|11149815|FG004|COMPLETED|Period 4||5
10025730|NCT01873950|11149811|FG000|NOT COMPLETED|Period 4||0
10025731|NCT01873950|11149812|FG001|NOT COMPLETED|Period 4||0
10025732|NCT01873950|11149813|FG002|NOT COMPLETED|Period 4||0
10025733|NCT01873950|11149814|FG003|NOT COMPLETED|Period 4||0
10025734|NCT01873950|11149815|FG004|NOT COMPLETED|Period 4||0
10025735|NCT01873950|11149811|FG000|STARTED|Period 5||4
10025736|NCT01873950|11149812|FG001|STARTED|Period 5||5
10025737|NCT01873950|11149813|FG002|STARTED|Period 5||4
10025738|NCT01873950|11149814|FG003|STARTED|Period 5||4
10114677|NCT02518620|11245450|FG000|STARTED|Overall Study||257
10114678|NCT02518620|11245451|FG001|STARTED|Overall Study||149
10114679|NCT02518620|11245450|FG000|COMPLETED|Overall Study||205
10114680|NCT02518620|11245451|FG001|COMPLETED|Overall Study||123
10114681|NCT02518620|11245450|FG000|NOT COMPLETED|Overall Study||52
10114682|NCT02518620|11245451|FG001|NOT COMPLETED|Overall Study||26
10114683|NCT02518685|11245461|FG000|STARTED|Overall Study||213
10114684|NCT02518685|11245462|FG001|STARTED|Overall Study||89
10114685|NCT02518685|11245461|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
10114686|NCT02518685|11245462|FG001|Safety Cohort|Overall Study||89
10114687|NCT02518685|11245461|FG000|Randomized Cohort|Overall Study||181
10114688|NCT02518685|11245462|FG001|Randomized Cohort|Overall Study||89
10114689|NCT02518685|11245461|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
10114690|NCT02518685|11245462|FG001|Enrolled|Overall Study||89
10114691|NCT02518685|11245461|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
10114692|NCT02518685|11245462|FG001|Per Protocol Analysis|Overall Study||89
10114693|NCT02518685|11245461|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
10114694|NCT02518685|11245462|FG001|COMPLETED|Overall Study||79
10114695|NCT02518685|11245461|FG000|NOT COMPLETED|Overall Study||49
10114696|NCT02518685|11245462|FG001|NOT COMPLETED|Overall Study||10
10114697|NCT02518919|11245472|FG000|STARTED|Overall Study||21
10114698|NCT02518919|11245473|FG001|STARTED|Overall Study||21
10114699|NCT02518919|11245474|FG002|STARTED|Overall Study||21
10114700|NCT02518919|11245472|FG000|COMPLETED|Overall Study||20
10114701|NCT02518919|11245473|FG001|COMPLETED|Overall Study||20
10114702|NCT02518919|11245474|FG002|COMPLETED|Overall Study||19
10114703|NCT02518919|11245472|FG000|NOT COMPLETED|Overall Study||1
10025739|NCT01873950|11149815|FG004|STARTED|Period 5||4
10025740|NCT01873950|11149811|FG000|COMPLETED|Period 5||4
10025741|NCT01873950|11149812|FG001|COMPLETED|Period 5||5
10025742|NCT01873950|11149813|FG002|COMPLETED|Period 5||4
10025743|NCT01873950|11149814|FG003|COMPLETED|Period 5||3
10025744|NCT01873950|11149815|FG004|COMPLETED|Period 5||4
10025745|NCT01873950|11149811|FG000|NOT COMPLETED|Period 5||0
10025746|NCT01873950|11149812|FG001|NOT COMPLETED|Period 5||0
10025747|NCT01873950|11149813|FG002|NOT COMPLETED|Period 5||0
10025748|NCT01873950|11149814|FG003|NOT COMPLETED|Period 5||1
10025749|NCT01873950|11149815|FG004|NOT COMPLETED|Period 5||0
10025750|NCT01873989|11149831|FG000|STARTED|Overall Study||8
10025751|NCT01873989|11149832|FG001|STARTED|Overall Study||7
10025752|NCT01873989|11149831|FG000|COMPLETED|Overall Study||7
10025753|NCT01873989|11149832|FG001|COMPLETED|Overall Study||6
10025754|NCT01873989|11149831|FG000|NOT COMPLETED|Overall Study||1
10025755|NCT01873989|11149832|FG001|NOT COMPLETED|Overall Study||1
10025756|NCT01874054|11149838|FG000|STARTED|Overall Study||55
10025757|NCT01874054|11149838|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
10025758|NCT01874054|11149838|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17
10025759|NCT01874054|11149838|FG000|COMPLETED|Overall Study||0
10025760|NCT01874054|11149838|FG000|NOT COMPLETED|Overall Study||55
10025761|NCT01874119|11149842|FG000|STARTED|First Intervention (6 Days)||8
10025762|NCT01874119|11149843|FG001|STARTED|First Intervention (6 Days)||5
10025763|NCT01874119|11149842|FG000|COMPLETED|First Intervention (6 Days)||7
10025764|NCT01874119|11149843|FG001|COMPLETED|First Intervention (6 Days)||5
10025765|NCT01874119|11149842|FG000|NOT COMPLETED|First Intervention (6 Days)||1
10025766|NCT01874119|11149843|FG001|NOT COMPLETED|First Intervention (6 Days)||0
10025767|NCT01874119|11149842|FG000|STARTED|Washout (7 Days)||7
10025768|NCT01874119|11149843|FG001|STARTED|Washout (7 Days)||5
10025769|NCT01874119|11149842|FG000|COMPLETED|Washout (7 Days)||4
10025770|NCT01874119|11149843|FG001|COMPLETED|Washout (7 Days)||3
10025771|NCT01874119|11149842|FG000|NOT COMPLETED|Washout (7 Days)||3
10025772|NCT01874119|11149843|FG001|NOT COMPLETED|Washout (7 Days)||2
10025773|NCT01874119|11149842|FG000|STARTED|Second Intervention (6 Days)||4
10025774|NCT01874119|11149843|FG001|STARTED|Second Intervention (6 Days)||3
10025775|NCT01874119|11149842|FG000|COMPLETED|Second Intervention (6 Days)||4
10025776|NCT01874119|11149843|FG001|COMPLETED|Second Intervention (6 Days)||3
10025777|NCT01874119|11149842|FG000|NOT COMPLETED|Second Intervention (6 Days)||0
10025778|NCT01874119|11149843|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
10025779|NCT01874132|11149852|FG000|STARTED|Overall Study||22
10025780|NCT01874132|11149853|FG001|STARTED|Overall Study||22
10025781|NCT01874132|11149854|FG002|STARTED|Overall Study||22
10025782|NCT01874132|11149852|FG000|COMPLETED|Overall Study||18
10025783|NCT01874132|11149853|FG001|COMPLETED|Overall Study||18
10025784|NCT01874132|11149854|FG002|COMPLETED|Overall Study||19
10025785|NCT01874132|11149852|FG000|NOT COMPLETED|Overall Study||4
10025786|NCT01874132|11149853|FG001|NOT COMPLETED|Overall Study||4
10025787|NCT01874132|11149854|FG002|NOT COMPLETED|Overall Study||3
10025788|NCT01874145|11149864|FG000|STARTED|Core Period||101
10025789|NCT01874145|11149865|FG001|STARTED|Core Period||108
10025790|NCT01874145|11149864|FG000|Full Analysis Set|Core Period||100
10025791|NCT01874145|11149865|FG001|Full Analysis Set|Core Period||108
10025792|NCT01874145|11149864|FG000|COMPLETED|Core Period||98
10025793|NCT01874145|11149865|FG001|COMPLETED|Core Period||101
10025794|NCT01874145|11149864|FG000|NOT COMPLETED|Core Period||3
10025795|NCT01874145|11149865|FG001|NOT COMPLETED|Core Period||7
10025796|NCT01874145|11149864|FG000|STARTED|Extension Period|Switchers|97
10025797|NCT01874145|11149865|FG001|STARTED|Extension Period|Non-Switchers|101
10025798|NCT01874145|11149864|FG000|Full Analysis Set|Extension Period||95
10025799|NCT01874145|11149865|FG001|Full Analysis Set|Extension Period||101
10025800|NCT01874145|11149864|FG000|COMPLETED|Extension Period||91
10025801|NCT01874145|11149865|FG001|COMPLETED|Extension Period||97
10025802|NCT01874145|11149864|FG000|NOT COMPLETED|Extension Period||6
10025803|NCT01874145|11149865|FG001|NOT COMPLETED|Extension Period||4
10025804|NCT01874262|11149877|FG000|STARTED|Overall Study||91
10025805|NCT01874262|11149878|FG001|STARTED|Overall Study||83
10025806|NCT01874262|11149877|FG000|Not Correctly Randomised|Overall Study||2
10025807|NCT01874262|11149878|FG001|Not Correctly Randomised|Overall Study||0
10025808|NCT01874262|11149877|FG000|Not Included Due to Tehnical Issues|Overall Study||3
10025809|NCT01874262|11149878|FG001|Not Included Due to Tehnical Issues|Overall Study||3
10025810|NCT01874262|11149877|FG000|COMPLETED|Overall Study||86
10114704|NCT02518919|11245473|FG001|NOT COMPLETED|Overall Study||1
10114705|NCT02518919|11245474|FG002|NOT COMPLETED|Overall Study||2
10114706|NCT02518971|11245484|FG000|STARTED|Overall Study||87
10114707|NCT02518971|11245485|FG001|STARTED|Overall Study||87
10114708|NCT02518971|11245484|FG000|COMPLETED|Overall Study||64
10114709|NCT02518971|11245485|FG001|COMPLETED|Overall Study||67
10114710|NCT02518971|11245484|FG000|NOT COMPLETED|Overall Study||23
10114711|NCT02518971|11245485|FG001|NOT COMPLETED|Overall Study||20
10114712|NCT02518997|11245492|FG000|STARTED|Overall Study||18
10114713|NCT02518997|11245492|FG000|COMPLETED|Overall Study||18
10114714|NCT02518997|11245492|FG000|NOT COMPLETED|Overall Study||0
10114715|NCT02519023|11245501|FG000|STARTED|Overall Study||49
10114716|NCT02519023|11245502|FG001|STARTED|Overall Study||38
10114717|NCT02519023|11245501|FG000|COMPLETED|Overall Study||31
10114718|NCT02519023|11245502|FG001|COMPLETED|Overall Study||31
10114719|NCT02519023|11245501|FG000|NOT COMPLETED|Overall Study||18
10114720|NCT02519023|11245502|FG001|NOT COMPLETED|Overall Study||7
10114721|NCT02519036|11245514|FG000|STARTED|Overall Study||12
10114722|NCT02519036|11245515|FG001|STARTED|Overall Study||3
10114723|NCT02519036|11245516|FG002|STARTED|Overall Study||6
10114724|NCT02519036|11245517|FG003|STARTED|Overall Study||6
10114725|NCT02519036|11245518|FG004|STARTED|Overall Study||9
10114726|NCT02519036|11245519|FG005|STARTED|Overall Study||10
10114727|NCT02519036|11245514|FG000|COMPLETED|Overall Study||12
10114728|NCT02519036|11245515|FG001|COMPLETED|Overall Study||3
10114729|NCT02519036|11245516|FG002|COMPLETED|Overall Study||6
10114730|NCT02519036|11245517|FG003|COMPLETED|Overall Study||6
10114731|NCT02519036|11245518|FG004|COMPLETED|Overall Study||9
10114732|NCT02519036|11245519|FG005|COMPLETED|Overall Study||10
10114733|NCT02519036|11245514|FG000|NOT COMPLETED|Overall Study||0
10114734|NCT02519036|11245515|FG001|NOT COMPLETED|Overall Study||0
10114735|NCT02519036|11245516|FG002|NOT COMPLETED|Overall Study||0
10114736|NCT02519036|11245517|FG003|NOT COMPLETED|Overall Study||0
10114737|NCT02519036|11245518|FG004|NOT COMPLETED|Overall Study||0
10114738|NCT02519036|11245519|FG005|NOT COMPLETED|Overall Study||0
10114739|NCT02519231|11245540|FG000|STARTED|Overall Study||14
10114740|NCT02519231|11245541|FG001|STARTED|Overall Study||14
10114741|NCT02519231|11245540|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
10114742|NCT02519231|11245541|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
10114743|NCT02519231|11245540|FG000|NOT COMPLETED|Overall Study||2
10114744|NCT02519231|11245541|FG001|NOT COMPLETED|Overall Study||6
10114745|NCT02519244|11245549|FG000|STARTED|Overall Study||10
10114746|NCT02519244|11245549|FG000|COMPLETED|Overall Study||10
10025811|NCT01874262|11149878|FG001|COMPLETED|Overall Study||80
10025812|NCT01874262|11149877|FG000|NOT COMPLETED|Overall Study||5
10025813|NCT01874262|11149878|FG001|NOT COMPLETED|Overall Study||3
10025814|NCT01874275|11149886|FG000|STARTED|Overall Study||4
10025815|NCT01874275|11149887|FG001|STARTED|Overall Study||2
10025816|NCT01874275|11149886|FG000|COMPLETED|Overall Study||3
10025817|NCT01874275|11149887|FG001|COMPLETED|Overall Study||2
10025818|NCT01874275|11149886|FG000|NOT COMPLETED|Overall Study||1
10025819|NCT01874275|11149887|FG001|NOT COMPLETED|Overall Study||0
10025820|NCT01874288|11149904|FG000|STARTED|Overall Study||3
10025821|NCT01874288|11149905|FG001|STARTED|Overall Study||3
10114747|NCT02519244|11245549|FG000|NOT COMPLETED|Overall Study||0
10114748|NCT02519387|11245553|FG000|STARTED|Overall Study||78
10114749|NCT02519387|11245553|FG000|COMPLETED|Overall Study||56
10114750|NCT02519387|11245553|FG000|NOT COMPLETED|Overall Study||22
10114751|NCT02519491|11245559|FG000|STARTED|Overall Study||219
10114752|NCT02519491|11245560|FG001|STARTED|Overall Study||219
10114753|NCT02519491|11245559|FG000|COMPLETED|Overall Study||219
10025822|NCT01874288|11149906|FG002|STARTED|Overall Study||9
10025823|NCT01874288|11149907|FG003|STARTED|Overall Study||7
10025824|NCT01874288|11149908|FG004|STARTED|Overall Study||2
10025825|NCT01874288|11149904|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10025826|NCT01874288|11149905|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10025827|NCT01874288|11149906|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
10025828|NCT01874288|11149907|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
10025829|NCT01874288|11149908|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
10025830|NCT01874288|11149904|FG000|COMPLETED|Overall Study||0
10025831|NCT01874288|11149905|FG001|COMPLETED|Overall Study||3
10025832|NCT01874288|11149906|FG002|COMPLETED|Overall Study||4
10025833|NCT01874288|11149907|FG003|COMPLETED|Overall Study||0
10025834|NCT01874288|11149908|FG004|COMPLETED|Overall Study||0
10025835|NCT01874288|11149904|FG000|NOT COMPLETED|Overall Study||3
10025836|NCT01874288|11149905|FG001|NOT COMPLETED|Overall Study||0
10025837|NCT01874288|11149906|FG002|NOT COMPLETED|Overall Study||5
10025838|NCT01874288|11149907|FG003|NOT COMPLETED|Overall Study||7
10025839|NCT01874288|11149908|FG004|NOT COMPLETED|Overall Study||2
10025840|NCT01874340|11149925|FG000|STARTED|Overall Study||6
10114754|NCT02519491|11245560|FG001|COMPLETED|Overall Study||219
10114755|NCT02519491|11245559|FG000|NOT COMPLETED|Overall Study||0
10114756|NCT02519491|11245560|FG001|NOT COMPLETED|Overall Study||0
10114757|NCT02519504|11245568|FG000|STARTED|Overall Study||319
10114758|NCT02519504|11245569|FG001|STARTED|Overall Study||247
10114759|NCT02519504|11245568|FG000|Attended Direct Testing|Overall Study||212
10114760|NCT02519504|11245569|FG001|Attended Direct Testing|Overall Study||149
10114761|NCT02519504|11245568|FG000|COMPLETED|Overall Study||206
10114762|NCT02519504|11245569|FG001|COMPLETED|Overall Study||144
10114763|NCT02519504|11245568|FG000|NOT COMPLETED|Overall Study||113
10114764|NCT02519504|11245569|FG001|NOT COMPLETED|Overall Study||103
10114765|NCT02519595|11245578|FG000|STARTED|Overall Study||58
10114766|NCT02519595|11245579|FG001|STARTED|Overall Study||57
10114767|NCT02519595|11245580|FG002|STARTED|Overall Study||56
10114768|NCT02519595|11245578|FG000|COMPLETED|Overall Study||50
10114769|NCT02519595|11245579|FG001|COMPLETED|Overall Study||35
10114770|NCT02519595|11245580|FG002|COMPLETED|Overall Study||40
10114771|NCT02519595|11245578|FG000|NOT COMPLETED|Overall Study||8
10114772|NCT02519595|11245579|FG001|NOT COMPLETED|Overall Study||22
10114773|NCT02519595|11245580|FG002|NOT COMPLETED|Overall Study||16
10114774|NCT02519621|11245591|FG000|STARTED|Overall Study||30
10114775|NCT02519621|11245592|FG001|STARTED|Overall Study||30
10114776|NCT02519621|11245593|FG002|STARTED|Overall Study||30
10114777|NCT02519621|11245591|FG000|COMPLETED|Overall Study||30
10114778|NCT02519621|11245592|FG001|COMPLETED|Overall Study||30
10114779|NCT02519621|11245593|FG002|COMPLETED|Overall Study||30
10114780|NCT02519621|11245591|FG000|NOT COMPLETED|Overall Study||0
10114781|NCT02519621|11245592|FG001|NOT COMPLETED|Overall Study||0
10114782|NCT02519621|11245593|FG002|NOT COMPLETED|Overall Study||0
10114783|NCT02519842|11245603|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
10114784|NCT02519842|11245604|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
10114785|NCT02519842|11245605|FG002|STARTED|Base Study: Cycle 1||0
9695882|NCT00834275|10795156|FG000|NOT COMPLETED|Washout of 7 Days||0
10025841|NCT01874340|11149926|FG001|STARTED|Overall Study||8
10025842|NCT01874340|11149927|FG002|STARTED|Overall Study||8
10025843|NCT01874340|11149928|FG003|STARTED|Overall Study||6
10025844|NCT01874340|11149925|FG000|COMPLETED|Overall Study||0
10025845|NCT01874340|11149926|FG001|COMPLETED|Overall Study||0
9695883|NCT00834275|10795157|FG001|NOT COMPLETED|Washout of 7 Days||0
10025846|NCT01874340|11149927|FG002|COMPLETED|Overall Study||0
10114786|NCT02519842|11245603|FG000|Treated|Base Study: Cycle 1||37
10114787|NCT02519842|11245604|FG001|Treated|Base Study: Cycle 1||34
10114788|NCT02519842|11245605|FG002|Treated|Base Study: Cycle 1||0
10114789|NCT02519842|11245603|FG000|COMPLETED|Base Study: Cycle 1||36
10025847|NCT01874340|11149928|FG003|COMPLETED|Overall Study||1
10025848|NCT01874340|11149925|FG000|NOT COMPLETED|Overall Study||6
10025849|NCT01874340|11149926|FG001|NOT COMPLETED|Overall Study||8
10025850|NCT01874340|11149927|FG002|NOT COMPLETED|Overall Study||8
10025851|NCT01874340|11149928|FG003|NOT COMPLETED|Overall Study||5
10025852|NCT01874392|11149938|FG000|STARTED|Overall Study||9
10025853|NCT01874392|11149938|FG000|COMPLETED|Overall Study||9
10025854|NCT01874392|11149938|FG000|NOT COMPLETED|Overall Study||0
10025855|NCT01874431|11149950|FG000|STARTED|Overall Study||96
10025856|NCT01874431|11149951|FG001|STARTED|Overall Study||92
10025857|NCT01874431|11149952|FG002|STARTED|Overall Study||100
10025858|NCT01874431|11149953|FG003|STARTED|Overall Study||98
10025859|NCT01874431|11149954|FG004|STARTED|Overall Study||98
10025860|NCT01874431|11149955|FG005|STARTED|Overall Study||125
10025861|NCT01874431|11149956|FG006|STARTED|Overall Study||120
10025862|NCT01874431|11149957|FG007|STARTED|Overall Study||94
10025863|NCT01874431|11149950|FG000|Participants Received Treatment|Overall Study||96
10025864|NCT01874431|11149951|FG001|Participants Received Treatment|Overall Study||92
10025865|NCT01874431|11149952|FG002|Participants Received Treatment|Overall Study||100
10025866|NCT01874431|11149953|FG003|Participants Received Treatment|Overall Study||97
10025867|NCT01874431|11149954|FG004|Participants Received Treatment|Overall Study||98
10025868|NCT01874431|11149955|FG005|Participants Received Treatment|Overall Study||125
10025869|NCT01874431|11149956|FG006|Participants Received Treatment|Overall Study||119
10025870|NCT01874431|11149957|FG007|Participants Received Treatment|Overall Study||94
10025871|NCT01874431|11149950|FG000|COMPLETED|Overall Study||90
10025872|NCT01874431|11149951|FG001|COMPLETED|Overall Study||87
10025873|NCT01874431|11149952|FG002|COMPLETED|Overall Study||90
10025874|NCT01874431|11149953|FG003|COMPLETED|Overall Study||91
10025875|NCT01874431|11149954|FG004|COMPLETED|Overall Study||90
10025876|NCT01874431|11149955|FG005|COMPLETED|Overall Study||114
10025877|NCT01874431|11149956|FG006|COMPLETED|Overall Study||112
10025878|NCT01874431|11149957|FG007|COMPLETED|Overall Study||90
10025879|NCT01874431|11149950|FG000|NOT COMPLETED|Overall Study||6
10025880|NCT01874431|11149951|FG001|NOT COMPLETED|Overall Study||5
10025881|NCT01874431|11149952|FG002|NOT COMPLETED|Overall Study||10
10025882|NCT01874431|11149953|FG003|NOT COMPLETED|Overall Study||7
10025883|NCT01874431|11149954|FG004|NOT COMPLETED|Overall Study||8
10025884|NCT01874431|11149955|FG005|NOT COMPLETED|Overall Study||11
10025885|NCT01874431|11149956|FG006|NOT COMPLETED|Overall Study||8
10025886|NCT01874431|11149957|FG007|NOT COMPLETED|Overall Study||4
10025887|NCT01874535|11149977|FG000|STARTED|Overall Study||207
10025888|NCT01874535|11149978|FG001|STARTED|Overall Study||201
10025889|NCT01874535|11149977|FG000|COMPLETED|Overall Study||152
10025890|NCT01874535|11149978|FG001|COMPLETED|Overall Study||157
10025891|NCT01874535|11149977|FG000|NOT COMPLETED|Overall Study||55
10025892|NCT01874535|11149978|FG001|NOT COMPLETED|Overall Study||44
10025893|NCT01874665|11149986|FG000|STARTED|Overall Study||30
10025894|NCT01874665|11149987|FG001|STARTED|Overall Study||15
10025895|NCT01874665|11149986|FG000|COMPLETED|Overall Study||0
10025896|NCT01874665|11149987|FG001|COMPLETED|Overall Study||0
10025897|NCT01874665|11149986|FG000|NOT COMPLETED|Overall Study||30
10025898|NCT01874665|11149987|FG001|NOT COMPLETED|Overall Study||15
10025899|NCT01874756|11149998|FG000|STARTED|Overall Study||29
10025900|NCT01874756|11149999|FG001|STARTED|Overall Study||10
10025901|NCT01874756|11150000|FG002|STARTED|Overall Study||29
10025902|NCT01874756|11150001|FG003|STARTED|Overall Study||27
10025903|NCT01874756|11149998|FG000|COMPLETED|Overall Study||28
10025904|NCT01874756|11149999|FG001|COMPLETED|Overall Study||10
10025905|NCT01874756|11150000|FG002|COMPLETED|Overall Study||27
10025906|NCT01874756|11150001|FG003|COMPLETED|Overall Study||21
10025907|NCT01874756|11149998|FG000|NOT COMPLETED|Overall Study||1
10025908|NCT01874756|11149999|FG001|NOT COMPLETED|Overall Study||0
10025909|NCT01874756|11150000|FG002|NOT COMPLETED|Overall Study||2
10025910|NCT01874756|11150001|FG003|NOT COMPLETED|Overall Study||6
10025911|NCT01874951|11150013|FG000|STARTED|Overall Study||6
10025912|NCT01874951|11150014|FG001|STARTED|Overall Study||6
10025913|NCT01874951|11150013|FG000|COMPLETED|Overall Study||6
10025914|NCT01874951|11150014|FG001|COMPLETED|Overall Study||6
10025915|NCT01874951|11150013|FG000|NOT COMPLETED|Overall Study||0
10025916|NCT01874951|11150014|FG001|NOT COMPLETED|Overall Study||0
10025917|NCT01875159|11150025|FG000|STARTED|Overall Study||45
10025918|NCT01875159|11150026|FG001|STARTED|Overall Study||53
10025919|NCT01875159|11150025|FG000|COMPLETED|Overall Study||42
10025920|NCT01875159|11150026|FG001|COMPLETED|Overall Study||53
10025921|NCT01875159|11150025|FG000|NOT COMPLETED|Overall Study||3
10025922|NCT01875159|11150026|FG001|NOT COMPLETED|Overall Study||0
10025923|NCT01875237|11150034|FG000|STARTED|Overall Study||2
10025924|NCT01875237|11150035|FG001|STARTED|Overall Study||1
10025925|NCT01875237|11150034|FG000|COMPLETED|Overall Study||0
10025926|NCT01875237|11150035|FG001|COMPLETED|Overall Study||1
10025927|NCT01875237|11150034|FG000|NOT COMPLETED|Overall Study||2
10025928|NCT01875237|11150035|FG001|NOT COMPLETED|Overall Study||0
10025929|NCT01875250|11150045|FG000|STARTED|Overall Study||19
10025930|NCT01875250|11150046|FG001|STARTED|Overall Study||19
10025931|NCT01875250|11150045|FG000|COMPLETED|Overall Study||17
10025932|NCT01875250|11150046|FG001|COMPLETED|Overall Study||19
10025933|NCT01875250|11150045|FG000|NOT COMPLETED|Overall Study||2
10025934|NCT01875250|11150046|FG001|NOT COMPLETED|Overall Study||0
10025935|NCT01875367|11150056|FG000|STARTED|Overall Study||81
10025936|NCT01875367|11150057|FG001|STARTED|Overall Study||85
10025937|NCT01875367|11150056|FG000|COMPLETED|Overall Study||76
10025938|NCT01875367|11150057|FG001|COMPLETED|Overall Study||83
10025939|NCT01875367|11150056|FG000|NOT COMPLETED|Overall Study||5
10025940|NCT01875367|11150057|FG001|NOT COMPLETED|Overall Study||2
10025941|NCT01875445|11150069|FG000|STARTED|Overall Study||19
10025942|NCT01875445|11150070|FG001|STARTED|Overall Study||19
10025943|NCT01875445|11150069|FG000|COMPLETED|Overall Study||12
10025944|NCT01875445|11150070|FG001|COMPLETED|Overall Study||19
10025945|NCT01875445|11150069|FG000|NOT COMPLETED|Overall Study||7
10025946|NCT01875445|11150070|FG001|NOT COMPLETED|Overall Study||0
10025947|NCT01875471|11150078|FG000|STARTED|Overall Study||137
10025948|NCT01875471|11150079|FG001|STARTED|Overall Study||138
10025949|NCT01875471|11150078|FG000|Completed Per Protocol|Overall Study||127
10025950|NCT01875471|11150079|FG001|Completed Per Protocol|Overall Study||123
10025951|NCT01875471|11150078|FG000|COMPLETED|Overall Study||136
9695884|NCT00834275|10795156|FG000|STARTED|Second Intervention||13
9695885|NCT00834275|10795157|FG001|STARTED|Second Intervention||13
9695886|NCT00834275|10795156|FG000|COMPLETED|Second Intervention||13
9695887|NCT00834275|10795157|FG001|COMPLETED|Second Intervention||13
9695888|NCT00834275|10795156|FG000|NOT COMPLETED|Second Intervention||0
9695889|NCT00834275|10795157|FG001|NOT COMPLETED|Second Intervention||0
9695890|NCT00834249|10795163|FG000|STARTED|First Intervention||9
9695891|NCT00834249|10795164|FG001|STARTED|First Intervention||9
9961662|NCT01474512|11081383|FG007|NOT COMPLETED|Induction Period||0
9695892|NCT00834249|10795163|FG000|COMPLETED|First Intervention||9
9961663|NCT01474512|11081384|FG008|NOT COMPLETED|Induction Period||0
9961664|NCT01474512|11081385|FG009|NOT COMPLETED|Induction Period||0
9961665|NCT01474512|11081386|FG010|NOT COMPLETED|Induction Period||0
9961666|NCT01474512|11081387|FG011|NOT COMPLETED|Induction Period||0
9961667|NCT01474512|11081388|FG012|NOT COMPLETED|Induction Period||0
9961668|NCT01474512|11081389|FG013|NOT COMPLETED|Induction Period||0
9961669|NCT01474512|11081390|FG014|NOT COMPLETED|Induction Period||0
9961670|NCT01474512|11081391|FG015|NOT COMPLETED|Induction Period||0
9961671|NCT01474512|11081392|FG016|NOT COMPLETED|Induction Period||0
9961672|NCT01474512|11081393|FG017|NOT COMPLETED|Induction Period||0
9961673|NCT01474512|11081376|FG000|STARTED|Maintenance Period||0
9961674|NCT01474512|11081377|FG001|STARTED|Maintenance Period||0
10025952|NCT01875471|11150079|FG001|COMPLETED|Overall Study||137
10025953|NCT01875471|11150078|FG000|NOT COMPLETED|Overall Study||1
10025954|NCT01875471|11150079|FG001|NOT COMPLETED|Overall Study||1
10025955|NCT01875510|11150087|FG000|STARTED|Overall Study||40
10025956|NCT01875510|11150088|FG001|STARTED|Overall Study||40
10025957|NCT01875510|11150087|FG000|COMPLETED|Overall Study||40
10025958|NCT01875510|11150088|FG001|COMPLETED|Overall Study||40
10025959|NCT01875510|11150087|FG000|NOT COMPLETED|Overall Study||0
10025960|NCT01875510|11150088|FG001|NOT COMPLETED|Overall Study||0
10025961|NCT01875731|11150096|FG000|STARTED|Overall Study||34
10025962|NCT01875731|11150097|FG001|STARTED|Overall Study||32
10025963|NCT01875731|11150096|FG000|COMPLETED|Overall Study||33
10025964|NCT01875731|11150097|FG001|COMPLETED|Overall Study||32
10025965|NCT01875731|11150096|FG000|NOT COMPLETED|Overall Study||1
10025966|NCT01875731|11150097|FG001|NOT COMPLETED|Overall Study||0
10081246|NCT02258477|11209686|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0
10081247|NCT02258477|11209687|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0
10081248|NCT02258477|11209688|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0
10081249|NCT02258529|11209697|FG000|STARTED|Overall Study||10
10081250|NCT02258529|11209697|FG000|COMPLETED|Overall Study||0
10081251|NCT02258529|11209697|FG000|NOT COMPLETED|Overall Study||10
10081252|NCT02259010|11209701|FG000|STARTED|Overall Study||24
10081253|NCT02259010|11209701|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
10081254|NCT02259010|11209701|FG000|NOT COMPLETED|Overall Study||5
10081255|NCT02259088|11209709|FG000|STARTED|Overall Study||307
10081256|NCT02259088|11209710|FG001|STARTED|Overall Study||77
10081257|NCT02259088|11209709|FG000|Full Analysis Set|Overall Study||307
10081258|NCT02259088|11209710|FG001|Full Analysis Set|Overall Study||77
10081259|NCT02259088|11209709|FG000|Treated (Safety Analysis Set)|Overall Study||307
10081260|NCT02259088|11209710|FG001|Treated (Safety Analysis Set)|Overall Study||75
10081261|NCT02259088|11209709|FG000|COMPLETED|Overall Study||279
10081262|NCT02259088|11209710|FG001|COMPLETED|Overall Study||63
10081263|NCT02259088|11209709|FG000|NOT COMPLETED|Overall Study||28
10081264|NCT02259088|11209710|FG001|NOT COMPLETED|Overall Study||14
10081265|NCT02259114|11209721|FG000|STARTED|Overall Study||21
10081266|NCT02259114|11209722|FG001|STARTED|Overall Study||4
10081267|NCT02259114|11209723|FG002|STARTED|Overall Study||13
10081268|NCT02259114|11209724|FG003|STARTED|Overall Study||3
10081269|NCT02259114|11209725|FG004|STARTED|Overall Study||6
10081270|NCT02259114|11209721|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
10081271|NCT02259114|11209722|FG001|Treated|Overall Study||4
10081272|NCT02259114|11209723|FG002|Treated|Overall Study||13
10081273|NCT02259114|11209724|FG003|Treated|Overall Study||3
10081274|NCT02259114|11209725|FG004|Treated|Overall Study||6
10081275|NCT02259114|11209721|FG000|COMPLETED|Overall Study||0
10081276|NCT02259114|11209722|FG001|COMPLETED|Overall Study||0
10081277|NCT02259114|11209723|FG002|COMPLETED|Overall Study||0
10081278|NCT02259114|11209724|FG003|COMPLETED|Overall Study||0
10081279|NCT02259114|11209725|FG004|COMPLETED|Overall Study||0
10081280|NCT02259114|11209721|FG000|NOT COMPLETED|Overall Study||21
10081281|NCT02259114|11209722|FG001|NOT COMPLETED|Overall Study||4
10081282|NCT02259114|11209723|FG002|NOT COMPLETED|Overall Study||13
10081283|NCT02259114|11209724|FG003|NOT COMPLETED|Overall Study||3
10081284|NCT02259114|11209725|FG004|NOT COMPLETED|Overall Study||6
10081285|NCT02259231|11209744|FG000|STARTED|Overall Study||6
10081286|NCT02259231|11209745|FG001|STARTED|Overall Study||6
10081287|NCT02259231|11209746|FG002|STARTED|Overall Study||6
10081288|NCT02259231|11209747|FG003|STARTED|Overall Study||6
10081289|NCT02259231|11209748|FG004|STARTED|Overall Study||6
10081290|NCT02259231|11209749|FG005|STARTED|Overall Study||6
10081291|NCT02259231|11209750|FG006|STARTED|Overall Study||5
10081292|NCT02259231|11209744|FG000|COMPLETED|Overall Study||0
10081293|NCT02259231|11209745|FG001|COMPLETED|Overall Study||0
10081294|NCT02259231|11209746|FG002|COMPLETED|Overall Study||0
10081295|NCT02259231|11209747|FG003|COMPLETED|Overall Study||0
10081296|NCT02259231|11209748|FG004|COMPLETED|Overall Study||0
10081297|NCT02259231|11209749|FG005|COMPLETED|Overall Study||0
10081298|NCT02259231|11209750|FG006|COMPLETED|Overall Study||0
10081299|NCT02259231|11209744|FG000|NOT COMPLETED|Overall Study||6
10114790|NCT02519842|11245604|FG001|COMPLETED|Base Study: Cycle 1||34
10114791|NCT02519842|11245605|FG002|COMPLETED|Base Study: Cycle 1||0
10114792|NCT02519842|11245603|FG000|NOT COMPLETED|Base Study: Cycle 1||2
10114793|NCT02519842|11245604|FG001|NOT COMPLETED|Base Study: Cycle 1||3
10114794|NCT02519842|11245605|FG002|NOT COMPLETED|Base Study: Cycle 1||0
10114795|NCT02519842|11245603|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
10114796|NCT02519842|11245604|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
10114797|NCT02519842|11245605|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
10114798|NCT02519842|11245603|FG000|Treated|Optional Extension: Cycles 2-6||0
10114799|NCT02519842|11245604|FG001|Treated|Optional Extension: Cycles 2-6||0
10081300|NCT02259231|11209745|FG001|NOT COMPLETED|Overall Study||6
10081301|NCT02259231|11209746|FG002|NOT COMPLETED|Overall Study||6
10081302|NCT02259231|11209747|FG003|NOT COMPLETED|Overall Study||6
10081303|NCT02259231|11209748|FG004|NOT COMPLETED|Overall Study||6
10081304|NCT02259231|11209749|FG005|NOT COMPLETED|Overall Study||6
10081305|NCT02259231|11209750|FG006|NOT COMPLETED|Overall Study||5
10081306|NCT02259348|11209766|FG000|STARTED|Overall Study||12
10081307|NCT02259348|11209766|FG000|One Year Post-transplant|Overall Study||2
9695893|NCT00834249|10795164|FG001|COMPLETED|First Intervention||9
9695894|NCT00834249|10795163|FG000|NOT COMPLETED|First Intervention||0
9695895|NCT00834249|10795164|FG001|NOT COMPLETED|First Intervention||0
9695896|NCT00834249|10795163|FG000|STARTED|Washout: 7 Days||9
9695897|NCT00834249|10795164|FG001|STARTED|Washout: 7 Days||9
9695898|NCT00834249|10795163|FG000|COMPLETED|Washout: 7 Days||8
9695899|NCT00834249|10795164|FG001|COMPLETED|Washout: 7 Days||8
9695900|NCT00834249|10795163|FG000|NOT COMPLETED|Washout: 7 Days||1
9695901|NCT00834249|10795164|FG001|NOT COMPLETED|Washout: 7 Days||1
9695902|NCT00834249|10795163|FG000|STARTED|Second Intervention||8
9695903|NCT00834249|10795164|FG001|STARTED|Second Intervention||8
9695904|NCT00834249|10795163|FG000|COMPLETED|Second Intervention||7
9695905|NCT00834249|10795164|FG001|COMPLETED|Second Intervention||8
9695906|NCT00834249|10795163|FG000|NOT COMPLETED|Second Intervention||1
9695907|NCT00834249|10795164|FG001|NOT COMPLETED|Second Intervention||0
9695908|NCT00834197|10795170|FG000|STARTED|First Intervention||16
9695909|NCT00834197|10795171|FG001|STARTED|First Intervention||16
9695910|NCT00834197|10795170|FG000|COMPLETED|First Intervention||16
9695911|NCT00834197|10795171|FG001|COMPLETED|First Intervention||16
9695912|NCT00834197|10795170|FG000|NOT COMPLETED|First Intervention||0
9695913|NCT00834197|10795171|FG001|NOT COMPLETED|First Intervention||0
9695914|NCT00834197|10795170|FG000|STARTED|Washout of 14 Days||16
9695915|NCT00834197|10795171|FG001|STARTED|Washout of 14 Days||16
9695916|NCT00834197|10795170|FG000|COMPLETED|Washout of 14 Days||16
9695917|NCT00834197|10795171|FG001|COMPLETED|Washout of 14 Days||16
9695918|NCT00834197|10795170|FG000|NOT COMPLETED|Washout of 14 Days||0
9695919|NCT00834197|10795171|FG001|NOT COMPLETED|Washout of 14 Days||0
9695920|NCT00834197|10795170|FG000|STARTED|Second Intervention||16
9695921|NCT00834197|10795171|FG001|STARTED|Second Intervention||16
9695922|NCT00834197|10795170|FG000|COMPLETED|Second Intervention||16
9695923|NCT00834197|10795171|FG001|COMPLETED|Second Intervention||16
9695924|NCT00834197|10795170|FG000|NOT COMPLETED|Second Intervention||0
9695925|NCT00834197|10795171|FG001|NOT COMPLETED|Second Intervention||0
9695926|NCT00834132|10795177|FG000|STARTED|First Intervention||12
9695927|NCT00834132|10795178|FG001|STARTED|First Intervention||12
9695928|NCT00834132|10795177|FG000|COMPLETED|First Intervention||12
9695929|NCT00834132|10795178|FG001|COMPLETED|First Intervention||12
9695930|NCT00834132|10795177|FG000|NOT COMPLETED|First Intervention||0
9695931|NCT00834132|10795178|FG001|NOT COMPLETED|First Intervention||0
9695932|NCT00834132|10795177|FG000|STARTED|Washout: 21 Days||12
9695933|NCT00834132|10795178|FG001|STARTED|Washout: 21 Days||12
9695934|NCT00834132|10795177|FG000|COMPLETED|Washout: 21 Days||12
9695935|NCT00834132|10795178|FG001|COMPLETED|Washout: 21 Days||12
9695936|NCT00834132|10795177|FG000|NOT COMPLETED|Washout: 21 Days||0
9695937|NCT00834132|10795178|FG001|NOT COMPLETED|Washout: 21 Days||0
9695938|NCT00834132|10795177|FG000|STARTED|Second Intervention||12
9695939|NCT00834132|10795178|FG001|STARTED|Second Intervention||12
9695940|NCT00834132|10795177|FG000|COMPLETED|Second Intervention||12
9695941|NCT00834132|10795178|FG001|COMPLETED|Second Intervention||12
9695942|NCT00834132|10795177|FG000|NOT COMPLETED|Second Intervention||0
9695943|NCT00834132|10795178|FG001|NOT COMPLETED|Second Intervention||0
9695944|NCT00834067|10795184|FG000|STARTED|First Intervention||30
9695945|NCT00834067|10795185|FG001|STARTED|First Intervention||30
9695946|NCT00834067|10795184|FG000|COMPLETED|First Intervention||30
9695947|NCT00834067|10795185|FG001|COMPLETED|First Intervention||30
9695948|NCT00834067|10795184|FG000|NOT COMPLETED|First Intervention||0
9695949|NCT00834067|10795185|FG001|NOT COMPLETED|First Intervention||0
9695950|NCT00834067|10795184|FG000|STARTED|Washout of 21 Days||30
9695951|NCT00834067|10795185|FG001|STARTED|Washout of 21 Days||30
9695952|NCT00834067|10795184|FG000|COMPLETED|Washout of 21 Days||30
9695953|NCT00834067|10795185|FG001|COMPLETED|Washout of 21 Days||29
9695954|NCT00834067|10795184|FG000|NOT COMPLETED|Washout of 21 Days||0
9695955|NCT00834067|10795185|FG001|NOT COMPLETED|Washout of 21 Days||1
9695956|NCT00834067|10795184|FG000|STARTED|Second Intervention||30
9695957|NCT00834067|10795185|FG001|STARTED|Second Intervention||29
9695958|NCT00834067|10795184|FG000|COMPLETED|Second Intervention||30
9695959|NCT00834067|10795185|FG001|COMPLETED|Second Intervention||29
9695960|NCT00834067|10795184|FG000|NOT COMPLETED|Second Intervention||0
9695961|NCT00834067|10795185|FG001|NOT COMPLETED|Second Intervention||0
9695962|NCT00833937|10795191|FG000|STARTED|First Intervention||12
9695963|NCT00833937|10795192|FG001|STARTED|First Intervention||12
9695964|NCT00833937|10795191|FG000|COMPLETED|First Intervention||12
9695965|NCT00833937|10795192|FG001|COMPLETED|First Intervention||12
9695966|NCT00833937|10795191|FG000|NOT COMPLETED|First Intervention||0
9695967|NCT00833937|10795192|FG001|NOT COMPLETED|First Intervention||0
9695968|NCT00833937|10795191|FG000|STARTED|Washout||12
9695969|NCT00833937|10795192|FG001|STARTED|Washout||12
9695970|NCT00833937|10795191|FG000|COMPLETED|Washout||11
9695971|NCT00833937|10795192|FG001|COMPLETED|Washout||12
9695972|NCT00833937|10795191|FG000|NOT COMPLETED|Washout||1
9695973|NCT00833937|10795192|FG001|NOT COMPLETED|Washout||0
9695974|NCT00833937|10795191|FG000|STARTED|Second Intervention||11
9695975|NCT00833937|10795192|FG001|STARTED|Second Intervention||12
9695976|NCT00833937|10795191|FG000|COMPLETED|Second Intervention||11
9695977|NCT00833937|10795192|FG001|COMPLETED|Second Intervention||12
9695978|NCT00833937|10795191|FG000|NOT COMPLETED|Second Intervention||0
9695979|NCT00833937|10795192|FG001|NOT COMPLETED|Second Intervention||0
9695980|NCT00833664|10795198|FG000|STARTED|First Intervention||11
9695981|NCT00833664|10795199|FG001|STARTED|First Intervention||11
9695982|NCT00833664|10795198|FG000|COMPLETED|First Intervention||11
9695983|NCT00833664|10795199|FG001|COMPLETED|First Intervention||11
9695984|NCT00833664|10795198|FG000|NOT COMPLETED|First Intervention||0
9695985|NCT00833664|10795199|FG001|NOT COMPLETED|First Intervention||0
9695986|NCT00833664|10795198|FG000|STARTED|Washout: 14 Days||11
9695987|NCT00833664|10795199|FG001|STARTED|Washout: 14 Days||11
9695988|NCT00833664|10795198|FG000|COMPLETED|Washout: 14 Days||10
9695989|NCT00833664|10795199|FG001|COMPLETED|Washout: 14 Days||11
9695990|NCT00833664|10795198|FG000|NOT COMPLETED|Washout: 14 Days||1
9695991|NCT00833664|10795199|FG001|NOT COMPLETED|Washout: 14 Days||0
9695992|NCT00833664|10795198|FG000|STARTED|Second Intervention||10
9695993|NCT00833664|10795199|FG001|STARTED|Second Intervention||11
9695994|NCT00833664|10795198|FG000|COMPLETED|Second Intervention||10
9695995|NCT00833664|10795199|FG001|COMPLETED|Second Intervention||11
9695996|NCT00833664|10795198|FG000|NOT COMPLETED|Second Intervention||0
9695997|NCT00833664|10795199|FG001|NOT COMPLETED|Second Intervention||0
9695998|NCT00833586|10795205|FG000|STARTED|First Intervention||14
9695999|NCT00833586|10795206|FG001|STARTED|First Intervention||14
9696000|NCT00833586|10795205|FG000|COMPLETED|First Intervention||14
9696001|NCT00833586|10795206|FG001|COMPLETED|First Intervention||14
9696002|NCT00833586|10795205|FG000|NOT COMPLETED|First Intervention||0
9696003|NCT00833586|10795206|FG001|NOT COMPLETED|First Intervention||0
9696004|NCT00833586|10795205|FG000|STARTED|Washout: 14 Days||14
9696005|NCT00833586|10795206|FG001|STARTED|Washout: 14 Days||14
9696006|NCT00833586|10795205|FG000|COMPLETED|Washout: 14 Days||14
9696007|NCT00833586|10795206|FG001|COMPLETED|Washout: 14 Days||14
9696008|NCT00833586|10795205|FG000|NOT COMPLETED|Washout: 14 Days||0
9696009|NCT00833586|10795206|FG001|NOT COMPLETED|Washout: 14 Days||0
9696010|NCT00833586|10795205|FG000|STARTED|Second Intervention||14
9696011|NCT00833586|10795206|FG001|STARTED|Second Intervention||14
9696012|NCT00833586|10795205|FG000|COMPLETED|Second Intervention||14
9696013|NCT00833586|10795206|FG001|COMPLETED|Second Intervention||14
9696014|NCT00833586|10795205|FG000|NOT COMPLETED|Second Intervention||0
9696015|NCT00833586|10795206|FG001|NOT COMPLETED|Second Intervention||0
9696016|NCT00833521|10795212|FG000|STARTED|First Intervention||19
9696017|NCT00833521|10795213|FG001|STARTED|First Intervention||19
9696018|NCT00833521|10795212|FG000|COMPLETED|First Intervention||19
9696019|NCT00833521|10795213|FG001|COMPLETED|First Intervention||19
9696020|NCT00833521|10795212|FG000|NOT COMPLETED|First Intervention||0
9696021|NCT00833521|10795213|FG001|NOT COMPLETED|First Intervention||0
9696022|NCT00833521|10795212|FG000|STARTED|Second Intervention||19
9696023|NCT00833521|10795213|FG001|STARTED|Second Intervention||19
9696024|NCT00833521|10795212|FG000|COMPLETED|Second Intervention||19
9696025|NCT00833521|10795213|FG001|COMPLETED|Second Intervention||19
9696026|NCT00833521|10795212|FG000|NOT COMPLETED|Second Intervention||0
9696027|NCT00833521|10795213|FG001|NOT COMPLETED|Second Intervention||0
9696028|NCT00830336|10795219|FG000|STARTED|First Intervention||40
9696029|NCT00830336|10795220|FG001|STARTED|First Intervention||40
9696030|NCT00830336|10795219|FG000|COMPLETED|First Intervention||40
9696031|NCT00830336|10795220|FG001|COMPLETED|First Intervention||40
9961675|NCT01474512|11081378|FG002|STARTED|Maintenance Period||0
9961676|NCT01474512|11081379|FG003|STARTED|Maintenance Period||226
9961677|NCT01474512|11081380|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
9961678|NCT01474512|11081381|FG005|STARTED|Maintenance Period||229
9961679|NCT01474512|11081382|FG006|STARTED|Maintenance Period||16
9961680|NCT01474512|11081383|FG007|STARTED|Maintenance Period||391
9961681|NCT01474512|11081384|FG008|STARTED|Maintenance Period||78
9696032|NCT00830336|10795219|FG000|NOT COMPLETED|First Intervention||0
9696033|NCT00830336|10795220|FG001|NOT COMPLETED|First Intervention||0
9696034|NCT00830336|10795219|FG000|STARTED|Washout: 21 Days||40
9696035|NCT00830336|10795220|FG001|STARTED|Washout: 21 Days||40
9696036|NCT00830336|10795219|FG000|COMPLETED|Washout: 21 Days||39
9696037|NCT00830336|10795220|FG001|COMPLETED|Washout: 21 Days||40
9696038|NCT00830336|10795219|FG000|NOT COMPLETED|Washout: 21 Days||1
9696039|NCT00830336|10795220|FG001|NOT COMPLETED|Washout: 21 Days||0
9696040|NCT00830336|10795219|FG000|STARTED|Second Intervention||39
9696041|NCT00830336|10795220|FG001|STARTED|Second Intervention||40
9696042|NCT00830336|10795219|FG000|COMPLETED|Second Intervention||39
9696043|NCT00830336|10795220|FG001|COMPLETED|Second Intervention||40
9696044|NCT00830336|10795219|FG000|NOT COMPLETED|Second Intervention||0
9696045|NCT00830336|10795220|FG001|NOT COMPLETED|Second Intervention||0
9696046|NCT00830258|10795226|FG000|STARTED|First Intervention||30
9696047|NCT00830258|10795227|FG001|STARTED|First Intervention||30
9696048|NCT00830258|10795226|FG000|COMPLETED|First Intervention||29
9696049|NCT00830258|10795227|FG001|COMPLETED|First Intervention||30
9696050|NCT00830258|10795226|FG000|NOT COMPLETED|First Intervention||1
9696051|NCT00830258|10795227|FG001|NOT COMPLETED|First Intervention||0
9696052|NCT00830258|10795226|FG000|STARTED|Washout: 7 Days||29
9696053|NCT00830258|10795227|FG001|STARTED|Washout: 7 Days||30
9696054|NCT00830258|10795226|FG000|COMPLETED|Washout: 7 Days||28
9696055|NCT00830258|10795227|FG001|COMPLETED|Washout: 7 Days||30
9696056|NCT00830258|10795226|FG000|NOT COMPLETED|Washout: 7 Days||1
9696057|NCT00830258|10795227|FG001|NOT COMPLETED|Washout: 7 Days||0
9696058|NCT00830258|10795226|FG000|STARTED|Second Intervention||28
9696059|NCT00830258|10795227|FG001|STARTED|Second Intervention||30
9696060|NCT00830258|10795226|FG000|COMPLETED|Second Intervention||28
9696061|NCT00830258|10795227|FG001|COMPLETED|Second Intervention||30
9696062|NCT00830258|10795226|FG000|NOT COMPLETED|Second Intervention||0
9847456|NCT00853840|10959963|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
9847457|NCT00853840|10959964|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
9847458|NCT00853840|10959963|FG000|COMPLETED|Period 2||9
9847459|NCT00853840|10959964|FG001|COMPLETED|Period 2||9
9847460|NCT00853840|10959963|FG000|NOT COMPLETED|Period 2||0
9847461|NCT00853840|10959964|FG001|NOT COMPLETED|Period 2||0
9847462|NCT00853905|10959973|FG000|STARTED|Overall Study||37
9847463|NCT00853905|10959974|FG001|STARTED|Overall Study||40
9847464|NCT00853905|10959973|FG000|COMPLETED|Overall Study||35
9847465|NCT00853905|10959974|FG001|COMPLETED|Overall Study||36
9847466|NCT00853905|10959973|FG000|NOT COMPLETED|Overall Study||2
9847467|NCT00853905|10959974|FG001|NOT COMPLETED|Overall Study||4
9847468|NCT00853957|10959985|FG000|STARTED|Overall Study||220
9847469|NCT00853957|10959986|FG001|STARTED|Overall Study||223
9847470|NCT00853957|10959985|FG000|COMPLETED|Overall Study||206
9847471|NCT00853957|10959986|FG001|COMPLETED|Overall Study||204
9847472|NCT00853957|10959985|FG000|NOT COMPLETED|Overall Study||14
9847473|NCT00853957|10959986|FG001|NOT COMPLETED|Overall Study||19
9847474|NCT00853970|10959994|FG000|STARTED|Overall Study||152
9847475|NCT00853970|10959995|FG001|STARTED|Overall Study||147
9847476|NCT00853970|10959994|FG000|COMPLETED|Overall Study||146
9847477|NCT00853970|10959995|FG001|COMPLETED|Overall Study||144
9847478|NCT00853970|10959994|FG000|NOT COMPLETED|Overall Study||6
9847479|NCT00853970|10959995|FG001|NOT COMPLETED|Overall Study||3
9847480|NCT00853996|10960001|FG000|STARTED|Overall Study||25
9961682|NCT01474512|11081385|FG009|STARTED|Maintenance Period||62
9961683|NCT01474512|11081386|FG010|STARTED|Maintenance Period||0
9847481|NCT00853996|10960001|FG000|COMPLETED|Overall Study||25
9847482|NCT00853996|10960001|FG000|NOT COMPLETED|Overall Study||0
9847483|NCT00854061|10960005|FG000|STARTED|Overall Study||172
9847484|NCT00854061|10960005|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
9961684|NCT01474512|11081387|FG011|STARTED|Maintenance Period||0
9696063|NCT00830258|10795227|FG001|NOT COMPLETED|Second Intervention||0
9696064|NCT00830219|10795233|FG000|STARTED|First Intervention||23
9696065|NCT00830219|10795234|FG001|STARTED|First Intervention||23
9696066|NCT00830219|10795233|FG000|COMPLETED|First Intervention||23
9696067|NCT00830219|10795234|FG001|COMPLETED|First Intervention||23
9696068|NCT00830219|10795233|FG000|NOT COMPLETED|First Intervention||0
9696069|NCT00830219|10795234|FG001|NOT COMPLETED|First Intervention||0
9696070|NCT00830219|10795233|FG000|STARTED|Washout of 7 Days||23
9696071|NCT00830219|10795234|FG001|STARTED|Washout of 7 Days||23
9696072|NCT00830219|10795233|FG000|COMPLETED|Washout of 7 Days||22
10025967|NCT01875783|11150103|FG000|STARTED|Overall Study||385
10025968|NCT01875783|11150103|FG000|COMPLETED|Overall Study||385
9696073|NCT00830219|10795234|FG001|COMPLETED|Washout of 7 Days||22
9696074|NCT00830219|10795233|FG000|NOT COMPLETED|Washout of 7 Days||1
9696075|NCT00830219|10795234|FG001|NOT COMPLETED|Washout of 7 Days||1
9696076|NCT00830219|10795233|FG000|STARTED|Second Intervention||22
9696077|NCT00830219|10795234|FG001|STARTED|Second Intervention||22
9696078|NCT00830219|10795233|FG000|COMPLETED|Second Intervention||22
9696079|NCT00830219|10795234|FG001|COMPLETED|Second Intervention||22
9696080|NCT00830219|10795233|FG000|NOT COMPLETED|Second Intervention||0
9696081|NCT00830219|10795234|FG001|NOT COMPLETED|Second Intervention||0
9696082|NCT00830206|10795240|FG000|STARTED|First Intervention||40
9696083|NCT00830206|10795241|FG001|STARTED|First Intervention||40
9696084|NCT00830206|10795240|FG000|COMPLETED|First Intervention||40
9696085|NCT00830206|10795241|FG001|COMPLETED|First Intervention||40
9696086|NCT00830206|10795240|FG000|NOT COMPLETED|First Intervention||0
9696087|NCT00830206|10795241|FG001|NOT COMPLETED|First Intervention||0
9696088|NCT00830206|10795240|FG000|STARTED|Washout: 21 Days||40
9696089|NCT00830206|10795241|FG001|STARTED|Washout: 21 Days||40
9696090|NCT00830206|10795240|FG000|COMPLETED|Washout: 21 Days||39
9696091|NCT00830206|10795241|FG001|COMPLETED|Washout: 21 Days||39
9696092|NCT00830206|10795240|FG000|NOT COMPLETED|Washout: 21 Days||1
9696093|NCT00830206|10795241|FG001|NOT COMPLETED|Washout: 21 Days||1
9696094|NCT00830206|10795240|FG000|STARTED|Second Intervention||39
9696095|NCT00830206|10795241|FG001|STARTED|Second Intervention||39
9696096|NCT00830206|10795240|FG000|COMPLETED|Second Intervention||39
9696097|NCT00830206|10795241|FG001|COMPLETED|Second Intervention||39
9696098|NCT00830206|10795240|FG000|NOT COMPLETED|Second Intervention||0
9696099|NCT00830206|10795241|FG001|NOT COMPLETED|Second Intervention||0
9696100|NCT00830024|10795247|FG000|STARTED|First Intervention||18
9696101|NCT00830024|10795248|FG001|STARTED|First Intervention||18
9696102|NCT00830024|10795247|FG000|COMPLETED|First Intervention||18
9696103|NCT00830024|10795248|FG001|COMPLETED|First Intervention||18
9696104|NCT00830024|10795247|FG000|NOT COMPLETED|First Intervention||0
9696105|NCT00830024|10795248|FG001|NOT COMPLETED|First Intervention||0
9696106|NCT00830024|10795247|FG000|STARTED|Washout: 7 Days||18
9696107|NCT00830024|10795248|FG001|STARTED|Washout: 7 Days||18
9696108|NCT00830024|10795247|FG000|COMPLETED|Washout: 7 Days||17
9847485|NCT00854061|10960005|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
9847486|NCT00854061|10960005|FG000|COMPLETED|Overall Study||149
9847487|NCT00854061|10960005|FG000|NOT COMPLETED|Overall Study||23
9847488|NCT00854087|10960013|FG000|STARTED|Overall Study||59
9847489|NCT00854087|10960014|FG001|STARTED|Overall Study||59
9847490|NCT00854087|10960013|FG000|COMPLETED|Overall Study||40
9847491|NCT00854087|10960014|FG001|COMPLETED|Overall Study||40
9847492|NCT00854087|10960013|FG000|NOT COMPLETED|Overall Study||19
9961685|NCT01474512|11081388|FG012|STARTED|Maintenance Period||0
9961686|NCT01474512|11081389|FG013|STARTED|Maintenance Period||0
9961687|NCT01474512|11081390|FG014|STARTED|Maintenance Period||0
9961688|NCT01474512|11081391|FG015|STARTED|Maintenance Period||0
9961689|NCT01474512|11081392|FG016|STARTED|Maintenance Period||0
9961690|NCT01474512|11081393|FG017|STARTED|Maintenance Period||0
9696109|NCT00830024|10795248|FG001|COMPLETED|Washout: 7 Days||18
9696110|NCT00830024|10795247|FG000|NOT COMPLETED|Washout: 7 Days||1
9696111|NCT00830024|10795248|FG001|NOT COMPLETED|Washout: 7 Days||0
9961691|NCT01474512|11081376|FG000|Received Study Drug|Maintenance Period||0
10025969|NCT01875783|11150103|FG000|NOT COMPLETED|Overall Study||0
10081308|NCT02259348|11209766|FG000|COMPLETED|Overall Study||2
9696112|NCT00830024|10795247|FG000|STARTED|Second Intervention||17
9696113|NCT00830024|10795248|FG001|STARTED|Second Intervention||18
9696114|NCT00830024|10795247|FG000|COMPLETED|Second Intervention||17
9696115|NCT00830024|10795248|FG001|COMPLETED|Second Intervention||18
9847493|NCT00854087|10960014|FG001|NOT COMPLETED|Overall Study||19
9847494|NCT00854100|10960023|FG000|STARTED|Overall Study||81
9847495|NCT00854100|10960024|FG001|STARTED|Overall Study||76
10025970|NCT01875848|11150111|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
10025971|NCT01875848|11150112|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
10025972|NCT01875848|11150111|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
10114800|NCT02519842|11245605|FG002|Treated|Optional Extension: Cycles 2-6||55
10114801|NCT02519842|11245603|FG000|COMPLETED|Optional Extension: Cycles 2-6||0
10114802|NCT02519842|11245604|FG001|COMPLETED|Optional Extension: Cycles 2-6||0
10114803|NCT02519842|11245605|FG002|COMPLETED|Optional Extension: Cycles 2-6||26
10114804|NCT02519842|11245603|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0
10114805|NCT02519842|11245604|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0
10114806|NCT02519842|11245605|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29
10114807|NCT02519855|11245615|FG000|STARTED|Overall Study|Participants are included as treated|441
10114808|NCT02519855|11245616|FG001|STARTED|Overall Study|Participants are included as treated|441
10114809|NCT02519855|11245615|FG000|Vaccinated on Day 1|Overall Study||440
10114810|NCT02519855|11245616|FG001|Vaccinated on Day 1|Overall Study||441
10114811|NCT02519855|11245615|FG000|Vaccinated at Week 4|Overall Study||432
10114812|NCT02519855|11245616|FG001|Vaccinated at Week 4|Overall Study||424
10114813|NCT02519855|11245615|FG000|COMPLETED|Overall Study||438
10114814|NCT02519855|11245616|FG001|COMPLETED|Overall Study||437
10114815|NCT02519855|11245615|FG000|NOT COMPLETED|Overall Study||3
10025973|NCT01875848|11150112|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
10025974|NCT01875848|11150111|FG000|NOT COMPLETED|Overall Study||2
10025975|NCT01875848|11150112|FG001|NOT COMPLETED|Overall Study||0
10025976|NCT01875861|11150120|FG000|STARTED|Pre-implementation||4779
10025977|NCT01875861|11150121|FG001|STARTED|Pre-implementation||3714
10025978|NCT01875861|11150120|FG000|COMPLETED|Pre-implementation||4779
10025979|NCT01875861|11150121|FG001|COMPLETED|Pre-implementation||3714
10025980|NCT01875861|11150120|FG000|NOT COMPLETED|Pre-implementation||0
10025981|NCT01875861|11150121|FG001|NOT COMPLETED|Pre-implementation||0
10025982|NCT01875861|11150120|FG000|STARTED|Implementation||4546
10025983|NCT01875861|11150121|FG001|STARTED|Implementation||3444
10025984|NCT01875861|11150120|FG000|COMPLETED|Implementation||4546
10025985|NCT01875861|11150121|FG001|COMPLETED|Implementation||3444
10025986|NCT01875861|11150120|FG000|NOT COMPLETED|Implementation||0
10025987|NCT01875861|11150121|FG001|NOT COMPLETED|Implementation||0
10025988|NCT01875861|11150120|FG000|STARTED|Sustainability||4306
10025989|NCT01875861|11150121|FG001|STARTED|Sustainability||3444
10025990|NCT01875861|11150120|FG000|COMPLETED|Sustainability||4306
10025991|NCT01875861|11150121|FG001|COMPLETED|Sustainability||3444
10114816|NCT02519855|11245616|FG001|NOT COMPLETED|Overall Study||4
10114817|NCT02520089|11245624|FG000|STARTED|Overall Study||12
10114818|NCT02520089|11245625|FG001|STARTED|Overall Study||11
10114819|NCT02520089|11245624|FG000|COMPLETED|Overall Study||9
10114820|NCT02520089|11245625|FG001|COMPLETED|Overall Study||7
10114821|NCT02520089|11245624|FG000|NOT COMPLETED|Overall Study||3
10114822|NCT02520089|11245625|FG001|NOT COMPLETED|Overall Study||4
10114823|NCT02520284|11245634|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54
10114824|NCT02520284|11245635|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56
10114825|NCT02520284|11245636|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55
10114826|NCT02520284|11245634|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52
10114827|NCT02520284|11245635|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
10114828|NCT02520284|11245636|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
10114829|NCT02520284|11245634|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
10114830|NCT02520284|11245635|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
10114831|NCT02520284|11245636|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
10114832|NCT02520284|11245634|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
10114833|NCT02520284|11245635|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
10114834|NCT02520284|11245636|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
10114835|NCT02520284|11245634|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
10114836|NCT02520284|11245635|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
10114837|NCT02520284|11245636|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
10114838|NCT02520284|11245634|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
10114839|NCT02520284|11245635|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
10114840|NCT02520284|11245636|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
9696116|NCT00830024|10795247|FG000|NOT COMPLETED|Second Intervention||0
9696117|NCT00830024|10795248|FG001|NOT COMPLETED|Second Intervention||0
9696118|NCT00829998|10795254|FG000|STARTED|First Intervention||21
9696119|NCT00829998|10795255|FG001|STARTED|First Intervention||20
9696120|NCT00829998|10795254|FG000|COMPLETED|First Intervention||21
9696121|NCT00829998|10795255|FG001|COMPLETED|First Intervention||20
9696122|NCT00829998|10795254|FG000|NOT COMPLETED|First Intervention||0
9696123|NCT00829998|10795255|FG001|NOT COMPLETED|First Intervention||0
9696124|NCT00829998|10795254|FG000|STARTED|Washout||21
9696125|NCT00829998|10795255|FG001|STARTED|Washout||20
9696126|NCT00829998|10795254|FG000|COMPLETED|Washout||21
9696127|NCT00829998|10795255|FG001|COMPLETED|Washout||19
9696128|NCT00829998|10795254|FG000|NOT COMPLETED|Washout||0
9696129|NCT00829998|10795255|FG001|NOT COMPLETED|Washout||1
9696130|NCT00829998|10795254|FG000|STARTED|Second Intervention||21
9696131|NCT00829998|10795255|FG001|STARTED|Second Intervention||19
9696132|NCT00829998|10795254|FG000|COMPLETED|Second Intervention||21
9696133|NCT00829998|10795255|FG001|COMPLETED|Second Intervention||19
9696134|NCT00829998|10795254|FG000|NOT COMPLETED|Second Intervention||0
9696135|NCT00829998|10795255|FG001|NOT COMPLETED|Second Intervention||0
9696136|NCT00829868|10795261|FG000|STARTED|First Intervention||21
9696137|NCT00829868|10795262|FG001|STARTED|First Intervention||21
9696138|NCT00829868|10795261|FG000|COMPLETED|First Intervention||21
9696139|NCT00829868|10795262|FG001|COMPLETED|First Intervention||21
9696140|NCT00829868|10795261|FG000|NOT COMPLETED|First Intervention||0
9696141|NCT00829868|10795262|FG001|NOT COMPLETED|First Intervention||0
9696142|NCT00829868|10795261|FG000|STARTED|Washout||21
9696143|NCT00829868|10795262|FG001|STARTED|Washout||21
9696144|NCT00829868|10795261|FG000|COMPLETED|Washout||20
9696145|NCT00829868|10795262|FG001|COMPLETED|Washout||21
9696146|NCT00829868|10795261|FG000|NOT COMPLETED|Washout||1
9696147|NCT00829868|10795262|FG001|NOT COMPLETED|Washout||0
9696148|NCT00829868|10795261|FG000|STARTED|Second Intervention||20
9696149|NCT00829868|10795262|FG001|STARTED|Second Intervention||21
9696150|NCT00829868|10795261|FG000|COMPLETED|Second Intervention||20
9696151|NCT00829868|10795262|FG001|COMPLETED|Second Intervention||21
9696152|NCT00829868|10795261|FG000|NOT COMPLETED|Second Intervention||0
9696153|NCT00829868|10795262|FG001|NOT COMPLETED|Second Intervention||0
9696154|NCT00829790|10795268|FG000|STARTED|First Intervention||15
9696155|NCT00829790|10795269|FG001|STARTED|First Intervention||15
9696156|NCT00829790|10795268|FG000|COMPLETED|First Intervention||15
9696157|NCT00829790|10795269|FG001|COMPLETED|First Intervention||15
9696158|NCT00829790|10795268|FG000|NOT COMPLETED|First Intervention||0
9696159|NCT00829790|10795269|FG001|NOT COMPLETED|First Intervention||0
9696160|NCT00829790|10795268|FG000|STARTED|Washout of 14 Days||15
9696161|NCT00829790|10795269|FG001|STARTED|Washout of 14 Days||15
9696162|NCT00829790|10795268|FG000|COMPLETED|Washout of 14 Days||15
9696163|NCT00829790|10795269|FG001|COMPLETED|Washout of 14 Days||14
9696164|NCT00829790|10795268|FG000|NOT COMPLETED|Washout of 14 Days||0
9696165|NCT00829790|10795269|FG001|NOT COMPLETED|Washout of 14 Days||1
9696166|NCT00829790|10795268|FG000|STARTED|Second Intervention||15
9696167|NCT00829790|10795269|FG001|STARTED|Second Intervention||14
9696168|NCT00829790|10795268|FG000|COMPLETED|Second Intervention||15
9847496|NCT00854100|10960025|FG002|STARTED|Overall Study||74
9847497|NCT00854100|10960023|FG000|COMPLETED|Overall Study||72
9847498|NCT00854100|10960024|FG001|COMPLETED|Overall Study||70
9847499|NCT00854100|10960025|FG002|COMPLETED|Overall Study||63
9847500|NCT00854100|10960023|FG000|NOT COMPLETED|Overall Study||9
9961692|NCT01474512|11081377|FG001|Received Study Drug|Maintenance Period||0
9961693|NCT01474512|11081378|FG002|Received Study Drug|Maintenance Period||0
9961694|NCT01474512|11081379|FG003|Received Study Drug|Maintenance Period||226
9961695|NCT01474512|11081380|FG004|Received Study Drug|Maintenance Period||227
9961696|NCT01474512|11081381|FG005|Received Study Drug|Maintenance Period||229
9961697|NCT01474512|11081382|FG006|Received Study Drug|Maintenance Period||16
9847501|NCT00854100|10960024|FG001|NOT COMPLETED|Overall Study||6
9847502|NCT00854100|10960025|FG002|NOT COMPLETED|Overall Study||11
9847503|NCT00854113|10960045|FG000|STARTED|Overall Study||6
9847504|NCT00854113|10960046|FG001|STARTED|Overall Study||6
9847505|NCT00854113|10960047|FG002|STARTED|Overall Study||6
9696169|NCT00829790|10795269|FG001|COMPLETED|Second Intervention||14
9696170|NCT00829790|10795268|FG000|NOT COMPLETED|Second Intervention||0
9696171|NCT00829790|10795269|FG001|NOT COMPLETED|Second Intervention||0
9696172|NCT00829764|10795275|FG000|STARTED|First Intervention||15
9696173|NCT00829764|10795276|FG001|STARTED|First Intervention||15
9696174|NCT00829764|10795275|FG000|COMPLETED|First Intervention||13
9696175|NCT00829764|10795276|FG001|COMPLETED|First Intervention||14
9696176|NCT00829764|10795275|FG000|NOT COMPLETED|First Intervention||2
9696177|NCT00829764|10795276|FG001|NOT COMPLETED|First Intervention||1
9696178|NCT00829764|10795275|FG000|STARTED|Washout of 14 Days||13
9696179|NCT00829764|10795276|FG001|STARTED|Washout of 14 Days||14
9696180|NCT00829764|10795275|FG000|COMPLETED|Washout of 14 Days||13
9696181|NCT00829764|10795276|FG001|COMPLETED|Washout of 14 Days||14
9696182|NCT00829764|10795275|FG000|NOT COMPLETED|Washout of 14 Days||0
9696183|NCT00829764|10795276|FG001|NOT COMPLETED|Washout of 14 Days||0
9696184|NCT00829764|10795275|FG000|STARTED|Second Intervention||13
9696185|NCT00829764|10795276|FG001|STARTED|Second Intervention||14
9696186|NCT00829764|10795275|FG000|COMPLETED|Second Intervention||13
9696187|NCT00829764|10795276|FG001|COMPLETED|Second Intervention||14
9696188|NCT00829764|10795275|FG000|NOT COMPLETED|Second Intervention||0
9696189|NCT00829764|10795276|FG001|NOT COMPLETED|Second Intervention||0
9696190|NCT00829712|10795282|FG000|STARTED|First Intervention||12
9696191|NCT00829712|10795283|FG001|STARTED|First Intervention||12
9696192|NCT00829712|10795282|FG000|COMPLETED|First Intervention||12
9696193|NCT00829712|10795283|FG001|COMPLETED|First Intervention||12
9696194|NCT00829712|10795282|FG000|NOT COMPLETED|First Intervention||0
9696195|NCT00829712|10795283|FG001|NOT COMPLETED|First Intervention||0
9696196|NCT00829712|10795282|FG000|STARTED|Washout of 7 Days||12
9696197|NCT00829712|10795283|FG001|STARTED|Washout of 7 Days||12
10025992|NCT01875861|11150120|FG000|NOT COMPLETED|Sustainability||0
10025993|NCT01875861|11150121|FG001|NOT COMPLETED|Sustainability||0
9696198|NCT00829712|10795282|FG000|COMPLETED|Washout of 7 Days||12
9696199|NCT00829712|10795283|FG001|COMPLETED|Washout of 7 Days||11
9696200|NCT00829712|10795282|FG000|NOT COMPLETED|Washout of 7 Days||0
9696201|NCT00829712|10795283|FG001|NOT COMPLETED|Washout of 7 Days||1
9696202|NCT00829712|10795282|FG000|STARTED|Second Intervention||12
9696203|NCT00829712|10795283|FG001|STARTED|Second Intervention||11
9696204|NCT00829712|10795282|FG000|COMPLETED|Second Intervention||12
9696205|NCT00829712|10795283|FG001|COMPLETED|Second Intervention||11
9696206|NCT00829712|10795282|FG000|NOT COMPLETED|Second Intervention||0
9696207|NCT00829712|10795283|FG001|NOT COMPLETED|Second Intervention||0
9696208|NCT00829686|10795289|FG000|STARTED|Overall Study||13
9696209|NCT00829686|10795290|FG001|STARTED|Overall Study||18
9696210|NCT00829686|10795289|FG000|COMPLETED|Overall Study||13
9696211|NCT00829686|10795290|FG001|COMPLETED|Overall Study||18
9696212|NCT00829686|10795289|FG000|NOT COMPLETED|Overall Study||0
9696213|NCT00829686|10795290|FG001|NOT COMPLETED|Overall Study||0
9696214|NCT00829673|10795296|FG000|STARTED|First Intervention||12
9696215|NCT00829673|10795297|FG001|STARTED|First Intervention||12
10025994|NCT01875874|11150128|FG000|STARTED|Overall Study||8
9696216|NCT00829673|10795296|FG000|COMPLETED|First Intervention||12
9696217|NCT00829673|10795297|FG001|COMPLETED|First Intervention||12
9696218|NCT00829673|10795296|FG000|NOT COMPLETED|First Intervention||0
9696219|NCT00829673|10795297|FG001|NOT COMPLETED|First Intervention||0
9696220|NCT00829673|10795296|FG000|STARTED|Washout of 7 Days||12
9696221|NCT00829673|10795297|FG001|STARTED|Washout of 7 Days||12
10025995|NCT01875874|11150128|FG000|COMPLETED|Overall Study||5
9696222|NCT00829673|10795296|FG000|COMPLETED|Washout of 7 Days||11
9696223|NCT00829673|10795297|FG001|COMPLETED|Washout of 7 Days||12
9696224|NCT00829673|10795296|FG000|NOT COMPLETED|Washout of 7 Days||1
9696225|NCT00829673|10795297|FG001|NOT COMPLETED|Washout of 7 Days||0
9696226|NCT00829673|10795296|FG000|STARTED|Second Intervention||11
9696227|NCT00829673|10795297|FG001|STARTED|Second Intervention||12
9696228|NCT00829673|10795296|FG000|COMPLETED|Second Intervention||11
9696229|NCT00829673|10795297|FG001|COMPLETED|Second Intervention||12
9696230|NCT00829673|10795296|FG000|NOT COMPLETED|Second Intervention||0
9696231|NCT00829673|10795297|FG001|NOT COMPLETED|Second Intervention||0
9696232|NCT00829530|10795303|FG000|STARTED|First Intervention||20
9696233|NCT00829530|10795304|FG001|STARTED|First Intervention||20
9696234|NCT00829530|10795303|FG000|COMPLETED|First Intervention||20
9696235|NCT00829530|10795304|FG001|COMPLETED|First Intervention||18
9696236|NCT00829530|10795303|FG000|NOT COMPLETED|First Intervention||0
9696237|NCT00829530|10795304|FG001|NOT COMPLETED|First Intervention||2
9696238|NCT00829530|10795303|FG000|STARTED|Washout of 42 Days||20
9696239|NCT00829530|10795304|FG001|STARTED|Washout of 42 Days||18
9696240|NCT00829530|10795303|FG000|COMPLETED|Washout of 42 Days||20
9696241|NCT00829530|10795304|FG001|COMPLETED|Washout of 42 Days||18
9696242|NCT00829530|10795303|FG000|NOT COMPLETED|Washout of 42 Days||0
9696243|NCT00829530|10795304|FG001|NOT COMPLETED|Washout of 42 Days||0
9696244|NCT00829530|10795303|FG000|STARTED|Second Intervention||20
9696245|NCT00829530|10795304|FG001|STARTED|Second Intervention||18
9696246|NCT00829530|10795303|FG000|COMPLETED|Second Intervention||19
9696247|NCT00829530|10795304|FG001|COMPLETED|Second Intervention||18
9696248|NCT00829530|10795303|FG000|NOT COMPLETED|Second Intervention||1
9696249|NCT00829530|10795304|FG001|NOT COMPLETED|Second Intervention||0
9696250|NCT00829504|10795310|FG000|STARTED|First Intervention||22
9696251|NCT00829504|10795311|FG001|STARTED|First Intervention||22
9696252|NCT00829504|10795310|FG000|COMPLETED|First Intervention||21
9696253|NCT00829504|10795311|FG001|COMPLETED|First Intervention||22
9696254|NCT00829504|10795310|FG000|NOT COMPLETED|First Intervention||1
10025996|NCT01875874|11150128|FG000|NOT COMPLETED|Overall Study||3
10025997|NCT01875978|11150135|FG000|STARTED|Study 4weeks||20
10025998|NCT01875978|11150136|FG001|STARTED|Study 4weeks||20
9696255|NCT00829504|10795311|FG001|NOT COMPLETED|First Intervention||0
9696256|NCT00829504|10795310|FG000|STARTED|Washout of 7 Days||21
9696257|NCT00829504|10795311|FG001|STARTED|Washout of 7 Days||22
9696258|NCT00829504|10795310|FG000|COMPLETED|Washout of 7 Days||20
9696259|NCT00829504|10795311|FG001|COMPLETED|Washout of 7 Days||22
9696260|NCT00829504|10795310|FG000|NOT COMPLETED|Washout of 7 Days||1
9696261|NCT00829504|10795311|FG001|NOT COMPLETED|Washout of 7 Days||0
9696262|NCT00829504|10795310|FG000|STARTED|Second Intervention||20
9696263|NCT00829504|10795311|FG001|STARTED|Second Intervention||22
9696264|NCT00829504|10795310|FG000|COMPLETED|Second Intervention||19
9696265|NCT00829504|10795311|FG001|COMPLETED|Second Intervention||22
9696266|NCT00829504|10795310|FG000|NOT COMPLETED|Second Intervention||1
9696267|NCT00829504|10795311|FG001|NOT COMPLETED|Second Intervention||0
9696268|NCT00829452|10795317|FG000|STARTED|First Intervention||20
9696269|NCT00829452|10795318|FG001|STARTED|First Intervention||20
9696270|NCT00829452|10795317|FG000|COMPLETED|First Intervention||20
9696271|NCT00829452|10795318|FG001|COMPLETED|First Intervention||19
9696272|NCT00829452|10795317|FG000|NOT COMPLETED|First Intervention||0
9696273|NCT00829452|10795318|FG001|NOT COMPLETED|First Intervention||1
9696274|NCT00829452|10795317|FG000|STARTED|Washout of 42 Days||20
9696275|NCT00829452|10795318|FG001|STARTED|Washout of 42 Days||19
9696276|NCT00829452|10795317|FG000|COMPLETED|Washout of 42 Days||20
9696277|NCT00829452|10795318|FG001|COMPLETED|Washout of 42 Days||18
9696278|NCT00829452|10795317|FG000|NOT COMPLETED|Washout of 42 Days||0
9696279|NCT00829452|10795318|FG001|NOT COMPLETED|Washout of 42 Days||1
9696280|NCT00829452|10795317|FG000|STARTED|Second Intervention||20
9696281|NCT00829452|10795318|FG001|STARTED|Second Intervention||18
10025999|NCT01875978|11150135|FG000|COMPLETED|Study 4weeks||20
10026000|NCT01875978|11150136|FG001|COMPLETED|Study 4weeks||20
10026001|NCT01875978|11150135|FG000|NOT COMPLETED|Study 4weeks||0
10026002|NCT01875978|11150136|FG001|NOT COMPLETED|Study 4weeks||0
9696282|NCT00829452|10795317|FG000|COMPLETED|Second Intervention||20
9696283|NCT00829452|10795318|FG001|COMPLETED|Second Intervention||17
9696284|NCT00829452|10795317|FG000|NOT COMPLETED|Second Intervention||0
9696285|NCT00829452|10795318|FG001|NOT COMPLETED|Second Intervention||1
9696286|NCT00829426|10795324|FG000|STARTED|First Intervention||16
9696287|NCT00829426|10795325|FG001|STARTED|First Intervention||16
9696288|NCT00829426|10795324|FG000|COMPLETED|First Intervention||16
9696289|NCT00829426|10795325|FG001|COMPLETED|First Intervention||16
10026003|NCT01875978|11150135|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
9696290|NCT00829426|10795324|FG000|NOT COMPLETED|First Intervention||0
9696291|NCT00829426|10795325|FG001|NOT COMPLETED|First Intervention||0
9696292|NCT00829426|10795324|FG000|STARTED|Washout: 7 Days||16
9696293|NCT00829426|10795325|FG001|STARTED|Washout: 7 Days||16
9696294|NCT00829426|10795324|FG000|COMPLETED|Washout: 7 Days||15
9696295|NCT00829426|10795325|FG001|COMPLETED|Washout: 7 Days||16
9696296|NCT00829426|10795324|FG000|NOT COMPLETED|Washout: 7 Days||1
9696297|NCT00829426|10795325|FG001|NOT COMPLETED|Washout: 7 Days||0
9696298|NCT00829426|10795324|FG000|STARTED|Second Intervention||15
9696299|NCT00829426|10795325|FG001|STARTED|Second Intervention||16
9696300|NCT00829426|10795324|FG000|COMPLETED|Second Intervention||15
9696301|NCT00829426|10795325|FG001|COMPLETED|Second Intervention||16
9696302|NCT00829426|10795324|FG000|NOT COMPLETED|Second Intervention||0
9696303|NCT00829426|10795325|FG001|NOT COMPLETED|Second Intervention||0
9696304|NCT00829309|10795331|FG000|STARTED|First Intervention||8
9696305|NCT00829309|10795332|FG001|STARTED|First Intervention||8
9696306|NCT00829309|10795331|FG000|COMPLETED|First Intervention||8
9696307|NCT00829309|10795332|FG001|COMPLETED|First Intervention||8
9696308|NCT00829309|10795331|FG000|NOT COMPLETED|First Intervention||0
9696309|NCT00829309|10795332|FG001|NOT COMPLETED|First Intervention||0
9696310|NCT00829309|10795331|FG000|STARTED|Washout: 7 Days||8
9696311|NCT00829309|10795332|FG001|STARTED|Washout: 7 Days||8
9696312|NCT00829309|10795331|FG000|COMPLETED|Washout: 7 Days||7
9696313|NCT00829309|10795332|FG001|COMPLETED|Washout: 7 Days||8
9696314|NCT00829309|10795331|FG000|NOT COMPLETED|Washout: 7 Days||1
9696315|NCT00829309|10795332|FG001|NOT COMPLETED|Washout: 7 Days||0
9696316|NCT00829309|10795331|FG000|STARTED|Second Intervention||7
9696317|NCT00829309|10795332|FG001|STARTED|Second Intervention||8
9696318|NCT00829309|10795331|FG000|COMPLETED|Second Intervention||7
9696319|NCT00829309|10795332|FG001|COMPLETED|Second Intervention||8
9696320|NCT00829309|10795331|FG000|NOT COMPLETED|Second Intervention||0
9696321|NCT00829309|10795332|FG001|NOT COMPLETED|Second Intervention||0
9696322|NCT00828321|10795338|FG000|STARTED|First Intervention||20
9696323|NCT00828321|10795339|FG001|STARTED|First Intervention||20
9696324|NCT00828321|10795338|FG000|COMPLETED|First Intervention||20
9696325|NCT00828321|10795339|FG001|COMPLETED|First Intervention||20
9696326|NCT00828321|10795338|FG000|NOT COMPLETED|First Intervention||0
9696327|NCT00828321|10795339|FG001|NOT COMPLETED|First Intervention||0
9696328|NCT00828321|10795338|FG000|STARTED|Washout of 42 Days||20
9696329|NCT00828321|10795339|FG001|STARTED|Washout of 42 Days||20
9696330|NCT00828321|10795338|FG000|COMPLETED|Washout of 42 Days||18
9696331|NCT00828321|10795339|FG001|COMPLETED|Washout of 42 Days||20
9696332|NCT00828321|10795338|FG000|NOT COMPLETED|Washout of 42 Days||2
9696333|NCT00828321|10795339|FG001|NOT COMPLETED|Washout of 42 Days||0
9696334|NCT00828321|10795338|FG000|STARTED|Second Intervention||18
9696335|NCT00828321|10795339|FG001|STARTED|Second Intervention||20
9696336|NCT00828321|10795338|FG000|COMPLETED|Second Intervention||18
9696337|NCT00828321|10795339|FG001|COMPLETED|Second Intervention||19
9696338|NCT00828321|10795338|FG000|NOT COMPLETED|Second Intervention||0
9696339|NCT00828321|10795339|FG001|NOT COMPLETED|Second Intervention||1
9727143|NCT00105157|10826688|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
9727144|NCT00105157|10826689|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
9727145|NCT00105157|10826690|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
9727146|NCT00105157|10826691|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
9727147|NCT00105183|10826702|FG000|STARTED|Overall Study|Randomized|82
9727148|NCT00105183|10826703|FG001|STARTED|Overall Study|Randomized|79
9727149|NCT00105183|10826704|FG002|STARTED|Overall Study|Randomized|62
9727150|NCT00105183|10826702|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60
9727151|NCT00105183|10826703|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60
9727152|NCT00105183|10826704|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39
9727153|NCT00105183|10826702|FG000|NOT COMPLETED|Overall Study||22
9727154|NCT00105183|10826703|FG001|NOT COMPLETED|Overall Study||19
9727155|NCT00105183|10826704|FG002|NOT COMPLETED|Overall Study||23
9727156|NCT00105196|10826714|FG000|STARTED|Overall Study||177
9727157|NCT00105196|10826715|FG001|STARTED|Overall Study||172
9727158|NCT00105196|10826714|FG000|COMPLETED|Overall Study||147
9727159|NCT00105196|10826715|FG001|COMPLETED|Overall Study||149
9727160|NCT00105196|10826714|FG000|NOT COMPLETED|Overall Study||30
9727161|NCT00105196|10826715|FG001|NOT COMPLETED|Overall Study||23
9727162|NCT00105235|10826721|FG000|STARTED|Overall Study||27
9727163|NCT00105235|10826721|FG000|COMPLETED|Overall Study||20
9727164|NCT00105235|10826721|FG000|NOT COMPLETED|Overall Study||7
9727165|NCT00105443|10826731|FG000|STARTED|Double-Blind Treatment||242
9727166|NCT00105443|10826732|FG001|STARTED|Double-Blind Treatment||57
9727167|NCT00105443|10826733|FG002|STARTED|Double-Blind Treatment||256
9727168|NCT00105443|10826734|FG003|STARTED|Double-Blind Treatment||47
9727169|NCT00105443|10826731|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
9727170|NCT00105443|10826732|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
9727171|NCT00105443|10826733|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
10026004|NCT01875978|11150136|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
10026005|NCT01875978|11150135|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
10026006|NCT01875978|11150136|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
10026007|NCT01875978|11150135|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
9696340|NCT00806403|10795345|FG000|STARTED|Overall Study||104
9696341|NCT00806403|10795346|FG001|STARTED|Overall Study||101
9696342|NCT00806403|10795345|FG000|COMPLETED|Overall Study||100
9696343|NCT00806403|10795346|FG001|COMPLETED|Overall Study||98
9696344|NCT00806403|10795345|FG000|NOT COMPLETED|Overall Study||4
9696345|NCT00806403|10795346|FG001|NOT COMPLETED|Overall Study||3
9696346|NCT00803517|10795352|FG000|STARTED|Overall Study||12
9696347|NCT00803517|10795353|FG001|STARTED|Overall Study||12
9696348|NCT00803517|10795352|FG000|COMPLETED|Overall Study||12
9696349|NCT00803517|10795353|FG001|COMPLETED|Overall Study||12
9696350|NCT00803517|10795352|FG000|NOT COMPLETED|Overall Study||0
9696351|NCT00803517|10795353|FG001|NOT COMPLETED|Overall Study||0
9696352|NCT00803413|10795361|FG000|STARTED|Overall Period||28
9696353|NCT00803413|10795362|FG001|STARTED|Overall Period||32
9696354|NCT00803413|10795363|FG002|STARTED|Overall Period||29
9696355|NCT00803413|10795364|FG003|STARTED|Overall Period||30
9696356|NCT00803413|10795361|FG000|COMPLETED|Overall Period||28
9696357|NCT00803413|10795362|FG001|COMPLETED|Overall Period||32
9696358|NCT00803413|10795363|FG002|COMPLETED|Overall Period||29
9696359|NCT00803413|10795364|FG003|COMPLETED|Overall Period||30
9696360|NCT00803413|10795361|FG000|NOT COMPLETED|Overall Period||0
9696361|NCT00803413|10795362|FG001|NOT COMPLETED|Overall Period||0
9696362|NCT00803413|10795363|FG002|NOT COMPLETED|Overall Period||0
9696363|NCT00803413|10795364|FG003|NOT COMPLETED|Overall Period||0
9696364|NCT00803114|10795372|FG000|STARTED|Overall Study||113
9696365|NCT00803114|10795373|FG001|STARTED|Overall Study||115
9696366|NCT00803114|10795372|FG000|COMPLETED|Overall Study||113
9696367|NCT00803114|10795373|FG001|COMPLETED|Overall Study||115
9696368|NCT00803114|10795372|FG000|NOT COMPLETED|Overall Study||0
9696369|NCT00803114|10795373|FG001|NOT COMPLETED|Overall Study||0
9696370|NCT00799292|10795379|FG000|STARTED|Overall Study||29
9696371|NCT00799292|10795380|FG001|STARTED|Overall Study||29
9696372|NCT00799292|10795379|FG000|COMPLETED|Overall Study||29
9696373|NCT00799292|10795380|FG001|COMPLETED|Overall Study||29
9696374|NCT00799292|10795379|FG000|NOT COMPLETED|Overall Study||0
9696375|NCT00799292|10795380|FG001|NOT COMPLETED|Overall Study||0
9696376|NCT00796523|10795386|FG000|STARTED|Overall Study||27
9696377|NCT00796523|10795387|FG001|STARTED|Overall Study||24
9696378|NCT00796523|10795386|FG000|COMPLETED|Overall Study||18
9696379|NCT00796523|10795387|FG001|COMPLETED|Overall Study||17
9696380|NCT00796523|10795386|FG000|NOT COMPLETED|Overall Study||9
9696381|NCT00796523|10795387|FG001|NOT COMPLETED|Overall Study||7
9696382|NCT00794924|10795393|FG000|STARTED|Overall Study|14 patients refused to start the study|174
9696383|NCT00794924|10795394|FG001|STARTED|Overall Study|14 patients refused to start the study|171
9696384|NCT00794924|10795393|FG000|COMPLETED|Overall Study||114
9696385|NCT00794924|10795394|FG001|COMPLETED|Overall Study||101
9696386|NCT00794924|10795393|FG000|NOT COMPLETED|Overall Study||60
9696387|NCT00794924|10795394|FG001|NOT COMPLETED|Overall Study||70
9696388|NCT00794677|10795400|FG000|STARTED|First Intervention||13
9696389|NCT00794677|10795401|FG001|STARTED|First Intervention||13
9696390|NCT00794677|10795400|FG000|COMPLETED|First Intervention||11
9696391|NCT00794677|10795401|FG001|COMPLETED|First Intervention||13
9696392|NCT00794677|10795400|FG000|NOT COMPLETED|First Intervention||2
9696393|NCT00794677|10795401|FG001|NOT COMPLETED|First Intervention||0
9696394|NCT00794677|10795400|FG000|STARTED|Second Intervention||11
9696395|NCT00794677|10795401|FG001|STARTED|Second Intervention||13
9696396|NCT00794677|10795400|FG000|COMPLETED|Second Intervention||11
9696397|NCT00794677|10795401|FG001|COMPLETED|Second Intervention||13
9696398|NCT00794677|10795400|FG000|NOT COMPLETED|Second Intervention||0
10026008|NCT01875978|11150136|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
10026009|NCT01875991|11150146|FG000|STARTED|Overall Study||108
9696399|NCT00794677|10795401|FG001|NOT COMPLETED|Second Intervention||0
9696400|NCT00792116|10795407|FG000|STARTED|Overall Study||53
9696401|NCT00792116|10795408|FG001|STARTED|Overall Study||55
9696402|NCT00792116|10795407|FG000|COMPLETED|Overall Study||52
9696403|NCT00792116|10795408|FG001|COMPLETED|Overall Study||54
9696404|NCT00792116|10795407|FG000|NOT COMPLETED|Overall Study||1
9696405|NCT00792116|10795408|FG001|NOT COMPLETED|Overall Study||1
9727172|NCT00105443|10826734|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
9727173|NCT00105443|10826731|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
9727174|NCT00105443|10826732|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
9727175|NCT00105443|10826733|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
9727176|NCT00105443|10826734|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
9727177|NCT00105443|10826731|FG000|NOT COMPLETED|Double-Blind Treatment||14
9727178|NCT00105443|10826732|FG001|NOT COMPLETED|Double-Blind Treatment||0
9727179|NCT00105443|10826733|FG002|NOT COMPLETED|Double-Blind Treatment||11
9727180|NCT00105443|10826734|FG003|NOT COMPLETED|Double-Blind Treatment||0
9727181|NCT00105443|10826731|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
9727182|NCT00105443|10826732|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
9727183|NCT00105443|10826733|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
9727184|NCT00105443|10826734|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
9727185|NCT00105443|10826731|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
9727186|NCT00105443|10826732|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
10026010|NCT01875991|11150147|FG001|STARTED|Overall Study||109
9727187|NCT00105443|10826733|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
10026011|NCT01875991|11150146|FG000|Received Etanercept in Period 1|Overall Study||108
10026012|NCT01875991|11150147|FG001|Received Etanercept in Period 1|Overall Study||108
10026013|NCT01875991|11150146|FG000|Received Etanercept in Period 2|Overall Study||102
10026014|NCT01875991|11150147|FG001|Received Etanercept in Period 2|Overall Study||103
10026015|NCT01875991|11150146|FG000|COMPLETED|Overall Study||101
10026016|NCT01875991|11150147|FG001|COMPLETED|Overall Study||103
10026017|NCT01875991|11150146|FG000|NOT COMPLETED|Overall Study||7
10026018|NCT01875991|11150147|FG001|NOT COMPLETED|Overall Study||6
10026019|NCT01876043|11150156|FG000|STARTED|Overall Study||24
9696406|NCT00758563|10795414|FG000|STARTED|Overall Study||7
9696407|NCT00758563|10795415|FG001|STARTED|Overall Study||8
10026020|NCT01876043|11150156|FG000|Interim Analysis Population|Overall Study||17
9696408|NCT00758563|10795414|FG000|COMPLETED|Overall Study||7
9696409|NCT00758563|10795415|FG001|COMPLETED|Overall Study||8
9696410|NCT00758563|10795414|FG000|NOT COMPLETED|Overall Study||0
9696411|NCT00758563|10795415|FG001|NOT COMPLETED|Overall Study||0
9696412|NCT00758290|10795421|FG000|STARTED|Overall Study||11
9696413|NCT00758290|10795422|FG001|STARTED|Overall Study||12
9696414|NCT00758290|10795421|FG000|COMPLETED|Overall Study||11
9696415|NCT00758290|10795422|FG001|COMPLETED|Overall Study||12
9696416|NCT00758290|10795421|FG000|NOT COMPLETED|Overall Study||0
9696417|NCT00758290|10795422|FG001|NOT COMPLETED|Overall Study||0
9696418|NCT00756574|10795428|FG000|STARTED|Overall Study||225
9696419|NCT00756574|10795429|FG001|STARTED|Overall Study||221
9696420|NCT00756574|10795428|FG000|COMPLETED|Overall Study||212
9696421|NCT00756574|10795429|FG001|COMPLETED|Overall Study||210
9696422|NCT00756574|10795428|FG000|NOT COMPLETED|Overall Study||13
9696423|NCT00756574|10795429|FG001|NOT COMPLETED|Overall Study||11
9696424|NCT00740727|10795433|FG000|STARTED|Overall Study||18
9696425|NCT00740727|10795433|FG000|COMPLETED|Overall Study||18
9696426|NCT00740727|10795433|FG000|NOT COMPLETED|Overall Study||0
9696427|NCT00740480|10795436|FG000|STARTED|Overall Study||25
9696428|NCT00740480|10795436|FG000|COMPLETED|Overall Study||23
9696429|NCT00740480|10795436|FG000|NOT COMPLETED|Overall Study||2
9696430|NCT00724698|10795439|FG000|STARTED|Overall Study||3011
9696431|NCT00724698|10795439|FG000|COMPLETED|Overall Study||2921
9696432|NCT00724698|10795439|FG000|NOT COMPLETED|Overall Study||90
9696433|NCT00711555|10795442|FG000|STARTED|Overall Study||22
9696434|NCT00711555|10795442|FG000|COMPLETED|Overall Study||19
9696435|NCT00711555|10795442|FG000|NOT COMPLETED|Overall Study||3
9727188|NCT00105443|10826734|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
9727189|NCT00105443|10826731|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
9727190|NCT00105443|10826732|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
9727191|NCT00105443|10826733|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
9727192|NCT00105443|10826734|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
9727193|NCT00105443|10826731|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
9727194|NCT00105443|10826732|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
9696436|NCT00676494|10795445|FG000|STARTED|Overall Study||172
9696437|NCT00676494|10795445|FG000|COMPLETED|Overall Study||158
9696438|NCT00676494|10795445|FG000|NOT COMPLETED|Overall Study||14
9696439|NCT00662389|10795448|FG000|STARTED|Overall Study||4
9696440|NCT00662389|10795448|FG000|COMPLETED|Overall Study||4
9696441|NCT00662389|10795448|FG000|NOT COMPLETED|Overall Study||0
9727195|NCT00105443|10826733|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
9727196|NCT00105443|10826734|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
9727197|NCT00105443|10826731|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0
9727198|NCT00105443|10826732|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
9727199|NCT00105443|10826733|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0
9727200|NCT00105443|10826734|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
9727201|NCT00105443|10826731|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
9727202|NCT00105443|10826732|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
9727203|NCT00105443|10826733|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
9727204|NCT00105443|10826734|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
9727205|NCT00105469|10826745|FG000|STARTED|Overall Study||365
9727206|NCT00105469|10826746|FG001|STARTED|Overall Study||378
9727207|NCT00105469|10826745|FG000|COMPLETED|Overall Study||343
9727208|NCT00105469|10826746|FG001|COMPLETED|Overall Study||367
9727209|NCT00105469|10826745|FG000|NOT COMPLETED|Overall Study||22
9727210|NCT00105469|10826746|FG001|NOT COMPLETED|Overall Study||11
9727211|NCT00105482|10826754|FG000|STARTED|Overall Study||87
9727212|NCT00105482|10826755|FG001|STARTED|Overall Study||85
9727213|NCT00105482|10826754|FG000|COMPLETED|Overall Study||28
9727214|NCT00105482|10826755|FG001|COMPLETED|Overall Study||30
9727215|NCT00105482|10826754|FG000|NOT COMPLETED|Overall Study||59
9727216|NCT00105482|10826755|FG001|NOT COMPLETED|Overall Study||55
9727217|NCT00105508|10826763|FG000|STARTED|Overall Study||253
9727218|NCT00105508|10826764|FG001|STARTED|Overall Study||253
9727219|NCT00105508|10826763|FG000|COMPLETED|Overall Study||213
9727220|NCT00105508|10826764|FG001|COMPLETED|Overall Study||217
9727221|NCT00105508|10826763|FG000|NOT COMPLETED|Overall Study||40
9727222|NCT00105508|10826764|FG001|NOT COMPLETED|Overall Study||36
9727223|NCT00105521|10826774|FG000|STARTED|Overall Study||98
9727224|NCT00105521|10826775|FG001|STARTED|Overall Study||101
9727225|NCT00105521|10826776|FG002|STARTED|Overall Study||97
9727226|NCT00105521|10826777|FG003|STARTED|Overall Study||102
9727227|NCT00105521|10826774|FG000|COMPLETED|Overall Study||83
9727228|NCT00105521|10826775|FG001|COMPLETED|Overall Study||90
9727229|NCT00105521|10826776|FG002|COMPLETED|Overall Study||80
9727230|NCT00105521|10826777|FG003|COMPLETED|Overall Study||85
9727231|NCT00105521|10826774|FG000|NOT COMPLETED|Overall Study||15
9727232|NCT00105521|10826775|FG001|NOT COMPLETED|Overall Study||11
9727233|NCT00105521|10826776|FG002|NOT COMPLETED|Overall Study||17
9727234|NCT00105521|10826777|FG003|NOT COMPLETED|Overall Study||17
9727235|NCT00105534|10826789|FG000|STARTED|Overall Study||335
9727236|NCT00105534|10826790|FG001|STARTED|Overall Study||350
9727237|NCT00105534|10826789|FG000|COMPLETED|Overall Study||313
9727238|NCT00105534|10826790|FG001|COMPLETED|Overall Study||317
9727239|NCT00105534|10826789|FG000|NOT COMPLETED|Overall Study||22
9727240|NCT00105534|10826790|FG001|NOT COMPLETED|Overall Study||33
9847506|NCT00854113|10960048|FG003|STARTED|Overall Study||6
9847507|NCT00854113|10960049|FG004|STARTED|Overall Study||6
9847508|NCT00854113|10960050|FG005|STARTED|Overall Study||6
9847509|NCT00854113|10960051|FG006|STARTED|Overall Study||12
9847510|NCT00854113|10960052|FG007|STARTED|Overall Study||8
9847511|NCT00854113|10960053|FG008|STARTED|Overall Study||8
9961698|NCT01474512|11081383|FG007|Received Study Drug|Maintenance Period||391
9961699|NCT01474512|11081384|FG008|Received Study Drug|Maintenance Period||78
9961700|NCT01474512|11081385|FG009|Received Study Drug|Maintenance Period||62
9727241|NCT00105586|10826798|FG000|STARTED|Overall Study||92
9727242|NCT00105586|10826799|FG001|STARTED|Overall Study||85
9727243|NCT00105586|10826798|FG000|COMPLETED|Overall Study||75
9727244|NCT00105586|10826799|FG001|COMPLETED|Overall Study||69
9696442|NCT00659061|10795453|FG000|STARTED|Overall Study||308
9696443|NCT00659061|10795454|FG001|STARTED|Overall Study||302
9696444|NCT00659061|10795453|FG000|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
9696445|NCT00659061|10795454|FG001|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
9696446|NCT00659061|10795453|FG000|NOT COMPLETED|Overall Study||21
9696447|NCT00659061|10795454|FG001|NOT COMPLETED|Overall Study||15
9961701|NCT01474512|11081386|FG010|Received Study Drug|Maintenance Period||0
9961702|NCT01474512|11081387|FG011|Received Study Drug|Maintenance Period||0
9961703|NCT01474512|11081388|FG012|Received Study Drug|Maintenance Period||0
9961704|NCT01474512|11081389|FG013|Received Study Drug|Maintenance Period||0
9961705|NCT01474512|11081390|FG014|Received Study Drug|Maintenance Period||0
9961706|NCT01474512|11081391|FG015|Received Study Drug|Maintenance Period||0
9961707|NCT01474512|11081392|FG016|Received Study Drug|Maintenance Period||0
9961708|NCT01474512|11081393|FG017|Received Study Drug|Maintenance Period||0
9961709|NCT01474512|11081376|FG000|Relapsed Population Received Drug|Maintenance Period||0
9961710|NCT01474512|11081377|FG001|Relapsed Population Received Drug|Maintenance Period||0
9961711|NCT01474512|11081378|FG002|Relapsed Population Received Drug|Maintenance Period||0
9961712|NCT01474512|11081379|FG003|Relapsed Population Received Drug|Maintenance Period||0
9961713|NCT01474512|11081380|FG004|Relapsed Population Received Drug|Maintenance Period||0
9961714|NCT01474512|11081381|FG005|Relapsed Population Received Drug|Maintenance Period||0
9967751|NCT01516008|11088085|FG000|COMPLETED|Overall Study||69
9967752|NCT01516008|11088086|FG001|COMPLETED|Overall Study||105
9967753|NCT01516008|11088087|FG002|COMPLETED|Overall Study||99
9967754|NCT01516008|11088085|FG000|NOT COMPLETED|Overall Study||45
9967755|NCT01516008|11088086|FG001|NOT COMPLETED|Overall Study||16
9967756|NCT01516008|11088087|FG002|NOT COMPLETED|Overall Study||18
9696448|NCT00654992|10795460|FG000|STARTED|Overall Study||36
9967757|NCT01516268|11088097|FG000|STARTED|Overall Study||25
10026021|NCT01876043|11150156|FG000|COMPLETED|Overall Study||22
10026022|NCT01876043|11150156|FG000|NOT COMPLETED|Overall Study||2
10026023|NCT01876082|11150162|FG000|STARTED|Overall Study||48
10026024|NCT01876082|11150163|FG001|STARTED|Overall Study||24
10026025|NCT01876082|11150162|FG000|Safety Population|Overall Study||48
10026026|NCT01876082|11150163|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22
10026027|NCT01876082|11150162|FG000|COMPLETED|Overall Study||46
10026028|NCT01876082|11150163|FG001|COMPLETED|Overall Study||20
10114841|NCT02520284|11245634|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
10114842|NCT02520284|11245635|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
10114843|NCT02520284|11245636|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
10114844|NCT02520284|11245634|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
10114845|NCT02520284|11245635|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
10114846|NCT02520284|11245636|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
10026029|NCT01876082|11150162|FG000|NOT COMPLETED|Overall Study||2
10026030|NCT01876082|11150163|FG001|NOT COMPLETED|Overall Study||4
10026031|NCT01876212|11150171|FG000|STARTED|Overall Study||9
9696449|NCT00654992|10795461|FG001|STARTED|Overall Study||35
9696450|NCT00654992|10795460|FG000|COMPLETED|Overall Study||36
9696451|NCT00654992|10795461|FG001|COMPLETED|Overall Study||35
9696452|NCT00654992|10795460|FG000|NOT COMPLETED|Overall Study||0
9696453|NCT00654992|10795461|FG001|NOT COMPLETED|Overall Study||0
9727245|NCT00105586|10826798|FG000|NOT COMPLETED|Overall Study||17
9727246|NCT00105586|10826799|FG001|NOT COMPLETED|Overall Study||16
10026032|NCT01876212|11150172|FG001|STARTED|Overall Study||6
10026033|NCT01876212|11150171|FG000|COMPLETED|Overall Study||9
10026034|NCT01876212|11150172|FG001|COMPLETED|Overall Study||6
10026035|NCT01876212|11150171|FG000|NOT COMPLETED|Overall Study||0
10026036|NCT01876212|11150172|FG001|NOT COMPLETED|Overall Study||0
10026037|NCT01876251|11150181|FG000|STARTED|Overall Study||15
10026038|NCT01876251|11150182|FG001|STARTED|Overall Study||3
10026039|NCT01876251|11150183|FG002|STARTED|Overall Study||11
10026040|NCT01876251|11150181|FG000|COMPLETED|Overall Study||0
10026041|NCT01876251|11150182|FG001|COMPLETED|Overall Study||0
10026042|NCT01876251|11150183|FG002|COMPLETED|Overall Study||0
9727247|NCT00105989|10826807|FG000|STARTED|Acute - Open Label: Week 0-10||514
9727248|NCT00105989|10826808|FG001|STARTED|Acute - Open Label: Week 0-10||0
9727249|NCT00105989|10826807|FG000|COMPLETED|Acute - Open Label: Week 0-10||413
9727250|NCT00105989|10826808|FG001|COMPLETED|Acute - Open Label: Week 0-10||0
9727251|NCT00105989|10826807|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101
9727252|NCT00105989|10826808|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0
9727253|NCT00105989|10826807|FG000|STARTED|Continuation - Open Label:Week 10-34||413
9727254|NCT00105989|10826808|FG001|STARTED|Continuation - Open Label:Week 10-34||0
9727255|NCT00105989|10826807|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288
9727256|NCT00105989|10826808|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0
9727257|NCT00105989|10826807|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
9727258|NCT00105989|10826808|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
10026043|NCT01876251|11150181|FG000|NOT COMPLETED|Overall Study||15
10026044|NCT01876251|11150182|FG001|NOT COMPLETED|Overall Study||3
10026045|NCT01876251|11150183|FG002|NOT COMPLETED|Overall Study||11
9696454|NCT00581477|10795465|FG000|STARTED|Overall Study|8 patients were enrolled|8
9696455|NCT00581477|10795465|FG000|Dose Selection Trial With Droxidopa|Overall Study|2 patients had been treated with droxidopa prior to enrollment and their data is not included. Since droxidopa restores the norepinephrine that is absent in untreated patients with DBH deficiency, we present only the results for naive patients.|6
9696456|NCT00581477|10795465|FG000|Droxidopa 25 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 25 mg of Droxidopa.|6
9696457|NCT00581477|10795465|FG000|Droxidopa 50 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 50 mg of Droxidopa.|6
9696458|NCT00581477|10795465|FG000|Droxidopa 100 mg|Overall Study|Because dosing was individualized for the participants, only 4 of the 6 patients were administered 100 mg of Droxidopa.|6
9961715|NCT01474512|11081382|FG006|Relapsed Population Received Drug|Maintenance Period||0
9961716|NCT01474512|11081383|FG007|Relapsed Population Received Drug|Maintenance Period||0
9961717|NCT01474512|11081384|FG008|Relapsed Population Received Drug|Maintenance Period||0
9961718|NCT01474512|11081385|FG009|Relapsed Population Received Drug|Maintenance Period||0
9961719|NCT01474512|11081386|FG010|Relapsed Population Received Drug|Maintenance Period||348
9961720|NCT01474512|11081387|FG011|Relapsed Population Received Drug|Maintenance Period||0
9961721|NCT01474512|11081388|FG012|Relapsed Population Received Drug|Maintenance Period||0
10026046|NCT01876329|11150195|FG000|STARTED|Overall Study||45
10026047|NCT01876329|11150196|FG001|STARTED|Overall Study||36
10026048|NCT01876329|11150197|FG002|STARTED|Overall Study||44
10026049|NCT01876329|11150195|FG000|COMPLETED|Overall Study||45
10026050|NCT01876329|11150196|FG001|COMPLETED|Overall Study||36
10026051|NCT01876329|11150197|FG002|COMPLETED|Overall Study||44
10026052|NCT01876329|11150195|FG000|NOT COMPLETED|Overall Study||0
10026053|NCT01876329|11150196|FG001|NOT COMPLETED|Overall Study||0
10026054|NCT01876329|11150197|FG002|NOT COMPLETED|Overall Study||0
10026055|NCT01876368|11150207|FG000|STARTED|Overall Study||188
10026056|NCT01876368|11150208|FG001|STARTED|Overall Study||188
10026057|NCT01876368|11150207|FG000|Full Analysis Set (FAS)|Overall Study||188
10026058|NCT01876368|11150208|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
10026059|NCT01876368|11150207|FG000|Safety Set (SAF)|Overall Study||188
10026060|NCT01876368|11150208|FG001|Safety Set (SAF)|Overall Study||187
10026061|NCT01876368|11150207|FG000|COMPLETED|Overall Study||179
10026062|NCT01876368|11150208|FG001|COMPLETED|Overall Study||175
10026063|NCT01876368|11150207|FG000|NOT COMPLETED|Overall Study||9
10026064|NCT01876368|11150208|FG001|NOT COMPLETED|Overall Study||13
10026065|NCT01876381|11150214|FG000|STARTED|Overall Study||23
10026066|NCT01876381|11150214|FG000|COMPLETED|Overall Study||16
10026067|NCT01876381|11150214|FG000|NOT COMPLETED|Overall Study||7
10026068|NCT01876420|11150218|FG000|STARTED|Overall Study||60
10026069|NCT01876420|11150218|FG000|COMPLETED|Overall Study||59
10026070|NCT01876420|11150218|FG000|NOT COMPLETED|Overall Study||1
10026071|NCT01876446|11150224|FG000|STARTED|Overall Study||20
10026072|NCT01876446|11150225|FG001|STARTED|Overall Study||18
10026073|NCT01876446|11150224|FG000|COMPLETED|Overall Study||18
10026074|NCT01876446|11150225|FG001|COMPLETED|Overall Study||12
10026075|NCT01876446|11150224|FG000|NOT COMPLETED|Overall Study||2
10026076|NCT01876446|11150225|FG001|NOT COMPLETED|Overall Study||6
10026077|NCT01876485|11150233|FG000|STARTED|Overall Study||140
10026078|NCT01876485|11150234|FG001|STARTED|Overall Study||140
10026079|NCT01876485|11150233|FG000|Post-Intervention|Overall Study||125
9696459|NCT00581477|10795465|FG000|Droxidopa 200 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 200 mg of Droxidopa.|6
9696460|NCT00581477|10795465|FG000|Droxidopa 250 mg|Overall Study|Because dosing was individualized for the participants, only 2 of the 6 patients were administered 250 mg of Droxidopa.|6
9696461|NCT00581477|10795465|FG000|Droxidopa 300 mg|Overall Study|Because dosing was individualized for the participants, only 1 of the 6 patients was administered 300 mg of Droxidopa.|6
9696462|NCT00581477|10795465|FG000|COMPLETED|Overall Study||6
9696463|NCT00581477|10795465|FG000|NOT COMPLETED|Overall Study||2
9727259|NCT00105989|10826807|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146
9727260|NCT00105989|10826808|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142
9727261|NCT00105989|10826807|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
9727262|NCT00105989|10826808|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
9727263|NCT00105989|10826807|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
9727264|NCT00105989|10826808|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
9727265|NCT00106002|10826824|FG000|STARTED|Overall Study||37
9727266|NCT00106002|10826824|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
9727267|NCT00106002|10826824|FG000|NOT COMPLETED|Overall Study||2
9727268|NCT00106028|10826830|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
9727269|NCT00106028|10826831|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
9727270|NCT00106028|10826830|FG000|Month 12 Completed/Started Open Label|Overall Study||49
9727271|NCT00106028|10826831|FG001|Month 12 Completed/Started Open Label|Overall Study||87
9727272|NCT00106028|10826830|FG000|COMPLETED|Overall Study|Completed Month 36|43
9727273|NCT00106028|10826831|FG001|COMPLETED|Overall Study|Completed Month 36|82
9727274|NCT00106028|10826830|FG000|NOT COMPLETED|Overall Study||6
9727275|NCT00106028|10826831|FG001|NOT COMPLETED|Overall Study||12
9727276|NCT00106080|10826841|FG000|STARTED|Overall Study||194
9727277|NCT00106080|10826842|FG001|STARTED|Overall Study||182
9727278|NCT00106080|10826841|FG000|COMPLETED|Overall Study||151
9727279|NCT00106080|10826842|FG001|COMPLETED|Overall Study||155
9727280|NCT00106080|10826841|FG000|NOT COMPLETED|Overall Study||43
9727281|NCT00106080|10826842|FG001|NOT COMPLETED|Overall Study||27
9727282|NCT00106106|10826850|FG000|STARTED|Overall Study||26
9727283|NCT00106106|10826851|FG001|STARTED|Overall Study||23
9727284|NCT00106106|10826850|FG000|Completed Both MRS Scans|Overall Study||18
9727285|NCT00106106|10826851|FG001|Completed Both MRS Scans|Overall Study||15
9727286|NCT00106106|10826850|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
9727287|NCT00106106|10826851|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
9727288|NCT00106106|10826850|FG000|NOT COMPLETED|Overall Study||4
9727289|NCT00106106|10826851|FG001|NOT COMPLETED|Overall Study||4
9727290|NCT00106119|10826857|FG000|STARTED|First Intervention||7
9727291|NCT00106119|10826858|FG001|STARTED|First Intervention||7
9727292|NCT00106119|10826857|FG000|COMPLETED|First Intervention||7
9727293|NCT00106119|10826858|FG001|COMPLETED|First Intervention||7
9727294|NCT00106119|10826857|FG000|NOT COMPLETED|First Intervention||0
9727295|NCT00106119|10826858|FG001|NOT COMPLETED|First Intervention||0
9727296|NCT00106119|10826857|FG000|STARTED|Washout Period of 30 Days||7
9727297|NCT00106119|10826858|FG001|STARTED|Washout Period of 30 Days||7
9727298|NCT00106119|10826857|FG000|COMPLETED|Washout Period of 30 Days||7
9727299|NCT00106119|10826858|FG001|COMPLETED|Washout Period of 30 Days||7
9727300|NCT00106119|10826857|FG000|NOT COMPLETED|Washout Period of 30 Days||0
9727301|NCT00106119|10826858|FG001|NOT COMPLETED|Washout Period of 30 Days||0
9727302|NCT00106119|10826857|FG000|STARTED|Second Intervention||7
10026080|NCT01876485|11150234|FG001|Post-Intervention|Overall Study||129
10026081|NCT01876485|11150233|FG000|Maintenance|Overall Study||116
10026082|NCT01876485|11150234|FG001|Maintenance|Overall Study||114
9696464|NCT00554294|10795481|FG000|STARTED|Overall Study||1469
9696465|NCT00554294|10795482|FG001|STARTED|Overall Study||1721
9696466|NCT00554294|10795481|FG000|COMPLETED|Overall Study||1309
9696467|NCT00554294|10795482|FG001|COMPLETED|Overall Study||1641
9696468|NCT00554294|10795481|FG000|NOT COMPLETED|Overall Study||160
9696469|NCT00554294|10795482|FG001|NOT COMPLETED|Overall Study||80
9696470|NCT00554190|10795486|FG000|STARTED|Overall Study|29 subjects treated.|29
9696471|NCT00554190|10795486|FG000|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
9696472|NCT00554190|10795486|FG000|NOT COMPLETED|Overall Study||10
9696473|NCT00546273|10795495|FG000|STARTED|I||4
9696474|NCT00546273|10795496|FG001|STARTED|I||0
9696475|NCT00546273|10795497|FG002|STARTED|I||0
9696476|NCT00546273|10795498|FG003|STARTED|I||0
9696477|NCT00546273|10795499|FG004|STARTED|I||2
9696478|NCT00546273|10795495|FG000|COMPLETED|I||4
9696479|NCT00546273|10795496|FG001|COMPLETED|I||0
9696480|NCT00546273|10795497|FG002|COMPLETED|I||0
9696481|NCT00546273|10795498|FG003|COMPLETED|I||0
9696482|NCT00546273|10795499|FG004|COMPLETED|I||2
9696483|NCT00546273|10795495|FG000|NOT COMPLETED|I||0
9696484|NCT00546273|10795496|FG001|NOT COMPLETED|I||0
9696485|NCT00546273|10795497|FG002|NOT COMPLETED|I||0
9696486|NCT00546273|10795498|FG003|NOT COMPLETED|I||0
9696487|NCT00546273|10795499|FG004|NOT COMPLETED|I||0
9696488|NCT00546273|10795495|FG000|STARTED|II||0
9696489|NCT00546273|10795496|FG001|STARTED|II||4
9696490|NCT00546273|10795497|FG002|STARTED|II||0
9696491|NCT00546273|10795498|FG003|STARTED|II||0
9696492|NCT00546273|10795499|FG004|STARTED|II||2
9696493|NCT00546273|10795495|FG000|COMPLETED|II||0
9696494|NCT00546273|10795496|FG001|COMPLETED|II||4
9696495|NCT00546273|10795497|FG002|COMPLETED|II||0
9696496|NCT00546273|10795498|FG003|COMPLETED|II||0
9696497|NCT00546273|10795499|FG004|COMPLETED|II||2
9696498|NCT00546273|10795495|FG000|NOT COMPLETED|II||0
9696499|NCT00546273|10795496|FG001|NOT COMPLETED|II||0
9696500|NCT00546273|10795497|FG002|NOT COMPLETED|II||0
9696501|NCT00546273|10795498|FG003|NOT COMPLETED|II||0
9696502|NCT00546273|10795499|FG004|NOT COMPLETED|II||0
9696503|NCT00546273|10795495|FG000|STARTED|III||0
9696504|NCT00546273|10795496|FG001|STARTED|III||0
9696505|NCT00546273|10795497|FG002|STARTED|III||4
9696506|NCT00546273|10795498|FG003|STARTED|III||0
9696507|NCT00546273|10795499|FG004|STARTED|III||2
9696508|NCT00546273|10795495|FG000|COMPLETED|III||0
9696509|NCT00546273|10795496|FG001|COMPLETED|III||0
9696510|NCT00546273|10795497|FG002|COMPLETED|III||4
9696511|NCT00546273|10795498|FG003|COMPLETED|III||0
9696512|NCT00546273|10795499|FG004|COMPLETED|III||2
9696513|NCT00546273|10795495|FG000|NOT COMPLETED|III||0
9696514|NCT00546273|10795496|FG001|NOT COMPLETED|III||0
9696515|NCT00546273|10795497|FG002|NOT COMPLETED|III||0
9696516|NCT00546273|10795498|FG003|NOT COMPLETED|III||0
9696517|NCT00546273|10795499|FG004|NOT COMPLETED|III||0
9696518|NCT00546273|10795495|FG000|STARTED|IV||0
9696519|NCT00546273|10795496|FG001|STARTED|IV||0
10026083|NCT01876485|11150233|FG000|COMPLETED|Overall Study||116
10026084|NCT01876485|11150234|FG001|COMPLETED|Overall Study||114
10026085|NCT01876485|11150233|FG000|NOT COMPLETED|Overall Study||24
9696520|NCT00546273|10795497|FG002|STARTED|IV||0
9696521|NCT00546273|10795498|FG003|STARTED|IV||4
9696522|NCT00546273|10795499|FG004|STARTED|IV||2
9696523|NCT00546273|10795495|FG000|COMPLETED|IV||0
9696524|NCT00546273|10795496|FG001|COMPLETED|IV||0
9696525|NCT00546273|10795497|FG002|COMPLETED|IV||0
9696526|NCT00546273|10795498|FG003|COMPLETED|IV||4
9696527|NCT00546273|10795499|FG004|COMPLETED|IV||2
9696528|NCT00546273|10795495|FG000|NOT COMPLETED|IV||0
9696529|NCT00546273|10795496|FG001|NOT COMPLETED|IV||0
9696530|NCT00546273|10795497|FG002|NOT COMPLETED|IV||0
9696531|NCT00546273|10795498|FG003|NOT COMPLETED|IV||0
9696532|NCT00546273|10795499|FG004|NOT COMPLETED|IV||0
9696533|NCT00529152|10795506|FG000|STARTED|Overall Study||100
9696534|NCT00529152|10795506|FG000|COMPLETED|Overall Study||95
9696535|NCT00529152|10795506|FG000|NOT COMPLETED|Overall Study||5
9696536|NCT00526227|10795509|FG000|STARTED|Overall Study||81
9696537|NCT00526227|10795509|FG000|COMPLETED|Overall Study||79
9696538|NCT00526227|10795509|FG000|NOT COMPLETED|Overall Study||2
9696539|NCT00513617|10795517|FG000|STARTED|Overall Study||36
9696540|NCT00513617|10795518|FG001|STARTED|Overall Study||35
9696541|NCT00513617|10795519|FG002|STARTED|Overall Study||38
9696542|NCT00513617|10795517|FG000|COMPLETED|Overall Study||25
9696543|NCT00513617|10795518|FG001|COMPLETED|Overall Study||25
10026086|NCT01876485|11150234|FG001|NOT COMPLETED|Overall Study||26
9696544|NCT00513617|10795519|FG002|COMPLETED|Overall Study||30
9696545|NCT00513617|10795517|FG000|NOT COMPLETED|Overall Study||11
9696546|NCT00513617|10795518|FG001|NOT COMPLETED|Overall Study||10
9696547|NCT00513617|10795519|FG002|NOT COMPLETED|Overall Study||8
9727303|NCT00106119|10826858|FG001|STARTED|Second Intervention||7
9727304|NCT00106119|10826857|FG000|COMPLETED|Second Intervention||7
9727305|NCT00106119|10826858|FG001|COMPLETED|Second Intervention||7
9727306|NCT00106119|10826857|FG000|NOT COMPLETED|Second Intervention||0
9727307|NCT00106119|10826858|FG001|NOT COMPLETED|Second Intervention||0
9727308|NCT00106184|10826866|FG000|STARTED|Overall Study||96
9727309|NCT00106184|10826867|FG001|STARTED|Overall Study||104
9727310|NCT00106184|10826866|FG000|Treated|Overall Study|96 subjects were randomized.|93
9727311|NCT00106184|10826867|FG001|Treated|Overall Study|104 subjects were randomized.|102
9727312|NCT00106184|10826866|FG000|COMPLETED|Overall Study||93
9727313|NCT00106184|10826867|FG001|COMPLETED|Overall Study||102
9727314|NCT00106184|10826866|FG000|NOT COMPLETED|Overall Study||3
9727315|NCT00106184|10826867|FG001|NOT COMPLETED|Overall Study||2
9727316|NCT00106249|10826877|FG000|STARTED|Overall Study||14
9727317|NCT00106249|10826878|FG001|STARTED|Overall Study||13
9727318|NCT00106249|10826877|FG000|COMPLETED|Overall Study||11
9727319|NCT00106249|10826878|FG001|COMPLETED|Overall Study||11
9727320|NCT00106249|10826877|FG000|NOT COMPLETED|Overall Study||3
9727321|NCT00106249|10826878|FG001|NOT COMPLETED|Overall Study||2
9727322|NCT00106353|10826886|FG000|STARTED|Part 1||4
9727323|NCT00106353|10826887|FG001|STARTED|Part 1||5
9727324|NCT00106353|10826888|FG002|STARTED|Part 1||3
9727325|NCT00106353|10826889|FG003|STARTED|Part 1||7
9727326|NCT00106353|10826890|FG004|STARTED|Part 1||0
9727327|NCT00106353|10826891|FG005|STARTED|Part 1||0
9727328|NCT00106353|10826892|FG006|STARTED|Part 1||0
9727329|NCT00106353|10826886|FG000|COMPLETED|Part 1||0
9727330|NCT00106353|10826887|FG001|COMPLETED|Part 1||0
9727331|NCT00106353|10826888|FG002|COMPLETED|Part 1||0
9727332|NCT00106353|10826889|FG003|COMPLETED|Part 1||0
9727333|NCT00106353|10826890|FG004|COMPLETED|Part 1||0
9727334|NCT00106353|10826891|FG005|COMPLETED|Part 1||0
9727335|NCT00106353|10826892|FG006|COMPLETED|Part 1||0
9727336|NCT00106353|10826886|FG000|NOT COMPLETED|Part 1||4
9727337|NCT00106353|10826887|FG001|NOT COMPLETED|Part 1||5
9727338|NCT00106353|10826888|FG002|NOT COMPLETED|Part 1||3
9727339|NCT00106353|10826889|FG003|NOT COMPLETED|Part 1||7
9727340|NCT00106353|10826890|FG004|NOT COMPLETED|Part 1||0
9727341|NCT00106353|10826891|FG005|NOT COMPLETED|Part 1||0
9727342|NCT00106353|10826892|FG006|NOT COMPLETED|Part 1||0
9727343|NCT00106353|10826886|FG000|STARTED|Part 2||0
9727344|NCT00106353|10826887|FG001|STARTED|Part 2||0
9727345|NCT00106353|10826888|FG002|STARTED|Part 2||0
9727346|NCT00106353|10826889|FG003|STARTED|Part 2||0
9727347|NCT00106353|10826890|FG004|STARTED|Part 2||17
9727348|NCT00106353|10826891|FG005|STARTED|Part 2||19
9727349|NCT00106353|10826892|FG006|STARTED|Part 2||16
9727350|NCT00106353|10826886|FG000|COMPLETED|Part 2||0
9727351|NCT00106353|10826887|FG001|COMPLETED|Part 2||0
9727352|NCT00106353|10826888|FG002|COMPLETED|Part 2||0
9727353|NCT00106353|10826889|FG003|COMPLETED|Part 2||0
9727354|NCT00106353|10826890|FG004|COMPLETED|Part 2||1
9727355|NCT00106353|10826891|FG005|COMPLETED|Part 2||1
9727356|NCT00106353|10826892|FG006|COMPLETED|Part 2||0
9727357|NCT00106353|10826886|FG000|NOT COMPLETED|Part 2||0
9727358|NCT00106353|10826887|FG001|NOT COMPLETED|Part 2||0
9727359|NCT00106353|10826888|FG002|NOT COMPLETED|Part 2||0
9727360|NCT00106353|10826889|FG003|NOT COMPLETED|Part 2||0
9727361|NCT00106353|10826890|FG004|NOT COMPLETED|Part 2||16
9727362|NCT00106353|10826891|FG005|NOT COMPLETED|Part 2||18
9727363|NCT00106353|10826892|FG006|NOT COMPLETED|Part 2||16
9727364|NCT00106392|10826915|FG000|STARTED|Overall Study||62
9727365|NCT00106392|10826916|FG001|STARTED|Overall Study||69
9727366|NCT00106392|10826915|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
9727367|NCT00106392|10826916|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
9727368|NCT00106392|10826915|FG000|Full Analysis Set (FAS)|Overall Study||53
9727369|NCT00106392|10826916|FG001|Full Analysis Set (FAS)|Overall Study||61
9727370|NCT00106392|10826915|FG000|COMPLETED|Overall Study||36
9727371|NCT00106392|10826916|FG001|COMPLETED|Overall Study||42
9727372|NCT00106392|10826915|FG000|NOT COMPLETED|Overall Study||26
9727373|NCT00106392|10826916|FG001|NOT COMPLETED|Overall Study||27
9727374|NCT00106431|10826922|FG000|STARTED|Overall Study||102
9727375|NCT00106431|10826922|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
9727376|NCT00106431|10826922|FG000|NOT COMPLETED|Overall Study||65
9727377|NCT00106535|10826929|FG000|STARTED|2-year Placebo Controlled Period||394
9727378|NCT00106535|10826930|FG001|STARTED|2-year Placebo Controlled Period||401
9847512|NCT00854113|10960054|FG009|STARTED|Overall Study||8
9847513|NCT00854113|10960055|FG010|STARTED|Overall Study||6
9847514|NCT00854113|10960045|FG000|COMPLETED|Overall Study||6
9847515|NCT00854113|10960046|FG001|COMPLETED|Overall Study||6
9847516|NCT00854113|10960047|FG002|COMPLETED|Overall Study||6
9847517|NCT00854113|10960048|FG003|COMPLETED|Overall Study||6
9847518|NCT00854113|10960049|FG004|COMPLETED|Overall Study||6
9847519|NCT00854113|10960050|FG005|COMPLETED|Overall Study||6
9696548|NCT00495222|10795524|FG000|STARTED|Overall Study||9
9696549|NCT00495222|10795524|FG000|COMPLETED|Overall Study||9
9696550|NCT00495222|10795524|FG000|NOT COMPLETED|Overall Study||0
9696551|NCT00495131|10795529|FG000|STARTED|Overall Study||154
9696552|NCT00495131|10795530|FG001|STARTED|Overall Study||154
9847520|NCT00854113|10960051|FG006|COMPLETED|Overall Study||12
9847521|NCT00854113|10960052|FG007|COMPLETED|Overall Study||5
10026087|NCT01876511|11150243|FG000|STARTED|Overall Study||41
10026088|NCT01876511|11150244|FG001|STARTED|Overall Study||25
10026089|NCT01876511|11150245|FG002|STARTED|Overall Study||47
10026090|NCT01876511|11150243|FG000|Stages 1 and 2|Overall Study||24
10026091|NCT01876511|11150244|FG001|Stages 1 and 2|Overall Study||25
10026092|NCT01876511|11150245|FG002|Stages 1 and 2|Overall Study||21
9696553|NCT00495131|10795529|FG000|COMPLETED|Overall Study||147
9696554|NCT00495131|10795530|FG001|COMPLETED|Overall Study||148
9696555|NCT00495131|10795529|FG000|NOT COMPLETED|Overall Study||7
9696556|NCT00495131|10795530|FG001|NOT COMPLETED|Overall Study||6
9696557|NCT00491738|10795536|FG000|STARTED|Overall Study||7
9696558|NCT00491738|10795537|FG001|STARTED|Overall Study||9
9696559|NCT00491738|10795536|FG000|COMPLETED|Overall Study||7
9696560|NCT00491738|10795537|FG001|COMPLETED|Overall Study||9
9696561|NCT00491738|10795536|FG000|NOT COMPLETED|Overall Study||0
9696562|NCT00491738|10795537|FG001|NOT COMPLETED|Overall Study||0
9696563|NCT00484419|10795544|FG000|STARTED|Overall Study||57
9696564|NCT00484419|10795545|FG001|STARTED|Overall Study||56
9696565|NCT00484419|10795546|FG002|STARTED|Overall Study||56
9696566|NCT00484419|10795544|FG000|COMPLETED|Overall Study||45
9696567|NCT00484419|10795545|FG001|COMPLETED|Overall Study||51
9696568|NCT00484419|10795546|FG002|COMPLETED|Overall Study||45
9696569|NCT00484419|10795544|FG000|NOT COMPLETED|Overall Study||12
9696570|NCT00484419|10795545|FG001|NOT COMPLETED|Overall Study||5
9696571|NCT00484419|10795546|FG002|NOT COMPLETED|Overall Study||11
9696572|NCT00479258|10795553|FG000|STARTED|Overall Study||0
9696573|NCT00479258|10795554|FG001|STARTED|Overall Study||0
9696574|NCT00479258|10795553|FG000|COMPLETED|Overall Study||0
9696575|NCT00479258|10795554|FG001|COMPLETED|Overall Study||0
9696576|NCT00479258|10795553|FG000|NOT COMPLETED|Overall Study||0
10026093|NCT01876511|11150243|FG000|COMPLETED|Overall Study||18
10026094|NCT01876511|11150244|FG001|COMPLETED|Overall Study||0
10026095|NCT01876511|11150245|FG002|COMPLETED|Overall Study||16
9696577|NCT00479258|10795554|FG001|NOT COMPLETED|Overall Study||0
9696578|NCT00474188|10795558|FG000|STARTED|Overall Study||26
9696579|NCT00474188|10795558|FG000|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
9696580|NCT00474188|10795558|FG000|NOT COMPLETED|Overall Study||6
9727379|NCT00106535|10826931|FG002|STARTED|2-year Placebo Controlled Period||401
9727380|NCT00106535|10826932|FG003|STARTED|2-year Placebo Controlled Period||0
10026096|NCT01876511|11150243|FG000|NOT COMPLETED|Overall Study||23
10026097|NCT01876511|11150244|FG001|NOT COMPLETED|Overall Study||25
9727381|NCT00106535|10826929|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
9727382|NCT00106535|10826930|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
9727383|NCT00106535|10826931|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
9727384|NCT00106535|10826932|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
9727385|NCT00106535|10826929|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
9727386|NCT00106535|10826930|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
9727387|NCT00106535|10826931|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
9727388|NCT00106535|10826932|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
9727389|NCT00106535|10826929|FG000|Completed Week 24|2-year Placebo Controlled Period||356
9727390|NCT00106535|10826930|FG001|Completed Week 24|2-year Placebo Controlled Period||373
9727391|NCT00106535|10826931|FG002|Completed Week 24|2-year Placebo Controlled Period||366
9727392|NCT00106535|10826932|FG003|Completed Week 24|2-year Placebo Controlled Period||0
9727393|NCT00106535|10826929|FG000|Completed Week 52|2-year Placebo Controlled Period||326
9727394|NCT00106535|10826930|FG001|Completed Week 52|2-year Placebo Controlled Period||342
9727395|NCT00106535|10826931|FG002|Completed Week 52|2-year Placebo Controlled Period||338
9727396|NCT00106535|10826932|FG003|Completed Week 52|2-year Placebo Controlled Period||0
9727397|NCT00106535|10826929|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
9727398|NCT00106535|10826930|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
9727399|NCT00106535|10826931|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
9727400|NCT00106535|10826932|FG003|COMPLETED|2-year Placebo Controlled Period||0
9727401|NCT00106535|10826929|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107
9727402|NCT00106535|10826930|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92
9727403|NCT00106535|10826931|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91
9727404|NCT00106535|10826932|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0
9727405|NCT00106535|10826929|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0
9727406|NCT00106535|10826930|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0
9847522|NCT00854113|10960053|FG008|COMPLETED|Overall Study||7
9847523|NCT00854113|10960054|FG009|COMPLETED|Overall Study||8
9847524|NCT00854113|10960055|FG010|COMPLETED|Overall Study||6
9847525|NCT00854113|10960045|FG000|NOT COMPLETED|Overall Study||0
10026098|NCT01876511|11150245|FG002|NOT COMPLETED|Overall Study||31
10026099|NCT01876706|11150255|FG000|STARTED|Overall Study||51
9696581|NCT00440531|10795564|FG000|STARTED|Overall Study||185
9696582|NCT00440531|10795565|FG001|STARTED|Overall Study||183
9696583|NCT00440531|10795566|FG002|STARTED|Overall Study||172
9696584|NCT00440531|10795564|FG000|Vaccination 1|Overall Study||183
9696585|NCT00440531|10795565|FG001|Vaccination 1|Overall Study||183
9696586|NCT00440531|10795566|FG002|Vaccination 1|Overall Study||172
9696587|NCT00440531|10795564|FG000|Vaccination 2|Overall Study||181
9696588|NCT00440531|10795565|FG001|Vaccination 2|Overall Study||182
9696589|NCT00440531|10795566|FG002|Vaccination 2|Overall Study||171
9696590|NCT00440531|10795564|FG000|Vaccination 3|Overall Study||176
9696591|NCT00440531|10795565|FG001|Vaccination 3|Overall Study||178
9696592|NCT00440531|10795566|FG002|Vaccination 3|Overall Study||166
9696593|NCT00440531|10795564|FG000|COMPLETED|Overall Study||175
9696594|NCT00440531|10795565|FG001|COMPLETED|Overall Study||178
9696595|NCT00440531|10795566|FG002|COMPLETED|Overall Study||165
9696596|NCT00440531|10795564|FG000|NOT COMPLETED|Overall Study||10
9696597|NCT00440531|10795565|FG001|NOT COMPLETED|Overall Study||5
9696598|NCT00440531|10795566|FG002|NOT COMPLETED|Overall Study||7
9696599|NCT00439738|10795574|FG000|STARTED|Overall Study||206
9696600|NCT00439738|10795575|FG001|STARTED|Overall Study||206
9696601|NCT00439738|10795574|FG000|COMPLETED|Overall Study||170
9696602|NCT00439738|10795575|FG001|COMPLETED|Overall Study||178
9696603|NCT00439738|10795574|FG000|NOT COMPLETED|Overall Study||36
9696604|NCT00439738|10795575|FG001|NOT COMPLETED|Overall Study||28
9696605|NCT00434226|10795581|FG000|STARTED|Overall Study||30
9696606|NCT00434226|10795582|FG001|STARTED|Overall Study||26
9696607|NCT00434226|10795581|FG000|COMPLETED|Overall Study||0
9696608|NCT00434226|10795582|FG001|COMPLETED|Overall Study||0
9696609|NCT00434226|10795581|FG000|NOT COMPLETED|Overall Study||30
9696610|NCT00434226|10795582|FG001|NOT COMPLETED|Overall Study||26
9696611|NCT00430950|10795588|FG000|STARTED|Overall Study||502
9696612|NCT00430950|10795589|FG001|STARTED|Overall Study||508
9696613|NCT00430950|10795588|FG000|COMPLETED|Overall Study||489
9696614|NCT00430950|10795589|FG001|COMPLETED|Overall Study||495
9696615|NCT00430950|10795588|FG000|NOT COMPLETED|Overall Study||13
9696616|NCT00430950|10795589|FG001|NOT COMPLETED|Overall Study||13
9696617|NCT00430508|10795597|FG000|STARTED|Overall Study||140
9696618|NCT00430508|10795598|FG001|STARTED|Overall Study||278
9696619|NCT00430508|10795599|FG002|STARTED|Overall Study||279
9696620|NCT00430508|10795600|FG003|STARTED|Overall Study||274
9696621|NCT00430508|10795597|FG000|COMPLETED|Overall Study||137
9696622|NCT00430508|10795598|FG001|COMPLETED|Overall Study||272
9696623|NCT00430508|10795599|FG002|COMPLETED|Overall Study||266
9696624|NCT00430508|10795600|FG003|COMPLETED|Overall Study||269
9696625|NCT00430508|10795597|FG000|NOT COMPLETED|Overall Study||3
9696626|NCT00430508|10795598|FG001|NOT COMPLETED|Overall Study||6
9696627|NCT00430508|10795599|FG002|NOT COMPLETED|Overall Study||13
9696628|NCT00430508|10795600|FG003|NOT COMPLETED|Overall Study||5
9696629|NCT00430092|10795609|FG000|STARTED|Overall Study||54
9696630|NCT00430092|10795610|FG001|STARTED|Overall Study||52
9696631|NCT00430092|10795611|FG002|STARTED|Overall Study||113
9696632|NCT00430092|10795609|FG000|COMPLETED|Overall Study||48
9696633|NCT00430092|10795610|FG001|COMPLETED|Overall Study||48
9696634|NCT00430092|10795611|FG002|COMPLETED|Overall Study||56
9696635|NCT00430092|10795609|FG000|NOT COMPLETED|Overall Study||6
9696636|NCT00430092|10795610|FG001|NOT COMPLETED|Overall Study||4
9696637|NCT00430092|10795611|FG002|NOT COMPLETED|Overall Study||57
9696638|NCT00429923|10795619|FG000|STARTED|Overall Study||57
9696639|NCT00429923|10795620|FG001|STARTED|Overall Study||55
9696640|NCT00429923|10795621|FG002|STARTED|Overall Study||107
9696641|NCT00429923|10795619|FG000|COMPLETED|Overall Study||52
9696642|NCT00429923|10795620|FG001|COMPLETED|Overall Study||51
9696643|NCT00429923|10795621|FG002|COMPLETED|Overall Study||68
9696644|NCT00429923|10795619|FG000|NOT COMPLETED|Overall Study||5
9696645|NCT00429923|10795620|FG001|NOT COMPLETED|Overall Study||4
9696646|NCT00429923|10795621|FG002|NOT COMPLETED|Overall Study||39
9696647|NCT00425100|10795626|FG000|STARTED|Overall Study||516
9696648|NCT00425100|10795626|FG000|COMPLETED|Overall Study||463
9696649|NCT00425100|10795626|FG000|NOT COMPLETED|Overall Study||53
9696650|NCT00415623|10795633|FG000|STARTED|Overall Study||154
9696651|NCT00415623|10795634|FG001|STARTED|Overall Study||151
9696652|NCT00415623|10795633|FG000|COMPLETED|Overall Study||149
9696653|NCT00415623|10795634|FG001|COMPLETED|Overall Study||146
9696654|NCT00415623|10795633|FG000|NOT COMPLETED|Overall Study||5
9696655|NCT00415623|10795634|FG001|NOT COMPLETED|Overall Study||5
9696656|NCT00412932|10795641|FG000|STARTED|Olmesartan (Olm) 20 mg||178
9696657|NCT00412932|10795641|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171
9696658|NCT00412932|10795641|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
9696659|NCT00412932|10795641|FG000|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
9696660|NCT00412932|10795641|FG000|COMPLETED|Olmesartan 40 mg||161
9696661|NCT00412932|10795641|FG000|NOT COMPLETED|Olmesartan 40 mg||8
9696662|NCT00412932|10795641|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
9696663|NCT00412932|10795641|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
9696664|NCT00412932|10795641|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
9696665|NCT00412932|10795641|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
9696666|NCT00412932|10795641|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
9696667|NCT00412932|10795641|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
9696668|NCT00397254|10795644|FG000|STARTED|Overall Study||79
9696669|NCT00397254|10795645|FG001|STARTED|Overall Study||76
9696670|NCT00397254|10795644|FG000|COMPLETED|Overall Study||77
9696671|NCT00397254|10795645|FG001|COMPLETED|Overall Study||74
9696672|NCT00397254|10795644|FG000|NOT COMPLETED|Overall Study||2
9696673|NCT00397254|10795645|FG001|NOT COMPLETED|Overall Study||2
9727407|NCT00106535|10826931|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0
9727408|NCT00106535|10826932|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
9727409|NCT00106535|10826929|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
9727410|NCT00106535|10826930|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
9727411|NCT00106535|10826931|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
9727412|NCT00106535|10826932|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
9727413|NCT00106535|10826929|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
9727414|NCT00106535|10826930|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
9727415|NCT00106535|10826931|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
9727416|NCT00106535|10826932|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
9727417|NCT00106639|10826947|FG000|STARTED|Overall Study||20
9727418|NCT00106639|10826948|FG001|STARTED|Overall Study||20
9727419|NCT00106639|10826949|FG002|STARTED|Overall Study||21
9727420|NCT00106639|10826947|FG000|COMPLETED|Overall Study||17
9727421|NCT00106639|10826948|FG001|COMPLETED|Overall Study||13
9727422|NCT00106639|10826949|FG002|COMPLETED|Overall Study||19
9727423|NCT00106639|10826947|FG000|NOT COMPLETED|Overall Study||3
9727424|NCT00106639|10826948|FG001|NOT COMPLETED|Overall Study||7
9727425|NCT00106639|10826949|FG002|NOT COMPLETED|Overall Study||2
9727426|NCT00106704|10826960|FG000|STARTED|Overall Study||222
9727427|NCT00106704|10826961|FG001|STARTED|Overall Study||219
9727428|NCT00106704|10826960|FG000|COMPLETED|Overall Study||91
9727429|NCT00106704|10826961|FG001|COMPLETED|Overall Study||68
9727430|NCT00106704|10826960|FG000|NOT COMPLETED|Overall Study||131
9727431|NCT00106704|10826961|FG001|NOT COMPLETED|Overall Study||151
9727432|NCT00106938|10826969|FG000|STARTED|Overall Study||1089
9727433|NCT00106938|10826970|FG001|STARTED|Overall Study||364
9727434|NCT00106938|10826969|FG000|COMPLETED|Overall Study||913
9727435|NCT00106938|10826970|FG001|COMPLETED|Overall Study||293
9727436|NCT00106938|10826969|FG000|NOT COMPLETED|Overall Study||176
9696674|NCT00393068|10795649|FG000|STARTED|Overall Study||62
9696675|NCT00393068|10795649|FG000|COMPLETED|Overall Study||44
9696676|NCT00393068|10795649|FG000|NOT COMPLETED|Overall Study||18
9696677|NCT00385515|10795655|FG000|STARTED|Overall Study||57
9696678|NCT00385515|10795656|FG001|STARTED|Overall Study||24
9696679|NCT00385515|10795655|FG000|COMPLETED|Overall Study||53
9847526|NCT00854113|10960046|FG001|NOT COMPLETED|Overall Study||0
9847527|NCT00854113|10960047|FG002|NOT COMPLETED|Overall Study||0
9847528|NCT00854113|10960048|FG003|NOT COMPLETED|Overall Study||0
9847529|NCT00854113|10960049|FG004|NOT COMPLETED|Overall Study||0
9847530|NCT00854113|10960050|FG005|NOT COMPLETED|Overall Study||0
9847531|NCT00854113|10960051|FG006|NOT COMPLETED|Overall Study||0
9847532|NCT00854113|10960052|FG007|NOT COMPLETED|Overall Study||3
9847533|NCT00854113|10960053|FG008|NOT COMPLETED|Overall Study||1
9847534|NCT00854113|10960054|FG009|NOT COMPLETED|Overall Study||0
9847535|NCT00854113|10960055|FG010|NOT COMPLETED|Overall Study||0
9847536|NCT00854308|10960081|FG000|STARTED|Overall Study||69
9847537|NCT00854308|10960082|FG001|STARTED|Overall Study||68
9847538|NCT00854308|10960081|FG000|Received Study Drug|Overall Study||69
9847539|NCT00854308|10960082|FG001|Received Study Drug|Overall Study||67
9847540|NCT00854308|10960081|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
9847541|NCT00854308|10960082|FG001|COMPLETED|Overall Study||1
9847542|NCT00854308|10960081|FG000|NOT COMPLETED|Overall Study||62
9847543|NCT00854308|10960082|FG001|NOT COMPLETED|Overall Study||67
9847544|NCT00854360|10960092|FG000|STARTED|Overall Study||118
9847545|NCT00854360|10960093|FG001|STARTED|Overall Study||123
9847546|NCT00854360|10960094|FG002|STARTED|Overall Study||122
9847547|NCT00854360|10960095|FG003|STARTED|Overall Study||124
9847548|NCT00854360|10960092|FG000|Intent to Treat / Safety Population|Overall Study||118
9847549|NCT00854360|10960093|FG001|Intent to Treat / Safety Population|Overall Study||123
9847550|NCT00854360|10960094|FG002|Intent to Treat / Safety Population|Overall Study||122
9847551|NCT00854360|10960095|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
9847552|NCT00854360|10960092|FG000|COMPLETED|Overall Study||116
9696680|NCT00385515|10795656|FG001|COMPLETED|Overall Study||21
9696681|NCT00385515|10795655|FG000|NOT COMPLETED|Overall Study||4
9696682|NCT00385515|10795656|FG001|NOT COMPLETED|Overall Study||3
9696683|NCT00362401|10795663|FG000|STARTED|Overall Study||15
9696684|NCT00362401|10795664|FG001|STARTED|Overall Study||29
9696685|NCT00362401|10795665|FG002|STARTED|Overall Study||40
9696686|NCT00362401|10795663|FG000|COMPLETED|Overall Study||15
9696687|NCT00362401|10795664|FG001|COMPLETED|Overall Study||29
9696688|NCT00362401|10795665|FG002|COMPLETED|Overall Study||40
9696689|NCT00362401|10795663|FG000|NOT COMPLETED|Overall Study||0
9696690|NCT00362401|10795664|FG001|NOT COMPLETED|Overall Study||0
9696691|NCT00362401|10795665|FG002|NOT COMPLETED|Overall Study||0
9696692|NCT00338104|10795673|FG000|STARTED|Overall Study||25
9696693|NCT00338104|10795674|FG001|STARTED|Overall Study||25
9696694|NCT00338104|10795675|FG002|STARTED|Overall Study||25
9696695|NCT00338104|10795673|FG000|COMPLETED|Overall Study||23
9696696|NCT00338104|10795674|FG001|COMPLETED|Overall Study||24
9696697|NCT00338104|10795675|FG002|COMPLETED|Overall Study||22
9696698|NCT00338104|10795673|FG000|NOT COMPLETED|Overall Study||2
9696699|NCT00338104|10795674|FG001|NOT COMPLETED|Overall Study||1
9696700|NCT00338104|10795675|FG002|NOT COMPLETED|Overall Study||3
9696701|NCT00336973|10795680|FG000|STARTED|Overall Study||66
9696702|NCT00336973|10795680|FG000|COMPLETED|Overall Study||33
9696703|NCT00336973|10795680|FG000|NOT COMPLETED|Overall Study||33
9727437|NCT00106938|10826970|FG001|NOT COMPLETED|Overall Study||71
9727438|NCT00106964|10826979|FG000|STARTED|Overall Study||118
9727439|NCT00106964|10826980|FG001|STARTED|Overall Study||126
9727440|NCT00106964|10826981|FG002|STARTED|Overall Study||127
9727441|NCT00106964|10826979|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
9727442|NCT00106964|10826980|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
9727443|NCT00106964|10826981|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
9727444|NCT00106964|10826979|FG000|NOT COMPLETED|Overall Study||13
9727445|NCT00106964|10826980|FG001|NOT COMPLETED|Overall Study||15
9727446|NCT00106964|10826981|FG002|NOT COMPLETED|Overall Study||7
9731844|NCT00136838|10831812|FG000|STARTED|First Intervention ( 5 Days)||6
9731845|NCT00136838|10831813|FG001|STARTED|First Intervention ( 5 Days)||6
9731846|NCT00136838|10831812|FG000|COMPLETED|First Intervention ( 5 Days)||6
9731847|NCT00136838|10831813|FG001|COMPLETED|First Intervention ( 5 Days)||6
9731848|NCT00136838|10831812|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0
9731849|NCT00136838|10831813|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0
9731850|NCT00136838|10831812|FG000|STARTED|Second Intervention ( 5 Days)||6
9731851|NCT00136838|10831813|FG001|STARTED|Second Intervention ( 5 Days)||6
9731852|NCT00136838|10831812|FG000|COMPLETED|Second Intervention ( 5 Days)||6
9731853|NCT00136838|10831813|FG001|COMPLETED|Second Intervention ( 5 Days)||6
9731854|NCT00136838|10831812|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0
9731855|NCT00136838|10831813|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0
9731856|NCT00136916|10831823|FG000|STARTED|Overall Study||319
9731857|NCT00136916|10831824|FG001|STARTED|Overall Study||316
9731858|NCT00136916|10831823|FG000|Received Treatment|Overall Study||316
9731859|NCT00136916|10831824|FG001|Received Treatment|Overall Study||311
9731860|NCT00136916|10831823|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
9731861|NCT00136916|10831824|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
9696704|NCT00326183|10795685|FG000|STARTED|Overall Study||1453
9696705|NCT00326183|10795686|FG001|STARTED|Overall Study||347
9696706|NCT00326183|10795685|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453
9696707|NCT00326183|10795686|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347
9696708|NCT00326183|10795685|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
9696709|NCT00326183|10795686|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325
9696710|NCT00326183|10795685|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301
9696711|NCT00326183|10795686|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292
9696712|NCT00326183|10795685|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
9696713|NCT00326183|10795686|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271
9696714|NCT00326183|10795685|FG000|COMPLETED|Overall Study||1253
9696715|NCT00326183|10795686|FG001|COMPLETED|Overall Study||264
9696716|NCT00326183|10795685|FG000|NOT COMPLETED|Overall Study||200
9696717|NCT00326183|10795686|FG001|NOT COMPLETED|Overall Study||83
10026100|NCT01876706|11150255|FG000|1 Month|Overall Study||51
10026101|NCT01876706|11150255|FG000|3 Months|Overall Study||51
9696718|NCT00323037|10795692|FG000|STARTED|Overall Study|Number randomized|165
9696719|NCT00323037|10795693|FG001|STARTED|Overall Study|Number randomized|153
9696720|NCT00323037|10795692|FG000|COMPLETED|Overall Study||132
9696721|NCT00323037|10795693|FG001|COMPLETED|Overall Study||126
9696722|NCT00323037|10795692|FG000|NOT COMPLETED|Overall Study||33
9696723|NCT00323037|10795693|FG001|NOT COMPLETED|Overall Study||27
9696724|NCT00318656|10795699|FG000|STARTED|Overall Study||12
9696725|NCT00318656|10795700|FG001|STARTED|Overall Study||11
9696726|NCT00318656|10795699|FG000|COMPLETED|Overall Study||12
9696727|NCT00318656|10795700|FG001|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
9696728|NCT00318656|10795699|FG000|NOT COMPLETED|Overall Study||0
9696729|NCT00318656|10795700|FG001|NOT COMPLETED|Overall Study||2
9696730|NCT00301262|10795706|FG000|STARTED|Double Blind Phase (DB)||94
9696731|NCT00301262|10795707|FG001|STARTED|Double Blind Phase (DB)||82
9696732|NCT00301262|10795706|FG000|COMPLETED|Double Blind Phase (DB)||84
9696733|NCT00301262|10795707|FG001|COMPLETED|Double Blind Phase (DB)||69
9696734|NCT00301262|10795706|FG000|NOT COMPLETED|Double Blind Phase (DB)||10
9696735|NCT00301262|10795707|FG001|NOT COMPLETED|Double Blind Phase (DB)||13
9696736|NCT00301262|10795706|FG000|STARTED|Open Label Phase (OL)||83
9961722|NCT01474512|11081389|FG013|Relapsed Population Received Drug|Maintenance Period||0
9961723|NCT01474512|11081390|FG014|Relapsed Population Received Drug|Maintenance Period||0
9961724|NCT01474512|11081391|FG015|Relapsed Population Received Drug|Maintenance Period||0
9961725|NCT01474512|11081392|FG016|Relapsed Population Received Drug|Maintenance Period||0
9961726|NCT01474512|11081393|FG017|Relapsed Population Received Drug|Maintenance Period||0
9961727|NCT01474512|11081376|FG000|Relapsed Population Completers|Maintenance Period||0
9961728|NCT01474512|11081377|FG001|Relapsed Population Completers|Maintenance Period||0
9961729|NCT01474512|11081378|FG002|Relapsed Population Completers|Maintenance Period||0
9961730|NCT01474512|11081379|FG003|Relapsed Population Completers|Maintenance Period||0
9961731|NCT01474512|11081380|FG004|Relapsed Population Completers|Maintenance Period||0
9961732|NCT01474512|11081381|FG005|Relapsed Population Completers|Maintenance Period||0
9961733|NCT01474512|11081382|FG006|Relapsed Population Completers|Maintenance Period||0
9961734|NCT01474512|11081383|FG007|Relapsed Population Completers|Maintenance Period||0
9961735|NCT01474512|11081384|FG008|Relapsed Population Completers|Maintenance Period||0
9961736|NCT01474512|11081385|FG009|Relapsed Population Completers|Maintenance Period||0
9961737|NCT01474512|11081386|FG010|Relapsed Population Completers|Maintenance Period||321
9961738|NCT01474512|11081387|FG011|Relapsed Population Completers|Maintenance Period||0
9961739|NCT01474512|11081388|FG012|Relapsed Population Completers|Maintenance Period||0
9961740|NCT01474512|11081389|FG013|Relapsed Population Completers|Maintenance Period||0
9961741|NCT01474512|11081390|FG014|Relapsed Population Completers|Maintenance Period||0
9961742|NCT01474512|11081391|FG015|Relapsed Population Completers|Maintenance Period||0
9961743|NCT01474512|11081392|FG016|Relapsed Population Completers|Maintenance Period||0
9961744|NCT01474512|11081393|FG017|Relapsed Population Completers|Maintenance Period||0
9961745|NCT01474512|11081376|FG000|COMPLETED|Maintenance Period||0
9961746|NCT01474512|11081377|FG001|COMPLETED|Maintenance Period||0
9961747|NCT01474512|11081378|FG002|COMPLETED|Maintenance Period||0
9961748|NCT01474512|11081379|FG003|COMPLETED|Maintenance Period||24
9961749|NCT01474512|11081380|FG004|COMPLETED|Maintenance Period||108
9961750|NCT01474512|11081381|FG005|COMPLETED|Maintenance Period||177
9961751|NCT01474512|11081382|FG006|COMPLETED|Maintenance Period||6
9961752|NCT01474512|11081383|FG007|COMPLETED|Maintenance Period||350
9961753|NCT01474512|11081384|FG008|COMPLETED|Maintenance Period||62
9696737|NCT00301262|10795707|FG001|STARTED|Open Label Phase (OL)||69
9696738|NCT00301262|10795706|FG000|COMPLETED|Open Label Phase (OL)||79
9696739|NCT00301262|10795707|FG001|COMPLETED|Open Label Phase (OL)||67
9696740|NCT00301262|10795706|FG000|NOT COMPLETED|Open Label Phase (OL)||4
9696741|NCT00301262|10795707|FG001|NOT COMPLETED|Open Label Phase (OL)||2
9696742|NCT00283868|10795734|FG000|STARTED|Overall Study||111
9696743|NCT00283868|10795735|FG001|STARTED|Overall Study||111
9961754|NCT01474512|11081385|FG009|COMPLETED|Maintenance Period||44
9961755|NCT01474512|11081386|FG010|COMPLETED|Maintenance Period||0
9961756|NCT01474512|11081387|FG011|COMPLETED|Maintenance Period||0
9961757|NCT01474512|11081388|FG012|COMPLETED|Maintenance Period||0
9961758|NCT01474512|11081389|FG013|COMPLETED|Maintenance Period||0
9961759|NCT01474512|11081390|FG014|COMPLETED|Maintenance Period||0
9961760|NCT01474512|11081391|FG015|COMPLETED|Maintenance Period||0
9961761|NCT01474512|11081392|FG016|COMPLETED|Maintenance Period||0
9961762|NCT01474512|11081393|FG017|COMPLETED|Maintenance Period||0
9961763|NCT01474512|11081376|FG000|NOT COMPLETED|Maintenance Period||0
9961764|NCT01474512|11081377|FG001|NOT COMPLETED|Maintenance Period||0
9961765|NCT01474512|11081378|FG002|NOT COMPLETED|Maintenance Period||0
9961766|NCT01474512|11081379|FG003|NOT COMPLETED|Maintenance Period||202
9961767|NCT01474512|11081380|FG004|NOT COMPLETED|Maintenance Period||119
9961768|NCT01474512|11081381|FG005|NOT COMPLETED|Maintenance Period||52
9961769|NCT01474512|11081382|FG006|NOT COMPLETED|Maintenance Period||10
9961770|NCT01474512|11081383|FG007|NOT COMPLETED|Maintenance Period||41
9961771|NCT01474512|11081384|FG008|NOT COMPLETED|Maintenance Period||16
9961772|NCT01474512|11081385|FG009|NOT COMPLETED|Maintenance Period||18
9961773|NCT01474512|11081386|FG010|NOT COMPLETED|Maintenance Period||0
9961774|NCT01474512|11081387|FG011|NOT COMPLETED|Maintenance Period||0
9961775|NCT01474512|11081388|FG012|NOT COMPLETED|Maintenance Period||0
9961776|NCT01474512|11081389|FG013|NOT COMPLETED|Maintenance Period||0
9961777|NCT01474512|11081390|FG014|NOT COMPLETED|Maintenance Period||0
9961778|NCT01474512|11081391|FG015|NOT COMPLETED|Maintenance Period||0
9961779|NCT01474512|11081392|FG016|NOT COMPLETED|Maintenance Period||0
9961780|NCT01474512|11081393|FG017|NOT COMPLETED|Maintenance Period||0
9961781|NCT01474512|11081376|FG000|STARTED|Long-Term Extension Period||0
9961782|NCT01474512|11081377|FG001|STARTED|Long-Term Extension Period||0
9961783|NCT01474512|11081378|FG002|STARTED|Long-Term Extension Period||0
9961784|NCT01474512|11081379|FG003|STARTED|Long-Term Extension Period||0
9961785|NCT01474512|11081380|FG004|STARTED|Long-Term Extension Period||0
9961786|NCT01474512|11081381|FG005|STARTED|Long-Term Extension Period||0
9961787|NCT01474512|11081382|FG006|STARTED|Long-Term Extension Period||0
9961788|NCT01474512|11081383|FG007|STARTED|Long-Term Extension Period||0
9961789|NCT01474512|11081384|FG008|STARTED|Long-Term Extension Period||0
9961790|NCT01474512|11081385|FG009|STARTED|Long-Term Extension Period||0
9961791|NCT01474512|11081386|FG010|STARTED|Long-Term Extension Period||0
9961792|NCT01474512|11081387|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
9961793|NCT01474512|11081388|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
9961794|NCT01474512|11081389|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
9961795|NCT01474512|11081390|FG014|STARTED|Long-Term Extension Period||0
9961796|NCT01474512|11081391|FG015|STARTED|Long-Term Extension Period||0
9961797|NCT01474512|11081392|FG016|STARTED|Long-Term Extension Period||0
9961798|NCT01474512|11081393|FG017|STARTED|Long-Term Extension Period||0
9961799|NCT01474512|11081376|FG000|COMPLETED|Long-Term Extension Period||0
9961800|NCT01474512|11081377|FG001|COMPLETED|Long-Term Extension Period||0
9961801|NCT01474512|11081378|FG002|COMPLETED|Long-Term Extension Period||0
9961802|NCT01474512|11081379|FG003|COMPLETED|Long-Term Extension Period||0
9961803|NCT01474512|11081380|FG004|COMPLETED|Long-Term Extension Period||0
9961804|NCT01474512|11081381|FG005|COMPLETED|Long-Term Extension Period||0
9961805|NCT01474512|11081382|FG006|COMPLETED|Long-Term Extension Period||0
9961806|NCT01474512|11081383|FG007|COMPLETED|Long-Term Extension Period||0
9961807|NCT01474512|11081384|FG008|COMPLETED|Long-Term Extension Period||0
9961808|NCT01474512|11081385|FG009|COMPLETED|Long-Term Extension Period||0
9961809|NCT01474512|11081386|FG010|COMPLETED|Long-Term Extension Period||0
9961810|NCT01474512|11081387|FG011|COMPLETED|Long-Term Extension Period||0
9961811|NCT01474512|11081388|FG012|COMPLETED|Long-Term Extension Period||836
9961812|NCT01474512|11081389|FG013|COMPLETED|Long-Term Extension Period||855
9961813|NCT01474512|11081390|FG014|COMPLETED|Long-Term Extension Period||0
9961814|NCT01474512|11081391|FG015|COMPLETED|Long-Term Extension Period||0
9961815|NCT01474512|11081392|FG016|COMPLETED|Long-Term Extension Period||0
9961816|NCT01474512|11081393|FG017|COMPLETED|Long-Term Extension Period||0
9961817|NCT01474512|11081376|FG000|NOT COMPLETED|Long-Term Extension Period||0
9961818|NCT01474512|11081377|FG001|NOT COMPLETED|Long-Term Extension Period||0
9961819|NCT01474512|11081378|FG002|NOT COMPLETED|Long-Term Extension Period||0
9847553|NCT00854360|10960093|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
9847554|NCT00854360|10960094|FG002|COMPLETED|Overall Study||120
9847555|NCT00854360|10960095|FG003|COMPLETED|Overall Study||114
9847556|NCT00854360|10960092|FG000|NOT COMPLETED|Overall Study||2
10114847|NCT02520284|11245634|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
9696744|NCT00283868|10795734|FG000|COMPLETED|Overall Study||104
9696745|NCT00283868|10795735|FG001|COMPLETED|Overall Study||103
9696746|NCT00283868|10795734|FG000|NOT COMPLETED|Overall Study||7
9696747|NCT00283868|10795735|FG001|NOT COMPLETED|Overall Study||8
9696748|NCT00282867|10795742|FG000|STARTED|Overall Study||24
9696749|NCT00282867|10795743|FG001|STARTED|Overall Study||25
9696750|NCT00282867|10795744|FG002|STARTED|Overall Study||25
9696751|NCT00282867|10795742|FG000|COMPLETED|Overall Study||23
9696752|NCT00282867|10795743|FG001|COMPLETED|Overall Study||24
9696753|NCT00282867|10795744|FG002|COMPLETED|Overall Study||25
9696754|NCT00282867|10795742|FG000|NOT COMPLETED|Overall Study||1
9696755|NCT00282867|10795743|FG001|NOT COMPLETED|Overall Study||1
9696756|NCT00282867|10795744|FG002|NOT COMPLETED|Overall Study||0
9696757|NCT00275340|10795751|FG000|STARTED|Overall Study||52
9696758|NCT00275340|10795752|FG001|STARTED|Overall Study||49
9696759|NCT00275340|10795751|FG000|COMPLETED|Overall Study||50
9696760|NCT00275340|10795752|FG001|COMPLETED|Overall Study||45
9696761|NCT00275340|10795751|FG000|NOT COMPLETED|Overall Study||2
9696762|NCT00275340|10795752|FG001|NOT COMPLETED|Overall Study||4
9696763|NCT00271544|10795756|FG000|STARTED|Overall Study|Total number of subjects enrolled.|190
9727447|NCT00107042|10827000|FG000|STARTED|Overall Study||60
9696764|NCT00271544|10795756|FG000|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
9696765|NCT00271544|10795756|FG000|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
9696766|NCT00271544|10795756|FG000|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
9696767|NCT00271544|10795756|FG000|NOT COMPLETED|Overall Study||20
9727448|NCT00107042|10827001|FG001|STARTED|Overall Study||63
9727449|NCT00107042|10827000|FG000|COMPLETED|Overall Study||38
9727450|NCT00107042|10827001|FG001|COMPLETED|Overall Study||47
9727451|NCT00107042|10827000|FG000|NOT COMPLETED|Overall Study||22
9727452|NCT00107042|10827001|FG001|NOT COMPLETED|Overall Study||16
9727453|NCT00107120|10827051|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
9727454|NCT00107120|10827052|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
9727455|NCT00107120|10827051|FG000|COMPLETED|Overall Study||126
9727456|NCT00107120|10827052|FG001|COMPLETED|Overall Study||133
9727457|NCT00107120|10827051|FG000|NOT COMPLETED|Overall Study||29
10026102|NCT01876706|11150255|FG000|6 Months|Overall Study||46
10026103|NCT01876706|11150255|FG000|12 Months|Overall Study||42
10026104|NCT01876706|11150255|FG000|24 Months|Overall Study||35
10026105|NCT01876706|11150255|FG000|36 Months|Overall Study||32
10026106|NCT01876706|11150255|FG000|48 Months|Overall Study||31
10026107|NCT01876706|11150255|FG000|60 Months|Overall Study||26
10026108|NCT01876706|11150255|FG000|COMPLETED|Overall Study||26
10026109|NCT01876706|11150255|FG000|NOT COMPLETED|Overall Study||25
10026110|NCT01876732|11150259|FG000|STARTED|Overall Study||132
10026111|NCT01876732|11150259|FG000|COMPLETED|Overall Study||57
10026112|NCT01876732|11150259|FG000|NOT COMPLETED|Overall Study||75
10026113|NCT01876784|11150266|FG000|STARTED|Overall Study||119
10026114|NCT01876784|11150267|FG001|STARTED|Overall Study||119
10026115|NCT01876784|11150266|FG000|Treated|Overall Study||117
10026116|NCT01876784|11150267|FG001|Treated|Overall Study||118
10026117|NCT01876784|11150266|FG000|COMPLETED|Overall Study||0
10026118|NCT01876784|11150267|FG001|COMPLETED|Overall Study||0
10026119|NCT01876784|11150266|FG000|NOT COMPLETED|Overall Study||119
10026120|NCT01876784|11150267|FG001|NOT COMPLETED|Overall Study||119
10026121|NCT01876810|11150273|FG000|STARTED|Overall Study||14
10026122|NCT01876810|11150274|FG001|STARTED|Overall Study||14
9696768|NCT00240500|10795778|FG000|STARTED|Overall Study||17
9696769|NCT00240500|10795779|FG001|STARTED|Overall Study||20
9696770|NCT00240500|10795780|FG002|STARTED|Overall Study||17
9696771|NCT00240500|10795781|FG003|STARTED|Overall Study||23
9696772|NCT00240500|10795782|FG004|STARTED|Overall Study||29
9696773|NCT00240500|10795783|FG005|STARTED|Overall Study||3
9696774|NCT00240500|10795778|FG000|COMPLETED|Overall Study||16
9696775|NCT00240500|10795779|FG001|COMPLETED|Overall Study||17
9696776|NCT00240500|10795780|FG002|COMPLETED|Overall Study||14
9696777|NCT00240500|10795781|FG003|COMPLETED|Overall Study||19
9696778|NCT00240500|10795782|FG004|COMPLETED|Overall Study||26
9696779|NCT00240500|10795783|FG005|COMPLETED|Overall Study||2
9696780|NCT00240500|10795778|FG000|NOT COMPLETED|Overall Study||1
9696781|NCT00240500|10795779|FG001|NOT COMPLETED|Overall Study||3
9696782|NCT00240500|10795780|FG002|NOT COMPLETED|Overall Study||3
9696783|NCT00240500|10795781|FG003|NOT COMPLETED|Overall Study||4
9696784|NCT00240500|10795782|FG004|NOT COMPLETED|Overall Study||3
9696785|NCT00240500|10795783|FG005|NOT COMPLETED|Overall Study||1
9696786|NCT00235326|10795793|FG000|STARTED|Overall Study||1575
9696787|NCT00235326|10795794|FG001|STARTED|Overall Study||2986
9696788|NCT00235326|10795793|FG000|COMPLETED|Overall Study||829
9696789|NCT00235326|10795794|FG001|COMPLETED|Overall Study||1586
9696790|NCT00235326|10795793|FG000|NOT COMPLETED|Overall Study||746
9696791|NCT00235326|10795794|FG001|NOT COMPLETED|Overall Study||1400
9696792|NCT00232141|10795800|FG000|STARTED|Overall Study||151
9696793|NCT00232141|10795801|FG001|STARTED|Overall Study||151
9696794|NCT00232141|10795800|FG000|COMPLETED|Overall Study||120
9696795|NCT00232141|10795801|FG001|COMPLETED|Overall Study||125
9696796|NCT00232141|10795800|FG000|NOT COMPLETED|Overall Study||31
9696797|NCT00232141|10795801|FG001|NOT COMPLETED|Overall Study||26
9696798|NCT00231153|10795807|FG000|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
9696799|NCT00231153|10795808|FG001|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
9696800|NCT00231153|10795807|FG000|COMPLETED|Overall Study||690
9696801|NCT00231153|10795808|FG001|COMPLETED|Overall Study||720
9696802|NCT00231153|10795807|FG000|NOT COMPLETED|Overall Study||217
9696803|NCT00231153|10795808|FG001|NOT COMPLETED|Overall Study||188
9696804|NCT00224003|10795812|FG000|STARTED|Overall Study|First patient in: April 2, 2003|23
9696805|NCT00224003|10795812|FG000|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
9696806|NCT00224003|10795812|FG000|NOT COMPLETED|Overall Study||7
9696807|NCT00162942|10795817|FG000|STARTED|Overall Study||157
9696808|NCT00162942|10795818|FG001|STARTED|Overall Study||78
9696809|NCT00162942|10795817|FG000|Week 12|Overall Study||127
9696810|NCT00162942|10795818|FG001|Week 12|Overall Study||61
9696811|NCT00162942|10795817|FG000|COMPLETED|Overall Study||51
9696812|NCT00162942|10795818|FG001|COMPLETED|Overall Study||26
9696813|NCT00162942|10795817|FG000|NOT COMPLETED|Overall Study||106
9696814|NCT00162942|10795818|FG001|NOT COMPLETED|Overall Study||52
9696815|NCT00147290|10795824|FG000|STARTED|Overall Study||266
9696816|NCT00147290|10795825|FG001|STARTED|Overall Study||260
9696817|NCT00147290|10795824|FG000|COMPLETED|Overall Study||266
9696818|NCT00147290|10795825|FG001|COMPLETED|Overall Study||260
9696819|NCT00147290|10795824|FG000|NOT COMPLETED|Overall Study||0
9696820|NCT00147290|10795825|FG001|NOT COMPLETED|Overall Study||0
9696821|NCT00147277|10795831|FG000|STARTED|Overall Study||475
9696822|NCT00147277|10795832|FG001|STARTED|Overall Study||450
9696823|NCT00147277|10795831|FG000|COMPLETED|Overall Study||475
9696824|NCT00147277|10795832|FG001|COMPLETED|Overall Study||450
9696825|NCT00147277|10795831|FG000|NOT COMPLETED|Overall Study||0
9696826|NCT00147277|10795832|FG001|NOT COMPLETED|Overall Study||0
9696827|NCT00126776|10795838|FG000|STARTED|Overall Study||372
9696828|NCT00126776|10795839|FG001|STARTED|Overall Study||371
9696829|NCT00126776|10795838|FG000|COMPLETED|Overall Study||372
9696830|NCT00126776|10795839|FG001|COMPLETED|Overall Study||371
9696831|NCT00126776|10795838|FG000|NOT COMPLETED|Overall Study||0
9696832|NCT00126776|10795839|FG001|NOT COMPLETED|Overall Study||0
9696833|NCT00120042|10795846|FG000|STARTED|Overall Study||85
9696834|NCT00120042|10795847|FG001|STARTED|Overall Study||83
9696835|NCT00120042|10795848|FG002|STARTED|Overall Study||83
9696836|NCT00120042|10795846|FG000|COMPLETED|Overall Study||85
9696837|NCT00120042|10795847|FG001|COMPLETED|Overall Study||83
9696838|NCT00120042|10795848|FG002|COMPLETED|Overall Study||83
9696839|NCT00120042|10795846|FG000|NOT COMPLETED|Overall Study||0
9696840|NCT00120042|10795847|FG001|NOT COMPLETED|Overall Study||0
9696841|NCT00120042|10795848|FG002|NOT COMPLETED|Overall Study||0
9696842|NCT00106626|10795857|FG000|STARTED|Overall Study||13
9696843|NCT00106626|10795858|FG001|STARTED|Overall Study||9
9696844|NCT00106626|10795859|FG002|STARTED|Overall Study||14
9696845|NCT00106626|10795860|FG003|STARTED|Overall Study||16
9696846|NCT00106626|10795857|FG000|COMPLETED|Overall Study||3
9696847|NCT00106626|10795858|FG001|COMPLETED|Overall Study||3
9696848|NCT00106626|10795859|FG002|COMPLETED|Overall Study||2
9696849|NCT00106626|10795860|FG003|COMPLETED|Overall Study||3
9696850|NCT00106626|10795857|FG000|NOT COMPLETED|Overall Study||10
9696851|NCT00106626|10795858|FG001|NOT COMPLETED|Overall Study||6
9696852|NCT00106626|10795859|FG002|NOT COMPLETED|Overall Study||12
9696853|NCT00106626|10795860|FG003|NOT COMPLETED|Overall Study||13
9727458|NCT00107120|10827052|FG001|NOT COMPLETED|Overall Study||24
9727459|NCT00107172|10827060|FG000|STARTED|Overall Study||114
9727460|NCT00107172|10827061|FG001|STARTED|Overall Study||108
9727461|NCT00107172|10827060|FG000|COMPLETED|Overall Study||109
9727462|NCT00107172|10827061|FG001|COMPLETED|Overall Study||103
9727463|NCT00107172|10827060|FG000|NOT COMPLETED|Overall Study||5
9727464|NCT00107172|10827061|FG001|NOT COMPLETED|Overall Study||5
9727465|NCT00107198|10827067|FG000|STARTED|Overall Study||188
9727466|NCT00107198|10827067|FG000|COMPLETED|Overall Study||136
9727467|NCT00107198|10827067|FG000|NOT COMPLETED|Overall Study||52
9727468|NCT00107276|10827071|FG000|STARTED|Overall Study||112
9727469|NCT00107276|10827071|FG000|Eligible|Overall Study||96
9727470|NCT00107276|10827071|FG000|COMPLETED|Overall Study||40
9727471|NCT00107276|10827071|FG000|NOT COMPLETED|Overall Study||72
9727472|NCT00107380|10827076|FG000|STARTED|Overall Study||86
9727473|NCT00107380|10827076|FG000|Eligible|Overall Study||84
9727474|NCT00107380|10827076|FG000|COMPLETED|Overall Study||56
9727475|NCT00107380|10827076|FG000|NOT COMPLETED|Overall Study||30
9727476|NCT00107536|10827081|FG000|STARTED|Overall Study||26
9727477|NCT00107536|10827081|FG000|COMPLETED|Overall Study||26
9727478|NCT00107536|10827081|FG000|NOT COMPLETED|Overall Study||0
9727479|NCT00107575|10827087|FG000|STARTED|Overall Study||119
9727480|NCT00107575|10827088|FG001|STARTED|Overall Study||117
9727481|NCT00107575|10827087|FG000|COMPLETED|Overall Study||108
9727482|NCT00107575|10827088|FG001|COMPLETED|Overall Study||107
9727483|NCT00107575|10827087|FG000|NOT COMPLETED|Overall Study||11
9727484|NCT00107575|10827088|FG001|NOT COMPLETED|Overall Study||10
9727485|NCT00107653|10827096|FG000|STARTED|Overall Study||269
9727486|NCT00107653|10827097|FG001|STARTED|Overall Study||300
9727487|NCT00107653|10827096|FG000|COMPLETED|Overall Study||190
9727488|NCT00107653|10827097|FG001|COMPLETED|Overall Study||224
9727489|NCT00107653|10827096|FG000|NOT COMPLETED|Overall Study||79
9727490|NCT00107653|10827097|FG001|NOT COMPLETED|Overall Study||76
9727491|NCT00107744|10827106|FG000|STARTED|Intervention 1 (8 Weeks)||117
9727492|NCT00107744|10827107|FG001|STARTED|Intervention 1 (8 Weeks)||117
9727493|NCT00107744|10827108|FG002|STARTED|Intervention 1 (8 Weeks)||118
9727494|NCT00107744|10827106|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
9727495|NCT00107744|10827107|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
9727496|NCT00107744|10827108|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
9727497|NCT00107744|10827106|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
9727498|NCT00107744|10827107|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
9961820|NCT01474512|11081379|FG003|NOT COMPLETED|Long-Term Extension Period||0
9961821|NCT01474512|11081380|FG004|NOT COMPLETED|Long-Term Extension Period||0
9961822|NCT01474512|11081381|FG005|NOT COMPLETED|Long-Term Extension Period||0
9961823|NCT01474512|11081382|FG006|NOT COMPLETED|Long-Term Extension Period||0
9961824|NCT01474512|11081383|FG007|NOT COMPLETED|Long-Term Extension Period||0
9961825|NCT01474512|11081384|FG008|NOT COMPLETED|Long-Term Extension Period||0
9961826|NCT01474512|11081385|FG009|NOT COMPLETED|Long-Term Extension Period||0
9727499|NCT00107744|10827108|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
9727500|NCT00107744|10827106|FG000|STARTED|Intervention 2 (8 Weeks)||101
9727501|NCT00107744|10827107|FG001|STARTED|Intervention 2 (8 Weeks)||104
9727502|NCT00107744|10827108|FG002|STARTED|Intervention 2 (8 Weeks)||101
9727503|NCT00107744|10827106|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
9727504|NCT00107744|10827107|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
9727505|NCT00107744|10827108|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
9727506|NCT00107744|10827106|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
9727507|NCT00107744|10827107|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
9727508|NCT00107744|10827108|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
9961827|NCT01474512|11081386|FG010|NOT COMPLETED|Long-Term Extension Period||0
9696854|NCT00089141|10795877|FG000|STARTED|Overall Study||74
9696855|NCT00089141|10795878|FG001|STARTED|Overall Study||77
9696856|NCT00089141|10795877|FG000|COMPLETED|Overall Study||56
9696857|NCT00089141|10795878|FG001|COMPLETED|Overall Study||53
9696858|NCT00089141|10795877|FG000|NOT COMPLETED|Overall Study||18
9696859|NCT00089141|10795878|FG001|NOT COMPLETED|Overall Study||24
9696860|NCT00083759|10795884|FG000|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
9696861|NCT00083759|10795885|FG001|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
9696862|NCT00083759|10795884|FG000|COMPLETED|Overall Study||66
9696863|NCT00083759|10795885|FG001|COMPLETED|Overall Study||66
9696864|NCT00083759|10795884|FG000|NOT COMPLETED|Overall Study||84
9696865|NCT00083759|10795885|FG001|NOT COMPLETED|Overall Study||83
9727509|NCT00107744|10827106|FG000|STARTED|Intervention 3 (8 Weeks)||93
9727510|NCT00107744|10827107|FG001|STARTED|Intervention 3 (8 Weeks)||92
9727511|NCT00107744|10827108|FG002|STARTED|Intervention 3 (8 Weeks)||88
9727512|NCT00107744|10827106|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
9727513|NCT00107744|10827107|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
9696866|NCT03513068|10795891|FG000|STARTED|Overall Study||54
9696867|NCT03513068|10795892|FG001|STARTED|Overall Study||54
9696868|NCT03513068|10795891|FG000|COMPLETED|Overall Study||49
9696869|NCT03513068|10795892|FG001|COMPLETED|Overall Study||48
9696870|NCT03513068|10795891|FG000|NOT COMPLETED|Overall Study||5
9696871|NCT03513068|10795892|FG001|NOT COMPLETED|Overall Study||6
9696872|NCT03507127|10795900|FG000|STARTED|Overall Study||3
9696873|NCT03507127|10795901|FG001|STARTED|Overall Study||2
9696874|NCT03507127|10795900|FG000|COMPLETED|Overall Study||1
9696875|NCT03507127|10795901|FG001|COMPLETED|Overall Study||1
9696876|NCT03507127|10795900|FG000|NOT COMPLETED|Overall Study||2
9696877|NCT03507127|10795901|FG001|NOT COMPLETED|Overall Study||1
9696878|NCT03502811|10795907|FG000|STARTED|Overall Study||1041
9696879|NCT03502811|10795907|FG000|COMPLETED|Overall Study||722
9696880|NCT03502811|10795907|FG000|NOT COMPLETED|Overall Study||319
9696881|NCT04789382|10795915|FG000|STARTED|First Wear Period (2 Hours)||9
9696882|NCT04789382|10795916|FG001|STARTED|First Wear Period (2 Hours)||9
9696883|NCT04789382|10795917|FG002|STARTED|First Wear Period (2 Hours)||9
9696884|NCT04789382|10795918|FG003|STARTED|First Wear Period (2 Hours)||9
9696885|NCT04789382|10795915|FG000|COMPLETED|First Wear Period (2 Hours)||9
9696886|NCT04789382|10795916|FG001|COMPLETED|First Wear Period (2 Hours)||9
9696887|NCT04789382|10795917|FG002|COMPLETED|First Wear Period (2 Hours)||9
9696888|NCT04789382|10795918|FG003|COMPLETED|First Wear Period (2 Hours)||9
9696889|NCT04789382|10795915|FG000|NOT COMPLETED|First Wear Period (2 Hours)||0
9696890|NCT04789382|10795916|FG001|NOT COMPLETED|First Wear Period (2 Hours)||0
9696891|NCT04789382|10795917|FG002|NOT COMPLETED|First Wear Period (2 Hours)||0
9696892|NCT04789382|10795918|FG003|NOT COMPLETED|First Wear Period (2 Hours)||0
9696893|NCT04789382|10795915|FG000|STARTED|Washout (Day of & Day Prior to Visit 3)||9
9696894|NCT04789382|10795916|FG001|STARTED|Washout (Day of & Day Prior to Visit 3)||9
9696895|NCT04789382|10795917|FG002|STARTED|Washout (Day of & Day Prior to Visit 3)||9
9696896|NCT04789382|10795918|FG003|STARTED|Washout (Day of & Day Prior to Visit 3)||9
9696897|NCT04789382|10795915|FG000|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
9696898|NCT04789382|10795916|FG001|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
9696899|NCT04789382|10795917|FG002|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
9696900|NCT04789382|10795918|FG003|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
9696901|NCT04789382|10795915|FG000|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
9696902|NCT04789382|10795916|FG001|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
9696903|NCT04789382|10795917|FG002|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
9696904|NCT04789382|10795918|FG003|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
9696905|NCT04789382|10795915|FG000|STARTED|Second Wear Period (2 Hours)||9
9696906|NCT04789382|10795916|FG001|STARTED|Second Wear Period (2 Hours)||9
9696907|NCT04789382|10795917|FG002|STARTED|Second Wear Period (2 Hours)||9
9696908|NCT04789382|10795918|FG003|STARTED|Second Wear Period (2 Hours)||9
9696909|NCT04789382|10795915|FG000|COMPLETED|Second Wear Period (2 Hours)||9
9696910|NCT04789382|10795916|FG001|COMPLETED|Second Wear Period (2 Hours)||9
9696911|NCT04789382|10795917|FG002|COMPLETED|Second Wear Period (2 Hours)||9
9696912|NCT04789382|10795918|FG003|COMPLETED|Second Wear Period (2 Hours)||9
9696913|NCT04789382|10795915|FG000|NOT COMPLETED|Second Wear Period (2 Hours)||0
9696914|NCT04789382|10795916|FG001|NOT COMPLETED|Second Wear Period (2 Hours)||0
9696915|NCT04789382|10795917|FG002|NOT COMPLETED|Second Wear Period (2 Hours)||0
9696916|NCT04789382|10795918|FG003|NOT COMPLETED|Second Wear Period (2 Hours)||0
9696917|NCT04428333|10795932|FG000|STARTED|Overall Study||57
9696918|NCT04428333|10795933|FG001|STARTED|Overall Study||59
9696919|NCT04428333|10795932|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||52
9696920|NCT04428333|10795933|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||55
9696921|NCT04428333|10795932|FG000|Safety Population|Overall Study||50
9696922|NCT04428333|10795933|FG001|Safety Population|Overall Study||65
9696923|NCT04428333|10795932|FG000|COMPLETED|Overall Study||3
9696924|NCT04428333|10795933|FG001|COMPLETED|Overall Study||1
9696925|NCT04428333|10795932|FG000|NOT COMPLETED|Overall Study||54
9696926|NCT04428333|10795933|FG001|NOT COMPLETED|Overall Study||58
9696927|NCT03530995|10795941|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35
9696928|NCT03530995|10795942|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38
9696929|NCT03530995|10795941|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35
9696930|NCT03530995|10795942|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38
9696931|NCT03530995|10795941|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
9696932|NCT03530995|10795942|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
9696933|NCT03530995|10795941|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35
9696934|NCT03530995|10795942|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38
9696935|NCT03530995|10795941|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35
10026123|NCT01876810|11150273|FG000|COMPLETED|Overall Study||14
10026124|NCT01876810|11150274|FG001|COMPLETED|Overall Study||13
10026125|NCT01876810|11150273|FG000|NOT COMPLETED|Overall Study||0
9696936|NCT03530995|10795942|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38
9696937|NCT03530995|10795941|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
9696938|NCT03530995|10795942|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
9696939|NCT03530995|10795941|FG000|STARTED|Part 1 Period 3||35
9696940|NCT03530995|10795942|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
9696941|NCT03530995|10795941|FG000|COMPLETED|Part 1 Period 3||32
9696942|NCT03530995|10795942|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
9696943|NCT03530995|10795941|FG000|NOT COMPLETED|Part 1 Period 3||3
9696944|NCT03530995|10795942|FG001|NOT COMPLETED|Part 1 Period 3||0
9696945|NCT03530995|10795941|FG000|STARTED|Part 1 Period 4||32
9696946|NCT03530995|10795942|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
9696947|NCT03530995|10795941|FG000|COMPLETED|Part 1 Period 4||30
9696948|NCT03530995|10795942|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
9696949|NCT03530995|10795941|FG000|NOT COMPLETED|Part 1 Period 4||2
9696950|NCT03530995|10795942|FG001|NOT COMPLETED|Part 1 Period 4||0
9696951|NCT03373006|10795964|FG000|STARTED|Overall Study||20
9696952|NCT03373006|10795964|FG000|COMPLETED|Overall Study||20
9696953|NCT03373006|10795964|FG000|NOT COMPLETED|Overall Study||0
9696954|NCT03368937|10795968|FG000|STARTED|Overall Study||5
9696955|NCT03368937|10795968|FG000|COMPLETED|Overall Study||5
9696956|NCT03368937|10795968|FG000|NOT COMPLETED|Overall Study||0
9696957|NCT03204812|10795972|FG000|STARTED|Overall Study||26
9696958|NCT03204812|10795972|FG000|COMPLETED|Overall Study||23
9696959|NCT03204812|10795972|FG000|NOT COMPLETED|Overall Study||3
9696960|NCT03199391|10795976|FG000|STARTED|Overall Study||71
9696961|NCT03199391|10795976|FG000|COMPLETED|Overall Study||55
9696962|NCT03199391|10795976|FG000|NOT COMPLETED|Overall Study||16
9696963|NCT03084471|10795980|FG000|STARTED|Overall Study||867
9696964|NCT03084471|10795980|FG000|COMPLETED|Overall Study||0
9696965|NCT03084471|10795980|FG000|NOT COMPLETED|Overall Study||867
9696966|NCT03072459|10795987|FG000|STARTED|Overall Study||128
9696967|NCT03072459|10795987|FG000|COMPLETED|Overall Study||126
9696968|NCT03072459|10795987|FG000|NOT COMPLETED|Overall Study||2
9696969|NCT03029234|10795991|FG000|STARTED|Overall Study||126
9696970|NCT03029234|10795991|FG000|Received Carfilzomib|Overall Study||123
9696971|NCT03029234|10795991|FG000|COMPLETED|Overall Study||27
9696972|NCT03029234|10795991|FG000|NOT COMPLETED|Overall Study||99
9696973|NCT03019406|10795999|FG000|STARTED|PAP: up to 25 Weeks||6
9696974|NCT03019406|10796000|FG001|STARTED|PAP: up to 25 Weeks||5
9696975|NCT03019406|10796001|FG002|STARTED|PAP: up to 25 Weeks||5
9696976|NCT03019406|10796002|FG003|STARTED|PAP: up to 25 Weeks||6
9696977|NCT03019406|10795999|FG000|Treated|PAP: up to 25 Weeks||6
9696978|NCT03019406|10796000|FG001|Treated|PAP: up to 25 Weeks||5
9696979|NCT03019406|10796001|FG002|Treated|PAP: up to 25 Weeks||5
9696980|NCT03019406|10796002|FG003|Treated|PAP: up to 25 Weeks||6
9696981|NCT03019406|10795999|FG000|COMPLETED|PAP: up to 25 Weeks||6
9696982|NCT03019406|10796000|FG001|COMPLETED|PAP: up to 25 Weeks||5
9696983|NCT03019406|10796001|FG002|COMPLETED|PAP: up to 25 Weeks||5
9696984|NCT03019406|10796002|FG003|COMPLETED|PAP: up to 25 Weeks||6
9696985|NCT03019406|10795999|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0
9696986|NCT03019406|10796000|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0
9696987|NCT03019406|10796001|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0
9696988|NCT03019406|10796002|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0
9696989|NCT03019406|10795999|FG000|STARTED|ETP: Ongoing From Week 26||6
9696990|NCT03019406|10796000|FG001|STARTED|ETP: Ongoing From Week 26||5
9696991|NCT03019406|10796001|FG002|STARTED|ETP: Ongoing From Week 26||5
9696992|NCT03019406|10796002|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3
9696993|NCT03019406|10795999|FG000|COMPLETED|ETP: Ongoing From Week 26||0
9696994|NCT03019406|10796000|FG001|COMPLETED|ETP: Ongoing From Week 26||0
9696995|NCT03019406|10796001|FG002|COMPLETED|ETP: Ongoing From Week 26||0
9696996|NCT03019406|10796002|FG003|COMPLETED|ETP: Ongoing From Week 26||0
9696997|NCT03019406|10795999|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6
9696998|NCT03019406|10796000|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5
9696999|NCT03019406|10796001|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5
9697000|NCT03019406|10796002|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3
9697001|NCT02874144|10796017|FG000|STARTED|Overall Study||22
9697002|NCT02874144|10796018|FG001|STARTED|Overall Study||21
9697003|NCT02874144|10796017|FG000|COMPLETED|Overall Study||19
9697004|NCT02874144|10796018|FG001|COMPLETED|Overall Study||16
9697005|NCT02874144|10796017|FG000|NOT COMPLETED|Overall Study||3
9697006|NCT02874144|10796018|FG001|NOT COMPLETED|Overall Study||5
9727514|NCT00107744|10827108|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
9847557|NCT00854360|10960093|FG001|NOT COMPLETED|Overall Study||3
9847558|NCT00854360|10960094|FG002|NOT COMPLETED|Overall Study||2
9847559|NCT00854360|10960095|FG003|NOT COMPLETED|Overall Study||10
9847560|NCT00854373|10960107|FG000|STARTED|Overall Study||95
9847561|NCT00854373|10960108|FG001|STARTED|Overall Study||93
9847562|NCT00854373|10960107|FG000|COMPLETED|Overall Study||93
9847563|NCT00854373|10960108|FG001|COMPLETED|Overall Study||89
9847564|NCT00854373|10960107|FG000|NOT COMPLETED|Overall Study||2
9847565|NCT00854373|10960108|FG001|NOT COMPLETED|Overall Study||4
9847566|NCT00854581|10960114|FG000|STARTED|Induction (Up to Day 21)||13
9847567|NCT00854581|10960114|FG000|COMPLETED|Induction (Up to Day 21)||7
9847568|NCT00854581|10960114|FG000|NOT COMPLETED|Induction (Up to Day 21)||6
10026126|NCT01876810|11150274|FG001|NOT COMPLETED|Overall Study||1
10026127|NCT01876823|11150283|FG000|STARTED|Overall Study||35
10026128|NCT01876823|11150283|FG000|COMPLETED|Overall Study||26
10026129|NCT01876823|11150283|FG000|NOT COMPLETED|Overall Study||9
10026130|NCT01876901|11150289|FG000|STARTED|Overall Study||65
10026131|NCT01876901|11150290|FG001|STARTED|Overall Study||59
10026132|NCT01876901|11150289|FG000|COMPLETED|Overall Study||48
9847569|NCT00854581|10960114|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7
9847570|NCT00854581|10960114|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
9847571|NCT00854581|10960114|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
9847572|NCT00854581|10960114|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5
9847573|NCT00854581|10960114|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
9847574|NCT00854581|10960114|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
9847575|NCT00854594|10960125|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
9847576|NCT00854594|10960126|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
9847577|NCT00854594|10960125|FG000|COMPLETED|Overall Study||48
9847578|NCT00854594|10960126|FG001|COMPLETED|Overall Study||69
9961828|NCT01474512|11081387|FG011|NOT COMPLETED|Long-Term Extension Period||26
9961829|NCT01474512|11081388|FG012|NOT COMPLETED|Long-Term Extension Period||218
9961830|NCT01474512|11081389|FG013|NOT COMPLETED|Long-Term Extension Period||220
9961831|NCT01474512|11081390|FG014|NOT COMPLETED|Long-Term Extension Period||0
9961832|NCT01474512|11081391|FG015|NOT COMPLETED|Long-Term Extension Period||0
9961833|NCT01474512|11081392|FG016|NOT COMPLETED|Long-Term Extension Period||0
9961834|NCT01474512|11081393|FG017|NOT COMPLETED|Long-Term Extension Period||0
9961835|NCT01474512|11081376|FG000|STARTED|Post-Treatment Follow-Up||0
9961836|NCT01474512|11081377|FG001|STARTED|Post-Treatment Follow-Up||0
9961837|NCT01474512|11081378|FG002|STARTED|Post-Treatment Follow-Up||0
9961838|NCT01474512|11081379|FG003|STARTED|Post-Treatment Follow-Up||0
9961839|NCT01474512|11081380|FG004|STARTED|Post-Treatment Follow-Up||0
10026133|NCT01876901|11150290|FG001|COMPLETED|Overall Study||52
9727515|NCT00107744|10827106|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
9727516|NCT00107744|10827107|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
9727517|NCT00107744|10827108|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
9727518|NCT00107783|10827118|FG000|STARTED|Overall Study||20
9727519|NCT00107783|10827119|FG001|STARTED|Overall Study||20
9727520|NCT00107783|10827118|FG000|COMPLETED|Overall Study||17
9727521|NCT00107783|10827119|FG001|COMPLETED|Overall Study||16
9727522|NCT00107783|10827118|FG000|NOT COMPLETED|Overall Study||3
9697043|NCT02611830|10796049|FG000|STARTED|OL Induction Phase||383
9697044|NCT02611830|10796050|FG001|STARTED|OL Induction Phase||0
9697045|NCT02611830|10796051|FG002|STARTED|OL Induction Phase||0
9697046|NCT02611830|10796052|FG003|STARTED|OL Induction Phase||0
9697047|NCT02611830|10796049|FG000|COMPLETED|OL Induction Phase||353
9697048|NCT02611830|10796050|FG001|COMPLETED|OL Induction Phase||0
9697049|NCT02611830|10796051|FG002|COMPLETED|OL Induction Phase||0
9697050|NCT02611830|10796052|FG003|COMPLETED|OL Induction Phase||0
9697051|NCT02611830|10796049|FG000|NOT COMPLETED|OL Induction Phase||30
9697052|NCT02611830|10796050|FG001|NOT COMPLETED|OL Induction Phase||0
9697053|NCT02611830|10796051|FG002|NOT COMPLETED|OL Induction Phase||0
9697054|NCT02611830|10796052|FG003|NOT COMPLETED|OL Induction Phase||0
9697055|NCT02611830|10796049|FG000|STARTED|Maintenance Phase||0
9697056|NCT02611830|10796050|FG001|STARTED|Maintenance Phase||56
9697057|NCT02611830|10796051|FG002|STARTED|Maintenance Phase||106
9697058|NCT02611830|10796052|FG003|STARTED|Maintenance Phase||54
9697059|NCT02611830|10796049|FG000|COMPLETED|Maintenance Phase||0
9697060|NCT02611830|10796050|FG001|COMPLETED|Maintenance Phase||20
9697061|NCT02611830|10796051|FG002|COMPLETED|Maintenance Phase||75
9697062|NCT02611830|10796052|FG003|COMPLETED|Maintenance Phase||39
9697063|NCT02611830|10796049|FG000|NOT COMPLETED|Maintenance Phase||0
9697064|NCT02611830|10796050|FG001|NOT COMPLETED|Maintenance Phase||36
9697065|NCT02611830|10796051|FG002|NOT COMPLETED|Maintenance Phase||31
9697066|NCT02611830|10796052|FG003|NOT COMPLETED|Maintenance Phase||15
9697067|NCT02611817|10796064|FG000|STARTED|Open-label Induction Phase||644
9697068|NCT02611817|10796065|FG001|STARTED|Open-label Induction Phase||0
9697069|NCT02611817|10796066|FG002|STARTED|Open-label Induction Phase||0
9697070|NCT02611817|10796064|FG000|COMPLETED|Open-label Induction Phase||594
9697071|NCT02611817|10796065|FG001|COMPLETED|Open-label Induction Phase||0
9697072|NCT02611817|10796066|FG002|COMPLETED|Open-label Induction Phase||0
9697073|NCT02611817|10796064|FG000|NOT COMPLETED|Open-label Induction Phase||50
9697074|NCT02611817|10796065|FG001|NOT COMPLETED|Open-label Induction Phase||0
9697075|NCT02611817|10796066|FG002|NOT COMPLETED|Open-label Induction Phase||0
9697076|NCT02611817|10796064|FG000|STARTED|Double-blind Maintenance Phase||0
9697077|NCT02611817|10796065|FG001|STARTED|Double-blind Maintenance Phase||135
9697078|NCT02611817|10796066|FG002|STARTED|Double-blind Maintenance Phase||275
9697079|NCT02611817|10796064|FG000|COMPLETED|Double-blind Maintenance Phase||0
9697080|NCT02611817|10796065|FG001|COMPLETED|Double-blind Maintenance Phase||73
9697081|NCT02611817|10796066|FG002|COMPLETED|Double-blind Maintenance Phase||168
9697082|NCT02611817|10796064|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
9697083|NCT02611817|10796065|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62
9697084|NCT02611817|10796066|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107
9697085|NCT02557139|10796076|FG000|STARTED|Overall Study||8
9697086|NCT02557139|10796077|FG001|STARTED|Overall Study||8
9697087|NCT02557139|10796078|FG002|STARTED|Overall Study||7
9697088|NCT02557139|10796076|FG000|COMPLETED|Overall Study||6
9961840|NCT01474512|11081381|FG005|STARTED|Post-Treatment Follow-Up||0
9961841|NCT01474512|11081382|FG006|STARTED|Post-Treatment Follow-Up||0
9961842|NCT01474512|11081383|FG007|STARTED|Post-Treatment Follow-Up||0
9961843|NCT01474512|11081384|FG008|STARTED|Post-Treatment Follow-Up||0
9961844|NCT01474512|11081385|FG009|STARTED|Post-Treatment Follow-Up||0
9961845|NCT01474512|11081386|FG010|STARTED|Post-Treatment Follow-Up||0
9961846|NCT01474512|11081387|FG011|STARTED|Post-Treatment Follow-Up||0
9961847|NCT01474512|11081388|FG012|STARTED|Post-Treatment Follow-Up||0
9961848|NCT01474512|11081389|FG013|STARTED|Post-Treatment Follow-Up||0
9961849|NCT01474512|11081390|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
9961850|NCT01474512|11081391|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
9961851|NCT01474512|11081392|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
9961852|NCT01474512|11081393|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
9961853|NCT01474512|11081376|FG000|COMPLETED|Post-Treatment Follow-Up||0
9961854|NCT01474512|11081377|FG001|COMPLETED|Post-Treatment Follow-Up||0
9961855|NCT01474512|11081378|FG002|COMPLETED|Post-Treatment Follow-Up||0
9961856|NCT01474512|11081379|FG003|COMPLETED|Post-Treatment Follow-Up||0
9961857|NCT01474512|11081380|FG004|COMPLETED|Post-Treatment Follow-Up||0
9961858|NCT01474512|11081381|FG005|COMPLETED|Post-Treatment Follow-Up||0
9961859|NCT01474512|11081382|FG006|COMPLETED|Post-Treatment Follow-Up||0
9961860|NCT01474512|11081383|FG007|COMPLETED|Post-Treatment Follow-Up||0
9961861|NCT01474512|11081384|FG008|COMPLETED|Post-Treatment Follow-Up||0
9961862|NCT01474512|11081385|FG009|COMPLETED|Post-Treatment Follow-Up||0
9961863|NCT01474512|11081386|FG010|COMPLETED|Post-Treatment Follow-Up||0
9961864|NCT01474512|11081387|FG011|COMPLETED|Post-Treatment Follow-Up||0
9961865|NCT01474512|11081388|FG012|COMPLETED|Post-Treatment Follow-Up||0
9961866|NCT01474512|11081389|FG013|COMPLETED|Post-Treatment Follow-Up||0
9697089|NCT02557139|10796077|FG001|COMPLETED|Overall Study||8
9697090|NCT02557139|10796078|FG002|COMPLETED|Overall Study||5
9697091|NCT02557139|10796076|FG000|NOT COMPLETED|Overall Study||2
9697092|NCT02557139|10796077|FG001|NOT COMPLETED|Overall Study||0
9697093|NCT02557139|10796078|FG002|NOT COMPLETED|Overall Study||2
9697094|NCT02488759|10796101|FG000|STARTED|Overall Study||113
9697095|NCT02488759|10796102|FG001|STARTED|Overall Study||195
9697096|NCT02488759|10796103|FG002|STARTED|Overall Study||133
9697097|NCT02488759|10796104|FG003|STARTED|Overall Study||8
9697098|NCT02488759|10796105|FG004|STARTED|Overall Study||6
9697099|NCT02488759|10796106|FG005|STARTED|Overall Study||123
9697100|NCT02488759|10796101|FG000|COMPLETED|Overall Study||2
9697101|NCT02488759|10796102|FG001|COMPLETED|Overall Study||0
9697102|NCT02488759|10796103|FG002|COMPLETED|Overall Study||2
9697103|NCT02488759|10796104|FG003|COMPLETED|Overall Study||0
9697104|NCT02488759|10796105|FG004|COMPLETED|Overall Study||0
9697105|NCT02488759|10796106|FG005|COMPLETED|Overall Study||0
9697106|NCT02488759|10796101|FG000|NOT COMPLETED|Overall Study||111
9697107|NCT02488759|10796102|FG001|NOT COMPLETED|Overall Study||195
9697108|NCT02488759|10796103|FG002|NOT COMPLETED|Overall Study||131
9697109|NCT02488759|10796104|FG003|NOT COMPLETED|Overall Study||8
9697110|NCT02488759|10796105|FG004|NOT COMPLETED|Overall Study||6
9697111|NCT02488759|10796106|FG005|NOT COMPLETED|Overall Study||123
10026134|NCT01876901|11150289|FG000|NOT COMPLETED|Overall Study||17
10026135|NCT01876901|11150290|FG001|NOT COMPLETED|Overall Study||7
10026136|NCT01876979|11150299|FG000|STARTED|Overall Study||2
10026137|NCT01876979|11150300|FG001|STARTED|Overall Study||3
10026138|NCT01876979|11150299|FG000|COMPLETED|Overall Study||0
10026139|NCT01876979|11150300|FG001|COMPLETED|Overall Study||0
10026140|NCT01876979|11150299|FG000|NOT COMPLETED|Overall Study||2
10026141|NCT01876979|11150300|FG001|NOT COMPLETED|Overall Study||3
10026142|NCT01876992|11150308|FG000|STARTED|Overall Study||5
10026143|NCT01876992|11150309|FG001|STARTED|Overall Study||5
9697112|NCT02211131|10796122|FG000|STARTED|Overall Study||74
9697113|NCT02211131|10796123|FG001|STARTED|Overall Study||76
9697114|NCT02211131|10796122|FG000|COMPLETED|Overall Study||0
9697115|NCT02211131|10796123|FG001|COMPLETED|Overall Study||0
9697116|NCT02211131|10796122|FG000|NOT COMPLETED|Overall Study||74
9697117|NCT02211131|10796123|FG001|NOT COMPLETED|Overall Study||76
9697118|NCT02186847|10796138|FG000|STARTED|Overall Study||84
9697119|NCT02186847|10796139|FG001|STARTED|Overall Study||86
9697120|NCT02186847|10796138|FG000|Eligible Population|Overall Study||81
9697121|NCT02186847|10796139|FG001|Eligible Population|Overall Study||86
9697122|NCT02186847|10796138|FG000|Eligible and Started Protocol Treatment|Overall Study||76
9697123|NCT02186847|10796139|FG001|Eligible and Started Protocol Treatment|Overall Study||82
9697124|NCT02186847|10796138|FG000|COMPLETED|Overall Study||81
9697125|NCT02186847|10796139|FG001|COMPLETED|Overall Study||86
9697126|NCT02186847|10796138|FG000|NOT COMPLETED|Overall Study||3
9697127|NCT02186847|10796139|FG001|NOT COMPLETED|Overall Study||0
9697128|NCT02101034|10796150|FG000|STARTED|Overall Study||3
9697129|NCT02101034|10796151|FG001|STARTED|Overall Study||6
9697130|NCT02101034|10796152|FG002|STARTED|Overall Study||31
9697131|NCT02101034|10796153|FG003|STARTED|Overall Study||32
9697132|NCT02101034|10796154|FG004|STARTED|Overall Study||24
9697133|NCT02101034|10796150|FG000|COMPLETED|Overall Study||3
9697134|NCT02101034|10796151|FG001|COMPLETED|Overall Study||6
9697135|NCT02101034|10796152|FG002|COMPLETED|Overall Study||30
9697136|NCT02101034|10796153|FG003|COMPLETED|Overall Study||32
9697137|NCT02101034|10796154|FG004|COMPLETED|Overall Study||24
9697138|NCT02101034|10796150|FG000|NOT COMPLETED|Overall Study||0
9697139|NCT02101034|10796151|FG001|NOT COMPLETED|Overall Study||0
9697140|NCT02101034|10796152|FG002|NOT COMPLETED|Overall Study||1
10026144|NCT01876992|11150308|FG000|COMPLETED|Overall Study||5
10026145|NCT01876992|11150309|FG001|COMPLETED|Overall Study||5
9697141|NCT02101034|10796153|FG003|NOT COMPLETED|Overall Study||0
9961867|NCT01474512|11081390|FG014|COMPLETED|Post-Treatment Follow-Up||0
9697142|NCT02101034|10796154|FG004|NOT COMPLETED|Overall Study||0
9697143|NCT02041533|10796174|FG000|STARTED|Overall Study||271
9697144|NCT02041533|10796175|FG001|STARTED|Overall Study||270
9697145|NCT02041533|10796174|FG000|Began Treatment|Overall Study||267
9697146|NCT02041533|10796175|FG001|Began Treatment|Overall Study||263
9697147|NCT02041533|10796174|FG000|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
9697148|NCT02041533|10796175|FG001|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
9697149|NCT02041533|10796174|FG000|NOT COMPLETED|Overall Study||228
9697150|NCT02041533|10796175|FG001|NOT COMPLETED|Overall Study||258
9697151|NCT01865617|10796194|FG000|STARTED|Overall Study||39
9697152|NCT01865617|10796195|FG001|STARTED|Overall Study||5
10026146|NCT01876992|11150308|FG000|NOT COMPLETED|Overall Study||0
10026147|NCT01876992|11150309|FG001|NOT COMPLETED|Overall Study||0
10026148|NCT01877083|11150316|FG000|STARTED|Treatment Phase||25
10026149|NCT01877083|11150316|FG000|COMPLETED|Treatment Phase||5
10026150|NCT01877083|11150316|FG000|NOT COMPLETED|Treatment Phase||20
10026151|NCT01877083|11150316|FG000|STARTED|Extension Phase||5
10026152|NCT01877083|11150316|FG000|COMPLETED|Extension Phase||0
10026153|NCT01877083|11150316|FG000|NOT COMPLETED|Extension Phase||5
9697153|NCT01865617|10796196|FG002|STARTED|Overall Study||2
9697154|NCT01865617|10796197|FG003|STARTED|Overall Study||1
9697155|NCT01865617|10796198|FG004|STARTED|Overall Study||18
9697156|NCT01865617|10796199|FG005|STARTED|Overall Study||5
9697157|NCT01865617|10796200|FG006|STARTED|Overall Study||22
9697158|NCT01865617|10796201|FG007|STARTED|Overall Study||1
9697159|NCT01865617|10796202|FG008|STARTED|Overall Study||20
9697160|NCT01865617|10796203|FG009|STARTED|Overall Study||5
9697161|NCT01865617|10796204|FG010|STARTED|Overall Study||49
9697162|NCT01865617|10796205|FG011|STARTED|Overall Study||10
9697163|NCT01865617|10796206|FG012|STARTED|Overall Study||20
9697164|NCT01865617|10796194|FG000|COMPLETED|Overall Study||9
9697165|NCT01865617|10796195|FG001|COMPLETED|Overall Study||2
9697166|NCT01865617|10796196|FG002|COMPLETED|Overall Study||1
9697167|NCT01865617|10796197|FG003|COMPLETED|Overall Study||0
9697168|NCT01865617|10796198|FG004|COMPLETED|Overall Study||11
9697169|NCT01865617|10796199|FG005|COMPLETED|Overall Study||4
9697170|NCT01865617|10796200|FG006|COMPLETED|Overall Study||10
9697171|NCT01865617|10796201|FG007|COMPLETED|Overall Study||0
9697172|NCT01865617|10796202|FG008|COMPLETED|Overall Study||9
9697173|NCT01865617|10796203|FG009|COMPLETED|Overall Study||2
9697174|NCT01865617|10796204|FG010|COMPLETED|Overall Study||17
9697175|NCT01865617|10796205|FG011|COMPLETED|Overall Study||4
9697176|NCT01865617|10796206|FG012|COMPLETED|Overall Study||7
9697177|NCT01865617|10796194|FG000|NOT COMPLETED|Overall Study||30
9697178|NCT01865617|10796195|FG001|NOT COMPLETED|Overall Study||3
9697179|NCT01865617|10796196|FG002|NOT COMPLETED|Overall Study||1
9697180|NCT01865617|10796197|FG003|NOT COMPLETED|Overall Study||1
9697181|NCT01865617|10796198|FG004|NOT COMPLETED|Overall Study||7
10026154|NCT01877148|11150322|FG000|STARTED|Overall Study||6
10026155|NCT01877148|11150323|FG001|STARTED|Overall Study||6
10026156|NCT01877148|11150322|FG000|COMPLETED|Overall Study||5
9697182|NCT01865617|10796199|FG005|NOT COMPLETED|Overall Study||1
9697183|NCT01865617|10796200|FG006|NOT COMPLETED|Overall Study||12
9697184|NCT01865617|10796201|FG007|NOT COMPLETED|Overall Study||1
9697185|NCT01865617|10796202|FG008|NOT COMPLETED|Overall Study||11
9697186|NCT01865617|10796203|FG009|NOT COMPLETED|Overall Study||3
9697187|NCT01865617|10796204|FG010|NOT COMPLETED|Overall Study||32
9697188|NCT01865617|10796205|FG011|NOT COMPLETED|Overall Study||6
9697189|NCT01865617|10796206|FG012|NOT COMPLETED|Overall Study||13
10026157|NCT01877148|11150323|FG001|COMPLETED|Overall Study||5
10026158|NCT01877148|11150322|FG000|NOT COMPLETED|Overall Study||1
10026159|NCT01877148|11150323|FG001|NOT COMPLETED|Overall Study||1
10026160|NCT01877161|11150329|FG000|STARTED|First Session of Stimulation||12
10026161|NCT01877161|11150329|FG000|COMPLETED|First Session of Stimulation||12
10026162|NCT01877161|11150329|FG000|NOT COMPLETED|First Session of Stimulation||0
10026163|NCT01877161|11150329|FG000|STARTED|Washout (at Least 3 Days)||12
10026164|NCT01877161|11150329|FG000|COMPLETED|Washout (at Least 3 Days)||12
10026165|NCT01877161|11150329|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
10026166|NCT01877161|11150329|FG000|STARTED|Second Session of Stimulation||12
10026167|NCT01877161|11150329|FG000|COMPLETED|Second Session of Stimulation||12
10026168|NCT01877161|11150329|FG000|NOT COMPLETED|Second Session of Stimulation||0
9697190|NCT01828112|10796239|FG000|STARTED|Overall Study||115
9697191|NCT01828112|10796240|FG001|STARTED|Overall Study||116
9697192|NCT01828112|10796239|FG000|Entered Extension Treatment Phase|Overall Study||0
9697193|NCT01828112|10796240|FG001|Entered Extension Treatment Phase|Overall Study||74
9697194|NCT01828112|10796239|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7
9697195|NCT01828112|10796240|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5
9697196|NCT01828112|10796239|FG000|Entered Survival Follow-up Phase|Overall Study||61
9697197|NCT01828112|10796240|FG001|Entered Survival Follow-up Phase|Overall Study||19
9697198|NCT01828112|10796239|FG000|Discontinued From Study|Overall Study||14
9697199|NCT01828112|10796240|FG001|Discontinued From Study|Overall Study||10
9697200|NCT01828112|10796239|FG000|Untreated Patients|Overall Study||0
9697201|NCT01828112|10796240|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3
9697202|NCT01828112|10796239|FG000|Untreated|Overall Study||0
9697203|NCT01828112|10796240|FG001|Untreated|Overall Study||3
9697204|NCT01828112|10796239|FG000|Treated|Overall Study||115
9697205|NCT01828112|10796240|FG001|Treated|Overall Study||113
9697206|NCT01828112|10796239|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
9697207|NCT01828112|10796240|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
9697208|NCT01828112|10796239|FG000|NOT COMPLETED|Overall Study||82
9697209|NCT01828112|10796240|FG001|NOT COMPLETED|Overall Study||108
9697210|NCT01733888|10796250|FG000|STARTED|Overall Study||20
9697211|NCT01733888|10796251|FG001|STARTED|Overall Study||20
9697212|NCT01733888|10796252|FG002|STARTED|Overall Study||20
9697213|NCT01733888|10796253|FG003|STARTED|Overall Study||20
9697214|NCT01733888|10796250|FG000|COMPLETED|Overall Study||20
9697215|NCT01733888|10796251|FG001|COMPLETED|Overall Study||20
9697216|NCT01733888|10796252|FG002|COMPLETED|Overall Study||20
9697217|NCT01733888|10796253|FG003|COMPLETED|Overall Study||20
9697218|NCT01733888|10796250|FG000|NOT COMPLETED|Overall Study||0
9697219|NCT01733888|10796251|FG001|NOT COMPLETED|Overall Study||0
9697220|NCT01733888|10796252|FG002|NOT COMPLETED|Overall Study||0
9697221|NCT01733888|10796253|FG003|NOT COMPLETED|Overall Study||0
9697222|NCT01709981|10796265|FG000|STARTED|Overall Study||141
9697223|NCT01709981|10796266|FG001|STARTED|Overall Study||139
9697224|NCT01709981|10796265|FG000|COMPLETED|Overall Study||141
9697225|NCT01709981|10796266|FG001|COMPLETED|Overall Study||139
9697226|NCT01709981|10796265|FG000|NOT COMPLETED|Overall Study||0
9697227|NCT01709981|10796266|FG001|NOT COMPLETED|Overall Study||0
9697228|NCT01670500|10796274|FG000|STARTED|Overall Study||58
9697229|NCT01670500|10796275|FG001|STARTED|Overall Study||60
9697230|NCT01670500|10796274|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
9697231|NCT01670500|10796275|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
9697232|NCT01670500|10796274|FG000|NOT COMPLETED|Overall Study||1
9697233|NCT01670500|10796275|FG001|NOT COMPLETED|Overall Study||0
9697234|NCT01593254|10796283|FG000|STARTED|Treatment Period||86
9697235|NCT01593254|10796284|FG001|STARTED|Treatment Period||174
9697236|NCT01593254|10796283|FG000|Crossed Over to Dasatinib|Treatment Period||42
9697237|NCT01593254|10796284|FG001|Crossed Over to Dasatinib|Treatment Period||0
9697238|NCT01593254|10796283|FG000|COMPLETED|Treatment Period||72
9697239|NCT01593254|10796284|FG001|COMPLETED|Treatment Period||143
9697240|NCT01593254|10796283|FG000|NOT COMPLETED|Treatment Period||14
9697241|NCT01593254|10796284|FG001|NOT COMPLETED|Treatment Period||31
9697242|NCT01593254|10796283|FG000|STARTED|Follow-Up Period||14
9697243|NCT01593254|10796284|FG001|STARTED|Follow-Up Period||28
9697244|NCT01593254|10796283|FG000|COMPLETED|Follow-Up Period||11
9697245|NCT01593254|10796284|FG001|COMPLETED|Follow-Up Period||17
9697246|NCT01593254|10796283|FG000|NOT COMPLETED|Follow-Up Period||3
9697247|NCT01593254|10796284|FG001|NOT COMPLETED|Follow-Up Period||11
9697248|NCT01453101|10796291|FG000|STARTED|Overall Study||54
9697249|NCT01453101|10796291|FG000|COMPLETED|Overall Study||54
9697250|NCT01453101|10796291|FG000|NOT COMPLETED|Overall Study||0
9727523|NCT00107783|10827119|FG001|NOT COMPLETED|Overall Study||4
9727524|NCT00107900|10827131|FG000|STARTED|Overall Study||85
9727525|NCT00107900|10827132|FG001|STARTED|Overall Study||75
9727526|NCT00107900|10827133|FG002|STARTED|Overall Study||129
9727527|NCT00107900|10827134|FG003|STARTED|Overall Study||99
9727528|NCT00107900|10827135|FG004|STARTED|Overall Study||115
9727529|NCT00107900|10827136|FG005|STARTED|Overall Study||103
9727530|NCT00107900|10827131|FG000|COMPLETED|Overall Study||75
9727531|NCT00107900|10827132|FG001|COMPLETED|Overall Study||72
9727532|NCT00107900|10827133|FG002|COMPLETED|Overall Study||104
9727533|NCT00107900|10827134|FG003|COMPLETED|Overall Study||87
9727534|NCT00107900|10827135|FG004|COMPLETED|Overall Study||94
9727535|NCT00107900|10827136|FG005|COMPLETED|Overall Study||94
9727536|NCT00107900|10827131|FG000|NOT COMPLETED|Overall Study||10
9697251|NCT04604184|10796297|FG000|STARTED|Overall Study||67
9697252|NCT04604184|10796298|FG001|STARTED|Overall Study||66
9697253|NCT04604184|10796297|FG000|Treated|Overall Study||65
9697254|NCT04604184|10796298|FG001|Treated|Overall Study||64
9697255|NCT04604184|10796297|FG000|COMPLETED|Overall Study||47
9697256|NCT04604184|10796298|FG001|COMPLETED|Overall Study||47
9697257|NCT04604184|10796297|FG000|NOT COMPLETED|Overall Study||20
9697258|NCT04604184|10796298|FG001|NOT COMPLETED|Overall Study||19
9697259|NCT04368429|10796306|FG000|STARTED|Overall Study||180
9697260|NCT04368429|10796307|FG001|STARTED|Overall Study||180
9697261|NCT04368429|10796306|FG000|Safety Analysis Set|Overall Study||179
9697262|NCT04368429|10796307|FG001|Safety Analysis Set|Overall Study||180
9697263|NCT04368429|10796306|FG000|COMPLETED|Overall Study||179
9697264|NCT04368429|10796307|FG001|COMPLETED|Overall Study||180
9697265|NCT04368429|10796306|FG000|NOT COMPLETED|Overall Study||1
9697266|NCT04368429|10796307|FG001|NOT COMPLETED|Overall Study||0
9697267|NCT04266158|10796313|FG000|STARTED|Overall Study||0
9697268|NCT04266158|10796313|FG000|COMPLETED|Overall Study||0
9697269|NCT04266158|10796313|FG000|NOT COMPLETED|Overall Study||0
9697270|NCT04155840|10796317|FG000|STARTED|Overall Study||1
9697271|NCT04155840|10796317|FG000|COMPLETED|Overall Study||1
9697272|NCT04155840|10796317|FG000|NOT COMPLETED|Overall Study||0
9697273|NCT03865316|10796321|FG000|STARTED|Overall Study||108
9697274|NCT03865316|10796321|FG000|COMPLETED|Overall Study||100
9697275|NCT03865316|10796321|FG000|NOT COMPLETED|Overall Study||8
9697276|NCT03688555|10796327|FG000|STARTED|Run-in Period||10
9697277|NCT03688555|10796328|FG001|STARTED|Run-in Period||0
9697278|NCT03688555|10796329|FG002|STARTED|Run-in Period||0
9697279|NCT03688555|10796327|FG000|COMPLETED|Run-in Period||10
9697280|NCT03688555|10796328|FG001|COMPLETED|Run-in Period||0
9697281|NCT03688555|10796329|FG002|COMPLETED|Run-in Period||0
9697282|NCT03688555|10796327|FG000|NOT COMPLETED|Run-in Period||0
9697283|NCT03688555|10796328|FG001|NOT COMPLETED|Run-in Period||0
9697284|NCT03688555|10796329|FG002|NOT COMPLETED|Run-in Period||0
9697285|NCT03688555|10796327|FG000|STARTED|Treatment Period|All 10 participants that completed the run-in period were eligible to be randomized to ACT-774312 or placebo.|0
9697286|NCT03688555|10796328|FG001|STARTED|Treatment Period||7
9697287|NCT03688555|10796329|FG002|STARTED|Treatment Period||3
9697288|NCT03688555|10796327|FG000|COMPLETED|Treatment Period||0
9697289|NCT03688555|10796328|FG001|COMPLETED|Treatment Period||7
9697290|NCT03688555|10796329|FG002|COMPLETED|Treatment Period||2
9697291|NCT03688555|10796327|FG000|NOT COMPLETED|Treatment Period||0
9697292|NCT03688555|10796328|FG001|NOT COMPLETED|Treatment Period||0
9697293|NCT03688555|10796329|FG002|NOT COMPLETED|Treatment Period||1
10026169|NCT01877161|11150329|FG000|STARTED|Washout (at Least 3 Days)||12
10026170|NCT01877161|11150329|FG000|COMPLETED|Washout (at Least 3 Days)||12
10026171|NCT01877161|11150329|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
10026172|NCT01877161|11150329|FG000|STARTED|Third Session of Stimulation||12
10026173|NCT01877161|11150329|FG000|COMPLETED|Third Session of Stimulation||12
10026174|NCT01877161|11150329|FG000|NOT COMPLETED|Third Session of Stimulation||0
10026175|NCT01877187|11150337|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39
10026176|NCT01877187|11150337|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
9697294|NCT03593213|10796339|FG000|STARTED|Open-label Treatment Period (18 Weeks)|Out of 162 participants who completed Open-label Treatment Period, 159 participants were randomized to Double-blind treatment Period.|587
9697295|NCT03593213|10796340|FG001|STARTED|Open-label Treatment Period (18 Weeks)||0
9697296|NCT03593213|10796341|FG002|STARTED|Open-label Treatment Period (18 Weeks)||0
9697297|NCT03593213|10796342|FG003|STARTED|Open-label Treatment Period (18 Weeks)||0
9697298|NCT03593213|10796339|FG000|COMPLETED|Open-label Treatment Period (18 Weeks)||162
10026177|NCT01877187|11150337|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
10026178|NCT01877187|11150337|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
9697299|NCT03593213|10796340|FG001|COMPLETED|Open-label Treatment Period (18 Weeks)||0
9697300|NCT03593213|10796341|FG002|COMPLETED|Open-label Treatment Period (18 Weeks)||0
9697301|NCT03593213|10796342|FG003|COMPLETED|Open-label Treatment Period (18 Weeks)||0
10026179|NCT01877187|11150337|FG000|NOT COMPLETED|Overall Study||22
10026180|NCT01877239|11150344|FG000|STARTED|Overall Study||111
10026181|NCT01877239|11150344|FG000|Treated|Overall Study||76
10026182|NCT01877239|11150344|FG000|COMPLETED|Overall Study||61
9697302|NCT03593213|10796339|FG000|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||425
9697303|NCT03593213|10796340|FG001|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
9697304|NCT03593213|10796341|FG002|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
9697305|NCT03593213|10796342|FG003|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
9697306|NCT03593213|10796339|FG000|STARTED|Double-blind Treatment Period (26 Weeks)||0
9697307|NCT03593213|10796340|FG001|STARTED|Double-blind Treatment Period (26 Weeks)||54
9697308|NCT03593213|10796341|FG002|STARTED|Double-blind Treatment Period (26 Weeks)||49
9697309|NCT03593213|10796342|FG003|STARTED|Double-blind Treatment Period (26 Weeks)||56
9697310|NCT03593213|10796339|FG000|Safety Population|Double-blind Treatment Period (26 Weeks)||0
9697311|NCT03593213|10796340|FG001|Safety Population|Double-blind Treatment Period (26 Weeks)||53
9697312|NCT03593213|10796341|FG002|Safety Population|Double-blind Treatment Period (26 Weeks)||49
9697313|NCT03593213|10796342|FG003|Safety Population|Double-blind Treatment Period (26 Weeks)||54
9697314|NCT03593213|10796339|FG000|COMPLETED|Double-blind Treatment Period (26 Weeks)||0
9697315|NCT03593213|10796340|FG001|COMPLETED|Double-blind Treatment Period (26 Weeks)||14
9697316|NCT03593213|10796341|FG002|COMPLETED|Double-blind Treatment Period (26 Weeks)||16
9697317|NCT03593213|10796342|FG003|COMPLETED|Double-blind Treatment Period (26 Weeks)||21
9697318|NCT03593213|10796339|FG000|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||0
9697319|NCT03593213|10796340|FG001|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||40
9697320|NCT03593213|10796341|FG002|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||33
9697321|NCT03593213|10796342|FG003|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||35
9697322|NCT03349723|10796363|FG000|STARTED|Overall Study||6
9697323|NCT03349723|10796364|FG001|STARTED|Overall Study||6
9697324|NCT03349723|10796365|FG002|STARTED|Overall Study||6
9697325|NCT03349723|10796366|FG003|STARTED|Overall Study||6
9697326|NCT03349723|10796367|FG004|STARTED|Overall Study||6
9697327|NCT03349723|10796368|FG005|STARTED|Overall Study||6
9697328|NCT03349723|10796369|FG006|STARTED|Overall Study||6
9697329|NCT03349723|10796370|FG007|STARTED|Overall Study||14
10026183|NCT01877239|11150344|FG000|NOT COMPLETED|Overall Study||50
10026184|NCT01877265|11150348|FG000|STARTED|Treatment Period 1||3
10026185|NCT01877265|11150349|FG001|STARTED|Treatment Period 1||3
10026186|NCT01877265|11150350|FG002|STARTED|Treatment Period 1||3
10026187|NCT01877265|11150351|FG003|STARTED|Treatment Period 1||3
10026188|NCT01877265|11150352|FG004|STARTED|Treatment Period 1||3
10026189|NCT01877265|11150353|FG005|STARTED|Treatment Period 1||3
9697330|NCT03349723|10796363|FG000|COMPLETED|Overall Study||6
9697331|NCT03349723|10796364|FG001|COMPLETED|Overall Study||6
9697332|NCT03349723|10796365|FG002|COMPLETED|Overall Study||6
9697333|NCT03349723|10796366|FG003|COMPLETED|Overall Study||6
10026190|NCT01877265|11150348|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3
10026191|NCT01877265|11150349|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3
10026192|NCT01877265|11150350|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3
10026193|NCT01877265|11150351|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3
10026194|NCT01877265|11150352|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3
9697334|NCT03349723|10796367|FG004|COMPLETED|Overall Study||6
9697335|NCT03349723|10796368|FG005|COMPLETED|Overall Study||6
9697336|NCT03349723|10796369|FG006|COMPLETED|Overall Study||6
9697337|NCT03349723|10796370|FG007|COMPLETED|Overall Study||14
9697338|NCT03349723|10796363|FG000|NOT COMPLETED|Overall Study||0
9697339|NCT03349723|10796364|FG001|NOT COMPLETED|Overall Study||0
9697340|NCT03349723|10796365|FG002|NOT COMPLETED|Overall Study||0
9697341|NCT03349723|10796366|FG003|NOT COMPLETED|Overall Study||0
9697342|NCT03349723|10796367|FG004|NOT COMPLETED|Overall Study||0
9697343|NCT03349723|10796368|FG005|NOT COMPLETED|Overall Study||0
9697344|NCT03349723|10796369|FG006|NOT COMPLETED|Overall Study||0
9697345|NCT03349723|10796370|FG007|NOT COMPLETED|Overall Study||0
9697346|NCT03248531|10796391|FG000|STARTED|Overall Study||22
9697347|NCT03248531|10796392|FG001|STARTED|Overall Study||22
9697348|NCT03248531|10796393|FG002|STARTED|Overall Study||46
9697349|NCT03248531|10796391|FG000|Completed Week 12|Overall Study||19
9697350|NCT03248531|10796392|FG001|Completed Week 12|Overall Study||18
9697351|NCT03248531|10796393|FG002|Completed Week 12|Overall Study||42
9697352|NCT03248531|10796391|FG000|COMPLETED|Overall Study||18
9697353|NCT03248531|10796392|FG001|COMPLETED|Overall Study||17
9697354|NCT03248531|10796393|FG002|COMPLETED|Overall Study||38
9697355|NCT03248531|10796391|FG000|NOT COMPLETED|Overall Study||4
9697356|NCT03248531|10796392|FG001|NOT COMPLETED|Overall Study||5
9697357|NCT03248531|10796393|FG002|NOT COMPLETED|Overall Study||8
9697358|NCT03205605|10796408|FG000|STARTED|Overall Study||13
9697359|NCT03205605|10796408|FG000|COMPLETED|Overall Study||12
9697360|NCT03205605|10796408|FG000|NOT COMPLETED|Overall Study||1
9727537|NCT00107900|10827132|FG001|NOT COMPLETED|Overall Study||3
9727538|NCT00107900|10827133|FG002|NOT COMPLETED|Overall Study||25
9727539|NCT00107900|10827134|FG003|NOT COMPLETED|Overall Study||12
9727540|NCT00107900|10827135|FG004|NOT COMPLETED|Overall Study||21
9727541|NCT00107900|10827136|FG005|NOT COMPLETED|Overall Study||9
9727542|NCT00107952|10827152|FG000|STARTED|Overall Study||381
9727543|NCT00107952|10827153|FG001|STARTED|Overall Study||380
9727544|NCT00107952|10827152|FG000|COMPLETED|Overall Study||286
9727545|NCT00107952|10827153|FG001|COMPLETED|Overall Study||299
9727546|NCT00107952|10827152|FG000|NOT COMPLETED|Overall Study||95
9727547|NCT00107952|10827153|FG001|NOT COMPLETED|Overall Study||81
9727548|NCT00107978|10827161|FG000|STARTED|Overall Study||458
9961868|NCT01474512|11081391|FG015|COMPLETED|Post-Treatment Follow-Up||17
9961869|NCT01474512|11081392|FG016|COMPLETED|Post-Treatment Follow-Up||544
9961870|NCT01474512|11081393|FG017|COMPLETED|Post-Treatment Follow-Up||239
9961871|NCT01474512|11081376|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0
9961872|NCT01474512|11081377|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0
9961873|NCT01474512|11081378|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0
9961874|NCT01474512|11081379|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0
9961875|NCT01474512|11081380|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0
9961876|NCT01474512|11081381|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0
9961877|NCT01474512|11081382|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0
9961878|NCT01474512|11081383|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0
9961879|NCT01474512|11081384|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0
9961880|NCT01474512|11081385|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0
9961881|NCT01474512|11081386|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0
9961882|NCT01474512|11081387|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0
9961883|NCT01474512|11081388|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0
9961884|NCT01474512|11081389|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0
10026195|NCT01877265|11150353|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3
10026196|NCT01877265|11150348|FG000|COMPLETED|Treatment Period 1||3
10026197|NCT01877265|11150349|FG001|COMPLETED|Treatment Period 1||3
9727549|NCT00107978|10827162|FG001|STARTED|Overall Study||481
9727550|NCT00107978|10827161|FG000|COMPLETED|Overall Study||425
9727551|NCT00107978|10827162|FG001|COMPLETED|Overall Study||431
9727552|NCT00107978|10827161|FG000|NOT COMPLETED|Overall Study||33
9727553|NCT00107978|10827162|FG001|NOT COMPLETED|Overall Study||50
9727554|NCT00107991|10827168|FG000|STARTED|Eligibility Assessment||38
9727555|NCT00107991|10827168|FG000|COMPLETED|Eligibility Assessment||15
9727556|NCT00107991|10827168|FG000|NOT COMPLETED|Eligibility Assessment||23
9727557|NCT00107991|10827168|FG000|STARTED|12 Week Treatment Period||15
9727558|NCT00107991|10827168|FG000|COMPLETED|12 Week Treatment Period||10
9727559|NCT00107991|10827168|FG000|NOT COMPLETED|12 Week Treatment Period||5
10026198|NCT01877265|11150350|FG002|COMPLETED|Treatment Period 1||2
10026199|NCT01877265|11150351|FG003|COMPLETED|Treatment Period 1||3
10026200|NCT01877265|11150352|FG004|COMPLETED|Treatment Period 1||3
9961885|NCT01474512|11081390|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18
9961886|NCT01474512|11081391|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8
9961887|NCT01474512|11081392|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156
9961888|NCT01474512|11081393|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46
9961889|NCT01474538|11081425|FG000|STARTED|Treatment Period 1||60
9961890|NCT01474538|11081426|FG001|STARTED|Treatment Period 1||62
9961891|NCT01474538|11081425|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
9961892|NCT01474538|11081426|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
9961893|NCT01474538|11081425|FG000|COMPLETED|Treatment Period 1||57
9961894|NCT01474538|11081426|FG001|COMPLETED|Treatment Period 1||58
10026201|NCT01877265|11150353|FG005|COMPLETED|Treatment Period 1||3
10026202|NCT01877265|11150348|FG000|NOT COMPLETED|Treatment Period 1||0
10026203|NCT01877265|11150349|FG001|NOT COMPLETED|Treatment Period 1||0
9961895|NCT01474538|11081425|FG000|NOT COMPLETED|Treatment Period 1||3
10026204|NCT01877265|11150350|FG002|NOT COMPLETED|Treatment Period 1||1
10026205|NCT01877265|11150351|FG003|NOT COMPLETED|Treatment Period 1||0
10026206|NCT01877265|11150352|FG004|NOT COMPLETED|Treatment Period 1||0
10026207|NCT01877265|11150353|FG005|NOT COMPLETED|Treatment Period 1||0
10026208|NCT01877265|11150348|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3
9697361|NCT02556736|10796418|FG000|STARTED|Overall Study||14
9697362|NCT02556736|10796418|FG000|COMPLETED|Overall Study||14
9697363|NCT02556736|10796418|FG000|NOT COMPLETED|Overall Study||0
9697364|NCT02484456|10796424|FG000|STARTED|First Treatment Period: Week 1||10
9697365|NCT02484456|10796425|FG001|STARTED|First Treatment Period: Week 1||9
9697366|NCT02484456|10796424|FG000|COMPLETED|First Treatment Period: Week 1||10
9697367|NCT02484456|10796425|FG001|COMPLETED|First Treatment Period: Week 1||9
9697368|NCT02484456|10796424|FG000|NOT COMPLETED|First Treatment Period: Week 1||0
9697369|NCT02484456|10796425|FG001|NOT COMPLETED|First Treatment Period: Week 1||0
9697370|NCT02484456|10796424|FG000|STARTED|First Treatment Period: Week 2||10
9697371|NCT02484456|10796425|FG001|STARTED|First Treatment Period: Week 2||9
9697372|NCT02484456|10796424|FG000|COMPLETED|First Treatment Period: Week 2||10
9697373|NCT02484456|10796425|FG001|COMPLETED|First Treatment Period: Week 2||9
9697374|NCT02484456|10796424|FG000|NOT COMPLETED|First Treatment Period: Week 2||0
9697375|NCT02484456|10796425|FG001|NOT COMPLETED|First Treatment Period: Week 2||0
9697376|NCT02484456|10796424|FG000|STARTED|Washout Period||10
9697377|NCT02484456|10796425|FG001|STARTED|Washout Period||9
9697378|NCT02484456|10796424|FG000|COMPLETED|Washout Period||10
9697379|NCT02484456|10796425|FG001|COMPLETED|Washout Period||8
9697380|NCT02484456|10796424|FG000|NOT COMPLETED|Washout Period||0
9697381|NCT02484456|10796425|FG001|NOT COMPLETED|Washout Period||1
9697382|NCT02484456|10796424|FG000|STARTED|Second Treatment Period: Week 1||10
9697383|NCT02484456|10796425|FG001|STARTED|Second Treatment Period: Week 1||8
9697384|NCT02484456|10796424|FG000|COMPLETED|Second Treatment Period: Week 1||9
9697385|NCT02484456|10796425|FG001|COMPLETED|Second Treatment Period: Week 1||7
9697386|NCT02484456|10796424|FG000|NOT COMPLETED|Second Treatment Period: Week 1||1
9697387|NCT02484456|10796425|FG001|NOT COMPLETED|Second Treatment Period: Week 1||1
9697388|NCT02484456|10796424|FG000|STARTED|Second Treatment Period: Week 2||9
9697389|NCT02484456|10796425|FG001|STARTED|Second Treatment Period: Week 2||7
9697390|NCT02484456|10796424|FG000|COMPLETED|Second Treatment Period: Week 2||9
9697391|NCT02484456|10796425|FG001|COMPLETED|Second Treatment Period: Week 2||6
9697392|NCT02484456|10796424|FG000|NOT COMPLETED|Second Treatment Period: Week 2||0
9697393|NCT02484456|10796425|FG001|NOT COMPLETED|Second Treatment Period: Week 2||1
9697394|NCT02481830|10796434|FG000|STARTED|Overall Study||284
9697395|NCT02481830|10796435|FG001|STARTED|Overall Study||285
9697396|NCT02481830|10796434|FG000|COMPLETED|Overall Study||282
9697397|NCT02481830|10796435|FG001|COMPLETED|Overall Study||265
9697398|NCT02481830|10796434|FG000|NOT COMPLETED|Overall Study||2
9697399|NCT02481830|10796435|FG001|NOT COMPLETED|Overall Study||20
9697400|NCT02234323|10796441|FG000|STARTED|All Enrolled||108
9697401|NCT02234323|10796441|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
9697402|NCT02234323|10796441|FG000|NOT COMPLETED|All Enrolled||5
9697403|NCT02234323|10796441|FG000|STARTED|All Treated||103
9697404|NCT02234323|10796441|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
9697405|NCT02234323|10796441|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
9697406|NCT02234323|10796441|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
9697407|NCT02234323|10796441|FG000|COMPLETED|All Treated||85
9697408|NCT02234323|10796441|FG000|NOT COMPLETED|All Treated||18
9697409|NCT02220855|10796447|FG000|STARTED|Overall Study||14
9697410|NCT02220855|10796447|FG000|COMPLETED|Overall Study||0
9697411|NCT02220855|10796447|FG000|NOT COMPLETED|Overall Study||14
9697412|NCT01791595|10796458|FG000|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
9697413|NCT01791595|10796459|FG001|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697414|NCT01791595|10796460|FG002|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697415|NCT01791595|10796461|FG003|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697416|NCT01791595|10796462|FG004|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697417|NCT01791595|10796463|FG005|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697418|NCT01791595|10796464|FG006|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697419|NCT01791595|10796458|FG000|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697420|NCT01791595|10796459|FG001|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697421|NCT01791595|10796460|FG002|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697422|NCT01791595|10796461|FG003|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697423|NCT01791595|10796462|FG004|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697424|NCT01791595|10796463|FG005|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697425|NCT01791595|10796464|FG006|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697426|NCT01791595|10796458|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
9697427|NCT01791595|10796459|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697428|NCT01791595|10796460|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697429|NCT01791595|10796461|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697430|NCT01791595|10796462|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697431|NCT01791595|10796463|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697432|NCT01791595|10796464|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
9697433|NCT01791595|10796458|FG000|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10026209|NCT01877265|11150349|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3
10026210|NCT01877265|11150350|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2
10026211|NCT01877265|11150351|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3
9697434|NCT01791595|10796459|FG001|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
9697435|NCT01791595|10796460|FG002|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697436|NCT01791595|10796461|FG003|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697437|NCT01791595|10796462|FG004|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10026212|NCT01877265|11150352|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3
10026213|NCT01877265|11150353|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3
10026214|NCT01877265|11150348|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3
9697438|NCT01791595|10796463|FG005|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697439|NCT01791595|10796464|FG006|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697440|NCT01791595|10796458|FG000|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697441|NCT01791595|10796459|FG001|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697442|NCT01791595|10796460|FG002|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697443|NCT01791595|10796461|FG003|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697444|NCT01791595|10796462|FG004|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697445|NCT01791595|10796463|FG005|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697446|NCT01791595|10796464|FG006|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697447|NCT01791595|10796458|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697448|NCT01791595|10796459|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
9697449|NCT01791595|10796460|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697450|NCT01791595|10796461|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697451|NCT01791595|10796462|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697452|NCT01791595|10796463|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697453|NCT01791595|10796464|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
9697454|NCT01791595|10796458|FG000|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697455|NCT01791595|10796459|FG001|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697456|NCT01791595|10796460|FG002|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
9697457|NCT01791595|10796461|FG003|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697458|NCT01791595|10796462|FG004|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697459|NCT01791595|10796463|FG005|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697460|NCT01791595|10796464|FG006|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697461|NCT01791595|10796458|FG000|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697462|NCT01791595|10796459|FG001|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697463|NCT01791595|10796460|FG002|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697464|NCT01791595|10796461|FG003|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697465|NCT01791595|10796462|FG004|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697466|NCT01791595|10796463|FG005|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697467|NCT01791595|10796464|FG006|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697468|NCT01791595|10796458|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697469|NCT01791595|10796459|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697470|NCT01791595|10796460|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
9697471|NCT01791595|10796461|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697472|NCT01791595|10796462|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697473|NCT01791595|10796463|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697474|NCT01791595|10796464|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
9697475|NCT01791595|10796458|FG000|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697476|NCT01791595|10796459|FG001|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697477|NCT01791595|10796460|FG002|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697478|NCT01791595|10796461|FG003|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||5
9697479|NCT01791595|10796462|FG004|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697480|NCT01791595|10796463|FG005|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697481|NCT01791595|10796464|FG006|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697482|NCT01791595|10796458|FG000|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697483|NCT01791595|10796459|FG001|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10026215|NCT01877265|11150349|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3
9697484|NCT01791595|10796460|FG002|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697485|NCT01791595|10796461|FG003|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||1
9697486|NCT01791595|10796462|FG004|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697487|NCT01791595|10796463|FG005|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697488|NCT01791595|10796464|FG006|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697489|NCT01791595|10796458|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697490|NCT01791595|10796459|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697491|NCT01791595|10796460|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697492|NCT01791595|10796461|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||4
9697493|NCT01791595|10796462|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697494|NCT01791595|10796463|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697495|NCT01791595|10796464|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
9697496|NCT01791595|10796458|FG000|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697497|NCT01791595|10796459|FG001|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697498|NCT01791595|10796460|FG002|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697499|NCT01791595|10796461|FG003|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9961896|NCT01474538|11081426|FG001|NOT COMPLETED|Treatment Period 1||4
9961897|NCT01474538|11081425|FG000|STARTED|Treatment Period 2||57
9961898|NCT01474538|11081426|FG001|STARTED|Treatment Period 2||58
9961899|NCT01474538|11081425|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
9961900|NCT01474538|11081426|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
9961901|NCT01474538|11081425|FG000|COMPLETED|Treatment Period 2||51
9961902|NCT01474538|11081426|FG001|COMPLETED|Treatment Period 2||56
9961903|NCT01474538|11081425|FG000|NOT COMPLETED|Treatment Period 2||6
9961904|NCT01474538|11081426|FG001|NOT COMPLETED|Treatment Period 2||2
9961905|NCT01474551|11081432|FG000|STARTED|Overall Study||2
9961906|NCT01474551|11081432|FG000|COMPLETED|Overall Study||1
10026216|NCT01877265|11150350|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2
10026217|NCT01877265|11150351|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10026218|NCT01877265|11150352|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10026219|NCT01877265|11150353|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10026220|NCT01877265|11150348|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10026221|NCT01877265|11150349|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10026222|NCT01877265|11150350|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10026223|NCT01877265|11150351|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10026224|NCT01877265|11150352|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10026225|NCT01877265|11150353|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10026226|NCT01877265|11150348|FG000|STARTED|Treatment Period 2||3
10026227|NCT01877265|11150349|FG001|STARTED|Treatment Period 2||3
10026228|NCT01877265|11150350|FG002|STARTED|Treatment Period 2||2
10026229|NCT01877265|11150351|FG003|STARTED|Treatment Period 2||3
10026230|NCT01877265|11150352|FG004|STARTED|Treatment Period 2||3
10026231|NCT01877265|11150353|FG005|STARTED|Treatment Period 2||3
10026232|NCT01877265|11150348|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3
10026233|NCT01877265|11150349|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3
10026234|NCT01877265|11150350|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2
10026235|NCT01877265|11150351|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3
10026236|NCT01877265|11150352|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3
9697500|NCT01791595|10796462|FG004|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
9697501|NCT01791595|10796463|FG005|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697502|NCT01791595|10796464|FG006|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10026237|NCT01877265|11150353|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3
10026238|NCT01877265|11150348|FG000|COMPLETED|Treatment Period 2||3
9961907|NCT01474551|11081432|FG000|NOT COMPLETED|Overall Study||1
9961908|NCT01474590|11081438|FG000|STARTED|Overall Study||133
9961909|NCT01474590|11081439|FG001|STARTED|Overall Study||133
9961910|NCT01474590|11081438|FG000|COMPLETED|Overall Study||105
9961911|NCT01474590|11081439|FG001|COMPLETED|Overall Study||116
9961912|NCT01474590|11081438|FG000|NOT COMPLETED|Overall Study||28
9961913|NCT01474590|11081439|FG001|NOT COMPLETED|Overall Study||17
9697503|NCT01791595|10796458|FG000|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697504|NCT01791595|10796459|FG001|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697505|NCT01791595|10796460|FG002|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697506|NCT01791595|10796461|FG003|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697507|NCT01791595|10796462|FG004|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697508|NCT01791595|10796463|FG005|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697509|NCT01791595|10796464|FG006|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697510|NCT01791595|10796458|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697511|NCT01791595|10796459|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697512|NCT01791595|10796460|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697513|NCT01791595|10796461|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697514|NCT01791595|10796462|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
9697515|NCT01791595|10796463|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697516|NCT01791595|10796464|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
9697517|NCT01791595|10796458|FG000|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697518|NCT01791595|10796459|FG001|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697519|NCT01791595|10796460|FG002|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697520|NCT01791595|10796461|FG003|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697521|NCT01791595|10796462|FG004|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697522|NCT01791595|10796463|FG005|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
9697523|NCT01791595|10796464|FG006|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697524|NCT01791595|10796458|FG000|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697525|NCT01791595|10796459|FG001|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697526|NCT01791595|10796460|FG002|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697527|NCT01791595|10796461|FG003|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697528|NCT01791595|10796462|FG004|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697529|NCT01791595|10796463|FG005|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697530|NCT01791595|10796464|FG006|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697531|NCT01791595|10796458|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697532|NCT01791595|10796459|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697533|NCT01791595|10796460|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697534|NCT01791595|10796461|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697535|NCT01791595|10796462|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697536|NCT01791595|10796463|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
9697537|NCT01791595|10796464|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
9697538|NCT01791595|10796458|FG000|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697539|NCT01791595|10796459|FG001|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697540|NCT01791595|10796460|FG002|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697541|NCT01791595|10796461|FG003|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697542|NCT01791595|10796462|FG004|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697543|NCT01791595|10796463|FG005|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697544|NCT01791595|10796464|FG006|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||11
9697545|NCT01791595|10796458|FG000|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697546|NCT01791595|10796459|FG001|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697547|NCT01791595|10796460|FG002|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697548|NCT01791595|10796461|FG003|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697549|NCT01791595|10796462|FG004|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697550|NCT01791595|10796463|FG005|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697551|NCT01791595|10796464|FG006|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||1
9697552|NCT01791595|10796458|FG000|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697553|NCT01791595|10796459|FG001|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697554|NCT01791595|10796460|FG002|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697555|NCT01791595|10796461|FG003|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697556|NCT01791595|10796462|FG004|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697557|NCT01791595|10796463|FG005|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
9697558|NCT01791595|10796464|FG006|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||10
9697559|NCT01192776|10796488|FG000|STARTED|Overall Study||95
9697560|NCT01192776|10796489|FG001|STARTED|Overall Study||90
9697561|NCT01192776|10796490|FG002|STARTED|Overall Study||96
9697562|NCT01192776|10796491|FG003|STARTED|Overall Study||83
9697563|NCT01192776|10796488|FG000|Died Prior to Discharge|Overall Study||7
9697564|NCT01192776|10796489|FG001|Died Prior to Discharge|Overall Study||13
9697565|NCT01192776|10796490|FG002|Died Prior to Discharge|Overall Study||15
9697566|NCT01192776|10796491|FG003|Died Prior to Discharge|Overall Study||14
9697567|NCT01192776|10796488|FG000|Died After Discharge|Overall Study||1
9697568|NCT01192776|10796489|FG001|Died After Discharge|Overall Study||2
9697569|NCT01192776|10796490|FG002|Died After Discharge|Overall Study||3
9697570|NCT01192776|10796491|FG003|Died After Discharge|Overall Study||1
9697571|NCT01192776|10796488|FG000|COMPLETED|Overall Study||84
9697572|NCT01192776|10796489|FG001|COMPLETED|Overall Study||69
9697573|NCT01192776|10796490|FG002|COMPLETED|Overall Study||75
9697574|NCT01192776|10796491|FG003|COMPLETED|Overall Study||63
9697575|NCT01192776|10796488|FG000|NOT COMPLETED|Overall Study||11
9697576|NCT01192776|10796489|FG001|NOT COMPLETED|Overall Study||21
9697577|NCT01192776|10796490|FG002|NOT COMPLETED|Overall Study||21
9697578|NCT01192776|10796491|FG003|NOT COMPLETED|Overall Study||20
9697579|NCT00089791|10796505|FG000|STARTED|Overall Study||3906
9697580|NCT00089791|10796506|FG001|STARTED|Overall Study||3902
9697581|NCT00089791|10796505|FG000|Received Study Medication|Overall Study||3883
9697582|NCT00089791|10796506|FG001|Received Study Medication|Overall Study||3879
9697583|NCT00089791|10796505|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
9697584|NCT00089791|10796506|FG001|Safety Analysis Set|Overall Study||3886
9697585|NCT00089791|10796505|FG000|COMPLETED|Overall Study||3206
9697586|NCT00089791|10796506|FG001|COMPLETED|Overall Study||3272
9697587|NCT00089791|10796505|FG000|NOT COMPLETED|Overall Study||700
9697588|NCT00089791|10796506|FG001|NOT COMPLETED|Overall Study||630
9727560|NCT00107991|10827168|FG000|STARTED|18-Week Post Treatment Assessment||10
9727561|NCT00107991|10827168|FG000|COMPLETED|18-Week Post Treatment Assessment||8
9727562|NCT00107991|10827168|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2
9727563|NCT00108069|10827174|FG000|STARTED|Overall Study||30
9727564|NCT00108069|10827175|FG001|STARTED|Overall Study||13
9727565|NCT00108069|10827174|FG000|COMPLETED|Overall Study||0
9727566|NCT00108069|10827175|FG001|COMPLETED|Overall Study||0
9727567|NCT00108069|10827174|FG000|NOT COMPLETED|Overall Study||30
9727568|NCT00108069|10827175|FG001|NOT COMPLETED|Overall Study||13
9727569|NCT00108082|10827190|FG000|STARTED|Overall Study||91
9961914|NCT01474681|11081447|FG000|STARTED|Overall Study||1
9961915|NCT01474681|11081448|FG001|STARTED|Overall Study||8
9961916|NCT01474681|11081449|FG002|STARTED|Overall Study||3
9961917|NCT01474681|11081450|FG003|STARTED|Overall Study||15
9961918|NCT01474681|11081447|FG000|COMPLETED|Overall Study||1
9961919|NCT01474681|11081448|FG001|COMPLETED|Overall Study||5
9961920|NCT01474681|11081449|FG002|COMPLETED|Overall Study||1
9961921|NCT01474681|11081450|FG003|COMPLETED|Overall Study||9
9961922|NCT01474681|11081447|FG000|NOT COMPLETED|Overall Study||0
9961923|NCT01474681|11081448|FG001|NOT COMPLETED|Overall Study||3
9961924|NCT01474681|11081449|FG002|NOT COMPLETED|Overall Study||2
9961925|NCT01474681|11081450|FG003|NOT COMPLETED|Overall Study||6
9961926|NCT01474746|11081466|FG000|STARTED|Overall Study||30
9961927|NCT01474746|11081467|FG001|STARTED|Overall Study||27
9961928|NCT01474746|11081466|FG000|COMPLETED|Overall Study||27
9961929|NCT01474746|11081467|FG001|COMPLETED|Overall Study||25
9961930|NCT01474746|11081466|FG000|NOT COMPLETED|Overall Study||3
9697589|NCT03397264|10796517|FG000|STARTED|Overall Study||3
9697590|NCT03397264|10796518|FG001|STARTED|Overall Study||3
9697591|NCT03397264|10796519|FG002|STARTED|Overall Study||3
9697592|NCT03397264|10796520|FG003|STARTED|Overall Study||96
9697593|NCT03397264|10796521|FG004|STARTED|Overall Study||48
9697594|NCT03397264|10796517|FG000|COMPLETED|Overall Study||3
9697595|NCT03397264|10796518|FG001|COMPLETED|Overall Study||3
9697596|NCT03397264|10796519|FG002|COMPLETED|Overall Study||3
9697597|NCT03397264|10796520|FG003|COMPLETED|Overall Study||89
9697598|NCT03397264|10796521|FG004|COMPLETED|Overall Study||47
9697599|NCT03397264|10796517|FG000|NOT COMPLETED|Overall Study||0
10026239|NCT01877265|11150349|FG001|COMPLETED|Treatment Period 2||3
10026240|NCT01877265|11150350|FG002|COMPLETED|Treatment Period 2||2
9697600|NCT03397264|10796518|FG001|NOT COMPLETED|Overall Study||0
9697601|NCT03397264|10796519|FG002|NOT COMPLETED|Overall Study||0
9697602|NCT03397264|10796520|FG003|NOT COMPLETED|Overall Study||7
9697603|NCT03397264|10796521|FG004|NOT COMPLETED|Overall Study||1
9697604|NCT03392883|10796537|FG000|STARTED|Overall Study||1264
9697605|NCT03392883|10796538|FG001|STARTED|Overall Study||45
9697606|NCT03392883|10796539|FG002|STARTED|Overall Study||39
9697607|NCT03392883|10796537|FG000|COMPLETED|Overall Study||928
9697608|NCT03392883|10796538|FG001|COMPLETED|Overall Study||32
9697609|NCT03392883|10796539|FG002|COMPLETED|Overall Study||30
9697610|NCT03392883|10796537|FG000|NOT COMPLETED|Overall Study||336
9697611|NCT03392883|10796538|FG001|NOT COMPLETED|Overall Study||13
9697612|NCT03392883|10796539|FG002|NOT COMPLETED|Overall Study||9
9697613|NCT03376789|10796547|FG000|STARTED|Overall Study||108
9697614|NCT03376789|10796548|FG001|STARTED|Overall Study||111
9697615|NCT03376789|10796547|FG000|COMPLETED|Overall Study||103
9697616|NCT03376789|10796548|FG001|COMPLETED|Overall Study||102
9697617|NCT03376789|10796547|FG000|NOT COMPLETED|Overall Study||5
9697618|NCT03376789|10796548|FG001|NOT COMPLETED|Overall Study||9
9697619|NCT03342742|10796556|FG000|STARTED|Overall Study||15
9697620|NCT03342742|10796557|FG001|STARTED|Overall Study||13
9697621|NCT03342742|10796556|FG000|COMPLETED|Overall Study||13
9697622|NCT03342742|10796557|FG001|COMPLETED|Overall Study||11
9697623|NCT03342742|10796556|FG000|NOT COMPLETED|Overall Study||2
9697624|NCT03342742|10796557|FG001|NOT COMPLETED|Overall Study||2
9697625|NCT03333590|10796567|FG000|STARTED|Overall Study||1
9697626|NCT03333590|10796568|FG001|STARTED|Overall Study||1
9697627|NCT03333590|10796567|FG000|COMPLETED|Overall Study||1
9697628|NCT03333590|10796568|FG001|COMPLETED|Overall Study||1
9697629|NCT03333590|10796567|FG000|NOT COMPLETED|Overall Study||0
9697630|NCT03333590|10796568|FG001|NOT COMPLETED|Overall Study||0
9697631|NCT03307967|10796576|FG000|STARTED|Overall Study||40
9697632|NCT03307967|10796576|FG000|COMPLETED|Overall Study||36
9697633|NCT03307967|10796576|FG000|NOT COMPLETED|Overall Study||4
9697634|NCT03290326|10796580|FG000|STARTED|Overall Study||10
9697635|NCT03290326|10796580|FG000|COMPLETED|Overall Study||10
9697636|NCT03290326|10796580|FG000|NOT COMPLETED|Overall Study||0
9697640|NCT03272711|10796592|FG000|STARTED|Overall Study||51
9697641|NCT03272711|10796593|FG001|STARTED|Overall Study||49
9697642|NCT03272711|10796592|FG000|COMPLETED|Overall Study||44
9697643|NCT03272711|10796593|FG001|COMPLETED|Overall Study||41
9697644|NCT03272711|10796592|FG000|NOT COMPLETED|Overall Study||7
9697645|NCT03272711|10796593|FG001|NOT COMPLETED|Overall Study||8
9697646|NCT03271983|10796599|FG000|STARTED|Overall Study|The plan was to do n=12 volunteers; however, funding was terminated due to pandemic so only 7 volunteers were completed.|7
9697647|NCT03271983|10796599|FG000|COMPLETED|Overall Study||7
10026241|NCT01877265|11150351|FG003|COMPLETED|Treatment Period 2||3
10026242|NCT01877265|11150352|FG004|COMPLETED|Treatment Period 2||3
9697648|NCT03271983|10796599|FG000|NOT COMPLETED|Overall Study||0
9697649|NCT03246789|10796609|FG000|STARTED|Overall Study||24
9697650|NCT03246789|10796610|FG001|STARTED|Overall Study||15
9697651|NCT03246789|10796609|FG000|COMPLETED|Overall Study||24
10026243|NCT01877265|11150353|FG005|COMPLETED|Treatment Period 2||3
10026244|NCT01877265|11150348|FG000|NOT COMPLETED|Treatment Period 2||0
10026245|NCT01877265|11150349|FG001|NOT COMPLETED|Treatment Period 2||0
9697637|NCT03288129|10796586|FG000|STARTED|Overall Study||54
9697638|NCT03288129|10796586|FG000|COMPLETED|Overall Study||32
9697639|NCT03288129|10796586|FG000|NOT COMPLETED|Overall Study||22
9697652|NCT03246789|10796610|FG001|COMPLETED|Overall Study||15
9697653|NCT03246789|10796609|FG000|NOT COMPLETED|Overall Study||0
9697654|NCT03246789|10796610|FG001|NOT COMPLETED|Overall Study||0
9727570|NCT00108082|10827191|FG001|STARTED|Overall Study||100
9727571|NCT00108082|10827192|FG002|STARTED|Overall Study||96
9727572|NCT00108082|10827190|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
9727573|NCT00108082|10827191|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
9727574|NCT00108082|10827192|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
9727575|NCT00108082|10827190|FG000|NOT COMPLETED|Overall Study||38
9727576|NCT00108082|10827191|FG001|NOT COMPLETED|Overall Study||32
9727577|NCT00108082|10827192|FG002|NOT COMPLETED|Overall Study||43
9727578|NCT00108160|10827202|FG000|STARTED|Overall Study||83
9727579|NCT00108160|10827203|FG001|STARTED|Overall Study||63
9727580|NCT00108160|10827202|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
9727581|NCT00108160|10827203|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
9727582|NCT00108160|10827202|FG000|Completed Visit 1 (2 Wks)|Overall Study||72
9727583|NCT00108160|10827203|FG001|Completed Visit 1 (2 Wks)|Overall Study||54
9727584|NCT00108160|10827202|FG000|Completed Visit 2 (3 mo)|Overall Study||54
9727585|NCT00108160|10827203|FG001|Completed Visit 2 (3 mo)|Overall Study||46
9727586|NCT00108160|10827202|FG000|Completed Visit 3 (6 mo)|Overall Study||44
9727587|NCT00108160|10827203|FG001|Completed Visit 3 (6 mo)|Overall Study||38
9727588|NCT00108160|10827202|FG000|Completed Visit 4 (9 mo)|Overall Study||38
9727589|NCT00108160|10827203|FG001|Completed Visit 4 (9 mo)|Overall Study||37
9727590|NCT00108160|10827202|FG000|Completed Visit 5 (12 mo)|Overall Study||37
9727591|NCT00108160|10827203|FG001|Completed Visit 5 (12 mo)|Overall Study||37
9727592|NCT00108160|10827202|FG000|Completed Visit 6 (15 mo)|Overall Study||36
9727593|NCT00108160|10827203|FG001|Completed Visit 6 (15 mo)|Overall Study||33
9727594|NCT00108160|10827202|FG000|Completed Visit 7 (18 mo)|Overall Study||34
9727595|NCT00108160|10827203|FG001|Completed Visit 7 (18 mo)|Overall Study||31
9727596|NCT00108160|10827202|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
9727597|NCT00108160|10827203|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
9727598|NCT00108160|10827202|FG000|NOT COMPLETED|Overall Study||39
9727599|NCT00108160|10827203|FG001|NOT COMPLETED|Overall Study||21
9727600|NCT00108277|10827214|FG000|STARTED|Overall Study||29
9727601|NCT00108277|10827215|FG001|STARTED|Overall Study||28
9727602|NCT00108277|10827216|FG002|STARTED|Overall Study||35
9727603|NCT00108277|10827214|FG000|COMPLETED|Overall Study||19
9727604|NCT00108277|10827215|FG001|COMPLETED|Overall Study||16
9727605|NCT00108277|10827216|FG002|COMPLETED|Overall Study||19
9727606|NCT00108277|10827214|FG000|NOT COMPLETED|Overall Study||10
9727607|NCT00108277|10827215|FG001|NOT COMPLETED|Overall Study||12
9727608|NCT00108277|10827216|FG002|NOT COMPLETED|Overall Study||16
9727609|NCT00108303|10827227|FG000|STARTED|Overall Study||179
9727610|NCT00108303|10827228|FG001|STARTED|Overall Study||179
9727611|NCT00108303|10827229|FG002|STARTED|Overall Study||180
9727612|NCT00108303|10827227|FG000|COMPLETED|Overall Study||179
9727613|NCT00108303|10827228|FG001|COMPLETED|Overall Study||179
10026246|NCT01877265|11150350|FG002|NOT COMPLETED|Treatment Period 2||0
10026247|NCT01877265|11150351|FG003|NOT COMPLETED|Treatment Period 2||0
10026248|NCT01877265|11150352|FG004|NOT COMPLETED|Treatment Period 2||0
10026249|NCT01877265|11150353|FG005|NOT COMPLETED|Treatment Period 2||0
10026250|NCT01877265|11150348|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3
10026251|NCT01877265|11150349|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3
10026252|NCT01877265|11150350|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2
10026253|NCT01877265|11150351|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3
10026254|NCT01877265|11150352|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3
10026255|NCT01877265|11150353|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3
10114848|NCT02520284|11245635|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
10114849|NCT02520284|11245636|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
10114850|NCT02520310|11245650|FG000|STARTED|At 30 Days Clinical Follow-up||30
10114851|NCT02520310|11245650|FG000|COMPLETED|At 30 Days Clinical Follow-up||30
10114852|NCT02520310|11245650|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0
10114853|NCT02520310|11245650|FG000|STARTED|At 6 Months Clinical Follow-up||30
10114854|NCT02520310|11245650|FG000|COMPLETED|At 6 Months Clinical Follow-up||29
10114855|NCT02520310|11245650|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1
10114856|NCT02520310|11245650|FG000|STARTED|At 1 Year Clinical Follow-up||29
10114857|NCT02520310|11245650|FG000|COMPLETED|At 1 Year Clinical Follow-up||28
10114858|NCT02520310|11245650|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1
10114859|NCT02520310|11245650|FG000|STARTED|At 2 Year Clinical Follow-up||28
10114860|NCT02520310|11245650|FG000|COMPLETED|At 2 Year Clinical Follow-up||28
10114861|NCT02520310|11245650|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0
10114862|NCT02520310|11245650|FG000|STARTED|AT 3 Year Clinical Follow-up||28
10114863|NCT02520310|11245650|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24
10114864|NCT02520310|11245650|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
10114865|NCT02520310|11245650|FG000|STARTED|AT 4 Year Clinical Follow-up||24
10114866|NCT02520310|11245650|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22
10114867|NCT02520310|11245650|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
10114868|NCT02520388|11245658|FG000|STARTED|Overall Study||82
10114869|NCT02520388|11245659|FG001|STARTED|Overall Study||81
9697655|NCT03241225|10796618|FG000|STARTED|Overall Study||24
9697656|NCT03241225|10796619|FG001|STARTED|Overall Study||16
10114870|NCT02520388|11245658|FG000|Treated|Overall Study||81
10114871|NCT02520388|11245659|FG001|Treated|Overall Study||80
10114872|NCT02520388|11245658|FG000|COMPLETED|Overall Study||73
10114873|NCT02520388|11245659|FG001|COMPLETED|Overall Study||65
10114874|NCT02520388|11245658|FG000|NOT COMPLETED|Overall Study||9
10114875|NCT02520388|11245659|FG001|NOT COMPLETED|Overall Study||16
10114876|NCT02520414|11245665|FG000|STARTED|Overall Study||10
10114877|NCT02520414|11245665|FG000|COMPLETED|Overall Study||10
10114878|NCT02520414|11245665|FG000|NOT COMPLETED|Overall Study||0
10114879|NCT02520518|11245673|FG000|STARTED|Overall Study||3
10114880|NCT02520518|11245674|FG001|STARTED|Overall Study||1
10114881|NCT02520518|11245675|FG002|STARTED|Overall Study||3
10114882|NCT02520518|11245676|FG003|STARTED|Overall Study||2
10114883|NCT02520518|11245673|FG000|COMPLETED|Overall Study||3
10114884|NCT02520518|11245674|FG001|COMPLETED|Overall Study||1
10114885|NCT02520518|11245675|FG002|COMPLETED|Overall Study||1
10114886|NCT02520518|11245676|FG003|COMPLETED|Overall Study||1
10114887|NCT02520518|11245673|FG000|NOT COMPLETED|Overall Study||0
10114888|NCT02520518|11245674|FG001|NOT COMPLETED|Overall Study||0
10114889|NCT02520518|11245675|FG002|NOT COMPLETED|Overall Study||2
10114890|NCT02520518|11245676|FG003|NOT COMPLETED|Overall Study||1
10114891|NCT02520531|11245690|FG000|STARTED|Overall Study||42
10114892|NCT02520531|11245691|FG001|STARTED|Overall Study||42
10114893|NCT02520531|11245690|FG000|COMPLETED|Overall Study||36
10114894|NCT02520531|11245691|FG001|COMPLETED|Overall Study||36
10114895|NCT02520531|11245690|FG000|NOT COMPLETED|Overall Study||6
10114896|NCT02520531|11245691|FG001|NOT COMPLETED|Overall Study||6
9697657|NCT03241225|10796618|FG000|COMPLETED|Overall Study||17
9697658|NCT03241225|10796619|FG001|COMPLETED|Overall Study||14
9697659|NCT03241225|10796618|FG000|NOT COMPLETED|Overall Study||7
10026256|NCT01877265|11150348|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10026257|NCT01877265|11150349|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10026258|NCT01877265|11150350|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2
10026259|NCT01877265|11150351|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10026260|NCT01877265|11150352|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10026261|NCT01877265|11150353|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2
10026262|NCT01877265|11150348|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10026263|NCT01877265|11150349|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10026264|NCT01877265|11150350|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10026265|NCT01877265|11150351|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10026266|NCT01877265|11150352|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10026267|NCT01877265|11150353|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
10026268|NCT01877265|11150348|FG000|STARTED|Treatment Period 3||3
10026269|NCT01877265|11150349|FG001|STARTED|Treatment Period 3||3
10026270|NCT01877265|11150350|FG002|STARTED|Treatment Period 3||2
10026271|NCT01877265|11150351|FG003|STARTED|Treatment Period 3||3
10026272|NCT01877265|11150352|FG004|STARTED|Treatment Period 3||3
10026273|NCT01877265|11150353|FG005|STARTED|Treatment Period 3||2
10026274|NCT01877265|11150348|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3
10026275|NCT01877265|11150349|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3
10026276|NCT01877265|11150350|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2
9847579|NCT00854594|10960125|FG000|NOT COMPLETED|Overall Study||0
9847580|NCT00854594|10960126|FG001|NOT COMPLETED|Overall Study||0
9847581|NCT00854607|10960132|FG000|STARTED|Enrollment||116
9847582|NCT00854607|10960132|FG000|COMPLETED|Enrollment||116
9847583|NCT00854607|10960132|FG000|NOT COMPLETED|Enrollment||0
9847584|NCT00854607|10960132|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116
9847585|NCT00854607|10960132|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
9847586|NCT00854607|10960132|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
9847587|NCT00854620|10960143|FG000|STARTED|Overall Study||9
9847588|NCT00854620|10960143|FG000|COMPLETED|Overall Study||8
9847589|NCT00854620|10960143|FG000|NOT COMPLETED|Overall Study||1
9847590|NCT00854724|10960149|FG000|STARTED|First Intervention||8
9847591|NCT00854724|10960150|FG001|STARTED|First Intervention||8
9847592|NCT00854724|10960149|FG000|COMPLETED|First Intervention||7
9847593|NCT00854724|10960150|FG001|COMPLETED|First Intervention||7
9847594|NCT00854724|10960149|FG000|NOT COMPLETED|First Intervention||1
9847595|NCT00854724|10960150|FG001|NOT COMPLETED|First Intervention||1
9847596|NCT00854724|10960149|FG000|STARTED|Washout||7
9847597|NCT00854724|10960150|FG001|STARTED|Washout||7
10026277|NCT01877265|11150351|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3
10026278|NCT01877265|11150352|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3
10026279|NCT01877265|11150353|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2
10026280|NCT01877265|11150348|FG000|COMPLETED|Treatment Period 3||2
9847598|NCT00854724|10960149|FG000|COMPLETED|Washout||6
9847599|NCT00854724|10960150|FG001|COMPLETED|Washout||6
9847600|NCT00854724|10960149|FG000|NOT COMPLETED|Washout||1
9847601|NCT00854724|10960150|FG001|NOT COMPLETED|Washout||1
9847602|NCT00854724|10960149|FG000|STARTED|Second Intervention||6
9697660|NCT03241225|10796619|FG001|NOT COMPLETED|Overall Study||2
9727614|NCT00108303|10827229|FG002|COMPLETED|Overall Study||180
9727615|NCT00108303|10827227|FG000|NOT COMPLETED|Overall Study||0
9847603|NCT00854724|10960150|FG001|STARTED|Second Intervention||6
9847604|NCT00854724|10960149|FG000|COMPLETED|Second Intervention||5
9847605|NCT00854724|10960150|FG001|COMPLETED|Second Intervention||5
9847606|NCT00854724|10960149|FG000|NOT COMPLETED|Second Intervention||1
9847607|NCT00854724|10960150|FG001|NOT COMPLETED|Second Intervention||1
9847608|NCT00854828|10960160|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30
9847609|NCT00854828|10960161|FG001|STARTED|Overall Study||33
9847610|NCT00854828|10960162|FG002|STARTED|Overall Study||112
9847611|NCT00854828|10960163|FG003|STARTED|Overall Study||111
9847612|NCT00854828|10960160|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24
9847613|NCT00854828|10960161|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32
9847614|NCT00854828|10960162|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112
9847615|NCT00854828|10960163|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106
9847616|NCT00854828|10960160|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26
9847617|NCT00854828|10960161|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32
9847618|NCT00854828|10960162|FG002|12 Months Post Intervention|Overall Study||112
9847619|NCT00854828|10960163|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101
9847620|NCT00854828|10960160|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27
9847621|NCT00854828|10960161|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31
9847622|NCT00854828|10960162|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104
9847623|NCT00854828|10960163|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94
9847624|NCT00854828|10960160|FG000|COMPLETED|Overall Study||27
9847625|NCT00854828|10960161|FG001|COMPLETED|Overall Study||31
9847626|NCT00854828|10960162|FG002|COMPLETED|Overall Study||104
9847627|NCT00854828|10960163|FG003|COMPLETED|Overall Study||94
9847628|NCT00854828|10960160|FG000|NOT COMPLETED|Overall Study||3
9847629|NCT00854828|10960161|FG001|NOT COMPLETED|Overall Study||2
9847630|NCT00854828|10960162|FG002|NOT COMPLETED|Overall Study||8
9847631|NCT00854828|10960163|FG003|NOT COMPLETED|Overall Study||17
9847632|NCT00854906|10960173|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
9847633|NCT00854906|10960173|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
9847634|NCT00854906|10960173|FG000|NOT COMPLETED|Overall Study||1
9847635|NCT00855010|10960182|FG000|STARTED|Overall Study||23
9847636|NCT00855010|10960183|FG001|STARTED|Overall Study||19
9727616|NCT00108303|10827228|FG001|NOT COMPLETED|Overall Study||0
9697661|NCT03225846|10796632|FG000|STARTED|Overall Study||22
9697662|NCT03225846|10796633|FG001|STARTED|Overall Study||9
9697663|NCT03225846|10796634|FG002|STARTED|Overall Study||12
9697664|NCT03225846|10796635|FG003|STARTED|Overall Study||15
9697665|NCT03225846|10796636|FG004|STARTED|Overall Study||8
9697666|NCT03225846|10796637|FG005|STARTED|Overall Study||9
9697667|NCT03225846|10796638|FG006|STARTED|Overall Study||13
9697668|NCT03225846|10796632|FG000|Single Dose Period Only|Overall Study||6
9697669|NCT03225846|10796633|FG001|Single Dose Period Only|Overall Study||3
9697670|NCT03225846|10796634|FG002|Single Dose Period Only|Overall Study||4
9697671|NCT03225846|10796635|FG003|Single Dose Period Only|Overall Study||7
9697672|NCT03225846|10796636|FG004|Single Dose Period Only|Overall Study||8
9697673|NCT03225846|10796637|FG005|Single Dose Period Only|Overall Study||0
9697674|NCT03225846|10796638|FG006|Single Dose Period Only|Overall Study||4
9697675|NCT03225846|10796632|FG000|Multiple Dose Period Only|Overall Study||3
9697676|NCT03225846|10796633|FG001|Multiple Dose Period Only|Overall Study||0
9697677|NCT03225846|10796634|FG002|Multiple Dose Period Only|Overall Study||3
9697678|NCT03225846|10796635|FG003|Multiple Dose Period Only|Overall Study||6
9697679|NCT03225846|10796636|FG004|Multiple Dose Period Only|Overall Study||0
9697680|NCT03225846|10796637|FG005|Multiple Dose Period Only|Overall Study||0
9697681|NCT03225846|10796638|FG006|Multiple Dose Period Only|Overall Study||4
9697682|NCT03225846|10796632|FG000|Single Dose and Multiple Dose|Overall Study||13
9697683|NCT03225846|10796633|FG001|Single Dose and Multiple Dose|Overall Study||6
9697684|NCT03225846|10796634|FG002|Single Dose and Multiple Dose|Overall Study||5
9697685|NCT03225846|10796635|FG003|Single Dose and Multiple Dose|Overall Study||2
9697686|NCT03225846|10796636|FG004|Single Dose and Multiple Dose|Overall Study||0
9697687|NCT03225846|10796637|FG005|Single Dose and Multiple Dose|Overall Study||9
9697688|NCT03225846|10796638|FG006|Single Dose and Multiple Dose|Overall Study||5
9697689|NCT03225846|10796632|FG000|COMPLETED|Overall Study||22
9697690|NCT03225846|10796633|FG001|COMPLETED|Overall Study||7
9697691|NCT03225846|10796634|FG002|COMPLETED|Overall Study||11
9697692|NCT03225846|10796635|FG003|COMPLETED|Overall Study||15
9697693|NCT03225846|10796636|FG004|COMPLETED|Overall Study||8
9697694|NCT03225846|10796637|FG005|COMPLETED|Overall Study||9
9697695|NCT03225846|10796638|FG006|COMPLETED|Overall Study||6
9697696|NCT03225846|10796632|FG000|NOT COMPLETED|Overall Study||0
9697697|NCT03225846|10796633|FG001|NOT COMPLETED|Overall Study||2
9697698|NCT03225846|10796634|FG002|NOT COMPLETED|Overall Study||1
9697699|NCT03225846|10796635|FG003|NOT COMPLETED|Overall Study||0
9697700|NCT03225846|10796636|FG004|NOT COMPLETED|Overall Study||0
9697701|NCT03225846|10796637|FG005|NOT COMPLETED|Overall Study||0
9697702|NCT03225846|10796638|FG006|NOT COMPLETED|Overall Study||7
9727617|NCT00108303|10827229|FG002|NOT COMPLETED|Overall Study||0
9727618|NCT00108355|10827243|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
9727619|NCT00108355|10827244|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
9727620|NCT00108355|10827243|FG000|COMPLETED|Overall Study||13
9727621|NCT00108355|10827244|FG001|COMPLETED|Overall Study||12
9727622|NCT00108355|10827243|FG000|NOT COMPLETED|Overall Study||2
9727623|NCT00108355|10827244|FG001|NOT COMPLETED|Overall Study||2
9727624|NCT00108485|10827252|FG000|STARTED|Overall Study||5
9727625|NCT00108485|10827253|FG001|STARTED|Overall Study||4
9727626|NCT00108485|10827252|FG000|COMPLETED|Overall Study||2
9727627|NCT00108485|10827253|FG001|COMPLETED|Overall Study||2
9727628|NCT00108485|10827252|FG000|NOT COMPLETED|Overall Study||3
9727629|NCT00108485|10827253|FG001|NOT COMPLETED|Overall Study||2
9961931|NCT01474746|11081467|FG001|NOT COMPLETED|Overall Study||2
9961932|NCT01474772|11081475|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
9961933|NCT01474772|11081476|FG001|STARTED|Period 1|STARTED=treated|102
9961934|NCT01474772|11081475|FG000|COMPLETED|Period 1||89
9961935|NCT01474772|11081476|FG001|COMPLETED|Period 1||99
9961936|NCT01474772|11081475|FG000|NOT COMPLETED|Period 1||12
9961937|NCT01474772|11081476|FG001|NOT COMPLETED|Period 1||3
9961938|NCT01474772|11081475|FG000|STARTED|Washout||89
9961939|NCT01474772|11081476|FG001|STARTED|Washout||99
9961940|NCT01474772|11081475|FG000|COMPLETED|Washout||86
9961941|NCT01474772|11081476|FG001|COMPLETED|Washout||97
9961942|NCT01474772|11081475|FG000|NOT COMPLETED|Washout||3
9961943|NCT01474772|11081476|FG001|NOT COMPLETED|Washout||2
9961944|NCT01474772|11081475|FG000|STARTED|Period 2||86
9961945|NCT01474772|11081476|FG001|STARTED|Period 2||97
9961946|NCT01474772|11081475|FG000|COMPLETED|Period 2||77
9961947|NCT01474772|11081476|FG001|COMPLETED|Period 2||87
9961948|NCT01474772|11081475|FG000|NOT COMPLETED|Period 2||9
9727630|NCT00108524|10827261|FG000|STARTED|Overall Study||81
9727631|NCT00108524|10827262|FG001|STARTED|Overall Study||79
9727632|NCT00108524|10827261|FG000|COMPLETED|Overall Study||52
9961949|NCT01474772|11081476|FG001|NOT COMPLETED|Period 2||10
9961950|NCT01474772|11081475|FG000|STARTED|Follow-up||77
10026281|NCT01877265|11150349|FG001|COMPLETED|Treatment Period 3||3
10026282|NCT01877265|11150350|FG002|COMPLETED|Treatment Period 3||2
10026283|NCT01877265|11150351|FG003|COMPLETED|Treatment Period 3||3
10026284|NCT01877265|11150352|FG004|COMPLETED|Treatment Period 3||3
10026285|NCT01877265|11150353|FG005|COMPLETED|Treatment Period 3||2
10026286|NCT01877265|11150348|FG000|NOT COMPLETED|Treatment Period 3||1
10026287|NCT01877265|11150349|FG001|NOT COMPLETED|Treatment Period 3||0
10026288|NCT01877265|11150350|FG002|NOT COMPLETED|Treatment Period 3||0
10026289|NCT01877265|11150351|FG003|NOT COMPLETED|Treatment Period 3||0
10026290|NCT01877265|11150352|FG004|NOT COMPLETED|Treatment Period 3||0
10026291|NCT01877265|11150353|FG005|NOT COMPLETED|Treatment Period 3||0
10026292|NCT01877278|11150366|FG000|STARTED|Overall Study||33
10026293|NCT01877278|11150367|FG001|STARTED|Overall Study||33
10026294|NCT01877278|11150366|FG000|COMPLETED|Overall Study||30
10026295|NCT01877278|11150367|FG001|COMPLETED|Overall Study||30
9697703|NCT03221270|10796665|FG000|STARTED|Overall Study||8
9697704|NCT03221270|10796666|FG001|STARTED|Overall Study||6
9697705|NCT03221270|10796667|FG002|STARTED|Overall Study||5
9697706|NCT03221270|10796668|FG003|STARTED|Overall Study||6
9697707|NCT03221270|10796665|FG000|Completed 5-Day Treatment|Overall Study||8
9697708|NCT03221270|10796666|FG001|Completed 5-Day Treatment|Overall Study||6
9697709|NCT03221270|10796667|FG002|Completed 5-Day Treatment|Overall Study||5
9697710|NCT03221270|10796668|FG003|Completed 5-Day Treatment|Overall Study||6
9697711|NCT03221270|10796665|FG000|Completed 8-Week Maintenance|Overall Study||4
9697712|NCT03221270|10796666|FG001|Completed 8-Week Maintenance|Overall Study||6
9697713|NCT03221270|10796667|FG002|Completed 8-Week Maintenance|Overall Study||5
9697714|NCT03221270|10796668|FG003|Completed 8-Week Maintenance|Overall Study||5
9697715|NCT03221270|10796665|FG000|COMPLETED|Overall Study||4
9697716|NCT03221270|10796666|FG001|COMPLETED|Overall Study||6
9697717|NCT03221270|10796667|FG002|COMPLETED|Overall Study||5
9697718|NCT03221270|10796668|FG003|COMPLETED|Overall Study||5
9697719|NCT03221270|10796665|FG000|NOT COMPLETED|Overall Study||4
9697720|NCT03221270|10796666|FG001|NOT COMPLETED|Overall Study||0
9697721|NCT03221270|10796667|FG002|NOT COMPLETED|Overall Study||0
10026296|NCT01877278|11150366|FG000|NOT COMPLETED|Overall Study||3
10026297|NCT01877278|11150367|FG001|NOT COMPLETED|Overall Study||3
10026298|NCT01877408|11150375|FG000|STARTED|Overall Study||50
10026299|NCT01877408|11150376|FG001|STARTED|Overall Study||100
10026300|NCT01877408|11150375|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
9697722|NCT03221270|10796668|FG003|NOT COMPLETED|Overall Study||1
9697723|NCT03195088|10796681|FG000|STARTED|Overall Study||4
9697724|NCT03195088|10796682|FG001|STARTED|Overall Study||6
9697725|NCT03195088|10796683|FG002|STARTED|Overall Study||6
9697726|NCT03195088|10796681|FG000|COMPLETED|Overall Study||4
9961951|NCT01474772|11081476|FG001|STARTED|Follow-up||87
9961952|NCT01474772|11081475|FG000|COMPLETED|Follow-up||77
10026301|NCT01877408|11150376|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
10026302|NCT01877408|11150375|FG000|NOT COMPLETED|Overall Study||0
10026303|NCT01877408|11150376|FG001|NOT COMPLETED|Overall Study||2
10026304|NCT01877421|11150415|FG000|STARTED|Phase 1||2
10026305|NCT01877421|11150416|FG001|STARTED|Phase 1||1
10026306|NCT01877421|11150417|FG002|STARTED|Phase 1||4
10026307|NCT01877421|11150418|FG003|STARTED|Phase 1||2
10026308|NCT01877421|11150419|FG004|STARTED|Phase 1||4
10026309|NCT01877421|11150420|FG005|STARTED|Phase 1||2
10026310|NCT01877421|11150421|FG006|STARTED|Phase 1||4
10026311|NCT01877421|11150422|FG007|STARTED|Phase 1||2
10026312|NCT01877421|11150423|FG008|STARTED|Phase 1||7
10026313|NCT01877421|11150424|FG009|STARTED|Phase 1||3
9697727|NCT03195088|10796682|FG001|COMPLETED|Overall Study||6
9697728|NCT03195088|10796683|FG002|COMPLETED|Overall Study||6
9697729|NCT03195088|10796681|FG000|NOT COMPLETED|Overall Study||0
9697730|NCT03195088|10796682|FG001|NOT COMPLETED|Overall Study||0
9697731|NCT03195088|10796683|FG002|NOT COMPLETED|Overall Study||0
9697732|NCT03191903|10796696|FG000|STARTED|Overall Study||251
9697733|NCT03191903|10796697|FG001|STARTED|Overall Study||251
9961953|NCT01474772|11081476|FG001|COMPLETED|Follow-up||86
9961954|NCT01474772|11081475|FG000|NOT COMPLETED|Follow-up||0
9961955|NCT01474772|11081476|FG001|NOT COMPLETED|Follow-up||1
9961956|NCT01474863|11081485|FG000|STARTED|Overall Study||26
9961957|NCT01474863|11081486|FG001|STARTED|Overall Study||22
9961958|NCT01474863|11081487|FG002|STARTED|Overall Study||24
9961959|NCT01474863|11081485|FG000|COMPLETED|Overall Study||26
9961960|NCT01474863|11081486|FG001|COMPLETED|Overall Study||22
9961961|NCT01474863|11081487|FG002|COMPLETED|Overall Study||24
9961962|NCT01474863|11081485|FG000|NOT COMPLETED|Overall Study||0
9961963|NCT01474863|11081486|FG001|NOT COMPLETED|Overall Study||0
9961964|NCT01474863|11081487|FG002|NOT COMPLETED|Overall Study||0
9961965|NCT01474876|11081498|FG000|STARTED|Overall Study||403
9961966|NCT01474876|11081499|FG001|STARTED|Overall Study||151
9961967|NCT01474876|11081500|FG002|STARTED|Overall Study||1
9961968|NCT01474876|11081498|FG000|COMPLETED|Overall Study||337
9961969|NCT01474876|11081499|FG001|COMPLETED|Overall Study||128
9961970|NCT01474876|11081500|FG002|COMPLETED|Overall Study||1
9961971|NCT01474876|11081498|FG000|NOT COMPLETED|Overall Study||66
9961972|NCT01474876|11081499|FG001|NOT COMPLETED|Overall Study||23
9961973|NCT01474876|11081500|FG002|NOT COMPLETED|Overall Study||0
9697734|NCT03191903|10796698|FG002|STARTED|Overall Study||74
9697735|NCT03191903|10796696|FG000|Intent to Treat Population|Overall Study||251
9697736|NCT03191903|10796697|FG001|Intent to Treat Population|Overall Study||251
9697737|NCT03191903|10796698|FG002|Intent to Treat Population|Overall Study||74
9697738|NCT03191903|10796696|FG000|COMPLETED|Overall Study||244
9697739|NCT03191903|10796697|FG001|COMPLETED|Overall Study||246
9697740|NCT03191903|10796698|FG002|COMPLETED|Overall Study||70
9697741|NCT03191903|10796696|FG000|NOT COMPLETED|Overall Study||7
9697742|NCT03191903|10796697|FG001|NOT COMPLETED|Overall Study||5
9697743|NCT03191903|10796698|FG002|NOT COMPLETED|Overall Study||4
9727633|NCT00108524|10827262|FG001|COMPLETED|Overall Study||61
9727634|NCT00108524|10827261|FG000|NOT COMPLETED|Overall Study||29
9727635|NCT00108524|10827262|FG001|NOT COMPLETED|Overall Study||18
9727636|NCT00108550|10827270|FG000|STARTED|Overall Study||55
9727637|NCT00108550|10827271|FG001|STARTED|Overall Study||53
9727638|NCT00108550|10827270|FG000|COMPLETED|Overall Study||39
9727639|NCT00108550|10827271|FG001|COMPLETED|Overall Study||37
9727640|NCT00108550|10827270|FG000|NOT COMPLETED|Overall Study||16
9727641|NCT00108550|10827271|FG001|NOT COMPLETED|Overall Study||16
9727642|NCT00108628|10827279|FG000|STARTED|Overall Study||61
9727643|NCT00108628|10827280|FG001|STARTED|Overall Study||63
9727644|NCT00108628|10827279|FG000|Received One or More Sessions|Overall Study||53
9727645|NCT00108628|10827280|FG001|Received One or More Sessions|Overall Study||58
9727646|NCT00108628|10827279|FG000|Completed Treatment|Overall Study||42
9727647|NCT00108628|10827280|FG001|Completed Treatment|Overall Study||57
9727648|NCT00108628|10827279|FG000|COMPLETED|Overall Study||41
9727649|NCT00108628|10827280|FG001|COMPLETED|Overall Study||53
9727650|NCT00108628|10827279|FG000|NOT COMPLETED|Overall Study||20
9727651|NCT00108628|10827280|FG001|NOT COMPLETED|Overall Study||10
9727652|NCT00108732|10827286|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
9727653|NCT00108732|10827286|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
9727654|NCT00108732|10827286|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
9727655|NCT00108732|10827286|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
9727656|NCT00108732|10827286|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
9727657|NCT00108732|10827286|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
9727658|NCT00108732|10827286|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
9727659|NCT00108745|10827293|FG000|STARTED|Overall Study||387
9727660|NCT00108745|10827294|FG001|STARTED|Overall Study||384
9727661|NCT00108745|10827295|FG002|STARTED|Overall Study||386
9727662|NCT00108745|10827293|FG000|COMPLETED|Overall Study||353
9727663|NCT00108745|10827294|FG001|COMPLETED|Overall Study||349
9727664|NCT00108745|10827295|FG002|COMPLETED|Overall Study||349
9727665|NCT00108745|10827293|FG000|NOT COMPLETED|Overall Study||34
9727666|NCT00108745|10827294|FG001|NOT COMPLETED|Overall Study||35
9727667|NCT00108745|10827295|FG002|NOT COMPLETED|Overall Study||37
9727668|NCT00108862|10827305|FG000|STARTED|Overall Study||405
9727669|NCT00108862|10827306|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
9727670|NCT00108862|10827305|FG000|COMPLETED|Overall Study||337
9727671|NCT00108862|10827306|FG001|COMPLETED|Overall Study||339
9727672|NCT00108862|10827305|FG000|NOT COMPLETED|Overall Study||68
9727673|NCT00108862|10827306|FG001|NOT COMPLETED|Overall Study||62
9727674|NCT00108953|10827314|FG000|STARTED|Treatment Period|ITT population|47
9727675|NCT00108953|10827315|FG001|STARTED|Treatment Period|ITT population|49
9727676|NCT00108953|10827314|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47
9727677|NCT00108953|10827315|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49
9727678|NCT00108953|10827314|FG000|NOT COMPLETED|Treatment Period||0
9727679|NCT00108953|10827315|FG001|NOT COMPLETED|Treatment Period||0
9727680|NCT00108953|10827314|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
9727681|NCT00108953|10827315|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
9697744|NCT03186794|10796711|FG000|STARTED|Overall Study||20
9697745|NCT03186794|10796711|FG000|COMPLETED|Overall Study||16
9697746|NCT03186794|10796711|FG000|NOT COMPLETED|Overall Study||4
9697747|NCT04289051|10796716|FG000|STARTED|Overall Study||13
9697748|NCT04289051|10796717|FG001|STARTED|Overall Study||13
9697749|NCT04289051|10796718|FG002|STARTED|Overall Study||13
9697750|NCT04289051|10796716|FG000|First Intervention (2 Weeks)|Overall Study||13
9697751|NCT04289051|10796717|FG001|First Intervention (2 Weeks)|Overall Study||13
9697752|NCT04289051|10796718|FG002|First Intervention (2 Weeks)|Overall Study||11
9697753|NCT04289051|10796716|FG000|Washout (1 Week)|Overall Study||13
9697754|NCT04289051|10796717|FG001|Washout (1 Week)|Overall Study||13
9697755|NCT04289051|10796718|FG002|Washout (1 Week)|Overall Study||11
9697756|NCT04289051|10796716|FG000|Second Intervention (2 Weeks)|Overall Study||13
9697757|NCT04289051|10796717|FG001|Second Intervention (2 Weeks)|Overall Study||13
9697758|NCT04289051|10796718|FG002|Second Intervention (2 Weeks)|Overall Study||11
9697759|NCT04289051|10796716|FG000|Washout (1 Week)|Overall Study||13
9697760|NCT04289051|10796717|FG001|Washout (1 Week)|Overall Study||13
9697761|NCT04289051|10796718|FG002|Washout (1 Week)|Overall Study||11
9697762|NCT04289051|10796716|FG000|Third Intervention (2 Weeks)|Overall Study||13
9697763|NCT04289051|10796717|FG001|Third Intervention (2 Weeks)|Overall Study||13
9697764|NCT04289051|10796718|FG002|Third Intervention (2 Weeks)|Overall Study||11
9697765|NCT04289051|10796716|FG000|COMPLETED|Overall Study||13
9697766|NCT04289051|10796717|FG001|COMPLETED|Overall Study||13
9697767|NCT04289051|10796718|FG002|COMPLETED|Overall Study||11
9697768|NCT04289051|10796716|FG000|NOT COMPLETED|Overall Study||0
9697769|NCT04289051|10796717|FG001|NOT COMPLETED|Overall Study||0
9697770|NCT04289051|10796718|FG002|NOT COMPLETED|Overall Study||2
9697771|NCT04210180|10796726|FG000|STARTED|Overall Study||25
9697772|NCT04210180|10796726|FG000|COMPLETED|Overall Study||23
9697773|NCT04210180|10796726|FG000|NOT COMPLETED|Overall Study||2
9697774|NCT04097223|10796730|FG000|STARTED|Overall Study||17464
9697775|NCT04097223|10796730|FG000|COMPLETED|Overall Study||17464
9697776|NCT04097223|10796730|FG000|NOT COMPLETED|Overall Study||0
9697777|NCT03675308|10796769|FG000|STARTED|Overall Study||481
9697778|NCT03675308|10796770|FG001|STARTED|Overall Study||483
9697779|NCT03675308|10796769|FG000|COMPLETED|Overall Study||467
9697780|NCT03675308|10796770|FG001|COMPLETED|Overall Study||473
9697781|NCT03675308|10796769|FG000|NOT COMPLETED|Overall Study||14
9697782|NCT03675308|10796770|FG001|NOT COMPLETED|Overall Study||10
9697783|NCT03573817|10796778|FG000|STARTED|Overall Study||63
9697784|NCT03573817|10796779|FG001|STARTED|Overall Study||59
9697785|NCT03573817|10796778|FG000|Randomized and Treated With Study Drug|Overall Study||63
9697786|NCT03573817|10796779|FG001|Randomized and Treated With Study Drug|Overall Study||59
9697787|NCT03573817|10796778|FG000|COMPLETED|Overall Study||62
9697788|NCT03573817|10796779|FG001|COMPLETED|Overall Study||55
9697789|NCT03573817|10796778|FG000|NOT COMPLETED|Overall Study||1
9697790|NCT03573817|10796779|FG001|NOT COMPLETED|Overall Study||4
9697791|NCT03318861|10796795|FG000|STARTED|Overall Study||3
9697792|NCT03318861|10796796|FG001|STARTED|Overall Study||4
9697793|NCT03318861|10796797|FG002|STARTED|Overall Study||3
9697794|NCT03318861|10796798|FG003|STARTED|Overall Study||4
9697795|NCT03318861|10796799|FG004|STARTED|Overall Study||3
9697796|NCT03318861|10796795|FG000|COMPLETED|Overall Study||0
9697797|NCT03318861|10796796|FG001|COMPLETED|Overall Study||0
9697798|NCT03318861|10796797|FG002|COMPLETED|Overall Study||0
9697799|NCT03318861|10796798|FG003|COMPLETED|Overall Study||0
9697800|NCT03318861|10796799|FG004|COMPLETED|Overall Study||0
9697801|NCT03318861|10796795|FG000|NOT COMPLETED|Overall Study||3
9697802|NCT03318861|10796796|FG001|NOT COMPLETED|Overall Study||4
9697803|NCT03318861|10796797|FG002|NOT COMPLETED|Overall Study||3
9697804|NCT03318861|10796798|FG003|NOT COMPLETED|Overall Study||4
9697805|NCT03318861|10796799|FG004|NOT COMPLETED|Overall Study||3
9697806|NCT03170349|10796811|FG000|STARTED|At 30 Days Follow-up||124
9697807|NCT03170349|10796811|FG000|COMPLETED|At 30 Days Follow-up||123
9697808|NCT03170349|10796811|FG000|NOT COMPLETED|At 30 Days Follow-up||1
9697809|NCT03170349|10796811|FG000|STARTED|At 6 Months Follow-up||123
9697810|NCT03170349|10796811|FG000|COMPLETED|At 6 Months Follow-up||114
9697811|NCT03170349|10796811|FG000|NOT COMPLETED|At 6 Months Follow-up||9
9697812|NCT03119064|10796817|FG000|STARTED|Overall Study||9
9697813|NCT03119064|10796818|FG001|STARTED|Overall Study||3
9697814|NCT03119064|10796819|FG002|STARTED|Overall Study||0
9697815|NCT03119064|10796817|FG000|COMPLETED|Overall Study||9
9697816|NCT03119064|10796818|FG001|COMPLETED|Overall Study||3
9697817|NCT03119064|10796819|FG002|COMPLETED|Overall Study||0
9697818|NCT03119064|10796817|FG000|NOT COMPLETED|Overall Study||0
9697819|NCT03119064|10796818|FG001|NOT COMPLETED|Overall Study||0
9697820|NCT03119064|10796819|FG002|NOT COMPLETED|Overall Study||0
9697821|NCT03095456|10796828|FG000|STARTED|Overall Study||103
9847637|NCT00855010|10960182|FG000|COMPLETED|Overall Study||19
9847638|NCT00855010|10960183|FG001|COMPLETED|Overall Study||18
9847639|NCT00855010|10960182|FG000|NOT COMPLETED|Overall Study||4
9847640|NCT00855010|10960183|FG001|NOT COMPLETED|Overall Study||1
9847641|NCT00855062|10960195|FG000|STARTED|Step1||36
9847642|NCT00855062|10960196|FG001|STARTED|Step1||37
10026314|NCT01877421|11150425|FG010|STARTED|Phase 1||7
10026315|NCT01877421|11150426|FG011|STARTED|Phase 1||3
10026316|NCT01877421|11150427|FG012|STARTED|Phase 1||7
9847643|NCT00855062|10960195|FG000|COMPLETED|Step1||26
10026317|NCT01877421|11150428|FG013|STARTED|Phase 1||3
9697822|NCT03095456|10796829|FG001|STARTED|Overall Study||104
9697823|NCT03095456|10796828|FG000|COMPLETED|Overall Study||99
9697824|NCT03095456|10796829|FG001|COMPLETED|Overall Study||96
9697825|NCT03095456|10796828|FG000|NOT COMPLETED|Overall Study||4
9697826|NCT03095456|10796829|FG001|NOT COMPLETED|Overall Study||8
9697827|NCT03064113|10796839|FG000|STARTED|Intervention 1 (2 Days)||8
9697828|NCT03064113|10796840|FG001|STARTED|Intervention 1 (2 Days)||8
9697829|NCT03064113|10796841|FG002|STARTED|Intervention 1 (2 Days)||8
9697830|NCT03064113|10796842|FG003|STARTED|Intervention 1 (2 Days)||8
9697831|NCT03064113|10796839|FG000|COMPLETED|Intervention 1 (2 Days)||8
10026318|NCT01877421|11150429|FG014|STARTED|Phase 1||7
10026319|NCT01877421|11150430|FG015|STARTED|Phase 1||3
9697832|NCT03064113|10796840|FG001|COMPLETED|Intervention 1 (2 Days)||8
9697833|NCT03064113|10796841|FG002|COMPLETED|Intervention 1 (2 Days)||8
9697834|NCT03064113|10796842|FG003|COMPLETED|Intervention 1 (2 Days)||8
9697835|NCT03064113|10796839|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0
9697836|NCT03064113|10796840|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0
9697837|NCT03064113|10796841|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0
9697838|NCT03064113|10796842|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0
9697839|NCT03064113|10796839|FG000|STARTED|Washout (7 Days)||8
9697840|NCT03064113|10796840|FG001|STARTED|Washout (7 Days)||8
9697841|NCT03064113|10796841|FG002|STARTED|Washout (7 Days)||8
9697842|NCT03064113|10796842|FG003|STARTED|Washout (7 Days)||8
9697843|NCT03064113|10796839|FG000|COMPLETED|Washout (7 Days)||8
9697844|NCT03064113|10796840|FG001|COMPLETED|Washout (7 Days)||8
9697845|NCT03064113|10796841|FG002|COMPLETED|Washout (7 Days)||8
9697846|NCT03064113|10796842|FG003|COMPLETED|Washout (7 Days)||8
9697847|NCT03064113|10796839|FG000|NOT COMPLETED|Washout (7 Days)||0
9697848|NCT03064113|10796840|FG001|NOT COMPLETED|Washout (7 Days)||0
9697849|NCT03064113|10796841|FG002|NOT COMPLETED|Washout (7 Days)||0
9697850|NCT03064113|10796842|FG003|NOT COMPLETED|Washout (7 Days)||0
9697851|NCT03064113|10796839|FG000|STARTED|Intervention 2 (2 Days)||8
9697852|NCT03064113|10796840|FG001|STARTED|Intervention 2 (2 Days)||8
9697853|NCT03064113|10796841|FG002|STARTED|Intervention 2 (2 Days)||8
9697854|NCT03064113|10796842|FG003|STARTED|Intervention 2 (2 Days)||8
9697855|NCT03064113|10796839|FG000|COMPLETED|Intervention 2 (2 Days)||8
9697856|NCT03064113|10796840|FG001|COMPLETED|Intervention 2 (2 Days)||8
9697857|NCT03064113|10796841|FG002|COMPLETED|Intervention 2 (2 Days)||8
9697858|NCT03064113|10796842|FG003|COMPLETED|Intervention 2 (2 Days)||8
9697859|NCT03064113|10796839|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0
9697860|NCT03064113|10796840|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0
9697861|NCT03064113|10796841|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0
9697862|NCT03064113|10796842|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0
9697863|NCT03064113|10796839|FG000|STARTED|Washout (7 Days)||8
9697864|NCT03064113|10796840|FG001|STARTED|Washout (7 Days)||8
9697865|NCT03064113|10796841|FG002|STARTED|Washout (7 Days)||8
9697866|NCT03064113|10796842|FG003|STARTED|Washout (7 Days)||8
9697867|NCT03064113|10796839|FG000|COMPLETED|Washout (7 Days)||8
9697868|NCT03064113|10796840|FG001|COMPLETED|Washout (7 Days)||8
9697869|NCT03064113|10796841|FG002|COMPLETED|Washout (7 Days)||8
9697870|NCT03064113|10796842|FG003|COMPLETED|Washout (7 Days)||8
9697871|NCT03064113|10796839|FG000|NOT COMPLETED|Washout (7 Days)||0
9697872|NCT03064113|10796840|FG001|NOT COMPLETED|Washout (7 Days)||0
9697873|NCT03064113|10796841|FG002|NOT COMPLETED|Washout (7 Days)||0
9697874|NCT03064113|10796842|FG003|NOT COMPLETED|Washout (7 Days)||0
9697875|NCT03064113|10796839|FG000|STARTED|Intervention 3 (2 Days)||8
9697876|NCT03064113|10796840|FG001|STARTED|Intervention 3 (2 Days)||8
9697877|NCT03064113|10796841|FG002|STARTED|Intervention 3 (2 Days)||8
9697878|NCT03064113|10796842|FG003|STARTED|Intervention 3 (2 Days)||8
9697879|NCT03064113|10796839|FG000|COMPLETED|Intervention 3 (2 Days)||8
10026320|NCT01877421|11150431|FG016|STARTED|Phase 1||7
10026321|NCT01877421|11150432|FG017|STARTED|Phase 1||3
10026322|NCT01877421|11150415|FG000|COMPLETED|Phase 1||2
9697880|NCT03064113|10796840|FG001|COMPLETED|Intervention 3 (2 Days)||8
9697881|NCT03064113|10796841|FG002|COMPLETED|Intervention 3 (2 Days)||8
9697882|NCT03064113|10796842|FG003|COMPLETED|Intervention 3 (2 Days)||8
9697883|NCT03064113|10796839|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0
9697884|NCT03064113|10796840|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0
9697885|NCT03064113|10796841|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0
9697886|NCT03064113|10796842|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0
9697887|NCT03064113|10796839|FG000|STARTED|Washout (7 Days)||8
9697888|NCT03064113|10796840|FG001|STARTED|Washout (7 Days)||8
9697889|NCT03064113|10796841|FG002|STARTED|Washout (7 Days)||8
9697890|NCT03064113|10796842|FG003|STARTED|Washout (7 Days)||8
9697891|NCT03064113|10796839|FG000|COMPLETED|Washout (7 Days)||8
9697892|NCT03064113|10796840|FG001|COMPLETED|Washout (7 Days)||8
9697893|NCT03064113|10796841|FG002|COMPLETED|Washout (7 Days)||8
9697894|NCT03064113|10796842|FG003|COMPLETED|Washout (7 Days)||8
9697895|NCT03064113|10796839|FG000|NOT COMPLETED|Washout (7 Days)||0
9697896|NCT03064113|10796840|FG001|NOT COMPLETED|Washout (7 Days)||0
9697897|NCT03064113|10796841|FG002|NOT COMPLETED|Washout (7 Days)||0
9697898|NCT03064113|10796842|FG003|NOT COMPLETED|Washout (7 Days)||0
9697899|NCT03064113|10796839|FG000|STARTED|Intervention 4 (2 Days)||8
9697900|NCT03064113|10796840|FG001|STARTED|Intervention 4 (2 Days)||8
9697901|NCT03064113|10796841|FG002|STARTED|Intervention 4 (2 Days)||8
10026323|NCT01877421|11150416|FG001|COMPLETED|Phase 1||1
10026324|NCT01877421|11150417|FG002|COMPLETED|Phase 1||4
10026325|NCT01877421|11150418|FG003|COMPLETED|Phase 1||2
9697902|NCT03064113|10796842|FG003|STARTED|Intervention 4 (2 Days)||8
9697903|NCT03064113|10796839|FG000|COMPLETED|Intervention 4 (2 Days)||8
9697904|NCT03064113|10796840|FG001|COMPLETED|Intervention 4 (2 Days)||8
9697905|NCT03064113|10796841|FG002|COMPLETED|Intervention 4 (2 Days)||8
9697906|NCT03064113|10796842|FG003|COMPLETED|Intervention 4 (2 Days)||8
9697907|NCT03064113|10796839|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0
9697908|NCT03064113|10796840|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0
9697909|NCT03064113|10796841|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0
9697910|NCT03064113|10796842|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0
9697911|NCT03064113|10796839|FG000|STARTED|Washout (7 Days)||8
9697912|NCT03064113|10796840|FG001|STARTED|Washout (7 Days)||8
9697913|NCT03064113|10796841|FG002|STARTED|Washout (7 Days)||8
9697914|NCT03064113|10796842|FG003|STARTED|Washout (7 Days)||8
9697915|NCT03064113|10796839|FG000|COMPLETED|Washout (7 Days)||8
9697916|NCT03064113|10796840|FG001|COMPLETED|Washout (7 Days)||8
9697917|NCT03064113|10796841|FG002|COMPLETED|Washout (7 Days)||8
9697918|NCT03064113|10796842|FG003|COMPLETED|Washout (7 Days)||8
9697919|NCT03064113|10796839|FG000|NOT COMPLETED|Washout (7 Days)||0
9697920|NCT03064113|10796840|FG001|NOT COMPLETED|Washout (7 Days)||0
9697921|NCT03064113|10796841|FG002|NOT COMPLETED|Washout (7 Days)||0
9697922|NCT03064113|10796842|FG003|NOT COMPLETED|Washout (7 Days)||0
9697923|NCT02938013|10796855|FG000|STARTED|Overall Study||5
9697924|NCT02938013|10796856|FG001|STARTED|Overall Study||5
9697925|NCT02938013|10796857|FG002|STARTED|Overall Study||5
9697926|NCT02938013|10796855|FG000|COMPLETED|Overall Study||5
9697927|NCT02938013|10796856|FG001|COMPLETED|Overall Study||5
9697928|NCT02938013|10796857|FG002|COMPLETED|Overall Study||5
9697929|NCT02938013|10796855|FG000|NOT COMPLETED|Overall Study||0
9697930|NCT02938013|10796856|FG001|NOT COMPLETED|Overall Study||0
9697931|NCT02938013|10796857|FG002|NOT COMPLETED|Overall Study||0
9697932|NCT02919683|10796867|FG000|STARTED|Pre-Surgery Intervention||15
9697933|NCT02919683|10796868|FG001|STARTED|Pre-Surgery Intervention||15
9697934|NCT02919683|10796867|FG000|COMPLETED|Pre-Surgery Intervention||15
9697935|NCT02919683|10796868|FG001|COMPLETED|Pre-Surgery Intervention||15
9697936|NCT02919683|10796867|FG000|NOT COMPLETED|Pre-Surgery Intervention||0
9697937|NCT02919683|10796868|FG001|NOT COMPLETED|Pre-Surgery Intervention||0
9697938|NCT02919683|10796867|FG000|STARTED|Post-Surgery Follow-Up||15
9697939|NCT02919683|10796868|FG001|STARTED|Post-Surgery Follow-Up||15
9697940|NCT02919683|10796867|FG000|COMPLETED|Post-Surgery Follow-Up||12
9697941|NCT02919683|10796868|FG001|COMPLETED|Post-Surgery Follow-Up||13
9697942|NCT02919683|10796867|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3
9697943|NCT02919683|10796868|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2
9697944|NCT02901548|10796875|FG000|STARTED|Overall Study||17
9697945|NCT02901548|10796875|FG000|COMPLETED|Overall Study||13
9697946|NCT02901548|10796875|FG000|NOT COMPLETED|Overall Study||4
9697947|NCT02790138|10796881|FG000|STARTED|Overall Study||51
9697948|NCT02790138|10796882|FG001|STARTED|Overall Study||51
9697949|NCT02790138|10796881|FG000|COMPLETED|Overall Study||30
9697950|NCT02790138|10796882|FG001|COMPLETED|Overall Study||32
9697951|NCT02790138|10796881|FG000|NOT COMPLETED|Overall Study||21
9697952|NCT02790138|10796882|FG001|NOT COMPLETED|Overall Study||19
9697953|NCT02642315|10796889|FG000|STARTED|Overall Study||10
9697954|NCT02642315|10796889|FG000|COMPLETED|Overall Study||8
9697955|NCT02642315|10796889|FG000|NOT COMPLETED|Overall Study||2
10026326|NCT01877421|11150419|FG004|COMPLETED|Phase 1||4
9697956|NCT02518139|10796896|FG000|STARTED|Overall Study||364
9697957|NCT02518139|10796897|FG001|STARTED|Overall Study||335
9697958|NCT02518139|10796898|FG002|STARTED|Overall Study||356
10026327|NCT01877421|11150420|FG005|COMPLETED|Phase 1||2
9697959|NCT02518139|10796896|FG000|COMPLETED|Overall Study||219
9697960|NCT02518139|10796897|FG001|COMPLETED|Overall Study||191
9697961|NCT02518139|10796898|FG002|COMPLETED|Overall Study||262
9697962|NCT02518139|10796896|FG000|NOT COMPLETED|Overall Study||145
9697963|NCT02518139|10796897|FG001|NOT COMPLETED|Overall Study||144
9697964|NCT02518139|10796898|FG002|NOT COMPLETED|Overall Study||94
9697965|NCT02514239|10796916|FG000|STARTED|Overall Study||5
9697966|NCT02514239|10796917|FG001|STARTED|Overall Study||4
9697967|NCT02514239|10796918|FG002|STARTED|Overall Study||3
9697968|NCT02514239|10796919|FG003|STARTED|Overall Study||3
9697969|NCT02514239|10796920|FG004|STARTED|Overall Study||3
9697970|NCT02514239|10796921|FG005|STARTED|Overall Study||5
9697971|NCT02514239|10796922|FG006|STARTED|Overall Study||4
9697972|NCT02514239|10796923|FG007|STARTED|Overall Study||3
9697973|NCT02514239|10796924|FG008|STARTED|Overall Study||10
9697974|NCT02514239|10796925|FG009|STARTED|Overall Study||3
9697975|NCT02514239|10796916|FG000|Treated|Overall Study||5
9697976|NCT02514239|10796917|FG001|Treated|Overall Study||3
9697977|NCT02514239|10796918|FG002|Treated|Overall Study||3
9697978|NCT02514239|10796919|FG003|Treated|Overall Study||3
9697979|NCT02514239|10796920|FG004|Treated|Overall Study||3
9697980|NCT02514239|10796921|FG005|Treated|Overall Study||5
9697981|NCT02514239|10796922|FG006|Treated|Overall Study||4
9697982|NCT02514239|10796923|FG007|Treated|Overall Study||3
9697983|NCT02514239|10796924|FG008|Treated|Overall Study||10
9697984|NCT02514239|10796925|FG009|Treated|Overall Study||3
9697985|NCT02514239|10796916|FG000|COMPLETED|Overall Study||0
9961974|NCT01474915|11081508|FG000|STARTED|Overall Study||60
9961975|NCT01474915|11081509|FG001|STARTED|Overall Study||61
9961976|NCT01474915|11081508|FG000|COMPLETED|Overall Study||50
9961977|NCT01474915|11081509|FG001|COMPLETED|Overall Study||51
9961978|NCT01474915|11081508|FG000|NOT COMPLETED|Overall Study||10
9961979|NCT01474915|11081509|FG001|NOT COMPLETED|Overall Study||10
9967758|NCT01516268|11088098|FG001|STARTED|Overall Study||25
9967759|NCT01516268|11088097|FG000|COMPLETED|Overall Study||25
9967760|NCT01516268|11088098|FG001|COMPLETED|Overall Study||25
9967761|NCT01516268|11088097|FG000|NOT COMPLETED|Overall Study||0
9967762|NCT01516268|11088098|FG001|NOT COMPLETED|Overall Study||0
9967763|NCT01516424|11088106|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
9967764|NCT01516424|11088107|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
9967765|NCT01516424|11088106|FG000|COMPLETED|Overall Study||96
9967766|NCT01516424|11088107|FG001|COMPLETED|Overall Study||114
9967767|NCT01516424|11088106|FG000|NOT COMPLETED|Overall Study||35
9967768|NCT01516424|11088107|FG001|NOT COMPLETED|Overall Study||22
9967769|NCT01516437|11088117|FG000|STARTED|Overall Study||24
9967770|NCT01516437|11088118|FG001|STARTED|Overall Study||24
9967771|NCT01516437|11088119|FG002|STARTED|Overall Study||15
9967772|NCT01516437|11088120|FG003|STARTED|Overall Study||7
9967773|NCT01516437|11088117|FG000|COMPLETED|Overall Study||24
9967774|NCT01516437|11088118|FG001|COMPLETED|Overall Study||24
9967775|NCT01516437|11088119|FG002|COMPLETED|Overall Study||14
9967776|NCT01516437|11088120|FG003|COMPLETED|Overall Study||6
9967777|NCT01516437|11088117|FG000|NOT COMPLETED|Overall Study||0
9967778|NCT01516437|11088118|FG001|NOT COMPLETED|Overall Study||0
9967779|NCT01516437|11088119|FG002|NOT COMPLETED|Overall Study||1
9967780|NCT01516437|11088120|FG003|NOT COMPLETED|Overall Study||1
9967781|NCT01516632|11088134|FG000|STARTED|Overall Study||101
9967782|NCT01516632|11088135|FG001|STARTED|Overall Study||63
9967783|NCT01516632|11088134|FG000|COMPLETED|Overall Study||77
9967784|NCT01516632|11088135|FG001|COMPLETED|Overall Study||48
9967785|NCT01516632|11088134|FG000|NOT COMPLETED|Overall Study||24
9967786|NCT01516632|11088135|FG001|NOT COMPLETED|Overall Study||15
9697986|NCT02514239|10796917|FG001|COMPLETED|Overall Study||0
9697987|NCT02514239|10796918|FG002|COMPLETED|Overall Study||1
9697988|NCT02514239|10796919|FG003|COMPLETED|Overall Study||0
9697989|NCT02514239|10796920|FG004|COMPLETED|Overall Study||0
9697990|NCT02514239|10796921|FG005|COMPLETED|Overall Study||1
9697991|NCT02514239|10796922|FG006|COMPLETED|Overall Study||0
9697992|NCT02514239|10796923|FG007|COMPLETED|Overall Study||0
10026328|NCT01877421|11150421|FG006|COMPLETED|Phase 1||4
10026329|NCT01877421|11150422|FG007|COMPLETED|Phase 1||2
10026330|NCT01877421|11150423|FG008|COMPLETED|Phase 1||7
10026331|NCT01877421|11150424|FG009|COMPLETED|Phase 1||3
10026332|NCT01877421|11150425|FG010|COMPLETED|Phase 1||7
10026333|NCT01877421|11150426|FG011|COMPLETED|Phase 1||3
10026334|NCT01877421|11150427|FG012|COMPLETED|Phase 1||7
10026335|NCT01877421|11150428|FG013|COMPLETED|Phase 1||3
10026336|NCT01877421|11150429|FG014|COMPLETED|Phase 1||7
10026337|NCT01877421|11150430|FG015|COMPLETED|Phase 1||3
10026338|NCT01877421|11150431|FG016|COMPLETED|Phase 1||7
10026339|NCT01877421|11150432|FG017|COMPLETED|Phase 1||3
10026340|NCT01877421|11150415|FG000|NOT COMPLETED|Phase 1||0
10026341|NCT01877421|11150416|FG001|NOT COMPLETED|Phase 1||0
10026342|NCT01877421|11150417|FG002|NOT COMPLETED|Phase 1||0
10026343|NCT01877421|11150418|FG003|NOT COMPLETED|Phase 1||0
10026344|NCT01877421|11150419|FG004|NOT COMPLETED|Phase 1||0
10026345|NCT01877421|11150420|FG005|NOT COMPLETED|Phase 1||0
10026346|NCT01877421|11150421|FG006|NOT COMPLETED|Phase 1||0
10026347|NCT01877421|11150422|FG007|NOT COMPLETED|Phase 1||0
10026348|NCT01877421|11150423|FG008|NOT COMPLETED|Phase 1||0
10026349|NCT01877421|11150424|FG009|NOT COMPLETED|Phase 1||0
9697993|NCT02514239|10796924|FG008|COMPLETED|Overall Study||2
10026350|NCT01877421|11150425|FG010|NOT COMPLETED|Phase 1||0
10026351|NCT01877421|11150426|FG011|NOT COMPLETED|Phase 1||0
10026352|NCT01877421|11150427|FG012|NOT COMPLETED|Phase 1||0
10026353|NCT01877421|11150428|FG013|NOT COMPLETED|Phase 1||0
10026354|NCT01877421|11150429|FG014|NOT COMPLETED|Phase 1||0
10026355|NCT01877421|11150430|FG015|NOT COMPLETED|Phase 1||0
10026356|NCT01877421|11150431|FG016|NOT COMPLETED|Phase 1||0
10026357|NCT01877421|11150432|FG017|NOT COMPLETED|Phase 1||0
10026358|NCT01877421|11150415|FG000|STARTED|Phase 2||0
10026359|NCT01877421|11150416|FG001|STARTED|Phase 2||0
10026360|NCT01877421|11150417|FG002|STARTED|Phase 2||4
10026361|NCT01877421|11150418|FG003|STARTED|Phase 2||2
10026362|NCT01877421|11150419|FG004|STARTED|Phase 2||7
10026363|NCT01877421|11150420|FG005|STARTED|Phase 2||3
10026364|NCT01877421|11150421|FG006|STARTED|Phase 2||7
10026365|NCT01877421|11150422|FG007|STARTED|Phase 2||2
10026366|NCT01877421|11150423|FG008|STARTED|Phase 2||6
10026367|NCT01877421|11150424|FG009|STARTED|Phase 2||3
10026368|NCT01877421|11150425|FG010|STARTED|Phase 2||7
10026369|NCT01877421|11150426|FG011|STARTED|Phase 2||3
10026370|NCT01877421|11150427|FG012|STARTED|Phase 2||7
10026371|NCT01877421|11150428|FG013|STARTED|Phase 2||3
10026372|NCT01877421|11150429|FG014|STARTED|Phase 2||7
10026373|NCT01877421|11150430|FG015|STARTED|Phase 2||3
10026374|NCT01877421|11150431|FG016|STARTED|Phase 2||0
10026375|NCT01877421|11150432|FG017|STARTED|Phase 2||0
10026376|NCT01877421|11150415|FG000|COMPLETED|Phase 2||0
10026377|NCT01877421|11150416|FG001|COMPLETED|Phase 2||0
10026378|NCT01877421|11150417|FG002|COMPLETED|Phase 2||4
10026379|NCT01877421|11150418|FG003|COMPLETED|Phase 2||2
10026380|NCT01877421|11150419|FG004|COMPLETED|Phase 2||7
10026381|NCT01877421|11150420|FG005|COMPLETED|Phase 2||3
10026382|NCT01877421|11150421|FG006|COMPLETED|Phase 2||6
9697994|NCT02514239|10796925|FG009|COMPLETED|Overall Study||0
9697995|NCT02514239|10796916|FG000|NOT COMPLETED|Overall Study||5
9697996|NCT02514239|10796917|FG001|NOT COMPLETED|Overall Study||4
10026383|NCT01877421|11150422|FG007|COMPLETED|Phase 2||2
10026384|NCT01877421|11150423|FG008|COMPLETED|Phase 2||5
10026385|NCT01877421|11150424|FG009|COMPLETED|Phase 2||3
10026386|NCT01877421|11150425|FG010|COMPLETED|Phase 2||5
10026387|NCT01877421|11150426|FG011|COMPLETED|Phase 2||3
10026388|NCT01877421|11150427|FG012|COMPLETED|Phase 2||6
10026389|NCT01877421|11150428|FG013|COMPLETED|Phase 2||3
10026390|NCT01877421|11150429|FG014|COMPLETED|Phase 2||7
10026391|NCT01877421|11150430|FG015|COMPLETED|Phase 2||2
10026392|NCT01877421|11150431|FG016|COMPLETED|Phase 2||0
9847644|NCT00855062|10960196|FG001|COMPLETED|Step1||26
9847645|NCT00855062|10960195|FG000|NOT COMPLETED|Step1||10
9847646|NCT00855062|10960196|FG001|NOT COMPLETED|Step1||11
9847647|NCT00855062|10960195|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
9847648|NCT00855062|10960196|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
9847649|NCT00855062|10960195|FG000|COMPLETED|Step2||13
9847650|NCT00855062|10960196|FG001|COMPLETED|Step2||15
9847651|NCT00855062|10960195|FG000|NOT COMPLETED|Step2||6
9847652|NCT00855062|10960196|FG001|NOT COMPLETED|Step2||6
9847653|NCT00855166|10960204|FG000|STARTED|Overall Study||91
9847654|NCT00855166|10960205|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
9847655|NCT00855166|10960204|FG000|COMPLETED|Overall Study||86
9847656|NCT00855166|10960205|FG001|COMPLETED|Overall Study||83
9847657|NCT00855166|10960204|FG000|NOT COMPLETED|Overall Study||5
9697997|NCT02514239|10796918|FG002|NOT COMPLETED|Overall Study||2
9697998|NCT02514239|10796919|FG003|NOT COMPLETED|Overall Study||3
9697999|NCT02514239|10796920|FG004|NOT COMPLETED|Overall Study||3
9698000|NCT02514239|10796921|FG005|NOT COMPLETED|Overall Study||4
9698001|NCT02514239|10796922|FG006|NOT COMPLETED|Overall Study||4
9698002|NCT02514239|10796923|FG007|NOT COMPLETED|Overall Study||3
9698003|NCT02514239|10796924|FG008|NOT COMPLETED|Overall Study||8
9698004|NCT02514239|10796925|FG009|NOT COMPLETED|Overall Study||3
9698005|NCT02512510|10796968|FG000|STARTED|Overall Study||205
9698006|NCT02512510|10796969|FG001|STARTED|Overall Study||197
9698007|NCT02512510|10796970|FG002|STARTED|Overall Study||209
9698008|NCT02512510|10796968|FG000|COMPLETED|Overall Study||163
9698009|NCT02512510|10796969|FG001|COMPLETED|Overall Study||162
9698010|NCT02512510|10796970|FG002|COMPLETED|Overall Study||157
9698011|NCT02512510|10796968|FG000|NOT COMPLETED|Overall Study||42
9698012|NCT02512510|10796969|FG001|NOT COMPLETED|Overall Study||35
9698013|NCT02512510|10796970|FG002|NOT COMPLETED|Overall Study||52
9698014|NCT02459080|10796981|FG000|STARTED|Overall Study||212
9698015|NCT02459080|10796982|FG001|STARTED|Overall Study||198
9698016|NCT02459080|10796983|FG002|STARTED|Overall Study||209
9698017|NCT02459080|10796981|FG000|COMPLETED|Overall Study||168
9698018|NCT02459080|10796982|FG001|COMPLETED|Overall Study||158
9698019|NCT02459080|10796983|FG002|COMPLETED|Overall Study||151
9698020|NCT02459080|10796981|FG000|NOT COMPLETED|Overall Study||44
9698021|NCT02459080|10796982|FG001|NOT COMPLETED|Overall Study||40
9698022|NCT02459080|10796983|FG002|NOT COMPLETED|Overall Study||58
9698023|NCT02245672|10796994|FG000|STARTED|Overall Study||512
9698024|NCT02245672|10796995|FG001|STARTED|Overall Study||513
9698025|NCT02245672|10796996|FG002|STARTED|Overall Study||103
9698026|NCT02245672|10796994|FG000|COMPLETED|Overall Study||499
9698027|NCT02245672|10796995|FG001|COMPLETED|Overall Study||500
9698028|NCT02245672|10796996|FG002|COMPLETED|Overall Study||98
9698029|NCT02245672|10796994|FG000|NOT COMPLETED|Overall Study||13
9698030|NCT02245672|10796995|FG001|NOT COMPLETED|Overall Study||13
9698031|NCT02245672|10796996|FG002|NOT COMPLETED|Overall Study||5
9698032|NCT02109172|10797004|FG000|STARTED|Overall Study||11
9698033|NCT02109172|10797005|FG001|STARTED|Overall Study||11
9698034|NCT02109172|10797006|FG002|STARTED|Overall Study||10
9698035|NCT02109172|10797007|FG003|STARTED|Overall Study||11
9698036|NCT02109172|10797008|FG004|STARTED|Overall Study||10
9698037|NCT02109172|10797009|FG005|STARTED|Overall Study||11
9698038|NCT02109172|10797004|FG000|COMPLETED|Overall Study||10
9698039|NCT02109172|10797005|FG001|COMPLETED|Overall Study||11
9698040|NCT02109172|10797006|FG002|COMPLETED|Overall Study||9
9698041|NCT02109172|10797007|FG003|COMPLETED|Overall Study||10
9698042|NCT02109172|10797008|FG004|COMPLETED|Overall Study||9
9698043|NCT02109172|10797009|FG005|COMPLETED|Overall Study||10
9698044|NCT02109172|10797004|FG000|NOT COMPLETED|Overall Study||1
9698045|NCT02109172|10797005|FG001|NOT COMPLETED|Overall Study||0
9698046|NCT02109172|10797006|FG002|NOT COMPLETED|Overall Study||1
9698047|NCT02109172|10797007|FG003|NOT COMPLETED|Overall Study||1
9698048|NCT02109172|10797008|FG004|NOT COMPLETED|Overall Study||1
9698049|NCT02109172|10797009|FG005|NOT COMPLETED|Overall Study||1
9698050|NCT02040792|10797022|FG000|STARTED|Overall Study||70
9698051|NCT02040792|10797023|FG001|STARTED|Overall Study||68
9698052|NCT02040792|10797024|FG002|STARTED|Overall Study||71
9698053|NCT02040792|10797025|FG003|STARTED|Overall Study||71
9698054|NCT02040792|10797026|FG004|STARTED|Overall Study||74
9698055|NCT02040792|10797022|FG000|COMPLETED|Overall Study||64
9847658|NCT00855166|10960205|FG001|NOT COMPLETED|Overall Study||8
9847659|NCT00855218|10960215|FG000|STARTED|Overall Study||154
9847660|NCT00855218|10960216|FG001|STARTED|Overall Study||153
9698056|NCT02040792|10797023|FG001|COMPLETED|Overall Study||65
9698057|NCT02040792|10797024|FG002|COMPLETED|Overall Study||68
9698058|NCT02040792|10797025|FG003|COMPLETED|Overall Study||64
9698059|NCT02040792|10797026|FG004|COMPLETED|Overall Study||67
9698060|NCT02040792|10797022|FG000|NOT COMPLETED|Overall Study||6
9698061|NCT02040792|10797023|FG001|NOT COMPLETED|Overall Study||3
9698062|NCT02040792|10797024|FG002|NOT COMPLETED|Overall Study||3
9698063|NCT02040792|10797025|FG003|NOT COMPLETED|Overall Study||7
9698064|NCT02040792|10797026|FG004|NOT COMPLETED|Overall Study||7
9698065|NCT01979003|10797038|FG000|STARTED|Overall Study||100
9698066|NCT01979003|10797038|FG000|COMPLETED|Overall Study||72
9698067|NCT01979003|10797038|FG000|NOT COMPLETED|Overall Study||28
9961980|NCT01474993|11081518|FG000|STARTED|Overall Study||15
9698068|NCT01704404|10797042|FG000|STARTED|Overall Study||11
9698069|NCT01704404|10797043|FG001|STARTED|Overall Study||10
9698070|NCT01704404|10797044|FG002|STARTED|Overall Study||10
9698071|NCT01704404|10797045|FG003|STARTED|Overall Study||11
9698072|NCT01704404|10797046|FG004|STARTED|Overall Study||11
9698073|NCT01704404|10797047|FG005|STARTED|Overall Study||9
9698074|NCT01704404|10797042|FG000|COMPLETED|Overall Study||10
9698075|NCT01704404|10797043|FG001|COMPLETED|Overall Study||9
9698076|NCT01704404|10797044|FG002|COMPLETED|Overall Study||9
9698077|NCT01704404|10797045|FG003|COMPLETED|Overall Study||8
9698078|NCT01704404|10797046|FG004|COMPLETED|Overall Study||10
9698079|NCT01704404|10797047|FG005|COMPLETED|Overall Study||9
9698080|NCT01704404|10797042|FG000|NOT COMPLETED|Overall Study||1
9698081|NCT01704404|10797043|FG001|NOT COMPLETED|Overall Study||1
9698082|NCT01704404|10797044|FG002|NOT COMPLETED|Overall Study||1
9698083|NCT01704404|10797045|FG003|NOT COMPLETED|Overall Study||3
9698084|NCT01704404|10797046|FG004|NOT COMPLETED|Overall Study||1
9698085|NCT01704404|10797047|FG005|NOT COMPLETED|Overall Study||0
9698086|NCT01307813|10797063|FG000|STARTED|Overall Study||4
9961981|NCT01474993|11081519|FG001|STARTED|Overall Study||29
9961982|NCT01474993|11081518|FG000|COMPLETED|Overall Study||14
9961983|NCT01474993|11081519|FG001|COMPLETED|Overall Study||26
9961984|NCT01474993|11081518|FG000|NOT COMPLETED|Overall Study||1
9961985|NCT01474993|11081519|FG001|NOT COMPLETED|Overall Study||3
10026393|NCT01877421|11150432|FG017|COMPLETED|Phase 2||0
9698087|NCT01307813|10797063|FG000|COMPLETED|Overall Study||4
9698088|NCT01307813|10797063|FG000|NOT COMPLETED|Overall Study||0
9698089|NCT00799396|10797067|FG000|STARTED|Clopidogrel Treatment||682
9698090|NCT00799396|10797067|FG000|COMPLETED|Clopidogrel Treatment||669
9698091|NCT00799396|10797067|FG000|NOT COMPLETED|Clopidogrel Treatment||13
9698092|NCT00799396|10797067|FG000|STARTED|Clopidogrel Plus Aspirin||669
9698093|NCT00799396|10797067|FG000|COMPLETED|Clopidogrel Plus Aspirin||663
9698094|NCT00799396|10797067|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6
9698095|NCT00069238|10797071|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
9698096|NCT00069238|10797072|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
9698097|NCT00069238|10797073|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
9698098|NCT00069238|10797071|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
9698099|NCT00069238|10797072|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
9698100|NCT00069238|10797073|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
9698101|NCT00069238|10797071|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
9698102|NCT00069238|10797072|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
9698103|NCT00069238|10797073|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
9698104|NCT00069238|10797071|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
9698105|NCT00069238|10797072|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
9698106|NCT00069238|10797073|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
9698107|NCT00069238|10797071|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
9698108|NCT00069238|10797072|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
9698109|NCT00069238|10797073|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
9698110|NCT00069238|10797071|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
9698111|NCT00069238|10797072|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
9698112|NCT00069238|10797073|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
9698113|NCT00069238|10797071|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
9698114|NCT00069238|10797072|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
9698115|NCT00069238|10797073|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
9698116|NCT00069238|10797071|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
9698117|NCT00069238|10797072|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
9698118|NCT00069238|10797073|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
9698119|NCT00069238|10797071|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
9698120|NCT00069238|10797072|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
9698121|NCT00069238|10797073|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
9727682|NCT00108953|10827314|FG000|COMPLETED|Follow-up||11
9727683|NCT00108953|10827315|FG001|COMPLETED|Follow-up||12
9727684|NCT00108953|10827314|FG000|NOT COMPLETED|Follow-up||29
9727685|NCT00108953|10827315|FG001|NOT COMPLETED|Follow-up||33
9727686|NCT00109005|10827325|FG000|STARTED|Overall Study||8
10026394|NCT01877421|11150415|FG000|NOT COMPLETED|Phase 2||0
10026395|NCT01877421|11150416|FG001|NOT COMPLETED|Phase 2||0
9727687|NCT00109005|10827326|FG001|STARTED|Overall Study||9
9727688|NCT00109005|10827325|FG000|COMPLETED|Overall Study||8
9727689|NCT00109005|10827326|FG001|COMPLETED|Overall Study||9
9727690|NCT00109005|10827325|FG000|NOT COMPLETED|Overall Study||0
9727691|NCT00109005|10827326|FG001|NOT COMPLETED|Overall Study||0
9727692|NCT00109031|10827337|FG000|STARTED|Overall Study||11
9727693|NCT00109031|10827338|FG001|STARTED|Overall Study||10
9727694|NCT00109031|10827339|FG002|STARTED|Overall Study||14
9727695|NCT00109031|10827340|FG003|STARTED|Overall Study||12
9727696|NCT00109031|10827337|FG000|COMPLETED|Overall Study||11
9727697|NCT00109031|10827338|FG001|COMPLETED|Overall Study||8
9727698|NCT00109031|10827339|FG002|COMPLETED|Overall Study||12
9727699|NCT00109031|10827340|FG003|COMPLETED|Overall Study||12
9727700|NCT00109031|10827337|FG000|NOT COMPLETED|Overall Study||0
9727701|NCT00109031|10827338|FG001|NOT COMPLETED|Overall Study||2
9727702|NCT00109031|10827339|FG002|NOT COMPLETED|Overall Study||2
9727703|NCT00109031|10827340|FG003|NOT COMPLETED|Overall Study||0
9847661|NCT00855218|10960215|FG000|Participants Received Treatment|Overall Study||153
9847662|NCT00855218|10960216|FG001|Participants Received Treatment|Overall Study||151
9847663|NCT00855218|10960215|FG000|COMPLETED|Overall Study||0
9847664|NCT00855218|10960216|FG001|COMPLETED|Overall Study||0
9847665|NCT00855218|10960215|FG000|NOT COMPLETED|Overall Study||154
9847666|NCT00855218|10960216|FG001|NOT COMPLETED|Overall Study||153
9847667|NCT00855309|10960224|FG000|STARTED|Overall Study||57
9847668|NCT00855309|10960225|FG001|STARTED|Overall Study||55
9847669|NCT00855309|10960224|FG000|COMPLETED|Overall Study||56
9847670|NCT00855309|10960225|FG001|COMPLETED|Overall Study||55
9847671|NCT00855309|10960224|FG000|NOT COMPLETED|Overall Study||1
9847672|NCT00855309|10960225|FG001|NOT COMPLETED|Overall Study||0
9847673|NCT00855335|10960236|FG000|STARTED|Overall Study||18
9847674|NCT00855335|10960237|FG001|STARTED|Overall Study||18
9698122|NCT03138499|10797080|FG000|STARTED|Overall Study||12
9698123|NCT03138499|10797081|FG001|STARTED|Overall Study||11
9698124|NCT03138499|10797080|FG000|COMPLETED|Overall Study||3
9698125|NCT03138499|10797081|FG001|COMPLETED|Overall Study||1
9698126|NCT03138499|10797080|FG000|NOT COMPLETED|Overall Study||9
9698127|NCT03138499|10797081|FG001|NOT COMPLETED|Overall Study||10
9698128|NCT03107208|10797090|FG000|STARTED|Overall Study||30
9698129|NCT03107208|10797091|FG001|STARTED|Overall Study||27
9698130|NCT03107208|10797090|FG000|Received Intervention|Overall Study||26
9698131|NCT03107208|10797091|FG001|Received Intervention|Overall Study||24
9698132|NCT03107208|10797090|FG000|COMPLETED|Overall Study||26
9698133|NCT03107208|10797091|FG001|COMPLETED|Overall Study||24
9698134|NCT03107208|10797090|FG000|NOT COMPLETED|Overall Study||4
9698135|NCT03107208|10797091|FG001|NOT COMPLETED|Overall Study||3
9698136|NCT04509739|10797097|FG000|STARTED|Overall Study||16
9698137|NCT04509739|10797097|FG000|COMPLETED|Overall Study||15
9698138|NCT04509739|10797097|FG000|NOT COMPLETED|Overall Study||1
9698139|NCT04391959|10797103|FG000|STARTED|Overall Study||16
9698140|NCT04391959|10797104|FG001|STARTED|Overall Study|One subject should have been excluded based upon Schirmer test = 0 mm at baseline < 5mm. Subject was removed from the study.|15
9698141|NCT04391959|10797103|FG000|COMPLETED|Overall Study||15
9698142|NCT04391959|10797104|FG001|COMPLETED|Overall Study||10
9698143|NCT04391959|10797103|FG000|NOT COMPLETED|Overall Study||1
9698144|NCT04391959|10797104|FG001|NOT COMPLETED|Overall Study||5
9698145|NCT04368364|10797113|FG000|STARTED|Overall Study||1
9698146|NCT04368364|10797114|FG001|STARTED|Overall Study||1
9698147|NCT04368364|10797115|FG002|STARTED|Overall Study||1
9698148|NCT04368364|10797113|FG000|COMPLETED|Overall Study||1
9698149|NCT04368364|10797114|FG001|COMPLETED|Overall Study||1
9698150|NCT04368364|10797115|FG002|COMPLETED|Overall Study||1
9698151|NCT04368364|10797113|FG000|NOT COMPLETED|Overall Study||0
9698152|NCT04368364|10797114|FG001|NOT COMPLETED|Overall Study||0
9698153|NCT04368364|10797115|FG002|NOT COMPLETED|Overall Study||0
9698154|NCT04244084|10797125|FG000|STARTED|Overall Study||118
9698155|NCT04244084|10797126|FG001|STARTED|Overall Study||122
9698156|NCT04244084|10797125|FG000|COMPLETED|Overall Study||118
9698157|NCT04244084|10797126|FG001|COMPLETED|Overall Study||122
9698158|NCT04244084|10797125|FG000|NOT COMPLETED|Overall Study||0
9698159|NCT04244084|10797126|FG001|NOT COMPLETED|Overall Study||0
9698160|NCT04189588|10797134|FG000|STARTED|Overall Study||17
9698161|NCT04189588|10797135|FG001|STARTED|Overall Study||17
9698162|NCT04189588|10797134|FG000|Completed Treatment|Overall Study||17
9698163|NCT04189588|10797135|FG001|Completed Treatment|Overall Study||17
9698164|NCT04189588|10797134|FG000|COMPLETED|Overall Study||17
9698165|NCT04189588|10797135|FG001|COMPLETED|Overall Study||15
9698166|NCT04189588|10797134|FG000|NOT COMPLETED|Overall Study||0
9698167|NCT04189588|10797135|FG001|NOT COMPLETED|Overall Study||2
9698168|NCT04150562|10797141|FG000|STARTED|Overall Study||2
9698169|NCT04150562|10797142|FG001|STARTED|Overall Study||0
9698170|NCT04150562|10797141|FG000|COMPLETED|Overall Study||2
9698171|NCT04150562|10797142|FG001|COMPLETED|Overall Study||0
9698172|NCT04150562|10797141|FG000|NOT COMPLETED|Overall Study||0
9698173|NCT04150562|10797142|FG001|NOT COMPLETED|Overall Study||0
9698174|NCT04115748|10797150|FG000|STARTED|Main Study (Up to 16 Weeks)||19
9698175|NCT04115748|10797151|FG001|STARTED|Main Study (Up to 16 Weeks)||19
9698176|NCT04115748|10797152|FG002|STARTED|Main Study (Up to 16 Weeks)||9
9698177|NCT04115748|10797153|FG003|STARTED|Main Study (Up to 16 Weeks)||20
9698178|NCT04115748|10797154|FG004|STARTED|Main Study (Up to 16 Weeks)||0
9698179|NCT04115748|10797155|FG005|STARTED|Main Study (Up to 16 Weeks)||0
9698180|NCT04115748|10797156|FG006|STARTED|Main Study (Up to 16 Weeks)||0
9698181|NCT04115748|10797157|FG007|STARTED|Main Study (Up to 16 Weeks)||0
9698182|NCT04115748|10797158|FG008|STARTED|Main Study (Up to 16 Weeks)||0
9698183|NCT04115748|10797159|FG009|STARTED|Main Study (Up to 16 Weeks)||0
9698184|NCT04115748|10797150|FG000|COMPLETED|Main Study (Up to 16 Weeks)||4
9698185|NCT04115748|10797151|FG001|COMPLETED|Main Study (Up to 16 Weeks)||3
9698186|NCT04115748|10797152|FG002|COMPLETED|Main Study (Up to 16 Weeks)||2
9698187|NCT04115748|10797153|FG003|COMPLETED|Main Study (Up to 16 Weeks)||4
9847675|NCT00855335|10960238|FG002|STARTED|Overall Study||15
9847676|NCT00855335|10960239|FG003|STARTED|Overall Study||19
9847677|NCT00855335|10960240|FG004|STARTED|Overall Study||7
9847678|NCT00855335|10960236|FG000|COMPLETED|Overall Study||13
9847679|NCT00855335|10960237|FG001|COMPLETED|Overall Study||16
9847680|NCT00855335|10960238|FG002|COMPLETED|Overall Study||10
9847681|NCT00855335|10960239|FG003|COMPLETED|Overall Study||12
9847682|NCT00855335|10960240|FG004|COMPLETED|Overall Study||6
9961986|NCT01475071|11081527|FG000|STARTED|Overall Study||100
9698188|NCT04115748|10797154|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
9698189|NCT04115748|10797155|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
9698190|NCT04115748|10797156|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
9698191|NCT04115748|10797157|FG007|COMPLETED|Main Study (Up to 16 Weeks)||0
9698192|NCT04115748|10797158|FG008|COMPLETED|Main Study (Up to 16 Weeks)||0
9698193|NCT04115748|10797159|FG009|COMPLETED|Main Study (Up to 16 Weeks)||0
9698194|NCT04115748|10797150|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||15
9698195|NCT04115748|10797151|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
9698196|NCT04115748|10797152|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||7
9698197|NCT04115748|10797153|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
9698198|NCT04115748|10797154|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9698199|NCT04115748|10797155|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9698200|NCT04115748|10797156|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9698201|NCT04115748|10797157|FG007|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9698202|NCT04115748|10797158|FG008|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9698203|NCT04115748|10797159|FG009|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
9698204|NCT04115748|10797150|FG000|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|0
9698205|NCT04115748|10797151|FG001|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|0
9698206|NCT04115748|10797152|FG002|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
9698207|NCT04115748|10797153|FG003|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
9698208|NCT04115748|10797154|FG004|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|4
9727704|NCT00109343|10827353|FG000|STARTED|Overall Study||510
9727705|NCT00109343|10827354|FG001|STARTED|Overall Study||258
9727706|NCT00109343|10827355|FG002|STARTED|Overall Study||259
9727707|NCT00109343|10827353|FG000|Vaccinated at Visit 1|Overall Study||510
9727708|NCT00109343|10827354|FG001|Vaccinated at Visit 1|Overall Study||258
9727709|NCT00109343|10827355|FG002|Vaccinated at Visit 1|Overall Study||259
9727710|NCT00109343|10827353|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
9727711|NCT00109343|10827354|FG001|Vaccinated at Visit 2|Overall Study||246
9727712|NCT00109343|10827355|FG002|Vaccinated at Visit 2|Overall Study||246
9727713|NCT00109343|10827353|FG000|Vaccinated at Visit 4|Overall Study||466
9727714|NCT00109343|10827354|FG001|Vaccinated at Visit 4|Overall Study||235
9727715|NCT00109343|10827355|FG002|Vaccinated at Visit 4|Overall Study||240
9727716|NCT00109343|10827353|FG000|COMPLETED|Overall Study||446
9727717|NCT00109343|10827354|FG001|COMPLETED|Overall Study||221
9727718|NCT00109343|10827355|FG002|COMPLETED|Overall Study||229
9727719|NCT00109343|10827353|FG000|NOT COMPLETED|Overall Study||64
9727720|NCT00109343|10827354|FG001|NOT COMPLETED|Overall Study||37
9727721|NCT00109343|10827355|FG002|NOT COMPLETED|Overall Study||30
9727722|NCT00109473|10827365|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
9727723|NCT00109473|10827366|FG001|STARTED|Baseline (0 Through 12 Weeks)||10
9727724|NCT00109473|10827365|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10
9727725|NCT00109473|10827366|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10
9727726|NCT00109473|10827365|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10
9727727|NCT00109473|10827366|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
9727728|NCT00109473|10827365|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
9727729|NCT00109473|10827366|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
9727730|NCT00109473|10827365|FG000|STARTED|Week 12 to Week 24||10
9727731|NCT00109473|10827366|FG001|STARTED|Week 12 to Week 24||9
9727732|NCT00109473|10827365|FG000|Analyzed|Week 12 to Week 24||9
9727733|NCT00109473|10827366|FG001|Analyzed|Week 12 to Week 24||9
9727734|NCT00109473|10827365|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
9727735|NCT00109473|10827366|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
9727736|NCT00109473|10827365|FG000|NOT COMPLETED|Week 12 to Week 24||1
9727737|NCT00109473|10827366|FG001|NOT COMPLETED|Week 12 to Week 24||0
9727738|NCT00109473|10827365|FG000|STARTED|52 Week Extension Phase||9
9727739|NCT00109473|10827366|FG001|STARTED|52 Week Extension Phase||8
9727740|NCT00109473|10827365|FG000|Analyzed|52 Week Extension Phase||9
9727741|NCT00109473|10827366|FG001|Analyzed|52 Week Extension Phase||8
9727742|NCT00109473|10827365|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
9727743|NCT00109473|10827366|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
9727744|NCT00109473|10827365|FG000|NOT COMPLETED|52 Week Extension Phase||4
9727745|NCT00109473|10827366|FG001|NOT COMPLETED|52 Week Extension Phase||5
9727746|NCT00109577|10827377|FG000|STARTED|Overall Study||20
9727747|NCT00109577|10827378|FG001|STARTED|Overall Study||20
9727748|NCT00109577|10827377|FG000|COMPLETED|Overall Study||17
9727749|NCT00109577|10827378|FG001|COMPLETED|Overall Study||17
9727750|NCT00109577|10827377|FG000|NOT COMPLETED|Overall Study||3
9727751|NCT00109577|10827378|FG001|NOT COMPLETED|Overall Study||3
9727752|NCT00109590|10827387|FG000|STARTED|Overall Study||57
9727753|NCT00109590|10827388|FG001|STARTED|Overall Study||58
9727754|NCT00109590|10827389|FG002|STARTED|Overall Study||60
9727755|NCT00109590|10827387|FG000|RECEIVED TREATMENT|Overall Study||56
9847683|NCT00855335|10960236|FG000|NOT COMPLETED|Overall Study||5
9847684|NCT00855335|10960237|FG001|NOT COMPLETED|Overall Study||2
9847685|NCT00855335|10960238|FG002|NOT COMPLETED|Overall Study||5
9847686|NCT00855335|10960239|FG003|NOT COMPLETED|Overall Study||7
9847687|NCT00855335|10960240|FG004|NOT COMPLETED|Overall Study||1
9847688|NCT00855413|10960265|FG000|STARTED|Overall Study||15
9698209|NCT04115748|10797155|FG005|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|3
9698210|NCT04115748|10797156|FG006|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|1
9698211|NCT04115748|10797157|FG007|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|1
9698212|NCT04115748|10797158|FG008|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|2
9698213|NCT04115748|10797159|FG009|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|2
9698214|NCT04115748|10797150|FG000|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698215|NCT04115748|10797151|FG001|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698216|NCT04115748|10797152|FG002|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698217|NCT04115748|10797153|FG003|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698218|NCT04115748|10797154|FG004|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698219|NCT04115748|10797155|FG005|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698220|NCT04115748|10797156|FG006|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698221|NCT04115748|10797157|FG007|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698222|NCT04115748|10797158|FG008|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698223|NCT04115748|10797159|FG009|COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698224|NCT04115748|10797150|FG000|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698225|NCT04115748|10797151|FG001|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698226|NCT04115748|10797152|FG002|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698227|NCT04115748|10797153|FG003|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
9698228|NCT04115748|10797154|FG004|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||4
9698229|NCT04115748|10797155|FG005|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||3
9698230|NCT04115748|10797156|FG006|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
9698231|NCT04115748|10797157|FG007|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
9698232|NCT04115748|10797158|FG008|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
9698233|NCT04115748|10797159|FG009|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
9698234|NCT04044664|10797184|FG000|STARTED|Stage 1||103
9698235|NCT04044664|10797185|FG001|STARTED|Stage 1||26
9698236|NCT04044664|10797186|FG002|STARTED|Stage 1||23
9698237|NCT04044664|10797184|FG000|COMPLETED|Stage 1||86
9698238|NCT04044664|10797185|FG001|COMPLETED|Stage 1||19
9698239|NCT04044664|10797186|FG002|COMPLETED|Stage 1||20
9698240|NCT04044664|10797184|FG000|NOT COMPLETED|Stage 1||17
9698241|NCT04044664|10797185|FG001|NOT COMPLETED|Stage 1||7
9698242|NCT04044664|10797186|FG002|NOT COMPLETED|Stage 1||3
9698243|NCT04044664|10797184|FG000|STARTED|Stage 2||76
9698244|NCT04044664|10797185|FG001|STARTED|Stage 2||26
9698245|NCT04044664|10797186|FG002|STARTED|Stage 2||22
9698246|NCT04044664|10797184|FG000|From Placebo, Responder|Stage 2||20
9698247|NCT04044664|10797185|FG001|From Placebo, Responder|Stage 2||13
9698248|NCT04044664|10797186|FG002|From Placebo, Responder|Stage 2||11
9698249|NCT04044664|10797184|FG000|From Placebo, Non-Responder|Stage 2||18
9698250|NCT04044664|10797185|FG001|From Placebo, Non-Responder|Stage 2||13
9698251|NCT04044664|10797186|FG002|From Placebo, Non-Responder|Stage 2||11
9698252|NCT04044664|10797184|FG000|From NYX-783 (10 mg or 50 mg)|Stage 2||38
9698253|NCT04044664|10797185|FG001|From NYX-783 (10 mg or 50 mg)|Stage 2||0
9698254|NCT04044664|10797186|FG002|From NYX-783 (10 mg or 50 mg)|Stage 2||0
9698255|NCT04044664|10797184|FG000|COMPLETED|Stage 2||67
9698256|NCT04044664|10797185|FG001|COMPLETED|Stage 2||24
9698257|NCT04044664|10797186|FG002|COMPLETED|Stage 2||21
9698258|NCT04044664|10797184|FG000|NOT COMPLETED|Stage 2||9
9698259|NCT04044664|10797185|FG001|NOT COMPLETED|Stage 2||2
9698260|NCT04044664|10797186|FG002|NOT COMPLETED|Stage 2||1
9698261|NCT04009850|10797196|FG000|STARTED|Overall Study||3
9847689|NCT00855413|10960265|FG000|COMPLETED|Overall Study||15
9847690|NCT00855413|10960265|FG000|NOT COMPLETED|Overall Study||0
9847691|NCT00855439|10960271|FG000|STARTED|Overall Study||22
9847692|NCT00855439|10960272|FG001|STARTED|Overall Study||24
9847693|NCT00855439|10960271|FG000|COMPLETED|Overall Study||19
9847694|NCT00855439|10960272|FG001|COMPLETED|Overall Study||24
9847695|NCT00855439|10960271|FG000|NOT COMPLETED|Overall Study||3
9847696|NCT00855439|10960272|FG001|NOT COMPLETED|Overall Study||0
9847697|NCT00855465|10960280|FG000|STARTED|Treatment Period||174
10026396|NCT01877421|11150417|FG002|NOT COMPLETED|Phase 2||0
10026397|NCT01877421|11150418|FG003|NOT COMPLETED|Phase 2||0
10026398|NCT01877421|11150419|FG004|NOT COMPLETED|Phase 2||0
10026399|NCT01877421|11150420|FG005|NOT COMPLETED|Phase 2||0
10026400|NCT01877421|11150421|FG006|NOT COMPLETED|Phase 2||1
10026401|NCT01877421|11150422|FG007|NOT COMPLETED|Phase 2||0
10026402|NCT01877421|11150423|FG008|NOT COMPLETED|Phase 2||1
10026403|NCT01877421|11150424|FG009|NOT COMPLETED|Phase 2||0
10026404|NCT01877421|11150425|FG010|NOT COMPLETED|Phase 2||2
10026405|NCT01877421|11150426|FG011|NOT COMPLETED|Phase 2||0
10026406|NCT01877421|11150427|FG012|NOT COMPLETED|Phase 2||1
10026407|NCT01877421|11150428|FG013|NOT COMPLETED|Phase 2||0
10026408|NCT01877421|11150429|FG014|NOT COMPLETED|Phase 2||0
10026409|NCT01877421|11150430|FG015|NOT COMPLETED|Phase 2||1
10026410|NCT01877421|11150431|FG016|NOT COMPLETED|Phase 2||0
10026411|NCT01877421|11150432|FG017|NOT COMPLETED|Phase 2||0
9698262|NCT04009850|10797197|FG001|STARTED|Overall Study||0
9698263|NCT04009850|10797196|FG000|COMPLETED|Overall Study||3
9698264|NCT04009850|10797197|FG001|COMPLETED|Overall Study||0
9698265|NCT04009850|10797196|FG000|NOT COMPLETED|Overall Study||0
9698266|NCT04009850|10797197|FG001|NOT COMPLETED|Overall Study||0
9698267|NCT03994731|10797205|FG000|STARTED|Run-in Period (From Week -4 to Day 1)||100
9698268|NCT03994731|10797206|FG001|STARTED|Run-in Period (From Week -4 to Day 1)||52
9698269|NCT03994731|10797205|FG000|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||98
9698270|NCT03994731|10797206|FG001|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||51
9698271|NCT03994731|10797205|FG000|COMPLETED|Run-in Period (From Week -4 to Day 1)||96
9698272|NCT03994731|10797206|FG001|COMPLETED|Run-in Period (From Week -4 to Day 1)||49
9698273|NCT03994731|10797205|FG000|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||4
9698274|NCT03994731|10797206|FG001|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||3
9698275|NCT03994731|10797205|FG000|STARTED|Pegloticase + IMM Period||96
9698276|NCT03994731|10797206|FG001|STARTED|Pegloticase + IMM Period||49
9698277|NCT03994731|10797205|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||38
9698278|NCT03994731|10797206|FG001|Discontinued Study Treatment Early|Pegloticase + IMM Period||33
9698279|NCT03994731|10797205|FG000|COMPLETED|Pegloticase + IMM Period||76
9698280|NCT03994731|10797206|FG001|COMPLETED|Pegloticase + IMM Period||34
9698281|NCT03994731|10797205|FG000|NOT COMPLETED|Pegloticase + IMM Period||20
9698282|NCT03994731|10797206|FG001|NOT COMPLETED|Pegloticase + IMM Period||15
9727756|NCT00109590|10827388|FG001|RECEIVED TREATMENT|Overall Study||56
9727757|NCT00109590|10827389|FG002|RECEIVED TREATMENT|Overall Study||57
9727758|NCT00109590|10827387|FG000|COMPLETED|Overall Study||55
9727759|NCT00109590|10827388|FG001|COMPLETED|Overall Study||56
9727760|NCT00109590|10827389|FG002|COMPLETED|Overall Study||56
9727761|NCT00109590|10827387|FG000|NOT COMPLETED|Overall Study||2
9727762|NCT00109590|10827388|FG001|NOT COMPLETED|Overall Study||2
9727763|NCT00109590|10827389|FG002|NOT COMPLETED|Overall Study||4
9727764|NCT00109707|10827414|FG000|STARTED|Overall Study||321
9727765|NCT00109707|10827415|FG001|STARTED|Overall Study||137
9727766|NCT00109707|10827416|FG002|STARTED|Overall Study||49
9727767|NCT00109707|10827414|FG000|Entered Extension Study|Overall Study||106
9727768|NCT00109707|10827415|FG001|Entered Extension Study|Overall Study||15
9727769|NCT00109707|10827416|FG002|Entered Extension Study|Overall Study||15
9727770|NCT00109707|10827414|FG000|COMPLETED|Overall Study||67
9727771|NCT00109707|10827415|FG001|COMPLETED|Overall Study||8
9727772|NCT00109707|10827416|FG002|COMPLETED|Overall Study||8
9727773|NCT00109707|10827414|FG000|NOT COMPLETED|Overall Study||254
9727774|NCT00109707|10827415|FG001|NOT COMPLETED|Overall Study||129
9727775|NCT00109707|10827416|FG002|NOT COMPLETED|Overall Study||41
9727776|NCT00109733|10827430|FG000|STARTED|Overall Study||15
9727777|NCT00109733|10827431|FG001|STARTED|Overall Study||16
9727778|NCT00109733|10827430|FG000|COMPLETED|Overall Study||13
9727779|NCT00109733|10827431|FG001|COMPLETED|Overall Study||12
9727780|NCT00109733|10827430|FG000|NOT COMPLETED|Overall Study||2
9727781|NCT00109733|10827431|FG001|NOT COMPLETED|Overall Study||4
9727782|NCT00109772|10827439|FG000|STARTED|Double-blind Treatment||90
9727783|NCT00109772|10827440|FG001|STARTED|Double-blind Treatment||94
9727784|NCT00109772|10827439|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
9727785|NCT00109772|10827440|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
9727786|NCT00109772|10827439|FG000|COMPLETED|Double-blind Treatment||68
9727787|NCT00109772|10827440|FG001|COMPLETED|Double-blind Treatment||79
9727788|NCT00109772|10827439|FG000|NOT COMPLETED|Double-blind Treatment||22
9727789|NCT00109772|10827440|FG001|NOT COMPLETED|Double-blind Treatment||15
9727790|NCT00109772|10827439|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
9727791|NCT00109772|10827440|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
9961987|NCT01475071|11081527|FG000|COMPLETED|Overall Study||92
9961988|NCT01475071|11081527|FG000|NOT COMPLETED|Overall Study||8
9961989|NCT01475097|11081535|FG000|STARTED|Overall Study||128
9961990|NCT01475097|11081536|FG001|STARTED|Overall Study||127
9961991|NCT01475097|11081535|FG000|COMPLETED|Overall Study||127
9961992|NCT01475097|11081536|FG001|COMPLETED|Overall Study||126
9961993|NCT01475097|11081535|FG000|NOT COMPLETED|Overall Study||1
9961994|NCT01475097|11081536|FG001|NOT COMPLETED|Overall Study||1
9961995|NCT01475136|11081546|FG000|STARTED|Overall Study||7
10114897|NCT02521181|11245700|FG000|STARTED|Overall Study||52
10114898|NCT02521181|11245701|FG001|STARTED|Overall Study||90
10114899|NCT02521181|11245702|FG002|STARTED|Overall Study||52
9731862|NCT00136916|10831823|FG000|NOT COMPLETED|Overall Study||125
9961996|NCT01475136|11081547|FG001|STARTED|Overall Study||9
9961997|NCT01475136|11081548|FG002|STARTED|Overall Study||9
10114900|NCT02521181|11245700|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52
10114901|NCT02521181|11245701|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90
10114902|NCT02521181|11245702|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52
9961998|NCT01475136|11081549|FG003|STARTED|Overall Study||12
9961999|NCT01475136|11081546|FG000|Received 1 Dose of Study Drug|Overall Study||7
9962000|NCT01475136|11081547|FG001|Received 1 Dose of Study Drug|Overall Study||6
10114903|NCT02521181|11245700|FG000|NOT COMPLETED|Overall Study||0
10114904|NCT02521181|11245701|FG001|NOT COMPLETED|Overall Study||0
9698283|NCT03963895|10797218|FG000|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
9698284|NCT03963895|10797219|FG001|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
9698285|NCT03963895|10797220|FG002|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
9698286|NCT03963895|10797218|FG000|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
9698287|NCT03963895|10797219|FG001|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
9698288|NCT03963895|10797220|FG002|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
9698289|NCT03963895|10797218|FG000|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
9698290|NCT03963895|10797219|FG001|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
9698291|NCT03963895|10797220|FG002|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
9698292|NCT03963895|10797218|FG000|STARTED|Dosing Period (Study Day 1)||12
9698293|NCT03963895|10797219|FG001|STARTED|Dosing Period (Study Day 1)||12
9698294|NCT03963895|10797220|FG002|STARTED|Dosing Period (Study Day 1)||12
9698295|NCT03963895|10797218|FG000|COMPLETED|Dosing Period (Study Day 1)||12
9698296|NCT03963895|10797219|FG001|COMPLETED|Dosing Period (Study Day 1)||12
9698297|NCT03963895|10797220|FG002|COMPLETED|Dosing Period (Study Day 1)||12
9698298|NCT03963895|10797218|FG000|NOT COMPLETED|Dosing Period (Study Day 1)||0
9698299|NCT03963895|10797219|FG001|NOT COMPLETED|Dosing Period (Study Day 1)||0
9698300|NCT03963895|10797220|FG002|NOT COMPLETED|Dosing Period (Study Day 1)||0
9698301|NCT03963895|10797218|FG000|STARTED|Recovery Period (Study Day 3)||12
9698302|NCT03963895|10797219|FG001|STARTED|Recovery Period (Study Day 3)||12
9698303|NCT03963895|10797220|FG002|STARTED|Recovery Period (Study Day 3)||12
9698304|NCT03963895|10797218|FG000|COMPLETED|Recovery Period (Study Day 3)||12
9698305|NCT03963895|10797219|FG001|COMPLETED|Recovery Period (Study Day 3)||12
9698306|NCT03963895|10797220|FG002|COMPLETED|Recovery Period (Study Day 3)||12
9698307|NCT03963895|10797218|FG000|NOT COMPLETED|Recovery Period (Study Day 3)||0
9698308|NCT03963895|10797219|FG001|NOT COMPLETED|Recovery Period (Study Day 3)||0
9698309|NCT03963895|10797220|FG002|NOT COMPLETED|Recovery Period (Study Day 3)||0
9698310|NCT03963895|10797218|FG000|STARTED|Follow-up Period (Study Day 14)||12
9698311|NCT03963895|10797219|FG001|STARTED|Follow-up Period (Study Day 14)||12
9698312|NCT03963895|10797220|FG002|STARTED|Follow-up Period (Study Day 14)||12
9698313|NCT03963895|10797218|FG000|COMPLETED|Follow-up Period (Study Day 14)||12
9698314|NCT03963895|10797219|FG001|COMPLETED|Follow-up Period (Study Day 14)||11
9698315|NCT03963895|10797220|FG002|COMPLETED|Follow-up Period (Study Day 14)||12
9698316|NCT03963895|10797218|FG000|NOT COMPLETED|Follow-up Period (Study Day 14)||0
9698317|NCT03963895|10797219|FG001|NOT COMPLETED|Follow-up Period (Study Day 14)||1
9698318|NCT03963895|10797220|FG002|NOT COMPLETED|Follow-up Period (Study Day 14)||0
9698319|NCT03924622|10797234|FG000|STARTED|Overall Study||12
9698320|NCT03924622|10797235|FG001|STARTED|Overall Study||12
9698321|NCT03924622|10797236|FG002|STARTED|Overall Study||12
9698322|NCT03924622|10797237|FG003|STARTED|Overall Study||12
9698323|NCT03924622|10797238|FG004|STARTED|Overall Study||12
9698324|NCT03924622|10797239|FG005|STARTED|Overall Study||12
9698325|NCT03924622|10797234|FG000|COMPLETED|Overall Study||10
9698326|NCT03924622|10797235|FG001|COMPLETED|Overall Study||9
9698327|NCT03924622|10797236|FG002|COMPLETED|Overall Study||9
9698328|NCT03924622|10797237|FG003|COMPLETED|Overall Study||8
9698329|NCT03924622|10797238|FG004|COMPLETED|Overall Study||9
9698330|NCT03924622|10797239|FG005|COMPLETED|Overall Study||9
9698331|NCT03924622|10797234|FG000|NOT COMPLETED|Overall Study||2
9698332|NCT03924622|10797235|FG001|NOT COMPLETED|Overall Study||3
9698333|NCT03924622|10797236|FG002|NOT COMPLETED|Overall Study||3
9698334|NCT03924622|10797237|FG003|NOT COMPLETED|Overall Study||4
9698335|NCT03924622|10797238|FG004|NOT COMPLETED|Overall Study||3
9698336|NCT03924622|10797239|FG005|NOT COMPLETED|Overall Study||3
9698337|NCT03905811|10797255|FG000|STARTED|Overall Study||8
9698338|NCT03905811|10797256|FG001|STARTED|Overall Study||5
9698339|NCT03905811|10797255|FG000|COMPLETED|Overall Study||6
9698340|NCT03905811|10797256|FG001|COMPLETED|Overall Study||5
9698341|NCT03905811|10797255|FG000|NOT COMPLETED|Overall Study||2
9698342|NCT03905811|10797256|FG001|NOT COMPLETED|Overall Study||0
9698343|NCT03867396|10797262|FG000|STARTED|Intervention 1||8
9698344|NCT03867396|10797263|FG001|STARTED|Intervention 1||8
9698345|NCT03867396|10797264|FG002|STARTED|Intervention 1||7
9698346|NCT03867396|10797265|FG003|STARTED|Intervention 1||5
9698347|NCT03867396|10797266|FG004|STARTED|Intervention 1||7
9698348|NCT03867396|10797267|FG005|STARTED|Intervention 1||5
9698349|NCT03867396|10797262|FG000|Data Collection|Intervention 1||8
9698350|NCT03867396|10797263|FG001|Data Collection|Intervention 1||5
9698351|NCT03867396|10797264|FG002|Data Collection|Intervention 1||7
9698352|NCT03867396|10797265|FG003|Data Collection|Intervention 1||5
9698353|NCT03867396|10797266|FG004|Data Collection|Intervention 1||0
9698354|NCT03867396|10797267|FG005|Data Collection|Intervention 1||0
9698355|NCT03867396|10797262|FG000|COMPLETED|Intervention 1||8
9698356|NCT03867396|10797263|FG001|COMPLETED|Intervention 1||5
9698357|NCT03867396|10797264|FG002|COMPLETED|Intervention 1||7
9698358|NCT03867396|10797265|FG003|COMPLETED|Intervention 1||5
9698359|NCT03867396|10797266|FG004|COMPLETED|Intervention 1||0
9698360|NCT03867396|10797267|FG005|COMPLETED|Intervention 1||0
9698361|NCT03867396|10797262|FG000|NOT COMPLETED|Intervention 1||0
9698362|NCT03867396|10797263|FG001|NOT COMPLETED|Intervention 1||3
9698363|NCT03867396|10797264|FG002|NOT COMPLETED|Intervention 1||0
9698364|NCT03867396|10797265|FG003|NOT COMPLETED|Intervention 1||0
9698365|NCT03867396|10797266|FG004|NOT COMPLETED|Intervention 1||7
9698366|NCT03867396|10797267|FG005|NOT COMPLETED|Intervention 1||5
9698367|NCT03867396|10797262|FG000|STARTED|Intervention 2||8
9698368|NCT03867396|10797263|FG001|STARTED|Intervention 2||5
9698369|NCT03867396|10797264|FG002|STARTED|Intervention 2||7
9698370|NCT03867396|10797265|FG003|STARTED|Intervention 2||5
9698371|NCT03867396|10797266|FG004|STARTED|Intervention 2||0
9698372|NCT03867396|10797267|FG005|STARTED|Intervention 2||0
9698373|NCT03867396|10797262|FG000|COMPLETED|Intervention 2||8
9698374|NCT03867396|10797263|FG001|COMPLETED|Intervention 2||5
9698375|NCT03867396|10797264|FG002|COMPLETED|Intervention 2||7
9698376|NCT03867396|10797265|FG003|COMPLETED|Intervention 2||5
9962001|NCT01475136|11081548|FG002|Received 1 Dose of Study Drug|Overall Study||6
9962002|NCT01475136|11081549|FG003|Received 1 Dose of Study Drug|Overall Study||7
9962003|NCT01475136|11081546|FG000|COMPLETED|Overall Study||6
9962004|NCT01475136|11081547|FG001|COMPLETED|Overall Study||6
9962005|NCT01475136|11081548|FG002|COMPLETED|Overall Study||6
9962006|NCT01475136|11081549|FG003|COMPLETED|Overall Study||7
10114905|NCT02521181|11245702|FG002|NOT COMPLETED|Overall Study||0
10114906|NCT02521259|11245712|FG000|STARTED|Overall Study||35
10114907|NCT02521259|11245713|FG001|STARTED|Overall Study||33
10114908|NCT02521259|11245712|FG000|COMPLETED|Overall Study||34
10114909|NCT02521259|11245713|FG001|COMPLETED|Overall Study||28
10114910|NCT02521259|11245712|FG000|NOT COMPLETED|Overall Study||1
10114911|NCT02521259|11245713|FG001|NOT COMPLETED|Overall Study||5
10114912|NCT02521376|11245723|FG000|STARTED|Overall Study||8
10114913|NCT02521376|11245724|FG001|STARTED|Overall Study||18
10114914|NCT02521376|11245725|FG002|STARTED|Overall Study||10
10114915|NCT02521376|11245726|FG003|STARTED|Overall Study||20
9962007|NCT01475136|11081546|FG000|NOT COMPLETED|Overall Study||1
9962008|NCT01475136|11081547|FG001|NOT COMPLETED|Overall Study||3
9962009|NCT01475136|11081548|FG002|NOT COMPLETED|Overall Study||3
9962010|NCT01475136|11081549|FG003|NOT COMPLETED|Overall Study||5
9698377|NCT03867396|10797266|FG004|COMPLETED|Intervention 2||0
9698378|NCT03867396|10797267|FG005|COMPLETED|Intervention 2||0
9698379|NCT03867396|10797262|FG000|NOT COMPLETED|Intervention 2||0
9698380|NCT03867396|10797263|FG001|NOT COMPLETED|Intervention 2||0
9698381|NCT03867396|10797264|FG002|NOT COMPLETED|Intervention 2||0
9698382|NCT03867396|10797265|FG003|NOT COMPLETED|Intervention 2||0
9698383|NCT03867396|10797266|FG004|NOT COMPLETED|Intervention 2||0
9698384|NCT03867396|10797267|FG005|NOT COMPLETED|Intervention 2||0
9698385|NCT03867396|10797262|FG000|STARTED|Intervention 3||8
9698386|NCT03867396|10797263|FG001|STARTED|Intervention 3||5
9698387|NCT03867396|10797264|FG002|STARTED|Intervention 3||7
9698388|NCT03867396|10797265|FG003|STARTED|Intervention 3||5
9962011|NCT01475162|11081559|FG000|STARTED|Overall Study||14
10114916|NCT02521376|11245723|FG000|COMPLETED|Overall Study||7
9698389|NCT03867396|10797266|FG004|STARTED|Intervention 3||0
9698390|NCT03867396|10797267|FG005|STARTED|Intervention 3||0
9698391|NCT03867396|10797262|FG000|COMPLETED|Intervention 3||8
9698392|NCT03867396|10797263|FG001|COMPLETED|Intervention 3||5
9698393|NCT03867396|10797264|FG002|COMPLETED|Intervention 3||7
9698394|NCT03867396|10797265|FG003|COMPLETED|Intervention 3||5
9698395|NCT03867396|10797266|FG004|COMPLETED|Intervention 3||0
9698396|NCT03867396|10797267|FG005|COMPLETED|Intervention 3||0
9698397|NCT03867396|10797262|FG000|NOT COMPLETED|Intervention 3||0
9698398|NCT03867396|10797263|FG001|NOT COMPLETED|Intervention 3||0
9698399|NCT03867396|10797264|FG002|NOT COMPLETED|Intervention 3||0
9698400|NCT03867396|10797265|FG003|NOT COMPLETED|Intervention 3||0
9698401|NCT03867396|10797266|FG004|NOT COMPLETED|Intervention 3||0
9698402|NCT03867396|10797267|FG005|NOT COMPLETED|Intervention 3||0
9698403|NCT03807843|10797280|FG000|STARTED|Overall Study||21
9698404|NCT03807843|10797281|FG001|STARTED|Overall Study||20
9698405|NCT03807843|10797280|FG000|COMPLETED|Overall Study||20
9698406|NCT03807843|10797281|FG001|COMPLETED|Overall Study||20
9698407|NCT03807843|10797280|FG000|NOT COMPLETED|Overall Study||1
9698408|NCT03807843|10797281|FG001|NOT COMPLETED|Overall Study||0
9698409|NCT03802513|10797287|FG000|STARTED|Overall Study||10
9698410|NCT03802513|10797287|FG000|COMPLETED|Overall Study||9
9698411|NCT03802513|10797287|FG000|NOT COMPLETED|Overall Study||1
9698412|NCT03681184|10797293|FG000|STARTED|6-Month Double-Blind Period||13
9698413|NCT03681184|10797294|FG001|STARTED|6-Month Double-Blind Period||26
9698414|NCT03681184|10797293|FG000|COMPLETED|6-Month Double-Blind Period||13
9698415|NCT03681184|10797294|FG001|COMPLETED|6-Month Double-Blind Period||25
9698416|NCT03681184|10797293|FG000|NOT COMPLETED|6-Month Double-Blind Period||0
9698417|NCT03681184|10797294|FG001|NOT COMPLETED|6-Month Double-Blind Period||1
9698418|NCT03681184|10797293|FG000|STARTED|3-Month Blinded Extension Period||13
9698419|NCT03681184|10797294|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
9698420|NCT03681184|10797293|FG000|COMPLETED|3-Month Blinded Extension Period||1
9698421|NCT03681184|10797294|FG001|COMPLETED|3-Month Blinded Extension Period||1
9698422|NCT03681184|10797293|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12
9698423|NCT03681184|10797294|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23
9698424|NCT03681184|10797293|FG000|STARTED|Open-Label Extension Period||1
9698425|NCT03681184|10797294|FG001|STARTED|Open-Label Extension Period||1
9698426|NCT03681184|10797293|FG000|COMPLETED|Open-Label Extension Period||0
9698427|NCT03681184|10797294|FG001|COMPLETED|Open-Label Extension Period||0
9698428|NCT03681184|10797293|FG000|NOT COMPLETED|Open-Label Extension Period||1
9698429|NCT03681184|10797294|FG001|NOT COMPLETED|Open-Label Extension Period||1
9698430|NCT03679767|10797304|FG000|STARTED|Overall Study||35
9698431|NCT03679767|10797305|FG001|STARTED|Overall Study||23
9847698|NCT00855465|10960281|FG001|STARTED|Treatment Period||88
9847699|NCT00855465|10960280|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
9847700|NCT00855465|10960281|FG001|Participants Received Treatment|Treatment Period||88
9847701|NCT00855465|10960280|FG000|COMPLETED|Treatment Period||160
9847702|NCT00855465|10960281|FG001|COMPLETED|Treatment Period||83
9847703|NCT00855465|10960280|FG000|NOT COMPLETED|Treatment Period||14
9847704|NCT00855465|10960281|FG001|NOT COMPLETED|Treatment Period||5
9847705|NCT00855465|10960280|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
9847706|NCT00855465|10960281|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
9847707|NCT00855465|10960280|FG000|COMPLETED|Follow-up Period (FUP)||9
9847708|NCT00855465|10960281|FG001|COMPLETED|Follow-up Period (FUP)||2
9847709|NCT00855465|10960280|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
9847710|NCT00855465|10960281|FG001|NOT COMPLETED|Follow-up Period (FUP)||2
9698432|NCT03679767|10797306|FG002|STARTED|Overall Study||29
9698433|NCT03679767|10797307|FG003|STARTED|Overall Study||34
9698434|NCT03679767|10797304|FG000|COMPLETED|Overall Study||0
9698435|NCT03679767|10797305|FG001|COMPLETED|Overall Study||0
9698436|NCT03679767|10797306|FG002|COMPLETED|Overall Study||0
9698437|NCT03679767|10797307|FG003|COMPLETED|Overall Study||0
9698438|NCT03679767|10797304|FG000|NOT COMPLETED|Overall Study||35
9698439|NCT03679767|10797305|FG001|NOT COMPLETED|Overall Study||23
9698440|NCT03679767|10797306|FG002|NOT COMPLETED|Overall Study||29
9698441|NCT03679767|10797307|FG003|NOT COMPLETED|Overall Study||34
9698442|NCT03576716|10797321|FG000|STARTED|Overall Study||10
9698443|NCT03576716|10797322|FG001|STARTED|Overall Study||9
9698444|NCT03576716|10797321|FG000|COMPLETED|Overall Study||10
9698445|NCT03576716|10797322|FG001|COMPLETED|Overall Study||8
9698446|NCT03576716|10797321|FG000|NOT COMPLETED|Overall Study||0
9698447|NCT03576716|10797322|FG001|NOT COMPLETED|Overall Study||1
9727792|NCT00109772|10827439|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
9727793|NCT00109772|10827440|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
9727794|NCT00109772|10827439|FG000|NOT COMPLETED|Open-label Extension||45
9727795|NCT00109772|10827440|FG001|NOT COMPLETED|Open-label Extension||49
9727796|NCT00109837|10827446|FG000|STARTED|Overall Study||79
9727797|NCT00109837|10827446|FG000|Eligible|Overall Study||78
9727798|NCT00109837|10827446|FG000|Eligible and Ph-|Overall Study||61
9727799|NCT00109837|10827446|FG000|Eligible and Ph- and Treated|Overall Study||60
9727800|NCT00109837|10827446|FG000|COMPLETED|Overall Study||56
9727801|NCT00109837|10827446|FG000|NOT COMPLETED|Overall Study||23
9727802|NCT00109850|10827454|FG000|STARTED|Overall Study||22
9727803|NCT00109850|10827454|FG000|Eligible|Overall Study||21
9727804|NCT00109850|10827454|FG000|Eligible and Began Protocol Therapy|Overall Study||21
9727805|NCT00109850|10827454|FG000|COMPLETED|Overall Study||18
9727806|NCT00109850|10827454|FG000|NOT COMPLETED|Overall Study||4
9727807|NCT00109876|10827458|FG000|STARTED|Overall Study||51
9727808|NCT00109876|10827458|FG000|COMPLETED|Overall Study||51
9727809|NCT00109876|10827458|FG000|NOT COMPLETED|Overall Study||0
9727810|NCT00109928|10827462|FG000|STARTED|Overall Study||34
9727811|NCT00109928|10827462|FG000|Eligible|Overall Study||33
9727812|NCT00109928|10827462|FG000|Eligible and Began Protocol Therapy|Overall Study||33
9727813|NCT00109928|10827462|FG000|COMPLETED|Overall Study||21
9727814|NCT00109928|10827462|FG000|NOT COMPLETED|Overall Study||13
9727815|NCT00109967|10827469|FG000|STARTED|Overall Study||50
9727816|NCT00109967|10827470|FG001|STARTED|Overall Study||21
9727817|NCT00109967|10827469|FG000|COMPLETED|Overall Study||30
9727818|NCT00109967|10827470|FG001|COMPLETED|Overall Study||15
9727819|NCT00109967|10827469|FG000|NOT COMPLETED|Overall Study||20
9727820|NCT00109967|10827470|FG001|NOT COMPLETED|Overall Study||6
9727821|NCT00110019|10827478|FG000|STARTED|Overall Study||410
9727822|NCT00110019|10827479|FG001|STARTED|Overall Study||413
9727823|NCT00110019|10827478|FG000|Eligible|Overall Study||395
9727824|NCT00110019|10827479|FG001|Eligible|Overall Study||398
9727825|NCT00110019|10827478|FG000|Treated|Overall Study||393
10026412|NCT01877538|11150512|FG000|STARTED|Overall Study||7
10026413|NCT01877538|11150512|FG000|COMPLETED|Overall Study||7
10026414|NCT01877538|11150512|FG000|NOT COMPLETED|Overall Study||0
10026415|NCT01877551|11150518|FG000|STARTED|Overall Study||13
10026416|NCT01877551|11150519|FG001|STARTED|Overall Study||14
10026417|NCT01877551|11150518|FG000|COMPLETED|Overall Study||13
10026418|NCT01877551|11150519|FG001|COMPLETED|Overall Study||13
10026419|NCT01877551|11150518|FG000|NOT COMPLETED|Overall Study||0
10026420|NCT01877551|11150519|FG001|NOT COMPLETED|Overall Study||1
10026421|NCT01877642|11150527|FG000|STARTED|Overall Study||4
10026422|NCT01877642|11150528|FG001|STARTED|Overall Study||3
10026423|NCT01877642|11150529|FG002|STARTED|Overall Study||3
10026424|NCT01877642|11150530|FG003|STARTED|Overall Study||3
10026425|NCT01877642|11150531|FG004|STARTED|Overall Study||3
10114917|NCT02521376|11245724|FG001|COMPLETED|Overall Study||18
10114918|NCT02521376|11245725|FG002|COMPLETED|Overall Study||10
10114919|NCT02521376|11245726|FG003|COMPLETED|Overall Study||20
10114920|NCT02521376|11245723|FG000|NOT COMPLETED|Overall Study||1
10114921|NCT02521376|11245724|FG001|NOT COMPLETED|Overall Study||0
10114922|NCT02521376|11245725|FG002|NOT COMPLETED|Overall Study||0
9727826|NCT00110019|10827479|FG001|Treated|Overall Study||397
9727827|NCT00110019|10827478|FG000|COMPLETED|Overall Study||4
9727828|NCT00110019|10827479|FG001|COMPLETED|Overall Study||0
9727829|NCT00110019|10827478|FG000|NOT COMPLETED|Overall Study||406
9727830|NCT00110019|10827479|FG001|NOT COMPLETED|Overall Study||413
9727831|NCT00110084|10827485|FG000|STARTED|Overall Study||50
9727832|NCT00110084|10827485|FG000|COMPLETED|Overall Study||22
9727833|NCT00110084|10827485|FG000|NOT COMPLETED|Overall Study||28
9727834|NCT00110136|10827489|FG000|STARTED|Overall Study||9
9727835|NCT00110136|10827489|FG000|COMPLETED|Overall Study||9
9727836|NCT00110136|10827489|FG000|NOT COMPLETED|Overall Study||0
9727837|NCT00110149|10827494|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12
9727838|NCT00110149|10827494|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
10026426|NCT01877642|11150532|FG005|STARTED|Overall Study||3
10026427|NCT01877642|11150533|FG006|STARTED|Overall Study||3
10026428|NCT01877642|11150527|FG000|COMPLETED|Overall Study||4
10026429|NCT01877642|11150528|FG001|COMPLETED|Overall Study||3
10114923|NCT02521376|11245726|FG003|NOT COMPLETED|Overall Study||0
9727839|NCT00110149|10827494|FG000|COMPLETED|Overall Study||9
9698448|NCT03500692|10797328|FG000|STARTED|Overall Study||500
9698449|NCT03500692|10797328|FG000|COMPLETED|Overall Study||391
9698450|NCT03500692|10797328|FG000|NOT COMPLETED|Overall Study||109
9698451|NCT03367819|10797334|FG000|STARTED|Overall Study||24
9698452|NCT03367819|10797335|FG001|STARTED|Overall Study||20
9698453|NCT03367819|10797334|FG000|COMPLETED|Overall Study||0
9698454|NCT03367819|10797335|FG001|COMPLETED|Overall Study||1
9698455|NCT03367819|10797334|FG000|NOT COMPLETED|Overall Study||24
9698456|NCT03367819|10797335|FG001|NOT COMPLETED|Overall Study||19
9698457|NCT03182868|10797351|FG000|STARTED|Overall Study||12
9698458|NCT03182868|10797352|FG001|STARTED|Overall Study||20
9698459|NCT03182868|10797353|FG002|STARTED|Overall Study||21
9698460|NCT03182868|10797354|FG003|STARTED|Overall Study||1
9698461|NCT03182868|10797355|FG004|STARTED|Overall Study||24
9698462|NCT03182868|10797351|FG000|COMPLETED|Overall Study||9
9698463|NCT03182868|10797352|FG001|COMPLETED|Overall Study||20
9698464|NCT03182868|10797353|FG002|COMPLETED|Overall Study||17
9698465|NCT03182868|10797354|FG003|COMPLETED|Overall Study||0
9698466|NCT03182868|10797355|FG004|COMPLETED|Overall Study||16
9698467|NCT03182868|10797351|FG000|NOT COMPLETED|Overall Study||3
9698468|NCT03182868|10797352|FG001|NOT COMPLETED|Overall Study||0
9698469|NCT03182868|10797353|FG002|NOT COMPLETED|Overall Study||4
9698470|NCT03182868|10797354|FG003|NOT COMPLETED|Overall Study||1
9698471|NCT03182868|10797355|FG004|NOT COMPLETED|Overall Study||8
9698472|NCT03125902|10797368|FG000|STARTED|Overall Study||220
9698473|NCT03125902|10797369|FG001|STARTED|Overall Study||431
9698474|NCT03125902|10797368|FG000|COMPLETED|Overall Study||0
9698475|NCT03125902|10797369|FG001|COMPLETED|Overall Study||0
9698476|NCT03125902|10797368|FG000|NOT COMPLETED|Overall Study||220
9698477|NCT03125902|10797369|FG001|NOT COMPLETED|Overall Study||431
9698478|NCT03077620|10797380|FG000|STARTED|Overall Study||14
9698479|NCT03077620|10797381|FG001|STARTED|Overall Study||14
9698480|NCT03077620|10797382|FG002|STARTED|Overall Study||14
9698481|NCT03077620|10797383|FG003|STARTED|Overall Study||6
9698482|NCT03077620|10797380|FG000|COMPLETED|Overall Study||13
9698483|NCT03077620|10797381|FG001|COMPLETED|Overall Study||13
9698484|NCT03077620|10797382|FG002|COMPLETED|Overall Study||12
9698485|NCT03077620|10797383|FG003|COMPLETED|Overall Study||6
9698486|NCT03077620|10797380|FG000|NOT COMPLETED|Overall Study||1
9698487|NCT03077620|10797381|FG001|NOT COMPLETED|Overall Study||1
9698488|NCT03077620|10797382|FG002|NOT COMPLETED|Overall Study||2
9698489|NCT03077620|10797383|FG003|NOT COMPLETED|Overall Study||0
9698490|NCT03027414|10797396|FG000|STARTED|Overall Study||28
9698491|NCT03027414|10797397|FG001|STARTED|Overall Study||0
9698492|NCT03027414|10797398|FG002|STARTED|Overall Study||26
9698493|NCT03027414|10797396|FG000|COMPLETED|Overall Study||19
9698494|NCT03027414|10797397|FG001|COMPLETED|Overall Study||0
9698495|NCT03027414|10797398|FG002|COMPLETED|Overall Study||20
9698496|NCT03027414|10797396|FG000|NOT COMPLETED|Overall Study||9
9698497|NCT03027414|10797397|FG001|NOT COMPLETED|Overall Study||0
9698498|NCT03027414|10797398|FG002|NOT COMPLETED|Overall Study||6
9698499|NCT02951052|10797408|FG000|STARTED|Overall Study||308
9698500|NCT02951052|10797409|FG001|STARTED|Overall Study||308
9698501|NCT02951052|10797408|FG000|COMPLETED|Overall Study||281
9698502|NCT02951052|10797409|FG001|COMPLETED|Overall Study||290
9698503|NCT02951052|10797408|FG000|NOT COMPLETED|Overall Study||27
9698504|NCT02951052|10797409|FG001|NOT COMPLETED|Overall Study||18
9698505|NCT02724410|10797421|FG000|STARTED|Overall Study||44
9698506|NCT02724410|10797422|FG001|STARTED|Overall Study||38
9698507|NCT02724410|10797421|FG000|COMPLETED|Overall Study||44
9962012|NCT01475162|11081559|FG000|COMPLETED|Overall Study||0
9962013|NCT01475162|11081559|FG000|NOT COMPLETED|Overall Study||14
9962014|NCT01475175|11081564|FG000|STARTED|Overall Study||12
9962015|NCT01475175|11081564|FG000|COMPLETED|Overall Study||12
9962016|NCT01475175|11081564|FG000|NOT COMPLETED|Overall Study||0
9962017|NCT01475214|11081571|FG000|STARTED|Overall Study||84
9962018|NCT01475214|11081572|FG001|STARTED|Overall Study||79
10114924|NCT02521766|11245746|FG000|STARTED|Overall Study||49
9698508|NCT02724410|10797422|FG001|COMPLETED|Overall Study||38
9698509|NCT02724410|10797421|FG000|NOT COMPLETED|Overall Study||0
9698510|NCT02724410|10797422|FG001|NOT COMPLETED|Overall Study||0
9698511|NCT02598583|10797430|FG000|STARTED|Primary Evaluation Period||6
9698512|NCT02598583|10797431|FG001|STARTED|Primary Evaluation Period||7
9698513|NCT02598583|10797430|FG000|COMPLETED|Primary Evaluation Period||6
9698514|NCT02598583|10797431|FG001|COMPLETED|Primary Evaluation Period||7
9698515|NCT02598583|10797430|FG000|NOT COMPLETED|Primary Evaluation Period||0
9698516|NCT02598583|10797431|FG001|NOT COMPLETED|Primary Evaluation Period||0
9698517|NCT02598583|10797430|FG000|STARTED|Extension Period||6
9698518|NCT02598583|10797431|FG001|STARTED|Extension Period||7
9698519|NCT02598583|10797430|FG000|COMPLETED|Extension Period||5
9698520|NCT02598583|10797431|FG001|COMPLETED|Extension Period||7
9698521|NCT02598583|10797430|FG000|NOT COMPLETED|Extension Period||1
9698522|NCT02598583|10797431|FG001|NOT COMPLETED|Extension Period||0
9698523|NCT02550093|10797437|FG000|STARTED|Intervention 1||10
9698524|NCT02550093|10797438|FG001|STARTED|Intervention 1||10
9962019|NCT01475214|11081573|FG002|STARTED|Overall Study||81
9698525|NCT02550093|10797437|FG000|COMPLETED|Intervention 1||10
9698526|NCT02550093|10797438|FG001|COMPLETED|Intervention 1||10
9962020|NCT01475214|11081571|FG000|COMPLETED|Overall Study||79
9698527|NCT02550093|10797437|FG000|NOT COMPLETED|Intervention 1||0
9698528|NCT02550093|10797438|FG001|NOT COMPLETED|Intervention 1||0
9698529|NCT02550093|10797437|FG000|STARTED|Wash-out Period||10
9698530|NCT02550093|10797438|FG001|STARTED|Wash-out Period||10
9698531|NCT02550093|10797437|FG000|COMPLETED|Wash-out Period||10
9698532|NCT02550093|10797438|FG001|COMPLETED|Wash-out Period||10
9698533|NCT02550093|10797437|FG000|NOT COMPLETED|Wash-out Period||0
9698534|NCT02550093|10797438|FG001|NOT COMPLETED|Wash-out Period||0
9698535|NCT02550093|10797437|FG000|STARTED|Intervention 2||10
9698536|NCT02550093|10797438|FG001|STARTED|Intervention 2||10
9698537|NCT02550093|10797437|FG000|COMPLETED|Intervention 2||10
9698538|NCT02550093|10797438|FG001|COMPLETED|Intervention 2||10
9698539|NCT02550093|10797437|FG000|NOT COMPLETED|Intervention 2||0
9698540|NCT02550093|10797438|FG001|NOT COMPLETED|Intervention 2||0
9698541|NCT02536794|10797446|FG000|STARTED|Reached 1st Response Assessment||30
9698542|NCT02536794|10797446|FG000|Started Treatment|Reached 1st Response Assessment||30
9698543|NCT02536794|10797446|FG000|Attempted First Cycle|Reached 1st Response Assessment||30
9698544|NCT02536794|10797446|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24
9698545|NCT02536794|10797446|FG000|Reached First Response|Reached 1st Response Assessment||24
9698546|NCT02536794|10797446|FG000|COMPLETED|Reached 1st Response Assessment||24
9698547|NCT02536794|10797446|FG000|NOT COMPLETED|Reached 1st Response Assessment||6
9698548|NCT02536794|10797446|FG000|STARTED|Continued Treatment After 1st Response||24
9698549|NCT02536794|10797446|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
9698550|NCT02536794|10797446|FG000|COMPLETED|Continued Treatment After 1st Response||16
9698551|NCT02536794|10797446|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8
9698552|NCT02536794|10797446|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
9698553|NCT02536794|10797446|FG000|COMPLETED|Follow up for 3 Years or Death||29
9698554|NCT02536794|10797446|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0
9727840|NCT00110149|10827494|FG000|NOT COMPLETED|Overall Study||3
9727841|NCT00110214|10827501|FG000|STARTED|Overall Study||526
9727842|NCT00110214|10827502|FG001|STARTED|Overall Study||524
9727843|NCT00110214|10827501|FG000|COMPLETED|Overall Study||17
9727844|NCT00110214|10827502|FG001|COMPLETED|Overall Study||21
9727845|NCT00110214|10827501|FG000|NOT COMPLETED|Overall Study||509
9727846|NCT00110214|10827502|FG001|NOT COMPLETED|Overall Study||503
9727847|NCT00110266|10827508|FG000|STARTED|Overall Study||173
9727848|NCT00110266|10827508|FG000|COMPLETED|Overall Study||95
9727849|NCT00110266|10827508|FG000|NOT COMPLETED|Overall Study||78
9727850|NCT00110305|10827517|FG000|STARTED|Overall Study||279
9727851|NCT00110305|10827518|FG001|STARTED|Overall Study||89
9727852|NCT00110305|10827517|FG000|COMPLETED|Overall Study||165
9727853|NCT00110305|10827518|FG001|COMPLETED|Overall Study||57
9727854|NCT00110305|10827517|FG000|NOT COMPLETED|Overall Study||114
9727855|NCT00110305|10827518|FG001|NOT COMPLETED|Overall Study||32
9727856|NCT00110357|10827537|FG000|STARTED|Overall Study||27
9727857|NCT00110357|10827538|FG001|STARTED|Overall Study||19
9727858|NCT00110357|10827537|FG000|COMPLETED|Overall Study|Number Still on Study|0
9727859|NCT00110357|10827538|FG001|COMPLETED|Overall Study|Number Still on Study|0
9727860|NCT00110357|10827537|FG000|NOT COMPLETED|Overall Study||27
9727861|NCT00110357|10827538|FG001|NOT COMPLETED|Overall Study||19
9727862|NCT00110396|10827571|FG000|STARTED|Overall Study||260
9727863|NCT00110396|10827571|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
9962021|NCT01475214|11081572|FG001|COMPLETED|Overall Study||75
9962022|NCT01475214|11081573|FG002|COMPLETED|Overall Study||79
9962023|NCT01475214|11081571|FG000|NOT COMPLETED|Overall Study||5
9962024|NCT01475214|11081572|FG001|NOT COMPLETED|Overall Study||4
9727864|NCT00110396|10827571|FG000|NOT COMPLETED|Overall Study||36
9727865|NCT00110461|10827578|FG000|STARTED|30-Week, Double-blind Treatment Phase||98
9727866|NCT00110461|10827579|FG001|STARTED|30-Week, Double-blind Treatment Phase||99
9727867|NCT00110461|10827580|FG002|STARTED|30-Week, Double-blind Treatment Phase||99
9727868|NCT00110461|10827578|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34
9962025|NCT01475214|11081573|FG002|NOT COMPLETED|Overall Study||2
9727869|NCT00110461|10827579|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22
9698555|NCT02463773|10797450|FG000|STARTED|Overall Study||14
9698556|NCT02463773|10797450|FG000|COMPLETED|Overall Study||14
9698557|NCT02463773|10797450|FG000|NOT COMPLETED|Overall Study||0
9698558|NCT02356575|10797456|FG000|STARTED|Overall Study||80
9698559|NCT02356575|10797457|FG001|STARTED|Overall Study||80
9698560|NCT02356575|10797456|FG000|COMPLETED|Overall Study||80
9698561|NCT02356575|10797457|FG001|COMPLETED|Overall Study||80
9698562|NCT02356575|10797456|FG000|NOT COMPLETED|Overall Study||0
9698563|NCT02356575|10797457|FG001|NOT COMPLETED|Overall Study||0
9698564|NCT02285114|10797466|FG000|STARTED|Overall Study||29
9698565|NCT02285114|10797467|FG001|STARTED|Overall Study||9
9698566|NCT02285114|10797468|FG002|STARTED|Overall Study||3
9698567|NCT02285114|10797466|FG000|COMPLETED|Overall Study||7
9698568|NCT02285114|10797467|FG001|COMPLETED|Overall Study||2
9698569|NCT02285114|10797468|FG002|COMPLETED|Overall Study||0
9698570|NCT02285114|10797466|FG000|NOT COMPLETED|Overall Study||22
9698571|NCT02285114|10797467|FG001|NOT COMPLETED|Overall Study||7
9698572|NCT02285114|10797468|FG002|NOT COMPLETED|Overall Study||3
9698573|NCT02263508|10797485|FG000|STARTED|Overall Study||21
9698574|NCT02263508|10797486|FG001|STARTED|Overall Study||346
9698575|NCT02263508|10797487|FG002|STARTED|Overall Study||346
9698576|NCT02263508|10797485|FG000|Received Talimogene Laherparepvec/Placebo|Overall Study||21
9698577|NCT02263508|10797486|FG001|Received Talimogene Laherparepvec/Placebo|Overall Study||345
9698578|NCT02263508|10797487|FG002|Received Talimogene Laherparepvec/Placebo|Overall Study||343
10026430|NCT01877642|11150529|FG002|COMPLETED|Overall Study||3
9698579|NCT02263508|10797485|FG000|Received Pembrolizumab|Overall Study||21
9698580|NCT02263508|10797486|FG001|Received Pembrolizumab|Overall Study||345
9698581|NCT02263508|10797487|FG002|Received Pembrolizumab|Overall Study||343
9698582|NCT02263508|10797485|FG000|COMPLETED|Overall Study||0
9698583|NCT02263508|10797486|FG001|COMPLETED|Overall Study||0
9698584|NCT02263508|10797487|FG002|COMPLETED|Overall Study||0
9698585|NCT02263508|10797485|FG000|NOT COMPLETED|Overall Study||21
9698586|NCT02263508|10797486|FG001|NOT COMPLETED|Overall Study||346
9698587|NCT02263508|10797487|FG002|NOT COMPLETED|Overall Study||346
9698588|NCT02246530|10797500|FG000|STARTED|Overall Study||9
9698589|NCT02246530|10797501|FG001|STARTED|Overall Study||2
9698590|NCT02246530|10797500|FG000|COMPLETED|Overall Study||5
9698591|NCT02246530|10797501|FG001|COMPLETED|Overall Study||2
9698592|NCT02246530|10797500|FG000|NOT COMPLETED|Overall Study||4
9698593|NCT02246530|10797501|FG001|NOT COMPLETED|Overall Study||0
9698594|NCT02002819|10797509|FG000|STARTED|Overall Study||17
9698595|NCT02002819|10797510|FG001|STARTED|Overall Study||17
9698596|NCT02002819|10797509|FG000|COMPLETED|Overall Study|4 Discontinued intervention because of participant's decision|13
9727870|NCT00110461|10827580|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12
10026431|NCT01877642|11150530|FG003|COMPLETED|Overall Study||3
10026432|NCT01877642|11150531|FG004|COMPLETED|Overall Study||3
9698597|NCT02002819|10797510|FG001|COMPLETED|Overall Study|"1 Discontinued intervention because of participant's decision~1 Excluded per protocol because of biomarkers inconsistent with AD"|15
9698598|NCT02002819|10797509|FG000|NOT COMPLETED|Overall Study||4
9698599|NCT02002819|10797510|FG001|NOT COMPLETED|Overall Study||2
9698600|NCT01936857|10797534|FG000|STARTED|Overall Study||141
9698601|NCT01936857|10797535|FG001|STARTED|Overall Study||140
9698602|NCT01936857|10797534|FG000|COMPLETED|Overall Study||107
9698603|NCT01936857|10797535|FG001|COMPLETED|Overall Study||115
9698604|NCT01936857|10797534|FG000|NOT COMPLETED|Overall Study||34
9698605|NCT01936857|10797535|FG001|NOT COMPLETED|Overall Study||25
9698606|NCT01865539|10797543|FG000|STARTED|Overall Study||21
9698607|NCT01865539|10797544|FG001|STARTED|Overall Study||30
9698608|NCT01865539|10797543|FG000|COMPLETED|Overall Study||21
9698609|NCT01865539|10797544|FG001|COMPLETED|Overall Study||30
9698610|NCT01865539|10797543|FG000|NOT COMPLETED|Overall Study||0
9698611|NCT01865539|10797544|FG001|NOT COMPLETED|Overall Study||0
9962026|NCT01475253|11081585|FG000|STARTED|Randomized, Blinded Study||47
9962027|NCT01475253|11081586|FG001|STARTED|Randomized, Blinded Study||46
9962028|NCT01475253|11081587|FG002|STARTED|Randomized, Blinded Study||11
9962029|NCT01475253|11081588|FG003|STARTED|Randomized, Blinded Study||0
9962030|NCT01475253|11081585|FG000|COMPLETED|Randomized, Blinded Study||45
9962031|NCT01475253|11081586|FG001|COMPLETED|Randomized, Blinded Study||45
9962032|NCT01475253|11081587|FG002|COMPLETED|Randomized, Blinded Study||11
9962033|NCT01475253|11081588|FG003|COMPLETED|Randomized, Blinded Study||0
9962034|NCT01475253|11081585|FG000|NOT COMPLETED|Randomized, Blinded Study||2
9962035|NCT01475253|11081586|FG001|NOT COMPLETED|Randomized, Blinded Study||1
9962036|NCT01475253|11081587|FG002|NOT COMPLETED|Randomized, Blinded Study||0
9962037|NCT01475253|11081588|FG003|NOT COMPLETED|Randomized, Blinded Study||0
9962038|NCT01475253|11081585|FG000|STARTED|Open Label Extension||0
9962039|NCT01475253|11081586|FG001|STARTED|Open Label Extension||0
9962040|NCT01475253|11081587|FG002|STARTED|Open Label Extension||0
9962041|NCT01475253|11081588|FG003|STARTED|Open Label Extension||56
9962042|NCT01475253|11081585|FG000|COMPLETED|Open Label Extension||0
9962043|NCT01475253|11081586|FG001|COMPLETED|Open Label Extension||0
9962044|NCT01475253|11081587|FG002|COMPLETED|Open Label Extension||0
9962045|NCT01475253|11081588|FG003|COMPLETED|Open Label Extension||56
9962046|NCT01475253|11081585|FG000|NOT COMPLETED|Open Label Extension||0
9962047|NCT01475253|11081586|FG001|NOT COMPLETED|Open Label Extension||0
9962048|NCT01475253|11081587|FG002|NOT COMPLETED|Open Label Extension||0
9962049|NCT01475253|11081588|FG003|NOT COMPLETED|Open Label Extension||0
9962050|NCT01475305|11081598|FG000|STARTED|Overall Study||4
9962051|NCT01475305|11081599|FG001|STARTED|Overall Study||3
9962052|NCT01475305|11081598|FG000|End of Quarantine, Day 15|Overall Study||4
9962053|NCT01475305|11081599|FG001|End of Quarantine, Day 15|Overall Study||3
9962054|NCT01475305|11081598|FG000|COMPLETED|Overall Study||4
9962055|NCT01475305|11081599|FG001|COMPLETED|Overall Study||3
9962056|NCT01475305|11081598|FG000|NOT COMPLETED|Overall Study||0
9962057|NCT01475305|11081599|FG001|NOT COMPLETED|Overall Study||0
9698622|NCT01715285|10797561|FG000|STARTED|Treatment Period||597
9698623|NCT01715285|10797562|FG001|STARTED|Treatment Period||602
9698624|NCT01715285|10797563|FG002|STARTED|Treatment Period||0
9698625|NCT01715285|10797561|FG000|ITT Population|Treatment Period||597
9847711|NCT00855582|10960290|FG000|STARTED|Overall Study||198
10114925|NCT02521766|11245747|FG001|STARTED|Overall Study||65
10114926|NCT02521766|11245746|FG000|Per Protocol|Overall Study||47
10114927|NCT02521766|11245747|FG001|Per Protocol|Overall Study||65
10114928|NCT02521766|11245746|FG000|COMPLETED|Overall Study||44
10114929|NCT02521766|11245747|FG001|COMPLETED|Overall Study||62
10114930|NCT02521766|11245746|FG000|NOT COMPLETED|Overall Study||5
10114931|NCT02521766|11245747|FG001|NOT COMPLETED|Overall Study||3
10114932|NCT02521792|11245764|FG000|STARTED|Overall Study||6
10114933|NCT02521792|11245764|FG000|Received Treatment|Overall Study||4
10114934|NCT02521792|11245764|FG000|COMPLETED|Overall Study||0
10114935|NCT02521792|11245764|FG000|NOT COMPLETED|Overall Study||6
10114936|NCT02521870|11245776|FG000|STARTED|Phase 1: Dose Escalation||6
10114937|NCT02521870|11245777|FG001|STARTED|Phase 1: Dose Escalation||5
10114938|NCT02521870|11245778|FG002|STARTED|Phase 1: Dose Escalation||5
10114939|NCT02521870|11245779|FG003|STARTED|Phase 1: Dose Escalation||6
10114940|NCT02521870|11245780|FG004|STARTED|Phase 1: Dose Escalation||0
10114941|NCT02521870|11245781|FG005|STARTED|Phase 1: Dose Escalation||0
10114942|NCT02521870|11245782|FG006|STARTED|Phase 1: Dose Escalation||0
10114943|NCT02521870|11245783|FG007|STARTED|Phase 1: Dose Escalation||0
10114944|NCT02521870|11245784|FG008|STARTED|Phase 1: Dose Escalation||0
10114945|NCT02521870|11245785|FG009|STARTED|Phase 1: Dose Escalation||0
10114946|NCT02521870|11245786|FG010|STARTED|Phase 1: Dose Escalation||0
10114947|NCT02521870|11245787|FG011|STARTED|Phase 1: Dose Escalation||0
10114948|NCT02521870|11245776|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
10114949|NCT02521870|11245777|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
10114950|NCT02521870|11245778|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114951|NCT02521870|11245779|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
10114952|NCT02521870|11245780|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114953|NCT02521870|11245781|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114954|NCT02521870|11245782|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114955|NCT02521870|11245783|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114956|NCT02521870|11245784|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114957|NCT02521870|11245785|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114958|NCT02521870|11245786|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114959|NCT02521870|11245787|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10114960|NCT02521870|11245776|FG000|COMPLETED|Phase 1: Dose Escalation||1
10114961|NCT02521870|11245777|FG001|COMPLETED|Phase 1: Dose Escalation||1
10114962|NCT02521870|11245778|FG002|COMPLETED|Phase 1: Dose Escalation||1
10114963|NCT02521870|11245779|FG003|COMPLETED|Phase 1: Dose Escalation||0
10114964|NCT02521870|11245780|FG004|COMPLETED|Phase 1: Dose Escalation||0
10114965|NCT02521870|11245781|FG005|COMPLETED|Phase 1: Dose Escalation||0
10114966|NCT02521870|11245782|FG006|COMPLETED|Phase 1: Dose Escalation||0
10114967|NCT02521870|11245783|FG007|COMPLETED|Phase 1: Dose Escalation||0
10114968|NCT02521870|11245784|FG008|COMPLETED|Phase 1: Dose Escalation||0
10114969|NCT02521870|11245785|FG009|COMPLETED|Phase 1: Dose Escalation||0
10114970|NCT02521870|11245786|FG010|COMPLETED|Phase 1: Dose Escalation||0
10114971|NCT02521870|11245787|FG011|COMPLETED|Phase 1: Dose Escalation||0
10114972|NCT02521870|11245776|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5
10114973|NCT02521870|11245777|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4
10114974|NCT02521870|11245778|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4
10114975|NCT02521870|11245779|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6
10114976|NCT02521870|11245780|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0
10114977|NCT02521870|11245781|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0
10114978|NCT02521870|11245782|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0
10114979|NCT02521870|11245783|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0
10114980|NCT02521870|11245784|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0
10114981|NCT02521870|11245785|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0
10114982|NCT02521870|11245786|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0
10114983|NCT02521870|11245787|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0
10114984|NCT02521870|11245776|FG000|STARTED|Phase 2: Dose Expansion||0
10114985|NCT02521870|11245777|FG001|STARTED|Phase 2: Dose Expansion||0
10114986|NCT02521870|11245778|FG002|STARTED|Phase 2: Dose Expansion||0
10114987|NCT02521870|11245779|FG003|STARTED|Phase 2: Dose Expansion||0
10114988|NCT02521870|11245780|FG004|STARTED|Phase 2: Dose Expansion||57
10114989|NCT02521870|11245781|FG005|STARTED|Phase 2: Dose Expansion||25
10114990|NCT02521870|11245782|FG006|STARTED|Phase 2: Dose Expansion||23
10114991|NCT02521870|11245783|FG007|STARTED|Phase 2: Dose Expansion||9
10026433|NCT01877642|11150532|FG005|COMPLETED|Overall Study||3
10026434|NCT01877642|11150533|FG006|COMPLETED|Overall Study||3
10026435|NCT01877642|11150527|FG000|NOT COMPLETED|Overall Study||0
9962058|NCT01475331|11081608|FG000|STARTED|Overall Study||23
9962059|NCT01475331|11081609|FG001|STARTED|Overall Study||23
9962060|NCT01475331|11081608|FG000|COMPLETED|Overall Study||18
9962061|NCT01475331|11081609|FG001|COMPLETED|Overall Study||21
9962062|NCT01475331|11081608|FG000|NOT COMPLETED|Overall Study||5
9962063|NCT01475331|11081609|FG001|NOT COMPLETED|Overall Study||2
9962064|NCT01475370|11081618|FG000|STARTED|Overall Study||3
9962065|NCT01475370|11081619|FG001|STARTED|Overall Study||3
9962066|NCT01475370|11081620|FG002|STARTED|Overall Study||3
9962067|NCT01475370|11081618|FG000|COMPLETED|Overall Study||0
10026436|NCT01877642|11150528|FG001|NOT COMPLETED|Overall Study||0
9698626|NCT01715285|10797562|FG001|ITT Population|Treatment Period||602
9698627|NCT01715285|10797563|FG002|ITT Population|Treatment Period||0
9698628|NCT01715285|10797561|FG000|Safety Population|Treatment Period||597
9698629|NCT01715285|10797562|FG001|Safety Population|Treatment Period||602
9698630|NCT01715285|10797563|FG002|Safety Population|Treatment Period||0
9698631|NCT01715285|10797561|FG000|COMPLETED|Treatment Period||0
9698632|NCT01715285|10797562|FG001|COMPLETED|Treatment Period||0
9698633|NCT01715285|10797563|FG002|COMPLETED|Treatment Period||0
9698634|NCT01715285|10797561|FG000|NOT COMPLETED|Treatment Period||597
9698635|NCT01715285|10797562|FG001|NOT COMPLETED|Treatment Period||602
9698636|NCT01715285|10797563|FG002|NOT COMPLETED|Treatment Period||0
9698637|NCT01715285|10797561|FG000|STARTED|Open-label (OL) Extension Phase||157
9698638|NCT01715285|10797562|FG001|STARTED|Open-label (OL) Extension Phase||0
9698639|NCT01715285|10797563|FG002|STARTED|Open-label (OL) Extension Phase||72
9698640|NCT01715285|10797561|FG000|COMPLETED|Open-label (OL) Extension Phase||0
9698641|NCT01715285|10797562|FG001|COMPLETED|Open-label (OL) Extension Phase||0
9698642|NCT01715285|10797563|FG002|COMPLETED|Open-label (OL) Extension Phase||0
9698643|NCT01715285|10797561|FG000|NOT COMPLETED|Open-label (OL) Extension Phase||157
9698644|NCT01715285|10797562|FG001|NOT COMPLETED|Open-label (OL) Extension Phase||0
9698645|NCT01715285|10797563|FG002|NOT COMPLETED|Open-label (OL) Extension Phase||72
9698646|NCT01613118|10797574|FG000|STARTED|Double-blind||13
9698647|NCT01613118|10797575|FG001|STARTED|Double-blind||26
10026437|NCT01877642|11150529|FG002|NOT COMPLETED|Overall Study||0
10026438|NCT01877642|11150530|FG003|NOT COMPLETED|Overall Study||0
10026439|NCT01877642|11150531|FG004|NOT COMPLETED|Overall Study||0
9698648|NCT01613118|10797576|FG002|STARTED|Double-blind||34
9698649|NCT01613118|10797577|FG003|STARTED|Double-blind||36
9698650|NCT01613118|10797574|FG000|COMPLETED|Double-blind||13
9698651|NCT01613118|10797575|FG001|COMPLETED|Double-blind||23
9698652|NCT01613118|10797576|FG002|COMPLETED|Double-blind||32
9698653|NCT01613118|10797577|FG003|COMPLETED|Double-blind||35
9698654|NCT01613118|10797574|FG000|NOT COMPLETED|Double-blind||0
9698655|NCT01613118|10797575|FG001|NOT COMPLETED|Double-blind||3
9698656|NCT01613118|10797576|FG002|NOT COMPLETED|Double-blind||2
9698657|NCT01613118|10797577|FG003|NOT COMPLETED|Double-blind||1
10026440|NCT01877642|11150532|FG005|NOT COMPLETED|Overall Study||0
10026441|NCT01877642|11150533|FG006|NOT COMPLETED|Overall Study||0
10026442|NCT01877668|11150547|FG000|STARTED|Overall Study|Received treatment|107
10026443|NCT01877668|11150548|FG001|STARTED|Overall Study|Received treatment|104
9698658|NCT01613118|10797574|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
9698659|NCT01613118|10797575|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
9698660|NCT01613118|10797576|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
9698661|NCT01613118|10797577|FG003|STARTED|Open-label Extension||0
9698662|NCT01613118|10797574|FG000|COMPLETED|Open-label Extension|OLE ongoing|0
9698663|NCT01613118|10797575|FG001|COMPLETED|Open-label Extension|OLE ongoing|0
9698664|NCT01613118|10797576|FG002|COMPLETED|Open-label Extension|OLE ongoing|0
9698665|NCT01613118|10797577|FG003|COMPLETED|Open-label Extension||0
9698666|NCT01613118|10797574|FG000|NOT COMPLETED|Open-label Extension||21
9698667|NCT01613118|10797575|FG001|NOT COMPLETED|Open-label Extension||42
9698668|NCT01613118|10797576|FG002|NOT COMPLETED|Open-label Extension||40
9698669|NCT01613118|10797577|FG003|NOT COMPLETED|Open-label Extension||0
9727871|NCT00110461|10827578|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
9727872|NCT00110461|10827579|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
9727873|NCT00110461|10827580|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
9727874|NCT00110461|10827578|FG000|STARTED|Acute Phase||98
9727875|NCT00110461|10827579|FG001|STARTED|Acute Phase||99
9727876|NCT00110461|10827580|FG002|STARTED|Acute Phase||99
9727877|NCT00110461|10827578|FG000|COMPLETED|Acute Phase||84
10026444|NCT01877668|11150549|FG002|STARTED|Overall Study|Received treatment|106
10026445|NCT01877668|11150550|FG003|STARTED|Overall Study|Received treatment|52
10026446|NCT01877668|11150551|FG004|STARTED|Overall Study|Received treatment|53
9698670|NCT04585776|10797588|FG000|STARTED|Overall Study||31
9698671|NCT04585776|10797588|FG000|Received Atleast 1 Dose of Study Drug|Overall Study||31
9698672|NCT04585776|10797588|FG000|COMPLETED|Overall Study||31
10026447|NCT01877668|11150547|FG000|COMPLETED|Overall Study||96
10026448|NCT01877668|11150548|FG001|COMPLETED|Overall Study||96
10026449|NCT01877668|11150549|FG002|COMPLETED|Overall Study||94
10026450|NCT01877668|11150550|FG003|COMPLETED|Overall Study||44
10026451|NCT01877668|11150551|FG004|COMPLETED|Overall Study||43
10026452|NCT01877668|11150547|FG000|NOT COMPLETED|Overall Study||11
10026453|NCT01877668|11150548|FG001|NOT COMPLETED|Overall Study||8
10026454|NCT01877668|11150549|FG002|NOT COMPLETED|Overall Study||12
10026455|NCT01877668|11150550|FG003|NOT COMPLETED|Overall Study||8
10026456|NCT01877668|11150551|FG004|NOT COMPLETED|Overall Study||10
10026457|NCT01877720|11150567|FG000|STARTED|Overall Study||8
10026458|NCT01877720|11150568|FG001|STARTED|Overall Study||8
10026459|NCT01877720|11150567|FG000|1st Intervention|Overall Study||7
10026460|NCT01877720|11150568|FG001|1st Intervention|Overall Study||8
10026461|NCT01877720|11150567|FG000|2nd Intervention|Overall Study||7
10026462|NCT01877720|11150568|FG001|2nd Intervention|Overall Study||8
10026463|NCT01877720|11150567|FG000|COMPLETED|Overall Study||7
10114992|NCT02521870|11245784|FG008|STARTED|Phase 2: Dose Expansion||24
10114993|NCT02521870|11245785|FG009|STARTED|Phase 2: Dose Expansion||28
10114994|NCT02521870|11245786|FG010|STARTED|Phase 2: Dose Expansion||23
10114995|NCT02521870|11245787|FG011|STARTED|Phase 2: Dose Expansion||30
10114996|NCT02521870|11245776|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10114997|NCT02521870|11245777|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10114998|NCT02521870|11245778|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10114999|NCT02521870|11245779|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10115000|NCT02521870|11245780|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
10115001|NCT02521870|11245781|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
10115002|NCT02521870|11245782|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
10115003|NCT02521870|11245783|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
10115004|NCT02521870|11245784|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
10115005|NCT02521870|11245785|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
10115006|NCT02521870|11245786|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
10115007|NCT02521870|11245787|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
10115008|NCT02521870|11245776|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115009|NCT02521870|11245777|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115010|NCT02521870|11245778|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115011|NCT02521870|11245779|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115012|NCT02521870|11245780|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
10115013|NCT02521870|11245781|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
10115014|NCT02521870|11245782|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115015|NCT02521870|11245783|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115016|NCT02521870|11245784|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115017|NCT02521870|11245785|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115018|NCT02521870|11245786|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115019|NCT02521870|11245787|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10115020|NCT02521870|11245776|FG000|COMPLETED|Phase 2: Dose Expansion||0
10115021|NCT02521870|11245777|FG001|COMPLETED|Phase 2: Dose Expansion||0
10115022|NCT02521870|11245778|FG002|COMPLETED|Phase 2: Dose Expansion||0
10115023|NCT02521870|11245779|FG003|COMPLETED|Phase 2: Dose Expansion||0
10115024|NCT02521870|11245780|FG004|COMPLETED|Phase 2: Dose Expansion||5
10115025|NCT02521870|11245781|FG005|COMPLETED|Phase 2: Dose Expansion||0
10115026|NCT02521870|11245782|FG006|COMPLETED|Phase 2: Dose Expansion||0
10115027|NCT02521870|11245783|FG007|COMPLETED|Phase 2: Dose Expansion||0
10115028|NCT02521870|11245784|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
10115029|NCT02521870|11245785|FG009|COMPLETED|Phase 2: Dose Expansion||0
10115030|NCT02521870|11245786|FG010|COMPLETED|Phase 2: Dose Expansion||0
10115031|NCT02521870|11245787|FG011|COMPLETED|Phase 2: Dose Expansion||0
10026464|NCT01877720|11150568|FG001|COMPLETED|Overall Study||8
10026465|NCT01877720|11150567|FG000|NOT COMPLETED|Overall Study||1
10026466|NCT01877720|11150568|FG001|NOT COMPLETED|Overall Study||0
10026467|NCT01877915|11150576|FG000|STARTED|Overall Study||2507
10026468|NCT01877915|11150577|FG001|STARTED|Overall Study||2515
10026469|NCT01877915|11150576|FG000|COMPLETED|Overall Study||2453
10026470|NCT01877915|11150577|FG001|COMPLETED|Overall Study||2447
10026471|NCT01877915|11150576|FG000|NOT COMPLETED|Overall Study||54
10026472|NCT01877915|11150577|FG001|NOT COMPLETED|Overall Study||68
10026473|NCT01877941|11150583|FG000|STARTED|Overall Study||39
10026474|NCT01877941|11150583|FG000|COMPLETED|Overall Study||39
9698673|NCT04585776|10797588|FG000|NOT COMPLETED|Overall Study||0
9727878|NCT00110461|10827579|FG001|COMPLETED|Acute Phase||77
9727879|NCT00110461|10827580|FG002|COMPLETED|Acute Phase||76
9727880|NCT00110461|10827578|FG000|NOT COMPLETED|Acute Phase||14
9727881|NCT00110461|10827579|FG001|NOT COMPLETED|Acute Phase||22
9727882|NCT00110461|10827580|FG002|NOT COMPLETED|Acute Phase||23
9727883|NCT00110513|10827588|FG000|STARTED|Overall Study||18
9727884|NCT00110513|10827588|FG000|COMPLETED|Overall Study||18
9727885|NCT00110513|10827588|FG000|NOT COMPLETED|Overall Study||0
9727886|NCT00110617|10827594|FG000|STARTED|Overall Study||135
9727887|NCT00110617|10827595|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
9727888|NCT00110617|10827594|FG000|Safety Set 1; Received Study Drug|Overall Study||135
9727889|NCT00110617|10827595|FG001|Safety Set 1; Received Study Drug|Overall Study||56
9727890|NCT00110617|10827594|FG000|Full Analysis 2; Received ICL670|Overall Study||135
9727891|NCT00110617|10827595|FG001|Full Analysis 2; Received ICL670|Overall Study||53
9727892|NCT00110617|10827594|FG000|On Going at Week 24|Overall Study||126
9727893|NCT00110617|10827595|FG001|On Going at Week 24|Overall Study||53
9727894|NCT00110617|10827594|FG000|COMPLETED|Overall Study||96
9727895|NCT00110617|10827595|FG001|COMPLETED|Overall Study||39
9727896|NCT00110617|10827594|FG000|NOT COMPLETED|Overall Study||39
9727897|NCT00110617|10827595|FG001|NOT COMPLETED|Overall Study||29
9727898|NCT00110812|10827606|FG000|STARTED|Main Study||91
9727899|NCT00110812|10827607|FG001|STARTED|Main Study||89
9727900|NCT00110812|10827608|FG002|STARTED|Main Study||87
9727901|NCT00110812|10827606|FG000|COMPLETED|Main Study||83
9727902|NCT00110812|10827607|FG001|COMPLETED|Main Study||78
9727903|NCT00110812|10827608|FG002|COMPLETED|Main Study||74
9727904|NCT00110812|10827606|FG000|NOT COMPLETED|Main Study||8
9727905|NCT00110812|10827607|FG001|NOT COMPLETED|Main Study||11
9727906|NCT00110812|10827608|FG002|NOT COMPLETED|Main Study||13
9698674|NCT04209725|10797592|FG000|STARTED|Overall Study||1
9698675|NCT04209725|10797592|FG000|COMPLETED|Overall Study||0
9698676|NCT04209725|10797592|FG000|NOT COMPLETED|Overall Study||1
9698677|NCT04185909|10797596|FG000|STARTED|Overall Study||55
9698678|NCT04185909|10797596|FG000|COMPLETED|Overall Study||54
9698679|NCT04185909|10797596|FG000|NOT COMPLETED|Overall Study||1
9698680|NCT04076943|10797600|FG000|STARTED|Overall Study||92
9698681|NCT04076943|10797600|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92
9698682|NCT04076943|10797600|FG000|COMPLETED|Overall Study||58
9698683|NCT04076943|10797600|FG000|NOT COMPLETED|Overall Study||34
9698684|NCT03982043|10797606|FG000|STARTED|Overall Study||43
9698685|NCT03982043|10797607|FG001|STARTED|Overall Study||4
9698686|NCT03982043|10797606|FG000|COMPLETED|Overall Study||43
9698687|NCT03982043|10797607|FG001|COMPLETED|Overall Study||4
9698688|NCT03982043|10797606|FG000|NOT COMPLETED|Overall Study||0
9698689|NCT03982043|10797607|FG001|NOT COMPLETED|Overall Study||0
9698690|NCT03905694|10797614|FG000|STARTED|Primary Analysis Period||18
9698691|NCT03905694|10797614|FG000|COMPLETED|Primary Analysis Period||18
9698692|NCT03905694|10797614|FG000|NOT COMPLETED|Primary Analysis Period||0
9698693|NCT03905694|10797614|FG000|STARTED|Long-term Extension Period||18
9698694|NCT03905694|10797614|FG000|COMPLETED|Long-term Extension Period||0
9698695|NCT03905694|10797614|FG000|NOT COMPLETED|Long-term Extension Period||18
9698696|NCT03332498|10797621|FG000|STARTED|Overall Study||4
9698697|NCT03332498|10797622|FG001|STARTED|Overall Study||4
9698698|NCT03332498|10797623|FG002|STARTED|Overall Study||32
9698699|NCT03332498|10797621|FG000|COMPLETED|Overall Study||4
9698700|NCT03332498|10797622|FG001|COMPLETED|Overall Study||4
9698701|NCT03332498|10797623|FG002|COMPLETED|Overall Study||30
9698702|NCT03332498|10797621|FG000|NOT COMPLETED|Overall Study||0
9698703|NCT03332498|10797622|FG001|NOT COMPLETED|Overall Study||0
9698704|NCT03332498|10797623|FG002|NOT COMPLETED|Overall Study||2
9698705|NCT03122301|10797632|FG000|STARTED|Overall Study||1
9698706|NCT03122301|10797633|FG001|STARTED|Overall Study||1
9698707|NCT03122301|10797632|FG000|COMPLETED|Overall Study||1
9698708|NCT03122301|10797633|FG001|COMPLETED|Overall Study||1
9698709|NCT03122301|10797632|FG000|NOT COMPLETED|Overall Study||0
9698710|NCT03122301|10797633|FG001|NOT COMPLETED|Overall Study||0
9698711|NCT02900976|10797641|FG000|STARTED|Overall Study||2
9698712|NCT02900976|10797642|FG001|STARTED|Overall Study||16
9698713|NCT02900976|10797641|FG000|COMPLETED|Overall Study||2
9698714|NCT02900976|10797642|FG001|COMPLETED|Overall Study||7
9698715|NCT02900976|10797641|FG000|NOT COMPLETED|Overall Study||0
9698716|NCT02900976|10797642|FG001|NOT COMPLETED|Overall Study||9
9698717|NCT02807350|10797651|FG000|STARTED|Overall Study||196
9698718|NCT02807350|10797652|FG001|STARTED|Overall Study||190
9698719|NCT02807350|10797651|FG000|6 mo Follow Up Visit|Overall Study||188
9698720|NCT02807350|10797652|FG001|6 mo Follow Up Visit|Overall Study||171
9698721|NCT02807350|10797651|FG000|12 mo Follow Up Visit|Overall Study||189
9698722|NCT02807350|10797652|FG001|12 mo Follow Up Visit|Overall Study||169
9698723|NCT02807350|10797651|FG000|15 mo Follow Up Visit|Overall Study||180
9698724|NCT02807350|10797652|FG001|15 mo Follow Up Visit|Overall Study||153
9698725|NCT02807350|10797651|FG000|COMPLETED|Overall Study||176
9698726|NCT02807350|10797652|FG001|COMPLETED|Overall Study||155
9698727|NCT02807350|10797651|FG000|NOT COMPLETED|Overall Study||20
9698728|NCT02807350|10797652|FG001|NOT COMPLETED|Overall Study||35
9698729|NCT02720185|10797658|FG000|STARTED|Overall Study||5
9698730|NCT02720185|10797658|FG000|COMPLETED|Overall Study||4
9698731|NCT02720185|10797658|FG000|NOT COMPLETED|Overall Study||1
9698732|NCT02710669|10797665|FG000|STARTED|Overall Study||85
9698733|NCT02710669|10797666|FG001|STARTED|Overall Study||86
9698734|NCT02710669|10797667|FG002|STARTED|Overall Study||21
9698735|NCT02710669|10797665|FG000|COMPLETED|Overall Study||71
9698736|NCT02710669|10797666|FG001|COMPLETED|Overall Study||75
9698737|NCT02710669|10797667|FG002|COMPLETED|Overall Study||19
9698738|NCT02710669|10797665|FG000|NOT COMPLETED|Overall Study||14
9698739|NCT02710669|10797666|FG001|NOT COMPLETED|Overall Study||11
9698740|NCT02710669|10797667|FG002|NOT COMPLETED|Overall Study||2
9698741|NCT02684461|10797678|FG000|STARTED|Overall Study||7
9698742|NCT02684461|10797679|FG001|STARTED|Overall Study||7
9698743|NCT02684461|10797680|FG002|STARTED|Overall Study||6
9962068|NCT01475370|11081619|FG001|COMPLETED|Overall Study||0
9962069|NCT01475370|11081620|FG002|COMPLETED|Overall Study||0
10115032|NCT02521870|11245776|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0
10115033|NCT02521870|11245777|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0
10115034|NCT02521870|11245778|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0
10115035|NCT02521870|11245779|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0
10115036|NCT02521870|11245780|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52
10115037|NCT02521870|11245781|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25
10115038|NCT02521870|11245782|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23
10115039|NCT02521870|11245783|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9
10115040|NCT02521870|11245784|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22
10115041|NCT02521870|11245785|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28
9698744|NCT02684461|10797678|FG000|COMPLETED|Overall Study||5
9698745|NCT02684461|10797679|FG001|COMPLETED|Overall Study||5
9698746|NCT02684461|10797680|FG002|COMPLETED|Overall Study||6
9698747|NCT02684461|10797678|FG000|NOT COMPLETED|Overall Study||2
9698748|NCT02684461|10797679|FG001|NOT COMPLETED|Overall Study||2
9698749|NCT02684461|10797680|FG002|NOT COMPLETED|Overall Study||0
9698750|NCT02657343|10797700|FG000|STARTED|Overall Study||3
9698751|NCT02657343|10797701|FG001|STARTED|Overall Study||3
9698752|NCT02657343|10797702|FG002|STARTED|Overall Study||3
9698753|NCT02657343|10797703|FG003|STARTED|Overall Study||3
9698754|NCT02657343|10797704|FG004|STARTED|Overall Study||13
9698755|NCT02657343|10797705|FG005|STARTED|Overall Study||0
9698756|NCT02657343|10797700|FG000|COMPLETED|Overall Study||2
9698757|NCT02657343|10797701|FG001|COMPLETED|Overall Study||1
9698758|NCT02657343|10797702|FG002|COMPLETED|Overall Study||3
9698759|NCT02657343|10797703|FG003|COMPLETED|Overall Study||3
9698760|NCT02657343|10797704|FG004|COMPLETED|Overall Study||12
9698761|NCT02657343|10797705|FG005|COMPLETED|Overall Study||0
9698762|NCT02657343|10797700|FG000|NOT COMPLETED|Overall Study||1
9698763|NCT02657343|10797701|FG001|NOT COMPLETED|Overall Study||2
9698764|NCT02657343|10797702|FG002|NOT COMPLETED|Overall Study||0
9698765|NCT02657343|10797703|FG003|NOT COMPLETED|Overall Study||0
9698766|NCT02657343|10797704|FG004|NOT COMPLETED|Overall Study||1
9698767|NCT02657343|10797705|FG005|NOT COMPLETED|Overall Study||0
9698768|NCT02368132|10797722|FG000|STARTED|Overall Study||112
9698769|NCT02368132|10797723|FG001|STARTED|Overall Study||122
9698770|NCT02368132|10797724|FG002|STARTED|Overall Study||85
9698771|NCT02368132|10797722|FG000|COMPLETED|Overall Study||32
9698772|NCT02368132|10797723|FG001|COMPLETED|Overall Study||71
9698773|NCT02368132|10797724|FG002|COMPLETED|Overall Study||50
9698774|NCT02368132|10797722|FG000|NOT COMPLETED|Overall Study||80
9698775|NCT02368132|10797723|FG001|NOT COMPLETED|Overall Study||51
9698776|NCT02368132|10797724|FG002|NOT COMPLETED|Overall Study||35
9698777|NCT02063724|10797732|FG000|STARTED|Overall Study||15
9698778|NCT02063724|10797732|FG000|COMPLETED|Overall Study||14
9698779|NCT02063724|10797732|FG000|NOT COMPLETED|Overall Study||1
9698780|NCT01776723|10797741|FG000|STARTED|Overall Study||6
9698781|NCT01776723|10797742|FG001|STARTED|Overall Study||4
9698782|NCT01776723|10797743|FG002|STARTED|Overall Study||5
9698783|NCT01776723|10797744|FG003|STARTED|Overall Study||5
9698784|NCT01776723|10797745|FG004|STARTED|Overall Study||30
9698785|NCT01776723|10797741|FG000|COMPLETED|Overall Study||6
9698786|NCT01776723|10797742|FG001|COMPLETED|Overall Study||4
9698787|NCT01776723|10797743|FG002|COMPLETED|Overall Study||5
9698788|NCT01776723|10797744|FG003|COMPLETED|Overall Study||5
9698789|NCT01776723|10797745|FG004|COMPLETED|Overall Study||30
9698790|NCT01776723|10797741|FG000|NOT COMPLETED|Overall Study||0
9698791|NCT01776723|10797742|FG001|NOT COMPLETED|Overall Study||0
9698792|NCT01776723|10797743|FG002|NOT COMPLETED|Overall Study||0
9698793|NCT01776723|10797744|FG003|NOT COMPLETED|Overall Study||0
9698794|NCT01776723|10797745|FG004|NOT COMPLETED|Overall Study||0
9698795|NCT01119807|10797764|FG000|STARTED|Overall Study||67
9698796|NCT01119807|10797765|FG001|STARTED|Overall Study||51
9698797|NCT01119807|10797766|FG002|STARTED|Overall Study||64
9698798|NCT01119807|10797764|FG000|COMPLETED|Overall Study||67
9698799|NCT01119807|10797765|FG001|COMPLETED|Overall Study||51
9698800|NCT01119807|10797766|FG002|COMPLETED|Overall Study||64
9698801|NCT01119807|10797764|FG000|NOT COMPLETED|Overall Study||0
9698802|NCT01119807|10797765|FG001|NOT COMPLETED|Overall Study||0
9698803|NCT01119807|10797766|FG002|NOT COMPLETED|Overall Study||0
9698804|NCT00601900|10797776|FG000|STARTED|Overall Study||195
9698805|NCT00601900|10797777|FG001|STARTED|Overall Study||199
9698806|NCT00601900|10797776|FG000|COMPLETED|Overall Study||195
9698807|NCT00601900|10797777|FG001|COMPLETED|Overall Study||196
9698808|NCT00601900|10797776|FG000|NOT COMPLETED|Overall Study||0
9698809|NCT00601900|10797777|FG001|NOT COMPLETED|Overall Study||3
9698810|NCT01295944|10797783|FG000|STARTED|Overall Study||35
9698811|NCT01295944|10797783|FG000|COMPLETED|Overall Study||17
9698812|NCT01295944|10797783|FG000|NOT COMPLETED|Overall Study||18
9698813|NCT01285557|10797789|FG000|STARTED|Overall Study||239
9698814|NCT01285557|10797790|FG001|STARTED|Overall Study||122
9698815|NCT01285557|10797789|FG000|Treated|Overall Study||238
9698816|NCT01285557|10797790|FG001|Treated|Overall Study||121
9698817|NCT01285557|10797789|FG000|As Treated (AT) Population|Overall Study||230
9698818|NCT01285557|10797790|FG001|As Treated (AT) Population|Overall Study||118
9698819|NCT01285557|10797789|FG000|COMPLETED|Overall Study||0
9698820|NCT01285557|10797790|FG001|COMPLETED|Overall Study||0
9698821|NCT01285557|10797789|FG000|NOT COMPLETED|Overall Study||239
9698822|NCT01285557|10797790|FG001|NOT COMPLETED|Overall Study||122
9698823|NCT01032603|10797798|FG000|STARTED|Overall Study||101
9698824|NCT01032603|10797799|FG001|STARTED|Overall Study||96
9698825|NCT01032603|10797798|FG000|COMPLETED|Overall Study||86
9698826|NCT01032603|10797799|FG001|COMPLETED|Overall Study||77
9698827|NCT01032603|10797798|FG000|NOT COMPLETED|Overall Study||15
9698828|NCT01032603|10797799|FG001|NOT COMPLETED|Overall Study||19
9698829|NCT00977691|10797808|FG000|STARTED|Overall Study||3
9698830|NCT00977691|10797809|FG001|STARTED|Overall Study||8
9698831|NCT00977691|10797810|FG002|STARTED|Overall Study||12
9698832|NCT00977691|10797808|FG000|COMPLETED|Overall Study||3
9698833|NCT00977691|10797809|FG001|COMPLETED|Overall Study||7
9698834|NCT00977691|10797810|FG002|COMPLETED|Overall Study||12
9698835|NCT00977691|10797808|FG000|NOT COMPLETED|Overall Study||0
9698836|NCT00977691|10797809|FG001|NOT COMPLETED|Overall Study||1
9698837|NCT00977691|10797810|FG002|NOT COMPLETED|Overall Study||0
9698838|NCT00964002|10797820|FG000|STARTED|Overall Study||61
9698839|NCT00964002|10797820|FG000|Assessable for Safety|Overall Study|59 patients were assessable for safety, they received treatment at least once.|59
9698840|NCT00964002|10797820|FG000|COMPLETED|Overall Study||53
9698841|NCT00964002|10797820|FG000|NOT COMPLETED|Overall Study||8
9727907|NCT00110812|10827606|FG000|STARTED|Extended Follow-up||80
9727908|NCT00110812|10827607|FG001|STARTED|Extended Follow-up||69
9727909|NCT00110812|10827608|FG002|STARTED|Extended Follow-up||73
9727910|NCT00110812|10827606|FG000|COMPLETED|Extended Follow-up||78
9727911|NCT00110812|10827607|FG001|COMPLETED|Extended Follow-up||65
9727912|NCT00110812|10827608|FG002|COMPLETED|Extended Follow-up||69
9727913|NCT00110812|10827606|FG000|NOT COMPLETED|Extended Follow-up||2
9727914|NCT00110812|10827607|FG001|NOT COMPLETED|Extended Follow-up||4
9727915|NCT00110812|10827608|FG002|NOT COMPLETED|Extended Follow-up||4
9727916|NCT00110890|10827623|FG000|STARTED|Overall Study||368
9727917|NCT00110890|10827624|FG001|STARTED|Overall Study||184
9727918|NCT00110890|10827623|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
9727919|NCT00110890|10827624|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
9727920|NCT00110890|10827623|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
9727921|NCT00110890|10827624|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
9727922|NCT00110890|10827623|FG000|COMPLETED|Overall Study|Follow-up Phase|7
9727923|NCT00110890|10827624|FG001|COMPLETED|Overall Study|Follow-up Phase|5
10026475|NCT01877941|11150583|FG000|NOT COMPLETED|Overall Study||0
9698842|NCT00887783|10797826|FG000|STARTED|Overall Study||58
9698843|NCT00887783|10797827|FG001|STARTED|Overall Study||59
9698844|NCT00887783|10797826|FG000|COMPLETED|Overall Study||58
9698845|NCT00887783|10797827|FG001|COMPLETED|Overall Study||59
9698846|NCT00887783|10797826|FG000|NOT COMPLETED|Overall Study||0
9698847|NCT00887783|10797827|FG001|NOT COMPLETED|Overall Study||0
9698848|NCT00790218|10797833|FG000|STARTED|Overall Study||6
9698849|NCT00790218|10797834|FG001|STARTED|Overall Study||6
9698850|NCT00790218|10797835|FG002|STARTED|Overall Study||7
9698851|NCT00790218|10797833|FG000|COMPLETED|Overall Study||5
9698852|NCT00790218|10797834|FG001|COMPLETED|Overall Study||6
9698853|NCT00790218|10797835|FG002|COMPLETED|Overall Study||7
9698854|NCT00790218|10797833|FG000|NOT COMPLETED|Overall Study||1
9698855|NCT00790218|10797834|FG001|NOT COMPLETED|Overall Study||0
9698856|NCT00790218|10797835|FG002|NOT COMPLETED|Overall Study||0
9698857|NCT00583778|10797845|FG000|STARTED|Overall Study||74
9698858|NCT00583778|10797846|FG001|STARTED|Overall Study||67
9698859|NCT00583778|10797845|FG000|COMPLETED|Overall Study||74
9698860|NCT00583778|10797846|FG001|COMPLETED|Overall Study||67
9698861|NCT00583778|10797845|FG000|NOT COMPLETED|Overall Study||0
9698862|NCT00583778|10797846|FG001|NOT COMPLETED|Overall Study||0
9698869|NCT00432094|10797864|FG000|STARTED|Overall Study||14
10026476|NCT01878006|11150588|FG000|STARTED|Study Session 1||5
9698870|NCT00432094|10797865|FG001|STARTED|Overall Study||9
9698871|NCT00432094|10797864|FG000|COMPLETED|Overall Study||14
9698872|NCT00432094|10797865|FG001|COMPLETED|Overall Study||9
9698873|NCT00432094|10797864|FG000|NOT COMPLETED|Overall Study||0
9698874|NCT00432094|10797865|FG001|NOT COMPLETED|Overall Study||0
9698875|NCT00416351|10797875|FG000|STARTED|Overall Study||1
9698876|NCT00416351|10797876|FG001|STARTED|Overall Study||3
9698877|NCT00416351|10797877|FG002|STARTED|Overall Study||4
9698878|NCT00416351|10797878|FG003|STARTED|Overall Study||17
9698879|NCT00416351|10797879|FG004|STARTED|Overall Study||4
9698880|NCT00416351|10797875|FG000|COMPLETED|Overall Study||1
9698881|NCT00416351|10797876|FG001|COMPLETED|Overall Study||3
9698882|NCT00416351|10797877|FG002|COMPLETED|Overall Study||4
9698883|NCT00416351|10797878|FG003|COMPLETED|Overall Study||17
9698884|NCT00416351|10797879|FG004|COMPLETED|Overall Study||4
9698885|NCT00416351|10797875|FG000|NOT COMPLETED|Overall Study||0
9698886|NCT00416351|10797876|FG001|NOT COMPLETED|Overall Study||0
9698887|NCT00416351|10797877|FG002|NOT COMPLETED|Overall Study||0
9698888|NCT00416351|10797878|FG003|NOT COMPLETED|Overall Study||0
9698889|NCT00416351|10797879|FG004|NOT COMPLETED|Overall Study||0
9698890|NCT00145600|10797900|FG000|STARTED|Overall Study||91
9698891|NCT00145600|10797901|FG001|STARTED|Overall Study||46
9698892|NCT00145600|10797902|FG002|STARTED|Overall Study||13
9698893|NCT00145600|10797903|FG003|STARTED|Overall Study||146
9698894|NCT00145600|10797900|FG000|COMPLETED|Overall Study||83
9698895|NCT00145600|10797901|FG001|COMPLETED|Overall Study||36
9698896|NCT00145600|10797902|FG002|COMPLETED|Overall Study||8
9698897|NCT00145600|10797903|FG003|COMPLETED|Overall Study||130
10026477|NCT01878006|11150589|FG001|STARTED|Study Session 1||5
9698898|NCT00145600|10797900|FG000|NOT COMPLETED|Overall Study||8
9698899|NCT00145600|10797901|FG001|NOT COMPLETED|Overall Study||10
9698900|NCT00145600|10797902|FG002|NOT COMPLETED|Overall Study||5
10026478|NCT01878006|11150588|FG000|COMPLETED|Study Session 1||5
9698901|NCT00145600|10797903|FG003|NOT COMPLETED|Overall Study||16
9698902|NCT00072358|10797927|FG000|STARTED|Overall Study||291
9698903|NCT00072358|10797927|FG000|COMPLETED|Overall Study||291
9698904|NCT00072358|10797927|FG000|NOT COMPLETED|Overall Study||0
9727924|NCT00110890|10827623|FG000|NOT COMPLETED|Overall Study||361
9727925|NCT00110890|10827624|FG001|NOT COMPLETED|Overall Study||179
9727926|NCT00110994|10827632|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51
9727927|NCT00110994|10827633|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50
9727928|NCT00110994|10827632|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51
9727929|NCT00110994|10827633|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50
9727930|NCT00110994|10827632|FG000|COMPLETED|Double-blind (DB) Treatment||9
9962070|NCT01475370|11081618|FG000|NOT COMPLETED|Overall Study||3
9962071|NCT01475370|11081619|FG001|NOT COMPLETED|Overall Study||3
9962072|NCT01475370|11081620|FG002|NOT COMPLETED|Overall Study||3
9962073|NCT01475461|11081634|FG000|STARTED|Run-in Period||376
9962074|NCT01475461|11081635|FG001|STARTED|Run-in Period||0
9962075|NCT01475461|11081636|FG002|STARTED|Run-in Period||0
9962076|NCT01475461|11081637|FG003|STARTED|Run-in Period||0
10115042|NCT02521870|11245786|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23
10115043|NCT02521870|11245787|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30
10115044|NCT02521948|11245817|FG000|STARTED|Overall Study||50
10115045|NCT02521948|11245817|FG000|COMPLETED|Overall Study||37
10115046|NCT02521948|11245817|FG000|NOT COMPLETED|Overall Study||13
10115047|NCT02521974|11245826|FG000|STARTED|Overall Study||50
10115048|NCT02521974|11245827|FG001|STARTED|Overall Study||114
10115049|NCT02521974|11245826|FG000|COMPLETED|Overall Study||47
10115050|NCT02521974|11245827|FG001|COMPLETED|Overall Study||110
10115051|NCT02521974|11245826|FG000|NOT COMPLETED|Overall Study||3
10115052|NCT02521974|11245827|FG001|NOT COMPLETED|Overall Study||4
9962077|NCT01475461|11081638|FG004|STARTED|Run-in Period||0
9962078|NCT01475461|11081639|FG005|STARTED|Run-in Period||0
9962079|NCT01475461|11081640|FG006|STARTED|Run-in Period||0
9962080|NCT01475461|11081634|FG000|COMPLETED|Run-in Period||335
9962081|NCT01475461|11081635|FG001|COMPLETED|Run-in Period||0
9962082|NCT01475461|11081636|FG002|COMPLETED|Run-in Period||0
9962083|NCT01475461|11081637|FG003|COMPLETED|Run-in Period||0
9962084|NCT01475461|11081638|FG004|COMPLETED|Run-in Period||0
9962085|NCT01475461|11081639|FG005|COMPLETED|Run-in Period||0
9962086|NCT01475461|11081640|FG006|COMPLETED|Run-in Period||0
9962087|NCT01475461|11081634|FG000|NOT COMPLETED|Run-in Period||41
9727931|NCT00110994|10827633|FG001|COMPLETED|Double-blind (DB) Treatment||3
9962088|NCT01475461|11081635|FG001|NOT COMPLETED|Run-in Period||0
9962089|NCT01475461|11081636|FG002|NOT COMPLETED|Run-in Period||0
9962090|NCT01475461|11081637|FG003|NOT COMPLETED|Run-in Period||0
9962091|NCT01475461|11081638|FG004|NOT COMPLETED|Run-in Period||0
9962092|NCT01475461|11081639|FG005|NOT COMPLETED|Run-in Period||0
10115053|NCT02522104|11245837|FG000|STARTED|Overall Study||13
10115054|NCT02522104|11245838|FG001|STARTED|Overall Study||15
10115055|NCT02522104|11245839|FG002|STARTED|Overall Study||12
9698905|NCT03089281|10797933|FG000|STARTED|Overall Study||225
9698906|NCT03089281|10797934|FG001|STARTED|Overall Study||215
9698907|NCT03089281|10797933|FG000|COMPLETED|Overall Study||197
9698908|NCT03089281|10797934|FG001|COMPLETED|Overall Study||198
9698909|NCT03089281|10797933|FG000|NOT COMPLETED|Overall Study||28
9698910|NCT03089281|10797934|FG001|NOT COMPLETED|Overall Study||17
9698911|NCT03085563|10797942|FG000|STARTED|Overall Study||19
9698912|NCT03085563|10797943|FG001|STARTED|Overall Study||41
9698913|NCT03085563|10797942|FG000|COMPLETED|Overall Study||19
9698914|NCT03085563|10797943|FG001|COMPLETED|Overall Study||41
9698915|NCT03085563|10797942|FG000|NOT COMPLETED|Overall Study||0
9698916|NCT03085563|10797943|FG001|NOT COMPLETED|Overall Study||0
9698939|NCT03056443|10797986|FG000|STARTED|Overall Study||13
9698940|NCT03056443|10797986|FG000|COMPLETED|Overall Study||13
9698941|NCT03056443|10797986|FG000|NOT COMPLETED|Overall Study||0
9698942|NCT03020225|10797993|FG000|STARTED|Overall Study||12
9698943|NCT03020225|10797994|FG001|STARTED|Overall Study||11
9698944|NCT03020225|10797995|FG002|STARTED|Overall Study||13
9698945|NCT03020225|10797993|FG000|COMPLETED|Overall Study||12
9698946|NCT03020225|10797994|FG001|COMPLETED|Overall Study||11
9698947|NCT03020225|10797995|FG002|COMPLETED|Overall Study||13
9698948|NCT03020225|10797993|FG000|NOT COMPLETED|Overall Study||0
9698949|NCT03020225|10797994|FG001|NOT COMPLETED|Overall Study||0
9698950|NCT03020225|10797995|FG002|NOT COMPLETED|Overall Study||0
9698951|NCT03004586|10798027|FG000|STARTED|Overall Study||31
9698952|NCT03004586|10798028|FG001|STARTED|Overall Study||30
9698953|NCT03004586|10798027|FG000|COMPLETED|Overall Study||31
9698954|NCT03004586|10798028|FG001|COMPLETED|Overall Study||30
9698955|NCT03004586|10798027|FG000|NOT COMPLETED|Overall Study||0
9698956|NCT03004586|10798028|FG001|NOT COMPLETED|Overall Study||0
9698957|NCT05110014|10798038|FG000|STARTED|Overall Study||12239
9698958|NCT05110014|10798039|FG001|STARTED|Overall Study||10787
9698959|NCT05110014|10798038|FG000|COMPLETED|Overall Study||12239
9698960|NCT05110014|10798039|FG001|COMPLETED|Overall Study||10787
9698961|NCT05110014|10798038|FG000|NOT COMPLETED|Overall Study||0
9698962|NCT05110014|10798039|FG001|NOT COMPLETED|Overall Study||0
9698963|NCT04980040|10798047|FG000|STARTED|Overall Study||3623
9698964|NCT04980040|10798047|FG000|COMPLETED|Overall Study||3131
9698965|NCT04980040|10798047|FG000|NOT COMPLETED|Overall Study||492
10026479|NCT01878006|11150589|FG001|COMPLETED|Study Session 1||5
10026480|NCT01878006|11150588|FG000|NOT COMPLETED|Study Session 1||0
10026481|NCT01878006|11150589|FG001|NOT COMPLETED|Study Session 1||0
10026482|NCT01878006|11150588|FG000|STARTED|Study Session 2||5
10026483|NCT01878006|11150589|FG001|STARTED|Study Session 2||5
9698966|NCT04218279|10798053|FG000|STARTED|Overall Study||316
9698967|NCT04218279|10798054|FG001|STARTED|Overall Study||362
9698968|NCT04218279|10798053|FG000|COMPLETED|Overall Study||211
9698969|NCT04218279|10798054|FG001|COMPLETED|Overall Study||225
9698970|NCT04218279|10798053|FG000|NOT COMPLETED|Overall Study||105
9698971|NCT04218279|10798054|FG001|NOT COMPLETED|Overall Study||137
9698972|NCT04167670|10798063|FG000|STARTED|Overall Study||349
9698973|NCT04167670|10798064|FG001|STARTED|Overall Study||349
9698974|NCT04167670|10798065|FG002|STARTED|Overall Study||348
9698975|NCT04167670|10798063|FG000|Received Study Drugs|Overall Study||348
9698976|NCT04167670|10798064|FG001|Received Study Drugs|Overall Study||346
9698977|NCT04167670|10798065|FG002|Received Study Drugs|Overall Study||345
9698978|NCT04167670|10798063|FG000|COMPLETED|Overall Study||334
9698979|NCT04167670|10798064|FG001|COMPLETED|Overall Study||331
9698980|NCT04167670|10798065|FG002|COMPLETED|Overall Study||334
9698981|NCT04167670|10798063|FG000|NOT COMPLETED|Overall Study||15
9698982|NCT04167670|10798064|FG001|NOT COMPLETED|Overall Study||18
9698983|NCT04167670|10798065|FG002|NOT COMPLETED|Overall Study||14
9698984|NCT04076917|10798073|FG000|STARTED|Overall Study||84
9698985|NCT04076917|10798073|FG000|COMPLETED|Overall Study||15
9698986|NCT04076917|10798073|FG000|NOT COMPLETED|Overall Study||69
10026484|NCT01878006|11150588|FG000|COMPLETED|Study Session 2||5
10026485|NCT01878006|11150589|FG001|COMPLETED|Study Session 2||5
9698987|NCT04000009|10798077|FG000|STARTED|Overall Study||235
9698988|NCT04000009|10798077|FG000|COMPLETED|Overall Study||70
9698989|NCT04000009|10798077|FG000|NOT COMPLETED|Overall Study||165
9698990|NCT03988335|10798083|FG000|STARTED|Overall Study||16
9698991|NCT03988335|10798084|FG001|STARTED|Overall Study||19
9698917|NCT03084367|10797949|FG000|STARTED|Overall Study||500
9698918|NCT03084367|10797949|FG000|Analyzable iFR Pullback Assessment Post Angiographically Successful PCI|Overall Study||467
9698919|NCT03084367|10797949|FG000|COMPLETED|Overall Study||463
9698920|NCT03084367|10797949|FG000|NOT COMPLETED|Overall Study||37
9698992|NCT03988335|10798083|FG000|COMPLETED|Overall Study||14
9698993|NCT03988335|10798084|FG001|COMPLETED|Overall Study||18
9698994|NCT03988335|10798083|FG000|NOT COMPLETED|Overall Study||2
9698995|NCT03988335|10798084|FG001|NOT COMPLETED|Overall Study||1
9727932|NCT00110994|10827632|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42
9727933|NCT00110994|10827633|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47
9727934|NCT00110994|10827632|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
9727935|NCT00110994|10827633|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
9727936|NCT00110994|10827632|FG000|COMPLETED|Active Follow-up||0
9727937|NCT00110994|10827633|FG001|COMPLETED|Active Follow-up||0
9727938|NCT00110994|10827632|FG000|NOT COMPLETED|Active Follow-up||1
9727939|NCT00110994|10827633|FG001|NOT COMPLETED|Active Follow-up||2
9727940|NCT00110994|10827632|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
9727941|NCT00110994|10827633|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
9727942|NCT00110994|10827632|FG000|COMPLETED|Long Term Follow-up||22
9727943|NCT00110994|10827633|FG001|COMPLETED|Long Term Follow-up||30
9727944|NCT00110994|10827632|FG000|NOT COMPLETED|Long Term Follow-up||19
9727945|NCT00110994|10827633|FG001|NOT COMPLETED|Long Term Follow-up||17
9727946|NCT00111007|10827641|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135
9727947|NCT00111007|10827642|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135
9727948|NCT00111007|10827641|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134
9727949|NCT00111007|10827642|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134
9727950|NCT00111007|10827641|FG000|COMPLETED|Double-blind (DB) Treatment||27
9727951|NCT00111007|10827642|FG001|COMPLETED|Double-blind (DB) Treatment||24
9727952|NCT00111007|10827641|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108
9727953|NCT00111007|10827642|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111
9727954|NCT00111007|10827641|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
9727955|NCT00111007|10827642|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
9727956|NCT00111007|10827641|FG000|COMPLETED|Active Follow-up||0
9727957|NCT00111007|10827642|FG001|COMPLETED|Active Follow-up||2
9727958|NCT00111007|10827641|FG000|NOT COMPLETED|Active Follow-up||6
9727959|NCT00111007|10827642|FG001|NOT COMPLETED|Active Follow-up||2
9727960|NCT00111007|10827641|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
9727961|NCT00111007|10827642|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
9727962|NCT00111007|10827641|FG000|COMPLETED|Long Term Follow-up||54
9727963|NCT00111007|10827642|FG001|COMPLETED|Long Term Follow-up||62
9727964|NCT00111007|10827641|FG000|NOT COMPLETED|Long Term Follow-up||47
9727965|NCT00111007|10827642|FG001|NOT COMPLETED|Long Term Follow-up||45
9727966|NCT00111228|10827651|FG000|STARTED|Overall Study||54
9727967|NCT00111228|10827652|FG001|STARTED|Overall Study||54
9727968|NCT00111228|10827653|FG002|STARTED|Overall Study||54
9727969|NCT00111228|10827651|FG000|COMPLETED|Overall Study||49
9727970|NCT00111228|10827652|FG001|COMPLETED|Overall Study||53
9727971|NCT00111228|10827653|FG002|COMPLETED|Overall Study||54
9727972|NCT00111228|10827651|FG000|NOT COMPLETED|Overall Study||5
10115056|NCT02522104|11245837|FG000|COMPLETED|Overall Study||10
10115057|NCT02522104|11245838|FG001|COMPLETED|Overall Study||12
10115058|NCT02522104|11245839|FG002|COMPLETED|Overall Study||5
10115059|NCT02522104|11245837|FG000|NOT COMPLETED|Overall Study||3
10115060|NCT02522104|11245838|FG001|NOT COMPLETED|Overall Study||3
10115061|NCT02522104|11245839|FG002|NOT COMPLETED|Overall Study||7
10115062|NCT02522286|11245854|FG000|STARTED|Overall Study||78
10115063|NCT02522286|11245855|FG001|STARTED|Overall Study||75
10115064|NCT02522286|11245856|FG002|STARTED|Overall Study||75
10115065|NCT02522286|11245857|FG003|STARTED|Overall Study||78
10115066|NCT02522286|11245854|FG000|COMPLETED|Overall Study||75
10115067|NCT02522286|11245855|FG001|COMPLETED|Overall Study||75
10115068|NCT02522286|11245856|FG002|COMPLETED|Overall Study||75
10115069|NCT02522286|11245857|FG003|COMPLETED|Overall Study||75
10115070|NCT02522286|11245854|FG000|NOT COMPLETED|Overall Study||3
9698921|NCT03082898|10797960|FG000|STARTED|Overall Study||27
9698922|NCT03082898|10797961|FG001|STARTED|Overall Study||12
9698923|NCT03082898|10797960|FG000|COMPLETED|Overall Study||24
9698924|NCT03082898|10797961|FG001|COMPLETED|Overall Study||11
9698925|NCT03082898|10797960|FG000|NOT COMPLETED|Overall Study||3
9698926|NCT03082898|10797961|FG001|NOT COMPLETED|Overall Study||1
9698927|NCT03082313|10797967|FG000|STARTED|Overall Study||12
9698928|NCT03082313|10797967|FG000|COMPLETED|Overall Study||12
9698929|NCT03082313|10797967|FG000|NOT COMPLETED|Overall Study||0
9698930|NCT03082391|10797973|FG000|STARTED|Overall Study||173
9698931|NCT03082391|10797974|FG001|STARTED|Overall Study||177
9698932|NCT03082391|10797973|FG000|COMPLETED|Overall Study||173
9698933|NCT03082391|10797974|FG001|COMPLETED|Overall Study||177
9698934|NCT03082391|10797973|FG000|NOT COMPLETED|Overall Study||0
9698935|NCT03082391|10797974|FG001|NOT COMPLETED|Overall Study||0
9698996|NCT03792737|10798093|FG000|STARTED|Overall Study||166
9698997|NCT03792737|10798094|FG001|STARTED|Overall Study||167
9698998|NCT03792737|10798095|FG002|STARTED|Overall Study||167
9698999|NCT03792737|10798093|FG000|Safety Analysis Set|Overall Study||162
10026486|NCT01878006|11150588|FG000|NOT COMPLETED|Study Session 2||0
10026487|NCT01878006|11150589|FG001|NOT COMPLETED|Study Session 2||0
10026488|NCT01878084|11150595|FG000|STARTED|Overall Study||9
10026489|NCT01878084|11150595|FG000|Test(Received TAMP Bioglass) s|Overall Study||7
10026490|NCT01878084|11150595|FG000|Control (Sockets Were Left Empty)|Overall Study||7
10026491|NCT01878084|11150595|FG000|COMPLETED|Overall Study||7
10026492|NCT01878084|11150595|FG000|NOT COMPLETED|Overall Study||2
10026493|NCT01878097|11150602|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
10081309|NCT02259348|11209766|FG000|NOT COMPLETED|Overall Study||10
9698936|NCT03081767|10797980|FG000|STARTED|Overall Study||199
9698937|NCT03081767|10797980|FG000|COMPLETED|Overall Study||199
9698938|NCT03081767|10797980|FG000|NOT COMPLETED|Overall Study||0
9847712|NCT00855582|10960291|FG001|STARTED|Overall Study||208
9847713|NCT00855582|10960292|FG002|STARTED|Overall Study||200
9847714|NCT00855582|10960290|FG000|COMPLETED|Overall Study||172
9847715|NCT00855582|10960291|FG001|COMPLETED|Overall Study||184
9847716|NCT00855582|10960292|FG002|COMPLETED|Overall Study||170
9847717|NCT00855582|10960290|FG000|NOT COMPLETED|Overall Study||26
9699000|NCT03792737|10798094|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
9699001|NCT03792737|10798095|FG002|Safety Analysis Set|Overall Study||162
9699002|NCT03792737|10798093|FG000|Full Analysis Set|Overall Study||162
9699003|NCT03792737|10798094|FG001|Full Analysis Set|Overall Study||160
9699004|NCT03792737|10798095|FG002|Full Analysis Set|Overall Study||162
9699005|NCT03792737|10798093|FG000|COMPLETED|Overall Study||160
9699006|NCT03792737|10798094|FG001|COMPLETED|Overall Study||159
9699007|NCT03792737|10798095|FG002|COMPLETED|Overall Study||158
9699008|NCT03792737|10798093|FG000|NOT COMPLETED|Overall Study||6
9699009|NCT03792737|10798094|FG001|NOT COMPLETED|Overall Study||8
9699010|NCT03792737|10798095|FG002|NOT COMPLETED|Overall Study||9
9699011|NCT03674112|10798105|FG000|STARTED|Overall Study||80
9699012|NCT03674112|10798106|FG001|STARTED|Overall Study||80
9699013|NCT03674112|10798105|FG000|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
9699014|NCT03674112|10798106|FG001|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
9699015|NCT03674112|10798105|FG000|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
9699016|NCT03674112|10798106|FG001|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
9699017|NCT03674112|10798105|FG000|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
9699018|NCT03674112|10798106|FG001|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
9699019|NCT03674112|10798105|FG000|COMPLETED|Overall Study||0
9699020|NCT03674112|10798106|FG001|COMPLETED|Overall Study||0
9699021|NCT03674112|10798105|FG000|NOT COMPLETED|Overall Study||80
9699022|NCT03674112|10798106|FG001|NOT COMPLETED|Overall Study||80
9699023|NCT03618641|10798132|FG000|STARTED|Overall Study||34
9699024|NCT03618641|10798132|FG000|COMPLETED|Overall Study||34
9699025|NCT03618641|10798132|FG000|NOT COMPLETED|Overall Study||0
9699026|NCT03584464|10798136|FG000|STARTED|Overall Study||205
9699027|NCT03584464|10798136|FG000|COMPLETED|Overall Study|Number of subjects that competed 1 year follow up or had a CEC event|204
9699028|NCT03584464|10798136|FG000|NOT COMPLETED|Overall Study||1
9699029|NCT03441477|10798140|FG000|STARTED|Overall Study||225
9699030|NCT03441477|10798140|FG000|COMPLETED|Overall Study||224
9699031|NCT03441477|10798140|FG000|NOT COMPLETED|Overall Study||1
9699032|NCT03205371|10798158|FG000|STARTED|Overall Study||107
9962093|NCT01475461|11081640|FG006|NOT COMPLETED|Run-in Period||0
9962094|NCT01475461|11081634|FG000|STARTED|Treatment Period||0
9962095|NCT01475461|11081635|FG001|STARTED|Treatment Period||57
9962096|NCT01475461|11081636|FG002|STARTED|Treatment Period||57
9962097|NCT01475461|11081637|FG003|STARTED|Treatment Period||54
9962098|NCT01475461|11081638|FG004|STARTED|Treatment Period||56
9962099|NCT01475461|11081639|FG005|STARTED|Treatment Period||56
9962100|NCT01475461|11081640|FG006|STARTED|Treatment Period||55
9962101|NCT01475461|11081634|FG000|COMPLETED|Treatment Period||0
9962102|NCT01475461|11081635|FG001|COMPLETED|Treatment Period||48
9962103|NCT01475461|11081636|FG002|COMPLETED|Treatment Period||53
10026494|NCT01878097|11150603|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
10026495|NCT01878097|11150602|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
9962104|NCT01475461|11081637|FG003|COMPLETED|Treatment Period||46
9699033|NCT03205371|10798159|FG001|STARTED|Overall Study||53
9699034|NCT03205371|10798160|FG002|STARTED|Overall Study||53
9699035|NCT03205371|10798161|FG003|STARTED|Overall Study||86
9699036|NCT03205371|10798162|FG004|STARTED|Overall Study||42
9699037|NCT03205371|10798163|FG005|STARTED|Overall Study||42
9699038|NCT03205371|10798164|FG006|STARTED|Overall Study||200
9699039|NCT03205371|10798165|FG007|STARTED|Overall Study||100
9699040|NCT03205371|10798166|FG008|STARTED|Overall Study||100
9699041|NCT03205371|10798167|FG009|STARTED|Overall Study||200
9699042|NCT03205371|10798168|FG010|STARTED|Overall Study||100
9699043|NCT03205371|10798169|FG011|STARTED|Overall Study||100
9699044|NCT03205371|10798158|FG000|Safety Analysis Set (SafAS)|Overall Study||103
9699045|NCT03205371|10798159|FG001|Safety Analysis Set (SafAS)|Overall Study||52
9699046|NCT03205371|10798160|FG002|Safety Analysis Set (SafAS)|Overall Study||53
9962105|NCT01475461|11081638|FG004|COMPLETED|Treatment Period||52
9962106|NCT01475461|11081639|FG005|COMPLETED|Treatment Period||51
9962107|NCT01475461|11081640|FG006|COMPLETED|Treatment Period||53
9962108|NCT01475461|11081634|FG000|NOT COMPLETED|Treatment Period||0
9962109|NCT01475461|11081635|FG001|NOT COMPLETED|Treatment Period||9
10115071|NCT02522286|11245855|FG001|NOT COMPLETED|Overall Study||0
9699047|NCT03205371|10798161|FG003|Safety Analysis Set (SafAS)|Overall Study||86
9699048|NCT03205371|10798162|FG004|Safety Analysis Set (SafAS)|Overall Study||42
9699049|NCT03205371|10798163|FG005|Safety Analysis Set (SafAS)|Overall Study||42
9699050|NCT03205371|10798164|FG006|Safety Analysis Set (SafAS)|Overall Study||200
9699051|NCT03205371|10798165|FG007|Safety Analysis Set (SafAS)|Overall Study||100
9699052|NCT03205371|10798166|FG008|Safety Analysis Set (SafAS)|Overall Study||100
9699053|NCT03205371|10798167|FG009|Safety Analysis Set (SafAS)|Overall Study||200
9699054|NCT03205371|10798168|FG010|Safety Analysis Set (SafAS)|Overall Study||100
9699055|NCT03205371|10798169|FG011|Safety Analysis Set (SafAS)|Overall Study||99
9699056|NCT03205371|10798158|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92
9699057|NCT03205371|10798159|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45
9699058|NCT03205371|10798160|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50
9699059|NCT03205371|10798161|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85
9699060|NCT03205371|10798162|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42
9699061|NCT03205371|10798163|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42
9699062|NCT03205371|10798164|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155
9699063|NCT03205371|10798165|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79
9699064|NCT03205371|10798166|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68
9699065|NCT03205371|10798167|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196
9699066|NCT03205371|10798168|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96
9699067|NCT03205371|10798169|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92
9699068|NCT03205371|10798158|FG000|COMPLETED|Overall Study||103
9699069|NCT03205371|10798159|FG001|COMPLETED|Overall Study||52
9699070|NCT03205371|10798160|FG002|COMPLETED|Overall Study||53
9699071|NCT03205371|10798161|FG003|COMPLETED|Overall Study||86
9699072|NCT03205371|10798162|FG004|COMPLETED|Overall Study||42
9699073|NCT03205371|10798163|FG005|COMPLETED|Overall Study||42
9699074|NCT03205371|10798164|FG006|COMPLETED|Overall Study||190
9699075|NCT03205371|10798165|FG007|COMPLETED|Overall Study||97
9699076|NCT03205371|10798166|FG008|COMPLETED|Overall Study||95
9699077|NCT03205371|10798167|FG009|COMPLETED|Overall Study||200
9699078|NCT03205371|10798168|FG010|COMPLETED|Overall Study||100
9699079|NCT03205371|10798169|FG011|COMPLETED|Overall Study||99
9699080|NCT03205371|10798158|FG000|NOT COMPLETED|Overall Study||4
9699081|NCT03205371|10798159|FG001|NOT COMPLETED|Overall Study||1
9699082|NCT03205371|10798160|FG002|NOT COMPLETED|Overall Study||0
9699083|NCT03205371|10798161|FG003|NOT COMPLETED|Overall Study||0
9699084|NCT03205371|10798162|FG004|NOT COMPLETED|Overall Study||0
9699085|NCT03205371|10798163|FG005|NOT COMPLETED|Overall Study||0
9699086|NCT03205371|10798164|FG006|NOT COMPLETED|Overall Study||10
9699087|NCT03205371|10798165|FG007|NOT COMPLETED|Overall Study||3
9699088|NCT03205371|10798166|FG008|NOT COMPLETED|Overall Study||5
9699089|NCT03205371|10798167|FG009|NOT COMPLETED|Overall Study||0
9699090|NCT03205371|10798168|FG010|NOT COMPLETED|Overall Study||0
9699091|NCT03205371|10798169|FG011|NOT COMPLETED|Overall Study||1
9699092|NCT03165721|10798218|FG000|STARTED|Overall Study||7
9699093|NCT03165721|10798219|FG001|STARTED|Overall Study||1
9699094|NCT03165721|10798220|FG002|STARTED|Overall Study||1
10115072|NCT02522286|11245856|FG002|NOT COMPLETED|Overall Study||0
10115073|NCT02522286|11245857|FG003|NOT COMPLETED|Overall Study||3
10115074|NCT02522299|11245869|FG000|STARTED|Overall Study||22
10115075|NCT02522299|11245870|FG001|STARTED|Overall Study||22
10115076|NCT02522299|11245869|FG000|COMPLETED|Overall Study||18
10115077|NCT02522299|11245870|FG001|COMPLETED|Overall Study||21
10115078|NCT02522299|11245869|FG000|NOT COMPLETED|Overall Study||4
10115079|NCT02522299|11245870|FG001|NOT COMPLETED|Overall Study||1
10115080|NCT02522325|11245890|FG000|STARTED|Overall Study||15
10115081|NCT02522325|11245891|FG001|STARTED|Overall Study||15
10115082|NCT02522325|11245890|FG000|COMPLETED|Overall Study||15
10115083|NCT02522325|11245891|FG001|COMPLETED|Overall Study||14
9699095|NCT03165721|10798218|FG000|COMPLETED|Overall Study||3
9699096|NCT03165721|10798219|FG001|COMPLETED|Overall Study||1
9699097|NCT03165721|10798220|FG002|COMPLETED|Overall Study||1
9699098|NCT03165721|10798218|FG000|NOT COMPLETED|Overall Study||4
9699099|NCT03165721|10798219|FG001|NOT COMPLETED|Overall Study||0
9699100|NCT03165721|10798220|FG002|NOT COMPLETED|Overall Study||0
10115084|NCT02522325|11245890|FG000|NOT COMPLETED|Overall Study||0
10115085|NCT02522325|11245891|FG001|NOT COMPLETED|Overall Study||1
9699101|NCT03130959|10798240|FG000|STARTED|Treatment Period||23
9962110|NCT01475461|11081636|FG002|NOT COMPLETED|Treatment Period||4
9962111|NCT01475461|11081637|FG003|NOT COMPLETED|Treatment Period||8
9962112|NCT01475461|11081638|FG004|NOT COMPLETED|Treatment Period||4
9962113|NCT01475461|11081639|FG005|NOT COMPLETED|Treatment Period||5
9962114|NCT01475461|11081640|FG006|NOT COMPLETED|Treatment Period||2
9962115|NCT01475474|11081673|FG000|STARTED|Baseline Period - 4 Weeks||97
9699102|NCT03130959|10798241|FG001|STARTED|Treatment Period||22
9699103|NCT03130959|10798242|FG002|STARTED|Treatment Period||16
9699104|NCT03130959|10798243|FG003|STARTED|Treatment Period||15
9699105|NCT03130959|10798244|FG004|STARTED|Treatment Period||15
9699106|NCT03130959|10798245|FG005|STARTED|Treatment Period||15
9699107|NCT03130959|10798246|FG006|STARTED|Treatment Period||12
9699108|NCT03130959|10798247|FG007|STARTED|Treatment Period||10
9699109|NCT03130959|10798248|FG008|STARTED|Treatment Period||19
9699110|NCT03130959|10798249|FG009|STARTED|Treatment Period||19
9699111|NCT03130959|10798240|FG000|COMPLETED|Treatment Period||2
9699112|NCT03130959|10798241|FG001|COMPLETED|Treatment Period||1
9699113|NCT03130959|10798242|FG002|COMPLETED|Treatment Period||1
9699114|NCT03130959|10798243|FG003|COMPLETED|Treatment Period||0
9699115|NCT03130959|10798244|FG004|COMPLETED|Treatment Period||0
9699116|NCT03130959|10798245|FG005|COMPLETED|Treatment Period||0
9699117|NCT03130959|10798246|FG006|COMPLETED|Treatment Period||0
9699118|NCT03130959|10798247|FG007|COMPLETED|Treatment Period||0
9699119|NCT03130959|10798248|FG008|COMPLETED|Treatment Period||0
9699120|NCT03130959|10798249|FG009|COMPLETED|Treatment Period||1
9699121|NCT03130959|10798240|FG000|NOT COMPLETED|Treatment Period||21
9962116|NCT01475474|11081673|FG000|COMPLETED|Baseline Period - 4 Weeks||91
9962117|NCT01475474|11081673|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6
9962118|NCT01475474|11081673|FG000|STARTED|Treatment Period - 12 Weeks||91
9962119|NCT01475474|11081673|FG000|COMPLETED|Treatment Period - 12 Weeks||73
9962120|NCT01475474|11081673|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18
9699122|NCT03130959|10798241|FG001|NOT COMPLETED|Treatment Period||21
9699123|NCT03130959|10798242|FG002|NOT COMPLETED|Treatment Period||15
9962121|NCT01475474|11081673|FG000|STARTED|Return to Baseline Period - 4 Weeks||73
9962122|NCT01475474|11081673|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71
10026496|NCT01878097|11150603|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
10026497|NCT01878097|11150602|FG000|NOT COMPLETED|Baseline||2497
10026498|NCT01878097|11150603|FG001|NOT COMPLETED|Baseline||1800
10026499|NCT01878097|11150602|FG000|STARTED|Implementation Year 1||11742
10026500|NCT01878097|11150603|FG001|STARTED|Implementation Year 1||9866
9699124|NCT03130959|10798243|FG003|NOT COMPLETED|Treatment Period||15
10026501|NCT01878097|11150602|FG000|COMPLETED|Implementation Year 1||8540
9699125|NCT03130959|10798244|FG004|NOT COMPLETED|Treatment Period||15
9699126|NCT03130959|10798245|FG005|NOT COMPLETED|Treatment Period||15
9699127|NCT03130959|10798246|FG006|NOT COMPLETED|Treatment Period||12
9699128|NCT03130959|10798247|FG007|NOT COMPLETED|Treatment Period||10
9699129|NCT03130959|10798248|FG008|NOT COMPLETED|Treatment Period||19
9699130|NCT03130959|10798249|FG009|NOT COMPLETED|Treatment Period||18
9699131|NCT03130959|10798240|FG000|STARTED|Follow-up Period||23
9699132|NCT03130959|10798241|FG001|STARTED|Follow-up Period||22
9699133|NCT03130959|10798242|FG002|STARTED|Follow-up Period||16
9699134|NCT03130959|10798243|FG003|STARTED|Follow-up Period||15
9699135|NCT03130959|10798244|FG004|STARTED|Follow-up Period||15
9699136|NCT03130959|10798245|FG005|STARTED|Follow-up Period||15
9699137|NCT03130959|10798246|FG006|STARTED|Follow-up Period||12
9699138|NCT03130959|10798247|FG007|STARTED|Follow-up Period||10
9699139|NCT03130959|10798248|FG008|STARTED|Follow-up Period||19
9699140|NCT03130959|10798249|FG009|STARTED|Follow-up Period||19
9699141|NCT03130959|10798240|FG000|COMPLETED|Follow-up Period||3
9699142|NCT03130959|10798241|FG001|COMPLETED|Follow-up Period||2
9699143|NCT03130959|10798242|FG002|COMPLETED|Follow-up Period||4
9699144|NCT03130959|10798243|FG003|COMPLETED|Follow-up Period||1
9699145|NCT03130959|10798244|FG004|COMPLETED|Follow-up Period||1
9699146|NCT03130959|10798245|FG005|COMPLETED|Follow-up Period||5
9699147|NCT03130959|10798246|FG006|COMPLETED|Follow-up Period||3
9699148|NCT03130959|10798247|FG007|COMPLETED|Follow-up Period||2
9699149|NCT03130959|10798248|FG008|COMPLETED|Follow-up Period||1
9699150|NCT03130959|10798249|FG009|COMPLETED|Follow-up Period||3
9699151|NCT03130959|10798240|FG000|NOT COMPLETED|Follow-up Period||20
9699152|NCT03130959|10798241|FG001|NOT COMPLETED|Follow-up Period||20
9699153|NCT03130959|10798242|FG002|NOT COMPLETED|Follow-up Period||12
9699154|NCT03130959|10798243|FG003|NOT COMPLETED|Follow-up Period||14
9699155|NCT03130959|10798244|FG004|NOT COMPLETED|Follow-up Period||14
9962123|NCT01475474|11081673|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
9962124|NCT01475487|11081680|FG000|STARTED|Overall Study||25
9962125|NCT01475487|11081681|FG001|STARTED|Overall Study||25
9962126|NCT01475487|11081680|FG000|COMPLETED|Overall Study||23
9962127|NCT01475487|11081681|FG001|COMPLETED|Overall Study||24
9962128|NCT01475487|11081680|FG000|NOT COMPLETED|Overall Study||2
9962129|NCT01475487|11081681|FG001|NOT COMPLETED|Overall Study||1
9962130|NCT01475513|11081689|FG000|STARTED|Overall Study||20
9962131|NCT01475513|11081690|FG001|STARTED|Overall Study||26
9962132|NCT01475513|11081689|FG000|COMPLETED|Overall Study||17
9962133|NCT01475513|11081690|FG001|COMPLETED|Overall Study||16
9962134|NCT01475513|11081689|FG000|NOT COMPLETED|Overall Study||3
9962135|NCT01475513|11081690|FG001|NOT COMPLETED|Overall Study||10
9962136|NCT01475643|11081700|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
9962137|NCT01475643|11081701|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
9962138|NCT01475643|11081700|FG000|COMPLETED|Overall Study||40
9962139|NCT01475643|11081701|FG001|COMPLETED|Overall Study||43
9962140|NCT01475643|11081700|FG000|NOT COMPLETED|Overall Study||14
9962141|NCT01475643|11081701|FG001|NOT COMPLETED|Overall Study||10
9962142|NCT01475721|11081709|FG000|STARTED|Overall Study||5834
9962143|NCT01475721|11081710|FG001|STARTED|Overall Study||5845
9962144|NCT01475721|11081709|FG000|COMPLETED|Overall Study||5823
9962145|NCT01475721|11081710|FG001|COMPLETED|Overall Study||5831
9962146|NCT01475721|11081709|FG000|NOT COMPLETED|Overall Study||11
9962147|NCT01475721|11081710|FG001|NOT COMPLETED|Overall Study||14
9962148|NCT01475734|11081718|FG000|STARTED|Overall Study||22
9962149|NCT01475734|11081719|FG001|STARTED|Overall Study||22
9962150|NCT01475734|11081718|FG000|COMPLETED|Overall Study||20
9962151|NCT01475734|11081719|FG001|COMPLETED|Overall Study||21
9962152|NCT01475734|11081718|FG000|NOT COMPLETED|Overall Study||2
9962153|NCT01475734|11081719|FG001|NOT COMPLETED|Overall Study||1
9962154|NCT01475825|11081729|FG000|STARTED|Overall Study||104
9962155|NCT01475825|11081730|FG001|STARTED|Overall Study||51
9962156|NCT01475825|11081731|FG002|STARTED|Overall Study||102
9962157|NCT01475825|11081732|FG003|STARTED|Overall Study||52
9962158|NCT01475825|11081729|FG000|Randomized and Treated|Overall Study||104
9962159|NCT01475825|11081730|FG001|Randomized and Treated|Overall Study||51
10115086|NCT02522377|11245899|FG000|STARTED|Overall Study||7
10115087|NCT02522377|11245900|FG001|STARTED|Overall Study||5
10115088|NCT02522377|11245899|FG000|COMPLETED|Overall Study||3
10115089|NCT02522377|11245900|FG001|COMPLETED|Overall Study||5
10115090|NCT02522377|11245899|FG000|NOT COMPLETED|Overall Study||4
10115091|NCT02522377|11245900|FG001|NOT COMPLETED|Overall Study||0
10115092|NCT02522403|11245908|FG000|STARTED|Overall Study||17
10115093|NCT02522403|11245909|FG001|STARTED|Overall Study||19
10115094|NCT02522403|11245908|FG000|COMPLETED|Overall Study||13
10115095|NCT02522403|11245909|FG001|COMPLETED|Overall Study||13
10115096|NCT02522403|11245908|FG000|NOT COMPLETED|Overall Study||4
10115097|NCT02522403|11245909|FG001|NOT COMPLETED|Overall Study||6
9699156|NCT03130959|10798245|FG005|NOT COMPLETED|Follow-up Period||10
9699157|NCT03130959|10798246|FG006|NOT COMPLETED|Follow-up Period||9
9699158|NCT03130959|10798247|FG007|NOT COMPLETED|Follow-up Period||8
9699159|NCT03130959|10798248|FG008|NOT COMPLETED|Follow-up Period||18
9962160|NCT01475825|11081731|FG002|Randomized and Treated|Overall Study||102
9962161|NCT01475825|11081732|FG003|Randomized and Treated|Overall Study||52
9962162|NCT01475825|11081729|FG000|Completed Blinded Treatment Period|Overall Study||60
10115098|NCT02522442|11245917|FG000|STARTED|Overall Study||26
10115099|NCT02522442|11245918|FG001|STARTED|Overall Study||22
9699160|NCT03130959|10798249|FG009|NOT COMPLETED|Follow-up Period||16
9699161|NCT02955797|10798288|FG000|STARTED|Overall Study||306
9699162|NCT02955797|10798289|FG001|STARTED|Overall Study||306
9699163|NCT02955797|10798290|FG002|STARTED|Overall Study||203
9699164|NCT02955797|10798291|FG003|STARTED|Overall Study||103
9699165|NCT02955797|10798288|FG000|Safety Analysis Set (SafAS)|Overall Study||303
9699166|NCT02955797|10798289|FG001|Safety Analysis Set (SafAS)|Overall Study||306
9699167|NCT02955797|10798290|FG002|Safety Analysis Set (SafAS)|Overall Study||203
9699168|NCT02955797|10798291|FG003|Safety Analysis Set (SafAS)|Overall Study||102
9699169|NCT02955797|10798288|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293
9699170|NCT02955797|10798289|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296
9699171|NCT02955797|10798290|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198
9699172|NCT02955797|10798291|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99
9699173|NCT02955797|10798288|FG000|COMPLETED|Overall Study||303
9699174|NCT02955797|10798289|FG001|COMPLETED|Overall Study||303
9699175|NCT02955797|10798290|FG002|COMPLETED|Overall Study||203
9699176|NCT02955797|10798291|FG003|COMPLETED|Overall Study||101
9699177|NCT02955797|10798288|FG000|NOT COMPLETED|Overall Study||3
9699178|NCT02955797|10798289|FG001|NOT COMPLETED|Overall Study||3
9699179|NCT02955797|10798290|FG002|NOT COMPLETED|Overall Study||0
9699180|NCT02955797|10798291|FG003|NOT COMPLETED|Overall Study||2
9699181|NCT02859415|10798306|FG000|STARTED|Overall Study||1
9699182|NCT02859415|10798307|FG001|STARTED|Overall Study||2
9699183|NCT02859415|10798306|FG000|COMPLETED|Overall Study||0
9699184|NCT02859415|10798307|FG001|COMPLETED|Overall Study||1
9699185|NCT02859415|10798306|FG000|NOT COMPLETED|Overall Study||1
9699186|NCT02859415|10798307|FG001|NOT COMPLETED|Overall Study||1
9699187|NCT02842866|10798316|FG000|STARTED|Overall Study||451
9699188|NCT02842866|10798317|FG001|STARTED|Overall Study||455
10026502|NCT01878097|11150603|FG001|COMPLETED|Implementation Year 1||7317
10026503|NCT01878097|11150602|FG000|NOT COMPLETED|Implementation Year 1||3202
10026504|NCT01878097|11150603|FG001|NOT COMPLETED|Implementation Year 1||2549
10026505|NCT01878097|11150602|FG000|STARTED|Implementation Year 2||11567
10026506|NCT01878097|11150603|FG001|STARTED|Implementation Year 2||9611
9699189|NCT02842866|10798316|FG000|Vaccinated|Overall Study||448
9699190|NCT02842866|10798317|FG001|Vaccinated|Overall Study||453
9699191|NCT02842866|10798316|FG000|COMPLETED|Overall Study||444
9699192|NCT02842866|10798317|FG001|COMPLETED|Overall Study||452
9699193|NCT02842866|10798316|FG000|NOT COMPLETED|Overall Study||7
9699194|NCT02842866|10798317|FG001|NOT COMPLETED|Overall Study||3
9699195|NCT02842853|10798327|FG000|STARTED|Overall Study||902
9699196|NCT02842853|10798328|FG001|STARTED|Overall Study||895
9699197|NCT02842853|10798329|FG002|STARTED|Overall Study||906
9699198|NCT02842853|10798330|FG003|STARTED|Overall Study||641
9699199|NCT02842853|10798327|FG000|Vaccinated|Overall Study||895
9699200|NCT02842853|10798328|FG001|Vaccinated|Overall Study||886
9699201|NCT02842853|10798329|FG002|Vaccinated|Overall Study||900
9699202|NCT02842853|10798330|FG003|Vaccinated|Overall Study||636
9847718|NCT00855582|10960291|FG001|NOT COMPLETED|Overall Study||24
9847719|NCT00855582|10960292|FG002|NOT COMPLETED|Overall Study||30
9847720|NCT00855595|10960305|FG000|STARTED|Overall Study||106
9847721|NCT00855595|10960306|FG001|STARTED|Overall Study||101
9847722|NCT00855595|10960305|FG000|COMPLETED|Overall Study||100
9847723|NCT00855595|10960306|FG001|COMPLETED|Overall Study||94
9847724|NCT00855595|10960305|FG000|NOT COMPLETED|Overall Study||6
9847725|NCT00855595|10960306|FG001|NOT COMPLETED|Overall Study||7
9847726|NCT00855738|10960312|FG000|STARTED|Overall Study||111
9847727|NCT00855738|10960312|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
9847728|NCT00855738|10960312|FG000|COMPLETED|Overall Study||106
9847729|NCT00855738|10960312|FG000|NOT COMPLETED|Overall Study||5
9962163|NCT01475825|11081730|FG001|Completed Blinded Treatment Period|Overall Study||42
9962164|NCT01475825|11081731|FG002|Completed Blinded Treatment Period|Overall Study||59
9962165|NCT01475825|11081732|FG003|Completed Blinded Treatment Period|Overall Study||40
9962166|NCT01475825|11081729|FG000|Entered Open-Label Continuation|Overall Study||45
9962167|NCT01475825|11081730|FG001|Entered Open-Label Continuation|Overall Study||31
9962168|NCT01475825|11081731|FG002|Entered Open-Label Continuation|Overall Study||44
9962169|NCT01475825|11081732|FG003|Entered Open-Label Continuation|Overall Study||29
9962170|NCT01475825|11081729|FG000|Completed Open-Label Continuation|Overall Study||37
9962171|NCT01475825|11081730|FG001|Completed Open-Label Continuation|Overall Study||19
9962172|NCT01475825|11081731|FG002|Completed Open-Label Continuation|Overall Study||38
9962173|NCT01475825|11081732|FG003|Completed Open-Label Continuation|Overall Study||22
9962174|NCT01475825|11081729|FG000|COMPLETED|Overall Study||37
9962175|NCT01475825|11081730|FG001|COMPLETED|Overall Study||19
9962176|NCT01475825|11081731|FG002|COMPLETED|Overall Study||38
9962177|NCT01475825|11081732|FG003|COMPLETED|Overall Study||22
9962178|NCT01475825|11081729|FG000|NOT COMPLETED|Overall Study||67
9962179|NCT01475825|11081730|FG001|NOT COMPLETED|Overall Study||32
9962180|NCT01475825|11081731|FG002|NOT COMPLETED|Overall Study||64
9962181|NCT01475825|11081732|FG003|NOT COMPLETED|Overall Study||30
9962182|NCT01475838|11081744|FG000|STARTED|Randomized Phase||293
10026507|NCT01878097|11150602|FG000|COMPLETED|Implementation Year 2||8286
10026508|NCT01878097|11150603|FG001|COMPLETED|Implementation Year 2||6770
10026509|NCT01878097|11150602|FG000|NOT COMPLETED|Implementation Year 2||3281
10026510|NCT01878097|11150603|FG001|NOT COMPLETED|Implementation Year 2||2841
10026511|NCT01878097|11150602|FG000|STARTED|Implementation Year 3||10540
10115100|NCT02522442|11245917|FG000|COMPLETED|Overall Study||26
10115101|NCT02522442|11245918|FG001|COMPLETED|Overall Study||22
10115102|NCT02522442|11245917|FG000|NOT COMPLETED|Overall Study||0
10115103|NCT02522442|11245918|FG001|NOT COMPLETED|Overall Study||0
10115104|NCT02522481|11245924|FG000|STARTED|Overall Study||175
10115105|NCT02522481|11245924|FG000|COMPLETED|Overall Study||172
10115106|NCT02522481|11245924|FG000|NOT COMPLETED|Overall Study||3
10115107|NCT02522494|11245937|FG000|STARTED|Overall Study||51
10115108|NCT02522494|11245938|FG001|STARTED|Overall Study||51
10115109|NCT02522494|11245937|FG000|Post-CVT Visit Interview|Overall Study||37
10115110|NCT02522494|11245938|FG001|Post-CVT Visit Interview|Overall Study||48
10115111|NCT02522494|11245937|FG000|4-Week Follow Up|Overall Study||37
9962183|NCT01475838|11081745|FG001|STARTED|Randomized Phase||145
9962184|NCT01475838|11081744|FG000|COMPLETED|Randomized Phase||263
9962185|NCT01475838|11081745|FG001|COMPLETED|Randomized Phase||109
10115112|NCT02522494|11245938|FG001|4-Week Follow Up|Overall Study||46
10115113|NCT02522494|11245937|FG000|COMPLETED|Overall Study||37
9699203|NCT02842853|10798327|FG000|Safety Analysis Set (SafAS)|Overall Study||895
9699204|NCT02842853|10798328|FG001|Safety Analysis Set (SafAS)|Overall Study||883
9699205|NCT02842853|10798329|FG002|Safety Analysis Set (SafAS)|Overall Study||898
9699206|NCT02842853|10798330|FG003|Safety Analysis Set (SafAS)|Overall Study||635
9962186|NCT01475838|11081744|FG000|NOT COMPLETED|Randomized Phase||30
10026512|NCT01878097|11150603|FG001|STARTED|Implementation Year 3||9750
10026513|NCT01878097|11150602|FG000|COMPLETED|Implementation Year 3||7046
9699207|NCT02842853|10798327|FG000|COMPLETED|Overall Study||879
10115114|NCT02522494|11245938|FG001|COMPLETED|Overall Study||46
9699208|NCT02842853|10798328|FG001|COMPLETED|Overall Study||861
9699209|NCT02842853|10798329|FG002|COMPLETED|Overall Study||885
9699210|NCT02842853|10798330|FG003|COMPLETED|Overall Study||617
9699211|NCT02842853|10798327|FG000|NOT COMPLETED|Overall Study||23
9699212|NCT02842853|10798328|FG001|NOT COMPLETED|Overall Study||34
9699213|NCT02842853|10798329|FG002|NOT COMPLETED|Overall Study||21
9699214|NCT02842853|10798330|FG003|NOT COMPLETED|Overall Study||24
9699215|NCT02752906|10798344|FG000|STARTED|Overall Study||403
9699216|NCT02752906|10798345|FG001|STARTED|Overall Study||407
9699217|NCT02752906|10798344|FG000|Vaccinated|Overall Study||402
9699218|NCT02752906|10798345|FG001|Vaccinated|Overall Study||407
9699219|NCT02752906|10798344|FG000|COMPLETED|Overall Study||396
9699220|NCT02752906|10798345|FG001|COMPLETED|Overall Study||402
9699221|NCT02752906|10798344|FG000|NOT COMPLETED|Overall Study||7
9699222|NCT02752906|10798345|FG001|NOT COMPLETED|Overall Study||5
9699223|NCT02693691|10798351|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234
9699224|NCT02693691|10798351|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184
9699225|NCT02693691|10798351|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
9699226|NCT02693691|10798351|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184
9699227|NCT02693691|10798351|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
9699228|NCT02693691|10798351|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
9699229|NCT02540330|10798357|FG000|STARTED|Overall Study||2
9699230|NCT02540330|10798358|FG001|STARTED|Overall Study||1
9962187|NCT01475838|11081745|FG001|NOT COMPLETED|Randomized Phase||36
9962188|NCT01475838|11081744|FG000|STARTED|Extension Phase||42
9962189|NCT01475838|11081745|FG001|STARTED|Extension Phase||20
9962190|NCT01475838|11081744|FG000|COMPLETED|Extension Phase||41
9962191|NCT01475838|11081745|FG001|COMPLETED|Extension Phase||20
9962192|NCT01475838|11081744|FG000|NOT COMPLETED|Extension Phase||1
9962193|NCT01475838|11081745|FG001|NOT COMPLETED|Extension Phase||0
9962194|NCT01475851|11081754|FG000|STARTED|Overall Study||13
9962195|NCT01475851|11081755|FG001|STARTED|Overall Study||21
9962196|NCT01475851|11081754|FG000|COMPLETED|Overall Study||12
9962197|NCT01475851|11081755|FG001|COMPLETED|Overall Study||21
9962198|NCT01475851|11081754|FG000|NOT COMPLETED|Overall Study||1
9962199|NCT01475851|11081755|FG001|NOT COMPLETED|Overall Study||0
9962200|NCT01475955|11081766|FG000|STARTED|Overall Study||48
9962201|NCT01475955|11081767|FG001|STARTED|Overall Study||48
9962202|NCT01475955|11081768|FG002|STARTED|Overall Study||47
9962203|NCT01475955|11081769|FG003|STARTED|Overall Study||46
9962204|NCT01475955|11081770|FG004|STARTED|Overall Study||46
9962205|NCT01475955|11081766|FG000|COMPLETED|Overall Study||47
9962206|NCT01475955|11081767|FG001|COMPLETED|Overall Study||48
9962207|NCT01475955|11081768|FG002|COMPLETED|Overall Study||44
9962208|NCT01475955|11081769|FG003|COMPLETED|Overall Study||46
9962209|NCT01475955|11081770|FG004|COMPLETED|Overall Study||46
9962210|NCT01475955|11081766|FG000|NOT COMPLETED|Overall Study||1
9962211|NCT01475955|11081767|FG001|NOT COMPLETED|Overall Study||0
9962212|NCT01475955|11081768|FG002|NOT COMPLETED|Overall Study||3
9962213|NCT01475955|11081769|FG003|NOT COMPLETED|Overall Study||0
9962214|NCT01475955|11081770|FG004|NOT COMPLETED|Overall Study||0
9962215|NCT01476202|11081804|FG000|STARTED|Overall Study||40
9962216|NCT01476202|11081805|FG001|STARTED|Overall Study||40
9962217|NCT01476202|11081806|FG002|STARTED|Overall Study||40
9962218|NCT01476202|11081804|FG000|COMPLETED|Overall Study||40
9962219|NCT01476202|11081805|FG001|COMPLETED|Overall Study||40
9962220|NCT01476202|11081806|FG002|COMPLETED|Overall Study||40
9962221|NCT01476202|11081804|FG000|NOT COMPLETED|Overall Study||0
9962222|NCT01476202|11081805|FG001|NOT COMPLETED|Overall Study||0
9962223|NCT01476202|11081806|FG002|NOT COMPLETED|Overall Study||0
9962224|NCT01476267|11081817|FG000|STARTED|Overall Study||6
9962225|NCT01476267|11081817|FG000|COMPLETED|Overall Study||6
9962226|NCT01476267|11081817|FG000|NOT COMPLETED|Overall Study||0
9962227|NCT01476345|11081821|FG000|STARTED|Period 1||40
9962228|NCT01476345|11081822|FG001|STARTED|Period 1||40
9962229|NCT01476345|11081821|FG000|Received at Least 1 Dose of Study Drug|Period 1||40
9962230|NCT01476345|11081822|FG001|Received at Least 1 Dose of Study Drug|Period 1||40
9962231|NCT01476345|11081821|FG000|COMPLETED|Period 1||40
9962232|NCT01476345|11081822|FG001|COMPLETED|Period 1||40
10115115|NCT02522494|11245937|FG000|NOT COMPLETED|Overall Study||14
10115116|NCT02522494|11245938|FG001|NOT COMPLETED|Overall Study||5
10115117|NCT02522624|11245946|FG000|STARTED|Overall Study||165
10115118|NCT02522624|11245947|FG001|STARTED|Overall Study||163
10115119|NCT02522624|11245946|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
10115120|NCT02522624|11245947|FG001|COMPLETED|Overall Study||163
10115121|NCT02522624|11245946|FG000|NOT COMPLETED|Overall Study||1
10115122|NCT02522624|11245947|FG001|NOT COMPLETED|Overall Study||0
10115123|NCT02522728|11245955|FG000|STARTED|Overall Study||28
9699231|NCT02540330|10798357|FG000|COMPLETED|Overall Study||2
9699232|NCT02540330|10798358|FG001|COMPLETED|Overall Study||1
9699233|NCT02540330|10798357|FG000|NOT COMPLETED|Overall Study||0
9699234|NCT02540330|10798358|FG001|NOT COMPLETED|Overall Study||0
9962233|NCT01476345|11081821|FG000|NOT COMPLETED|Period 1||0
9962234|NCT01476345|11081822|FG001|NOT COMPLETED|Period 1||0
9962235|NCT01476345|11081821|FG000|STARTED|Period 2||40
9962236|NCT01476345|11081822|FG001|STARTED|Period 2||40
9962237|NCT01476345|11081821|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
9962238|NCT01476345|11081822|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
9962239|NCT01476345|11081821|FG000|NOT COMPLETED|Period 2||0
9962240|NCT01476345|11081822|FG001|NOT COMPLETED|Period 2||0
9699235|NCT02417701|10798364|FG000|STARTED|Overall Study||34
9699236|NCT02417701|10798364|FG000|COMPLETED|Overall Study||34
9699237|NCT02417701|10798364|FG000|NOT COMPLETED|Overall Study||0
9699238|NCT02388906|10798373|FG000|STARTED|Pre-Treatment Period||453
9699239|NCT02388906|10798374|FG001|STARTED|Pre-Treatment Period||453
9699240|NCT02388906|10798373|FG000|COMPLETED|Pre-Treatment Period||452
9699241|NCT02388906|10798374|FG001|COMPLETED|Pre-Treatment Period||453
9699242|NCT02388906|10798373|FG000|NOT COMPLETED|Pre-Treatment Period||1
9699243|NCT02388906|10798374|FG001|NOT COMPLETED|Pre-Treatment Period||0
9699244|NCT02388906|10798373|FG000|STARTED|Treatment Period||452
9699245|NCT02388906|10798374|FG001|STARTED|Treatment Period||453
9699246|NCT02388906|10798373|FG000|COMPLETED|Treatment Period||275
9699247|NCT02388906|10798374|FG001|COMPLETED|Treatment Period||122
9699248|NCT02388906|10798373|FG000|NOT COMPLETED|Treatment Period||177
9699249|NCT02388906|10798374|FG001|NOT COMPLETED|Treatment Period||331
9699250|NCT02384993|10798382|FG000|STARTED|Overall Study||12
9699251|NCT02384993|10798383|FG001|STARTED|Overall Study||12
9699252|NCT02384993|10798382|FG000|COMPLETED|Overall Study||12
9699253|NCT02384993|10798383|FG001|COMPLETED|Overall Study||11
9699254|NCT02384993|10798382|FG000|NOT COMPLETED|Overall Study||0
9699255|NCT02384993|10798383|FG001|NOT COMPLETED|Overall Study||1
9727973|NCT00111228|10827652|FG001|NOT COMPLETED|Overall Study||1
9727974|NCT00111228|10827653|FG002|NOT COMPLETED|Overall Study||0
9727975|NCT00111241|10827663|FG000|STARTED|Overall Study||45
9727976|NCT00111241|10827664|FG001|STARTED|Overall Study||70
9727977|NCT00111241|10827663|FG000|COMPLETED|Overall Study||30
9727978|NCT00111241|10827664|FG001|COMPLETED|Overall Study||62
9727979|NCT00111241|10827663|FG000|NOT COMPLETED|Overall Study||15
9727980|NCT00111241|10827664|FG001|NOT COMPLETED|Overall Study||8
9727981|NCT00111475|10827682|FG000|STARTED|Overall Study||4
9727982|NCT00111475|10827683|FG001|STARTED|Overall Study||4
9699256|NCT02304302|10798392|FG000|STARTED|Overall Study||79
9699257|NCT02304302|10798393|FG001|STARTED|Overall Study||81
9699258|NCT02304302|10798392|FG000|COMPLETED|Overall Study||76
9699259|NCT02304302|10798393|FG001|COMPLETED|Overall Study||73
9699260|NCT02304302|10798392|FG000|NOT COMPLETED|Overall Study||3
9699261|NCT02304302|10798393|FG001|NOT COMPLETED|Overall Study||8
9699262|NCT02269670|10798403|FG000|STARTED|Overall Study||3
9699263|NCT02269670|10798403|FG000|COMPLETED|Overall Study||0
9699264|NCT02269670|10798403|FG000|NOT COMPLETED|Overall Study||3
9699265|NCT02086175|10798407|FG000|STARTED|Overall Study||25
9962241|NCT01476345|11081821|FG000|STARTED|Period 3||39
9962242|NCT01476345|11081822|FG001|STARTED|Period 3||39
9962243|NCT01476345|11081821|FG000|COMPLETED|Period 3||39
9962244|NCT01476345|11081822|FG001|COMPLETED|Period 3||39
9962245|NCT01476345|11081821|FG000|NOT COMPLETED|Period 3||0
9962246|NCT01476345|11081822|FG001|NOT COMPLETED|Period 3||0
9962247|NCT01476345|11081821|FG000|STARTED|Period 4||39
9962248|NCT01476345|11081822|FG001|STARTED|Period 4||39
9962249|NCT01476345|11081821|FG000|COMPLETED|Period 4||39
9962250|NCT01476345|11081822|FG001|COMPLETED|Period 4||39
9962251|NCT01476345|11081821|FG000|NOT COMPLETED|Period 4||0
9962252|NCT01476345|11081822|FG001|NOT COMPLETED|Period 4||0
9962253|NCT01476449|11081830|FG000|STARTED|Overall Study||10
9962254|NCT01476449|11081831|FG001|STARTED|Overall Study||10
9699266|NCT02086175|10798407|FG000|COMPLETED|Overall Study||25
9962255|NCT01476449|11081830|FG000|COMPLETED|Overall Study||8
9962256|NCT01476449|11081831|FG001|COMPLETED|Overall Study||8
9699267|NCT02086175|10798407|FG000|NOT COMPLETED|Overall Study||0
9699268|NCT01860976|10798413|FG000|STARTED|Blinded Treatment||213
9699269|NCT01860976|10798414|FG001|STARTED|Blinded Treatment||211
9699270|NCT01860976|10798413|FG000|COMPLETED|Blinded Treatment||125
9699271|NCT01860976|10798414|FG001|COMPLETED|Blinded Treatment||98
9699272|NCT01860976|10798413|FG000|NOT COMPLETED|Blinded Treatment||88
9699273|NCT01860976|10798414|FG001|NOT COMPLETED|Blinded Treatment||113
9699274|NCT01860976|10798413|FG000|STARTED|Open-Label||197
9699275|NCT01860976|10798414|FG001|STARTED|Open-Label||185
9699276|NCT01860976|10798413|FG000|COMPLETED|Open-Label||169
9699277|NCT01860976|10798414|FG001|COMPLETED|Open-Label||166
9699278|NCT01860976|10798413|FG000|NOT COMPLETED|Open-Label||28
9699279|NCT01860976|10798414|FG001|NOT COMPLETED|Open-Label||19
9699280|NCT01860976|10798413|FG000|STARTED|Long Term Extension||106
9699281|NCT01860976|10798414|FG001|STARTED|Long Term Extension||0
9699282|NCT01860976|10798413|FG000|COMPLETED|Long Term Extension||81
9699283|NCT01860976|10798414|FG001|COMPLETED|Long Term Extension||0
9699284|NCT01860976|10798413|FG000|NOT COMPLETED|Long Term Extension||25
9699285|NCT01860976|10798414|FG001|NOT COMPLETED|Long Term Extension||0
9699286|NCT01761266|10798425|FG000|STARTED|Overall Study||478
9699287|NCT01761266|10798426|FG001|STARTED|Overall Study||476
9699288|NCT01761266|10798425|FG000|Treated|Overall Study||476
9699289|NCT01761266|10798426|FG001|Treated|Overall Study||475
9699290|NCT01761266|10798425|FG000|COMPLETED|Overall Study||0
9699291|NCT01761266|10798426|FG001|COMPLETED|Overall Study||0
9699292|NCT01761266|10798425|FG000|NOT COMPLETED|Overall Study||478
9699293|NCT01761266|10798426|FG001|NOT COMPLETED|Overall Study||476
9699294|NCT01550289|10798437|FG000|STARTED|Overall Study||128
9699295|NCT01550289|10798438|FG001|STARTED|Overall Study||61
9699296|NCT01550289|10798437|FG000|COMPLETED|Overall Study||115
9699297|NCT01550289|10798438|FG001|COMPLETED|Overall Study||57
9699298|NCT01550289|10798437|FG000|NOT COMPLETED|Overall Study||13
9699299|NCT01550289|10798438|FG001|NOT COMPLETED|Overall Study||4
9699300|NCT01346709|10798446|FG000|STARTED|Overall Study||5450
9699301|NCT01346709|10798446|FG000|COMPLETED|Overall Study||5099
9699302|NCT01346709|10798446|FG000|NOT COMPLETED|Overall Study||351
9699303|NCT01081951|10798452|FG000|STARTED|Overall Study||81
9699304|NCT01081951|10798453|FG001|STARTED|Overall Study||81
9962257|NCT01476449|11081830|FG000|NOT COMPLETED|Overall Study||2
9962258|NCT01476449|11081831|FG001|NOT COMPLETED|Overall Study||2
9962259|NCT01476475|11081839|FG000|STARTED|Overall Study||161
9962260|NCT01476475|11081840|FG001|STARTED|Overall Study||162
9962261|NCT01476475|11081839|FG000|COMPLETED|Overall Study||150
9962262|NCT01476475|11081840|FG001|COMPLETED|Overall Study||159
9962263|NCT01476475|11081839|FG000|NOT COMPLETED|Overall Study||11
9962264|NCT01476475|11081840|FG001|NOT COMPLETED|Overall Study||3
9962265|NCT01476644|11081847|FG000|STARTED|Overall Study||161
9962266|NCT01476644|11081847|FG000|COMPLETED|Overall Study||122
9962267|NCT01476644|11081847|FG000|NOT COMPLETED|Overall Study||39
9962268|NCT01476696|11081852|FG000|STARTED|Overall Study||15
9962269|NCT01476696|11081853|FG001|STARTED|Overall Study||9
9962270|NCT01476696|11081854|FG002|STARTED|Overall Study||9
9962271|NCT01476696|11081852|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
9962272|NCT01476696|11081853|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
9962273|NCT01476696|11081854|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
9699305|NCT01081951|10798452|FG000|Received Study Treatment|Overall Study||81
9699306|NCT01081951|10798453|FG001|Received Study Treatment|Overall Study||75
9699307|NCT01081951|10798452|FG000|Entered Maintenance Phase|Overall Study||66
9699308|NCT01081951|10798453|FG001|Entered Maintenance Phase|Overall Study||55
9699309|NCT01081951|10798452|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11
9699310|NCT01081951|10798453|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0
9699311|NCT01081951|10798452|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
9699312|NCT01081951|10798453|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
9699313|NCT01081951|10798452|FG000|NOT COMPLETED|Overall Study||56
9699314|NCT01081951|10798453|FG001|NOT COMPLETED|Overall Study||55
9699315|NCT01074190|10798462|FG000|STARTED|Overall Study||115
9699316|NCT01074190|10798463|FG001|STARTED|Overall Study||115
9699317|NCT01074190|10798464|FG002|STARTED|Overall Study||115
9699318|NCT01074190|10798462|FG000|COMPLETED|Overall Study||111
9699319|NCT01074190|10798463|FG001|COMPLETED|Overall Study||109
9699320|NCT01074190|10798464|FG002|COMPLETED|Overall Study||112
9699321|NCT01074190|10798462|FG000|NOT COMPLETED|Overall Study||4
9699322|NCT01074190|10798463|FG001|NOT COMPLETED|Overall Study||6
9699323|NCT01074190|10798464|FG002|NOT COMPLETED|Overall Study||3
9699324|NCT00875524|10798477|FG000|STARTED|Overall Study||120
9699325|NCT00875524|10798478|FG001|STARTED|Overall Study||60
9699326|NCT00875524|10798477|FG000|Received Vaccination 1|Overall Study||120
9699327|NCT00875524|10798478|FG001|Received Vaccination 1|Overall Study||60
9699328|NCT00875524|10798477|FG000|Received Vaccination 2|Overall Study||116
9699329|NCT00875524|10798478|FG001|Received Vaccination 2|Overall Study||58
9699330|NCT00875524|10798477|FG000|Received Vaccination 3|Overall Study||114
9699331|NCT00875524|10798478|FG001|Received Vaccination 3|Overall Study||58
9699332|NCT00875524|10798477|FG000|COMPLETED|Overall Study||112
9699333|NCT00875524|10798478|FG001|COMPLETED|Overall Study||54
9699334|NCT00875524|10798477|FG000|NOT COMPLETED|Overall Study||8
9699335|NCT00875524|10798478|FG001|NOT COMPLETED|Overall Study||6
9699336|NCT00842530|10798486|FG000|STARTED|Overall Study||2669
9699337|NCT00842530|10798487|FG001|STARTED|Overall Study||1333
9699338|NCT00842530|10798486|FG000|Received Vaccination 1|Overall Study||2666
9699339|NCT00842530|10798487|FG001|Received Vaccination 1|Overall Study||1331
9699340|NCT00842530|10798486|FG000|Received Vaccination 2|Overall Study||2584
9699341|NCT00842530|10798487|FG001|Received Vaccination 2|Overall Study||1300
9699342|NCT00842530|10798486|FG000|Received Vaccination 3|Overall Study||2557
9699343|NCT00842530|10798487|FG001|Received Vaccination 3|Overall Study||1282
9699344|NCT00842530|10798486|FG000|COMPLETED|Overall Study||2552
9699345|NCT00842530|10798487|FG001|COMPLETED|Overall Study||1276
9699346|NCT00842530|10798486|FG000|NOT COMPLETED|Overall Study||117
9699347|NCT00842530|10798487|FG001|NOT COMPLETED|Overall Study||57
9699348|NCT00788151|10798496|FG000|STARTED|Overall Study||200
9699349|NCT00788151|10798497|FG001|STARTED|Overall Study||100
9699350|NCT00788151|10798496|FG000|Received Vaccination 1|Overall Study||199
9699351|NCT00788151|10798497|FG001|Received Vaccination 1|Overall Study||99
9699352|NCT00788151|10798496|FG000|Received Vaccination 2|Overall Study||188
9699353|NCT00788151|10798497|FG001|Received Vaccination 2|Overall Study||92
9699354|NCT00788151|10798496|FG000|Received Vaccination 3|Overall Study||186
9699355|NCT00788151|10798497|FG001|Received Vaccination 3|Overall Study||90
9699356|NCT00788151|10798496|FG000|COMPLETED|Overall Study||186
9699357|NCT00788151|10798497|FG001|COMPLETED|Overall Study||90
9699358|NCT00788151|10798496|FG000|NOT COMPLETED|Overall Study||14
9699359|NCT00788151|10798497|FG001|NOT COMPLETED|Overall Study||10
9699360|NCT00539591|10798506|FG000|STARTED|Overall Study||23
9699361|NCT00539591|10798507|FG001|STARTED|Overall Study||2
9699362|NCT00539591|10798508|FG002|STARTED|Overall Study||4
9699363|NCT00539591|10798506|FG000|COMPLETED|Overall Study||18
9699364|NCT00539591|10798507|FG001|COMPLETED|Overall Study||0
9699365|NCT00539591|10798508|FG002|COMPLETED|Overall Study||1
9699366|NCT00539591|10798506|FG000|NOT COMPLETED|Overall Study||5
9699367|NCT00539591|10798507|FG001|NOT COMPLETED|Overall Study||2
9699368|NCT00539591|10798508|FG002|NOT COMPLETED|Overall Study||3
9727983|NCT00111475|10827684|FG002|STARTED|Overall Study||4
9727984|NCT00111475|10827685|FG003|STARTED|Overall Study||4
9727985|NCT00111475|10827686|FG004|STARTED|Overall Study||4
9727986|NCT00111475|10827687|FG005|STARTED|Overall Study||4
9727987|NCT00111475|10827688|FG006|STARTED|Overall Study||4
9727988|NCT00111475|10827689|FG007|STARTED|Overall Study||8
9727989|NCT00111475|10827690|FG008|STARTED|Overall Study||8
10026514|NCT01878097|11150603|FG001|COMPLETED|Implementation Year 3||6770
10026515|NCT01878097|11150602|FG000|NOT COMPLETED|Implementation Year 3||3494
10026516|NCT01878097|11150603|FG001|NOT COMPLETED|Implementation Year 3||2980
10026517|NCT01878097|11150602|FG000|STARTED|Implementation Year 4||10585
10026518|NCT01878097|11150603|FG001|STARTED|Implementation Year 4||9614
10026519|NCT01878097|11150602|FG000|COMPLETED|Implementation Year 4||6981
9699369|NCT04794751|10798544|FG000|STARTED|Period 1||38
9699370|NCT04794751|10798545|FG001|STARTED|Period 1||37
9699371|NCT04794751|10798544|FG000|COMPLETED|Period 1||36
9699372|NCT04794751|10798545|FG001|COMPLETED|Period 1||32
9699373|NCT04794751|10798544|FG000|NOT COMPLETED|Period 1||2
9699374|NCT04794751|10798545|FG001|NOT COMPLETED|Period 1||5
9699375|NCT04794751|10798544|FG000|STARTED|Period 2||36
9699376|NCT04794751|10798545|FG001|STARTED|Period 2||32
9699377|NCT04794751|10798544|FG000|COMPLETED|Period 2||35
9699378|NCT04794751|10798545|FG001|COMPLETED|Period 2||29
9699379|NCT04794751|10798544|FG000|NOT COMPLETED|Period 2||1
9699380|NCT04794751|10798545|FG001|NOT COMPLETED|Period 2||3
9847730|NCT00855816|10960320|FG000|STARTED|Overall Study||47
9847731|NCT00855816|10960321|FG001|STARTED|Overall Study||33
9847732|NCT00855816|10960320|FG000|COMPLETED|Overall Study||21
9847733|NCT00855816|10960321|FG001|COMPLETED|Overall Study||12
9847734|NCT00855816|10960320|FG000|NOT COMPLETED|Overall Study||26
9847735|NCT00855816|10960321|FG001|NOT COMPLETED|Overall Study||21
9847736|NCT00855842|10960327|FG000|STARTED|Overall Study||4
9962274|NCT01476696|11081852|FG000|COMPLETED|Overall Study||12
9962275|NCT01476696|11081853|FG001|COMPLETED|Overall Study||8
9962276|NCT01476696|11081854|FG002|COMPLETED|Overall Study||9
9962277|NCT01476696|11081852|FG000|NOT COMPLETED|Overall Study||3
9962278|NCT01476696|11081853|FG001|NOT COMPLETED|Overall Study||1
9962279|NCT01476696|11081854|FG002|NOT COMPLETED|Overall Study||0
9962280|NCT01476722|11081867|FG000|STARTED|Overall Study||125
9962281|NCT01476722|11081867|FG000|COMPLETED|Overall Study||124
9962282|NCT01476722|11081867|FG000|NOT COMPLETED|Overall Study||1
9962283|NCT01476748|11081874|FG000|STARTED|Overall Study||5
9962284|NCT01476748|11081875|FG001|STARTED|Overall Study||5
9962285|NCT01476748|11081876|FG002|STARTED|Overall Study||5
9962286|NCT01476748|11081874|FG000|COMPLETED|Overall Study||5
9962287|NCT01476748|11081875|FG001|COMPLETED|Overall Study||5
9962288|NCT01476748|11081876|FG002|COMPLETED|Overall Study||5
9962289|NCT01476748|11081874|FG000|NOT COMPLETED|Overall Study||0
9962290|NCT01476748|11081875|FG001|NOT COMPLETED|Overall Study||0
9962291|NCT01476748|11081876|FG002|NOT COMPLETED|Overall Study||0
9962292|NCT01477320|11081886|FG000|STARTED|Overall Study||62
9962293|NCT01477320|11081887|FG001|STARTED|Overall Study||62
9962294|NCT01477320|11081886|FG000|COMPLETED|Overall Study||55
9699381|NCT04794751|10798544|FG000|STARTED|Period 3||35
9699382|NCT04794751|10798545|FG001|STARTED|Period 3||29
9847737|NCT00855842|10960327|FG000|COMPLETED|Overall Study||4
9847738|NCT00855842|10960327|FG000|NOT COMPLETED|Overall Study||0
9847739|NCT00855868|10960333|FG000|STARTED|Overall Study||13
9962295|NCT01477320|11081887|FG001|COMPLETED|Overall Study||47
9962296|NCT01477320|11081886|FG000|NOT COMPLETED|Overall Study||7
9699383|NCT04794751|10798544|FG000|COMPLETED|Period 3||35
9699384|NCT04794751|10798545|FG001|COMPLETED|Period 3||29
9699385|NCT04794751|10798544|FG000|NOT COMPLETED|Period 3||0
9699386|NCT04794751|10798545|FG001|NOT COMPLETED|Period 3||0
9699387|NCT04584645|10798553|FG000|STARTED|Overall Study||24570
9699388|NCT04584645|10798554|FG001|STARTED|Overall Study||24568
9699389|NCT04584645|10798553|FG000|COMPLETED|Overall Study||5575
9699390|NCT04584645|10798554|FG001|COMPLETED|Overall Study||5662
9699391|NCT04584645|10798553|FG000|NOT COMPLETED|Overall Study||18995
9699392|NCT04584645|10798554|FG001|NOT COMPLETED|Overall Study||18906
9699393|NCT04538170|10798580|FG000|STARTED|Overall Study||158
9699394|NCT04538170|10798581|FG001|STARTED|Overall Study||265
9699395|NCT04538170|10798580|FG000|COMPLETED|Overall Study||54
9699396|NCT04538170|10798581|FG001|COMPLETED|Overall Study||55
9699397|NCT04538170|10798580|FG000|NOT COMPLETED|Overall Study||104
9699398|NCT04538170|10798581|FG001|NOT COMPLETED|Overall Study||210
9699399|NCT04461015|10798593|FG000|STARTED|Overall Study||5
9699400|NCT04461015|10798594|FG001|STARTED|Overall Study||7
9699401|NCT04461015|10798593|FG000|COMPLETED|Overall Study||5
9699402|NCT04461015|10798594|FG001|COMPLETED|Overall Study||5
9699403|NCT04461015|10798593|FG000|NOT COMPLETED|Overall Study||0
9699404|NCT04461015|10798594|FG001|NOT COMPLETED|Overall Study||2
9699405|NCT04380961|10798602|FG000|STARTED|Overall Study||140
9699406|NCT04380961|10798603|FG001|STARTED|Overall Study||72
9699407|NCT04380961|10798602|FG000|Treated|Overall Study||139
9699408|NCT04380961|10798603|FG001|Treated|Overall Study||70
9699409|NCT04380961|10798602|FG000|Participants Who Entered the Follow-up Phase|Overall Study||118
9699410|NCT04380961|10798603|FG001|Participants Who Entered the Follow-up Phase|Overall Study||57
9699411|NCT04380961|10798602|FG000|COMPLETED|Overall Study||96
9699412|NCT04380961|10798603|FG001|COMPLETED|Overall Study||43
9699413|NCT04380961|10798602|FG000|NOT COMPLETED|Overall Study||44
9699414|NCT04380961|10798603|FG001|NOT COMPLETED|Overall Study||29
10026520|NCT01878097|11150603|FG001|COMPLETED|Implementation Year 4||6607
10026521|NCT01878097|11150602|FG000|NOT COMPLETED|Implementation Year 4||3604
10026522|NCT01878097|11150603|FG001|NOT COMPLETED|Implementation Year 4||3007
10026523|NCT01878149|11150611|FG000|STARTED|Overall Study||21
10026524|NCT01878149|11150612|FG001|STARTED|Overall Study||17
10026525|NCT01878149|11150611|FG000|COMPLETED|Overall Study||19
10026526|NCT01878149|11150612|FG001|COMPLETED|Overall Study||15
10026527|NCT01878149|11150611|FG000|NOT COMPLETED|Overall Study||2
10026528|NCT01878149|11150612|FG001|NOT COMPLETED|Overall Study||2
10026529|NCT01878175|11150618|FG000|STARTED|Overall Study||15
10026530|NCT01878175|11150618|FG000|COMPLETED|Overall Study||13
10026531|NCT01878175|11150618|FG000|NOT COMPLETED|Overall Study||2
10026532|NCT01878214|11150625|FG000|STARTED|Overall Study||223
10026533|NCT01878214|11150626|FG001|STARTED|Overall Study||219
10026534|NCT01878214|11150625|FG000|COMPLETED|Overall Study||170
9699424|NCT04341441|10798631|FG000|STARTED|Overall Study||197
9699425|NCT04341441|10798632|FG001|STARTED|Overall Study||201
9699426|NCT04341441|10798633|FG002|STARTED|Overall Study||200
9699427|NCT04341441|10798634|FG003|STARTED|Overall Study||26
9699428|NCT04341441|10798631|FG000|COMPLETED|Overall Study||188
9699429|NCT04341441|10798632|FG001|COMPLETED|Overall Study||199
9699430|NCT04341441|10798633|FG002|COMPLETED|Overall Study||191
9699431|NCT04341441|10798634|FG003|COMPLETED|Overall Study||26
9699432|NCT04341441|10798631|FG000|NOT COMPLETED|Overall Study||9
9699433|NCT04341441|10798632|FG001|NOT COMPLETED|Overall Study||2
9699434|NCT04341441|10798633|FG002|NOT COMPLETED|Overall Study||9
9699435|NCT04341441|10798634|FG003|NOT COMPLETED|Overall Study||0
9699436|NCT04332419|10798644|FG000|STARTED|Overall Study||11
9699437|NCT04332419|10798644|FG000|COMPLETED|Overall Study||10
9699438|NCT04332419|10798644|FG000|NOT COMPLETED|Overall Study||1
9699439|NCT04239872|10798648|FG000|STARTED|Overall Study||11
9699440|NCT04239872|10798649|FG001|STARTED|Overall Study||9
9699441|NCT04239872|10798648|FG000|COMPLETED|Overall Study||11
9699442|NCT04239872|10798649|FG001|COMPLETED|Overall Study||8
9699443|NCT04239872|10798648|FG000|NOT COMPLETED|Overall Study||0
9699444|NCT04239872|10798649|FG001|NOT COMPLETED|Overall Study||1
9699445|NCT04141917|10798657|FG000|STARTED|Surveillance Year 1||63
9699446|NCT04141917|10798658|FG001|STARTED|Surveillance Year 1||76
9699447|NCT04141917|10798659|FG002|STARTED|Surveillance Year 1||81
9699448|NCT04141917|10798660|FG003|STARTED|Surveillance Year 1||324
9699449|NCT04141917|10798657|FG000|COMPLETED|Surveillance Year 1||63
9699450|NCT04141917|10798658|FG001|COMPLETED|Surveillance Year 1||76
9699451|NCT04141917|10798659|FG002|COMPLETED|Surveillance Year 1||81
9699452|NCT04141917|10798660|FG003|COMPLETED|Surveillance Year 1||324
9699453|NCT04141917|10798657|FG000|NOT COMPLETED|Surveillance Year 1||0
9699454|NCT04141917|10798658|FG001|NOT COMPLETED|Surveillance Year 1||0
9699455|NCT04141917|10798659|FG002|NOT COMPLETED|Surveillance Year 1||0
9699456|NCT04141917|10798660|FG003|NOT COMPLETED|Surveillance Year 1||0
9699457|NCT04141917|10798657|FG000|STARTED|Surveillance + Test and Treat Year 1||358
9962297|NCT01477320|11081887|FG001|NOT COMPLETED|Overall Study||15
9962298|NCT01477333|11081893|FG000|STARTED|Overall Study||18
9962299|NCT01477333|11081893|FG000|COMPLETED|Overall Study||15
9962300|NCT01477333|11081893|FG000|NOT COMPLETED|Overall Study||3
9699458|NCT04141917|10798658|FG001|STARTED|Surveillance + Test and Treat Year 1||153
9962301|NCT01477450|11081904|FG000|STARTED|Overall Study||10
9699459|NCT04141917|10798659|FG002|STARTED|Surveillance + Test and Treat Year 1||82
9699460|NCT04141917|10798660|FG003|STARTED|Surveillance + Test and Treat Year 1||83
9699461|NCT04141917|10798657|FG000|COMPLETED|Surveillance + Test and Treat Year 1||358
9699462|NCT04141917|10798658|FG001|COMPLETED|Surveillance + Test and Treat Year 1||153
9699463|NCT04141917|10798659|FG002|COMPLETED|Surveillance + Test and Treat Year 1||82
9699464|NCT04141917|10798660|FG003|COMPLETED|Surveillance + Test and Treat Year 1||83
9699465|NCT04141917|10798657|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
9699466|NCT04141917|10798658|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
9699467|NCT04141917|10798659|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
9699468|NCT04141917|10798660|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
9699469|NCT04141917|10798657|FG000|STARTED|Summer Surveillance||73
9699470|NCT04141917|10798658|FG001|STARTED|Summer Surveillance||39
9699471|NCT04141917|10798659|FG002|STARTED|Summer Surveillance||54
9699472|NCT04141917|10798660|FG003|STARTED|Summer Surveillance||20
9699473|NCT04141917|10798657|FG000|COMPLETED|Summer Surveillance||73
9699474|NCT04141917|10798658|FG001|COMPLETED|Summer Surveillance||39
9699475|NCT04141917|10798659|FG002|COMPLETED|Summer Surveillance||54
9699476|NCT04141917|10798660|FG003|COMPLETED|Summer Surveillance||20
9699477|NCT04141917|10798657|FG000|NOT COMPLETED|Summer Surveillance||0
9699478|NCT04141917|10798658|FG001|NOT COMPLETED|Summer Surveillance||0
9699479|NCT04141917|10798659|FG002|NOT COMPLETED|Summer Surveillance||0
9699480|NCT04141917|10798660|FG003|NOT COMPLETED|Summer Surveillance||0
9699481|NCT04141917|10798657|FG000|STARTED|Surveillance Year 2||3
9699482|NCT04141917|10798658|FG001|STARTED|Surveillance Year 2||3
9699483|NCT04141917|10798659|FG002|STARTED|Surveillance Year 2||10
9699484|NCT04141917|10798660|FG003|STARTED|Surveillance Year 2||7
9699485|NCT04141917|10798657|FG000|COMPLETED|Surveillance Year 2||3
9699486|NCT04141917|10798658|FG001|COMPLETED|Surveillance Year 2||3
9699487|NCT04141917|10798659|FG002|COMPLETED|Surveillance Year 2||10
9699488|NCT04141917|10798660|FG003|COMPLETED|Surveillance Year 2||7
9699489|NCT04141917|10798657|FG000|NOT COMPLETED|Surveillance Year 2||0
9699490|NCT04141917|10798658|FG001|NOT COMPLETED|Surveillance Year 2||0
9699491|NCT04141917|10798659|FG002|NOT COMPLETED|Surveillance Year 2||0
9699492|NCT04141917|10798660|FG003|NOT COMPLETED|Surveillance Year 2||0
9699493|NCT04141917|10798657|FG000|STARTED|Surveillance + Test and Treat Year 2||62
9699494|NCT04141917|10798658|FG001|STARTED|Surveillance + Test and Treat Year 2||13
9699495|NCT04141917|10798659|FG002|STARTED|Surveillance + Test and Treat Year 2||3
9699496|NCT04141917|10798660|FG003|STARTED|Surveillance + Test and Treat Year 2||3
9699497|NCT04141917|10798657|FG000|COMPLETED|Surveillance + Test and Treat Year 2||62
9699498|NCT04141917|10798658|FG001|COMPLETED|Surveillance + Test and Treat Year 2||13
9699499|NCT04141917|10798659|FG002|COMPLETED|Surveillance + Test and Treat Year 2||3
9699500|NCT04141917|10798660|FG003|COMPLETED|Surveillance + Test and Treat Year 2||3
9699501|NCT04141917|10798657|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
9699502|NCT04141917|10798658|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
9699503|NCT04141917|10798659|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
9699504|NCT04141917|10798660|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
9699505|NCT04128696|10798668|FG000|STARTED|Overall Study||158
9699506|NCT04128696|10798669|FG001|STARTED|Overall Study||157
9699507|NCT04128696|10798668|FG000|Modified Intent to Treat (mITT) Population|Overall Study||157
9699508|NCT04128696|10798669|FG001|Modified Intent to Treat (mITT) Population|Overall Study||156
9699509|NCT04128696|10798668|FG000|Safety Population|Overall Study||159
9699510|NCT04128696|10798669|FG001|Safety Population|Overall Study||156
9699511|NCT04128696|10798668|FG000|COMPLETED|Overall Study||51
9699512|NCT04128696|10798669|FG001|COMPLETED|Overall Study||38
9699513|NCT04128696|10798668|FG000|NOT COMPLETED|Overall Study||107
9962302|NCT01477450|11081905|FG001|STARTED|Overall Study||10
9962303|NCT01477450|11081906|FG002|STARTED|Overall Study||10
9962304|NCT01477450|11081904|FG000|COMPLETED|Overall Study||10
9962305|NCT01477450|11081905|FG001|COMPLETED|Overall Study||10
9962306|NCT01477450|11081906|FG002|COMPLETED|Overall Study||10
9962307|NCT01477450|11081904|FG000|NOT COMPLETED|Overall Study||0
9962308|NCT01477450|11081905|FG001|NOT COMPLETED|Overall Study||0
9962309|NCT01477450|11081906|FG002|NOT COMPLETED|Overall Study||0
9962310|NCT01477463|11081916|FG000|STARTED|Overall Study||18
9962311|NCT01477463|11081917|FG001|STARTED|Overall Study||6
10115124|NCT02522728|11245956|FG001|STARTED|Overall Study||30
10115125|NCT02522728|11245955|FG000|COMPLETED|Overall Study||16
10115126|NCT02522728|11245956|FG001|COMPLETED|Overall Study||19
10115127|NCT02522728|11245955|FG000|NOT COMPLETED|Overall Study||12
10115128|NCT02522728|11245956|FG001|NOT COMPLETED|Overall Study||11
10115129|NCT02522767|11245964|FG000|STARTED|Double-blind||114
10115130|NCT02522767|11245965|FG001|STARTED|Double-blind||114
10115131|NCT02522767|11245964|FG000|COMPLETED|Double-blind||103
10115132|NCT02522767|11245965|FG001|COMPLETED|Double-blind||90
10115133|NCT02522767|11245964|FG000|NOT COMPLETED|Double-blind||11
10115134|NCT02522767|11245965|FG001|NOT COMPLETED|Double-blind||24
10115135|NCT02522767|11245964|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
9699514|NCT04128696|10798669|FG001|NOT COMPLETED|Overall Study||119
9699515|NCT04091581|10798677|FG000|STARTED|Overall Study||10
9699516|NCT04091581|10798678|FG001|STARTED|Overall Study||11
9962312|NCT01477463|11081916|FG000|COMPLETED|Overall Study||18
9962313|NCT01477463|11081917|FG001|COMPLETED|Overall Study||6
9962314|NCT01477463|11081916|FG000|NOT COMPLETED|Overall Study||0
9699517|NCT04091581|10798677|FG000|COMPLETED|Overall Study||10
9699518|NCT04091581|10798678|FG001|COMPLETED|Overall Study||10
9699519|NCT04091581|10798677|FG000|NOT COMPLETED|Overall Study||0
9699520|NCT04091581|10798678|FG001|NOT COMPLETED|Overall Study||1
9699521|NCT03986671|10798687|FG000|STARTED|Overall Study||36
9699522|NCT03986671|10798688|FG001|STARTED|Overall Study||9
9699523|NCT03986671|10798689|FG002|STARTED|Overall Study||5
9699524|NCT03986671|10798687|FG000|Passed a Screening Visit With ENT|Overall Study||6
9699525|NCT03986671|10798688|FG001|Passed a Screening Visit With ENT|Overall Study||5
9699526|NCT03986671|10798689|FG002|Passed a Screening Visit With ENT|Overall Study||5
9699527|NCT03986671|10798687|FG000|COMPLETED|Overall Study||6
9699528|NCT03986671|10798688|FG001|COMPLETED|Overall Study||5
9699529|NCT03986671|10798689|FG002|COMPLETED|Overall Study||5
9699530|NCT03986671|10798687|FG000|NOT COMPLETED|Overall Study||30
9699531|NCT03986671|10798688|FG001|NOT COMPLETED|Overall Study||4
9962315|NCT01477463|11081917|FG001|NOT COMPLETED|Overall Study||0
9962316|NCT01477567|11081932|FG000|STARTED|Overall Study||5
9962317|NCT01477567|11081933|FG001|STARTED|Overall Study||6
9962318|NCT01477567|11081934|FG002|STARTED|Overall Study||6
9962319|NCT01477567|11081935|FG003|STARTED|Overall Study||6
9962320|NCT01477567|11081936|FG004|STARTED|Overall Study||6
9962321|NCT01477567|11081937|FG005|STARTED|Overall Study||5
9962322|NCT01477567|11081938|FG006|STARTED|Overall Study||6
9962323|NCT01477567|11081932|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5
9962324|NCT01477567|11081933|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9962325|NCT01477567|11081934|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9962326|NCT01477567|11081935|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9962327|NCT01477567|11081936|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
9962328|NCT01477567|11081937|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
9962329|NCT01477567|11081938|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
9962330|NCT01477567|11081932|FG000|COMPLETED|Overall Study||5
9962331|NCT01477567|11081933|FG001|COMPLETED|Overall Study||6
9962332|NCT01477567|11081934|FG002|COMPLETED|Overall Study||6
9962333|NCT01477567|11081935|FG003|COMPLETED|Overall Study||6
9962334|NCT01477567|11081936|FG004|COMPLETED|Overall Study||6
9962335|NCT01477567|11081937|FG005|COMPLETED|Overall Study||5
9962336|NCT01477567|11081938|FG006|COMPLETED|Overall Study||6
9962337|NCT01477567|11081932|FG000|NOT COMPLETED|Overall Study||0
9962338|NCT01477567|11081933|FG001|NOT COMPLETED|Overall Study||0
9962339|NCT01477567|11081934|FG002|NOT COMPLETED|Overall Study||0
9962340|NCT01477567|11081935|FG003|NOT COMPLETED|Overall Study||0
9962341|NCT01477567|11081936|FG004|NOT COMPLETED|Overall Study||0
9962342|NCT01477567|11081937|FG005|NOT COMPLETED|Overall Study||0
9962343|NCT01477567|11081938|FG006|NOT COMPLETED|Overall Study||0
9962344|NCT01477710|11081959|FG000|STARTED|Overall Study||30
9962345|NCT01477710|11081959|FG000|COMPLETED|Overall Study||30
9962346|NCT01477710|11081959|FG000|NOT COMPLETED|Overall Study||0
9962347|NCT01477749|11081967|FG000|STARTED|Overall Study||47
9962348|NCT01477749|11081967|FG000|COMPLETED|Overall Study||43
9962349|NCT01477749|11081967|FG000|NOT COMPLETED|Overall Study||4
9962350|NCT01477762|11081975|FG000|STARTED|Overall Study||25
9962351|NCT01477762|11081976|FG001|STARTED|Overall Study||33
10115136|NCT02522767|11245965|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
10115137|NCT02522767|11245964|FG000|COMPLETED|Open-label||83
10115138|NCT02522767|11245965|FG001|COMPLETED|Open-label||75
10115139|NCT02522767|11245964|FG000|NOT COMPLETED|Open-label||5
10115140|NCT02522767|11245965|FG001|NOT COMPLETED|Open-label||7
10115141|NCT02522780|11245975|FG000|STARTED|Overall Study||138
10115142|NCT02522780|11245976|FG001|STARTED|Overall Study||138
10115143|NCT02522780|11245975|FG000|Treated|Overall Study||137
10115144|NCT02522780|11245976|FG001|Treated|Overall Study||135
10115145|NCT02522780|11245975|FG000|Intention-to-treat (ITT) Population|Overall Study||136
9699532|NCT03986671|10798689|FG002|NOT COMPLETED|Overall Study||0
9699533|NCT03850535|10798701|FG000|STARTED|Overall Study||4
9699534|NCT03850535|10798702|FG001|STARTED|Overall Study||9
9699535|NCT03850535|10798703|FG002|STARTED|Overall Study||6
9699536|NCT03850535|10798704|FG003|STARTED|Overall Study||4
9699537|NCT03850535|10798701|FG000|COMPLETED|Overall Study||0
9699538|NCT03850535|10798702|FG001|COMPLETED|Overall Study||0
9699539|NCT03850535|10798703|FG002|COMPLETED|Overall Study||0
9699540|NCT03850535|10798704|FG003|COMPLETED|Overall Study||0
9699541|NCT03850535|10798701|FG000|NOT COMPLETED|Overall Study||4
9699542|NCT03850535|10798702|FG001|NOT COMPLETED|Overall Study||9
9699543|NCT03850535|10798703|FG002|NOT COMPLETED|Overall Study||6
9699544|NCT03850535|10798704|FG003|NOT COMPLETED|Overall Study||4
9699545|NCT03839628|10798714|FG000|STARTED|Overall Study||9
9699546|NCT03839628|10798714|FG000|COMPLETED|Overall Study||8
10115146|NCT02522780|11245976|FG001|Intention-to-treat (ITT) Population|Overall Study||136
10115147|NCT02522780|11245975|FG000|COMPLETED|Overall Study||121
10115148|NCT02522780|11245976|FG001|COMPLETED|Overall Study||111
9699547|NCT03839628|10798714|FG000|NOT COMPLETED|Overall Study||1
9699548|NCT03791398|10798721|FG000|STARTED|Overall Study||13
9699549|NCT03791398|10798722|FG001|STARTED|Overall Study||0
9699550|NCT03791398|10798723|FG002|STARTED|Overall Study||0
9962352|NCT01477762|11081977|FG002|STARTED|Overall Study||20
9962353|NCT01477762|11081978|FG003|STARTED|Overall Study||13
9962354|NCT01477762|11081975|FG000|COMPLETED|Overall Study||16
9962355|NCT01477762|11081976|FG001|COMPLETED|Overall Study||20
9699551|NCT03791398|10798721|FG000|COMPLETED|Overall Study||11
9699552|NCT03791398|10798722|FG001|COMPLETED|Overall Study||0
9699553|NCT03791398|10798723|FG002|COMPLETED|Overall Study||0
9699554|NCT03791398|10798721|FG000|NOT COMPLETED|Overall Study||2
9699555|NCT03791398|10798722|FG001|NOT COMPLETED|Overall Study||0
9699556|NCT03791398|10798723|FG002|NOT COMPLETED|Overall Study||0
9699557|NCT03759041|10798730|FG000|STARTED|Overall Study||69
9699558|NCT03759041|10798731|FG001|STARTED|Overall Study||68
9699559|NCT03759041|10798732|FG002|STARTED|Overall Study||66
9699560|NCT03759041|10798730|FG000|COMPLETED|Overall Study||42
9699561|NCT03759041|10798731|FG001|COMPLETED|Overall Study||34
9699562|NCT03759041|10798732|FG002|COMPLETED|Overall Study||38
9699563|NCT03759041|10798730|FG000|NOT COMPLETED|Overall Study||27
9699564|NCT03759041|10798731|FG001|NOT COMPLETED|Overall Study||34
9699565|NCT03759041|10798732|FG002|NOT COMPLETED|Overall Study||28
9699566|NCT03726879|10798742|FG000|STARTED|Overall Study||226
9699567|NCT03726879|10798743|FG001|STARTED|Overall Study||228
9699568|NCT03726879|10798742|FG000|COMPLETED|Overall Study||0
9699569|NCT03726879|10798743|FG001|COMPLETED|Overall Study||0
9699570|NCT03726879|10798742|FG000|NOT COMPLETED|Overall Study||226
9699571|NCT03726879|10798743|FG001|NOT COMPLETED|Overall Study||228
9699572|NCT03726346|10798749|FG000|STARTED|Overall Study||39
9699573|NCT03726346|10798749|FG000|COMPLETED|Overall Study||39
9699574|NCT03726346|10798749|FG000|NOT COMPLETED|Overall Study||0
9699575|NCT03714425|10798755|FG000|STARTED|Overall Study||62
9699576|NCT03714425|10798756|FG001|STARTED|Overall Study||57
9699577|NCT03714425|10798755|FG000|COMPLETED|Overall Study||55
9699578|NCT03714425|10798756|FG001|COMPLETED|Overall Study||46
9699579|NCT03714425|10798755|FG000|NOT COMPLETED|Overall Study||7
9699580|NCT03714425|10798756|FG001|NOT COMPLETED|Overall Study||11
9699581|NCT03703882|10798764|FG000|STARTED|Overall Study||88
9699582|NCT03703882|10798765|FG001|STARTED|Overall Study||43
9699583|NCT03703882|10798764|FG000|COMPLETED|Overall Study||85
9699584|NCT03703882|10798765|FG001|COMPLETED|Overall Study||37
9699585|NCT03703882|10798764|FG000|NOT COMPLETED|Overall Study||3
9699586|NCT03703882|10798765|FG001|NOT COMPLETED|Overall Study||6
9699587|NCT03615040|10798773|FG000|STARTED|Overall Study||42
9699588|NCT03615040|10798774|FG001|STARTED|Overall Study||39
9699589|NCT03615040|10798773|FG000|COMPLETED|Overall Study||36
9699590|NCT03615040|10798774|FG001|COMPLETED|Overall Study||34
9699591|NCT03615040|10798773|FG000|NOT COMPLETED|Overall Study||6
9699592|NCT03615040|10798774|FG001|NOT COMPLETED|Overall Study||5
9699593|NCT03611075|10798789|FG000|STARTED|Overall Study||16
9699594|NCT03611075|10798790|FG001|STARTED|Overall Study||15
9699595|NCT03611075|10798791|FG002|STARTED|Overall Study||16
9699596|NCT03611075|10798792|FG003|STARTED|Overall Study||17
9699597|NCT03611075|10798793|FG004|STARTED|Overall Study||13
9699598|NCT03611075|10798794|FG005|STARTED|Overall Study||18
9699599|NCT03611075|10798795|FG006|STARTED|Overall Study||15
9699600|NCT03611075|10798796|FG007|STARTED|Overall Study||17
9699601|NCT03611075|10798797|FG008|STARTED|Overall Study||17
9699602|NCT03611075|10798789|FG000|COMPLETED|Overall Study||15
9699603|NCT03611075|10798790|FG001|COMPLETED|Overall Study||13
9699604|NCT03611075|10798791|FG002|COMPLETED|Overall Study||14
9699605|NCT03611075|10798792|FG003|COMPLETED|Overall Study||13
9699606|NCT03611075|10798793|FG004|COMPLETED|Overall Study||13
9699607|NCT03611075|10798794|FG005|COMPLETED|Overall Study||18
9699608|NCT03611075|10798795|FG006|COMPLETED|Overall Study||13
9699609|NCT03611075|10798796|FG007|COMPLETED|Overall Study||17
9699610|NCT03611075|10798797|FG008|COMPLETED|Overall Study||17
9699611|NCT03611075|10798789|FG000|NOT COMPLETED|Overall Study||1
9699612|NCT03611075|10798790|FG001|NOT COMPLETED|Overall Study||2
9699613|NCT03611075|10798791|FG002|NOT COMPLETED|Overall Study||2
9699614|NCT03611075|10798792|FG003|NOT COMPLETED|Overall Study||4
9699615|NCT03611075|10798793|FG004|NOT COMPLETED|Overall Study||0
9699616|NCT03611075|10798794|FG005|NOT COMPLETED|Overall Study||0
9699617|NCT03611075|10798795|FG006|NOT COMPLETED|Overall Study||2
9699618|NCT03611075|10798796|FG007|NOT COMPLETED|Overall Study||0
9699619|NCT03611075|10798797|FG008|NOT COMPLETED|Overall Study||0
9699620|NCT03595176|10798842|FG000|STARTED|Overall Study||47
9699621|NCT03595176|10798843|FG001|STARTED|Overall Study||384
10026535|NCT01878214|11150626|FG001|COMPLETED|Overall Study||175
10026536|NCT01878214|11150625|FG000|NOT COMPLETED|Overall Study||53
10026537|NCT01878214|11150626|FG001|NOT COMPLETED|Overall Study||44
10026538|NCT01878253|11150632|FG000|STARTED|Overall Study||95
9699622|NCT03595176|10798842|FG000|COMPLETED|Overall Study||47
9699623|NCT03595176|10798843|FG001|COMPLETED|Overall Study||381
9699624|NCT03595176|10798842|FG000|NOT COMPLETED|Overall Study||0
9699625|NCT03595176|10798843|FG001|NOT COMPLETED|Overall Study||3
10026539|NCT01878253|11150632|FG000|Pre-Operative|Overall Study||95
10115149|NCT02522780|11245975|FG000|NOT COMPLETED|Overall Study||17
10115150|NCT02522780|11245976|FG001|NOT COMPLETED|Overall Study||27
10115151|NCT02522845|11245985|FG000|STARTED|Overall Study||100
10115152|NCT02522845|11245986|FG001|STARTED|Overall Study||104
10115153|NCT02522845|11245985|FG000|COMPLETED|Overall Study||63
10115154|NCT02522845|11245986|FG001|COMPLETED|Overall Study||69
10115155|NCT02522845|11245985|FG000|NOT COMPLETED|Overall Study||37
10115156|NCT02522845|11245986|FG001|NOT COMPLETED|Overall Study||35
10115157|NCT02522884|11245992|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213
10115158|NCT02522884|11245992|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195
10115159|NCT02522884|11245992|FG000|NOT COMPLETED|Overall Study||18
10115160|NCT02523196|11245996|FG000|STARTED|Overall Study||20
10115161|NCT02523196|11245996|FG000|Received HVPG|Overall Study||20
10115162|NCT02523196|11245996|FG000|Received HQ Shunt|Overall Study||20
10115163|NCT02523196|11245996|FG000|COMPLETED|Overall Study||20
10115164|NCT02523196|11245996|FG000|NOT COMPLETED|Overall Study||0
10115165|NCT02523235|11246007|FG000|STARTED|Overall Study||56
10115166|NCT02523235|11246008|FG001|STARTED|Overall Study||58
10115167|NCT02523235|11246007|FG000|COMPLETED|Overall Study||56
10115168|NCT02523235|11246008|FG001|COMPLETED|Overall Study||58
10115169|NCT02523235|11246007|FG000|NOT COMPLETED|Overall Study||0
10115170|NCT02523235|11246008|FG001|NOT COMPLETED|Overall Study||0
10115171|NCT02523586|11246015|FG000|STARTED|Overall Study||14
10115172|NCT02523586|11246015|FG000|COMPLETED|Overall Study||10
10115173|NCT02523586|11246015|FG000|NOT COMPLETED|Overall Study||4
10115174|NCT02523599|11246028|FG000|STARTED|Overall Study||204
10115175|NCT02523599|11246029|FG001|STARTED|Overall Study||101
10115176|NCT02523599|11246028|FG000|Randomized But Not Treated|Overall Study||1
10115177|NCT02523599|11246029|FG001|Randomized But Not Treated|Overall Study||0
10115178|NCT02523599|11246028|FG000|COMPLETED|Overall Study||196
10115179|NCT02523599|11246029|FG001|COMPLETED|Overall Study||100
10115180|NCT02523599|11246028|FG000|NOT COMPLETED|Overall Study||8
10115181|NCT02523599|11246029|FG001|NOT COMPLETED|Overall Study||1
10115182|NCT02523690|11246037|FG000|STARTED|Overall Study||3
10115183|NCT02523690|11246038|FG001|STARTED|Overall Study||2
10115184|NCT02523690|11246037|FG000|COMPLETED|Overall Study||3
10115185|NCT02523690|11246038|FG001|COMPLETED|Overall Study||2
10115186|NCT02523690|11246037|FG000|NOT COMPLETED|Overall Study||0
10115187|NCT02523690|11246038|FG001|NOT COMPLETED|Overall Study||0
10115188|NCT02523924|11246044|FG000|STARTED|Overall Study||31
10115189|NCT02523924|11246044|FG000|COMPLETED|Overall Study||31
10115190|NCT02523924|11246044|FG000|NOT COMPLETED|Overall Study||0
10115191|NCT02524054|11246050|FG000|STARTED|Overall Study||7
10115192|NCT02524054|11246051|FG001|STARTED|Overall Study||9
10115193|NCT02524054|11246052|FG002|STARTED|Overall Study||8
10115194|NCT02524054|11246050|FG000|COMPLETED|Overall Study||7
10115195|NCT02524054|11246051|FG001|COMPLETED|Overall Study||9
10115196|NCT02524054|11246052|FG002|COMPLETED|Overall Study||8
10115197|NCT02524054|11246050|FG000|NOT COMPLETED|Overall Study||0
10115198|NCT02524054|11246051|FG001|NOT COMPLETED|Overall Study||0
10115199|NCT02524054|11246052|FG002|NOT COMPLETED|Overall Study||0
10115200|NCT02524106|11246064|FG000|STARTED|Overall Study||6
10115201|NCT02524106|11246065|FG001|STARTED|Overall Study||5
10115202|NCT02524106|11246064|FG000|COMPLETED|Overall Study||6
10115203|NCT02524106|11246065|FG001|COMPLETED|Overall Study||5
10115204|NCT02524106|11246064|FG000|NOT COMPLETED|Overall Study||0
10115205|NCT02524106|11246065|FG001|NOT COMPLETED|Overall Study||0
10115206|NCT02524119|11246071|FG000|STARTED|Overall Study||5
10115207|NCT02524119|11246071|FG000|COMPLETED|Overall Study||5
10115208|NCT02524119|11246071|FG000|NOT COMPLETED|Overall Study||0
10115209|NCT02524145|11246078|FG000|STARTED|Overall Study||15
10115210|NCT02524145|11246079|FG001|STARTED|Overall Study||15
10115211|NCT02524145|11246080|FG002|STARTED|Overall Study||10
10115212|NCT02524145|11246078|FG000|COMPLETED|Overall Study||13
10115213|NCT02524145|11246079|FG001|COMPLETED|Overall Study||13
10115214|NCT02524145|11246080|FG002|COMPLETED|Overall Study||7
10115215|NCT02524145|11246078|FG000|NOT COMPLETED|Overall Study||2
10115216|NCT02524145|11246079|FG001|NOT COMPLETED|Overall Study||2
10115217|NCT02524145|11246080|FG002|NOT COMPLETED|Overall Study||3
10115218|NCT02524158|11246090|FG000|STARTED|12-weeks Assessment||76
10115219|NCT02524158|11246091|FG001|STARTED|12-weeks Assessment||76
10115220|NCT02524158|11246090|FG000|COMPLETED|12-weeks Assessment||57
10115221|NCT02524158|11246091|FG001|COMPLETED|12-weeks Assessment||63
10115222|NCT02524158|11246090|FG000|NOT COMPLETED|12-weeks Assessment||19
10115223|NCT02524158|11246091|FG001|NOT COMPLETED|12-weeks Assessment||13
10115224|NCT02524158|11246090|FG000|STARTED|6-month Assessment||76
10115225|NCT02524158|11246091|FG001|STARTED|6-month Assessment||76
10115226|NCT02524158|11246090|FG000|COMPLETED|6-month Assessment||54
10115227|NCT02524158|11246091|FG001|COMPLETED|6-month Assessment||55
10115228|NCT02524158|11246090|FG000|NOT COMPLETED|6-month Assessment||22
10115229|NCT02524158|11246091|FG001|NOT COMPLETED|6-month Assessment||21
10115230|NCT02524418|11246100|FG000|STARTED|Overall Study||88
10115231|NCT02524418|11246100|FG000|COMPLETED|Overall Study||75
10115232|NCT02524418|11246100|FG000|NOT COMPLETED|Overall Study||13
10115233|NCT02524561|11246110|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
10115234|NCT02524561|11246111|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
9699626|NCT03541317|10798851|FG000|STARTED|Stage 1 of the Implementation||6
9699627|NCT03541317|10798852|FG001|STARTED|Stage 1 of the Implementation||37
9699628|NCT03541317|10798853|FG002|STARTED|Stage 1 of the Implementation||38
9699629|NCT03541317|10798854|FG003|STARTED|Stage 1 of the Implementation||9
9699630|NCT03541317|10798855|FG004|STARTED|Stage 1 of the Implementation||43
9699631|NCT03541317|10798856|FG005|STARTED|Stage 1 of the Implementation||36
9699632|NCT03541317|10798851|FG000|COMPLETED|Stage 1 of the Implementation||6
9699633|NCT03541317|10798852|FG001|COMPLETED|Stage 1 of the Implementation||37
9699634|NCT03541317|10798853|FG002|COMPLETED|Stage 1 of the Implementation||38
9699635|NCT03541317|10798854|FG003|COMPLETED|Stage 1 of the Implementation||9
9699636|NCT03541317|10798855|FG004|COMPLETED|Stage 1 of the Implementation||43
9699637|NCT03541317|10798856|FG005|COMPLETED|Stage 1 of the Implementation||36
9699638|NCT03541317|10798851|FG000|NOT COMPLETED|Stage 1 of the Implementation||0
9699639|NCT03541317|10798852|FG001|NOT COMPLETED|Stage 1 of the Implementation||0
9699640|NCT03541317|10798853|FG002|NOT COMPLETED|Stage 1 of the Implementation||0
10115235|NCT02524561|11246112|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
10115236|NCT02524561|11246110|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
10115237|NCT02524561|11246111|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
10115238|NCT02524561|11246112|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
10115239|NCT02524561|11246110|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168
10115240|NCT02524561|11246111|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162
10115241|NCT02524561|11246112|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187
10115242|NCT02524561|11246110|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
10115243|NCT02524561|11246111|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
10115244|NCT02524561|11246112|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
10115245|NCT02524561|11246110|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
10115246|NCT02524561|11246111|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
10115247|NCT02524561|11246112|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
10115248|NCT02524561|11246110|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
10115249|NCT02524561|11246111|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
10115250|NCT02524561|11246112|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
10115251|NCT02524561|11246110|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168
10115252|NCT02524561|11246111|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162
10115253|NCT02524561|11246112|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187
10115254|NCT02524561|11246110|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
10115255|NCT02524561|11246111|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
10115256|NCT02524561|11246112|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
10115257|NCT02524561|11246110|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
10115258|NCT02524561|11246111|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
10115259|NCT02524561|11246112|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
10115260|NCT02524561|11246110|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
10115261|NCT02524561|11246111|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
10115262|NCT02524561|11246112|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
10115263|NCT02524561|11246110|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168
10115264|NCT02524561|11246111|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162
10115265|NCT02524561|11246112|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187
10115266|NCT02524561|11246110|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
10115267|NCT02524561|11246111|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
10115268|NCT02524561|11246112|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
10115269|NCT02524665|11246120|FG000|STARTED|Overall Study||20
10115270|NCT02524665|11246120|FG000|COMPLETED|Overall Study||19
10115271|NCT02524665|11246120|FG000|NOT COMPLETED|Overall Study||1
10115272|NCT02524730|11246125|FG000|STARTED|Overall Study||205
10115273|NCT02524730|11246125|FG000|COMPLETED|Overall Study||159
10115274|NCT02524730|11246125|FG000|NOT COMPLETED|Overall Study||46
10115275|NCT02524769|11246129|FG000|STARTED|Overall Study||27
10115276|NCT02524769|11246129|FG000|COMPLETED|Overall Study||17
10115277|NCT02524769|11246129|FG000|NOT COMPLETED|Overall Study||10
10115278|NCT02524847|11246133|FG000|STARTED|Overall Study||29
10115279|NCT02524847|11246133|FG000|Completed Treatment Up to Week 12|Overall Study||14
10115280|NCT02524847|11246133|FG000|Started Second Line Treatment|Overall Study||5
10115281|NCT02524847|11246133|FG000|COMPLETED|Overall Study||15
10115282|NCT02524847|11246133|FG000|NOT COMPLETED|Overall Study||14
10115283|NCT02524977|11246140|FG000|STARTED|Overall Study||738
10115284|NCT02524977|11246141|FG001|STARTED|Overall Study||846
10115285|NCT02524977|11246140|FG000|COMPLETED|Overall Study||692
10115286|NCT02524977|11246141|FG001|COMPLETED|Overall Study||801
10115287|NCT02524977|11246140|FG000|NOT COMPLETED|Overall Study||46
10115288|NCT02524977|11246141|FG001|NOT COMPLETED|Overall Study||45
10115289|NCT02525055|11246155|FG000|STARTED|Overall Study||6
10115290|NCT02525055|11246156|FG001|STARTED|Overall Study||6
10115291|NCT02525055|11246157|FG002|STARTED|Overall Study||6
9699641|NCT03541317|10798854|FG003|NOT COMPLETED|Stage 1 of the Implementation||0
10026540|NCT01878253|11150632|FG000|6 Weeks|Overall Study||95
9699642|NCT03541317|10798855|FG004|NOT COMPLETED|Stage 1 of the Implementation||0
9699643|NCT03541317|10798856|FG005|NOT COMPLETED|Stage 1 of the Implementation||0
9699644|NCT03541317|10798851|FG000|STARTED|Stage 2 of the Implementation||6
9699645|NCT03541317|10798852|FG001|STARTED|Stage 2 of the Implementation||37
9699646|NCT03541317|10798853|FG002|STARTED|Stage 2 of the Implementation||38
9699647|NCT03541317|10798854|FG003|STARTED|Stage 2 of the Implementation||9
9699648|NCT03541317|10798855|FG004|STARTED|Stage 2 of the Implementation||43
9699649|NCT03541317|10798856|FG005|STARTED|Stage 2 of the Implementation||36
9699650|NCT03541317|10798851|FG000|COMPLETED|Stage 2 of the Implementation||5
9699651|NCT03541317|10798852|FG001|COMPLETED|Stage 2 of the Implementation||37
9699652|NCT03541317|10798853|FG002|COMPLETED|Stage 2 of the Implementation||38
9699653|NCT03541317|10798854|FG003|COMPLETED|Stage 2 of the Implementation||9
9699654|NCT03541317|10798855|FG004|COMPLETED|Stage 2 of the Implementation||43
9699655|NCT03541317|10798856|FG005|COMPLETED|Stage 2 of the Implementation||36
9699656|NCT03541317|10798851|FG000|NOT COMPLETED|Stage 2 of the Implementation||1
9699657|NCT03541317|10798852|FG001|NOT COMPLETED|Stage 2 of the Implementation||0
9699658|NCT03541317|10798853|FG002|NOT COMPLETED|Stage 2 of the Implementation||0
9699659|NCT03541317|10798854|FG003|NOT COMPLETED|Stage 2 of the Implementation||0
9699660|NCT03541317|10798855|FG004|NOT COMPLETED|Stage 2 of the Implementation||0
9699661|NCT03541317|10798856|FG005|NOT COMPLETED|Stage 2 of the Implementation||0
9699662|NCT03523117|10798870|FG000|STARTED|Overall Study||40
9699663|NCT03523117|10798871|FG001|STARTED|Overall Study||39
9699664|NCT03523117|10798870|FG000|COMPLETED|Overall Study||39
9699665|NCT03523117|10798871|FG001|COMPLETED|Overall Study||37
9699666|NCT03523117|10798870|FG000|NOT COMPLETED|Overall Study||1
9699667|NCT03523117|10798871|FG001|NOT COMPLETED|Overall Study||2
9699668|NCT03412565|10798881|FG000|STARTED|Overall Study||67
10026541|NCT01878253|11150632|FG000|6 Months|Overall Study||90
9699669|NCT03412565|10798882|FG001|STARTED|Overall Study||67
9699670|NCT03412565|10798883|FG002|STARTED|Overall Study||65
9699671|NCT03412565|10798884|FG003|STARTED|Overall Study||66
9699672|NCT03412565|10798881|FG000|COMPLETED|Overall Study||66
9699673|NCT03412565|10798882|FG001|COMPLETED|Overall Study||2
9699674|NCT03412565|10798883|FG002|COMPLETED|Overall Study||3
9699675|NCT03412565|10798884|FG003|COMPLETED|Overall Study||12
9699676|NCT03412565|10798881|FG000|NOT COMPLETED|Overall Study||1
9699677|NCT03412565|10798882|FG001|NOT COMPLETED|Overall Study||65
9699678|NCT03412565|10798883|FG002|NOT COMPLETED|Overall Study||62
9699679|NCT03412565|10798884|FG003|NOT COMPLETED|Overall Study||54
9699680|NCT03400943|10798903|FG000|STARTED|Treatment Period 1||23
9699681|NCT03400943|10798904|FG001|STARTED|Treatment Period 1||23
9699682|NCT03400943|10798905|FG002|STARTED|Treatment Period 1||24
9699683|NCT03400943|10798906|FG003|STARTED|Treatment Period 1||23
9699684|NCT03400943|10798903|FG000|Treated|Treatment Period 1||18
9699685|NCT03400943|10798904|FG001|Treated|Treatment Period 1||21
9699686|NCT03400943|10798905|FG002|Treated|Treatment Period 1||20
9699687|NCT03400943|10798906|FG003|Treated|Treatment Period 1||20
9962356|NCT01477762|11081977|FG002|COMPLETED|Overall Study||16
9962357|NCT01477762|11081978|FG003|COMPLETED|Overall Study||11
9962358|NCT01477762|11081975|FG000|NOT COMPLETED|Overall Study||9
9962359|NCT01477762|11081976|FG001|NOT COMPLETED|Overall Study||13
9962360|NCT01477762|11081977|FG002|NOT COMPLETED|Overall Study||4
9962361|NCT01477762|11081978|FG003|NOT COMPLETED|Overall Study||2
9962362|NCT01477853|11081991|FG000|STARTED|Phase A||55
9962363|NCT01477853|11081992|FG001|STARTED|Phase A||56
9962364|NCT01477853|11081993|FG002|STARTED|Phase A||55
9962365|NCT01477853|11081991|FG000|COMPLETED|Phase A||12
9962366|NCT01477853|11081992|FG001|COMPLETED|Phase A||11
9962367|NCT01477853|11081993|FG002|COMPLETED|Phase A||11
9962368|NCT01477853|11081991|FG000|NOT COMPLETED|Phase A||43
9962369|NCT01477853|11081992|FG001|NOT COMPLETED|Phase A||45
9962370|NCT01477853|11081993|FG002|NOT COMPLETED|Phase A||44
9962371|NCT01477853|11081991|FG000|STARTED|Phase B||12
9962372|NCT01477853|11081992|FG001|STARTED|Phase B||11
10026542|NCT01878253|11150632|FG000|1 Year|Overall Study||88
10026543|NCT01878253|11150632|FG000|2 Year|Overall Study||86
10026544|NCT01878253|11150632|FG000|COMPLETED|Overall Study||86
10026545|NCT01878253|11150632|FG000|NOT COMPLETED|Overall Study||9
10115292|NCT02525055|11246158|FG003|STARTED|Overall Study||6
10115293|NCT02525055|11246159|FG004|STARTED|Overall Study||6
10115294|NCT02525055|11246160|FG005|STARTED|Overall Study||16
10115295|NCT02525055|11246155|FG000|COMPLETED|Overall Study||6
10115296|NCT02525055|11246156|FG001|COMPLETED|Overall Study||6
10115297|NCT02525055|11246157|FG002|COMPLETED|Overall Study||6
10115298|NCT02525055|11246158|FG003|COMPLETED|Overall Study||6
10115299|NCT02525055|11246159|FG004|COMPLETED|Overall Study||6
10115300|NCT02525055|11246160|FG005|COMPLETED|Overall Study||16
10115301|NCT02525055|11246155|FG000|NOT COMPLETED|Overall Study||0
10115302|NCT02525055|11246156|FG001|NOT COMPLETED|Overall Study||0
10115303|NCT02525055|11246157|FG002|NOT COMPLETED|Overall Study||0
10115304|NCT02525055|11246158|FG003|NOT COMPLETED|Overall Study||0
10115305|NCT02525055|11246159|FG004|NOT COMPLETED|Overall Study||0
10115306|NCT02525055|11246160|FG005|NOT COMPLETED|Overall Study||0
10115307|NCT02525094|11246176|FG000|STARTED|Overall Study||57
10115308|NCT02525094|11246177|FG001|STARTED|Overall Study||56
10115309|NCT02525094|11246176|FG000|Treated|Overall Study||56
10115310|NCT02525094|11246177|FG001|Treated|Overall Study||55
10115311|NCT02525094|11246176|FG000|COMPLETED|Overall Study||49
10115312|NCT02525094|11246177|FG001|COMPLETED|Overall Study||48
10115313|NCT02525094|11246176|FG000|NOT COMPLETED|Overall Study||8
10115314|NCT02525094|11246177|FG001|NOT COMPLETED|Overall Study||8
10115315|NCT02525133|11246186|FG000|STARTED|Overall Study||213
10115316|NCT02525133|11246187|FG001|STARTED|Overall Study||106
10115317|NCT02525133|11246186|FG000|Randomized But Not Treated|Overall Study||4
10115318|NCT02525133|11246187|FG001|Randomized But Not Treated|Overall Study||0
10115319|NCT02525133|11246186|FG000|COMPLETED|Overall Study||203
10115320|NCT02525133|11246187|FG001|COMPLETED|Overall Study||103
10115321|NCT02525133|11246186|FG000|NOT COMPLETED|Overall Study||10
10115322|NCT02525133|11246187|FG001|NOT COMPLETED|Overall Study||3
10115323|NCT02525263|11246193|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
10115324|NCT02525263|11246193|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
10115325|NCT02525263|11246193|FG000|NOT COMPLETED|Overall Study||0
9699688|NCT03400943|10798903|FG000|COMPLETED|Treatment Period 1||18
9699689|NCT03400943|10798904|FG001|COMPLETED|Treatment Period 1||21
9699690|NCT03400943|10798905|FG002|COMPLETED|Treatment Period 1||18
9699691|NCT03400943|10798906|FG003|COMPLETED|Treatment Period 1||18
9962373|NCT01477853|11081993|FG002|STARTED|Phase B||11
9962374|NCT01477853|11081991|FG000|COMPLETED|Phase B||0
9962375|NCT01477853|11081992|FG001|COMPLETED|Phase B||0
9962376|NCT01477853|11081993|FG002|COMPLETED|Phase B||0
9962377|NCT01477853|11081991|FG000|NOT COMPLETED|Phase B||12
10026546|NCT01878292|11150644|FG000|STARTED|Randomized||174
10026547|NCT01878292|11150645|FG001|STARTED|Randomized||175
10026548|NCT01878292|11150646|FG002|STARTED|Randomized||180
10026549|NCT01878292|11150644|FG000|COMPLETED|Randomized||171
10026550|NCT01878292|11150645|FG001|COMPLETED|Randomized||175
10026551|NCT01878292|11150646|FG002|COMPLETED|Randomized||180
10115326|NCT02525471|11246199|FG000|STARTED|Overall Study||24
10115327|NCT02525471|11246199|FG000|Randomized/Treated|Overall Study||16
9699692|NCT03400943|10798903|FG000|NOT COMPLETED|Treatment Period 1||5
9699693|NCT03400943|10798904|FG001|NOT COMPLETED|Treatment Period 1||2
9699694|NCT03400943|10798905|FG002|NOT COMPLETED|Treatment Period 1||6
9699695|NCT03400943|10798906|FG003|NOT COMPLETED|Treatment Period 1||5
9699696|NCT03400943|10798903|FG000|STARTED|Post-treatment Period 1||18
9699697|NCT03400943|10798904|FG001|STARTED|Post-treatment Period 1||0
9699698|NCT03400943|10798905|FG002|STARTED|Post-treatment Period 1||18
9699699|NCT03400943|10798906|FG003|STARTED|Post-treatment Period 1||18
10026552|NCT01878292|11150644|FG000|NOT COMPLETED|Randomized||3
10026553|NCT01878292|11150645|FG001|NOT COMPLETED|Randomized||0
10026554|NCT01878292|11150646|FG002|NOT COMPLETED|Randomized||0
9699700|NCT03400943|10798903|FG000|COMPLETED|Post-treatment Period 1||7
9699701|NCT03400943|10798904|FG001|COMPLETED|Post-treatment Period 1||0
9699702|NCT03400943|10798905|FG002|COMPLETED|Post-treatment Period 1||7
9699703|NCT03400943|10798906|FG003|COMPLETED|Post-treatment Period 1||5
9699704|NCT03400943|10798903|FG000|NOT COMPLETED|Post-treatment Period 1||11
9699705|NCT03400943|10798904|FG001|NOT COMPLETED|Post-treatment Period 1||0
9699706|NCT03400943|10798905|FG002|NOT COMPLETED|Post-treatment Period 1||11
9699707|NCT03400943|10798906|FG003|NOT COMPLETED|Post-treatment Period 1||13
9699708|NCT03400943|10798903|FG000|STARTED|Treatment Period 2||7
9699709|NCT03400943|10798904|FG001|STARTED|Treatment Period 2||21
9699710|NCT03400943|10798905|FG002|STARTED|Treatment Period 2||7
9699711|NCT03400943|10798906|FG003|STARTED|Treatment Period 2||5
9699712|NCT03400943|10798903|FG000|COMPLETED|Treatment Period 2||6
9699713|NCT03400943|10798904|FG001|COMPLETED|Treatment Period 2||13
9699714|NCT03400943|10798905|FG002|COMPLETED|Treatment Period 2||7
9699715|NCT03400943|10798906|FG003|COMPLETED|Treatment Period 2||5
9699716|NCT03400943|10798903|FG000|NOT COMPLETED|Treatment Period 2||1
9699717|NCT03400943|10798904|FG001|NOT COMPLETED|Treatment Period 2||8
9699718|NCT03400943|10798905|FG002|NOT COMPLETED|Treatment Period 2||0
9699719|NCT03400943|10798906|FG003|NOT COMPLETED|Treatment Period 2||0
9699720|NCT03400943|10798903|FG000|STARTED|Follow-up Period||7
9699721|NCT03400943|10798904|FG001|STARTED|Follow-up Period||15
9699722|NCT03400943|10798905|FG002|STARTED|Follow-up Period||7
9699723|NCT03400943|10798906|FG003|STARTED|Follow-up Period||5
9699724|NCT03400943|10798903|FG000|COMPLETED|Follow-up Period||6
9699725|NCT03400943|10798904|FG001|COMPLETED|Follow-up Period||15
9699726|NCT03400943|10798905|FG002|COMPLETED|Follow-up Period||7
9699727|NCT03400943|10798906|FG003|COMPLETED|Follow-up Period||5
9699728|NCT03400943|10798903|FG000|NOT COMPLETED|Follow-up Period||1
9699729|NCT03400943|10798904|FG001|NOT COMPLETED|Follow-up Period||0
9699730|NCT03400943|10798905|FG002|NOT COMPLETED|Follow-up Period||0
9699731|NCT03400943|10798906|FG003|NOT COMPLETED|Follow-up Period||0
9699732|NCT03396952|10798918|FG000|STARTED|Overall Study||27
9699733|NCT03396952|10798918|FG000|COMPLETED|Overall Study||27
9699734|NCT03396952|10798918|FG000|NOT COMPLETED|Overall Study||0
9699747|NCT03302234|10798941|FG000|STARTED|Overall Study||284
9699748|NCT03302234|10798942|FG001|STARTED|Overall Study||284
9699749|NCT03302234|10798941|FG000|COMPLETED|Overall Study||146
9699750|NCT03302234|10798942|FG001|COMPLETED|Overall Study||147
9699751|NCT03302234|10798941|FG000|NOT COMPLETED|Overall Study||138
9699752|NCT03302234|10798942|FG001|NOT COMPLETED|Overall Study||137
10026555|NCT01878292|11150644|FG000|STARTED|Double-blind Treatment Period||171
10026556|NCT01878292|11150645|FG001|STARTED|Double-blind Treatment Period||175
10026557|NCT01878292|11150646|FG002|STARTED|Double-blind Treatment Period||180
10026558|NCT01878292|11150644|FG000|COMPLETED|Double-blind Treatment Period||142
10026559|NCT01878292|11150645|FG001|COMPLETED|Double-blind Treatment Period||149
10026560|NCT01878292|11150646|FG002|COMPLETED|Double-blind Treatment Period||161
10026561|NCT01878292|11150644|FG000|NOT COMPLETED|Double-blind Treatment Period||29
10026562|NCT01878292|11150645|FG001|NOT COMPLETED|Double-blind Treatment Period||26
10026563|NCT01878292|11150646|FG002|NOT COMPLETED|Double-blind Treatment Period||19
10026564|NCT01878292|11150644|FG000|STARTED|Double-blind Down-Taper Period||127
9699753|NCT03292588|10798951|FG000|STARTED|Overall Study||146
9699754|NCT03292588|10798952|FG001|STARTED|Overall Study||144
9699755|NCT03292588|10798951|FG000|COMPLETED|Overall Study||126
9699756|NCT03292588|10798952|FG001|COMPLETED|Overall Study||122
9699757|NCT03292588|10798951|FG000|NOT COMPLETED|Overall Study||20
9699758|NCT03292588|10798952|FG001|NOT COMPLETED|Overall Study||22
9699759|NCT03277105|10798962|FG000|STARTED|Overall Study||259
9699760|NCT03277105|10798963|FG001|STARTED|Overall Study||263
9699761|NCT03277105|10798962|FG000|Safety Analysis Set|Overall Study||258
9699762|NCT03277105|10798963|FG001|Safety Analysis Set|Overall Study||260
9699763|NCT03277105|10798962|FG000|COMPLETED|Overall Study||0
9699764|NCT03277105|10798963|FG001|COMPLETED|Overall Study||0
9699765|NCT03277105|10798962|FG000|NOT COMPLETED|Overall Study||259
9699766|NCT03277105|10798963|FG001|NOT COMPLETED|Overall Study||263
9699767|NCT03272763|10798969|FG000|STARTED|Overall Study||38
9699768|NCT03272763|10798969|FG000|COMPLETED|Overall Study||38
9699769|NCT03272763|10798969|FG000|NOT COMPLETED|Overall Study||0
9699770|NCT03251326|10798973|FG000|STARTED|Overall Study||1
9699771|NCT03251326|10798974|FG001|STARTED|Overall Study||1
9699772|NCT03251326|10798975|FG002|STARTED|Overall Study||1
9699773|NCT03251326|10798976|FG003|STARTED|Overall Study||1
9699774|NCT03251326|10798973|FG000|COMPLETED|Overall Study||1
9699775|NCT03251326|10798974|FG001|COMPLETED|Overall Study||1
9699776|NCT03251326|10798975|FG002|COMPLETED|Overall Study||0
9699777|NCT03251326|10798976|FG003|COMPLETED|Overall Study||0
9699778|NCT03251326|10798973|FG000|NOT COMPLETED|Overall Study||0
9699779|NCT03251326|10798974|FG001|NOT COMPLETED|Overall Study||0
9699780|NCT03251326|10798975|FG002|NOT COMPLETED|Overall Study||1
9699781|NCT03251326|10798976|FG003|NOT COMPLETED|Overall Study||1
9699782|NCT03232346|10798988|FG000|STARTED|Overall Study||6
9699783|NCT03232346|10798989|FG001|STARTED|Overall Study||5
9699784|NCT03232346|10798988|FG000|COMPLETED|Overall Study||2
9699785|NCT03232346|10798989|FG001|COMPLETED|Overall Study||3
9699786|NCT03232346|10798988|FG000|NOT COMPLETED|Overall Study||4
9699787|NCT03232346|10798989|FG001|NOT COMPLETED|Overall Study||2
9699788|NCT03208244|10798995|FG000|STARTED|Overall Study||33
9699789|NCT03208244|10798995|FG000|COMPLETED|Overall Study||32
9699790|NCT03208244|10798995|FG000|NOT COMPLETED|Overall Study||1
9699791|NCT03201965|10799002|FG000|STARTED|Overall Study||28
9699792|NCT03201965|10799003|FG001|STARTED|Overall Study||193
9699793|NCT03201965|10799004|FG002|STARTED|Overall Study||195
9699794|NCT03201965|10799002|FG000|Treated|Overall Study||28
9699795|NCT03201965|10799003|FG001|Treated|Overall Study||188
9699796|NCT03201965|10799004|FG002|Treated|Overall Study||193
9699797|NCT03201965|10799002|FG000|COMPLETED|Overall Study||0
9699798|NCT03201965|10799003|FG001|COMPLETED|Overall Study||0
9699799|NCT03201965|10799004|FG002|COMPLETED|Overall Study||0
9699800|NCT03201965|10799002|FG000|NOT COMPLETED|Overall Study||28
10026565|NCT01878292|11150645|FG001|STARTED|Double-blind Down-Taper Period||140
9699801|NCT03201965|10799003|FG001|NOT COMPLETED|Overall Study||193
9699802|NCT03201965|10799004|FG002|NOT COMPLETED|Overall Study||195
9699803|NCT03187379|10799013|FG000|STARTED|Overall Study||50
9699804|NCT03187379|10799014|FG001|STARTED|Overall Study||52
9699805|NCT03187379|10799013|FG000|COMPLETED|Overall Study||50
9699806|NCT03187379|10799014|FG001|COMPLETED|Overall Study||52
9699807|NCT03187379|10799013|FG000|NOT COMPLETED|Overall Study||0
9699808|NCT03187379|10799014|FG001|NOT COMPLETED|Overall Study||0
9699809|NCT03122886|10799022|FG000|STARTED|Overall Study||10
9699810|NCT03122886|10799023|FG001|STARTED|Overall Study||9
9699811|NCT03122886|10799022|FG000|COMPLETED|Overall Study||9
9699812|NCT03122886|10799023|FG001|COMPLETED|Overall Study||7
9699813|NCT03122886|10799022|FG000|NOT COMPLETED|Overall Study||1
9699814|NCT03122886|10799023|FG001|NOT COMPLETED|Overall Study||2
9699815|NCT03077360|10799032|FG000|STARTED|Overall Study||17
9699816|NCT03077360|10799033|FG001|STARTED|Overall Study||17
9699817|NCT03077360|10799034|FG002|STARTED|Overall Study||14
10026566|NCT01878292|11150646|FG002|STARTED|Double-blind Down-Taper Period||146
10026567|NCT01878292|11150644|FG000|COMPLETED|Double-blind Down-Taper Period||122
10026568|NCT01878292|11150645|FG001|COMPLETED|Double-blind Down-Taper Period||132
9699818|NCT03077360|10799032|FG000|COMPLETED|Overall Study||17
9699819|NCT03077360|10799033|FG001|COMPLETED|Overall Study||16
9699820|NCT03077360|10799034|FG002|COMPLETED|Overall Study||12
9699821|NCT03077360|10799032|FG000|NOT COMPLETED|Overall Study||0
9699822|NCT03077360|10799033|FG001|NOT COMPLETED|Overall Study||1
9699823|NCT03077360|10799034|FG002|NOT COMPLETED|Overall Study||2
9699824|NCT03050060|10799043|FG000|STARTED|Overall Study||20
9699825|NCT03050060|10799043|FG000|COMPLETED|Overall Study||5
9699826|NCT03050060|10799043|FG000|NOT COMPLETED|Overall Study||15
9699827|NCT02968381|10799049|FG000|STARTED|Overall Study||61
9699828|NCT02968381|10799050|FG001|STARTED|Overall Study||60
9699829|NCT02968381|10799049|FG000|COMPLETED|Overall Study||56
9699830|NCT02968381|10799050|FG001|COMPLETED|Overall Study||50
9699831|NCT02968381|10799049|FG000|NOT COMPLETED|Overall Study||5
9699832|NCT02968381|10799050|FG001|NOT COMPLETED|Overall Study||10
9699833|NCT02847637|10799060|FG000|STARTED|Overall Study||18
9699834|NCT02847637|10799061|FG001|STARTED|Overall Study||36
9699835|NCT02847637|10799062|FG002|STARTED|Overall Study||35
9699836|NCT02847637|10799063|FG003|STARTED|Overall Study||63
9699837|NCT02847637|10799060|FG000|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
9699838|NCT02847637|10799061|FG001|Completed 24 Weeks on No Prophylaxis|Overall Study||0
9699839|NCT02847637|10799062|FG002|Completed 24 Weeks on No Prophylaxis|Overall Study||0
9699840|NCT02847637|10799063|FG003|Completed 24 Weeks on No Prophylaxis|Overall Study||0
9699841|NCT02847637|10799060|FG000|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
9699842|NCT02847637|10799061|FG001|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
9699843|NCT02847637|10799062|FG002|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
9699844|NCT02847637|10799063|FG003|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
10026569|NCT01878292|11150646|FG002|COMPLETED|Double-blind Down-Taper Period||142
9699845|NCT02847637|10799060|FG000|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
9699846|NCT02847637|10799061|FG001|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
9699847|NCT02847637|10799062|FG002|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
9699848|NCT02847637|10799063|FG003|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
9699849|NCT02847637|10799060|FG000|COMPLETED|Overall Study||1
9699850|NCT02847637|10799061|FG001|COMPLETED|Overall Study||1
9699851|NCT02847637|10799062|FG002|COMPLETED|Overall Study||0
9699852|NCT02847637|10799063|FG003|COMPLETED|Overall Study||0
9699853|NCT02847637|10799060|FG000|NOT COMPLETED|Overall Study||17
9699854|NCT02847637|10799061|FG001|NOT COMPLETED|Overall Study||35
9699855|NCT02847637|10799062|FG002|NOT COMPLETED|Overall Study||35
9699856|NCT02847637|10799063|FG003|NOT COMPLETED|Overall Study||63
9699857|NCT02837042|10799083|FG000|STARTED|Overall Study||6
9699858|NCT02837042|10799083|FG000|COMPLETED|Overall Study||6
9699859|NCT02837042|10799083|FG000|NOT COMPLETED|Overall Study||0
9699860|NCT02770391|10799087|FG000|STARTED|Overall Study||54
9699861|NCT02770391|10799087|FG000|COMPLETED|Overall Study||48
9699862|NCT02770391|10799087|FG000|NOT COMPLETED|Overall Study||6
9699863|NCT02650986|10799095|FG000|STARTED|Overall Study||3
9699864|NCT02650986|10799096|FG001|STARTED|Overall Study||3
9699865|NCT02650986|10799097|FG002|STARTED|Overall Study||3
9699866|NCT02650986|10799098|FG003|STARTED|Overall Study||6
9699867|NCT02650986|10799095|FG000|COMPLETED|Overall Study||3
9699868|NCT02650986|10799096|FG001|COMPLETED|Overall Study||3
9699869|NCT02650986|10799097|FG002|COMPLETED|Overall Study||3
9699870|NCT02650986|10799098|FG003|COMPLETED|Overall Study||6
9699871|NCT02650986|10799095|FG000|NOT COMPLETED|Overall Study||0
9699872|NCT02650986|10799096|FG001|NOT COMPLETED|Overall Study||0
9699873|NCT02650986|10799097|FG002|NOT COMPLETED|Overall Study||0
9699874|NCT02650986|10799098|FG003|NOT COMPLETED|Overall Study||0
9699875|NCT02648724|10799115|FG000|STARTED|Overall Study||3
9699876|NCT02648724|10799116|FG001|STARTED|Overall Study||3
9699877|NCT02648724|10799117|FG002|STARTED|Overall Study||3
9699878|NCT02648724|10799118|FG003|STARTED|Overall Study||3
9699879|NCT02648724|10799119|FG004|STARTED|Overall Study||25
9699880|NCT02648724|10799120|FG005|STARTED|Overall Study||8
9699881|NCT02648724|10799121|FG006|STARTED|Overall Study||12
9699882|NCT02648724|10799115|FG000|COMPLETED|Overall Study||0
9962378|NCT01477853|11081992|FG001|NOT COMPLETED|Phase B||11
9962379|NCT01477853|11081993|FG002|NOT COMPLETED|Phase B||11
9962380|NCT01477892|11082003|FG000|STARTED|Overall Study||7
9962381|NCT01477892|11082004|FG001|STARTED|Overall Study||7
9962382|NCT01477892|11082003|FG000|COMPLETED|Overall Study||7
9962383|NCT01477892|11082004|FG001|COMPLETED|Overall Study||5
9962384|NCT01477892|11082003|FG000|NOT COMPLETED|Overall Study||0
9962385|NCT01477892|11082004|FG001|NOT COMPLETED|Overall Study||2
9962386|NCT01478009|11082012|FG000|STARTED|Overall Study||50
9962387|NCT01478009|11082013|FG001|STARTED|Overall Study||50
9962388|NCT01478009|11082012|FG000|COMPLETED|Overall Study||49
9962389|NCT01478009|11082013|FG001|COMPLETED|Overall Study||49
9962390|NCT01478009|11082012|FG000|NOT COMPLETED|Overall Study||1
9962391|NCT01478009|11082013|FG001|NOT COMPLETED|Overall Study||1
9962392|NCT01478048|11082021|FG000|STARTED|Overall Study||77
9962393|NCT01478048|11082022|FG001|STARTED|Overall Study||75
9962394|NCT01478048|11082021|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
10026570|NCT01878292|11150644|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5
10026571|NCT01878292|11150645|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8
10026572|NCT01878292|11150646|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4
10026573|NCT01878383|11150656|FG000|STARTED|Overall Study||50
10026574|NCT01878383|11150657|FG001|STARTED|Overall Study||12500
10026575|NCT01878383|11150656|FG000|COMPLETED|Overall Study||50
10026576|NCT01878383|11150657|FG001|COMPLETED|Overall Study||11001
10026577|NCT01878383|11150656|FG000|NOT COMPLETED|Overall Study||0
9699883|NCT02648724|10799116|FG001|COMPLETED|Overall Study||0
9699884|NCT02648724|10799117|FG002|COMPLETED|Overall Study||0
9699885|NCT02648724|10799118|FG003|COMPLETED|Overall Study||0
9699886|NCT02648724|10799119|FG004|COMPLETED|Overall Study||0
9699887|NCT02648724|10799120|FG005|COMPLETED|Overall Study||0
9699888|NCT02648724|10799121|FG006|COMPLETED|Overall Study||0
9699889|NCT02648724|10799115|FG000|NOT COMPLETED|Overall Study||3
9699890|NCT02648724|10799116|FG001|NOT COMPLETED|Overall Study||3
9699891|NCT02648724|10799117|FG002|NOT COMPLETED|Overall Study||3
9699892|NCT02648724|10799118|FG003|NOT COMPLETED|Overall Study||3
9699893|NCT02648724|10799119|FG004|NOT COMPLETED|Overall Study||25
9699894|NCT02648724|10799120|FG005|NOT COMPLETED|Overall Study||8
9699895|NCT02648724|10799121|FG006|NOT COMPLETED|Overall Study||12
9699896|NCT02614794|10799155|FG000|STARTED|Overall Study||410
9699897|NCT02614794|10799156|FG001|STARTED|Overall Study||202
9699898|NCT02614794|10799155|FG000|COMPLETED|Overall Study||0
9699899|NCT02614794|10799156|FG001|COMPLETED|Overall Study||0
9699900|NCT02614794|10799155|FG000|NOT COMPLETED|Overall Study||410
9699901|NCT02614794|10799156|FG001|NOT COMPLETED|Overall Study||202
9699902|NCT02554474|10799164|FG000|STARTED|Overall Study||59
9699903|NCT02554474|10799165|FG001|STARTED|Overall Study||59
9699904|NCT02554474|10799164|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
9699905|NCT02554474|10799165|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
9699906|NCT02554474|10799164|FG000|NOT COMPLETED|Overall Study||3
9699907|NCT02554474|10799165|FG001|NOT COMPLETED|Overall Study||2
9699908|NCT02554318|10799173|FG000|STARTED|Overall Study||75
9699909|NCT02554318|10799174|FG001|STARTED|Overall Study||72
9699910|NCT02554318|10799173|FG000|COMPLETED|Overall Study||65
9699911|NCT02554318|10799174|FG001|COMPLETED|Overall Study||64
9699912|NCT02554318|10799173|FG000|NOT COMPLETED|Overall Study||10
9699913|NCT02554318|10799174|FG001|NOT COMPLETED|Overall Study||8
9699920|NCT02508532|10799202|FG000|STARTED|Part 1 - Dose Determining Period||6
9699921|NCT02508532|10799203|FG001|STARTED|Part 1 - Dose Determining Period||6
9699922|NCT02508532|10799204|FG002|STARTED|Part 1 - Dose Determining Period||6
9699923|NCT02508532|10799205|FG003|STARTED|Part 1 - Dose Determining Period||6
9699924|NCT02508532|10799206|FG004|STARTED|Part 1 - Dose Determining Period||6
9699925|NCT02508532|10799207|FG005|STARTED|Part 1 - Dose Determining Period||6
9699926|NCT02508532|10799208|FG006|STARTED|Part 1 - Dose Determining Period||7
9699927|NCT02508532|10799209|FG007|STARTED|Part 1 - Dose Determining Period||3
9699928|NCT02508532|10799210|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
9699929|NCT02508532|10799202|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
9699930|NCT02508532|10799203|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
9699931|NCT02508532|10799204|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
9699932|NCT02508532|10799205|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
9699933|NCT02508532|10799206|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
9699934|NCT02508532|10799207|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
9699935|NCT02508532|10799208|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
9699936|NCT02508532|10799209|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
9699937|NCT02508532|10799210|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
9699938|NCT02508532|10799202|FG000|COMPLETED|Part 1 - Dose Determining Period||6
9699939|NCT02508532|10799203|FG001|COMPLETED|Part 1 - Dose Determining Period||6
9699940|NCT02508532|10799204|FG002|COMPLETED|Part 1 - Dose Determining Period||6
9699941|NCT02508532|10799205|FG003|COMPLETED|Part 1 - Dose Determining Period||6
9699942|NCT02508532|10799206|FG004|COMPLETED|Part 1 - Dose Determining Period||6
9699943|NCT02508532|10799207|FG005|COMPLETED|Part 1 - Dose Determining Period||6
9699944|NCT02508532|10799208|FG006|COMPLETED|Part 1 - Dose Determining Period||6
9699945|NCT02508532|10799209|FG007|COMPLETED|Part 1 - Dose Determining Period||2
9699946|NCT02508532|10799210|FG008|COMPLETED|Part 1 - Dose Determining Period||0
9699947|NCT02508532|10799202|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0
9699948|NCT02508532|10799203|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0
9699949|NCT02508532|10799204|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0
9699950|NCT02508532|10799205|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0
9699951|NCT02508532|10799206|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0
9699952|NCT02508532|10799207|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0
9699953|NCT02508532|10799208|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1
9699954|NCT02508532|10799209|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1
9699955|NCT02508532|10799210|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0
9699956|NCT02508532|10799202|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
9699957|NCT02508532|10799203|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
9699958|NCT02508532|10799204|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
9699959|NCT02508532|10799205|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
9699960|NCT02508532|10799206|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
9699961|NCT02508532|10799207|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0
9699962|NCT02508532|10799208|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0
9699963|NCT02508532|10799209|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10115328|NCT02525471|11246199|FG000|COMPLETED|Overall Study||13
10115329|NCT02525471|11246199|FG000|NOT COMPLETED|Overall Study||11
10115330|NCT02525523|11246206|FG000|STARTED|Overall Study||69
10115331|NCT02525523|11246207|FG001|STARTED|Overall Study||69
10115332|NCT02525523|11246206|FG000|COMPLETED|Overall Study||46
10115333|NCT02525523|11246207|FG001|COMPLETED|Overall Study||44
10115334|NCT02525523|11246206|FG000|NOT COMPLETED|Overall Study||23
10115335|NCT02525523|11246207|FG001|NOT COMPLETED|Overall Study||25
9699964|NCT02508532|10799210|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
9699965|NCT02508532|10799202|FG000|COMPLETED|Part 2 - Treatment||0
9699966|NCT02508532|10799203|FG001|COMPLETED|Part 2 - Treatment||0
9699967|NCT02508532|10799204|FG002|COMPLETED|Part 2 - Treatment||0
9699968|NCT02508532|10799205|FG003|COMPLETED|Part 2 - Treatment||0
9699969|NCT02508532|10799206|FG004|COMPLETED|Part 2 - Treatment||0
9699970|NCT02508532|10799207|FG005|COMPLETED|Part 2 - Treatment||0
9699971|NCT02508532|10799208|FG006|COMPLETED|Part 2 - Treatment||0
9699972|NCT02508532|10799209|FG007|COMPLETED|Part 2 - Treatment||0
9699973|NCT02508532|10799210|FG008|COMPLETED|Part 2 - Treatment||0
9699974|NCT02508532|10799202|FG000|NOT COMPLETED|Part 2 - Treatment||0
9699975|NCT02508532|10799203|FG001|NOT COMPLETED|Part 2 - Treatment||0
9699976|NCT02508532|10799204|FG002|NOT COMPLETED|Part 2 - Treatment||0
9699977|NCT02508532|10799205|FG003|NOT COMPLETED|Part 2 - Treatment||0
9699978|NCT02508532|10799206|FG004|NOT COMPLETED|Part 2 - Treatment||0
9699979|NCT02508532|10799207|FG005|NOT COMPLETED|Part 2 - Treatment||0
9699980|NCT02508532|10799208|FG006|NOT COMPLETED|Part 2 - Treatment||0
9699981|NCT02508532|10799209|FG007|NOT COMPLETED|Part 2 - Treatment||0
9699982|NCT02508532|10799210|FG008|NOT COMPLETED|Part 2 - Treatment||217
9699983|NCT02508532|10799202|FG000|STARTED|Part 1 and Part 2 End of Study||6
9699984|NCT02508532|10799203|FG001|STARTED|Part 1 and Part 2 End of Study||6
9699985|NCT02508532|10799204|FG002|STARTED|Part 1 and Part 2 End of Study||6
9699986|NCT02508532|10799205|FG003|STARTED|Part 1 and Part 2 End of Study||6
9699987|NCT02508532|10799206|FG004|STARTED|Part 1 and Part 2 End of Study||6
9699988|NCT02508532|10799207|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
9699989|NCT02508532|10799208|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
9699990|NCT02508532|10799209|FG007|STARTED|Part 1 and Part 2 End of Study||3
9699991|NCT02508532|10799210|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
9699992|NCT02508532|10799202|FG000|COMPLETED|Part 1 and Part 2 End of Study||0
9699993|NCT02508532|10799203|FG001|COMPLETED|Part 1 and Part 2 End of Study||0
9699994|NCT02508532|10799204|FG002|COMPLETED|Part 1 and Part 2 End of Study||0
9699995|NCT02508532|10799205|FG003|COMPLETED|Part 1 and Part 2 End of Study||0
9699996|NCT02508532|10799206|FG004|COMPLETED|Part 1 and Part 2 End of Study||0
9699997|NCT02508532|10799207|FG005|COMPLETED|Part 1 and Part 2 End of Study||0
9699998|NCT02508532|10799208|FG006|COMPLETED|Part 1 and Part 2 End of Study||0
9699999|NCT02508532|10799209|FG007|COMPLETED|Part 1 and Part 2 End of Study||0
9700000|NCT02508532|10799210|FG008|COMPLETED|Part 1 and Part 2 End of Study||0
9700001|NCT02508532|10799202|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6
9700002|NCT02508532|10799203|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6
9700003|NCT02508532|10799204|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6
9700004|NCT02508532|10799205|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6
9700005|NCT02508532|10799206|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6
9700006|NCT02508532|10799207|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0
9700007|NCT02508532|10799208|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0
9700008|NCT02508532|10799209|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3
9700009|NCT02508532|10799210|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217
9700010|NCT02489318|10799241|FG000|STARTED|Randomized||527
9700011|NCT02489318|10799242|FG001|STARTED|Randomized||525
9700012|NCT02489318|10799241|FG000|COMPLETED|Randomized||527
9700013|NCT02489318|10799242|FG001|COMPLETED|Randomized||524
9700014|NCT02489318|10799241|FG000|NOT COMPLETED|Randomized||0
9700015|NCT02489318|10799242|FG001|NOT COMPLETED|Randomized||1
9700016|NCT02489318|10799241|FG000|STARTED|Treated||527
9700017|NCT02489318|10799242|FG001|STARTED|Treated||524
9700018|NCT02489318|10799241|FG000|COMPLETED|Treated|Participants crossed over from placebo to apalutamide after positive results at interim analysis.|208
9700019|NCT02489318|10799242|FG001|COMPLETED|Treated||0
9700020|NCT02489318|10799241|FG000|NOT COMPLETED|Treated||319
9700021|NCT02489318|10799242|FG001|NOT COMPLETED|Treated||524
9700022|NCT02454933|10794106|FG000|STARTED|Overall Study||17
9700023|NCT02454933|10794107|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
9727990|NCT00111475|10827691|FG009|STARTED|Overall Study||1
10026578|NCT01878383|11150657|FG001|NOT COMPLETED|Overall Study||1499
10026579|NCT01878526|11150665|FG000|STARTED|Overall Study||40
10026580|NCT01878526|11150666|FG001|STARTED|Overall Study||40
10026581|NCT01878526|11150665|FG000|COMPLETED|Overall Study||37
10026582|NCT01878526|11150666|FG001|COMPLETED|Overall Study||38
10026583|NCT01878526|11150665|FG000|NOT COMPLETED|Overall Study||3
10026584|NCT01878526|11150666|FG001|NOT COMPLETED|Overall Study||2
10026585|NCT01878604|11150673|FG000|STARTED|Overall Study||5
10026586|NCT01878604|11150673|FG000|COMPLETED|Overall Study||5
10026587|NCT01878604|11150673|FG000|NOT COMPLETED|Overall Study||0
10026588|NCT01878656|11150680|FG000|STARTED|Overall Study||72
9700024|NCT02454933|10794106|FG000|Treatment Group Randomised to|Overall Study||15
9700025|NCT02454933|10794107|FG001|Treatment Group Randomised to|Overall Study||14
9700026|NCT02454933|10794106|FG000|COMPLETED|Overall Study||9
9700027|NCT02454933|10794107|FG001|COMPLETED|Overall Study||4
9700028|NCT02454933|10794106|FG000|NOT COMPLETED|Overall Study||8
9700029|NCT02454933|10794107|FG001|NOT COMPLETED|Overall Study||8
9700030|NCT02426684|10794112|FG000|STARTED|Overall Study||17
9700031|NCT02426684|10794112|FG000|COMPLETED|Overall Study||16
9700032|NCT02426684|10794112|FG000|NOT COMPLETED|Overall Study||1
9700033|NCT02421939|10799251|FG000|STARTED|Overall Study||247
9700034|NCT02421939|10799252|FG001|STARTED|Overall Study||124
9700035|NCT02421939|10799251|FG000|Treated|Overall Study||246
9700036|NCT02421939|10799252|FG001|Treated|Overall Study||109
9700037|NCT02421939|10799251|FG000|COMPLETED|Overall Study||38
9700038|NCT02421939|10799252|FG001|COMPLETED|Overall Study||0
9700039|NCT02421939|10799251|FG000|NOT COMPLETED|Overall Study||209
9700040|NCT02421939|10799252|FG001|NOT COMPLETED|Overall Study||124
9700041|NCT02358031|10799261|FG000|STARTED|Overall Study||301
9700042|NCT02358031|10799262|FG001|STARTED|Overall Study||281
9700043|NCT02358031|10799263|FG002|STARTED|Overall Study||300
9700044|NCT02358031|10799261|FG000|Treated|Overall Study||300
9962395|NCT01478048|11082022|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
9962396|NCT01478048|11082021|FG000|COMPLETED|Overall Study||0
9962397|NCT01478048|11082022|FG001|COMPLETED|Overall Study||0
9962398|NCT01478048|11082021|FG000|NOT COMPLETED|Overall Study||77
9962399|NCT01478048|11082022|FG001|NOT COMPLETED|Overall Study||75
9962400|NCT01478087|11082028|FG000|STARTED|Overall Study||3
9962401|NCT01478087|11082028|FG000|COMPLETED|Overall Study||2
9962402|NCT01478087|11082028|FG000|NOT COMPLETED|Overall Study||1
9962403|NCT01478256|11082034|FG000|STARTED|Overall Study||15
9962404|NCT01478256|11082035|FG001|STARTED|Overall Study||15
9962405|NCT01478256|11082034|FG000|COMPLETED|Overall Study||15
9962406|NCT01478256|11082035|FG001|COMPLETED|Overall Study||15
9962407|NCT01478256|11082034|FG000|NOT COMPLETED|Overall Study||0
9962408|NCT01478256|11082035|FG001|NOT COMPLETED|Overall Study||0
9962409|NCT01478321|11082043|FG000|STARTED|Concurrent Therapy (5 Weeks)||54
9962410|NCT01478321|11082043|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38
10026589|NCT01878656|11150681|FG001|STARTED|Overall Study||72
10026590|NCT01878656|11150680|FG000|COMPLETED|Overall Study||72
10026591|NCT01878656|11150681|FG001|COMPLETED|Overall Study||72
10026592|NCT01878656|11150680|FG000|NOT COMPLETED|Overall Study||0
10026593|NCT01878656|11150681|FG001|NOT COMPLETED|Overall Study||0
10026594|NCT01878799|11150689|FG000|STARTED|Overall Study||37
10026595|NCT01878799|11150690|FG001|STARTED|Overall Study||13
10026596|NCT01878799|11150689|FG000|COMPLETED|Overall Study||36
10026597|NCT01878799|11150690|FG001|COMPLETED|Overall Study||13
10026598|NCT01878799|11150689|FG000|NOT COMPLETED|Overall Study||1
10026599|NCT01878799|11150690|FG001|NOT COMPLETED|Overall Study||0
10026600|NCT01878812|11150698|FG000|STARTED|Overall Study||60
10026601|NCT01878812|11150699|FG001|STARTED|Overall Study||57
10026602|NCT01878812|11150698|FG000|COMPLETED|Overall Study||60
10026603|NCT01878812|11150699|FG001|COMPLETED|Overall Study||57
10026604|NCT01878812|11150698|FG000|NOT COMPLETED|Overall Study||0
10026605|NCT01878812|11150699|FG001|NOT COMPLETED|Overall Study||0
10026606|NCT01878825|11150707|FG000|STARTED|Overall Study||60
10026607|NCT01878825|11150708|FG001|STARTED|Overall Study||60
10026608|NCT01878825|11150707|FG000|COMPLETED|Overall Study||60
10026609|NCT01878825|11150708|FG001|COMPLETED|Overall Study||60
10026610|NCT01878825|11150707|FG000|NOT COMPLETED|Overall Study||0
10026611|NCT01878825|11150708|FG001|NOT COMPLETED|Overall Study||0
10026612|NCT01878890|11150727|FG000|STARTED|Overall Study||5
10026613|NCT01878890|11150728|FG001|STARTED|Overall Study||11
10026614|NCT01878890|11150729|FG002|STARTED|Overall Study||4
10026615|NCT01878890|11150730|FG003|STARTED|Overall Study||5
10026616|NCT01878890|11150727|FG000|COMPLETED|Overall Study||5
10026617|NCT01878890|11150728|FG001|COMPLETED|Overall Study||10
9700045|NCT02358031|10799262|FG001|Treated|Overall Study||276
9700046|NCT02358031|10799263|FG002|Treated|Overall Study||287
9700047|NCT02358031|10799261|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301
9700048|NCT02358031|10799262|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0
9700049|NCT02358031|10799263|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300
9700050|NCT02358031|10799261|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0
9700051|NCT02358031|10799262|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281
9700052|NCT02358031|10799263|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278
9700053|NCT02358031|10799261|FG000|COMPLETED|Overall Study||0
9700054|NCT02358031|10799262|FG001|COMPLETED|Overall Study||0
9700055|NCT02358031|10799263|FG002|COMPLETED|Overall Study||0
9700056|NCT02358031|10799261|FG000|NOT COMPLETED|Overall Study||301
9700057|NCT02358031|10799262|FG001|NOT COMPLETED|Overall Study||281
9700058|NCT02358031|10799263|FG002|NOT COMPLETED|Overall Study||300
9700059|NCT02337751|10794118|FG000|STARTED|Overall Study||95
9700060|NCT02337751|10794119|FG001|STARTED|Overall Study||103
9700061|NCT02337751|10794118|FG000|COMPLETED|Overall Study||84
9700062|NCT02337751|10794119|FG001|COMPLETED|Overall Study||87
9700063|NCT02337751|10794118|FG000|NOT COMPLETED|Overall Study||11
9700064|NCT02337751|10794119|FG001|NOT COMPLETED|Overall Study||16
9700065|NCT02337725|10794128|FG000|STARTED|Overall Study||126
9700066|NCT02337725|10794129|FG001|STARTED|Overall Study||118
9700067|NCT02337725|10794128|FG000|COMPLETED|Overall Study||100
9700068|NCT02337725|10794129|FG001|COMPLETED|Overall Study||110
9700069|NCT02337725|10794128|FG000|NOT COMPLETED|Overall Study||26
9700070|NCT02337725|10794129|FG001|NOT COMPLETED|Overall Study||8
9700071|NCT02332655|10794135|FG000|STARTED|Overall Study||5
9700072|NCT02332655|10794135|FG000|COMPLETED|Overall Study||4
9700073|NCT02332655|10794135|FG000|NOT COMPLETED|Overall Study||1
9700074|NCT02317705|10799271|FG000|STARTED|Overall Study||48
9700075|NCT02317705|10799271|FG000|Safety Population|Overall Study||44
9700076|NCT02317705|10799271|FG000|Modified Intent-to-Treat (mITT)|Overall Study||29
9700077|NCT02317705|10799271|FG000|COMPLETED|Overall Study||43
9700078|NCT02317705|10799271|FG000|NOT COMPLETED|Overall Study||5
9700079|NCT02277444|10799275|FG000|STARTED|Overall Study||130
9700080|NCT02277444|10799275|FG000|Treated|Overall Study||127
9700081|NCT02277444|10799275|FG000|COMPLETED|Overall Study||0
9700082|NCT02277444|10799275|FG000|NOT COMPLETED|Overall Study||130
9700083|NCT02272803|10799281|FG000|STARTED|Overall Study||40
9700084|NCT02272803|10799282|FG001|STARTED|Overall Study||42
9700085|NCT02272803|10799281|FG000|COMPLETED|Overall Study||0
9700086|NCT02272803|10799282|FG001|COMPLETED|Overall Study||0
9700087|NCT02272803|10799281|FG000|NOT COMPLETED|Overall Study||40
9700088|NCT02272803|10799282|FG001|NOT COMPLETED|Overall Study||42
9700089|NCT02257736|10799290|FG000|STARTED|Overall Study||490
9700090|NCT02257736|10799291|FG001|STARTED|Overall Study||492
9700091|NCT02257736|10799290|FG000|COMPLETED|Overall Study||39
9700092|NCT02257736|10799291|FG001|COMPLETED|Overall Study||45
9700093|NCT02257736|10799290|FG000|NOT COMPLETED|Overall Study||451
9700094|NCT02257736|10799291|FG001|NOT COMPLETED|Overall Study||447
9700095|NCT02252172|10799299|FG000|STARTED|Overall Study||369
9700096|NCT02252172|10799300|FG001|STARTED|Overall Study||368
9700097|NCT02252172|10799299|FG000|Treated|Overall Study||365
9700098|NCT02252172|10799300|FG001|Treated|Overall Study||364
9700099|NCT02252172|10799299|FG000|COMPLETED|Overall Study||90
9700100|NCT02252172|10799300|FG001|COMPLETED|Overall Study||69
9700101|NCT02252172|10799299|FG000|NOT COMPLETED|Overall Study||279
9700102|NCT02252172|10799300|FG001|NOT COMPLETED|Overall Study||299
9700103|NCT02240134|10799309|FG000|STARTED|Overall Study||176
9700104|NCT02240134|10799310|FG001|STARTED|Overall Study||176
9700105|NCT02240134|10799311|FG002|STARTED|Overall Study||171
9700106|NCT02240134|10799309|FG000|COMPLETED|Overall Study||126
9700107|NCT02240134|10799310|FG001|COMPLETED|Overall Study||123
9700108|NCT02240134|10799311|FG002|COMPLETED|Overall Study||118
9700109|NCT02240134|10799309|FG000|NOT COMPLETED|Overall Study||50
9700110|NCT02240134|10799310|FG001|NOT COMPLETED|Overall Study||53
9700111|NCT02240134|10799311|FG002|NOT COMPLETED|Overall Study||53
9700112|NCT02197234|10799319|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
9700113|NCT02197234|10799319|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
9700114|NCT02197234|10799319|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
9700115|NCT02197234|10799319|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
9700116|NCT02197234|10799319|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
9700117|NCT02197234|10799319|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
9700118|NCT02197234|10799319|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
9700119|NCT02197234|10799319|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
9700120|NCT02197234|10799319|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
9700121|NCT02197234|10799319|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
9700122|NCT02197234|10799319|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
9700123|NCT02197234|10799319|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
9700124|NCT02195479|10799328|FG000|STARTED|Overall Study||356
9700125|NCT02195479|10799329|FG001|STARTED|Overall Study||350
9700126|NCT02195479|10799328|FG000|Treated|Overall Study||354
9700127|NCT02195479|10799329|FG001|Treated|Overall Study||346
9700128|NCT02195479|10799328|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
9700129|NCT02195479|10799329|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
9700130|NCT02195479|10799328|FG000|NOT COMPLETED|Overall Study||356
9700131|NCT02195479|10799329|FG001|NOT COMPLETED|Overall Study||350
9700132|NCT02158585|10799337|FG000|STARTED|Overall Study||8
9700133|NCT02158585|10799338|FG001|STARTED|Overall Study||7
9700134|NCT02158585|10799337|FG000|COMPLETED|Overall Study||7
9700135|NCT02158585|10799338|FG001|COMPLETED|Overall Study||6
9700136|NCT02158585|10799337|FG000|NOT COMPLETED|Overall Study||1
9962411|NCT01478321|11082043|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
9962412|NCT01478321|11082043|FG000|STARTED|Started Adjuvant Therapy||38
9962413|NCT01478321|11082043|FG000|Completed First Cycle|Started Adjuvant Therapy||37
10026618|NCT01878890|11150729|FG002|COMPLETED|Overall Study||4
10026619|NCT01878890|11150730|FG003|COMPLETED|Overall Study||5
10026620|NCT01878890|11150727|FG000|NOT COMPLETED|Overall Study||0
10026621|NCT01878890|11150728|FG001|NOT COMPLETED|Overall Study||1
10026622|NCT01878890|11150729|FG002|NOT COMPLETED|Overall Study||0
10115336|NCT02525536|11246216|FG000|STARTED|Overall Study||6
10115337|NCT02525536|11246217|FG001|STARTED|Overall Study||6
10115338|NCT02525536|11246218|FG002|STARTED|Overall Study||6
10115339|NCT02525536|11246216|FG000|COMPLETED|Overall Study||6
10115340|NCT02525536|11246217|FG001|COMPLETED|Overall Study||6
10115341|NCT02525536|11246218|FG002|COMPLETED|Overall Study||6
10115342|NCT02525536|11246216|FG000|NOT COMPLETED|Overall Study||0
10115343|NCT02525536|11246217|FG001|NOT COMPLETED|Overall Study||0
10115344|NCT02525536|11246218|FG002|NOT COMPLETED|Overall Study||0
10115345|NCT02525549|11246229|FG000|STARTED|Overall Study||365
10115346|NCT02525549|11246230|FG001|STARTED|Overall Study||360
10115347|NCT02525549|11246231|FG002|STARTED|Overall Study||178
10115348|NCT02525549|11246229|FG000|COMPLETED|Overall Study||330
10115349|NCT02525549|11246230|FG001|COMPLETED|Overall Study||307
10115350|NCT02525549|11246231|FG002|COMPLETED|Overall Study||159
10115351|NCT02525549|11246229|FG000|NOT COMPLETED|Overall Study||35
10115352|NCT02525549|11246230|FG001|NOT COMPLETED|Overall Study||53
10115353|NCT02525549|11246231|FG002|NOT COMPLETED|Overall Study||19
10115354|NCT02525575|11246239|FG000|STARTED|Overall Study||37
10115355|NCT02525575|11246239|FG000|COMPLETED|Overall Study||22
10115356|NCT02525575|11246239|FG000|NOT COMPLETED|Overall Study||15
10115357|NCT02525588|11246245|FG000|STARTED|Overall Study||48
10115358|NCT02525588|11246246|FG001|STARTED|Overall Study||48
10115359|NCT02525588|11246245|FG000|COMPLETED|Overall Study||42
10115360|NCT02525588|11246246|FG001|COMPLETED|Overall Study||45
10115361|NCT02525588|11246245|FG000|NOT COMPLETED|Overall Study||6
10115362|NCT02525588|11246246|FG001|NOT COMPLETED|Overall Study||3
10115363|NCT02525627|11246254|FG000|STARTED|Overall Study||16
10115364|NCT02525627|11246255|FG001|STARTED|Overall Study||18
10115365|NCT02525627|11246254|FG000|COMPLETED|Overall Study||2
10115366|NCT02525627|11246255|FG001|COMPLETED|Overall Study||5
10115367|NCT02525627|11246254|FG000|NOT COMPLETED|Overall Study||14
10115368|NCT02525627|11246255|FG001|NOT COMPLETED|Overall Study||13
10115369|NCT02525653|11246261|FG000|STARTED|Overall Study||40
10115370|NCT02525653|11246261|FG000|COMPLETED|Overall Study||40
10115371|NCT02525653|11246261|FG000|NOT COMPLETED|Overall Study||0
10115372|NCT02525718|11246267|FG000|STARTED|Overall Study||23
10115373|NCT02525718|11246268|FG001|STARTED|Overall Study||24
10115374|NCT02525718|11246267|FG000|COMPLETED|Overall Study||22
10115375|NCT02525718|11246268|FG001|COMPLETED|Overall Study||23
10115376|NCT02525718|11246267|FG000|NOT COMPLETED|Overall Study||1
10115377|NCT02525718|11246268|FG001|NOT COMPLETED|Overall Study||1
9962414|NCT01478321|11082043|FG000|COMPLETED|Started Adjuvant Therapy||37
9962415|NCT01478321|11082043|FG000|NOT COMPLETED|Started Adjuvant Therapy||1
10026623|NCT01878890|11150730|FG003|NOT COMPLETED|Overall Study||0
10026624|NCT01879059|11150741|FG000|STARTED|Overall Study||13
10026625|NCT01879059|11150741|FG000|COMPLETED|Overall Study||13
10026626|NCT01879059|11150741|FG000|NOT COMPLETED|Overall Study||0
10026627|NCT01879072|11150745|FG000|STARTED|Overall Study||1860
10026628|NCT01879072|11150745|FG000|COMPLETED|Overall Study||1709
10026629|NCT01879072|11150745|FG000|NOT COMPLETED|Overall Study||151
10026630|NCT01879176|11150751|FG000|STARTED|Overall Study||24
10026631|NCT01879176|11150752|FG001|STARTED|Overall Study||22
10026632|NCT01879176|11150751|FG000|COMPLETED|Overall Study||16
10026633|NCT01879176|11150752|FG001|COMPLETED|Overall Study||16
10026634|NCT01879176|11150751|FG000|NOT COMPLETED|Overall Study||8
9962416|NCT01478321|11082043|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37
9962417|NCT01478321|11082043|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
9962418|NCT01478321|11082043|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
10026635|NCT01879176|11150752|FG001|NOT COMPLETED|Overall Study||6
10026636|NCT01879319|11150760|FG000|STARTED|Overall Study||82
10115378|NCT02525744|11246274|FG000|STARTED|Period 1||6
9700137|NCT02158585|10799338|FG001|NOT COMPLETED|Overall Study||1
10026637|NCT01879319|11150761|FG001|STARTED|Overall Study||82
10115379|NCT02525744|11246275|FG001|STARTED|Period 1||6
10115380|NCT02525744|11246276|FG002|STARTED|Period 1||6
10115381|NCT02525744|11246277|FG003|STARTED|Period 1||6
10115382|NCT02525744|11246274|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
9700138|NCT02136134|10799347|FG000|STARTED|Overall Study||247
9700139|NCT02136134|10799348|FG001|STARTED|Overall Study||251
9700140|NCT02136134|10799347|FG000|Treated|Overall Study||237
9700141|NCT02136134|10799348|FG001|Treated|Overall Study||243
9700142|NCT02136134|10799347|FG000|COMPLETED|Overall Study||0
9700143|NCT02136134|10799348|FG001|COMPLETED|Overall Study||0
9700144|NCT02136134|10799347|FG000|NOT COMPLETED|Overall Study||247
9700145|NCT02136134|10799348|FG001|NOT COMPLETED|Overall Study||251
9700146|NCT02130687|10794142|FG000|STARTED|Washout||36
9700147|NCT02130687|10794143|FG001|STARTED|Washout||35
9700148|NCT02130687|10794144|FG002|STARTED|Washout||35
9700149|NCT02130687|10794142|FG000|COMPLETED|Washout||36
9700150|NCT02130687|10794143|FG001|COMPLETED|Washout||33
9700151|NCT02130687|10794144|FG002|COMPLETED|Washout||31
9700152|NCT02130687|10794142|FG000|NOT COMPLETED|Washout||0
9700153|NCT02130687|10794143|FG001|NOT COMPLETED|Washout||2
9700154|NCT02130687|10794144|FG002|NOT COMPLETED|Washout||4
9700155|NCT02130687|10794142|FG000|STARTED|Drug 1 Only||36
9700156|NCT02130687|10794143|FG001|STARTED|Drug 1 Only||33
9700157|NCT02130687|10794144|FG002|STARTED|Drug 1 Only||31
9700158|NCT02130687|10794142|FG000|COMPLETED|Drug 1 Only||33
9700159|NCT02130687|10794143|FG001|COMPLETED|Drug 1 Only||30
9700160|NCT02130687|10794144|FG002|COMPLETED|Drug 1 Only||30
9700161|NCT02130687|10794142|FG000|NOT COMPLETED|Drug 1 Only||3
9700162|NCT02130687|10794143|FG001|NOT COMPLETED|Drug 1 Only||3
9700163|NCT02130687|10794144|FG002|NOT COMPLETED|Drug 1 Only||1
9700164|NCT02130687|10794142|FG000|STARTED|Crossover Period 1||33
9700165|NCT02130687|10794143|FG001|STARTED|Crossover Period 1||30
9700166|NCT02130687|10794144|FG002|STARTED|Crossover Period 1||30
9700167|NCT02130687|10794142|FG000|COMPLETED|Crossover Period 1||33
9700168|NCT02130687|10794143|FG001|COMPLETED|Crossover Period 1||30
9700169|NCT02130687|10794144|FG002|COMPLETED|Crossover Period 1||30
9700170|NCT02130687|10794142|FG000|NOT COMPLETED|Crossover Period 1||0
9700171|NCT02130687|10794143|FG001|NOT COMPLETED|Crossover Period 1||0
9700172|NCT02130687|10794144|FG002|NOT COMPLETED|Crossover Period 1||0
9700173|NCT02130687|10794142|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33
9700174|NCT02130687|10794143|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30
9700175|NCT02130687|10794144|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30
9700176|NCT02130687|10794142|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
9700177|NCT02130687|10794143|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
9700178|NCT02130687|10794144|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
9700179|NCT02130687|10794142|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
9700180|NCT02130687|10794143|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
9700181|NCT02130687|10794144|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
9700182|NCT02130687|10794142|FG000|STARTED|Crossover Period 2||33
9700183|NCT02130687|10794143|FG001|STARTED|Crossover Period 2||26
9700184|NCT02130687|10794144|FG002|STARTED|Crossover Period 2||29
9700185|NCT02130687|10794142|FG000|COMPLETED|Crossover Period 2||33
9700186|NCT02130687|10794143|FG001|COMPLETED|Crossover Period 2||26
9700187|NCT02130687|10794144|FG002|COMPLETED|Crossover Period 2||29
9700188|NCT02130687|10794142|FG000|NOT COMPLETED|Crossover Period 2||0
9700189|NCT02130687|10794143|FG001|NOT COMPLETED|Crossover Period 2||0
9700190|NCT02130687|10794144|FG002|NOT COMPLETED|Crossover Period 2||0
9700191|NCT02130687|10794142|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33
9700192|NCT02130687|10794143|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26
9700193|NCT02130687|10794144|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29
9700194|NCT02130687|10794142|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
9700195|NCT02130687|10794143|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
9700196|NCT02130687|10794144|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
9700197|NCT02130687|10794142|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
9700198|NCT02130687|10794143|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
9700199|NCT02130687|10794144|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
9700200|NCT02130687|10794142|FG000|STARTED|Crossover Period 3||33
9700201|NCT02130687|10794143|FG001|STARTED|Crossover Period 3||25
9847740|NCT00855868|10960334|FG001|STARTED|Overall Study||15
9847741|NCT00855868|10960333|FG000|COMPLETED|Overall Study||12
9847742|NCT00855868|10960334|FG001|COMPLETED|Overall Study||14
9847743|NCT00855868|10960333|FG000|NOT COMPLETED|Overall Study||1
9847744|NCT00855868|10960334|FG001|NOT COMPLETED|Overall Study||1
9847745|NCT00855894|10960340|FG000|STARTED|Overall Study||41
9847746|NCT00855894|10960340|FG000|COMPLETED|Overall Study||8
9847747|NCT00855894|10960340|FG000|NOT COMPLETED|Overall Study||33
9847748|NCT00855920|10960347|FG000|STARTED|Overall Study||76
9847749|NCT00855920|10960348|FG001|STARTED|Overall Study||74
9847750|NCT00855920|10960349|FG002|STARTED|Overall Study||75
9847751|NCT00855920|10960347|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
9847752|NCT00855920|10960348|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
9847753|NCT00855920|10960349|FG002|Safety Population|Overall Study||75
9847754|NCT00855920|10960347|FG000|COMPLETED|Overall Study||68
9847755|NCT00855920|10960348|FG001|COMPLETED|Overall Study||65
9847756|NCT00855920|10960349|FG002|COMPLETED|Overall Study||64
9847757|NCT00855920|10960347|FG000|NOT COMPLETED|Overall Study||8
9847758|NCT00855920|10960348|FG001|NOT COMPLETED|Overall Study||9
9847759|NCT00855920|10960349|FG002|NOT COMPLETED|Overall Study||11
9847760|NCT00855933|10960359|FG000|STARTED|Overall Study||30
9847761|NCT00855933|10960360|FG001|STARTED|Overall Study||30
9847762|NCT00855933|10960359|FG000|COMPLETED|Overall Study||30
9847763|NCT00855933|10960360|FG001|COMPLETED|Overall Study||29
9847764|NCT00855933|10960359|FG000|NOT COMPLETED|Overall Study||0
9847765|NCT00855933|10960360|FG001|NOT COMPLETED|Overall Study||1
9847766|NCT00855959|10960366|FG000|STARTED|Overall Study||108
9847767|NCT00855959|10960366|FG000|Patients Who Received Pulmicort Respules|Overall Study||105
9847768|NCT00855959|10960366|FG000|COMPLETED|Overall Study||99
9847769|NCT00855959|10960366|FG000|NOT COMPLETED|Overall Study||9
9847770|NCT00856024|10960370|FG000|STARTED|Overall Study||902
9847771|NCT00856024|10960370|FG000|COMPLETED|Overall Study||902
9847772|NCT00856024|10960370|FG000|NOT COMPLETED|Overall Study||0
9847773|NCT00856050|10960376|FG000|STARTED|Overall Study||26
9847774|NCT00856050|10960376|FG000|COMPLETED|Overall Study||26
9847775|NCT00856050|10960376|FG000|NOT COMPLETED|Overall Study||0
9847776|NCT00856180|10960380|FG000|STARTED|Overall Study||20
9847777|NCT00856180|10960380|FG000|COMPLETED|Overall Study||0
9847778|NCT00856180|10960380|FG000|NOT COMPLETED|Overall Study||20
9847779|NCT00856193|10960386|FG000|STARTED|Period 1||16
9847780|NCT00856193|10960387|FG001|STARTED|Period 1||17
9847781|NCT00856193|10960386|FG000|COMPLETED|Period 1||16
9847782|NCT00856193|10960387|FG001|COMPLETED|Period 1||17
9847783|NCT00856193|10960386|FG000|NOT COMPLETED|Period 1||0
9847784|NCT00856193|10960387|FG001|NOT COMPLETED|Period 1||0
9847785|NCT00856193|10960386|FG000|STARTED|Period 2||16
9847786|NCT00856193|10960387|FG001|STARTED|Period 2||17
9847787|NCT00856193|10960386|FG000|COMPLETED|Period 2||16
9847788|NCT00856193|10960387|FG001|COMPLETED|Period 2||15
9847789|NCT00856193|10960386|FG000|NOT COMPLETED|Period 2||0
9847790|NCT00856193|10960387|FG001|NOT COMPLETED|Period 2||2
9847791|NCT00856206|10960395|FG000|STARTED|Overall Study||330
9847792|NCT00856206|10960396|FG001|STARTED|Overall Study||985
9847793|NCT00856206|10960395|FG000|COMPLETED|Overall Study||276
9847794|NCT00856206|10960396|FG001|COMPLETED|Overall Study||824
9847795|NCT00856206|10960395|FG000|NOT COMPLETED|Overall Study||54
9847796|NCT00856206|10960396|FG001|NOT COMPLETED|Overall Study||161
9847797|NCT00856232|10960405|FG000|STARTED|Overall Study||26
9847798|NCT00856232|10960406|FG001|STARTED|Overall Study||29
9847799|NCT00856232|10960407|FG002|STARTED|Overall Study||36
9847800|NCT00856232|10960405|FG000|COMPLETED|Overall Study||26
9847801|NCT00856232|10960406|FG001|COMPLETED|Overall Study||29
9847802|NCT00856232|10960407|FG002|COMPLETED|Overall Study||36
9847803|NCT00856232|10960405|FG000|NOT COMPLETED|Overall Study||0
10026638|NCT01879319|11150760|FG000|Received Treatment|Overall Study||82
10026639|NCT01879319|11150761|FG001|Received Treatment|Overall Study||82
9700202|NCT02130687|10794144|FG002|STARTED|Crossover Period 3||27
9700203|NCT02130687|10794142|FG000|COMPLETED|Crossover Period 3||33
10026640|NCT01879319|11150760|FG000|COMPLETED|Overall Study||80
9700204|NCT02130687|10794143|FG001|COMPLETED|Crossover Period 3||25
9700205|NCT02130687|10794144|FG002|COMPLETED|Crossover Period 3||27
9962419|NCT01478321|11082043|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
9700206|NCT02130687|10794142|FG000|NOT COMPLETED|Crossover Period 3||0
9700207|NCT02130687|10794143|FG001|NOT COMPLETED|Crossover Period 3||0
9700208|NCT02130687|10794144|FG002|NOT COMPLETED|Crossover Period 3||0
9700209|NCT02076009|10799356|FG000|STARTED|Overall Study||283
9700210|NCT02076009|10799357|FG001|STARTED|Overall Study||286
9700211|NCT02076009|10799356|FG000|Treated|Overall Study||281
9700212|NCT02076009|10799357|FG001|Treated|Overall Study||283
9700213|NCT02076009|10799356|FG000|COMPLETED|Overall Study||0
9700214|NCT02076009|10799357|FG001|COMPLETED|Overall Study||0
9700215|NCT02076009|10799356|FG000|NOT COMPLETED|Overall Study||283
9700216|NCT02076009|10799357|FG001|NOT COMPLETED|Overall Study||286
9700217|NCT02043678|10799365|FG000|STARTED|Overall Study||401
9700218|NCT02043678|10799366|FG001|STARTED|Overall Study||405
9700219|NCT02043678|10799365|FG000|Treated|Overall Study||390
9700220|NCT02043678|10799366|FG001|Treated|Overall Study||396
9700221|NCT02043678|10799365|FG000|COMPLETED|Overall Study||0
9700222|NCT02043678|10799366|FG001|COMPLETED|Overall Study||0
10026641|NCT01879319|11150761|FG001|COMPLETED|Overall Study||77
10026642|NCT01879319|11150760|FG000|NOT COMPLETED|Overall Study||2
10026643|NCT01879319|11150761|FG001|NOT COMPLETED|Overall Study||5
10026644|NCT01879332|11150770|FG000|STARTED|Overall Study||6
10026645|NCT01879332|11150771|FG001|STARTED|Overall Study||6
10026646|NCT01879332|11150772|FG002|STARTED|Overall Study||4
9700223|NCT02043678|10799365|FG000|NOT COMPLETED|Overall Study||401
9700224|NCT02043678|10799366|FG001|NOT COMPLETED|Overall Study||405
9700225|NCT01994382|10794187|FG000|STARTED|Overall Study||3
9700226|NCT01994382|10794188|FG001|STARTED|Overall Study||6
9700227|NCT01994382|10794189|FG002|STARTED|Overall Study||7
9700228|NCT01994382|10794190|FG003|STARTED|Overall Study||3
9700229|NCT01994382|10794191|FG004|STARTED|Overall Study||3
9700230|NCT01994382|10794192|FG005|STARTED|Overall Study||3
9700231|NCT01994382|10794193|FG006|STARTED|Overall Study||4
9700232|NCT01994382|10794194|FG007|STARTED|Overall Study||6
9700233|NCT01994382|10794195|FG008|STARTED|Overall Study||3
9700234|NCT01994382|10794196|FG009|STARTED|Overall Study||5
9700235|NCT01994382|10794197|FG010|STARTED|Overall Study||42
9700236|NCT01994382|10794198|FG011|STARTED|Overall Study||12
9700237|NCT01994382|10794199|FG012|STARTED|Overall Study||26
9700238|NCT01994382|10794200|FG013|STARTED|Overall Study||6
9700239|NCT01994382|10794201|FG014|STARTED|Overall Study||28
9700240|NCT01994382|10794202|FG015|STARTED|Overall Study||65
9700241|NCT01994382|10794203|FG016|STARTED|Overall Study||41
9700242|NCT01994382|10794187|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9700243|NCT01994382|10794188|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9700244|NCT01994382|10794189|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
9700245|NCT01994382|10794190|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
9700246|NCT01994382|10794191|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
9700247|NCT01994382|10794192|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
9700248|NCT01994382|10794193|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
9700249|NCT01994382|10794194|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
9700250|NCT01994382|10794195|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
9700251|NCT01994382|10794196|FG009|Received at Least 1 Dose of Study Drug|Overall Study||5
9700252|NCT01994382|10794197|FG010|Received at Least 1 Dose of Study Drug|Overall Study||42
9700253|NCT01994382|10794198|FG011|Received at Least 1 Dose of Study Drug|Overall Study||12
9700254|NCT01994382|10794199|FG012|Received at Least 1 Dose of Study Drug|Overall Study||26
9700255|NCT01994382|10794200|FG013|Received at Least 1 Dose of Study Drug|Overall Study||6
9700256|NCT01994382|10794201|FG014|Received at Least 1 Dose of Study Drug|Overall Study||28
10026647|NCT01879332|11150770|FG000|COMPLETED|Overall Study||0
10026648|NCT01879332|11150771|FG001|COMPLETED|Overall Study||0
10026649|NCT01879332|11150772|FG002|COMPLETED|Overall Study||0
10026650|NCT01879332|11150770|FG000|NOT COMPLETED|Overall Study||6
10026651|NCT01879332|11150771|FG001|NOT COMPLETED|Overall Study||6
9700257|NCT01994382|10794202|FG015|Received at Least 1 Dose of Study Drug|Overall Study||65
9700258|NCT01994382|10794203|FG016|Received at Least 1 Dose of Study Drug|Overall Study||41
9700259|NCT01994382|10794187|FG000|COMPLETED|Overall Study||0
9700260|NCT01994382|10794188|FG001|COMPLETED|Overall Study||0
9700261|NCT01994382|10794189|FG002|COMPLETED|Overall Study||0
9700262|NCT01994382|10794190|FG003|COMPLETED|Overall Study||0
9700263|NCT01994382|10794191|FG004|COMPLETED|Overall Study||0
9700264|NCT01994382|10794192|FG005|COMPLETED|Overall Study||0
10026652|NCT01879332|11150772|FG002|NOT COMPLETED|Overall Study||4
10026653|NCT01879345|11150783|FG000|STARTED|Single-dose Period||6
10026654|NCT01879345|11150784|FG001|STARTED|Single-dose Period||6
10026655|NCT01879345|11150785|FG002|STARTED|Single-dose Period||6
10026656|NCT01879345|11150783|FG000|COMPLETED|Single-dose Period||6
10026657|NCT01879345|11150784|FG001|COMPLETED|Single-dose Period||6
10026658|NCT01879345|11150785|FG002|COMPLETED|Single-dose Period||6
10026659|NCT01879345|11150783|FG000|NOT COMPLETED|Single-dose Period||0
10026660|NCT01879345|11150784|FG001|NOT COMPLETED|Single-dose Period||0
10026661|NCT01879345|11150785|FG002|NOT COMPLETED|Single-dose Period||0
10026662|NCT01879345|11150783|FG000|STARTED|7-day Multiple-dose Period||6
10026663|NCT01879345|11150784|FG001|STARTED|7-day Multiple-dose Period||6
10026664|NCT01879345|11150785|FG002|STARTED|7-day Multiple-dose Period||6
10026665|NCT01879345|11150783|FG000|COMPLETED|7-day Multiple-dose Period||6
10026666|NCT01879345|11150784|FG001|COMPLETED|7-day Multiple-dose Period||6
10026667|NCT01879345|11150785|FG002|COMPLETED|7-day Multiple-dose Period||6
10026668|NCT01879345|11150783|FG000|NOT COMPLETED|7-day Multiple-dose Period||0
10026669|NCT01879345|11150784|FG001|NOT COMPLETED|7-day Multiple-dose Period||0
10026670|NCT01879345|11150785|FG002|NOT COMPLETED|7-day Multiple-dose Period||0
10026671|NCT01879371|11150801|FG000|STARTED|Overall Study||6
10026672|NCT01879371|11150802|FG001|STARTED|Overall Study||6
10026673|NCT01879371|11150803|FG002|STARTED|Overall Study||6
10026674|NCT01879371|11150804|FG003|STARTED|Overall Study||6
10026675|NCT01879371|11150805|FG004|STARTED|Overall Study||6
10026676|NCT01879371|11150806|FG005|STARTED|Overall Study||6
10026677|NCT01879371|11150801|FG000|COMPLETED|Overall Study||6
9700265|NCT01994382|10794193|FG006|COMPLETED|Overall Study||0
9847804|NCT00856232|10960406|FG001|NOT COMPLETED|Overall Study||0
10026678|NCT01879371|11150802|FG001|COMPLETED|Overall Study||6
10026679|NCT01879371|11150803|FG002|COMPLETED|Overall Study||6
10026680|NCT01879371|11150804|FG003|COMPLETED|Overall Study||6
10026681|NCT01879371|11150805|FG004|COMPLETED|Overall Study||6
10026682|NCT01879371|11150806|FG005|COMPLETED|Overall Study||6
10026683|NCT01879371|11150801|FG000|NOT COMPLETED|Overall Study||0
10026684|NCT01879371|11150802|FG001|NOT COMPLETED|Overall Study||0
10026685|NCT01879371|11150803|FG002|NOT COMPLETED|Overall Study||0
10026686|NCT01879371|11150804|FG003|NOT COMPLETED|Overall Study||0
10026687|NCT01879371|11150805|FG004|NOT COMPLETED|Overall Study||0
10026688|NCT01879371|11150806|FG005|NOT COMPLETED|Overall Study||0
10026689|NCT01879410|11150816|FG000|STARTED|Overall Study||350
10026690|NCT01879410|11150817|FG001|STARTED|Overall Study||350
10026691|NCT01879410|11150816|FG000|Intent-to-Treat Population|Overall Study||349
10026692|NCT01879410|11150817|FG001|Intent-to-Treat Population|Overall Study||348
10026693|NCT01879410|11150816|FG000|COMPLETED|Overall Study||326
10026694|NCT01879410|11150817|FG001|COMPLETED|Overall Study||312
10026695|NCT01879410|11150816|FG000|NOT COMPLETED|Overall Study||24
10026696|NCT01879410|11150817|FG001|NOT COMPLETED|Overall Study||38
10026697|NCT01879540|11150823|FG000|STARTED|Overall Study||63
10026698|NCT01879540|11150823|FG000|COMPLETED|Overall Study||63
10026699|NCT01879540|11150823|FG000|NOT COMPLETED|Overall Study||0
10026700|NCT01879553|11150829|FG000|STARTED|Overall Study||63
10026701|NCT01879553|11150830|FG001|STARTED|Overall Study||63
10026702|NCT01879553|11150829|FG000|COMPLETED|Overall Study||62
10026703|NCT01879553|11150830|FG001|COMPLETED|Overall Study||63
10026704|NCT01879553|11150829|FG000|NOT COMPLETED|Overall Study||1
10026705|NCT01879553|11150830|FG001|NOT COMPLETED|Overall Study||0
10026706|NCT01879579|11150839|FG000|STARTED|Overall Study||33
10026707|NCT01879579|11150840|FG001|STARTED|Overall Study||28
10026708|NCT01879579|11150839|FG000|COMPLETED|Overall Study||28
10026709|NCT01879579|11150840|FG001|COMPLETED|Overall Study||26
10026710|NCT01879579|11150839|FG000|NOT COMPLETED|Overall Study||5
10026711|NCT01879579|11150840|FG001|NOT COMPLETED|Overall Study||2
10115383|NCT02525744|11246275|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
9700266|NCT01994382|10794194|FG007|COMPLETED|Overall Study||0
9700267|NCT01994382|10794195|FG008|COMPLETED|Overall Study||0
9700268|NCT01994382|10794196|FG009|COMPLETED|Overall Study||0
9700269|NCT01994382|10794197|FG010|COMPLETED|Overall Study||0
10026712|NCT01879618|11150849|FG000|STARTED|Overall Study||152
10026713|NCT01879618|11150849|FG000|COMPLETED|Overall Study||131
10026714|NCT01879618|11150849|FG000|NOT COMPLETED|Overall Study||21
10026715|NCT01879683|11150853|FG000|STARTED|Overall Study||10
10026716|NCT01879683|11150853|FG000|COMPLETED|Overall Study||9
9700270|NCT01994382|10794198|FG011|COMPLETED|Overall Study||0
9700271|NCT01994382|10794199|FG012|COMPLETED|Overall Study||0
9700272|NCT01994382|10794200|FG013|COMPLETED|Overall Study||0
9700273|NCT01994382|10794201|FG014|COMPLETED|Overall Study||0
9700274|NCT01994382|10794202|FG015|COMPLETED|Overall Study||0
9700275|NCT01994382|10794203|FG016|COMPLETED|Overall Study||0
9700276|NCT01994382|10794187|FG000|NOT COMPLETED|Overall Study||3
9700277|NCT01994382|10794188|FG001|NOT COMPLETED|Overall Study||6
9700278|NCT01994382|10794189|FG002|NOT COMPLETED|Overall Study||7
9700279|NCT01994382|10794190|FG003|NOT COMPLETED|Overall Study||3
9700280|NCT01994382|10794191|FG004|NOT COMPLETED|Overall Study||3
9700281|NCT01994382|10794192|FG005|NOT COMPLETED|Overall Study||3
9700282|NCT01994382|10794193|FG006|NOT COMPLETED|Overall Study||4
9700283|NCT01994382|10794194|FG007|NOT COMPLETED|Overall Study||6
9700284|NCT01994382|10794195|FG008|NOT COMPLETED|Overall Study||3
9700285|NCT01994382|10794196|FG009|NOT COMPLETED|Overall Study||5
9700286|NCT01994382|10794197|FG010|NOT COMPLETED|Overall Study||42
9700287|NCT01994382|10794198|FG011|NOT COMPLETED|Overall Study||12
9700288|NCT01994382|10794199|FG012|NOT COMPLETED|Overall Study||26
9700289|NCT01994382|10794200|FG013|NOT COMPLETED|Overall Study||6
9700290|NCT01994382|10794201|FG014|NOT COMPLETED|Overall Study||28
9700291|NCT01994382|10794202|FG015|NOT COMPLETED|Overall Study||65
9700292|NCT01994382|10794203|FG016|NOT COMPLETED|Overall Study||41
9700293|NCT01896531|10794248|FG000|STARTED|Overall Study||71
9700294|NCT01896531|10794249|FG001|STARTED|Overall Study||82
9700295|NCT01896531|10794248|FG000|Treated|Overall Study||70
9700296|NCT01896531|10794249|FG001|Treated|Overall Study||82
9700297|NCT01896531|10794248|FG000|COMPLETED|Overall Study||0
9700298|NCT01896531|10794249|FG001|COMPLETED|Overall Study||0
9700299|NCT01896531|10794248|FG000|NOT COMPLETED|Overall Study||71
9700300|NCT01896531|10794249|FG001|NOT COMPLETED|Overall Study||82
9700301|NCT01864603|10794257|FG000|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|79818
9700302|NCT01864603|10794258|FG001|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|70577
9700303|NCT01864603|10794257|FG000|COMPLETED|Stage 1||71028
9700304|NCT01864603|10794258|FG001|COMPLETED|Stage 1||62912
9700305|NCT01864603|10794257|FG000|NOT COMPLETED|Stage 1||8790
9700306|NCT01864603|10794258|FG001|NOT COMPLETED|Stage 1||7665
9700307|NCT01864603|10794257|FG000|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|91533
9700308|NCT01864603|10794258|FG001|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|92558
9700309|NCT01864603|10794257|FG000|COMPLETED|Stage 2||5477
9700310|NCT01864603|10794258|FG001|COMPLETED|Stage 2||0
9700311|NCT01864603|10794257|FG000|NOT COMPLETED|Stage 2||86056
9700312|NCT01864603|10794258|FG001|NOT COMPLETED|Stage 2||92558
9700313|NCT01828099|10799374|FG000|STARTED|Overall Study||189
9700314|NCT01828099|10799375|FG001|STARTED|Overall Study||187
9700315|NCT01828099|10799374|FG000|Untreated Patients|Overall Study||0
9700316|NCT01828099|10799375|FG001|Untreated Patients|Overall Study||12
9700317|NCT01828099|10799374|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189
9700318|NCT01828099|10799375|FG001|Treated|Overall Study||175
9700319|NCT01828099|10799374|FG000|Discontinued From Treatment Phase|Overall Study||94
9700320|NCT01828099|10799375|FG001|Discontinued From Treatment Phase|Overall Study||157
9700321|NCT01828099|10799374|FG000|Entered Extension-treatment Phase|Overall Study||0
9700322|NCT01828099|10799375|FG001|Entered Extension-treatment Phase|Overall Study||81
9700323|NCT01828099|10799374|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10
9700324|NCT01828099|10799375|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16
9700325|NCT01828099|10799374|FG000|Entered Survival Follow-up Phase|Overall Study||64
9700326|NCT01828099|10799375|FG001|Entered Survival Follow-up Phase|Overall Study||31
9700327|NCT01828099|10799374|FG000|Discontinued From Study|Overall Study||20
9700328|NCT01828099|10799375|FG001|Discontinued From Study|Overall Study||29
9700329|NCT01828099|10799374|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
9700330|NCT01828099|10799375|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
9700331|NCT01828099|10799374|FG000|NOT COMPLETED|Overall Study||94
9700332|NCT01828099|10799375|FG001|NOT COMPLETED|Overall Study||157
9700333|NCT01757535|10799383|FG000|STARTED|Overall Study||238
9700334|NCT01757535|10799384|FG001|STARTED|Overall Study||234
9700335|NCT01757535|10799383|FG000|Received Treatment|Overall Study||236
9700336|NCT01757535|10799384|FG001|Received Treatment|Overall Study||233
9700337|NCT01757535|10799383|FG000|COMPLETED|Overall Study||45
9700338|NCT01757535|10799384|FG001|COMPLETED|Overall Study||26
9700339|NCT01757535|10799383|FG000|NOT COMPLETED|Overall Study||193
9700340|NCT01757535|10799384|FG001|NOT COMPLETED|Overall Study||208
9700341|NCT01719744|10799390|FG000|STARTED|Overall Study||25
9700342|NCT01719744|10799390|FG000|COMPLETED|Overall Study||25
9700343|NCT01719744|10799390|FG000|NOT COMPLETED|Overall Study||0
9700344|NCT01684722|10799398|FG000|STARTED|Overall Study||333
9700345|NCT01684722|10799399|FG001|STARTED|Overall Study||289
9700346|NCT01684722|10799400|FG002|STARTED|Overall Study||320
9700347|NCT01684722|10799401|FG003|STARTED|Overall Study||370
9700348|NCT01684722|10799398|FG000|COMPLETED|Overall Study||236
9700349|NCT01684722|10799399|FG001|COMPLETED|Overall Study||212
9700350|NCT01684722|10799400|FG002|COMPLETED|Overall Study||226
9700351|NCT01684722|10799401|FG003|COMPLETED|Overall Study||260
9700352|NCT01684722|10799398|FG000|NOT COMPLETED|Overall Study||97
9700353|NCT01684722|10799399|FG001|NOT COMPLETED|Overall Study||77
9700354|NCT01684722|10799400|FG002|NOT COMPLETED|Overall Study||94
9700355|NCT01684722|10799401|FG003|NOT COMPLETED|Overall Study||110
9700356|NCT01615029|10799421|FG000|STARTED|Overall Study||3
9700357|NCT01615029|10799422|FG001|STARTED|Overall Study||3
9700358|NCT01615029|10799423|FG002|STARTED|Overall Study||4
9700359|NCT01615029|10799424|FG003|STARTED|Overall Study||3
9700360|NCT01615029|10799425|FG004|STARTED|Overall Study||32
9700361|NCT01615029|10799421|FG000|COMPLETED|Overall Study||0
9700362|NCT01615029|10799422|FG001|COMPLETED|Overall Study||0
9700363|NCT01615029|10799423|FG002|COMPLETED|Overall Study||0
9700364|NCT01615029|10799424|FG003|COMPLETED|Overall Study||0
9700365|NCT01615029|10799425|FG004|COMPLETED|Overall Study||0
9700366|NCT01615029|10799421|FG000|NOT COMPLETED|Overall Study||3
9700367|NCT01615029|10799422|FG001|NOT COMPLETED|Overall Study||3
9700368|NCT01615029|10799423|FG002|NOT COMPLETED|Overall Study||4
9700369|NCT01615029|10799424|FG003|NOT COMPLETED|Overall Study||3
9700370|NCT01615029|10799425|FG004|NOT COMPLETED|Overall Study||32
9700371|NCT01516346|10799440|FG000|STARTED|Overall Study||13
9700372|NCT01516346|10799441|FG001|STARTED|Overall Study||15
9700373|NCT01516346|10799442|FG002|STARTED|Overall Study||16
9700374|NCT01516346|10799440|FG000|COMPLETED|Overall Study||7
9700375|NCT01516346|10799441|FG001|COMPLETED|Overall Study||9
9700376|NCT01516346|10799442|FG002|COMPLETED|Overall Study||11
9700377|NCT01516346|10799440|FG000|NOT COMPLETED|Overall Study||6
9700378|NCT01516346|10799441|FG001|NOT COMPLETED|Overall Study||6
9700379|NCT01516346|10799442|FG002|NOT COMPLETED|Overall Study||5
9700380|NCT01399372|10799452|FG000|STARTED|Overall Study||47
9700381|NCT01399372|10799453|FG001|STARTED|Overall Study||44
9700382|NCT01399372|10799452|FG000|Eligible|Overall Study||44
9700383|NCT01399372|10799453|FG001|Eligible|Overall Study||43
9700384|NCT01399372|10799452|FG000|Eligible and Started Protocol Treatment|Overall Study||43
9700385|NCT01399372|10799453|FG001|Eligible and Started Protocol Treatment|Overall Study||43
9700386|NCT01399372|10799452|FG000|COMPLETED|Overall Study||44
9700387|NCT01399372|10799453|FG001|COMPLETED|Overall Study||43
9700388|NCT01399372|10799452|FG000|NOT COMPLETED|Overall Study||3
9700389|NCT01399372|10799453|FG001|NOT COMPLETED|Overall Study||1
9700390|NCT01314118|10799459|FG000|STARTED|Overall Study||131
9700391|NCT01314118|10799459|FG000|COMPLETED|Overall Study||0
9700392|NCT01314118|10799459|FG000|NOT COMPLETED|Overall Study||131
9700393|NCT01303796|10799465|FG000|STARTED|Lead In Phase||21
9700394|NCT01303796|10799466|FG001|STARTED|Lead In Phase|Intend-to-Treat study subject population|0
9700395|NCT01303796|10799467|FG002|STARTED|Lead In Phase|Intend-to-Treat study subject population|0
9700396|NCT01303796|10799465|FG000|COMPLETED|Lead In Phase||21
9700397|NCT01303796|10799466|FG001|COMPLETED|Lead In Phase||0
9700398|NCT01303796|10799467|FG002|COMPLETED|Lead In Phase||0
9700399|NCT01303796|10799465|FG000|NOT COMPLETED|Lead In Phase||0
9700400|NCT01303796|10799466|FG001|NOT COMPLETED|Lead In Phase||0
9700401|NCT01303796|10799467|FG002|NOT COMPLETED|Lead In Phase||0
9700402|NCT01303796|10799465|FG000|STARTED|Randomized Phase III||0
9700403|NCT01303796|10799466|FG001|STARTED|Randomized Phase III||241
9700404|NCT01303796|10799467|FG002|STARTED|Randomized Phase III||241
9700405|NCT01303796|10799465|FG000|COMPLETED|Randomized Phase III||0
9700406|NCT01303796|10799466|FG001|COMPLETED|Randomized Phase III||241
9700407|NCT01303796|10799467|FG002|COMPLETED|Randomized Phase III||241
9700408|NCT01303796|10799465|FG000|NOT COMPLETED|Randomized Phase III||0
9700409|NCT01303796|10799466|FG001|NOT COMPLETED|Randomized Phase III||0
9700410|NCT01303796|10799467|FG002|NOT COMPLETED|Randomized Phase III||0
9700411|NCT01235923|10799476|FG000|STARTED|Overall Study||10
9700412|NCT01235923|10799477|FG001|STARTED|Overall Study||10
9700413|NCT01235923|10799476|FG000|COMPLETED|Overall Study||10
10115384|NCT02525744|11246276|FG002|Received at Least 1 Dose of Study Drug|Period 1||5
10115385|NCT02525744|11246277|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10115386|NCT02525744|11246274|FG000|COMPLETED|Period 1||6
10115387|NCT02525744|11246275|FG001|COMPLETED|Period 1||6
10115388|NCT02525744|11246276|FG002|COMPLETED|Period 1||5
9700414|NCT01235923|10799477|FG001|COMPLETED|Overall Study||10
9700415|NCT01235923|10799476|FG000|NOT COMPLETED|Overall Study||0
9700416|NCT01235923|10799477|FG001|NOT COMPLETED|Overall Study||0
9700417|NCT01171898|10799487|FG000|STARTED|Overall Study||30
9700418|NCT01171898|10799488|FG001|STARTED|Overall Study||51
10115389|NCT02525744|11246277|FG003|COMPLETED|Period 1||6
10115390|NCT02525744|11246274|FG000|NOT COMPLETED|Period 1||0
9700419|NCT01171898|10799489|FG002|STARTED|Overall Study||25
9700420|NCT01171898|10799490|FG003|STARTED|Overall Study||21
9700421|NCT01171898|10799487|FG000|COMPLETED|Overall Study||26
9700422|NCT01171898|10799488|FG001|COMPLETED|Overall Study||32
9700423|NCT01171898|10799489|FG002|COMPLETED|Overall Study||13
9700424|NCT01171898|10799490|FG003|COMPLETED|Overall Study||15
9700425|NCT01171898|10799487|FG000|NOT COMPLETED|Overall Study||4
9700426|NCT01171898|10799488|FG001|NOT COMPLETED|Overall Study||19
9700427|NCT01171898|10799489|FG002|NOT COMPLETED|Overall Study||12
9700428|NCT01171898|10799490|FG003|NOT COMPLETED|Overall Study||6
9700429|NCT01120964|10799505|FG000|STARTED|Overall Study||11
9700430|NCT01120964|10799506|FG001|STARTED|Overall Study||11
9700431|NCT01120964|10799505|FG000|COMPLETED|Overall Study||10
9700432|NCT01120964|10799506|FG001|COMPLETED|Overall Study||11
9700433|NCT01120964|10799505|FG000|NOT COMPLETED|Overall Study||1
9700434|NCT01120964|10799506|FG001|NOT COMPLETED|Overall Study||0
9700435|NCT01082211|10799512|FG000|STARTED|Overall Study||65
9700436|NCT01082211|10799512|FG000|Has Baseline PT QOL Data|Overall Study||46
9700437|NCT01082211|10799512|FG000|Has Baseline MD QOL Data|Overall Study||44
9700438|NCT01082211|10799512|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36
9700439|NCT01082211|10799512|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35
9700440|NCT01082211|10799512|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32
9700441|NCT01082211|10799512|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27
9700442|NCT01082211|10799512|FG000|All Eligible Patients|Overall Study||58
9700443|NCT01082211|10799512|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
9700444|NCT01082211|10799512|FG000|NOT COMPLETED|Overall Study||7
9700445|NCT01080196|10799521|FG000|STARTED|Overall Study||68
9700446|NCT01080196|10799522|FG001|STARTED|Overall Study||66
9700447|NCT01080196|10799521|FG000|COMPLETED|Overall Study||68
9700448|NCT01080196|10799522|FG001|COMPLETED|Overall Study||66
9700449|NCT01080196|10799521|FG000|NOT COMPLETED|Overall Study||0
9700450|NCT01080196|10799522|FG001|NOT COMPLETED|Overall Study||0
9700451|NCT00976911|10799532|FG000|STARTED|Overall Study||182
9700452|NCT00976911|10799533|FG001|STARTED|Overall Study||179
9700453|NCT00976911|10799532|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
9700454|NCT00976911|10799533|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
9700455|NCT00976911|10799532|FG000|NOT COMPLETED|Overall Study||182
9700456|NCT00976911|10799533|FG001|NOT COMPLETED|Overall Study||179
10026717|NCT01879683|11150853|FG000|NOT COMPLETED|Overall Study||1
10026718|NCT01879722|11150867|FG000|STARTED|Overall Study||7
10026719|NCT01879722|11150868|FG001|STARTED|Overall Study||8
9700457|NCT00746590|10799539|FG000|STARTED|Overall Study||1
9700458|NCT00746590|10799539|FG000|COMPLETED|Overall Study||0
9700459|NCT00746590|10799539|FG000|NOT COMPLETED|Overall Study||1
9700460|NCT00712582|10799546|FG000|STARTED|Overall Study||60
9700461|NCT00712582|10799547|FG001|STARTED|Overall Study||32
9700462|NCT00712582|10799548|FG002|STARTED|Overall Study||4
9700463|NCT00712582|10799546|FG000|COMPLETED|Overall Study||60
9700464|NCT00712582|10799547|FG001|COMPLETED|Overall Study||32
9700465|NCT00712582|10799548|FG002|COMPLETED|Overall Study||4
9700466|NCT00712582|10799546|FG000|NOT COMPLETED|Overall Study||0
9700467|NCT00712582|10799547|FG001|NOT COMPLETED|Overall Study||0
9700468|NCT00712582|10799548|FG002|NOT COMPLETED|Overall Study||0
9700469|NCT00693238|10799558|FG000|STARTED|Overall Study||122
9700470|NCT00693238|10799559|FG001|STARTED|Overall Study||106
9700471|NCT00693238|10799558|FG000|COMPLETED|Overall Study||122
9700472|NCT00693238|10799559|FG001|COMPLETED|Overall Study||106
9700473|NCT00693238|10799558|FG000|NOT COMPLETED|Overall Study||0
9700474|NCT00693238|10799559|FG001|NOT COMPLETED|Overall Study||0
9700475|NCT00679783|10799572|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4
9700476|NCT00679783|10799573|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13
9700477|NCT00679783|10799574|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3
9700478|NCT00679783|10799575|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45
9700479|NCT00679783|10799576|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5
9700480|NCT00679783|10799577|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5
9700481|NCT00679783|10799578|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16
9700482|NCT00679783|10799572|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
9700483|NCT00679783|10799573|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
9700484|NCT00679783|10799574|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
9700485|NCT00679783|10799575|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
9700486|NCT00679783|10799576|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
9700487|NCT00679783|10799577|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
9700488|NCT00679783|10799578|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
10026720|NCT01879722|11150869|FG002|STARTED|Overall Study||7
9700489|NCT00679783|10799572|FG000|NOT COMPLETED|Overall Study||2
9700490|NCT00679783|10799573|FG001|NOT COMPLETED|Overall Study||3
9700491|NCT00679783|10799574|FG002|NOT COMPLETED|Overall Study||1
9700492|NCT00679783|10799575|FG003|NOT COMPLETED|Overall Study||20
10026721|NCT01879722|11150870|FG003|STARTED|Overall Study||8
10026722|NCT01879722|11150871|FG004|STARTED|Overall Study||8
9700493|NCT00679783|10799576|FG004|NOT COMPLETED|Overall Study||1
9700494|NCT00679783|10799577|FG005|NOT COMPLETED|Overall Study||0
9700495|NCT00679783|10799578|FG006|NOT COMPLETED|Overall Study||1
9700496|NCT00573131|10799596|FG000|STARTED|Overall Study||72
9700497|NCT00573131|10799597|FG001|STARTED|Overall Study||65
9700498|NCT00573131|10799596|FG000|COMPLETED|Overall Study||62
9700499|NCT00573131|10799597|FG001|COMPLETED|Overall Study||57
9700500|NCT00573131|10799596|FG000|NOT COMPLETED|Overall Study||10
9700501|NCT00573131|10799597|FG001|NOT COMPLETED|Overall Study||8
9700502|NCT00533949|10799607|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
9700503|NCT00533949|10799608|FG001|STARTED|Overall Study||121
9700504|NCT00533949|10799609|FG002|STARTED|Overall Study||147
9700505|NCT00533949|10799610|FG003|STARTED|Overall Study||110
9700506|NCT00533949|10799607|FG000|COMPLETED|Overall Study||151
9700507|NCT00533949|10799608|FG001|COMPLETED|Overall Study||107
9700508|NCT00533949|10799609|FG002|COMPLETED|Overall Study||137
9700509|NCT00533949|10799610|FG003|COMPLETED|Overall Study||100
9700510|NCT00533949|10799607|FG000|NOT COMPLETED|Overall Study||15
9700511|NCT00533949|10799608|FG001|NOT COMPLETED|Overall Study||14
9700512|NCT00533949|10799609|FG002|NOT COMPLETED|Overall Study||10
9700513|NCT00533949|10799610|FG003|NOT COMPLETED|Overall Study||10
9700514|NCT00529763|10799631|FG000|STARTED|Overall Study||25
9700515|NCT00529763|10799632|FG001|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
9700516|NCT00529763|10799633|FG002|STARTED|Overall Study||59
9700517|NCT00529763|10799631|FG000|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
9700518|NCT00529763|10799632|FG001|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
9700519|NCT00529763|10799633|FG002|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
9700520|NCT00529763|10799631|FG000|NOT COMPLETED|Overall Study||10
9700521|NCT00529763|10799632|FG001|NOT COMPLETED|Overall Study||33
9700522|NCT00529763|10799633|FG002|NOT COMPLETED|Overall Study||7
9700523|NCT00479765|10799648|FG000|STARTED|Overall Study||4
9700524|NCT00479765|10799648|FG000|COMPLETED|Overall Study||0
9700525|NCT00479765|10799648|FG000|NOT COMPLETED|Overall Study||4
9700526|NCT00450411|10799652|FG000|STARTED|Overall Study||100
9700527|NCT00450411|10799652|FG000|Eligible and Started Protocol Treatment|Overall Study||92
9700528|NCT00450411|10799652|FG000|COMPLETED|Overall Study||92
9700529|NCT00450411|10799652|FG000|NOT COMPLETED|Overall Study||8
9700530|NCT00412880|10799656|FG000|STARTED|Overall Study||23
9700531|NCT00412880|10799656|FG000|COMPLETED|Overall Study||0
9700532|NCT00412880|10799656|FG000|NOT COMPLETED|Overall Study||23
9700533|NCT00376623|10799663|FG000|STARTED|Overall Study||49
9700534|NCT00376623|10799664|FG001|STARTED|Overall Study||26
9700535|NCT00376623|10799665|FG002|STARTED|Overall Study||21
9700536|NCT00376623|10799663|FG000|Treated With BI 2536|Overall Study||48
9700537|NCT00376623|10799664|FG001|Treated With BI 2536|Overall Study||26
9700538|NCT00376623|10799665|FG002|Treated With BI 2536|Overall Study||21
9700539|NCT00376623|10799663|FG000|COMPLETED|Overall Study||0
9700540|NCT00376623|10799664|FG001|COMPLETED|Overall Study||0
9700541|NCT00376623|10799665|FG002|COMPLETED|Overall Study||0
9700542|NCT00376623|10799663|FG000|NOT COMPLETED|Overall Study||49
9847805|NCT00856232|10960407|FG002|NOT COMPLETED|Overall Study||0
9962420|NCT01478321|11082043|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
9962421|NCT01478321|11082043|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
9962422|NCT01478321|11082043|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
9962423|NCT01478347|11082047|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
9962424|NCT01478347|11082047|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
9847806|NCT00856245|10960417|FG000|STARTED|Overall Study||19
9847807|NCT00856245|10960417|FG000|COMPLETED|Overall Study||14
9847808|NCT00856245|10960417|FG000|NOT COMPLETED|Overall Study||5
9847809|NCT00856284|10960424|FG000|STARTED|Overall Study||880
9847810|NCT00856284|10960425|FG001|STARTED|Overall Study||885
9847811|NCT00856284|10960426|FG002|STARTED|Overall Study||874
9847812|NCT00856284|10960424|FG000|Received Study Drug|Overall Study||873
9847813|NCT00856284|10960425|FG001|Received Study Drug|Overall Study||878
9847814|NCT00856284|10960426|FG002|Received Study Drug|Overall Study||869
9847815|NCT00856284|10960424|FG000|COMPLETED|Overall Study||472
9847816|NCT00856284|10960425|FG001|COMPLETED|Overall Study||493
9847817|NCT00856284|10960426|FG002|COMPLETED|Overall Study||427
9847818|NCT00856284|10960424|FG000|NOT COMPLETED|Overall Study||408
9847819|NCT00856284|10960425|FG001|NOT COMPLETED|Overall Study||392
9700543|NCT00376623|10799664|FG001|NOT COMPLETED|Overall Study||26
9700544|NCT00376623|10799665|FG002|NOT COMPLETED|Overall Study||21
9700545|NCT00288080|10799681|FG000|STARTED|Overall Study||307
9700546|NCT00288080|10799682|FG001|STARTED|Overall Study||305
9700547|NCT00288080|10799681|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
9700548|NCT00288080|10799682|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
9700549|NCT00288080|10799681|FG000|NOT COMPLETED|Overall Study||26
9847820|NCT00856284|10960426|FG002|NOT COMPLETED|Overall Study||447
9847821|NCT00856297|10960439|FG000|STARTED|Overall Study||131
9847822|NCT00856297|10960440|FG001|STARTED|Overall Study||76
9847823|NCT00856297|10960441|FG002|STARTED|Overall Study||107
9847824|NCT00856297|10960442|FG003|STARTED|Overall Study||44
9847825|NCT00856297|10960443|FG004|STARTED|Overall Study||31
9847826|NCT00856297|10960439|FG000|COMPLETED|Overall Study||129
9847827|NCT00856297|10960440|FG001|COMPLETED|Overall Study||76
9847828|NCT00856297|10960441|FG002|COMPLETED|Overall Study||107
9847829|NCT00856297|10960442|FG003|COMPLETED|Overall Study||44
9847830|NCT00856297|10960443|FG004|COMPLETED|Overall Study||31
9847831|NCT00856297|10960439|FG000|NOT COMPLETED|Overall Study||2
9847832|NCT00856297|10960440|FG001|NOT COMPLETED|Overall Study||0
9847833|NCT00856297|10960441|FG002|NOT COMPLETED|Overall Study||0
9847834|NCT00856297|10960442|FG003|NOT COMPLETED|Overall Study||0
9847835|NCT00856297|10960443|FG004|NOT COMPLETED|Overall Study||0
9847836|NCT00856323|10960460|FG000|STARTED|Overall Study||53
9847837|NCT00856323|10960460|FG000|COMPLETED|Overall Study||51
9847838|NCT00856323|10960460|FG000|NOT COMPLETED|Overall Study||2
9847839|NCT00856349|10960464|FG000|STARTED|Overall Study||4132
9847840|NCT00856349|10960464|FG000|12 Month Follow-up|Overall Study||3228
9847841|NCT00856349|10960464|FG000|18 Month Follow-up|Overall Study||2467
9847842|NCT00856349|10960464|FG000|24 Month Follow-up|Overall Study||1698
9847843|NCT00856349|10960464|FG000|COMPLETED|Overall Study||3111
9847844|NCT00856349|10960464|FG000|NOT COMPLETED|Overall Study||1021
9847845|NCT00856375|10960472|FG000|STARTED|Overall Study||42
9847846|NCT00856375|10960473|FG001|STARTED|Overall Study||41
9847847|NCT00856375|10960472|FG000|COMPLETED|Overall Study||0
9847848|NCT00856375|10960473|FG001|COMPLETED|Overall Study||0
9847849|NCT00856375|10960472|FG000|NOT COMPLETED|Overall Study||42
9847850|NCT00856375|10960473|FG001|NOT COMPLETED|Overall Study||41
9847851|NCT00856388|10960479|FG000|STARTED|Overall Study||62
9847852|NCT00856388|10960479|FG000|COMPLETED|Overall Study||61
9847853|NCT00856388|10960479|FG000|NOT COMPLETED|Overall Study||1
9847854|NCT00856414|10960484|FG000|STARTED|Overall Study||45
9847855|NCT00856414|10960484|FG000|COMPLETED|Overall Study||45
9847856|NCT00856414|10960484|FG000|NOT COMPLETED|Overall Study||0
9847857|NCT00856492|10960491|FG000|STARTED|Overall Study||99
9847858|NCT00856492|10960492|FG001|STARTED|Overall Study||63
9847859|NCT00856492|10960493|FG002|STARTED|Overall Study||53
9847860|NCT00856492|10960491|FG000|Toxicity Eval|Overall Study||96
9847861|NCT00856492|10960492|FG001|Toxicity Eval|Overall Study||60
9847862|NCT00856492|10960493|FG002|Toxicity Eval|Overall Study||51
9847863|NCT00856492|10960491|FG000|COMPLETED|Overall Study||98
9847864|NCT00856492|10960492|FG001|COMPLETED|Overall Study||62
9847865|NCT00856492|10960493|FG002|COMPLETED|Overall Study||51
9847866|NCT00856492|10960491|FG000|NOT COMPLETED|Overall Study||1
9847867|NCT00856492|10960492|FG001|NOT COMPLETED|Overall Study||1
9847868|NCT00856492|10960493|FG002|NOT COMPLETED|Overall Study||2
9847869|NCT00856518|10960506|FG000|STARTED|Overall Study||24
9847870|NCT00856518|10960507|FG001|STARTED|Overall Study||18
9847871|NCT00856518|10960506|FG000|COMPLETED|Overall Study||20
9847872|NCT00856518|10960507|FG001|COMPLETED|Overall Study||16
9847873|NCT00856518|10960506|FG000|NOT COMPLETED|Overall Study||4
9847874|NCT00856518|10960507|FG001|NOT COMPLETED|Overall Study||2
9847875|NCT00856544|10960519|FG000|STARTED|Overall Study||318
9847876|NCT00856544|10960520|FG001|STARTED|Overall Study||318
9847877|NCT00856544|10960521|FG002|STARTED|Overall Study||79
9700550|NCT00288080|10799682|FG001|NOT COMPLETED|Overall Study||23
9700551|NCT00194714|10799688|FG000|STARTED|Overall Study|Number of patients consented|22
9700552|NCT00194714|10799688|FG000|COMPLETED|Overall Study|Number of patients that received study treatment with the study vaccine|21
9700553|NCT00194714|10799688|FG000|NOT COMPLETED|Overall Study||1
9847878|NCT00856544|10960522|FG003|STARTED|Overall Study||80
9847879|NCT00856544|10960519|FG000|Treated|Overall Study||315
9847880|NCT00856544|10960520|FG001|Treated|Overall Study||318
9700554|NCT00099437|10799694|FG000|STARTED|Overall Study|randomised patients|374
9700555|NCT00099437|10799695|FG001|STARTED|Overall Study|randomised patients|362
9700556|NCT00099437|10799694|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
9700557|NCT00099437|10799695|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
9700558|NCT00099437|10799694|FG000|NOT COMPLETED|Overall Study||366
9700559|NCT00099437|10799695|FG001|NOT COMPLETED|Overall Study||349
9727991|NCT00111475|10827682|FG000|COMPLETED|Overall Study||4
9727992|NCT00111475|10827683|FG001|COMPLETED|Overall Study||4
9727993|NCT00111475|10827684|FG002|COMPLETED|Overall Study||4
9727994|NCT00111475|10827685|FG003|COMPLETED|Overall Study||4
9727995|NCT00111475|10827686|FG004|COMPLETED|Overall Study||4
9727996|NCT00111475|10827687|FG005|COMPLETED|Overall Study||3
9727997|NCT00111475|10827688|FG006|COMPLETED|Overall Study||4
9727998|NCT00111475|10827689|FG007|COMPLETED|Overall Study||8
9727999|NCT00111475|10827690|FG008|COMPLETED|Overall Study||8
9728000|NCT00111475|10827691|FG009|COMPLETED|Overall Study||1
9728001|NCT00111475|10827682|FG000|NOT COMPLETED|Overall Study||0
9728002|NCT00111475|10827683|FG001|NOT COMPLETED|Overall Study||0
9728003|NCT00111475|10827684|FG002|NOT COMPLETED|Overall Study||0
9728004|NCT00111475|10827685|FG003|NOT COMPLETED|Overall Study||0
9728005|NCT00111475|10827686|FG004|NOT COMPLETED|Overall Study||0
9728006|NCT00111475|10827687|FG005|NOT COMPLETED|Overall Study||1
9728007|NCT00111475|10827688|FG006|NOT COMPLETED|Overall Study||0
9728008|NCT00111475|10827689|FG007|NOT COMPLETED|Overall Study||0
9728009|NCT00111475|10827690|FG008|NOT COMPLETED|Overall Study||0
9728010|NCT00111475|10827691|FG009|NOT COMPLETED|Overall Study||0
9728011|NCT00111657|10827718|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
9728012|NCT00111657|10827718|FG000|COMPLETED|Overall Study|Completed all intended doses.|21
9728013|NCT00111657|10827718|FG000|NOT COMPLETED|Overall Study||16
9728014|NCT00111761|10827726|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0
9728015|NCT00111761|10827727|FG001|STARTED|Part 1||19
9728016|NCT00111761|10827726|FG000|COMPLETED|Part 1||0
9728017|NCT00111761|10827727|FG001|COMPLETED|Part 1|Completed through safety followup|14
9728018|NCT00111761|10827726|FG000|NOT COMPLETED|Part 1||0
9728019|NCT00111761|10827727|FG001|NOT COMPLETED|Part 1||5
9728020|NCT00111761|10827726|FG000|STARTED|Part 2||24
9728021|NCT00111761|10827727|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0
9728022|NCT00111761|10827726|FG000|COMPLETED|Part 2||16
9728023|NCT00111761|10827727|FG001|COMPLETED|Part 2||0
9728024|NCT00111761|10827726|FG000|NOT COMPLETED|Part 2||8
9962425|NCT01478347|11082047|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
9962426|NCT01478347|11082047|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
9962427|NCT01478347|11082047|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
9962428|NCT01478347|11082047|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
9962429|NCT01478360|11082053|FG000|STARTED|Overall Study||31
9962430|NCT01478360|11082054|FG001|STARTED|Overall Study||15
9962431|NCT01478360|11082053|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31
9962432|NCT01478360|11082054|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15
9962433|NCT01478360|11082053|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
9962434|NCT01478360|11082054|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0
9962435|NCT01478360|11082053|FG000|COMPLETED|Overall Study||29
9962436|NCT01478360|11082054|FG001|COMPLETED|Overall Study||12
9962437|NCT01478360|11082053|FG000|NOT COMPLETED|Overall Study||2
9962438|NCT01478360|11082054|FG001|NOT COMPLETED|Overall Study||3
9962439|NCT01478373|11082060|FG000|STARTED|Treatment Phase||39
9962440|NCT01478373|11082060|FG000|COMPLETED|Treatment Phase||38
9962441|NCT01478373|11082060|FG000|NOT COMPLETED|Treatment Phase||1
9962442|NCT01478373|11082060|FG000|STARTED|Survival Phase||38
9962443|NCT01478373|11082060|FG000|COMPLETED|Survival Phase||0
9962444|NCT01478373|11082060|FG000|NOT COMPLETED|Survival Phase||38
9962445|NCT01478581|11082068|FG000|STARTED|Overall Study||13
9962446|NCT01478581|11082069|FG001|STARTED|Overall Study||18
9962447|NCT01478581|11082070|FG002|STARTED|Overall Study||18
9962448|NCT01478581|11082071|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
9962449|NCT01478581|11082068|FG000|COMPLETED|Overall Study||13
9962450|NCT01478581|11082069|FG001|COMPLETED|Overall Study||18
9962451|NCT01478581|11082070|FG002|COMPLETED|Overall Study||18
9962452|NCT01478581|11082071|FG003|COMPLETED|Overall Study||43
9962453|NCT01478581|11082068|FG000|NOT COMPLETED|Overall Study||0
9962454|NCT01478581|11082069|FG001|NOT COMPLETED|Overall Study||0
9962455|NCT01478581|11082070|FG002|NOT COMPLETED|Overall Study||0
9962456|NCT01478581|11082071|FG003|NOT COMPLETED|Overall Study||0
9962457|NCT01478594|11082087|FG000|STARTED|Overall Study||177
9962458|NCT01478594|11082088|FG001|STARTED|Overall Study||88
9962459|NCT01478594|11082087|FG000|Treated|Overall Study||177
9962460|NCT01478594|11082088|FG001|Treated|Overall Study||87
9962461|NCT01478594|11082087|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
9962462|NCT01478594|11082088|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
9962463|NCT01478594|11082087|FG000|NOT COMPLETED|Overall Study||65
9962464|NCT01478594|11082088|FG001|NOT COMPLETED|Overall Study||28
9962465|NCT01478620|11082147|FG000|STARTED|Overall Study||125
9962466|NCT01478620|11082147|FG000|COMPLETED|Overall Study||119
9962467|NCT01478620|11082147|FG000|NOT COMPLETED|Overall Study||6
10026723|NCT01879722|11150872|FG005|STARTED|Overall Study||9
10026724|NCT01879722|11150873|FG006|STARTED|Overall Study||8
10026725|NCT01879722|11150874|FG007|STARTED|Overall Study||8
10026726|NCT01879722|11150875|FG008|STARTED|Overall Study||8
10026727|NCT01879722|11150876|FG009|STARTED|Overall Study||6
10026728|NCT01879722|11150867|FG000|COMPLETED|Overall Study||7
10026729|NCT01879722|11150868|FG001|COMPLETED|Overall Study||7
10026730|NCT01879722|11150869|FG002|COMPLETED|Overall Study||7
10026731|NCT01879722|11150870|FG003|COMPLETED|Overall Study||7
10026732|NCT01879722|11150871|FG004|COMPLETED|Overall Study||7
10026733|NCT01879722|11150872|FG005|COMPLETED|Overall Study||9
10115391|NCT02525744|11246275|FG001|NOT COMPLETED|Period 1||0
10115392|NCT02525744|11246276|FG002|NOT COMPLETED|Period 1||1
10115393|NCT02525744|11246277|FG003|NOT COMPLETED|Period 1||0
10115394|NCT02525744|11246274|FG000|STARTED|Period 2||6
10115395|NCT02525744|11246275|FG001|STARTED|Period 2||6
10115396|NCT02525744|11246276|FG002|STARTED|Period 2||5
10115397|NCT02525744|11246277|FG003|STARTED|Period 2||6
10115398|NCT02525744|11246274|FG000|Received at Least 1 Dose of Study Drug|Period 2||6
10115399|NCT02525744|11246275|FG001|Received at Least 1 Dose of Study Drug|Period 2||6
10115400|NCT02525744|11246276|FG002|Received at Least 1 Dose of Study Drug|Period 2||5
10115401|NCT02525744|11246277|FG003|Received at Least 1 Dose of Study Drug|Period 2||6
10115402|NCT02525744|11246274|FG000|COMPLETED|Period 2||6
10115403|NCT02525744|11246275|FG001|COMPLETED|Period 2||6
10115404|NCT02525744|11246276|FG002|COMPLETED|Period 2||5
10115405|NCT02525744|11246277|FG003|COMPLETED|Period 2||6
10115406|NCT02525744|11246274|FG000|NOT COMPLETED|Period 2||0
9962468|NCT01478828|11082151|FG000|STARTED|Overall Study||2
9962469|NCT01478828|11082151|FG000|COMPLETED|Overall Study||1
9962470|NCT01478828|11082151|FG000|NOT COMPLETED|Overall Study||1
9962471|NCT01478854|11082156|FG000|STARTED|Overall Study||30
9962472|NCT01478854|11082156|FG000|COMPLETED|Overall Study||30
9962473|NCT01478854|11082156|FG000|NOT COMPLETED|Overall Study||0
9962474|NCT01478958|11082163|FG000|STARTED|Overall Study||67
9962475|NCT01478958|11082164|FG001|STARTED|Overall Study||66
9962476|NCT01478958|11082165|FG002|STARTED|Overall Study||69
9962477|NCT01478958|11082163|FG000|COMPLETED|Overall Study||65
9962478|NCT01478958|11082164|FG001|COMPLETED|Overall Study||64
10026734|NCT01879722|11150873|FG006|COMPLETED|Overall Study||8
10026735|NCT01879722|11150874|FG007|COMPLETED|Overall Study||7
10026736|NCT01879722|11150875|FG008|COMPLETED|Overall Study||6
10115407|NCT02525744|11246275|FG001|NOT COMPLETED|Period 2||0
9700563|NCT02883673|10799705|FG000|STARTED|Overall Study||107
9700564|NCT02883673|10799705|FG000|COMPLETED|Overall Study||107
10026737|NCT01879722|11150876|FG009|COMPLETED|Overall Study||6
10026738|NCT01879722|11150867|FG000|NOT COMPLETED|Overall Study||0
9700565|NCT02883673|10799705|FG000|NOT COMPLETED|Overall Study||0
9728025|NCT00111761|10827727|FG001|NOT COMPLETED|Part 2||0
9728026|NCT00111800|10827739|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64
9728027|NCT00111800|10827740|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61
9728028|NCT00111800|10827741|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63
9728029|NCT00111800|10827742|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66
9728030|NCT00111800|10827743|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60
9728031|NCT00111800|10827744|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61
9728032|NCT00111800|10827739|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49
9728033|NCT00111800|10827740|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47
9728034|NCT00111800|10827741|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54
9728035|NCT00111800|10827742|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60
9728036|NCT00111800|10827743|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55
9728037|NCT00111800|10827744|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56
9728038|NCT00111800|10827739|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
9728039|NCT00111800|10827740|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
9728040|NCT00111800|10827741|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
9728041|NCT00111800|10827742|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
9728042|NCT00111800|10827743|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
9728043|NCT00111800|10827744|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
9728044|NCT00111800|10827739|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48
9728045|NCT00111800|10827740|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47
9728046|NCT00111800|10827741|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54
9728047|NCT00111800|10827742|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59
9728048|NCT00111800|10827743|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55
9728049|NCT00111800|10827744|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55
9728050|NCT00111800|10827739|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
9728051|NCT00111800|10827740|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
9728052|NCT00111800|10827741|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
9728053|NCT00111800|10827742|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
9728054|NCT00111800|10827743|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
9728055|NCT00111800|10827744|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
9728056|NCT00111800|10827739|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
9728057|NCT00111800|10827740|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
9728058|NCT00111800|10827741|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
9847881|NCT00856544|10960521|FG002|Treated|Overall Study||79
9847882|NCT00856544|10960522|FG003|Treated|Overall Study||80
9847883|NCT00856544|10960519|FG000|COMPLETED|Overall Study||261
10026739|NCT01879722|11150868|FG001|NOT COMPLETED|Overall Study||1
9700566|NCT02878785|10799710|FG000|STARTED|Overall Study||3
9700567|NCT02878785|10799711|FG001|STARTED|Overall Study||0
9700568|NCT02878785|10799712|FG002|STARTED|Overall Study||0
9700569|NCT02878785|10799713|FG003|STARTED|Overall Study||0
9700570|NCT02878785|10799714|FG004|STARTED|Overall Study||0
9700571|NCT02878785|10799715|FG005|STARTED|Overall Study||0
9700572|NCT02878785|10799716|FG006|STARTED|Overall Study||0
9700573|NCT02878785|10799717|FG007|STARTED|Overall Study||0
9700574|NCT02878785|10799718|FG008|STARTED|Overall Study||3
9700575|NCT02878785|10799719|FG009|STARTED|Overall Study||7
9700576|NCT02878785|10799720|FG010|STARTED|Overall Study||3
9700577|NCT02878785|10799721|FG011|STARTED|Overall Study||3
9700578|NCT02878785|10799722|FG012|STARTED|Overall Study||3
9700579|NCT02878785|10799723|FG013|STARTED|Overall Study||3
9700580|NCT02878785|10799710|FG000|COMPLETED|Overall Study||3
9700581|NCT02878785|10799711|FG001|COMPLETED|Overall Study||0
9700582|NCT02878785|10799712|FG002|COMPLETED|Overall Study||0
9700583|NCT02878785|10799713|FG003|COMPLETED|Overall Study||0
9700584|NCT02878785|10799714|FG004|COMPLETED|Overall Study||0
9700585|NCT02878785|10799715|FG005|COMPLETED|Overall Study||0
9700586|NCT02878785|10799716|FG006|COMPLETED|Overall Study||0
9700587|NCT02878785|10799717|FG007|COMPLETED|Overall Study||0
9700588|NCT02878785|10799718|FG008|COMPLETED|Overall Study||3
9700589|NCT02878785|10799719|FG009|COMPLETED|Overall Study||7
9700590|NCT02878785|10799720|FG010|COMPLETED|Overall Study||3
9700591|NCT02878785|10799721|FG011|COMPLETED|Overall Study||3
9700592|NCT02878785|10799722|FG012|COMPLETED|Overall Study||3
9700593|NCT02878785|10799723|FG013|COMPLETED|Overall Study||3
9700594|NCT02878785|10799710|FG000|NOT COMPLETED|Overall Study||0
9700595|NCT02878785|10799711|FG001|NOT COMPLETED|Overall Study||0
9700596|NCT02878785|10799712|FG002|NOT COMPLETED|Overall Study||0
9700597|NCT02878785|10799713|FG003|NOT COMPLETED|Overall Study||0
9700598|NCT02878785|10799714|FG004|NOT COMPLETED|Overall Study||0
9700599|NCT02878785|10799715|FG005|NOT COMPLETED|Overall Study||0
9700600|NCT02878785|10799716|FG006|NOT COMPLETED|Overall Study||0
9700601|NCT02878785|10799717|FG007|NOT COMPLETED|Overall Study||0
9700602|NCT02878785|10799718|FG008|NOT COMPLETED|Overall Study||0
9700603|NCT02878785|10799719|FG009|NOT COMPLETED|Overall Study||0
9700604|NCT02878785|10799720|FG010|NOT COMPLETED|Overall Study||0
9700605|NCT02878785|10799721|FG011|NOT COMPLETED|Overall Study||0
9700606|NCT02878785|10799722|FG012|NOT COMPLETED|Overall Study||0
9700607|NCT02878785|10799723|FG013|NOT COMPLETED|Overall Study||0
9728059|NCT00111800|10827742|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
9728060|NCT00111800|10827743|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
9728061|NCT00111800|10827744|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
9728062|NCT00111813|10827767|FG000|STARTED|Overall Study||3
9728063|NCT00111813|10827768|FG001|STARTED|Overall Study||3
9728064|NCT00111813|10827769|FG002|STARTED|Overall Study||10
9728065|NCT00111813|10827770|FG003|STARTED|Overall Study||6
9728066|NCT00111813|10827771|FG004|STARTED|Overall Study||6
9728067|NCT00111813|10827772|FG005|STARTED|Overall Study||6
9728068|NCT00111813|10827767|FG000|COMPLETED|Overall Study||0
9728069|NCT00111813|10827768|FG001|COMPLETED|Overall Study||0
10026740|NCT01879722|11150869|FG002|NOT COMPLETED|Overall Study||0
10026741|NCT01879722|11150870|FG003|NOT COMPLETED|Overall Study||1
9700608|NCT04794270|10799740|FG000|STARTED|Period 1||35
9700609|NCT04794270|10799741|FG001|STARTED|Period 1||36
9700610|NCT04794270|10799740|FG000|COMPLETED|Period 1||33
9700611|NCT04794270|10799741|FG001|COMPLETED|Period 1||36
9700612|NCT04794270|10799740|FG000|NOT COMPLETED|Period 1||2
9700613|NCT04794270|10799741|FG001|NOT COMPLETED|Period 1||0
9700614|NCT04794270|10799740|FG000|STARTED|Period 2||33
9700615|NCT04794270|10799741|FG001|STARTED|Period 2||36
9700616|NCT04794270|10799740|FG000|COMPLETED|Period 2||32
9700617|NCT04794270|10799741|FG001|COMPLETED|Period 2||36
9700618|NCT04794270|10799740|FG000|NOT COMPLETED|Period 2||1
9700619|NCT04794270|10799741|FG001|NOT COMPLETED|Period 2||0
9700620|NCT04701814|10799749|FG000|STARTED|Overall Study||20
9700621|NCT04701814|10799750|FG001|STARTED|Overall Study||18
9700622|NCT04701814|10799749|FG000|COMPLETED|Overall Study||15
9700623|NCT04701814|10799750|FG001|COMPLETED|Overall Study||15
9700624|NCT04701814|10799749|FG000|NOT COMPLETED|Overall Study||5
9700625|NCT04701814|10799750|FG001|NOT COMPLETED|Overall Study||3
9700626|NCT04650282|10799760|FG000|STARTED|Overall Study||1
9700627|NCT04650282|10799761|FG001|STARTED|Overall Study||1
9700628|NCT04650282|10799760|FG000|COMPLETED|Overall Study||1
9700629|NCT04650282|10799761|FG001|COMPLETED|Overall Study||1
9700630|NCT04650282|10799760|FG000|NOT COMPLETED|Overall Study||0
9700631|NCT04650282|10799761|FG001|NOT COMPLETED|Overall Study||0
9700638|NCT04394286|10799779|FG000|STARTED|Overall Study||0
9700639|NCT04394286|10799780|FG001|STARTED|Overall Study||0
9700640|NCT04394286|10799781|FG002|STARTED|Overall Study||0
9700641|NCT04394286|10799779|FG000|COMPLETED|Overall Study||0
9700642|NCT04394286|10799780|FG001|COMPLETED|Overall Study||0
9700643|NCT04394286|10799781|FG002|COMPLETED|Overall Study||0
9700644|NCT04394286|10799779|FG000|NOT COMPLETED|Overall Study||0
9700645|NCT04394286|10799780|FG001|NOT COMPLETED|Overall Study||0
9700646|NCT04394286|10799781|FG002|NOT COMPLETED|Overall Study||0
9700647|NCT04327986|10799789|FG000|STARTED|Overall Study||3
9700648|NCT04327986|10799790|FG001|STARTED|Overall Study||0
9962479|NCT01478958|11082165|FG002|COMPLETED|Overall Study||66
9962480|NCT01478958|11082163|FG000|NOT COMPLETED|Overall Study||2
9962481|NCT01478958|11082164|FG001|NOT COMPLETED|Overall Study||2
9962482|NCT01478958|11082165|FG002|NOT COMPLETED|Overall Study||3
9962483|NCT01478971|11082173|FG000|STARTED|Standard of Care Period||184
9962484|NCT01478971|11082173|FG000|Received Treatment|Standard of Care Period||178
9962485|NCT01478971|11082173|FG000|COMPLETED|Standard of Care Period||159
9962486|NCT01478971|11082173|FG000|NOT COMPLETED|Standard of Care Period||25
10026742|NCT01879722|11150871|FG004|NOT COMPLETED|Overall Study||1
10026743|NCT01879722|11150872|FG005|NOT COMPLETED|Overall Study||0
9700649|NCT04327986|10799791|FG002|STARTED|Overall Study||0
9700650|NCT04327986|10799789|FG000|COMPLETED|Overall Study||0
9700651|NCT04327986|10799790|FG001|COMPLETED|Overall Study||0
9700652|NCT04327986|10799791|FG002|COMPLETED|Overall Study||0
9700653|NCT04327986|10799789|FG000|NOT COMPLETED|Overall Study||3
9700654|NCT04327986|10799790|FG001|NOT COMPLETED|Overall Study||0
9700655|NCT04327986|10799791|FG002|NOT COMPLETED|Overall Study||0
9700656|NCT04086121|10799795|FG000|STARTED|Overall Study||14
9700657|NCT04086121|10799795|FG000|COMPLETED|Overall Study||1
9700658|NCT04086121|10799795|FG000|NOT COMPLETED|Overall Study||13
9700659|NCT04067843|10799801|FG000|STARTED|Overall Study||10
9700660|NCT04067843|10799802|FG001|STARTED|Overall Study||10
9700661|NCT04067843|10799801|FG000|COMPLETED|Overall Study||10
9700662|NCT04067843|10799802|FG001|COMPLETED|Overall Study||10
9700663|NCT04067843|10799801|FG000|NOT COMPLETED|Overall Study||0
9700664|NCT04067843|10799802|FG001|NOT COMPLETED|Overall Study||0
9700665|NCT04066738|10799810|FG000|STARTED|Overall Study||2
9700666|NCT04066738|10799810|FG000|COMPLETED|Overall Study||2
9700667|NCT04066738|10799810|FG000|NOT COMPLETED|Overall Study||0
9728070|NCT00111813|10827769|FG002|COMPLETED|Overall Study||0
9728071|NCT00111813|10827770|FG003|COMPLETED|Overall Study||1
9728072|NCT00111813|10827771|FG004|COMPLETED|Overall Study||0
9728073|NCT00111813|10827772|FG005|COMPLETED|Overall Study||0
9728074|NCT00111813|10827767|FG000|NOT COMPLETED|Overall Study||3
9728075|NCT00111813|10827768|FG001|NOT COMPLETED|Overall Study||3
9728076|NCT00111813|10827769|FG002|NOT COMPLETED|Overall Study||10
9728077|NCT00111813|10827770|FG003|NOT COMPLETED|Overall Study||5
9728078|NCT00111813|10827771|FG004|NOT COMPLETED|Overall Study||6
9728079|NCT00111813|10827772|FG005|NOT COMPLETED|Overall Study||6
9728080|NCT00111839|10827790|FG000|STARTED|Overall Study||50
9728081|NCT00111839|10827791|FG001|STARTED|Overall Study||51
9728082|NCT00111839|10827792|FG002|STARTED|Overall Study||49
9728083|NCT00111839|10827790|FG000|Treated|Overall Study||50
9728084|NCT00111839|10827791|FG001|Treated|Overall Study||51
9728085|NCT00111839|10827792|FG002|Treated|Overall Study||47
9728086|NCT00111839|10827790|FG000|COMPLETED|Overall Study||2
9728087|NCT00111839|10827791|FG001|COMPLETED|Overall Study||5
9728088|NCT00111839|10827792|FG002|COMPLETED|Overall Study||0
9728089|NCT00111839|10827790|FG000|NOT COMPLETED|Overall Study||48
9728090|NCT00111839|10827791|FG001|NOT COMPLETED|Overall Study||46
9728091|NCT00111839|10827792|FG002|NOT COMPLETED|Overall Study||49
9728092|NCT00111917|10827802|FG000|STARTED|Overall Study||9
9728093|NCT00111917|10827803|FG001|STARTED|Overall Study||4
9728094|NCT00111917|10827802|FG000|COMPLETED|Overall Study||8
9728095|NCT00111917|10827803|FG001|COMPLETED|Overall Study||3
10115408|NCT02525744|11246276|FG002|NOT COMPLETED|Period 2||0
10115409|NCT02525744|11246277|FG003|NOT COMPLETED|Period 2||0
10115410|NCT02525744|11246274|FG000|STARTED|Period 3||6
10115411|NCT02525744|11246275|FG001|STARTED|Period 3||6
10115412|NCT02525744|11246276|FG002|STARTED|Period 3||5
9700668|NCT03933020|10799814|FG000|STARTED|Overall Study||0
9700669|NCT03933020|10799814|FG000|Received an Intervention|Overall Study||0
9700670|NCT03933020|10799814|FG000|COMPLETED|Overall Study||0
9700671|NCT03933020|10799814|FG000|NOT COMPLETED|Overall Study||0
9700672|NCT03793608|10799820|FG000|STARTED|Overall Study||1
9700673|NCT03793608|10799821|FG001|STARTED|Overall Study||24
9700674|NCT03793608|10799820|FG000|Treated|Overall Study||1
9700675|NCT03793608|10799821|FG001|Treated|Overall Study||24
9700676|NCT03793608|10799820|FG000|Safety Analysis Set (SAF)|Overall Study|1 participant randomized to placebo was not analyzed and thus excluded from analyses.|0
9700677|NCT03793608|10799821|FG001|Safety Analysis Set (SAF)|Overall Study||24
9700678|NCT03793608|10799820|FG000|COMPLETED|Overall Study||1
9700679|NCT03793608|10799821|FG001|COMPLETED|Overall Study||24
9700680|NCT03793608|10799820|FG000|NOT COMPLETED|Overall Study||0
9700681|NCT03793608|10799821|FG001|NOT COMPLETED|Overall Study||0
9700682|NCT03655054|10799826|FG000|STARTED|Overall Study||23
9700683|NCT03655054|10799826|FG000|COMPLETED|Overall Study||22
9700684|NCT03655054|10799826|FG000|NOT COMPLETED|Overall Study||1
9700685|NCT03601117|10799832|FG000|STARTED|Overall Study||20
9700686|NCT03601117|10799833|FG001|STARTED|Overall Study||2
9700687|NCT03601117|10799832|FG000|COMPLETED|Overall Study||17
9700688|NCT03601117|10799833|FG001|COMPLETED|Overall Study||1
9700689|NCT03601117|10799832|FG000|NOT COMPLETED|Overall Study||3
9700690|NCT03601117|10799833|FG001|NOT COMPLETED|Overall Study||1
9700691|NCT03542266|10799841|FG000|STARTED|Treatment Phase||21
9700692|NCT03542266|10799841|FG000|COMPLETED|Treatment Phase||18
9700693|NCT03542266|10799841|FG000|NOT COMPLETED|Treatment Phase||3
9700694|NCT03542266|10799841|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
9700695|NCT03542266|10799841|FG000|COMPLETED|Post-treatment Follow-up Phase||0
9700696|NCT03542266|10799841|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15
9700697|NCT03529409|10799848|FG000|STARTED|Randomized||30
9700698|NCT03529409|10799849|FG001|STARTED|Randomized||31
9700699|NCT03529409|10799850|FG002|STARTED|Randomized||5
9700700|NCT03529409|10799848|FG000|COMPLETED|Randomized||30
9700701|NCT03529409|10799849|FG001|COMPLETED|Randomized||31
9700702|NCT03529409|10799850|FG002|COMPLETED|Randomized||0
9700703|NCT03529409|10799848|FG000|NOT COMPLETED|Randomized||0
9700704|NCT03529409|10799849|FG001|NOT COMPLETED|Randomized||0
9700705|NCT03529409|10799850|FG002|NOT COMPLETED|Randomized||5
9700706|NCT03529409|10799848|FG000|STARTED|Post-treatment Assessment||30
9700707|NCT03529409|10799849|FG001|STARTED|Post-treatment Assessment||31
9700708|NCT03529409|10799850|FG002|STARTED|Post-treatment Assessment||0
9700709|NCT03529409|10799848|FG000|COMPLETED|Post-treatment Assessment||26
9700710|NCT03529409|10799849|FG001|COMPLETED|Post-treatment Assessment||26
9700711|NCT03529409|10799850|FG002|COMPLETED|Post-treatment Assessment||0
10115413|NCT02525744|11246277|FG003|STARTED|Period 3||6
10115414|NCT02525744|11246274|FG000|Received at Least 1 Dose of Study Drug|Period 3||6
9700712|NCT03529409|10799848|FG000|NOT COMPLETED|Post-treatment Assessment||4
9700713|NCT03529409|10799849|FG001|NOT COMPLETED|Post-treatment Assessment||5
9847884|NCT00856544|10960520|FG001|COMPLETED|Overall Study||252
9847885|NCT00856544|10960521|FG002|COMPLETED|Overall Study||71
10115415|NCT02525744|11246275|FG001|Received at Least 1 Dose of Study Drug|Period 3||6
9962487|NCT01478971|11082173|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
9962488|NCT01478971|11082173|FG000|COMPLETED|Peginesatide Treatment Period||143
9962489|NCT01478971|11082173|FG000|NOT COMPLETED|Peginesatide Treatment Period||14
9962490|NCT01479127|11082181|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8
9962491|NCT01479127|11082181|FG000|Started LCIG|Overall Study||6
9962492|NCT01479127|11082181|FG000|COMPLETED|Overall Study||5
10026744|NCT01879722|11150873|FG006|NOT COMPLETED|Overall Study||0
9700714|NCT03529409|10799850|FG002|NOT COMPLETED|Post-treatment Assessment||0
9700715|NCT03529409|10799848|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28
9700716|NCT03529409|10799849|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30
9700717|NCT03529409|10799850|FG002|STARTED|Follow-up Assessment||0
9700718|NCT03529409|10799848|FG000|COMPLETED|Follow-up Assessment||27
9700719|NCT03529409|10799849|FG001|COMPLETED|Follow-up Assessment||29
9700720|NCT03529409|10799850|FG002|COMPLETED|Follow-up Assessment||0
9700721|NCT03529409|10799848|FG000|NOT COMPLETED|Follow-up Assessment||1
9700722|NCT03529409|10799849|FG001|NOT COMPLETED|Follow-up Assessment||1
9700723|NCT03529409|10799850|FG002|NOT COMPLETED|Follow-up Assessment||0
9700724|NCT03516812|10799857|FG000|STARTED|Overall Study||36
9700725|NCT03516812|10799857|FG000|COMPLETED|Overall Study||30
9700726|NCT03516812|10799857|FG000|NOT COMPLETED|Overall Study||6
9700727|NCT03477396|10799861|FG000|STARTED|Overall Study||2
9700728|NCT03477396|10799861|FG000|COMPLETED|Overall Study||2
9700729|NCT03477396|10799861|FG000|NOT COMPLETED|Overall Study||0
9700730|NCT03463577|10799871|FG000|STARTED|Overall Study||16606
9700731|NCT03463577|10799872|FG001|STARTED|Overall Study||16606
9700732|NCT03463577|10799873|FG002|STARTED|Overall Study||65
9700733|NCT03463577|10799874|FG003|STARTED|Overall Study||16350
9700734|NCT03463577|10799875|FG004|STARTED|Overall Study||16088
9700735|NCT03463577|10799876|FG005|STARTED|Overall Study||68
9700736|NCT03463577|10799871|FG000|COMPLETED|Overall Study||16366
9700737|NCT03463577|10799872|FG001|COMPLETED|Overall Study||16166
9700738|NCT03463577|10799873|FG002|COMPLETED|Overall Study||65
9700739|NCT03463577|10799874|FG003|COMPLETED|Overall Study||16335
9700740|NCT03463577|10799875|FG004|COMPLETED|Overall Study||16071
9700741|NCT03463577|10799876|FG005|COMPLETED|Overall Study||68
9700742|NCT03463577|10799871|FG000|NOT COMPLETED|Overall Study||240
9700743|NCT03463577|10799872|FG001|NOT COMPLETED|Overall Study||440
9700744|NCT03463577|10799873|FG002|NOT COMPLETED|Overall Study||0
9700745|NCT03463577|10799874|FG003|NOT COMPLETED|Overall Study||15
9700746|NCT03463577|10799875|FG004|NOT COMPLETED|Overall Study||17
9700747|NCT03463577|10799876|FG005|NOT COMPLETED|Overall Study||0
9700748|NCT03373760|10799892|FG000|STARTED|Overall Study||58
9700749|NCT03373760|10799892|FG000|COMPLETED|Overall Study||0
9700750|NCT03373760|10799892|FG000|NOT COMPLETED|Overall Study||58
9728096|NCT00111917|10827802|FG000|NOT COMPLETED|Overall Study||1
9728097|NCT00111917|10827803|FG001|NOT COMPLETED|Overall Study||1
9728098|NCT00112047|10827815|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
9962493|NCT01479127|11082181|FG000|NOT COMPLETED|Overall Study||3
9700751|NCT03253627|10799901|FG000|STARTED|Overall Study||12
9700752|NCT03253627|10799902|FG001|STARTED|Overall Study||11
9700753|NCT03253627|10799901|FG000|Post-intervention|Overall Study||11
9700754|NCT03253627|10799902|FG001|Post-intervention|Overall Study||9
9700755|NCT03253627|10799901|FG000|COMPLETED|Overall Study||10
9700756|NCT03253627|10799902|FG001|COMPLETED|Overall Study||7
9700757|NCT03253627|10799901|FG000|NOT COMPLETED|Overall Study||2
9700758|NCT03253627|10799902|FG001|NOT COMPLETED|Overall Study||4
9700759|NCT03202628|10799908|FG000|STARTED|Overall Study||8
9700760|NCT03202628|10799908|FG000|COMPLETED|Overall Study||8
9700761|NCT03202628|10799908|FG000|NOT COMPLETED|Overall Study||0
9962494|NCT01479270|11082191|FG000|STARTED|Overall Study||28
9962495|NCT01479270|11082192|FG001|STARTED|Overall Study||28
9962496|NCT01479270|11082191|FG000|COMPLETED|Overall Study||28
9962497|NCT01479270|11082192|FG001|COMPLETED|Overall Study||28
9962498|NCT01479270|11082191|FG000|NOT COMPLETED|Overall Study||0
9962499|NCT01479270|11082192|FG001|NOT COMPLETED|Overall Study||0
9962500|NCT01479348|11082201|FG000|STARTED|Overall Study||5
9962501|NCT01479348|11082202|FG001|STARTED|Overall Study||0
9962502|NCT01479348|11082201|FG000|COMPLETED|Overall Study||5
9962503|NCT01479348|11082202|FG001|COMPLETED|Overall Study||0
9962504|NCT01479348|11082201|FG000|NOT COMPLETED|Overall Study||0
9962505|NCT01479348|11082202|FG001|NOT COMPLETED|Overall Study||0
9962506|NCT01479374|11082209|FG000|STARTED|Overall Study||66
9962507|NCT01479374|11082210|FG001|STARTED|Overall Study||68
9962508|NCT01479374|11082211|FG002|STARTED|Overall Study||68
9962509|NCT01479374|11082209|FG000|COMPLETED|Overall Study||63
9962510|NCT01479374|11082210|FG001|COMPLETED|Overall Study||60
9962511|NCT01479374|11082211|FG002|COMPLETED|Overall Study||63
9962512|NCT01479374|11082209|FG000|NOT COMPLETED|Overall Study||3
9962513|NCT01479374|11082210|FG001|NOT COMPLETED|Overall Study||8
9962514|NCT01479374|11082211|FG002|NOT COMPLETED|Overall Study||5
9962515|NCT01479426|11082221|FG000|STARTED|Overall Study||40
9962516|NCT01479426|11082222|FG001|STARTED|Overall Study||40
9962517|NCT01479426|11082221|FG000|COMPLETED|Overall Study||36
9962518|NCT01479426|11082222|FG001|COMPLETED|Overall Study||37
9962519|NCT01479426|11082221|FG000|NOT COMPLETED|Overall Study||4
9962520|NCT01479426|11082222|FG001|NOT COMPLETED|Overall Study||3
9962521|NCT01479439|11082231|FG000|STARTED|Overall Study||15
9962522|NCT01479439|11082232|FG001|STARTED|Overall Study||13
9962523|NCT01479439|11082233|FG002|STARTED|Overall Study||8
9962524|NCT01479439|11082231|FG000|COMPLETED|Overall Study||14
9962525|NCT01479439|11082232|FG001|COMPLETED|Overall Study||12
9962526|NCT01479439|11082233|FG002|COMPLETED|Overall Study||6
9962527|NCT01479439|11082231|FG000|NOT COMPLETED|Overall Study||1
9962528|NCT01479439|11082232|FG001|NOT COMPLETED|Overall Study||1
9962529|NCT01479439|11082233|FG002|NOT COMPLETED|Overall Study||2
9962530|NCT01479465|11082248|FG000|STARTED|Overall Study||11
9700762|NCT03168555|10799912|FG000|STARTED|Visit 1 (Pro-operative)||23
9700763|NCT03168555|10799912|FG000|COMPLETED|Visit 1 (Pro-operative)||22
9700764|NCT03168555|10799912|FG000|NOT COMPLETED|Visit 1 (Pro-operative)||1
9700765|NCT03168555|10799912|FG000|STARTED|Visit 2 (Post-operative)||22
9700766|NCT03168555|10799912|FG000|COMPLETED|Visit 2 (Post-operative)||18
9700767|NCT03168555|10799912|FG000|NOT COMPLETED|Visit 2 (Post-operative)||4
9700768|NCT03135119|10799921|FG000|STARTED|Overall Study||16
9962531|NCT01479465|11082249|FG001|STARTED|Overall Study||84
9962532|NCT01479465|11082250|FG002|STARTED|Overall Study||86
9962533|NCT01479465|11082251|FG003|STARTED|Overall Study||85
9962534|NCT01479465|11082248|FG000|COMPLETED|Overall Study||0
9962535|NCT01479465|11082249|FG001|COMPLETED|Overall Study||0
9962536|NCT01479465|11082250|FG002|COMPLETED|Overall Study||0
9962537|NCT01479465|11082251|FG003|COMPLETED|Overall Study||0
9962538|NCT01479465|11082248|FG000|NOT COMPLETED|Overall Study||11
9962539|NCT01479465|11082249|FG001|NOT COMPLETED|Overall Study||84
9962540|NCT01479465|11082250|FG002|NOT COMPLETED|Overall Study||86
9962541|NCT01479465|11082251|FG003|NOT COMPLETED|Overall Study||85
9700769|NCT03135119|10799922|FG001|STARTED|Overall Study||17
9700770|NCT03135119|10799921|FG000|COMPLETED|Overall Study||11
9700771|NCT03135119|10799922|FG001|COMPLETED|Overall Study||14
9700772|NCT03135119|10799921|FG000|NOT COMPLETED|Overall Study||5
9700773|NCT03135119|10799922|FG001|NOT COMPLETED|Overall Study||3
9700774|NCT03128411|10799928|FG000|STARTED|Treatment Phase||60
9700775|NCT03128411|10799928|FG000|Received Treatment|Treatment Phase||60
9700776|NCT03128411|10799928|FG000|COMPLETED|Treatment Phase||36
9700777|NCT03128411|10799928|FG000|NOT COMPLETED|Treatment Phase||24
9700778|NCT03128411|10799928|FG000|STARTED|Long Term Follow-up Phase|Participants who discontinued treatment phase, entered in long term follow up phase.|24
9700779|NCT03128411|10799928|FG000|COMPLETED|Long Term Follow-up Phase||22
9700780|NCT03128411|10799928|FG000|NOT COMPLETED|Long Term Follow-up Phase||2
9700781|NCT03097328|10799932|FG000|STARTED|Overall Study||39
9700782|NCT03097328|10799932|FG000|Treated|Overall Study||38
9700783|NCT03097328|10799932|FG000|COMPLETED|Overall Study||0
9700784|NCT03097328|10799932|FG000|NOT COMPLETED|Overall Study||39
9700785|NCT03070600|10799938|FG000|STARTED|Overall Study||2250
9700786|NCT03070600|10799939|FG001|STARTED|Overall Study||2197
9700787|NCT03070600|10799938|FG000|COMPLETED|Overall Study||2156
9700788|NCT03070600|10799939|FG001|COMPLETED|Overall Study||2032
9700789|NCT03070600|10799938|FG000|NOT COMPLETED|Overall Study||94
9700790|NCT03070600|10799939|FG001|NOT COMPLETED|Overall Study||165
9700791|NCT03068715|10799951|FG000|STARTED|Overall Study||15
9700792|NCT03068715|10799952|FG001|STARTED|Overall Study||15
9700793|NCT03068715|10799951|FG000|COMPLETED|Overall Study||14
9700794|NCT03068715|10799952|FG001|COMPLETED|Overall Study||15
9700795|NCT03068715|10799951|FG000|NOT COMPLETED|Overall Study||1
9700796|NCT03068715|10799952|FG001|NOT COMPLETED|Overall Study||0
9700797|NCT02981472|10799962|FG000|STARTED|Pre-Treatment Period||129
9700798|NCT02981472|10799963|FG001|STARTED|Pre-Treatment Period||63
9700799|NCT02981472|10799962|FG000|COMPLETED|Pre-Treatment Period||126
9700800|NCT02981472|10799963|FG001|COMPLETED|Pre-Treatment Period||62
9700801|NCT02981472|10799962|FG000|NOT COMPLETED|Pre-Treatment Period||3
9700802|NCT02981472|10799963|FG001|NOT COMPLETED|Pre-Treatment Period||1
9700803|NCT02981472|10799962|FG000|STARTED|Treatment Period||126
9700804|NCT02981472|10799963|FG001|STARTED|Treatment Period||62
9700805|NCT02981472|10799962|FG000|COMPLETED|Treatment Period||119
9700806|NCT02981472|10799963|FG001|COMPLETED|Treatment Period||60
9700807|NCT02981472|10799962|FG000|NOT COMPLETED|Treatment Period||7
9700808|NCT02981472|10799963|FG001|NOT COMPLETED|Treatment Period||2
9728099|NCT00112047|10827816|FG001|STARTED|Randomized Phase|ITT analysis population|254
9728100|NCT00112047|10827815|FG000|COMPLETED|Randomized Phase||187
9728101|NCT00112047|10827816|FG001|COMPLETED|Randomized Phase||166
9728102|NCT00112047|10827815|FG000|NOT COMPLETED|Randomized Phase||70
9728103|NCT00112047|10827816|FG001|NOT COMPLETED|Randomized Phase||88
9728104|NCT00112047|10827815|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
9728105|NCT00112047|10827816|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
9728106|NCT00112047|10827815|FG000|COMPLETED|Atripla Phase||142
9728107|NCT00112047|10827816|FG001|COMPLETED|Atripla Phase||106
9728108|NCT00112047|10827815|FG000|NOT COMPLETED|Atripla Phase||18
9728109|NCT00112047|10827816|FG001|NOT COMPLETED|Atripla Phase||20
9728110|NCT00112112|10827829|FG000|STARTED|Overall Study||10
10026745|NCT01879722|11150874|FG007|NOT COMPLETED|Overall Study||1
10026746|NCT01879722|11150875|FG008|NOT COMPLETED|Overall Study||2
10026747|NCT01879722|11150876|FG009|NOT COMPLETED|Overall Study||0
10081310|NCT02259400|11209772|FG000|STARTED|Overall Study||62
10081311|NCT02259400|11209773|FG001|STARTED|Overall Study||62
10081312|NCT02259400|11209772|FG000|COMPLETED|Overall Study||62
10081313|NCT02259400|11209773|FG001|COMPLETED|Overall Study||60
10081314|NCT02259400|11209772|FG000|NOT COMPLETED|Overall Study||0
10081315|NCT02259400|11209773|FG001|NOT COMPLETED|Overall Study||2
10081316|NCT02259582|11209782|FG000|STARTED|Overall Study||25
10081317|NCT02259582|11209783|FG001|STARTED|Overall Study||28
9728111|NCT00112112|10827830|FG001|STARTED|Overall Study||10
9728112|NCT00112112|10827829|FG000|COMPLETED|Overall Study||10
9728113|NCT00112112|10827830|FG001|COMPLETED|Overall Study||10
9728114|NCT00112112|10827829|FG000|NOT COMPLETED|Overall Study||0
9728115|NCT00112112|10827830|FG001|NOT COMPLETED|Overall Study||0
9728116|NCT00112125|10827838|FG000|STARTED|Overall Study||213
9728117|NCT00112125|10827839|FG001|STARTED|Overall Study||215
9728118|NCT00112125|10827838|FG000|COMPLETED|Overall Study||189
9728119|NCT00112125|10827839|FG001|COMPLETED|Overall Study||193
9728120|NCT00112125|10827838|FG000|NOT COMPLETED|Overall Study||24
9728121|NCT00112125|10827839|FG001|NOT COMPLETED|Overall Study||22
9728122|NCT00112151|10827851|FG000|STARTED|Overall Study||28
9728123|NCT00112151|10827852|FG001|STARTED|Overall Study||28
9728124|NCT00112151|10827853|FG002|STARTED|Overall Study||28
9728125|NCT00112151|10827854|FG003|STARTED|Overall Study||27
10081318|NCT02259582|11209784|FG002|STARTED|Overall Study||29
10081319|NCT02259582|11209782|FG000|COMPLETED|Overall Study||9
10081320|NCT02259582|11209783|FG001|COMPLETED|Overall Study||11
10081321|NCT02259582|11209784|FG002|COMPLETED|Overall Study||8
9700809|NCT02853760|10799975|FG000|STARTED|First Intervention (3 Hours)||7
9700810|NCT02853760|10799976|FG001|STARTED|First Intervention (3 Hours)||10
9700811|NCT02853760|10799977|FG002|STARTED|First Intervention (3 Hours)||7
9700812|NCT02853760|10799978|FG003|STARTED|First Intervention (3 Hours)||8
9700813|NCT02853760|10799979|FG004|STARTED|First Intervention (3 Hours)||8
9700814|NCT02853760|10799980|FG005|STARTED|First Intervention (3 Hours)||7
9700815|NCT02853760|10799975|FG000|COMPLETED|First Intervention (3 Hours)||7
9700816|NCT02853760|10799976|FG001|COMPLETED|First Intervention (3 Hours)||10
9700817|NCT02853760|10799977|FG002|COMPLETED|First Intervention (3 Hours)||7
9700818|NCT02853760|10799978|FG003|COMPLETED|First Intervention (3 Hours)||8
9700819|NCT02853760|10799979|FG004|COMPLETED|First Intervention (3 Hours)||8
9700820|NCT02853760|10799980|FG005|COMPLETED|First Intervention (3 Hours)||7
9700821|NCT02853760|10799975|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
9700822|NCT02853760|10799976|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
9700823|NCT02853760|10799977|FG002|NOT COMPLETED|First Intervention (3 Hours)||0
9700824|NCT02853760|10799978|FG003|NOT COMPLETED|First Intervention (3 Hours)||0
9700825|NCT02853760|10799979|FG004|NOT COMPLETED|First Intervention (3 Hours)||0
9700826|NCT02853760|10799980|FG005|NOT COMPLETED|First Intervention (3 Hours)||0
9700827|NCT02853760|10799975|FG000|STARTED|Washout (1 Week)||7
9700828|NCT02853760|10799976|FG001|STARTED|Washout (1 Week)||10
9700829|NCT02853760|10799977|FG002|STARTED|Washout (1 Week)||7
9700830|NCT02853760|10799978|FG003|STARTED|Washout (1 Week)||8
9700831|NCT02853760|10799979|FG004|STARTED|Washout (1 Week)||8
9700832|NCT02853760|10799980|FG005|STARTED|Washout (1 Week)||7
9700833|NCT02853760|10799975|FG000|COMPLETED|Washout (1 Week)||7
9700834|NCT02853760|10799976|FG001|COMPLETED|Washout (1 Week)||10
9700835|NCT02853760|10799977|FG002|COMPLETED|Washout (1 Week)||6
9700836|NCT02853760|10799978|FG003|COMPLETED|Washout (1 Week)||6
9700837|NCT02853760|10799979|FG004|COMPLETED|Washout (1 Week)||8
9700838|NCT02853760|10799980|FG005|COMPLETED|Washout (1 Week)||5
9700839|NCT02853760|10799975|FG000|NOT COMPLETED|Washout (1 Week)||0
9700840|NCT02853760|10799976|FG001|NOT COMPLETED|Washout (1 Week)||0
9700841|NCT02853760|10799977|FG002|NOT COMPLETED|Washout (1 Week)||1
9700842|NCT02853760|10799978|FG003|NOT COMPLETED|Washout (1 Week)||2
9700843|NCT02853760|10799979|FG004|NOT COMPLETED|Washout (1 Week)||0
9700844|NCT02853760|10799980|FG005|NOT COMPLETED|Washout (1 Week)||2
9962542|NCT01479478|11082263|FG000|STARTED|Overall Study||125
9962543|NCT01479478|11082264|FG001|STARTED|Overall Study||126
9962544|NCT01479478|11082263|FG000|COMPLETED|Overall Study||125
9962545|NCT01479478|11082264|FG001|COMPLETED|Overall Study||126
9962546|NCT01479478|11082263|FG000|NOT COMPLETED|Overall Study||0
9962547|NCT01479478|11082264|FG001|NOT COMPLETED|Overall Study||0
9962548|NCT01479517|11082273|FG000|STARTED|Overall Study||10
9962549|NCT01479517|11082274|FG001|STARTED|Overall Study||10
9962550|NCT01479517|11082275|FG002|STARTED|Overall Study||10
9962551|NCT01479517|11082273|FG000|COMPLETED|Overall Study||10
9962552|NCT01479517|11082274|FG001|COMPLETED|Overall Study||10
9962553|NCT01479517|11082275|FG002|COMPLETED|Overall Study||10
9962554|NCT01479517|11082273|FG000|NOT COMPLETED|Overall Study||0
9962555|NCT01479517|11082274|FG001|NOT COMPLETED|Overall Study||0
9962556|NCT01479517|11082275|FG002|NOT COMPLETED|Overall Study||0
9962557|NCT01479530|11082285|FG000|STARTED|Overall Study||158
9962558|NCT01479530|11082286|FG001|STARTED|Overall Study||163
9962559|NCT01479530|11082285|FG000|COMPLETED|Overall Study||148
9962560|NCT01479530|11082286|FG001|COMPLETED|Overall Study||151
9962561|NCT01479530|11082285|FG000|NOT COMPLETED|Overall Study||10
9962562|NCT01479530|11082286|FG001|NOT COMPLETED|Overall Study||12
9962563|NCT01479543|11082297|FG000|STARTED|Overall Study||21
9962564|NCT01479543|11082298|FG001|STARTED|Overall Study||20
9962565|NCT01479543|11082299|FG002|STARTED|Overall Study||21
9962566|NCT01479543|11082300|FG003|STARTED|Overall Study||20
9962567|NCT01479543|11082301|FG004|STARTED|Overall Study||21
9962568|NCT01479543|11082297|FG000|COMPLETED|Overall Study||20
9962569|NCT01479543|11082298|FG001|COMPLETED|Overall Study||20
9962570|NCT01479543|11082299|FG002|COMPLETED|Overall Study||20
9962571|NCT01479543|11082300|FG003|COMPLETED|Overall Study||20
9962572|NCT01479543|11082301|FG004|COMPLETED|Overall Study||20
9962573|NCT01479543|11082297|FG000|NOT COMPLETED|Overall Study||1
9962574|NCT01479543|11082298|FG001|NOT COMPLETED|Overall Study||0
9962575|NCT01479543|11082299|FG002|NOT COMPLETED|Overall Study||1
9962576|NCT01479543|11082300|FG003|NOT COMPLETED|Overall Study||0
9962577|NCT01479543|11082301|FG004|NOT COMPLETED|Overall Study||1
9962578|NCT01479595|11082315|FG000|STARTED|Overall Study||44
9962579|NCT01479595|11082316|FG001|STARTED|Overall Study||21
10026748|NCT04838054|11150903|FG000|STARTED|Overall Study||29
10026749|NCT04838054|11150904|FG001|STARTED|Overall Study||28
9962580|NCT01479595|11082315|FG000|PK Analysis Set|Overall Study||42
9962581|NCT01479595|11082316|FG001|PK Analysis Set|Overall Study||0
9962582|NCT01479595|11082315|FG000|Per Protocol Analysis Set|Overall Study||41
9962583|NCT01479595|11082316|FG001|Per Protocol Analysis Set|Overall Study||20
10026750|NCT04838054|11150903|FG000|COMPLETED|Overall Study||27
10026751|NCT04838054|11150904|FG001|COMPLETED|Overall Study||28
10026752|NCT04838054|11150903|FG000|NOT COMPLETED|Overall Study||2
9962584|NCT01479595|11082315|FG000|COMPLETED|Overall Study||42
9962585|NCT01479595|11082316|FG001|COMPLETED|Overall Study||19
9962586|NCT01479595|11082315|FG000|NOT COMPLETED|Overall Study||2
9962587|NCT01479595|11082316|FG001|NOT COMPLETED|Overall Study||2
10026753|NCT04838054|11150904|FG001|NOT COMPLETED|Overall Study||0
10026754|NCT04495829|11150910|FG000|STARTED|Overall Study||70
9700845|NCT02853760|10799975|FG000|STARTED|Second Intervention (3 Hours)||7
9700846|NCT02853760|10799976|FG001|STARTED|Second Intervention (3 Hours)||10
9700847|NCT02853760|10799977|FG002|STARTED|Second Intervention (3 Hours)||6
9700848|NCT02853760|10799978|FG003|STARTED|Second Intervention (3 Hours)||6
9700849|NCT02853760|10799979|FG004|STARTED|Second Intervention (3 Hours)||8
9700850|NCT02853760|10799980|FG005|STARTED|Second Intervention (3 Hours)||5
9700851|NCT02853760|10799975|FG000|COMPLETED|Second Intervention (3 Hours)||7
9700852|NCT02853760|10799976|FG001|COMPLETED|Second Intervention (3 Hours)||10
9700853|NCT02853760|10799977|FG002|COMPLETED|Second Intervention (3 Hours)||6
9700854|NCT02853760|10799978|FG003|COMPLETED|Second Intervention (3 Hours)||6
9700855|NCT02853760|10799979|FG004|COMPLETED|Second Intervention (3 Hours)||8
9700856|NCT02853760|10799980|FG005|COMPLETED|Second Intervention (3 Hours)||5
9700857|NCT02853760|10799975|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
9700858|NCT02853760|10799976|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
9700859|NCT02853760|10799977|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0
9700860|NCT02853760|10799978|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0
9700861|NCT02853760|10799979|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0
9700862|NCT02853760|10799980|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0
9700863|NCT02853760|10799975|FG000|STARTED|Washout (1 Week)||7
9700864|NCT02853760|10799976|FG001|STARTED|Washout (1 Week)||10
9700865|NCT02853760|10799977|FG002|STARTED|Washout (1 Week)||6
9700866|NCT02853760|10799978|FG003|STARTED|Washout (1 Week)||6
9700867|NCT02853760|10799979|FG004|STARTED|Washout (1 Week)||8
9700868|NCT02853760|10799980|FG005|STARTED|Washout (1 Week)||5
9700869|NCT02853760|10799975|FG000|COMPLETED|Washout (1 Week)||7
9700870|NCT02853760|10799976|FG001|COMPLETED|Washout (1 Week)||10
9700871|NCT02853760|10799977|FG002|COMPLETED|Washout (1 Week)||6
9700872|NCT02853760|10799978|FG003|COMPLETED|Washout (1 Week)||6
9700873|NCT02853760|10799979|FG004|COMPLETED|Washout (1 Week)||8
9700874|NCT02853760|10799980|FG005|COMPLETED|Washout (1 Week)||5
9700875|NCT02853760|10799975|FG000|NOT COMPLETED|Washout (1 Week)||0
9700876|NCT02853760|10799976|FG001|NOT COMPLETED|Washout (1 Week)||0
9700877|NCT02853760|10799977|FG002|NOT COMPLETED|Washout (1 Week)||0
9700878|NCT02853760|10799978|FG003|NOT COMPLETED|Washout (1 Week)||0
9700879|NCT02853760|10799979|FG004|NOT COMPLETED|Washout (1 Week)||0
9700880|NCT02853760|10799980|FG005|NOT COMPLETED|Washout (1 Week)||0
9700881|NCT02853760|10799975|FG000|STARTED|Third Intervention (3 Hours)||7
9700882|NCT02853760|10799976|FG001|STARTED|Third Intervention (3 Hours)||10
9700883|NCT02853760|10799977|FG002|STARTED|Third Intervention (3 Hours)||6
9700884|NCT02853760|10799978|FG003|STARTED|Third Intervention (3 Hours)||6
9700885|NCT02853760|10799979|FG004|STARTED|Third Intervention (3 Hours)||8
9700886|NCT02853760|10799980|FG005|STARTED|Third Intervention (3 Hours)||5
9700887|NCT02853760|10799975|FG000|COMPLETED|Third Intervention (3 Hours)||7
9700888|NCT02853760|10799976|FG001|COMPLETED|Third Intervention (3 Hours)||10
9700889|NCT02853760|10799977|FG002|COMPLETED|Third Intervention (3 Hours)||6
9700890|NCT02853760|10799978|FG003|COMPLETED|Third Intervention (3 Hours)||6
9700891|NCT02853760|10799979|FG004|COMPLETED|Third Intervention (3 Hours)||8
9700892|NCT02853760|10799980|FG005|COMPLETED|Third Intervention (3 Hours)||5
9700893|NCT02853760|10799975|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0
9700894|NCT02853760|10799976|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0
9700895|NCT02853760|10799977|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0
9700896|NCT02853760|10799978|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0
9700897|NCT02853760|10799979|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0
9700898|NCT02853760|10799980|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0
9700899|NCT02789657|10799992|FG000|STARTED|Overall Study||27
9700900|NCT02789657|10799993|FG001|STARTED|Overall Study||3
9700901|NCT02789657|10799994|FG002|STARTED|Overall Study||0
9700902|NCT02789657|10799995|FG003|STARTED|Overall Study||2
9700903|NCT02789657|10799992|FG000|COMPLETED|Overall Study||25
9700904|NCT02789657|10799993|FG001|COMPLETED|Overall Study||3
9700905|NCT02789657|10799994|FG002|COMPLETED|Overall Study||0
9700906|NCT02789657|10799995|FG003|COMPLETED|Overall Study||2
9700907|NCT02789657|10799992|FG000|NOT COMPLETED|Overall Study||2
9700908|NCT02789657|10799993|FG001|NOT COMPLETED|Overall Study||0
9700909|NCT02789657|10799994|FG002|NOT COMPLETED|Overall Study||0
9700910|NCT02789657|10799995|FG003|NOT COMPLETED|Overall Study||0
9700911|NCT02743871|10800018|FG000|STARTED|Overall Study||6
9700912|NCT02743871|10800019|FG001|STARTED|Overall Study||6
9700913|NCT02743871|10800020|FG002|STARTED|Overall Study||6
9700914|NCT02743871|10800021|FG003|STARTED|Overall Study||3
9700915|NCT02743871|10800022|FG004|STARTED|Overall Study||4
9700916|NCT02743871|10800023|FG005|STARTED|Overall Study||6
9700917|NCT02743871|10800024|FG006|STARTED|Overall Study||6
9700918|NCT02743871|10800025|FG007|STARTED|Overall Study||8
9700919|NCT02743871|10800026|FG008|STARTED|Overall Study||2
9700920|NCT02743871|10800027|FG009|STARTED|Overall Study||2
9700921|NCT02743871|10800028|FG010|STARTED|Overall Study||11
9700922|NCT02743871|10800029|FG011|STARTED|Overall Study||9
9700923|NCT02743871|10800030|FG012|STARTED|Overall Study||20
9700924|NCT02743871|10800031|FG013|STARTED|Overall Study||8
9700925|NCT02743871|10800018|FG000|COMPLETED|Overall Study||5
9700926|NCT02743871|10800019|FG001|COMPLETED|Overall Study||6
9700927|NCT02743871|10800020|FG002|COMPLETED|Overall Study||6
9700928|NCT02743871|10800021|FG003|COMPLETED|Overall Study||2
9700929|NCT02743871|10800022|FG004|COMPLETED|Overall Study||4
9700930|NCT02743871|10800023|FG005|COMPLETED|Overall Study||6
9700931|NCT02743871|10800024|FG006|COMPLETED|Overall Study||5
9700932|NCT02743871|10800025|FG007|COMPLETED|Overall Study||8
9962588|NCT01479621|11082328|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909
9962589|NCT01479621|11082329|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9962590|NCT01479621|11082330|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9962591|NCT01479621|11082331|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9962592|NCT01479621|11082332|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9962593|NCT01479621|11082333|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9962594|NCT01479621|11082334|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
9962595|NCT01479621|11082328|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
9962596|NCT01479621|11082329|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962597|NCT01479621|11082330|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962598|NCT01479621|11082331|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962599|NCT01479621|11082332|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962600|NCT01479621|11082333|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962601|NCT01479621|11082334|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962602|NCT01479621|11082328|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
9962603|NCT01479621|11082329|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962604|NCT01479621|11082330|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962605|NCT01479621|11082331|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10026755|NCT04495829|11150910|FG000|COMPLETED|Overall Study||65
10026756|NCT04495829|11150910|FG000|NOT COMPLETED|Overall Study||5
10081322|NCT02259582|11209782|FG000|NOT COMPLETED|Overall Study||16
10081323|NCT02259582|11209783|FG001|NOT COMPLETED|Overall Study||17
10081324|NCT02259582|11209784|FG002|NOT COMPLETED|Overall Study||21
10081325|NCT02259608|11209792|FG000|STARTED|Overall Study||15
9700933|NCT02743871|10800026|FG008|COMPLETED|Overall Study||2
9700934|NCT02743871|10800027|FG009|COMPLETED|Overall Study||2
9700935|NCT02743871|10800028|FG010|COMPLETED|Overall Study||10
9700936|NCT02743871|10800029|FG011|COMPLETED|Overall Study||6
9700937|NCT02743871|10800030|FG012|COMPLETED|Overall Study||5
9700938|NCT02743871|10800031|FG013|COMPLETED|Overall Study||1
9700939|NCT02743871|10800018|FG000|NOT COMPLETED|Overall Study||1
10081326|NCT02259608|11209792|FG000|COMPLETED|Overall Study||15
10081327|NCT02259608|11209792|FG000|NOT COMPLETED|Overall Study||0
10081328|NCT02259699|11209798|FG000|STARTED|Overall Study||64
10081329|NCT02259699|11209799|FG001|STARTED|Overall Study||60
10081330|NCT02259699|11209798|FG000|COMPLETED|Overall Study||37
10081331|NCT02259699|11209799|FG001|COMPLETED|Overall Study||40
10081332|NCT02259699|11209798|FG000|NOT COMPLETED|Overall Study||27
10081333|NCT02259699|11209799|FG001|NOT COMPLETED|Overall Study||20
10081334|NCT02260154|11209805|FG000|STARTED|Overall Study||220
10081335|NCT02260154|11209805|FG000|COMPLETED|Overall Study||218
10081336|NCT02260154|11209805|FG000|NOT COMPLETED|Overall Study||2
10081337|NCT02260180|11209813|FG000|STARTED|Overall Study||39
10081338|NCT02260180|11209814|FG001|STARTED|Overall Study||39
10081339|NCT02260180|11209815|FG002|STARTED|Overall Study||41
9700940|NCT02743871|10800019|FG001|NOT COMPLETED|Overall Study||0
9700941|NCT02743871|10800020|FG002|NOT COMPLETED|Overall Study||0
9700942|NCT02743871|10800021|FG003|NOT COMPLETED|Overall Study||1
9700943|NCT02743871|10800022|FG004|NOT COMPLETED|Overall Study||0
9700944|NCT02743871|10800023|FG005|NOT COMPLETED|Overall Study||0
9700945|NCT02743871|10800024|FG006|NOT COMPLETED|Overall Study||1
9700946|NCT02743871|10800025|FG007|NOT COMPLETED|Overall Study||0
9700947|NCT02743871|10800026|FG008|NOT COMPLETED|Overall Study||0
9700948|NCT02743871|10800027|FG009|NOT COMPLETED|Overall Study||0
9700949|NCT02743871|10800028|FG010|NOT COMPLETED|Overall Study||1
9700950|NCT02743871|10800029|FG011|NOT COMPLETED|Overall Study||3
9700951|NCT02743871|10800030|FG012|NOT COMPLETED|Overall Study||15
9700952|NCT02743871|10800031|FG013|NOT COMPLETED|Overall Study||7
9700953|NCT02707198|10800076|FG000|STARTED|Overall Study||2
9700954|NCT02707198|10800077|FG001|STARTED|Overall Study||0
9700955|NCT02707198|10800078|FG002|STARTED|Overall Study||0
9700956|NCT02707198|10800076|FG000|COMPLETED|Overall Study||2
9700957|NCT02707198|10800077|FG001|COMPLETED|Overall Study||0
9700958|NCT02707198|10800078|FG002|COMPLETED|Overall Study||0
9700959|NCT02707198|10800076|FG000|NOT COMPLETED|Overall Study||0
9700960|NCT02707198|10800077|FG001|NOT COMPLETED|Overall Study||0
9700961|NCT02707198|10800078|FG002|NOT COMPLETED|Overall Study||0
9700962|NCT02673398|10800086|FG000|STARTED|Overall Study||25
9700963|NCT02673398|10800086|FG000|COMPLETED|Overall Study||25
9700964|NCT02673398|10800086|FG000|NOT COMPLETED|Overall Study||0
9700965|NCT02614261|10800093|FG000|STARTED|Double-Blind Treatment Phase||559
9700966|NCT02614261|10800094|FG001|STARTED|Double-Blind Treatment Phase||279
9700967|NCT02614261|10800095|FG002|STARTED|Double-Blind Treatment Phase||279
9700968|NCT02614261|10800096|FG003|STARTED|Double-Blind Treatment Phase||0
9700969|NCT02614261|10800093|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||558
9700970|NCT02614261|10800094|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||278
9700971|NCT02614261|10800095|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||277
9700972|NCT02614261|10800096|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||0
9700973|NCT02614261|10800093|FG000|Safety Population|Double-Blind Treatment Phase||558
9700974|NCT02614261|10800094|FG001|Safety Population|Double-Blind Treatment Phase|5 participants discontinued after receiving loading dose of 240mg. They were included under 240mg arm for safety analysis.|273
9700975|NCT02614261|10800095|FG002|Safety Population|Double-Blind Treatment Phase||282
9700976|NCT02614261|10800096|FG003|Safety Population|Double-Blind Treatment Phase||0
9700977|NCT02614261|10800093|FG000|COMPLETED|Double-Blind Treatment Phase||509
9700978|NCT02614261|10800094|FG001|COMPLETED|Double-Blind Treatment Phase||262
9700979|NCT02614261|10800095|FG002|COMPLETED|Double-Blind Treatment Phase||266
9700980|NCT02614261|10800096|FG003|COMPLETED|Double-Blind Treatment Phase||0
9700981|NCT02614261|10800093|FG000|NOT COMPLETED|Double-Blind Treatment Phase||50
9700982|NCT02614261|10800094|FG001|NOT COMPLETED|Double-Blind Treatment Phase||17
9700983|NCT02614261|10800095|FG002|NOT COMPLETED|Double-Blind Treatment Phase||13
9700984|NCT02614261|10800096|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
9700985|NCT02614261|10800093|FG000|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|501
9700986|NCT02614261|10800094|FG001|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|259
9700987|NCT02614261|10800095|FG002|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|262
9700988|NCT02614261|10800096|FG003|STARTED|Open-Label Extension Phase||0
9700989|NCT02614261|10800093|FG000|Safety Population|Open-Label Extension Phase||501
9700990|NCT02614261|10800094|FG001|Safety Population|Open-Label Extension Phase||259
9700991|NCT02614261|10800095|FG002|Safety Population|Open-Label Extension Phase||262
9700992|NCT02614261|10800096|FG003|Safety Population|Open-Label Extension Phase||0
9700993|NCT02614261|10800093|FG000|COMPLETED|Open-Label Extension Phase||413
9700994|NCT02614261|10800094|FG001|COMPLETED|Open-Label Extension Phase||204
9700995|NCT02614261|10800095|FG002|COMPLETED|Open-Label Extension Phase||208
9700996|NCT02614261|10800096|FG003|COMPLETED|Open-Label Extension Phase||0
9700997|NCT02614261|10800093|FG000|NOT COMPLETED|Open-Label Extension Phase||88
9700998|NCT02614261|10800094|FG001|NOT COMPLETED|Open-Label Extension Phase||55
9700999|NCT02614261|10800095|FG002|NOT COMPLETED|Open-Label Extension Phase||54
9701000|NCT02614261|10800096|FG003|NOT COMPLETED|Open-Label Extension Phase||0
9701001|NCT02614261|10800093|FG000|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|453
9701002|NCT02614261|10800094|FG001|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|228
9701003|NCT02614261|10800095|FG002|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|231
9701004|NCT02614261|10800096|FG003|STARTED|Follow-up Phase||0
9701005|NCT02614261|10800093|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||15
9728126|NCT00112151|10827855|FG004|STARTED|Overall Study||28
9728127|NCT00112151|10827856|FG005|STARTED|Overall Study||28
9728128|NCT00112151|10827851|FG000|COMPLETED|Overall Study||24
10115416|NCT02525744|11246276|FG002|Received at Least 1 Dose of Study Drug|Period 3||5
10115417|NCT02525744|11246277|FG003|Received at Least 1 Dose of Study Drug|Period 3||6
10115418|NCT02525744|11246274|FG000|COMPLETED|Period 3||6
10115419|NCT02525744|11246275|FG001|COMPLETED|Period 3||5
9701006|NCT02614261|10800094|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase|1 among these participants discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase.|5
9701007|NCT02614261|10800095|FG002|Entered From Double-blind Treatment Phase|Follow-up Phase||3
9701008|NCT02614261|10800096|FG003|Entered From Double-blind Treatment Phase|Follow-up Phase||0
9701009|NCT02614261|10800093|FG000|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||15
9701010|NCT02614261|10800094|FG001|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase|1 participant who discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase was included under 240mg arm for safety analysis.|4
9728129|NCT00112151|10827852|FG001|COMPLETED|Overall Study||23
9962606|NCT01479621|11082332|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962607|NCT01479621|11082333|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962608|NCT01479621|11082334|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
9962609|NCT01479621|11082328|FG000|STARTED|Treatment Period||0
9962610|NCT01479621|11082329|FG001|STARTED|Treatment Period||103
9962611|NCT01479621|11082330|FG002|STARTED|Treatment Period||104
9962612|NCT01479621|11082331|FG003|STARTED|Treatment Period||104
9962613|NCT01479621|11082332|FG004|STARTED|Treatment Period||103
9962614|NCT01479621|11082333|FG005|STARTED|Treatment Period||104
9962615|NCT01479621|11082334|FG006|STARTED|Treatment Period||104
9962616|NCT01479621|11082328|FG000|Safety Population|Treatment Period||0
9962617|NCT01479621|11082329|FG001|Safety Population|Treatment Period||103
9962618|NCT01479621|11082330|FG002|Safety Population|Treatment Period||104
9962619|NCT01479621|11082331|FG003|Safety Population|Treatment Period||104
9962620|NCT01479621|11082332|FG004|Safety Population|Treatment Period||103
9962621|NCT01479621|11082333|FG005|Safety Population|Treatment Period||104
9962622|NCT01479621|11082334|FG006|Safety Population|Treatment Period||104
9962623|NCT01479621|11082328|FG000|Full Analysis Set|Treatment Period||0
9962624|NCT01479621|11082329|FG001|Full Analysis Set|Treatment Period||102
9962625|NCT01479621|11082330|FG002|Full Analysis Set|Treatment Period||101
9962626|NCT01479621|11082331|FG003|Full Analysis Set|Treatment Period||102
9962627|NCT01479621|11082332|FG004|Full Analysis Set|Treatment Period||102
9962628|NCT01479621|11082333|FG005|Full Analysis Set|Treatment Period||102
9962629|NCT01479621|11082334|FG006|Full Analysis Set|Treatment Period||102
9962630|NCT01479621|11082328|FG000|COMPLETED|Treatment Period||0
9962631|NCT01479621|11082329|FG001|COMPLETED|Treatment Period||79
9962632|NCT01479621|11082330|FG002|COMPLETED|Treatment Period||83
9962633|NCT01479621|11082331|FG003|COMPLETED|Treatment Period||92
9962634|NCT01479621|11082332|FG004|COMPLETED|Treatment Period||82
9962635|NCT01479621|11082333|FG005|COMPLETED|Treatment Period||63
9962636|NCT01479621|11082334|FG006|COMPLETED|Treatment Period||84
9962637|NCT01479621|11082328|FG000|NOT COMPLETED|Treatment Period||0
9962638|NCT01479621|11082329|FG001|NOT COMPLETED|Treatment Period||24
9962639|NCT01479621|11082330|FG002|NOT COMPLETED|Treatment Period||21
9962640|NCT01479621|11082331|FG003|NOT COMPLETED|Treatment Period||12
9962641|NCT01479621|11082332|FG004|NOT COMPLETED|Treatment Period||21
9962642|NCT01479621|11082333|FG005|NOT COMPLETED|Treatment Period||41
9962643|NCT01479621|11082334|FG006|NOT COMPLETED|Treatment Period||20
9962644|NCT01479725|11082350|FG000|STARTED|Overall Study||6
9962645|NCT01479725|11082351|FG001|STARTED|Overall Study||2
9962646|NCT01479725|11082350|FG000|COMPLETED|Overall Study||4
9962647|NCT01479725|11082351|FG001|COMPLETED|Overall Study||1
9962648|NCT01479725|11082350|FG000|NOT COMPLETED|Overall Study||2
9962649|NCT01479725|11082351|FG001|NOT COMPLETED|Overall Study||1
9962650|NCT01479764|11082359|FG000|STARTED|Randomized||76
9962651|NCT01479764|11082360|FG001|STARTED|Randomized||78
9962652|NCT01479764|11082359|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
9962653|NCT01479764|11082360|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
9962654|NCT01479764|11082359|FG000|NOT COMPLETED|Randomized||2
9962655|NCT01479764|11082360|FG001|NOT COMPLETED|Randomized||1
9962656|NCT01479764|11082359|FG000|STARTED|Treated||74
9962657|NCT01479764|11082360|FG001|STARTED|Treated||77
9962658|NCT01479764|11082359|FG000|COMPLETED|Treated||74
9962659|NCT01479764|11082360|FG001|COMPLETED|Treated||75
9962660|NCT01479764|11082359|FG000|NOT COMPLETED|Treated||0
9962661|NCT01479764|11082360|FG001|NOT COMPLETED|Treated||2
9962662|NCT01479777|11082366|FG000|STARTED|Overall Study||12
9962663|NCT01479777|11082366|FG000|COMPLETED|Overall Study||10
9962664|NCT01479777|11082366|FG000|NOT COMPLETED|Overall Study||2
9962665|NCT01479868|11082370|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
9962666|NCT01479868|11082370|FG000|COMPLETED|Overall Study||97
9962667|NCT01479868|11082370|FG000|NOT COMPLETED|Overall Study||9
9962668|NCT01479985|11082376|FG000|STARTED|Overall Study||167
9962669|NCT01479985|11082377|FG001|STARTED|Overall Study||86
9962670|NCT01479985|11082376|FG000|Baseline Survey|Overall Study||166
9962671|NCT01479985|11082377|FG001|Baseline Survey|Overall Study||85
10115420|NCT02525744|11246276|FG002|COMPLETED|Period 3||5
10115421|NCT02525744|11246277|FG003|COMPLETED|Period 3||6
10115422|NCT02525744|11246274|FG000|NOT COMPLETED|Period 3||0
10115423|NCT02525744|11246275|FG001|NOT COMPLETED|Period 3||1
10115424|NCT02525744|11246276|FG002|NOT COMPLETED|Period 3||0
10115425|NCT02525744|11246277|FG003|NOT COMPLETED|Period 3||0
10115426|NCT02525744|11246274|FG000|STARTED|Period 4||6
10115427|NCT02525744|11246275|FG001|STARTED|Period 4||5
10115428|NCT02525744|11246276|FG002|STARTED|Period 4||5
10115429|NCT02525744|11246277|FG003|STARTED|Period 4||6
9701011|NCT02614261|10800095|FG002|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||4
9701012|NCT02614261|10800096|FG003|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||0
9701013|NCT02614261|10800093|FG000|Entered From Open-label Extension Phase|Follow-up Phase||438
9701014|NCT02614261|10800094|FG001|Entered From Open-label Extension Phase|Follow-up Phase||223
9701015|NCT02614261|10800095|FG002|Entered From Open-label Extension Phase|Follow-up Phase||228
9701016|NCT02614261|10800096|FG003|Entered From Open-label Extension Phase|Follow-up Phase||0
9701017|NCT02614261|10800093|FG000|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||438
9701018|NCT02614261|10800094|FG001|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||223
9701019|NCT02614261|10800095|FG002|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||228
9701020|NCT02614261|10800096|FG003|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||0
9701021|NCT02614261|10800093|FG000|COMPLETED|Follow-up Phase||421
9701022|NCT02614261|10800094|FG001|COMPLETED|Follow-up Phase||217
9701023|NCT02614261|10800095|FG002|COMPLETED|Follow-up Phase||217
9701024|NCT02614261|10800096|FG003|COMPLETED|Follow-up Phase||0
9701025|NCT02614261|10800093|FG000|NOT COMPLETED|Follow-up Phase||32
9701026|NCT02614261|10800094|FG001|NOT COMPLETED|Follow-up Phase||11
9701027|NCT02614261|10800095|FG002|NOT COMPLETED|Follow-up Phase||14
9701028|NCT02614261|10800096|FG003|NOT COMPLETED|Follow-up Phase||0
9701029|NCT02614261|10800093|FG000|STARTED|Israel Addendum|Main study arm.|0
9701030|NCT02614261|10800094|FG001|STARTED|Israel Addendum|Main study arm.|0
9701031|NCT02614261|10800095|FG002|STARTED|Israel Addendum|Main study arm.|0
9701032|NCT02614261|10800096|FG003|STARTED|Israel Addendum|Eligible participants from main study enrolled in Israel addendum.|29
9701033|NCT02614261|10800093|FG000|Safety Population|Israel Addendum||0
9701034|NCT02614261|10800094|FG001|Safety Population|Israel Addendum||0
9701035|NCT02614261|10800095|FG002|Safety Population|Israel Addendum||0
9701036|NCT02614261|10800096|FG003|Safety Population|Israel Addendum||29
9701037|NCT02614261|10800093|FG000|COMPLETED|Israel Addendum||0
9701038|NCT02614261|10800094|FG001|COMPLETED|Israel Addendum||0
9701039|NCT02614261|10800095|FG002|COMPLETED|Israel Addendum||0
9701040|NCT02614261|10800096|FG003|COMPLETED|Israel Addendum||25
9701041|NCT02614261|10800093|FG000|NOT COMPLETED|Israel Addendum||0
9701042|NCT02614261|10800094|FG001|NOT COMPLETED|Israel Addendum||0
9701043|NCT02614261|10800095|FG002|NOT COMPLETED|Israel Addendum||0
9701044|NCT02614261|10800096|FG003|NOT COMPLETED|Israel Addendum||4
9701045|NCT02527434|10800125|FG000|STARTED|Overall Study||32
9701046|NCT02527434|10800126|FG001|STARTED|Overall Study||12
9701047|NCT02527434|10800127|FG002|STARTED|Overall Study||20
9701048|NCT02527434|10800125|FG000|Started Retreatment Phase (COMBO)|Overall Study||7
9701049|NCT02527434|10800126|FG001|Started Retreatment Phase (COMBO)|Overall Study||5
9701050|NCT02527434|10800127|FG002|Started Retreatment Phase (COMBO)|Overall Study||4
9847886|NCT00856544|10960522|FG003|COMPLETED|Overall Study||67
9847887|NCT00856544|10960519|FG000|NOT COMPLETED|Overall Study||57
9847888|NCT00856544|10960520|FG001|NOT COMPLETED|Overall Study||66
9847889|NCT00856544|10960521|FG002|NOT COMPLETED|Overall Study||8
9847890|NCT00856544|10960522|FG003|NOT COMPLETED|Overall Study||13
9847891|NCT00856557|10960546|FG000|STARTED|Overall Study||62
9847892|NCT00856557|10960547|FG001|STARTED|Overall Study||76
9847893|NCT00856557|10960546|FG000|Received Intervention/Control|Overall Study||62
9847894|NCT00856557|10960547|FG001|Received Intervention/Control|Overall Study||76
9847895|NCT00856557|10960546|FG000|Tested With Standardized Patients|Overall Study||62
9847896|NCT00856557|10960547|FG001|Tested With Standardized Patients|Overall Study||76
9847897|NCT00856557|10960546|FG000|With Patients With Contextual Flags|Overall Study||50
9847898|NCT00856557|10960547|FG001|With Patients With Contextual Flags|Overall Study||60
9847899|NCT00856557|10960546|FG000|COMPLETED|Overall Study||50
9847900|NCT00856557|10960547|FG001|COMPLETED|Overall Study||60
9847901|NCT00856557|10960546|FG000|NOT COMPLETED|Overall Study||12
9847902|NCT00856557|10960547|FG001|NOT COMPLETED|Overall Study||16
9847903|NCT00856583|10960555|FG000|STARTED|Overall Study|Patients treated|4905
9847904|NCT00856583|10960556|FG001|STARTED|Overall Study|Patients treated|4904
9847905|NCT00856583|10960555|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
9847906|NCT00856583|10960556|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
9847907|NCT00856583|10960555|FG000|NOT COMPLETED|Overall Study||3137
9847908|NCT00856583|10960556|FG001|NOT COMPLETED|Overall Study||2597
9847909|NCT00856609|10960564|FG000|STARTED|Overall Study||41
9847910|NCT00856609|10960565|FG001|STARTED|Overall Study||39
9847911|NCT00856609|10960564|FG000|COMPLETED|Overall Study||40
9847912|NCT00856609|10960565|FG001|COMPLETED|Overall Study||39
9962672|NCT01479985|11082376|FG000|COMPLETED|Overall Study||161
9962673|NCT01479985|11082377|FG001|COMPLETED|Overall Study||80
9962674|NCT01479985|11082376|FG000|NOT COMPLETED|Overall Study||6
9962675|NCT01479985|11082377|FG001|NOT COMPLETED|Overall Study||6
9962676|NCT01480076|11082385|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901
9962677|NCT01480076|11082385|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
9962678|NCT01480076|11082385|FG000|COMPLETED|Overall Study||611
9962679|NCT01480076|11082385|FG000|NOT COMPLETED|Overall Study||290
9962680|NCT01480089|11082403|FG000|STARTED|Overall Study||25
9962681|NCT01480089|11082404|FG001|STARTED|Overall Study||30
9962682|NCT01480089|11082403|FG000|COMPLETED|Overall Study||25
9962683|NCT01480089|11082404|FG001|COMPLETED|Overall Study||30
10115430|NCT02525744|11246274|FG000|Received at Least 1 Dose of Study Drug|Period 4||6
9701051|NCT02527434|10800125|FG000|Started Retreatment Phase (MEDI)|Overall Study||4
9701052|NCT02527434|10800126|FG001|Started Retreatment Phase (MEDI)|Overall Study||0
9701053|NCT02527434|10800127|FG002|Started Retreatment Phase (MEDI)|Overall Study||1
9701054|NCT02527434|10800125|FG000|COMPLETED|Overall Study||4
9701055|NCT02527434|10800126|FG001|COMPLETED|Overall Study||1
9701056|NCT02527434|10800127|FG002|COMPLETED|Overall Study||0
9701057|NCT02527434|10800125|FG000|NOT COMPLETED|Overall Study||28
9701058|NCT02527434|10800126|FG001|NOT COMPLETED|Overall Study||11
9701059|NCT02527434|10800127|FG002|NOT COMPLETED|Overall Study||20
9701060|NCT02513667|10800147|FG000|STARTED|Overall Study||8
9701061|NCT02513667|10800148|FG001|STARTED|Overall Study||6
9701062|NCT02513667|10800147|FG000|COMPLETED|Overall Study||8
9701063|NCT02513667|10800148|FG001|COMPLETED|Overall Study||5
9701064|NCT02513667|10800147|FG000|NOT COMPLETED|Overall Study||0
9701065|NCT02513667|10800148|FG001|NOT COMPLETED|Overall Study||1
9701078|NCT02415556|10800175|FG000|STARTED|Overall Study||57
9701079|NCT02415556|10800176|FG001|STARTED|Overall Study||58
9701080|NCT02415556|10800177|FG002|STARTED|Overall Study||65
10115431|NCT02525744|11246275|FG001|Received at Least 1 Dose of Study Drug|Period 4||5
10115432|NCT02525744|11246276|FG002|Received at Least 1 Dose of Study Drug|Period 4||5
9701081|NCT02415556|10800178|FG003|STARTED|Overall Study||64
9701082|NCT02415556|10800175|FG000|COMPLETED|Overall Study||32
9701083|NCT02415556|10800176|FG001|COMPLETED|Overall Study||37
9701084|NCT02415556|10800177|FG002|COMPLETED|Overall Study||43
9701085|NCT02415556|10800178|FG003|COMPLETED|Overall Study||44
9701086|NCT02415556|10800175|FG000|NOT COMPLETED|Overall Study||25
9701087|NCT02415556|10800176|FG001|NOT COMPLETED|Overall Study||21
9701088|NCT02415556|10800177|FG002|NOT COMPLETED|Overall Study||22
9701089|NCT02415556|10800178|FG003|NOT COMPLETED|Overall Study||20
9701090|NCT02389374|10800191|FG000|STARTED|Overall Study||55
9701091|NCT02389374|10800192|FG001|STARTED|Overall Study||115
9701092|NCT02389374|10800193|FG002|STARTED|Overall Study||11
9701093|NCT02389374|10800191|FG000|COMPLETED|Overall Study||46
9701094|NCT02389374|10800192|FG001|COMPLETED|Overall Study||87
9701095|NCT02389374|10800193|FG002|COMPLETED|Overall Study||10
9701096|NCT02389374|10800191|FG000|NOT COMPLETED|Overall Study||9
9701097|NCT02389374|10800192|FG001|NOT COMPLETED|Overall Study||28
9701098|NCT02389374|10800193|FG002|NOT COMPLETED|Overall Study||1
9701099|NCT02386839|10800204|FG000|STARTED|Overall Study||36
9701100|NCT02386839|10800205|FG001|STARTED|Overall Study||40
9701101|NCT02386839|10800204|FG000|COMPLETED|Overall Study||20
9701102|NCT02386839|10800205|FG001|COMPLETED|Overall Study||25
9701103|NCT02386839|10800204|FG000|NOT COMPLETED|Overall Study||16
9701104|NCT02386839|10800205|FG001|NOT COMPLETED|Overall Study||15
9701105|NCT02362503|10800218|FG000|STARTED|Double-blind Period-Up to 8 Days||69
9701106|NCT02362503|10800219|FG001|STARTED|Double-blind Period-Up to 8 Days||203
9701107|NCT02362503|10800220|FG002|STARTED|Double-blind Period-Up to 8 Days||0
9701108|NCT02362503|10800218|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68
9701109|NCT02362503|10800219|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199
9701110|NCT02362503|10800220|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0
9701111|NCT02362503|10800218|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
9701112|NCT02362503|10800219|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
9701113|NCT02362503|10800220|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
9701114|NCT02362503|10800218|FG000|STARTED|Open Label Period-Up to 96 Weeks||68
9701115|NCT02362503|10800219|FG001|STARTED|Open Label Period-Up to 96 Weeks||199
9701116|NCT02362503|10800220|FG002|STARTED|Open Label Period-Up to 96 Weeks||99
9701117|NCT02362503|10800218|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0
9962684|NCT01480089|11082403|FG000|NOT COMPLETED|Overall Study||0
9701118|NCT02362503|10800219|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0
9701119|NCT02362503|10800220|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0
9701120|NCT02362503|10800218|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
9701121|NCT02362503|10800219|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
9701122|NCT02362503|10800220|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
9728130|NCT00112151|10827853|FG002|COMPLETED|Overall Study||25
9728131|NCT00112151|10827854|FG003|COMPLETED|Overall Study||24
9728132|NCT00112151|10827855|FG004|COMPLETED|Overall Study||22
9962685|NCT01480089|11082404|FG001|NOT COMPLETED|Overall Study||0
9728133|NCT00112151|10827856|FG005|COMPLETED|Overall Study||25
9701123|NCT02312258|10800233|FG000|STARTED|Overall Study||281
9701124|NCT02312258|10800234|FG001|STARTED|Overall Study||425
9701125|NCT02312258|10800233|FG000|COMPLETED|Overall Study||30
9847913|NCT00856609|10960564|FG000|NOT COMPLETED|Overall Study||1
9847914|NCT00856609|10960565|FG001|NOT COMPLETED|Overall Study||0
9847915|NCT00856635|10960573|FG000|STARTED|Overall Study||22
9847916|NCT00856635|10960574|FG001|STARTED|Overall Study||22
9847917|NCT00856635|10960573|FG000|Received Study Drug|Overall Study||20
9847918|NCT00856635|10960574|FG001|Received Study Drug|Overall Study||20
9847919|NCT00856635|10960573|FG000|COMPLETED|Overall Study||12
9847920|NCT00856635|10960574|FG001|COMPLETED|Overall Study||14
9847921|NCT00856635|10960573|FG000|NOT COMPLETED|Overall Study||10
9847922|NCT00856635|10960574|FG001|NOT COMPLETED|Overall Study||8
9847923|NCT00856661|10960584|FG000|STARTED|Overall Study|Randomised|135
9847924|NCT00856661|10960585|FG001|STARTED|Overall Study|Randomised|135
9847925|NCT00856661|10960584|FG000|Treated|Overall Study||126
9847926|NCT00856661|10960585|FG001|Treated|Overall Study||131
9847927|NCT00856661|10960584|FG000|Randomized Not Treated|Overall Study||9
9847928|NCT00856661|10960585|FG001|Randomized Not Treated|Overall Study||4
9847929|NCT00856661|10960584|FG000|COMPLETED|Overall Study||108
9847930|NCT00856661|10960585|FG001|COMPLETED|Overall Study||106
9847931|NCT00856661|10960584|FG000|NOT COMPLETED|Overall Study||27
9847932|NCT00856661|10960585|FG001|NOT COMPLETED|Overall Study||29
9847933|NCT00856726|10960591|FG000|STARTED|Overall Study||26
9847934|NCT00856726|10960591|FG000|COMPLETED|Overall Study||26
9847935|NCT00856726|10960591|FG000|NOT COMPLETED|Overall Study||0
9847936|NCT00856739|10960598|FG000|STARTED|Overall Study||70
9847937|NCT00856739|10960599|FG001|STARTED|Overall Study||52
9847938|NCT00856739|10960600|FG002|STARTED|Overall Study||55
9847939|NCT00856739|10960598|FG000|COMPLETED|Overall Study||70
9847940|NCT00856739|10960599|FG001|COMPLETED|Overall Study||52
9847941|NCT00856739|10960600|FG002|COMPLETED|Overall Study||55
9847942|NCT00856739|10960598|FG000|NOT COMPLETED|Overall Study||0
9847943|NCT00856739|10960599|FG001|NOT COMPLETED|Overall Study||0
9847944|NCT00856739|10960600|FG002|NOT COMPLETED|Overall Study||0
9847945|NCT00856778|10960611|FG000|STARTED|Overall Study||98
9847946|NCT00856778|10960611|FG000|COMPLETED|Overall Study||74
9847947|NCT00856778|10960611|FG000|NOT COMPLETED|Overall Study||24
9847948|NCT00856791|10960615|FG000|STARTED|Overall Study||1
9847949|NCT00856791|10960615|FG000|COMPLETED|Overall Study||1
9847950|NCT00856791|10960615|FG000|NOT COMPLETED|Overall Study||0
9847951|NCT00856830|10960623|FG000|STARTED|Irinotecan & Bendamustine||3
9847952|NCT00856830|10960624|FG001|STARTED|Irinotecan & Bendamustine||6
9847953|NCT00856830|10960625|FG002|STARTED|Irinotecan & Bendamustine||6
9847954|NCT00856830|10960626|FG003|STARTED|Irinotecan & Bendamustine||15
9847955|NCT00856830|10960623|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
9847956|NCT00856830|10960624|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
9847957|NCT00856830|10960625|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
9847958|NCT00856830|10960626|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
9847959|NCT00856830|10960623|FG000|COMPLETED|Irinotecan & Bendamustine||3
9847960|NCT00856830|10960624|FG001|COMPLETED|Irinotecan & Bendamustine||6
9847961|NCT00856830|10960625|FG002|COMPLETED|Irinotecan & Bendamustine||6
9847962|NCT00856830|10960626|FG003|COMPLETED|Irinotecan & Bendamustine||12
9847963|NCT00856830|10960623|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0
9847964|NCT00856830|10960624|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0
9847965|NCT00856830|10960625|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0
9847966|NCT00856830|10960626|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3
9847967|NCT00856830|10960623|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3
9847968|NCT00856830|10960624|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6
9847969|NCT00856830|10960625|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6
9847970|NCT00856830|10960626|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12
9847971|NCT00856830|10960623|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
9847972|NCT00856830|10960624|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
9847973|NCT00856830|10960625|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
9847974|NCT00856830|10960626|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
9847975|NCT00856830|10960623|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
9962686|NCT01480219|11082412|FG000|STARTED|Overall Study||325
9962687|NCT01480219|11082413|FG001|STARTED|Overall Study||142
9962688|NCT01480219|11082412|FG000|COMPLETED|Overall Study||325
9962689|NCT01480219|11082413|FG001|COMPLETED|Overall Study||142
9962690|NCT01480219|11082412|FG000|NOT COMPLETED|Overall Study||0
9962691|NCT01480219|11082413|FG001|NOT COMPLETED|Overall Study||0
9962692|NCT01480232|11082423|FG000|STARTED|Overall Study||40
9962693|NCT01480232|11082424|FG001|STARTED|Overall Study||41
9962694|NCT01480232|11082425|FG002|STARTED|Overall Study||38
9962695|NCT01480232|11082426|FG003|STARTED|Overall Study||41
9962696|NCT01480232|11082423|FG000|COMPLETED|Overall Study||22
9962697|NCT01480232|11082424|FG001|COMPLETED|Overall Study||19
9962698|NCT01480232|11082425|FG002|COMPLETED|Overall Study||21
9962699|NCT01480232|11082426|FG003|COMPLETED|Overall Study||22
9962700|NCT01480232|11082423|FG000|NOT COMPLETED|Overall Study||18
9847976|NCT00856830|10960624|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
9847977|NCT00856830|10960625|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
9847978|NCT00856830|10960626|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
9847979|NCT00856843|10960633|FG000|STARTED|Overall Study||68
9962701|NCT01480232|11082424|FG001|NOT COMPLETED|Overall Study||22
9962702|NCT01480232|11082425|FG002|NOT COMPLETED|Overall Study||17
9701126|NCT02312258|10800234|FG001|COMPLETED|Overall Study||66
9701127|NCT02312258|10800233|FG000|NOT COMPLETED|Overall Study||251
9701128|NCT02312258|10800234|FG001|NOT COMPLETED|Overall Study||359
9701129|NCT02243605|10800242|FG000|STARTED|Stage 1 - Interim Analysis Population||23
9701130|NCT02243605|10800243|FG001|STARTED|Stage 1 - Interim Analysis Population||22
9701131|NCT02243605|10800242|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21
9701132|NCT02243605|10800243|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21
9701133|NCT02243605|10800242|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
9701134|NCT02243605|10800243|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
9962703|NCT01480232|11082426|FG003|NOT COMPLETED|Overall Study||19
9962704|NCT01480258|11082438|FG000|STARTED|Infant Series||656
9962705|NCT01480258|11082439|FG001|STARTED|Infant Series||659
9962706|NCT01480258|11082438|FG000|Vaccinated|Infant Series||653
9962707|NCT01480258|11082439|FG001|Vaccinated|Infant Series||659
9962708|NCT01480258|11082438|FG000|COMPLETED|Infant Series||649
9962709|NCT01480258|11082439|FG001|COMPLETED|Infant Series||651
9962710|NCT01480258|11082438|FG000|NOT COMPLETED|Infant Series||7
9962711|NCT01480258|11082439|FG001|NOT COMPLETED|Infant Series||8
9962712|NCT01480258|11082438|FG000|STARTED|Interim Period||649
9962713|NCT01480258|11082439|FG001|STARTED|Interim Period||651
9962714|NCT01480258|11082438|FG000|COMPLETED|Interim Period||639
9962715|NCT01480258|11082439|FG001|COMPLETED|Interim Period||642
9962716|NCT01480258|11082438|FG000|NOT COMPLETED|Interim Period||10
9962717|NCT01480258|11082439|FG001|NOT COMPLETED|Interim Period||9
9962718|NCT01480258|11082438|FG000|STARTED|Toddler Dose||639
9962719|NCT01480258|11082439|FG001|STARTED|Toddler Dose||642
9962720|NCT01480258|11082438|FG000|COMPLETED|Toddler Dose||639
9962721|NCT01480258|11082439|FG001|COMPLETED|Toddler Dose||642
9962722|NCT01480258|11082438|FG000|NOT COMPLETED|Toddler Dose||0
9962723|NCT01480258|11082439|FG001|NOT COMPLETED|Toddler Dose||0
9962724|NCT01480284|11082447|FG000|STARTED|Overall Study||110
9962725|NCT01480284|11082448|FG001|STARTED|Overall Study||56
9962726|NCT01480284|11082447|FG000|COMPLETED|Overall Study||102
9962727|NCT01480284|11082448|FG001|COMPLETED|Overall Study||56
9962728|NCT01480284|11082447|FG000|NOT COMPLETED|Overall Study||8
9962729|NCT01480284|11082448|FG001|NOT COMPLETED|Overall Study||0
9962730|NCT01480297|11082454|FG000|STARTED|Overall Study||8
9962731|NCT01480297|11082454|FG000|COMPLETED|Overall Study||8
9962732|NCT01480297|11082454|FG000|NOT COMPLETED|Overall Study||0
9962733|NCT01480596|11082460|FG000|STARTED|Overall Study||22
9962734|NCT01480596|11082461|FG001|STARTED|Overall Study||18
9962735|NCT01480596|11082460|FG000|COMPLETED|Overall Study||17
9962736|NCT01480596|11082461|FG001|COMPLETED|Overall Study||16
9962737|NCT01480596|11082460|FG000|NOT COMPLETED|Overall Study||5
9962738|NCT01480596|11082461|FG001|NOT COMPLETED|Overall Study||2
9962739|NCT01480674|11082467|FG000|STARTED|Overall Study||160
9962740|NCT01480674|11082467|FG000|Safety Set|Overall Study||154
9962741|NCT01480674|11082467|FG000|Analysed Set|Overall Study||128
9962742|NCT01480674|11082467|FG000|COMPLETED|Overall Study||125
9962743|NCT01480674|11082467|FG000|NOT COMPLETED|Overall Study||35
9962744|NCT01480843|11082471|FG000|STARTED|Overall Study||65
9962745|NCT01480843|11082471|FG000|COMPLETED|Overall Study||60
9962746|NCT01480843|11082471|FG000|NOT COMPLETED|Overall Study||5
9962747|NCT01481116|11082478|FG000|STARTED|Overall Study||824
9962748|NCT01481116|11082479|FG001|STARTED|Overall Study||817
9962749|NCT01481116|11082480|FG002|STARTED|Overall Study||813
9962750|NCT01481116|11082478|FG000|Treated|Overall Study||822
9962751|NCT01481116|11082479|FG001|Treated|Overall Study||816
10026757|NCT03861052|11150918|FG000|STARTED|Overall Study||159
10026758|NCT03861052|11150919|FG001|STARTED|Overall Study||158
10026759|NCT03861052|11150920|FG002|STARTED|Overall Study||160
10026760|NCT03861052|11150921|FG003|STARTED|Overall Study||159
10026761|NCT03861052|11150918|FG000|Received at Least One Dose of Study Drug|Overall Study||159
10026762|NCT03861052|11150919|FG001|Received at Least One Dose of Study Drug|Overall Study||158
10026763|NCT03861052|11150920|FG002|Received at Least One Dose of Study Drug|Overall Study||160
10026764|NCT03861052|11150921|FG003|Received at Least One Dose of Study Drug|Overall Study||159
10026765|NCT03861052|11150918|FG000|COMPLETED|Overall Study||155
10026766|NCT03861052|11150919|FG001|COMPLETED|Overall Study||151
10026767|NCT03861052|11150920|FG002|COMPLETED|Overall Study||155
10026768|NCT03861052|11150921|FG003|COMPLETED|Overall Study||154
10026769|NCT03861052|11150918|FG000|NOT COMPLETED|Overall Study||4
10026770|NCT03861052|11150919|FG001|NOT COMPLETED|Overall Study||7
10026771|NCT03861052|11150920|FG002|NOT COMPLETED|Overall Study||5
10026772|NCT03861052|11150921|FG003|NOT COMPLETED|Overall Study||5
10026773|NCT03846453|11150938|FG000|STARTED|Placebo Run-in (14 Days)||1108
10026774|NCT03846453|11150939|FG001|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
9701135|NCT02243605|10800242|FG000|STARTED|Stage 2 - Final Analysis Population||45
9962752|NCT01481116|11082480|FG002|Treated|Overall Study||813
9962753|NCT01481116|11082478|FG000|COMPLETED|Overall Study||0
9962754|NCT01481116|11082479|FG001|COMPLETED|Overall Study||0
9962755|NCT01481116|11082480|FG002|COMPLETED|Overall Study||0
9962756|NCT01481116|11082478|FG000|NOT COMPLETED|Overall Study||824
9962757|NCT01481116|11082479|FG001|NOT COMPLETED|Overall Study||817
9962758|NCT01481116|11082480|FG002|NOT COMPLETED|Overall Study||813
9962759|NCT01481129|11082488|FG000|STARTED|Overall Study||22
9962760|NCT01481129|11082488|FG000|COMPLETED|Overall Study||22
10026775|NCT03846453|11150940|FG002|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
10026776|NCT03846453|11150938|FG000|COMPLETED|Placebo Run-in (14 Days)||637
9701136|NCT02243605|10800243|FG001|STARTED|Stage 2 - Final Analysis Population||45
9701137|NCT02243605|10800242|FG000|COMPLETED|Stage 2 - Final Analysis Population||39
9701138|NCT02243605|10800243|FG001|COMPLETED|Stage 2 - Final Analysis Population||42
9701139|NCT02243605|10800242|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6
9701140|NCT02243605|10800243|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3
9701144|NCT02213380|10800255|FG000|STARTED|Underwent Randomization||476
9701145|NCT02213380|10800256|FG001|STARTED|Underwent Randomization||474
9701146|NCT02213380|10800255|FG000|COMPLETED|Underwent Randomization||471
9701147|NCT02213380|10800256|FG001|COMPLETED|Underwent Randomization||471
9701148|NCT02213380|10800255|FG000|NOT COMPLETED|Underwent Randomization||5
9701149|NCT02213380|10800256|FG001|NOT COMPLETED|Underwent Randomization||3
9701150|NCT02213380|10800255|FG000|STARTED|Per-protocol Analysis||471
9701151|NCT02213380|10800256|FG001|STARTED|Per-protocol Analysis||471
9701152|NCT02213380|10800255|FG000|COMPLETED|Per-protocol Analysis||439
9701153|NCT02213380|10800256|FG001|COMPLETED|Per-protocol Analysis||435
9701154|NCT02213380|10800255|FG000|NOT COMPLETED|Per-protocol Analysis||32
9701155|NCT02213380|10800256|FG001|NOT COMPLETED|Per-protocol Analysis||36
9701156|NCT02184195|10800264|FG000|STARTED|Overall Study||92
9701157|NCT02184195|10800265|FG001|STARTED|Overall Study||62
9701158|NCT02184195|10800264|FG000|COMPLETED|Overall Study||49
9701159|NCT02184195|10800265|FG001|COMPLETED|Overall Study||27
9701160|NCT02184195|10800264|FG000|NOT COMPLETED|Overall Study||43
9701161|NCT02184195|10800265|FG001|NOT COMPLETED|Overall Study||35
9701162|NCT02113592|10800273|FG000|STARTED|Overall Study||433
9701163|NCT02113592|10800274|FG001|STARTED|Overall Study||417
9701164|NCT02113592|10800273|FG000|COMPLETED|Overall Study||414
9701165|NCT02113592|10800274|FG001|COMPLETED|Overall Study||402
9701166|NCT02113592|10800273|FG000|NOT COMPLETED|Overall Study||19
9701167|NCT02113592|10800274|FG001|NOT COMPLETED|Overall Study||15
9701168|NCT02089685|10800286|FG000|STARTED|Overall Study||23
9701169|NCT02089685|10800287|FG001|STARTED|Overall Study||14
9701170|NCT02089685|10800288|FG002|STARTED|Overall Study||3
9701171|NCT02089685|10800289|FG003|STARTED|Overall Study||153
9701172|NCT02089685|10800290|FG004|STARTED|Overall Study||51
9701173|NCT02089685|10800291|FG005|STARTED|Overall Study||51
9701174|NCT02089685|10800286|FG000|Treated|Overall Study||22
9701175|NCT02089685|10800287|FG001|Treated|Overall Study||14
9701176|NCT02089685|10800288|FG002|Treated|Overall Study||3
9701177|NCT02089685|10800289|FG003|Treated|Overall Study||153
9701178|NCT02089685|10800290|FG004|Treated|Overall Study||51
9701179|NCT02089685|10800291|FG005|Treated|Overall Study||51
9701180|NCT02089685|10800286|FG000|COMPLETED|Overall Study||0
9701181|NCT02089685|10800287|FG001|COMPLETED|Overall Study||0
9701182|NCT02089685|10800288|FG002|COMPLETED|Overall Study||0
9701183|NCT02089685|10800289|FG003|COMPLETED|Overall Study||0
9701184|NCT02089685|10800290|FG004|COMPLETED|Overall Study||0
9701185|NCT02089685|10800291|FG005|COMPLETED|Overall Study||0
9701186|NCT02089685|10800286|FG000|NOT COMPLETED|Overall Study||23
9701187|NCT02089685|10800287|FG001|NOT COMPLETED|Overall Study||14
9701188|NCT02089685|10800288|FG002|NOT COMPLETED|Overall Study||3
9701189|NCT02089685|10800289|FG003|NOT COMPLETED|Overall Study||153
9701190|NCT02089685|10800290|FG004|NOT COMPLETED|Overall Study||51
9701191|NCT02089685|10800291|FG005|NOT COMPLETED|Overall Study||51
9701192|NCT02075320|10800315|FG000|STARTED|Overall Study||50
9701193|NCT02075320|10800315|FG000|COMPLETED|Overall Study||48
9701194|NCT02075320|10800315|FG000|NOT COMPLETED|Overall Study||2
9701195|NCT02007512|10800323|FG000|STARTED|Double Blind Treatment Period||63
9701196|NCT02007512|10800324|FG001|STARTED|Double Blind Treatment Period||64
9701197|NCT02007512|10800325|FG002|STARTED|Double Blind Treatment Period||60
9701198|NCT02007512|10800326|FG003|STARTED|Double Blind Treatment Period||60
9701199|NCT02007512|10800323|FG000|Treated|Double Blind Treatment Period||62
9701200|NCT02007512|10800324|FG001|Treated|Double Blind Treatment Period||63
9701201|NCT02007512|10800325|FG002|Treated|Double Blind Treatment Period||60
9701202|NCT02007512|10800326|FG003|Treated|Double Blind Treatment Period||60
9701203|NCT02007512|10800323|FG000|COMPLETED|Double Blind Treatment Period||0
9701204|NCT02007512|10800324|FG001|COMPLETED|Double Blind Treatment Period||0
9701205|NCT02007512|10800325|FG002|COMPLETED|Double Blind Treatment Period||0
9701206|NCT02007512|10800326|FG003|COMPLETED|Double Blind Treatment Period||0
9701207|NCT02007512|10800323|FG000|NOT COMPLETED|Double Blind Treatment Period||63
9701208|NCT02007512|10800324|FG001|NOT COMPLETED|Double Blind Treatment Period||64
9701209|NCT02007512|10800325|FG002|NOT COMPLETED|Double Blind Treatment Period||60
9701210|NCT02007512|10800326|FG003|NOT COMPLETED|Double Blind Treatment Period||60
9701211|NCT02007512|10800323|FG000|STARTED|Open Label Treatment Period||0
9701212|NCT02007512|10800324|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
9701213|NCT02007512|10800325|FG002|STARTED|Open Label Treatment Period||0
9701214|NCT02007512|10800326|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
9701215|NCT02007512|10800323|FG000|COMPLETED|Open Label Treatment Period||0
9701216|NCT02007512|10800324|FG001|COMPLETED|Open Label Treatment Period||0
9701217|NCT02007512|10800325|FG002|COMPLETED|Open Label Treatment Period||0
9701218|NCT02007512|10800326|FG003|COMPLETED|Open Label Treatment Period||0
9701219|NCT02007512|10800323|FG000|NOT COMPLETED|Open Label Treatment Period||0
9701220|NCT02007512|10800324|FG001|NOT COMPLETED|Open Label Treatment Period||21
9701221|NCT02007512|10800325|FG002|NOT COMPLETED|Open Label Treatment Period||0
9701222|NCT02007512|10800326|FG003|NOT COMPLETED|Open Label Treatment Period||12
9701223|NCT01999179|10800339|FG000|STARTED|Overall Study||27
9701224|NCT01999179|10800339|FG000|COMPLETED|Overall Study||20
9701225|NCT01999179|10800339|FG000|NOT COMPLETED|Overall Study||7
9701226|NCT01858688|10800343|FG000|STARTED|Overall Study||101
9701227|NCT01858688|10800343|FG000|Biopsied at Baseline|Overall Study||97
9701228|NCT01858688|10800343|FG000|MRI Assessed|Overall Study||91
9701229|NCT01858688|10800343|FG000|COMPLETED|Overall Study||81
9701230|NCT01858688|10800343|FG000|NOT COMPLETED|Overall Study||20
9701231|NCT01796197|10800347|FG000|STARTED|Overall Study||23
9701232|NCT01796197|10800347|FG000|COMPLETED|Overall Study||21
9701233|NCT01796197|10800347|FG000|NOT COMPLETED|Overall Study||2
9701234|NCT01751906|10800353|FG000|STARTED|Overall Study||1322
9701235|NCT01751906|10800354|FG001|STARTED|Overall Study||686
9701236|NCT01751906|10800353|FG000|COMPLETED|Overall Study||1059
9701237|NCT01751906|10800354|FG001|COMPLETED|Overall Study||555
9701238|NCT01751906|10800353|FG000|NOT COMPLETED|Overall Study||263
9701239|NCT01751906|10800354|FG001|NOT COMPLETED|Overall Study||131
9701240|NCT01665144|10800362|FG000|STARTED|Overall Study||1105
9701241|NCT01665144|10800363|FG001|STARTED|Overall Study||546
9701242|NCT01665144|10800362|FG000|Safety Set|Overall Study||1099
9701243|NCT01665144|10800363|FG001|Safety Set|Overall Study||546
9701244|NCT01665144|10800362|FG000|Full Analysis Set|Overall Study||1099
9701245|NCT01665144|10800363|FG001|Full Analysis Set|Overall Study||546
9701246|NCT01665144|10800362|FG000|COMPLETED|Overall Study||903
9701247|NCT01665144|10800363|FG001|COMPLETED|Overall Study||424
9701248|NCT01665144|10800362|FG000|NOT COMPLETED|Overall Study||202
9701249|NCT01665144|10800363|FG001|NOT COMPLETED|Overall Study||122
9701250|NCT01551550|10800371|FG000|STARTED|Overall Study||41
9701251|NCT01551550|10800372|FG001|STARTED|Overall Study||41
9701252|NCT01551550|10800371|FG000|COMPLETED|Overall Study||41
9701253|NCT01551550|10800372|FG001|COMPLETED|Overall Study||40
9701254|NCT01551550|10800371|FG000|NOT COMPLETED|Overall Study||0
9701255|NCT01551550|10800372|FG001|NOT COMPLETED|Overall Study||1
9701256|NCT01372254|10800380|FG000|STARTED|Overall Study||47
9701257|NCT01372254|10800381|FG001|STARTED|Overall Study||49
9701258|NCT01372254|10800380|FG000|COMPLETED|Overall Study||43
9701259|NCT01372254|10800381|FG001|COMPLETED|Overall Study||46
9701260|NCT01372254|10800380|FG000|NOT COMPLETED|Overall Study||4
9701261|NCT01372254|10800381|FG001|NOT COMPLETED|Overall Study||3
9701262|NCT01351766|10800387|FG000|STARTED|Overall Study||39
9701263|NCT01351766|10800387|FG000|COMPLETED|Overall Study||36
9701264|NCT01351766|10800387|FG000|NOT COMPLETED|Overall Study||3
9701265|NCT01199380|10800393|FG000|STARTED|Overall Study||88
9701266|NCT01199380|10800394|FG001|STARTED|Overall Study||96
9701267|NCT01199380|10800393|FG000|COMPLETED|Overall Study||78
9701268|NCT01199380|10800394|FG001|COMPLETED|Overall Study||81
9701269|NCT01199380|10800393|FG000|NOT COMPLETED|Overall Study||10
9701270|NCT01199380|10800394|FG001|NOT COMPLETED|Overall Study||15
9728134|NCT00112151|10827851|FG000|NOT COMPLETED|Overall Study||4
9728135|NCT00112151|10827852|FG001|NOT COMPLETED|Overall Study||5
9728136|NCT00112151|10827853|FG002|NOT COMPLETED|Overall Study||3
9728137|NCT00112151|10827854|FG003|NOT COMPLETED|Overall Study||3
10026777|NCT03846453|11150939|FG001|COMPLETED|Placebo Run-in (14 Days)||0
10026778|NCT03846453|11150940|FG002|COMPLETED|Placebo Run-in (14 Days)||0
10026779|NCT03846453|11150938|FG000|NOT COMPLETED|Placebo Run-in (14 Days)||471
10026780|NCT03846453|11150939|FG001|NOT COMPLETED|Placebo Run-in (14 Days)||0
10026781|NCT03846453|11150940|FG002|NOT COMPLETED|Placebo Run-in (14 Days)||0
10026782|NCT03846453|11150938|FG000|STARTED|Randomized Treatment Period (Days 57±3)|All participants who completed the placebo run-in period and qualified were randomized to either 0.25% HL036 Ophthalmic Solution group or placebo group.|0
10026783|NCT03846453|11150939|FG001|STARTED|Randomized Treatment Period (Days 57±3)||318
10026784|NCT03846453|11150940|FG002|STARTED|Randomized Treatment Period (Days 57±3)||319
10026785|NCT03846453|11150938|FG000|COMPLETED|Randomized Treatment Period (Days 57±3)||0
10026786|NCT03846453|11150939|FG001|COMPLETED|Randomized Treatment Period (Days 57±3)||291
9728138|NCT00112151|10827855|FG004|NOT COMPLETED|Overall Study||6
9728139|NCT00112151|10827856|FG005|NOT COMPLETED|Overall Study||3
9728140|NCT00112242|10827872|FG000|STARTED|Overall Study||10
9728141|NCT00112242|10827873|FG001|STARTED|Overall Study||5
9728142|NCT00112242|10827874|FG002|STARTED|Overall Study||5
9728143|NCT00112242|10827875|FG003|STARTED|Overall Study||10
9728144|NCT00112242|10827876|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
9728145|NCT00112242|10827872|FG000|Cycle 1 Completed|Overall Study||10
9728146|NCT00112242|10827873|FG001|Cycle 1 Completed|Overall Study||5
9728147|NCT00112242|10827874|FG002|Cycle 1 Completed|Overall Study||5
9728148|NCT00112242|10827875|FG003|Cycle 1 Completed|Overall Study||9
9728149|NCT00112242|10827876|FG004|Cycle 1 Completed|Overall Study||7
9728150|NCT00112242|10827872|FG000|Cycle 2 Completed|Overall Study||8
9728151|NCT00112242|10827873|FG001|Cycle 2 Completed|Overall Study||3
9728152|NCT00112242|10827874|FG002|Cycle 2 Completed|Overall Study||4
9728153|NCT00112242|10827875|FG003|Cycle 2 Completed|Overall Study||8
9728154|NCT00112242|10827876|FG004|Cycle 2 Completed|Overall Study||4
9728155|NCT00112242|10827872|FG000|Cycle 3 Completed|Overall Study||5
9728156|NCT00112242|10827873|FG001|Cycle 3 Completed|Overall Study||3
9728157|NCT00112242|10827874|FG002|Cycle 3 Completed|Overall Study||4
9728158|NCT00112242|10827875|FG003|Cycle 3 Completed|Overall Study||4
9728159|NCT00112242|10827876|FG004|Cycle 3 Completed|Overall Study||2
9701271|NCT00810017|10800400|FG000|STARTED|Overall Study||2
9701272|NCT00810017|10800400|FG000|COMPLETED|Overall Study||0
9701273|NCT00810017|10800400|FG000|NOT COMPLETED|Overall Study||2
9701274|NCT00669669|10800404|FG000|STARTED|Overall Study||12
9701275|NCT00669669|10800404|FG000|COMPLETED|Overall Study||11
9701276|NCT00669669|10800404|FG000|NOT COMPLETED|Overall Study||1
9701277|NCT00549848|10800411|FG000|STARTED|Overall Study||206
9701278|NCT00549848|10800412|FG001|STARTED|Overall Study||208
9701279|NCT00549848|10800413|FG002|STARTED|Overall Study||184
9701280|NCT00549848|10800411|FG000|COMPLETED|Overall Study||194
9701281|NCT00549848|10800412|FG001|COMPLETED|Overall Study||188
9701282|NCT00549848|10800413|FG002|COMPLETED|Overall Study||133
9701283|NCT00549848|10800411|FG000|NOT COMPLETED|Overall Study||12
9962761|NCT01481129|11082488|FG000|NOT COMPLETED|Overall Study||0
9962762|NCT01481324|11082495|FG000|STARTED|Overall Study||21
9962763|NCT01481324|11082496|FG001|STARTED|Overall Study||24
9962764|NCT01481324|11082497|FG002|STARTED|Overall Study||22
9962765|NCT01481324|11082495|FG000|Month 1-Wear Rate Data|Overall Study||15
9962766|NCT01481324|11082496|FG001|Month 1-Wear Rate Data|Overall Study||16
9962767|NCT01481324|11082497|FG002|Month 1-Wear Rate Data|Overall Study||8
9962768|NCT01481324|11082495|FG000|Month 2-Wear Rate Data|Overall Study||9
9962769|NCT01481324|11082496|FG001|Month 2-Wear Rate Data|Overall Study||13
9962770|NCT01481324|11082497|FG002|Month 2-Wear Rate Data|Overall Study||7
9962771|NCT01481324|11082495|FG000|Month 3-Wear Rate Data|Overall Study||7
9962772|NCT01481324|11082496|FG001|Month 3-Wear Rate Data|Overall Study||11
9962773|NCT01481324|11082497|FG002|Month 3-Wear Rate Data|Overall Study||6
9962774|NCT01481324|11082495|FG000|COMPLETED|Overall Study||21
9962775|NCT01481324|11082496|FG001|COMPLETED|Overall Study||22
9962776|NCT01481324|11082497|FG002|COMPLETED|Overall Study||20
9962777|NCT01481324|11082495|FG000|NOT COMPLETED|Overall Study||0
9962778|NCT01481324|11082496|FG001|NOT COMPLETED|Overall Study||2
9962779|NCT01481324|11082497|FG002|NOT COMPLETED|Overall Study||2
9962780|NCT01481376|11082505|FG000|STARTED|Overall Study||200
9962781|NCT01481376|11082505|FG000|COMPLETED|Overall Study||169
9962782|NCT01481376|11082505|FG000|NOT COMPLETED|Overall Study||31
9962783|NCT01481545|11082511|FG000|STARTED|Overall Study||16
9962784|NCT01481545|11082512|FG001|STARTED|Overall Study||46
9962785|NCT01481545|11082511|FG000|COMPLETED|Overall Study||11
9962786|NCT01481545|11082512|FG001|COMPLETED|Overall Study||40
9962787|NCT01481545|11082511|FG000|NOT COMPLETED|Overall Study||5
9962788|NCT01481545|11082512|FG001|NOT COMPLETED|Overall Study||6
9962789|NCT01481558|11082522|FG000|STARTED|Overall Study||20
9962790|NCT01481558|11082523|FG001|STARTED|Overall Study||20
9962791|NCT01481558|11082522|FG000|COMPLETED|Overall Study||20
9962792|NCT01481558|11082523|FG001|COMPLETED|Overall Study||20
9962793|NCT01481558|11082522|FG000|NOT COMPLETED|Overall Study||0
9962794|NCT01481558|11082523|FG001|NOT COMPLETED|Overall Study||0
9962795|NCT01481740|11082531|FG000|STARTED|Overall Study||90
9962796|NCT01481740|11082532|FG001|STARTED|Overall Study||88
9962797|NCT01481740|11082531|FG000|COMPLETED|Overall Study||79
9962798|NCT01481740|11082532|FG001|COMPLETED|Overall Study||81
9962799|NCT01481740|11082531|FG000|NOT COMPLETED|Overall Study||11
9962800|NCT01481740|11082532|FG001|NOT COMPLETED|Overall Study||7
9962801|NCT01481779|11082540|FG000|STARTED|Overall Study||295
9962802|NCT01481779|11082541|FG001|STARTED|Overall Study||160
9962803|NCT01481779|11082540|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294
9962804|NCT01481779|11082541|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
9962805|NCT01481779|11082540|FG000|COMPLETED|Overall Study||225
9962806|NCT01481779|11082541|FG001|COMPLETED|Overall Study||132
9962807|NCT01481779|11082540|FG000|NOT COMPLETED|Overall Study||70
9962808|NCT01481779|11082541|FG001|NOT COMPLETED|Overall Study||28
9962809|NCT01481896|11082547|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
9962810|NCT01481896|11082547|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
9962811|NCT01481896|11082547|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
9962812|NCT01481896|11082547|FG000|NOT COMPLETED|Overall Study||12
9962813|NCT01482065|11082563|FG000|STARTED|Overall Study||4
9962814|NCT01482065|11082564|FG001|STARTED|Overall Study||5
9962815|NCT01482065|11082563|FG000|COMPLETED|Overall Study||4
9962816|NCT01482065|11082564|FG001|COMPLETED|Overall Study||4
9962817|NCT01482065|11082563|FG000|NOT COMPLETED|Overall Study||0
9962818|NCT01482065|11082564|FG001|NOT COMPLETED|Overall Study||1
9962819|NCT01482091|11082572|FG000|STARTED|Overall Study||25
9962820|NCT01482091|11082573|FG001|STARTED|Overall Study||24
9962821|NCT01482091|11082572|FG000|COMPLETED|Overall Study||25
9962822|NCT01482091|11082573|FG001|COMPLETED|Overall Study||24
10026787|NCT03846453|11150940|FG002|COMPLETED|Randomized Treatment Period (Days 57±3)||294
9701284|NCT00549848|10800412|FG001|NOT COMPLETED|Overall Study||20
9701285|NCT00549848|10800413|FG002|NOT COMPLETED|Overall Study||51
9962823|NCT01482091|11082572|FG000|NOT COMPLETED|Overall Study||0
9962824|NCT01482091|11082573|FG001|NOT COMPLETED|Overall Study||0
9962825|NCT01482169|11082579|FG000|STARTED|Overall Study||48
9962826|NCT01482169|11082579|FG000|COMPLETED|Overall Study||46
9962827|NCT01482169|11082579|FG000|NOT COMPLETED|Overall Study||2
9701286|NCT00433511|10800432|FG000|STARTED|Step 1||1000
9701287|NCT00433511|10800433|FG001|STARTED|Step 1||1986
9701288|NCT00433511|10800434|FG002|STARTED|Step 1||2008
9701289|NCT00433511|10800432|FG000|Patients Who Received Treatment|Step 1||972
9847980|NCT00856843|10960634|FG001|STARTED|Overall Study||68
9847981|NCT00856843|10960633|FG000|COMPLETED|Overall Study||66
9847982|NCT00856843|10960634|FG001|COMPLETED|Overall Study||63
9847983|NCT00856843|10960633|FG000|NOT COMPLETED|Overall Study||2
9847984|NCT00856843|10960634|FG001|NOT COMPLETED|Overall Study||5
9847985|NCT00856856|10960640|FG000|STARTED|Baseline||101
9847986|NCT00856856|10960640|FG000|COMPLETED|Baseline||101
9847987|NCT00856856|10960640|FG000|NOT COMPLETED|Baseline||0
9701290|NCT00433511|10800433|FG001|Patients Who Received Treatment|Step 1||1922
9701291|NCT00433511|10800434|FG002|Patients Who Received Treatment|Step 1||1942
9701292|NCT00433511|10800432|FG000|Patients in Genetic Ancestry Analysis|Step 1||575
9701293|NCT00433511|10800433|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126
9701294|NCT00433511|10800434|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158
9701295|NCT00433511|10800432|FG000|COMPLETED|Step 1||864
9701296|NCT00433511|10800433|FG001|COMPLETED|Step 1||1601
9701297|NCT00433511|10800434|FG002|COMPLETED|Step 1||1618
9701298|NCT00433511|10800432|FG000|NOT COMPLETED|Step 1||136
9701299|NCT00433511|10800433|FG001|NOT COMPLETED|Step 1||385
9701300|NCT00433511|10800434|FG002|NOT COMPLETED|Step 1||390
9701301|NCT00433511|10800432|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
9701302|NCT00433511|10800433|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
9701303|NCT00433511|10800434|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
9701304|NCT00433511|10800432|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0
9701305|NCT00433511|10800433|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0
9701306|NCT00433511|10800434|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168
9701307|NCT00433511|10800432|FG000|COMPLETED|Step 2 (Arm D)||0
9701308|NCT00433511|10800433|FG001|COMPLETED|Step 2 (Arm D)||0
9701309|NCT00433511|10800434|FG002|COMPLETED|Step 2 (Arm D)||825
9701310|NCT00433511|10800432|FG000|NOT COMPLETED|Step 2 (Arm D)||0
9701311|NCT00433511|10800433|FG001|NOT COMPLETED|Step 2 (Arm D)||0
9701312|NCT00433511|10800434|FG002|NOT COMPLETED|Step 2 (Arm D)||491
9962828|NCT01482221|11082589|FG000|STARTED|Overall Study||101
9962829|NCT01482221|11082590|FG001|STARTED|Overall Study||101
9962830|NCT01482221|11082591|FG002|STARTED|Overall Study||100
9962831|NCT01482221|11082589|FG000|COMPLETED|Overall Study||80
9962832|NCT01482221|11082590|FG001|COMPLETED|Overall Study||81
9962833|NCT01482221|11082591|FG002|COMPLETED|Overall Study||77
9962834|NCT01482221|11082589|FG000|NOT COMPLETED|Overall Study||21
9962835|NCT01482221|11082590|FG001|NOT COMPLETED|Overall Study||20
9962836|NCT01482221|11082591|FG002|NOT COMPLETED|Overall Study||23
9962837|NCT01482312|11082599|FG000|STARTED|Period 1, 90 Minutes of Wear||10
9962838|NCT01482312|11082600|FG001|STARTED|Period 1, 90 Minutes of Wear||9
9962839|NCT01482312|11082601|FG002|STARTED|Period 1, 90 Minutes of Wear||10
9962840|NCT01482312|11082599|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9
10026788|NCT03846453|11150938|FG000|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||0
10026789|NCT03846453|11150939|FG001|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||27
10026790|NCT03846453|11150940|FG002|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||25
10026791|NCT03605862|11150950|FG000|STARTED|Overall Study||872
9701319|NCT00314366|10800460|FG000|STARTED|Overall Study||11
9701320|NCT00314366|10800461|FG001|STARTED|Overall Study||10
9701321|NCT00314366|10800460|FG000|COMPLETED|Overall Study||10
9701322|NCT00314366|10800461|FG001|COMPLETED|Overall Study||10
9701323|NCT00314366|10800460|FG000|NOT COMPLETED|Overall Study||1
9701324|NCT00314366|10800461|FG001|NOT COMPLETED|Overall Study||0
9701325|NCT00187226|10800476|FG000|STARTED|Overall Study||88
9701326|NCT00187226|10800477|FG001|STARTED|Overall Study||49
9701327|NCT00187226|10800478|FG002|STARTED|Overall Study||28
9701328|NCT00187226|10800479|FG003|STARTED|Overall Study||2
9701329|NCT00187226|10800480|FG004|STARTED|Overall Study||34
9701330|NCT00187226|10800481|FG005|STARTED|Overall Study||1
9701331|NCT00187226|10800476|FG000|COMPLETED|Overall Study||88
9701332|NCT00187226|10800477|FG001|COMPLETED|Overall Study||49
9701333|NCT00187226|10800478|FG002|COMPLETED|Overall Study||28
9701334|NCT00187226|10800479|FG003|COMPLETED|Overall Study||2
9701335|NCT00187226|10800480|FG004|COMPLETED|Overall Study||34
9701336|NCT00187226|10800481|FG005|COMPLETED|Overall Study||1
9701337|NCT00187226|10800476|FG000|NOT COMPLETED|Overall Study||0
9701338|NCT00187226|10800477|FG001|NOT COMPLETED|Overall Study||0
9847988|NCT00856856|10960640|FG000|STARTED|30-day Clinical Follow-up||101
9847989|NCT00856856|10960640|FG000|COMPLETED|30-day Clinical Follow-up||101
9847990|NCT00856856|10960640|FG000|NOT COMPLETED|30-day Clinical Follow-up||0
9847991|NCT00856856|10960640|FG000|STARTED|180-day Clinical Follow-up||101
9847992|NCT00856856|10960640|FG000|COMPLETED|180-day Clinical Follow-up||101
9847993|NCT00856856|10960640|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
9962841|NCT01482312|11082600|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9
9962842|NCT01482312|11082601|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10
9962843|NCT01482312|11082599|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
9701339|NCT00187226|10800478|FG002|NOT COMPLETED|Overall Study||0
9701340|NCT00187226|10800479|FG003|NOT COMPLETED|Overall Study||0
9701341|NCT00187226|10800480|FG004|NOT COMPLETED|Overall Study||0
9701342|NCT00187226|10800481|FG005|NOT COMPLETED|Overall Study||0
9701343|NCT00119847|10800497|FG000|STARTED|Overall Study||149
9701344|NCT00119847|10800498|FG001|STARTED|Overall Study||151
9701345|NCT00119847|10800497|FG000|COMPLETED|Overall Study||118
9701346|NCT00119847|10800498|FG001|COMPLETED|Overall Study||119
9701347|NCT00119847|10800497|FG000|NOT COMPLETED|Overall Study||31
9701348|NCT00119847|10800498|FG001|NOT COMPLETED|Overall Study||32
9728160|NCT00112242|10827872|FG000|COMPLETED|Overall Study||5
9728161|NCT00112242|10827873|FG001|COMPLETED|Overall Study||3
9728162|NCT00112242|10827874|FG002|COMPLETED|Overall Study||4
9728163|NCT00112242|10827875|FG003|COMPLETED|Overall Study||4
9728164|NCT00112242|10827876|FG004|COMPLETED|Overall Study||2
9728165|NCT00112242|10827872|FG000|NOT COMPLETED|Overall Study||5
9728166|NCT00112242|10827873|FG001|NOT COMPLETED|Overall Study||2
9728167|NCT00112242|10827874|FG002|NOT COMPLETED|Overall Study||1
9728168|NCT00112242|10827875|FG003|NOT COMPLETED|Overall Study||6
9728169|NCT00112242|10827876|FG004|NOT COMPLETED|Overall Study||7
9728170|NCT00112294|10827898|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325
9728171|NCT00112294|10827899|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320
9728172|NCT00112294|10827898|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
9728173|NCT00112294|10827899|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
9728174|NCT00112294|10827898|FG000|COMPLETED|Overall Study|Off all study therapies.|320
9728175|NCT00112294|10827899|FG001|COMPLETED|Overall Study|Off all study therapies.|320
9728176|NCT00112294|10827898|FG000|NOT COMPLETED|Overall Study||5
9728177|NCT00112294|10827899|FG001|NOT COMPLETED|Overall Study||0
9728178|NCT00112359|10827907|FG000|STARTED|Overall Study||84
9728179|NCT00112359|10827908|FG001|STARTED|Overall Study||80
9728180|NCT00112359|10827907|FG000|COMPLETED|Overall Study||57
9728181|NCT00112359|10827908|FG001|COMPLETED|Overall Study||67
9728182|NCT00112359|10827907|FG000|NOT COMPLETED|Overall Study||27
9728183|NCT00112359|10827908|FG001|NOT COMPLETED|Overall Study||13
9728184|NCT00112385|10827916|FG000|STARTED|Overall Study||11
9728185|NCT00112385|10827917|FG001|STARTED|Overall Study||5
9728186|NCT00112385|10827916|FG000|COMPLETED|Overall Study||10
9728187|NCT00112385|10827917|FG001|COMPLETED|Overall Study||4
9728188|NCT00112385|10827916|FG000|NOT COMPLETED|Overall Study||1
9728189|NCT00112385|10827917|FG001|NOT COMPLETED|Overall Study||1
9728190|NCT00112437|10827928|FG000|STARTED|Year 1 (12-Month Base Study)||83
9728191|NCT00112437|10827929|FG001|STARTED|Year 1 (12-Month Base Study)||82
9728192|NCT00112437|10827930|FG002|STARTED|Year 1 (12-Month Base Study)||77
9728193|NCT00112437|10827931|FG003|STARTED|Year 1 (12-Month Base Study)||79
9728194|NCT00112437|10827932|FG004|STARTED|Year 1 (12-Month Base Study)||78
9962844|NCT01482312|11082600|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
9962845|NCT01482312|11082601|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
9962846|NCT01482312|11082599|FG000|STARTED|Period 2, 90 Minutes of Wear||9
9962847|NCT01482312|11082600|FG001|STARTED|Period 2, 90 Minutes of Wear||9
9962848|NCT01482312|11082601|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
9962849|NCT01482312|11082599|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8
9962850|NCT01482312|11082600|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9
9962851|NCT01482312|11082601|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9
9962852|NCT01482312|11082599|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
9962853|NCT01482312|11082600|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
9962854|NCT01482312|11082601|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
9962855|NCT01482312|11082599|FG000|STARTED|Period 3, 90 Minutes of Wear||8
9962856|NCT01482312|11082600|FG001|STARTED|Period 3, 90 Minutes of Wear||9
9962857|NCT01482312|11082601|FG002|STARTED|Period 3, 90 Minutes of Wear||9
9962858|NCT01482312|11082599|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8
9962859|NCT01482312|11082600|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9
9962860|NCT01482312|11082601|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9
9728195|NCT00112437|10827933|FG005|STARTED|Year 1 (12-Month Base Study)||0
9728196|NCT00112437|10827934|FG006|STARTED|Year 1 (12-Month Base Study)||0
9728197|NCT00112437|10827935|FG007|STARTED|Year 1 (12-Month Base Study)||0
9728198|NCT00112437|10827936|FG008|STARTED|Year 1 (12-Month Base Study)||0
9728199|NCT00112437|10827937|FG009|STARTED|Year 1 (12-Month Base Study)||0
9728200|NCT00112437|10827938|FG010|STARTED|Year 1 (12-Month Base Study)||0
9728201|NCT00112437|10827939|FG011|STARTED|Year 1 (12-Month Base Study)||0
9962861|NCT01482312|11082599|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
9962862|NCT01482312|11082600|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
9962863|NCT01482312|11082601|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
9962864|NCT01482351|11082611|FG000|STARTED|Overall Study||68
9962865|NCT01482351|11082611|FG000|6 Months|Overall Study|14 dropped out|54
9962866|NCT01482351|11082611|FG000|12 Months|Overall Study||54
9962867|NCT01482351|11082611|FG000|COMPLETED|Overall Study||54
9962868|NCT01482351|11082611|FG000|NOT COMPLETED|Overall Study||14
9962869|NCT01482429|11082621|FG000|STARTED|Care Usual||0
9962870|NCT01482429|11082622|FG001|STARTED|Care Usual||269
9962871|NCT01482429|11082621|FG000|COMPLETED|Care Usual||0
9962872|NCT01482429|11082622|FG001|COMPLETED|Care Usual||96
9962873|NCT01482429|11082621|FG000|NOT COMPLETED|Care Usual||0
10026792|NCT03605862|11150951|FG001|STARTED|Overall Study||884
10026793|NCT03605862|11150950|FG000|COMPLETED|Overall Study||844
9962874|NCT01482429|11082622|FG001|NOT COMPLETED|Care Usual||173
9701349|NCT04748783|10800509|FG000|STARTED|Overall Study||0
9701350|NCT04748783|10800510|FG001|STARTED|Overall Study||1
9701351|NCT04748783|10800511|FG002|STARTED|Overall Study||0
9701352|NCT04748783|10800512|FG003|STARTED|Overall Study||0
9701353|NCT04748783|10800513|FG004|STARTED|Overall Study||1
9701354|NCT04748783|10800509|FG000|COMPLETED|Overall Study||0
9701355|NCT04748783|10800510|FG001|COMPLETED|Overall Study||1
9701356|NCT04748783|10800511|FG002|COMPLETED|Overall Study||0
9701357|NCT04748783|10800512|FG003|COMPLETED|Overall Study||0
9962875|NCT01482429|11082621|FG000|STARTED|Protocol||414
9701358|NCT04748783|10800513|FG004|COMPLETED|Overall Study||1
9962876|NCT01482429|11082622|FG001|STARTED|Protocol||0
9962877|NCT01482429|11082621|FG000|COMPLETED|Protocol||139
9962878|NCT01482429|11082622|FG001|COMPLETED|Protocol||0
9962879|NCT01482429|11082621|FG000|NOT COMPLETED|Protocol||275
9962880|NCT01482429|11082622|FG001|NOT COMPLETED|Protocol||0
9967787|NCT01516684|11088145|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
9967788|NCT01516684|11088146|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
9967789|NCT01516684|11088145|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|
9701359|NCT04748783|10800509|FG000|NOT COMPLETED|Overall Study||0
9701360|NCT04748783|10800510|FG001|NOT COMPLETED|Overall Study||0
9967790|NCT01516684|11088146|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|
9967791|NCT01516684|11088145|FG000|NOT COMPLETED|Overall Study||
9967792|NCT01516684|11088146|FG001|NOT COMPLETED|Overall Study||
9967793|NCT01516736|11088156|FG000|STARTED|Overall Study||155
9967794|NCT01516736|11088157|FG001|STARTED|Overall Study||153
9967795|NCT01516736|11088156|FG000|COMPLETED|Overall Study||135
9967796|NCT01516736|11088157|FG001|COMPLETED|Overall Study||140
9967797|NCT01516736|11088156|FG000|NOT COMPLETED|Overall Study||20
9967798|NCT01516736|11088157|FG001|NOT COMPLETED|Overall Study||13
9967799|NCT01516749|11088163|FG000|STARTED|Active Therapy||6
9967800|NCT01516749|11088163|FG000|COMPLETED|Active Therapy||5
9967801|NCT01516749|11088163|FG000|NOT COMPLETED|Active Therapy||1
9967802|NCT01516749|11088163|FG000|STARTED|Follow-up Off Therapy||5
9967803|NCT01516749|11088163|FG000|COMPLETED|Follow-up Off Therapy||4
9967804|NCT01516749|11088163|FG000|NOT COMPLETED|Follow-up Off Therapy||1
9967805|NCT01516879|11088169|FG000|STARTED|Overall Study||303
9967806|NCT01516879|11088170|FG001|STARTED|Overall Study||602
9967807|NCT01516879|11088169|FG000|Received Treatment|Overall Study||302
9967808|NCT01516879|11088170|FG001|Received Treatment|Overall Study||599
9967809|NCT01516879|11088169|FG000|COMPLETED|Overall Study||287
9967810|NCT01516879|11088170|FG001|COMPLETED|Overall Study||568
9967811|NCT01516879|11088169|FG000|NOT COMPLETED|Overall Study||16
9967812|NCT01516879|11088170|FG001|NOT COMPLETED|Overall Study||34
9967813|NCT01516892|11088176|FG000|STARTED|Overall Study||716
9967814|NCT01516892|11088176|FG000|COMPLETED|Overall Study||373
9967815|NCT01516892|11088176|FG000|NOT COMPLETED|Overall Study||343
9967816|NCT01516957|11088183|FG000|STARTED|Placebo-controlled Phase||55
9967817|NCT01516957|11088184|FG001|STARTED|Placebo-controlled Phase||57
9967818|NCT01516957|11088185|FG002|STARTED|Placebo-controlled Phase||56
9967819|NCT01516957|11088186|FG003|STARTED|Placebo-controlled Phase||0
9967820|NCT01516957|11088183|FG000|COMPLETED|Placebo-controlled Phase||52
9967821|NCT01516957|11088184|FG001|COMPLETED|Placebo-controlled Phase||53
9967822|NCT01516957|11088185|FG002|COMPLETED|Placebo-controlled Phase||51
9967823|NCT01516957|11088186|FG003|COMPLETED|Placebo-controlled Phase||0
9967824|NCT01516957|11088183|FG000|NOT COMPLETED|Placebo-controlled Phase||3
9967825|NCT01516957|11088184|FG001|NOT COMPLETED|Placebo-controlled Phase||4
9967826|NCT01516957|11088185|FG002|NOT COMPLETED|Placebo-controlled Phase||5
9967827|NCT01516957|11088186|FG003|NOT COMPLETED|Placebo-controlled Phase||0
9967828|NCT01516957|11088183|FG000|STARTED|Open-label Phase||0
9967829|NCT01516957|11088184|FG001|STARTED|Open-label Phase||0
9967830|NCT01516957|11088185|FG002|STARTED|Open-label Phase||0
9967831|NCT01516957|11088186|FG003|STARTED|Open-label Phase||156
9967832|NCT01516957|11088183|FG000|COMPLETED|Open-label Phase||0
9967833|NCT01516957|11088184|FG001|COMPLETED|Open-label Phase||0
9967834|NCT01516957|11088185|FG002|COMPLETED|Open-label Phase||0
9967835|NCT01516957|11088186|FG003|COMPLETED|Open-label Phase||0
9967836|NCT01516957|11088183|FG000|NOT COMPLETED|Open-label Phase||0
9967837|NCT01516957|11088184|FG001|NOT COMPLETED|Open-label Phase||0
9967838|NCT01516957|11088185|FG002|NOT COMPLETED|Open-label Phase||0
9967839|NCT01516957|11088186|FG003|NOT COMPLETED|Open-label Phase||156
9967840|NCT01516970|11088197|FG000|STARTED|Overall Study||159
9967841|NCT01516970|11088198|FG001|STARTED|Overall Study||153
9967842|NCT01516970|11088197|FG000|COMPLETED|Overall Study||141
9967843|NCT01516970|11088198|FG001|COMPLETED|Overall Study||132
9967844|NCT01516970|11088197|FG000|NOT COMPLETED|Overall Study||18
9967845|NCT01516970|11088198|FG001|NOT COMPLETED|Overall Study||21
9967846|NCT01517074|11088204|FG000|STARTED|Overall Study||5
9967847|NCT01517074|11088204|FG000|COMPLETED|Overall Study||5
9967848|NCT01517074|11088204|FG000|NOT COMPLETED|Overall Study||0
9967849|NCT01517178|11088213|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
9967850|NCT01517178|11088214|FG001|STARTED|Period 1||11
9967851|NCT01517178|11088213|FG000|COMPLETED|Period 1||12
9701361|NCT04748783|10800511|FG002|NOT COMPLETED|Overall Study||0
9701362|NCT04748783|10800512|FG003|NOT COMPLETED|Overall Study||0
9701363|NCT04748783|10800513|FG004|NOT COMPLETED|Overall Study||0
9701364|NCT04482647|10800526|FG000|STARTED|Overall Study||100
9701365|NCT04482647|10800526|FG000|COMPLETED|Overall Study||88
9701366|NCT04482647|10800526|FG000|NOT COMPLETED|Overall Study||12
9701367|NCT04405570|10800534|FG000|STARTED|Overall Study||23
9701368|NCT04405570|10800535|FG001|STARTED|Overall Study||64
9701369|NCT04405570|10800536|FG002|STARTED|Overall Study||55
9701370|NCT04405570|10800537|FG003|STARTED|Overall Study||62
9701371|NCT04405570|10800534|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0
9701372|NCT04405570|10800535|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2
9701373|NCT04405570|10800536|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0
9701374|NCT04405570|10800537|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0
9701375|NCT04405570|10800534|FG000|Number of Subjects in the Safety Population|Overall Study||23
9701376|NCT04405570|10800535|FG001|Number of Subjects in the Safety Population|Overall Study||62
9701377|NCT04405570|10800536|FG002|Number of Subjects in the Safety Population|Overall Study||55
9701378|NCT04405570|10800537|FG003|Number of Subjects in the Safety Population|Overall Study||62
9701379|NCT04405570|10800534|FG000|Number of Subjects in the mITT Population|Overall Study||23
9701380|NCT04405570|10800535|FG001|Number of Subjects in the mITT Population|Overall Study||61
9701381|NCT04405570|10800536|FG002|Number of Subjects in the mITT Population|Overall Study||53
9701382|NCT04405570|10800537|FG003|Number of Subjects in the mITT Population|Overall Study||61
9701383|NCT04405570|10800534|FG000|COMPLETED|Overall Study||23
9701384|NCT04405570|10800535|FG001|COMPLETED|Overall Study||59
9701385|NCT04405570|10800536|FG002|COMPLETED|Overall Study||52
9701386|NCT04405570|10800537|FG003|COMPLETED|Overall Study||61
9701387|NCT04405570|10800534|FG000|NOT COMPLETED|Overall Study||0
9701388|NCT04405570|10800535|FG001|NOT COMPLETED|Overall Study||5
9701389|NCT04405570|10800536|FG002|NOT COMPLETED|Overall Study||3
9701390|NCT04405570|10800537|FG003|NOT COMPLETED|Overall Study||1
9728202|NCT00112437|10827940|FG012|STARTED|Year 1 (12-Month Base Study)||0
9728203|NCT00112437|10827941|FG013|STARTED|Year 1 (12-Month Base Study)||0
9728204|NCT00112437|10827942|FG014|STARTED|Year 1 (12-Month Base Study)||0
9728205|NCT00112437|10827943|FG015|STARTED|Year 1 (12-Month Base Study)||0
9728206|NCT00112437|10827944|FG016|STARTED|Year 1 (12-Month Base Study)||0
9728207|NCT00112437|10827945|FG017|STARTED|Year 1 (12-Month Base Study)||0
9728208|NCT00112437|10827946|FG018|STARTED|Year 1 (12-Month Base Study)||0
9728209|NCT00112437|10827947|FG019|STARTED|Year 1 (12-Month Base Study)||0
9728210|NCT00112437|10827948|FG020|STARTED|Year 1 (12-Month Base Study)||0
9728211|NCT00112437|10827949|FG021|STARTED|Year 1 (12-Month Base Study)||0
9728212|NCT00112437|10827950|FG022|STARTED|Year 1 (12-Month Base Study)||0
9728213|NCT00112437|10827951|FG023|STARTED|Year 1 (12-Month Base Study)||0
9728214|NCT00112437|10827952|FG024|STARTED|Year 1 (12-Month Base Study)||0
9728215|NCT00112437|10827953|FG025|STARTED|Year 1 (12-Month Base Study)||0
9728216|NCT00112437|10827928|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
9728217|NCT00112437|10827929|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
9728218|NCT00112437|10827930|FG002|COMPLETED|Year 1 (12-Month Base Study)||65
9728219|NCT00112437|10827931|FG003|COMPLETED|Year 1 (12-Month Base Study)||71
9728220|NCT00112437|10827932|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
9728221|NCT00112437|10827933|FG005|COMPLETED|Year 1 (12-Month Base Study)||0
9728222|NCT00112437|10827934|FG006|COMPLETED|Year 1 (12-Month Base Study)||0
9728223|NCT00112437|10827935|FG007|COMPLETED|Year 1 (12-Month Base Study)||0
9728224|NCT00112437|10827936|FG008|COMPLETED|Year 1 (12-Month Base Study)||0
9728225|NCT00112437|10827937|FG009|COMPLETED|Year 1 (12-Month Base Study)||0
9728226|NCT00112437|10827938|FG010|COMPLETED|Year 1 (12-Month Base Study)||0
9728227|NCT00112437|10827939|FG011|COMPLETED|Year 1 (12-Month Base Study)||0
9728228|NCT00112437|10827940|FG012|COMPLETED|Year 1 (12-Month Base Study)||0
9728229|NCT00112437|10827941|FG013|COMPLETED|Year 1 (12-Month Base Study)||0
9728230|NCT00112437|10827942|FG014|COMPLETED|Year 1 (12-Month Base Study)||0
9728231|NCT00112437|10827943|FG015|COMPLETED|Year 1 (12-Month Base Study)||0
9728232|NCT00112437|10827944|FG016|COMPLETED|Year 1 (12-Month Base Study)||0
9728233|NCT00112437|10827945|FG017|COMPLETED|Year 1 (12-Month Base Study)||0
9728234|NCT00112437|10827946|FG018|COMPLETED|Year 1 (12-Month Base Study)||0
9728235|NCT00112437|10827947|FG019|COMPLETED|Year 1 (12-Month Base Study)||0
9728236|NCT00112437|10827948|FG020|COMPLETED|Year 1 (12-Month Base Study)||0
9728237|NCT00112437|10827949|FG021|COMPLETED|Year 1 (12-Month Base Study)||0
9728238|NCT00112437|10827950|FG022|COMPLETED|Year 1 (12-Month Base Study)||0
9728239|NCT00112437|10827951|FG023|COMPLETED|Year 1 (12-Month Base Study)||0
9728240|NCT00112437|10827952|FG024|COMPLETED|Year 1 (12-Month Base Study)||0
9728241|NCT00112437|10827953|FG025|COMPLETED|Year 1 (12-Month Base Study)||0
9728242|NCT00112437|10827928|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15
9728243|NCT00112437|10827929|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18
9728244|NCT00112437|10827930|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12
9728245|NCT00112437|10827931|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8
9728246|NCT00112437|10827932|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12
9728247|NCT00112437|10827933|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728248|NCT00112437|10827934|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9701391|NCT04135937|10800550|FG000|STARTED|Overall Study||12
9701392|NCT04135937|10800550|FG000|COMPLETED|Overall Study||9
9701393|NCT04135937|10800550|FG000|NOT COMPLETED|Overall Study||3
9962881|NCT01482715|11082641|FG000|STARTED|Overall Study||6
9962882|NCT01482715|11082642|FG001|STARTED|Overall Study||3
9962883|NCT01482715|11082643|FG002|STARTED|Overall Study||4
9962884|NCT01482715|11082644|FG003|STARTED|Overall Study||9
9962885|NCT01482715|11082645|FG004|STARTED|Overall Study||4
9962886|NCT01482715|11082646|FG005|STARTED|Overall Study||3
9962887|NCT01482715|11082647|FG006|STARTED|Overall Study||8
9962888|NCT01482715|11082648|FG007|STARTED|Overall Study||9
9962889|NCT01482715|11082649|FG008|STARTED|Overall Study||7
9962890|NCT01482715|11082650|FG009|STARTED|Overall Study||3
9962891|NCT01482715|11082651|FG010|STARTED|Overall Study||42
9962892|NCT01482715|11082652|FG011|STARTED|Overall Study||12
9962893|NCT01482715|11082653|FG012|STARTED|Overall Study||26
9962894|NCT01482715|11082641|FG000|COMPLETED|Overall Study||6
9962895|NCT01482715|11082642|FG001|COMPLETED|Overall Study||3
9962896|NCT01482715|11082643|FG002|COMPLETED|Overall Study||4
9962897|NCT01482715|11082644|FG003|COMPLETED|Overall Study||9
9962898|NCT01482715|11082645|FG004|COMPLETED|Overall Study||4
9962899|NCT01482715|11082646|FG005|COMPLETED|Overall Study||3
9962900|NCT01482715|11082647|FG006|COMPLETED|Overall Study||8
9962901|NCT01482715|11082648|FG007|COMPLETED|Overall Study||9
9962902|NCT01482715|11082649|FG008|COMPLETED|Overall Study||7
9962903|NCT01482715|11082650|FG009|COMPLETED|Overall Study||3
9962904|NCT01482715|11082651|FG010|COMPLETED|Overall Study||42
9962905|NCT01482715|11082652|FG011|COMPLETED|Overall Study||12
9962906|NCT01482715|11082653|FG012|COMPLETED|Overall Study||26
9962907|NCT01482715|11082641|FG000|NOT COMPLETED|Overall Study||0
9962908|NCT01482715|11082642|FG001|NOT COMPLETED|Overall Study||0
9962909|NCT01482715|11082643|FG002|NOT COMPLETED|Overall Study||0
9962910|NCT01482715|11082644|FG003|NOT COMPLETED|Overall Study||0
9962911|NCT01482715|11082645|FG004|NOT COMPLETED|Overall Study||0
9962912|NCT01482715|11082646|FG005|NOT COMPLETED|Overall Study||0
9962913|NCT01482715|11082647|FG006|NOT COMPLETED|Overall Study||0
9962914|NCT01482715|11082648|FG007|NOT COMPLETED|Overall Study||0
9962915|NCT01482715|11082649|FG008|NOT COMPLETED|Overall Study||0
9962916|NCT01482715|11082650|FG009|NOT COMPLETED|Overall Study||0
9962917|NCT01482715|11082651|FG010|NOT COMPLETED|Overall Study||0
9962918|NCT01482715|11082652|FG011|NOT COMPLETED|Overall Study||0
9962919|NCT01482715|11082653|FG012|NOT COMPLETED|Overall Study||0
9962920|NCT01482767|11082696|FG000|STARTED|Overall Study||135
9962921|NCT01482767|11082697|FG001|STARTED|Overall Study||127
9962922|NCT01482767|11082696|FG000|COMPLETED|Overall Study||81
9962923|NCT01482767|11082697|FG001|COMPLETED|Overall Study||78
9962924|NCT01482767|11082696|FG000|NOT COMPLETED|Overall Study||54
9962925|NCT01482767|11082697|FG001|NOT COMPLETED|Overall Study||49
9962926|NCT01482819|11082703|FG000|STARTED|Overall Study||21
9962927|NCT01482819|11082703|FG000|COMPLETED|Overall Study||19
9962928|NCT01482819|11082703|FG000|NOT COMPLETED|Overall Study||2
9962929|NCT01482884|11082713|FG000|STARTED|Overall Study|One participant did not receive study treatment|56
9962930|NCT01482884|11082714|FG001|STARTED|Overall Study||55
9962931|NCT01482884|11082713|FG000|COMPLETED|Overall Study||43
9962932|NCT01482884|11082714|FG001|COMPLETED|Overall Study||37
9962933|NCT01482884|11082713|FG000|NOT COMPLETED|Overall Study||13
9962934|NCT01482884|11082714|FG001|NOT COMPLETED|Overall Study||18
9962935|NCT01482910|11082722|FG000|STARTED|Overall Study||228
9962936|NCT01482910|11082723|FG001|STARTED|Overall Study||76
10026794|NCT03605862|11150951|FG001|COMPLETED|Overall Study||858
10026795|NCT03605862|11150950|FG000|NOT COMPLETED|Overall Study||28
10026796|NCT03605862|11150951|FG001|NOT COMPLETED|Overall Study||26
10026797|NCT03541252|11150958|FG000|STARTED|Overall Study||20
10026798|NCT03541252|11150958|FG000|COMPLETED|Overall Study||19
10026799|NCT03541252|11150958|FG000|NOT COMPLETED|Overall Study||1
10081340|NCT02260180|11209813|FG000|COMPLETED|Overall Study||37
9701394|NCT03989232|10800556|FG000|STARTED|Overall Study||481
9701395|NCT03989232|10800557|FG001|STARTED|Overall Study||480
9701396|NCT03989232|10800556|FG000|Exposed|Overall Study||480
9701397|NCT03989232|10800557|FG001|Exposed|Overall Study||479
9701398|NCT03989232|10800556|FG000|Safety Analysis Set (SAS)|Overall Study||480
9701399|NCT03989232|10800557|FG001|Safety Analysis Set (SAS)|Overall Study||479
9701400|NCT03989232|10800556|FG000|Full Analysis Set (FAS)|Overall Study||481
9962937|NCT01482910|11082722|FG000|Completed Week 28|Overall Study||216
9962938|NCT01482910|11082723|FG001|Completed Week 28|Overall Study||71
9962939|NCT01482910|11082722|FG000|COMPLETED|Overall Study||213
9962940|NCT01482910|11082723|FG001|COMPLETED|Overall Study||67
9962941|NCT01482910|11082722|FG000|NOT COMPLETED|Overall Study||15
9962942|NCT01482910|11082723|FG001|NOT COMPLETED|Overall Study||9
9962943|NCT01482962|11082733|FG000|STARTED|Overall Study||138
9962944|NCT01482962|11082734|FG001|STARTED|Overall Study||133
9962945|NCT01482962|11082733|FG000|Safety Population: Received Study Drug|Overall Study||137
9962946|NCT01482962|11082734|FG001|Safety Population: Received Study Drug|Overall Study||127
9962947|NCT01482962|11082733|FG000|COMPLETED|Overall Study||0
9962948|NCT01482962|11082734|FG001|COMPLETED|Overall Study||0
9962949|NCT01482962|11082733|FG000|NOT COMPLETED|Overall Study||138
9962950|NCT01482962|11082734|FG001|NOT COMPLETED|Overall Study||133
9962951|NCT01483118|11082744|FG000|STARTED|Overall Study||23
10081341|NCT02260180|11209814|FG001|COMPLETED|Overall Study||39
9701401|NCT03989232|10800557|FG001|Full Analysis Set (FAS)|Overall Study||480
9701402|NCT03989232|10800556|FG000|COMPLETED|Overall Study||471
10081342|NCT02260180|11209815|FG002|COMPLETED|Overall Study||40
9701403|NCT03989232|10800557|FG001|COMPLETED|Overall Study||462
9701404|NCT03989232|10800556|FG000|NOT COMPLETED|Overall Study||10
9701405|NCT03989232|10800557|FG001|NOT COMPLETED|Overall Study||18
9701406|NCT03896295|10800565|FG000|STARTED|Overall Study||7
9701407|NCT03896295|10800566|FG001|STARTED|Overall Study||30
9701408|NCT03896295|10800565|FG000|COMPLETED|Overall Study||0
9701409|NCT03896295|10800566|FG001|COMPLETED|Overall Study||0
9701410|NCT03896295|10800565|FG000|NOT COMPLETED|Overall Study||7
9701411|NCT03896295|10800566|FG001|NOT COMPLETED|Overall Study||30
9701412|NCT03213457|10800580|FG000|STARTED|Overall Study||194
9701413|NCT03213457|10800581|FG001|STARTED|Overall Study||98
9701414|NCT03213457|10800582|FG002|STARTED|Overall Study||389
9701415|NCT03213457|10800580|FG000|Randomized and Treated|Overall Study||193
9701416|NCT03213457|10800581|FG001|Randomized and Treated|Overall Study||97
9962952|NCT01483118|11082745|FG001|STARTED|Overall Study||22
9962953|NCT01483118|11082744|FG000|Completed 3 Months|Overall Study||15
9962954|NCT01483118|11082745|FG001|Completed 3 Months|Overall Study||11
9962955|NCT01483118|11082744|FG000|COMPLETED|Overall Study||11
9962956|NCT01483118|11082745|FG001|COMPLETED|Overall Study||6
9962957|NCT01483118|11082744|FG000|NOT COMPLETED|Overall Study||12
9962958|NCT01483118|11082745|FG001|NOT COMPLETED|Overall Study||16
9962959|NCT01483144|11082756|FG000|STARTED|Overall Study||56
9962960|NCT01483144|11082757|FG001|STARTED|Overall Study||57
9962961|NCT01483144|11082758|FG002|STARTED|Overall Study||58
9962962|NCT01483144|11082756|FG000|COMPLETED|Overall Study||41
9962963|NCT01483144|11082757|FG001|COMPLETED|Overall Study||44
9962964|NCT01483144|11082758|FG002|COMPLETED|Overall Study||43
9962965|NCT01483144|11082756|FG000|NOT COMPLETED|Overall Study||15
9962966|NCT01483144|11082757|FG001|NOT COMPLETED|Overall Study||13
9962967|NCT01483144|11082758|FG002|NOT COMPLETED|Overall Study||15
9962968|NCT01483183|11082776|FG000|STARTED|Overall Study||4
9962969|NCT01483183|11082777|FG001|STARTED|Overall Study||1
9962970|NCT01483183|11082778|FG002|STARTED|Overall Study||5
9962971|NCT01483183|11082779|FG003|STARTED|Overall Study||3
9962972|NCT01483183|11082780|FG004|STARTED|Overall Study||4
9962973|NCT01483183|11082781|FG005|STARTED|Overall Study||4
9962974|NCT01483183|11082782|FG006|STARTED|Overall Study||6
9962975|NCT01483183|11082783|FG007|STARTED|Overall Study||4
9962976|NCT01483183|11082784|FG008|STARTED|Overall Study||4
9962977|NCT01483183|11082785|FG009|STARTED|Overall Study||5
9962978|NCT01483183|11082776|FG000|COMPLETED|Overall Study||4
9962979|NCT01483183|11082777|FG001|COMPLETED|Overall Study||1
9962980|NCT01483183|11082778|FG002|COMPLETED|Overall Study||5
9962981|NCT01483183|11082779|FG003|COMPLETED|Overall Study||3
9962982|NCT01483183|11082780|FG004|COMPLETED|Overall Study||4
9962983|NCT01483183|11082781|FG005|COMPLETED|Overall Study||4
9962984|NCT01483183|11082782|FG006|COMPLETED|Overall Study||4
9962985|NCT01483183|11082783|FG007|COMPLETED|Overall Study||4
9962986|NCT01483183|11082784|FG008|COMPLETED|Overall Study||4
9962987|NCT01483183|11082785|FG009|COMPLETED|Overall Study||4
9962988|NCT01483183|11082776|FG000|NOT COMPLETED|Overall Study||0
9962989|NCT01483183|11082777|FG001|NOT COMPLETED|Overall Study||0
9962990|NCT01483183|11082778|FG002|NOT COMPLETED|Overall Study||0
9962991|NCT01483183|11082779|FG003|NOT COMPLETED|Overall Study||0
9962992|NCT01483183|11082780|FG004|NOT COMPLETED|Overall Study||0
9962993|NCT01483183|11082781|FG005|NOT COMPLETED|Overall Study||0
9962994|NCT01483183|11082782|FG006|NOT COMPLETED|Overall Study||2
9962995|NCT01483183|11082783|FG007|NOT COMPLETED|Overall Study||0
9962996|NCT01483183|11082784|FG008|NOT COMPLETED|Overall Study||0
9962997|NCT01483183|11082785|FG009|NOT COMPLETED|Overall Study||1
9962998|NCT01483352|11082813|FG000|STARTED|Overall Study||12
9962999|NCT01483352|11082813|FG000|COMPLETED|Overall Study||12
9963000|NCT01483352|11082813|FG000|NOT COMPLETED|Overall Study||0
9963001|NCT01483378|11082817|FG000|STARTED|Overall Study||100
9963002|NCT01483378|11082818|FG001|STARTED|Overall Study||66
9963003|NCT01483378|11082817|FG000|COMPLETED|Overall Study||100
9963004|NCT01483378|11082818|FG001|COMPLETED|Overall Study||66
9963005|NCT01483378|11082817|FG000|NOT COMPLETED|Overall Study||0
9963006|NCT01483378|11082818|FG001|NOT COMPLETED|Overall Study||0
9963007|NCT01483560|11082826|FG000|STARTED|Overall Study||219
9963008|NCT01483560|11082827|FG001|STARTED|Overall Study||209
9963009|NCT01483560|11082826|FG000|COMPLETED|Overall Study||193
9963010|NCT01483560|11082827|FG001|COMPLETED|Overall Study||194
9963011|NCT01483560|11082826|FG000|NOT COMPLETED|Overall Study||26
9963012|NCT01483560|11082827|FG001|NOT COMPLETED|Overall Study||15
9701417|NCT03213457|10800582|FG002|Randomized and Treated|Overall Study||389
9963013|NCT01483599|11082840|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42
9963014|NCT01483599|11082841|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41
9963015|NCT01483599|11082842|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41
9963016|NCT01483599|11082843|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42
9963017|NCT01483599|11082844|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42
9963018|NCT01483599|11082845|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42
9963019|NCT01483599|11082846|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43
9963020|NCT01483599|11082847|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0
9963021|NCT01483599|11082848|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0
9963022|NCT01483599|11082849|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0
9963023|NCT01483599|11082850|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0
9963024|NCT01483599|11082851|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0
9963025|NCT01483599|11082852|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0
9967852|NCT01517178|11088214|FG001|COMPLETED|Period 1||6
9701418|NCT03213457|10800580|FG000|COMPLETED|Overall Study||106
9701419|NCT03213457|10800581|FG001|COMPLETED|Overall Study||59
9701420|NCT03213457|10800582|FG002|COMPLETED|Overall Study||215
9701421|NCT03213457|10800580|FG000|NOT COMPLETED|Overall Study||88
9701422|NCT03213457|10800581|FG001|NOT COMPLETED|Overall Study||39
9963026|NCT01483599|11082853|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0
9963027|NCT01483599|11082840|FG000|Treated|Controlled Period (CP) (up to Week 16)||42
9963028|NCT01483599|11082841|FG001|Treated|Controlled Period (CP) (up to Week 16)||41
9963029|NCT01483599|11082842|FG002|Treated|Controlled Period (CP) (up to Week 16)||41
9963030|NCT01483599|11082843|FG003|Treated|Controlled Period (CP) (up to Week 16)||42
9963031|NCT01483599|11082844|FG004|Treated|Controlled Period (CP) (up to Week 16)||42
9963032|NCT01483599|11082845|FG005|Treated|Controlled Period (CP) (up to Week 16)||41
9963033|NCT01483599|11082846|FG006|Treated|Controlled Period (CP) (up to Week 16)||43
9963034|NCT01483599|11082847|FG007|Treated|Controlled Period (CP) (up to Week 16)||0
9963035|NCT01483599|11082848|FG008|Treated|Controlled Period (CP) (up to Week 16)||0
9963036|NCT01483599|11082849|FG009|Treated|Controlled Period (CP) (up to Week 16)||0
9963037|NCT01483599|11082850|FG010|Treated|Controlled Period (CP) (up to Week 16)||0
9963038|NCT01483599|11082851|FG011|Treated|Controlled Period (CP) (up to Week 16)||0
9963039|NCT01483599|11082852|FG012|Treated|Controlled Period (CP) (up to Week 16)||0
9963040|NCT01483599|11082853|FG013|Treated|Controlled Period (CP) (up to Week 16)||0
9963041|NCT01483599|11082840|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39
9963042|NCT01483599|11082841|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38
9963043|NCT01483599|11082842|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41
9963044|NCT01483599|11082843|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39
9963045|NCT01483599|11082844|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40
9963046|NCT01483599|11082845|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38
9963047|NCT01483599|11082846|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39
9963048|NCT01483599|11082847|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963049|NCT01483599|11082848|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963050|NCT01483599|11082849|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963051|NCT01483599|11082850|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963052|NCT01483599|11082851|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963053|NCT01483599|11082852|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963054|NCT01483599|11082853|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10026800|NCT03401112|11150967|FG000|STARTED|Overall Study||15
10026801|NCT03401112|11150968|FG001|STARTED|Overall Study||26
10026802|NCT03401112|11150969|FG002|STARTED|Overall Study||22
10026803|NCT03401112|11150970|FG003|STARTED|Overall Study||27
10026804|NCT03401112|11150971|FG004|STARTED|Overall Study||10
10026805|NCT03401112|11150967|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10026806|NCT03401112|11150968|FG001|Received at Least 1 Dose of Study Drug|Overall Study||26
10026807|NCT03401112|11150969|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
10026808|NCT03401112|11150970|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
10026809|NCT03401112|11150971|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10
10026810|NCT03401112|11150967|FG000|COMPLETED|Overall Study||10
10026811|NCT03401112|11150968|FG001|COMPLETED|Overall Study||19
10026812|NCT03401112|11150969|FG002|COMPLETED|Overall Study||11
10026813|NCT03401112|11150970|FG003|COMPLETED|Overall Study||21
10026814|NCT03401112|11150971|FG004|COMPLETED|Overall Study||10
10026815|NCT03401112|11150967|FG000|NOT COMPLETED|Overall Study||5
10026816|NCT03401112|11150968|FG001|NOT COMPLETED|Overall Study||7
10026817|NCT03401112|11150969|FG002|NOT COMPLETED|Overall Study||11
10026818|NCT03401112|11150970|FG003|NOT COMPLETED|Overall Study||6
10026819|NCT03401112|11150971|FG004|NOT COMPLETED|Overall Study||0
10026820|NCT03362112|11150998|FG000|STARTED|Overall Study||1713
10026821|NCT03362112|11150998|FG000|COMPLETED|Overall Study||1622
10026822|NCT03362112|11150998|FG000|NOT COMPLETED|Overall Study||91
10026823|NCT03158298|11151002|FG000|STARTED|Overall Study||82
10026824|NCT03158298|11151002|FG000|COMPLETED|Overall Study||82
9701423|NCT03213457|10800582|FG002|NOT COMPLETED|Overall Study||174
9728249|NCT00112437|10827935|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728250|NCT00112437|10827936|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728251|NCT00112437|10827937|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728252|NCT00112437|10827938|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728253|NCT00112437|10827939|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728254|NCT00112437|10827940|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728255|NCT00112437|10827941|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728256|NCT00112437|10827942|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728257|NCT00112437|10827943|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728258|NCT00112437|10827944|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728259|NCT00112437|10827945|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728260|NCT00112437|10827946|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9963055|NCT01483599|11082840|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
10026825|NCT03158298|11151002|FG000|NOT COMPLETED|Overall Study||0
10026826|NCT03041701|11151009|FG000|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||7
10026827|NCT03041701|11151010|FG001|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||6
10026828|NCT03041701|11151011|FG002|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||0
10026829|NCT03041701|11151009|FG000|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||6
10026830|NCT03041701|11151010|FG001|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||5
9701424|NCT02982720|10800590|FG000|STARTED|Overall Study||4
9701425|NCT02982720|10800590|FG000|COMPLETED|Overall Study||0
9701426|NCT02982720|10800590|FG000|NOT COMPLETED|Overall Study||4
9701427|NCT02548754|10800596|FG000|STARTED|Overall Study||26
9701428|NCT02548754|10800597|FG001|STARTED|Overall Study||27
9701429|NCT02548754|10800596|FG000|COMPLETED|Overall Study||24
9701430|NCT02548754|10800597|FG001|COMPLETED|Overall Study||23
9701431|NCT02548754|10800596|FG000|NOT COMPLETED|Overall Study||2
9701432|NCT02548754|10800597|FG001|NOT COMPLETED|Overall Study||4
9701433|NCT02375672|10800603|FG000|STARTED|Overall Study||30
9701434|NCT02375672|10800603|FG000|COMPLETED|Overall Study||10
9701435|NCT02375672|10800603|FG000|NOT COMPLETED|Overall Study||20
9701436|NCT02329327|10800609|FG000|STARTED|Overall Study||477
9701437|NCT02329327|10800610|FG001|STARTED|Overall Study||2
9701438|NCT02329327|10800609|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477
10026831|NCT03041701|11151011|FG002|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
10026832|NCT03041701|11151009|FG000|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
10026833|NCT03041701|11151010|FG001|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
10026834|NCT03041701|11151011|FG002|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
10026835|NCT03041701|11151009|FG000|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10026836|NCT03041701|11151010|FG001|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10026837|NCT03041701|11151011|FG002|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
10026838|NCT03041701|11151009|FG000|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10026839|NCT03041701|11151010|FG001|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
9963056|NCT01483599|11082841|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
9963057|NCT01483599|11082842|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963058|NCT01483599|11082843|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
9963059|NCT01483599|11082844|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
9963060|NCT01483599|11082845|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
9963061|NCT01483599|11082846|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
9701439|NCT02329327|10800610|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
9701440|NCT02329327|10800609|FG000|Efficacy Population|Overall Study||347
9701441|NCT02329327|10800610|FG001|Efficacy Population|Overall Study||2
9701442|NCT02329327|10800609|FG000|Death|Overall Study||3
9701443|NCT02329327|10800610|FG001|Death|Overall Study||0
9701444|NCT02329327|10800609|FG000|COMPLETED|Overall Study||392
9701445|NCT02329327|10800610|FG001|COMPLETED|Overall Study||2
9701446|NCT02329327|10800609|FG000|NOT COMPLETED|Overall Study||85
9701447|NCT02329327|10800610|FG001|NOT COMPLETED|Overall Study||0
9701448|NCT02153645|10800632|FG000|STARTED|Overall Study||30
9701449|NCT02153645|10800633|FG001|STARTED|Overall Study||29
9701450|NCT02153645|10800634|FG002|STARTED|Overall Study||28
9701451|NCT02153645|10800632|FG000|COMPLETED|Overall Study||17
9701452|NCT02153645|10800633|FG001|COMPLETED|Overall Study||19
9701453|NCT02153645|10800634|FG002|COMPLETED|Overall Study||18
9701454|NCT02153645|10800632|FG000|NOT COMPLETED|Overall Study||13
9701455|NCT02153645|10800633|FG001|NOT COMPLETED|Overall Study||10
9701456|NCT02153645|10800634|FG002|NOT COMPLETED|Overall Study||10
9701457|NCT02153632|10800645|FG000|STARTED|Overall Study||45
9701458|NCT02153632|10800646|FG001|STARTED|Overall Study||46
9701459|NCT02153632|10800647|FG002|STARTED|Overall Study||44
9701460|NCT02153632|10800645|FG000|COMPLETED|Overall Study||27
9701461|NCT02153632|10800646|FG001|COMPLETED|Overall Study||27
9701462|NCT02153632|10800647|FG002|COMPLETED|Overall Study||25
9701463|NCT02153632|10800645|FG000|NOT COMPLETED|Overall Study||18
9701464|NCT02153632|10800646|FG001|NOT COMPLETED|Overall Study||19
9701465|NCT02153632|10800647|FG002|NOT COMPLETED|Overall Study||19
9701466|NCT01689909|10800657|FG000|STARTED|Overall Study||51
9701467|NCT01689909|10800658|FG001|STARTED|Overall Study||52
9701468|NCT01689909|10800657|FG000|COMPLETED|Overall Study||51
9701469|NCT01689909|10800658|FG001|COMPLETED|Overall Study||52
9701470|NCT01689909|10800657|FG000|NOT COMPLETED|Overall Study||0
9701471|NCT01689909|10800658|FG001|NOT COMPLETED|Overall Study||0
9701472|NCT01566149|10800668|FG000|STARTED|Overall Study||24
9701473|NCT01566149|10800669|FG001|STARTED|Overall Study||25
9963062|NCT01483599|11082847|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963063|NCT01483599|11082848|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963064|NCT01483599|11082849|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10026840|NCT03041701|11151011|FG002|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10026841|NCT03041701|11151009|FG000|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10026842|NCT03041701|11151010|FG001|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10026843|NCT03041701|11151011|FG002|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
10026844|NCT03000179|11151022|FG000|STARTED|Overall Study||8
10026845|NCT03000179|11151022|FG000|COMPLETED|Overall Study||6
10026846|NCT03000179|11151022|FG000|NOT COMPLETED|Overall Study||2
10026847|NCT02876835|11151028|FG000|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1937
10026848|NCT02876835|11151029|FG001|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1935
10026849|NCT02876835|11151028|FG000|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1937
10026850|NCT02876835|11151029|FG001|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1935
10026851|NCT02876835|11151028|FG000|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
10081343|NCT02260180|11209813|FG000|NOT COMPLETED|Overall Study||2
9701474|NCT01566149|10800668|FG000|COMPLETED|Overall Study||21
9701475|NCT01566149|10800669|FG001|COMPLETED|Overall Study||23
9701476|NCT01566149|10800668|FG000|NOT COMPLETED|Overall Study||3
9701477|NCT01566149|10800669|FG001|NOT COMPLETED|Overall Study||2
9701478|NCT01481935|10800677|FG000|STARTED|Overall Study||97
9701479|NCT01481935|10800678|FG001|STARTED|Overall Study||93
9847994|NCT00856856|10960640|FG000|STARTED|270-day Clinical Follow-up||101
9847995|NCT00856856|10960640|FG000|COMPLETED|270-day Clinical Follow-up||101
9847996|NCT00856856|10960640|FG000|NOT COMPLETED|270-day Clinical Follow-up||0
9847997|NCT00856856|10960640|FG000|STARTED|1-year Clinical Follow-up||101
9847998|NCT00856856|10960640|FG000|COMPLETED|1-year Clinical Follow-up||101
9847999|NCT00856856|10960640|FG000|NOT COMPLETED|1-year Clinical Follow-up||0
9848000|NCT00856856|10960640|FG000|STARTED|2-year Clinical Follow-up||101
9848001|NCT00856856|10960640|FG000|COMPLETED|2-year Clinical Follow-up||100
9848002|NCT00856856|10960640|FG000|NOT COMPLETED|2-year Clinical Follow-up||1
9848003|NCT00856856|10960640|FG000|STARTED|3-year Clinical Follow-up||100
9848004|NCT00856856|10960640|FG000|COMPLETED|3-year Clinical Follow-up||100
9848005|NCT00856856|10960640|FG000|NOT COMPLETED|3-year Clinical Follow-up||0
9848006|NCT00856856|10960640|FG000|STARTED|4-year Clinical Follow-up||100
9848007|NCT00856856|10960640|FG000|COMPLETED|4-year Clinical Follow-up||99
9963065|NCT01483599|11082850|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963066|NCT01483599|11082851|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963067|NCT01483599|11082852|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963068|NCT01483599|11082853|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
9963069|NCT01483599|11082840|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0
9963070|NCT01483599|11082841|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0
9963071|NCT01483599|11082842|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0
9963072|NCT01483599|11082843|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0
9963073|NCT01483599|11082844|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0
9963074|NCT01483599|11082845|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0
9963075|NCT01483599|11082846|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0
9963076|NCT01483599|11082847|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39
9963077|NCT01483599|11082848|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38
9963078|NCT01483599|11082849|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41
9963079|NCT01483599|11082850|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39
9963080|NCT01483599|11082851|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40
9963081|NCT01483599|11082852|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38
9963082|NCT01483599|11082853|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39
9963083|NCT01483599|11082840|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963084|NCT01483599|11082841|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963085|NCT01483599|11082842|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963086|NCT01483599|11082843|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963087|NCT01483599|11082844|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963088|NCT01483599|11082845|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963089|NCT01483599|11082846|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963090|NCT01483599|11082847|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37
9963091|NCT01483599|11082848|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29
9963092|NCT01483599|11082849|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37
9963093|NCT01483599|11082850|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37
9963094|NCT01483599|11082851|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39
9963095|NCT01483599|11082852|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35
9963096|NCT01483599|11082853|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32
9963097|NCT01483599|11082840|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963098|NCT01483599|11082841|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963099|NCT01483599|11082842|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963100|NCT01483599|11082843|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963101|NCT01483599|11082844|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963102|NCT01483599|11082845|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963103|NCT01483599|11082846|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
9963104|NCT01483599|11082847|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
9963105|NCT01483599|11082848|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
9963106|NCT01483599|11082849|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
9963107|NCT01483599|11082850|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
9963108|NCT01483599|11082851|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
9701480|NCT01481935|10800677|FG000|COMPLETED|Overall Study||97
9701481|NCT01481935|10800678|FG001|COMPLETED|Overall Study||93
9701482|NCT01481935|10800677|FG000|NOT COMPLETED|Overall Study||0
9701483|NCT01481935|10800678|FG001|NOT COMPLETED|Overall Study||0
9701484|NCT01386125|10800686|FG000|STARTED|Overall Study||375
9701485|NCT01386125|10800687|FG001|STARTED|Overall Study||373
9701486|NCT01386125|10800686|FG000|COMPLETED|Overall Study||350
9701487|NCT01386125|10800687|FG001|COMPLETED|Overall Study||336
9701488|NCT01386125|10800686|FG000|NOT COMPLETED|Overall Study||25
9701489|NCT01386125|10800687|FG001|NOT COMPLETED|Overall Study||37
9701490|NCT01257568|10800693|FG000|STARTED|Overall Study||40
9701491|NCT01257568|10800693|FG000|COMPLETED|Overall Study||7
9701492|NCT01257568|10800693|FG000|NOT COMPLETED|Overall Study||33
9701493|NCT01165424|10800699|FG000|STARTED|Overall Study||80
9701494|NCT01165424|10800699|FG000|COMPLETED|Overall Study||76
9701495|NCT01165424|10800699|FG000|NOT COMPLETED|Overall Study||4
9701496|NCT01135134|10800705|FG000|STARTED|Overall Study||220
9701497|NCT01135134|10800706|FG001|STARTED|Overall Study||113
9701498|NCT01135134|10800705|FG000|COMPLETED|Overall Study||218
9701499|NCT01135134|10800706|FG001|COMPLETED|Overall Study||112
9701500|NCT01135134|10800705|FG000|NOT COMPLETED|Overall Study||2
9701501|NCT01135134|10800706|FG001|NOT COMPLETED|Overall Study||1
9701502|NCT00867165|10800714|FG000|STARTED|Overall Study||93
9701503|NCT00867165|10800715|FG001|STARTED|Overall Study||45
9701504|NCT00867165|10800714|FG000|COMPLETED|Overall Study||89
9701505|NCT00867165|10800715|FG001|COMPLETED|Overall Study||45
9701506|NCT00867165|10800714|FG000|NOT COMPLETED|Overall Study||4
9701507|NCT00867165|10800715|FG001|NOT COMPLETED|Overall Study||0
9701508|NCT00733005|10800723|FG000|STARTED|Overall Study||162
9701509|NCT00733005|10800724|FG001|STARTED|Overall Study||162
9701510|NCT00733005|10800723|FG000|COMPLETED|Overall Study||160
9701511|NCT00733005|10800724|FG001|COMPLETED|Overall Study||159
9701512|NCT00733005|10800723|FG000|NOT COMPLETED|Overall Study||2
9701513|NCT00733005|10800724|FG001|NOT COMPLETED|Overall Study||3
9701514|NCT00732381|10800732|FG000|STARTED|Overall Study||176
9701515|NCT00732381|10800733|FG001|STARTED|Overall Study||175
9701516|NCT00732381|10800732|FG000|COMPLETED|Overall Study||174
9701517|NCT00732381|10800733|FG001|COMPLETED|Overall Study||174
9701518|NCT00732381|10800732|FG000|NOT COMPLETED|Overall Study||2
9701519|NCT00732381|10800733|FG001|NOT COMPLETED|Overall Study||1
9701520|NCT00654095|10800739|FG000|STARTED|Overall Study||146
9701521|NCT00654095|10800739|FG000|COMPLETED|Overall Study||114
9701522|NCT00654095|10800739|FG000|NOT COMPLETED|Overall Study||32
9701523|NCT00653523|10800743|FG000|STARTED|Overall Study||151
9701524|NCT00653523|10800743|FG000|COMPLETED|Overall Study||132
9701525|NCT00653523|10800743|FG000|NOT COMPLETED|Overall Study||19
9701526|NCT00599027|10800749|FG000|STARTED|Overall Study||26
9701527|NCT00599027|10800750|FG001|STARTED|Overall Study||25
9701528|NCT00599027|10800749|FG000|COMPLETED|Overall Study||25
9701529|NCT00599027|10800750|FG001|COMPLETED|Overall Study||22
9701530|NCT00599027|10800749|FG000|NOT COMPLETED|Overall Study||1
9701531|NCT00599027|10800750|FG001|NOT COMPLETED|Overall Study||3
9701532|NCT00552032|10800758|FG000|STARTED|Overall Study||66
9701533|NCT00552032|10800759|FG001|STARTED|Overall Study||66
9701534|NCT00552032|10800758|FG000|COMPLETED|Overall Study||49
9701535|NCT00552032|10800759|FG001|COMPLETED|Overall Study||47
9701536|NCT00552032|10800758|FG000|NOT COMPLETED|Overall Study||17
9701537|NCT00552032|10800759|FG001|NOT COMPLETED|Overall Study||19
9701538|NCT00546052|10800765|FG000|STARTED|Overall Study||1738
9701539|NCT00546052|10800765|FG000|Week 4|Overall Study||1714
9701540|NCT00546052|10800765|FG000|Week 8|Overall Study||1680
9701541|NCT00546052|10800765|FG000|Week 12|Overall Study||1650
9701542|NCT00546052|10800765|FG000|Week 32|Overall Study||1583
9963109|NCT01483599|11082852|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
9963110|NCT01483599|11082853|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
9963111|NCT01483625|11082884|FG000|STARTED|Overall Study||72
9963112|NCT01483625|11082885|FG001|STARTED|Overall Study||68
9963113|NCT01483625|11082884|FG000|COMPLETED|Overall Study||68
9963114|NCT01483625|11082885|FG001|COMPLETED|Overall Study||66
9963115|NCT01483625|11082884|FG000|NOT COMPLETED|Overall Study||4
9963116|NCT01483625|11082885|FG001|NOT COMPLETED|Overall Study||2
9963117|NCT01483651|11082891|FG000|STARTED|Overall Study||1
9963118|NCT01483651|11082892|FG001|STARTED|Overall Study||3
9963119|NCT01483651|11082893|FG002|STARTED|Overall Study||2
9963120|NCT01483651|11082894|FG003|STARTED|Overall Study||1
9963121|NCT01483651|11082895|FG004|STARTED|Overall Study||2
9963122|NCT01483651|11082896|FG005|STARTED|Overall Study||2
9963123|NCT01483651|11082891|FG000|COMPLETED|Overall Study||1
9963124|NCT01483651|11082892|FG001|COMPLETED|Overall Study||2
9963125|NCT01483651|11082893|FG002|COMPLETED|Overall Study||1
9963126|NCT01483651|11082894|FG003|COMPLETED|Overall Study||1
9963127|NCT01483651|11082895|FG004|COMPLETED|Overall Study||2
9963128|NCT01483651|11082896|FG005|COMPLETED|Overall Study||1
9963129|NCT01483651|11082891|FG000|NOT COMPLETED|Overall Study||0
9963130|NCT01483651|11082892|FG001|NOT COMPLETED|Overall Study||1
9963131|NCT01483651|11082893|FG002|NOT COMPLETED|Overall Study||1
9963132|NCT01483651|11082894|FG003|NOT COMPLETED|Overall Study||0
9963133|NCT01483651|11082895|FG004|NOT COMPLETED|Overall Study||0
9701543|NCT00546052|10800765|FG000|Week 52|Overall Study||1511
9701544|NCT00546052|10800765|FG000|COMPLETED|Overall Study||1511
9701545|NCT00546052|10800765|FG000|NOT COMPLETED|Overall Study||227
9701546|NCT00442117|10800774|FG000|STARTED|Overall Study||85
9701547|NCT00442117|10800775|FG001|STARTED|Overall Study||87
9963134|NCT01483651|11082896|FG005|NOT COMPLETED|Overall Study||1
9963135|NCT01483690|11082906|FG000|STARTED|Overall Study||5
9963136|NCT01483690|11082907|FG001|STARTED|Overall Study||18
9963137|NCT01483690|11082906|FG000|COMPLETED|Overall Study||3
9963138|NCT01483690|11082907|FG001|COMPLETED|Overall Study||13
9701548|NCT00442117|10800774|FG000|COMPLETED|Overall Study||47
9963139|NCT01483690|11082906|FG000|NOT COMPLETED|Overall Study||2
9963140|NCT01483690|11082907|FG001|NOT COMPLETED|Overall Study||5
9963141|NCT01483807|11082913|FG000|STARTED|First Treatment Phase (7 Weeks)||10
9701549|NCT00442117|10800775|FG001|COMPLETED|Overall Study||49
9701550|NCT00442117|10800774|FG000|NOT COMPLETED|Overall Study||38
9701551|NCT00442117|10800775|FG001|NOT COMPLETED|Overall Study||38
9701552|NCT00424008|10800783|FG000|STARTED|Overall Study||371
9963142|NCT01483807|11082914|FG001|STARTED|First Treatment Phase (7 Weeks)||10
9963143|NCT01483807|11082913|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10
9701553|NCT00424008|10800784|FG001|STARTED|Overall Study||351
9701554|NCT00424008|10800783|FG000|COMPLETED|Overall Study||22
9701555|NCT00424008|10800784|FG001|COMPLETED|Overall Study||16
9701556|NCT00424008|10800783|FG000|NOT COMPLETED|Overall Study||349
9701557|NCT00424008|10800784|FG001|NOT COMPLETED|Overall Study||335
9701558|NCT00423176|10800793|FG000|STARTED|Overall Study||114
9701559|NCT00423176|10800794|FG001|STARTED|Overall Study||123
9701560|NCT00423176|10800793|FG000|COMPLETED|Overall Study||98
9701561|NCT00423176|10800794|FG001|COMPLETED|Overall Study||94
9701562|NCT00423176|10800793|FG000|NOT COMPLETED|Overall Study||16
9701563|NCT00423176|10800794|FG001|NOT COMPLETED|Overall Study||29
9701564|NCT00383240|10800804|FG000|STARTED|Overall Study||191
9701565|NCT00383240|10800805|FG001|STARTED|Overall Study||192
9701566|NCT00383240|10800806|FG002|STARTED|Overall Study||202
9701567|NCT00383240|10800807|FG003|STARTED|Overall Study||196
9701568|NCT00383240|10800804|FG000|COMPLETED|Overall Study||156
9701569|NCT00383240|10800805|FG001|COMPLETED|Overall Study||159
9701570|NCT00383240|10800806|FG002|COMPLETED|Overall Study||117
9701571|NCT00383240|10800807|FG003|COMPLETED|Overall Study||119
9701572|NCT00383240|10800804|FG000|NOT COMPLETED|Overall Study||35
9701573|NCT00383240|10800805|FG001|NOT COMPLETED|Overall Study||33
9701574|NCT00383240|10800806|FG002|NOT COMPLETED|Overall Study||85
9701575|NCT00383240|10800807|FG003|NOT COMPLETED|Overall Study||77
9728261|NCT00112437|10827947|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728262|NCT00112437|10827948|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728263|NCT00112437|10827949|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728264|NCT00112437|10827950|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728265|NCT00112437|10827951|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728266|NCT00112437|10827952|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728267|NCT00112437|10827953|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0
9728268|NCT00112437|10827928|FG000|STARTED|Year 2 (12-Month Extension)||0
9728269|NCT00112437|10827929|FG001|STARTED|Year 2 (12-Month Extension)||0
9728270|NCT00112437|10827930|FG002|STARTED|Year 2 (12-Month Extension)||0
9728271|NCT00112437|10827931|FG003|STARTED|Year 2 (12-Month Extension)||0
9728272|NCT00112437|10827932|FG004|STARTED|Year 2 (12-Month Extension)||0
9728273|NCT00112437|10827933|FG005|STARTED|Year 2 (12-Month Extension)||63
9728274|NCT00112437|10827934|FG006|STARTED|Year 2 (12-Month Extension)||62
9728275|NCT00112437|10827935|FG007|STARTED|Year 2 (12-Month Extension)||63
9728276|NCT00112437|10827936|FG008|STARTED|Year 2 (12-Month Extension)||69
9728277|NCT00112437|10827937|FG009|STARTED|Year 2 (12-Month Extension)||63
9728278|NCT00112437|10827938|FG010|STARTED|Year 2 (12-Month Extension)||0
9728279|NCT00112437|10827939|FG011|STARTED|Year 2 (12-Month Extension)||0
9728280|NCT00112437|10827940|FG012|STARTED|Year 2 (12-Month Extension)||0
9728281|NCT00112437|10827941|FG013|STARTED|Year 2 (12-Month Extension)||0
9728282|NCT00112437|10827942|FG014|STARTED|Year 2 (12-Month Extension)||0
9728283|NCT00112437|10827943|FG015|STARTED|Year 2 (12-Month Extension)||0
9728284|NCT00112437|10827944|FG016|STARTED|Year 2 (12-Month Extension)||0
9728285|NCT00112437|10827945|FG017|STARTED|Year 2 (12-Month Extension)||0
9728286|NCT00112437|10827946|FG018|STARTED|Year 2 (12-Month Extension)||0
9728287|NCT00112437|10827947|FG019|STARTED|Year 2 (12-Month Extension)||0
9728288|NCT00112437|10827948|FG020|STARTED|Year 2 (12-Month Extension)||0
9728289|NCT00112437|10827949|FG021|STARTED|Year 2 (12-Month Extension)||0
9728290|NCT00112437|10827950|FG022|STARTED|Year 2 (12-Month Extension)||0
9728291|NCT00112437|10827951|FG023|STARTED|Year 2 (12-Month Extension)||0
9728292|NCT00112437|10827952|FG024|STARTED|Year 2 (12-Month Extension)||0
9728293|NCT00112437|10827953|FG025|STARTED|Year 2 (12-Month Extension)||0
9728294|NCT00112437|10827928|FG000|COMPLETED|Year 2 (12-Month Extension)||0
9728295|NCT00112437|10827929|FG001|COMPLETED|Year 2 (12-Month Extension)||0
9728296|NCT00112437|10827930|FG002|COMPLETED|Year 2 (12-Month Extension)||0
9728297|NCT00112437|10827931|FG003|COMPLETED|Year 2 (12-Month Extension)||0
9728298|NCT00112437|10827932|FG004|COMPLETED|Year 2 (12-Month Extension)||0
9728299|NCT00112437|10827933|FG005|COMPLETED|Year 2 (12-Month Extension)||60
9728300|NCT00112437|10827934|FG006|COMPLETED|Year 2 (12-Month Extension)||53
9728301|NCT00112437|10827935|FG007|COMPLETED|Year 2 (12-Month Extension)||55
9728302|NCT00112437|10827936|FG008|COMPLETED|Year 2 (12-Month Extension)||62
9728303|NCT00112437|10827937|FG009|COMPLETED|Year 2 (12-Month Extension)||50
9728304|NCT00112437|10827938|FG010|COMPLETED|Year 2 (12-Month Extension)||0
9728305|NCT00112437|10827939|FG011|COMPLETED|Year 2 (12-Month Extension)||0
9728306|NCT00112437|10827940|FG012|COMPLETED|Year 2 (12-Month Extension)||0
9728307|NCT00112437|10827941|FG013|COMPLETED|Year 2 (12-Month Extension)||0
9728308|NCT00112437|10827942|FG014|COMPLETED|Year 2 (12-Month Extension)||0
9728309|NCT00112437|10827943|FG015|COMPLETED|Year 2 (12-Month Extension)||0
9728310|NCT00112437|10827944|FG016|COMPLETED|Year 2 (12-Month Extension)||0
9728311|NCT00112437|10827945|FG017|COMPLETED|Year 2 (12-Month Extension)||0
9728312|NCT00112437|10827946|FG018|COMPLETED|Year 2 (12-Month Extension)||0
9728313|NCT00112437|10827947|FG019|COMPLETED|Year 2 (12-Month Extension)||0
9728314|NCT00112437|10827948|FG020|COMPLETED|Year 2 (12-Month Extension)||0
9728315|NCT00112437|10827949|FG021|COMPLETED|Year 2 (12-Month Extension)||0
9728316|NCT00112437|10827950|FG022|COMPLETED|Year 2 (12-Month Extension)||0
9728317|NCT00112437|10827951|FG023|COMPLETED|Year 2 (12-Month Extension)||0
9728318|NCT00112437|10827952|FG024|COMPLETED|Year 2 (12-Month Extension)||0
9728319|NCT00112437|10827953|FG025|COMPLETED|Year 2 (12-Month Extension)||0
9728320|NCT00112437|10827928|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0
9701576|NCT02797067|10800820|FG000|STARTED|Overall Study||685
9701577|NCT02797067|10800821|FG001|STARTED|Overall Study||685
9701578|NCT02797067|10800820|FG000|COMPLETED|Overall Study||685
9701579|NCT02797067|10800821|FG001|COMPLETED|Overall Study||685
9701580|NCT02797067|10800820|FG000|NOT COMPLETED|Overall Study||0
9701581|NCT02797067|10800821|FG001|NOT COMPLETED|Overall Study||0
9701582|NCT02787499|10800829|FG000|STARTED|Overall Study||423
9701583|NCT02787499|10800830|FG001|STARTED|Overall Study||417
9701584|NCT02787499|10800829|FG000|COMPLETED|Overall Study||423
9701585|NCT02787499|10800830|FG001|COMPLETED|Overall Study||417
9701586|NCT02787499|10800829|FG000|NOT COMPLETED|Overall Study||0
9701587|NCT02787499|10800830|FG001|NOT COMPLETED|Overall Study||0
9701588|NCT02765399|10800838|FG000|STARTED|Overall Study||16
9701589|NCT02765399|10800839|FG001|STARTED|Overall Study||7
9701590|NCT02765399|10800838|FG000|COMPLETED|Overall Study||15
9701591|NCT02765399|10800839|FG001|COMPLETED|Overall Study||7
9701592|NCT02765399|10800838|FG000|NOT COMPLETED|Overall Study||1
9701593|NCT02765399|10800839|FG001|NOT COMPLETED|Overall Study||0
9701594|NCT04529096|10800847|FG000|STARTED|Overall Study||100
9701595|NCT04529096|10800848|FG001|STARTED|Overall Study||49
9701596|NCT04529096|10800847|FG000|Received at Least 1 Dose of Study Drug|Overall Study||100
9701597|NCT04529096|10800848|FG001|Received at Least 1 Dose of Study Drug|Overall Study||49
9701598|NCT04529096|10800847|FG000|COMPLETED|Overall Study||86
9701599|NCT04529096|10800848|FG001|COMPLETED|Overall Study||43
9701600|NCT04529096|10800847|FG000|NOT COMPLETED|Overall Study||14
9701601|NCT04529096|10800848|FG001|NOT COMPLETED|Overall Study||6
9701602|NCT04468074|10800856|FG000|STARTED|Overall Study||31
9701603|NCT04468074|10800857|FG001|STARTED|Overall Study||30
9701604|NCT04468074|10800856|FG000|COMPLETED|Overall Study||30
9701605|NCT04468074|10800857|FG001|COMPLETED|Overall Study||30
9701606|NCT04468074|10800856|FG000|NOT COMPLETED|Overall Study||1
9701607|NCT04468074|10800857|FG001|NOT COMPLETED|Overall Study||0
9701608|NCT04456686|10800865|FG000|STARTED|Overall Study||78
9701609|NCT04456686|10800866|FG001|STARTED|Overall Study||39
9701610|NCT04456686|10800865|FG000|Received at Least 1 Dose of Study Drug|Overall Study||77
9701611|NCT04456686|10800866|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
9701612|NCT04456686|10800865|FG000|COMPLETED|Overall Study||63
9701613|NCT04456686|10800866|FG001|COMPLETED|Overall Study||32
9701614|NCT04456686|10800865|FG000|NOT COMPLETED|Overall Study||15
9701615|NCT04456686|10800866|FG001|NOT COMPLETED|Overall Study||7
9701616|NCT03894969|10800877|FG000|STARTED|Overall Study||134
9701617|NCT03894969|10800878|FG001|STARTED|Overall Study||134
9701618|NCT03894969|10800879|FG002|STARTED|Overall Study||122
9701619|NCT03894969|10800880|FG003|STARTED|Overall Study||135
9701620|NCT03894969|10800881|FG004|STARTED|Overall Study||16
9701621|NCT03894969|10800877|FG000|COMPLETED|Overall Study||129
9701622|NCT03894969|10800878|FG001|COMPLETED|Overall Study||129
9701623|NCT03894969|10800879|FG002|COMPLETED|Overall Study||118
9701624|NCT03894969|10800880|FG003|COMPLETED|Overall Study||128
9701625|NCT03894969|10800881|FG004|COMPLETED|Overall Study||2
9701626|NCT03894969|10800877|FG000|NOT COMPLETED|Overall Study||5
9701627|NCT03894969|10800878|FG001|NOT COMPLETED|Overall Study||5
9701628|NCT03894969|10800879|FG002|NOT COMPLETED|Overall Study||4
9701629|NCT03894969|10800880|FG003|NOT COMPLETED|Overall Study||7
9701630|NCT03894969|10800881|FG004|NOT COMPLETED|Overall Study||14
9701631|NCT03523273|10800897|FG000|STARTED|Overall Study||67
9701632|NCT03523273|10800898|FG001|STARTED|Overall Study||69
9701633|NCT03523273|10800897|FG000|COMPLETED|Overall Study||59
9701634|NCT03523273|10800898|FG001|COMPLETED|Overall Study||65
9701635|NCT03523273|10800897|FG000|NOT COMPLETED|Overall Study||8
9701636|NCT03523273|10800898|FG001|NOT COMPLETED|Overall Study||4
9701637|NCT03464136|10800906|FG000|STARTED|Overall Study||195
9701638|NCT03464136|10800907|FG001|STARTED|Overall Study||191
9701639|NCT03464136|10800906|FG000|COMPLETED|Overall Study||165
9701640|NCT03464136|10800907|FG001|COMPLETED|Overall Study||166
9701641|NCT03464136|10800906|FG000|NOT COMPLETED|Overall Study||30
9701642|NCT03464136|10800907|FG001|NOT COMPLETED|Overall Study||25
9701643|NCT03338816|10800915|FG000|STARTED|6-Month Double-blind Period||46
9701644|NCT03338816|10800916|FG001|STARTED|6-Month Double-blind Period||48
9701645|NCT03338816|10800917|FG002|STARTED|6-Month Double-blind Period||0
9701646|NCT03338816|10800918|FG003|STARTED|6-Month Double-blind Period||0
9701647|NCT03338816|10800915|FG000|COMPLETED|6-Month Double-blind Period||46
9963144|NCT01483807|11082914|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10
9701648|NCT03338816|10800916|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period due to an adverse event but completed the 6-month DB Visit|48
9701649|NCT03338816|10800917|FG002|COMPLETED|6-Month Double-blind Period||0
9701650|NCT03338816|10800918|FG003|COMPLETED|6-Month Double-blind Period||0
9701651|NCT03338816|10800915|FG000|NOT COMPLETED|6-Month Double-blind Period||0
9701652|NCT03338816|10800916|FG001|NOT COMPLETED|6-Month Double-blind Period||0
9701653|NCT03338816|10800917|FG002|NOT COMPLETED|6-Month Double-blind Period||0
9701654|NCT03338816|10800918|FG003|NOT COMPLETED|6-Month Double-blind Period||0
9701655|NCT03338816|10800915|FG000|STARTED|6-Month DB + Open-Label Extension Period||0
9701656|NCT03338816|10800916|FG001|STARTED|6-Month DB + Open-Label Extension Period||0
9701657|NCT03338816|10800917|FG002|STARTED|6-Month DB + Open-Label Extension Period||46
9701658|NCT03338816|10800918|FG003|STARTED|6-Month DB + Open-Label Extension Period||47
9701659|NCT03338816|10800915|FG000|COMPLETED|6-Month DB + Open-Label Extension Period||0
9701660|NCT03338816|10800916|FG001|COMPLETED|6-Month DB + Open-Label Extension Period||0
9701661|NCT03338816|10800917|FG002|COMPLETED|6-Month DB + Open-Label Extension Period||38
9701662|NCT03338816|10800918|FG003|COMPLETED|6-Month DB + Open-Label Extension Period||41
9701663|NCT03338816|10800915|FG000|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0
9701664|NCT03338816|10800916|FG001|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0
9701665|NCT03338816|10800917|FG002|NOT COMPLETED|6-Month DB + Open-Label Extension Period||8
9701666|NCT03338816|10800918|FG003|NOT COMPLETED|6-Month DB + Open-Label Extension Period||6
9701667|NCT03318809|10800929|FG000|STARTED|Overall Study||6
9701668|NCT03318809|10800930|FG001|STARTED|Overall Study||6
9701669|NCT03318809|10800929|FG000|COMPLETED|Overall Study||6
9701670|NCT03318809|10800930|FG001|COMPLETED|Overall Study||6
9701671|NCT03318809|10800929|FG000|NOT COMPLETED|Overall Study||0
9701672|NCT03318809|10800930|FG001|NOT COMPLETED|Overall Study||0
9701673|NCT03317496|10800940|FG000|STARTED|Phase 1b Lead-in: Treatment||6
9701674|NCT03317496|10800941|FG001|STARTED|Phase 1b Lead-in: Treatment||13
9701675|NCT03317496|10800942|FG002|STARTED|Phase 1b Lead-in: Treatment||6
9701676|NCT03317496|10800943|FG003|STARTED|Phase 1b Lead-in: Treatment||6
9701677|NCT03317496|10800944|FG004|STARTED|Phase 1b Lead-in: Treatment||0
9701678|NCT03317496|10800940|FG000|COMPLETED|Phase 1b Lead-in: Treatment||0
9701679|NCT03317496|10800941|FG001|COMPLETED|Phase 1b Lead-in: Treatment||0
9701680|NCT03317496|10800942|FG002|COMPLETED|Phase 1b Lead-in: Treatment||0
9701681|NCT03317496|10800943|FG003|COMPLETED|Phase 1b Lead-in: Treatment||0
9701682|NCT03317496|10800944|FG004|COMPLETED|Phase 1b Lead-in: Treatment||0
9963145|NCT01483807|11082913|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
9963146|NCT01483807|11082914|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
9963147|NCT01483807|11082913|FG000|STARTED|Washout (2 Weeks)||10
9963148|NCT01483807|11082914|FG001|STARTED|Washout (2 Weeks)||10
9963149|NCT01483807|11082913|FG000|COMPLETED|Washout (2 Weeks)||10
9963150|NCT01483807|11082914|FG001|COMPLETED|Washout (2 Weeks)||10
9963151|NCT01483807|11082913|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9963152|NCT01483807|11082914|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9963153|NCT01483807|11082913|FG000|STARTED|Second Treatment Phase (7 Weeks)||10
9963154|NCT01483807|11082914|FG001|STARTED|Second Treatment Phase (7 Weeks)||10
9963155|NCT01483807|11082913|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10
9963156|NCT01483807|11082914|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10
9963157|NCT01483807|11082913|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
9963158|NCT01483807|11082914|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
9963159|NCT01483924|11082927|FG000|STARTED|Overall Study||12
9963160|NCT01483924|11082928|FG001|STARTED|Overall Study||12
9963161|NCT01483924|11082929|FG002|STARTED|Overall Study||12
9963162|NCT01483924|11082930|FG003|STARTED|Overall Study||12
9963163|NCT01483924|11082931|FG004|STARTED|Overall Study||12
9963164|NCT01483924|11082927|FG000|COMPLETED|Overall Study||10
9963165|NCT01483924|11082928|FG001|COMPLETED|Overall Study||12
9963166|NCT01483924|11082929|FG002|COMPLETED|Overall Study||11
9963167|NCT01483924|11082930|FG003|COMPLETED|Overall Study||8
9963168|NCT01483924|11082931|FG004|COMPLETED|Overall Study||10
9963169|NCT01483924|11082927|FG000|NOT COMPLETED|Overall Study||2
9963170|NCT01483924|11082928|FG001|NOT COMPLETED|Overall Study||0
9963171|NCT01483924|11082929|FG002|NOT COMPLETED|Overall Study||1
9963172|NCT01483924|11082930|FG003|NOT COMPLETED|Overall Study||4
9963173|NCT01483924|11082931|FG004|NOT COMPLETED|Overall Study||2
9963174|NCT01483937|11082954|FG000|STARTED|Overall Study||15
9963175|NCT01483937|11082955|FG001|STARTED|Overall Study||17
9963176|NCT01483937|11082954|FG000|COMPLETED|Overall Study||11
9963177|NCT01483937|11082955|FG001|COMPLETED|Overall Study||14
9963178|NCT01483937|11082954|FG000|NOT COMPLETED|Overall Study||4
9963179|NCT01483937|11082955|FG001|NOT COMPLETED|Overall Study||3
9963180|NCT01483963|11082969|FG000|STARTED|Overall Study||10
9963181|NCT01483963|11082970|FG001|STARTED|Overall Study||10
9963182|NCT01483963|11082971|FG002|STARTED|Overall Study||10
9963183|NCT01483963|11082972|FG003|STARTED|Overall Study||10
9963184|NCT01483963|11082973|FG004|STARTED|Overall Study||10
9963185|NCT01483963|11082969|FG000|COMPLETED|Overall Study||10
9963186|NCT01483963|11082970|FG001|COMPLETED|Overall Study||10
9963187|NCT01483963|11082971|FG002|COMPLETED|Overall Study||10
9963188|NCT01483963|11082972|FG003|COMPLETED|Overall Study||10
9963189|NCT01483963|11082973|FG004|COMPLETED|Overall Study||10
9963190|NCT01483963|11082969|FG000|NOT COMPLETED|Overall Study||0
9963191|NCT01483963|11082970|FG001|NOT COMPLETED|Overall Study||0
9963192|NCT01483963|11082971|FG002|NOT COMPLETED|Overall Study||0
9963193|NCT01483963|11082972|FG003|NOT COMPLETED|Overall Study||0
9963194|NCT01483963|11082973|FG004|NOT COMPLETED|Overall Study||0
9963195|NCT01484028|11082986|FG000|STARTED|Period 1||66
9963196|NCT01484028|11082987|FG001|STARTED|Period 1||70
9963197|NCT01484028|11082988|FG002|STARTED|Period 1||64
9963198|NCT01484028|11082989|FG003|STARTED|Period 1||67
9963199|NCT01484028|11082986|FG000|COMPLETED|Period 1||66
9963200|NCT01484028|11082987|FG001|COMPLETED|Period 1||67
9963201|NCT01484028|11082988|FG002|COMPLETED|Period 1||64
9963202|NCT01484028|11082989|FG003|COMPLETED|Period 1||66
9963203|NCT01484028|11082986|FG000|NOT COMPLETED|Period 1||0
9963204|NCT01484028|11082987|FG001|NOT COMPLETED|Period 1||3
9963205|NCT01484028|11082988|FG002|NOT COMPLETED|Period 1||0
9963206|NCT01484028|11082989|FG003|NOT COMPLETED|Period 1||1
9963207|NCT01484028|11082986|FG000|STARTED|Period 2||66
9963208|NCT01484028|11082987|FG001|STARTED|Period 2||67
9963209|NCT01484028|11082988|FG002|STARTED|Period 2||64
9963210|NCT01484028|11082989|FG003|STARTED|Period 2||66
9701683|NCT03317496|10800940|FG000|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
9701684|NCT03317496|10800941|FG001|NOT COMPLETED|Phase 1b Lead-in: Treatment||13
9701685|NCT03317496|10800942|FG002|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
9701686|NCT03317496|10800943|FG003|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
9701687|NCT03317496|10800944|FG004|NOT COMPLETED|Phase 1b Lead-in: Treatment||0
9701688|NCT03317496|10800940|FG000|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|4
9701689|NCT03317496|10800941|FG001|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|11
9701690|NCT03317496|10800942|FG002|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|5
9701691|NCT03317496|10800943|FG003|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|4
9701692|NCT03317496|10800944|FG004|STARTED|Phase 1b Lead-in: Follow-up||0
9701693|NCT03317496|10800940|FG000|COMPLETED|Phase 1b Lead-in: Follow-up||0
9701694|NCT03317496|10800941|FG001|COMPLETED|Phase 1b Lead-in: Follow-up||0
9701695|NCT03317496|10800942|FG002|COMPLETED|Phase 1b Lead-in: Follow-up||0
9701696|NCT03317496|10800943|FG003|COMPLETED|Phase 1b Lead-in: Follow-up||0
9701697|NCT03317496|10800944|FG004|COMPLETED|Phase 1b Lead-in: Follow-up||0
9701698|NCT03317496|10800940|FG000|NOT COMPLETED|Phase 1b Lead-in: Follow-up||4
9701699|NCT03317496|10800941|FG001|NOT COMPLETED|Phase 1b Lead-in: Follow-up||11
9701700|NCT03317496|10800942|FG002|NOT COMPLETED|Phase 1b Lead-in: Follow-up||5
9701701|NCT03317496|10800943|FG003|NOT COMPLETED|Phase 1b Lead-in: Follow-up||4
9701702|NCT03317496|10800944|FG004|NOT COMPLETED|Phase 1b Lead-in: Follow-up||0
9701703|NCT03317496|10800940|FG000|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 800 mg + Pemetrexed/Carboplatin did not enter Phase 2.|0
9701704|NCT03317496|10800941|FG001|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 800 mg + Gemcitabine/Cisplatin did not enter Phase 2.|0
9701705|NCT03317496|10800942|FG002|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 1200 mg + Pemetrexed/Carboplatin did not enter Phase 2.|0
9701706|NCT03317496|10800943|FG003|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 1200 mg + Gemcitabine/Cisplatin did not enter Phase 2.|0
9701707|NCT03317496|10800944|FG004|STARTED|Phase 2: Treatment|Additional participants were enrolled in Phase 2.|35
9701708|NCT03317496|10800940|FG000|COMPLETED|Phase 2: Treatment||0
9701709|NCT03317496|10800941|FG001|COMPLETED|Phase 2: Treatment||0
9701710|NCT03317496|10800942|FG002|COMPLETED|Phase 2: Treatment||0
9701711|NCT03317496|10800943|FG003|COMPLETED|Phase 2: Treatment||0
9701712|NCT03317496|10800944|FG004|COMPLETED|Phase 2: Treatment||0
9701713|NCT03317496|10800940|FG000|NOT COMPLETED|Phase 2: Treatment||0
9701714|NCT03317496|10800941|FG001|NOT COMPLETED|Phase 2: Treatment||0
9701715|NCT03317496|10800942|FG002|NOT COMPLETED|Phase 2: Treatment||0
9701716|NCT03317496|10800943|FG003|NOT COMPLETED|Phase 2: Treatment||0
9701717|NCT03317496|10800944|FG004|NOT COMPLETED|Phase 2: Treatment||35
9701718|NCT03317496|10800940|FG000|STARTED|Phase 2: Follow-up||0
9701719|NCT03317496|10800941|FG001|STARTED|Phase 2: Follow-up||0
9701720|NCT03317496|10800942|FG002|STARTED|Phase 2: Follow-up||0
9701721|NCT03317496|10800943|FG003|STARTED|Phase 2: Follow-up||0
9701722|NCT03317496|10800944|FG004|STARTED|Phase 2: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|25
9701723|NCT03317496|10800940|FG000|COMPLETED|Phase 2: Follow-up||0
9701724|NCT03317496|10800941|FG001|COMPLETED|Phase 2: Follow-up||0
9701725|NCT03317496|10800942|FG002|COMPLETED|Phase 2: Follow-up||0
9701726|NCT03317496|10800943|FG003|COMPLETED|Phase 2: Follow-up||0
9701727|NCT03317496|10800944|FG004|COMPLETED|Phase 2: Follow-up||0
9701728|NCT03317496|10800940|FG000|NOT COMPLETED|Phase 2: Follow-up||0
9701729|NCT03317496|10800941|FG001|NOT COMPLETED|Phase 2: Follow-up||0
9701730|NCT03317496|10800942|FG002|NOT COMPLETED|Phase 2: Follow-up||0
9701731|NCT03317496|10800943|FG003|NOT COMPLETED|Phase 2: Follow-up||0
9701732|NCT03317496|10800944|FG004|NOT COMPLETED|Phase 2: Follow-up||25
9701733|NCT03260894|10800957|FG000|STARTED|Overall Study||64
9701734|NCT03260894|10800958|FG001|STARTED|Overall Study||65
9701735|NCT03260894|10800957|FG000|Intention-to-Treat (ITT)|Overall Study||64
9701736|NCT03260894|10800958|FG001|Intention-to-Treat (ITT)|Overall Study||65
9701737|NCT03260894|10800957|FG000|All Subjects as Treated (ASaT)|Overall Study||64
9701738|NCT03260894|10800958|FG001|All Subjects as Treated (ASaT)|Overall Study||63
9701739|NCT03260894|10800957|FG000|COMPLETED|Overall Study||18
9701740|NCT03260894|10800958|FG001|COMPLETED|Overall Study||15
9701741|NCT03260894|10800957|FG000|NOT COMPLETED|Overall Study||46
9701742|NCT03260894|10800958|FG001|NOT COMPLETED|Overall Study||50
9701743|NCT03215810|10800964|FG000|STARTED|Overall Study||20
9701744|NCT03215810|10800964|FG000|COMPLETED|Overall Study||16
9701745|NCT03215810|10800964|FG000|NOT COMPLETED|Overall Study||4
9701746|NCT03123822|10800971|FG000|STARTED|Overall Study||1
9701747|NCT03123822|10800972|FG001|STARTED|Overall Study||1
9701748|NCT03123822|10800973|FG002|STARTED|Overall Study||3
9701749|NCT03123822|10800971|FG000|COMPLETED|Overall Study||1
9701750|NCT03123822|10800972|FG001|COMPLETED|Overall Study||1
9701751|NCT03123822|10800973|FG002|COMPLETED|Overall Study||3
9701752|NCT03123822|10800971|FG000|NOT COMPLETED|Overall Study||0
9701753|NCT03123822|10800972|FG001|NOT COMPLETED|Overall Study||0
9701754|NCT03123822|10800973|FG002|NOT COMPLETED|Overall Study||0
9701755|NCT03067129|10800985|FG000|STARTED|Overall Study||47
9701756|NCT03067129|10800986|FG001|STARTED|Overall Study||29
9701757|NCT03067129|10800987|FG002|STARTED|Overall Study||27
9701758|NCT03067129|10800988|FG003|STARTED|Overall Study||24
9701759|NCT03067129|10800985|FG000|COMPLETED|Overall Study||2
9701760|NCT03067129|10800986|FG001|COMPLETED|Overall Study||1
9701761|NCT03067129|10800987|FG002|COMPLETED|Overall Study||0
9701762|NCT03067129|10800988|FG003|COMPLETED|Overall Study||0
9701763|NCT03067129|10800985|FG000|NOT COMPLETED|Overall Study||45
9701764|NCT03067129|10800986|FG001|NOT COMPLETED|Overall Study||28
9701765|NCT03067129|10800987|FG002|NOT COMPLETED|Overall Study||27
9701766|NCT03067129|10800988|FG003|NOT COMPLETED|Overall Study||24
9701767|NCT03053102|10801006|FG000|STARTED|Study Part 1: 28-Day Treatment||10
9701768|NCT03053102|10801006|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
9701769|NCT03053102|10801006|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10
9701770|NCT03053102|10801006|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
9701771|NCT03053102|10801006|FG000|STARTED|Study Part 2: 84-Day Treatment||10
9701772|NCT03053102|10801006|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8
9701773|NCT03053102|10801006|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
9963211|NCT01484028|11082986|FG000|COMPLETED|Period 2||66
9963212|NCT01484028|11082987|FG001|COMPLETED|Period 2||67
9963213|NCT01484028|11082988|FG002|COMPLETED|Period 2||64
9963214|NCT01484028|11082989|FG003|COMPLETED|Period 2||66
9963215|NCT01484028|11082986|FG000|NOT COMPLETED|Period 2||0
9963216|NCT01484028|11082987|FG001|NOT COMPLETED|Period 2||0
9963217|NCT01484028|11082988|FG002|NOT COMPLETED|Period 2||0
9963218|NCT01484028|11082989|FG003|NOT COMPLETED|Period 2||0
9963219|NCT01484041|11082997|FG000|STARTED|Overall Study||12
9963220|NCT01484041|11082997|FG000|COMPLETED|Overall Study||12
9963221|NCT01484041|11082997|FG000|NOT COMPLETED|Overall Study||0
9963222|NCT01484054|11083001|FG000|STARTED|Period 1||50
9963223|NCT01484054|11083002|FG001|STARTED|Period 1||50
9963224|NCT01484054|11083001|FG000|COMPLETED|Period 1||50
9963225|NCT01484054|11083002|FG001|COMPLETED|Period 1||49
9963226|NCT01484054|11083001|FG000|NOT COMPLETED|Period 1||0
9963227|NCT01484054|11083002|FG001|NOT COMPLETED|Period 1||1
9963228|NCT01484054|11083001|FG000|STARTED|Period 2||50
9963229|NCT01484054|11083002|FG001|STARTED|Period 2||49
9963230|NCT01484054|11083001|FG000|COMPLETED|Period 2||50
9963231|NCT01484054|11083002|FG001|COMPLETED|Period 2||49
9963232|NCT01484054|11083001|FG000|NOT COMPLETED|Period 2||0
9963233|NCT01484054|11083002|FG001|NOT COMPLETED|Period 2||0
9963234|NCT01484132|11083009|FG000|STARTED|Overall Study||113
9963235|NCT01484132|11083009|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
9963236|NCT01484132|11083009|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
9963237|NCT01484132|11083009|FG000|NOT COMPLETED|Overall Study||22
9963238|NCT01484197|11083013|FG000|STARTED|Treatment Period 1||9
9963239|NCT01484197|11083014|FG001|STARTED|Treatment Period 1||9
9963240|NCT01484197|11083015|FG002|STARTED|Treatment Period 1||9
9963241|NCT01484197|11083016|FG003|STARTED|Treatment Period 1||9
9963242|NCT01484197|11083013|FG000|COMPLETED|Treatment Period 1||8
9963243|NCT01484197|11083014|FG001|COMPLETED|Treatment Period 1||9
9963244|NCT01484197|11083015|FG002|COMPLETED|Treatment Period 1||9
9963245|NCT01484197|11083016|FG003|COMPLETED|Treatment Period 1||9
9963246|NCT01484197|11083013|FG000|NOT COMPLETED|Treatment Period 1||1
9963247|NCT01484197|11083014|FG001|NOT COMPLETED|Treatment Period 1||0
9963248|NCT01484197|11083015|FG002|NOT COMPLETED|Treatment Period 1||0
9963249|NCT01484197|11083016|FG003|NOT COMPLETED|Treatment Period 1||0
9963250|NCT01484197|11083013|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
9963251|NCT01484197|11083014|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
9963252|NCT01484197|11083015|FG002|STARTED|Treatment Period 2||9
9963253|NCT01484197|11083016|FG003|STARTED|Treatment Period 2||9
9963254|NCT01484197|11083013|FG000|COMPLETED|Treatment Period 2||7
9963255|NCT01484197|11083014|FG001|COMPLETED|Treatment Period 2||8
9963256|NCT01484197|11083015|FG002|COMPLETED|Treatment Period 2||9
9963257|NCT01484197|11083016|FG003|COMPLETED|Treatment Period 2||8
9963258|NCT01484197|11083013|FG000|NOT COMPLETED|Treatment Period 2||0
9963259|NCT01484197|11083014|FG001|NOT COMPLETED|Treatment Period 2||0
9963260|NCT01484197|11083015|FG002|NOT COMPLETED|Treatment Period 2||0
9963261|NCT01484197|11083016|FG003|NOT COMPLETED|Treatment Period 2||1
9963262|NCT01484197|11083013|FG000|STARTED|Treatment Period 3||7
9963263|NCT01484197|11083014|FG001|STARTED|Treatment Period 3||8
9963264|NCT01484197|11083015|FG002|STARTED|Treatment Period 3||9
9963265|NCT01484197|11083016|FG003|STARTED|Treatment Period 3||8
9963266|NCT01484197|11083013|FG000|COMPLETED|Treatment Period 3||7
9963267|NCT01484197|11083014|FG001|COMPLETED|Treatment Period 3||8
9963268|NCT01484197|11083015|FG002|COMPLETED|Treatment Period 3||9
9963269|NCT01484197|11083016|FG003|COMPLETED|Treatment Period 3||8
9963270|NCT01484197|11083013|FG000|NOT COMPLETED|Treatment Period 3||0
9963271|NCT01484197|11083014|FG001|NOT COMPLETED|Treatment Period 3||0
9963272|NCT01484197|11083015|FG002|NOT COMPLETED|Treatment Period 3||0
9701774|NCT02964078|10801011|FG000|STARTED|Overall Study||27
9963273|NCT01484197|11083016|FG003|NOT COMPLETED|Treatment Period 3||0
9963274|NCT01484197|11083013|FG000|STARTED|Treatment Period 4||7
9963275|NCT01484197|11083014|FG001|STARTED|Treatment Period 4||8
9963276|NCT01484197|11083015|FG002|STARTED|Treatment Period 4||9
9963277|NCT01484197|11083016|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
9963278|NCT01484197|11083013|FG000|COMPLETED|Treatment Period 4||7
9963279|NCT01484197|11083014|FG001|COMPLETED|Treatment Period 4||8
9701775|NCT02964078|10801011|FG000|COMPLETED|Overall Study||27
9701776|NCT02964078|10801011|FG000|NOT COMPLETED|Overall Study||0
9701777|NCT02937818|10801019|FG000|STARTED|Overall Study||21
9701778|NCT02937818|10801020|FG001|STARTED|Overall Study||20
9701779|NCT02937818|10801021|FG002|STARTED|Overall Study||10
9701780|NCT02937818|10801022|FG003|STARTED|Overall Study||21
9701781|NCT02937818|10801019|FG000|COMPLETED|Overall Study||0
9701782|NCT02937818|10801020|FG001|COMPLETED|Overall Study||0
9701783|NCT02937818|10801021|FG002|COMPLETED|Overall Study||0
9701784|NCT02937818|10801022|FG003|COMPLETED|Overall Study||0
9701785|NCT02937818|10801019|FG000|NOT COMPLETED|Overall Study||21
9701786|NCT02937818|10801020|FG001|NOT COMPLETED|Overall Study||20
9701787|NCT02937818|10801021|FG002|NOT COMPLETED|Overall Study||10
9701788|NCT02937818|10801022|FG003|NOT COMPLETED|Overall Study||21
9701789|NCT02920476|10801035|FG000|STARTED|Overall Study||4
9701790|NCT02920476|10801035|FG000|COMPLETED|Overall Study||3
9701791|NCT02920476|10801035|FG000|NOT COMPLETED|Overall Study||1
9701792|NCT02875860|10801041|FG000|STARTED|Overall Study||2
9701793|NCT02875860|10801042|FG001|STARTED|Overall Study||3
9701794|NCT02875860|10801041|FG000|COMPLETED|Overall Study||2
9701795|NCT02875860|10801042|FG001|COMPLETED|Overall Study||2
9701796|NCT02875860|10801041|FG000|NOT COMPLETED|Overall Study||0
9701797|NCT02875860|10801042|FG001|NOT COMPLETED|Overall Study||1
9701798|NCT02833844|10801050|FG000|STARTED|Double-Blind Period||157
9701799|NCT02833844|10801051|FG001|STARTED|Double-Blind Period||310
9701800|NCT02833844|10801050|FG000|Randomized and Treated|Double-Blind Period||157
9701801|NCT02833844|10801051|FG001|Randomized and Treated|Double-Blind Period||307
9701802|NCT02833844|10801050|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155
9701803|NCT02833844|10801051|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303
9701804|NCT02833844|10801050|FG000|NOT COMPLETED|Double-Blind Period||2
9701805|NCT02833844|10801051|FG001|NOT COMPLETED|Double-Blind Period||7
9701806|NCT02833844|10801050|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
9701807|NCT02833844|10801051|FG001|STARTED|Open-Label Period||303
9701808|NCT02833844|10801050|FG000|Received Open-Label Study Drug|Open-Label Period||152
9701809|NCT02833844|10801051|FG001|Received Open-Label Study Drug|Open-Label Period||299
9701810|NCT02833844|10801050|FG000|COMPLETED|Open-Label Period||150
9701811|NCT02833844|10801051|FG001|COMPLETED|Open-Label Period||301
9701812|NCT02833844|10801050|FG000|NOT COMPLETED|Open-Label Period||2
9701813|NCT02833844|10801051|FG001|NOT COMPLETED|Open-Label Period||2
9701814|NCT02779855|10801062|FG000|STARTED|Overall Study||4
9701815|NCT02779855|10801063|FG001|STARTED|Overall Study||6
9701816|NCT02779855|10801064|FG002|STARTED|Overall Study||40
9701817|NCT02779855|10801062|FG000|COMPLETED|Overall Study||3
9701818|NCT02779855|10801063|FG001|COMPLETED|Overall Study||6
9701819|NCT02779855|10801064|FG002|COMPLETED|Overall Study||40
9701820|NCT02779855|10801062|FG000|NOT COMPLETED|Overall Study||1
9701821|NCT02779855|10801063|FG001|NOT COMPLETED|Overall Study||0
9701822|NCT02779855|10801064|FG002|NOT COMPLETED|Overall Study||0
9701823|NCT02663271|10801073|FG000|STARTED|Overall Study||9
9701824|NCT02663271|10801073|FG000|COMPLETED|Overall Study||3
9701825|NCT02663271|10801073|FG000|NOT COMPLETED|Overall Study||6
9701826|NCT02633267|10801079|FG000|STARTED|Overall Study||120
9701827|NCT02633267|10801080|FG001|STARTED|Overall Study||130
9701828|NCT02633267|10801079|FG000|COMPLETED|Overall Study||89
9701829|NCT02633267|10801080|FG001|COMPLETED|Overall Study||91
9701830|NCT02633267|10801079|FG000|NOT COMPLETED|Overall Study||31
9701831|NCT02633267|10801080|FG001|NOT COMPLETED|Overall Study||39
9701832|NCT02573493|10801090|FG000|STARTED|Overall Study||40
9701833|NCT02573493|10801091|FG001|STARTED|Overall Study||40
9701834|NCT02573493|10801092|FG002|STARTED|Overall Study||15
9701835|NCT02573493|10801093|FG003|STARTED|Overall Study||1
9701836|NCT02573493|10801090|FG000|COMPLETED|Overall Study||40
10026852|NCT02876835|11151029|FG001|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
10026853|NCT02876835|11151028|FG000|STARTED|Treatment Period (51.1 Month)||1937
10026854|NCT02876835|11151029|FG001|STARTED|Treatment Period (51.1 Month)||1935
9701837|NCT02573493|10801091|FG001|COMPLETED|Overall Study||40
9701838|NCT02573493|10801092|FG002|COMPLETED|Overall Study||15
9701839|NCT02573493|10801093|FG003|COMPLETED|Overall Study||0
9701840|NCT02573493|10801090|FG000|NOT COMPLETED|Overall Study||0
9701841|NCT02573493|10801091|FG001|NOT COMPLETED|Overall Study||0
9701842|NCT02573493|10801092|FG002|NOT COMPLETED|Overall Study||0
9701843|NCT02573493|10801093|FG003|NOT COMPLETED|Overall Study||1
9701844|NCT02414607|10801119|FG000|STARTED|Overall Study||11
9701845|NCT02414607|10801120|FG001|STARTED|Overall Study||13
9701846|NCT02414607|10801119|FG000|COMPLETED|Overall Study||9
9701847|NCT02414607|10801120|FG001|COMPLETED|Overall Study||11
9701848|NCT02414607|10801119|FG000|NOT COMPLETED|Overall Study||2
9701849|NCT02414607|10801120|FG001|NOT COMPLETED|Overall Study||2
9701850|NCT02279173|10801126|FG000|STARTED|Overall Study||203
9701851|NCT02279173|10801126|FG000|Received Treatment|Overall Study||203
9701852|NCT02279173|10801126|FG000|Enrolled Under Protocol Supplement|Overall Study||79
9701853|NCT02279173|10801126|FG000|COMPLETED|Overall Study||109
9701854|NCT02279173|10801126|FG000|NOT COMPLETED|Overall Study||94
9701855|NCT02258451|10801134|FG000|STARTED|Overall Study||142
9701856|NCT02258451|10801135|FG001|STARTED|Overall Study||141
9701857|NCT02258451|10801134|FG000|COMPLETED|Overall Study||0
9701858|NCT02258451|10801135|FG001|COMPLETED|Overall Study||0
9701859|NCT02258451|10801134|FG000|NOT COMPLETED|Overall Study||142
9701860|NCT02258451|10801135|FG001|NOT COMPLETED|Overall Study||141
9701861|NCT02186834|10801143|FG000|STARTED|Dose Escalation||6
9701862|NCT02186834|10801144|FG001|STARTED|Dose Escalation||3
9701863|NCT02186834|10801145|FG002|STARTED|Dose Escalation||0
9701864|NCT02186834|10801146|FG003|STARTED|Dose Escalation||7
9701865|NCT02186834|10801147|FG004|STARTED|Dose Escalation||4
9701866|NCT02186834|10801148|FG005|STARTED|Dose Escalation||0
9701867|NCT02186834|10801143|FG000|COMPLETED|Dose Escalation||6
9701868|NCT02186834|10801144|FG001|COMPLETED|Dose Escalation||3
9701869|NCT02186834|10801145|FG002|COMPLETED|Dose Escalation||0
9701870|NCT02186834|10801146|FG003|COMPLETED|Dose Escalation||6
9701871|NCT02186834|10801147|FG004|COMPLETED|Dose Escalation||4
9701872|NCT02186834|10801148|FG005|COMPLETED|Dose Escalation||0
9701873|NCT02186834|10801143|FG000|NOT COMPLETED|Dose Escalation||0
9701874|NCT02186834|10801144|FG001|NOT COMPLETED|Dose Escalation||0
9701875|NCT02186834|10801145|FG002|NOT COMPLETED|Dose Escalation||0
9701876|NCT02186834|10801146|FG003|NOT COMPLETED|Dose Escalation||1
9701877|NCT02186834|10801147|FG004|NOT COMPLETED|Dose Escalation||0
9701878|NCT02186834|10801148|FG005|NOT COMPLETED|Dose Escalation||0
9701879|NCT02186834|10801143|FG000|STARTED|Treatment at RP2D||0
9701880|NCT02186834|10801144|FG001|STARTED|Treatment at RP2D||0
9701881|NCT02186834|10801145|FG002|STARTED|Treatment at RP2D||0
9701882|NCT02186834|10801146|FG003|STARTED|Treatment at RP2D||0
9701883|NCT02186834|10801147|FG004|STARTED|Treatment at RP2D||0
9701884|NCT02186834|10801148|FG005|STARTED|Treatment at RP2D||14
9701885|NCT02186834|10801143|FG000|COMPLETED|Treatment at RP2D||0
9701886|NCT02186834|10801144|FG001|COMPLETED|Treatment at RP2D||0
9701887|NCT02186834|10801145|FG002|COMPLETED|Treatment at RP2D||0
9701888|NCT02186834|10801146|FG003|COMPLETED|Treatment at RP2D||0
9701889|NCT02186834|10801147|FG004|COMPLETED|Treatment at RP2D||0
9701890|NCT02186834|10801148|FG005|COMPLETED|Treatment at RP2D||13
9701891|NCT02186834|10801143|FG000|NOT COMPLETED|Treatment at RP2D||0
9701892|NCT02186834|10801144|FG001|NOT COMPLETED|Treatment at RP2D||0
9701893|NCT02186834|10801145|FG002|NOT COMPLETED|Treatment at RP2D||0
9701894|NCT02186834|10801146|FG003|NOT COMPLETED|Treatment at RP2D||0
9701895|NCT02186834|10801147|FG004|NOT COMPLETED|Treatment at RP2D||0
9701896|NCT02186834|10801148|FG005|NOT COMPLETED|Treatment at RP2D||1
9701897|NCT02163733|10801159|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18
9701898|NCT02163733|10801160|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20
9701899|NCT02163733|10801161|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0
9701900|NCT02163733|10801159|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
9701901|NCT02163733|10801160|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
9701902|NCT02163733|10801161|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
9701903|NCT02163733|10801159|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
9701904|NCT02163733|10801160|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
9963280|NCT01484197|11083015|FG002|COMPLETED|Treatment Period 4||9
9963281|NCT01484197|11083016|FG003|COMPLETED|Treatment Period 4||6
9963282|NCT01484197|11083013|FG000|NOT COMPLETED|Treatment Period 4||0
9963283|NCT01484197|11083014|FG001|NOT COMPLETED|Treatment Period 4||0
9963284|NCT01484197|11083015|FG002|NOT COMPLETED|Treatment Period 4||0
9963285|NCT01484197|11083016|FG003|NOT COMPLETED|Treatment Period 4||0
9963286|NCT01484275|11083028|FG000|STARTED|Overall Study||43
9963287|NCT01484275|11083029|FG001|STARTED|Overall Study||42
9963288|NCT01484275|11083028|FG000|COMPLETED|Overall Study||0
9963289|NCT01484275|11083029|FG001|COMPLETED|Overall Study||0
9963290|NCT01484275|11083028|FG000|NOT COMPLETED|Overall Study||43
9963291|NCT01484275|11083029|FG001|NOT COMPLETED|Overall Study||42
9963292|NCT01484288|11083035|FG000|STARTED|Overall Study||11
9963293|NCT01484288|11083035|FG000|COMPLETED|Overall Study||11
9963294|NCT01484288|11083035|FG000|NOT COMPLETED|Overall Study||0
9963295|NCT01484340|11083041|FG000|STARTED|Overall Study||281
9963296|NCT01484340|11083042|FG001|STARTED|Overall Study||279
9963297|NCT01484340|11083041|FG000|COMPLETED|Overall Study||281
9963298|NCT01484340|11083042|FG001|COMPLETED|Overall Study||279
9963299|NCT01484340|11083041|FG000|NOT COMPLETED|Overall Study||0
9963300|NCT01484340|11083042|FG001|NOT COMPLETED|Overall Study||0
9963301|NCT01484431|11083051|FG000|STARTED|Period 1: Low Dose||6
9963302|NCT01484431|11083052|FG001|STARTED|Period 1: Low Dose||7
9963303|NCT01484431|11083053|FG002|STARTED|Period 1: Low Dose||6
9963304|NCT01484431|11083051|FG000|Received 2 mg|Period 1: Low Dose||1
9963305|NCT01484431|11083052|FG001|Received 2 mg|Period 1: Low Dose||0
9963306|NCT01484431|11083053|FG002|Received 2 mg|Period 1: Low Dose||0
9963307|NCT01484431|11083051|FG000|Received 4 mg|Period 1: Low Dose||5
9963308|NCT01484431|11083052|FG001|Received 4 mg|Period 1: Low Dose||0
9963309|NCT01484431|11083053|FG002|Received 4 mg|Period 1: Low Dose||0
9701905|NCT02163733|10801161|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
9701906|NCT02163733|10801159|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18
9701907|NCT02163733|10801160|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20
9701908|NCT02163733|10801161|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0
9701909|NCT02163733|10801159|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
9701910|NCT02163733|10801160|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
9701911|NCT02163733|10801161|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
9701912|NCT02163733|10801159|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
9701913|NCT02163733|10801160|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
9963310|NCT01484431|11083051|FG000|Received 5 mg|Period 1: Low Dose||0
9963311|NCT01484431|11083052|FG001|Received 5 mg|Period 1: Low Dose||7
9963312|NCT01484431|11083053|FG002|Received 5 mg|Period 1: Low Dose||0
9963313|NCT01484431|11083051|FG000|Received 10 mg|Period 1: Low Dose||0
9963314|NCT01484431|11083052|FG001|Received 10 mg|Period 1: Low Dose||0
9963315|NCT01484431|11083053|FG002|Received 10 mg|Period 1: Low Dose||6
9701914|NCT02163733|10801161|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
9701915|NCT02163733|10801159|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
9701916|NCT02163733|10801160|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
9701917|NCT02163733|10801161|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
9701918|NCT02163733|10801159|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
9701919|NCT02163733|10801160|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
9701920|NCT02163733|10801161|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
9701921|NCT02163733|10801159|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
9701922|NCT02163733|10801160|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
9701923|NCT02163733|10801161|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
9701924|NCT01844505|10801171|FG000|STARTED|Overall Study||313
9701925|NCT01844505|10801172|FG001|STARTED|Overall Study||313
9701926|NCT01844505|10801173|FG002|STARTED|Overall Study||311
9701927|NCT01844505|10801171|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
9701928|NCT01844505|10801172|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
9701929|NCT01844505|10801173|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
9701930|NCT01844505|10801171|FG000|NOT COMPLETED|Overall Study||249
9701931|NCT01844505|10801172|FG001|NOT COMPLETED|Overall Study||269
9701932|NCT01844505|10801173|FG002|NOT COMPLETED|Overall Study||295
9701933|NCT01781390|10801184|FG000|STARTED|Overall Study||35
9701934|NCT01781390|10801185|FG001|STARTED|Overall Study||35
9701935|NCT01781390|10801186|FG002|STARTED|Overall Study||36
9701936|NCT01781390|10801184|FG000|COMPLETED|Overall Study||32
9701937|NCT01781390|10801185|FG001|COMPLETED|Overall Study||28
9701938|NCT01781390|10801186|FG002|COMPLETED|Overall Study||32
9701939|NCT01781390|10801184|FG000|NOT COMPLETED|Overall Study||3
9701940|NCT01781390|10801185|FG001|NOT COMPLETED|Overall Study||7
9701941|NCT01781390|10801186|FG002|NOT COMPLETED|Overall Study||4
9701942|NCT01701674|10801194|FG000|STARTED|Overall Study||13
9701943|NCT01701674|10801194|FG000|COMPLETED|Overall Study||12
9701944|NCT01701674|10801194|FG000|NOT COMPLETED|Overall Study||1
9701945|NCT01640301|10801200|FG000|STARTED|Overall Study||13
9701946|NCT01640301|10801201|FG001|STARTED|Overall Study||15
9701947|NCT01640301|10801200|FG000|COMPLETED|Overall Study||13
9701948|NCT01640301|10801201|FG001|COMPLETED|Overall Study||7
9701949|NCT01640301|10801200|FG000|NOT COMPLETED|Overall Study||0
9701950|NCT01640301|10801201|FG001|NOT COMPLETED|Overall Study||8
9701951|NCT01575860|10801209|FG000|STARTED|Overall Study||8
9701952|NCT01575860|10801209|FG000|COMPLETED|Overall Study||6
9701953|NCT01575860|10801209|FG000|NOT COMPLETED|Overall Study||2
9701954|NCT01402908|10801216|FG000|STARTED|Overall Study||258
9701955|NCT01402908|10801217|FG001|STARTED|Overall Study||261
9701956|NCT01402908|10801216|FG000|COMPLETED|Overall Study||224
9701957|NCT01402908|10801217|FG001|COMPLETED|Overall Study||243
9701958|NCT01402908|10801216|FG000|NOT COMPLETED|Overall Study||34
9701959|NCT01402908|10801217|FG001|NOT COMPLETED|Overall Study||18
9701960|NCT01397201|10801228|FG000|STARTED|Overall Study||6
9701961|NCT01397201|10801229|FG001|STARTED|Overall Study||6
9701962|NCT01397201|10801230|FG002|STARTED|Overall Study||6
9701963|NCT01397201|10801231|FG003|STARTED|Overall Study||7
9701964|NCT01397201|10801232|FG004|STARTED|Overall Study||5
9701965|NCT01397201|10801228|FG000|Treated|Overall Study||6
9701966|NCT01397201|10801229|FG001|Treated|Overall Study||6
9701967|NCT01397201|10801230|FG002|Treated|Overall Study||5
9701968|NCT01397201|10801231|FG003|Treated|Overall Study||7
9701969|NCT01397201|10801232|FG004|Treated|Overall Study||5
9701970|NCT01397201|10801228|FG000|COMPLETED|Overall Study||1
9701971|NCT01397201|10801229|FG001|COMPLETED|Overall Study||0
9701972|NCT01397201|10801230|FG002|COMPLETED|Overall Study||0
9701973|NCT01397201|10801231|FG003|COMPLETED|Overall Study||2
9701974|NCT01397201|10801232|FG004|COMPLETED|Overall Study||1
9701975|NCT01397201|10801228|FG000|NOT COMPLETED|Overall Study||5
9701976|NCT01397201|10801229|FG001|NOT COMPLETED|Overall Study||6
9701977|NCT01397201|10801230|FG002|NOT COMPLETED|Overall Study||6
9701978|NCT01397201|10801231|FG003|NOT COMPLETED|Overall Study||5
9701979|NCT01397201|10801232|FG004|NOT COMPLETED|Overall Study||4
9701980|NCT01397162|10801249|FG000|STARTED|Overall Study||8
9701981|NCT01397162|10801250|FG001|STARTED|Overall Study||5
9701982|NCT01397162|10801251|FG002|STARTED|Overall Study||4
9701983|NCT01397162|10801252|FG003|STARTED|Overall Study||6
9701984|NCT01397162|10801253|FG004|STARTED|Overall Study||6
9701985|NCT01397162|10801249|FG000|COMPLETED|Overall Study||1
9701986|NCT01397162|10801250|FG001|COMPLETED|Overall Study||1
9701987|NCT01397162|10801251|FG002|COMPLETED|Overall Study||1
9701988|NCT01397162|10801252|FG003|COMPLETED|Overall Study||1
9701989|NCT01397162|10801253|FG004|COMPLETED|Overall Study||3
9701990|NCT01397162|10801249|FG000|NOT COMPLETED|Overall Study||7
9701991|NCT01397162|10801250|FG001|NOT COMPLETED|Overall Study||4
9701992|NCT01397162|10801251|FG002|NOT COMPLETED|Overall Study||3
9701993|NCT01397162|10801252|FG003|NOT COMPLETED|Overall Study||5
9701994|NCT01397162|10801253|FG004|NOT COMPLETED|Overall Study||3
9701995|NCT01396278|10801275|FG000|STARTED|Overall Study||2
9701996|NCT01396278|10801276|FG001|STARTED|Overall Study||2
9701997|NCT01396278|10801277|FG002|STARTED|Overall Study||1
9701998|NCT01396278|10801278|FG003|STARTED|Overall Study||2
9701999|NCT01396278|10801279|FG004|STARTED|Overall Study||2
9702000|NCT01396278|10801275|FG000|COMPLETED|Overall Study||0
9702001|NCT01396278|10801276|FG001|COMPLETED|Overall Study||1
9702002|NCT01396278|10801277|FG002|COMPLETED|Overall Study||0
9702003|NCT01396278|10801278|FG003|COMPLETED|Overall Study||0
9848008|NCT00856856|10960640|FG000|NOT COMPLETED|4-year Clinical Follow-up||1
9963316|NCT01484431|11083051|FG000|COMPLETED|Period 1: Low Dose||6
9963317|NCT01484431|11083052|FG001|COMPLETED|Period 1: Low Dose||7
9963318|NCT01484431|11083053|FG002|COMPLETED|Period 1: Low Dose||6
9963319|NCT01484431|11083051|FG000|NOT COMPLETED|Period 1: Low Dose||0
9963320|NCT01484431|11083052|FG001|NOT COMPLETED|Period 1: Low Dose||0
9963321|NCT01484431|11083053|FG002|NOT COMPLETED|Period 1: Low Dose||0
9963322|NCT01484431|11083051|FG000|STARTED|Period 1: High Dose||6
9963323|NCT01484431|11083052|FG001|STARTED|Period 1: High Dose||7
9963324|NCT01484431|11083053|FG002|STARTED|Period 1: High Dose||6
9963325|NCT01484431|11083051|FG000|Received 8 mg|Period 1: High Dose||1
9963326|NCT01484431|11083052|FG001|Received 8 mg|Period 1: High Dose||0
9963327|NCT01484431|11083053|FG002|Received 8 mg|Period 1: High Dose||0
9963328|NCT01484431|11083051|FG000|Received 10 mg|Period 1: High Dose||1
9963329|NCT01484431|11083052|FG001|Received 10 mg|Period 1: High Dose||1
9963330|NCT01484431|11083053|FG002|Received 10 mg|Period 1: High Dose||0
9963331|NCT01484431|11083051|FG000|Received 15 mg|Period 1: High Dose||1
9963332|NCT01484431|11083052|FG001|Received 15 mg|Period 1: High Dose||1
9963333|NCT01484431|11083053|FG002|Received 15 mg|Period 1: High Dose||0
9963334|NCT01484431|11083051|FG000|Received 20 mg|Period 1: High Dose||3
9963335|NCT01484431|11083052|FG001|Received 20 mg|Period 1: High Dose||5
9963336|NCT01484431|11083053|FG002|Received 20 mg|Period 1: High Dose||1
9963337|NCT01484431|11083051|FG000|Received 40 mg|Period 1: High Dose||0
9963338|NCT01484431|11083052|FG001|Received 40 mg|Period 1: High Dose||0
9963339|NCT01484431|11083053|FG002|Received 40 mg|Period 1: High Dose||5
9963340|NCT01484431|11083051|FG000|COMPLETED|Period 1: High Dose||6
9963341|NCT01484431|11083052|FG001|COMPLETED|Period 1: High Dose||6
9963342|NCT01484431|11083053|FG002|COMPLETED|Period 1: High Dose||6
9963343|NCT01484431|11083051|FG000|NOT COMPLETED|Period 1: High Dose||0
9963344|NCT01484431|11083052|FG001|NOT COMPLETED|Period 1: High Dose||1
9963345|NCT01484431|11083053|FG002|NOT COMPLETED|Period 1: High Dose||0
9963346|NCT01484431|11083051|FG000|STARTED|Period 2||6
9963347|NCT01484431|11083052|FG001|STARTED|Period 2||6
9963348|NCT01484431|11083053|FG002|STARTED|Period 2||6
9963349|NCT01484431|11083051|FG000|Received 7 mg|Period 2||1
9963350|NCT01484431|11083052|FG001|Received 7 mg|Period 2||0
9963351|NCT01484431|11083053|FG002|Received 7 mg|Period 2||0
9963352|NCT01484431|11083051|FG000|Received 7.5 mg|Period 2||0
9702004|NCT01396278|10801279|FG004|COMPLETED|Overall Study||0
9702005|NCT01396278|10801275|FG000|NOT COMPLETED|Overall Study||2
9848009|NCT00856856|10960640|FG000|STARTED|5-year Clinical Follow-up||100
9848010|NCT00856856|10960640|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
9848011|NCT00856856|10960640|FG000|NOT COMPLETED|5-year Clinical Follow-up||0
9848012|NCT00856908|10960651|FG000|STARTED|Overall Study||15
9848013|NCT00856908|10960652|FG001|STARTED|Overall Study||5
9848014|NCT00856908|10960651|FG000|COMPLETED|Overall Study||14
9848015|NCT00856908|10960652|FG001|COMPLETED|Overall Study||5
9848016|NCT00856908|10960651|FG000|NOT COMPLETED|Overall Study||1
9848017|NCT00856908|10960652|FG001|NOT COMPLETED|Overall Study||0
9848018|NCT00856973|10960661|FG000|STARTED|Overall Study||162
9848019|NCT00856973|10960662|FG001|STARTED|Overall Study||163
9848020|NCT00856973|10960663|FG002|STARTED|Overall Study||161
9848021|NCT00856973|10960661|FG000|COMPLETED|Overall Study||126
9848022|NCT00856973|10960662|FG001|COMPLETED|Overall Study||122
9702006|NCT01396278|10801276|FG001|NOT COMPLETED|Overall Study||1
9702007|NCT01396278|10801277|FG002|NOT COMPLETED|Overall Study||1
9702008|NCT01396278|10801278|FG003|NOT COMPLETED|Overall Study||2
9702009|NCT01396278|10801279|FG004|NOT COMPLETED|Overall Study||2
9702010|NCT00783367|10801293|FG000|STARTED|Overall Study||27
9702011|NCT00783367|10801294|FG001|STARTED|Overall Study||23
9702012|NCT00783367|10801293|FG000|COMPLETED|Overall Study||27
9702013|NCT00783367|10801294|FG001|COMPLETED|Overall Study||23
9702014|NCT00783367|10801293|FG000|NOT COMPLETED|Overall Study||0
9702015|NCT00783367|10801294|FG001|NOT COMPLETED|Overall Study||0
9702016|NCT00247728|10801303|FG000|STARTED|Overall Study||58
9702017|NCT00247728|10801304|FG001|STARTED|Overall Study||57
9702018|NCT00247728|10801305|FG002|STARTED|Overall Study||57
9702019|NCT00247728|10801303|FG000|COMPLETED|Overall Study||55
9702020|NCT00247728|10801304|FG001|COMPLETED|Overall Study||51
9702021|NCT00247728|10801305|FG002|COMPLETED|Overall Study||43
9702022|NCT00247728|10801303|FG000|NOT COMPLETED|Overall Study||3
9702023|NCT00247728|10801304|FG001|NOT COMPLETED|Overall Study||6
9702024|NCT00247728|10801305|FG002|NOT COMPLETED|Overall Study||14
9702025|NCT00130442|10801317|FG000|STARTED|Overall Study||66
9702026|NCT00130442|10801318|FG001|STARTED|Overall Study||68
9702027|NCT00130442|10801317|FG000|COMPLETED|Overall Study||65
9702028|NCT00130442|10801318|FG001|COMPLETED|Overall Study||66
9702029|NCT00130442|10801317|FG000|NOT COMPLETED|Overall Study||1
9702030|NCT00130442|10801318|FG001|NOT COMPLETED|Overall Study||2
9728321|NCT00112437|10827929|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728322|NCT00112437|10827930|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728323|NCT00112437|10827931|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728324|NCT00112437|10827932|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728325|NCT00112437|10827933|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3
9728326|NCT00112437|10827934|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9
9728327|NCT00112437|10827935|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8
9728328|NCT00112437|10827936|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7
9728329|NCT00112437|10827937|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13
9728330|NCT00112437|10827938|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728331|NCT00112437|10827939|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728332|NCT00112437|10827940|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728333|NCT00112437|10827941|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728334|NCT00112437|10827942|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728335|NCT00112437|10827943|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728336|NCT00112437|10827944|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728337|NCT00112437|10827945|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728338|NCT00112437|10827946|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728339|NCT00112437|10827947|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728340|NCT00112437|10827948|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0
10026855|NCT02876835|11151028|FG000|COMPLETED|Treatment Period (51.1 Month)||1873
10026856|NCT02876835|11151029|FG001|COMPLETED|Treatment Period (51.1 Month)||1870
10026857|NCT02876835|11151028|FG000|NOT COMPLETED|Treatment Period (51.1 Month)||64
9728341|NCT00112437|10827949|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728342|NCT00112437|10827950|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728343|NCT00112437|10827951|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728344|NCT00112437|10827952|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728345|NCT00112437|10827953|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0
9728346|NCT00112437|10827928|FG000|STARTED|Year 3 (12-Month Extension)||0
9728347|NCT00112437|10827929|FG001|STARTED|Year 3 (12-Month Extension)||0
9728348|NCT00112437|10827930|FG002|STARTED|Year 3 (12-Month Extension)||0
9728349|NCT00112437|10827931|FG003|STARTED|Year 3 (12-Month Extension)||0
9728350|NCT00112437|10827932|FG004|STARTED|Year 3 (12-Month Extension)||0
9728351|NCT00112437|10827933|FG005|STARTED|Year 3 (12-Month Extension)||0
9728352|NCT00112437|10827934|FG006|STARTED|Year 3 (12-Month Extension)||0
9728353|NCT00112437|10827935|FG007|STARTED|Year 3 (12-Month Extension)||0
9728354|NCT00112437|10827936|FG008|STARTED|Year 3 (12-Month Extension)||0
9728355|NCT00112437|10827937|FG009|STARTED|Year 3 (12-Month Extension)||0
9728356|NCT00112437|10827938|FG010|STARTED|Year 3 (12-Month Extension)||19
9728357|NCT00112437|10827939|FG011|STARTED|Year 3 (12-Month Extension)||22
9728358|NCT00112437|10827940|FG012|STARTED|Year 3 (12-Month Extension)||18
9728359|NCT00112437|10827941|FG013|STARTED|Year 3 (12-Month Extension)||17
9728360|NCT00112437|10827942|FG014|STARTED|Year 3 (12-Month Extension)||18
9728361|NCT00112437|10827943|FG015|STARTED|Year 3 (12-Month Extension)||17
9728362|NCT00112437|10827944|FG016|STARTED|Year 3 (12-Month Extension)||19
9728363|NCT00112437|10827945|FG017|STARTED|Year 3 (12-Month Extension)||21
9728364|NCT00112437|10827946|FG018|STARTED|Year 3 (12-Month Extension)||18
9728365|NCT00112437|10827947|FG019|STARTED|Year 3 (12-Month Extension)||20
9728366|NCT00112437|10827948|FG020|STARTED|Year 3 (12-Month Extension)||0
9728367|NCT00112437|10827949|FG021|STARTED|Year 3 (12-Month Extension)||0
9728368|NCT00112437|10827950|FG022|STARTED|Year 3 (12-Month Extension)||0
9728369|NCT00112437|10827951|FG023|STARTED|Year 3 (12-Month Extension)||0
9728370|NCT00112437|10827952|FG024|STARTED|Year 3 (12-Month Extension)||0
9728371|NCT00112437|10827953|FG025|STARTED|Year 3 (12-Month Extension)||0
9728372|NCT00112437|10827928|FG000|COMPLETED|Year 3 (12-Month Extension)||0
9728373|NCT00112437|10827929|FG001|COMPLETED|Year 3 (12-Month Extension)||0
9728374|NCT00112437|10827930|FG002|COMPLETED|Year 3 (12-Month Extension)||0
9728375|NCT00112437|10827931|FG003|COMPLETED|Year 3 (12-Month Extension)||0
10026858|NCT02876835|11151029|FG001|NOT COMPLETED|Treatment Period (51.1 Month)||65
9702031|NCT04539262|10801334|FG000|STARTED|Overall Study||12
9702032|NCT04539262|10801335|FG001|STARTED|Overall Study||13
9702033|NCT04539262|10801336|FG002|STARTED|Overall Study||12
9702034|NCT04539262|10801337|FG003|STARTED|Overall Study||12
9702035|NCT04539262|10801338|FG004|STARTED|Overall Study||12
9702036|NCT04539262|10801339|FG005|STARTED|Overall Study||13
9702037|NCT04539262|10801340|FG006|STARTED|Overall Study||62
9702038|NCT04539262|10801341|FG007|STARTED|Overall Study||20
9702039|NCT04539262|10801334|FG000|COMPLETED|Overall Study||12
9702040|NCT04539262|10801335|FG001|COMPLETED|Overall Study||12
9702041|NCT04539262|10801336|FG002|COMPLETED|Overall Study||11
9702042|NCT04539262|10801337|FG003|COMPLETED|Overall Study||11
9702043|NCT04539262|10801338|FG004|COMPLETED|Overall Study||12
9702044|NCT04539262|10801339|FG005|COMPLETED|Overall Study||13
9702045|NCT04539262|10801340|FG006|COMPLETED|Overall Study||61
9702046|NCT04539262|10801341|FG007|COMPLETED|Overall Study||20
9702047|NCT04539262|10801334|FG000|NOT COMPLETED|Overall Study||0
9963353|NCT01484431|11083052|FG001|Received 7.5 mg|Period 2||2
9963354|NCT01484431|11083053|FG002|Received 7.5 mg|Period 2||0
9963355|NCT01484431|11083051|FG000|Received 8 mg|Period 2||1
9963356|NCT01484431|11083052|FG001|Received 8 mg|Period 2||0
9963357|NCT01484431|11083053|FG002|Received 8 mg|Period 2||0
9963358|NCT01484431|11083051|FG000|Received 10 mg|Period 2||0
9963359|NCT01484431|11083052|FG001|Received 10 mg|Period 2||1
9963360|NCT01484431|11083053|FG002|Received 10 mg|Period 2||0
9963361|NCT01484431|11083051|FG000|Received 15 mg|Period 2||1
9963362|NCT01484431|11083052|FG001|Received 15 mg|Period 2||2
9963363|NCT01484431|11083053|FG002|Received 15 mg|Period 2||1
9963364|NCT01484431|11083051|FG000|Received 20 mg|Period 2||3
10026859|NCT02860039|11151038|FG000|STARTED|Overall Study||84
10026860|NCT02860039|11151039|FG001|STARTED|Overall Study||86
10026861|NCT02860039|11151038|FG000|Visit 1|Overall Study||84
10026862|NCT02860039|11151039|FG001|Visit 1|Overall Study||86
10026863|NCT02860039|11151038|FG000|Visit 2|Overall Study||83
10026864|NCT02860039|11151039|FG001|Visit 2|Overall Study||84
9702048|NCT04539262|10801335|FG001|NOT COMPLETED|Overall Study||1
9963365|NCT01484431|11083052|FG001|Received 20 mg|Period 2||1
9963366|NCT01484431|11083053|FG002|Received 20 mg|Period 2||4
9963367|NCT01484431|11083051|FG000|Received 40 mg|Period 2||0
9963368|NCT01484431|11083052|FG001|Received 40 mg|Period 2||0
9963369|NCT01484431|11083053|FG002|Received 40 mg|Period 2||1
9963370|NCT01484431|11083051|FG000|COMPLETED|Period 2||5
9963371|NCT01484431|11083052|FG001|COMPLETED|Period 2||5
9963372|NCT01484431|11083053|FG002|COMPLETED|Period 2||4
9963373|NCT01484431|11083051|FG000|NOT COMPLETED|Period 2||1
9963374|NCT01484431|11083052|FG001|NOT COMPLETED|Period 2||1
9963375|NCT01484431|11083053|FG002|NOT COMPLETED|Period 2||2
9963376|NCT01484496|11083068|FG000|STARTED|Period 1||280
9963377|NCT01484496|11083069|FG001|STARTED|Period 1||556
9963378|NCT01484496|11083070|FG002|STARTED|Period 1||0
9963379|NCT01484496|11083071|FG003|STARTED|Period 1||0
9963380|NCT01484496|11083068|FG000|COMPLETED|Period 1||214
9963381|NCT01484496|11083069|FG001|COMPLETED|Period 1||463
9963382|NCT01484496|11083070|FG002|COMPLETED|Period 1||0
9963383|NCT01484496|11083071|FG003|COMPLETED|Period 1||0
9963384|NCT01484496|11083068|FG000|NOT COMPLETED|Period 1||66
9963385|NCT01484496|11083069|FG001|NOT COMPLETED|Period 1||93
9963386|NCT01484496|11083070|FG002|NOT COMPLETED|Period 1||0
9963387|NCT01484496|11083071|FG003|NOT COMPLETED|Period 1||0
9963388|NCT01484496|11083068|FG000|STARTED|Period 2||0
9963389|NCT01484496|11083069|FG001|STARTED|Period 2||0
9963390|NCT01484496|11083070|FG002|STARTED|Period 2||206
9963391|NCT01484496|11083071|FG003|STARTED|Period 2||456
9963392|NCT01484496|11083068|FG000|COMPLETED|Period 2||0
9963393|NCT01484496|11083069|FG001|COMPLETED|Period 2||0
9963394|NCT01484496|11083070|FG002|COMPLETED|Period 2||191
9963395|NCT01484496|11083071|FG003|COMPLETED|Period 2||434
9963396|NCT01484496|11083068|FG000|NOT COMPLETED|Period 2||0
9963397|NCT01484496|11083069|FG001|NOT COMPLETED|Period 2||0
9963398|NCT01484496|11083070|FG002|NOT COMPLETED|Period 2||15
9963399|NCT01484496|11083071|FG003|NOT COMPLETED|Period 2||22
9963400|NCT01484561|11083081|FG000|STARTED|Overall Study||97
9963401|NCT01484561|11083082|FG001|STARTED|Overall Study||51
9963402|NCT01484561|11083081|FG000|COMPLETED|Overall Study||88
9963403|NCT01484561|11083082|FG001|COMPLETED|Overall Study||45
9963404|NCT01484561|11083081|FG000|NOT COMPLETED|Overall Study||9
9963405|NCT01484561|11083082|FG001|NOT COMPLETED|Overall Study||6
9963406|NCT01484626|11083088|FG000|STARTED|Overall Study||3
9963407|NCT01484626|11083088|FG000|COMPLETED|Overall Study||3
9963408|NCT01484626|11083088|FG000|NOT COMPLETED|Overall Study||0
9963409|NCT01484652|11083094|FG000|STARTED|Overall Study||166
9963410|NCT01484652|11083095|FG001|STARTED|Overall Study||163
9702049|NCT04539262|10801336|FG002|NOT COMPLETED|Overall Study||1
9702050|NCT04539262|10801337|FG003|NOT COMPLETED|Overall Study||1
9702051|NCT04539262|10801338|FG004|NOT COMPLETED|Overall Study||0
9963411|NCT01484652|11083094|FG000|COMPLETED|Overall Study||151
9963412|NCT01484652|11083095|FG001|COMPLETED|Overall Study||142
9963413|NCT01484652|11083094|FG000|NOT COMPLETED|Overall Study||15
9702052|NCT04539262|10801339|FG005|NOT COMPLETED|Overall Study||0
9702053|NCT04539262|10801340|FG006|NOT COMPLETED|Overall Study||1
9702054|NCT04539262|10801341|FG007|NOT COMPLETED|Overall Study||0
9963414|NCT01484652|11083095|FG001|NOT COMPLETED|Overall Study||21
9963415|NCT01484834|11083105|FG000|STARTED|Overall Study||65
9963416|NCT01484834|11083106|FG001|STARTED|Overall Study||62
9963417|NCT01484834|11083107|FG002|STARTED|Overall Study||39
10026865|NCT02860039|11151038|FG000|Visit 3|Overall Study||77
9702055|NCT04482439|10801362|FG000|STARTED|Overall Study||35
9702056|NCT04482439|10801362|FG000|COMPLETED|Overall Study||33
9702057|NCT04482439|10801362|FG000|NOT COMPLETED|Overall Study||2
9702058|NCT04465162|10801367|FG000|STARTED|Overall Study||73
9702059|NCT04465162|10801367|FG000|COMPLETED|Overall Study||73
9702060|NCT04465162|10801367|FG000|NOT COMPLETED|Overall Study||0
9702061|NCT04404725|10801371|FG000|STARTED|First Intervention||32
9702062|NCT04404725|10801372|FG001|STARTED|First Intervention||31
9702063|NCT04404725|10801371|FG000|COMPLETED|First Intervention||32
9702064|NCT04404725|10801372|FG001|COMPLETED|First Intervention||29
9702065|NCT04404725|10801371|FG000|NOT COMPLETED|First Intervention||0
9702066|NCT04404725|10801372|FG001|NOT COMPLETED|First Intervention||2
9702067|NCT04404725|10801371|FG000|STARTED|Second Intervention||32
9702068|NCT04404725|10801372|FG001|STARTED|Second Intervention||29
9702069|NCT04404725|10801371|FG000|COMPLETED|Second Intervention||31
9702070|NCT04404725|10801372|FG001|COMPLETED|Second Intervention||27
9702071|NCT04404725|10801371|FG000|NOT COMPLETED|Second Intervention||1
9702072|NCT04404725|10801372|FG001|NOT COMPLETED|Second Intervention||2
9702073|NCT04382586|10801380|FG000|STARTED|Overall Study||30
9702074|NCT04382586|10801381|FG001|STARTED|Overall Study||33
9702075|NCT04382586|10801380|FG000|COMPLETED|Overall Study||13
9702076|NCT04382586|10801381|FG001|COMPLETED|Overall Study||17
9702077|NCT04382586|10801380|FG000|NOT COMPLETED|Overall Study||17
9702078|NCT04382586|10801381|FG001|NOT COMPLETED|Overall Study||16
9702079|NCT04348656|10801389|FG000|STARTED|Overall Study||627
9702080|NCT04348656|10801390|FG001|STARTED|Overall Study||313
9702081|NCT04348656|10801389|FG000|Baseline Population|Overall Study||625
9702082|NCT04348656|10801390|FG001|Baseline Population|Overall Study||313
9702083|NCT04348656|10801389|FG000|Intention to Treat Analysis|Overall Study||614
9702084|NCT04348656|10801390|FG001|Intention to Treat Analysis|Overall Study||307
9702085|NCT04348656|10801389|FG000|Per Protocol Analysis|Overall Study||548
9702086|NCT04348656|10801390|FG001|Per Protocol Analysis|Overall Study||303
9702087|NCT04348656|10801389|FG000|COMPLETED|Overall Study||614
9702088|NCT04348656|10801390|FG001|COMPLETED|Overall Study||307
9702089|NCT04348656|10801389|FG000|NOT COMPLETED|Overall Study||13
9702090|NCT04348656|10801390|FG001|NOT COMPLETED|Overall Study||6
9963418|NCT01484834|11083108|FG003|STARTED|Overall Study||24
9963419|NCT01484834|11083105|FG000|COMPLETED|Overall Study||60
9963420|NCT01484834|11083106|FG001|COMPLETED|Overall Study||54
9963421|NCT01484834|11083107|FG002|COMPLETED|Overall Study||38
9963422|NCT01484834|11083108|FG003|COMPLETED|Overall Study||20
9963423|NCT01484834|11083105|FG000|NOT COMPLETED|Overall Study||5
9963424|NCT01484834|11083106|FG001|NOT COMPLETED|Overall Study||8
9963425|NCT01484834|11083107|FG002|NOT COMPLETED|Overall Study||1
9963426|NCT01484834|11083108|FG003|NOT COMPLETED|Overall Study||4
9963427|NCT01484873|11083118|FG000|STARTED|Overall Study||10
9963428|NCT01484873|11083118|FG000|COMPLETED|Overall Study||8
9963429|NCT01484873|11083118|FG000|NOT COMPLETED|Overall Study||2
9963430|NCT01484912|11083125|FG000|STARTED|Overall Study||39
9963431|NCT01484912|11083126|FG001|STARTED|Overall Study||40
9963432|NCT01484912|11083125|FG000|COMPLETED|Overall Study||38
9963433|NCT01484912|11083126|FG001|COMPLETED|Overall Study||39
9963434|NCT01484912|11083125|FG000|NOT COMPLETED|Overall Study||1
9963435|NCT01484912|11083126|FG001|NOT COMPLETED|Overall Study||1
9963436|NCT01484938|11083132|FG000|STARTED|Overall Study||175
9963437|NCT01484938|11083132|FG000|COMPLETED|Overall Study||171
9963438|NCT01484938|11083132|FG000|NOT COMPLETED|Overall Study||4
9963439|NCT01484951|11083136|FG000|STARTED|Overall Study||74
9963440|NCT01484951|11083136|FG000|COMPLETED|Overall Study||69
9963441|NCT01484951|11083136|FG000|NOT COMPLETED|Overall Study||5
9963442|NCT01484977|11083140|FG000|STARTED|Overall Study||120
9963443|NCT01484977|11083140|FG000|COMPLETED|Overall Study||93
9963444|NCT01484977|11083140|FG000|NOT COMPLETED|Overall Study||27
9963445|NCT01485055|11083144|FG000|STARTED|Overall Study||11
9963446|NCT01485055|11083144|FG000|COMPLETED|Overall Study||11
9963447|NCT01485055|11083144|FG000|NOT COMPLETED|Overall Study||0
9963448|NCT01485094|11083151|FG000|STARTED|Overall Study||20
9963449|NCT01485094|11083152|FG001|STARTED|Overall Study||20
9963450|NCT01485094|11083153|FG002|STARTED|Overall Study||19
9963451|NCT01485094|11083151|FG000|COMPLETED|Overall Study||17
9728376|NCT00112437|10827932|FG004|COMPLETED|Year 3 (12-Month Extension)||0
9728377|NCT00112437|10827933|FG005|COMPLETED|Year 3 (12-Month Extension)||0
9963452|NCT01485094|11083152|FG001|COMPLETED|Overall Study||18
9963453|NCT01485094|11083153|FG002|COMPLETED|Overall Study||18
9963454|NCT01485094|11083151|FG000|NOT COMPLETED|Overall Study||3
9963455|NCT01485094|11083152|FG001|NOT COMPLETED|Overall Study||2
9963456|NCT01485094|11083153|FG002|NOT COMPLETED|Overall Study||1
9963457|NCT01485120|11083161|FG000|STARTED|Overall Study||34
9728378|NCT00112437|10827934|FG006|COMPLETED|Year 3 (12-Month Extension)||0
9728379|NCT00112437|10827935|FG007|COMPLETED|Year 3 (12-Month Extension)||0
9728380|NCT00112437|10827936|FG008|COMPLETED|Year 3 (12-Month Extension)||0
9728381|NCT00112437|10827937|FG009|COMPLETED|Year 3 (12-Month Extension)||0
9728382|NCT00112437|10827938|FG010|COMPLETED|Year 3 (12-Month Extension)||17
9728383|NCT00112437|10827939|FG011|COMPLETED|Year 3 (12-Month Extension)||17
9963458|NCT01485120|11083161|FG000|COMPLETED|Overall Study||32
9963459|NCT01485120|11083161|FG000|NOT COMPLETED|Overall Study||2
9963460|NCT01485172|11083172|FG000|STARTED|Overall Study||40
9963461|NCT01485172|11083173|FG001|STARTED|Overall Study||13
9963462|NCT01485172|11083174|FG002|STARTED|Overall Study||41
9963463|NCT01485172|11083175|FG003|STARTED|Overall Study||40
9963464|NCT01485172|11083176|FG004|STARTED|Overall Study||39
9702091|NCT04283253|10801396|FG000|STARTED|Overall Study||1
9702092|NCT04283253|10801396|FG000|COMPLETED|Overall Study||1
9702093|NCT04283253|10801396|FG000|NOT COMPLETED|Overall Study||0
9963465|NCT01485172|11083177|FG005|STARTED|Overall Study||13
9963466|NCT01485172|11083172|FG000|COMPLETED|Overall Study||33
9963467|NCT01485172|11083173|FG001|COMPLETED|Overall Study||12
10026866|NCT02860039|11151039|FG001|Visit 3|Overall Study||84
10026867|NCT02860039|11151038|FG000|Visit 4|Overall Study||73
10026868|NCT02860039|11151039|FG001|Visit 4|Overall Study||82
10026869|NCT02860039|11151038|FG000|Visit 1 Repeat|Overall Study||31
10026870|NCT02860039|11151039|FG001|Visit 1 Repeat|Overall Study||35
10026871|NCT02860039|11151038|FG000|Visit 2 Repeat|Overall Study||30
10026872|NCT02860039|11151039|FG001|Visit 2 Repeat|Overall Study||35
10026873|NCT02860039|11151038|FG000|Visit 3 Repeat|Overall Study||29
10026874|NCT02860039|11151039|FG001|Visit 3 Repeat|Overall Study||35
10026875|NCT02860039|11151038|FG000|Visit 4 Repeat|Overall Study||26
10026876|NCT02860039|11151039|FG001|Visit 4 Repeat|Overall Study||22
10026877|NCT02860039|11151038|FG000|COMPLETED|Overall Study||73
10026878|NCT02860039|11151039|FG001|COMPLETED|Overall Study||82
10026879|NCT02860039|11151038|FG000|NOT COMPLETED|Overall Study||11
10026880|NCT02860039|11151039|FG001|NOT COMPLETED|Overall Study||4
10026881|NCT02743728|11151045|FG000|STARTED|Overall Study||20
10026882|NCT02743728|11151045|FG000|COMPLETED|Overall Study||20
10026883|NCT02743728|11151045|FG000|NOT COMPLETED|Overall Study||0
10026884|NCT02482389|11151049|FG000|STARTED|Overall Study||3
10026885|NCT02482389|11151049|FG000|COMPLETED|Overall Study||3
10026886|NCT02482389|11151049|FG000|NOT COMPLETED|Overall Study||0
10081344|NCT02260180|11209814|FG001|NOT COMPLETED|Overall Study||0
10081345|NCT02260180|11209815|FG002|NOT COMPLETED|Overall Study||1
10081346|NCT02260258|11209825|FG000|STARTED|Overall Study||39
10081347|NCT02260258|11209826|FG001|STARTED|Overall Study||44
10081348|NCT02260258|11209825|FG000|COMPLETED|Overall Study||37
10081349|NCT02260258|11209826|FG001|COMPLETED|Overall Study||43
10081350|NCT02260258|11209825|FG000|NOT COMPLETED|Overall Study||2
10081351|NCT02260258|11209826|FG001|NOT COMPLETED|Overall Study||1
10081352|NCT02260388|11209837|FG000|STARTED|Overall Study||134
10081353|NCT02260388|11209838|FG001|STARTED|Overall Study||126
10081354|NCT02260388|11209839|FG002|STARTED|Overall Study||73
10081355|NCT02260388|11209840|FG003|STARTED|Overall Study||69
10081356|NCT02260388|11209837|FG000|COMPLETED|Overall Study||132
10081357|NCT02260388|11209838|FG001|COMPLETED|Overall Study||118
10081358|NCT02260388|11209839|FG002|COMPLETED|Overall Study||70
10081359|NCT02260388|11209840|FG003|COMPLETED|Overall Study||65
10081360|NCT02260388|11209837|FG000|NOT COMPLETED|Overall Study||2
10081361|NCT02260388|11209838|FG001|NOT COMPLETED|Overall Study||8
10081362|NCT02260388|11209839|FG002|NOT COMPLETED|Overall Study||3
10081363|NCT02260388|11209840|FG003|NOT COMPLETED|Overall Study||4
10081364|NCT02260401|11209852|FG000|STARTED|Overall Study||80
10081365|NCT02260401|11209853|FG001|STARTED|Overall Study||85
10081366|NCT02260401|11209852|FG000|COMPLETED|Overall Study||75
10081367|NCT02260401|11209853|FG001|COMPLETED|Overall Study||73
10081368|NCT02260401|11209852|FG000|NOT COMPLETED|Overall Study||5
10081369|NCT02260401|11209853|FG001|NOT COMPLETED|Overall Study||12
10081370|NCT02260440|11209859|FG000|STARTED|Overall Study||31
10081371|NCT02260440|11209859|FG000|COMPLETED|Overall Study||31
10081372|NCT02260440|11209859|FG000|NOT COMPLETED|Overall Study||0
10081373|NCT02260492|11209866|FG000|STARTED|Overall Study||418
10081374|NCT02260492|11209867|FG001|STARTED|Overall Study||419
10081375|NCT02260492|11209868|FG002|STARTED|Overall Study||42
10081376|NCT02260492|11209866|FG000|Completed Day 1|Overall Study||418
10081377|NCT02260492|11209867|FG001|Completed Day 1|Overall Study||419
10081378|NCT02260492|11209868|FG002|Completed Day 1|Overall Study||42
10081379|NCT02260492|11209866|FG000|COMPLETED|Overall Study||395
10081380|NCT02260492|11209867|FG001|COMPLETED|Overall Study||406
10081381|NCT02260492|11209868|FG002|COMPLETED|Overall Study||37
10081382|NCT02260492|11209866|FG000|NOT COMPLETED|Overall Study||23
10081383|NCT02260492|11209867|FG001|NOT COMPLETED|Overall Study||13
10081384|NCT02260492|11209868|FG002|NOT COMPLETED|Overall Study||5
10081385|NCT02260531|11209879|FG000|STARTED|Overall Study||21
10081386|NCT02260531|11209880|FG001|STARTED|Overall Study||7
9963468|NCT01485172|11083174|FG002|COMPLETED|Overall Study||34
9963469|NCT01485172|11083175|FG003|COMPLETED|Overall Study||32
9963470|NCT01485172|11083176|FG004|COMPLETED|Overall Study||34
9963471|NCT01485172|11083177|FG005|COMPLETED|Overall Study||9
9963472|NCT01485172|11083172|FG000|NOT COMPLETED|Overall Study||7
9963473|NCT01485172|11083173|FG001|NOT COMPLETED|Overall Study||1
9702094|NCT04246541|10801402|FG000|STARTED|Overall Study||25
9963474|NCT01485172|11083174|FG002|NOT COMPLETED|Overall Study||7
9963475|NCT01485172|11083175|FG003|NOT COMPLETED|Overall Study||8
10081387|NCT02260531|11209881|FG002|STARTED|Overall Study||8
10081388|NCT02260531|11209879|FG000|COMPLETED|Overall Study||21
10081389|NCT02260531|11209880|FG001|COMPLETED|Overall Study||7
10081390|NCT02260531|11209881|FG002|COMPLETED|Overall Study||8
10081391|NCT02260531|11209879|FG000|NOT COMPLETED|Overall Study||0
10081392|NCT02260531|11209880|FG001|NOT COMPLETED|Overall Study||0
10081393|NCT02260531|11209881|FG002|NOT COMPLETED|Overall Study||0
10081394|NCT02260622|11209898|FG000|STARTED|Overall Study||11
10081395|NCT02260622|11209899|FG001|STARTED|Overall Study||9
10081396|NCT02260622|11209898|FG000|COMPLETED|Overall Study||11
10081397|NCT02260622|11209899|FG001|COMPLETED|Overall Study||9
10081398|NCT02260622|11209898|FG000|NOT COMPLETED|Overall Study||0
10081399|NCT02260622|11209899|FG001|NOT COMPLETED|Overall Study||0
10081400|NCT02260635|11209907|FG000|STARTED|Double-Blind Treatment Period||27
9702095|NCT04246541|10801403|FG001|STARTED|Overall Study||23
9702096|NCT04246541|10801402|FG000|COMPLETED|Overall Study||22
9702097|NCT04246541|10801403|FG001|COMPLETED|Overall Study||20
9702098|NCT04246541|10801402|FG000|NOT COMPLETED|Overall Study||3
9702099|NCT04246541|10801403|FG001|NOT COMPLETED|Overall Study||3
9728384|NCT00112437|10827940|FG012|COMPLETED|Year 3 (12-Month Extension)||18
9728385|NCT00112437|10827941|FG013|COMPLETED|Year 3 (12-Month Extension)||16
9728386|NCT00112437|10827942|FG014|COMPLETED|Year 3 (12-Month Extension)||17
9728387|NCT00112437|10827943|FG015|COMPLETED|Year 3 (12-Month Extension)||13
9728388|NCT00112437|10827944|FG016|COMPLETED|Year 3 (12-Month Extension)||16
9728389|NCT00112437|10827945|FG017|COMPLETED|Year 3 (12-Month Extension)||20
9728390|NCT00112437|10827946|FG018|COMPLETED|Year 3 (12-Month Extension)||16
9728391|NCT00112437|10827947|FG019|COMPLETED|Year 3 (12-Month Extension)||19
9728392|NCT00112437|10827948|FG020|COMPLETED|Year 3 (12-Month Extension)||0
9728393|NCT00112437|10827949|FG021|COMPLETED|Year 3 (12-Month Extension)||0
9728394|NCT00112437|10827950|FG022|COMPLETED|Year 3 (12-Month Extension)||0
9728395|NCT00112437|10827951|FG023|COMPLETED|Year 3 (12-Month Extension)||0
9728396|NCT00112437|10827952|FG024|COMPLETED|Year 3 (12-Month Extension)||0
9728397|NCT00112437|10827953|FG025|COMPLETED|Year 3 (12-Month Extension)||0
9728398|NCT00112437|10827928|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728399|NCT00112437|10827929|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728400|NCT00112437|10827930|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728401|NCT00112437|10827931|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728402|NCT00112437|10827932|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728403|NCT00112437|10827933|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728404|NCT00112437|10827934|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728405|NCT00112437|10827935|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728406|NCT00112437|10827936|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728407|NCT00112437|10827937|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728408|NCT00112437|10827938|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2
9728409|NCT00112437|10827939|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5
9728410|NCT00112437|10827940|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728411|NCT00112437|10827941|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1
9728412|NCT00112437|10827942|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1
9728413|NCT00112437|10827943|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4
9728414|NCT00112437|10827944|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3
9728415|NCT00112437|10827945|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1
9728416|NCT00112437|10827946|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2
9728417|NCT00112437|10827947|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1
9728418|NCT00112437|10827948|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728419|NCT00112437|10827949|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728420|NCT00112437|10827950|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728421|NCT00112437|10827951|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728422|NCT00112437|10827952|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728423|NCT00112437|10827953|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0
9728424|NCT00112437|10827928|FG000|STARTED|Years 4-5 (24-Month Extension)||0
9728425|NCT00112437|10827929|FG001|STARTED|Years 4-5 (24-Month Extension)||0
9728426|NCT00112437|10827930|FG002|STARTED|Years 4-5 (24-Month Extension)||0
9728427|NCT00112437|10827931|FG003|STARTED|Years 4-5 (24-Month Extension)||0
9728428|NCT00112437|10827932|FG004|STARTED|Years 4-5 (24-Month Extension)||0
9728429|NCT00112437|10827933|FG005|STARTED|Years 4-5 (24-Month Extension)||0
9728430|NCT00112437|10827934|FG006|STARTED|Years 4-5 (24-Month Extension)||0
9728431|NCT00112437|10827935|FG007|STARTED|Years 4-5 (24-Month Extension)||0
9728432|NCT00112437|10827936|FG008|STARTED|Years 4-5 (24-Month Extension)||0
9728433|NCT00112437|10827937|FG009|STARTED|Years 4-5 (24-Month Extension)||0
9728434|NCT00112437|10827938|FG010|STARTED|Years 4-5 (24-Month Extension)||0
9728435|NCT00112437|10827939|FG011|STARTED|Years 4-5 (24-Month Extension)||0
9728436|NCT00112437|10827940|FG012|STARTED|Years 4-5 (24-Month Extension)||0
9728437|NCT00112437|10827941|FG013|STARTED|Years 4-5 (24-Month Extension)||0
9728438|NCT00112437|10827942|FG014|STARTED|Years 4-5 (24-Month Extension)||0
9728439|NCT00112437|10827943|FG015|STARTED|Years 4-5 (24-Month Extension)||0
9728440|NCT00112437|10827944|FG016|STARTED|Years 4-5 (24-Month Extension)||0
9728441|NCT00112437|10827945|FG017|STARTED|Years 4-5 (24-Month Extension)||0
9728442|NCT00112437|10827946|FG018|STARTED|Years 4-5 (24-Month Extension)||0
9728443|NCT00112437|10827947|FG019|STARTED|Years 4-5 (24-Month Extension)||0
9728444|NCT00112437|10827948|FG020|STARTED|Years 4-5 (24-Month Extension)||41
9728445|NCT00112437|10827949|FG021|STARTED|Years 4-5 (24-Month Extension)||100
9728446|NCT00112437|10827950|FG022|STARTED|Years 4-5 (24-Month Extension)||0
9728447|NCT00112437|10827951|FG023|STARTED|Years 4-5 (24-Month Extension)||0
9728448|NCT00112437|10827952|FG024|STARTED|Years 4-5 (24-Month Extension)||0
9728449|NCT00112437|10827953|FG025|STARTED|Years 4-5 (24-Month Extension)||0
9728450|NCT00112437|10827928|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0
9728451|NCT00112437|10827929|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0
9728452|NCT00112437|10827930|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0
9728453|NCT00112437|10827931|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0
9728454|NCT00112437|10827932|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0
9728455|NCT00112437|10827933|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0
9728456|NCT00112437|10827934|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0
9728457|NCT00112437|10827935|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0
9728458|NCT00112437|10827936|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0
9728459|NCT00112437|10827937|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0
9702100|NCT04079881|10801411|FG000|STARTED|Overall Study||1
9702101|NCT04079881|10801412|FG001|STARTED|Overall Study||0
9702102|NCT04079881|10801411|FG000|COMPLETED|Overall Study||1
9702103|NCT04079881|10801412|FG001|COMPLETED|Overall Study||0
9702104|NCT04079881|10801411|FG000|NOT COMPLETED|Overall Study||0
9702105|NCT04079881|10801412|FG001|NOT COMPLETED|Overall Study||0
9702106|NCT03950674|10801421|FG000|STARTED|Overall Study||25
9702107|NCT03950674|10801422|FG001|STARTED|Overall Study||15
9702108|NCT03950674|10801421|FG000|Treated|Overall Study||25
9702109|NCT03950674|10801422|FG001|Treated|Overall Study||15
9702110|NCT03950674|10801421|FG000|Switched to Pembrolizumab|Overall Study||0
9702111|NCT03950674|10801422|FG001|Switched to Pembrolizumab|Overall Study||4
9702112|NCT03950674|10801421|FG000|COMPLETED|Overall Study||0
9702113|NCT03950674|10801422|FG001|COMPLETED|Overall Study||0
9702114|NCT03950674|10801421|FG000|NOT COMPLETED|Overall Study||25
9702115|NCT03950674|10801422|FG001|NOT COMPLETED|Overall Study||15
9702116|NCT03868839|10801429|FG000|STARTED|Overall Study||6
9702117|NCT03868839|10801429|FG000|COMPLETED|Overall Study||5
9702118|NCT03868839|10801429|FG000|NOT COMPLETED|Overall Study||1
9702119|NCT03847974|10801433|FG000|STARTED|Overall Study||32
9702120|NCT03847974|10801433|FG000|COMPLETED|Overall Study||26
9702121|NCT03847974|10801433|FG000|NOT COMPLETED|Overall Study||6
10026887|NCT02232282|11151055|FG000|STARTED|Overall Study||10
10026888|NCT02232282|11151056|FG001|STARTED|Overall Study||12
10026889|NCT02232282|11151055|FG000|COMPLETED|Overall Study||10
10026890|NCT02232282|11151056|FG001|COMPLETED|Overall Study||11
10026891|NCT02232282|11151055|FG000|NOT COMPLETED|Overall Study||0
10026892|NCT02232282|11151056|FG001|NOT COMPLETED|Overall Study||1
10026893|NCT01492361|11151068|FG000|STARTED|Overall Study||4089
10026894|NCT01492361|11151069|FG001|STARTED|Overall Study||4090
10026895|NCT01492361|11151068|FG000|Completed Final Visit|Overall Study||3419
9702125|NCT03787095|10801443|FG000|STARTED|Overall Study||4
9702126|NCT03787095|10801444|FG001|STARTED|Overall Study||1
9702127|NCT03787095|10801443|FG000|COMPLETED|Overall Study||4
9702128|NCT03787095|10801444|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1
9702129|NCT03787095|10801443|FG000|NOT COMPLETED|Overall Study||0
9702130|NCT03787095|10801444|FG001|NOT COMPLETED|Overall Study||0
9702131|NCT03746951|10801453|FG000|STARTED|Overall Study||8
9702132|NCT03746951|10801454|FG001|STARTED|Overall Study||7
9702133|NCT03746951|10801453|FG000|COMPLETED|Overall Study||8
9702134|NCT03746951|10801454|FG001|COMPLETED|Overall Study||7
9702135|NCT03746951|10801453|FG000|NOT COMPLETED|Overall Study||0
9702136|NCT03746951|10801454|FG001|NOT COMPLETED|Overall Study||0
9702137|NCT03685747|10801460|FG000|STARTED|Overall Study||4
9702138|NCT03685747|10801460|FG000|COMPLETED|Overall Study||4
9702139|NCT03685747|10801460|FG000|NOT COMPLETED|Overall Study||0
9702140|NCT03671148|10801466|FG000|STARTED|Overall Study||220
9702141|NCT03671148|10801467|FG001|STARTED|Overall Study||224
9702142|NCT03671148|10801466|FG000|Received Study Drug|Overall Study||219
9702143|NCT03671148|10801467|FG001|Received Study Drug|Overall Study||224
9702144|NCT03671148|10801466|FG000|COMPLETED|Overall Study||199
9702145|NCT03671148|10801467|FG001|COMPLETED|Overall Study||215
9702146|NCT03671148|10801466|FG000|NOT COMPLETED|Overall Study||21
9702147|NCT03671148|10801467|FG001|NOT COMPLETED|Overall Study||9
9702148|NCT03640949|10801475|FG000|STARTED|Overall Study||237
9702149|NCT03640949|10801476|FG001|STARTED|Overall Study||264
9702150|NCT03640949|10801475|FG000|COMPLETED|Overall Study||237
9702151|NCT03640949|10801476|FG001|COMPLETED|Overall Study||264
9702152|NCT03640949|10801475|FG000|NOT COMPLETED|Overall Study||0
9702153|NCT03640949|10801476|FG001|NOT COMPLETED|Overall Study||0
9702154|NCT03615508|10801482|FG000|STARTED|Overall Study||1
9702155|NCT03615508|10801482|FG000|COMPLETED|Overall Study||1
9702156|NCT03615508|10801482|FG000|NOT COMPLETED|Overall Study||0
9702157|NCT03607487|10801490|FG000|STARTED|Overall Study||9
9702158|NCT03607487|10801491|FG001|STARTED|Overall Study||9
9702159|NCT03607487|10801492|FG002|STARTED|Overall Study||9
9702160|NCT03607487|10801493|FG003|STARTED|Overall Study||8
9702161|NCT03607487|10801490|FG000|COMPLETED|Overall Study||7
9702162|NCT03607487|10801491|FG001|COMPLETED|Overall Study||9
10026896|NCT01492361|11151069|FG001|Completed Final Visit|Overall Study||3335
10115433|NCT02525744|11246277|FG003|Received at Least 1 Dose of Study Drug|Period 4||6
10115434|NCT02525744|11246274|FG000|COMPLETED|Period 4||5
10115435|NCT02525744|11246275|FG001|COMPLETED|Period 4||5
10115436|NCT02525744|11246276|FG002|COMPLETED|Period 4||5
10115437|NCT02525744|11246277|FG003|COMPLETED|Period 4||6
9702163|NCT03607487|10801492|FG002|COMPLETED|Overall Study||9
9702164|NCT03607487|10801493|FG003|COMPLETED|Overall Study||7
9702165|NCT03607487|10801490|FG000|NOT COMPLETED|Overall Study||2
9702166|NCT03607487|10801491|FG001|NOT COMPLETED|Overall Study||0
9702167|NCT03607487|10801492|FG002|NOT COMPLETED|Overall Study||0
9702168|NCT03607487|10801493|FG003|NOT COMPLETED|Overall Study||1
9702169|NCT03586687|10801508|FG000|STARTED|Overall Study||6
10026897|NCT01492361|11151068|FG000|Death Before Final Visit|Overall Study||265
9702170|NCT03586687|10801509|FG001|STARTED|Overall Study||9
9702171|NCT03586687|10801510|FG002|STARTED|Overall Study||4
9702172|NCT03586687|10801508|FG000|COMPLETED|Overall Study||6
9702173|NCT03586687|10801509|FG001|COMPLETED|Overall Study||9
10026898|NCT01492361|11151069|FG001|Death Before Final Visit|Overall Study||295
9702174|NCT03586687|10801510|FG002|COMPLETED|Overall Study||4
9702175|NCT03586687|10801508|FG000|NOT COMPLETED|Overall Study||0
9702176|NCT03586687|10801509|FG001|NOT COMPLETED|Overall Study||0
9702177|NCT03586687|10801510|FG002|NOT COMPLETED|Overall Study||0
9702178|NCT03529773|10801558|FG000|STARTED|Overall Study||12
9702179|NCT03529773|10801559|FG001|STARTED|Overall Study||12
9702180|NCT03529773|10801560|FG002|STARTED|Overall Study||12
9702181|NCT03529773|10801561|FG003|STARTED|Overall Study||12
9702182|NCT03529773|10801562|FG004|STARTED|Overall Study||12
9702183|NCT03529773|10801563|FG005|STARTED|Overall Study||12
9702184|NCT03529773|10801564|FG006|STARTED|Overall Study||12
9702185|NCT03529773|10801565|FG007|STARTED|Overall Study||12
9702186|NCT03529773|10801566|FG008|STARTED|Overall Study||12
9963476|NCT01485172|11083176|FG004|NOT COMPLETED|Overall Study||5
9963477|NCT01485172|11083177|FG005|NOT COMPLETED|Overall Study||4
9963478|NCT01485354|11083191|FG000|STARTED|Overall Study||17
9963479|NCT01485354|11083191|FG000|COMPLETED|Overall Study||12
9963480|NCT01485354|11083191|FG000|NOT COMPLETED|Overall Study||5
9963481|NCT01485380|11083195|FG000|STARTED|Overall Study||20
9963482|NCT01485380|11083195|FG000|COMPLETED|Overall Study||17
9963483|NCT01485380|11083195|FG000|NOT COMPLETED|Overall Study||3
9963484|NCT01485393|11083199|FG000|STARTED|Overall Study||5
9963485|NCT01485393|11083200|FG001|STARTED|Overall Study||5
9963486|NCT01485393|11083199|FG000|COMPLETED|Overall Study||5
9963487|NCT01485393|11083200|FG001|COMPLETED|Overall Study||5
9963488|NCT01485393|11083199|FG000|NOT COMPLETED|Overall Study||0
9963489|NCT01485393|11083200|FG001|NOT COMPLETED|Overall Study||0
9963490|NCT01485536|11083207|FG000|STARTED|Overall Study||21
9963491|NCT01485536|11083207|FG000|COMPLETED|Overall Study||17
9963492|NCT01485536|11083207|FG000|NOT COMPLETED|Overall Study||4
9963493|NCT01485588|11083214|FG000|STARTED|Overall Study||6
9963494|NCT01485588|11083215|FG001|STARTED|Overall Study||6
9963495|NCT01485588|11083216|FG002|STARTED|Overall Study||6
9963496|NCT01485588|11083214|FG000|COMPLETED|Overall Study||6
9963497|NCT01485588|11083215|FG001|COMPLETED|Overall Study||6
9963498|NCT01485588|11083216|FG002|COMPLETED|Overall Study||6
9963499|NCT01485588|11083214|FG000|NOT COMPLETED|Overall Study||0
9963500|NCT01485588|11083215|FG001|NOT COMPLETED|Overall Study||0
9963501|NCT01485588|11083216|FG002|NOT COMPLETED|Overall Study||0
9963502|NCT01485614|11083230|FG000|STARTED|Randomization||96
9963503|NCT01485614|11083231|FG001|STARTED|Randomization||90
9963504|NCT01485614|11083232|FG002|STARTED|Randomization||9
9963505|NCT01485614|11083233|FG003|STARTED|Randomization||5
9963506|NCT01485614|11083230|FG000|COMPLETED|Randomization||95
9963507|NCT01485614|11083231|FG001|COMPLETED|Randomization||90
9963508|NCT01485614|11083232|FG002|COMPLETED|Randomization||9
9963509|NCT01485614|11083233|FG003|COMPLETED|Randomization||5
9963510|NCT01485614|11083230|FG000|NOT COMPLETED|Randomization||1
9963511|NCT01485614|11083231|FG001|NOT COMPLETED|Randomization||0
9963512|NCT01485614|11083232|FG002|NOT COMPLETED|Randomization||0
9963513|NCT01485614|11083233|FG003|NOT COMPLETED|Randomization||0
9963514|NCT01485614|11083230|FG000|STARTED|Weeks 0-20||95
9963515|NCT01485614|11083231|FG001|STARTED|Weeks 0-20||90
9963516|NCT01485614|11083232|FG002|STARTED|Weeks 0-20||9
9963517|NCT01485614|11083233|FG003|STARTED|Weeks 0-20||5
9963518|NCT01485614|11083230|FG000|Treated|Weeks 0-20||95
9963519|NCT01485614|11083231|FG001|Treated|Weeks 0-20||90
9963520|NCT01485614|11083232|FG002|Treated|Weeks 0-20||9
9963521|NCT01485614|11083233|FG003|Treated|Weeks 0-20||5
9963522|NCT01485614|11083230|FG000|COMPLETED|Weeks 0-20||85
9963523|NCT01485614|11083231|FG001|COMPLETED|Weeks 0-20||86
9963524|NCT01485614|11083232|FG002|COMPLETED|Weeks 0-20||8
9963525|NCT01485614|11083233|FG003|COMPLETED|Weeks 0-20||5
9963526|NCT01485614|11083230|FG000|NOT COMPLETED|Weeks 0-20||10
9963527|NCT01485614|11083231|FG001|NOT COMPLETED|Weeks 0-20||4
9963528|NCT01485614|11083232|FG002|NOT COMPLETED|Weeks 0-20||1
9963529|NCT01485614|11083233|FG003|NOT COMPLETED|Weeks 0-20||0
9963530|NCT01485614|11083230|FG000|STARTED|Weeks 20-54||85
9963531|NCT01485614|11083231|FG001|STARTED|Weeks 20-54||86
9963532|NCT01485614|11083232|FG002|STARTED|Weeks 20-54||8
9963533|NCT01485614|11083233|FG003|STARTED|Weeks 20-54||5
9963534|NCT01485614|11083230|FG000|COMPLETED|Weeks 20-54||74
9963535|NCT01485614|11083231|FG001|COMPLETED|Weeks 20-54||78
9963536|NCT01485614|11083232|FG002|COMPLETED|Weeks 20-54||6
9702187|NCT03529773|10801567|FG009|STARTED|Overall Study||12
9702188|NCT03529773|10801568|FG010|STARTED|Overall Study||12
9702189|NCT03529773|10801569|FG011|STARTED|Overall Study||12
9702190|NCT03529773|10801570|FG012|STARTED|Overall Study||12
9702191|NCT03529773|10801571|FG013|STARTED|Overall Study||12
9702192|NCT03529773|10801572|FG014|STARTED|Overall Study||41
9963537|NCT01485614|11083233|FG003|COMPLETED|Weeks 20-54||5
9963538|NCT01485614|11083230|FG000|NOT COMPLETED|Weeks 20-54||11
9963539|NCT01485614|11083231|FG001|NOT COMPLETED|Weeks 20-54||8
9963540|NCT01485614|11083232|FG002|NOT COMPLETED|Weeks 20-54||2
9963541|NCT01485614|11083233|FG003|NOT COMPLETED|Weeks 20-54||0
9963542|NCT01485627|11083251|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244
9963543|NCT01485627|11083252|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241
9963544|NCT01485627|11083251|FG000|Allocated Caregivers: Total|Overall Study||105
9963545|NCT01485627|11083252|FG001|Allocated Caregivers: Total|Overall Study||99
9963546|NCT01485627|11083251|FG000|Bereaved Caregivers: Total|Overall Study||63
9963547|NCT01485627|11083252|FG001|Bereaved Caregivers: Total|Overall Study||64
9963548|NCT01485627|11083251|FG000|Bereaved Caregivers: 1 Month|Overall Study||51
9963549|NCT01485627|11083252|FG001|Bereaved Caregivers: 1 Month|Overall Study||51
9702193|NCT03529773|10801573|FG015|STARTED|Overall Study||42
9702194|NCT03529773|10801574|FG016|STARTED|Overall Study||41
9702195|NCT03529773|10801575|FG017|STARTED|Overall Study||41
9702196|NCT03529773|10801576|FG018|STARTED|Overall Study||41
9702197|NCT03529773|10801577|FG019|STARTED|Overall Study||41
9702198|NCT03529773|10801578|FG020|STARTED|Overall Study||41
9702199|NCT03529773|10801579|FG021|STARTED|Overall Study||41
9702200|NCT03529773|10801580|FG022|STARTED|Overall Study||41
9702201|NCT03529773|10801581|FG023|STARTED|Overall Study||41
9702202|NCT03529773|10801582|FG024|STARTED|Overall Study||41
9702203|NCT03529773|10801583|FG025|STARTED|Overall Study||41
9702204|NCT03529773|10801584|FG026|STARTED|Overall Study||41
9702205|NCT03529773|10801585|FG027|STARTED|Overall Study||41
9702206|NCT03529773|10801586|FG028|STARTED|Overall Study||41
9702207|NCT03529773|10801587|FG029|STARTED|Overall Study||40
9702208|NCT03529773|10801588|FG030|STARTED|Overall Study||42
9702209|NCT03529773|10801589|FG031|STARTED|Overall Study||40
9702210|NCT03529773|10801590|FG032|STARTED|Overall Study||40
9702211|NCT03529773|10801591|FG033|STARTED|Overall Study||41
9702212|NCT03529773|10801592|FG034|STARTED|Overall Study||41
9702213|NCT03529773|10801593|FG035|STARTED|Overall Study||40
9702214|NCT03529773|10801594|FG036|STARTED|Overall Study||41
9702215|NCT03529773|10801595|FG037|STARTED|Overall Study||42
9702216|NCT03529773|10801596|FG038|STARTED|Overall Study||43
9702217|NCT03529773|10801597|FG039|STARTED|Overall Study||41
9702218|NCT03529773|10801558|FG000|COMPLETED|Overall Study||12
9702219|NCT03529773|10801559|FG001|COMPLETED|Overall Study||12
9702220|NCT03529773|10801560|FG002|COMPLETED|Overall Study||11
9702221|NCT03529773|10801561|FG003|COMPLETED|Overall Study||12
9702222|NCT03529773|10801562|FG004|COMPLETED|Overall Study||11
9702223|NCT03529773|10801563|FG005|COMPLETED|Overall Study||11
9702224|NCT03529773|10801564|FG006|COMPLETED|Overall Study||12
9702225|NCT03529773|10801565|FG007|COMPLETED|Overall Study||11
9702226|NCT03529773|10801566|FG008|COMPLETED|Overall Study||12
9702227|NCT03529773|10801567|FG009|COMPLETED|Overall Study||11
9702228|NCT03529773|10801568|FG010|COMPLETED|Overall Study||11
9702229|NCT03529773|10801569|FG011|COMPLETED|Overall Study||12
9702230|NCT03529773|10801570|FG012|COMPLETED|Overall Study||10
9702231|NCT03529773|10801571|FG013|COMPLETED|Overall Study||11
9702232|NCT03529773|10801572|FG014|COMPLETED|Overall Study||35
9702233|NCT03529773|10801573|FG015|COMPLETED|Overall Study||38
9702234|NCT03529773|10801574|FG016|COMPLETED|Overall Study||40
9702235|NCT03529773|10801575|FG017|COMPLETED|Overall Study||35
9702236|NCT03529773|10801576|FG018|COMPLETED|Overall Study||37
9702237|NCT03529773|10801577|FG019|COMPLETED|Overall Study||37
9702238|NCT03529773|10801578|FG020|COMPLETED|Overall Study||34
9702239|NCT03529773|10801579|FG021|COMPLETED|Overall Study||36
9702240|NCT03529773|10801580|FG022|COMPLETED|Overall Study||34
9702241|NCT03529773|10801581|FG023|COMPLETED|Overall Study||35
9702242|NCT03529773|10801582|FG024|COMPLETED|Overall Study||33
9702243|NCT03529773|10801583|FG025|COMPLETED|Overall Study||30
9702244|NCT03529773|10801584|FG026|COMPLETED|Overall Study||32
9702245|NCT03529773|10801585|FG027|COMPLETED|Overall Study||39
9702246|NCT03529773|10801586|FG028|COMPLETED|Overall Study||40
9702247|NCT03529773|10801587|FG029|COMPLETED|Overall Study||40
9702248|NCT03529773|10801588|FG030|COMPLETED|Overall Study||39
9702249|NCT03529773|10801589|FG031|COMPLETED|Overall Study||40
9702250|NCT03529773|10801590|FG032|COMPLETED|Overall Study||40
9702251|NCT03529773|10801591|FG033|COMPLETED|Overall Study||39
9702252|NCT03529773|10801592|FG034|COMPLETED|Overall Study||37
9702253|NCT03529773|10801593|FG035|COMPLETED|Overall Study||36
9702254|NCT03529773|10801594|FG036|COMPLETED|Overall Study||39
9702255|NCT03529773|10801595|FG037|COMPLETED|Overall Study||36
9702256|NCT03529773|10801596|FG038|COMPLETED|Overall Study||39
9702257|NCT03529773|10801597|FG039|COMPLETED|Overall Study||37
9702258|NCT03529773|10801558|FG000|NOT COMPLETED|Overall Study||0
9702259|NCT03529773|10801559|FG001|NOT COMPLETED|Overall Study||0
9702260|NCT03529773|10801560|FG002|NOT COMPLETED|Overall Study||1
9702261|NCT03529773|10801561|FG003|NOT COMPLETED|Overall Study||0
9702262|NCT03529773|10801562|FG004|NOT COMPLETED|Overall Study||1
9702263|NCT03529773|10801563|FG005|NOT COMPLETED|Overall Study||1
9702264|NCT03529773|10801564|FG006|NOT COMPLETED|Overall Study||0
9702265|NCT03529773|10801565|FG007|NOT COMPLETED|Overall Study||1
9702266|NCT03529773|10801566|FG008|NOT COMPLETED|Overall Study||0
9702267|NCT03529773|10801567|FG009|NOT COMPLETED|Overall Study||1
9963550|NCT01485627|11083251|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49
9963551|NCT01485627|11083252|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52
9963552|NCT01485627|11083251|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48
9963553|NCT01485627|11083252|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49
9963554|NCT01485627|11083251|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178
9963555|NCT01485627|11083252|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184
9702268|NCT03529773|10801568|FG010|NOT COMPLETED|Overall Study||1
9702269|NCT03529773|10801569|FG011|NOT COMPLETED|Overall Study||0
9702270|NCT03529773|10801570|FG012|NOT COMPLETED|Overall Study||2
9702271|NCT03529773|10801571|FG013|NOT COMPLETED|Overall Study||1
9702272|NCT03529773|10801572|FG014|NOT COMPLETED|Overall Study||6
9702273|NCT03529773|10801573|FG015|NOT COMPLETED|Overall Study||4
9702274|NCT03529773|10801574|FG016|NOT COMPLETED|Overall Study||1
9702275|NCT03529773|10801575|FG017|NOT COMPLETED|Overall Study||6
9702276|NCT03529773|10801576|FG018|NOT COMPLETED|Overall Study||4
9702277|NCT03529773|10801577|FG019|NOT COMPLETED|Overall Study||4
9702278|NCT03529773|10801578|FG020|NOT COMPLETED|Overall Study||7
9702279|NCT03529773|10801579|FG021|NOT COMPLETED|Overall Study||5
9702280|NCT03529773|10801580|FG022|NOT COMPLETED|Overall Study||7
9702281|NCT03529773|10801581|FG023|NOT COMPLETED|Overall Study||6
9702282|NCT03529773|10801582|FG024|NOT COMPLETED|Overall Study||8
9848023|NCT00856973|10960663|FG002|COMPLETED|Overall Study||123
9848024|NCT00856973|10960661|FG000|NOT COMPLETED|Overall Study||36
9848025|NCT00856973|10960662|FG001|NOT COMPLETED|Overall Study||41
9848026|NCT00856973|10960663|FG002|NOT COMPLETED|Overall Study||38
9848027|NCT00856986|10960680|FG000|STARTED|Run-in Period, Weeks -12-0||161
9848028|NCT00856986|10960681|FG001|STARTED|Run-in Period, Weeks -12-0||162
9848029|NCT00856986|10960682|FG002|STARTED|Run-in Period, Weeks -12-0||498
9848030|NCT00856986|10960683|FG003|STARTED|Run-in Period, Weeks -12-0||167
9848031|NCT00856986|10960684|FG004|STARTED|Run-in Period, Weeks -12-0||0
9848032|NCT00856986|10960680|FG000|COMPLETED|Run-in Period, Weeks -12-0||161
9848033|NCT00856986|10960681|FG001|COMPLETED|Run-in Period, Weeks -12-0||162
9848034|NCT00856986|10960682|FG002|COMPLETED|Run-in Period, Weeks -12-0||498
9848035|NCT00856986|10960683|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
9848036|NCT00856986|10960684|FG004|COMPLETED|Run-in Period, Weeks -12-0||0
9848037|NCT00856986|10960680|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0
9848038|NCT00856986|10960681|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0
9848039|NCT00856986|10960682|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0
9848040|NCT00856986|10960683|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167
9848041|NCT00856986|10960684|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0
9848042|NCT00856986|10960680|FG000|STARTED|Main Period, Weeks 0-26||161
9848043|NCT00856986|10960681|FG001|STARTED|Main Period, Weeks 0-26||162
9848044|NCT00856986|10960682|FG002|STARTED|Main Period, Weeks 0-26||498
9848045|NCT00856986|10960683|FG003|STARTED|Main Period, Weeks 0-26||0
9848046|NCT00856986|10960684|FG004|STARTED|Main Period, Weeks 0-26||0
9848047|NCT00856986|10960680|FG000|COMPLETED|Main Period, Weeks 0-26||127
9848048|NCT00856986|10960681|FG001|COMPLETED|Main Period, Weeks 0-26||144
9848049|NCT00856986|10960682|FG002|COMPLETED|Main Period, Weeks 0-26||470
9848050|NCT00856986|10960683|FG003|COMPLETED|Main Period, Weeks 0-26||0
9848051|NCT00856986|10960684|FG004|COMPLETED|Main Period, Weeks 0-26||0
9848052|NCT00856986|10960680|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34
9848053|NCT00856986|10960681|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18
9848054|NCT00856986|10960682|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28
9963556|NCT01485627|11083251|FG000|NOT COMPLETED|Overall Study||66
9963557|NCT01485627|11083252|FG001|NOT COMPLETED|Overall Study||57
9963558|NCT01485640|11083262|FG000|STARTED|Overall Study||162
9963559|NCT01485640|11083262|FG000|COMPLETED|Overall Study||40
9963560|NCT01485640|11083262|FG000|NOT COMPLETED|Overall Study||122
9963561|NCT01485770|11083268|FG000|STARTED|First Intervention (2 Weeks)||17
9963562|NCT01485770|11083269|FG001|STARTED|First Intervention (2 Weeks)||16
9963563|NCT01485770|11083268|FG000|COMPLETED|First Intervention (2 Weeks)||17
9963564|NCT01485770|11083269|FG001|COMPLETED|First Intervention (2 Weeks)||16
9963565|NCT01485770|11083268|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
9963566|NCT01485770|11083269|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
9963567|NCT01485770|11083268|FG000|STARTED|Second Intervention (2 Weeks)||17
9963568|NCT01485770|11083269|FG001|STARTED|Second Intervention (2 Weeks)||16
9963569|NCT01485770|11083268|FG000|COMPLETED|Second Intervention (2 Weeks)||17
9963570|NCT01485770|11083269|FG001|COMPLETED|Second Intervention (2 Weeks)||16
9963571|NCT01485770|11083268|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
9963572|NCT01485770|11083269|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
9963573|NCT01485796|11083277|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37
9963574|NCT01485796|11083277|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
9963575|NCT01485796|11083277|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
9963576|NCT01485796|11083277|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
9963577|NCT01485796|11083277|FG000|STARTED|Period 2: Epoch 2||36
9963578|NCT01485796|11083277|FG000|Treated in Epoch 2|Period 2: Epoch 2||36
9963579|NCT01485796|11083277|FG000|COMPLETED|Period 2: Epoch 2||1
9963580|NCT01485796|11083277|FG000|NOT COMPLETED|Period 2: Epoch 2||35
9963581|NCT01485796|11083277|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37
9963582|NCT01485796|11083277|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
9963583|NCT01485796|11083277|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
9963584|NCT01485796|11083277|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
9963585|NCT01485796|11083277|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
9963586|NCT01485796|11083277|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
9963587|NCT01485796|11083277|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
9963588|NCT01485796|11083277|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
9963589|NCT01485796|11083277|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
9963590|NCT01485796|11083277|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
9963591|NCT01485887|11083285|FG000|STARTED|Overall Study||50
9963592|NCT01485887|11083285|FG000|COMPLETED|Overall Study||38
9963593|NCT01485887|11083285|FG000|NOT COMPLETED|Overall Study||12
9963594|NCT01485991|11083291|FG000|STARTED|Overall Study||385
9963595|NCT01485991|11083292|FG001|STARTED|Overall Study||386
9848055|NCT00856986|10960683|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0
9848056|NCT00856986|10960684|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0
9848057|NCT00856986|10960680|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
9702283|NCT03529773|10801583|FG025|NOT COMPLETED|Overall Study||11
9702284|NCT03529773|10801584|FG026|NOT COMPLETED|Overall Study||9
9702285|NCT03529773|10801585|FG027|NOT COMPLETED|Overall Study||2
9702286|NCT03529773|10801586|FG028|NOT COMPLETED|Overall Study||1
9702287|NCT03529773|10801587|FG029|NOT COMPLETED|Overall Study||0
9702288|NCT03529773|10801588|FG030|NOT COMPLETED|Overall Study||3
9702289|NCT03529773|10801589|FG031|NOT COMPLETED|Overall Study||0
9702290|NCT03529773|10801590|FG032|NOT COMPLETED|Overall Study||0
9963596|NCT01485991|11083291|FG000|Treated|Overall Study||379
9963597|NCT01485991|11083292|FG001|Treated|Overall Study||384
9963598|NCT01485991|11083291|FG000|COMPLETED|Overall Study||353
9963599|NCT01485991|11083292|FG001|COMPLETED|Overall Study||350
9963600|NCT01485991|11083291|FG000|NOT COMPLETED|Overall Study||32
9963601|NCT01485991|11083292|FG001|NOT COMPLETED|Overall Study||36
9963602|NCT01486043|11083298|FG000|STARTED|Overall Study||4
9963603|NCT01486043|11083298|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
9963604|NCT01486043|11083298|FG000|NOT COMPLETED|Overall Study||2
9963605|NCT01486199|11083304|FG000|STARTED|Baseline Study Day||10
9963606|NCT01486199|11083305|FG001|STARTED|Baseline Study Day||10
9963607|NCT01486199|11083304|FG000|COMPLETED|Baseline Study Day||10
9963608|NCT01486199|11083305|FG001|COMPLETED|Baseline Study Day||9
9963609|NCT01486199|11083304|FG000|NOT COMPLETED|Baseline Study Day||0
9963610|NCT01486199|11083305|FG001|NOT COMPLETED|Baseline Study Day||1
9963611|NCT01486199|11083304|FG000|STARTED|Two Year Period Between Study Days||10
9963612|NCT01486199|11083305|FG001|STARTED|Two Year Period Between Study Days||0
9963613|NCT01486199|11083304|FG000|COMPLETED|Two Year Period Between Study Days||9
9963614|NCT01486199|11083305|FG001|COMPLETED|Two Year Period Between Study Days||0
9963615|NCT01486199|11083304|FG000|NOT COMPLETED|Two Year Period Between Study Days||1
9963616|NCT01486199|11083305|FG001|NOT COMPLETED|Two Year Period Between Study Days||0
9963617|NCT01486199|11083304|FG000|STARTED|Study Day at t= 2 Years||9
9963618|NCT01486199|11083305|FG001|STARTED|Study Day at t= 2 Years||0
9963619|NCT01486199|11083304|FG000|COMPLETED|Study Day at t= 2 Years||9
9963620|NCT01486199|11083305|FG001|COMPLETED|Study Day at t= 2 Years||0
9963621|NCT01486199|11083304|FG000|NOT COMPLETED|Study Day at t= 2 Years||0
9963622|NCT01486199|11083305|FG001|NOT COMPLETED|Study Day at t= 2 Years||0
9963623|NCT01486238|11083313|FG000|STARTED|Overall Study||23
9963624|NCT01486238|11083314|FG001|STARTED|Overall Study||49
9963625|NCT01486238|11083313|FG000|COMPLETED|Overall Study||21
9963626|NCT01486238|11083314|FG001|COMPLETED|Overall Study||43
9963627|NCT01486238|11083313|FG000|NOT COMPLETED|Overall Study||2
9963628|NCT01486238|11083314|FG001|NOT COMPLETED|Overall Study||6
9963629|NCT01486316|11083323|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
9963630|NCT01486316|11083324|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
9963631|NCT01486316|11083325|FG002|STARTED|Overall Study|Exited prior to implant|5
9963632|NCT01486316|11083326|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2
9963633|NCT01486316|11083323|FG000|COMPLETED|Overall Study||3
9963634|NCT01486316|11083324|FG001|COMPLETED|Overall Study||7
9963635|NCT01486316|11083325|FG002|COMPLETED|Overall Study||0
9963636|NCT01486316|11083326|FG003|COMPLETED|Overall Study||0
9963637|NCT01486316|11083323|FG000|NOT COMPLETED|Overall Study||4
9963638|NCT01486316|11083324|FG001|NOT COMPLETED|Overall Study||3
9963639|NCT01486316|11083325|FG002|NOT COMPLETED|Overall Study||5
10026899|NCT01492361|11151068|FG000|COMPLETED|Overall Study||3684
10026900|NCT01492361|11151069|FG001|COMPLETED|Overall Study||3630
10026901|NCT01492361|11151068|FG000|NOT COMPLETED|Overall Study||405
10026902|NCT01492361|11151069|FG001|NOT COMPLETED|Overall Study||460
10026903|NCT01296711|11151083|FG000|STARTED|Overall Study||20
10026904|NCT01296711|11151084|FG001|STARTED|Overall Study||20
10026905|NCT01296711|11151085|FG002|STARTED|Overall Study||21
10026906|NCT01296711|11151086|FG003|STARTED|Overall Study||20
10026907|NCT01296711|11151087|FG004|STARTED|Overall Study||17
10026908|NCT01296711|11151088|FG005|STARTED|Overall Study||16
10026909|NCT01296711|11151089|FG006|STARTED|Overall Study||40
10026910|NCT01296711|11151090|FG007|STARTED|Overall Study||36
10026911|NCT01296711|11151083|FG000|COMPLETED|Overall Study||4
10026912|NCT01296711|11151084|FG001|COMPLETED|Overall Study||12
10026913|NCT01296711|11151085|FG002|COMPLETED|Overall Study||8
10026914|NCT01296711|11151086|FG003|COMPLETED|Overall Study||7
10026915|NCT01296711|11151087|FG004|COMPLETED|Overall Study||7
10026916|NCT01296711|11151088|FG005|COMPLETED|Overall Study||5
9702291|NCT03529773|10801591|FG033|NOT COMPLETED|Overall Study||2
9702292|NCT03529773|10801592|FG034|NOT COMPLETED|Overall Study||4
9702293|NCT03529773|10801593|FG035|NOT COMPLETED|Overall Study||4
9702294|NCT03529773|10801594|FG036|NOT COMPLETED|Overall Study||2
9702295|NCT03529773|10801595|FG037|NOT COMPLETED|Overall Study||6
9963640|NCT01486316|11083326|FG003|NOT COMPLETED|Overall Study||2
9963641|NCT01486446|11083337|FG000|STARTED|Overall Study||7
9963642|NCT01486446|11083338|FG001|STARTED|Overall Study||1
9963643|NCT01486446|11083337|FG000|COMPLETED|Overall Study||6
9963644|NCT01486446|11083338|FG001|COMPLETED|Overall Study||1
9963645|NCT01486446|11083337|FG000|NOT COMPLETED|Overall Study||1
10026917|NCT01296711|11151089|FG006|COMPLETED|Overall Study||9
10026918|NCT01296711|11151090|FG007|COMPLETED|Overall Study||15
10026919|NCT01296711|11151083|FG000|NOT COMPLETED|Overall Study||16
10026920|NCT01296711|11151084|FG001|NOT COMPLETED|Overall Study||8
10026921|NCT01296711|11151085|FG002|NOT COMPLETED|Overall Study||13
10026922|NCT01296711|11151086|FG003|NOT COMPLETED|Overall Study||13
9702296|NCT03529773|10801596|FG038|NOT COMPLETED|Overall Study||4
9702297|NCT03529773|10801597|FG039|NOT COMPLETED|Overall Study||4
9702298|NCT03502070|10801700|FG000|STARTED|Overall Study||47
9702299|NCT03502070|10801700|FG000|COMPLETED|Overall Study||45
9702300|NCT03502070|10801700|FG000|NOT COMPLETED|Overall Study||2
9702301|NCT03485911|10801707|FG000|STARTED|Overall Study||41
9702302|NCT03485911|10801708|FG001|STARTED|Overall Study||40
9702303|NCT03485911|10801709|FG002|STARTED|Overall Study||40
9702304|NCT03485911|10801707|FG000|COMPLETED|Overall Study||40
9702305|NCT03485911|10801708|FG001|COMPLETED|Overall Study||38
9702306|NCT03485911|10801709|FG002|COMPLETED|Overall Study||36
9702307|NCT03485911|10801707|FG000|NOT COMPLETED|Overall Study||1
9702308|NCT03485911|10801708|FG001|NOT COMPLETED|Overall Study||2
9702309|NCT03485911|10801709|FG002|NOT COMPLETED|Overall Study||4
9702310|NCT03403634|10801717|FG000|STARTED|Overall Study|19 patients were accrued and completed consent.|19
9702311|NCT03403634|10801717|FG000|Treated|Overall Study|4 patients became ineligible prior to the start of treatment.|15
9702312|NCT03403634|10801717|FG000|COMPLETED|Overall Study||12
9702313|NCT03403634|10801717|FG000|NOT COMPLETED|Overall Study||7
9702314|NCT03382041|10801723|FG000|STARTED|Overall Study||7
9702315|NCT03382041|10801724|FG001|STARTED|Overall Study||13
9702316|NCT03382041|10801723|FG000|COMPLETED|Overall Study||3
9702317|NCT03382041|10801724|FG001|COMPLETED|Overall Study||4
9702318|NCT03382041|10801723|FG000|NOT COMPLETED|Overall Study||4
9702319|NCT03382041|10801724|FG001|NOT COMPLETED|Overall Study||9
9702320|NCT03332095|10801732|FG000|STARTED|Overall Study||10
9702321|NCT03332095|10801733|FG001|STARTED|Overall Study||45
9702322|NCT03332095|10801732|FG000|Received at Least One Dose of Study Treatment|Overall Study||9
9702323|NCT03332095|10801733|FG001|Received at Least One Dose of Study Treatment|Overall Study||45
9702324|NCT03332095|10801732|FG000|COMPLETED|Overall Study||9
9702325|NCT03332095|10801733|FG001|COMPLETED|Overall Study||44
9702326|NCT03332095|10801732|FG000|NOT COMPLETED|Overall Study||1
9702327|NCT03332095|10801733|FG001|NOT COMPLETED|Overall Study||1
9702328|NCT03201419|10801748|FG000|STARTED|Overall Study||60
9702329|NCT03201419|10801749|FG001|STARTED|Overall Study||27
9702330|NCT03201419|10801750|FG002|STARTED|Overall Study||24
9702331|NCT03201419|10801751|FG003|STARTED|Overall Study||14
9702332|NCT03201419|10801752|FG004|STARTED|Overall Study||13
9702333|NCT03201419|10801753|FG005|STARTED|Overall Study||34
9702334|NCT03201419|10801754|FG006|STARTED|Overall Study||87
9702335|NCT03201419|10801755|FG007|STARTED|Overall Study||26
9702336|NCT03201419|10801756|FG008|STARTED|Overall Study||17
9702337|NCT03201419|10801748|FG000|COMPLETED|Overall Study||52
10026923|NCT01296711|11151087|FG004|NOT COMPLETED|Overall Study||10
10026924|NCT01296711|11151088|FG005|NOT COMPLETED|Overall Study||11
10026925|NCT01296711|11151089|FG006|NOT COMPLETED|Overall Study||31
10026926|NCT01296711|11151090|FG007|NOT COMPLETED|Overall Study||21
10026927|NCT00084656|11151111|FG000|STARTED|Overall Study||25
10026928|NCT00084656|11151112|FG001|STARTED|Overall Study||25
10026929|NCT00084656|11151113|FG002|STARTED|Overall Study||26
10026930|NCT00084656|11151111|FG000|COMPLETED|Overall Study||0
10026931|NCT00084656|11151112|FG001|COMPLETED|Overall Study||0
10026932|NCT00084656|11151113|FG002|COMPLETED|Overall Study||0
10026933|NCT00084656|11151111|FG000|NOT COMPLETED|Overall Study||25
10026934|NCT00084656|11151112|FG001|NOT COMPLETED|Overall Study||25
10026935|NCT00084656|11151113|FG002|NOT COMPLETED|Overall Study||26
10026936|NCT01879735|11151125|FG000|STARTED|Overall Study||6
10026937|NCT01879735|11151126|FG001|STARTED|Overall Study||16
10026938|NCT01879735|11151125|FG000|COMPLETED|Overall Study||6
10026939|NCT01879735|11151126|FG001|COMPLETED|Overall Study||16
10115438|NCT02525744|11246274|FG000|NOT COMPLETED|Period 4||1
10115439|NCT02525744|11246275|FG001|NOT COMPLETED|Period 4||0
10115440|NCT02525744|11246276|FG002|NOT COMPLETED|Period 4||0
10115441|NCT02525744|11246277|FG003|NOT COMPLETED|Period 4||0
10115442|NCT02525744|11246274|FG000|STARTED|Period 5||5
10115443|NCT02525744|11246275|FG001|STARTED|Period 5||5
10115444|NCT02525744|11246276|FG002|STARTED|Period 5||5
10115445|NCT02525744|11246277|FG003|STARTED|Period 5||6
10115446|NCT02525744|11246274|FG000|Received at Least 1 Dose of Study Drug|Period 5||4
10115447|NCT02525744|11246275|FG001|Received at Least 1 Dose of Study Drug|Period 5||5
10115448|NCT02525744|11246276|FG002|Received at Least 1 Dose of Study Drug|Period 5||5
10115449|NCT02525744|11246277|FG003|Received at Least 1 Dose of Study Drug|Period 5||6
10115450|NCT02525744|11246274|FG000|COMPLETED|Period 5||4
9702338|NCT03201419|10801749|FG001|COMPLETED|Overall Study||24
9702339|NCT03201419|10801750|FG002|COMPLETED|Overall Study||22
9702340|NCT03201419|10801751|FG003|COMPLETED|Overall Study||14
9702341|NCT03201419|10801752|FG004|COMPLETED|Overall Study||12
9702342|NCT03201419|10801753|FG005|COMPLETED|Overall Study||33
9702343|NCT03201419|10801754|FG006|COMPLETED|Overall Study||81
9702344|NCT03201419|10801755|FG007|COMPLETED|Overall Study||25
9702345|NCT03201419|10801756|FG008|COMPLETED|Overall Study||15
9702346|NCT03201419|10801748|FG000|NOT COMPLETED|Overall Study||8
10026940|NCT01879735|11151125|FG000|NOT COMPLETED|Overall Study||0
10026941|NCT01879735|11151126|FG001|NOT COMPLETED|Overall Study||0
10026942|NCT01879800|11151134|FG000|STARTED|Overall Study||14
10026943|NCT01879800|11151135|FG001|STARTED|Overall Study||30
10026944|NCT01879800|11151134|FG000|COMPLETED|Overall Study||14
10026945|NCT01879800|11151135|FG001|COMPLETED|Overall Study||26
10026946|NCT01879800|11151134|FG000|NOT COMPLETED|Overall Study||0
10115451|NCT02525744|11246275|FG001|COMPLETED|Period 5||5
10115452|NCT02525744|11246276|FG002|COMPLETED|Period 5||5
10115453|NCT02525744|11246277|FG003|COMPLETED|Period 5||6
9702347|NCT03201419|10801749|FG001|NOT COMPLETED|Overall Study||3
9702348|NCT03201419|10801750|FG002|NOT COMPLETED|Overall Study||2
9702349|NCT03201419|10801751|FG003|NOT COMPLETED|Overall Study||0
9702350|NCT03201419|10801752|FG004|NOT COMPLETED|Overall Study||1
9702351|NCT03201419|10801753|FG005|NOT COMPLETED|Overall Study||1
9702352|NCT03201419|10801754|FG006|NOT COMPLETED|Overall Study||6
9702353|NCT03201419|10801755|FG007|NOT COMPLETED|Overall Study||1
9702354|NCT03201419|10801756|FG008|NOT COMPLETED|Overall Study||2
9702355|NCT03197766|10801792|FG000|STARTED|Overall Study||60
9702356|NCT03197766|10801793|FG001|STARTED|Overall Study||61
9702357|NCT03197766|10801792|FG000|COMPLETED|Overall Study||58
9702358|NCT03197766|10801793|FG001|COMPLETED|Overall Study||61
9702359|NCT03197766|10801792|FG000|NOT COMPLETED|Overall Study||2
9702360|NCT03197766|10801793|FG001|NOT COMPLETED|Overall Study||0
9728460|NCT00112437|10827938|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0
9728461|NCT00112437|10827939|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0
9728462|NCT00112437|10827940|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0
9728463|NCT00112437|10827941|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0
9728464|NCT00112437|10827942|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0
9728465|NCT00112437|10827943|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0
9728466|NCT00112437|10827944|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0
9728467|NCT00112437|10827945|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0
9728468|NCT00112437|10827946|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0
9728469|NCT00112437|10827947|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0
9728470|NCT00112437|10827948|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37
9728471|NCT00112437|10827949|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92
9728472|NCT00112437|10827950|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0
9728473|NCT00112437|10827951|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0
9728474|NCT00112437|10827952|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0
9728475|NCT00112437|10827953|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0
9728476|NCT00112437|10827928|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728477|NCT00112437|10827929|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728478|NCT00112437|10827930|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728479|NCT00112437|10827931|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728480|NCT00112437|10827932|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728481|NCT00112437|10827933|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728482|NCT00112437|10827934|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728483|NCT00112437|10827935|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728484|NCT00112437|10827936|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728485|NCT00112437|10827937|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728486|NCT00112437|10827938|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728487|NCT00112437|10827939|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728488|NCT00112437|10827940|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728489|NCT00112437|10827941|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728490|NCT00112437|10827942|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728491|NCT00112437|10827943|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728492|NCT00112437|10827944|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728493|NCT00112437|10827945|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728494|NCT00112437|10827946|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728495|NCT00112437|10827947|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728496|NCT00112437|10827948|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
9728497|NCT00112437|10827949|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
9728498|NCT00112437|10827950|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728499|NCT00112437|10827951|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728500|NCT00112437|10827952|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728501|NCT00112437|10827953|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
9728502|NCT00112437|10827928|FG000|STARTED|Years 6-10 (60-Month Extension)||0
9728503|NCT00112437|10827929|FG001|STARTED|Years 6-10 (60-Month Extension)||0
9728504|NCT00112437|10827930|FG002|STARTED|Years 6-10 (60-Month Extension)||0
9728505|NCT00112437|10827931|FG003|STARTED|Years 6-10 (60-Month Extension)||0
9728506|NCT00112437|10827932|FG004|STARTED|Years 6-10 (60-Month Extension)||0
9728507|NCT00112437|10827933|FG005|STARTED|Years 6-10 (60-Month Extension)||0
9728508|NCT00112437|10827934|FG006|STARTED|Years 6-10 (60-Month Extension)||0
9728509|NCT00112437|10827935|FG007|STARTED|Years 6-10 (60-Month Extension)||0
9728510|NCT00112437|10827936|FG008|STARTED|Years 6-10 (60-Month Extension)||0
9728511|NCT00112437|10827937|FG009|STARTED|Years 6-10 (60-Month Extension)||0
9728512|NCT00112437|10827938|FG010|STARTED|Years 6-10 (60-Month Extension)||0
9728513|NCT00112437|10827939|FG011|STARTED|Years 6-10 (60-Month Extension)||0
9728514|NCT00112437|10827940|FG012|STARTED|Years 6-10 (60-Month Extension)||0
9728515|NCT00112437|10827941|FG013|STARTED|Years 6-10 (60-Month Extension)||0
9728516|NCT00112437|10827942|FG014|STARTED|Years 6-10 (60-Month Extension)||0
9728517|NCT00112437|10827943|FG015|STARTED|Years 6-10 (60-Month Extension)||0
9728518|NCT00112437|10827944|FG016|STARTED|Years 6-10 (60-Month Extension)||0
9728519|NCT00112437|10827945|FG017|STARTED|Years 6-10 (60-Month Extension)||0
9728520|NCT00112437|10827946|FG018|STARTED|Years 6-10 (60-Month Extension)||0
9728521|NCT00112437|10827947|FG019|STARTED|Years 6-10 (60-Month Extension)||0
9728522|NCT00112437|10827948|FG020|STARTED|Years 6-10 (60-Month Extension)||0
9728523|NCT00112437|10827949|FG021|STARTED|Years 6-10 (60-Month Extension)||0
9728524|NCT00112437|10827950|FG022|STARTED|Years 6-10 (60-Month Extension)||28
9728525|NCT00112437|10827951|FG023|STARTED|Years 6-10 (60-Month Extension)||34
9702361|NCT05143801|10801799|FG000|STARTED|Overall Study||10
9702362|NCT05143801|10801799|FG000|COMPLETED|Overall Study||10
9702363|NCT05143801|10801799|FG000|NOT COMPLETED|Overall Study||0
9702364|NCT04516759|10801811|FG000|STARTED|Overall Study|excluding 2 subjects who were randomized but did not start treatment|80
9702365|NCT04516759|10801812|FG001|STARTED|Overall Study|excluding 1 subject who was randomized but did not start treatment|73
9963646|NCT01486446|11083338|FG001|NOT COMPLETED|Overall Study||0
9963647|NCT01486615|11083348|FG000|STARTED|Overall Study||20
9963648|NCT01486615|11083349|FG001|STARTED|Overall Study||20
9963649|NCT01486615|11083350|FG002|STARTED|Overall Study||20
9963650|NCT01486615|11083351|FG003|STARTED|Overall Study||20
9963651|NCT01486615|11083348|FG000|COMPLETED|Overall Study||20
9963652|NCT01486615|11083349|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
9963653|NCT01486615|11083350|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
10026947|NCT01879800|11151135|FG001|NOT COMPLETED|Overall Study||4
10026948|NCT01879826|11151143|FG000|STARTED|Overall Study||41
10026949|NCT01879826|11151144|FG001|STARTED|Overall Study||40
10026950|NCT01879826|11151143|FG000|COMPLETED|Overall Study||41
10026951|NCT01879826|11151144|FG001|COMPLETED|Overall Study||40
10026952|NCT01879826|11151143|FG000|NOT COMPLETED|Overall Study||0
10026953|NCT01879826|11151144|FG001|NOT COMPLETED|Overall Study||0
10026954|NCT01879852|11151152|FG000|STARTED|Overall Study||14
10026955|NCT01879852|11151153|FG001|STARTED|Overall Study||13
10026956|NCT01879852|11151152|FG000|COMPLETED|Overall Study||12
10026957|NCT01879852|11151153|FG001|COMPLETED|Overall Study||13
10026958|NCT01879852|11151152|FG000|NOT COMPLETED|Overall Study||2
10026959|NCT01879852|11151153|FG001|NOT COMPLETED|Overall Study||0
10026960|NCT01880047|11151163|FG000|STARTED|Weeks 0-2||17
10026961|NCT01880047|11151164|FG001|STARTED|Weeks 0-2||9
10026962|NCT01880047|11151165|FG002|STARTED|Weeks 0-2||5
10026963|NCT01880047|11151166|FG003|STARTED|Weeks 0-2||3
10026964|NCT01880047|11151163|FG000|COMPLETED|Weeks 0-2||17
10026965|NCT01880047|11151164|FG001|COMPLETED|Weeks 0-2||8
10026966|NCT01880047|11151165|FG002|COMPLETED|Weeks 0-2||4
10026967|NCT01880047|11151166|FG003|COMPLETED|Weeks 0-2||2
10026968|NCT01880047|11151163|FG000|NOT COMPLETED|Weeks 0-2||0
10026969|NCT01880047|11151164|FG001|NOT COMPLETED|Weeks 0-2||1
10026970|NCT01880047|11151165|FG002|NOT COMPLETED|Weeks 0-2||1
10026971|NCT01880047|11151166|FG003|NOT COMPLETED|Weeks 0-2||1
10026972|NCT01880047|11151163|FG000|STARTED|Weeks 3-4||17
10026973|NCT01880047|11151164|FG001|STARTED|Weeks 3-4||8
10026974|NCT01880047|11151165|FG002|STARTED|Weeks 3-4||4
10026975|NCT01880047|11151166|FG003|STARTED|Weeks 3-4||2
10026976|NCT01880047|11151163|FG000|COMPLETED|Weeks 3-4||17
10026977|NCT01880047|11151164|FG001|COMPLETED|Weeks 3-4||7
10026978|NCT01880047|11151165|FG002|COMPLETED|Weeks 3-4||4
10026979|NCT01880047|11151166|FG003|COMPLETED|Weeks 3-4||2
10026980|NCT01880047|11151163|FG000|NOT COMPLETED|Weeks 3-4||0
10026981|NCT01880047|11151164|FG001|NOT COMPLETED|Weeks 3-4||1
10026982|NCT01880047|11151165|FG002|NOT COMPLETED|Weeks 3-4||0
10026983|NCT01880047|11151166|FG003|NOT COMPLETED|Weeks 3-4||0
10026984|NCT01880047|11151163|FG000|STARTED|Weeks 5-8||17
10026985|NCT01880047|11151164|FG001|STARTED|Weeks 5-8||7
10026986|NCT01880047|11151165|FG002|STARTED|Weeks 5-8||4
10026987|NCT01880047|11151166|FG003|STARTED|Weeks 5-8||2
10026988|NCT01880047|11151163|FG000|COMPLETED|Weeks 5-8||15
10026989|NCT01880047|11151164|FG001|COMPLETED|Weeks 5-8||6
10026990|NCT01880047|11151165|FG002|COMPLETED|Weeks 5-8||4
10026991|NCT01880047|11151166|FG003|COMPLETED|Weeks 5-8||2
10026992|NCT01880047|11151163|FG000|NOT COMPLETED|Weeks 5-8||2
10026993|NCT01880047|11151164|FG001|NOT COMPLETED|Weeks 5-8||1
10026994|NCT01880047|11151165|FG002|NOT COMPLETED|Weeks 5-8||0
10026995|NCT01880047|11151166|FG003|NOT COMPLETED|Weeks 5-8||0
10026996|NCT01880047|11151163|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
10026997|NCT01880047|11151164|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
10026998|NCT01880047|11151165|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
10026999|NCT01880047|11151166|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
10027000|NCT01880047|11151163|FG000|COMPLETED|Extension Phase - 18 Months||6
10027001|NCT01880047|11151164|FG001|COMPLETED|Extension Phase - 18 Months||3
10027002|NCT01880047|11151165|FG002|COMPLETED|Extension Phase - 18 Months||3
9702366|NCT04516759|10801811|FG000|COMPLETED|Overall Study||79
9702367|NCT04516759|10801812|FG001|COMPLETED|Overall Study||71
9702368|NCT04516759|10801811|FG000|NOT COMPLETED|Overall Study||1
9702369|NCT04516759|10801812|FG001|NOT COMPLETED|Overall Study||2
9702370|NCT03930446|10801820|FG000|STARTED|Overall Study||40
9702371|NCT03930446|10801821|FG001|STARTED|Overall Study||40
10027003|NCT01880047|11151166|FG003|COMPLETED|Extension Phase - 18 Months||0
10027004|NCT01880047|11151163|FG000|NOT COMPLETED|Extension Phase - 18 Months||9
10027005|NCT01880047|11151164|FG001|NOT COMPLETED|Extension Phase - 18 Months||3
10027006|NCT01880047|11151165|FG002|NOT COMPLETED|Extension Phase - 18 Months||1
10027007|NCT01880047|11151166|FG003|NOT COMPLETED|Extension Phase - 18 Months||2
10027008|NCT01880073|11151183|FG000|STARTED|Overall Study||24
10027009|NCT01880073|11151183|FG000|COMPLETED|Overall Study||24
10027010|NCT01880073|11151183|FG000|NOT COMPLETED|Overall Study||0
10027011|NCT01880086|11151189|FG000|STARTED|Overall Study||6
10027012|NCT01880086|11151190|FG001|STARTED|Overall Study||7
10027013|NCT01880086|11151189|FG000|COMPLETED|Overall Study||5
10027014|NCT01880086|11151190|FG001|COMPLETED|Overall Study||6
9702372|NCT03930446|10801820|FG000|COMPLETED|Overall Study||40
9702373|NCT03930446|10801821|FG001|COMPLETED|Overall Study||40
9702374|NCT03930446|10801820|FG000|NOT COMPLETED|Overall Study||0
9702375|NCT03930446|10801821|FG001|NOT COMPLETED|Overall Study||0
9702376|NCT03492099|10801827|FG000|STARTED|Overall Study||47
9702377|NCT03492099|10801827|FG000|COMPLETED|Overall Study||43
9702378|NCT03492099|10801827|FG000|NOT COMPLETED|Overall Study||4
9728526|NCT00112437|10827952|FG024|STARTED|Years 6-10 (60-Month Extension)||23
9728527|NCT00112437|10827953|FG025|STARTED|Years 6-10 (60-Month Extension)||32
9728528|NCT00112437|10827928|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0
9728529|NCT00112437|10827929|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0
9728530|NCT00112437|10827930|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0
9728531|NCT00112437|10827931|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0
9728532|NCT00112437|10827932|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0
10027015|NCT01880086|11151189|FG000|NOT COMPLETED|Overall Study||1
10027016|NCT01880086|11151190|FG001|NOT COMPLETED|Overall Study||1
10115454|NCT02525744|11246274|FG000|NOT COMPLETED|Period 5||1
9728533|NCT00112437|10827933|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0
9728534|NCT00112437|10827934|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0
9728535|NCT00112437|10827935|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0
9728536|NCT00112437|10827936|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0
9728537|NCT00112437|10827937|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0
9728538|NCT00112437|10827938|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0
9728539|NCT00112437|10827939|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0
9728540|NCT00112437|10827940|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0
9728541|NCT00112437|10827941|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0
9728542|NCT00112437|10827942|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0
9728543|NCT00112437|10827943|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0
9963654|NCT01486615|11083351|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
9963655|NCT01486615|11083348|FG000|NOT COMPLETED|Overall Study||0
9963656|NCT01486615|11083349|FG001|NOT COMPLETED|Overall Study||1
9963657|NCT01486615|11083350|FG002|NOT COMPLETED|Overall Study||2
9963658|NCT01486615|11083351|FG003|NOT COMPLETED|Overall Study||2
9963659|NCT01486758|11083363|FG000|STARTED|Overall Study||20
9963660|NCT01486758|11083364|FG001|STARTED|Overall Study||20
9963661|NCT01486758|11083363|FG000|COMPLETED|Overall Study||20
9963662|NCT01486758|11083364|FG001|COMPLETED|Overall Study||19
9963663|NCT01486758|11083363|FG000|NOT COMPLETED|Overall Study||0
9963664|NCT01486758|11083364|FG001|NOT COMPLETED|Overall Study||1
9963665|NCT01486784|11083377|FG000|STARTED|Overall Study||3
9963666|NCT01486784|11083378|FG001|STARTED|Overall Study||7
9963667|NCT01486784|11083379|FG002|STARTED|Overall Study||6
9963668|NCT01486784|11083380|FG003|STARTED|Overall Study||1
9963669|NCT01486784|11083381|FG004|STARTED|Overall Study||5
9963670|NCT01486784|11083382|FG005|STARTED|Overall Study||5
9963671|NCT01486784|11083377|FG000|Completed Cycle 1|Overall Study||2
9963672|NCT01486784|11083378|FG001|Completed Cycle 1|Overall Study||6
9963673|NCT01486784|11083379|FG002|Completed Cycle 1|Overall Study||3
9963674|NCT01486784|11083380|FG003|Completed Cycle 1|Overall Study||1
9963675|NCT01486784|11083381|FG004|Completed Cycle 1|Overall Study||3
9963676|NCT01486784|11083382|FG005|Completed Cycle 1|Overall Study||2
9963677|NCT01486784|11083377|FG000|Received Treatment|Overall Study||3
9963678|NCT01486784|11083378|FG001|Received Treatment|Overall Study||7
9963679|NCT01486784|11083379|FG002|Received Treatment|Overall Study||5
9963680|NCT01486784|11083380|FG003|Received Treatment|Overall Study||1
9963681|NCT01486784|11083381|FG004|Received Treatment|Overall Study||3
9963682|NCT01486784|11083382|FG005|Received Treatment|Overall Study||2
9963683|NCT01486784|11083377|FG000|COMPLETED|Overall Study||3
9963684|NCT01486784|11083378|FG001|COMPLETED|Overall Study||7
9963685|NCT01486784|11083379|FG002|COMPLETED|Overall Study||5
9963686|NCT01486784|11083380|FG003|COMPLETED|Overall Study||1
9963687|NCT01486784|11083381|FG004|COMPLETED|Overall Study||3
9963688|NCT01486784|11083382|FG005|COMPLETED|Overall Study||2
9963689|NCT01486784|11083377|FG000|NOT COMPLETED|Overall Study||0
9963690|NCT01486784|11083378|FG001|NOT COMPLETED|Overall Study||0
9963691|NCT01486784|11083379|FG002|NOT COMPLETED|Overall Study||1
9963692|NCT01486784|11083380|FG003|NOT COMPLETED|Overall Study||0
9963693|NCT01486784|11083381|FG004|NOT COMPLETED|Overall Study||2
9963694|NCT01486784|11083382|FG005|NOT COMPLETED|Overall Study||3
9963695|NCT01486810|11083396|FG000|STARTED|Overall Study||17
9963696|NCT01486810|11083396|FG000|COMPLETED|Overall Study||9
9963697|NCT01486810|11083396|FG000|NOT COMPLETED|Overall Study||8
9963698|NCT01486927|11083400|FG000|STARTED|Overall Study||174
9963699|NCT01486927|11083400|FG000|COMPLETED|Overall Study||161
9963700|NCT01486927|11083400|FG000|NOT COMPLETED|Overall Study||13
9963701|NCT01486966|11083413|FG000|STARTED|Overall Study||29
9963702|NCT01486966|11083414|FG001|STARTED|Overall Study||29
9963703|NCT01486966|11083413|FG000|COMPLETED|Overall Study||29
9963704|NCT01486966|11083414|FG001|COMPLETED|Overall Study||27
9963705|NCT01486966|11083413|FG000|NOT COMPLETED|Overall Study||0
9963706|NCT01486966|11083414|FG001|NOT COMPLETED|Overall Study||2
9963707|NCT01487161|11083424|FG000|STARTED|Overall Study||58
9963708|NCT01487161|11083425|FG001|STARTED|Overall Study||59
9963709|NCT01487161|11083426|FG002|STARTED|Overall Study||60
9963710|NCT01487161|11083427|FG003|STARTED|Overall Study||52
9963711|NCT01487161|11083424|FG000|COMPLETED|Overall Study||56
9963712|NCT01487161|11083425|FG001|COMPLETED|Overall Study||57
9963713|NCT01487161|11083426|FG002|COMPLETED|Overall Study||59
10027017|NCT01880099|11151199|FG000|STARTED|Overall Study||17
9702379|NCT03409276|10801837|FG000|STARTED|Overall Study||2
9702380|NCT03409276|10801838|FG001|STARTED|Overall Study||10
9702381|NCT03409276|10801839|FG002|STARTED|Overall Study||6
9702382|NCT03409276|10801840|FG003|STARTED|Overall Study||21
9702383|NCT03409276|10801841|FG004|STARTED|Overall Study||21
9702384|NCT03409276|10801837|FG000|Month 2.5 Immunogenicity Cohort|Overall Study||2
9702385|NCT03409276|10801838|FG001|Month 2.5 Immunogenicity Cohort|Overall Study||10
9963714|NCT01487161|11083427|FG003|COMPLETED|Overall Study||50
9963715|NCT01487161|11083424|FG000|NOT COMPLETED|Overall Study||2
9963716|NCT01487161|11083425|FG001|NOT COMPLETED|Overall Study||2
9963717|NCT01487161|11083426|FG002|NOT COMPLETED|Overall Study||1
9963718|NCT01487161|11083427|FG003|NOT COMPLETED|Overall Study||2
9963719|NCT01487200|11083446|FG000|STARTED|Overall Study||5
9963720|NCT01487200|11083447|FG001|STARTED|Overall Study||7
9963721|NCT01487200|11083448|FG002|STARTED|Overall Study||7
9963722|NCT01487200|11083449|FG003|STARTED|Overall Study||5
9963723|NCT01487200|11083446|FG000|COMPLETED|Overall Study||5
9963724|NCT01487200|11083447|FG001|COMPLETED|Overall Study||6
9963725|NCT01487200|11083448|FG002|COMPLETED|Overall Study||7
9963726|NCT01487200|11083449|FG003|COMPLETED|Overall Study||5
9963727|NCT01487200|11083446|FG000|NOT COMPLETED|Overall Study||0
9963728|NCT01487200|11083447|FG001|NOT COMPLETED|Overall Study||1
9963729|NCT01487200|11083448|FG002|NOT COMPLETED|Overall Study||0
9963730|NCT01487200|11083449|FG003|NOT COMPLETED|Overall Study||0
9963731|NCT01487265|11083460|FG000|STARTED|Overall Study||37
9963732|NCT01487265|11083460|FG000|COMPLETED|Overall Study||0
9963733|NCT01487265|11083460|FG000|NOT COMPLETED|Overall Study||37
9963734|NCT01487525|11083466|FG000|STARTED|Overall Study||22
9963735|NCT01487525|11083467|FG001|STARTED|Overall Study||20
9963736|NCT01487525|11083466|FG000|COMPLETED|Overall Study||22
9963737|NCT01487525|11083467|FG001|COMPLETED|Overall Study||19
9963738|NCT01487525|11083466|FG000|NOT COMPLETED|Overall Study||0
9963739|NCT01487525|11083467|FG001|NOT COMPLETED|Overall Study||1
9963740|NCT01487577|11083473|FG000|STARTED|Overall Study||19
9963741|NCT01487577|11083473|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
10027018|NCT01880099|11151200|FG001|STARTED|Overall Study||21
10027019|NCT01880099|11151201|FG002|STARTED|Overall Study||22
10027020|NCT01880099|11151199|FG000|COMPLETED|Overall Study||9
9963742|NCT01487577|11083473|FG000|NOT COMPLETED|Overall Study||1
9963743|NCT01487668|11083479|FG000|STARTED|Overall Study||146
9963744|NCT01487668|11083480|FG001|STARTED|Overall Study||141
9963745|NCT01487668|11083479|FG000|COMPLETED|Overall Study||121
9963746|NCT01487668|11083480|FG001|COMPLETED|Overall Study||124
9963747|NCT01487668|11083479|FG000|NOT COMPLETED|Overall Study||25
9963748|NCT01487668|11083480|FG001|NOT COMPLETED|Overall Study||17
9963749|NCT01487863|11083490|FG000|STARTED|Overall Study||35
9963750|NCT01487863|11083491|FG001|STARTED|Overall Study||34
9963751|NCT01487863|11083490|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35
9963752|NCT01487863|11083491|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34
9963753|NCT01487863|11083490|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
9963754|NCT01487863|11083491|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
9963755|NCT01487863|11083490|FG000|COMPLETED|Overall Study||16
9963756|NCT01487863|11083491|FG001|COMPLETED|Overall Study||15
9963757|NCT01487863|11083490|FG000|NOT COMPLETED|Overall Study||19
9963758|NCT01487863|11083491|FG001|NOT COMPLETED|Overall Study||19
9963759|NCT01487954|11083499|FG000|STARTED|Overall Study||29
10027021|NCT01880099|11151200|FG001|COMPLETED|Overall Study||11
9702386|NCT03409276|10801839|FG002|Month 2.5 Immunogenicity Cohort|Overall Study||0
9702387|NCT03409276|10801840|FG003|Month 2.5 Immunogenicity Cohort|Overall Study||0
9702388|NCT03409276|10801841|FG004|Month 2.5 Immunogenicity Cohort|Overall Study||0
9702389|NCT03409276|10801837|FG000|Month 8.5 Immunogenicity Cohort|Overall Study||0
9702390|NCT03409276|10801838|FG001|Month 8.5 Immunogenicity Cohort|Overall Study||0
9702391|NCT03409276|10801839|FG002|Month 8.5 Immunogenicity Cohort|Overall Study||6
9702392|NCT03409276|10801840|FG003|Month 8.5 Immunogenicity Cohort|Overall Study||19
9702393|NCT03409276|10801841|FG004|Month 8.5 Immunogenicity Cohort|Overall Study||16
9702394|NCT03409276|10801837|FG000|COMPLETED|Overall Study||2
9702395|NCT03409276|10801838|FG001|COMPLETED|Overall Study||10
9702396|NCT03409276|10801839|FG002|COMPLETED|Overall Study||6
9702397|NCT03409276|10801840|FG003|COMPLETED|Overall Study||19
9702398|NCT03409276|10801841|FG004|COMPLETED|Overall Study||18
9702399|NCT03409276|10801837|FG000|NOT COMPLETED|Overall Study||0
9702400|NCT03409276|10801838|FG001|NOT COMPLETED|Overall Study||0
9702401|NCT03409276|10801839|FG002|NOT COMPLETED|Overall Study||0
9702402|NCT03409276|10801840|FG003|NOT COMPLETED|Overall Study||2
9702403|NCT03409276|10801841|FG004|NOT COMPLETED|Overall Study||3
9702404|NCT03312907|10801860|FG000|STARTED|Overall Study||72
9963760|NCT01487954|11083500|FG001|STARTED|Overall Study||16
9963761|NCT01487954|11083499|FG000|Safety lead-in|Overall Study||10
9963762|NCT01487954|11083500|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
9963763|NCT01487954|11083499|FG000|COMPLETED|Overall Study||29
9963764|NCT01487954|11083500|FG001|COMPLETED|Overall Study||16
9963765|NCT01487954|11083499|FG000|NOT COMPLETED|Overall Study||0
9963766|NCT01487954|11083500|FG001|NOT COMPLETED|Overall Study||0
9963767|NCT01488019|11083508|FG000|STARTED|Overall Study||541
9702405|NCT03312907|10801861|FG001|STARTED|Overall Study||144
9702406|NCT03312907|10801862|FG002|STARTED|Overall Study||76
9702407|NCT03312907|10801860|FG000|COMPLETED|Overall Study||55
9702408|NCT03312907|10801861|FG001|COMPLETED|Overall Study||114
9702409|NCT03312907|10801862|FG002|COMPLETED|Overall Study||57
9702410|NCT03312907|10801860|FG000|NOT COMPLETED|Overall Study||17
9702411|NCT03312907|10801861|FG001|NOT COMPLETED|Overall Study||30
9702412|NCT03312907|10801862|FG002|NOT COMPLETED|Overall Study||19
9702413|NCT03148756|10801872|FG000|STARTED|Overall Study||0
9702414|NCT03148756|10801873|FG001|STARTED|Overall Study||2
9702415|NCT03148756|10801872|FG000|COMPLETED|Overall Study||0
9702416|NCT03148756|10801873|FG001|COMPLETED|Overall Study||1
9702417|NCT03148756|10801872|FG000|NOT COMPLETED|Overall Study||0
9702418|NCT03148756|10801873|FG001|NOT COMPLETED|Overall Study||1
9702419|NCT03079102|10801881|FG000|STARTED|Overall Study||30
9702420|NCT03079102|10801882|FG001|STARTED|Overall Study||27
9702421|NCT03079102|10801881|FG000|COMPLETED|Overall Study||30
9702422|NCT03079102|10801882|FG001|COMPLETED|Overall Study|One subject had study drug discontinued by the PI after 3h of therapy due to progressive hemodynamic deterioration (worsening hypotension and shock). Discontinuation of study drug did not impact this deterioration.|26
9702423|NCT03079102|10801881|FG000|NOT COMPLETED|Overall Study||0
9702424|NCT03079102|10801882|FG001|NOT COMPLETED|Overall Study||1
9702425|NCT02944513|10801890|FG000|STARTED|Overall Study||35
9702426|NCT02944513|10801891|FG001|STARTED|Overall Study||33
9702427|NCT02944513|10801890|FG000|COMPLETED|Overall Study||31
9702428|NCT02944513|10801891|FG001|COMPLETED|Overall Study||32
9702429|NCT02944513|10801890|FG000|NOT COMPLETED|Overall Study||4
9702430|NCT02944513|10801891|FG001|NOT COMPLETED|Overall Study||1
9702431|NCT02913222|10801899|FG000|STARTED|Overall Study||23
9702432|NCT02913222|10801900|FG001|STARTED|Overall Study||23
9702433|NCT02913222|10801899|FG000|COMPLETED|Overall Study||22
9702434|NCT02913222|10801900|FG001|COMPLETED|Overall Study||21
9702435|NCT02913222|10801899|FG000|NOT COMPLETED|Overall Study||1
9702436|NCT02913222|10801900|FG001|NOT COMPLETED|Overall Study||2
9702437|NCT02734433|10801908|FG000|STARTED|Overall Study||3
9702438|NCT02734433|10801909|FG001|STARTED|Overall Study||8
9702439|NCT02734433|10801908|FG000|COMPLETED|Overall Study||1
9702440|NCT02734433|10801909|FG001|COMPLETED|Overall Study||0
9702441|NCT02734433|10801908|FG000|NOT COMPLETED|Overall Study||2
9702442|NCT02734433|10801909|FG001|NOT COMPLETED|Overall Study||8
9702443|NCT02474927|10801915|FG000|STARTED|Overall Study||22
9702444|NCT02474927|10801915|FG000|COMPLETED|Overall Study||22
9702445|NCT02474927|10801915|FG000|NOT COMPLETED|Overall Study||0
9702446|NCT02145507|10801921|FG000|STARTED|First Donation||82
9702447|NCT02145507|10801922|FG001|STARTED|First Donation||88
9702448|NCT02145507|10801921|FG000|Randomized to Have Blood Processed With SOLX (IP)|First Donation||52
9702449|NCT02145507|10801922|FG001|Randomized to Have Blood Processed With SOLX (IP)|First Donation||51
9702450|NCT02145507|10801921|FG000|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||30
9702451|NCT02145507|10801922|FG001|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||37
9702452|NCT02145507|10801921|FG000|COMPLETED|First Donation||70
9702453|NCT02145507|10801922|FG001|COMPLETED|First Donation||67
9702454|NCT02145507|10801921|FG000|NOT COMPLETED|First Donation||12
9702455|NCT02145507|10801922|FG001|NOT COMPLETED|First Donation||21
9702456|NCT02145507|10801921|FG000|STARTED|Second Donation||65
9702457|NCT02145507|10801922|FG001|STARTED|Second Donation|Note: Of the 65 participants who started the second period in Arm 2, there were 3 screen failures, therefore only n=62 participants received their alternate procedure.|65
9702458|NCT02145507|10801921|FG000|Blood Processed With AS-3 (CP)|Second Donation||39
9702459|NCT02145507|10801922|FG001|Blood Processed With AS-3 (CP)|Second Donation||35
9702460|NCT02145507|10801921|FG000|Blood Processed With SOLX (IP)|Second Donation||26
9702461|NCT02145507|10801922|FG001|Blood Processed With SOLX (IP)|Second Donation||27
9702462|NCT02145507|10801921|FG000|COMPLETED|Second Donation||63
9702463|NCT02145507|10801922|FG001|COMPLETED|Second Donation||60
9702464|NCT02145507|10801921|FG000|NOT COMPLETED|Second Donation||2
9702465|NCT02145507|10801922|FG001|NOT COMPLETED|Second Donation||5
9702466|NCT02120469|10801936|FG000|STARTED|Overall Study||13
9702467|NCT02120469|10801937|FG001|STARTED|Overall Study||10
9702468|NCT02120469|10801938|FG002|STARTED|Overall Study||4
9702469|NCT02120469|10801936|FG000|COMPLETED|Overall Study||12
9702470|NCT02120469|10801937|FG001|COMPLETED|Overall Study||10
9702471|NCT02120469|10801938|FG002|COMPLETED|Overall Study||3
9702472|NCT02120469|10801936|FG000|NOT COMPLETED|Overall Study||1
9702473|NCT02120469|10801937|FG001|NOT COMPLETED|Overall Study||0
9702474|NCT02120469|10801938|FG002|NOT COMPLETED|Overall Study||1
9702475|NCT02048722|10801948|FG000|STARTED|2 Cycles of Treatment||31
9702476|NCT02048722|10801948|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31
9702477|NCT02048722|10801948|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23
9702478|NCT02048722|10801948|FG000|COMPLETED|2 Cycles of Treatment||23
9702479|NCT02048722|10801948|FG000|NOT COMPLETED|2 Cycles of Treatment||8
9702480|NCT02048722|10801948|FG000|STARTED|Reached 1st Response/Continued Treatment||23
9702481|NCT02048722|10801948|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23
9702482|NCT02048722|10801948|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
9702483|NCT02048722|10801948|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13
9702484|NCT02048722|10801948|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
9702485|NCT02048722|10801948|FG000|STARTED|Follow up 5 Years or Cut of Timepoint||31
9702486|NCT02048722|10801948|FG000|COMPLETED|Follow up 5 Years or Cut of Timepoint||4
9702487|NCT02048722|10801948|FG000|NOT COMPLETED|Follow up 5 Years or Cut of Timepoint||27
9702488|NCT01896102|10801952|FG000|STARTED|Overall Study||32
9702489|NCT01896102|10801952|FG000|COMPLETED|Overall Study||29
9702490|NCT01896102|10801952|FG000|NOT COMPLETED|Overall Study||3
9702491|NCT01885078|10801965|FG000|STARTED|Treatment Period||451
9702492|NCT01885078|10801966|FG001|STARTED|Treatment Period||1091
9702493|NCT01885078|10801967|FG002|STARTED|Treatment Period||180
9702494|NCT01885078|10801968|FG003|STARTED|Treatment Period||403
9702495|NCT01885078|10801969|FG004|STARTED|Treatment Period||117
9702496|NCT01885078|10801970|FG005|STARTED|Treatment Period||331
9702497|NCT01885078|10801971|FG006|STARTED|Treatment Period||221
9702498|NCT01885078|10801972|FG007|STARTED|Treatment Period||83
9702499|NCT01885078|10801973|FG008|STARTED|Treatment Period||0
9702500|NCT01885078|10801974|FG009|STARTED|Treatment Period||0
9702501|NCT01885078|10801965|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451
9702502|NCT01885078|10801966|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090
9702503|NCT01885078|10801967|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180
9702504|NCT01885078|10801968|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403
9702505|NCT01885078|10801969|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117
9702506|NCT01885078|10801970|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331
9702507|NCT01885078|10801971|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221
9702508|NCT01885078|10801972|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83
9702509|NCT01885078|10801973|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0
9702510|NCT01885078|10801974|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0
9848058|NCT00856986|10960681|FG001|STARTED|Extension Period, Weeks 26-52||144
9963768|NCT01488019|11083509|FG001|STARTED|Overall Study||530
9963769|NCT01488019|11083508|FG000|COMPLETED|Overall Study||294
9963770|NCT01488019|11083509|FG001|COMPLETED|Overall Study||226
9963771|NCT01488019|11083508|FG000|NOT COMPLETED|Overall Study||247
9963772|NCT01488019|11083509|FG001|NOT COMPLETED|Overall Study||304
9963773|NCT01488071|11083519|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253
9963774|NCT01488071|11083520|FG001|STARTED|Overall Study|APTS|242
9963775|NCT01488071|11083519|FG000|COMPLETED|Overall Study||200
9963776|NCT01488071|11083520|FG001|COMPLETED|Overall Study||179
9963777|NCT01488071|11083519|FG000|NOT COMPLETED|Overall Study||53
9963778|NCT01488071|11083520|FG001|NOT COMPLETED|Overall Study||63
9963779|NCT01488097|11083526|FG000|STARTED|Overall Study||8
9963780|NCT01488097|11083526|FG000|Received Study Drug in Extension Study|Overall Study||8
9963781|NCT01488097|11083526|FG000|COMPLETED|Overall Study||7
9963782|NCT01488097|11083526|FG000|NOT COMPLETED|Overall Study||1
9963783|NCT01488188|11083532|FG000|STARTED|Overall Study||20
9963784|NCT01488188|11083533|FG001|STARTED|Overall Study||20
9963785|NCT01488188|11083532|FG000|COMPLETED|Overall Study||20
9963786|NCT01488188|11083533|FG001|COMPLETED|Overall Study||20
9963787|NCT01488188|11083532|FG000|NOT COMPLETED|Overall Study||0
9963788|NCT01488188|11083533|FG001|NOT COMPLETED|Overall Study||0
10027022|NCT01880099|11151201|FG002|COMPLETED|Overall Study||15
10027023|NCT01880099|11151199|FG000|NOT COMPLETED|Overall Study||8
10027024|NCT01880099|11151200|FG001|NOT COMPLETED|Overall Study||10
10027025|NCT01880099|11151201|FG002|NOT COMPLETED|Overall Study||7
10027026|NCT01880320|11151212|FG000|STARTED|Overall Study||217
10027027|NCT01880320|11151213|FG001|STARTED|Overall Study||217
10027028|NCT01880320|11151214|FG002|STARTED|Overall Study||69
10027029|NCT01880320|11151212|FG000|COMPLETED|Overall Study||197
10027030|NCT01880320|11151213|FG001|COMPLETED|Overall Study||192
10027031|NCT01880320|11151214|FG002|COMPLETED|Overall Study||61
10027032|NCT01880320|11151212|FG000|NOT COMPLETED|Overall Study||20
10027033|NCT01880320|11151213|FG001|NOT COMPLETED|Overall Study||25
10027034|NCT01880320|11151214|FG002|NOT COMPLETED|Overall Study||8
10027035|NCT01880424|11151224|FG000|STARTED|Overall Study||417
10027036|NCT01880424|11151225|FG001|STARTED|Overall Study||422
10027037|NCT01880424|11151224|FG000|COMPLETED|Overall Study||384
10027038|NCT01880424|11151225|FG001|COMPLETED|Overall Study||367
10027039|NCT01880424|11151224|FG000|NOT COMPLETED|Overall Study||33
10027040|NCT01880424|11151225|FG001|NOT COMPLETED|Overall Study||55
10027041|NCT01880437|11151234|FG000|STARTED|Overall Study||15
10027042|NCT01880437|11151235|FG001|STARTED|Overall Study||4
10027043|NCT01880437|11151236|FG002|STARTED|Overall Study||19
10027044|NCT01880437|11151234|FG000|COMPLETED|Overall Study||0
10027045|NCT01880437|11151235|FG001|COMPLETED|Overall Study||0
10027046|NCT01880437|11151236|FG002|COMPLETED|Overall Study||0
10027047|NCT01880437|11151234|FG000|NOT COMPLETED|Overall Study||15
10027048|NCT01880437|11151235|FG001|NOT COMPLETED|Overall Study||4
10027049|NCT01880437|11151236|FG002|NOT COMPLETED|Overall Study||19
10027050|NCT01880515|11151248|FG000|STARTED|Overall Study||53
10027051|NCT01880515|11151249|FG001|STARTED|Overall Study||54
10027052|NCT01880515|11151248|FG000|COMPLETED|Overall Study||45
9963789|NCT01488279|11083541|FG000|STARTED|Overall Study||5
9963790|NCT01488279|11083542|FG001|STARTED|Overall Study||5
10027053|NCT01880515|11151249|FG001|COMPLETED|Overall Study||45
10027054|NCT01880515|11151248|FG000|NOT COMPLETED|Overall Study||8
10027055|NCT01880515|11151249|FG001|NOT COMPLETED|Overall Study||9
10027056|NCT01880528|11151258|FG000|STARTED|Overall Study||12
10027057|NCT01880528|11151259|FG001|STARTED|Overall Study||11
10027058|NCT01880528|11151258|FG000|COMPLETED|Overall Study||11
10027059|NCT01880528|11151259|FG001|COMPLETED|Overall Study||10
10027060|NCT01880528|11151258|FG000|NOT COMPLETED|Overall Study||1
10027061|NCT01880528|11151259|FG001|NOT COMPLETED|Overall Study||1
10027062|NCT01880554|11151265|FG000|STARTED|Overall Study|Patients enrolled in the study|68
10027063|NCT01880554|11151265|FG000|Population Eligible|Overall Study||58
10027064|NCT01880554|11151265|FG000|Population Eligible and Assessable|Overall Study||54
9702511|NCT01885078|10801965|FG000|COMPLETED|Treatment Period||19
9702512|NCT01885078|10801966|FG001|COMPLETED|Treatment Period||64
9702513|NCT01885078|10801967|FG002|COMPLETED|Treatment Period||49
9702514|NCT01885078|10801968|FG003|COMPLETED|Treatment Period||120
9702515|NCT01885078|10801969|FG004|COMPLETED|Treatment Period||27
9702516|NCT01885078|10801970|FG005|COMPLETED|Treatment Period||81
9702517|NCT01885078|10801971|FG006|COMPLETED|Treatment Period||0
9702518|NCT01885078|10801972|FG007|COMPLETED|Treatment Period||55
9702519|NCT01885078|10801973|FG008|COMPLETED|Treatment Period||0
9702520|NCT01885078|10801974|FG009|COMPLETED|Treatment Period||0
9702521|NCT01885078|10801965|FG000|NOT COMPLETED|Treatment Period||432
9702522|NCT01885078|10801966|FG001|NOT COMPLETED|Treatment Period||1027
9702523|NCT01885078|10801967|FG002|NOT COMPLETED|Treatment Period||131
9702524|NCT01885078|10801968|FG003|NOT COMPLETED|Treatment Period||283
9702525|NCT01885078|10801969|FG004|NOT COMPLETED|Treatment Period||90
9702526|NCT01885078|10801970|FG005|NOT COMPLETED|Treatment Period||250
9702527|NCT01885078|10801971|FG006|NOT COMPLETED|Treatment Period||221
9702528|NCT01885078|10801972|FG007|NOT COMPLETED|Treatment Period||28
9702529|NCT01885078|10801973|FG008|NOT COMPLETED|Treatment Period||0
9702530|NCT01885078|10801974|FG009|NOT COMPLETED|Treatment Period||0
9702531|NCT01885078|10801965|FG000|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
9702532|NCT01885078|10801966|FG001|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
9702533|NCT01885078|10801967|FG002|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
9702534|NCT01885078|10801968|FG003|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
9702535|NCT01885078|10801969|FG004|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
9702536|NCT01885078|10801970|FG005|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
9702537|NCT01885078|10801971|FG006|STARTED|Step-down Period||0
9702538|NCT01885078|10801972|FG007|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
9702539|NCT01885078|10801973|FG008|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|592
9702540|NCT01885078|10801974|FG009|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|594
9702541|NCT01885078|10801965|FG000|Complete Through Week 96|Step-down Period||0
9702542|NCT01885078|10801966|FG001|Complete Through Week 96|Step-down Period||0
9702543|NCT01885078|10801967|FG002|Complete Through Week 96|Step-down Period||0
9702544|NCT01885078|10801968|FG003|Complete Through Week 96|Step-down Period||0
9702545|NCT01885078|10801969|FG004|Complete Through Week 96|Step-down Period||0
9702546|NCT01885078|10801970|FG005|Complete Through Week 96|Step-down Period||0
9702547|NCT01885078|10801971|FG006|Complete Through Week 96|Step-down Period||0
9702548|NCT01885078|10801972|FG007|Complete Through Week 96|Step-down Period||0
9702549|NCT01885078|10801973|FG008|Complete Through Week 96|Step-down Period||407
9702550|NCT01885078|10801974|FG009|Complete Through Week 96|Step-down Period||455
9702551|NCT01885078|10801965|FG000|COMPLETED|Step-down Period||0
9702552|NCT01885078|10801966|FG001|COMPLETED|Step-down Period||0
9702553|NCT01885078|10801967|FG002|COMPLETED|Step-down Period||0
9702554|NCT01885078|10801968|FG003|COMPLETED|Step-down Period||0
9702555|NCT01885078|10801969|FG004|COMPLETED|Step-down Period||0
9963791|NCT01488279|11083541|FG000|COMPLETED|Overall Study||5
9963792|NCT01488279|11083542|FG001|COMPLETED|Overall Study||5
9963793|NCT01488279|11083541|FG000|NOT COMPLETED|Overall Study||0
9963794|NCT01488279|11083542|FG001|NOT COMPLETED|Overall Study||0
9963795|NCT01488318|11083551|FG000|STARTED|Overall Study||14
9963796|NCT01488318|11083551|FG000|COMPLETED|Overall Study||14
9963797|NCT01488318|11083551|FG000|NOT COMPLETED|Overall Study||0
9963798|NCT01488370|11083558|FG000|STARTED|Overall Study||22
9963799|NCT01488370|11083559|FG001|STARTED|Overall Study||23
9963800|NCT01488370|11083560|FG002|STARTED|Overall Study||20
9963801|NCT01488370|11083558|FG000|COMPLETED|Overall Study||22
9963802|NCT01488370|11083559|FG001|COMPLETED|Overall Study||22
9963803|NCT01488370|11083560|FG002|COMPLETED|Overall Study||19
9963804|NCT01488370|11083558|FG000|NOT COMPLETED|Overall Study||0
9963805|NCT01488370|11083559|FG001|NOT COMPLETED|Overall Study||1
9963806|NCT01488370|11083560|FG002|NOT COMPLETED|Overall Study||1
9963807|NCT01488409|11083570|FG000|STARTED|Overall Study||20
9963808|NCT01488409|11083571|FG001|STARTED|Overall Study||19
9963809|NCT01488409|11083570|FG000|COMPLETED|Overall Study||16
9963810|NCT01488409|11083571|FG001|COMPLETED|Overall Study||15
9963811|NCT01488409|11083570|FG000|NOT COMPLETED|Overall Study||4
10027065|NCT01880554|11151265|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
10027066|NCT01880554|11151265|FG000|NOT COMPLETED|Overall Study||16
10027067|NCT01880593|11151272|FG000|STARTED|Overall Study||18
10027068|NCT01880593|11151273|FG001|STARTED|Overall Study||16
10027069|NCT01880593|11151272|FG000|COMPLETED|Overall Study||10
10027070|NCT01880593|11151273|FG001|COMPLETED|Overall Study||10
10027071|NCT01880593|11151272|FG000|NOT COMPLETED|Overall Study||8
10027072|NCT01880593|11151273|FG001|NOT COMPLETED|Overall Study||6
10027073|NCT01880697|11151281|FG000|STARTED|Overall Study||63
10027074|NCT01880697|11151282|FG001|STARTED|Overall Study||63
10027075|NCT01880697|11151281|FG000|COMPLETED|Overall Study||63
9963812|NCT01488409|11083571|FG001|NOT COMPLETED|Overall Study||4
10027076|NCT01880697|11151282|FG001|COMPLETED|Overall Study||62
10027077|NCT01880697|11151281|FG000|NOT COMPLETED|Overall Study||0
10027078|NCT01880697|11151282|FG001|NOT COMPLETED|Overall Study||1
9702556|NCT01885078|10801970|FG005|COMPLETED|Step-down Period||0
9702557|NCT01885078|10801971|FG006|COMPLETED|Step-down Period||0
9702558|NCT01885078|10801972|FG007|COMPLETED|Step-down Period||0
9702559|NCT01885078|10801973|FG008|COMPLETED|Step-down Period||523
9702560|NCT01885078|10801974|FG009|COMPLETED|Step-down Period||533
9702561|NCT01885078|10801965|FG000|NOT COMPLETED|Step-down Period||0
9702562|NCT01885078|10801966|FG001|NOT COMPLETED|Step-down Period||0
9702563|NCT01885078|10801967|FG002|NOT COMPLETED|Step-down Period||0
9702564|NCT01885078|10801968|FG003|NOT COMPLETED|Step-down Period||0
9702565|NCT01885078|10801969|FG004|NOT COMPLETED|Step-down Period||0
9702566|NCT01885078|10801970|FG005|NOT COMPLETED|Step-down Period||0
9702567|NCT01885078|10801971|FG006|NOT COMPLETED|Step-down Period||0
9702568|NCT01885078|10801972|FG007|NOT COMPLETED|Step-down Period||0
9702569|NCT01885078|10801973|FG008|NOT COMPLETED|Step-down Period||69
9702570|NCT01885078|10801974|FG009|NOT COMPLETED|Step-down Period||61
9702571|NCT01047683|10801998|FG000|STARTED|Overall Study||76
9702572|NCT01047683|10801999|FG001|STARTED|Overall Study||76
9702573|NCT01047683|10802000|FG002|STARTED|Overall Study||77
9702574|NCT01047683|10801998|FG000|COMPLETED|Overall Study||71
9702575|NCT01047683|10801999|FG001|COMPLETED|Overall Study||70
9702576|NCT01047683|10802000|FG002|COMPLETED|Overall Study||74
9702577|NCT01047683|10801998|FG000|NOT COMPLETED|Overall Study||5
9702578|NCT01047683|10801999|FG001|NOT COMPLETED|Overall Study||6
9702579|NCT01047683|10802000|FG002|NOT COMPLETED|Overall Study||3
9702580|NCT01047501|10802011|FG000|STARTED|Overall Study||233
9702581|NCT01047501|10802012|FG001|STARTED|Overall Study||236
9702582|NCT01047501|10802013|FG002|STARTED|Overall Study||233
9702583|NCT01047501|10802011|FG000|COMPLETED|Overall Study||217
9702584|NCT01047501|10802012|FG001|COMPLETED|Overall Study||225
9702585|NCT01047501|10802013|FG002|COMPLETED|Overall Study||221
9702586|NCT01047501|10802011|FG000|NOT COMPLETED|Overall Study||16
9702587|NCT01047501|10802012|FG001|NOT COMPLETED|Overall Study||11
9702588|NCT01047501|10802013|FG002|NOT COMPLETED|Overall Study||12
9702589|NCT00981656|10802021|FG000|STARTED|Overall Study||37
9702590|NCT00981656|10802021|FG000|Eligible and Started Study Treatment|Overall Study||34
9702591|NCT00981656|10802021|FG000|COMPLETED|Overall Study||34
9702592|NCT00981656|10802021|FG000|NOT COMPLETED|Overall Study||3
9728544|NCT00112437|10827944|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0
9728545|NCT00112437|10827945|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0
9728546|NCT00112437|10827946|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0
9728547|NCT00112437|10827947|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0
9728548|NCT00112437|10827948|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0
9728549|NCT00112437|10827949|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0
9728550|NCT00112437|10827950|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23
9728551|NCT00112437|10827951|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22
9728552|NCT00112437|10827952|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22
9728553|NCT00112437|10827953|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27
9728554|NCT00112437|10827928|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728555|NCT00112437|10827929|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728556|NCT00112437|10827930|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728557|NCT00112437|10827931|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728558|NCT00112437|10827932|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728559|NCT00112437|10827933|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728560|NCT00112437|10827934|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728561|NCT00112437|10827935|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728562|NCT00112437|10827936|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728563|NCT00112437|10827937|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728564|NCT00112437|10827938|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728565|NCT00112437|10827939|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728566|NCT00112437|10827940|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728567|NCT00112437|10827941|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728568|NCT00112437|10827942|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728569|NCT00112437|10827943|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728570|NCT00112437|10827944|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728571|NCT00112437|10827945|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728572|NCT00112437|10827946|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728573|NCT00112437|10827947|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728574|NCT00112437|10827948|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728575|NCT00112437|10827949|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
9728576|NCT00112437|10827950|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
9728577|NCT00112437|10827951|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
9728578|NCT00112437|10827952|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
9728579|NCT00112437|10827953|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
9728580|NCT00112463|10828007|FG000|STARTED|Overall Study||40
9728581|NCT00112463|10828007|FG000|COMPLETED|Overall Study||1
9728582|NCT00112463|10828007|FG000|NOT COMPLETED|Overall Study||39
9728583|NCT00112489|10828012|FG000|STARTED|Overall Study|All patients enrolled on study|55
9728584|NCT00112489|10828012|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15
9728585|NCT00112489|10828012|FG000|NOT COMPLETED|Overall Study||40
9728586|NCT00112502|10828030|FG000|STARTED|Overall Study||22
9728587|NCT00112502|10828031|FG001|STARTED|Overall Study||22
9728588|NCT00112502|10828032|FG002|STARTED|Overall Study||22
9728589|NCT00112502|10828033|FG003|STARTED|Overall Study||22
9702593|NCT00838526|10802027|FG000|STARTED|Overall Study|Treated|59
9702594|NCT00838526|10802028|FG001|STARTED|Overall Study|Treated|176
9702595|NCT00838526|10802027|FG000|COMPLETED|Overall Study||35
9702596|NCT00838526|10802028|FG001|COMPLETED|Overall Study||137
9702597|NCT00838526|10802027|FG000|NOT COMPLETED|Overall Study||24
9963813|NCT01488448|11083579|FG000|STARTED|Overall Study||113
9963814|NCT01488448|11083580|FG001|STARTED|Overall Study||114
9963815|NCT01488448|11083579|FG000|COMPLETED|Overall Study||93
9963816|NCT01488448|11083580|FG001|COMPLETED|Overall Study||97
9963817|NCT01488448|11083579|FG000|NOT COMPLETED|Overall Study||20
9963818|NCT01488448|11083580|FG001|NOT COMPLETED|Overall Study||17
9963819|NCT01488487|11083588|FG000|STARTED|Overall Study||24
9963820|NCT01488487|11083588|FG000|Received Treatment|Overall Study||24
9963821|NCT01488487|11083588|FG000|COMPLETED|Overall Study||15
10027079|NCT01880723|11151290|FG000|STARTED|Overall Study||16
10027080|NCT01880723|11151291|FG001|STARTED|Overall Study||16
10027081|NCT01880723|11151290|FG000|COMPLETED|Overall Study||16
10027082|NCT01880723|11151291|FG001|COMPLETED|Overall Study||16
10027083|NCT01880723|11151290|FG000|NOT COMPLETED|Overall Study||0
10027084|NCT01880723|11151291|FG001|NOT COMPLETED|Overall Study||0
10027085|NCT01880736|11151301|FG000|STARTED|Overall Study||114
10027086|NCT01880736|11151302|FG001|STARTED|Overall Study||115
10027087|NCT01880736|11151303|FG002|STARTED|Overall Study||115
10027088|NCT01880736|11151304|FG003|STARTED|Overall Study||114
10027089|NCT01880736|11151301|FG000|COMPLETED|Overall Study||113
10027090|NCT01880736|11151302|FG001|COMPLETED|Overall Study||113
10027091|NCT01880736|11151303|FG002|COMPLETED|Overall Study||114
10027092|NCT01880736|11151304|FG003|COMPLETED|Overall Study||108
10027093|NCT01880736|11151301|FG000|NOT COMPLETED|Overall Study||1
10027094|NCT01880736|11151302|FG001|NOT COMPLETED|Overall Study||2
10027095|NCT01880736|11151303|FG002|NOT COMPLETED|Overall Study||1
10027096|NCT01880736|11151304|FG003|NOT COMPLETED|Overall Study||6
10027097|NCT01880840|11151316|FG000|STARTED|Overall Study||95
10027098|NCT01880840|11151317|FG001|STARTED|Overall Study||96
10027099|NCT01880840|11151316|FG000|COMPLETED|Overall Study||87
10027100|NCT01880840|11151317|FG001|COMPLETED|Overall Study||91
10027101|NCT01880840|11151316|FG000|NOT COMPLETED|Overall Study||8
10027102|NCT01880840|11151317|FG001|NOT COMPLETED|Overall Study||5
10027103|NCT01881009|11151325|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16
10027104|NCT01881009|11151326|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0
10027105|NCT01881009|11151325|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16
10027106|NCT01881009|11151326|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0
10027107|NCT01881009|11151325|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
10027108|NCT01881009|11151326|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
10027109|NCT01881009|11151325|FG000|STARTED|Summer Camp Session (6 Days)||0
10027110|NCT01881009|11151326|FG001|STARTED|Summer Camp Session (6 Days)||22
10027111|NCT01881009|11151325|FG000|COMPLETED|Summer Camp Session (6 Days)||0
10027112|NCT01881009|11151326|FG001|COMPLETED|Summer Camp Session (6 Days)||21
10027113|NCT01881009|11151325|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0
10027114|NCT01881009|11151326|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1
10027115|NCT01881087|11151336|FG000|STARTED|Overall Study||60
10027116|NCT01881087|11151337|FG001|STARTED|Overall Study||61
10027117|NCT01881087|11151338|FG002|STARTED|Overall Study||62
10027118|NCT01881087|11151336|FG000|COMPLETED|Overall Study||59
10027119|NCT01881087|11151337|FG001|COMPLETED|Overall Study||61
10027120|NCT01881087|11151338|FG002|COMPLETED|Overall Study||60
10027121|NCT01881087|11151336|FG000|NOT COMPLETED|Overall Study||1
10027122|NCT01881087|11151337|FG001|NOT COMPLETED|Overall Study||0
10027123|NCT01881087|11151338|FG002|NOT COMPLETED|Overall Study||2
10027124|NCT01881113|11151348|FG000|STARTED|Overall Study||51
10027125|NCT01881113|11151349|FG001|STARTED|Overall Study||50
10027126|NCT01881113|11151348|FG000|COMPLETED|Overall Study||43
10027127|NCT01881113|11151349|FG001|COMPLETED|Overall Study||44
10027128|NCT01881113|11151348|FG000|NOT COMPLETED|Overall Study||8
10027129|NCT01881113|11151349|FG001|NOT COMPLETED|Overall Study||6
10027130|NCT01881126|11151357|FG000|STARTED|Overall Study||47
10027131|NCT01881126|11151358|FG001|STARTED|Overall Study||46
10027132|NCT01881126|11151357|FG000|COMPLETED|Overall Study||46
10027133|NCT01881126|11151358|FG001|COMPLETED|Overall Study||44
10027134|NCT01881126|11151357|FG000|NOT COMPLETED|Overall Study||1
10027135|NCT01881126|11151358|FG001|NOT COMPLETED|Overall Study||2
10027136|NCT01881230|11151367|FG000|STARTED|Overall Study||61
10027137|NCT01881230|11151368|FG001|STARTED|Overall Study||64
9702598|NCT00838526|10802028|FG001|NOT COMPLETED|Overall Study||39
10027138|NCT01881230|11151369|FG002|STARTED|Overall Study||66
10027139|NCT01881230|11151367|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
10027140|NCT01881230|11151368|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
10027141|NCT01881230|11151369|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
9963822|NCT01488487|11083588|FG000|NOT COMPLETED|Overall Study||9
9963823|NCT01488578|11083592|FG000|STARTED|Overall Study||11157
10027142|NCT01881230|11151367|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
10027143|NCT01881230|11151368|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
10027144|NCT01881230|11151369|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
10081401|NCT02260635|11209908|FG001|STARTED|Double-Blind Treatment Period||27
9702599|NCT00126672|10802034|FG000|STARTED|Overall Study||36
9702600|NCT00126672|10802034|FG000|COMPLETED|Overall Study||28
9702601|NCT00126672|10802034|FG000|NOT COMPLETED|Overall Study||8
9702602|NCT03172780|10802041|FG000|STARTED|Overall Study||406
9702603|NCT03172780|10802042|FG001|STARTED|Overall Study||409
9702604|NCT03172780|10802043|FG002|STARTED|Overall Study||405
9702605|NCT03172780|10802041|FG000|COMPLETED|Overall Study||388
9702606|NCT03172780|10802042|FG001|COMPLETED|Overall Study||389
9702607|NCT03172780|10802043|FG002|COMPLETED|Overall Study||389
9702608|NCT03172780|10802041|FG000|NOT COMPLETED|Overall Study||18
9702609|NCT03172780|10802042|FG001|NOT COMPLETED|Overall Study||20
9702610|NCT03172780|10802043|FG002|NOT COMPLETED|Overall Study||16
9702611|NCT03151304|10802051|FG000|STARTED|Overall Study||64
9702612|NCT03151304|10802051|FG000|COMPLETED|Overall Study||0
9702613|NCT03151304|10802051|FG000|NOT COMPLETED|Overall Study||64
9702614|NCT03113409|10802055|FG000|STARTED|Overall Study||10
9702615|NCT03113409|10802056|FG001|STARTED|Overall Study|Study procedure was never started|0
9702616|NCT03113409|10802057|FG002|STARTED|Overall Study|Study procedure was never started|0
9702617|NCT03113409|10802055|FG000|COMPLETED|Overall Study||5
9702618|NCT03113409|10802056|FG001|COMPLETED|Overall Study||0
9702619|NCT03113409|10802057|FG002|COMPLETED|Overall Study||0
9702620|NCT03113409|10802055|FG000|NOT COMPLETED|Overall Study||5
9702621|NCT03113409|10802056|FG001|NOT COMPLETED|Overall Study||0
9702622|NCT03113409|10802057|FG002|NOT COMPLETED|Overall Study||0
9702623|NCT03007979|10802061|FG000|STARTED|Overall Study||55
9702624|NCT03007979|10802061|FG000|COMPLETED|Overall Study||54
9702625|NCT03007979|10802061|FG000|NOT COMPLETED|Overall Study||1
9702626|NCT02953340|10802067|FG000|STARTED|Overall Study||118
9702627|NCT02953340|10802068|FG001|STARTED|Overall Study||119
9702628|NCT02953340|10802067|FG000|Safety Population|Overall Study||117
9702629|NCT02953340|10802068|FG001|Safety Population|Overall Study||118
9702630|NCT02953340|10802067|FG000|Entered Safety Follow-up Period|Overall Study||117
9702631|NCT02953340|10802068|FG001|Entered Safety Follow-up Period|Overall Study||118
9702632|NCT02953340|10802067|FG000|COMPLETED|Overall Study||96
9702633|NCT02953340|10802068|FG001|COMPLETED|Overall Study||85
9702634|NCT02953340|10802067|FG000|NOT COMPLETED|Overall Study||22
9702635|NCT02953340|10802068|FG001|NOT COMPLETED|Overall Study||34
9702642|NCT02855944|10802091|FG000|STARTED|Period 1: Treatment||233
9702643|NCT02855944|10802092|FG001|STARTED|Period 1: Treatment||116
9702644|NCT02855944|10802091|FG000|COMPLETED|Period 1: Treatment||188
9702645|NCT02855944|10802092|FG001|COMPLETED|Period 1: Treatment||108
9702646|NCT02855944|10802091|FG000|NOT COMPLETED|Period 1: Treatment||45
9702647|NCT02855944|10802092|FG001|NOT COMPLETED|Period 1: Treatment||8
9702648|NCT02855944|10802091|FG000|STARTED|Period 2: Crossover to Rucaparib||0
9702649|NCT02855944|10802092|FG001|STARTED|Period 2: Crossover to Rucaparib||74
9702650|NCT02855944|10802091|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0
9702651|NCT02855944|10802092|FG001|COMPLETED|Period 2: Crossover to Rucaparib||47
9702652|NCT02855944|10802091|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0
9702653|NCT02855944|10802092|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||27
9702654|NCT02851407|10802101|FG000|STARTED|Overall Study||190
9702655|NCT02851407|10802102|FG001|STARTED|Overall Study||182
9702656|NCT02851407|10802101|FG000|COMPLETED|Overall Study||120
9702657|NCT02851407|10802102|FG001|COMPLETED|Overall Study||121
9702658|NCT02851407|10802101|FG000|NOT COMPLETED|Overall Study||70
9702659|NCT02851407|10802102|FG001|NOT COMPLETED|Overall Study||61
9702660|NCT02707276|10802112|FG000|STARTED|Overall Study||3
9702661|NCT02707276|10802113|FG001|STARTED|Overall Study||5
9702662|NCT02707276|10802114|FG002|STARTED|Overall Study||3
9702663|NCT02707276|10802115|FG003|STARTED|Overall Study||2
9702664|NCT02707276|10802112|FG000|COMPLETED|Overall Study||3
9702665|NCT02707276|10802113|FG001|COMPLETED|Overall Study||5
9702666|NCT02707276|10802114|FG002|COMPLETED|Overall Study||3
9702667|NCT02707276|10802115|FG003|COMPLETED|Overall Study||2
9702668|NCT02707276|10802112|FG000|NOT COMPLETED|Overall Study||0
9702669|NCT02707276|10802113|FG001|NOT COMPLETED|Overall Study||0
9702670|NCT02707276|10802114|FG002|NOT COMPLETED|Overall Study||0
9702671|NCT02707276|10802115|FG003|NOT COMPLETED|Overall Study||0
9702672|NCT02666430|10802127|FG000|STARTED|Baseline||64
9702673|NCT02666430|10802128|FG001|STARTED|Baseline||63
9702674|NCT02666430|10802127|FG000|COMPLETED|Baseline||64
9702675|NCT02666430|10802128|FG001|COMPLETED|Baseline||63
9702676|NCT02666430|10802127|FG000|NOT COMPLETED|Baseline||0
9702677|NCT02666430|10802128|FG001|NOT COMPLETED|Baseline||0
9702678|NCT02666430|10802127|FG000|STARTED|Period 1||64
9702679|NCT02666430|10802128|FG001|STARTED|Period 1||63
9702680|NCT02666430|10802127|FG000|COMPLETED|Period 1||63
9702681|NCT02666430|10802128|FG001|COMPLETED|Period 1||62
9702682|NCT02666430|10802127|FG000|NOT COMPLETED|Period 1||1
9702683|NCT02666430|10802128|FG001|NOT COMPLETED|Period 1||1
9702684|NCT02666430|10802127|FG000|STARTED|Period 2||63
9702685|NCT02666430|10802128|FG001|STARTED|Period 2||62
9702686|NCT02666430|10802127|FG000|COMPLETED|Period 2||62
9702687|NCT02666430|10802128|FG001|COMPLETED|Period 2||58
9702688|NCT02666430|10802127|FG000|NOT COMPLETED|Period 2||1
9702689|NCT02666430|10802128|FG001|NOT COMPLETED|Period 2||4
9702690|NCT02666430|10802127|FG000|STARTED|Period 3||62
9702691|NCT02666430|10802128|FG001|STARTED|Period 3||58
9702692|NCT02666430|10802127|FG000|COMPLETED|Period 3||61
9702693|NCT02666430|10802128|FG001|COMPLETED|Period 3||58
9702694|NCT02666430|10802127|FG000|NOT COMPLETED|Period 3||1
9702695|NCT02666430|10802128|FG001|NOT COMPLETED|Period 3||0
9702696|NCT02643420|10802136|FG000|STARTED|Overall Study||196
9702697|NCT02643420|10802137|FG001|STARTED|Overall Study||210
9702698|NCT02643420|10802136|FG000|Safety Population|Overall Study|One participant was randomized to the Arm 2: Pegfilgrastim and TC but was inadvertently administered SPI-2012 on Cycle 1, Day 2 and was included in the Arm 1: SPI-2012 and TC for the Safety Population.|197
9702699|NCT02643420|10802137|FG001|Safety Population|Overall Study||208
9702700|NCT02643420|10802136|FG000|COMPLETED|Overall Study||142
9702701|NCT02643420|10802137|FG001|COMPLETED|Overall Study||145
9702702|NCT02643420|10802136|FG000|NOT COMPLETED|Overall Study||54
9702703|NCT02643420|10802137|FG001|NOT COMPLETED|Overall Study||65
9702704|NCT02639559|10802151|FG000|STARTED|Overall Study||25
9702705|NCT02639559|10802152|FG001|STARTED|Overall Study||25
9702706|NCT02639559|10802151|FG000|COMPLETED|Overall Study||24
9702707|NCT02639559|10802152|FG001|COMPLETED|Overall Study||22
9702708|NCT02639559|10802151|FG000|NOT COMPLETED|Overall Study||1
9702709|NCT02639559|10802152|FG001|NOT COMPLETED|Overall Study||3
9702710|NCT02569476|10802158|FG000|STARTED|Overall Study||119
9702711|NCT02569476|10802158|FG000|COMPLETED|Overall Study||0
9702712|NCT02569476|10802158|FG000|NOT COMPLETED|Overall Study||119
9702713|NCT02549209|10802168|FG000|STARTED|Overall Study||46
9702714|NCT02549209|10802168|FG000|COMPLETED|Overall Study||46
9702715|NCT02549209|10802168|FG000|NOT COMPLETED|Overall Study||0
9702716|NCT02496676|10802174|FG000|STARTED|Phase 1 - Period 1||2
9702717|NCT02496676|10802175|FG001|STARTED|Phase 1 - Period 1||3
9702718|NCT02496676|10802174|FG000|COMPLETED|Phase 1 - Period 1||2
9702719|NCT02496676|10802175|FG001|COMPLETED|Phase 1 - Period 1||2
9702720|NCT02496676|10802174|FG000|NOT COMPLETED|Phase 1 - Period 1||0
9702721|NCT02496676|10802175|FG001|NOT COMPLETED|Phase 1 - Period 1||1
9702722|NCT02496676|10802174|FG000|STARTED|Phase 1 - Period 2||2
9702723|NCT02496676|10802175|FG001|STARTED|Phase 1 - Period 2||2
9702724|NCT02496676|10802174|FG000|COMPLETED|Phase 1 - Period 2||2
9702725|NCT02496676|10802175|FG001|COMPLETED|Phase 1 - Period 2||2
9702726|NCT02496676|10802174|FG000|NOT COMPLETED|Phase 1 - Period 2||0
10027145|NCT01881230|11151367|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0
10027146|NCT01881230|11151368|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0
10027147|NCT01881230|11151369|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0
10027148|NCT01881230|11151367|FG000|NOT COMPLETED|Overall Study||61
10027149|NCT01881230|11151368|FG001|NOT COMPLETED|Overall Study||64
10027150|NCT01881230|11151369|FG002|NOT COMPLETED|Overall Study||66
10027151|NCT01881373|11151380|FG000|STARTED|Baseline|Cross-sectional sample|1517
10027152|NCT01881373|11151381|FG001|STARTED|Baseline|Cross-sectional sample|1491
10027153|NCT01881373|11151382|FG002|STARTED|Baseline|Cross-sectional sample|1321
10027154|NCT01881373|11151380|FG000|COMPLETED|Baseline|Cross-sectional sample|1517
10027155|NCT01881373|11151381|FG001|COMPLETED|Baseline|Cross-sectional sample|1491
10027156|NCT01881373|11151382|FG002|COMPLETED|Baseline|Cross-sectional sample|1321
10027157|NCT01881373|11151380|FG000|NOT COMPLETED|Baseline||0
10027158|NCT01881373|11151381|FG001|NOT COMPLETED|Baseline||0
10027159|NCT01881373|11151382|FG002|NOT COMPLETED|Baseline||0
10027160|NCT01881373|11151380|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
10027161|NCT01881373|11151381|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
10027162|NCT01881373|11151382|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
10027163|NCT01881373|11151380|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
10027164|NCT01881373|11151381|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
10027165|NCT01881373|11151382|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
10027166|NCT01881373|11151380|FG000|NOT COMPLETED|24 Months||0
10027167|NCT01881373|11151381|FG001|NOT COMPLETED|24 Months||0
10027168|NCT01881373|11151382|FG002|NOT COMPLETED|24 Months||0
10027169|NCT01881412|11151396|FG000|STARTED|Overall Study||59
10027170|NCT01881412|11151397|FG001|STARTED|Overall Study||59
10027171|NCT01881412|11151396|FG000|COMPLETED|Overall Study||49
10027172|NCT01881412|11151397|FG001|COMPLETED|Overall Study||57
10027173|NCT01881412|11151396|FG000|NOT COMPLETED|Overall Study||10
10027174|NCT01881412|11151397|FG001|NOT COMPLETED|Overall Study||2
10027175|NCT01881620|11151403|FG000|STARTED|Overall Study||109
10027176|NCT01881620|11151403|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
10027177|NCT01881620|11151403|FG000|NOT COMPLETED|Overall Study||4
10027178|NCT01881737|11151407|FG000|STARTED|Overall Study|This is a pilot study|15
10027179|NCT01881737|11151407|FG000|Number Screened|Overall Study||15
10027180|NCT01881737|11151407|FG000|COMPLETED|Overall Study||10
10027181|NCT01881737|11151407|FG000|NOT COMPLETED|Overall Study||5
10027182|NCT01881750|11151415|FG000|STARTED|Overall Study||27
10027183|NCT01881750|11151416|FG001|STARTED|Overall Study||26
10027184|NCT01881750|11151415|FG000|COMPLETED|Overall Study||25
10027185|NCT01881750|11151416|FG001|COMPLETED|Overall Study||22
10027186|NCT01881750|11151415|FG000|NOT COMPLETED|Overall Study||2
9702727|NCT02496676|10802175|FG001|NOT COMPLETED|Phase 1 - Period 2||0
9702728|NCT02496676|10802174|FG000|STARTED|Washout Period||2
9702729|NCT02496676|10802175|FG001|STARTED|Washout Period||2
10027187|NCT01881750|11151416|FG001|NOT COMPLETED|Overall Study||4
9702730|NCT02496676|10802174|FG000|COMPLETED|Washout Period||2
9702731|NCT02496676|10802175|FG001|COMPLETED|Washout Period||2
10027188|NCT01881776|11151427|FG000|STARTED|Overall Study||24
10027189|NCT01881776|11151428|FG001|STARTED|Overall Study||24
10027190|NCT01881776|11151429|FG002|STARTED|Overall Study||22
10027191|NCT01881776|11151427|FG000|COMPLETED|Overall Study||23
10027192|NCT01881776|11151428|FG001|COMPLETED|Overall Study||20
10027193|NCT01881776|11151429|FG002|COMPLETED|Overall Study||20
10027194|NCT01881776|11151427|FG000|NOT COMPLETED|Overall Study||1
10027195|NCT01881776|11151428|FG001|NOT COMPLETED|Overall Study||4
10027196|NCT01881776|11151429|FG002|NOT COMPLETED|Overall Study||2
10027197|NCT01881789|11151443|FG000|STARTED|Overall Study||3
10027198|NCT01881789|11151444|FG001|STARTED|Overall Study||7
10027199|NCT01881789|11151445|FG002|STARTED|Overall Study||3
10027200|NCT01881789|11151446|FG003|STARTED|Overall Study||3
10027201|NCT01881789|11151447|FG004|STARTED|Overall Study||2
10027202|NCT01881789|11151448|FG005|STARTED|Overall Study||3
10027203|NCT01881789|11151443|FG000|COMPLETED|Overall Study||0
10027204|NCT01881789|11151444|FG001|COMPLETED|Overall Study||0
10027205|NCT01881789|11151445|FG002|COMPLETED|Overall Study||0
10027206|NCT01881789|11151446|FG003|COMPLETED|Overall Study||0
10027207|NCT01881789|11151447|FG004|COMPLETED|Overall Study||0
10027208|NCT01881789|11151448|FG005|COMPLETED|Overall Study||0
10027209|NCT01881789|11151443|FG000|NOT COMPLETED|Overall Study||3
10027210|NCT01881789|11151444|FG001|NOT COMPLETED|Overall Study||7
10027211|NCT01881789|11151445|FG002|NOT COMPLETED|Overall Study||3
10027212|NCT01881789|11151446|FG003|NOT COMPLETED|Overall Study||3
10027213|NCT01881789|11151447|FG004|NOT COMPLETED|Overall Study||2
10027214|NCT01881789|11151448|FG005|NOT COMPLETED|Overall Study||3
10027215|NCT01881828|11151465|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71
10027216|NCT01881828|11151466|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69
10027217|NCT01881828|11151465|FG000|COMPLETED|Overall Study||71
10027218|NCT01881828|11151466|FG001|COMPLETED|Overall Study||69
10027219|NCT01881828|11151465|FG000|NOT COMPLETED|Overall Study||0
10027220|NCT01881828|11151466|FG001|NOT COMPLETED|Overall Study||0
10027221|NCT01881867|11151474|FG000|STARTED|Overall Study||26
10027222|NCT01881867|11151475|FG001|STARTED|Overall Study||28
10027223|NCT01881867|11151474|FG000|COMPLETED|Overall Study||14
10027224|NCT01881867|11151475|FG001|COMPLETED|Overall Study||15
10027225|NCT01881867|11151474|FG000|NOT COMPLETED|Overall Study||12
10027226|NCT01881867|11151475|FG001|NOT COMPLETED|Overall Study||13
10027227|NCT01882062|11151483|FG000|STARTED|Overall Study|16th of may 2013|10
10027228|NCT01882062|11151483|FG000|COMPLETED|Overall Study|18th of july 2013|10
10027229|NCT01882062|11151483|FG000|NOT COMPLETED|Overall Study||0
10027230|NCT01882088|11151487|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
10027231|NCT01882088|11151487|FG000|COMPLETED|Overall Study||30
10027232|NCT01882088|11151487|FG000|NOT COMPLETED|Overall Study||5
10027233|NCT01882257|11151494|FG000|STARTED|Study Origination to Beginning Therapy||11
10027234|NCT01882257|11151495|FG001|STARTED|Study Origination to Beginning Therapy||40
10027235|NCT01882257|11151496|FG002|STARTED|Study Origination to Beginning Therapy||23
10027236|NCT01882257|11151494|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11
10027237|NCT01882257|11151495|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
10027238|NCT01882257|11151496|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
10027239|NCT01882257|11151494|FG000|COMPLETED|Study Origination to Beginning Therapy||11
10027240|NCT01882257|11151495|FG001|COMPLETED|Study Origination to Beginning Therapy||38
10027241|NCT01882257|11151496|FG002|COMPLETED|Study Origination to Beginning Therapy||22
10027242|NCT01882257|11151494|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0
10027243|NCT01882257|11151495|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2
10027244|NCT01882257|11151496|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1
10027245|NCT01882257|11151494|FG000|STARTED|Therapy Portion of Study (12 Months)||11
10027246|NCT01882257|11151495|FG001|STARTED|Therapy Portion of Study (12 Months)||38
10027247|NCT01882257|11151496|FG002|STARTED|Therapy Portion of Study (12 Months)||22
10027248|NCT01882257|11151494|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11
10027249|NCT01882257|11151495|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27
10027250|NCT01882257|11151496|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18
10027251|NCT01882257|11151494|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
10027252|NCT01882257|11151495|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
10027253|NCT01882257|11151496|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
10027254|NCT01882413|11151503|FG000|STARTED|Overall Study||204
10027255|NCT01882413|11151503|FG000|COMPLETED|Overall Study||204
10027256|NCT01882413|11151503|FG000|NOT COMPLETED|Overall Study||0
10027257|NCT01882439|11151511|FG000|STARTED|Overall Study|Received treatment|131
10027258|NCT01882439|11151512|FG001|STARTED|Overall Study|Received treatment|132
10027259|NCT01882439|11151513|FG002|STARTED|Overall Study|Received treatment|66
10027260|NCT01882439|11151514|FG003|STARTED|Overall Study|Received treatment|65
10027261|NCT01882439|11151511|FG000|COMPLETED|Overall Study||122
10027262|NCT01882439|11151512|FG001|COMPLETED|Overall Study||111
10027263|NCT01882439|11151513|FG002|COMPLETED|Overall Study||56
10027264|NCT01882439|11151514|FG003|COMPLETED|Overall Study||56
10027265|NCT01882439|11151511|FG000|NOT COMPLETED|Overall Study||9
10027266|NCT01882439|11151512|FG001|NOT COMPLETED|Overall Study||21
10027267|NCT01882439|11151513|FG002|NOT COMPLETED|Overall Study||10
9702732|NCT02496676|10802174|FG000|NOT COMPLETED|Washout Period||0
9702733|NCT02496676|10802175|FG001|NOT COMPLETED|Washout Period||0
9702734|NCT02496676|10802174|FG000|STARTED|Phase 2 - IV MgSO4||2
9702735|NCT02496676|10802175|FG001|STARTED|Phase 2 - IV MgSO4||2
9702736|NCT02496676|10802174|FG000|COMPLETED|Phase 2 - IV MgSO4||2
9702737|NCT02496676|10802175|FG001|COMPLETED|Phase 2 - IV MgSO4||1
9702738|NCT02496676|10802174|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0
9702739|NCT02496676|10802175|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1
9702740|NCT02496676|10802174|FG000|STARTED|Phase 2 - Oral Magnesium||2
9702741|NCT02496676|10802175|FG001|STARTED|Phase 2 - Oral Magnesium||1
9702742|NCT02496676|10802174|FG000|COMPLETED|Phase 2 - Oral Magnesium||2
9702743|NCT02496676|10802175|FG001|COMPLETED|Phase 2 - Oral Magnesium||1
9702744|NCT02496676|10802174|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0
9702745|NCT02496676|10802175|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0
9702746|NCT02494141|10802191|FG000|STARTED|Overall Study||34
9702747|NCT02494141|10802192|FG001|STARTED|Overall Study||34
9702748|NCT02494141|10802191|FG000|COMPLETED|Overall Study||28
9702749|NCT02494141|10802192|FG001|COMPLETED|Overall Study||29
9702750|NCT02494141|10802191|FG000|NOT COMPLETED|Overall Study||6
9702751|NCT02494141|10802192|FG001|NOT COMPLETED|Overall Study||5
9702752|NCT02412618|10802200|FG000|STARTED|Overall Study||50
9702753|NCT02412618|10802201|FG001|STARTED|Overall Study||50
9702754|NCT02412618|10802200|FG000|COMPLETED|Overall Study||48
9702755|NCT02412618|10802201|FG001|COMPLETED|Overall Study||48
9702756|NCT02412618|10802200|FG000|NOT COMPLETED|Overall Study||2
9702757|NCT02412618|10802201|FG001|NOT COMPLETED|Overall Study||2
9702758|NCT02373683|10802209|FG000|STARTED|Overall Study||6
9702759|NCT02373683|10802210|FG001|STARTED|Overall Study||4
9702760|NCT02373683|10802209|FG000|COMPLETED|Overall Study||6
9702761|NCT02373683|10802210|FG001|COMPLETED|Overall Study||4
9702762|NCT02373683|10802209|FG000|NOT COMPLETED|Overall Study||0
9702763|NCT02373683|10802210|FG001|NOT COMPLETED|Overall Study||0
9702764|NCT02351180|10802218|FG000|STARTED|Overall Study||8
9702765|NCT02351180|10802219|FG001|STARTED|Overall Study||8
9702766|NCT02351180|10802218|FG000|COMPLETED|Overall Study||7
9702767|NCT02351180|10802219|FG001|COMPLETED|Overall Study||8
9702768|NCT02351180|10802218|FG000|NOT COMPLETED|Overall Study||1
9702769|NCT02351180|10802219|FG001|NOT COMPLETED|Overall Study||0
9702770|NCT02337764|10802225|FG000|STARTED|Overall Study||222
9702771|NCT02337764|10802225|FG000|COMPLETED|Overall Study||162
9702772|NCT02337764|10802225|FG000|NOT COMPLETED|Overall Study||60
10027268|NCT01882439|11151514|FG003|NOT COMPLETED|Overall Study||9
10027269|NCT01882465|11151529|FG000|STARTED|Period 1||6
10027270|NCT01882465|11151530|FG001|STARTED|Period 1||6
10027271|NCT01882465|11151531|FG002|STARTED|Period 1||5
10027272|NCT01882465|11151532|FG003|STARTED|Period 1||6
10027273|NCT01882465|11151533|FG004|STARTED|Period 1||5
10027274|NCT01882465|11151534|FG005|STARTED|Period 1||5
10027275|NCT01882465|11151535|FG006|STARTED|Period 1||1
10027276|NCT01882465|11151529|FG000|COMPLETED|Period 1||6
10027277|NCT01882465|11151530|FG001|COMPLETED|Period 1||6
10027278|NCT01882465|11151531|FG002|COMPLETED|Period 1||5
10027279|NCT01882465|11151532|FG003|COMPLETED|Period 1||5
10027280|NCT01882465|11151533|FG004|COMPLETED|Period 1||5
10027281|NCT01882465|11151534|FG005|COMPLETED|Period 1||5
10027282|NCT01882465|11151535|FG006|COMPLETED|Period 1||0
10027283|NCT01882465|11151529|FG000|NOT COMPLETED|Period 1||0
10027284|NCT01882465|11151530|FG001|NOT COMPLETED|Period 1||0
9848059|NCT00856986|10960682|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
9848060|NCT00856986|10960683|FG003|STARTED|Extension Period, Weeks 26-52||0
9848061|NCT00856986|10960684|FG004|STARTED|Extension Period, Weeks 26-52||0
9848062|NCT00856986|10960680|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122
9848063|NCT00856986|10960681|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140
10027285|NCT01882465|11151531|FG002|NOT COMPLETED|Period 1||0
10027286|NCT01882465|11151532|FG003|NOT COMPLETED|Period 1||1
9702773|NCT02337738|10802232|FG000|STARTED|Overall Study||141
9702774|NCT02337738|10802233|FG001|STARTED|Overall Study||134
9702775|NCT02337738|10802234|FG002|STARTED|Overall Study||129
9702776|NCT02337738|10802232|FG000|COMPLETED|Overall Study||119
9702777|NCT02337738|10802233|FG001|COMPLETED|Overall Study||104
9702778|NCT02337738|10802234|FG002|COMPLETED|Overall Study||103
9702779|NCT02337738|10802232|FG000|NOT COMPLETED|Overall Study||22
9702780|NCT02337738|10802233|FG001|NOT COMPLETED|Overall Study||30
9702781|NCT02337738|10802234|FG002|NOT COMPLETED|Overall Study||26
9702782|NCT02332187|10802244|FG000|STARTED|Overall Study||5
9702783|NCT02332187|10802245|FG001|STARTED|Overall Study||10
9702784|NCT02332187|10802244|FG000|COMPLETED|Overall Study||3
10027287|NCT01882465|11151533|FG004|NOT COMPLETED|Period 1||0
9702785|NCT02332187|10802245|FG001|COMPLETED|Overall Study||7
9702786|NCT02332187|10802244|FG000|NOT COMPLETED|Overall Study||2
9702787|NCT02332187|10802245|FG001|NOT COMPLETED|Overall Study||3
9728590|NCT00112502|10828034|FG004|STARTED|Overall Study||23
9728591|NCT00112502|10828035|FG005|STARTED|Overall Study||22
9728592|NCT00112502|10828036|FG006|STARTED|Overall Study||23
9728593|NCT00112502|10828037|FG007|STARTED|Overall Study||22
9728594|NCT00112502|10828030|FG000|COMPLETED|Overall Study||22
9728595|NCT00112502|10828031|FG001|COMPLETED|Overall Study||21
9728596|NCT00112502|10828032|FG002|COMPLETED|Overall Study||21
9728597|NCT00112502|10828033|FG003|COMPLETED|Overall Study||18
9728598|NCT00112502|10828034|FG004|COMPLETED|Overall Study||21
9728599|NCT00112502|10828035|FG005|COMPLETED|Overall Study||17
9728600|NCT00112502|10828036|FG006|COMPLETED|Overall Study||20
9728601|NCT00112502|10828037|FG007|COMPLETED|Overall Study||15
9728602|NCT00112502|10828030|FG000|NOT COMPLETED|Overall Study||0
9728603|NCT00112502|10828031|FG001|NOT COMPLETED|Overall Study||1
9728604|NCT00112502|10828032|FG002|NOT COMPLETED|Overall Study||1
9728605|NCT00112502|10828033|FG003|NOT COMPLETED|Overall Study||4
9728606|NCT00112502|10828034|FG004|NOT COMPLETED|Overall Study||2
9728607|NCT00112502|10828035|FG005|NOT COMPLETED|Overall Study||5
9728608|NCT00112502|10828036|FG006|NOT COMPLETED|Overall Study||3
9728609|NCT00112502|10828037|FG007|NOT COMPLETED|Overall Study||7
9728610|NCT00112580|10828067|FG000|STARTED|Overall Study||8
9728611|NCT00112580|10828068|FG001|STARTED|Overall Study||19
9728612|NCT00112580|10828067|FG000|COMPLETED|Overall Study||0
9728613|NCT00112580|10828068|FG001|COMPLETED|Overall Study||0
9728614|NCT00112580|10828067|FG000|NOT COMPLETED|Overall Study||8
9728615|NCT00112580|10828068|FG001|NOT COMPLETED|Overall Study||19
9728616|NCT00112593|10828073|FG000|STARTED|Overall Study||5
9728617|NCT00112593|10828073|FG000|COMPLETED|Overall Study||5
9728618|NCT00112593|10828073|FG000|NOT COMPLETED|Overall Study||0
9728619|NCT00112671|10828077|FG000|STARTED|Overall Study||17
9728620|NCT00112671|10828077|FG000|COMPLETED|Overall Study||17
9728621|NCT00112671|10828077|FG000|NOT COMPLETED|Overall Study||0
9728622|NCT00112723|10828081|FG000|STARTED|Overall Study||13
9728623|NCT00112723|10828082|FG001|STARTED|Overall Study||19
9728624|NCT00112723|10828083|FG002|STARTED|Overall Study||14
9728625|NCT00112723|10828081|FG000|Patients Evaluable for Toxicity|Overall Study||11
9728626|NCT00112723|10828082|FG001|Patients Evaluable for Toxicity|Overall Study||12
9728627|NCT00112723|10828083|FG002|Patients Evaluable for Toxicity|Overall Study||12
9728628|NCT00112723|10828081|FG000|COMPLETED|Overall Study||11
9728629|NCT00112723|10828082|FG001|COMPLETED|Overall Study||12
9728630|NCT00112723|10828083|FG002|COMPLETED|Overall Study||12
9728631|NCT00112723|10828081|FG000|NOT COMPLETED|Overall Study||2
9728632|NCT00112723|10828082|FG001|NOT COMPLETED|Overall Study||7
9728633|NCT00112723|10828083|FG002|NOT COMPLETED|Overall Study||2
9728634|NCT00112736|10828107|FG000|STARTED|Overall Study||22
9728635|NCT00112736|10828108|FG001|STARTED|Overall Study||47
9728636|NCT00112736|10828107|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
9728637|NCT00112736|10828108|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
9728638|NCT00112736|10828107|FG000|NOT COMPLETED|Overall Study||1
9728639|NCT00112736|10828108|FG001|NOT COMPLETED|Overall Study||0
9728640|NCT00112827|10828125|FG000|STARTED|Overall Study||3
9728641|NCT00112827|10828126|FG001|STARTED|Overall Study||4
9728642|NCT00112827|10828127|FG002|STARTED|Overall Study||4
9728643|NCT00112827|10828128|FG003|STARTED|Overall Study||36
9728644|NCT00112827|10828129|FG004|STARTED|Overall Study||7
9728645|NCT00112827|10828125|FG000|COMPLETED|Overall Study||3
9728646|NCT00112827|10828126|FG001|COMPLETED|Overall Study||4
9728647|NCT00112827|10828127|FG002|COMPLETED|Overall Study||4
9728648|NCT00112827|10828128|FG003|COMPLETED|Overall Study||36
9728649|NCT00112827|10828129|FG004|COMPLETED|Overall Study||7
9728650|NCT00112827|10828125|FG000|NOT COMPLETED|Overall Study||0
9728651|NCT00112827|10828126|FG001|NOT COMPLETED|Overall Study||0
9728652|NCT00112827|10828127|FG002|NOT COMPLETED|Overall Study||0
9728653|NCT00112827|10828128|FG003|NOT COMPLETED|Overall Study||0
9728654|NCT00112827|10828129|FG004|NOT COMPLETED|Overall Study||0
9728655|NCT00112866|10828144|FG000|STARTED|Overall Study||15
9728656|NCT00112866|10828145|FG001|STARTED|Overall Study||15
9728657|NCT00112866|10828144|FG000|COMPLETED|Overall Study||13
9728658|NCT00112866|10828145|FG001|COMPLETED|Overall Study||13
9728659|NCT00112866|10828144|FG000|NOT COMPLETED|Overall Study||2
9728660|NCT00112866|10828145|FG001|NOT COMPLETED|Overall Study||2
9728661|NCT00112905|10828159|FG000|STARTED|Overall Study||27
9728662|NCT00112905|10828159|FG000|Eligible and Treated|Overall Study||22
9728663|NCT00112905|10828159|FG000|COMPLETED|Overall Study||15
9728664|NCT00112905|10828159|FG000|NOT COMPLETED|Overall Study||12
9728665|NCT00112918|10828166|FG000|STARTED|Overall Study||1151
9728666|NCT00112918|10828167|FG001|STARTED|Overall Study||1155
9728667|NCT00112918|10828168|FG002|STARTED|Overall Study||1145
9728668|NCT00112918|10828166|FG000|Received Treatment|Overall Study||1126
9728669|NCT00112918|10828167|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
9728670|NCT00112918|10828168|FG002|Received Treatment|Overall Study||1135
9728671|NCT00112918|10828166|FG000|Stage III Disease Population|Overall Study||955
9728672|NCT00112918|10828167|FG001|Stage III Disease Population|Overall Study||960
9728673|NCT00112918|10828168|FG002|Stage III Disease Population|Overall Study||952
9731863|NCT00136916|10831824|FG001|NOT COMPLETED|Overall Study||104
9702788|NCT02227875|10802253|FG000|STARTED|Overall Study||277
9702789|NCT02227875|10802254|FG001|STARTED|Overall Study||283
9702790|NCT02227875|10802253|FG000|COMPLETED|Overall Study||240
9702791|NCT02227875|10802254|FG001|COMPLETED|Overall Study||250
9702792|NCT02227875|10802253|FG000|NOT COMPLETED|Overall Study||37
9702793|NCT02227875|10802254|FG001|NOT COMPLETED|Overall Study||33
9702794|NCT02227862|10802262|FG000|STARTED|Overall Study||280
9702795|NCT02227862|10802263|FG001|STARTED|Overall Study||278
9702796|NCT02227862|10802262|FG000|Week 24|Overall Study||269
9702797|NCT02227862|10802263|FG001|Week 24|Overall Study||263
9702798|NCT02227862|10802262|FG000|COMPLETED|Overall Study||261
9702799|NCT02227862|10802263|FG001|COMPLETED|Overall Study||256
9702800|NCT02227862|10802262|FG000|NOT COMPLETED|Overall Study||19
9702801|NCT02227862|10802263|FG001|NOT COMPLETED|Overall Study||22
9702802|NCT02200939|10802271|FG000|STARTED|Overall Study||33
9702803|NCT02200939|10802272|FG001|STARTED|Overall Study||115
9702804|NCT02200939|10802271|FG000|COMPLETED|Overall Study||31
9702805|NCT02200939|10802272|FG001|COMPLETED|Overall Study||104
9702806|NCT02200939|10802271|FG000|NOT COMPLETED|Overall Study||2
9702807|NCT02200939|10802272|FG001|NOT COMPLETED|Overall Study||11
9702808|NCT02108964|10802290|FG000|STARTED|Overall Study||17
9702809|NCT02108964|10802291|FG001|STARTED|Overall Study||38
9702810|NCT02108964|10802292|FG002|STARTED|Overall Study||73
9702811|NCT02108964|10802293|FG003|STARTED|Overall Study||8
9702812|NCT02108964|10802294|FG004|STARTED|Overall Study||28
9702813|NCT02108964|10802295|FG005|STARTED|Overall Study||5
9702814|NCT02108964|10802296|FG006|STARTED|Overall Study||11
9702815|NCT02108964|10802297|FG007|STARTED|Overall Study||45
9702816|NCT02108964|10802290|FG000|COMPLETED|Overall Study||3
9702817|NCT02108964|10802291|FG001|COMPLETED|Overall Study||6
9702818|NCT02108964|10802292|FG002|COMPLETED|Overall Study||8
9702819|NCT02108964|10802293|FG003|COMPLETED|Overall Study||2
9702820|NCT02108964|10802294|FG004|COMPLETED|Overall Study||3
9702821|NCT02108964|10802295|FG005|COMPLETED|Overall Study||0
9702822|NCT02108964|10802296|FG006|COMPLETED|Overall Study||0
9702823|NCT02108964|10802297|FG007|COMPLETED|Overall Study||33
9702824|NCT02108964|10802290|FG000|NOT COMPLETED|Overall Study||14
9702825|NCT02108964|10802291|FG001|NOT COMPLETED|Overall Study||32
9702826|NCT02108964|10802292|FG002|NOT COMPLETED|Overall Study||65
9702827|NCT02108964|10802293|FG003|NOT COMPLETED|Overall Study||6
9702828|NCT02108964|10802294|FG004|NOT COMPLETED|Overall Study||25
9702829|NCT02108964|10802295|FG005|NOT COMPLETED|Overall Study||5
9702830|NCT02108964|10802296|FG006|NOT COMPLETED|Overall Study||11
9702831|NCT02108964|10802297|FG007|NOT COMPLETED|Overall Study||12
9702832|NCT02022566|10802318|FG000|STARTED|Overall Study||227
9702833|NCT02022566|10802319|FG001|STARTED|Overall Study||90
9702834|NCT02022566|10802318|FG000|COMPLETED|Overall Study||169
9702835|NCT02022566|10802319|FG001|COMPLETED|Overall Study||49
10027288|NCT01882465|11151534|FG005|NOT COMPLETED|Period 1||0
10027289|NCT01882465|11151535|FG006|NOT COMPLETED|Period 1||1
10027290|NCT01882465|11151529|FG000|STARTED|Period 2||6
10027291|NCT01882465|11151530|FG001|STARTED|Period 2||6
10027292|NCT01882465|11151531|FG002|STARTED|Period 2||5
10027293|NCT01882465|11151532|FG003|STARTED|Period 2||5
10027294|NCT01882465|11151533|FG004|STARTED|Period 2||5
10027295|NCT01882465|11151534|FG005|STARTED|Period 2||5
10027296|NCT01882465|11151535|FG006|STARTED|Period 2||0
10027297|NCT01882465|11151529|FG000|COMPLETED|Period 2||6
10027298|NCT01882465|11151530|FG001|COMPLETED|Period 2||6
10027299|NCT01882465|11151531|FG002|COMPLETED|Period 2||5
10027300|NCT01882465|11151532|FG003|COMPLETED|Period 2||5
10027301|NCT01882465|11151533|FG004|COMPLETED|Period 2||4
10027302|NCT01882465|11151534|FG005|COMPLETED|Period 2||5
10027303|NCT01882465|11151535|FG006|COMPLETED|Period 2||0
10027304|NCT01882465|11151529|FG000|NOT COMPLETED|Period 2||0
10027305|NCT01882465|11151530|FG001|NOT COMPLETED|Period 2||0
10027306|NCT01882465|11151531|FG002|NOT COMPLETED|Period 2||0
10027307|NCT01882465|11151532|FG003|NOT COMPLETED|Period 2||0
10027308|NCT01882465|11151533|FG004|NOT COMPLETED|Period 2||1
10027309|NCT01882465|11151534|FG005|NOT COMPLETED|Period 2||0
10027310|NCT01882465|11151535|FG006|NOT COMPLETED|Period 2||0
10027311|NCT01882465|11151529|FG000|STARTED|Period 3||6
10027312|NCT01882465|11151530|FG001|STARTED|Period 3||6
10027313|NCT01882465|11151531|FG002|STARTED|Period 3||5
10027314|NCT01882465|11151532|FG003|STARTED|Period 3||5
10027315|NCT01882465|11151533|FG004|STARTED|Period 3||4
10027316|NCT01882465|11151534|FG005|STARTED|Period 3||5
10027317|NCT01882465|11151535|FG006|STARTED|Period 3||0
10027318|NCT01882465|11151529|FG000|COMPLETED|Period 3||6
10027319|NCT01882465|11151530|FG001|COMPLETED|Period 3||6
10027320|NCT01882465|11151531|FG002|COMPLETED|Period 3||5
9702836|NCT02022566|10802318|FG000|NOT COMPLETED|Overall Study||58
10027321|NCT01882465|11151532|FG003|COMPLETED|Period 3||5
10027322|NCT01882465|11151533|FG004|COMPLETED|Period 3||4
10027323|NCT01882465|11151534|FG005|COMPLETED|Period 3||5
9702837|NCT02022566|10802319|FG001|NOT COMPLETED|Overall Study||41
9702838|NCT01989598|10802325|FG000|STARTED|Overall Study|Includes pts receiving Single agent Trametinib and pts who are receiving Trametinib with AKT Inhibitor GSK2141795|25
9702839|NCT01989598|10802325|FG000|Dual Therapy With Trametinib and GSK2141795|Overall Study|Patients with progressive disease or who achieve less than PR after 4 courses also received Akt inhibitor GSK2141795 PO daily on days 1-28 along with Tremetinib|12
9731864|NCT00136955|10831832|FG000|STARTED|Overall Study||41
9731865|NCT00136955|10831832|FG000|COMPLETED|Overall Study||18
10027324|NCT01882465|11151535|FG006|COMPLETED|Period 3||0
10027325|NCT01882465|11151529|FG000|NOT COMPLETED|Period 3||0
10027326|NCT01882465|11151530|FG001|NOT COMPLETED|Period 3||0
9702840|NCT01989598|10802325|FG000|COMPLETED|Overall Study|Note: 25 patients enrolled, however, one patient unevaluable was not included in analysis|25
9702841|NCT01989598|10802325|FG000|NOT COMPLETED|Overall Study||0
9702842|NCT01939275|10802334|FG000|STARTED|Overall Study||8
9702843|NCT01939275|10802334|FG000|COMPLETED|Overall Study||8
9702844|NCT01939275|10802334|FG000|NOT COMPLETED|Overall Study||0
9702845|NCT01922895|10802340|FG000|STARTED|Overall Study||24
9702846|NCT01922895|10802341|FG001|STARTED|Overall Study||21
9702847|NCT01922895|10802340|FG000|COMPLETED|Overall Study||18
9702848|NCT01922895|10802341|FG001|COMPLETED|Overall Study||7
9702849|NCT01922895|10802340|FG000|NOT COMPLETED|Overall Study||6
9702850|NCT01922895|10802341|FG001|NOT COMPLETED|Overall Study||14
9702851|NCT01901289|10802347|FG000|STARTED|Overall Study||200
9702852|NCT01901289|10802347|FG000|12-Month Follow-up|Overall Study||194
9702853|NCT01901289|10802347|FG000|COMPLETED|Overall Study||115
9702854|NCT01901289|10802347|FG000|NOT COMPLETED|Overall Study||85
9702855|NCT01831895|10802351|FG000|STARTED|Overall Study||17
9702856|NCT01831895|10802351|FG000|COMPLETED|Overall Study||15
9702857|NCT01831895|10802351|FG000|NOT COMPLETED|Overall Study||2
9702858|NCT01831076|10802357|FG000|STARTED|Overall Study||31
9702859|NCT01831076|10802358|FG001|STARTED|Overall Study||5
9702860|NCT01831076|10802357|FG000|COMPLETED|Overall Study||30
9702861|NCT01831076|10802358|FG001|COMPLETED|Overall Study||4
9702862|NCT01831076|10802357|FG000|NOT COMPLETED|Overall Study||1
9702863|NCT01831076|10802358|FG001|NOT COMPLETED|Overall Study||1
9702864|NCT01595581|10802366|FG000|STARTED|Overall Study||7
9702865|NCT01595581|10802367|FG001|STARTED|Overall Study||7
9702866|NCT01595581|10802366|FG000|COMPLETED|Overall Study||6
9702867|NCT01595581|10802367|FG001|COMPLETED|Overall Study||7
9702868|NCT01595581|10802366|FG000|NOT COMPLETED|Overall Study||1
9702869|NCT01595581|10802367|FG001|NOT COMPLETED|Overall Study||0
9702870|NCT01514682|10802377|FG000|STARTED|Overall Study||19
9702871|NCT01514682|10802378|FG001|STARTED|Overall Study||20
9702872|NCT01514682|10802377|FG000|COMPLETED|Overall Study||13
9702873|NCT01514682|10802378|FG001|COMPLETED|Overall Study||14
9702874|NCT01514682|10802377|FG000|NOT COMPLETED|Overall Study||6
9702875|NCT01514682|10802378|FG001|NOT COMPLETED|Overall Study||6
9702876|NCT01453140|10802384|FG000|STARTED|Overall Study|3 patients were enrolled|3
9702877|NCT01453140|10802384|FG000|COMPLETED|Overall Study|All three patients experienced grade 4 limiting toxicities (possible treatment related)|0
9702878|NCT01453140|10802384|FG000|NOT COMPLETED|Overall Study||3
9702879|NCT01408641|10802394|FG000|STARTED|Overall Study||1
9702880|NCT01408641|10802395|FG001|STARTED|Overall Study||0
9702881|NCT01408641|10802394|FG000|COMPLETED|Overall Study||0
9702882|NCT01408641|10802395|FG001|COMPLETED|Overall Study||0
9702883|NCT01408641|10802394|FG000|NOT COMPLETED|Overall Study||1
9702884|NCT01408641|10802395|FG001|NOT COMPLETED|Overall Study||0
9702885|NCT01032265|10802403|FG000|STARTED|Overall Study||126
9702886|NCT01032265|10802404|FG001|STARTED|Overall Study||124
9702887|NCT01032265|10802403|FG000|COMPLETED|Overall Study||113
9702888|NCT01032265|10802404|FG001|COMPLETED|Overall Study||107
9702889|NCT01032265|10802403|FG000|NOT COMPLETED|Overall Study||13
9702890|NCT01032265|10802404|FG001|NOT COMPLETED|Overall Study||17
9702891|NCT00653068|10802414|FG000|STARTED|Overall Study||70
9702892|NCT00653068|10802414|FG000|COMPLETED|Overall Study||20
9702893|NCT00653068|10802414|FG000|NOT COMPLETED|Overall Study||50
9702894|NCT00193479|10802421|FG000|STARTED|Induction Chemotherapy||51
9702895|NCT00193479|10802421|FG000|COMPLETED|Induction Chemotherapy||48
9702896|NCT00193479|10802421|FG000|NOT COMPLETED|Induction Chemotherapy||3
9702897|NCT00193479|10802421|FG000|STARTED|Maintenance Rituximab||48
9702898|NCT00193479|10802421|FG000|COMPLETED|Maintenance Rituximab||44
9702899|NCT00193479|10802421|FG000|NOT COMPLETED|Maintenance Rituximab||4
9702900|NCT00193427|10802425|FG000|STARTED|Overall Study||75
9702901|NCT00193427|10802425|FG000|COMPLETED|Overall Study||26
9702902|NCT00193427|10802425|FG000|NOT COMPLETED|Overall Study||49
9702903|NCT00193414|10802430|FG000|STARTED|Overall Study||72
9702904|NCT00193414|10802430|FG000|COMPLETED|Overall Study||14
9702905|NCT00193414|10802430|FG000|NOT COMPLETED|Overall Study||58
9702906|NCT00085735|10802440|FG000|STARTED|Overall Study||64
9702907|NCT00085735|10802441|FG001|STARTED|Overall Study||64
9702908|NCT00085735|10802442|FG002|STARTED|Overall Study||63
9702909|NCT00085735|10802443|FG003|STARTED|Overall Study||65
9702910|NCT00085735|10802444|FG004|STARTED|Overall Study||147
9702911|NCT00085735|10802445|FG005|STARTED|Overall Study||146
9702912|NCT00085735|10802440|FG000|COMPLETED|Overall Study||52
9702913|NCT00085735|10802441|FG001|COMPLETED|Overall Study||54
9702914|NCT00085735|10802442|FG002|COMPLETED|Overall Study||46
9702915|NCT00085735|10802443|FG003|COMPLETED|Overall Study||46
9702916|NCT00085735|10802444|FG004|COMPLETED|Overall Study||105
9702917|NCT00085735|10802445|FG005|COMPLETED|Overall Study||115
9702918|NCT00085735|10802440|FG000|NOT COMPLETED|Overall Study||12
9702919|NCT00085735|10802441|FG001|NOT COMPLETED|Overall Study||10
9702920|NCT00085735|10802442|FG002|NOT COMPLETED|Overall Study||17
9702921|NCT00085735|10802443|FG003|NOT COMPLETED|Overall Study||19
9702922|NCT00085735|10802444|FG004|NOT COMPLETED|Overall Study||42
9702923|NCT00085735|10802445|FG005|NOT COMPLETED|Overall Study||31
9702924|NCT00003042|10802474|FG000|STARTED|Overall Study||14
9702925|NCT00003042|10802475|FG001|STARTED|Overall Study||27
9702926|NCT00003042|10802474|FG000|COMPLETED|Overall Study||14
9702927|NCT00003042|10802475|FG001|COMPLETED|Overall Study||27
9702928|NCT00003042|10802474|FG000|NOT COMPLETED|Overall Study||0
9702929|NCT00003042|10802475|FG001|NOT COMPLETED|Overall Study||0
9731866|NCT00136955|10831832|FG000|NOT COMPLETED|Overall Study||23
9702930|NCT04399356|10802483|FG000|STARTED|Overall Study||36
9702931|NCT04399356|10802484|FG001|STARTED|Overall Study||37
9702932|NCT04399356|10802483|FG000|COMPLETED|Overall Study||33
9702933|NCT04399356|10802484|FG001|COMPLETED|Overall Study||34
9702934|NCT04399356|10802483|FG000|NOT COMPLETED|Overall Study||3
9702935|NCT04399356|10802484|FG001|NOT COMPLETED|Overall Study||3
9702987|NCT03933449|10802542|FG000|STARTED|Overall Study||62
9702988|NCT03933449|10802543|FG001|STARTED|Overall Study||61
9702989|NCT03933449|10802542|FG000|Treated|Overall Study||62
9702990|NCT03933449|10802543|FG001|Treated|Overall Study||59
9702991|NCT03933449|10802542|FG000|COMPLETED|Overall Study||0
9702992|NCT03933449|10802543|FG001|COMPLETED|Overall Study||0
9702993|NCT03933449|10802542|FG000|NOT COMPLETED|Overall Study||62
9702994|NCT03933449|10802543|FG001|NOT COMPLETED|Overall Study||61
9702995|NCT03826667|10802549|FG000|STARTED|Overall Study||464
9702996|NCT03826667|10802549|FG000|HEALICOIL™ PK Preloaded Suture Anchors|Overall Study||193
9702997|NCT03826667|10802549|FG000|BIORAPTOR™ 2.3 PK Suture Anchors/BIORAPTOR™ Curved 2.3 PK Suture Anchors|Overall Study||41
9702998|NCT03826667|10802549|FG000|MULTIFIX™ S Ultra Knotless Fixation System|Overall Study||78
9702999|NCT03826667|10802549|FG000|FOOTPRINT™ Ultra PK Suture Anchors|Overall Study||136
10027327|NCT01882465|11151531|FG002|NOT COMPLETED|Period 3||0
10027328|NCT01882465|11151532|FG003|NOT COMPLETED|Period 3||0
10027329|NCT01882465|11151533|FG004|NOT COMPLETED|Period 3||0
10027330|NCT01882465|11151534|FG005|NOT COMPLETED|Period 3||0
10027331|NCT01882465|11151535|FG006|NOT COMPLETED|Period 3||0
10027332|NCT01882543|11151545|FG000|STARTED|Overall Study||37
10027333|NCT01882543|11151546|FG001|STARTED|Overall Study||32
10027334|NCT01882543|11151545|FG000|COMPLETED|Overall Study||33
10027335|NCT01882543|11151546|FG001|COMPLETED|Overall Study||29
10027336|NCT01882543|11151545|FG000|NOT COMPLETED|Overall Study||4
10027337|NCT01882543|11151546|FG001|NOT COMPLETED|Overall Study||3
10027338|NCT01882647|11151555|FG000|STARTED|Overall Study||110
10027339|NCT01882647|11151556|FG001|STARTED|Overall Study||112
10027340|NCT01882647|11151555|FG000|COMPLETED|Overall Study||108
9703000|NCT03826667|10802549|FG000|TWINFIX™ Ultra PK Suture Anchors/TWINFIX™ Ultra Preloaded and With Needles|Overall Study||57
9703001|NCT03826667|10802549|FG000|SPEEDSCREW™ Knotless Fixation System|Overall Study||59
10027341|NCT01882647|11151556|FG001|COMPLETED|Overall Study||106
10027342|NCT01882647|11151555|FG000|NOT COMPLETED|Overall Study||2
10027343|NCT01882647|11151556|FG001|NOT COMPLETED|Overall Study||6
10027344|NCT01882725|11151562|FG000|STARTED|Overall Study||14
10027345|NCT01882725|11151562|FG000|COMPLETED|Overall Study||14
10027346|NCT01882725|11151562|FG000|NOT COMPLETED|Overall Study||0
10027347|NCT01882764|11151568|FG000|STARTED|Overall Study||47
10027348|NCT01882764|11151569|FG001|STARTED|Overall Study||19
10027349|NCT01882764|11151568|FG000|COMPLETED|Overall Study||0
10027350|NCT01882764|11151569|FG001|COMPLETED|Overall Study||1
10027351|NCT01882764|11151568|FG000|NOT COMPLETED|Overall Study||47
10027352|NCT01882764|11151569|FG001|NOT COMPLETED|Overall Study||18
10027353|NCT01882803|11151575|FG000|STARTED|Overall Study||129
10027354|NCT01882803|11151575|FG000|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
10027355|NCT01882803|11151575|FG000|NOT COMPLETED|Overall Study||94
10027356|NCT01882829|11151580|FG000|STARTED|Overall Study||20
10027357|NCT01882829|11151580|FG000|COMPLETED|Overall Study||14
10027358|NCT01882829|11151580|FG000|NOT COMPLETED|Overall Study||6
10027359|NCT01882868|11151584|FG000|STARTED|Overall Study||62
10027360|NCT01882868|11151584|FG000|COMPLETED|Overall Study||62
10027361|NCT01882868|11151584|FG000|NOT COMPLETED|Overall Study||0
10027362|NCT01882907|11151590|FG000|STARTED|Overall Study||117
10027363|NCT01882907|11151591|FG001|STARTED|Overall Study||111
10027364|NCT01882907|11151590|FG000|COMPLETED|Overall Study||103
10027365|NCT01882907|11151591|FG001|COMPLETED|Overall Study||83
10027366|NCT01882907|11151590|FG000|NOT COMPLETED|Overall Study||14
10027367|NCT01882907|11151591|FG001|NOT COMPLETED|Overall Study||28
10027368|NCT01882985|11151599|FG000|STARTED|Overall Study||14
10027369|NCT01882985|11151599|FG000|COMPLETED|Overall Study||12
10027370|NCT01882985|11151599|FG000|NOT COMPLETED|Overall Study||2
10027371|NCT01883141|11151603|FG000|STARTED|Overall Study||31
10027372|NCT01883141|11151603|FG000|Passing Eligibility|Overall Study||30
10027373|NCT01883141|11151603|FG000|EP Study Performed|Overall Study||30
10027374|NCT01883141|11151603|FG000|Usable EP Data|Overall Study||26
10027375|NCT01883141|11151603|FG000|BiV Pacing-Distal|Overall Study||24
10027376|NCT01883141|11151603|FG000|BiV Pacing-Mid|Overall Study||25
10027377|NCT01883141|11151603|FG000|BiV Pacing-Standard Therapy|Overall Study||26
10027378|NCT01883141|11151603|FG000|Multispot-pacing|Overall Study||24
9703002|NCT03826667|10802549|FG000|SpeedLock Knotless Fixation Device|Overall Study||18
9703003|NCT03826667|10802549|FG000|COMPLETED|Overall Study||443
10027379|NCT01883141|11151603|FG000|BiV Pacing-Anterior|Overall Study||23
10027380|NCT01883141|11151603|FG000|Biv Pacing-Posterior|Overall Study||22
10027381|NCT01883141|11151603|FG000|Multivein|Overall Study||23
9703004|NCT03826667|10802549|FG000|NOT COMPLETED|Overall Study||21
10027382|NCT01883141|11151603|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31
10027383|NCT01883141|11151603|FG000|NOT COMPLETED|Overall Study||0
10027384|NCT01883362|11151609|FG000|STARTED|Treatment||30
10027385|NCT01883362|11151610|FG001|STARTED|Treatment||30
10027386|NCT01883362|11151609|FG000|COMPLETED|Treatment||14
9703005|NCT03600909|10802562|FG000|STARTED|Overall Study||0
9703006|NCT03600909|10802563|FG001|STARTED|Overall Study||3
9703007|NCT03600909|10802564|FG002|STARTED|Overall Study||0
10027387|NCT01883362|11151610|FG001|COMPLETED|Treatment||16
9702936|NCT04350905|10802490|FG000|STARTED|Overall Study||42
9702937|NCT04350905|10802490|FG000|COMPLETED|Overall Study||41
9702938|NCT04350905|10802490|FG000|NOT COMPLETED|Overall Study||1
9702939|NCT04236635|10802494|FG000|STARTED|Overall Study||2
9702940|NCT04236635|10802495|FG001|STARTED|Overall Study||1
9702941|NCT04236635|10802496|FG002|STARTED|Overall Study||1
9702942|NCT04236635|10802497|FG003|STARTED|Overall Study||4
9702943|NCT04236635|10802498|FG004|STARTED|Overall Study||1
9702944|NCT04236635|10802499|FG005|STARTED|Overall Study||1
9702945|NCT04236635|10802494|FG000|Safety Population|Overall Study||2
9702946|NCT04236635|10802495|FG001|Safety Population|Overall Study||1
9702947|NCT04236635|10802496|FG002|Safety Population|Overall Study||1
9702948|NCT04236635|10802497|FG003|Safety Population|Overall Study||4
9702949|NCT04236635|10802498|FG004|Safety Population|Overall Study||1
9702950|NCT04236635|10802499|FG005|Safety Population|Overall Study||1
9702951|NCT04236635|10802494|FG000|Evaluable Population|Overall Study||2
9702952|NCT04236635|10802495|FG001|Evaluable Population|Overall Study||1
9702953|NCT04236635|10802496|FG002|Evaluable Population|Overall Study||1
9702954|NCT04236635|10802497|FG003|Evaluable Population|Overall Study||2
9702955|NCT04236635|10802498|FG004|Evaluable Population|Overall Study||1
9702956|NCT04236635|10802499|FG005|Evaluable Population|Overall Study||1
9702957|NCT04236635|10802494|FG000|COMPLETED|Overall Study||2
9702958|NCT04236635|10802495|FG001|COMPLETED|Overall Study||1
9702959|NCT04236635|10802496|FG002|COMPLETED|Overall Study||1
9702960|NCT04236635|10802497|FG003|COMPLETED|Overall Study||4
9702961|NCT04236635|10802498|FG004|COMPLETED|Overall Study||1
9702962|NCT04236635|10802499|FG005|COMPLETED|Overall Study||1
9702963|NCT04236635|10802494|FG000|NOT COMPLETED|Overall Study||0
9702964|NCT04236635|10802495|FG001|NOT COMPLETED|Overall Study||0
9702965|NCT04236635|10802496|FG002|NOT COMPLETED|Overall Study||0
9702966|NCT04236635|10802497|FG003|NOT COMPLETED|Overall Study||0
9702967|NCT04236635|10802498|FG004|NOT COMPLETED|Overall Study||0
9702968|NCT04236635|10802499|FG005|NOT COMPLETED|Overall Study||0
9702969|NCT04156399|10802514|FG000|STARTED|Overall Study||6
9702970|NCT04156399|10802514|FG000|COMPLETED|Overall Study|Of the six participants who started the study, two completed all 10 acupuncture sessions, two completed 9 sessions, and one completed 8 sessions. The three who completed 8 or 9 sessions were unable to complete due to the COVID-19 lockdowns, however, we were able to collect post-test measures for them. Finally, one participant was hospitalized (unrelated to acupuncture) and could not complete the study nor provide post-test measures.|2
9702971|NCT04156399|10802514|FG000|NOT COMPLETED|Overall Study||4
9702978|NCT04115228|10802527|FG000|STARTED|Overall Study||10
9702979|NCT04115228|10802527|FG000|COMPLETED|Overall Study||10
9702980|NCT04115228|10802527|FG000|NOT COMPLETED|Overall Study||0
9702981|NCT04052620|10802533|FG000|STARTED|Overall Study||150
9702982|NCT04052620|10802534|FG001|STARTED|Overall Study||152
9702983|NCT04052620|10802533|FG000|COMPLETED|Overall Study||143
9702984|NCT04052620|10802534|FG001|COMPLETED|Overall Study||145
9702985|NCT04052620|10802533|FG000|NOT COMPLETED|Overall Study||7
9702986|NCT04052620|10802534|FG001|NOT COMPLETED|Overall Study||7
9703008|NCT03600909|10802562|FG000|COMPLETED|Overall Study||0
9703009|NCT03600909|10802563|FG001|COMPLETED|Overall Study||0
9703010|NCT03600909|10802564|FG002|COMPLETED|Overall Study||0
9703011|NCT03600909|10802562|FG000|NOT COMPLETED|Overall Study||0
9703012|NCT03600909|10802563|FG001|NOT COMPLETED|Overall Study||3
9703013|NCT03600909|10802564|FG002|NOT COMPLETED|Overall Study||0
9728674|NCT00112918|10828166|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
9728675|NCT00112918|10828167|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
9728676|NCT00112918|10828168|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
9728677|NCT00112918|10828166|FG000|NOT COMPLETED|Overall Study||297
9728678|NCT00112918|10828167|FG001|NOT COMPLETED|Overall Study||345
10027388|NCT01883362|11151609|FG000|NOT COMPLETED|Treatment||16
10027389|NCT01883362|11151610|FG001|NOT COMPLETED|Treatment||14
10027390|NCT01883362|11151609|FG000|STARTED|Post Treatment Follow-up||26
10027391|NCT01883362|11151610|FG001|STARTED|Post Treatment Follow-up||27
10027392|NCT01883362|11151609|FG000|COMPLETED|Post Treatment Follow-up||10
10027393|NCT01883362|11151610|FG001|COMPLETED|Post Treatment Follow-up||13
10027394|NCT01883362|11151609|FG000|NOT COMPLETED|Post Treatment Follow-up||16
10027395|NCT01883362|11151610|FG001|NOT COMPLETED|Post Treatment Follow-up||14
10027396|NCT01883427|11151622|FG000|STARTED|Overall Study||20
10027397|NCT01883427|11151623|FG001|STARTED|Overall Study||20
10027398|NCT01883427|11151622|FG000|COMPLETED|Overall Study||20
10027399|NCT01883427|11151623|FG001|COMPLETED|Overall Study||20
10027400|NCT01883427|11151622|FG000|NOT COMPLETED|Overall Study||0
10027401|NCT01883427|11151623|FG001|NOT COMPLETED|Overall Study||0
10027402|NCT01883440|11151631|FG000|STARTED|Overall Study||45
10027403|NCT01883440|11151632|FG001|STARTED|Overall Study||45
10027404|NCT01883440|11151631|FG000|COMPLETED|Overall Study||42
10027405|NCT01883440|11151632|FG001|COMPLETED|Overall Study||45
10027406|NCT01883440|11151631|FG000|NOT COMPLETED|Overall Study||3
10027407|NCT01883440|11151632|FG001|NOT COMPLETED|Overall Study||0
10027408|NCT01883453|11151641|FG000|STARTED|Overall Study||73
9703014|NCT03368781|10802572|FG000|STARTED|Overall Study||128
9703015|NCT03368781|10802572|FG000|COMPLETED|Overall Study||103
9703016|NCT03368781|10802572|FG000|NOT COMPLETED|Overall Study||25
9703017|NCT03366428|10802580|FG000|STARTED|Overall Study||51
9703018|NCT03366428|10802580|FG000|COMPLETED|Overall Study||0
9703019|NCT03366428|10802580|FG000|NOT COMPLETED|Overall Study||51
9703020|NCT03221660|10802586|FG000|STARTED|Overall Study||50
9703021|NCT03221660|10802586|FG000|COMPLETED|Overall Study||50
9703022|NCT03221660|10802586|FG000|NOT COMPLETED|Overall Study||0
9703023|NCT03131219|10802592|FG000|STARTED|Initial Evaluation Period||21
9703024|NCT03131219|10802593|FG001|STARTED|Initial Evaluation Period||10
9703025|NCT03131219|10802592|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
9703026|NCT03131219|10802593|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
9703027|NCT03131219|10802592|FG000|COMPLETED|Initial Evaluation Period||17
9703028|NCT03131219|10802593|FG001|COMPLETED|Initial Evaluation Period||10
9703029|NCT03131219|10802592|FG000|NOT COMPLETED|Initial Evaluation Period||4
9703030|NCT03131219|10802593|FG001|NOT COMPLETED|Initial Evaluation Period||0
9703031|NCT03131219|10802592|FG000|STARTED|Extension Period||17
9703032|NCT03131219|10802593|FG001|STARTED|Extension Period||10
9703033|NCT03131219|10802592|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17
9703034|NCT03131219|10802593|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10
9703035|NCT03131219|10802592|FG000|Ongoing|Extension Period||16
9703036|NCT03131219|10802593|FG001|Ongoing|Extension Period||10
9703037|NCT03131219|10802592|FG000|COMPLETED|Extension Period||0
9703038|NCT03131219|10802593|FG001|COMPLETED|Extension Period||0
9703039|NCT03131219|10802592|FG000|NOT COMPLETED|Extension Period||17
9703040|NCT03131219|10802593|FG001|NOT COMPLETED|Extension Period||10
9703041|NCT03075527|10802599|FG000|STARTED|Overall Study||19
9703042|NCT03075527|10802599|FG000|COMPLETED|Overall Study||17
9703043|NCT03075527|10802599|FG000|NOT COMPLETED|Overall Study||2
9703044|NCT02756611|10802603|FG000|STARTED|Overall Study||258
9703045|NCT02756611|10802603|FG000|COMPLETED|Overall Study||2
9703046|NCT02756611|10802603|FG000|NOT COMPLETED|Overall Study||256
9703047|NCT02724878|10802607|FG000|STARTED|Overall Study||65
9703048|NCT02724878|10802607|FG000|Treated|Overall Study||60
9703049|NCT02724878|10802607|FG000|Responders|Overall Study||20
9703050|NCT02724878|10802607|FG000|COMPLETED|Overall Study||0
9703051|NCT02724878|10802607|FG000|NOT COMPLETED|Overall Study||65
9703052|NCT02605993|10802615|FG000|STARTED|Treatment Period||6
9703053|NCT02605993|10802616|FG001|STARTED|Treatment Period||6
9703054|NCT02605993|10802617|FG002|STARTED|Treatment Period||7
9703055|NCT02605993|10802618|FG003|STARTED|Treatment Period||7
9703056|NCT02605993|10802615|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6
9703057|NCT02605993|10802616|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
9703058|NCT02605993|10802617|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7
9703059|NCT02605993|10802618|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7
9703060|NCT02605993|10802615|FG000|COMPLETED|Treatment Period||6
9703061|NCT02605993|10802616|FG001|COMPLETED|Treatment Period||6
9703062|NCT02605993|10802617|FG002|COMPLETED|Treatment Period||7
9703063|NCT02605993|10802618|FG003|COMPLETED|Treatment Period||7
9703064|NCT02605993|10802615|FG000|NOT COMPLETED|Treatment Period||0
9703065|NCT02605993|10802616|FG001|NOT COMPLETED|Treatment Period||0
9703066|NCT02605993|10802617|FG002|NOT COMPLETED|Treatment Period||0
9703067|NCT02605993|10802618|FG003|NOT COMPLETED|Treatment Period||0
10027409|NCT01883453|11151642|FG001|STARTED|Overall Study||73
10027410|NCT01883453|11151641|FG000|COMPLETED|Overall Study||48
10027411|NCT01883453|11151642|FG001|COMPLETED|Overall Study||50
10027412|NCT01883453|11151641|FG000|NOT COMPLETED|Overall Study||25
10027413|NCT01883453|11151642|FG001|NOT COMPLETED|Overall Study||23
10027414|NCT01883492|11151650|FG000|STARTED|Overall Study||75
10027415|NCT01883492|11151651|FG001|STARTED|Overall Study||78
10027416|NCT01883492|11151650|FG000|COMPLETED|Overall Study||62
10027417|NCT01883492|11151651|FG001|COMPLETED|Overall Study||67
10027418|NCT01883492|11151650|FG000|NOT COMPLETED|Overall Study||13
10027419|NCT01883492|11151651|FG001|NOT COMPLETED|Overall Study||11
10027420|NCT01883635|11151659|FG000|STARTED|Overall Study||24
10027421|NCT01883635|11151660|FG001|STARTED|Overall Study||20
10027422|NCT01883635|11151659|FG000|COMPLETED|Overall Study||20
10027423|NCT01883635|11151660|FG001|COMPLETED|Overall Study||20
10027424|NCT01883635|11151659|FG000|NOT COMPLETED|Overall Study||4
10027425|NCT01883635|11151660|FG001|NOT COMPLETED|Overall Study||0
10027426|NCT01883856|11151670|FG000|STARTED|Overall Study||26
10027427|NCT01883856|11151671|FG001|STARTED|Overall Study||26
10027428|NCT01883856|11151670|FG000|COMPLETED|Overall Study||26
10027429|NCT01883856|11151671|FG001|COMPLETED|Overall Study||26
10027430|NCT01883856|11151670|FG000|NOT COMPLETED|Overall Study||0
10027431|NCT01883856|11151671|FG001|NOT COMPLETED|Overall Study||0
9703068|NCT02605993|10802615|FG000|STARTED|Extension Period||6
9703069|NCT02605993|10802616|FG001|STARTED|Extension Period||6
9703070|NCT02605993|10802617|FG002|STARTED|Extension Period||7
9703071|NCT02605993|10802618|FG003|STARTED|Extension Period||7
9703072|NCT02605993|10802615|FG000|COMPLETED|Extension Period||0
9703073|NCT02605993|10802616|FG001|COMPLETED|Extension Period||0
10027432|NCT01883895|11151677|FG000|STARTED|Overall Study||34
9703074|NCT02605993|10802617|FG002|COMPLETED|Extension Period||0
9703075|NCT02605993|10802618|FG003|COMPLETED|Extension Period||0
9703076|NCT02605993|10802615|FG000|NOT COMPLETED|Extension Period||6
10027433|NCT01883895|11151677|FG000|COMPLETED|Overall Study||32
10027434|NCT01883895|11151677|FG000|NOT COMPLETED|Overall Study||2
9703077|NCT02605993|10802616|FG001|NOT COMPLETED|Extension Period||6
9703078|NCT02605993|10802617|FG002|NOT COMPLETED|Extension Period||7
9703079|NCT02605993|10802618|FG003|NOT COMPLETED|Extension Period||7
9703080|NCT02522715|10802630|FG000|STARTED|Overall Study||3
9703081|NCT02522715|10802631|FG001|STARTED|Overall Study|+1 early withdrawal|33
10027435|NCT01883986|11151683|FG000|STARTED|Overall Study|Allocated to intervention arm|20
10027436|NCT01883986|11151684|FG001|STARTED|Overall Study|Allocated to usual care arm|20
10027437|NCT01883986|11151683|FG000|Did Not Complete Study|Overall Study||3
10027438|NCT01883986|11151684|FG001|Did Not Complete Study|Overall Study|Did not completed study|1
10027439|NCT01883986|11151683|FG000|COMPLETED|Overall Study|Received allocated intervention|17
10027440|NCT01883986|11151684|FG001|COMPLETED|Overall Study|Completed study|19
10027441|NCT01883986|11151683|FG000|NOT COMPLETED|Overall Study||3
10027442|NCT01883986|11151684|FG001|NOT COMPLETED|Overall Study||1
10027443|NCT01883999|11151690|FG000|STARTED|Overall Study||64
10027444|NCT01883999|11151690|FG000|COMPLETED|Overall Study||61
10027445|NCT01883999|11151690|FG000|NOT COMPLETED|Overall Study||3
10027446|NCT01884025|11151696|FG000|STARTED|Overall Study||13
10027447|NCT01884025|11151697|FG001|STARTED|Overall Study||14
10027448|NCT01884025|11151696|FG000|COMPLETED|Overall Study||10
10027449|NCT01884025|11151697|FG001|COMPLETED|Overall Study||10
10027450|NCT01884025|11151696|FG000|NOT COMPLETED|Overall Study||3
10027451|NCT01884025|11151697|FG001|NOT COMPLETED|Overall Study||4
10027452|NCT01884064|11151705|FG000|STARTED|Overall Study||12
10027453|NCT01884064|11151706|FG001|STARTED|Overall Study||5
10027454|NCT01884064|11151705|FG000|COMPLETED|Overall Study||12
10027455|NCT01884064|11151706|FG001|COMPLETED|Overall Study||5
10027456|NCT01884064|11151705|FG000|NOT COMPLETED|Overall Study||0
10027457|NCT01884064|11151706|FG001|NOT COMPLETED|Overall Study||0
10027458|NCT01884311|11151712|FG000|STARTED|Overall Study||38
10027459|NCT01884311|11151712|FG000|COMPLETED|Overall Study||33
10027460|NCT01884311|11151712|FG000|NOT COMPLETED|Overall Study||5
10081402|NCT02260635|11209907|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
10081403|NCT02260635|11209908|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
10081404|NCT02260635|11209907|FG000|COMPLETED|Double-Blind Treatment Period||26
10081405|NCT02260635|11209908|FG001|COMPLETED|Double-Blind Treatment Period||25
10081406|NCT02260635|11209907|FG000|NOT COMPLETED|Double-Blind Treatment Period||1
10081407|NCT02260635|11209908|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
10081408|NCT02260635|11209907|FG000|STARTED|Open-Label Extension||26
10081409|NCT02260635|11209908|FG001|STARTED|Open-Label Extension||25
10081410|NCT02260635|11209907|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26
10081411|NCT02260635|11209908|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25
10081412|NCT02260635|11209907|FG000|COMPLETED|Open-Label Extension||0
10081413|NCT02260635|11209908|FG001|COMPLETED|Open-Label Extension||0
10081414|NCT02260635|11209907|FG000|NOT COMPLETED|Open-Label Extension||26
10081415|NCT02260635|11209908|FG001|NOT COMPLETED|Open-Label Extension||25
10081416|NCT02260648|11209919|FG000|STARTED|Overall Study||53
10081417|NCT02260648|11209920|FG001|STARTED|Overall Study||46
10081418|NCT02260648|11209921|FG002|STARTED|Overall Study||50
10081419|NCT02260648|11209919|FG000|Received at Least One Dose of Study Drug|Overall Study||53
10081420|NCT02260648|11209920|FG001|Received at Least One Dose of Study Drug|Overall Study||46
10081421|NCT02260648|11209921|FG002|Received at Least One Dose of Study Drug|Overall Study||50
10081422|NCT02260648|11209919|FG000|COMPLETED|Overall Study||35
10081423|NCT02260648|11209920|FG001|COMPLETED|Overall Study||33
10081424|NCT02260648|11209921|FG002|COMPLETED|Overall Study||42
10081425|NCT02260648|11209919|FG000|NOT COMPLETED|Overall Study||18
10081426|NCT02260648|11209920|FG001|NOT COMPLETED|Overall Study||13
10081427|NCT02260648|11209921|FG002|NOT COMPLETED|Overall Study||8
10081428|NCT02260791|11209931|FG000|STARTED|Overall Study||366
10081429|NCT02260791|11209932|FG001|STARTED|Overall Study||362
10081430|NCT02260791|11209931|FG000|COMPLETED|Overall Study||333
10081431|NCT02260791|11209932|FG001|COMPLETED|Overall Study||328
10081432|NCT02260791|11209931|FG000|NOT COMPLETED|Overall Study||33
10081433|NCT02260791|11209932|FG001|NOT COMPLETED|Overall Study||34
10081434|NCT02260804|11209940|FG000|STARTED|Induction Study Period||130
10081435|NCT02260804|11209941|FG001|STARTED|Induction Study Period||128
10081436|NCT02260804|11209940|FG000|COMPLETED|Induction Study Period||128
9703082|NCT02522715|10802630|FG000|COMPLETED|Overall Study||3
9703083|NCT02522715|10802631|FG001|COMPLETED|Overall Study||33
9703084|NCT02522715|10802630|FG000|NOT COMPLETED|Overall Study||0
9703085|NCT02522715|10802631|FG001|NOT COMPLETED|Overall Study||0
9703086|NCT02487095|10802642|FG000|STARTED|Phase I Dose Escalation||6
9703087|NCT02487095|10802643|FG001|STARTED|Phase I Dose Escalation||6
9703088|NCT02487095|10802644|FG002|STARTED|Phase I Dose Escalation||3
9703089|NCT02487095|10802645|FG003|STARTED|Phase I Dose Escalation||6
9703090|NCT02487095|10802646|FG004|STARTED|Phase I Dose Escalation||0
9703091|NCT02487095|10802642|FG000|COMPLETED|Phase I Dose Escalation||6
9703092|NCT02487095|10802643|FG001|COMPLETED|Phase I Dose Escalation||6
9703093|NCT02487095|10802644|FG002|COMPLETED|Phase I Dose Escalation||3
9703094|NCT02487095|10802645|FG003|COMPLETED|Phase I Dose Escalation||6
9703095|NCT02487095|10802646|FG004|COMPLETED|Phase I Dose Escalation||0
9703096|NCT02487095|10802642|FG000|NOT COMPLETED|Phase I Dose Escalation||0
10081437|NCT02260804|11209941|FG001|COMPLETED|Induction Study Period||128
9703097|NCT02487095|10802643|FG001|NOT COMPLETED|Phase I Dose Escalation||0
9703098|NCT02487095|10802644|FG002|NOT COMPLETED|Phase I Dose Escalation||0
9703099|NCT02487095|10802645|FG003|NOT COMPLETED|Phase I Dose Escalation||0
9703100|NCT02487095|10802646|FG004|NOT COMPLETED|Phase I Dose Escalation||0
9703101|NCT02487095|10802642|FG000|STARTED|Dose Expansion||0
9703102|NCT02487095|10802643|FG001|STARTED|Dose Expansion||0
9703103|NCT02487095|10802644|FG002|STARTED|Dose Expansion||0
9703104|NCT02487095|10802645|FG003|STARTED|Dose Expansion||0
9703105|NCT02487095|10802646|FG004|STARTED|Dose Expansion||41
9703106|NCT02487095|10802642|FG000|COMPLETED|Dose Expansion||0
9703107|NCT02487095|10802643|FG001|COMPLETED|Dose Expansion||0
9703108|NCT02487095|10802644|FG002|COMPLETED|Dose Expansion||0
9703109|NCT02487095|10802645|FG003|COMPLETED|Dose Expansion||0
9703110|NCT02487095|10802646|FG004|COMPLETED|Dose Expansion||40
9703111|NCT02487095|10802642|FG000|NOT COMPLETED|Dose Expansion||0
9703112|NCT02487095|10802643|FG001|NOT COMPLETED|Dose Expansion||0
9703113|NCT02487095|10802644|FG002|NOT COMPLETED|Dose Expansion||0
9703114|NCT02487095|10802645|FG003|NOT COMPLETED|Dose Expansion||0
9703115|NCT02487095|10802646|FG004|NOT COMPLETED|Dose Expansion||1
9703116|NCT02347917|10802668|FG000|STARTED|Overall Study||4
9703117|NCT02347917|10802669|FG001|STARTED|Overall Study||24
9703118|NCT02347917|10802668|FG000|Discontinued beforeBBI608 Administration|Overall Study||0
9703119|NCT02347917|10802669|FG001|Discontinued beforeBBI608 Administration|Overall Study||0
9703120|NCT02347917|10802668|FG000|Start BBI608 Administration|Overall Study||4
9703121|NCT02347917|10802669|FG001|Start BBI608 Administration|Overall Study||24
9703122|NCT02347917|10802668|FG000|Discontinued in DLT Evaluation Period|Overall Study||1
9703123|NCT02347917|10802669|FG001|Discontinued in DLT Evaluation Period|Overall Study||0
9703124|NCT02347917|10802668|FG000|Complete DLT Evaluation Period|Overall Study||3
9703125|NCT02347917|10802669|FG001|Complete DLT Evaluation Period|Overall Study||0
9703126|NCT02347917|10802668|FG000|Discontinued After BBI608 Administration|Overall Study||4
9703127|NCT02347917|10802669|FG001|Discontinued After BBI608 Administration|Overall Study||24
9703128|NCT02347917|10802668|FG000|Discontinued Before Survival Observation|Overall Study||0
9703129|NCT02347917|10802669|FG001|Discontinued Before Survival Observation|Overall Study||1
9703130|NCT02347917|10802668|FG000|COMPLETED|Overall Study||4
9703131|NCT02347917|10802669|FG001|COMPLETED|Overall Study||23
9703132|NCT02347917|10802668|FG000|NOT COMPLETED|Overall Study||0
9703133|NCT02347917|10802669|FG001|NOT COMPLETED|Overall Study||1
9703134|NCT02344108|10802683|FG000|STARTED|Overall Study||42
9703135|NCT02344108|10802683|FG000|COMPLETED|Overall Study||42
9703136|NCT02344108|10802683|FG000|NOT COMPLETED|Overall Study||0
9703137|NCT02335658|10802693|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
9703138|NCT02335658|10802694|FG001|STARTED|Overall Study||103
9703139|NCT02335658|10802693|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
9703140|NCT02335658|10802694|FG001|COMPLETED|Overall Study||59
9703141|NCT02335658|10802693|FG000|NOT COMPLETED|Overall Study||40
9703142|NCT02335658|10802694|FG001|NOT COMPLETED|Overall Study||44
9703143|NCT02287584|10802705|FG000|STARTED|the Double-blind Phase||190
9703144|NCT02287584|10802706|FG001|STARTED|the Double-blind Phase||196
9703145|NCT02287584|10802707|FG002|STARTED|the Double-blind Phase||194
9703146|NCT02287584|10802708|FG003|STARTED|the Double-blind Phase||0
9703147|NCT02287584|10802709|FG004|STARTED|the Double-blind Phase||0
9703148|NCT02287584|10802710|FG005|STARTED|the Double-blind Phase||0
9703149|NCT02287584|10802705|FG000|COMPLETED|the Double-blind Phase||138
9703150|NCT02287584|10802706|FG001|COMPLETED|the Double-blind Phase||149
9703151|NCT02287584|10802707|FG002|COMPLETED|the Double-blind Phase||161
9703152|NCT02287584|10802708|FG003|COMPLETED|the Double-blind Phase||0
9703153|NCT02287584|10802709|FG004|COMPLETED|the Double-blind Phase||0
9703154|NCT02287584|10802710|FG005|COMPLETED|the Double-blind Phase||0
9703155|NCT02287584|10802705|FG000|NOT COMPLETED|the Double-blind Phase||52
9703156|NCT02287584|10802706|FG001|NOT COMPLETED|the Double-blind Phase||47
9703157|NCT02287584|10802707|FG002|NOT COMPLETED|the Double-blind Phase||33
9703158|NCT02287584|10802708|FG003|NOT COMPLETED|the Double-blind Phase||0
9703159|NCT02287584|10802709|FG004|NOT COMPLETED|the Double-blind Phase||0
9703160|NCT02287584|10802710|FG005|NOT COMPLETED|the Double-blind Phase||0
9703161|NCT02287584|10802705|FG000|STARTED|the Open-label Phase||0
9703162|NCT02287584|10802706|FG001|STARTED|the Open-label Phase||0
9703163|NCT02287584|10802707|FG002|STARTED|the Open-label Phase||0
9703164|NCT02287584|10802708|FG003|STARTED|the Open-label Phase||138
9703165|NCT02287584|10802709|FG004|STARTED|the Open-label Phase||149
9703166|NCT02287584|10802710|FG005|STARTED|the Open-label Phase||161
9703167|NCT02287584|10802705|FG000|Treated|the Open-label Phase||0
9703168|NCT02287584|10802706|FG001|Treated|the Open-label Phase||0
9703169|NCT02287584|10802707|FG002|Treated|the Open-label Phase||0
9703170|NCT02287584|10802708|FG003|Treated|the Open-label Phase||131
9703171|NCT02287584|10802709|FG004|Treated|the Open-label Phase||143
9703172|NCT02287584|10802710|FG005|Treated|the Open-label Phase||157
9703173|NCT02287584|10802705|FG000|COMPLETED|the Open-label Phase||0
9703174|NCT02287584|10802706|FG001|COMPLETED|the Open-label Phase||0
9703175|NCT02287584|10802707|FG002|COMPLETED|the Open-label Phase||0
9703176|NCT02287584|10802708|FG003|COMPLETED|the Open-label Phase||81
9703177|NCT02287584|10802709|FG004|COMPLETED|the Open-label Phase||87
9703178|NCT02287584|10802710|FG005|COMPLETED|the Open-label Phase||104
9703179|NCT02287584|10802705|FG000|NOT COMPLETED|the Open-label Phase||0
9703180|NCT02287584|10802706|FG001|NOT COMPLETED|the Open-label Phase||0
9703181|NCT02287584|10802707|FG002|NOT COMPLETED|the Open-label Phase||0
9703182|NCT02287584|10802708|FG003|NOT COMPLETED|the Open-label Phase||57
9703183|NCT02287584|10802709|FG004|NOT COMPLETED|the Open-label Phase||62
9703184|NCT02287584|10802710|FG005|NOT COMPLETED|the Open-label Phase||57
9703185|NCT02178566|10802726|FG000|STARTED|Overall Study||0
9703186|NCT02178566|10802727|FG001|STARTED|Overall Study|no data available|1
9703187|NCT02178566|10802726|FG000|COMPLETED|Overall Study||0
9703188|NCT02178566|10802727|FG001|COMPLETED|Overall Study|no data available|0
9703189|NCT02178566|10802726|FG000|NOT COMPLETED|Overall Study||0
9703190|NCT02178566|10802727|FG001|NOT COMPLETED|Overall Study||1
9703191|NCT02173301|10802737|FG000|STARTED|Overall Study||49
9848064|NCT00856986|10960682|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461
9848065|NCT00856986|10960683|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0
9848066|NCT00856986|10960684|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0
9848067|NCT00856986|10960680|FG000|COMPLETED|Extension Period, Weeks 26-52||108
9848068|NCT00856986|10960681|FG001|COMPLETED|Extension Period, Weeks 26-52||130
9848069|NCT00856986|10960682|FG002|COMPLETED|Extension Period, Weeks 26-52||432
9848070|NCT00856986|10960683|FG003|COMPLETED|Extension Period, Weeks 26-52||0
9848071|NCT00856986|10960684|FG004|COMPLETED|Extension Period, Weeks 26-52||0
9848072|NCT00856986|10960680|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19
9848073|NCT00856986|10960681|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14
9848074|NCT00856986|10960682|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38
9848075|NCT00856986|10960683|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0
10027461|NCT01884337|11151721|FG000|STARTED|Treatment||326
10027462|NCT01884337|11151722|FG001|STARTED|Treatment||172
10027463|NCT01884337|11151721|FG000|Continuing Into Follow-up Period|Treatment||324
10027464|NCT01884337|11151722|FG001|Continuing Into Follow-up Period|Treatment||171
10027465|NCT01884337|11151721|FG000|COMPLETED|Treatment||322
10027466|NCT01884337|11151722|FG001|COMPLETED|Treatment||170
10027467|NCT01884337|11151721|FG000|NOT COMPLETED|Treatment||4
10027468|NCT01884337|11151722|FG001|NOT COMPLETED|Treatment||2
10027469|NCT01884337|11151721|FG000|STARTED|Follow-up Period||324
10027470|NCT01884337|11151722|FG001|STARTED|Follow-up Period||171
10027471|NCT01884337|11151721|FG000|COMPLETED|Follow-up Period||323
10027472|NCT01884337|11151722|FG001|COMPLETED|Follow-up Period||170
10027473|NCT01884337|11151721|FG000|NOT COMPLETED|Follow-up Period||1
10027474|NCT01884337|11151722|FG001|NOT COMPLETED|Follow-up Period||1
10027475|NCT01884350|11151730|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
10027476|NCT01884350|11151731|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
10027477|NCT01884350|11151732|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
10027478|NCT01884350|11151730|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
10027479|NCT01884350|11151731|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
10027480|NCT01884350|11151732|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
10027481|NCT01884350|11151730|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
10027482|NCT01884350|11151731|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
10027483|NCT01884350|11151732|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
10027484|NCT01884350|11151730|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
10027485|NCT01884350|11151731|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
10027486|NCT01884350|11151732|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
10027487|NCT01884350|11151730|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
10027488|NCT01884350|11151731|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
10027489|NCT01884350|11151732|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
10027490|NCT01884350|11151730|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
10027491|NCT01884350|11151731|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
10027492|NCT01884350|11151732|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
10027493|NCT01884350|11151730|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
10027494|NCT01884350|11151731|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
10027495|NCT01884350|11151732|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
10027496|NCT01884350|11151730|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
10027497|NCT01884350|11151731|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
10027498|NCT01884350|11151732|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
10027499|NCT01884519|11151744|FG000|STARTED|Overall Study||60
10027500|NCT01884519|11151745|FG001|STARTED|Overall Study||60
10027501|NCT01884519|11151744|FG000|COMPLETED|Overall Study||60
10027502|NCT01884519|11151745|FG001|COMPLETED|Overall Study||60
10027503|NCT01884519|11151744|FG000|NOT COMPLETED|Overall Study||0
10027504|NCT01884519|11151745|FG001|NOT COMPLETED|Overall Study||0
10027505|NCT01884545|11151763|FG000|STARTED|Overall Study||50
10027506|NCT01884545|11151764|FG001|STARTED|Overall Study||49
10027507|NCT01884545|11151765|FG002|STARTED|Overall Study||49
10027508|NCT01884545|11151766|FG003|STARTED|Overall Study||52
10027509|NCT01884545|11151763|FG000|COMPLETED|Overall Study||37
10027510|NCT01884545|11151764|FG001|COMPLETED|Overall Study||31
10027511|NCT01884545|11151765|FG002|COMPLETED|Overall Study||35
10027512|NCT01884545|11151766|FG003|COMPLETED|Overall Study||43
10027513|NCT01884545|11151763|FG000|NOT COMPLETED|Overall Study||13
10027514|NCT01884545|11151764|FG001|NOT COMPLETED|Overall Study||18
9703192|NCT02173301|10802738|FG001|STARTED|Overall Study||55
9703193|NCT02173301|10802739|FG002|STARTED|Overall Study||48
9703194|NCT02173301|10802740|FG003|STARTED|Overall Study||48
9703195|NCT02173301|10802737|FG000|COMPLETED|Overall Study||29
9703196|NCT02173301|10802738|FG001|COMPLETED|Overall Study||32
9703197|NCT02173301|10802739|FG002|COMPLETED|Overall Study||28
9703198|NCT02173301|10802740|FG003|COMPLETED|Overall Study||33
9703199|NCT02173301|10802737|FG000|NOT COMPLETED|Overall Study||20
9703200|NCT02173301|10802738|FG001|NOT COMPLETED|Overall Study||23
9703201|NCT02173301|10802739|FG002|NOT COMPLETED|Overall Study||20
9703202|NCT02173301|10802740|FG003|NOT COMPLETED|Overall Study||15
9703203|NCT01986114|10802750|FG000|STARTED|Overall Study||495
9703204|NCT01986114|10802750|FG000|COMPLETED|Overall Study||339
9703205|NCT01986114|10802750|FG000|NOT COMPLETED|Overall Study||156
9703206|NCT01986101|10802759|FG000|STARTED|Overall Study||172
10115455|NCT02525744|11246275|FG001|NOT COMPLETED|Period 5||0
10115456|NCT02525744|11246276|FG002|NOT COMPLETED|Period 5||0
10115457|NCT02525744|11246277|FG003|NOT COMPLETED|Period 5||0
10115458|NCT02525861|11246289|FG000|STARTED|Overall Study||18
10115459|NCT02525861|11246290|FG001|STARTED|Overall Study||16
10115460|NCT02525861|11246289|FG000|COMPLETED|Overall Study||17
10115461|NCT02525861|11246290|FG001|COMPLETED|Overall Study||14
9848076|NCT00856986|10960684|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0
9848077|NCT00856999|10960696|FG000|STARTED|Overall Study||50
9703207|NCT01986101|10802760|FG001|STARTED|Overall Study||184
9703208|NCT01986101|10802761|FG002|STARTED|Overall Study||169
9703209|NCT01986101|10802759|FG000|Intent-to-Treat Population|Overall Study||171
9703210|NCT01986101|10802760|FG001|Intent-to-Treat Population|Overall Study||182
9703211|NCT01986101|10802761|FG002|Intent-to-Treat Population|Overall Study||169
9703212|NCT01986101|10802759|FG000|Safety Population|Overall Study||172
9703213|NCT01986101|10802760|FG001|Safety Population|Overall Study||184
9703214|NCT01986101|10802761|FG002|Safety Population|Overall Study||169
9703215|NCT01986101|10802759|FG000|COMPLETED|Overall Study||139
9703216|NCT01986101|10802760|FG001|COMPLETED|Overall Study||157
9703217|NCT01986101|10802761|FG002|COMPLETED|Overall Study||137
9703218|NCT01986101|10802759|FG000|NOT COMPLETED|Overall Study||33
9703219|NCT01986101|10802760|FG001|NOT COMPLETED|Overall Study||27
9703220|NCT01986101|10802761|FG002|NOT COMPLETED|Overall Study||32
9703221|NCT01972035|10802774|FG000|STARTED|Overall Study||66
9703222|NCT01972035|10802775|FG001|STARTED|Overall Study||71
9703223|NCT01972035|10802774|FG000|COMPLETED|Overall Study||27
9703224|NCT01972035|10802775|FG001|COMPLETED|Overall Study||44
9703225|NCT01972035|10802774|FG000|NOT COMPLETED|Overall Study||39
9703226|NCT01972035|10802775|FG001|NOT COMPLETED|Overall Study||27
9703227|NCT01955980|10802783|FG000|STARTED|Overall Study||10
9703228|NCT01955980|10802784|FG001|STARTED|Overall Study||9
9703229|NCT01955980|10802783|FG000|COMPLETED|Overall Study||10
9703230|NCT01955980|10802784|FG001|COMPLETED|Overall Study||9
9703231|NCT01955980|10802783|FG000|NOT COMPLETED|Overall Study||0
9703232|NCT01955980|10802784|FG001|NOT COMPLETED|Overall Study||0
9703233|NCT01946711|10802793|FG000|STARTED|Overall Study||8
9703234|NCT01946711|10802794|FG001|STARTED|Overall Study||6
9703235|NCT01946711|10802793|FG000|COMPLETED|Overall Study||8
9703236|NCT01946711|10802794|FG001|COMPLETED|Overall Study||6
9703237|NCT01946711|10802793|FG000|NOT COMPLETED|Overall Study||0
9703238|NCT01946711|10802794|FG001|NOT COMPLETED|Overall Study||0
9703239|NCT01891994|10802800|FG000|STARTED|Overall Study||40
9703240|NCT01891994|10802800|FG000|COMPLETED|Overall Study||40
9703241|NCT01891994|10802800|FG000|NOT COMPLETED|Overall Study||0
9703242|NCT01839396|10802806|FG000|STARTED|Overall Study||121
9703243|NCT01839396|10802807|FG001|STARTED|Overall Study||39
9703244|NCT01839396|10802806|FG000|COMPLETED|Overall Study||121
9703245|NCT01839396|10802807|FG001|COMPLETED|Overall Study||39
9703246|NCT01839396|10802806|FG000|NOT COMPLETED|Overall Study||0
9703247|NCT01839396|10802807|FG001|NOT COMPLETED|Overall Study||0
9703248|NCT01813305|10802815|FG000|STARTED|Overall Study||98
9703249|NCT01813305|10802816|FG001|STARTED|Overall Study||26
9703250|NCT01813305|10802815|FG000|COMPLETED|Overall Study||63
9703251|NCT01813305|10802816|FG001|COMPLETED|Overall Study||18
9703252|NCT01813305|10802815|FG000|NOT COMPLETED|Overall Study||35
9703253|NCT01813305|10802816|FG001|NOT COMPLETED|Overall Study||8
9728679|NCT00112918|10828168|FG002|NOT COMPLETED|Overall Study||299
9728680|NCT00112957|10828176|FG000|STARTED|Overall Study||23
9728681|NCT00112957|10828176|FG000|COMPLETED|Overall Study||4
9728682|NCT00112957|10828176|FG000|NOT COMPLETED|Overall Study||19
9728683|NCT00113022|10828182|FG000|STARTED|Overall Study||5
9728684|NCT00113022|10828183|FG001|STARTED|Overall Study||4
9728685|NCT00113022|10828182|FG000|COMPLETED|Overall Study||2
9728686|NCT00113022|10828183|FG001|COMPLETED|Overall Study||2
9728687|NCT00113022|10828182|FG000|NOT COMPLETED|Overall Study||3
9728688|NCT00113022|10828183|FG001|NOT COMPLETED|Overall Study||2
9728689|NCT00113087|10828191|FG000|STARTED|Overall Study||115
9728690|NCT00113087|10828192|FG001|STARTED|Overall Study||115
9728691|NCT00113087|10828191|FG000|COMPLETED|Overall Study||91
9728692|NCT00113087|10828192|FG001|COMPLETED|Overall Study||94
9728693|NCT00113087|10828191|FG000|NOT COMPLETED|Overall Study||24
10115462|NCT02525861|11246289|FG000|NOT COMPLETED|Overall Study||1
10115463|NCT02525861|11246290|FG001|NOT COMPLETED|Overall Study||2
9703254|NCT01680965|10802828|FG000|STARTED|Overall Study||3
9703255|NCT01680965|10802829|FG001|STARTED|Overall Study||3
9703256|NCT01680965|10802830|FG002|STARTED|Overall Study||6
9703257|NCT01680965|10802831|FG003|STARTED|Overall Study||32
9703258|NCT01680965|10802828|FG000|COMPLETED|Overall Study||3
9703259|NCT01680965|10802829|FG001|COMPLETED|Overall Study||3
9703260|NCT01680965|10802830|FG002|COMPLETED|Overall Study||6
9703261|NCT01680965|10802831|FG003|COMPLETED|Overall Study||26
9703262|NCT01680965|10802828|FG000|NOT COMPLETED|Overall Study||0
9703263|NCT01680965|10802829|FG001|NOT COMPLETED|Overall Study||0
9703264|NCT01680965|10802830|FG002|NOT COMPLETED|Overall Study||0
9703265|NCT01680965|10802831|FG003|NOT COMPLETED|Overall Study||6
10027515|NCT01884545|11151765|FG002|NOT COMPLETED|Overall Study||14
10027516|NCT01884545|11151766|FG003|NOT COMPLETED|Overall Study||9
10027517|NCT01884571|11151776|FG000|STARTED|Overall Study||31
10027518|NCT01884571|11151776|FG000|COMPLETED|Overall Study||23
10027519|NCT01884571|11151776|FG000|NOT COMPLETED|Overall Study||8
10027520|NCT01884597|11151783|FG000|STARTED|Overall Study||5
10027521|NCT01884597|11151784|FG001|STARTED|Overall Study||3
10027522|NCT01884597|11151785|FG002|STARTED|Overall Study||16
10027523|NCT01884597|11151783|FG000|COMPLETED|Overall Study||4
10027524|NCT01884597|11151784|FG001|COMPLETED|Overall Study||2
10027525|NCT01884597|11151785|FG002|COMPLETED|Overall Study||15
10027526|NCT01884597|11151783|FG000|NOT COMPLETED|Overall Study||1
10027527|NCT01884597|11151784|FG001|NOT COMPLETED|Overall Study||1
10027528|NCT01884597|11151785|FG002|NOT COMPLETED|Overall Study||1
10027529|NCT01884675|11151801|FG000|STARTED|Overall Study||16
10027530|NCT01884675|11151802|FG001|STARTED|Overall Study||17
10027531|NCT01884675|11151801|FG000|COMPLETED|Overall Study||13
10027532|NCT01884675|11151802|FG001|COMPLETED|Overall Study||15
10027533|NCT01884675|11151801|FG000|NOT COMPLETED|Overall Study||3
10027534|NCT01884675|11151802|FG001|NOT COMPLETED|Overall Study||2
10027535|NCT01884688|11151810|FG000|STARTED|Overall Study||3
10027536|NCT01884688|11151810|FG000|COMPLETED|Overall Study||1
10027537|NCT01884688|11151810|FG000|NOT COMPLETED|Overall Study||2
10027538|NCT01884844|11151816|FG000|STARTED|Overall Study||16
10027539|NCT01884844|11151817|FG001|STARTED|Overall Study||17
10027540|NCT01884844|11151816|FG000|COMPLETED|Overall Study||13
10027541|NCT01884844|11151817|FG001|COMPLETED|Overall Study||12
10027542|NCT01884844|11151816|FG000|NOT COMPLETED|Overall Study||3
10027543|NCT01884844|11151817|FG001|NOT COMPLETED|Overall Study||5
10027544|NCT01885000|11151825|FG000|STARTED|Overall Study||48
10027545|NCT01885000|11151826|FG001|STARTED|Overall Study||44
10027546|NCT01885000|11151825|FG000|COMPLETED|Overall Study||46
10027547|NCT01885000|11151826|FG001|COMPLETED|Overall Study||42
10027548|NCT01885000|11151825|FG000|NOT COMPLETED|Overall Study||2
10027549|NCT01885000|11151826|FG001|NOT COMPLETED|Overall Study||2
10027550|NCT01885104|11151834|FG000|STARTED|Overall Study||31
10027551|NCT01885104|11151835|FG001|STARTED|Overall Study||34
10027552|NCT01885104|11151834|FG000|COMPLETED|Overall Study||29
10027553|NCT01885104|11151835|FG001|COMPLETED|Overall Study||33
10027554|NCT01885104|11151834|FG000|NOT COMPLETED|Overall Study||2
10027555|NCT01885104|11151835|FG001|NOT COMPLETED|Overall Study||1
10027556|NCT01885117|11151843|FG000|STARTED|Overall Study||61
10027557|NCT01885117|11151844|FG001|STARTED|Overall Study||64
10027558|NCT01885117|11151843|FG000|COMPLETED|Overall Study||61
10027559|NCT01885117|11151844|FG001|COMPLETED|Overall Study||64
10027560|NCT01885117|11151843|FG000|NOT COMPLETED|Overall Study||0
10027561|NCT01885117|11151844|FG001|NOT COMPLETED|Overall Study||0
10027562|NCT01885182|11151852|FG000|STARTED|Overall Study||117
10027563|NCT01885182|11151853|FG001|STARTED|Overall Study||115
10027564|NCT01885182|11151852|FG000|Safety Population|Overall Study||114
10027565|NCT01885182|11151853|FG001|Safety Population|Overall Study||111
10027566|NCT01885182|11151852|FG000|FAP Population|Overall Study||107
10027567|NCT01885182|11151853|FG001|FAP Population|Overall Study||106
10027568|NCT01885182|11151852|FG000|COMPLETED|Overall Study||83
10027569|NCT01885182|11151853|FG001|COMPLETED|Overall Study||93
10027570|NCT01885182|11151852|FG000|NOT COMPLETED|Overall Study||34
10027571|NCT01885182|11151853|FG001|NOT COMPLETED|Overall Study||22
10027572|NCT01885195|11151861|FG000|STARTED|Overall Study||110
10027573|NCT01885195|11151861|FG000|COMPLETED|Overall Study||0
10027574|NCT01885195|11151861|FG000|NOT COMPLETED|Overall Study||110
10027575|NCT01885208|11151867|FG000|STARTED|Overall Study||406
10027576|NCT01885208|11151868|FG001|STARTED|Overall Study||407
10027577|NCT01885208|11151867|FG000|Exposed|Overall Study||404
10027578|NCT01885208|11151868|FG001|Exposed|Overall Study||405
10027579|NCT01885208|11151867|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
10027580|NCT01885208|11151868|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
10027581|NCT01885208|11151867|FG000|COMPLETED|Overall Study||374
10027582|NCT01885208|11151868|FG001|COMPLETED|Overall Study||369
10027583|NCT01885208|11151867|FG000|NOT COMPLETED|Overall Study||32
10027584|NCT01885208|11151868|FG001|NOT COMPLETED|Overall Study||38
10027585|NCT01885559|11151876|FG000|STARTED|Overall Study||242
10027586|NCT01885559|11151877|FG001|STARTED|Overall Study||244
10115464|NCT02525874|11246298|FG000|STARTED|Overall Study||218
10027587|NCT01885559|11151876|FG000|COMPLETED|Overall Study||218
9703266|NCT01614912|10802839|FG000|STARTED|Overall Study||284
9703267|NCT01614912|10802839|FG000|COMPLETED|Overall Study||159
10027588|NCT01885559|11151877|FG001|COMPLETED|Overall Study||208
10027589|NCT01885559|11151876|FG000|NOT COMPLETED|Overall Study||24
10115465|NCT02525874|11246298|FG000|COMPLETED|Overall Study||158
9703268|NCT01614912|10802839|FG000|NOT COMPLETED|Overall Study||125
9703269|NCT01614899|10802846|FG000|STARTED|Overall Study||150
9703270|NCT01614899|10802847|FG001|STARTED|Overall Study||155
9703271|NCT01614899|10802848|FG002|STARTED|Overall Study||152
9703272|NCT01614899|10802846|FG000|COMPLETED|Overall Study||106
9703273|NCT01614899|10802847|FG001|COMPLETED|Overall Study||116
9703274|NCT01614899|10802848|FG002|COMPLETED|Overall Study||110
9703275|NCT01614899|10802846|FG000|NOT COMPLETED|Overall Study||44
9703276|NCT01614899|10802847|FG001|NOT COMPLETED|Overall Study||39
9703277|NCT01614899|10802848|FG002|NOT COMPLETED|Overall Study||42
9703278|NCT01592370|10802863|FG000|STARTED|Overall Study||105
9703279|NCT01592370|10802864|FG001|STARTED|Overall Study||65
9703280|NCT01592370|10802865|FG002|STARTED|Overall Study||72
9703281|NCT01592370|10802866|FG003|STARTED|Overall Study||6
9703282|NCT01592370|10802867|FG004|STARTED|Overall Study||5
9703283|NCT01592370|10802868|FG005|STARTED|Overall Study||41
9703284|NCT01592370|10802869|FG006|STARTED|Overall Study||22
9703285|NCT01592370|10802863|FG000|COMPLETED|Overall Study||1
9703286|NCT01592370|10802864|FG001|COMPLETED|Overall Study||40
9703287|NCT01592370|10802865|FG002|COMPLETED|Overall Study||0
9703288|NCT01592370|10802866|FG003|COMPLETED|Overall Study||1
9703289|NCT01592370|10802867|FG004|COMPLETED|Overall Study||1
9703290|NCT01592370|10802868|FG005|COMPLETED|Overall Study||7
9703291|NCT01592370|10802869|FG006|COMPLETED|Overall Study||6
9703292|NCT01592370|10802863|FG000|NOT COMPLETED|Overall Study||104
9848078|NCT00856999|10960696|FG000|COMPLETED|Overall Study||45
9848079|NCT00856999|10960696|FG000|NOT COMPLETED|Overall Study||5
9848080|NCT00857207|10960703|FG000|STARTED|Overall Study||48
9848081|NCT00857207|10960704|FG001|STARTED|Overall Study||3
9848082|NCT00857207|10960703|FG000|COMPLETED|Overall Study||14
10027590|NCT01885559|11151877|FG001|NOT COMPLETED|Overall Study||36
10027591|NCT01885871|11151883|FG000|STARTED|Overall Study||20
10027592|NCT01885871|11151883|FG000|COMPLETED|Overall Study||20
9703293|NCT01592370|10802864|FG001|NOT COMPLETED|Overall Study||25
9703294|NCT01592370|10802865|FG002|NOT COMPLETED|Overall Study||72
9703295|NCT01592370|10802866|FG003|NOT COMPLETED|Overall Study||5
9703296|NCT01592370|10802867|FG004|NOT COMPLETED|Overall Study||4
9703297|NCT01592370|10802868|FG005|NOT COMPLETED|Overall Study||34
9703298|NCT01592370|10802869|FG006|NOT COMPLETED|Overall Study||16
9703299|NCT00711269|10802893|FG000|STARTED|Overall Study||131
9703300|NCT00711269|10802894|FG001|STARTED|Overall Study||131
9703301|NCT00711269|10802895|FG002|STARTED|Overall Study||133
9703302|NCT00711269|10802896|FG003|STARTED|Overall Study||65
9703303|NCT00711269|10802893|FG000|COMPLETED|Overall Study||87
9703304|NCT00711269|10802894|FG001|COMPLETED|Overall Study||83
9703305|NCT00711269|10802895|FG002|COMPLETED|Overall Study||83
9703306|NCT00711269|10802896|FG003|COMPLETED|Overall Study||51
9703307|NCT00711269|10802893|FG000|NOT COMPLETED|Overall Study||44
9703308|NCT00711269|10802894|FG001|NOT COMPLETED|Overall Study||48
9703309|NCT00711269|10802895|FG002|NOT COMPLETED|Overall Study||50
9703310|NCT00711269|10802896|FG003|NOT COMPLETED|Overall Study||14
9703311|NCT00152477|10802910|FG000|STARTED|Chemotherapy Period||50
9703312|NCT00152477|10802911|FG001|STARTED|Chemotherapy Period||56
9703313|NCT00152477|10802912|FG002|STARTED|Chemotherapy Period||59
9703314|NCT00152477|10802910|FG000|Part II|Chemotherapy Period||50
9703315|NCT00152477|10802911|FG001|Part II|Chemotherapy Period||53
9703316|NCT00152477|10802912|FG002|Part II|Chemotherapy Period||53
9703317|NCT00152477|10802910|FG000|COMPLETED|Chemotherapy Period||22
9703318|NCT00152477|10802911|FG001|COMPLETED|Chemotherapy Period||34
9703319|NCT00152477|10802912|FG002|COMPLETED|Chemotherapy Period||39
9848083|NCT00857207|10960704|FG001|COMPLETED|Overall Study||3
9848084|NCT00857207|10960703|FG000|NOT COMPLETED|Overall Study||34
9848085|NCT00857207|10960704|FG001|NOT COMPLETED|Overall Study||0
9848086|NCT00857220|10960711|FG000|STARTED|Overall Study||304
9848087|NCT00857220|10960711|FG000|COMPLETED|Overall Study||121
9848088|NCT00857220|10960711|FG000|NOT COMPLETED|Overall Study||183
9848089|NCT00857233|10960715|FG000|STARTED|Overall Study||297
9848090|NCT00857233|10960715|FG000|COMPLETED|Overall Study||242
9848091|NCT00857233|10960715|FG000|NOT COMPLETED|Overall Study||55
9848092|NCT00857246|10960719|FG000|STARTED|Induction Regimen||30
9848093|NCT00857246|10960719|FG000|COMPLETED|Induction Regimen||27
10027593|NCT01885871|11151883|FG000|NOT COMPLETED|Overall Study||0
10027594|NCT01885897|11151893|FG000|STARTED|Overall Study||6
10027595|NCT01885897|11151894|FG001|STARTED|Overall Study||3
10027596|NCT01885897|11151895|FG002|STARTED|Overall Study||4
10027597|NCT01885897|11151896|FG003|STARTED|Overall Study||3
10027598|NCT01885897|11151897|FG004|STARTED|Overall Study||8
10027599|NCT01885897|11151898|FG005|STARTED|Overall Study||9
10027600|NCT01885897|11151893|FG000|COMPLETED|Overall Study||6
10027601|NCT01885897|11151894|FG001|COMPLETED|Overall Study||3
9848094|NCT00857246|10960719|FG000|NOT COMPLETED|Induction Regimen||3
9848095|NCT00857246|10960719|FG000|STARTED|Surgery (Curative)||27
9848096|NCT00857246|10960719|FG000|COMPLETED|Surgery (Curative)||21
9848097|NCT00857246|10960719|FG000|NOT COMPLETED|Surgery (Curative)||6
9848098|NCT00857246|10960719|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
9848099|NCT00857246|10960719|FG000|COMPLETED|ChemoRT||12
9703320|NCT00152477|10802910|FG000|NOT COMPLETED|Chemotherapy Period||28
9703321|NCT00152477|10802911|FG001|NOT COMPLETED|Chemotherapy Period||22
9703322|NCT00152477|10802912|FG002|NOT COMPLETED|Chemotherapy Period||20
9728694|NCT00113087|10828192|FG001|NOT COMPLETED|Overall Study||21
9848100|NCT00857246|10960719|FG000|NOT COMPLETED|ChemoRT||3
10027602|NCT01885897|11151895|FG002|COMPLETED|Overall Study||4
9703323|NCT00152477|10802910|FG000|STARTED|Monotherapy Period|7 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|15
9703324|NCT00152477|10802911|FG001|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|29
9703325|NCT00152477|10802912|FG002|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|34
9703326|NCT00152477|10802910|FG000|Part II|Monotherapy Period||13
9703327|NCT00152477|10802911|FG001|Part II|Monotherapy Period||26
9703328|NCT00152477|10802912|FG002|Part II|Monotherapy Period||29
9703329|NCT00152477|10802910|FG000|COMPLETED|Monotherapy Period||0
9703330|NCT00152477|10802911|FG001|COMPLETED|Monotherapy Period||0
9703331|NCT00152477|10802912|FG002|COMPLETED|Monotherapy Period||0
9703332|NCT00152477|10802910|FG000|NOT COMPLETED|Monotherapy Period||15
9703333|NCT00152477|10802911|FG001|NOT COMPLETED|Monotherapy Period||29
9703334|NCT00152477|10802912|FG002|NOT COMPLETED|Monotherapy Period||34
9728695|NCT00113217|10828198|FG000|STARTED|Overall Study||50
9728696|NCT00113217|10828198|FG000|COMPLETED|Overall Study||50
9728697|NCT00113217|10828198|FG000|NOT COMPLETED|Overall Study||0
9728698|NCT00113230|10828202|FG000|STARTED|Overall Study||25
9728699|NCT00113230|10828202|FG000|COMPLETED|Overall Study||25
9728700|NCT00113230|10828202|FG000|NOT COMPLETED|Overall Study||0
9728701|NCT00113269|10828210|FG000|STARTED|Overall Study||76
9728702|NCT00113269|10828211|FG001|STARTED|Overall Study||70
9728703|NCT00113269|10828212|FG002|STARTED|Overall Study||175
9728704|NCT00113269|10828213|FG003|STARTED|Overall Study||180
9728705|NCT00113269|10828210|FG000|Received Treatment|Overall Study||70
9728706|NCT00113269|10828211|FG001|Received Treatment|Overall Study||69
9728707|NCT00113269|10828212|FG002|Received Treatment|Overall Study||164
9728708|NCT00113269|10828213|FG003|Received Treatment|Overall Study||171
9728709|NCT00113269|10828210|FG000|COMPLETED|Overall Study||51
9728710|NCT00113269|10828211|FG001|COMPLETED|Overall Study||48
9728711|NCT00113269|10828212|FG002|COMPLETED|Overall Study||134
9728712|NCT00113269|10828213|FG003|COMPLETED|Overall Study||140
10027603|NCT01885897|11151896|FG003|COMPLETED|Overall Study||3
10027604|NCT01885897|11151897|FG004|COMPLETED|Overall Study||8
10027605|NCT01885897|11151898|FG005|COMPLETED|Overall Study||9
10027606|NCT01885897|11151893|FG000|NOT COMPLETED|Overall Study||0
10027607|NCT01885897|11151894|FG001|NOT COMPLETED|Overall Study||0
10027608|NCT01885897|11151895|FG002|NOT COMPLETED|Overall Study||0
10027609|NCT01885897|11151896|FG003|NOT COMPLETED|Overall Study||0
10027610|NCT01885897|11151897|FG004|NOT COMPLETED|Overall Study||0
10027611|NCT01885897|11151898|FG005|NOT COMPLETED|Overall Study||0
10027612|NCT01885910|11151912|FG000|STARTED|Overall Study||32
10027613|NCT01885910|11151912|FG000|COMPLETED|Overall Study||24
10027614|NCT01885910|11151912|FG000|NOT COMPLETED|Overall Study||8
10027615|NCT01885936|11151920|FG000|STARTED|Overall Study||8
10027616|NCT01885936|11151921|FG001|STARTED|Overall Study||5
10027617|NCT01885936|11151920|FG000|COMPLETED|Overall Study||7
10027618|NCT01885936|11151921|FG001|COMPLETED|Overall Study||5
10027619|NCT01885936|11151920|FG000|NOT COMPLETED|Overall Study||1
10027620|NCT01885936|11151921|FG001|NOT COMPLETED|Overall Study||0
10027621|NCT01886105|11151927|FG000|STARTED|Overall Study||4
10027622|NCT01886105|11151927|FG000|COMPLETED|Overall Study||1
10027623|NCT01886105|11151927|FG000|NOT COMPLETED|Overall Study||3
10027624|NCT01886235|11151932|FG000|STARTED|Overall Study||10
10027625|NCT01886235|11151932|FG000|COMPLETED|Overall Study||10
10027626|NCT01886235|11151932|FG000|NOT COMPLETED|Overall Study||0
10027627|NCT01886287|11151936|FG000|STARTED|Overall Study||2
10027628|NCT01886287|11151936|FG000|COMPLETED|Overall Study||0
10027629|NCT01886287|11151936|FG000|NOT COMPLETED|Overall Study||2
10027630|NCT01886300|11151940|FG000|STARTED|Overall Study||16
10027631|NCT01886300|11151940|FG000|COMPLETED|Overall Study||0
10027632|NCT01886300|11151940|FG000|NOT COMPLETED|Overall Study||16
10027633|NCT01886313|11151946|FG000|STARTED|Overall Study||6
10027634|NCT01886313|11151947|FG001|STARTED|Overall Study||5
10027635|NCT01886313|11151946|FG000|COMPLETED|Overall Study||5
10027636|NCT01886313|11151947|FG001|COMPLETED|Overall Study||4
10027637|NCT01886313|11151946|FG000|NOT COMPLETED|Overall Study||1
10027638|NCT01886313|11151947|FG001|NOT COMPLETED|Overall Study||1
10027639|NCT01886378|11151953|FG000|STARTED|Overall Study||29
10027640|NCT01886378|11151953|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25
10027641|NCT01886378|11151953|FG000|COMPLETED|Overall Study||24
10027642|NCT01886378|11151953|FG000|NOT COMPLETED|Overall Study||5
10027643|NCT01886690|11151959|FG000|STARTED|Overall Study||75
10027644|NCT01886690|11151960|FG001|STARTED|Overall Study||73
10027645|NCT01886690|11151959|FG000|COMPLETED|Overall Study||75
10027646|NCT01886690|11151960|FG001|COMPLETED|Overall Study||71
10027647|NCT01886690|11151959|FG000|NOT COMPLETED|Overall Study||0
10027648|NCT01886690|11151960|FG001|NOT COMPLETED|Overall Study||2
10027649|NCT01886716|11151970|FG000|STARTED|Week 1||24
10027650|NCT01886716|11151971|FG001|STARTED|Week 1||20
10027651|NCT01886716|11151972|FG002|STARTED|Week 1||22
10027652|NCT01886716|11151973|FG003|STARTED|Week 1||20
10027653|NCT01886716|11151970|FG000|COMPLETED|Week 1||24
9728713|NCT00113269|10828210|FG000|NOT COMPLETED|Overall Study||25
9728714|NCT00113269|10828211|FG001|NOT COMPLETED|Overall Study||22
9728715|NCT00113269|10828212|FG002|NOT COMPLETED|Overall Study||41
9728716|NCT00113269|10828213|FG003|NOT COMPLETED|Overall Study||40
10027654|NCT01886716|11151971|FG001|COMPLETED|Week 1||20
10027655|NCT01886716|11151972|FG002|COMPLETED|Week 1||20
10027656|NCT01886716|11151973|FG003|COMPLETED|Week 1||18
10027657|NCT01886716|11151970|FG000|NOT COMPLETED|Week 1||0
10027658|NCT01886716|11151971|FG001|NOT COMPLETED|Week 1||0
9703335|NCT04585646|10802923|FG000|STARTED|First Intervention||32
9703336|NCT04585646|10802924|FG001|STARTED|First Intervention||32
9703337|NCT04585646|10802923|FG000|COMPLETED|First Intervention||31
9703338|NCT04585646|10802924|FG001|COMPLETED|First Intervention||28
9703339|NCT04585646|10802923|FG000|NOT COMPLETED|First Intervention||1
9703340|NCT04585646|10802924|FG001|NOT COMPLETED|First Intervention||4
9703341|NCT04585646|10802923|FG000|STARTED|Second Intervention||31
9703342|NCT04585646|10802924|FG001|STARTED|Second Intervention||28
9703343|NCT04585646|10802923|FG000|COMPLETED|Second Intervention||31
9703344|NCT04585646|10802924|FG001|COMPLETED|Second Intervention||28
9703345|NCT04585646|10802923|FG000|NOT COMPLETED|Second Intervention||0
9703346|NCT04585646|10802924|FG001|NOT COMPLETED|Second Intervention||0
9703382|NCT04115189|10802977|FG001|NOT COMPLETED|Overall Study||0
9703383|NCT04010695|10802987|FG000|STARTED|Overall Study||250
9703384|NCT04010695|10802987|FG000|COMPLETED|Overall Study||250
9703385|NCT04010695|10802987|FG000|NOT COMPLETED|Overall Study||0
9703386|NCT04003623|10802994|FG000|STARTED|Overall Study||1
9703387|NCT04003623|10802995|FG001|STARTED|Overall Study||0
9703388|NCT04003623|10802994|FG000|COMPLETED|Overall Study||0
9703389|NCT04003623|10802995|FG001|COMPLETED|Overall Study||0
9703390|NCT04003623|10802994|FG000|NOT COMPLETED|Overall Study||1
9703391|NCT04003623|10802995|FG001|NOT COMPLETED|Overall Study||0
9703392|NCT03967847|10803003|FG000|STARTED|Overall Study||21
9703393|NCT03967847|10803004|FG001|STARTED|Overall Study||23
9703394|NCT03967847|10803003|FG000|COMPLETED|Overall Study||21
9703395|NCT03967847|10803004|FG001|COMPLETED|Overall Study||23
9703396|NCT03967847|10803003|FG000|NOT COMPLETED|Overall Study||0
9703397|NCT03967847|10803004|FG001|NOT COMPLETED|Overall Study||0
9728717|NCT00113295|10828225|FG000|STARTED|Overall Study||11
9728718|NCT00113295|10828226|FG001|STARTED|Overall Study||11
9728719|NCT00113295|10828225|FG000|COMPLETED|Overall Study||6
9728720|NCT00113295|10828226|FG001|COMPLETED|Overall Study||10
10027659|NCT01886716|11151972|FG002|NOT COMPLETED|Week 1||2
10027660|NCT01886716|11151973|FG003|NOT COMPLETED|Week 1||2
10027661|NCT01886716|11151970|FG000|STARTED|Week 2||24
9728721|NCT00113295|10828225|FG000|NOT COMPLETED|Overall Study||5
9728722|NCT00113295|10828226|FG001|NOT COMPLETED|Overall Study||1
9728723|NCT00113321|10828234|FG000|STARTED|Overall Study||16
9728724|NCT00113321|10828234|FG000|COMPLETED|Overall Study||16
9728725|NCT00113321|10828234|FG000|NOT COMPLETED|Overall Study||0
9728726|NCT00113334|10828238|FG000|STARTED|Overall Study||6
9728727|NCT00113334|10828238|FG000|COMPLETED|Overall Study||6
9728728|NCT00113334|10828238|FG000|NOT COMPLETED|Overall Study||0
9728729|NCT00113360|10828242|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67
9728730|NCT00113360|10828242|FG000|COMPLETED|Overall Study||60
9728731|NCT00113360|10828242|FG000|NOT COMPLETED|Overall Study||7
9728732|NCT00113373|10828246|FG000|STARTED|Overall Study||28
9728733|NCT00113373|10828246|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25
9728734|NCT00113373|10828246|FG000|NOT COMPLETED|Overall Study||3
9731867|NCT00137046|10831838|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
9731868|NCT00137046|10831839|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
9731869|NCT00137046|10831838|FG000|Received Study Treatment|Overall Study||290
9731870|NCT00137046|10831839|FG001|Received Study Treatment|Overall Study||290
9731871|NCT00137046|10831838|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
9731872|NCT00137046|10831839|FG001|COMPLETED|Overall Study||198
9731873|NCT00137046|10831838|FG000|NOT COMPLETED|Overall Study||99
9731874|NCT00137046|10831839|FG001|NOT COMPLETED|Overall Study||93
9731875|NCT00137111|10831853|FG000|STARTED|Window Therapy||0
9731876|NCT00137111|10831854|FG001|STARTED|Window Therapy||176
9731877|NCT00137111|10831855|FG002|STARTED|Window Therapy||180
9731878|NCT00137111|10831856|FG003|STARTED|Window Therapy||142
9731879|NCT00137111|10831853|FG000|COMPLETED|Window Therapy||0
9731880|NCT00137111|10831854|FG001|COMPLETED|Window Therapy||176
9731881|NCT00137111|10831855|FG002|COMPLETED|Window Therapy||180
9731882|NCT00137111|10831856|FG003|COMPLETED|Window Therapy||142
9731883|NCT00137111|10831853|FG000|NOT COMPLETED|Window Therapy||0
9731884|NCT00137111|10831854|FG001|NOT COMPLETED|Window Therapy||0
9731885|NCT00137111|10831855|FG002|NOT COMPLETED|Window Therapy||0
9731886|NCT00137111|10831856|FG003|NOT COMPLETED|Window Therapy||0
9731887|NCT00137111|10831853|FG000|STARTED|Total Therapy||498
9731888|NCT00137111|10831854|FG001|STARTED|Total Therapy||0
9731889|NCT00137111|10831855|FG002|STARTED|Total Therapy||0
9731890|NCT00137111|10831856|FG003|STARTED|Total Therapy||0
9731891|NCT00137111|10831853|FG000|COMPLETED|Total Therapy||458
9731892|NCT00137111|10831854|FG001|COMPLETED|Total Therapy||0
9731893|NCT00137111|10831855|FG002|COMPLETED|Total Therapy||0
9731894|NCT00137111|10831856|FG003|COMPLETED|Total Therapy||0
10027662|NCT01886716|11151971|FG001|STARTED|Week 2||20
10027663|NCT01886716|11151972|FG002|STARTED|Week 2||20
9731895|NCT00137111|10831853|FG000|NOT COMPLETED|Total Therapy||40
9731896|NCT00137111|10831854|FG001|NOT COMPLETED|Total Therapy||0
9731897|NCT00137111|10831855|FG002|NOT COMPLETED|Total Therapy||0
9731898|NCT00137111|10831856|FG003|NOT COMPLETED|Total Therapy||0
9731899|NCT00137267|10831865|FG000|STARTED|Overall Study||55
9731900|NCT00137267|10831866|FG001|STARTED|Overall Study||47
9731901|NCT00137267|10831865|FG000|COMPLETED|Overall Study||40
9731902|NCT00137267|10831866|FG001|COMPLETED|Overall Study||26
9731903|NCT00137267|10831865|FG000|NOT COMPLETED|Overall Study||15
9731904|NCT00137267|10831866|FG001|NOT COMPLETED|Overall Study||21
9703347|NCT04451330|10802933|FG000|STARTED|Overall Study||133
9703348|NCT04451330|10802934|FG001|STARTED|Overall Study||69
9703349|NCT04451330|10802933|FG000|COMPLETED|Overall Study||123
9703350|NCT04451330|10802934|FG001|COMPLETED|Overall Study||65
9703351|NCT04451330|10802933|FG000|NOT COMPLETED|Overall Study||10
9703352|NCT04451330|10802934|FG001|NOT COMPLETED|Overall Study||4
9703353|NCT04300010|10802943|FG000|STARTED|Overall Study||20
9703354|NCT04300010|10802944|FG001|STARTED|Overall Study||20
9703355|NCT04300010|10802945|FG002|STARTED|Overall Study||20
9703356|NCT04300010|10802946|FG003|STARTED|Overall Study||60
9703357|NCT04300010|10802943|FG000|COMPLETED|Overall Study||20
9703358|NCT04300010|10802944|FG001|COMPLETED|Overall Study||20
9703359|NCT04300010|10802945|FG002|COMPLETED|Overall Study||20
9703360|NCT04300010|10802946|FG003|COMPLETED|Overall Study||60
9703361|NCT04300010|10802943|FG000|NOT COMPLETED|Overall Study||0
9703362|NCT04300010|10802944|FG001|NOT COMPLETED|Overall Study||0
9703363|NCT04300010|10802945|FG002|NOT COMPLETED|Overall Study||0
9703364|NCT04300010|10802946|FG003|NOT COMPLETED|Overall Study||0
9703365|NCT04206670|10802957|FG000|STARTED|Overall Study||148
9703366|NCT04206670|10802958|FG001|STARTED|Overall Study||68
9703367|NCT04206670|10802957|FG000|COMPLETED|Overall Study||124
9703368|NCT04206670|10802958|FG001|COMPLETED|Overall Study||65
9703369|NCT04206670|10802957|FG000|NOT COMPLETED|Overall Study||24
10027664|NCT01886716|11151973|FG003|STARTED|Week 2||18
10027665|NCT01886716|11151970|FG000|COMPLETED|Week 2||21
10027666|NCT01886716|11151971|FG001|COMPLETED|Week 2||18
9703370|NCT04206670|10802958|FG001|NOT COMPLETED|Overall Study||3
9703371|NCT04173962|10802967|FG000|STARTED|Overall Study||12
9703372|NCT04173962|10802968|FG001|STARTED|Overall Study||12
9703373|NCT04173962|10802967|FG000|COMPLETED|Overall Study||12
9703374|NCT04173962|10802968|FG001|COMPLETED|Overall Study||12
9703375|NCT04173962|10802967|FG000|NOT COMPLETED|Overall Study||0
10027667|NCT01886716|11151972|FG002|COMPLETED|Week 2||19
10027668|NCT01886716|11151973|FG003|COMPLETED|Week 2||15
10027669|NCT01886716|11151970|FG000|NOT COMPLETED|Week 2||3
10027670|NCT01886716|11151971|FG001|NOT COMPLETED|Week 2||2
10027671|NCT01886716|11151972|FG002|NOT COMPLETED|Week 2||1
10027672|NCT01886716|11151973|FG003|NOT COMPLETED|Week 2||3
10027673|NCT01886716|11151970|FG000|STARTED|Week 3||21
10027674|NCT01886716|11151971|FG001|STARTED|Week 3||18
10027675|NCT01886716|11151972|FG002|STARTED|Week 3||19
10027676|NCT01886716|11151973|FG003|STARTED|Week 3||15
10027677|NCT01886716|11151970|FG000|COMPLETED|Week 3||20
10027678|NCT01886716|11151971|FG001|COMPLETED|Week 3||17
10027679|NCT01886716|11151972|FG002|COMPLETED|Week 3||19
10027680|NCT01886716|11151973|FG003|COMPLETED|Week 3||14
10027681|NCT01886716|11151970|FG000|NOT COMPLETED|Week 3||1
10027682|NCT01886716|11151971|FG001|NOT COMPLETED|Week 3||1
10027683|NCT01886716|11151972|FG002|NOT COMPLETED|Week 3||0
10027684|NCT01886716|11151973|FG003|NOT COMPLETED|Week 3||1
10027685|NCT01886716|11151970|FG000|STARTED|Week 4||20
10027686|NCT01886716|11151971|FG001|STARTED|Week 4||17
10027687|NCT01886716|11151972|FG002|STARTED|Week 4||19
10027688|NCT01886716|11151973|FG003|STARTED|Week 4||14
10027689|NCT01886716|11151970|FG000|COMPLETED|Week 4||20
10027690|NCT01886716|11151971|FG001|COMPLETED|Week 4||17
10027691|NCT01886716|11151972|FG002|COMPLETED|Week 4||19
10027692|NCT01886716|11151973|FG003|COMPLETED|Week 4||14
10027693|NCT01886716|11151970|FG000|NOT COMPLETED|Week 4||0
10027694|NCT01886716|11151971|FG001|NOT COMPLETED|Week 4||0
10027695|NCT01886716|11151972|FG002|NOT COMPLETED|Week 4||0
10027696|NCT01886716|11151973|FG003|NOT COMPLETED|Week 4||0
10027697|NCT01886716|11151970|FG000|STARTED|1-Week Post Follow-Up||20
10027698|NCT01886716|11151971|FG001|STARTED|1-Week Post Follow-Up||17
10027699|NCT01886716|11151972|FG002|STARTED|1-Week Post Follow-Up||19
10027700|NCT01886716|11151973|FG003|STARTED|1-Week Post Follow-Up||14
10027701|NCT01886716|11151970|FG000|COMPLETED|1-Week Post Follow-Up||20
10027702|NCT01886716|11151971|FG001|COMPLETED|1-Week Post Follow-Up||17
10027703|NCT01886716|11151972|FG002|COMPLETED|1-Week Post Follow-Up||19
10027704|NCT01886716|11151973|FG003|COMPLETED|1-Week Post Follow-Up||14
10027705|NCT01886716|11151970|FG000|NOT COMPLETED|1-Week Post Follow-Up||0
10027706|NCT01886716|11151971|FG001|NOT COMPLETED|1-Week Post Follow-Up||0
10027707|NCT01886716|11151972|FG002|NOT COMPLETED|1-Week Post Follow-Up||0
10027708|NCT01886716|11151973|FG003|NOT COMPLETED|1-Week Post Follow-Up||0
10027709|NCT01886716|11151970|FG000|STARTED|1-Month Post Follow-Up||20
10027710|NCT01886716|11151971|FG001|STARTED|1-Month Post Follow-Up||17
10027711|NCT01886716|11151972|FG002|STARTED|1-Month Post Follow-Up||19
10027712|NCT01886716|11151973|FG003|STARTED|1-Month Post Follow-Up||14
10027713|NCT01886716|11151970|FG000|COMPLETED|1-Month Post Follow-Up||20
10027714|NCT01886716|11151971|FG001|COMPLETED|1-Month Post Follow-Up||17
10027715|NCT01886716|11151972|FG002|COMPLETED|1-Month Post Follow-Up||19
10027716|NCT01886716|11151973|FG003|COMPLETED|1-Month Post Follow-Up||14
9703376|NCT04173962|10802968|FG001|NOT COMPLETED|Overall Study||0
9703377|NCT04115189|10802976|FG000|STARTED|Overall Study||42
9703378|NCT04115189|10802977|FG001|STARTED|Overall Study||15
9703379|NCT04115189|10802976|FG000|COMPLETED|Overall Study||42
9703380|NCT04115189|10802977|FG001|COMPLETED|Overall Study||15
10027717|NCT01886716|11151970|FG000|NOT COMPLETED|1-Month Post Follow-Up||0
10027718|NCT01886716|11151971|FG001|NOT COMPLETED|1-Month Post Follow-Up||0
10027719|NCT01886716|11151972|FG002|NOT COMPLETED|1-Month Post Follow-Up||0
10027720|NCT01886716|11151973|FG003|NOT COMPLETED|1-Month Post Follow-Up||0
9703381|NCT04115189|10802976|FG000|NOT COMPLETED|Overall Study||0
10027721|NCT01886781|11151985|FG000|STARTED|Overall Study||54
10027722|NCT01886781|11151986|FG001|STARTED|Overall Study||27
9703398|NCT03828383|10803013|FG000|STARTED|Overall Study||41
9703399|NCT03828383|10803014|FG001|STARTED|Overall Study||37
9703400|NCT03828383|10803013|FG000|COMPLETED|Overall Study||34
9703401|NCT03828383|10803014|FG001|COMPLETED|Overall Study||30
9703402|NCT03828383|10803013|FG000|NOT COMPLETED|Overall Study||7
9703403|NCT03828383|10803014|FG001|NOT COMPLETED|Overall Study||7
9703404|NCT03817853|10803020|FG000|STARTED|Induction Phase||113
9703405|NCT03817853|10803021|FG001|STARTED|Induction Phase||0
9703406|NCT03817853|10803022|FG002|STARTED|Induction Phase||0
9703407|NCT03817853|10803020|FG000|COMPLETED|Induction Phase||62
9703408|NCT03817853|10803021|FG001|COMPLETED|Induction Phase||0
9703409|NCT03817853|10803022|FG002|COMPLETED|Induction Phase||0
9703410|NCT03817853|10803020|FG000|NOT COMPLETED|Induction Phase||51
9703411|NCT03817853|10803021|FG001|NOT COMPLETED|Induction Phase||0
9703412|NCT03817853|10803022|FG002|NOT COMPLETED|Induction Phase||0
9703413|NCT03817853|10803020|FG000|STARTED|Maintenance/ Follow-up Phase||0
9703414|NCT03817853|10803021|FG001|STARTED|Maintenance/ Follow-up Phase||56
9703415|NCT03817853|10803022|FG002|STARTED|Maintenance/ Follow-up Phase||17
9703416|NCT03817853|10803020|FG000|COMPLETED|Maintenance/ Follow-up Phase||0
9703417|NCT03817853|10803021|FG001|COMPLETED|Maintenance/ Follow-up Phase||0
9703418|NCT03817853|10803022|FG002|COMPLETED|Maintenance/ Follow-up Phase||11
9703419|NCT03817853|10803020|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0
9703420|NCT03817853|10803021|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56
9703421|NCT03817853|10803022|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6
9703422|NCT03717480|10803030|FG000|STARTED|Overall Study||2
9703423|NCT03717480|10803030|FG000|Receipt of Investigational Product/Study Treatment|Overall Study||1
9703424|NCT03717480|10803030|FG000|COMPLETED|Overall Study||1
9703425|NCT03717480|10803030|FG000|NOT COMPLETED|Overall Study||1
9703426|NCT03615066|10803037|FG000|STARTED|Main Study||26
9703427|NCT03615066|10803038|FG001|STARTED|Main Study||28
9703428|NCT03615066|10803039|FG002|STARTED|Main Study||13
9703429|NCT03615066|10803037|FG000|COMPLETED|Main Study|2 participants did not receive all doses of study treatments but were considered to have completed the Main Study because the participants entered the TFFU Phase.|26
9703430|NCT03615066|10803038|FG001|COMPLETED|Main Study|1 participant did not receive all doses of study treatments but was considered to have completed the Main Study because the participant entered the TFFU Phase.|27
9703431|NCT03615066|10803039|FG002|COMPLETED|Main Study||11
9703432|NCT03615066|10803037|FG000|NOT COMPLETED|Main Study||0
9703433|NCT03615066|10803038|FG001|NOT COMPLETED|Main Study||1
9703434|NCT03615066|10803039|FG002|NOT COMPLETED|Main Study||2
9703435|NCT03615066|10803037|FG000|STARTED|Treatment-free Follow-up (TFFU) Phase|13 participants who completed Main study did not enter TFFU phase.|13
9703436|NCT03615066|10803038|FG001|STARTED|Treatment-free Follow-up (TFFU) Phase|15 participants who completed Main study did not enter TFFU phase.|12
9703437|NCT03615066|10803039|FG002|STARTED|Treatment-free Follow-up (TFFU) Phase|9 participants who completed Main study did not enter TFFU phase.|2
9703438|NCT03615066|10803037|FG000|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
9703439|NCT03615066|10803038|FG001|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
9703440|NCT03615066|10803039|FG002|COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
9703441|NCT03615066|10803037|FG000|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
9703442|NCT03615066|10803038|FG001|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||1
9703443|NCT03615066|10803039|FG002|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||0
9703444|NCT03557931|10803054|FG000|STARTED|Overall Study||100
9703445|NCT03557931|10803055|FG001|STARTED|Overall Study||65
9703446|NCT03557931|10803056|FG002|STARTED|Overall Study||68
9703447|NCT03557931|10803054|FG000|COMPLETED|Overall Study||69
9703448|NCT03557931|10803055|FG001|COMPLETED|Overall Study||46
9703449|NCT03557931|10803056|FG002|COMPLETED|Overall Study||55
9703450|NCT03557931|10803054|FG000|NOT COMPLETED|Overall Study||31
9703451|NCT03557931|10803055|FG001|NOT COMPLETED|Overall Study||19
9703452|NCT03557931|10803056|FG002|NOT COMPLETED|Overall Study||13
9703453|NCT03251144|10803068|FG000|STARTED|Overall Study||15
9703454|NCT03251144|10803069|FG001|STARTED|Overall Study||11
9703455|NCT03251144|10803068|FG000|COMPLETED|Overall Study||15
9703456|NCT03251144|10803069|FG001|COMPLETED|Overall Study||11
9703457|NCT03251144|10803068|FG000|NOT COMPLETED|Overall Study||0
9703458|NCT03251144|10803069|FG001|NOT COMPLETED|Overall Study||0
9703459|NCT02596035|10803078|FG000|STARTED|Overall Study||97
9703460|NCT02596035|10803079|FG001|STARTED|Overall Study||44
9703461|NCT02596035|10803080|FG002|STARTED|Overall Study||1
9703462|NCT02596035|10803078|FG000|COMPLETED|Overall Study||11
9703463|NCT02596035|10803079|FG001|COMPLETED|Overall Study||0
9703464|NCT02596035|10803080|FG002|COMPLETED|Overall Study||0
9703465|NCT02596035|10803078|FG000|NOT COMPLETED|Overall Study||86
9703466|NCT02596035|10803079|FG001|NOT COMPLETED|Overall Study||44
9703467|NCT02596035|10803080|FG002|NOT COMPLETED|Overall Study||1
9703468|NCT02576509|10803089|FG000|STARTED|Pre-Treatment Period||371
9703469|NCT02576509|10803090|FG001|STARTED|Pre-Treatment Period||372
9703470|NCT02576509|10803089|FG000|COMPLETED|Pre-Treatment Period||367
9703471|NCT02576509|10803090|FG001|COMPLETED|Pre-Treatment Period||363
9703472|NCT02576509|10803089|FG000|NOT COMPLETED|Pre-Treatment Period||4
9703473|NCT02576509|10803090|FG001|NOT COMPLETED|Pre-Treatment Period||9
9703474|NCT02576509|10803089|FG000|STARTED|Treatment Period||367
9703475|NCT02576509|10803090|FG001|STARTED|Treatment Period||363
9703476|NCT02576509|10803089|FG000|COMPLETED|Treatment Period||38
9703477|NCT02576509|10803090|FG001|COMPLETED|Treatment Period||8
9703478|NCT02576509|10803089|FG000|NOT COMPLETED|Treatment Period||329
9703479|NCT02576509|10803090|FG001|NOT COMPLETED|Treatment Period||355
9703480|NCT02576509|10803089|FG000|STARTED|Follow-up Period||367
9703481|NCT02576509|10803090|FG001|STARTED|Follow-up Period||363
9703482|NCT02576509|10803089|FG000|COMPLETED|Follow-up Period||318
9703483|NCT02576509|10803090|FG001|COMPLETED|Follow-up Period||311
9703484|NCT02576509|10803089|FG000|NOT COMPLETED|Follow-up Period||49
9703485|NCT02576509|10803090|FG001|NOT COMPLETED|Follow-up Period||52
9703492|NCT02448225|10803105|FG000|STARTED|Overall Study||46
9703493|NCT02448225|10803105|FG000|COMPLETED|Overall Study||26
9703494|NCT02448225|10803105|FG000|NOT COMPLETED|Overall Study||20
9703495|NCT02352948|10803118|FG000|STARTED|Overall Study||62
9703496|NCT02352948|10803119|FG001|STARTED|Overall Study||64
9703497|NCT02352948|10803120|FG002|STARTED|Overall Study||174
9703498|NCT02352948|10803121|FG003|STARTED|Overall Study||118
9703499|NCT02352948|10803122|FG004|STARTED|Overall Study||117
9703500|NCT02352948|10803123|FG005|STARTED|Overall Study||60
9703501|NCT02352948|10803118|FG000|Received Treatment|Overall Study||62
9703502|NCT02352948|10803119|FG001|Received Treatment|Overall Study||63
9703503|NCT02352948|10803120|FG002|Received Treatment|Overall Study||173
9703504|NCT02352948|10803121|FG003|Received Treatment|Overall Study||110
9703505|NCT02352948|10803122|FG004|Received Treatment|Overall Study||117
9703506|NCT02352948|10803123|FG005|Received Treatment|Overall Study||60
9703507|NCT02352948|10803118|FG000|Completed Study Treatment|Overall Study||15
9703508|NCT02352948|10803119|FG001|Completed Study Treatment|Overall Study||0
9703509|NCT02352948|10803120|FG002|Completed Study Treatment|Overall Study||36
9703510|NCT02352948|10803121|FG003|Completed Study Treatment|Overall Study||0
9703511|NCT02352948|10803122|FG004|Completed Study Treatment|Overall Study||23
10027723|NCT01886781|11151985|FG000|COMPLETED|Overall Study||40
10027724|NCT01886781|11151986|FG001|COMPLETED|Overall Study||25
10027725|NCT01886781|11151985|FG000|NOT COMPLETED|Overall Study||14
10027726|NCT01886781|11151986|FG001|NOT COMPLETED|Overall Study||2
10027727|NCT01886807|11151995|FG000|STARTED|Overall Study||164
10027728|NCT01886807|11151996|FG001|STARTED|Overall Study||155
10027729|NCT01886807|11151997|FG002|STARTED|Overall Study||163
10027730|NCT01886807|11151995|FG000|COMPLETED|Overall Study||159
10027731|NCT01886807|11151996|FG001|COMPLETED|Overall Study||145
10027732|NCT01886807|11151997|FG002|COMPLETED|Overall Study||153
10027733|NCT01886807|11151995|FG000|NOT COMPLETED|Overall Study||5
10027734|NCT01886807|11151996|FG001|NOT COMPLETED|Overall Study||10
10027735|NCT01886807|11151997|FG002|NOT COMPLETED|Overall Study||10
10027736|NCT01886833|11152008|FG000|STARTED|Overall Study||420
10027737|NCT01886833|11152008|FG000|COMPLETED|Overall Study||216
10027738|NCT01886833|11152008|FG000|NOT COMPLETED|Overall Study||204
10027739|NCT01886937|11152017|FG000|STARTED|Overall Study||7
10027740|NCT01886937|11152018|FG001|STARTED|Overall Study||6
10027741|NCT01886937|11152017|FG000|COMPLETED|Overall Study||7
10027742|NCT01886937|11152018|FG001|COMPLETED|Overall Study||6
10027743|NCT01886937|11152017|FG000|NOT COMPLETED|Overall Study||0
10027744|NCT01886937|11152018|FG001|NOT COMPLETED|Overall Study||0
10027745|NCT01887132|11152024|FG000|STARTED|Overall Study||4
10027746|NCT01887132|11152024|FG000|COMPLETED|Overall Study||4
10027747|NCT01887132|11152024|FG000|NOT COMPLETED|Overall Study||0
10027748|NCT01887171|11152030|FG000|STARTED|Overall Study||43
10027749|NCT01887171|11152031|FG001|STARTED|Overall Study||43
10027750|NCT01887171|11152030|FG000|COMPLETED|Overall Study||43
10027751|NCT01887171|11152031|FG001|COMPLETED|Overall Study||43
10027752|NCT01887171|11152030|FG000|NOT COMPLETED|Overall Study||0
10027753|NCT01887171|11152031|FG001|NOT COMPLETED|Overall Study||0
10027754|NCT01887210|11152039|FG000|STARTED|Overall Study||33
10027755|NCT01887210|11152040|FG001|STARTED|Overall Study||33
10027756|NCT01887210|11152039|FG000|COMPLETED|Overall Study||32
10027757|NCT01887210|11152040|FG001|COMPLETED|Overall Study||29
10027758|NCT01887210|11152039|FG000|NOT COMPLETED|Overall Study||1
10027759|NCT01887210|11152040|FG001|NOT COMPLETED|Overall Study||4
10027760|NCT01887327|11152049|FG000|STARTED|Overall Study||30
10027761|NCT01887327|11152050|FG001|STARTED|Overall Study||31
10027762|NCT01887327|11152051|FG002|STARTED|Overall Study||30
10027763|NCT01887327|11152049|FG000|COMPLETED|Overall Study||29
10027764|NCT01887327|11152050|FG001|COMPLETED|Overall Study||27
10027765|NCT01887327|11152051|FG002|COMPLETED|Overall Study||27
10027766|NCT01887327|11152049|FG000|NOT COMPLETED|Overall Study||1
10027767|NCT01887327|11152050|FG001|NOT COMPLETED|Overall Study||4
10027768|NCT01887327|11152051|FG002|NOT COMPLETED|Overall Study||3
10027769|NCT01887353|11152062|FG000|STARTED|Overall Study||4
10027770|NCT01887353|11152063|FG001|STARTED|Overall Study||4
9703512|NCT02352948|10803123|FG005|Completed Study Treatment|Overall Study||4
9703513|NCT02352948|10803118|FG000|COMPLETED|Overall Study||13
9703514|NCT02352948|10803119|FG001|COMPLETED|Overall Study||5
9703515|NCT02352948|10803120|FG002|COMPLETED|Overall Study||45
9703516|NCT02352948|10803121|FG003|COMPLETED|Overall Study||19
10027771|NCT01887353|11152062|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
10027772|NCT01887353|11152063|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
10027773|NCT01887353|11152062|FG000|NOT COMPLETED|Overall Study||4
10027774|NCT01887353|11152063|FG001|NOT COMPLETED|Overall Study||3
10027775|NCT01887418|11152072|FG000|STARTED|Overall Study||15
10027776|NCT01887418|11152073|FG001|STARTED|Overall Study||14
9703517|NCT02352948|10803122|FG004|COMPLETED|Overall Study||29
9703518|NCT02352948|10803123|FG005|COMPLETED|Overall Study||11
10027777|NCT01887418|11152074|FG002|STARTED|Overall Study||10
10027778|NCT01887418|11152072|FG000|COMPLETED|Overall Study||15
10027779|NCT01887418|11152073|FG001|COMPLETED|Overall Study||14
10027780|NCT01887418|11152074|FG002|COMPLETED|Overall Study||9
10027781|NCT01887418|11152072|FG000|NOT COMPLETED|Overall Study||0
10027782|NCT01887418|11152073|FG001|NOT COMPLETED|Overall Study||0
10027783|NCT01887418|11152074|FG002|NOT COMPLETED|Overall Study||1
10027784|NCT01887470|11152086|FG000|STARTED|Overall Study||10
10027785|NCT01887470|11152087|FG001|STARTED|Overall Study||10
10027786|NCT01887470|11152088|FG002|STARTED|Overall Study||10
10027787|NCT01887470|11152089|FG003|STARTED|Overall Study||10
10027788|NCT01887470|11152086|FG000|COMPLETED|Overall Study||10
10027789|NCT01887470|11152087|FG001|COMPLETED|Overall Study||10
10027790|NCT01887470|11152088|FG002|COMPLETED|Overall Study||10
10027791|NCT01887470|11152089|FG003|COMPLETED|Overall Study||10
10027792|NCT01887470|11152086|FG000|NOT COMPLETED|Overall Study||0
10027793|NCT01887470|11152087|FG001|NOT COMPLETED|Overall Study||0
10027794|NCT01887470|11152088|FG002|NOT COMPLETED|Overall Study||0
10027795|NCT01887470|11152089|FG003|NOT COMPLETED|Overall Study||0
10027796|NCT01887587|11152099|FG000|STARTED|Overall Study||5
10027797|NCT01887587|11152099|FG000|COMPLETED|Overall Study||5
10027798|NCT01887587|11152099|FG000|NOT COMPLETED|Overall Study||0
10027799|NCT01887600|11152106|FG000|STARTED|Overall Study||391
10027800|NCT01887600|11152107|FG001|STARTED|Overall Study||203
10027801|NCT01887600|11152106|FG000|Treatment Received|Overall Study||391
10027802|NCT01887600|11152107|FG001|Treatment Received|Overall Study||203
10027803|NCT01887600|11152106|FG000|COMPLETED|Overall Study||245
10027804|NCT01887600|11152107|FG001|COMPLETED|Overall Study||89
10027805|NCT01887600|11152106|FG000|NOT COMPLETED|Overall Study||146
10027806|NCT01887600|11152107|FG001|NOT COMPLETED|Overall Study||114
10027807|NCT01887678|11152116|FG000|STARTED|Overall Study||119
10027808|NCT01887678|11152117|FG001|STARTED|Overall Study||113
10027809|NCT01887678|11152116|FG000|COMPLETED|Overall Study||102
10027810|NCT01887678|11152117|FG001|COMPLETED|Overall Study||85
10027811|NCT01887678|11152116|FG000|NOT COMPLETED|Overall Study||17
10027812|NCT01887678|11152117|FG001|NOT COMPLETED|Overall Study||28
10027813|NCT01887717|11152125|FG000|STARTED|Overall Study||17
10027814|NCT01887717|11152126|FG001|STARTED|Overall Study||19
10027815|NCT01887717|11152125|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10027816|NCT01887717|11152126|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10027817|NCT01887717|11152125|FG000|COMPLETED|Overall Study||11
10027818|NCT01887717|11152126|FG001|COMPLETED|Overall Study||8
10027819|NCT01887717|11152125|FG000|NOT COMPLETED|Overall Study||6
10027820|NCT01887717|11152126|FG001|NOT COMPLETED|Overall Study||11
10027821|NCT01887990|11152136|FG000|STARTED|Overall Study||7
10027822|NCT01887990|11152137|FG001|STARTED|Overall Study||7
10027823|NCT01887990|11152138|FG002|STARTED|Overall Study||2
10027824|NCT01887990|11152139|FG003|STARTED|Overall Study||2
10027825|NCT01887990|11152136|FG000|COMPLETED|Overall Study||7
10027826|NCT01887990|11152137|FG001|COMPLETED|Overall Study||7
10027827|NCT01887990|11152138|FG002|COMPLETED|Overall Study||2
10027828|NCT01887990|11152139|FG003|COMPLETED|Overall Study||2
10027829|NCT01887990|11152136|FG000|NOT COMPLETED|Overall Study||0
10027830|NCT01887990|11152137|FG001|NOT COMPLETED|Overall Study||0
10027831|NCT01887990|11152138|FG002|NOT COMPLETED|Overall Study||0
10027832|NCT01887990|11152139|FG003|NOT COMPLETED|Overall Study||0
10027833|NCT01888003|11152154|FG000|STARTED|Overall Study||5
10027834|NCT01888003|11152155|FG001|STARTED|Overall Study||6
10027835|NCT01888003|11152156|FG002|STARTED|Overall Study||40
10027836|NCT01888003|11152154|FG000|COMPLETED|Overall Study||0
10027837|NCT01888003|11152155|FG001|COMPLETED|Overall Study||0
10027838|NCT01888003|11152156|FG002|COMPLETED|Overall Study||0
10027839|NCT01888003|11152154|FG000|NOT COMPLETED|Overall Study||5
10027840|NCT01888003|11152155|FG001|NOT COMPLETED|Overall Study||6
10027841|NCT01888003|11152156|FG002|NOT COMPLETED|Overall Study||40
10027842|NCT01888367|11152167|FG000|STARTED|Overall Study||296
10027843|NCT01888367|11152168|FG001|STARTED|Overall Study||71
10027844|NCT01888367|11152169|FG002|STARTED|Overall Study||78
10027845|NCT01888367|11152167|FG000|COMPLETED|Overall Study||288
10027846|NCT01888367|11152168|FG001|COMPLETED|Overall Study||66
10027847|NCT01888367|11152169|FG002|COMPLETED|Overall Study||73
10027848|NCT01888367|11152167|FG000|NOT COMPLETED|Overall Study||8
10027849|NCT01888367|11152168|FG001|NOT COMPLETED|Overall Study||5
10027850|NCT01888367|11152169|FG002|NOT COMPLETED|Overall Study||5
10027851|NCT01888432|11152179|FG000|STARTED|12-month Analysis (FAS)||142
10027852|NCT01888432|11152180|FG001|STARTED|12-month Analysis (FAS)||142
10027853|NCT01888432|11152179|FG000|COMPLETED|12-month Analysis (FAS)||131
10027854|NCT01888432|11152180|FG001|COMPLETED|12-month Analysis (FAS)||133
10027855|NCT01888432|11152179|FG000|NOT COMPLETED|12-month Analysis (FAS)||11
10115466|NCT02525874|11246298|FG000|NOT COMPLETED|Overall Study||60
10027856|NCT01888432|11152180|FG001|NOT COMPLETED|12-month Analysis (FAS)||9
10027857|NCT01888432|11152179|FG000|STARTED|24-month Analysis (FAS)||142
10027858|NCT01888432|11152180|FG001|STARTED|24-month Analysis (FAS)||142
10027859|NCT01888432|11152179|FG000|COMPLETED|24-month Analysis (FAS)||125
10027860|NCT01888432|11152180|FG001|COMPLETED|24-month Analysis (FAS)||125
10027861|NCT01888432|11152179|FG000|NOT COMPLETED|24-month Analysis (FAS)||17
10027862|NCT01888432|11152180|FG001|NOT COMPLETED|24-month Analysis (FAS)||17
10027863|NCT01888432|11152179|FG000|STARTED|36-month Analysis (Extension)||13
10027864|NCT01888432|11152180|FG001|STARTED|36-month Analysis (Extension)||5
9703519|NCT02352948|10803118|FG000|NOT COMPLETED|Overall Study||49
9703520|NCT02352948|10803119|FG001|NOT COMPLETED|Overall Study||59
9703521|NCT02352948|10803120|FG002|NOT COMPLETED|Overall Study||129
9703522|NCT02352948|10803121|FG003|NOT COMPLETED|Overall Study||99
9703523|NCT02352948|10803122|FG004|NOT COMPLETED|Overall Study||88
9703524|NCT02352948|10803123|FG005|NOT COMPLETED|Overall Study||49
9703525|NCT02318095|10803143|FG000|STARTED|Overall Study||40
9703526|NCT02318095|10803143|FG000|COMPLETED|Overall Study||39
9703527|NCT02318095|10803143|FG000|NOT COMPLETED|Overall Study||1
9703528|NCT02257528|10803148|FG000|STARTED|Overall Study||26
9703529|NCT02257528|10803148|FG000|COMPLETED|Overall Study||25
9703530|NCT02257528|10803148|FG000|NOT COMPLETED|Overall Study||1
9703531|NCT02155647|10803154|FG000|STARTED|Overall Study||88
9703532|NCT02155647|10803155|FG001|STARTED|Overall Study||116
10027865|NCT01888432|11152179|FG000|COMPLETED|36-month Analysis (Extension)||12
10027866|NCT01888432|11152180|FG001|COMPLETED|36-month Analysis (Extension)||5
10027867|NCT01888432|11152179|FG000|NOT COMPLETED|36-month Analysis (Extension)||1
10027868|NCT01888432|11152180|FG001|NOT COMPLETED|36-month Analysis (Extension)||0
10027869|NCT01888484|11152188|FG000|STARTED|Overall Study||12
10027870|NCT01888484|11152189|FG001|STARTED|Overall Study||14
10027871|NCT01888484|11152190|FG002|STARTED|Overall Study||12
10027872|NCT01888484|11152191|FG003|STARTED|Overall Study||37
10027873|NCT01888484|11152188|FG000|COMPLETED|Overall Study||12
10027874|NCT01888484|11152189|FG001|COMPLETED|Overall Study||14
10027875|NCT01888484|11152190|FG002|COMPLETED|Overall Study||8
10027876|NCT01888484|11152191|FG003|COMPLETED|Overall Study||34
10027877|NCT01888484|11152188|FG000|NOT COMPLETED|Overall Study||0
10027878|NCT01888484|11152189|FG001|NOT COMPLETED|Overall Study||0
10027879|NCT01888484|11152190|FG002|NOT COMPLETED|Overall Study||4
10115467|NCT02526160|11246304|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66
9703533|NCT02155647|10803154|FG000|COMPLETED|Overall Study||47
9703534|NCT02155647|10803155|FG001|COMPLETED|Overall Study||64
10027880|NCT01888484|11152191|FG003|NOT COMPLETED|Overall Study||3
10027881|NCT01888497|11152196|FG000|STARTED|First Intervention Period||13
10027882|NCT01888497|11152197|FG001|STARTED|First Intervention Period||14
10027883|NCT01888497|11152198|FG002|STARTED|First Intervention Period||15
10027884|NCT01888497|11152199|FG003|STARTED|First Intervention Period||17
10027885|NCT01888497|11152196|FG000|COMPLETED|First Intervention Period||13
10027886|NCT01888497|11152197|FG001|COMPLETED|First Intervention Period||14
10027887|NCT01888497|11152198|FG002|COMPLETED|First Intervention Period||15
10027888|NCT01888497|11152199|FG003|COMPLETED|First Intervention Period||17
10027889|NCT01888497|11152196|FG000|NOT COMPLETED|First Intervention Period||0
10027890|NCT01888497|11152197|FG001|NOT COMPLETED|First Intervention Period||0
10027891|NCT01888497|11152198|FG002|NOT COMPLETED|First Intervention Period||0
10027892|NCT01888497|11152199|FG003|NOT COMPLETED|First Intervention Period||0
10027893|NCT01888497|11152196|FG000|STARTED|Washout Period 1||13
10027894|NCT01888497|11152197|FG001|STARTED|Washout Period 1||14
10027895|NCT01888497|11152198|FG002|STARTED|Washout Period 1||15
10027896|NCT01888497|11152199|FG003|STARTED|Washout Period 1||17
10027897|NCT01888497|11152196|FG000|COMPLETED|Washout Period 1||13
10027898|NCT01888497|11152197|FG001|COMPLETED|Washout Period 1||14
10027899|NCT01888497|11152198|FG002|COMPLETED|Washout Period 1||14
10027900|NCT01888497|11152199|FG003|COMPLETED|Washout Period 1||16
10027901|NCT01888497|11152196|FG000|NOT COMPLETED|Washout Period 1||0
10027902|NCT01888497|11152197|FG001|NOT COMPLETED|Washout Period 1||0
10027903|NCT01888497|11152198|FG002|NOT COMPLETED|Washout Period 1||1
10027904|NCT01888497|11152199|FG003|NOT COMPLETED|Washout Period 1||1
10027905|NCT01888497|11152196|FG000|STARTED|Second Intervention Period||13
10027906|NCT01888497|11152197|FG001|STARTED|Second Intervention Period||14
10027907|NCT01888497|11152198|FG002|STARTED|Second Intervention Period||14
10027908|NCT01888497|11152199|FG003|STARTED|Second Intervention Period||16
10027909|NCT01888497|11152196|FG000|COMPLETED|Second Intervention Period||13
10027910|NCT01888497|11152197|FG001|COMPLETED|Second Intervention Period||14
10027911|NCT01888497|11152198|FG002|COMPLETED|Second Intervention Period||14
10027912|NCT01888497|11152199|FG003|COMPLETED|Second Intervention Period||16
10027913|NCT01888497|11152196|FG000|NOT COMPLETED|Second Intervention Period||0
10027914|NCT01888497|11152197|FG001|NOT COMPLETED|Second Intervention Period||0
10027915|NCT01888497|11152198|FG002|NOT COMPLETED|Second Intervention Period||0
10027916|NCT01888497|11152199|FG003|NOT COMPLETED|Second Intervention Period||0
10027917|NCT01888497|11152196|FG000|STARTED|Washout Period 2||13
10027918|NCT01888497|11152197|FG001|STARTED|Washout Period 2||14
10027919|NCT01888497|11152198|FG002|STARTED|Washout Period 2||14
10027920|NCT01888497|11152199|FG003|STARTED|Washout Period 2||16
10027921|NCT01888497|11152196|FG000|COMPLETED|Washout Period 2||13
9703535|NCT02155647|10803154|FG000|NOT COMPLETED|Overall Study||41
9703536|NCT02155647|10803155|FG001|NOT COMPLETED|Overall Study||52
10027922|NCT01888497|11152197|FG001|COMPLETED|Washout Period 2||14
10027923|NCT01888497|11152198|FG002|COMPLETED|Washout Period 2||14
10027924|NCT01888497|11152199|FG003|COMPLETED|Washout Period 2||14
10027925|NCT01888497|11152196|FG000|NOT COMPLETED|Washout Period 2||0
10027926|NCT01888497|11152197|FG001|NOT COMPLETED|Washout Period 2||0
10027927|NCT01888497|11152198|FG002|NOT COMPLETED|Washout Period 2||0
10027928|NCT01888497|11152199|FG003|NOT COMPLETED|Washout Period 2||2
10027929|NCT01888497|11152196|FG000|STARTED|Third Intervention Period||13
10027930|NCT01888497|11152197|FG001|STARTED|Third Intervention Period||14
9728735|NCT00113425|10828255|FG000|STARTED|Overall Study||44
9728736|NCT00113425|10828255|FG000|COMPLETED|Overall Study||29
9728737|NCT00113425|10828255|FG000|NOT COMPLETED|Overall Study||15
9728738|NCT00113490|10828262|FG000|STARTED|Overall Study||66
9728739|NCT00113490|10828263|FG001|STARTED|Overall Study||70
9728740|NCT00113490|10828262|FG000|COMPLETED|Overall Study||64
9728741|NCT00113490|10828263|FG001|COMPLETED|Overall Study||67
9728742|NCT00113490|10828262|FG000|NOT COMPLETED|Overall Study||2
9728743|NCT00113490|10828263|FG001|NOT COMPLETED|Overall Study||3
9728744|NCT00113516|10828269|FG000|STARTED|Part 1||84
9728745|NCT00113516|10828270|FG001|STARTED|Part 1||0
9728746|NCT00113516|10828269|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
9728747|NCT00113516|10828270|FG001|COMPLETED|Part 1||0
9728748|NCT00113516|10828269|FG000|NOT COMPLETED|Part 1||84
9728749|NCT00113516|10828270|FG001|NOT COMPLETED|Part 1||0
9728750|NCT00113516|10828269|FG000|STARTED|Part 2||0
9728751|NCT00113516|10828270|FG001|STARTED|Part 2||66
9728752|NCT00113516|10828269|FG000|COMPLETED|Part 2||0
9728753|NCT00113516|10828270|FG001|COMPLETED|Part 2||0
9728754|NCT00113516|10828269|FG000|NOT COMPLETED|Part 2||0
9728755|NCT00113516|10828270|FG001|NOT COMPLETED|Part 2||66
9728756|NCT00113529|10828276|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
9728757|NCT00113529|10828276|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
9728758|NCT00113529|10828276|FG000|NOT COMPLETED|Overall Study||34
9728759|NCT00113555|10828280|FG000|STARTED|Overall Study||221
9728760|NCT00113555|10828280|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
9728761|NCT00113555|10828280|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
9728762|NCT00113555|10828280|FG000|NOT COMPLETED|Overall Study||79
9728763|NCT00113568|10828285|FG000|STARTED|Overall Study||784
9728764|NCT00113568|10828285|FG000|Intent to Treat Population|Overall Study||723
9728765|NCT00113568|10828285|FG000|COMPLETED|Overall Study||239
9728766|NCT00113568|10828285|FG000|NOT COMPLETED|Overall Study||545
9728767|NCT00113607|10828291|FG000|STARTED|Overall Study|Number of randomized participants|335
9728768|NCT00113607|10828292|FG001|STARTED|Overall Study|Number of randomized participants|337
9728769|NCT00113607|10828291|FG000|COMPLETED|Overall Study||0
9728770|NCT00113607|10828292|FG001|COMPLETED|Overall Study||0
9728771|NCT00113607|10828291|FG000|NOT COMPLETED|Overall Study||335
9728772|NCT00113607|10828292|FG001|NOT COMPLETED|Overall Study||337
9728773|NCT00113763|10828301|FG000|STARTED|Overall Study||231
9728774|NCT00113763|10828302|FG001|STARTED|Overall Study||232
9728775|NCT00113763|10828301|FG000|Received Study Drug|Overall Study||229
9728776|NCT00113763|10828302|FG001|Received Study Drug|Overall Study||0
9728777|NCT00113763|10828301|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
9728778|NCT00113763|10828302|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
9728779|NCT00113763|10828301|FG000|NOT COMPLETED|Overall Study||73
9728780|NCT00113763|10828302|FG001|NOT COMPLETED|Overall Study||26
9728781|NCT00113841|10828311|FG000|STARTED|Overall Study||16
9728782|NCT00113841|10828312|FG001|STARTED|Overall Study||17
9728783|NCT00113841|10828311|FG000|COMPLETED|Overall Study||15
9728784|NCT00113841|10828312|FG001|COMPLETED|Overall Study||15
9728785|NCT00113841|10828311|FG000|NOT COMPLETED|Overall Study||1
9728786|NCT00113841|10828312|FG001|NOT COMPLETED|Overall Study||2
9728787|NCT00113880|10828321|FG000|STARTED|Overall Study||63061
10027931|NCT01888497|11152198|FG002|STARTED|Third Intervention Period||14
10027932|NCT01888497|11152199|FG003|STARTED|Third Intervention Period||14
10027933|NCT01888497|11152196|FG000|COMPLETED|Third Intervention Period||13
10027934|NCT01888497|11152197|FG001|COMPLETED|Third Intervention Period||14
10027935|NCT01888497|11152198|FG002|COMPLETED|Third Intervention Period||14
10027936|NCT01888497|11152199|FG003|COMPLETED|Third Intervention Period||14
10027937|NCT01888497|11152196|FG000|NOT COMPLETED|Third Intervention Period||0
10027938|NCT01888497|11152197|FG001|NOT COMPLETED|Third Intervention Period||0
10027939|NCT01888497|11152198|FG002|NOT COMPLETED|Third Intervention Period||0
10027940|NCT01888497|11152199|FG003|NOT COMPLETED|Third Intervention Period||0
10027941|NCT01888497|11152196|FG000|STARTED|Washout Period 3||13
10027942|NCT01888497|11152197|FG001|STARTED|Washout Period 3||14
10027943|NCT01888497|11152198|FG002|STARTED|Washout Period 3||14
10027944|NCT01888497|11152199|FG003|STARTED|Washout Period 3||14
10027945|NCT01888497|11152196|FG000|COMPLETED|Washout Period 3||13
10027946|NCT01888497|11152197|FG001|COMPLETED|Washout Period 3||14
10027947|NCT01888497|11152198|FG002|COMPLETED|Washout Period 3||14
10027948|NCT01888497|11152199|FG003|COMPLETED|Washout Period 3||14
10027949|NCT01888497|11152196|FG000|NOT COMPLETED|Washout Period 3||0
10027950|NCT01888497|11152197|FG001|NOT COMPLETED|Washout Period 3||0
10027951|NCT01888497|11152198|FG002|NOT COMPLETED|Washout Period 3||0
10027952|NCT01888497|11152199|FG003|NOT COMPLETED|Washout Period 3||0
10027953|NCT01888497|11152196|FG000|STARTED|Fourth Intervention Period||13
9728788|NCT00113880|10828322|FG001|STARTED|Overall Study||71949
9728789|NCT00113880|10828323|FG002|STARTED|Overall Study||62492
9728790|NCT00113880|10828321|FG000|COMPLETED|Overall Study||63061
10027954|NCT01888497|11152197|FG001|STARTED|Fourth Intervention Period||14
10027955|NCT01888497|11152198|FG002|STARTED|Fourth Intervention Period||14
10027956|NCT01888497|11152199|FG003|STARTED|Fourth Intervention Period||14
10027957|NCT01888497|11152196|FG000|COMPLETED|Fourth Intervention Period||13
9703540|NCT02032810|10803167|FG000|STARTED|Overall Study||6
9703541|NCT02032810|10803168|FG001|STARTED|Overall Study||11
9703542|NCT02032810|10803167|FG000|COMPLETED|Overall Study||6
9703543|NCT02032810|10803168|FG001|COMPLETED|Overall Study||11
9703544|NCT02032810|10803167|FG000|NOT COMPLETED|Overall Study||0
9703545|NCT02032810|10803168|FG001|NOT COMPLETED|Overall Study||0
9703546|NCT01979211|10803178|FG000|STARTED|Overall Study||24
9703547|NCT01979211|10803178|FG000|COMPLETED|Overall Study||24
9703548|NCT01979211|10803178|FG000|NOT COMPLETED|Overall Study||0
9703549|NCT01904903|10803182|FG000|STARTED|Overall Study||31
9703550|NCT01904903|10803182|FG000|COMPLETED|Overall Study||30
9703551|NCT01904903|10803182|FG000|NOT COMPLETED|Overall Study||1
9703552|NCT01827384|10803200|FG000|STARTED|Overall Study||13
9703553|NCT01827384|10803201|FG001|STARTED|Overall Study||1
9703554|NCT01827384|10803202|FG002|STARTED|Overall Study||9
9703555|NCT01827384|10803203|FG003|STARTED|Overall Study||1
9703556|NCT01827384|10803204|FG004|STARTED|Overall Study||1
9703557|NCT01827384|10803205|FG005|STARTED|Overall Study||22
9703558|NCT01827384|10803206|FG006|STARTED|Overall Study||2
9703559|NCT01827384|10803207|FG007|STARTED|Overall Study||1
9703560|NCT01827384|10803208|FG008|STARTED|Overall Study||2
9703561|NCT01827384|10803209|FG009|STARTED|Overall Study||15
9703562|NCT01827384|10803210|FG010|STARTED|Overall Study||7
9703563|NCT01827384|10803211|FG011|STARTED|Overall Study||1
9703564|NCT01827384|10803212|FG012|STARTED|Overall Study||2
9703565|NCT01827384|10803213|FG013|STARTED|Overall Study||131
9703566|NCT01827384|10803200|FG000|COMPLETED|Overall Study||13
9703567|NCT01827384|10803201|FG001|COMPLETED|Overall Study||1
9703568|NCT01827384|10803202|FG002|COMPLETED|Overall Study||9
9703569|NCT01827384|10803203|FG003|COMPLETED|Overall Study||1
9703570|NCT01827384|10803204|FG004|COMPLETED|Overall Study||1
9703571|NCT01827384|10803205|FG005|COMPLETED|Overall Study||22
9703572|NCT01827384|10803206|FG006|COMPLETED|Overall Study||2
9703573|NCT01827384|10803207|FG007|COMPLETED|Overall Study||1
9703574|NCT01827384|10803208|FG008|COMPLETED|Overall Study||2
9703575|NCT01827384|10803209|FG009|COMPLETED|Overall Study||15
9703576|NCT01827384|10803210|FG010|COMPLETED|Overall Study||7
9703577|NCT01827384|10803211|FG011|COMPLETED|Overall Study||1
9703578|NCT01827384|10803212|FG012|COMPLETED|Overall Study||2
9703579|NCT01827384|10803213|FG013|COMPLETED|Overall Study||0
9703580|NCT01827384|10803200|FG000|NOT COMPLETED|Overall Study||0
9703581|NCT01827384|10803201|FG001|NOT COMPLETED|Overall Study||0
9703582|NCT01827384|10803202|FG002|NOT COMPLETED|Overall Study||0
9703583|NCT01827384|10803203|FG003|NOT COMPLETED|Overall Study||0
9703584|NCT01827384|10803204|FG004|NOT COMPLETED|Overall Study||0
9703585|NCT01827384|10803205|FG005|NOT COMPLETED|Overall Study||0
9703586|NCT01827384|10803206|FG006|NOT COMPLETED|Overall Study||0
9703587|NCT01827384|10803207|FG007|NOT COMPLETED|Overall Study||0
9703588|NCT01827384|10803208|FG008|NOT COMPLETED|Overall Study||0
9703589|NCT01827384|10803209|FG009|NOT COMPLETED|Overall Study||0
9703590|NCT01827384|10803210|FG010|NOT COMPLETED|Overall Study||0
9703591|NCT01827384|10803211|FG011|NOT COMPLETED|Overall Study||0
9703592|NCT01827384|10803212|FG012|NOT COMPLETED|Overall Study||0
9703593|NCT01827384|10803213|FG013|NOT COMPLETED|Overall Study||131
9703594|NCT01778946|10803243|FG000|STARTED|Overall Study||7
9703595|NCT01778946|10803243|FG000|COMPLETED|Overall Study||4
9703596|NCT01778946|10803243|FG000|NOT COMPLETED|Overall Study||3
9703597|NCT01636258|10803249|FG000|STARTED|Overall Study||13
9703598|NCT01636258|10803250|FG001|STARTED|Overall Study||14
9703599|NCT01636258|10803249|FG000|COMPLETED|Overall Study||12
9703600|NCT01636258|10803250|FG001|COMPLETED|Overall Study||14
9703601|NCT01636258|10803249|FG000|NOT COMPLETED|Overall Study||1
9703602|NCT01636258|10803250|FG001|NOT COMPLETED|Overall Study||0
9703603|NCT01597388|10803266|FG000|STARTED|Overall Study||6
9703604|NCT01597388|10803267|FG001|STARTED|Overall Study||13
9703605|NCT01597388|10803268|FG002|STARTED|Overall Study||14
9703606|NCT01597388|10803269|FG003|STARTED|Overall Study||10
9703607|NCT01597388|10803270|FG004|STARTED|Overall Study||37
9703608|NCT01597388|10803271|FG005|STARTED|Overall Study||4
10027958|NCT01888497|11152197|FG001|COMPLETED|Fourth Intervention Period||14
10027959|NCT01888497|11152198|FG002|COMPLETED|Fourth Intervention Period||14
10027960|NCT01888497|11152199|FG003|COMPLETED|Fourth Intervention Period||14
10027961|NCT01888497|11152196|FG000|NOT COMPLETED|Fourth Intervention Period||0
10027962|NCT01888497|11152197|FG001|NOT COMPLETED|Fourth Intervention Period||0
9703609|NCT01597388|10803272|FG006|STARTED|Overall Study||8
9703610|NCT01597388|10803273|FG007|STARTED|Overall Study||5
9703611|NCT01597388|10803274|FG008|STARTED|Overall Study||2
9703612|NCT01597388|10803266|FG000|COMPLETED|Overall Study||6
9703613|NCT01597388|10803267|FG001|COMPLETED|Overall Study||13
9703614|NCT01597388|10803268|FG002|COMPLETED|Overall Study||14
9703615|NCT01597388|10803269|FG003|COMPLETED|Overall Study||10
9703616|NCT01597388|10803270|FG004|COMPLETED|Overall Study||37
9703617|NCT01597388|10803271|FG005|COMPLETED|Overall Study||4
9703618|NCT01597388|10803272|FG006|COMPLETED|Overall Study||8
9703619|NCT01597388|10803273|FG007|COMPLETED|Overall Study||5
9703620|NCT01597388|10803274|FG008|COMPLETED|Overall Study||2
9703621|NCT01597388|10803266|FG000|NOT COMPLETED|Overall Study||0
9703622|NCT01597388|10803267|FG001|NOT COMPLETED|Overall Study||0
9703623|NCT01597388|10803268|FG002|NOT COMPLETED|Overall Study||0
9703624|NCT01597388|10803269|FG003|NOT COMPLETED|Overall Study||0
9703625|NCT01597388|10803270|FG004|NOT COMPLETED|Overall Study||0
9703626|NCT01597388|10803271|FG005|NOT COMPLETED|Overall Study||0
10027963|NCT01888497|11152198|FG002|NOT COMPLETED|Fourth Intervention Period||0
9703627|NCT01597388|10803272|FG006|NOT COMPLETED|Overall Study||0
9703628|NCT01597388|10803273|FG007|NOT COMPLETED|Overall Study||0
9703629|NCT01597388|10803274|FG008|NOT COMPLETED|Overall Study||0
10115468|NCT02526160|11246305|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68
10115469|NCT02526160|11246304|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
10115470|NCT02526160|11246305|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
10027964|NCT01888497|11152199|FG003|NOT COMPLETED|Fourth Intervention Period||0
10027965|NCT01888640|11152212|FG000|STARTED|Overall Study||103
10027966|NCT01888640|11152213|FG001|STARTED|Overall Study||99
10027967|NCT01888640|11152214|FG002|STARTED|Overall Study||99
10027968|NCT01888640|11152212|FG000|COMPLETED|Overall Study||76
10027969|NCT01888640|11152213|FG001|COMPLETED|Overall Study||68
10027970|NCT01888640|11152214|FG002|COMPLETED|Overall Study||94
10027971|NCT01888640|11152212|FG000|NOT COMPLETED|Overall Study||27
10027972|NCT01888640|11152213|FG001|NOT COMPLETED|Overall Study||31
10027973|NCT01888640|11152214|FG002|NOT COMPLETED|Overall Study||5
10027974|NCT01888874|11152232|FG000|STARTED|Period 1 (Baseline up to Week 12)||86
10027975|NCT01888874|11152233|FG001|STARTED|Period 1 (Baseline up to Week 12)||82
10027976|NCT01888874|11152234|FG002|STARTED|Period 1 (Baseline up to Week 12)||85
10027977|NCT01888874|11152235|FG003|STARTED|Period 1 (Baseline up to Week 12)||86
10027978|NCT01888874|11152236|FG004|STARTED|Period 1 (Baseline up to Week 12)||86
10027979|NCT01888874|11152237|FG005|STARTED|Period 1 (Baseline up to Week 12)||85
10027980|NCT01888874|11152238|FG006|STARTED|Period 1 (Baseline up to Week 12)||84
10027981|NCT01888874|11152232|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83
10027982|NCT01888874|11152233|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76
10027983|NCT01888874|11152234|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78
10027984|NCT01888874|11152235|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80
10027985|NCT01888874|11152236|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77
10027986|NCT01888874|11152237|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80
10027987|NCT01888874|11152238|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83
10027988|NCT01888874|11152232|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
10027989|NCT01888874|11152233|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
10027990|NCT01888874|11152234|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
10027991|NCT01888874|11152235|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
10027992|NCT01888874|11152236|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
10027993|NCT01888874|11152237|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
10027994|NCT01888874|11152238|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
10027995|NCT01888874|11152232|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
10027996|NCT01888874|11152233|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
10027997|NCT01888874|11152234|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
10027998|NCT01888874|11152235|FG003|STARTED|Period 2 (Week 13 to Week 24)||80
10027999|NCT01888874|11152236|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
10028000|NCT01888874|11152237|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
10028001|NCT01888874|11152238|FG006|STARTED|Period 2 (Week 13 to Week 24)||83
10028002|NCT01888874|11152232|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50
10028003|NCT01888874|11152233|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55
10028004|NCT01888874|11152234|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104
10028005|NCT01888874|11152235|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78
10028006|NCT01888874|11152236|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57
10028007|NCT01888874|11152237|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109
10028008|NCT01888874|11152238|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80
10028009|NCT01888874|11152232|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10028010|NCT01888874|11152233|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
10028011|NCT01888874|11152234|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
10028012|NCT01888874|11152235|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
10028013|NCT01888874|11152236|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10028014|NCT01888874|11152237|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10028015|NCT01888874|11152238|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10028016|NCT01888900|11152257|FG000|STARTED|Overall Study||22
10028017|NCT01888900|11152258|FG001|STARTED|Overall Study||13
10028018|NCT01888900|11152257|FG000|COMPLETED|Overall Study||22
10028019|NCT01888900|11152258|FG001|COMPLETED|Overall Study||11
10028020|NCT01888900|11152257|FG000|NOT COMPLETED|Overall Study||0
10115471|NCT02526160|11246304|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
10115472|NCT02526160|11246305|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
10115473|NCT02526160|11246304|FG000|STARTED|Open-label Treatment Continuation Period||66
9703630|NCT01517802|10803311|FG000|STARTED|Overall Study||31
9703631|NCT01517802|10803311|FG000|COMPLETED|Overall Study||30
9703632|NCT01517802|10803311|FG000|NOT COMPLETED|Overall Study||1
10028021|NCT01888900|11152258|FG001|NOT COMPLETED|Overall Study||2
10028022|NCT01888952|11152266|FG000|STARTED|Overall Study||10
10028023|NCT01888952|11152266|FG000|COMPLETED|Overall Study||10
9703643|NCT01081262|10803328|FG000|STARTED|Overall Study||13
9703644|NCT01081262|10803329|FG001|STARTED|Overall Study||13
9703645|NCT01081262|10803330|FG002|STARTED|Overall Study||13
9703646|NCT01081262|10803331|FG003|STARTED|Overall Study||11
9703647|NCT01081262|10803328|FG000|COMPLETED|Overall Study||13
9703648|NCT01081262|10803329|FG001|COMPLETED|Overall Study||13
9703649|NCT01081262|10803330|FG002|COMPLETED|Overall Study||13
9703650|NCT01081262|10803331|FG003|COMPLETED|Overall Study||11
9703651|NCT01081262|10803328|FG000|NOT COMPLETED|Overall Study||0
9703652|NCT01081262|10803329|FG001|NOT COMPLETED|Overall Study||0
10028024|NCT01888952|11152266|FG000|NOT COMPLETED|Overall Study||0
10028025|NCT01888965|11152270|FG000|STARTED|Overall Study||9
10028026|NCT01888965|11152270|FG000|COMPLETED|Overall Study||0
10028027|NCT01888965|11152270|FG000|NOT COMPLETED|Overall Study||9
10028028|NCT01889069|11152276|FG000|STARTED|Overall Study||158
10028029|NCT01889069|11152276|FG000|COMPLETED|Overall Study||113
10028030|NCT01889069|11152276|FG000|NOT COMPLETED|Overall Study||45
10028031|NCT01889251|11152288|FG000|STARTED|Overall Study||115
10028032|NCT01889251|11152289|FG001|STARTED|Overall Study||57
10028033|NCT01889251|11152288|FG000|COMPLETED|Overall Study||114
10028034|NCT01889251|11152289|FG001|COMPLETED|Overall Study||57
10028035|NCT01889251|11152288|FG000|NOT COMPLETED|Overall Study||1
10028036|NCT01889251|11152289|FG001|NOT COMPLETED|Overall Study||0
10028037|NCT01889355|11152295|FG000|STARTED|Overall Study||115
10028038|NCT01889355|11152295|FG000|COMPLETED|Overall Study||113
10028039|NCT01889355|11152295|FG000|NOT COMPLETED|Overall Study||2
10028040|NCT01889563|11152301|FG000|STARTED|Overall Study||17
10028041|NCT01889563|11152302|FG001|STARTED|Overall Study||15
10028042|NCT01889563|11152301|FG000|COMPLETED|Overall Study||10
10028043|NCT01889563|11152302|FG001|COMPLETED|Overall Study||10
10028044|NCT01889563|11152301|FG000|NOT COMPLETED|Overall Study||7
10028045|NCT01889563|11152302|FG001|NOT COMPLETED|Overall Study||5
10028046|NCT01889602|11152311|FG000|STARTED|First Intervention||20
10028047|NCT01889602|11152312|FG001|STARTED|First Intervention||20
10028048|NCT01889602|11152313|FG002|STARTED|First Intervention||20
10028049|NCT01889602|11152311|FG000|COMPLETED|First Intervention||19
10028050|NCT01889602|11152312|FG001|COMPLETED|First Intervention||17
10028051|NCT01889602|11152313|FG002|COMPLETED|First Intervention||18
10028052|NCT01889602|11152311|FG000|NOT COMPLETED|First Intervention||1
10028053|NCT01889602|11152312|FG001|NOT COMPLETED|First Intervention||3
10028054|NCT01889602|11152313|FG002|NOT COMPLETED|First Intervention||2
10028055|NCT01889602|11152311|FG000|STARTED|First Washout Period of at Least 2 Weeks||19
10028056|NCT01889602|11152312|FG001|STARTED|First Washout Period of at Least 2 Weeks||17
10028057|NCT01889602|11152313|FG002|STARTED|First Washout Period of at Least 2 Weeks||18
10028058|NCT01889602|11152311|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19
10028059|NCT01889602|11152312|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17
10028060|NCT01889602|11152313|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18
10028061|NCT01889602|11152311|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
10028062|NCT01889602|11152312|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
10028063|NCT01889602|11152313|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
10028064|NCT01889602|11152311|FG000|STARTED|Second Intervention||19
10028065|NCT01889602|11152312|FG001|STARTED|Second Intervention||17
10028066|NCT01889602|11152313|FG002|STARTED|Second Intervention||18
10028067|NCT01889602|11152311|FG000|COMPLETED|Second Intervention||18
10028068|NCT01889602|11152312|FG001|COMPLETED|Second Intervention||17
10028069|NCT01889602|11152313|FG002|COMPLETED|Second Intervention||16
10028070|NCT01889602|11152311|FG000|NOT COMPLETED|Second Intervention||1
10028071|NCT01889602|11152312|FG001|NOT COMPLETED|Second Intervention||0
10028072|NCT01889602|11152313|FG002|NOT COMPLETED|Second Intervention||2
10028073|NCT01889602|11152311|FG000|STARTED|Second Washout Period of at Least 2 Week||18
10028074|NCT01889602|11152312|FG001|STARTED|Second Washout Period of at Least 2 Week||17
10028075|NCT01889602|11152313|FG002|STARTED|Second Washout Period of at Least 2 Week||16
10028076|NCT01889602|11152311|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18
10028077|NCT01889602|11152312|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17
10115474|NCT02526160|11246305|FG001|STARTED|Open-label Treatment Continuation Period||67
9703653|NCT01081262|10803330|FG002|NOT COMPLETED|Overall Study||0
9703654|NCT01081262|10803331|FG003|NOT COMPLETED|Overall Study||0
9728791|NCT00113880|10828322|FG001|COMPLETED|Overall Study||71949
10028078|NCT01889602|11152313|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16
10028079|NCT01889602|11152311|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
10028080|NCT01889602|11152312|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
10028081|NCT01889602|11152313|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
10028082|NCT01889602|11152311|FG000|STARTED|Third Intervention||18
10028083|NCT01889602|11152312|FG001|STARTED|Third Intervention||17
10028084|NCT01889602|11152313|FG002|STARTED|Third Intervention||16
10028085|NCT01889602|11152311|FG000|COMPLETED|Third Intervention||15
9703663|NCT00455325|10803351|FG000|STARTED|Cohort 1: Placebo||35
9703664|NCT00455325|10803352|FG001|STARTED|Cohort 1: Placebo||0
9703665|NCT00455325|10803353|FG002|STARTED|Cohort 1: Placebo||0
9703666|NCT00455325|10803354|FG003|STARTED|Cohort 1: Placebo||0
9703667|NCT00455325|10803351|FG000|COMPLETED|Cohort 1: Placebo||27
9703668|NCT00455325|10803352|FG001|COMPLETED|Cohort 1: Placebo||0
9703669|NCT00455325|10803353|FG002|COMPLETED|Cohort 1: Placebo||0
9703670|NCT00455325|10803354|FG003|COMPLETED|Cohort 1: Placebo||0
9703671|NCT00455325|10803351|FG000|NOT COMPLETED|Cohort 1: Placebo||8
9703672|NCT00455325|10803352|FG001|NOT COMPLETED|Cohort 1: Placebo||0
9703673|NCT00455325|10803353|FG002|NOT COMPLETED|Cohort 1: Placebo||0
9703674|NCT00455325|10803354|FG003|NOT COMPLETED|Cohort 1: Placebo||0
9703675|NCT00455325|10803351|FG000|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
9703676|NCT00455325|10803352|FG001|STARTED|Cohort 2: 80 mg Chloroquine Weekly||27
9703677|NCT00455325|10803353|FG002|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
9703678|NCT00455325|10803354|FG003|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
9703679|NCT00455325|10803351|FG000|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
9703680|NCT00455325|10803352|FG001|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||26
9703681|NCT00455325|10803353|FG002|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
9703682|NCT00455325|10803354|FG003|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
9703683|NCT00455325|10803351|FG000|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
9703684|NCT00455325|10803352|FG001|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||1
9703685|NCT00455325|10803353|FG002|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
9703686|NCT00455325|10803354|FG003|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
9703687|NCT00455325|10803351|FG000|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
9703688|NCT00455325|10803352|FG001|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
9703689|NCT00455325|10803353|FG002|STARTED|Cohort 3: 80 mg Chloroquine Daily||26
9703690|NCT00455325|10803354|FG003|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
9703691|NCT00455325|10803351|FG000|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
9703692|NCT00455325|10803352|FG001|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
9703693|NCT00455325|10803353|FG002|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||25
9703694|NCT00455325|10803354|FG003|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
9703695|NCT00455325|10803351|FG000|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
9703696|NCT00455325|10803352|FG001|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
9703697|NCT00455325|10803353|FG002|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||1
9703698|NCT00455325|10803354|FG003|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
9703699|NCT00455325|10803351|FG000|STARTED|Cohort 4: 250mg Chloroquine Daily||0
10028086|NCT01889602|11152312|FG001|COMPLETED|Third Intervention||15
10028087|NCT01889602|11152313|FG002|COMPLETED|Third Intervention||16
9703700|NCT00455325|10803352|FG001|STARTED|Cohort 4: 250mg Chloroquine Daily||0
9703701|NCT00455325|10803353|FG002|STARTED|Cohort 4: 250mg Chloroquine Daily||0
9703702|NCT00455325|10803354|FG003|STARTED|Cohort 4: 250mg Chloroquine Daily||25
9703703|NCT00455325|10803351|FG000|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
9703704|NCT00455325|10803352|FG001|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
9703705|NCT00455325|10803353|FG002|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
9703706|NCT00455325|10803354|FG003|COMPLETED|Cohort 4: 250mg Chloroquine Daily||25
9703707|NCT00455325|10803351|FG000|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
9703708|NCT00455325|10803352|FG001|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
9703709|NCT00455325|10803353|FG002|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
9703710|NCT00455325|10803354|FG003|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
9703711|NCT00321555|10803365|FG000|STARTED|Overall Study||15
9703712|NCT00321555|10803365|FG000|COMPLETED|Overall Study||9
9703713|NCT00321555|10803365|FG000|NOT COMPLETED|Overall Study||6
10028088|NCT01889602|11152311|FG000|NOT COMPLETED|Third Intervention||3
9728792|NCT00113880|10828323|FG002|COMPLETED|Overall Study||62492
9728793|NCT00113880|10828321|FG000|NOT COMPLETED|Overall Study||0
9728794|NCT00113880|10828322|FG001|NOT COMPLETED|Overall Study||0
9728795|NCT00113880|10828323|FG002|NOT COMPLETED|Overall Study||0
9728796|NCT00114114|10828344|FG000|STARTED|Overall Study||26
9728797|NCT00114114|10828345|FG001|STARTED|Overall Study||25
9728798|NCT00114114|10828346|FG002|STARTED|Overall Study||31
9728799|NCT00114114|10828347|FG003|STARTED|Overall Study||35
9728800|NCT00114114|10828348|FG004|STARTED|Overall Study||29
9728801|NCT00114114|10828349|FG005|STARTED|Overall Study||31
9728802|NCT00114114|10828344|FG000|COMPLETED|Overall Study||21
9728803|NCT00114114|10828345|FG001|COMPLETED|Overall Study||24
9728804|NCT00114114|10828346|FG002|COMPLETED|Overall Study||30
9728805|NCT00114114|10828347|FG003|COMPLETED|Overall Study||31
9728806|NCT00114114|10828348|FG004|COMPLETED|Overall Study||27
9728807|NCT00114114|10828349|FG005|COMPLETED|Overall Study||30
9728808|NCT00114114|10828344|FG000|NOT COMPLETED|Overall Study||5
9728809|NCT00114114|10828345|FG001|NOT COMPLETED|Overall Study||1
9728810|NCT00114114|10828346|FG002|NOT COMPLETED|Overall Study||1
9728811|NCT00114114|10828347|FG003|NOT COMPLETED|Overall Study||4
10028089|NCT01889602|11152312|FG001|NOT COMPLETED|Third Intervention||2
10028090|NCT01889602|11152313|FG002|NOT COMPLETED|Third Intervention||0
10028091|NCT01889602|11152311|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15
10028092|NCT01889602|11152312|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15
10028093|NCT01889602|11152313|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16
10028094|NCT01889602|11152311|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15
10028095|NCT01889602|11152312|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15
10028096|NCT01889602|11152313|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16
10028097|NCT01889602|11152311|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
10028098|NCT01889602|11152312|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
10028099|NCT01889602|11152313|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
10028100|NCT01889667|11152332|FG000|STARTED|Overall Study||10
10028101|NCT01889667|11152333|FG001|STARTED|Overall Study||10
10028102|NCT01889667|11152334|FG002|STARTED|Overall Study||10
10028103|NCT01889667|11152332|FG000|COMPLETED|Overall Study||10
10028104|NCT01889667|11152333|FG001|COMPLETED|Overall Study||10
10028105|NCT01889667|11152334|FG002|COMPLETED|Overall Study||10
10028106|NCT01889667|11152332|FG000|NOT COMPLETED|Overall Study||0
10028107|NCT01889667|11152333|FG001|NOT COMPLETED|Overall Study||0
10028108|NCT01889667|11152334|FG002|NOT COMPLETED|Overall Study||0
10028109|NCT01889797|11152346|FG000|STARTED|Overall Study||16
10028110|NCT01889797|11152347|FG001|STARTED|Overall Study||16
10028111|NCT01889797|11152346|FG000|COMPLETED|Overall Study||16
10028112|NCT01889797|11152347|FG001|COMPLETED|Overall Study||16
10028113|NCT01889797|11152346|FG000|NOT COMPLETED|Overall Study||0
10028114|NCT01889797|11152347|FG001|NOT COMPLETED|Overall Study||0
10028115|NCT01889862|11152353|FG000|STARTED|Part 1 (Up to 13 Weeks)||86
10028116|NCT01889862|11152354|FG001|STARTED|Part 1 (Up to 13 Weeks)||0
10028117|NCT01889862|11152355|FG002|STARTED|Part 1 (Up to 13 Weeks)||78
10028118|NCT01889862|11152356|FG003|STARTED|Part 1 (Up to 13 Weeks)||0
10028119|NCT01889862|11152357|FG004|STARTED|Part 1 (Up to 13 Weeks)||0
10028120|NCT01889862|11152353|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
10028121|NCT01889862|11152354|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0
10028122|NCT01889862|11152355|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78
10028123|NCT01889862|11152356|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0
10028124|NCT01889862|11152357|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0
10028125|NCT01889862|11152353|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
10028126|NCT01889862|11152354|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
9728812|NCT00114114|10828348|FG004|NOT COMPLETED|Overall Study||2
9728813|NCT00114114|10828349|FG005|NOT COMPLETED|Overall Study||1
9728814|NCT00114127|10828367|FG000|STARTED|Overall Study||13
9728815|NCT00114127|10828368|FG001|STARTED|Overall Study||15
9728816|NCT00114127|10828367|FG000|COMPLETED|Overall Study||9
9728817|NCT00114127|10828368|FG001|COMPLETED|Overall Study||11
9728818|NCT00114127|10828367|FG000|NOT COMPLETED|Overall Study||4
10028127|NCT01889862|11152355|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
10028128|NCT01889862|11152356|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
10028129|NCT01889862|11152357|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
10081438|NCT02260804|11209940|FG000|NOT COMPLETED|Induction Study Period||2
9728819|NCT00114127|10828368|FG001|NOT COMPLETED|Overall Study||4
9728820|NCT00114166|10828376|FG000|STARTED|Overall Study||15
9703754|NCT04471935|10803384|FG000|STARTED|Overall Study||10
9703755|NCT04471935|10803384|FG000|COMPLETED|Overall Study||8
9703756|NCT04471935|10803384|FG000|NOT COMPLETED|Overall Study||2
9703775|NCT04180540|10803406|FG000|STARTED|Overall Study||55
9703776|NCT04180540|10803407|FG001|STARTED|Overall Study||54
9703777|NCT04180540|10803406|FG000|COMPLETED|Overall Study||53
9703778|NCT04180540|10803407|FG001|COMPLETED|Overall Study||54
9703779|NCT04180540|10803406|FG000|NOT COMPLETED|Overall Study||2
9703780|NCT04180540|10803407|FG001|NOT COMPLETED|Overall Study||0
9703781|NCT03912298|10803413|FG000|STARTED|Overall Study||7
9703782|NCT03912298|10803413|FG000|COMPLETED|Overall Study||7
9703783|NCT03912298|10803413|FG000|NOT COMPLETED|Overall Study||0
9703784|NCT04551677|10803420|FG000|STARTED|Overall Study||29
9703785|NCT04551677|10803421|FG001|STARTED|Overall Study||31
9703786|NCT04551677|10803422|FG002|STARTED|Overall Study||30
9703787|NCT04551677|10803420|FG000|Vaccinated|Overall Study||29
9703788|NCT04551677|10803421|FG001|Vaccinated|Overall Study||31
9703789|NCT04551677|10803422|FG002|Vaccinated|Overall Study||30
9703790|NCT04551677|10803420|FG000|COMPLETED|Overall Study||29
9703791|NCT04551677|10803421|FG001|COMPLETED|Overall Study||31
9703792|NCT04551677|10803422|FG002|COMPLETED|Overall Study||30
9703793|NCT04551677|10803420|FG000|NOT COMPLETED|Overall Study||0
9703794|NCT04551677|10803421|FG001|NOT COMPLETED|Overall Study||0
9703795|NCT04551677|10803422|FG002|NOT COMPLETED|Overall Study||0
9703796|NCT04498832|10803432|FG000|STARTED|Overall Study||1049
9703797|NCT04498832|10803433|FG001|STARTED|Overall Study||1051
9703798|NCT04498832|10803432|FG000|COMPLETED|Overall Study||1048
9703799|NCT04498832|10803433|FG001|COMPLETED|Overall Study||1047
9703800|NCT04498832|10803432|FG000|NOT COMPLETED|Overall Study||1
9703801|NCT04498832|10803433|FG001|NOT COMPLETED|Overall Study||4
9703802|NCT04109222|10803442|FG000|STARTED|Overall Study||30
9703803|NCT04109222|10803443|FG001|STARTED|Overall Study||30
9703804|NCT04109222|10803444|FG002|STARTED|Overall Study||30
9703805|NCT04109222|10803442|FG000|COMPLETED|Overall Study||29
9703806|NCT04109222|10803443|FG001|COMPLETED|Overall Study||30
9703807|NCT04109222|10803444|FG002|COMPLETED|Overall Study||30
9703808|NCT04109222|10803442|FG000|NOT COMPLETED|Overall Study||1
9703809|NCT04109222|10803443|FG001|NOT COMPLETED|Overall Study||0
9703810|NCT04109222|10803444|FG002|NOT COMPLETED|Overall Study||0
9703811|NCT04046939|10803456|FG000|STARTED|Screening Period||534
9703812|NCT04046939|10803457|FG001|STARTED|Screening Period||0
9703813|NCT04046939|10803458|FG002|STARTED|Screening Period||0
9703814|NCT04046939|10803459|FG003|STARTED|Screening Period||0
9703815|NCT04046939|10803456|FG000|Received Placebo During Run-In Period|Screening Period||144
9703816|NCT04046939|10803457|FG001|Received Placebo During Run-In Period|Screening Period||0
9703817|NCT04046939|10803458|FG002|Received Placebo During Run-In Period|Screening Period||0
9703818|NCT04046939|10803459|FG003|Received Placebo During Run-In Period|Screening Period||0
9703819|NCT04046939|10803456|FG000|COMPLETED|Screening Period||103
9703820|NCT04046939|10803457|FG001|COMPLETED|Screening Period||0
9703821|NCT04046939|10803458|FG002|COMPLETED|Screening Period||0
9703822|NCT04046939|10803459|FG003|COMPLETED|Screening Period||0
9703823|NCT04046939|10803456|FG000|NOT COMPLETED|Screening Period||431
9703824|NCT04046939|10803457|FG001|NOT COMPLETED|Screening Period||0
9703825|NCT04046939|10803458|FG002|NOT COMPLETED|Screening Period||0
9703826|NCT04046939|10803459|FG003|NOT COMPLETED|Screening Period||0
9703827|NCT04046939|10803456|FG000|STARTED|Primary Assessment Period||27
9703828|NCT04046939|10803457|FG001|STARTED|Primary Assessment Period||22
9703829|NCT04046939|10803458|FG002|STARTED|Primary Assessment Period||26
9703830|NCT04046939|10803459|FG003|STARTED|Primary Assessment Period||28
9703831|NCT04046939|10803456|FG000|COMPLETED|Primary Assessment Period||25
9703832|NCT04046939|10803457|FG001|COMPLETED|Primary Assessment Period||22
9703833|NCT04046939|10803458|FG002|COMPLETED|Primary Assessment Period||24
9703834|NCT04046939|10803459|FG003|COMPLETED|Primary Assessment Period||28
9703835|NCT04046939|10803456|FG000|NOT COMPLETED|Primary Assessment Period||2
9703836|NCT04046939|10803457|FG001|NOT COMPLETED|Primary Assessment Period||0
9703837|NCT04046939|10803458|FG002|NOT COMPLETED|Primary Assessment Period||2
9703838|NCT04046939|10803459|FG003|NOT COMPLETED|Primary Assessment Period||0
9703839|NCT04046939|10803456|FG000|STARTED|Eosinophil Recovery Period||25
9703840|NCT04046939|10803457|FG001|STARTED|Eosinophil Recovery Period||22
9703841|NCT04046939|10803458|FG002|STARTED|Eosinophil Recovery Period||24
9703842|NCT04046939|10803459|FG003|STARTED|Eosinophil Recovery Period||28
9703843|NCT04046939|10803456|FG000|COMPLETED|Eosinophil Recovery Period||24
9703844|NCT04046939|10803457|FG001|COMPLETED|Eosinophil Recovery Period||22
9703845|NCT04046939|10803458|FG002|COMPLETED|Eosinophil Recovery Period||24
9703846|NCT04046939|10803459|FG003|COMPLETED|Eosinophil Recovery Period||27
9703847|NCT04046939|10803456|FG000|NOT COMPLETED|Eosinophil Recovery Period||1
9703848|NCT04046939|10803457|FG001|NOT COMPLETED|Eosinophil Recovery Period||0
9703849|NCT04046939|10803458|FG002|NOT COMPLETED|Eosinophil Recovery Period||0
9703850|NCT04046939|10803459|FG003|NOT COMPLETED|Eosinophil Recovery Period||1
9703851|NCT03912259|10803477|FG000|STARTED|Overall Study||83
9703852|NCT03912259|10803478|FG001|STARTED|Overall Study||82
9703853|NCT03912259|10803477|FG000|COMPLETED|Overall Study||66
9703854|NCT03912259|10803478|FG001|COMPLETED|Overall Study||76
9703855|NCT03912259|10803477|FG000|NOT COMPLETED|Overall Study||17
9703856|NCT03912259|10803478|FG001|NOT COMPLETED|Overall Study||6
9703857|NCT03890367|10803488|FG000|STARTED|Overall Study||232
9703858|NCT03890367|10803489|FG001|STARTED|Overall Study||235
10028130|NCT01889862|11152353|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
10028131|NCT01889862|11152354|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
10028132|NCT01889862|11152355|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
10028133|NCT01889862|11152356|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
10028134|NCT01889862|11152357|FG004|STARTED|Part 2 (8 Weeks)||0
10028135|NCT01889862|11152353|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
10028136|NCT01889862|11152354|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
10028137|NCT01889862|11152355|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
10028138|NCT01889862|11152356|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
10028139|NCT01889862|11152357|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
10028140|NCT01889862|11152353|FG000|COMPLETED|Part 2 (8 Weeks)||34
10028141|NCT01889862|11152354|FG001|COMPLETED|Part 2 (8 Weeks)||15
10028142|NCT01889862|11152355|FG002|COMPLETED|Part 2 (8 Weeks)||31
10028143|NCT01889862|11152356|FG003|COMPLETED|Part 2 (8 Weeks)||14
10028144|NCT01889862|11152357|FG004|COMPLETED|Part 2 (8 Weeks)||0
10028145|NCT01889862|11152353|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
10028146|NCT01889862|11152354|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0
10028147|NCT01889862|11152355|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1
10028148|NCT01889862|11152356|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0
10028149|NCT01889862|11152357|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0
10028150|NCT01889862|11152353|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
10028151|NCT01889862|11152354|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
10028152|NCT01889862|11152355|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
10028153|NCT01889862|11152356|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
10028154|NCT01889862|11152357|FG004|STARTED|Part 3A/B (6 Week)||0
10028155|NCT01889862|11152353|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
10028156|NCT01889862|11152354|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
10028157|NCT01889862|11152355|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
10028158|NCT01889862|11152356|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
10028159|NCT01889862|11152357|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
10028160|NCT01889862|11152353|FG000|COMPLETED|Part 3A/B (6 Week)||48
10028161|NCT01889862|11152354|FG001|COMPLETED|Part 3A/B (6 Week)||0
10028162|NCT01889862|11152355|FG002|COMPLETED|Part 3A/B (6 Week)||41
10028163|NCT01889862|11152356|FG003|COMPLETED|Part 3A/B (6 Week)||0
10028164|NCT01889862|11152357|FG004|COMPLETED|Part 3A/B (6 Week)||0
10028165|NCT01889862|11152353|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0
10028166|NCT01889862|11152354|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0
10028167|NCT01889862|11152355|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0
10028168|NCT01889862|11152356|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0
10028169|NCT01889862|11152357|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0
10028170|NCT01889862|11152353|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
10028171|NCT01889862|11152354|FG001|STARTED|Part 4 (Up to 274 Weeks)||0
10028172|NCT01889862|11152355|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
10028173|NCT01889862|11152356|FG003|STARTED|Part 4 (Up to 274 Weeks)||0
10028174|NCT01889862|11152357|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
10028175|NCT01889862|11152353|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0
10028176|NCT01889862|11152354|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0
10028177|NCT01889862|11152355|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0
10028178|NCT01889862|11152356|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0
10028179|NCT01889862|11152357|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172
10028180|NCT01889862|11152353|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10028181|NCT01889862|11152354|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10028182|NCT01889862|11152355|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10028183|NCT01889862|11152356|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10028184|NCT01889862|11152357|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
9703859|NCT03890367|10803490|FG002|STARTED|Overall Study||240
9703860|NCT03890367|10803488|FG000|Safety Analysis Set|Overall Study||230
9703861|NCT03890367|10803489|FG001|Safety Analysis Set|Overall Study||232
9703862|NCT03890367|10803490|FG002|Safety Analysis Set|Overall Study||239
9703863|NCT03890367|10803488|FG000|COMPLETED|Overall Study||228
9703864|NCT03890367|10803489|FG001|COMPLETED|Overall Study||229
9703865|NCT03890367|10803490|FG002|COMPLETED|Overall Study||239
9703866|NCT03890367|10803488|FG000|NOT COMPLETED|Overall Study||4
9703867|NCT03890367|10803489|FG001|NOT COMPLETED|Overall Study||6
9703868|NCT03890367|10803490|FG002|NOT COMPLETED|Overall Study||1
9703869|NCT03784898|10803498|FG000|STARTED|Overall Study||13
9703870|NCT03784898|10803498|FG000|COMPLETED|Overall Study||13
9703871|NCT03784898|10803498|FG000|NOT COMPLETED|Overall Study||0
9728821|NCT00114166|10828377|FG001|STARTED|Overall Study||66
9728822|NCT00114166|10828376|FG000|COMPLETED|Overall Study||15
9728823|NCT00114166|10828377|FG001|COMPLETED|Overall Study||65
9728824|NCT00114166|10828376|FG000|NOT COMPLETED|Overall Study||0
9728825|NCT00114166|10828377|FG001|NOT COMPLETED|Overall Study||1
9728826|NCT00114218|10828385|FG000|STARTED|Overall Study||28
9728827|NCT00114218|10828385|FG000|COMPLETED|Overall Study||24
9728828|NCT00114218|10828385|FG000|NOT COMPLETED|Overall Study||4
9728829|NCT00114231|10828391|FG000|STARTED|Overall Study||62
9728830|NCT00114231|10828392|FG001|STARTED|Overall Study||28
9728831|NCT00114231|10828391|FG000|COMPLETED|Overall Study||53
9728832|NCT00114231|10828392|FG001|COMPLETED|Overall Study||26
9728833|NCT00114231|10828391|FG000|NOT COMPLETED|Overall Study||9
9728834|NCT00114231|10828392|FG001|NOT COMPLETED|Overall Study||2
9728835|NCT00114244|10828399|FG000|STARTED|Overall Study||15
9728836|NCT00114244|10828400|FG001|STARTED|Overall Study||37
9728837|NCT00114244|10828399|FG000|COMPLETED|Overall Study||13
9728838|NCT00114244|10828400|FG001|COMPLETED|Overall Study||30
9728839|NCT00114244|10828399|FG000|NOT COMPLETED|Overall Study||2
9728840|NCT00114244|10828400|FG001|NOT COMPLETED|Overall Study||7
9728841|NCT00114504|10828408|FG000|STARTED|Overall Study||21
9728842|NCT00114504|10828409|FG001|STARTED|Overall Study||22
9728843|NCT00114504|10828408|FG000|COMPLETED|Overall Study||21
9728844|NCT00114504|10828409|FG001|COMPLETED|Overall Study||22
9728845|NCT00114504|10828408|FG000|NOT COMPLETED|Overall Study||0
9728846|NCT00114504|10828409|FG001|NOT COMPLETED|Overall Study||0
9728847|NCT00114517|10828423|FG000|STARTED|Overall Study||137
9728848|NCT00114517|10828424|FG001|STARTED|Overall Study||134
9728849|NCT00114517|10828425|FG002|STARTED|Overall Study||186
9728850|NCT00114517|10828426|FG003|STARTED|Overall Study||186
9728851|NCT00114517|10828423|FG000|COMPLETED|Overall Study||125
9728852|NCT00114517|10828424|FG001|COMPLETED|Overall Study||123
9728853|NCT00114517|10828425|FG002|COMPLETED|Overall Study||172
9728854|NCT00114517|10828426|FG003|COMPLETED|Overall Study||176
9728855|NCT00114517|10828423|FG000|NOT COMPLETED|Overall Study||12
9728856|NCT00114517|10828424|FG001|NOT COMPLETED|Overall Study||11
9728857|NCT00114517|10828425|FG002|NOT COMPLETED|Overall Study||14
9728858|NCT00114517|10828426|FG003|NOT COMPLETED|Overall Study||10
9728859|NCT00114530|10828434|FG000|STARTED|Overall Study||36
9728860|NCT00114530|10828435|FG001|STARTED|Overall Study||39
9728861|NCT00114530|10828434|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
9728862|NCT00114530|10828435|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
9728863|NCT00114530|10828434|FG000|NOT COMPLETED|Overall Study||9
10028185|NCT01890031|11152387|FG000|STARTED|Overall Study||50
10028186|NCT01890031|11152388|FG001|STARTED|Overall Study||50
10028187|NCT01890031|11152389|FG002|STARTED|Overall Study||12
10028188|NCT01890031|11152390|FG003|STARTED|Overall Study||11
10028189|NCT01890031|11152391|FG004|STARTED|Overall Study||8
10028190|NCT01890031|11152387|FG000|COMPLETED|Overall Study||50
10028191|NCT01890031|11152388|FG001|COMPLETED|Overall Study||50
10028192|NCT01890031|11152389|FG002|COMPLETED|Overall Study||12
10028193|NCT01890031|11152390|FG003|COMPLETED|Overall Study||11
10028194|NCT01890031|11152391|FG004|COMPLETED|Overall Study||8
10028195|NCT01890031|11152387|FG000|NOT COMPLETED|Overall Study||0
10028196|NCT01890031|11152388|FG001|NOT COMPLETED|Overall Study||0
10028197|NCT01890031|11152389|FG002|NOT COMPLETED|Overall Study||0
10028198|NCT01890031|11152390|FG003|NOT COMPLETED|Overall Study||0
10028199|NCT01890031|11152391|FG004|NOT COMPLETED|Overall Study||0
10028200|NCT01890109|11152405|FG000|STARTED|Overall Study||52
10028201|NCT01890109|11152406|FG001|STARTED|Overall Study||51
10028202|NCT01890109|11152405|FG000|Received Study Treatment|Overall Study||52
10028203|NCT01890109|11152406|FG001|Received Study Treatment|Overall Study||50
10028204|NCT01890109|11152405|FG000|COMPLETED|Overall Study||51
10028205|NCT01890109|11152406|FG001|COMPLETED|Overall Study||46
10028206|NCT01890109|11152405|FG000|NOT COMPLETED|Overall Study||1
10028207|NCT01890109|11152406|FG001|NOT COMPLETED|Overall Study||5
10028208|NCT01890122|11152417|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
10028209|NCT01890122|11152418|FG001|STARTED|Overall Study||163
10028210|NCT01890122|11152419|FG002|STARTED|Overall Study||159
10028211|NCT01890122|11152420|FG003|STARTED|Overall Study||163
9728864|NCT00114530|10828435|FG001|NOT COMPLETED|Overall Study||20
9728865|NCT00114634|10828445|FG000|STARTED|Overall Study||13
9728866|NCT00114634|10828445|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
9728867|NCT00114634|10828445|FG000|NOT COMPLETED|Overall Study||3
9728868|NCT00114738|10828451|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53
9728869|NCT00114738|10828452|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0
9728870|NCT00114738|10828453|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0
9703872|NCT03607422|10803508|FG000|STARTED|Overall Study||242
9703873|NCT03607422|10803509|FG001|STARTED|Overall Study||243
9703874|NCT03607422|10803510|FG002|STARTED|Overall Study||247
9703875|NCT03607422|10803511|FG003|STARTED|Overall Study||60
9703876|NCT03607422|10803512|FG004|STARTED|Overall Study||58
9703877|NCT03607422|10803513|FG005|STARTED|Overall Study||62
9703878|NCT03607422|10803508|FG000|COMPLETED|Overall Study||204
9703879|NCT03607422|10803509|FG001|COMPLETED|Overall Study||233
9703880|NCT03607422|10803510|FG002|COMPLETED|Overall Study||235
9703881|NCT03607422|10803511|FG003|COMPLETED|Overall Study||55
9703882|NCT03607422|10803512|FG004|COMPLETED|Overall Study||55
9703883|NCT03607422|10803513|FG005|COMPLETED|Overall Study||59
9703884|NCT03607422|10803508|FG000|NOT COMPLETED|Overall Study||38
9703885|NCT03607422|10803509|FG001|NOT COMPLETED|Overall Study||10
9703886|NCT03607422|10803510|FG002|NOT COMPLETED|Overall Study||12
9703887|NCT03607422|10803511|FG003|NOT COMPLETED|Overall Study||5
9703888|NCT03607422|10803512|FG004|NOT COMPLETED|Overall Study||3
9703889|NCT03607422|10803513|FG005|NOT COMPLETED|Overall Study||3
9703890|NCT03600805|10803531|FG000|STARTED|Overall Study||28
9703891|NCT03600805|10803532|FG001|STARTED|Overall Study||14
9703892|NCT03600805|10803533|FG002|STARTED|Overall Study||14
9703893|NCT03600805|10803534|FG003|STARTED|Overall Study||27
9703894|NCT03600805|10803531|FG000|Week 52 Analysis Set Population|Overall Study||10
9703895|NCT03600805|10803532|FG001|Week 52 Analysis Set Population|Overall Study||6
9703896|NCT03600805|10803533|FG002|Week 52 Analysis Set Population|Overall Study||7
9703897|NCT03600805|10803534|FG003|Week 52 Analysis Set Population|Overall Study||13
9703898|NCT03600805|10803531|FG000|COMPLETED|Overall Study||9
9703899|NCT03600805|10803532|FG001|COMPLETED|Overall Study||6
9703900|NCT03600805|10803533|FG002|COMPLETED|Overall Study||6
9703901|NCT03600805|10803534|FG003|COMPLETED|Overall Study||8
9703902|NCT03600805|10803531|FG000|NOT COMPLETED|Overall Study||19
9703903|NCT03600805|10803532|FG001|NOT COMPLETED|Overall Study||8
9703904|NCT03600805|10803533|FG002|NOT COMPLETED|Overall Study||8
9703905|NCT03600805|10803534|FG003|NOT COMPLETED|Overall Study||19
9703906|NCT03584724|10803548|FG000|STARTED|Overall Study||25
9703907|NCT03584724|10803549|FG001|STARTED|Overall Study||24
9703908|NCT03584724|10803548|FG000|COMPLETED|Overall Study||18
9703909|NCT03584724|10803549|FG001|COMPLETED|Overall Study||23
9703910|NCT03584724|10803548|FG000|NOT COMPLETED|Overall Study||7
9703911|NCT03584724|10803549|FG001|NOT COMPLETED|Overall Study||1
9703912|NCT03434119|10803557|FG000|STARTED|Overall Study||116
9703913|NCT03434119|10803558|FG001|STARTED|Overall Study||125
9703914|NCT03434119|10803557|FG000|Treated|Overall Study||115
9703915|NCT03434119|10803558|FG001|Treated|Overall Study||125
10028212|NCT01890122|11152417|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
10028213|NCT01890122|11152418|FG001|Treated|Overall Study||162
10028214|NCT01890122|11152419|FG002|Treated|Overall Study||159
10028215|NCT01890122|11152420|FG003|Treated|Overall Study||163
10028216|NCT01890122|11152417|FG000|COMPLETED|Overall Study||135
10028217|NCT01890122|11152418|FG001|COMPLETED|Overall Study||126
10028218|NCT01890122|11152419|FG002|COMPLETED|Overall Study||146
10028219|NCT01890122|11152420|FG003|COMPLETED|Overall Study||104
10028220|NCT01890122|11152417|FG000|NOT COMPLETED|Overall Study||27
10028221|NCT01890122|11152418|FG001|NOT COMPLETED|Overall Study||37
10028222|NCT01890122|11152419|FG002|NOT COMPLETED|Overall Study||13
10028223|NCT01890122|11152420|FG003|NOT COMPLETED|Overall Study||59
10028224|NCT01890148|11152430|FG000|STARTED|Overall Study||5
10028225|NCT01890148|11152430|FG000|COMPLETED|Overall Study||4
10028226|NCT01890148|11152430|FG000|NOT COMPLETED|Overall Study||1
10028227|NCT01890226|11152436|FG000|STARTED|Overall Study||155
10028228|NCT01890226|11152437|FG001|STARTED|Overall Study||156
10028229|NCT01890226|11152436|FG000|COMPLETED|Overall Study||155
10028230|NCT01890226|11152437|FG001|COMPLETED|Overall Study||156
10028231|NCT01890226|11152436|FG000|NOT COMPLETED|Overall Study||0
10028232|NCT01890226|11152437|FG001|NOT COMPLETED|Overall Study||0
10028233|NCT01890265|11152449|FG000|STARTED|Overall Study||50
10028234|NCT01890265|11152450|FG001|STARTED|Overall Study||53
10028235|NCT01890265|11152451|FG002|STARTED|Overall Study||24
10028236|NCT01890265|11152452|FG003|STARTED|Overall Study||12
10028237|NCT01890265|11152453|FG004|STARTED|Overall Study||15
10028238|NCT01890265|11152454|FG005|STARTED|Overall Study||6
10028239|NCT01890265|11152449|FG000|Safety Population|Overall Study||50
10028240|NCT01890265|11152450|FG001|Safety Population|Overall Study||53
10028241|NCT01890265|11152451|FG002|Safety Population|Overall Study||24
10028242|NCT01890265|11152452|FG003|Safety Population|Overall Study||12
10028243|NCT01890265|11152453|FG004|Safety Population|Overall Study||15
10028244|NCT01890265|11152454|FG005|Safety Population|Overall Study||6
10028245|NCT01890265|11152449|FG000|Intent-to-Treat (ITT) Population|Overall Study||50
9703916|NCT03434119|10803557|FG000|COMPLETED|Overall Study||9
9703917|NCT03434119|10803558|FG001|COMPLETED|Overall Study||12
9703918|NCT03434119|10803557|FG000|NOT COMPLETED|Overall Study||107
9703919|NCT03434119|10803558|FG001|NOT COMPLETED|Overall Study||113
9703920|NCT03417245|10803566|FG000|STARTED|Overall Study||40
9703921|NCT03417245|10803567|FG001|STARTED|Overall Study||80
9703922|NCT03417245|10803566|FG000|Treated|Overall Study||40
9703923|NCT03417245|10803567|FG001|Treated|Overall Study||79
9703924|NCT03417245|10803566|FG000|COMPLETED|Overall Study||37
10028246|NCT01890265|11152450|FG001|Intent-to-Treat (ITT) Population|Overall Study||51
10028247|NCT01890265|11152451|FG002|Intent-to-Treat (ITT) Population|Overall Study||24
10028248|NCT01890265|11152452|FG003|Intent-to-Treat (ITT) Population|Overall Study||12
9703925|NCT03417245|10803567|FG001|COMPLETED|Overall Study||79
9703926|NCT03417245|10803566|FG000|NOT COMPLETED|Overall Study||3
9703927|NCT03417245|10803567|FG001|NOT COMPLETED|Overall Study||1
9703928|NCT03417102|10803575|FG000|STARTED|Overall Study||19
9703929|NCT03417102|10803576|FG001|STARTED|Overall Study||38
9848101|NCT00857259|10960729|FG000|STARTED|Overall Study||8
9848102|NCT00857259|10960730|FG001|STARTED|Overall Study||1
9848103|NCT00857259|10960731|FG002|STARTED|Overall Study||7
9848104|NCT00857259|10960729|FG000|COMPLETED|Overall Study||7
9848105|NCT00857259|10960730|FG001|COMPLETED|Overall Study||1
9848106|NCT00857259|10960731|FG002|COMPLETED|Overall Study||6
9848107|NCT00857259|10960729|FG000|NOT COMPLETED|Overall Study||1
9848108|NCT00857259|10960730|FG001|NOT COMPLETED|Overall Study||0
9848109|NCT00857259|10960731|FG002|NOT COMPLETED|Overall Study||1
9848110|NCT00857272|10960743|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
9848111|NCT00857272|10960744|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
9848112|NCT00857272|10960743|FG000|COMPLETED|Overall Study||145
9848113|NCT00857272|10960744|FG001|COMPLETED|Overall Study||145
9848114|NCT00857272|10960743|FG000|NOT COMPLETED|Overall Study||9
9848115|NCT00857272|10960744|FG001|NOT COMPLETED|Overall Study||9
9848116|NCT00857311|10960754|FG000|STARTED|Overall Study||9
9848117|NCT00857311|10960755|FG001|STARTED|Overall Study||0
9848118|NCT00857311|10960756|FG002|STARTED|Overall Study||8
9848119|NCT00857311|10960757|FG003|STARTED|Overall Study||0
9848120|NCT00857311|10960754|FG000|COMPLETED|Overall Study||8
9848121|NCT00857311|10960755|FG001|COMPLETED|Overall Study||0
9848122|NCT00857311|10960756|FG002|COMPLETED|Overall Study||8
9848123|NCT00857311|10960757|FG003|COMPLETED|Overall Study||0
9848124|NCT00857311|10960754|FG000|NOT COMPLETED|Overall Study||1
9848125|NCT00857311|10960755|FG001|NOT COMPLETED|Overall Study||0
9848126|NCT00857311|10960756|FG002|NOT COMPLETED|Overall Study||0
9848127|NCT00857311|10960757|FG003|NOT COMPLETED|Overall Study||0
9848128|NCT00857389|10960763|FG000|STARTED|Overall Study||60
9848129|NCT00857389|10960763|FG000|COMPLETED|Overall Study||58
9848130|NCT00857389|10960763|FG000|NOT COMPLETED|Overall Study||2
9848131|NCT00857415|10960769|FG000|STARTED|Overall Study||152
9848132|NCT00857415|10960770|FG001|STARTED|Overall Study||74
9848133|NCT00857415|10960769|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37
9848134|NCT00857415|10960770|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
9848135|NCT00857415|10960769|FG000|COMPLETED|Overall Study||35
9848136|NCT00857415|10960770|FG001|COMPLETED|Overall Study||74
9848137|NCT00857415|10960769|FG000|NOT COMPLETED|Overall Study||117
9848138|NCT00857415|10960770|FG001|NOT COMPLETED|Overall Study||0
9848139|NCT00857454|10960776|FG000|STARTED|Overall Study||71
9848140|NCT00857454|10960776|FG000|COMPLETED|Overall Study||51
9848141|NCT00857454|10960776|FG000|NOT COMPLETED|Overall Study||20
9848142|NCT00857493|10960782|FG000|STARTED|Overall Study||62
9848143|NCT00857493|10960783|FG001|STARTED|Overall Study||58
9848144|NCT00857493|10960782|FG000|COMPLETED|Overall Study||59
9848145|NCT00857493|10960783|FG001|COMPLETED|Overall Study||58
9848146|NCT00857493|10960782|FG000|NOT COMPLETED|Overall Study||3
9848147|NCT00857493|10960783|FG001|NOT COMPLETED|Overall Study||0
9848148|NCT00857506|10960792|FG000|STARTED|Overall Study||31
9848149|NCT00857506|10960793|FG001|STARTED|Overall Study||52
9848150|NCT00857506|10960794|FG002|STARTED|Overall Study||69
10028249|NCT01890265|11152453|FG004|Intent-to-Treat (ITT) Population|Overall Study||15
10028250|NCT01890265|11152454|FG005|Intent-to-Treat (ITT) Population|Overall Study||6
10028251|NCT01890265|11152449|FG000|COMPLETED|Overall Study||40
10028252|NCT01890265|11152450|FG001|COMPLETED|Overall Study||40
10028253|NCT01890265|11152451|FG002|COMPLETED|Overall Study||20
10028254|NCT01890265|11152452|FG003|COMPLETED|Overall Study||12
10028255|NCT01890265|11152453|FG004|COMPLETED|Overall Study||13
10028256|NCT01890265|11152454|FG005|COMPLETED|Overall Study||6
10028257|NCT01890265|11152449|FG000|NOT COMPLETED|Overall Study||10
10028258|NCT01890265|11152450|FG001|NOT COMPLETED|Overall Study||13
10028259|NCT01890265|11152451|FG002|NOT COMPLETED|Overall Study||4
10028260|NCT01890265|11152452|FG003|NOT COMPLETED|Overall Study||0
10028261|NCT01890265|11152453|FG004|NOT COMPLETED|Overall Study||2
10028262|NCT01890265|11152454|FG005|NOT COMPLETED|Overall Study||0
10028263|NCT01890343|11152467|FG000|STARTED|Overall Study||8
10028264|NCT01890343|11152468|FG001|STARTED|Overall Study||10
10028265|NCT01890343|11152469|FG002|STARTED|Overall Study||10
10028266|NCT01890343|11152467|FG000|COMPLETED|Overall Study||8
10028267|NCT01890343|11152468|FG001|COMPLETED|Overall Study||10
10028268|NCT01890343|11152469|FG002|COMPLETED|Overall Study||10
10028269|NCT01890343|11152467|FG000|NOT COMPLETED|Overall Study||0
10028270|NCT01890343|11152468|FG001|NOT COMPLETED|Overall Study||0
10028271|NCT01890343|11152469|FG002|NOT COMPLETED|Overall Study||0
10028272|NCT01890421|11152477|FG000|STARTED|Overall Study||426
10028273|NCT01890421|11152477|FG000|COMPLETED|Overall Study||415
9848151|NCT00857506|10960792|FG000|COMPLETED|Overall Study||16
9848152|NCT00857506|10960793|FG001|COMPLETED|Overall Study||37
9848153|NCT00857506|10960794|FG002|COMPLETED|Overall Study||51
9848154|NCT00857506|10960792|FG000|NOT COMPLETED|Overall Study||15
9848155|NCT00857506|10960793|FG001|NOT COMPLETED|Overall Study||15
9848156|NCT00857506|10960794|FG002|NOT COMPLETED|Overall Study||18
10028274|NCT01890421|11152477|FG000|NOT COMPLETED|Overall Study||11
9848157|NCT00857532|10960814|FG000|STARTED|Overall Study||31
9848158|NCT00857532|10960814|FG000|COMPLETED|Overall Study||31
10028275|NCT01890434|11152481|FG000|STARTED|Overall Study||478
9703930|NCT03417102|10803575|FG000|Safety Analysis Set|Overall Study||19
9703931|NCT03417102|10803576|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41
9703932|NCT03417102|10803575|FG000|COMPLETED|Overall Study||19
9703933|NCT03417102|10803576|FG001|COMPLETED|Overall Study||33
9703934|NCT03417102|10803575|FG000|NOT COMPLETED|Overall Study||0
9703935|NCT03417102|10803576|FG001|NOT COMPLETED|Overall Study||5
9703942|NCT03278626|10803588|FG000|STARTED|Overall Study||12
9703943|NCT03278626|10803588|FG000|COMPLETED|Overall Study||7
9703944|NCT03278626|10803588|FG000|NOT COMPLETED|Overall Study||5
9703945|NCT03211858|10803594|FG000|STARTED|Overall Study||301
9703946|NCT03211858|10803595|FG001|STARTED|Overall Study||296
9703947|NCT03211858|10803594|FG000|Treated|Overall Study||301
9703948|NCT03211858|10803595|FG001|Treated|Overall Study||296
9703949|NCT03211858|10803594|FG000|COMPLETED|Overall Study||264
9703950|NCT03211858|10803595|FG001|COMPLETED|Overall Study||263
9703951|NCT03211858|10803594|FG000|NOT COMPLETED|Overall Study||37
9703952|NCT03211858|10803595|FG001|NOT COMPLETED|Overall Study||33
9703953|NCT03093480|10803605|FG000|STARTED|Overall Study||16
9703954|NCT03093480|10803605|FG000|Tapering Period|Overall Study||10
9703955|NCT03093480|10803605|FG000|Follow-up Period|Overall Study||10
9703956|NCT03093480|10803605|FG000|COMPLETED|Overall Study||16
9703957|NCT03093480|10803605|FG000|NOT COMPLETED|Overall Study||0
9703958|NCT03077438|10803611|FG000|STARTED|Overall Study||499
9703959|NCT03077438|10803612|FG001|STARTED|Overall Study||501
9703960|NCT03077438|10803611|FG000|Safety Analysis Set (SafAS)|Overall Study||498
9703961|NCT03077438|10803612|FG001|Safety Analysis Set (SafAS)|Overall Study||494
9703962|NCT03077438|10803611|FG000|COMPLETED|Overall Study||487
9703963|NCT03077438|10803612|FG001|COMPLETED|Overall Study||487
9703964|NCT03077438|10803611|FG000|NOT COMPLETED|Overall Study||12
9703965|NCT03077438|10803612|FG001|NOT COMPLETED|Overall Study||14
9703966|NCT03045653|10803622|FG000|STARTED|Overall Study||30
9703967|NCT03045653|10803622|FG000|COMPLETED|Overall Study||30
9703968|NCT03045653|10803622|FG000|NOT COMPLETED|Overall Study||0
9703969|NCT02948959|10803628|FG000|STARTED|52 Weeks Treatment Period||135
9703970|NCT02948959|10803629|FG001|STARTED|52 Weeks Treatment Period||273
9703971|NCT02948959|10803628|FG000|Treated|52 Weeks Treatment Period||135
9703972|NCT02948959|10803629|FG001|Treated|52 Weeks Treatment Period||270
9703973|NCT02948959|10803628|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134
9703974|NCT02948959|10803629|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271
9703975|NCT02948959|10803628|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114
9703976|NCT02948959|10803629|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236
9703977|NCT02948959|10803628|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84
9703978|NCT02948959|10803629|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175
10115475|NCT02526160|11246304|FG000|COMPLETED|Open-label Treatment Continuation Period||63
10115476|NCT02526160|11246305|FG001|COMPLETED|Open-label Treatment Continuation Period||63
9703979|NCT02948959|10803628|FG000|COMPLETED|52 Weeks Treatment Period||130
9703980|NCT02948959|10803629|FG001|COMPLETED|52 Weeks Treatment Period||248
9703981|NCT02948959|10803628|FG000|NOT COMPLETED|52 Weeks Treatment Period||5
9703982|NCT02948959|10803629|FG001|NOT COMPLETED|52 Weeks Treatment Period||25
9703983|NCT02948959|10803628|FG000|STARTED|12 Weeks Follow-up Period||9
9703984|NCT02948959|10803629|FG001|STARTED|12 Weeks Follow-up Period||31
9703985|NCT02948959|10803628|FG000|COMPLETED|12 Weeks Follow-up Period||4
9703986|NCT02948959|10803629|FG001|COMPLETED|12 Weeks Follow-up Period||19
9703987|NCT02948959|10803628|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5
9703988|NCT02948959|10803629|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12
9703989|NCT02878603|10803645|FG000|STARTED|Overall Study||29
9703990|NCT02878603|10803646|FG001|STARTED|Overall Study||75
9703991|NCT02878603|10803645|FG000|COMPLETED|Overall Study||23
9703992|NCT02878603|10803646|FG001|COMPLETED|Overall Study||70
9703993|NCT02878603|10803645|FG000|NOT COMPLETED|Overall Study||6
9703994|NCT02878603|10803646|FG001|NOT COMPLETED|Overall Study||5
9703995|NCT02864407|10803652|FG000|STARTED|Overall Study||3223
9703996|NCT02864407|10803652|FG000|Effectiveness Analysis Set|Overall Study||2105
9703997|NCT02864407|10803652|FG000|Long-term Safety Analysis Set|Overall Study||813
9703998|NCT02864407|10803652|FG000|Long-term Effectiveness Analysis Set|Overall Study||767
9703999|NCT02864407|10803652|FG000|COMPLETED|Overall Study||3100
9704000|NCT02864407|10803652|FG000|NOT COMPLETED|Overall Study||123
9704001|NCT02846532|10803659|FG000|STARTED|Overall Study||12
9704002|NCT02846532|10803660|FG001|STARTED|Overall Study||66
9704003|NCT02846532|10803661|FG002|STARTED|Overall Study||34
9704004|NCT02846532|10803659|FG000|COMPLETED|Overall Study||11
9704005|NCT02846532|10803660|FG001|COMPLETED|Overall Study||63
9704006|NCT02846532|10803661|FG002|COMPLETED|Overall Study||33
9704007|NCT02846532|10803659|FG000|NOT COMPLETED|Overall Study||1
9704008|NCT02846532|10803660|FG001|NOT COMPLETED|Overall Study||3
9704009|NCT02846532|10803661|FG002|NOT COMPLETED|Overall Study||1
9704010|NCT02688933|10803671|FG000|STARTED|Overall Study||320
9704011|NCT02688933|10803672|FG001|STARTED|Overall Study||318
9704012|NCT02688933|10803671|FG000|COMPLETED|Overall Study||291
9704013|NCT02688933|10803672|FG001|COMPLETED|Overall Study||281
9704014|NCT02688933|10803671|FG000|NOT COMPLETED|Overall Study||29
9704015|NCT02688933|10803672|FG001|NOT COMPLETED|Overall Study||37
9704016|NCT02550197|10803680|FG000|STARTED|Overall Study||200
9704017|NCT02550197|10803681|FG001|STARTED|Overall Study||100
9704018|NCT02550197|10803680|FG000|COMPLETED|Overall Study||200
9704019|NCT02550197|10803681|FG001|COMPLETED|Overall Study||100
9704020|NCT02550197|10803680|FG000|NOT COMPLETED|Overall Study||0
9704021|NCT02550197|10803681|FG001|NOT COMPLETED|Overall Study||0
9704022|NCT02492165|10803691|FG000|STARTED|Overall Study||100
9704023|NCT02492165|10803692|FG001|STARTED|Overall Study||60
9704024|NCT02492165|10803693|FG002|STARTED|Overall Study||60
9704025|NCT02492165|10803694|FG003|STARTED|Overall Study||30
9704026|NCT02492165|10803691|FG000|COMPLETED|Overall Study||100
9704027|NCT02492165|10803692|FG001|COMPLETED|Overall Study||59
9704028|NCT02492165|10803693|FG002|COMPLETED|Overall Study||60
9704029|NCT02492165|10803694|FG003|COMPLETED|Overall Study||30
9704030|NCT02492165|10803691|FG000|NOT COMPLETED|Overall Study||0
9704031|NCT02492165|10803692|FG001|NOT COMPLETED|Overall Study||1
9704032|NCT02492165|10803693|FG002|NOT COMPLETED|Overall Study||0
9704033|NCT02492165|10803694|FG003|NOT COMPLETED|Overall Study||0
9704034|NCT02476006|10803704|FG000|STARTED|Overall Study||998
9704035|NCT02476006|10803704|FG000|Treated|Overall Study||994
9704036|NCT02476006|10803704|FG000|COMPLETED|Overall Study||878
9704037|NCT02476006|10803704|FG000|NOT COMPLETED|Overall Study||120
10028276|NCT01890434|11152481|FG000|Evaluated for Efficacy|Overall Study||389
10028277|NCT01890434|11152481|FG000|COMPLETED|Overall Study||458
10028278|NCT01890434|11152481|FG000|NOT COMPLETED|Overall Study||20
9704038|NCT02468414|10803710|FG000|STARTED|Overall Study||3
9704039|NCT02468414|10803711|FG001|STARTED|Overall Study||0
9704040|NCT02468414|10803710|FG000|Successfully Screened|Overall Study||2
9704041|NCT02468414|10803711|FG001|Successfully Screened|Overall Study||0
10028279|NCT01890473|11152487|FG000|STARTED|Overall Study||111
10028280|NCT01890473|11152488|FG001|STARTED|Overall Study||113
10028281|NCT01890473|11152487|FG000|COMPLETED|Overall Study||109
10028282|NCT01890473|11152488|FG001|COMPLETED|Overall Study||113
10028283|NCT01890473|11152487|FG000|NOT COMPLETED|Overall Study||2
10028284|NCT01890473|11152488|FG001|NOT COMPLETED|Overall Study||0
10028285|NCT01890512|11152496|FG000|STARTED|Overall Study||20
10028286|NCT01890512|11152496|FG000|COMPLETED|Overall Study||17
10028287|NCT01890512|11152496|FG000|NOT COMPLETED|Overall Study||3
10028288|NCT01890642|11152503|FG000|STARTED|Overall Study||56
10028289|NCT01890642|11152504|FG001|STARTED|Overall Study||53
10028290|NCT01890642|11152505|FG002|STARTED|Overall Study||96
10028291|NCT01890642|11152503|FG000|COMPLETED|Overall Study||56
10028292|NCT01890642|11152504|FG001|COMPLETED|Overall Study||53
10028293|NCT01890642|11152505|FG002|COMPLETED|Overall Study||96
10028294|NCT01890642|11152503|FG000|NOT COMPLETED|Overall Study||0
10028295|NCT01890642|11152504|FG001|NOT COMPLETED|Overall Study||0
10028296|NCT01890642|11152505|FG002|NOT COMPLETED|Overall Study||0
10028297|NCT01890707|11152515|FG000|STARTED|Overall Study||11
10028298|NCT01890707|11152516|FG001|STARTED|Overall Study||8
10028299|NCT01890707|11152515|FG000|COMPLETED|Overall Study||10
10028300|NCT01890707|11152516|FG001|COMPLETED|Overall Study||7
10028301|NCT01890707|11152515|FG000|NOT COMPLETED|Overall Study||1
10028302|NCT01890707|11152516|FG001|NOT COMPLETED|Overall Study||1
10028303|NCT01890746|11152524|FG000|STARTED|Overall Study||74
10028304|NCT01890746|11152525|FG001|STARTED|Overall Study||74
10028305|NCT01890746|11152524|FG000|COMPLETED|Overall Study||22
10028306|NCT01890746|11152525|FG001|COMPLETED|Overall Study||33
10028307|NCT01890746|11152524|FG000|NOT COMPLETED|Overall Study||52
10028308|NCT01890746|11152525|FG001|NOT COMPLETED|Overall Study||41
10028309|NCT01890785|11152537|FG000|STARTED|First Intervention||5
10028310|NCT01890785|11152538|FG001|STARTED|First Intervention||5
10028311|NCT01890785|11152539|FG002|STARTED|First Intervention||5
10028312|NCT01890785|11152540|FG003|STARTED|First Intervention||5
10028313|NCT01890785|11152541|FG004|STARTED|First Intervention||5
10028314|NCT01890785|11152542|FG005|STARTED|First Intervention||5
10028315|NCT01890785|11152537|FG000|COMPLETED|First Intervention||5
10028316|NCT01890785|11152538|FG001|COMPLETED|First Intervention||5
10028317|NCT01890785|11152539|FG002|COMPLETED|First Intervention||5
10028318|NCT01890785|11152540|FG003|COMPLETED|First Intervention||5
10028319|NCT01890785|11152541|FG004|COMPLETED|First Intervention||5
10028320|NCT01890785|11152542|FG005|COMPLETED|First Intervention||5
10028321|NCT01890785|11152537|FG000|NOT COMPLETED|First Intervention||0
10028322|NCT01890785|11152538|FG001|NOT COMPLETED|First Intervention||0
10028323|NCT01890785|11152539|FG002|NOT COMPLETED|First Intervention||0
10028324|NCT01890785|11152540|FG003|NOT COMPLETED|First Intervention||0
10028325|NCT01890785|11152541|FG004|NOT COMPLETED|First Intervention||0
9704042|NCT02468414|10803710|FG000|Harvesting|Overall Study||1
10028326|NCT01890785|11152542|FG005|NOT COMPLETED|First Intervention||0
10028327|NCT01890785|11152537|FG000|STARTED|Second Intervention||5
10028328|NCT01890785|11152538|FG001|STARTED|Second Intervention||5
10028329|NCT01890785|11152539|FG002|STARTED|Second Intervention||5
10028330|NCT01890785|11152540|FG003|STARTED|Second Intervention||5
10028331|NCT01890785|11152541|FG004|STARTED|Second Intervention||5
10028332|NCT01890785|11152542|FG005|STARTED|Second Intervention||5
10028333|NCT01890785|11152537|FG000|COMPLETED|Second Intervention||5
10028334|NCT01890785|11152538|FG001|COMPLETED|Second Intervention||5
9704043|NCT02468414|10803711|FG001|Harvesting|Overall Study||0
9704044|NCT02468414|10803710|FG000|Implantation|Overall Study||1
10028335|NCT01890785|11152539|FG002|COMPLETED|Second Intervention||5
10028336|NCT01890785|11152540|FG003|COMPLETED|Second Intervention||5
10028337|NCT01890785|11152541|FG004|COMPLETED|Second Intervention||5
10028338|NCT01890785|11152542|FG005|COMPLETED|Second Intervention||5
10028339|NCT01890785|11152537|FG000|NOT COMPLETED|Second Intervention||0
10028340|NCT01890785|11152538|FG001|NOT COMPLETED|Second Intervention||0
10028341|NCT01890785|11152539|FG002|NOT COMPLETED|Second Intervention||0
10028342|NCT01890785|11152540|FG003|NOT COMPLETED|Second Intervention||0
10028343|NCT01890785|11152541|FG004|NOT COMPLETED|Second Intervention||0
10028344|NCT01890785|11152542|FG005|NOT COMPLETED|Second Intervention||0
10028345|NCT01890785|11152537|FG000|STARTED|Third Intervention||5
10028346|NCT01890785|11152538|FG001|STARTED|Third Intervention||5
10028347|NCT01890785|11152539|FG002|STARTED|Third Intervention||5
10028348|NCT01890785|11152540|FG003|STARTED|Third Intervention||5
10028349|NCT01890785|11152541|FG004|STARTED|Third Intervention||5
10028350|NCT01890785|11152542|FG005|STARTED|Third Intervention||5
10028351|NCT01890785|11152537|FG000|COMPLETED|Third Intervention||5
10028352|NCT01890785|11152538|FG001|COMPLETED|Third Intervention||4
10028353|NCT01890785|11152539|FG002|COMPLETED|Third Intervention||5
10028354|NCT01890785|11152540|FG003|COMPLETED|Third Intervention||5
10028355|NCT01890785|11152541|FG004|COMPLETED|Third Intervention||5
10028356|NCT01890785|11152542|FG005|COMPLETED|Third Intervention||5
10028357|NCT01890785|11152537|FG000|NOT COMPLETED|Third Intervention||0
10028358|NCT01890785|11152538|FG001|NOT COMPLETED|Third Intervention||1
10028359|NCT01890785|11152539|FG002|NOT COMPLETED|Third Intervention||0
10028360|NCT01890785|11152540|FG003|NOT COMPLETED|Third Intervention||0
10028361|NCT01890785|11152541|FG004|NOT COMPLETED|Third Intervention||0
10028362|NCT01890785|11152542|FG005|NOT COMPLETED|Third Intervention||0
10028363|NCT01890915|11152553|FG000|STARTED|Overall Study||11
10028364|NCT01890915|11152554|FG001|STARTED|Overall Study||10
10028365|NCT01890915|11152553|FG000|COMPLETED|Overall Study||8
10028366|NCT01890915|11152554|FG001|COMPLETED|Overall Study||9
10028367|NCT01890915|11152553|FG000|NOT COMPLETED|Overall Study||3
10028368|NCT01890915|11152554|FG001|NOT COMPLETED|Overall Study||1
10028369|NCT01890954|11152562|FG000|STARTED|Overall Study||9
10028370|NCT01890954|11152563|FG001|STARTED|Overall Study||8
10028371|NCT01890954|11152562|FG000|COMPLETED|Overall Study||8
10028372|NCT01890954|11152563|FG001|COMPLETED|Overall Study||8
10028373|NCT01890954|11152562|FG000|NOT COMPLETED|Overall Study||1
10028374|NCT01890954|11152563|FG001|NOT COMPLETED|Overall Study||0
10028375|NCT01890967|11152575|FG000|STARTED|Overall Study||88
10028376|NCT01890967|11152576|FG001|STARTED|Overall Study||88
10028377|NCT01890967|11152577|FG002|STARTED|Overall Study||88
10028378|NCT01890967|11152578|FG003|STARTED|Overall Study||88
10028379|NCT01890967|11152579|FG004|STARTED|Overall Study||87
10028380|NCT01890967|11152580|FG005|STARTED|Overall Study||88
10028381|NCT01890967|11152575|FG000|Received at Least One Dose of Study Drug|Overall Study||87
10028382|NCT01890967|11152576|FG001|Received at Least One Dose of Study Drug|Overall Study||87
10028383|NCT01890967|11152577|FG002|Received at Least One Dose of Study Drug|Overall Study||86
10028384|NCT01890967|11152578|FG003|Received at Least One Dose of Study Drug|Overall Study||86
10028385|NCT01890967|11152579|FG004|Received at Least One Dose of Study Drug|Overall Study||86
10028386|NCT01890967|11152580|FG005|Received at Least One Dose of Study Drug|Overall Study||87
10028387|NCT01890967|11152575|FG000|COMPLETED|Overall Study||78
10028388|NCT01890967|11152576|FG001|COMPLETED|Overall Study||77
10028389|NCT01890967|11152577|FG002|COMPLETED|Overall Study||78
10028390|NCT01890967|11152578|FG003|COMPLETED|Overall Study||77
10028391|NCT01890967|11152579|FG004|COMPLETED|Overall Study||77
10028392|NCT01890967|11152580|FG005|COMPLETED|Overall Study||75
10028393|NCT01890967|11152575|FG000|NOT COMPLETED|Overall Study||10
10028394|NCT01890967|11152576|FG001|NOT COMPLETED|Overall Study||11
10028395|NCT01890967|11152577|FG002|NOT COMPLETED|Overall Study||10
10028396|NCT01890967|11152578|FG003|NOT COMPLETED|Overall Study||11
10028397|NCT01890967|11152579|FG004|NOT COMPLETED|Overall Study||10
9704045|NCT02468414|10803711|FG001|Implantation|Overall Study||0
9704046|NCT02468414|10803710|FG000|Safety Follow-up|Overall Study||0
9704047|NCT02468414|10803711|FG001|Safety Follow-up|Overall Study||0
9704048|NCT02468414|10803710|FG000|COMPLETED|Overall Study||0
9704049|NCT02468414|10803711|FG001|COMPLETED|Overall Study||0
9704050|NCT02468414|10803710|FG000|NOT COMPLETED|Overall Study||3
9704051|NCT02468414|10803711|FG001|NOT COMPLETED|Overall Study||0
9704052|NCT02462876|10803717|FG000|STARTED|Overall Study||60
10028398|NCT01890967|11152580|FG005|NOT COMPLETED|Overall Study||13
9704053|NCT02462876|10803717|FG000|COMPLETED|Overall Study||33
10028399|NCT01891305|11152603|FG000|STARTED|Overall Study||12
10028400|NCT01891305|11152604|FG001|STARTED|Overall Study||12
10028401|NCT01891305|11152605|FG002|STARTED|Overall Study||14
10028402|NCT01891305|11152606|FG003|STARTED|Overall Study||12
10028403|NCT01891305|11152603|FG000|COMPLETED|Overall Study||9
10028404|NCT01891305|11152604|FG001|COMPLETED|Overall Study||11
10028405|NCT01891305|11152605|FG002|COMPLETED|Overall Study||11
10028406|NCT01891305|11152606|FG003|COMPLETED|Overall Study||12
10028407|NCT01891305|11152603|FG000|NOT COMPLETED|Overall Study||3
10028408|NCT01891305|11152604|FG001|NOT COMPLETED|Overall Study||1
10028409|NCT01891305|11152605|FG002|NOT COMPLETED|Overall Study||3
10028410|NCT01891305|11152606|FG003|NOT COMPLETED|Overall Study||0
10028411|NCT01891331|11152620|FG000|STARTED|Overall Study||14
10028412|NCT01891331|11152621|FG001|STARTED|Overall Study||12
10028413|NCT01891331|11152622|FG002|STARTED|Overall Study||14
9704054|NCT02462876|10803717|FG000|NOT COMPLETED|Overall Study||27
9704055|NCT02332590|10803723|FG000|STARTED|DB Period (up to 24 Weeks)||185
9704056|NCT02332590|10803724|FG001|STARTED|DB Period (up to 24 Weeks)||184
9704057|NCT02332590|10803723|FG000|Treated|DB Period (up to 24 Weeks)||184
9704058|NCT02332590|10803724|FG001|Treated|DB Period (up to 24 Weeks)||184
9704059|NCT02332590|10803723|FG000|COMPLETED|DB Period (up to 24 Weeks)|155 participants entered OLE period and 1 did not enroll.|156
9704060|NCT02332590|10803724|FG001|COMPLETED|DB Period (up to 24 Weeks)||165
10028414|NCT01891331|11152623|FG003|STARTED|Overall Study||15
10028415|NCT01891331|11152620|FG000|COMPLETED|Overall Study||12
10028416|NCT01891331|11152621|FG001|COMPLETED|Overall Study||10
10028417|NCT01891331|11152622|FG002|COMPLETED|Overall Study||13
10028418|NCT01891331|11152623|FG003|COMPLETED|Overall Study||13
10028419|NCT01891331|11152620|FG000|NOT COMPLETED|Overall Study||2
10028420|NCT01891331|11152621|FG001|NOT COMPLETED|Overall Study||2
10028421|NCT01891331|11152622|FG002|NOT COMPLETED|Overall Study||1
10028422|NCT01891331|11152623|FG003|NOT COMPLETED|Overall Study||2
10028423|NCT01891357|11152633|FG000|STARTED|Overall Study||64
10028424|NCT01891357|11152633|FG000|COMPLETED|Overall Study||61
10028425|NCT01891357|11152633|FG000|NOT COMPLETED|Overall Study||3
10028426|NCT01891669|11152647|FG000|STARTED|Overall Study||2
10028427|NCT01891669|11152648|FG001|STARTED|Overall Study||2
10028428|NCT01891669|11152649|FG002|STARTED|Overall Study||2
10028429|NCT01891669|11152650|FG003|STARTED|Overall Study||2
10028430|NCT01891669|11152651|FG004|STARTED|Overall Study||2
10028431|NCT01891669|11152652|FG005|STARTED|Overall Study||2
10028432|NCT01891669|11152653|FG006|STARTED|Overall Study||2
10028433|NCT01891669|11152654|FG007|STARTED|Overall Study||6
10028434|NCT01891669|11152655|FG008|STARTED|Overall Study||3
10028435|NCT01891669|11152656|FG009|STARTED|Overall Study||3
10028436|NCT01891669|11152647|FG000|COMPLETED|Overall Study||0
10028437|NCT01891669|11152648|FG001|COMPLETED|Overall Study||1
10028438|NCT01891669|11152649|FG002|COMPLETED|Overall Study||2
10028439|NCT01891669|11152650|FG003|COMPLETED|Overall Study||2
10028440|NCT01891669|11152651|FG004|COMPLETED|Overall Study||2
10028441|NCT01891669|11152652|FG005|COMPLETED|Overall Study||2
10028442|NCT01891669|11152653|FG006|COMPLETED|Overall Study||1
10028443|NCT01891669|11152654|FG007|COMPLETED|Overall Study||2
10028444|NCT01891669|11152655|FG008|COMPLETED|Overall Study||2
10028445|NCT01891669|11152656|FG009|COMPLETED|Overall Study||1
10028446|NCT01891669|11152647|FG000|NOT COMPLETED|Overall Study||2
10028447|NCT01891669|11152648|FG001|NOT COMPLETED|Overall Study||1
10028448|NCT01891669|11152649|FG002|NOT COMPLETED|Overall Study||0
10028449|NCT01891669|11152650|FG003|NOT COMPLETED|Overall Study||0
10028450|NCT01891669|11152651|FG004|NOT COMPLETED|Overall Study||0
10028451|NCT01891669|11152652|FG005|NOT COMPLETED|Overall Study||0
10028452|NCT01891669|11152653|FG006|NOT COMPLETED|Overall Study||1
10028453|NCT01891669|11152654|FG007|NOT COMPLETED|Overall Study||4
10028454|NCT01891669|11152655|FG008|NOT COMPLETED|Overall Study||1
10028455|NCT01891669|11152656|FG009|NOT COMPLETED|Overall Study||2
10028456|NCT01891721|11152690|FG000|STARTED|Overall Study||39
10028457|NCT01891721|11152691|FG001|STARTED|Overall Study||40
10028458|NCT01891721|11152692|FG002|STARTED|Overall Study||20
10028459|NCT01891721|11152690|FG000|COMPLETED|Overall Study||29
10028460|NCT01891721|11152691|FG001|COMPLETED|Overall Study||35
10028461|NCT01891721|11152692|FG002|COMPLETED|Overall Study||19
10028462|NCT01891721|11152690|FG000|NOT COMPLETED|Overall Study||10
10028463|NCT01891721|11152691|FG001|NOT COMPLETED|Overall Study||5
10028464|NCT01891721|11152692|FG002|NOT COMPLETED|Overall Study||1
10028465|NCT01891734|11152702|FG000|STARTED|Overall Study||17
10028466|NCT01891734|11152703|FG001|STARTED|Overall Study||16
10028467|NCT01891734|11152702|FG000|COMPLETED|Overall Study||14
10028468|NCT01891734|11152703|FG001|COMPLETED|Overall Study||13
10028469|NCT01891734|11152702|FG000|NOT COMPLETED|Overall Study||3
10028470|NCT01891734|11152703|FG001|NOT COMPLETED|Overall Study||3
10028471|NCT01891864|11152713|FG000|STARTED|Treatment Period 1||264
9704061|NCT02332590|10803723|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29
9704062|NCT02332590|10803724|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19
9704063|NCT02332590|10803723|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155
9704064|NCT02332590|10803724|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165
9731905|NCT00137280|10831874|FG000|STARTED|Overall Study||389
9848159|NCT00857532|10960814|FG000|NOT COMPLETED|Overall Study||0
10028472|NCT01891864|11152714|FG001|STARTED|Treatment Period 1||267
10028473|NCT01891864|11152715|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10028474|NCT01891864|11152716|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10028475|NCT01891864|11152717|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10028476|NCT01891864|11152718|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10028477|NCT01891864|11152713|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
10028478|NCT01891864|11152714|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
10028479|NCT01891864|11152715|FG002|COMPLETED|Treatment Period 1||0
10028480|NCT01891864|11152716|FG003|COMPLETED|Treatment Period 1||0
10028481|NCT01891864|11152717|FG004|COMPLETED|Treatment Period 1||0
10028482|NCT01891864|11152718|FG005|COMPLETED|Treatment Period 1||0
10028483|NCT01891864|11152713|FG000|NOT COMPLETED|Treatment Period 1||8
10028484|NCT01891864|11152714|FG001|NOT COMPLETED|Treatment Period 1||12
9704065|NCT02332590|10803723|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108
9704066|NCT02332590|10803724|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120
9704067|NCT02332590|10803723|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47
9704068|NCT02332590|10803724|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45
9704069|NCT02255656|10803732|FG000|STARTED|Overall Study||1062
9704070|NCT02255656|10803732|FG000|COMPLETED|Overall Study||592
9704071|NCT02255656|10803732|FG000|NOT COMPLETED|Overall Study||470
9704072|NCT02134028|10803751|FG000|STARTED|Overall Study||111
9704073|NCT02134028|10803752|FG001|STARTED|Overall Study||421
9704074|NCT02134028|10803753|FG002|STARTED|Overall Study||517
9704075|NCT02134028|10803754|FG003|STARTED|Overall Study||1013
9704076|NCT02134028|10803755|FG004|STARTED|Overall Study||97
9704077|NCT02134028|10803756|FG005|STARTED|Overall Study||90
9704078|NCT02134028|10803757|FG006|STARTED|Overall Study||19
9704079|NCT02134028|10803758|FG007|STARTED|Overall Study||14
9704080|NCT02134028|10803751|FG000|COMPLETED|Overall Study||102
9704081|NCT02134028|10803752|FG001|COMPLETED|Overall Study||379
9704082|NCT02134028|10803753|FG002|COMPLETED|Overall Study||465
9704083|NCT02134028|10803754|FG003|COMPLETED|Overall Study||908
9704084|NCT02134028|10803755|FG004|COMPLETED|Overall Study||83
9704085|NCT02134028|10803756|FG005|COMPLETED|Overall Study||76
9704086|NCT02134028|10803757|FG006|COMPLETED|Overall Study||15
9704087|NCT02134028|10803758|FG007|COMPLETED|Overall Study||11
9704088|NCT02134028|10803751|FG000|NOT COMPLETED|Overall Study||9
9704089|NCT02134028|10803752|FG001|NOT COMPLETED|Overall Study||42
9704090|NCT02134028|10803753|FG002|NOT COMPLETED|Overall Study||52
10028485|NCT01891864|11152715|FG002|NOT COMPLETED|Treatment Period 1||0
10028486|NCT01891864|11152716|FG003|NOT COMPLETED|Treatment Period 1||0
10028487|NCT01891864|11152717|FG004|NOT COMPLETED|Treatment Period 1||0
9704091|NCT02134028|10803754|FG003|NOT COMPLETED|Overall Study||105
9704092|NCT02134028|10803755|FG004|NOT COMPLETED|Overall Study||14
9704093|NCT02134028|10803756|FG005|NOT COMPLETED|Overall Study||14
9704094|NCT02134028|10803757|FG006|NOT COMPLETED|Overall Study||4
9704095|NCT02134028|10803758|FG007|NOT COMPLETED|Overall Study||3
9704096|NCT02037620|10803778|FG000|STARTED|Overall Study||5
9704097|NCT02037620|10803778|FG000|COMPLETED|Overall Study||4
9704098|NCT02037620|10803778|FG000|NOT COMPLETED|Overall Study||1
9728871|NCT00114738|10828451|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
9728872|NCT00114738|10828452|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
9728873|NCT00114738|10828453|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
9728874|NCT00114738|10828451|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
9728875|NCT00114738|10828452|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
9728876|NCT00114738|10828453|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
9728877|NCT00114738|10828451|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51
9728878|NCT00114738|10828452|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0
9728879|NCT00114738|10828453|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0
9728880|NCT00114738|10828451|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
9728881|NCT00114738|10828452|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
9728882|NCT00114738|10828453|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
9728883|NCT00114738|10828451|FG000|STARTED|Screening for Randomization||51
9728884|NCT00114738|10828452|FG001|STARTED|Screening for Randomization||0
9728885|NCT00114738|10828453|FG002|STARTED|Screening for Randomization||0
9728886|NCT00114738|10828451|FG000|COMPLETED|Screening for Randomization||30
9728887|NCT00114738|10828452|FG001|COMPLETED|Screening for Randomization||0
9728888|NCT00114738|10828453|FG002|COMPLETED|Screening for Randomization||0
9728889|NCT00114738|10828451|FG000|NOT COMPLETED|Screening for Randomization||21
9728890|NCT00114738|10828452|FG001|NOT COMPLETED|Screening for Randomization||0
9728891|NCT00114738|10828453|FG002|NOT COMPLETED|Screening for Randomization||0
10028488|NCT01891864|11152718|FG005|NOT COMPLETED|Treatment Period 1||0
10028489|NCT01891864|11152713|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10028490|NCT01891864|11152714|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10028491|NCT01891864|11152715|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
10028492|NCT01891864|11152716|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
10028493|NCT01891864|11152717|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
10028494|NCT01891864|11152718|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
10028495|NCT01891864|11152713|FG000|COMPLETED|Treatment Period 2||0
9728892|NCT00114738|10828451|FG000|STARTED|Randomization||0
9728893|NCT00114738|10828452|FG001|STARTED|Randomization||14
9728894|NCT00114738|10828453|FG002|STARTED|Randomization||16
9728895|NCT00114738|10828451|FG000|COMPLETED|Randomization||0
9728896|NCT00114738|10828452|FG001|COMPLETED|Randomization||14
9728897|NCT00114738|10828453|FG002|COMPLETED|Randomization||16
9728898|NCT00114738|10828451|FG000|NOT COMPLETED|Randomization||0
9728899|NCT00114738|10828452|FG001|NOT COMPLETED|Randomization||0
9728900|NCT00114738|10828453|FG002|NOT COMPLETED|Randomization||0
9728901|NCT00114777|10828463|FG000|STARTED|Randomization to Month 36||184
9728902|NCT00114777|10828464|FG001|STARTED|Randomization to Month 36||175
9728903|NCT00114777|10828465|FG002|STARTED|Randomization to Month 36||184
10115477|NCT02526160|11246304|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3
10115478|NCT02526160|11246305|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4
10028496|NCT01891864|11152714|FG001|COMPLETED|Treatment Period 2||0
10028497|NCT01891864|11152715|FG002|COMPLETED|Treatment Period 2||143
10028498|NCT01891864|11152716|FG003|COMPLETED|Treatment Period 2||142
10028499|NCT01891864|11152717|FG004|COMPLETED|Treatment Period 2||96
10028500|NCT01891864|11152718|FG005|COMPLETED|Treatment Period 2||91
10028501|NCT01891864|11152713|FG000|NOT COMPLETED|Treatment Period 2||0
10028502|NCT01891864|11152714|FG001|NOT COMPLETED|Treatment Period 2||0
10028503|NCT01891864|11152715|FG002|NOT COMPLETED|Treatment Period 2||7
10028504|NCT01891864|11152716|FG003|NOT COMPLETED|Treatment Period 2||9
10028505|NCT01891864|11152717|FG004|NOT COMPLETED|Treatment Period 2||4
10028506|NCT01891864|11152718|FG005|NOT COMPLETED|Treatment Period 2||5
10028507|NCT01891864|11152713|FG000|STARTED|Extension Period||0
10028508|NCT01891864|11152714|FG001|STARTED|Extension Period||0
10028509|NCT01891864|11152715|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
9704225|NCT01900444|10803810|FG000|STARTED|Overall Study||119
9704226|NCT01900444|10803810|FG000|COMPLETED|Overall Study||116
9704227|NCT01900444|10803810|FG000|NOT COMPLETED|Overall Study||3
9704228|NCT01887912|10803816|FG000|STARTED|Overall Study||6201
9704229|NCT01887912|10803817|FG001|STARTED|Overall Study||3101
9704230|NCT01887912|10803816|FG000|Safety Population|Overall Study||6113
9704231|NCT01887912|10803817|FG001|Safety Population|Overall Study||3057
9704232|NCT01887912|10803816|FG000|COMPLETED|Overall Study||4809
9704233|NCT01887912|10803817|FG001|COMPLETED|Overall Study||2370
9704234|NCT01887912|10803816|FG000|NOT COMPLETED|Overall Study||1392
9704235|NCT01887912|10803817|FG001|NOT COMPLETED|Overall Study||731
9704236|NCT01751126|10803826|FG000|STARTED|Period I||57
9704237|NCT01751126|10803827|FG001|STARTED|Period I||54
9704238|NCT01751126|10803828|FG002|STARTED|Period I||58
9704239|NCT01751126|10803826|FG000|COMPLETED|Period I||51
9704240|NCT01751126|10803827|FG001|COMPLETED|Period I||43
10028510|NCT01891864|11152716|FG003|STARTED|Extension Period||142
10028511|NCT01891864|11152717|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
9704241|NCT01751126|10803828|FG002|COMPLETED|Period I||49
9704242|NCT01751126|10803826|FG000|NOT COMPLETED|Period I||6
9704243|NCT01751126|10803827|FG001|NOT COMPLETED|Period I||11
9704244|NCT01751126|10803828|FG002|NOT COMPLETED|Period I||9
9704245|NCT01751126|10803826|FG000|STARTED|Period II||72
9704246|NCT01751126|10803827|FG001|STARTED|Period II||70
9704247|NCT01751126|10803828|FG002|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (High or Low dose) for a safety 8-month follow-up period.|0
9704248|NCT01751126|10803826|FG000|COMPLETED|Period II||72
9704249|NCT01751126|10803827|FG001|COMPLETED|Period II||70
9704250|NCT01751126|10803828|FG002|COMPLETED|Period II||0
9704251|NCT01751126|10803826|FG000|NOT COMPLETED|Period II||0
9704252|NCT01751126|10803827|FG001|NOT COMPLETED|Period II||0
9704253|NCT01751126|10803828|FG002|NOT COMPLETED|Period II||0
9704260|NCT01437423|10803860|FG000|STARTED|Overall Study||662
9704261|NCT01437423|10803860|FG000|COMPLETED|Overall Study||647
9704262|NCT01437423|10803860|FG000|NOT COMPLETED|Overall Study||15
9704263|NCT01410890|10803866|FG000|STARTED|Overall Study||10
9704264|NCT01410890|10803867|FG001|STARTED|Overall Study||11
9704265|NCT01410890|10803866|FG000|Treated|Overall Study||10
9704266|NCT01410890|10803867|FG001|Treated|Overall Study||10
9704267|NCT01410890|10803866|FG000|COMPLETED|Overall Study||10
9704268|NCT01410890|10803867|FG001|COMPLETED|Overall Study||10
9704269|NCT01410890|10803866|FG000|NOT COMPLETED|Overall Study||0
9704270|NCT01410890|10803867|FG001|NOT COMPLETED|Overall Study||1
9704283|NCT01190228|10803887|FG000|STARTED|Overall Study||349
9704284|NCT01190228|10803888|FG001|STARTED|Overall Study||46
9704285|NCT01190228|10803889|FG002|STARTED|Overall Study||59
9704286|NCT01190228|10803887|FG000|COMPLETED|Overall Study||344
9704287|NCT01190228|10803888|FG001|COMPLETED|Overall Study||46
9704288|NCT01190228|10803889|FG002|COMPLETED|Overall Study||59
9704289|NCT01190228|10803887|FG000|NOT COMPLETED|Overall Study||5
9704290|NCT01190228|10803888|FG001|NOT COMPLETED|Overall Study||0
9704291|NCT01190228|10803889|FG002|NOT COMPLETED|Overall Study||0
9704292|NCT01146652|10803901|FG000|STARTED|Overall Study||1912
9704293|NCT01146652|10803902|FG001|STARTED|Overall Study||111
9704294|NCT01146652|10803901|FG000|Treated|Overall Study||1910
9704295|NCT01146652|10803902|FG001|Treated|Overall Study||111
9704296|NCT01146652|10803901|FG000|Enrolled in the Sub-study|Overall Study||110
9704297|NCT01146652|10803902|FG001|Enrolled in the Sub-study|Overall Study||14
9704298|NCT01146652|10803901|FG000|Discontinued From the Sub-study|Overall Study||1
9704299|NCT01146652|10803902|FG001|Discontinued From the Sub-study|Overall Study||2
9704300|NCT01146652|10803901|FG000|Switched Back to Main Study|Overall Study||108
9704301|NCT01146652|10803902|FG001|Switched Back to Main Study|Overall Study||13
9704302|NCT01146652|10803901|FG000|COMPLETED|Overall Study||961
9704303|NCT01146652|10803902|FG001|COMPLETED|Overall Study||66
10028512|NCT01891864|11152718|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
10028513|NCT01891864|11152713|FG000|COMPLETED|Extension Period||0
10028514|NCT01891864|11152714|FG001|COMPLETED|Extension Period||0
10028515|NCT01891864|11152715|FG002|COMPLETED|Extension Period||132
10028516|NCT01891864|11152716|FG003|COMPLETED|Extension Period||137
10028517|NCT01891864|11152717|FG004|COMPLETED|Extension Period||88
10028518|NCT01891864|11152718|FG005|COMPLETED|Extension Period||90
10028519|NCT01891864|11152713|FG000|NOT COMPLETED|Extension Period||0
10028520|NCT01891864|11152714|FG001|NOT COMPLETED|Extension Period||0
10028521|NCT01891864|11152715|FG002|NOT COMPLETED|Extension Period||8
10028522|NCT01891864|11152716|FG003|NOT COMPLETED|Extension Period||5
10028523|NCT01891864|11152717|FG004|NOT COMPLETED|Extension Period||7
9704304|NCT01146652|10803901|FG000|NOT COMPLETED|Overall Study||951
9704305|NCT01146652|10803902|FG001|NOT COMPLETED|Overall Study||45
10028524|NCT01891864|11152718|FG005|NOT COMPLETED|Extension Period||0
10028525|NCT01891890|11152733|FG000|STARTED|Overall Study||24
10028526|NCT01891890|11152734|FG001|STARTED|Overall Study||27
10028527|NCT01891890|11152735|FG002|STARTED|Overall Study||21
10028528|NCT01891890|11152733|FG000|COMPLETED|Overall Study||17
9704306|NCT01049035|10803922|FG000|STARTED|Overall Study||107
9704307|NCT01049035|10803923|FG001|STARTED|Overall Study||108
9704308|NCT01049035|10803924|FG002|STARTED|Overall Study||107
9704309|NCT01049035|10803925|FG003|STARTED|Overall Study||75
9704310|NCT01049035|10803926|FG004|STARTED|Overall Study||75
10028529|NCT01891890|11152734|FG001|COMPLETED|Overall Study||24
9704311|NCT01049035|10803927|FG005|STARTED|Overall Study||54
9704312|NCT01049035|10803928|FG006|STARTED|Overall Study||54
9704313|NCT01049035|10803922|FG000|Safety Population|Overall Study||104
9704314|NCT01049035|10803923|FG001|Safety Population|Overall Study||102
9704315|NCT01049035|10803924|FG002|Safety Population|Overall Study||100
9704316|NCT01049035|10803925|FG003|Safety Population|Overall Study||74
9704317|NCT01049035|10803926|FG004|Safety Population|Overall Study||70
9704318|NCT01049035|10803927|FG005|Safety Population|Overall Study||52
9704319|NCT01049035|10803928|FG006|Safety Population|Overall Study||49
9704320|NCT01049035|10803922|FG000|COMPLETED|Overall Study||74
9704321|NCT01049035|10803923|FG001|COMPLETED|Overall Study||87
9704322|NCT01049035|10803924|FG002|COMPLETED|Overall Study||80
9704323|NCT01049035|10803925|FG003|COMPLETED|Overall Study||64
9704324|NCT01049035|10803926|FG004|COMPLETED|Overall Study||71
9704325|NCT01049035|10803927|FG005|COMPLETED|Overall Study||42
9704326|NCT01049035|10803928|FG006|COMPLETED|Overall Study||39
9704327|NCT01049035|10803922|FG000|NOT COMPLETED|Overall Study||33
9704328|NCT01049035|10803923|FG001|NOT COMPLETED|Overall Study||21
9704329|NCT01049035|10803924|FG002|NOT COMPLETED|Overall Study||27
9704330|NCT01049035|10803925|FG003|NOT COMPLETED|Overall Study||11
9704331|NCT01049035|10803926|FG004|NOT COMPLETED|Overall Study||4
9704332|NCT01049035|10803927|FG005|NOT COMPLETED|Overall Study||12
9704333|NCT01049035|10803928|FG006|NOT COMPLETED|Overall Study||15
9704334|NCT00728884|10803954|FG000|STARTED|Implant Placement Surgery||162
9704335|NCT00728884|10803954|FG000|COMPLETED|Implant Placement Surgery||162
9704336|NCT00728884|10803954|FG000|NOT COMPLETED|Implant Placement Surgery||0
9704337|NCT00728884|10803954|FG000|STARTED|Permanent Prosthesis Placement||162
9704338|NCT00728884|10803954|FG000|COMPLETED|Permanent Prosthesis Placement||149
9704339|NCT00728884|10803954|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13
9704340|NCT00728884|10803954|FG000|STARTED|One Year Post Placement Follow-up||149
9704341|NCT00728884|10803954|FG000|COMPLETED|One Year Post Placement Follow-up||145
9704342|NCT00728884|10803954|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4
9704343|NCT00728884|10803954|FG000|STARTED|Two Year Post Placement Follow-up||145
9704344|NCT00728884|10803954|FG000|COMPLETED|Two Year Post Placement Follow-up||145
9704345|NCT00728884|10803954|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
9704346|NCT00727090|10803960|FG000|STARTED|Overall Study||3
9704347|NCT00727090|10803961|FG001|STARTED|Overall Study||3
9704348|NCT00727090|10803960|FG000|COMPLETED|Overall Study||3
9704349|NCT00727090|10803961|FG001|COMPLETED|Overall Study||3
9704350|NCT00727090|10803960|FG000|NOT COMPLETED|Overall Study||0
9848160|NCT00857545|10960823|FG000|STARTED|Overall Study||86
9848161|NCT00857545|10960824|FG001|STARTED|Overall Study||85
9848162|NCT00857545|10960823|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86
9848163|NCT00857545|10960824|FG001|COMPLETED|Overall Study||85
9848164|NCT00857545|10960823|FG000|NOT COMPLETED|Overall Study||0
10028530|NCT01891890|11152735|FG002|COMPLETED|Overall Study||14
10028531|NCT01891890|11152733|FG000|NOT COMPLETED|Overall Study||7
10028532|NCT01891890|11152734|FG001|NOT COMPLETED|Overall Study||3
10028533|NCT01891890|11152735|FG002|NOT COMPLETED|Overall Study||7
10028534|NCT01891968|11152743|FG000|STARTED|Overall Study||15
10028535|NCT01891968|11152743|FG000|COMPLETED|Overall Study||15
10028536|NCT01891968|11152743|FG000|NOT COMPLETED|Overall Study||0
10028537|NCT01892007|11152749|FG000|STARTED|Overall Study||27
10028538|NCT01892007|11152750|FG001|STARTED|Overall Study||30
10028539|NCT01892007|11152749|FG000|COMPLETED|Overall Study||27
10028540|NCT01892007|11152750|FG001|COMPLETED|Overall Study||30
10028541|NCT01892007|11152749|FG000|NOT COMPLETED|Overall Study||0
10028542|NCT01892007|11152750|FG001|NOT COMPLETED|Overall Study||0
10028543|NCT01892020|11152756|FG000|STARTED|Period 1||81
10028544|NCT01892020|11152757|FG001|STARTED|Period 1||80
10028545|NCT01892020|11152756|FG000|COMPLETED|Period 1||78
10028546|NCT01892020|11152757|FG001|COMPLETED|Period 1||74
10028547|NCT01892020|11152756|FG000|NOT COMPLETED|Period 1||3
10028548|NCT01892020|11152757|FG001|NOT COMPLETED|Period 1||6
10028549|NCT01892020|11152756|FG000|STARTED|Period 2||78
10028550|NCT01892020|11152757|FG001|STARTED|Period 2||74
10028551|NCT01892020|11152756|FG000|COMPLETED|Period 2||77
10028552|NCT01892020|11152757|FG001|COMPLETED|Period 2||74
10028553|NCT01892020|11152756|FG000|NOT COMPLETED|Period 2||1
10028554|NCT01892020|11152757|FG001|NOT COMPLETED|Period 2||0
10028555|NCT01892163|11152765|FG000|STARTED|Overall Study||50
10028556|NCT01892163|11152766|FG001|STARTED|Overall Study||50
10028557|NCT01892163|11152765|FG000|COMPLETED|Overall Study||48
10028558|NCT01892163|11152766|FG001|COMPLETED|Overall Study||49
10028559|NCT01892163|11152765|FG000|NOT COMPLETED|Overall Study||2
10028560|NCT01892163|11152766|FG001|NOT COMPLETED|Overall Study||1
10028561|NCT01892189|11152781|FG000|STARTED|First Intervention Period (1 Day)||3
10028562|NCT01892189|11152782|FG001|STARTED|First Intervention Period (1 Day)||3
10028563|NCT01892189|11152783|FG002|STARTED|First Intervention Period (1 Day)||3
10028564|NCT01892189|11152784|FG003|STARTED|First Intervention Period (1 Day)||3
10028565|NCT01892189|11152785|FG004|STARTED|First Intervention Period (1 Day)||3
10028566|NCT01892189|11152786|FG005|STARTED|First Intervention Period (1 Day)||3
9704351|NCT00727090|10803961|FG001|NOT COMPLETED|Overall Study||0
9704352|NCT00726063|10803971|FG000|STARTED|Overall Study|Number of implants= 239|122
10028567|NCT01892189|11152787|FG006|STARTED|First Intervention Period (1 Day)||3
10028568|NCT01892189|11152788|FG007|STARTED|First Intervention Period (1 Day)||3
10028569|NCT01892189|11152789|FG008|STARTED|First Intervention Period (1 Day)||3
10028570|NCT01892189|11152781|FG000|COMPLETED|First Intervention Period (1 Day)||3
10028571|NCT01892189|11152782|FG001|COMPLETED|First Intervention Period (1 Day)||3
9704353|NCT00726063|10803972|FG001|STARTED|Overall Study|Number of implants= 246|119
9704354|NCT00726063|10803971|FG000|COMPLETED|Overall Study|Number of implants =230|113
9704355|NCT00726063|10803972|FG001|COMPLETED|Overall Study|Number of implants = 239|112
9704356|NCT00726063|10803971|FG000|NOT COMPLETED|Overall Study||9
9704357|NCT00726063|10803972|FG001|NOT COMPLETED|Overall Study||7
9704358|NCT00725049|10803980|FG000|STARTED|Overall Study||17
9704359|NCT00725049|10803981|FG001|STARTED|Overall Study||20
9704360|NCT00725049|10803980|FG000|COMPLETED|Overall Study||17
9704361|NCT00725049|10803981|FG001|COMPLETED|Overall Study||20
9704362|NCT00725049|10803980|FG000|NOT COMPLETED|Overall Study||0
9704363|NCT00725049|10803981|FG001|NOT COMPLETED|Overall Study||0
9704364|NCT00713206|10803989|FG000|STARTED|Overall Study||65
9704365|NCT00713206|10803990|FG001|STARTED|Overall Study||57
9704366|NCT00713206|10803989|FG000|COMPLETED|Overall Study||60
9704367|NCT00713206|10803990|FG001|COMPLETED|Overall Study||53
9704368|NCT00713206|10803989|FG000|NOT COMPLETED|Overall Study||5
9704369|NCT00713206|10803990|FG001|NOT COMPLETED|Overall Study||4
10028572|NCT01892189|11152783|FG002|COMPLETED|First Intervention Period (1 Day)||3
10028573|NCT01892189|11152784|FG003|COMPLETED|First Intervention Period (1 Day)||3
10028574|NCT01892189|11152785|FG004|COMPLETED|First Intervention Period (1 Day)||3
10028575|NCT01892189|11152786|FG005|COMPLETED|First Intervention Period (1 Day)||3
10028576|NCT01892189|11152787|FG006|COMPLETED|First Intervention Period (1 Day)||3
10028577|NCT01892189|11152788|FG007|COMPLETED|First Intervention Period (1 Day)||3
10028578|NCT01892189|11152789|FG008|COMPLETED|First Intervention Period (1 Day)||3
10028579|NCT01892189|11152781|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
10028580|NCT01892189|11152782|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
10028581|NCT01892189|11152783|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
10028582|NCT01892189|11152784|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
10028583|NCT01892189|11152785|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
10028584|NCT01892189|11152786|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
10028585|NCT01892189|11152787|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
10028586|NCT01892189|11152788|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
10028587|NCT01892189|11152789|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
10028588|NCT01892189|11152781|FG000|STARTED|Washout Period 1 (7 Days)||3
10028589|NCT01892189|11152782|FG001|STARTED|Washout Period 1 (7 Days)||3
10028590|NCT01892189|11152783|FG002|STARTED|Washout Period 1 (7 Days)||3
10028591|NCT01892189|11152784|FG003|STARTED|Washout Period 1 (7 Days)||3
10028592|NCT01892189|11152785|FG004|STARTED|Washout Period 1 (7 Days)||3
10028593|NCT01892189|11152786|FG005|STARTED|Washout Period 1 (7 Days)||3
10028594|NCT01892189|11152787|FG006|STARTED|Washout Period 1 (7 Days)||3
10028595|NCT01892189|11152788|FG007|STARTED|Washout Period 1 (7 Days)||3
10028596|NCT01892189|11152789|FG008|STARTED|Washout Period 1 (7 Days)||3
10028597|NCT01892189|11152781|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10028598|NCT01892189|11152782|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10028599|NCT01892189|11152783|FG002|COMPLETED|Washout Period 1 (7 Days)||1
10028600|NCT01892189|11152784|FG003|COMPLETED|Washout Period 1 (7 Days)||2
10028601|NCT01892189|11152785|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10028602|NCT01892189|11152786|FG005|COMPLETED|Washout Period 1 (7 Days)||2
10028603|NCT01892189|11152787|FG006|COMPLETED|Washout Period 1 (7 Days)||2
10028604|NCT01892189|11152788|FG007|COMPLETED|Washout Period 1 (7 Days)||3
10028605|NCT01892189|11152789|FG008|COMPLETED|Washout Period 1 (7 Days)||1
10028606|NCT01892189|11152781|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10028607|NCT01892189|11152782|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10028608|NCT01892189|11152783|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2
10028609|NCT01892189|11152784|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
10028610|NCT01892189|11152785|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10028611|NCT01892189|11152786|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
10028612|NCT01892189|11152787|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1
10028613|NCT01892189|11152788|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
10028614|NCT01892189|11152789|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2
10028615|NCT01892189|11152781|FG000|STARTED|Second Intervention Period (1 Day)||3
10028616|NCT01892189|11152782|FG001|STARTED|Second Intervention Period (1 Day)||3
10028617|NCT01892189|11152783|FG002|STARTED|Second Intervention Period (1 Day)||1
10028618|NCT01892189|11152784|FG003|STARTED|Second Intervention Period (1 Day)||2
10028619|NCT01892189|11152785|FG004|STARTED|Second Intervention Period (1 Day)||3
10081439|NCT02260804|11209941|FG001|NOT COMPLETED|Induction Study Period||0
10028620|NCT01892189|11152786|FG005|STARTED|Second Intervention Period (1 Day)||2
10028621|NCT01892189|11152787|FG006|STARTED|Second Intervention Period (1 Day)||2
10028622|NCT01892189|11152788|FG007|STARTED|Second Intervention Period (1 Day)||3
10028623|NCT01892189|11152789|FG008|STARTED|Second Intervention Period (1 Day)||1
10028624|NCT01892189|11152781|FG000|COMPLETED|Second Intervention Period (1 Day)||3
10028625|NCT01892189|11152782|FG001|COMPLETED|Second Intervention Period (1 Day)||3
10028626|NCT01892189|11152783|FG002|COMPLETED|Second Intervention Period (1 Day)||1
10028627|NCT01892189|11152784|FG003|COMPLETED|Second Intervention Period (1 Day)||2
10028628|NCT01892189|11152785|FG004|COMPLETED|Second Intervention Period (1 Day)||3
10028629|NCT01892189|11152786|FG005|COMPLETED|Second Intervention Period (1 Day)||2
10028630|NCT01892189|11152787|FG006|COMPLETED|Second Intervention Period (1 Day)||2
10028631|NCT01892189|11152788|FG007|COMPLETED|Second Intervention Period (1 Day)||3
10028632|NCT01892189|11152789|FG008|COMPLETED|Second Intervention Period (1 Day)||1
10028633|NCT01892189|11152781|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028634|NCT01892189|11152782|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028635|NCT01892189|11152783|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028636|NCT01892189|11152784|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028637|NCT01892189|11152785|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028638|NCT01892189|11152786|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028639|NCT01892189|11152787|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028640|NCT01892189|11152788|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028641|NCT01892189|11152789|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
10028642|NCT01892189|11152781|FG000|STARTED|Washout Period 2 (7 Days)||3
10028643|NCT01892189|11152782|FG001|STARTED|Washout Period 2 (7 Days)||3
10028644|NCT01892189|11152783|FG002|STARTED|Washout Period 2 (7 Days)||1
10028645|NCT01892189|11152784|FG003|STARTED|Washout Period 2 (7 Days)||2
10028646|NCT01892189|11152785|FG004|STARTED|Washout Period 2 (7 Days)||3
10028647|NCT01892189|11152786|FG005|STARTED|Washout Period 2 (7 Days)||2
10028648|NCT01892189|11152787|FG006|STARTED|Washout Period 2 (7 Days)||2
10028649|NCT01892189|11152788|FG007|STARTED|Washout Period 2 (7 Days)||3
10028650|NCT01892189|11152789|FG008|STARTED|Washout Period 2 (7 Days)||1
10028651|NCT01892189|11152781|FG000|COMPLETED|Washout Period 2 (7 Days)||3
10028652|NCT01892189|11152782|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10028653|NCT01892189|11152783|FG002|COMPLETED|Washout Period 2 (7 Days)||1
10028654|NCT01892189|11152784|FG003|COMPLETED|Washout Period 2 (7 Days)||2
10028655|NCT01892189|11152785|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10028656|NCT01892189|11152786|FG005|COMPLETED|Washout Period 2 (7 Days)||2
10028657|NCT01892189|11152787|FG006|COMPLETED|Washout Period 2 (7 Days)||2
10115479|NCT02526160|11246304|FG000|STARTED|Open-Label Treatment Extension Period I||63
10115480|NCT02526160|11246305|FG001|STARTED|Open-Label Treatment Extension Period I||63
10115481|NCT02526160|11246304|FG000|COMPLETED|Open-Label Treatment Extension Period I||60
10115482|NCT02526160|11246305|FG001|COMPLETED|Open-Label Treatment Extension Period I||59
10115483|NCT02526160|11246304|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3
10028658|NCT01892189|11152788|FG007|COMPLETED|Washout Period 2 (7 Days)||3
10028659|NCT01892189|11152789|FG008|COMPLETED|Washout Period 2 (7 Days)||1
10028660|NCT01892189|11152781|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028661|NCT01892189|11152782|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028662|NCT01892189|11152783|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028663|NCT01892189|11152784|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028664|NCT01892189|11152785|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028665|NCT01892189|11152786|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028666|NCT01892189|11152787|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028667|NCT01892189|11152788|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028668|NCT01892189|11152789|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
10028669|NCT01892189|11152781|FG000|STARTED|Third Intervention Period (1 Day)||3
10028670|NCT01892189|11152782|FG001|STARTED|Third Intervention Period (1 Day)||3
10028671|NCT01892189|11152783|FG002|STARTED|Third Intervention Period (1 Day)||1
10028672|NCT01892189|11152784|FG003|STARTED|Third Intervention Period (1 Day)||2
10028673|NCT01892189|11152785|FG004|STARTED|Third Intervention Period (1 Day)||3
10028674|NCT01892189|11152786|FG005|STARTED|Third Intervention Period (1 Day)||2
10028675|NCT01892189|11152787|FG006|STARTED|Third Intervention Period (1 Day)||2
10028676|NCT01892189|11152788|FG007|STARTED|Third Intervention Period (1 Day)||3
10028677|NCT01892189|11152789|FG008|STARTED|Third Intervention Period (1 Day)||1
10028678|NCT01892189|11152781|FG000|COMPLETED|Third Intervention Period (1 Day)||3
10028679|NCT01892189|11152782|FG001|COMPLETED|Third Intervention Period (1 Day)||3
10028680|NCT01892189|11152783|FG002|COMPLETED|Third Intervention Period (1 Day)||1
10028681|NCT01892189|11152784|FG003|COMPLETED|Third Intervention Period (1 Day)||2
10028682|NCT01892189|11152785|FG004|COMPLETED|Third Intervention Period (1 Day)||3
10028683|NCT01892189|11152786|FG005|COMPLETED|Third Intervention Period (1 Day)||2
10028684|NCT01892189|11152787|FG006|COMPLETED|Third Intervention Period (1 Day)||2
10028685|NCT01892189|11152788|FG007|COMPLETED|Third Intervention Period (1 Day)||3
10028686|NCT01892189|11152789|FG008|COMPLETED|Third Intervention Period (1 Day)||1
10028687|NCT01892189|11152781|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028688|NCT01892189|11152782|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028689|NCT01892189|11152783|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028690|NCT01892189|11152784|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028691|NCT01892189|11152785|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028692|NCT01892189|11152786|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028693|NCT01892189|11152787|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028694|NCT01892189|11152788|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028695|NCT01892189|11152789|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
10028696|NCT01892267|11152806|FG000|STARTED|Overall Study||9
10028697|NCT01892267|11152807|FG001|STARTED|Overall Study||10
10028698|NCT01892267|11152806|FG000|COMPLETED|Overall Study||9
10028699|NCT01892267|11152807|FG001|COMPLETED|Overall Study||10
10028700|NCT01892267|11152806|FG000|NOT COMPLETED|Overall Study||0
10028701|NCT01892267|11152807|FG001|NOT COMPLETED|Overall Study||0
10028702|NCT01892293|11152813|FG000|STARTED|Overall Study||6
10028703|NCT01892293|11152813|FG000|Received T-cell|Overall Study||2
10028704|NCT01892293|11152813|FG000|COMPLETED|Overall Study||2
10028705|NCT01892293|11152813|FG000|NOT COMPLETED|Overall Study||4
10028706|NCT01892306|11152819|FG000|STARTED|Overall Study||13
10028707|NCT01892306|11152820|FG001|STARTED|Overall Study||16
10028708|NCT01892306|11152819|FG000|COMPLETED|Overall Study||8
10028709|NCT01892306|11152820|FG001|COMPLETED|Overall Study||10
10028710|NCT01892306|11152819|FG000|NOT COMPLETED|Overall Study||5
10028711|NCT01892306|11152820|FG001|NOT COMPLETED|Overall Study||6
10028712|NCT01892345|11152828|FG000|STARTED|Overall Study||96
10028713|NCT01892345|11152829|FG001|STARTED|Overall Study||47
10028714|NCT01892345|11152828|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96
10028715|NCT01892345|11152829|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47
10028716|NCT01892345|11152828|FG000|COMPLETED|Overall Study||80
10028717|NCT01892345|11152829|FG001|COMPLETED|Overall Study||44
10028718|NCT01892345|11152828|FG000|NOT COMPLETED|Overall Study||16
10028719|NCT01892345|11152829|FG001|NOT COMPLETED|Overall Study||3
10028720|NCT01892436|11152839|FG000|STARTED|Overall Study||147
10028721|NCT01892436|11152840|FG001|STARTED|Overall Study||161
10028722|NCT01892436|11152841|FG002|STARTED|Overall Study||74
10028723|NCT01892436|11152842|FG003|STARTED|Overall Study||75
10028724|NCT01892436|11152839|FG000|COMPLETED|Overall Study||124
10028725|NCT01892436|11152840|FG001|COMPLETED|Overall Study||132
10028726|NCT01892436|11152841|FG002|COMPLETED|Overall Study||63
10028727|NCT01892436|11152842|FG003|COMPLETED|Overall Study||61
10028728|NCT01892436|11152839|FG000|NOT COMPLETED|Overall Study||23
10028729|NCT01892436|11152840|FG001|NOT COMPLETED|Overall Study||29
10028730|NCT01892436|11152841|FG002|NOT COMPLETED|Overall Study||11
10028731|NCT01892436|11152842|FG003|NOT COMPLETED|Overall Study||14
10028732|NCT01892501|11152852|FG000|STARTED|Overall Study||75
10028733|NCT01892501|11152852|FG000|Group A : Biopsy Surgically Possible|Overall Study||72
10028734|NCT01892501|11152852|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3
10028735|NCT01892501|11152852|FG000|COMPLETED|Overall Study||47
10028736|NCT01892501|11152852|FG000|NOT COMPLETED|Overall Study||28
10028737|NCT01892540|11152859|FG000|STARTED|Overall Study||15
10028738|NCT01892540|11152860|FG001|STARTED|Overall Study||0
10028739|NCT01892540|11152861|FG002|STARTED|Overall Study||28
10028740|NCT01892540|11152859|FG000|COMPLETED|Overall Study||15
10028741|NCT01892540|11152860|FG001|COMPLETED|Overall Study||0
10028742|NCT01892540|11152861|FG002|COMPLETED|Overall Study||25
10028743|NCT01892540|11152859|FG000|NOT COMPLETED|Overall Study||0
10028744|NCT01892540|11152860|FG001|NOT COMPLETED|Overall Study||0
10028745|NCT01892540|11152861|FG002|NOT COMPLETED|Overall Study||3
10081440|NCT02260804|11209940|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
10081441|NCT02260804|11209941|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
10081442|NCT02260804|11209940|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111
10081443|NCT02260804|11209941|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105
10081444|NCT02260804|11209940|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
10081445|NCT02260804|11209941|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
10081446|NCT02260804|11209940|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
10081447|NCT02260804|11209941|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
10081448|NCT02260804|11209940|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
10081449|NCT02260804|11209941|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
10081450|NCT02260804|11209940|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
10081451|NCT02260804|11209941|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
10081452|NCT02260817|11209949|FG000|STARTED|Overall Study||14
10081453|NCT02260817|11209950|FG001|STARTED|Overall Study||95
10081454|NCT02260817|11209949|FG000|COMPLETED|Overall Study||14
10081455|NCT02260817|11209950|FG001|COMPLETED|Overall Study||58
10081456|NCT02260817|11209949|FG000|NOT COMPLETED|Overall Study||0
10081457|NCT02260817|11209950|FG001|NOT COMPLETED|Overall Study||37
10081458|NCT02260882|11209958|FG000|STARTED|Overall Study||161
10081459|NCT02260882|11209959|FG001|STARTED|Overall Study||82
10081460|NCT02260882|11209958|FG000|COMPLETED|Overall Study||161
10081461|NCT02260882|11209959|FG001|COMPLETED|Overall Study||81
10081462|NCT02260882|11209958|FG000|NOT COMPLETED|Overall Study||0
10081463|NCT02260882|11209959|FG001|NOT COMPLETED|Overall Study||1
10081464|NCT02260921|11209968|FG000|STARTED|Overall Study||121
10081465|NCT02260921|11209969|FG001|STARTED|Overall Study||59
10081466|NCT02260921|11209968|FG000|Per-Protocol Population|Overall Study||112
10081467|NCT02260921|11209969|FG001|Per-Protocol Population|Overall Study||56
9704396|NCT00569127|10804011|FG000|STARTED|Overall Study||214
9704397|NCT00569127|10804012|FG001|STARTED|Overall Study||213
9704398|NCT00569127|10804011|FG000|Eligible|Overall Study||200
9704399|NCT00569127|10804012|FG001|Eligible|Overall Study||202
9704400|NCT00569127|10804011|FG000|COMPLETED|Overall Study||0
10081468|NCT02260921|11209968|FG000|COMPLETED|Overall Study||107
10081469|NCT02260921|11209969|FG001|COMPLETED|Overall Study||55
10081470|NCT02260921|11209968|FG000|NOT COMPLETED|Overall Study||14
10081471|NCT02260921|11209969|FG001|NOT COMPLETED|Overall Study||4
10081472|NCT02260934|11209977|FG000|STARTED|Overall Study||22
10081473|NCT02260934|11209978|FG001|STARTED|Overall Study||21
10081474|NCT02260934|11209977|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
10115484|NCT02526160|11246305|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4
9704401|NCT00569127|10804012|FG001|COMPLETED|Overall Study||0
9704402|NCT00569127|10804011|FG000|NOT COMPLETED|Overall Study||214
10028746|NCT01892657|11152869|FG000|STARTED|Overall Study||128
10028747|NCT01892657|11152869|FG000|COMPLETED|Overall Study||110
10028748|NCT01892657|11152869|FG000|NOT COMPLETED|Overall Study||18
10028749|NCT01892709|11152885|FG000|STARTED|Overall Study||215
10028750|NCT01892709|11152885|FG000|COMPLETED|Overall Study||215
10028751|NCT01892709|11152885|FG000|NOT COMPLETED|Overall Study||0
10028752|NCT01892865|11152895|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
10028753|NCT01892865|11152896|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
10028754|NCT01892865|11152895|FG000|COMPLETED|Overall Study||356
10028755|NCT01892865|11152896|FG001|COMPLETED|Overall Study||379
10028756|NCT01892865|11152895|FG000|NOT COMPLETED|Overall Study||0
10028757|NCT01892865|11152896|FG001|NOT COMPLETED|Overall Study||0
10028758|NCT01893203|11152902|FG000|STARTED|Overall Study||14
10028759|NCT01893203|11152902|FG000|COMPLETED|Overall Study||13
10028760|NCT01893203|11152902|FG000|NOT COMPLETED|Overall Study||1
10028761|NCT01893281|11152906|FG000|STARTED|Overall Study||78
10028762|NCT01893281|11152906|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78
10028763|NCT01893281|11152906|FG000|COMPLETED|Overall Study||75
10028764|NCT01893281|11152906|FG000|NOT COMPLETED|Overall Study||3
10028765|NCT01893346|11152914|FG000|STARTED|Overall Study||11
10028766|NCT01893346|11152915|FG001|STARTED|Overall Study||8
10028767|NCT01893346|11152916|FG002|STARTED|Overall Study||8
10028768|NCT01893346|11152917|FG003|STARTED|Overall Study||8
10028769|NCT01893346|11152914|FG000|Patients Who Received Full Infusion|Overall Study||8
10028770|NCT01893346|11152915|FG001|Patients Who Received Full Infusion|Overall Study||8
10028771|NCT01893346|11152916|FG002|Patients Who Received Full Infusion|Overall Study||8
10028772|NCT01893346|11152917|FG003|Patients Who Received Full Infusion|Overall Study||8
10028773|NCT01893346|11152914|FG000|COMPLETED|Overall Study||8
10028774|NCT01893346|11152915|FG001|COMPLETED|Overall Study||7
10028775|NCT01893346|11152916|FG002|COMPLETED|Overall Study||8
10028776|NCT01893346|11152917|FG003|COMPLETED|Overall Study||8
10028777|NCT01893346|11152914|FG000|NOT COMPLETED|Overall Study||3
10028778|NCT01893346|11152915|FG001|NOT COMPLETED|Overall Study||1
10028779|NCT01893346|11152916|FG002|NOT COMPLETED|Overall Study||0
10028780|NCT01893346|11152917|FG003|NOT COMPLETED|Overall Study||0
10028781|NCT01893372|11152929|FG000|STARTED|Overall Study||7
10028782|NCT01893372|11152930|FG001|STARTED|Overall Study||22
10028783|NCT01893372|11152929|FG000|COMPLETED|Overall Study||7
10028784|NCT01893372|11152930|FG001|COMPLETED|Overall Study||22
10028785|NCT01893372|11152929|FG000|NOT COMPLETED|Overall Study||0
10028786|NCT01893372|11152930|FG001|NOT COMPLETED|Overall Study||0
10028787|NCT01893411|11152939|FG000|STARTED|Overall Study||156
10028788|NCT01893411|11152940|FG001|STARTED|Overall Study||77
10028789|NCT01893411|11152941|FG002|STARTED|Overall Study||78
10028790|NCT01893411|11152939|FG000|COMPLETED|Overall Study||139
10028791|NCT01893411|11152940|FG001|COMPLETED|Overall Study||70
10028792|NCT01893411|11152941|FG002|COMPLETED|Overall Study||69
10028793|NCT01893411|11152939|FG000|NOT COMPLETED|Overall Study||17
10028794|NCT01893411|11152940|FG001|NOT COMPLETED|Overall Study||7
10028795|NCT01893411|11152941|FG002|NOT COMPLETED|Overall Study||9
10028796|NCT01893567|11152949|FG000|STARTED|Overall Study||28
10028797|NCT01893567|11152949|FG000|COMPLETED|Overall Study||28
10028798|NCT01893567|11152949|FG000|NOT COMPLETED|Overall Study||0
10028799|NCT01893632|11152955|FG000|STARTED|Overall Study||1
10028800|NCT01893632|11152956|FG001|STARTED|Overall Study||1
10028801|NCT01893632|11152955|FG000|COMPLETED|Overall Study||1
10028802|NCT01893632|11152956|FG001|COMPLETED|Overall Study||1
10028803|NCT01893632|11152955|FG000|NOT COMPLETED|Overall Study||0
10028804|NCT01893632|11152956|FG001|NOT COMPLETED|Overall Study||0
10028805|NCT01893801|11152962|FG000|STARTED|Overall Study||25
10028806|NCT01893801|11152962|FG000|COMPLETED|Overall Study||25
10028807|NCT01893801|11152962|FG000|NOT COMPLETED|Overall Study||0
10028808|NCT01893827|11152970|FG000|STARTED|Overall Study||117
10028809|NCT01893827|11152971|FG001|STARTED|Overall Study||120
10028810|NCT01893827|11152970|FG000|COMPLETED|Overall Study||98
9704403|NCT00569127|10804012|FG001|NOT COMPLETED|Overall Study||213
9728904|NCT00114777|10828463|FG000|COMPLETED|Randomization to Month 36||109
9728905|NCT00114777|10828464|FG001|COMPLETED|Randomization to Month 36||114
9728906|NCT00114777|10828465|FG002|COMPLETED|Randomization to Month 36||100
9728907|NCT00114777|10828463|FG000|NOT COMPLETED|Randomization to Month 36||75
9728908|NCT00114777|10828464|FG001|NOT COMPLETED|Randomization to Month 36||61
10028811|NCT01893827|11152971|FG001|COMPLETED|Overall Study||94
10028812|NCT01893827|11152970|FG000|NOT COMPLETED|Overall Study||19
10028813|NCT01893827|11152971|FG001|NOT COMPLETED|Overall Study||26
10028814|NCT01893879|11152979|FG000|STARTED|Overall Study||7
10028815|NCT01893879|11152980|FG001|STARTED|Overall Study||7
10028816|NCT01893879|11152979|FG000|COMPLETED|Overall Study||5
10028817|NCT01893879|11152980|FG001|COMPLETED|Overall Study||4
10028818|NCT01893879|11152979|FG000|NOT COMPLETED|Overall Study||2
10028819|NCT01893879|11152980|FG001|NOT COMPLETED|Overall Study||3
10028820|NCT01893905|11152988|FG000|STARTED|Overall Study||80
10028821|NCT01893905|11152989|FG001|STARTED|Overall Study||78
10028822|NCT01893905|11152988|FG000|COMPLETED|Overall Study||55
10028823|NCT01893905|11152989|FG001|COMPLETED|Overall Study||64
10028824|NCT01893905|11152988|FG000|NOT COMPLETED|Overall Study||25
10028825|NCT01893905|11152989|FG001|NOT COMPLETED|Overall Study||14
10028826|NCT01893983|11152997|FG000|STARTED|Overall Study||140
9704404|NCT04654351|10804018|FG000|STARTED|Overall Study||2
9704405|NCT04654351|10804018|FG000|COMPLETED|Overall Study||2
9704406|NCT04654351|10804018|FG000|NOT COMPLETED|Overall Study||0
9704435|NCT04095416|10804061|FG000|STARTED|Overall Study||13
9704436|NCT04095416|10804062|FG001|STARTED|Overall Study||19
9704437|NCT04095416|10804061|FG000|COMPLETED|Overall Study||10
9704438|NCT04095416|10804062|FG001|COMPLETED|Overall Study||19
9704439|NCT04095416|10804061|FG000|NOT COMPLETED|Overall Study||3
10028827|NCT01893983|11152998|FG001|STARTED|Overall Study||140
10028828|NCT01893983|11152997|FG000|COMPLETED|Overall Study||130
10028829|NCT01893983|11152998|FG001|COMPLETED|Overall Study||134
10028830|NCT01893983|11152997|FG000|NOT COMPLETED|Overall Study||10
10028831|NCT01893983|11152998|FG001|NOT COMPLETED|Overall Study||6
10028832|NCT01894022|11153006|FG000|STARTED|Overall Study||9
10028833|NCT01894022|11153007|FG001|STARTED|Overall Study||10
10028834|NCT01894022|11153006|FG000|COMPLETED|Overall Study||0
10028835|NCT01894022|11153007|FG001|COMPLETED|Overall Study||0
10028836|NCT01894022|11153006|FG000|NOT COMPLETED|Overall Study||9
10028837|NCT01894022|11153007|FG001|NOT COMPLETED|Overall Study||10
10028838|NCT01894087|11153016|FG000|STARTED|Overall Study||102
10028839|NCT01894087|11153017|FG001|STARTED|Overall Study||102
10028840|NCT01894087|11153016|FG000|COMPLETED|Overall Study||96
10028841|NCT01894087|11153017|FG001|COMPLETED|Overall Study||102
10028842|NCT01894087|11153016|FG000|NOT COMPLETED|Overall Study||6
10028843|NCT01894087|11153017|FG001|NOT COMPLETED|Overall Study||0
10028844|NCT01894100|11153025|FG000|STARTED|Overall Study||15
10028845|NCT01894100|11153026|FG001|STARTED|Overall Study||15
10028846|NCT01894100|11153025|FG000|COMPLETED|Overall Study||12
10028847|NCT01894100|11153026|FG001|COMPLETED|Overall Study||14
10028848|NCT01894100|11153025|FG000|NOT COMPLETED|Overall Study||3
10028849|NCT01894100|11153026|FG001|NOT COMPLETED|Overall Study||1
10028850|NCT01894152|11153032|FG000|STARTED|Overall Study||2002
10028851|NCT01894152|11153032|FG000|COMPLETED|Overall Study||1851
10028852|NCT01894152|11153032|FG000|NOT COMPLETED|Overall Study||151
10028853|NCT01894178|11153038|FG000|STARTED|Overall Study||30
10028854|NCT01894178|11153039|FG001|STARTED|Overall Study||30
10028855|NCT01894178|11153038|FG000|COMPLETED|Overall Study||30
10028856|NCT01894178|11153039|FG001|COMPLETED|Overall Study||30
10028857|NCT01894178|11153038|FG000|NOT COMPLETED|Overall Study||0
10028858|NCT01894178|11153039|FG001|NOT COMPLETED|Overall Study||0
10028859|NCT01894230|11153047|FG000|STARTED|Overall Study||83
10028860|NCT01894230|11153048|FG001|STARTED|Overall Study||76
10028861|NCT01894230|11153047|FG000|COMPLETED|Overall Study||76
10028862|NCT01894230|11153048|FG001|COMPLETED|Overall Study||69
10028863|NCT01894230|11153047|FG000|NOT COMPLETED|Overall Study||7
10028864|NCT01894230|11153048|FG001|NOT COMPLETED|Overall Study||7
10028865|NCT01894243|11153057|FG000|STARTED|Overall Study||13
10028866|NCT01894243|11153058|FG001|STARTED|Overall Study||10
10028867|NCT01894243|11153059|FG002|STARTED|Overall Study||8
10028868|NCT01894243|11153057|FG000|Completed Treatment in Part A|Overall Study||13
10028869|NCT01894243|11153058|FG001|Completed Treatment in Part A|Overall Study||10
10028870|NCT01894243|11153059|FG002|Completed Treatment in Part A|Overall Study||8
10028871|NCT01894243|11153057|FG000|Ongoing Into Part B|Overall Study||13
10028872|NCT01894243|11153058|FG001|Ongoing Into Part B|Overall Study||10
10028873|NCT01894243|11153059|FG002|Ongoing Into Part B|Overall Study||8
10028874|NCT01894243|11153057|FG000|COMPLETED|Overall Study||0
10028875|NCT01894243|11153058|FG001|COMPLETED|Overall Study||0
10028876|NCT01894243|11153059|FG002|COMPLETED|Overall Study||0
10028877|NCT01894243|11153057|FG000|NOT COMPLETED|Overall Study||13
10028878|NCT01894243|11153058|FG001|NOT COMPLETED|Overall Study||10
10028879|NCT01894243|11153059|FG002|NOT COMPLETED|Overall Study||8
10028880|NCT01894256|11153077|FG000|STARTED|Part A||15
10028881|NCT01894256|11153078|FG001|STARTED|Part A||15
10028882|NCT01894256|11153079|FG002|STARTED|Part A||14
10028883|NCT01894256|11153077|FG000|COMPLETED|Part A||15
9704440|NCT04095416|10804062|FG001|NOT COMPLETED|Overall Study||0
9704441|NCT04532099|10804071|FG000|STARTED|First Wear Period (30 Days)||33
9704442|NCT04532099|10804072|FG001|STARTED|First Wear Period (30 Days)||33
9704443|NCT04532099|10804073|FG002|STARTED|First Wear Period (30 Days)||66
9704444|NCT04532099|10804071|FG000|COMPLETED|First Wear Period (30 Days)||32
9704445|NCT04532099|10804072|FG001|COMPLETED|First Wear Period (30 Days)||33
9704446|NCT04532099|10804073|FG002|COMPLETED|First Wear Period (30 Days)||66
9704447|NCT04532099|10804071|FG000|NOT COMPLETED|First Wear Period (30 Days)||1
10028884|NCT01894256|11153078|FG001|COMPLETED|Part A||14
10028885|NCT01894256|11153079|FG002|COMPLETED|Part A||14
10028886|NCT01894256|11153077|FG000|NOT COMPLETED|Part A||0
10028887|NCT01894256|11153078|FG001|NOT COMPLETED|Part A||1
10028888|NCT01894256|11153079|FG002|NOT COMPLETED|Part A||0
10028889|NCT01894256|11153077|FG000|STARTED|Part B||15
10028890|NCT01894256|11153078|FG001|STARTED|Part B||14
10028891|NCT01894256|11153079|FG002|STARTED|Part B||14
10028892|NCT01894256|11153077|FG000|COMPLETED|Part B||0
10028893|NCT01894256|11153078|FG001|COMPLETED|Part B||0
10028894|NCT01894256|11153079|FG002|COMPLETED|Part B||0
10028895|NCT01894256|11153077|FG000|NOT COMPLETED|Part B||15
10028896|NCT01894256|11153078|FG001|NOT COMPLETED|Part B||14
10028897|NCT01894256|11153079|FG002|NOT COMPLETED|Part B||14
10028898|NCT01894477|11153092|FG000|STARTED|Overall Study||35
9704448|NCT04532099|10804072|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
9704449|NCT04532099|10804073|FG002|NOT COMPLETED|First Wear Period (30 Days)||0
10028899|NCT01894477|11153093|FG001|STARTED|Overall Study||67
10028900|NCT01894477|11153092|FG000|COMPLETED|Overall Study||35
10028901|NCT01894477|11153093|FG001|COMPLETED|Overall Study||65
9704407|NCT04422990|10804025|FG000|STARTED|Overall Study||50
9704408|NCT04422990|10804026|FG001|STARTED|Overall Study||97
9704409|NCT04422990|10804025|FG000|COMPLETED|Overall Study||47
9704410|NCT04422990|10804026|FG001|COMPLETED|Overall Study||96
9704411|NCT04422990|10804025|FG000|NOT COMPLETED|Overall Study||3
9704412|NCT04422990|10804026|FG001|NOT COMPLETED|Overall Study||1
9704413|NCT04388319|10804035|FG000|STARTED|Enrolled in Study||26
9704414|NCT04388319|10804035|FG000|COMPLETED|Enrolled in Study||24
9704415|NCT04388319|10804035|FG000|NOT COMPLETED|Enrolled in Study||2
9704416|NCT04388319|10804035|FG000|STARTED|Treatment Period||24
9704417|NCT04388319|10804035|FG000|COMPLETED|Treatment Period||23
9704418|NCT04388319|10804035|FG000|NOT COMPLETED|Treatment Period||1
9704419|NCT04358549|10804041|FG000|STARTED|Overall Study||25
9704420|NCT04358549|10804042|FG001|STARTED|Overall Study||25
9704421|NCT04358549|10804041|FG000|ITT Population (Randomized Subjects)|Overall Study||25
9704422|NCT04358549|10804042|FG001|ITT Population (Randomized Subjects)|Overall Study||25
9704423|NCT04358549|10804041|FG000|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||24
9704424|NCT04358549|10804042|FG001|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||25
9704425|NCT04358549|10804041|FG000|COMPLETED|Overall Study||15
9704426|NCT04358549|10804042|FG001|COMPLETED|Overall Study||17
9704427|NCT04358549|10804041|FG000|NOT COMPLETED|Overall Study||10
9704428|NCT04358549|10804042|FG001|NOT COMPLETED|Overall Study||8
9704429|NCT04229888|10804048|FG000|STARTED|Overall Study||14
9704430|NCT04229888|10804048|FG000|COMPLETED|Overall Study||14
9704431|NCT04229888|10804048|FG000|NOT COMPLETED|Overall Study||0
9704432|NCT04221828|10804055|FG000|STARTED|Overall Study||1
9704433|NCT04221828|10804055|FG000|COMPLETED|Overall Study||1
9704434|NCT04221828|10804055|FG000|NOT COMPLETED|Overall Study||0
9704450|NCT04532099|10804071|FG000|STARTED|Second Wear Period (30 Days)||32
9704451|NCT04532099|10804072|FG001|STARTED|Second Wear Period (30 Days)||33
9704452|NCT04532099|10804073|FG002|STARTED|Second Wear Period (30 Days)|Part B is single product; therefore, only one wear period.|0
9704453|NCT04532099|10804071|FG000|COMPLETED|Second Wear Period (30 Days)||32
9704454|NCT04532099|10804072|FG001|COMPLETED|Second Wear Period (30 Days)||33
9704455|NCT04532099|10804073|FG002|COMPLETED|Second Wear Period (30 Days)||0
9704456|NCT04532099|10804071|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
9704457|NCT04532099|10804072|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
9704458|NCT04532099|10804073|FG002|NOT COMPLETED|Second Wear Period (30 Days)||0
9728909|NCT00114777|10828465|FG002|NOT COMPLETED|Randomization to Month 36||84
9728910|NCT00114777|10828463|FG000|STARTED|Long-Term Extension to Month 84||104
9728911|NCT00114777|10828464|FG001|STARTED|Long-Term Extension to Month 84||113
9728912|NCT00114777|10828465|FG002|STARTED|Long-Term Extension to Month 84||87
9728913|NCT00114777|10828463|FG000|COMPLETED|Long-Term Extension to Month 84||74
9728914|NCT00114777|10828464|FG001|COMPLETED|Long-Term Extension to Month 84||84
9728915|NCT00114777|10828465|FG002|COMPLETED|Long-Term Extension to Month 84||57
9728916|NCT00114777|10828463|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30
9728917|NCT00114777|10828464|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29
9728918|NCT00114777|10828465|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30
9728919|NCT00114959|10828474|FG000|STARTED|Overall Study||15
9728920|NCT00114959|10828474|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
9728921|NCT00114959|10828474|FG000|NOT COMPLETED|Overall Study||8
9728922|NCT00114972|10828480|FG000|STARTED|Overall Study||897
9728923|NCT00114972|10828481|FG001|STARTED|Overall Study||903
9728924|NCT00114972|10828480|FG000|COMPLETED|Overall Study||849
9728925|NCT00114972|10828481|FG001|COMPLETED|Overall Study||891
9728926|NCT00114972|10828480|FG000|NOT COMPLETED|Overall Study||48
9728927|NCT00114972|10828481|FG001|NOT COMPLETED|Overall Study||12
9728928|NCT00115037|10828489|FG000|STARTED|Phase1||152
9728929|NCT00115037|10828490|FG001|STARTED|Phase1||150
9728930|NCT00115037|10828491|FG002|STARTED|Phase1||0
9728931|NCT00115037|10828492|FG003|STARTED|Phase1||0
9728932|NCT00115037|10828493|FG004|STARTED|Phase1||0
9728933|NCT00115037|10828494|FG005|STARTED|Phase1||0
9728934|NCT00115037|10828489|FG000|COMPLETED|Phase1||127
9728935|NCT00115037|10828490|FG001|COMPLETED|Phase1||123
9728936|NCT00115037|10828491|FG002|COMPLETED|Phase1||0
9728937|NCT00115037|10828492|FG003|COMPLETED|Phase1||0
9728938|NCT00115037|10828493|FG004|COMPLETED|Phase1||0
9728939|NCT00115037|10828494|FG005|COMPLETED|Phase1||0
9728940|NCT00115037|10828489|FG000|NOT COMPLETED|Phase1||25
9728941|NCT00115037|10828490|FG001|NOT COMPLETED|Phase1||27
9728942|NCT00115037|10828491|FG002|NOT COMPLETED|Phase1||0
9728943|NCT00115037|10828492|FG003|NOT COMPLETED|Phase1||0
9728944|NCT00115037|10828493|FG004|NOT COMPLETED|Phase1||0
9728945|NCT00115037|10828494|FG005|NOT COMPLETED|Phase1||0
9728946|NCT00115037|10828489|FG000|STARTED|Phase2||0
9728947|NCT00115037|10828490|FG001|STARTED|Phase2||0
9728948|NCT00115037|10828491|FG002|STARTED|Phase2||91
9848165|NCT00857545|10960824|FG001|NOT COMPLETED|Overall Study||0
9848166|NCT00857584|10960832|FG000|STARTED|Overall Study||14
9728949|NCT00115037|10828492|FG003|STARTED|Phase2||92
9728950|NCT00115037|10828493|FG004|STARTED|Phase2||34
9728951|NCT00115037|10828494|FG005|STARTED|Phase2||33
9728952|NCT00115037|10828489|FG000|COMPLETED|Phase2||0
9728953|NCT00115037|10828490|FG001|COMPLETED|Phase2||0
9728954|NCT00115037|10828491|FG002|COMPLETED|Phase2||76
9848167|NCT00857584|10960833|FG001|STARTED|Overall Study||13
9728955|NCT00115037|10828492|FG003|COMPLETED|Phase2||77
9728956|NCT00115037|10828493|FG004|COMPLETED|Phase2||28
9728957|NCT00115037|10828494|FG005|COMPLETED|Phase2||21
9704459|NCT04385199|10804087|FG000|STARTED|Overall Study||20
9704460|NCT04385199|10804088|FG001|STARTED|Overall Study||10
9704461|NCT04385199|10804087|FG000|COMPLETED|Overall Study||19
10028902|NCT01894477|11153092|FG000|NOT COMPLETED|Overall Study||0
10028903|NCT01894477|11153093|FG001|NOT COMPLETED|Overall Study||2
10028904|NCT01894503|11153099|FG000|STARTED|Overall Study||5
10028905|NCT01894503|11153099|FG000|COMPLETED|Overall Study||5
10028906|NCT01894503|11153099|FG000|NOT COMPLETED|Overall Study||0
10028907|NCT01894516|11153108|FG000|STARTED|Period 1 (Baseline up to Week 12)||72
10028908|NCT01894516|11153109|FG001|STARTED|Period 1 (Baseline up to Week 12)||72
10028909|NCT01894516|11153110|FG002|STARTED|Period 1 (Baseline up to Week 12)||70
10028910|NCT01894516|11153111|FG003|STARTED|Period 1 (Baseline up to Week 12)||69
10028911|NCT01894516|11153108|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65
10028912|NCT01894516|11153109|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67
10028913|NCT01894516|11153110|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67
10028914|NCT01894516|11153111|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66
10028915|NCT01894516|11153108|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
10028916|NCT01894516|11153109|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
10028917|NCT01894516|11153110|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
10028918|NCT01894516|11153111|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
10028919|NCT01894516|11153108|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
10028920|NCT01894516|11153109|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
10028921|NCT01894516|11153110|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
10028922|NCT01894516|11153111|FG003|STARTED|Period 2 (Week 13 to Week 24)||66
10028923|NCT01894516|11153108|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0
10028924|NCT01894516|11153109|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50
10028925|NCT01894516|11153110|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142
10028926|NCT01894516|11153111|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65
10028927|NCT01894516|11153108|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
10028928|NCT01894516|11153109|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
10028929|NCT01894516|11153110|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
10028930|NCT01894516|11153111|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
10028931|NCT01894555|11153125|FG000|STARTED|Overall Study||33
10028932|NCT01894555|11153125|FG000|COMPLETED|Overall Study||33
10028933|NCT01894555|11153125|FG000|NOT COMPLETED|Overall Study||0
10028934|NCT01894568|11153131|FG000|STARTED|Overall Study||192
10028935|NCT01894568|11153132|FG001|STARTED|Overall Study||196
10028936|NCT01894568|11153131|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192
10028937|NCT01894568|11153132|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
10028938|NCT01894568|11153131|FG000|COMPLETED|Overall Study||182
10028939|NCT01894568|11153132|FG001|COMPLETED|Overall Study||186
10028940|NCT01894568|11153131|FG000|NOT COMPLETED|Overall Study||10
10028941|NCT01894568|11153132|FG001|NOT COMPLETED|Overall Study||10
10028942|NCT01894581|11153141|FG000|STARTED|Overall Study||20
10028943|NCT01894581|11153142|FG001|STARTED|Overall Study||19
10028944|NCT01894581|11153141|FG000|COMPLETED|Overall Study||15
10028945|NCT01894581|11153142|FG001|COMPLETED|Overall Study||12
10028946|NCT01894581|11153141|FG000|NOT COMPLETED|Overall Study||5
10028947|NCT01894581|11153142|FG001|NOT COMPLETED|Overall Study||7
10028948|NCT01894607|11153148|FG000|STARTED|Overall Study||11
10028949|NCT01894607|11153148|FG000|COMPLETED|Overall Study||10
10028950|NCT01894607|11153148|FG000|NOT COMPLETED|Overall Study||1
10028951|NCT01894620|11153154|FG000|STARTED|Overall Study||6
10028952|NCT01894620|11153155|FG001|STARTED|Overall Study||5
10028953|NCT01894620|11153154|FG000|COMPLETED|Overall Study||6
10028954|NCT01894620|11153155|FG001|COMPLETED|Overall Study||4
10028955|NCT01894620|11153154|FG000|NOT COMPLETED|Overall Study||0
10028956|NCT01894620|11153155|FG001|NOT COMPLETED|Overall Study||1
10028957|NCT01894672|11153163|FG000|STARTED|Overall Study||7
10028958|NCT01894672|11153163|FG000|COMPLETED|Overall Study||7
10028959|NCT01894672|11153163|FG000|NOT COMPLETED|Overall Study||0
10028960|NCT01894776|11153168|FG000|STARTED|Overall Study||15
10028961|NCT01894776|11153168|FG000|COMPLETED|Overall Study||14
10028962|NCT01894776|11153168|FG000|NOT COMPLETED|Overall Study||1
10028963|NCT01894841|11153174|FG000|STARTED|Overall Study||52
10028964|NCT01894841|11153175|FG001|STARTED|Overall Study||53
10028965|NCT01894841|11153174|FG000|COMPLETED|Overall Study||34
10028966|NCT01894841|11153175|FG001|COMPLETED|Overall Study||44
9704462|NCT04385199|10804088|FG001|COMPLETED|Overall Study||10
9704463|NCT04385199|10804087|FG000|NOT COMPLETED|Overall Study||1
9704464|NCT04385199|10804088|FG001|NOT COMPLETED|Overall Study||0
9704465|NCT04382053|10804096|FG000|STARTED|Overall Study||71
9704466|NCT04382053|10804097|FG001|STARTED|Overall Study||72
9704467|NCT04382053|10804096|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70
9704468|NCT04382053|10804097|FG001|Safety Analysis Set|Overall Study||72
9704469|NCT04382053|10804096|FG000|PD Analysis Set|Overall Study||62
9704470|NCT04382053|10804097|FG001|PD Analysis Set|Overall Study||68
10028967|NCT01894841|11153174|FG000|NOT COMPLETED|Overall Study||18
10028968|NCT01894841|11153175|FG001|NOT COMPLETED|Overall Study||9
10028969|NCT01894906|11153187|FG000|STARTED|Overall Study||6
10028970|NCT01894906|11153188|FG001|STARTED|Overall Study||6
10028971|NCT01894906|11153187|FG000|Treatment A|Overall Study||6
10028972|NCT01894906|11153188|FG001|Treatment A|Overall Study||6
9704471|NCT04382053|10804096|FG000|COMPLETED|Overall Study||62
9704472|NCT04382053|10804097|FG001|COMPLETED|Overall Study||59
9704473|NCT04382053|10804096|FG000|NOT COMPLETED|Overall Study||9
9704474|NCT04382053|10804097|FG001|NOT COMPLETED|Overall Study||13
9704475|NCT04311177|10804106|FG000|STARTED|Overall Study||58
9704476|NCT04311177|10804107|FG001|STARTED|Overall Study||59
9704477|NCT04311177|10804106|FG000|COMPLETED|Overall Study||50
9704478|NCT04311177|10804107|FG001|COMPLETED|Overall Study||55
9704479|NCT04311177|10804106|FG000|NOT COMPLETED|Overall Study||8
9704480|NCT04311177|10804107|FG001|NOT COMPLETED|Overall Study||4
9704481|NCT04241133|10804115|FG000|STARTED|Overall Study||44
9704482|NCT04241133|10804116|FG001|STARTED|Overall Study||34
9704483|NCT04241133|10804115|FG000|COMPLETED|Overall Study||30
9704484|NCT04241133|10804116|FG001|COMPLETED|Overall Study||0
9704485|NCT04241133|10804115|FG000|NOT COMPLETED|Overall Study||14
9704486|NCT04241133|10804116|FG001|NOT COMPLETED|Overall Study||34
9728958|NCT00115037|10828489|FG000|NOT COMPLETED|Phase2||0
9728959|NCT00115037|10828490|FG001|NOT COMPLETED|Phase2||0
9728960|NCT00115037|10828491|FG002|NOT COMPLETED|Phase2||15
9728961|NCT00115037|10828492|FG003|NOT COMPLETED|Phase2||15
9728962|NCT00115037|10828493|FG004|NOT COMPLETED|Phase2||6
9728963|NCT00115037|10828494|FG005|NOT COMPLETED|Phase2||12
9728964|NCT00115063|10828510|FG000|STARTED|Overall Study||200
9728965|NCT00115063|10828511|FG001|STARTED|Overall Study||190
9728966|NCT00115063|10828510|FG000|COMPLETED|Overall Study||101
9728967|NCT00115063|10828511|FG001|COMPLETED|Overall Study||86
9728968|NCT00115063|10828510|FG000|NOT COMPLETED|Overall Study||99
9728969|NCT00115063|10828511|FG001|NOT COMPLETED|Overall Study||104
9728970|NCT00115076|10828517|FG000|STARTED|Overall Study||30
9728971|NCT00115076|10828517|FG000|COMPLETED|Overall Study||30
9728972|NCT00115076|10828517|FG000|NOT COMPLETED|Overall Study||0
9728973|NCT00115297|10828523|FG000|STARTED|Overall Study||30
9728974|NCT00115297|10828524|FG001|STARTED|Overall Study||32
9728975|NCT00115297|10828523|FG000|COMPLETED|Overall Study||30
9728976|NCT00115297|10828524|FG001|COMPLETED|Overall Study||32
9728977|NCT00115297|10828523|FG000|NOT COMPLETED|Overall Study||0
9728978|NCT00115297|10828524|FG001|NOT COMPLETED|Overall Study||0
9728979|NCT00115336|10828535|FG000|STARTED|Overall Study||6
9728980|NCT00115336|10828536|FG001|STARTED|Overall Study||4
9728981|NCT00115336|10828535|FG000|COMPLETED|Overall Study||6
9728982|NCT00115336|10828536|FG001|COMPLETED|Overall Study||3
9728983|NCT00115336|10828535|FG000|NOT COMPLETED|Overall Study||0
9728984|NCT00115336|10828536|FG001|NOT COMPLETED|Overall Study||1
9728985|NCT00115349|10828546|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11
9728986|NCT00115349|10828547|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9
9728987|NCT00115349|10828546|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0
9728988|NCT00115349|10828547|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0
9728989|NCT00115349|10828546|FG000|NOT COMPLETED|Overall Study||11
9728990|NCT00115349|10828547|FG001|NOT COMPLETED|Overall Study||9
9728991|NCT00115739|10828553|FG000|STARTED|Overall Study||11
9728992|NCT00115739|10828553|FG000|COMPLETED|Overall Study||8
9728993|NCT00115739|10828553|FG000|NOT COMPLETED|Overall Study||3
9728994|NCT00115765|10828563|FG000|STARTED|Overall Study||115
9728995|NCT00115765|10828564|FG001|STARTED|Overall Study||413
9728996|NCT00115765|10828565|FG002|STARTED|Overall Study||410
9728997|NCT00115765|10828566|FG003|STARTED|Overall Study||115
10028973|NCT01894906|11153187|FG000|Treatment B|Overall Study||6
10028974|NCT01894906|11153188|FG001|Treatment B|Overall Study||6
10028975|NCT01894906|11153187|FG000|Treatment C|Overall Study||6
10028976|NCT01894906|11153188|FG001|Treatment C|Overall Study||6
10028977|NCT01894906|11153187|FG000|Treatment D|Overall Study||6
9728998|NCT00115765|10828563|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80
9728999|NCT00115765|10828564|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313
9729000|NCT00115765|10828565|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289
9729001|NCT00115765|10828566|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84
9729002|NCT00115765|10828563|FG000|NOT COMPLETED|Overall Study||35
9729003|NCT00115765|10828564|FG001|NOT COMPLETED|Overall Study||100
9729004|NCT00115765|10828565|FG002|NOT COMPLETED|Overall Study||121
9729005|NCT00115765|10828566|FG003|NOT COMPLETED|Overall Study||31
9729006|NCT00115778|10828574|FG000|STARTED|Overall Study||6
9729007|NCT00115778|10828575|FG001|STARTED|Overall Study||5
9729008|NCT00115778|10828574|FG000|COMPLETED|Overall Study||6
9729009|NCT00115778|10828575|FG001|COMPLETED|Overall Study||4
9729010|NCT00115778|10828574|FG000|NOT COMPLETED|Overall Study||0
9729011|NCT00115778|10828575|FG001|NOT COMPLETED|Overall Study||1
9729012|NCT00115804|10828581|FG000|STARTED|Overall Study||6
9729013|NCT00115804|10828581|FG000|COMPLETED|Overall Study||4
9729014|NCT00115804|10828581|FG000|NOT COMPLETED|Overall Study||2
9729015|NCT00115869|10828589|FG000|STARTED|Overall Study||4211
9729016|NCT00115869|10828590|FG001|STARTED|Overall Study||4177
9729017|NCT00115869|10828589|FG000|Completed Data Collection at 12th Grade|Overall Study||3876
9729018|NCT00115869|10828590|FG001|Completed Data Collection at 12th Grade|Overall Study||3847
9729019|NCT00115869|10828589|FG000|COMPLETED|Overall Study||3894
9729020|NCT00115869|10828590|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
9729021|NCT00115869|10828589|FG000|NOT COMPLETED|Overall Study||317
9729022|NCT00115869|10828590|FG001|NOT COMPLETED|Overall Study||296
10028978|NCT01894906|11153188|FG001|Treatment D|Overall Study||6
10028979|NCT01894906|11153187|FG000|Treatment E|Overall Study||6
9704487|NCT04190693|10804126|FG000|STARTED|Overall Study||4
9704488|NCT04190693|10804127|FG001|STARTED|Overall Study||7
9704489|NCT04190693|10804128|FG002|STARTED|Overall Study||12
9704490|NCT04190693|10804129|FG003|STARTED|Overall Study||7
9704491|NCT04190693|10804126|FG000|COMPLETED|Overall Study||4
9704492|NCT04190693|10804127|FG001|COMPLETED|Overall Study||7
9704493|NCT04190693|10804128|FG002|COMPLETED|Overall Study||12
9704494|NCT04190693|10804129|FG003|COMPLETED|Overall Study||7
9704495|NCT04190693|10804126|FG000|NOT COMPLETED|Overall Study||0
9704496|NCT04190693|10804127|FG001|NOT COMPLETED|Overall Study||0
9704497|NCT04190693|10804128|FG002|NOT COMPLETED|Overall Study||0
9704498|NCT04190693|10804129|FG003|NOT COMPLETED|Overall Study||0
9704499|NCT04170608|10804139|FG000|STARTED|Overall Study||10
9704500|NCT04170608|10804139|FG000|COMPLETED|Overall Study||10
9704501|NCT04170608|10804139|FG000|NOT COMPLETED|Overall Study||0
9704502|NCT04150068|10804146|FG000|STARTED|Functional Mono/Oral Lead-in (14 Days)||24
9704503|NCT04150068|10804147|FG001|STARTED|Functional Mono/Oral Lead-in (14 Days)||12
9704504|NCT04150068|10804148|FG002|STARTED|Functional Mono/Oral Lead-in (14 Days)||36
9704505|NCT04150068|10804146|FG000|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||24
9704506|NCT04150068|10804147|FG001|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||12
9704507|NCT04150068|10804148|FG002|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||36
9704508|NCT04150068|10804146|FG000|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
9704509|NCT04150068|10804147|FG001|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
9704510|NCT04150068|10804148|FG002|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
9704511|NCT04150068|10804146|FG000|STARTED|Maintenance Period (Week 26 Analysis)||24
9704512|NCT04150068|10804147|FG001|STARTED|Maintenance Period (Week 26 Analysis)||12
9704513|NCT04150068|10804148|FG002|STARTED|Maintenance Period (Week 26 Analysis)||36
9704514|NCT04150068|10804146|FG000|COMPLETED|Maintenance Period (Week 26 Analysis)||0
9704515|NCT04150068|10804147|FG001|COMPLETED|Maintenance Period (Week 26 Analysis)||0
9704516|NCT04150068|10804148|FG002|COMPLETED|Maintenance Period (Week 26 Analysis)||0
9704517|NCT04150068|10804146|FG000|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||24
9704518|NCT04150068|10804147|FG001|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||12
9704519|NCT04150068|10804148|FG002|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||36
9704520|NCT04133519|10804157|FG000|STARTED|Overall Study||188
9704521|NCT04133519|10804158|FG001|STARTED|Overall Study||190
9704522|NCT04133519|10804157|FG000|COMPLETED|Overall Study||182
9704523|NCT04133519|10804158|FG001|COMPLETED|Overall Study||184
9704524|NCT04133519|10804157|FG000|NOT COMPLETED|Overall Study||6
9704525|NCT04133519|10804158|FG001|NOT COMPLETED|Overall Study||6
9704526|NCT04118270|10804166|FG000|STARTED|Overall Study||37
9704527|NCT04118270|10804167|FG001|STARTED|Overall Study||13
9704528|NCT04118270|10804166|FG000|Completed Provider Accuracy Assessment|Overall Study|Only the Providers were eligible for completing the Provider Accuracy Assessment.|0
9704529|NCT04118270|10804167|FG001|Completed Provider Accuracy Assessment|Overall Study||10
9704530|NCT04118270|10804166|FG000|COMPLETED|Overall Study||37
9704531|NCT04118270|10804167|FG001|COMPLETED|Overall Study||13
9704532|NCT04118270|10804166|FG000|NOT COMPLETED|Overall Study||0
9704533|NCT04118270|10804167|FG001|NOT COMPLETED|Overall Study||0
9704534|NCT04098367|10804178|FG000|STARTED|Overall Study||63
9704535|NCT04098367|10804179|FG001|STARTED|Overall Study||65
9704536|NCT04098367|10804180|FG002|STARTED|Overall Study||65
9704537|NCT04098367|10804178|FG000|First Eye Implanted|Overall Study||63
9704538|NCT04098367|10804179|FG001|First Eye Implanted|Overall Study||65
9704539|NCT04098367|10804180|FG002|First Eye Implanted|Overall Study||65
9704540|NCT04098367|10804178|FG000|Second Eye Implanted|Overall Study||63
9704541|NCT04098367|10804179|FG001|Second Eye Implanted|Overall Study||65
9704542|NCT04098367|10804180|FG002|Second Eye Implanted|Overall Study||63
9704543|NCT04098367|10804178|FG000|COMPLETED|Overall Study||61
9704544|NCT04098367|10804179|FG001|COMPLETED|Overall Study||60
9704545|NCT04098367|10804180|FG002|COMPLETED|Overall Study||61
9704546|NCT04098367|10804178|FG000|NOT COMPLETED|Overall Study||2
9704547|NCT04098367|10804179|FG001|NOT COMPLETED|Overall Study||5
9704548|NCT04098367|10804180|FG002|NOT COMPLETED|Overall Study||4
9704549|NCT04091087|10804197|FG000|STARTED|Overall Study||33
9704550|NCT04091087|10804198|FG001|STARTED|Overall Study||33
9704551|NCT04091087|10804197|FG000|Treated|Overall Study||32
9704552|NCT04091087|10804198|FG001|Treated|Overall Study||33
9704553|NCT04091087|10804197|FG000|COMPLETED|Overall Study||23
9704554|NCT04091087|10804198|FG001|COMPLETED|Overall Study||26
9704555|NCT04091087|10804197|FG000|NOT COMPLETED|Overall Study||10
9704556|NCT04091087|10804198|FG001|NOT COMPLETED|Overall Study||7
9704557|NCT04009629|10804206|FG000|STARTED|Overall Study||23
9704558|NCT04009629|10804207|FG001|STARTED|Overall Study||38
9704559|NCT04009629|10804206|FG000|COMPLETED|Overall Study||21
9704560|NCT04009629|10804207|FG001|COMPLETED|Overall Study||38
9704561|NCT04009629|10804206|FG000|NOT COMPLETED|Overall Study||2
9704562|NCT04009629|10804207|FG001|NOT COMPLETED|Overall Study||0
9704563|NCT03937908|10804216|FG000|STARTED|Overall Study||2
9704564|NCT03937908|10804217|FG001|STARTED|Overall Study||3
9704565|NCT03937908|10804216|FG000|COMPLETED|Overall Study||2
9704566|NCT03937908|10804217|FG001|COMPLETED|Overall Study||2
9848168|NCT00857584|10960832|FG000|Week 1|Overall Study||14
9704567|NCT03937908|10804216|FG000|NOT COMPLETED|Overall Study||0
9704568|NCT03937908|10804217|FG001|NOT COMPLETED|Overall Study||1
9704569|NCT03891264|10804223|FG000|STARTED|Overall Study||7
9704570|NCT03891264|10804223|FG000|Received Intervention|Overall Study||3
9704571|NCT03891264|10804223|FG000|COMPLETED|Overall Study||2
9704572|NCT03891264|10804223|FG000|NOT COMPLETED|Overall Study||5
9704573|NCT03839082|10804229|FG000|STARTED|Initial Randomization||33
9704574|NCT03839082|10804230|FG001|STARTED|Initial Randomization||37
9704575|NCT03839082|10804229|FG000|COMPLETED|Initial Randomization||7
9704576|NCT03839082|10804230|FG001|COMPLETED|Initial Randomization||12
9704577|NCT03839082|10804229|FG000|NOT COMPLETED|Initial Randomization||26
9704578|NCT03839082|10804230|FG001|NOT COMPLETED|Initial Randomization||25
9704579|NCT03839082|10804229|FG000|STARTED|Crossover to Other Arm||7
9704580|NCT03839082|10804230|FG001|STARTED|Crossover to Other Arm||12
9704581|NCT03839082|10804229|FG000|COMPLETED|Crossover to Other Arm||0
9704582|NCT03839082|10804230|FG001|COMPLETED|Crossover to Other Arm||0
9704583|NCT03839082|10804229|FG000|NOT COMPLETED|Crossover to Other Arm||7
9704584|NCT03839082|10804230|FG001|NOT COMPLETED|Crossover to Other Arm||12
9704585|NCT03835351|10804238|FG000|STARTED|Overall Study||241
9704586|NCT03835351|10804239|FG001|STARTED|Overall Study||250
9704587|NCT03835351|10804238|FG000|COMPLETED|Overall Study||241
9704588|NCT03835351|10804239|FG001|COMPLETED|Overall Study||250
9704589|NCT03835351|10804238|FG000|NOT COMPLETED|Overall Study||0
9704590|NCT03835351|10804239|FG001|NOT COMPLETED|Overall Study||0
9704591|NCT03823300|10804247|FG000|STARTED|Overall Study||331
9704592|NCT03823300|10804248|FG001|STARTED|Overall Study||327
10028980|NCT01894906|11153188|FG001|Treatment E|Overall Study||6
10028981|NCT01894906|11153187|FG000|Treatment F|Overall Study||6
10028982|NCT01894906|11153188|FG001|Treatment F|Overall Study||6
10028983|NCT01894906|11153187|FG000|COMPLETED|Overall Study||6
10028984|NCT01894906|11153188|FG001|COMPLETED|Overall Study||6
9704593|NCT03823300|10804247|FG000|Received at Least One Dose of Study Drug|Overall Study||331
9704594|NCT03823300|10804248|FG001|Received at Least One Dose of Study Drug|Overall Study||326
9704595|NCT03823300|10804247|FG000|Completed up to Week 48|Overall Study||321
9704596|NCT03823300|10804248|FG001|Completed up to Week 48|Overall Study||309
9704597|NCT03823300|10804247|FG000|COMPLETED|Overall Study||0
9704598|NCT03823300|10804248|FG001|COMPLETED|Overall Study||0
9704599|NCT03823300|10804247|FG000|NOT COMPLETED|Overall Study||331
9704600|NCT03823300|10804248|FG001|NOT COMPLETED|Overall Study||327
9704601|NCT03823287|10804256|FG000|STARTED|Overall Study||334
9704602|NCT03823287|10804257|FG001|STARTED|Overall Study||337
9704603|NCT03823287|10804256|FG000|Received at Least One Dose of Study Drug|Overall Study||333
9704604|NCT03823287|10804257|FG001|Received at Least One Dose of Study Drug|Overall Study||336
9704605|NCT03823287|10804256|FG000|Completed up to Week 48|Overall Study||319
9704606|NCT03823287|10804257|FG001|Completed up to Week 48|Overall Study||323
9704607|NCT03823287|10804256|FG000|COMPLETED|Overall Study||0
9704608|NCT03823287|10804257|FG001|COMPLETED|Overall Study||0
9704609|NCT03823287|10804256|FG000|NOT COMPLETED|Overall Study||334
9704610|NCT03823287|10804257|FG001|NOT COMPLETED|Overall Study||337
9704611|NCT03815175|10804263|FG000|STARTED|Overall Study||1605
9704612|NCT03815175|10804263|FG000|COMPLETED|Overall Study||1439
9704613|NCT03815175|10804263|FG000|NOT COMPLETED|Overall Study||166
9704614|NCT03812224|10804269|FG000|STARTED|Double-blind Treatment Period||131
9704615|NCT03812224|10804270|FG001|STARTED|Double-blind Treatment Period||130
9704616|NCT03812224|10804269|FG000|COMPLETED|Double-blind Treatment Period||127
9704617|NCT03812224|10804270|FG001|COMPLETED|Double-blind Treatment Period||127
9704618|NCT03812224|10804269|FG000|NOT COMPLETED|Double-blind Treatment Period||4
9704619|NCT03812224|10804270|FG001|NOT COMPLETED|Double-blind Treatment Period||3
9704620|NCT03812224|10804269|FG000|STARTED|Open-label Treatment Period||127
9704621|NCT03812224|10804270|FG001|STARTED|Open-label Treatment Period||127
9704622|NCT03812224|10804269|FG000|COMPLETED|Open-label Treatment Period||125
9704623|NCT03812224|10804270|FG001|COMPLETED|Open-label Treatment Period||124
9704624|NCT03812224|10804269|FG000|NOT COMPLETED|Open-label Treatment Period||2
9704625|NCT03812224|10804270|FG001|NOT COMPLETED|Open-label Treatment Period||3
9729023|NCT00115934|10828600|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
9729024|NCT00115934|10828601|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
9729025|NCT00115934|10828600|FG000|COMPLETED|Overall Study||275
9729026|NCT00115934|10828601|FG001|COMPLETED|Overall Study||274
9729027|NCT00115934|10828600|FG000|NOT COMPLETED|Overall Study||4
9729028|NCT00115934|10828601|FG001|NOT COMPLETED|Overall Study||2
9729029|NCT00116168|10828611|FG000|STARTED|Overall Study||6
9729030|NCT00116168|10828612|FG001|STARTED|Overall Study||11
9729031|NCT00116168|10828613|FG002|STARTED|Overall Study||6
9729032|NCT00116168|10828614|FG003|STARTED|Overall Study||6
10028985|NCT01894906|11153187|FG000|NOT COMPLETED|Overall Study||0
9729033|NCT00116168|10828611|FG000|COMPLETED|Overall Study||0
9729034|NCT00116168|10828612|FG001|COMPLETED|Overall Study||6
9729035|NCT00116168|10828613|FG002|COMPLETED|Overall Study||6
9729036|NCT00116168|10828614|FG003|COMPLETED|Overall Study||6
9729037|NCT00116168|10828611|FG000|NOT COMPLETED|Overall Study||6
9729038|NCT00116168|10828612|FG001|NOT COMPLETED|Overall Study||5
9729039|NCT00116168|10828613|FG002|NOT COMPLETED|Overall Study||0
9729040|NCT00116168|10828614|FG003|NOT COMPLETED|Overall Study||0
9729041|NCT00116207|10828626|FG000|STARTED|Overall Study||22
9729042|NCT00116207|10828627|FG001|STARTED|Overall Study||22
9729043|NCT00116207|10828626|FG000|COMPLETED|Overall Study||13
9729044|NCT00116207|10828627|FG001|COMPLETED|Overall Study||18
9729045|NCT00116207|10828626|FG000|NOT COMPLETED|Overall Study||9
10028986|NCT01894906|11153188|FG001|NOT COMPLETED|Overall Study||0
10028987|NCT01894919|11153219|FG000|STARTED|Overall Study||98
9704626|NCT03794024|10804279|FG000|STARTED|Overall Study||1
9704627|NCT03794024|10804280|FG001|STARTED|Overall Study||0
9704628|NCT03794024|10804279|FG000|COMPLETED|Overall Study||0
9704629|NCT03794024|10804280|FG001|COMPLETED|Overall Study||0
9704630|NCT03794024|10804279|FG000|NOT COMPLETED|Overall Study||1
9704631|NCT03794024|10804280|FG001|NOT COMPLETED|Overall Study||0
9704632|NCT03770455|10804286|FG000|STARTED|Overall Study||5
9704633|NCT03770455|10804286|FG000|COMPLETED|Overall Study||5
9704634|NCT03770455|10804286|FG000|NOT COMPLETED|Overall Study||0
9704635|NCT03714178|10804290|FG000|STARTED|Overall Study||71
9704636|NCT03714178|10804290|FG000|COMPLETED|Overall Study||71
9704637|NCT03714178|10804290|FG000|NOT COMPLETED|Overall Study||0
9704638|NCT03709342|10804294|FG000|STARTED|Overall Study||7
9704639|NCT03709342|10804294|FG000|COMPLETED|Overall Study||7
9704640|NCT03709342|10804294|FG000|NOT COMPLETED|Overall Study||0
9704641|NCT03691623|10804304|FG000|STARTED|Overall Study||39
9704642|NCT03691623|10804305|FG001|STARTED|Overall Study||38
9704643|NCT03691623|10804306|FG002|STARTED|Overall Study||38
9704644|NCT03691623|10804307|FG003|STARTED|Overall Study||21
9704645|NCT03691623|10804308|FG004|STARTED|Overall Study||21
9704646|NCT03691623|10804309|FG005|STARTED|Overall Study||21
9704647|NCT03691623|10804304|FG000|Inoculated With Challenge Virus|Overall Study||39
9704648|NCT03691623|10804305|FG001|Inoculated With Challenge Virus|Overall Study||38
9704649|NCT03691623|10804306|FG002|Inoculated With Challenge Virus|Overall Study||38
9704650|NCT03691623|10804307|FG003|Inoculated With Challenge Virus|Overall Study||21
9704651|NCT03691623|10804308|FG004|Inoculated With Challenge Virus|Overall Study||21
9704652|NCT03691623|10804309|FG005|Inoculated With Challenge Virus|Overall Study||21
9848169|NCT00857584|10960833|FG001|Week 1|Overall Study||13
9848170|NCT00857584|10960832|FG000|Week 2|Overall Study||14
10028988|NCT01894919|11153220|FG001|STARTED|Overall Study||47
10028989|NCT01894919|11153221|FG002|STARTED|Overall Study||89
10028990|NCT01894919|11153222|FG003|STARTED|Overall Study||43
10028991|NCT01894919|11153223|FG004|STARTED|Overall Study||81
10028992|NCT01894919|11153224|FG005|STARTED|Overall Study||39
10028993|NCT01894919|11153225|FG006|STARTED|Overall Study||32
10028994|NCT01894919|11153226|FG007|STARTED|Overall Study||36
10028995|NCT01894919|11153227|FG008|STARTED|Overall Study||91
10028996|NCT01894919|11153228|FG009|STARTED|Overall Study||90
10028997|NCT01894919|11153229|FG010|STARTED|Overall Study||100
10028998|NCT01894919|11153230|FG011|STARTED|Overall Study||55
10028999|NCT01894919|11153231|FG012|STARTED|Overall Study||50
10029000|NCT01894919|11153219|FG000|COMPLETED|Overall Study||96
9848171|NCT00857584|10960833|FG001|Week 2|Overall Study||11
9848172|NCT00857584|10960832|FG000|Week 4|Overall Study||11
9848173|NCT00857584|10960833|FG001|Week 4|Overall Study||9
9848174|NCT00857584|10960832|FG000|Week 8|Overall Study||10
9848175|NCT00857584|10960833|FG001|Week 8|Overall Study||8
9848176|NCT00857584|10960832|FG000|COMPLETED|Overall Study||10
9848177|NCT00857584|10960833|FG001|COMPLETED|Overall Study||8
9848178|NCT00857584|10960832|FG000|NOT COMPLETED|Overall Study||4
9848179|NCT00857584|10960833|FG001|NOT COMPLETED|Overall Study||5
9848180|NCT00857623|10960841|FG000|STARTED|Overall Study||62
9848181|NCT00857623|10960842|FG001|STARTED|Overall Study||65
9848182|NCT00857623|10960841|FG000|COMPLETED|Overall Study||48
9848183|NCT00857623|10960842|FG001|COMPLETED|Overall Study||55
9848184|NCT00857623|10960841|FG000|NOT COMPLETED|Overall Study||14
9848185|NCT00857623|10960842|FG001|NOT COMPLETED|Overall Study||10
9848186|NCT00857649|10960850|FG000|STARTED|Overall Study||182
9848187|NCT00857649|10960851|FG001|STARTED|Overall Study||187
9848188|NCT00857649|10960850|FG000|COMPLETED|Overall Study||151
9848189|NCT00857649|10960851|FG001|COMPLETED|Overall Study||155
9848190|NCT00857649|10960850|FG000|NOT COMPLETED|Overall Study||31
9848191|NCT00857649|10960851|FG001|NOT COMPLETED|Overall Study||32
9848192|NCT00857714|10960857|FG000|STARTED|Overall Study||1
9848193|NCT00857714|10960857|FG000|COMPLETED|Overall Study||1
9848194|NCT00857714|10960857|FG000|NOT COMPLETED|Overall Study||0
9848195|NCT00857727|10960863|FG000|STARTED|Overall Study||14
9848196|NCT00857727|10960864|FG001|STARTED|Overall Study||14
9848197|NCT00857727|10960863|FG000|COMPLETED|Overall Study||14
9848198|NCT00857727|10960864|FG001|COMPLETED|Overall Study||14
9848199|NCT00857727|10960863|FG000|NOT COMPLETED|Overall Study||0
9848200|NCT00857727|10960864|FG001|NOT COMPLETED|Overall Study||0
9848201|NCT00857766|10960872|FG000|STARTED|Overall Study||123
9848202|NCT00857766|10960873|FG001|STARTED|Overall Study||126
9848203|NCT00857766|10960872|FG000|COMPLETED|Overall Study||92
9848204|NCT00857766|10960873|FG001|COMPLETED|Overall Study||96
9848205|NCT00857766|10960872|FG000|NOT COMPLETED|Overall Study||31
9848206|NCT00857766|10960873|FG001|NOT COMPLETED|Overall Study||30
9848207|NCT00857792|10960879|FG000|STARTED|Overall Study||120
9848208|NCT00857792|10960879|FG000|COMPLETED|Overall Study||108
9848209|NCT00857792|10960879|FG000|NOT COMPLETED|Overall Study||12
9848210|NCT00857818|10960885|FG000|STARTED|Overall Study||14
9848211|NCT00857818|10960886|FG001|STARTED|Overall Study||14
9848212|NCT00857818|10960885|FG000|Received Treatment|Overall Study||14
9848213|NCT00857818|10960886|FG001|Received Treatment|Overall Study||12
10029001|NCT01894919|11153220|FG001|COMPLETED|Overall Study||47
10029002|NCT01894919|11153221|FG002|COMPLETED|Overall Study||89
10029003|NCT01894919|11153222|FG003|COMPLETED|Overall Study||43
10029004|NCT01894919|11153223|FG004|COMPLETED|Overall Study||78
10029005|NCT01894919|11153224|FG005|COMPLETED|Overall Study||39
10029006|NCT01894919|11153225|FG006|COMPLETED|Overall Study||32
10029007|NCT01894919|11153226|FG007|COMPLETED|Overall Study||36
10029008|NCT01894919|11153227|FG008|COMPLETED|Overall Study||91
9704653|NCT03691623|10804304|FG000|Received Treatment|Overall Study||38
9704654|NCT03691623|10804305|FG001|Received Treatment|Overall Study||38
10029009|NCT01894919|11153228|FG009|COMPLETED|Overall Study||89
10029010|NCT01894919|11153229|FG010|COMPLETED|Overall Study||98
10029011|NCT01894919|11153230|FG011|COMPLETED|Overall Study||55
10029012|NCT01894919|11153231|FG012|COMPLETED|Overall Study||50
10029013|NCT01894919|11153219|FG000|NOT COMPLETED|Overall Study||2
10029014|NCT01894919|11153220|FG001|NOT COMPLETED|Overall Study||0
10029015|NCT01894919|11153221|FG002|NOT COMPLETED|Overall Study||0
10029016|NCT01894919|11153222|FG003|NOT COMPLETED|Overall Study||0
10029017|NCT01894919|11153223|FG004|NOT COMPLETED|Overall Study||3
10029018|NCT01894919|11153224|FG005|NOT COMPLETED|Overall Study||0
10029019|NCT01894919|11153225|FG006|NOT COMPLETED|Overall Study||0
10029020|NCT01894919|11153226|FG007|NOT COMPLETED|Overall Study||0
10029021|NCT01894919|11153227|FG008|NOT COMPLETED|Overall Study||0
10029022|NCT01894919|11153228|FG009|NOT COMPLETED|Overall Study||1
9704655|NCT03691623|10804306|FG002|Received Treatment|Overall Study||38
9704656|NCT03691623|10804307|FG003|Received Treatment|Overall Study||21
9704657|NCT03691623|10804308|FG004|Received Treatment|Overall Study||21
9704658|NCT03691623|10804309|FG005|Received Treatment|Overall Study||21
9704659|NCT03691623|10804304|FG000|COMPLETED|Overall Study||39
9704660|NCT03691623|10804305|FG001|COMPLETED|Overall Study||38
9848214|NCT00857818|10960885|FG000|COMPLETED|Overall Study||3
9848215|NCT00857818|10960886|FG001|COMPLETED|Overall Study||6
9848216|NCT00857818|10960885|FG000|NOT COMPLETED|Overall Study||11
9848217|NCT00857818|10960886|FG001|NOT COMPLETED|Overall Study||8
9848218|NCT00857857|10960892|FG000|STARTED|Overall Study||24
9848219|NCT00857857|10960892|FG000|COMPLETED|Overall Study||24
9848220|NCT00857857|10960892|FG000|NOT COMPLETED|Overall Study||0
10029023|NCT01894919|11153229|FG010|NOT COMPLETED|Overall Study||2
10029024|NCT01894919|11153230|FG011|NOT COMPLETED|Overall Study||0
10029025|NCT01894919|11153231|FG012|NOT COMPLETED|Overall Study||0
10029026|NCT01894984|11153275|FG000|STARTED|Overall Study||396
10029027|NCT01894984|11153276|FG001|STARTED|Overall Study||244
10029028|NCT01894984|11153275|FG000|COMPLETED|Overall Study||82
10029029|NCT01894984|11153276|FG001|COMPLETED|Overall Study||69
10029030|NCT01894984|11153275|FG000|NOT COMPLETED|Overall Study||314
10029031|NCT01894984|11153276|FG001|NOT COMPLETED|Overall Study||175
10029032|NCT01895036|11153282|FG000|STARTED|Overall Study||6
10029033|NCT01895036|11153282|FG000|COMPLETED|Overall Study||6
10029034|NCT01895036|11153282|FG000|NOT COMPLETED|Overall Study||0
10029035|NCT01895062|11153288|FG000|STARTED|Overall Study||30
10029036|NCT01895062|11153289|FG001|STARTED|Overall Study||24
10029037|NCT01895062|11153288|FG000|COMPLETED|Overall Study||30
10029038|NCT01895062|11153289|FG001|COMPLETED|Overall Study||24
10029039|NCT01895062|11153288|FG000|NOT COMPLETED|Overall Study||0
10029040|NCT01895062|11153289|FG001|NOT COMPLETED|Overall Study||0
10029041|NCT01895088|11153295|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
10029042|NCT01895088|11153295|FG000|COMPLETED|Overall Study||253
10029043|NCT01895088|11153295|FG000|NOT COMPLETED|Overall Study||18
10115485|NCT02526160|11246304|FG000|STARTED|Open-Label Treatment Extension Period II||52
10115486|NCT02526160|11246305|FG001|STARTED|Open-Label Treatment Extension Period II||49
10115487|NCT02526160|11246304|FG000|COMPLETED|Open-Label Treatment Extension Period II||51
10115488|NCT02526160|11246305|FG001|COMPLETED|Open-Label Treatment Extension Period II||49
10115489|NCT02526160|11246304|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1
10115490|NCT02526160|11246305|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0
10115491|NCT02526212|11246318|FG000|STARTED|Overall Study||10
10115492|NCT02526212|11246319|FG001|STARTED|Overall Study||8
10115493|NCT02526212|11246318|FG000|COMPLETED|Overall Study||8
10115494|NCT02526212|11246319|FG001|COMPLETED|Overall Study||7
10115495|NCT02526212|11246318|FG000|NOT COMPLETED|Overall Study||2
10115496|NCT02526212|11246319|FG001|NOT COMPLETED|Overall Study||1
10115497|NCT02526277|11246329|FG000|STARTED|Overall Study||8
10115498|NCT02526277|11246330|FG001|STARTED|Overall Study||6
10115499|NCT02526277|11246331|FG002|STARTED|Overall Study||7
10115500|NCT02526277|11246332|FG003|STARTED|Overall Study||7
10115501|NCT02526277|11246329|FG000|COMPLETED|Overall Study||8
10115502|NCT02526277|11246330|FG001|COMPLETED|Overall Study||6
10115503|NCT02526277|11246331|FG002|COMPLETED|Overall Study||7
10115504|NCT02526277|11246332|FG003|COMPLETED|Overall Study||7
10115505|NCT02526277|11246329|FG000|NOT COMPLETED|Overall Study||0
10115506|NCT02526277|11246330|FG001|NOT COMPLETED|Overall Study||0
10115507|NCT02526277|11246331|FG002|NOT COMPLETED|Overall Study||0
10115508|NCT02526277|11246332|FG003|NOT COMPLETED|Overall Study||0
10115509|NCT02526290|11246345|FG000|STARTED|Overall Study||97
10115510|NCT02526290|11246345|FG000|COMPLETED|Overall Study||89
10115511|NCT02526290|11246345|FG000|NOT COMPLETED|Overall Study||8
10115512|NCT02526524|11246355|FG000|STARTED|Overall Study||94
10115513|NCT02526524|11246356|FG001|STARTED|Overall Study||95
10115514|NCT02526524|11246357|FG002|STARTED|Overall Study||96
9704661|NCT03691623|10804306|FG002|COMPLETED|Overall Study||38
9704662|NCT03691623|10804307|FG003|COMPLETED|Overall Study||21
9704663|NCT03691623|10804308|FG004|COMPLETED|Overall Study||21
10029044|NCT01895101|11153302|FG000|STARTED|Overall Study||250
10029045|NCT01895101|11153303|FG001|STARTED|Overall Study||250
10029046|NCT01895101|11153304|FG002|STARTED|Overall Study||250
10029047|NCT01895101|11153302|FG000|COMPLETED|Overall Study||249
9704664|NCT03691623|10804309|FG005|COMPLETED|Overall Study||21
9704665|NCT03691623|10804304|FG000|NOT COMPLETED|Overall Study||0
9704666|NCT03691623|10804305|FG001|NOT COMPLETED|Overall Study||0
9704667|NCT03691623|10804306|FG002|NOT COMPLETED|Overall Study||0
9704668|NCT03691623|10804307|FG003|NOT COMPLETED|Overall Study||0
9704669|NCT03691623|10804308|FG004|NOT COMPLETED|Overall Study||0
9704670|NCT03691623|10804309|FG005|NOT COMPLETED|Overall Study||0
9704671|NCT03689374|10804328|FG000|STARTED|Run-in Period (12 Weeks)||2274
9704672|NCT03689374|10804329|FG001|STARTED|Run-in Period (12 Weeks)||0
9704673|NCT03689374|10804330|FG002|STARTED|Run-in Period (12 Weeks)||0
9704674|NCT03689374|10804328|FG000|COMPLETED|Run-in Period (12 Weeks)||1748
9704675|NCT03689374|10804329|FG001|COMPLETED|Run-in Period (12 Weeks)||0
9704676|NCT03689374|10804330|FG002|COMPLETED|Run-in Period (12 Weeks)||0
9704677|NCT03689374|10804328|FG000|NOT COMPLETED|Run-in Period (12 Weeks)||526
9704678|NCT03689374|10804329|FG001|NOT COMPLETED|Run-in Period (12 Weeks)||0
9704679|NCT03689374|10804330|FG002|NOT COMPLETED|Run-in Period (12 Weeks)||0
9704680|NCT03689374|10804328|FG000|STARTED|Treatment Period (Week 0 to 52)||0
9704681|NCT03689374|10804329|FG001|STARTED|Treatment Period (Week 0 to 52)||874
9704682|NCT03689374|10804330|FG002|STARTED|Treatment Period (Week 0 to 52)||874
9704683|NCT03689374|10804328|FG000|Treated|Treatment Period (Week 0 to 52)||0
9704684|NCT03689374|10804329|FG001|Treated|Treatment Period (Week 0 to 52)||874
9704685|NCT03689374|10804330|FG002|Treated|Treatment Period (Week 0 to 52)||864
9704686|NCT03689374|10804328|FG000|Full Analysis Set|Treatment Period (Week 0 to 52)||0
9704687|NCT03689374|10804329|FG001|Full Analysis Set|Treatment Period (Week 0 to 52)||874
9704688|NCT03689374|10804330|FG002|Full Analysis Set|Treatment Period (Week 0 to 52)||874
9704689|NCT03689374|10804328|FG000|Safety Analysis Set|Treatment Period (Week 0 to 52)||0
9704690|NCT03689374|10804329|FG001|Safety Analysis Set|Treatment Period (Week 0 to 52)||874
9704691|NCT03689374|10804330|FG002|Safety Analysis Set|Treatment Period (Week 0 to 52)||864
9704692|NCT03689374|10804328|FG000|COMPLETED|Treatment Period (Week 0 to 52)||0
9704693|NCT03689374|10804329|FG001|COMPLETED|Treatment Period (Week 0 to 52)||850
9704694|NCT03689374|10804330|FG002|COMPLETED|Treatment Period (Week 0 to 52)||831
9704695|NCT03689374|10804328|FG000|NOT COMPLETED|Treatment Period (Week 0 to 52)||0
9704696|NCT03689374|10804329|FG001|NOT COMPLETED|Treatment Period (Week 0 to 52)||24
9704697|NCT03689374|10804330|FG002|NOT COMPLETED|Treatment Period (Week 0 to 52)||43
9704698|NCT03604549|10804338|FG000|STARTED|Overall Study||29
9704699|NCT03604549|10804339|FG001|STARTED|Overall Study||29
9704700|NCT03604549|10804338|FG000|COMPLETED|Overall Study||24
9704701|NCT03604549|10804339|FG001|COMPLETED|Overall Study||24
9704702|NCT03604549|10804338|FG000|NOT COMPLETED|Overall Study||5
9704703|NCT03604549|10804339|FG001|NOT COMPLETED|Overall Study||5
9704704|NCT03603639|10804345|FG000|STARTED|Treatment Period 1 (Day 1)||1
9704705|NCT03603639|10804346|FG001|STARTED|Treatment Period 1 (Day 1)||1
9704706|NCT03603639|10804347|FG002|STARTED|Treatment Period 1 (Day 1)||1
9704707|NCT03603639|10804348|FG003|STARTED|Treatment Period 1 (Day 1)||1
9704708|NCT03603639|10804349|FG004|STARTED|Treatment Period 1 (Day 1)||1
9704709|NCT03603639|10804350|FG005|STARTED|Treatment Period 1 (Day 1)||1
9704710|NCT03603639|10804345|FG000|COMPLETED|Treatment Period 1 (Day 1)||1
9704711|NCT03603639|10804346|FG001|COMPLETED|Treatment Period 1 (Day 1)||1
9704712|NCT03603639|10804347|FG002|COMPLETED|Treatment Period 1 (Day 1)||1
9704713|NCT03603639|10804348|FG003|COMPLETED|Treatment Period 1 (Day 1)||1
9704714|NCT03603639|10804349|FG004|COMPLETED|Treatment Period 1 (Day 1)||1
9704715|NCT03603639|10804350|FG005|COMPLETED|Treatment Period 1 (Day 1)||1
9704716|NCT03603639|10804345|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9704717|NCT03603639|10804346|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9704718|NCT03603639|10804347|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9704719|NCT03603639|10804348|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9704720|NCT03603639|10804349|FG004|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9704721|NCT03603639|10804350|FG005|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9704722|NCT03603639|10804345|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
9704723|NCT03603639|10804346|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
9704724|NCT03603639|10804347|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
9704725|NCT03603639|10804348|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
9704726|NCT03603639|10804349|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
9704727|NCT03603639|10804350|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
9704728|NCT03603639|10804345|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704729|NCT03603639|10804346|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704730|NCT03603639|10804347|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704731|NCT03603639|10804348|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704732|NCT03603639|10804349|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704733|NCT03603639|10804350|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704734|NCT03603639|10804345|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704735|NCT03603639|10804346|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704736|NCT03603639|10804347|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704737|NCT03603639|10804348|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704738|NCT03603639|10804349|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704739|NCT03603639|10804350|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704740|NCT03603639|10804345|FG000|STARTED|Treatment Period 2 (Day 1)||1
9704741|NCT03603639|10804346|FG001|STARTED|Treatment Period 2 (Day 1)||1
9704742|NCT03603639|10804347|FG002|STARTED|Treatment Period 2 (Day 1)||1
9704743|NCT03603639|10804348|FG003|STARTED|Treatment Period 2 (Day 1)||1
9704744|NCT03603639|10804349|FG004|STARTED|Treatment Period 2 (Day 1)||1
9704745|NCT03603639|10804350|FG005|STARTED|Treatment Period 2 (Day 1)||1
9704746|NCT03603639|10804345|FG000|COMPLETED|Treatment Period 2 (Day 1)||1
9704747|NCT03603639|10804346|FG001|COMPLETED|Treatment Period 2 (Day 1)||1
9704748|NCT03603639|10804347|FG002|COMPLETED|Treatment Period 2 (Day 1)||1
9704749|NCT03603639|10804348|FG003|COMPLETED|Treatment Period 2 (Day 1)||1
10029048|NCT01895101|11153303|FG001|COMPLETED|Overall Study||245
10029049|NCT01895101|11153304|FG002|COMPLETED|Overall Study||245
10029050|NCT01895101|11153302|FG000|NOT COMPLETED|Overall Study||1
10029051|NCT01895101|11153303|FG001|NOT COMPLETED|Overall Study||5
10029052|NCT01895101|11153304|FG002|NOT COMPLETED|Overall Study||5
10029053|NCT01895127|11153314|FG000|STARTED|Screening||4
10029054|NCT01895127|11153315|FG001|STARTED|Screening||7
10029055|NCT01895127|11153314|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
10029056|NCT01895127|11153315|FG001|COMPLETED|Screening||7
10029057|NCT01895127|11153314|FG000|NOT COMPLETED|Screening||0
10029058|NCT01895127|11153315|FG001|NOT COMPLETED|Screening||0
10029059|NCT01895127|11153314|FG000|STARTED|Treatment Period (Week 0-Month 3)||3
10029060|NCT01895127|11153315|FG001|STARTED|Treatment Period (Week 0-Month 3)||7
10029061|NCT01895127|11153314|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3
10029062|NCT01895127|11153315|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7
10029063|NCT01895127|11153314|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
10029064|NCT01895127|11153315|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
10029065|NCT01895127|11153314|FG000|STARTED|Month 3 Follow-up & Biopsy||3
10029066|NCT01895127|11153315|FG001|STARTED|Month 3 Follow-up & Biopsy||7
10029067|NCT01895127|11153314|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3
10029068|NCT01895127|11153315|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7
9704750|NCT03603639|10804349|FG004|COMPLETED|Treatment Period 2 (Day 1)||1
9704751|NCT03603639|10804350|FG005|COMPLETED|Treatment Period 2 (Day 1)||1
10029069|NCT01895127|11153314|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
10029070|NCT01895127|11153315|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
10029071|NCT01895127|11153314|FG000|STARTED|Long Term Follow-up (Month 3-12)||3
10029072|NCT01895127|11153315|FG001|STARTED|Long Term Follow-up (Month 3-12)||7
10029073|NCT01895127|11153314|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1
10029074|NCT01895127|11153315|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4
10029075|NCT01895127|11153314|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
10029076|NCT01895127|11153315|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
10029077|NCT01895270|11153324|FG000|STARTED|Study Medications Induction (W1-4)||11
10029078|NCT01895270|11153325|FG001|STARTED|Study Medications Induction (W1-4)||14
10029079|NCT01895270|11153324|FG000|COMPLETED|Study Medications Induction (W1-4)||5
10029080|NCT01895270|11153325|FG001|COMPLETED|Study Medications Induction (W1-4)||8
10029081|NCT01895270|11153324|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6
10029082|NCT01895270|11153325|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6
10029083|NCT01895270|11153324|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5
10029084|NCT01895270|11153325|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
10029085|NCT01895270|11153324|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
10029086|NCT01895270|11153325|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
10029087|NCT01895270|11153324|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
10029088|NCT01895270|11153325|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
10029089|NCT01895270|11153324|FG000|STARTED|Isradipine Taper (W7-8)||2
10029090|NCT01895270|11153325|FG001|STARTED|Isradipine Taper (W7-8)||2
10029091|NCT01895270|11153324|FG000|COMPLETED|Isradipine Taper (W7-8)||2
10029092|NCT01895270|11153325|FG001|COMPLETED|Isradipine Taper (W7-8)||0
10029093|NCT01895270|11153324|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0
10029094|NCT01895270|11153325|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2
10029095|NCT01895309|11153333|FG000|STARTED|Overall Study||299
10029096|NCT01895309|11153334|FG001|STARTED|Overall Study||297
10029097|NCT01895309|11153333|FG000|COMPLETED|Overall Study||259
10029098|NCT01895309|11153334|FG001|COMPLETED|Overall Study||246
10029099|NCT01895309|11153333|FG000|NOT COMPLETED|Overall Study||40
10029100|NCT01895309|11153334|FG001|NOT COMPLETED|Overall Study||51
10029101|NCT01895322|11153344|FG000|STARTED|Overall Study||20
10029102|NCT01895322|11153344|FG000|COMPLETED|Overall Study||7
10029103|NCT01895322|11153344|FG000|NOT COMPLETED|Overall Study||13
10029104|NCT01895335|11153349|FG000|STARTED|Overall Study||1001
10029105|NCT01895335|11153349|FG000|Treated|Overall Study||1000
10029106|NCT01895335|11153349|FG000|COMPLETED|Overall Study||786
10029107|NCT01895335|11153349|FG000|NOT COMPLETED|Overall Study||215
10029108|NCT01895361|11153356|FG000|STARTED|Overall Study||67
10029109|NCT01895361|11153357|FG001|STARTED|Overall Study||66
10029110|NCT01895361|11153358|FG002|STARTED|Overall Study||65
9704752|NCT03603639|10804345|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9704753|NCT03603639|10804346|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10029111|NCT01895361|11153356|FG000|COMPLETED|Overall Study||43
10029112|NCT01895361|11153357|FG001|COMPLETED|Overall Study||45
10029113|NCT01895361|11153358|FG002|COMPLETED|Overall Study||41
10029114|NCT01895361|11153356|FG000|NOT COMPLETED|Overall Study||24
10029115|NCT01895361|11153357|FG001|NOT COMPLETED|Overall Study||21
10029116|NCT01895361|11153358|FG002|NOT COMPLETED|Overall Study||24
10029117|NCT01895452|11153368|FG000|STARTED|Overall Study||65
10029118|NCT01895452|11153369|FG001|STARTED|Overall Study||226
10029119|NCT01895452|11153368|FG000|COMPLETED|Overall Study||61
10029120|NCT01895452|11153369|FG001|COMPLETED|Overall Study||198
9704754|NCT03603639|10804347|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9704755|NCT03603639|10804348|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9704756|NCT03603639|10804349|FG004|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9704757|NCT03603639|10804350|FG005|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9704758|NCT03603639|10804345|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
9704759|NCT03603639|10804346|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
9704760|NCT03603639|10804347|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
9704761|NCT03603639|10804348|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
9704762|NCT03603639|10804349|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
9704763|NCT03603639|10804350|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
9704764|NCT03603639|10804345|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704765|NCT03603639|10804346|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
9704766|NCT03603639|10804347|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||0
9704767|NCT03603639|10804348|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||0
9704768|NCT03603639|10804349|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||0
9704769|NCT03603639|10804350|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||0
9704770|NCT03603639|10804345|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704771|NCT03603639|10804346|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
9704772|NCT03603639|10804347|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
9704773|NCT03603639|10804348|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
9704774|NCT03603639|10804349|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
9704775|NCT03603639|10804350|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
9704776|NCT03603639|10804345|FG000|STARTED|Treatment Period 3 (Day 1)||1
9704777|NCT03603639|10804346|FG001|STARTED|Treatment Period 3 (Day 1)||1
9704778|NCT03603639|10804347|FG002|STARTED|Treatment Period 3 (Day 1)||0
9704779|NCT03603639|10804348|FG003|STARTED|Treatment Period 3 (Day 1)||0
9704780|NCT03603639|10804349|FG004|STARTED|Treatment Period 3 (Day 1)||0
9704781|NCT03603639|10804350|FG005|STARTED|Treatment Period 3 (Day 1)||0
9704782|NCT03603639|10804345|FG000|COMPLETED|Treatment Period 3 (Day 1)||1
9704783|NCT03603639|10804346|FG001|COMPLETED|Treatment Period 3 (Day 1)||1
9704784|NCT03603639|10804347|FG002|COMPLETED|Treatment Period 3 (Day 1)||0
9704785|NCT03603639|10804348|FG003|COMPLETED|Treatment Period 3 (Day 1)||0
9704786|NCT03603639|10804349|FG004|COMPLETED|Treatment Period 3 (Day 1)||0
9704787|NCT03603639|10804350|FG005|COMPLETED|Treatment Period 3 (Day 1)||0
9704788|NCT03603639|10804345|FG000|NOT COMPLETED|Treatment Period 3 (Day 1)||0
9704789|NCT03603639|10804346|FG001|NOT COMPLETED|Treatment Period 3 (Day 1)||0
9704790|NCT03603639|10804347|FG002|NOT COMPLETED|Treatment Period 3 (Day 1)||0
9704791|NCT03603639|10804348|FG003|NOT COMPLETED|Treatment Period 3 (Day 1)||0
9704792|NCT03603639|10804349|FG004|NOT COMPLETED|Treatment Period 3 (Day 1)||0
9704793|NCT03603639|10804350|FG005|NOT COMPLETED|Treatment Period 3 (Day 1)||0
9704794|NCT03587636|10804362|FG000|STARTED|Overall Study||39
9704795|NCT03587636|10804363|FG001|STARTED|Overall Study||38
9704796|NCT03587636|10804362|FG000|COMPLETED|Overall Study||37
9704797|NCT03587636|10804363|FG001|COMPLETED|Overall Study||33
9704798|NCT03587636|10804362|FG000|NOT COMPLETED|Overall Study||2
9704799|NCT03587636|10804363|FG001|NOT COMPLETED|Overall Study||5
9704800|NCT03574129|10804371|FG000|STARTED|Overall Study||578
9704801|NCT03574129|10804372|FG001|STARTED|Overall Study||488
9704802|NCT03574129|10804371|FG000|COMPLETED|Overall Study||506
9704803|NCT03574129|10804372|FG001|COMPLETED|Overall Study||440
10029121|NCT01895452|11153368|FG000|NOT COMPLETED|Overall Study||4
10029122|NCT01895452|11153369|FG001|NOT COMPLETED|Overall Study||28
10029123|NCT01895543|11153375|FG000|STARTED|Overall Study||411
10029124|NCT01895543|11153375|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
10029125|NCT01895543|11153375|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
10029126|NCT01895543|11153375|FG000|COMPLETED|Overall Study||282
10029127|NCT01895543|11153375|FG000|NOT COMPLETED|Overall Study||129
10029128|NCT01895608|11153383|FG000|STARTED|Overall Study||10
10029129|NCT01895608|11153384|FG001|STARTED|Overall Study||7
10029130|NCT01895608|11153385|FG002|STARTED|Overall Study||11
10029131|NCT01895608|11153386|FG003|STARTED|Overall Study||6
10029132|NCT01895608|11153383|FG000|COMPLETED|Overall Study||10
10029133|NCT01895608|11153384|FG001|COMPLETED|Overall Study||6
10029134|NCT01895608|11153385|FG002|COMPLETED|Overall Study||8
10029135|NCT01895608|11153386|FG003|COMPLETED|Overall Study||6
10029136|NCT01895608|11153383|FG000|NOT COMPLETED|Overall Study||0
10029137|NCT01895608|11153384|FG001|NOT COMPLETED|Overall Study||1
10029138|NCT01895608|11153385|FG002|NOT COMPLETED|Overall Study||3
10029139|NCT01895608|11153386|FG003|NOT COMPLETED|Overall Study||0
10029140|NCT01895634|11153396|FG000|STARTED|Overall Study||49
9704804|NCT03574129|10804371|FG000|NOT COMPLETED|Overall Study||72
9704805|NCT03574129|10804372|FG001|NOT COMPLETED|Overall Study||48
9704806|NCT03573336|10804393|FG000|STARTED|Overall Study||2
9848221|NCT00857896|10960904|FG000|STARTED|Baseline to Week 4||21
10029141|NCT01895634|11153396|FG000|COMPLETED|Overall Study||46
10029142|NCT01895634|11153396|FG000|NOT COMPLETED|Overall Study||3
10029143|NCT01895647|11153403|FG000|STARTED|Overall Study||8
10029144|NCT01895647|11153404|FG001|STARTED|Overall Study||10
10029145|NCT01895647|11153405|FG002|STARTED|Overall Study||7
9704807|NCT03573336|10804394|FG001|STARTED|Overall Study||4
9704808|NCT03573336|10804395|FG002|STARTED|Overall Study||2
9704809|NCT03573336|10804393|FG000|Treated|Overall Study||2
9704810|NCT03573336|10804394|FG001|Treated|Overall Study||4
9704811|NCT03573336|10804395|FG002|Treated|Overall Study||2
9704812|NCT03573336|10804393|FG000|COMPLETED|Overall Study||0
9704813|NCT03573336|10804394|FG001|COMPLETED|Overall Study||0
9704814|NCT03573336|10804395|FG002|COMPLETED|Overall Study||0
9704815|NCT03573336|10804393|FG000|NOT COMPLETED|Overall Study||2
9704816|NCT03573336|10804394|FG001|NOT COMPLETED|Overall Study||4
9704817|NCT03573336|10804395|FG002|NOT COMPLETED|Overall Study||2
9704818|NCT03570697|10804405|FG000|STARTED|Overall Study||82
9704819|NCT03570697|10804406|FG001|STARTED|Overall Study||82
9704820|NCT03570697|10804405|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
10029146|NCT01895647|11153403|FG000|COMPLETED|Overall Study||8
10029147|NCT01895647|11153404|FG001|COMPLETED|Overall Study||10
10029148|NCT01895647|11153405|FG002|COMPLETED|Overall Study||7
10029149|NCT01895647|11153403|FG000|NOT COMPLETED|Overall Study||0
10029150|NCT01895647|11153404|FG001|NOT COMPLETED|Overall Study||0
10029151|NCT01895647|11153405|FG002|NOT COMPLETED|Overall Study||0
10029152|NCT01895777|11153415|FG000|STARTED|Overall Study||177
10029153|NCT01895777|11153416|FG001|STARTED|Overall Study||90
10029154|NCT01895777|11153415|FG000|Treated|Overall Study||176
10029155|NCT01895777|11153416|FG001|Treated|Overall Study||90
10029156|NCT01895777|11153415|FG000|COMPLETED|Overall Study||168
10029157|NCT01895777|11153416|FG001|COMPLETED|Overall Study||85
10029158|NCT01895777|11153415|FG000|NOT COMPLETED|Overall Study||9
10029159|NCT01895777|11153416|FG001|NOT COMPLETED|Overall Study||5
10029160|NCT01895855|11153427|FG000|STARTED|Overall Study||95
10029161|NCT01895855|11153428|FG001|STARTED|Overall Study||102
10029162|NCT01895855|11153427|FG000|COMPLETED|Overall Study||95
10029163|NCT01895855|11153428|FG001|COMPLETED|Overall Study||102
10029164|NCT01895855|11153427|FG000|NOT COMPLETED|Overall Study||0
10029165|NCT01895855|11153428|FG001|NOT COMPLETED|Overall Study||0
10029166|NCT01895946|11153440|FG000|STARTED|Overall Study||18
10029167|NCT01895946|11153441|FG001|STARTED|Overall Study||12
10029168|NCT01895946|11153440|FG000|COMPLETED|Overall Study||18
10029169|NCT01895946|11153441|FG001|COMPLETED|Overall Study||12
10029170|NCT01895946|11153440|FG000|NOT COMPLETED|Overall Study||0
10029171|NCT01895946|11153441|FG001|NOT COMPLETED|Overall Study||0
10029172|NCT01895972|11153447|FG000|STARTED|Overall Study||130
10029173|NCT01895972|11153447|FG000|COMPLETED|Overall Study||121
10029174|NCT01895972|11153447|FG000|NOT COMPLETED|Overall Study||9
10029175|NCT01896050|11153453|FG000|STARTED|Overall Study||93
10029176|NCT01896050|11153454|FG001|STARTED|Overall Study||22
10029177|NCT01896050|11153453|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
10029178|NCT01896050|11153454|FG001|COMPLETED|Overall Study||20
10029179|NCT01896050|11153453|FG000|NOT COMPLETED|Overall Study||38
10029180|NCT01896050|11153454|FG001|NOT COMPLETED|Overall Study||2
10029181|NCT01896115|11153464|FG000|STARTED|Overall Study||16
10029182|NCT01896115|11153465|FG001|STARTED|Overall Study||24
10029183|NCT01896115|11153464|FG000|Phase 1 Short PW|Overall Study||15
10029184|NCT01896115|11153465|FG001|Phase 1 Short PW|Overall Study||0
10029185|NCT01896115|11153464|FG000|Phase 1 Conventional PW|Overall Study||15
9704821|NCT03570697|10804406|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
9704822|NCT03570697|10804405|FG000|COMPLETED|Overall Study||76
9704823|NCT03570697|10804406|FG001|COMPLETED|Overall Study||79
9704824|NCT03570697|10804405|FG000|NOT COMPLETED|Overall Study||6
9704825|NCT03570697|10804406|FG001|NOT COMPLETED|Overall Study||3
9704826|NCT03548051|10804414|FG000|STARTED|Overall Study||6
9704827|NCT03548051|10804415|FG001|STARTED|Overall Study||4
9704828|NCT03548051|10804414|FG000|COMPLETED|Overall Study||4
9704829|NCT03548051|10804415|FG001|COMPLETED|Overall Study||3
9704830|NCT03548051|10804414|FG000|NOT COMPLETED|Overall Study||2
9704831|NCT03548051|10804415|FG001|NOT COMPLETED|Overall Study||1
9729046|NCT00116207|10828627|FG001|NOT COMPLETED|Overall Study||4
9729047|NCT00116272|10828635|FG000|STARTED|Overall Study||370
9729048|NCT00116272|10828636|FG001|STARTED|Overall Study||164
9729049|NCT00116272|10828635|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
9729050|NCT00116272|10828636|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
9729051|NCT00116272|10828635|FG000|NOT COMPLETED|Overall Study||11
9729052|NCT00116272|10828636|FG001|NOT COMPLETED|Overall Study||6
9729053|NCT00116337|10828644|FG000|STARTED|Overall Study||17
9729054|NCT00116337|10828644|FG000|COMPLETED|Overall Study||17
9729055|NCT00116337|10828644|FG000|NOT COMPLETED|Overall Study||0
9729056|NCT00116428|10828657|FG000|STARTED|Overall Study||106
9729057|NCT00116428|10828658|FG001|STARTED|Overall Study||61
9729058|NCT00116428|10828657|FG000|Underwent Study Ablation Procedure|Overall Study||103
9729059|NCT00116428|10828658|FG001|Underwent Study Ablation Procedure|Overall Study||36
9729060|NCT00116428|10828657|FG000|COMPLETED|Overall Study||103
10029186|NCT01896115|11153465|FG001|Phase 1 Conventional PW|Overall Study||0
10029187|NCT01896115|11153464|FG000|Phase 1 Dorsal Steering|Overall Study||15
10029188|NCT01896115|11153465|FG001|Phase 1 Dorsal Steering|Overall Study||0
10029189|NCT01896115|11153464|FG000|Phase 1 Ventral Steering|Overall Study||15
10029190|NCT01896115|11153465|FG001|Phase 1 Ventral Steering|Overall Study||0
10029191|NCT01896115|11153464|FG000|Phase 2 Single Contact|Overall Study||0
10029192|NCT01896115|11153465|FG001|Phase 2 Single Contact|Overall Study||24
10029193|NCT01896115|11153464|FG000|Phase 2 Steering|Overall Study||0
9729061|NCT00116428|10828658|FG001|COMPLETED|Overall Study||56
9729062|NCT00116428|10828657|FG000|NOT COMPLETED|Overall Study||3
9729063|NCT00116428|10828658|FG001|NOT COMPLETED|Overall Study||5
9729064|NCT00116558|10828670|FG000|STARTED|Overall Study||80
9704832|NCT03525886|10804425|FG000|STARTED|Cohort 1 (50 mg QHS)||8
9704833|NCT03525886|10804426|FG001|STARTED|Cohort 1 (50 mg QHS)||0
9704834|NCT03525886|10804427|FG002|STARTED|Cohort 1 (50 mg QHS)||0
9704835|NCT03525886|10804428|FG003|STARTED|Cohort 1 (50 mg QHS)||0
9704836|NCT03525886|10804425|FG000|COMPLETED|Cohort 1 (50 mg QHS)||8
9704837|NCT03525886|10804426|FG001|COMPLETED|Cohort 1 (50 mg QHS)||0
9704838|NCT03525886|10804427|FG002|COMPLETED|Cohort 1 (50 mg QHS)||0
9704839|NCT03525886|10804428|FG003|COMPLETED|Cohort 1 (50 mg QHS)||0
9704840|NCT03525886|10804425|FG000|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10029194|NCT01896115|11153465|FG001|Phase 2 Steering|Overall Study||24
10029195|NCT01896115|11153464|FG000|COMPLETED|Overall Study||15
10029196|NCT01896115|11153465|FG001|COMPLETED|Overall Study||24
10029197|NCT01896115|11153464|FG000|NOT COMPLETED|Overall Study||1
10029198|NCT01896115|11153465|FG001|NOT COMPLETED|Overall Study||0
10029199|NCT01896128|11153478|FG000|STARTED|Overall Study||8
10029200|NCT01896128|11153479|FG001|STARTED|Overall Study||11
10029201|NCT01896128|11153478|FG000|COMPLETED|Overall Study||5
10029202|NCT01896128|11153479|FG001|COMPLETED|Overall Study||8
10029203|NCT01896128|11153478|FG000|NOT COMPLETED|Overall Study||3
10029204|NCT01896128|11153479|FG001|NOT COMPLETED|Overall Study||3
10029205|NCT01896193|11153489|FG000|STARTED|Overall Study||62
10029206|NCT01896193|11153490|FG001|STARTED|Overall Study||65
10029207|NCT01896193|11153489|FG000|COMPLETED|Overall Study||41
10029208|NCT01896193|11153490|FG001|COMPLETED|Overall Study||53
10029209|NCT01896193|11153489|FG000|NOT COMPLETED|Overall Study||21
10029210|NCT01896193|11153490|FG001|NOT COMPLETED|Overall Study||12
10029211|NCT01896206|11153498|FG000|STARTED|Overall Study||21
10029212|NCT01896206|11153498|FG000|COMPLETED|Overall Study||21
10029213|NCT01896206|11153498|FG000|NOT COMPLETED|Overall Study||0
10029214|NCT01896232|11153504|FG000|STARTED|Overall Study||343
10029215|NCT01896232|11153505|FG001|STARTED|Overall Study||340
10029216|NCT01896232|11153504|FG000|Received Treatment|Overall Study||341
10029217|NCT01896232|11153505|FG001|Received Treatment|Overall Study||338
10029218|NCT01896232|11153504|FG000|COMPLETED|Overall Study||294
10029219|NCT01896232|11153505|FG001|COMPLETED|Overall Study||287
10029220|NCT01896232|11153504|FG000|NOT COMPLETED|Overall Study||49
10029221|NCT01896232|11153505|FG001|NOT COMPLETED|Overall Study||53
10029222|NCT01896271|11153511|FG000|STARTED|Overall Study||30
10029223|NCT01896271|11153511|FG000|COMPLETED|Overall Study||20
10029224|NCT01896271|11153511|FG000|NOT COMPLETED|Overall Study||10
10029225|NCT01896297|11153515|FG000|STARTED|Overall Study||60
10029226|NCT01896297|11153515|FG000|COMPLETED|Overall Study||59
10029227|NCT01896297|11153515|FG000|NOT COMPLETED|Overall Study||1
10029228|NCT01896544|11153522|FG000|STARTED|Overall Study||10
10029229|NCT01896544|11153523|FG001|STARTED|Overall Study||10
10029230|NCT01896544|11153524|FG002|STARTED|Overall Study||10
10029231|NCT01896544|11153522|FG000|COMPLETED|Overall Study||10
10029232|NCT01896544|11153523|FG001|COMPLETED|Overall Study||10
10029233|NCT01896544|11153524|FG002|COMPLETED|Overall Study||10
10029234|NCT01896544|11153522|FG000|NOT COMPLETED|Overall Study||0
10029235|NCT01896544|11153523|FG001|NOT COMPLETED|Overall Study||0
10029236|NCT01896544|11153524|FG002|NOT COMPLETED|Overall Study||0
10029237|NCT01896557|11153537|FG000|STARTED|Clopidogrel Alone||44
10029238|NCT01896557|11153538|FG001|STARTED|Clopidogrel Alone||48
10029239|NCT01896557|11153537|FG000|COMPLETED|Clopidogrel Alone||43
10029240|NCT01896557|11153538|FG001|COMPLETED|Clopidogrel Alone||48
10029241|NCT01896557|11153537|FG000|NOT COMPLETED|Clopidogrel Alone||1
10029242|NCT01896557|11153538|FG001|NOT COMPLETED|Clopidogrel Alone||0
10029243|NCT01896557|11153537|FG000|STARTED|Clopidogrel + GI Protector||43
10029244|NCT01896557|11153538|FG001|STARTED|Clopidogrel + GI Protector||48
10029245|NCT01896557|11153537|FG000|COMPLETED|Clopidogrel + GI Protector||41
10029246|NCT01896557|11153538|FG001|COMPLETED|Clopidogrel + GI Protector||44
10029247|NCT01896557|11153537|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2
10029248|NCT01896557|11153538|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4
10029249|NCT01896687|11153546|FG000|STARTED|Overall Study||15
10029250|NCT01896687|11153547|FG001|STARTED|Overall Study||15
10029251|NCT01896687|11153546|FG000|COMPLETED|Overall Study||15
10029252|NCT01896687|11153547|FG001|COMPLETED|Overall Study||15
10029253|NCT01896687|11153546|FG000|NOT COMPLETED|Overall Study||0
10029254|NCT01896687|11153547|FG001|NOT COMPLETED|Overall Study||0
10029255|NCT01896700|11153555|FG000|STARTED|Overall Study||12
10029256|NCT01896700|11153556|FG001|STARTED|Overall Study||12
10029257|NCT01896700|11153555|FG000|COMPLETED|Overall Study||8
10029258|NCT01896700|11153556|FG001|COMPLETED|Overall Study||6
10029259|NCT01896700|11153555|FG000|NOT COMPLETED|Overall Study||4
10029260|NCT01896700|11153556|FG001|NOT COMPLETED|Overall Study||6
10029261|NCT01896726|11153562|FG000|STARTED|Treatment Period 1 (Days 1-22)||20
10029262|NCT01896726|11153562|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20
10029263|NCT01896726|11153562|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20
10029264|NCT01896726|11153562|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
10029265|NCT01896726|11153562|FG000|STARTED|Treatment Period 2 (Days 23-31)||20
10029266|NCT01896726|11153562|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
10029267|NCT01896726|11153562|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18
10029268|NCT01896726|11153562|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18
10029269|NCT01896726|11153562|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
10029270|NCT01896856|11153575|FG000|STARTED|Overall Study||6
10029271|NCT01896856|11153576|FG001|STARTED|Overall Study||3
10029272|NCT01896856|11153577|FG002|STARTED|Overall Study||7
10029273|NCT01896856|11153578|FG003|STARTED|Overall Study||6
9704841|NCT03525886|10804426|FG001|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
9704842|NCT03525886|10804427|FG002|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
9704843|NCT03525886|10804428|FG003|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
9704844|NCT03525886|10804425|FG000|STARTED|Cohort 2 (100 mg QHS)||0
9704845|NCT03525886|10804426|FG001|STARTED|Cohort 2 (100 mg QHS)||7
9704846|NCT03525886|10804427|FG002|STARTED|Cohort 2 (100 mg QHS)||0
9704847|NCT03525886|10804428|FG003|STARTED|Cohort 2 (100 mg QHS)||0
9704848|NCT03525886|10804425|FG000|COMPLETED|Cohort 2 (100 mg QHS)||0
9704849|NCT03525886|10804426|FG001|COMPLETED|Cohort 2 (100 mg QHS)||7
9704850|NCT03525886|10804427|FG002|COMPLETED|Cohort 2 (100 mg QHS)||0
9704851|NCT03525886|10804428|FG003|COMPLETED|Cohort 2 (100 mg QHS)||0
9704852|NCT03525886|10804425|FG000|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
9704853|NCT03525886|10804426|FG001|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
9704854|NCT03525886|10804427|FG002|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
9704855|NCT03525886|10804428|FG003|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
9704856|NCT03525886|10804425|FG000|STARTED|Cohort 3 (100 mg QPM)||0
9704857|NCT03525886|10804426|FG001|STARTED|Cohort 3 (100 mg QPM)||0
9704858|NCT03525886|10804427|FG002|STARTED|Cohort 3 (100 mg QPM)||8
9704859|NCT03525886|10804428|FG003|STARTED|Cohort 3 (100 mg QPM)||0
9704860|NCT03525886|10804425|FG000|COMPLETED|Cohort 3 (100 mg QPM)||0
9704861|NCT03525886|10804426|FG001|COMPLETED|Cohort 3 (100 mg QPM)||0
9704862|NCT03525886|10804427|FG002|COMPLETED|Cohort 3 (100 mg QPM)||8
9704863|NCT03525886|10804428|FG003|COMPLETED|Cohort 3 (100 mg QPM)||0
9704864|NCT03525886|10804425|FG000|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
9704865|NCT03525886|10804426|FG001|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
9704866|NCT03525886|10804427|FG002|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
9704867|NCT03525886|10804428|FG003|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
9704868|NCT03525886|10804425|FG000|STARTED|Cohort 4 (100 mg BID)||0
9704869|NCT03525886|10804426|FG001|STARTED|Cohort 4 (100 mg BID)||0
9704870|NCT03525886|10804427|FG002|STARTED|Cohort 4 (100 mg BID)||0
9704871|NCT03525886|10804428|FG003|STARTED|Cohort 4 (100 mg BID)||8
9704872|NCT03525886|10804425|FG000|COMPLETED|Cohort 4 (100 mg BID)||0
9704873|NCT03525886|10804426|FG001|COMPLETED|Cohort 4 (100 mg BID)||0
9704874|NCT03525886|10804427|FG002|COMPLETED|Cohort 4 (100 mg BID)||0
9704875|NCT03525886|10804428|FG003|COMPLETED|Cohort 4 (100 mg BID)||8
9704876|NCT03525886|10804425|FG000|NOT COMPLETED|Cohort 4 (100 mg BID)||0
9704877|NCT03525886|10804426|FG001|NOT COMPLETED|Cohort 4 (100 mg BID)||0
9704878|NCT03525886|10804427|FG002|NOT COMPLETED|Cohort 4 (100 mg BID)||0
9704879|NCT03525886|10804428|FG003|NOT COMPLETED|Cohort 4 (100 mg BID)||0
9704880|NCT03503318|10804441|FG000|STARTED|Overall Study||181
9704881|NCT03503318|10804442|FG001|STARTED|Overall Study||183
9704882|NCT03503318|10804443|FG002|STARTED|Overall Study||180
9704883|NCT03503318|10804441|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179
9704884|NCT03503318|10804442|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183
9704885|NCT03503318|10804443|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180
9704886|NCT03503318|10804441|FG000|COMPLETED|Overall Study||142
9704887|NCT03503318|10804442|FG001|COMPLETED|Overall Study||144
9704888|NCT03503318|10804443|FG002|COMPLETED|Overall Study||140
9704889|NCT03503318|10804441|FG000|NOT COMPLETED|Overall Study||39
9704890|NCT03503318|10804442|FG001|NOT COMPLETED|Overall Study||39
9704891|NCT03503318|10804443|FG002|NOT COMPLETED|Overall Study||40
9704892|NCT03493854|10804453|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
9704893|NCT03493854|10804454|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
9704894|NCT03493854|10804453|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
9704895|NCT03493854|10804454|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
9704896|NCT03493854|10804453|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
9704897|NCT03493854|10804454|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
9704898|NCT03493854|10804453|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
9704899|NCT03493854|10804454|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
9704900|NCT03493854|10804453|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
9704901|NCT03493854|10804454|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
9704902|NCT03493854|10804453|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
9704903|NCT03493854|10804454|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
9704904|NCT03493854|10804453|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
9704905|NCT03493854|10804454|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
9704906|NCT03493854|10804453|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
9704907|NCT03493854|10804454|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
9704908|NCT03493854|10804453|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
9704909|NCT03493854|10804454|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
9704910|NCT03493854|10804453|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
9704911|NCT03493854|10804454|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
9704912|NCT03493854|10804453|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
9704913|NCT03493854|10804454|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
9704914|NCT03493451|10804463|FG000|STARTED|Overall Study||22
9704915|NCT03493451|10804464|FG001|STARTED|Overall Study||44
10029274|NCT01896856|11153579|FG004|STARTED|Overall Study||62
10029275|NCT01896856|11153580|FG005|STARTED|Overall Study||34
10029276|NCT01896856|11153575|FG000|COMPLETED|Overall Study||6
9704916|NCT03493451|10804465|FG002|STARTED|Overall Study||11
9704917|NCT03493451|10804463|FG000|COMPLETED|Overall Study||0
9704918|NCT03493451|10804464|FG001|COMPLETED|Overall Study||0
9704919|NCT03493451|10804465|FG002|COMPLETED|Overall Study||0
9704920|NCT03493451|10804463|FG000|NOT COMPLETED|Overall Study||22
9704921|NCT03493451|10804464|FG001|NOT COMPLETED|Overall Study||44
9704922|NCT03493451|10804465|FG002|NOT COMPLETED|Overall Study||11
9704923|NCT03476239|10804473|FG000|STARTED|Overall Study||121
9704924|NCT03476239|10804473|FG000|Received Blinatumomab|Overall Study||120
9704925|NCT03476239|10804473|FG000|Interim Analysis Set|Overall Study||90
9704926|NCT03476239|10804473|FG000|COMPLETED|Overall Study||23
9704927|NCT03476239|10804473|FG000|NOT COMPLETED|Overall Study||98
9704928|NCT03431168|10804479|FG000|STARTED|Overall Study||155
9704929|NCT03431168|10804480|FG001|STARTED|Overall Study||153
9704930|NCT03431168|10804479|FG000|COMPLETED|Overall Study||132
9704931|NCT03431168|10804480|FG001|COMPLETED|Overall Study||129
9704932|NCT03431168|10804479|FG000|NOT COMPLETED|Overall Study||23
9704933|NCT03431168|10804480|FG001|NOT COMPLETED|Overall Study||24
9704934|NCT03401749|10804489|FG000|STARTED|Overall Study||59
9704935|NCT03401749|10804490|FG001|STARTED|Overall Study||67
9704936|NCT03401749|10804491|FG002|STARTED|Overall Study||77
9704937|NCT03401749|10804489|FG000|COMPLETED|Overall Study||39
9704938|NCT03401749|10804490|FG001|COMPLETED|Overall Study||51
9704939|NCT03401749|10804491|FG002|COMPLETED|Overall Study||51
9704940|NCT03401749|10804489|FG000|NOT COMPLETED|Overall Study||20
9704941|NCT03401749|10804490|FG001|NOT COMPLETED|Overall Study||16
9704942|NCT03401749|10804491|FG002|NOT COMPLETED|Overall Study||26
9704943|NCT03337113|10804503|FG000|STARTED|Overall Study||13
9704944|NCT03337113|10804504|FG001|STARTED|Overall Study||12
9704945|NCT03337113|10804505|FG002|STARTED|Overall Study||12
9704946|NCT03337113|10804506|FG003|STARTED|Overall Study||13
9704947|NCT03337113|10804503|FG000|COMPLETED|Overall Study||12
9704948|NCT03337113|10804504|FG001|COMPLETED|Overall Study||9
9704949|NCT03337113|10804505|FG002|COMPLETED|Overall Study||11
9704950|NCT03337113|10804506|FG003|COMPLETED|Overall Study||11
9704951|NCT03337113|10804503|FG000|NOT COMPLETED|Overall Study||1
9704952|NCT03337113|10804504|FG001|NOT COMPLETED|Overall Study||3
9704953|NCT03337113|10804505|FG002|NOT COMPLETED|Overall Study||1
10029277|NCT01896856|11153576|FG001|COMPLETED|Overall Study||3
10029278|NCT01896856|11153577|FG002|COMPLETED|Overall Study||6
10029279|NCT01896856|11153578|FG003|COMPLETED|Overall Study||6
10029280|NCT01896856|11153579|FG004|COMPLETED|Overall Study||62
10029281|NCT01896856|11153580|FG005|COMPLETED|Overall Study||34
10029282|NCT01896856|11153575|FG000|NOT COMPLETED|Overall Study||0
10115515|NCT02526524|11246358|FG003|STARTED|Overall Study||96
10115516|NCT02526524|11246359|FG004|STARTED|Overall Study||96
10115517|NCT02526524|11246360|FG005|STARTED|Overall Study||94
10115518|NCT02526524|11246355|FG000|COMPLETED|Overall Study||82
10115519|NCT02526524|11246356|FG001|COMPLETED|Overall Study||86
10115520|NCT02526524|11246357|FG002|COMPLETED|Overall Study||70
10115521|NCT02526524|11246358|FG003|COMPLETED|Overall Study||89
10115522|NCT02526524|11246359|FG004|COMPLETED|Overall Study||72
10115523|NCT02526524|11246360|FG005|COMPLETED|Overall Study||73
10029283|NCT01896856|11153576|FG001|NOT COMPLETED|Overall Study||0
10029284|NCT01896856|11153577|FG002|NOT COMPLETED|Overall Study||1
10029285|NCT01896856|11153578|FG003|NOT COMPLETED|Overall Study||0
10029286|NCT01896856|11153579|FG004|NOT COMPLETED|Overall Study||0
10029287|NCT01896856|11153580|FG005|NOT COMPLETED|Overall Study||0
10029288|NCT01896869|11153597|FG000|STARTED|Overall Study||41
10029289|NCT01896869|11153598|FG001|STARTED|Overall Study||42
10029290|NCT01896869|11153597|FG000|COMPLETED|Overall Study||40
10029291|NCT01896869|11153598|FG001|COMPLETED|Overall Study||36
10029292|NCT01896869|11153597|FG000|NOT COMPLETED|Overall Study||1
10029293|NCT01896869|11153598|FG001|NOT COMPLETED|Overall Study||6
10029294|NCT01896895|11153609|FG000|STARTED|Double-blind MP||20
10029295|NCT01896895|11153610|FG001|STARTED|Double-blind MP||22
10029296|NCT01896895|11153611|FG002|STARTED|Double-blind MP||19
10029297|NCT01896895|11153612|FG003|STARTED|Double-blind MP||0
10029298|NCT01896895|11153609|FG000|COMPLETED|Double-blind MP||19
10029299|NCT01896895|11153610|FG001|COMPLETED|Double-blind MP||20
10029300|NCT01896895|11153611|FG002|COMPLETED|Double-blind MP||16
10029301|NCT01896895|11153612|FG003|COMPLETED|Double-blind MP||0
10029302|NCT01896895|11153609|FG000|NOT COMPLETED|Double-blind MP||1
10029303|NCT01896895|11153610|FG001|NOT COMPLETED|Double-blind MP||2
10115524|NCT02526524|11246355|FG000|NOT COMPLETED|Overall Study||12
10115525|NCT02526524|11246356|FG001|NOT COMPLETED|Overall Study||9
10029304|NCT01896895|11153611|FG002|NOT COMPLETED|Double-blind MP||3
10029305|NCT01896895|11153612|FG003|NOT COMPLETED|Double-blind MP||0
10029306|NCT01896895|11153609|FG000|STARTED|OLEX Period||0
10029307|NCT01896895|11153610|FG001|STARTED|OLEX Period||0
10029308|NCT01896895|11153611|FG002|STARTED|OLEX Period||0
10115526|NCT02526524|11246357|FG002|NOT COMPLETED|Overall Study||26
9704954|NCT03337113|10804506|FG003|NOT COMPLETED|Overall Study||2
9729065|NCT00116558|10828671|FG001|STARTED|Overall Study||26
9729066|NCT00116558|10828672|FG002|STARTED|Overall Study||47
9729067|NCT00116558|10828670|FG000|COMPLETED|Overall Study||49
9729068|NCT00116558|10828671|FG001|COMPLETED|Overall Study||11
9729069|NCT00116558|10828672|FG002|COMPLETED|Overall Study||14
10029309|NCT01896895|11153612|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
10029310|NCT01896895|11153609|FG000|COMPLETED|OLEX Period||0
10029311|NCT01896895|11153610|FG001|COMPLETED|OLEX Period||0
10029312|NCT01896895|11153611|FG002|COMPLETED|OLEX Period||0
9704955|NCT03257631|10804520|FG000|STARTED|Overall Study||11
9704956|NCT03257631|10804521|FG001|STARTED|Overall Study||9
9704957|NCT03257631|10804522|FG002|STARTED|Overall Study||23
9704958|NCT03257631|10804523|FG003|STARTED|Overall Study||10
9704959|NCT03257631|10804520|FG000|Received Study Drug|Overall Study||11
9704960|NCT03257631|10804521|FG001|Received Study Drug|Overall Study||9
9704961|NCT03257631|10804522|FG002|Received Study Drug|Overall Study||22
9704962|NCT03257631|10804523|FG003|Received Study Drug|Overall Study||10
9704963|NCT03257631|10804520|FG000|COMPLETED|Overall Study||0
9704964|NCT03257631|10804521|FG001|COMPLETED|Overall Study||0
9704965|NCT03257631|10804522|FG002|COMPLETED|Overall Study||0
9704966|NCT03257631|10804523|FG003|COMPLETED|Overall Study||0
9704967|NCT03257631|10804520|FG000|NOT COMPLETED|Overall Study||11
9704968|NCT03257631|10804521|FG001|NOT COMPLETED|Overall Study||9
9704969|NCT03257631|10804522|FG002|NOT COMPLETED|Overall Study||23
9704970|NCT03257631|10804523|FG003|NOT COMPLETED|Overall Study||10
9704971|NCT03253796|10804538|FG000|STARTED|Period 1: Run-In||323
9704972|NCT03253796|10804539|FG001|STARTED|Period 1: Run-In||0
9704973|NCT03253796|10804540|FG002|STARTED|Period 1: Run-In||0
9704974|NCT03253796|10804541|FG003|STARTED|Period 1: Run-In||0
9704975|NCT03253796|10804542|FG004|STARTED|Period 1: Run-In||0
9704976|NCT03253796|10804538|FG000|COMPLETED|Period 1: Run-In||207
9704977|NCT03253796|10804539|FG001|COMPLETED|Period 1: Run-In||0
9704978|NCT03253796|10804540|FG002|COMPLETED|Period 1: Run-In||0
9704979|NCT03253796|10804541|FG003|COMPLETED|Period 1: Run-In||0
9704980|NCT03253796|10804542|FG004|COMPLETED|Period 1: Run-In||0
9704981|NCT03253796|10804538|FG000|NOT COMPLETED|Period 1: Run-In||116
9704982|NCT03253796|10804539|FG001|NOT COMPLETED|Period 1: Run-In||0
9704983|NCT03253796|10804540|FG002|NOT COMPLETED|Period 1: Run-In||0
9704984|NCT03253796|10804541|FG003|NOT COMPLETED|Period 1: Run-In||0
9704985|NCT03253796|10804542|FG004|NOT COMPLETED|Period 1: Run-In||0
9704986|NCT03253796|10804538|FG000|STARTED|Period 2: Withdrawal vs Continued Tx||0
9704987|NCT03253796|10804539|FG001|STARTED|Period 2: Withdrawal vs Continued Tx||63
9704988|NCT03253796|10804540|FG002|STARTED|Period 2: Withdrawal vs Continued Tx||64
9704989|NCT03253796|10804541|FG003|STARTED|Period 2: Withdrawal vs Continued Tx||62
9704990|NCT03253796|10804542|FG004|STARTED|Period 2: Withdrawal vs Continued Tx||0
9704991|NCT03253796|10804538|FG000|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
9704992|NCT03253796|10804539|FG001|COMPLETED|Period 2: Withdrawal vs Continued Tx||53
9704993|NCT03253796|10804540|FG002|COMPLETED|Period 2: Withdrawal vs Continued Tx||43
9704994|NCT03253796|10804541|FG003|COMPLETED|Period 2: Withdrawal vs Continued Tx||21
9704995|NCT03253796|10804542|FG004|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
9704996|NCT03253796|10804538|FG000|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
9704997|NCT03253796|10804539|FG001|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||10
9704998|NCT03253796|10804540|FG002|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||21
9704999|NCT03253796|10804541|FG003|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||41
9705000|NCT03253796|10804542|FG004|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
9705001|NCT03253796|10804538|FG000|STARTED|Period 2: Open-Label Retreatment||0
10029313|NCT01896895|11153612|FG003|COMPLETED|OLEX Period||39
10029314|NCT01896895|11153609|FG000|NOT COMPLETED|OLEX Period||0
10029315|NCT01896895|11153610|FG001|NOT COMPLETED|OLEX Period||0
10115527|NCT02526524|11246358|FG003|NOT COMPLETED|Overall Study||7
10029316|NCT01896895|11153611|FG002|NOT COMPLETED|OLEX Period||0
10029317|NCT01896895|11153612|FG003|NOT COMPLETED|OLEX Period||0
10029318|NCT01896921|11153621|FG000|STARTED|Overall Study||7
10029319|NCT01896921|11153621|FG000|COMPLETED|Overall Study||5
10029320|NCT01896921|11153621|FG000|NOT COMPLETED|Overall Study||2
10029321|NCT01896934|11153625|FG000|STARTED|Overall Study||21
10029322|NCT01896934|11153625|FG000|COMPLETED|Overall Study||19
10029323|NCT01896934|11153625|FG000|NOT COMPLETED|Overall Study||2
10029324|NCT01896986|11153631|FG000|STARTED|Overall Study||14
10029325|NCT01896986|11153632|FG001|STARTED|Overall Study||23
10029326|NCT01896986|11153631|FG000|COMPLETED|Overall Study||0
10029327|NCT01896986|11153632|FG001|COMPLETED|Overall Study||0
10029328|NCT01896986|11153631|FG000|NOT COMPLETED|Overall Study||14
10029329|NCT01896986|11153632|FG001|NOT COMPLETED|Overall Study||23
10029330|NCT01897025|11153640|FG000|STARTED|Overall Study||10
10029331|NCT01897025|11153641|FG001|STARTED|Overall Study||9
10029332|NCT01897025|11153640|FG000|COMPLETED|Overall Study||10
10029333|NCT01897025|11153641|FG001|COMPLETED|Overall Study||9
10029334|NCT01897025|11153640|FG000|NOT COMPLETED|Overall Study||0
10029335|NCT01897025|11153641|FG001|NOT COMPLETED|Overall Study||0
10029336|NCT01897077|11153649|FG000|STARTED|Overall Study||0
10029337|NCT01897077|11153650|FG001|STARTED|Overall Study||5
10029338|NCT01897077|11153649|FG000|COMPLETED|Overall Study||0
10029339|NCT01897077|11153650|FG001|COMPLETED|Overall Study||5
9705002|NCT03253796|10804539|FG001|STARTED|Period 2: Open-Label Retreatment||0
9705003|NCT03253796|10804540|FG002|STARTED|Period 2: Open-Label Retreatment||0
9705004|NCT03253796|10804541|FG003|STARTED|Period 2: Open-Label Retreatment||0
9705005|NCT03253796|10804542|FG004|STARTED|Period 2: Open-Label Retreatment||63
9705006|NCT03253796|10804538|FG000|COMPLETED|Period 2: Open-Label Retreatment||0
9705007|NCT03253796|10804539|FG001|COMPLETED|Period 2: Open-Label Retreatment||0
9705008|NCT03253796|10804540|FG002|COMPLETED|Period 2: Open-Label Retreatment||0
10029340|NCT01897077|11153649|FG000|NOT COMPLETED|Overall Study||0
10029341|NCT01897077|11153650|FG001|NOT COMPLETED|Overall Study||0
10029342|NCT01897233|11153656|FG000|STARTED|Part A (14 Days)||10
10029343|NCT01897233|11153656|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
10029344|NCT01897233|11153656|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
9705009|NCT03253796|10804541|FG003|COMPLETED|Period 2: Open-Label Retreatment||0
9705010|NCT03253796|10804542|FG004|COMPLETED|Period 2: Open-Label Retreatment||58
9705011|NCT03253796|10804538|FG000|NOT COMPLETED|Period 2: Open-Label Retreatment||0
9705012|NCT03253796|10804539|FG001|NOT COMPLETED|Period 2: Open-Label Retreatment||0
9705013|NCT03253796|10804540|FG002|NOT COMPLETED|Period 2: Open-Label Retreatment||0
9705014|NCT03253796|10804541|FG003|NOT COMPLETED|Period 2: Open-Label Retreatment||0
9705015|NCT03253796|10804542|FG004|NOT COMPLETED|Period 2: Open-Label Retreatment||5
9705016|NCT03233048|10804557|FG000|STARTED|Overall Study||5
10029345|NCT01897233|11153656|FG000|COMPLETED|Part A (14 Days)||10
10029346|NCT01897233|11153656|FG000|NOT COMPLETED|Part A (14 Days)||0
10029347|NCT01897233|11153656|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
10029348|NCT01897233|11153656|FG000|COMPLETED|Part B (24 Weeks)||54
10029349|NCT01897233|11153656|FG000|NOT COMPLETED|Part B (24 Weeks)||4
10029350|NCT01897285|11153664|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
10029351|NCT01897285|11153664|FG000|COMPLETED|Overall Study||20
10029352|NCT01897285|11153664|FG000|NOT COMPLETED|Overall Study||0
10029353|NCT01897402|11153672|FG000|STARTED|Overall Study||265
10029354|NCT01897402|11153673|FG001|STARTED|Overall Study||260
10029355|NCT01897402|11153672|FG000|COMPLETED|Overall Study||246
10029356|NCT01897402|11153673|FG001|COMPLETED|Overall Study||244
10029357|NCT01897402|11153672|FG000|NOT COMPLETED|Overall Study||19
10029358|NCT01897402|11153673|FG001|NOT COMPLETED|Overall Study||16
10029359|NCT01897493|11153685|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
10029360|NCT01897493|11153685|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
10029361|NCT01897493|11153685|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
10029362|NCT01897493|11153685|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
10029363|NCT01897493|11153685|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
10029364|NCT01897493|11153685|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
10029365|NCT01897493|11153685|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
10029366|NCT01897493|11153685|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
10029367|NCT01897532|11153694|FG000|STARTED|Discontinuation From Treatment||3492
10115528|NCT02526524|11246359|FG004|NOT COMPLETED|Overall Study||24
10115529|NCT02526524|11246360|FG005|NOT COMPLETED|Overall Study||21
10115530|NCT02526550|11246374|FG000|STARTED|Overall Study||50
10115531|NCT02526550|11246374|FG000|COMPLETED|Overall Study||49
10115532|NCT02526550|11246374|FG000|NOT COMPLETED|Overall Study||1
10115533|NCT02526654|11246380|FG000|STARTED|Overall Study||79
10115534|NCT02526654|11246381|FG001|STARTED|Overall Study||36
10115535|NCT02526654|11246380|FG000|COMPLETED|Overall Study||79
10115536|NCT02526654|11246381|FG001|COMPLETED|Overall Study||36
10115537|NCT02526654|11246380|FG000|NOT COMPLETED|Overall Study||0
10115538|NCT02526654|11246381|FG001|NOT COMPLETED|Overall Study||0
10115539|NCT02526667|11246390|FG000|STARTED|Abdomen||284
10115540|NCT02526667|11246391|FG001|STARTED|Abdomen||56
10115541|NCT02526667|11246392|FG002|STARTED|Abdomen||281
10115542|NCT02526667|11246390|FG000|COMPLETED|Abdomen||284
10115543|NCT02526667|11246391|FG001|COMPLETED|Abdomen||56
10115544|NCT02526667|11246392|FG002|COMPLETED|Abdomen||281
10115545|NCT02526667|11246390|FG000|NOT COMPLETED|Abdomen||0
10115546|NCT02526667|11246391|FG001|NOT COMPLETED|Abdomen||0
10115547|NCT02526667|11246392|FG002|NOT COMPLETED|Abdomen||0
9705017|NCT03233048|10804557|FG000|COMPLETED|Overall Study||4
10115548|NCT02526667|11246390|FG000|STARTED|Groin||290
10115549|NCT02526667|11246391|FG001|STARTED|Groin||56
10115550|NCT02526667|11246392|FG002|STARTED|Groin||294
10115551|NCT02526667|11246390|FG000|COMPLETED|Groin||290
10115552|NCT02526667|11246391|FG001|COMPLETED|Groin||56
10115553|NCT02526667|11246392|FG002|COMPLETED|Groin||294
10115554|NCT02526667|11246390|FG000|NOT COMPLETED|Groin||0
10115555|NCT02526667|11246391|FG001|NOT COMPLETED|Groin||0
10115556|NCT02526667|11246392|FG002|NOT COMPLETED|Groin||0
10115557|NCT02526680|11246406|FG000|STARTED|Overall Study||27
10115558|NCT02526680|11246406|FG000|COMPLETED|Overall Study||27
10115559|NCT02526680|11246406|FG000|NOT COMPLETED|Overall Study||0
10115560|NCT02526693|11246413|FG000|STARTED|Overall Study||53
10115561|NCT02526693|11246414|FG001|STARTED|Overall Study||51
10115562|NCT02526693|11246413|FG000|COMPLETED|Overall Study||50
10115563|NCT02526693|11246414|FG001|COMPLETED|Overall Study||50
10115564|NCT02526693|11246413|FG000|NOT COMPLETED|Overall Study||3
10115565|NCT02526693|11246414|FG001|NOT COMPLETED|Overall Study||1
10115566|NCT02527148|11246426|FG000|STARTED|Overall Study||50
10115567|NCT02527148|11246427|FG001|STARTED|Overall Study||50
10115568|NCT02527148|11246426|FG000|COMPLETED|Overall Study||49
10115569|NCT02527148|11246427|FG001|COMPLETED|Overall Study||50
10115570|NCT02527148|11246426|FG000|NOT COMPLETED|Overall Study||1
9705018|NCT03233048|10804557|FG000|NOT COMPLETED|Overall Study||1
10029368|NCT01897532|11153695|FG001|STARTED|Discontinuation From Treatment||3499
10029369|NCT01897532|11153694|FG000|Treated|Discontinuation From Treatment||3485
10029370|NCT01897532|11153695|FG001|Treated|Discontinuation From Treatment||3494
10115571|NCT02527148|11246427|FG001|NOT COMPLETED|Overall Study||0
10115572|NCT02527161|11246435|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
10115573|NCT02527161|11246435|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
10115574|NCT02527161|11246435|FG000|NOT COMPLETED|Overall Study||132
10115575|NCT02527265|11246442|FG000|STARTED|Overall Study||15
10115576|NCT02527265|11246443|FG001|STARTED|Overall Study||15
10115577|NCT02527265|11246442|FG000|COMPLETED|Overall Study||13
9705019|NCT03138252|10804563|FG000|STARTED|Overall Study||90
9705020|NCT03138252|10804564|FG001|STARTED|Overall Study||90
9705021|NCT03138252|10804563|FG000|COMPLETED|Overall Study||90
10029371|NCT01897532|11153694|FG000|COMPLETED|Discontinuation From Treatment||2530
10029372|NCT01897532|11153695|FG001|COMPLETED|Discontinuation From Treatment||2660
10029373|NCT01897532|11153694|FG000|NOT COMPLETED|Discontinuation From Treatment||962
10029374|NCT01897532|11153695|FG001|NOT COMPLETED|Discontinuation From Treatment||839
10029375|NCT01897532|11153694|FG000|STARTED|Discontinuation From Trial||3492
10029376|NCT01897532|11153695|FG001|STARTED|Discontinuation From Trial||3499
10029377|NCT01897532|11153694|FG000|Treated|Discontinuation From Trial||3485
10029378|NCT01897532|11153695|FG001|Treated|Discontinuation From Trial||3494
10029379|NCT01897532|11153694|FG000|COMPLETED|Discontinuation From Trial||3430
10029380|NCT01897532|11153695|FG001|COMPLETED|Discontinuation From Trial||3458
10029381|NCT01897532|11153694|FG000|NOT COMPLETED|Discontinuation From Trial||62
10029382|NCT01897532|11153695|FG001|NOT COMPLETED|Discontinuation From Trial||41
10029383|NCT01897714|11153707|FG000|STARTED|Phase I (Dose Escalation)||4
10029384|NCT01897714|11153708|FG001|STARTED|Phase I (Dose Escalation)||7
10029385|NCT01897714|11153709|FG002|STARTED|Phase I (Dose Escalation)||6
10029386|NCT01897714|11153710|FG003|STARTED|Phase I (Dose Escalation)||6
10029387|NCT01897714|11153711|FG004|STARTED|Phase I (Dose Escalation)||0
10029388|NCT01897714|11153712|FG005|STARTED|Phase I (Dose Escalation)||0
10029389|NCT01897714|11153707|FG000|COMPLETED|Phase I (Dose Escalation)||1
10029390|NCT01897714|11153708|FG001|COMPLETED|Phase I (Dose Escalation)||0
10029391|NCT01897714|11153709|FG002|COMPLETED|Phase I (Dose Escalation)||1
10029392|NCT01897714|11153710|FG003|COMPLETED|Phase I (Dose Escalation)||0
10029393|NCT01897714|11153711|FG004|COMPLETED|Phase I (Dose Escalation)||0
10029394|NCT01897714|11153712|FG005|COMPLETED|Phase I (Dose Escalation)||0
10029395|NCT01897714|11153707|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3
10029396|NCT01897714|11153708|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7
10029397|NCT01897714|11153709|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5
10029398|NCT01897714|11153710|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6
10029399|NCT01897714|11153711|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0
10029400|NCT01897714|11153712|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0
10029401|NCT01897714|11153707|FG000|STARTED|Phase II (MTD)||0
10029402|NCT01897714|11153708|FG001|STARTED|Phase II (MTD)||0
10029403|NCT01897714|11153709|FG002|STARTED|Phase II (MTD)||0
10029404|NCT01897714|11153710|FG003|STARTED|Phase II (MTD)||0
10029405|NCT01897714|11153711|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
10029406|NCT01897714|11153712|FG005|STARTED|Phase II (MTD)||13
10029407|NCT01897714|11153707|FG000|COMPLETED|Phase II (MTD)||0
10029408|NCT01897714|11153708|FG001|COMPLETED|Phase II (MTD)||0
10029409|NCT01897714|11153709|FG002|COMPLETED|Phase II (MTD)||0
10029410|NCT01897714|11153710|FG003|COMPLETED|Phase II (MTD)||0
10029411|NCT01897714|11153711|FG004|COMPLETED|Phase II (MTD)||15
10029412|NCT01897714|11153712|FG005|COMPLETED|Phase II (MTD)||2
10029413|NCT01897714|11153707|FG000|NOT COMPLETED|Phase II (MTD)||0
10029414|NCT01897714|11153708|FG001|NOT COMPLETED|Phase II (MTD)||0
10029415|NCT01897714|11153709|FG002|NOT COMPLETED|Phase II (MTD)||0
10029416|NCT01897714|11153710|FG003|NOT COMPLETED|Phase II (MTD)||0
10029417|NCT01897714|11153711|FG004|NOT COMPLETED|Phase II (MTD)||30
10029418|NCT01897714|11153712|FG005|NOT COMPLETED|Phase II (MTD)||11
10029419|NCT01897727|11153730|FG000|STARTED|Overall Study||8
10029420|NCT01897727|11153731|FG001|STARTED|Overall Study||9
10029421|NCT01897727|11153730|FG000|COMPLETED|Overall Study||8
10029422|NCT01897727|11153731|FG001|COMPLETED|Overall Study||8
10029423|NCT01897727|11153730|FG000|NOT COMPLETED|Overall Study||0
10029424|NCT01897727|11153731|FG001|NOT COMPLETED|Overall Study||1
10029425|NCT01897766|11153737|FG000|STARTED|Overall Study||482
10029426|NCT01897766|11153737|FG000|COMPLETED|Overall Study||482
10029427|NCT01897766|11153737|FG000|NOT COMPLETED|Overall Study||0
10029428|NCT01897792|11153743|FG000|STARTED|Overall Study||6
10029429|NCT01897792|11153744|FG001|STARTED|Overall Study||5
10029430|NCT01897792|11153743|FG000|COMPLETED|Overall Study||6
10029431|NCT01897792|11153744|FG001|COMPLETED|Overall Study||5
10029432|NCT01897792|11153743|FG000|NOT COMPLETED|Overall Study||0
10029433|NCT01897792|11153744|FG001|NOT COMPLETED|Overall Study||0
10029434|NCT01897896|11153756|FG000|STARTED|Overall Study||82
10029435|NCT01897896|11153757|FG001|STARTED|Overall Study||37
10029436|NCT01897896|11153756|FG000|COMPLETED|Overall Study||56
10029437|NCT01897896|11153757|FG001|COMPLETED|Overall Study||25
10029438|NCT01897896|11153756|FG000|NOT COMPLETED|Overall Study||26
10029439|NCT01897896|11153757|FG001|NOT COMPLETED|Overall Study||12
10029440|NCT01898013|11153767|FG000|STARTED|Visit 3 (Randomization Visit)||45
10029441|NCT01898013|11153768|FG001|STARTED|Visit 3 (Randomization Visit)||49
10029442|NCT01898013|11153767|FG000|COMPLETED|Visit 3 (Randomization Visit)||45
10029443|NCT01898013|11153768|FG001|COMPLETED|Visit 3 (Randomization Visit)||49
10029444|NCT01898013|11153767|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0
10029445|NCT01898013|11153768|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0
10029446|NCT01898013|11153767|FG000|STARTED|Visit 4||45
10029447|NCT01898013|11153768|FG001|STARTED|Visit 4||49
10029448|NCT01898013|11153767|FG000|COMPLETED|Visit 4||45
10029449|NCT01898013|11153768|FG001|COMPLETED|Visit 4||48
10029450|NCT01898013|11153767|FG000|NOT COMPLETED|Visit 4||0
10029451|NCT01898013|11153768|FG001|NOT COMPLETED|Visit 4||1
10029452|NCT01898013|11153767|FG000|STARTED|Visit 5||45
10029453|NCT01898013|11153768|FG001|STARTED|Visit 5||48
10029454|NCT01898013|11153767|FG000|COMPLETED|Visit 5||44
9705022|NCT03138252|10804564|FG001|COMPLETED|Overall Study||90
9705023|NCT03138252|10804563|FG000|NOT COMPLETED|Overall Study||0
9705024|NCT03138252|10804564|FG001|NOT COMPLETED|Overall Study||0
9705025|NCT03116399|10804572|FG000|STARTED|Overall Study||128
9705026|NCT03116399|10804573|FG001|STARTED|Overall Study||120
9705027|NCT03116399|10804572|FG000|6-month|Overall Study||98
9705028|NCT03116399|10804573|FG001|6-month|Overall Study||108
9705029|NCT03116399|10804572|FG000|9-month|Overall Study||91
9705030|NCT03116399|10804573|FG001|9-month|Overall Study||101
9705031|NCT03116399|10804572|FG000|COMPLETED|Overall Study||88
9705032|NCT03116399|10804573|FG001|COMPLETED|Overall Study||96
9705033|NCT03116399|10804572|FG000|NOT COMPLETED|Overall Study||40
9705034|NCT03116399|10804573|FG001|NOT COMPLETED|Overall Study||24
9705035|NCT03064126|10804583|FG000|STARTED|Overall Study||278
9705036|NCT03064126|10804584|FG001|STARTED|Overall Study||98
9705037|NCT03064126|10804585|FG002|STARTED|Overall Study||52
9705038|NCT03064126|10804586|FG003|STARTED|Overall Study||12
9705039|NCT03064126|10804583|FG000|COMPLETED|Overall Study||252
10029455|NCT01898013|11153768|FG001|COMPLETED|Visit 5||47
10029456|NCT01898013|11153767|FG000|NOT COMPLETED|Visit 5||1
10029457|NCT01898013|11153768|FG001|NOT COMPLETED|Visit 5||1
10029458|NCT01898013|11153767|FG000|STARTED|Visit 6||44
10029459|NCT01898013|11153768|FG001|STARTED|Visit 6||47
10029460|NCT01898013|11153767|FG000|COMPLETED|Visit 6||41
10029461|NCT01898013|11153768|FG001|COMPLETED|Visit 6||42
10029462|NCT01898013|11153767|FG000|NOT COMPLETED|Visit 6||3
10029463|NCT01898013|11153768|FG001|NOT COMPLETED|Visit 6||5
10029464|NCT01898078|11153776|FG000|STARTED|Overall Study||13
10029465|NCT01898078|11153777|FG001|STARTED|Overall Study||13
10029466|NCT01898078|11153776|FG000|COMPLETED|Overall Study|Completed treatment|7
10029467|NCT01898078|11153777|FG001|COMPLETED|Overall Study|Completed treatment|5
10029468|NCT01898078|11153776|FG000|NOT COMPLETED|Overall Study||6
10029469|NCT01898078|11153777|FG001|NOT COMPLETED|Overall Study||8
10029470|NCT01898091|11153787|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
10029471|NCT01898091|11153788|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
10029472|NCT01898091|11153787|FG000|COMPLETED|Overall Study||23
10029473|NCT01898091|11153788|FG001|COMPLETED|Overall Study||19
10029474|NCT01898091|11153787|FG000|NOT COMPLETED|Overall Study||2
10029475|NCT01898091|11153788|FG001|NOT COMPLETED|Overall Study||6
10029476|NCT01898130|11153794|FG000|STARTED|Treatment||27
10029477|NCT01898130|11153794|FG000|Reached 1st Response/2 Cycles|Treatment||24
10029478|NCT01898130|11153794|FG000|Went on to Start Cycle 3|Treatment||21
10029479|NCT01898130|11153794|FG000|COMPLETED|Treatment||21
10029480|NCT01898130|11153794|FG000|NOT COMPLETED|Treatment||6
10029481|NCT01898130|11153794|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
10029482|NCT01898130|11153794|FG000|COMPLETED|Follow up Until PD or Death||26
10029483|NCT01898130|11153794|FG000|NOT COMPLETED|Follow up Until PD or Death||1
10029484|NCT01898195|11153801|FG000|STARTED|Varenicline Adherence||53
10029485|NCT01898195|11153802|FG001|STARTED|Varenicline Adherence||54
10029486|NCT01898195|11153803|FG002|STARTED|Varenicline Adherence||51
10029487|NCT01898195|11153801|FG000|COMPLETED|Varenicline Adherence||18
10029488|NCT01898195|11153802|FG001|COMPLETED|Varenicline Adherence||16
10029489|NCT01898195|11153803|FG002|COMPLETED|Varenicline Adherence||15
10029490|NCT01898195|11153801|FG000|NOT COMPLETED|Varenicline Adherence||35
10029491|NCT01898195|11153802|FG001|NOT COMPLETED|Varenicline Adherence||38
10029492|NCT01898195|11153803|FG002|NOT COMPLETED|Varenicline Adherence||36
10029493|NCT01898195|11153801|FG000|STARTED|Smoking Abstinence||53
10029494|NCT01898195|11153802|FG001|STARTED|Smoking Abstinence||54
10029495|NCT01898195|11153803|FG002|STARTED|Smoking Abstinence||51
10029496|NCT01898195|11153801|FG000|COMPLETED|Smoking Abstinence||18
10029497|NCT01898195|11153802|FG001|COMPLETED|Smoking Abstinence||16
10029498|NCT01898195|11153803|FG002|COMPLETED|Smoking Abstinence||15
10029499|NCT01898195|11153801|FG000|NOT COMPLETED|Smoking Abstinence||35
10029500|NCT01898195|11153802|FG001|NOT COMPLETED|Smoking Abstinence||38
10029501|NCT01898195|11153803|FG002|NOT COMPLETED|Smoking Abstinence||36
10029502|NCT01898208|11153814|FG000|STARTED|Overall Study||247
10029503|NCT01898208|11153815|FG001|STARTED|Overall Study||247
10029504|NCT01898208|11153816|FG002|STARTED|Overall Study||249
10029505|NCT01898208|11153814|FG000|COMPLETED|Overall Study||207
10029506|NCT01898208|11153815|FG001|COMPLETED|Overall Study||198
10029507|NCT01898208|11153816|FG002|COMPLETED|Overall Study||212
10029508|NCT01898208|11153814|FG000|NOT COMPLETED|Overall Study||40
10029509|NCT01898208|11153815|FG001|NOT COMPLETED|Overall Study||49
10029510|NCT01898208|11153816|FG002|NOT COMPLETED|Overall Study||37
10029511|NCT01898286|11153824|FG000|STARTED|Overall Study||38
10029512|NCT01898286|11153824|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
10029513|NCT01898286|11153824|FG000|NOT COMPLETED|Overall Study||3
10029514|NCT01898299|11153830|FG000|STARTED|Post Treatment (One Week)||47
10029515|NCT01898299|11153831|FG001|STARTED|Post Treatment (One Week)||42
10029516|NCT01898299|11153830|FG000|COMPLETED|Post Treatment (One Week)||47
9705040|NCT03064126|10804584|FG001|COMPLETED|Overall Study||91
9705041|NCT03064126|10804585|FG002|COMPLETED|Overall Study||49
9705042|NCT03064126|10804586|FG003|COMPLETED|Overall Study||11
9705043|NCT03064126|10804583|FG000|NOT COMPLETED|Overall Study||26
9705044|NCT03064126|10804584|FG001|NOT COMPLETED|Overall Study||7
9705045|NCT03064126|10804585|FG002|NOT COMPLETED|Overall Study||3
9705046|NCT03064126|10804586|FG003|NOT COMPLETED|Overall Study||1
9705047|NCT03020160|10804599|FG000|STARTED|Overall Study||7
9705048|NCT03020160|10804600|FG001|STARTED|Overall Study||41
9705049|NCT03020160|10804599|FG000|Completed 24 Weeks in the Study|Overall Study||7
9705050|NCT03020160|10804600|FG001|Completed 24 Weeks in the Study|Overall Study||41
9705051|NCT03020160|10804599|FG000|COMPLETED|Overall Study||0
9705052|NCT03020160|10804600|FG001|COMPLETED|Overall Study||0
9705053|NCT03020160|10804599|FG000|NOT COMPLETED|Overall Study||7
9705054|NCT03020160|10804600|FG001|NOT COMPLETED|Overall Study||41
9705055|NCT02943993|10804607|FG000|STARTED|Overall Study|Disposition data are based on Baseline Analysis Set (BAS) defined as All-Documented Patient Set participants with any documentation at the Baseline data collection point who fulfil the BAS criteria.|2655
9705056|NCT02943993|10804607|FG000|COMPLETED|Overall Study||2325
9705057|NCT02943993|10804607|FG000|NOT COMPLETED|Overall Study||330
9705058|NCT02939989|10804613|FG000|STARTED|Overall Study||5
9705059|NCT02939989|10804614|FG001|STARTED|Overall Study||28
9705060|NCT02939989|10804613|FG000|COMPLETED|Overall Study||5
9705061|NCT02939989|10804614|FG001|COMPLETED|Overall Study||28
9705062|NCT02939989|10804613|FG000|NOT COMPLETED|Overall Study||0
9705063|NCT02939989|10804614|FG001|NOT COMPLETED|Overall Study||0
9705076|NCT02877134|10804644|FG000|STARTED|Overall Study||72
9705077|NCT02877134|10804645|FG001|STARTED|Overall Study||73
9705078|NCT02877134|10804646|FG002|STARTED|Overall Study||48
9705079|NCT02877134|10804647|FG003|STARTED|Overall Study||50
9705080|NCT02877134|10804648|FG004|STARTED|Overall Study||49
9705081|NCT02877134|10804649|FG005|STARTED|Overall Study||49
9705082|NCT02877134|10804650|FG006|STARTED|Overall Study||47
9705083|NCT02877134|10804644|FG000|Placebo Non Responders at Week 12|Overall Study||44
9705084|NCT02877134|10804645|FG001|Placebo Non Responders at Week 12|Overall Study||0
9705085|NCT02877134|10804646|FG002|Placebo Non Responders at Week 12|Overall Study||31
9705086|NCT02877134|10804647|FG003|Placebo Non Responders at Week 12|Overall Study||0
9705087|NCT02877134|10804648|FG004|Placebo Non Responders at Week 12|Overall Study||0
9705088|NCT02877134|10804649|FG005|Placebo Non Responders at Week 12|Overall Study||0
9705089|NCT02877134|10804650|FG006|Placebo Non Responders at Week 12|Overall Study||0
9705090|NCT02877134|10804644|FG000|COMPLETED|Overall Study||58
9705091|NCT02877134|10804645|FG001|COMPLETED|Overall Study||48
9705092|NCT02877134|10804646|FG002|COMPLETED|Overall Study||42
9705093|NCT02877134|10804647|FG003|COMPLETED|Overall Study||37
9705094|NCT02877134|10804648|FG004|COMPLETED|Overall Study||43
9705095|NCT02877134|10804649|FG005|COMPLETED|Overall Study||42
9705096|NCT02877134|10804650|FG006|COMPLETED|Overall Study||46
9705097|NCT02877134|10804644|FG000|NOT COMPLETED|Overall Study||14
10029517|NCT01898299|11153831|FG001|COMPLETED|Post Treatment (One Week)||42
10029518|NCT01898299|11153830|FG000|NOT COMPLETED|Post Treatment (One Week)||0
10029519|NCT01898299|11153831|FG001|NOT COMPLETED|Post Treatment (One Week)||0
10029520|NCT01898299|11153830|FG000|STARTED|Post Treatment (One Month)||47
10029521|NCT01898299|11153831|FG001|STARTED|Post Treatment (One Month)||42
9705098|NCT02877134|10804645|FG001|NOT COMPLETED|Overall Study||25
9705099|NCT02877134|10804646|FG002|NOT COMPLETED|Overall Study||6
9705100|NCT02877134|10804647|FG003|NOT COMPLETED|Overall Study||13
9705101|NCT02877134|10804648|FG004|NOT COMPLETED|Overall Study||6
9705102|NCT02877134|10804649|FG005|NOT COMPLETED|Overall Study||7
9705103|NCT02877134|10804650|FG006|NOT COMPLETED|Overall Study||1
9729070|NCT00116558|10828670|FG000|NOT COMPLETED|Overall Study||31
9729071|NCT00116558|10828671|FG001|NOT COMPLETED|Overall Study||15
10029522|NCT01898299|11153830|FG000|COMPLETED|Post Treatment (One Month)||44
10029523|NCT01898299|11153831|FG001|COMPLETED|Post Treatment (One Month)||38
10029524|NCT01898299|11153830|FG000|NOT COMPLETED|Post Treatment (One Month)||3
10029525|NCT01898299|11153831|FG001|NOT COMPLETED|Post Treatment (One Month)||4
10029526|NCT01898403|11153837|FG000|STARTED|Overall Study||50
10029527|NCT01898403|11153837|FG000|COMPLETED|Overall Study||50
10029528|NCT01898403|11153837|FG000|NOT COMPLETED|Overall Study||0
10029529|NCT01898429|11153843|FG000|STARTED|Phase 1||5
9729072|NCT00116558|10828672|FG002|NOT COMPLETED|Overall Study||33
9729073|NCT00116584|10828681|FG000|STARTED|Overall Study||36
9729074|NCT00116584|10828682|FG001|STARTED|Overall Study||36
9729075|NCT00116584|10828681|FG000|COMPLETED|Overall Study||34
9729076|NCT00116584|10828682|FG001|COMPLETED|Overall Study||35
10029530|NCT01898429|11153844|FG001|STARTED|Phase 1||0
9729077|NCT00116584|10828681|FG000|NOT COMPLETED|Overall Study||2
9729078|NCT00116584|10828682|FG001|NOT COMPLETED|Overall Study||1
9705104|NCT02763579|10804670|FG000|STARTED|Overall Study||201
9705105|NCT02763579|10804671|FG001|STARTED|Overall Study||202
9705106|NCT02763579|10804670|FG000|COMPLETED|Overall Study||0
9705107|NCT02763579|10804671|FG001|COMPLETED|Overall Study||0
9705108|NCT02763579|10804670|FG000|NOT COMPLETED|Overall Study||201
9705109|NCT02763579|10804671|FG001|NOT COMPLETED|Overall Study||202
9705110|NCT02762708|10804681|FG000|STARTED|Study 1 - RYGB vs Caloric Restriction||3
9705111|NCT02762708|10804682|FG001|STARTED|Study 1 - RYGB vs Caloric Restriction||9
9705112|NCT02762708|10804683|FG002|STARTED|Study 1 - RYGB vs Caloric Restriction||0
9705113|NCT02762708|10804684|FG003|STARTED|Study 1 - RYGB vs Caloric Restriction||0
9705114|NCT02762708|10804681|FG000|COMPLETED|Study 1 - RYGB vs Caloric Restriction||3
9705115|NCT02762708|10804682|FG001|COMPLETED|Study 1 - RYGB vs Caloric Restriction||7
9705116|NCT02762708|10804683|FG002|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
9705117|NCT02762708|10804684|FG003|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
9705118|NCT02762708|10804681|FG000|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
9705119|NCT02762708|10804682|FG001|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||2
9705120|NCT02762708|10804683|FG002|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
9705121|NCT02762708|10804684|FG003|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
9705122|NCT02762708|10804681|FG000|STARTED|Study 2 - Exendin (9,39) Amide Study||0
9705123|NCT02762708|10804682|FG001|STARTED|Study 2 - Exendin (9,39) Amide Study||0
9705124|NCT02762708|10804683|FG002|STARTED|Study 2 - Exendin (9,39) Amide Study||1
9705125|NCT02762708|10804684|FG003|STARTED|Study 2 - Exendin (9,39) Amide Study||0
9705126|NCT02762708|10804681|FG000|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
9705127|NCT02762708|10804682|FG001|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
9705128|NCT02762708|10804683|FG002|COMPLETED|Study 2 - Exendin (9,39) Amide Study||1
9705129|NCT02762708|10804684|FG003|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
9705130|NCT02762708|10804681|FG000|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
9705131|NCT02762708|10804682|FG001|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
9705132|NCT02762708|10804683|FG002|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
9705133|NCT02762708|10804684|FG003|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
9705134|NCT02743494|10804696|FG000|STARTED|Pre-treatment Period||532
9705135|NCT02743494|10804697|FG001|STARTED|Pre-treatment Period||262
9705136|NCT02743494|10804696|FG000|COMPLETED|Pre-treatment Period||532
9705137|NCT02743494|10804697|FG001|COMPLETED|Pre-treatment Period||260
9705138|NCT02743494|10804696|FG000|NOT COMPLETED|Pre-treatment Period||0
9705139|NCT02743494|10804697|FG001|NOT COMPLETED|Pre-treatment Period||2
9705140|NCT02743494|10804696|FG000|STARTED|Treatment Period||532
9705141|NCT02743494|10804697|FG001|STARTED|Treatment Period||260
9705142|NCT02743494|10804696|FG000|COMPLETED|Treatment Period||31
9705143|NCT02743494|10804697|FG001|COMPLETED|Treatment Period||19
9705144|NCT02743494|10804696|FG000|NOT COMPLETED|Treatment Period||501
9705145|NCT02743494|10804697|FG001|NOT COMPLETED|Treatment Period||241
9705146|NCT02741570|10804705|FG000|STARTED|Pre-Treatment Period||472
9705147|NCT02741570|10804706|FG001|STARTED|Pre-Treatment Period||475
9705148|NCT02741570|10804705|FG000|COMPLETED|Pre-Treatment Period||468
9705149|NCT02741570|10804706|FG001|COMPLETED|Pre-Treatment Period||441
9705150|NCT02741570|10804705|FG000|NOT COMPLETED|Pre-Treatment Period||4
9705151|NCT02741570|10804706|FG001|NOT COMPLETED|Pre-Treatment Period||34
9705152|NCT02741570|10804705|FG000|STARTED|Treatment Period||468
9705153|NCT02741570|10804706|FG001|STARTED|Treatment Period||441
9705154|NCT02741570|10804705|FG000|COMPLETED|Treatment Period||0
9705155|NCT02741570|10804706|FG001|COMPLETED|Treatment Period||7
9705156|NCT02741570|10804705|FG000|NOT COMPLETED|Treatment Period||468
9705157|NCT02741570|10804706|FG001|NOT COMPLETED|Treatment Period||434
9705158|NCT02720952|10804712|FG000|STARTED|Overall Study||24
9705159|NCT02720952|10804712|FG000|COMPLETED|Overall Study||24
9705160|NCT02720952|10804712|FG000|NOT COMPLETED|Overall Study||0
9705161|NCT02667587|10804722|FG000|STARTED|Pre-Treatment||358
9705162|NCT02667587|10804723|FG001|STARTED|Pre-Treatment||358
9705163|NCT02667587|10804722|FG000|COMPLETED|Pre-Treatment||354
9705164|NCT02667587|10804723|FG001|COMPLETED|Pre-Treatment||355
9705165|NCT02667587|10804722|FG000|NOT COMPLETED|Pre-Treatment||4
9705166|NCT02667587|10804723|FG001|NOT COMPLETED|Pre-Treatment||3
9705167|NCT02667587|10804722|FG000|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|355
9705168|NCT02667587|10804723|FG001|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|354
10029531|NCT01898429|11153845|FG002|STARTED|Phase 1||0
9705169|NCT02667587|10804722|FG000|COMPLETED|End of Treatment||37
9705170|NCT02667587|10804723|FG001|COMPLETED|End of Treatment||44
9705171|NCT02667587|10804722|FG000|NOT COMPLETED|End of Treatment||318
9705172|NCT02667587|10804723|FG001|NOT COMPLETED|End of Treatment||310
9705173|NCT02621606|10804732|FG000|STARTED|Overall Study||3
9705174|NCT02621606|10804733|FG001|STARTED|Overall Study||7
9705175|NCT02621606|10804734|FG002|STARTED|Overall Study||10
9705176|NCT02621606|10804732|FG000|Treated|Overall Study||3
9705177|NCT02621606|10804733|FG001|Treated|Overall Study||7
9705178|NCT02621606|10804734|FG002|Treated|Overall Study||10
9705179|NCT02621606|10804732|FG000|COMPLETED|Overall Study||3
9705180|NCT02621606|10804733|FG001|COMPLETED|Overall Study||6
9705181|NCT02621606|10804734|FG002|COMPLETED|Overall Study||10
9705182|NCT02621606|10804732|FG000|NOT COMPLETED|Overall Study||0
9705183|NCT02621606|10804733|FG001|NOT COMPLETED|Overall Study||1
10029532|NCT01898429|11153843|FG000|COMPLETED|Phase 1||5
9705184|NCT02621606|10804734|FG002|NOT COMPLETED|Overall Study||0
9705185|NCT02613507|10804744|FG000|STARTED|Overall Study||338
9705186|NCT02613507|10804745|FG001|STARTED|Overall Study||166
9705187|NCT02613507|10804744|FG000|COMPLETED|Overall Study||50
9705188|NCT02613507|10804745|FG001|COMPLETED|Overall Study||2
10029533|NCT01898429|11153844|FG001|COMPLETED|Phase 1||0
10029534|NCT01898429|11153845|FG002|COMPLETED|Phase 1||0
10029535|NCT01898429|11153843|FG000|NOT COMPLETED|Phase 1||0
10029536|NCT01898429|11153844|FG001|NOT COMPLETED|Phase 1||0
10029537|NCT01898429|11153845|FG002|NOT COMPLETED|Phase 1||0
10029538|NCT01898429|11153843|FG000|STARTED|Phase 2||0
10029539|NCT01898429|11153844|FG001|STARTED|Phase 2||5
10029540|NCT01898429|11153845|FG002|STARTED|Phase 2||0
10029541|NCT01898429|11153843|FG000|COMPLETED|Phase 2||0
10029542|NCT01898429|11153844|FG001|COMPLETED|Phase 2||5
10029543|NCT01898429|11153845|FG002|COMPLETED|Phase 2||0
10029544|NCT01898429|11153843|FG000|NOT COMPLETED|Phase 2||0
10029545|NCT01898429|11153844|FG001|NOT COMPLETED|Phase 2||0
10029546|NCT01898429|11153845|FG002|NOT COMPLETED|Phase 2||0
10029547|NCT01898429|11153843|FG000|STARTED|Phase 3||0
10029548|NCT01898429|11153844|FG001|STARTED|Phase 3||0
10029549|NCT01898429|11153845|FG002|STARTED|Phase 3||5
10029550|NCT01898429|11153843|FG000|COMPLETED|Phase 3||0
10029551|NCT01898429|11153844|FG001|COMPLETED|Phase 3||0
10029552|NCT01898429|11153845|FG002|COMPLETED|Phase 3||5
10029553|NCT01898429|11153843|FG000|NOT COMPLETED|Phase 3||0
10029554|NCT01898429|11153844|FG001|NOT COMPLETED|Phase 3||0
10029555|NCT01898429|11153845|FG002|NOT COMPLETED|Phase 3||0
10029556|NCT01898442|11153852|FG000|STARTED|Overall Study||17
10029557|NCT01898442|11153853|FG001|STARTED|Overall Study||17
10029558|NCT01898442|11153854|FG002|STARTED|Overall Study||18
10029559|NCT01898442|11153852|FG000|COMPLETED|Overall Study||16
10029560|NCT01898442|11153853|FG001|COMPLETED|Overall Study||15
10029561|NCT01898442|11153854|FG002|COMPLETED|Overall Study||15
10029562|NCT01898442|11153852|FG000|NOT COMPLETED|Overall Study||1
10029563|NCT01898442|11153853|FG001|NOT COMPLETED|Overall Study||2
10029564|NCT01898442|11153854|FG002|NOT COMPLETED|Overall Study||3
10029565|NCT01898598|11153864|FG000|STARTED|Overall Study||12
10029566|NCT01898598|11153865|FG001|STARTED|Overall Study||6
10029567|NCT01898598|11153864|FG000|Treated|Overall Study||11
10029568|NCT01898598|11153865|FG001|Treated|Overall Study||5
10029569|NCT01898598|11153864|FG000|COMPLETED|Overall Study||8
10029570|NCT01898598|11153865|FG001|COMPLETED|Overall Study||4
10029571|NCT01898598|11153864|FG000|NOT COMPLETED|Overall Study||4
10029572|NCT01898598|11153865|FG001|NOT COMPLETED|Overall Study||2
10029573|NCT01898611|11153873|FG000|STARTED|Overall Study||5
10029574|NCT01898611|11153874|FG001|STARTED|Overall Study||11
10029575|NCT01898611|11153873|FG000|COMPLETED|Overall Study||5
10029576|NCT01898611|11153874|FG001|COMPLETED|Overall Study||10
9705189|NCT02613507|10804744|FG000|NOT COMPLETED|Overall Study||288
9705190|NCT02613507|10804745|FG001|NOT COMPLETED|Overall Study||164
9705194|NCT02557945|10804757|FG000|STARTED|Overall Study||3
9705195|NCT02557945|10804758|FG001|STARTED|Overall Study||3
9705196|NCT02557945|10804757|FG000|COMPLETED|Overall Study||3
9705197|NCT02557945|10804758|FG001|COMPLETED|Overall Study||3
9705198|NCT02557945|10804757|FG000|NOT COMPLETED|Overall Study||0
9705199|NCT02557945|10804758|FG001|NOT COMPLETED|Overall Study||0
9705200|NCT02553915|10804768|FG000|STARTED|Overall Study||15
9705201|NCT02553915|10804769|FG001|STARTED|Overall Study||15
9705202|NCT02553915|10804770|FG002|STARTED|Overall Study||15
9705203|NCT02553915|10804771|FG003|STARTED|Overall Study||16
9705204|NCT02553915|10804768|FG000|COMPLETED|Overall Study||11
9705205|NCT02553915|10804769|FG001|COMPLETED|Overall Study||14
9705206|NCT02553915|10804770|FG002|COMPLETED|Overall Study||12
9705207|NCT02553915|10804771|FG003|COMPLETED|Overall Study||13
9705208|NCT02553915|10804768|FG000|NOT COMPLETED|Overall Study||4
9705209|NCT02553915|10804769|FG001|NOT COMPLETED|Overall Study||1
9705210|NCT02553915|10804770|FG002|NOT COMPLETED|Overall Study||3
9705211|NCT02553915|10804771|FG003|NOT COMPLETED|Overall Study||3
9705212|NCT02550873|10804783|FG000|STARTED|Randomized Double Blind||78
9705213|NCT02550873|10804784|FG001|STARTED|Randomized Double Blind||39
9705214|NCT02550873|10804785|FG002|STARTED|Randomized Double Blind||0
9705215|NCT02550873|10804783|FG000|Received Treatment|Randomized Double Blind||77
9705216|NCT02550873|10804784|FG001|Received Treatment|Randomized Double Blind||39
9705217|NCT02550873|10804785|FG002|Received Treatment|Randomized Double Blind||0
9705218|NCT02550873|10804783|FG000|Continue to Open Label Extension|Randomized Double Blind||74
9705219|NCT02550873|10804784|FG001|Continue to Open Label Extension|Randomized Double Blind||37
9705220|NCT02550873|10804785|FG002|Continue to Open Label Extension|Randomized Double Blind||0
10029577|NCT01898611|11153873|FG000|NOT COMPLETED|Overall Study||0
10029578|NCT01898611|11153874|FG001|NOT COMPLETED|Overall Study||1
9705221|NCT02550873|10804783|FG000|COMPLETED|Randomized Double Blind||74
9705222|NCT02550873|10804784|FG001|COMPLETED|Randomized Double Blind||37
9705223|NCT02550873|10804785|FG002|COMPLETED|Randomized Double Blind||0
10081475|NCT02260934|11209978|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
10081476|NCT02260934|11209977|FG000|NOT COMPLETED|Overall Study||3
10081477|NCT02260934|11209978|FG001|NOT COMPLETED|Overall Study||4
10081478|NCT02260986|11209994|FG000|STARTED|Overall Study||315
10081479|NCT02260986|11209995|FG001|STARTED|Overall Study||106
9705224|NCT02550873|10804783|FG000|NOT COMPLETED|Randomized Double Blind||4
9705225|NCT02550873|10804784|FG001|NOT COMPLETED|Randomized Double Blind||2
9705226|NCT02550873|10804785|FG002|NOT COMPLETED|Randomized Double Blind||0
9705227|NCT02550873|10804783|FG000|STARTED|Open Label Extension||0
9705228|NCT02550873|10804784|FG001|STARTED|Open Label Extension||0
9705229|NCT02550873|10804785|FG002|STARTED|Open Label Extension||111
9705230|NCT02550873|10804783|FG000|COMPLETED|Open Label Extension||0
9705231|NCT02550873|10804784|FG001|COMPLETED|Open Label Extension||0
9705232|NCT02550873|10804785|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
9705233|NCT02550873|10804783|FG000|NOT COMPLETED|Open Label Extension||0
9705234|NCT02550873|10804784|FG001|NOT COMPLETED|Open Label Extension||0
9705235|NCT02550873|10804785|FG002|NOT COMPLETED|Open Label Extension||111
9705236|NCT02542267|10804807|FG000|STARTED|Overall Study||108
10029579|NCT01898689|11153882|FG000|STARTED|Overall Study||10
9705237|NCT02542267|10804807|FG000|COMPLETED|Overall Study||53
9705238|NCT02542267|10804807|FG000|NOT COMPLETED|Overall Study||55
9705271|NCT02483585|10804853|FG000|STARTED|Double-blind Treatment Phase||291
9705272|NCT02483585|10804854|FG001|STARTED|Double-blind Treatment Phase||286
9705273|NCT02483585|10804853|FG000|Received Treatment|Double-blind Treatment Phase||289
9705274|NCT02483585|10804854|FG001|Received Treatment|Double-blind Treatment Phase||283
9705275|NCT02483585|10804853|FG000|COMPLETED|Double-blind Treatment Phase||275
9705276|NCT02483585|10804854|FG001|COMPLETED|Double-blind Treatment Phase||271
9705277|NCT02483585|10804853|FG000|NOT COMPLETED|Double-blind Treatment Phase||16
9705278|NCT02483585|10804854|FG001|NOT COMPLETED|Double-blind Treatment Phase||15
9705279|NCT02483585|10804853|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
9705280|NCT02483585|10804854|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
9705281|NCT02483585|10804853|FG000|COMPLETED|Open-label Treatment Phase||243
9705282|NCT02483585|10804854|FG001|COMPLETED|Open-label Treatment Phase||243
9705283|NCT02483585|10804853|FG000|NOT COMPLETED|Open-label Treatment Phase||27
9705284|NCT02483585|10804854|FG001|NOT COMPLETED|Open-label Treatment Phase||25
9705285|NCT02462603|10804864|FG000|STARTED|Overall Study||44
9705286|NCT02462603|10804864|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
9705287|NCT02462603|10804864|FG000|EITT Population|Overall Study||40
9705288|NCT02462603|10804864|FG000|COMPLETED|Overall Study||40
9705289|NCT02462603|10804864|FG000|NOT COMPLETED|Overall Study||4
10029580|NCT01898689|11153883|FG001|STARTED|Overall Study||14
10029581|NCT01898689|11153882|FG000|COMPLETED|Overall Study||10
10029582|NCT01898689|11153883|FG001|COMPLETED|Overall Study||14
10029583|NCT01898689|11153882|FG000|NOT COMPLETED|Overall Study||0
10029584|NCT01898689|11153883|FG001|NOT COMPLETED|Overall Study||0
10029585|NCT01898754|11153893|FG000|STARTED|Overall Study||494
10029586|NCT01898754|11153894|FG001|STARTED|Overall Study||497
10029587|NCT01898754|11153893|FG000|COMPLETED|Overall Study||400
9705290|NCT02456740|10804871|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319
9705291|NCT02456740|10804872|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317
9705292|NCT02456740|10804873|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319
9705293|NCT02456740|10804874|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0
9705294|NCT02456740|10804875|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0
9705295|NCT02456740|10804876|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10029588|NCT01898754|11153894|FG001|COMPLETED|Overall Study||403
10029589|NCT01898754|11153893|FG000|NOT COMPLETED|Overall Study||94
10029590|NCT01898754|11153894|FG001|NOT COMPLETED|Overall Study||94
10029591|NCT01898806|11153900|FG000|STARTED|Overall Study||11
9705296|NCT02456740|10804877|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0
9705297|NCT02456740|10804878|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0
9705298|NCT02456740|10804879|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0
9705299|NCT02456740|10804871|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
9705300|NCT02456740|10804872|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
9705301|NCT02456740|10804873|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
9705302|NCT02456740|10804874|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
9705303|NCT02456740|10804875|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
9705304|NCT02456740|10804876|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
9705305|NCT02456740|10804877|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
9705306|NCT02456740|10804878|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
9705307|NCT02456740|10804879|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
9705308|NCT02456740|10804871|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
9705309|NCT02456740|10804872|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
9705310|NCT02456740|10804873|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
9848222|NCT00857896|10960904|FG000|COMPLETED|Baseline to Week 4||20
9848223|NCT00857896|10960904|FG000|NOT COMPLETED|Baseline to Week 4||1
9848224|NCT00857896|10960904|FG000|STARTED|Week 5 to Week 8||20
9848225|NCT00857896|10960904|FG000|COMPLETED|Week 5 to Week 8||20
9848226|NCT00857896|10960904|FG000|NOT COMPLETED|Week 5 to Week 8||0
9848227|NCT00857948|10960913|FG000|STARTED|Overall Study||18
9848228|NCT00857948|10960914|FG001|STARTED|Overall Study||18
9848229|NCT00857948|10960915|FG002|STARTED|Overall Study||19
9848230|NCT00857948|10960916|FG003|STARTED|Overall Study||23
9848231|NCT00857948|10960913|FG000|COMPLETED|Overall Study||15
9848232|NCT00857948|10960914|FG001|COMPLETED|Overall Study||18
9848233|NCT00857948|10960915|FG002|COMPLETED|Overall Study||18
9848234|NCT00857948|10960916|FG003|COMPLETED|Overall Study||23
9848235|NCT00857948|10960913|FG000|NOT COMPLETED|Overall Study||3
9848236|NCT00857948|10960914|FG001|NOT COMPLETED|Overall Study||0
9848237|NCT00857948|10960915|FG002|NOT COMPLETED|Overall Study||1
9848238|NCT00857948|10960916|FG003|NOT COMPLETED|Overall Study||0
9848239|NCT00857961|10960926|FG000|STARTED|Overall Study||21
9848240|NCT00857961|10960926|FG000|COMPLETED|Overall Study||21
9848241|NCT00857961|10960926|FG000|NOT COMPLETED|Overall Study||0
9848242|NCT00858013|10960938|FG000|STARTED|Overall Study||46
9848243|NCT00858013|10960939|FG001|STARTED|Overall Study||42
9848244|NCT00858013|10960938|FG000|COMPLETED|Overall Study||24
9848245|NCT00858013|10960939|FG001|COMPLETED|Overall Study||23
9848246|NCT00858013|10960938|FG000|NOT COMPLETED|Overall Study||22
9848247|NCT00858013|10960939|FG001|NOT COMPLETED|Overall Study||19
9848248|NCT00858117|10960945|FG000|STARTED|Treatment on Study||30
9848249|NCT00858117|10960945|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28
9848250|NCT00858117|10960945|FG000|COMPLETED|Treatment on Study||28
9848251|NCT00858117|10960945|FG000|NOT COMPLETED|Treatment on Study||2
9848252|NCT00858117|10960945|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
9848253|NCT00858117|10960945|FG000|COMPLETED|Follow up for 5 Years||17
9848254|NCT00858117|10960945|FG000|NOT COMPLETED|Follow up for 5 Years||13
9848255|NCT00858130|10960949|FG000|STARTED|Overall Study||12
9848256|NCT00858130|10960949|FG000|COMPLETED|Overall Study||12
9848257|NCT00858130|10960949|FG000|NOT COMPLETED|Overall Study||0
9848258|NCT00858143|10960954|FG000|STARTED|Overall Study|Baseline|311
9848259|NCT00858143|10960954|FG000|COMPLETED|Overall Study||261
9848260|NCT00858143|10960954|FG000|NOT COMPLETED|Overall Study||50
9848261|NCT00858208|10960958|FG000|STARTED|Overall Study||85
9848262|NCT00858208|10960958|FG000|COMPLETED|Overall Study||6
9848263|NCT00858208|10960958|FG000|NOT COMPLETED|Overall Study||79
9848264|NCT00858234|10960962|FG000|STARTED|Overall Study||9
9848265|NCT00858234|10960962|FG000|COMPLETED|Overall Study||0
9848266|NCT00858234|10960962|FG000|NOT COMPLETED|Overall Study||9
9848267|NCT00858247|10960968|FG000|STARTED|Baseline Assessment||25
9848268|NCT00858247|10960969|FG001|STARTED|Baseline Assessment||26
9848269|NCT00858247|10960968|FG000|COMPLETED|Baseline Assessment||23
9848270|NCT00858247|10960969|FG001|COMPLETED|Baseline Assessment||24
9848271|NCT00858247|10960968|FG000|NOT COMPLETED|Baseline Assessment||2
9848272|NCT00858247|10960969|FG001|NOT COMPLETED|Baseline Assessment||2
9848273|NCT00858247|10960968|FG000|STARTED|Week 12 Follow-up||23
9848274|NCT00858247|10960969|FG001|STARTED|Week 12 Follow-up||24
9848275|NCT00858247|10960968|FG000|COMPLETED|Week 12 Follow-up||23
9848276|NCT00858247|10960969|FG001|COMPLETED|Week 12 Follow-up||23
9848277|NCT00858247|10960968|FG000|NOT COMPLETED|Week 12 Follow-up||0
10115578|NCT02527265|11246443|FG001|COMPLETED|Overall Study||11
9848278|NCT00858247|10960969|FG001|NOT COMPLETED|Week 12 Follow-up||1
9848279|NCT00858364|10960977|FG000|STARTED|Overall Study||846
9848280|NCT00858364|10960978|FG001|STARTED|Overall Study||1703
9848281|NCT00858364|10960977|FG000|Received Study Drug|Overall Study||837
9848282|NCT00858364|10960978|FG001|Received Study Drug|Overall Study||1681
9848283|NCT00858364|10960977|FG000|COMPLETED|Overall Study||642
9848284|NCT00858364|10960978|FG001|COMPLETED|Overall Study||1246
9848285|NCT00858364|10960977|FG000|NOT COMPLETED|Overall Study||204
9848286|NCT00858364|10960978|FG001|NOT COMPLETED|Overall Study||457
9848287|NCT00858390|10960986|FG000|STARTED|Overall Study||18
9848288|NCT00858390|10960987|FG001|STARTED|Overall Study||18
9848289|NCT00858390|10960986|FG000|COMPLETED|Overall Study||18
9848290|NCT00858390|10960987|FG001|COMPLETED|Overall Study||18
9705311|NCT02456740|10804874|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705312|NCT02456740|10804875|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705313|NCT02456740|10804876|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705314|NCT02456740|10804877|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705315|NCT02456740|10804878|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705316|NCT02456740|10804879|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705317|NCT02456740|10804871|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
9705318|NCT02456740|10804872|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
9705319|NCT02456740|10804873|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
9705320|NCT02456740|10804874|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705321|NCT02456740|10804875|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705322|NCT02456740|10804876|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10029592|NCT01898806|11153900|FG000|COMPLETED|Overall Study||8
10029593|NCT01898806|11153900|FG000|NOT COMPLETED|Overall Study||3
10029594|NCT01898884|11153909|FG000|STARTED|Single Dose Period||8
10029595|NCT01898884|11153910|FG001|STARTED|Single Dose Period||6
10029596|NCT01898884|11153911|FG002|STARTED|Single Dose Period||6
10029597|NCT01898884|11153912|FG003|STARTED|Single Dose Period||6
10029598|NCT01898884|11153913|FG004|STARTED|Single Dose Period||6
10029599|NCT01898884|11153914|FG005|STARTED|Single Dose Period||0
10029600|NCT01898884|11153915|FG006|STARTED|Single Dose Period||0
10029601|NCT01898884|11153916|FG007|STARTED|Single Dose Period||0
10029602|NCT01898884|11153917|FG008|STARTED|Single Dose Period||0
10029603|NCT01898884|11153909|FG000|COMPLETED|Single Dose Period||8
10029604|NCT01898884|11153910|FG001|COMPLETED|Single Dose Period||6
10029605|NCT01898884|11153911|FG002|COMPLETED|Single Dose Period||6
10029606|NCT01898884|11153912|FG003|COMPLETED|Single Dose Period||6
10029607|NCT01898884|11153913|FG004|COMPLETED|Single Dose Period||6
10029608|NCT01898884|11153914|FG005|COMPLETED|Single Dose Period||0
10029609|NCT01898884|11153915|FG006|COMPLETED|Single Dose Period||0
10029610|NCT01898884|11153916|FG007|COMPLETED|Single Dose Period||0
10029611|NCT01898884|11153917|FG008|COMPLETED|Single Dose Period||0
10029612|NCT01898884|11153909|FG000|NOT COMPLETED|Single Dose Period||0
10029613|NCT01898884|11153910|FG001|NOT COMPLETED|Single Dose Period||0
10029614|NCT01898884|11153911|FG002|NOT COMPLETED|Single Dose Period||0
10029615|NCT01898884|11153912|FG003|NOT COMPLETED|Single Dose Period||0
10029616|NCT01898884|11153913|FG004|NOT COMPLETED|Single Dose Period||0
10029617|NCT01898884|11153914|FG005|NOT COMPLETED|Single Dose Period||0
10029618|NCT01898884|11153915|FG006|NOT COMPLETED|Single Dose Period||0
10029619|NCT01898884|11153916|FG007|NOT COMPLETED|Single Dose Period||0
10029620|NCT01898884|11153917|FG008|NOT COMPLETED|Single Dose Period||0
10029621|NCT01898884|11153909|FG000|STARTED|Multiple Dose Period||0
10029622|NCT01898884|11153910|FG001|STARTED|Multiple Dose Period||0
10029623|NCT01898884|11153911|FG002|STARTED|Multiple Dose Period||0
10029624|NCT01898884|11153912|FG003|STARTED|Multiple Dose Period||0
10029625|NCT01898884|11153913|FG004|STARTED|Multiple Dose Period||0
10029626|NCT01898884|11153914|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10029627|NCT01898884|11153915|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10029628|NCT01898884|11153916|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10029629|NCT01898884|11153917|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10029630|NCT01898884|11153909|FG000|Treated|Multiple Dose Period||0
10029631|NCT01898884|11153910|FG001|Treated|Multiple Dose Period||0
10029632|NCT01898884|11153911|FG002|Treated|Multiple Dose Period||0
10029633|NCT01898884|11153912|FG003|Treated|Multiple Dose Period||0
10029634|NCT01898884|11153913|FG004|Treated|Multiple Dose Period||0
10029635|NCT01898884|11153914|FG005|Treated|Multiple Dose Period||6
10029636|NCT01898884|11153915|FG006|Treated|Multiple Dose Period||6
10029637|NCT01898884|11153916|FG007|Treated|Multiple Dose Period||6
10029638|NCT01898884|11153917|FG008|Treated|Multiple Dose Period||5
10029639|NCT01898884|11153909|FG000|COMPLETED|Multiple Dose Period||0
10029640|NCT01898884|11153910|FG001|COMPLETED|Multiple Dose Period||0
10029641|NCT01898884|11153911|FG002|COMPLETED|Multiple Dose Period||0
10029642|NCT01898884|11153912|FG003|COMPLETED|Multiple Dose Period||0
10029643|NCT01898884|11153913|FG004|COMPLETED|Multiple Dose Period||0
10029644|NCT01898884|11153914|FG005|COMPLETED|Multiple Dose Period||6
10029645|NCT01898884|11153915|FG006|COMPLETED|Multiple Dose Period||5
10029646|NCT01898884|11153916|FG007|COMPLETED|Multiple Dose Period||6
10029647|NCT01898884|11153917|FG008|COMPLETED|Multiple Dose Period||5
10029648|NCT01898884|11153909|FG000|NOT COMPLETED|Multiple Dose Period||0
10029649|NCT01898884|11153910|FG001|NOT COMPLETED|Multiple Dose Period||0
10029650|NCT01898884|11153911|FG002|NOT COMPLETED|Multiple Dose Period||0
10029651|NCT01898884|11153912|FG003|NOT COMPLETED|Multiple Dose Period||0
10029652|NCT01898884|11153913|FG004|NOT COMPLETED|Multiple Dose Period||0
10029653|NCT01898884|11153914|FG005|NOT COMPLETED|Multiple Dose Period||0
10029654|NCT01898884|11153915|FG006|NOT COMPLETED|Multiple Dose Period||1
10029655|NCT01898884|11153916|FG007|NOT COMPLETED|Multiple Dose Period||0
9705323|NCT02456740|10804877|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10029656|NCT01898884|11153917|FG008|NOT COMPLETED|Multiple Dose Period||1
10029657|NCT01898923|11153955|FG000|STARTED|Overall Study||122
10029658|NCT01898923|11153956|FG001|STARTED|Overall Study||114
9705324|NCT02456740|10804878|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705325|NCT02456740|10804879|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
9705326|NCT02456740|10804871|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
9705327|NCT02456740|10804872|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
9705328|NCT02456740|10804873|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
9705329|NCT02456740|10804874|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
9705330|NCT02456740|10804875|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
9705331|NCT02456740|10804876|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
9705332|NCT02456740|10804877|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
9705333|NCT02456740|10804878|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
9705334|NCT02456740|10804879|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
9705335|NCT02456740|10804871|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9705336|NCT02456740|10804872|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9705337|NCT02456740|10804873|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9705338|NCT02456740|10804874|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
9705339|NCT02456740|10804875|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
9705340|NCT02456740|10804876|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
9705341|NCT02456740|10804877|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
9705342|NCT02456740|10804878|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
9705343|NCT02456740|10804879|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
9705344|NCT02456740|10804871|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9705345|NCT02456740|10804872|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9705346|NCT02456740|10804873|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
9705347|NCT02456740|10804874|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
9705348|NCT02456740|10804875|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
9705349|NCT02456740|10804876|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
9705350|NCT02456740|10804877|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
9705351|NCT02456740|10804878|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
9705352|NCT02456740|10804879|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
9705353|NCT02438410|10804889|FG000|STARTED|Overall Study||13
9705354|NCT02438410|10804889|FG000|COMPLETED|Overall Study||13
9705355|NCT02438410|10804889|FG000|NOT COMPLETED|Overall Study||0
9705362|NCT02420717|10804906|FG000|STARTED|Overall Study||5
9705363|NCT02420717|10804907|FG001|STARTED|Overall Study||3
9705364|NCT02420717|10804908|FG002|STARTED|Overall Study||3
9705365|NCT02420717|10804906|FG000|COMPLETED|Overall Study||3
9705366|NCT02420717|10804907|FG001|COMPLETED|Overall Study||3
9705367|NCT02420717|10804908|FG002|COMPLETED|Overall Study||3
9705368|NCT02420717|10804906|FG000|NOT COMPLETED|Overall Study||2
9705369|NCT02420717|10804907|FG001|NOT COMPLETED|Overall Study||0
9705370|NCT02420717|10804908|FG002|NOT COMPLETED|Overall Study||0
9705371|NCT02408068|10804916|FG000|STARTED|Treatment 1 (1.5 Days)||3
9705372|NCT02408068|10804917|FG001|STARTED|Treatment 1 (1.5 Days)||3
9705373|NCT02408068|10804918|FG002|STARTED|Treatment 1 (1.5 Days)||3
9705374|NCT02408068|10804919|FG003|STARTED|Treatment 1 (1.5 Days)||3
9705375|NCT02408068|10804920|FG004|STARTED|Treatment 1 (1.5 Days)||3
9705376|NCT02408068|10804921|FG005|STARTED|Treatment 1 (1.5 Days)||3
9705377|NCT02408068|10804916|FG000|COMPLETED|Treatment 1 (1.5 Days)||3
9705378|NCT02408068|10804917|FG001|COMPLETED|Treatment 1 (1.5 Days)||3
9705379|NCT02408068|10804918|FG002|COMPLETED|Treatment 1 (1.5 Days)||3
9705380|NCT02408068|10804919|FG003|COMPLETED|Treatment 1 (1.5 Days)||3
9705381|NCT02408068|10804920|FG004|COMPLETED|Treatment 1 (1.5 Days)||3
9705382|NCT02408068|10804921|FG005|COMPLETED|Treatment 1 (1.5 Days)||3
9705383|NCT02408068|10804916|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0
9705384|NCT02408068|10804917|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0
9705385|NCT02408068|10804918|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0
9705386|NCT02408068|10804919|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0
9705387|NCT02408068|10804920|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0
9705388|NCT02408068|10804921|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0
9705389|NCT02408068|10804916|FG000|STARTED|Washout Period 1 (7 Days)||3
9705390|NCT02408068|10804917|FG001|STARTED|Washout Period 1 (7 Days)||3
9705391|NCT02408068|10804918|FG002|STARTED|Washout Period 1 (7 Days)||3
9705392|NCT02408068|10804919|FG003|STARTED|Washout Period 1 (7 Days)||3
9705393|NCT02408068|10804920|FG004|STARTED|Washout Period 1 (7 Days)||3
9705394|NCT02408068|10804921|FG005|STARTED|Washout Period 1 (7 Days)||3
9705395|NCT02408068|10804916|FG000|COMPLETED|Washout Period 1 (7 Days)||3
9705396|NCT02408068|10804917|FG001|COMPLETED|Washout Period 1 (7 Days)||3
9705397|NCT02408068|10804918|FG002|COMPLETED|Washout Period 1 (7 Days)||3
9705398|NCT02408068|10804919|FG003|COMPLETED|Washout Period 1 (7 Days)||3
9705399|NCT02408068|10804920|FG004|COMPLETED|Washout Period 1 (7 Days)||3
9705400|NCT02408068|10804921|FG005|COMPLETED|Washout Period 1 (7 Days)||3
9705401|NCT02408068|10804916|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9705402|NCT02408068|10804917|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9705403|NCT02408068|10804918|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9705404|NCT02408068|10804919|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
9705405|NCT02408068|10804920|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
9705406|NCT02408068|10804921|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
9705407|NCT02408068|10804916|FG000|STARTED|Treatment 2 (1.5 Days)||3
9705408|NCT02408068|10804917|FG001|STARTED|Treatment 2 (1.5 Days)||3
9705409|NCT02408068|10804918|FG002|STARTED|Treatment 2 (1.5 Days)||3
9705410|NCT02408068|10804919|FG003|STARTED|Treatment 2 (1.5 Days)||3
9705411|NCT02408068|10804920|FG004|STARTED|Treatment 2 (1.5 Days)||3
9705412|NCT02408068|10804921|FG005|STARTED|Treatment 2 (1.5 Days)||3
9705413|NCT02408068|10804916|FG000|COMPLETED|Treatment 2 (1.5 Days)||3
9705414|NCT02408068|10804917|FG001|COMPLETED|Treatment 2 (1.5 Days)||3
9705415|NCT02408068|10804918|FG002|COMPLETED|Treatment 2 (1.5 Days)||3
9705416|NCT02408068|10804919|FG003|COMPLETED|Treatment 2 (1.5 Days)||3
9848291|NCT00858390|10960986|FG000|NOT COMPLETED|Overall Study||0
9848292|NCT00858390|10960987|FG001|NOT COMPLETED|Overall Study||0
9848293|NCT00858403|10960993|FG000|STARTED|Overall Study||7
9848294|NCT00858403|10960993|FG000|COMPLETED|Overall Study||2
9848295|NCT00858403|10960993|FG000|NOT COMPLETED|Overall Study||5
9848296|NCT00858442|10960999|FG000|STARTED|From Surgery to Start Compression;||21
9848297|NCT00858442|10961000|FG001|STARTED|From Surgery to Start Compression;||23
9848298|NCT00858442|10960999|FG000|COMPLETED|From Surgery to Start Compression;||21
9848299|NCT00858442|10961000|FG001|COMPLETED|From Surgery to Start Compression;||23
9848300|NCT00858442|10960999|FG000|NOT COMPLETED|From Surgery to Start Compression;||0
9848301|NCT00858442|10961000|FG001|NOT COMPLETED|From Surgery to Start Compression;||0
9848302|NCT00858442|10960999|FG000|STARTED|Compression:Start to Finish||21
9848303|NCT00858442|10961000|FG001|STARTED|Compression:Start to Finish||23
9848304|NCT00858442|10960999|FG000|COMPLETED|Compression:Start to Finish||20
9848305|NCT00858442|10961000|FG001|COMPLETED|Compression:Start to Finish||20
9848306|NCT00858442|10960999|FG000|NOT COMPLETED|Compression:Start to Finish||1
9848307|NCT00858442|10961000|FG001|NOT COMPLETED|Compression:Start to Finish||3
9848308|NCT00858468|10961009|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
9848309|NCT00858468|10961010|FG001|STARTED|Overall Study||192
9848310|NCT00858468|10961009|FG000|COMPLETED|Overall Study||201
9848311|NCT00858468|10961010|FG001|COMPLETED|Overall Study||192
9848312|NCT00858468|10961009|FG000|NOT COMPLETED|Overall Study||0
9848313|NCT00858468|10961010|FG001|NOT COMPLETED|Overall Study||0
10029659|NCT01898923|11153955|FG000|COMPLETED|Overall Study||106
10029660|NCT01898923|11153956|FG001|COMPLETED|Overall Study||93
10029661|NCT01898923|11153955|FG000|NOT COMPLETED|Overall Study||16
10029662|NCT01898923|11153956|FG001|NOT COMPLETED|Overall Study||21
10029663|NCT01899053|11153976|FG000|STARTED|Overall Study||7
10029664|NCT01899053|11153977|FG001|STARTED|Overall Study||3
10029665|NCT01899053|11153978|FG002|STARTED|Overall Study||7
10029666|NCT01899053|11153979|FG003|STARTED|Overall Study||3
10029667|NCT01899053|11153980|FG004|STARTED|Overall Study||6
10029668|NCT01899053|11153981|FG005|STARTED|Overall Study||3
10029669|NCT01899053|11153982|FG006|STARTED|Overall Study||3
10029670|NCT01899053|11153983|FG007|STARTED|Overall Study||3
10029671|NCT01899053|11153984|FG008|STARTED|Overall Study||6
10029672|NCT01899053|11153985|FG009|STARTED|Overall Study||3
10029673|NCT01899053|11153986|FG010|STARTED|Overall Study||16
10029674|NCT01899053|11153987|FG011|STARTED|Overall Study||7
10029675|NCT01899053|11153988|FG012|STARTED|Overall Study||14
10029676|NCT01899053|11153989|FG013|STARTED|Overall Study||20
10029677|NCT01899053|11153976|FG000|COMPLETED|Overall Study||0
10029678|NCT01899053|11153977|FG001|COMPLETED|Overall Study||0
10029679|NCT01899053|11153978|FG002|COMPLETED|Overall Study||0
10029680|NCT01899053|11153979|FG003|COMPLETED|Overall Study||0
10029681|NCT01899053|11153980|FG004|COMPLETED|Overall Study||0
10029682|NCT01899053|11153981|FG005|COMPLETED|Overall Study||0
10029683|NCT01899053|11153982|FG006|COMPLETED|Overall Study||0
10029684|NCT01899053|11153983|FG007|COMPLETED|Overall Study||0
10029685|NCT01899053|11153984|FG008|COMPLETED|Overall Study||0
10029686|NCT01899053|11153985|FG009|COMPLETED|Overall Study||0
10029687|NCT01899053|11153986|FG010|COMPLETED|Overall Study||0
10029688|NCT01899053|11153987|FG011|COMPLETED|Overall Study||0
10029689|NCT01899053|11153988|FG012|COMPLETED|Overall Study||0
10029690|NCT01899053|11153989|FG013|COMPLETED|Overall Study||0
10029691|NCT01899053|11153976|FG000|NOT COMPLETED|Overall Study||7
10029692|NCT01899053|11153977|FG001|NOT COMPLETED|Overall Study||3
10029693|NCT01899053|11153978|FG002|NOT COMPLETED|Overall Study||7
10029694|NCT01899053|11153979|FG003|NOT COMPLETED|Overall Study||3
10029695|NCT01899053|11153980|FG004|NOT COMPLETED|Overall Study||6
10029696|NCT01899053|11153981|FG005|NOT COMPLETED|Overall Study||3
9848314|NCT00858494|10961016|FG000|STARTED|Overall Study||49
10029697|NCT01899053|11153982|FG006|NOT COMPLETED|Overall Study||3
10029698|NCT01899053|11153983|FG007|NOT COMPLETED|Overall Study||3
10029699|NCT01899053|11153984|FG008|NOT COMPLETED|Overall Study||6
10029700|NCT01899053|11153985|FG009|NOT COMPLETED|Overall Study||3
9705417|NCT02408068|10804920|FG004|COMPLETED|Treatment 2 (1.5 Days)||3
9848315|NCT00858494|10961016|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
9848316|NCT00858494|10961016|FG000|NOT COMPLETED|Overall Study||4
10029701|NCT01899053|11153986|FG010|NOT COMPLETED|Overall Study||16
10029702|NCT01899053|11153987|FG011|NOT COMPLETED|Overall Study||7
10029703|NCT01899053|11153988|FG012|NOT COMPLETED|Overall Study||14
10029704|NCT01899053|11153989|FG013|NOT COMPLETED|Overall Study||20
10029705|NCT01899300|11154021|FG000|STARTED|Overall Study||1
10029706|NCT01899300|11154022|FG001|STARTED|Overall Study||0
10029707|NCT01899300|11154021|FG000|COMPLETED|Overall Study||1
9705418|NCT02408068|10804921|FG005|COMPLETED|Treatment 2 (1.5 Days)||3
9705419|NCT02408068|10804916|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0
9705420|NCT02408068|10804917|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0
9705421|NCT02408068|10804918|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0
9705422|NCT02408068|10804919|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0
9705423|NCT02408068|10804920|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0
9705424|NCT02408068|10804921|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0
9705425|NCT02408068|10804916|FG000|STARTED|Washout Period 2 (7 Days)||3
9705426|NCT02408068|10804917|FG001|STARTED|Washout Period 2 (7 Days)||3
9705427|NCT02408068|10804918|FG002|STARTED|Washout Period 2 (7 Days)||3
9705428|NCT02408068|10804919|FG003|STARTED|Washout Period 2 (7 Days)||3
9705429|NCT02408068|10804920|FG004|STARTED|Washout Period 2 (7 Days)||3
9705430|NCT02408068|10804921|FG005|STARTED|Washout Period 2 (7 Days)||3
9705431|NCT02408068|10804916|FG000|COMPLETED|Washout Period 2 (7 Days)||3
9705432|NCT02408068|10804917|FG001|COMPLETED|Washout Period 2 (7 Days)||3
9705433|NCT02408068|10804918|FG002|COMPLETED|Washout Period 2 (7 Days)||3
9705434|NCT02408068|10804919|FG003|COMPLETED|Washout Period 2 (7 Days)||3
9705435|NCT02408068|10804920|FG004|COMPLETED|Washout Period 2 (7 Days)||3
9705436|NCT02408068|10804921|FG005|COMPLETED|Washout Period 2 (7 Days)||3
9705437|NCT02408068|10804916|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9705438|NCT02408068|10804917|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9705439|NCT02408068|10804918|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9705440|NCT02408068|10804919|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9705441|NCT02408068|10804920|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
9705442|NCT02408068|10804921|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
9705443|NCT02408068|10804916|FG000|STARTED|Treatment 3 (1.5 Days)||3
9705444|NCT02408068|10804917|FG001|STARTED|Treatment 3 (1.5 Days)||3
9705445|NCT02408068|10804918|FG002|STARTED|Treatment 3 (1.5 Days)||3
9705446|NCT02408068|10804919|FG003|STARTED|Treatment 3 (1.5 Days)||3
9705447|NCT02408068|10804920|FG004|STARTED|Treatment 3 (1.5 Days)||3
9705448|NCT02408068|10804921|FG005|STARTED|Treatment 3 (1.5 Days)||3
9705449|NCT02408068|10804916|FG000|COMPLETED|Treatment 3 (1.5 Days)||3
9705450|NCT02408068|10804917|FG001|COMPLETED|Treatment 3 (1.5 Days)||3
9705451|NCT02408068|10804918|FG002|COMPLETED|Treatment 3 (1.5 Days)||2
9705452|NCT02408068|10804919|FG003|COMPLETED|Treatment 3 (1.5 Days)||3
9705453|NCT02408068|10804920|FG004|COMPLETED|Treatment 3 (1.5 Days)||3
9705454|NCT02408068|10804921|FG005|COMPLETED|Treatment 3 (1.5 Days)||3
9705455|NCT02408068|10804916|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0
9705456|NCT02408068|10804917|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0
9705457|NCT02408068|10804918|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1
9705458|NCT02408068|10804919|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0
9705459|NCT02408068|10804920|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0
9705460|NCT02408068|10804921|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0
9705461|NCT02315703|10804940|FG000|STARTED|Overall Study||50
9705462|NCT02315703|10804941|FG001|STARTED|Overall Study||49
9705463|NCT02315703|10804942|FG002|STARTED|Overall Study||49
9705464|NCT02315703|10804943|FG003|STARTED|Overall Study||48
9705465|NCT02315703|10804944|FG004|STARTED|Overall Study||49
9705466|NCT02315703|10804945|FG005|STARTED|Overall Study||49
9705467|NCT02315703|10804946|FG006|STARTED|Overall Study||50
9705468|NCT02315703|10804947|FG007|STARTED|Overall Study||49
9705469|NCT02315703|10804940|FG000|COMPLETED|Overall Study||44
9705470|NCT02315703|10804941|FG001|COMPLETED|Overall Study||39
9705471|NCT02315703|10804942|FG002|COMPLETED|Overall Study||44
9705472|NCT02315703|10804943|FG003|COMPLETED|Overall Study||39
9705473|NCT02315703|10804944|FG004|COMPLETED|Overall Study||41
9705474|NCT02315703|10804945|FG005|COMPLETED|Overall Study||43
9705475|NCT02315703|10804946|FG006|COMPLETED|Overall Study||37
9705476|NCT02315703|10804947|FG007|COMPLETED|Overall Study||42
9705477|NCT02315703|10804940|FG000|NOT COMPLETED|Overall Study||6
9705478|NCT02315703|10804941|FG001|NOT COMPLETED|Overall Study||10
9705479|NCT02315703|10804942|FG002|NOT COMPLETED|Overall Study||5
10029708|NCT01899300|11154022|FG001|COMPLETED|Overall Study||0
10029709|NCT01899300|11154021|FG000|NOT COMPLETED|Overall Study||0
10029710|NCT01899300|11154022|FG001|NOT COMPLETED|Overall Study||0
10029711|NCT01899677|11154030|FG000|STARTED|Overall Study||35
10029712|NCT01899677|11154031|FG001|STARTED|Overall Study||35
10029713|NCT01899677|11154030|FG000|COMPLETED|Overall Study||25
10029714|NCT01899677|11154031|FG001|COMPLETED|Overall Study||28
10029715|NCT01899677|11154030|FG000|NOT COMPLETED|Overall Study||10
10029716|NCT01899677|11154031|FG001|NOT COMPLETED|Overall Study||7
10029717|NCT01899742|11154039|FG000|STARTED|Overall Study||247
10029718|NCT01899742|11154040|FG001|STARTED|Overall Study||247
10029719|NCT01899742|11154039|FG000|COMPLETED|Overall Study||230
10029720|NCT01899742|11154040|FG001|COMPLETED|Overall Study||231
9705480|NCT02315703|10804943|FG003|NOT COMPLETED|Overall Study||9
9705481|NCT02315703|10804944|FG004|NOT COMPLETED|Overall Study||8
9705482|NCT02315703|10804945|FG005|NOT COMPLETED|Overall Study||6
9705483|NCT02315703|10804946|FG006|NOT COMPLETED|Overall Study||13
9705484|NCT02315703|10804947|FG007|NOT COMPLETED|Overall Study||7
9729079|NCT00116649|10828688|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
9729080|NCT00116649|10828688|FG000|COMPLETED|Overall Study||396
9729081|NCT00116649|10828688|FG000|NOT COMPLETED|Overall Study||155
9729082|NCT00116688|10828694|FG000|STARTED|Overall Study||292
9729083|NCT00116688|10828695|FG001|STARTED|Overall Study||21
10029721|NCT01899742|11154039|FG000|NOT COMPLETED|Overall Study||17
10029722|NCT01899742|11154040|FG001|NOT COMPLETED|Overall Study||16
10029723|NCT01899768|11154046|FG000|STARTED|Part A||16
9705497|NCT02174861|10804974|FG000|STARTED|Overall Study||609
9705498|NCT02174861|10804974|FG000|Enrolled in CHU Substudy|Overall Study||53
9705499|NCT02174861|10804974|FG000|COMPLETED|Overall Study||451
9705500|NCT02174861|10804974|FG000|NOT COMPLETED|Overall Study||158
9705501|NCT02052739|10804982|FG000|STARTED|Overall Study||19
9705502|NCT02052739|10804983|FG001|STARTED|Overall Study||6
9705503|NCT02052739|10804982|FG000|COMPLETED|Overall Study||14
9705504|NCT02052739|10804983|FG001|COMPLETED|Overall Study||5
9705505|NCT02052739|10804982|FG000|NOT COMPLETED|Overall Study||5
9705506|NCT02052739|10804983|FG001|NOT COMPLETED|Overall Study||1
9705517|NCT01944020|10805002|FG000|STARTED|Overall Study||17
9705518|NCT01944020|10805003|FG001|STARTED|Overall Study||12
9705519|NCT01944020|10805002|FG000|COMPLETED|Overall Study||12
9705520|NCT01944020|10805003|FG001|COMPLETED|Overall Study||12
9705521|NCT01944020|10805002|FG000|NOT COMPLETED|Overall Study||5
9705522|NCT01944020|10805003|FG001|NOT COMPLETED|Overall Study||0
9705529|NCT01689519|10805023|FG000|STARTED|Intent to Treat||247
9705530|NCT01689519|10805024|FG001|STARTED|Intent to Treat||248
9705531|NCT01689519|10805023|FG000|COMPLETED|Intent to Treat||0
9705532|NCT01689519|10805024|FG001|COMPLETED|Intent to Treat||0
9705533|NCT01689519|10805023|FG000|NOT COMPLETED|Intent to Treat||247
9705534|NCT01689519|10805024|FG001|NOT COMPLETED|Intent to Treat||248
9705535|NCT01689519|10805023|FG000|STARTED|Safety Population||248
9705536|NCT01689519|10805024|FG001|STARTED|Safety Population||245
9705537|NCT01689519|10805023|FG000|COMPLETED|Safety Population||0
9705538|NCT01689519|10805024|FG001|COMPLETED|Safety Population||0
9705539|NCT01689519|10805023|FG000|NOT COMPLETED|Safety Population||248
9705540|NCT01689519|10805024|FG001|NOT COMPLETED|Safety Population||245
9705541|NCT01622088|10805030|FG000|STARTED|Overall Study||616
9705542|NCT01622088|10805030|FG000|COMPLETED|Overall Study||0
9705543|NCT01622088|10805030|FG000|NOT COMPLETED|Overall Study||616
9705544|NCT01486264|10805037|FG000|STARTED|Overall Study||142
9705545|NCT01486264|10805038|FG001|STARTED|Overall Study||141
9705546|NCT01486264|10805037|FG000|Treated|Overall Study||142
9705547|NCT01486264|10805038|FG001|Treated|Overall Study||140
9705548|NCT01486264|10805037|FG000|COMPLETED|Overall Study||113
9705549|NCT01486264|10805038|FG001|COMPLETED|Overall Study||94
9705550|NCT01486264|10805037|FG000|NOT COMPLETED|Overall Study||29
9705551|NCT01486264|10805038|FG001|NOT COMPLETED|Overall Study||47
9705552|NCT01419080|10805044|FG000|STARTED|Overall Study||797
9705553|NCT01419080|10805044|FG000|COMPLETED|Overall Study||666
9705554|NCT01419080|10805044|FG000|NOT COMPLETED|Overall Study||131
9705555|NCT01317160|10805052|FG000|STARTED|Overall Study||75
9705556|NCT01317160|10805053|FG001|STARTED|Overall Study||75
9705557|NCT01317160|10805052|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
9705558|NCT01317160|10805053|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
9705559|NCT01317160|10805052|FG000|COMPLETED|Overall Study||71
9705560|NCT01317160|10805053|FG001|COMPLETED|Overall Study||69
9705561|NCT01317160|10805052|FG000|NOT COMPLETED|Overall Study||4
9705562|NCT01317160|10805053|FG001|NOT COMPLETED|Overall Study||6
9705563|NCT01234532|10805059|FG000|STARTED|Overall Study||5
9705564|NCT01234532|10805059|FG000|COMPLETED|Overall Study||5
9705565|NCT01234532|10805059|FG000|NOT COMPLETED|Overall Study||0
9705578|NCT01154335|10805077|FG000|STARTED|Overall Study||7
9705579|NCT01154335|10805078|FG001|STARTED|Overall Study||6
9705580|NCT01154335|10805079|FG002|STARTED|Overall Study||5
9705581|NCT01154335|10805077|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
9705582|NCT01154335|10805078|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
9705583|NCT01154335|10805079|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
9705584|NCT01154335|10805077|FG000|NOT COMPLETED|Overall Study||7
9705585|NCT01154335|10805078|FG001|NOT COMPLETED|Overall Study||6
9705586|NCT01154335|10805079|FG002|NOT COMPLETED|Overall Study||5
9705590|NCT01143116|10805095|FG000|STARTED|Overall Study||10
9705591|NCT01143116|10805096|FG001|STARTED|Overall Study||10
9705592|NCT01143116|10805095|FG000|COMPLETED|Overall Study||10
9705593|NCT01143116|10805096|FG001|COMPLETED|Overall Study||10
9705594|NCT01143116|10805095|FG000|NOT COMPLETED|Overall Study||0
9705595|NCT01143116|10805096|FG001|NOT COMPLETED|Overall Study||0
10029724|NCT01899768|11154046|FG000|COMPLETED|Part A||13
10029725|NCT01899768|11154046|FG000|NOT COMPLETED|Part A||3
10029726|NCT01899768|11154046|FG000|STARTED|Part B||13
10029727|NCT01899768|11154046|FG000|COMPLETED|Part B||11
10029728|NCT01899768|11154046|FG000|NOT COMPLETED|Part B||2
10029729|NCT01899768|11154046|FG000|STARTED|Part C||11
10029730|NCT01899768|11154046|FG000|COMPLETED|Part C||11
10029731|NCT01899768|11154046|FG000|NOT COMPLETED|Part C||0
10029732|NCT01899911|11154054|FG000|STARTED|Overall Study||12
10029733|NCT01899911|11154054|FG000|COMPLETED|Overall Study||12
10029734|NCT01899911|11154054|FG000|NOT COMPLETED|Overall Study||0
10029735|NCT01900054|11154058|FG000|STARTED|Overall Study||58
10029736|NCT01900054|11154058|FG000|COMPLETED|Overall Study||56
10029737|NCT01900054|11154058|FG000|NOT COMPLETED|Overall Study||2
10029738|NCT01900067|11154064|FG000|STARTED|Overall Study||134
10029739|NCT01900067|11154065|FG001|STARTED|Overall Study||137
10029740|NCT01900067|11154064|FG000|COMPLETED|Overall Study||122
10029741|NCT01900067|11154065|FG001|COMPLETED|Overall Study||124
10029742|NCT01900067|11154064|FG000|NOT COMPLETED|Overall Study||12
10029743|NCT01900067|11154065|FG001|NOT COMPLETED|Overall Study||13
10029744|NCT01900249|11154074|FG000|STARTED|Overall Study||67
10029745|NCT01900249|11154075|FG001|STARTED|Overall Study||68
10029746|NCT01900249|11154076|FG002|STARTED|Overall Study||69
10029747|NCT01900249|11154074|FG000|COMPLETED|Overall Study||64
10029748|NCT01900249|11154075|FG001|COMPLETED|Overall Study||63
10029749|NCT01900249|11154076|FG002|COMPLETED|Overall Study||65
10029750|NCT01900249|11154074|FG000|NOT COMPLETED|Overall Study||3
10029751|NCT01900249|11154075|FG001|NOT COMPLETED|Overall Study||5
10029752|NCT01900249|11154076|FG002|NOT COMPLETED|Overall Study||4
10029753|NCT01900314|11154086|FG000|STARTED|Overall Study||20
10029754|NCT01900314|11154087|FG001|STARTED|Overall Study||20
10029755|NCT01900314|11154086|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
10029756|NCT01900314|11154087|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
10029757|NCT01900314|11154086|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
10029758|NCT01900314|11154087|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
10029759|NCT01900314|11154086|FG000|NOT COMPLETED|Overall Study||4
10029760|NCT01900314|11154087|FG001|NOT COMPLETED|Overall Study||4
10029761|NCT01900392|11154097|FG000|STARTED|Overall Study||39
10029762|NCT01900392|11154098|FG001|STARTED|Overall Study||75
10029763|NCT01900392|11154099|FG002|STARTED|Overall Study||77
10029764|NCT01900392|11154097|FG000|COMPLETED|Overall Study||38
10029765|NCT01900392|11154098|FG001|COMPLETED|Overall Study||74
10029766|NCT01900392|11154099|FG002|COMPLETED|Overall Study||77
10029767|NCT01900392|11154097|FG000|NOT COMPLETED|Overall Study||1
10029768|NCT01900392|11154098|FG001|NOT COMPLETED|Overall Study||1
10029769|NCT01900392|11154099|FG002|NOT COMPLETED|Overall Study||0
10029770|NCT01900431|11154109|FG000|STARTED|Principal Treatment Period (Part A)||20
10029771|NCT01900431|11154110|FG001|STARTED|Principal Treatment Period (Part A)||38
10029772|NCT01900431|11154111|FG002|STARTED|Principal Treatment Period (Part A)||0
10029773|NCT01900431|11154109|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
10029774|NCT01900431|11154110|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
10029775|NCT01900431|11154111|FG002|COMPLETED|Principal Treatment Period (Part A)||0
10029776|NCT01900431|11154109|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7
10029777|NCT01900431|11154110|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10
10029778|NCT01900431|11154111|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0
10029779|NCT01900431|11154109|FG000|STARTED|Extended Treatment Period (Part B)||8
10029780|NCT01900431|11154110|FG001|STARTED|Extended Treatment Period (Part B)||22
10029781|NCT01900431|11154111|FG002|STARTED|Extended Treatment Period (Part B)||0
10029782|NCT01900431|11154109|FG000|COMPLETED|Extended Treatment Period (Part B)||7
10029783|NCT01900431|11154110|FG001|COMPLETED|Extended Treatment Period (Part B)||12
10029784|NCT01900431|11154111|FG002|COMPLETED|Extended Treatment Period (Part B)||0
10029785|NCT01900431|11154109|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1
10029786|NCT01900431|11154110|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10
10029787|NCT01900431|11154111|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0
10029788|NCT01900431|11154109|FG000|STARTED|Open-Label Treatment Period (Part C)||0
10029789|NCT01900431|11154110|FG001|STARTED|Open-Label Treatment Period (Part C)||0
10029790|NCT01900431|11154111|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
10029791|NCT01900431|11154109|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0
10029792|NCT01900431|11154110|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0
10029793|NCT01900431|11154111|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13
10029794|NCT01900431|11154109|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
10029795|NCT01900431|11154110|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
10029796|NCT01900431|11154111|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
10029797|NCT01900561|11154121|FG000|STARTED|Overall Study||278
10029798|NCT01900561|11154122|FG001|STARTED|Overall Study||278
10029799|NCT01900561|11154121|FG000|COMPLETED|Overall Study||261
10029800|NCT01900561|11154122|FG001|COMPLETED|Overall Study||269
10029801|NCT01900561|11154121|FG000|NOT COMPLETED|Overall Study||17
10029802|NCT01900561|11154122|FG001|NOT COMPLETED|Overall Study||9
10029803|NCT01900652|11154130|FG000|STARTED|Overall Study||83
10029804|NCT01900652|11154131|FG001|STARTED|Overall Study||28
10029805|NCT01900652|11154130|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66
10029806|NCT01900652|11154131|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23
10029807|NCT01900652|11154130|FG000|COMPLETED|Overall Study||75
10029808|NCT01900652|11154131|FG001|COMPLETED|Overall Study||25
10029809|NCT01900652|11154130|FG000|NOT COMPLETED|Overall Study||8
10029810|NCT01900652|11154131|FG001|NOT COMPLETED|Overall Study||3
10029811|NCT01900665|11154144|FG000|STARTED|Placebo Controlled Period||1057
10029812|NCT01900665|11154145|FG001|STARTED|Placebo Controlled Period||1072
10029813|NCT01900665|11154144|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
10029814|NCT01900665|11154145|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
10029815|NCT01900665|11154144|FG000|COMPLETED|Placebo Controlled Period||914
10029816|NCT01900665|11154145|FG001|COMPLETED|Placebo Controlled Period||908
10029817|NCT01900665|11154144|FG000|NOT COMPLETED|Placebo Controlled Period||143
10029818|NCT01900665|11154145|FG001|NOT COMPLETED|Placebo Controlled Period||164
10029819|NCT01900665|11154144|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
10029820|NCT01900665|11154145|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
10029821|NCT01900665|11154144|FG000|COMPLETED|Open Label Period||0
10029822|NCT01900665|11154145|FG001|COMPLETED|Open Label Period||0
10029823|NCT01900665|11154144|FG000|NOT COMPLETED|Open Label Period||881
10029824|NCT01900665|11154145|FG001|NOT COMPLETED|Open Label Period||859
10029825|NCT01900704|11154157|FG000|STARTED|Overall Study||270
10029826|NCT01900704|11154158|FG001|STARTED|Overall Study||270
10029827|NCT01900704|11154159|FG002|STARTED|Overall Study||270
10029828|NCT01900704|11154157|FG000|COMPLETED|Overall Study||229
10029829|NCT01900704|11154158|FG001|COMPLETED|Overall Study||235
10029830|NCT01900704|11154159|FG002|COMPLETED|Overall Study||237
10029831|NCT01900704|11154157|FG000|NOT COMPLETED|Overall Study||41
10029832|NCT01900704|11154158|FG001|NOT COMPLETED|Overall Study||35
10029833|NCT01900704|11154159|FG002|NOT COMPLETED|Overall Study||33
10029834|NCT01900899|11154170|FG000|STARTED|Overall Study||159
10029835|NCT01900899|11154171|FG001|STARTED|Overall Study||25
10029836|NCT01900899|11154170|FG000|COMPLETED|Overall Study||150
10029837|NCT01900899|11154171|FG001|COMPLETED|Overall Study||24
10029838|NCT01900899|11154170|FG000|NOT COMPLETED|Overall Study||9
10029839|NCT01900899|11154171|FG001|NOT COMPLETED|Overall Study||1
10029840|NCT01901055|11154179|FG000|STARTED|Randomization But Not Titrated||49
10029841|NCT01901055|11154180|FG001|STARTED|Randomization But Not Titrated||49
10029842|NCT01901055|11154179|FG000|COMPLETED|Randomization But Not Titrated||48
10029843|NCT01901055|11154180|FG001|COMPLETED|Randomization But Not Titrated||47
10029844|NCT01901055|11154179|FG000|NOT COMPLETED|Randomization But Not Titrated||1
10029845|NCT01901055|11154180|FG001|NOT COMPLETED|Randomization But Not Titrated||2
10029846|NCT01901055|11154179|FG000|STARTED|Started Protocol to Week 6||48
10029847|NCT01901055|11154180|FG001|STARTED|Started Protocol to Week 6||47
10029848|NCT01901055|11154179|FG000|COMPLETED|Started Protocol to Week 6||45
10029849|NCT01901055|11154180|FG001|COMPLETED|Started Protocol to Week 6||43
10029850|NCT01901055|11154179|FG000|NOT COMPLETED|Started Protocol to Week 6||3
10029851|NCT01901055|11154180|FG001|NOT COMPLETED|Started Protocol to Week 6||4
10029852|NCT01901055|11154179|FG000|STARTED|Week 12 Assessment||45
10029853|NCT01901055|11154180|FG001|STARTED|Week 12 Assessment||43
10029854|NCT01901055|11154179|FG000|COMPLETED|Week 12 Assessment||44
10029855|NCT01901055|11154180|FG001|COMPLETED|Week 12 Assessment||39
10029856|NCT01901055|11154179|FG000|NOT COMPLETED|Week 12 Assessment||1
10029857|NCT01901055|11154180|FG001|NOT COMPLETED|Week 12 Assessment||4
10029858|NCT01901055|11154179|FG000|STARTED|Week 24||44
10029859|NCT01901055|11154180|FG001|STARTED|Week 24||39
10029860|NCT01901055|11154179|FG000|COMPLETED|Week 24||30
10029861|NCT01901055|11154180|FG001|COMPLETED|Week 24||20
10029862|NCT01901055|11154179|FG000|NOT COMPLETED|Week 24||14
10029863|NCT01901055|11154180|FG001|NOT COMPLETED|Week 24||19
10029864|NCT01901055|11154179|FG000|STARTED|Week 36||30
10029865|NCT01901055|11154180|FG001|STARTED|Week 36||20
10029866|NCT01901055|11154179|FG000|COMPLETED|Week 36||30
10029867|NCT01901055|11154180|FG001|COMPLETED|Week 36||15
10029868|NCT01901055|11154179|FG000|NOT COMPLETED|Week 36||0
10029869|NCT01901055|11154180|FG001|NOT COMPLETED|Week 36||5
10115579|NCT02527265|11246442|FG000|NOT COMPLETED|Overall Study||2
10115580|NCT02527265|11246443|FG001|NOT COMPLETED|Overall Study||4
10115581|NCT02527343|11246451|FG000|STARTED|RT Period: Weeks 1 to 52||19
10115582|NCT02527343|11246452|FG001|STARTED|RT Period: Weeks 1 to 52||21
10029870|NCT01901146|11154191|FG000|STARTED|Neoadjuvant Phase||364
10029871|NCT01901146|11154192|FG001|STARTED|Neoadjuvant Phase||361
10029872|NCT01901146|11154193|FG002|STARTED|Neoadjuvant Phase||0
10029873|NCT01901146|11154194|FG003|STARTED|Neoadjuvant Phase||0
10029874|NCT01901146|11154195|FG004|STARTED|Neoadjuvant Phase||0
10029875|NCT01901146|11154191|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
10029876|NCT01901146|11154192|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
10029877|NCT01901146|11154193|FG002|COMPLETED|Neoadjuvant Phase||0
10029878|NCT01901146|11154194|FG003|COMPLETED|Neoadjuvant Phase||0
10029879|NCT01901146|11154195|FG004|COMPLETED|Neoadjuvant Phase||0
10029880|NCT01901146|11154191|FG000|NOT COMPLETED|Neoadjuvant Phase||6
10029881|NCT01901146|11154192|FG001|NOT COMPLETED|Neoadjuvant Phase||14
10029882|NCT01901146|11154193|FG002|NOT COMPLETED|Neoadjuvant Phase||0
10029883|NCT01901146|11154194|FG003|NOT COMPLETED|Neoadjuvant Phase||0
10029884|NCT01901146|11154195|FG004|NOT COMPLETED|Neoadjuvant Phase||0
10029885|NCT01901146|11154191|FG000|STARTED|Adjuvant Phase||0
10029886|NCT01901146|11154192|FG001|STARTED|Adjuvant Phase||0
10029887|NCT01901146|11154193|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
10029888|NCT01901146|11154194|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
10029889|NCT01901146|11154195|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
10029890|NCT01901146|11154191|FG000|COMPLETED|Adjuvant Phase||0
10029891|NCT01901146|11154192|FG001|COMPLETED|Adjuvant Phase||0
10029892|NCT01901146|11154193|FG002|COMPLETED|Adjuvant Phase||323
10029893|NCT01901146|11154194|FG003|COMPLETED|Adjuvant Phase||164
10029894|NCT01901146|11154195|FG004|COMPLETED|Adjuvant Phase||157
10029895|NCT01901146|11154191|FG000|NOT COMPLETED|Adjuvant Phase||0
10029896|NCT01901146|11154192|FG001|NOT COMPLETED|Adjuvant Phase||0
10029897|NCT01901146|11154193|FG002|NOT COMPLETED|Adjuvant Phase||26
10029898|NCT01901146|11154194|FG003|NOT COMPLETED|Adjuvant Phase||7
10029899|NCT01901146|11154195|FG004|NOT COMPLETED|Adjuvant Phase||14
10029900|NCT01901185|11154204|FG000|STARTED|Overall Study||77
10029901|NCT01901185|11154204|FG000|Received Etanercept With Autoinjector A|Overall Study||75
10029902|NCT01901185|11154204|FG000|COMPLETED|Overall Study||75
10029903|NCT01901185|11154204|FG000|NOT COMPLETED|Overall Study||2
10029904|NCT01901211|11154210|FG000|STARTED|First Ten-week Period||6
10029905|NCT01901211|11154211|FG001|STARTED|First Ten-week Period||5
10029906|NCT01901211|11154210|FG000|COMPLETED|First Ten-week Period||6
10029907|NCT01901211|11154211|FG001|COMPLETED|First Ten-week Period||5
10029908|NCT01901211|11154210|FG000|NOT COMPLETED|First Ten-week Period||0
10029909|NCT01901211|11154211|FG001|NOT COMPLETED|First Ten-week Period||0
10029910|NCT01901211|11154210|FG000|STARTED|Washout (6 Weeks)||6
10029911|NCT01901211|11154211|FG001|STARTED|Washout (6 Weeks)||5
10029912|NCT01901211|11154210|FG000|COMPLETED|Washout (6 Weeks)||6
10029913|NCT01901211|11154211|FG001|COMPLETED|Washout (6 Weeks)||5
10029914|NCT01901211|11154210|FG000|NOT COMPLETED|Washout (6 Weeks)||0
10029915|NCT01901211|11154211|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10029916|NCT01901211|11154210|FG000|STARTED|Second Ten-week Period||6
10029917|NCT01901211|11154211|FG001|STARTED|Second Ten-week Period||5
10029918|NCT01901211|11154210|FG000|COMPLETED|Second Ten-week Period||6
10029919|NCT01901211|11154211|FG001|COMPLETED|Second Ten-week Period||5
10029920|NCT01901211|11154210|FG000|NOT COMPLETED|Second Ten-week Period||0
10029921|NCT01901211|11154211|FG001|NOT COMPLETED|Second Ten-week Period||0
10029922|NCT01901250|11154219|FG000|STARTED|Overall Study||260
10029923|NCT01901250|11154220|FG001|STARTED|Overall Study||265
10029924|NCT01901250|11154219|FG000|End of Kidergarten|Overall Study||215
10029925|NCT01901250|11154220|FG001|End of Kidergarten|Overall Study||212
10029926|NCT01901250|11154219|FG000|Start of 1st Grade|Overall Study||173
10029927|NCT01901250|11154220|FG001|Start of 1st Grade|Overall Study||176
10029928|NCT01901250|11154219|FG000|End of 1st Grade|Overall Study||143
10029929|NCT01901250|11154220|FG001|End of 1st Grade|Overall Study||151
10029930|NCT01901250|11154219|FG000|COMPLETED|Overall Study||122
10029931|NCT01901250|11154220|FG001|COMPLETED|Overall Study||139
10029932|NCT01901250|11154219|FG000|NOT COMPLETED|Overall Study||138
10029933|NCT01901250|11154220|FG001|NOT COMPLETED|Overall Study||126
10029934|NCT01901302|11154228|FG000|STARTED|Overall Study||31
10029935|NCT01901302|11154229|FG001|STARTED|Overall Study||30
10029936|NCT01901302|11154228|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10029937|NCT01901302|11154229|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
10115583|NCT02527343|11246453|FG002|STARTED|RT Period: Weeks 1 to 52||0
10029938|NCT01901302|11154228|FG000|COMPLETED|Overall Study||4
10029939|NCT01901302|11154229|FG001|COMPLETED|Overall Study||7
10029940|NCT01901302|11154228|FG000|NOT COMPLETED|Overall Study||27
10029941|NCT01901302|11154229|FG001|NOT COMPLETED|Overall Study||23
10029942|NCT01901328|11154237|FG000|STARTED|Overall Study||26
10029943|NCT01901328|11154238|FG001|STARTED|Overall Study||23
10029944|NCT01901328|11154237|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
10029945|NCT01901328|11154238|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23
10029946|NCT01901328|11154237|FG000|COMPLETED|Overall Study||4
10029947|NCT01901328|11154238|FG001|COMPLETED|Overall Study||2
10029948|NCT01901328|11154237|FG000|NOT COMPLETED|Overall Study||22
10029949|NCT01901328|11154238|FG001|NOT COMPLETED|Overall Study||21
10029950|NCT01901341|11154247|FG000|STARTED|Overall Study||22
10029951|NCT01901341|11154248|FG001|STARTED|Overall Study||22
10029952|NCT01901341|11154247|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
10029953|NCT01901341|11154248|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22
10029954|NCT01901341|11154247|FG000|COMPLETED|Overall Study||2
10029955|NCT01901341|11154248|FG001|COMPLETED|Overall Study||1
10029956|NCT01901341|11154247|FG000|NOT COMPLETED|Overall Study||20
10029957|NCT01901341|11154248|FG001|NOT COMPLETED|Overall Study||21
10029958|NCT01901393|11154257|FG000|STARTED|Overall Study||51
10029959|NCT01901393|11154258|FG001|STARTED|Overall Study||49
10029960|NCT01901393|11154257|FG000|COMPLETED|Overall Study||50
10029961|NCT01901393|11154258|FG001|COMPLETED|Overall Study||49
10029962|NCT01901393|11154257|FG000|NOT COMPLETED|Overall Study||1
10029963|NCT01901393|11154258|FG001|NOT COMPLETED|Overall Study||0
10029964|NCT01901419|11154266|FG000|STARTED|Overall Study||40
10029965|NCT01901419|11154267|FG001|STARTED|Overall Study||40
10029966|NCT01901419|11154266|FG000|COMPLETED|Overall Study||32
10029967|NCT01901419|11154267|FG001|COMPLETED|Overall Study||31
10029968|NCT01901419|11154266|FG000|NOT COMPLETED|Overall Study||8
10029969|NCT01901419|11154267|FG001|NOT COMPLETED|Overall Study||9
10029970|NCT01901575|11154273|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
10029971|NCT01901575|11154273|FG000|COMPLETED|Overall Study||16
10029972|NCT01901575|11154273|FG000|NOT COMPLETED|Overall Study||0
10029973|NCT01901588|11154280|FG000|STARTED|Overall Study||32
10029974|NCT01901588|11154281|FG001|STARTED|Overall Study||31
10029975|NCT01901588|11154280|FG000|COMPLETED|Overall Study||32
10029976|NCT01901588|11154281|FG001|COMPLETED|Overall Study||31
10029977|NCT01901588|11154280|FG000|NOT COMPLETED|Overall Study||0
10029978|NCT01901588|11154281|FG001|NOT COMPLETED|Overall Study||0
10029979|NCT01901614|11154289|FG000|STARTED|Overall Study||3
10029980|NCT01901614|11154290|FG001|STARTED|Overall Study||2
10029981|NCT01901614|11154289|FG000|COMPLETED|Overall Study||1
10029982|NCT01901614|11154290|FG001|COMPLETED|Overall Study||1
10029983|NCT01901614|11154289|FG000|NOT COMPLETED|Overall Study||2
10029984|NCT01901614|11154290|FG001|NOT COMPLETED|Overall Study||1
10029985|NCT01901653|11154309|FG000|STARTED|Overall Study||3
10029986|NCT01901653|11154310|FG001|STARTED|Overall Study||1
10029987|NCT01901653|11154311|FG002|STARTED|Overall Study||11
10029988|NCT01901653|11154312|FG003|STARTED|Overall Study||3
10029989|NCT01901653|11154313|FG004|STARTED|Overall Study||2
10029990|NCT01901653|11154314|FG005|STARTED|Overall Study||3
10029991|NCT01901653|11154315|FG006|STARTED|Overall Study||7
10029992|NCT01901653|11154316|FG007|STARTED|Overall Study||10
10029993|NCT01901653|11154317|FG008|STARTED|Overall Study||1
10029994|NCT01901653|11154318|FG009|STARTED|Overall Study||18
10029995|NCT01901653|11154319|FG010|STARTED|Overall Study||2
10029996|NCT01901653|11154320|FG011|STARTED|Overall Study||16
10029997|NCT01901653|11154321|FG012|STARTED|Overall Study||5
10029998|NCT01901653|11154309|FG000|COMPLETED|Overall Study||0
10029999|NCT01901653|11154310|FG001|COMPLETED|Overall Study||0
10030000|NCT01901653|11154311|FG002|COMPLETED|Overall Study||0
10030001|NCT01901653|11154312|FG003|COMPLETED|Overall Study||0
10030002|NCT01901653|11154313|FG004|COMPLETED|Overall Study||0
10030003|NCT01901653|11154314|FG005|COMPLETED|Overall Study||0
10030004|NCT01901653|11154315|FG006|COMPLETED|Overall Study||0
10030005|NCT01901653|11154316|FG007|COMPLETED|Overall Study||0
10030006|NCT01901653|11154317|FG008|COMPLETED|Overall Study||0
10030007|NCT01901653|11154318|FG009|COMPLETED|Overall Study||0
10030008|NCT01901653|11154319|FG010|COMPLETED|Overall Study||0
10030009|NCT01901653|11154320|FG011|COMPLETED|Overall Study||0
10030010|NCT01901653|11154321|FG012|COMPLETED|Overall Study||0
10030011|NCT01901653|11154309|FG000|NOT COMPLETED|Overall Study||3
10030012|NCT01901653|11154310|FG001|NOT COMPLETED|Overall Study||1
10030013|NCT01901653|11154311|FG002|NOT COMPLETED|Overall Study||11
10030014|NCT01901653|11154312|FG003|NOT COMPLETED|Overall Study||3
10030015|NCT01901653|11154313|FG004|NOT COMPLETED|Overall Study||2
10030016|NCT01901653|11154314|FG005|NOT COMPLETED|Overall Study||3
10030017|NCT01901653|11154315|FG006|NOT COMPLETED|Overall Study||7
10030018|NCT01901653|11154316|FG007|NOT COMPLETED|Overall Study||10
10030019|NCT01901653|11154317|FG008|NOT COMPLETED|Overall Study||1
10030020|NCT01901653|11154318|FG009|NOT COMPLETED|Overall Study||18
10030021|NCT01901653|11154319|FG010|NOT COMPLETED|Overall Study||2
10030022|NCT01901653|11154320|FG011|NOT COMPLETED|Overall Study||16
10030023|NCT01901653|11154321|FG012|NOT COMPLETED|Overall Study||5
10030024|NCT01901809|11154351|FG000|STARTED|Overall Study||19
10030025|NCT01901809|11154352|FG001|STARTED|Overall Study||23
10030026|NCT01901809|11154353|FG002|STARTED|Overall Study||24
10030027|NCT01901809|11154354|FG003|STARTED|Overall Study||24
10030028|NCT01901809|11154351|FG000|COMPLETED|Overall Study||19
10030029|NCT01901809|11154352|FG001|COMPLETED|Overall Study||23
10030030|NCT01901809|11154353|FG002|COMPLETED|Overall Study||21
10030031|NCT01901809|11154354|FG003|COMPLETED|Overall Study||22
10030032|NCT01901809|11154351|FG000|NOT COMPLETED|Overall Study||0
10030033|NCT01901809|11154352|FG001|NOT COMPLETED|Overall Study||0
10030034|NCT01901809|11154353|FG002|NOT COMPLETED|Overall Study||3
10030035|NCT01901809|11154354|FG003|NOT COMPLETED|Overall Study||2
10030036|NCT01901848|11154370|FG000|STARTED|Randomized and Treated||25
10030037|NCT01901848|11154371|FG001|STARTED|Randomized and Treated||25
10030038|NCT01901848|11154370|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
10030039|NCT01901848|11154371|FG001|COMPLETED|Randomized and Treated||19
10030040|NCT01901848|11154370|FG000|NOT COMPLETED|Randomized and Treated||3
10030041|NCT01901848|11154371|FG001|NOT COMPLETED|Randomized and Treated||6
10030042|NCT01901848|11154370|FG000|STARTED|Removed From Analyses||22
10030043|NCT01901848|11154371|FG001|STARTED|Removed From Analyses||19
10030044|NCT01901848|11154370|FG000|COMPLETED|Removed From Analyses||12
10030045|NCT01901848|11154371|FG001|COMPLETED|Removed From Analyses||19
10030046|NCT01901848|11154370|FG000|NOT COMPLETED|Removed From Analyses||10
10030047|NCT01901848|11154371|FG001|NOT COMPLETED|Removed From Analyses||0
10030048|NCT01901874|11154377|FG000|STARTED|Procedure||312
10030049|NCT01901874|11154377|FG000|COMPLETED|Procedure||312
10030050|NCT01901874|11154377|FG000|NOT COMPLETED|Procedure||0
10030051|NCT01901874|11154377|FG000|STARTED|Screening Committee Retrospective Review||312
10030052|NCT01901874|11154377|FG000|COMPLETED|Screening Committee Retrospective Review||265
10030053|NCT01901874|11154377|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47
10030054|NCT01901874|11154377|FG000|STARTED|30-Day MAE Evaluation||265
10030055|NCT01901874|11154377|FG000|COMPLETED|30-Day MAE Evaluation||264
10030056|NCT01901874|11154377|FG000|NOT COMPLETED|30-Day MAE Evaluation||1
10030057|NCT01901874|11154377|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264
10030058|NCT01901874|11154377|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244
10030059|NCT01901874|11154377|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
10030060|NCT01902004|11154383|FG000|STARTED|Overall Study||48
10030061|NCT01902004|11154384|FG001|STARTED|Overall Study||47
10030062|NCT01902004|11154383|FG000|COMPLETED|Overall Study||33
10030063|NCT01902004|11154384|FG001|COMPLETED|Overall Study||29
10030064|NCT01902004|11154383|FG000|NOT COMPLETED|Overall Study||15
10030065|NCT01902004|11154384|FG001|NOT COMPLETED|Overall Study||18
10030066|NCT01902134|11154396|FG000|STARTED|Overall Study||159
10030067|NCT01902134|11154397|FG001|STARTED|Overall Study||161
10030068|NCT01902134|11154398|FG002|STARTED|Overall Study||160
10030069|NCT01902134|11154399|FG003|STARTED|Overall Study||54
10030070|NCT01902134|11154400|FG004|STARTED|Overall Study||53
10030071|NCT01902134|11154401|FG005|STARTED|Overall Study||54
10030072|NCT01902134|11154396|FG000|Single-dose Phase|Overall Study||159
10030073|NCT01902134|11154397|FG001|Single-dose Phase|Overall Study||161
10030074|NCT01902134|11154398|FG002|Single-dose Phase|Overall Study||160
10030075|NCT01902134|11154399|FG003|Single-dose Phase|Overall Study||54
10030076|NCT01902134|11154400|FG004|Single-dose Phase|Overall Study||53
10030077|NCT01902134|11154401|FG005|Single-dose Phase|Overall Study||54
10030078|NCT01902134|11154396|FG000|Multiple-dose Phase|Overall Study||159
10030079|NCT01902134|11154397|FG001|Multiple-dose Phase|Overall Study||160
10030080|NCT01902134|11154398|FG002|Multiple-dose Phase|Overall Study||160
10030081|NCT01902134|11154399|FG003|Multiple-dose Phase|Overall Study||54
10030082|NCT01902134|11154400|FG004|Multiple-dose Phase|Overall Study||53
10030083|NCT01902134|11154401|FG005|Multiple-dose Phase|Overall Study||52
10030084|NCT01902134|11154396|FG000|COMPLETED|Overall Study||151
10030085|NCT01902134|11154397|FG001|COMPLETED|Overall Study||150
10030086|NCT01902134|11154398|FG002|COMPLETED|Overall Study||145
10030087|NCT01902134|11154399|FG003|COMPLETED|Overall Study||52
10030088|NCT01902134|11154400|FG004|COMPLETED|Overall Study||46
10030089|NCT01902134|11154401|FG005|COMPLETED|Overall Study||45
10030090|NCT01902134|11154396|FG000|NOT COMPLETED|Overall Study||8
10030091|NCT01902134|11154397|FG001|NOT COMPLETED|Overall Study||11
10030092|NCT01902134|11154398|FG002|NOT COMPLETED|Overall Study||15
10030093|NCT01902134|11154399|FG003|NOT COMPLETED|Overall Study||2
10030094|NCT01902134|11154400|FG004|NOT COMPLETED|Overall Study||7
10030095|NCT01902134|11154401|FG005|NOT COMPLETED|Overall Study||9
10030096|NCT01902303|11154419|FG000|STARTED|Overall Study|Allocated to placebo|77
10030097|NCT01902303|11154420|FG001|STARTED|Overall Study|Allocated to active treatment|81
10030098|NCT01902303|11154419|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
10030099|NCT01902303|11154420|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
10030100|NCT01902303|11154419|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
10030101|NCT01902303|11154420|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
10030102|NCT01902303|11154419|FG000|NOT COMPLETED|Overall Study||23
10030103|NCT01902303|11154420|FG001|NOT COMPLETED|Overall Study||24
10030104|NCT01902459|11154430|FG000|STARTED|Overall Study||75
10030105|NCT01902459|11154431|FG001|STARTED|Overall Study||75
10030106|NCT01902459|11154430|FG000|COMPLETED|Overall Study||75
10030107|NCT01902459|11154431|FG001|COMPLETED|Overall Study||75
10030108|NCT01902459|11154430|FG000|NOT COMPLETED|Overall Study||0
10030109|NCT01902459|11154431|FG001|NOT COMPLETED|Overall Study||0
10030110|NCT01902628|11154437|FG000|STARTED|Overall Study||437
10030111|NCT01902628|11154437|FG000|COMPLETED|Overall Study||354
10030112|NCT01902628|11154437|FG000|NOT COMPLETED|Overall Study||83
10030113|NCT01902758|11154443|FG000|STARTED|Overall Study||14
10030114|NCT01902758|11154444|FG001|STARTED|Overall Study||14
10030115|NCT01902758|11154443|FG000|COMPLETED|Overall Study||14
10030116|NCT01902758|11154444|FG001|COMPLETED|Overall Study||14
10030117|NCT01902758|11154443|FG000|NOT COMPLETED|Overall Study||0
10030118|NCT01902758|11154444|FG001|NOT COMPLETED|Overall Study||0
10030119|NCT01902901|11154452|FG000|STARTED|Overall Study||180
10030120|NCT01902901|11154453|FG001|STARTED|Overall Study||203
10030121|NCT01902901|11154452|FG000|COMPLETED|Overall Study||180
10030122|NCT01902901|11154453|FG001|COMPLETED|Overall Study||201
10030123|NCT01902901|11154452|FG000|NOT COMPLETED|Overall Study||0
10030124|NCT01902901|11154453|FG001|NOT COMPLETED|Overall Study||2
10030125|NCT01902953|11154459|FG000|STARTED|Overall Study||16
10030126|NCT01902953|11154459|FG000|COMPLETED|Overall Study||16
10030127|NCT01902953|11154459|FG000|NOT COMPLETED|Overall Study||0
10030128|NCT01903005|11154465|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
10030129|NCT01903005|11154465|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
10030130|NCT01903005|11154465|FG000|NOT COMPLETED|Overall Study||373
10030131|NCT01903031|11154473|FG000|STARTED|Overall Study||27
10030132|NCT01903031|11154474|FG001|STARTED|Overall Study||28
10030133|NCT01903031|11154475|FG002|STARTED|Overall Study||29
10030134|NCT01903031|11154473|FG000|COMPLETED|Overall Study||25
10030135|NCT01903031|11154474|FG001|COMPLETED|Overall Study||25
10030136|NCT01903031|11154475|FG002|COMPLETED|Overall Study||24
10030137|NCT01903031|11154473|FG000|NOT COMPLETED|Overall Study||2
10030138|NCT01903031|11154474|FG001|NOT COMPLETED|Overall Study||3
10030139|NCT01903031|11154475|FG002|NOT COMPLETED|Overall Study||5
10030140|NCT01903148|11154488|FG000|STARTED|Overall Study||441
10030141|NCT01903148|11154488|FG000|COMPLETED|Overall Study||441
10030142|NCT01903148|11154488|FG000|NOT COMPLETED|Overall Study||0
10030143|NCT01903187|11154496|FG000|STARTED|Procedure||2
10030144|NCT01903187|11154497|FG001|STARTED|Procedure||2
10030145|NCT01903187|11154496|FG000|COMPLETED|Procedure||2
10030146|NCT01903187|11154497|FG001|COMPLETED|Procedure||2
10030147|NCT01903187|11154496|FG000|NOT COMPLETED|Procedure||0
10030148|NCT01903187|11154497|FG001|NOT COMPLETED|Procedure||0
10030149|NCT01903187|11154496|FG000|STARTED|1 Month||2
10030150|NCT01903187|11154497|FG001|STARTED|1 Month||2
10030151|NCT01903187|11154496|FG000|COMPLETED|1 Month||2
10030152|NCT01903187|11154497|FG001|COMPLETED|1 Month||2
10030153|NCT01903187|11154496|FG000|NOT COMPLETED|1 Month||0
10030154|NCT01903187|11154497|FG001|NOT COMPLETED|1 Month||0
10030155|NCT01903187|11154496|FG000|STARTED|3 Month||2
10030156|NCT01903187|11154497|FG001|STARTED|3 Month||0
10030157|NCT01903187|11154496|FG000|COMPLETED|3 Month||2
10030158|NCT01903187|11154497|FG001|COMPLETED|3 Month||0
10030159|NCT01903187|11154496|FG000|NOT COMPLETED|3 Month||0
10030160|NCT01903187|11154497|FG001|NOT COMPLETED|3 Month||0
10030161|NCT01903187|11154496|FG000|STARTED|6 Month||2
10030162|NCT01903187|11154497|FG001|STARTED|6 Month||0
10030163|NCT01903187|11154496|FG000|COMPLETED|6 Month||2
10030164|NCT01903187|11154497|FG001|COMPLETED|6 Month||0
10030165|NCT01903187|11154496|FG000|NOT COMPLETED|6 Month||0
10030166|NCT01903187|11154497|FG001|NOT COMPLETED|6 Month||0
10030167|NCT01903187|11154496|FG000|STARTED|12 Month||2
10030168|NCT01903187|11154497|FG001|STARTED|12 Month||0
10030169|NCT01903187|11154496|FG000|COMPLETED|12 Month||2
10030170|NCT01903187|11154497|FG001|COMPLETED|12 Month||0
10030171|NCT01903187|11154496|FG000|NOT COMPLETED|12 Month||0
10030172|NCT01903187|11154497|FG001|NOT COMPLETED|12 Month||0
10030173|NCT01903252|11154506|FG000|STARTED|Double-Blind Induction||409
10030174|NCT01903252|11154507|FG001|STARTED|Double-Blind Induction||408
10030175|NCT01903252|11154508|FG002|STARTED|Double-Blind Induction||0
10030176|NCT01903252|11154509|FG003|STARTED|Double-Blind Induction||0
10030177|NCT01903252|11154510|FG004|STARTED|Double-Blind Induction||0
10030178|NCT01903252|11154511|FG005|STARTED|Double-Blind Induction||0
10030179|NCT01903252|11154506|FG000|COMPLETED|Double-Blind Induction||370
10030180|NCT01903252|11154507|FG001|COMPLETED|Double-Blind Induction||367
10030181|NCT01903252|11154508|FG002|COMPLETED|Double-Blind Induction||0
10030182|NCT01903252|11154509|FG003|COMPLETED|Double-Blind Induction||0
10030183|NCT01903252|11154510|FG004|COMPLETED|Double-Blind Induction||0
10030184|NCT01903252|11154511|FG005|COMPLETED|Double-Blind Induction||0
10030185|NCT01903252|11154506|FG000|NOT COMPLETED|Double-Blind Induction||39
10030186|NCT01903252|11154507|FG001|NOT COMPLETED|Double-Blind Induction||41
10030187|NCT01903252|11154508|FG002|NOT COMPLETED|Double-Blind Induction||0
10030188|NCT01903252|11154509|FG003|NOT COMPLETED|Double-Blind Induction||0
10030189|NCT01903252|11154510|FG004|NOT COMPLETED|Double-Blind Induction||0
10030190|NCT01903252|11154511|FG005|NOT COMPLETED|Double-Blind Induction||0
10030191|NCT01903252|11154506|FG000|STARTED|Extended Induction, Open-Label||0
10030192|NCT01903252|11154507|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
10030193|NCT01903252|11154508|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
10030194|NCT01903252|11154509|FG003|STARTED|Extended Induction, Open-Label||0
10030195|NCT01903252|11154510|FG004|STARTED|Extended Induction, Open-Label||0
10030196|NCT01903252|11154511|FG005|STARTED|Extended Induction, Open-Label||0
10030197|NCT01903252|11154506|FG000|COMPLETED|Extended Induction, Open-Label||0
10030198|NCT01903252|11154507|FG001|COMPLETED|Extended Induction, Open-Label||0
10030199|NCT01903252|11154508|FG002|COMPLETED|Extended Induction, Open-Label||220
10030200|NCT01903252|11154509|FG003|COMPLETED|Extended Induction, Open-Label||0
10030201|NCT01903252|11154510|FG004|COMPLETED|Extended Induction, Open-Label||0
10030202|NCT01903252|11154511|FG005|COMPLETED|Extended Induction, Open-Label||0
10030203|NCT01903252|11154506|FG000|NOT COMPLETED|Extended Induction, Open-Label||0
10030204|NCT01903252|11154507|FG001|NOT COMPLETED|Extended Induction, Open-Label||0
10030205|NCT01903252|11154508|FG002|NOT COMPLETED|Extended Induction, Open-Label||23
10030206|NCT01903252|11154509|FG003|NOT COMPLETED|Extended Induction, Open-Label||0
10030207|NCT01903252|11154510|FG004|NOT COMPLETED|Extended Induction, Open-Label||0
10030208|NCT01903252|11154511|FG005|NOT COMPLETED|Extended Induction, Open-Label||0
10030209|NCT01903252|11154506|FG000|STARTED|Maintenance, Open-Label||0
10030210|NCT01903252|11154507|FG001|STARTED|Maintenance, Open-Label||0
10030211|NCT01903252|11154508|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
10030212|NCT01903252|11154509|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
10030213|NCT01903252|11154510|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
10030214|NCT01903252|11154511|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
10030215|NCT01903252|11154506|FG000|COMPLETED|Maintenance, Open-Label||0
10030216|NCT01903252|11154507|FG001|COMPLETED|Maintenance, Open-Label||0
10030217|NCT01903252|11154508|FG002|COMPLETED|Maintenance, Open-Label||0
10030218|NCT01903252|11154509|FG003|COMPLETED|Maintenance, Open-Label||196
10030219|NCT01903252|11154510|FG004|COMPLETED|Maintenance, Open-Label||253
10030220|NCT01903252|11154511|FG005|COMPLETED|Maintenance, Open-Label||181
10030221|NCT01903252|11154506|FG000|NOT COMPLETED|Maintenance, Open-Label||0
10030222|NCT01903252|11154507|FG001|NOT COMPLETED|Maintenance, Open-Label||0
10030223|NCT01903252|11154508|FG002|NOT COMPLETED|Maintenance, Open-Label||0
10030224|NCT01903252|11154509|FG003|NOT COMPLETED|Maintenance, Open-Label||6
10030225|NCT01903252|11154510|FG004|NOT COMPLETED|Maintenance, Open-Label||21
10030226|NCT01903252|11154511|FG005|NOT COMPLETED|Maintenance, Open-Label||18
10030227|NCT01903265|11154531|FG000|STARTED|Overall Study||103
10030228|NCT01903265|11154532|FG001|STARTED|Overall Study||102
10030229|NCT01903265|11154531|FG000|COMPLETED|Overall Study||89
10030230|NCT01903265|11154532|FG001|COMPLETED|Overall Study||85
10030231|NCT01903265|11154531|FG000|NOT COMPLETED|Overall Study||14
10030232|NCT01903265|11154532|FG001|NOT COMPLETED|Overall Study||17
10030233|NCT01903356|11154538|FG000|STARTED|Overall Study||724
10030234|NCT01903356|11154538|FG000|COMPLETED|Overall Study||709
10030235|NCT01903356|11154538|FG000|NOT COMPLETED|Overall Study||15
10030236|NCT01903434|11154542|FG000|STARTED|Treatment Period 1||30
10030237|NCT01903434|11154543|FG001|STARTED|Treatment Period 1||30
10030238|NCT01903434|11154542|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
10030239|NCT01903434|11154543|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
10030240|NCT01903434|11154542|FG000|COMPLETED|Treatment Period 1||30
10030241|NCT01903434|11154543|FG001|COMPLETED|Treatment Period 1||30
10030242|NCT01903434|11154542|FG000|NOT COMPLETED|Treatment Period 1||0
10030243|NCT01903434|11154543|FG001|NOT COMPLETED|Treatment Period 1||0
10030244|NCT01903434|11154542|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30
10030245|NCT01903434|11154543|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30
10030246|NCT01903434|11154542|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
10030247|NCT01903434|11154543|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
10030248|NCT01903434|11154542|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
10030249|NCT01903434|11154543|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
10030250|NCT01903434|11154542|FG000|STARTED|Treatment Period 2||29
10030251|NCT01903434|11154543|FG001|STARTED|Treatment Period 2||28
10030252|NCT01903434|11154542|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
10030253|NCT01903434|11154543|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
10030254|NCT01903434|11154542|FG000|COMPLETED|Treatment Period 2||29
10030255|NCT01903434|11154543|FG001|COMPLETED|Treatment Period 2||28
10030256|NCT01903434|11154542|FG000|NOT COMPLETED|Treatment Period 2||0
10030257|NCT01903434|11154543|FG001|NOT COMPLETED|Treatment Period 2||0
10030258|NCT01903434|11154542|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29
10030259|NCT01903434|11154543|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28
10030260|NCT01903434|11154542|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
10030261|NCT01903434|11154543|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
10030262|NCT01903434|11154542|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10030263|NCT01903434|11154543|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
9848317|NCT00858507|10961022|FG000|STARTED|Overall Study||105
9848318|NCT00858507|10961023|FG001|STARTED|Overall Study||116
9848319|NCT00858507|10961022|FG000|COMPLETED|Overall Study||83
9848320|NCT00858507|10961023|FG001|COMPLETED|Overall Study||101
9848321|NCT00858507|10961022|FG000|NOT COMPLETED|Overall Study||22
9848322|NCT00858507|10961023|FG001|NOT COMPLETED|Overall Study||15
10030264|NCT01903434|11154542|FG000|STARTED|Treatment Period 3||29
10030265|NCT01903434|11154543|FG001|STARTED|Treatment Period 3||28
9848323|NCT00858637|10961031|FG000|STARTED|Active Comparison Phase||127
9848324|NCT00858637|10961032|FG001|STARTED|Active Comparison Phase||0
9848325|NCT00858637|10961033|FG002|STARTED|Active Comparison Phase||0
9848326|NCT00858637|10961034|FG003|STARTED|Active Comparison Phase||133
9848327|NCT00858637|10961035|FG004|STARTED|Active Comparison Phase||0
9848328|NCT00858637|10961036|FG005|STARTED|Active Comparison Phase||0
9848329|NCT00858637|10961031|FG000|COMPLETED|Active Comparison Phase||103
9848330|NCT00858637|10961032|FG001|COMPLETED|Active Comparison Phase||0
9848331|NCT00858637|10961033|FG002|COMPLETED|Active Comparison Phase||0
9848332|NCT00858637|10961034|FG003|COMPLETED|Active Comparison Phase||115
9848333|NCT00858637|10961035|FG004|COMPLETED|Active Comparison Phase||0
9848334|NCT00858637|10961036|FG005|COMPLETED|Active Comparison Phase||0
10030266|NCT01903434|11154542|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
10030267|NCT01903434|11154543|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
10030268|NCT01903434|11154542|FG000|COMPLETED|Treatment Period 3||29
10030269|NCT01903434|11154543|FG001|COMPLETED|Treatment Period 3||28
10030270|NCT01903434|11154542|FG000|NOT COMPLETED|Treatment Period 3||0
10030271|NCT01903434|11154543|FG001|NOT COMPLETED|Treatment Period 3||0
10030272|NCT01903460|11154553|FG000|STARTED|Overall Study||6
10030273|NCT01903460|11154554|FG001|STARTED|Overall Study||8
10030274|NCT01903460|11154555|FG002|STARTED|Overall Study||3
10030275|NCT01903460|11154556|FG003|STARTED|Overall Study||3
10030276|NCT01903460|11154553|FG000|COMPLETED|Overall Study||6
10030277|NCT01903460|11154554|FG001|COMPLETED|Overall Study||8
10030278|NCT01903460|11154555|FG002|COMPLETED|Overall Study||3
10030279|NCT01903460|11154556|FG003|COMPLETED|Overall Study||2
10030280|NCT01903460|11154553|FG000|NOT COMPLETED|Overall Study||0
10030281|NCT01903460|11154554|FG001|NOT COMPLETED|Overall Study||0
10030282|NCT01903460|11154555|FG002|NOT COMPLETED|Overall Study||0
10030283|NCT01903460|11154556|FG003|NOT COMPLETED|Overall Study||1
10030284|NCT01903525|11154567|FG000|STARTED|Overall Study||20
10030285|NCT01903525|11154568|FG001|STARTED|Overall Study||20
10030286|NCT01903525|11154567|FG000|COMPLETED|Overall Study||15
10030287|NCT01903525|11154568|FG001|COMPLETED|Overall Study||10
10030288|NCT01903525|11154567|FG000|NOT COMPLETED|Overall Study||5
10030289|NCT01903525|11154568|FG001|NOT COMPLETED|Overall Study||10
10030290|NCT01903564|11154576|FG000|STARTED|Overall Study||10
10030291|NCT01903564|11154577|FG001|STARTED|Overall Study||29
10030292|NCT01903564|11154576|FG000|COMPLETED|Overall Study||10
10030293|NCT01903564|11154577|FG001|COMPLETED|Overall Study||29
10030294|NCT01903564|11154576|FG000|NOT COMPLETED|Overall Study||0
10030295|NCT01903564|11154577|FG001|NOT COMPLETED|Overall Study||0
10030296|NCT01903720|11154583|FG000|STARTED|Overall Study||71
10030297|NCT01903720|11154583|FG000|COMPLETED|Overall Study||59
10030298|NCT01903720|11154583|FG000|NOT COMPLETED|Overall Study||12
10030299|NCT01903733|11154591|FG000|STARTED|Overall Study||250
10030300|NCT01903733|11154592|FG001|STARTED|Overall Study||284
10030301|NCT01903733|11154593|FG002|STARTED|Overall Study||119
10030302|NCT01903733|11154594|FG003|STARTED|Overall Study||167
10030303|NCT01903733|11154591|FG000|Full Analysis Set|Overall Study||250
10030304|NCT01903733|11154592|FG001|Full Analysis Set|Overall Study||284
10030305|NCT01903733|11154593|FG002|Full Analysis Set|Overall Study||119
10030306|NCT01903733|11154594|FG003|Full Analysis Set|Overall Study||167
10030307|NCT01903733|11154591|FG000|Safety Analysis Set|Overall Study||248
10030308|NCT01903733|11154592|FG001|Safety Analysis Set|Overall Study||284
10030309|NCT01903733|11154593|FG002|Safety Analysis Set|Overall Study||119
10030310|NCT01903733|11154594|FG003|Safety Analysis Set|Overall Study||167
10030311|NCT01903733|11154591|FG000|Enrolled in B1871040|Overall Study||124
10030312|NCT01903733|11154592|FG001|Enrolled in B1871040|Overall Study||90
10030313|NCT01903733|11154593|FG002|Enrolled in B1871040|Overall Study||28
10030314|NCT01903733|11154594|FG003|Enrolled in B1871040|Overall Study||18
10030315|NCT01903733|11154591|FG000|Treated in B1871040|Overall Study||98
10030316|NCT01903733|11154592|FG001|Treated in B1871040|Overall Study||69
10030317|NCT01903733|11154593|FG002|Treated in B1871040|Overall Study||13
10030318|NCT01903733|11154594|FG003|Treated in B1871040|Overall Study||8
10030319|NCT01903733|11154591|FG000|COMPLETED|Overall Study||144
10030320|NCT01903733|11154592|FG001|COMPLETED|Overall Study||158
10030321|NCT01903733|11154593|FG002|COMPLETED|Overall Study||58
10030322|NCT01903733|11154594|FG003|COMPLETED|Overall Study||48
10030323|NCT01903733|11154591|FG000|NOT COMPLETED|Overall Study||106
10030324|NCT01903733|11154592|FG001|NOT COMPLETED|Overall Study||126
10030325|NCT01903733|11154593|FG002|NOT COMPLETED|Overall Study||61
10030326|NCT01903733|11154594|FG003|NOT COMPLETED|Overall Study||119
10030327|NCT01903798|11154618|FG000|STARTED|Overall Study||2
10030328|NCT01903798|11154619|FG001|STARTED|Overall Study||0
10030329|NCT01903798|11154620|FG002|STARTED|Overall Study||1
10030330|NCT01903798|11154621|FG003|STARTED|Overall Study||1
10030331|NCT01903798|11154618|FG000|COMPLETED|Overall Study||2
10030332|NCT01903798|11154619|FG001|COMPLETED|Overall Study||0
10030333|NCT01903798|11154620|FG002|COMPLETED|Overall Study||1
10030334|NCT01903798|11154621|FG003|COMPLETED|Overall Study||1
10030335|NCT01903798|11154618|FG000|NOT COMPLETED|Overall Study||0
10030336|NCT01903798|11154619|FG001|NOT COMPLETED|Overall Study||0
10030337|NCT01903798|11154620|FG002|NOT COMPLETED|Overall Study||0
10030338|NCT01903798|11154621|FG003|NOT COMPLETED|Overall Study||0
10030339|NCT01903811|11154633|FG000|STARTED|Overall Study||72
10030340|NCT01903811|11154634|FG001|STARTED|Overall Study||71
10030341|NCT01903811|11154633|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
10030342|NCT01903811|11154634|FG001|Crossover to Arm II|Overall Study||0
10030343|NCT01903811|11154633|FG000|COMPLETED|Overall Study||64
10030344|NCT01903811|11154634|FG001|COMPLETED|Overall Study||57
10030345|NCT01903811|11154633|FG000|NOT COMPLETED|Overall Study||8
10030346|NCT01903811|11154634|FG001|NOT COMPLETED|Overall Study||14
10030347|NCT01903837|11154647|FG000|STARTED|Part A||75
10030348|NCT01903837|11154648|FG001|STARTED|Part A||80
10030349|NCT01903837|11154649|FG002|STARTED|Part A||86
10030350|NCT01903837|11154650|FG003|STARTED|Part A||68
10030351|NCT01903837|11154647|FG000|COMPLETED|Part A||56
10030352|NCT01903837|11154648|FG001|COMPLETED|Part A||52
10030353|NCT01903837|11154649|FG002|COMPLETED|Part A||58
10030354|NCT01903837|11154650|FG003|COMPLETED|Part A||55
10030355|NCT01903837|11154647|FG000|NOT COMPLETED|Part A||19
10030356|NCT01903837|11154648|FG001|NOT COMPLETED|Part A||28
10030357|NCT01903837|11154649|FG002|NOT COMPLETED|Part A||28
10030358|NCT01903837|11154650|FG003|NOT COMPLETED|Part A||13
10030359|NCT01903837|11154647|FG000|STARTED|Part B||54
10030360|NCT01903837|11154648|FG001|STARTED|Part B||52
10030361|NCT01903837|11154649|FG002|STARTED|Part B||57
10030362|NCT01903837|11154650|FG003|STARTED|Part B||55
10030363|NCT01903837|11154647|FG000|COMPLETED|Part B||45
10030364|NCT01903837|11154648|FG001|COMPLETED|Part B||46
10030365|NCT01903837|11154649|FG002|COMPLETED|Part B||52
10030366|NCT01903837|11154650|FG003|COMPLETED|Part B||44
10030367|NCT01903837|11154647|FG000|NOT COMPLETED|Part B||9
10030368|NCT01903837|11154648|FG001|NOT COMPLETED|Part B||6
10030369|NCT01903837|11154649|FG002|NOT COMPLETED|Part B||5
10030370|NCT01903837|11154650|FG003|NOT COMPLETED|Part B||11
10030371|NCT01903863|11154683|FG000|STARTED|Overall Study||15
10030372|NCT01903863|11154684|FG001|STARTED|Overall Study||16
10030373|NCT01903863|11154683|FG000|COMPLETED|Overall Study||13
10030374|NCT01903863|11154684|FG001|COMPLETED|Overall Study||16
10030375|NCT01903863|11154683|FG000|NOT COMPLETED|Overall Study||2
10030376|NCT01903863|11154684|FG001|NOT COMPLETED|Overall Study||0
10030377|NCT01903876|11154692|FG000|STARTED|Baseline to Post-Intervention Period||367
10030378|NCT01903876|11154693|FG001|STARTED|Baseline to Post-Intervention Period||376
10030379|NCT01903876|11154692|FG000|COMPLETED|Baseline to Post-Intervention Period||183
10030380|NCT01903876|11154693|FG001|COMPLETED|Baseline to Post-Intervention Period||268
10030381|NCT01903876|11154692|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184
10030382|NCT01903876|11154693|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108
10030383|NCT01903876|11154692|FG000|STARTED|Six-Month Follow-up Period||183
10030384|NCT01903876|11154693|FG001|STARTED|Six-Month Follow-up Period||268
10030385|NCT01903876|11154692|FG000|COMPLETED|Six-Month Follow-up Period||92
10030386|NCT01903876|11154693|FG001|COMPLETED|Six-Month Follow-up Period||123
10030387|NCT01903876|11154692|FG000|NOT COMPLETED|Six-Month Follow-up Period||91
10030388|NCT01903876|11154693|FG001|NOT COMPLETED|Six-Month Follow-up Period||145
10030389|NCT01903993|11154701|FG000|STARTED|Overall Study||143
10030390|NCT01903993|11154702|FG001|STARTED|Overall Study||144
10030391|NCT01903993|11154701|FG000|Received Treatment|Overall Study||135
10030392|NCT01903993|11154702|FG001|Received Treatment|Overall Study||142
10030393|NCT01903993|11154701|FG000|COMPLETED|Overall Study||0
10030394|NCT01903993|11154702|FG001|COMPLETED|Overall Study||0
10030395|NCT01903993|11154701|FG000|NOT COMPLETED|Overall Study||143
10030396|NCT01903993|11154702|FG001|NOT COMPLETED|Overall Study||144
10030397|NCT01904019|11154709|FG000|STARTED|Pre-operative||95
10030398|NCT01904019|11154709|FG000|COMPLETED|Pre-operative||95
10030399|NCT01904019|11154709|FG000|NOT COMPLETED|Pre-operative||0
10030400|NCT01904019|11154709|FG000|STARTED|1 Year Follow-up||95
10030401|NCT01904019|11154709|FG000|COMPLETED|1 Year Follow-up||86
10030402|NCT01904019|11154709|FG000|NOT COMPLETED|1 Year Follow-up||9
10030403|NCT01904019|11154709|FG000|STARTED|3 Year Follow-up||86
10030404|NCT01904019|11154709|FG000|COMPLETED|3 Year Follow-up||71
10030405|NCT01904019|11154709|FG000|NOT COMPLETED|3 Year Follow-up||15
10030406|NCT01904019|11154709|FG000|STARTED|5 Year Follow-up||71
10030407|NCT01904019|11154709|FG000|COMPLETED|5 Year Follow-up||65
10030408|NCT01904019|11154709|FG000|NOT COMPLETED|5 Year Follow-up||6
10030409|NCT01904058|11154717|FG000|STARTED|Overall Study||21
10030410|NCT01904058|11154718|FG001|STARTED|Overall Study||21
10030411|NCT01904058|11154719|FG002|STARTED|Overall Study||11
10030412|NCT01904058|11154720|FG003|STARTED|Overall Study||13
10030413|NCT01904058|11154717|FG000|COMPLETED|Overall Study||18
10030414|NCT01904058|11154718|FG001|COMPLETED|Overall Study||21
10030415|NCT01904058|11154719|FG002|COMPLETED|Overall Study||10
10030416|NCT01904058|11154720|FG003|COMPLETED|Overall Study||12
10030417|NCT01904058|11154717|FG000|NOT COMPLETED|Overall Study||3
10030418|NCT01904058|11154718|FG001|NOT COMPLETED|Overall Study||0
10030419|NCT01904058|11154719|FG002|NOT COMPLETED|Overall Study||1
10030420|NCT01904058|11154720|FG003|NOT COMPLETED|Overall Study||1
10030421|NCT01904071|11154739|FG000|STARTED|Overall Study||24
10030422|NCT01904071|11154740|FG001|STARTED|Overall Study||20
10030423|NCT01904071|11154741|FG002|STARTED|Overall Study||20
10030424|NCT01904071|11154739|FG000|COMPLETED|Overall Study||24
10030425|NCT01904071|11154740|FG001|COMPLETED|Overall Study||20
10030426|NCT01904071|11154741|FG002|COMPLETED|Overall Study||20
10030427|NCT01904071|11154739|FG000|NOT COMPLETED|Overall Study||0
10030428|NCT01904071|11154740|FG001|NOT COMPLETED|Overall Study||0
10030429|NCT01904071|11154741|FG002|NOT COMPLETED|Overall Study||0
10030430|NCT01904149|11154755|FG000|STARTED|Overall Study||152
10030431|NCT01904149|11154756|FG001|STARTED|Overall Study||151
10030432|NCT01904149|11154757|FG002|STARTED|Overall Study||150
10030433|NCT01904149|11154758|FG003|STARTED|Overall Study||51
10030434|NCT01904149|11154759|FG004|STARTED|Overall Study||51
10030435|NCT01904149|11154760|FG005|STARTED|Overall Study||51
10030436|NCT01904149|11154755|FG000|Single-dose Phase|Overall Study||152
10030437|NCT01904149|11154756|FG001|Single-dose Phase|Overall Study||151
10030438|NCT01904149|11154757|FG002|Single-dose Phase|Overall Study||150
10030439|NCT01904149|11154758|FG003|Single-dose Phase|Overall Study||51
10030440|NCT01904149|11154759|FG004|Single-dose Phase|Overall Study||51
10030441|NCT01904149|11154760|FG005|Single-dose Phase|Overall Study||51
10030442|NCT01904149|11154755|FG000|Multiple-dose Phase|Overall Study||150
10030443|NCT01904149|11154756|FG001|Multiple-dose Phase|Overall Study||146
10030444|NCT01904149|11154757|FG002|Multiple-dose Phase|Overall Study||149
10030445|NCT01904149|11154758|FG003|Multiple-dose Phase|Overall Study||48
10030446|NCT01904149|11154759|FG004|Multiple-dose Phase|Overall Study||48
10030447|NCT01904149|11154760|FG005|Multiple-dose Phase|Overall Study||49
10030448|NCT01904149|11154755|FG000|COMPLETED|Overall Study||147
10030449|NCT01904149|11154756|FG001|COMPLETED|Overall Study||140
10030450|NCT01904149|11154757|FG002|COMPLETED|Overall Study||148
10030451|NCT01904149|11154758|FG003|COMPLETED|Overall Study||47
10030452|NCT01904149|11154759|FG004|COMPLETED|Overall Study||46
10030453|NCT01904149|11154760|FG005|COMPLETED|Overall Study||48
10030454|NCT01904149|11154755|FG000|NOT COMPLETED|Overall Study||5
10030455|NCT01904149|11154756|FG001|NOT COMPLETED|Overall Study||11
10030456|NCT01904149|11154757|FG002|NOT COMPLETED|Overall Study||2
10030457|NCT01904149|11154758|FG003|NOT COMPLETED|Overall Study||4
10030458|NCT01904149|11154759|FG004|NOT COMPLETED|Overall Study||5
10030459|NCT01904149|11154760|FG005|NOT COMPLETED|Overall Study||3
10030460|NCT01904383|11154776|FG000|STARTED|Overall Study||4057
10030461|NCT01904383|11154776|FG000|Treated|Overall Study||3940
10030462|NCT01904383|11154776|FG000|COMPLETED|Overall Study||2283
10030463|NCT01904383|11154776|FG000|NOT COMPLETED|Overall Study||1774
10030464|NCT01904448|11154780|FG000|STARTED|Overall Study||5
10030465|NCT01904448|11154780|FG000|COMPLETED|Overall Study||5
10030466|NCT01904448|11154780|FG000|NOT COMPLETED|Overall Study||0
10030467|NCT01904526|11154785|FG000|STARTED|Overall Study||5
10030468|NCT01904526|11154785|FG000|COMPLETED|Overall Study||5
10030469|NCT01904526|11154785|FG000|NOT COMPLETED|Overall Study||0
10030470|NCT01904604|11154796|FG000|STARTED|Overall Study||25
10030471|NCT01904604|11154797|FG001|STARTED|Overall Study||25
10030472|NCT01904604|11154798|FG002|STARTED|Overall Study||25
10030473|NCT01904604|11154796|FG000|Completed Week 52 OFC|Overall Study||22
10030474|NCT01904604|11154797|FG001|Completed Week 52 OFC|Overall Study||21
10030475|NCT01904604|11154798|FG002|Completed Week 52 OFC|Overall Study||25
10030476|NCT01904604|11154796|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
10030477|NCT01904604|11154797|FG001|Began Crossover Treatment|Overall Study||21
10030478|NCT01904604|11154798|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
10030479|NCT01904604|11154796|FG000|Completed Week 130 OFC|Overall Study||18
10030480|NCT01904604|11154797|FG001|Completed Week 130 OFC|Overall Study||18
10030481|NCT01904604|11154798|FG002|Completed Week 130 OFC|Overall Study||23
10030482|NCT01904604|11154796|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
10030483|NCT01904604|11154797|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
10030484|NCT01904604|11154798|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
10030485|NCT01904604|11154796|FG000|NOT COMPLETED|Overall Study||7
10030486|NCT01904604|11154797|FG001|NOT COMPLETED|Overall Study||7
10030487|NCT01904604|11154798|FG002|NOT COMPLETED|Overall Study||2
10030488|NCT01904721|11154816|FG000|STARTED|Overall Study||13
10030489|NCT01904721|11154817|FG001|STARTED|Overall Study||13
10030490|NCT01904721|11154818|FG002|STARTED|Overall Study||12
10030491|NCT01904721|11154819|FG003|STARTED|Overall Study||12
10030492|NCT01904721|11154820|FG004|STARTED|Overall Study||65
10030493|NCT01904721|11154821|FG005|STARTED|Overall Study||65
10030494|NCT01904721|11154822|FG006|STARTED|Overall Study||64
10030495|NCT01904721|11154816|FG000|COMPLETED|Overall Study||13
10030496|NCT01904721|11154817|FG001|COMPLETED|Overall Study||13
10030497|NCT01904721|11154818|FG002|COMPLETED|Overall Study||11
10030498|NCT01904721|11154819|FG003|COMPLETED|Overall Study||11
10030499|NCT01904721|11154820|FG004|COMPLETED|Overall Study||57
10115584|NCT02527343|11246454|FG003|STARTED|RT Period: Weeks 1 to 52||0
10115585|NCT02527343|11246455|FG004|STARTED|RT Period: Weeks 1 to 52||0
10115586|NCT02527343|11246456|FG005|STARTED|RT Period: Weeks 1 to 52||0
10115587|NCT02527343|11246451|FG000|COMPLETED|RT Period: Weeks 1 to 52||13
10030500|NCT01904721|11154821|FG005|COMPLETED|Overall Study||56
10030501|NCT01904721|11154822|FG006|COMPLETED|Overall Study||57
10030502|NCT01904721|11154816|FG000|NOT COMPLETED|Overall Study||0
10030503|NCT01904721|11154817|FG001|NOT COMPLETED|Overall Study||0
10030504|NCT01904721|11154818|FG002|NOT COMPLETED|Overall Study||1
10030505|NCT01904721|11154819|FG003|NOT COMPLETED|Overall Study||1
10030506|NCT01904721|11154820|FG004|NOT COMPLETED|Overall Study||8
10030507|NCT01904721|11154821|FG005|NOT COMPLETED|Overall Study||9
10030508|NCT01904721|11154822|FG006|NOT COMPLETED|Overall Study||7
10030509|NCT01904760|11154836|FG000|STARTED|Overall Study||40
10030510|NCT01904760|11154837|FG001|STARTED|Overall Study||40
10030511|NCT01904760|11154836|FG000|COMPLETED|Overall Study||39
10030512|NCT01904760|11154837|FG001|COMPLETED|Overall Study||40
10030513|NCT01904760|11154836|FG000|NOT COMPLETED|Overall Study||1
10030514|NCT01904760|11154837|FG001|NOT COMPLETED|Overall Study||0
10030515|NCT01904773|11154843|FG000|STARTED|Screen||28
10030516|NCT01904773|11154844|FG001|STARTED|Screen||0
10030517|NCT01904773|11154845|FG002|STARTED|Screen||0
10030518|NCT01904773|11154846|FG003|STARTED|Screen||0
10030519|NCT01904773|11154847|FG004|STARTED|Screen||0
10030520|NCT01904773|11154848|FG005|STARTED|Screen||0
10030521|NCT01904773|11154849|FG006|STARTED|Screen||0
10030522|NCT01904773|11154850|FG007|STARTED|Screen||0
10030523|NCT01904773|11154851|FG008|STARTED|Screen||0
10030524|NCT01904773|11154843|FG000|COMPLETED|Screen||24
10030525|NCT01904773|11154844|FG001|COMPLETED|Screen||0
10030526|NCT01904773|11154845|FG002|COMPLETED|Screen||0
10030527|NCT01904773|11154846|FG003|COMPLETED|Screen||0
10030528|NCT01904773|11154847|FG004|COMPLETED|Screen||0
10030529|NCT01904773|11154848|FG005|COMPLETED|Screen||0
10030530|NCT01904773|11154849|FG006|COMPLETED|Screen||0
10030531|NCT01904773|11154850|FG007|COMPLETED|Screen||0
10030532|NCT01904773|11154851|FG008|COMPLETED|Screen||0
10030533|NCT01904773|11154843|FG000|NOT COMPLETED|Screen||4
10030534|NCT01904773|11154844|FG001|NOT COMPLETED|Screen||0
10030535|NCT01904773|11154845|FG002|NOT COMPLETED|Screen||0
10030536|NCT01904773|11154846|FG003|NOT COMPLETED|Screen||0
10030537|NCT01904773|11154847|FG004|NOT COMPLETED|Screen||0
10030538|NCT01904773|11154848|FG005|NOT COMPLETED|Screen||0
10030539|NCT01904773|11154849|FG006|NOT COMPLETED|Screen||0
10030540|NCT01904773|11154850|FG007|NOT COMPLETED|Screen||0
10030541|NCT01904773|11154851|FG008|NOT COMPLETED|Screen||0
10030542|NCT01904773|11154843|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
10030543|NCT01904773|11154844|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030544|NCT01904773|11154845|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030545|NCT01904773|11154846|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030546|NCT01904773|11154847|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030547|NCT01904773|11154848|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030548|NCT01904773|11154849|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030549|NCT01904773|11154850|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030550|NCT01904773|11154851|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030551|NCT01904773|11154843|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
10030552|NCT01904773|11154844|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030553|NCT01904773|11154845|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030554|NCT01904773|11154846|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030555|NCT01904773|11154847|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030556|NCT01904773|11154848|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030557|NCT01904773|11154849|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030558|NCT01904773|11154850|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030559|NCT01904773|11154851|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030560|NCT01904773|11154843|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030561|NCT01904773|11154844|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030562|NCT01904773|11154845|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030563|NCT01904773|11154846|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030564|NCT01904773|11154847|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030565|NCT01904773|11154848|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030566|NCT01904773|11154849|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030567|NCT01904773|11154850|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030568|NCT01904773|11154851|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10030569|NCT01904773|11154843|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
10030570|NCT01904773|11154844|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030571|NCT01904773|11154845|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030572|NCT01904773|11154846|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030573|NCT01904773|11154847|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030574|NCT01904773|11154848|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030575|NCT01904773|11154849|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030576|NCT01904773|11154850|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030577|NCT01904773|11154851|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030578|NCT01904773|11154843|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
10030579|NCT01904773|11154844|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030580|NCT01904773|11154845|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030581|NCT01904773|11154846|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030582|NCT01904773|11154847|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030583|NCT01904773|11154848|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030584|NCT01904773|11154849|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030585|NCT01904773|11154850|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030586|NCT01904773|11154851|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030587|NCT01904773|11154843|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
10030588|NCT01904773|11154844|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030589|NCT01904773|11154845|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030590|NCT01904773|11154846|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030591|NCT01904773|11154847|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030592|NCT01904773|11154848|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030593|NCT01904773|11154849|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030594|NCT01904773|11154850|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030595|NCT01904773|11154851|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030596|NCT01904773|11154843|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
10030597|NCT01904773|11154844|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030598|NCT01904773|11154845|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030599|NCT01904773|11154846|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030600|NCT01904773|11154847|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030601|NCT01904773|11154848|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030602|NCT01904773|11154849|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030603|NCT01904773|11154850|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030604|NCT01904773|11154851|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030605|NCT01904773|11154843|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
10030606|NCT01904773|11154844|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030607|NCT01904773|11154845|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030608|NCT01904773|11154846|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030609|NCT01904773|11154847|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030610|NCT01904773|11154848|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030611|NCT01904773|11154849|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030612|NCT01904773|11154850|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030613|NCT01904773|11154851|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10030614|NCT01904773|11154843|FG000|STARTED|First Intervention||0
10030615|NCT01904773|11154844|FG001|STARTED|First Intervention||2
10030616|NCT01904773|11154845|FG002|STARTED|First Intervention||1
10030617|NCT01904773|11154846|FG003|STARTED|First Intervention||2
10030618|NCT01904773|11154847|FG004|STARTED|First Intervention||3
10030619|NCT01904773|11154848|FG005|STARTED|First Intervention||4
10030620|NCT01904773|11154849|FG006|STARTED|First Intervention||4
10030621|NCT01904773|11154850|FG007|STARTED|First Intervention||3
10030622|NCT01904773|11154851|FG008|STARTED|First Intervention||4
10030623|NCT01904773|11154843|FG000|COMPLETED|First Intervention||0
10030624|NCT01904773|11154844|FG001|COMPLETED|First Intervention||2
10030625|NCT01904773|11154845|FG002|COMPLETED|First Intervention||1
10030626|NCT01904773|11154846|FG003|COMPLETED|First Intervention||2
10030627|NCT01904773|11154847|FG004|COMPLETED|First Intervention||3
10030628|NCT01904773|11154848|FG005|COMPLETED|First Intervention||4
10030629|NCT01904773|11154849|FG006|COMPLETED|First Intervention||3
10030630|NCT01904773|11154850|FG007|COMPLETED|First Intervention||3
10030631|NCT01904773|11154851|FG008|COMPLETED|First Intervention||4
10030632|NCT01904773|11154843|FG000|NOT COMPLETED|First Intervention||0
10030633|NCT01904773|11154844|FG001|NOT COMPLETED|First Intervention||0
10030634|NCT01904773|11154845|FG002|NOT COMPLETED|First Intervention||0
10030635|NCT01904773|11154846|FG003|NOT COMPLETED|First Intervention||0
10030636|NCT01904773|11154847|FG004|NOT COMPLETED|First Intervention||0
10030637|NCT01904773|11154848|FG005|NOT COMPLETED|First Intervention||0
10030638|NCT01904773|11154849|FG006|NOT COMPLETED|First Intervention||1
10030639|NCT01904773|11154850|FG007|NOT COMPLETED|First Intervention||0
10030640|NCT01904773|11154851|FG008|NOT COMPLETED|First Intervention||0
10030641|NCT01904773|11154843|FG000|STARTED|Placebo Washout First Intervention||0
10030642|NCT01904773|11154844|FG001|STARTED|Placebo Washout First Intervention||2
10030643|NCT01904773|11154845|FG002|STARTED|Placebo Washout First Intervention||1
10030644|NCT01904773|11154846|FG003|STARTED|Placebo Washout First Intervention||2
10030645|NCT01904773|11154847|FG004|STARTED|Placebo Washout First Intervention||3
10030646|NCT01904773|11154848|FG005|STARTED|Placebo Washout First Intervention||4
10030647|NCT01904773|11154849|FG006|STARTED|Placebo Washout First Intervention||3
10030648|NCT01904773|11154850|FG007|STARTED|Placebo Washout First Intervention||3
10030649|NCT01904773|11154851|FG008|STARTED|Placebo Washout First Intervention||4
10030650|NCT01904773|11154843|FG000|COMPLETED|Placebo Washout First Intervention||0
10030651|NCT01904773|11154844|FG001|COMPLETED|Placebo Washout First Intervention||1
10030652|NCT01904773|11154845|FG002|COMPLETED|Placebo Washout First Intervention||1
10030653|NCT01904773|11154846|FG003|COMPLETED|Placebo Washout First Intervention||2
10030654|NCT01904773|11154847|FG004|COMPLETED|Placebo Washout First Intervention||3
10030655|NCT01904773|11154848|FG005|COMPLETED|Placebo Washout First Intervention||4
10030656|NCT01904773|11154849|FG006|COMPLETED|Placebo Washout First Intervention||3
10030657|NCT01904773|11154850|FG007|COMPLETED|Placebo Washout First Intervention||3
10030658|NCT01904773|11154851|FG008|COMPLETED|Placebo Washout First Intervention||4
10030659|NCT01904773|11154843|FG000|NOT COMPLETED|Placebo Washout First Intervention||0
10030660|NCT01904773|11154844|FG001|NOT COMPLETED|Placebo Washout First Intervention||1
10030661|NCT01904773|11154845|FG002|NOT COMPLETED|Placebo Washout First Intervention||0
10030662|NCT01904773|11154846|FG003|NOT COMPLETED|Placebo Washout First Intervention||0
10030663|NCT01904773|11154847|FG004|NOT COMPLETED|Placebo Washout First Intervention||0
10030664|NCT01904773|11154848|FG005|NOT COMPLETED|Placebo Washout First Intervention||0
10030665|NCT01904773|11154849|FG006|NOT COMPLETED|Placebo Washout First Intervention||0
10030666|NCT01904773|11154850|FG007|NOT COMPLETED|Placebo Washout First Intervention||0
10030667|NCT01904773|11154851|FG008|NOT COMPLETED|Placebo Washout First Intervention||0
10030668|NCT01904773|11154843|FG000|STARTED|Second Intervention||0
10030669|NCT01904773|11154844|FG001|STARTED|Second Intervention||1
10030670|NCT01904773|11154845|FG002|STARTED|Second Intervention||1
10030671|NCT01904773|11154846|FG003|STARTED|Second Intervention||2
10030672|NCT01904773|11154847|FG004|STARTED|Second Intervention||3
10030673|NCT01904773|11154848|FG005|STARTED|Second Intervention||4
10030674|NCT01904773|11154849|FG006|STARTED|Second Intervention||3
10030675|NCT01904773|11154850|FG007|STARTED|Second Intervention||3
10030676|NCT01904773|11154851|FG008|STARTED|Second Intervention||4
10030677|NCT01904773|11154843|FG000|COMPLETED|Second Intervention||0
10030678|NCT01904773|11154844|FG001|COMPLETED|Second Intervention||1
10030679|NCT01904773|11154845|FG002|COMPLETED|Second Intervention||1
10030680|NCT01904773|11154846|FG003|COMPLETED|Second Intervention||2
10030681|NCT01904773|11154847|FG004|COMPLETED|Second Intervention||3
10030682|NCT01904773|11154848|FG005|COMPLETED|Second Intervention||4
10030683|NCT01904773|11154849|FG006|COMPLETED|Second Intervention||3
10030684|NCT01904773|11154850|FG007|COMPLETED|Second Intervention||3
10030685|NCT01904773|11154851|FG008|COMPLETED|Second Intervention||4
10030686|NCT01904773|11154843|FG000|NOT COMPLETED|Second Intervention||0
10030687|NCT01904773|11154844|FG001|NOT COMPLETED|Second Intervention||0
10030688|NCT01904773|11154845|FG002|NOT COMPLETED|Second Intervention||0
10030689|NCT01904773|11154846|FG003|NOT COMPLETED|Second Intervention||0
10030690|NCT01904773|11154847|FG004|NOT COMPLETED|Second Intervention||0
10030691|NCT01904773|11154848|FG005|NOT COMPLETED|Second Intervention||0
10030692|NCT01904773|11154849|FG006|NOT COMPLETED|Second Intervention||0
10030693|NCT01904773|11154850|FG007|NOT COMPLETED|Second Intervention||0
10030694|NCT01904773|11154851|FG008|NOT COMPLETED|Second Intervention||0
10030695|NCT01904773|11154843|FG000|STARTED|Placebo Washout Second Intervention||0
10030696|NCT01904773|11154844|FG001|STARTED|Placebo Washout Second Intervention||1
10030697|NCT01904773|11154845|FG002|STARTED|Placebo Washout Second Intervention||1
10030698|NCT01904773|11154846|FG003|STARTED|Placebo Washout Second Intervention||2
10030699|NCT01904773|11154847|FG004|STARTED|Placebo Washout Second Intervention||3
10030700|NCT01904773|11154848|FG005|STARTED|Placebo Washout Second Intervention||4
10030701|NCT01904773|11154849|FG006|STARTED|Placebo Washout Second Intervention||3
10030702|NCT01904773|11154850|FG007|STARTED|Placebo Washout Second Intervention||3
10030703|NCT01904773|11154851|FG008|STARTED|Placebo Washout Second Intervention||4
10030704|NCT01904773|11154843|FG000|COMPLETED|Placebo Washout Second Intervention||0
10030705|NCT01904773|11154844|FG001|COMPLETED|Placebo Washout Second Intervention||1
10030706|NCT01904773|11154845|FG002|COMPLETED|Placebo Washout Second Intervention||1
10030707|NCT01904773|11154846|FG003|COMPLETED|Placebo Washout Second Intervention||2
10030708|NCT01904773|11154847|FG004|COMPLETED|Placebo Washout Second Intervention||3
10030709|NCT01904773|11154848|FG005|COMPLETED|Placebo Washout Second Intervention||4
10030710|NCT01904773|11154849|FG006|COMPLETED|Placebo Washout Second Intervention||3
10030711|NCT01904773|11154850|FG007|COMPLETED|Placebo Washout Second Intervention||3
10030712|NCT01904773|11154851|FG008|COMPLETED|Placebo Washout Second Intervention||4
10030713|NCT01904773|11154843|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0
10030714|NCT01904773|11154844|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0
10030715|NCT01904773|11154845|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0
10030716|NCT01904773|11154846|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0
10030717|NCT01904773|11154847|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0
10030718|NCT01904773|11154848|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0
10030719|NCT01904773|11154849|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0
10030720|NCT01904773|11154850|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0
10030721|NCT01904773|11154851|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0
10030722|NCT01904773|11154843|FG000|STARTED|Third Intervention||0
10030723|NCT01904773|11154844|FG001|STARTED|Third Intervention||1
10030724|NCT01904773|11154845|FG002|STARTED|Third Intervention||1
10030725|NCT01904773|11154846|FG003|STARTED|Third Intervention||2
10030726|NCT01904773|11154847|FG004|STARTED|Third Intervention||3
10030727|NCT01904773|11154848|FG005|STARTED|Third Intervention||4
10030728|NCT01904773|11154849|FG006|STARTED|Third Intervention||3
10030729|NCT01904773|11154850|FG007|STARTED|Third Intervention||3
10030730|NCT01904773|11154851|FG008|STARTED|Third Intervention||4
10030731|NCT01904773|11154843|FG000|COMPLETED|Third Intervention||0
10030732|NCT01904773|11154844|FG001|COMPLETED|Third Intervention||1
10030733|NCT01904773|11154845|FG002|COMPLETED|Third Intervention||1
10030734|NCT01904773|11154846|FG003|COMPLETED|Third Intervention||2
10030735|NCT01904773|11154847|FG004|COMPLETED|Third Intervention||3
10030736|NCT01904773|11154848|FG005|COMPLETED|Third Intervention||4
10030737|NCT01904773|11154849|FG006|COMPLETED|Third Intervention||3
10030738|NCT01904773|11154850|FG007|COMPLETED|Third Intervention||3
10030739|NCT01904773|11154851|FG008|COMPLETED|Third Intervention||4
10030740|NCT01904773|11154843|FG000|NOT COMPLETED|Third Intervention||0
10030741|NCT01904773|11154844|FG001|NOT COMPLETED|Third Intervention||0
10030742|NCT01904773|11154845|FG002|NOT COMPLETED|Third Intervention||0
10030743|NCT01904773|11154846|FG003|NOT COMPLETED|Third Intervention||0
10030744|NCT01904773|11154847|FG004|NOT COMPLETED|Third Intervention||0
10030745|NCT01904773|11154848|FG005|NOT COMPLETED|Third Intervention||0
10030746|NCT01904773|11154849|FG006|NOT COMPLETED|Third Intervention||0
10030747|NCT01904773|11154850|FG007|NOT COMPLETED|Third Intervention||0
10030748|NCT01904773|11154851|FG008|NOT COMPLETED|Third Intervention||0
10030749|NCT01904773|11154843|FG000|STARTED|Placebo Washout Third Intervention||0
10030750|NCT01904773|11154844|FG001|STARTED|Placebo Washout Third Intervention||1
10030751|NCT01904773|11154845|FG002|STARTED|Placebo Washout Third Intervention||1
10030752|NCT01904773|11154846|FG003|STARTED|Placebo Washout Third Intervention||2
10030753|NCT01904773|11154847|FG004|STARTED|Placebo Washout Third Intervention||3
10030754|NCT01904773|11154848|FG005|STARTED|Placebo Washout Third Intervention||4
10030755|NCT01904773|11154849|FG006|STARTED|Placebo Washout Third Intervention||3
10030756|NCT01904773|11154850|FG007|STARTED|Placebo Washout Third Intervention||3
10030757|NCT01904773|11154851|FG008|STARTED|Placebo Washout Third Intervention||4
10030758|NCT01904773|11154843|FG000|COMPLETED|Placebo Washout Third Intervention||0
10030759|NCT01904773|11154844|FG001|COMPLETED|Placebo Washout Third Intervention||1
10030760|NCT01904773|11154845|FG002|COMPLETED|Placebo Washout Third Intervention||1
10030761|NCT01904773|11154846|FG003|COMPLETED|Placebo Washout Third Intervention||2
10030762|NCT01904773|11154847|FG004|COMPLETED|Placebo Washout Third Intervention||3
10030763|NCT01904773|11154848|FG005|COMPLETED|Placebo Washout Third Intervention||4
10030764|NCT01904773|11154849|FG006|COMPLETED|Placebo Washout Third Intervention||3
10030765|NCT01904773|11154850|FG007|COMPLETED|Placebo Washout Third Intervention||3
10030766|NCT01904773|11154851|FG008|COMPLETED|Placebo Washout Third Intervention||4
10030767|NCT01904773|11154843|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0
10030768|NCT01904773|11154844|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0
10030769|NCT01904773|11154845|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0
10030770|NCT01904773|11154846|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0
10030771|NCT01904773|11154847|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0
10030772|NCT01904773|11154848|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0
10030773|NCT01904773|11154849|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0
10030774|NCT01904773|11154850|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0
10030775|NCT01904773|11154851|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0
10030776|NCT01904773|11154843|FG000|STARTED|Fourth Intervention||0
10030777|NCT01904773|11154844|FG001|STARTED|Fourth Intervention||1
10030778|NCT01904773|11154845|FG002|STARTED|Fourth Intervention||1
10030779|NCT01904773|11154846|FG003|STARTED|Fourth Intervention||2
10030780|NCT01904773|11154847|FG004|STARTED|Fourth Intervention||3
10030781|NCT01904773|11154848|FG005|STARTED|Fourth Intervention||4
10030782|NCT01904773|11154849|FG006|STARTED|Fourth Intervention||3
10030783|NCT01904773|11154850|FG007|STARTED|Fourth Intervention||3
10030784|NCT01904773|11154851|FG008|STARTED|Fourth Intervention||4
10030785|NCT01904773|11154843|FG000|COMPLETED|Fourth Intervention||0
10030786|NCT01904773|11154844|FG001|COMPLETED|Fourth Intervention||1
10030787|NCT01904773|11154845|FG002|COMPLETED|Fourth Intervention||1
10030788|NCT01904773|11154846|FG003|COMPLETED|Fourth Intervention||2
10030789|NCT01904773|11154847|FG004|COMPLETED|Fourth Intervention||3
10030790|NCT01904773|11154848|FG005|COMPLETED|Fourth Intervention||4
10030791|NCT01904773|11154849|FG006|COMPLETED|Fourth Intervention||3
10030792|NCT01904773|11154850|FG007|COMPLETED|Fourth Intervention||3
10030793|NCT01904773|11154851|FG008|COMPLETED|Fourth Intervention||4
10030794|NCT01904773|11154843|FG000|NOT COMPLETED|Fourth Intervention||0
10030795|NCT01904773|11154844|FG001|NOT COMPLETED|Fourth Intervention||0
10030796|NCT01904773|11154845|FG002|NOT COMPLETED|Fourth Intervention||0
10030797|NCT01904773|11154846|FG003|NOT COMPLETED|Fourth Intervention||0
10030798|NCT01904773|11154847|FG004|NOT COMPLETED|Fourth Intervention||0
10030799|NCT01904773|11154848|FG005|NOT COMPLETED|Fourth Intervention||0
10030800|NCT01904773|11154849|FG006|NOT COMPLETED|Fourth Intervention||0
10030801|NCT01904773|11154850|FG007|NOT COMPLETED|Fourth Intervention||0
10030802|NCT01904773|11154851|FG008|NOT COMPLETED|Fourth Intervention||0
10030803|NCT01904773|11154843|FG000|STARTED|Placebo Washout Fourth Intervention||0
10030804|NCT01904773|11154844|FG001|STARTED|Placebo Washout Fourth Intervention||1
10030805|NCT01904773|11154845|FG002|STARTED|Placebo Washout Fourth Intervention||1
10030806|NCT01904773|11154846|FG003|STARTED|Placebo Washout Fourth Intervention||2
10030807|NCT01904773|11154847|FG004|STARTED|Placebo Washout Fourth Intervention||3
10030808|NCT01904773|11154848|FG005|STARTED|Placebo Washout Fourth Intervention||4
10030809|NCT01904773|11154849|FG006|STARTED|Placebo Washout Fourth Intervention||3
10030810|NCT01904773|11154850|FG007|STARTED|Placebo Washout Fourth Intervention||3
10030811|NCT01904773|11154851|FG008|STARTED|Placebo Washout Fourth Intervention||4
10030812|NCT01904773|11154843|FG000|COMPLETED|Placebo Washout Fourth Intervention||0
10030813|NCT01904773|11154844|FG001|COMPLETED|Placebo Washout Fourth Intervention||1
10030814|NCT01904773|11154845|FG002|COMPLETED|Placebo Washout Fourth Intervention||1
10030815|NCT01904773|11154846|FG003|COMPLETED|Placebo Washout Fourth Intervention||2
10030816|NCT01904773|11154847|FG004|COMPLETED|Placebo Washout Fourth Intervention||3
10115588|NCT02527343|11246452|FG001|COMPLETED|RT Period: Weeks 1 to 52||14
10115589|NCT02527343|11246453|FG002|COMPLETED|RT Period: Weeks 1 to 52||0
10115590|NCT02527343|11246454|FG003|COMPLETED|RT Period: Weeks 1 to 52||0
10030817|NCT01904773|11154848|FG005|COMPLETED|Placebo Washout Fourth Intervention||4
10030818|NCT01904773|11154849|FG006|COMPLETED|Placebo Washout Fourth Intervention||3
10030819|NCT01904773|11154850|FG007|COMPLETED|Placebo Washout Fourth Intervention||3
10030820|NCT01904773|11154851|FG008|COMPLETED|Placebo Washout Fourth Intervention||4
10030821|NCT01904773|11154843|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030822|NCT01904773|11154844|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030823|NCT01904773|11154845|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030824|NCT01904773|11154846|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030825|NCT01904773|11154847|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030826|NCT01904773|11154848|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030827|NCT01904773|11154849|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030828|NCT01904773|11154850|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030829|NCT01904773|11154851|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10030830|NCT01904773|11154843|FG000|STARTED|Fifth Intervention||0
10030831|NCT01904773|11154844|FG001|STARTED|Fifth Intervention||1
10030832|NCT01904773|11154845|FG002|STARTED|Fifth Intervention||1
10030833|NCT01904773|11154846|FG003|STARTED|Fifth Intervention||2
10030834|NCT01904773|11154847|FG004|STARTED|Fifth Intervention||3
10030835|NCT01904773|11154848|FG005|STARTED|Fifth Intervention||4
10030836|NCT01904773|11154849|FG006|STARTED|Fifth Intervention||3
10030837|NCT01904773|11154850|FG007|STARTED|Fifth Intervention||3
10030838|NCT01904773|11154851|FG008|STARTED|Fifth Intervention||4
10030839|NCT01904773|11154843|FG000|COMPLETED|Fifth Intervention||0
10030840|NCT01904773|11154844|FG001|COMPLETED|Fifth Intervention||1
10030841|NCT01904773|11154845|FG002|COMPLETED|Fifth Intervention||1
10030842|NCT01904773|11154846|FG003|COMPLETED|Fifth Intervention||2
10030843|NCT01904773|11154847|FG004|COMPLETED|Fifth Intervention||3
10030844|NCT01904773|11154848|FG005|COMPLETED|Fifth Intervention||4
10030845|NCT01904773|11154849|FG006|COMPLETED|Fifth Intervention||3
10030846|NCT01904773|11154850|FG007|COMPLETED|Fifth Intervention||2
10030847|NCT01904773|11154851|FG008|COMPLETED|Fifth Intervention||4
10030848|NCT01904773|11154843|FG000|NOT COMPLETED|Fifth Intervention||0
10030849|NCT01904773|11154844|FG001|NOT COMPLETED|Fifth Intervention||0
10030850|NCT01904773|11154845|FG002|NOT COMPLETED|Fifth Intervention||0
10030851|NCT01904773|11154846|FG003|NOT COMPLETED|Fifth Intervention||0
10030852|NCT01904773|11154847|FG004|NOT COMPLETED|Fifth Intervention||0
10030853|NCT01904773|11154848|FG005|NOT COMPLETED|Fifth Intervention||0
10030854|NCT01904773|11154849|FG006|NOT COMPLETED|Fifth Intervention||0
10030855|NCT01904773|11154850|FG007|NOT COMPLETED|Fifth Intervention||1
10030856|NCT01904773|11154851|FG008|NOT COMPLETED|Fifth Intervention||0
10030857|NCT01904773|11154843|FG000|STARTED|Placebo Washout Fifth Intervention||0
10030858|NCT01904773|11154844|FG001|STARTED|Placebo Washout Fifth Intervention||1
10030859|NCT01904773|11154845|FG002|STARTED|Placebo Washout Fifth Intervention||1
10030860|NCT01904773|11154846|FG003|STARTED|Placebo Washout Fifth Intervention||2
10030861|NCT01904773|11154847|FG004|STARTED|Placebo Washout Fifth Intervention||3
10030862|NCT01904773|11154848|FG005|STARTED|Placebo Washout Fifth Intervention||4
10030863|NCT01904773|11154849|FG006|STARTED|Placebo Washout Fifth Intervention||3
10030864|NCT01904773|11154850|FG007|STARTED|Placebo Washout Fifth Intervention||2
10030865|NCT01904773|11154851|FG008|STARTED|Placebo Washout Fifth Intervention||4
10030866|NCT01904773|11154843|FG000|COMPLETED|Placebo Washout Fifth Intervention||0
10030867|NCT01904773|11154844|FG001|COMPLETED|Placebo Washout Fifth Intervention||0
10030868|NCT01904773|11154845|FG002|COMPLETED|Placebo Washout Fifth Intervention||1
10115591|NCT02527343|11246455|FG004|COMPLETED|RT Period: Weeks 1 to 52||0
10115592|NCT02527343|11246456|FG005|COMPLETED|RT Period: Weeks 1 to 52||0
10115593|NCT02527343|11246451|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6
10030869|NCT01904773|11154846|FG003|COMPLETED|Placebo Washout Fifth Intervention||2
10030870|NCT01904773|11154847|FG004|COMPLETED|Placebo Washout Fifth Intervention||3
10030871|NCT01904773|11154848|FG005|COMPLETED|Placebo Washout Fifth Intervention||4
10030872|NCT01904773|11154849|FG006|COMPLETED|Placebo Washout Fifth Intervention||3
10030873|NCT01904773|11154850|FG007|COMPLETED|Placebo Washout Fifth Intervention||2
10030874|NCT01904773|11154851|FG008|COMPLETED|Placebo Washout Fifth Intervention||4
10030875|NCT01904773|11154843|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030876|NCT01904773|11154844|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1
10030877|NCT01904773|11154845|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030878|NCT01904773|11154846|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030879|NCT01904773|11154847|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030880|NCT01904773|11154848|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030881|NCT01904773|11154849|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030882|NCT01904773|11154850|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030883|NCT01904773|11154851|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10030884|NCT01904773|11154843|FG000|STARTED|Sixth Intervention||0
10030885|NCT01904773|11154844|FG001|STARTED|Sixth Intervention||0
10030886|NCT01904773|11154845|FG002|STARTED|Sixth Intervention||1
10030887|NCT01904773|11154846|FG003|STARTED|Sixth Intervention||2
10030888|NCT01904773|11154847|FG004|STARTED|Sixth Intervention||3
10030889|NCT01904773|11154848|FG005|STARTED|Sixth Intervention||4
10030890|NCT01904773|11154849|FG006|STARTED|Sixth Intervention||3
10030891|NCT01904773|11154850|FG007|STARTED|Sixth Intervention||2
10030892|NCT01904773|11154851|FG008|STARTED|Sixth Intervention||4
10030893|NCT01904773|11154843|FG000|COMPLETED|Sixth Intervention||0
10030894|NCT01904773|11154844|FG001|COMPLETED|Sixth Intervention||0
10030895|NCT01904773|11154845|FG002|COMPLETED|Sixth Intervention||1
10030896|NCT01904773|11154846|FG003|COMPLETED|Sixth Intervention||2
10030897|NCT01904773|11154847|FG004|COMPLETED|Sixth Intervention||3
10030898|NCT01904773|11154848|FG005|COMPLETED|Sixth Intervention||4
10030899|NCT01904773|11154849|FG006|COMPLETED|Sixth Intervention||3
10030900|NCT01904773|11154850|FG007|COMPLETED|Sixth Intervention||2
10030901|NCT01904773|11154851|FG008|COMPLETED|Sixth Intervention||4
10030902|NCT01904773|11154843|FG000|NOT COMPLETED|Sixth Intervention||0
10030903|NCT01904773|11154844|FG001|NOT COMPLETED|Sixth Intervention||0
10030904|NCT01904773|11154845|FG002|NOT COMPLETED|Sixth Intervention||0
10030905|NCT01904773|11154846|FG003|NOT COMPLETED|Sixth Intervention||0
10030906|NCT01904773|11154847|FG004|NOT COMPLETED|Sixth Intervention||0
10030907|NCT01904773|11154848|FG005|NOT COMPLETED|Sixth Intervention||0
10030908|NCT01904773|11154849|FG006|NOT COMPLETED|Sixth Intervention||0
10030909|NCT01904773|11154850|FG007|NOT COMPLETED|Sixth Intervention||0
10030910|NCT01904773|11154851|FG008|NOT COMPLETED|Sixth Intervention||0
10030911|NCT01904864|11154865|FG000|STARTED|Overall Study||40
10030912|NCT01904864|11154866|FG001|STARTED|Overall Study||40
10030913|NCT01904864|11154865|FG000|COMPLETED|Overall Study||31
10030914|NCT01904864|11154866|FG001|COMPLETED|Overall Study||28
10030915|NCT01904864|11154865|FG000|NOT COMPLETED|Overall Study||9
10030916|NCT01904864|11154866|FG001|NOT COMPLETED|Overall Study||12
10030917|NCT01905241|11154872|FG000|STARTED|Overall Study||20
10030918|NCT01905241|11154872|FG000|COMPLETED|Overall Study||20
10030919|NCT01905241|11154872|FG000|NOT COMPLETED|Overall Study||0
10030920|NCT01905254|11154876|FG000|STARTED|Overall Study||34
10030921|NCT01905254|11154876|FG000|COMPLETED|Overall Study||34
10030922|NCT01905254|11154876|FG000|NOT COMPLETED|Overall Study||0
10030923|NCT01905267|11154882|FG000|STARTED|Overall Study||17
10030924|NCT01905267|11154883|FG001|STARTED|Overall Study||16
10030925|NCT01905267|11154882|FG000|COMPLETED|Overall Study||15
10030926|NCT01905267|11154883|FG001|COMPLETED|Overall Study||14
10030927|NCT01905267|11154882|FG000|NOT COMPLETED|Overall Study||2
10030928|NCT01905267|11154883|FG001|NOT COMPLETED|Overall Study||2
10030929|NCT01905423|11154894|FG000|STARTED|Overall Study||4456
10030930|NCT01905423|11154895|FG001|STARTED|Overall Study||3297
10030931|NCT01905423|11154896|FG002|STARTED|Overall Study||4111
10030932|NCT01905423|11154897|FG003|STARTED|Overall Study||2757
10030933|NCT01905423|11154898|FG004|STARTED|Overall Study||2487
10030934|NCT01905423|11154894|FG000|Baseline|Overall Study||1443
10030935|NCT01905423|11154895|FG001|Baseline|Overall Study||722
10030936|NCT01905423|11154896|FG002|Baseline|Overall Study||1033
10030937|NCT01905423|11154897|FG003|Baseline|Overall Study||1482
10030938|NCT01905423|11154898|FG004|Baseline|Overall Study||1326
10030939|NCT01905423|11154894|FG000|Year 1 Follow-up|Overall Study||994
10030940|NCT01905423|11154895|FG001|Year 1 Follow-up|Overall Study||846
10030941|NCT01905423|11154896|FG002|Year 1 Follow-up|Overall Study||1007
10030942|NCT01905423|11154897|FG003|Year 1 Follow-up|Overall Study||1275
10030943|NCT01905423|11154898|FG004|Year 1 Follow-up|Overall Study||1161
10030944|NCT01905423|11154894|FG000|Year 2 Follow-up|Overall Study||1114
10030945|NCT01905423|11154895|FG001|Year 2 Follow-up|Overall Study||858
10030946|NCT01905423|11154896|FG002|Year 2 Follow-up|Overall Study||1043
10030947|NCT01905423|11154897|FG003|Year 2 Follow-up|Overall Study||0
10030948|NCT01905423|11154898|FG004|Year 2 Follow-up|Overall Study||0
10030949|NCT01905423|11154894|FG000|Year 3 Follow-up|Overall Study||905
10030950|NCT01905423|11154895|FG001|Year 3 Follow-up|Overall Study||871
10030951|NCT01905423|11154896|FG002|Year 3 Follow-up|Overall Study||1028
10030952|NCT01905423|11154897|FG003|Year 3 Follow-up|Overall Study||0
10030953|NCT01905423|11154898|FG004|Year 3 Follow-up|Overall Study||0
10030954|NCT01905423|11154894|FG000|COMPLETED|Overall Study||4456
10030955|NCT01905423|11154895|FG001|COMPLETED|Overall Study||3297
10030956|NCT01905423|11154896|FG002|COMPLETED|Overall Study||4111
10030957|NCT01905423|11154897|FG003|COMPLETED|Overall Study||2757
10030958|NCT01905423|11154898|FG004|COMPLETED|Overall Study||2487
10030959|NCT01905423|11154894|FG000|NOT COMPLETED|Overall Study||0
10030960|NCT01905423|11154895|FG001|NOT COMPLETED|Overall Study||0
10030961|NCT01905423|11154896|FG002|NOT COMPLETED|Overall Study||0
10030962|NCT01905423|11154897|FG003|NOT COMPLETED|Overall Study||0
10030963|NCT01905423|11154898|FG004|NOT COMPLETED|Overall Study||0
10030964|NCT01905540|11154914|FG000|STARTED|Period 1||7
10030965|NCT01905540|11154915|FG001|STARTED|Period 1||7
10030966|NCT01905540|11154916|FG002|STARTED|Period 1||7
10030967|NCT01905540|11154917|FG003|STARTED|Period 1||7
10030968|NCT01905540|11154914|FG000|COMPLETED|Period 1||7
10030969|NCT01905540|11154915|FG001|COMPLETED|Period 1||7
10030970|NCT01905540|11154916|FG002|COMPLETED|Period 1||7
10030971|NCT01905540|11154917|FG003|COMPLETED|Period 1||7
10030972|NCT01905540|11154914|FG000|NOT COMPLETED|Period 1||0
10030973|NCT01905540|11154915|FG001|NOT COMPLETED|Period 1||0
10030974|NCT01905540|11154916|FG002|NOT COMPLETED|Period 1||0
10030975|NCT01905540|11154917|FG003|NOT COMPLETED|Period 1||0
10030976|NCT01905540|11154914|FG000|STARTED|Period 2||7
10030977|NCT01905540|11154915|FG001|STARTED|Period 2||7
10030978|NCT01905540|11154916|FG002|STARTED|Period 2||7
10030979|NCT01905540|11154917|FG003|STARTED|Period 2||7
10030980|NCT01905540|11154914|FG000|COMPLETED|Period 2||7
10030981|NCT01905540|11154915|FG001|COMPLETED|Period 2||7
10030982|NCT01905540|11154916|FG002|COMPLETED|Period 2||7
10030983|NCT01905540|11154917|FG003|COMPLETED|Period 2||7
10030984|NCT01905540|11154914|FG000|NOT COMPLETED|Period 2||0
10030985|NCT01905540|11154915|FG001|NOT COMPLETED|Period 2||0
10030986|NCT01905540|11154916|FG002|NOT COMPLETED|Period 2||0
10030987|NCT01905540|11154917|FG003|NOT COMPLETED|Period 2||0
10030988|NCT01905540|11154914|FG000|STARTED|Period 3||7
10030989|NCT01905540|11154915|FG001|STARTED|Period 3||7
10030990|NCT01905540|11154916|FG002|STARTED|Period 3||7
10030991|NCT01905540|11154917|FG003|STARTED|Period 3||7
10030992|NCT01905540|11154914|FG000|COMPLETED|Period 3||6
10030993|NCT01905540|11154915|FG001|COMPLETED|Period 3||7
10030994|NCT01905540|11154916|FG002|COMPLETED|Period 3||6
10030995|NCT01905540|11154917|FG003|COMPLETED|Period 3||6
10030996|NCT01905540|11154914|FG000|NOT COMPLETED|Period 3||1
10030997|NCT01905540|11154915|FG001|NOT COMPLETED|Period 3||0
10030998|NCT01905540|11154916|FG002|NOT COMPLETED|Period 3||1
10030999|NCT01905540|11154917|FG003|NOT COMPLETED|Period 3||1
10031000|NCT01905553|11154929|FG000|STARTED|Period 1||5
10031001|NCT01905553|11154930|FG001|STARTED|Period 1||4
10031002|NCT01905553|11154929|FG000|COMPLETED|Period 1||5
10031003|NCT01905553|11154930|FG001|COMPLETED|Period 1||4
10031004|NCT01905553|11154929|FG000|NOT COMPLETED|Period 1||0
10031005|NCT01905553|11154930|FG001|NOT COMPLETED|Period 1||0
10031006|NCT01905553|11154929|FG000|STARTED|Period 2||5
10031007|NCT01905553|11154930|FG001|STARTED|Period 2||4
10031008|NCT01905553|11154929|FG000|COMPLETED|Period 2||4
9706226|NCT01094782|10805162|FG000|STARTED|Overall Study||39
9706227|NCT01094782|10805163|FG001|STARTED|Overall Study||39
9706228|NCT01094782|10805164|FG002|STARTED|Overall Study||34
9706229|NCT01094782|10805165|FG003|STARTED|Overall Study||56
10031009|NCT01905553|11154930|FG001|COMPLETED|Period 2||4
10031010|NCT01905553|11154929|FG000|NOT COMPLETED|Period 2||1
10031011|NCT01905553|11154930|FG001|NOT COMPLETED|Period 2||0
10031012|NCT01905592|11154938|FG000|STARTED|Overall Study||71
10031013|NCT01905592|11154939|FG001|STARTED|Overall Study||135
10031014|NCT01905592|11154938|FG000|COMPLETED|Overall Study||0
10031015|NCT01905592|11154939|FG001|COMPLETED|Overall Study||0
10031016|NCT01905592|11154938|FG000|NOT COMPLETED|Overall Study||71
10031017|NCT01905592|11154939|FG001|NOT COMPLETED|Overall Study||135
10031018|NCT01905657|11154948|FG000|STARTED|Overall Study||345
10031019|NCT01905657|11154949|FG001|STARTED|Overall Study||346
10031020|NCT01905657|11154950|FG002|STARTED|Overall Study||343
10031021|NCT01905657|11154948|FG000|Treated|Overall Study||339
10031022|NCT01905657|11154949|FG001|Treated|Overall Study||343
10031023|NCT01905657|11154950|FG002|Treated|Overall Study||309
10031024|NCT01905657|11154948|FG000|Received Second Course of Pembrolizumab|Overall Study||14
10031025|NCT01905657|11154949|FG001|Received Second Course of Pembrolizumab|Overall Study||7
10031026|NCT01905657|11154950|FG002|Received Second Course of Pembrolizumab|Overall Study||0
10031027|NCT01905657|11154948|FG000|Switched Over to Pembrolizumab|Overall Study||0
10031028|NCT01905657|11154949|FG001|Switched Over to Pembrolizumab|Overall Study||0
10031029|NCT01905657|11154950|FG002|Switched Over to Pembrolizumab|Overall Study||8
9706230|NCT01094782|10805166|FG004|STARTED|Overall Study||42
9706231|NCT01094782|10805167|FG005|STARTED|Overall Study||38
9706232|NCT01094782|10805162|FG000|COMPLETED|Overall Study||31
9706233|NCT01094782|10805163|FG001|COMPLETED|Overall Study||29
9706234|NCT01094782|10805164|FG002|COMPLETED|Overall Study||31
9706235|NCT01094782|10805165|FG003|COMPLETED|Overall Study||45
9706236|NCT01094782|10805166|FG004|COMPLETED|Overall Study||31
9706237|NCT01094782|10805167|FG005|COMPLETED|Overall Study||30
9706238|NCT01094782|10805162|FG000|NOT COMPLETED|Overall Study||8
9706239|NCT01094782|10805163|FG001|NOT COMPLETED|Overall Study||10
9706240|NCT01094782|10805164|FG002|NOT COMPLETED|Overall Study||3
9706241|NCT01094782|10805165|FG003|NOT COMPLETED|Overall Study||11
9706242|NCT01094782|10805166|FG004|NOT COMPLETED|Overall Study||11
9706243|NCT01094782|10805167|FG005|NOT COMPLETED|Overall Study||8
9706244|NCT01033032|10805186|FG000|STARTED|Overall Study||3
9706245|NCT01033032|10805187|FG001|STARTED|Overall Study||3
9706246|NCT01033032|10805188|FG002|STARTED|Overall Study||3
9706247|NCT01033032|10805189|FG003|STARTED|Overall Study||6
9706248|NCT01033032|10805190|FG004|STARTED|Overall Study||63
9706249|NCT01033032|10805186|FG000|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
9706250|NCT01033032|10805187|FG001|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
9706251|NCT01033032|10805188|FG002|COMPLETED|Overall Study||3
9706252|NCT01033032|10805189|FG003|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
9706253|NCT01033032|10805190|FG004|COMPLETED|Overall Study||0
9706254|NCT01033032|10805186|FG000|NOT COMPLETED|Overall Study||3
9706255|NCT01033032|10805187|FG001|NOT COMPLETED|Overall Study||3
9706256|NCT01033032|10805188|FG002|NOT COMPLETED|Overall Study||0
9706257|NCT01033032|10805189|FG003|NOT COMPLETED|Overall Study||6
9706258|NCT01033032|10805190|FG004|NOT COMPLETED|Overall Study||63
10031030|NCT01905657|11154948|FG000|COMPLETED|Overall Study||142
10031031|NCT01905657|11154949|FG001|COMPLETED|Overall Study||159
10031032|NCT01905657|11154950|FG002|COMPLETED|Overall Study||143
10031033|NCT01905657|11154948|FG000|NOT COMPLETED|Overall Study||203
10031034|NCT01905657|11154949|FG001|NOT COMPLETED|Overall Study||187
10031035|NCT01905657|11154950|FG002|NOT COMPLETED|Overall Study||200
10031036|NCT01905683|11154961|FG000|STARTED|Overall Study||370
10031037|NCT01905683|11154961|FG000|COMPLETED|Overall Study||319
10031038|NCT01905683|11154961|FG000|NOT COMPLETED|Overall Study||51
10031039|NCT01905943|11154965|FG000|STARTED|Overall Study||972
10031040|NCT01905943|11154965|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658
10031041|NCT01905943|11154965|FG000|NOT COMPLETED|Overall Study||314
10031042|NCT01905956|11154986|FG000|STARTED|Overall Study|Randomized|60
10031043|NCT01905956|11154987|FG001|STARTED|Overall Study|Randomized|59
10031044|NCT01905956|11154986|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
10031045|NCT01905956|11154987|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
10031046|NCT01905956|11154986|FG000|COMPLETED|Overall Study|Per-protocol population|54
10031047|NCT01905956|11154987|FG001|COMPLETED|Overall Study|Per-protocol population|48
10031048|NCT01905956|11154986|FG000|NOT COMPLETED|Overall Study||6
10031049|NCT01905956|11154987|FG001|NOT COMPLETED|Overall Study||11
10031050|NCT01906008|11154995|FG000|STARTED|Overall Study||59
10031051|NCT01906008|11154996|FG001|STARTED|Overall Study||61
10031052|NCT01906008|11154995|FG000|COMPLETED|Overall Study||32
10031053|NCT01906008|11154996|FG001|COMPLETED|Overall Study||34
9706265|NCT00942331|10805212|FG000|STARTED|Overall Study||252
9706266|NCT00942331|10805213|FG001|STARTED|Overall Study||254
9706267|NCT00942331|10805212|FG000|COMPLETED|Overall Study||237
9706268|NCT00942331|10805213|FG001|COMPLETED|Overall Study||232
9706269|NCT00942331|10805212|FG000|NOT COMPLETED|Overall Study||15
9706270|NCT00942331|10805213|FG001|NOT COMPLETED|Overall Study||22
9706271|NCT00932737|10805221|FG000|STARTED|Overall Study||87
9706272|NCT00932737|10805222|FG001|STARTED|Overall Study||88
9706273|NCT00932737|10805221|FG000|COMPLETED|Overall Study||86
9706274|NCT00932737|10805222|FG001|COMPLETED|Overall Study||87
9706275|NCT00932737|10805221|FG000|NOT COMPLETED|Overall Study||1
9706276|NCT00932737|10805222|FG001|NOT COMPLETED|Overall Study||1
9706277|NCT00893516|10805230|FG000|STARTED|Overall Study||0
9706278|NCT00893516|10805231|FG001|STARTED|Overall Study||0
9848335|NCT00858637|10961031|FG000|NOT COMPLETED|Active Comparison Phase||24
10031054|NCT01906008|11154995|FG000|NOT COMPLETED|Overall Study||27
10031055|NCT01906008|11154996|FG001|NOT COMPLETED|Overall Study||27
10031056|NCT01906346|11155002|FG000|STARTED|Overall Study||9
10031057|NCT01906346|11155002|FG000|COMPLETED|Overall Study||8
10031058|NCT01906346|11155002|FG000|NOT COMPLETED|Overall Study||1
10031059|NCT01906372|11155008|FG000|STARTED|Overall Study||12
10031060|NCT01906372|11155008|FG000|Visit 7: Treatment Phase Completed|Overall Study||10
10031061|NCT01906372|11155008|FG000|Visit 10: Follow up Phase Completed|Overall Study||8
10031062|NCT01906372|11155008|FG000|COMPLETED|Overall Study||10
9706279|NCT00893516|10805230|FG000|COMPLETED|Overall Study||0
10031063|NCT01906372|11155008|FG000|NOT COMPLETED|Overall Study||2
10031064|NCT01906476|11155015|FG000|STARTED|Overall Study||157
10031065|NCT01906476|11155016|FG001|STARTED|Overall Study||155
10031066|NCT01906476|11155015|FG000|COMPLETED|Overall Study||140
9706280|NCT00893516|10805231|FG001|COMPLETED|Overall Study||0
9706281|NCT00893516|10805230|FG000|NOT COMPLETED|Overall Study||0
9706282|NCT00893516|10805231|FG001|NOT COMPLETED|Overall Study||0
9706283|NCT00848757|10805239|FG000|STARTED|Overall Study||65
9706284|NCT00848757|10805240|FG001|STARTED|Overall Study||65
9706285|NCT00848757|10805239|FG000|COMPLETED|Overall Study||61
9706286|NCT00848757|10805240|FG001|COMPLETED|Overall Study||61
9706287|NCT00848757|10805239|FG000|NOT COMPLETED|Overall Study||4
9706288|NCT00848757|10805240|FG001|NOT COMPLETED|Overall Study||4
9706298|NCT00710710|10805264|FG000|STARTED|Overall Study||45
9706299|NCT00710710|10805265|FG001|STARTED|Overall Study||44
9706300|NCT00710710|10805264|FG000|Treated|Overall Study||43
9706301|NCT00710710|10805265|FG001|Treated|Overall Study||43
9706302|NCT00710710|10805264|FG000|COMPLETED|Overall Study||0
9706303|NCT00710710|10805265|FG001|COMPLETED|Overall Study||0
9706304|NCT00710710|10805264|FG000|NOT COMPLETED|Overall Study||45
9706305|NCT00710710|10805265|FG001|NOT COMPLETED|Overall Study||44
9706306|NCT00608023|10805274|FG000|STARTED|Overall Study||92
9706307|NCT00608023|10805275|FG001|STARTED|Overall Study||85
9706308|NCT00608023|10805276|FG002|STARTED|Overall Study||86
9706309|NCT00608023|10805274|FG000|COMPLETED|Overall Study||80
10031067|NCT01906476|11155016|FG001|COMPLETED|Overall Study||139
10031068|NCT01906476|11155015|FG000|NOT COMPLETED|Overall Study||17
10031069|NCT01906476|11155016|FG001|NOT COMPLETED|Overall Study||16
10031070|NCT01906515|11155024|FG000|STARTED|Overall Study||45
10031071|NCT01906515|11155025|FG001|STARTED|Overall Study||61
10031072|NCT01906515|11155024|FG000|COMPLETED|Overall Study||45
10031073|NCT01906515|11155025|FG001|COMPLETED|Overall Study||61
10031074|NCT01906515|11155024|FG000|NOT COMPLETED|Overall Study||0
10031075|NCT01906515|11155025|FG001|NOT COMPLETED|Overall Study||0
10031076|NCT01906658|11155036|FG000|STARTED|Overall Study||11
10031077|NCT01906658|11155037|FG001|STARTED|Overall Study||11
10031078|NCT01906658|11155038|FG002|STARTED|Overall Study||10
10031079|NCT01906658|11155039|FG003|STARTED|Overall Study||11
10031080|NCT01906658|11155036|FG000|COMPLETED|Overall Study||9
10031081|NCT01906658|11155037|FG001|COMPLETED|Overall Study||10
10031082|NCT01906658|11155038|FG002|COMPLETED|Overall Study||7
10031083|NCT01906658|11155039|FG003|COMPLETED|Overall Study||11
10031084|NCT01906658|11155036|FG000|NOT COMPLETED|Overall Study||2
10031085|NCT01906658|11155037|FG001|NOT COMPLETED|Overall Study||1
10031086|NCT01906658|11155038|FG002|NOT COMPLETED|Overall Study||3
10031087|NCT01906658|11155039|FG003|NOT COMPLETED|Overall Study||0
10031088|NCT01906866|11155051|FG000|STARTED|Overall Study||60
10031089|NCT01906866|11155052|FG001|STARTED|Overall Study||65
10031090|NCT01906866|11155051|FG000|COMPLETED|Overall Study||51
10031091|NCT01906866|11155052|FG001|COMPLETED|Overall Study||44
10031092|NCT01906866|11155051|FG000|NOT COMPLETED|Overall Study||9
10031093|NCT01906866|11155052|FG001|NOT COMPLETED|Overall Study||21
10031094|NCT01907087|11155061|FG000|STARTED|Overall Study||24
10031095|NCT01907087|11155061|FG000|COMPLETED|Overall Study||23
10031096|NCT01907087|11155061|FG000|NOT COMPLETED|Overall Study||1
10031097|NCT01907100|11155069|FG000|STARTED|Overall Study||43
10031098|NCT01907100|11155070|FG001|STARTED|Overall Study||44
9706310|NCT00608023|10805275|FG001|COMPLETED|Overall Study||63
9706311|NCT00608023|10805276|FG002|COMPLETED|Overall Study||72
9706312|NCT00608023|10805274|FG000|NOT COMPLETED|Overall Study||12
9706313|NCT00608023|10805275|FG001|NOT COMPLETED|Overall Study||22
9706314|NCT00608023|10805276|FG002|NOT COMPLETED|Overall Study||14
9706315|NCT00551616|10805289|FG000|STARTED|Overall Study||1104
9706316|NCT00551616|10805290|FG001|STARTED|Overall Study||1117
9706317|NCT00551616|10805289|FG000|COMPLETED|Overall Study||1056
9706318|NCT00551616|10805290|FG001|COMPLETED|Overall Study||1077
9706319|NCT00551616|10805289|FG000|NOT COMPLETED|Overall Study||48
9706320|NCT00551616|10805290|FG001|NOT COMPLETED|Overall Study||40
9706321|NCT00520767|10805296|FG000|STARTED|Overall Study||35
9706322|NCT00520767|10805296|FG000|COMPLETED|Overall Study||33
9706323|NCT00520767|10805296|FG000|NOT COMPLETED|Overall Study||2
9729084|NCT00116688|10828694|FG000|Received Study Medication|Overall Study||291
10031099|NCT01907100|11155071|FG002|STARTED|Overall Study||229
9729085|NCT00116688|10828695|FG001|Received Study Medication|Overall Study||20
9729086|NCT00116688|10828694|FG000|COMPLETED|Overall Study||200
10031100|NCT01907100|11155072|FG003|STARTED|Overall Study||229
9729087|NCT00116688|10828695|FG001|COMPLETED|Overall Study||17
9729088|NCT00116688|10828694|FG000|NOT COMPLETED|Overall Study||92
10031101|NCT01907100|11155069|FG000|Treated Patients|Overall Study||41
10031102|NCT01907100|11155070|FG001|Treated Patients|Overall Study||44
10031103|NCT01907100|11155071|FG002|Treated Patients|Overall Study||228
10031104|NCT01907100|11155072|FG003|Treated Patients|Overall Study||227
10031105|NCT01907100|11155069|FG000|COMPLETED|Overall Study||1
10031106|NCT01907100|11155070|FG001|COMPLETED|Overall Study||4
9729089|NCT00116688|10828695|FG001|NOT COMPLETED|Overall Study||4
10031107|NCT01907100|11155071|FG002|COMPLETED|Overall Study||82
10031108|NCT01907100|11155072|FG003|COMPLETED|Overall Study||83
10031109|NCT01907100|11155069|FG000|NOT COMPLETED|Overall Study||42
10031110|NCT01907100|11155070|FG001|NOT COMPLETED|Overall Study||40
10031111|NCT01907100|11155071|FG002|NOT COMPLETED|Overall Study||147
10031112|NCT01907100|11155072|FG003|NOT COMPLETED|Overall Study||146
10031113|NCT01907113|11155085|FG000|STARTED|Overall Study||8
10031114|NCT01907113|11155086|FG001|STARTED|Overall Study||9
10031115|NCT01907113|11155087|FG002|STARTED|Overall Study||7
10031116|NCT01907113|11155088|FG003|STARTED|Overall Study||8
10031117|NCT01907113|11155089|FG004|STARTED|Overall Study||8
10031118|NCT01907113|11155085|FG000|COMPLETED|Overall Study||8
10031119|NCT01907113|11155086|FG001|COMPLETED|Overall Study||9
10031120|NCT01907113|11155087|FG002|COMPLETED|Overall Study||7
10031121|NCT01907113|11155088|FG003|COMPLETED|Overall Study||8
10031122|NCT01907113|11155089|FG004|COMPLETED|Overall Study||8
10031123|NCT01907113|11155085|FG000|NOT COMPLETED|Overall Study||0
10031124|NCT01907113|11155086|FG001|NOT COMPLETED|Overall Study||0
10031125|NCT01907113|11155087|FG002|NOT COMPLETED|Overall Study||0
10031126|NCT01907113|11155088|FG003|NOT COMPLETED|Overall Study||0
10031127|NCT01907113|11155089|FG004|NOT COMPLETED|Overall Study||0
10031128|NCT01907217|11155103|FG000|STARTED|Overall Study||69
10031129|NCT01907217|11155104|FG001|STARTED|Overall Study||69
10031130|NCT01907217|11155103|FG000|COMPLETED|Overall Study||69
10031131|NCT01907217|11155104|FG001|COMPLETED|Overall Study||67
10031132|NCT01907217|11155103|FG000|NOT COMPLETED|Overall Study||0
10031133|NCT01907217|11155104|FG001|NOT COMPLETED|Overall Study||2
10081480|NCT02260986|11209996|FG002|STARTED|Overall Study||319
10081481|NCT02260986|11209994|FG000|Safety Population|Overall Study||315
10081482|NCT02260986|11209995|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
10081483|NCT02260986|11209996|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
10081484|NCT02260986|11209994|FG000|COMPLETED|Overall Study||225
10081485|NCT02260986|11209995|FG001|COMPLETED|Overall Study||93
10081486|NCT02260986|11209996|FG002|COMPLETED|Overall Study||278
10081487|NCT02260986|11209994|FG000|NOT COMPLETED|Overall Study||90
10081488|NCT02260986|11209995|FG001|NOT COMPLETED|Overall Study||13
10081489|NCT02260986|11209996|FG002|NOT COMPLETED|Overall Study||41
10081490|NCT02261428|11210011|FG000|STARTED|Overall Study|Washout (30 minutes)|10
10081491|NCT02261428|11210012|FG001|STARTED|Overall Study|Washout (30 minutes)|10
10081492|NCT02261428|11210011|FG000|COMPLETED|Overall Study||10
10081493|NCT02261428|11210012|FG001|COMPLETED|Overall Study||10
10081494|NCT02261428|11210011|FG000|NOT COMPLETED|Overall Study||0
10081495|NCT02261428|11210012|FG001|NOT COMPLETED|Overall Study||0
10081496|NCT02261467|11210032|FG000|STARTED|Overall Study||101
10081497|NCT02261467|11210033|FG001|STARTED|Overall Study||290
10081498|NCT02261467|11210032|FG000|COMPLETED|Overall Study||80
10081499|NCT02261467|11210033|FG001|COMPLETED|Overall Study||253
10081500|NCT02261467|11210032|FG000|NOT COMPLETED|Overall Study||21
10081501|NCT02261467|11210033|FG001|NOT COMPLETED|Overall Study||37
10081502|NCT02261493|11210042|FG000|STARTED|Overall Study||156
10081503|NCT02261493|11210043|FG001|STARTED|Overall Study||318
10081504|NCT02261493|11210044|FG002|STARTED|Overall Study||313
10081505|NCT02261493|11210042|FG000|COMPLETED|Overall Study||126
10081506|NCT02261493|11210043|FG001|COMPLETED|Overall Study||271
10081507|NCT02261493|11210044|FG002|COMPLETED|Overall Study||287
10081508|NCT02261493|11210042|FG000|NOT COMPLETED|Overall Study||30
10081509|NCT02261493|11210043|FG001|NOT COMPLETED|Overall Study||47
10081510|NCT02261493|11210044|FG002|NOT COMPLETED|Overall Study||26
10081511|NCT02261597|11210054|FG000|STARTED|Overall Study||22
10081512|NCT02261597|11210055|FG001|STARTED|Overall Study||22
10081513|NCT02261597|11210054|FG000|COMPLETED|Overall Study||22
10081514|NCT02261597|11210055|FG001|COMPLETED|Overall Study||22
10081515|NCT02261597|11210054|FG000|NOT COMPLETED|Overall Study||0
10081516|NCT02261597|11210055|FG001|NOT COMPLETED|Overall Study||0
10081517|NCT02261714|11210061|FG000|STARTED|Overall Study||32
10081518|NCT02261714|11210061|FG000|COMPLETED|Overall Study||4
10081519|NCT02261714|11210061|FG000|NOT COMPLETED|Overall Study||28
10081520|NCT02261727|11210069|FG000|STARTED|Overall Study||568
10081521|NCT02261727|11210070|FG001|STARTED|Overall Study||554
10081522|NCT02261727|11210071|FG002|STARTED|Overall Study||548
10081523|NCT02261727|11210069|FG000|COMPLETED|Overall Study||411
10081524|NCT02261727|11210070|FG001|COMPLETED|Overall Study||408
10081525|NCT02261727|11210071|FG002|COMPLETED|Overall Study||423
10081526|NCT02261727|11210069|FG000|NOT COMPLETED|Overall Study||157
10081527|NCT02261727|11210070|FG001|NOT COMPLETED|Overall Study||146
10081528|NCT02261727|11210071|FG002|NOT COMPLETED|Overall Study||125
10081529|NCT02261805|11210079|FG000|STARTED|Overall Study||3
10081530|NCT02261805|11210080|FG001|STARTED|Overall Study||6
10081531|NCT02261805|11210081|FG002|STARTED|Overall Study||2
10081532|NCT02261805|11210079|FG000|COMPLETED|Overall Study||3
10081533|NCT02261805|11210080|FG001|COMPLETED|Overall Study||6
10081534|NCT02261805|11210081|FG002|COMPLETED|Overall Study||2
10081535|NCT02261805|11210079|FG000|NOT COMPLETED|Overall Study||0
10081536|NCT02261805|11210080|FG001|NOT COMPLETED|Overall Study||0
10081537|NCT02261805|11210081|FG002|NOT COMPLETED|Overall Study||0
10081538|NCT02261818|11210087|FG000|STARTED|Overall Study||30
10081539|NCT02261818|11210087|FG000|COMPLETED|Overall Study||27
10081540|NCT02261818|11210087|FG000|NOT COMPLETED|Overall Study||3
10081541|NCT02261948|11210093|FG000|STARTED|Overall Study||23
10081542|NCT02261948|11210094|FG001|STARTED|Overall Study||19
10081543|NCT02261948|11210093|FG000|COMPLETED|Overall Study||23
10081544|NCT02261948|11210094|FG001|COMPLETED|Overall Study||19
10081545|NCT02261948|11210093|FG000|NOT COMPLETED|Overall Study||0
10031134|NCT01907269|11155114|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342
10031135|NCT01907269|11155115|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342
10031136|NCT01907269|11155114|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953
10031137|NCT01907269|11155115|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053
10031138|NCT01907269|11155114|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
10031139|NCT01907269|11155115|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
10031140|NCT01907269|11155114|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178
10031141|NCT01907269|11155115|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250
10031142|NCT01907269|11155114|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859
10031143|NCT01907269|11155115|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970
10031144|NCT01907269|11155114|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
10031145|NCT01907269|11155115|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
10031146|NCT01907321|11155121|FG000|STARTED|Overall Study||14
10031147|NCT01907321|11155121|FG000|COMPLETED|Overall Study||12
10031148|NCT01907321|11155121|FG000|NOT COMPLETED|Overall Study||2
10031149|NCT01907334|11155125|FG000|STARTED|Overall Study||6
10031150|NCT01907334|11155126|FG001|STARTED|Overall Study||4
10031151|NCT01907334|11155125|FG000|COMPLETED|Overall Study||6
10031152|NCT01907334|11155126|FG001|COMPLETED|Overall Study||4
10031153|NCT01907334|11155125|FG000|NOT COMPLETED|Overall Study||0
10031154|NCT01907334|11155126|FG001|NOT COMPLETED|Overall Study||0
10031155|NCT01907490|11155131|FG000|STARTED|Overall Study||38
10031156|NCT01907490|11155131|FG000|COMPLETED|Overall Study||38
10031157|NCT01907490|11155131|FG000|NOT COMPLETED|Overall Study||0
10031158|NCT01907516|11155138|FG000|STARTED|First Intervention (3 Weeks)||50
10031159|NCT01907516|11155139|FG001|STARTED|First Intervention (3 Weeks)||50
10031160|NCT01907516|11155138|FG000|COMPLETED|First Intervention (3 Weeks)||40
10031161|NCT01907516|11155139|FG001|COMPLETED|First Intervention (3 Weeks)||34
10031162|NCT01907516|11155138|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10
10031163|NCT01907516|11155139|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16
10031164|NCT01907516|11155138|FG000|STARTED|Second Intervention (3 Weeks)||40
10031165|NCT01907516|11155139|FG001|STARTED|Second Intervention (3 Weeks)||34
10031166|NCT01907516|11155138|FG000|COMPLETED|Second Intervention (3 Weeks)||40
10031167|NCT01907516|11155139|FG001|COMPLETED|Second Intervention (3 Weeks)||34
10031168|NCT01907516|11155138|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10031169|NCT01907516|11155139|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10031170|NCT01907607|11155146|FG000|STARTED|Overall Study||29
10031171|NCT01907607|11155146|FG000|COMPLETED|Overall Study||29
10031172|NCT01907607|11155146|FG000|NOT COMPLETED|Overall Study||0
10031173|NCT01907737|11155150|FG000|STARTED|Overall Study||22
10031174|NCT01907737|11155150|FG000|COMPLETED|Overall Study||21
10031175|NCT01907737|11155150|FG000|NOT COMPLETED|Overall Study||1
10031176|NCT01907815|11155162|FG000|STARTED|Overall Study||17
10031177|NCT01907815|11155163|FG001|STARTED|Overall Study||7
10031178|NCT01907815|11155162|FG000|COMPLETED|Overall Study||16
10031179|NCT01907815|11155163|FG001|COMPLETED|Overall Study||7
10031180|NCT01907815|11155162|FG000|NOT COMPLETED|Overall Study||1
10031181|NCT01907815|11155163|FG001|NOT COMPLETED|Overall Study||0
10031182|NCT01907828|11155173|FG000|STARTED|Overall Study||39
10031183|NCT01907828|11155174|FG001|STARTED|Overall Study||22
10031184|NCT01907828|11155173|FG000|Underwent Procedure|Overall Study||39
10031185|NCT01907828|11155174|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20
10031186|NCT01907828|11155173|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37
10031187|NCT01907828|11155174|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17
10031188|NCT01907828|11155173|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36
10031189|NCT01907828|11155174|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16
10031190|NCT01907828|11155173|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35
10031191|NCT01907828|11155174|FG001|6-month Follow-up|Overall Study||16
10031192|NCT01907828|11155173|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34
10031193|NCT01907828|11155174|FG001|12-month Follow-up|Overall Study||16
10031194|NCT01907828|11155173|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32
10031195|NCT01907828|11155174|FG001|24-month Follow-up|Overall Study||16
10031196|NCT01907828|11155173|FG000|COMPLETED|Overall Study||32
10031197|NCT01907828|11155174|FG001|COMPLETED|Overall Study||16
10031198|NCT01907828|11155173|FG000|NOT COMPLETED|Overall Study||7
10031199|NCT01907828|11155174|FG001|NOT COMPLETED|Overall Study||6
10031200|NCT01907854|11155182|FG000|STARTED|Overall Study||203
10031201|NCT01907854|11155183|FG001|STARTED|Overall Study||204
10031202|NCT01907854|11155182|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
10031203|NCT01907854|11155183|FG001|Exposed|Overall Study||204
10031204|NCT01907854|11155182|FG000|COMPLETED|Overall Study||187
10031205|NCT01907854|11155183|FG001|COMPLETED|Overall Study||191
10031206|NCT01907854|11155182|FG000|NOT COMPLETED|Overall Study||16
10031207|NCT01907854|11155183|FG001|NOT COMPLETED|Overall Study||13
10031208|NCT01907906|11155191|FG000|STARTED|Overall Study||16
10031209|NCT01907906|11155192|FG001|STARTED|Overall Study||13
10031210|NCT01907906|11155191|FG000|COMPLETED|Overall Study||12
10031211|NCT01907906|11155192|FG001|COMPLETED|Overall Study||12
10031212|NCT01907906|11155191|FG000|NOT COMPLETED|Overall Study||4
10031213|NCT01907906|11155192|FG001|NOT COMPLETED|Overall Study||1
10031214|NCT01908062|11155202|FG000|STARTED|Overall Study||26
10031215|NCT01908062|11155203|FG001|STARTED|Overall Study||25
10031216|NCT01908062|11155202|FG000|COMPLETED|Overall Study||24
10031217|NCT01908062|11155203|FG001|COMPLETED|Overall Study||22
10031218|NCT01908062|11155202|FG000|NOT COMPLETED|Overall Study||2
10031219|NCT01908062|11155203|FG001|NOT COMPLETED|Overall Study||3
10031220|NCT01908101|11155212|FG000|STARTED|Overall Study||68
10031221|NCT01908101|11155212|FG000|COMPLETED|Overall Study||59
10031222|NCT01908101|11155212|FG000|NOT COMPLETED|Overall Study||9
10031223|NCT01908127|11155218|FG000|STARTED|Overall Study||23
10031224|NCT01908127|11155219|FG001|STARTED|Overall Study||23
10031225|NCT01908127|11155218|FG000|COMPLETED|Overall Study||22
10031226|NCT01908127|11155219|FG001|COMPLETED|Overall Study||23
10031227|NCT01908127|11155218|FG000|NOT COMPLETED|Overall Study||1
10031228|NCT01908127|11155219|FG001|NOT COMPLETED|Overall Study||0
10031229|NCT01908140|11155227|FG000|STARTED|Overall Study||468
10031230|NCT01908140|11155228|FG001|STARTED|Overall Study||465
10031231|NCT01908140|11155227|FG000|COMPLETED|Overall Study||402
10031232|NCT01908140|11155228|FG001|COMPLETED|Overall Study||386
10031233|NCT01908140|11155227|FG000|NOT COMPLETED|Overall Study||66
10031234|NCT01908140|11155228|FG001|NOT COMPLETED|Overall Study||79
10031235|NCT01908205|11155236|FG000|STARTED|Overall Study||30
10031236|NCT01908205|11155237|FG001|STARTED|Overall Study||30
10031237|NCT01908205|11155236|FG000|COMPLETED|Overall Study||25
10031238|NCT01908205|11155237|FG001|COMPLETED|Overall Study||29
10031239|NCT01908205|11155236|FG000|NOT COMPLETED|Overall Study||5
10031240|NCT01908205|11155237|FG001|NOT COMPLETED|Overall Study||1
10031241|NCT01908426|11155258|FG000|STARTED|Overall Study||470
10031242|NCT01908426|11155259|FG001|STARTED|Overall Study||237
10031243|NCT01908426|11155258|FG000|COMPLETED|Overall Study||73
10031244|NCT01908426|11155259|FG001|COMPLETED|Overall Study||26
10031245|NCT01908426|11155258|FG000|NOT COMPLETED|Overall Study||397
10031246|NCT01908426|11155259|FG001|NOT COMPLETED|Overall Study||211
10031247|NCT01908530|11155268|FG000|STARTED|Overall Study||8
10031248|NCT01908530|11155269|FG001|STARTED|Overall Study||8
10031249|NCT01908530|11155270|FG002|STARTED|Overall Study||10
10031250|NCT01908530|11155268|FG000|COMPLETED|Overall Study||8
10031251|NCT01908530|11155269|FG001|COMPLETED|Overall Study||8
10031252|NCT01908530|11155270|FG002|COMPLETED|Overall Study||10
10031253|NCT01908530|11155268|FG000|NOT COMPLETED|Overall Study||0
10031254|NCT01908530|11155269|FG001|NOT COMPLETED|Overall Study||0
10031255|NCT01908530|11155270|FG002|NOT COMPLETED|Overall Study||0
10031256|NCT01908582|11155281|FG000|STARTED|Period 1||26
10031257|NCT01908582|11155281|FG000|Received at Least One Dose of Study Drug|Period 1||26
10031258|NCT01908582|11155281|FG000|COMPLETED|Period 1||26
10031259|NCT01908582|11155281|FG000|NOT COMPLETED|Period 1||0
10031260|NCT01908582|11155281|FG000|STARTED|Period 2||26
10031261|NCT01908582|11155281|FG000|COMPLETED|Period 2||24
10031262|NCT01908582|11155281|FG000|NOT COMPLETED|Period 2||2
10031263|NCT01908634|11155288|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10
10031264|NCT01908634|11155288|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10
10031265|NCT01908634|11155288|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
10031266|NCT01908634|11155288|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10
10031267|NCT01908634|11155288|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
10031268|NCT01908634|11155288|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
10031269|NCT01908634|11155288|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9
10031270|NCT01908634|11155288|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
10031271|NCT01908634|11155288|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
10031272|NCT01908634|11155288|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4
10031273|NCT01908634|11155288|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
10031274|NCT01908634|11155288|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
10031275|NCT01908699|11155298|FG000|STARTED|Overall Study||137
10031276|NCT01908699|11155299|FG001|STARTED|Overall Study||136
10031277|NCT01908699|11155298|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136
10031278|NCT01908699|11155299|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135
10031279|NCT01908699|11155298|FG000|COMPLETED|Overall Study||62
10031280|NCT01908699|11155299|FG001|COMPLETED|Overall Study||58
10031281|NCT01908699|11155298|FG000|NOT COMPLETED|Overall Study||75
10031282|NCT01908699|11155299|FG001|NOT COMPLETED|Overall Study||78
10031283|NCT01908751|11155309|FG000|STARTED|Overall Study||22
10031284|NCT01908751|11155310|FG001|STARTED|Overall Study||23
10031285|NCT01908751|11155311|FG002|STARTED|Overall Study||21
10031286|NCT01908751|11155312|FG003|STARTED|Overall Study||20
10031287|NCT01908751|11155309|FG000|COMPLETED|Overall Study||17
10031288|NCT01908751|11155310|FG001|COMPLETED|Overall Study||18
10031289|NCT01908751|11155311|FG002|COMPLETED|Overall Study||16
10031290|NCT01908751|11155312|FG003|COMPLETED|Overall Study||16
10031291|NCT01908751|11155309|FG000|NOT COMPLETED|Overall Study||5
10031292|NCT01908751|11155310|FG001|NOT COMPLETED|Overall Study||5
10031293|NCT01908751|11155311|FG002|NOT COMPLETED|Overall Study||5
10031294|NCT01908751|11155312|FG003|NOT COMPLETED|Overall Study||4
10031295|NCT01908803|11155324|FG000|STARTED|Overall Study||46
10031296|NCT01908803|11155325|FG001|STARTED|Overall Study||24
10031297|NCT01908803|11155324|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
10031298|NCT01908803|11155325|FG001|Treated|Overall Study||24
10115594|NCT02527343|11246452|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7
10115595|NCT02527343|11246453|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10031299|NCT01908803|11155324|FG000|COMPLETED|Overall Study||42
10031300|NCT01908803|11155325|FG001|COMPLETED|Overall Study||23
10031301|NCT01908803|11155324|FG000|NOT COMPLETED|Overall Study||4
10031302|NCT01908803|11155325|FG001|NOT COMPLETED|Overall Study||1
10031303|NCT01908816|11155336|FG000|STARTED|Overall Study||93
10031304|NCT01908816|11155337|FG001|STARTED|Overall Study||84
10031305|NCT01908816|11155338|FG002|STARTED|Overall Study||58
10031306|NCT01908816|11155339|FG003|STARTED|Overall Study||35
10031307|NCT01908816|11155336|FG000|COMPLETED|Overall Study||0
10031308|NCT01908816|11155337|FG001|COMPLETED|Overall Study||0
10031309|NCT01908816|11155338|FG002|COMPLETED|Overall Study||0
10031310|NCT01908816|11155339|FG003|COMPLETED|Overall Study||0
10031311|NCT01908816|11155336|FG000|NOT COMPLETED|Overall Study||93
10031312|NCT01908816|11155337|FG001|NOT COMPLETED|Overall Study||84
10031313|NCT01908816|11155338|FG002|NOT COMPLETED|Overall Study||58
10031314|NCT01908816|11155339|FG003|NOT COMPLETED|Overall Study||35
10031315|NCT01908829|11155355|FG000|STARTED|Overall Study||727
10031316|NCT01908829|11155356|FG001|STARTED|Overall Study||728
10031317|NCT01908829|11155357|FG002|STARTED|Overall Study||719
10031318|NCT01908829|11155355|FG000|Treated With Double-blind Drug|Overall Study||725
10031319|NCT01908829|11155356|FG001|Treated With Double-blind Drug|Overall Study||728
10031320|NCT01908829|11155357|FG002|Treated With Double-blind Drug|Overall Study||719
10031321|NCT01908829|11155355|FG000|COMPLETED|Overall Study||678
10031322|NCT01908829|11155356|FG001|COMPLETED|Overall Study||679
10031323|NCT01908829|11155357|FG002|COMPLETED|Overall Study||680
10031324|NCT01908829|11155355|FG000|NOT COMPLETED|Overall Study||49
10031325|NCT01908829|11155356|FG001|NOT COMPLETED|Overall Study||49
10031326|NCT01908829|11155357|FG002|NOT COMPLETED|Overall Study||39
10031327|NCT01908842|11155367|FG000|STARTED|Induction||383
10031328|NCT01908842|11155368|FG001|STARTED|Induction||375
10031329|NCT01908842|11155367|FG000|COMPLETED|Induction||357
10031330|NCT01908842|11155368|FG001|COMPLETED|Induction||344
10031331|NCT01908842|11155367|FG000|NOT COMPLETED|Induction||26
10031332|NCT01908842|11155368|FG001|NOT COMPLETED|Induction||31
10031333|NCT01908842|11155367|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357
10031334|NCT01908842|11155368|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344
10031335|NCT01908842|11155367|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
10031336|NCT01908842|11155368|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
10031337|NCT01908842|11155367|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
10031338|NCT01908842|11155368|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
10031339|NCT01908842|11155367|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
10031340|NCT01908842|11155368|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
10031341|NCT01908842|11155367|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
10031342|NCT01908842|11155368|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
10031343|NCT01908842|11155367|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
10031344|NCT01908842|11155368|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
10031345|NCT01908907|11155376|FG000|STARTED|Overall Study||31
10031346|NCT01908907|11155377|FG001|STARTED|Overall Study||29
10031347|NCT01908907|11155376|FG000|COMPLETED|Overall Study||29
10031348|NCT01908907|11155377|FG001|COMPLETED|Overall Study||29
10031349|NCT01908907|11155376|FG000|NOT COMPLETED|Overall Study||2
10031350|NCT01908907|11155377|FG001|NOT COMPLETED|Overall Study||0
10031351|NCT01908972|11155389|FG000|STARTED|Overall Study||17
10031352|NCT01908972|11155390|FG001|STARTED|Overall Study||17
10031353|NCT01908972|11155389|FG000|COMPLETED|Overall Study||15
10031354|NCT01908972|11155390|FG001|COMPLETED|Overall Study||17
10031355|NCT01908972|11155389|FG000|NOT COMPLETED|Overall Study||2
10031356|NCT01908972|11155390|FG001|NOT COMPLETED|Overall Study||0
10031357|NCT01909011|11155398|FG000|STARTED|Overall Study||7
10031358|NCT01909011|11155399|FG001|STARTED|Overall Study||9
10031359|NCT01909011|11155398|FG000|COMPLETED|Overall Study||7
10031360|NCT01909011|11155399|FG001|COMPLETED|Overall Study||9
10031361|NCT01909011|11155398|FG000|NOT COMPLETED|Overall Study||0
10031362|NCT01909011|11155399|FG001|NOT COMPLETED|Overall Study||0
10031363|NCT01909141|11155407|FG000|STARTED|Overall Study||50
10031364|NCT01909141|11155408|FG001|STARTED|Overall Study||50
10031365|NCT01909141|11155407|FG000|COMPLETED|Overall Study||50
10031366|NCT01909141|11155408|FG001|COMPLETED|Overall Study||50
10031367|NCT01909141|11155407|FG000|NOT COMPLETED|Overall Study||0
10031368|NCT01909141|11155408|FG001|NOT COMPLETED|Overall Study||0
10031369|NCT01909154|11155416|FG000|STARTED|Overall Study||12
10031370|NCT01909154|11155416|FG000|COMPLETED|Overall Study||12
10031371|NCT01909154|11155416|FG000|NOT COMPLETED|Overall Study||0
10031372|NCT01909180|11155420|FG000|STARTED|Overall Study||49
10031373|NCT01909180|11155420|FG000|COMPLETED|Overall Study||49
10031374|NCT01909180|11155420|FG000|NOT COMPLETED|Overall Study||0
10031375|NCT01909336|11155429|FG000|STARTED|Overall Study||53
10031376|NCT01909336|11155430|FG001|STARTED|Overall Study||53
10031377|NCT01909336|11155431|FG002|STARTED|Overall Study||55
10031378|NCT01909336|11155429|FG000|COMPLETED|Overall Study||49
10031379|NCT01909336|11155430|FG001|COMPLETED|Overall Study||50
10031380|NCT01909336|11155431|FG002|COMPLETED|Overall Study||52
10031381|NCT01909336|11155429|FG000|NOT COMPLETED|Overall Study||4
10031382|NCT01909336|11155430|FG001|NOT COMPLETED|Overall Study||3
10031383|NCT01909336|11155431|FG002|NOT COMPLETED|Overall Study||3
10031384|NCT01909466|11155439|FG000|STARTED|Overall Study||68
10031385|NCT01909466|11155440|FG001|STARTED|Overall Study||73
10031386|NCT01909466|11155439|FG000|COMPLETED|Overall Study||46
10031387|NCT01909466|11155440|FG001|COMPLETED|Overall Study||50
10031388|NCT01909466|11155439|FG000|NOT COMPLETED|Overall Study||22
10031389|NCT01909466|11155440|FG001|NOT COMPLETED|Overall Study||23
10031390|NCT01909674|11155446|FG000|STARTED|Overall Study||12
10031391|NCT01909674|11155447|FG001|STARTED|Overall Study||9
10031392|NCT01909674|11155446|FG000|COMPLETED|Overall Study||7
10031393|NCT01909674|11155447|FG001|COMPLETED|Overall Study||7
10031394|NCT01909674|11155446|FG000|NOT COMPLETED|Overall Study||5
10031395|NCT01909674|11155447|FG001|NOT COMPLETED|Overall Study||2
10031396|NCT01909713|11155453|FG000|STARTED|Overall Study||35
10031397|NCT01909713|11155453|FG000|COMPLETED|Overall Study||35
10031398|NCT01909713|11155453|FG000|NOT COMPLETED|Overall Study||0
10031399|NCT01909778|11155478|FG000|STARTED|Overall Study||2
10031400|NCT01909778|11155478|FG000|COMPLETED|Overall Study||1
10031401|NCT01909778|11155478|FG000|NOT COMPLETED|Overall Study||1
10031402|NCT01909791|11155487|FG000|STARTED|Overall Study||226
10031403|NCT01909791|11155488|FG001|STARTED|Overall Study||240
10031404|NCT01909791|11155489|FG002|STARTED|Overall Study||236
10031405|NCT01909791|11155487|FG000|COMPLETED|Overall Study||205
10031406|NCT01909791|11155488|FG001|COMPLETED|Overall Study||212
10031407|NCT01909791|11155489|FG002|COMPLETED|Overall Study||208
10031408|NCT01909791|11155487|FG000|NOT COMPLETED|Overall Study||21
10031409|NCT01909791|11155488|FG001|NOT COMPLETED|Overall Study||28
10031410|NCT01909791|11155489|FG002|NOT COMPLETED|Overall Study||28
10031411|NCT01909804|11155514|FG000|STARTED|Overall Study||26
10031412|NCT01909804|11155515|FG001|STARTED|Overall Study||28
10031413|NCT01909804|11155516|FG002|STARTED|Overall Study||27
10031414|NCT01909804|11155517|FG003|STARTED|Overall Study||26
10031415|NCT01909804|11155518|FG004|STARTED|Overall Study||26
10031416|NCT01909804|11155519|FG005|STARTED|Overall Study||25
10031417|NCT01909804|11155520|FG006|STARTED|Overall Study||27
10031418|NCT01909804|11155521|FG007|STARTED|Overall Study||26
10031419|NCT01909804|11155522|FG008|STARTED|Overall Study||27
10031420|NCT01909804|11155523|FG009|STARTED|Overall Study||29
10031421|NCT01909804|11155524|FG010|STARTED|Overall Study||27
10031422|NCT01909804|11155525|FG011|STARTED|Overall Study||29
10031423|NCT01909804|11155514|FG000|COMPLETED|Overall Study||22
10031424|NCT01909804|11155515|FG001|COMPLETED|Overall Study||27
10031425|NCT01909804|11155516|FG002|COMPLETED|Overall Study||27
10031426|NCT01909804|11155517|FG003|COMPLETED|Overall Study||26
10031427|NCT01909804|11155518|FG004|COMPLETED|Overall Study||18
10031428|NCT01909804|11155519|FG005|COMPLETED|Overall Study||21
10031429|NCT01909804|11155520|FG006|COMPLETED|Overall Study||25
10031430|NCT01909804|11155521|FG007|COMPLETED|Overall Study||25
10031431|NCT01909804|11155522|FG008|COMPLETED|Overall Study||27
10031432|NCT01909804|11155523|FG009|COMPLETED|Overall Study||28
10031433|NCT01909804|11155524|FG010|COMPLETED|Overall Study||26
10031434|NCT01909804|11155525|FG011|COMPLETED|Overall Study||26
10031435|NCT01909804|11155514|FG000|NOT COMPLETED|Overall Study||4
10031436|NCT01909804|11155515|FG001|NOT COMPLETED|Overall Study||1
10031437|NCT01909804|11155516|FG002|NOT COMPLETED|Overall Study||0
10031438|NCT01909804|11155517|FG003|NOT COMPLETED|Overall Study||0
10031439|NCT01909804|11155518|FG004|NOT COMPLETED|Overall Study||8
10031440|NCT01909804|11155519|FG005|NOT COMPLETED|Overall Study||4
10031441|NCT01909804|11155520|FG006|NOT COMPLETED|Overall Study||2
10031442|NCT01909804|11155521|FG007|NOT COMPLETED|Overall Study||1
10031443|NCT01909804|11155522|FG008|NOT COMPLETED|Overall Study||0
10031444|NCT01909804|11155523|FG009|NOT COMPLETED|Overall Study||1
10031445|NCT01909804|11155524|FG010|NOT COMPLETED|Overall Study||1
10031446|NCT01909804|11155525|FG011|NOT COMPLETED|Overall Study||3
10031447|NCT01909973|11155549|FG000|STARTED|Overall Study||8
10031448|NCT01909973|11155550|FG001|STARTED|Overall Study||7
10031449|NCT01909973|11155549|FG000|COMPLETED|Overall Study||7
10031450|NCT01909973|11155550|FG001|COMPLETED|Overall Study||7
10031451|NCT01909973|11155549|FG000|NOT COMPLETED|Overall Study||1
10031452|NCT01909973|11155550|FG001|NOT COMPLETED|Overall Study||0
10031453|NCT01910064|11155556|FG000|STARTED|Overall Study||436
10031454|NCT01910064|11155556|FG000|COMPLETED|Overall Study||391
10031455|NCT01910064|11155556|FG000|NOT COMPLETED|Overall Study||45
10031456|NCT01910116|11155562|FG000|STARTED|Overall Study||110
10031457|NCT01910116|11155563|FG001|STARTED|Overall Study||110
10031458|NCT01910116|11155562|FG000|Week 4|Overall Study||106
10031459|NCT01910116|11155563|FG001|Week 4|Overall Study||102
10031460|NCT01910116|11155562|FG000|Week 8|Overall Study||98
10031461|NCT01910116|11155563|FG001|Week 8|Overall Study||99
10031462|NCT01910116|11155562|FG000|Week 12|Overall Study||97
10031463|NCT01910116|11155563|FG001|Week 12|Overall Study||96
10031464|NCT01910116|11155562|FG000|Week 16|Overall Study||96
10031465|NCT01910116|11155563|FG001|Week 16|Overall Study||94
10031466|NCT01910116|11155562|FG000|COMPLETED|Overall Study||96
10031467|NCT01910116|11155563|FG001|COMPLETED|Overall Study||94
10031468|NCT01910116|11155562|FG000|NOT COMPLETED|Overall Study||14
10031469|NCT01910116|11155563|FG001|NOT COMPLETED|Overall Study||16
10031470|NCT01910129|11155571|FG000|STARTED|Run-in Period Phase 1||0
10031471|NCT01910129|11155572|FG001|STARTED|Run-in Period Phase 1||0
10031472|NCT01910129|11155573|FG002|STARTED|Run-in Period Phase 1||13
10031473|NCT01910129|11155571|FG000|COMPLETED|Run-in Period Phase 1||0
10031474|NCT01910129|11155572|FG001|COMPLETED|Run-in Period Phase 1||0
10031475|NCT01910129|11155573|FG002|COMPLETED|Run-in Period Phase 1||13
10031476|NCT01910129|11155571|FG000|NOT COMPLETED|Run-in Period Phase 1||0
10031477|NCT01910129|11155572|FG001|NOT COMPLETED|Run-in Period Phase 1||0
10031478|NCT01910129|11155573|FG002|NOT COMPLETED|Run-in Period Phase 1||0
10031479|NCT01910129|11155571|FG000|STARTED|Randomized Phase 2||7
10031480|NCT01910129|11155572|FG001|STARTED|Randomized Phase 2||6
10031481|NCT01910129|11155573|FG002|STARTED|Randomized Phase 2||0
10031482|NCT01910129|11155571|FG000|COMPLETED|Randomized Phase 2||5
10031483|NCT01910129|11155572|FG001|COMPLETED|Randomized Phase 2||5
10031484|NCT01910129|11155573|FG002|COMPLETED|Randomized Phase 2||0
10031485|NCT01910129|11155571|FG000|NOT COMPLETED|Randomized Phase 2||2
10031486|NCT01910129|11155572|FG001|NOT COMPLETED|Randomized Phase 2||1
10031487|NCT01910129|11155573|FG002|NOT COMPLETED|Randomized Phase 2||0
10031488|NCT01910129|11155571|FG000|STARTED|Randomized Phase 3||5
10031489|NCT01910129|11155572|FG001|STARTED|Randomized Phase 3||5
10031490|NCT01910129|11155573|FG002|STARTED|Randomized Phase 3||0
10031491|NCT01910129|11155571|FG000|COMPLETED|Randomized Phase 3||5
10031492|NCT01910129|11155572|FG001|COMPLETED|Randomized Phase 3||4
10031493|NCT01910129|11155573|FG002|COMPLETED|Randomized Phase 3||0
10031494|NCT01910129|11155571|FG000|NOT COMPLETED|Randomized Phase 3||0
10031495|NCT01910129|11155572|FG001|NOT COMPLETED|Randomized Phase 3||1
10031496|NCT01910129|11155573|FG002|NOT COMPLETED|Randomized Phase 3||0
10115596|NCT02527343|11246454|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10115597|NCT02527343|11246455|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10115598|NCT02527343|11246456|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10115599|NCT02527343|11246451|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10115600|NCT02527343|11246452|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10115601|NCT02527343|11246453|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7
10115602|NCT02527343|11246454|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9
10031497|NCT01910181|11155591|FG000|STARTED|Overall Study||46
10031498|NCT01910181|11155591|FG000|PK Cohort|Overall Study||20
10031499|NCT01910181|11155591|FG000|Expansion Cohort|Overall Study||26
10031500|NCT01910181|11155591|FG000|COMPLETED|Overall Study||0
10031501|NCT01910181|11155591|FG000|NOT COMPLETED|Overall Study||46
10031502|NCT01910298|11155598|FG000|STARTED|Overall Study||76
10031503|NCT01910298|11155599|FG001|STARTED|Overall Study||55
10031504|NCT01910298|11155598|FG000|Safety Set|Overall Study||76
10031505|NCT01910298|11155599|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
10031506|NCT01910298|11155598|FG000|COMPLETED|Overall Study||71
10031507|NCT01910298|11155599|FG001|COMPLETED|Overall Study||23
10031508|NCT01910298|11155598|FG000|NOT COMPLETED|Overall Study||5
10031509|NCT01910298|11155599|FG001|NOT COMPLETED|Overall Study||32
10031510|NCT01910311|11155605|FG000|STARTED|Period 1 (Days 1-2)||18
10031511|NCT01910311|11155605|FG000|Received Baricitinib|Period 1 (Days 1-2)||18
10031512|NCT01910311|11155605|FG000|COMPLETED|Period 1 (Days 1-2)||18
10031513|NCT01910311|11155605|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
10031514|NCT01910311|11155605|FG000|STARTED|Period 2 (Days 3-32)||18
10031515|NCT01910311|11155605|FG000|Received Baricitinib|Period 2 (Days 3-32)||18
10031516|NCT01910311|11155605|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
10031517|NCT01910311|11155605|FG000|COMPLETED|Period 2 (Days 3-32)||18
10031518|NCT01910311|11155605|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0
10031519|NCT01910519|11155615|FG000|STARTED|Overall Study||35
10031520|NCT01910519|11155616|FG001|STARTED|Overall Study||15
10031521|NCT01910519|11155615|FG000|COMPLETED|Overall Study||31
10031522|NCT01910519|11155616|FG001|COMPLETED|Overall Study||15
10031523|NCT01910519|11155615|FG000|NOT COMPLETED|Overall Study||4
10031524|NCT01910519|11155616|FG001|NOT COMPLETED|Overall Study||0
10031525|NCT01910636|11155624|FG000|STARTED|Overall Study||90
10031526|NCT01910636|11155625|FG001|STARTED|Overall Study||63
10031527|NCT01910636|11155624|FG000|COMPLETED|Overall Study||90
10031528|NCT01910636|11155625|FG001|COMPLETED|Overall Study||63
10031529|NCT01910636|11155624|FG000|NOT COMPLETED|Overall Study||0
10031530|NCT01910636|11155625|FG001|NOT COMPLETED|Overall Study||0
10031531|NCT01910688|11155631|FG000|STARTED|Overall Study||25
10031532|NCT01910688|11155631|FG000|3.5month|Overall Study||25
10031533|NCT01910688|11155631|FG000|2nd RFA Treatment|Overall Study||22
10031534|NCT01910688|11155631|FG000|7.5months|Overall Study||24
10031535|NCT01910688|11155631|FG000|3rd RFA Treatment|Overall Study||18
10031536|NCT01910688|11155631|FG000|12months|Overall Study||22
10031537|NCT01910688|11155631|FG000|COMPLETED|Overall Study||20
10031538|NCT01910688|11155631|FG000|NOT COMPLETED|Overall Study||5
10031539|NCT01910792|11155637|FG000|STARTED|Overall Study||9
10031540|NCT01910792|11155638|FG001|STARTED|Overall Study||10
10031541|NCT01910792|11155637|FG000|COMPLETED|Overall Study||9
10031542|NCT01910792|11155638|FG001|COMPLETED|Overall Study||10
10031543|NCT01910792|11155637|FG000|NOT COMPLETED|Overall Study||0
10031544|NCT01910792|11155638|FG001|NOT COMPLETED|Overall Study||0
10031545|NCT01910831|11155644|FG000|STARTED|Overall Study||20
10031546|NCT01910831|11155644|FG000|COMPLETED|Overall Study||19
10031547|NCT01910831|11155644|FG000|NOT COMPLETED|Overall Study||1
10031548|NCT01911065|11155651|FG000|STARTED|Overall Study||45
10031549|NCT01911065|11155652|FG001|STARTED|Overall Study||9
10031550|NCT01911065|11155651|FG000|COMPLETED|Overall Study||45
10031551|NCT01911065|11155652|FG001|COMPLETED|Overall Study||9
10115603|NCT02527343|11246455|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10031552|NCT01911065|11155651|FG000|NOT COMPLETED|Overall Study||0
10031553|NCT01911065|11155652|FG001|NOT COMPLETED|Overall Study||0
10031554|NCT01911169|11155660|FG000|STARTED|Overall Study||6
10031555|NCT01911169|11155661|FG001|STARTED|Overall Study||3
10031556|NCT01911169|11155660|FG000|COMPLETED|Overall Study||6
10031557|NCT01911169|11155661|FG001|COMPLETED|Overall Study||3
10031558|NCT01911169|11155660|FG000|NOT COMPLETED|Overall Study||0
10031559|NCT01911169|11155661|FG001|NOT COMPLETED|Overall Study||0
10031560|NCT01911221|11155667|FG000|STARTED|Overall Study||13
10031561|NCT01911221|11155667|FG000|COMPLETED|Overall Study||13
10031562|NCT01911221|11155667|FG000|NOT COMPLETED|Overall Study||0
10031563|NCT01911260|11155675|FG000|STARTED|Supplementation Period||50
10031564|NCT01911260|11155676|FG001|STARTED|Supplementation Period||50
10031565|NCT01911260|11155677|FG002|STARTED|Supplementation Period||49
10031566|NCT01911260|11155678|FG003|STARTED|Supplementation Period||50
10031567|NCT01911260|11155675|FG000|COMPLETED|Supplementation Period||40
10031568|NCT01911260|11155676|FG001|COMPLETED|Supplementation Period||38
10031569|NCT01911260|11155677|FG002|COMPLETED|Supplementation Period||39
10031570|NCT01911260|11155678|FG003|COMPLETED|Supplementation Period||42
10031571|NCT01911260|11155675|FG000|NOT COMPLETED|Supplementation Period||10
10031572|NCT01911260|11155676|FG001|NOT COMPLETED|Supplementation Period||12
10031573|NCT01911260|11155677|FG002|NOT COMPLETED|Supplementation Period||10
10031574|NCT01911260|11155678|FG003|NOT COMPLETED|Supplementation Period||8
10031575|NCT01911260|11155675|FG000|STARTED|Follow-up Period||40
10031576|NCT01911260|11155676|FG001|STARTED|Follow-up Period||38
10031577|NCT01911260|11155677|FG002|STARTED|Follow-up Period||39
10031578|NCT01911260|11155678|FG003|STARTED|Follow-up Period||42
10031579|NCT01911260|11155675|FG000|COMPLETED|Follow-up Period||27
10031580|NCT01911260|11155676|FG001|COMPLETED|Follow-up Period||18
10031581|NCT01911260|11155677|FG002|COMPLETED|Follow-up Period||24
10031582|NCT01911260|11155678|FG003|COMPLETED|Follow-up Period||30
10031583|NCT01911260|11155675|FG000|NOT COMPLETED|Follow-up Period||13
10031584|NCT01911260|11155676|FG001|NOT COMPLETED|Follow-up Period||20
10031585|NCT01911260|11155677|FG002|NOT COMPLETED|Follow-up Period||15
10031586|NCT01911260|11155678|FG003|NOT COMPLETED|Follow-up Period||12
10031587|NCT01911273|11155690|FG000|STARTED|Overall Study||1
10031588|NCT01911273|11155691|FG001|STARTED|Overall Study||2
10031589|NCT01911273|11155690|FG000|COMPLETED|Overall Study||0
10031590|NCT01911273|11155691|FG001|COMPLETED|Overall Study||0
10031591|NCT01911273|11155690|FG000|NOT COMPLETED|Overall Study||1
10031592|NCT01911273|11155691|FG001|NOT COMPLETED|Overall Study||2
10031593|NCT01911351|11155699|FG000|STARTED|Overall Study||39
10031594|NCT01911351|11155700|FG001|STARTED|Overall Study||43
10031595|NCT01911351|11155699|FG000|COMPLETED|Overall Study||39
10031596|NCT01911351|11155700|FG001|COMPLETED|Overall Study||43
10031597|NCT01911351|11155699|FG000|NOT COMPLETED|Overall Study||0
10031598|NCT01911351|11155700|FG001|NOT COMPLETED|Overall Study||0
10031599|NCT01911390|11155710|FG000|STARTED|Overall Study||10
10031600|NCT01911390|11155711|FG001|STARTED|Overall Study||10
10031601|NCT01911390|11155712|FG002|STARTED|Overall Study||10
10031602|NCT01911390|11155713|FG003|STARTED|Overall Study||11
10031603|NCT01911390|11155710|FG000|COMPLETED|Overall Study||9
10031604|NCT01911390|11155711|FG001|COMPLETED|Overall Study||10
10031605|NCT01911390|11155712|FG002|COMPLETED|Overall Study||9
10031606|NCT01911390|11155713|FG003|COMPLETED|Overall Study||10
10031607|NCT01911390|11155710|FG000|NOT COMPLETED|Overall Study||1
10031608|NCT01911390|11155711|FG001|NOT COMPLETED|Overall Study||0
10031609|NCT01911390|11155712|FG002|NOT COMPLETED|Overall Study||1
10031610|NCT01911390|11155713|FG003|NOT COMPLETED|Overall Study||1
10031611|NCT01911403|11155725|FG000|STARTED|Overall Study||61
10031612|NCT01911403|11155726|FG001|STARTED|Overall Study||62
10031613|NCT01911403|11155725|FG000|COMPLETED|Overall Study||52
10031614|NCT01911403|11155726|FG001|COMPLETED|Overall Study||59
10031615|NCT01911403|11155725|FG000|NOT COMPLETED|Overall Study||9
10031616|NCT01911403|11155726|FG001|NOT COMPLETED|Overall Study||3
10031617|NCT01911429|11155735|FG000|STARTED|Overall Study||108
10031618|NCT01911429|11155736|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
10031619|NCT01911429|11155737|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
10031620|NCT01911429|11155735|FG000|COMPLETED|Overall Study||96
10031621|NCT01911429|11155736|FG001|COMPLETED|Overall Study||96
10031622|NCT01911429|11155737|FG002|COMPLETED|Overall Study||93
10031623|NCT01911429|11155735|FG000|NOT COMPLETED|Overall Study||12
10031624|NCT01911429|11155736|FG001|NOT COMPLETED|Overall Study||10
10031625|NCT01911429|11155737|FG002|NOT COMPLETED|Overall Study||20
10031626|NCT01911442|11155748|FG000|STARTED|Overall Study||49
10031627|NCT01911442|11155749|FG001|STARTED|Overall Study||51
10031628|NCT01911442|11155750|FG002|STARTED|Overall Study||50
10031629|NCT01911442|11155748|FG000|COMPLETED|Overall Study||43
10031630|NCT01911442|11155749|FG001|COMPLETED|Overall Study||47
10031631|NCT01911442|11155750|FG002|COMPLETED|Overall Study||38
10031632|NCT01911442|11155748|FG000|NOT COMPLETED|Overall Study||6
10031633|NCT01911442|11155749|FG001|NOT COMPLETED|Overall Study||4
10031634|NCT01911442|11155750|FG002|NOT COMPLETED|Overall Study||12
10031635|NCT01911546|11155762|FG000|STARTED|Overall Study||20
10031636|NCT01911546|11155762|FG000|COMPLETED|Overall Study||14
10031637|NCT01911546|11155762|FG000|NOT COMPLETED|Overall Study||6
10031638|NCT01911689|11155768|FG000|STARTED|Overall Study||117
10031639|NCT01911689|11155769|FG001|STARTED|Overall Study||51
10031640|NCT01911689|11155768|FG000|COMPLETED|Overall Study||117
10031641|NCT01911689|11155769|FG001|COMPLETED|Overall Study||51
10031642|NCT01911689|11155768|FG000|NOT COMPLETED|Overall Study||0
10031643|NCT01911689|11155769|FG001|NOT COMPLETED|Overall Study||0
10031644|NCT01911780|11155784|FG000|STARTED|Double-blind Period (8 Weeks)||68
10031645|NCT01911780|11155785|FG001|STARTED|Double-blind Period (8 Weeks)||64
10031646|NCT01911780|11155784|FG000|COMPLETED|Double-blind Period (8 Weeks)||65
10031647|NCT01911780|11155785|FG001|COMPLETED|Double-blind Period (8 Weeks)||61
10031648|NCT01911780|11155784|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3
10031649|NCT01911780|11155785|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3
10031650|NCT01911780|11155784|FG000|STARTED|Extension Period (52 Weeks)||65
10031651|NCT01911780|11155785|FG001|STARTED|Extension Period (52 Weeks)||61
10031652|NCT01911780|11155784|FG000|COMPLETED|Extension Period (52 Weeks)||61
10031653|NCT01911780|11155785|FG001|COMPLETED|Extension Period (52 Weeks)||58
10031654|NCT01911780|11155784|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
10031655|NCT01911780|11155785|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3
10031656|NCT01911819|11155798|FG000|STARTED|Overall Study||10
10031657|NCT01911819|11155799|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
10031658|NCT01911819|11155800|FG002|STARTED|Overall Study||10
10031659|NCT01911819|11155798|FG000|COMPLETED|Overall Study||9
10031660|NCT01911819|11155799|FG001|COMPLETED|Overall Study||9
10031661|NCT01911819|11155800|FG002|COMPLETED|Overall Study||10
10031662|NCT01911819|11155798|FG000|NOT COMPLETED|Overall Study||1
10031663|NCT01911819|11155799|FG001|NOT COMPLETED|Overall Study||2
10031664|NCT01911819|11155800|FG002|NOT COMPLETED|Overall Study||0
10031665|NCT01911845|11155808|FG000|STARTED|Overall Study||38
10031666|NCT01911845|11155808|FG000|Completed Study Drug|Overall Study||37
10031667|NCT01911845|11155808|FG000|COMPLETED|Overall Study||32
10031668|NCT01911845|11155808|FG000|NOT COMPLETED|Overall Study||6
10031669|NCT01911910|11155816|FG000|STARTED|Overall Study||197
10031670|NCT01911910|11155817|FG001|STARTED|Overall Study||205
10031671|NCT01911910|11155816|FG000|COMPLETED|Overall Study||184
10031672|NCT01911910|11155817|FG001|COMPLETED|Overall Study||194
10031673|NCT01911910|11155816|FG000|NOT COMPLETED|Overall Study||13
10031674|NCT01911910|11155817|FG001|NOT COMPLETED|Overall Study||11
10031675|NCT01912222|11155826|FG000|STARTED|Part A: Pharmacokinetic Period||13
10031676|NCT01912222|11155827|FG001|STARTED|Part A: Pharmacokinetic Period||15
10031677|NCT01912222|11155828|FG002|STARTED|Part A: Pharmacokinetic Period||20
10031678|NCT01912222|11155826|FG000|COMPLETED|Part A: Pharmacokinetic Period||12
10031679|NCT01912222|11155827|FG001|COMPLETED|Part A: Pharmacokinetic Period||13
10031680|NCT01912222|11155828|FG002|COMPLETED|Part A: Pharmacokinetic Period||18
10031681|NCT01912222|11155826|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1
10031682|NCT01912222|11155827|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2
10031683|NCT01912222|11155828|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2
10031684|NCT01912222|11155826|FG000|STARTED|Part B: Treatment Period||13
10031685|NCT01912222|11155827|FG001|STARTED|Part B: Treatment Period||15
10031686|NCT01912222|11155828|FG002|STARTED|Part B: Treatment Period||20
10031687|NCT01912222|11155826|FG000|COMPLETED|Part B: Treatment Period||0
10031688|NCT01912222|11155827|FG001|COMPLETED|Part B: Treatment Period||0
10031689|NCT01912222|11155828|FG002|COMPLETED|Part B: Treatment Period||0
10031690|NCT01912222|11155826|FG000|NOT COMPLETED|Part B: Treatment Period||13
10031691|NCT01912222|11155827|FG001|NOT COMPLETED|Part B: Treatment Period||15
10031692|NCT01912222|11155828|FG002|NOT COMPLETED|Part B: Treatment Period||20
10031693|NCT01912274|11155837|FG000|STARTED|Overall Study||50
10031694|NCT01912274|11155837|FG000|COMPLETED|Overall Study||50
10031695|NCT01912274|11155837|FG000|NOT COMPLETED|Overall Study||0
10031696|NCT01912287|11155844|FG000|STARTED|Overall Study||93
10031697|NCT01912287|11155845|FG001|STARTED|Overall Study||90
10031698|NCT01912287|11155846|FG002|STARTED|Overall Study||43
10031699|NCT01912287|11155844|FG000|COMPLETED|Overall Study||60
10031700|NCT01912287|11155845|FG001|COMPLETED|Overall Study||67
10031701|NCT01912287|11155846|FG002|COMPLETED|Overall Study||28
10031702|NCT01912287|11155844|FG000|NOT COMPLETED|Overall Study||33
10031703|NCT01912287|11155845|FG001|NOT COMPLETED|Overall Study||23
10031704|NCT01912287|11155846|FG002|NOT COMPLETED|Overall Study||15
10031705|NCT01912339|11155856|FG000|STARTED|Blinded (0 to 3 Months)||136
10031706|NCT01912339|11155857|FG001|STARTED|Blinded (0 to 3 Months)||61
10031707|NCT01912339|11155858|FG002|STARTED|Blinded (0 to 3 Months)||0
10031708|NCT01912339|11155856|FG000|COMPLETED|Blinded (0 to 3 Months)||134
10031709|NCT01912339|11155857|FG001|COMPLETED|Blinded (0 to 3 Months)||61
10031710|NCT01912339|11155858|FG002|COMPLETED|Blinded (0 to 3 Months)||0
10031711|NCT01912339|11155856|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2
10031712|NCT01912339|11155857|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0
10031713|NCT01912339|11155858|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0
10031714|NCT01912339|11155856|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134
10031715|NCT01912339|11155857|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61
10031716|NCT01912339|11155858|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0
10031717|NCT01912339|11155856|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
10031718|NCT01912339|11155857|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
10031719|NCT01912339|11155858|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
10031720|NCT01912339|11155856|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
10031721|NCT01912339|11155857|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
10031722|NCT01912339|11155858|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
10031723|NCT01912339|11155856|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
10031724|NCT01912339|11155857|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
10031725|NCT01912339|11155858|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
10031726|NCT01912339|11155856|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10031727|NCT01912339|11155857|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10031728|NCT01912339|11155858|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10031729|NCT01912339|11155856|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
10031730|NCT01912339|11155857|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10031731|NCT01912339|11155858|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
10031732|NCT01912352|11155864|FG000|STARTED|Overall Study||83
10031733|NCT01912352|11155864|FG000|COMPLETED|Overall Study||78
10031734|NCT01912352|11155864|FG000|NOT COMPLETED|Overall Study||5
10031735|NCT01912456|11155870|FG000|STARTED|Period 1||22
10031736|NCT01912456|11155871|FG001|STARTED|Period 1||23
10031737|NCT01912456|11155872|FG002|STARTED|Period 1||23
10031738|NCT01912456|11155873|FG003|STARTED|Period 1||22
10031739|NCT01912456|11155870|FG000|COMPLETED|Period 1||20
10031740|NCT01912456|11155871|FG001|COMPLETED|Period 1||22
10031741|NCT01912456|11155872|FG002|COMPLETED|Period 1||21
10031742|NCT01912456|11155873|FG003|COMPLETED|Period 1||19
10031743|NCT01912456|11155870|FG000|NOT COMPLETED|Period 1||2
10031744|NCT01912456|11155871|FG001|NOT COMPLETED|Period 1||1
10031745|NCT01912456|11155872|FG002|NOT COMPLETED|Period 1||2
10031746|NCT01912456|11155873|FG003|NOT COMPLETED|Period 1||3
10031747|NCT01912456|11155870|FG000|STARTED|Period 2||20
10031748|NCT01912456|11155871|FG001|STARTED|Period 2||22
10031749|NCT01912456|11155872|FG002|STARTED|Period 2||21
10031750|NCT01912456|11155873|FG003|STARTED|Period 2||19
10031751|NCT01912456|11155870|FG000|COMPLETED|Period 2||20
10031752|NCT01912456|11155871|FG001|COMPLETED|Period 2||20
10031753|NCT01912456|11155872|FG002|COMPLETED|Period 2||21
10031754|NCT01912456|11155873|FG003|COMPLETED|Period 2||18
10031755|NCT01912456|11155870|FG000|NOT COMPLETED|Period 2||0
10031756|NCT01912456|11155871|FG001|NOT COMPLETED|Period 2||2
10031757|NCT01912456|11155872|FG002|NOT COMPLETED|Period 2||0
10031758|NCT01912456|11155873|FG003|NOT COMPLETED|Period 2||1
10031759|NCT01912495|11155883|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
10031760|NCT01912495|11155883|FG000|COMPLETED|Overall Study||57
10031761|NCT01912495|11155883|FG000|NOT COMPLETED|Overall Study||0
10031762|NCT01912599|11155892|FG000|STARTED|Overall Study||20
10031763|NCT01912599|11155893|FG001|STARTED|Overall Study||16
10031764|NCT01912599|11155892|FG000|COMPLETED|Overall Study||20
10031765|NCT01912599|11155893|FG001|COMPLETED|Overall Study||15
10031766|NCT01912599|11155892|FG000|NOT COMPLETED|Overall Study||0
10031767|NCT01912599|11155893|FG001|NOT COMPLETED|Overall Study||1
10031768|NCT01912612|11155901|FG000|STARTED|Overall Study||36
10031769|NCT01912612|11155902|FG001|STARTED|Overall Study||40
10031770|NCT01912612|11155903|FG002|STARTED|Overall Study||3
10031771|NCT01912612|11155901|FG000|COMPLETED|Overall Study||31
10031772|NCT01912612|11155902|FG001|COMPLETED|Overall Study||40
10031773|NCT01912612|11155903|FG002|COMPLETED|Overall Study||0
10031774|NCT01912612|11155901|FG000|NOT COMPLETED|Overall Study||5
10031775|NCT01912612|11155902|FG001|NOT COMPLETED|Overall Study||0
10031776|NCT01912612|11155903|FG002|NOT COMPLETED|Overall Study||3
10031777|NCT01912716|11155911|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
10031778|NCT01912716|11155912|FG001|STARTED|Overall Study||515
10031779|NCT01912716|11155911|FG000|Receipt of 2nd Dose|Overall Study||511
10031780|NCT01912716|11155912|FG001|Receipt of 2nd Dose|Overall Study||503
10031781|NCT01912716|11155911|FG000|5-day Follow-up|Overall Study||522
10031782|NCT01912716|11155912|FG001|5-day Follow-up|Overall Study||515
10031783|NCT01912716|11155911|FG000|3-day Follow-up|Overall Study||521
10031784|NCT01912716|11155912|FG001|3-day Follow-up|Overall Study||513
10031785|NCT01912716|11155911|FG000|COMPLETED|Overall Study||522
10031786|NCT01912716|11155912|FG001|COMPLETED|Overall Study||515
10031787|NCT01912716|11155911|FG000|NOT COMPLETED|Overall Study||0
10031788|NCT01912716|11155912|FG001|NOT COMPLETED|Overall Study||0
10031789|NCT01912729|11155922|FG000|STARTED|Overall Study||20
10031790|NCT01912729|11155923|FG001|STARTED|Overall Study||20
10031791|NCT01912729|11155922|FG000|COMPLETED|Overall Study||20
10031792|NCT01912729|11155923|FG001|COMPLETED|Overall Study||19
10031793|NCT01912729|11155922|FG000|NOT COMPLETED|Overall Study||0
10031794|NCT01912729|11155923|FG001|NOT COMPLETED|Overall Study||1
10031795|NCT01912768|11155931|FG000|STARTED|Overall Study||239
10031796|NCT01912768|11155932|FG001|STARTED|Overall Study||113
10031797|NCT01912768|11155931|FG000|COMPLETED|Overall Study||229
10031798|NCT01912768|11155932|FG001|COMPLETED|Overall Study||109
10031799|NCT01912768|11155931|FG000|NOT COMPLETED|Overall Study||10
10031800|NCT01912768|11155932|FG001|NOT COMPLETED|Overall Study||4
10031801|NCT01912781|11155941|FG000|STARTED|Overall Study||71
10031802|NCT01912781|11155942|FG001|STARTED|Overall Study||35
10031803|NCT01912781|11155941|FG000|COMPLETED|Overall Study||69
10031804|NCT01912781|11155942|FG001|COMPLETED|Overall Study||35
10031805|NCT01912781|11155941|FG000|NOT COMPLETED|Overall Study||2
10031806|NCT01912781|11155942|FG001|NOT COMPLETED|Overall Study||0
10031807|NCT01912807|11155951|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150
10031808|NCT01912807|11155952|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150
10031809|NCT01912807|11155951|FG000|Randomized|Overall Study||144
10031810|NCT01912807|11155952|FG001|Randomized|Overall Study||146
10031811|NCT01912807|11155951|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108
10031812|NCT01912807|11155952|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109
10031813|NCT01912807|11155951|FG000|NOT COMPLETED|Overall Study||42
10031814|NCT01912807|11155952|FG001|NOT COMPLETED|Overall Study||41
10031815|NCT01912872|11155962|FG000|STARTED|Overall Study||16
10031816|NCT01912872|11155963|FG001|STARTED|Overall Study||17
10031817|NCT01912872|11155964|FG002|STARTED|Overall Study||40
10031818|NCT01912872|11155965|FG003|STARTED|Overall Study||39
10031819|NCT01912872|11155962|FG000|Completed Study Treatment at Month 12|Overall Study||11
10031820|NCT01912872|11155963|FG001|Completed Study Treatment at Month 12|Overall Study||13
10031821|NCT01912872|11155964|FG002|Completed Study Treatment at Month 12|Overall Study||30
10031822|NCT01912872|11155965|FG003|Completed Study Treatment at Month 12|Overall Study||27
10031823|NCT01912872|11155962|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5
10031824|NCT01912872|11155963|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4
10031825|NCT01912872|11155964|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10
10031826|NCT01912872|11155965|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11
10031827|NCT01912872|11155962|FG000|COMPLETED|Overall Study||11
10031828|NCT01912872|11155963|FG001|COMPLETED|Overall Study||13
10031829|NCT01912872|11155964|FG002|COMPLETED|Overall Study||30
10031830|NCT01912872|11155965|FG003|COMPLETED|Overall Study||27
10031831|NCT01912872|11155962|FG000|NOT COMPLETED|Overall Study||5
10031832|NCT01912872|11155963|FG001|NOT COMPLETED|Overall Study||4
10031833|NCT01912872|11155964|FG002|NOT COMPLETED|Overall Study||10
10031834|NCT01912872|11155965|FG003|NOT COMPLETED|Overall Study||12
10031835|NCT01912963|11155979|FG000|STARTED|Overall Study||6
10031836|NCT01912963|11155980|FG001|STARTED|Overall Study||19
10031837|NCT01912963|11155981|FG002|STARTED|Overall Study||7
10031838|NCT01912963|11155979|FG000|COMPLETED|Overall Study||0
10031839|NCT01912963|11155980|FG001|COMPLETED|Overall Study||0
10031840|NCT01912963|11155981|FG002|COMPLETED|Overall Study||0
10031841|NCT01912963|11155979|FG000|NOT COMPLETED|Overall Study||6
10031842|NCT01912963|11155980|FG001|NOT COMPLETED|Overall Study||19
10031843|NCT01912963|11155981|FG002|NOT COMPLETED|Overall Study||7
10031844|NCT01913041|11155989|FG000|STARTED|Overall Study||869
10031845|NCT01913041|11155989|FG000|COMPLETED|Overall Study||830
10031846|NCT01913041|11155989|FG000|NOT COMPLETED|Overall Study||39
10031847|NCT01913314|11155993|FG000|STARTED|Overall Study||6
10031848|NCT01913314|11155993|FG000|Received Study Drug|Overall Study||6
10031849|NCT01913314|11155993|FG000|COMPLETED|Overall Study||6
10031850|NCT01913314|11155993|FG000|NOT COMPLETED|Overall Study||0
10031851|NCT01913340|11155999|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
10031852|NCT01913340|11156000|FG001|STARTED|Overall Study||26
10031853|NCT01913340|11155999|FG000|COMPLETED|Overall Study||21
10031854|NCT01913340|11156000|FG001|COMPLETED|Overall Study||20
10031855|NCT01913340|11155999|FG000|NOT COMPLETED|Overall Study||3
10031856|NCT01913340|11156000|FG001|NOT COMPLETED|Overall Study||6
10031857|NCT01913353|11156008|FG000|STARTED|Overall Study||221
10031858|NCT01913353|11156009|FG001|STARTED|Overall Study||219
10031859|NCT01913353|11156008|FG000|COMPLETED|Overall Study||189
10031860|NCT01913353|11156009|FG001|COMPLETED|Overall Study||204
10031861|NCT01913353|11156008|FG000|NOT COMPLETED|Overall Study||32
10031862|NCT01913353|11156009|FG001|NOT COMPLETED|Overall Study||15
10031863|NCT01913405|11156022|FG000|STARTED|Overall Study||22
10031864|NCT01913405|11156022|FG000|COMPLETED|Overall Study||20
10031865|NCT01913405|11156022|FG000|NOT COMPLETED|Overall Study||2
10031866|NCT01913470|11156041|FG000|STARTED|Overall Study||5
10031867|NCT01913470|11156042|FG001|STARTED|Overall Study||7
10031868|NCT01913470|11156041|FG000|COMPLETED|Overall Study||5
10031869|NCT01913470|11156042|FG001|COMPLETED|Overall Study||4
10031870|NCT01913470|11156041|FG000|NOT COMPLETED|Overall Study||0
10031871|NCT01913470|11156042|FG001|NOT COMPLETED|Overall Study||3
10031872|NCT01913483|11156051|FG000|STARTED|Overall Study||367
10031873|NCT01913483|11156052|FG001|STARTED|Overall Study||365
10031874|NCT01913483|11156051|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335
10031875|NCT01913483|11156052|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321
10031876|NCT01913483|11156051|FG000|COMPLETED|Overall Study||346
10031877|NCT01913483|11156052|FG001|COMPLETED|Overall Study||343
10031878|NCT01913483|11156051|FG000|NOT COMPLETED|Overall Study||21
10031879|NCT01913483|11156052|FG001|NOT COMPLETED|Overall Study||22
10031880|NCT01913535|11156063|FG000|STARTED|Phase 1 (Days 0-2)||2
10031881|NCT01913535|11156064|FG001|STARTED|Phase 1 (Days 0-2)||2
10031882|NCT01913535|11156065|FG002|STARTED|Phase 1 (Days 0-2)||1
10031883|NCT01913535|11156066|FG003|STARTED|Phase 1 (Days 0-2)||2
10031884|NCT01913535|11156067|FG004|STARTED|Phase 1 (Days 0-2)||1
10031885|NCT01913535|11156063|FG000|COMPLETED|Phase 1 (Days 0-2)||2
10031886|NCT01913535|11156064|FG001|COMPLETED|Phase 1 (Days 0-2)||2
10031887|NCT01913535|11156065|FG002|COMPLETED|Phase 1 (Days 0-2)||1
10031888|NCT01913535|11156066|FG003|COMPLETED|Phase 1 (Days 0-2)||2
10031889|NCT01913535|11156067|FG004|COMPLETED|Phase 1 (Days 0-2)||1
10031890|NCT01913535|11156063|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0
10031891|NCT01913535|11156064|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0
10031892|NCT01913535|11156065|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0
10031893|NCT01913535|11156066|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0
10031894|NCT01913535|11156067|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0
10031895|NCT01913535|11156063|FG000|STARTED|Phase 2 (Days 3-5)||2
10031896|NCT01913535|11156064|FG001|STARTED|Phase 2 (Days 3-5)||2
10031897|NCT01913535|11156065|FG002|STARTED|Phase 2 (Days 3-5)||1
10031898|NCT01913535|11156066|FG003|STARTED|Phase 2 (Days 3-5)||2
10031899|NCT01913535|11156067|FG004|STARTED|Phase 2 (Days 3-5)||1
10031900|NCT01913535|11156063|FG000|COMPLETED|Phase 2 (Days 3-5)||2
10031901|NCT01913535|11156064|FG001|COMPLETED|Phase 2 (Days 3-5)||2
10031902|NCT01913535|11156065|FG002|COMPLETED|Phase 2 (Days 3-5)||1
10031903|NCT01913535|11156066|FG003|COMPLETED|Phase 2 (Days 3-5)||2
10031904|NCT01913535|11156067|FG004|COMPLETED|Phase 2 (Days 3-5)||1
10031905|NCT01913535|11156063|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0
10031906|NCT01913535|11156064|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0
10031907|NCT01913535|11156065|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0
10031908|NCT01913535|11156066|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0
10031909|NCT01913535|11156067|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0
10031910|NCT01913600|11156080|FG000|STARTED|Overall Study||56
10031911|NCT01913600|11156080|FG000|COMPLETED|Overall Study||55
10031912|NCT01913600|11156080|FG000|NOT COMPLETED|Overall Study||1
10031913|NCT01913639|11156084|FG000|STARTED|Overall Study||39
10031914|NCT01913639|11156084|FG000|COMPLETED|Overall Study||36
10031915|NCT01913639|11156084|FG000|NOT COMPLETED|Overall Study||3
10031916|NCT01914003|11156090|FG000|STARTED|Overall Study||27
10031917|NCT01914003|11156091|FG001|STARTED|Overall Study||26
10031918|NCT01914003|11156090|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
10031919|NCT01914003|11156091|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
10031920|NCT01914003|11156090|FG000|NOT COMPLETED|Overall Study||8
10031921|NCT01914003|11156091|FG001|NOT COMPLETED|Overall Study||12
10031922|NCT01914159|11156097|FG000|STARTED|Overall Study||24
10031923|NCT01914159|11156097|FG000|COMPLETED|Overall Study||21
10031924|NCT01914159|11156097|FG000|NOT COMPLETED|Overall Study||3
10031925|NCT01914393|11156104|FG000|STARTED|Overall Study||271
10031926|NCT01914393|11156105|FG001|STARTED|Overall Study||125
10031927|NCT01914393|11156106|FG002|STARTED|Overall Study||306
10031928|NCT01914393|11156104|FG000|COMPLETED|Overall Study||156
10031929|NCT01914393|11156105|FG001|COMPLETED|Overall Study||54
10031930|NCT01914393|11156106|FG002|COMPLETED|Overall Study||168
10031931|NCT01914393|11156104|FG000|NOT COMPLETED|Overall Study||115
10031932|NCT01914393|11156105|FG001|NOT COMPLETED|Overall Study||71
10031933|NCT01914393|11156106|FG002|NOT COMPLETED|Overall Study||138
10031934|NCT01914510|11156118|FG000|STARTED|Overall Study||40
10031935|NCT01914510|11156118|FG000|COMPLETED|Overall Study||38
10031936|NCT01914510|11156118|FG000|NOT COMPLETED|Overall Study||2
10031937|NCT01914666|11156126|FG000|STARTED|Treatment Period||68
10031938|NCT01914666|11156127|FG001|STARTED|Treatment Period||42
10031939|NCT01914666|11156128|FG002|STARTED|Treatment Period||41
10031940|NCT01914666|11156126|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68
10031941|NCT01914666|11156127|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42
10031942|NCT01914666|11156128|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41
10031943|NCT01914666|11156126|FG000|COMPLETED|Treatment Period||55
10031944|NCT01914666|11156127|FG001|COMPLETED|Treatment Period||36
10031945|NCT01914666|11156128|FG002|COMPLETED|Treatment Period||33
10031946|NCT01914666|11156126|FG000|NOT COMPLETED|Treatment Period||13
10031947|NCT01914666|11156127|FG001|NOT COMPLETED|Treatment Period||6
10031948|NCT01914666|11156128|FG002|NOT COMPLETED|Treatment Period||8
10031949|NCT01914666|11156126|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
10031950|NCT01914666|11156127|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
10031951|NCT01914666|11156128|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
10031952|NCT01914666|11156126|FG000|COMPLETED|Tapering Period||59
10031953|NCT01914666|11156127|FG001|COMPLETED|Tapering Period||39
10031954|NCT01914666|11156128|FG002|COMPLETED|Tapering Period||40
10031955|NCT01914666|11156126|FG000|NOT COMPLETED|Tapering Period||0
10031956|NCT01914666|11156127|FG001|NOT COMPLETED|Tapering Period||0
10031957|NCT01914666|11156128|FG002|NOT COMPLETED|Tapering Period||0
10031958|NCT01914679|11156134|FG000|STARTED|Overall Study||17
10031959|NCT01914679|11156134|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17
10031960|NCT01914679|11156134|FG000|COMPLETED|Overall Study||12
10031961|NCT01914679|11156134|FG000|NOT COMPLETED|Overall Study||5
10031962|NCT01914757|11156141|FG000|STARTED|Overall Study||425
10031963|NCT01914757|11156142|FG001|STARTED|Overall Study||441
10031964|NCT01914757|11156143|FG002|STARTED|Overall Study||440
10031965|NCT01914757|11156141|FG000|COMPLETED|Overall Study||389
10031966|NCT01914757|11156142|FG001|COMPLETED|Overall Study||390
10031967|NCT01914757|11156143|FG002|COMPLETED|Overall Study||402
10031968|NCT01914757|11156141|FG000|NOT COMPLETED|Overall Study||36
10031969|NCT01914757|11156142|FG001|NOT COMPLETED|Overall Study||51
10031970|NCT01914757|11156143|FG002|NOT COMPLETED|Overall Study||38
10081546|NCT02261948|11210094|FG001|NOT COMPLETED|Overall Study||0
10081547|NCT02261961|11210102|FG000|STARTED|Overall Study||22
10081548|NCT02261961|11210103|FG001|STARTED|Overall Study||22
10081549|NCT02261961|11210102|FG000|COMPLETED|Overall Study||13
10081550|NCT02261961|11210103|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20
10081551|NCT02261961|11210102|FG000|NOT COMPLETED|Overall Study||9
10081552|NCT02261961|11210103|FG001|NOT COMPLETED|Overall Study||2
10081553|NCT02261974|11210122|FG000|STARTED|Overall Study||123
10081554|NCT02261974|11210123|FG001|STARTED|Overall Study||63
10081555|NCT02261974|11210122|FG000|Treated|Overall Study||117
10081556|NCT02261974|11210123|FG001|Treated|Overall Study||57
10081557|NCT02261974|11210122|FG000|COMPLETED|Overall Study||108
10081558|NCT02261974|11210123|FG001|COMPLETED|Overall Study||56
10081559|NCT02261974|11210122|FG000|NOT COMPLETED|Overall Study||15
10081560|NCT02261974|11210123|FG001|NOT COMPLETED|Overall Study||7
10081561|NCT02262039|11210131|FG000|STARTED|Overall Study||14
10081562|NCT02262039|11210132|FG001|STARTED|Overall Study||27
10081563|NCT02262039|11210131|FG000|COMPLETED|Overall Study||14
10081564|NCT02262039|11210132|FG001|COMPLETED|Overall Study||27
10081565|NCT02262039|11210131|FG000|NOT COMPLETED|Overall Study||0
10081566|NCT02262039|11210132|FG001|NOT COMPLETED|Overall Study||0
10081567|NCT02262078|11210140|FG000|STARTED|Overall Study||13
10081568|NCT02262078|11210141|FG001|STARTED|Overall Study||13
10081569|NCT02262078|11210140|FG000|COMPLETED|Overall Study||13
10031971|NCT01914926|11156153|FG000|STARTED|Overall Study||29
10031972|NCT01914926|11156154|FG001|STARTED|Overall Study||25
10031973|NCT01914926|11156153|FG000|COMPLETED|Overall Study||28
10031974|NCT01914926|11156154|FG001|COMPLETED|Overall Study||24
10031975|NCT01914926|11156153|FG000|NOT COMPLETED|Overall Study||1
10031976|NCT01914926|11156154|FG001|NOT COMPLETED|Overall Study||1
10031977|NCT01915095|11156167|FG000|STARTED|Overall Study||10
10031978|NCT01915095|11156168|FG001|STARTED|Overall Study||10
10031979|NCT01915095|11156169|FG002|STARTED|Overall Study||5
10031980|NCT01915095|11156170|FG003|STARTED|Overall Study||8
10031981|NCT01915095|11156171|FG004|STARTED|Overall Study||9
10031982|NCT01915095|11156167|FG000|SCI|Overall Study||5
10031983|NCT01915095|11156168|FG001|SCI|Overall Study||5
10031984|NCT01915095|11156169|FG002|SCI|Overall Study||5
10031985|NCT01915095|11156170|FG003|SCI|Overall Study||8
10031986|NCT01915095|11156171|FG004|SCI|Overall Study||9
10031987|NCT01915095|11156167|FG000|Control|Overall Study||5
10031988|NCT01915095|11156168|FG001|Control|Overall Study||5
10031989|NCT01915095|11156169|FG002|Control|Overall Study||0
10031990|NCT01915095|11156170|FG003|Control|Overall Study||0
10031991|NCT01915095|11156171|FG004|Control|Overall Study||0
9848336|NCT00858637|10961032|FG001|NOT COMPLETED|Active Comparison Phase||0
9848337|NCT00858637|10961033|FG002|NOT COMPLETED|Active Comparison Phase||0
9848338|NCT00858637|10961034|FG003|NOT COMPLETED|Active Comparison Phase||18
9848339|NCT00858637|10961035|FG004|NOT COMPLETED|Active Comparison Phase||0
9848340|NCT00858637|10961036|FG005|NOT COMPLETED|Active Comparison Phase||0
9848341|NCT00858637|10961031|FG000|STARTED|Placebo-controlled Withdrawal Phase||0
9848342|NCT00858637|10961032|FG001|STARTED|Placebo-controlled Withdrawal Phase||49
9848343|NCT00858637|10961033|FG002|STARTED|Placebo-controlled Withdrawal Phase||54
9848344|NCT00858637|10961034|FG003|STARTED|Placebo-controlled Withdrawal Phase||0
9848345|NCT00858637|10961035|FG004|STARTED|Placebo-controlled Withdrawal Phase||56
9848346|NCT00858637|10961036|FG005|STARTED|Placebo-controlled Withdrawal Phase||59
9848347|NCT00858637|10961031|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0
9848348|NCT00858637|10961032|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49
9848349|NCT00858637|10961033|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53
9848350|NCT00858637|10961034|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0
9848351|NCT00858637|10961035|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55
9848352|NCT00858637|10961036|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58
10031992|NCT01915095|11156167|FG000|COMPLETED|Overall Study||10
10031993|NCT01915095|11156168|FG001|COMPLETED|Overall Study||10
10031994|NCT01915095|11156169|FG002|COMPLETED|Overall Study||5
10031995|NCT01915095|11156170|FG003|COMPLETED|Overall Study||4
10031996|NCT01915095|11156171|FG004|COMPLETED|Overall Study||3
10031997|NCT01915095|11156167|FG000|NOT COMPLETED|Overall Study||0
10031998|NCT01915095|11156168|FG001|NOT COMPLETED|Overall Study||0
10031999|NCT01915095|11156169|FG002|NOT COMPLETED|Overall Study||0
10032000|NCT01915095|11156170|FG003|NOT COMPLETED|Overall Study||4
10032001|NCT01915095|11156171|FG004|NOT COMPLETED|Overall Study||6
10032002|NCT01915108|11156196|FG000|STARTED|Overall Study||32
10032003|NCT01915108|11156197|FG001|STARTED|Overall Study||32
10032004|NCT01915108|11156198|FG002|STARTED|Overall Study||32
10032005|NCT01915108|11156199|FG003|STARTED|Overall Study||32
10032006|NCT01915108|11156196|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30
10032007|NCT01915108|11156197|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29
10032008|NCT01915108|11156198|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31
10032009|NCT01915108|11156199|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30
10032010|NCT01915108|11156196|FG000|NOT COMPLETED|Overall Study||2
10032011|NCT01915108|11156197|FG001|NOT COMPLETED|Overall Study||3
10032012|NCT01915108|11156198|FG002|NOT COMPLETED|Overall Study||1
10032013|NCT01915108|11156199|FG003|NOT COMPLETED|Overall Study||2
10032014|NCT01915173|11156213|FG000|STARTED|Overall Study||6
10032015|NCT01915173|11156214|FG001|STARTED|Overall Study||6
10032016|NCT01915173|11156215|FG002|STARTED|Overall Study||6
10032017|NCT01915173|11156216|FG003|STARTED|Overall Study||6
10032018|NCT01915173|11156213|FG000|COMPLETED|Overall Study||6
10032019|NCT01915173|11156214|FG001|COMPLETED|Overall Study||6
10032020|NCT01915173|11156215|FG002|COMPLETED|Overall Study||6
10032021|NCT01915173|11156216|FG003|COMPLETED|Overall Study||6
10032022|NCT01915173|11156213|FG000|NOT COMPLETED|Overall Study||0
10032023|NCT01915173|11156214|FG001|NOT COMPLETED|Overall Study||0
10032024|NCT01915173|11156215|FG002|NOT COMPLETED|Overall Study||0
10032025|NCT01915173|11156216|FG003|NOT COMPLETED|Overall Study||0
10032026|NCT01915303|11156226|FG000|STARTED|Core Phase||68
10032027|NCT01915303|11156226|FG000|COMPLETED|Core Phase||52
10032028|NCT01915303|11156226|FG000|NOT COMPLETED|Core Phase||16
10032029|NCT01915303|11156226|FG000|STARTED|Extension Phase||29
10032030|NCT01915303|11156226|FG000|COMPLETED|Extension Phase||12
9848353|NCT00858637|10961031|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
10032031|NCT01915303|11156226|FG000|NOT COMPLETED|Extension Phase||17
10032032|NCT01915563|11156232|FG000|STARTED|Overall Study||243
10032033|NCT01915563|11156233|FG001|STARTED|Overall Study||227
10032034|NCT01915563|11156232|FG000|COMPLETED|Overall Study||243
10032035|NCT01915563|11156233|FG001|COMPLETED|Overall Study||227
10032036|NCT01915563|11156232|FG000|NOT COMPLETED|Overall Study||0
10032037|NCT01915563|11156233|FG001|NOT COMPLETED|Overall Study||0
10032038|NCT01915732|11156241|FG000|STARTED|Overall Study||500
10032039|NCT01915732|11156242|FG001|STARTED|Overall Study||516
10032040|NCT01915732|11156241|FG000|COMPLETED|Overall Study||430
10032041|NCT01915732|11156242|FG001|COMPLETED|Overall Study||445
10032042|NCT01915732|11156241|FG000|NOT COMPLETED|Overall Study||70
10032043|NCT01915732|11156242|FG001|NOT COMPLETED|Overall Study||71
10032044|NCT01915771|11156248|FG000|STARTED|Day 1||15
10032045|NCT01915771|11156248|FG000|COMPLETED|Day 1||14
10032046|NCT01915771|11156248|FG000|NOT COMPLETED|Day 1||1
10032047|NCT01915771|11156248|FG000|STARTED|Day 15||14
10032048|NCT01915771|11156248|FG000|COMPLETED|Day 15||13
10032049|NCT01915771|11156248|FG000|NOT COMPLETED|Day 15||1
10032050|NCT01915823|11156258|FG000|STARTED|Overall Study||173
10032051|NCT01915823|11156259|FG001|STARTED|Overall Study||175
10032052|NCT01915823|11156258|FG000|COMPLETED|Overall Study||171
10032053|NCT01915823|11156259|FG001|COMPLETED|Overall Study||173
10032054|NCT01915823|11156258|FG000|NOT COMPLETED|Overall Study||2
10032055|NCT01915823|11156259|FG001|NOT COMPLETED|Overall Study||2
10032056|NCT01915849|11156269|FG000|STARTED|Treatment Period 1 (4 Days)||5
10032057|NCT01915849|11156270|FG001|STARTED|Treatment Period 1 (4 Days)||3
10032058|NCT01915849|11156271|FG002|STARTED|Treatment Period 1 (4 Days)||3
10032059|NCT01915849|11156272|FG003|STARTED|Treatment Period 1 (4 Days)||3
10032060|NCT01915849|11156269|FG000|COMPLETED|Treatment Period 1 (4 Days)||3
10032061|NCT01915849|11156270|FG001|COMPLETED|Treatment Period 1 (4 Days)||3
10032062|NCT01915849|11156271|FG002|COMPLETED|Treatment Period 1 (4 Days)||3
10032063|NCT01915849|11156272|FG003|COMPLETED|Treatment Period 1 (4 Days)||3
10032064|NCT01915849|11156269|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2
10032065|NCT01915849|11156270|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10032066|NCT01915849|11156271|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10032067|NCT01915849|11156272|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10032068|NCT01915849|11156269|FG000|STARTED|Treatment Period 2 (4 Days)||3
10032069|NCT01915849|11156270|FG001|STARTED|Treatment Period 2 (4 Days)||3
10032070|NCT01915849|11156271|FG002|STARTED|Treatment Period 2 (4 Days)||3
10032071|NCT01915849|11156272|FG003|STARTED|Treatment Period 2 (4 Days)||3
10032072|NCT01915849|11156269|FG000|COMPLETED|Treatment Period 2 (4 Days)||3
10032073|NCT01915849|11156270|FG001|COMPLETED|Treatment Period 2 (4 Days)||3
10032074|NCT01915849|11156271|FG002|COMPLETED|Treatment Period 2 (4 Days)||3
10032075|NCT01915849|11156272|FG003|COMPLETED|Treatment Period 2 (4 Days)||3
10032076|NCT01915849|11156269|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10032077|NCT01915849|11156270|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10032078|NCT01915849|11156271|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10032079|NCT01915849|11156272|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10032080|NCT01915849|11156269|FG000|STARTED|Treatment Period 3 (4 Days)||3
10032081|NCT01915849|11156270|FG001|STARTED|Treatment Period 3 (4 Days)||3
10032082|NCT01915849|11156271|FG002|STARTED|Treatment Period 3 (4 Days)||3
10032083|NCT01915849|11156272|FG003|STARTED|Treatment Period 3 (4 Days)||3
10032084|NCT01915849|11156269|FG000|COMPLETED|Treatment Period 3 (4 Days)||3
10032085|NCT01915849|11156270|FG001|COMPLETED|Treatment Period 3 (4 Days)||3
10032086|NCT01915849|11156271|FG002|COMPLETED|Treatment Period 3 (4 Days)||3
10032087|NCT01915849|11156272|FG003|COMPLETED|Treatment Period 3 (4 Days)||3
10032088|NCT01915849|11156269|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10032089|NCT01915849|11156270|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10032090|NCT01915849|11156271|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10032091|NCT01915849|11156272|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10032092|NCT01915849|11156269|FG000|STARTED|Treatment Period 4 (4 Days)||3
10032093|NCT01915849|11156270|FG001|STARTED|Treatment Period 4 (4 Days)||3
10032094|NCT01915849|11156271|FG002|STARTED|Treatment Period 4 (4 Days)||3
10032095|NCT01915849|11156272|FG003|STARTED|Treatment Period 4 (4 Days)||3
10032096|NCT01915849|11156269|FG000|COMPLETED|Treatment Period 4 (4 Days)||3
10032097|NCT01915849|11156270|FG001|COMPLETED|Treatment Period 4 (4 Days)||3
10032098|NCT01915849|11156271|FG002|COMPLETED|Treatment Period 4 (4 Days)||3
10032099|NCT01915849|11156272|FG003|COMPLETED|Treatment Period 4 (4 Days)||3
10032100|NCT01915849|11156269|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10032101|NCT01915849|11156270|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10032102|NCT01915849|11156271|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10032103|NCT01915849|11156272|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10032104|NCT01915914|11156282|FG000|STARTED|Acute Phase||123
10032105|NCT01915914|11156283|FG001|STARTED|Acute Phase||0
10032106|NCT01915914|11156284|FG002|STARTED|Acute Phase||0
10032107|NCT01915914|11156285|FG003|STARTED|Acute Phase||0
10032108|NCT01915914|11156282|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4
10032109|NCT01915914|11156283|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0
10032110|NCT01915914|11156284|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0
10032111|NCT01915914|11156285|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0
10032112|NCT01915914|11156282|FG000|COMPLETED|Acute Phase||111
10032113|NCT01915914|11156283|FG001|COMPLETED|Acute Phase||0
10032114|NCT01915914|11156284|FG002|COMPLETED|Acute Phase||0
10032115|NCT01915914|11156285|FG003|COMPLETED|Acute Phase||0
10032116|NCT01915914|11156282|FG000|NOT COMPLETED|Acute Phase||12
10032117|NCT01915914|11156283|FG001|NOT COMPLETED|Acute Phase||0
10032118|NCT01915914|11156284|FG002|NOT COMPLETED|Acute Phase||0
10032119|NCT01915914|11156285|FG003|NOT COMPLETED|Acute Phase||0
10032120|NCT01915914|11156282|FG000|STARTED|Maintenance Phase||0
10032121|NCT01915914|11156283|FG001|STARTED|Maintenance Phase||54
10032122|NCT01915914|11156284|FG002|STARTED|Maintenance Phase||53
10032123|NCT01915914|11156285|FG003|STARTED|Maintenance Phase||0
10032124|NCT01915914|11156282|FG000|COMPLETED|Maintenance Phase||0
10032125|NCT01915914|11156283|FG001|COMPLETED|Maintenance Phase||48
10032126|NCT01915914|11156284|FG002|COMPLETED|Maintenance Phase||51
10032127|NCT01915914|11156285|FG003|COMPLETED|Maintenance Phase||0
10032128|NCT01915914|11156282|FG000|NOT COMPLETED|Maintenance Phase||0
10032129|NCT01915914|11156283|FG001|NOT COMPLETED|Maintenance Phase||6
10032130|NCT01915914|11156284|FG002|NOT COMPLETED|Maintenance Phase||2
10032131|NCT01915914|11156285|FG003|NOT COMPLETED|Maintenance Phase||0
10032132|NCT01915914|11156282|FG000|STARTED|Follow-up Phase||0
10032133|NCT01915914|11156283|FG001|STARTED|Follow-up Phase||0
10032134|NCT01915914|11156284|FG002|STARTED|Follow-up Phase||0
10032135|NCT01915914|11156285|FG003|STARTED|Follow-up Phase||66
10032136|NCT01915914|11156282|FG000|COMPLETED|Follow-up Phase||0
10032137|NCT01915914|11156283|FG001|COMPLETED|Follow-up Phase||0
10032138|NCT01915914|11156284|FG002|COMPLETED|Follow-up Phase||0
10032139|NCT01915914|11156285|FG003|COMPLETED|Follow-up Phase||64
10032140|NCT01915914|11156282|FG000|NOT COMPLETED|Follow-up Phase||0
10032141|NCT01915914|11156283|FG001|NOT COMPLETED|Follow-up Phase||0
10032142|NCT01915914|11156284|FG002|NOT COMPLETED|Follow-up Phase||0
10032143|NCT01915914|11156285|FG003|NOT COMPLETED|Follow-up Phase||2
10032144|NCT01915940|11156305|FG000|STARTED|Pre-randomization Washout Period||169
10032145|NCT01915940|11156306|FG001|STARTED|Pre-randomization Washout Period||0
10032146|NCT01915940|11156307|FG002|STARTED|Pre-randomization Washout Period||0
10032147|NCT01915940|11156305|FG000|COMPLETED|Pre-randomization Washout Period||130
10032148|NCT01915940|11156306|FG001|COMPLETED|Pre-randomization Washout Period||0
10032149|NCT01915940|11156307|FG002|COMPLETED|Pre-randomization Washout Period||0
10032150|NCT01915940|11156305|FG000|NOT COMPLETED|Pre-randomization Washout Period||39
10032151|NCT01915940|11156306|FG001|NOT COMPLETED|Pre-randomization Washout Period||0
10032152|NCT01915940|11156307|FG002|NOT COMPLETED|Pre-randomization Washout Period||0
10032153|NCT01915940|11156305|FG000|STARTED|Treatment Period||0
10032154|NCT01915940|11156306|FG001|STARTED|Treatment Period||64
10032155|NCT01915940|11156307|FG002|STARTED|Treatment Period||66
10032156|NCT01915940|11156305|FG000|COMPLETED|Treatment Period||0
10032157|NCT01915940|11156306|FG001|COMPLETED|Treatment Period||53
10032158|NCT01915940|11156307|FG002|COMPLETED|Treatment Period||62
10032159|NCT01915940|11156305|FG000|NOT COMPLETED|Treatment Period||0
10032160|NCT01915940|11156306|FG001|NOT COMPLETED|Treatment Period||11
10032161|NCT01915940|11156307|FG002|NOT COMPLETED|Treatment Period||4
10032162|NCT01916109|11156313|FG000|STARTED|Overall Study||4
10032163|NCT01916109|11156313|FG000|COMPLETED|Overall Study||3
10032164|NCT01916109|11156313|FG000|NOT COMPLETED|Overall Study||1
10032165|NCT01916226|11156321|FG000|STARTED|Overall Study||170
10032166|NCT01916226|11156322|FG001|STARTED|Overall Study||170
10032167|NCT01916226|11156323|FG002|STARTED|Overall Study||171
10032168|NCT01916226|11156324|FG003|STARTED|Overall Study||171
10032169|NCT01916226|11156321|FG000|COMPLETED|Overall Study||169
10032170|NCT01916226|11156322|FG001|COMPLETED|Overall Study||169
10032171|NCT01916226|11156323|FG002|COMPLETED|Overall Study||168
10032172|NCT01916226|11156324|FG003|COMPLETED|Overall Study||167
10032173|NCT01916226|11156321|FG000|NOT COMPLETED|Overall Study||1
10032174|NCT01916226|11156322|FG001|NOT COMPLETED|Overall Study||1
10032175|NCT01916226|11156323|FG002|NOT COMPLETED|Overall Study||3
10032176|NCT01916226|11156324|FG003|NOT COMPLETED|Overall Study||4
10032177|NCT01916304|11156335|FG000|STARTED|Overall Study||101
10032178|NCT01916304|11156335|FG000|Safety Set|Overall Study||101
10032179|NCT01916304|11156335|FG000|Intent-to-Treat Set|Overall Study||84
10032180|NCT01916304|11156335|FG000|COMPLETED|Overall Study||84
10032181|NCT01916304|11156335|FG000|NOT COMPLETED|Overall Study||17
10032182|NCT01916629|11156341|FG000|STARTED|Overall Study||7
10032183|NCT01916629|11156342|FG001|STARTED|Overall Study||5
10032184|NCT01916629|11156341|FG000|COMPLETED|Overall Study||7
10032185|NCT01916629|11156342|FG001|COMPLETED|Overall Study||5
10032186|NCT01916629|11156341|FG000|NOT COMPLETED|Overall Study||0
10032187|NCT01916629|11156342|FG001|NOT COMPLETED|Overall Study||0
10032188|NCT01916655|11156351|FG000|STARTED|Overall Study||131
10032189|NCT01916655|11156352|FG001|STARTED|Overall Study||109
10032190|NCT01916655|11156353|FG002|STARTED|Overall Study||120
10032191|NCT01916655|11156351|FG000|COMPLETED|Overall Study||116
10032192|NCT01916655|11156352|FG001|COMPLETED|Overall Study||89
10032193|NCT01916655|11156353|FG002|COMPLETED|Overall Study||91
10032194|NCT01916655|11156351|FG000|NOT COMPLETED|Overall Study||15
10032195|NCT01916655|11156352|FG001|NOT COMPLETED|Overall Study||20
10032196|NCT01916655|11156353|FG002|NOT COMPLETED|Overall Study||29
10032197|NCT01916681|11156365|FG000|STARTED|Overall Study||123
10032198|NCT01916681|11156366|FG001|STARTED|Overall Study||120
10032199|NCT01916681|11156367|FG002|STARTED|Overall Study||123
10032200|NCT01916681|11156368|FG003|STARTED|Overall Study||125
10032201|NCT01916681|11156365|FG000|COMPLETED|Overall Study||123
10032202|NCT01916681|11156366|FG001|COMPLETED|Overall Study||120
10032203|NCT01916681|11156367|FG002|COMPLETED|Overall Study||123
10032204|NCT01916681|11156368|FG003|COMPLETED|Overall Study||125
10032205|NCT01916681|11156365|FG000|NOT COMPLETED|Overall Study||0
10032206|NCT01916681|11156366|FG001|NOT COMPLETED|Overall Study||0
10032207|NCT01916681|11156367|FG002|NOT COMPLETED|Overall Study||0
10032208|NCT01916681|11156368|FG003|NOT COMPLETED|Overall Study||0
10032209|NCT01916824|11156381|FG000|STARTED|Overall Study||24
10032210|NCT01916824|11156382|FG001|STARTED|Overall Study||29
10032211|NCT01916824|11156381|FG000|COMPLETED|Overall Study||17
10032212|NCT01916824|11156382|FG001|COMPLETED|Overall Study||20
10032213|NCT01916824|11156381|FG000|NOT COMPLETED|Overall Study||7
10032214|NCT01916824|11156382|FG001|NOT COMPLETED|Overall Study||9
10032215|NCT01916928|11156388|FG000|STARTED|Overall Study||50
10032216|NCT01916928|11156388|FG000|COMPLETED|Overall Study||50
10032217|NCT01916928|11156388|FG000|NOT COMPLETED|Overall Study||0
10032218|NCT01916941|11156394|FG000|STARTED|Overall Study||18
10032219|NCT01916941|11156395|FG001|STARTED|Overall Study||18
10032220|NCT01916941|11156394|FG000|COMPLETED|Overall Study||13
10032221|NCT01916941|11156395|FG001|COMPLETED|Overall Study||14
10032222|NCT01916941|11156394|FG000|NOT COMPLETED|Overall Study||5
10032223|NCT01916941|11156395|FG001|NOT COMPLETED|Overall Study||4
10032224|NCT01917006|11156408|FG000|STARTED|Randomized-treatment Period||5
10032225|NCT01917006|11156409|FG001|STARTED|Randomized-treatment Period||7
10032226|NCT01917006|11156410|FG002|STARTED|Randomized-treatment Period||8
10032227|NCT01917006|11156411|FG003|STARTED|Randomized-treatment Period||8
10032228|NCT01917006|11156412|FG004|STARTED|Randomized-treatment Period||8
10032229|NCT01917006|11156413|FG005|STARTED|Randomized-treatment Period||8
10032230|NCT01917006|11156414|FG006|STARTED|Randomized-treatment Period||15
10032231|NCT01917006|11156415|FG007|STARTED|Randomized-treatment Period||0
10032232|NCT01917006|11156408|FG000|COMPLETED|Randomized-treatment Period||3
10032233|NCT01917006|11156409|FG001|COMPLETED|Randomized-treatment Period||7
10032234|NCT01917006|11156410|FG002|COMPLETED|Randomized-treatment Period||8
10032235|NCT01917006|11156411|FG003|COMPLETED|Randomized-treatment Period||7
10032236|NCT01917006|11156412|FG004|COMPLETED|Randomized-treatment Period||8
10032237|NCT01917006|11156413|FG005|COMPLETED|Randomized-treatment Period||7
10032238|NCT01917006|11156414|FG006|COMPLETED|Randomized-treatment Period||14
10032239|NCT01917006|11156415|FG007|COMPLETED|Randomized-treatment Period||0
10032240|NCT01917006|11156408|FG000|NOT COMPLETED|Randomized-treatment Period||2
10032241|NCT01917006|11156409|FG001|NOT COMPLETED|Randomized-treatment Period||0
10032242|NCT01917006|11156410|FG002|NOT COMPLETED|Randomized-treatment Period||0
10032243|NCT01917006|11156411|FG003|NOT COMPLETED|Randomized-treatment Period||1
10032244|NCT01917006|11156412|FG004|NOT COMPLETED|Randomized-treatment Period||0
10032245|NCT01917006|11156413|FG005|NOT COMPLETED|Randomized-treatment Period||1
10032246|NCT01917006|11156414|FG006|NOT COMPLETED|Randomized-treatment Period||1
10032247|NCT01917006|11156415|FG007|NOT COMPLETED|Randomized-treatment Period||0
10032248|NCT01917006|11156408|FG000|STARTED|Open-label Period||0
10032249|NCT01917006|11156409|FG001|STARTED|Open-label Period||0
10032250|NCT01917006|11156410|FG002|STARTED|Open-label Period||0
10032251|NCT01917006|11156411|FG003|STARTED|Open-label Period||0
10032252|NCT01917006|11156412|FG004|STARTED|Open-label Period||0
10032253|NCT01917006|11156413|FG005|STARTED|Open-label Period||0
10032254|NCT01917006|11156414|FG006|STARTED|Open-label Period||0
10032255|NCT01917006|11156415|FG007|STARTED|Open-label Period||8
10032256|NCT01917006|11156408|FG000|COMPLETED|Open-label Period||0
10032257|NCT01917006|11156409|FG001|COMPLETED|Open-label Period||0
10032258|NCT01917006|11156410|FG002|COMPLETED|Open-label Period||0
10032259|NCT01917006|11156411|FG003|COMPLETED|Open-label Period||0
10032260|NCT01917006|11156412|FG004|COMPLETED|Open-label Period||0
10032261|NCT01917006|11156413|FG005|COMPLETED|Open-label Period||0
10032262|NCT01917006|11156414|FG006|COMPLETED|Open-label Period||0
10032263|NCT01917006|11156415|FG007|COMPLETED|Open-label Period||6
10032264|NCT01917006|11156408|FG000|NOT COMPLETED|Open-label Period||0
10032265|NCT01917006|11156409|FG001|NOT COMPLETED|Open-label Period||0
10032266|NCT01917006|11156410|FG002|NOT COMPLETED|Open-label Period||0
10032267|NCT01917006|11156411|FG003|NOT COMPLETED|Open-label Period||0
10032268|NCT01917006|11156412|FG004|NOT COMPLETED|Open-label Period||0
10032269|NCT01917006|11156413|FG005|NOT COMPLETED|Open-label Period||0
10032270|NCT01917006|11156414|FG006|NOT COMPLETED|Open-label Period||0
10032271|NCT01917006|11156415|FG007|NOT COMPLETED|Open-label Period||2
10032272|NCT01917084|11156432|FG000|STARTED|Overall Study||20
10032273|NCT01917084|11156432|FG000|COMPLETED|Overall Study||19
10032274|NCT01917084|11156432|FG000|NOT COMPLETED|Overall Study||1
10032275|NCT01917136|11156436|FG000|STARTED|Overall Study||21
10032276|NCT01917136|11156436|FG000|COMPLETED|Overall Study||21
10032277|NCT01917136|11156436|FG000|NOT COMPLETED|Overall Study||0
10032278|NCT01917188|11156443|FG000|STARTED|Overall Study||29
10032279|NCT01917188|11156444|FG001|STARTED|Overall Study||23
10032280|NCT01917188|11156445|FG002|STARTED|Overall Study||20
10032281|NCT01917188|11156443|FG000|COMPLETED|Overall Study||17
10032282|NCT01917188|11156444|FG001|COMPLETED|Overall Study||17
10032283|NCT01917188|11156445|FG002|COMPLETED|Overall Study||11
10032284|NCT01917188|11156443|FG000|NOT COMPLETED|Overall Study||12
10032285|NCT01917188|11156444|FG001|NOT COMPLETED|Overall Study||6
10032286|NCT01917188|11156445|FG002|NOT COMPLETED|Overall Study||9
10032287|NCT01917214|11156453|FG000|STARTED|Overall Study||212
10032288|NCT01917214|11156453|FG000|COMPLETED|Overall Study||212
10032289|NCT01917214|11156453|FG000|NOT COMPLETED|Overall Study||0
10032290|NCT01917344|11156458|FG000|STARTED|Overall Study||10
10032291|NCT01917344|11156458|FG000|COMPLETED|Overall Study||9
10032292|NCT01917344|11156458|FG000|NOT COMPLETED|Overall Study||1
10032293|NCT01917513|11156464|FG000|STARTED|Overall Study||502
10032294|NCT01917513|11156465|FG001|STARTED|Overall Study||498
10032295|NCT01917513|11156464|FG000|COMPLETED|Overall Study||407
10032296|NCT01917513|11156465|FG001|COMPLETED|Overall Study||396
10032297|NCT01917513|11156464|FG000|NOT COMPLETED|Overall Study||95
10032298|NCT01917513|11156465|FG001|NOT COMPLETED|Overall Study||102
10032299|NCT01917526|11156473|FG000|STARTED|Overall Study||250
10032300|NCT01917526|11156474|FG001|STARTED|Overall Study||250
10032301|NCT01917526|11156473|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
10032302|NCT01917526|11156474|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
10032303|NCT01917526|11156473|FG000|NOT COMPLETED|Overall Study||1
10032304|NCT01917526|11156474|FG001|NOT COMPLETED|Overall Study||1
10032305|NCT01917656|11156482|FG000|STARTED|Overall Study||172
10032306|NCT01917656|11156483|FG001|STARTED|Overall Study||171
10032307|NCT01917656|11156482|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
10032308|NCT01917656|11156483|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
10032309|NCT01917656|11156482|FG000|Exposed During Ramadan (Fasting)|Overall Study||152
10032310|NCT01917656|11156483|FG001|Exposed During Ramadan (Fasting)|Overall Study||163
10032311|NCT01917656|11156482|FG000|COMPLETED|Overall Study||146
10032312|NCT01917656|11156483|FG001|COMPLETED|Overall Study||147
10032313|NCT01917656|11156482|FG000|NOT COMPLETED|Overall Study||26
10032314|NCT01917656|11156483|FG001|NOT COMPLETED|Overall Study||24
10032315|NCT01917682|11156489|FG000|STARTED|Overall Study||754
10032316|NCT01917682|11156489|FG000|COMPLETED|Overall Study||754
10032317|NCT01917682|11156489|FG000|NOT COMPLETED|Overall Study||0
10032318|NCT01917747|11156496|FG000|STARTED|Overall Study||60
10032319|NCT01917747|11156497|FG001|STARTED|Overall Study||46
10032320|NCT01917747|11156496|FG000|COMPLETED|Overall Study||41
10032321|NCT01917747|11156497|FG001|COMPLETED|Overall Study||35
10032322|NCT01917747|11156496|FG000|NOT COMPLETED|Overall Study||19
10032323|NCT01917747|11156497|FG001|NOT COMPLETED|Overall Study||11
10032324|NCT01917773|11156507|FG000|STARTED|Overall Study||13
10032325|NCT01917773|11156507|FG000|COMPLETED|Overall Study||13
10032326|NCT01917773|11156507|FG000|NOT COMPLETED|Overall Study||0
10032327|NCT01917812|11156516|FG000|STARTED|Overall Study||16
10032328|NCT01917812|11156517|FG001|STARTED|Overall Study||16
10032329|NCT01917812|11156518|FG002|STARTED|Overall Study||16
10032330|NCT01917812|11156516|FG000|COMPLETED|Overall Study||15
10032331|NCT01917812|11156517|FG001|COMPLETED|Overall Study||16
10032332|NCT01917812|11156518|FG002|COMPLETED|Overall Study||16
10032333|NCT01917812|11156516|FG000|NOT COMPLETED|Overall Study||1
10032334|NCT01917812|11156517|FG001|NOT COMPLETED|Overall Study||0
10032335|NCT01917812|11156518|FG002|NOT COMPLETED|Overall Study||0
10032336|NCT01917968|11156528|FG000|STARTED|Overall Study||225
10032337|NCT01917968|11156529|FG001|STARTED|Overall Study||485
10032338|NCT01917968|11156528|FG000|COMPLETED|Overall Study||171
10032339|NCT01917968|11156529|FG001|COMPLETED|Overall Study||401
10032340|NCT01917968|11156528|FG000|NOT COMPLETED|Overall Study||54
10032341|NCT01917968|11156529|FG001|NOT COMPLETED|Overall Study||84
10032342|NCT01918072|11156542|FG000|STARTED|Controlled Trial Step One - Six Months||11
10032343|NCT01918072|11156543|FG001|STARTED|Controlled Trial Step One - Six Months||0
10032344|NCT01918072|11156544|FG002|STARTED|Controlled Trial Step One - Six Months||0
10032345|NCT01918072|11156542|FG000|Intervention|Controlled Trial Step One - Six Months||1
10032346|NCT01918072|11156543|FG001|Intervention|Controlled Trial Step One - Six Months||0
10032347|NCT01918072|11156544|FG002|Intervention|Controlled Trial Step One - Six Months||0
10032348|NCT01918072|11156542|FG000|Control|Controlled Trial Step One - Six Months||10
10032349|NCT01918072|11156543|FG001|Control|Controlled Trial Step One - Six Months||0
10032350|NCT01918072|11156544|FG002|Control|Controlled Trial Step One - Six Months||0
10032351|NCT01918072|11156542|FG000|COMPLETED|Controlled Trial Step One - Six Months||11
10032352|NCT01918072|11156543|FG001|COMPLETED|Controlled Trial Step One - Six Months||0
10032353|NCT01918072|11156544|FG002|COMPLETED|Controlled Trial Step One - Six Months||0
10032354|NCT01918072|11156542|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0
10032355|NCT01918072|11156543|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0
10032356|NCT01918072|11156544|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0
10032357|NCT01918072|11156542|FG000|STARTED|Controlled Trial Step Two - Six Months||11
10032358|NCT01918072|11156543|FG001|STARTED|Controlled Trial Step Two - Six Months||0
10032359|NCT01918072|11156544|FG002|STARTED|Controlled Trial Step Two - Six Months||0
10032360|NCT01918072|11156542|FG000|Intervention|Controlled Trial Step Two - Six Months||7
10032361|NCT01918072|11156543|FG001|Intervention|Controlled Trial Step Two - Six Months||0
10032362|NCT01918072|11156544|FG002|Intervention|Controlled Trial Step Two - Six Months||0
10032363|NCT01918072|11156542|FG000|Control|Controlled Trial Step Two - Six Months||4
10032364|NCT01918072|11156543|FG001|Control|Controlled Trial Step Two - Six Months||0
10032365|NCT01918072|11156544|FG002|Control|Controlled Trial Step Two - Six Months||0
10032366|NCT01918072|11156542|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11
10032367|NCT01918072|11156543|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0
10032368|NCT01918072|11156544|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0
10032369|NCT01918072|11156542|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
10032370|NCT01918072|11156543|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
10032371|NCT01918072|11156544|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
10032372|NCT01918072|11156542|FG000|STARTED|Controlled Trial Step Three - Six Months||11
10032373|NCT01918072|11156543|FG001|STARTED|Controlled Trial Step Three - Six Months||0
10032374|NCT01918072|11156544|FG002|STARTED|Controlled Trial Step Three - Six Months||0
10032375|NCT01918072|11156542|FG000|Intervention|Controlled Trial Step Three - Six Months||9
10032376|NCT01918072|11156543|FG001|Intervention|Controlled Trial Step Three - Six Months||0
10032377|NCT01918072|11156544|FG002|Intervention|Controlled Trial Step Three - Six Months||0
10032378|NCT01918072|11156542|FG000|Control|Controlled Trial Step Three - Six Months||2
10032379|NCT01918072|11156543|FG001|Control|Controlled Trial Step Three - Six Months||0
10032380|NCT01918072|11156544|FG002|Control|Controlled Trial Step Three - Six Months||0
10032381|NCT01918072|11156542|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11
10032382|NCT01918072|11156543|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0
10032383|NCT01918072|11156544|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0
10032384|NCT01918072|11156542|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
10032385|NCT01918072|11156543|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
10032386|NCT01918072|11156544|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
10032387|NCT01918072|11156542|FG000|STARTED|Controlled Trial Step Four - Six Months||11
10032388|NCT01918072|11156543|FG001|STARTED|Controlled Trial Step Four - Six Months||0
10032389|NCT01918072|11156544|FG002|STARTED|Controlled Trial Step Four - Six Months||0
10032390|NCT01918072|11156542|FG000|Intervention|Controlled Trial Step Four - Six Months||11
10032391|NCT01918072|11156543|FG001|Intervention|Controlled Trial Step Four - Six Months||0
10032392|NCT01918072|11156544|FG002|Intervention|Controlled Trial Step Four - Six Months||0
10032393|NCT01918072|11156542|FG000|Control|Controlled Trial Step Four - Six Months||0
10032394|NCT01918072|11156543|FG001|Control|Controlled Trial Step Four - Six Months||0
10032395|NCT01918072|11156544|FG002|Control|Controlled Trial Step Four - Six Months||0
10032396|NCT01918072|11156542|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11
10032397|NCT01918072|11156543|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0
10032398|NCT01918072|11156544|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0
10032399|NCT01918072|11156542|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
10032400|NCT01918072|11156543|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
10032401|NCT01918072|11156544|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
10032402|NCT01918072|11156542|FG000|STARTED|Controlled Trial Step Five - Four Months||11
10032403|NCT01918072|11156543|FG001|STARTED|Controlled Trial Step Five - Four Months||0
10032404|NCT01918072|11156544|FG002|STARTED|Controlled Trial Step Five - Four Months||0
10032405|NCT01918072|11156542|FG000|Intervention|Controlled Trial Step Five - Four Months||11
10032406|NCT01918072|11156543|FG001|Intervention|Controlled Trial Step Five - Four Months||0
10032407|NCT01918072|11156544|FG002|Intervention|Controlled Trial Step Five - Four Months||0
10032408|NCT01918072|11156542|FG000|Control|Controlled Trial Step Five - Four Months||0
10032409|NCT01918072|11156543|FG001|Control|Controlled Trial Step Five - Four Months||0
10032410|NCT01918072|11156544|FG002|Control|Controlled Trial Step Five - Four Months||0
10032411|NCT01918072|11156542|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11
10032412|NCT01918072|11156543|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0
10032413|NCT01918072|11156544|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0
10032414|NCT01918072|11156542|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
10032415|NCT01918072|11156543|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
10032416|NCT01918072|11156544|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
10032417|NCT01918072|11156542|FG000|STARTED|E-consult Assessment Period||0
10032418|NCT01918072|11156543|FG001|STARTED|E-consult Assessment Period||42
10032419|NCT01918072|11156544|FG002|STARTED|E-consult Assessment Period||0
10032420|NCT01918072|11156542|FG000|COMPLETED|E-consult Assessment Period||0
10032421|NCT01918072|11156543|FG001|COMPLETED|E-consult Assessment Period||42
10032422|NCT01918072|11156544|FG002|COMPLETED|E-consult Assessment Period||0
10032423|NCT01918072|11156542|FG000|NOT COMPLETED|E-consult Assessment Period||0
10032424|NCT01918072|11156543|FG001|NOT COMPLETED|E-consult Assessment Period||0
10032425|NCT01918072|11156544|FG002|NOT COMPLETED|E-consult Assessment Period||0
10032426|NCT01918072|11156542|FG000|STARTED|Quality Assessment Period||0
10032427|NCT01918072|11156543|FG001|STARTED|Quality Assessment Period||0
10032428|NCT01918072|11156544|FG002|STARTED|Quality Assessment Period||202
10032429|NCT01918072|11156542|FG000|COMPLETED|Quality Assessment Period||0
10032430|NCT01918072|11156543|FG001|COMPLETED|Quality Assessment Period||0
10032431|NCT01918072|11156544|FG002|COMPLETED|Quality Assessment Period||202
10032432|NCT01918072|11156542|FG000|NOT COMPLETED|Quality Assessment Period||0
10032433|NCT01918072|11156543|FG001|NOT COMPLETED|Quality Assessment Period||0
10032434|NCT01918072|11156544|FG002|NOT COMPLETED|Quality Assessment Period||0
10032435|NCT01918085|11156556|FG000|STARTED|Test Period 1: Strata Strip||10
10032436|NCT01918085|11156557|FG001|STARTED|Test Period 1: Strata Strip||12
10032437|NCT01918085|11156556|FG000|COMPLETED|Test Period 1: Strata Strip||10
10032438|NCT01918085|11156557|FG001|COMPLETED|Test Period 1: Strata Strip||11
10032439|NCT01918085|11156556|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0
10032440|NCT01918085|11156557|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1
10032441|NCT01918085|11156556|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10
10032442|NCT01918085|11156557|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11
10032443|NCT01918085|11156556|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10
10032444|NCT01918085|11156557|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11
10032445|NCT01918085|11156556|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
10032446|NCT01918085|11156557|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
10032447|NCT01918085|11156556|FG000|STARTED|Test Period 2: Strata Strip||10
10032448|NCT01918085|11156557|FG001|STARTED|Test Period 2: Strata Strip||11
10032449|NCT01918085|11156556|FG000|COMPLETED|Test Period 2: Strata Strip||10
10032450|NCT01918085|11156557|FG001|COMPLETED|Test Period 2: Strata Strip||11
10032451|NCT01918085|11156556|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0
10032452|NCT01918085|11156557|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0
10032453|NCT01918085|11156556|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10
10032454|NCT01918085|11156557|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11
10032455|NCT01918085|11156556|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10
10032456|NCT01918085|11156557|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11
10032457|NCT01918085|11156556|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
10032458|NCT01918085|11156557|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
10032459|NCT01918189|11156565|FG000|STARTED|Overall Study||59
10032460|NCT01918189|11156565|FG000|Completed Baseline Assessment|Overall Study||58
10032461|NCT01918189|11156565|FG000|Completed Follow-up Assessment|Overall Study||41
10032462|NCT01918189|11156565|FG000|COMPLETED|Overall Study||41
10032463|NCT01918189|11156565|FG000|NOT COMPLETED|Overall Study||18
10032464|NCT01918306|11156572|FG000|STARTED|Overall Study||6
10032465|NCT01918306|11156573|FG001|STARTED|Overall Study|No patients enrolled|0
10032466|NCT01918306|11156574|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
10032467|NCT01918306|11156575|FG003|STARTED|Overall Study||3
10032468|NCT01918306|11156572|FG000|COMPLETED|Overall Study||0
10032469|NCT01918306|11156573|FG001|COMPLETED|Overall Study||0
10032470|NCT01918306|11156574|FG002|COMPLETED|Overall Study||0
10032471|NCT01918306|11156575|FG003|COMPLETED|Overall Study||0
10032472|NCT01918306|11156572|FG000|NOT COMPLETED|Overall Study||6
10032473|NCT01918306|11156573|FG001|NOT COMPLETED|Overall Study||0
10032474|NCT01918306|11156574|FG002|NOT COMPLETED|Overall Study||2
10032475|NCT01918306|11156575|FG003|NOT COMPLETED|Overall Study||3
10032476|NCT01918332|11156599|FG000|STARTED|Overall Study||43
10032477|NCT01918332|11156600|FG001|STARTED|Overall Study||41
10032478|NCT01918332|11156601|FG002|STARTED|Overall Study||39
10032479|NCT01918332|11156602|FG003|STARTED|Overall Study||45
10032480|NCT01918332|11156599|FG000|COMPLETED|Overall Study||35
10032481|NCT01918332|11156600|FG001|COMPLETED|Overall Study||36
10032482|NCT01918332|11156601|FG002|COMPLETED|Overall Study||30
10032483|NCT01918332|11156602|FG003|COMPLETED|Overall Study||38
10032484|NCT01918332|11156599|FG000|NOT COMPLETED|Overall Study||8
10032485|NCT01918332|11156600|FG001|NOT COMPLETED|Overall Study||5
10032486|NCT01918332|11156601|FG002|NOT COMPLETED|Overall Study||9
10032487|NCT01918332|11156602|FG003|NOT COMPLETED|Overall Study||7
10032488|NCT01918371|11156614|FG000|STARTED|Overall Study||166
10032489|NCT01918371|11156615|FG001|STARTED|Overall Study||157
10032490|NCT01918371|11156614|FG000|Participants With Complete Data|Overall Study||165
10032491|NCT01918371|11156615|FG001|Participants With Complete Data|Overall Study||156
10032492|NCT01918371|11156614|FG000|COMPLETED|Overall Study||165
10032493|NCT01918371|11156615|FG001|COMPLETED|Overall Study||156
10032494|NCT01918371|11156614|FG000|NOT COMPLETED|Overall Study||1
10032495|NCT01918371|11156615|FG001|NOT COMPLETED|Overall Study||1
10032496|NCT01918761|11156621|FG000|STARTED|Overall Study||5
10032497|NCT01918761|11156621|FG000|COMPLETED|Overall Study||5
10032498|NCT01918761|11156621|FG000|NOT COMPLETED|Overall Study||0
10032499|NCT01918774|11156625|FG000|STARTED|Overall Study||57
10032500|NCT01918774|11156625|FG000|COMPLETED|Overall Study||52
10032501|NCT01918774|11156625|FG000|NOT COMPLETED|Overall Study||5
10032502|NCT01918800|11156631|FG000|STARTED|Overall Study||109
10032503|NCT01918800|11156632|FG001|STARTED|Overall Study||109
10032504|NCT01918800|11156631|FG000|COMPLETED|Overall Study||100
10032505|NCT01918800|11156632|FG001|COMPLETED|Overall Study||104
10032506|NCT01918800|11156631|FG000|NOT COMPLETED|Overall Study||9
10032507|NCT01918800|11156632|FG001|NOT COMPLETED|Overall Study||5
10032508|NCT01919112|11156641|FG000|STARTED|Primary Analysis-day 5 of Intervention||14
10032509|NCT01919112|11156642|FG001|STARTED|Primary Analysis-day 5 of Intervention||13
10032510|NCT01919112|11156643|FG002|STARTED|Primary Analysis-day 5 of Intervention||15
10032511|NCT01919112|11156641|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14
10032512|NCT01919112|11156642|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13
10032513|NCT01919112|11156643|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15
10032514|NCT01919112|11156641|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
10032515|NCT01919112|11156642|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
10032516|NCT01919112|11156643|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
10032517|NCT01919112|11156641|FG000|STARTED|Secondary Analysis-day 30||14
10032518|NCT01919112|11156642|FG001|STARTED|Secondary Analysis-day 30||13
10032519|NCT01919112|11156643|FG002|STARTED|Secondary Analysis-day 30||15
10032520|NCT01919112|11156641|FG000|COMPLETED|Secondary Analysis-day 30||12
10032521|NCT01919112|11156642|FG001|COMPLETED|Secondary Analysis-day 30||12
10032522|NCT01919112|11156643|FG002|COMPLETED|Secondary Analysis-day 30||14
10032523|NCT01919112|11156641|FG000|NOT COMPLETED|Secondary Analysis-day 30||2
10032524|NCT01919112|11156642|FG001|NOT COMPLETED|Secondary Analysis-day 30||1
10032525|NCT01919112|11156643|FG002|NOT COMPLETED|Secondary Analysis-day 30||1
10032526|NCT01919164|11156656|FG000|STARTED|Overall Study||108
10032527|NCT01919164|11156657|FG001|STARTED|Overall Study||110
10032528|NCT01919164|11156658|FG002|STARTED|Overall Study||111
10032529|NCT01919164|11156659|FG003|STARTED|Overall Study||110
10032530|NCT01919164|11156660|FG004|STARTED|Overall Study||110
10032531|NCT01919164|11156656|FG000|Safety Analysis Set|Overall Study||107
10032532|NCT01919164|11156657|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
10032533|NCT01919164|11156658|FG002|Safety Analysis Set|Overall Study||111
10032534|NCT01919164|11156659|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
10032535|NCT01919164|11156660|FG004|Safety Analysis Set|Overall Study||109
10032536|NCT01919164|11156656|FG000|COMPLETED|Overall Study||65
10032537|NCT01919164|11156657|FG001|COMPLETED|Overall Study||80
10032538|NCT01919164|11156658|FG002|COMPLETED|Overall Study||74
10032539|NCT01919164|11156659|FG003|COMPLETED|Overall Study||82
10032540|NCT01919164|11156660|FG004|COMPLETED|Overall Study||77
10032541|NCT01919164|11156656|FG000|NOT COMPLETED|Overall Study||43
10032542|NCT01919164|11156657|FG001|NOT COMPLETED|Overall Study||30
10032543|NCT01919164|11156658|FG002|NOT COMPLETED|Overall Study||37
10032544|NCT01919164|11156659|FG003|NOT COMPLETED|Overall Study||28
10032545|NCT01919164|11156660|FG004|NOT COMPLETED|Overall Study||33
10032546|NCT01919190|11156674|FG000|STARTED|Overall Study|Met eligibility criteria|33
10032547|NCT01919190|11156675|FG001|STARTED|Overall Study|Met eligibility criteria|34
10032548|NCT01919190|11156674|FG000|COMPLETED|Overall Study||30
10032549|NCT01919190|11156675|FG001|COMPLETED|Overall Study||34
10032550|NCT01919190|11156674|FG000|NOT COMPLETED|Overall Study||3
10032551|NCT01919190|11156675|FG001|NOT COMPLETED|Overall Study||0
10032552|NCT01919216|11156685|FG000|STARTED|Overall Study||28
10032553|NCT01919216|11156686|FG001|STARTED|Overall Study||21
10032554|NCT01919216|11156687|FG002|STARTED|Overall Study||5
10032555|NCT01919216|11156685|FG000|COMPLETED|Overall Study||26
10032556|NCT01919216|11156686|FG001|COMPLETED|Overall Study||20
10032557|NCT01919216|11156687|FG002|COMPLETED|Overall Study||4
10032558|NCT01919216|11156685|FG000|NOT COMPLETED|Overall Study||2
10032559|NCT01919216|11156686|FG001|NOT COMPLETED|Overall Study||1
10032560|NCT01919216|11156687|FG002|NOT COMPLETED|Overall Study||1
10032561|NCT01919229|11156698|FG000|STARTED|Overall Study||4
10032562|NCT01919229|11156699|FG001|STARTED|Overall Study||6
10032563|NCT01919229|11156700|FG002|STARTED|Overall Study||4
10032564|NCT01919229|11156698|FG000|COMPLETED|Overall Study||4
10032565|NCT01919229|11156699|FG001|COMPLETED|Overall Study||6
10032566|NCT01919229|11156700|FG002|COMPLETED|Overall Study||3
10032567|NCT01919229|11156698|FG000|NOT COMPLETED|Overall Study||0
10032568|NCT01919229|11156699|FG001|NOT COMPLETED|Overall Study||0
10032569|NCT01919229|11156700|FG002|NOT COMPLETED|Overall Study||1
10032570|NCT01919307|11156708|FG000|STARTED|Overall Study||29
10032571|NCT01919307|11156708|FG000|COMPLETED|Overall Study||20
10032572|NCT01919307|11156708|FG000|NOT COMPLETED|Overall Study||9
10115604|NCT02527343|11246456|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10115605|NCT02527343|11246451|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115606|NCT02527343|11246452|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115607|NCT02527343|11246453|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6
10115608|NCT02527343|11246454|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7
10032573|NCT01919398|11156715|FG000|STARTED|Overall Study||3
10032574|NCT01919398|11156716|FG001|STARTED|Overall Study||3
10032575|NCT01919398|11156717|FG002|STARTED|Overall Study||13
10032576|NCT01919398|11156715|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10032577|NCT01919398|11156716|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10032578|NCT01919398|11156717|FG002|Received at Least One Dose of Study Drug|Overall Study||13
10032579|NCT01919398|11156715|FG000|COMPLETED|Overall Study||3
10032580|NCT01919398|11156716|FG001|COMPLETED|Overall Study||3
10032581|NCT01919398|11156717|FG002|COMPLETED|Overall Study||9
10032582|NCT01919398|11156715|FG000|NOT COMPLETED|Overall Study||0
10032583|NCT01919398|11156716|FG001|NOT COMPLETED|Overall Study||0
10032584|NCT01919398|11156717|FG002|NOT COMPLETED|Overall Study||4
10032585|NCT01919411|11156727|FG000|STARTED|Overall Study||43
10032586|NCT01919411|11156728|FG001|STARTED|Overall Study||46
10032587|NCT01919411|11156727|FG000|COMPLETED|Overall Study||38
10032588|NCT01919411|11156728|FG001|COMPLETED|Overall Study||41
10032589|NCT01919411|11156727|FG000|NOT COMPLETED|Overall Study||5
10032590|NCT01919411|11156728|FG001|NOT COMPLETED|Overall Study||5
10032591|NCT01919450|11156738|FG000|STARTED|Overall Study||20
10032592|NCT01919450|11156739|FG001|STARTED|Overall Study||20
10032593|NCT01919450|11156740|FG002|STARTED|Overall Study||20
10032594|NCT01919450|11156741|FG003|STARTED|Overall Study||20
10032595|NCT01919450|11156738|FG000|COMPLETED|Overall Study||20
10032596|NCT01919450|11156739|FG001|COMPLETED|Overall Study||20
10032597|NCT01919450|11156740|FG002|COMPLETED|Overall Study||20
10032598|NCT01919450|11156741|FG003|COMPLETED|Overall Study||19
10032599|NCT01919450|11156738|FG000|NOT COMPLETED|Overall Study||0
10032600|NCT01919450|11156739|FG001|NOT COMPLETED|Overall Study||0
10032601|NCT01919450|11156740|FG002|NOT COMPLETED|Overall Study||0
10032602|NCT01919450|11156741|FG003|NOT COMPLETED|Overall Study||1
10032603|NCT01919489|11156753|FG000|STARTED|Overall Study||136
10032604|NCT01919489|11156754|FG001|STARTED|Overall Study||137
10032605|NCT01919489|11156753|FG000|COMPLETED|Overall Study||80
10032606|NCT01919489|11156754|FG001|COMPLETED|Overall Study||93
10032607|NCT01919489|11156753|FG000|NOT COMPLETED|Overall Study||56
10032608|NCT01919489|11156754|FG001|NOT COMPLETED|Overall Study||44
10032609|NCT01919606|11156762|FG000|STARTED|Overall Study||1
10032610|NCT01919606|11156763|FG001|STARTED|Overall Study||0
10032611|NCT01919606|11156762|FG000|COMPLETED|Overall Study||1
10032612|NCT01919606|11156763|FG001|COMPLETED|Overall Study||0
10032613|NCT01919606|11156762|FG000|NOT COMPLETED|Overall Study||0
10032614|NCT01919606|11156763|FG001|NOT COMPLETED|Overall Study||0
10032615|NCT01919697|11156771|FG000|STARTED|Overall Study||224
10032616|NCT01919697|11156772|FG001|STARTED|Overall Study||2146
10032617|NCT01919697|11156771|FG000|COMPLETED|Overall Study||171
10032618|NCT01919697|11156772|FG001|COMPLETED|Overall Study||1761
10032619|NCT01919697|11156771|FG000|NOT COMPLETED|Overall Study||53
10032620|NCT01919697|11156772|FG001|NOT COMPLETED|Overall Study||385
10032621|NCT01919723|11156781|FG000|STARTED|Overall Study||35
10032622|NCT01919723|11156782|FG001|STARTED|Overall Study||35
10032623|NCT01919723|11156781|FG000|COMPLETED|Overall Study||33
10032624|NCT01919723|11156782|FG001|COMPLETED|Overall Study||33
10032625|NCT01919723|11156781|FG000|NOT COMPLETED|Overall Study||2
10032626|NCT01919723|11156782|FG001|NOT COMPLETED|Overall Study||2
10032627|NCT01919801|11156790|FG000|STARTED|Overall Study||61
10032628|NCT01919801|11156791|FG001|STARTED|Overall Study||60
10032629|NCT01919801|11156790|FG000|COMPLETED|Overall Study||60
10032630|NCT01919801|11156791|FG001|COMPLETED|Overall Study||57
10032631|NCT01919801|11156790|FG000|NOT COMPLETED|Overall Study||1
10032632|NCT01919801|11156791|FG001|NOT COMPLETED|Overall Study||3
10032633|NCT01919814|11156797|FG000|STARTED|Overall Study||30
10032634|NCT01919814|11156798|FG001|STARTED|Overall Study||30
10032635|NCT01919814|11156797|FG000|COMPLETED|Overall Study||27
10032636|NCT01919814|11156798|FG001|COMPLETED|Overall Study||30
10032637|NCT01919814|11156797|FG000|NOT COMPLETED|Overall Study||3
10032638|NCT01919814|11156798|FG001|NOT COMPLETED|Overall Study||0
10032639|NCT01919970|11156806|FG000|STARTED|Overall Study||14
10032640|NCT01919970|11156807|FG001|STARTED|Overall Study||18
10032641|NCT01919970|11156806|FG000|COMPLETED|Overall Study||11
10032642|NCT01919970|11156807|FG001|COMPLETED|Overall Study||18
10032643|NCT01919970|11156806|FG000|NOT COMPLETED|Overall Study||3
10032644|NCT01919970|11156807|FG001|NOT COMPLETED|Overall Study||0
10032645|NCT01919996|11156813|FG000|STARTED|Overall Study||8
10032646|NCT01919996|11156813|FG000|COMPLETED|Overall Study||8
10032647|NCT01919996|11156813|FG000|NOT COMPLETED|Overall Study||0
10032648|NCT01920061|11156837|FG000|STARTED|Overall Study||4
10032649|NCT01920061|11156838|FG001|STARTED|Overall Study||5
10032650|NCT01920061|11156839|FG002|STARTED|Overall Study||3
10032651|NCT01920061|11156840|FG003|STARTED|Overall Study||4
10032652|NCT01920061|11156841|FG004|STARTED|Overall Study||5
10032653|NCT01920061|11156842|FG005|STARTED|Overall Study||4
10032654|NCT01920061|11156843|FG006|STARTED|Overall Study||3
10032655|NCT01920061|11156844|FG007|STARTED|Overall Study||3
10032656|NCT01920061|11156845|FG008|STARTED|Overall Study||3
10032657|NCT01920061|11156846|FG009|STARTED|Overall Study||3
10032658|NCT01920061|11156847|FG010|STARTED|Overall Study||10
10032659|NCT01920061|11156848|FG011|STARTED|Overall Study||5
10032660|NCT01920061|11156849|FG012|STARTED|Overall Study||3
10032661|NCT01920061|11156850|FG013|STARTED|Overall Study||16
10032662|NCT01920061|11156851|FG014|STARTED|Overall Study||4
10032663|NCT01920061|11156852|FG015|STARTED|Overall Study||7
10032664|NCT01920061|11156853|FG016|STARTED|Overall Study||3
10032665|NCT01920061|11156854|FG017|STARTED|Overall Study||3
10032666|NCT01920061|11156855|FG018|STARTED|Overall Study||10
10032667|NCT01920061|11156856|FG019|STARTED|Overall Study||12
10032668|NCT01920061|11156837|FG000|Received Treatment|Overall Study||4
10032669|NCT01920061|11156838|FG001|Received Treatment|Overall Study||5
10032670|NCT01920061|11156839|FG002|Received Treatment|Overall Study||3
10032671|NCT01920061|11156840|FG003|Received Treatment|Overall Study||3
10032672|NCT01920061|11156841|FG004|Received Treatment|Overall Study||5
10032673|NCT01920061|11156842|FG005|Received Treatment|Overall Study||4
10032674|NCT01920061|11156843|FG006|Received Treatment|Overall Study||3
10032675|NCT01920061|11156844|FG007|Received Treatment|Overall Study||3
10032676|NCT01920061|11156845|FG008|Received Treatment|Overall Study||3
10032677|NCT01920061|11156846|FG009|Received Treatment|Overall Study||3
10032678|NCT01920061|11156847|FG010|Received Treatment|Overall Study||10
10032679|NCT01920061|11156848|FG011|Received Treatment|Overall Study||5
10032680|NCT01920061|11156849|FG012|Received Treatment|Overall Study||2
10032681|NCT01920061|11156850|FG013|Received Treatment|Overall Study||15
10032682|NCT01920061|11156851|FG014|Received Treatment|Overall Study||4
10032683|NCT01920061|11156852|FG015|Received Treatment|Overall Study||7
10032684|NCT01920061|11156853|FG016|Received Treatment|Overall Study||3
10032685|NCT01920061|11156854|FG017|Received Treatment|Overall Study||3
10032686|NCT01920061|11156855|FG018|Received Treatment|Overall Study||10
10032687|NCT01920061|11156856|FG019|Received Treatment|Overall Study||12
10032688|NCT01920061|11156837|FG000|COMPLETED|Overall Study||2
10032689|NCT01920061|11156838|FG001|COMPLETED|Overall Study||1
10032690|NCT01920061|11156839|FG002|COMPLETED|Overall Study||1
10032691|NCT01920061|11156840|FG003|COMPLETED|Overall Study||2
10032692|NCT01920061|11156841|FG004|COMPLETED|Overall Study||3
10032693|NCT01920061|11156842|FG005|COMPLETED|Overall Study||2
10032694|NCT01920061|11156843|FG006|COMPLETED|Overall Study||2
10032695|NCT01920061|11156844|FG007|COMPLETED|Overall Study||2
10032696|NCT01920061|11156845|FG008|COMPLETED|Overall Study||2
10032697|NCT01920061|11156846|FG009|COMPLETED|Overall Study||1
10032698|NCT01920061|11156847|FG010|COMPLETED|Overall Study||5
10032699|NCT01920061|11156848|FG011|COMPLETED|Overall Study||2
10032700|NCT01920061|11156849|FG012|COMPLETED|Overall Study||1
10032701|NCT01920061|11156850|FG013|COMPLETED|Overall Study||10
10032702|NCT01920061|11156851|FG014|COMPLETED|Overall Study||3
10032703|NCT01920061|11156852|FG015|COMPLETED|Overall Study||4
10032704|NCT01920061|11156853|FG016|COMPLETED|Overall Study||1
10032705|NCT01920061|11156854|FG017|COMPLETED|Overall Study||1
10032706|NCT01920061|11156855|FG018|COMPLETED|Overall Study||4
10032707|NCT01920061|11156856|FG019|COMPLETED|Overall Study||8
10032708|NCT01920061|11156837|FG000|NOT COMPLETED|Overall Study||2
10032709|NCT01920061|11156838|FG001|NOT COMPLETED|Overall Study||4
10032710|NCT01920061|11156839|FG002|NOT COMPLETED|Overall Study||2
10032711|NCT01920061|11156840|FG003|NOT COMPLETED|Overall Study||2
10032712|NCT01920061|11156841|FG004|NOT COMPLETED|Overall Study||2
10032713|NCT01920061|11156842|FG005|NOT COMPLETED|Overall Study||2
10032714|NCT01920061|11156843|FG006|NOT COMPLETED|Overall Study||1
10032715|NCT01920061|11156844|FG007|NOT COMPLETED|Overall Study||1
10032716|NCT01920061|11156845|FG008|NOT COMPLETED|Overall Study||1
10032717|NCT01920061|11156846|FG009|NOT COMPLETED|Overall Study||2
10032718|NCT01920061|11156847|FG010|NOT COMPLETED|Overall Study||5
10032719|NCT01920061|11156848|FG011|NOT COMPLETED|Overall Study||3
10032720|NCT01920061|11156849|FG012|NOT COMPLETED|Overall Study||2
10032721|NCT01920061|11156850|FG013|NOT COMPLETED|Overall Study||6
10032722|NCT01920061|11156851|FG014|NOT COMPLETED|Overall Study||1
10032723|NCT01920061|11156852|FG015|NOT COMPLETED|Overall Study||3
10032724|NCT01920061|11156853|FG016|NOT COMPLETED|Overall Study||2
10032725|NCT01920061|11156854|FG017|NOT COMPLETED|Overall Study||2
10032726|NCT01920061|11156855|FG018|NOT COMPLETED|Overall Study||6
10032727|NCT01920061|11156856|FG019|NOT COMPLETED|Overall Study||4
10032728|NCT01920152|11156921|FG000|STARTED|Overall Study||19
10032729|NCT01920152|11156922|FG001|STARTED|Overall Study||15
10032730|NCT01920152|11156921|FG000|COMPLETED|Overall Study||18
10032731|NCT01920152|11156922|FG001|COMPLETED|Overall Study||13
10032732|NCT01920152|11156921|FG000|NOT COMPLETED|Overall Study||1
10032733|NCT01920152|11156922|FG001|NOT COMPLETED|Overall Study||2
10032734|NCT01920178|11156930|FG000|STARTED|Overall Study||5
10032735|NCT01920178|11156931|FG001|STARTED|Overall Study||2
10032736|NCT01920178|11156930|FG000|COMPLETED|Overall Study||3
10032737|NCT01920178|11156931|FG001|COMPLETED|Overall Study||1
10032738|NCT01920178|11156930|FG000|NOT COMPLETED|Overall Study||2
10032739|NCT01920178|11156931|FG001|NOT COMPLETED|Overall Study||1
10032740|NCT01920282|11156940|FG000|STARTED|Overall Study||15
10032741|NCT01920282|11156941|FG001|STARTED|Overall Study||15
10032742|NCT01920282|11156942|FG002|STARTED|Overall Study||15
10032743|NCT01920282|11156940|FG000|COMPLETED|Overall Study||15
10032744|NCT01920282|11156941|FG001|COMPLETED|Overall Study||15
10032745|NCT01920282|11156942|FG002|COMPLETED|Overall Study||15
10032746|NCT01920282|11156940|FG000|NOT COMPLETED|Overall Study||0
10032747|NCT01920282|11156941|FG001|NOT COMPLETED|Overall Study||0
10032748|NCT01920282|11156942|FG002|NOT COMPLETED|Overall Study||0
10032749|NCT01920477|11156952|FG000|STARTED|Overall Study||17
10032750|NCT01920477|11156953|FG001|STARTED|Overall Study||18
10032751|NCT01920477|11156952|FG000|Requiried Individualized Follow-up|Overall Study||1
10032752|NCT01920477|11156953|FG001|Requiried Individualized Follow-up|Overall Study||0
10032753|NCT01920477|11156952|FG000|COMPLETED|Overall Study||2
10032754|NCT01920477|11156953|FG001|COMPLETED|Overall Study||1
10032755|NCT01920477|11156952|FG000|NOT COMPLETED|Overall Study||15
10032756|NCT01920477|11156953|FG001|NOT COMPLETED|Overall Study||17
10032757|NCT01920555|11156964|FG000|STARTED|Overall Study||18
10032758|NCT01920555|11156965|FG001|STARTED|Overall Study||20
10032759|NCT01920555|11156966|FG002|STARTED|Overall Study||22
10032760|NCT01920555|11156967|FG003|STARTED|Overall Study||20
10032761|NCT01920555|11156968|FG004|STARTED|Overall Study||19
10032762|NCT01920555|11156964|FG000|COMPLETED|Overall Study||14
10032763|NCT01920555|11156965|FG001|COMPLETED|Overall Study||16
10032764|NCT01920555|11156966|FG002|COMPLETED|Overall Study||21
10032765|NCT01920555|11156967|FG003|COMPLETED|Overall Study||17
10032766|NCT01920555|11156968|FG004|COMPLETED|Overall Study||18
10032767|NCT01920555|11156964|FG000|NOT COMPLETED|Overall Study||4
10032768|NCT01920555|11156965|FG001|NOT COMPLETED|Overall Study||4
10032769|NCT01920555|11156966|FG002|NOT COMPLETED|Overall Study||1
10032770|NCT01920555|11156967|FG003|NOT COMPLETED|Overall Study||3
10032771|NCT01920555|11156968|FG004|NOT COMPLETED|Overall Study||1
10032772|NCT01920568|11156982|FG000|STARTED|Overall Study||326
10032773|NCT01920568|11156983|FG001|STARTED|Overall Study||159
10032774|NCT01920568|11156982|FG000|COMPLETED|Overall Study||175
10032775|NCT01920568|11156983|FG001|COMPLETED|Overall Study||75
10032776|NCT01920568|11156982|FG000|NOT COMPLETED|Overall Study||151
10032777|NCT01920568|11156983|FG001|NOT COMPLETED|Overall Study||84
10032778|NCT01920594|11156992|FG000|STARTED|Overall Study||27
10032779|NCT01920594|11156993|FG001|STARTED|Overall Study||28
10032780|NCT01920594|11156992|FG000|COMPLETED|Overall Study||20
10032781|NCT01920594|11156993|FG001|COMPLETED|Overall Study||25
10032782|NCT01920594|11156992|FG000|NOT COMPLETED|Overall Study||7
10032783|NCT01920594|11156993|FG001|NOT COMPLETED|Overall Study||3
10032784|NCT01920711|11157001|FG000|STARTED|Overall Study||2419
10032785|NCT01920711|11157002|FG001|STARTED|Overall Study||2403
10032786|NCT01920711|11157001|FG000|COMPLETED|Overall Study||2055
10032787|NCT01920711|11157002|FG001|COMPLETED|Overall Study||2030
10032788|NCT01920711|11157001|FG000|NOT COMPLETED|Overall Study||364
10032789|NCT01920711|11157002|FG001|NOT COMPLETED|Overall Study||373
10032790|NCT01920802|11157012|FG000|STARTED|Overall Study||11
10032791|NCT01920802|11157013|FG001|STARTED|Overall Study||9
10032792|NCT01920802|11157014|FG002|STARTED|Overall Study||11
10032793|NCT01920802|11157012|FG000|COMPLETED|Overall Study||7
10032794|NCT01920802|11157013|FG001|COMPLETED|Overall Study||7
10032795|NCT01920802|11157014|FG002|COMPLETED|Overall Study||10
10032796|NCT01920802|11157012|FG000|NOT COMPLETED|Overall Study||4
10032797|NCT01920802|11157013|FG001|NOT COMPLETED|Overall Study||2
10032798|NCT01920802|11157014|FG002|NOT COMPLETED|Overall Study||1
10032799|NCT01920854|11157029|FG000|STARTED|Overall Study||12
10032800|NCT01920854|11157030|FG001|STARTED|Overall Study||6
10032801|NCT01920854|11157031|FG002|STARTED|Overall Study||6
10032802|NCT01920854|11157032|FG003|STARTED|Overall Study||6
10032803|NCT01920854|11157033|FG004|STARTED|Overall Study||6
10032804|NCT01920854|11157034|FG005|STARTED|Overall Study||6
10032805|NCT01920854|11157035|FG006|STARTED|Overall Study||6
10032806|NCT01920854|11157029|FG000|COMPLETED|Overall Study||11
10032807|NCT01920854|11157030|FG001|COMPLETED|Overall Study||6
10032808|NCT01920854|11157031|FG002|COMPLETED|Overall Study||6
10032809|NCT01920854|11157032|FG003|COMPLETED|Overall Study||6
10032810|NCT01920854|11157033|FG004|COMPLETED|Overall Study||5
10032811|NCT01920854|11157034|FG005|COMPLETED|Overall Study||6
10032812|NCT01920854|11157035|FG006|COMPLETED|Overall Study||5
10032813|NCT01920854|11157029|FG000|NOT COMPLETED|Overall Study||1
10032814|NCT01920854|11157030|FG001|NOT COMPLETED|Overall Study||0
10032815|NCT01920854|11157031|FG002|NOT COMPLETED|Overall Study||0
10032816|NCT01920854|11157032|FG003|NOT COMPLETED|Overall Study||0
10032817|NCT01920854|11157033|FG004|NOT COMPLETED|Overall Study||1
10032818|NCT01920854|11157034|FG005|NOT COMPLETED|Overall Study||0
10032819|NCT01920854|11157035|FG006|NOT COMPLETED|Overall Study||1
10032820|NCT01920893|11157072|FG000|STARTED|Overall Study||30
10032821|NCT01920893|11157073|FG001|STARTED|Overall Study||30
10032822|NCT01920893|11157072|FG000|Treated (Safety Population)|Overall Study||30
10032823|NCT01920893|11157073|FG001|Treated (Safety Population)|Overall Study||30
10032824|NCT01920893|11157072|FG000|COMPLETED|Overall Study||23
10032825|NCT01920893|11157073|FG001|COMPLETED|Overall Study||28
10032826|NCT01920893|11157072|FG000|NOT COMPLETED|Overall Study||7
10032827|NCT01920893|11157073|FG001|NOT COMPLETED|Overall Study||2
10032828|NCT01920958|11157080|FG000|STARTED|Overall Study||233
10032829|NCT01920958|11157080|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
10032830|NCT01920958|11157080|FG000|NOT COMPLETED|Overall Study||5
10032831|NCT01921101|11157086|FG000|STARTED|Overall Study||40
10032832|NCT01921101|11157087|FG001|STARTED|Overall Study||38
10032833|NCT01921101|11157086|FG000|COMPLETED|Overall Study||24
10032834|NCT01921101|11157087|FG001|COMPLETED|Overall Study||32
10032835|NCT01921101|11157086|FG000|NOT COMPLETED|Overall Study||16
10032836|NCT01921101|11157087|FG001|NOT COMPLETED|Overall Study||6
10032837|NCT01921179|11157095|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24
10032838|NCT01921179|11157096|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22
10032839|NCT01921179|11157095|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
10032840|NCT01921179|11157096|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
10032841|NCT01921179|11157095|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
10032842|NCT01921179|11157096|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
10032843|NCT01921179|11157095|FG000|STARTED|Long Term Follow-up After GOALS Training||34
10032844|NCT01921179|11157096|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
10032845|NCT01921179|11157095|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32
10032846|NCT01921179|11157096|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0
10032847|NCT01921179|11157095|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
10032848|NCT01921179|11157096|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
10032849|NCT01921205|11157105|FG000|STARTED|Overall Study||172
10032850|NCT01921205|11157106|FG001|STARTED|Overall Study||171
10032851|NCT01921205|11157105|FG000|COMPLETED|Overall Study||151
10032852|NCT01921205|11157106|FG001|COMPLETED|Overall Study||151
10032853|NCT01921205|11157105|FG000|NOT COMPLETED|Overall Study||21
10032854|NCT01921205|11157106|FG001|NOT COMPLETED|Overall Study||20
10032855|NCT01921257|11157112|FG000|STARTED|Overall Study||16
10032856|NCT01921257|11157112|FG000|Placebo run-in|Overall Study||16
10032857|NCT01921257|11157112|FG000|Active Treatment|Overall Study||13
10032858|NCT01921257|11157112|FG000|COMPLETED|Overall Study||13
10032859|NCT01921257|11157112|FG000|NOT COMPLETED|Overall Study||3
10032860|NCT01921270|11157117|FG000|STARTED|Overall Study||18
10032861|NCT01921270|11157117|FG000|COMPLETED|Overall Study||17
10032862|NCT01921270|11157117|FG000|NOT COMPLETED|Overall Study||1
10032863|NCT01921296|11157121|FG000|STARTED|Overall Study||2
10032864|NCT01921296|11157121|FG000|COMPLETED|Overall Study||2
10032865|NCT01921296|11157121|FG000|NOT COMPLETED|Overall Study||0
10032866|NCT01921322|11157127|FG000|STARTED|Overall Study||57
10032867|NCT01921322|11157128|FG001|STARTED|Overall Study||61
10032868|NCT01921322|11157127|FG000|COMPLETED|Overall Study||42
10032869|NCT01921322|11157128|FG001|COMPLETED|Overall Study||44
10032870|NCT01921322|11157127|FG000|NOT COMPLETED|Overall Study||15
10032871|NCT01921322|11157128|FG001|NOT COMPLETED|Overall Study||17
10032872|NCT01921348|11157136|FG000|STARTED|Overall Study||9
10032873|NCT01921348|11157137|FG001|STARTED|Overall Study||9
10032874|NCT01921348|11157136|FG000|COMPLETED|Overall Study||8
10032875|NCT01921348|11157137|FG001|COMPLETED|Overall Study||7
10032876|NCT01921348|11157136|FG000|NOT COMPLETED|Overall Study||1
10032877|NCT01921348|11157137|FG001|NOT COMPLETED|Overall Study||2
10032878|NCT01921387|11157143|FG000|STARTED|Overall Study||20
10032879|NCT01921387|11157143|FG000|COMPLETED|Overall Study||19
10032880|NCT01921387|11157143|FG000|NOT COMPLETED|Overall Study||1
10032881|NCT01921452|11157147|FG000|STARTED|Overall Study||283
10032882|NCT01921452|11157147|FG000|COMPLETED|Overall Study||283
10032883|NCT01921452|11157147|FG000|NOT COMPLETED|Overall Study||0
10032884|NCT01921517|11157154|FG000|STARTED|Overall Study||42
10032885|NCT01921517|11157155|FG001|STARTED|Overall Study||38
10032886|NCT01921517|11157154|FG000|COMPLETED|Overall Study||27
10032887|NCT01921517|11157155|FG001|COMPLETED|Overall Study||29
10032888|NCT01921517|11157154|FG000|NOT COMPLETED|Overall Study||15
10032889|NCT01921517|11157155|FG001|NOT COMPLETED|Overall Study||9
10032890|NCT01921634|11157161|FG000|STARTED|Overall Study||300
10032891|NCT01921634|11157161|FG000|COMPLETED|Overall Study||300
10032892|NCT01921634|11157161|FG000|NOT COMPLETED|Overall Study||0
10032893|NCT01921751|11157169|FG000|STARTED|Overall Study||4
10032894|NCT01921751|11157170|FG001|STARTED|Overall Study||4
10032895|NCT01921751|11157171|FG002|STARTED|Overall Study||5
10032896|NCT01921751|11157169|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4
10032897|NCT01921751|11157170|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4
10032898|NCT01921751|11157171|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5
10032899|NCT01921751|11157169|FG000|NOT COMPLETED|Overall Study||0
10032900|NCT01921751|11157170|FG001|NOT COMPLETED|Overall Study||0
10032901|NCT01921751|11157171|FG002|NOT COMPLETED|Overall Study||0
10032902|NCT01921829|11157182|FG000|STARTED|Overall Study||10
10032903|NCT01921829|11157183|FG001|STARTED|Overall Study||9
10032904|NCT01921829|11157182|FG000|COMPLETED|Overall Study||10
10032905|NCT01921829|11157183|FG001|COMPLETED|Overall Study||8
10032906|NCT01921829|11157182|FG000|NOT COMPLETED|Overall Study||0
10032907|NCT01921829|11157183|FG001|NOT COMPLETED|Overall Study||1
10032908|NCT01921894|11157192|FG000|STARTED|Overall Study||8
10032909|NCT01921894|11157193|FG001|STARTED|Overall Study||8
10032910|NCT01921894|11157194|FG002|STARTED|Overall Study||8
10032911|NCT01921894|11157192|FG000|COMPLETED|Overall Study||8
10032912|NCT01921894|11157193|FG001|COMPLETED|Overall Study||8
10032913|NCT01921894|11157194|FG002|COMPLETED|Overall Study||8
10032914|NCT01921894|11157192|FG000|NOT COMPLETED|Overall Study||0
10032915|NCT01921894|11157193|FG001|NOT COMPLETED|Overall Study||0
10032916|NCT01921894|11157194|FG002|NOT COMPLETED|Overall Study||0
10032917|NCT01922011|11157216|FG000|STARTED|Overall Study|Randomized participants|75
10032918|NCT01922011|11157217|FG001|STARTED|Overall Study|Randomized participants|74
10032919|NCT01922011|11157216|FG000|Treated|Overall Study|Treated Participants|73
10032920|NCT01922011|11157217|FG001|Treated|Overall Study|Treated Participants|73
10032921|NCT01922011|11157216|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
10032922|NCT01922011|11157217|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
10032923|NCT01922011|11157216|FG000|COMPLETED|Overall Study||69
10032924|NCT01922011|11157217|FG001|COMPLETED|Overall Study||69
10032925|NCT01922011|11157216|FG000|NOT COMPLETED|Overall Study||6
10032926|NCT01922011|11157217|FG001|NOT COMPLETED|Overall Study||5
10032927|NCT01922024|11157231|FG000|STARTED|Overall Study||1653
10032928|NCT01922024|11157232|FG001|STARTED|Overall Study||471
10032929|NCT01922024|11157231|FG000|COMPLETED|Overall Study||1653
10032930|NCT01922024|11157232|FG001|COMPLETED|Overall Study||471
10032931|NCT01922024|11157231|FG000|NOT COMPLETED|Overall Study||0
10032932|NCT01922024|11157232|FG001|NOT COMPLETED|Overall Study||0
10032933|NCT01922037|11157240|FG000|STARTED|Overall Study||69
10032934|NCT01922037|11157241|FG001|STARTED|Overall Study||737
10032935|NCT01922037|11157240|FG000|Treated|Overall Study||69
10032936|NCT01922037|11157241|FG001|Treated|Overall Study||732
10032937|NCT01922037|11157240|FG000|COMPLETED|Overall Study||59
10032938|NCT01922037|11157241|FG001|COMPLETED|Overall Study||563
10032939|NCT01922037|11157240|FG000|NOT COMPLETED|Overall Study||10
10032940|NCT01922037|11157241|FG001|NOT COMPLETED|Overall Study||174
10032941|NCT01922050|11157263|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10032942|NCT01922050|11157264|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10032943|NCT01922050|11157265|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6
10032944|NCT01922050|11157266|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6
10032945|NCT01922050|11157267|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17
10032946|NCT01922050|11157268|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18
10032947|NCT01922050|11157269|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10032948|NCT01922050|11157270|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10032949|NCT01922050|11157271|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6
10032950|NCT01922050|11157272|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10032951|NCT01922050|11157273|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10032952|NCT01922050|11157274|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10032953|NCT01922050|11157275|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10032954|NCT01922050|11157276|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10032955|NCT01922050|11157263|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10032956|NCT01922050|11157264|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10032957|NCT01922050|11157265|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
10032958|NCT01922050|11157266|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
10032959|NCT01922050|11157267|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
10032960|NCT01922050|11157268|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
10032961|NCT01922050|11157269|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10032962|NCT01922050|11157270|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10032963|NCT01922050|11157271|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
10032964|NCT01922050|11157272|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10032965|NCT01922050|11157273|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032966|NCT01922050|11157274|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032967|NCT01922050|11157275|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032968|NCT01922050|11157276|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032969|NCT01922050|11157263|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032970|NCT01922050|11157264|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032971|NCT01922050|11157265|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032972|NCT01922050|11157266|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032973|NCT01922050|11157267|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032974|NCT01922050|11157268|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032975|NCT01922050|11157269|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032976|NCT01922050|11157270|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032977|NCT01922050|11157271|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032978|NCT01922050|11157272|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032979|NCT01922050|11157273|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032980|NCT01922050|11157274|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032981|NCT01922050|11157275|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032982|NCT01922050|11157276|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10032983|NCT01922050|11157263|FG000|STARTED|Part 2 Double-blind Phase||0
10032984|NCT01922050|11157264|FG001|STARTED|Part 2 Double-blind Phase||0
10032985|NCT01922050|11157265|FG002|STARTED|Part 2 Double-blind Phase||0
10032986|NCT01922050|11157266|FG003|STARTED|Part 2 Double-blind Phase||0
10032987|NCT01922050|11157267|FG004|STARTED|Part 2 Double-blind Phase||0
10032988|NCT01922050|11157268|FG005|STARTED|Part 2 Double-blind Phase||0
10032989|NCT01922050|11157269|FG006|STARTED|Part 2 Double-blind Phase||0
10032990|NCT01922050|11157270|FG007|STARTED|Part 2 Double-blind Phase||0
10032991|NCT01922050|11157271|FG008|STARTED|Part 2 Double-blind Phase||0
10032992|NCT01922050|11157272|FG009|STARTED|Part 2 Double-blind Phase||0
10032993|NCT01922050|11157273|FG010|STARTED|Part 2 Double-blind Phase||62
10032994|NCT01922050|11157274|FG011|STARTED|Part 2 Double-blind Phase||60
10032995|NCT01922050|11157275|FG012|STARTED|Part 2 Double-blind Phase||62
10032996|NCT01922050|11157276|FG013|STARTED|Part 2 Double-blind Phase||59
10032997|NCT01922050|11157263|FG000|COMPLETED|Part 2 Double-blind Phase||0
10032998|NCT01922050|11157264|FG001|COMPLETED|Part 2 Double-blind Phase||0
10032999|NCT01922050|11157265|FG002|COMPLETED|Part 2 Double-blind Phase||0
10033000|NCT01922050|11157266|FG003|COMPLETED|Part 2 Double-blind Phase||0
10033001|NCT01922050|11157267|FG004|COMPLETED|Part 2 Double-blind Phase||0
10033002|NCT01922050|11157268|FG005|COMPLETED|Part 2 Double-blind Phase||0
10033003|NCT01922050|11157269|FG006|COMPLETED|Part 2 Double-blind Phase||0
10033004|NCT01922050|11157270|FG007|COMPLETED|Part 2 Double-blind Phase||0
10033005|NCT01922050|11157271|FG008|COMPLETED|Part 2 Double-blind Phase||0
10033006|NCT01922050|11157272|FG009|COMPLETED|Part 2 Double-blind Phase||0
10033007|NCT01922050|11157273|FG010|COMPLETED|Part 2 Double-blind Phase||61
10033008|NCT01922050|11157274|FG011|COMPLETED|Part 2 Double-blind Phase||58
10033009|NCT01922050|11157275|FG012|COMPLETED|Part 2 Double-blind Phase||62
10033010|NCT01922050|11157276|FG013|COMPLETED|Part 2 Double-blind Phase||56
10033011|NCT01922050|11157263|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
10033012|NCT01922050|11157264|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
10033013|NCT01922050|11157265|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
10033014|NCT01922050|11157266|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
10033015|NCT01922050|11157267|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
10033016|NCT01922050|11157268|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
10033017|NCT01922050|11157269|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0
10033018|NCT01922050|11157270|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
10033019|NCT01922050|11157271|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0
10033020|NCT01922050|11157272|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0
10033021|NCT01922050|11157273|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1
10033022|NCT01922050|11157274|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2
10033023|NCT01922050|11157275|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0
10033024|NCT01922050|11157276|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3
10033025|NCT01922089|11157308|FG000|STARTED|Overall Study||247
10033026|NCT01922089|11157309|FG001|STARTED|Overall Study||251
10033027|NCT01922089|11157308|FG000|Safety Set|Overall Study||246
10033028|NCT01922089|11157309|FG001|Safety Set|Overall Study||251
10033029|NCT01922089|11157308|FG000|COMPLETED|Overall Study||208
10033030|NCT01922089|11157309|FG001|COMPLETED|Overall Study||221
10033031|NCT01922089|11157308|FG000|NOT COMPLETED|Overall Study||39
10033032|NCT01922089|11157309|FG001|NOT COMPLETED|Overall Study||30
10033033|NCT01922102|11157318|FG000|STARTED|Overall Study||182
10033034|NCT01922102|11157319|FG001|STARTED|Overall Study||184
10033035|NCT01922102|11157320|FG002|STARTED|Overall Study||91
10033036|NCT01922102|11157318|FG000|COMPLETED|Overall Study||173
10033037|NCT01922102|11157319|FG001|COMPLETED|Overall Study||175
10033038|NCT01922102|11157320|FG002|COMPLETED|Overall Study||83
10033039|NCT01922102|11157318|FG000|NOT COMPLETED|Overall Study||9
10033040|NCT01922102|11157319|FG001|NOT COMPLETED|Overall Study||9
10033041|NCT01922102|11157320|FG002|NOT COMPLETED|Overall Study||8
10033042|NCT01922115|11157334|FG000|STARTED|Overall Study||28
10033043|NCT01922115|11157335|FG001|STARTED|Overall Study||31
10033044|NCT01922115|11157334|FG000|COMPLETED|Overall Study||21
10033045|NCT01922115|11157335|FG001|COMPLETED|Overall Study||24
10033046|NCT01922115|11157334|FG000|NOT COMPLETED|Overall Study||7
10033047|NCT01922115|11157335|FG001|NOT COMPLETED|Overall Study||7
10033048|NCT01922219|11157341|FG000|STARTED|Overall Study||37
10033049|NCT01922219|11157341|FG000|COMPLETED|Overall Study||28
10033050|NCT01922219|11157341|FG000|NOT COMPLETED|Overall Study||9
10033051|NCT01922258|11157347|FG000|STARTED|Overall Study||133
10033052|NCT01922258|11157348|FG001|STARTED|Overall Study||137
10033053|NCT01922258|11157347|FG000|COMPLETED|Overall Study||117
10033054|NCT01922258|11157348|FG001|COMPLETED|Overall Study||121
10033055|NCT01922258|11157347|FG000|NOT COMPLETED|Overall Study||16
10033056|NCT01922258|11157348|FG001|NOT COMPLETED|Overall Study||16
10033057|NCT01922271|11157356|FG000|STARTED|PERIOD 1||76
10033058|NCT01922271|11157357|FG001|STARTED|PERIOD 1||76
10033059|NCT01922271|11157356|FG000|COMPLETED|PERIOD 1||76
10033060|NCT01922271|11157357|FG001|COMPLETED|PERIOD 1||76
10033061|NCT01922271|11157356|FG000|NOT COMPLETED|PERIOD 1||0
10033062|NCT01922271|11157357|FG001|NOT COMPLETED|PERIOD 1||0
10033063|NCT01922271|11157356|FG000|STARTED|WASHOUT Period||76
10033064|NCT01922271|11157357|FG001|STARTED|WASHOUT Period||76
10033065|NCT01922271|11157356|FG000|COMPLETED|WASHOUT Period||75
10033066|NCT01922271|11157357|FG001|COMPLETED|WASHOUT Period||76
10033067|NCT01922271|11157356|FG000|NOT COMPLETED|WASHOUT Period||1
10033068|NCT01922271|11157357|FG001|NOT COMPLETED|WASHOUT Period||0
10033069|NCT01922271|11157356|FG000|STARTED|PERIOD 2||75
10033070|NCT01922271|11157357|FG001|STARTED|PERIOD 2||76
10033071|NCT01922271|11157356|FG000|COMPLETED|PERIOD 2||75
10033072|NCT01922271|11157357|FG001|COMPLETED|PERIOD 2||76
10033073|NCT01922271|11157356|FG000|NOT COMPLETED|PERIOD 2||0
10033074|NCT01922271|11157357|FG001|NOT COMPLETED|PERIOD 2||0
10033075|NCT01922336|11157366|FG000|STARTED|Overall Study||53
10033076|NCT01922336|11157367|FG001|STARTED|Overall Study||53
10033077|NCT01922336|11157368|FG002|STARTED|Overall Study||53
10033078|NCT01922336|11157366|FG000|COMPLETED|Overall Study||53
10033079|NCT01922336|11157367|FG001|COMPLETED|Overall Study||53
10033080|NCT01922336|11157368|FG002|COMPLETED|Overall Study||53
10033081|NCT01922336|11157366|FG000|NOT COMPLETED|Overall Study||0
10033082|NCT01922336|11157367|FG001|NOT COMPLETED|Overall Study||0
10033083|NCT01922336|11157368|FG002|NOT COMPLETED|Overall Study||0
10081570|NCT02262078|11210141|FG001|COMPLETED|Overall Study||13
10081571|NCT02262078|11210140|FG000|NOT COMPLETED|Overall Study||0
10081572|NCT02262078|11210141|FG001|NOT COMPLETED|Overall Study||0
10081573|NCT02262130|11210147|FG000|STARTED|Overall Study||10
10081574|NCT02262130|11210147|FG000|COMPLETED|Overall Study||10
10081575|NCT02262130|11210147|FG000|NOT COMPLETED|Overall Study||0
10081576|NCT02262260|11210153|FG000|STARTED|Overall Study||45
10081577|NCT02262260|11210154|FG001|STARTED|Overall Study||42
10081578|NCT02262260|11210153|FG000|COMPLETED|Overall Study||34
10081579|NCT02262260|11210154|FG001|COMPLETED|Overall Study||32
10081580|NCT02262260|11210153|FG000|NOT COMPLETED|Overall Study||11
10081581|NCT02262260|11210154|FG001|NOT COMPLETED|Overall Study||10
10081582|NCT02262364|11210160|FG000|STARTED|Study Enrollment||11
10081583|NCT02262364|11210160|FG000|COMPLETED|Study Enrollment||11
10081584|NCT02262364|11210160|FG000|NOT COMPLETED|Study Enrollment||0
10081585|NCT02262364|11210160|FG000|STARTED|Blood Draw for Device Processing||11
10081586|NCT02262364|11210160|FG000|COMPLETED|Blood Draw for Device Processing||10
10081587|NCT02262364|11210160|FG000|NOT COMPLETED|Blood Draw for Device Processing||1
10081588|NCT02262364|11210160|FG000|STARTED|Injection With APS||10
10081589|NCT02262364|11210160|FG000|COMPLETED|Injection With APS||10
10081590|NCT02262364|11210160|FG000|NOT COMPLETED|Injection With APS||0
10081591|NCT02262364|11210160|FG000|STARTED|Follow-Up Through 12 Months||10
10081592|NCT02262364|11210160|FG000|COMPLETED|Follow-Up Through 12 Months||10
10081593|NCT02262364|11210160|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0
10081594|NCT02262377|11210166|FG000|STARTED|Overall Study||80
10081595|NCT02262377|11210167|FG001|STARTED|Overall Study||79
10081596|NCT02262377|11210166|FG000|COMPLETED|Overall Study||68
10081597|NCT02262377|11210167|FG001|COMPLETED|Overall Study||73
10081598|NCT02262377|11210166|FG000|NOT COMPLETED|Overall Study||12
10081599|NCT02262377|11210167|FG001|NOT COMPLETED|Overall Study||6
10081600|NCT02262507|11210174|FG000|STARTED|Overall Study||410
10081601|NCT02262507|11210174|FG000|COMPLETED|Overall Study||410
10081602|NCT02262507|11210174|FG000|NOT COMPLETED|Overall Study||0
10081603|NCT02262728|11210181|FG000|STARTED|Treatment Period (12 Weeks)||19
10081604|NCT02262728|11210182|FG001|STARTED|Treatment Period (12 Weeks)||21
10081605|NCT02262728|11210181|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
10081606|NCT02262728|11210182|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
10081607|NCT02262728|11210181|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0
10081608|NCT02262728|11210182|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
10081609|NCT02262728|11210181|FG000|STARTED|Follow-up Phase (3 Years)||19
10081610|NCT02262728|11210182|FG001|STARTED|Follow-up Phase (3 Years)||21
10081611|NCT02262728|11210181|FG000|COMPLETED|Follow-up Phase (3 Years)||15
10081612|NCT02262728|11210182|FG001|COMPLETED|Follow-up Phase (3 Years)||18
10081613|NCT02262728|11210181|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4
10081614|NCT02262728|11210182|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3
10081615|NCT02262754|11210191|FG000|STARTED|Overall Study||74
10081616|NCT02262754|11210192|FG001|STARTED|Overall Study||74
10081617|NCT02262754|11210193|FG002|STARTED|Overall Study||74
10081618|NCT02262754|11210191|FG000|COMPLETED|Overall Study||58
10081619|NCT02262754|11210192|FG001|COMPLETED|Overall Study||65
10081620|NCT02262754|11210193|FG002|COMPLETED|Overall Study||65
10081621|NCT02262754|11210191|FG000|NOT COMPLETED|Overall Study||16
10081622|NCT02262754|11210192|FG001|NOT COMPLETED|Overall Study||9
10081623|NCT02262754|11210193|FG002|NOT COMPLETED|Overall Study||9
10081624|NCT02263014|11210205|FG000|STARTED|Overall Study||44
10081625|NCT02263014|11210206|FG001|STARTED|Overall Study||208
10081626|NCT02263014|11210205|FG000|COMPLETED|Overall Study||44
10081627|NCT02263014|11210206|FG001|COMPLETED|Overall Study||208
10081628|NCT02263014|11210205|FG000|NOT COMPLETED|Overall Study||0
10081629|NCT02263014|11210206|FG001|NOT COMPLETED|Overall Study||0
10081630|NCT02263040|11210216|FG000|STARTED|Overall Study||87
10081631|NCT02263040|11210217|FG001|STARTED|Overall Study||83
10081632|NCT02263040|11210216|FG000|COMPLETED|Overall Study||87
10081633|NCT02263040|11210217|FG001|COMPLETED|Overall Study||83
10081634|NCT02263040|11210216|FG000|NOT COMPLETED|Overall Study||0
10081635|NCT02263040|11210217|FG001|NOT COMPLETED|Overall Study||0
10081636|NCT02263079|11210230|FG000|STARTED|Overall Study||26
10081637|NCT02263079|11210231|FG001|STARTED|Overall Study||33
10081638|NCT02263079|11210232|FG002|STARTED|Overall Study||3
10081639|NCT02263079|11210230|FG000|COMPLETED|Overall Study||23
10081640|NCT02263079|11210231|FG001|COMPLETED|Overall Study||25
10081641|NCT02263079|11210232|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3
10081642|NCT02263079|11210230|FG000|NOT COMPLETED|Overall Study||3
10033084|NCT01922349|11157380|FG000|STARTED|Single Rising Dose (SRD) Period||25
10033085|NCT01922349|11157381|FG001|STARTED|Single Rising Dose (SRD) Period||27
10033086|NCT01922349|11157382|FG002|STARTED|Single Rising Dose (SRD) Period||18
10033087|NCT01922349|11157383|FG003|STARTED|Single Rising Dose (SRD) Period||27
10033088|NCT01922349|11157380|FG000|COMPLETED|Single Rising Dose (SRD) Period||25
10033089|NCT01922349|11157381|FG001|COMPLETED|Single Rising Dose (SRD) Period||27
10033090|NCT01922349|11157382|FG002|COMPLETED|Single Rising Dose (SRD) Period||18
10033091|NCT01922349|11157383|FG003|COMPLETED|Single Rising Dose (SRD) Period||27
10033092|NCT01922349|11157380|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10033093|NCT01922349|11157381|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10033094|NCT01922349|11157382|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10033095|NCT01922349|11157383|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10033096|NCT01922349|11157380|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
10033097|NCT01922349|11157381|FG001|STARTED|Multiple Rising Dose (MRD) Period||27
10033098|NCT01922349|11157382|FG002|STARTED|Multiple Rising Dose (MRD) Period||18
10033099|NCT01922349|11157383|FG003|STARTED|Multiple Rising Dose (MRD) Period||27
10033100|NCT01922349|11157380|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24
10033101|NCT01922349|11157381|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27
10033102|NCT01922349|11157382|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18
10033103|NCT01922349|11157383|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26
10033104|NCT01922349|11157380|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
10033105|NCT01922349|11157381|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
10033106|NCT01922349|11157382|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
10033107|NCT01922349|11157383|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
10033108|NCT01922739|11157419|FG000|STARTED|Titration/Adjustment Period||182
10033109|NCT01922739|11157419|FG000|Safety Analysis Set|Titration/Adjustment Period||182
10033110|NCT01922739|11157419|FG000|COMPLETED|Titration/Adjustment Period||170
10033111|NCT01922739|11157419|FG000|NOT COMPLETED|Titration/Adjustment Period||12
10033112|NCT01922739|11157419|FG000|STARTED|Open-label Treatment Period||170
10033113|NCT01922739|11157419|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
10033114|NCT01922739|11157419|FG000|COMPLETED|Open-label Treatment Period||136
10033115|NCT01922739|11157419|FG000|NOT COMPLETED|Open-label Treatment Period||34
10033116|NCT01922934|11157437|FG000|STARTED|Eligible Patients||428
10033117|NCT01922934|11157438|FG001|STARTED|Eligible Patients||4302
10033118|NCT01922934|11157437|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
10033119|NCT01922934|11157438|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
10033120|NCT01922934|11157437|FG000|NOT COMPLETED|Eligible Patients||53
10033121|NCT01922934|11157438|FG001|NOT COMPLETED|Eligible Patients||88
10033122|NCT01922934|11157437|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375
10033123|NCT01922934|11157438|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
10033124|NCT01922934|11157437|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
10033125|NCT01922934|11157438|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
10033126|NCT01922934|11157437|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
10033127|NCT01922934|11157438|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
9706324|NCT00492050|10805300|FG000|STARTED|Overall Study||37
9706325|NCT00492050|10805300|FG000|Inadequate Response to First Two Cycles|Overall Study||25
9706326|NCT00492050|10805300|FG000|Inadequate Response to First 3 Cycles|Overall Study||12
9729090|NCT00116753|10828704|FG000|STARTED|Overall Study|Randomised.|153
9848354|NCT00858637|10961032|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
9848355|NCT00858637|10961033|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
9848356|NCT00858637|10961034|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
9848357|NCT00858637|10961035|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
9848358|NCT00858637|10961036|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
9848359|NCT00858689|10961046|FG000|STARTED|Overall Study||20
9848360|NCT00858689|10961046|FG000|COMPLETED|Overall Study||19
9848361|NCT00858689|10961046|FG000|NOT COMPLETED|Overall Study||1
9848362|NCT00858780|10961050|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
9848363|NCT00858780|10961051|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848364|NCT00858780|10961052|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10033128|NCT01922934|11157437|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
10033129|NCT01922934|11157438|FG001|STARTED|Visit 1- Weight Measured||4214
10033130|NCT01922934|11157437|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
10033131|NCT01922934|11157438|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
10033132|NCT01922934|11157437|FG000|NOT COMPLETED|Visit 1- Weight Measured||21
10033133|NCT01922934|11157438|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284
10033134|NCT01922934|11157437|FG000|STARTED|Visit 12 / Final Visits||119
10033135|NCT01922934|11157438|FG001|STARTED|Visit 12 / Final Visits||2930
10033136|NCT01922934|11157437|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
10033137|NCT01922934|11157438|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
10033138|NCT01922934|11157437|FG000|NOT COMPLETED|Visit 12 / Final Visits||6
10033139|NCT01922934|11157438|FG001|NOT COMPLETED|Visit 12 / Final Visits||290
10033140|NCT01922986|11157448|FG000|STARTED|Overall Study||2
10033141|NCT01922986|11157449|FG001|STARTED|Overall Study||2
10033142|NCT01922986|11157448|FG000|COMPLETED|Overall Study||2
10033143|NCT01922986|11157449|FG001|COMPLETED|Overall Study||2
10033144|NCT01922986|11157448|FG000|NOT COMPLETED|Overall Study||0
10033145|NCT01922986|11157449|FG001|NOT COMPLETED|Overall Study||0
10033146|NCT01923129|11157457|FG000|STARTED|Overall Study||71
10033147|NCT01923129|11157458|FG001|STARTED|Overall Study||71
10033148|NCT01923129|11157457|FG000|COMPLETED|Overall Study||71
10033149|NCT01923129|11157458|FG001|COMPLETED|Overall Study||71
10033150|NCT01923129|11157457|FG000|NOT COMPLETED|Overall Study||0
10033151|NCT01923129|11157458|FG001|NOT COMPLETED|Overall Study||0
10033152|NCT01923181|11157473|FG000|STARTED|Overall Study||70
10033153|NCT01923181|11157474|FG001|STARTED|Overall Study||70
10033154|NCT01923181|11157475|FG002|STARTED|Overall Study||69
10033155|NCT01923181|11157476|FG003|STARTED|Overall Study||70
10033156|NCT01923181|11157477|FG004|STARTED|Overall Study||71
10033157|NCT01923181|11157478|FG005|STARTED|Overall Study||70
10033158|NCT01923181|11157479|FG006|STARTED|Overall Study||70
10033159|NCT01923181|11157480|FG007|STARTED|Overall Study||69
10033160|NCT01923181|11157481|FG008|STARTED|Overall Study||71
10033161|NCT01923181|11157473|FG000|Full Analysis Set (FAS)|Overall Study||70
10033162|NCT01923181|11157474|FG001|Full Analysis Set (FAS)|Overall Study||70
10033163|NCT01923181|11157475|FG002|Full Analysis Set (FAS)|Overall Study||69
10033164|NCT01923181|11157476|FG003|Full Analysis Set (FAS)|Overall Study||70
10033165|NCT01923181|11157477|FG004|Full Analysis Set (FAS)|Overall Study||71
10033166|NCT01923181|11157478|FG005|Full Analysis Set (FAS)|Overall Study||70
10033167|NCT01923181|11157479|FG006|Full Analysis Set (FAS)|Overall Study||70
10033168|NCT01923181|11157480|FG007|Full Analysis Set (FAS)|Overall Study||69
10033169|NCT01923181|11157481|FG008|Full Analysis Set (FAS)|Overall Study||71
10033170|NCT01923181|11157473|FG000|Safety Analysis Set (SAS)|Overall Study||70
10033171|NCT01923181|11157474|FG001|Safety Analysis Set (SAS)|Overall Study||70
10033172|NCT01923181|11157475|FG002|Safety Analysis Set (SAS)|Overall Study||69
10033173|NCT01923181|11157476|FG003|Safety Analysis Set (SAS)|Overall Study||70
10033174|NCT01923181|11157477|FG004|Safety Analysis Set (SAS)|Overall Study||71
10033175|NCT01923181|11157478|FG005|Safety Analysis Set (SAS)|Overall Study||70
10033176|NCT01923181|11157479|FG006|Safety Analysis Set (SAS)|Overall Study||70
10033177|NCT01923181|11157480|FG007|Safety Analysis Set (SAS)|Overall Study||69
10033178|NCT01923181|11157481|FG008|Safety Analysis Set (SAS)|Overall Study||71
10033179|NCT01923181|11157473|FG000|COMPLETED|Overall Study||67
10033180|NCT01923181|11157474|FG001|COMPLETED|Overall Study||64
10033181|NCT01923181|11157475|FG002|COMPLETED|Overall Study||67
10033182|NCT01923181|11157476|FG003|COMPLETED|Overall Study||65
10033183|NCT01923181|11157477|FG004|COMPLETED|Overall Study||63
10033184|NCT01923181|11157478|FG005|COMPLETED|Overall Study||66
10033185|NCT01923181|11157479|FG006|COMPLETED|Overall Study||62
10033186|NCT01923181|11157480|FG007|COMPLETED|Overall Study||61
10033187|NCT01923181|11157481|FG008|COMPLETED|Overall Study||68
10033188|NCT01923181|11157473|FG000|NOT COMPLETED|Overall Study||3
10033189|NCT01923181|11157474|FG001|NOT COMPLETED|Overall Study||6
10033190|NCT01923181|11157475|FG002|NOT COMPLETED|Overall Study||2
10033191|NCT01923181|11157476|FG003|NOT COMPLETED|Overall Study||5
10033192|NCT01923181|11157477|FG004|NOT COMPLETED|Overall Study||8
10033193|NCT01923181|11157478|FG005|NOT COMPLETED|Overall Study||4
10033194|NCT01923181|11157479|FG006|NOT COMPLETED|Overall Study||8
10033195|NCT01923181|11157480|FG007|NOT COMPLETED|Overall Study||8
10033196|NCT01923181|11157481|FG008|NOT COMPLETED|Overall Study||3
10033197|NCT01923285|11157506|FG000|STARTED|Overall Study||76
10033198|NCT01923285|11157507|FG001|STARTED|Overall Study||76
10033199|NCT01923285|11157506|FG000|Modified Intent-to-treat|Overall Study||73
10033200|NCT01923285|11157507|FG001|Modified Intent-to-treat|Overall Study||73
10033201|NCT01923285|11157506|FG000|COMPLETED|Overall Study||69
10033202|NCT01923285|11157507|FG001|COMPLETED|Overall Study||70
10033203|NCT01923285|11157506|FG000|NOT COMPLETED|Overall Study||7
10033204|NCT01923285|11157507|FG001|NOT COMPLETED|Overall Study||6
10033205|NCT01923311|11157515|FG000|STARTED|Overall Study||17
10033206|NCT01923311|11157516|FG001|STARTED|Overall Study||14
10033207|NCT01923311|11157515|FG000|COMPLETED|Overall Study||0
10033208|NCT01923311|11157516|FG001|COMPLETED|Overall Study||13
10033209|NCT01923311|11157515|FG000|NOT COMPLETED|Overall Study||17
10033210|NCT01923311|11157516|FG001|NOT COMPLETED|Overall Study||1
10033211|NCT01923363|11157523|FG000|STARTED|Overall Study||29
10033212|NCT01923363|11157523|FG000|COMPLETED|Overall Study||28
10033213|NCT01923363|11157523|FG000|NOT COMPLETED|Overall Study||1
10033214|NCT01923389|11157529|FG000|STARTED|Overall Study||2
10033215|NCT01923389|11157530|FG001|STARTED|Overall Study||2
10033216|NCT01923389|11157529|FG000|COMPLETED|Overall Study||1
10033217|NCT01923389|11157530|FG001|COMPLETED|Overall Study||2
10033218|NCT01923389|11157529|FG000|NOT COMPLETED|Overall Study||1
10033219|NCT01923389|11157530|FG001|NOT COMPLETED|Overall Study||0
10033220|NCT01923428|11157541|FG000|STARTED|Overall Study||88
10033221|NCT01923428|11157542|FG001|STARTED|Overall Study||89
10033222|NCT01923428|11157543|FG002|STARTED|Overall Study||89
10033223|NCT01923428|11157544|FG003|STARTED|Overall Study||90
10033224|NCT01923428|11157541|FG000|COMPLETED|Overall Study||69
10033225|NCT01923428|11157542|FG001|COMPLETED|Overall Study||77
10033226|NCT01923428|11157543|FG002|COMPLETED|Overall Study||78
10033227|NCT01923428|11157544|FG003|COMPLETED|Overall Study||80
10033228|NCT01923428|11157541|FG000|NOT COMPLETED|Overall Study||19
10033229|NCT01923428|11157542|FG001|NOT COMPLETED|Overall Study||12
10033230|NCT01923428|11157543|FG002|NOT COMPLETED|Overall Study||11
10033231|NCT01923428|11157544|FG003|NOT COMPLETED|Overall Study||10
10033232|NCT01923467|11157554|FG000|STARTED|Overall Study|Offered stop smoking program|767
10033233|NCT01923467|11157554|FG000|Baseline Completed, Enrolled|Overall Study||288
10033234|NCT01923467|11157554|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226
10033235|NCT01923467|11157554|FG000|NOT COMPLETED|Overall Study||541
10033236|NCT01923740|11157560|FG000|STARTED|Overall Study||227
10033237|NCT01923740|11157561|FG001|STARTED|Overall Study||232
10033238|NCT01923740|11157560|FG000|COMPLETED|Overall Study||221
10033239|NCT01923740|11157561|FG001|COMPLETED|Overall Study||223
10033240|NCT01923740|11157560|FG000|NOT COMPLETED|Overall Study||6
10033241|NCT01923740|11157561|FG001|NOT COMPLETED|Overall Study||9
10033242|NCT01923805|11157569|FG000|STARTED|Overall Study|early termination|3
10033243|NCT01923805|11157570|FG001|STARTED|Overall Study|early termination|5
10033244|NCT01923805|11157569|FG000|COMPLETED|Overall Study||0
10033245|NCT01923805|11157570|FG001|COMPLETED|Overall Study||0
10033246|NCT01923805|11157569|FG000|NOT COMPLETED|Overall Study||3
10033247|NCT01923805|11157570|FG001|NOT COMPLETED|Overall Study||5
10033248|NCT01923896|11157578|FG000|STARTED|Overall Study||8
10033249|NCT01923896|11157579|FG001|STARTED|Overall Study||8
10033250|NCT01923896|11157578|FG000|COMPLETED|Overall Study||7
10033251|NCT01923896|11157579|FG001|COMPLETED|Overall Study||8
10033252|NCT01923896|11157578|FG000|NOT COMPLETED|Overall Study||1
10033253|NCT01923896|11157579|FG001|NOT COMPLETED|Overall Study||0
10033254|NCT01923961|11157588|FG000|STARTED|First Intervention||3
10033255|NCT01923961|11157589|FG001|STARTED|First Intervention||3
10033256|NCT01923961|11157590|FG002|STARTED|First Intervention||2
10033257|NCT01923961|11157588|FG000|COMPLETED|First Intervention||3
10033258|NCT01923961|11157589|FG001|COMPLETED|First Intervention||3
10033259|NCT01923961|11157590|FG002|COMPLETED|First Intervention||2
10033260|NCT01923961|11157588|FG000|NOT COMPLETED|First Intervention||0
10033261|NCT01923961|11157589|FG001|NOT COMPLETED|First Intervention||0
10033262|NCT01923961|11157590|FG002|NOT COMPLETED|First Intervention||0
10033263|NCT01923961|11157588|FG000|STARTED|Washout (1 Week)||3
10033264|NCT01923961|11157589|FG001|STARTED|Washout (1 Week)||3
10033265|NCT01923961|11157590|FG002|STARTED|Washout (1 Week)||2
10033266|NCT01923961|11157588|FG000|COMPLETED|Washout (1 Week)||3
10033267|NCT01923961|11157589|FG001|COMPLETED|Washout (1 Week)||3
10033268|NCT01923961|11157590|FG002|COMPLETED|Washout (1 Week)||2
10033269|NCT01923961|11157588|FG000|NOT COMPLETED|Washout (1 Week)||0
10033270|NCT01923961|11157589|FG001|NOT COMPLETED|Washout (1 Week)||0
10033271|NCT01923961|11157590|FG002|NOT COMPLETED|Washout (1 Week)||0
10033272|NCT01923961|11157588|FG000|STARTED|Second Intervention||3
10033273|NCT01923961|11157589|FG001|STARTED|Second Intervention||3
10033274|NCT01923961|11157590|FG002|STARTED|Second Intervention||2
10033275|NCT01923961|11157588|FG000|COMPLETED|Second Intervention||3
10033276|NCT01923961|11157589|FG001|COMPLETED|Second Intervention||3
10033277|NCT01923961|11157590|FG002|COMPLETED|Second Intervention||2
10033278|NCT01923961|11157588|FG000|NOT COMPLETED|Second Intervention||0
10033279|NCT01923961|11157589|FG001|NOT COMPLETED|Second Intervention||0
10033280|NCT01923961|11157590|FG002|NOT COMPLETED|Second Intervention||0
10033281|NCT01923961|11157588|FG000|STARTED|Washout (1 Week)||3
10033282|NCT01923961|11157589|FG001|STARTED|Washout (1 Week)||3
10033283|NCT01923961|11157590|FG002|STARTED|Washout (1 Week)||2
10033284|NCT01923961|11157588|FG000|COMPLETED|Washout (1 Week)||3
10033285|NCT01923961|11157589|FG001|COMPLETED|Washout (1 Week)||3
10033286|NCT01923961|11157590|FG002|COMPLETED|Washout (1 Week)||2
10033287|NCT01923961|11157588|FG000|NOT COMPLETED|Washout (1 Week)||0
10033288|NCT01923961|11157589|FG001|NOT COMPLETED|Washout (1 Week)||0
10033289|NCT01923961|11157590|FG002|NOT COMPLETED|Washout (1 Week)||0
10033290|NCT01923961|11157588|FG000|STARTED|Third Intervention||3
10033291|NCT01923961|11157589|FG001|STARTED|Third Intervention||3
10033292|NCT01923961|11157590|FG002|STARTED|Third Intervention||2
10033293|NCT01923961|11157588|FG000|COMPLETED|Third Intervention||3
10033294|NCT01923961|11157589|FG001|COMPLETED|Third Intervention||3
10033295|NCT01923961|11157590|FG002|COMPLETED|Third Intervention||2
10033296|NCT01923961|11157588|FG000|NOT COMPLETED|Third Intervention||0
10033297|NCT01923961|11157589|FG001|NOT COMPLETED|Third Intervention||0
10033298|NCT01923961|11157590|FG002|NOT COMPLETED|Third Intervention||0
10033299|NCT01924169|11157598|FG000|STARTED|Overall Study||3
10033300|NCT01924169|11157598|FG000|COMPLETED|Overall Study||3
10033301|NCT01924169|11157598|FG000|NOT COMPLETED|Overall Study||0
10033302|NCT01924182|11157604|FG000|STARTED|Overall Study||3
10033303|NCT01924182|11157605|FG001|STARTED|Overall Study||0
10033304|NCT01924182|11157604|FG000|COMPLETED|Overall Study||2
10033305|NCT01924182|11157605|FG001|COMPLETED|Overall Study||0
10033306|NCT01924182|11157604|FG000|NOT COMPLETED|Overall Study||1
10033307|NCT01924182|11157605|FG001|NOT COMPLETED|Overall Study||0
10033308|NCT01924299|11157613|FG000|STARTED|Period 1||18
10033309|NCT01924299|11157614|FG001|STARTED|Period 1||18
10033310|NCT01924299|11157613|FG000|Received Baricitinib|Period 1||18
10033311|NCT01924299|11157614|FG001|Received Baricitinib|Period 1||18
10033312|NCT01924299|11157613|FG000|COMPLETED|Period 1||18
10033313|NCT01924299|11157614|FG001|COMPLETED|Period 1||18
10033314|NCT01924299|11157613|FG000|NOT COMPLETED|Period 1||0
10033315|NCT01924299|11157614|FG001|NOT COMPLETED|Period 1||0
10033316|NCT01924299|11157613|FG000|STARTED|Period 2||18
10033317|NCT01924299|11157614|FG001|STARTED|Period 2||18
10033318|NCT01924299|11157613|FG000|Received at Least 1 Dose of Study Drug|Period 2||18
10033319|NCT01924299|11157614|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
10033320|NCT01924299|11157613|FG000|Received Baricitinib|Period 2||17
10033321|NCT01924299|11157614|FG001|Received Baricitinib|Period 2||17
10033322|NCT01924299|11157613|FG000|COMPLETED|Period 2||17
10033323|NCT01924299|11157614|FG001|COMPLETED|Period 2||17
10033324|NCT01924299|11157613|FG000|NOT COMPLETED|Period 2||1
10033325|NCT01924299|11157614|FG001|NOT COMPLETED|Period 2||1
10033326|NCT01924364|11157626|FG000|STARTED|Overall Study||7
10033327|NCT01924364|11157626|FG000|COMPLETED|Overall Study||4
10033328|NCT01924364|11157626|FG000|NOT COMPLETED|Overall Study||3
10033329|NCT01924390|11157643|FG000|STARTED|Overall Study||22
10033330|NCT01924390|11157644|FG001|STARTED|Overall Study||22
10033331|NCT01924390|11157643|FG000|COMPLETED|Overall Study||21
10033332|NCT01924390|11157644|FG001|COMPLETED|Overall Study||21
10033333|NCT01924390|11157643|FG000|NOT COMPLETED|Overall Study||1
10033334|NCT01924390|11157644|FG001|NOT COMPLETED|Overall Study||1
10033335|NCT01924429|11157652|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17
10033336|NCT01924429|11157653|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13
10033337|NCT01924429|11157652|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
10033338|NCT01924429|11157653|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
10033339|NCT01924429|11157652|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
10033340|NCT01924429|11157653|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
10033341|NCT01924429|11157652|FG000|STARTED|Washout Period (2 Weeks)||17
10033342|NCT01924429|11157653|FG001|STARTED|Washout Period (2 Weeks)||13
10033343|NCT01924429|11157652|FG000|COMPLETED|Washout Period (2 Weeks)||14
10033344|NCT01924429|11157653|FG001|COMPLETED|Washout Period (2 Weeks)||11
10033345|NCT01924429|11157652|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3
10033346|NCT01924429|11157653|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
10033347|NCT01924429|11157652|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14
10033348|NCT01924429|11157653|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11
10033349|NCT01924429|11157652|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
10033350|NCT01924429|11157653|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
10033351|NCT01924429|11157652|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
10033352|NCT01924429|11157653|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
10033353|NCT01924442|11157663|FG000|STARTED|Overall Study||1099
10033354|NCT01924442|11157664|FG001|STARTED|Overall Study||1104
10033355|NCT01924442|11157663|FG000|COMPLETED|Overall Study||1059
10033356|NCT01924442|11157664|FG001|COMPLETED|Overall Study||967
10033357|NCT01924442|11157663|FG000|NOT COMPLETED|Overall Study||40
10033358|NCT01924442|11157664|FG001|NOT COMPLETED|Overall Study||137
10033359|NCT01924559|11157670|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
10033360|NCT01924559|11157670|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
10033361|NCT01924559|11157670|FG000|NOT COMPLETED|Overall Study||0
10033362|NCT01924689|11157690|FG000|STARTED|Overall Study||3
10033363|NCT01924689|11157691|FG001|STARTED|Overall Study||3
10033364|NCT01924689|11157692|FG002|STARTED|Overall Study||4
10033365|NCT01924689|11157693|FG003|STARTED|Overall Study||6
10033366|NCT01924689|11157694|FG004|STARTED|Overall Study||6
10033367|NCT01924689|11157695|FG005|STARTED|Overall Study||2
10033368|NCT01924689|11157690|FG000|COMPLETED|Overall Study||0
10033369|NCT01924689|11157691|FG001|COMPLETED|Overall Study||0
10033370|NCT01924689|11157692|FG002|COMPLETED|Overall Study||0
10033371|NCT01924689|11157693|FG003|COMPLETED|Overall Study||0
10033372|NCT01924689|11157694|FG004|COMPLETED|Overall Study||0
10033373|NCT01924689|11157695|FG005|COMPLETED|Overall Study||0
10033374|NCT01924689|11157690|FG000|NOT COMPLETED|Overall Study||3
10033375|NCT01924689|11157691|FG001|NOT COMPLETED|Overall Study||3
10033376|NCT01924689|11157692|FG002|NOT COMPLETED|Overall Study||4
10033377|NCT01924689|11157693|FG003|NOT COMPLETED|Overall Study||6
10033378|NCT01924689|11157694|FG004|NOT COMPLETED|Overall Study||6
10033379|NCT01924689|11157695|FG005|NOT COMPLETED|Overall Study||2
10033380|NCT01924754|11157716|FG000|STARTED|Overall Study||50
10033381|NCT01924754|11157717|FG001|STARTED|Overall Study||50
10033382|NCT01924754|11157718|FG002|STARTED|Overall Study||50
10033383|NCT01924754|11157716|FG000|COMPLETED|Overall Study||49
10033384|NCT01924754|11157717|FG001|COMPLETED|Overall Study||47
10033385|NCT01924754|11157718|FG002|COMPLETED|Overall Study||47
10033386|NCT01924754|11157716|FG000|NOT COMPLETED|Overall Study||1
10033387|NCT01924754|11157717|FG001|NOT COMPLETED|Overall Study||3
10033388|NCT01924754|11157718|FG002|NOT COMPLETED|Overall Study||3
10033389|NCT01924767|11157734|FG000|STARTED|Overall Study||12
10033390|NCT01924767|11157735|FG001|STARTED|Overall Study||9
10033391|NCT01924767|11157736|FG002|STARTED|Overall Study||9
10033392|NCT01924767|11157737|FG003|STARTED|Overall Study||9
10033393|NCT01924767|11157738|FG004|STARTED|Overall Study||9
10033394|NCT01924767|11157734|FG000|COMPLETED|Overall Study||11
10033395|NCT01924767|11157735|FG001|COMPLETED|Overall Study||9
10033396|NCT01924767|11157736|FG002|COMPLETED|Overall Study||8
10033397|NCT01924767|11157737|FG003|COMPLETED|Overall Study||9
10033398|NCT01924767|11157738|FG004|COMPLETED|Overall Study||9
10033399|NCT01924767|11157734|FG000|NOT COMPLETED|Overall Study||1
10033400|NCT01924767|11157735|FG001|NOT COMPLETED|Overall Study||0
10033401|NCT01924767|11157736|FG002|NOT COMPLETED|Overall Study||1
10033402|NCT01924767|11157737|FG003|NOT COMPLETED|Overall Study||0
10033403|NCT01924767|11157738|FG004|NOT COMPLETED|Overall Study||0
10033404|NCT01924806|11157757|FG000|STARTED|Overall Study||5
10033405|NCT01924806|11157758|FG001|STARTED|Overall Study||4
10033406|NCT01924806|11157757|FG000|COMPLETED|Overall Study||3
10033407|NCT01924806|11157758|FG001|COMPLETED|Overall Study||3
10033408|NCT01924806|11157757|FG000|NOT COMPLETED|Overall Study||2
10033409|NCT01924806|11157758|FG001|NOT COMPLETED|Overall Study||1
10033410|NCT01924845|11157764|FG000|STARTED|Overall Study||24
10033411|NCT01924845|11157764|FG000|COMPLETED|Overall Study||18
10033412|NCT01924845|11157764|FG000|NOT COMPLETED|Overall Study||6
10033413|NCT01924871|11157770|FG000|STARTED|Overall Study||31
10033414|NCT01924871|11157771|FG001|STARTED|Overall Study||31
10033415|NCT01924871|11157770|FG000|COMPLETED|Overall Study||25
10033416|NCT01924871|11157771|FG001|COMPLETED|Overall Study||29
10033417|NCT01924871|11157770|FG000|NOT COMPLETED|Overall Study||6
10033418|NCT01924871|11157771|FG001|NOT COMPLETED|Overall Study||2
10033419|NCT01924949|11157777|FG000|STARTED|Overall Study||5
10033420|NCT01924949|11157777|FG000|COMPLETED|Overall Study||5
10033421|NCT01924949|11157777|FG000|NOT COMPLETED|Overall Study||0
10033422|NCT01924975|11157783|FG000|STARTED|Overall Study||51
10033423|NCT01924975|11157784|FG001|STARTED|Overall Study||51
10033424|NCT01924975|11157783|FG000|COMPLETED|Overall Study||51
10033425|NCT01924975|11157784|FG001|COMPLETED|Overall Study||51
10033426|NCT01924975|11157783|FG000|NOT COMPLETED|Overall Study||0
10033427|NCT01924975|11157784|FG001|NOT COMPLETED|Overall Study||0
10033428|NCT01924988|11157790|FG000|STARTED|Overall Study||15
10033429|NCT01924988|11157790|FG000|COMPLETED|Overall Study||15
10033430|NCT01924988|11157790|FG000|NOT COMPLETED|Overall Study||0
10033431|NCT01925014|11157799|FG000|STARTED|Overall Study||1535
10033432|NCT01925014|11157800|FG001|STARTED|Overall Study||1539
10033433|NCT01925014|11157799|FG000|COMPLETED|Overall Study||1526
10033434|NCT01925014|11157800|FG001|COMPLETED|Overall Study||1520
10033435|NCT01925014|11157799|FG000|NOT COMPLETED|Overall Study||9
10033436|NCT01925014|11157800|FG001|NOT COMPLETED|Overall Study||19
10033437|NCT01925144|11157806|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
10033438|NCT01925144|11157806|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
10033439|NCT01925144|11157806|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
10033440|NCT01925144|11157806|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
10033441|NCT01925144|11157806|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
10033442|NCT01925144|11157806|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
10033443|NCT01925144|11157806|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
10033444|NCT01925144|11157806|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
10033445|NCT01925144|11157806|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
10033446|NCT01925170|11157813|FG000|STARTED|Overall Study||1638
10033447|NCT01925170|11157813|FG000|COMPLETED|Overall Study||1585
10033448|NCT01925170|11157813|FG000|NOT COMPLETED|Overall Study||53
10033449|NCT01925183|11157821|FG000|STARTED|Overall Study||3
10033450|NCT01925183|11157822|FG001|STARTED|Overall Study||3
10033451|NCT01925183|11157821|FG000|COMPLETED|Overall Study||2
10033452|NCT01925183|11157822|FG001|COMPLETED|Overall Study||3
10033453|NCT01925183|11157821|FG000|NOT COMPLETED|Overall Study||1
10033454|NCT01925183|11157822|FG001|NOT COMPLETED|Overall Study||0
10033455|NCT01925209|11157832|FG000|STARTED|Treatment Epoch||63
10033456|NCT01925209|11157833|FG001|STARTED|Treatment Epoch||63
10033457|NCT01925209|11157834|FG002|STARTED|Treatment Epoch||63
10033458|NCT01925209|11157835|FG003|STARTED|Treatment Epoch||62
10033459|NCT01925209|11157832|FG000|Full Analysis Set|Treatment Epoch||63
10033460|NCT01925209|11157833|FG001|Full Analysis Set|Treatment Epoch||63
10033461|NCT01925209|11157834|FG002|Full Analysis Set|Treatment Epoch||63
10033462|NCT01925209|11157835|FG003|Full Analysis Set|Treatment Epoch||62
10033463|NCT01925209|11157832|FG000|COMPLETED|Treatment Epoch||54
10033464|NCT01925209|11157833|FG001|COMPLETED|Treatment Epoch||55
10033465|NCT01925209|11157834|FG002|COMPLETED|Treatment Epoch||56
10033466|NCT01925209|11157835|FG003|COMPLETED|Treatment Epoch||57
10033467|NCT01925209|11157832|FG000|NOT COMPLETED|Treatment Epoch||9
10033468|NCT01925209|11157833|FG001|NOT COMPLETED|Treatment Epoch||8
10033469|NCT01925209|11157834|FG002|NOT COMPLETED|Treatment Epoch||7
10033470|NCT01925209|11157835|FG003|NOT COMPLETED|Treatment Epoch||5
10033471|NCT01925209|11157832|FG000|STARTED|Maintenance Treatment Epoch||49
10033472|NCT01925209|11157833|FG001|STARTED|Maintenance Treatment Epoch||46
10033473|NCT01925209|11157834|FG002|STARTED|Maintenance Treatment Epoch||52
10033474|NCT01925209|11157835|FG003|STARTED|Maintenance Treatment Epoch||50
10033475|NCT01925209|11157832|FG000|COMPLETED|Maintenance Treatment Epoch||49
10033476|NCT01925209|11157833|FG001|COMPLETED|Maintenance Treatment Epoch||45
10033477|NCT01925209|11157834|FG002|COMPLETED|Maintenance Treatment Epoch||50
10033478|NCT01925209|11157835|FG003|COMPLETED|Maintenance Treatment Epoch||48
10033479|NCT01925209|11157832|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0
10033480|NCT01925209|11157833|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1
10033481|NCT01925209|11157834|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2
10033482|NCT01925209|11157835|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2
10033483|NCT01925209|11157832|FG000|STARTED|Follow-up||57
10033484|NCT01925209|11157833|FG001|STARTED|Follow-up||61
10033485|NCT01925209|11157834|FG002|STARTED|Follow-up||56
10033486|NCT01925209|11157835|FG003|STARTED|Follow-up||58
10033487|NCT01925209|11157832|FG000|COMPLETED|Follow-up||56
10033488|NCT01925209|11157833|FG001|COMPLETED|Follow-up||55
10033489|NCT01925209|11157834|FG002|COMPLETED|Follow-up||55
10033490|NCT01925209|11157835|FG003|COMPLETED|Follow-up||54
10033491|NCT01925209|11157832|FG000|NOT COMPLETED|Follow-up||1
10033492|NCT01925209|11157833|FG001|NOT COMPLETED|Follow-up||6
10033493|NCT01925209|11157834|FG002|NOT COMPLETED|Follow-up||1
10033494|NCT01925209|11157835|FG003|NOT COMPLETED|Follow-up||4
10033495|NCT01925274|11157848|FG000|STARTED|Overall Study||7
10033496|NCT01925274|11157849|FG001|STARTED|Overall Study||6
10033497|NCT01925274|11157850|FG002|STARTED|Overall Study||6
10033498|NCT01925274|11157848|FG000|COMPLETED|Overall Study||0
10033499|NCT01925274|11157849|FG001|COMPLETED|Overall Study||0
10033500|NCT01925274|11157850|FG002|COMPLETED|Overall Study||0
10033501|NCT01925274|11157848|FG000|NOT COMPLETED|Overall Study||7
10033502|NCT01925274|11157849|FG001|NOT COMPLETED|Overall Study||6
10033503|NCT01925274|11157850|FG002|NOT COMPLETED|Overall Study||6
10033504|NCT01925339|11157862|FG000|STARTED|Overall Study||20
10033505|NCT01925339|11157863|FG001|STARTED|Overall Study||20
10033506|NCT01925339|11157862|FG000|COMPLETED|Overall Study||18
10033507|NCT01925339|11157863|FG001|COMPLETED|Overall Study||20
10033508|NCT01925339|11157862|FG000|NOT COMPLETED|Overall Study||2
10033509|NCT01925339|11157863|FG001|NOT COMPLETED|Overall Study||0
10033510|NCT01925404|11157873|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|
10033511|NCT01925404|11157874|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
10033512|NCT01925404|11157875|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
10033513|NCT01925404|11157876|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
10033514|NCT01925404|11157873|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10033515|NCT01925404|11157874|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10033516|NCT01925404|11157875|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10033517|NCT01925404|11157876|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10033518|NCT01925404|11157873|FG000|NOT COMPLETED|Overall Study||
10033519|NCT01925404|11157874|FG001|NOT COMPLETED|Overall Study||
10033520|NCT01925404|11157875|FG002|NOT COMPLETED|Overall Study||
10033521|NCT01925404|11157876|FG003|NOT COMPLETED|Overall Study||
10033522|NCT01925417|11157886|FG000|STARTED|Overall Study||34
10033523|NCT01925417|11157886|FG000|COMPLETED|Overall Study||31
10033524|NCT01925417|11157886|FG000|NOT COMPLETED|Overall Study||3
10033525|NCT01925469|11157893|FG000|STARTED|Overall Study||15
10033526|NCT01925469|11157894|FG001|STARTED|Overall Study||15
10033527|NCT01925469|11157893|FG000|COMPLETED|Overall Study||14
10033528|NCT01925469|11157894|FG001|COMPLETED|Overall Study||15
10033529|NCT01925469|11157893|FG000|NOT COMPLETED|Overall Study||1
10033530|NCT01925469|11157894|FG001|NOT COMPLETED|Overall Study||0
10033531|NCT01925612|11157905|FG000|STARTED|Overall Study||29
10033532|NCT01925612|11157906|FG001|STARTED|Overall Study||22
10033533|NCT01925612|11157907|FG002|STARTED|Overall Study||11
10033534|NCT01925612|11157908|FG003|STARTED|Overall Study||11
10033535|NCT01925612|11157909|FG004|STARTED|Overall Study||12
10033536|NCT01925612|11157905|FG000|COMPLETED|Overall Study||25
10033537|NCT01925612|11157906|FG001|COMPLETED|Overall Study||18
10033538|NCT01925612|11157907|FG002|COMPLETED|Overall Study||10
10033539|NCT01925612|11157908|FG003|COMPLETED|Overall Study||10
10033540|NCT01925612|11157909|FG004|COMPLETED|Overall Study||10
10033541|NCT01925612|11157905|FG000|NOT COMPLETED|Overall Study||4
10033542|NCT01925612|11157906|FG001|NOT COMPLETED|Overall Study||4
10033543|NCT01925612|11157907|FG002|NOT COMPLETED|Overall Study||1
10033544|NCT01925612|11157908|FG003|NOT COMPLETED|Overall Study||1
10033545|NCT01925612|11157909|FG004|NOT COMPLETED|Overall Study||2
10033546|NCT01925677|11157921|FG000|STARTED|Overall Study||3
10033547|NCT01925677|11157921|FG000|COMPLETED|Overall Study||3
10033548|NCT01925677|11157921|FG000|NOT COMPLETED|Overall Study||0
10033549|NCT01925703|11157925|FG000|STARTED|Overall Study||13
10033550|NCT01925703|11157925|FG000|Dosing Regimen Completed|Overall Study||12
10033551|NCT01925703|11157925|FG000|Full Iron Repletion Achieved|Overall Study||11
10033552|NCT01925703|11157925|FG000|Follow-up Completed|Overall Study||9
10033553|NCT01925703|11157925|FG000|COMPLETED|Overall Study||9
10033554|NCT01925703|11157925|FG000|NOT COMPLETED|Overall Study||4
10033555|NCT01925768|11157931|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
10033556|NCT01925768|11157932|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
10033557|NCT01925768|11157931|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
10033558|NCT01925768|11157932|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
10033559|NCT01925768|11157931|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
10033560|NCT01925768|11157932|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
10033561|NCT01925768|11157931|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
10033562|NCT01925768|11157932|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
10081643|NCT02263079|11210231|FG001|NOT COMPLETED|Overall Study||8
10033563|NCT01925768|11157931|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
10033564|NCT01925768|11157932|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
10033565|NCT01925768|11157931|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
10033566|NCT01925768|11157932|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
10033567|NCT01925768|11157931|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
10033568|NCT01925768|11157932|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
10033569|NCT01925768|11157931|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
10033570|NCT01925768|11157932|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
10033571|NCT01925768|11157931|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
10033572|NCT01925768|11157932|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
10033573|NCT01925781|11157944|FG000|STARTED|Overall Study||5
10033574|NCT01925781|11157945|FG001|STARTED|Overall Study||5
10033575|NCT01925781|11157944|FG000|COMPLETED|Overall Study||3
10033576|NCT01925781|11157945|FG001|COMPLETED|Overall Study||1
10033577|NCT01925781|11157944|FG000|NOT COMPLETED|Overall Study||2
10033578|NCT01925781|11157945|FG001|NOT COMPLETED|Overall Study||4
10033579|NCT01925950|11157953|FG000|STARTED|Part 1||1
10033580|NCT01925950|11157954|FG001|STARTED|Part 1||1
10033581|NCT01925950|11157953|FG000|COMPLETED|Part 1||1
10033582|NCT01925950|11157954|FG001|COMPLETED|Part 1||1
10033583|NCT01925950|11157953|FG000|NOT COMPLETED|Part 1||0
10033584|NCT01925950|11157954|FG001|NOT COMPLETED|Part 1||0
10033585|NCT01925950|11157953|FG000|STARTED|Part 2||1
10033586|NCT01925950|11157954|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
10033587|NCT01925950|11157953|FG000|COMPLETED|Part 2||0
10033588|NCT01925950|11157954|FG001|COMPLETED|Part 2||0
10033589|NCT01925950|11157953|FG000|NOT COMPLETED|Part 2||1
10033590|NCT01925950|11157954|FG001|NOT COMPLETED|Part 2||0
10033591|NCT01925989|11157962|FG000|STARTED|Period 1||7
10033592|NCT01925989|11157963|FG001|STARTED|Period 1||8
10033593|NCT01925989|11157964|FG002|STARTED|Period 1||12
10033594|NCT01925989|11157962|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
10033595|NCT01925989|11157963|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
10033596|NCT01925989|11157964|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
10033597|NCT01925989|11157962|FG000|COMPLETED|Period 1||6
10033598|NCT01925989|11157963|FG001|COMPLETED|Period 1||6
10033599|NCT01925989|11157964|FG002|COMPLETED|Period 1||12
10033600|NCT01925989|11157962|FG000|NOT COMPLETED|Period 1||1
10033601|NCT01925989|11157963|FG001|NOT COMPLETED|Period 1||2
10033602|NCT01925989|11157964|FG002|NOT COMPLETED|Period 1||0
10033603|NCT01925989|11157962|FG000|STARTED|Period 2||6
10033604|NCT01925989|11157963|FG001|STARTED|Period 2||6
10033605|NCT01925989|11157964|FG002|STARTED|Period 2||12
10033606|NCT01925989|11157962|FG000|COMPLETED|Period 2||6
10033607|NCT01925989|11157963|FG001|COMPLETED|Period 2||6
10033608|NCT01925989|11157964|FG002|COMPLETED|Period 2||12
10033609|NCT01925989|11157962|FG000|NOT COMPLETED|Period 2||0
10033610|NCT01925989|11157963|FG001|NOT COMPLETED|Period 2||0
10033611|NCT01925989|11157964|FG002|NOT COMPLETED|Period 2||0
10033612|NCT01926015|11157978|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
10033613|NCT01926015|11157979|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
10033614|NCT01926015|11157978|FG000|Received >=1 Vaccination|Overall Study||94
10033615|NCT01926015|11157979|FG001|Received >=1 Vaccination|Overall Study||96
10115609|NCT02527343|11246455|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115610|NCT02527343|11246456|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115611|NCT02527343|11246451|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115612|NCT02527343|11246452|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115613|NCT02527343|11246453|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1
10115614|NCT02527343|11246454|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2
10115615|NCT02527343|11246455|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115616|NCT02527343|11246456|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10115617|NCT02527343|11246451|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0
10115618|NCT02527343|11246452|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0
10115619|NCT02527343|11246453|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0
10115620|NCT02527343|11246454|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0
10115621|NCT02527343|11246455|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
10115622|NCT02527343|11246456|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
10115623|NCT02527343|11246451|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10115624|NCT02527343|11246452|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10115625|NCT02527343|11246453|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10115626|NCT02527343|11246454|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10115627|NCT02527343|11246455|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1
10115628|NCT02527343|11246456|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3
10115629|NCT02527343|11246451|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10115630|NCT02527343|11246452|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10115631|NCT02527343|11246453|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10115632|NCT02527343|11246454|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10033616|NCT01926015|11157978|FG000|COMPLETED|Overall Study||94
10033617|NCT01926015|11157979|FG001|COMPLETED|Overall Study||95
10033618|NCT01926015|11157978|FG000|NOT COMPLETED|Overall Study||2
10033619|NCT01926015|11157979|FG001|NOT COMPLETED|Overall Study||1
10033620|NCT01926028|11157988|FG000|STARTED|Overall Study||85
10033621|NCT01926028|11157989|FG001|STARTED|Overall Study||89
10033622|NCT01926028|11157990|FG002|STARTED|Overall Study||14
10033623|NCT01926028|11157988|FG000|COMPLETED|Overall Study||64
10033624|NCT01926028|11157989|FG001|COMPLETED|Overall Study||67
10033625|NCT01926028|11157990|FG002|COMPLETED|Overall Study||12
10033626|NCT01926028|11157988|FG000|NOT COMPLETED|Overall Study||21
10033627|NCT01926028|11157989|FG001|NOT COMPLETED|Overall Study||22
10033628|NCT01926028|11157990|FG002|NOT COMPLETED|Overall Study||2
10033629|NCT01926119|11157999|FG000|STARTED|Overall Study||4
10033630|NCT01926119|11157999|FG000|COMPLETED|Overall Study||3
10033631|NCT01926119|11157999|FG000|NOT COMPLETED|Overall Study||1
10033632|NCT01926444|11158007|FG000|STARTED|Overall Study||56
10033633|NCT01926444|11158008|FG001|STARTED|Overall Study||52
10033634|NCT01926444|11158009|FG002|STARTED|Overall Study||57
10033635|NCT01926444|11158010|FG003|STARTED|Overall Study||103
10033636|NCT01926444|11158007|FG000|COMPLETED|Overall Study||56
10033637|NCT01926444|11158008|FG001|COMPLETED|Overall Study||52
10033638|NCT01926444|11158009|FG002|COMPLETED|Overall Study||53
10033639|NCT01926444|11158010|FG003|COMPLETED|Overall Study||101
10033640|NCT01926444|11158007|FG000|NOT COMPLETED|Overall Study||0
10033641|NCT01926444|11158008|FG001|NOT COMPLETED|Overall Study||0
10033642|NCT01926444|11158009|FG002|NOT COMPLETED|Overall Study||4
10033643|NCT01926444|11158010|FG003|NOT COMPLETED|Overall Study||2
10033644|NCT01926496|11158022|FG000|STARTED|Overall Study||240
10033645|NCT01926496|11158023|FG001|STARTED|Overall Study||245
10033646|NCT01926496|11158022|FG000|COMPLETED|Overall Study||203
10033647|NCT01926496|11158023|FG001|COMPLETED|Overall Study||197
10033648|NCT01926496|11158022|FG000|NOT COMPLETED|Overall Study||37
10033649|NCT01926496|11158023|FG001|NOT COMPLETED|Overall Study||48
10033650|NCT01926509|11158037|FG000|STARTED|Overall Study||6
10033651|NCT01926509|11158038|FG001|STARTED|Overall Study||6
10033652|NCT01926509|11158039|FG002|STARTED|Overall Study||5
10033653|NCT01926509|11158040|FG003|STARTED|Overall Study||6
10033654|NCT01926509|11158037|FG000|COMPLETED|Overall Study||5
10033655|NCT01926509|11158038|FG001|COMPLETED|Overall Study||6
10033656|NCT01926509|11158039|FG002|COMPLETED|Overall Study||5
10033657|NCT01926509|11158040|FG003|COMPLETED|Overall Study||6
10033658|NCT01926509|11158037|FG000|NOT COMPLETED|Overall Study||1
10033659|NCT01926509|11158038|FG001|NOT COMPLETED|Overall Study||0
10033660|NCT01926509|11158039|FG002|NOT COMPLETED|Overall Study||0
10033661|NCT01926509|11158040|FG003|NOT COMPLETED|Overall Study||0
10033662|NCT01926626|11158050|FG000|STARTED|Overall Study||38
10033663|NCT01926626|11158050|FG000|Received Moclobemide|Overall Study||37
10033664|NCT01926626|11158050|FG000|COMPLETED|Overall Study||16
10033665|NCT01926626|11158050|FG000|NOT COMPLETED|Overall Study||22
10033666|NCT01926782|11158060|FG000|STARTED|Overall Study||157
10033667|NCT01926782|11158061|FG001|STARTED|Overall Study||78
10033668|NCT01926782|11158062|FG002|STARTED|Overall Study||312
10033669|NCT01926782|11158063|FG003|STARTED|Overall Study||73
10033670|NCT01926782|11158064|FG004|STARTED|Overall Study||37
10033671|NCT01926782|11158065|FG005|STARTED|Overall Study||146
10033672|NCT01926782|11158060|FG000|Treated|Overall Study||157
10033673|NCT01926782|11158061|FG001|Treated|Overall Study||78
10033674|NCT01926782|11158062|FG002|Treated|Overall Study||312
10033675|NCT01926782|11158063|FG003|Treated|Overall Study||72
10033676|NCT01926782|11158064|FG004|Treated|Overall Study||37
10033677|NCT01926782|11158065|FG005|Treated|Overall Study||146
10033678|NCT01926782|11158060|FG000|Completed 24 Weeks Treatment Period|Overall Study||137
10033679|NCT01926782|11158061|FG001|Completed 24 Weeks Treatment Period|Overall Study||68
10033680|NCT01926782|11158062|FG002|Completed 24 Weeks Treatment Period|Overall Study||285
10033681|NCT01926782|11158063|FG003|Completed 24 Weeks Treatment Period|Overall Study||58
10033682|NCT01926782|11158064|FG004|Completed 24 Weeks Treatment Period|Overall Study||31
10033683|NCT01926782|11158065|FG005|Completed 24 Weeks Treatment Period|Overall Study||120
10033684|NCT01926782|11158060|FG000|COMPLETED|Overall Study||129
10033685|NCT01926782|11158061|FG001|COMPLETED|Overall Study||65
10033686|NCT01926782|11158062|FG002|COMPLETED|Overall Study||272
10033687|NCT01926782|11158063|FG003|COMPLETED|Overall Study||53
10033688|NCT01926782|11158064|FG004|COMPLETED|Overall Study||29
10033689|NCT01926782|11158065|FG005|COMPLETED|Overall Study||105
10033690|NCT01926782|11158060|FG000|NOT COMPLETED|Overall Study||28
10033691|NCT01926782|11158061|FG001|NOT COMPLETED|Overall Study||13
10033692|NCT01926782|11158062|FG002|NOT COMPLETED|Overall Study||40
10033693|NCT01926782|11158063|FG003|NOT COMPLETED|Overall Study||20
10033694|NCT01926782|11158064|FG004|NOT COMPLETED|Overall Study||8
10033695|NCT01926782|11158065|FG005|NOT COMPLETED|Overall Study||41
10033696|NCT01926886|11158080|FG000|STARTED|Overall Study||102
10033697|NCT01926886|11158081|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
10033698|NCT01926886|11158080|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
10033699|NCT01926886|11158081|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
10033700|NCT01926886|11158080|FG000|COMPLETED|Overall Study||70
10081644|NCT02263079|11210232|FG002|NOT COMPLETED|Overall Study||0
10081645|NCT02263118|11210244|FG000|STARTED|Overall Study||24
10033701|NCT01926886|11158081|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
10033702|NCT01926886|11158080|FG000|NOT COMPLETED|Overall Study||32
10033703|NCT01926886|11158081|FG001|NOT COMPLETED|Overall Study||0
10033704|NCT01926977|11158089|FG000|STARTED|Overall Study||47
10033705|NCT01926977|11158090|FG001|STARTED|Overall Study||53
10033706|NCT01926977|11158089|FG000|COMPLETED|Overall Study||47
10033707|NCT01926977|11158090|FG001|COMPLETED|Overall Study||53
10033708|NCT01926977|11158089|FG000|NOT COMPLETED|Overall Study||0
10033709|NCT01926977|11158090|FG001|NOT COMPLETED|Overall Study||0
10033710|NCT01927055|11158099|FG000|STARTED|Open-label||61
10033711|NCT01927055|11158100|FG001|STARTED|Open-label||0
10033712|NCT01927055|11158101|FG002|STARTED|Open-label||0
10033713|NCT01927055|11158099|FG000|COMPLETED|Open-label||45
10033714|NCT01927055|11158100|FG001|COMPLETED|Open-label||0
10033715|NCT01927055|11158101|FG002|COMPLETED|Open-label||0
10033716|NCT01927055|11158099|FG000|NOT COMPLETED|Open-label||16
10033717|NCT01927055|11158100|FG001|NOT COMPLETED|Open-label||0
10033718|NCT01927055|11158101|FG002|NOT COMPLETED|Open-label||0
10033719|NCT01927055|11158099|FG000|STARTED|Double-Blind||0
10033720|NCT01927055|11158100|FG001|STARTED|Double-Blind||22
10033721|NCT01927055|11158101|FG002|STARTED|Double-Blind||23
10033722|NCT01927055|11158099|FG000|COMPLETED|Double-Blind||0
10033723|NCT01927055|11158100|FG001|COMPLETED|Double-Blind||11
10033724|NCT01927055|11158101|FG002|COMPLETED|Double-Blind||10
10033725|NCT01927055|11158099|FG000|NOT COMPLETED|Double-Blind||0
10033726|NCT01927055|11158100|FG001|NOT COMPLETED|Double-Blind||11
10033727|NCT01927055|11158101|FG002|NOT COMPLETED|Double-Blind||13
10033728|NCT01927120|11158108|FG000|STARTED|Overall Study||20
10033729|NCT01927120|11158108|FG000|COMPLETED|Overall Study||10
10033730|NCT01927120|11158108|FG000|NOT COMPLETED|Overall Study||10
10033731|NCT01927341|11158117|FG000|STARTED|Phase 1b||10
10033732|NCT01927341|11158118|FG001|STARTED|Phase 1b||0
10033733|NCT01927341|11158119|FG002|STARTED|Phase 1b||0
10033734|NCT01927341|11158120|FG003|STARTED|Phase 1b||0
10033735|NCT01927341|11158121|FG004|STARTED|Phase 1b||0
10033736|NCT01927341|11158117|FG000|COMPLETED|Phase 1b||0
10033737|NCT01927341|11158118|FG001|COMPLETED|Phase 1b||0
10033738|NCT01927341|11158119|FG002|COMPLETED|Phase 1b||0
10033739|NCT01927341|11158120|FG003|COMPLETED|Phase 1b||0
10033740|NCT01927341|11158121|FG004|COMPLETED|Phase 1b||0
10033741|NCT01927341|11158117|FG000|NOT COMPLETED|Phase 1b||10
10033742|NCT01927341|11158118|FG001|NOT COMPLETED|Phase 1b||0
10033743|NCT01927341|11158119|FG002|NOT COMPLETED|Phase 1b||0
10033744|NCT01927341|11158120|FG003|NOT COMPLETED|Phase 1b||0
10033745|NCT01927341|11158121|FG004|NOT COMPLETED|Phase 1b||0
10033746|NCT01927341|11158117|FG000|STARTED|Phase 2||0
10033747|NCT01927341|11158118|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
10033748|NCT01927341|11158119|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
10033749|NCT01927341|11158120|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
10033750|NCT01927341|11158121|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
10033751|NCT01927341|11158117|FG000|COMPLETED|Phase 2||0
10033752|NCT01927341|11158118|FG001|COMPLETED|Phase 2||0
10033753|NCT01927341|11158119|FG002|COMPLETED|Phase 2||0
10033754|NCT01927341|11158120|FG003|COMPLETED|Phase 2||0
10033755|NCT01927341|11158121|FG004|COMPLETED|Phase 2||0
9706327|NCT00492050|10805300|FG000|If Adequate Response to First Two Cycles-participants Proceed to Stem Cell Collection|Overall Study||30
9706328|NCT00492050|10805300|FG000|COMPLETED|Overall Study||28
9706329|NCT00492050|10805300|FG000|NOT COMPLETED|Overall Study||9
9706330|NCT00456261|10805306|FG000|STARTED|Combination Therapy||55
9706331|NCT00456261|10805307|FG001|STARTED|Combination Therapy||55
9706332|NCT00456261|10805306|FG000|COMPLETED|Combination Therapy||3
10033756|NCT01927341|11158117|FG000|NOT COMPLETED|Phase 2||0
10033757|NCT01927341|11158118|FG001|NOT COMPLETED|Phase 2||15
10033758|NCT01927341|11158119|FG002|NOT COMPLETED|Phase 2||5
10033759|NCT01927341|11158120|FG003|NOT COMPLETED|Phase 2||15
10033760|NCT01927341|11158121|FG004|NOT COMPLETED|Phase 2||8
10033761|NCT01927367|11158139|FG000|STARTED|Overall Study||597
10033762|NCT01927367|11158140|FG001|STARTED|Overall Study||548
10033763|NCT01927367|11158139|FG000|COMPLETED|Overall Study||590
10033764|NCT01927367|11158140|FG001|COMPLETED|Overall Study||543
10033765|NCT01927367|11158139|FG000|NOT COMPLETED|Overall Study||7
10033766|NCT01927367|11158140|FG001|NOT COMPLETED|Overall Study||5
10033767|NCT01927497|11158148|FG000|STARTED|Overall Study||50
10033768|NCT01927497|11158149|FG001|STARTED|Overall Study||54
10033769|NCT01927497|11158148|FG000|COMPLETED|Overall Study||48
10033770|NCT01927497|11158149|FG001|COMPLETED|Overall Study||53
10033771|NCT01927497|11158148|FG000|NOT COMPLETED|Overall Study||2
10033772|NCT01927497|11158149|FG001|NOT COMPLETED|Overall Study||1
10033773|NCT01927562|11158155|FG000|STARTED|Overall Study||57
10033774|NCT01927562|11158155|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
10033775|NCT01927562|11158155|FG000|NOT COMPLETED|Overall Study||38
10033776|NCT01927575|11158159|FG000|STARTED|Overall Study||1
10033777|NCT01927575|11158159|FG000|COMPLETED|Overall Study||1
10033778|NCT01927575|11158159|FG000|NOT COMPLETED|Overall Study||0
10033779|NCT01927627|11158167|FG000|STARTED|Overall Study||42
10033780|NCT01927627|11158167|FG000|COMPLETED|Overall Study||37
10033781|NCT01927627|11158167|FG000|NOT COMPLETED|Overall Study||5
10033782|NCT01927718|11158171|FG000|STARTED|Overall Study||10
10033783|NCT01927718|11158171|FG000|COMPLETED|Overall Study||10
10115633|NCT02527343|11246455|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11
10115634|NCT02527343|11246456|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9
10115635|NCT02527343|11246451|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0
10115636|NCT02527343|11246452|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0
10115637|NCT02527343|11246453|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0
10115638|NCT02527343|11246454|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0
10115639|NCT02527343|11246455|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1
10115640|NCT02527343|11246456|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2
10115641|NCT02527343|11246451|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115642|NCT02527343|11246452|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115643|NCT02527343|11246453|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115644|NCT02527343|11246454|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115645|NCT02527343|11246455|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115646|NCT02527343|11246456|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115647|NCT02527343|11246451|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115648|NCT02527343|11246452|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115649|NCT02527343|11246453|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115650|NCT02527343|11246454|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10115651|NCT02527343|11246455|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1
10115652|NCT02527343|11246456|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2
10115653|NCT02527343|11246451|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0
10115654|NCT02527343|11246452|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0
10115655|NCT02527343|11246453|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0
10115656|NCT02527343|11246454|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0
10115657|NCT02527343|11246455|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
10115658|NCT02527343|11246456|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
10115659|NCT02527343|11246451|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115660|NCT02527343|11246452|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115661|NCT02527343|11246453|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115662|NCT02527343|11246454|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115663|NCT02527343|11246455|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11
10115664|NCT02527343|11246456|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11
10115665|NCT02527343|11246451|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115666|NCT02527343|11246452|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115667|NCT02527343|11246453|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115668|NCT02527343|11246454|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10115669|NCT02527343|11246455|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
10115670|NCT02527343|11246456|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
10115671|NCT02527421|11246473|FG000|STARTED|Overall Study||2
10115672|NCT02527421|11246474|FG001|STARTED|Overall Study||1
10115673|NCT02527421|11246473|FG000|COMPLETED|Overall Study||1
10115674|NCT02527421|11246474|FG001|COMPLETED|Overall Study||1
10115675|NCT02527421|11246473|FG000|NOT COMPLETED|Overall Study||1
10115676|NCT02527421|11246474|FG001|NOT COMPLETED|Overall Study||0
10115677|NCT02527512|11246482|FG000|STARTED|Overall Study||85
10115678|NCT02527512|11246483|FG001|STARTED|Overall Study||82
10115679|NCT02527512|11246482|FG000|COMPLETED|Overall Study||77
10115680|NCT02527512|11246483|FG001|COMPLETED|Overall Study||76
10115681|NCT02527512|11246482|FG000|NOT COMPLETED|Overall Study||8
10115682|NCT02527512|11246483|FG001|NOT COMPLETED|Overall Study||6
10115683|NCT02527694|11246495|FG000|STARTED|Overall Study||20
10115684|NCT02527694|11246496|FG001|STARTED|Overall Study||29
10115685|NCT02527694|11246495|FG000|COMPLETED|Overall Study||10
10115686|NCT02527694|11246496|FG001|COMPLETED|Overall Study||21
10115687|NCT02527694|11246495|FG000|NOT COMPLETED|Overall Study||10
10115688|NCT02527694|11246496|FG001|NOT COMPLETED|Overall Study||8
10115689|NCT02528188|11246507|FG000|STARTED|Overall Study||1008
10033784|NCT01927718|11158171|FG000|NOT COMPLETED|Overall Study||0
10033785|NCT01927757|11158175|FG000|STARTED|Overall Study||90
10033786|NCT01927757|11158175|FG000|Received Etanercept|Overall Study||88
10033787|NCT01927757|11158175|FG000|COMPLETED|Overall Study||67
10033788|NCT01927757|11158175|FG000|NOT COMPLETED|Overall Study||23
10033789|NCT01927861|11158185|FG000|STARTED|Pivotal Phase (104 Weeks)||25
10033790|NCT01927861|11158186|FG001|STARTED|Pivotal Phase (104 Weeks)||26
10033791|NCT01927861|11158185|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25
10033792|NCT01927861|11158186|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26
10033793|NCT01927861|11158185|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
10033794|NCT01927861|11158186|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
10033795|NCT01927861|11158185|FG000|STARTED|Extension Phase (104 Weeks)||25
10033796|NCT01927861|11158186|FG001|STARTED|Extension Phase (104 Weeks)||26
10033797|NCT01927861|11158185|FG000|COMPLETED|Extension Phase (104 Weeks)||25
10033798|NCT01927861|11158186|FG001|COMPLETED|Extension Phase (104 Weeks)||23
10033799|NCT01927861|11158185|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0
10033800|NCT01927861|11158186|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3
10033801|NCT01927861|11158185|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
10033802|NCT01927861|11158186|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
10033803|NCT01927861|11158185|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15
10033804|NCT01927861|11158186|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14
10033805|NCT01927861|11158185|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
10033806|NCT01927861|11158186|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
10033807|NCT01927887|11158192|FG000|STARTED|Overall Study||12
10033808|NCT01927887|11158192|FG000|COMPLETED|Overall Study||12
9706333|NCT00456261|10805307|FG001|COMPLETED|Combination Therapy||29
9706334|NCT00456261|10805306|FG000|NOT COMPLETED|Combination Therapy||52
9706335|NCT00456261|10805307|FG001|NOT COMPLETED|Combination Therapy||26
9706336|NCT00456261|10805306|FG000|STARTED|Maintenance Therapy||3
9706337|NCT00456261|10805307|FG001|STARTED|Maintenance Therapy||29
9706338|NCT00456261|10805306|FG000|COMPLETED|Maintenance Therapy||3
9706339|NCT00456261|10805307|FG001|COMPLETED|Maintenance Therapy||29
9706340|NCT00456261|10805306|FG000|NOT COMPLETED|Maintenance Therapy||0
9706341|NCT00456261|10805307|FG001|NOT COMPLETED|Maintenance Therapy||0
9706342|NCT00448630|10805313|FG000|STARTED|Overall Study||328
9706343|NCT00448630|10805313|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
9706344|NCT00448630|10805313|FG000|NOT COMPLETED|Overall Study||27
9706345|NCT00345345|10805330|FG000|STARTED|Overall Study||29
9706346|NCT00345345|10805330|FG000|COMPLETED|Overall Study||27
9706347|NCT00345345|10805330|FG000|NOT COMPLETED|Overall Study||2
9706348|NCT00127127|10805339|FG000|STARTED|Overall Study||3
10033809|NCT01927887|11158192|FG000|NOT COMPLETED|Overall Study||0
10033810|NCT01928030|11158197|FG000|STARTED|Overall Study||3
10033811|NCT01928030|11158198|FG001|STARTED|Overall Study||0
10033812|NCT01928030|11158199|FG002|STARTED|Overall Study||0
10033813|NCT01928030|11158197|FG000|COMPLETED|Overall Study||3
10033814|NCT01928030|11158198|FG001|COMPLETED|Overall Study||0
10033815|NCT01928030|11158199|FG002|COMPLETED|Overall Study||0
10033816|NCT01928030|11158197|FG000|NOT COMPLETED|Overall Study||0
10033817|NCT01928030|11158198|FG001|NOT COMPLETED|Overall Study||0
10033818|NCT01928030|11158199|FG002|NOT COMPLETED|Overall Study||0
10033819|NCT01928186|11158206|FG000|STARTED|Overall Study||28
10033820|NCT01928186|11158206|FG000|COMPLETED|Overall Study||28
10033821|NCT01928186|11158206|FG000|NOT COMPLETED|Overall Study||0
10033822|NCT01928199|11158212|FG000|STARTED|Overall Study||32
10033823|NCT01928199|11158213|FG001|STARTED|Overall Study||29
10033824|NCT01928199|11158212|FG000|COMPLETED|Overall Study||32
10033825|NCT01928199|11158213|FG001|COMPLETED|Overall Study||29
10033826|NCT01928199|11158212|FG000|NOT COMPLETED|Overall Study||0
10033827|NCT01928199|11158213|FG001|NOT COMPLETED|Overall Study||0
10033828|NCT01928225|11158221|FG000|STARTED|Overall Study||90
10033829|NCT01928225|11158222|FG001|STARTED|Overall Study||90
10033830|NCT01928225|11158221|FG000|COMPLETED|Overall Study||87
10033831|NCT01928225|11158222|FG001|COMPLETED|Overall Study||87
10033832|NCT01928225|11158221|FG000|NOT COMPLETED|Overall Study||3
10033833|NCT01928225|11158222|FG001|NOT COMPLETED|Overall Study||3
10033834|NCT01928290|11158231|FG000|STARTED|Overall Study||41
10033835|NCT01928290|11158232|FG001|STARTED|Overall Study||26
10033836|NCT01928290|11158231|FG000|COMPLETED|Overall Study||41
10033837|NCT01928290|11158232|FG001|COMPLETED|Overall Study||26
10033838|NCT01928290|11158231|FG000|NOT COMPLETED|Overall Study||0
10033839|NCT01928290|11158232|FG001|NOT COMPLETED|Overall Study||0
10033840|NCT01928329|11158240|FG000|STARTED|Overall Study||40
10033841|NCT01928329|11158241|FG001|STARTED|Overall Study||39
10033842|NCT01928329|11158240|FG000|COMPLETED|Overall Study||28
10033843|NCT01928329|11158241|FG001|COMPLETED|Overall Study||25
10033844|NCT01928329|11158240|FG000|NOT COMPLETED|Overall Study||12
10033845|NCT01928329|11158241|FG001|NOT COMPLETED|Overall Study||14
10033846|NCT01928381|11158247|FG000|STARTED|Screening for Pain Training||143
10033847|NCT01928381|11158248|FG001|STARTED|Screening for Pain Training||0
10033848|NCT01928381|11158249|FG002|STARTED|Screening for Pain Training||0
10033849|NCT01928381|11158250|FG003|STARTED|Screening for Pain Training||0
10033850|NCT01928381|11158251|FG004|STARTED|Screening for Pain Training||0
10033851|NCT01928381|11158252|FG005|STARTED|Screening for Pain Training||0
10033852|NCT01928381|11158253|FG006|STARTED|Screening for Pain Training||0
10033853|NCT01928381|11158247|FG000|COMPLETED|Screening for Pain Training||83
10033854|NCT01928381|11158248|FG001|COMPLETED|Screening for Pain Training||0
10033855|NCT01928381|11158249|FG002|COMPLETED|Screening for Pain Training||0
10033856|NCT01928381|11158250|FG003|COMPLETED|Screening for Pain Training||0
10033857|NCT01928381|11158251|FG004|COMPLETED|Screening for Pain Training||0
10033858|NCT01928381|11158252|FG005|COMPLETED|Screening for Pain Training||0
10033859|NCT01928381|11158253|FG006|COMPLETED|Screening for Pain Training||0
10033860|NCT01928381|11158247|FG000|NOT COMPLETED|Screening for Pain Training||60
10033861|NCT01928381|11158248|FG001|NOT COMPLETED|Screening for Pain Training||0
10033862|NCT01928381|11158249|FG002|NOT COMPLETED|Screening for Pain Training||0
10033863|NCT01928381|11158250|FG003|NOT COMPLETED|Screening for Pain Training||0
9706349|NCT00127127|10805340|FG001|STARTED|Overall Study||6
9706350|NCT00127127|10805341|FG002|STARTED|Overall Study||3
9706351|NCT00127127|10805342|FG003|STARTED|Overall Study||6
10033864|NCT01928381|11158251|FG004|NOT COMPLETED|Screening for Pain Training||0
10033865|NCT01928381|11158252|FG005|NOT COMPLETED|Screening for Pain Training||0
10033866|NCT01928381|11158253|FG006|NOT COMPLETED|Screening for Pain Training||0
10033867|NCT01928381|11158247|FG000|STARTED|Part 1 - Pain Training||83
9706352|NCT00127127|10805339|FG000|COMPLETED|Overall Study||2
9706353|NCT00127127|10805340|FG001|COMPLETED|Overall Study||1
10033868|NCT01928381|11158248|FG001|STARTED|Part 1 - Pain Training||0
10033869|NCT01928381|11158249|FG002|STARTED|Part 1 - Pain Training||0
10033870|NCT01928381|11158250|FG003|STARTED|Part 1 - Pain Training||0
10033871|NCT01928381|11158251|FG004|STARTED|Part 1 - Pain Training||0
10033872|NCT01928381|11158252|FG005|STARTED|Part 1 - Pain Training||0
10033873|NCT01928381|11158253|FG006|STARTED|Part 1 - Pain Training||0
10033874|NCT01928381|11158247|FG000|COMPLETED|Part 1 - Pain Training||48
10033875|NCT01928381|11158248|FG001|COMPLETED|Part 1 - Pain Training||0
10033876|NCT01928381|11158249|FG002|COMPLETED|Part 1 - Pain Training||0
10033877|NCT01928381|11158250|FG003|COMPLETED|Part 1 - Pain Training||0
10033878|NCT01928381|11158251|FG004|COMPLETED|Part 1 - Pain Training||0
10033879|NCT01928381|11158252|FG005|COMPLETED|Part 1 - Pain Training||0
10033880|NCT01928381|11158253|FG006|COMPLETED|Part 1 - Pain Training||0
10033881|NCT01928381|11158247|FG000|NOT COMPLETED|Part 1 - Pain Training||35
10033882|NCT01928381|11158248|FG001|NOT COMPLETED|Part 1 - Pain Training||0
10033883|NCT01928381|11158249|FG002|NOT COMPLETED|Part 1 - Pain Training||0
10033884|NCT01928381|11158250|FG003|NOT COMPLETED|Part 1 - Pain Training||0
10033885|NCT01928381|11158251|FG004|NOT COMPLETED|Part 1 - Pain Training||0
10033886|NCT01928381|11158252|FG005|NOT COMPLETED|Part 1 - Pain Training||0
10033887|NCT01928381|11158253|FG006|NOT COMPLETED|Part 1 - Pain Training||0
10033888|NCT01928381|11158247|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48
10033889|NCT01928381|11158248|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0
10033890|NCT01928381|11158249|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0
10033891|NCT01928381|11158250|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0
10033892|NCT01928381|11158251|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0
10033893|NCT01928381|11158252|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0
10033894|NCT01928381|11158253|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0
10033895|NCT01928381|11158247|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34
10033896|NCT01928381|11158248|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033897|NCT01928381|11158249|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033898|NCT01928381|11158250|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033899|NCT01928381|11158251|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033900|NCT01928381|11158252|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033901|NCT01928381|11158253|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033902|NCT01928381|11158247|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
10033903|NCT01928381|11158248|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033904|NCT01928381|11158249|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033905|NCT01928381|11158250|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033906|NCT01928381|11158251|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033907|NCT01928381|11158252|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033908|NCT01928381|11158253|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10033909|NCT01928381|11158247|FG000|STARTED|Part 2 - First Intervention||0
10033910|NCT01928381|11158248|FG001|STARTED|Part 2 - First Intervention||6
10033911|NCT01928381|11158249|FG002|STARTED|Part 2 - First Intervention||6
10033912|NCT01928381|11158250|FG003|STARTED|Part 2 - First Intervention||6
10033913|NCT01928381|11158251|FG004|STARTED|Part 2 - First Intervention||4
10033914|NCT01928381|11158252|FG005|STARTED|Part 2 - First Intervention||6
10033915|NCT01928381|11158253|FG006|STARTED|Part 2 - First Intervention||6
10033916|NCT01928381|11158247|FG000|COMPLETED|Part 2 - First Intervention||0
10033917|NCT01928381|11158248|FG001|COMPLETED|Part 2 - First Intervention||6
10033918|NCT01928381|11158249|FG002|COMPLETED|Part 2 - First Intervention||4
10033919|NCT01928381|11158250|FG003|COMPLETED|Part 2 - First Intervention||5
10033920|NCT01928381|11158251|FG004|COMPLETED|Part 2 - First Intervention||4
10033921|NCT01928381|11158252|FG005|COMPLETED|Part 2 - First Intervention||5
10033922|NCT01928381|11158253|FG006|COMPLETED|Part 2 - First Intervention||5
10033923|NCT01928381|11158247|FG000|NOT COMPLETED|Part 2 - First Intervention||0
10033924|NCT01928381|11158248|FG001|NOT COMPLETED|Part 2 - First Intervention||0
10033925|NCT01928381|11158249|FG002|NOT COMPLETED|Part 2 - First Intervention||2
10033926|NCT01928381|11158250|FG003|NOT COMPLETED|Part 2 - First Intervention||1
10033927|NCT01928381|11158251|FG004|NOT COMPLETED|Part 2 - First Intervention||0
10033928|NCT01928381|11158252|FG005|NOT COMPLETED|Part 2 - First Intervention||1
10033929|NCT01928381|11158253|FG006|NOT COMPLETED|Part 2 - First Intervention||1
10033930|NCT01928381|11158247|FG000|STARTED|Washout First Intervention||0
10033931|NCT01928381|11158248|FG001|STARTED|Washout First Intervention||6
10033932|NCT01928381|11158249|FG002|STARTED|Washout First Intervention||4
10033933|NCT01928381|11158250|FG003|STARTED|Washout First Intervention||5
10033934|NCT01928381|11158251|FG004|STARTED|Washout First Intervention||4
10033935|NCT01928381|11158252|FG005|STARTED|Washout First Intervention||5
10033936|NCT01928381|11158253|FG006|STARTED|Washout First Intervention||5
10033937|NCT01928381|11158247|FG000|COMPLETED|Washout First Intervention||0
10033938|NCT01928381|11158248|FG001|COMPLETED|Washout First Intervention||6
10033939|NCT01928381|11158249|FG002|COMPLETED|Washout First Intervention||4
10033940|NCT01928381|11158250|FG003|COMPLETED|Washout First Intervention||5
10033941|NCT01928381|11158251|FG004|COMPLETED|Washout First Intervention||3
10033942|NCT01928381|11158252|FG005|COMPLETED|Washout First Intervention||5
10033943|NCT01928381|11158253|FG006|COMPLETED|Washout First Intervention||5
10033944|NCT01928381|11158247|FG000|NOT COMPLETED|Washout First Intervention||0
10033945|NCT01928381|11158248|FG001|NOT COMPLETED|Washout First Intervention||0
10033946|NCT01928381|11158249|FG002|NOT COMPLETED|Washout First Intervention||0
10033947|NCT01928381|11158250|FG003|NOT COMPLETED|Washout First Intervention||0
10033948|NCT01928381|11158251|FG004|NOT COMPLETED|Washout First Intervention||1
10033949|NCT01928381|11158252|FG005|NOT COMPLETED|Washout First Intervention||0
10033950|NCT01928381|11158253|FG006|NOT COMPLETED|Washout First Intervention||0
10033951|NCT01928381|11158247|FG000|STARTED|Part 2 - Second Intervention||0
10033952|NCT01928381|11158248|FG001|STARTED|Part 2 - Second Intervention||6
10033953|NCT01928381|11158249|FG002|STARTED|Part 2 - Second Intervention||4
10033954|NCT01928381|11158250|FG003|STARTED|Part 2 - Second Intervention||5
10033955|NCT01928381|11158251|FG004|STARTED|Part 2 - Second Intervention||3
10033956|NCT01928381|11158252|FG005|STARTED|Part 2 - Second Intervention||5
10033957|NCT01928381|11158253|FG006|STARTED|Part 2 - Second Intervention||5
10033958|NCT01928381|11158247|FG000|COMPLETED|Part 2 - Second Intervention||0
10033959|NCT01928381|11158248|FG001|COMPLETED|Part 2 - Second Intervention||5
10033960|NCT01928381|11158249|FG002|COMPLETED|Part 2 - Second Intervention||4
10033961|NCT01928381|11158250|FG003|COMPLETED|Part 2 - Second Intervention||4
10033962|NCT01928381|11158251|FG004|COMPLETED|Part 2 - Second Intervention||3
10033963|NCT01928381|11158252|FG005|COMPLETED|Part 2 - Second Intervention||5
10033964|NCT01928381|11158253|FG006|COMPLETED|Part 2 - Second Intervention||5
10033965|NCT01928381|11158247|FG000|NOT COMPLETED|Part 2 - Second Intervention||0
10033966|NCT01928381|11158248|FG001|NOT COMPLETED|Part 2 - Second Intervention||1
10033967|NCT01928381|11158249|FG002|NOT COMPLETED|Part 2 - Second Intervention||0
10033968|NCT01928381|11158250|FG003|NOT COMPLETED|Part 2 - Second Intervention||1
10033969|NCT01928381|11158251|FG004|NOT COMPLETED|Part 2 - Second Intervention||0
10033970|NCT01928381|11158252|FG005|NOT COMPLETED|Part 2 - Second Intervention||0
10033971|NCT01928381|11158253|FG006|NOT COMPLETED|Part 2 - Second Intervention||0
10033972|NCT01928381|11158247|FG000|STARTED|Washout Second Intervention||0
10033973|NCT01928381|11158248|FG001|STARTED|Washout Second Intervention||5
10033974|NCT01928381|11158249|FG002|STARTED|Washout Second Intervention||4
10033975|NCT01928381|11158250|FG003|STARTED|Washout Second Intervention||4
10033976|NCT01928381|11158251|FG004|STARTED|Washout Second Intervention||3
10033977|NCT01928381|11158252|FG005|STARTED|Washout Second Intervention||5
10033978|NCT01928381|11158253|FG006|STARTED|Washout Second Intervention||5
10033979|NCT01928381|11158247|FG000|COMPLETED|Washout Second Intervention||0
10033980|NCT01928381|11158248|FG001|COMPLETED|Washout Second Intervention||5
10033981|NCT01928381|11158249|FG002|COMPLETED|Washout Second Intervention||4
10033982|NCT01928381|11158250|FG003|COMPLETED|Washout Second Intervention||4
10033983|NCT01928381|11158251|FG004|COMPLETED|Washout Second Intervention||3
10033984|NCT01928381|11158252|FG005|COMPLETED|Washout Second Intervention||5
10033985|NCT01928381|11158253|FG006|COMPLETED|Washout Second Intervention||5
10033986|NCT01928381|11158247|FG000|NOT COMPLETED|Washout Second Intervention||0
10033987|NCT01928381|11158248|FG001|NOT COMPLETED|Washout Second Intervention||0
10033988|NCT01928381|11158249|FG002|NOT COMPLETED|Washout Second Intervention||0
10033989|NCT01928381|11158250|FG003|NOT COMPLETED|Washout Second Intervention||0
10033990|NCT01928381|11158251|FG004|NOT COMPLETED|Washout Second Intervention||0
10033991|NCT01928381|11158252|FG005|NOT COMPLETED|Washout Second Intervention||0
10033992|NCT01928381|11158253|FG006|NOT COMPLETED|Washout Second Intervention||0
10033993|NCT01928381|11158247|FG000|STARTED|Part 2 - Third Intervention||0
10033994|NCT01928381|11158248|FG001|STARTED|Part 2 - Third Intervention||5
10033995|NCT01928381|11158249|FG002|STARTED|Part 2 - Third Intervention||4
10033996|NCT01928381|11158250|FG003|STARTED|Part 2 - Third Intervention||4
10033997|NCT01928381|11158251|FG004|STARTED|Part 2 - Third Intervention||3
10033998|NCT01928381|11158252|FG005|STARTED|Part 2 - Third Intervention||5
10033999|NCT01928381|11158253|FG006|STARTED|Part 2 - Third Intervention||5
10034000|NCT01928381|11158247|FG000|COMPLETED|Part 2 - Third Intervention||0
10034001|NCT01928381|11158248|FG001|COMPLETED|Part 2 - Third Intervention||5
10034002|NCT01928381|11158249|FG002|COMPLETED|Part 2 - Third Intervention||4
10034003|NCT01928381|11158250|FG003|COMPLETED|Part 2 - Third Intervention||4
10034004|NCT01928381|11158251|FG004|COMPLETED|Part 2 - Third Intervention||3
10034005|NCT01928381|11158252|FG005|COMPLETED|Part 2 - Third Intervention||5
10034006|NCT01928381|11158253|FG006|COMPLETED|Part 2 - Third Intervention||5
10034007|NCT01928381|11158247|FG000|NOT COMPLETED|Part 2 - Third Intervention||0
10034008|NCT01928381|11158248|FG001|NOT COMPLETED|Part 2 - Third Intervention||0
10034009|NCT01928381|11158249|FG002|NOT COMPLETED|Part 2 - Third Intervention||0
10034010|NCT01928381|11158250|FG003|NOT COMPLETED|Part 2 - Third Intervention||0
10034011|NCT01928381|11158251|FG004|NOT COMPLETED|Part 2 - Third Intervention||0
10034012|NCT01928381|11158252|FG005|NOT COMPLETED|Part 2 - Third Intervention||0
10034013|NCT01928381|11158253|FG006|NOT COMPLETED|Part 2 - Third Intervention||0
10034014|NCT01928381|11158247|FG000|STARTED|Part 2 - Post Third Intervention||0
10034015|NCT01928381|11158248|FG001|STARTED|Part 2 - Post Third Intervention||5
10034016|NCT01928381|11158249|FG002|STARTED|Part 2 - Post Third Intervention||4
10034017|NCT01928381|11158250|FG003|STARTED|Part 2 - Post Third Intervention||4
10034018|NCT01928381|11158251|FG004|STARTED|Part 2 - Post Third Intervention||3
10034019|NCT01928381|11158252|FG005|STARTED|Part 2 - Post Third Intervention||5
10034020|NCT01928381|11158253|FG006|STARTED|Part 2 - Post Third Intervention||5
10034021|NCT01928381|11158247|FG000|COMPLETED|Part 2 - Post Third Intervention||0
10034022|NCT01928381|11158248|FG001|COMPLETED|Part 2 - Post Third Intervention||5
10034023|NCT01928381|11158249|FG002|COMPLETED|Part 2 - Post Third Intervention||3
10034024|NCT01928381|11158250|FG003|COMPLETED|Part 2 - Post Third Intervention||4
10034025|NCT01928381|11158251|FG004|COMPLETED|Part 2 - Post Third Intervention||3
10034026|NCT01928381|11158252|FG005|COMPLETED|Part 2 - Post Third Intervention||5
10081646|NCT02263118|11210245|FG001|STARTED|Overall Study||32
10034027|NCT01928381|11158253|FG006|COMPLETED|Part 2 - Post Third Intervention||5
10034028|NCT01928381|11158247|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0
10034029|NCT01928381|11158248|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0
10034030|NCT01928381|11158249|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1
10034031|NCT01928381|11158250|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0
10034032|NCT01928381|11158251|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0
10034033|NCT01928381|11158252|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0
10034034|NCT01928381|11158253|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0
10034035|NCT01928433|11158266|FG000|STARTED|Overall Study||76
10034036|NCT01928433|11158267|FG001|STARTED|Overall Study||75
10034037|NCT01928433|11158268|FG002|STARTED|Overall Study||74
10034038|NCT01928433|11158266|FG000|COMPLETED|Overall Study||56
10034039|NCT01928433|11158267|FG001|COMPLETED|Overall Study||54
10034040|NCT01928433|11158268|FG002|COMPLETED|Overall Study||46
10034041|NCT01928433|11158266|FG000|NOT COMPLETED|Overall Study||20
10034042|NCT01928433|11158267|FG001|NOT COMPLETED|Overall Study||21
10034043|NCT01928433|11158268|FG002|NOT COMPLETED|Overall Study||28
10034044|NCT01928446|11158281|FG000|STARTED|Overall Study||255
10034045|NCT01928446|11158282|FG001|STARTED|Overall Study||264
10034046|NCT01928446|11158281|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
10034047|NCT01928446|11158282|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
10034048|NCT01928446|11158281|FG000|NOT COMPLETED|Overall Study||111
10034049|NCT01928446|11158282|FG001|NOT COMPLETED|Overall Study||139
10034050|NCT01928472|11158294|FG000|STARTED|Overall Study||98
10034051|NCT01928472|11158295|FG001|STARTED|Overall Study||104
10034052|NCT01928472|11158296|FG002|STARTED|Overall Study||98
10034053|NCT01928472|11158297|FG003|STARTED|Overall Study||102
10034054|NCT01928472|11158294|FG000|COMPLETED|Overall Study||90
10034055|NCT01928472|11158295|FG001|COMPLETED|Overall Study||96
10034056|NCT01928472|11158296|FG002|COMPLETED|Overall Study||91
10034057|NCT01928472|11158297|FG003|COMPLETED|Overall Study||100
10034058|NCT01928472|11158294|FG000|NOT COMPLETED|Overall Study||8
10034059|NCT01928472|11158295|FG001|NOT COMPLETED|Overall Study||8
10034060|NCT01928472|11158296|FG002|NOT COMPLETED|Overall Study||7
10034061|NCT01928472|11158297|FG003|NOT COMPLETED|Overall Study||2
10034062|NCT01928485|11158310|FG000|STARTED|Overall Study||4
10034063|NCT01928485|11158311|FG001|STARTED|Overall Study||2
10034064|NCT01928485|11158310|FG000|COMPLETED|Overall Study||4
10034065|NCT01928485|11158311|FG001|COMPLETED|Overall Study||1
10034066|NCT01928485|11158310|FG000|NOT COMPLETED|Overall Study||0
10034067|NCT01928485|11158311|FG001|NOT COMPLETED|Overall Study||1
10034068|NCT01928524|11158324|FG000|STARTED|Overall Study||3
10034069|NCT01928524|11158325|FG001|STARTED|Overall Study||3
10034070|NCT01928524|11158326|FG002|STARTED|Overall Study||6
10034071|NCT01928524|11158327|FG003|STARTED|Overall Study||6
10034072|NCT01928524|11158328|FG004|STARTED|Overall Study||3
10034073|NCT01928524|11158329|FG005|STARTED|Overall Study||8
10034074|NCT01928524|11158330|FG006|STARTED|Overall Study||5
10034075|NCT01928524|11158324|FG000|COMPLETED|Overall Study||3
10034076|NCT01928524|11158325|FG001|COMPLETED|Overall Study||3
10034077|NCT01928524|11158326|FG002|COMPLETED|Overall Study||6
10034078|NCT01928524|11158327|FG003|COMPLETED|Overall Study||6
10034079|NCT01928524|11158328|FG004|COMPLETED|Overall Study||3
10034080|NCT01928524|11158329|FG005|COMPLETED|Overall Study||8
10034081|NCT01928524|11158330|FG006|COMPLETED|Overall Study||5
10034082|NCT01928524|11158324|FG000|NOT COMPLETED|Overall Study||0
10034083|NCT01928524|11158325|FG001|NOT COMPLETED|Overall Study||0
10034084|NCT01928524|11158326|FG002|NOT COMPLETED|Overall Study||0
10034085|NCT01928524|11158327|FG003|NOT COMPLETED|Overall Study||0
10034086|NCT01928524|11158328|FG004|NOT COMPLETED|Overall Study||0
10034087|NCT01928524|11158329|FG005|NOT COMPLETED|Overall Study||0
10034088|NCT01928524|11158330|FG006|NOT COMPLETED|Overall Study||0
10034089|NCT01928680|11158346|FG000|STARTED|Overall Study||33
10034090|NCT01928680|11158346|FG000|COMPLETED|Overall Study||33
10034091|NCT01928680|11158346|FG000|NOT COMPLETED|Overall Study||0
10034092|NCT01928693|11158353|FG000|STARTED|Overall Study||0
10034093|NCT01928693|11158354|FG001|STARTED|Overall Study||1
10034094|NCT01928693|11158355|FG002|STARTED|Overall Study||1
10034095|NCT01928693|11158353|FG000|COMPLETED|Overall Study||0
10034096|NCT01928693|11158354|FG001|COMPLETED|Overall Study||1
10034097|NCT01928693|11158355|FG002|COMPLETED|Overall Study||1
10034098|NCT01928693|11158353|FG000|NOT COMPLETED|Overall Study||0
10034099|NCT01928693|11158354|FG001|NOT COMPLETED|Overall Study||0
10034100|NCT01928693|11158355|FG002|NOT COMPLETED|Overall Study||0
10034101|NCT01928719|11158365|FG000|STARTED|Overall Study||122
10034102|NCT01928719|11158366|FG001|STARTED|Overall Study||123
10034103|NCT01928719|11158365|FG000|COMPLETED|Overall Study||70
10034104|NCT01928719|11158366|FG001|COMPLETED|Overall Study||104
10034105|NCT01928719|11158365|FG000|NOT COMPLETED|Overall Study||52
10034106|NCT01928719|11158366|FG001|NOT COMPLETED|Overall Study||19
10034107|NCT01928758|11158376|FG000|STARTED|Overall Study||94
10034108|NCT01928758|11158377|FG001|STARTED|Overall Study||94
10034109|NCT01928758|11158376|FG000|COMPLETED|Overall Study||69
10034110|NCT01928758|11158377|FG001|COMPLETED|Overall Study||74
10034111|NCT01928758|11158376|FG000|NOT COMPLETED|Overall Study||25
10034112|NCT01928758|11158377|FG001|NOT COMPLETED|Overall Study||20
10034113|NCT01928771|11158387|FG000|STARTED|Overall Study||400
10034114|NCT01928771|11158388|FG001|STARTED|Overall Study||398
10034115|NCT01928771|11158389|FG002|STARTED|Overall Study||407
10034116|NCT01928771|11158387|FG000|Received Treatment|Overall Study||399
10034117|NCT01928771|11158388|FG001|Received Treatment|Overall Study||398
10034118|NCT01928771|11158389|FG002|Received Treatment|Overall Study||407
10034119|NCT01928771|11158387|FG000|COMPLETED|Overall Study||354
10034120|NCT01928771|11158388|FG001|COMPLETED|Overall Study||358
10034121|NCT01928771|11158389|FG002|COMPLETED|Overall Study||367
10034122|NCT01928771|11158387|FG000|NOT COMPLETED|Overall Study||46
10034123|NCT01928771|11158388|FG001|NOT COMPLETED|Overall Study||40
10034124|NCT01928771|11158389|FG002|NOT COMPLETED|Overall Study||40
10034125|NCT01928797|11158399|FG000|STARTED|Overall Study||30
10034126|NCT01928797|11158400|FG001|STARTED|Overall Study||30
10034127|NCT01928797|11158399|FG000|COMPLETED|Overall Study||30
10034128|NCT01928797|11158400|FG001|COMPLETED|Overall Study||30
10034129|NCT01928797|11158399|FG000|NOT COMPLETED|Overall Study||0
10034130|NCT01928797|11158400|FG001|NOT COMPLETED|Overall Study||0
10034131|NCT01928849|11158410|FG000|STARTED|Overall Study||66
10034132|NCT01928849|11158411|FG001|STARTED|Overall Study||62
10034133|NCT01928849|11158410|FG000|COMPLETED|Overall Study||52
10034134|NCT01928849|11158411|FG001|COMPLETED|Overall Study||55
10034135|NCT01928849|11158410|FG000|NOT COMPLETED|Overall Study||14
10034136|NCT01928849|11158411|FG001|NOT COMPLETED|Overall Study||7
10034137|NCT01928862|11158422|FG000|STARTED|Overall Study||16
10034138|NCT01928862|11158423|FG001|STARTED|Overall Study||16
10034139|NCT01928862|11158424|FG002|STARTED|Overall Study||16
10034140|NCT01928862|11158425|FG003|STARTED|Overall Study||16
10034141|NCT01928862|11158426|FG004|STARTED|Overall Study||14
10034142|NCT01928862|11158422|FG000|COMPLETED|Overall Study||15
10034143|NCT01928862|11158423|FG001|COMPLETED|Overall Study||16
10034144|NCT01928862|11158424|FG002|COMPLETED|Overall Study||16
10034145|NCT01928862|11158425|FG003|COMPLETED|Overall Study||16
10034146|NCT01928862|11158426|FG004|COMPLETED|Overall Study||13
10034147|NCT01928862|11158422|FG000|NOT COMPLETED|Overall Study||1
10034148|NCT01928862|11158423|FG001|NOT COMPLETED|Overall Study||0
10034149|NCT01928862|11158424|FG002|NOT COMPLETED|Overall Study||0
10034150|NCT01928862|11158425|FG003|NOT COMPLETED|Overall Study||0
10034151|NCT01928862|11158426|FG004|NOT COMPLETED|Overall Study||1
10034152|NCT01928927|11158441|FG000|STARTED|Overall Study||29
10034153|NCT01928927|11158442|FG001|STARTED|Overall Study||15
10034154|NCT01928927|11158441|FG000|COMPLETED|Overall Study||27
10034155|NCT01928927|11158442|FG001|COMPLETED|Overall Study||14
10034156|NCT01928927|11158441|FG000|NOT COMPLETED|Overall Study||2
10034157|NCT01928927|11158442|FG001|NOT COMPLETED|Overall Study||1
10034158|NCT01928940|11158454|FG000|STARTED|Overall Study||6
10034159|NCT01928940|11158455|FG001|STARTED|Overall Study||6
10034160|NCT01928940|11158454|FG000|COMPLETED|Overall Study||6
10034161|NCT01928940|11158455|FG001|COMPLETED|Overall Study||5
10034162|NCT01928940|11158454|FG000|NOT COMPLETED|Overall Study||0
10034163|NCT01928940|11158455|FG001|NOT COMPLETED|Overall Study||1
10034164|NCT01929018|11158464|FG000|STARTED|Overall Study||19
10034165|NCT01929018|11158465|FG001|STARTED|Overall Study||19
10034166|NCT01929018|11158464|FG000|COMPLETED|Overall Study||18
10034167|NCT01929018|11158465|FG001|COMPLETED|Overall Study||18
10034168|NCT01929018|11158464|FG000|NOT COMPLETED|Overall Study||1
10034169|NCT01929018|11158465|FG001|NOT COMPLETED|Overall Study||1
10034170|NCT01929031|11158475|FG000|STARTED|Overall Study||213
10034171|NCT01929031|11158476|FG001|STARTED|Overall Study||209
10034172|NCT01929031|11158477|FG002|STARTED|Overall Study||35
10034173|NCT01929031|11158478|FG003|STARTED|Overall Study||35
10034174|NCT01929031|11158479|FG004|STARTED|Overall Study||34
10034175|NCT01929031|11158480|FG005|STARTED|Overall Study||36
10034176|NCT01929031|11158475|FG000|COMPLETED|Overall Study||209
10034177|NCT01929031|11158476|FG001|COMPLETED|Overall Study||207
10034178|NCT01929031|11158477|FG002|COMPLETED|Overall Study||34
10034179|NCT01929031|11158478|FG003|COMPLETED|Overall Study||35
10034180|NCT01929031|11158479|FG004|COMPLETED|Overall Study||33
10034181|NCT01929031|11158480|FG005|COMPLETED|Overall Study||35
10034182|NCT01929031|11158475|FG000|NOT COMPLETED|Overall Study||4
10034183|NCT01929031|11158476|FG001|NOT COMPLETED|Overall Study||2
10034184|NCT01929031|11158477|FG002|NOT COMPLETED|Overall Study||1
10034185|NCT01929031|11158478|FG003|NOT COMPLETED|Overall Study||0
10034186|NCT01929031|11158479|FG004|NOT COMPLETED|Overall Study||1
10034187|NCT01929031|11158480|FG005|NOT COMPLETED|Overall Study||1
10034188|NCT01929044|11158492|FG000|STARTED|Overall Study||153
10034189|NCT01929044|11158493|FG001|STARTED|Overall Study||146
10034190|NCT01929044|11158492|FG000|COMPLETED|Overall Study||142
10034191|NCT01929044|11158493|FG001|COMPLETED|Overall Study||129
10034192|NCT01929044|11158492|FG000|NOT COMPLETED|Overall Study||11
10034193|NCT01929044|11158493|FG001|NOT COMPLETED|Overall Study||17
10034194|NCT01929057|11158501|FG000|STARTED|Overall Study||31
10034195|NCT01929057|11158502|FG001|STARTED|Overall Study||3
10034196|NCT01929057|11158501|FG000|COMPLETED|Overall Study||31
10034197|NCT01929057|11158502|FG001|COMPLETED|Overall Study||3
10034198|NCT01929057|11158501|FG000|NOT COMPLETED|Overall Study||0
10034199|NCT01929057|11158502|FG001|NOT COMPLETED|Overall Study||0
10034200|NCT01929083|11158510|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
10034201|NCT01929083|11158511|FG001|STARTED|Intervention 1||9
10034202|NCT01929083|11158510|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7
10034203|NCT01929083|11158511|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9
10034204|NCT01929083|11158510|FG000|COMPLETED|Intervention 1||7
10034205|NCT01929083|11158511|FG001|COMPLETED|Intervention 1||9
10034206|NCT01929083|11158510|FG000|NOT COMPLETED|Intervention 1||3
10034207|NCT01929083|11158511|FG001|NOT COMPLETED|Intervention 1||0
10034208|NCT01929083|11158510|FG000|STARTED|Intervention 2||7
10034209|NCT01929083|11158511|FG001|STARTED|Intervention 2||9
10034210|NCT01929083|11158510|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7
10034211|NCT01929083|11158511|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8
10034212|NCT01929083|11158510|FG000|COMPLETED|Intervention 2||7
10034213|NCT01929083|11158511|FG001|COMPLETED|Intervention 2||8
10034214|NCT01929083|11158510|FG000|NOT COMPLETED|Intervention 2||0
10034215|NCT01929083|11158511|FG001|NOT COMPLETED|Intervention 2||1
10034216|NCT01929109|11158522|FG000|STARTED|Period 1 (All Groups)||14
10034217|NCT01929109|11158523|FG001|STARTED|Period 1 (All Groups)||8
10034218|NCT01929109|11158524|FG002|STARTED|Period 1 (All Groups)||9
10034219|NCT01929109|11158525|FG003|STARTED|Period 1 (All Groups)||8
10034220|NCT01929109|11158526|FG004|STARTED|Period 1 (All Groups)||8
10034221|NCT01929109|11158522|FG000|COMPLETED|Period 1 (All Groups)||14
10034222|NCT01929109|11158523|FG001|COMPLETED|Period 1 (All Groups)||8
10034223|NCT01929109|11158524|FG002|COMPLETED|Period 1 (All Groups)||8
10034224|NCT01929109|11158525|FG003|COMPLETED|Period 1 (All Groups)||8
10034225|NCT01929109|11158526|FG004|COMPLETED|Period 1 (All Groups)||8
10034226|NCT01929109|11158522|FG000|NOT COMPLETED|Period 1 (All Groups)||0
10034227|NCT01929109|11158523|FG001|NOT COMPLETED|Period 1 (All Groups)||0
10034228|NCT01929109|11158524|FG002|NOT COMPLETED|Period 1 (All Groups)||1
10034229|NCT01929109|11158525|FG003|NOT COMPLETED|Period 1 (All Groups)||0
10034230|NCT01929109|11158526|FG004|NOT COMPLETED|Period 1 (All Groups)||0
10034231|NCT01929109|11158522|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0
10034232|NCT01929109|11158523|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0
10034233|NCT01929109|11158524|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0
10034234|NCT01929109|11158525|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0
10034235|NCT01929109|11158526|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8
10034236|NCT01929109|11158522|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034237|NCT01929109|11158523|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034238|NCT01929109|11158524|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034239|NCT01929109|11158525|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034240|NCT01929109|11158526|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
10034241|NCT01929109|11158522|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034242|NCT01929109|11158523|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034243|NCT01929109|11158524|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034244|NCT01929109|11158525|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10034245|NCT01929109|11158526|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10081647|NCT02263118|11210246|FG002|STARTED|Overall Study||30
10081648|NCT02263118|11210247|FG003|STARTED|Overall Study||14
10081649|NCT02263118|11210244|FG000|COMPLETED|Overall Study||20
10081650|NCT02263118|11210245|FG001|COMPLETED|Overall Study||24
10081651|NCT02263118|11210246|FG002|COMPLETED|Overall Study||22
10081652|NCT02263118|11210247|FG003|COMPLETED|Overall Study||12
10081653|NCT02263118|11210244|FG000|NOT COMPLETED|Overall Study||4
10081654|NCT02263118|11210245|FG001|NOT COMPLETED|Overall Study||8
10081655|NCT02263118|11210246|FG002|NOT COMPLETED|Overall Study||8
10081656|NCT02263118|11210247|FG003|NOT COMPLETED|Overall Study||2
10081657|NCT02263131|11210261|FG000|STARTED|Overall Study||347
10081658|NCT02263131|11210262|FG001|STARTED|Overall Study||69
10081659|NCT02263131|11210261|FG000|COMPLETED|Overall Study||337
10081660|NCT02263131|11210262|FG001|COMPLETED|Overall Study||68
10081661|NCT02263131|11210261|FG000|NOT COMPLETED|Overall Study||10
10081662|NCT02263131|11210262|FG001|NOT COMPLETED|Overall Study||1
10081663|NCT02263326|11210270|FG000|STARTED|Overall Study||44
10081664|NCT02263326|11210271|FG001|STARTED|Overall Study||45
10081665|NCT02263326|11210270|FG000|COMPLETED|Overall Study||43
10081666|NCT02263326|11210271|FG001|COMPLETED|Overall Study||44
10081667|NCT02263326|11210270|FG000|NOT COMPLETED|Overall Study||1
10081668|NCT02263326|11210271|FG001|NOT COMPLETED|Overall Study||1
10081669|NCT02263547|11210277|FG000|STARTED|Overall Study||14
10081670|NCT02263547|11210277|FG000|COMPLETED|Overall Study||11
10081671|NCT02263547|11210277|FG000|NOT COMPLETED|Overall Study||3
10081672|NCT02263833|11210281|FG000|STARTED|Overall Study||742
10081673|NCT02263833|11210281|FG000|COMPLETED|Overall Study||742
10081674|NCT02263833|11210281|FG000|NOT COMPLETED|Overall Study||0
10081675|NCT02263911|11210285|FG000|STARTED|Period 1||4
10081676|NCT02263911|11210286|FG001|STARTED|Period 1||4
10081677|NCT02263911|11210287|FG002|STARTED|Period 1||4
10081678|NCT02263911|11210288|FG003|STARTED|Period 1||4
10081679|NCT02263911|11210285|FG000|COMPLETED|Period 1||4
10081680|NCT02263911|11210286|FG001|COMPLETED|Period 1||4
10081681|NCT02263911|11210287|FG002|COMPLETED|Period 1||4
10081682|NCT02263911|11210288|FG003|COMPLETED|Period 1||4
10081683|NCT02263911|11210285|FG000|NOT COMPLETED|Period 1||0
10081684|NCT02263911|11210286|FG001|NOT COMPLETED|Period 1||0
10081685|NCT02263911|11210287|FG002|NOT COMPLETED|Period 1||0
10081686|NCT02263911|11210288|FG003|NOT COMPLETED|Period 1||0
10081687|NCT02263911|11210285|FG000|STARTED|Period 1 Washout||4
10081688|NCT02263911|11210286|FG001|STARTED|Period 1 Washout||4
10081689|NCT02263911|11210287|FG002|STARTED|Period 1 Washout||4
10081690|NCT02263911|11210288|FG003|STARTED|Period 1 Washout||4
10081691|NCT02263911|11210285|FG000|COMPLETED|Period 1 Washout||4
10081692|NCT02263911|11210286|FG001|COMPLETED|Period 1 Washout||4
10081693|NCT02263911|11210287|FG002|COMPLETED|Period 1 Washout||4
10081694|NCT02263911|11210288|FG003|COMPLETED|Period 1 Washout||4
10081695|NCT02263911|11210285|FG000|NOT COMPLETED|Period 1 Washout||0
10081696|NCT02263911|11210286|FG001|NOT COMPLETED|Period 1 Washout||0
10081697|NCT02263911|11210287|FG002|NOT COMPLETED|Period 1 Washout||0
10034246|NCT01929135|11158543|FG000|STARTED|Overall Study||19
10034247|NCT01929135|11158544|FG001|STARTED|Overall Study||19
10034248|NCT01929135|11158543|FG000|COMPLETED|Overall Study||18
10034249|NCT01929135|11158544|FG001|COMPLETED|Overall Study||18
10034250|NCT01929135|11158543|FG000|NOT COMPLETED|Overall Study||1
10034251|NCT01929135|11158544|FG001|NOT COMPLETED|Overall Study||1
10034252|NCT01929226|11158554|FG000|STARTED|Overall Study||210
10034253|NCT01929226|11158555|FG001|STARTED|Overall Study||70
10034254|NCT01929226|11158554|FG000|COMPLETED|Overall Study||205
10034255|NCT01929226|11158555|FG001|COMPLETED|Overall Study||69
10034256|NCT01929226|11158554|FG000|NOT COMPLETED|Overall Study||5
10034257|NCT01929226|11158555|FG001|NOT COMPLETED|Overall Study||1
10034258|NCT01929291|11158562|FG000|STARTED|Overall Study||672
10034259|NCT01929291|11158562|FG000|COMPLETED|Overall Study||672
10034260|NCT01929291|11158562|FG000|NOT COMPLETED|Overall Study||0
10034261|NCT01929317|11158568|FG000|STARTED|Dose Increase Effect Verification Phase||61
10034262|NCT01929317|11158569|FG001|STARTED|Dose Increase Effect Verification Phase||20
10034263|NCT01929317|11158568|FG000|COMPLETED|Dose Increase Effect Verification Phase||52
10034264|NCT01929317|11158569|FG001|COMPLETED|Dose Increase Effect Verification Phase||19
10034265|NCT01929317|11158568|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9
10034266|NCT01929317|11158569|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1
10034267|NCT01929317|11158568|FG000|STARTED|Long-term Phase||44
10034268|NCT01929317|11158569|FG001|STARTED|Long-term Phase||18
10034269|NCT01929317|11158568|FG000|COMPLETED|Long-term Phase||25
10034270|NCT01929317|11158569|FG001|COMPLETED|Long-term Phase||14
10034271|NCT01929317|11158568|FG000|NOT COMPLETED|Long-term Phase||19
10034272|NCT01929317|11158569|FG001|NOT COMPLETED|Long-term Phase||4
10034273|NCT01929343|11158584|FG000|STARTED|Overall Study||12
10034274|NCT01929343|11158585|FG001|STARTED|Overall Study||9
10034275|NCT01929343|11158586|FG002|STARTED|Overall Study||12
10034276|NCT01929343|11158584|FG000|COMPLETED|Overall Study||11
10034277|NCT01929343|11158585|FG001|COMPLETED|Overall Study||7
10034278|NCT01929343|11158586|FG002|COMPLETED|Overall Study||12
10034279|NCT01929343|11158584|FG000|NOT COMPLETED|Overall Study||1
10034280|NCT01929343|11158585|FG001|NOT COMPLETED|Overall Study||2
10034281|NCT01929343|11158586|FG002|NOT COMPLETED|Overall Study||0
10034282|NCT01929395|11158597|FG000|STARTED|Overall Study||19
10034283|NCT01929395|11158598|FG001|STARTED|Overall Study||70
10034284|NCT01929395|11158599|FG002|STARTED|Overall Study||70
10034285|NCT01929395|11158597|FG000|COMPLETED|Overall Study||18
10034286|NCT01929395|11158598|FG001|COMPLETED|Overall Study||69
10034287|NCT01929395|11158599|FG002|COMPLETED|Overall Study||69
10034288|NCT01929395|11158597|FG000|NOT COMPLETED|Overall Study||1
10034289|NCT01929395|11158598|FG001|NOT COMPLETED|Overall Study||1
10034290|NCT01929395|11158599|FG002|NOT COMPLETED|Overall Study||1
10034291|NCT01929408|11158607|FG000|STARTED|Overall Study||703
10034292|NCT01929408|11158607|FG000|COMPLETED|Overall Study||695
10034293|NCT01929408|11158607|FG000|NOT COMPLETED|Overall Study||8
10034294|NCT01929460|11158613|FG000|STARTED|Overall Study||13
10034295|NCT01929460|11158614|FG001|STARTED|Overall Study||13
10034296|NCT01929460|11158613|FG000|COMPLETED|Overall Study||13
10034297|NCT01929460|11158614|FG001|COMPLETED|Overall Study||13
10034298|NCT01929460|11158613|FG000|NOT COMPLETED|Overall Study||0
10034299|NCT01929460|11158614|FG001|NOT COMPLETED|Overall Study||0
10034300|NCT01929473|11158620|FG000|STARTED|Overall Study|0 day|3830
10034301|NCT01929473|11158620|FG000|365 Day|Overall Study||3589
10034302|NCT01929473|11158620|FG000|COMPLETED|Overall Study||3243
10034303|NCT01929473|11158620|FG000|NOT COMPLETED|Overall Study||587
10034304|NCT01929642|11158624|FG000|STARTED|Overall Study||3
10034305|NCT01929642|11158624|FG000|COMPLETED|Overall Study||1
10034306|NCT01929642|11158624|FG000|NOT COMPLETED|Overall Study||2
10034307|NCT01929681|11158632|FG000|STARTED|Overall Study||28
10034308|NCT01929681|11158633|FG001|STARTED|Overall Study||25
10034309|NCT01929681|11158632|FG000|COMPLETED|Overall Study||26
10115690|NCT02528188|11246508|FG001|STARTED|Overall Study||1005
10115691|NCT02528188|11246509|FG002|STARTED|Overall Study||1008
10115692|NCT02528188|11246507|FG000|Treated|Overall Study||1002
10034310|NCT01929681|11158633|FG001|COMPLETED|Overall Study||24
10034311|NCT01929681|11158632|FG000|NOT COMPLETED|Overall Study||2
10034312|NCT01929681|11158633|FG001|NOT COMPLETED|Overall Study||1
10034313|NCT01929707|11158639|FG000|STARTED|Intervention Period 1||6
10034314|NCT01929707|11158640|FG001|STARTED|Intervention Period 1||8
10034315|NCT01929707|11158641|FG002|STARTED|Intervention Period 1||12
10034316|NCT01929707|11158642|FG003|STARTED|Intervention Period 1||10
10034317|NCT01929707|11158643|FG004|STARTED|Intervention Period 1||0
10034318|NCT01929707|11158644|FG005|STARTED|Intervention Period 1||0
10034319|NCT01929707|11158645|FG006|STARTED|Intervention Period 1||0
10034320|NCT01929707|11158646|FG007|STARTED|Intervention Period 1||0
10034321|NCT01929707|11158639|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
10034322|NCT01929707|11158640|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
10034323|NCT01929707|11158641|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
10034324|NCT01929707|11158642|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
10034325|NCT01929707|11158643|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10034326|NCT01929707|11158644|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10034327|NCT01929707|11158645|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10034328|NCT01929707|11158646|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10034329|NCT01929707|11158639|FG000|COMPLETED|Intervention Period 1||6
10034330|NCT01929707|11158640|FG001|COMPLETED|Intervention Period 1||8
10034331|NCT01929707|11158641|FG002|COMPLETED|Intervention Period 1||12
10034332|NCT01929707|11158642|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
10034333|NCT01929707|11158643|FG004|COMPLETED|Intervention Period 1||0
10034334|NCT01929707|11158644|FG005|COMPLETED|Intervention Period 1||0
10034335|NCT01929707|11158645|FG006|COMPLETED|Intervention Period 1||0
10034336|NCT01929707|11158646|FG007|COMPLETED|Intervention Period 1||0
10034337|NCT01929707|11158639|FG000|NOT COMPLETED|Intervention Period 1||0
10034338|NCT01929707|11158640|FG001|NOT COMPLETED|Intervention Period 1||0
10034339|NCT01929707|11158641|FG002|NOT COMPLETED|Intervention Period 1||0
10034340|NCT01929707|11158642|FG003|NOT COMPLETED|Intervention Period 1||3
10034341|NCT01929707|11158643|FG004|NOT COMPLETED|Intervention Period 1||0
10034342|NCT01929707|11158644|FG005|NOT COMPLETED|Intervention Period 1||0
10034343|NCT01929707|11158645|FG006|NOT COMPLETED|Intervention Period 1||0
10034344|NCT01929707|11158646|FG007|NOT COMPLETED|Intervention Period 1||0
10034345|NCT01929707|11158639|FG000|STARTED|Washout Period ≥7 Days||6
10034346|NCT01929707|11158640|FG001|STARTED|Washout Period ≥7 Days||8
10034347|NCT01929707|11158641|FG002|STARTED|Washout Period ≥7 Days||12
10034348|NCT01929707|11158642|FG003|STARTED|Washout Period ≥7 Days||7
10034349|NCT01929707|11158643|FG004|STARTED|Washout Period ≥7 Days||0
10034350|NCT01929707|11158644|FG005|STARTED|Washout Period ≥7 Days||0
10034351|NCT01929707|11158645|FG006|STARTED|Washout Period ≥7 Days||0
10034352|NCT01929707|11158646|FG007|STARTED|Washout Period ≥7 Days||0
10034353|NCT01929707|11158639|FG000|COMPLETED|Washout Period ≥7 Days||6
10034354|NCT01929707|11158640|FG001|COMPLETED|Washout Period ≥7 Days||8
10034355|NCT01929707|11158641|FG002|COMPLETED|Washout Period ≥7 Days||12
10034356|NCT01929707|11158642|FG003|COMPLETED|Washout Period ≥7 Days||7
10034357|NCT01929707|11158643|FG004|COMPLETED|Washout Period ≥7 Days||0
10034358|NCT01929707|11158644|FG005|COMPLETED|Washout Period ≥7 Days||0
10034359|NCT01929707|11158645|FG006|COMPLETED|Washout Period ≥7 Days||0
10034360|NCT01929707|11158646|FG007|COMPLETED|Washout Period ≥7 Days||0
10034361|NCT01929707|11158639|FG000|NOT COMPLETED|Washout Period ≥7 Days||0
10034362|NCT01929707|11158640|FG001|NOT COMPLETED|Washout Period ≥7 Days||0
10034363|NCT01929707|11158641|FG002|NOT COMPLETED|Washout Period ≥7 Days||0
10034364|NCT01929707|11158642|FG003|NOT COMPLETED|Washout Period ≥7 Days||0
10034365|NCT01929707|11158643|FG004|NOT COMPLETED|Washout Period ≥7 Days||0
10034366|NCT01929707|11158644|FG005|NOT COMPLETED|Washout Period ≥7 Days||0
10034367|NCT01929707|11158645|FG006|NOT COMPLETED|Washout Period ≥7 Days||0
10034368|NCT01929707|11158646|FG007|NOT COMPLETED|Washout Period ≥7 Days||0
10034369|NCT01929707|11158639|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0
10034370|NCT01929707|11158640|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0
10034371|NCT01929707|11158641|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0
10034372|NCT01929707|11158642|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5
10034373|NCT01929707|11158643|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6
10034374|NCT01929707|11158644|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8
10034375|NCT01929707|11158645|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12
10034376|NCT01929707|11158646|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4
10034377|NCT01929707|11158639|FG000|COMPLETED|Intervention Period 2||0
10034378|NCT01929707|11158640|FG001|COMPLETED|Intervention Period 2||0
10034379|NCT01929707|11158641|FG002|COMPLETED|Intervention Period 2||0
10034380|NCT01929707|11158642|FG003|COMPLETED|Intervention Period 2||5
10034381|NCT01929707|11158643|FG004|COMPLETED|Intervention Period 2||6
10034382|NCT01929707|11158644|FG005|COMPLETED|Intervention Period 2||6
10034383|NCT01929707|11158645|FG006|COMPLETED|Intervention Period 2||12
10034384|NCT01929707|11158646|FG007|COMPLETED|Intervention Period 2||4
10034385|NCT01929707|11158639|FG000|NOT COMPLETED|Intervention Period 2||0
10034386|NCT01929707|11158640|FG001|NOT COMPLETED|Intervention Period 2||0
10034387|NCT01929707|11158641|FG002|NOT COMPLETED|Intervention Period 2||0
10034388|NCT01929707|11158642|FG003|NOT COMPLETED|Intervention Period 2||0
10034389|NCT01929707|11158643|FG004|NOT COMPLETED|Intervention Period 2||0
10034390|NCT01929707|11158644|FG005|NOT COMPLETED|Intervention Period 2||2
10034391|NCT01929707|11158645|FG006|NOT COMPLETED|Intervention Period 2||0
10034392|NCT01929707|11158646|FG007|NOT COMPLETED|Intervention Period 2||0
10034393|NCT01929759|11158667|FG000|STARTED|Overall Study||10
10034394|NCT01929759|11158667|FG000|COMPLETED|Overall Study||10
10034395|NCT01929759|11158667|FG000|NOT COMPLETED|Overall Study||0
10034396|NCT01929863|11158671|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7
10034397|NCT01929863|11158672|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8
10034398|NCT01929863|11158671|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
10034399|NCT01929863|11158672|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
10034400|NCT01929863|11158671|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
10034401|NCT01929863|11158672|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
10034402|NCT01929863|11158671|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6
10034403|NCT01929863|11158672|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7
10034404|NCT01929863|11158671|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6
10034405|NCT01929863|11158672|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7
10034406|NCT01929863|11158671|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
10034407|NCT01929863|11158672|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
10034408|NCT01929863|11158671|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6
10034409|NCT01929863|11158672|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7
10081698|NCT02263911|11210288|FG003|NOT COMPLETED|Period 1 Washout||0
10034410|NCT01929863|11158671|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
10034411|NCT01929863|11158672|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
10034412|NCT01929863|11158671|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
10115693|NCT02528188|11246508|FG001|Treated|Overall Study||998
10115694|NCT02528188|11246509|FG002|Treated|Overall Study||996
10115695|NCT02528188|11246507|FG000|COMPLETED|Overall Study||741
10034413|NCT01929863|11158672|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
10034414|NCT01929863|11158671|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
10034415|NCT01929863|11158672|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
10034416|NCT01929863|11158671|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
10034417|NCT01929863|11158672|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
10034418|NCT01929863|11158671|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
10034419|NCT01929863|11158672|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
10034420|NCT01929876|11158683|FG000|STARTED|Period 1||16
10034421|NCT01929876|11158683|FG000|COMPLETED|Period 1||16
10034422|NCT01929876|11158683|FG000|NOT COMPLETED|Period 1||0
10034423|NCT01929876|11158683|FG000|STARTED|Period 2||16
10034424|NCT01929876|11158683|FG000|COMPLETED|Period 2||15
10034425|NCT01929876|11158683|FG000|NOT COMPLETED|Period 2||1
10034426|NCT01929889|11158687|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
10034427|NCT01929889|11158687|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3
10034428|NCT01929889|11158687|FG000|NOT COMPLETED|Overall Study||5
10034429|NCT01929980|11158691|FG000|STARTED|Overall Study||4
10034430|NCT01929980|11158691|FG000|COMPLETED|Overall Study||3
10034431|NCT01929980|11158691|FG000|NOT COMPLETED|Overall Study||1
10034432|NCT01929993|11158697|FG000|STARTED|Overall Study||82
10034433|NCT01929993|11158698|FG001|STARTED|Overall Study||82
10034434|NCT01929993|11158697|FG000|COMPLETED|Overall Study||52
10034435|NCT01929993|11158698|FG001|COMPLETED|Overall Study||54
10034436|NCT01929993|11158697|FG000|NOT COMPLETED|Overall Study||30
10034437|NCT01929993|11158698|FG001|NOT COMPLETED|Overall Study||28
10034438|NCT01930045|11158704|FG000|STARTED|Part 1 - Period 1||3
10034439|NCT01930045|11158705|FG001|STARTED|Part 1 - Period 1||3
10034440|NCT01930045|11158706|FG002|STARTED|Part 1 - Period 1||3
10034441|NCT01930045|11158707|FG003|STARTED|Part 1 - Period 1||3
10034442|NCT01930045|11158708|FG004|STARTED|Part 1 - Period 1||3
10034443|NCT01930045|11158709|FG005|STARTED|Part 1 - Period 1||3
10034444|NCT01930045|11158704|FG000|COMPLETED|Part 1 - Period 1||3
10034445|NCT01930045|11158705|FG001|COMPLETED|Part 1 - Period 1||3
10034446|NCT01930045|11158706|FG002|COMPLETED|Part 1 - Period 1||3
10034447|NCT01930045|11158707|FG003|COMPLETED|Part 1 - Period 1||3
10034448|NCT01930045|11158708|FG004|COMPLETED|Part 1 - Period 1||3
10034449|NCT01930045|11158709|FG005|COMPLETED|Part 1 - Period 1||3
10034450|NCT01930045|11158704|FG000|NOT COMPLETED|Part 1 - Period 1||0
10034451|NCT01930045|11158705|FG001|NOT COMPLETED|Part 1 - Period 1||0
10034452|NCT01930045|11158706|FG002|NOT COMPLETED|Part 1 - Period 1||0
10034453|NCT01930045|11158707|FG003|NOT COMPLETED|Part 1 - Period 1||0
10034454|NCT01930045|11158708|FG004|NOT COMPLETED|Part 1 - Period 1||0
10034455|NCT01930045|11158709|FG005|NOT COMPLETED|Part 1 - Period 1||0
10034456|NCT01930045|11158704|FG000|STARTED|Part 1 - Period 2||3
10034457|NCT01930045|11158705|FG001|STARTED|Part 1 - Period 2||3
10034458|NCT01930045|11158706|FG002|STARTED|Part 1 - Period 2||3
10034459|NCT01930045|11158707|FG003|STARTED|Part 1 - Period 2||3
10034460|NCT01930045|11158708|FG004|STARTED|Part 1 - Period 2||3
10034461|NCT01930045|11158709|FG005|STARTED|Part 1 - Period 2||3
10034462|NCT01930045|11158704|FG000|COMPLETED|Part 1 - Period 2||3
10034463|NCT01930045|11158705|FG001|COMPLETED|Part 1 - Period 2||3
10034464|NCT01930045|11158706|FG002|COMPLETED|Part 1 - Period 2||3
10034465|NCT01930045|11158707|FG003|COMPLETED|Part 1 - Period 2||3
10034466|NCT01930045|11158708|FG004|COMPLETED|Part 1 - Period 2||3
10034467|NCT01930045|11158709|FG005|COMPLETED|Part 1 - Period 2||3
10034468|NCT01930045|11158704|FG000|NOT COMPLETED|Part 1 - Period 2||0
10034469|NCT01930045|11158705|FG001|NOT COMPLETED|Part 1 - Period 2||0
10034470|NCT01930045|11158706|FG002|NOT COMPLETED|Part 1 - Period 2||0
10034471|NCT01930045|11158707|FG003|NOT COMPLETED|Part 1 - Period 2||0
10034472|NCT01930045|11158708|FG004|NOT COMPLETED|Part 1 - Period 2||0
10034473|NCT01930045|11158709|FG005|NOT COMPLETED|Part 1 - Period 2||0
10034474|NCT01930045|11158704|FG000|STARTED|Part 1 - Period 3||3
10034475|NCT01930045|11158705|FG001|STARTED|Part 1 - Period 3||3
10034476|NCT01930045|11158706|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
10034477|NCT01930045|11158707|FG003|STARTED|Part 1 - Period 3||3
10034478|NCT01930045|11158708|FG004|STARTED|Part 1 - Period 3||3
10034479|NCT01930045|11158709|FG005|STARTED|Part 1 - Period 3||3
10034480|NCT01930045|11158704|FG000|COMPLETED|Part 1 - Period 3||3
10034481|NCT01930045|11158705|FG001|COMPLETED|Part 1 - Period 3||3
10034482|NCT01930045|11158706|FG002|COMPLETED|Part 1 - Period 3||2
10034483|NCT01930045|11158707|FG003|COMPLETED|Part 1 - Period 3||3
10034484|NCT01930045|11158708|FG004|COMPLETED|Part 1 - Period 3||3
10034485|NCT01930045|11158709|FG005|COMPLETED|Part 1 - Period 3||3
10034486|NCT01930045|11158704|FG000|NOT COMPLETED|Part 1 - Period 3||0
10034487|NCT01930045|11158705|FG001|NOT COMPLETED|Part 1 - Period 3||0
10034488|NCT01930045|11158706|FG002|NOT COMPLETED|Part 1 - Period 3||0
10034489|NCT01930045|11158707|FG003|NOT COMPLETED|Part 1 - Period 3||0
10034490|NCT01930045|11158708|FG004|NOT COMPLETED|Part 1 - Period 3||0
10034491|NCT01930045|11158709|FG005|NOT COMPLETED|Part 1 - Period 3||0
10034492|NCT01930045|11158704|FG000|STARTED|Pause (up to 37 Days)||3
10034493|NCT01930045|11158705|FG001|STARTED|Pause (up to 37 Days)||3
10115696|NCT02528188|11246508|FG001|COMPLETED|Overall Study||729
10034494|NCT01930045|11158706|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
10034495|NCT01930045|11158707|FG003|STARTED|Pause (up to 37 Days)||3
10034496|NCT01930045|11158708|FG004|STARTED|Pause (up to 37 Days)||3
10034497|NCT01930045|11158709|FG005|STARTED|Pause (up to 37 Days)||3
10034498|NCT01930045|11158704|FG000|COMPLETED|Pause (up to 37 Days)||3
10034499|NCT01930045|11158705|FG001|COMPLETED|Pause (up to 37 Days)||3
10034500|NCT01930045|11158706|FG002|COMPLETED|Pause (up to 37 Days)||3
10034501|NCT01930045|11158707|FG003|COMPLETED|Pause (up to 37 Days)||3
10034502|NCT01930045|11158708|FG004|COMPLETED|Pause (up to 37 Days)||3
10034503|NCT01930045|11158709|FG005|COMPLETED|Pause (up to 37 Days)||1
10115697|NCT02528188|11246509|FG002|COMPLETED|Overall Study||757
10115698|NCT02528188|11246507|FG000|NOT COMPLETED|Overall Study||267
10115699|NCT02528188|11246508|FG001|NOT COMPLETED|Overall Study||276
10115700|NCT02528188|11246509|FG002|NOT COMPLETED|Overall Study||251
10115701|NCT02528214|11246519|FG000|STARTED|Overall Study||107
10115702|NCT02528214|11246520|FG001|STARTED|Overall Study||103
10115703|NCT02528214|11246519|FG000|Treated|Overall Study||107
10115704|NCT02528214|11246520|FG001|Treated|Overall Study||103
10115705|NCT02528214|11246519|FG000|COMPLETED|Overall Study||107
10115706|NCT02528214|11246520|FG001|COMPLETED|Overall Study||100
10115707|NCT02528214|11246519|FG000|NOT COMPLETED|Overall Study||0
10115708|NCT02528214|11246520|FG001|NOT COMPLETED|Overall Study||3
10115709|NCT02528253|11246532|FG000|STARTED|Overall Study||205
10115710|NCT02528253|11246533|FG001|STARTED|Overall Study||204
10115711|NCT02528253|11246534|FG002|STARTED|Overall Study||407
10115712|NCT02528253|11246535|FG003|STARTED|Overall Study||407
10115713|NCT02528253|11246536|FG004|STARTED|Overall Study||602
10115714|NCT02528253|11246532|FG000|Intent to Treat Population|Overall Study||202
10115715|NCT02528253|11246533|FG001|Intent to Treat Population|Overall Study||204
10115716|NCT02528253|11246534|FG002|Intent to Treat Population|Overall Study||407
10115717|NCT02528253|11246535|FG003|Intent to Treat Population|Overall Study||407
10115718|NCT02528253|11246536|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
10115719|NCT02528253|11246532|FG000|Treated at Week 16|Overall Study||99
10115720|NCT02528253|11246533|FG001|Treated at Week 16|Overall Study||95
10115721|NCT02528253|11246534|FG002|Treated at Week 16|Overall Study||236
10115722|NCT02528253|11246535|FG003|Treated at Week 16|Overall Study||242
10115723|NCT02528253|11246536|FG004|Treated at Week 16|Overall Study||307
10115724|NCT02528253|11246532|FG000|COMPLETED|Overall Study||130
10115725|NCT02528253|11246533|FG001|COMPLETED|Overall Study||134
10115726|NCT02528253|11246534|FG002|COMPLETED|Overall Study||267
10115727|NCT02528253|11246535|FG003|COMPLETED|Overall Study||271
10115728|NCT02528253|11246536|FG004|COMPLETED|Overall Study||379
10115729|NCT02528253|11246532|FG000|NOT COMPLETED|Overall Study||75
10115730|NCT02528253|11246533|FG001|NOT COMPLETED|Overall Study||70
10115731|NCT02528253|11246534|FG002|NOT COMPLETED|Overall Study||140
10115732|NCT02528253|11246535|FG003|NOT COMPLETED|Overall Study||136
10115733|NCT02528253|11246536|FG004|NOT COMPLETED|Overall Study||223
10196092|NCT03358407|11324480|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196093|NCT03358407|11324481|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196094|NCT03358407|11324482|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196095|NCT03358407|11324483|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196096|NCT03358407|11324484|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196097|NCT03358407|11324485|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196098|NCT03358407|11324486|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196099|NCT03358407|11324477|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196100|NCT03358407|11324478|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196101|NCT03358407|11324479|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
10196102|NCT03358407|11324480|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196103|NCT03358407|11324481|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10196104|NCT03358407|11324482|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196105|NCT03358407|11324483|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196106|NCT03358407|11324484|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196107|NCT03358407|11324485|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196108|NCT03358407|11324486|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196109|NCT03358407|11324477|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196110|NCT03358407|11324478|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196111|NCT03358407|11324479|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
10196112|NCT03358407|11324480|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196113|NCT03358407|11324481|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196114|NCT03358407|11324482|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196115|NCT03358407|11324483|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196116|NCT03358407|11324484|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196117|NCT03358407|11324485|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196118|NCT03358407|11324486|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10196119|NCT03358407|11324477|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196120|NCT03358407|11324478|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196121|NCT03358407|11324479|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
10034504|NCT01930045|11158704|FG000|NOT COMPLETED|Pause (up to 37 Days)||0
10034505|NCT01930045|11158705|FG001|NOT COMPLETED|Pause (up to 37 Days)||0
10034506|NCT01930045|11158706|FG002|NOT COMPLETED|Pause (up to 37 Days)||0
10034507|NCT01930045|11158707|FG003|NOT COMPLETED|Pause (up to 37 Days)||0
10034508|NCT01930045|11158708|FG004|NOT COMPLETED|Pause (up to 37 Days)||0
10034509|NCT01930045|11158709|FG005|NOT COMPLETED|Pause (up to 37 Days)||2
10034510|NCT01930045|11158704|FG000|STARTED|Part 2 - Period 4||3
10034511|NCT01930045|11158705|FG001|STARTED|Part 2 - Period 4||3
10034512|NCT01930045|11158706|FG002|STARTED|Part 2 - Period 4||3
10034513|NCT01930045|11158707|FG003|STARTED|Part 2 - Period 4||3
10034514|NCT01930045|11158708|FG004|STARTED|Part 2 - Period 4||3
10034515|NCT01930045|11158709|FG005|STARTED|Part 2 - Period 4||1
10034516|NCT01930045|11158704|FG000|COMPLETED|Part 2 - Period 4||3
10034517|NCT01930045|11158705|FG001|COMPLETED|Part 2 - Period 4||3
10034518|NCT01930045|11158706|FG002|COMPLETED|Part 2 - Period 4||3
10034519|NCT01930045|11158707|FG003|COMPLETED|Part 2 - Period 4||3
10034520|NCT01930045|11158708|FG004|COMPLETED|Part 2 - Period 4||3
10034521|NCT01930045|11158709|FG005|COMPLETED|Part 2 - Period 4||1
10034522|NCT01930045|11158704|FG000|NOT COMPLETED|Part 2 - Period 4||0
10034523|NCT01930045|11158705|FG001|NOT COMPLETED|Part 2 - Period 4||0
10034524|NCT01930045|11158706|FG002|NOT COMPLETED|Part 2 - Period 4||0
10034525|NCT01930045|11158707|FG003|NOT COMPLETED|Part 2 - Period 4||0
10034526|NCT01930045|11158708|FG004|NOT COMPLETED|Part 2 - Period 4||0
10034527|NCT01930045|11158709|FG005|NOT COMPLETED|Part 2 - Period 4||0
10034528|NCT01930045|11158704|FG000|STARTED|Part 2 - Period 5||3
10034529|NCT01930045|11158705|FG001|STARTED|Part 2 - Period 5||3
10034530|NCT01930045|11158706|FG002|STARTED|Part 2 - Period 5||3
10034531|NCT01930045|11158707|FG003|STARTED|Part 2 - Period 5||3
10034532|NCT01930045|11158708|FG004|STARTED|Part 2 - Period 5||3
10034533|NCT01930045|11158709|FG005|STARTED|Part 2 - Period 5||1
10034534|NCT01930045|11158704|FG000|COMPLETED|Part 2 - Period 5||3
10034535|NCT01930045|11158705|FG001|COMPLETED|Part 2 - Period 5||3
10034536|NCT01930045|11158706|FG002|COMPLETED|Part 2 - Period 5||3
10034537|NCT01930045|11158707|FG003|COMPLETED|Part 2 - Period 5||3
10034538|NCT01930045|11158708|FG004|COMPLETED|Part 2 - Period 5||3
10034539|NCT01930045|11158709|FG005|COMPLETED|Part 2 - Period 5||1
10034540|NCT01930045|11158704|FG000|NOT COMPLETED|Part 2 - Period 5||0
10034541|NCT01930045|11158705|FG001|NOT COMPLETED|Part 2 - Period 5||0
10034542|NCT01930045|11158706|FG002|NOT COMPLETED|Part 2 - Period 5||0
10034543|NCT01930045|11158707|FG003|NOT COMPLETED|Part 2 - Period 5||0
10034544|NCT01930045|11158708|FG004|NOT COMPLETED|Part 2 - Period 5||0
10034545|NCT01930045|11158709|FG005|NOT COMPLETED|Part 2 - Period 5||0
10034546|NCT01930058|11158724|FG000|STARTED|Overall Study||3
10034547|NCT01930058|11158725|FG001|STARTED|Overall Study||3
10034548|NCT01930058|11158726|FG002|STARTED|Overall Study||3
10034549|NCT01930058|11158724|FG000|COMPLETED|Overall Study||3
10034550|NCT01930058|11158725|FG001|COMPLETED|Overall Study||3
10034551|NCT01930058|11158726|FG002|COMPLETED|Overall Study||3
10034552|NCT01930058|11158724|FG000|NOT COMPLETED|Overall Study||0
10034553|NCT01930058|11158725|FG001|NOT COMPLETED|Overall Study||0
10034554|NCT01930058|11158726|FG002|NOT COMPLETED|Overall Study||0
10034555|NCT01930162|11158733|FG000|STARTED|Overall Study||9
10034556|NCT01930162|11158733|FG000|COMPLETED|Overall Study||4
10034557|NCT01930162|11158733|FG000|NOT COMPLETED|Overall Study||5
10034558|NCT01930175|11158741|FG000|STARTED|Core Study||7
10034559|NCT01930175|11158742|FG001|STARTED|Core Study||2
10034560|NCT01930175|11158743|FG002|STARTED|Core Study||4
10034561|NCT01930175|11158741|FG000|Safety Analysis Set|Core Study||7
10034562|NCT01930175|11158742|FG001|Safety Analysis Set|Core Study||2
10034563|NCT01930175|11158743|FG002|Safety Analysis Set|Core Study||4
10034564|NCT01930175|11158741|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7
10034565|NCT01930175|11158742|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2
10034566|NCT01930175|11158743|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
10034567|NCT01930175|11158741|FG000|COMPLETED|Core Study||7
10034568|NCT01930175|11158742|FG001|COMPLETED|Core Study||1
10034569|NCT01930175|11158743|FG002|COMPLETED|Core Study||3
10034570|NCT01930175|11158741|FG000|NOT COMPLETED|Core Study||0
10034571|NCT01930175|11158742|FG001|NOT COMPLETED|Core Study||1
10034572|NCT01930175|11158743|FG002|NOT COMPLETED|Core Study||1
10034573|NCT01930175|11158741|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
10034574|NCT01930175|11158742|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
10034575|NCT01930175|11158743|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
10034576|NCT01930175|11158741|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10034577|NCT01930175|11158742|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10034578|NCT01930175|11158743|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
10034579|NCT01930175|11158741|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10034580|NCT01930175|11158742|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10034581|NCT01930175|11158743|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10034582|NCT01930188|11158755|FG000|STARTED|Overall Study||409
10034583|NCT01930188|11158756|FG001|STARTED|Overall Study||409
10034584|NCT01930188|11158757|FG002|STARTED|Overall Study||407
10034585|NCT01930188|11158755|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
10034586|NCT01930188|11158756|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
10034587|NCT01930188|11158757|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
10034588|NCT01930188|11158755|FG000|COMPLETED|Overall Study||387
10034589|NCT01930188|11158756|FG001|COMPLETED|Overall Study||388
10034590|NCT01930188|11158757|FG002|COMPLETED|Overall Study||388
10034591|NCT01930188|11158755|FG000|NOT COMPLETED|Overall Study||22
10034592|NCT01930188|11158756|FG001|NOT COMPLETED|Overall Study||21
10034593|NCT01930188|11158757|FG002|NOT COMPLETED|Overall Study||19
10034594|NCT01930214|11158769|FG000|STARTED|Overall Study||100
10034595|NCT01930214|11158770|FG001|STARTED|Overall Study||117
10034596|NCT01930214|11158771|FG002|STARTED|Overall Study||133
10034597|NCT01930214|11158769|FG000|COMPLETED|Overall Study||80
10034598|NCT01930214|11158770|FG001|COMPLETED|Overall Study||96
10034599|NCT01930214|11158771|FG002|COMPLETED|Overall Study||108
10034600|NCT01930214|11158769|FG000|NOT COMPLETED|Overall Study||20
10034601|NCT01930214|11158770|FG001|NOT COMPLETED|Overall Study||21
10034602|NCT01930214|11158771|FG002|NOT COMPLETED|Overall Study||25
10034603|NCT01930435|11158779|FG000|STARTED|Overall Study||20
10034604|NCT01930435|11158779|FG000|COMPLETED|Overall Study||20
10034605|NCT01930435|11158779|FG000|NOT COMPLETED|Overall Study||0
10034606|NCT01930487|11158784|FG000|STARTED|First Intervention (30 Days)||21
10034607|NCT01930487|11158785|FG001|STARTED|First Intervention (30 Days)||25
10034608|NCT01930487|11158784|FG000|COMPLETED|First Intervention (30 Days)||19
10034609|NCT01930487|11158785|FG001|COMPLETED|First Intervention (30 Days)||23
10034610|NCT01930487|11158784|FG000|NOT COMPLETED|First Intervention (30 Days)||2
10034611|NCT01930487|11158785|FG001|NOT COMPLETED|First Intervention (30 Days)||2
10034612|NCT01930487|11158784|FG000|STARTED|Washout Period (3 Weeks)||19
10034613|NCT01930487|11158785|FG001|STARTED|Washout Period (3 Weeks)||23
10034614|NCT01930487|11158784|FG000|COMPLETED|Washout Period (3 Weeks)||19
10034615|NCT01930487|11158785|FG001|COMPLETED|Washout Period (3 Weeks)||23
10034616|NCT01930487|11158784|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
10034617|NCT01930487|11158785|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
10034618|NCT01930487|11158784|FG000|STARTED|Second Intervention (30 Days)||19
10034619|NCT01930487|11158785|FG001|STARTED|Second Intervention (30 Days)||23
10034620|NCT01930487|11158784|FG000|COMPLETED|Second Intervention (30 Days)||19
10034621|NCT01930487|11158785|FG001|COMPLETED|Second Intervention (30 Days)||23
10034622|NCT01930487|11158784|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10034623|NCT01930487|11158785|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
10034624|NCT01930643|11158793|FG000|STARTED|Overall Study||7
10034625|NCT01930643|11158794|FG001|STARTED|Overall Study||6
10034626|NCT01930643|11158793|FG000|COMPLETED|Overall Study||7
10034627|NCT01930643|11158794|FG001|COMPLETED|Overall Study||6
10034628|NCT01930643|11158793|FG000|NOT COMPLETED|Overall Study||0
10034629|NCT01930643|11158794|FG001|NOT COMPLETED|Overall Study||0
10034630|NCT01930747|11158803|FG000|STARTED|Overall Study||16
10034631|NCT01930747|11158804|FG001|STARTED|Overall Study||14
10034632|NCT01930747|11158805|FG002|STARTED|Overall Study||12
10034633|NCT01930747|11158803|FG000|COMPLETED|Overall Study||16
10034634|NCT01930747|11158804|FG001|COMPLETED|Overall Study||14
10034635|NCT01930747|11158805|FG002|COMPLETED|Overall Study||12
10034636|NCT01930747|11158803|FG000|NOT COMPLETED|Overall Study||0
10034637|NCT01930747|11158804|FG001|NOT COMPLETED|Overall Study||0
10034638|NCT01930747|11158805|FG002|NOT COMPLETED|Overall Study||0
10034639|NCT01930799|11158813|FG000|STARTED|Overall Study||120
10034640|NCT01930799|11158813|FG000|COMPLETED|Overall Study||112
10034641|NCT01930799|11158813|FG000|NOT COMPLETED|Overall Study||8
10034642|NCT01930890|11158821|FG000|STARTED|Overall Study||14
10034643|NCT01930890|11158822|FG001|STARTED|Overall Study||33
10034644|NCT01930890|11158823|FG002|STARTED|Overall Study||13
10034645|NCT01930890|11158824|FG003|STARTED|Overall Study||27
10034646|NCT01930890|11158821|FG000|COMPLETED|Overall Study||0
10034647|NCT01930890|11158822|FG001|COMPLETED|Overall Study||0
10034648|NCT01930890|11158823|FG002|COMPLETED|Overall Study||0
10034649|NCT01930890|11158824|FG003|COMPLETED|Overall Study||0
10034650|NCT01930890|11158821|FG000|NOT COMPLETED|Overall Study||14
10034651|NCT01930890|11158822|FG001|NOT COMPLETED|Overall Study||33
10034652|NCT01930890|11158823|FG002|NOT COMPLETED|Overall Study||13
10034653|NCT01930890|11158824|FG003|NOT COMPLETED|Overall Study||27
10034654|NCT01931059|11158836|FG000|STARTED|Day 1||6
10034655|NCT01931059|11158837|FG001|STARTED|Day 1||5
10034656|NCT01931059|11158836|FG000|COMPLETED|Day 1||6
10034657|NCT01931059|11158837|FG001|COMPLETED|Day 1||4
10034658|NCT01931059|11158836|FG000|NOT COMPLETED|Day 1||0
10034659|NCT01931059|11158837|FG001|NOT COMPLETED|Day 1||1
10034660|NCT01931059|11158836|FG000|STARTED|Day2||6
10034661|NCT01931059|11158837|FG001|STARTED|Day2||4
10034662|NCT01931059|11158836|FG000|COMPLETED|Day2||6
10034663|NCT01931059|11158837|FG001|COMPLETED|Day2||4
10034664|NCT01931059|11158836|FG000|NOT COMPLETED|Day2||0
10034665|NCT01931059|11158837|FG001|NOT COMPLETED|Day2||0
10034666|NCT01931059|11158836|FG000|STARTED|Day3||6
10034667|NCT01931059|11158837|FG001|STARTED|Day3||4
10034668|NCT01931059|11158836|FG000|COMPLETED|Day3||5
10034669|NCT01931059|11158837|FG001|COMPLETED|Day3||4
10034670|NCT01931059|11158836|FG000|NOT COMPLETED|Day3||1
10034671|NCT01931059|11158837|FG001|NOT COMPLETED|Day3||0
10034672|NCT01931150|11158851|FG000|STARTED|Overall Study||5
10034673|NCT01931150|11158852|FG001|STARTED|Overall Study||6
10034674|NCT01931150|11158851|FG000|COMPLETED|Overall Study||4
10034675|NCT01931150|11158852|FG001|COMPLETED|Overall Study||4
10034676|NCT01931150|11158851|FG000|NOT COMPLETED|Overall Study||1
10034677|NCT01931150|11158852|FG001|NOT COMPLETED|Overall Study||2
10034678|NCT01931163|11158858|FG000|STARTED|Overall Study||22
10034679|NCT01931163|11158858|FG000|COMPLETED|Overall Study||22
10034680|NCT01931163|11158858|FG000|NOT COMPLETED|Overall Study||0
10034681|NCT01931202|11158865|FG000|STARTED|Overall Study||8
10034682|NCT01931202|11158866|FG001|STARTED|Overall Study||51
10034683|NCT01931202|11158867|FG002|STARTED|Overall Study||49
10034684|NCT01931202|11158865|FG000|COMPLETED|Overall Study||8
10034685|NCT01931202|11158866|FG001|COMPLETED|Overall Study||46
10034686|NCT01931202|11158867|FG002|COMPLETED|Overall Study||45
10034687|NCT01931202|11158865|FG000|NOT COMPLETED|Overall Study||0
10034688|NCT01931202|11158866|FG001|NOT COMPLETED|Overall Study||5
10034689|NCT01931202|11158867|FG002|NOT COMPLETED|Overall Study||4
10034690|NCT01931397|11158878|FG000|STARTED|Overall Study||30
10034691|NCT01931397|11158878|FG000|COMPLETED|Overall Study||19
10034692|NCT01931397|11158878|FG000|NOT COMPLETED|Overall Study||11
10034693|NCT01931462|11158886|FG000|STARTED|Overall Study||2
10034694|NCT01931462|11158886|FG000|COMPLETED|Overall Study||1
10034695|NCT01931462|11158886|FG000|NOT COMPLETED|Overall Study||1
10034696|NCT01931475|11158892|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205
10034697|NCT01931475|11158893|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202
10034698|NCT01931475|11158892|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
10034699|NCT01931475|11158893|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
10034700|NCT01931475|11158892|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166
10034701|NCT01931475|11158893|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176
10034702|NCT01931475|11158892|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
10034703|NCT01931475|11158893|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
10034704|NCT01931475|11158892|FG000|STARTED|Period 2: Extension Treatment Phase||166
10034705|NCT01931475|11158893|FG001|STARTED|Period 2: Extension Treatment Phase||176
10034706|NCT01931475|11158892|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
10034707|NCT01931475|11158893|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
10034708|NCT01931475|11158892|FG000|COMPLETED|Period 2: Extension Treatment Phase||162
10034709|NCT01931475|11158893|FG001|COMPLETED|Period 2: Extension Treatment Phase||157
10034710|NCT01931475|11158892|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4
10034711|NCT01931475|11158893|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19
10034712|NCT01931527|11158906|FG000|STARTED|Overall Study||16
10034713|NCT01931527|11158907|FG001|STARTED|Overall Study||15
10034714|NCT01931527|11158906|FG000|COMPLETED|Overall Study||16
10034715|NCT01931527|11158907|FG001|COMPLETED|Overall Study||15
10034716|NCT01931527|11158906|FG000|NOT COMPLETED|Overall Study||0
10034717|NCT01931527|11158907|FG001|NOT COMPLETED|Overall Study||0
10034718|NCT01931566|11158920|FG000|STARTED|Overall Study||433
10034719|NCT01931566|11158921|FG001|STARTED|Overall Study||1516
10034720|NCT01931566|11158922|FG002|STARTED|Overall Study||1545
10034721|NCT01931566|11158920|FG000|Treated|Overall Study||427
10034722|NCT01931566|11158921|FG001|Treated|Overall Study||1507
10034723|NCT01931566|11158922|FG002|Treated|Overall Study||1531
10034724|NCT01931566|11158920|FG000|COMPLETED|Overall Study||4
10034725|NCT01931566|11158921|FG001|COMPLETED|Overall Study||40
10034726|NCT01931566|11158922|FG002|COMPLETED|Overall Study||39
10034727|NCT01931566|11158920|FG000|NOT COMPLETED|Overall Study||429
10034728|NCT01931566|11158921|FG001|NOT COMPLETED|Overall Study||1476
10034729|NCT01931566|11158922|FG002|NOT COMPLETED|Overall Study||1506
10034730|NCT01931670|11158934|FG000|STARTED|Treatment Period||360
10034731|NCT01931670|11158935|FG001|STARTED|Treatment Period||226
10034732|NCT01931670|11158936|FG002|STARTED|Treatment Period||229
10034733|NCT01931670|11158934|FG000|COMPLETED|Treatment Period||270
10034734|NCT01931670|11158935|FG001|COMPLETED|Treatment Period||178
10034735|NCT01931670|11158936|FG002|COMPLETED|Treatment Period||184
10034736|NCT01931670|11158934|FG000|NOT COMPLETED|Treatment Period||90
10034737|NCT01931670|11158935|FG001|NOT COMPLETED|Treatment Period||48
10034738|NCT01931670|11158936|FG002|NOT COMPLETED|Treatment Period||45
10034739|NCT01931670|11158934|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
10034740|NCT01931670|11158935|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
10034741|NCT01931670|11158936|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
10034742|NCT01931670|11158934|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
10034743|NCT01931670|11158935|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
10034744|NCT01931670|11158936|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
10034745|NCT01931670|11158934|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
10034746|NCT01931670|11158935|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
10115734|NCT02528305|11246567|FG000|STARTED|Overall Study||12
10115735|NCT02528305|11246567|FG000|End of Control Period Assessment|Overall Study||11
10115736|NCT02528305|11246567|FG000|End of Intervention Period Assessment|Overall Study||9
10115737|NCT02528305|11246567|FG000|COMPLETED|Overall Study||9
10115738|NCT02528305|11246567|FG000|NOT COMPLETED|Overall Study||3
10115739|NCT02528318|11246578|FG000|STARTED|Overall Study||8
10115740|NCT02528318|11246579|FG001|STARTED|Overall Study||8
10115741|NCT02528318|11246580|FG002|STARTED|Overall Study||8
10115742|NCT02528318|11246581|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
10115743|NCT02528318|11246582|FG004|STARTED|Overall Study||24
10115744|NCT02528318|11246578|FG000|COMPLETED|Overall Study||8
10115745|NCT02528318|11246579|FG001|COMPLETED|Overall Study||8
10115746|NCT02528318|11246580|FG002|COMPLETED|Overall Study||8
10115747|NCT02528318|11246581|FG003|COMPLETED|Overall Study||0
10034747|NCT01931670|11158936|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
10034748|NCT01931670|11158934|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
10034749|NCT01931670|11158935|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
10034750|NCT01931670|11158936|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
10034751|NCT01931670|11158934|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
10034752|NCT01931670|11158935|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
10034753|NCT01931670|11158936|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
10034754|NCT01931735|11158948|FG000|STARTED|Randomized Phase||4
10034755|NCT01931735|11158949|FG001|STARTED|Randomized Phase||3
10034756|NCT01931735|11158950|FG002|STARTED|Randomized Phase||9
10034757|NCT01931735|11158951|FG003|STARTED|Randomized Phase||0
10034758|NCT01931735|11158948|FG000|COMPLETED|Randomized Phase||2
10034759|NCT01931735|11158949|FG001|COMPLETED|Randomized Phase||1
10034760|NCT01931735|11158950|FG002|COMPLETED|Randomized Phase||4
10034761|NCT01931735|11158951|FG003|COMPLETED|Randomized Phase||0
10034762|NCT01931735|11158948|FG000|NOT COMPLETED|Randomized Phase||2
10034763|NCT01931735|11158949|FG001|NOT COMPLETED|Randomized Phase||2
10034764|NCT01931735|11158950|FG002|NOT COMPLETED|Randomized Phase||5
10034765|NCT01931735|11158951|FG003|NOT COMPLETED|Randomized Phase||0
10034766|NCT01931735|11158948|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
10034767|NCT01931735|11158949|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
10034768|NCT01931735|11158950|FG002|STARTED|Observational Non-Randomized Phase||0
10034769|NCT01931735|11158951|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
10034770|NCT01931735|11158948|FG000|COMPLETED|Observational Non-Randomized Phase||2
10034771|NCT01931735|11158949|FG001|COMPLETED|Observational Non-Randomized Phase||1
10034772|NCT01931735|11158950|FG002|COMPLETED|Observational Non-Randomized Phase||0
10034773|NCT01931735|11158951|FG003|COMPLETED|Observational Non-Randomized Phase||9
10034774|NCT01931735|11158948|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0
10034775|NCT01931735|11158949|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0
10034776|NCT01931735|11158950|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0
10034777|NCT01931735|11158951|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2
10034778|NCT01931839|11158968|FG000|STARTED|Overall Study||335
10034779|NCT01931839|11158969|FG001|STARTED|Overall Study||178
10034780|NCT01931839|11158970|FG002|STARTED|Overall Study||340
10034781|NCT01931839|11158971|FG003|STARTED|Overall Study||176
10034782|NCT01931839|11158972|FG004|STARTED|Overall Study||19
10034783|NCT01931839|11158973|FG005|STARTED|Overall Study||55
10034784|NCT01931839|11158974|FG006|STARTED|Overall Study||60
10034785|NCT01931839|11158968|FG000|Full Analysis Set (As Randomized)|Overall Study||334
10034786|NCT01931839|11158969|FG001|Full Analysis Set (As Randomized)|Overall Study||179
10034787|NCT01931839|11158970|FG002|Full Analysis Set (As Randomized)|Overall Study||340
10034788|NCT01931839|11158971|FG003|Full Analysis Set (As Randomized)|Overall Study||176
10034789|NCT01931839|11158972|FG004|Full Analysis Set (As Randomized)|Overall Study||19
10034790|NCT01931839|11158973|FG005|Full Analysis Set (As Randomized)|Overall Study||55
10034791|NCT01931839|11158974|FG006|Full Analysis Set (As Randomized)|Overall Study||60
10034792|NCT01931839|11158968|FG000|Safety Analysis Set (As Dosed)|Overall Study||335
10034793|NCT01931839|11158969|FG001|Safety Analysis Set (As Dosed)|Overall Study||178
10034794|NCT01931839|11158970|FG002|Safety Analysis Set (As Dosed)|Overall Study||340
10034795|NCT01931839|11158971|FG003|Safety Analysis Set (As Dosed)|Overall Study||176
10034796|NCT01931839|11158972|FG004|Safety Analysis Set (As Dosed)|Overall Study||19
10034797|NCT01931839|11158973|FG005|Safety Analysis Set (As Dosed)|Overall Study||55
10034798|NCT01931839|11158974|FG006|Safety Analysis Set (As Dosed)|Overall Study||60
10034799|NCT01931839|11158968|FG000|COMPLETED|Overall Study||294
10034800|NCT01931839|11158969|FG001|COMPLETED|Overall Study||152
10034801|NCT01931839|11158970|FG002|COMPLETED|Overall Study||301
10034802|NCT01931839|11158971|FG003|COMPLETED|Overall Study||162
10034803|NCT01931839|11158972|FG004|COMPLETED|Overall Study||18
10034804|NCT01931839|11158973|FG005|COMPLETED|Overall Study||50
10034805|NCT01931839|11158974|FG006|COMPLETED|Overall Study||56
10034806|NCT01931839|11158968|FG000|NOT COMPLETED|Overall Study||41
10034807|NCT01931839|11158969|FG001|NOT COMPLETED|Overall Study||26
10034808|NCT01931839|11158970|FG002|NOT COMPLETED|Overall Study||39
10034809|NCT01931839|11158971|FG003|NOT COMPLETED|Overall Study||14
10115748|NCT02528318|11246582|FG004|COMPLETED|Overall Study||24
10115749|NCT02528318|11246578|FG000|NOT COMPLETED|Overall Study||0
10115750|NCT02528318|11246579|FG001|NOT COMPLETED|Overall Study||0
10115751|NCT02528318|11246580|FG002|NOT COMPLETED|Overall Study||0
10115752|NCT02528318|11246581|FG003|NOT COMPLETED|Overall Study||0
10115753|NCT02528318|11246582|FG004|NOT COMPLETED|Overall Study||0
10115754|NCT02528331|11246594|FG000|STARTED|Overall Study||2
10115755|NCT02528331|11246594|FG000|COMPLETED|Overall Study||0
10115756|NCT02528331|11246594|FG000|NOT COMPLETED|Overall Study||2
10115757|NCT02528357|11246617|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10115758|NCT02528357|11246618|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10115759|NCT02528357|11246619|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
10115760|NCT02528357|11246620|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
10115761|NCT02528357|11246621|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
10115762|NCT02528357|11246622|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
10115763|NCT02528357|11246623|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
10115764|NCT02528357|11246624|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
10034810|NCT01931839|11158972|FG004|NOT COMPLETED|Overall Study||1
10034811|NCT01931839|11158973|FG005|NOT COMPLETED|Overall Study||5
10034812|NCT01931839|11158974|FG006|NOT COMPLETED|Overall Study||4
10034813|NCT01931865|11158994|FG000|STARTED|Overall Study||12
10034814|NCT01931865|11158994|FG000|COMPLETED|Overall Study||8
10034815|NCT01931865|11158994|FG000|NOT COMPLETED|Overall Study||4
10034816|NCT01931878|11158999|FG000|STARTED|First Intervention||10
10034817|NCT01931878|11159000|FG001|STARTED|First Intervention||14
10034818|NCT01931878|11158999|FG000|COMPLETED|First Intervention||9
10034819|NCT01931878|11159000|FG001|COMPLETED|First Intervention||14
10034820|NCT01931878|11158999|FG000|NOT COMPLETED|First Intervention||1
10034821|NCT01931878|11159000|FG001|NOT COMPLETED|First Intervention||0
10034822|NCT01931878|11158999|FG000|STARTED|Second Intervention (After 3 Months)||9
10034823|NCT01931878|11159000|FG001|STARTED|Second Intervention (After 3 Months)||14
10034824|NCT01931878|11158999|FG000|COMPLETED|Second Intervention (After 3 Months)||9
10034825|NCT01931878|11159000|FG001|COMPLETED|Second Intervention (After 3 Months)||12
10034826|NCT01931878|11158999|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0
10034827|NCT01931878|11159000|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2
10034828|NCT01931956|11159014|FG000|STARTED|Overall Study||59
10034829|NCT01931956|11159015|FG001|STARTED|Overall Study||7
10034830|NCT01931956|11159016|FG002|STARTED|Overall Study||628
10034831|NCT01931956|11159017|FG003|STARTED|Overall Study||271
10034832|NCT01931956|11159014|FG000|COMPLETED|Overall Study||8
10034833|NCT01931956|11159015|FG001|COMPLETED|Overall Study||0
10034834|NCT01931956|11159016|FG002|COMPLETED|Overall Study||141
10034835|NCT01931956|11159017|FG003|COMPLETED|Overall Study||138
10034836|NCT01931956|11159014|FG000|NOT COMPLETED|Overall Study||51
10034837|NCT01931956|11159015|FG001|NOT COMPLETED|Overall Study||7
10034838|NCT01931956|11159016|FG002|NOT COMPLETED|Overall Study||487
10034839|NCT01931956|11159017|FG003|NOT COMPLETED|Overall Study||133
10034840|NCT01931995|11159042|FG000|STARTED|First Intervention (1 Day)||23
10034841|NCT01931995|11159043|FG001|STARTED|First Intervention (1 Day)||22
10034842|NCT01931995|11159042|FG000|COMPLETED|First Intervention (1 Day)||19
10034843|NCT01931995|11159043|FG001|COMPLETED|First Intervention (1 Day)||18
10034844|NCT01931995|11159042|FG000|NOT COMPLETED|First Intervention (1 Day)||4
10034845|NCT01931995|11159043|FG001|NOT COMPLETED|First Intervention (1 Day)||4
10034846|NCT01931995|11159042|FG000|STARTED|Washout (at Least 6 Days)||19
10034847|NCT01931995|11159043|FG001|STARTED|Washout (at Least 6 Days)||18
10034848|NCT01931995|11159042|FG000|COMPLETED|Washout (at Least 6 Days)||19
10034849|NCT01931995|11159043|FG001|COMPLETED|Washout (at Least 6 Days)||18
10034850|NCT01931995|11159042|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0
10034851|NCT01931995|11159043|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0
10034852|NCT01931995|11159042|FG000|STARTED|Second Intervention (1 Day)||18
10034853|NCT01931995|11159043|FG001|STARTED|Second Intervention (1 Day)||19
10034854|NCT01931995|11159042|FG000|COMPLETED|Second Intervention (1 Day)||18
10034855|NCT01931995|11159043|FG001|COMPLETED|Second Intervention (1 Day)||19
10034856|NCT01931995|11159042|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10034857|NCT01931995|11159043|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10034858|NCT01932060|11159051|FG000|STARTED|Overall Study||27
10034859|NCT01932060|11159052|FG001|STARTED|Overall Study||24
10034860|NCT01932060|11159051|FG000|COMPLETED|Overall Study||27
10034861|NCT01932060|11159052|FG001|COMPLETED|Overall Study||24
10034862|NCT01932060|11159051|FG000|NOT COMPLETED|Overall Study||0
10034863|NCT01932060|11159052|FG001|NOT COMPLETED|Overall Study||0
10034864|NCT01932112|11159058|FG000|STARTED|Overall Study||378
10034865|NCT01932112|11159058|FG000|COMPLETED|Overall Study||378
10034866|NCT01932112|11159058|FG000|NOT COMPLETED|Overall Study||0
10034867|NCT01932164|11159062|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
10034868|NCT01932164|11159062|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
10034869|NCT01932164|11159062|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
10034870|NCT01932164|11159062|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
10034871|NCT01932164|11159062|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
10034872|NCT01932164|11159062|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
10034873|NCT01932164|11159062|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
10034874|NCT01932164|11159062|FG000|NOT COMPLETED|Overall Study||0
10034875|NCT01932242|11159068|FG000|STARTED|Overall Study||35
10034876|NCT01932242|11159069|FG001|STARTED|Overall Study||35
10034877|NCT01932242|11159068|FG000|COMPLETED|Overall Study||30
10034878|NCT01932242|11159069|FG001|COMPLETED|Overall Study||30
10034879|NCT01932242|11159068|FG000|NOT COMPLETED|Overall Study||5
10034880|NCT01932242|11159069|FG001|NOT COMPLETED|Overall Study||5
10034881|NCT01932294|11159075|FG000|STARTED|Overall Study||171
10034882|NCT01932294|11159075|FG000|COMPLETED|Overall Study||72
10034883|NCT01932294|11159075|FG000|NOT COMPLETED|Overall Study||99
10034884|NCT01932437|11159082|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
10034885|NCT01932437|11159083|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
10034886|NCT01932437|11159084|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034887|NCT01932437|11159085|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034888|NCT01932437|11159086|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034889|NCT01932437|11159087|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034890|NCT01932437|11159082|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
10034891|NCT01932437|11159083|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
10034892|NCT01932437|11159084|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034893|NCT01932437|11159085|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034894|NCT01932437|11159086|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034895|NCT01932437|11159087|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034896|NCT01932437|11159082|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034897|NCT01932437|11159083|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034898|NCT01932437|11159084|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034899|NCT01932437|11159085|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034900|NCT01932437|11159086|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034901|NCT01932437|11159087|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10034902|NCT01932437|11159082|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
10034903|NCT01932437|11159083|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034904|NCT01932437|11159084|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
10034905|NCT01932437|11159085|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034906|NCT01932437|11159086|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034907|NCT01932437|11159087|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034908|NCT01932437|11159082|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
10034909|NCT01932437|11159083|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034910|NCT01932437|11159084|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
10034911|NCT01932437|11159085|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034912|NCT01932437|11159086|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034913|NCT01932437|11159087|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034914|NCT01932437|11159082|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034915|NCT01932437|11159083|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034916|NCT01932437|11159084|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034917|NCT01932437|11159085|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034918|NCT01932437|11159086|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034919|NCT01932437|11159087|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10034920|NCT01932437|11159082|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
10034921|NCT01932437|11159083|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034922|NCT01932437|11159084|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034923|NCT01932437|11159085|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
10034924|NCT01932437|11159086|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034925|NCT01932437|11159087|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034926|NCT01932437|11159082|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
10034927|NCT01932437|11159083|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034928|NCT01932437|11159084|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034929|NCT01932437|11159085|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
10034930|NCT01932437|11159086|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034931|NCT01932437|11159087|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034932|NCT01932437|11159082|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034933|NCT01932437|11159083|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034934|NCT01932437|11159084|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034935|NCT01932437|11159085|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034936|NCT01932437|11159086|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034937|NCT01932437|11159087|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10034938|NCT01932437|11159082|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
10034939|NCT01932437|11159083|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034940|NCT01932437|11159084|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034941|NCT01932437|11159085|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034942|NCT01932437|11159086|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
10034943|NCT01932437|11159087|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034944|NCT01932437|11159082|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
10034945|NCT01932437|11159083|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034946|NCT01932437|11159084|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034947|NCT01932437|11159085|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034948|NCT01932437|11159086|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
10034949|NCT01932437|11159087|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034950|NCT01932437|11159082|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034951|NCT01932437|11159083|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034952|NCT01932437|11159084|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034953|NCT01932437|11159085|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034954|NCT01932437|11159086|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034955|NCT01932437|11159087|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10034956|NCT01932437|11159082|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
10034957|NCT01932437|11159083|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034958|NCT01932437|11159084|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034959|NCT01932437|11159085|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034960|NCT01932437|11159086|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034961|NCT01932437|11159087|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
10034962|NCT01932437|11159082|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
10034963|NCT01932437|11159083|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034964|NCT01932437|11159084|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034965|NCT01932437|11159085|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034966|NCT01932437|11159086|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034967|NCT01932437|11159087|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
10034968|NCT01932437|11159082|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034969|NCT01932437|11159083|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034970|NCT01932437|11159084|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034971|NCT01932437|11159085|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034972|NCT01932437|11159086|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10034973|NCT01932437|11159087|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
10034974|NCT01932606|11159110|FG000|STARTED|Overall Study||14
10034975|NCT01932606|11159111|FG001|STARTED|Overall Study||14
10034976|NCT01932606|11159110|FG000|COMPLETED|Overall Study||14
10034977|NCT01932606|11159111|FG001|COMPLETED|Overall Study||14
10034978|NCT01932606|11159110|FG000|NOT COMPLETED|Overall Study||0
10034979|NCT01932606|11159111|FG001|NOT COMPLETED|Overall Study||0
10034980|NCT01932697|11159119|FG000|STARTED|Overall Study||38
10034981|NCT01932697|11159120|FG001|STARTED|Overall Study||43
10034982|NCT01932697|11159119|FG000|COMPLETED|Overall Study||36
10034983|NCT01932697|11159120|FG001|COMPLETED|Overall Study||43
10034984|NCT01932697|11159119|FG000|NOT COMPLETED|Overall Study||2
10034985|NCT01932697|11159120|FG001|NOT COMPLETED|Overall Study||0
10034986|NCT01932762|11159132|FG000|STARTED|Overall Study||30
10034987|NCT01932762|11159133|FG001|STARTED|Overall Study||30
10034988|NCT01932762|11159134|FG002|STARTED|Overall Study||19
10034989|NCT01932762|11159135|FG003|STARTED|Overall Study||19
10034990|NCT01932762|11159132|FG000|COMPLETED|Overall Study||24
10034991|NCT01932762|11159133|FG001|COMPLETED|Overall Study||28
10034992|NCT01932762|11159134|FG002|COMPLETED|Overall Study||19
10115765|NCT02528357|11246625|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115766|NCT02528357|11246626|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115767|NCT02528357|11246627|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115768|NCT02528357|11246628|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115769|NCT02528357|11246629|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115770|NCT02528357|11246630|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115771|NCT02528357|11246631|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115772|NCT02528357|11246632|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115773|NCT02528357|11246633|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115774|NCT02528357|11246634|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115775|NCT02528357|11246635|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115776|NCT02528357|11246617|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10115777|NCT02528357|11246618|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115778|NCT02528357|11246619|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
10115779|NCT02528357|11246620|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
10115780|NCT02528357|11246621|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
10115781|NCT02528357|11246622|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10115782|NCT02528357|11246623|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
10115783|NCT02528357|11246624|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10115784|NCT02528357|11246625|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115785|NCT02528357|11246626|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115786|NCT02528357|11246627|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115787|NCT02528357|11246628|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115788|NCT02528357|11246629|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115789|NCT02528357|11246630|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115790|NCT02528357|11246631|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115791|NCT02528357|11246632|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115792|NCT02528357|11246633|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115793|NCT02528357|11246634|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115794|NCT02528357|11246635|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115795|NCT02528357|11246617|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115796|NCT02528357|11246618|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10115797|NCT02528357|11246619|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10115798|NCT02528357|11246620|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10115799|NCT02528357|11246621|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
10115800|NCT02528357|11246622|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10115801|NCT02528357|11246623|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10115802|NCT02528357|11246624|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10115803|NCT02528357|11246625|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115804|NCT02528357|11246626|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115805|NCT02528357|11246627|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115806|NCT02528357|11246628|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10034993|NCT01932762|11159135|FG003|COMPLETED|Overall Study||18
10034994|NCT01932762|11159132|FG000|NOT COMPLETED|Overall Study||6
10034995|NCT01932762|11159133|FG001|NOT COMPLETED|Overall Study||2
10034996|NCT01932762|11159134|FG002|NOT COMPLETED|Overall Study||0
10034997|NCT01932762|11159135|FG003|NOT COMPLETED|Overall Study||1
10034998|NCT01932788|11159147|FG000|STARTED|Overall Study||173
10034999|NCT01932788|11159148|FG001|STARTED|Overall Study||169
10035000|NCT01932788|11159147|FG000|COMPLETED|Overall Study||135
10035001|NCT01932788|11159148|FG001|COMPLETED|Overall Study||118
10035002|NCT01932788|11159147|FG000|NOT COMPLETED|Overall Study||38
10035003|NCT01932788|11159148|FG001|NOT COMPLETED|Overall Study||51
10035004|NCT01932970|11159154|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
10035005|NCT01932970|11159154|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
10035006|NCT01932970|11159154|FG000|COMPLETED|Overall Study||140
10035007|NCT01932970|11159154|FG000|NOT COMPLETED|Overall Study||18
10035008|NCT01932996|11159160|FG000|STARTED|Overall Study||172
10035009|NCT01932996|11159161|FG001|STARTED|Overall Study||180
10035010|NCT01932996|11159160|FG000|COMPLETED|Overall Study||170
10035011|NCT01932996|11159161|FG001|COMPLETED|Overall Study||180
10035012|NCT01932996|11159160|FG000|NOT COMPLETED|Overall Study||2
10035013|NCT01932996|11159161|FG001|NOT COMPLETED|Overall Study||0
10035014|NCT01933048|11159169|FG000|STARTED|Overall Study||548
10035015|NCT01933048|11159170|FG001|STARTED|Overall Study||529
10035016|NCT01933048|11159169|FG000|COMPLETED|Overall Study||523
10035017|NCT01933048|11159170|FG001|COMPLETED|Overall Study||501
10035018|NCT01933048|11159169|FG000|NOT COMPLETED|Overall Study||25
10035019|NCT01933048|11159170|FG001|NOT COMPLETED|Overall Study||28
10035020|NCT01933113|11159179|FG000|STARTED|Overall Study||3
10035021|NCT01933113|11159179|FG000|COMPLETED|Overall Study||2
10035022|NCT01933113|11159179|FG000|NOT COMPLETED|Overall Study||1
10035023|NCT01933217|11159185|FG000|STARTED|Randomization (4 Weeks)||12
10035024|NCT01933217|11159186|FG001|STARTED|Randomization (4 Weeks)||14
10035025|NCT01933217|11159185|FG000|COMPLETED|Randomization (4 Weeks)||10
10035026|NCT01933217|11159186|FG001|COMPLETED|Randomization (4 Weeks)||10
10035027|NCT01933217|11159185|FG000|NOT COMPLETED|Randomization (4 Weeks)||2
10035028|NCT01933217|11159186|FG001|NOT COMPLETED|Randomization (4 Weeks)||4
10035029|NCT01933217|11159185|FG000|STARTED|Crossover (4 Weeks)||10
10035030|NCT01933217|11159186|FG001|STARTED|Crossover (4 Weeks)||10
10035031|NCT01933217|11159185|FG000|COMPLETED|Crossover (4 Weeks)||10
10035032|NCT01933217|11159186|FG001|COMPLETED|Crossover (4 Weeks)||10
10035033|NCT01933217|11159185|FG000|NOT COMPLETED|Crossover (4 Weeks)||0
10035034|NCT01933217|11159186|FG001|NOT COMPLETED|Crossover (4 Weeks)||0
10035035|NCT01933230|11159194|FG000|STARTED|Overall Study||2
10035036|NCT01933230|11159194|FG000|COMPLETED|Overall Study||2
10035037|NCT01933230|11159194|FG000|NOT COMPLETED|Overall Study||0
10035038|NCT01933243|11159200|FG000|STARTED|Overall Study||12
10035039|NCT01933243|11159201|FG001|STARTED|Overall Study||12
10035040|NCT01933243|11159200|FG000|COMPLETED|Overall Study||10
10035041|NCT01933243|11159201|FG001|COMPLETED|Overall Study||8
10035042|NCT01933243|11159200|FG000|NOT COMPLETED|Overall Study||2
10035043|NCT01933243|11159201|FG001|NOT COMPLETED|Overall Study||4
10035044|NCT01933334|11159209|FG000|STARTED|Overall Study||32
10035045|NCT01933334|11159210|FG001|STARTED|Overall Study||31
10035046|NCT01933334|11159209|FG000|COMPLETED|Overall Study||27
10035047|NCT01933334|11159210|FG001|COMPLETED|Overall Study||29
10035048|NCT01933334|11159209|FG000|NOT COMPLETED|Overall Study||5
10035049|NCT01933334|11159210|FG001|NOT COMPLETED|Overall Study||2
10035050|NCT01933399|11159219|FG000|STARTED|Overall Study||29
10035051|NCT01933399|11159220|FG001|STARTED|Overall Study||32
10035052|NCT01933399|11159221|FG002|STARTED|Overall Study||37
10035053|NCT01933399|11159219|FG000|COMPLETED|Overall Study||29
10035054|NCT01933399|11159220|FG001|COMPLETED|Overall Study||32
10035055|NCT01933399|11159221|FG002|COMPLETED|Overall Study||37
10035056|NCT01933399|11159219|FG000|NOT COMPLETED|Overall Study||0
10035057|NCT01933399|11159220|FG001|NOT COMPLETED|Overall Study||0
10035058|NCT01933399|11159221|FG002|NOT COMPLETED|Overall Study||0
10035059|NCT01933425|11159229|FG000|STARTED|Overall Study||7
10035060|NCT01933425|11159230|FG001|STARTED|Overall Study||7
10035061|NCT01933425|11159229|FG000|COMPLETED|Overall Study||7
10035062|NCT01933425|11159230|FG001|COMPLETED|Overall Study||7
10035063|NCT01933425|11159229|FG000|NOT COMPLETED|Overall Study||0
10035064|NCT01933425|11159230|FG001|NOT COMPLETED|Overall Study||0
10035065|NCT01933464|11159240|FG000|STARTED|Overall Study||5
10035066|NCT01933464|11159241|FG001|STARTED|Overall Study||5
10035067|NCT01933464|11159240|FG000|COMPLETED|Overall Study||5
10035068|NCT01933464|11159241|FG001|COMPLETED|Overall Study||5
10035069|NCT01933464|11159240|FG000|NOT COMPLETED|Overall Study||0
10035070|NCT01933464|11159241|FG001|NOT COMPLETED|Overall Study||0
10035071|NCT01933594|11159253|FG000|STARTED|Overall Study||12
10035072|NCT01933594|11159254|FG001|STARTED|Overall Study||12
10035073|NCT01933594|11159255|FG002|STARTED|Overall Study||12
10035074|NCT01933594|11159256|FG003|STARTED|Overall Study||7
10035075|NCT01933594|11159257|FG004|STARTED|Overall Study||13
10035076|NCT01933594|11159258|FG005|STARTED|Overall Study||3
10035077|NCT01933594|11159253|FG000|COMPLETED|Overall Study||11
10035078|NCT01933594|11159254|FG001|COMPLETED|Overall Study||12
10035079|NCT01933594|11159255|FG002|COMPLETED|Overall Study||12
10035080|NCT01933594|11159256|FG003|COMPLETED|Overall Study||7
10035081|NCT01933594|11159257|FG004|COMPLETED|Overall Study||11
10035082|NCT01933594|11159258|FG005|COMPLETED|Overall Study||3
10035083|NCT01933594|11159253|FG000|NOT COMPLETED|Overall Study||1
10035084|NCT01933594|11159254|FG001|NOT COMPLETED|Overall Study||0
10035085|NCT01933594|11159255|FG002|NOT COMPLETED|Overall Study||0
10035086|NCT01933594|11159256|FG003|NOT COMPLETED|Overall Study||0
10035087|NCT01933594|11159257|FG004|NOT COMPLETED|Overall Study||2
10035088|NCT01933594|11159258|FG005|NOT COMPLETED|Overall Study||0
10035089|NCT01933672|11159276|FG000|STARTED|Metformin Run-in Period||43
10035090|NCT01933672|11159277|FG001|STARTED|Metformin Run-in Period||0
10035091|NCT01933672|11159278|FG002|STARTED|Metformin Run-in Period||0
10035092|NCT01933672|11159279|FG003|STARTED|Metformin Run-in Period||0
10035093|NCT01933672|11159280|FG004|STARTED|Metformin Run-in Period||0
10035094|NCT01933672|11159281|FG005|STARTED|Metformin Run-in Period||0
10035095|NCT01933672|11159282|FG006|STARTED|Metformin Run-in Period||0
10035096|NCT01933672|11159276|FG000|Received Treatment|Metformin Run-in Period||43
10035097|NCT01933672|11159277|FG001|Received Treatment|Metformin Run-in Period||0
10035098|NCT01933672|11159278|FG002|Received Treatment|Metformin Run-in Period||0
10035099|NCT01933672|11159279|FG003|Received Treatment|Metformin Run-in Period||0
10115807|NCT02528357|11246629|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115808|NCT02528357|11246630|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115809|NCT02528357|11246631|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115810|NCT02528357|11246632|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115811|NCT02528357|11246633|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115812|NCT02528357|11246634|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115813|NCT02528357|11246635|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10115814|NCT02528357|11246617|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115815|NCT02528357|11246618|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115816|NCT02528357|11246619|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115817|NCT02528357|11246620|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115818|NCT02528357|11246621|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115819|NCT02528357|11246622|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10035100|NCT01933672|11159280|FG004|Received Treatment|Metformin Run-in Period||0
10035101|NCT01933672|11159281|FG005|Received Treatment|Metformin Run-in Period||0
10035102|NCT01933672|11159282|FG006|Received Treatment|Metformin Run-in Period||0
10035103|NCT01933672|11159276|FG000|COMPLETED|Metformin Run-in Period||33
10035104|NCT01933672|11159277|FG001|COMPLETED|Metformin Run-in Period||0
10035105|NCT01933672|11159278|FG002|COMPLETED|Metformin Run-in Period||0
10035106|NCT01933672|11159279|FG003|COMPLETED|Metformin Run-in Period||0
10035107|NCT01933672|11159280|FG004|COMPLETED|Metformin Run-in Period||0
10035108|NCT01933672|11159281|FG005|COMPLETED|Metformin Run-in Period||0
10035109|NCT01933672|11159282|FG006|COMPLETED|Metformin Run-in Period||0
10035110|NCT01933672|11159276|FG000|NOT COMPLETED|Metformin Run-in Period||10
10035111|NCT01933672|11159277|FG001|NOT COMPLETED|Metformin Run-in Period||0
10035112|NCT01933672|11159278|FG002|NOT COMPLETED|Metformin Run-in Period||0
10035113|NCT01933672|11159279|FG003|NOT COMPLETED|Metformin Run-in Period||0
10035114|NCT01933672|11159280|FG004|NOT COMPLETED|Metformin Run-in Period||0
10035115|NCT01933672|11159281|FG005|NOT COMPLETED|Metformin Run-in Period||0
10035116|NCT01933672|11159282|FG006|NOT COMPLETED|Metformin Run-in Period||0
10035117|NCT01933672|11159276|FG000|STARTED|First Intervention Period (12-16 Days)||0
10035118|NCT01933672|11159277|FG001|STARTED|First Intervention Period (12-16 Days)||7
10035119|NCT01933672|11159278|FG002|STARTED|First Intervention Period (12-16 Days)||3
10035120|NCT01933672|11159279|FG003|STARTED|First Intervention Period (12-16 Days)||5
10035121|NCT01933672|11159280|FG004|STARTED|First Intervention Period (12-16 Days)||7
10035122|NCT01933672|11159281|FG005|STARTED|First Intervention Period (12-16 Days)||5
10035123|NCT01933672|11159282|FG006|STARTED|First Intervention Period (12-16 Days)||6
10035124|NCT01933672|11159276|FG000|COMPLETED|First Intervention Period (12-16 Days)||0
10035125|NCT01933672|11159277|FG001|COMPLETED|First Intervention Period (12-16 Days)||7
10035126|NCT01933672|11159278|FG002|COMPLETED|First Intervention Period (12-16 Days)||2
10035127|NCT01933672|11159279|FG003|COMPLETED|First Intervention Period (12-16 Days)||5
10035128|NCT01933672|11159280|FG004|COMPLETED|First Intervention Period (12-16 Days)||6
10035129|NCT01933672|11159281|FG005|COMPLETED|First Intervention Period (12-16 Days)||4
10035130|NCT01933672|11159282|FG006|COMPLETED|First Intervention Period (12-16 Days)||6
10035131|NCT01933672|11159276|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10035132|NCT01933672|11159277|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10035133|NCT01933672|11159278|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1
10035134|NCT01933672|11159279|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10035135|NCT01933672|11159280|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1
10035136|NCT01933672|11159281|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1
10035137|NCT01933672|11159282|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10035138|NCT01933672|11159276|FG000|STARTED|First Washout Period (7-14 Days)||0
10035139|NCT01933672|11159277|FG001|STARTED|First Washout Period (7-14 Days)||7
10035140|NCT01933672|11159278|FG002|STARTED|First Washout Period (7-14 Days)||2
10035141|NCT01933672|11159279|FG003|STARTED|First Washout Period (7-14 Days)||5
10035142|NCT01933672|11159280|FG004|STARTED|First Washout Period (7-14 Days)||6
10035143|NCT01933672|11159281|FG005|STARTED|First Washout Period (7-14 Days)||4
10035144|NCT01933672|11159282|FG006|STARTED|First Washout Period (7-14 Days)||6
10035145|NCT01933672|11159276|FG000|COMPLETED|First Washout Period (7-14 Days)||0
10035146|NCT01933672|11159277|FG001|COMPLETED|First Washout Period (7-14 Days)||7
10035147|NCT01933672|11159278|FG002|COMPLETED|First Washout Period (7-14 Days)||2
10035148|NCT01933672|11159279|FG003|COMPLETED|First Washout Period (7-14 Days)||5
10035149|NCT01933672|11159280|FG004|COMPLETED|First Washout Period (7-14 Days)||6
10035150|NCT01933672|11159281|FG005|COMPLETED|First Washout Period (7-14 Days)||4
10035151|NCT01933672|11159282|FG006|COMPLETED|First Washout Period (7-14 Days)||6
10035152|NCT01933672|11159276|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0
10035153|NCT01933672|11159277|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0
10035154|NCT01933672|11159278|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0
10035155|NCT01933672|11159279|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0
10035156|NCT01933672|11159280|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0
10035157|NCT01933672|11159281|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0
10035158|NCT01933672|11159282|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0
10035159|NCT01933672|11159276|FG000|STARTED|Second Intervention Period (12-16 Days)||0
10035160|NCT01933672|11159277|FG001|STARTED|Second Intervention Period (12-16 Days)||7
10035161|NCT01933672|11159278|FG002|STARTED|Second Intervention Period (12-16 Days)||2
10035162|NCT01933672|11159279|FG003|STARTED|Second Intervention Period (12-16 Days)||5
10035163|NCT01933672|11159280|FG004|STARTED|Second Intervention Period (12-16 Days)||6
10035164|NCT01933672|11159281|FG005|STARTED|Second Intervention Period (12-16 Days)||4
10035165|NCT01933672|11159282|FG006|STARTED|Second Intervention Period (12-16 Days)||6
10035166|NCT01933672|11159276|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0
10035167|NCT01933672|11159277|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6
10035168|NCT01933672|11159278|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1
10035169|NCT01933672|11159279|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5
10035170|NCT01933672|11159280|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6
10035171|NCT01933672|11159281|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4
10035172|NCT01933672|11159282|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6
10035173|NCT01933672|11159276|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10035174|NCT01933672|11159277|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
10035175|NCT01933672|11159278|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
10035176|NCT01933672|11159279|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10035177|NCT01933672|11159280|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10035178|NCT01933672|11159281|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10035179|NCT01933672|11159282|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10035180|NCT01933672|11159276|FG000|STARTED|Second Washout Period (7-14 Days)||0
10035181|NCT01933672|11159277|FG001|STARTED|Second Washout Period (7-14 Days)||6
10035182|NCT01933672|11159278|FG002|STARTED|Second Washout Period (7-14 Days)||1
10035183|NCT01933672|11159279|FG003|STARTED|Second Washout Period (7-14 Days)||5
10035184|NCT01933672|11159280|FG004|STARTED|Second Washout Period (7-14 Days)||6
10035185|NCT01933672|11159281|FG005|STARTED|Second Washout Period (7-14 Days)||4
10035186|NCT01933672|11159282|FG006|STARTED|Second Washout Period (7-14 Days)||6
10035187|NCT01933672|11159276|FG000|COMPLETED|Second Washout Period (7-14 Days)||0
10035188|NCT01933672|11159277|FG001|COMPLETED|Second Washout Period (7-14 Days)||6
10035189|NCT01933672|11159278|FG002|COMPLETED|Second Washout Period (7-14 Days)||1
10035190|NCT01933672|11159279|FG003|COMPLETED|Second Washout Period (7-14 Days)||5
10035191|NCT01933672|11159280|FG004|COMPLETED|Second Washout Period (7-14 Days)||6
10035192|NCT01933672|11159281|FG005|COMPLETED|Second Washout Period (7-14 Days)||4
10035193|NCT01933672|11159282|FG006|COMPLETED|Second Washout Period (7-14 Days)||6
10035194|NCT01933672|11159276|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10035195|NCT01933672|11159277|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10035196|NCT01933672|11159278|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10035197|NCT01933672|11159279|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10035198|NCT01933672|11159280|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10035199|NCT01933672|11159281|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10035200|NCT01933672|11159282|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10035201|NCT01933672|11159276|FG000|STARTED|Third Intervention Period (12-16 Days)||0
10035202|NCT01933672|11159277|FG001|STARTED|Third Intervention Period (12-16 Days)||6
10035203|NCT01933672|11159278|FG002|STARTED|Third Intervention Period (12-16 Days)||1
10035204|NCT01933672|11159279|FG003|STARTED|Third Intervention Period (12-16 Days)||5
10035205|NCT01933672|11159280|FG004|STARTED|Third Intervention Period (12-16 Days)||6
10035206|NCT01933672|11159281|FG005|STARTED|Third Intervention Period (12-16 Days)||4
10035207|NCT01933672|11159282|FG006|STARTED|Third Intervention Period (12-16 Days)||6
10035208|NCT01933672|11159276|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0
10035209|NCT01933672|11159277|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5
10035210|NCT01933672|11159278|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1
10035211|NCT01933672|11159279|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4
10035212|NCT01933672|11159280|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6
10035213|NCT01933672|11159281|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4
10035214|NCT01933672|11159282|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6
10035215|NCT01933672|11159276|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10035216|NCT01933672|11159277|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
10035217|NCT01933672|11159278|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10035218|NCT01933672|11159279|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
10035219|NCT01933672|11159280|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10035220|NCT01933672|11159281|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10035221|NCT01933672|11159282|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10035222|NCT01933776|11159297|FG000|STARTED|Overall Study||20
10035223|NCT01933776|11159298|FG001|STARTED|Overall Study||20
10035224|NCT01933776|11159297|FG000|COMPLETED|Overall Study||20
10035225|NCT01933776|11159298|FG001|COMPLETED|Overall Study||20
10035226|NCT01933776|11159297|FG000|NOT COMPLETED|Overall Study||0
10035227|NCT01933776|11159298|FG001|NOT COMPLETED|Overall Study||0
10035228|NCT01933789|11159313|FG000|STARTED|Overall Study||65
10035229|NCT01933789|11159314|FG001|STARTED|Overall Study||67
10035230|NCT01933789|11159315|FG002|STARTED|Overall Study||2
10035231|NCT01933789|11159316|FG003|STARTED|Overall Study||2
10035232|NCT01933789|11159317|FG004|STARTED|Overall Study||249
10035233|NCT01933789|11159318|FG005|STARTED|Overall Study||288
10035234|NCT01933789|11159319|FG006|STARTED|Overall Study||58
10035235|NCT01933789|11159320|FG007|STARTED|Overall Study||61
10035236|NCT01933789|11159321|FG008|STARTED|Overall Study||25
10035237|NCT01933789|11159313|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
10035238|NCT01933789|11159314|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
10035239|NCT01933789|11159315|FG002|Had Target Visit|Overall Study||2
10035240|NCT01933789|11159316|FG003|Had Target Visit|Overall Study||2
10035241|NCT01933789|11159317|FG004|Had Target Visit|Overall Study||228
10035242|NCT01933789|11159318|FG005|Had Target Visit|Overall Study||266
10035243|NCT01933789|11159319|FG006|Had Target Visit|Overall Study||0
10035244|NCT01933789|11159320|FG007|Had Target Visit|Overall Study||0
10035245|NCT01933789|11159321|FG008|Had Target Visit|Overall Study||0
10035246|NCT01933789|11159313|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
10035247|NCT01933789|11159314|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
10035248|NCT01933789|11159315|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
10035249|NCT01933789|11159316|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
10035250|NCT01933789|11159317|FG004|Completed After-visit Survey|Overall Study||0
10035251|NCT01933789|11159318|FG005|Completed After-visit Survey|Overall Study||0
10035252|NCT01933789|11159319|FG006|Completed After-visit Survey|Overall Study||0
10035253|NCT01933789|11159320|FG007|Completed After-visit Survey|Overall Study||0
10035254|NCT01933789|11159321|FG008|Completed After-visit Survey|Overall Study||0
10035255|NCT01933789|11159313|FG000|Completed 2-Week Survey|Overall Study||0
10035256|NCT01933789|11159314|FG001|Completed 2-Week Survey|Overall Study||0
10035257|NCT01933789|11159315|FG002|Completed 2-Week Survey|Overall Study||0
10035258|NCT01933789|11159316|FG003|Completed 2-Week Survey|Overall Study||0
10035259|NCT01933789|11159317|FG004|Completed 2-Week Survey|Overall Study||184
10035260|NCT01933789|11159318|FG005|Completed 2-Week Survey|Overall Study||215
10035261|NCT01933789|11159319|FG006|Completed 2-Week Survey|Overall Study||0
10035262|NCT01933789|11159320|FG007|Completed 2-Week Survey|Overall Study||0
10035263|NCT01933789|11159321|FG008|Completed 2-Week Survey|Overall Study||0
10035264|NCT01933789|11159313|FG000|Completed 3-Month Survey|Overall Study||0
10035265|NCT01933789|11159314|FG001|Completed 3-Month Survey|Overall Study||0
10035266|NCT01933789|11159315|FG002|Completed 3-Month Survey|Overall Study||0
10035267|NCT01933789|11159316|FG003|Completed 3-Month Survey|Overall Study||0
10035268|NCT01933789|11159317|FG004|Completed 3-Month Survey|Overall Study||176
10035269|NCT01933789|11159318|FG005|Completed 3-Month Survey|Overall Study||211
10035270|NCT01933789|11159319|FG006|Completed 3-Month Survey|Overall Study||37
10035271|NCT01933789|11159320|FG007|Completed 3-Month Survey|Overall Study||43
10035272|NCT01933789|11159321|FG008|Completed 3-Month Survey|Overall Study||0
10035273|NCT01933789|11159313|FG000|Completed 6-Month Survey|Overall Study||0
10035274|NCT01933789|11159314|FG001|Completed 6-Month Survey|Overall Study||0
10035275|NCT01933789|11159315|FG002|Completed 6-Month Survey|Overall Study||0
10035276|NCT01933789|11159316|FG003|Completed 6-Month Survey|Overall Study||0
10035277|NCT01933789|11159317|FG004|Completed 6-Month Survey|Overall Study||160
10035278|NCT01933789|11159318|FG005|Completed 6-Month Survey|Overall Study||188
10035279|NCT01933789|11159319|FG006|Completed 6-Month Survey|Overall Study||35
10035280|NCT01933789|11159320|FG007|Completed 6-Month Survey|Overall Study||40
10035281|NCT01933789|11159321|FG008|Completed 6-Month Survey|Overall Study||0
10035282|NCT01933789|11159313|FG000|Qualitative Interviews|Overall Study||0
10035283|NCT01933789|11159314|FG001|Qualitative Interviews|Overall Study||0
10035284|NCT01933789|11159315|FG002|Qualitative Interviews|Overall Study||0
10035285|NCT01933789|11159316|FG003|Qualitative Interviews|Overall Study||0
10035286|NCT01933789|11159317|FG004|Qualitative Interviews|Overall Study||0
10035287|NCT01933789|11159318|FG005|Qualitative Interviews|Overall Study||0
10035288|NCT01933789|11159319|FG006|Qualitative Interviews|Overall Study||0
10035289|NCT01933789|11159320|FG007|Qualitative Interviews|Overall Study||0
10035290|NCT01933789|11159321|FG008|Qualitative Interviews|Overall Study||25
10035291|NCT01933789|11159313|FG000|COMPLETED|Overall Study||59
10035292|NCT01933789|11159314|FG001|COMPLETED|Overall Study||66
10035293|NCT01933789|11159315|FG002|COMPLETED|Overall Study||2
10035294|NCT01933789|11159316|FG003|COMPLETED|Overall Study||1
10035295|NCT01933789|11159317|FG004|COMPLETED|Overall Study||190
10035296|NCT01933789|11159318|FG005|COMPLETED|Overall Study||221
10035297|NCT01933789|11159319|FG006|COMPLETED|Overall Study||43
10035298|NCT01933789|11159320|FG007|COMPLETED|Overall Study||47
10035299|NCT01933789|11159321|FG008|COMPLETED|Overall Study||25
10035300|NCT01933789|11159313|FG000|NOT COMPLETED|Overall Study||6
10035301|NCT01933789|11159314|FG001|NOT COMPLETED|Overall Study||1
10035302|NCT01933789|11159315|FG002|NOT COMPLETED|Overall Study||0
10035303|NCT01933789|11159316|FG003|NOT COMPLETED|Overall Study||1
10035304|NCT01933789|11159317|FG004|NOT COMPLETED|Overall Study||59
10035305|NCT01933789|11159318|FG005|NOT COMPLETED|Overall Study||67
10035306|NCT01933789|11159319|FG006|NOT COMPLETED|Overall Study||15
10035307|NCT01933789|11159320|FG007|NOT COMPLETED|Overall Study||14
10035308|NCT01933789|11159321|FG008|NOT COMPLETED|Overall Study||0
10035309|NCT01933880|11159343|FG000|STARTED|Overall Study||153
10035310|NCT01933880|11159344|FG001|STARTED|Overall Study||41
10035311|NCT01933880|11159343|FG000|COMPLETED|Overall Study||123
10035312|NCT01933880|11159344|FG001|COMPLETED|Overall Study||40
10035313|NCT01933880|11159343|FG000|NOT COMPLETED|Overall Study||30
10035314|NCT01933880|11159344|FG001|NOT COMPLETED|Overall Study||1
10035315|NCT01933919|11159357|FG000|STARTED|Double-blind Placebo-controlled Phase||19
10035316|NCT01933919|11159358|FG001|STARTED|Double-blind Placebo-controlled Phase||19
10035317|NCT01933919|11159357|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19
10035318|NCT01933919|11159358|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19
10035319|NCT01933919|11159357|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19
10035320|NCT01933919|11159358|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15
10035321|NCT01933919|11159357|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
10035322|NCT01933919|11159358|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
10035323|NCT01933919|11159357|FG000|STARTED|Open-label Long-term Phase||19
10035324|NCT01933919|11159358|FG001|STARTED|Open-label Long-term Phase||15
10035325|NCT01933919|11159357|FG000|COMPLETED|Open-label Long-term Phase||12
10035326|NCT01933919|11159358|FG001|COMPLETED|Open-label Long-term Phase||9
10035327|NCT01933919|11159357|FG000|NOT COMPLETED|Open-label Long-term Phase||7
10035328|NCT01933919|11159358|FG001|NOT COMPLETED|Open-label Long-term Phase||6
10035329|NCT01933984|11159378|FG000|STARTED|Overall Study||26
10035330|NCT01933984|11159379|FG001|STARTED|Overall Study||25
10035331|NCT01933984|11159378|FG000|COMPLETED|Overall Study||26
10035332|NCT01933984|11159379|FG001|COMPLETED|Overall Study||25
10035333|NCT01933984|11159378|FG000|NOT COMPLETED|Overall Study||0
10035334|NCT01933984|11159379|FG001|NOT COMPLETED|Overall Study||0
10035335|NCT01934010|11159392|FG000|STARTED|Overall Study||114
10035336|NCT01934010|11159393|FG001|STARTED|Overall Study||67
10035337|NCT01934010|11159394|FG002|STARTED|Overall Study||76
10035338|NCT01934010|11159392|FG000|COMPLETED|Overall Study||91
10035339|NCT01934010|11159393|FG001|COMPLETED|Overall Study||56
10035340|NCT01934010|11159394|FG002|COMPLETED|Overall Study||74
10035341|NCT01934010|11159392|FG000|NOT COMPLETED|Overall Study||23
10035342|NCT01934010|11159393|FG001|NOT COMPLETED|Overall Study||11
10035343|NCT01934010|11159394|FG002|NOT COMPLETED|Overall Study||2
10035344|NCT01934140|11159413|FG000|STARTED|Persistence Phase (Year 6-10)||235
10035345|NCT01934140|11159414|FG001|STARTED|Persistence Phase (Year 6-10)||76
10035346|NCT01934140|11159413|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
10035347|NCT01934140|11159414|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
10035348|NCT01934140|11159413|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83
10035349|NCT01934140|11159414|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25
10035350|NCT01934140|11159413|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
10035351|NCT01934140|11159414|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
10035352|NCT01934140|11159413|FG000|Vaccinated|Booster Phase (6 Months)||164
10035353|NCT01934140|11159414|FG001|Vaccinated|Booster Phase (6 Months)||56
10035354|NCT01934140|11159413|FG000|COMPLETED|Booster Phase (6 Months)||159
10035355|NCT01934140|11159414|FG001|COMPLETED|Booster Phase (6 Months)||53
10035356|NCT01934140|11159413|FG000|NOT COMPLETED|Booster Phase (6 Months)||5
10035357|NCT01934140|11159414|FG001|NOT COMPLETED|Booster Phase (6 Months)||3
10035358|NCT01934192|11159426|FG000|STARTED|Overall Study||40
10035359|NCT01934192|11159427|FG001|STARTED|Overall Study||44
10035360|NCT01934192|11159428|FG002|STARTED|Overall Study||4
10035361|NCT01934192|11159429|FG003|STARTED|Overall Study||4
10035362|NCT01934192|11159426|FG000|COMPLETED|Overall Study||31
10035363|NCT01934192|11159427|FG001|COMPLETED|Overall Study||37
10035364|NCT01934192|11159428|FG002|COMPLETED|Overall Study||3
10035365|NCT01934192|11159429|FG003|COMPLETED|Overall Study||3
10035366|NCT01934192|11159426|FG000|NOT COMPLETED|Overall Study||9
10035367|NCT01934192|11159427|FG001|NOT COMPLETED|Overall Study||7
10035368|NCT01934192|11159428|FG002|NOT COMPLETED|Overall Study||1
10035369|NCT01934192|11159429|FG003|NOT COMPLETED|Overall Study||1
10035370|NCT01934218|11159452|FG000|STARTED|Double-blind Phase||404
10035371|NCT01934218|11159453|FG001|STARTED|Double-blind Phase||410
10035372|NCT01934218|11159452|FG000|Analyzed Participants|Double-blind Phase||402
10035373|NCT01934218|11159453|FG001|Analyzed Participants|Double-blind Phase||407
10035374|NCT01934218|11159452|FG000|COMPLETED|Double-blind Phase||356
10035375|NCT01934218|11159453|FG001|COMPLETED|Double-blind Phase||356
10035376|NCT01934218|11159452|FG000|NOT COMPLETED|Double-blind Phase||48
10035377|NCT01934218|11159453|FG001|NOT COMPLETED|Double-blind Phase||54
10035378|NCT01934218|11159452|FG000|STARTED|Open-Label Phase||316
10035379|NCT01934218|11159453|FG001|STARTED|Open-Label Phase||328
10035380|NCT01934218|11159452|FG000|COMPLETED|Open-Label Phase||290
10035381|NCT01934218|11159453|FG001|COMPLETED|Open-Label Phase||304
10035382|NCT01934218|11159452|FG000|NOT COMPLETED|Open-Label Phase||26
10035383|NCT01934218|11159453|FG001|NOT COMPLETED|Open-Label Phase||24
10035384|NCT01934231|11159459|FG000|STARTED|Overall Study||27
10035385|NCT01934231|11159459|FG000|COMPLETED|Overall Study||27
10035386|NCT01934231|11159459|FG000|NOT COMPLETED|Overall Study||0
10035387|NCT01934335|11159465|FG000|STARTED|Overall Study||7
10035388|NCT01934335|11159466|FG001|STARTED|Overall Study||5
10035389|NCT01934335|11159465|FG000|COMPLETED|Overall Study||6
10035390|NCT01934335|11159466|FG001|COMPLETED|Overall Study||4
10035391|NCT01934335|11159465|FG000|NOT COMPLETED|Overall Study||1
10035392|NCT01934335|11159466|FG001|NOT COMPLETED|Overall Study||1
10035393|NCT01934517|11159472|FG000|STARTED|Overall Study||25
10035394|NCT01934517|11159472|FG000|COMPLETED|Overall Study||25
10035395|NCT01934517|11159472|FG000|NOT COMPLETED|Overall Study||0
10035396|NCT01934556|11159483|FG000|STARTED|Overall Study||30
10035397|NCT01934556|11159484|FG001|STARTED|Overall Study||60
10035398|NCT01934556|11159485|FG002|STARTED|Overall Study||60
10035399|NCT01934556|11159483|FG000|COMPLETED|Overall Study||25
10035400|NCT01934556|11159484|FG001|COMPLETED|Overall Study||44
10035401|NCT01934556|11159485|FG002|COMPLETED|Overall Study||50
10035402|NCT01934556|11159483|FG000|NOT COMPLETED|Overall Study||5
10035403|NCT01934556|11159484|FG001|NOT COMPLETED|Overall Study||16
10035404|NCT01934556|11159485|FG002|NOT COMPLETED|Overall Study||10
10035405|NCT01934582|11159493|FG000|STARTED|Overall Study||13
10035406|NCT01934582|11159493|FG000|COMPLETED|Overall Study||13
10035407|NCT01934582|11159493|FG000|NOT COMPLETED|Overall Study||0
10035408|NCT01934790|11159499|FG000|STARTED|Treatment|Eligible for treatment|45
10035409|NCT01934790|11159499|FG000|Participants Received Study Treatment|Treatment||44
10035410|NCT01934790|11159499|FG000|COMPLETED|Treatment||29
10035411|NCT01934790|11159499|FG000|NOT COMPLETED|Treatment||16
10035412|NCT01934790|11159499|FG000|STARTED|Active Follow up||34
10035413|NCT01934790|11159499|FG000|COMPLETED|Active Follow up||10
10035414|NCT01934790|11159499|FG000|NOT COMPLETED|Active Follow up||24
10035415|NCT01934790|11159499|FG000|STARTED|Long Term Follow up||12
10035416|NCT01934790|11159499|FG000|COMPLETED|Long Term Follow up||12
10035417|NCT01934790|11159499|FG000|NOT COMPLETED|Long Term Follow up||0
10035418|NCT01934894|11159505|FG000|STARTED|Overall Study||6
10035419|NCT01934894|11159506|FG001|STARTED|Overall Study||5
10035420|NCT01934894|11159505|FG000|COMPLETED|Overall Study||0
10035421|NCT01934894|11159506|FG001|COMPLETED|Overall Study||0
10035422|NCT01934894|11159505|FG000|NOT COMPLETED|Overall Study||6
10035423|NCT01934894|11159506|FG001|NOT COMPLETED|Overall Study||5
10035424|NCT01934972|11159517|FG000|STARTED|Overall Study||13
10035425|NCT01934972|11159518|FG001|STARTED|Overall Study||11
10035426|NCT01934972|11159517|FG000|COMPLETED|Overall Study||4
10035427|NCT01934972|11159518|FG001|COMPLETED|Overall Study||5
10035428|NCT01934972|11159517|FG000|NOT COMPLETED|Overall Study||9
10035429|NCT01934972|11159518|FG001|NOT COMPLETED|Overall Study||6
10035430|NCT01935180|11159526|FG000|STARTED|Overall Study||573
10035431|NCT01935180|11159527|FG001|STARTED|Overall Study||575
10035432|NCT01935180|11159526|FG000|COMPLETED|Overall Study||552
10035433|NCT01935180|11159527|FG001|COMPLETED|Overall Study||561
10035434|NCT01935180|11159526|FG000|NOT COMPLETED|Overall Study||21
10035435|NCT01935180|11159527|FG001|NOT COMPLETED|Overall Study||14
10035436|NCT01935622|11159536|FG000|STARTED|Overall Study||3
10035437|NCT01935622|11159537|FG001|STARTED|Overall Study||3
10035438|NCT01935622|11159538|FG002|STARTED|Overall Study||4
10035439|NCT01935622|11159536|FG000|COMPLETED|Overall Study||1
10035440|NCT01935622|11159537|FG001|COMPLETED|Overall Study||1
10035441|NCT01935622|11159538|FG002|COMPLETED|Overall Study||4
10035442|NCT01935622|11159536|FG000|NOT COMPLETED|Overall Study||2
10035443|NCT01935622|11159537|FG001|NOT COMPLETED|Overall Study||2
10035444|NCT01935622|11159538|FG002|NOT COMPLETED|Overall Study||0
10035445|NCT01935700|11159548|FG000|STARTED|Overall Study||14
10035446|NCT01935700|11159549|FG001|STARTED|Overall Study||86
10035447|NCT01935700|11159548|FG000|COMPLETED|Overall Study||9
10035448|NCT01935700|11159549|FG001|COMPLETED|Overall Study||86
10035449|NCT01935700|11159548|FG000|NOT COMPLETED|Overall Study||5
10035450|NCT01935700|11159549|FG001|NOT COMPLETED|Overall Study||0
10035451|NCT01935791|11159557|FG000|STARTED|Period 1||4
10035452|NCT01935791|11159558|FG001|STARTED|Period 1||4
10035453|NCT01935791|11159559|FG002|STARTED|Period 1||3
10035454|NCT01935791|11159560|FG003|STARTED|Period 1||0
10035455|NCT01935791|11159561|FG004|STARTED|Period 1||0
10035456|NCT01935791|11159562|FG005|STARTED|Period 1||0
10035457|NCT01935791|11159563|FG006|STARTED|Period 1||0
10035458|NCT01935791|11159564|FG007|STARTED|Period 1||0
10035459|NCT01935791|11159565|FG008|STARTED|Period 1||0
10035460|NCT01935791|11159557|FG000|COMPLETED|Period 1||4
10035461|NCT01935791|11159558|FG001|COMPLETED|Period 1||4
10035462|NCT01935791|11159559|FG002|COMPLETED|Period 1||3
10035463|NCT01935791|11159560|FG003|COMPLETED|Period 1||0
10035464|NCT01935791|11159561|FG004|COMPLETED|Period 1||0
10035465|NCT01935791|11159562|FG005|COMPLETED|Period 1||0
10035466|NCT01935791|11159563|FG006|COMPLETED|Period 1||0
10035467|NCT01935791|11159564|FG007|COMPLETED|Period 1||0
10035468|NCT01935791|11159565|FG008|COMPLETED|Period 1||0
10035469|NCT01935791|11159557|FG000|NOT COMPLETED|Period 1||0
10035470|NCT01935791|11159558|FG001|NOT COMPLETED|Period 1||0
10035471|NCT01935791|11159559|FG002|NOT COMPLETED|Period 1||0
10035472|NCT01935791|11159560|FG003|NOT COMPLETED|Period 1||0
10035473|NCT01935791|11159561|FG004|NOT COMPLETED|Period 1||0
10035474|NCT01935791|11159562|FG005|NOT COMPLETED|Period 1||0
10035475|NCT01935791|11159563|FG006|NOT COMPLETED|Period 1||0
10035476|NCT01935791|11159564|FG007|NOT COMPLETED|Period 1||0
10035477|NCT01935791|11159565|FG008|NOT COMPLETED|Period 1||0
10035478|NCT01935791|11159557|FG000|STARTED|Period 2||0
10035479|NCT01935791|11159558|FG001|STARTED|Period 2||0
10035480|NCT01935791|11159559|FG002|STARTED|Period 2||0
10035481|NCT01935791|11159560|FG003|STARTED|Period 2||2
10035482|NCT01935791|11159561|FG004|STARTED|Period 2||3
10035483|NCT01935791|11159562|FG005|STARTED|Period 2||1
10035484|NCT01935791|11159563|FG006|STARTED|Period 2||1
10035485|NCT01935791|11159564|FG007|STARTED|Period 2||3
10035486|NCT01935791|11159565|FG008|STARTED|Period 2||1
10035487|NCT01935791|11159557|FG000|COMPLETED|Period 2||0
10035488|NCT01935791|11159558|FG001|COMPLETED|Period 2||0
10035489|NCT01935791|11159559|FG002|COMPLETED|Period 2||0
10035490|NCT01935791|11159560|FG003|COMPLETED|Period 2||2
10035491|NCT01935791|11159561|FG004|COMPLETED|Period 2||3
10035492|NCT01935791|11159562|FG005|COMPLETED|Period 2||1
10035493|NCT01935791|11159563|FG006|COMPLETED|Period 2||1
10035494|NCT01935791|11159564|FG007|COMPLETED|Period 2||3
10035495|NCT01935791|11159565|FG008|COMPLETED|Period 2||1
10035496|NCT01935791|11159557|FG000|NOT COMPLETED|Period 2||0
10035497|NCT01935791|11159558|FG001|NOT COMPLETED|Period 2||0
10035498|NCT01935791|11159559|FG002|NOT COMPLETED|Period 2||0
10035499|NCT01935791|11159560|FG003|NOT COMPLETED|Period 2||0
10035500|NCT01935791|11159561|FG004|NOT COMPLETED|Period 2||0
10035501|NCT01935791|11159562|FG005|NOT COMPLETED|Period 2||0
10035502|NCT01935791|11159563|FG006|NOT COMPLETED|Period 2||0
10035503|NCT01935791|11159564|FG007|NOT COMPLETED|Period 2||0
10035504|NCT01935791|11159565|FG008|NOT COMPLETED|Period 2||0
10035505|NCT01936181|11159581|FG000|STARTED|Randomised, Double-blind||291
10035506|NCT01936181|11159582|FG001|STARTED|Randomised, Double-blind||293
10035507|NCT01936181|11159583|FG002|STARTED|Randomised, Double-blind||0
10035508|NCT01936181|11159584|FG003|STARTED|Randomised, Double-blind||0
10035509|NCT01936181|11159581|FG000|COMPLETED|Randomised, Double-blind||227
10035510|NCT01936181|11159582|FG001|COMPLETED|Randomised, Double-blind||225
10035511|NCT01936181|11159583|FG002|COMPLETED|Randomised, Double-blind||0
10115820|NCT02528357|11246623|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115821|NCT02528357|11246624|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115822|NCT02528357|11246625|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10115823|NCT02528357|11246626|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10115824|NCT02528357|11246627|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
10115825|NCT02528357|11246628|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
10115826|NCT02528357|11246629|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
10115827|NCT02528357|11246630|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
10115828|NCT02528357|11246631|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
10115829|NCT02528357|11246632|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10115830|NCT02528357|11246633|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115831|NCT02528357|11246634|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115832|NCT02528357|11246635|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115833|NCT02528357|11246617|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115834|NCT02528357|11246618|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115835|NCT02528357|11246619|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115836|NCT02528357|11246620|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115837|NCT02528357|11246621|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115838|NCT02528357|11246622|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115839|NCT02528357|11246623|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115840|NCT02528357|11246624|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115841|NCT02528357|11246625|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10115842|NCT02528357|11246626|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10115843|NCT02528357|11246627|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
10115844|NCT02528357|11246628|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
10115845|NCT02528357|11246629|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
10115846|NCT02528357|11246630|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
10115847|NCT02528357|11246631|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10115848|NCT02528357|11246632|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10115849|NCT02528357|11246633|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115850|NCT02528357|11246634|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115851|NCT02528357|11246635|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115852|NCT02528357|11246617|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115853|NCT02528357|11246618|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115854|NCT02528357|11246619|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115855|NCT02528357|11246620|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115856|NCT02528357|11246621|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115857|NCT02528357|11246622|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115858|NCT02528357|11246623|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115859|NCT02528357|11246624|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115860|NCT02528357|11246625|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
10035512|NCT01936181|11159584|FG003|COMPLETED|Randomised, Double-blind||0
10035513|NCT01936181|11159581|FG000|NOT COMPLETED|Randomised, Double-blind||64
10035514|NCT01936181|11159582|FG001|NOT COMPLETED|Randomised, Double-blind||68
10035515|NCT01936181|11159583|FG002|NOT COMPLETED|Randomised, Double-blind||0
10035516|NCT01936181|11159584|FG003|NOT COMPLETED|Randomised, Double-blind||0
10035517|NCT01936181|11159581|FG000|STARTED|Transition-extension||201
10035518|NCT01936181|11159582|FG001|STARTED|Transition-extension||0
10035519|NCT01936181|11159583|FG002|STARTED|Transition-extension||94
10035520|NCT01936181|11159584|FG003|STARTED|Transition-extension||101
10035521|NCT01936181|11159581|FG000|COMPLETED|Transition-extension||186
10035522|NCT01936181|11159582|FG001|COMPLETED|Transition-extension||0
10035523|NCT01936181|11159583|FG002|COMPLETED|Transition-extension||88
10035524|NCT01936181|11159584|FG003|COMPLETED|Transition-extension||96
10035525|NCT01936181|11159581|FG000|NOT COMPLETED|Transition-extension||15
10035526|NCT01936181|11159582|FG001|NOT COMPLETED|Transition-extension||0
10035527|NCT01936181|11159583|FG002|NOT COMPLETED|Transition-extension||6
10035528|NCT01936181|11159584|FG003|NOT COMPLETED|Transition-extension||5
10035529|NCT01936259|11159597|FG000|STARTED|Overall Study||130
10035530|NCT01936259|11159598|FG001|STARTED|Overall Study||131
10035531|NCT01936259|11159597|FG000|COMPLETED|Overall Study||118
10035532|NCT01936259|11159598|FG001|COMPLETED|Overall Study||111
10035533|NCT01936259|11159597|FG000|NOT COMPLETED|Overall Study||12
10035534|NCT01936259|11159598|FG001|NOT COMPLETED|Overall Study||20
10035535|NCT01936324|11159607|FG000|STARTED|Overall Study||6
10035536|NCT01936324|11159608|FG001|STARTED|Overall Study||53
10035537|NCT01936324|11159609|FG002|STARTED|Overall Study||55
10035538|NCT01936324|11159607|FG000|COMPLETED|Overall Study||6
10035539|NCT01936324|11159608|FG001|COMPLETED|Overall Study||47
10035540|NCT01936324|11159609|FG002|COMPLETED|Overall Study||50
10035541|NCT01936324|11159607|FG000|NOT COMPLETED|Overall Study||0
10035542|NCT01936324|11159608|FG001|NOT COMPLETED|Overall Study||6
10035543|NCT01936324|11159609|FG002|NOT COMPLETED|Overall Study||5
10035544|NCT01936363|11159618|FG000|STARTED|Overall Study||32
10035545|NCT01936363|11159619|FG001|STARTED|Overall Study||33
10035546|NCT01936363|11159618|FG000|COMPLETED|Overall Study||32
10035547|NCT01936363|11159619|FG001|COMPLETED|Overall Study||33
10035548|NCT01936363|11159618|FG000|NOT COMPLETED|Overall Study||0
10035549|NCT01936363|11159619|FG001|NOT COMPLETED|Overall Study||0
10035550|NCT01936389|11159627|FG000|STARTED|Overall Study||5
10035551|NCT01936389|11159628|FG001|STARTED|Overall Study||5
10035552|NCT01936389|11159627|FG000|COMPLETED|Overall Study||4
10035553|NCT01936389|11159628|FG001|COMPLETED|Overall Study||5
10035554|NCT01936389|11159627|FG000|NOT COMPLETED|Overall Study||1
10035555|NCT01936389|11159628|FG001|NOT COMPLETED|Overall Study||0
10035556|NCT01936467|11159636|FG000|STARTED|Overall Study||60
10035557|NCT01936467|11159637|FG001|STARTED|Overall Study||61
10035558|NCT01936467|11159636|FG000|COMPLETED|Overall Study||60
10035559|NCT01936467|11159637|FG001|COMPLETED|Overall Study||61
10035560|NCT01936467|11159636|FG000|NOT COMPLETED|Overall Study||0
10035561|NCT01936467|11159637|FG001|NOT COMPLETED|Overall Study||0
10035562|NCT01936519|11159649|FG000|STARTED|Overall Study||12
10035563|NCT01936519|11159650|FG001|STARTED|Overall Study||12
10035564|NCT01936519|11159649|FG000|COMPLETED|Overall Study||11
10035565|NCT01936519|11159650|FG001|COMPLETED|Overall Study||8
10035566|NCT01936519|11159649|FG000|NOT COMPLETED|Overall Study||1
10035567|NCT01936519|11159650|FG001|NOT COMPLETED|Overall Study||4
10035568|NCT01936623|11159661|FG000|STARTED|Overall Study||40
10035569|NCT01936623|11159662|FG001|STARTED|Overall Study||40
10035570|NCT01936623|11159661|FG000|COMPLETED|Overall Study||40
10035571|NCT01936623|11159662|FG001|COMPLETED|Overall Study||35
10035572|NCT01936623|11159661|FG000|NOT COMPLETED|Overall Study||0
10035573|NCT01936623|11159662|FG001|NOT COMPLETED|Overall Study||5
10035574|NCT01936649|11159668|FG000|STARTED|Overall Study||63
10035575|NCT01936649|11159668|FG000|Treated|Overall Study||51
10035576|NCT01936649|11159668|FG000|COMPLETED|Overall Study||50
10035577|NCT01936649|11159668|FG000|NOT COMPLETED|Overall Study||13
10035578|NCT01936662|11159674|FG000|STARTED|Overall Study||42
10035579|NCT01936662|11159675|FG001|STARTED|Overall Study||42
10035580|NCT01936662|11159674|FG000|COMPLETED|Overall Study||42
10035581|NCT01936662|11159675|FG001|COMPLETED|Overall Study||42
10035582|NCT01936662|11159674|FG000|NOT COMPLETED|Overall Study||0
10035583|NCT01936662|11159675|FG001|NOT COMPLETED|Overall Study||0
10081699|NCT02263911|11210285|FG000|STARTED|Period 2||4
10081700|NCT02263911|11210286|FG001|STARTED|Period 2||4
10081701|NCT02263911|11210287|FG002|STARTED|Period 2||4
10081702|NCT02263911|11210288|FG003|STARTED|Period 2||4
10081703|NCT02263911|11210285|FG000|COMPLETED|Period 2||4
10081704|NCT02263911|11210286|FG001|COMPLETED|Period 2||4
10081705|NCT02263911|11210287|FG002|COMPLETED|Period 2||4
10081706|NCT02263911|11210288|FG003|COMPLETED|Period 2||4
10081707|NCT02263911|11210285|FG000|NOT COMPLETED|Period 2||0
10081708|NCT02263911|11210286|FG001|NOT COMPLETED|Period 2||0
10081709|NCT02263911|11210287|FG002|NOT COMPLETED|Period 2||0
10081710|NCT02263911|11210288|FG003|NOT COMPLETED|Period 2||0
10081711|NCT02263911|11210285|FG000|STARTED|Period 2 Washout||4
10081712|NCT02263911|11210286|FG001|STARTED|Period 2 Washout||4
10081713|NCT02263911|11210287|FG002|STARTED|Period 2 Washout||4
10081714|NCT02263911|11210288|FG003|STARTED|Period 2 Washout||4
10081715|NCT02263911|11210285|FG000|COMPLETED|Period 2 Washout||4
10081716|NCT02263911|11210286|FG001|COMPLETED|Period 2 Washout||4
10081717|NCT02263911|11210287|FG002|COMPLETED|Period 2 Washout||4
10081718|NCT02263911|11210288|FG003|COMPLETED|Period 2 Washout||4
10081719|NCT02263911|11210285|FG000|NOT COMPLETED|Period 2 Washout||0
10081720|NCT02263911|11210286|FG001|NOT COMPLETED|Period 2 Washout||0
10081721|NCT02263911|11210287|FG002|NOT COMPLETED|Period 2 Washout||0
10081722|NCT02263911|11210288|FG003|NOT COMPLETED|Period 2 Washout||0
10081723|NCT02263911|11210285|FG000|STARTED|Period 3||4
10081724|NCT02263911|11210286|FG001|STARTED|Period 3||4
10081725|NCT02263911|11210287|FG002|STARTED|Period 3||4
10035584|NCT01936844|11159685|FG000|STARTED|Overall Study||15
10035585|NCT01936844|11159686|FG001|STARTED|Overall Study||15
10035586|NCT01936844|11159685|FG000|COMPLETED|Overall Study||9
10035587|NCT01936844|11159686|FG001|COMPLETED|Overall Study||8
10035588|NCT01936844|11159685|FG000|NOT COMPLETED|Overall Study||6
10035589|NCT01936844|11159686|FG001|NOT COMPLETED|Overall Study||7
10035590|NCT01936870|11159692|FG000|STARTED|Overall Study||2492
10035591|NCT01936870|11159692|FG000|COMPLETED|Overall Study||2303
10035592|NCT01936870|11159692|FG000|NOT COMPLETED|Overall Study||189
10035593|NCT01936896|11159696|FG000|STARTED|Overall Study||10
10035594|NCT01936896|11159696|FG000|COMPLETED|Overall Study||10
10035595|NCT01936896|11159696|FG000|NOT COMPLETED|Overall Study||0
10035596|NCT01936909|11159703|FG000|STARTED|Overall Study||20
10035597|NCT01936909|11159704|FG001|STARTED|Overall Study||20
10035598|NCT01936909|11159705|FG002|STARTED|Overall Study||20
10035599|NCT01936909|11159703|FG000|COMPLETED|Overall Study||10
10035600|NCT01936909|11159704|FG001|COMPLETED|Overall Study||12
10035601|NCT01936909|11159705|FG002|COMPLETED|Overall Study||14
10035602|NCT01936909|11159703|FG000|NOT COMPLETED|Overall Study||10
10035603|NCT01936909|11159704|FG001|NOT COMPLETED|Overall Study||8
10035604|NCT01936909|11159705|FG002|NOT COMPLETED|Overall Study||6
10035605|NCT01936948|11159717|FG000|STARTED|Overall Study||227
10035606|NCT01936948|11159718|FG001|STARTED|Overall Study||231
10035607|NCT01936948|11159719|FG002|STARTED|Overall Study||237
10035608|NCT01936948|11159720|FG003|STARTED|Overall Study||233
10035609|NCT01936948|11159717|FG000|Crossover|Overall Study||31
10035610|NCT01936948|11159718|FG001|Crossover|Overall Study||27
10035611|NCT01936948|11159719|FG002|Crossover|Overall Study||22
10035612|NCT01936948|11159720|FG003|Crossover|Overall Study||25
10035613|NCT01936948|11159717|FG000|COMPLETED|Overall Study||227
10035614|NCT01936948|11159718|FG001|COMPLETED|Overall Study||228
10035615|NCT01936948|11159719|FG002|COMPLETED|Overall Study||234
10035616|NCT01936948|11159720|FG003|COMPLETED|Overall Study||230
10035617|NCT01936948|11159717|FG000|NOT COMPLETED|Overall Study||0
10035618|NCT01936948|11159718|FG001|NOT COMPLETED|Overall Study||3
10035619|NCT01936948|11159719|FG002|NOT COMPLETED|Overall Study||3
10035620|NCT01936948|11159720|FG003|NOT COMPLETED|Overall Study||3
10035621|NCT01937026|11159728|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
10035622|NCT01937026|11159728|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
10035623|NCT01937026|11159728|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
10035624|NCT01937026|11159728|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
10035625|NCT01937026|11159728|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
10035626|NCT01937026|11159728|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
10035627|NCT01937026|11159728|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
10035628|NCT01937026|11159728|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
10035629|NCT01937026|11159728|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
10035630|NCT01937117|11159735|FG000|STARTED|Overall Study||88
10035631|NCT01937117|11159735|FG000|COMPLETED|Overall Study||75
10035632|NCT01937117|11159735|FG000|NOT COMPLETED|Overall Study||13
10035633|NCT01937130|11159743|FG000|STARTED|Overall Study||5
10035634|NCT01937130|11159744|FG001|STARTED|Overall Study||7
10035635|NCT01937130|11159745|FG002|STARTED|Overall Study||5
10035636|NCT01937130|11159746|FG003|STARTED|Overall Study||4
10035637|NCT01937130|11159743|FG000|COMPLETED|Overall Study||0
10035638|NCT01937130|11159744|FG001|COMPLETED|Overall Study||3
10035639|NCT01937130|11159745|FG002|COMPLETED|Overall Study||2
10035640|NCT01937130|11159746|FG003|COMPLETED|Overall Study||2
10035641|NCT01937130|11159743|FG000|NOT COMPLETED|Overall Study||5
10035642|NCT01937130|11159744|FG001|NOT COMPLETED|Overall Study||4
10035643|NCT01937130|11159745|FG002|NOT COMPLETED|Overall Study||3
10035644|NCT01937130|11159746|FG003|NOT COMPLETED|Overall Study||2
10035645|NCT01937195|11159756|FG000|STARTED|Overall Study||95
10035646|NCT01937195|11159756|FG000|COMPLETED|Overall Study||95
10035647|NCT01937195|11159756|FG000|NOT COMPLETED|Overall Study||0
10035648|NCT01937260|11159762|FG000|STARTED|Overall Study||21
10035649|NCT01937260|11159763|FG001|STARTED|Overall Study||10
10035650|NCT01937260|11159762|FG000|COMPLETED|Overall Study||20
10035651|NCT01937260|11159763|FG001|COMPLETED|Overall Study||10
10035652|NCT01937260|11159762|FG000|NOT COMPLETED|Overall Study||1
10035653|NCT01937260|11159763|FG001|NOT COMPLETED|Overall Study||0
10035654|NCT01937299|11159771|FG000|STARTED|Overall Study||117
10035655|NCT01937299|11159772|FG001|STARTED|Overall Study||116
10035656|NCT01937299|11159771|FG000|COMPLETED|Overall Study||103
10035657|NCT01937299|11159772|FG001|COMPLETED|Overall Study||112
10035658|NCT01937299|11159771|FG000|NOT COMPLETED|Overall Study||14
10035659|NCT01937299|11159772|FG001|NOT COMPLETED|Overall Study||4
10035660|NCT01937312|11159781|FG000|STARTED|Overall Study||94
10035661|NCT01937312|11159782|FG001|STARTED|Overall Study||95
10035662|NCT01937312|11159781|FG000|Treated|Overall Study||93
10035663|NCT01937312|11159782|FG001|Treated|Overall Study||95
10035664|NCT01937312|11159781|FG000|COMPLETED|Overall Study||83
10035665|NCT01937312|11159782|FG001|COMPLETED|Overall Study||92
10035666|NCT01937312|11159781|FG000|NOT COMPLETED|Overall Study||11
10035667|NCT01937312|11159782|FG001|NOT COMPLETED|Overall Study||3
10035668|NCT01937351|11159791|FG000|STARTED|Overall Study||134
10035669|NCT01937351|11159792|FG001|STARTED|Overall Study||28
10035670|NCT01937351|11159791|FG000|Treated w Study Device|Overall Study||130
10035671|NCT01937351|11159792|FG001|Treated w Study Device|Overall Study||28
10035672|NCT01937351|11159791|FG000|30-Day Follow-up|Overall Study||128
10035673|NCT01937351|11159792|FG001|30-Day Follow-up|Overall Study||27
10035674|NCT01937351|11159791|FG000|6-Month Follow-up|Overall Study||125
10035675|NCT01937351|11159792|FG001|6-Month Follow-up|Overall Study||26
10035676|NCT01937351|11159791|FG000|COMPLETED|Overall Study||125
10035677|NCT01937351|11159792|FG001|COMPLETED|Overall Study||26
10035678|NCT01937351|11159791|FG000|NOT COMPLETED|Overall Study||9
10035679|NCT01937351|11159792|FG001|NOT COMPLETED|Overall Study||2
10035680|NCT01937364|11159799|FG000|STARTED|Overall Study||9
10035681|NCT01937364|11159800|FG001|STARTED|Overall Study||8
10035682|NCT01937364|11159799|FG000|COMPLETED|Overall Study||7
10035683|NCT01937364|11159800|FG001|COMPLETED|Overall Study||7
10035684|NCT01937364|11159799|FG000|NOT COMPLETED|Overall Study||2
10035685|NCT01937364|11159800|FG001|NOT COMPLETED|Overall Study||1
10035686|NCT01937390|11159806|FG000|STARTED|Overall Study||585
10035687|NCT01937390|11159806|FG000|COMPLETED|Overall Study||550
10035688|NCT01937390|11159806|FG000|NOT COMPLETED|Overall Study||35
10035689|NCT01937520|11159812|FG000|STARTED|Overall Study||11
10035690|NCT01937520|11159813|FG001|STARTED|Overall Study||9
10035691|NCT01937520|11159812|FG000|COMPLETED|Overall Study||11
10035692|NCT01937520|11159813|FG001|COMPLETED|Overall Study||9
10035693|NCT01937520|11159812|FG000|NOT COMPLETED|Overall Study||0
10035694|NCT01937520|11159813|FG001|NOT COMPLETED|Overall Study||0
10035695|NCT01937559|11159823|FG000|STARTED|Overall Study||61
10035696|NCT01937559|11159824|FG001|STARTED|Overall Study||61
10035697|NCT01937559|11159825|FG002|STARTED|Overall Study||66
10035698|NCT01937559|11159823|FG000|COMPLETED|Overall Study||50
10035699|NCT01937559|11159824|FG001|COMPLETED|Overall Study||50
10035700|NCT01937559|11159825|FG002|COMPLETED|Overall Study||66
10035701|NCT01937559|11159823|FG000|NOT COMPLETED|Overall Study||11
10035702|NCT01937559|11159824|FG001|NOT COMPLETED|Overall Study||11
10035703|NCT01937559|11159825|FG002|NOT COMPLETED|Overall Study||0
10035704|NCT01937598|11159837|FG000|STARTED|Overall Study||8
10035705|NCT01937598|11159838|FG001|STARTED|Overall Study||8
10035706|NCT01937598|11159837|FG000|COMPLETED|Overall Study||8
10035707|NCT01937598|11159838|FG001|COMPLETED|Overall Study||8
10035708|NCT01937598|11159837|FG000|NOT COMPLETED|Overall Study||0
10035709|NCT01937598|11159838|FG001|NOT COMPLETED|Overall Study||0
10035710|NCT01937624|11159844|FG000|STARTED|Overall Study||51
10035711|NCT01937624|11159844|FG000|COMPLETED|Overall Study||51
10035712|NCT01937624|11159844|FG000|NOT COMPLETED|Overall Study||0
10035713|NCT01937715|11159853|FG000|STARTED|Overall Study||3
10035714|NCT01937715|11159854|FG001|STARTED|Overall Study||4
10035715|NCT01937715|11159855|FG002|STARTED|Overall Study||3
10035716|NCT01937715|11159856|FG003|STARTED|Overall Study||5
10035717|NCT01937715|11159857|FG004|STARTED|Overall Study||3
10035718|NCT01937715|11159853|FG000|COMPLETED|Overall Study||3
10035719|NCT01937715|11159854|FG001|COMPLETED|Overall Study||3
10035720|NCT01937715|11159855|FG002|COMPLETED|Overall Study||3
10035721|NCT01937715|11159856|FG003|COMPLETED|Overall Study||1
10035722|NCT01937715|11159857|FG004|COMPLETED|Overall Study||1
10035723|NCT01937715|11159853|FG000|NOT COMPLETED|Overall Study||0
10035724|NCT01937715|11159854|FG001|NOT COMPLETED|Overall Study||1
10035725|NCT01937715|11159855|FG002|NOT COMPLETED|Overall Study||0
10035726|NCT01937715|11159856|FG003|NOT COMPLETED|Overall Study||4
10035727|NCT01937715|11159857|FG004|NOT COMPLETED|Overall Study||2
10035728|NCT01937871|11159872|FG000|STARTED|Overall Study||361
10035729|NCT01937871|11159873|FG001|STARTED|Overall Study||363
10035730|NCT01937871|11159874|FG002|STARTED|Overall Study||185
10035731|NCT01937871|11159872|FG000|Received at Least One Dose of Study Drug|Overall Study||361
10035732|NCT01937871|11159873|FG001|Received at Least One Dose of Study Drug|Overall Study||362
10035733|NCT01937871|11159874|FG002|Received at Least One Dose of Study Drug|Overall Study||185
10035734|NCT01937871|11159872|FG000|COMPLETED|Overall Study||337
10035735|NCT01937871|11159873|FG001|COMPLETED|Overall Study||346
10035736|NCT01937871|11159874|FG002|COMPLETED|Overall Study||174
10035737|NCT01937871|11159872|FG000|NOT COMPLETED|Overall Study||24
10035738|NCT01937871|11159873|FG001|NOT COMPLETED|Overall Study||17
10035739|NCT01937871|11159874|FG002|NOT COMPLETED|Overall Study||11
10035740|NCT01937884|11159887|FG000|STARTED|Overall Study||7
10035741|NCT01937884|11159888|FG001|STARTED|Overall Study||11
10035742|NCT01937884|11159887|FG000|COMPLETED|Overall Study||6
10035743|NCT01937884|11159888|FG001|COMPLETED|Overall Study||11
10035744|NCT01937884|11159887|FG000|NOT COMPLETED|Overall Study||1
10035745|NCT01937884|11159888|FG001|NOT COMPLETED|Overall Study||0
10035746|NCT01937975|11159899|FG000|STARTED|Overall Study||8
10035747|NCT01937975|11159900|FG001|STARTED|Overall Study||8
10035748|NCT01937975|11159901|FG002|STARTED|Overall Study||8
10035749|NCT01937975|11159899|FG000|COMPLETED|Overall Study||8
10035750|NCT01937975|11159900|FG001|COMPLETED|Overall Study||8
10035751|NCT01937975|11159901|FG002|COMPLETED|Overall Study||8
10035752|NCT01937975|11159899|FG000|NOT COMPLETED|Overall Study||0
10035753|NCT01937975|11159900|FG001|NOT COMPLETED|Overall Study||0
10035754|NCT01937975|11159901|FG002|NOT COMPLETED|Overall Study||0
10035755|NCT01938040|11159915|FG000|STARTED|Overall Study||28
10035756|NCT01938040|11159916|FG001|STARTED|Overall Study||27
10035757|NCT01938040|11159915|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
10035758|NCT01938040|11159916|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
10035759|NCT01938040|11159915|FG000|Behavior Metrics|Overall Study||28
10035760|NCT01938040|11159916|FG001|Behavior Metrics|Overall Study||27
10035761|NCT01938040|11159915|FG000|COMPLETED|Overall Study||28
10035762|NCT01938040|11159916|FG001|COMPLETED|Overall Study||27
10035763|NCT01938040|11159915|FG000|NOT COMPLETED|Overall Study||0
10035764|NCT01938040|11159916|FG001|NOT COMPLETED|Overall Study||0
10035765|NCT01938066|11159930|FG000|STARTED|Overall Study||15
10035766|NCT01938066|11159931|FG001|STARTED|Overall Study||15
10035767|NCT01938066|11159930|FG000|COMPLETED|Overall Study||14
10035768|NCT01938066|11159931|FG001|COMPLETED|Overall Study||13
10035769|NCT01938066|11159930|FG000|NOT COMPLETED|Overall Study||1
10035770|NCT01938066|11159931|FG001|NOT COMPLETED|Overall Study||2
10035771|NCT01938079|11159939|FG000|STARTED|Overall Study||10
10035772|NCT01938079|11159940|FG001|STARTED|Overall Study||10
10035773|NCT01938079|11159939|FG000|COMPLETED|Overall Study||10
10035774|NCT01938079|11159940|FG001|COMPLETED|Overall Study||10
10035775|NCT01938079|11159939|FG000|NOT COMPLETED|Overall Study||0
10035776|NCT01938079|11159940|FG001|NOT COMPLETED|Overall Study||0
10035777|NCT01938170|11159946|FG000|STARTED|Overall Study||41
10035778|NCT01938170|11159946|FG000|COMPLETED|Overall Study||41
10035779|NCT01938170|11159946|FG000|NOT COMPLETED|Overall Study||0
10035780|NCT01938378|11159953|FG000|STARTED|Overall Study||41
10035781|NCT01938378|11159953|FG000|COMPLETED|Overall Study||41
10035782|NCT01938378|11159953|FG000|NOT COMPLETED|Overall Study||0
10035783|NCT01938391|11159971|FG000|STARTED|Baseline||25
10035784|NCT01938391|11159971|FG000|COMPLETED|Baseline||25
10035785|NCT01938391|11159971|FG000|NOT COMPLETED|Baseline||0
10035786|NCT01938391|11159971|FG000|STARTED|2 Week Follow up||25
10035787|NCT01938391|11159971|FG000|COMPLETED|2 Week Follow up||25
10035788|NCT01938391|11159971|FG000|NOT COMPLETED|2 Week Follow up||0
10035789|NCT01938391|11159971|FG000|STARTED|6 Month Follow up||25
10035790|NCT01938391|11159971|FG000|COMPLETED|6 Month Follow up||24
10035791|NCT01938391|11159971|FG000|NOT COMPLETED|6 Month Follow up||1
10035792|NCT01938391|11159971|FG000|STARTED|12 Month Follow up||24
10035793|NCT01938391|11159971|FG000|COMPLETED|12 Month Follow up||22
10035794|NCT01938391|11159971|FG000|NOT COMPLETED|12 Month Follow up||2
10035795|NCT01938430|11159989|FG000|STARTED|Overall Study||30
10035796|NCT01938430|11159990|FG001|STARTED|Overall Study||29
10035797|NCT01938430|11159991|FG002|STARTED|Overall Study||23
10035798|NCT01938430|11159992|FG003|STARTED|Overall Study||26
10035799|NCT01938430|11159993|FG004|STARTED|Overall Study||55
10035800|NCT01938430|11159994|FG005|STARTED|Overall Study||56
10035801|NCT01938430|11159995|FG006|STARTED|Overall Study||26
10035802|NCT01938430|11159996|FG007|STARTED|Overall Study||25
10035803|NCT01938430|11159997|FG008|STARTED|Overall Study||26
10035804|NCT01938430|11159998|FG009|STARTED|Overall Study||26
10035805|NCT01938430|11159999|FG010|STARTED|Overall Study||6
10035806|NCT01938430|11160000|FG011|STARTED|Overall Study||4
10035807|NCT01938430|11160001|FG012|STARTED|Overall Study||4
10035808|NCT01938430|11160002|FG013|STARTED|Overall Study||3
10035809|NCT01938430|11159989|FG000|COMPLETED|Overall Study||26
10035810|NCT01938430|11159990|FG001|COMPLETED|Overall Study||26
10035811|NCT01938430|11159991|FG002|COMPLETED|Overall Study||18
10035812|NCT01938430|11159992|FG003|COMPLETED|Overall Study||24
10035813|NCT01938430|11159993|FG004|COMPLETED|Overall Study||55
10035814|NCT01938430|11159994|FG005|COMPLETED|Overall Study||55
10035815|NCT01938430|11159995|FG006|COMPLETED|Overall Study||24
10035816|NCT01938430|11159996|FG007|COMPLETED|Overall Study||24
10035817|NCT01938430|11159997|FG008|COMPLETED|Overall Study||22
10035818|NCT01938430|11159998|FG009|COMPLETED|Overall Study||23
10035819|NCT01938430|11159999|FG010|COMPLETED|Overall Study||3
10035820|NCT01938430|11160000|FG011|COMPLETED|Overall Study||3
10035821|NCT01938430|11160001|FG012|COMPLETED|Overall Study||4
10035822|NCT01938430|11160002|FG013|COMPLETED|Overall Study||2
10035823|NCT01938430|11159989|FG000|NOT COMPLETED|Overall Study||4
10035824|NCT01938430|11159990|FG001|NOT COMPLETED|Overall Study||3
10035825|NCT01938430|11159991|FG002|NOT COMPLETED|Overall Study||5
10035826|NCT01938430|11159992|FG003|NOT COMPLETED|Overall Study||2
10035827|NCT01938430|11159993|FG004|NOT COMPLETED|Overall Study||0
10035828|NCT01938430|11159994|FG005|NOT COMPLETED|Overall Study||1
10035829|NCT01938430|11159995|FG006|NOT COMPLETED|Overall Study||2
10035830|NCT01938430|11159996|FG007|NOT COMPLETED|Overall Study||1
10035831|NCT01938430|11159997|FG008|NOT COMPLETED|Overall Study||4
10035832|NCT01938430|11159998|FG009|NOT COMPLETED|Overall Study||3
10035833|NCT01938430|11159999|FG010|NOT COMPLETED|Overall Study||3
10035834|NCT01938430|11160000|FG011|NOT COMPLETED|Overall Study||1
10035835|NCT01938430|11160001|FG012|NOT COMPLETED|Overall Study||0
10035836|NCT01938430|11160002|FG013|NOT COMPLETED|Overall Study||1
10035837|NCT01938573|11160057|FG000|STARTED|Overall Study||15
10035838|NCT01938573|11160058|FG001|STARTED|Overall Study||6
10035839|NCT01938573|11160057|FG000|COMPLETED|Overall Study||13
10035840|NCT01938573|11160058|FG001|COMPLETED|Overall Study||6
10035841|NCT01938573|11160057|FG000|NOT COMPLETED|Overall Study||2
10035842|NCT01938573|11160058|FG001|NOT COMPLETED|Overall Study||0
10035843|NCT01938625|11160065|FG000|STARTED|Overall Study||10
10035844|NCT01938625|11160066|FG001|STARTED|Overall Study||25
10035845|NCT01938625|11160065|FG000|COMPLETED|Overall Study||10
10035846|NCT01938625|11160066|FG001|COMPLETED|Overall Study||23
10035847|NCT01938625|11160065|FG000|NOT COMPLETED|Overall Study||0
10035848|NCT01938625|11160066|FG001|NOT COMPLETED|Overall Study||2
10035849|NCT01938664|11160074|FG000|STARTED|Overall Study||20
10035850|NCT01938664|11160075|FG001|STARTED|Overall Study||10
10035851|NCT01938664|11160074|FG000|COMPLETED|Overall Study||5
10035852|NCT01938664|11160075|FG001|COMPLETED|Overall Study||0
10035853|NCT01938664|11160074|FG000|NOT COMPLETED|Overall Study||15
10035854|NCT01938664|11160075|FG001|NOT COMPLETED|Overall Study||10
10035855|NCT01938846|11160084|FG000|STARTED|Overall Study||41
10035856|NCT01938846|11160085|FG001|STARTED|Overall Study||25
10035857|NCT01938846|11160086|FG002|STARTED|Overall Study||24
10115861|NCT02528357|11246626|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
10115862|NCT02528357|11246627|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
10115863|NCT02528357|11246628|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
10115864|NCT02528357|11246629|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10115865|NCT02528357|11246630|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
10115866|NCT02528357|11246631|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
10115867|NCT02528357|11246632|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115868|NCT02528357|11246633|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115869|NCT02528357|11246634|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115870|NCT02528357|11246635|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10115871|NCT02528357|11246617|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115872|NCT02528357|11246618|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115873|NCT02528357|11246619|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115874|NCT02528357|11246620|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115875|NCT02528357|11246621|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115876|NCT02528357|11246622|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115877|NCT02528357|11246623|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115878|NCT02528357|11246624|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115879|NCT02528357|11246625|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115880|NCT02528357|11246626|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115881|NCT02528357|11246627|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115882|NCT02528357|11246628|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115883|NCT02528357|11246629|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115884|NCT02528357|11246630|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115885|NCT02528357|11246631|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115886|NCT02528357|11246632|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10035858|NCT01938846|11160084|FG000|COMPLETED|Overall Study||0
10035859|NCT01938846|11160085|FG001|COMPLETED|Overall Study||0
10035860|NCT01938846|11160086|FG002|COMPLETED|Overall Study||0
10035861|NCT01938846|11160084|FG000|NOT COMPLETED|Overall Study||41
10035862|NCT01938846|11160085|FG001|NOT COMPLETED|Overall Study||25
10035863|NCT01938846|11160086|FG002|NOT COMPLETED|Overall Study||24
10035864|NCT01938989|11160127|FG000|STARTED|Overall Study||77
10035865|NCT01938989|11160128|FG001|STARTED|Overall Study||77
10035866|NCT01938989|11160127|FG000|COMPLETED|Overall Study||77
10035867|NCT01938989|11160128|FG001|COMPLETED|Overall Study||77
10035868|NCT01938989|11160127|FG000|NOT COMPLETED|Overall Study||0
10035869|NCT01938989|11160128|FG001|NOT COMPLETED|Overall Study||0
10035870|NCT01939002|11160136|FG000|STARTED|Overall Study||103
10035871|NCT01939002|11160137|FG001|STARTED|Overall Study||98
10035872|NCT01939002|11160136|FG000|COMPLETED|Overall Study||84
10035873|NCT01939002|11160137|FG001|COMPLETED|Overall Study||80
10035874|NCT01939002|11160136|FG000|NOT COMPLETED|Overall Study||19
10035875|NCT01939002|11160137|FG001|NOT COMPLETED|Overall Study||18
10035876|NCT01939028|11160148|FG000|STARTED|Overall Study||58
10035877|NCT01939028|11160148|FG000|COMPLETED|Overall Study||46
10035878|NCT01939028|11160148|FG000|NOT COMPLETED|Overall Study||12
10035879|NCT01939145|11160154|FG000|STARTED|Overall Study||49
10035880|NCT01939145|11160155|FG001|STARTED|Overall Study||51
10035881|NCT01939145|11160154|FG000|COMPLETED|Overall Study||47
10035882|NCT01939145|11160155|FG001|COMPLETED|Overall Study||44
10035883|NCT01939145|11160154|FG000|NOT COMPLETED|Overall Study||2
10035884|NCT01939145|11160155|FG001|NOT COMPLETED|Overall Study||7
10035885|NCT01939158|11160165|FG000|STARTED|Overall Study||203
10035886|NCT01939158|11160166|FG001|STARTED|Overall Study||198
10035887|NCT01939158|11160167|FG002|STARTED|Overall Study||201
10035888|NCT01939158|11160168|FG003|STARTED|Overall Study||201
10035889|NCT01939158|11160165|FG000|Vaccinated|Overall Study||203
10035890|NCT01939158|11160166|FG001|Vaccinated|Overall Study||197
10035891|NCT01939158|11160167|FG002|Vaccinated|Overall Study||201
10035892|NCT01939158|11160168|FG003|Vaccinated|Overall Study||201
10035893|NCT01939158|11160165|FG000|COMPLETED|Overall Study||156
10035894|NCT01939158|11160166|FG001|COMPLETED|Overall Study||146
10035895|NCT01939158|11160167|FG002|COMPLETED|Overall Study||160
10035896|NCT01939158|11160168|FG003|COMPLETED|Overall Study||157
10035897|NCT01939158|11160165|FG000|NOT COMPLETED|Overall Study||47
10035898|NCT01939158|11160166|FG001|NOT COMPLETED|Overall Study||52
10035899|NCT01939158|11160167|FG002|NOT COMPLETED|Overall Study||41
10035900|NCT01939158|11160168|FG003|NOT COMPLETED|Overall Study||44
10035901|NCT01939197|11160189|FG000|STARTED|Overall Study||31
10035902|NCT01939197|11160190|FG001|STARTED|Overall Study||32
10035903|NCT01939197|11160191|FG002|STARTED|Overall Study||10
10035904|NCT01939197|11160192|FG003|STARTED|Overall Study||12
10035905|NCT01939197|11160193|FG004|STARTED|Overall Study||200
10035906|NCT01939197|11160194|FG005|STARTED|Overall Study||5
10035907|NCT01939197|11160195|FG006|STARTED|Overall Study||28
10035908|NCT01939197|11160189|FG000|COMPLETED|Overall Study||30
10035909|NCT01939197|11160190|FG001|COMPLETED|Overall Study||31
10035910|NCT01939197|11160191|FG002|COMPLETED|Overall Study||10
10035911|NCT01939197|11160192|FG003|COMPLETED|Overall Study||11
10035912|NCT01939197|11160193|FG004|COMPLETED|Overall Study||196
10035913|NCT01939197|11160194|FG005|COMPLETED|Overall Study||4
10035914|NCT01939197|11160195|FG006|COMPLETED|Overall Study||26
10035915|NCT01939197|11160189|FG000|NOT COMPLETED|Overall Study||1
10035916|NCT01939197|11160190|FG001|NOT COMPLETED|Overall Study||1
10035917|NCT01939197|11160191|FG002|NOT COMPLETED|Overall Study||0
10035918|NCT01939197|11160192|FG003|NOT COMPLETED|Overall Study||1
10035919|NCT01939197|11160193|FG004|NOT COMPLETED|Overall Study||4
10035920|NCT01939197|11160194|FG005|NOT COMPLETED|Overall Study||1
10035921|NCT01939197|11160195|FG006|NOT COMPLETED|Overall Study||2
10035922|NCT01939288|11160227|FG000|STARTED|Overall Study||5
10035923|NCT01939288|11160228|FG001|STARTED|Overall Study||5
10035924|NCT01939288|11160227|FG000|COMPLETED|Overall Study||5
10035925|NCT01939288|11160228|FG001|COMPLETED|Overall Study||5
10035926|NCT01939288|11160227|FG000|NOT COMPLETED|Overall Study||0
9706354|NCT00127127|10805341|FG002|COMPLETED|Overall Study||3
9706355|NCT00127127|10805342|FG003|COMPLETED|Overall Study||3
9706356|NCT00127127|10805339|FG000|NOT COMPLETED|Overall Study||1
9706357|NCT00127127|10805340|FG001|NOT COMPLETED|Overall Study||5
9706358|NCT00127127|10805341|FG002|NOT COMPLETED|Overall Study||0
9706359|NCT00127127|10805342|FG003|NOT COMPLETED|Overall Study||3
10035927|NCT01939288|11160228|FG001|NOT COMPLETED|Overall Study||0
10035928|NCT01939301|11160235|FG000|STARTED|Overall Study||39
10035929|NCT01939301|11160236|FG001|STARTED|Overall Study||39
10035930|NCT01939301|11160235|FG000|COMPLETED|Overall Study||38
10035931|NCT01939301|11160236|FG001|COMPLETED|Overall Study||38
10035932|NCT01939301|11160235|FG000|NOT COMPLETED|Overall Study||1
10035933|NCT01939301|11160236|FG001|NOT COMPLETED|Overall Study||1
10035934|NCT01939314|11160244|FG000|STARTED|Overall Study||45
10035935|NCT01939314|11160245|FG001|STARTED|Overall Study||48
10035936|NCT01939314|11160244|FG000|15 Minute Endpoint|Overall Study||41
10035937|NCT01939314|11160245|FG001|15 Minute Endpoint|Overall Study||46
10035938|NCT01939314|11160244|FG000|24 Hour Endpoint|Overall Study||36
10035939|NCT01939314|11160245|FG001|24 Hour Endpoint|Overall Study||40
10035940|NCT01939314|11160244|FG000|COMPLETED|Overall Study||36
10035941|NCT01939314|11160245|FG001|COMPLETED|Overall Study||40
10035942|NCT01939314|11160244|FG000|NOT COMPLETED|Overall Study||9
10035943|NCT01939314|11160245|FG001|NOT COMPLETED|Overall Study||8
10035944|NCT01939353|11160253|FG000|STARTED|Placebo Run-in (1 Week)||45
10035945|NCT01939353|11160253|FG000|COMPLETED|Placebo Run-in (1 Week)||41
10035946|NCT01939353|11160253|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4
10035947|NCT01939353|11160253|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41
10035948|NCT01939353|11160253|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37
10035949|NCT01939353|11160253|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4
10035950|NCT01939366|11160262|FG000|STARTED|Overall Study||66
10035951|NCT01939366|11160263|FG001|STARTED|Overall Study||64
10035952|NCT01939366|11160264|FG002|STARTED|Overall Study||65
10035953|NCT01939366|11160265|FG003|STARTED|Overall Study||68
10035954|NCT01939366|11160266|FG004|STARTED|Overall Study||66
10035955|NCT01939366|11160262|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64
10035956|NCT01939366|11160263|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61
10035957|NCT01939366|11160264|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63
10035958|NCT01939366|11160265|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65
10035959|NCT01939366|11160266|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63
10035960|NCT01939366|11160262|FG000|Safety Set|Overall Study||64
10035961|NCT01939366|11160263|FG001|Safety Set|Overall Study||61
10035962|NCT01939366|11160264|FG002|Safety Set|Overall Study||62
10035963|NCT01939366|11160265|FG003|Safety Set|Overall Study||65
10035964|NCT01939366|11160266|FG004|Safety Set|Overall Study||62
10035965|NCT01939366|11160262|FG000|Full Analysis Set|Overall Study||64
10035966|NCT01939366|11160263|FG001|Full Analysis Set|Overall Study||60
10035967|NCT01939366|11160264|FG002|Full Analysis Set|Overall Study||61
10035968|NCT01939366|11160265|FG003|Full Analysis Set|Overall Study||65
10035969|NCT01939366|11160266|FG004|Full Analysis Set|Overall Study||62
10035970|NCT01939366|11160262|FG000|Per Protocol Set|Overall Study||58
10035971|NCT01939366|11160263|FG001|Per Protocol Set|Overall Study||55
10035972|NCT01939366|11160264|FG002|Per Protocol Set|Overall Study||50
10035973|NCT01939366|11160265|FG003|Per Protocol Set|Overall Study||51
10035974|NCT01939366|11160266|FG004|Per Protocol Set|Overall Study||49
10035975|NCT01939366|11160262|FG000|COMPLETED|Overall Study||52
10035976|NCT01939366|11160263|FG001|COMPLETED|Overall Study||41
10035977|NCT01939366|11160264|FG002|COMPLETED|Overall Study||27
10035978|NCT01939366|11160265|FG003|COMPLETED|Overall Study||51
10035979|NCT01939366|11160266|FG004|COMPLETED|Overall Study||48
10035980|NCT01939366|11160262|FG000|NOT COMPLETED|Overall Study||14
10035981|NCT01939366|11160263|FG001|NOT COMPLETED|Overall Study||23
10035982|NCT01939366|11160264|FG002|NOT COMPLETED|Overall Study||38
10035983|NCT01939366|11160265|FG003|NOT COMPLETED|Overall Study||17
10035984|NCT01939366|11160266|FG004|NOT COMPLETED|Overall Study||18
10035985|NCT01939405|11160280|FG000|STARTED|Overall Study||30
10035986|NCT01939405|11160281|FG001|STARTED|Overall Study||30
10035987|NCT01939405|11160280|FG000|COMPLETED|Overall Study||27
10035988|NCT01939405|11160281|FG001|COMPLETED|Overall Study||28
10035989|NCT01939405|11160280|FG000|NOT COMPLETED|Overall Study||3
10035990|NCT01939405|11160281|FG001|NOT COMPLETED|Overall Study||2
10035991|NCT01939496|11160290|FG000|STARTED|Overall Study||56
10035992|NCT01939496|11160291|FG001|STARTED|Overall Study||57
10035993|NCT01939496|11160292|FG002|STARTED|Overall Study||56
10035994|NCT01939496|11160290|FG000|COMPLETED|Overall Study||47
10035995|NCT01939496|11160291|FG001|COMPLETED|Overall Study||54
10035996|NCT01939496|11160292|FG002|COMPLETED|Overall Study||54
10035997|NCT01939496|11160290|FG000|NOT COMPLETED|Overall Study||9
10035998|NCT01939496|11160291|FG001|NOT COMPLETED|Overall Study||3
10035999|NCT01939496|11160292|FG002|NOT COMPLETED|Overall Study||2
10036000|NCT01939548|11160303|FG000|STARTED|Overall Study||78
10036001|NCT01939548|11160304|FG001|STARTED|Overall Study||82
10036002|NCT01939548|11160305|FG002|STARTED|Overall Study||80
9848365|NCT00858780|10961053|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848366|NCT00858780|10961054|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848367|NCT00858780|10961050|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
9848368|NCT00858780|10961051|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848369|NCT00858780|10961052|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10036003|NCT01939548|11160303|FG000|COMPLETED|Overall Study||41
10036004|NCT01939548|11160304|FG001|COMPLETED|Overall Study||33
10036005|NCT01939548|11160305|FG002|COMPLETED|Overall Study||50
10036006|NCT01939548|11160303|FG000|NOT COMPLETED|Overall Study||37
10036007|NCT01939548|11160304|FG001|NOT COMPLETED|Overall Study||49
10036008|NCT01939548|11160305|FG002|NOT COMPLETED|Overall Study||30
10036009|NCT01939899|11160318|FG000|STARTED|Lead-in Dose Finding Phase||3
10036010|NCT01939899|11160319|FG001|STARTED|Lead-in Dose Finding Phase||7
10036011|NCT01939899|11160320|FG002|STARTED|Lead-in Dose Finding Phase||6
10036012|NCT01939899|11160321|FG003|STARTED|Lead-in Dose Finding Phase||0
10036013|NCT01939899|11160322|FG004|STARTED|Lead-in Dose Finding Phase||0
10036014|NCT01939899|11160318|FG000|COMPLETED|Lead-in Dose Finding Phase||1
10036015|NCT01939899|11160319|FG001|COMPLETED|Lead-in Dose Finding Phase||0
10036016|NCT01939899|11160320|FG002|COMPLETED|Lead-in Dose Finding Phase||1
10036017|NCT01939899|11160321|FG003|COMPLETED|Lead-in Dose Finding Phase||0
10036018|NCT01939899|11160322|FG004|COMPLETED|Lead-in Dose Finding Phase||0
10036019|NCT01939899|11160318|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2
10036020|NCT01939899|11160319|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7
10036021|NCT01939899|11160320|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5
10036022|NCT01939899|11160321|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0
10036023|NCT01939899|11160322|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0
10036024|NCT01939899|11160318|FG000|STARTED|Phase 2||0
10036025|NCT01939899|11160319|FG001|STARTED|Phase 2||0
10036026|NCT01939899|11160320|FG002|STARTED|Phase 2||0
10036027|NCT01939899|11160321|FG003|STARTED|Phase 2||12
10036028|NCT01939899|11160322|FG004|STARTED|Phase 2||1
10036029|NCT01939899|11160318|FG000|COMPLETED|Phase 2||0
10036030|NCT01939899|11160319|FG001|COMPLETED|Phase 2||0
10036031|NCT01939899|11160320|FG002|COMPLETED|Phase 2||0
10036032|NCT01939899|11160321|FG003|COMPLETED|Phase 2||1
10036033|NCT01939899|11160322|FG004|COMPLETED|Phase 2||0
10036034|NCT01939899|11160318|FG000|NOT COMPLETED|Phase 2||0
10036035|NCT01939899|11160319|FG001|NOT COMPLETED|Phase 2||0
10036036|NCT01939899|11160320|FG002|NOT COMPLETED|Phase 2||0
10036037|NCT01939899|11160321|FG003|NOT COMPLETED|Phase 2||11
10036038|NCT01939899|11160322|FG004|NOT COMPLETED|Phase 2||1
10036039|NCT01939938|11160340|FG000|STARTED|Overall Study||10
10036040|NCT01939938|11160340|FG000|COMPLETED|Overall Study||10
10036041|NCT01939938|11160340|FG000|NOT COMPLETED|Overall Study||0
10036042|NCT01939977|11160348|FG000|STARTED|Overall Study||46
9848370|NCT00858780|10961053|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848371|NCT00858780|10961054|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10081726|NCT02263911|11210288|FG003|STARTED|Period 3||4
10081727|NCT02263911|11210285|FG000|COMPLETED|Period 3||4
10081728|NCT02263911|11210286|FG001|COMPLETED|Period 3||4
10081729|NCT02263911|11210287|FG002|COMPLETED|Period 3||4
10081730|NCT02263911|11210288|FG003|COMPLETED|Period 3||4
10081731|NCT02263911|11210285|FG000|NOT COMPLETED|Period 3||0
10081732|NCT02263911|11210286|FG001|NOT COMPLETED|Period 3||0
10081733|NCT02263911|11210287|FG002|NOT COMPLETED|Period 3||0
10081734|NCT02263911|11210288|FG003|NOT COMPLETED|Period 3||0
10081735|NCT02263911|11210285|FG000|STARTED|Period 3 Washout||4
10081736|NCT02263911|11210286|FG001|STARTED|Period 3 Washout||4
10081737|NCT02263911|11210287|FG002|STARTED|Period 3 Washout||4
10081738|NCT02263911|11210288|FG003|STARTED|Period 3 Washout||4
10081739|NCT02263911|11210285|FG000|COMPLETED|Period 3 Washout||4
10081740|NCT02263911|11210286|FG001|COMPLETED|Period 3 Washout||4
10081741|NCT02263911|11210287|FG002|COMPLETED|Period 3 Washout||4
10081742|NCT02263911|11210288|FG003|COMPLETED|Period 3 Washout||4
10081743|NCT02263911|11210285|FG000|NOT COMPLETED|Period 3 Washout||0
10081744|NCT02263911|11210286|FG001|NOT COMPLETED|Period 3 Washout||0
10081745|NCT02263911|11210287|FG002|NOT COMPLETED|Period 3 Washout||0
10081746|NCT02263911|11210288|FG003|NOT COMPLETED|Period 3 Washout||0
10081747|NCT02263911|11210285|FG000|STARTED|Period 4||4
10081748|NCT02263911|11210286|FG001|STARTED|Period 4||4
10081749|NCT02263911|11210287|FG002|STARTED|Period 4||4
10115887|NCT02528357|11246633|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
10115888|NCT02528357|11246634|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
10115889|NCT02528357|11246635|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
10036043|NCT01939977|11160349|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
10036044|NCT01939977|11160348|FG000|COMPLETED|Overall Study||37
10036045|NCT01939977|11160349|FG001|COMPLETED|Overall Study||41
10036046|NCT01939977|11160348|FG000|NOT COMPLETED|Overall Study||9
10036047|NCT01939977|11160349|FG001|NOT COMPLETED|Overall Study||7
10036048|NCT01940120|11160355|FG000|STARTED|Overall Study||78
10036049|NCT01940120|11160355|FG000|COMPLETED|Overall Study||30
10036050|NCT01940120|11160355|FG000|NOT COMPLETED|Overall Study||48
10036051|NCT01940146|11160364|FG000|STARTED|Overall Study||56
10036052|NCT01940146|11160365|FG001|STARTED|Overall Study||55
10036053|NCT01940146|11160366|FG002|STARTED|Overall Study||56
10036054|NCT01940146|11160367|FG003|STARTED|Overall Study||55
10036055|NCT01940146|11160364|FG000|COMPLETED|Overall Study||55
10036056|NCT01940146|11160365|FG001|COMPLETED|Overall Study||55
10036057|NCT01940146|11160366|FG002|COMPLETED|Overall Study||55
10036058|NCT01940146|11160367|FG003|COMPLETED|Overall Study||53
10036059|NCT01940146|11160364|FG000|NOT COMPLETED|Overall Study||1
10036060|NCT01940146|11160365|FG001|NOT COMPLETED|Overall Study||0
10036061|NCT01940146|11160366|FG002|NOT COMPLETED|Overall Study||1
10036062|NCT01940146|11160367|FG003|NOT COMPLETED|Overall Study||2
10036063|NCT01940276|11160379|FG000|STARTED|Overall Study||50
10036064|NCT01940276|11160380|FG001|STARTED|Overall Study||50
10036065|NCT01940276|11160379|FG000|COMPLETED|Overall Study||50
10036066|NCT01940276|11160380|FG001|COMPLETED|Overall Study||50
10036067|NCT01940276|11160379|FG000|NOT COMPLETED|Overall Study||0
10036068|NCT01940276|11160380|FG001|NOT COMPLETED|Overall Study||0
10036069|NCT01940354|11160388|FG000|STARTED|Overall Study||110
10036070|NCT01940354|11160389|FG001|STARTED|Overall Study||110
10036071|NCT01940354|11160388|FG000|COMPLETED|Overall Study||106
10036072|NCT01940354|11160389|FG001|COMPLETED|Overall Study||108
10036073|NCT01940354|11160388|FG000|NOT COMPLETED|Overall Study||4
10036074|NCT01940354|11160389|FG001|NOT COMPLETED|Overall Study||2
10036075|NCT01940484|11160395|FG000|STARTED|Overall Study||98
10036076|NCT01940484|11160395|FG000|COMPLETED|Overall Study||88
10036077|NCT01940484|11160395|FG000|NOT COMPLETED|Overall Study||10
10036078|NCT01940497|11160401|FG000|STARTED|Overall Study||121
10036079|NCT01940497|11160402|FG001|STARTED|Overall Study||119
10036080|NCT01940497|11160401|FG000|Treated|Overall Study||115
10036081|NCT01940497|11160402|FG001|Treated|Overall Study||113
10036082|NCT01940497|11160401|FG000|Treated: Adjuvant|Overall Study||95
10036083|NCT01940497|11160402|FG001|Treated: Adjuvant|Overall Study||92
10036084|NCT01940497|11160401|FG000|Treated: Neoadjuvant|Overall Study||20
10036085|NCT01940497|11160402|FG001|Treated: Neoadjuvant|Overall Study||21
10036086|NCT01940497|11160401|FG000|COMPLETED|Overall Study||100
10036087|NCT01940497|11160402|FG001|COMPLETED|Overall Study||101
10036088|NCT01940497|11160401|FG000|NOT COMPLETED|Overall Study||21
10036089|NCT01940497|11160402|FG001|NOT COMPLETED|Overall Study||18
10036090|NCT01940510|11160419|FG000|STARTED|Overall Study||24
10036091|NCT01940510|11160419|FG000|COMPLETED|Overall Study||24
10036092|NCT01940510|11160419|FG000|NOT COMPLETED|Overall Study||0
10036093|NCT01940523|11160428|FG000|STARTED|Overall Study||320
10036094|NCT01940523|11160429|FG001|STARTED|Overall Study||320
10036095|NCT01940523|11160428|FG000|COMPLETED|Overall Study||320
10036096|NCT01940523|11160429|FG001|COMPLETED|Overall Study||320
10036097|NCT01940523|11160428|FG000|NOT COMPLETED|Overall Study||0
10036098|NCT01940523|11160429|FG001|NOT COMPLETED|Overall Study||0
10036099|NCT01940705|11160441|FG000|STARTED|Overall Study||66
10036100|NCT01940705|11160442|FG001|STARTED|Overall Study||67
10036101|NCT01940705|11160443|FG002|STARTED|Overall Study||69
10036102|NCT01940705|11160444|FG003|STARTED|Overall Study||67
10036103|NCT01940705|11160441|FG000|COMPLETED|Overall Study||62
10036104|NCT01940705|11160442|FG001|COMPLETED|Overall Study||59
10036105|NCT01940705|11160443|FG002|COMPLETED|Overall Study||61
10036106|NCT01940705|11160444|FG003|COMPLETED|Overall Study||63
10036107|NCT01940705|11160441|FG000|NOT COMPLETED|Overall Study||4
10036108|NCT01940705|11160442|FG001|NOT COMPLETED|Overall Study||8
10036109|NCT01940705|11160443|FG002|NOT COMPLETED|Overall Study||8
10036110|NCT01940705|11160444|FG003|NOT COMPLETED|Overall Study||4
10036111|NCT01940887|11160459|FG000|STARTED|Year 1||322
10036112|NCT01940887|11160460|FG001|STARTED|Year 1||320
10036113|NCT01940887|11160459|FG000|COMPLETED|Year 1||283
10036114|NCT01940887|11160460|FG001|COMPLETED|Year 1||297
10036115|NCT01940887|11160459|FG000|NOT COMPLETED|Year 1||39
10036116|NCT01940887|11160460|FG001|NOT COMPLETED|Year 1||23
10036117|NCT01940887|11160459|FG000|STARTED|Year 2||283
10036118|NCT01940887|11160460|FG001|STARTED|Year 2||297
10036119|NCT01940887|11160459|FG000|COMPLETED|Year 2||66
10036120|NCT01940887|11160460|FG001|COMPLETED|Year 2||75
10036121|NCT01940887|11160459|FG000|NOT COMPLETED|Year 2||217
10036122|NCT01940887|11160460|FG001|NOT COMPLETED|Year 2||222
10036123|NCT01940900|11160468|FG000|STARTED|Overall Study||311
10036124|NCT01940900|11160469|FG001|STARTED|Overall Study||315
10036125|NCT01940900|11160468|FG000|COMPLETED|Overall Study||282
10036126|NCT01940900|11160469|FG001|COMPLETED|Overall Study||284
10036127|NCT01940900|11160468|FG000|NOT COMPLETED|Overall Study||29
10036128|NCT01940900|11160469|FG001|NOT COMPLETED|Overall Study||31
10036129|NCT01940939|11160477|FG000|STARTED|Overall Study||35
10036130|NCT01940939|11160478|FG001|STARTED|Overall Study||35
10036131|NCT01940939|11160477|FG000|COMPLETED|Overall Study||33
10036132|NCT01940939|11160478|FG001|COMPLETED|Overall Study||27
10036133|NCT01940939|11160477|FG000|NOT COMPLETED|Overall Study||2
10036134|NCT01940939|11160478|FG001|NOT COMPLETED|Overall Study||8
10036135|NCT01941030|11160486|FG000|STARTED|Overall Study||25
10036136|NCT01941030|11160487|FG001|STARTED|Overall Study||26
10036137|NCT01941030|11160486|FG000|COMPLETED|Overall Study||12
10036138|NCT01941030|11160487|FG001|COMPLETED|Overall Study||13
10036139|NCT01941030|11160486|FG000|NOT COMPLETED|Overall Study||13
10036140|NCT01941030|11160487|FG001|NOT COMPLETED|Overall Study||13
10036141|NCT01941095|11160493|FG000|STARTED|Overall Study||97
10036142|NCT01941095|11160493|FG000|COMPLETED|Overall Study||41
10036143|NCT01941095|11160493|FG000|NOT COMPLETED|Overall Study||56
10036144|NCT01941186|11160500|FG000|STARTED|Randomization/Allocation to Study Group||31
10036145|NCT01941186|11160501|FG001|STARTED|Randomization/Allocation to Study Group||33
10036146|NCT01941186|11160500|FG000|COMPLETED|Randomization/Allocation to Study Group||31
10036147|NCT01941186|11160501|FG001|COMPLETED|Randomization/Allocation to Study Group||33
10036148|NCT01941186|11160500|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0
10036149|NCT01941186|11160501|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0
10036150|NCT01941186|11160500|FG000|STARTED|Follow-up||31
10036151|NCT01941186|11160501|FG001|STARTED|Follow-up||33
10036152|NCT01941186|11160500|FG000|COMPLETED|Follow-up||30
10036153|NCT01941186|11160501|FG001|COMPLETED|Follow-up||33
10036154|NCT01941186|11160500|FG000|NOT COMPLETED|Follow-up||1
10036155|NCT01941186|11160501|FG001|NOT COMPLETED|Follow-up||0
10036156|NCT01941472|11160520|FG000|STARTED|Overall Study||40
10036157|NCT01941472|11160520|FG000|COMPLETED|Overall Study||40
10036158|NCT01941472|11160520|FG000|NOT COMPLETED|Overall Study||0
10036159|NCT01941485|11160524|FG000|STARTED|Overall Study||59
10036160|NCT01941485|11160524|FG000|COMPLETED|Overall Study||59
10036161|NCT01941485|11160524|FG000|NOT COMPLETED|Overall Study||0
10036162|NCT01941498|11160546|FG000|STARTED|Overall Study||97
10036163|NCT01941498|11160546|FG000|COMPLETED|Overall Study||96
10036164|NCT01941498|11160546|FG000|NOT COMPLETED|Overall Study||1
10036165|NCT01941537|11160567|FG000|STARTED|Overall Study||40
10036166|NCT01941537|11160568|FG001|STARTED|Overall Study||20
10036167|NCT01941537|11160567|FG000|COMPLETED|Overall Study||36
10036168|NCT01941537|11160568|FG001|COMPLETED|Overall Study||17
10036169|NCT01941537|11160567|FG000|NOT COMPLETED|Overall Study||4
10036170|NCT01941537|11160568|FG001|NOT COMPLETED|Overall Study||3
10036171|NCT01941628|11160577|FG000|STARTED|Overall Study||46
10036172|NCT01941628|11160578|FG001|STARTED|Overall Study||45
10036173|NCT01941628|11160577|FG000|COMPLETED|Overall Study||45
10036174|NCT01941628|11160578|FG001|COMPLETED|Overall Study||45
10036175|NCT01941628|11160577|FG000|NOT COMPLETED|Overall Study||1
10036176|NCT01941628|11160578|FG001|NOT COMPLETED|Overall Study||0
10036177|NCT01941745|11160588|FG000|STARTED|Overall Study||22
10036178|NCT01941745|11160589|FG001|STARTED|Overall Study||22
10036179|NCT01941745|11160590|FG002|STARTED|Overall Study||21
10036180|NCT01941745|11160591|FG003|STARTED|Overall Study||23
10036181|NCT01941745|11160588|FG000|COMPLETED|Overall Study||22
10036182|NCT01941745|11160589|FG001|COMPLETED|Overall Study||22
10036183|NCT01941745|11160590|FG002|COMPLETED|Overall Study||21
10036184|NCT01941745|11160591|FG003|COMPLETED|Overall Study||23
10036185|NCT01941745|11160588|FG000|NOT COMPLETED|Overall Study||0
10036186|NCT01941745|11160589|FG001|NOT COMPLETED|Overall Study||0
10036187|NCT01941745|11160590|FG002|NOT COMPLETED|Overall Study||0
10036188|NCT01941745|11160591|FG003|NOT COMPLETED|Overall Study||0
10036189|NCT01941927|11160606|FG000|STARTED|Overall Study||10
10036190|NCT01941927|11160607|FG001|STARTED|Overall Study||10
10036191|NCT01941927|11160606|FG000|COMPLETED|Overall Study||10
10036192|NCT01941927|11160607|FG001|COMPLETED|Overall Study||10
10036193|NCT01941927|11160606|FG000|NOT COMPLETED|Overall Study||0
10036194|NCT01941927|11160607|FG001|NOT COMPLETED|Overall Study||0
10036195|NCT01941940|11160613|FG000|STARTED|Overall Study||227
10036196|NCT01941940|11160613|FG000|COMPLETED|Overall Study||194
10036197|NCT01941940|11160613|FG000|NOT COMPLETED|Overall Study||33
10036198|NCT01942148|11160617|FG000|STARTED|Overall Study||68
10036199|NCT01942148|11160617|FG000|COMPLETED|Overall Study||41
10036200|NCT01942148|11160617|FG000|NOT COMPLETED|Overall Study||27
10036201|NCT01942161|11160624|FG000|STARTED|Overall Study||35
10036202|NCT01942161|11160625|FG001|STARTED|Overall Study||30
10036203|NCT01942161|11160626|FG002|STARTED|Overall Study||41
10036204|NCT01942161|11160624|FG000|COMPLETED|Overall Study||27
10036205|NCT01942161|11160625|FG001|COMPLETED|Overall Study||24
10036206|NCT01942161|11160626|FG002|COMPLETED|Overall Study||35
10115890|NCT02528357|11246617|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10036207|NCT01942161|11160624|FG000|NOT COMPLETED|Overall Study||8
10036208|NCT01942161|11160625|FG001|NOT COMPLETED|Overall Study||6
10036209|NCT01942161|11160626|FG002|NOT COMPLETED|Overall Study||6
10036210|NCT01942486|11160634|FG000|STARTED|Overall Study||35
10036211|NCT01942486|11160634|FG000|COMPLETED|Overall Study||8
10036212|NCT01942486|11160634|FG000|NOT COMPLETED|Overall Study||27
10036213|NCT01942590|11160640|FG000|STARTED|Overall Study||8
10036214|NCT01942590|11160641|FG001|STARTED|Overall Study||5
10036215|NCT01942590|11160640|FG000|COMPLETED|Overall Study||7
10036216|NCT01942590|11160641|FG001|COMPLETED|Overall Study||4
10036217|NCT01942590|11160640|FG000|NOT COMPLETED|Overall Study||1
10036218|NCT01942590|11160641|FG001|NOT COMPLETED|Overall Study||1
10036219|NCT01942668|11160653|FG000|STARTED|Overall Study||418
10036220|NCT01942668|11160654|FG001|STARTED|Overall Study||426
10036221|NCT01942668|11160655|FG002|STARTED|Overall Study||422
10036222|NCT01942668|11160656|FG003|STARTED|Overall Study||427
10036223|NCT01942668|11160657|FG004|STARTED|Overall Study||152
10036224|NCT01942668|11160653|FG000|COMPLETED|Overall Study||284
10036225|NCT01942668|11160654|FG001|COMPLETED|Overall Study||305
10036226|NCT01942668|11160655|FG002|COMPLETED|Overall Study||312
10036227|NCT01942668|11160656|FG003|COMPLETED|Overall Study||281
10036228|NCT01942668|11160657|FG004|COMPLETED|Overall Study||93
10036229|NCT01942668|11160653|FG000|NOT COMPLETED|Overall Study||134
10036230|NCT01942668|11160654|FG001|NOT COMPLETED|Overall Study||121
10036231|NCT01942668|11160655|FG002|NOT COMPLETED|Overall Study||110
10036232|NCT01942668|11160656|FG003|NOT COMPLETED|Overall Study||146
10036233|NCT01942668|11160657|FG004|NOT COMPLETED|Overall Study||59
10036234|NCT01942694|11160676|FG000|STARTED|Overall Study||1212
10036235|NCT01942694|11160677|FG001|STARTED|Overall Study||1211
10036236|NCT01942694|11160676|FG000|COMPLETED|Overall Study||1211
10036237|NCT01942694|11160677|FG001|COMPLETED|Overall Study||1211
10036238|NCT01942694|11160676|FG000|NOT COMPLETED|Overall Study||1
10036239|NCT01942694|11160677|FG001|NOT COMPLETED|Overall Study||0
10036240|NCT01942707|11160685|FG000|STARTED|Overall Study||23
10036241|NCT01942707|11160686|FG001|STARTED|Overall Study||23
10036242|NCT01942707|11160685|FG000|COMPLETED|Overall Study||23
10036243|NCT01942707|11160686|FG001|COMPLETED|Overall Study||23
10036244|NCT01942707|11160685|FG000|NOT COMPLETED|Overall Study||0
10036245|NCT01942707|11160686|FG001|NOT COMPLETED|Overall Study||0
10036246|NCT01942720|11160692|FG000|STARTED|Overall Study||74
9848372|NCT00858780|10961050|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
9848373|NCT00858780|10961051|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848374|NCT00858780|10961052|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848375|NCT00858780|10961053|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10036247|NCT01942720|11160692|FG000|COMPLETED|Overall Study||53
10036248|NCT01942720|11160692|FG000|NOT COMPLETED|Overall Study||21
10036249|NCT01942733|11160696|FG000|STARTED|Overall Study||44
10036250|NCT01942733|11160696|FG000|COMPLETED|Overall Study||41
10036251|NCT01942733|11160696|FG000|NOT COMPLETED|Overall Study||3
10036252|NCT01942785|11160700|FG000|STARTED|Overall Study||54
10036253|NCT01942785|11160700|FG000|COMPLETED|Overall Study||50
10036254|NCT01942785|11160700|FG000|NOT COMPLETED|Overall Study||4
10036255|NCT01942993|11160706|FG000|STARTED|Overall Study||3
10036256|NCT01942993|11160706|FG000|COMPLETED|Overall Study||1
10036257|NCT01942993|11160706|FG000|NOT COMPLETED|Overall Study||2
10036258|NCT01943110|11160710|FG000|STARTED|Overall Study||30
10036259|NCT01943110|11160710|FG000|COMPLETED|Overall Study||30
10036260|NCT01943110|11160710|FG000|NOT COMPLETED|Overall Study||0
10036261|NCT01943227|11160728|FG000|STARTED|Overall Study||10
10036262|NCT01943227|11160729|FG001|STARTED|Overall Study||10
10036263|NCT01943227|11160728|FG000|COMPLETED|Overall Study||10
10036264|NCT01943227|11160729|FG001|COMPLETED|Overall Study||10
10036265|NCT01943227|11160728|FG000|NOT COMPLETED|Overall Study||0
10036266|NCT01943227|11160729|FG001|NOT COMPLETED|Overall Study||0
10036267|NCT01943292|11160738|FG000|STARTED|Overall Study||3
10036268|NCT01943292|11160739|FG001|STARTED|Overall Study||3
10036269|NCT01943292|11160740|FG002|STARTED|Overall Study||3
10036270|NCT01943292|11160738|FG000|Completed Cycle 1|Overall Study||3
10036271|NCT01943292|11160739|FG001|Completed Cycle 1|Overall Study||3
10036272|NCT01943292|11160740|FG002|Completed Cycle 1|Overall Study||3
10036273|NCT01943292|11160738|FG000|Completed Treatment|Overall Study||3
10036274|NCT01943292|11160739|FG001|Completed Treatment|Overall Study||3
10115891|NCT02528357|11246618|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10036275|NCT01943292|11160740|FG002|Completed Treatment|Overall Study||3
10036276|NCT01943292|11160738|FG000|Completed Follow-Up|Overall Study||2
10036277|NCT01943292|11160739|FG001|Completed Follow-Up|Overall Study||3
10036278|NCT01943292|11160740|FG002|Completed Follow-Up|Overall Study||3
10036279|NCT01943292|11160738|FG000|COMPLETED|Overall Study||2
10036280|NCT01943292|11160739|FG001|COMPLETED|Overall Study||3
10036281|NCT01943292|11160740|FG002|COMPLETED|Overall Study||3
10036282|NCT01943292|11160738|FG000|NOT COMPLETED|Overall Study||1
10036283|NCT01943292|11160739|FG001|NOT COMPLETED|Overall Study||0
10036284|NCT01943292|11160740|FG002|NOT COMPLETED|Overall Study||0
10036285|NCT01943344|11160748|FG000|STARTED|Overall Study||12
10036286|NCT01943344|11160748|FG000|COMPLETED|Overall Study||9
10036287|NCT01943344|11160748|FG000|NOT COMPLETED|Overall Study||3
10036288|NCT01943435|11160757|FG000|STARTED|Baseline Eligibility and Randomization||88
10036289|NCT01943435|11160758|FG001|STARTED|Baseline Eligibility and Randomization||84
10036290|NCT01943435|11160759|FG002|STARTED|Baseline Eligibility and Randomization||87
10036291|NCT01943435|11160757|FG000|COMPLETED|Baseline Eligibility and Randomization||84
10036292|NCT01943435|11160758|FG001|COMPLETED|Baseline Eligibility and Randomization||72
10036293|NCT01943435|11160759|FG002|COMPLETED|Baseline Eligibility and Randomization||84
10036294|NCT01943435|11160757|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4
10036295|NCT01943435|11160758|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12
10115892|NCT02528357|11246619|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10036296|NCT01943435|11160759|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3
10036297|NCT01943435|11160757|FG000|STARTED|Intervention Period||84
10036298|NCT01943435|11160758|FG001|STARTED|Intervention Period||72
10036299|NCT01943435|11160759|FG002|STARTED|Intervention Period||84
10036300|NCT01943435|11160757|FG000|COMPLETED|Intervention Period||81
10036301|NCT01943435|11160758|FG001|COMPLETED|Intervention Period||69
10036302|NCT01943435|11160759|FG002|COMPLETED|Intervention Period||80
10036303|NCT01943435|11160757|FG000|NOT COMPLETED|Intervention Period||3
10036304|NCT01943435|11160758|FG001|NOT COMPLETED|Intervention Period||3
10036305|NCT01943435|11160759|FG002|NOT COMPLETED|Intervention Period||4
10036306|NCT01943435|11160757|FG000|STARTED|2 Month Follow up||81
10036307|NCT01943435|11160758|FG001|STARTED|2 Month Follow up||69
10036308|NCT01943435|11160759|FG002|STARTED|2 Month Follow up||80
10036309|NCT01943435|11160757|FG000|COMPLETED|2 Month Follow up||79
10036310|NCT01943435|11160758|FG001|COMPLETED|2 Month Follow up||66
10036311|NCT01943435|11160759|FG002|COMPLETED|2 Month Follow up||80
10036312|NCT01943435|11160757|FG000|NOT COMPLETED|2 Month Follow up||2
10036313|NCT01943435|11160758|FG001|NOT COMPLETED|2 Month Follow up||3
10036314|NCT01943435|11160759|FG002|NOT COMPLETED|2 Month Follow up||0
10036315|NCT01943435|11160757|FG000|STARTED|6 Month Follow up||79
10036316|NCT01943435|11160758|FG001|STARTED|6 Month Follow up||66
10036317|NCT01943435|11160759|FG002|STARTED|6 Month Follow up||80
10036318|NCT01943435|11160757|FG000|COMPLETED|6 Month Follow up||67
10036319|NCT01943435|11160758|FG001|COMPLETED|6 Month Follow up||59
10036320|NCT01943435|11160759|FG002|COMPLETED|6 Month Follow up||65
10036321|NCT01943435|11160757|FG000|NOT COMPLETED|6 Month Follow up||12
10036322|NCT01943435|11160758|FG001|NOT COMPLETED|6 Month Follow up||7
10036323|NCT01943435|11160759|FG002|NOT COMPLETED|6 Month Follow up||15
10036324|NCT01943461|11160771|FG000|STARTED|Overall Study||5
10036325|NCT01943461|11160772|FG001|STARTED|Overall Study||6
10036326|NCT01943461|11160773|FG002|STARTED|Overall Study||6
10036327|NCT01943461|11160774|FG003|STARTED|Overall Study||40
10036328|NCT01943461|11160771|FG000|COMPLETED|Overall Study||5
10036329|NCT01943461|11160772|FG001|COMPLETED|Overall Study||6
10036330|NCT01943461|11160773|FG002|COMPLETED|Overall Study||6
10036331|NCT01943461|11160774|FG003|COMPLETED|Overall Study||40
10036332|NCT01943461|11160771|FG000|NOT COMPLETED|Overall Study||0
10036333|NCT01943461|11160772|FG001|NOT COMPLETED|Overall Study||0
10036334|NCT01943461|11160773|FG002|NOT COMPLETED|Overall Study||0
10036335|NCT01943461|11160774|FG003|NOT COMPLETED|Overall Study||0
10036336|NCT01943474|11160786|FG000|STARTED|Overall Study||123
10036337|NCT01943474|11160787|FG001|STARTED|Overall Study||125
10036338|NCT01943474|11160786|FG000|COMPLETED|Overall Study||123
10036339|NCT01943474|11160787|FG001|COMPLETED|Overall Study||125
10036340|NCT01943474|11160786|FG000|NOT COMPLETED|Overall Study||0
10036341|NCT01943474|11160787|FG001|NOT COMPLETED|Overall Study||0
10036342|NCT01943539|11160793|FG000|STARTED|Overall Study||44
9706360|NCT00085982|10805379|FG000|STARTED|Overall Study||11
9706361|NCT00085982|10805379|FG000|COMPLETED|Overall Study||5
9706362|NCT00085982|10805379|FG000|NOT COMPLETED|Overall Study||6
9706363|NCT00061945|10805385|FG000|STARTED|Registration Through Course 3||119
10036343|NCT01943539|11160794|FG001|STARTED|Overall Study||40
10036344|NCT01943539|11160793|FG000|COMPLETED|Overall Study||40
10036345|NCT01943539|11160794|FG001|COMPLETED|Overall Study||40
10036346|NCT01943539|11160793|FG000|NOT COMPLETED|Overall Study||4
10036347|NCT01943539|11160794|FG001|NOT COMPLETED|Overall Study||0
10036348|NCT01943552|11160803|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
10036349|NCT01943552|11160804|FG001|STARTED|Overall Study||94
10036350|NCT01943552|11160803|FG000|COMPLETED|Overall Study||71
10036351|NCT01943552|11160804|FG001|COMPLETED|Overall Study||69
10036352|NCT01943552|11160803|FG000|NOT COMPLETED|Overall Study||25
10036353|NCT01943552|11160804|FG001|NOT COMPLETED|Overall Study||25
10036354|NCT01943565|11160813|FG000|STARTED|Overall Study||11
10036355|NCT01943565|11160814|FG001|STARTED|Overall Study||9
10036356|NCT01943565|11160815|FG002|STARTED|Overall Study||9
10036357|NCT01943565|11160813|FG000|COMPLETED|Overall Study||11
10036358|NCT01943565|11160814|FG001|COMPLETED|Overall Study||9
10036359|NCT01943565|11160815|FG002|COMPLETED|Overall Study||9
10036360|NCT01943565|11160813|FG000|NOT COMPLETED|Overall Study||0
10036361|NCT01943565|11160814|FG001|NOT COMPLETED|Overall Study||0
10036362|NCT01943565|11160815|FG002|NOT COMPLETED|Overall Study||0
10036363|NCT01943591|11160825|FG000|STARTED|Overall Study||104
10036364|NCT01943591|11160826|FG001|STARTED|Overall Study||106
10036365|NCT01943591|11160825|FG000|COMPLETED|Overall Study||99
10036366|NCT01943591|11160826|FG001|COMPLETED|Overall Study||95
10036367|NCT01943591|11160825|FG000|NOT COMPLETED|Overall Study||5
10036368|NCT01943591|11160826|FG001|NOT COMPLETED|Overall Study||11
9706364|NCT00061945|10805386|FG001|STARTED|Registration Through Course 3||181
10036369|NCT01943799|11160836|FG000|STARTED|Overall Study||27
10036370|NCT01943799|11160837|FG001|STARTED|Overall Study||50
10036371|NCT01943799|11160838|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
10036372|NCT01943799|11160839|FG003|STARTED|Overall Study||50
10036373|NCT01943799|11160836|FG000|COMPLETED|Overall Study||22
10036374|NCT01943799|11160837|FG001|COMPLETED|Overall Study||47
10036375|NCT01943799|11160838|FG002|COMPLETED|Overall Study||49
10036376|NCT01943799|11160839|FG003|COMPLETED|Overall Study||50
10036377|NCT01943799|11160836|FG000|NOT COMPLETED|Overall Study||5
10036378|NCT01943799|11160837|FG001|NOT COMPLETED|Overall Study||3
10036379|NCT01943799|11160838|FG002|NOT COMPLETED|Overall Study||2
10036380|NCT01943799|11160839|FG003|NOT COMPLETED|Overall Study||0
10036381|NCT01943851|11160867|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1
10036382|NCT01943851|11160868|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1
10036383|NCT01943851|11160869|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1
10036384|NCT01943851|11160870|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5
10036385|NCT01943851|11160871|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1
10036386|NCT01943851|11160872|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4
10036387|NCT01943851|11160873|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8
10036388|NCT01943851|11160874|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18
10036389|NCT01943851|11160875|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3
10036390|NCT01943851|11160876|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8
10036391|NCT01943851|11160877|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1
10036392|NCT01943851|11160878|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7
10036393|NCT01943851|11160879|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7
10036394|NCT01943851|11160880|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16
10036395|NCT01943851|11160881|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6
10036396|NCT01943851|11160882|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0
10036397|NCT01943851|11160883|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0
10036398|NCT01943851|11160884|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0
10036399|NCT01943851|11160867|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036400|NCT01943851|11160868|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036401|NCT01943851|11160869|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036402|NCT01943851|11160870|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
10036403|NCT01943851|11160871|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036404|NCT01943851|11160872|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
10036405|NCT01943851|11160873|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
10036406|NCT01943851|11160874|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
10036407|NCT01943851|11160875|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
10036408|NCT01943851|11160876|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
10036409|NCT01943851|11160877|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036410|NCT01943851|11160878|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
10036411|NCT01943851|11160879|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
10036412|NCT01943851|11160880|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
10036413|NCT01943851|11160881|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
10036414|NCT01943851|11160882|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036415|NCT01943851|11160883|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036416|NCT01943851|11160884|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036417|NCT01943851|11160867|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036418|NCT01943851|11160868|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036419|NCT01943851|11160869|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036420|NCT01943851|11160870|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036421|NCT01943851|11160871|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036422|NCT01943851|11160872|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036423|NCT01943851|11160873|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036424|NCT01943851|11160874|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
10036425|NCT01943851|11160875|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036426|NCT01943851|11160876|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036427|NCT01943851|11160877|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036428|NCT01943851|11160878|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036429|NCT01943851|11160879|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036430|NCT01943851|11160880|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10036431|NCT01943851|11160881|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036432|NCT01943851|11160882|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036433|NCT01943851|11160883|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036434|NCT01943851|11160884|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10036435|NCT01943851|11160867|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036436|NCT01943851|11160868|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036437|NCT01943851|11160869|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036438|NCT01943851|11160870|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036439|NCT01943851|11160871|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036440|NCT01943851|11160872|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036441|NCT01943851|11160873|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036442|NCT01943851|11160874|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036443|NCT01943851|11160875|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036444|NCT01943851|11160876|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036445|NCT01943851|11160877|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036446|NCT01943851|11160878|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036447|NCT01943851|11160879|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036448|NCT01943851|11160880|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036449|NCT01943851|11160881|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0
10036450|NCT01943851|11160882|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7
10036451|NCT01943851|11160883|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16
10036452|NCT01943851|11160884|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1
10036453|NCT01943851|11160867|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036454|NCT01943851|11160868|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036455|NCT01943851|11160869|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036456|NCT01943851|11160870|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036457|NCT01943851|11160871|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036458|NCT01943851|11160872|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036459|NCT01943851|11160873|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036460|NCT01943851|11160874|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036461|NCT01943851|11160875|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036462|NCT01943851|11160876|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036463|NCT01943851|11160877|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036464|NCT01943851|11160878|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036465|NCT01943851|11160879|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036466|NCT01943851|11160880|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036467|NCT01943851|11160881|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036468|NCT01943851|11160882|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
10036469|NCT01943851|11160883|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
10036470|NCT01943851|11160884|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036471|NCT01943851|11160867|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036472|NCT01943851|11160868|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036473|NCT01943851|11160869|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036474|NCT01943851|11160870|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036475|NCT01943851|11160871|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036476|NCT01943851|11160872|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036477|NCT01943851|11160873|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036478|NCT01943851|11160874|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036479|NCT01943851|11160875|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036480|NCT01943851|11160876|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036481|NCT01943851|11160877|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036482|NCT01943851|11160878|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036483|NCT01943851|11160879|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036484|NCT01943851|11160880|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036485|NCT01943851|11160881|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10036486|NCT01943851|11160882|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
10036487|NCT01943851|11160883|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
10036488|NCT01943851|11160884|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
10036489|NCT01943864|11160925|FG000|STARTED|Overall Study||20
10036490|NCT01943864|11160925|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
10036491|NCT01943864|11160925|FG000|NOT COMPLETED|Overall Study||0
10036492|NCT01943916|11160929|FG000|STARTED|Overall Study||2105
10036493|NCT01943916|11160929|FG000|COMPLETED|Overall Study||1739
10036494|NCT01943916|11160929|FG000|NOT COMPLETED|Overall Study||366
10081750|NCT02263911|11210288|FG003|STARTED|Period 4||4
10081751|NCT02263911|11210285|FG000|COMPLETED|Period 4||4
10081752|NCT02263911|11210286|FG001|COMPLETED|Period 4||4
10081753|NCT02263911|11210287|FG002|COMPLETED|Period 4||4
10081754|NCT02263911|11210288|FG003|COMPLETED|Period 4||4
10081755|NCT02263911|11210285|FG000|NOT COMPLETED|Period 4||0
10081756|NCT02263911|11210286|FG001|NOT COMPLETED|Period 4||0
10081757|NCT02263911|11210287|FG002|NOT COMPLETED|Period 4||0
10081758|NCT02263911|11210288|FG003|NOT COMPLETED|Period 4||0
10081759|NCT02263911|11210285|FG000|STARTED|Period 4 Washout||4
10081760|NCT02263911|11210286|FG001|STARTED|Period 4 Washout||4
10081761|NCT02263911|11210287|FG002|STARTED|Period 4 Washout||4
10081762|NCT02263911|11210288|FG003|STARTED|Period 4 Washout||4
10081763|NCT02263911|11210285|FG000|COMPLETED|Period 4 Washout||4
10081764|NCT02263911|11210286|FG001|COMPLETED|Period 4 Washout||4
10081765|NCT02263911|11210287|FG002|COMPLETED|Period 4 Washout||4
10081766|NCT02263911|11210288|FG003|COMPLETED|Period 4 Washout||4
10081767|NCT02263911|11210285|FG000|NOT COMPLETED|Period 4 Washout||0
10081768|NCT02263911|11210286|FG001|NOT COMPLETED|Period 4 Washout||0
10081769|NCT02263911|11210287|FG002|NOT COMPLETED|Period 4 Washout||0
10081770|NCT02263911|11210288|FG003|NOT COMPLETED|Period 4 Washout||0
10081771|NCT02263911|11210285|FG000|STARTED|Period 5||4
10081772|NCT02263911|11210286|FG001|STARTED|Period 5||4
10081773|NCT02263911|11210287|FG002|STARTED|Period 5||4
10081774|NCT02263911|11210288|FG003|STARTED|Period 5||4
10081775|NCT02263911|11210285|FG000|COMPLETED|Period 5||4
10081776|NCT02263911|11210286|FG001|COMPLETED|Period 5||4
10081777|NCT02263911|11210287|FG002|COMPLETED|Period 5||4
10081778|NCT02263911|11210288|FG003|COMPLETED|Period 5||4
10081779|NCT02263911|11210285|FG000|NOT COMPLETED|Period 5||0
10081780|NCT02263911|11210286|FG001|NOT COMPLETED|Period 5||0
10081781|NCT02263911|11210287|FG002|NOT COMPLETED|Period 5||0
10081782|NCT02263911|11210288|FG003|NOT COMPLETED|Period 5||0
10081783|NCT02264249|11210305|FG000|STARTED|Overall Study||21
10081784|NCT02264249|11210306|FG001|STARTED|Overall Study||187
10081785|NCT02264249|11210307|FG002|STARTED|Overall Study||241
10081786|NCT02264249|11210305|FG000|COMPLETED|Overall Study||21
10081787|NCT02264249|11210306|FG001|COMPLETED|Overall Study||187
10081788|NCT02264249|11210307|FG002|COMPLETED|Overall Study||241
10081789|NCT02264249|11210305|FG000|NOT COMPLETED|Overall Study||0
10081790|NCT02264249|11210306|FG001|NOT COMPLETED|Overall Study||0
10081791|NCT02264249|11210307|FG002|NOT COMPLETED|Overall Study||0
10081792|NCT02264353|11210315|FG000|STARTED|Overall Study||20
10081793|NCT02264353|11210316|FG001|STARTED|Overall Study||24
10081794|NCT02264353|11210315|FG000|COMPLETED|Overall Study||17
10081795|NCT02264353|11210316|FG001|COMPLETED|Overall Study||24
10081796|NCT02264353|11210315|FG000|NOT COMPLETED|Overall Study||3
10081797|NCT02264353|11210316|FG001|NOT COMPLETED|Overall Study||0
10081798|NCT02264574|11210324|FG000|STARTED|Overall Study||113
10081799|NCT02264574|11210325|FG001|STARTED|Overall Study||116
10081800|NCT02264574|11210324|FG000|COMPLETED|Overall Study||84
10081801|NCT02264574|11210325|FG001|COMPLETED|Overall Study||86
10081802|NCT02264574|11210324|FG000|NOT COMPLETED|Overall Study||29
10081803|NCT02264574|11210325|FG001|NOT COMPLETED|Overall Study||30
10081804|NCT02264639|11210336|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
10081805|NCT02264639|11210337|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
10081806|NCT02264639|11210338|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
10081807|NCT02264639|11210339|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
10081808|NCT02264639|11210340|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
10081809|NCT02264639|11210336|FG000|COMPLETED|Overall Study||0
10081810|NCT02264639|11210337|FG001|COMPLETED|Overall Study||1
10081811|NCT02264639|11210338|FG002|COMPLETED|Overall Study||0
10081812|NCT02264639|11210339|FG003|COMPLETED|Overall Study||1
10081813|NCT02264639|11210340|FG004|COMPLETED|Overall Study||3
10036495|NCT01944046|11160940|FG000|STARTED|Randomized to DB||146
10036496|NCT01944046|11160941|FG001|STARTED|Randomized to DB||144
10036497|NCT01944046|11160940|FG000|COMPLETED|Randomized to DB||125
10036498|NCT01944046|11160941|FG001|COMPLETED|Randomized to DB||125
10036499|NCT01944046|11160940|FG000|NOT COMPLETED|Randomized to DB||21
10036500|NCT01944046|11160941|FG001|NOT COMPLETED|Randomized to DB||19
10036501|NCT01944046|11160940|FG000|STARTED|Open Label Eligible and Consented||124
10036502|NCT01944046|11160941|FG001|STARTED|Open Label Eligible and Consented||124
10036503|NCT01944046|11160940|FG000|COMPLETED|Open Label Eligible and Consented||110
10036504|NCT01944046|11160941|FG001|COMPLETED|Open Label Eligible and Consented||116
10036505|NCT01944046|11160940|FG000|NOT COMPLETED|Open Label Eligible and Consented||14
10036506|NCT01944046|11160941|FG001|NOT COMPLETED|Open Label Eligible and Consented||8
10036507|NCT01944098|11160953|FG000|STARTED|Overall Study||10
10036508|NCT01944098|11160954|FG001|STARTED|Overall Study||10
10036509|NCT01944098|11160953|FG000|COMPLETED|Overall Study||9
10036510|NCT01944098|11160954|FG001|COMPLETED|Overall Study||10
10036511|NCT01944098|11160953|FG000|NOT COMPLETED|Overall Study||1
10036512|NCT01944098|11160954|FG001|NOT COMPLETED|Overall Study||0
10036513|NCT01944293|11160962|FG000|STARTED|Overall Study||7
10036514|NCT01944293|11160963|FG001|STARTED|Overall Study||9
10036515|NCT01944293|11160962|FG000|COMPLETED|Overall Study||7
10036516|NCT01944293|11160963|FG001|COMPLETED|Overall Study||9
10036517|NCT01944293|11160962|FG000|NOT COMPLETED|Overall Study||0
10036518|NCT01944293|11160963|FG001|NOT COMPLETED|Overall Study||0
10036519|NCT01944319|11160971|FG000|STARTED|Overall Study||40
10036520|NCT01944319|11160972|FG001|STARTED|Overall Study||39
10036521|NCT01944319|11160971|FG000|COMPLETED|Overall Study||40
10036522|NCT01944319|11160972|FG001|COMPLETED|Overall Study||39
10036523|NCT01944319|11160971|FG000|NOT COMPLETED|Overall Study||0
10036524|NCT01944319|11160972|FG001|NOT COMPLETED|Overall Study||0
10036525|NCT01944345|11160979|FG000|STARTED|Overall Study||69
10036526|NCT01944345|11160979|FG000|COMPLETED|Overall Study||69
10036527|NCT01944345|11160979|FG000|NOT COMPLETED|Overall Study||0
10036528|NCT01944371|11160986|FG000|STARTED|Overall Study||10
10036529|NCT01944371|11160987|FG001|STARTED|Overall Study||10
10036530|NCT01944371|11160988|FG002|STARTED|Overall Study||10
10036531|NCT01944371|11160986|FG000|COMPLETED|Overall Study||10
10036532|NCT01944371|11160987|FG001|COMPLETED|Overall Study||10
10036533|NCT01944371|11160988|FG002|COMPLETED|Overall Study||10
10036534|NCT01944371|11160986|FG000|NOT COMPLETED|Overall Study||0
10036535|NCT01944371|11160987|FG001|NOT COMPLETED|Overall Study||0
10036536|NCT01944371|11160988|FG002|NOT COMPLETED|Overall Study||0
10036537|NCT01944423|11160998|FG000|STARTED|Overall Study||27
10036538|NCT01944423|11160999|FG001|STARTED|Overall Study||26
10036539|NCT01944423|11160998|FG000|End of Treatment|Overall Study||21
10036540|NCT01944423|11160999|FG001|End of Treatment|Overall Study||20
10036541|NCT01944423|11160998|FG000|1-month Follow-up|Overall Study||22
10036542|NCT01944423|11160999|FG001|1-month Follow-up|Overall Study||19
10036543|NCT01944423|11160998|FG000|4-month Follow-up|Overall Study||19
10036544|NCT01944423|11160999|FG001|4-month Follow-up|Overall Study||16
10036545|NCT01944423|11160998|FG000|COMPLETED|Overall Study|6-month follow-up|19
10036546|NCT01944423|11160999|FG001|COMPLETED|Overall Study|6-month follow-up|17
10036547|NCT01944423|11160998|FG000|NOT COMPLETED|Overall Study||8
10036548|NCT01944423|11160999|FG001|NOT COMPLETED|Overall Study||9
10036549|NCT01944462|11161005|FG000|STARTED|PPPP Educational Program||203
10036550|NCT01944462|11161005|FG000|Baseline|PPPP Educational Program||203
10036551|NCT01944462|11161005|FG000|Post-Test|PPPP Educational Program||187
10036552|NCT01944462|11161005|FG000|3 Month Follow-Up|PPPP Educational Program||143
10036553|NCT01944462|11161005|FG000|COMPLETED|PPPP Educational Program||143
10036554|NCT01944462|11161005|FG000|NOT COMPLETED|PPPP Educational Program||60
10036555|NCT01944462|11161005|FG000|STARTED|Optional Vaccination||20
10036556|NCT01944462|11161005|FG000|COMPLETED|Optional Vaccination||20
10036557|NCT01944462|11161005|FG000|NOT COMPLETED|Optional Vaccination||0
10036558|NCT01944631|11161012|FG000|STARTED|Overall Study||100
10036559|NCT01944631|11161013|FG001|STARTED|Overall Study||100
10036560|NCT01944631|11161012|FG000|COMPLETED|Overall Study||96
10036561|NCT01944631|11161013|FG001|COMPLETED|Overall Study||98
10036562|NCT01944631|11161012|FG000|NOT COMPLETED|Overall Study||4
10036563|NCT01944631|11161013|FG001|NOT COMPLETED|Overall Study||2
10036564|NCT01944644|11161021|FG000|STARTED|Overall Study||34
10036565|NCT01944644|11161022|FG001|STARTED|Overall Study||32
10036566|NCT01944644|11161021|FG000|COMPLETED|Overall Study||34
10036567|NCT01944644|11161022|FG001|COMPLETED|Overall Study||32
10036568|NCT01944644|11161021|FG000|NOT COMPLETED|Overall Study||0
10036569|NCT01944644|11161022|FG001|NOT COMPLETED|Overall Study||0
10036570|NCT01944670|11161028|FG000|STARTED|Overall Study||26
10036571|NCT01944670|11161028|FG000|COMPLETED|Overall Study||24
10036572|NCT01944670|11161028|FG000|NOT COMPLETED|Overall Study||2
10036573|NCT01944722|11161034|FG000|STARTED|Overall Study||33858
10036574|NCT01944722|11161034|FG000|COMPLETED|Overall Study||24343
10036575|NCT01944722|11161034|FG000|NOT COMPLETED|Overall Study||9515
10036576|NCT01944774|11161046|FG000|STARTED|Overall Study||69
10036577|NCT01944774|11161047|FG001|STARTED|Overall Study||68
10036578|NCT01944774|11161048|FG002|STARTED|Overall Study||70
10036579|NCT01944774|11161046|FG000|Received Treatment|Overall Study||68
10036580|NCT01944774|11161047|FG001|Received Treatment|Overall Study||67
10036581|NCT01944774|11161048|FG002|Received Treatment|Overall Study||70
10036582|NCT01944774|11161046|FG000|COMPLETED|Overall Study||63
10036583|NCT01944774|11161047|FG001|COMPLETED|Overall Study||60
10036584|NCT01944774|11161048|FG002|COMPLETED|Overall Study||62
10036585|NCT01944774|11161046|FG000|NOT COMPLETED|Overall Study||6
10036586|NCT01944774|11161047|FG001|NOT COMPLETED|Overall Study||8
10036587|NCT01944774|11161048|FG002|NOT COMPLETED|Overall Study||8
10036588|NCT01944839|11161061|FG000|STARTED|Overall Study||309
10036589|NCT01944839|11161062|FG001|STARTED|Overall Study||310
10036590|NCT01944839|11161061|FG000|COMPLETED|Overall Study||287
10036591|NCT01944839|11161062|FG001|COMPLETED|Overall Study||282
10036592|NCT01944839|11161061|FG000|NOT COMPLETED|Overall Study||22
10036593|NCT01944839|11161062|FG001|NOT COMPLETED|Overall Study||28
10036594|NCT01944878|11161070|FG000|STARTED|Overall Study||127
10036595|NCT01944878|11161071|FG001|STARTED|Overall Study||328
10036596|NCT01944878|11161070|FG000|COMPLETED|Overall Study||127
10036597|NCT01944878|11161071|FG001|COMPLETED|Overall Study||328
10036598|NCT01944878|11161070|FG000|NOT COMPLETED|Overall Study||0
10036599|NCT01944878|11161071|FG001|NOT COMPLETED|Overall Study||0
10036600|NCT01944930|11161081|FG000|STARTED|Overall Study||12
10036601|NCT01944930|11161082|FG001|STARTED|Overall Study||11
10036602|NCT01944930|11161081|FG000|COMPLETED|Overall Study||10
10036603|NCT01944930|11161082|FG001|COMPLETED|Overall Study||10
10036604|NCT01944930|11161081|FG000|NOT COMPLETED|Overall Study||2
10036605|NCT01944930|11161082|FG001|NOT COMPLETED|Overall Study||1
10036606|NCT01944969|11161088|FG000|STARTED|Overall Study||26
10036607|NCT01944969|11161088|FG000|COMPLETED|Overall Study||0
10036608|NCT01944969|11161088|FG000|NOT COMPLETED|Overall Study||26
10036609|NCT01945034|11161097|FG000|STARTED|Overall Study||67
10036610|NCT01945034|11161098|FG001|STARTED|Overall Study||85
10036611|NCT01945034|11161099|FG002|STARTED|Overall Study||152
10036612|NCT01945034|11161097|FG000|COMPLETED|Overall Study||66
10036613|NCT01945034|11161098|FG001|COMPLETED|Overall Study||80
10036614|NCT01945034|11161099|FG002|COMPLETED|Overall Study||145
10036615|NCT01945034|11161097|FG000|NOT COMPLETED|Overall Study||1
10036616|NCT01945034|11161098|FG001|NOT COMPLETED|Overall Study||5
10036617|NCT01945034|11161099|FG002|NOT COMPLETED|Overall Study||7
10036618|NCT01945086|11161110|FG000|STARTED|Overall Study||27
10036619|NCT01945086|11161111|FG001|STARTED|Overall Study||24
10036620|NCT01945086|11161112|FG002|STARTED|Overall Study||28
10036621|NCT01945086|11161110|FG000|COMPLETED|Overall Study||26
10036622|NCT01945086|11161111|FG001|COMPLETED|Overall Study||24
10036623|NCT01945086|11161112|FG002|COMPLETED|Overall Study||26
10036624|NCT01945086|11161110|FG000|NOT COMPLETED|Overall Study||1
10036625|NCT01945086|11161111|FG001|NOT COMPLETED|Overall Study||0
10036626|NCT01945086|11161112|FG002|NOT COMPLETED|Overall Study||2
10036627|NCT01945112|11161120|FG000|STARTED|Overall Study|total number of sites where tape was applied|77
10036628|NCT01945112|11161121|FG001|STARTED|Overall Study|total number of sites where tape was applied|51
10036629|NCT01945112|11161120|FG000|COMPLETED|Overall Study||77
10036630|NCT01945112|11161121|FG001|COMPLETED|Overall Study||51
10036631|NCT01945112|11161120|FG000|NOT COMPLETED|Overall Study||0
10036632|NCT01945112|11161121|FG001|NOT COMPLETED|Overall Study||0
10036633|NCT01945138|11161128|FG000|STARTED|Overall Study||7
10036634|NCT01945138|11161129|FG001|STARTED|Overall Study||7
10036635|NCT01945138|11161128|FG000|COMPLETED|Overall Study||7
10036636|NCT01945138|11161129|FG001|COMPLETED|Overall Study||7
10036637|NCT01945138|11161128|FG000|NOT COMPLETED|Overall Study||0
10036638|NCT01945138|11161129|FG001|NOT COMPLETED|Overall Study||0
10036639|NCT01945216|11161138|FG000|STARTED|Overall Study||3317
10036640|NCT01945216|11161138|FG000|COMPLETED|Overall Study||3218
10036641|NCT01945216|11161138|FG000|NOT COMPLETED|Overall Study||99
10036642|NCT01945242|11161148|FG000|STARTED|Overall Study||1251
10036643|NCT01945242|11161149|FG001|STARTED|Overall Study||123
10036644|NCT01945242|11161148|FG000|COMPLETED|Overall Study||1248
10036645|NCT01945242|11161149|FG001|COMPLETED|Overall Study||120
10036646|NCT01945242|11161148|FG000|NOT COMPLETED|Overall Study||3
10036647|NCT01945242|11161149|FG001|NOT COMPLETED|Overall Study||3
10036648|NCT01945281|11161158|FG000|STARTED|Overall Study||34
10036649|NCT01945281|11161159|FG001|STARTED|Overall Study||17
10036650|NCT01945281|11161158|FG000|Treated|Overall Study||33
10036651|NCT01945281|11161159|FG001|Treated|Overall Study||16
10036652|NCT01945281|11161158|FG000|COMPLETED|Overall Study||28
10036653|NCT01945281|11161159|FG001|COMPLETED|Overall Study||13
10036654|NCT01945281|11161158|FG000|NOT COMPLETED|Overall Study||6
10036655|NCT01945281|11161159|FG001|NOT COMPLETED|Overall Study||4
10036656|NCT01945294|11161168|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
10036657|NCT01945294|11161169|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
10036658|NCT01945294|11161170|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
10036659|NCT01945294|11161171|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
10036660|NCT01945294|11161168|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
10036661|NCT01945294|11161169|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10036662|NCT01945294|11161170|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10036663|NCT01945294|11161171|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10036664|NCT01945294|11161168|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
10036665|NCT01945294|11161169|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10036666|NCT01945294|11161170|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10036667|NCT01945294|11161171|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10036668|NCT01945294|11161168|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
10036669|NCT01945294|11161169|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
10036670|NCT01945294|11161170|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
10036671|NCT01945294|11161171|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
10036672|NCT01945294|11161168|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
10036673|NCT01945294|11161169|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
10036674|NCT01945294|11161170|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
10036675|NCT01945294|11161171|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
10036676|NCT01945294|11161168|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
10036677|NCT01945294|11161169|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
10036678|NCT01945294|11161170|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
10036679|NCT01945294|11161171|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
10036680|NCT01945489|11161182|FG000|STARTED|Cycle 1||129
10036681|NCT01945489|11161183|FG001|STARTED|Cycle 1||125
10036682|NCT01945489|11161182|FG000|COMPLETED|Cycle 1||116
10036683|NCT01945489|11161183|FG001|COMPLETED|Cycle 1||121
10036684|NCT01945489|11161182|FG000|NOT COMPLETED|Cycle 1||13
10036685|NCT01945489|11161183|FG001|NOT COMPLETED|Cycle 1||4
10036686|NCT01945489|11161182|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
10036687|NCT01945489|11161183|FG001|STARTED|Cycle 2||107
10036688|NCT01945489|11161182|FG000|COMPLETED|Cycle 2||87
10036689|NCT01945489|11161183|FG001|COMPLETED|Cycle 2||106
10036690|NCT01945489|11161182|FG000|NOT COMPLETED|Cycle 2||1
10036691|NCT01945489|11161183|FG001|NOT COMPLETED|Cycle 2||1
10036692|NCT01945580|11161192|FG000|STARTED|Overall Study||228
10036693|NCT01945580|11161193|FG001|STARTED|Overall Study||485
10036694|NCT01945580|11161192|FG000|COMPLETED|Overall Study||176
10036695|NCT01945580|11161193|FG001|COMPLETED|Overall Study||401
10036696|NCT01945580|11161192|FG000|NOT COMPLETED|Overall Study||52
10036697|NCT01945580|11161193|FG001|NOT COMPLETED|Overall Study||84
10036698|NCT01945593|11161207|FG000|STARTED|Overall Study||3
10036699|NCT01945593|11161208|FG001|STARTED|Overall Study||64
10036700|NCT01945593|11161209|FG002|STARTED|Overall Study||26
10036701|NCT01945593|11161210|FG003|STARTED|Overall Study||125
10036702|NCT01945593|11161207|FG000|COMPLETED|Overall Study||3
10036703|NCT01945593|11161208|FG001|COMPLETED|Overall Study||56
10036704|NCT01945593|11161209|FG002|COMPLETED|Overall Study||23
10036705|NCT01945593|11161210|FG003|COMPLETED|Overall Study||105
10036706|NCT01945593|11161207|FG000|NOT COMPLETED|Overall Study||0
10036707|NCT01945593|11161208|FG001|NOT COMPLETED|Overall Study||8
10036708|NCT01945593|11161209|FG002|NOT COMPLETED|Overall Study||3
10036709|NCT01945593|11161210|FG003|NOT COMPLETED|Overall Study||20
10036710|NCT01945710|11161232|FG000|STARTED|Overall Study||7
10036711|NCT01945710|11161233|FG001|STARTED|Overall Study||6
10036712|NCT01945710|11161234|FG002|STARTED|Overall Study||7
10036713|NCT01945710|11161235|FG003|STARTED|Overall Study||3
10036714|NCT01945710|11161236|FG004|STARTED|Overall Study||9
10036715|NCT01945710|11161237|FG005|STARTED|Overall Study||3
10036716|NCT01945710|11161238|FG006|STARTED|Overall Study||23
10036717|NCT01945710|11161232|FG000|COMPLETED|Overall Study||0
10036718|NCT01945710|11161233|FG001|COMPLETED|Overall Study||0
10036719|NCT01945710|11161234|FG002|COMPLETED|Overall Study||0
10036720|NCT01945710|11161235|FG003|COMPLETED|Overall Study||0
10036721|NCT01945710|11161236|FG004|COMPLETED|Overall Study||0
10036722|NCT01945710|11161237|FG005|COMPLETED|Overall Study||0
10036723|NCT01945710|11161238|FG006|COMPLETED|Overall Study||0
10036724|NCT01945710|11161232|FG000|NOT COMPLETED|Overall Study||7
10036725|NCT01945710|11161233|FG001|NOT COMPLETED|Overall Study||6
10036726|NCT01945710|11161234|FG002|NOT COMPLETED|Overall Study||7
10036727|NCT01945710|11161235|FG003|NOT COMPLETED|Overall Study||3
10036728|NCT01945710|11161236|FG004|NOT COMPLETED|Overall Study||9
10036729|NCT01945710|11161237|FG005|NOT COMPLETED|Overall Study||3
10036730|NCT01945710|11161238|FG006|NOT COMPLETED|Overall Study||23
10036731|NCT01945866|11161258|FG000|STARTED|Overall Study||65
10036732|NCT01945866|11161259|FG001|STARTED|Overall Study||64
10036733|NCT01945866|11161258|FG000|COMPLETED|Overall Study||63
10036734|NCT01945866|11161259|FG001|COMPLETED|Overall Study||64
10036735|NCT01945866|11161258|FG000|NOT COMPLETED|Overall Study||2
10036736|NCT01945866|11161259|FG001|NOT COMPLETED|Overall Study||0
10036737|NCT01945944|11161268|FG000|STARTED|Overall Study||9
10036738|NCT01945944|11161269|FG001|STARTED|Overall Study||9
10036739|NCT01945944|11161268|FG000|COMPLETED|Overall Study||8
10036740|NCT01945944|11161269|FG001|COMPLETED|Overall Study||6
10036741|NCT01945944|11161268|FG000|NOT COMPLETED|Overall Study||1
10036742|NCT01945944|11161269|FG001|NOT COMPLETED|Overall Study||3
10036743|NCT01945970|11161277|FG000|STARTED|Overall Study||5
10036744|NCT01945970|11161278|FG001|STARTED|Overall Study||5
10036745|NCT01945970|11161279|FG002|STARTED|Overall Study||5
10036746|NCT01945970|11161280|FG003|STARTED|Overall Study||5
10036747|NCT01945970|11161281|FG004|STARTED|Overall Study||5
10036748|NCT01945970|11161282|FG005|STARTED|Overall Study||5
10036749|NCT01945970|11161277|FG000|COMPLETED|Overall Study||5
10036750|NCT01945970|11161278|FG001|COMPLETED|Overall Study||5
10036751|NCT01945970|11161279|FG002|COMPLETED|Overall Study||5
10036752|NCT01945970|11161280|FG003|COMPLETED|Overall Study||5
10036753|NCT01945970|11161281|FG004|COMPLETED|Overall Study||5
10036754|NCT01945970|11161282|FG005|COMPLETED|Overall Study||5
10036755|NCT01945970|11161277|FG000|NOT COMPLETED|Overall Study||0
10036756|NCT01945970|11161278|FG001|NOT COMPLETED|Overall Study||0
10036757|NCT01945970|11161279|FG002|NOT COMPLETED|Overall Study||0
10036758|NCT01945970|11161280|FG003|NOT COMPLETED|Overall Study||0
10036759|NCT01945970|11161281|FG004|NOT COMPLETED|Overall Study||0
10036760|NCT01945970|11161282|FG005|NOT COMPLETED|Overall Study||0
10036761|NCT01945996|11161294|FG000|STARTED|Overall Study||22
10036762|NCT01945996|11161295|FG001|STARTED|Overall Study||22
10036763|NCT01945996|11161294|FG000|COMPLETED|Overall Study||19
10036764|NCT01945996|11161295|FG001|COMPLETED|Overall Study||17
10036765|NCT01945996|11161294|FG000|NOT COMPLETED|Overall Study||3
10036766|NCT01945996|11161295|FG001|NOT COMPLETED|Overall Study||5
10036767|NCT01946126|11161305|FG000|STARTED|Overall Study||184
10036768|NCT01946126|11161306|FG001|STARTED|Overall Study||275
10036769|NCT01946126|11161305|FG000|COMPLETED|Overall Study||184
10036770|NCT01946126|11161306|FG001|COMPLETED|Overall Study||275
10036771|NCT01946126|11161305|FG000|NOT COMPLETED|Overall Study||0
10036772|NCT01946126|11161306|FG001|NOT COMPLETED|Overall Study||0
10036773|NCT01946152|11161316|FG000|STARTED|Overall Study||3
10036774|NCT01946152|11161317|FG001|STARTED|Overall Study||3
10036775|NCT01946152|11161318|FG002|STARTED|Overall Study||6
10036776|NCT01946152|11161319|FG003|STARTED|Overall Study||8
10036777|NCT01946152|11161316|FG000|COMPLETED|Overall Study||2
10036778|NCT01946152|11161317|FG001|COMPLETED|Overall Study||0
10036779|NCT01946152|11161318|FG002|COMPLETED|Overall Study||0
10036780|NCT01946152|11161319|FG003|COMPLETED|Overall Study||0
10036781|NCT01946152|11161316|FG000|NOT COMPLETED|Overall Study||1
10036782|NCT01946152|11161317|FG001|NOT COMPLETED|Overall Study||3
10036783|NCT01946152|11161318|FG002|NOT COMPLETED|Overall Study||6
10036784|NCT01946152|11161319|FG003|NOT COMPLETED|Overall Study||8
10036785|NCT01946165|11161333|FG000|STARTED|Overall Study||45
10036786|NCT01946165|11161334|FG001|STARTED|Overall Study||23
10036787|NCT01946165|11161333|FG000|COMPLETED|Overall Study||43
10036788|NCT01946165|11161334|FG001|COMPLETED|Overall Study||21
10036789|NCT01946165|11161333|FG000|NOT COMPLETED|Overall Study||2
10036790|NCT01946165|11161334|FG001|NOT COMPLETED|Overall Study||2
10036791|NCT01946178|11161341|FG000|STARTED|Overall Study||73
10036792|NCT01946178|11161341|FG000|COMPLETED|Overall Study||71
10036793|NCT01946178|11161341|FG000|NOT COMPLETED|Overall Study||2
10036794|NCT01946191|11161351|FG000|STARTED|Allocation||98
10036795|NCT01946191|11161352|FG001|STARTED|Allocation||96
10036796|NCT01946191|11161351|FG000|COMPLETED|Allocation||97
10036797|NCT01946191|11161352|FG001|COMPLETED|Allocation||95
10036798|NCT01946191|11161351|FG000|NOT COMPLETED|Allocation||1
10036799|NCT01946191|11161352|FG001|NOT COMPLETED|Allocation||1
10036800|NCT01946191|11161351|FG000|STARTED|Follow-Up, 24-mo Endpoint||97
10036801|NCT01946191|11161352|FG001|STARTED|Follow-Up, 24-mo Endpoint||95
10036802|NCT01946191|11161351|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80
10036803|NCT01946191|11161352|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77
10036804|NCT01946191|11161351|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
10036805|NCT01946191|11161352|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
10036806|NCT01946191|11161351|FG000|STARTED|Primary Outcome Analysis||98
10036807|NCT01946191|11161352|FG001|STARTED|Primary Outcome Analysis||95
10036808|NCT01946191|11161351|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
10036809|NCT01946191|11161352|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
10036810|NCT01946191|11161351|FG000|NOT COMPLETED|Primary Outcome Analysis||18
10036811|NCT01946191|11161352|FG001|NOT COMPLETED|Primary Outcome Analysis||18
10036812|NCT01946243|11161359|FG000|STARTED|Overall Study||96
10036813|NCT01946243|11161359|FG000|COMPLETED|Overall Study||96
10036814|NCT01946243|11161359|FG000|NOT COMPLETED|Overall Study||0
10036815|NCT01946282|11161368|FG000|STARTED|Year 1||6565
10036816|NCT01946282|11161369|FG001|STARTED|Year 1||1000
10036817|NCT01946282|11161370|FG002|STARTED|Year 1||1000
10036818|NCT01946282|11161368|FG000|COMPLETED|Year 1||2379
10036819|NCT01946282|11161369|FG001|COMPLETED|Year 1||392
10036820|NCT01946282|11161370|FG002|COMPLETED|Year 1||346
10036821|NCT01946282|11161368|FG000|NOT COMPLETED|Year 1||4186
10036822|NCT01946282|11161369|FG001|NOT COMPLETED|Year 1||608
10036823|NCT01946282|11161370|FG002|NOT COMPLETED|Year 1||654
10115893|NCT02528357|11246620|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115894|NCT02528357|11246621|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115895|NCT02528357|11246622|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115896|NCT02528357|11246623|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115897|NCT02528357|11246624|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115898|NCT02528357|11246625|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115899|NCT02528357|11246626|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115900|NCT02528357|11246627|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115901|NCT02528357|11246628|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115902|NCT02528357|11246629|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115903|NCT02528357|11246630|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115904|NCT02528357|11246631|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115905|NCT02528357|11246632|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115906|NCT02528357|11246633|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
10115907|NCT02528357|11246634|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
10115908|NCT02528357|11246635|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
10115909|NCT02528357|11246617|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115910|NCT02528357|11246618|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10036824|NCT01946282|11161368|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
10036825|NCT01946282|11161369|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
10036826|NCT01946282|11161370|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
10036827|NCT01946282|11161368|FG000|COMPLETED|Year 2||1248
10036828|NCT01946282|11161369|FG001|COMPLETED|Year 2||210
10036829|NCT01946282|11161370|FG002|COMPLETED|Year 2||184
10036830|NCT01946282|11161368|FG000|NOT COMPLETED|Year 2||803
10036831|NCT01946282|11161369|FG001|NOT COMPLETED|Year 2||131
10036832|NCT01946282|11161370|FG002|NOT COMPLETED|Year 2||115
10036833|NCT01946282|11161368|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
10036834|NCT01946282|11161369|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
10036835|NCT01946282|11161370|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
10036836|NCT01946282|11161368|FG000|COMPLETED|Year 3||856
10036837|NCT01946282|11161369|FG001|COMPLETED|Year 3||141
10036838|NCT01946282|11161370|FG002|COMPLETED|Year 3||140
10036839|NCT01946282|11161368|FG000|NOT COMPLETED|Year 3||288
10036840|NCT01946282|11161369|FG001|NOT COMPLETED|Year 3||43
10036841|NCT01946282|11161370|FG002|NOT COMPLETED|Year 3||30
10036842|NCT01946412|11161380|FG000|STARTED|Overall Study||33
10036843|NCT01946412|11161380|FG000|COMPLETED|Overall Study||28
10036844|NCT01946412|11161380|FG000|NOT COMPLETED|Overall Study||5
10036845|NCT01946425|11161388|FG000|STARTED|Overall Study||30
10036846|NCT01946425|11161389|FG001|STARTED|Overall Study||30
10036847|NCT01946425|11161388|FG000|COMPLETED|Overall Study||28
10036848|NCT01946425|11161389|FG001|COMPLETED|Overall Study||30
10036849|NCT01946425|11161388|FG000|NOT COMPLETED|Overall Study||2
10036850|NCT01946425|11161389|FG001|NOT COMPLETED|Overall Study||0
10036851|NCT01946438|11161400|FG000|STARTED|Overall Study||52
10036852|NCT01946438|11161401|FG001|STARTED|Overall Study||52
10036853|NCT01946438|11161402|FG002|STARTED|Overall Study||52
10036854|NCT01946438|11161403|FG003|STARTED|Overall Study||52
10036855|NCT01946438|11161400|FG000|COMPLETED|Overall Study||50
10036856|NCT01946438|11161401|FG001|COMPLETED|Overall Study||52
10036857|NCT01946438|11161402|FG002|COMPLETED|Overall Study||51
10036858|NCT01946438|11161403|FG003|COMPLETED|Overall Study||51
10036859|NCT01946438|11161400|FG000|NOT COMPLETED|Overall Study||2
10036860|NCT01946438|11161401|FG001|NOT COMPLETED|Overall Study||0
10036861|NCT01946438|11161402|FG002|NOT COMPLETED|Overall Study||1
10036862|NCT01946438|11161403|FG003|NOT COMPLETED|Overall Study||1
10036863|NCT01946529|11161422|FG000|STARTED|End of Window Therapy (2 Courses)||1
10036864|NCT01946529|11161423|FG001|STARTED|End of Window Therapy (2 Courses)||17
10036865|NCT01946529|11161424|FG002|STARTED|End of Window Therapy (2 Courses)||6
10036866|NCT01946529|11161422|FG000|COMPLETED|End of Window Therapy (2 Courses)||1
10036867|NCT01946529|11161423|FG001|COMPLETED|End of Window Therapy (2 Courses)||16
10036868|NCT01946529|11161424|FG002|COMPLETED|End of Window Therapy (2 Courses)||6
10036869|NCT01946529|11161422|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0
10036870|NCT01946529|11161423|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1
10036871|NCT01946529|11161424|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0
10036872|NCT01946529|11161422|FG000|STARTED|Completion of All Therapy||1
10036873|NCT01946529|11161423|FG001|STARTED|Completion of All Therapy||16
10036874|NCT01946529|11161424|FG002|STARTED|Completion of All Therapy||6
10036875|NCT01946529|11161422|FG000|COMPLETED|Completion of All Therapy||0
10036876|NCT01946529|11161423|FG001|COMPLETED|Completion of All Therapy||0
10036877|NCT01946529|11161424|FG002|COMPLETED|Completion of All Therapy||0
10036878|NCT01946529|11161422|FG000|NOT COMPLETED|Completion of All Therapy||1
10036879|NCT01946529|11161423|FG001|NOT COMPLETED|Completion of All Therapy||16
10036880|NCT01946529|11161424|FG002|NOT COMPLETED|Completion of All Therapy||6
10036881|NCT01946802|11161431|FG000|STARTED|Overall Study||44
10036882|NCT01946802|11161431|FG000|COMPLETED|Overall Study||39
10036883|NCT01946802|11161431|FG000|NOT COMPLETED|Overall Study||5
10036884|NCT01946880|11161437|FG000|STARTED|Overall Study||50
10036885|NCT01946880|11161438|FG001|STARTED|Overall Study||52
10036886|NCT01946880|11161437|FG000|COMPLETED|Overall Study||43
10036887|NCT01946880|11161438|FG001|COMPLETED|Overall Study||49
10036888|NCT01946880|11161437|FG000|NOT COMPLETED|Overall Study||7
10036889|NCT01946880|11161438|FG001|NOT COMPLETED|Overall Study||3
10036890|NCT01947127|11161446|FG000|STARTED|Overall Study||166
10036891|NCT01947127|11161447|FG001|STARTED|Overall Study||292
10036892|NCT01947127|11161446|FG000|COMPLETED|Overall Study||143
10036893|NCT01947127|11161447|FG001|COMPLETED|Overall Study||249
10036894|NCT01947127|11161446|FG000|NOT COMPLETED|Overall Study||23
10036895|NCT01947127|11161447|FG001|NOT COMPLETED|Overall Study||43
10036896|NCT01947153|11161453|FG000|STARTED|Test Period 1||18
10036897|NCT01947153|11161454|FG001|STARTED|Test Period 1||18
10036898|NCT01947153|11161453|FG000|COMPLETED|Test Period 1||18
10036899|NCT01947153|11161454|FG001|COMPLETED|Test Period 1||18
10036900|NCT01947153|11161453|FG000|NOT COMPLETED|Test Period 1||0
10036901|NCT01947153|11161454|FG001|NOT COMPLETED|Test Period 1||0
10036902|NCT01947153|11161453|FG000|STARTED|Test Period 2||18
10036903|NCT01947153|11161454|FG001|STARTED|Test Period 2||18
10036904|NCT01947153|11161453|FG000|COMPLETED|Test Period 2||18
10036905|NCT01947153|11161454|FG001|COMPLETED|Test Period 2||18
10036906|NCT01947153|11161453|FG000|NOT COMPLETED|Test Period 2||0
10036907|NCT01947153|11161454|FG001|NOT COMPLETED|Test Period 2||0
10036908|NCT01947283|11161467|FG000|STARTED|Overall Study||89
10036909|NCT01947283|11161468|FG001|STARTED|Overall Study||68
10036910|NCT01947283|11161469|FG002|STARTED|Overall Study||83
10036911|NCT01947283|11161470|FG003|STARTED|Overall Study||72
10036912|NCT01947283|11161471|FG004|STARTED|Overall Study||95
10036913|NCT01947283|11161472|FG005|STARTED|Overall Study||34
10036914|NCT01947283|11161473|FG006|STARTED|Overall Study||40
10036915|NCT01947283|11161467|FG000|Baseline Assessment|Overall Study||89
10036916|NCT01947283|11161468|FG001|Baseline Assessment|Overall Study||68
10036917|NCT01947283|11161469|FG002|Baseline Assessment|Overall Study||83
10036918|NCT01947283|11161470|FG003|Baseline Assessment|Overall Study||72
10036919|NCT01947283|11161471|FG004|Baseline Assessment|Overall Study||0
10036920|NCT01947283|11161472|FG005|Baseline Assessment|Overall Study||34
10036921|NCT01947283|11161473|FG006|Baseline Assessment|Overall Study||40
10036922|NCT01947283|11161467|FG000|Follow-up Assessment|Overall Study||64
10036923|NCT01947283|11161468|FG001|Follow-up Assessment|Overall Study||51
10036924|NCT01947283|11161469|FG002|Follow-up Assessment|Overall Study||65
10036925|NCT01947283|11161470|FG003|Follow-up Assessment|Overall Study||59
10036926|NCT01947283|11161471|FG004|Follow-up Assessment|Overall Study||0
10036927|NCT01947283|11161472|FG005|Follow-up Assessment|Overall Study||27
10036928|NCT01947283|11161473|FG006|Follow-up Assessment|Overall Study||36
10036929|NCT01947283|11161467|FG000|Clinical Recording|Overall Study||65
10036930|NCT01947283|11161468|FG001|Clinical Recording|Overall Study||54
10036931|NCT01947283|11161469|FG002|Clinical Recording|Overall Study||68
10036932|NCT01947283|11161470|FG003|Clinical Recording|Overall Study||57
10036933|NCT01947283|11161471|FG004|Clinical Recording|Overall Study||0
10036934|NCT01947283|11161472|FG005|Clinical Recording|Overall Study||0
10036935|NCT01947283|11161473|FG006|Clinical Recording|Overall Study||0
10036936|NCT01947283|11161467|FG000|End-of-Intervention Assessment|Overall Study||74
10036937|NCT01947283|11161468|FG001|End-of-Intervention Assessment|Overall Study||53
10036938|NCT01947283|11161469|FG002|End-of-Intervention Assessment|Overall Study||73
10036939|NCT01947283|11161470|FG003|End-of-Intervention Assessment|Overall Study||66
10036940|NCT01947283|11161471|FG004|End-of-Intervention Assessment|Overall Study||0
10036941|NCT01947283|11161472|FG005|End-of-Intervention Assessment|Overall Study||32
10036942|NCT01947283|11161473|FG006|End-of-Intervention Assessment|Overall Study||33
10036943|NCT01947283|11161467|FG000|In Analysis|Overall Study||89
10036944|NCT01947283|11161468|FG001|In Analysis|Overall Study||68
10036945|NCT01947283|11161469|FG002|In Analysis|Overall Study||83
10036946|NCT01947283|11161470|FG003|In Analysis|Overall Study||72
10036947|NCT01947283|11161471|FG004|In Analysis|Overall Study||95
10036948|NCT01947283|11161472|FG005|In Analysis|Overall Study||30
10036949|NCT01947283|11161473|FG006|In Analysis|Overall Study||38
10036950|NCT01947283|11161467|FG000|Completed NRCT Baseline Assessment|Overall Study||0
10036951|NCT01947283|11161468|FG001|Completed NRCT Baseline Assessment|Overall Study||0
10036952|NCT01947283|11161469|FG002|Completed NRCT Baseline Assessment|Overall Study||0
10036953|NCT01947283|11161470|FG003|Completed NRCT Baseline Assessment|Overall Study||0
10036954|NCT01947283|11161471|FG004|Completed NRCT Baseline Assessment|Overall Study||95
10036955|NCT01947283|11161472|FG005|Completed NRCT Baseline Assessment|Overall Study||0
10036956|NCT01947283|11161473|FG006|Completed NRCT Baseline Assessment|Overall Study||0
10036957|NCT01947283|11161467|FG000|COMPLETED|Overall Study||60
10036958|NCT01947283|11161468|FG001|COMPLETED|Overall Study||45
10036959|NCT01947283|11161469|FG002|COMPLETED|Overall Study||62
10036960|NCT01947283|11161470|FG003|COMPLETED|Overall Study||55
10036961|NCT01947283|11161471|FG004|COMPLETED|Overall Study||95
10036962|NCT01947283|11161472|FG005|COMPLETED|Overall Study||27
10036963|NCT01947283|11161473|FG006|COMPLETED|Overall Study||32
10036964|NCT01947283|11161467|FG000|NOT COMPLETED|Overall Study||29
10036965|NCT01947283|11161468|FG001|NOT COMPLETED|Overall Study||23
10036966|NCT01947283|11161469|FG002|NOT COMPLETED|Overall Study||21
10036967|NCT01947283|11161470|FG003|NOT COMPLETED|Overall Study||17
10036968|NCT01947283|11161471|FG004|NOT COMPLETED|Overall Study||0
10036969|NCT01947283|11161472|FG005|NOT COMPLETED|Overall Study||7
10036970|NCT01947283|11161473|FG006|NOT COMPLETED|Overall Study||8
10036971|NCT01947335|11161492|FG000|STARTED|Overall Study||42
10036972|NCT01947335|11161493|FG001|STARTED|Overall Study||41
10036973|NCT01947335|11161492|FG000|COMPLETED|Overall Study||42
10036974|NCT01947335|11161493|FG001|COMPLETED|Overall Study||41
10036975|NCT01947335|11161492|FG000|NOT COMPLETED|Overall Study||0
10036976|NCT01947335|11161493|FG001|NOT COMPLETED|Overall Study||0
10036977|NCT01947491|11161503|FG000|STARTED|Overall Study||174
10036978|NCT01947491|11161504|FG001|STARTED|Overall Study||87
10036979|NCT01947491|11161505|FG002|STARTED|Overall Study||90
10036980|NCT01947491|11161506|FG003|STARTED|Overall Study||43
10036981|NCT01947491|11161503|FG000|COMPLETED|Overall Study||166
10036982|NCT01947491|11161504|FG001|COMPLETED|Overall Study||81
10036983|NCT01947491|11161505|FG002|COMPLETED|Overall Study||88
10036984|NCT01947491|11161506|FG003|COMPLETED|Overall Study||38
10036985|NCT01947491|11161503|FG000|NOT COMPLETED|Overall Study||8
10036986|NCT01947491|11161504|FG001|NOT COMPLETED|Overall Study||6
10036987|NCT01947491|11161505|FG002|NOT COMPLETED|Overall Study||2
10036988|NCT01947491|11161506|FG003|NOT COMPLETED|Overall Study||5
10036989|NCT01947517|11161518|FG000|STARTED|Overall Study||26
10036990|NCT01947517|11161519|FG001|STARTED|Overall Study||26
10115911|NCT02528357|11246619|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10036991|NCT01947517|11161518|FG000|COMPLETED|Overall Study||25
10036992|NCT01947517|11161519|FG001|COMPLETED|Overall Study||25
10036993|NCT01947517|11161518|FG000|NOT COMPLETED|Overall Study||1
10036994|NCT01947517|11161519|FG001|NOT COMPLETED|Overall Study||1
10036995|NCT01947582|11161525|FG000|STARTED|Overall Study||2
10036996|NCT01947582|11161525|FG000|COMPLETED|Overall Study||1
10036997|NCT01947582|11161525|FG000|NOT COMPLETED|Overall Study||1
10036998|NCT01947647|11161531|FG000|STARTED|Treatment Phase||46
10036999|NCT01947647|11161532|FG001|STARTED|Treatment Phase||47
10037000|NCT01947647|11161531|FG000|COMPLETED|Treatment Phase||29
10037001|NCT01947647|11161532|FG001|COMPLETED|Treatment Phase||21
10037002|NCT01947647|11161531|FG000|NOT COMPLETED|Treatment Phase||17
10037003|NCT01947647|11161532|FG001|NOT COMPLETED|Treatment Phase||26
10037004|NCT01947647|11161531|FG000|STARTED|6-month Followup Phase||29
10037005|NCT01947647|11161532|FG001|STARTED|6-month Followup Phase||21
10037006|NCT01947647|11161531|FG000|COMPLETED|6-month Followup Phase||20
10037007|NCT01947647|11161532|FG001|COMPLETED|6-month Followup Phase||13
10037008|NCT01947647|11161531|FG000|NOT COMPLETED|6-month Followup Phase||9
10037009|NCT01947647|11161532|FG001|NOT COMPLETED|6-month Followup Phase||8
10037010|NCT01947816|11161538|FG000|STARTED|Overall Study||1593
10037011|NCT01947816|11161538|FG000|COMPLETED|Overall Study||1523
10037012|NCT01947816|11161538|FG000|NOT COMPLETED|Overall Study||70
10037013|NCT01947855|11161545|FG000|STARTED|Overall Study||21
10115912|NCT02528357|11246620|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115913|NCT02528357|11246621|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115914|NCT02528357|11246622|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115915|NCT02528357|11246623|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115916|NCT02528357|11246624|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115917|NCT02528357|11246625|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115918|NCT02528357|11246626|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115919|NCT02528357|11246627|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115920|NCT02528357|11246628|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115921|NCT02528357|11246629|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115922|NCT02528357|11246630|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115923|NCT02528357|11246631|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115924|NCT02528357|11246632|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10115925|NCT02528357|11246633|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
10115926|NCT02528357|11246634|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
10115927|NCT02528357|11246635|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
10115928|NCT02528370|11246677|FG000|STARTED|Overall Study||119
10115929|NCT02528370|11246678|FG001|STARTED|Overall Study||78
10115930|NCT02528370|11246677|FG000|COMPLETED|Overall Study||102
10115931|NCT02528370|11246678|FG001|COMPLETED|Overall Study||77
10115932|NCT02528370|11246677|FG000|NOT COMPLETED|Overall Study||17
10115933|NCT02528370|11246678|FG001|NOT COMPLETED|Overall Study||1
10115934|NCT02528409|11246686|FG000|STARTED|Overall Study||40
10115935|NCT02528409|11246687|FG001|STARTED|Overall Study||40
10037014|NCT01947855|11161546|FG001|STARTED|Overall Study||20
10037015|NCT01947855|11161547|FG002|STARTED|Overall Study||19
10037016|NCT01947855|11161545|FG000|COMPLETED|Overall Study||20
10037017|NCT01947855|11161546|FG001|COMPLETED|Overall Study||20
10037018|NCT01947855|11161547|FG002|COMPLETED|Overall Study||19
10037019|NCT01947855|11161545|FG000|NOT COMPLETED|Overall Study||1
10037020|NCT01947855|11161546|FG001|NOT COMPLETED|Overall Study||0
10037021|NCT01947855|11161547|FG002|NOT COMPLETED|Overall Study||0
10037022|NCT01947894|11161558|FG000|STARTED|Overall Study||247
10037023|NCT01947894|11161559|FG001|STARTED|Overall Study||42
10037024|NCT01947894|11161560|FG002|STARTED|Overall Study||88
10037025|NCT01947894|11161558|FG000|Treated|Overall Study||246
10037026|NCT01947894|11161559|FG001|Treated|Overall Study||41
10037027|NCT01947894|11161560|FG002|Treated|Overall Study||87
10037028|NCT01947894|11161558|FG000|COMPLETED|Overall Study||160
10037029|NCT01947894|11161559|FG001|COMPLETED|Overall Study||24
10037030|NCT01947894|11161560|FG002|COMPLETED|Overall Study||61
10037031|NCT01947894|11161558|FG000|NOT COMPLETED|Overall Study||87
10037032|NCT01947894|11161559|FG001|NOT COMPLETED|Overall Study||18
10037033|NCT01947894|11161560|FG002|NOT COMPLETED|Overall Study||27
10037034|NCT01947907|11161572|FG000|STARTED|Overall Study||12
10037035|NCT01947907|11161573|FG001|STARTED|Overall Study||14
10037036|NCT01947907|11161574|FG002|STARTED|Overall Study||14
10037037|NCT01947907|11161575|FG003|STARTED|Overall Study||13
10037038|NCT01947907|11161572|FG000|COMPLETED|Overall Study||12
10037039|NCT01947907|11161573|FG001|COMPLETED|Overall Study||14
10037040|NCT01947907|11161574|FG002|COMPLETED|Overall Study||14
10037041|NCT01947907|11161575|FG003|COMPLETED|Overall Study||13
10037042|NCT01947907|11161572|FG000|NOT COMPLETED|Overall Study||0
10037043|NCT01947907|11161573|FG001|NOT COMPLETED|Overall Study||0
10037044|NCT01947907|11161574|FG002|NOT COMPLETED|Overall Study||0
10037045|NCT01947907|11161575|FG003|NOT COMPLETED|Overall Study||0
10037046|NCT01947946|11161588|FG000|STARTED|Overall Study||3
10037047|NCT01947946|11161589|FG001|STARTED|Overall Study||5
10037048|NCT01947946|11161590|FG002|STARTED|Overall Study||5
10037049|NCT01947946|11161588|FG000|COMPLETED|Overall Study|Study Stopped|0
10037050|NCT01947946|11161589|FG001|COMPLETED|Overall Study||0
10037051|NCT01947946|11161590|FG002|COMPLETED|Overall Study||0
10037052|NCT01947946|11161588|FG000|NOT COMPLETED|Overall Study||3
10037053|NCT01947946|11161589|FG001|NOT COMPLETED|Overall Study||5
10037054|NCT01947946|11161590|FG002|NOT COMPLETED|Overall Study||5
10037055|NCT01948050|11161600|FG000|STARTED|Overall Study||16
10037056|NCT01948050|11161601|FG001|STARTED|Overall Study||8
10037057|NCT01948050|11161600|FG000|COMPLETED|Overall Study||16
10115936|NCT02528409|11246686|FG000|COMPLETED|Overall Study||18
10115937|NCT02528409|11246687|FG001|COMPLETED|Overall Study||24
10115938|NCT02528409|11246686|FG000|NOT COMPLETED|Overall Study||22
10115939|NCT02528409|11246687|FG001|NOT COMPLETED|Overall Study||16
10115940|NCT02528721|11246695|FG000|STARTED|Overall Study||203
10115941|NCT02528721|11246696|FG001|STARTED|Overall Study||79
10037058|NCT01948050|11161601|FG001|COMPLETED|Overall Study||7
10037059|NCT01948050|11161600|FG000|NOT COMPLETED|Overall Study||0
10037060|NCT01948050|11161601|FG001|NOT COMPLETED|Overall Study||1
10037061|NCT01948063|11161609|FG000|STARTED|Overall Study||20
10037062|NCT01948063|11161610|FG001|STARTED|Overall Study||21
10037063|NCT01948063|11161609|FG000|COMPLETED|Overall Study||19
10037064|NCT01948063|11161610|FG001|COMPLETED|Overall Study||19
10037065|NCT01948063|11161609|FG000|NOT COMPLETED|Overall Study||1
10037066|NCT01948063|11161610|FG001|NOT COMPLETED|Overall Study||2
10037067|NCT01948076|11161618|FG000|STARTED|Overall Study||20
10037068|NCT01948076|11161619|FG001|STARTED|Overall Study||20
10037069|NCT01948076|11161618|FG000|COMPLETED|Overall Study||20
10037070|NCT01948076|11161619|FG001|COMPLETED|Overall Study||19
10037071|NCT01948076|11161618|FG000|NOT COMPLETED|Overall Study||0
10037072|NCT01948076|11161619|FG001|NOT COMPLETED|Overall Study||1
10037073|NCT01948141|11161627|FG000|STARTED|Overall Study||6
10037074|NCT01948141|11161627|FG000|COMPLETED|Overall Study||6
10115942|NCT02528721|11246695|FG000|COMPLETED|Overall Study||196
10115943|NCT02528721|11246696|FG001|COMPLETED|Overall Study||76
10115944|NCT02528721|11246695|FG000|NOT COMPLETED|Overall Study||7
10115945|NCT02528721|11246696|FG001|NOT COMPLETED|Overall Study||3
10115946|NCT02528786|11246702|FG000|STARTED|Overall Study||8
10115947|NCT02528786|11246702|FG000|COMPLETED|Overall Study||8
10115948|NCT02528786|11246702|FG000|NOT COMPLETED|Overall Study||0
10115949|NCT02528942|11246706|FG000|STARTED|Overall Study||101
10115950|NCT02528942|11246706|FG000|COMPLETED|Overall Study||67
10115951|NCT02528942|11246706|FG000|NOT COMPLETED|Overall Study||34
10115952|NCT02529072|11246712|FG000|STARTED|Overall Study||3
10115953|NCT02529072|11246713|FG001|STARTED|Overall Study||3
10115954|NCT02529072|11246712|FG000|COMPLETED|Overall Study||3
10115955|NCT02529072|11246713|FG001|COMPLETED|Overall Study||3
10115956|NCT02529072|11246712|FG000|NOT COMPLETED|Overall Study||0
10115957|NCT02529072|11246713|FG001|NOT COMPLETED|Overall Study||0
10115958|NCT02529137|11246719|FG000|STARTED|Overall Study||2000
10115959|NCT02529137|11246719|FG000|COMPLETED|Overall Study||1992
10115960|NCT02529137|11246719|FG000|NOT COMPLETED|Overall Study||8
10115961|NCT02529488|11246724|FG000|STARTED|Overall Study||149
10115962|NCT02529488|11246724|FG000|COMPLETED|Overall Study||145
10115963|NCT02529488|11246724|FG000|NOT COMPLETED|Overall Study||4
10115964|NCT02529553|11246741|FG000|STARTED|Overall Study||1
10115965|NCT02529553|11246742|FG001|STARTED|Overall Study||1
10115966|NCT02529553|11246743|FG002|STARTED|Overall Study||1
10115967|NCT02529553|11246744|FG003|STARTED|Overall Study||3
10115968|NCT02529553|11246745|FG004|STARTED|Overall Study||3
10115969|NCT02529553|11246746|FG005|STARTED|Overall Study||4
10115970|NCT02529553|11246747|FG006|STARTED|Overall Study||3
10115971|NCT02529553|11246748|FG007|STARTED|Overall Study||6
10115972|NCT02529553|11246749|FG008|STARTED|Overall Study||3
10115973|NCT02529553|11246741|FG000|COMPLETED|Overall Study||0
10115974|NCT02529553|11246742|FG001|COMPLETED|Overall Study||0
10115975|NCT02529553|11246743|FG002|COMPLETED|Overall Study||0
10115976|NCT02529553|11246744|FG003|COMPLETED|Overall Study||0
10115977|NCT02529553|11246745|FG004|COMPLETED|Overall Study||0
10115978|NCT02529553|11246746|FG005|COMPLETED|Overall Study||0
10115979|NCT02529553|11246747|FG006|COMPLETED|Overall Study||0
10115980|NCT02529553|11246748|FG007|COMPLETED|Overall Study||0
10115981|NCT02529553|11246749|FG008|COMPLETED|Overall Study||0
10115982|NCT02529553|11246741|FG000|NOT COMPLETED|Overall Study||1
10115983|NCT02529553|11246742|FG001|NOT COMPLETED|Overall Study||1
10115984|NCT02529553|11246743|FG002|NOT COMPLETED|Overall Study||1
10115985|NCT02529553|11246744|FG003|NOT COMPLETED|Overall Study||3
10115986|NCT02529553|11246745|FG004|NOT COMPLETED|Overall Study||3
10115987|NCT02529553|11246746|FG005|NOT COMPLETED|Overall Study||4
10115988|NCT02529553|11246747|FG006|NOT COMPLETED|Overall Study||3
10115989|NCT02529553|11246748|FG007|NOT COMPLETED|Overall Study||6
10115990|NCT02529553|11246749|FG008|NOT COMPLETED|Overall Study||3
10115991|NCT02529995|11246772|FG000|STARTED|Part A||15
10115992|NCT02529995|11246773|FG001|STARTED|Part A||16
10115993|NCT02529995|11246772|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
10115994|NCT02529995|11246773|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
10115995|NCT02529995|11246772|FG000|NOT COMPLETED|Part A||15
10115996|NCT02529995|11246773|FG001|NOT COMPLETED|Part A||16
10115997|NCT02529995|11246772|FG000|STARTED|Part B||15
10115998|NCT02529995|11246773|FG001|STARTED|Part B||16
10115999|NCT02529995|11246772|FG000|COMPLETED|Part B||9
10116000|NCT02529995|11246773|FG001|COMPLETED|Part B||4
10116001|NCT02529995|11246772|FG000|NOT COMPLETED|Part B||6
10116002|NCT02529995|11246773|FG001|NOT COMPLETED|Part B||12
10116003|NCT02530125|11246779|FG000|STARTED|Completed Treatment||4
10116004|NCT02530125|11246779|FG000|COMPLETED|Completed Treatment||3
10116005|NCT02530125|11246779|FG000|NOT COMPLETED|Completed Treatment||1
10116006|NCT02530125|11246779|FG000|STARTED|Followed for Survival for 2 Years||3
10116007|NCT02530125|11246779|FG000|COMPLETED|Followed for Survival for 2 Years||0
10116008|NCT02530125|11246779|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3
10116009|NCT02530151|11246785|FG000|STARTED|Overall Study||37
10116010|NCT02530151|11246786|FG001|STARTED|Overall Study||33
10116011|NCT02530151|11246785|FG000|COMPLETED|Overall Study||16
10116012|NCT02530151|11246786|FG001|COMPLETED|Overall Study||17
10116013|NCT02530151|11246785|FG000|NOT COMPLETED|Overall Study||21
10037075|NCT01948141|11161627|FG000|NOT COMPLETED|Overall Study||0
10037076|NCT01948193|11161631|FG000|STARTED|Overall Study||177
10116014|NCT02530151|11246786|FG001|NOT COMPLETED|Overall Study||16
10116015|NCT02530242|11246794|FG000|STARTED|Overall Study||16
10116016|NCT02530242|11246795|FG001|STARTED|Overall Study||16
10116017|NCT02530242|11246794|FG000|COMPLETED|Overall Study||16
10037077|NCT01948193|11161631|FG000|COMPLETED|Overall Study||168
10037078|NCT01948193|11161631|FG000|NOT COMPLETED|Overall Study||9
10037079|NCT01948258|11161636|FG000|STARTED|Overall Study||395
10037080|NCT01948258|11161636|FG000|COMPLETED|Overall Study||233
10037081|NCT01948258|11161636|FG000|NOT COMPLETED|Overall Study||162
10037082|NCT01948310|11161642|FG000|STARTED|Overall Study||19
10037083|NCT01948310|11161643|FG001|STARTED|Overall Study||18
10037084|NCT01948310|11161642|FG000|COMPLETED|Overall Study||16
10116018|NCT02530242|11246795|FG001|COMPLETED|Overall Study||15
10116019|NCT02530242|11246794|FG000|NOT COMPLETED|Overall Study||0
10116020|NCT02530242|11246795|FG001|NOT COMPLETED|Overall Study||1
10116021|NCT02530281|11246803|FG000|STARTED|Overall Study||229
10116022|NCT02530281|11246804|FG001|STARTED|Overall Study||115
10116023|NCT02530281|11246803|FG000|COMPLETED|Overall Study||208
10116024|NCT02530281|11246804|FG001|COMPLETED|Overall Study||112
10116025|NCT02530281|11246803|FG000|NOT COMPLETED|Overall Study||21
10116026|NCT02530281|11246804|FG001|NOT COMPLETED|Overall Study||3
10116027|NCT02530294|11246814|FG000|STARTED|Overall Study||234
10116028|NCT02530294|11246815|FG001|STARTED|Overall Study||119
10116029|NCT02530294|11246814|FG000|COMPLETED|Overall Study||218
10116030|NCT02530294|11246815|FG001|COMPLETED|Overall Study||113
10116031|NCT02530294|11246814|FG000|NOT COMPLETED|Overall Study||16
10116032|NCT02530294|11246815|FG001|NOT COMPLETED|Overall Study||6
10116033|NCT02530385|11246823|FG000|STARTED|Overall Study||12
10116034|NCT02530385|11246824|FG001|STARTED|Overall Study||12
10116035|NCT02530385|11246823|FG000|COMPLETED|Overall Study||12
10116036|NCT02530385|11246824|FG001|COMPLETED|Overall Study||11
10116037|NCT02530385|11246823|FG000|NOT COMPLETED|Overall Study||0
10116038|NCT02530385|11246824|FG001|NOT COMPLETED|Overall Study||1
10116039|NCT02530450|11246832|FG000|STARTED|Overall Study||16
10116040|NCT02530450|11246833|FG001|STARTED|Overall Study||14
10116041|NCT02530450|11246832|FG000|COMPLETED|Overall Study||10
10116042|NCT02530450|11246833|FG001|COMPLETED|Overall Study||9
10116043|NCT02530450|11246832|FG000|NOT COMPLETED|Overall Study||6
10116044|NCT02530450|11246833|FG001|NOT COMPLETED|Overall Study||5
10116045|NCT02530476|11246843|FG000|STARTED|Overall Study||4
10116046|NCT02530476|11246844|FG001|STARTED|Overall Study||3
10116047|NCT02530476|11246845|FG002|STARTED|Overall Study||7
10037085|NCT01948310|11161643|FG001|COMPLETED|Overall Study||13
10037086|NCT01948310|11161642|FG000|NOT COMPLETED|Overall Study||3
10037087|NCT01948310|11161643|FG001|NOT COMPLETED|Overall Study||5
10037088|NCT01948375|11161651|FG000|STARTED|Overall Study||30
10037089|NCT01948375|11161652|FG001|STARTED|Overall Study||30
10037090|NCT01948375|11161651|FG000|COMPLETED|Overall Study||30
10037091|NCT01948375|11161652|FG001|COMPLETED|Overall Study||30
10037092|NCT01948375|11161651|FG000|NOT COMPLETED|Overall Study||0
10037093|NCT01948375|11161652|FG001|NOT COMPLETED|Overall Study||0
10037094|NCT01948388|11161662|FG000|STARTED|Overall Study||10
10037095|NCT01948388|11161663|FG001|STARTED|Overall Study||10
10037096|NCT01948388|11161662|FG000|COMPLETED|Overall Study||8
10037097|NCT01948388|11161663|FG001|COMPLETED|Overall Study||9
10037098|NCT01948388|11161662|FG000|NOT COMPLETED|Overall Study||2
10037099|NCT01948388|11161663|FG001|NOT COMPLETED|Overall Study||1
10037100|NCT01948427|11161676|FG000|STARTED|Overall Study||49
10037101|NCT01948427|11161677|FG001|STARTED|Overall Study||89
10037102|NCT01948427|11161678|FG002|STARTED|Overall Study||4
10037103|NCT01948427|11161679|FG003|STARTED|Overall Study||1
10037104|NCT01948427|11161680|FG004|STARTED|Overall Study||60
10037105|NCT01948427|11161676|FG000|COMPLETED|Overall Study||42
10037106|NCT01948427|11161677|FG001|COMPLETED|Overall Study||72
10037107|NCT01948427|11161678|FG002|COMPLETED|Overall Study||4
10037108|NCT01948427|11161679|FG003|COMPLETED|Overall Study||1
10037109|NCT01948427|11161680|FG004|COMPLETED|Overall Study||46
10037110|NCT01948427|11161676|FG000|NOT COMPLETED|Overall Study||7
10037111|NCT01948427|11161677|FG001|NOT COMPLETED|Overall Study||17
10037112|NCT01948427|11161678|FG002|NOT COMPLETED|Overall Study||0
10037113|NCT01948427|11161679|FG003|NOT COMPLETED|Overall Study||0
10037114|NCT01948427|11161680|FG004|NOT COMPLETED|Overall Study||14
10037115|NCT01948518|11161697|FG000|STARTED|Overall Study||15
10037116|NCT01948518|11161697|FG000|COMPLETED|Overall Study||15
10037117|NCT01948518|11161697|FG000|NOT COMPLETED|Overall Study||0
10037118|NCT01948739|11161701|FG000|STARTED|Overall Study||18
10037119|NCT01948739|11161701|FG000|Received Intervention|Overall Study||10
10037120|NCT01948739|11161701|FG000|COMPLETED|Overall Study||10
10037121|NCT01948739|11161701|FG000|NOT COMPLETED|Overall Study||8
10037122|NCT01948791|11161705|FG000|STARTED|Overall Study||222
10037123|NCT01948791|11161705|FG000|COMPLETED|Overall Study||151
10037124|NCT01948791|11161705|FG000|NOT COMPLETED|Overall Study||71
10037125|NCT01948830|11161711|FG000|STARTED|Overall Study||323
10037126|NCT01948830|11161712|FG001|STARTED|Overall Study||327
10037127|NCT01948830|11161711|FG000|Safety Set|Overall Study||323
10037128|NCT01948830|11161712|FG001|Safety Set|Overall Study||326
10037129|NCT01948830|11161711|FG000|COMPLETED|Overall Study||290
10037130|NCT01948830|11161712|FG001|COMPLETED|Overall Study||295
10037131|NCT01948830|11161711|FG000|NOT COMPLETED|Overall Study||33
10037132|NCT01948830|11161712|FG001|NOT COMPLETED|Overall Study||32
10116048|NCT02530476|11246846|FG003|STARTED|Overall Study||3
10116049|NCT02530476|11246843|FG000|COMPLETED|Overall Study||4
10116050|NCT02530476|11246844|FG001|COMPLETED|Overall Study||3
10037133|NCT01948908|11161721|FG000|STARTED|Overall Study||33
10037134|NCT01948908|11161722|FG001|STARTED|Overall Study||33
10037135|NCT01948908|11161723|FG002|STARTED|Overall Study||33
10037136|NCT01948908|11161721|FG000|COMPLETED|Overall Study||32
10037137|NCT01948908|11161722|FG001|COMPLETED|Overall Study||33
10037138|NCT01948908|11161723|FG002|COMPLETED|Overall Study||31
10037139|NCT01948908|11161721|FG000|NOT COMPLETED|Overall Study||1
10037140|NCT01948908|11161722|FG001|NOT COMPLETED|Overall Study||0
10037141|NCT01948908|11161723|FG002|NOT COMPLETED|Overall Study||2
10037142|NCT01948947|11161733|FG000|STARTED|Overall Study||14
10037143|NCT01948947|11161734|FG001|STARTED|Overall Study||15
10037144|NCT01948947|11161733|FG000|COMPLETED|Overall Study||14
10037145|NCT01948947|11161734|FG001|COMPLETED|Overall Study||15
10037146|NCT01948947|11161733|FG000|NOT COMPLETED|Overall Study||0
10037147|NCT01948947|11161734|FG001|NOT COMPLETED|Overall Study||0
10037148|NCT01948986|11161745|FG000|STARTED|Overall Study||6
10037149|NCT01948986|11161746|FG001|STARTED|Overall Study||8
10037150|NCT01948986|11161747|FG002|STARTED|Overall Study||8
10037151|NCT01948986|11161748|FG003|STARTED|Overall Study||6
10037152|NCT01948986|11161749|FG004|STARTED|Overall Study||8
10037153|NCT01948986|11161745|FG000|COMPLETED|Overall Study||6
10037154|NCT01948986|11161746|FG001|COMPLETED|Overall Study||8
10037155|NCT01948986|11161747|FG002|COMPLETED|Overall Study||8
10037156|NCT01948986|11161748|FG003|COMPLETED|Overall Study||6
10037157|NCT01948986|11161749|FG004|COMPLETED|Overall Study||8
10037158|NCT01948986|11161745|FG000|NOT COMPLETED|Overall Study||0
10037159|NCT01948986|11161746|FG001|NOT COMPLETED|Overall Study||0
10037160|NCT01948986|11161747|FG002|NOT COMPLETED|Overall Study||0
10037161|NCT01948986|11161748|FG003|NOT COMPLETED|Overall Study||0
10037162|NCT01948986|11161749|FG004|NOT COMPLETED|Overall Study||0
10037163|NCT01949051|11161761|FG000|STARTED|Treatment Period 1 (7 Days)||13
10037164|NCT01949051|11161762|FG001|STARTED|Treatment Period 1 (7 Days)||13
10037165|NCT01949051|11161763|FG002|STARTED|Treatment Period 1 (7 Days)||13
10037166|NCT01949051|11161764|FG003|STARTED|Treatment Period 1 (7 Days)||13
10037167|NCT01949051|11161765|FG004|STARTED|Treatment Period 1 (7 Days)||13
10037168|NCT01949051|11161766|FG005|STARTED|Treatment Period 1 (7 Days)||13
10037169|NCT01949051|11161761|FG000|COMPLETED|Treatment Period 1 (7 Days)||11
10037170|NCT01949051|11161762|FG001|COMPLETED|Treatment Period 1 (7 Days)||13
10037171|NCT01949051|11161763|FG002|COMPLETED|Treatment Period 1 (7 Days)||13
10037172|NCT01949051|11161764|FG003|COMPLETED|Treatment Period 1 (7 Days)||12
10037173|NCT01949051|11161765|FG004|COMPLETED|Treatment Period 1 (7 Days)||13
10037174|NCT01949051|11161766|FG005|COMPLETED|Treatment Period 1 (7 Days)||13
10037175|NCT01949051|11161761|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2
10037176|NCT01949051|11161762|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10037177|NCT01949051|11161763|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10037178|NCT01949051|11161764|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1
10037179|NCT01949051|11161765|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10037180|NCT01949051|11161766|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10037181|NCT01949051|11161761|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11
10037182|NCT01949051|11161762|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13
10037183|NCT01949051|11161763|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13
10037184|NCT01949051|11161764|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12
10037185|NCT01949051|11161765|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13
10037186|NCT01949051|11161766|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13
10037187|NCT01949051|11161761|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11
10037188|NCT01949051|11161762|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10037189|NCT01949051|11161763|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10037190|NCT01949051|11161764|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12
10037191|NCT01949051|11161765|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10037192|NCT01949051|11161766|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10037193|NCT01949051|11161761|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10037194|NCT01949051|11161762|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10037195|NCT01949051|11161763|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10037196|NCT01949051|11161764|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10037197|NCT01949051|11161765|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10037198|NCT01949051|11161766|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10037199|NCT01949051|11161761|FG000|STARTED|Treatment Period 2 (7 Days)||11
10037200|NCT01949051|11161762|FG001|STARTED|Treatment Period 2 (7 Days)||13
10037201|NCT01949051|11161763|FG002|STARTED|Treatment Period 2 (7 Days)||13
10037202|NCT01949051|11161764|FG003|STARTED|Treatment Period 2 (7 Days)||12
10037203|NCT01949051|11161765|FG004|STARTED|Treatment Period 2 (7 Days)||13
10037204|NCT01949051|11161766|FG005|STARTED|Treatment Period 2 (7 Days)||13
10037205|NCT01949051|11161761|FG000|COMPLETED|Treatment Period 2 (7 Days)||11
10037206|NCT01949051|11161762|FG001|COMPLETED|Treatment Period 2 (7 Days)||12
10037207|NCT01949051|11161763|FG002|COMPLETED|Treatment Period 2 (7 Days)||12
10037208|NCT01949051|11161764|FG003|COMPLETED|Treatment Period 2 (7 Days)||12
10037209|NCT01949051|11161765|FG004|COMPLETED|Treatment Period 2 (7 Days)||13
10037210|NCT01949051|11161766|FG005|COMPLETED|Treatment Period 2 (7 Days)||12
10037211|NCT01949051|11161761|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10037212|NCT01949051|11161762|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1
10037213|NCT01949051|11161763|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1
10037214|NCT01949051|11161764|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10037215|NCT01949051|11161765|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10037216|NCT01949051|11161766|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1
10037217|NCT01949051|11161761|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11
10037218|NCT01949051|11161762|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12
10037219|NCT01949051|11161763|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12
10037220|NCT01949051|11161764|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12
10037221|NCT01949051|11161765|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13
10037222|NCT01949051|11161766|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12
10037223|NCT01949051|11161761|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11
10037224|NCT01949051|11161762|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10037225|NCT01949051|11161763|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10037226|NCT01949051|11161764|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10037227|NCT01949051|11161765|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13
10037228|NCT01949051|11161766|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10037229|NCT01949051|11161761|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10037230|NCT01949051|11161762|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10037231|NCT01949051|11161763|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10037232|NCT01949051|11161764|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10037233|NCT01949051|11161765|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10037234|NCT01949051|11161766|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10037235|NCT01949051|11161761|FG000|STARTED|Treatment Period 3 (7 Days)||11
10037236|NCT01949051|11161762|FG001|STARTED|Treatment Period 3 (7 Days)||12
10037237|NCT01949051|11161763|FG002|STARTED|Treatment Period 3 (7 Days)||12
10037238|NCT01949051|11161764|FG003|STARTED|Treatment Period 3 (7 Days)||12
10037239|NCT01949051|11161765|FG004|STARTED|Treatment Period 3 (7 Days)||13
10037240|NCT01949051|11161766|FG005|STARTED|Treatment Period 3 (7 Days)||12
10037241|NCT01949051|11161761|FG000|COMPLETED|Treatment Period 3 (7 Days)||11
10037242|NCT01949051|11161762|FG001|COMPLETED|Treatment Period 3 (7 Days)||12
10037243|NCT01949051|11161763|FG002|COMPLETED|Treatment Period 3 (7 Days)||12
10037244|NCT01949051|11161764|FG003|COMPLETED|Treatment Period 3 (7 Days)||12
10037245|NCT01949051|11161765|FG004|COMPLETED|Treatment Period 3 (7 Days)||13
10037246|NCT01949051|11161766|FG005|COMPLETED|Treatment Period 3 (7 Days)||12
10037247|NCT01949051|11161761|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10037248|NCT01949051|11161762|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10037249|NCT01949051|11161763|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10037250|NCT01949051|11161764|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10037251|NCT01949051|11161765|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10037252|NCT01949051|11161766|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10037253|NCT01949090|11161779|FG000|STARTED|Overall Study||60
10037254|NCT01949090|11161780|FG001|STARTED|Overall Study||60
10037255|NCT01949090|11161781|FG002|STARTED|Overall Study||60
10037256|NCT01949090|11161782|FG003|STARTED|Overall Study||60
10037257|NCT01949090|11161783|FG004|STARTED|Overall Study||120
10037258|NCT01949090|11161779|FG000|COMPLETED|Overall Study||56
10037259|NCT01949090|11161780|FG001|COMPLETED|Overall Study||58
10037260|NCT01949090|11161781|FG002|COMPLETED|Overall Study||58
10037261|NCT01949090|11161782|FG003|COMPLETED|Overall Study||59
10037262|NCT01949090|11161783|FG004|COMPLETED|Overall Study||116
10037263|NCT01949090|11161779|FG000|NOT COMPLETED|Overall Study||4
10037264|NCT01949090|11161780|FG001|NOT COMPLETED|Overall Study||2
10037265|NCT01949090|11161781|FG002|NOT COMPLETED|Overall Study||2
10037266|NCT01949090|11161782|FG003|NOT COMPLETED|Overall Study||1
10037267|NCT01949090|11161783|FG004|NOT COMPLETED|Overall Study||4
10037268|NCT01949116|11161798|FG000|STARTED|Overall Study||86
10037269|NCT01949116|11161799|FG001|STARTED|Overall Study||90
10037270|NCT01949116|11161798|FG000|COMPLETED|Overall Study||78
10037271|NCT01949116|11161799|FG001|COMPLETED|Overall Study||84
10037272|NCT01949116|11161798|FG000|NOT COMPLETED|Overall Study||8
10037273|NCT01949116|11161799|FG001|NOT COMPLETED|Overall Study||6
10037274|NCT01949142|11161811|FG000|STARTED|Overall Study||179
10037275|NCT01949142|11161812|FG001|STARTED|Overall Study||87
10037276|NCT01949142|11161811|FG000|COMPLETED|Overall Study||176
10037277|NCT01949142|11161812|FG001|COMPLETED|Overall Study||86
10037278|NCT01949142|11161811|FG000|NOT COMPLETED|Overall Study||3
10037279|NCT01949142|11161812|FG001|NOT COMPLETED|Overall Study||1
10037280|NCT01949155|11161821|FG000|STARTED|Overall Study||178
10037281|NCT01949155|11161822|FG001|STARTED|Overall Study||88
10037282|NCT01949155|11161821|FG000|COMPLETED|Overall Study||176
10037283|NCT01949155|11161822|FG001|COMPLETED|Overall Study||88
10037284|NCT01949155|11161821|FG000|NOT COMPLETED|Overall Study||2
10037285|NCT01949155|11161822|FG001|NOT COMPLETED|Overall Study||0
10037286|NCT01949337|11161831|FG000|STARTED|Overall Study||657
10037287|NCT01949337|11161832|FG001|STARTED|Overall Study||654
10037288|NCT01949337|11161831|FG000|COMPLETED|Overall Study||657
10037289|NCT01949337|11161832|FG001|COMPLETED|Overall Study||654
10037290|NCT01949337|11161831|FG000|NOT COMPLETED|Overall Study||0
10037291|NCT01949337|11161832|FG001|NOT COMPLETED|Overall Study||0
10037292|NCT01949389|11161838|FG000|STARTED|Overall Study||51
10037293|NCT01949389|11161838|FG000|COMPLETED|Overall Study||51
10037294|NCT01949389|11161838|FG000|NOT COMPLETED|Overall Study||0
10037295|NCT01949480|11161844|FG000|STARTED|Overall Study||20
10037296|NCT01949480|11161845|FG001|STARTED|Overall Study||22
10037297|NCT01949480|11161844|FG000|COMPLETED|Overall Study||15
10037298|NCT01949480|11161845|FG001|COMPLETED|Overall Study||14
10037299|NCT01949480|11161844|FG000|NOT COMPLETED|Overall Study||5
10037300|NCT01949480|11161845|FG001|NOT COMPLETED|Overall Study||8
10037301|NCT01949532|11161853|FG000|STARTED|Overall Study||15
10037302|NCT01949532|11161854|FG001|STARTED|Overall Study||11
10037303|NCT01949532|11161853|FG000|COMPLETED|Overall Study||12
10037304|NCT01949532|11161854|FG001|COMPLETED|Overall Study||8
10037305|NCT01949532|11161853|FG000|NOT COMPLETED|Overall Study||3
10037306|NCT01949532|11161854|FG001|NOT COMPLETED|Overall Study||3
10037307|NCT01949545|11161864|FG000|STARTED|Overall Study||11
10037308|NCT01949545|11161865|FG001|STARTED|Overall Study||17
10037309|NCT01949545|11161866|FG002|STARTED|Overall Study||14
10037310|NCT01949545|11161867|FG003|STARTED|Overall Study||4
10037311|NCT01949545|11161864|FG000|COMPLETED|Overall Study||11
10037312|NCT01949545|11161865|FG001|COMPLETED|Overall Study||17
10037313|NCT01949545|11161866|FG002|COMPLETED|Overall Study||14
10037314|NCT01949545|11161867|FG003|COMPLETED|Overall Study||4
10037315|NCT01949545|11161864|FG000|NOT COMPLETED|Overall Study||0
10037316|NCT01949545|11161865|FG001|NOT COMPLETED|Overall Study||0
10037317|NCT01949545|11161866|FG002|NOT COMPLETED|Overall Study||0
10037318|NCT01949545|11161867|FG003|NOT COMPLETED|Overall Study||0
10037319|NCT01949662|11161879|FG000|STARTED|Overall Study||47
10037320|NCT01949662|11161880|FG001|STARTED|Overall Study||43
10037321|NCT01949662|11161879|FG000|COMPLETED|Overall Study||29
10037322|NCT01949662|11161880|FG001|COMPLETED|Overall Study||29
10037323|NCT01949662|11161879|FG000|NOT COMPLETED|Overall Study||18
10037324|NCT01949662|11161880|FG001|NOT COMPLETED|Overall Study||14
10037325|NCT01949779|11161886|FG000|STARTED|Overall Study||81
10037326|NCT01949779|11161886|FG000|COMPLETED|Overall Study||79
10037327|NCT01949779|11161886|FG000|NOT COMPLETED|Overall Study||2
10037328|NCT01949844|11161890|FG000|STARTED|Overall Study||44
10037329|NCT01949844|11161890|FG000|COMPLETED|Overall Study||44
10037330|NCT01949844|11161890|FG000|NOT COMPLETED|Overall Study||0
10037331|NCT01949870|11161894|FG000|STARTED|Overall Study||6
10037332|NCT01949870|11161894|FG000|Received Treatment|Overall Study||4
10037333|NCT01949870|11161894|FG000|COMPLETED|Overall Study||0
10037334|NCT01949870|11161894|FG000|NOT COMPLETED|Overall Study||6
10037335|NCT01950013|11161901|FG000|STARTED|Overall Study||15
10037336|NCT01950013|11161902|FG001|STARTED|Overall Study||15
10037337|NCT01950013|11161903|FG002|STARTED|Overall Study||15
10037338|NCT01950013|11161901|FG000|COMPLETED|Overall Study||15
10037339|NCT01950013|11161902|FG001|COMPLETED|Overall Study||13
10037340|NCT01950013|11161903|FG002|COMPLETED|Overall Study||15
10037341|NCT01950013|11161901|FG000|NOT COMPLETED|Overall Study||0
10037342|NCT01950013|11161902|FG001|NOT COMPLETED|Overall Study||2
10037343|NCT01950013|11161903|FG002|NOT COMPLETED|Overall Study||0
10037344|NCT01950039|11161913|FG000|STARTED|Overall Study||15
10037345|NCT01950039|11161914|FG001|STARTED|Overall Study||13
10037346|NCT01950039|11161913|FG000|Study Drug Initiated|Overall Study||14
10037347|NCT01950039|11161914|FG001|Study Drug Initiated|Overall Study||13
10037348|NCT01950039|11161913|FG000|Completed Clamp|Overall Study||13
10037349|NCT01950039|11161914|FG001|Completed Clamp|Overall Study||12
10037350|NCT01950039|11161913|FG000|Completed MRI|Overall Study||13
10037351|NCT01950039|11161914|FG001|Completed MRI|Overall Study||12
10037352|NCT01950039|11161913|FG000|Completed Endothelial Evaluation|Overall Study||14
10037353|NCT01950039|11161914|FG001|Completed Endothelial Evaluation|Overall Study||12
10037354|NCT01950039|11161913|FG000|COMPLETED|Overall Study||14
10037355|NCT01950039|11161914|FG001|COMPLETED|Overall Study||13
10037356|NCT01950039|11161913|FG000|NOT COMPLETED|Overall Study||1
10037357|NCT01950039|11161914|FG001|NOT COMPLETED|Overall Study||0
10037358|NCT01950078|11161922|FG000|STARTED|Overall Study||1025
10037359|NCT01950078|11161923|FG001|STARTED|Overall Study||508
10037360|NCT01950078|11161922|FG000|COMPLETED|Overall Study||1005
10037361|NCT01950078|11161923|FG001|COMPLETED|Overall Study||496
10037362|NCT01950078|11161922|FG000|NOT COMPLETED|Overall Study||20
10037363|NCT01950078|11161923|FG001|NOT COMPLETED|Overall Study||12
10037364|NCT01950169|11161932|FG000|STARTED|Overall Study||28
10037365|NCT01950169|11161933|FG001|STARTED|Overall Study||26
10037366|NCT01950169|11161934|FG002|STARTED|Overall Study||25
10037367|NCT01950169|11161932|FG000|COMPLETED|Overall Study||25
10037368|NCT01950169|11161933|FG001|COMPLETED|Overall Study||18
10037369|NCT01950169|11161934|FG002|COMPLETED|Overall Study||24
10037370|NCT01950169|11161932|FG000|NOT COMPLETED|Overall Study||3
10037371|NCT01950169|11161933|FG001|NOT COMPLETED|Overall Study||8
10037372|NCT01950169|11161934|FG002|NOT COMPLETED|Overall Study||1
10037373|NCT01950260|11161945|FG000|STARTED|Overall Study||30
10037374|NCT01950260|11161946|FG001|STARTED|Overall Study||31
10037375|NCT01950260|11161945|FG000|COMPLETED|Overall Study||30
10037376|NCT01950260|11161946|FG001|COMPLETED|Overall Study||31
10037377|NCT01950260|11161945|FG000|NOT COMPLETED|Overall Study||0
10037378|NCT01950260|11161946|FG001|NOT COMPLETED|Overall Study||0
10037379|NCT01950273|11161954|FG000|STARTED|Overall Study||49
10037380|NCT01950273|11161955|FG001|STARTED|Overall Study||46
10037381|NCT01950273|11161954|FG000|COMPLETED|Overall Study||45
10037382|NCT01950273|11161955|FG001|COMPLETED|Overall Study||46
10037383|NCT01950273|11161954|FG000|NOT COMPLETED|Overall Study||4
10037384|NCT01950273|11161955|FG001|NOT COMPLETED|Overall Study||0
10037385|NCT01950299|11161964|FG000|STARTED|Overall Study||33
10037386|NCT01950299|11161965|FG001|STARTED|Overall Study||31
10037387|NCT01950299|11161966|FG002|STARTED|Overall Study||35
10037388|NCT01950299|11161964|FG000|COMPLETED|Overall Study||22
10116051|NCT02530476|11246845|FG002|COMPLETED|Overall Study||7
10116052|NCT02530476|11246846|FG003|COMPLETED|Overall Study||3
10116053|NCT02530476|11246843|FG000|NOT COMPLETED|Overall Study||0
10037389|NCT01950299|11161965|FG001|COMPLETED|Overall Study||27
10037390|NCT01950299|11161966|FG002|COMPLETED|Overall Study||28
10037391|NCT01950299|11161964|FG000|NOT COMPLETED|Overall Study||11
10037392|NCT01950299|11161965|FG001|NOT COMPLETED|Overall Study||4
10037393|NCT01950299|11161966|FG002|NOT COMPLETED|Overall Study||7
10037394|NCT01950364|11161976|FG000|STARTED|Overall Study||10
10037395|NCT01950364|11161977|FG001|STARTED|Overall Study||10
10037396|NCT01950364|11161976|FG000|COMPLETED|Overall Study||0
10037397|NCT01950364|11161977|FG001|COMPLETED|Overall Study||0
10037398|NCT01950364|11161976|FG000|NOT COMPLETED|Overall Study||10
10037399|NCT01950364|11161977|FG001|NOT COMPLETED|Overall Study||10
10037400|NCT01950663|11161983|FG000|STARTED|Overall Study||468
10037401|NCT01950663|11161983|FG000|COMPLETED|Overall Study||467
10037402|NCT01950663|11161983|FG000|NOT COMPLETED|Overall Study||1
10037403|NCT01950741|11161987|FG000|STARTED|Overall Study||48
10037404|NCT01950741|11161987|FG000|COMPLETED|Overall Study||45
10037405|NCT01950741|11161987|FG000|NOT COMPLETED|Overall Study||3
10081814|NCT02264639|11210336|FG000|NOT COMPLETED|Overall Study||2
10081815|NCT02264639|11210337|FG001|NOT COMPLETED|Overall Study||0
10081816|NCT02264639|11210338|FG002|NOT COMPLETED|Overall Study||1
10081817|NCT02264639|11210339|FG003|NOT COMPLETED|Overall Study||0
10081818|NCT02264639|11210340|FG004|NOT COMPLETED|Overall Study||1
10081819|NCT02264821|11210358|FG000|STARTED|Overall Study|Double Blind|64
10081820|NCT02264821|11210359|FG001|STARTED|Overall Study|Double Blind|64
10081821|NCT02264821|11210360|FG002|STARTED|Overall Study|Double Blind|64
10081822|NCT02264821|11210358|FG000|COMPLETED|Overall Study||63
10081823|NCT02264821|11210359|FG001|COMPLETED|Overall Study||61
10081824|NCT02264821|11210360|FG002|COMPLETED|Overall Study||58
10081825|NCT02264821|11210358|FG000|NOT COMPLETED|Overall Study||1
10081826|NCT02264821|11210359|FG001|NOT COMPLETED|Overall Study||3
10081827|NCT02264821|11210360|FG002|NOT COMPLETED|Overall Study||6
10081828|NCT02264990|11210370|FG000|STARTED|Overall Study||297
10081829|NCT02264990|11210371|FG001|STARTED|Overall Study||298
10081830|NCT02264990|11210370|FG000|Received Treatment|Overall Study||288
10081831|NCT02264990|11210371|FG001|Received Treatment|Overall Study||293
10081832|NCT02264990|11210370|FG000|Received Maintenance Therapy|Overall Study||148
10081833|NCT02264990|11210371|FG001|Received Maintenance Therapy|Overall Study||123
10081834|NCT02264990|11210370|FG000|COMPLETED|Overall Study||37
10081835|NCT02264990|11210371|FG001|COMPLETED|Overall Study||39
10081836|NCT02264990|11210370|FG000|NOT COMPLETED|Overall Study||260
10081837|NCT02264990|11210371|FG001|NOT COMPLETED|Overall Study||259
10081838|NCT02265224|11210378|FG000|STARTED|Overall Study||48
10081839|NCT02265224|11210378|FG000|COMPLETED|Overall Study||48
10081840|NCT02265224|11210378|FG000|NOT COMPLETED|Overall Study||0
10081841|NCT02265237|11210389|FG000|STARTED|As Enrolled (Overall Study)||59
10081842|NCT02265237|11210390|FG001|STARTED|As Enrolled (Overall Study)||61
10081843|NCT02265237|11210391|FG002|STARTED|As Enrolled (Overall Study)||61
10081844|NCT02265237|11210392|FG003|STARTED|As Enrolled (Overall Study)||3
10081845|NCT02265237|11210389|FG000|COMPLETED|As Enrolled (Overall Study)||54
10081846|NCT02265237|11210390|FG001|COMPLETED|As Enrolled (Overall Study)||58
10081847|NCT02265237|11210391|FG002|COMPLETED|As Enrolled (Overall Study)||51
10081848|NCT02265237|11210392|FG003|COMPLETED|As Enrolled (Overall Study)||2
10081849|NCT02265237|11210389|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5
10081850|NCT02265237|11210390|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3
10081851|NCT02265237|11210391|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10
10081852|NCT02265237|11210392|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1
10081853|NCT02265237|11210389|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
10081854|NCT02265237|11210390|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
10081855|NCT02265237|11210391|FG002|STARTED|As Treated (Overall Study)||61
10081856|NCT02265237|11210392|FG003|STARTED|As Treated (Overall Study)||3
10081857|NCT02265237|11210389|FG000|COMPLETED|As Treated (Overall Study)||55
10081858|NCT02265237|11210390|FG001|COMPLETED|As Treated (Overall Study)||57
10081859|NCT02265237|11210391|FG002|COMPLETED|As Treated (Overall Study)||51
10081860|NCT02265237|11210392|FG003|COMPLETED|As Treated (Overall Study)||2
10081861|NCT02265237|11210389|FG000|NOT COMPLETED|As Treated (Overall Study)||5
10081862|NCT02265237|11210390|FG001|NOT COMPLETED|As Treated (Overall Study)||3
10081863|NCT02265237|11210391|FG002|NOT COMPLETED|As Treated (Overall Study)||10
10081864|NCT02265237|11210392|FG003|NOT COMPLETED|As Treated (Overall Study)||1
10081865|NCT02265341|11210403|FG000|STARTED|Overall Study||12
10081866|NCT02265341|11210403|FG000|COMPLETED|Overall Study||12
10081867|NCT02265341|11210403|FG000|NOT COMPLETED|Overall Study||0
10116054|NCT02530476|11246844|FG001|NOT COMPLETED|Overall Study||0
10116055|NCT02530476|11246845|FG002|NOT COMPLETED|Overall Study||0
10116056|NCT02530476|11246846|FG003|NOT COMPLETED|Overall Study||0
10116057|NCT02530515|11246859|FG000|STARTED|Overall Study||0
10116058|NCT02530515|11246860|FG001|STARTED|Overall Study||0
10116059|NCT02530515|11246861|FG002|STARTED|Overall Study||8
10116060|NCT02530515|11246859|FG000|COMPLETED|Overall Study||0
10116061|NCT02530515|11246860|FG001|COMPLETED|Overall Study||0
10116062|NCT02530515|11246861|FG002|COMPLETED|Overall Study||8
10116063|NCT02530515|11246859|FG000|NOT COMPLETED|Overall Study||0
10116064|NCT02530515|11246860|FG001|NOT COMPLETED|Overall Study||0
10116065|NCT02530515|11246861|FG002|NOT COMPLETED|Overall Study||0
10116066|NCT02530528|11246869|FG000|STARTED|Overall Study||13
10116067|NCT02530528|11246870|FG001|STARTED|Overall Study||13
10116068|NCT02530528|11246871|FG002|STARTED|Overall Study||14
10116069|NCT02530528|11246872|FG003|STARTED|Overall Study||14
10116070|NCT02530528|11246873|FG004|STARTED|Overall Study||13
10116071|NCT02530528|11246874|FG005|STARTED|Overall Study||13
10116072|NCT02530528|11246875|FG006|STARTED|Overall Study||14
10116073|NCT02530528|11246876|FG007|STARTED|Overall Study||14
10116074|NCT02530528|11246869|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12
10116075|NCT02530528|11246870|FG001|COMPLETED|Overall Study||12
10116076|NCT02530528|11246871|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12
10116077|NCT02530528|11246872|FG003|COMPLETED|Overall Study||12
10037406|NCT01950780|11161991|FG000|STARTED|Overall Study||12
10037407|NCT01950780|11161991|FG000|COMPLETED|Overall Study||12
10037408|NCT01950780|11161991|FG000|NOT COMPLETED|Overall Study||0
10037409|NCT01950819|11161998|FG000|STARTED|Overall Study||1022
10037410|NCT01950819|11161999|FG001|STARTED|Overall Study||1015
10037411|NCT01950819|11161998|FG000|COMPLETED|Overall Study||893
10037412|NCT01950819|11161999|FG001|COMPLETED|Overall Study||881
10037413|NCT01950819|11161998|FG000|NOT COMPLETED|Overall Study||129
10037414|NCT01950819|11161999|FG001|NOT COMPLETED|Overall Study||134
10037415|NCT01951066|11162005|FG000|STARTED|First Intervention (Baseline to Week 16)||10
10037416|NCT01951066|11162006|FG001|STARTED|First Intervention (Baseline to Week 16)||10
10037417|NCT01951066|11162005|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10
10037418|NCT01951066|11162006|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10
10037419|NCT01951066|11162005|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
10037420|NCT01951066|11162006|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
10037421|NCT01951066|11162005|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10
10037422|NCT01951066|11162006|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10
10037423|NCT01951066|11162005|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10
10037424|NCT01951066|11162006|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10
10037425|NCT01951066|11162005|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
10037426|NCT01951066|11162006|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
10037427|NCT01951092|11162011|FG000|STARTED|Overall Study||32
10037428|NCT01951092|11162011|FG000|COMPLETED|Overall Study||20
10037429|NCT01951092|11162011|FG000|NOT COMPLETED|Overall Study||12
10037430|NCT01951105|11162018|FG000|STARTED|Overall Study||11
10037431|NCT01951105|11162019|FG001|STARTED|Overall Study||31
10037432|NCT01951105|11162020|FG002|STARTED|Overall Study||30
10037433|NCT01951105|11162018|FG000|Completed 12 Weeks Treatment|Overall Study||10
10037434|NCT01951105|11162019|FG001|Completed 12 Weeks Treatment|Overall Study||24
10037435|NCT01951105|11162020|FG002|Completed 12 Weeks Treatment|Overall Study||28
10037436|NCT01951105|11162018|FG000|COMPLETED|Overall Study||10
10037437|NCT01951105|11162019|FG001|COMPLETED|Overall Study||21
10037438|NCT01951105|11162020|FG002|COMPLETED|Overall Study||28
10037439|NCT01951105|11162018|FG000|NOT COMPLETED|Overall Study||1
10037440|NCT01951105|11162019|FG001|NOT COMPLETED|Overall Study||10
10037441|NCT01951105|11162020|FG002|NOT COMPLETED|Overall Study||2
10037442|NCT01951118|11162034|FG000|STARTED|Overall Study||121
10037443|NCT01951118|11162034|FG000|COMPLETED|Overall Study||94
10037444|NCT01951118|11162034|FG000|NOT COMPLETED|Overall Study||27
10037445|NCT01951157|11162046|FG000|STARTED|Overall Study||22
10037446|NCT01951157|11162047|FG001|STARTED|Overall Study||22
10037447|NCT01951157|11162048|FG002|STARTED|Overall Study||25
10037448|NCT01951157|11162046|FG000|COMPLETED|Overall Study||0
10037449|NCT01951157|11162047|FG001|COMPLETED|Overall Study||0
10037450|NCT01951157|11162048|FG002|COMPLETED|Overall Study||0
10037451|NCT01951157|11162046|FG000|NOT COMPLETED|Overall Study||22
10037452|NCT01951157|11162047|FG001|NOT COMPLETED|Overall Study||22
10037453|NCT01951157|11162048|FG002|NOT COMPLETED|Overall Study||25
10037454|NCT01951170|11162057|FG000|STARTED|Overall Study||52
10037455|NCT01951170|11162057|FG000|COMPLETED|Overall Study||51
10037456|NCT01951170|11162057|FG000|NOT COMPLETED|Overall Study||1
10037457|NCT01951261|11162063|FG000|STARTED|Overall Study||58
10037458|NCT01951261|11162064|FG001|STARTED|Overall Study||58
10037459|NCT01951261|11162063|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9
10037460|NCT01951261|11162064|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6
10037461|NCT01951261|11162063|FG000|COMPLETED|Overall Study||49
10037462|NCT01951261|11162064|FG001|COMPLETED|Overall Study||52
10037463|NCT01951261|11162063|FG000|NOT COMPLETED|Overall Study||9
10037464|NCT01951261|11162064|FG001|NOT COMPLETED|Overall Study||6
10037465|NCT01951326|11162072|FG000|STARTED|Overall Study||166
10037466|NCT01951326|11162073|FG001|STARTED|Overall Study||165
10037467|NCT01951326|11162072|FG000|COMPLETED|Overall Study||87
10037468|NCT01951326|11162073|FG001|COMPLETED|Overall Study||87
10037469|NCT01951326|11162072|FG000|NOT COMPLETED|Overall Study||79
10037470|NCT01951326|11162073|FG001|NOT COMPLETED|Overall Study||78
10037471|NCT01951339|11162082|FG000|STARTED|Overall Study||15
10037472|NCT01951339|11162083|FG001|STARTED|Overall Study||15
10116078|NCT02530528|11246873|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12
10116079|NCT02530528|11246874|FG005|COMPLETED|Overall Study||12
10116080|NCT02530528|11246875|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12
10116081|NCT02530528|11246876|FG007|COMPLETED|Overall Study||12
10116082|NCT02530528|11246869|FG000|NOT COMPLETED|Overall Study||1
10116083|NCT02530528|11246870|FG001|NOT COMPLETED|Overall Study||1
10037473|NCT01951339|11162082|FG000|COMPLETED|Overall Study||13
10037474|NCT01951339|11162083|FG001|COMPLETED|Overall Study||14
10037475|NCT01951339|11162082|FG000|NOT COMPLETED|Overall Study||2
10037476|NCT01951339|11162083|FG001|NOT COMPLETED|Overall Study||1
10037477|NCT01951352|11162089|FG000|STARTED|Overall Study||10
10037478|NCT01951352|11162089|FG000|COMPLETED|Overall Study||10
10037479|NCT01951352|11162089|FG000|NOT COMPLETED|Overall Study||0
10037480|NCT01951391|11162095|FG000|STARTED|Overall Study||5
10037481|NCT01951391|11162096|FG001|STARTED|Overall Study||5
10037482|NCT01951391|11162095|FG000|COMPLETED|Overall Study||5
10037483|NCT01951391|11162096|FG001|COMPLETED|Overall Study||5
10037484|NCT01951391|11162095|FG000|NOT COMPLETED|Overall Study||0
10037485|NCT01951391|11162096|FG001|NOT COMPLETED|Overall Study||0
10037486|NCT01951417|11162104|FG000|STARTED|Overall Study||81
10037487|NCT01951417|11162104|FG000|COMPLETED|Overall Study||72
10037488|NCT01951417|11162104|FG000|NOT COMPLETED|Overall Study||9
10037489|NCT01951573|11162112|FG000|STARTED|Period 1, First 9 Hours of Wear||17
10037490|NCT01951573|11162113|FG001|STARTED|Period 1, First 9 Hours of Wear||17
10037491|NCT01951573|11162112|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17
10037492|NCT01951573|11162113|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17
10037493|NCT01951573|11162112|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
10037494|NCT01951573|11162113|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
10037495|NCT01951573|11162112|FG000|STARTED|Washout Period||17
10037496|NCT01951573|11162113|FG001|STARTED|Washout Period||17
10037497|NCT01951573|11162112|FG000|COMPLETED|Washout Period||17
10037498|NCT01951573|11162113|FG001|COMPLETED|Washout Period||16
10037499|NCT01951573|11162112|FG000|NOT COMPLETED|Washout Period||0
10037500|NCT01951573|11162113|FG001|NOT COMPLETED|Washout Period||1
10037501|NCT01951573|11162112|FG000|STARTED|Period 2, Second 9 Hours of Wear||17
10037502|NCT01951573|11162113|FG001|STARTED|Period 2, Second 9 Hours of Wear||16
10037503|NCT01951573|11162112|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17
10037504|NCT01951573|11162113|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16
10037505|NCT01951573|11162112|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
10037506|NCT01951573|11162113|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
10037507|NCT01951586|11162121|FG000|STARTED|Overall Study||78
10037508|NCT01951586|11162122|FG001|STARTED|Overall Study||148
10037509|NCT01951586|11162121|FG000|Received Study Drug|Overall Study||76
10037510|NCT01951586|11162122|FG001|Received Study Drug|Overall Study||145
10037511|NCT01951586|11162121|FG000|COMPLETED|Overall Study||0
10037512|NCT01951586|11162122|FG001|COMPLETED|Overall Study||0
10037513|NCT01951586|11162121|FG000|NOT COMPLETED|Overall Study||78
10037514|NCT01951586|11162122|FG001|NOT COMPLETED|Overall Study||148
10037515|NCT01951625|11162134|FG000|STARTED|Treatment Period||92
10037516|NCT01951625|11162135|FG001|STARTED|Treatment Period||91
10037517|NCT01951625|11162136|FG002|STARTED|Treatment Period||91
10037518|NCT01951625|11162137|FG003|STARTED|Treatment Period||91
10037519|NCT01951625|11162138|FG004|STARTED|Treatment Period||91
10037520|NCT01951625|11162134|FG000|COMPLETED|Treatment Period||73
10037521|NCT01951625|11162135|FG001|COMPLETED|Treatment Period||70
10037522|NCT01951625|11162136|FG002|COMPLETED|Treatment Period||76
10037523|NCT01951625|11162137|FG003|COMPLETED|Treatment Period||69
10037524|NCT01951625|11162138|FG004|COMPLETED|Treatment Period||74
10037525|NCT01951625|11162134|FG000|NOT COMPLETED|Treatment Period||19
10037526|NCT01951625|11162135|FG001|NOT COMPLETED|Treatment Period||21
10037527|NCT01951625|11162136|FG002|NOT COMPLETED|Treatment Period||15
10037528|NCT01951625|11162137|FG003|NOT COMPLETED|Treatment Period||22
10037529|NCT01951625|11162138|FG004|NOT COMPLETED|Treatment Period||17
10037530|NCT01951625|11162134|FG000|STARTED|Follow Up Period||87
10037531|NCT01951625|11162135|FG001|STARTED|Follow Up Period||88
10037532|NCT01951625|11162136|FG002|STARTED|Follow Up Period||88
10037533|NCT01951625|11162137|FG003|STARTED|Follow Up Period||87
10037534|NCT01951625|11162138|FG004|STARTED|Follow Up Period||88
10037535|NCT01951625|11162134|FG000|COMPLETED|Follow Up Period||79
10037536|NCT01951625|11162135|FG001|COMPLETED|Follow Up Period||79
10037537|NCT01951625|11162136|FG002|COMPLETED|Follow Up Period||84
10037538|NCT01951625|11162137|FG003|COMPLETED|Follow Up Period||76
10037539|NCT01951625|11162138|FG004|COMPLETED|Follow Up Period||78
10037540|NCT01951625|11162134|FG000|NOT COMPLETED|Follow Up Period||8
10037541|NCT01951625|11162135|FG001|NOT COMPLETED|Follow Up Period||9
10037542|NCT01951625|11162136|FG002|NOT COMPLETED|Follow Up Period||4
10037543|NCT01951625|11162137|FG003|NOT COMPLETED|Follow Up Period||11
10037544|NCT01951625|11162138|FG004|NOT COMPLETED|Follow Up Period||10
10037545|NCT01951638|11162156|FG000|STARTED|Treatment Period||93
10037546|NCT01951638|11162157|FG001|STARTED|Treatment Period||96
10037547|NCT01951638|11162158|FG002|STARTED|Treatment Period||96
10037548|NCT01951638|11162159|FG003|STARTED|Treatment Period||96
10037549|NCT01951638|11162160|FG004|STARTED|Treatment Period||96
10037550|NCT01951638|11162156|FG000|COMPLETED|Treatment Period||80
10037551|NCT01951638|11162157|FG001|COMPLETED|Treatment Period||82
10037552|NCT01951638|11162158|FG002|COMPLETED|Treatment Period||83
10037553|NCT01951638|11162159|FG003|COMPLETED|Treatment Period||80
10037554|NCT01951638|11162160|FG004|COMPLETED|Treatment Period||86
10037555|NCT01951638|11162156|FG000|NOT COMPLETED|Treatment Period||13
10037556|NCT01951638|11162157|FG001|NOT COMPLETED|Treatment Period||14
10037557|NCT01951638|11162158|FG002|NOT COMPLETED|Treatment Period||13
10037558|NCT01951638|11162159|FG003|NOT COMPLETED|Treatment Period||16
10037559|NCT01951638|11162160|FG004|NOT COMPLETED|Treatment Period||10
10037560|NCT01951638|11162156|FG000|STARTED|Follow-up Period||89
10037561|NCT01951638|11162157|FG001|STARTED|Follow-up Period||95
10037562|NCT01951638|11162158|FG002|STARTED|Follow-up Period||95
10037563|NCT01951638|11162159|FG003|STARTED|Follow-up Period||88
10037564|NCT01951638|11162160|FG004|STARTED|Follow-up Period||94
10037565|NCT01951638|11162156|FG000|COMPLETED|Follow-up Period||87
10037566|NCT01951638|11162157|FG001|COMPLETED|Follow-up Period||86
10037567|NCT01951638|11162158|FG002|COMPLETED|Follow-up Period||90
10037568|NCT01951638|11162159|FG003|COMPLETED|Follow-up Period||80
10037569|NCT01951638|11162160|FG004|COMPLETED|Follow-up Period||89
10037570|NCT01951638|11162156|FG000|NOT COMPLETED|Follow-up Period||2
10037571|NCT01951638|11162157|FG001|NOT COMPLETED|Follow-up Period||9
10037572|NCT01951638|11162158|FG002|NOT COMPLETED|Follow-up Period||5
10037573|NCT01951638|11162159|FG003|NOT COMPLETED|Follow-up Period||8
10037574|NCT01951638|11162160|FG004|NOT COMPLETED|Follow-up Period||5
10037575|NCT01951651|11162174|FG000|STARTED|Overall Study||12
10037576|NCT01951651|11162175|FG001|STARTED|Overall Study||12
10037577|NCT01951651|11162174|FG000|COMPLETED|Overall Study||8
10037578|NCT01951651|11162175|FG001|COMPLETED|Overall Study||10
10037579|NCT01951651|11162174|FG000|NOT COMPLETED|Overall Study||4
10037580|NCT01951651|11162175|FG001|NOT COMPLETED|Overall Study||2
10037581|NCT01951703|11162183|FG000|STARTED|First Intervention||64
10037582|NCT01951703|11162184|FG001|STARTED|First Intervention||63
10037583|NCT01951703|11162183|FG000|COMPLETED|First Intervention||61
10037584|NCT01951703|11162184|FG001|COMPLETED|First Intervention||62
10037585|NCT01951703|11162183|FG000|NOT COMPLETED|First Intervention||3
10037586|NCT01951703|11162184|FG001|NOT COMPLETED|First Intervention||1
10037587|NCT01951703|11162183|FG000|STARTED|Second Intervention||61
10037588|NCT01951703|11162184|FG001|STARTED|Second Intervention||62
10037589|NCT01951703|11162183|FG000|COMPLETED|Second Intervention||61
10037590|NCT01951703|11162184|FG001|COMPLETED|Second Intervention||60
10037591|NCT01951703|11162183|FG000|NOT COMPLETED|Second Intervention||0
10037592|NCT01951703|11162184|FG001|NOT COMPLETED|Second Intervention||2
10037593|NCT01951768|11162193|FG000|STARTED|Overall Study||43
10037594|NCT01951768|11162194|FG001|STARTED|Overall Study||45
10037595|NCT01951768|11162193|FG000|COMPLETED|Overall Study|43 patients|43
10037596|NCT01951768|11162194|FG001|COMPLETED|Overall Study|45 patients|45
10037597|NCT01951768|11162193|FG000|NOT COMPLETED|Overall Study||0
10037598|NCT01951768|11162194|FG001|NOT COMPLETED|Overall Study||0
10037599|NCT01951820|11162202|FG000|STARTED|Overall Study||34
10037600|NCT01951820|11162203|FG001|STARTED|Overall Study||30
10037601|NCT01951820|11162202|FG000|COMPLETED|Overall Study||34
10037602|NCT01951820|11162203|FG001|COMPLETED|Overall Study||30
10037603|NCT01951820|11162202|FG000|NOT COMPLETED|Overall Study||0
10037604|NCT01951820|11162203|FG001|NOT COMPLETED|Overall Study||0
10037605|NCT01951950|11162211|FG000|STARTED|Overall Study||26
10037606|NCT01951950|11162212|FG001|STARTED|Overall Study||26
10037607|NCT01951950|11162211|FG000|COMPLETED|Overall Study||20
10037608|NCT01951950|11162212|FG001|COMPLETED|Overall Study||20
10037609|NCT01951950|11162211|FG000|NOT COMPLETED|Overall Study||6
10037610|NCT01951950|11162212|FG001|NOT COMPLETED|Overall Study||6
10037611|NCT01951963|11162220|FG000|STARTED|Overall Study||31
10037612|NCT01951963|11162221|FG001|STARTED|Overall Study||32
10037613|NCT01951963|11162220|FG000|COMPLETED|Overall Study||31
10037614|NCT01951963|11162221|FG001|COMPLETED|Overall Study||32
10037615|NCT01951963|11162220|FG000|NOT COMPLETED|Overall Study||0
10037616|NCT01951963|11162221|FG001|NOT COMPLETED|Overall Study||0
10037617|NCT01952015|11162231|FG000|STARTED|Induction||12
10037618|NCT01952015|11162231|FG000|COMPLETED|Induction||11
10116084|NCT02530528|11246871|FG002|NOT COMPLETED|Overall Study||2
10116085|NCT02530528|11246872|FG003|NOT COMPLETED|Overall Study||2
10116086|NCT02530528|11246873|FG004|NOT COMPLETED|Overall Study||1
10116087|NCT02530528|11246874|FG005|NOT COMPLETED|Overall Study||1
10116088|NCT02530528|11246875|FG006|NOT COMPLETED|Overall Study||2
10116089|NCT02530528|11246876|FG007|NOT COMPLETED|Overall Study||2
10116090|NCT02530541|11246890|FG000|STARTED|Overall Study||21
10116091|NCT02530541|11246891|FG001|STARTED|Overall Study||23
10116092|NCT02530541|11246892|FG002|STARTED|Overall Study||22
10116093|NCT02530541|11246893|FG003|STARTED|Overall Study||21
10116094|NCT02530541|11246894|FG004|STARTED|Overall Study||20
10116095|NCT02530541|11246895|FG005|STARTED|Overall Study||19
10116096|NCT02530541|11246890|FG000|COMPLETED|Overall Study||14
10116097|NCT02530541|11246891|FG001|COMPLETED|Overall Study||15
10116098|NCT02530541|11246892|FG002|COMPLETED|Overall Study||14
10116099|NCT02530541|11246893|FG003|COMPLETED|Overall Study||15
10116100|NCT02530541|11246894|FG004|COMPLETED|Overall Study||15
10116101|NCT02530541|11246895|FG005|COMPLETED|Overall Study||14
10116102|NCT02530541|11246890|FG000|NOT COMPLETED|Overall Study||7
10116103|NCT02530541|11246891|FG001|NOT COMPLETED|Overall Study||8
10116104|NCT02530541|11246892|FG002|NOT COMPLETED|Overall Study||8
10116105|NCT02530541|11246893|FG003|NOT COMPLETED|Overall Study||6
10116106|NCT02530541|11246894|FG004|NOT COMPLETED|Overall Study||5
10116107|NCT02530541|11246895|FG005|NOT COMPLETED|Overall Study||5
10116108|NCT02530554|11246904|FG000|STARTED|Overall Study||12
10116109|NCT02530554|11246905|FG001|STARTED|Overall Study||14
10116110|NCT02530554|11246906|FG002|STARTED|Overall Study||12
10116111|NCT02530554|11246907|FG003|STARTED|Overall Study||14
10116112|NCT02530554|11246904|FG000|COMPLETED|Overall Study||12
10116113|NCT02530554|11246905|FG001|COMPLETED|Overall Study||14
10116114|NCT02530554|11246906|FG002|COMPLETED|Overall Study||12
10116115|NCT02530554|11246907|FG003|COMPLETED|Overall Study||14
10116116|NCT02530554|11246904|FG000|NOT COMPLETED|Overall Study||0
10116117|NCT02530554|11246905|FG001|NOT COMPLETED|Overall Study||0
10116118|NCT02530554|11246906|FG002|NOT COMPLETED|Overall Study||0
10116119|NCT02530554|11246907|FG003|NOT COMPLETED|Overall Study||0
10116120|NCT02530619|11246914|FG000|STARTED|Registered for Study||26
10037619|NCT01952015|11162231|FG000|NOT COMPLETED|Induction||1
10037620|NCT01952015|11162231|FG000|STARTED|Maintenance||11
10037621|NCT01952015|11162231|FG000|COMPLETED|Maintenance||9
10037622|NCT01952015|11162231|FG000|NOT COMPLETED|Maintenance||2
10037623|NCT01952015|11162231|FG000|STARTED|Treatment Period 3||9
10037624|NCT01952015|11162231|FG000|COMPLETED|Treatment Period 3||0
10037625|NCT01952015|11162231|FG000|NOT COMPLETED|Treatment Period 3||9
10116121|NCT02530619|11246914|FG000|Registered|Registered for Study||26
10116122|NCT02530619|11246914|FG000|Received 1st Dose of Alisertib|Registered for Study||24
10116123|NCT02530619|11246914|FG000|COMPLETED|Registered for Study||24
10116124|NCT02530619|11246914|FG000|NOT COMPLETED|Registered for Study||2
10037626|NCT01952041|11162249|FG000|STARTED|Overall Study||62
10037627|NCT01952041|11162250|FG001|STARTED|Overall Study||64
10037628|NCT01952041|11162249|FG000|COMPLETED|Overall Study||45
10037629|NCT01952041|11162250|FG001|COMPLETED|Overall Study||43
10037630|NCT01952041|11162249|FG000|NOT COMPLETED|Overall Study||17
10037631|NCT01952041|11162250|FG001|NOT COMPLETED|Overall Study||21
10037632|NCT01952054|11162256|FG000|STARTED|Overall Study||6
10037633|NCT01952054|11162256|FG000|COMPLETED|Overall Study||5
10037634|NCT01952054|11162256|FG000|NOT COMPLETED|Overall Study||1
10037635|NCT01952080|11162264|FG000|STARTED|Overall Study||5
10037636|NCT01952080|11162265|FG001|STARTED|Overall Study||8
10037637|NCT01952080|11162266|FG002|STARTED|Overall Study||14
10037638|NCT01952080|11162267|FG003|STARTED|Overall Study||15
10037639|NCT01952080|11162264|FG000|Treated|Overall Study||5
10037640|NCT01952080|11162265|FG001|Treated|Overall Study||8
10037641|NCT01952080|11162266|FG002|Treated|Overall Study||14
10037642|NCT01952080|11162267|FG003|Treated|Overall Study||15
10037643|NCT01952080|11162264|FG000|COMPLETED|Overall Study||5
10037644|NCT01952080|11162265|FG001|COMPLETED|Overall Study||7
10037645|NCT01952080|11162266|FG002|COMPLETED|Overall Study||14
10037646|NCT01952080|11162267|FG003|COMPLETED|Overall Study||14
10037647|NCT01952080|11162264|FG000|NOT COMPLETED|Overall Study||0
10037648|NCT01952080|11162265|FG001|NOT COMPLETED|Overall Study||1
10037649|NCT01952080|11162266|FG002|NOT COMPLETED|Overall Study||0
10037650|NCT01952080|11162267|FG003|NOT COMPLETED|Overall Study||1
10037651|NCT01952145|11162279|FG000|STARTED|Overall Study||278
10037652|NCT01952145|11162280|FG001|STARTED|Overall Study||279
10037653|NCT01952145|11162279|FG000|COMPLETED|Overall Study||250
10037654|NCT01952145|11162280|FG001|COMPLETED|Overall Study||265
10037655|NCT01952145|11162279|FG000|NOT COMPLETED|Overall Study||28
10037656|NCT01952145|11162280|FG001|NOT COMPLETED|Overall Study||14
10037657|NCT01952301|11162286|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
10037658|NCT01952301|11162286|FG000|COMPLETED|Overall Study||30
10037659|NCT01952301|11162286|FG000|NOT COMPLETED|Overall Study||0
10037660|NCT01952366|11162292|FG000|STARTED|Overall Study||169
10037661|NCT01952366|11162292|FG000|COMPLETED|Overall Study||138
10037662|NCT01952366|11162292|FG000|NOT COMPLETED|Overall Study||31
10037663|NCT01952418|11162301|FG000|STARTED|Overall Study||910
10037664|NCT01952418|11162302|FG001|STARTED|Overall Study||895
10037665|NCT01952418|11162301|FG000|COMPLETED|Overall Study||910
10037666|NCT01952418|11162302|FG001|COMPLETED|Overall Study||895
10037667|NCT01952418|11162301|FG000|NOT COMPLETED|Overall Study||0
10037668|NCT01952418|11162302|FG001|NOT COMPLETED|Overall Study||0
10037669|NCT01952444|11162310|FG000|STARTED|Overall Study||20
10037670|NCT01952444|11162311|FG001|STARTED|Overall Study||20
10037671|NCT01952444|11162310|FG000|COMPLETED|Overall Study||20
10037672|NCT01952444|11162311|FG001|COMPLETED|Overall Study||19
10037673|NCT01952444|11162310|FG000|NOT COMPLETED|Overall Study||0
10037674|NCT01952444|11162311|FG001|NOT COMPLETED|Overall Study||1
10037675|NCT01952470|11162324|FG000|STARTED|Overall Study||16
10037676|NCT01952470|11162325|FG001|STARTED|Overall Study||16
10037677|NCT01952470|11162324|FG000|ITT Analysis|Overall Study||16
10037678|NCT01952470|11162325|FG001|ITT Analysis|Overall Study||16
10037679|NCT01952470|11162324|FG000|Discontinued Intervention|Overall Study||2
10037680|NCT01952470|11162325|FG001|Discontinued Intervention|Overall Study||1
10037681|NCT01952470|11162324|FG000|Death|Overall Study||1
10037682|NCT01952470|11162325|FG001|Death|Overall Study||1
10037683|NCT01952470|11162324|FG000|Missing Baseline LCI 2% Data.|Overall Study||0
10037684|NCT01952470|11162325|FG001|Missing Baseline LCI 2% Data.|Overall Study||2
10037685|NCT01952470|11162324|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2
10037686|NCT01952470|11162325|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1
10037687|NCT01952470|11162324|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1
10037688|NCT01952470|11162325|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0
10037689|NCT01952470|11162324|FG000|COMPLETED|Overall Study||13
10037690|NCT01952470|11162325|FG001|COMPLETED|Overall Study||13
10037691|NCT01952470|11162324|FG000|NOT COMPLETED|Overall Study||3
10037692|NCT01952470|11162325|FG001|NOT COMPLETED|Overall Study||3
10037693|NCT01952600|11162334|FG000|STARTED|Overall Study||80
10037694|NCT01952600|11162335|FG001|STARTED|Overall Study||90
10037695|NCT01952600|11162336|FG002|STARTED|Overall Study||45
10037696|NCT01952600|11162334|FG000|COMPLETED|Overall Study||65
10037697|NCT01952600|11162335|FG001|COMPLETED|Overall Study||77
10037698|NCT01952600|11162336|FG002|COMPLETED|Overall Study||38
10037699|NCT01952600|11162334|FG000|NOT COMPLETED|Overall Study||15
10037700|NCT01952600|11162335|FG001|NOT COMPLETED|Overall Study||13
10037701|NCT01952600|11162336|FG002|NOT COMPLETED|Overall Study||7
10037702|NCT01952665|11162346|FG000|STARTED|Overall Study||37
10037703|NCT01952665|11162347|FG001|STARTED|Overall Study||26
10037704|NCT01952665|11162346|FG000|COMPLETED|Overall Study||31
10037705|NCT01952665|11162347|FG001|COMPLETED|Overall Study||20
10037706|NCT01952665|11162346|FG000|NOT COMPLETED|Overall Study||6
10037707|NCT01952665|11162347|FG001|NOT COMPLETED|Overall Study||6
10037708|NCT01952678|11162358|FG000|STARTED|Overall Study||102
10037709|NCT01952678|11162359|FG001|STARTED|Overall Study||102
10037710|NCT01952678|11162358|FG000|COMPLETED|Overall Study||102
10037711|NCT01952678|11162359|FG001|COMPLETED|Overall Study||102
10037712|NCT01952678|11162358|FG000|NOT COMPLETED|Overall Study||0
10037713|NCT01952678|11162359|FG001|NOT COMPLETED|Overall Study||0
10037714|NCT01952691|11162375|FG000|STARTED|Overall Study||22
10037715|NCT01952691|11162375|FG000|COMPLETED|Overall Study||20
10037716|NCT01952691|11162375|FG000|NOT COMPLETED|Overall Study||2
10037717|NCT01952834|11162379|FG000|STARTED|Overall Study||21
10037718|NCT01952834|11162379|FG000|COMPLETED|Overall Study||20
10037719|NCT01952834|11162379|FG000|NOT COMPLETED|Overall Study||1
10037720|NCT01953003|11162386|FG000|STARTED|Overall Study||56
10037721|NCT01953003|11162387|FG001|STARTED|Overall Study||56
10037722|NCT01953003|11162386|FG000|COMPLETED|Overall Study||0
10037723|NCT01953003|11162387|FG001|COMPLETED|Overall Study||1
10037724|NCT01953003|11162386|FG000|NOT COMPLETED|Overall Study||56
10037725|NCT01953003|11162387|FG001|NOT COMPLETED|Overall Study||55
10037726|NCT01953081|11162395|FG000|STARTED|Overall Study||7
10037727|NCT01953081|11162396|FG001|STARTED|Overall Study||6
10037728|NCT01953081|11162395|FG000|COMPLETED|Overall Study||5
10037729|NCT01953081|11162396|FG001|COMPLETED|Overall Study||3
10037730|NCT01953081|11162395|FG000|NOT COMPLETED|Overall Study||2
10037731|NCT01953081|11162396|FG001|NOT COMPLETED|Overall Study||3
10037732|NCT01953211|11162402|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64
10037733|NCT01953211|11162402|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64
10037734|NCT01953211|11162402|FG000|NOT COMPLETED|Overall Study||0
10037735|NCT01953224|11162410|FG000|STARTED|Overall Study||20
10037736|NCT01953224|11162411|FG001|STARTED|Overall Study||20
10037737|NCT01953224|11162410|FG000|COMPLETED|Overall Study||18
10037738|NCT01953224|11162411|FG001|COMPLETED|Overall Study||17
10037739|NCT01953224|11162410|FG000|NOT COMPLETED|Overall Study||2
10037740|NCT01953224|11162411|FG001|NOT COMPLETED|Overall Study||3
10037741|NCT01953237|11162419|FG000|STARTED|Overall Study||10
10037742|NCT01953237|11162420|FG001|STARTED|Overall Study||21
10037743|NCT01953237|11162419|FG000|COMPLETED|Overall Study||10
10037744|NCT01953237|11162420|FG001|COMPLETED|Overall Study||21
10037745|NCT01953237|11162419|FG000|NOT COMPLETED|Overall Study||0
10037746|NCT01953237|11162420|FG001|NOT COMPLETED|Overall Study||0
10037747|NCT01953328|11162434|FG000|STARTED|Overall Study||49
10037748|NCT01953328|11162435|FG001|STARTED|Overall Study||50
10037749|NCT01953328|11162436|FG002|STARTED|Overall Study||50
10037750|NCT01953328|11162437|FG003|STARTED|Overall Study||50
10037751|NCT01953328|11162438|FG004|STARTED|Overall Study||52
10037752|NCT01953328|11162439|FG005|STARTED|Overall Study||51
10037753|NCT01953328|11162440|FG006|STARTED|Overall Study||51
10037754|NCT01953328|11162441|FG007|STARTED|Overall Study||51
10037755|NCT01953328|11162434|FG000|Received Treatment|Overall Study||49
10037756|NCT01953328|11162435|FG001|Received Treatment|Overall Study||50
10037757|NCT01953328|11162436|FG002|Received Treatment|Overall Study||50
10037758|NCT01953328|11162437|FG003|Received Treatment|Overall Study||50
10037759|NCT01953328|11162438|FG004|Received Treatment|Overall Study||52
10037760|NCT01953328|11162439|FG005|Received Treatment|Overall Study||51
10037761|NCT01953328|11162440|FG006|Received Treatment|Overall Study||51
10037762|NCT01953328|11162441|FG007|Received Treatment|Overall Study||51
10037763|NCT01953328|11162434|FG000|COMPLETED|Overall Study||49
10037764|NCT01953328|11162435|FG001|COMPLETED|Overall Study||50
10037765|NCT01953328|11162436|FG002|COMPLETED|Overall Study||50
10037766|NCT01953328|11162437|FG003|COMPLETED|Overall Study||50
10037767|NCT01953328|11162438|FG004|COMPLETED|Overall Study||50
10037768|NCT01953328|11162439|FG005|COMPLETED|Overall Study||51
10037769|NCT01953328|11162440|FG006|COMPLETED|Overall Study||51
10037770|NCT01953328|11162441|FG007|COMPLETED|Overall Study||51
10037771|NCT01953328|11162434|FG000|NOT COMPLETED|Overall Study||0
10037772|NCT01953328|11162435|FG001|NOT COMPLETED|Overall Study||0
10037773|NCT01953328|11162436|FG002|NOT COMPLETED|Overall Study||0
10037774|NCT01953328|11162437|FG003|NOT COMPLETED|Overall Study||0
10037775|NCT01953328|11162438|FG004|NOT COMPLETED|Overall Study||2
10037776|NCT01953328|11162439|FG005|NOT COMPLETED|Overall Study||0
10037777|NCT01953328|11162440|FG006|NOT COMPLETED|Overall Study||0
10037778|NCT01953328|11162441|FG007|NOT COMPLETED|Overall Study||0
10037779|NCT01953354|11162461|FG000|STARTED|Overall Study||9
10037780|NCT01953354|11162462|FG001|STARTED|Overall Study||7
10037781|NCT01953354|11162461|FG000|COMPLETED|Overall Study||8
10037782|NCT01953354|11162462|FG001|COMPLETED|Overall Study||5
10037783|NCT01953354|11162461|FG000|NOT COMPLETED|Overall Study||1
10037784|NCT01953354|11162462|FG001|NOT COMPLETED|Overall Study||2
10037785|NCT01953432|11162470|FG000|STARTED|Overall Study||22
10037786|NCT01953432|11162471|FG001|STARTED|Overall Study||21
10037787|NCT01953432|11162470|FG000|COMPLETED|Overall Study||8
10037788|NCT01953432|11162471|FG001|COMPLETED|Overall Study||6
10037789|NCT01953432|11162470|FG000|NOT COMPLETED|Overall Study||14
10037790|NCT01953432|11162471|FG001|NOT COMPLETED|Overall Study||15
10037791|NCT01953575|11162480|FG000|STARTED|Overall Study||10
10037792|NCT01953575|11162481|FG001|STARTED|Overall Study||10
10037793|NCT01953575|11162482|FG002|STARTED|Overall Study||10
10037794|NCT01953575|11162480|FG000|COMPLETED|Overall Study||10
10037795|NCT01953575|11162481|FG001|COMPLETED|Overall Study||10
10037796|NCT01953575|11162482|FG002|COMPLETED|Overall Study||10
10037797|NCT01953575|11162480|FG000|NOT COMPLETED|Overall Study||0
10037798|NCT01953575|11162481|FG001|NOT COMPLETED|Overall Study||0
10037799|NCT01953575|11162482|FG002|NOT COMPLETED|Overall Study||0
10037800|NCT01953601|11162493|FG000|STARTED|Part 1 (Base Study)||485
10037801|NCT01953601|11162494|FG001|STARTED|Part 1 (Base Study)||484
10037802|NCT01953601|11162495|FG002|STARTED|Part 1 (Base Study)||485
10037803|NCT01953601|11162493|FG000|Treated|Part 1 (Base Study)||483
10037804|NCT01953601|11162494|FG001|Treated|Part 1 (Base Study)||484
10037805|NCT01953601|11162495|FG002|Treated|Part 1 (Base Study)||484
10037806|NCT01953601|11162493|FG000|COMPLETED|Part 1 (Base Study)||234
10037807|NCT01953601|11162494|FG001|COMPLETED|Part 1 (Base Study)||231
10037808|NCT01953601|11162495|FG002|COMPLETED|Part 1 (Base Study)||239
10037809|NCT01953601|11162493|FG000|NOT COMPLETED|Part 1 (Base Study)||251
10037810|NCT01953601|11162494|FG001|NOT COMPLETED|Part 1 (Base Study)||253
10037811|NCT01953601|11162495|FG002|NOT COMPLETED|Part 1 (Base Study)||246
10037812|NCT01953601|11162493|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
10037813|NCT01953601|11162494|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
10037814|NCT01953601|11162495|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
10037815|NCT01953601|11162493|FG000|Treated|Part 2 (Extension Study)||197
10037816|NCT01953601|11162494|FG001|Treated|Part 2 (Extension Study)||191
10037817|NCT01953601|11162495|FG002|Treated|Part 2 (Extension Study)||204
10037818|NCT01953601|11162493|FG000|COMPLETED|Part 2 (Extension Study)||0
10037819|NCT01953601|11162494|FG001|COMPLETED|Part 2 (Extension Study)||0
10037820|NCT01953601|11162495|FG002|COMPLETED|Part 2 (Extension Study)||0
10037821|NCT01953601|11162493|FG000|NOT COMPLETED|Part 2 (Extension Study)||198
10037822|NCT01953601|11162494|FG001|NOT COMPLETED|Part 2 (Extension Study)||191
10037823|NCT01953601|11162495|FG002|NOT COMPLETED|Part 2 (Extension Study)||204
10037824|NCT01953692|11162515|FG000|STARTED|Overall Study||28
10037825|NCT01953692|11162516|FG001|STARTED|Overall Study||30
10037826|NCT01953692|11162517|FG002|STARTED|Overall Study||31
10037827|NCT01953692|11162518|FG003|STARTED|Overall Study||21
10037828|NCT01953692|11162519|FG004|STARTED|Overall Study||4
10037829|NCT01953692|11162520|FG005|STARTED|Overall Study||22
10037830|NCT01953692|11162521|FG006|STARTED|Overall Study||42
10037831|NCT01953692|11162522|FG007|STARTED|Overall Study||13
10037832|NCT01953692|11162523|FG008|STARTED|Overall Study||6
10037833|NCT01953692|11162515|FG000|COMPLETED|Overall Study||1
10037834|NCT01953692|11162516|FG001|COMPLETED|Overall Study||5
10037835|NCT01953692|11162517|FG002|COMPLETED|Overall Study||11
10037836|NCT01953692|11162518|FG003|COMPLETED|Overall Study||7
10037837|NCT01953692|11162519|FG004|COMPLETED|Overall Study||1
10037838|NCT01953692|11162520|FG005|COMPLETED|Overall Study||4
10037839|NCT01953692|11162521|FG006|COMPLETED|Overall Study||10
10037840|NCT01953692|11162522|FG007|COMPLETED|Overall Study||3
10037841|NCT01953692|11162523|FG008|COMPLETED|Overall Study||1
10037842|NCT01953692|11162515|FG000|NOT COMPLETED|Overall Study||27
10037843|NCT01953692|11162516|FG001|NOT COMPLETED|Overall Study||25
10037844|NCT01953692|11162517|FG002|NOT COMPLETED|Overall Study||20
10037845|NCT01953692|11162518|FG003|NOT COMPLETED|Overall Study||14
10037846|NCT01953692|11162519|FG004|NOT COMPLETED|Overall Study||3
10037847|NCT01953692|11162520|FG005|NOT COMPLETED|Overall Study||18
10037848|NCT01953692|11162521|FG006|NOT COMPLETED|Overall Study||32
10037849|NCT01953692|11162522|FG007|NOT COMPLETED|Overall Study||10
10037850|NCT01953692|11162523|FG008|NOT COMPLETED|Overall Study||5
10037851|NCT01953783|11162553|FG000|STARTED|Overall Study||7
10037852|NCT01953783|11162553|FG000|COMPLETED|Overall Study||5
10037853|NCT01953783|11162553|FG000|NOT COMPLETED|Overall Study||2
10037854|NCT01953874|11162559|FG000|STARTED|Overall Study||65
10037855|NCT01953874|11162560|FG001|STARTED|Overall Study||61
10037856|NCT01953874|11162559|FG000|COMPLETED|Overall Study||65
10037857|NCT01953874|11162560|FG001|COMPLETED|Overall Study||61
10037858|NCT01953874|11162559|FG000|NOT COMPLETED|Overall Study||0
10037859|NCT01953874|11162560|FG001|NOT COMPLETED|Overall Study||0
10037860|NCT01953913|11162567|FG000|STARTED|Overall Study||542
10037861|NCT01953913|11162567|FG000|Treated|Overall Study||541
10037862|NCT01953913|11162567|FG000|COMPLETED|Overall Study||0
10037863|NCT01953913|11162567|FG000|NOT COMPLETED|Overall Study||542
10037864|NCT01954017|11162574|FG000|STARTED|Overall Study||36
10037865|NCT01954017|11162575|FG001|STARTED|Overall Study||33
10037866|NCT01954017|11162576|FG002|STARTED|Overall Study||34
10037867|NCT01954017|11162574|FG000|COMPLETED|Overall Study||31
10037868|NCT01954017|11162575|FG001|COMPLETED|Overall Study||25
10037869|NCT01954017|11162576|FG002|COMPLETED|Overall Study||21
10037870|NCT01954017|11162574|FG000|NOT COMPLETED|Overall Study||5
10037871|NCT01954017|11162575|FG001|NOT COMPLETED|Overall Study||8
10037872|NCT01954017|11162576|FG002|NOT COMPLETED|Overall Study||13
10037873|NCT01954056|11162612|FG000|STARTED|Birth to 60 Days of Life||6
10037874|NCT01954056|11162613|FG001|STARTED|Birth to 60 Days of Life||6
10037875|NCT01954056|11162612|FG000|COMPLETED|Birth to 60 Days of Life||6
10037876|NCT01954056|11162613|FG001|COMPLETED|Birth to 60 Days of Life||6
10037877|NCT01954056|11162612|FG000|NOT COMPLETED|Birth to 60 Days of Life||0
10037878|NCT01954056|11162613|FG001|NOT COMPLETED|Birth to 60 Days of Life||0
10037879|NCT01954056|11162612|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6
10037880|NCT01954056|11162613|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6
10037881|NCT01954056|11162612|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
10037882|NCT01954056|11162613|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
10037883|NCT01954056|11162612|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
10037884|NCT01954056|11162613|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
10037885|NCT01954082|11162621|FG000|STARTED|Overall Study||317
10037886|NCT01954082|11162622|FG001|STARTED|Overall Study||321
10037887|NCT01954082|11162621|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
10037888|NCT01954082|11162622|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
10116125|NCT02530619|11246914|FG000|STARTED|Completed 1st Cycle of Treatment||24
10037889|NCT01954082|11162621|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
10037890|NCT01954082|11162622|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
10037891|NCT01954082|11162621|FG000|NOT COMPLETED|Overall Study||68
10037892|NCT01954082|11162622|FG001|NOT COMPLETED|Overall Study||57
10037893|NCT01954121|11162630|FG000|STARTED|Overall Study||220
10037894|NCT01954121|11162631|FG001|STARTED|Overall Study||216
10037895|NCT01954121|11162630|FG000|COMPLETED|Overall Study||93
10037896|NCT01954121|11162631|FG001|COMPLETED|Overall Study||125
10037897|NCT01954121|11162630|FG000|NOT COMPLETED|Overall Study||127
10037898|NCT01954121|11162631|FG001|NOT COMPLETED|Overall Study||91
10037899|NCT01954251|11162639|FG000|STARTED|Overall Study||413
10037900|NCT01954251|11162640|FG001|STARTED|Overall Study||415
10037901|NCT01954251|11162639|FG000|COMPLETED|Overall Study||400
10037902|NCT01954251|11162640|FG001|COMPLETED|Overall Study||396
10037903|NCT01954251|11162639|FG000|NOT COMPLETED|Overall Study||13
10037904|NCT01954251|11162640|FG001|NOT COMPLETED|Overall Study||19
10037905|NCT01954264|11162647|FG000|STARTED|Overall Study||2421
10037906|NCT01954264|11162647|FG000|COMPLETED|Overall Study||2421
10037907|NCT01954264|11162647|FG000|NOT COMPLETED|Overall Study||0
10037908|NCT01954342|11162668|FG000|STARTED|Overall Study||36
10037909|NCT01954342|11162669|FG001|STARTED|Overall Study||8
10037910|NCT01954342|11162670|FG002|STARTED|Overall Study||10
10037911|NCT01954342|11162671|FG003|STARTED|Overall Study||18
10037912|NCT01954342|11162668|FG000|COMPLETED|Overall Study||36
10037913|NCT01954342|11162669|FG001|COMPLETED|Overall Study||8
10037914|NCT01954342|11162670|FG002|COMPLETED|Overall Study||10
10037915|NCT01954342|11162671|FG003|COMPLETED|Overall Study||0
10037916|NCT01954342|11162668|FG000|NOT COMPLETED|Overall Study||0
10037917|NCT01954342|11162669|FG001|NOT COMPLETED|Overall Study||0
10037918|NCT01954342|11162670|FG002|NOT COMPLETED|Overall Study||0
10037919|NCT01954342|11162671|FG003|NOT COMPLETED|Overall Study||18
10037920|NCT01954394|11162683|FG000|STARTED|Overall Study|Enrolled|331
10037921|NCT01954394|11162684|FG001|STARTED|Overall Study|Enrolled|655
10037922|NCT01954394|11162683|FG000|Treated|Overall Study|Safety population|330
10037923|NCT01954394|11162684|FG001|Treated|Overall Study|Safety population|655
10037924|NCT01954394|11162683|FG000|COMPLETED|Overall Study||301
10037925|NCT01954394|11162684|FG001|COMPLETED|Overall Study||598
10037926|NCT01954394|11162683|FG000|NOT COMPLETED|Overall Study||30
10037927|NCT01954394|11162684|FG001|NOT COMPLETED|Overall Study||57
10037928|NCT01954628|11162694|FG000|STARTED|Overall Study||200
10037929|NCT01954628|11162695|FG001|STARTED|Overall Study||200
10037930|NCT01954628|11162694|FG000|Full Analysis Set (FAS)|Overall Study||200
10037931|NCT01954628|11162695|FG001|Full Analysis Set (FAS)|Overall Study||198
10037932|NCT01954628|11162694|FG000|Safety Set|Overall Study||200
10037933|NCT01954628|11162695|FG001|Safety Set|Overall Study||200
10037934|NCT01954628|11162694|FG000|Pharmacokinetic Population|Overall Study||181
10037935|NCT01954628|11162695|FG001|Pharmacokinetic Population|Overall Study||0
10037936|NCT01954628|11162694|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37
10037937|NCT01954628|11162695|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32
10037938|NCT01954628|11162694|FG000|COMPLETED|Overall Study||169
10037939|NCT01954628|11162695|FG001|COMPLETED|Overall Study||173
10037940|NCT01954628|11162694|FG000|NOT COMPLETED|Overall Study||31
10037941|NCT01954628|11162695|FG001|NOT COMPLETED|Overall Study||27
10037942|NCT01954745|11162705|FG000|STARTED|Overall Study||19
10037943|NCT01954745|11162705|FG000|COMPLETED|Overall Study||0
10037944|NCT01954745|11162705|FG000|NOT COMPLETED|Overall Study||19
10037945|NCT01954771|11162712|FG000|STARTED|Overall Study||29
10037946|NCT01954771|11162713|FG001|STARTED|Overall Study||32
10037947|NCT01954771|11162714|FG002|STARTED|Overall Study||28
10037948|NCT01954771|11162712|FG000|COMPLETED|Overall Study||22
10037949|NCT01954771|11162713|FG001|COMPLETED|Overall Study||29
10037950|NCT01954771|11162714|FG002|COMPLETED|Overall Study||25
10037951|NCT01954771|11162712|FG000|NOT COMPLETED|Overall Study||7
10037952|NCT01954771|11162713|FG001|NOT COMPLETED|Overall Study||3
10037953|NCT01954771|11162714|FG002|NOT COMPLETED|Overall Study||3
10037954|NCT01954927|11162727|FG000|STARTED|Overall Study||45
10037955|NCT01954927|11162728|FG001|STARTED|Overall Study||45
10037956|NCT01954927|11162727|FG000|COMPLETED|Overall Study||42
10037957|NCT01954927|11162728|FG001|COMPLETED|Overall Study||44
10037958|NCT01954927|11162727|FG000|NOT COMPLETED|Overall Study||3
10037959|NCT01954927|11162728|FG001|NOT COMPLETED|Overall Study||1
10037960|NCT01955005|11162736|FG000|STARTED|Overall Study||30
10037961|NCT01955005|11162737|FG001|STARTED|Overall Study||30
10037962|NCT01955005|11162736|FG000|COMPLETED|Overall Study||27
10037963|NCT01955005|11162737|FG001|COMPLETED|Overall Study||25
10037964|NCT01955005|11162736|FG000|NOT COMPLETED|Overall Study||3
10037965|NCT01955005|11162737|FG001|NOT COMPLETED|Overall Study||5
10037966|NCT01955044|11162746|FG000|STARTED|Overall Study||10
10037967|NCT01955044|11162747|FG001|STARTED|Overall Study||10
10037968|NCT01955044|11162748|FG002|STARTED|Overall Study||10
10037969|NCT01955044|11162746|FG000|COMPLETED|Overall Study||9
10037970|NCT01955044|11162747|FG001|COMPLETED|Overall Study||9
10037971|NCT01955044|11162748|FG002|COMPLETED|Overall Study||10
10037972|NCT01955044|11162746|FG000|NOT COMPLETED|Overall Study||1
10037973|NCT01955044|11162747|FG001|NOT COMPLETED|Overall Study||1
10037974|NCT01955044|11162748|FG002|NOT COMPLETED|Overall Study||0
10037975|NCT01955083|11162758|FG000|STARTED|Overall Study||15
10037976|NCT01955083|11162759|FG001|STARTED|Overall Study||15
10037977|NCT01955083|11162758|FG000|COMPLETED|Overall Study||14
10037978|NCT01955083|11162759|FG001|COMPLETED|Overall Study||14
10037979|NCT01955083|11162758|FG000|NOT COMPLETED|Overall Study||1
10037980|NCT01955083|11162759|FG001|NOT COMPLETED|Overall Study||1
10037981|NCT01955122|11162791|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
10037982|NCT01955122|11162792|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
10037983|NCT01955122|11162791|FG000|No.Patients Enrolled|Overall Study||64
10037984|NCT01955122|11162792|FG001|No.Patients Enrolled|Overall Study||62
10037985|NCT01955122|11162791|FG000|No. Patients Completed Double Procedure|Overall Study||59
10037986|NCT01955122|11162792|FG001|No. Patients Completed Double Procedure|Overall Study||57
10037987|NCT01955122|11162791|FG000|COMPLETED|Overall Study||59
10037988|NCT01955122|11162792|FG001|COMPLETED|Overall Study||57
10037989|NCT01955122|11162791|FG000|NOT COMPLETED|Overall Study||5
10037990|NCT01955122|11162792|FG001|NOT COMPLETED|Overall Study||5
10037991|NCT01955161|11162807|FG000|STARTED|Overall Study||310
10037992|NCT01955161|11162808|FG001|STARTED|Overall Study||313
10037993|NCT01955161|11162809|FG002|STARTED|Overall Study||310
10037994|NCT01955161|11162807|FG000|Treated|Overall Study||308
10037995|NCT01955161|11162808|FG001|Treated|Overall Study||313
10037996|NCT01955161|11162809|FG002|Treated|Overall Study||309
10037997|NCT01955161|11162807|FG000|COMPLETED|Overall Study||283
10037998|NCT01955161|11162808|FG001|COMPLETED|Overall Study||288
10037999|NCT01955161|11162809|FG002|COMPLETED|Overall Study||275
10038000|NCT01955161|11162807|FG000|NOT COMPLETED|Overall Study||27
10038001|NCT01955161|11162808|FG001|NOT COMPLETED|Overall Study||25
10038002|NCT01955161|11162809|FG002|NOT COMPLETED|Overall Study||35
10038003|NCT01955369|11162817|FG000|STARTED|Overall Study||200
10038004|NCT01955369|11162817|FG000|COMPLETED|Overall Study||200
10038005|NCT01955369|11162817|FG000|NOT COMPLETED|Overall Study||0
10038006|NCT01955382|11162823|FG000|STARTED|Overall Study||35
10038007|NCT01955382|11162824|FG001|STARTED|Overall Study||35
10038008|NCT01955382|11162823|FG000|COMPLETED|Overall Study||35
10038009|NCT01955382|11162824|FG001|COMPLETED|Overall Study||35
10038010|NCT01955382|11162823|FG000|NOT COMPLETED|Overall Study||0
10038011|NCT01955382|11162824|FG001|NOT COMPLETED|Overall Study||0
10038012|NCT01955434|11162831|FG000|STARTED|Overall Study||25
10038013|NCT01955434|11162831|FG000|COMPLETED|Overall Study||25
10038014|NCT01955434|11162831|FG000|NOT COMPLETED|Overall Study||0
10038015|NCT01955473|11162840|FG000|STARTED|Overall Study||3
10038016|NCT01955473|11162841|FG001|STARTED|Overall Study||6
10038017|NCT01955473|11162842|FG002|STARTED|Overall Study||6
10038018|NCT01955473|11162843|FG003|STARTED|Overall Study||6
10038019|NCT01955473|11162844|FG004|STARTED|Overall Study||30
10038020|NCT01955473|11162840|FG000|COMPLETED|Overall Study||3
10038021|NCT01955473|11162841|FG001|COMPLETED|Overall Study||6
10038022|NCT01955473|11162842|FG002|COMPLETED|Overall Study||6
10038023|NCT01955473|11162843|FG003|COMPLETED|Overall Study||6
10038024|NCT01955473|11162844|FG004|COMPLETED|Overall Study||30
10038025|NCT01955473|11162840|FG000|NOT COMPLETED|Overall Study||0
10038026|NCT01955473|11162841|FG001|NOT COMPLETED|Overall Study||0
10038027|NCT01955473|11162842|FG002|NOT COMPLETED|Overall Study||0
10038028|NCT01955473|11162843|FG003|NOT COMPLETED|Overall Study||0
10038029|NCT01955473|11162844|FG004|NOT COMPLETED|Overall Study||0
10038030|NCT01955564|11162867|FG000|STARTED|Overall Study||18
10038031|NCT01955564|11162868|FG001|STARTED|Overall Study||6
10038032|NCT01955564|11162869|FG002|STARTED|Overall Study||6
10038033|NCT01955564|11162870|FG003|STARTED|Overall Study||6
10116126|NCT02530619|11246914|FG000|COMPLETED|Completed 1st Cycle of Treatment||24
10116127|NCT02530619|11246914|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0
10116128|NCT02530619|11246914|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24
10116129|NCT02530619|11246914|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14
10116130|NCT02530619|11246914|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
10116131|NCT02530619|11246914|FG000|STARTED|Continued Treatment Cycle 7+||14
10116132|NCT02530619|11246914|FG000|COMPLETED|Continued Treatment Cycle 7+||14
10116133|NCT02530619|11246914|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0
10116134|NCT02530619|11246914|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
10116135|NCT02530619|11246914|FG000|COMPLETED|Follow-up Period (6 Months)||10
10116136|NCT02530619|11246914|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11
10116137|NCT02530671|11246920|FG000|STARTED|Overall Study||55
10116138|NCT02530671|11246921|FG001|STARTED|Overall Study||55
10116139|NCT02530671|11246920|FG000|COMPLETED|Overall Study||52
10116140|NCT02530671|11246921|FG001|COMPLETED|Overall Study||55
10116141|NCT02530671|11246920|FG000|NOT COMPLETED|Overall Study||3
10116142|NCT02530671|11246921|FG001|NOT COMPLETED|Overall Study||0
10038034|NCT01955564|11162871|FG004|STARTED|Overall Study||6
10038035|NCT01955564|11162872|FG005|STARTED|Overall Study||6
10038036|NCT01955564|11162873|FG006|STARTED|Overall Study||6
10038037|NCT01955564|11162867|FG000|COMPLETED|Overall Study||18
10038038|NCT01955564|11162868|FG001|COMPLETED|Overall Study||6
10038039|NCT01955564|11162869|FG002|COMPLETED|Overall Study||6
10038040|NCT01955564|11162870|FG003|COMPLETED|Overall Study||6
10038041|NCT01955564|11162871|FG004|COMPLETED|Overall Study||6
10038042|NCT01955564|11162872|FG005|COMPLETED|Overall Study||6
10038043|NCT01955564|11162873|FG006|COMPLETED|Overall Study||6
10116143|NCT02530905|11246929|FG000|STARTED|Double-Blind Period (12 Weeks)||4
10116144|NCT02530905|11246930|FG001|STARTED|Double-Blind Period (12 Weeks)||8
10116145|NCT02530905|11246931|FG002|STARTED|Double-Blind Period (12 Weeks)||0
10116146|NCT02530905|11246929|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
10116147|NCT02530905|11246930|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
10038044|NCT01955564|11162867|FG000|NOT COMPLETED|Overall Study||0
10038045|NCT01955564|11162868|FG001|NOT COMPLETED|Overall Study||0
10038046|NCT01955564|11162869|FG002|NOT COMPLETED|Overall Study||0
10038047|NCT01955564|11162870|FG003|NOT COMPLETED|Overall Study||0
10038048|NCT01955564|11162871|FG004|NOT COMPLETED|Overall Study||0
10038049|NCT01955564|11162872|FG005|NOT COMPLETED|Overall Study||0
10038050|NCT01955564|11162873|FG006|NOT COMPLETED|Overall Study||0
10038051|NCT01955629|11162895|FG000|STARTED|Overall Study||4
10038052|NCT01955629|11162895|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
10038053|NCT01955629|11162895|FG000|NOT COMPLETED|Overall Study||0
10038054|NCT01955707|11162901|FG000|STARTED|Overall Study||82
10038055|NCT01955707|11162902|FG001|STARTED|Overall Study||79
10038056|NCT01955707|11162901|FG000|Withdrew Prior to Dosing|Overall Study||0
10038057|NCT01955707|11162902|FG001|Withdrew Prior to Dosing|Overall Study||1
10038058|NCT01955707|11162901|FG000|Dosed|Overall Study||82
10038059|NCT01955707|11162902|FG001|Dosed|Overall Study||78
10038060|NCT01955707|11162901|FG000|Received Total Volume of Study Drug|Overall Study||82
10038061|NCT01955707|11162902|FG001|Received Total Volume of Study Drug|Overall Study||77
10038062|NCT01955707|11162901|FG000|COMPLETED|Overall Study||62
10038063|NCT01955707|11162902|FG001|COMPLETED|Overall Study||57
10038064|NCT01955707|11162901|FG000|NOT COMPLETED|Overall Study||20
10038065|NCT01955707|11162902|FG001|NOT COMPLETED|Overall Study||22
10038066|NCT01955720|11162908|FG000|STARTED|Overall Study||13
10038067|NCT01955720|11162909|FG001|STARTED|Overall Study||13
10038068|NCT01955720|11162910|FG002|STARTED|Overall Study||3
10038069|NCT01955720|11162911|FG003|STARTED|Overall Study||3
10038070|NCT01955720|11162912|FG004|STARTED|Overall Study||7
10038071|NCT01955720|11162913|FG005|STARTED|Overall Study||7
10038072|NCT01955720|11162908|FG000|Healthy Subjects Aged 45-64|Overall Study||3
10038073|NCT01955720|11162909|FG001|Healthy Subjects Aged 45-64|Overall Study||3
10038074|NCT01955720|11162910|FG002|Healthy Subjects Aged 45-64|Overall Study||3
10038075|NCT01955720|11162911|FG003|Healthy Subjects Aged 45-64|Overall Study||3
10038076|NCT01955720|11162912|FG004|Healthy Subjects Aged 45-64|Overall Study||0
10038077|NCT01955720|11162913|FG005|Healthy Subjects Aged 45-64|Overall Study||0
10038078|NCT01955720|11162908|FG000|Healthy Subjects Aged 65-80|Overall Study||4
10038079|NCT01955720|11162909|FG001|Healthy Subjects Aged 65-80|Overall Study||4
10038080|NCT01955720|11162910|FG002|Healthy Subjects Aged 65-80|Overall Study||0
10038081|NCT01955720|11162911|FG003|Healthy Subjects Aged 65-80|Overall Study||0
10038082|NCT01955720|11162912|FG004|Healthy Subjects Aged 65-80|Overall Study||4
10038083|NCT01955720|11162913|FG005|Healthy Subjects Aged 65-80|Overall Study||4
10038084|NCT01955720|11162908|FG000|Subjects With Mild Renal Impairment|Overall Study||3
10038085|NCT01955720|11162909|FG001|Subjects With Mild Renal Impairment|Overall Study||3
10038086|NCT01955720|11162910|FG002|Subjects With Mild Renal Impairment|Overall Study||0
10038087|NCT01955720|11162911|FG003|Subjects With Mild Renal Impairment|Overall Study||0
10038088|NCT01955720|11162912|FG004|Subjects With Mild Renal Impairment|Overall Study||3
10038089|NCT01955720|11162913|FG005|Subjects With Mild Renal Impairment|Overall Study||3
10038090|NCT01955720|11162908|FG000|Subjects With Moderate Renal Impairment|Overall Study||3
10038091|NCT01955720|11162909|FG001|Subjects With Moderate Renal Impairment|Overall Study||3
10038092|NCT01955720|11162910|FG002|Subjects With Moderate Renal Impairment|Overall Study||0
10038093|NCT01955720|11162911|FG003|Subjects With Moderate Renal Impairment|Overall Study||0
10038094|NCT01955720|11162912|FG004|Subjects With Moderate Renal Impairment|Overall Study||0
10038095|NCT01955720|11162913|FG005|Subjects With Moderate Renal Impairment|Overall Study||0
10038096|NCT01955720|11162908|FG000|COMPLETED|Overall Study||13
10038097|NCT01955720|11162909|FG001|COMPLETED|Overall Study||13
10038098|NCT01955720|11162910|FG002|COMPLETED|Overall Study||3
10038099|NCT01955720|11162911|FG003|COMPLETED|Overall Study||3
10038100|NCT01955720|11162912|FG004|COMPLETED|Overall Study||7
10038101|NCT01955720|11162913|FG005|COMPLETED|Overall Study||7
10038102|NCT01955720|11162908|FG000|NOT COMPLETED|Overall Study||0
10038103|NCT01955720|11162909|FG001|NOT COMPLETED|Overall Study||0
10038104|NCT01955720|11162910|FG002|NOT COMPLETED|Overall Study||0
10038105|NCT01955720|11162911|FG003|NOT COMPLETED|Overall Study||0
10038106|NCT01955720|11162912|FG004|NOT COMPLETED|Overall Study||0
10038107|NCT01955720|11162913|FG005|NOT COMPLETED|Overall Study||0
10038108|NCT01955733|11162962|FG000|STARTED|Period 1||33
10038109|NCT01955733|11162963|FG001|STARTED|Period 1||29
10038110|NCT01955733|11162964|FG002|STARTED|Period 1||29
10038111|NCT01955733|11162962|FG000|COMPLETED|Period 1||32
10038112|NCT01955733|11162963|FG001|COMPLETED|Period 1||29
10038113|NCT01955733|11162964|FG002|COMPLETED|Period 1||29
10038114|NCT01955733|11162962|FG000|NOT COMPLETED|Period 1||1
10038115|NCT01955733|11162963|FG001|NOT COMPLETED|Period 1||0
10038116|NCT01955733|11162964|FG002|NOT COMPLETED|Period 1||0
10038117|NCT01955733|11162962|FG000|STARTED|Period 2||32
10038118|NCT01955733|11162963|FG001|STARTED|Period 2||29
10038119|NCT01955733|11162964|FG002|STARTED|Period 2||29
10038120|NCT01955733|11162962|FG000|COMPLETED|Period 2||20
10038121|NCT01955733|11162963|FG001|COMPLETED|Period 2||10
10038122|NCT01955733|11162964|FG002|COMPLETED|Period 2||8
10038123|NCT01955733|11162962|FG000|NOT COMPLETED|Period 2||12
10038124|NCT01955733|11162963|FG001|NOT COMPLETED|Period 2||19
10038125|NCT01955733|11162964|FG002|NOT COMPLETED|Period 2||21
10038126|NCT01955837|11162974|FG000|STARTED|Overall Study||271
10038127|NCT01955837|11162975|FG001|STARTED|Overall Study||135
10038128|NCT01955837|11162974|FG000|COMPLETED|Overall Study||271
10038129|NCT01955837|11162975|FG001|COMPLETED|Overall Study||135
10038130|NCT01955837|11162974|FG000|NOT COMPLETED|Overall Study||0
10038131|NCT01955837|11162975|FG001|NOT COMPLETED|Overall Study||0
10038132|NCT01955954|11162981|FG000|STARTED|Overall Study||69
10038133|NCT01955954|11162981|FG000|Received Treatment|Overall Study||66
10038134|NCT01955954|11162981|FG000|Completed Treatment|Overall Study||53
10038135|NCT01955954|11162981|FG000|Completed Post-treatment Assessement|Overall Study||48
10038136|NCT01955954|11162981|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46
10038137|NCT01955954|11162981|FG000|Completed 6-month Assessement|Overall Study||42
10038138|NCT01955954|11162981|FG000|COMPLETED|Overall Study|12-months|33
10038139|NCT01955954|11162981|FG000|NOT COMPLETED|Overall Study||36
10038140|NCT01956032|11162985|FG000|STARTED|Overall Study||15
10038141|NCT01956032|11162985|FG000|COMPLETED|Overall Study||15
10038142|NCT01956032|11162985|FG000|NOT COMPLETED|Overall Study||0
10038143|NCT01956071|11162989|FG000|STARTED|Overall Study||44
10038144|NCT01956071|11162989|FG000|COMPLETED|Overall Study||44
10038145|NCT01956071|11162989|FG000|NOT COMPLETED|Overall Study||0
10038146|NCT01956097|11162996|FG000|STARTED|Overall Study||30
10038147|NCT01956097|11162997|FG001|STARTED|Overall Study||30
10038148|NCT01956097|11162998|FG002|STARTED|Overall Study||15
10038149|NCT01956097|11162996|FG000|COMPLETED|Overall Study||24
10038150|NCT01956097|11162997|FG001|COMPLETED|Overall Study||28
10038151|NCT01956097|11162998|FG002|COMPLETED|Overall Study||15
10038152|NCT01956097|11162996|FG000|NOT COMPLETED|Overall Study||6
10038153|NCT01956097|11162997|FG001|NOT COMPLETED|Overall Study||2
10038154|NCT01956097|11162998|FG002|NOT COMPLETED|Overall Study||0
10038155|NCT01956123|11163008|FG000|STARTED|COS Cycle 2||252
10038156|NCT01956123|11163009|FG001|STARTED|COS Cycle 2||261
10038157|NCT01956123|11163010|FG002|STARTED|COS Cycle 2||0
10038158|NCT01956123|11163011|FG003|STARTED|COS Cycle 2||0
10038159|NCT01956123|11163008|FG000|COMPLETED|COS Cycle 2||238
10038160|NCT01956123|11163009|FG001|COMPLETED|COS Cycle 2||254
10038161|NCT01956123|11163010|FG002|COMPLETED|COS Cycle 2||0
10038162|NCT01956123|11163011|FG003|COMPLETED|COS Cycle 2||0
10038163|NCT01956123|11163008|FG000|NOT COMPLETED|COS Cycle 2||14
10038164|NCT01956123|11163009|FG001|NOT COMPLETED|COS Cycle 2||7
10038165|NCT01956123|11163010|FG002|NOT COMPLETED|COS Cycle 2||0
10038166|NCT01956123|11163011|FG003|NOT COMPLETED|COS Cycle 2||0
10038167|NCT01956123|11163008|FG000|STARTED|COS Cycle 3||0
10038168|NCT01956123|11163009|FG001|STARTED|COS Cycle 3||0
10038169|NCT01956123|11163010|FG002|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
10038170|NCT01956123|11163011|FG003|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
10038171|NCT01956123|11163008|FG000|COMPLETED|COS Cycle 3||0
10038172|NCT01956123|11163009|FG001|COMPLETED|COS Cycle 3||0
10038173|NCT01956123|11163010|FG002|COMPLETED|COS Cycle 3||89
10038174|NCT01956123|11163011|FG003|COMPLETED|COS Cycle 3||91
10038175|NCT01956123|11163008|FG000|NOT COMPLETED|COS Cycle 3||0
10038176|NCT01956123|11163009|FG001|NOT COMPLETED|COS Cycle 3||0
10038177|NCT01956123|11163010|FG002|NOT COMPLETED|COS Cycle 3||6
10038178|NCT01956123|11163011|FG003|NOT COMPLETED|COS Cycle 3||2
10038179|NCT01956240|11163024|FG000|STARTED|Overall Study||48
10038180|NCT01956240|11163025|FG001|STARTED|Overall Study||49
10038181|NCT01956240|11163024|FG000|COMPLETED|Overall Study||25
10038182|NCT01956240|11163025|FG001|COMPLETED|Overall Study||25
10038183|NCT01956240|11163024|FG000|NOT COMPLETED|Overall Study||23
10038184|NCT01956240|11163025|FG001|NOT COMPLETED|Overall Study||24
10038185|NCT01956279|11163033|FG000|STARTED|Overall Study||82
10038186|NCT01956279|11163034|FG001|STARTED|Overall Study||88
10038187|NCT01956279|11163033|FG000|COMPLETED|Overall Study||68
10038188|NCT01956279|11163034|FG001|COMPLETED|Overall Study||74
10038189|NCT01956279|11163033|FG000|NOT COMPLETED|Overall Study||14
10038190|NCT01956279|11163034|FG001|NOT COMPLETED|Overall Study||14
10038191|NCT01956435|11163040|FG000|STARTED|Overall Study||3
10038192|NCT01956435|11163041|FG001|STARTED|Overall Study||3
10038193|NCT01956435|11163040|FG000|COMPLETED|Overall Study||3
10038194|NCT01956435|11163041|FG001|COMPLETED|Overall Study||3
10038195|NCT01956435|11163040|FG000|NOT COMPLETED|Overall Study||0
10038196|NCT01956435|11163041|FG001|NOT COMPLETED|Overall Study||0
10038197|NCT01956773|11163050|FG000|STARTED|Overall Study||2520
10038198|NCT01956773|11163051|FG001|STARTED|Overall Study||100
10038199|NCT01956773|11163050|FG000|COMPLETED|Overall Study||1892
10038200|NCT01956773|11163051|FG001|COMPLETED|Overall Study||99
10038201|NCT01956773|11163050|FG000|NOT COMPLETED|Overall Study||628
10038202|NCT01956773|11163051|FG001|NOT COMPLETED|Overall Study||1
10038203|NCT01957085|11163057|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
10038204|NCT01957085|11163057|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
10038205|NCT01957085|11163057|FG000|NOT COMPLETED|Overall Study||0
10038206|NCT01957111|11163064|FG000|STARTED|Overall Study||16
10038207|NCT01957111|11163065|FG001|STARTED|Overall Study||16
10038208|NCT01957111|11163064|FG000|COMPLETED|Overall Study||15
10038209|NCT01957111|11163065|FG001|COMPLETED|Overall Study||15
10038210|NCT01957111|11163064|FG000|NOT COMPLETED|Overall Study||1
10038211|NCT01957111|11163065|FG001|NOT COMPLETED|Overall Study||1
10038212|NCT01957137|11163071|FG000|STARTED|Randomized Portion||30
10038213|NCT01957137|11163071|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
10038214|NCT01957137|11163071|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
10038215|NCT01957137|11163071|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
10038216|NCT01957137|11163071|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
10038217|NCT01957137|11163071|FG000|COMPLETED|Randomized Portion||28
10038218|NCT01957137|11163071|FG000|NOT COMPLETED|Randomized Portion||2
10038219|NCT01957137|11163071|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
10038220|NCT01957137|11163071|FG000|COMPLETED|No Stimulation||28
10038221|NCT01957137|11163071|FG000|NOT COMPLETED|No Stimulation||0
10038222|NCT01957150|11163085|FG000|STARTED|Overall Study||142
10038223|NCT01957150|11163086|FG001|STARTED|Overall Study||141
10038224|NCT01957150|11163085|FG000|COMPLETED|Overall Study||87
10038225|NCT01957150|11163086|FG001|COMPLETED|Overall Study||83
10038226|NCT01957150|11163085|FG000|NOT COMPLETED|Overall Study||55
10038227|NCT01957150|11163086|FG001|NOT COMPLETED|Overall Study||58
10038228|NCT01957163|11163095|FG000|STARTED|Overall Study||206
10038229|NCT01957163|11163096|FG001|STARTED|Overall Study||206
10038230|NCT01957163|11163097|FG002|STARTED|Overall Study||207
10038231|NCT01957163|11163095|FG000|COMPLETED|Overall Study||191
10038232|NCT01957163|11163096|FG001|COMPLETED|Overall Study||195
10038233|NCT01957163|11163097|FG002|COMPLETED|Overall Study||189
10038234|NCT01957163|11163095|FG000|NOT COMPLETED|Overall Study||15
10038235|NCT01957163|11163096|FG001|NOT COMPLETED|Overall Study||11
10038236|NCT01957163|11163097|FG002|NOT COMPLETED|Overall Study||18
10116148|NCT02530905|11246931|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
10116149|NCT02530905|11246929|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
10116150|NCT02530905|11246930|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
10116151|NCT02530905|11246931|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
10116152|NCT02530905|11246929|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
10116153|NCT02530905|11246930|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
10116154|NCT02530905|11246931|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
10116155|NCT02530905|11246929|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
10116156|NCT02530905|11246930|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
10116157|NCT02530905|11246931|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
10116158|NCT02530905|11246929|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4
10116159|NCT02530905|11246930|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8
10116160|NCT02530905|11246931|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0
10116161|NCT02530905|11246929|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10116162|NCT02530905|11246930|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10116163|NCT02530905|11246931|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10116164|NCT02530905|11246929|FG000|STARTED|Open Label Extension Period (132 Weeks)||0
10116165|NCT02530905|11246930|FG001|STARTED|Open Label Extension Period (132 Weeks)||0
10116166|NCT02530905|11246931|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
10116167|NCT02530905|11246929|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0
10116168|NCT02530905|11246930|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0
10116169|NCT02530905|11246931|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11
10116170|NCT02530905|11246929|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
10116171|NCT02530905|11246930|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
10116172|NCT02530905|11246931|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
10116173|NCT02530970|11246953|FG000|STARTED|Overall Study||1025
10116174|NCT02530970|11246953|FG000|COMPLETED|Overall Study||891
10116175|NCT02530970|11246953|FG000|NOT COMPLETED|Overall Study||134
10116176|NCT02530996|11246957|FG000|STARTED|First Intervention||6
10116177|NCT02530996|11246958|FG001|STARTED|First Intervention||6
10116178|NCT02530996|11246957|FG000|COMPLETED|First Intervention||6
10116179|NCT02530996|11246958|FG001|COMPLETED|First Intervention||6
10116180|NCT02530996|11246957|FG000|NOT COMPLETED|First Intervention||0
10116181|NCT02530996|11246958|FG001|NOT COMPLETED|First Intervention||0
10116182|NCT02530996|11246957|FG000|STARTED|Washout (5 Days)||6
10116183|NCT02530996|11246958|FG001|STARTED|Washout (5 Days)||6
10116184|NCT02530996|11246957|FG000|COMPLETED|Washout (5 Days)||6
10116185|NCT02530996|11246958|FG001|COMPLETED|Washout (5 Days)||6
10116186|NCT02530996|11246957|FG000|NOT COMPLETED|Washout (5 Days)||0
10116187|NCT02530996|11246958|FG001|NOT COMPLETED|Washout (5 Days)||0
10116188|NCT02530996|11246957|FG000|STARTED|Second Intervention||6
10116189|NCT02530996|11246958|FG001|STARTED|Second Intervention||6
10116190|NCT02530996|11246957|FG000|COMPLETED|Second Intervention||6
10116191|NCT02530996|11246958|FG001|COMPLETED|Second Intervention||6
10116192|NCT02530996|11246957|FG000|NOT COMPLETED|Second Intervention||0
10116193|NCT02530996|11246958|FG001|NOT COMPLETED|Second Intervention||0
10116194|NCT02531022|11246970|FG000|STARTED|Overall Study||55
10116195|NCT02531022|11246971|FG001|STARTED|Overall Study||50
10116196|NCT02531022|11246970|FG000|COMPLETED|Overall Study||55
10116197|NCT02531022|11246971|FG001|COMPLETED|Overall Study||48
10116198|NCT02531022|11246970|FG000|NOT COMPLETED|Overall Study||0
10116199|NCT02531022|11246971|FG001|NOT COMPLETED|Overall Study||2
10116200|NCT02531035|11246979|FG000|STARTED|Overall Study||705
10116201|NCT02531035|11246980|FG001|STARTED|Overall Study||700
10116202|NCT02531035|11246979|FG000|Treated|Overall Study||703
10116203|NCT02531035|11246980|FG001|Treated|Overall Study||699
10116204|NCT02531035|11246979|FG000|COMPLETED|Overall Study||624
10116205|NCT02531035|11246980|FG001|COMPLETED|Overall Study||605
10116206|NCT02531035|11246979|FG000|NOT COMPLETED|Overall Study||81
10116207|NCT02531035|11246980|FG001|NOT COMPLETED|Overall Study||95
10116208|NCT02531113|11246986|FG000|STARTED|Induction Period: Week 0 to 12||69
10038237|NCT01957202|11163105|FG000|STARTED|Treatment Period 1 (8 Days)||3
10038238|NCT01957202|11163106|FG001|STARTED|Treatment Period 1 (8 Days)||6
10038239|NCT01957202|11163107|FG002|STARTED|Treatment Period 1 (8 Days)||6
10038240|NCT01957202|11163108|FG003|STARTED|Treatment Period 1 (8 Days)||3
10038241|NCT01957202|11163109|FG004|STARTED|Treatment Period 1 (8 Days)||3
10038242|NCT01957202|11163110|FG005|STARTED|Treatment Period 1 (8 Days)||2
10038243|NCT01957202|11163111|FG006|STARTED|Treatment Period 1 (8 Days)||3
10038244|NCT01957202|11163112|FG007|STARTED|Treatment Period 1 (8 Days)||3
10038245|NCT01957202|11163113|FG008|STARTED|Treatment Period 1 (8 Days)||3
10038246|NCT01957202|11163114|FG009|STARTED|Treatment Period 1 (8 Days)||6
10038247|NCT01957202|11163115|FG010|STARTED|Treatment Period 1 (8 Days)||3
10038248|NCT01957202|11163116|FG011|STARTED|Treatment Period 1 (8 Days)||6
10038249|NCT01957202|11163117|FG012|STARTED|Treatment Period 1 (8 Days)||3
10038250|NCT01957202|11163118|FG013|STARTED|Treatment Period 1 (8 Days)||3
10038251|NCT01957202|11163119|FG014|STARTED|Treatment Period 1 (8 Days)||6
10038252|NCT01957202|11163120|FG015|STARTED|Treatment Period 1 (8 Days)||3
10038253|NCT01957202|11163121|FG016|STARTED|Treatment Period 1 (8 Days)||6
10038254|NCT01957202|11163122|FG017|STARTED|Treatment Period 1 (8 Days)||3
10038255|NCT01957202|11163105|FG000|COMPLETED|Treatment Period 1 (8 Days)||3
10038256|NCT01957202|11163106|FG001|COMPLETED|Treatment Period 1 (8 Days)||6
10038257|NCT01957202|11163107|FG002|COMPLETED|Treatment Period 1 (8 Days)||6
10038258|NCT01957202|11163108|FG003|COMPLETED|Treatment Period 1 (8 Days)||3
10038259|NCT01957202|11163109|FG004|COMPLETED|Treatment Period 1 (8 Days)||3
10038260|NCT01957202|11163110|FG005|COMPLETED|Treatment Period 1 (8 Days)||2
10038261|NCT01957202|11163111|FG006|COMPLETED|Treatment Period 1 (8 Days)||3
10038262|NCT01957202|11163112|FG007|COMPLETED|Treatment Period 1 (8 Days)||3
10038263|NCT01957202|11163113|FG008|COMPLETED|Treatment Period 1 (8 Days)||3
10038264|NCT01957202|11163114|FG009|COMPLETED|Treatment Period 1 (8 Days)||6
10038265|NCT01957202|11163115|FG010|COMPLETED|Treatment Period 1 (8 Days)||3
10038266|NCT01957202|11163116|FG011|COMPLETED|Treatment Period 1 (8 Days)||6
10038267|NCT01957202|11163117|FG012|COMPLETED|Treatment Period 1 (8 Days)||3
10038268|NCT01957202|11163118|FG013|COMPLETED|Treatment Period 1 (8 Days)||3
10038269|NCT01957202|11163119|FG014|COMPLETED|Treatment Period 1 (8 Days)||6
10038270|NCT01957202|11163120|FG015|COMPLETED|Treatment Period 1 (8 Days)||3
10038271|NCT01957202|11163121|FG016|COMPLETED|Treatment Period 1 (8 Days)||6
10038272|NCT01957202|11163122|FG017|COMPLETED|Treatment Period 1 (8 Days)||3
10038273|NCT01957202|11163105|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038274|NCT01957202|11163106|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038275|NCT01957202|11163107|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038276|NCT01957202|11163108|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038277|NCT01957202|11163109|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038278|NCT01957202|11163110|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038279|NCT01957202|11163111|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038280|NCT01957202|11163112|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038281|NCT01957202|11163113|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038282|NCT01957202|11163114|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038283|NCT01957202|11163115|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038284|NCT01957202|11163116|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038285|NCT01957202|11163117|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038286|NCT01957202|11163118|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038287|NCT01957202|11163119|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038288|NCT01957202|11163120|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038289|NCT01957202|11163121|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038290|NCT01957202|11163122|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10038291|NCT01957202|11163105|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3
10038292|NCT01957202|11163106|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6
10038293|NCT01957202|11163107|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6
10038294|NCT01957202|11163108|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3
10038295|NCT01957202|11163109|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3
10038296|NCT01957202|11163110|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2
10038297|NCT01957202|11163111|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3
10038298|NCT01957202|11163112|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3
10038299|NCT01957202|11163113|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3
10038300|NCT01957202|11163114|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6
10038301|NCT01957202|11163115|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3
10038302|NCT01957202|11163116|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6
10038303|NCT01957202|11163117|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3
10038304|NCT01957202|11163118|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3
10038305|NCT01957202|11163119|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6
10038306|NCT01957202|11163120|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3
10038307|NCT01957202|11163121|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6
10038308|NCT01957202|11163122|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3
10116209|NCT02531113|11246986|FG000|COMPLETED|Induction Period: Week 0 to 12||58
10116210|NCT02531113|11246986|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11
10116211|NCT02531113|11246986|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
10038309|NCT01957202|11163105|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038310|NCT01957202|11163106|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10038311|NCT01957202|11163107|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10038312|NCT01957202|11163108|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038313|NCT01957202|11163109|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038314|NCT01957202|11163110|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2
10038315|NCT01957202|11163111|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038316|NCT01957202|11163112|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038317|NCT01957202|11163113|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038318|NCT01957202|11163114|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10038319|NCT01957202|11163115|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038320|NCT01957202|11163116|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10038321|NCT01957202|11163117|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038322|NCT01957202|11163118|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038323|NCT01957202|11163119|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10038324|NCT01957202|11163120|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038325|NCT01957202|11163121|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10038326|NCT01957202|11163122|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10038327|NCT01957202|11163105|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038328|NCT01957202|11163106|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038329|NCT01957202|11163107|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038330|NCT01957202|11163108|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038331|NCT01957202|11163109|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038332|NCT01957202|11163110|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038333|NCT01957202|11163111|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038334|NCT01957202|11163112|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038335|NCT01957202|11163113|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038336|NCT01957202|11163114|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038337|NCT01957202|11163115|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038338|NCT01957202|11163116|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038339|NCT01957202|11163117|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038340|NCT01957202|11163118|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038341|NCT01957202|11163119|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038342|NCT01957202|11163120|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038343|NCT01957202|11163121|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038344|NCT01957202|11163122|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10038345|NCT01957202|11163105|FG000|STARTED|Treatment Period 2 (8 Days)||3
10038346|NCT01957202|11163106|FG001|STARTED|Treatment Period 2 (8 Days)||6
10038347|NCT01957202|11163107|FG002|STARTED|Treatment Period 2 (8 Days)||6
10038348|NCT01957202|11163108|FG003|STARTED|Treatment Period 2 (8 Days)||3
10038349|NCT01957202|11163109|FG004|STARTED|Treatment Period 2 (8 Days)||3
10038350|NCT01957202|11163110|FG005|STARTED|Treatment Period 2 (8 Days)||2
10038351|NCT01957202|11163111|FG006|STARTED|Treatment Period 2 (8 Days)||3
10038352|NCT01957202|11163112|FG007|STARTED|Treatment Period 2 (8 Days)||3
10038353|NCT01957202|11163113|FG008|STARTED|Treatment Period 2 (8 Days)||3
10038354|NCT01957202|11163114|FG009|STARTED|Treatment Period 2 (8 Days)||6
10038355|NCT01957202|11163115|FG010|STARTED|Treatment Period 2 (8 Days)||3
10038356|NCT01957202|11163116|FG011|STARTED|Treatment Period 2 (8 Days)||6
10038357|NCT01957202|11163117|FG012|STARTED|Treatment Period 2 (8 Days)||3
10038358|NCT01957202|11163118|FG013|STARTED|Treatment Period 2 (8 Days)||3
10038359|NCT01957202|11163119|FG014|STARTED|Treatment Period 2 (8 Days)||6
10038360|NCT01957202|11163120|FG015|STARTED|Treatment Period 2 (8 Days)||3
10038361|NCT01957202|11163121|FG016|STARTED|Treatment Period 2 (8 Days)||6
10038362|NCT01957202|11163122|FG017|STARTED|Treatment Period 2 (8 Days)||3
10038363|NCT01957202|11163105|FG000|COMPLETED|Treatment Period 2 (8 Days)||3
10038364|NCT01957202|11163106|FG001|COMPLETED|Treatment Period 2 (8 Days)||5
10038365|NCT01957202|11163107|FG002|COMPLETED|Treatment Period 2 (8 Days)||6
10038366|NCT01957202|11163108|FG003|COMPLETED|Treatment Period 2 (8 Days)||3
10038367|NCT01957202|11163109|FG004|COMPLETED|Treatment Period 2 (8 Days)||3
10038368|NCT01957202|11163110|FG005|COMPLETED|Treatment Period 2 (8 Days)||2
10038369|NCT01957202|11163111|FG006|COMPLETED|Treatment Period 2 (8 Days)||3
10038370|NCT01957202|11163112|FG007|COMPLETED|Treatment Period 2 (8 Days)||3
10038371|NCT01957202|11163113|FG008|COMPLETED|Treatment Period 2 (8 Days)||3
10038372|NCT01957202|11163114|FG009|COMPLETED|Treatment Period 2 (8 Days)||6
10038373|NCT01957202|11163115|FG010|COMPLETED|Treatment Period 2 (8 Days)||3
10038374|NCT01957202|11163116|FG011|COMPLETED|Treatment Period 2 (8 Days)||6
10038375|NCT01957202|11163117|FG012|COMPLETED|Treatment Period 2 (8 Days)||3
10038376|NCT01957202|11163118|FG013|COMPLETED|Treatment Period 2 (8 Days)||3
10038377|NCT01957202|11163119|FG014|COMPLETED|Treatment Period 2 (8 Days)||6
10038378|NCT01957202|11163120|FG015|COMPLETED|Treatment Period 2 (8 Days)||3
10038379|NCT01957202|11163121|FG016|COMPLETED|Treatment Period 2 (8 Days)||5
10038380|NCT01957202|11163122|FG017|COMPLETED|Treatment Period 2 (8 Days)||3
10038381|NCT01957202|11163105|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038382|NCT01957202|11163106|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1
10038383|NCT01957202|11163107|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038384|NCT01957202|11163108|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038385|NCT01957202|11163109|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038386|NCT01957202|11163110|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038387|NCT01957202|11163111|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038388|NCT01957202|11163112|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038389|NCT01957202|11163113|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038390|NCT01957202|11163114|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038391|NCT01957202|11163115|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038392|NCT01957202|11163116|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038393|NCT01957202|11163117|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038394|NCT01957202|11163118|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038395|NCT01957202|11163119|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038396|NCT01957202|11163120|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038397|NCT01957202|11163121|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1
10038398|NCT01957202|11163122|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10038399|NCT01957202|11163105|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3
10038400|NCT01957202|11163106|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5
10038401|NCT01957202|11163107|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6
10038402|NCT01957202|11163108|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3
10038403|NCT01957202|11163109|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3
10038404|NCT01957202|11163110|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2
10038405|NCT01957202|11163111|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3
10038406|NCT01957202|11163112|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3
10038407|NCT01957202|11163113|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3
10038408|NCT01957202|11163114|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6
10038409|NCT01957202|11163115|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3
10038410|NCT01957202|11163116|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6
10038411|NCT01957202|11163117|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3
10038412|NCT01957202|11163118|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3
10038413|NCT01957202|11163119|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6
10038414|NCT01957202|11163120|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3
10038415|NCT01957202|11163121|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5
10038416|NCT01957202|11163122|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3
10038417|NCT01957202|11163105|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038418|NCT01957202|11163106|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5
10038419|NCT01957202|11163107|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10038420|NCT01957202|11163108|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038421|NCT01957202|11163109|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038422|NCT01957202|11163110|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2
10038423|NCT01957202|11163111|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038424|NCT01957202|11163112|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038425|NCT01957202|11163113|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038426|NCT01957202|11163114|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10038427|NCT01957202|11163115|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038428|NCT01957202|11163116|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10038429|NCT01957202|11163117|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038430|NCT01957202|11163118|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038431|NCT01957202|11163119|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10116212|NCT02531113|11246986|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14
10116213|NCT02531113|11246986|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
10116214|NCT02531321|11246992|FG000|STARTED|Overall Study||7
10116215|NCT02531321|11246993|FG001|STARTED|Overall Study||10
10116216|NCT02531321|11246992|FG000|COMPLETED|Overall Study||5
10116217|NCT02531321|11246993|FG001|COMPLETED|Overall Study||10
10116218|NCT02531321|11246992|FG000|NOT COMPLETED|Overall Study||2
10116219|NCT02531321|11246993|FG001|NOT COMPLETED|Overall Study||0
10116220|NCT02531373|11247008|FG000|STARTED|Overall Study||20
10116221|NCT02531373|11247009|FG001|STARTED|Overall Study||20
10116222|NCT02531373|11247010|FG002|STARTED|Overall Study||20
10116223|NCT02531373|11247011|FG003|STARTED|Overall Study||20
10116224|NCT02531373|11247012|FG004|STARTED|Overall Study||51
10116225|NCT02531373|11247013|FG005|STARTED|Overall Study||51
10116226|NCT02531373|11247014|FG006|STARTED|Overall Study||52
10116227|NCT02531373|11247015|FG007|STARTED|Overall Study||52
10116228|NCT02531373|11247016|FG008|STARTED|Overall Study||52
10116229|NCT02531373|11247008|FG000|Vaccination 1|Overall Study||20
10116230|NCT02531373|11247009|FG001|Vaccination 1|Overall Study||20
10116231|NCT02531373|11247010|FG002|Vaccination 1|Overall Study||20
10116232|NCT02531373|11247011|FG003|Vaccination 1|Overall Study||20
10116233|NCT02531373|11247012|FG004|Vaccination 1|Overall Study||50
10116234|NCT02531373|11247013|FG005|Vaccination 1|Overall Study||50
10116235|NCT02531373|11247014|FG006|Vaccination 1|Overall Study||52
10116236|NCT02531373|11247015|FG007|Vaccination 1|Overall Study||52
10116237|NCT02531373|11247016|FG008|Vaccination 1|Overall Study||52
10116238|NCT02531373|11247008|FG000|Vaccination 2|Overall Study||0
10116239|NCT02531373|11247009|FG001|Vaccination 2|Overall Study||0
10116240|NCT02531373|11247010|FG002|Vaccination 2|Overall Study||0
10116241|NCT02531373|11247011|FG003|Vaccination 2|Overall Study||0
10116242|NCT02531373|11247012|FG004|Vaccination 2|Overall Study||49
10116243|NCT02531373|11247013|FG005|Vaccination 2|Overall Study||48
10116244|NCT02531373|11247014|FG006|Vaccination 2|Overall Study||50
10116245|NCT02531373|11247015|FG007|Vaccination 2|Overall Study||51
10116246|NCT02531373|11247016|FG008|Vaccination 2|Overall Study||51
10116247|NCT02531373|11247008|FG000|Vaccination 3|Overall Study||0
10116248|NCT02531373|11247009|FG001|Vaccination 3|Overall Study||0
10116249|NCT02531373|11247010|FG002|Vaccination 3|Overall Study||0
10116250|NCT02531373|11247011|FG003|Vaccination 3|Overall Study||0
10116251|NCT02531373|11247012|FG004|Vaccination 3|Overall Study||48
10116252|NCT02531373|11247013|FG005|Vaccination 3|Overall Study||47
10116253|NCT02531373|11247014|FG006|Vaccination 3|Overall Study||49
10116254|NCT02531373|11247015|FG007|Vaccination 3|Overall Study||51
10038432|NCT01957202|11163120|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038433|NCT01957202|11163121|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5
10038434|NCT01957202|11163122|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10038435|NCT01957202|11163105|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038436|NCT01957202|11163106|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038437|NCT01957202|11163107|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10116255|NCT02531373|11247016|FG008|Vaccination 3|Overall Study||49
10116256|NCT02531373|11247008|FG000|Vaccination 4|Overall Study||0
10116257|NCT02531373|11247009|FG001|Vaccination 4|Overall Study||0
10116258|NCT02531373|11247010|FG002|Vaccination 4|Overall Study||0
10116259|NCT02531373|11247011|FG003|Vaccination 4|Overall Study||0
10116260|NCT02531373|11247012|FG004|Vaccination 4|Overall Study||44
10116261|NCT02531373|11247013|FG005|Vaccination 4|Overall Study||43
10116262|NCT02531373|11247014|FG006|Vaccination 4|Overall Study||43
10116263|NCT02531373|11247015|FG007|Vaccination 4|Overall Study||43
10116264|NCT02531373|11247016|FG008|Vaccination 4|Overall Study||43
10116265|NCT02531373|11247008|FG000|COMPLETED|Overall Study||20
10116266|NCT02531373|11247009|FG001|COMPLETED|Overall Study||20
10116267|NCT02531373|11247010|FG002|COMPLETED|Overall Study||20
10116268|NCT02531373|11247011|FG003|COMPLETED|Overall Study||20
10116269|NCT02531373|11247012|FG004|COMPLETED|Overall Study||43
10116270|NCT02531373|11247013|FG005|COMPLETED|Overall Study||42
10116271|NCT02531373|11247014|FG006|COMPLETED|Overall Study||41
10116272|NCT02531373|11247015|FG007|COMPLETED|Overall Study||43
10116273|NCT02531373|11247016|FG008|COMPLETED|Overall Study||43
10116274|NCT02531373|11247008|FG000|NOT COMPLETED|Overall Study||0
10116275|NCT02531373|11247009|FG001|NOT COMPLETED|Overall Study||0
10116276|NCT02531373|11247010|FG002|NOT COMPLETED|Overall Study||0
10116277|NCT02531373|11247011|FG003|NOT COMPLETED|Overall Study||0
10116278|NCT02531373|11247012|FG004|NOT COMPLETED|Overall Study||8
10116279|NCT02531373|11247013|FG005|NOT COMPLETED|Overall Study||9
10116280|NCT02531373|11247014|FG006|NOT COMPLETED|Overall Study||11
10116281|NCT02531373|11247015|FG007|NOT COMPLETED|Overall Study||9
10116282|NCT02531373|11247016|FG008|NOT COMPLETED|Overall Study||9
10116283|NCT02531438|11247039|FG000|STARTED|Overall Study||386
10116284|NCT02531438|11247040|FG001|STARTED|Overall Study||388
10116285|NCT02531438|11247039|FG000|COMPLETED|Overall Study||356
10116286|NCT02531438|11247040|FG001|COMPLETED|Overall Study||362
10116287|NCT02531438|11247039|FG000|NOT COMPLETED|Overall Study||30
10116288|NCT02531438|11247040|FG001|NOT COMPLETED|Overall Study||26
10116289|NCT02531633|11247051|FG000|STARTED|Part A (52 Weeks)||42
10116290|NCT02531633|11247052|FG001|STARTED|Part A (52 Weeks)||39
10116291|NCT02531633|11247053|FG002|STARTED|Part A (52 Weeks)||26
10038438|NCT01957202|11163108|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038439|NCT01957202|11163109|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038440|NCT01957202|11163110|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038441|NCT01957202|11163111|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038442|NCT01957202|11163112|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038443|NCT01957202|11163113|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038444|NCT01957202|11163114|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038445|NCT01957202|11163115|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038446|NCT01957202|11163116|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038447|NCT01957202|11163117|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038448|NCT01957202|11163118|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038449|NCT01957202|11163119|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038450|NCT01957202|11163120|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038451|NCT01957202|11163121|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038452|NCT01957202|11163122|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10038453|NCT01957202|11163105|FG000|STARTED|Treatment Period 3 (8 Days)||3
10038454|NCT01957202|11163106|FG001|STARTED|Treatment Period 3 (8 Days)||5
10038455|NCT01957202|11163107|FG002|STARTED|Treatment Period 3 (8 Days)||6
10038456|NCT01957202|11163108|FG003|STARTED|Treatment Period 3 (8 Days)||3
10038457|NCT01957202|11163109|FG004|STARTED|Treatment Period 3 (8 Days)||3
10038458|NCT01957202|11163110|FG005|STARTED|Treatment Period 3 (8 Days)||2
10038459|NCT01957202|11163111|FG006|STARTED|Treatment Period 3 (8 Days)||3
10038460|NCT01957202|11163112|FG007|STARTED|Treatment Period 3 (8 Days)||3
10038461|NCT01957202|11163113|FG008|STARTED|Treatment Period 3 (8 Days)||3
10038462|NCT01957202|11163114|FG009|STARTED|Treatment Period 3 (8 Days)||6
10038463|NCT01957202|11163115|FG010|STARTED|Treatment Period 3 (8 Days)||3
10038464|NCT01957202|11163116|FG011|STARTED|Treatment Period 3 (8 Days)||6
10038465|NCT01957202|11163117|FG012|STARTED|Treatment Period 3 (8 Days)||3
10038466|NCT01957202|11163118|FG013|STARTED|Treatment Period 3 (8 Days)||3
10038467|NCT01957202|11163119|FG014|STARTED|Treatment Period 3 (8 Days)||6
10038468|NCT01957202|11163120|FG015|STARTED|Treatment Period 3 (8 Days)||3
10038469|NCT01957202|11163121|FG016|STARTED|Treatment Period 3 (8 Days)||5
10038470|NCT01957202|11163122|FG017|STARTED|Treatment Period 3 (8 Days)||3
10116292|NCT02531633|11247054|FG003|STARTED|Part A (52 Weeks)||27
10116293|NCT02531633|11247055|FG004|STARTED|Part A (52 Weeks)||27
10116294|NCT02531633|11247056|FG005|STARTED|Part A (52 Weeks)||0
10116295|NCT02531633|11247057|FG006|STARTED|Part A (52 Weeks)||0
10116296|NCT02531633|11247058|FG007|STARTED|Part A (52 Weeks)||0
10116297|NCT02531633|11247059|FG008|STARTED|Part A (52 Weeks)||0
10116298|NCT02531633|11247060|FG009|STARTED|Part A (52 Weeks)||0
10116299|NCT02531633|11247051|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
10038471|NCT01957202|11163105|FG000|COMPLETED|Treatment Period 3 (8 Days)||3
10038472|NCT01957202|11163106|FG001|COMPLETED|Treatment Period 3 (8 Days)||5
10038473|NCT01957202|11163107|FG002|COMPLETED|Treatment Period 3 (8 Days)||6
10038474|NCT01957202|11163108|FG003|COMPLETED|Treatment Period 3 (8 Days)||3
10038475|NCT01957202|11163109|FG004|COMPLETED|Treatment Period 3 (8 Days)||3
10038476|NCT01957202|11163110|FG005|COMPLETED|Treatment Period 3 (8 Days)||2
10038477|NCT01957202|11163111|FG006|COMPLETED|Treatment Period 3 (8 Days)||3
10038478|NCT01957202|11163112|FG007|COMPLETED|Treatment Period 3 (8 Days)||3
10038479|NCT01957202|11163113|FG008|COMPLETED|Treatment Period 3 (8 Days)||3
10038480|NCT01957202|11163114|FG009|COMPLETED|Treatment Period 3 (8 Days)||6
10038481|NCT01957202|11163115|FG010|COMPLETED|Treatment Period 3 (8 Days)||3
10038482|NCT01957202|11163116|FG011|COMPLETED|Treatment Period 3 (8 Days)||6
10038483|NCT01957202|11163117|FG012|COMPLETED|Treatment Period 3 (8 Days)||3
10038484|NCT01957202|11163118|FG013|COMPLETED|Treatment Period 3 (8 Days)||3
10038485|NCT01957202|11163119|FG014|COMPLETED|Treatment Period 3 (8 Days)||6
10038486|NCT01957202|11163120|FG015|COMPLETED|Treatment Period 3 (8 Days)||3
10038487|NCT01957202|11163121|FG016|COMPLETED|Treatment Period 3 (8 Days)||4
10038488|NCT01957202|11163122|FG017|COMPLETED|Treatment Period 3 (8 Days)||3
10038489|NCT01957202|11163105|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038490|NCT01957202|11163106|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038491|NCT01957202|11163107|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038492|NCT01957202|11163108|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038493|NCT01957202|11163109|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038494|NCT01957202|11163110|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038495|NCT01957202|11163111|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038496|NCT01957202|11163112|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038497|NCT01957202|11163113|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038498|NCT01957202|11163114|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038499|NCT01957202|11163115|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038500|NCT01957202|11163116|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038501|NCT01957202|11163117|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038502|NCT01957202|11163118|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038503|NCT01957202|11163119|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038504|NCT01957202|11163120|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038505|NCT01957202|11163121|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1
10038506|NCT01957202|11163122|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10038507|NCT01957215|11163134|FG000|STARTED|Overall Study||135
10038508|NCT01957215|11163135|FG001|STARTED|Overall Study||135
10038509|NCT01957215|11163134|FG000|COMPLETED|Overall Study||122
10038510|NCT01957215|11163135|FG001|COMPLETED|Overall Study||123
10038511|NCT01957215|11163134|FG000|NOT COMPLETED|Overall Study||13
10038512|NCT01957215|11163135|FG001|NOT COMPLETED|Overall Study||12
10038513|NCT01957384|11163145|FG000|STARTED|Test Period 1 (14 Days)||4
10038514|NCT01957384|11163146|FG001|STARTED|Test Period 1 (14 Days)||4
10038515|NCT01957384|11163147|FG002|STARTED|Test Period 1 (14 Days)||4
10038516|NCT01957384|11163148|FG003|STARTED|Test Period 1 (14 Days)||4
10038517|NCT01957384|11163149|FG004|STARTED|Test Period 1 (14 Days)||3
10038518|NCT01957384|11163150|FG005|STARTED|Test Period 1 (14 Days)||3
10038519|NCT01957384|11163145|FG000|COMPLETED|Test Period 1 (14 Days)||4
10038520|NCT01957384|11163146|FG001|COMPLETED|Test Period 1 (14 Days)||4
10038521|NCT01957384|11163147|FG002|COMPLETED|Test Period 1 (14 Days)||4
10038522|NCT01957384|11163148|FG003|COMPLETED|Test Period 1 (14 Days)||4
10038523|NCT01957384|11163149|FG004|COMPLETED|Test Period 1 (14 Days)||3
10038524|NCT01957384|11163150|FG005|COMPLETED|Test Period 1 (14 Days)||3
10038525|NCT01957384|11163145|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0
10038526|NCT01957384|11163146|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0
10038527|NCT01957384|11163147|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0
10038528|NCT01957384|11163148|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0
10038529|NCT01957384|11163149|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0
10038530|NCT01957384|11163150|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0
10038531|NCT01957384|11163145|FG000|STARTED|Test Period 2 (14 Days)||4
10038532|NCT01957384|11163146|FG001|STARTED|Test Period 2 (14 Days)||4
10038533|NCT01957384|11163147|FG002|STARTED|Test Period 2 (14 Days)||4
10038534|NCT01957384|11163148|FG003|STARTED|Test Period 2 (14 Days)||4
10038535|NCT01957384|11163149|FG004|STARTED|Test Period 2 (14 Days)||3
10038536|NCT01957384|11163150|FG005|STARTED|Test Period 2 (14 Days)||3
10038537|NCT01957384|11163145|FG000|COMPLETED|Test Period 2 (14 Days)||4
10038538|NCT01957384|11163146|FG001|COMPLETED|Test Period 2 (14 Days)||4
10038539|NCT01957384|11163147|FG002|COMPLETED|Test Period 2 (14 Days)||4
10038540|NCT01957384|11163148|FG003|COMPLETED|Test Period 2 (14 Days)||4
10038541|NCT01957384|11163149|FG004|COMPLETED|Test Period 2 (14 Days)||3
10038542|NCT01957384|11163150|FG005|COMPLETED|Test Period 2 (14 Days)||3
10038543|NCT01957384|11163145|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0
10038544|NCT01957384|11163146|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0
10038545|NCT01957384|11163147|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0
10038546|NCT01957384|11163148|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0
10038547|NCT01957384|11163149|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0
10038548|NCT01957384|11163150|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0
10038549|NCT01957384|11163145|FG000|STARTED|Test Period 3 (14 Days)||4
10038550|NCT01957384|11163146|FG001|STARTED|Test Period 3 (14 Days)||4
10038551|NCT01957384|11163147|FG002|STARTED|Test Period 3 (14 Days)||4
10038552|NCT01957384|11163148|FG003|STARTED|Test Period 3 (14 Days)||4
10038553|NCT01957384|11163149|FG004|STARTED|Test Period 3 (14 Days)||3
10038554|NCT01957384|11163150|FG005|STARTED|Test Period 3 (14 Days)||3
10038555|NCT01957384|11163145|FG000|COMPLETED|Test Period 3 (14 Days)||4
10038556|NCT01957384|11163146|FG001|COMPLETED|Test Period 3 (14 Days)||4
10038557|NCT01957384|11163147|FG002|COMPLETED|Test Period 3 (14 Days)||4
10038558|NCT01957384|11163148|FG003|COMPLETED|Test Period 3 (14 Days)||4
10038559|NCT01957384|11163149|FG004|COMPLETED|Test Period 3 (14 Days)||3
10038560|NCT01957384|11163150|FG005|COMPLETED|Test Period 3 (14 Days)||3
10038561|NCT01957384|11163145|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0
10038562|NCT01957384|11163146|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0
10038563|NCT01957384|11163147|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0
10038564|NCT01957384|11163148|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0
10038565|NCT01957384|11163149|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0
10038566|NCT01957384|11163150|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0
10038567|NCT01957397|11163158|FG000|STARTED|Baseline Own Product||13
10038568|NCT01957397|11163159|FG001|STARTED|Baseline Own Product||13
10038569|NCT01957397|11163158|FG000|COMPLETED|Baseline Own Product||13
10038570|NCT01957397|11163159|FG001|COMPLETED|Baseline Own Product||13
10038571|NCT01957397|11163158|FG000|NOT COMPLETED|Baseline Own Product||0
10038572|NCT01957397|11163159|FG001|NOT COMPLETED|Baseline Own Product||0
10038573|NCT01957397|11163158|FG000|STARTED|Test Period 1||13
10038574|NCT01957397|11163159|FG001|STARTED|Test Period 1||13
10038575|NCT01957397|11163158|FG000|COMPLETED|Test Period 1||11
10038576|NCT01957397|11163159|FG001|COMPLETED|Test Period 1||12
10038577|NCT01957397|11163158|FG000|NOT COMPLETED|Test Period 1||2
10038578|NCT01957397|11163159|FG001|NOT COMPLETED|Test Period 1||1
10038579|NCT01957397|11163158|FG000|STARTED|Test Period 2||11
10038580|NCT01957397|11163159|FG001|STARTED|Test Period 2||12
10038581|NCT01957397|11163158|FG000|COMPLETED|Test Period 2||11
10038582|NCT01957397|11163159|FG001|COMPLETED|Test Period 2||11
10038583|NCT01957397|11163158|FG000|NOT COMPLETED|Test Period 2||0
10038584|NCT01957397|11163159|FG001|NOT COMPLETED|Test Period 2||1
10038585|NCT01957397|11163158|FG000|STARTED|Test Period 3||11
10038586|NCT01957397|11163159|FG001|STARTED|Test Period 3||11
10038587|NCT01957397|11163158|FG000|COMPLETED|Test Period 3||9
10038588|NCT01957397|11163159|FG001|COMPLETED|Test Period 3||9
10038589|NCT01957397|11163158|FG000|NOT COMPLETED|Test Period 3||2
10038590|NCT01957397|11163159|FG001|NOT COMPLETED|Test Period 3||2
10038591|NCT01957410|11163169|FG000|STARTED|Open Label||13
10038592|NCT01957410|11163169|FG000|COMPLETED|Open Label||13
10038593|NCT01957410|11163169|FG000|NOT COMPLETED|Open Label||0
10038594|NCT01957410|11163169|FG000|STARTED|Optional Open Label||13
10038595|NCT01957410|11163169|FG000|COMPLETED|Optional Open Label||13
10038596|NCT01957410|11163169|FG000|NOT COMPLETED|Optional Open Label||0
10038597|NCT01957462|11163173|FG000|STARTED|Test Period 1||16
10038598|NCT01957462|11163174|FG001|STARTED|Test Period 1||15
10038599|NCT01957462|11163173|FG000|COMPLETED|Test Period 1||14
10038600|NCT01957462|11163174|FG001|COMPLETED|Test Period 1||15
10038601|NCT01957462|11163173|FG000|NOT COMPLETED|Test Period 1||2
10038602|NCT01957462|11163174|FG001|NOT COMPLETED|Test Period 1||0
10038603|NCT01957462|11163173|FG000|STARTED|Test Period 2||14
10038604|NCT01957462|11163174|FG001|STARTED|Test Period 2||15
10038605|NCT01957462|11163173|FG000|COMPLETED|Test Period 2||14
10038606|NCT01957462|11163174|FG001|COMPLETED|Test Period 2||15
10038607|NCT01957462|11163173|FG000|NOT COMPLETED|Test Period 2||0
10038608|NCT01957462|11163174|FG001|NOT COMPLETED|Test Period 2||0
10116300|NCT02531633|11247052|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116301|NCT02531633|11247053|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
10116302|NCT02531633|11247054|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116303|NCT02531633|11247055|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116304|NCT02531633|11247056|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116305|NCT02531633|11247057|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116306|NCT02531633|11247058|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116307|NCT02531633|11247059|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116308|NCT02531633|11247060|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10116309|NCT02531633|11247051|FG000|COMPLETED|Part A (52 Weeks)||8
10116310|NCT02531633|11247052|FG001|COMPLETED|Part A (52 Weeks)||5
10116311|NCT02531633|11247053|FG002|COMPLETED|Part A (52 Weeks)||4
10116312|NCT02531633|11247054|FG003|COMPLETED|Part A (52 Weeks)||5
10116313|NCT02531633|11247055|FG004|COMPLETED|Part A (52 Weeks)||4
10116314|NCT02531633|11247056|FG005|COMPLETED|Part A (52 Weeks)||0
10116315|NCT02531633|11247057|FG006|COMPLETED|Part A (52 Weeks)||0
10116316|NCT02531633|11247058|FG007|COMPLETED|Part A (52 Weeks)||0
10116317|NCT02531633|11247059|FG008|COMPLETED|Part A (52 Weeks)||0
10116318|NCT02531633|11247060|FG009|COMPLETED|Part A (52 Weeks)||0
10116319|NCT02531633|11247051|FG000|NOT COMPLETED|Part A (52 Weeks)||34
10116320|NCT02531633|11247052|FG001|NOT COMPLETED|Part A (52 Weeks)||34
10116321|NCT02531633|11247053|FG002|NOT COMPLETED|Part A (52 Weeks)||22
10116322|NCT02531633|11247054|FG003|NOT COMPLETED|Part A (52 Weeks)||22
10116323|NCT02531633|11247055|FG004|NOT COMPLETED|Part A (52 Weeks)||23
10116324|NCT02531633|11247056|FG005|NOT COMPLETED|Part A (52 Weeks)||0
10116325|NCT02531633|11247057|FG006|NOT COMPLETED|Part A (52 Weeks)||0
10116326|NCT02531633|11247058|FG007|NOT COMPLETED|Part A (52 Weeks)||0
10116327|NCT02531633|11247059|FG008|NOT COMPLETED|Part A (52 Weeks)||0
10116328|NCT02531633|11247060|FG009|NOT COMPLETED|Part A (52 Weeks)||0
10116329|NCT02531633|11247051|FG000|STARTED|Part B (104 Weeks)||0
10116330|NCT02531633|11247052|FG001|STARTED|Part B (104 Weeks)||0
10116331|NCT02531633|11247053|FG002|STARTED|Part B (104 Weeks)||0
10038609|NCT01957475|11163180|FG000|STARTED|Test Period 1||10
10038610|NCT01957475|11163181|FG001|STARTED|Test Period 1||10
10038611|NCT01957475|11163180|FG000|COMPLETED|Test Period 1||8
10038612|NCT01957475|11163181|FG001|COMPLETED|Test Period 1||9
10038613|NCT01957475|11163180|FG000|NOT COMPLETED|Test Period 1||2
10038614|NCT01957475|11163181|FG001|NOT COMPLETED|Test Period 1||1
10038615|NCT01957475|11163180|FG000|STARTED|Test Period 2||9
10038616|NCT01957475|11163181|FG001|STARTED|Test Period 2||8
10038617|NCT01957475|11163180|FG000|COMPLETED|Test Period 2||8
10038618|NCT01957475|11163181|FG001|COMPLETED|Test Period 2||8
10038619|NCT01957475|11163180|FG000|NOT COMPLETED|Test Period 2||1
10038620|NCT01957475|11163181|FG001|NOT COMPLETED|Test Period 2||0
10038621|NCT01957488|11163187|FG000|STARTED|Test Period 1 (2 Weeks)||30
10038622|NCT01957488|11163188|FG001|STARTED|Test Period 1 (2 Weeks)||31
10038623|NCT01957488|11163189|FG002|STARTED|Test Period 1 (2 Weeks)||30
10038624|NCT01957488|11163190|FG003|STARTED|Test Period 1 (2 Weeks)||32
10038625|NCT01957488|11163191|FG004|STARTED|Test Period 1 (2 Weeks)||30
10038626|NCT01957488|11163192|FG005|STARTED|Test Period 1 (2 Weeks)||30
10038627|NCT01957488|11163187|FG000|COMPLETED|Test Period 1 (2 Weeks)||27
10038628|NCT01957488|11163188|FG001|COMPLETED|Test Period 1 (2 Weeks)||28
10038629|NCT01957488|11163189|FG002|COMPLETED|Test Period 1 (2 Weeks)||26
10038630|NCT01957488|11163190|FG003|COMPLETED|Test Period 1 (2 Weeks)||29
10038631|NCT01957488|11163191|FG004|COMPLETED|Test Period 1 (2 Weeks)||27
10038632|NCT01957488|11163192|FG005|COMPLETED|Test Period 1 (2 Weeks)||24
10038633|NCT01957488|11163187|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10038634|NCT01957488|11163188|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10038635|NCT01957488|11163189|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4
10038636|NCT01957488|11163190|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10038637|NCT01957488|11163191|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10038638|NCT01957488|11163192|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6
10038639|NCT01957488|11163187|FG000|STARTED|Test Period 2 (2 Weeks)||27
10038640|NCT01957488|11163188|FG001|STARTED|Test Period 2 (2 Weeks)||28
10038641|NCT01957488|11163189|FG002|STARTED|Test Period 2 (2 Weeks)||26
10038642|NCT01957488|11163190|FG003|STARTED|Test Period 2 (2 Weeks)||29
10038643|NCT01957488|11163191|FG004|STARTED|Test Period 2 (2 Weeks)||27
10038644|NCT01957488|11163192|FG005|STARTED|Test Period 2 (2 Weeks)||24
10038645|NCT01957488|11163187|FG000|COMPLETED|Test Period 2 (2 Weeks)||24
10038646|NCT01957488|11163188|FG001|COMPLETED|Test Period 2 (2 Weeks)||27
10038647|NCT01957488|11163189|FG002|COMPLETED|Test Period 2 (2 Weeks)||25
10038648|NCT01957488|11163190|FG003|COMPLETED|Test Period 2 (2 Weeks)||28
10038649|NCT01957488|11163191|FG004|COMPLETED|Test Period 2 (2 Weeks)||25
10038650|NCT01957488|11163192|FG005|COMPLETED|Test Period 2 (2 Weeks)||23
10038651|NCT01957488|11163187|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3
10038652|NCT01957488|11163188|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10038653|NCT01957488|11163189|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10038654|NCT01957488|11163190|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10038655|NCT01957488|11163191|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2
10038656|NCT01957488|11163192|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10038657|NCT01957488|11163187|FG000|STARTED|Test Period 3 (2 Weeks)||24
10038658|NCT01957488|11163188|FG001|STARTED|Test Period 3 (2 Weeks)||27
10038659|NCT01957488|11163189|FG002|STARTED|Test Period 3 (2 Weeks)||25
10038660|NCT01957488|11163190|FG003|STARTED|Test Period 3 (2 Weeks)||28
10038661|NCT01957488|11163191|FG004|STARTED|Test Period 3 (2 Weeks)||25
10038662|NCT01957488|11163192|FG005|STARTED|Test Period 3 (2 Weeks)||23
10038663|NCT01957488|11163187|FG000|COMPLETED|Test Period 3 (2 Weeks)||23
10038664|NCT01957488|11163188|FG001|COMPLETED|Test Period 3 (2 Weeks)||26
10038665|NCT01957488|11163189|FG002|COMPLETED|Test Period 3 (2 Weeks)||25
10038666|NCT01957488|11163190|FG003|COMPLETED|Test Period 3 (2 Weeks)||28
10038667|NCT01957488|11163191|FG004|COMPLETED|Test Period 3 (2 Weeks)||25
10038668|NCT01957488|11163192|FG005|COMPLETED|Test Period 3 (2 Weeks)||23
10038669|NCT01957488|11163187|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1
10038670|NCT01957488|11163188|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1
10038671|NCT01957488|11163189|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10038672|NCT01957488|11163190|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10038673|NCT01957488|11163191|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10038674|NCT01957488|11163192|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10038675|NCT01957553|11163200|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61
10038676|NCT01957553|11163201|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66
10038677|NCT01957553|11163200|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54
10038678|NCT01957553|11163201|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63
10038679|NCT01957553|11163200|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
10038680|NCT01957553|11163201|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
10038681|NCT01957553|11163200|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54
10038682|NCT01957553|11163201|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63
10038683|NCT01957553|11163200|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51
10038684|NCT01957553|11163201|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56
10038685|NCT01957553|11163200|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
10038686|NCT01957553|11163201|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
10038687|NCT01957579|11163211|FG000|STARTED|Overall Study||3
10038688|NCT01957579|11163212|FG001|STARTED|Overall Study||7
10038689|NCT01957579|11163213|FG002|STARTED|Overall Study||4
10038690|NCT01957579|11163214|FG003|STARTED|Overall Study||6
10038691|NCT01957579|11163211|FG000|COMPLETED|Overall Study||3
10038692|NCT01957579|11163212|FG001|COMPLETED|Overall Study||6
10038693|NCT01957579|11163213|FG002|COMPLETED|Overall Study||2
10038694|NCT01957579|11163214|FG003|COMPLETED|Overall Study||6
10038695|NCT01957579|11163211|FG000|NOT COMPLETED|Overall Study||0
10038696|NCT01957579|11163212|FG001|NOT COMPLETED|Overall Study||1
10038697|NCT01957579|11163213|FG002|NOT COMPLETED|Overall Study||2
10038698|NCT01957579|11163214|FG003|NOT COMPLETED|Overall Study||0
10038699|NCT01957644|11163246|FG000|STARTED|Overall Study||6
10038700|NCT01957644|11163247|FG001|STARTED|Overall Study||6
10038701|NCT01957644|11163248|FG002|STARTED|Overall Study||1
10038702|NCT01957644|11163249|FG003|STARTED|Overall Study||2
10038703|NCT01957644|11163250|FG004|STARTED|Overall Study||1
10038704|NCT01957644|11163246|FG000|COMPLETED|Overall Study||0
10038705|NCT01957644|11163247|FG001|COMPLETED|Overall Study||0
10038706|NCT01957644|11163248|FG002|COMPLETED|Overall Study||0
10038707|NCT01957644|11163249|FG003|COMPLETED|Overall Study||0
10038708|NCT01957644|11163250|FG004|COMPLETED|Overall Study||0
10038709|NCT01957644|11163246|FG000|NOT COMPLETED|Overall Study||6
10038710|NCT01957644|11163247|FG001|NOT COMPLETED|Overall Study||6
10038711|NCT01957644|11163248|FG002|NOT COMPLETED|Overall Study||1
10038712|NCT01957644|11163249|FG003|NOT COMPLETED|Overall Study||2
10038713|NCT01957644|11163250|FG004|NOT COMPLETED|Overall Study||1
10038714|NCT01957657|11163264|FG000|STARTED|Overall Study||4
10038715|NCT01957657|11163264|FG000|COMPLETED|Overall Study||4
10038716|NCT01957657|11163264|FG000|NOT COMPLETED|Overall Study||0
10038717|NCT01957709|11163268|FG000|STARTED|Overall Study||8
10038718|NCT01957709|11163268|FG000|COMPLETED|Overall Study||7
10038719|NCT01957709|11163268|FG000|NOT COMPLETED|Overall Study||1
10038720|NCT01957761|11163272|FG000|STARTED|Overall Study||189
10038721|NCT01957761|11163272|FG000|COMPLETED|Overall Study||189
10038722|NCT01957761|11163272|FG000|NOT COMPLETED|Overall Study||0
10038723|NCT01957787|11163276|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
10038724|NCT01957787|11163276|FG000|Intent-to-Treat (ITT) Population|Overall Study||130
10038725|NCT01957787|11163276|FG000|Modified ITT (mITT) Population|Overall Study||128
10038726|NCT01957787|11163276|FG000|COMPLETED|Overall Study||95
10038727|NCT01957787|11163276|FG000|NOT COMPLETED|Overall Study||36
10038728|NCT01957865|11163283|FG000|STARTED|Overall Study||21
10038729|NCT01957865|11163284|FG001|STARTED|Overall Study||20
10038730|NCT01957865|11163285|FG002|STARTED|Overall Study||22
10038731|NCT01957865|11163283|FG000|COMPLETED|Overall Study||21
10038732|NCT01957865|11163284|FG001|COMPLETED|Overall Study||18
10038733|NCT01957865|11163285|FG002|COMPLETED|Overall Study||19
10038734|NCT01957865|11163283|FG000|NOT COMPLETED|Overall Study||0
10038735|NCT01957865|11163284|FG001|NOT COMPLETED|Overall Study||2
10038736|NCT01957865|11163285|FG002|NOT COMPLETED|Overall Study||3
10038737|NCT01957930|11163297|FG000|STARTED|Overall Study||35
10038738|NCT01957930|11163298|FG001|STARTED|Overall Study||37
10038739|NCT01957930|11163299|FG002|STARTED|Overall Study||19
10038740|NCT01957930|11163297|FG000|COMPLETED|Overall Study||35
10038741|NCT01957930|11163298|FG001|COMPLETED|Overall Study||37
10038742|NCT01957930|11163299|FG002|COMPLETED|Overall Study||19
10038743|NCT01957930|11163297|FG000|NOT COMPLETED|Overall Study||0
10038744|NCT01957930|11163298|FG001|NOT COMPLETED|Overall Study||0
10038745|NCT01957930|11163299|FG002|NOT COMPLETED|Overall Study||0
10038746|NCT01958008|11163310|FG000|STARTED|Overall Study||21
10038747|NCT01958008|11163311|FG001|STARTED|Overall Study||21
10038748|NCT01958008|11163312|FG002|STARTED|Overall Study||21
10038749|NCT01958008|11163313|FG003|STARTED|Overall Study||21
10038750|NCT01958008|11163310|FG000|COMPLETED|Overall Study||20
10038751|NCT01958008|11163311|FG001|COMPLETED|Overall Study||21
10038752|NCT01958008|11163312|FG002|COMPLETED|Overall Study||20
10038753|NCT01958008|11163313|FG003|COMPLETED|Overall Study||21
10038754|NCT01958008|11163310|FG000|NOT COMPLETED|Overall Study||1
10038755|NCT01958008|11163311|FG001|NOT COMPLETED|Overall Study||0
10038756|NCT01958008|11163312|FG002|NOT COMPLETED|Overall Study||1
10038757|NCT01958008|11163313|FG003|NOT COMPLETED|Overall Study||0
10038758|NCT01958060|11163332|FG000|STARTED|Overall Study||10
10038759|NCT01958060|11163333|FG001|STARTED|Overall Study||6
10038760|NCT01958060|11163334|FG002|STARTED|Overall Study||6
10038761|NCT01958060|11163335|FG003|STARTED|Overall Study||5
10038762|NCT01958060|11163336|FG004|STARTED|Overall Study||7
10038763|NCT01958060|11163337|FG005|STARTED|Overall Study||1
10038764|NCT01958060|11163332|FG000|COMPLETED|Overall Study||8
10038765|NCT01958060|11163333|FG001|COMPLETED|Overall Study||6
10038766|NCT01958060|11163334|FG002|COMPLETED|Overall Study||6
10038767|NCT01958060|11163335|FG003|COMPLETED|Overall Study||5
10038768|NCT01958060|11163336|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
10038769|NCT01958060|11163337|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
10038770|NCT01958060|11163332|FG000|NOT COMPLETED|Overall Study||2
10038771|NCT01958060|11163333|FG001|NOT COMPLETED|Overall Study||0
10038772|NCT01958060|11163334|FG002|NOT COMPLETED|Overall Study||0
10038773|NCT01958060|11163335|FG003|NOT COMPLETED|Overall Study||0
10038774|NCT01958060|11163336|FG004|NOT COMPLETED|Overall Study||1
10038775|NCT01958060|11163337|FG005|NOT COMPLETED|Overall Study||0
10038776|NCT01958073|11163358|FG000|STARTED|Randomized Period||9
10038777|NCT01958073|11163359|FG001|STARTED|Randomized Period||9
10038778|NCT01958073|11163360|FG002|STARTED|Randomized Period||17
10038779|NCT01958073|11163361|FG003|STARTED|Randomized Period||0
10038780|NCT01958073|11163362|FG004|STARTED|Randomized Period||0
10038781|NCT01958073|11163358|FG000|COMPLETED|Randomized Period||7
10038782|NCT01958073|11163359|FG001|COMPLETED|Randomized Period||8
10038783|NCT01958073|11163360|FG002|COMPLETED|Randomized Period||11
10038784|NCT01958073|11163361|FG003|COMPLETED|Randomized Period||0
10038785|NCT01958073|11163362|FG004|COMPLETED|Randomized Period||0
10038786|NCT01958073|11163358|FG000|NOT COMPLETED|Randomized Period||2
10038787|NCT01958073|11163359|FG001|NOT COMPLETED|Randomized Period||1
10038788|NCT01958073|11163360|FG002|NOT COMPLETED|Randomized Period||6
10038789|NCT01958073|11163361|FG003|NOT COMPLETED|Randomized Period||0
10038790|NCT01958073|11163362|FG004|NOT COMPLETED|Randomized Period||0
10038791|NCT01958073|11163358|FG000|STARTED|Open Label Period||0
10038792|NCT01958073|11163359|FG001|STARTED|Open Label Period||0
10038793|NCT01958073|11163360|FG002|STARTED|Open Label Period||0
10038794|NCT01958073|11163361|FG003|STARTED|Open Label Period||5
10038795|NCT01958073|11163362|FG004|STARTED|Open Label Period||17
10038796|NCT01958073|11163358|FG000|COMPLETED|Open Label Period||0
10038797|NCT01958073|11163359|FG001|COMPLETED|Open Label Period||0
10038798|NCT01958073|11163360|FG002|COMPLETED|Open Label Period||0
10038799|NCT01958073|11163361|FG003|COMPLETED|Open Label Period||5
10038800|NCT01958073|11163362|FG004|COMPLETED|Open Label Period||17
10038801|NCT01958073|11163358|FG000|NOT COMPLETED|Open Label Period||0
10038802|NCT01958073|11163359|FG001|NOT COMPLETED|Open Label Period||0
10038803|NCT01958073|11163360|FG002|NOT COMPLETED|Open Label Period||0
10038804|NCT01958073|11163361|FG003|NOT COMPLETED|Open Label Period||0
10038805|NCT01958073|11163362|FG004|NOT COMPLETED|Open Label Period||0
10038806|NCT01958112|11163378|FG000|STARTED|Overall Study||14
10038807|NCT01958112|11163378|FG000|COMPLETED|Overall Study||14
10038808|NCT01958112|11163378|FG000|NOT COMPLETED|Overall Study||0
10038809|NCT01958125|11163384|FG000|STARTED|Overall Study||50
10038810|NCT01958125|11163385|FG001|STARTED|Overall Study||52
10038811|NCT01958125|11163384|FG000|COMPLETED|Overall Study||48
10038812|NCT01958125|11163385|FG001|COMPLETED|Overall Study||44
10038813|NCT01958125|11163384|FG000|NOT COMPLETED|Overall Study||2
10038814|NCT01958125|11163385|FG001|NOT COMPLETED|Overall Study||8
10038815|NCT01958164|11163393|FG000|STARTED|Overall Study|Randomised and treated|6
10038816|NCT01958164|11163394|FG001|STARTED|Overall Study|Randomised and treated|10
10038817|NCT01958164|11163393|FG000|COMPLETED|Overall Study||4
10038818|NCT01958164|11163394|FG001|COMPLETED|Overall Study||5
10038819|NCT01958164|11163393|FG000|NOT COMPLETED|Overall Study||2
10038820|NCT01958164|11163394|FG001|NOT COMPLETED|Overall Study||5
10038821|NCT01958281|11163403|FG000|STARTED|Overall Study||10
10038822|NCT01958281|11163404|FG001|STARTED|Overall Study||10
10038823|NCT01958281|11163405|FG002|STARTED|Overall Study||18
10038824|NCT01958281|11163403|FG000|COMPLETED|Overall Study||4
10038825|NCT01958281|11163404|FG001|COMPLETED|Overall Study||6
10038826|NCT01958281|11163405|FG002|COMPLETED|Overall Study||18
10038827|NCT01958281|11163403|FG000|NOT COMPLETED|Overall Study||6
10038828|NCT01958281|11163404|FG001|NOT COMPLETED|Overall Study||4
10038829|NCT01958281|11163405|FG002|NOT COMPLETED|Overall Study||0
10038830|NCT01958294|11163414|FG000|STARTED|Overall Study||12
10038831|NCT01958294|11163414|FG000|COMPLETED|Overall Study||10
10038832|NCT01958294|11163414|FG000|NOT COMPLETED|Overall Study||2
10038833|NCT01958320|11163420|FG000|STARTED|Overall Study||104
10038834|NCT01958320|11163421|FG001|STARTED|Overall Study||98
10038835|NCT01958320|11163420|FG000|COMPLETED|Overall Study||104
10038836|NCT01958320|11163421|FG001|COMPLETED|Overall Study||98
10038837|NCT01958320|11163420|FG000|NOT COMPLETED|Overall Study||0
10038838|NCT01958320|11163421|FG001|NOT COMPLETED|Overall Study||0
10038839|NCT01958346|11163431|FG000|STARTED|Overall Study||39
10038840|NCT01958346|11163432|FG001|STARTED|Overall Study||39
10038841|NCT01958346|11163431|FG000|COMPLETED|Overall Study||39
10038842|NCT01958346|11163432|FG001|COMPLETED|Overall Study||39
10038843|NCT01958346|11163431|FG000|NOT COMPLETED|Overall Study||0
10038844|NCT01958346|11163432|FG001|NOT COMPLETED|Overall Study||0
10038845|NCT01958437|11163440|FG000|STARTED|Overall Study||11
10038846|NCT01958437|11163441|FG001|STARTED|Overall Study||11
10038847|NCT01958437|11163442|FG002|STARTED|Overall Study||11
10038848|NCT01958437|11163443|FG003|STARTED|Overall Study||11
10038849|NCT01958437|11163440|FG000|COMPLETED|Overall Study||11
10038850|NCT01958437|11163441|FG001|COMPLETED|Overall Study||11
10038851|NCT01958437|11163442|FG002|COMPLETED|Overall Study||10
10038852|NCT01958437|11163443|FG003|COMPLETED|Overall Study||10
10038853|NCT01958437|11163440|FG000|NOT COMPLETED|Overall Study||0
10038854|NCT01958437|11163441|FG001|NOT COMPLETED|Overall Study||0
10038855|NCT01958437|11163442|FG002|NOT COMPLETED|Overall Study||1
10038856|NCT01958437|11163443|FG003|NOT COMPLETED|Overall Study||1
10038857|NCT01958476|11163462|FG000|STARTED|Overall Study||59
10038858|NCT01958476|11163463|FG001|STARTED|Overall Study||58
10038859|NCT01958476|11163462|FG000|COMPLETED|Overall Study||58
10038860|NCT01958476|11163463|FG001|COMPLETED|Overall Study||58
10038861|NCT01958476|11163462|FG000|NOT COMPLETED|Overall Study||1
10038862|NCT01958476|11163463|FG001|NOT COMPLETED|Overall Study||0
10038863|NCT01958489|11163469|FG000|STARTED|Period 1||24
10038864|NCT01958489|11163470|FG001|STARTED|Period 1||0
10038865|NCT01958489|11163469|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
10038866|NCT01958489|11163470|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
10038867|NCT01958489|11163469|FG000|COMPLETED|Period 1||24
10038868|NCT01958489|11163470|FG001|COMPLETED|Period 1||0
10038869|NCT01958489|11163469|FG000|NOT COMPLETED|Period 1||0
10038870|NCT01958489|11163470|FG001|NOT COMPLETED|Period 1||0
10038871|NCT01958489|11163469|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
10038872|NCT01958489|11163470|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
10038873|NCT01958489|11163469|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
10038874|NCT01958489|11163470|FG001|Received at Least 1 Dose of Study Drug|Period 2||24
10038875|NCT01958489|11163469|FG000|COMPLETED|Period 2||0
10038876|NCT01958489|11163470|FG001|COMPLETED|Period 2||23
10038877|NCT01958489|11163469|FG000|NOT COMPLETED|Period 2||0
10038878|NCT01958489|11163470|FG001|NOT COMPLETED|Period 2||1
10038879|NCT01958606|11163483|FG000|STARTED|Overall Study||13
10038880|NCT01958606|11163484|FG001|STARTED|Overall Study||5
10038881|NCT01958606|11163483|FG000|COMPLETED|Overall Study||11
10038882|NCT01958606|11163484|FG001|COMPLETED|Overall Study||5
10038883|NCT01958606|11163483|FG000|NOT COMPLETED|Overall Study||2
10038884|NCT01958606|11163484|FG001|NOT COMPLETED|Overall Study||0
10038885|NCT01958619|11163494|FG000|STARTED|Overall Study||15
10038886|NCT01958619|11163495|FG001|STARTED|Overall Study||14
10038887|NCT01958619|11163496|FG002|STARTED|Overall Study||14
10038888|NCT01958619|11163497|FG003|STARTED|Overall Study||12
10038889|NCT01958619|11163494|FG000|COMPLETED|Overall Study||13
10038890|NCT01958619|11163495|FG001|COMPLETED|Overall Study||14
10038891|NCT01958619|11163496|FG002|COMPLETED|Overall Study||13
10038892|NCT01958619|11163497|FG003|COMPLETED|Overall Study||12
10038893|NCT01958619|11163494|FG000|NOT COMPLETED|Overall Study||2
10038894|NCT01958619|11163495|FG001|NOT COMPLETED|Overall Study||0
10038895|NCT01958619|11163496|FG002|NOT COMPLETED|Overall Study||1
10038896|NCT01958619|11163497|FG003|NOT COMPLETED|Overall Study||0
10038897|NCT01958645|11163510|FG000|STARTED|Overall Study||4
10038898|NCT01958645|11163511|FG001|STARTED|Overall Study||4
10038899|NCT01958645|11163512|FG002|STARTED|Overall Study||4
10038900|NCT01958645|11163510|FG000|COMPLETED|Overall Study||4
10038901|NCT01958645|11163511|FG001|COMPLETED|Overall Study||4
10038902|NCT01958645|11163512|FG002|COMPLETED|Overall Study||4
10038903|NCT01958645|11163510|FG000|NOT COMPLETED|Overall Study||0
10038904|NCT01958645|11163511|FG001|NOT COMPLETED|Overall Study||0
10038905|NCT01958645|11163512|FG002|NOT COMPLETED|Overall Study||0
10038906|NCT01958671|11163525|FG000|STARTED|Overall Study||156
10038907|NCT01958671|11163526|FG001|STARTED|Overall Study||152
10038908|NCT01958671|11163527|FG002|STARTED|Overall Study||153
10038909|NCT01958671|11163525|FG000|COMPLETED|Overall Study||137
10038910|NCT01958671|11163526|FG001|COMPLETED|Overall Study||128
10038911|NCT01958671|11163527|FG002|COMPLETED|Overall Study||121
10038912|NCT01958671|11163525|FG000|NOT COMPLETED|Overall Study||19
10038913|NCT01958671|11163526|FG001|NOT COMPLETED|Overall Study||24
10038914|NCT01958671|11163527|FG002|NOT COMPLETED|Overall Study||32
10038915|NCT01958788|11163539|FG000|STARTED|Overall Study||7
10038916|NCT01958788|11163539|FG000|COMPLETED|Overall Study||7
10038917|NCT01958788|11163539|FG000|NOT COMPLETED|Overall Study||0
10038918|NCT01958827|11163543|FG000|STARTED|Overall Study||28
10038919|NCT01958827|11163543|FG000|COMPLETED|Overall Study||18
10038920|NCT01958827|11163543|FG000|NOT COMPLETED|Overall Study||10
10038921|NCT01958918|11163549|FG000|STARTED|Overall Study||356
10038922|NCT01958918|11163550|FG001|STARTED|Overall Study||356
10038923|NCT01958918|11163549|FG000|Full Analysis Set|Overall Study||353
10038924|NCT01958918|11163550|FG001|Full Analysis Set|Overall Study||354
10038925|NCT01958918|11163549|FG000|COMPLETED|Overall Study||313
10038926|NCT01958918|11163550|FG001|COMPLETED|Overall Study||314
10038927|NCT01958918|11163549|FG000|NOT COMPLETED|Overall Study||43
10038928|NCT01958918|11163550|FG001|NOT COMPLETED|Overall Study||42
10038929|NCT01959035|11163556|FG000|STARTED|Overall Study||88
10038930|NCT01959035|11163556|FG000|COMPLETED|Overall Study||77
10038931|NCT01959035|11163556|FG000|NOT COMPLETED|Overall Study||11
10038932|NCT01959048|11163560|FG000|STARTED|Overall Study||3
10038933|NCT01959048|11163560|FG000|COMPLETED|Overall Study||3
10038934|NCT01959048|11163560|FG000|NOT COMPLETED|Overall Study||0
10038935|NCT01959113|11163564|FG000|STARTED|Overall Study||5
10038936|NCT01959113|11163564|FG000|COMPLETED|Overall Study||5
10038937|NCT01959113|11163564|FG000|NOT COMPLETED|Overall Study||0
10038938|NCT01959165|11163574|FG000|STARTED|Overall Study||13
10038939|NCT01959165|11163575|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
10038940|NCT01959165|11163576|FG002|STARTED|Overall Study||12
10038941|NCT01959165|11163577|FG003|STARTED|Overall Study||9
10038942|NCT01959165|11163574|FG000|COMPLETED|Overall Study||12
10038943|NCT01959165|11163575|FG001|COMPLETED|Overall Study||10
10038944|NCT01959165|11163576|FG002|COMPLETED|Overall Study||12
10038945|NCT01959165|11163577|FG003|COMPLETED|Overall Study||7
10038946|NCT01959165|11163574|FG000|NOT COMPLETED|Overall Study||1
10038947|NCT01959165|11163575|FG001|NOT COMPLETED|Overall Study||1
10038948|NCT01959165|11163576|FG002|NOT COMPLETED|Overall Study||0
10038949|NCT01959165|11163577|FG003|NOT COMPLETED|Overall Study||2
10038950|NCT01959178|11163587|FG000|STARTED|Overall Study||73
10038951|NCT01959178|11163588|FG001|STARTED|Overall Study||73
10038952|NCT01959178|11163587|FG000|COMPLETED|Overall Study||71
10038953|NCT01959178|11163588|FG001|COMPLETED|Overall Study||71
10038954|NCT01959178|11163587|FG000|NOT COMPLETED|Overall Study||2
10038955|NCT01959178|11163588|FG001|NOT COMPLETED|Overall Study||2
10038956|NCT01959230|11163596|FG000|STARTED|Overall Study||40
10038957|NCT01959230|11163597|FG001|STARTED|Overall Study||20
10038958|NCT01959230|11163596|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
10038959|NCT01959230|11163597|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
10038960|NCT01959230|11163596|FG000|COMPLETED|Overall Study||36
10038961|NCT01959230|11163597|FG001|COMPLETED|Overall Study||19
10038962|NCT01959230|11163596|FG000|NOT COMPLETED|Overall Study||4
10038963|NCT01959230|11163597|FG001|NOT COMPLETED|Overall Study||1
10038964|NCT01959243|11163605|FG000|STARTED|Overall Study||337
10038965|NCT01959243|11163606|FG001|STARTED|Overall Study||170
10038966|NCT01959243|11163605|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337
10038967|NCT01959243|11163606|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
10038968|NCT01959243|11163605|FG000|COMPLETED|Overall Study||324
10038969|NCT01959243|11163606|FG001|COMPLETED|Overall Study||166
10038970|NCT01959243|11163605|FG000|NOT COMPLETED|Overall Study||13
10038971|NCT01959243|11163606|FG001|NOT COMPLETED|Overall Study||4
10038972|NCT01959334|11163614|FG000|STARTED|First Dose||26
10038973|NCT01959334|11163615|FG001|STARTED|First Dose||49
10038974|NCT01959334|11163614|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
10038975|NCT01959334|11163615|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
10038976|NCT01959334|11163614|FG000|NOT COMPLETED|First Dose||0
10038977|NCT01959334|11163615|FG001|NOT COMPLETED|First Dose||0
10038978|NCT01959334|11163614|FG000|STARTED|Second Dose||26
10038979|NCT01959334|11163615|FG001|STARTED|Second Dose||49
10038980|NCT01959334|11163614|FG000|COMPLETED|Second Dose||25
10038981|NCT01959334|11163615|FG001|COMPLETED|Second Dose||49
10038982|NCT01959334|11163614|FG000|NOT COMPLETED|Second Dose||1
10038983|NCT01959334|11163615|FG001|NOT COMPLETED|Second Dose||0
10038984|NCT01959334|11163614|FG000|STARTED|Third Dose||25
10038985|NCT01959334|11163615|FG001|STARTED|Third Dose||49
10038986|NCT01959334|11163614|FG000|COMPLETED|Third Dose||25
10038987|NCT01959334|11163615|FG001|COMPLETED|Third Dose||48
10038988|NCT01959334|11163614|FG000|NOT COMPLETED|Third Dose||0
10038989|NCT01959334|11163615|FG001|NOT COMPLETED|Third Dose||1
10038990|NCT01959347|11163623|FG000|STARTED|Overall Study||238
10038991|NCT01959347|11163624|FG001|STARTED|Overall Study||242
10038992|NCT01959347|11163623|FG000|COMPLETED|Overall Study||229
10038993|NCT01959347|11163624|FG001|COMPLETED|Overall Study||235
10038994|NCT01959347|11163623|FG000|NOT COMPLETED|Overall Study||9
10038995|NCT01959347|11163624|FG001|NOT COMPLETED|Overall Study||7
10038996|NCT01959412|11163630|FG000|STARTED|Overall Study||15
10038997|NCT01959412|11163631|FG001|STARTED|Overall Study||15
10038998|NCT01959412|11163632|FG002|STARTED|Overall Study||15
10038999|NCT01959412|11163633|FG003|STARTED|Overall Study||15
10039000|NCT01959412|11163634|FG004|STARTED|Overall Study||16
10039001|NCT01959412|11163635|FG005|STARTED|Overall Study||15
10039002|NCT01959412|11163630|FG000|COMPLETED|Overall Study||14
10039003|NCT01959412|11163631|FG001|COMPLETED|Overall Study||14
10039004|NCT01959412|11163632|FG002|COMPLETED|Overall Study||15
10039005|NCT01959412|11163633|FG003|COMPLETED|Overall Study||13
10039006|NCT01959412|11163634|FG004|COMPLETED|Overall Study||13
10039007|NCT01959412|11163635|FG005|COMPLETED|Overall Study||15
10039008|NCT01959412|11163630|FG000|NOT COMPLETED|Overall Study||1
10039009|NCT01959412|11163631|FG001|NOT COMPLETED|Overall Study||1
10039010|NCT01959412|11163632|FG002|NOT COMPLETED|Overall Study||0
10039011|NCT01959412|11163633|FG003|NOT COMPLETED|Overall Study||2
10039012|NCT01959412|11163634|FG004|NOT COMPLETED|Overall Study||3
10039013|NCT01959412|11163635|FG005|NOT COMPLETED|Overall Study||0
10039014|NCT01959425|11163651|FG000|STARTED|Overall Study||32
10039015|NCT01959425|11163652|FG001|STARTED|Overall Study||31
10039016|NCT01959425|11163651|FG000|COMPLETED|Overall Study||20
10039017|NCT01959425|11163652|FG001|COMPLETED|Overall Study||23
10039018|NCT01959425|11163651|FG000|NOT COMPLETED|Overall Study||12
10039019|NCT01959425|11163652|FG001|NOT COMPLETED|Overall Study||8
10039020|NCT01959490|11163661|FG000|STARTED|Overall Study||5
10039021|NCT01959490|11163662|FG001|STARTED|Overall Study||6
10039022|NCT01959490|11163663|FG002|STARTED|Overall Study||5
10039023|NCT01959490|11163661|FG000|COMPLETED|Overall Study||5
10039024|NCT01959490|11163662|FG001|COMPLETED|Overall Study||6
10039025|NCT01959490|11163663|FG002|COMPLETED|Overall Study||5
10039026|NCT01959490|11163661|FG000|NOT COMPLETED|Overall Study||0
10039027|NCT01959490|11163662|FG001|NOT COMPLETED|Overall Study||0
10039028|NCT01959490|11163663|FG002|NOT COMPLETED|Overall Study||0
10039029|NCT01959503|11163673|FG000|STARTED|Overall Study||107
10039030|NCT01959503|11163674|FG001|STARTED|Overall Study||51
10039031|NCT01959503|11163673|FG000|COMPLETED|Overall Study||104
10039032|NCT01959503|11163674|FG001|COMPLETED|Overall Study||49
10039033|NCT01959503|11163673|FG000|NOT COMPLETED|Overall Study||3
10039034|NCT01959503|11163674|FG001|NOT COMPLETED|Overall Study||2
10039035|NCT01959516|11163680|FG000|STARTED|Epoch 1||63
10039036|NCT01959516|11163681|FG001|STARTED|Epoch 1||63
10039037|NCT01959516|11163680|FG000|Safety Population|Epoch 1||62
10039038|NCT01959516|11163681|FG001|Safety Population|Epoch 1||62
10039039|NCT01959516|11163680|FG000|ITT Population|Epoch 1||62
10039040|NCT01959516|11163681|FG001|ITT Population|Epoch 1||62
10039041|NCT01959516|11163680|FG000|COMPLETED|Epoch 1||53
10039042|NCT01959516|11163681|FG001|COMPLETED|Epoch 1||58
10039043|NCT01959516|11163680|FG000|NOT COMPLETED|Epoch 1||10
10039044|NCT01959516|11163681|FG001|NOT COMPLETED|Epoch 1||5
10039045|NCT01959516|11163680|FG000|STARTED|Epoch 2||63
10039046|NCT01959516|11163681|FG001|STARTED|Epoch 2||63
10039047|NCT01959516|11163680|FG000|COMPLETED|Epoch 2||61
10039048|NCT01959516|11163681|FG001|COMPLETED|Epoch 2||62
10039049|NCT01959516|11163680|FG000|NOT COMPLETED|Epoch 2||2
10039050|NCT01959516|11163681|FG001|NOT COMPLETED|Epoch 2||1
10039051|NCT01959529|11163689|FG000|STARTED|Overall Study||3818
10039052|NCT01959529|11163690|FG001|STARTED|Overall Study||3819
10039053|NCT01959529|11163689|FG000|Exposed|Overall Study||3809
10039054|NCT01959529|11163690|FG001|Exposed|Overall Study||3806
10039055|NCT01959529|11163689|FG000|COMPLETED|Overall Study||3742
10039056|NCT01959529|11163690|FG001|COMPLETED|Overall Study||3747
10039057|NCT01959529|11163689|FG000|NOT COMPLETED|Overall Study||76
10039058|NCT01959529|11163690|FG001|NOT COMPLETED|Overall Study||72
10039059|NCT01959542|11163696|FG000|STARTED|Overall Study||15
10039060|NCT01959542|11163696|FG000|Evaluable at Visit 1|Overall Study||12
10039061|NCT01959542|11163696|FG000|Evaluable at Visit 2|Overall Study||12
10039062|NCT01959542|11163696|FG000|COMPLETED|Overall Study||12
10039063|NCT01959542|11163696|FG000|NOT COMPLETED|Overall Study||3
10039064|NCT01959581|11163701|FG000|STARTED|Overall Study||30
10039065|NCT01959581|11163701|FG000|COMPLETED|Overall Study||25
10039066|NCT01959581|11163701|FG000|NOT COMPLETED|Overall Study||5
10039067|NCT01959607|11163707|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10039068|NCT01959607|11163708|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10039069|NCT01959607|11163709|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10039070|NCT01959607|11163710|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10116332|NCT02531633|11247054|FG003|STARTED|Part B (104 Weeks)||0
10116333|NCT02531633|11247055|FG004|STARTED|Part B (104 Weeks)||0
10116334|NCT02531633|11247056|FG005|STARTED|Part B (104 Weeks)||8
10116335|NCT02531633|11247057|FG006|STARTED|Part B (104 Weeks)||5
10116336|NCT02531633|11247058|FG007|STARTED|Part B (104 Weeks)||4
10116337|NCT02531633|11247059|FG008|STARTED|Part B (104 Weeks)||5
10116338|NCT02531633|11247060|FG009|STARTED|Part B (104 Weeks)||4
10116339|NCT02531633|11247051|FG000|COMPLETED|Part B (104 Weeks)||0
10116340|NCT02531633|11247052|FG001|COMPLETED|Part B (104 Weeks)||0
9706365|NCT00061945|10805385|FG000|COMPLETED|Registration Through Course 3||25
9706366|NCT00061945|10805386|FG001|COMPLETED|Registration Through Course 3||66
9706367|NCT00061945|10805385|FG000|NOT COMPLETED|Registration Through Course 3||94
10039071|NCT01959607|11163707|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10039072|NCT01959607|11163708|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
10039073|NCT01959607|11163709|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10039074|NCT01959607|11163710|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10039075|NCT01959607|11163707|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10039076|NCT01959607|11163708|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10039077|NCT01959607|11163709|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10039078|NCT01959607|11163710|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10039079|NCT01959607|11163707|FG000|STARTED|First Intervention (Day 1)||22
10039080|NCT01959607|11163708|FG001|STARTED|First Intervention (Day 1)||22
10116341|NCT02531633|11247053|FG002|COMPLETED|Part B (104 Weeks)||0
10116342|NCT02531633|11247054|FG003|COMPLETED|Part B (104 Weeks)||0
10116343|NCT02531633|11247055|FG004|COMPLETED|Part B (104 Weeks)||0
10116344|NCT02531633|11247056|FG005|COMPLETED|Part B (104 Weeks)||0
10116345|NCT02531633|11247057|FG006|COMPLETED|Part B (104 Weeks)||0
10116346|NCT02531633|11247058|FG007|COMPLETED|Part B (104 Weeks)||0
10116347|NCT02531633|11247059|FG008|COMPLETED|Part B (104 Weeks)||0
10116348|NCT02531633|11247060|FG009|COMPLETED|Part B (104 Weeks)||0
10116349|NCT02531633|11247051|FG000|NOT COMPLETED|Part B (104 Weeks)||0
10116350|NCT02531633|11247052|FG001|NOT COMPLETED|Part B (104 Weeks)||0
10116351|NCT02531633|11247053|FG002|NOT COMPLETED|Part B (104 Weeks)||0
10116352|NCT02531633|11247054|FG003|NOT COMPLETED|Part B (104 Weeks)||0
10116353|NCT02531633|11247055|FG004|NOT COMPLETED|Part B (104 Weeks)||0
10116354|NCT02531633|11247056|FG005|NOT COMPLETED|Part B (104 Weeks)||8
10116355|NCT02531633|11247057|FG006|NOT COMPLETED|Part B (104 Weeks)||5
10116356|NCT02531633|11247058|FG007|NOT COMPLETED|Part B (104 Weeks)||4
10116357|NCT02531633|11247059|FG008|NOT COMPLETED|Part B (104 Weeks)||5
10116358|NCT02531633|11247060|FG009|NOT COMPLETED|Part B (104 Weeks)||4
10116359|NCT02531646|11247103|FG000|STARTED|Overall Study||37
10116360|NCT02531646|11247104|FG001|STARTED|Overall Study||18
10116361|NCT02531646|11247105|FG002|STARTED|Overall Study||11
10116362|NCT02531646|11247103|FG000|COMPLETED|Overall Study||32
10116363|NCT02531646|11247104|FG001|COMPLETED|Overall Study||17
10116364|NCT02531646|11247105|FG002|COMPLETED|Overall Study||11
10116365|NCT02531646|11247103|FG000|NOT COMPLETED|Overall Study||5
10116366|NCT02531646|11247104|FG001|NOT COMPLETED|Overall Study||1
10116367|NCT02531646|11247105|FG002|NOT COMPLETED|Overall Study||0
10116368|NCT02531698|11247115|FG000|STARTED|Overall Study||294
10116369|NCT02531698|11247116|FG001|STARTED|Overall Study||106
10116370|NCT02531698|11247115|FG000|COMPLETED|Overall Study||283
10116371|NCT02531698|11247116|FG001|COMPLETED|Overall Study||104
10116372|NCT02531698|11247115|FG000|NOT COMPLETED|Overall Study||11
10116373|NCT02531698|11247116|FG001|NOT COMPLETED|Overall Study||2
10116374|NCT02531802|11247152|FG000|STARTED|Received Vaccination 1||15
10116375|NCT02531802|11247153|FG001|STARTED|Received Vaccination 1||15
10116376|NCT02531802|11247154|FG002|STARTED|Received Vaccination 1||15
10116377|NCT02531802|11247155|FG003|STARTED|Received Vaccination 1||15
10116378|NCT02531802|11247156|FG004|STARTED|Received Vaccination 1||15
10116379|NCT02531802|11247157|FG005|STARTED|Received Vaccination 1||3
10116380|NCT02531802|11247158|FG006|STARTED|Received Vaccination 1||15
10116381|NCT02531802|11247159|FG007|STARTED|Received Vaccination 1||15
10116382|NCT02531802|11247160|FG008|STARTED|Received Vaccination 1||15
10039081|NCT01959607|11163709|FG002|STARTED|First Intervention (Day 1)||9
10039082|NCT01959607|11163710|FG003|STARTED|First Intervention (Day 1)||9
10039083|NCT01959607|11163707|FG000|COMPLETED|First Intervention (Day 1)||21
10039084|NCT01959607|11163708|FG001|COMPLETED|First Intervention (Day 1)||21
10116383|NCT02531802|11247161|FG009|STARTED|Received Vaccination 1||52
10116384|NCT02531802|11247162|FG010|STARTED|Received Vaccination 1||15
10116385|NCT02531802|11247163|FG011|STARTED|Received Vaccination 1||15
10116386|NCT02531802|11247164|FG012|STARTED|Received Vaccination 1||15
10116387|NCT02531802|11247165|FG013|STARTED|Received Vaccination 1||15
10116388|NCT02531802|11247166|FG014|STARTED|Received Vaccination 1||40
10116389|NCT02531802|11247167|FG015|STARTED|Received Vaccination 1||30
10039085|NCT01959607|11163709|FG002|COMPLETED|First Intervention (Day 1)||9
10039086|NCT01959607|11163710|FG003|COMPLETED|First Intervention (Day 1)||9
10039087|NCT01959607|11163707|FG000|NOT COMPLETED|First Intervention (Day 1)||1
10039088|NCT01959607|11163708|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10039089|NCT01959607|11163709|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10039090|NCT01959607|11163710|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10039091|NCT01959607|11163707|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
10039092|NCT01959607|11163708|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
10039093|NCT01959607|11163709|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10039094|NCT01959607|11163710|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
10039095|NCT01959607|11163707|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
10039096|NCT01959607|11163708|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
10039097|NCT01959607|11163709|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10039098|NCT01959607|11163710|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
10039099|NCT01959607|11163707|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10039100|NCT01959607|11163708|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10039101|NCT01959607|11163709|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10039102|NCT01959607|11163710|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10039103|NCT01959607|11163707|FG000|STARTED|Second Intervention (Day 3)||21
10039104|NCT01959607|11163708|FG001|STARTED|Second Intervention (Day 3)||21
10039105|NCT01959607|11163709|FG002|STARTED|Second Intervention (Day 3)||9
10039106|NCT01959607|11163710|FG003|STARTED|Second Intervention (Day 3)||9
10039107|NCT01959607|11163707|FG000|COMPLETED|Second Intervention (Day 3)||21
10039108|NCT01959607|11163708|FG001|COMPLETED|Second Intervention (Day 3)||21
10039109|NCT01959607|11163709|FG002|COMPLETED|Second Intervention (Day 3)||9
10039110|NCT01959607|11163710|FG003|COMPLETED|Second Intervention (Day 3)||9
10039111|NCT01959607|11163707|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10039112|NCT01959607|11163708|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10039113|NCT01959607|11163709|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10039114|NCT01959607|11163710|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10039115|NCT01959672|11163719|FG000|STARTED|Overall Study||11
10039116|NCT01959672|11163719|FG000|COMPLETED|Overall Study||10
10039117|NCT01959672|11163719|FG000|NOT COMPLETED|Overall Study||1
10039118|NCT01959685|11163726|FG000|STARTED|Overall Study||9
10039119|NCT01959685|11163726|FG000|COMPLETED|Overall Study||9
10039120|NCT01959685|11163726|FG000|NOT COMPLETED|Overall Study||0
10039121|NCT01959698|11163737|FG000|STARTED|Overall Study||3
10039122|NCT01959698|11163738|FG001|STARTED|Overall Study||3
10039123|NCT01959698|11163739|FG002|STARTED|Overall Study||3
10039124|NCT01959698|11163740|FG003|STARTED|Overall Study||3
10039125|NCT01959698|11163741|FG004|STARTED|Overall Study||3
10039126|NCT01959698|11163742|FG005|STARTED|Overall Study||6
10039127|NCT01959698|11163743|FG006|STARTED|Overall Study||8
10039128|NCT01959698|11163737|FG000|COMPLETED|Overall Study||2
10039129|NCT01959698|11163738|FG001|COMPLETED|Overall Study||3
10039130|NCT01959698|11163739|FG002|COMPLETED|Overall Study||2
10039131|NCT01959698|11163740|FG003|COMPLETED|Overall Study||1
10039132|NCT01959698|11163741|FG004|COMPLETED|Overall Study||3
10039133|NCT01959698|11163742|FG005|COMPLETED|Overall Study||3
10039134|NCT01959698|11163743|FG006|COMPLETED|Overall Study||4
10039135|NCT01959698|11163737|FG000|NOT COMPLETED|Overall Study||1
10039136|NCT01959698|11163738|FG001|NOT COMPLETED|Overall Study||0
10039137|NCT01959698|11163739|FG002|NOT COMPLETED|Overall Study||1
10039138|NCT01959698|11163740|FG003|NOT COMPLETED|Overall Study||2
10039139|NCT01959698|11163741|FG004|NOT COMPLETED|Overall Study||0
10039140|NCT01959698|11163742|FG005|NOT COMPLETED|Overall Study||3
10039141|NCT01959698|11163743|FG006|NOT COMPLETED|Overall Study||4
10039142|NCT01959841|11163763|FG000|STARTED|Overall Study||252
10039143|NCT01959841|11163764|FG001|STARTED|Overall Study||250
10039144|NCT01959841|11163765|FG002|STARTED|Overall Study||249
10039145|NCT01959841|11163763|FG000|Full Analysis Set Included|Overall Study||247
10039146|NCT01959841|11163764|FG001|Full Analysis Set Included|Overall Study||243
10039147|NCT01959841|11163765|FG002|Full Analysis Set Included|Overall Study||245
10039148|NCT01959841|11163763|FG000|Full Analysis Set Excluded|Overall Study||5
10039149|NCT01959841|11163764|FG001|Full Analysis Set Excluded|Overall Study||7
10039150|NCT01959841|11163765|FG002|Full Analysis Set Excluded|Overall Study||4
10039151|NCT01959841|11163763|FG000|Reason FAS Excluding 1|Overall Study||5
10039152|NCT01959841|11163764|FG001|Reason FAS Excluding 1|Overall Study||5
10039153|NCT01959841|11163765|FG002|Reason FAS Excluding 1|Overall Study||4
10039154|NCT01959841|11163763|FG000|Reason FAS Excluding 2|Overall Study||0
10039155|NCT01959841|11163764|FG001|Reason FAS Excluding 2|Overall Study||1
10039156|NCT01959841|11163765|FG002|Reason FAS Excluding 2|Overall Study||0
10039157|NCT01959841|11163763|FG000|Reason FAS Excluding 3|Overall Study||0
10039158|NCT01959841|11163764|FG001|Reason FAS Excluding 3|Overall Study||1
10039159|NCT01959841|11163765|FG002|Reason FAS Excluding 3|Overall Study||0
10039160|NCT01959841|11163763|FG000|COMPLETED|Overall Study||209
10039161|NCT01959841|11163764|FG001|COMPLETED|Overall Study||193
10039162|NCT01959841|11163765|FG002|COMPLETED|Overall Study||206
10039163|NCT01959841|11163763|FG000|NOT COMPLETED|Overall Study||43
10039164|NCT01959841|11163764|FG001|NOT COMPLETED|Overall Study||57
10039165|NCT01959841|11163765|FG002|NOT COMPLETED|Overall Study||43
10039166|NCT01959880|11163777|FG000|STARTED|Overall Study||1132
10039167|NCT01959880|11163778|FG001|STARTED|Overall Study||369
10039168|NCT01959880|11163779|FG002|STARTED|Overall Study||209
10039169|NCT01959880|11163780|FG003|STARTED|Overall Study||181
10116390|NCT02531802|11247168|FG016|STARTED|Received Vaccination 1||30
10039170|NCT01959880|11163777|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
10039171|NCT01959880|11163778|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
9848376|NCT00858780|10961054|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
9848377|NCT00858780|10961050|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
9848378|NCT00858780|10961051|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
9848379|NCT00858780|10961052|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
9848380|NCT00858780|10961053|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
10039172|NCT01959880|11163779|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
10039173|NCT01959880|11163780|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
10039174|NCT01959880|11163777|FG000|NOT COMPLETED|Overall Study||1132
10039175|NCT01959880|11163778|FG001|NOT COMPLETED|Overall Study||369
10039176|NCT01959880|11163779|FG002|NOT COMPLETED|Overall Study||208
10039177|NCT01959880|11163780|FG003|NOT COMPLETED|Overall Study||181
10039178|NCT01959919|11163790|FG000|STARTED|Overall Study||86
10039179|NCT01959919|11163790|FG000|COMPLETED|Overall Study||84
10039180|NCT01959919|11163790|FG000|NOT COMPLETED|Overall Study||2
10039181|NCT01959932|11163797|FG000|STARTED|Overall Study||80
10039182|NCT01959932|11163798|FG001|STARTED|Overall Study||41
10039183|NCT01959932|11163799|FG002|STARTED|Overall Study||39
10039184|NCT01959932|11163797|FG000|COMPLETED|Overall Study||79
10039185|NCT01959932|11163798|FG001|COMPLETED|Overall Study||41
10039186|NCT01959932|11163799|FG002|COMPLETED|Overall Study||39
10116391|NCT02531802|11247169|FG017|STARTED|Received Vaccination 1||30
10116392|NCT02531802|11247170|FG018|STARTED|Received Vaccination 1||30
10116393|NCT02531802|11247171|FG019|STARTED|Received Vaccination 1||30
10116394|NCT02531802|11247172|FG020|STARTED|Received Vaccination 1||50
10116395|NCT02531802|11247152|FG000|COMPLETED|Received Vaccination 1||15
10116396|NCT02531802|11247153|FG001|COMPLETED|Received Vaccination 1||15
10116397|NCT02531802|11247154|FG002|COMPLETED|Received Vaccination 1||15
10116398|NCT02531802|11247155|FG003|COMPLETED|Received Vaccination 1||15
10116399|NCT02531802|11247156|FG004|COMPLETED|Received Vaccination 1||15
10116400|NCT02531802|11247157|FG005|COMPLETED|Received Vaccination 1||3
10116401|NCT02531802|11247158|FG006|COMPLETED|Received Vaccination 1||15
10116402|NCT02531802|11247159|FG007|COMPLETED|Received Vaccination 1||15
10116403|NCT02531802|11247160|FG008|COMPLETED|Received Vaccination 1||15
10116404|NCT02531802|11247161|FG009|COMPLETED|Received Vaccination 1||52
10116405|NCT02531802|11247162|FG010|COMPLETED|Received Vaccination 1||15
10116406|NCT02531802|11247163|FG011|COMPLETED|Received Vaccination 1||15
10116407|NCT02531802|11247164|FG012|COMPLETED|Received Vaccination 1||15
10116408|NCT02531802|11247165|FG013|COMPLETED|Received Vaccination 1||15
10116409|NCT02531802|11247166|FG014|COMPLETED|Received Vaccination 1||40
10116410|NCT02531802|11247167|FG015|COMPLETED|Received Vaccination 1||30
10116411|NCT02531802|11247168|FG016|COMPLETED|Received Vaccination 1||30
10116412|NCT02531802|11247169|FG017|COMPLETED|Received Vaccination 1||30
10116413|NCT02531802|11247170|FG018|COMPLETED|Received Vaccination 1||30
10116414|NCT02531802|11247171|FG019|COMPLETED|Received Vaccination 1||30
10116415|NCT02531802|11247172|FG020|COMPLETED|Received Vaccination 1||50
10116416|NCT02531802|11247152|FG000|NOT COMPLETED|Received Vaccination 1||0
10116417|NCT02531802|11247153|FG001|NOT COMPLETED|Received Vaccination 1||0
10116418|NCT02531802|11247154|FG002|NOT COMPLETED|Received Vaccination 1||0
10116419|NCT02531802|11247155|FG003|NOT COMPLETED|Received Vaccination 1||0
10116420|NCT02531802|11247156|FG004|NOT COMPLETED|Received Vaccination 1||0
10116421|NCT02531802|11247157|FG005|NOT COMPLETED|Received Vaccination 1||0
10116422|NCT02531802|11247158|FG006|NOT COMPLETED|Received Vaccination 1||0
10116423|NCT02531802|11247159|FG007|NOT COMPLETED|Received Vaccination 1||0
10116424|NCT02531802|11247160|FG008|NOT COMPLETED|Received Vaccination 1||0
10116425|NCT02531802|11247161|FG009|NOT COMPLETED|Received Vaccination 1||0
10116426|NCT02531802|11247162|FG010|NOT COMPLETED|Received Vaccination 1||0
10116427|NCT02531802|11247163|FG011|NOT COMPLETED|Received Vaccination 1||0
10116428|NCT02531802|11247164|FG012|NOT COMPLETED|Received Vaccination 1||0
10116429|NCT02531802|11247165|FG013|NOT COMPLETED|Received Vaccination 1||0
10116430|NCT02531802|11247166|FG014|NOT COMPLETED|Received Vaccination 1||0
10116431|NCT02531802|11247167|FG015|NOT COMPLETED|Received Vaccination 1||0
10116432|NCT02531802|11247168|FG016|NOT COMPLETED|Received Vaccination 1||0
10116433|NCT02531802|11247169|FG017|NOT COMPLETED|Received Vaccination 1||0
10116434|NCT02531802|11247170|FG018|NOT COMPLETED|Received Vaccination 1||0
10116435|NCT02531802|11247171|FG019|NOT COMPLETED|Received Vaccination 1||0
10116436|NCT02531802|11247172|FG020|NOT COMPLETED|Received Vaccination 1||0
10116437|NCT02531802|11247152|FG000|STARTED|Received Vaccination 2||15
10116438|NCT02531802|11247153|FG001|STARTED|Received Vaccination 2||15
10116439|NCT02531802|11247154|FG002|STARTED|Received Vaccination 2||15
10116440|NCT02531802|11247155|FG003|STARTED|Received Vaccination 2||15
10116441|NCT02531802|11247156|FG004|STARTED|Received Vaccination 2||15
10116442|NCT02531802|11247157|FG005|STARTED|Received Vaccination 2||3
10116443|NCT02531802|11247158|FG006|STARTED|Received Vaccination 2||15
10116444|NCT02531802|11247159|FG007|STARTED|Received Vaccination 2||15
10116445|NCT02531802|11247160|FG008|STARTED|Received Vaccination 2||15
10116446|NCT02531802|11247161|FG009|STARTED|Received Vaccination 2||52
10116447|NCT02531802|11247162|FG010|STARTED|Received Vaccination 2||15
10116448|NCT02531802|11247163|FG011|STARTED|Received Vaccination 2||15
10116449|NCT02531802|11247164|FG012|STARTED|Received Vaccination 2||15
10116450|NCT02531802|11247165|FG013|STARTED|Received Vaccination 2||15
10039187|NCT01959932|11163797|FG000|NOT COMPLETED|Overall Study||1
10039188|NCT01959932|11163798|FG001|NOT COMPLETED|Overall Study||0
10039189|NCT01959932|11163799|FG002|NOT COMPLETED|Overall Study||0
10039190|NCT01959945|11163812|FG000|STARTED|Overall Study||80
10039191|NCT01959945|11163813|FG001|STARTED|Overall Study||78
10039192|NCT01959945|11163814|FG002|STARTED|Overall Study||28
10039193|NCT01959945|11163815|FG003|STARTED|Overall Study||31
10039194|NCT01959945|11163812|FG000|COMPLETED|Overall Study||76
10039195|NCT01959945|11163813|FG001|COMPLETED|Overall Study||75
10039196|NCT01959945|11163814|FG002|COMPLETED|Overall Study||9
10039197|NCT01959945|11163815|FG003|COMPLETED|Overall Study||15
10039198|NCT01959945|11163812|FG000|NOT COMPLETED|Overall Study||4
10039199|NCT01959945|11163813|FG001|NOT COMPLETED|Overall Study||3
10039200|NCT01959945|11163814|FG002|NOT COMPLETED|Overall Study||19
10039201|NCT01959945|11163815|FG003|NOT COMPLETED|Overall Study||16
10039202|NCT01960075|11163830|FG000|STARTED|Overall Study||149
10039203|NCT01960075|11163831|FG001|STARTED|Overall Study||149
10039204|NCT01960075|11163832|FG002|STARTED|Overall Study||180
10039205|NCT01960075|11163830|FG000|COMPLETED|Overall Study||141
10039206|NCT01960075|11163831|FG001|COMPLETED|Overall Study||146
10039207|NCT01960075|11163832|FG002|COMPLETED|Overall Study||173
10039208|NCT01960075|11163830|FG000|NOT COMPLETED|Overall Study||8
10039209|NCT01960075|11163831|FG001|NOT COMPLETED|Overall Study||3
10039210|NCT01960075|11163832|FG002|NOT COMPLETED|Overall Study||7
10039211|NCT01960114|11163842|FG000|STARTED|Overall Study||134
10039212|NCT01960114|11163843|FG001|STARTED|Overall Study||269
10039213|NCT01960114|11163842|FG000|COMPLETED|Overall Study||133
10039214|NCT01960114|11163843|FG001|COMPLETED|Overall Study||268
10039215|NCT01960114|11163842|FG000|NOT COMPLETED|Overall Study||1
10039216|NCT01960114|11163843|FG001|NOT COMPLETED|Overall Study||1
10039217|NCT01960140|11163849|FG000|STARTED|Period 1 (Days 1-2)||40
10039218|NCT01960140|11163849|FG000|Received Simvastatin|Period 1 (Days 1-2)||40
10039219|NCT01960140|11163849|FG000|COMPLETED|Period 1 (Days 1-2)||40
10039220|NCT01960140|11163849|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
10039221|NCT01960140|11163849|FG000|STARTED|Period 2 (Days 3-18)||40
10039222|NCT01960140|11163849|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
10039223|NCT01960140|11163849|FG000|Received Simvastatin|Period 2 (Days 3-18)||38
10039224|NCT01960140|11163849|FG000|COMPLETED|Period 2 (Days 3-18)||38
10039225|NCT01960140|11163849|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2
10039226|NCT01960257|11163857|FG000|STARTED|Stage 1 (1-3 Weeks)||77
10039227|NCT01960257|11163858|FG001|STARTED|Stage 1 (1-3 Weeks)||0
10039228|NCT01960257|11163859|FG002|STARTED|Stage 1 (1-3 Weeks)||0
10039229|NCT01960257|11163857|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61
10039230|NCT01960257|11163858|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0
10039231|NCT01960257|11163859|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0
10039232|NCT01960257|11163857|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
10039233|NCT01960257|11163858|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
10039234|NCT01960257|11163859|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
10039235|NCT01960257|11163857|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10039236|NCT01960257|11163858|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
10039237|NCT01960257|11163859|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
10039238|NCT01960257|11163857|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10039239|NCT01960257|11163858|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
10039240|NCT01960257|11163859|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
10039241|NCT01960257|11163857|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10039242|NCT01960257|11163858|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10039243|NCT01960257|11163859|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10039244|NCT01960296|11163871|FG000|STARTED|Overall Study||23
10039245|NCT01960296|11163872|FG001|STARTED|Overall Study||25
10039246|NCT01960296|11163871|FG000|COMPLETED|Overall Study||21
10039247|NCT01960296|11163872|FG001|COMPLETED|Overall Study||22
10039248|NCT01960296|11163871|FG000|NOT COMPLETED|Overall Study||2
10039249|NCT01960296|11163872|FG001|NOT COMPLETED|Overall Study||3
10039250|NCT01960348|11163880|FG000|STARTED|Overall Study||148
10039251|NCT01960348|11163881|FG001|STARTED|Overall Study||77
10039252|NCT01960348|11163880|FG000|COMPLETED|Overall Study||138
10039253|NCT01960348|11163881|FG001|COMPLETED|Overall Study||55
10039254|NCT01960348|11163880|FG000|NOT COMPLETED|Overall Study||10
10039255|NCT01960348|11163881|FG001|NOT COMPLETED|Overall Study||22
10039256|NCT01960387|11163887|FG000|STARTED|Overall Study||2
10039257|NCT01960387|11163887|FG000|COMPLETED|Overall Study||2
10039258|NCT01960387|11163887|FG000|NOT COMPLETED|Overall Study||0
10039259|NCT01960400|11163893|FG000|STARTED|Overall Study||11
10039260|NCT01960400|11163894|FG001|STARTED|Overall Study||11
10039261|NCT01960400|11163893|FG000|COMPLETED|Overall Study||11
10039262|NCT01960400|11163894|FG001|COMPLETED|Overall Study||11
10039263|NCT01960400|11163893|FG000|NOT COMPLETED|Overall Study||0
10039264|NCT01960400|11163894|FG001|NOT COMPLETED|Overall Study||0
10039265|NCT01960413|11163902|FG000|STARTED|Overall Study||24
10039266|NCT01960413|11163903|FG001|STARTED|Overall Study||22
10039267|NCT01960413|11163902|FG000|COMPLETED|Overall Study||20
10039268|NCT01960413|11163903|FG001|COMPLETED|Overall Study||21
10039269|NCT01960413|11163902|FG000|NOT COMPLETED|Overall Study||4
10039270|NCT01960413|11163903|FG001|NOT COMPLETED|Overall Study||1
10039271|NCT01960465|11163911|FG000|STARTED|Overall Study||138
10039272|NCT01960465|11163912|FG001|STARTED|Overall Study||82
10039273|NCT01960465|11163911|FG000|COMPLETED|Overall Study||118
10039274|NCT01960465|11163912|FG001|COMPLETED|Overall Study||73
10039275|NCT01960465|11163911|FG000|NOT COMPLETED|Overall Study||20
10116451|NCT02531802|11247166|FG014|STARTED|Received Vaccination 2||40
10116452|NCT02531802|11247167|FG015|STARTED|Received Vaccination 2||30
10116453|NCT02531802|11247168|FG016|STARTED|Received Vaccination 2||30
10116454|NCT02531802|11247169|FG017|STARTED|Received Vaccination 2||30
10116455|NCT02531802|11247170|FG018|STARTED|Received Vaccination 2||30
10116456|NCT02531802|11247171|FG019|STARTED|Received Vaccination 2||30
10116457|NCT02531802|11247172|FG020|STARTED|Received Vaccination 2||50
10116458|NCT02531802|11247152|FG000|COMPLETED|Received Vaccination 2||15
10116459|NCT02531802|11247153|FG001|COMPLETED|Received Vaccination 2||15
10039276|NCT01960465|11163912|FG001|NOT COMPLETED|Overall Study||9
10039277|NCT01960725|11163920|FG000|STARTED|Overall Study||33
10039278|NCT01960725|11163921|FG001|STARTED|Overall Study||33
10039279|NCT01960725|11163920|FG000|Received First Vaccine|Overall Study||33
10039280|NCT01960725|11163921|FG001|Received First Vaccine|Overall Study||33
10039281|NCT01960725|11163920|FG000|Recieved Second Vaccine|Overall Study||33
10039282|NCT01960725|11163921|FG001|Recieved Second Vaccine|Overall Study||33
10039283|NCT01960725|11163920|FG000|Received Third Vaccine|Overall Study||32
10039284|NCT01960725|11163921|FG001|Received Third Vaccine|Overall Study||32
10039285|NCT01960725|11163920|FG000|COMPLETED|Overall Study||27
10039286|NCT01960725|11163921|FG001|COMPLETED|Overall Study||28
10039287|NCT01960725|11163920|FG000|NOT COMPLETED|Overall Study||6
10039288|NCT01960725|11163921|FG001|NOT COMPLETED|Overall Study||5
10039289|NCT01960790|11163927|FG000|STARTED|Overall Study||473
10039290|NCT01960790|11163927|FG000|COMPLETED|Overall Study||462
10039291|NCT01960790|11163927|FG000|NOT COMPLETED|Overall Study||11
10039292|NCT01960816|11163931|FG000|STARTED|Overall Study||33
10039293|NCT01960816|11163931|FG000|COMPLETED|Overall Study||32
10039294|NCT01960816|11163931|FG000|NOT COMPLETED|Overall Study||1
10039295|NCT01960842|11163935|FG000|STARTED|Overall Study||31
10039296|NCT01960842|11163935|FG000|COMPLETED|Overall Study||28
10039297|NCT01960842|11163935|FG000|NOT COMPLETED|Overall Study||3
10039298|NCT01960855|11163944|FG000|STARTED|Overall Study||56
10039299|NCT01960855|11163945|FG001|STARTED|Overall Study||55
10039300|NCT01960855|11163946|FG002|STARTED|Overall Study||55
10039301|NCT01960855|11163947|FG003|STARTED|Overall Study||55
10039302|NCT01960855|11163948|FG004|STARTED|Overall Study||55
10039303|NCT01960855|11163944|FG000|COMPLETED|Overall Study||45
10039304|NCT01960855|11163945|FG001|COMPLETED|Overall Study||51
10039305|NCT01960855|11163946|FG002|COMPLETED|Overall Study||46
10039306|NCT01960855|11163947|FG003|COMPLETED|Overall Study||51
10039307|NCT01960855|11163948|FG004|COMPLETED|Overall Study||50
10039308|NCT01960855|11163944|FG000|NOT COMPLETED|Overall Study||11
10039309|NCT01960855|11163945|FG001|NOT COMPLETED|Overall Study||4
10039310|NCT01960855|11163946|FG002|NOT COMPLETED|Overall Study||9
10039311|NCT01960855|11163947|FG003|NOT COMPLETED|Overall Study||4
10039312|NCT01960855|11163948|FG004|NOT COMPLETED|Overall Study||5
10039313|NCT01960907|11163962|FG000|STARTED|Overall Study||158
10039314|NCT01960907|11163963|FG001|STARTED|Overall Study||154
10039315|NCT01960907|11163962|FG000|COMPLETED|Overall Study||122
10039316|NCT01960907|11163963|FG001|COMPLETED|Overall Study||109
10039317|NCT01960907|11163962|FG000|NOT COMPLETED|Overall Study||36
10039318|NCT01960907|11163963|FG001|NOT COMPLETED|Overall Study||45
10039319|NCT01960998|11163974|FG000|STARTED|Overall Study||101
10039320|NCT01960998|11163975|FG001|STARTED|Overall Study||96
10039321|NCT01960998|11163974|FG000|COMPLETED|Overall Study||90
10039322|NCT01960998|11163975|FG001|COMPLETED|Overall Study||85
10039323|NCT01960998|11163974|FG000|NOT COMPLETED|Overall Study||11
10039324|NCT01960998|11163975|FG001|NOT COMPLETED|Overall Study||11
10039325|NCT01961089|11163983|FG000|STARTED|Overall Study||40
10039326|NCT01961089|11163983|FG000|COMPLETED|Overall Study||40
10039327|NCT01961089|11163983|FG000|NOT COMPLETED|Overall Study||0
10039328|NCT01961115|11163990|FG000|STARTED|Overall Study||2
10039329|NCT01961115|11163991|FG001|STARTED|Overall Study||0
10039330|NCT01961115|11163992|FG002|STARTED|Overall Study||9
10039331|NCT01961115|11163990|FG000|COMPLETED|Overall Study||0
10039332|NCT01961115|11163991|FG001|COMPLETED|Overall Study||0
10039333|NCT01961115|11163992|FG002|COMPLETED|Overall Study||5
10039334|NCT01961115|11163990|FG000|NOT COMPLETED|Overall Study||2
10039335|NCT01961115|11163991|FG001|NOT COMPLETED|Overall Study||0
10039336|NCT01961115|11163992|FG002|NOT COMPLETED|Overall Study||4
10039337|NCT01961167|11164000|FG000|STARTED|Overall Study||27
10039338|NCT01961167|11164000|FG000|COMPLETED|Overall Study||27
10039339|NCT01961167|11164000|FG000|NOT COMPLETED|Overall Study||0
10039340|NCT01961271|11164004|FG000|STARTED|Overall Study||114
10039341|NCT01961271|11164004|FG000|COMPLETED|Overall Study||64
10039342|NCT01961271|11164004|FG000|NOT COMPLETED|Overall Study||50
10039343|NCT01961297|11164010|FG000|STARTED|Overall Study||30
10039344|NCT01961297|11164011|FG001|STARTED|Overall Study||23
10039345|NCT01961297|11164010|FG000|COMPLETED|Overall Study||28
10039346|NCT01961297|11164011|FG001|COMPLETED|Overall Study||22
10116460|NCT02531802|11247154|FG002|COMPLETED|Received Vaccination 2||14
10039347|NCT01961297|11164010|FG000|NOT COMPLETED|Overall Study||2
10039348|NCT01961297|11164011|FG001|NOT COMPLETED|Overall Study||1
10039349|NCT01961323|11164017|FG000|STARTED|Overall Study||70
10039350|NCT01961323|11164017|FG000|COMPLETED|Overall Study||21
10039351|NCT01961323|11164017|FG000|NOT COMPLETED|Overall Study||49
10039352|NCT01961349|11164024|FG000|STARTED|Overall Study||54
10039353|NCT01961349|11164025|FG001|STARTED|Overall Study||107
10039354|NCT01961349|11164026|FG002|STARTED|Overall Study||111
10039355|NCT01961349|11164024|FG000|COMPLETED|Overall Study||51
10116461|NCT02531802|11247155|FG003|COMPLETED|Received Vaccination 2||15
10116462|NCT02531802|11247156|FG004|COMPLETED|Received Vaccination 2||15
10039356|NCT01961349|11164025|FG001|COMPLETED|Overall Study||101
10039357|NCT01961349|11164026|FG002|COMPLETED|Overall Study||109
10039358|NCT01961349|11164024|FG000|NOT COMPLETED|Overall Study||3
10039359|NCT01961349|11164025|FG001|NOT COMPLETED|Overall Study||6
10039360|NCT01961349|11164026|FG002|NOT COMPLETED|Overall Study||2
10039361|NCT01961362|11164034|FG000|STARTED|Overall Study||19
10039362|NCT01961362|11164034|FG000|COMPLETED|Overall Study||19
10039363|NCT01961362|11164034|FG000|NOT COMPLETED|Overall Study||0
10039364|NCT01961544|11164038|FG000|STARTED|Overall Study||101
10039365|NCT01961544|11164038|FG000|COMPLETED|Overall Study||88
10039366|NCT01961544|11164038|FG000|NOT COMPLETED|Overall Study||13
10039367|NCT01961609|11164044|FG000|STARTED|Initiation||119
10039368|NCT01961609|11164045|FG001|STARTED|Initiation||116
10039369|NCT01961609|11164046|FG002|STARTED|Initiation||0
10039370|NCT01961609|11164047|FG003|STARTED|Initiation||0
10039371|NCT01961609|11164044|FG000|Safety Set|Initiation||118
10039372|NCT01961609|11164045|FG001|Safety Set|Initiation||115
10039373|NCT01961609|11164046|FG002|Safety Set|Initiation||0
10039374|NCT01961609|11164047|FG003|Safety Set|Initiation||0
10039375|NCT01961609|11164044|FG000|Full Analysis Set|Initiation||118
10039376|NCT01961609|11164045|FG001|Full Analysis Set|Initiation||115
10039377|NCT01961609|11164046|FG002|Full Analysis Set|Initiation||0
10039378|NCT01961609|11164047|FG003|Full Analysis Set|Initiation||0
10039379|NCT01961609|11164044|FG000|COMPLETED|Initiation||107
10039380|NCT01961609|11164045|FG001|COMPLETED|Initiation||103
10039381|NCT01961609|11164046|FG002|COMPLETED|Initiation||0
10039382|NCT01961609|11164047|FG003|COMPLETED|Initiation||0
10039383|NCT01961609|11164044|FG000|NOT COMPLETED|Initiation||12
10039384|NCT01961609|11164045|FG001|NOT COMPLETED|Initiation||13
10039385|NCT01961609|11164046|FG002|NOT COMPLETED|Initiation||0
10039386|NCT01961609|11164047|FG003|NOT COMPLETED|Initiation||0
10039387|NCT01961609|11164044|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107
10039388|NCT01961609|11164045|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66
10039389|NCT01961609|11164046|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37
10039390|NCT01961609|11164047|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0
10039391|NCT01961609|11164044|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
10039392|NCT01961609|11164045|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
10039393|NCT01961609|11164046|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
10039394|NCT01961609|11164047|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
10039395|NCT01961609|11164044|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
10039396|NCT01961609|11164045|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
10039397|NCT01961609|11164046|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
10039398|NCT01961609|11164047|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
10039399|NCT01961609|11164044|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
10039400|NCT01961609|11164045|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
10039401|NCT01961609|11164046|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
10039402|NCT01961609|11164047|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
10039403|NCT01961609|11164044|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
10039404|NCT01961609|11164045|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
10039405|NCT01961609|11164046|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
10039406|NCT01961609|11164047|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
10039407|NCT01961609|11164044|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83
10039408|NCT01961609|11164045|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31
10039409|NCT01961609|11164046|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16
10039410|NCT01961609|11164047|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24
10039411|NCT01961609|11164044|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
10039412|NCT01961609|11164045|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
10039413|NCT01961609|11164046|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
10039414|NCT01961609|11164047|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
10039415|NCT01961609|11164044|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
10039416|NCT01961609|11164045|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
10039417|NCT01961609|11164046|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
10039418|NCT01961609|11164047|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
10039419|NCT01961609|11164044|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
10039420|NCT01961609|11164045|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
10039421|NCT01961609|11164046|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
10039422|NCT01961609|11164047|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
10039423|NCT01961609|11164044|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
10039424|NCT01961609|11164045|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
10039425|NCT01961609|11164046|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
10039426|NCT01961609|11164047|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
10039427|NCT01961687|11164064|FG000|STARTED|Overall Study||121
10039428|NCT01961687|11164064|FG000|COMPLETED|Overall Study||60
10039429|NCT01961687|11164064|FG000|NOT COMPLETED|Overall Study||61
10039430|NCT01961882|11164070|FG000|STARTED|Overall Study||69
10039431|NCT01961882|11164071|FG001|STARTED|Overall Study||65
10039432|NCT01961882|11164070|FG000|COMPLETED|Overall Study||19
10039433|NCT01961882|11164071|FG001|COMPLETED|Overall Study||23
10039434|NCT01961882|11164070|FG000|NOT COMPLETED|Overall Study||50
10039435|NCT01961882|11164071|FG001|NOT COMPLETED|Overall Study||42
10039436|NCT01961921|11164077|FG000|STARTED|Overall Study||27
10039437|NCT01961921|11164077|FG000|COMPLETED|Overall Study||25
10039438|NCT01961921|11164077|FG000|NOT COMPLETED|Overall Study||2
10039439|NCT01962025|11164083|FG000|STARTED|Overall Study||8
10039440|NCT01962025|11164084|FG001|STARTED|Overall Study||6
10039441|NCT01962025|11164083|FG000|COMPLETED|Overall Study||8
10039442|NCT01962025|11164084|FG001|COMPLETED|Overall Study||6
10039443|NCT01962025|11164083|FG000|NOT COMPLETED|Overall Study||0
10039444|NCT01962025|11164084|FG001|NOT COMPLETED|Overall Study||0
10039445|NCT01962103|11164101|FG000|STARTED|Phase 1||16
10039446|NCT01962103|11164102|FG001|STARTED|Phase 1||8
10039447|NCT01962103|11164103|FG002|STARTED|Phase 1||14
10039448|NCT01962103|11164104|FG003|STARTED|Phase 1||11
10039449|NCT01962103|11164105|FG004|STARTED|Phase 1||8
10039450|NCT01962103|11164106|FG005|STARTED|Phase 1||7
10039451|NCT01962103|11164107|FG006|STARTED|Phase 1||0
10039452|NCT01962103|11164108|FG007|STARTED|Phase 1||0
10039453|NCT01962103|11164109|FG008|STARTED|Phase 1||0
10039454|NCT01962103|11164101|FG000|COMPLETED|Phase 1||0
10039455|NCT01962103|11164102|FG001|COMPLETED|Phase 1||0
10039456|NCT01962103|11164103|FG002|COMPLETED|Phase 1||0
10039457|NCT01962103|11164104|FG003|COMPLETED|Phase 1||0
10039458|NCT01962103|11164105|FG004|COMPLETED|Phase 1||0
10039459|NCT01962103|11164106|FG005|COMPLETED|Phase 1||0
10039460|NCT01962103|11164107|FG006|COMPLETED|Phase 1||0
10039461|NCT01962103|11164108|FG007|COMPLETED|Phase 1||0
10039462|NCT01962103|11164109|FG008|COMPLETED|Phase 1||0
10039463|NCT01962103|11164101|FG000|NOT COMPLETED|Phase 1||16
10039464|NCT01962103|11164102|FG001|NOT COMPLETED|Phase 1||8
10039465|NCT01962103|11164103|FG002|NOT COMPLETED|Phase 1||14
10039466|NCT01962103|11164104|FG003|NOT COMPLETED|Phase 1||11
10039467|NCT01962103|11164105|FG004|NOT COMPLETED|Phase 1||8
10039468|NCT01962103|11164106|FG005|NOT COMPLETED|Phase 1||7
10039469|NCT01962103|11164107|FG006|NOT COMPLETED|Phase 1||0
10039470|NCT01962103|11164108|FG007|NOT COMPLETED|Phase 1||0
10039471|NCT01962103|11164109|FG008|NOT COMPLETED|Phase 1||0
10039472|NCT01962103|11164101|FG000|STARTED|Phase 2||0
10039473|NCT01962103|11164102|FG001|STARTED|Phase 2||0
10039474|NCT01962103|11164103|FG002|STARTED|Phase 2||0
10039475|NCT01962103|11164104|FG003|STARTED|Phase 2||0
10039476|NCT01962103|11164105|FG004|STARTED|Phase 2||0
10039477|NCT01962103|11164106|FG005|STARTED|Phase 2||0
10039478|NCT01962103|11164107|FG006|STARTED|Phase 2||14
10039479|NCT01962103|11164108|FG007|STARTED|Phase 2||14
10039480|NCT01962103|11164109|FG008|STARTED|Phase 2||14
10039481|NCT01962103|11164101|FG000|COMPLETED|Phase 2||0
10039482|NCT01962103|11164102|FG001|COMPLETED|Phase 2||0
10039483|NCT01962103|11164103|FG002|COMPLETED|Phase 2||0
10039484|NCT01962103|11164104|FG003|COMPLETED|Phase 2||0
10039485|NCT01962103|11164105|FG004|COMPLETED|Phase 2||0
10039486|NCT01962103|11164106|FG005|COMPLETED|Phase 2||0
10039487|NCT01962103|11164107|FG006|COMPLETED|Phase 2|completed treatment|0
10039488|NCT01962103|11164108|FG007|COMPLETED|Phase 2|completed treatment|0
10116463|NCT02531802|11247157|FG005|COMPLETED|Received Vaccination 2||0
10116464|NCT02531802|11247158|FG006|COMPLETED|Received Vaccination 2||15
10116465|NCT02531802|11247159|FG007|COMPLETED|Received Vaccination 2||15
10116466|NCT02531802|11247160|FG008|COMPLETED|Received Vaccination 2||15
10116467|NCT02531802|11247161|FG009|COMPLETED|Received Vaccination 2||49
10116468|NCT02531802|11247162|FG010|COMPLETED|Received Vaccination 2||13
10116469|NCT02531802|11247163|FG011|COMPLETED|Received Vaccination 2||15
10116470|NCT02531802|11247164|FG012|COMPLETED|Received Vaccination 2||13
10116471|NCT02531802|11247165|FG013|COMPLETED|Received Vaccination 2||13
10116472|NCT02531802|11247166|FG014|COMPLETED|Received Vaccination 2||39
10116473|NCT02531802|11247167|FG015|COMPLETED|Received Vaccination 2||30
10116474|NCT02531802|11247168|FG016|COMPLETED|Received Vaccination 2||30
10116475|NCT02531802|11247169|FG017|COMPLETED|Received Vaccination 2||26
10116476|NCT02531802|11247170|FG018|COMPLETED|Received Vaccination 2||27
10116477|NCT02531802|11247171|FG019|COMPLETED|Received Vaccination 2||29
10116478|NCT02531802|11247172|FG020|COMPLETED|Received Vaccination 2||49
10116479|NCT02531802|11247152|FG000|NOT COMPLETED|Received Vaccination 2||0
10116480|NCT02531802|11247153|FG001|NOT COMPLETED|Received Vaccination 2||0
10116481|NCT02531802|11247154|FG002|NOT COMPLETED|Received Vaccination 2||1
10116482|NCT02531802|11247155|FG003|NOT COMPLETED|Received Vaccination 2||0
10116483|NCT02531802|11247156|FG004|NOT COMPLETED|Received Vaccination 2||0
10116484|NCT02531802|11247157|FG005|NOT COMPLETED|Received Vaccination 2||3
10116485|NCT02531802|11247158|FG006|NOT COMPLETED|Received Vaccination 2||0
10116486|NCT02531802|11247159|FG007|NOT COMPLETED|Received Vaccination 2||0
10116487|NCT02531802|11247160|FG008|NOT COMPLETED|Received Vaccination 2||0
10116488|NCT02531802|11247161|FG009|NOT COMPLETED|Received Vaccination 2||3
10116489|NCT02531802|11247162|FG010|NOT COMPLETED|Received Vaccination 2||2
10116490|NCT02531802|11247163|FG011|NOT COMPLETED|Received Vaccination 2||0
10039489|NCT01962103|11164109|FG008|COMPLETED|Phase 2|completed treatment|0
10039490|NCT01962103|11164101|FG000|NOT COMPLETED|Phase 2||0
10039491|NCT01962103|11164102|FG001|NOT COMPLETED|Phase 2||0
10039492|NCT01962103|11164103|FG002|NOT COMPLETED|Phase 2||0
10039493|NCT01962103|11164104|FG003|NOT COMPLETED|Phase 2||0
10039494|NCT01962103|11164105|FG004|NOT COMPLETED|Phase 2||0
10039495|NCT01962103|11164106|FG005|NOT COMPLETED|Phase 2||0
10039496|NCT01962103|11164107|FG006|NOT COMPLETED|Phase 2||14
10039497|NCT01962103|11164108|FG007|NOT COMPLETED|Phase 2||14
10039498|NCT01962103|11164109|FG008|NOT COMPLETED|Phase 2||14
10039499|NCT01962207|11164133|FG000|STARTED|Persistence Phase (5 Years)||76
10039500|NCT01962207|11164134|FG001|STARTED|Persistence Phase (5 Years)||23
10039501|NCT01962207|11164135|FG002|STARTED|Persistence Phase (5 Years)||115
10039502|NCT01962207|11164136|FG003|STARTED|Persistence Phase (5 Years)||29
10039503|NCT01962207|11164133|FG000|COMPLETED|Persistence Phase (5 Years)||47
10039504|NCT01962207|11164134|FG001|COMPLETED|Persistence Phase (5 Years)||10
10039505|NCT01962207|11164135|FG002|COMPLETED|Persistence Phase (5 Years)||71
10039506|NCT01962207|11164136|FG003|COMPLETED|Persistence Phase (5 Years)||17
10039507|NCT01962207|11164133|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29
10039508|NCT01962207|11164134|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13
10039509|NCT01962207|11164135|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44
10039510|NCT01962207|11164136|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12
10039511|NCT01962207|11164133|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
10039512|NCT01962207|11164134|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
10039513|NCT01962207|11164135|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
10039514|NCT01962207|11164136|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
10039515|NCT01962207|11164133|FG000|COMPLETED|Booster Phase (6 Months)||67
10039516|NCT01962207|11164134|FG001|COMPLETED|Booster Phase (6 Months)||16
10039517|NCT01962207|11164135|FG002|COMPLETED|Booster Phase (6 Months)||77
10039518|NCT01962207|11164136|FG003|COMPLETED|Booster Phase (6 Months)||21
10039519|NCT01962207|11164133|FG000|NOT COMPLETED|Booster Phase (6 Months)||0
10039520|NCT01962207|11164134|FG001|NOT COMPLETED|Booster Phase (6 Months)||0
10039521|NCT01962207|11164135|FG002|NOT COMPLETED|Booster Phase (6 Months)||0
10039522|NCT01962207|11164136|FG003|NOT COMPLETED|Booster Phase (6 Months)||0
10039523|NCT01962298|11164155|FG000|STARTED|Overall Study||15
10039524|NCT01962298|11164156|FG001|STARTED|Overall Study||15
10039525|NCT01962298|11164157|FG002|STARTED|Overall Study||15
10039526|NCT01962298|11164158|FG003|STARTED|Overall Study||15
10039527|NCT01962298|11164159|FG004|STARTED|Overall Study||15
10039528|NCT01962298|11164155|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
10039529|NCT01962298|11164156|FG001|Received Intervention|Overall Study||15
10039530|NCT01962298|11164157|FG002|Received Intervention|Overall Study||15
10039531|NCT01962298|11164158|FG003|Received Intervention|Overall Study||15
10039532|NCT01962298|11164159|FG004|Received Intervention|Overall Study||15
10039533|NCT01962298|11164155|FG000|COMPLETED|Overall Study||12
10039534|NCT01962298|11164156|FG001|COMPLETED|Overall Study||11
10039535|NCT01962298|11164157|FG002|COMPLETED|Overall Study||10
10039536|NCT01962298|11164158|FG003|COMPLETED|Overall Study||13
10039537|NCT01962298|11164159|FG004|COMPLETED|Overall Study||9
10039538|NCT01962298|11164155|FG000|NOT COMPLETED|Overall Study||3
10039539|NCT01962298|11164156|FG001|NOT COMPLETED|Overall Study||4
10039540|NCT01962298|11164157|FG002|NOT COMPLETED|Overall Study||5
10039541|NCT01962298|11164158|FG003|NOT COMPLETED|Overall Study||2
10039542|NCT01962298|11164159|FG004|NOT COMPLETED|Overall Study||6
10039543|NCT01962428|11164173|FG000|STARTED|Overall Study||139
10039544|NCT01962428|11164174|FG001|STARTED|Overall Study||139
10039545|NCT01962428|11164173|FG000|COMPLETED|Overall Study||129
10039546|NCT01962428|11164174|FG001|COMPLETED|Overall Study||133
10039547|NCT01962428|11164173|FG000|NOT COMPLETED|Overall Study||10
10039548|NCT01962428|11164174|FG001|NOT COMPLETED|Overall Study||6
10039549|NCT01962441|11164183|FG000|STARTED|Randomized Period||200
10039550|NCT01962441|11164184|FG001|STARTED|Randomized Period||201
10039551|NCT01962441|11164185|FG002|STARTED|Randomized Period||200
10039552|NCT01962441|11164183|FG000|COMPLETED|Randomized Period||190
10039553|NCT01962441|11164184|FG001|COMPLETED|Randomized Period||190
10039554|NCT01962441|11164185|FG002|COMPLETED|Randomized Period||189
10039555|NCT01962441|11164183|FG000|NOT COMPLETED|Randomized Period||10
10039556|NCT01962441|11164184|FG001|NOT COMPLETED|Randomized Period||11
10039557|NCT01962441|11164185|FG002|NOT COMPLETED|Randomized Period||11
10039558|NCT01962441|11164183|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
10039559|NCT01962441|11164184|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
10039560|NCT01962441|11164185|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
10039561|NCT01962441|11164183|FG000|COMPLETED|Retreatment Substudy||18
10039562|NCT01962441|11164184|FG001|COMPLETED|Retreatment Substudy||10
10039563|NCT01962441|11164185|FG002|COMPLETED|Retreatment Substudy||0
10039564|NCT01962441|11164183|FG000|NOT COMPLETED|Retreatment Substudy||2
10039565|NCT01962441|11164184|FG001|NOT COMPLETED|Retreatment Substudy||0
10039566|NCT01962441|11164185|FG002|NOT COMPLETED|Retreatment Substudy||0
10039567|NCT01962493|11164196|FG000|STARTED|Overall Study||78
10039568|NCT01962493|11164197|FG001|STARTED|Overall Study||82
10039569|NCT01962493|11164196|FG000|COMPLETED|Overall Study||73
10039570|NCT01962493|11164197|FG001|COMPLETED|Overall Study||77
10039571|NCT01962493|11164196|FG000|NOT COMPLETED|Overall Study||5
10039572|NCT01962493|11164197|FG001|NOT COMPLETED|Overall Study||5
10039573|NCT01962558|11164205|FG000|STARTED|Overall Study||16
10039574|NCT01962558|11164206|FG001|STARTED|Overall Study||14
10039575|NCT01962558|11164205|FG000|Acute Study|Overall Study||16
10039576|NCT01962558|11164206|FG001|Acute Study|Overall Study||14
10039577|NCT01962558|11164205|FG000|12-Weeks|Overall Study||16
10039578|NCT01962558|11164206|FG001|12-Weeks|Overall Study||14
10039579|NCT01962558|11164205|FG000|COMPLETED|Overall Study||16
10039580|NCT01962558|11164206|FG001|COMPLETED|Overall Study||14
10039581|NCT01962558|11164205|FG000|NOT COMPLETED|Overall Study||0
10039582|NCT01962558|11164206|FG001|NOT COMPLETED|Overall Study||0
10039583|NCT01962688|11164214|FG000|STARTED|Overall Study||19
10039584|NCT01962688|11164215|FG001|STARTED|Overall Study||18
10039585|NCT01962688|11164214|FG000|COMPLETED|Overall Study||19
10039586|NCT01962688|11164215|FG001|COMPLETED|Overall Study||18
10039587|NCT01962688|11164214|FG000|NOT COMPLETED|Overall Study||0
10039588|NCT01962688|11164215|FG001|NOT COMPLETED|Overall Study||0
10039589|NCT01962714|11164223|FG000|STARTED|Overall Study||91
10039590|NCT01962714|11164224|FG001|STARTED|Overall Study||93
10039591|NCT01962714|11164223|FG000|Immediate Post-treatment Assessment|Overall Study||63
10039592|NCT01962714|11164224|FG001|Immediate Post-treatment Assessment|Overall Study||57
10039593|NCT01962714|11164223|FG000|3-month Follow-up|Overall Study||58
10039594|NCT01962714|11164224|FG001|3-month Follow-up|Overall Study||56
10039595|NCT01962714|11164223|FG000|COMPLETED|Overall Study||61
10039596|NCT01962714|11164224|FG001|COMPLETED|Overall Study||60
10039597|NCT01962714|11164223|FG000|NOT COMPLETED|Overall Study||30
10039598|NCT01962714|11164224|FG001|NOT COMPLETED|Overall Study||33
10039599|NCT01962870|11164232|FG000|STARTED|Overall Study||13
10039600|NCT01962870|11164233|FG001|STARTED|Overall Study||17
10039601|NCT01962870|11164232|FG000|COMPLETED|Overall Study||13
10039602|NCT01962870|11164233|FG001|COMPLETED|Overall Study||17
10039603|NCT01962870|11164232|FG000|NOT COMPLETED|Overall Study||0
10039604|NCT01962870|11164233|FG001|NOT COMPLETED|Overall Study||0
10039605|NCT01962896|11164239|FG000|STARTED|Overall Study||4
10039606|NCT01962896|11164239|FG000|COMPLETED|Overall Study||0
10039607|NCT01962896|11164239|FG000|NOT COMPLETED|Overall Study||4
10039608|NCT01962922|11164246|FG000|STARTED|PK Portion Day 7||27
10039609|NCT01962922|11164247|FG001|STARTED|PK Portion Day 7||23
10039610|NCT01962922|11164246|FG000|COMPLETED|PK Portion Day 7||23
10039611|NCT01962922|11164247|FG001|COMPLETED|PK Portion Day 7||23
10039612|NCT01962922|11164246|FG000|NOT COMPLETED|PK Portion Day 7||4
10039613|NCT01962922|11164247|FG001|NOT COMPLETED|PK Portion Day 7||0
10039614|NCT01962922|11164246|FG000|STARTED|PK Portion Day 14||23
10039615|NCT01962922|11164247|FG001|STARTED|PK Portion Day 14||23
10039616|NCT01962922|11164246|FG000|COMPLETED|PK Portion Day 14||23
10039617|NCT01962922|11164247|FG001|COMPLETED|PK Portion Day 14||23
10039618|NCT01962922|11164246|FG000|NOT COMPLETED|PK Portion Day 14||0
10039619|NCT01962922|11164247|FG001|NOT COMPLETED|PK Portion Day 14||0
10039620|NCT01962922|11164246|FG000|STARTED|PK Portion Day 21||23
10039621|NCT01962922|11164247|FG001|STARTED|PK Portion Day 21||23
10039622|NCT01962922|11164246|FG000|COMPLETED|PK Portion Day 21||23
10039623|NCT01962922|11164247|FG001|COMPLETED|PK Portion Day 21||23
10039624|NCT01962922|11164246|FG000|NOT COMPLETED|PK Portion Day 21||0
10039625|NCT01962922|11164247|FG001|NOT COMPLETED|PK Portion Day 21||0
10039626|NCT01962922|11164246|FG000|STARTED|Extendion Portion (up to Month 6)||23
10039627|NCT01962922|11164247|FG001|STARTED|Extendion Portion (up to Month 6)||23
10039628|NCT01962922|11164246|FG000|COMPLETED|Extendion Portion (up to Month 6)||18
10039629|NCT01962922|11164247|FG001|COMPLETED|Extendion Portion (up to Month 6)||20
10039630|NCT01962922|11164246|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5
10039631|NCT01962922|11164247|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3
10116491|NCT02531802|11247164|FG012|NOT COMPLETED|Received Vaccination 2||2
10116492|NCT02531802|11247165|FG013|NOT COMPLETED|Received Vaccination 2||2
10116493|NCT02531802|11247166|FG014|NOT COMPLETED|Received Vaccination 2||1
10116494|NCT02531802|11247167|FG015|NOT COMPLETED|Received Vaccination 2||0
10116495|NCT02531802|11247168|FG016|NOT COMPLETED|Received Vaccination 2||0
10116496|NCT02531802|11247169|FG017|NOT COMPLETED|Received Vaccination 2||4
10116497|NCT02531802|11247170|FG018|NOT COMPLETED|Received Vaccination 2||3
10116498|NCT02531802|11247171|FG019|NOT COMPLETED|Received Vaccination 2||1
10116499|NCT02531802|11247172|FG020|NOT COMPLETED|Received Vaccination 2||1
10116500|NCT02531867|11247245|FG000|STARTED|Overall Study||13
10116501|NCT02531867|11247245|FG000|COMPLETED|Overall Study||13
10116502|NCT02531867|11247245|FG000|NOT COMPLETED|Overall Study||0
10116503|NCT02531971|11247251|FG000|STARTED|Overall Study||11
10116504|NCT02531971|11247252|FG001|STARTED|Overall Study||13
10116505|NCT02531971|11247251|FG000|COMPLETED|Overall Study||11
10116506|NCT02531971|11247252|FG001|COMPLETED|Overall Study||13
10116507|NCT02531971|11247251|FG000|NOT COMPLETED|Overall Study||0
10116508|NCT02531971|11247252|FG001|NOT COMPLETED|Overall Study||0
10116509|NCT02532010|11247261|FG000|STARTED|Overall Study||9
10116510|NCT02532010|11247262|FG001|STARTED|Overall Study||4
10116511|NCT02532010|11247261|FG000|COMPLETED|Overall Study||0
10116512|NCT02532010|11247262|FG001|COMPLETED|Overall Study||0
10116513|NCT02532010|11247261|FG000|NOT COMPLETED|Overall Study||9
10116514|NCT02532010|11247262|FG001|NOT COMPLETED|Overall Study||4
10116515|NCT02532036|11247268|FG000|STARTED|Overall Study||2
10116516|NCT02532036|11247269|FG001|STARTED|Overall Study||0
10116517|NCT02532036|11247268|FG000|COMPLETED|Overall Study||2
10116518|NCT02532036|11247269|FG001|COMPLETED|Overall Study||0
10116519|NCT02532036|11247268|FG000|NOT COMPLETED|Overall Study||0
10116520|NCT02532036|11247269|FG001|NOT COMPLETED|Overall Study||0
10116521|NCT02532179|11247273|FG000|STARTED|Overall Study||12
10116522|NCT02532179|11247273|FG000|COMPLETED|Overall Study||9
10116523|NCT02532179|11247273|FG000|NOT COMPLETED|Overall Study||3
10116524|NCT02532283|11247279|FG000|STARTED|Overall Study||64
10116525|NCT02532283|11247280|FG001|STARTED|Overall Study||35
10116526|NCT02532283|11247279|FG000|Full Analysis Set|Overall Study||63
10116527|NCT02532283|11247280|FG001|Full Analysis Set|Overall Study||32
10116528|NCT02532283|11247279|FG000|COMPLETED|Overall Study||55
10116529|NCT02532283|11247280|FG001|COMPLETED|Overall Study||30
10116530|NCT02532283|11247279|FG000|NOT COMPLETED|Overall Study||9
10116531|NCT02532283|11247280|FG001|NOT COMPLETED|Overall Study||5
10116532|NCT02532374|11247288|FG000|STARTED|Overall Study||16
10116533|NCT02532374|11247288|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15
10116534|NCT02532374|11247288|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15
10039632|NCT01962961|11164256|FG000|STARTED|Overall Study||9
10039633|NCT01962961|11164257|FG001|STARTED|Overall Study||8
10039634|NCT01962961|11164258|FG002|STARTED|Overall Study||7
10039635|NCT01962961|11164256|FG000|COMPLETED|Overall Study||9
10039636|NCT01962961|11164257|FG001|COMPLETED|Overall Study||7
10039637|NCT01962961|11164258|FG002|COMPLETED|Overall Study||6
10039638|NCT01962961|11164256|FG000|NOT COMPLETED|Overall Study||0
10039639|NCT01962961|11164257|FG001|NOT COMPLETED|Overall Study||1
10039640|NCT01962961|11164258|FG002|NOT COMPLETED|Overall Study||1
10039641|NCT01962987|11164269|FG000|STARTED|Overall Study||190
10039642|NCT01962987|11164270|FG001|STARTED|Overall Study||191
10039643|NCT01962987|11164271|FG002|STARTED|Overall Study||95
10039644|NCT01962987|11164269|FG000|COMPLETED|Overall Study||160
10039645|NCT01962987|11164270|FG001|COMPLETED|Overall Study||163
10039646|NCT01962987|11164271|FG002|COMPLETED|Overall Study||83
10039647|NCT01962987|11164269|FG000|NOT COMPLETED|Overall Study||30
10039648|NCT01962987|11164270|FG001|NOT COMPLETED|Overall Study||28
10039649|NCT01962987|11164271|FG002|NOT COMPLETED|Overall Study||12
10039650|NCT01963078|11164283|FG000|STARTED|Overall Study||9
10039651|NCT01963078|11164284|FG001|STARTED|Overall Study||10
10039652|NCT01963078|11164285|FG002|STARTED|Overall Study||10
10039653|NCT01963078|11164286|FG003|STARTED|Overall Study||9
10039654|NCT01963078|11164283|FG000|COMPLETED|Overall Study||8
10039655|NCT01963078|11164284|FG001|COMPLETED|Overall Study||9
10039656|NCT01963078|11164285|FG002|COMPLETED|Overall Study||9
10039657|NCT01963078|11164286|FG003|COMPLETED|Overall Study||7
10039658|NCT01963078|11164283|FG000|NOT COMPLETED|Overall Study||1
10039659|NCT01963078|11164284|FG001|NOT COMPLETED|Overall Study||1
10039660|NCT01963078|11164285|FG002|NOT COMPLETED|Overall Study||1
10039661|NCT01963078|11164286|FG003|NOT COMPLETED|Overall Study||2
10039662|NCT01963091|11164298|FG000|STARTED|Overall Study||17
10039663|NCT01963091|11164299|FG001|STARTED|Overall Study||16
10039664|NCT01963091|11164298|FG000|COMPLETED|Overall Study||17
10039665|NCT01963091|11164299|FG001|COMPLETED|Overall Study||16
10039666|NCT01963091|11164298|FG000|NOT COMPLETED|Overall Study||0
10039667|NCT01963091|11164299|FG001|NOT COMPLETED|Overall Study||0
10039668|NCT01963117|11164305|FG000|STARTED|Overall Study||11
10039669|NCT01963117|11164305|FG000|COMPLETED|Overall Study||10
10039670|NCT01963117|11164305|FG000|NOT COMPLETED|Overall Study||1
10039671|NCT01963143|11164312|FG000|STARTED|Overall Study||14
10039672|NCT01963143|11164313|FG001|STARTED|Overall Study||19
10039673|NCT01963143|11164314|FG002|STARTED|Overall Study||15
10039674|NCT01963143|11164312|FG000|COMPLETED|Overall Study||14
10039675|NCT01963143|11164313|FG001|COMPLETED|Overall Study||18
10039676|NCT01963143|11164314|FG002|COMPLETED|Overall Study||14
10039677|NCT01963143|11164312|FG000|NOT COMPLETED|Overall Study||0
10039678|NCT01963143|11164313|FG001|NOT COMPLETED|Overall Study||1
10039679|NCT01963143|11164314|FG002|NOT COMPLETED|Overall Study||1
10039680|NCT01963169|11164323|FG000|STARTED|Overall Study||301
10039681|NCT01963169|11164324|FG001|STARTED|Overall Study||302
10039682|NCT01963169|11164325|FG002|STARTED|Overall Study||263
10039683|NCT01963169|11164323|FG000|COMPLETED|Overall Study||242
10039684|NCT01963169|11164324|FG001|COMPLETED|Overall Study||220
10039685|NCT01963169|11164325|FG002|COMPLETED|Overall Study||237
10039686|NCT01963169|11164323|FG000|NOT COMPLETED|Overall Study||59
10039687|NCT01963169|11164324|FG001|NOT COMPLETED|Overall Study||82
10039688|NCT01963169|11164325|FG002|NOT COMPLETED|Overall Study||26
10039689|NCT01963234|11164336|FG000|STARTED|Overall Study||268
10039690|NCT01963234|11164337|FG001|STARTED|Overall Study||171
10039691|NCT01963234|11164336|FG000|COMPLETED|Overall Study||207
10039692|NCT01963234|11164337|FG001|COMPLETED|Overall Study||171
10039693|NCT01963234|11164336|FG000|NOT COMPLETED|Overall Study||61
10039694|NCT01963234|11164337|FG001|NOT COMPLETED|Overall Study||0
10039695|NCT01963260|11164359|FG000|STARTED|Overall Study||6
10039696|NCT01963260|11164360|FG001|STARTED|Overall Study||6
10039697|NCT01963260|11164361|FG002|STARTED|Overall Study||6
10039698|NCT01963260|11164362|FG003|STARTED|Overall Study||6
10039699|NCT01963260|11164363|FG004|STARTED|Overall Study||6
10039700|NCT01963260|11164364|FG005|STARTED|Overall Study||10
10039701|NCT01963260|11164365|FG006|STARTED|Overall Study||3
10039702|NCT01963260|11164366|FG007|STARTED|Overall Study||2
10039703|NCT01963260|11164367|FG008|STARTED|Overall Study||1
10039704|NCT01963260|11164368|FG009|STARTED|Overall Study||4
10039705|NCT01963260|11164359|FG000|Treated|Overall Study||6
10039706|NCT01963260|11164360|FG001|Treated|Overall Study||6
10039707|NCT01963260|11164361|FG002|Treated|Overall Study||6
10039708|NCT01963260|11164362|FG003|Treated|Overall Study||6
10039709|NCT01963260|11164363|FG004|Treated|Overall Study||6
10039710|NCT01963260|11164364|FG005|Treated|Overall Study||10
10039711|NCT01963260|11164365|FG006|Treated|Overall Study||3
10039712|NCT01963260|11164366|FG007|Treated|Overall Study||2
10039713|NCT01963260|11164367|FG008|Treated|Overall Study||1
10039714|NCT01963260|11164368|FG009|Treated|Overall Study||4
10039715|NCT01963260|11164359|FG000|COMPLETED|Overall Study||4
10039716|NCT01963260|11164360|FG001|COMPLETED|Overall Study||6
10039717|NCT01963260|11164361|FG002|COMPLETED|Overall Study||6
10039718|NCT01963260|11164362|FG003|COMPLETED|Overall Study||5
10039719|NCT01963260|11164363|FG004|COMPLETED|Overall Study||4
10039720|NCT01963260|11164364|FG005|COMPLETED|Overall Study||10
10039721|NCT01963260|11164365|FG006|COMPLETED|Overall Study||3
10039722|NCT01963260|11164366|FG007|COMPLETED|Overall Study||2
10039723|NCT01963260|11164367|FG008|COMPLETED|Overall Study||1
10039724|NCT01963260|11164368|FG009|COMPLETED|Overall Study||4
10039725|NCT01963260|11164359|FG000|NOT COMPLETED|Overall Study||2
10039726|NCT01963260|11164360|FG001|NOT COMPLETED|Overall Study||0
10039727|NCT01963260|11164361|FG002|NOT COMPLETED|Overall Study||0
10039728|NCT01963260|11164362|FG003|NOT COMPLETED|Overall Study||1
10039729|NCT01963260|11164363|FG004|NOT COMPLETED|Overall Study||2
10039730|NCT01963260|11164364|FG005|NOT COMPLETED|Overall Study||0
10039731|NCT01963260|11164365|FG006|NOT COMPLETED|Overall Study||0
10039732|NCT01963260|11164366|FG007|NOT COMPLETED|Overall Study||0
10039733|NCT01963260|11164367|FG008|NOT COMPLETED|Overall Study||0
10039734|NCT01963260|11164368|FG009|NOT COMPLETED|Overall Study||0
10039735|NCT01963403|11164399|FG000|STARTED|Overall Study||13
10039736|NCT01963403|11164400|FG001|STARTED|Overall Study||13
10039737|NCT01963403|11164399|FG000|COMPLETED|Overall Study|Follow-up over three months|11
10039738|NCT01963403|11164400|FG001|COMPLETED|Overall Study|Follow-up over three months|9
10039739|NCT01963403|11164399|FG000|NOT COMPLETED|Overall Study||2
10039740|NCT01963403|11164400|FG001|NOT COMPLETED|Overall Study||4
10039741|NCT01963481|11164408|FG000|STARTED|Overall Study||23
10039742|NCT01963481|11164408|FG000|COMPLETED|Overall Study||23
10039743|NCT01963481|11164408|FG000|NOT COMPLETED|Overall Study||0
10039744|NCT01963611|11164417|FG000|STARTED|Overall Study||51
10039745|NCT01963611|11164418|FG001|STARTED|Overall Study||49
10039746|NCT01963611|11164419|FG002|STARTED|Overall Study||52
10039747|NCT01963611|11164420|FG003|STARTED|Overall Study||52
10039748|NCT01963611|11164421|FG004|STARTED|Overall Study||51
10039749|NCT01963611|11164417|FG000|Safety Analysis Set|Overall Study||51
10039750|NCT01963611|11164418|FG001|Safety Analysis Set|Overall Study||49
10039751|NCT01963611|11164419|FG002|Safety Analysis Set|Overall Study||52
10039752|NCT01963611|11164420|FG003|Safety Analysis Set|Overall Study||52
10039753|NCT01963611|11164421|FG004|Safety Analysis Set|Overall Study||50
10039754|NCT01963611|11164417|FG000|COMPLETED|Overall Study||0
10039755|NCT01963611|11164418|FG001|COMPLETED|Overall Study||0
10039756|NCT01963611|11164419|FG002|COMPLETED|Overall Study||0
10039757|NCT01963611|11164420|FG003|COMPLETED|Overall Study||0
10039758|NCT01963611|11164421|FG004|COMPLETED|Overall Study||0
10039759|NCT01963611|11164417|FG000|NOT COMPLETED|Overall Study||51
10039760|NCT01963611|11164418|FG001|NOT COMPLETED|Overall Study||49
10039761|NCT01963611|11164419|FG002|NOT COMPLETED|Overall Study||52
10039762|NCT01963611|11164420|FG003|NOT COMPLETED|Overall Study||52
10039763|NCT01963611|11164421|FG004|NOT COMPLETED|Overall Study||51
10039764|NCT01963676|11164436|FG000|STARTED|Overall Study||14
10039765|NCT01963676|11164437|FG001|STARTED|Overall Study||13
10039766|NCT01963676|11164436|FG000|COMPLETED|Overall Study||13
10039767|NCT01963676|11164437|FG001|COMPLETED|Overall Study||13
10039768|NCT01963676|11164436|FG000|NOT COMPLETED|Overall Study||1
10039769|NCT01963676|11164437|FG001|NOT COMPLETED|Overall Study||0
10039770|NCT01963767|11164445|FG000|STARTED|Overall Study||58
10039771|NCT01963767|11164446|FG001|STARTED|Overall Study||55
10039772|NCT01963767|11164445|FG000|COMPLETED|Overall Study||52
10039773|NCT01963767|11164446|FG001|COMPLETED|Overall Study||53
10039774|NCT01963767|11164445|FG000|NOT COMPLETED|Overall Study||6
10039775|NCT01963767|11164446|FG001|NOT COMPLETED|Overall Study||2
10039776|NCT01963793|11164452|FG000|STARTED|Overall Study||20
10039777|NCT01963793|11164452|FG000|COMPLETED|Overall Study||20
10039778|NCT01963793|11164452|FG000|NOT COMPLETED|Overall Study||0
10039779|NCT01963845|11164469|FG000|STARTED|Overall Study||25
10039780|NCT01963845|11164470|FG001|STARTED|Overall Study||25
10039781|NCT01963845|11164469|FG000|COMPLETED|Overall Study||25
10039782|NCT01963845|11164470|FG001|COMPLETED|Overall Study||25
10039783|NCT01963845|11164469|FG000|NOT COMPLETED|Overall Study||0
10039784|NCT01963845|11164470|FG001|NOT COMPLETED|Overall Study||0
10039785|NCT01963923|11164478|FG000|STARTED|3 Weeks Post-surgery||20
10039786|NCT01963923|11164479|FG001|STARTED|3 Weeks Post-surgery||20
10039787|NCT01963923|11164478|FG000|COMPLETED|3 Weeks Post-surgery||12
10039788|NCT01963923|11164479|FG001|COMPLETED|3 Weeks Post-surgery||10
10039789|NCT01963923|11164478|FG000|NOT COMPLETED|3 Weeks Post-surgery||8
10039790|NCT01963923|11164479|FG001|NOT COMPLETED|3 Weeks Post-surgery||10
10039791|NCT01963923|11164478|FG000|STARTED|3 Months Post-surgery||12
10039792|NCT01963923|11164479|FG001|STARTED|3 Months Post-surgery||10
10039793|NCT01963923|11164478|FG000|COMPLETED|3 Months Post-surgery||10
10039794|NCT01963923|11164479|FG001|COMPLETED|3 Months Post-surgery||9
10039795|NCT01963923|11164478|FG000|NOT COMPLETED|3 Months Post-surgery||2
10039796|NCT01963923|11164479|FG001|NOT COMPLETED|3 Months Post-surgery||1
10039797|NCT01964092|11164494|FG000|STARTED|Overall Study||229
10039798|NCT01964092|11164495|FG001|STARTED|Overall Study||181
10039799|NCT01964092|11164494|FG000|COMPLETED|Overall Study||227
10039800|NCT01964092|11164495|FG001|COMPLETED|Overall Study||181
10039801|NCT01964092|11164494|FG000|NOT COMPLETED|Overall Study||2
10039802|NCT01964092|11164495|FG001|NOT COMPLETED|Overall Study||0
10039803|NCT01964105|11164504|FG000|STARTED|Overall Study||15
10039804|NCT01964105|11164505|FG001|STARTED|Overall Study||75
10039805|NCT01964105|11164506|FG002|STARTED|Overall Study||10
10039806|NCT01964105|11164504|FG000|COMPLETED|Overall Study||13
10039807|NCT01964105|11164505|FG001|COMPLETED|Overall Study||62
10039808|NCT01964105|11164506|FG002|COMPLETED|Overall Study||10
10039809|NCT01964105|11164504|FG000|NOT COMPLETED|Overall Study||2
10039810|NCT01964105|11164505|FG001|NOT COMPLETED|Overall Study||13
10039811|NCT01964105|11164506|FG002|NOT COMPLETED|Overall Study||0
10039812|NCT01964222|11164516|FG000|STARTED|Overall Study||101
10039813|NCT01964222|11164517|FG001|STARTED|Overall Study||100
10039814|NCT01964222|11164516|FG000|COMPLETED|Overall Study||86
10039815|NCT01964222|11164517|FG001|COMPLETED|Overall Study||89
10039816|NCT01964222|11164516|FG000|NOT COMPLETED|Overall Study||15
10039817|NCT01964222|11164517|FG001|NOT COMPLETED|Overall Study||11
10039818|NCT01964300|11164525|FG000|STARTED|Overall Study||7
10039819|NCT01964300|11164526|FG001|STARTED|Overall Study||12
10039820|NCT01964300|11164525|FG000|COMPLETED|Overall Study||1
10039821|NCT01964300|11164526|FG001|COMPLETED|Overall Study||1
10039822|NCT01964300|11164525|FG000|NOT COMPLETED|Overall Study||6
10039823|NCT01964300|11164526|FG001|NOT COMPLETED|Overall Study||11
10039824|NCT01964326|11164532|FG000|STARTED|Overall Study||1311
10039825|NCT01964326|11164532|FG000|COMPLETED|Overall Study||1014
10039826|NCT01964326|11164532|FG000|NOT COMPLETED|Overall Study||297
10039827|NCT01964352|11164540|FG000|STARTED|Overall Study||204
10039828|NCT01964352|11164541|FG001|STARTED|Overall Study||203
10039829|NCT01964352|11164542|FG002|STARTED|Overall Study||202
10039830|NCT01964352|11164543|FG003|STARTED|Overall Study||203
10039831|NCT01964352|11164540|FG000|COMPLETED|Overall Study||178
10039832|NCT01964352|11164541|FG001|COMPLETED|Overall Study||192
10039833|NCT01964352|11164542|FG002|COMPLETED|Overall Study||196
10039834|NCT01964352|11164543|FG003|COMPLETED|Overall Study||195
10039835|NCT01964352|11164540|FG000|NOT COMPLETED|Overall Study||26
10039836|NCT01964352|11164541|FG001|NOT COMPLETED|Overall Study||11
10039837|NCT01964352|11164542|FG002|NOT COMPLETED|Overall Study||6
10039838|NCT01964352|11164543|FG003|NOT COMPLETED|Overall Study||8
10039839|NCT01964378|11164555|FG000|STARTED|Overall Study||66
10039840|NCT01964378|11164556|FG001|STARTED|Overall Study||66
10039841|NCT01964378|11164555|FG000|Participants Treated (Safety Set)|Overall Study||65
10039842|NCT01964378|11164556|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
10039843|NCT01964378|11164555|FG000|COMPLETED|Overall Study||41
10039844|NCT01964378|11164556|FG001|COMPLETED|Overall Study||45
10039845|NCT01964378|11164555|FG000|NOT COMPLETED|Overall Study||25
10039846|NCT01964378|11164556|FG001|NOT COMPLETED|Overall Study||21
10039847|NCT01964430|11164564|FG000|STARTED|Overall Study||432
10039848|NCT01964430|11164565|FG001|STARTED|Overall Study||434
10039849|NCT01964430|11164564|FG000|Treated Population|Overall Study||429
10039850|NCT01964430|11164565|FG001|Treated Population|Overall Study||423
10039851|NCT01964430|11164564|FG000|COMPLETED|Overall Study||287
10039852|NCT01964430|11164565|FG001|COMPLETED|Overall Study||310
10039853|NCT01964430|11164564|FG000|NOT COMPLETED|Overall Study||145
10039854|NCT01964430|11164565|FG001|NOT COMPLETED|Overall Study||124
10039855|NCT01964521|11164571|FG000|STARTED|Overall Study||24
10039856|NCT01964521|11164571|FG000|COMPLETED|Overall Study||20
10039857|NCT01964521|11164571|FG000|NOT COMPLETED|Overall Study||4
10039858|NCT01964547|11164578|FG000|STARTED|Overall Study||62
10039859|NCT01964547|11164579|FG001|STARTED|Overall Study||59
10039860|NCT01964547|11164578|FG000|COMPLETED|Overall Study||50
10116535|NCT02532374|11247288|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14
10116536|NCT02532374|11247288|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14
10116537|NCT02532374|11247288|FG000|COMPLETED|Overall Study||14
10116538|NCT02532374|11247288|FG000|NOT COMPLETED|Overall Study||2
10116539|NCT02532465|11247302|FG000|STARTED|Overall Study||25
10116540|NCT02532465|11247303|FG001|STARTED|Overall Study||25
10116541|NCT02532465|11247302|FG000|COMPLETED|Overall Study||24
10116542|NCT02532465|11247303|FG001|COMPLETED|Overall Study||24
10116543|NCT02532465|11247302|FG000|NOT COMPLETED|Overall Study||1
10116544|NCT02532465|11247303|FG001|NOT COMPLETED|Overall Study||1
10116545|NCT02532517|11247309|FG000|STARTED|Overall Study||45
10116546|NCT02532517|11247309|FG000|mITT Analysis Set|Overall Study||44
10116547|NCT02532517|11247309|FG000|COMPLETED|Overall Study||28
10116548|NCT02532517|11247309|FG000|NOT COMPLETED|Overall Study||17
10116549|NCT02532543|11247317|FG000|STARTED|Overall Study||3
10116550|NCT02532543|11247318|FG001|STARTED|Overall Study||4
10116551|NCT02532543|11247319|FG002|STARTED|Overall Study||5
10116552|NCT02532543|11247320|FG003|STARTED|Overall Study||4
10116553|NCT02532543|11247317|FG000|COMPLETED|Overall Study||3
10116554|NCT02532543|11247318|FG001|COMPLETED|Overall Study||4
10116555|NCT02532543|11247319|FG002|COMPLETED|Overall Study||4
10116556|NCT02532543|11247320|FG003|COMPLETED|Overall Study||4
10116557|NCT02532543|11247317|FG000|NOT COMPLETED|Overall Study||0
10116558|NCT02532543|11247318|FG001|NOT COMPLETED|Overall Study||0
10116559|NCT02532543|11247319|FG002|NOT COMPLETED|Overall Study||1
10116560|NCT02532543|11247320|FG003|NOT COMPLETED|Overall Study||0
10116561|NCT02532556|11247330|FG000|STARTED|Overall Study||12
10116562|NCT02532556|11247330|FG000|COMPLETED|Overall Study||12
10116563|NCT02532556|11247330|FG000|NOT COMPLETED|Overall Study||0
10116564|NCT02532647|11247343|FG000|STARTED|Overall Study||32
10116565|NCT02532647|11247344|FG001|STARTED|Overall Study||16
10116566|NCT02532647|11247345|FG002|STARTED|Overall Study||31
10116567|NCT02532647|11247343|FG000|Safety Population|Overall Study||31
10039861|NCT01964547|11164579|FG001|COMPLETED|Overall Study||48
10039862|NCT01964547|11164578|FG000|NOT COMPLETED|Overall Study||12
10116568|NCT02532647|11247344|FG001|Safety Population|Overall Study||16
10039863|NCT01964547|11164579|FG001|NOT COMPLETED|Overall Study||11
10039864|NCT01964716|11164587|FG000|STARTED|Overall Study||250
10039865|NCT01964716|11164588|FG001|STARTED|Overall Study||250
10039866|NCT01964716|11164587|FG000|Vaccinated Dose 1|Overall Study||250
10039867|NCT01964716|11164588|FG001|Vaccinated Dose 1|Overall Study||250
10039868|NCT01964716|11164587|FG000|Vaccinated Dose 2|Overall Study||249
10116569|NCT02532647|11247345|FG002|Safety Population|Overall Study||30
10116570|NCT02532647|11247343|FG000|COMPLETED|Overall Study||31
10039869|NCT01964716|11164588|FG001|Vaccinated Dose 2|Overall Study||248
10039870|NCT01964716|11164587|FG000|Vaccinated Dose 3|Overall Study||247
10039871|NCT01964716|11164588|FG001|Vaccinated Dose 3|Overall Study||244
10039872|NCT01964716|11164587|FG000|COMPLETED|Overall Study||245
10039873|NCT01964716|11164588|FG001|COMPLETED|Overall Study||244
10039874|NCT01964716|11164587|FG000|NOT COMPLETED|Overall Study||5
10039875|NCT01964716|11164588|FG001|NOT COMPLETED|Overall Study||6
10039876|NCT01964755|11164602|FG000|STARTED|Overall Study||6
10039877|NCT01964755|11164602|FG000|Cycle 2|Overall Study||5
10039878|NCT01964755|11164602|FG000|Cycle 3|Overall Study||4
10039879|NCT01964755|11164602|FG000|Cycle 4|Overall Study||4
10039880|NCT01964755|11164602|FG000|Cycle 5|Overall Study||4
10039881|NCT01964755|11164602|FG000|COMPLETED|Overall Study||4
10039882|NCT01964755|11164602|FG000|NOT COMPLETED|Overall Study||2
10039883|NCT01964898|11164608|FG000|STARTED|Overall Study||31
10039884|NCT01964898|11164609|FG001|STARTED|Overall Study||33
10039885|NCT01964898|11164608|FG000|12 Week Assessment|Overall Study||25
10039886|NCT01964898|11164609|FG001|12 Week Assessment|Overall Study||30
10039887|NCT01964898|11164608|FG000|COMPLETED|Overall Study||24
10039888|NCT01964898|11164609|FG001|COMPLETED|Overall Study||26
10039889|NCT01964898|11164608|FG000|NOT COMPLETED|Overall Study||7
10039890|NCT01964898|11164609|FG001|NOT COMPLETED|Overall Study||7
10039891|NCT01964924|11164615|FG000|STARTED|Trametinib Monotherapy||37
10039892|NCT01964924|11164616|FG001|STARTED|Trametinib Monotherapy||0
10039893|NCT01964924|11164615|FG000|COMPLETED|Trametinib Monotherapy||18
10039894|NCT01964924|11164616|FG001|COMPLETED|Trametinib Monotherapy||0
10039895|NCT01964924|11164615|FG000|NOT COMPLETED|Trametinib Monotherapy||19
10039896|NCT01964924|11164616|FG001|NOT COMPLETED|Trametinib Monotherapy||0
10039897|NCT01964924|11164615|FG000|STARTED|Trametinib + GSK2141||0
10039898|NCT01964924|11164616|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
10039899|NCT01964924|11164615|FG000|COMPLETED|Trametinib + GSK2141||0
10039900|NCT01964924|11164616|FG001|COMPLETED|Trametinib + GSK2141||19
10039901|NCT01964924|11164615|FG000|NOT COMPLETED|Trametinib + GSK2141||0
10039902|NCT01964924|11164616|FG001|NOT COMPLETED|Trametinib + GSK2141||0
10039903|NCT01964950|11164627|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
10039904|NCT01964950|11164627|FG000|COMPLETED|Overall Study||1076
10039905|NCT01964950|11164627|FG000|NOT COMPLETED|Overall Study||25
10039906|NCT01964963|11164634|FG000|STARTED|Overall Study||19192
10039907|NCT01964963|11164634|FG000|COMPLETED|Overall Study||18249
10039908|NCT01964963|11164634|FG000|NOT COMPLETED|Overall Study||943
10039909|NCT01964976|11164640|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
10039910|NCT01964976|11164640|FG000|COMPLETED|Overall Study||1065
10039911|NCT01964976|11164640|FG000|NOT COMPLETED|Overall Study||31
10039912|NCT01965002|11164647|FG000|STARTED|Overall Study||5
10039913|NCT01965002|11164647|FG000|COMPLETED|Overall Study||5
10039914|NCT01965002|11164647|FG000|NOT COMPLETED|Overall Study||0
10039915|NCT01965067|11164655|FG000|STARTED|Overall Study||30
10039916|NCT01965067|11164656|FG001|STARTED|Overall Study||30
10039917|NCT01965067|11164655|FG000|COMPLETED|Overall Study||30
10039918|NCT01965067|11164656|FG001|COMPLETED|Overall Study||30
10039919|NCT01965067|11164655|FG000|NOT COMPLETED|Overall Study||0
10039920|NCT01965067|11164656|FG001|NOT COMPLETED|Overall Study||0
10039921|NCT01965158|11164664|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
10039922|NCT01965158|11164665|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
10039923|NCT01965158|11164664|FG000|Received Treatment|Overall Study||272
10039924|NCT01965158|11164665|FG001|Received Treatment|Overall Study||273
10039925|NCT01965158|11164664|FG000|COMPLETED|Overall Study||233
10039926|NCT01965158|11164665|FG001|COMPLETED|Overall Study||238
10039927|NCT01965158|11164664|FG000|NOT COMPLETED|Overall Study||41
10039928|NCT01965158|11164665|FG001|NOT COMPLETED|Overall Study||35
10039929|NCT01965262|11164671|FG000|STARTED|First Intervention (7 Days)||15
10039930|NCT01965262|11164672|FG001|STARTED|First Intervention (7 Days)||15
10039931|NCT01965262|11164671|FG000|COMPLETED|First Intervention (7 Days)||15
10039932|NCT01965262|11164672|FG001|COMPLETED|First Intervention (7 Days)||15
10039933|NCT01965262|11164671|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10039934|NCT01965262|11164672|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10039935|NCT01965262|11164671|FG000|STARTED|Second Intervention (7 Days)||15
10039936|NCT01965262|11164672|FG001|STARTED|Second Intervention (7 Days)||15
10039937|NCT01965262|11164671|FG000|COMPLETED|Second Intervention (7 Days)||14
10039938|NCT01965262|11164672|FG001|COMPLETED|Second Intervention (7 Days)||5
10039939|NCT01965262|11164671|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
10039940|NCT01965262|11164672|FG001|NOT COMPLETED|Second Intervention (7 Days)||10
10039941|NCT01965288|11164680|FG000|STARTED|Overall Study||30
10039942|NCT01965288|11164681|FG001|STARTED|Overall Study||30
10039943|NCT01965288|11164680|FG000|COMPLETED|Overall Study||30
10039944|NCT01965288|11164681|FG001|COMPLETED|Overall Study||30
10039945|NCT01965288|11164680|FG000|NOT COMPLETED|Overall Study||0
10039946|NCT01965288|11164681|FG001|NOT COMPLETED|Overall Study||0
10039947|NCT01965327|11164699|FG000|STARTED|Overall Study||12
10039948|NCT01965327|11164699|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
10039949|NCT01965327|11164699|FG000|NOT COMPLETED|Overall Study||2
10039950|NCT01965366|11164705|FG000|STARTED|Overall Study||13
10039951|NCT01965366|11164706|FG001|STARTED|Overall Study||14
10039952|NCT01965366|11164705|FG000|COMPLETED|Overall Study||3
10039953|NCT01965366|11164706|FG001|COMPLETED|Overall Study||9
10039954|NCT01965366|11164705|FG000|NOT COMPLETED|Overall Study||10
10039955|NCT01965366|11164706|FG001|NOT COMPLETED|Overall Study||5
10039956|NCT01965431|11164712|FG000|STARTED|Overall Study|Started are actually Treated subjects|8
10039957|NCT01965431|11164713|FG001|STARTED|Overall Study||8
10039958|NCT01965431|11164714|FG002|STARTED|Overall Study||8
10039959|NCT01965431|11164715|FG003|STARTED|Overall Study||8
10039960|NCT01965431|11164716|FG004|STARTED|Overall Study||8
10039961|NCT01965431|11164717|FG005|STARTED|Overall Study||8
10039962|NCT01965431|11164712|FG000|COMPLETED|Overall Study||2
10039963|NCT01965431|11164713|FG001|COMPLETED|Overall Study||2
10039964|NCT01965431|11164714|FG002|COMPLETED|Overall Study||2
10039965|NCT01965431|11164715|FG003|COMPLETED|Overall Study||2
10039966|NCT01965431|11164716|FG004|COMPLETED|Overall Study||2
10039967|NCT01965431|11164717|FG005|COMPLETED|Overall Study||2
10039968|NCT01965431|11164712|FG000|NOT COMPLETED|Overall Study||6
10039969|NCT01965431|11164713|FG001|NOT COMPLETED|Overall Study||6
10039970|NCT01965431|11164714|FG002|NOT COMPLETED|Overall Study||6
10039971|NCT01965431|11164715|FG003|NOT COMPLETED|Overall Study||6
10039972|NCT01965431|11164716|FG004|NOT COMPLETED|Overall Study||6
10039973|NCT01965431|11164717|FG005|NOT COMPLETED|Overall Study||6
10039974|NCT01965535|11164729|FG000|STARTED|Overall Study||78
10039975|NCT01965535|11164730|FG001|STARTED|Overall Study||77
10039976|NCT01965535|11164729|FG000|COMPLETED|Overall Study||76
10039977|NCT01965535|11164730|FG001|COMPLETED|Overall Study||76
10039978|NCT01965535|11164729|FG000|NOT COMPLETED|Overall Study||2
10039979|NCT01965535|11164730|FG001|NOT COMPLETED|Overall Study||1
10039980|NCT01965561|11164736|FG000|STARTED|Overall Study||10
10039981|NCT01965561|11164736|FG000|COMPLETED|Overall Study||10
10039982|NCT01965561|11164736|FG000|NOT COMPLETED|Overall Study||0
10039983|NCT01965600|11164743|FG000|STARTED|First Intervention||6
10039984|NCT01965600|11164744|FG001|STARTED|First Intervention||8
10039985|NCT01965600|11164745|FG002|STARTED|First Intervention||5
10039986|NCT01965600|11164746|FG003|STARTED|First Intervention||4
10039987|NCT01965600|11164743|FG000|Received at Least One Dose of Drug|First Intervention||6
10039988|NCT01965600|11164744|FG001|Received at Least One Dose of Drug|First Intervention||8
10039989|NCT01965600|11164745|FG002|Received at Least One Dose of Drug|First Intervention||5
10039990|NCT01965600|11164746|FG003|Received at Least One Dose of Drug|First Intervention||4
10039991|NCT01965600|11164743|FG000|COMPLETED|First Intervention||6
10039992|NCT01965600|11164744|FG001|COMPLETED|First Intervention||8
10039993|NCT01965600|11164745|FG002|COMPLETED|First Intervention||5
10039994|NCT01965600|11164746|FG003|COMPLETED|First Intervention||4
10039995|NCT01965600|11164743|FG000|NOT COMPLETED|First Intervention||0
10039996|NCT01965600|11164744|FG001|NOT COMPLETED|First Intervention||0
10039997|NCT01965600|11164745|FG002|NOT COMPLETED|First Intervention||0
10039998|NCT01965600|11164746|FG003|NOT COMPLETED|First Intervention||0
10039999|NCT01965600|11164743|FG000|STARTED|Washout Period of Approximately 15 Days||6
10040000|NCT01965600|11164744|FG001|STARTED|Washout Period of Approximately 15 Days||8
10040001|NCT01965600|11164745|FG002|STARTED|Washout Period of Approximately 15 Days||5
10040002|NCT01965600|11164746|FG003|STARTED|Washout Period of Approximately 15 Days||4
10040003|NCT01965600|11164743|FG000|COMPLETED|Washout Period of Approximately 15 Days||4
10040004|NCT01965600|11164744|FG001|COMPLETED|Washout Period of Approximately 15 Days||4
10040005|NCT01965600|11164745|FG002|COMPLETED|Washout Period of Approximately 15 Days||3
10040006|NCT01965600|11164746|FG003|COMPLETED|Washout Period of Approximately 15 Days||2
10040007|NCT01965600|11164743|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2
10040008|NCT01965600|11164744|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4
10040009|NCT01965600|11164745|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2
10040010|NCT01965600|11164746|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2
10040011|NCT01965600|11164743|FG000|STARTED|Second Intervention||4
10040012|NCT01965600|11164744|FG001|STARTED|Second Intervention||4
10040013|NCT01965600|11164745|FG002|STARTED|Second Intervention||3
10040014|NCT01965600|11164746|FG003|STARTED|Second Intervention||2
10040015|NCT01965600|11164743|FG000|COMPLETED|Second Intervention||4
10040016|NCT01965600|11164744|FG001|COMPLETED|Second Intervention||4
10040017|NCT01965600|11164745|FG002|COMPLETED|Second Intervention||1
10040018|NCT01965600|11164746|FG003|COMPLETED|Second Intervention||0
10040019|NCT01965600|11164743|FG000|NOT COMPLETED|Second Intervention||0
10040020|NCT01965600|11164744|FG001|NOT COMPLETED|Second Intervention||0
10040021|NCT01965600|11164745|FG002|NOT COMPLETED|Second Intervention||2
10040022|NCT01965600|11164746|FG003|NOT COMPLETED|Second Intervention||2
10040023|NCT01965652|11164756|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
10040024|NCT01965652|11164757|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
10040025|NCT01965652|11164756|FG000|Received Treatment|Overall Study||622
10040026|NCT01965652|11164757|FG001|Received Treatment|Overall Study||623
10040027|NCT01965652|11164756|FG000|COMPLETED|Overall Study||413
10040028|NCT01965652|11164757|FG001|COMPLETED|Overall Study||413
10040029|NCT01965652|11164756|FG000|NOT COMPLETED|Overall Study||210
10040030|NCT01965652|11164757|FG001|NOT COMPLETED|Overall Study||210
10040031|NCT01965665|11164763|FG000|STARTED|Overall Study||20
10040032|NCT01965665|11164763|FG000|COMPLETED|Overall Study||19
10040033|NCT01965665|11164763|FG000|NOT COMPLETED|Overall Study||1
10040034|NCT01965756|11164769|FG000|STARTED|Overall Study||10
10040035|NCT01965756|11164770|FG001|STARTED|Overall Study||10
10040036|NCT01965756|11164769|FG000|COMPLETED|Overall Study||10
10040037|NCT01965756|11164770|FG001|COMPLETED|Overall Study||10
10040038|NCT01965756|11164769|FG000|NOT COMPLETED|Overall Study||0
10040039|NCT01965756|11164770|FG001|NOT COMPLETED|Overall Study||0
10040040|NCT01965834|11164780|FG000|STARTED|Overall Study||6
10040041|NCT01965834|11164780|FG000|COMPLETED|Overall Study||2
10040042|NCT01965834|11164780|FG000|NOT COMPLETED|Overall Study||4
10040043|NCT01965860|11164787|FG000|STARTED|Overall Study||11
10040044|NCT01965860|11164788|FG001|STARTED|Overall Study||10
10040045|NCT01965860|11164789|FG002|STARTED|Overall Study||11
10040046|NCT01965860|11164787|FG000|COMPLETED|Overall Study||9
10040047|NCT01965860|11164788|FG001|COMPLETED|Overall Study||10
10040048|NCT01965860|11164789|FG002|COMPLETED|Overall Study||10
10040049|NCT01965860|11164787|FG000|NOT COMPLETED|Overall Study||2
10040050|NCT01965860|11164788|FG001|NOT COMPLETED|Overall Study||0
10040051|NCT01965860|11164789|FG002|NOT COMPLETED|Overall Study||1
10040052|NCT01965899|11164797|FG000|STARTED|Overall Study||151
10040053|NCT01965899|11164797|FG000|COMPLETED|Overall Study||145
10040054|NCT01965899|11164797|FG000|NOT COMPLETED|Overall Study||6
10040055|NCT01965938|11164804|FG000|STARTED|Overall Study||21
10040056|NCT01965938|11164805|FG001|STARTED|Overall Study||20
10040057|NCT01965938|11164804|FG000|COMPLETED|Overall Study||20
10040058|NCT01965938|11164805|FG001|COMPLETED|Overall Study||20
10040059|NCT01965938|11164804|FG000|NOT COMPLETED|Overall Study||1
10040060|NCT01965938|11164805|FG001|NOT COMPLETED|Overall Study||0
10040061|NCT01966003|11164815|FG000|STARTED|Overall Study||328
10040062|NCT01966003|11164816|FG001|STARTED|Overall Study||314
10040063|NCT01966003|11164815|FG000|Received Study Drug|Overall Study||324
10040064|NCT01966003|11164816|FG001|Received Study Drug|Overall Study||309
10040065|NCT01966003|11164815|FG000|COMPLETED|Overall Study||58
10040066|NCT01966003|11164816|FG001|COMPLETED|Overall Study||44
10040067|NCT01966003|11164815|FG000|NOT COMPLETED|Overall Study||270
10040068|NCT01966003|11164816|FG001|NOT COMPLETED|Overall Study||270
10040069|NCT01966042|11164822|FG000|STARTED|Overall Study||13
10040070|NCT01966042|11164822|FG000|COMPLETED|Overall Study||11
10040071|NCT01966042|11164822|FG000|NOT COMPLETED|Overall Study||2
10040072|NCT01966068|11164828|FG000|STARTED|Overall Study||294
10040073|NCT01966068|11164828|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237
10040074|NCT01966068|11164828|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156
10040075|NCT01966068|11164828|FG000|COMPLETED|Overall Study||156
10040076|NCT01966068|11164828|FG000|NOT COMPLETED|Overall Study||138
10040077|NCT01966107|11164835|FG000|STARTED|Overall Study||1812
10040078|NCT01966107|11164836|FG001|STARTED|Overall Study||1818
10040079|NCT01966107|11164835|FG000|Full Analysis Set|Overall Study||1791
10040080|NCT01966107|11164836|FG001|Full Analysis Set|Overall Study||1798
10040081|NCT01966107|11164835|FG000|COMPLETED|Overall Study||1010
10040082|NCT01966107|11164836|FG001|COMPLETED|Overall Study||937
10040083|NCT01966107|11164835|FG000|NOT COMPLETED|Overall Study||802
10040084|NCT01966107|11164836|FG001|NOT COMPLETED|Overall Study||881
10040085|NCT01966120|11164844|FG000|STARTED|Overall Study||55
10040086|NCT01966120|11164845|FG001|STARTED|Overall Study||32
10040087|NCT01966120|11164844|FG000|COMPLETED|Overall Study||54
10040088|NCT01966120|11164845|FG001|COMPLETED|Overall Study||26
10040089|NCT01966120|11164844|FG000|NOT COMPLETED|Overall Study||1
10040090|NCT01966120|11164845|FG001|NOT COMPLETED|Overall Study||6
10040091|NCT01966159|11164853|FG000|STARTED|Overall Study||205
10040092|NCT01966159|11164854|FG001|STARTED|Overall Study||207
10040093|NCT01966159|11164853|FG000|COMPLETED|Overall Study||205
10040094|NCT01966159|11164854|FG001|COMPLETED|Overall Study||207
10040095|NCT01966159|11164853|FG000|NOT COMPLETED|Overall Study||0
10040096|NCT01966159|11164854|FG001|NOT COMPLETED|Overall Study||0
10040097|NCT01966354|11164863|FG000|STARTED|Overall Study||75
10040098|NCT01966354|11164864|FG001|STARTED|Overall Study||73
10040099|NCT01966354|11164865|FG002|STARTED|Overall Study||72
10040100|NCT01966354|11164863|FG000|COMPLETED|Overall Study||75
10040101|NCT01966354|11164864|FG001|COMPLETED|Overall Study||73
10040102|NCT01966354|11164865|FG002|COMPLETED|Overall Study||72
10040103|NCT01966354|11164863|FG000|NOT COMPLETED|Overall Study||0
10040104|NCT01966354|11164864|FG001|NOT COMPLETED|Overall Study||0
10040105|NCT01966354|11164865|FG002|NOT COMPLETED|Overall Study||0
10040106|NCT01966380|11164873|FG000|STARTED|Overall Study||3
10040107|NCT01966380|11164874|FG001|STARTED|Overall Study||3
10040108|NCT01966380|11164873|FG000|COMPLETED|Overall Study||3
10040109|NCT01966380|11164874|FG001|COMPLETED|Overall Study||2
10040110|NCT01966380|11164873|FG000|NOT COMPLETED|Overall Study||0
10040111|NCT01966380|11164874|FG001|NOT COMPLETED|Overall Study||1
10040112|NCT01966419|11164882|FG000|STARTED|Overall Study||115
10040113|NCT01966419|11164883|FG001|STARTED|Overall Study||116
10040114|NCT01966419|11164882|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115
10040115|NCT01966419|11164883|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116
10040116|NCT01966419|11164882|FG000|Safety Analysis Set (SAS)|Overall Study||112
10040117|NCT01966419|11164883|FG001|Safety Analysis Set (SAS)|Overall Study||114
10040118|NCT01966419|11164882|FG000|COMPLETED|Overall Study||74
10040119|NCT01966419|11164883|FG001|COMPLETED|Overall Study||80
10040120|NCT01966419|11164882|FG000|NOT COMPLETED|Overall Study||41
10040121|NCT01966419|11164883|FG001|NOT COMPLETED|Overall Study||36
10040122|NCT01966432|11164892|FG000|STARTED|Overall Study||10
10040123|NCT01966432|11164893|FG001|STARTED|Overall Study||34
10040124|NCT01966432|11164894|FG002|STARTED|Overall Study||54
10040125|NCT01966432|11164892|FG000|COMPLETED|Overall Study||5
10040126|NCT01966432|11164893|FG001|COMPLETED|Overall Study||21
10040127|NCT01966432|11164894|FG002|COMPLETED|Overall Study||28
10040128|NCT01966432|11164892|FG000|NOT COMPLETED|Overall Study||5
10040129|NCT01966432|11164893|FG001|NOT COMPLETED|Overall Study||13
10040130|NCT01966432|11164894|FG002|NOT COMPLETED|Overall Study||26
10040131|NCT01966445|11164910|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
10040132|NCT01966445|11164911|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
10040133|NCT01966445|11164912|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
10040134|NCT01966445|11164913|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
10040135|NCT01966445|11164914|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
10040136|NCT01966445|11164915|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
10040137|NCT01966445|11164916|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
10040138|NCT01966445|11164910|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10040139|NCT01966445|11164911|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10040140|NCT01966445|11164912|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10040141|NCT01966445|11164913|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
10040142|NCT01966445|11164914|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10040143|NCT01966445|11164915|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
10040144|NCT01966445|11164916|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
10040145|NCT01966445|11164910|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
10040146|NCT01966445|11164911|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
10040147|NCT01966445|11164912|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10040148|NCT01966445|11164913|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
10040149|NCT01966445|11164914|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
10040150|NCT01966445|11164915|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10040151|NCT01966445|11164916|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
10040152|NCT01966445|11164910|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10040153|NCT01966445|11164911|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10040154|NCT01966445|11164912|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10040155|NCT01966445|11164913|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10040156|NCT01966445|11164914|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10040157|NCT01966445|11164915|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10040158|NCT01966445|11164916|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
10040159|NCT01966445|11164910|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040160|NCT01966445|11164911|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040161|NCT01966445|11164912|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040162|NCT01966445|11164913|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040163|NCT01966445|11164914|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040164|NCT01966445|11164915|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040165|NCT01966445|11164916|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
10040166|NCT01966445|11164910|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040167|NCT01966445|11164911|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040168|NCT01966445|11164912|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040169|NCT01966445|11164913|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040170|NCT01966445|11164914|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040171|NCT01966445|11164915|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10040172|NCT01966445|11164916|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
10040173|NCT01966458|11164934|FG000|STARTED|Overall Study||308
10040174|NCT01966458|11164935|FG001|STARTED|Overall Study||157
10040175|NCT01966458|11164934|FG000|COMPLETED|Overall Study||304
10040176|NCT01966458|11164935|FG001|COMPLETED|Overall Study||155
10040177|NCT01966458|11164934|FG000|NOT COMPLETED|Overall Study||4
10040178|NCT01966458|11164935|FG001|NOT COMPLETED|Overall Study||2
10040179|NCT01966718|11164941|FG000|STARTED|Overall Study||8
10040180|NCT01966718|11164941|FG000|COMPLETED|Overall Study||8
10040181|NCT01966718|11164941|FG000|NOT COMPLETED|Overall Study||0
10040182|NCT01966770|11164947|FG000|STARTED|Overall Study||20
10040183|NCT01966770|11164947|FG000|COMPLETED|Overall Study||20
10040184|NCT01966770|11164947|FG000|NOT COMPLETED|Overall Study||0
10040185|NCT01966796|11164985|FG000|STARTED|Overall Study||15
10040186|NCT01966796|11164986|FG001|STARTED|Overall Study||51
10040187|NCT01966796|11164987|FG002|STARTED|Overall Study||195
10040188|NCT01966796|11164988|FG003|STARTED|Overall Study||269
10040189|NCT01966796|11164985|FG000|COMPLETED|Overall Study||15
10040190|NCT01966796|11164986|FG001|COMPLETED|Overall Study||51
10040191|NCT01966796|11164987|FG002|COMPLETED|Overall Study||195
10040192|NCT01966796|11164988|FG003|COMPLETED|Overall Study||269
10040193|NCT01966796|11164985|FG000|NOT COMPLETED|Overall Study||0
10040194|NCT01966796|11164986|FG001|NOT COMPLETED|Overall Study||0
10040195|NCT01966796|11164987|FG002|NOT COMPLETED|Overall Study||0
10040196|NCT01966796|11164988|FG003|NOT COMPLETED|Overall Study||0
10040197|NCT01966809|11165002|FG000|STARTED|Overall Study||1
10040198|NCT01966809|11165002|FG000|COMPLETED|Overall Study||1
10040199|NCT01966809|11165002|FG000|NOT COMPLETED|Overall Study||0
10040200|NCT01966900|11165008|FG000|STARTED|Overall Study||8
10040201|NCT01966900|11165009|FG001|STARTED|Overall Study||6
10040202|NCT01966900|11165008|FG000|COMPLETED|Overall Study||6
10040203|NCT01966900|11165009|FG001|COMPLETED|Overall Study||6
10040204|NCT01966900|11165008|FG000|NOT COMPLETED|Overall Study||2
10040205|NCT01966900|11165009|FG001|NOT COMPLETED|Overall Study||0
10040206|NCT01966926|11165017|FG000|STARTED|Overall Study||15
10040207|NCT01966926|11165018|FG001|STARTED|Overall Study||15
10040208|NCT01966926|11165017|FG000|COMPLETED|Overall Study||15
10040209|NCT01966926|11165018|FG001|COMPLETED|Overall Study||15
10040210|NCT01966926|11165017|FG000|NOT COMPLETED|Overall Study||0
10040211|NCT01966926|11165018|FG001|NOT COMPLETED|Overall Study||0
10040212|NCT01966978|11165026|FG000|STARTED|Overall Study||61
10040213|NCT01966978|11165027|FG001|STARTED|Overall Study||59
10040214|NCT01966978|11165026|FG000|COMPLETED|Overall Study||44
10040215|NCT01966978|11165027|FG001|COMPLETED|Overall Study||46
10040216|NCT01966978|11165026|FG000|NOT COMPLETED|Overall Study||17
10040217|NCT01966978|11165027|FG001|NOT COMPLETED|Overall Study||13
10040218|NCT01967069|11165035|FG000|STARTED|Overall Study||182
10040219|NCT01967069|11165036|FG001|STARTED|Overall Study||95
10040220|NCT01967069|11165035|FG000|COMPLETED|Overall Study||174
10040221|NCT01967069|11165036|FG001|COMPLETED|Overall Study||87
10040222|NCT01967069|11165035|FG000|NOT COMPLETED|Overall Study||8
10040223|NCT01967069|11165036|FG001|NOT COMPLETED|Overall Study||8
10040224|NCT01967121|11165045|FG000|STARTED|Overall Study||25
10040225|NCT01967121|11165046|FG001|STARTED|Overall Study||25
10040226|NCT01967121|11165047|FG002|STARTED|Overall Study||25
10040227|NCT01967121|11165045|FG000|COMPLETED|Overall Study||25
10040228|NCT01967121|11165046|FG001|COMPLETED|Overall Study||25
10040229|NCT01967121|11165047|FG002|COMPLETED|Overall Study||25
10040230|NCT01967121|11165045|FG000|NOT COMPLETED|Overall Study||0
10040231|NCT01967121|11165046|FG001|NOT COMPLETED|Overall Study||0
10040232|NCT01967121|11165047|FG002|NOT COMPLETED|Overall Study||0
10040233|NCT01967134|11165058|FG000|STARTED|Overall Study||8
10040234|NCT01967134|11165059|FG001|STARTED|Overall Study||8
10116571|NCT02532647|11247344|FG001|COMPLETED|Overall Study||16
10116572|NCT02532647|11247345|FG002|COMPLETED|Overall Study||30
10116573|NCT02532647|11247343|FG000|NOT COMPLETED|Overall Study||1
10116574|NCT02532647|11247344|FG001|NOT COMPLETED|Overall Study||0
10116575|NCT02532647|11247345|FG002|NOT COMPLETED|Overall Study||1
10116576|NCT02532764|11247363|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6
10116577|NCT02532764|11247364|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6
10116578|NCT02532764|11247365|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9
10116579|NCT02532764|11247366|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6
10116580|NCT02532764|11247367|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9
10116581|NCT02532764|11247368|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0
10116582|NCT02532764|11247369|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0
10116583|NCT02532764|11247370|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0
10116584|NCT02532764|11247371|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0
10116585|NCT02532764|11247372|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0
10116586|NCT02532764|11247363|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
10116587|NCT02532764|11247364|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
10116588|NCT02532764|11247365|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
10116589|NCT02532764|11247366|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
10116590|NCT02532764|11247367|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
10116591|NCT02532764|11247368|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116592|NCT02532764|11247369|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116593|NCT02532764|11247370|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116594|NCT02532764|11247371|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116595|NCT02532764|11247372|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116596|NCT02532764|11247363|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116597|NCT02532764|11247364|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116598|NCT02532764|11247365|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116599|NCT02532764|11247366|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116600|NCT02532764|11247367|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116601|NCT02532764|11247368|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116602|NCT02532764|11247369|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116603|NCT02532764|11247370|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116604|NCT02532764|11247371|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
9706368|NCT00061945|10805386|FG001|NOT COMPLETED|Registration Through Course 3||115
9706369|NCT00061945|10805385|FG000|STARTED|Course IV: Alemtuzumab||25
9706370|NCT00061945|10805386|FG001|STARTED|Course IV: Alemtuzumab||66
9706371|NCT00061945|10805385|FG000|COMPLETED|Course IV: Alemtuzumab||18
9706372|NCT00061945|10805386|FG001|COMPLETED|Course IV: Alemtuzumab||50
9706373|NCT00061945|10805385|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7
9706374|NCT00061945|10805386|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16
9706375|NCT04018612|10805398|FG000|STARTED|Overall Study||44
9706376|NCT04018612|10805399|FG001|STARTED|Overall Study||44
10040235|NCT01967134|11165060|FG002|STARTED|Overall Study||9
10116605|NCT02532764|11247372|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10116606|NCT02532764|11247363|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10116607|NCT02532764|11247364|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
9706377|NCT04018612|10805400|FG002|STARTED|Overall Study||22
9706378|NCT04018612|10805398|FG000|COMPLETED|Overall Study||43
9706379|NCT04018612|10805399|FG001|COMPLETED|Overall Study||44
9706380|NCT04018612|10805400|FG002|COMPLETED|Overall Study||21
9706381|NCT04018612|10805398|FG000|NOT COMPLETED|Overall Study||1
9706382|NCT04018612|10805399|FG001|NOT COMPLETED|Overall Study||0
9706383|NCT04018612|10805400|FG002|NOT COMPLETED|Overall Study||1
9706384|NCT03976648|10805410|FG000|STARTED|Overall Study||21
9706385|NCT03976648|10805411|FG001|STARTED|Overall Study||10
9706386|NCT03976648|10805410|FG000|COMPLETED|Overall Study||0
10040236|NCT01967134|11165058|FG000|COMPLETED|Overall Study||8
10040237|NCT01967134|11165059|FG001|COMPLETED|Overall Study||7
10040238|NCT01967134|11165060|FG002|COMPLETED|Overall Study||9
10040239|NCT01967134|11165058|FG000|NOT COMPLETED|Overall Study||0
10040240|NCT01967134|11165059|FG001|NOT COMPLETED|Overall Study||1
10040241|NCT01967134|11165060|FG002|NOT COMPLETED|Overall Study||0
10040242|NCT01967147|11165070|FG000|STARTED|Overall Study||112
10040243|NCT01967147|11165071|FG001|STARTED|Overall Study||102
10040244|NCT01967147|11165070|FG000|COMPLETED|Overall Study||99
10040245|NCT01967147|11165071|FG001|COMPLETED|Overall Study||82
10040246|NCT01967147|11165070|FG000|NOT COMPLETED|Overall Study||13
10040247|NCT01967147|11165071|FG001|NOT COMPLETED|Overall Study||20
10040248|NCT01967173|11165086|FG000|STARTED|Overall Study||69
10040249|NCT01967173|11165087|FG001|STARTED|Overall Study||69
10040250|NCT01967173|11165088|FG002|STARTED|Overall Study||71
10040251|NCT01967173|11165089|FG003|STARTED|Overall Study||71
10040252|NCT01967173|11165090|FG004|STARTED|Overall Study||73
10040253|NCT01967173|11165091|FG005|STARTED|Overall Study||72
10040254|NCT01967173|11165092|FG006|STARTED|Overall Study||75
10040255|NCT01967173|11165093|FG007|STARTED|Overall Study||74
10040256|NCT01967173|11165086|FG000|Completed 1st Period|Overall Study||58
10040257|NCT01967173|11165087|FG001|Completed 1st Period|Overall Study||60
10040258|NCT01967173|11165088|FG002|Completed 1st Period|Overall Study||67
10040259|NCT01967173|11165089|FG003|Completed 1st Period|Overall Study||65
10040260|NCT01967173|11165090|FG004|Completed 1st Period|Overall Study||64
10040261|NCT01967173|11165091|FG005|Completed 1st Period|Overall Study||62
10040262|NCT01967173|11165092|FG006|Completed 1st Period|Overall Study||67
10040263|NCT01967173|11165093|FG007|Completed 1st Period|Overall Study||69
10040264|NCT01967173|11165086|FG000|Completed 2nd Period|Overall Study||52
10040265|NCT01967173|11165087|FG001|Completed 2nd Period|Overall Study||58
10040266|NCT01967173|11165088|FG002|Completed 2nd Period|Overall Study||63
10040267|NCT01967173|11165089|FG003|Completed 2nd Period|Overall Study||62
10040268|NCT01967173|11165090|FG004|Completed 2nd Period|Overall Study||63
10040269|NCT01967173|11165091|FG005|Completed 2nd Period|Overall Study||57
10040270|NCT01967173|11165092|FG006|Completed 2nd Period|Overall Study||63
10040271|NCT01967173|11165093|FG007|Completed 2nd Period|Overall Study||61
10040272|NCT01967173|11165086|FG000|Completed 3rd Period|Overall Study||48
10040273|NCT01967173|11165087|FG001|Completed 3rd Period|Overall Study||54
10040274|NCT01967173|11165088|FG002|Completed 3rd Period|Overall Study||60
10040275|NCT01967173|11165089|FG003|Completed 3rd Period|Overall Study||61
10040276|NCT01967173|11165090|FG004|Completed 3rd Period|Overall Study||59
10040277|NCT01967173|11165091|FG005|Completed 3rd Period|Overall Study||56
10040278|NCT01967173|11165092|FG006|Completed 3rd Period|Overall Study||59
10040279|NCT01967173|11165093|FG007|Completed 3rd Period|Overall Study||56
10040280|NCT01967173|11165086|FG000|Completed 4th Period|Overall Study||45
10040281|NCT01967173|11165087|FG001|Completed 4th Period|Overall Study||52
10040282|NCT01967173|11165088|FG002|Completed 4th Period|Overall Study||55
10040283|NCT01967173|11165089|FG003|Completed 4th Period|Overall Study||57
10040284|NCT01967173|11165090|FG004|Completed 4th Period|Overall Study||56
10040285|NCT01967173|11165091|FG005|Completed 4th Period|Overall Study||49
10040286|NCT01967173|11165092|FG006|Completed 4th Period|Overall Study||57
10040287|NCT01967173|11165093|FG007|Completed 4th Period|Overall Study||50
10040288|NCT01967173|11165086|FG000|COMPLETED|Overall Study||45
10040289|NCT01967173|11165087|FG001|COMPLETED|Overall Study||52
10040290|NCT01967173|11165088|FG002|COMPLETED|Overall Study||55
10040291|NCT01967173|11165089|FG003|COMPLETED|Overall Study||57
10040292|NCT01967173|11165090|FG004|COMPLETED|Overall Study||56
10040293|NCT01967173|11165091|FG005|COMPLETED|Overall Study||49
10040294|NCT01967173|11165092|FG006|COMPLETED|Overall Study||57
10040295|NCT01967173|11165093|FG007|COMPLETED|Overall Study||50
10040296|NCT01967173|11165086|FG000|NOT COMPLETED|Overall Study||24
10040297|NCT01967173|11165087|FG001|NOT COMPLETED|Overall Study||17
10040298|NCT01967173|11165088|FG002|NOT COMPLETED|Overall Study||16
10040299|NCT01967173|11165089|FG003|NOT COMPLETED|Overall Study||14
10040300|NCT01967173|11165090|FG004|NOT COMPLETED|Overall Study||17
10040301|NCT01967173|11165091|FG005|NOT COMPLETED|Overall Study||23
10040302|NCT01967173|11165092|FG006|NOT COMPLETED|Overall Study||18
10040303|NCT01967173|11165093|FG007|NOT COMPLETED|Overall Study||24
10040304|NCT01967225|11165109|FG000|STARTED|Overall Study||84
10040305|NCT01967225|11165110|FG001|STARTED|Overall Study||41
10040306|NCT01967225|11165109|FG000|Participants Received Treatment|Overall Study||83
10040307|NCT01967225|11165110|FG001|Participants Received Treatment|Overall Study||41
10040308|NCT01967225|11165109|FG000|COMPLETED|Overall Study||72
10040309|NCT01967225|11165110|FG001|COMPLETED|Overall Study||38
10040310|NCT01967225|11165109|FG000|NOT COMPLETED|Overall Study||12
10040311|NCT01967225|11165110|FG001|NOT COMPLETED|Overall Study||3
10040312|NCT01967277|11165120|FG000|STARTED|Overall Study||22
10040313|NCT01967277|11165121|FG001|STARTED|Overall Study||22
10040314|NCT01967277|11165120|FG000|COMPLETED|Overall Study||21
10040315|NCT01967277|11165121|FG001|COMPLETED|Overall Study||19
10040316|NCT01967277|11165120|FG000|NOT COMPLETED|Overall Study||1
10040317|NCT01967277|11165121|FG001|NOT COMPLETED|Overall Study||3
10040318|NCT01967342|11165130|FG000|STARTED|Overall Study||98
10040319|NCT01967342|11165131|FG001|STARTED|Overall Study||95
10040320|NCT01967342|11165132|FG002|STARTED|Overall Study||97
10040321|NCT01967342|11165130|FG000|5-week Follow-up|Overall Study||83
10040322|NCT01967342|11165131|FG001|5-week Follow-up|Overall Study||78
10040323|NCT01967342|11165132|FG002|5-week Follow-up|Overall Study||76
10040324|NCT01967342|11165130|FG000|10-week Follow-up|Overall Study||78
10040325|NCT01967342|11165131|FG001|10-week Follow-up|Overall Study||83
10040326|NCT01967342|11165132|FG002|10-week Follow-up|Overall Study||80
10040327|NCT01967342|11165130|FG000|COMPLETED|Overall Study||71
10040328|NCT01967342|11165131|FG001|COMPLETED|Overall Study||70
10040329|NCT01967342|11165132|FG002|COMPLETED|Overall Study||68
10040330|NCT01967342|11165130|FG000|NOT COMPLETED|Overall Study||27
10040331|NCT01967342|11165131|FG001|NOT COMPLETED|Overall Study||25
10040332|NCT01967342|11165132|FG002|NOT COMPLETED|Overall Study||29
10040333|NCT01967433|11165142|FG000|STARTED|Overall Study||61
10040334|NCT01967433|11165143|FG001|STARTED|Overall Study||59
10040335|NCT01967433|11165142|FG000|COMPLETED|Overall Study||61
10040336|NCT01967433|11165143|FG001|COMPLETED|Overall Study||58
10040337|NCT01967433|11165142|FG000|NOT COMPLETED|Overall Study||0
10040338|NCT01967433|11165143|FG001|NOT COMPLETED|Overall Study||1
10040339|NCT01967537|11165155|FG000|STARTED|Overall Study||341
10040340|NCT01967537|11165155|FG000|COMPLETED|Overall Study||281
10040341|NCT01967537|11165155|FG000|NOT COMPLETED|Overall Study||60
10040342|NCT01967550|11165161|FG000|STARTED|Overall Study||153
10040343|NCT01967550|11165162|FG001|STARTED|Overall Study||151
10040344|NCT01967550|11165161|FG000|COMPLETED|Overall Study||148
10040345|NCT01967550|11165162|FG001|COMPLETED|Overall Study||149
10040346|NCT01967550|11165161|FG000|NOT COMPLETED|Overall Study||5
10040347|NCT01967550|11165162|FG001|NOT COMPLETED|Overall Study||2
10040348|NCT01967576|11165168|FG000|STARTED|Overall Study||14
10040349|NCT01967576|11165168|FG000|COMPLETED|Overall Study||7
10040350|NCT01967576|11165168|FG000|NOT COMPLETED|Overall Study||7
10040351|NCT01967628|11165174|FG000|STARTED|Overall Study||48
10040352|NCT01967628|11165175|FG001|STARTED|Overall Study||50
10040353|NCT01967628|11165174|FG000|COMPLETED|Overall Study||21
10040354|NCT01967628|11165175|FG001|COMPLETED|Overall Study||19
10040355|NCT01967628|11165174|FG000|NOT COMPLETED|Overall Study||27
10040356|NCT01967628|11165175|FG001|NOT COMPLETED|Overall Study||31
10040357|NCT01967641|11165181|FG000|STARTED|Randomized||51
10040358|NCT01967641|11165181|FG000|COMPLETED|Randomized|Completed week 12|43
10040359|NCT01967641|11165181|FG000|NOT COMPLETED|Randomized||8
10040360|NCT01967641|11165181|FG000|STARTED|Admission to Inpatient Phase||43
10040361|NCT01967641|11165181|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
10040362|NCT01967641|11165181|FG000|NOT COMPLETED|Admission to Inpatient Phase||12
10040363|NCT01967641|11165181|FG000|STARTED|12-week Outpatient Phase||31
10040364|NCT01967641|11165181|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
10040365|NCT01967641|11165181|FG000|NOT COMPLETED|12-week Outpatient Phase||13
10040366|NCT01967706|11165188|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10040367|NCT01967706|11165189|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10040368|NCT01967706|11165190|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10040369|NCT01967706|11165191|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10040370|NCT01967706|11165188|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10040371|NCT01967706|11165189|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
10040372|NCT01967706|11165190|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10040373|NCT01967706|11165191|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10040374|NCT01967706|11165188|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040375|NCT01967706|11165189|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040376|NCT01967706|11165190|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040377|NCT01967706|11165191|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040378|NCT01967706|11165188|FG000|STARTED|First Intervention (Day 1)||22
10040379|NCT01967706|11165189|FG001|STARTED|First Intervention (Day 1)||22
10040380|NCT01967706|11165190|FG002|STARTED|First Intervention (Day 1)||9
9848381|NCT00858780|10961054|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
9848382|NCT00858780|10961050|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
9848383|NCT00858780|10961051|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
10040381|NCT01967706|11165191|FG003|STARTED|First Intervention (Day 1)||9
10040382|NCT01967706|11165188|FG000|COMPLETED|First Intervention (Day 1)||21
10040383|NCT01967706|11165189|FG001|COMPLETED|First Intervention (Day 1)||22
10040384|NCT01967706|11165190|FG002|COMPLETED|First Intervention (Day 1)||9
10040385|NCT01967706|11165191|FG003|COMPLETED|First Intervention (Day 1)||9
10040386|NCT01967706|11165188|FG000|NOT COMPLETED|First Intervention (Day 1)||1
10040387|NCT01967706|11165189|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10040388|NCT01967706|11165190|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10040389|NCT01967706|11165191|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10040390|NCT01967706|11165188|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
10040391|NCT01967706|11165189|FG001|STARTED|Washout Period of 1 Day (Day 2)||22
10040392|NCT01967706|11165190|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10040393|NCT01967706|11165191|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
10040394|NCT01967706|11165188|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
10040395|NCT01967706|11165189|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22
10040396|NCT01967706|11165190|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10040397|NCT01967706|11165191|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
10040398|NCT01967706|11165188|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040399|NCT01967706|11165189|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040400|NCT01967706|11165190|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040401|NCT01967706|11165191|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040402|NCT01967706|11165188|FG000|STARTED|Second Intervention (Day 3)||21
10040403|NCT01967706|11165189|FG001|STARTED|Second Intervention (Day 3)||22
10040404|NCT01967706|11165190|FG002|STARTED|Second Intervention (Day 3)||9
10040405|NCT01967706|11165191|FG003|STARTED|Second Intervention (Day 3)||9
9848384|NCT00858780|10961052|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
10040406|NCT01967706|11165188|FG000|COMPLETED|Second Intervention (Day 3)||21
10040407|NCT01967706|11165189|FG001|COMPLETED|Second Intervention (Day 3)||22
10040408|NCT01967706|11165190|FG002|COMPLETED|Second Intervention (Day 3)||9
10040409|NCT01967706|11165191|FG003|COMPLETED|Second Intervention (Day 3)||9
10040410|NCT01967706|11165188|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10040411|NCT01967706|11165189|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10040412|NCT01967706|11165190|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10040413|NCT01967706|11165191|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10040414|NCT01967719|11165202|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10040415|NCT01967719|11165203|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10040416|NCT01967719|11165204|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10040417|NCT01967719|11165205|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10040418|NCT01967719|11165202|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10040419|NCT01967719|11165203|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
10040420|NCT01967719|11165204|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10040421|NCT01967719|11165205|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10040422|NCT01967719|11165202|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040423|NCT01967719|11165203|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040424|NCT01967719|11165204|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040425|NCT01967719|11165205|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040426|NCT01967719|11165202|FG000|STARTED|First Intervention (Day 1)||22
10040427|NCT01967719|11165203|FG001|STARTED|First Intervention (Day 1)||22
10040428|NCT01967719|11165204|FG002|STARTED|First Intervention (Day 1)||9
10040429|NCT01967719|11165205|FG003|STARTED|First Intervention (Day 1)||9
10040430|NCT01967719|11165202|FG000|COMPLETED|First Intervention (Day 1)||22
10040431|NCT01967719|11165203|FG001|COMPLETED|First Intervention (Day 1)||21
10040432|NCT01967719|11165204|FG002|COMPLETED|First Intervention (Day 1)||9
10040433|NCT01967719|11165205|FG003|COMPLETED|First Intervention (Day 1)||8
10040434|NCT01967719|11165202|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10040435|NCT01967719|11165203|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10040436|NCT01967719|11165204|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10040437|NCT01967719|11165205|FG003|NOT COMPLETED|First Intervention (Day 1)||1
10040438|NCT01967719|11165202|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
10040439|NCT01967719|11165203|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
10040440|NCT01967719|11165204|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10040441|NCT01967719|11165205|FG003|STARTED|Washout Period of 1 Day (Day 2)||8
10040442|NCT01967719|11165202|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
10040443|NCT01967719|11165203|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
10040444|NCT01967719|11165204|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10040445|NCT01967719|11165205|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8
10040446|NCT01967719|11165202|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040447|NCT01967719|11165203|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040448|NCT01967719|11165204|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040449|NCT01967719|11165205|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040450|NCT01967719|11165202|FG000|STARTED|Second Intervention (Day 3)||22
10040451|NCT01967719|11165203|FG001|STARTED|Second Intervention (Day 3)||21
10040452|NCT01967719|11165204|FG002|STARTED|Second Intervention (Day 3)||9
10040453|NCT01967719|11165205|FG003|STARTED|Second Intervention (Day 3)||8
10040454|NCT01967719|11165202|FG000|COMPLETED|Second Intervention (Day 3)||22
10040455|NCT01967719|11165203|FG001|COMPLETED|Second Intervention (Day 3)||20
10040456|NCT01967719|11165204|FG002|COMPLETED|Second Intervention (Day 3)||9
10040457|NCT01967719|11165205|FG003|COMPLETED|Second Intervention (Day 3)||8
10040458|NCT01967719|11165202|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10040459|NCT01967719|11165203|FG001|NOT COMPLETED|Second Intervention (Day 3)||1
10040460|NCT01967719|11165204|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10040461|NCT01967719|11165205|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10040462|NCT01967732|11165217|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10040463|NCT01967732|11165218|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10040464|NCT01967732|11165219|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10040465|NCT01967732|11165220|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10040466|NCT01967732|11165217|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10040467|NCT01967732|11165218|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21
10040468|NCT01967732|11165219|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10040469|NCT01967732|11165220|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10040470|NCT01967732|11165217|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040471|NCT01967732|11165218|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
10040472|NCT01967732|11165219|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040473|NCT01967732|11165220|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10040474|NCT01967732|11165217|FG000|STARTED|First Intervention (Day 1)||22
10040475|NCT01967732|11165218|FG001|STARTED|First Intervention (Day 1)||21
10040476|NCT01967732|11165219|FG002|STARTED|First Intervention (Day 1)||9
10040477|NCT01967732|11165220|FG003|STARTED|First Intervention (Day 1)||9
10040478|NCT01967732|11165217|FG000|COMPLETED|First Intervention (Day 1)||22
10040479|NCT01967732|11165218|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
10040480|NCT01967732|11165219|FG002|COMPLETED|First Intervention (Day 1)||9
10040481|NCT01967732|11165220|FG003|COMPLETED|First Intervention (Day 1)||9
10040482|NCT01967732|11165217|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10040483|NCT01967732|11165218|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10040484|NCT01967732|11165219|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10040485|NCT01967732|11165220|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10040486|NCT01967732|11165217|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
10040487|NCT01967732|11165218|FG001|STARTED|Washout Period of 1 Day (Day 2)||20
10040488|NCT01967732|11165219|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10040489|NCT01967732|11165220|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
10040490|NCT01967732|11165217|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
10040491|NCT01967732|11165218|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20
10040492|NCT01967732|11165219|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10040493|NCT01967732|11165220|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
10040494|NCT01967732|11165217|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040495|NCT01967732|11165218|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10116608|NCT02532764|11247365|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10116609|NCT02532764|11247366|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10116610|NCT02532764|11247367|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10116611|NCT02532764|11247368|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
10116612|NCT02532764|11247369|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
10116613|NCT02532764|11247370|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
10116614|NCT02532764|11247371|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
10116615|NCT02532764|11247372|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
10116616|NCT02532764|11247363|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116617|NCT02532764|11247364|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116618|NCT02532764|11247365|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116619|NCT02532764|11247366|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116620|NCT02532764|11247367|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116621|NCT02532764|11247368|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
10116622|NCT02532764|11247369|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
10116623|NCT02532764|11247370|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
10116624|NCT02532764|11247371|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
10116625|NCT02532764|11247372|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
10116626|NCT02532764|11247363|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116627|NCT02532764|11247364|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116628|NCT02532764|11247365|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116629|NCT02532764|11247366|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116630|NCT02532764|11247367|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116631|NCT02532764|11247368|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116632|NCT02532764|11247369|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10116633|NCT02532764|11247370|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
10116634|NCT02532764|11247371|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
10116635|NCT02532764|11247372|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
10116636|NCT02532855|11247401|FG000|STARTED|Overall Study||307
10116637|NCT02532855|11247402|FG001|STARTED|Overall Study||307
10116638|NCT02532855|11247401|FG000|Treated|Overall Study||307
10116639|NCT02532855|11247402|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
10116640|NCT02532855|11247401|FG000|COMPLETED|Overall Study||299
10116641|NCT02532855|11247402|FG001|COMPLETED|Overall Study||296
10116642|NCT02532855|11247401|FG000|NOT COMPLETED|Overall Study||8
10116643|NCT02532855|11247402|FG001|NOT COMPLETED|Overall Study||11
10116644|NCT02532933|11247410|FG000|STARTED|Overall Study||22
10116645|NCT02532933|11247411|FG001|STARTED|Overall Study||22
10116646|NCT02532933|11247410|FG000|COMPLETED|Overall Study||16
10116647|NCT02532933|11247411|FG001|COMPLETED|Overall Study||16
10116648|NCT02532933|11247410|FG000|NOT COMPLETED|Overall Study||6
10116649|NCT02532933|11247411|FG001|NOT COMPLETED|Overall Study||6
10116650|NCT02532972|11247417|FG000|STARTED|Overall Study||11
10116651|NCT02532972|11247417|FG000|COMPLETED|Overall Study||10
10116652|NCT02532972|11247417|FG000|NOT COMPLETED|Overall Study||1
10116653|NCT02532998|11247421|FG000|STARTED|Overall Study||23
10116654|NCT02532998|11247421|FG000|COMPLETED|Overall Study||23
10116655|NCT02532998|11247421|FG000|NOT COMPLETED|Overall Study||0
10116656|NCT02533063|11247437|FG000|STARTED|Intervention 1 (8 Weeks)||16
10116657|NCT02533063|11247438|FG001|STARTED|Intervention 1 (8 Weeks)||16
10116658|NCT02533063|11247437|FG000|COMPLETED|Intervention 1 (8 Weeks)||14
10116659|NCT02533063|11247438|FG001|COMPLETED|Intervention 1 (8 Weeks)||11
10116660|NCT02533063|11247437|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2
10116661|NCT02533063|11247438|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5
10116662|NCT02533063|11247437|FG000|STARTED|Washout (4 Weeks)||14
10116663|NCT02533063|11247438|FG001|STARTED|Washout (4 Weeks)||11
10116664|NCT02533063|11247437|FG000|COMPLETED|Washout (4 Weeks)||14
10116665|NCT02533063|11247438|FG001|COMPLETED|Washout (4 Weeks)||11
10116666|NCT02533063|11247437|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10040496|NCT01967732|11165219|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040497|NCT01967732|11165220|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10040498|NCT01967732|11165217|FG000|STARTED|Second Intervention (Day 3)||22
10040499|NCT01967732|11165218|FG001|STARTED|Second Intervention (Day 3)||20
10040500|NCT01967732|11165219|FG002|STARTED|Second Intervention (Day 3)||9
10040501|NCT01967732|11165220|FG003|STARTED|Second Intervention (Day 3)||9
10040502|NCT01967732|11165217|FG000|COMPLETED|Second Intervention (Day 3)||22
10040503|NCT01967732|11165218|FG001|COMPLETED|Second Intervention (Day 3)||20
10040504|NCT01967732|11165219|FG002|COMPLETED|Second Intervention (Day 3)||9
10040505|NCT01967732|11165220|FG003|COMPLETED|Second Intervention (Day 3)||9
10040506|NCT01967732|11165217|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10040507|NCT01967732|11165218|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10040508|NCT01967732|11165219|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10040509|NCT01967732|11165220|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10040510|NCT01967784|11165228|FG000|STARTED|Overall Study||100
10040511|NCT01967784|11165228|FG000|COMPLETED|Overall Study||100
10040512|NCT01967784|11165228|FG000|NOT COMPLETED|Overall Study||0
10040513|NCT01967836|11165232|FG000|STARTED|Overall Study||20
10040514|NCT01967836|11165232|FG000|COMPLETED|Overall Study||11
10040515|NCT01967836|11165232|FG000|NOT COMPLETED|Overall Study||9
10040516|NCT01967862|11165237|FG000|STARTED|Overall Study||54
10040517|NCT01967862|11165237|FG000|COMPLETED|Overall Study||54
10116667|NCT02533063|11247438|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10116668|NCT02533063|11247437|FG000|STARTED|Intervention 2 (8 Weeks)||14
10116669|NCT02533063|11247438|FG001|STARTED|Intervention 2 (8 Weeks)||11
10116670|NCT02533063|11247437|FG000|COMPLETED|Intervention 2 (8 Weeks)||14
10116671|NCT02533063|11247438|FG001|COMPLETED|Intervention 2 (8 Weeks)||11
10116672|NCT02533063|11247437|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0
10116673|NCT02533063|11247438|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0
10116674|NCT02533089|11247447|FG000|STARTED|Overall Study||605
10116675|NCT02533089|11247448|FG001|STARTED|Overall Study||548
10116676|NCT02533089|11247447|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
10116677|NCT02533089|11247448|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
10116678|NCT02533089|11247447|FG000|NOT COMPLETED|Overall Study||241
10116679|NCT02533089|11247448|FG001|NOT COMPLETED|Overall Study||114
10116680|NCT02533167|11247454|FG000|STARTED|Overall Study||70
10116681|NCT02533167|11247454|FG000|COMPLETED|Overall Study||55
10116682|NCT02533167|11247454|FG000|NOT COMPLETED|Overall Study||15
10116683|NCT02533180|11247461|FG000|STARTED|Overall Study||39
10116684|NCT02533180|11247462|FG001|STARTED|Overall Study||61
10116685|NCT02533180|11247461|FG000|COMPLETED|Overall Study||0
10116686|NCT02533180|11247462|FG001|COMPLETED|Overall Study||14
10116687|NCT02533180|11247461|FG000|NOT COMPLETED|Overall Study||39
10116688|NCT02533180|11247462|FG001|NOT COMPLETED|Overall Study||47
10116689|NCT02533258|11247467|FG000|STARTED|Overall Study||13
10116690|NCT02533258|11247467|FG000|COMPLETED|Overall Study||5
10116691|NCT02533258|11247467|FG000|NOT COMPLETED|Overall Study||8
10116692|NCT02533375|11247471|FG000|STARTED|Overall Study||10
10116693|NCT02533375|11247471|FG000|COMPLETED|Overall Study||5
10116694|NCT02533375|11247471|FG000|NOT COMPLETED|Overall Study||5
10116695|NCT02533401|11247475|FG000|STARTED|Overall Study||34
10116696|NCT02533401|11247475|FG000|COMPLETED|Overall Study||23
10116697|NCT02533401|11247475|FG000|NOT COMPLETED|Overall Study||11
10116698|NCT02533427|11247479|FG000|STARTED|Overall Study||15
10116699|NCT02533427|11247479|FG000|COMPLETED|Overall Study||15
10116700|NCT02533427|11247479|FG000|NOT COMPLETED|Overall Study||0
10116701|NCT02533453|11247486|FG000|STARTED|Overall Study||110
10116702|NCT02533453|11247486|FG000|COMPLETED|Overall Study||101
10116703|NCT02533453|11247486|FG000|NOT COMPLETED|Overall Study||9
10116704|NCT02533466|11247492|FG000|STARTED|Overall Study||16
10116705|NCT02533466|11247493|FG001|STARTED|Overall Study||14
10116706|NCT02533466|11247492|FG000|COMPLETED|Overall Study||16
10116707|NCT02533466|11247493|FG001|COMPLETED|Overall Study||14
10116708|NCT02533466|11247492|FG000|NOT COMPLETED|Overall Study||0
10116709|NCT02533466|11247493|FG001|NOT COMPLETED|Overall Study||0
10116710|NCT02533505|11247501|FG000|STARTED|Overall Study||26
10116711|NCT02533505|11247502|FG001|STARTED|Overall Study||25
10116712|NCT02533505|11247501|FG000|COMPLETED|Overall Study||23
10116713|NCT02533505|11247502|FG001|COMPLETED|Overall Study||24
10116714|NCT02533505|11247501|FG000|NOT COMPLETED|Overall Study||3
10116715|NCT02533505|11247502|FG001|NOT COMPLETED|Overall Study||1
10116716|NCT02533570|11247511|FG000|STARTED|Overall Study||4
10116717|NCT02533570|11247512|FG001|STARTED|Overall Study||8
10116718|NCT02533570|11247513|FG002|STARTED|Overall Study||8
10116719|NCT02533570|11247511|FG000|COMPLETED|Overall Study||4
10116720|NCT02533570|11247512|FG001|COMPLETED|Overall Study||7
10116721|NCT02533570|11247513|FG002|COMPLETED|Overall Study||7
10116722|NCT02533570|11247511|FG000|NOT COMPLETED|Overall Study||0
10116723|NCT02533570|11247512|FG001|NOT COMPLETED|Overall Study||1
10116724|NCT02533570|11247513|FG002|NOT COMPLETED|Overall Study||1
10116725|NCT02533674|11247529|FG000|STARTED|Dose Level I||5
10116726|NCT02533674|11247530|FG001|STARTED|Dose Level I||0
10116727|NCT02533674|11247531|FG002|STARTED|Dose Level I||0
10116728|NCT02533674|11247532|FG003|STARTED|Dose Level I||0
10116729|NCT02533674|11247533|FG004|STARTED|Dose Level I||0
10116730|NCT02533674|11247534|FG005|STARTED|Dose Level I||0
10116731|NCT02533674|11247535|FG006|STARTED|Dose Level I||0
10116732|NCT02533674|11247536|FG007|STARTED|Dose Level I||0
10116733|NCT02533674|11247529|FG000|COMPLETED|Dose Level I||0
10116734|NCT02533674|11247530|FG001|COMPLETED|Dose Level I||0
10116735|NCT02533674|11247531|FG002|COMPLETED|Dose Level I||0
10116736|NCT02533674|11247532|FG003|COMPLETED|Dose Level I||0
10116737|NCT02533674|11247533|FG004|COMPLETED|Dose Level I||0
10116738|NCT02533674|11247534|FG005|COMPLETED|Dose Level I||0
10116739|NCT02533674|11247535|FG006|COMPLETED|Dose Level I||0
10040518|NCT01967862|11165237|FG000|NOT COMPLETED|Overall Study||0
10040519|NCT01967888|11165243|FG000|STARTED|Overall Study||52
10116740|NCT02533674|11247536|FG007|COMPLETED|Dose Level I||0
10116741|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level I||5
10116742|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level I||0
10040520|NCT01967888|11165244|FG001|STARTED|Overall Study||52
10040521|NCT01967888|11165243|FG000|COMPLETED|Overall Study||42
10040522|NCT01967888|11165244|FG001|COMPLETED|Overall Study||45
10040523|NCT01967888|11165243|FG000|NOT COMPLETED|Overall Study||10
10040524|NCT01967888|11165244|FG001|NOT COMPLETED|Overall Study||7
10040525|NCT01967940|11165253|FG000|STARTED|Part 1||12
10040526|NCT01967940|11165254|FG001|STARTED|Part 1||28
10040527|NCT01967940|11165255|FG002|STARTED|Part 1||15
10040528|NCT01967940|11165256|FG003|STARTED|Part 1||0
10040529|NCT01967940|11165253|FG000|COMPLETED|Part 1||12
10040530|NCT01967940|11165254|FG001|COMPLETED|Part 1||28
10040531|NCT01967940|11165255|FG002|COMPLETED|Part 1||15
10040532|NCT01967940|11165256|FG003|COMPLETED|Part 1||0
10040533|NCT01967940|11165253|FG000|NOT COMPLETED|Part 1||0
10040534|NCT01967940|11165254|FG001|NOT COMPLETED|Part 1||0
10040535|NCT01967940|11165255|FG002|NOT COMPLETED|Part 1||0
10040536|NCT01967940|11165256|FG003|NOT COMPLETED|Part 1||0
10040537|NCT01967940|11165253|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
10040538|NCT01967940|11165254|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
10040539|NCT01967940|11165255|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
10040540|NCT01967940|11165256|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
10040541|NCT01967940|11165253|FG000|COMPLETED|Part 2||0
10040542|NCT01967940|11165254|FG001|COMPLETED|Part 2||0
10040543|NCT01967940|11165255|FG002|COMPLETED|Part 2||0
10040544|NCT01967940|11165256|FG003|COMPLETED|Part 2||35
10040545|NCT01967940|11165253|FG000|NOT COMPLETED|Part 2||0
10040546|NCT01967940|11165254|FG001|NOT COMPLETED|Part 2||0
10040547|NCT01967940|11165255|FG002|NOT COMPLETED|Part 2||0
10040548|NCT01967940|11165256|FG003|NOT COMPLETED|Part 2||3
10040549|NCT01968031|11165269|FG000|STARTED|Overall Study||204
10040550|NCT01968031|11165270|FG001|STARTED|Overall Study||202
10040551|NCT01968031|11165271|FG002|STARTED|Overall Study||207
10040552|NCT01968031|11165269|FG000|Completed Week 2|Overall Study||197
10040553|NCT01968031|11165270|FG001|Completed Week 2|Overall Study||190
10040554|NCT01968031|11165271|FG002|Completed Week 2|Overall Study||199
10040555|NCT01968031|11165269|FG000|Completed Week 6|Overall Study||191
10040556|NCT01968031|11165270|FG001|Completed Week 6|Overall Study||183
10040557|NCT01968031|11165271|FG002|Completed Week 6|Overall Study||187
10040558|NCT01968031|11165269|FG000|Completed Week 10|Overall Study||187
10040559|NCT01968031|11165270|FG001|Completed Week 10|Overall Study||181
10040560|NCT01968031|11165271|FG002|Completed Week 10|Overall Study||181
10040561|NCT01968031|11165269|FG000|COMPLETED|Overall Study||186
10040562|NCT01968031|11165270|FG001|COMPLETED|Overall Study||182
10040563|NCT01968031|11165271|FG002|COMPLETED|Overall Study||178
10040564|NCT01968031|11165269|FG000|NOT COMPLETED|Overall Study||18
10040565|NCT01968031|11165270|FG001|NOT COMPLETED|Overall Study||20
10040566|NCT01968031|11165271|FG002|NOT COMPLETED|Overall Study||29
10040567|NCT01968057|11165279|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
10040568|NCT01968057|11165279|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
10040569|NCT01968057|11165279|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
10040570|NCT01968057|11165279|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
10040571|NCT01968057|11165279|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
10040572|NCT01968057|11165279|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
10040573|NCT01968057|11165279|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
10040574|NCT01968057|11165279|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
10040575|NCT01968070|11165303|FG000|STARTED|Period 1||4
10040576|NCT01968070|11165304|FG001|STARTED|Period 1||4
10040577|NCT01968070|11165305|FG002|STARTED|Period 1||4
10040578|NCT01968070|11165306|FG003|STARTED|Period 1||4
10040579|NCT01968070|11165307|FG004|STARTED|Period 1||4
10040580|NCT01968070|11165308|FG005|STARTED|Period 1||4
10040581|NCT01968070|11165309|FG006|STARTED|Period 1||10
10040582|NCT01968070|11165310|FG007|STARTED|Period 1||2
10040583|NCT01968070|11165311|FG008|STARTED|Period 1||2
10040584|NCT01968070|11165312|FG009|STARTED|Period 1||9
10040585|NCT01968070|11165313|FG010|STARTED|Period 1||2
10040586|NCT01968070|11165314|FG011|STARTED|Period 1||2
10040587|NCT01968070|11165315|FG012|STARTED|Period 1||9
10040588|NCT01968070|11165316|FG013|STARTED|Period 1||2
10040589|NCT01968070|11165317|FG014|STARTED|Period 1||2
10040590|NCT01968070|11165318|FG015|STARTED|Period 1||9
10040591|NCT01968070|11165319|FG016|STARTED|Period 1||2
10040592|NCT01968070|11165320|FG017|STARTED|Period 1||2
10040593|NCT01968070|11165303|FG000|COMPLETED|Period 1||4
10040594|NCT01968070|11165304|FG001|COMPLETED|Period 1||3
10040595|NCT01968070|11165305|FG002|COMPLETED|Period 1||4
10040596|NCT01968070|11165306|FG003|COMPLETED|Period 1||2
10040597|NCT01968070|11165307|FG004|COMPLETED|Period 1||3
10040598|NCT01968070|11165308|FG005|COMPLETED|Period 1||4
10040599|NCT01968070|11165309|FG006|COMPLETED|Period 1||8
10040600|NCT01968070|11165310|FG007|COMPLETED|Period 1||2
10040601|NCT01968070|11165311|FG008|COMPLETED|Period 1||2
10040602|NCT01968070|11165312|FG009|COMPLETED|Period 1||9
10040603|NCT01968070|11165313|FG010|COMPLETED|Period 1||2
10040604|NCT01968070|11165314|FG011|COMPLETED|Period 1||1
10040605|NCT01968070|11165315|FG012|COMPLETED|Period 1||9
10040606|NCT01968070|11165316|FG013|COMPLETED|Period 1||2
10040607|NCT01968070|11165317|FG014|COMPLETED|Period 1||2
10040608|NCT01968070|11165318|FG015|COMPLETED|Period 1||8
10040609|NCT01968070|11165319|FG016|COMPLETED|Period 1||2
10040610|NCT01968070|11165320|FG017|COMPLETED|Period 1||2
10040611|NCT01968070|11165303|FG000|NOT COMPLETED|Period 1||0
10040612|NCT01968070|11165304|FG001|NOT COMPLETED|Period 1||1
10040613|NCT01968070|11165305|FG002|NOT COMPLETED|Period 1||0
10040614|NCT01968070|11165306|FG003|NOT COMPLETED|Period 1||2
10040615|NCT01968070|11165307|FG004|NOT COMPLETED|Period 1||1
10040616|NCT01968070|11165308|FG005|NOT COMPLETED|Period 1||0
10040617|NCT01968070|11165309|FG006|NOT COMPLETED|Period 1||2
10040618|NCT01968070|11165310|FG007|NOT COMPLETED|Period 1||0
10040619|NCT01968070|11165311|FG008|NOT COMPLETED|Period 1||0
10040620|NCT01968070|11165312|FG009|NOT COMPLETED|Period 1||0
10040621|NCT01968070|11165313|FG010|NOT COMPLETED|Period 1||0
10040622|NCT01968070|11165314|FG011|NOT COMPLETED|Period 1||1
10040623|NCT01968070|11165315|FG012|NOT COMPLETED|Period 1||0
10040624|NCT01968070|11165316|FG013|NOT COMPLETED|Period 1||0
10040625|NCT01968070|11165317|FG014|NOT COMPLETED|Period 1||0
10040626|NCT01968070|11165318|FG015|NOT COMPLETED|Period 1||1
10040627|NCT01968070|11165319|FG016|NOT COMPLETED|Period 1||0
10040628|NCT01968070|11165320|FG017|NOT COMPLETED|Period 1||0
10040629|NCT01968070|11165303|FG000|STARTED|Period 2||4
10040630|NCT01968070|11165304|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
10040631|NCT01968070|11165305|FG002|STARTED|Period 2||4
10040632|NCT01968070|11165306|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
10040633|NCT01968070|11165307|FG004|STARTED|Period 2||3
10040634|NCT01968070|11165308|FG005|STARTED|Period 2||4
10040635|NCT01968070|11165309|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040636|NCT01968070|11165310|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040637|NCT01968070|11165311|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040638|NCT01968070|11165312|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040639|NCT01968070|11165313|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040640|NCT01968070|11165314|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040641|NCT01968070|11165315|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040642|NCT01968070|11165316|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040643|NCT01968070|11165317|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040644|NCT01968070|11165318|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040645|NCT01968070|11165319|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
9848385|NCT00858780|10961053|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
9848386|NCT00858780|10961054|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
9848387|NCT00858780|10961050|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
9848388|NCT00858780|10961051|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
9848389|NCT00858780|10961052|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
9848390|NCT00858780|10961053|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
9848391|NCT00858780|10961054|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
9848392|NCT00858780|10961050|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0
9848393|NCT00858780|10961051|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0
9848394|NCT00858780|10961052|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0
9848395|NCT00858780|10961053|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0
9848396|NCT00858780|10961054|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
9848397|NCT00858780|10961050|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848398|NCT00858780|10961051|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848399|NCT00858780|10961052|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848400|NCT00858780|10961053|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848401|NCT00858780|10961054|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
9848402|NCT00858780|10961050|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848403|NCT00858780|10961051|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848404|NCT00858780|10961052|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848405|NCT00858780|10961053|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
9848406|NCT00858780|10961054|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
9848407|NCT00858832|10961066|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
10040646|NCT01968070|11165320|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10040647|NCT01968070|11165303|FG000|COMPLETED|Period 2||4
10040648|NCT01968070|11165304|FG001|COMPLETED|Period 2||4
10040649|NCT01968070|11165305|FG002|COMPLETED|Period 2||4
10040650|NCT01968070|11165306|FG003|COMPLETED|Period 2||4
10040651|NCT01968070|11165307|FG004|COMPLETED|Period 2||2
10040652|NCT01968070|11165308|FG005|COMPLETED|Period 2||4
10040653|NCT01968070|11165309|FG006|COMPLETED|Period 2||0
10040654|NCT01968070|11165310|FG007|COMPLETED|Period 2||0
10040655|NCT01968070|11165311|FG008|COMPLETED|Period 2||0
10040656|NCT01968070|11165312|FG009|COMPLETED|Period 2||0
10040657|NCT01968070|11165313|FG010|COMPLETED|Period 2||0
10040658|NCT01968070|11165314|FG011|COMPLETED|Period 2||0
10040659|NCT01968070|11165315|FG012|COMPLETED|Period 2||0
10040660|NCT01968070|11165316|FG013|COMPLETED|Period 2||0
10040661|NCT01968070|11165317|FG014|COMPLETED|Period 2||0
10040662|NCT01968070|11165318|FG015|COMPLETED|Period 2||0
10040663|NCT01968070|11165319|FG016|COMPLETED|Period 2||0
10040664|NCT01968070|11165320|FG017|COMPLETED|Period 2||0
10040665|NCT01968070|11165303|FG000|NOT COMPLETED|Period 2||0
10040666|NCT01968070|11165304|FG001|NOT COMPLETED|Period 2||0
10040667|NCT01968070|11165305|FG002|NOT COMPLETED|Period 2||0
10040668|NCT01968070|11165306|FG003|NOT COMPLETED|Period 2||0
10040669|NCT01968070|11165307|FG004|NOT COMPLETED|Period 2||1
10040670|NCT01968070|11165308|FG005|NOT COMPLETED|Period 2||0
10040671|NCT01968070|11165309|FG006|NOT COMPLETED|Period 2||0
10040672|NCT01968070|11165310|FG007|NOT COMPLETED|Period 2||0
10040673|NCT01968070|11165311|FG008|NOT COMPLETED|Period 2||0
10040674|NCT01968070|11165312|FG009|NOT COMPLETED|Period 2||0
10040675|NCT01968070|11165313|FG010|NOT COMPLETED|Period 2||0
10040676|NCT01968070|11165314|FG011|NOT COMPLETED|Period 2||0
10040677|NCT01968070|11165315|FG012|NOT COMPLETED|Period 2||0
10040678|NCT01968070|11165316|FG013|NOT COMPLETED|Period 2||0
10040679|NCT01968070|11165317|FG014|NOT COMPLETED|Period 2||0
10040680|NCT01968070|11165318|FG015|NOT COMPLETED|Period 2||0
10040681|NCT01968070|11165319|FG016|NOT COMPLETED|Period 2||0
10040682|NCT01968070|11165320|FG017|NOT COMPLETED|Period 2||0
10040683|NCT01968070|11165303|FG000|STARTED|Period 3||4
10040684|NCT01968070|11165304|FG001|STARTED|Period 3||4
10040685|NCT01968070|11165305|FG002|STARTED|Period 3||4
10040686|NCT01968070|11165306|FG003|STARTED|Period 3||4
10040687|NCT01968070|11165307|FG004|STARTED|Period 3||3
10040688|NCT01968070|11165308|FG005|STARTED|Period 3||4
10040689|NCT01968070|11165309|FG006|STARTED|Period 3||0
10040690|NCT01968070|11165310|FG007|STARTED|Period 3||0
10040691|NCT01968070|11165311|FG008|STARTED|Period 3||0
10040692|NCT01968070|11165312|FG009|STARTED|Period 3||0
10040693|NCT01968070|11165313|FG010|STARTED|Period 3||0
10040694|NCT01968070|11165314|FG011|STARTED|Period 3||0
10040695|NCT01968070|11165315|FG012|STARTED|Period 3||0
10040696|NCT01968070|11165316|FG013|STARTED|Period 3||0
10040697|NCT01968070|11165317|FG014|STARTED|Period 3||0
10040698|NCT01968070|11165318|FG015|STARTED|Period 3||0
10040699|NCT01968070|11165319|FG016|STARTED|Period 3||0
10040700|NCT01968070|11165320|FG017|STARTED|Period 3||0
10040701|NCT01968070|11165303|FG000|COMPLETED|Period 3||4
10040702|NCT01968070|11165304|FG001|COMPLETED|Period 3||4
10040703|NCT01968070|11165305|FG002|COMPLETED|Period 3||4
10040704|NCT01968070|11165306|FG003|COMPLETED|Period 3||4
10040705|NCT01968070|11165307|FG004|COMPLETED|Period 3||3
10040706|NCT01968070|11165308|FG005|COMPLETED|Period 3||4
10040707|NCT01968070|11165309|FG006|COMPLETED|Period 3||0
10040708|NCT01968070|11165310|FG007|COMPLETED|Period 3||0
10040709|NCT01968070|11165311|FG008|COMPLETED|Period 3||0
10040710|NCT01968070|11165312|FG009|COMPLETED|Period 3||0
10040711|NCT01968070|11165313|FG010|COMPLETED|Period 3||0
10040712|NCT01968070|11165314|FG011|COMPLETED|Period 3||0
10040713|NCT01968070|11165315|FG012|COMPLETED|Period 3||0
10040714|NCT01968070|11165316|FG013|COMPLETED|Period 3||0
10040715|NCT01968070|11165317|FG014|COMPLETED|Period 3||0
10040716|NCT01968070|11165318|FG015|COMPLETED|Period 3||0
10040717|NCT01968070|11165319|FG016|COMPLETED|Period 3||0
10040718|NCT01968070|11165320|FG017|COMPLETED|Period 3||0
10040719|NCT01968070|11165303|FG000|NOT COMPLETED|Period 3||0
10040720|NCT01968070|11165304|FG001|NOT COMPLETED|Period 3||0
10040721|NCT01968070|11165305|FG002|NOT COMPLETED|Period 3||0
10040722|NCT01968070|11165306|FG003|NOT COMPLETED|Period 3||0
10040723|NCT01968070|11165307|FG004|NOT COMPLETED|Period 3||0
10040724|NCT01968070|11165308|FG005|NOT COMPLETED|Period 3||0
10040725|NCT01968070|11165309|FG006|NOT COMPLETED|Period 3||0
10040726|NCT01968070|11165310|FG007|NOT COMPLETED|Period 3||0
10040727|NCT01968070|11165311|FG008|NOT COMPLETED|Period 3||0
10040728|NCT01968070|11165312|FG009|NOT COMPLETED|Period 3||0
10040729|NCT01968070|11165313|FG010|NOT COMPLETED|Period 3||0
10040730|NCT01968070|11165314|FG011|NOT COMPLETED|Period 3||0
10040731|NCT01968070|11165315|FG012|NOT COMPLETED|Period 3||0
10040732|NCT01968070|11165316|FG013|NOT COMPLETED|Period 3||0
10040733|NCT01968070|11165317|FG014|NOT COMPLETED|Period 3||0
10040734|NCT01968070|11165318|FG015|NOT COMPLETED|Period 3||0
10040735|NCT01968070|11165319|FG016|NOT COMPLETED|Period 3||0
10040736|NCT01968070|11165320|FG017|NOT COMPLETED|Period 3||0
10040737|NCT01968135|11165360|FG000|STARTED|Overall Study||16
10040738|NCT01968135|11165361|FG001|STARTED|Overall Study||16
10040739|NCT01968135|11165360|FG000|COMPLETED|Overall Study||16
10040740|NCT01968135|11165361|FG001|COMPLETED|Overall Study||16
10040741|NCT01968135|11165360|FG000|NOT COMPLETED|Overall Study||0
10040742|NCT01968135|11165361|FG001|NOT COMPLETED|Overall Study||0
10040743|NCT01968317|11165369|FG000|STARTED|Overall Study||76
10040744|NCT01968317|11165370|FG001|STARTED|Overall Study||74
10040745|NCT01968317|11165369|FG000|COMPLETED|Overall Study||76
10040746|NCT01968317|11165370|FG001|COMPLETED|Overall Study||74
10040747|NCT01968317|11165369|FG000|NOT COMPLETED|Overall Study||0
10040748|NCT01968317|11165370|FG001|NOT COMPLETED|Overall Study||0
10040749|NCT01968356|11165384|FG000|STARTED|Overall Study||101
10040750|NCT01968356|11165385|FG001|STARTED|Overall Study||93
10040751|NCT01968356|11165386|FG002|STARTED|Overall Study||96
10040752|NCT01968356|11165387|FG003|STARTED|Overall Study||32
10040753|NCT01968356|11165388|FG004|STARTED|Overall Study||97
10040754|NCT01968356|11165389|FG005|STARTED|Overall Study||99
10040755|NCT01968356|11165390|FG006|STARTED|Overall Study||97
10040756|NCT01968356|11165391|FG007|STARTED|Overall Study||31
10040757|NCT01968356|11165384|FG000|COMPLETED|Overall Study||101
10040758|NCT01968356|11165385|FG001|COMPLETED|Overall Study||93
10040759|NCT01968356|11165386|FG002|COMPLETED|Overall Study||96
10040760|NCT01968356|11165387|FG003|COMPLETED|Overall Study||32
10040761|NCT01968356|11165388|FG004|COMPLETED|Overall Study||97
10040762|NCT01968356|11165389|FG005|COMPLETED|Overall Study||99
10040763|NCT01968356|11165390|FG006|COMPLETED|Overall Study||97
10040764|NCT01968356|11165391|FG007|COMPLETED|Overall Study||31
10040765|NCT01968356|11165384|FG000|NOT COMPLETED|Overall Study||0
10040766|NCT01968356|11165385|FG001|NOT COMPLETED|Overall Study||0
10040767|NCT01968356|11165386|FG002|NOT COMPLETED|Overall Study||0
10040768|NCT01968356|11165387|FG003|NOT COMPLETED|Overall Study||0
10040769|NCT01968356|11165388|FG004|NOT COMPLETED|Overall Study||0
10040770|NCT01968356|11165389|FG005|NOT COMPLETED|Overall Study||0
10040771|NCT01968356|11165390|FG006|NOT COMPLETED|Overall Study||0
10040772|NCT01968356|11165391|FG007|NOT COMPLETED|Overall Study||0
10040773|NCT01968382|11165420|FG000|STARTED|Overall Study||18
10040774|NCT01968382|11165421|FG001|STARTED|Overall Study||19
10040775|NCT01968382|11165422|FG002|STARTED|Overall Study||20
10040776|NCT01968382|11165420|FG000|COMPLETED|Overall Study||18
10040777|NCT01968382|11165421|FG001|COMPLETED|Overall Study||19
10040778|NCT01968382|11165422|FG002|COMPLETED|Overall Study||20
10040779|NCT01968382|11165420|FG000|NOT COMPLETED|Overall Study||0
10040780|NCT01968382|11165421|FG001|NOT COMPLETED|Overall Study||0
10040781|NCT01968382|11165422|FG002|NOT COMPLETED|Overall Study||0
10116743|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level I||0
9706387|NCT03976648|10805411|FG001|COMPLETED|Overall Study||0
9706388|NCT03976648|10805410|FG000|NOT COMPLETED|Overall Study||21
9706389|NCT03976648|10805411|FG001|NOT COMPLETED|Overall Study||10
9706390|NCT03944486|10805417|FG000|STARTED|Overall Study||24
9706391|NCT03944486|10805417|FG000|COMPLETED|Overall Study||12
10116744|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level I||0
10116745|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level I||0
10116746|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level I||0
10116747|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level I||0
10116748|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level I||0
10116749|NCT02533674|11247529|FG000|STARTED|Dose Level II||0
10116750|NCT02533674|11247530|FG001|STARTED|Dose Level II||7
10116751|NCT02533674|11247531|FG002|STARTED|Dose Level II||0
10116752|NCT02533674|11247532|FG003|STARTED|Dose Level II||0
10116753|NCT02533674|11247533|FG004|STARTED|Dose Level II||0
10116754|NCT02533674|11247534|FG005|STARTED|Dose Level II||0
10116755|NCT02533674|11247535|FG006|STARTED|Dose Level II||0
10116756|NCT02533674|11247536|FG007|STARTED|Dose Level II||0
10116757|NCT02533674|11247529|FG000|COMPLETED|Dose Level II||0
10116758|NCT02533674|11247530|FG001|COMPLETED|Dose Level II||0
10116759|NCT02533674|11247531|FG002|COMPLETED|Dose Level II||0
10116760|NCT02533674|11247532|FG003|COMPLETED|Dose Level II||0
10116761|NCT02533674|11247533|FG004|COMPLETED|Dose Level II||0
10116762|NCT02533674|11247534|FG005|COMPLETED|Dose Level II||0
10116763|NCT02533674|11247535|FG006|COMPLETED|Dose Level II||0
10116764|NCT02533674|11247536|FG007|COMPLETED|Dose Level II||0
10116765|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level II||0
10116766|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level II||7
10116767|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level II||0
10116768|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level II||0
10116769|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level II||0
10116770|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level II||0
10116771|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level II||0
10116772|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level II||0
10116773|NCT02533674|11247529|FG000|STARTED|Dose Level III||0
9706392|NCT03944486|10805417|FG000|NOT COMPLETED|Overall Study||12
9729091|NCT00116753|10828705|FG001|STARTED|Overall Study||155
10116774|NCT02533674|11247530|FG001|STARTED|Dose Level III||0
10116775|NCT02533674|11247531|FG002|STARTED|Dose Level III||4
10116776|NCT02533674|11247532|FG003|STARTED|Dose Level III||0
10116777|NCT02533674|11247533|FG004|STARTED|Dose Level III||0
10116778|NCT02533674|11247534|FG005|STARTED|Dose Level III||0
10116779|NCT02533674|11247535|FG006|STARTED|Dose Level III||0
10116780|NCT02533674|11247536|FG007|STARTED|Dose Level III||0
10116781|NCT02533674|11247529|FG000|COMPLETED|Dose Level III||0
10116782|NCT02533674|11247530|FG001|COMPLETED|Dose Level III||0
10116783|NCT02533674|11247531|FG002|COMPLETED|Dose Level III||0
10116784|NCT02533674|11247532|FG003|COMPLETED|Dose Level III||0
10116785|NCT02533674|11247533|FG004|COMPLETED|Dose Level III||0
10116786|NCT02533674|11247534|FG005|COMPLETED|Dose Level III||0
10116787|NCT02533674|11247535|FG006|COMPLETED|Dose Level III||0
10040782|NCT01968421|11165432|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
10040783|NCT01968421|11165433|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
10040784|NCT01968421|11165432|FG000|Starting Trial|Overall Study||99
10040785|NCT01968421|11165433|FG001|Starting Trial|Overall Study||97
10040786|NCT01968421|11165432|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
10040787|NCT01968421|11165433|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
10040788|NCT01968421|11165432|FG000|NOT COMPLETED|Overall Study||0
10040789|NCT01968421|11165433|FG001|NOT COMPLETED|Overall Study||0
10040790|NCT01968434|11165441|FG000|STARTED|Overall Study||78
10040791|NCT01968434|11165442|FG001|STARTED|Overall Study||72
10040792|NCT01968434|11165441|FG000|COMPLETED|Overall Study||75
10040793|NCT01968434|11165442|FG001|COMPLETED|Overall Study||66
10040794|NCT01968434|11165441|FG000|NOT COMPLETED|Overall Study||3
10040795|NCT01968434|11165442|FG001|NOT COMPLETED|Overall Study||6
10040796|NCT01968447|11165450|FG000|STARTED|Overall Study||20
10040797|NCT01968447|11165451|FG001|STARTED|Overall Study||20
10040798|NCT01968447|11165450|FG000|COMPLETED|Overall Study||20
10040799|NCT01968447|11165451|FG001|COMPLETED|Overall Study||20
10040800|NCT01968447|11165450|FG000|NOT COMPLETED|Overall Study||0
10040801|NCT01968447|11165451|FG001|NOT COMPLETED|Overall Study||0
10040802|NCT01968551|11165460|FG000|STARTED|Open Label Phase (48 Weeks)||22
10040803|NCT01968551|11165461|FG001|STARTED|Open Label Phase (48 Weeks)||90
10040804|NCT01968551|11165462|FG002|STARTED|Open Label Phase (48 Weeks)||46
10040805|NCT01968551|11165460|FG000|COMPLETED|Open Label Phase (48 Weeks)||20
10040806|NCT01968551|11165461|FG001|COMPLETED|Open Label Phase (48 Weeks)||87
10040807|NCT01968551|11165462|FG002|COMPLETED|Open Label Phase (48 Weeks)||41
10040808|NCT01968551|11165460|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2
10040809|NCT01968551|11165461|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3
10040810|NCT01968551|11165462|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5
10040811|NCT01968551|11165460|FG000|STARTED|Extension Phase||20
10040812|NCT01968551|11165461|FG001|STARTED|Extension Phase||87
10040813|NCT01968551|11165462|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
10040814|NCT01968551|11165460|FG000|COMPLETED|Extension Phase||19
10040815|NCT01968551|11165461|FG001|COMPLETED|Extension Phase||86
10040816|NCT01968551|11165462|FG002|COMPLETED|Extension Phase||30
10040817|NCT01968551|11165460|FG000|NOT COMPLETED|Extension Phase||1
10040818|NCT01968551|11165461|FG001|NOT COMPLETED|Extension Phase||1
10040819|NCT01968551|11165462|FG002|NOT COMPLETED|Extension Phase||4
10040820|NCT01968694|11165476|FG000|STARTED|Visit 1 (1 Day)||10
10040821|NCT01968694|11165477|FG001|STARTED|Visit 1 (1 Day)||9
10040822|NCT01968694|11165476|FG000|COMPLETED|Visit 1 (1 Day)||10
10040823|NCT01968694|11165477|FG001|COMPLETED|Visit 1 (1 Day)||9
10040824|NCT01968694|11165476|FG000|NOT COMPLETED|Visit 1 (1 Day)||0
10040825|NCT01968694|11165477|FG001|NOT COMPLETED|Visit 1 (1 Day)||0
10040826|NCT01968694|11165476|FG000|STARTED|Washout (1 Month)||10
10040827|NCT01968694|11165477|FG001|STARTED|Washout (1 Month)||9
10040828|NCT01968694|11165476|FG000|COMPLETED|Washout (1 Month)||10
10040829|NCT01968694|11165477|FG001|COMPLETED|Washout (1 Month)||8
10040830|NCT01968694|11165476|FG000|NOT COMPLETED|Washout (1 Month)||0
10040831|NCT01968694|11165477|FG001|NOT COMPLETED|Washout (1 Month)||1
10040832|NCT01968694|11165476|FG000|STARTED|Visit 2 (1 Day)||10
10040833|NCT01968694|11165477|FG001|STARTED|Visit 2 (1 Day)||8
10040834|NCT01968694|11165476|FG000|COMPLETED|Visit 2 (1 Day)||10
10040835|NCT01968694|11165477|FG001|COMPLETED|Visit 2 (1 Day)||8
10040836|NCT01968694|11165476|FG000|NOT COMPLETED|Visit 2 (1 Day)||0
10040837|NCT01968694|11165477|FG001|NOT COMPLETED|Visit 2 (1 Day)||0
10040838|NCT01968707|11165493|FG000|STARTED|Overall Study||247
10040839|NCT01968707|11165494|FG001|STARTED|Overall Study||74
10040840|NCT01968707|11165495|FG002|STARTED|Overall Study||246
10040841|NCT01968707|11165496|FG003|STARTED|Overall Study||245
10040842|NCT01968707|11165497|FG004|STARTED|Overall Study||236
10040843|NCT01968707|11165498|FG005|STARTED|Overall Study||70
10040844|NCT01968707|11165499|FG006|STARTED|Overall Study||238
10040845|NCT01968707|11165500|FG007|STARTED|Overall Study||238
10040846|NCT01968707|11165493|FG000|COMPLETED|Overall Study||198
10040847|NCT01968707|11165494|FG001|COMPLETED|Overall Study||62
10040848|NCT01968707|11165495|FG002|COMPLETED|Overall Study||205
10040849|NCT01968707|11165496|FG003|COMPLETED|Overall Study||201
10040850|NCT01968707|11165497|FG004|COMPLETED|Overall Study||200
10040851|NCT01968707|11165498|FG005|COMPLETED|Overall Study||59
10040852|NCT01968707|11165499|FG006|COMPLETED|Overall Study||204
10040853|NCT01968707|11165500|FG007|COMPLETED|Overall Study||203
10040854|NCT01968707|11165493|FG000|NOT COMPLETED|Overall Study||49
10040855|NCT01968707|11165494|FG001|NOT COMPLETED|Overall Study||12
10040856|NCT01968707|11165495|FG002|NOT COMPLETED|Overall Study||41
10040857|NCT01968707|11165496|FG003|NOT COMPLETED|Overall Study||44
10040858|NCT01968707|11165497|FG004|NOT COMPLETED|Overall Study||36
10040859|NCT01968707|11165498|FG005|NOT COMPLETED|Overall Study||11
10040860|NCT01968707|11165499|FG006|NOT COMPLETED|Overall Study||34
10040861|NCT01968707|11165500|FG007|NOT COMPLETED|Overall Study||35
10040862|NCT01968811|11165533|FG000|STARTED|Overall Study||10
10040863|NCT01968811|11165533|FG000|COMPLETED|Overall Study||5
10040864|NCT01968811|11165533|FG000|NOT COMPLETED|Overall Study||5
10040865|NCT01968954|11165539|FG000|STARTED|Overall Study||354
10040866|NCT01968954|11165540|FG001|STARTED|Overall Study||357
10040867|NCT01968954|11165539|FG000|Treated|Overall Study||353
10040868|NCT01968954|11165540|FG001|Treated|Overall Study||356
10040869|NCT01968954|11165539|FG000|COMPLETED|Overall Study||314
10040870|NCT01968954|11165540|FG001|COMPLETED|Overall Study||314
10040871|NCT01968954|11165539|FG000|NOT COMPLETED|Overall Study||40
10040872|NCT01968954|11165540|FG001|NOT COMPLETED|Overall Study||43
10040873|NCT01968967|11165549|FG000|STARTED|Treatment Period||1071
10040874|NCT01968967|11165550|FG001|STARTED|Treatment Period||1068
10040875|NCT01968967|11165551|FG002|STARTED|Treatment Period||0
10040876|NCT01968967|11165552|FG003|STARTED|Treatment Period||0
10040877|NCT01968967|11165553|FG004|STARTED|Treatment Period||0
10040878|NCT01968967|11165549|FG000|Treated|Treatment Period||1065
10040879|NCT01968967|11165550|FG001|Treated|Treatment Period||1063
10040880|NCT01968967|11165551|FG002|Treated|Treatment Period||0
10040881|NCT01968967|11165552|FG003|Treated|Treatment Period||0
10040882|NCT01968967|11165553|FG004|Treated|Treatment Period||0
10040883|NCT01968967|11165549|FG000|COMPLETED|Treatment Period||925
10040884|NCT01968967|11165550|FG001|COMPLETED|Treatment Period||934
10040885|NCT01968967|11165551|FG002|COMPLETED|Treatment Period||0
10040886|NCT01968967|11165552|FG003|COMPLETED|Treatment Period||0
10040887|NCT01968967|11165553|FG004|COMPLETED|Treatment Period||0
10040888|NCT01968967|11165549|FG000|NOT COMPLETED|Treatment Period||146
10040889|NCT01968967|11165550|FG001|NOT COMPLETED|Treatment Period||134
10040890|NCT01968967|11165551|FG002|NOT COMPLETED|Treatment Period||0
10040891|NCT01968967|11165552|FG003|NOT COMPLETED|Treatment Period||0
10040892|NCT01968967|11165553|FG004|NOT COMPLETED|Treatment Period||0
10040893|NCT01968967|11165549|FG000|STARTED|Extension Period||0
10040894|NCT01968967|11165550|FG001|STARTED|Extension Period||0
10040895|NCT01968967|11165551|FG002|STARTED|Extension Period||47
10040896|NCT01968967|11165552|FG003|STARTED|Extension Period||19
10040897|NCT01968967|11165553|FG004|STARTED|Extension Period||39
10040898|NCT01968967|11165549|FG000|COMPLETED|Extension Period||0
10040899|NCT01968967|11165550|FG001|COMPLETED|Extension Period||0
10040900|NCT01968967|11165551|FG002|COMPLETED|Extension Period||45
10040901|NCT01968967|11165552|FG003|COMPLETED|Extension Period||19
10040902|NCT01968967|11165553|FG004|COMPLETED|Extension Period||34
10040903|NCT01968967|11165549|FG000|NOT COMPLETED|Extension Period||0
10040904|NCT01968967|11165550|FG001|NOT COMPLETED|Extension Period||0
10040905|NCT01968967|11165551|FG002|NOT COMPLETED|Extension Period||2
10040906|NCT01968967|11165552|FG003|NOT COMPLETED|Extension Period||0
10040907|NCT01968967|11165553|FG004|NOT COMPLETED|Extension Period||5
10040908|NCT01968980|11165569|FG000|STARTED|Overall Study||185
10040909|NCT01968980|11165570|FG001|STARTED|Overall Study||185
10040910|NCT01968980|11165569|FG000|COMPLETED|Overall Study||169
10040911|NCT01968980|11165570|FG001|COMPLETED|Overall Study||171
10040912|NCT01968980|11165569|FG000|NOT COMPLETED|Overall Study||16
10040913|NCT01968980|11165570|FG001|NOT COMPLETED|Overall Study||14
9963824|NCT01488578|11083592|FG000|COMPLETED|Overall Study||9321
9963825|NCT01488578|11083592|FG000|NOT COMPLETED|Overall Study||1836
9963826|NCT01488708|11083624|FG000|STARTED|Overall Study||940
9963827|NCT01488708|11083625|FG001|STARTED|Overall Study||578
9963828|NCT01488708|11083624|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937
9963829|NCT01488708|11083625|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578
9963830|NCT01488708|11083624|FG000|Participated in Follow Up|Overall Study||810
9963831|NCT01488708|11083625|FG001|Participated in Follow Up|Overall Study||526
9963832|NCT01488708|11083624|FG000|COMPLETED|Overall Study||0
9963833|NCT01488708|11083625|FG001|COMPLETED|Overall Study||0
9963834|NCT01488708|11083624|FG000|NOT COMPLETED|Overall Study||940
9963835|NCT01488708|11083625|FG001|NOT COMPLETED|Overall Study||578
10040914|NCT01969058|11165579|FG000|STARTED|Overall Study||50
10040915|NCT01969058|11165580|FG001|STARTED|Overall Study||26
10040916|NCT01969058|11165579|FG000|COMPLETED|Overall Study||47
10040917|NCT01969058|11165580|FG001|COMPLETED|Overall Study||26
10040918|NCT01969058|11165579|FG000|NOT COMPLETED|Overall Study||3
10040919|NCT01969058|11165580|FG001|NOT COMPLETED|Overall Study||0
10040920|NCT01969084|11165588|FG000|STARTED|Overall Study||19
10040921|NCT01969084|11165589|FG001|STARTED|Overall Study||22
10040922|NCT01969084|11165588|FG000|COMPLETED|Overall Study||19
10040923|NCT01969084|11165589|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
10040924|NCT01969084|11165588|FG000|NOT COMPLETED|Overall Study||0
10040925|NCT01969084|11165589|FG001|NOT COMPLETED|Overall Study||1
10040926|NCT01969162|11165599|FG000|STARTED|Overall Study||35
10040927|NCT01969162|11165599|FG000|COMPLETED|Overall Study||35
10040928|NCT01969162|11165599|FG000|NOT COMPLETED|Overall Study||0
10040929|NCT01969201|11165605|FG000|STARTED|Overall Study||352
10040930|NCT01969201|11165606|FG001|STARTED|Overall Study||358
10040931|NCT01969201|11165605|FG000|COMPLETED|Overall Study||307
10040932|NCT01969201|11165606|FG001|COMPLETED|Overall Study||313
10040933|NCT01969201|11165605|FG000|NOT COMPLETED|Overall Study||45
10040934|NCT01969201|11165606|FG001|NOT COMPLETED|Overall Study||45
10040935|NCT01969214|11165612|FG000|STARTED|Overall Study||101
10040936|NCT01969214|11165612|FG000|COMPLETED|Overall Study||86
10040937|NCT01969214|11165612|FG000|NOT COMPLETED|Overall Study||15
10040938|NCT01969240|11165618|FG000|STARTED|Overall Study||451
10040939|NCT01969240|11165619|FG001|STARTED|Overall Study||447
10040940|NCT01969240|11165618|FG000|COMPLETED|Overall Study||451
10040941|NCT01969240|11165619|FG001|COMPLETED|Overall Study||447
10040942|NCT01969240|11165618|FG000|NOT COMPLETED|Overall Study||0
10040943|NCT01969240|11165619|FG001|NOT COMPLETED|Overall Study||0
10040944|NCT01969435|11165627|FG000|STARTED|Overall Study||50
10040945|NCT01969435|11165627|FG000|COMPLETED|Overall Study||50
10040946|NCT01969435|11165627|FG000|NOT COMPLETED|Overall Study||0
10040947|NCT01969448|11165634|FG000|STARTED|Overall Study||55
9963836|NCT01488877|11083633|FG000|STARTED|Initial Randomization||1
9963837|NCT01488877|11083634|FG001|STARTED|Initial Randomization||5
10040948|NCT01969448|11165635|FG001|STARTED|Overall Study||24
10040949|NCT01969448|11165636|FG002|STARTED|Overall Study||0
10040950|NCT01969448|11165634|FG000|COMPLETED|Overall Study||55
10040951|NCT01969448|11165635|FG001|COMPLETED|Overall Study||24
10040952|NCT01969448|11165636|FG002|COMPLETED|Overall Study||0
10040953|NCT01969448|11165634|FG000|NOT COMPLETED|Overall Study||0
10040954|NCT01969448|11165635|FG001|NOT COMPLETED|Overall Study||0
10040955|NCT01969448|11165636|FG002|NOT COMPLETED|Overall Study||0
10040956|NCT01969500|11165646|FG000|STARTED|Overall Study||25
10040957|NCT01969500|11165647|FG001|STARTED|Overall Study||26
10040958|NCT01969500|11165646|FG000|COMPLETED|Overall Study||24
10040959|NCT01969500|11165647|FG001|COMPLETED|Overall Study||24
10040960|NCT01969500|11165646|FG000|NOT COMPLETED|Overall Study||1
10040961|NCT01969500|11165647|FG001|NOT COMPLETED|Overall Study||2
10040962|NCT01969539|11165653|FG000|STARTED|Overall Study||11
10040963|NCT01969539|11165653|FG000|COMPLETED|Overall Study||11
10040964|NCT01969539|11165653|FG000|NOT COMPLETED|Overall Study||0
10040965|NCT01969708|11165659|FG000|STARTED|Overall Study||180
10040966|NCT01969708|11165660|FG001|STARTED|Overall Study||182
10040967|NCT01969708|11165659|FG000|COMPLETED|Overall Study||175
10040968|NCT01969708|11165660|FG001|COMPLETED|Overall Study||173
10040969|NCT01969708|11165659|FG000|NOT COMPLETED|Overall Study||5
10040970|NCT01969708|11165660|FG001|NOT COMPLETED|Overall Study||9
10040971|NCT01969721|11165666|FG000|STARTED|Overall Study||58
10040972|NCT01969721|11165667|FG001|STARTED|Overall Study||69
10040973|NCT01969721|11165668|FG002|STARTED|Overall Study||50
10040974|NCT01969721|11165669|FG003|STARTED|Overall Study||52
10040975|NCT01969721|11165666|FG000|COMPLETED|Overall Study||54
10040976|NCT01969721|11165667|FG001|COMPLETED|Overall Study||57
10040977|NCT01969721|11165668|FG002|COMPLETED|Overall Study||45
10040978|NCT01969721|11165669|FG003|COMPLETED|Overall Study||46
10040979|NCT01969721|11165666|FG000|NOT COMPLETED|Overall Study||4
10040980|NCT01969721|11165667|FG001|NOT COMPLETED|Overall Study||12
10040981|NCT01969721|11165668|FG002|NOT COMPLETED|Overall Study||5
10116788|NCT02533674|11247536|FG007|COMPLETED|Dose Level III||0
10116789|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level III||0
10040982|NCT01969721|11165669|FG003|NOT COMPLETED|Overall Study||6
10040983|NCT01969747|11165683|FG000|STARTED|Overall Study||19
10040984|NCT01969747|11165684|FG001|STARTED|Overall Study||19
10040985|NCT01969747|11165685|FG002|STARTED|Overall Study||19
10040986|NCT01969747|11165686|FG003|STARTED|Overall Study||18
10040987|NCT01969747|11165683|FG000|COMPLETED|Overall Study||19
9706393|NCT03619902|10805421|FG000|STARTED|Overall Study||8
9706394|NCT03619902|10805421|FG000|COMPLETED|Overall Study||6
9706395|NCT03619902|10805421|FG000|NOT COMPLETED|Overall Study||2
9706396|NCT03617523|10805430|FG000|STARTED|Overall Study||30
10040988|NCT01969747|11165684|FG001|COMPLETED|Overall Study||19
10040989|NCT01969747|11165685|FG002|COMPLETED|Overall Study||19
10040990|NCT01969747|11165686|FG003|COMPLETED|Overall Study||18
10040991|NCT01969747|11165683|FG000|NOT COMPLETED|Overall Study||0
10040992|NCT01969747|11165684|FG001|NOT COMPLETED|Overall Study||0
10040993|NCT01969747|11165685|FG002|NOT COMPLETED|Overall Study||0
10040994|NCT01969747|11165686|FG003|NOT COMPLETED|Overall Study||0
10040995|NCT01969799|11165698|FG000|STARTED|Overall Study||71
10040996|NCT01969799|11165699|FG001|STARTED|Overall Study||72
10040997|NCT01969799|11165698|FG000|COMPLETED|Overall Study||54
10040998|NCT01969799|11165699|FG001|COMPLETED|Overall Study||58
10040999|NCT01969799|11165698|FG000|NOT COMPLETED|Overall Study||17
10041000|NCT01969799|11165699|FG001|NOT COMPLETED|Overall Study||14
10041001|NCT01969851|11165708|FG000|STARTED|Overall Study||10
10041002|NCT01969851|11165709|FG001|STARTED|Overall Study||24
10041003|NCT01969851|11165710|FG002|STARTED|Overall Study||21
10041004|NCT01969851|11165708|FG000|COMPLETED|Overall Study||9
10041005|NCT01969851|11165709|FG001|COMPLETED|Overall Study||21
10041006|NCT01969851|11165710|FG002|COMPLETED|Overall Study||14
10041007|NCT01969851|11165708|FG000|NOT COMPLETED|Overall Study||1
10041008|NCT01969851|11165709|FG001|NOT COMPLETED|Overall Study||3
10041009|NCT01969851|11165710|FG002|NOT COMPLETED|Overall Study||7
10041010|NCT01969916|11165718|FG000|STARTED|Overall Study||150
10041011|NCT01969916|11165718|FG000|COMPLETED|Overall Study||105
10041012|NCT01969916|11165718|FG000|NOT COMPLETED|Overall Study||45
10041013|NCT01970007|11165722|FG000|STARTED|Overall Study||243
10116790|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level III||0
10116791|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level III||4
10041014|NCT01970007|11165722|FG000|COMPLETED|Overall Study||188
10041015|NCT01970007|11165722|FG000|NOT COMPLETED|Overall Study||55
10041016|NCT01970176|11165728|FG000|STARTED|Overall Study||14
10041017|NCT01970176|11165729|FG001|STARTED|Overall Study||6
10041018|NCT01970176|11165728|FG000|COMPLETED|Overall Study||14
10041019|NCT01970176|11165729|FG001|COMPLETED|Overall Study||6
10041020|NCT01970176|11165728|FG000|NOT COMPLETED|Overall Study||0
10041021|NCT01970176|11165729|FG001|NOT COMPLETED|Overall Study||0
10041022|NCT01970241|11165737|FG000|STARTED|Overall Study||46
10041023|NCT01970241|11165738|FG001|STARTED|Overall Study||39
10041024|NCT01970241|11165737|FG000|COMPLETED|Overall Study||29
10041025|NCT01970241|11165738|FG001|COMPLETED|Overall Study||31
10041026|NCT01970241|11165737|FG000|NOT COMPLETED|Overall Study||17
10041027|NCT01970241|11165738|FG001|NOT COMPLETED|Overall Study||8
9706397|NCT03617523|10805431|FG001|STARTED|Overall Study||30
9706398|NCT03617523|10805432|FG002|STARTED|Overall Study||61
9706399|NCT03617523|10805433|FG003|STARTED|Overall Study||59
9706400|NCT03617523|10805434|FG004|STARTED|Overall Study||60
9706401|NCT03617523|10805430|FG000|COMPLETED|Overall Study||30
10116792|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level III||0
10041028|NCT01970371|11165749|FG000|STARTED|Overall Study||18
10041029|NCT01970371|11165750|FG001|STARTED|Overall Study||21
10041030|NCT01970371|11165751|FG002|STARTED|Overall Study||30
10041031|NCT01970371|11165749|FG000|COMPLETED|Overall Study||10
10041032|NCT01970371|11165750|FG001|COMPLETED|Overall Study||8
10041033|NCT01970371|11165751|FG002|COMPLETED|Overall Study||17
10041034|NCT01970371|11165749|FG000|NOT COMPLETED|Overall Study||8
10041035|NCT01970371|11165750|FG001|NOT COMPLETED|Overall Study||13
10041036|NCT01970371|11165751|FG002|NOT COMPLETED|Overall Study||13
10041037|NCT01970397|11165763|FG000|STARTED|Overall Study||69
10041038|NCT01970397|11165764|FG001|STARTED|Overall Study||69
10041039|NCT01970397|11165763|FG000|COMPLETED|Overall Study||67
10041040|NCT01970397|11165764|FG001|COMPLETED|Overall Study||64
10041041|NCT01970397|11165763|FG000|NOT COMPLETED|Overall Study||2
10041042|NCT01970397|11165764|FG001|NOT COMPLETED|Overall Study||5
10041043|NCT01970475|11165772|FG000|STARTED|Overall Study||264
10041044|NCT01970475|11165773|FG001|STARTED|Overall Study||262
10041045|NCT01970475|11165772|FG000|COMPLETED|Overall Study||243
10041046|NCT01970475|11165773|FG001|COMPLETED|Overall Study||251
10041047|NCT01970475|11165772|FG000|NOT COMPLETED|Overall Study||21
10041048|NCT01970475|11165773|FG001|NOT COMPLETED|Overall Study||11
10041049|NCT01970488|11165781|FG000|STARTED|Part 1: Through Week 16||175
10041050|NCT01970488|11165782|FG001|STARTED|Part 1: Through Week 16||175
10041051|NCT01970488|11165783|FG002|STARTED|Part 1: Through Week 16||0
10041052|NCT01970488|11165784|FG003|STARTED|Part 1: Through Week 16||0
10041053|NCT01970488|11165785|FG004|STARTED|Part 1: Through Week 16||0
10041054|NCT01970488|11165781|FG000|Received Treatment|Part 1: Through Week 16||174
10041055|NCT01970488|11165782|FG001|Received Treatment|Part 1: Through Week 16||173
10041056|NCT01970488|11165783|FG002|Received Treatment|Part 1: Through Week 16||0
10041057|NCT01970488|11165784|FG003|Received Treatment|Part 1: Through Week 16||0
10041058|NCT01970488|11165785|FG004|Received Treatment|Part 1: Through Week 16||0
10041059|NCT01970488|11165781|FG000|COMPLETED|Part 1: Through Week 16||164
10041060|NCT01970488|11165782|FG001|COMPLETED|Part 1: Through Week 16||162
10041061|NCT01970488|11165783|FG002|COMPLETED|Part 1: Through Week 16||0
10041062|NCT01970488|11165784|FG003|COMPLETED|Part 1: Through Week 16||0
10041063|NCT01970488|11165785|FG004|COMPLETED|Part 1: Through Week 16||0
10041064|NCT01970488|11165781|FG000|NOT COMPLETED|Part 1: Through Week 16||11
10041065|NCT01970488|11165782|FG001|NOT COMPLETED|Part 1: Through Week 16||13
10041066|NCT01970488|11165783|FG002|NOT COMPLETED|Part 1: Through Week 16||0
10041067|NCT01970488|11165784|FG003|NOT COMPLETED|Part 1: Through Week 16||0
10041068|NCT01970488|11165785|FG004|NOT COMPLETED|Part 1: Through Week 16||0
10041069|NCT01970488|11165781|FG000|STARTED|Part 2: Post Week 16||0
10041070|NCT01970488|11165782|FG001|STARTED|Part 2: Post Week 16||0
10041071|NCT01970488|11165783|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
10041072|NCT01970488|11165784|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
10041073|NCT01970488|11165785|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
10041074|NCT01970488|11165781|FG000|COMPLETED|Part 2: Post Week 16||0
10041075|NCT01970488|11165782|FG001|COMPLETED|Part 2: Post Week 16||0
10041076|NCT01970488|11165783|FG002|COMPLETED|Part 2: Post Week 16||135
10041077|NCT01970488|11165784|FG003|COMPLETED|Part 2: Post Week 16||71
10041078|NCT01970488|11165785|FG004|COMPLETED|Part 2: Post Week 16||69
10041079|NCT01970488|11165781|FG000|NOT COMPLETED|Part 2: Post Week 16||0
10041080|NCT01970488|11165782|FG001|NOT COMPLETED|Part 2: Post Week 16||0
10041081|NCT01970488|11165783|FG002|NOT COMPLETED|Part 2: Post Week 16||17
10041082|NCT01970488|11165784|FG003|NOT COMPLETED|Part 2: Post Week 16||8
10041083|NCT01970488|11165785|FG004|NOT COMPLETED|Part 2: Post Week 16||8
10041084|NCT01970527|11165802|FG000|STARTED|Pre-treatment/Baseline||9
10041085|NCT01970527|11165803|FG001|STARTED|Pre-treatment/Baseline||14
10041086|NCT01970527|11165802|FG000|COMPLETED|Pre-treatment/Baseline||8
10041087|NCT01970527|11165803|FG001|COMPLETED|Pre-treatment/Baseline||14
10041088|NCT01970527|11165802|FG000|NOT COMPLETED|Pre-treatment/Baseline||1
10041089|NCT01970527|11165803|FG001|NOT COMPLETED|Pre-treatment/Baseline||0
10041090|NCT01970527|11165802|FG000|STARTED|Treatment||8
10041091|NCT01970527|11165803|FG001|STARTED|Treatment||14
10041092|NCT01970527|11165802|FG000|COMPLETED|Treatment||8
10041093|NCT01970527|11165803|FG001|COMPLETED|Treatment||11
10041094|NCT01970527|11165802|FG000|NOT COMPLETED|Treatment||0
10041095|NCT01970527|11165803|FG001|NOT COMPLETED|Treatment||3
10041096|NCT01970527|11165802|FG000|STARTED|Follow-up Clinic Visit||8
10041097|NCT01970527|11165803|FG001|STARTED|Follow-up Clinic Visit||11
10041098|NCT01970527|11165802|FG000|COMPLETED|Follow-up Clinic Visit||7
10116793|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level III||0
10116794|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level III||0
10116795|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level III||0
10116796|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level III||0
10116797|NCT02533674|11247529|FG000|STARTED|Dose Level IV||0
10116798|NCT02533674|11247530|FG001|STARTED|Dose Level IV||0
10041099|NCT01970527|11165803|FG001|COMPLETED|Follow-up Clinic Visit||8
10041100|NCT01970527|11165802|FG000|NOT COMPLETED|Follow-up Clinic Visit||1
10041101|NCT01970527|11165803|FG001|NOT COMPLETED|Follow-up Clinic Visit||3
10041102|NCT01970540|11165815|FG000|STARTED|Overall Study||73
10041103|NCT01970540|11165816|FG001|STARTED|Overall Study||28
10041104|NCT01970540|11165817|FG002|STARTED|Overall Study||19
10041105|NCT01970540|11165815|FG000|COMPLETED|Overall Study||0
10116799|NCT02533674|11247531|FG002|STARTED|Dose Level IV||0
10116800|NCT02533674|11247532|FG003|STARTED|Dose Level IV||5
10041106|NCT01970540|11165816|FG001|COMPLETED|Overall Study||0
10041107|NCT01970540|11165817|FG002|COMPLETED|Overall Study||0
10041108|NCT01970540|11165815|FG000|NOT COMPLETED|Overall Study||73
10041109|NCT01970540|11165816|FG001|NOT COMPLETED|Overall Study||28
10041110|NCT01970540|11165817|FG002|NOT COMPLETED|Overall Study||19
10041111|NCT01970592|11165836|FG000|STARTED|Overall Study|Completed all training sessions|56
10041112|NCT01970592|11165836|FG000|COMPLETED|Overall Study||50
10041113|NCT01970592|11165836|FG000|NOT COMPLETED|Overall Study||6
10041114|NCT01970787|11165840|FG000|STARTED|Overall Study||22
10041115|NCT01970787|11165840|FG000|COMPLETED|Overall Study||21
10041116|NCT01970787|11165840|FG000|NOT COMPLETED|Overall Study||1
10041117|NCT01970878|11165848|FG000|STARTED|Overall Study||290
10041118|NCT01970878|11165849|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
10041119|NCT01970878|11165850|FG002|STARTED|Overall Study||213
10041120|NCT01970878|11165851|FG003|STARTED|Overall Study||171
10041121|NCT01970878|11165848|FG000|COMPLETED|Overall Study||253
10041122|NCT01970878|11165849|FG001|COMPLETED|Overall Study||191
10041123|NCT01970878|11165850|FG002|COMPLETED|Overall Study||187
10041124|NCT01970878|11165851|FG003|COMPLETED|Overall Study||147
10041125|NCT01970878|11165848|FG000|NOT COMPLETED|Overall Study||37
10041126|NCT01970878|11165849|FG001|NOT COMPLETED|Overall Study||27
10041127|NCT01970878|11165850|FG002|NOT COMPLETED|Overall Study||26
10041128|NCT01970878|11165851|FG003|NOT COMPLETED|Overall Study||24
10041129|NCT01970943|11165861|FG000|STARTED|Overall Study||11
10041130|NCT01970943|11165862|FG001|STARTED|Overall Study||12
10041131|NCT01970943|11165861|FG000|COMPLETED|Overall Study||8
10041132|NCT01970943|11165862|FG001|COMPLETED|Overall Study||11
10041133|NCT01970943|11165861|FG000|NOT COMPLETED|Overall Study||3
10041134|NCT01970943|11165862|FG001|NOT COMPLETED|Overall Study||1
10041135|NCT01970982|11165871|FG000|STARTED|Overall Study||80
10041136|NCT01970982|11165872|FG001|STARTED|Overall Study||40
10041137|NCT01970982|11165873|FG002|STARTED|Overall Study||40
10041138|NCT01970982|11165871|FG000|COMPLETED|Overall Study||80
10041139|NCT01970982|11165872|FG001|COMPLETED|Overall Study||40
10041140|NCT01970982|11165873|FG002|COMPLETED|Overall Study||38
10041141|NCT01970982|11165871|FG000|NOT COMPLETED|Overall Study||0
10041142|NCT01970982|11165872|FG001|NOT COMPLETED|Overall Study||0
10041143|NCT01970982|11165873|FG002|NOT COMPLETED|Overall Study||2
10041144|NCT01970995|11165885|FG000|STARTED|Confinement Period (Population at Day 5)||78
10041145|NCT01970995|11165886|FG001|STARTED|Confinement Period (Population at Day 5)||42
10041146|NCT01970995|11165887|FG002|STARTED|Confinement Period (Population at Day 5)||40
10041147|NCT01970995|11165885|FG000|COMPLETED|Confinement Period (Population at Day 5)||77
10041148|NCT01970995|11165886|FG001|COMPLETED|Confinement Period (Population at Day 5)||41
10041149|NCT01970995|11165887|FG002|COMPLETED|Confinement Period (Population at Day 5)||39
10041150|NCT01970995|11165885|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10041151|NCT01970995|11165886|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10041152|NCT01970995|11165887|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10041153|NCT01970995|11165885|FG000|STARTED|End of Study (Population at Day 90)||77
10041154|NCT01970995|11165886|FG001|STARTED|End of Study (Population at Day 90)||41
10041155|NCT01970995|11165887|FG002|STARTED|End of Study (Population at Day 90)||39
10041156|NCT01970995|11165885|FG000|COMPLETED|End of Study (Population at Day 90)||76
10041157|NCT01970995|11165886|FG001|COMPLETED|End of Study (Population at Day 90)||41
10041158|NCT01970995|11165887|FG002|COMPLETED|End of Study (Population at Day 90)||38
10041159|NCT01970995|11165885|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1
10041160|NCT01970995|11165886|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0
10041161|NCT01970995|11165887|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1
10041162|NCT01971086|11165895|FG000|STARTED|Overall Study||300
10041163|NCT01971086|11165895|FG000|COMPLETED|Overall Study||300
10041164|NCT01971086|11165895|FG000|NOT COMPLETED|Overall Study||0
10041165|NCT01971203|11165902|FG000|STARTED|Overall Study||26
10041166|NCT01971203|11165903|FG001|STARTED|Overall Study||29
10041167|NCT01971203|11165902|FG000|COMPLETED|Overall Study||17
10041168|NCT01971203|11165903|FG001|COMPLETED|Overall Study||21
10041169|NCT01971203|11165902|FG000|NOT COMPLETED|Overall Study||9
10041170|NCT01971203|11165903|FG001|NOT COMPLETED|Overall Study||8
10041171|NCT01971255|11165911|FG000|STARTED|Overall Study||32
10041172|NCT01971255|11165912|FG001|STARTED|Overall Study||42
10041173|NCT01971255|11165911|FG000|COMPLETED|Overall Study||31
10041174|NCT01971255|11165912|FG001|COMPLETED|Overall Study||40
10041175|NCT01971255|11165911|FG000|NOT COMPLETED|Overall Study||1
10041176|NCT01971255|11165912|FG001|NOT COMPLETED|Overall Study||2
10041177|NCT01971346|11165918|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
10041178|NCT01971346|11165918|FG000|COMPLETED|Overall Study||42
10041179|NCT01971346|11165918|FG000|NOT COMPLETED|Overall Study||8
10041180|NCT01971385|11165933|FG000|STARTED|Overall Study||17
10041181|NCT01971385|11165934|FG001|STARTED|Overall Study||18
10041182|NCT01971385|11165935|FG002|STARTED|Overall Study||19
10041183|NCT01971385|11165933|FG000|COMPLETED|Overall Study||14
10041184|NCT01971385|11165934|FG001|COMPLETED|Overall Study||13
10041185|NCT01971385|11165935|FG002|COMPLETED|Overall Study||15
10041186|NCT01971385|11165933|FG000|NOT COMPLETED|Overall Study||3
10041187|NCT01971385|11165934|FG001|NOT COMPLETED|Overall Study||5
10041188|NCT01971385|11165935|FG002|NOT COMPLETED|Overall Study||4
10041189|NCT01971463|11165942|FG000|STARTED|Overall Study||81
10041190|NCT01971463|11165942|FG000|COMPLETED|Overall Study||81
10041191|NCT01971463|11165942|FG000|NOT COMPLETED|Overall Study||0
10041192|NCT01971476|11165949|FG000|STARTED|Cohort 1: 2 to <12 Years||3
10041193|NCT01971476|11165950|FG001|STARTED|Cohort 1: 2 to <12 Years||3
10041194|NCT01971476|11165951|FG002|STARTED|Cohort 1: 2 to <12 Years||6
10041195|NCT01971476|11165949|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0
10041196|NCT01971476|11165950|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0
10041197|NCT01971476|11165951|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0
10041198|NCT01971476|11165949|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
10041199|NCT01971476|11165950|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
10041200|NCT01971476|11165951|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
10041201|NCT01971476|11165949|FG000|STARTED|Cohort 2: 12 to <18 Years||6
10041202|NCT01971476|11165950|FG001|STARTED|Cohort 2: 12 to <18 Years||4
10041203|NCT01971476|11165951|FG002|STARTED|Cohort 2: 12 to <18 Years||0
10041204|NCT01971476|11165949|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0
10041205|NCT01971476|11165950|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0
10041206|NCT01971476|11165951|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0
10041207|NCT01971476|11165949|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
10041208|NCT01971476|11165950|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
10041209|NCT01971476|11165951|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
10041210|NCT01971554|11165972|FG000|STARTED|Overall Study||9
10116801|NCT02533674|11247533|FG004|STARTED|Dose Level IV||0
10116802|NCT02533674|11247534|FG005|STARTED|Dose Level IV||0
10116803|NCT02533674|11247535|FG006|STARTED|Dose Level IV||0
10116804|NCT02533674|11247536|FG007|STARTED|Dose Level IV||0
10116805|NCT02533674|11247529|FG000|COMPLETED|Dose Level IV||0
10116806|NCT02533674|11247530|FG001|COMPLETED|Dose Level IV||0
10116807|NCT02533674|11247531|FG002|COMPLETED|Dose Level IV||0
10116808|NCT02533674|11247532|FG003|COMPLETED|Dose Level IV||0
10116809|NCT02533674|11247533|FG004|COMPLETED|Dose Level IV||0
10116810|NCT02533674|11247534|FG005|COMPLETED|Dose Level IV||0
10116811|NCT02533674|11247535|FG006|COMPLETED|Dose Level IV||0
10116812|NCT02533674|11247536|FG007|COMPLETED|Dose Level IV||0
10116813|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level IV||0
10116814|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level IV||0
10116815|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level IV||0
10116816|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level IV||5
10116817|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level IV||0
10116818|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level IV||0
10116819|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level IV||0
10116820|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level IV||0
10116821|NCT02533674|11247529|FG000|STARTED|Dose Level V||0
10116822|NCT02533674|11247530|FG001|STARTED|Dose Level V||0
10116823|NCT02533674|11247531|FG002|STARTED|Dose Level V||0
10116824|NCT02533674|11247532|FG003|STARTED|Dose Level V||0
10116825|NCT02533674|11247533|FG004|STARTED|Dose Level V||5
10116826|NCT02533674|11247534|FG005|STARTED|Dose Level V||0
10116827|NCT02533674|11247535|FG006|STARTED|Dose Level V||0
10116828|NCT02533674|11247536|FG007|STARTED|Dose Level V||0
10116829|NCT02533674|11247529|FG000|COMPLETED|Dose Level V||0
10116830|NCT02533674|11247530|FG001|COMPLETED|Dose Level V||0
10116831|NCT02533674|11247531|FG002|COMPLETED|Dose Level V||0
10116832|NCT02533674|11247532|FG003|COMPLETED|Dose Level V||0
10116833|NCT02533674|11247533|FG004|COMPLETED|Dose Level V||0
10116834|NCT02533674|11247534|FG005|COMPLETED|Dose Level V||0
10116835|NCT02533674|11247535|FG006|COMPLETED|Dose Level V||0
10116836|NCT02533674|11247536|FG007|COMPLETED|Dose Level V||0
10116837|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level V||0
10116838|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level V||0
10116839|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level V||0
10116840|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level V||0
10116841|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level V||5
10116842|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level V||0
10116843|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level V||0
10116844|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level V||0
10116845|NCT02533674|11247529|FG000|STARTED|Dose Level VI||0
10116846|NCT02533674|11247530|FG001|STARTED|Dose Level VI||0
10116847|NCT02533674|11247531|FG002|STARTED|Dose Level VI||0
10116848|NCT02533674|11247532|FG003|STARTED|Dose Level VI||0
10116849|NCT02533674|11247533|FG004|STARTED|Dose Level VI||0
10116850|NCT02533674|11247534|FG005|STARTED|Dose Level VI||9
10116851|NCT02533674|11247535|FG006|STARTED|Dose Level VI||0
10116852|NCT02533674|11247536|FG007|STARTED|Dose Level VI||0
10116853|NCT02533674|11247529|FG000|COMPLETED|Dose Level VI||0
10116854|NCT02533674|11247530|FG001|COMPLETED|Dose Level VI||0
10116855|NCT02533674|11247531|FG002|COMPLETED|Dose Level VI||0
10116856|NCT02533674|11247532|FG003|COMPLETED|Dose Level VI||0
10116857|NCT02533674|11247533|FG004|COMPLETED|Dose Level VI||0
10116858|NCT02533674|11247534|FG005|COMPLETED|Dose Level VI||0
10116859|NCT02533674|11247535|FG006|COMPLETED|Dose Level VI||0
10116860|NCT02533674|11247536|FG007|COMPLETED|Dose Level VI||0
10116861|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level VI||0
10116862|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level VI||0
10116863|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level VI||0
10116864|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level VI||0
10041211|NCT01971554|11165973|FG001|STARTED|Overall Study||18
10041212|NCT01971554|11165974|FG002|STARTED|Overall Study||18
10116865|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level VI||0
10116866|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level VI||9
10116867|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level VI||0
10116868|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level VI||0
10116869|NCT02533674|11247529|FG000|STARTED|Dose Level VII||0
10116870|NCT02533674|11247530|FG001|STARTED|Dose Level VII||0
10116871|NCT02533674|11247531|FG002|STARTED|Dose Level VII||0
10041213|NCT01971554|11165975|FG003|STARTED|Overall Study||18
10041214|NCT01971554|11165972|FG000|COMPLETED|Overall Study||8
10041215|NCT01971554|11165973|FG001|COMPLETED|Overall Study||18
10041216|NCT01971554|11165974|FG002|COMPLETED|Overall Study||18
10041217|NCT01971554|11165975|FG003|COMPLETED|Overall Study||18
10041218|NCT01971554|11165972|FG000|NOT COMPLETED|Overall Study||1
10041219|NCT01971554|11165973|FG001|NOT COMPLETED|Overall Study||0
10041220|NCT01971554|11165974|FG002|NOT COMPLETED|Overall Study||0
10041221|NCT01971554|11165975|FG003|NOT COMPLETED|Overall Study||0
10041222|NCT01971567|11165987|FG000|STARTED|Overall Study||56
10041223|NCT01971567|11165988|FG001|STARTED|Overall Study||51
10041224|NCT01971567|11165987|FG000|COMPLETED|Overall Study||52
10041225|NCT01971567|11165988|FG001|COMPLETED|Overall Study||49
10041226|NCT01971567|11165987|FG000|NOT COMPLETED|Overall Study||4
10041227|NCT01971567|11165988|FG001|NOT COMPLETED|Overall Study||2
10041228|NCT01971580|11165996|FG000|STARTED|Overall Study||14
10041229|NCT01971580|11165997|FG001|STARTED|Overall Study||14
10041230|NCT01971580|11165996|FG000|COMPLETED|Overall Study||10
10041231|NCT01971580|11165997|FG001|COMPLETED|Overall Study||9
10041232|NCT01971580|11165996|FG000|NOT COMPLETED|Overall Study||4
10041233|NCT01971580|11165997|FG001|NOT COMPLETED|Overall Study||5
10041234|NCT01971593|11166005|FG000|STARTED|Overall Study||14
10041235|NCT01971593|11166006|FG001|STARTED|Overall Study||12
10041236|NCT01971593|11166005|FG000|COMPLETED|Overall Study||9
10041237|NCT01971593|11166006|FG001|COMPLETED|Overall Study||8
10041238|NCT01971593|11166005|FG000|NOT COMPLETED|Overall Study||5
10041239|NCT01971593|11166006|FG001|NOT COMPLETED|Overall Study||4
10041240|NCT01971645|11166013|FG000|STARTED|Overall Study||25
10041241|NCT01971645|11166014|FG001|STARTED|Overall Study||27
10041242|NCT01971645|11166015|FG002|STARTED|Overall Study||25
10041243|NCT01971645|11166013|FG000|COMPLETED|Overall Study||23
10041244|NCT01971645|11166014|FG001|COMPLETED|Overall Study||27
10041245|NCT01971645|11166015|FG002|COMPLETED|Overall Study||23
10041246|NCT01971645|11166013|FG000|NOT COMPLETED|Overall Study||2
10041247|NCT01971645|11166014|FG001|NOT COMPLETED|Overall Study||0
10041248|NCT01971645|11166015|FG002|NOT COMPLETED|Overall Study||2
10041249|NCT01971723|11166025|FG000|STARTED|Overall Study||16
10041250|NCT01971723|11166026|FG001|STARTED|Overall Study||16
10041251|NCT01971723|11166025|FG000|COMPLETED|Overall Study||14
10041252|NCT01971723|11166026|FG001|COMPLETED|Overall Study||13
10041253|NCT01971723|11166025|FG000|NOT COMPLETED|Overall Study||2
10041254|NCT01971723|11166026|FG001|NOT COMPLETED|Overall Study||3
10041255|NCT01972061|11166035|FG000|STARTED|Overall Study||1
10041256|NCT01972061|11166036|FG001|STARTED|Overall Study||23
10041257|NCT01972061|11166037|FG002|STARTED|Overall Study||20
10041258|NCT01972061|11166035|FG000|COMPLETED|Overall Study||1
10041259|NCT01972061|11166036|FG001|COMPLETED|Overall Study||23
10041260|NCT01972061|11166037|FG002|COMPLETED|Overall Study||20
10041261|NCT01972061|11166035|FG000|NOT COMPLETED|Overall Study||0
10041262|NCT01972061|11166036|FG001|NOT COMPLETED|Overall Study||0
10041263|NCT01972061|11166037|FG002|NOT COMPLETED|Overall Study||0
10041264|NCT01972074|11166048|FG000|STARTED|Overall Study||22
10041265|NCT01972074|11166049|FG001|STARTED|Overall Study||21
10041266|NCT01972074|11166050|FG002|STARTED|Overall Study||18
10041267|NCT01972074|11166048|FG000|COMPLETED|Overall Study||16
10041268|NCT01972074|11166049|FG001|COMPLETED|Overall Study||17
10041269|NCT01972074|11166050|FG002|COMPLETED|Overall Study||15
10041270|NCT01972074|11166048|FG000|NOT COMPLETED|Overall Study||6
10041271|NCT01972074|11166049|FG001|NOT COMPLETED|Overall Study||4
10041272|NCT01972074|11166050|FG002|NOT COMPLETED|Overall Study||3
10041273|NCT01972152|11166057|FG000|STARTED|First Treatment Visit||5
10041274|NCT01972152|11166058|FG001|STARTED|First Treatment Visit||5
10041275|NCT01972152|11166059|FG002|STARTED|First Treatment Visit||5
10041276|NCT01972152|11166060|FG003|STARTED|First Treatment Visit||5
10041277|NCT01972152|11166061|FG004|STARTED|First Treatment Visit||5
10041278|NCT01972152|11166062|FG005|STARTED|First Treatment Visit||5
10041279|NCT01972152|11166057|FG000|COMPLETED|First Treatment Visit||5
10041280|NCT01972152|11166058|FG001|COMPLETED|First Treatment Visit||4
10041281|NCT01972152|11166059|FG002|COMPLETED|First Treatment Visit||5
10041282|NCT01972152|11166060|FG003|COMPLETED|First Treatment Visit||5
10041283|NCT01972152|11166061|FG004|COMPLETED|First Treatment Visit||5
10041284|NCT01972152|11166062|FG005|COMPLETED|First Treatment Visit||5
10041285|NCT01972152|11166057|FG000|NOT COMPLETED|First Treatment Visit||0
10041286|NCT01972152|11166058|FG001|NOT COMPLETED|First Treatment Visit||1
10041287|NCT01972152|11166059|FG002|NOT COMPLETED|First Treatment Visit||0
10041288|NCT01972152|11166060|FG003|NOT COMPLETED|First Treatment Visit||0
10041289|NCT01972152|11166061|FG004|NOT COMPLETED|First Treatment Visit||0
10041290|NCT01972152|11166062|FG005|NOT COMPLETED|First Treatment Visit||0
10041291|NCT01972152|11166057|FG000|STARTED|Second Treatment Visit||5
10041292|NCT01972152|11166058|FG001|STARTED|Second Treatment Visit||4
10041293|NCT01972152|11166059|FG002|STARTED|Second Treatment Visit||5
10041294|NCT01972152|11166060|FG003|STARTED|Second Treatment Visit||5
10041295|NCT01972152|11166061|FG004|STARTED|Second Treatment Visit||5
10041296|NCT01972152|11166062|FG005|STARTED|Second Treatment Visit||5
10041297|NCT01972152|11166057|FG000|COMPLETED|Second Treatment Visit||5
10041298|NCT01972152|11166058|FG001|COMPLETED|Second Treatment Visit||3
10041299|NCT01972152|11166059|FG002|COMPLETED|Second Treatment Visit||5
10041300|NCT01972152|11166060|FG003|COMPLETED|Second Treatment Visit||5
10041301|NCT01972152|11166061|FG004|COMPLETED|Second Treatment Visit||5
10041302|NCT01972152|11166062|FG005|COMPLETED|Second Treatment Visit||5
10041303|NCT01972152|11166057|FG000|NOT COMPLETED|Second Treatment Visit||0
10041304|NCT01972152|11166058|FG001|NOT COMPLETED|Second Treatment Visit||1
10041305|NCT01972152|11166059|FG002|NOT COMPLETED|Second Treatment Visit||0
10041306|NCT01972152|11166060|FG003|NOT COMPLETED|Second Treatment Visit||0
10041307|NCT01972152|11166061|FG004|NOT COMPLETED|Second Treatment Visit||0
10041308|NCT01972152|11166062|FG005|NOT COMPLETED|Second Treatment Visit||0
10041309|NCT01972152|11166057|FG000|STARTED|Third Treatment Visit||5
10041310|NCT01972152|11166058|FG001|STARTED|Third Treatment Visit||3
10041311|NCT01972152|11166059|FG002|STARTED|Third Treatment Visit||5
10041312|NCT01972152|11166060|FG003|STARTED|Third Treatment Visit||5
10041313|NCT01972152|11166061|FG004|STARTED|Third Treatment Visit||5
10041314|NCT01972152|11166062|FG005|STARTED|Third Treatment Visit||5
10041315|NCT01972152|11166057|FG000|COMPLETED|Third Treatment Visit||5
10041316|NCT01972152|11166058|FG001|COMPLETED|Third Treatment Visit||3
10041317|NCT01972152|11166059|FG002|COMPLETED|Third Treatment Visit||5
10041318|NCT01972152|11166060|FG003|COMPLETED|Third Treatment Visit||5
10041319|NCT01972152|11166061|FG004|COMPLETED|Third Treatment Visit||5
10041320|NCT01972152|11166062|FG005|COMPLETED|Third Treatment Visit||5
10041321|NCT01972152|11166057|FG000|NOT COMPLETED|Third Treatment Visit||0
10041322|NCT01972152|11166058|FG001|NOT COMPLETED|Third Treatment Visit||0
10041323|NCT01972152|11166059|FG002|NOT COMPLETED|Third Treatment Visit||0
10041324|NCT01972152|11166060|FG003|NOT COMPLETED|Third Treatment Visit||0
10041325|NCT01972152|11166061|FG004|NOT COMPLETED|Third Treatment Visit||0
10041326|NCT01972152|11166062|FG005|NOT COMPLETED|Third Treatment Visit||0
10041327|NCT01972204|11166075|FG000|STARTED|Overall Study||62
10041328|NCT01972204|11166076|FG001|STARTED|Overall Study||63
10041329|NCT01972204|11166075|FG000|COMPLETED|Overall Study||58
10041330|NCT01972204|11166076|FG001|COMPLETED|Overall Study||59
10041331|NCT01972204|11166075|FG000|NOT COMPLETED|Overall Study||4
10041332|NCT01972204|11166076|FG001|NOT COMPLETED|Overall Study||4
10041333|NCT01972282|11166082|FG000|STARTED|Overall Study||1020
10041334|NCT01972282|11166082|FG000|COMPLETED|Overall Study||1005
10041335|NCT01972282|11166082|FG000|NOT COMPLETED|Overall Study||15
10041336|NCT01972308|11166088|FG000|STARTED|Overall Study||156
10041337|NCT01972308|11166089|FG001|STARTED|Overall Study||156
10041338|NCT01972308|11166088|FG000|COMPLETED|Overall Study||148
10041339|NCT01972308|11166089|FG001|COMPLETED|Overall Study||148
10041340|NCT01972308|11166088|FG000|NOT COMPLETED|Overall Study||8
10041341|NCT01972308|11166089|FG001|NOT COMPLETED|Overall Study||8
10041342|NCT01972438|11166099|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
10041343|NCT01972438|11166100|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
10041344|NCT01972438|11166099|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6
10041345|NCT01972438|11166100|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6
10041346|NCT01972438|11166099|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
10041347|NCT01972438|11166100|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
10041348|NCT01972438|11166099|FG000|STARTED|Months 3-6 Crossover Period||6
10041349|NCT01972438|11166100|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
10041350|NCT01972438|11166099|FG000|COMPLETED|Months 3-6 Crossover Period||6
10041351|NCT01972438|11166100|FG001|COMPLETED|Months 3-6 Crossover Period||6
10041352|NCT01972438|11166099|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0
10041353|NCT01972438|11166100|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1
10041354|NCT01972438|11166099|FG000|STARTED|Months 6-12 Study Period||6
10041355|NCT01972438|11166100|FG001|STARTED|Months 6-12 Study Period||6
10041356|NCT01972438|11166099|FG000|COMPLETED|Months 6-12 Study Period||3
10041357|NCT01972438|11166100|FG001|COMPLETED|Months 6-12 Study Period||4
10041358|NCT01972438|11166099|FG000|NOT COMPLETED|Months 6-12 Study Period||3
10041359|NCT01972438|11166100|FG001|NOT COMPLETED|Months 6-12 Study Period||2
10041360|NCT01972438|11166099|FG000|STARTED|Post Month 12 Study Period||3
10041361|NCT01972438|11166100|FG001|STARTED|Post Month 12 Study Period||4
10041362|NCT01972438|11166099|FG000|COMPLETED|Post Month 12 Study Period||0
10041363|NCT01972438|11166100|FG001|COMPLETED|Post Month 12 Study Period||0
10041364|NCT01972438|11166099|FG000|NOT COMPLETED|Post Month 12 Study Period||3
10041365|NCT01972438|11166100|FG001|NOT COMPLETED|Post Month 12 Study Period||4
10041366|NCT01972464|11166110|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19
10041367|NCT01972464|11166111|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22
10041368|NCT01972464|11166110|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
10041369|NCT01972464|11166111|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
10041370|NCT01972464|11166110|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
10041371|NCT01972464|11166111|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
10041372|NCT01972464|11166110|FG000|STARTED|3-Month Follow-Up (Week 20)||16
10041373|NCT01972464|11166111|FG001|STARTED|3-Month Follow-Up (Week 20)||18
10041374|NCT01972464|11166110|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15
10041375|NCT01972464|11166111|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17
10041376|NCT01972464|11166110|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
10041377|NCT01972464|11166111|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
10041378|NCT01972516|11166120|FG000|STARTED|Overall Study||3
10041379|NCT01972516|11166121|FG001|STARTED|Overall Study||1
10041380|NCT01972516|11166120|FG000|COMPLETED|Overall Study||3
10041381|NCT01972516|11166121|FG001|COMPLETED|Overall Study||1
10041382|NCT01972516|11166120|FG000|NOT COMPLETED|Overall Study||0
10041383|NCT01972516|11166121|FG001|NOT COMPLETED|Overall Study||0
10041384|NCT01972529|11166131|FG000|STARTED|Overall Study||48
10041385|NCT01972529|11166132|FG001|STARTED|Overall Study||90
10041386|NCT01972529|11166133|FG002|STARTED|Overall Study||34
10041387|NCT01972529|11166134|FG003|STARTED|Overall Study||59
10041388|NCT01972529|11166131|FG000|COMPLETED|Overall Study||46
10041389|NCT01972529|11166132|FG001|COMPLETED|Overall Study||85
10041390|NCT01972529|11166133|FG002|COMPLETED|Overall Study||32
10041391|NCT01972529|11166134|FG003|COMPLETED|Overall Study||55
10041392|NCT01972529|11166131|FG000|NOT COMPLETED|Overall Study||2
10041393|NCT01972529|11166132|FG001|NOT COMPLETED|Overall Study||5
10041394|NCT01972529|11166133|FG002|NOT COMPLETED|Overall Study||2
10041395|NCT01972529|11166134|FG003|NOT COMPLETED|Overall Study||4
10041396|NCT01972568|11166148|FG000|STARTED|Overall Study||102
10041397|NCT01972568|11166149|FG001|STARTED|Overall Study||104
10041398|NCT01972568|11166150|FG002|STARTED|Overall Study||100
10041399|NCT01972568|11166148|FG000|COMPLETED|Overall Study||86
10041400|NCT01972568|11166149|FG001|COMPLETED|Overall Study||92
10041401|NCT01972568|11166150|FG002|COMPLETED|Overall Study||84
10041402|NCT01972568|11166148|FG000|NOT COMPLETED|Overall Study||16
10041403|NCT01972568|11166149|FG001|NOT COMPLETED|Overall Study||12
10041404|NCT01972568|11166150|FG002|NOT COMPLETED|Overall Study||16
10041405|NCT01972659|11166160|FG000|STARTED|Overall Study||40
10041406|NCT01972659|11166161|FG001|STARTED|Overall Study||40
10041407|NCT01972659|11166160|FG000|COMPLETED|Overall Study||36
10041408|NCT01972659|11166161|FG001|COMPLETED|Overall Study||37
10041409|NCT01972659|11166160|FG000|NOT COMPLETED|Overall Study||4
10041410|NCT01972659|11166161|FG001|NOT COMPLETED|Overall Study||3
10041411|NCT01972724|11166170|FG000|STARTED|Double-Blind||19
10041412|NCT01972724|11166171|FG001|STARTED|Double-Blind||18
10041413|NCT01972724|11166172|FG002|STARTED|Double-Blind||0
10041414|NCT01972724|11166170|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17
10041415|NCT01972724|11166171|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17
10116872|NCT02533674|11247532|FG003|STARTED|Dose Level VII||0
10116873|NCT02533674|11247533|FG004|STARTED|Dose Level VII||0
10116874|NCT02533674|11247534|FG005|STARTED|Dose Level VII||0
10116875|NCT02533674|11247535|FG006|STARTED|Dose Level VII||16
10116876|NCT02533674|11247536|FG007|STARTED|Dose Level VII||0
10116877|NCT02533674|11247529|FG000|COMPLETED|Dose Level VII||0
10116878|NCT02533674|11247530|FG001|COMPLETED|Dose Level VII||0
10116879|NCT02533674|11247531|FG002|COMPLETED|Dose Level VII||0
10116880|NCT02533674|11247532|FG003|COMPLETED|Dose Level VII||0
10116881|NCT02533674|11247533|FG004|COMPLETED|Dose Level VII||0
10116882|NCT02533674|11247534|FG005|COMPLETED|Dose Level VII||0
10116883|NCT02533674|11247535|FG006|COMPLETED|Dose Level VII||0
10116884|NCT02533674|11247536|FG007|COMPLETED|Dose Level VII||0
10116885|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level VII||0
10116886|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level VII||0
10116887|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level VII||0
10116888|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level VII||0
10116889|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level VII||0
10116890|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level VII||0
10116891|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level VII||16
10116892|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level VII||0
10116893|NCT02533674|11247529|FG000|STARTED|Dose Level VIII||0
10116894|NCT02533674|11247530|FG001|STARTED|Dose Level VIII||0
10116895|NCT02533674|11247531|FG002|STARTED|Dose Level VIII||0
10116896|NCT02533674|11247532|FG003|STARTED|Dose Level VIII||0
10116897|NCT02533674|11247533|FG004|STARTED|Dose Level VIII||0
10116898|NCT02533674|11247534|FG005|STARTED|Dose Level VIII||0
10116899|NCT02533674|11247535|FG006|STARTED|Dose Level VIII||0
10116900|NCT02533674|11247536|FG007|STARTED|Dose Level VIII||6
10116901|NCT02533674|11247529|FG000|COMPLETED|Dose Level VIII||0
10116902|NCT02533674|11247530|FG001|COMPLETED|Dose Level VIII||0
10116903|NCT02533674|11247531|FG002|COMPLETED|Dose Level VIII||0
10116904|NCT02533674|11247532|FG003|COMPLETED|Dose Level VIII||0
10116905|NCT02533674|11247533|FG004|COMPLETED|Dose Level VIII||0
10116906|NCT02533674|11247534|FG005|COMPLETED|Dose Level VIII||0
10116907|NCT02533674|11247535|FG006|COMPLETED|Dose Level VIII||0
10116908|NCT02533674|11247536|FG007|COMPLETED|Dose Level VIII||0
10116909|NCT02533674|11247529|FG000|NOT COMPLETED|Dose Level VIII||0
10116910|NCT02533674|11247530|FG001|NOT COMPLETED|Dose Level VIII||0
10116911|NCT02533674|11247531|FG002|NOT COMPLETED|Dose Level VIII||0
10116912|NCT02533674|11247532|FG003|NOT COMPLETED|Dose Level VIII||0
10116913|NCT02533674|11247533|FG004|NOT COMPLETED|Dose Level VIII||0
10116914|NCT02533674|11247534|FG005|NOT COMPLETED|Dose Level VIII||0
10116915|NCT02533674|11247535|FG006|NOT COMPLETED|Dose Level VIII||0
10116916|NCT02533674|11247536|FG007|NOT COMPLETED|Dose Level VIII||6
10116917|NCT02533726|11247556|FG000|STARTED|Initial Allocation||659
10116918|NCT02533726|11247557|FG001|STARTED|Initial Allocation||653
10041416|NCT01972724|11166172|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0
10041417|NCT01972724|11166170|FG000|COMPLETED|Double-Blind||10
10041418|NCT01972724|11166171|FG001|COMPLETED|Double-Blind||9
10041419|NCT01972724|11166172|FG002|COMPLETED|Double-Blind||0
10041420|NCT01972724|11166170|FG000|NOT COMPLETED|Double-Blind||9
10041421|NCT01972724|11166171|FG001|NOT COMPLETED|Double-Blind||9
10041422|NCT01972724|11166172|FG002|NOT COMPLETED|Double-Blind||0
10041423|NCT01972724|11166170|FG000|STARTED|Open-Label||0
10041424|NCT01972724|11166171|FG001|STARTED|Open-Label||0
10041425|NCT01972724|11166172|FG002|STARTED|Open-Label||77
10041426|NCT01972724|11166170|FG000|COMPLETED|Open-Label||0
10041427|NCT01972724|11166171|FG001|COMPLETED|Open-Label||0
10116919|NCT02533726|11247556|FG000|COMPLETED|Initial Allocation||659
10116920|NCT02533726|11247557|FG001|COMPLETED|Initial Allocation||653
10116921|NCT02533726|11247556|FG000|NOT COMPLETED|Initial Allocation||0
10116922|NCT02533726|11247557|FG001|NOT COMPLETED|Initial Allocation||0
10116923|NCT02533726|11247556|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
10116924|NCT02533726|11247557|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
10116925|NCT02533726|11247556|FG000|Per Protocol Population|Treatment||671
10116926|NCT02533726|11247557|FG001|Per Protocol Population|Treatment||555
10041428|NCT01972724|11166172|FG002|COMPLETED|Open-Label||72
10041429|NCT01972724|11166170|FG000|NOT COMPLETED|Open-Label||0
10041430|NCT01972724|11166171|FG001|NOT COMPLETED|Open-Label||0
10041431|NCT01972724|11166172|FG002|NOT COMPLETED|Open-Label||5
10041432|NCT01972776|11166186|FG000|STARTED|Part 1||6
10041433|NCT01972776|11166187|FG001|STARTED|Part 1||6
10041434|NCT01972776|11166188|FG002|STARTED|Part 1||8
10041435|NCT01972776|11166189|FG003|STARTED|Part 1||7
10041436|NCT01972776|11166190|FG004|STARTED|Part 1||0
10041437|NCT01972776|11166191|FG005|STARTED|Part 1||0
10041438|NCT01972776|11166186|FG000|COMPLETED|Part 1||6
10041439|NCT01972776|11166187|FG001|COMPLETED|Part 1||6
10041440|NCT01972776|11166188|FG002|COMPLETED|Part 1||6
10041441|NCT01972776|11166189|FG003|COMPLETED|Part 1||6
10041442|NCT01972776|11166190|FG004|COMPLETED|Part 1||0
10041443|NCT01972776|11166191|FG005|COMPLETED|Part 1||0
10041444|NCT01972776|11166186|FG000|NOT COMPLETED|Part 1||0
10041445|NCT01972776|11166187|FG001|NOT COMPLETED|Part 1||0
10041446|NCT01972776|11166188|FG002|NOT COMPLETED|Part 1||2
10041447|NCT01972776|11166189|FG003|NOT COMPLETED|Part 1||1
10041448|NCT01972776|11166190|FG004|NOT COMPLETED|Part 1||0
10041449|NCT01972776|11166191|FG005|NOT COMPLETED|Part 1||0
10041450|NCT01972776|11166186|FG000|STARTED|Part 2||0
10041451|NCT01972776|11166187|FG001|STARTED|Part 2||0
10041452|NCT01972776|11166188|FG002|STARTED|Part 2||0
10041453|NCT01972776|11166189|FG003|STARTED|Part 2||0
10041454|NCT01972776|11166190|FG004|STARTED|Part 2||14
10041455|NCT01972776|11166191|FG005|STARTED|Part 2||7
10041456|NCT01972776|11166186|FG000|COMPLETED|Part 2||0
10041457|NCT01972776|11166187|FG001|COMPLETED|Part 2||0
10041458|NCT01972776|11166188|FG002|COMPLETED|Part 2||0
10041459|NCT01972776|11166189|FG003|COMPLETED|Part 2||0
10041460|NCT01972776|11166190|FG004|COMPLETED|Part 2||1
10041461|NCT01972776|11166191|FG005|COMPLETED|Part 2||0
10041462|NCT01972776|11166186|FG000|NOT COMPLETED|Part 2||0
10041463|NCT01972776|11166187|FG001|NOT COMPLETED|Part 2||0
10041464|NCT01972776|11166188|FG002|NOT COMPLETED|Part 2||0
10041465|NCT01972776|11166189|FG003|NOT COMPLETED|Part 2||0
10041466|NCT01972776|11166190|FG004|NOT COMPLETED|Part 2||13
10041467|NCT01972776|11166191|FG005|NOT COMPLETED|Part 2||7
10041468|NCT01972789|11166207|FG000|STARTED|Overall Study||174
10041469|NCT01972789|11166208|FG001|STARTED|Overall Study||175
10041470|NCT01972789|11166207|FG000|COMPLETED|Overall Study||134
10041471|NCT01972789|11166208|FG001|COMPLETED|Overall Study||145
10041472|NCT01972789|11166207|FG000|NOT COMPLETED|Overall Study||40
10041473|NCT01972789|11166208|FG001|NOT COMPLETED|Overall Study||30
10041474|NCT01972841|11166220|FG000|STARTED|Overall Study||447
10041475|NCT01972841|11166221|FG001|STARTED|Overall Study||441
10041476|NCT01972841|11166222|FG002|STARTED|Overall Study||437
10041477|NCT01972841|11166223|FG003|STARTED|Overall Study||434
10041478|NCT01972841|11166224|FG004|STARTED|Overall Study||885
10041479|NCT01972841|11166225|FG005|STARTED|Overall Study||883
10041480|NCT01972841|11166220|FG000|COMPLETED|Overall Study||404
10041481|NCT01972841|11166221|FG001|COMPLETED|Overall Study||397
10041482|NCT01972841|11166222|FG002|COMPLETED|Overall Study||387
10041483|NCT01972841|11166223|FG003|COMPLETED|Overall Study||397
10041484|NCT01972841|11166224|FG004|COMPLETED|Overall Study||802
10041485|NCT01972841|11166225|FG005|COMPLETED|Overall Study||798
10041486|NCT01972841|11166220|FG000|NOT COMPLETED|Overall Study||43
10041487|NCT01972841|11166221|FG001|NOT COMPLETED|Overall Study||44
10041488|NCT01972841|11166222|FG002|NOT COMPLETED|Overall Study||50
10041489|NCT01972841|11166223|FG003|NOT COMPLETED|Overall Study||37
10041490|NCT01972841|11166224|FG004|NOT COMPLETED|Overall Study||83
10041491|NCT01972841|11166225|FG005|NOT COMPLETED|Overall Study||85
10041492|NCT01973036|11166241|FG000|STARTED|Overall Study||108
10041493|NCT01973036|11166242|FG001|STARTED|Overall Study||93
10041494|NCT01973036|11166241|FG000|Received Assigned Intervention|Overall Study||113
10041495|NCT01973036|11166242|FG001|Received Assigned Intervention|Overall Study||88
10041496|NCT01973036|11166241|FG000|COMPLETED|Overall Study||108
10041497|NCT01973036|11166242|FG001|COMPLETED|Overall Study||93
10041498|NCT01973036|11166241|FG000|NOT COMPLETED|Overall Study||0
10041499|NCT01973036|11166242|FG001|NOT COMPLETED|Overall Study||0
10041500|NCT01973205|11166251|FG000|STARTED|Overall Study||453
10041501|NCT01973205|11166252|FG001|STARTED|Overall Study||447
10041502|NCT01973205|11166251|FG000|COMPLETED|Overall Study||423
10041503|NCT01973205|11166252|FG001|COMPLETED|Overall Study||425
10041504|NCT01973205|11166251|FG000|NOT COMPLETED|Overall Study||30
10041505|NCT01973205|11166252|FG001|NOT COMPLETED|Overall Study||22
10041506|NCT01973218|11166260|FG000|STARTED|Overall Study||176
10041507|NCT01973218|11166261|FG001|STARTED|Overall Study||88
10041508|NCT01973218|11166260|FG000|COMPLETED|Overall Study||174
10041509|NCT01973218|11166261|FG001|COMPLETED|Overall Study||88
10041510|NCT01973218|11166260|FG000|NOT COMPLETED|Overall Study||2
10041511|NCT01973218|11166261|FG001|NOT COMPLETED|Overall Study||0
10041512|NCT01973231|11166271|FG000|STARTED|Overall Study||202
10041513|NCT01973231|11166272|FG001|STARTED|Overall Study||202
10041514|NCT01973231|11166271|FG000|COMPLETED|Overall Study||191
10041515|NCT01973231|11166272|FG001|COMPLETED|Overall Study||190
10041516|NCT01973231|11166271|FG000|NOT COMPLETED|Overall Study||11
10041517|NCT01973231|11166272|FG001|NOT COMPLETED|Overall Study||12
10041518|NCT01973283|11166278|FG000|STARTED|Overall Study||100
10041519|NCT01973283|11166278|FG000|COMPLETED|Overall Study||96
10041520|NCT01973283|11166278|FG000|NOT COMPLETED|Overall Study||4
10041521|NCT01973335|11166288|FG000|STARTED|Overall Study||9
10041522|NCT01973335|11166289|FG001|STARTED|Overall Study||7
10041523|NCT01973335|11166290|FG002|STARTED|Overall Study||9
10041524|NCT01973335|11166291|FG003|STARTED|Overall Study||9
10041525|NCT01973335|11166288|FG000|COMPLETED|Overall Study||9
10041526|NCT01973335|11166289|FG001|COMPLETED|Overall Study||7
10041527|NCT01973335|11166290|FG002|COMPLETED|Overall Study||9
10041528|NCT01973335|11166291|FG003|COMPLETED|Overall Study||9
10041529|NCT01973335|11166288|FG000|NOT COMPLETED|Overall Study||0
10041530|NCT01973335|11166289|FG001|NOT COMPLETED|Overall Study||0
10041531|NCT01973335|11166290|FG002|NOT COMPLETED|Overall Study||0
10041532|NCT01973335|11166291|FG003|NOT COMPLETED|Overall Study||0
10041533|NCT01973348|11166305|FG000|STARTED|Overall Study||27
10041534|NCT01973348|11166306|FG001|STARTED|Overall Study||18
10041535|NCT01973348|11166307|FG002|STARTED|Overall Study||0
10041536|NCT01973348|11166308|FG003|STARTED|Overall Study||0
10041537|NCT01973348|11166305|FG000|COMPLETED|Overall Study||19
10041538|NCT01973348|11166306|FG001|COMPLETED|Overall Study||15
10041539|NCT01973348|11166307|FG002|COMPLETED|Overall Study||0
10041540|NCT01973348|11166308|FG003|COMPLETED|Overall Study||0
10041541|NCT01973348|11166305|FG000|NOT COMPLETED|Overall Study||8
10041542|NCT01973348|11166306|FG001|NOT COMPLETED|Overall Study||3
10041543|NCT01973348|11166307|FG002|NOT COMPLETED|Overall Study||0
10041544|NCT01973348|11166308|FG003|NOT COMPLETED|Overall Study||0
10041545|NCT01973387|11166320|FG000|STARTED|Overall Study||106
10041546|NCT01973387|11166321|FG001|STARTED|Overall Study||54
10041547|NCT01973387|11166320|FG000|Treated|Overall Study||104
10041548|NCT01973387|11166321|FG001|Treated|Overall Study||52
10041549|NCT01973387|11166320|FG000|COMPLETED|Overall Study||0
10041550|NCT01973387|11166321|FG001|COMPLETED|Overall Study||36
10041551|NCT01973387|11166320|FG000|NOT COMPLETED|Overall Study||106
10041552|NCT01973387|11166321|FG001|NOT COMPLETED|Overall Study||18
10041553|NCT01973413|11166329|FG000|STARTED|Overall Study||12
10041554|NCT01973413|11166330|FG001|STARTED|Overall Study||20
10041555|NCT01973413|11166329|FG000|COMPLETED|Overall Study||11
10041556|NCT01973413|11166330|FG001|COMPLETED|Overall Study||20
10041557|NCT01973413|11166329|FG000|NOT COMPLETED|Overall Study||1
10041558|NCT01973413|11166330|FG001|NOT COMPLETED|Overall Study||0
10041559|NCT01973439|11166337|FG000|STARTED|Overall Study||23
10041560|NCT01973439|11166337|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
10041561|NCT01973439|11166337|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
10041562|NCT01973439|11166337|FG000|COMPLETED|Overall Study||18
10041563|NCT01973439|11166337|FG000|NOT COMPLETED|Overall Study||5
10041564|NCT01973491|11166341|FG000|STARTED|Baseline Control Period (8 Weeks)||37
10041565|NCT01973491|11166341|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19
10041566|NCT01973491|11166341|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
10041567|NCT01973491|11166341|FG000|STARTED|Titration Period(4 Weeks)||19
10041568|NCT01973491|11166341|FG000|COMPLETED|Titration Period(4 Weeks)||19
10041569|NCT01973491|11166341|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0
10041570|NCT01973491|11166341|FG000|STARTED|Treatment Period (16 Weeks)||19
10041571|NCT01973491|11166341|FG000|COMPLETED|Treatment Period (16 Weeks)||18
10041572|NCT01973491|11166341|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1
10041573|NCT01973569|11166348|FG000|STARTED|Overall Study||228
10041574|NCT01973569|11166349|FG001|STARTED|Overall Study||225
10041575|NCT01973569|11166350|FG002|STARTED|Overall Study||226
10041576|NCT01973569|11166348|FG000|Received Study Drug|Overall Study||222
10041577|NCT01973569|11166349|FG001|Received Study Drug|Overall Study||222
10041578|NCT01973569|11166350|FG002|Received Study Drug|Overall Study||223
10041579|NCT01973569|11166348|FG000|Did Not Receive Study Drug|Overall Study||6
10041580|NCT01973569|11166349|FG001|Did Not Receive Study Drug|Overall Study||3
10041581|NCT01973569|11166350|FG002|Did Not Receive Study Drug|Overall Study||3
10041582|NCT01973569|11166348|FG000|Discontinued Study Treatment|Overall Study||23
10041583|NCT01973569|11166349|FG001|Discontinued Study Treatment|Overall Study||22
10041584|NCT01973569|11166350|FG002|Discontinued Study Treatment|Overall Study||15
10041585|NCT01973569|11166348|FG000|Discontinued Study|Overall Study||23
10041586|NCT01973569|11166349|FG001|Discontinued Study|Overall Study||22
10041587|NCT01973569|11166350|FG002|Discontinued Study|Overall Study||15
10041588|NCT01973569|11166348|FG000|COMPLETED|Overall Study||199
10041589|NCT01973569|11166349|FG001|COMPLETED|Overall Study||200
10041590|NCT01973569|11166350|FG002|COMPLETED|Overall Study||208
10041591|NCT01973569|11166348|FG000|NOT COMPLETED|Overall Study||29
10041592|NCT01973569|11166349|FG001|NOT COMPLETED|Overall Study||25
10041593|NCT01973569|11166350|FG002|NOT COMPLETED|Overall Study||18
10041594|NCT01973595|11166362|FG000|STARTED|Intervention Phase 1||15
10041595|NCT01973595|11166363|FG001|STARTED|Intervention Phase 1||14
10041596|NCT01973595|11166364|FG002|STARTED|Intervention Phase 1||15
10041597|NCT01973595|11166365|FG003|STARTED|Intervention Phase 1||14
10041598|NCT01973595|11166362|FG000|COMPLETED|Intervention Phase 1||15
10041599|NCT01973595|11166363|FG001|COMPLETED|Intervention Phase 1||14
10041600|NCT01973595|11166364|FG002|COMPLETED|Intervention Phase 1||15
10041601|NCT01973595|11166365|FG003|COMPLETED|Intervention Phase 1||14
10041602|NCT01973595|11166362|FG000|NOT COMPLETED|Intervention Phase 1||0
10041603|NCT01973595|11166363|FG001|NOT COMPLETED|Intervention Phase 1||0
10041604|NCT01973595|11166364|FG002|NOT COMPLETED|Intervention Phase 1||0
10041605|NCT01973595|11166365|FG003|NOT COMPLETED|Intervention Phase 1||0
10041606|NCT01973595|11166362|FG000|STARTED|Washout||15
10041607|NCT01973595|11166363|FG001|STARTED|Washout||14
10041608|NCT01973595|11166364|FG002|STARTED|Washout||15
10041609|NCT01973595|11166365|FG003|STARTED|Washout||14
10041610|NCT01973595|11166362|FG000|COMPLETED|Washout||14
10041611|NCT01973595|11166363|FG001|COMPLETED|Washout||14
10041612|NCT01973595|11166364|FG002|COMPLETED|Washout||14
10041613|NCT01973595|11166365|FG003|COMPLETED|Washout||14
10041614|NCT01973595|11166362|FG000|NOT COMPLETED|Washout||1
10041615|NCT01973595|11166363|FG001|NOT COMPLETED|Washout||0
10041616|NCT01973595|11166364|FG002|NOT COMPLETED|Washout||1
10041617|NCT01973595|11166365|FG003|NOT COMPLETED|Washout||0
10041618|NCT01973595|11166362|FG000|STARTED|Intervention Phase 2||14
10041619|NCT01973595|11166363|FG001|STARTED|Intervention Phase 2||14
10041620|NCT01973595|11166364|FG002|STARTED|Intervention Phase 2||14
10041621|NCT01973595|11166365|FG003|STARTED|Intervention Phase 2||14
10041622|NCT01973595|11166362|FG000|COMPLETED|Intervention Phase 2||14
10041623|NCT01973595|11166363|FG001|COMPLETED|Intervention Phase 2||14
10041624|NCT01973595|11166364|FG002|COMPLETED|Intervention Phase 2||14
10041625|NCT01973595|11166365|FG003|COMPLETED|Intervention Phase 2||14
10041626|NCT01973595|11166362|FG000|NOT COMPLETED|Intervention Phase 2||0
10041627|NCT01973595|11166363|FG001|NOT COMPLETED|Intervention Phase 2||0
10041628|NCT01973595|11166364|FG002|NOT COMPLETED|Intervention Phase 2||0
10041629|NCT01973595|11166365|FG003|NOT COMPLETED|Intervention Phase 2||0
10041630|NCT01973608|11166380|FG000|STARTED|Overall Study||2
10041631|NCT01973608|11166381|FG001|STARTED|Overall Study||2
10041632|NCT01973608|11166382|FG002|STARTED|Overall Study||6
10041633|NCT01973608|11166383|FG003|STARTED|Overall Study||2
10041634|NCT01973608|11166380|FG000|COMPLETED|Overall Study||2
10041635|NCT01973608|11166381|FG001|COMPLETED|Overall Study||2
10041636|NCT01973608|11166382|FG002|COMPLETED|Overall Study||6
10041637|NCT01973608|11166383|FG003|COMPLETED|Overall Study||2
10041638|NCT01973608|11166380|FG000|NOT COMPLETED|Overall Study||0
10041639|NCT01973608|11166381|FG001|NOT COMPLETED|Overall Study||0
10041640|NCT01973608|11166382|FG002|NOT COMPLETED|Overall Study||0
10041641|NCT01973608|11166383|FG003|NOT COMPLETED|Overall Study||0
10041642|NCT01973777|11166397|FG000|STARTED|Overall Study|January 2014|51
10041643|NCT01973777|11166397|FG000|One Year Follow-up|Overall Study||44
10041644|NCT01973777|11166397|FG000|COMPLETED|Overall Study||44
10041645|NCT01973777|11166397|FG000|NOT COMPLETED|Overall Study||7
10041646|NCT01973972|11166403|FG000|STARTED|Overall Study||127
10041647|NCT01973972|11166404|FG001|STARTED|Overall Study||136
10041648|NCT01973972|11166403|FG000|COMPLETED|Overall Study||109
10041649|NCT01973972|11166404|FG001|COMPLETED|Overall Study||117
10041650|NCT01973972|11166403|FG000|NOT COMPLETED|Overall Study||18
10041651|NCT01973972|11166404|FG001|NOT COMPLETED|Overall Study||19
10041652|NCT01973998|11166412|FG000|STARTED|Overall Study||33
10041653|NCT01973998|11166413|FG001|STARTED|Overall Study||35
10041654|NCT01973998|11166412|FG000|COMPLETED|Overall Study||31
10041655|NCT01973998|11166413|FG001|COMPLETED|Overall Study||33
10041656|NCT01973998|11166412|FG000|NOT COMPLETED|Overall Study||2
10041657|NCT01973998|11166413|FG001|NOT COMPLETED|Overall Study||2
10041658|NCT01974050|11166419|FG000|STARTED|Overall Study||166
10041659|NCT01974050|11166419|FG000|COMPLETED|Overall Study||141
10041660|NCT01974050|11166419|FG000|NOT COMPLETED|Overall Study||25
10041661|NCT01974089|11166425|FG000|STARTED|Overall Study||53
10041662|NCT01974089|11166426|FG001|STARTED|Overall Study||101
10041663|NCT01974089|11166425|FG000|COMPLETED|Overall Study||53
10041664|NCT01974089|11166426|FG001|COMPLETED|Overall Study||101
10041665|NCT01974089|11166425|FG000|NOT COMPLETED|Overall Study||0
10041666|NCT01974089|11166426|FG001|NOT COMPLETED|Overall Study||0
10041667|NCT01974102|11166436|FG000|STARTED|Overall Study||22
10041668|NCT01974102|11166437|FG001|STARTED|Overall Study||20
10041669|NCT01974102|11166436|FG000|COMPLETED|Overall Study||15
10041670|NCT01974102|11166437|FG001|COMPLETED|Overall Study||19
10041671|NCT01974102|11166436|FG000|NOT COMPLETED|Overall Study||7
10041672|NCT01974102|11166437|FG001|NOT COMPLETED|Overall Study||1
10041673|NCT01974141|11166447|FG000|STARTED|Overall Study||1044
10041674|NCT01974141|11166448|FG001|STARTED|Overall Study||1058
10041675|NCT01974141|11166447|FG000|COMPLETED|Overall Study||948
10041676|NCT01974141|11166448|FG001|COMPLETED|Overall Study||976
10041677|NCT01974141|11166447|FG000|NOT COMPLETED|Overall Study||96
10041678|NCT01974141|11166448|FG001|NOT COMPLETED|Overall Study||82
10041679|NCT01974245|11166456|FG000|STARTED|Overall Study||27
10041680|NCT01974245|11166457|FG001|STARTED|Overall Study||28
10041681|NCT01974245|11166456|FG000|COMPLETED|Overall Study||18
10041682|NCT01974245|11166457|FG001|COMPLETED|Overall Study||20
10041683|NCT01974245|11166456|FG000|NOT COMPLETED|Overall Study||9
10041684|NCT01974245|11166457|FG001|NOT COMPLETED|Overall Study||8
10041685|NCT01974323|11166465|FG000|STARTED|Overall Study||1118
10041686|NCT01974323|11166466|FG001|STARTED|Overall Study||1120
10041687|NCT01974323|11166465|FG000|COMPLETED|Overall Study||1026
10041688|NCT01974323|11166466|FG001|COMPLETED|Overall Study||1027
10041689|NCT01974323|11166465|FG000|NOT COMPLETED|Overall Study||92
10041690|NCT01974323|11166466|FG001|NOT COMPLETED|Overall Study||93
10041691|NCT01974687|11166497|FG000|STARTED|Overall Study||6
10041692|NCT01974687|11166498|FG001|STARTED|Overall Study||6
10041693|NCT01974687|11166499|FG002|STARTED|Overall Study||6
10041694|NCT01974687|11166500|FG003|STARTED|Overall Study||6
10041695|NCT01974687|11166501|FG004|STARTED|Overall Study||2
10041696|NCT01974687|11166502|FG005|STARTED|Overall Study||6
10041697|NCT01974687|11166503|FG006|STARTED|Overall Study||3
10041698|NCT01974687|11166504|FG007|STARTED|Overall Study||3
10041699|NCT01974687|11166505|FG008|STARTED|Overall Study||3
10041700|NCT01974687|11166506|FG009|STARTED|Overall Study||3
10041701|NCT01974687|11166507|FG010|STARTED|Overall Study||3
10041702|NCT01974687|11166508|FG011|STARTED|Overall Study||13
10041703|NCT01974687|11166509|FG012|STARTED|Overall Study||13
10041704|NCT01974687|11166510|FG013|STARTED|Overall Study||10
10041705|NCT01974687|11166511|FG014|STARTED|Overall Study||19
10041706|NCT01974687|11166512|FG015|STARTED|Overall Study||9
10041707|NCT01974687|11166513|FG016|STARTED|Overall Study||9
10041708|NCT01974687|11166514|FG017|STARTED|Overall Study||11
10041709|NCT01974687|11166515|FG018|STARTED|Overall Study||9
10041710|NCT01974687|11166516|FG019|STARTED|Overall Study||3
10041711|NCT01974687|11166517|FG020|STARTED|Overall Study||3
10041712|NCT01974687|11166518|FG021|STARTED|Overall Study||8
10041713|NCT01974687|11166519|FG022|STARTED|Overall Study||8
10041714|NCT01974687|11166520|FG023|STARTED|Overall Study||6
10041715|NCT01974687|11166521|FG024|STARTED|Overall Study||10
10041716|NCT01974687|11166497|FG000|Treated|Overall Study||6
10041717|NCT01974687|11166498|FG001|Treated|Overall Study||6
10041718|NCT01974687|11166499|FG002|Treated|Overall Study||6
10041719|NCT01974687|11166500|FG003|Treated|Overall Study||6
10041720|NCT01974687|11166501|FG004|Treated|Overall Study||2
10041721|NCT01974687|11166502|FG005|Treated|Overall Study||6
10041722|NCT01974687|11166503|FG006|Treated|Overall Study||3
10041723|NCT01974687|11166504|FG007|Treated|Overall Study||3
10041724|NCT01974687|11166505|FG008|Treated|Overall Study||3
10041725|NCT01974687|11166506|FG009|Treated|Overall Study||3
10041726|NCT01974687|11166507|FG010|Treated|Overall Study||3
10041727|NCT01974687|11166508|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
10041728|NCT01974687|11166509|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
10041729|NCT01974687|11166510|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
10041730|NCT01974687|11166511|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
10041731|NCT01974687|11166512|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
10041732|NCT01974687|11166513|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
10041733|NCT01974687|11166514|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
10041734|NCT01974687|11166515|FG018|Treated|Overall Study||9
10041735|NCT01974687|11166516|FG019|Treated|Overall Study||3
10041736|NCT01974687|11166517|FG020|Treated|Overall Study||3
10041737|NCT01974687|11166518|FG021|Treated|Overall Study||8
10041738|NCT01974687|11166519|FG022|Treated|Overall Study||8
10041739|NCT01974687|11166520|FG023|Treated|Overall Study||6
10041740|NCT01974687|11166521|FG024|Treated|Overall Study||10
10041741|NCT01974687|11166497|FG000|COMPLETED|Overall Study||6
10041742|NCT01974687|11166498|FG001|COMPLETED|Overall Study||6
10041743|NCT01974687|11166499|FG002|COMPLETED|Overall Study||6
10041744|NCT01974687|11166500|FG003|COMPLETED|Overall Study||6
10041745|NCT01974687|11166501|FG004|COMPLETED|Overall Study||2
10041746|NCT01974687|11166502|FG005|COMPLETED|Overall Study||6
10041747|NCT01974687|11166503|FG006|COMPLETED|Overall Study||3
10041748|NCT01974687|11166504|FG007|COMPLETED|Overall Study||3
10041749|NCT01974687|11166505|FG008|COMPLETED|Overall Study||3
10041750|NCT01974687|11166506|FG009|COMPLETED|Overall Study||3
10041751|NCT01974687|11166507|FG010|COMPLETED|Overall Study||3
10041752|NCT01974687|11166508|FG011|COMPLETED|Overall Study||11
10041753|NCT01974687|11166509|FG012|COMPLETED|Overall Study||10
10041754|NCT01974687|11166510|FG013|COMPLETED|Overall Study||8
10041755|NCT01974687|11166511|FG014|COMPLETED|Overall Study||18
10041756|NCT01974687|11166512|FG015|COMPLETED|Overall Study||8
10041757|NCT01974687|11166513|FG016|COMPLETED|Overall Study||8
10041758|NCT01974687|11166514|FG017|COMPLETED|Overall Study||8
10041759|NCT01974687|11166515|FG018|COMPLETED|Overall Study||9
10041760|NCT01974687|11166516|FG019|COMPLETED|Overall Study||3
10041761|NCT01974687|11166517|FG020|COMPLETED|Overall Study||3
10041762|NCT01974687|11166518|FG021|COMPLETED|Overall Study||8
10041763|NCT01974687|11166519|FG022|COMPLETED|Overall Study||8
10041764|NCT01974687|11166520|FG023|COMPLETED|Overall Study||6
10041765|NCT01974687|11166521|FG024|COMPLETED|Overall Study||10
10041766|NCT01974687|11166497|FG000|NOT COMPLETED|Overall Study||0
10041767|NCT01974687|11166498|FG001|NOT COMPLETED|Overall Study||0
10041768|NCT01974687|11166499|FG002|NOT COMPLETED|Overall Study||0
10041769|NCT01974687|11166500|FG003|NOT COMPLETED|Overall Study||0
10041770|NCT01974687|11166501|FG004|NOT COMPLETED|Overall Study||0
10041771|NCT01974687|11166502|FG005|NOT COMPLETED|Overall Study||0
10041772|NCT01974687|11166503|FG006|NOT COMPLETED|Overall Study||0
10041773|NCT01974687|11166504|FG007|NOT COMPLETED|Overall Study||0
10041774|NCT01974687|11166505|FG008|NOT COMPLETED|Overall Study||0
10041775|NCT01974687|11166506|FG009|NOT COMPLETED|Overall Study||0
10041776|NCT01974687|11166507|FG010|NOT COMPLETED|Overall Study||0
10041777|NCT01974687|11166508|FG011|NOT COMPLETED|Overall Study||2
10041778|NCT01974687|11166509|FG012|NOT COMPLETED|Overall Study||3
10041779|NCT01974687|11166510|FG013|NOT COMPLETED|Overall Study||2
10041780|NCT01974687|11166511|FG014|NOT COMPLETED|Overall Study||1
10041781|NCT01974687|11166512|FG015|NOT COMPLETED|Overall Study||1
10041782|NCT01974687|11166513|FG016|NOT COMPLETED|Overall Study||1
10041783|NCT01974687|11166514|FG017|NOT COMPLETED|Overall Study||3
10041784|NCT01974687|11166515|FG018|NOT COMPLETED|Overall Study||0
10041785|NCT01974687|11166516|FG019|NOT COMPLETED|Overall Study||0
10041786|NCT01974687|11166517|FG020|NOT COMPLETED|Overall Study||0
10041787|NCT01974687|11166518|FG021|NOT COMPLETED|Overall Study||0
10041788|NCT01974687|11166519|FG022|NOT COMPLETED|Overall Study||0
10041789|NCT01974687|11166520|FG023|NOT COMPLETED|Overall Study||0
10041790|NCT01974687|11166521|FG024|NOT COMPLETED|Overall Study||0
10041791|NCT01974700|11166603|FG000|STARTED|Overall Study||5
10041792|NCT01974700|11166604|FG001|STARTED|Overall Study||3
10041793|NCT01974700|11166603|FG000|COMPLETED|Overall Study||5
10041794|NCT01974700|11166604|FG001|COMPLETED|Overall Study||3
10041795|NCT01974700|11166603|FG000|NOT COMPLETED|Overall Study||0
10041796|NCT01974700|11166604|FG001|NOT COMPLETED|Overall Study||0
10041797|NCT01974752|11166612|FG000|STARTED|Overall Study||97
10041798|NCT01974752|11166613|FG001|STARTED|Overall Study||32
10041799|NCT01974752|11166612|FG000|COMPLETED|Overall Study||60
10041800|NCT01974752|11166613|FG001|COMPLETED|Overall Study||17
10041801|NCT01974752|11166612|FG000|NOT COMPLETED|Overall Study||37
10041802|NCT01974752|11166613|FG001|NOT COMPLETED|Overall Study||15
10041803|NCT01974817|11166619|FG000|STARTED|Overall Study||25
10041804|NCT01974817|11166619|FG000|COMPLETED|Overall Study||17
10041805|NCT01974817|11166619|FG000|NOT COMPLETED|Overall Study||8
10041806|NCT01974895|11166625|FG000|STARTED|Overall Study||158
10041807|NCT01974895|11166626|FG001|STARTED|Overall Study||156
10041808|NCT01974895|11166625|FG000|COMPLETED|Overall Study||143
10041809|NCT01974895|11166626|FG001|COMPLETED|Overall Study||141
10041810|NCT01974895|11166625|FG000|NOT COMPLETED|Overall Study||15
10041811|NCT01974895|11166626|FG001|NOT COMPLETED|Overall Study||15
10041812|NCT01975090|11166632|FG000|STARTED|Overall Study||129
10041813|NCT01975090|11166632|FG000|6-month Follow-up|Overall Study||117
10041814|NCT01975090|11166632|FG000|COMPLETED|Overall Study||117
10041815|NCT01975090|11166632|FG000|NOT COMPLETED|Overall Study||12
10041816|NCT01975220|11166645|FG000|STARTED|Test Period 1||12
10041817|NCT01975220|11166646|FG001|STARTED|Test Period 1||12
10041818|NCT01975220|11166647|FG002|STARTED|Test Period 1||12
10041819|NCT01975220|11166648|FG003|STARTED|Test Period 1||12
10041820|NCT01975220|11166649|FG004|STARTED|Test Period 1||12
10041821|NCT01975220|11166650|FG005|STARTED|Test Period 1||12
10041822|NCT01975220|11166645|FG000|COMPLETED|Test Period 1||12
10041823|NCT01975220|11166646|FG001|COMPLETED|Test Period 1||11
10041824|NCT01975220|11166647|FG002|COMPLETED|Test Period 1||12
10041825|NCT01975220|11166648|FG003|COMPLETED|Test Period 1||12
10041826|NCT01975220|11166649|FG004|COMPLETED|Test Period 1||12
10041827|NCT01975220|11166650|FG005|COMPLETED|Test Period 1||12
10041828|NCT01975220|11166645|FG000|NOT COMPLETED|Test Period 1||0
9706402|NCT03617523|10805431|FG001|COMPLETED|Overall Study||30
9706403|NCT03617523|10805432|FG002|COMPLETED|Overall Study||61
9706404|NCT03617523|10805433|FG003|COMPLETED|Overall Study||59
9706405|NCT03617523|10805434|FG004|COMPLETED|Overall Study||60
9706406|NCT03617523|10805430|FG000|NOT COMPLETED|Overall Study||0
9706407|NCT03617523|10805431|FG001|NOT COMPLETED|Overall Study||0
10041829|NCT01975220|11166646|FG001|NOT COMPLETED|Test Period 1||1
10041830|NCT01975220|11166647|FG002|NOT COMPLETED|Test Period 1||0
10041831|NCT01975220|11166648|FG003|NOT COMPLETED|Test Period 1||0
10041832|NCT01975220|11166649|FG004|NOT COMPLETED|Test Period 1||0
10041833|NCT01975220|11166650|FG005|NOT COMPLETED|Test Period 1||0
10041834|NCT01975220|11166645|FG000|STARTED|Test Period 2||12
10041835|NCT01975220|11166646|FG001|STARTED|Test Period 2||11
10041836|NCT01975220|11166647|FG002|STARTED|Test Period 2||12
10041837|NCT01975220|11166648|FG003|STARTED|Test Period 2||12
10041838|NCT01975220|11166649|FG004|STARTED|Test Period 2||12
10041839|NCT01975220|11166650|FG005|STARTED|Test Period 2||12
10041840|NCT01975220|11166645|FG000|COMPLETED|Test Period 2||12
10041841|NCT01975220|11166646|FG001|COMPLETED|Test Period 2||11
10041842|NCT01975220|11166647|FG002|COMPLETED|Test Period 2||12
10041843|NCT01975220|11166648|FG003|COMPLETED|Test Period 2||12
10041844|NCT01975220|11166649|FG004|COMPLETED|Test Period 2||12
10041845|NCT01975220|11166650|FG005|COMPLETED|Test Period 2||12
10041846|NCT01975220|11166645|FG000|NOT COMPLETED|Test Period 2||0
10041847|NCT01975220|11166646|FG001|NOT COMPLETED|Test Period 2||0
10041848|NCT01975220|11166647|FG002|NOT COMPLETED|Test Period 2||0
10041849|NCT01975220|11166648|FG003|NOT COMPLETED|Test Period 2||0
10041850|NCT01975220|11166649|FG004|NOT COMPLETED|Test Period 2||0
10041851|NCT01975220|11166650|FG005|NOT COMPLETED|Test Period 2||0
10116927|NCT02533726|11247556|FG000|COMPLETED|Treatment||709
10116928|NCT02533726|11247557|FG001|COMPLETED|Treatment||603
10116929|NCT02533726|11247556|FG000|NOT COMPLETED|Treatment||0
10116930|NCT02533726|11247557|FG001|NOT COMPLETED|Treatment||0
10116931|NCT02533921|11247565|FG000|STARTED|Overall Study||104
10116932|NCT02533921|11247566|FG001|STARTED|Overall Study||106
10116933|NCT02533921|11247565|FG000|COMPLETED|Overall Study||88
10116934|NCT02533921|11247566|FG001|COMPLETED|Overall Study||95
10116935|NCT02533921|11247565|FG000|NOT COMPLETED|Overall Study||16
10116936|NCT02533921|11247566|FG001|NOT COMPLETED|Overall Study||11
10116937|NCT02533934|11247574|FG000|STARTED|Overall Study||42
10116938|NCT02533934|11247575|FG001|STARTED|Overall Study||26
10116939|NCT02533934|11247574|FG000|COMPLETED|Overall Study||42
10116940|NCT02533934|11247575|FG001|COMPLETED|Overall Study||26
10116941|NCT02533934|11247574|FG000|NOT COMPLETED|Overall Study||0
10116942|NCT02533934|11247575|FG001|NOT COMPLETED|Overall Study||0
10116943|NCT02533999|11247583|FG000|STARTED|Overall Study||38
10116944|NCT02533999|11247584|FG001|STARTED|Overall Study||37
10116945|NCT02533999|11247583|FG000|COMPLETED|Overall Study||32
10116946|NCT02533999|11247584|FG001|COMPLETED|Overall Study||30
10116947|NCT02533999|11247583|FG000|NOT COMPLETED|Overall Study||6
10116948|NCT02533999|11247584|FG001|NOT COMPLETED|Overall Study||7
10116949|NCT02534129|11247590|FG000|STARTED|Overall Study||13
9706408|NCT03617523|10805432|FG002|NOT COMPLETED|Overall Study||0
9706409|NCT03617523|10805433|FG003|NOT COMPLETED|Overall Study||0
10041852|NCT01975246|11166667|FG000|STARTED|Overall Study||149
10041853|NCT01975246|11166668|FG001|STARTED|Overall Study||160
10041854|NCT01975246|11166667|FG000|COMPLETED|Overall Study||145
10041855|NCT01975246|11166668|FG001|COMPLETED|Overall Study||158
10041856|NCT01975246|11166667|FG000|NOT COMPLETED|Overall Study||4
10041857|NCT01975246|11166668|FG001|NOT COMPLETED|Overall Study||2
10041858|NCT01975285|11166676|FG000|STARTED|Overall Study||30
10041859|NCT01975285|11166677|FG001|STARTED|Overall Study||30
10041860|NCT01975285|11166676|FG000|COMPLETED|Overall Study||28
10041861|NCT01975285|11166677|FG001|COMPLETED|Overall Study||28
10041862|NCT01975285|11166676|FG000|NOT COMPLETED|Overall Study||2
10041863|NCT01975285|11166677|FG001|NOT COMPLETED|Overall Study||2
10041864|NCT01975376|11166685|FG000|STARTED|Overall Study||8390
10041865|NCT01975376|11166686|FG001|STARTED|Overall Study||8394
10041866|NCT01975376|11166685|FG000|Treated|Overall Study||8374
10041867|NCT01975376|11166686|FG001|Treated|Overall Study||8386
10041868|NCT01975376|11166685|FG000|COMPLETED|Overall Study||8164
10041869|NCT01975376|11166686|FG001|COMPLETED|Overall Study||8177
10041870|NCT01975376|11166685|FG000|NOT COMPLETED|Overall Study||226
10041871|NCT01975376|11166686|FG001|NOT COMPLETED|Overall Study||217
10041872|NCT01975389|11166694|FG000|STARTED|Overall Study||5283
10041873|NCT01975389|11166695|FG001|STARTED|Overall Study||5281
10041874|NCT01975389|11166694|FG000|Treated|Overall Study||5279
10041875|NCT01975389|11166695|FG001|Treated|Overall Study||5276
10041876|NCT01975389|11166694|FG000|COMPLETED|Overall Study||5031
10041877|NCT01975389|11166695|FG001|COMPLETED|Overall Study||5045
10041878|NCT01975389|11166694|FG000|NOT COMPLETED|Overall Study||252
10041879|NCT01975389|11166695|FG001|NOT COMPLETED|Overall Study||236
10041880|NCT01975428|11166703|FG000|STARTED|Overall Study||85
10041881|NCT01975428|11166704|FG001|STARTED|Overall Study||97
10041882|NCT01975428|11166703|FG000|COMPLETED|Overall Study||65
10041883|NCT01975428|11166704|FG001|COMPLETED|Overall Study||83
10041884|NCT01975428|11166703|FG000|NOT COMPLETED|Overall Study||20
10041885|NCT01975428|11166704|FG001|NOT COMPLETED|Overall Study||14
10041886|NCT01975519|11166712|FG000|STARTED|Overall Study||3
10041887|NCT01975519|11166713|FG001|STARTED|Overall Study||108
10041888|NCT01975519|11166712|FG000|Phase 1b|Overall Study||3
10041889|NCT01975519|11166713|FG001|Phase 1b|Overall Study||23
10041890|NCT01975519|11166712|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0
10041891|NCT01975519|11166713|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63
10041892|NCT01975519|11166712|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0
10041893|NCT01975519|11166713|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22
10041894|NCT01975519|11166712|FG000|COMPLETED|Overall Study||3
10041895|NCT01975519|11166713|FG001|COMPLETED|Overall Study||108
10041896|NCT01975519|11166712|FG000|NOT COMPLETED|Overall Study||0
10041897|NCT01975519|11166713|FG001|NOT COMPLETED|Overall Study||0
10041898|NCT01975675|11166731|FG000|STARTED|Overall Study||83
10041899|NCT01975675|11166732|FG001|STARTED|Overall Study||83
10041900|NCT01975675|11166733|FG002|STARTED|Overall Study||88
10041901|NCT01975675|11166734|FG003|STARTED|Overall Study||87
10041902|NCT01975675|11166731|FG000|COMPLETED|Overall Study||83
10041903|NCT01975675|11166732|FG001|COMPLETED|Overall Study||82
10041904|NCT01975675|11166733|FG002|COMPLETED|Overall Study||88
10041905|NCT01975675|11166734|FG003|COMPLETED|Overall Study||87
10041906|NCT01975675|11166731|FG000|NOT COMPLETED|Overall Study||0
10041907|NCT01975675|11166732|FG001|NOT COMPLETED|Overall Study||1
10041908|NCT01975675|11166733|FG002|NOT COMPLETED|Overall Study||0
10041909|NCT01975675|11166734|FG003|NOT COMPLETED|Overall Study||0
10041910|NCT01975701|11166744|FG000|STARTED|Overall Study||26
10041911|NCT01975701|11166744|FG000|COMPLETED|Overall Study||1
10041912|NCT01975701|11166744|FG000|NOT COMPLETED|Overall Study||25
10041913|NCT01975831|11166757|FG000|STARTED|Overall Study||3
10041914|NCT01975831|11166758|FG001|STARTED|Overall Study||11
10041915|NCT01975831|11166759|FG002|STARTED|Overall Study||4
10041916|NCT01975831|11166760|FG003|STARTED|Overall Study||4
10041917|NCT01975831|11166761|FG004|STARTED|Overall Study||19
10041918|NCT01975831|11166762|FG005|STARTED|Overall Study||16
10041919|NCT01975831|11166763|FG006|STARTED|Overall Study||16
10041920|NCT01975831|11166764|FG007|STARTED|Overall Study||16
10041921|NCT01975831|11166765|FG008|STARTED|Overall Study||15
10041922|NCT01975831|11166757|FG000|COMPLETED|Overall Study||0
10041923|NCT01975831|11166758|FG001|COMPLETED|Overall Study||2
10041924|NCT01975831|11166759|FG002|COMPLETED|Overall Study||0
10041925|NCT01975831|11166760|FG003|COMPLETED|Overall Study||0
10041926|NCT01975831|11166761|FG004|COMPLETED|Overall Study||1
10041927|NCT01975831|11166762|FG005|COMPLETED|Overall Study||2
10041928|NCT01975831|11166763|FG006|COMPLETED|Overall Study||0
10041929|NCT01975831|11166764|FG007|COMPLETED|Overall Study||1
10041930|NCT01975831|11166765|FG008|COMPLETED|Overall Study||3
10041931|NCT01975831|11166757|FG000|NOT COMPLETED|Overall Study||3
10041932|NCT01975831|11166758|FG001|NOT COMPLETED|Overall Study||9
10041933|NCT01975831|11166759|FG002|NOT COMPLETED|Overall Study||4
10041934|NCT01975831|11166760|FG003|NOT COMPLETED|Overall Study||4
10041935|NCT01975831|11166761|FG004|NOT COMPLETED|Overall Study||18
10041936|NCT01975831|11166762|FG005|NOT COMPLETED|Overall Study||14
10041937|NCT01975831|11166763|FG006|NOT COMPLETED|Overall Study||16
10041938|NCT01975831|11166764|FG007|NOT COMPLETED|Overall Study||15
10041939|NCT01975831|11166765|FG008|NOT COMPLETED|Overall Study||12
10041940|NCT01975909|11166787|FG000|STARTED|Overall Study||10
10041941|NCT01975909|11166788|FG001|STARTED|Overall Study||10
10041942|NCT01975909|11166787|FG000|COMPLETED|Overall Study||10
10041943|NCT01975909|11166788|FG001|COMPLETED|Overall Study||10
10041944|NCT01975909|11166787|FG000|NOT COMPLETED|Overall Study||0
10041945|NCT01975909|11166788|FG001|NOT COMPLETED|Overall Study||0
10041946|NCT01975922|11166796|FG000|STARTED|Overall Study||45
10041947|NCT01975922|11166797|FG001|STARTED|Overall Study||52
10041948|NCT01975922|11166796|FG000|COMPLETED|Overall Study||45
10041949|NCT01975922|11166797|FG001|COMPLETED|Overall Study||43
10041950|NCT01975922|11166796|FG000|NOT COMPLETED|Overall Study||0
10041951|NCT01975922|11166797|FG001|NOT COMPLETED|Overall Study||9
10041952|NCT01975935|11166805|FG000|STARTED|Overall Study||21
10041953|NCT01975935|11166806|FG001|STARTED|Overall Study||21
10041954|NCT01975935|11166805|FG000|COMPLETED|Overall Study||18
10041955|NCT01975935|11166806|FG001|COMPLETED|Overall Study||20
10041956|NCT01975935|11166805|FG000|NOT COMPLETED|Overall Study||3
10041957|NCT01975935|11166806|FG001|NOT COMPLETED|Overall Study||1
10041958|NCT01975948|11166816|FG000|STARTED|Overall Study||56
10041959|NCT01975948|11166817|FG001|STARTED|Overall Study||55
10041960|NCT01975948|11166818|FG002|STARTED|Overall Study||72
10041961|NCT01975948|11166819|FG003|STARTED|Overall Study||57
10041962|NCT01975948|11166816|FG000|COMPLETED|Overall Study||39
10041963|NCT01975948|11166817|FG001|COMPLETED|Overall Study||34
10041964|NCT01975948|11166818|FG002|COMPLETED|Overall Study||65
10041965|NCT01975948|11166819|FG003|COMPLETED|Overall Study||51
10041966|NCT01975948|11166816|FG000|NOT COMPLETED|Overall Study||17
10041967|NCT01975948|11166817|FG001|NOT COMPLETED|Overall Study||21
10041968|NCT01975948|11166818|FG002|NOT COMPLETED|Overall Study||7
10041969|NCT01975948|11166819|FG003|NOT COMPLETED|Overall Study||6
10041970|NCT01975974|11166829|FG000|STARTED|Overall Study||100
10041971|NCT01975974|11166829|FG000|COMPLETED|Overall Study||100
10041972|NCT01975974|11166829|FG000|NOT COMPLETED|Overall Study||0
10041973|NCT01976104|11166837|FG000|STARTED|Overall Study||43
10041974|NCT01976104|11166838|FG001|STARTED|Overall Study||70
10041975|NCT01976104|11166839|FG002|STARTED|Overall Study||33
10041976|NCT01976104|11166840|FG003|STARTED|Overall Study||58
10041977|NCT01976104|11166837|FG000|COMPLETED|Overall Study||37
10041978|NCT01976104|11166838|FG001|COMPLETED|Overall Study||68
10041979|NCT01976104|11166839|FG002|COMPLETED|Overall Study||31
10041980|NCT01976104|11166840|FG003|COMPLETED|Overall Study||55
10041981|NCT01976104|11166837|FG000|NOT COMPLETED|Overall Study||6
10041982|NCT01976104|11166838|FG001|NOT COMPLETED|Overall Study||2
10041983|NCT01976104|11166839|FG002|NOT COMPLETED|Overall Study||2
10041984|NCT01976104|11166840|FG003|NOT COMPLETED|Overall Study||3
10041985|NCT01976299|11166853|FG000|STARTED|Overall Study||292
10041986|NCT01976299|11166854|FG001|STARTED|Overall Study||286
10041987|NCT01976299|11166853|FG000|Completed Procedure|Overall Study||283
10041988|NCT01976299|11166854|FG001|Completed Procedure|Overall Study||284
10041989|NCT01976299|11166853|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
10041990|NCT01976299|11166854|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
10041991|NCT01976299|11166853|FG000|NOT COMPLETED|Overall Study||23
10041992|NCT01976299|11166854|FG001|NOT COMPLETED|Overall Study||6
10041993|NCT01976312|11166862|FG000|STARTED|Overall Study||190
10041994|NCT01976312|11166863|FG001|STARTED|Overall Study||62
10041995|NCT01976312|11166862|FG000|Completed 3 Months|Overall Study||186
10041996|NCT01976312|11166863|FG001|Completed 3 Months|Overall Study||60
10041997|NCT01976312|11166862|FG000|Discontinued Study Prior to 3 Months|Overall Study||4
10041998|NCT01976312|11166863|FG001|Discontinued Study Prior to 3 Months|Overall Study||2
10041999|NCT01976312|11166862|FG000|COMPLETED|Overall Study|Completed study at 12 months|173
10042000|NCT01976312|11166863|FG001|COMPLETED|Overall Study|Completed study at 12 months|53
10042001|NCT01976312|11166862|FG000|NOT COMPLETED|Overall Study||17
10042002|NCT01976312|11166863|FG001|NOT COMPLETED|Overall Study||9
10042003|NCT01976338|11166872|FG000|STARTED|Overall Study||190
10042004|NCT01976338|11166873|FG001|STARTED|Overall Study||93
10042005|NCT01976338|11166872|FG000|Completed 6 Months|Overall Study||185
10116950|NCT02534129|11247591|FG001|STARTED|Overall Study||13
10116951|NCT02534129|11247590|FG000|COMPLETED|Overall Study||13
10116952|NCT02534129|11247591|FG001|COMPLETED|Overall Study||13
10116953|NCT02534129|11247590|FG000|NOT COMPLETED|Overall Study||0
10116954|NCT02534129|11247591|FG001|NOT COMPLETED|Overall Study||0
10116955|NCT02534285|11247599|FG000|STARTED|Overall Study||50
10116956|NCT02534285|11247600|FG001|STARTED|Overall Study||50
10116957|NCT02534285|11247599|FG000|COMPLETED|Overall Study||50
10116958|NCT02534285|11247600|FG001|COMPLETED|Overall Study||50
10116959|NCT02534285|11247599|FG000|NOT COMPLETED|Overall Study||0
10116960|NCT02534285|11247600|FG001|NOT COMPLETED|Overall Study||0
10116961|NCT02534324|11247608|FG000|STARTED|Overall Study||98
10116962|NCT02534324|11247609|FG001|STARTED|Overall Study||48
10116963|NCT02534324|11247608|FG000|COMPLETED|Overall Study||73
10116964|NCT02534324|11247609|FG001|COMPLETED|Overall Study||40
10042006|NCT01976338|11166873|FG001|Completed 6 Months|Overall Study||91
10042007|NCT01976338|11166872|FG000|Discontinued Study Prior to 6 Months|Overall Study||5
10042008|NCT01976338|11166873|FG001|Discontinued Study Prior to 6 Months|Overall Study||2
10116965|NCT02534324|11247608|FG000|NOT COMPLETED|Overall Study||25
10116966|NCT02534324|11247609|FG001|NOT COMPLETED|Overall Study||8
10042009|NCT01976338|11166872|FG000|COMPLETED|Overall Study|12 months|177
10042010|NCT01976338|11166873|FG001|COMPLETED|Overall Study|12 months|89
10042011|NCT01976338|11166872|FG000|NOT COMPLETED|Overall Study||13
10042012|NCT01976338|11166873|FG001|NOT COMPLETED|Overall Study||4
10042013|NCT01976364|11166880|FG000|STARTED|Main Study (36 Months)||686
10042014|NCT01976364|11166881|FG001|STARTED|Main Study (36 Months)||0
10042015|NCT01976364|11166882|FG002|STARTED|Main Study (36 Months)||0
10042016|NCT01976364|11166880|FG000|COMPLETED|Main Study (36 Months)||465
10042017|NCT01976364|11166881|FG001|COMPLETED|Main Study (36 Months)||0
10042018|NCT01976364|11166882|FG002|COMPLETED|Main Study (36 Months)||0
10042019|NCT01976364|11166880|FG000|NOT COMPLETED|Main Study (36 Months)||221
10042020|NCT01976364|11166881|FG001|NOT COMPLETED|Main Study (36 Months)||0
10042021|NCT01976364|11166882|FG002|NOT COMPLETED|Main Study (36 Months)||0
10042022|NCT01976364|11166880|FG000|STARTED|Sub-study (12 Months)||0
10042023|NCT01976364|11166881|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
10042024|NCT01976364|11166882|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
10042025|NCT01976364|11166880|FG000|COMPLETED|Sub-study (12 Months)||0
10042026|NCT01976364|11166881|FG001|COMPLETED|Sub-study (12 Months)||83
10042027|NCT01976364|11166882|FG002|COMPLETED|Sub-study (12 Months)||85
10042028|NCT01976364|11166880|FG000|NOT COMPLETED|Sub-study (12 Months)||0
10042029|NCT01976364|11166881|FG001|NOT COMPLETED|Sub-study (12 Months)||6
10042030|NCT01976364|11166882|FG002|NOT COMPLETED|Sub-study (12 Months)||5
10042031|NCT01976390|11166893|FG000|STARTED|Overall Study||41
10042032|NCT01976390|11166894|FG001|STARTED|Overall Study||19
10042033|NCT01976390|11166893|FG000|COMPLETED|Overall Study||41
10042034|NCT01976390|11166894|FG001|COMPLETED|Overall Study||19
10042035|NCT01976390|11166893|FG000|NOT COMPLETED|Overall Study||0
10042036|NCT01976390|11166894|FG001|NOT COMPLETED|Overall Study||0
10042037|NCT01976416|11166902|FG000|STARTED|Overall Study||104
10042038|NCT01976416|11166903|FG001|STARTED|Overall Study||104
10042039|NCT01976416|11166902|FG000|COMPLETED|Overall Study||102
10042040|NCT01976416|11166903|FG001|COMPLETED|Overall Study||102
10042041|NCT01976416|11166902|FG000|NOT COMPLETED|Overall Study||2
10042042|NCT01976416|11166903|FG001|NOT COMPLETED|Overall Study||2
10042043|NCT01976442|11166911|FG000|STARTED|Overall Study||69
10042044|NCT01976442|11166912|FG001|STARTED|Overall Study||31
10042045|NCT01976442|11166911|FG000|COMPLETED|Overall Study||69
10042046|NCT01976442|11166912|FG001|COMPLETED|Overall Study||31
10042047|NCT01976442|11166911|FG000|NOT COMPLETED|Overall Study||0
10042048|NCT01976442|11166912|FG001|NOT COMPLETED|Overall Study||0
10042049|NCT01976507|11166918|FG000|STARTED|Overall Study||101
10042050|NCT01976507|11166918|FG000|Received Initial Dose of Dabigatran|Overall Study||100
10042051|NCT01976507|11166918|FG000|COMPLETED|Overall Study||94
10042052|NCT01976507|11166918|FG000|NOT COMPLETED|Overall Study||7
10042053|NCT01976572|11166922|FG000|STARTED|Overall Study||6
10042054|NCT01976572|11166923|FG001|STARTED|Overall Study||6
10042055|NCT01976572|11166924|FG002|STARTED|Overall Study||6
10042056|NCT01976572|11166922|FG000|COMPLETED|Overall Study||6
10042057|NCT01976572|11166923|FG001|COMPLETED|Overall Study||6
10042058|NCT01976572|11166924|FG002|COMPLETED|Overall Study||6
10042059|NCT01976572|11166922|FG000|NOT COMPLETED|Overall Study||0
10042060|NCT01976572|11166923|FG001|NOT COMPLETED|Overall Study||0
10042061|NCT01976572|11166924|FG002|NOT COMPLETED|Overall Study||0
10042062|NCT01976624|11166933|FG000|STARTED|Overall Study||756
10042063|NCT01976624|11166933|FG000|COMPLETED|Overall Study||742
10042064|NCT01976624|11166933|FG000|NOT COMPLETED|Overall Study||14
10042065|NCT01976650|11166937|FG000|STARTED|Overall Study||724
10042066|NCT01976650|11166937|FG000|COMPLETED|Overall Study||718
10042067|NCT01976650|11166937|FG000|NOT COMPLETED|Overall Study||6
10042068|NCT01976663|11166941|FG000|STARTED|Overall Study||126
10042069|NCT01976663|11166941|FG000|Received Touch-up Treatment|Overall Study||63
10042070|NCT01976663|11166941|FG000|Received Asymmetry Correction|Overall Study||45
10042071|NCT01976663|11166941|FG000|Received Repeat Treatment|Overall Study||85
10042072|NCT01976663|11166941|FG000|COMPLETED|Overall Study||84
10042073|NCT01976663|11166941|FG000|NOT COMPLETED|Overall Study||42
10042074|NCT01976728|11166953|FG000|STARTED|Overall Study||10
10042075|NCT01976728|11166954|FG001|STARTED|Overall Study||9
10042076|NCT01976728|11166955|FG002|STARTED|Overall Study||10
10042077|NCT01976728|11166956|FG003|STARTED|Overall Study||10
10042078|NCT01976728|11166953|FG000|Dosed|Overall Study||10
10042079|NCT01976728|11166954|FG001|Dosed|Overall Study||9
10042080|NCT01976728|11166955|FG002|Dosed|Overall Study||10
10042081|NCT01976728|11166956|FG003|Dosed|Overall Study||10
10042082|NCT01976728|11166953|FG000|COMPLETED|Overall Study||9
10042083|NCT01976728|11166954|FG001|COMPLETED|Overall Study||9
10042084|NCT01976728|11166955|FG002|COMPLETED|Overall Study||10
10042085|NCT01976728|11166956|FG003|COMPLETED|Overall Study||10
10042086|NCT01976728|11166953|FG000|NOT COMPLETED|Overall Study||1
10042087|NCT01976728|11166954|FG001|NOT COMPLETED|Overall Study||0
10042088|NCT01976728|11166955|FG002|NOT COMPLETED|Overall Study||0
10042089|NCT01976728|11166956|FG003|NOT COMPLETED|Overall Study||0
10042090|NCT01976741|11166992|FG000|STARTED|Overall Study||4
10042091|NCT01976741|11166993|FG001|STARTED|Overall Study||4
10042092|NCT01976741|11166994|FG002|STARTED|Overall Study||4
10042093|NCT01976741|11166995|FG003|STARTED|Overall Study||3
10042094|NCT01976741|11166996|FG004|STARTED|Overall Study||4
10042095|NCT01976741|11166997|FG005|STARTED|Overall Study||4
10042096|NCT01976741|11166998|FG006|STARTED|Overall Study||23
10042097|NCT01976741|11166999|FG007|STARTED|Overall Study||74
10042098|NCT01976741|11167000|FG008|STARTED|Overall Study||8
10042099|NCT01976741|11167001|FG009|STARTED|Overall Study||40
10042100|NCT01976741|11166992|FG000|COMPLETED|Overall Study||3
10042101|NCT01976741|11166993|FG001|COMPLETED|Overall Study||4
10042102|NCT01976741|11166994|FG002|COMPLETED|Overall Study||1
10042103|NCT01976741|11166995|FG003|COMPLETED|Overall Study||2
10042104|NCT01976741|11166996|FG004|COMPLETED|Overall Study||4
10042105|NCT01976741|11166997|FG005|COMPLETED|Overall Study||4
10042106|NCT01976741|11166998|FG006|COMPLETED|Overall Study||19
10042107|NCT01976741|11166999|FG007|COMPLETED|Overall Study||62
10042108|NCT01976741|11167000|FG008|COMPLETED|Overall Study||7
10042109|NCT01976741|11167001|FG009|COMPLETED|Overall Study||36
10042110|NCT01976741|11166992|FG000|NOT COMPLETED|Overall Study||1
10042111|NCT01976741|11166993|FG001|NOT COMPLETED|Overall Study||0
10042112|NCT01976741|11166994|FG002|NOT COMPLETED|Overall Study||3
10042113|NCT01976741|11166995|FG003|NOT COMPLETED|Overall Study||1
10042114|NCT01976741|11166996|FG004|NOT COMPLETED|Overall Study||0
10042115|NCT01976741|11166997|FG005|NOT COMPLETED|Overall Study||0
10042116|NCT01976741|11166998|FG006|NOT COMPLETED|Overall Study||4
10042117|NCT01976741|11166999|FG007|NOT COMPLETED|Overall Study||12
10042118|NCT01976741|11167000|FG008|NOT COMPLETED|Overall Study||1
10042119|NCT01976741|11167001|FG009|NOT COMPLETED|Overall Study||4
10042120|NCT01976806|11167037|FG000|STARTED|Overall Study||27
10042121|NCT01976806|11167038|FG001|STARTED|Overall Study||28
10042122|NCT01976806|11167037|FG000|COMPLETED|Overall Study||24
10042123|NCT01976806|11167038|FG001|COMPLETED|Overall Study||22
10042124|NCT01976806|11167037|FG000|NOT COMPLETED|Overall Study||3
10042125|NCT01976806|11167038|FG001|NOT COMPLETED|Overall Study||6
10042126|NCT01976819|11167044|FG000|STARTED|Overall Study||16
10042127|NCT01976819|11167044|FG000|COMPLETED|Overall Study||11
10116967|NCT02534350|11247617|FG000|STARTED|Overall Study||41
10116968|NCT02534350|11247618|FG001|STARTED|Overall Study||20
10116969|NCT02534350|11247617|FG000|COMPLETED|Overall Study||37
10116970|NCT02534350|11247618|FG001|COMPLETED|Overall Study||20
10116971|NCT02534350|11247617|FG000|NOT COMPLETED|Overall Study||4
10116972|NCT02534350|11247618|FG001|NOT COMPLETED|Overall Study||0
10116973|NCT02534493|11247624|FG000|STARTED|Overall Study||13
10116974|NCT02534493|11247624|FG000|COMPLETED|Overall Study||11
10116975|NCT02534493|11247624|FG000|NOT COMPLETED|Overall Study||2
10116976|NCT02534883|11247632|FG000|STARTED|Overall Study||8
10116977|NCT02534883|11247633|FG001|STARTED|Overall Study||3
10116978|NCT02534883|11247632|FG000|COMPLETED|Overall Study||0
10116979|NCT02534883|11247633|FG001|COMPLETED|Overall Study||0
10116980|NCT02534883|11247632|FG000|NOT COMPLETED|Overall Study||8
10116981|NCT02534883|11247633|FG001|NOT COMPLETED|Overall Study||3
10116982|NCT02534896|11247642|FG000|STARTED|Overall Study||49
10116983|NCT02534896|11247643|FG001|STARTED|Overall Study||52
10116984|NCT02534896|11247644|FG002|STARTED|Overall Study||49
10116985|NCT02534896|11247642|FG000|COMPLETED|Overall Study||45
10116986|NCT02534896|11247643|FG001|COMPLETED|Overall Study||51
10116987|NCT02534896|11247644|FG002|COMPLETED|Overall Study||48
10116988|NCT02534896|11247642|FG000|NOT COMPLETED|Overall Study||4
10116989|NCT02534896|11247643|FG001|NOT COMPLETED|Overall Study||1
10116990|NCT02534896|11247644|FG002|NOT COMPLETED|Overall Study||1
10116991|NCT02534935|11247655|FG000|STARTED|Stage 1: 24 Months||44
10116992|NCT02534935|11247656|FG001|STARTED|Stage 1: 24 Months||220
10116993|NCT02534935|11247657|FG002|STARTED|Stage 1: 24 Months||132
10116994|NCT02534935|11247655|FG000|COMPLETED|Stage 1: 24 Months||44
10116995|NCT02534935|11247656|FG001|COMPLETED|Stage 1: 24 Months||210
10116996|NCT02534935|11247657|FG002|COMPLETED|Stage 1: 24 Months||127
10116997|NCT02534935|11247655|FG000|NOT COMPLETED|Stage 1: 24 Months||0
10116998|NCT02534935|11247656|FG001|NOT COMPLETED|Stage 1: 24 Months||10
10116999|NCT02534935|11247657|FG002|NOT COMPLETED|Stage 1: 24 Months||5
10117000|NCT02534935|11247655|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40
10117001|NCT02534935|11247656|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174
10117002|NCT02534935|11247657|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0
10117003|NCT02534935|11247655|FG000|COMPLETED|Stage 2: 8 Months||40
10117004|NCT02534935|11247656|FG001|COMPLETED|Stage 2: 8 Months||170
10117005|NCT02534935|11247657|FG002|COMPLETED|Stage 2: 8 Months||0
10117006|NCT02534935|11247655|FG000|NOT COMPLETED|Stage 2: 8 Months||0
10117007|NCT02534935|11247656|FG001|NOT COMPLETED|Stage 2: 8 Months||4
10117008|NCT02534935|11247657|FG002|NOT COMPLETED|Stage 2: 8 Months||0
10117009|NCT02534935|11247655|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0
10117010|NCT02534935|11247656|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148
10117011|NCT02534935|11247657|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0
10117012|NCT02534935|11247655|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0
10117013|NCT02534935|11247656|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147
10117014|NCT02534935|11247657|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0
10117015|NCT02534935|11247655|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
10117016|NCT02534935|11247656|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1
10042128|NCT01976819|11167044|FG000|NOT COMPLETED|Overall Study||5
10042129|NCT01976845|11167056|FG000|STARTED|Overall Study||48
10042130|NCT01976845|11167057|FG001|STARTED|Overall Study||48
10042131|NCT01976845|11167058|FG002|STARTED|Overall Study||43
10042132|NCT01976845|11167056|FG000|COMPLETED|Overall Study||40
10042133|NCT01976845|11167057|FG001|COMPLETED|Overall Study||40
10042134|NCT01976845|11167058|FG002|COMPLETED|Overall Study||40
10042135|NCT01976845|11167056|FG000|NOT COMPLETED|Overall Study||8
10042136|NCT01976845|11167057|FG001|NOT COMPLETED|Overall Study||8
10042137|NCT01976845|11167058|FG002|NOT COMPLETED|Overall Study||3
10042138|NCT01976871|11167066|FG000|STARTED|Overall Study||21
10042139|NCT01976871|11167066|FG000|COMPLETED|Overall Study||20
10042140|NCT01976871|11167066|FG000|NOT COMPLETED|Overall Study||1
10042141|NCT01976975|11167072|FG000|STARTED|Overall Study||226
10042142|NCT01976975|11167073|FG001|STARTED|Overall Study||44
10042143|NCT01976975|11167072|FG000|COMPLETED|Overall Study||79
10042144|NCT01976975|11167073|FG001|COMPLETED|Overall Study||32
10042145|NCT01976975|11167072|FG000|NOT COMPLETED|Overall Study||147
10042146|NCT01976975|11167073|FG001|NOT COMPLETED|Overall Study||12
10042147|NCT01976988|11167081|FG000|STARTED|Overall Study||208
10042148|NCT01976988|11167082|FG001|STARTED|Overall Study||202
10042149|NCT01976988|11167081|FG000|COMPLETED|Overall Study||192
10042150|NCT01976988|11167082|FG001|COMPLETED|Overall Study||184
10042151|NCT01976988|11167081|FG000|NOT COMPLETED|Overall Study||16
10042152|NCT01976988|11167082|FG001|NOT COMPLETED|Overall Study||18
10042153|NCT01977040|11167090|FG000|STARTED|Overall Study||68
10042154|NCT01977040|11167090|FG000|COMPLETED|Overall Study||66
10042155|NCT01977040|11167090|FG000|NOT COMPLETED|Overall Study||2
10042156|NCT01977092|11167100|FG000|STARTED|Overall Study||149
10042157|NCT01977092|11167101|FG001|STARTED|Overall Study||181
10042158|NCT01977092|11167100|FG000|COMPLETED|Overall Study||118
10042159|NCT01977092|11167101|FG001|COMPLETED|Overall Study||151
10042160|NCT01977092|11167100|FG000|NOT COMPLETED|Overall Study||31
10042161|NCT01977092|11167101|FG001|NOT COMPLETED|Overall Study||30
10042162|NCT01977222|11167107|FG000|STARTED|Overall Study||12
10042163|NCT01977222|11167107|FG000|COMPLETED|Overall Study||11
10042164|NCT01977222|11167107|FG000|NOT COMPLETED|Overall Study||1
10042165|NCT01977352|11167113|FG000|STARTED|Overall Study||21
10042166|NCT01977352|11167114|FG001|STARTED|Overall Study||21
10042167|NCT01977352|11167113|FG000|COMPLETED|Overall Study||20
10042168|NCT01977352|11167114|FG001|COMPLETED|Overall Study||19
10042169|NCT01977352|11167113|FG000|NOT COMPLETED|Overall Study||1
10042170|NCT01977352|11167114|FG001|NOT COMPLETED|Overall Study||2
10042171|NCT01977456|11167120|FG000|STARTED|Overall Study||27
10042172|NCT01977456|11167120|FG000|COMPLETED|Overall Study||22
10042173|NCT01977456|11167120|FG000|NOT COMPLETED|Overall Study||5
10042174|NCT01977482|11167130|FG000|STARTED|Overall Study||39
10042175|NCT01977482|11167131|FG001|STARTED|Overall Study||39
10042176|NCT01977482|11167132|FG002|STARTED|Overall Study||40
10042177|NCT01977482|11167133|FG003|STARTED|Overall Study||39
10042178|NCT01977482|11167134|FG004|STARTED|Overall Study||40
10042179|NCT01977482|11167135|FG005|STARTED|Overall Study||19
10042180|NCT01977482|11167130|FG000|COMPLETED|Overall Study||36
10042181|NCT01977482|11167131|FG001|COMPLETED|Overall Study||30
10042182|NCT01977482|11167132|FG002|COMPLETED|Overall Study||35
10042183|NCT01977482|11167133|FG003|COMPLETED|Overall Study||35
10042184|NCT01977482|11167134|FG004|COMPLETED|Overall Study||37
10042185|NCT01977482|11167135|FG005|COMPLETED|Overall Study||14
10042186|NCT01977482|11167130|FG000|NOT COMPLETED|Overall Study||3
10042187|NCT01977482|11167131|FG001|NOT COMPLETED|Overall Study||9
10042188|NCT01977482|11167132|FG002|NOT COMPLETED|Overall Study||5
10042189|NCT01977482|11167133|FG003|NOT COMPLETED|Overall Study||4
10042190|NCT01977482|11167134|FG004|NOT COMPLETED|Overall Study||3
10042191|NCT01977482|11167135|FG005|NOT COMPLETED|Overall Study||5
10042192|NCT01977547|11167156|FG000|STARTED|Overall Study||768
10042193|NCT01977547|11167157|FG001|STARTED|Overall Study||770
10042194|NCT01977547|11167156|FG000|COMPLETED|Overall Study||728
10042195|NCT01977547|11167157|FG001|COMPLETED|Overall Study||733
10042196|NCT01977547|11167156|FG000|NOT COMPLETED|Overall Study||40
10042197|NCT01977547|11167157|FG001|NOT COMPLETED|Overall Study||37
10042198|NCT01977573|11167167|FG000|STARTED|Overall Study||136
10042199|NCT01977573|11167168|FG001|STARTED|Overall Study||44
10042200|NCT01977573|11167169|FG002|STARTED|Overall Study||36
10042201|NCT01977573|11167170|FG003|STARTED|Overall Study||36
10042202|NCT01977573|11167167|FG000|COMPLETED|Overall Study||116
10042203|NCT01977573|11167168|FG001|COMPLETED|Overall Study||41
10042204|NCT01977573|11167169|FG002|COMPLETED|Overall Study||32
10042205|NCT01977573|11167170|FG003|COMPLETED|Overall Study||33
10042206|NCT01977573|11167167|FG000|NOT COMPLETED|Overall Study||20
10042207|NCT01977573|11167168|FG001|NOT COMPLETED|Overall Study||3
10042208|NCT01977573|11167169|FG002|NOT COMPLETED|Overall Study||4
10042209|NCT01977573|11167170|FG003|NOT COMPLETED|Overall Study||3
10042210|NCT01977599|11167183|FG000|STARTED|Overall Study||1118
10042211|NCT01977599|11167184|FG001|STARTED|Overall Study||1122
10042212|NCT01977599|11167183|FG000|COMPLETED|Overall Study||1118
10042213|NCT01977599|11167184|FG001|COMPLETED|Overall Study||1122
10042214|NCT01977599|11167183|FG000|NOT COMPLETED|Overall Study||0
10042215|NCT01977599|11167184|FG001|NOT COMPLETED|Overall Study||0
10042216|NCT01977612|11167192|FG000|STARTED|Overall Study||85
10042217|NCT01977612|11167193|FG001|STARTED|Overall Study||80
10042218|NCT01977612|11167192|FG000|COMPLETED|Overall Study||84
10042219|NCT01977612|11167193|FG001|COMPLETED|Overall Study||79
10042220|NCT01977612|11167192|FG000|NOT COMPLETED|Overall Study||1
10042221|NCT01977612|11167193|FG001|NOT COMPLETED|Overall Study||1
10042222|NCT01977625|11167199|FG000|STARTED|First Intervention (4 Weeks)||11
10042223|NCT01977625|11167200|FG001|STARTED|First Intervention (4 Weeks)||7
10042224|NCT01977625|11167199|FG000|COMPLETED|First Intervention (4 Weeks)||8
10042225|NCT01977625|11167200|FG001|COMPLETED|First Intervention (4 Weeks)||7
10042226|NCT01977625|11167199|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3
10042227|NCT01977625|11167200|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10042228|NCT01977625|11167199|FG000|STARTED|Washout (2 Weeks)||8
10042229|NCT01977625|11167200|FG001|STARTED|Washout (2 Weeks)||7
10042230|NCT01977625|11167199|FG000|COMPLETED|Washout (2 Weeks)||8
10042231|NCT01977625|11167200|FG001|COMPLETED|Washout (2 Weeks)||7
10042232|NCT01977625|11167199|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10042233|NCT01977625|11167200|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10042234|NCT01977625|11167199|FG000|STARTED|Second Intervention (4 Weeks)||8
10042235|NCT01977625|11167200|FG001|STARTED|Second Intervention (4 Weeks)||7
10042236|NCT01977625|11167199|FG000|COMPLETED|Second Intervention (4 Weeks)||7
10042237|NCT01977625|11167200|FG001|COMPLETED|Second Intervention (4 Weeks)||7
10042238|NCT01977625|11167199|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10042239|NCT01977625|11167200|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10042240|NCT01977651|11167208|FG000|STARTED|4 Month Treatment Period||423
10042241|NCT01977651|11167208|FG000|COMPLETED|4 Month Treatment Period||322
10042242|NCT01977651|11167208|FG000|NOT COMPLETED|4 Month Treatment Period||101
10042243|NCT01977651|11167208|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
10042244|NCT01977651|11167208|FG000|COMPLETED|1 Year Extension Period||157
10042245|NCT01977651|11167208|FG000|NOT COMPLETED|1 Year Extension Period||130
10042246|NCT01977651|11167208|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
10042247|NCT01977651|11167208|FG000|COMPLETED|Post 1 Year Extension Period||1
10042248|NCT01977651|11167208|FG000|NOT COMPLETED|Post 1 Year Extension Period||144
10042249|NCT01977677|11167215|FG000|STARTED|Overall Study||3
10042250|NCT01977677|11167216|FG001|STARTED|Overall Study||6
10042251|NCT01977677|11167217|FG002|STARTED|Overall Study||21
10042252|NCT01977677|11167215|FG000|COMPLETED|Overall Study||3
10042253|NCT01977677|11167216|FG001|COMPLETED|Overall Study||6
10042254|NCT01977677|11167217|FG002|COMPLETED|Overall Study||20
10042255|NCT01977677|11167215|FG000|NOT COMPLETED|Overall Study||0
10042256|NCT01977677|11167216|FG001|NOT COMPLETED|Overall Study||0
10042257|NCT01977677|11167217|FG002|NOT COMPLETED|Overall Study||1
10042258|NCT01977690|11167227|FG000|STARTED|Overall Study||15
10042259|NCT01977690|11167228|FG001|STARTED|Overall Study||15
10042260|NCT01977690|11167227|FG000|COMPLETED|Overall Study||15
10042261|NCT01977690|11167228|FG001|COMPLETED|Overall Study||11
10042262|NCT01977690|11167227|FG000|NOT COMPLETED|Overall Study||0
10042263|NCT01977690|11167228|FG001|NOT COMPLETED|Overall Study||4
10042264|NCT01977781|11167236|FG000|STARTED|Overall Study||24
10042265|NCT01977781|11167237|FG001|STARTED|Overall Study||16
10042266|NCT01977781|11167236|FG000|COMPLETED|Overall Study||18
10042267|NCT01977781|11167237|FG001|COMPLETED|Overall Study||15
10042268|NCT01977781|11167236|FG000|NOT COMPLETED|Overall Study||6
10042269|NCT01977781|11167237|FG001|NOT COMPLETED|Overall Study||1
10042270|NCT01977794|11167245|FG000|STARTED|Overall Study||100
10042271|NCT01977794|11167246|FG001|STARTED|Overall Study||100
10042272|NCT01977794|11167245|FG000|COMPLETED|Overall Study||92
10042273|NCT01977794|11167246|FG001|COMPLETED|Overall Study||94
10042274|NCT01977794|11167245|FG000|NOT COMPLETED|Overall Study||8
10042275|NCT01977794|11167246|FG001|NOT COMPLETED|Overall Study||6
10042276|NCT01977820|11167254|FG000|STARTED|Overall Study||1
10042277|NCT01977820|11167255|FG001|STARTED|Overall Study||1
10042278|NCT01977820|11167254|FG000|COMPLETED|Overall Study||0
10117017|NCT02534935|11247657|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
10117018|NCT02535000|11247685|FG000|STARTED|Overall Study||30
10117019|NCT02535000|11247686|FG001|STARTED|Overall Study||30
10117020|NCT02535000|11247685|FG000|COMPLETED|Overall Study||29
10117021|NCT02535000|11247686|FG001|COMPLETED|Overall Study||28
10117022|NCT02535000|11247685|FG000|NOT COMPLETED|Overall Study||1
10117023|NCT02535000|11247686|FG001|NOT COMPLETED|Overall Study||2
10117024|NCT02535026|11247692|FG000|STARTED|Overall Study||580
10117025|NCT02535026|11247692|FG000|COMPLETED|Overall Study||580
10117026|NCT02535026|11247692|FG000|NOT COMPLETED|Overall Study||0
10117027|NCT02535364|11247706|FG000|STARTED|Part A Screening Through Leukapheresis||82
10117028|NCT02535364|11247706|FG000|COMPLETED|Part A Screening Through Leukapheresis||57
10117029|NCT02535364|11247706|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25
10117030|NCT02535364|11247706|FG000|STARTED|Part B Screening||57
10117031|NCT02535364|11247706|FG000|COMPLETED|Part B Screening||40
10117032|NCT02535364|11247706|FG000|NOT COMPLETED|Part B Screening||17
10117033|NCT02535364|11247706|FG000|STARTED|Study Treatment||40
10117034|NCT02535364|11247706|FG000|COMPLETED|Study Treatment||38
10117035|NCT02535364|11247706|FG000|NOT COMPLETED|Study Treatment||2
10117036|NCT02535364|11247706|FG000|STARTED|12-Month Follow-up Period||38
10117037|NCT02535364|11247706|FG000|COMPLETED|12-Month Follow-up Period||3
10117038|NCT02535364|11247706|FG000|NOT COMPLETED|12-Month Follow-up Period||35
10117039|NCT02535416|11247719|FG000|STARTED|Overall Study||4
10117040|NCT02535416|11247720|FG001|STARTED|Overall Study||2
10117041|NCT02535416|11247721|FG002|STARTED|Overall Study||4
10117042|NCT02535416|11247722|FG003|STARTED|Overall Study||4
10117043|NCT02535416|11247723|FG004|STARTED|Overall Study||4
10117044|NCT02535416|11247724|FG005|STARTED|Overall Study||4
10117045|NCT02535416|11247725|FG006|STARTED|Overall Study||6
10117046|NCT02535416|11247726|FG007|STARTED|Overall Study||6
10117047|NCT02535416|11247727|FG008|STARTED|Overall Study||6
10117048|NCT02535416|11247719|FG000|COMPLETED|Overall Study||3
10117049|NCT02535416|11247720|FG001|COMPLETED|Overall Study||2
10117050|NCT02535416|11247721|FG002|COMPLETED|Overall Study||4
10117051|NCT02535416|11247722|FG003|COMPLETED|Overall Study||4
10117052|NCT02535416|11247723|FG004|COMPLETED|Overall Study||4
10117053|NCT02535416|11247724|FG005|COMPLETED|Overall Study||4
10117054|NCT02535416|11247725|FG006|COMPLETED|Overall Study||6
10117055|NCT02535416|11247726|FG007|COMPLETED|Overall Study||6
10117056|NCT02535416|11247727|FG008|COMPLETED|Overall Study||6
10117057|NCT02535416|11247719|FG000|NOT COMPLETED|Overall Study||1
10117058|NCT02535416|11247720|FG001|NOT COMPLETED|Overall Study||0
10117059|NCT02535416|11247721|FG002|NOT COMPLETED|Overall Study||0
10042279|NCT01977820|11167255|FG001|COMPLETED|Overall Study||0
10042280|NCT01977820|11167254|FG000|NOT COMPLETED|Overall Study||1
10042281|NCT01977820|11167255|FG001|NOT COMPLETED|Overall Study||1
10042282|NCT01977846|11167263|FG000|STARTED|Total Study - Retrospective||251
10042283|NCT01977846|11167264|FG001|STARTED|Total Study - Retrospective||0
10042284|NCT01977846|11167263|FG000|COMPLETED|Total Study - Retrospective||251
10042285|NCT01977846|11167264|FG001|COMPLETED|Total Study - Retrospective||0
10042286|NCT01977846|11167263|FG000|NOT COMPLETED|Total Study - Retrospective||0
10042287|NCT01977846|11167264|FG001|NOT COMPLETED|Total Study - Retrospective||0
10042288|NCT01977846|11167263|FG000|STARTED|Total Study - Prospective||0
10042289|NCT01977846|11167264|FG001|STARTED|Total Study - Prospective||259
10042290|NCT01977846|11167263|FG000|COMPLETED|Total Study - Prospective||0
10042291|NCT01977846|11167264|FG001|COMPLETED|Total Study - Prospective||230
10042292|NCT01977846|11167263|FG000|NOT COMPLETED|Total Study - Prospective||0
10042293|NCT01977846|11167264|FG001|NOT COMPLETED|Total Study - Prospective||29
10042294|NCT01977898|11167273|FG000|STARTED|Overall Study||28
10042295|NCT01977898|11167274|FG001|STARTED|Overall Study||35
10042296|NCT01977898|11167273|FG000|COMPLETED|Overall Study||27
10042297|NCT01977898|11167274|FG001|COMPLETED|Overall Study||34
10042298|NCT01977898|11167273|FG000|NOT COMPLETED|Overall Study||1
10042299|NCT01977898|11167274|FG001|NOT COMPLETED|Overall Study||1
10042300|NCT01977937|11167282|FG000|STARTED|Overall Study||27
10042301|NCT01977937|11167283|FG001|STARTED|Overall Study||28
10042302|NCT01977937|11167282|FG000|COMPLETED|Overall Study||24
10042303|NCT01977937|11167283|FG001|COMPLETED|Overall Study||26
10042304|NCT01977937|11167282|FG000|NOT COMPLETED|Overall Study||3
10042305|NCT01977937|11167283|FG001|NOT COMPLETED|Overall Study||2
10042306|NCT01978093|11167291|FG000|STARTED|Overall Study||297
10042307|NCT01978093|11167292|FG001|STARTED|Overall Study||303
10042308|NCT01978093|11167291|FG000|COMPLETED|Overall Study||232
10042309|NCT01978093|11167292|FG001|COMPLETED|Overall Study||230
10042310|NCT01978093|11167291|FG000|NOT COMPLETED|Overall Study||65
10042311|NCT01978093|11167292|FG001|NOT COMPLETED|Overall Study||73
10042312|NCT01978119|11167301|FG000|STARTED|Treatment Period 1 (12 Weeks)||40
10042313|NCT01978119|11167302|FG001|STARTED|Treatment Period 1 (12 Weeks)||42
10042314|NCT01978119|11167301|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38
10042315|NCT01978119|11167302|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42
10042316|NCT01978119|11167301|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
10042317|NCT01978119|11167302|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
10042318|NCT01978119|11167301|FG000|STARTED|Washout Period 1 (3 Weeks)||38
10042319|NCT01978119|11167302|FG001|STARTED|Washout Period 1 (3 Weeks)||42
10042320|NCT01978119|11167301|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38
10042321|NCT01978119|11167302|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42
10042322|NCT01978119|11167301|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
10042323|NCT01978119|11167302|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
10042324|NCT01978119|11167301|FG000|STARTED|Treatment Period 2 (12 Weeks)||38
10042325|NCT01978119|11167302|FG001|STARTED|Treatment Period 2 (12 Weeks)||42
10042326|NCT01978119|11167301|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38
10042327|NCT01978119|11167302|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40
10042328|NCT01978119|11167301|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
10042329|NCT01978119|11167302|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
10042330|NCT01978145|11167308|FG000|STARTED|Treatment Period 1||214
10042331|NCT01978145|11167309|FG001|STARTED|Treatment Period 1||212
10042332|NCT01978145|11167308|FG000|COMPLETED|Treatment Period 1||205
10042333|NCT01978145|11167309|FG001|COMPLETED|Treatment Period 1||196
10042334|NCT01978145|11167308|FG000|NOT COMPLETED|Treatment Period 1||9
10042335|NCT01978145|11167309|FG001|NOT COMPLETED|Treatment Period 1||16
10042336|NCT01978145|11167308|FG000|STARTED|Washout Period 1||205
10042337|NCT01978145|11167309|FG001|STARTED|Washout Period 1||196
10042338|NCT01978145|11167308|FG000|COMPLETED|Washout Period 1||204
10042339|NCT01978145|11167309|FG001|COMPLETED|Washout Period 1||193
10042340|NCT01978145|11167308|FG000|NOT COMPLETED|Washout Period 1||1
10042341|NCT01978145|11167309|FG001|NOT COMPLETED|Washout Period 1||3
10042342|NCT01978145|11167308|FG000|STARTED|Treatment Period 2||204
10042343|NCT01978145|11167309|FG001|STARTED|Treatment Period 2||193
10042344|NCT01978145|11167308|FG000|COMPLETED|Treatment Period 2||185
10042345|NCT01978145|11167309|FG001|COMPLETED|Treatment Period 2||179
10042346|NCT01978145|11167308|FG000|NOT COMPLETED|Treatment Period 2||19
10042347|NCT01978145|11167309|FG001|NOT COMPLETED|Treatment Period 2||14
10042348|NCT01978184|11167317|FG000|STARTED|Overall Study||43
10042349|NCT01978184|11167318|FG001|STARTED|Overall Study||61
10042350|NCT01978184|11167317|FG000|COMPLETED|Overall Study||30
10042351|NCT01978184|11167318|FG001|COMPLETED|Overall Study||41
10042352|NCT01978184|11167317|FG000|NOT COMPLETED|Overall Study||13
10042353|NCT01978184|11167318|FG001|NOT COMPLETED|Overall Study||20
10042354|NCT01978236|11167324|FG000|STARTED|Overall Study||6
10042355|NCT01978236|11167324|FG000|COMPLETED|Overall Study||4
10042356|NCT01978236|11167324|FG000|NOT COMPLETED|Overall Study||2
10042357|NCT01978262|11167328|FG000|STARTED|Overall Study||103
10042358|NCT01978262|11167328|FG000|COMPLETED|Overall Study||92
10042359|NCT01978262|11167328|FG000|NOT COMPLETED|Overall Study||11
10042360|NCT01978314|11167338|FG000|STARTED|Overall Study||8
10042361|NCT01978314|11167339|FG001|STARTED|Overall Study||8
10042362|NCT01978314|11167340|FG002|STARTED|Overall Study||8
10042363|NCT01978314|11167341|FG003|STARTED|Overall Study||1
10042364|NCT01978314|11167342|FG004|STARTED|Overall Study||8
10042365|NCT01978314|11167338|FG000|COMPLETED|Overall Study||8
10042366|NCT01978314|11167339|FG001|COMPLETED|Overall Study||8
10042367|NCT01978314|11167340|FG002|COMPLETED|Overall Study||8
10042368|NCT01978314|11167341|FG003|COMPLETED|Overall Study||1
10042369|NCT01978314|11167342|FG004|COMPLETED|Overall Study||8
10042370|NCT01978314|11167338|FG000|NOT COMPLETED|Overall Study||0
10042371|NCT01978314|11167339|FG001|NOT COMPLETED|Overall Study||0
10042372|NCT01978314|11167340|FG002|NOT COMPLETED|Overall Study||0
10042373|NCT01978314|11167341|FG003|NOT COMPLETED|Overall Study||0
10042374|NCT01978314|11167342|FG004|NOT COMPLETED|Overall Study||0
10042375|NCT01978509|11167368|FG000|STARTED|Overall Study||10
10042376|NCT01978509|11167369|FG001|STARTED|Overall Study||13
10042377|NCT01978509|11167370|FG002|STARTED|Overall Study||9
10042378|NCT01978509|11167368|FG000|COMPLETED|Overall Study||8
10042379|NCT01978509|11167369|FG001|COMPLETED|Overall Study||8
10042380|NCT01978509|11167370|FG002|COMPLETED|Overall Study||9
10042381|NCT01978509|11167368|FG000|NOT COMPLETED|Overall Study||2
10042382|NCT01978509|11167369|FG001|NOT COMPLETED|Overall Study||5
10042383|NCT01978509|11167370|FG002|NOT COMPLETED|Overall Study||0
10042384|NCT01978600|11167380|FG000|STARTED|Overall Study||44
10042385|NCT01978600|11167381|FG001|STARTED|Overall Study||42
10042386|NCT01978600|11167380|FG000|COMPLETED|Overall Study||44
10042387|NCT01978600|11167381|FG001|COMPLETED|Overall Study||42
10042388|NCT01978600|11167380|FG000|NOT COMPLETED|Overall Study||0
10042389|NCT01978600|11167381|FG001|NOT COMPLETED|Overall Study||0
10042390|NCT01978743|11167387|FG000|STARTED|Overall Study||10
10042391|NCT01978743|11167387|FG000|COMPLETED|Overall Study||10
10042392|NCT01978743|11167387|FG000|NOT COMPLETED|Overall Study||0
10042393|NCT01978912|11167396|FG000|STARTED|Overall Study||6
10042394|NCT01978912|11167397|FG001|STARTED|Overall Study||6
10042395|NCT01978912|11167398|FG002|STARTED|Overall Study||6
10042396|NCT01978912|11167399|FG003|STARTED|Overall Study||6
10042397|NCT01978912|11167396|FG000|COMPLETED|Overall Study||3
10042398|NCT01978912|11167397|FG001|COMPLETED|Overall Study||3
10042399|NCT01978912|11167398|FG002|COMPLETED|Overall Study||3
10042400|NCT01978912|11167399|FG003|COMPLETED|Overall Study||3
10042401|NCT01978912|11167396|FG000|NOT COMPLETED|Overall Study||3
10042402|NCT01978912|11167397|FG001|NOT COMPLETED|Overall Study||3
10042403|NCT01978912|11167398|FG002|NOT COMPLETED|Overall Study||3
10042404|NCT01978912|11167399|FG003|NOT COMPLETED|Overall Study||3
10042405|NCT01979016|11167411|FG000|STARTED|Overall Study||27
10042406|NCT01979016|11167412|FG001|STARTED|Overall Study||27
10042407|NCT01979016|11167411|FG000|COMPLETED|Overall Study||25
10042408|NCT01979016|11167412|FG001|COMPLETED|Overall Study||26
10042409|NCT01979016|11167411|FG000|NOT COMPLETED|Overall Study||2
10042410|NCT01979016|11167412|FG001|NOT COMPLETED|Overall Study||1
10042411|NCT01979029|11167420|FG000|STARTED|Overall Study||29
10042412|NCT01979029|11167421|FG001|STARTED|Overall Study||28
10042413|NCT01979029|11167420|FG000|COMPLETED|Overall Study||29
10042414|NCT01979029|11167421|FG001|COMPLETED|Overall Study||28
10042415|NCT01979029|11167420|FG000|NOT COMPLETED|Overall Study||0
10042416|NCT01979029|11167421|FG001|NOT COMPLETED|Overall Study||0
10042417|NCT01979133|11167427|FG000|STARTED|Overall Study||10
10042418|NCT01979133|11167427|FG000|COMPLETED|Overall Study||7
10042419|NCT01979133|11167427|FG000|NOT COMPLETED|Overall Study||3
10042420|NCT01979159|11167444|FG000|STARTED|Overall Study||4
10042421|NCT01979159|11167444|FG000|COMPLETED|Overall Study||4
10042422|NCT01979159|11167444|FG000|NOT COMPLETED|Overall Study||0
10042423|NCT01979185|11167452|FG000|STARTED|Period 1||15
10042424|NCT01979185|11167453|FG001|STARTED|Period 1||15
10042425|NCT01979185|11167452|FG000|COMPLETED|Period 1||15
10042426|NCT01979185|11167453|FG001|COMPLETED|Period 1||15
10042427|NCT01979185|11167452|FG000|NOT COMPLETED|Period 1||0
10042428|NCT01979185|11167453|FG001|NOT COMPLETED|Period 1||0
10042429|NCT01979185|11167452|FG000|STARTED|Period 2||15
10042430|NCT01979185|11167453|FG001|STARTED|Period 2||15
10042431|NCT01979185|11167452|FG000|COMPLETED|Period 2||15
10042432|NCT01979185|11167453|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
10042433|NCT01979185|11167452|FG000|NOT COMPLETED|Period 2||0
10042434|NCT01979185|11167453|FG001|NOT COMPLETED|Period 2||1
10042435|NCT01979276|11167459|FG000|STARTED|Overall Study||2
10042436|NCT01979276|11167459|FG000|COMPLETED|Overall Study||2
10042437|NCT01979276|11167459|FG000|NOT COMPLETED|Overall Study||0
10042438|NCT01979445|11167465|FG000|STARTED|Overall Study||3
10042439|NCT01979445|11167466|FG001|STARTED|Overall Study||3
10042440|NCT01979445|11167467|FG002|STARTED|Overall Study||6
10042441|NCT01979445|11167468|FG003|STARTED|Overall Study||3
10042442|NCT01979445|11167465|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10042443|NCT01979445|11167466|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10042444|NCT01979445|11167467|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10042445|NCT01979445|11167468|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10042446|NCT01979445|11167465|FG000|ITT Population|Overall Study||3
10042447|NCT01979445|11167466|FG001|ITT Population|Overall Study||3
10042448|NCT01979445|11167467|FG002|ITT Population|Overall Study||6
10042449|NCT01979445|11167468|FG003|ITT Population|Overall Study||3
10042450|NCT01979445|11167465|FG000|COMPLETED|Overall Study||3
10042451|NCT01979445|11167466|FG001|COMPLETED|Overall Study||3
10042452|NCT01979445|11167467|FG002|COMPLETED|Overall Study||6
10042453|NCT01979445|11167468|FG003|COMPLETED|Overall Study||3
10042454|NCT01979445|11167465|FG000|NOT COMPLETED|Overall Study||0
10042455|NCT01979445|11167466|FG001|NOT COMPLETED|Overall Study||0
10042456|NCT01979445|11167467|FG002|NOT COMPLETED|Overall Study||0
10042457|NCT01979445|11167468|FG003|NOT COMPLETED|Overall Study||0
10042458|NCT01979523|11167488|FG000|STARTED|Overall Study||21
10042459|NCT01979523|11167489|FG001|STARTED|Overall Study||21
10042460|NCT01979523|11167488|FG000|COMPLETED|Overall Study||20
10042461|NCT01979523|11167489|FG001|COMPLETED|Overall Study||21
10042462|NCT01979523|11167488|FG000|NOT COMPLETED|Overall Study||1
10042463|NCT01979523|11167489|FG001|NOT COMPLETED|Overall Study||0
10042464|NCT01979614|11167498|FG000|STARTED|Overall Study||30
10042465|NCT01979614|11167499|FG001|STARTED|Overall Study||28
10042466|NCT01979614|11167498|FG000|Safety Analysis Set|Overall Study||30
10042467|NCT01979614|11167499|FG001|Safety Analysis Set|Overall Study||28
10042468|NCT01979614|11167498|FG000|PK Analysis Set|Overall Study||30
10042469|NCT01979614|11167499|FG001|PK Analysis Set|Overall Study||0
10042470|NCT01979614|11167498|FG000|PD Analysis Set|Overall Study||25
10042471|NCT01979614|11167499|FG001|PD Analysis Set|Overall Study||26
10042472|NCT01979614|11167498|FG000|COMPLETED|Overall Study||29
10042473|NCT01979614|11167499|FG001|COMPLETED|Overall Study||27
10042474|NCT01979614|11167498|FG000|NOT COMPLETED|Overall Study||1
10042475|NCT01979614|11167499|FG001|NOT COMPLETED|Overall Study||1
10042476|NCT01979835|11167505|FG000|STARTED|Primary Outcome SA Measurment||1030
10042477|NCT01979835|11167505|FG000|COMPLETED|Primary Outcome SA Measurment||1012
10042478|NCT01979835|11167505|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18
10042479|NCT01979835|11167505|FG000|STARTED|Follow-up||1012
10042480|NCT01979835|11167505|FG000|COMPLETED|Follow-up||980
10042481|NCT01979835|11167505|FG000|NOT COMPLETED|Follow-up||32
10042482|NCT01979952|11167511|FG000|STARTED|Overall Study||56
10042483|NCT01979952|11167512|FG001|STARTED|Overall Study||57
10042484|NCT01979952|11167511|FG000|COMPLETED|Overall Study||48
10042485|NCT01979952|11167512|FG001|COMPLETED|Overall Study||51
10042486|NCT01979952|11167511|FG000|NOT COMPLETED|Overall Study||8
10042487|NCT01979952|11167512|FG001|NOT COMPLETED|Overall Study||6
10042488|NCT01980056|11167521|FG000|STARTED|Overall Study||4
10042489|NCT01980056|11167522|FG001|STARTED|Overall Study||4
10042490|NCT01980056|11167523|FG002|STARTED|Overall Study||2
10042491|NCT01980056|11167521|FG000|COMPLETED|Overall Study||3
10042492|NCT01980056|11167522|FG001|COMPLETED|Overall Study||3
10042493|NCT01980056|11167523|FG002|COMPLETED|Overall Study||2
10042494|NCT01980056|11167521|FG000|NOT COMPLETED|Overall Study||1
10042495|NCT01980056|11167522|FG001|NOT COMPLETED|Overall Study||1
10042496|NCT01980056|11167523|FG002|NOT COMPLETED|Overall Study||0
10042497|NCT01980095|11167537|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
10042498|NCT01980095|11167538|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
10042499|NCT01980095|11167537|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
10042500|NCT01980095|11167538|FG001|Treated|Overall Study||41
10042501|NCT01980095|11167537|FG000|COMPLETED|Overall Study||63
10042502|NCT01980095|11167538|FG001|COMPLETED|Overall Study||30
10042503|NCT01980095|11167537|FG000|NOT COMPLETED|Overall Study||15
10042504|NCT01980095|11167538|FG001|NOT COMPLETED|Overall Study||11
10042505|NCT01980485|11167548|FG000|STARTED|Overall Study||120
10042506|NCT01980485|11167549|FG001|STARTED|Overall Study||105
10042507|NCT01980485|11167548|FG000|COMPLETED|Overall Study||84
10042508|NCT01980485|11167549|FG001|COMPLETED|Overall Study||80
10042509|NCT01980485|11167548|FG000|NOT COMPLETED|Overall Study||36
10042510|NCT01980485|11167549|FG001|NOT COMPLETED|Overall Study||25
10042511|NCT01980524|11167557|FG000|STARTED|Study Day 1||4
10042512|NCT01980524|11167558|FG001|STARTED|Study Day 1||4
10042513|NCT01980524|11167557|FG000|COMPLETED|Study Day 1||4
10042514|NCT01980524|11167558|FG001|COMPLETED|Study Day 1||4
10042515|NCT01980524|11167557|FG000|NOT COMPLETED|Study Day 1||0
10042516|NCT01980524|11167558|FG001|NOT COMPLETED|Study Day 1||0
10042517|NCT01980524|11167557|FG000|STARTED|Washout (at Least 2 Weeks)||4
10042518|NCT01980524|11167558|FG001|STARTED|Washout (at Least 2 Weeks)||4
10042519|NCT01980524|11167557|FG000|COMPLETED|Washout (at Least 2 Weeks)||4
10042520|NCT01980524|11167558|FG001|COMPLETED|Washout (at Least 2 Weeks)||4
10042521|NCT01980524|11167557|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0
10042522|NCT01980524|11167558|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0
10042523|NCT01980524|11167557|FG000|STARTED|Study Day 2||4
10042524|NCT01980524|11167558|FG001|STARTED|Study Day 2||4
10042525|NCT01980524|11167557|FG000|COMPLETED|Study Day 2||4
10042526|NCT01980524|11167558|FG001|COMPLETED|Study Day 2||4
10042527|NCT01980524|11167557|FG000|NOT COMPLETED|Study Day 2||0
10042528|NCT01980524|11167558|FG001|NOT COMPLETED|Study Day 2||0
10042529|NCT01980589|11167567|FG000|STARTED|Overall Study||3
10042530|NCT01980589|11167568|FG001|STARTED|Overall Study||3
10042531|NCT01980589|11167569|FG002|STARTED|Overall Study||16
10042532|NCT01980589|11167567|FG000|COMPLETED|Overall Study||3
10042533|NCT01980589|11167568|FG001|COMPLETED|Overall Study||3
10042534|NCT01980589|11167569|FG002|COMPLETED|Overall Study||16
10042535|NCT01980589|11167567|FG000|NOT COMPLETED|Overall Study||0
10042536|NCT01980589|11167568|FG001|NOT COMPLETED|Overall Study||0
10042537|NCT01980589|11167569|FG002|NOT COMPLETED|Overall Study||0
10042538|NCT01980628|11167577|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
10042539|NCT01980628|11167577|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
10042540|NCT01980628|11167577|FG000|NOT COMPLETED|Overall Study||63
10042541|NCT01980654|11167584|FG000|STARTED|Overall Study||60
10042542|NCT01980654|11167585|FG001|STARTED|Overall Study||20
10042543|NCT01980654|11167584|FG000|COMPLETED|Overall Study||60
10042544|NCT01980654|11167585|FG001|COMPLETED|Overall Study||20
10042545|NCT01980654|11167584|FG000|NOT COMPLETED|Overall Study||0
10042546|NCT01980654|11167585|FG001|NOT COMPLETED|Overall Study||0
10042547|NCT01980706|11167594|FG000|STARTED|Overall Study||40
10042548|NCT01980706|11167595|FG001|STARTED|Overall Study||43
10042549|NCT01980706|11167596|FG002|STARTED|Overall Study||37
10042550|NCT01980706|11167594|FG000|COMPLETED|Overall Study||23
10042551|NCT01980706|11167595|FG001|COMPLETED|Overall Study||26
10042552|NCT01980706|11167596|FG002|COMPLETED|Overall Study||24
10042553|NCT01980706|11167594|FG000|NOT COMPLETED|Overall Study||17
10042554|NCT01980706|11167595|FG001|NOT COMPLETED|Overall Study||17
10042555|NCT01980706|11167596|FG002|NOT COMPLETED|Overall Study||13
10042556|NCT01980771|11167606|FG000|STARTED|Overall Study||436
10042557|NCT01980771|11167607|FG001|STARTED|Overall Study||424
10042558|NCT01980771|11167606|FG000|COMPLETED|Overall Study||352
10042559|NCT01980771|11167607|FG001|COMPLETED|Overall Study||305
10042560|NCT01980771|11167606|FG000|NOT COMPLETED|Overall Study||84
10042561|NCT01980771|11167607|FG001|NOT COMPLETED|Overall Study||119
10042562|NCT01980888|11167615|FG000|STARTED|Overall Study||157
10042563|NCT01980888|11167616|FG001|STARTED|Overall Study||154
10042564|NCT01980888|11167615|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
10042565|NCT01980888|11167616|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
10042566|NCT01980888|11167615|FG000|NOT COMPLETED|Overall Study||144
10042567|NCT01980888|11167616|FG001|NOT COMPLETED|Overall Study||133
10042568|NCT01980914|11167622|FG000|STARTED|Overall Study||11
10042569|NCT01980914|11167622|FG000|COMPLETED|Overall Study||11
10042570|NCT01980914|11167622|FG000|NOT COMPLETED|Overall Study||0
10042571|NCT01980992|11167629|FG000|STARTED|52 Weeks Blinded Study Treatment||23
10042572|NCT01980992|11167630|FG001|STARTED|52 Weeks Blinded Study Treatment||23
10042573|NCT01980992|11167629|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21
10042574|NCT01980992|11167630|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19
10042575|NCT01980992|11167629|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
10042576|NCT01980992|11167630|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
10042577|NCT01980992|11167629|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21
10042578|NCT01980992|11167630|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19
10042579|NCT01980992|11167629|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
10042580|NCT01980992|11167630|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
10042581|NCT01980992|11167629|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
10042582|NCT01980992|11167630|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
10042583|NCT01981057|11167645|FG000|STARTED|Overall Study||50
10042584|NCT01981057|11167646|FG001|STARTED|Overall Study||50
10042585|NCT01981057|11167645|FG000|COMPLETED|Overall Study||50
10042586|NCT01981057|11167646|FG001|COMPLETED|Overall Study||50
10042587|NCT01981057|11167645|FG000|NOT COMPLETED|Overall Study||0
10042588|NCT01981057|11167646|FG001|NOT COMPLETED|Overall Study||0
10042589|NCT01981109|11167652|FG000|STARTED|Overall Study||225
10042590|NCT01981109|11167652|FG000|COMPLETED|Overall Study||1
10042591|NCT01981109|11167652|FG000|NOT COMPLETED|Overall Study||224
10042592|NCT01981122|11167659|FG000|STARTED|Overall Study||25
10042593|NCT01981122|11167660|FG001|STARTED|Overall Study||27
10042594|NCT01981122|11167659|FG000|COMPLETED|Overall Study||11
10042595|NCT01981122|11167660|FG001|COMPLETED|Overall Study||7
10042596|NCT01981122|11167659|FG000|NOT COMPLETED|Overall Study||14
10042597|NCT01981122|11167660|FG001|NOT COMPLETED|Overall Study||20
10042598|NCT01981187|11167666|FG000|STARTED|Overall Study||12
10042599|NCT01981187|11167666|FG000|COMPLETED|Overall Study||0
10042600|NCT01981187|11167666|FG000|NOT COMPLETED|Overall Study||12
10042601|NCT01981356|11167672|FG000|STARTED|Overall Study||12
10042602|NCT01981356|11167673|FG001|STARTED|Overall Study||6
10042603|NCT01981356|11167672|FG000|COMPLETED|Overall Study||5
10042604|NCT01981356|11167673|FG001|COMPLETED|Overall Study||4
10042605|NCT01981356|11167672|FG000|NOT COMPLETED|Overall Study||7
10042606|NCT01981356|11167673|FG001|NOT COMPLETED|Overall Study||2
10042607|NCT01981473|11167683|FG000|STARTED|Overall Study||202
10042608|NCT01981473|11167684|FG001|STARTED|Overall Study||199
10042609|NCT01981473|11167685|FG002|STARTED|Overall Study||204
10042610|NCT01981473|11167683|FG000|COMPLETED|Overall Study||200
10042611|NCT01981473|11167684|FG001|COMPLETED|Overall Study||199
10042612|NCT01981473|11167685|FG002|COMPLETED|Overall Study||196
10042613|NCT01981473|11167683|FG000|NOT COMPLETED|Overall Study||2
10042614|NCT01981473|11167684|FG001|NOT COMPLETED|Overall Study||0
10042615|NCT01981473|11167685|FG002|NOT COMPLETED|Overall Study||8
10042616|NCT01981564|11167698|FG000|STARTED|Overall Study||107
10042617|NCT01981564|11167699|FG001|STARTED|Overall Study||115
10042618|NCT01981564|11167698|FG000|COMPLETED|Overall Study||98
10042619|NCT01981564|11167699|FG001|COMPLETED|Overall Study||106
10042620|NCT01981564|11167698|FG000|NOT COMPLETED|Overall Study||9
10042621|NCT01981564|11167699|FG001|NOT COMPLETED|Overall Study||9
10042622|NCT01981590|11167706|FG000|STARTED|Overall Study||15
10042623|NCT01981590|11167706|FG000|COMPLETED|Overall Study||15
10042624|NCT01981590|11167706|FG000|NOT COMPLETED|Overall Study||0
10042625|NCT01981616|11167713|FG000|STARTED|Overall Study||64
10042626|NCT01981616|11167714|FG001|STARTED|Overall Study||63
10042627|NCT01981616|11167713|FG000|COMPLETED|Overall Study||63
10042628|NCT01981616|11167714|FG001|COMPLETED|Overall Study||62
10042629|NCT01981616|11167713|FG000|NOT COMPLETED|Overall Study||1
10042630|NCT01981616|11167714|FG001|NOT COMPLETED|Overall Study||1
10042631|NCT01981759|11167722|FG000|STARTED|Overall Study||28
10042632|NCT01981759|11167723|FG001|STARTED|Overall Study||30
10042633|NCT01981759|11167722|FG000|Baseline (Week 1)|Overall Study||28
10042634|NCT01981759|11167723|FG001|Baseline (Week 1)|Overall Study||30
10042635|NCT01981759|11167722|FG000|Randomization (Week 3)|Overall Study||28
10042636|NCT01981759|11167723|FG001|Randomization (Week 3)|Overall Study||30
10042637|NCT01981759|11167722|FG000|Completed Week 12|Overall Study||22
10042638|NCT01981759|11167723|FG001|Completed Week 12|Overall Study||22
10042639|NCT01981759|11167722|FG000|COMPLETED|Overall Study||21
10042640|NCT01981759|11167723|FG001|COMPLETED|Overall Study||19
10042641|NCT01981759|11167722|FG000|NOT COMPLETED|Overall Study||7
10042642|NCT01981759|11167723|FG001|NOT COMPLETED|Overall Study||11
10042643|NCT01981772|11167731|FG000|STARTED|Overall Study||45
10042644|NCT01981772|11167732|FG001|STARTED|Overall Study||43
10042645|NCT01981772|11167731|FG000|COMPLETED|Overall Study||45
10042646|NCT01981772|11167732|FG001|COMPLETED|Overall Study||43
10042647|NCT01981772|11167731|FG000|NOT COMPLETED|Overall Study||0
10042648|NCT01981772|11167732|FG001|NOT COMPLETED|Overall Study||0
10117060|NCT02535416|11247722|FG003|NOT COMPLETED|Overall Study||0
10117061|NCT02535416|11247723|FG004|NOT COMPLETED|Overall Study||0
10117062|NCT02535416|11247724|FG005|NOT COMPLETED|Overall Study||0
10117063|NCT02535416|11247725|FG006|NOT COMPLETED|Overall Study||0
10117064|NCT02535416|11247726|FG007|NOT COMPLETED|Overall Study||0
10117065|NCT02535416|11247727|FG008|NOT COMPLETED|Overall Study||0
10117066|NCT02535481|11247753|FG000|STARTED|Overall Study||22
10117067|NCT02535481|11247754|FG001|STARTED|Overall Study||22
10117068|NCT02535481|11247753|FG000|COMPLETED|Overall Study||22
10117069|NCT02535481|11247754|FG001|COMPLETED|Overall Study||22
10117070|NCT02535481|11247753|FG000|NOT COMPLETED|Overall Study||0
10117071|NCT02535481|11247754|FG001|NOT COMPLETED|Overall Study||0
10117072|NCT02535572|11247762|FG000|STARTED|Overall Study||21
10117073|NCT02535572|11247763|FG001|STARTED|Overall Study||20
10117074|NCT02535572|11247762|FG000|COMPLETED|Overall Study||17
10117075|NCT02535572|11247763|FG001|COMPLETED|Overall Study||17
10117076|NCT02535572|11247762|FG000|NOT COMPLETED|Overall Study||4
10117077|NCT02535572|11247763|FG001|NOT COMPLETED|Overall Study||3
10117078|NCT02535611|11247772|FG000|STARTED|Overall Study||27
10117079|NCT02535611|11247773|FG001|STARTED|Overall Study||20
10117080|NCT02535611|11247772|FG000|COMPLETED|Overall Study||27
10117081|NCT02535611|11247773|FG001|COMPLETED|Overall Study||20
10117082|NCT02535611|11247772|FG000|NOT COMPLETED|Overall Study||0
10117083|NCT02535611|11247773|FG001|NOT COMPLETED|Overall Study||0
10117084|NCT02535715|11247779|FG000|STARTED|Overall Study||4
10117085|NCT02535715|11247780|FG001|STARTED|Overall Study||4
10117086|NCT02535715|11247781|FG002|STARTED|Overall Study||3
10117087|NCT02535715|11247779|FG000|COMPLETED|Overall Study||4
10117088|NCT02535715|11247780|FG001|COMPLETED|Overall Study||4
10117089|NCT02535715|11247781|FG002|COMPLETED|Overall Study||2
10117090|NCT02535715|11247779|FG000|NOT COMPLETED|Overall Study||0
10117091|NCT02535715|11247780|FG001|NOT COMPLETED|Overall Study||0
10117092|NCT02535715|11247781|FG002|NOT COMPLETED|Overall Study||1
10117093|NCT02535741|11247792|FG000|STARTED|Overall Study||168
10117094|NCT02535741|11247792|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
10117095|NCT02535741|11247792|FG000|NOT COMPLETED|Overall Study||32
10117096|NCT02535806|11247797|FG000|STARTED|Overall Study||2
10117097|NCT02535806|11247797|FG000|COMPLETED|Overall Study||2
10117098|NCT02535806|11247797|FG000|NOT COMPLETED|Overall Study||0
10117099|NCT02535949|11247804|FG000|STARTED|Overall Study||50
10117100|NCT02535949|11247805|FG001|STARTED|Overall Study||50
10117101|NCT02535949|11247806|FG002|STARTED|Overall Study||50
10117102|NCT02535949|11247804|FG000|COMPLETED|Overall Study||49
10117103|NCT02535949|11247805|FG001|COMPLETED|Overall Study||50
10117104|NCT02535949|11247806|FG002|COMPLETED|Overall Study||50
10117105|NCT02535949|11247804|FG000|NOT COMPLETED|Overall Study||1
10117106|NCT02535949|11247805|FG001|NOT COMPLETED|Overall Study||0
10117107|NCT02535949|11247806|FG002|NOT COMPLETED|Overall Study||0
10117108|NCT02536040|11247817|FG000|STARTED|Overall Study||30
10117109|NCT02536040|11247818|FG001|STARTED|Overall Study||36
10117110|NCT02536040|11247817|FG000|COMPLETED|Overall Study||29
10117111|NCT02536040|11247818|FG001|COMPLETED|Overall Study||35
10117112|NCT02536040|11247817|FG000|NOT COMPLETED|Overall Study||1
10117113|NCT02536040|11247818|FG001|NOT COMPLETED|Overall Study||1
10117114|NCT02536105|11247824|FG000|STARTED|Concerta Open Label||80
10117115|NCT02536105|11247824|FG000|Completion of Phase|Concerta Open Label||76
10117116|NCT02536105|11247824|FG000|COMPLETED|Concerta Open Label||72
10117117|NCT02536105|11247824|FG000|NOT COMPLETED|Concerta Open Label||8
10117118|NCT02536105|11247824|FG000|STARTED|Placebo||74
10117119|NCT02536105|11247824|FG000|Completion of Placebo Day|Placebo||74
10117120|NCT02536105|11247824|FG000|COMPLETED|Placebo||72
10117121|NCT02536105|11247824|FG000|NOT COMPLETED|Placebo||2
10117122|NCT02536105|11247824|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72
10117123|NCT02536105|11247824|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
10117124|NCT02536105|11247824|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72
10117125|NCT02536105|11247824|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
10117126|NCT02536105|11247824|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73
10117127|NCT02536105|11247824|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
10117128|NCT02536105|11247824|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72
10117129|NCT02536105|11247824|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
10117130|NCT02536105|11247824|FG000|STARTED|Methylphenidate HCl ER Suspension||74
10117131|NCT02536105|11247824|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
10117132|NCT02536105|11247824|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72
10117133|NCT02536105|11247824|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
10117134|NCT02536196|11247837|FG000|STARTED|Overall Study||262
10042649|NCT01981863|11167740|FG000|STARTED|Overall Study||20
10042650|NCT01981863|11167741|FG001|STARTED|Overall Study||20
10042651|NCT01981863|11167740|FG000|COMPLETED|Overall Study||20
10042652|NCT01981863|11167741|FG001|COMPLETED|Overall Study||20
10042653|NCT01981863|11167740|FG000|NOT COMPLETED|Overall Study||0
10042654|NCT01981863|11167741|FG001|NOT COMPLETED|Overall Study||0
10117135|NCT02536196|11247838|FG001|STARTED|Overall Study||121
10117136|NCT02536196|11247839|FG002|STARTED|Overall Study||95
10117137|NCT02536196|11247837|FG000|COMPLETED|Overall Study||233
10117138|NCT02536196|11247838|FG001|COMPLETED|Overall Study||107
10117139|NCT02536196|11247839|FG002|COMPLETED|Overall Study||95
10117140|NCT02536196|11247837|FG000|NOT COMPLETED|Overall Study||29
10117141|NCT02536196|11247838|FG001|NOT COMPLETED|Overall Study||14
10117142|NCT02536196|11247839|FG002|NOT COMPLETED|Overall Study||0
10117143|NCT02536248|11247848|FG000|STARTED|First Intervention (6 Weeks)||10
10117144|NCT02536248|11247849|FG001|STARTED|First Intervention (6 Weeks)||10
10117145|NCT02536248|11247848|FG000|COMPLETED|First Intervention (6 Weeks)||10
10117146|NCT02536248|11247849|FG001|COMPLETED|First Intervention (6 Weeks)||10
10117147|NCT02536248|11247848|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10117148|NCT02536248|11247849|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10117149|NCT02536248|11247848|FG000|STARTED|Wash-out (14 Days)||10
10117150|NCT02536248|11247849|FG001|STARTED|Wash-out (14 Days)||10
10117151|NCT02536248|11247848|FG000|COMPLETED|Wash-out (14 Days)||10
10117152|NCT02536248|11247849|FG001|COMPLETED|Wash-out (14 Days)||10
10117153|NCT02536248|11247848|FG000|NOT COMPLETED|Wash-out (14 Days)||0
10117154|NCT02536248|11247849|FG001|NOT COMPLETED|Wash-out (14 Days)||0
10117155|NCT02536248|11247848|FG000|STARTED|Second Intervention (6 Weeks)||10
10117156|NCT02536248|11247849|FG001|STARTED|Second Intervention (6 Weeks)||10
10117157|NCT02536248|11247848|FG000|COMPLETED|Second Intervention (6 Weeks)||10
10117158|NCT02536248|11247849|FG001|COMPLETED|Second Intervention (6 Weeks)||10
10117159|NCT02536248|11247848|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10117160|NCT02536248|11247849|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10117161|NCT02536313|11247857|FG000|STARTED|Overall Study||24
10117162|NCT02536313|11247858|FG001|STARTED|Overall Study||25
10117163|NCT02536313|11247857|FG000|COMPLETED|Overall Study||24
10117164|NCT02536313|11247858|FG001|COMPLETED|Overall Study||24
10117165|NCT02536313|11247857|FG000|NOT COMPLETED|Overall Study||0
10117166|NCT02536313|11247858|FG001|NOT COMPLETED|Overall Study||1
10117167|NCT02536378|11247868|FG000|STARTED|Overall Study||632
10117168|NCT02536378|11247869|FG001|STARTED|Overall Study||60
10117169|NCT02536378|11247868|FG000|COMPLETED|Overall Study||625
10117170|NCT02536378|11247869|FG001|COMPLETED|Overall Study||53
10117171|NCT02536378|11247868|FG000|NOT COMPLETED|Overall Study||7
10117172|NCT02536378|11247869|FG001|NOT COMPLETED|Overall Study||7
10196122|NCT03358407|11324480|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196123|NCT03358407|11324481|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196124|NCT03358407|11324482|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196125|NCT03358407|11324483|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196126|NCT03358407|11324484|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196127|NCT03358407|11324485|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196128|NCT03358407|11324486|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196129|NCT03358407|11324477|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196130|NCT03358407|11324478|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196131|NCT03358407|11324479|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196132|NCT03358407|11324480|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196133|NCT03358407|11324481|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10196134|NCT03358407|11324482|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196135|NCT03358407|11324483|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196136|NCT03358407|11324484|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196137|NCT03358407|11324485|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196138|NCT03358407|11324486|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196139|NCT03358407|11324477|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196140|NCT03358407|11324478|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196141|NCT03358407|11324479|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196142|NCT03358407|11324480|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196143|NCT03358407|11324481|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196144|NCT03358407|11324482|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196145|NCT03358407|11324483|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196146|NCT03358407|11324484|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196147|NCT03358407|11324485|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196148|NCT03358407|11324486|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10196149|NCT03358407|11324477|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196150|NCT03358407|11324478|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196151|NCT03358407|11324479|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196152|NCT03358407|11324480|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196153|NCT03358407|11324481|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196154|NCT03358407|11324482|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196155|NCT03358407|11324483|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196156|NCT03358407|11324484|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196157|NCT03358407|11324485|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10042655|NCT01981954|11167747|FG000|STARTED|Titration Period||23
10042656|NCT01981954|11167747|FG000|Treated|Titration Period||23
10042657|NCT01981954|11167747|FG000|COMPLETED|Titration Period||22
10042658|NCT01981954|11167747|FG000|NOT COMPLETED|Titration Period||1
10042659|NCT01981954|11167747|FG000|STARTED|Fixed-Dose Assessment Period||22
10042660|NCT01981954|11167747|FG000|Treated|Fixed-Dose Assessment Period||22
10042661|NCT01981954|11167747|FG000|COMPLETED|Fixed-Dose Assessment Period||21
10042662|NCT01981954|11167747|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1
10042663|NCT01981967|11167753|FG000|STARTED|Overall Study||6851
10042664|NCT01981967|11167754|FG001|STARTED|Overall Study||3149
10042665|NCT01981967|11167753|FG000|COMPLETED|Overall Study||6851
10042666|NCT01981967|11167754|FG001|COMPLETED|Overall Study||3149
10042667|NCT01981967|11167753|FG000|NOT COMPLETED|Overall Study||0
10042668|NCT01981967|11167754|FG001|NOT COMPLETED|Overall Study||0
10042669|NCT01982123|11167760|FG000|STARTED|Overall Study||12
10042670|NCT01982123|11167760|FG000|COMPLETED|Overall Study||12
10042671|NCT01982123|11167760|FG000|NOT COMPLETED|Overall Study||0
10042672|NCT01982240|11167767|FG000|STARTED|Overall Study||452
10042673|NCT01982240|11167768|FG001|STARTED|Overall Study||453
10042674|NCT01982240|11167769|FG002|STARTED|Overall Study||441
10042675|NCT01982240|11167767|FG000|COMPLETED|Overall Study||385
10042676|NCT01982240|11167768|FG001|COMPLETED|Overall Study||384
10042677|NCT01982240|11167769|FG002|COMPLETED|Overall Study||371
10042678|NCT01982240|11167767|FG000|NOT COMPLETED|Overall Study||67
10042679|NCT01982240|11167768|FG001|NOT COMPLETED|Overall Study||69
10042680|NCT01982240|11167769|FG002|NOT COMPLETED|Overall Study||70
10042681|NCT01982292|11167783|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215
10042682|NCT01982292|11167784|FG001|STARTED|Overall Study||108
10042683|NCT01982292|11167783|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
10042684|NCT01982292|11167784|FG001|Full Analaysis Set (FAS)|Overall Study||108
10042685|NCT01982292|11167783|FG000|Safety Set|Overall Study||212
10042686|NCT01982292|11167784|FG001|Safety Set|Overall Study||108
10042687|NCT01982292|11167783|FG000|COMPLETED|Overall Study||203
10042688|NCT01982292|11167784|FG001|COMPLETED|Overall Study||107
10042689|NCT01982292|11167783|FG000|NOT COMPLETED|Overall Study||12
10042690|NCT01982292|11167784|FG001|NOT COMPLETED|Overall Study||1
10042691|NCT01982331|11167792|FG000|STARTED|Received Vaccination 1||28
10042692|NCT01982331|11167793|FG001|STARTED|Received Vaccination 1||10
10042693|NCT01982331|11167792|FG000|COMPLETED|Received Vaccination 1||28
10042694|NCT01982331|11167793|FG001|COMPLETED|Received Vaccination 1||10
10042695|NCT01982331|11167792|FG000|NOT COMPLETED|Received Vaccination 1||0
10042696|NCT01982331|11167793|FG001|NOT COMPLETED|Received Vaccination 1||0
10042697|NCT01982331|11167792|FG000|STARTED|Received Vaccination 2||28
10042698|NCT01982331|11167793|FG001|STARTED|Received Vaccination 2||10
10042699|NCT01982331|11167792|FG000|COMPLETED|Received Vaccination 2||27
10042700|NCT01982331|11167793|FG001|COMPLETED|Received Vaccination 2||7
10042701|NCT01982331|11167792|FG000|NOT COMPLETED|Received Vaccination 2||1
10042702|NCT01982331|11167793|FG001|NOT COMPLETED|Received Vaccination 2||3
10042703|NCT01982331|11167792|FG000|STARTED|Completed Study (Day 112)||27
10042704|NCT01982331|11167793|FG001|STARTED|Completed Study (Day 112)||7
10042705|NCT01982331|11167792|FG000|COMPLETED|Completed Study (Day 112)||25
10042706|NCT01982331|11167793|FG001|COMPLETED|Completed Study (Day 112)||7
10042707|NCT01982331|11167792|FG000|NOT COMPLETED|Completed Study (Day 112)||2
10042708|NCT01982331|11167793|FG001|NOT COMPLETED|Completed Study (Day 112)||0
10042709|NCT01982435|11167801|FG000|STARTED|Overall Study||15
10042710|NCT01982435|11167802|FG001|STARTED|Overall Study||12
10042711|NCT01982435|11167801|FG000|COMPLETED|Overall Study||14
10042712|NCT01982435|11167802|FG001|COMPLETED|Overall Study||12
10042713|NCT01982435|11167801|FG000|NOT COMPLETED|Overall Study||1
10042714|NCT01982435|11167802|FG001|NOT COMPLETED|Overall Study||0
10042715|NCT01982539|11167808|FG000|STARTED|Overall Study||25
10042716|NCT01982539|11167808|FG000|COMPLETED|Overall Study||25
10042717|NCT01982539|11167808|FG000|NOT COMPLETED|Overall Study||0
10042718|NCT01982643|11167812|FG000|STARTED|Overall Study||49
10042719|NCT01982643|11167812|FG000|COMPLETED|Overall Study||37
10042720|NCT01982643|11167812|FG000|NOT COMPLETED|Overall Study||12
10042721|NCT01982682|11167816|FG000|STARTED|Overall Study||41
10042722|NCT01982682|11167816|FG000|COMPLETED|Overall Study||40
10042723|NCT01982682|11167816|FG000|NOT COMPLETED|Overall Study||1
10042724|NCT01982695|11167823|FG000|STARTED|Overall Study||12
10042725|NCT01982695|11167824|FG001|STARTED|Overall Study||11
10042726|NCT01982695|11167823|FG000|COMPLETED|Overall Study||12
10042727|NCT01982695|11167824|FG001|COMPLETED|Overall Study||10
10042728|NCT01982695|11167823|FG000|NOT COMPLETED|Overall Study||0
10042729|NCT01982695|11167824|FG001|NOT COMPLETED|Overall Study||1
10042730|NCT01982773|11167832|FG000|STARTED|Overall Study||58
10042731|NCT01982773|11167833|FG001|STARTED|Overall Study||60
10042732|NCT01982773|11167832|FG000|COMPLETED|Overall Study||50
10042733|NCT01982773|11167833|FG001|COMPLETED|Overall Study||56
10042734|NCT01982773|11167832|FG000|NOT COMPLETED|Overall Study||8
10042735|NCT01982773|11167833|FG001|NOT COMPLETED|Overall Study||4
10042736|NCT01982786|11167841|FG000|STARTED|Overall Study||29
10042737|NCT01982786|11167842|FG001|STARTED|Overall Study||28
10042738|NCT01982786|11167841|FG000|COMPLETED|Overall Study||29
10042739|NCT01982786|11167842|FG001|COMPLETED|Overall Study||28
10042740|NCT01982786|11167841|FG000|NOT COMPLETED|Overall Study||0
10042741|NCT01982786|11167842|FG001|NOT COMPLETED|Overall Study||0
10042742|NCT01982812|11167850|FG000|STARTED|Overall Study||23
10042743|NCT01982812|11167851|FG001|STARTED|Overall Study||21
10042744|NCT01982812|11167850|FG000|COMPLETED|Overall Study||22
10042745|NCT01982812|11167851|FG001|COMPLETED|Overall Study||11
10042746|NCT01982812|11167850|FG000|NOT COMPLETED|Overall Study||1
10042747|NCT01982812|11167851|FG001|NOT COMPLETED|Overall Study||10
10042748|NCT01982942|11167859|FG000|STARTED|Overall Study||129
10042749|NCT01982942|11167860|FG001|STARTED|Overall Study||126
10042750|NCT01982942|11167859|FG000|COMPLETED|Overall Study||108
10042751|NCT01982942|11167860|FG001|COMPLETED|Overall Study||112
10042752|NCT01982942|11167859|FG000|NOT COMPLETED|Overall Study||21
10042753|NCT01982942|11167860|FG001|NOT COMPLETED|Overall Study||14
10042754|NCT01982955|11167871|FG000|STARTED|Overall Study||6
10042755|NCT01982955|11167872|FG001|STARTED|Overall Study||12
10042756|NCT01982955|11167873|FG002|STARTED|Overall Study||31
10042757|NCT01982955|11167874|FG003|STARTED|Overall Study||24
10042758|NCT01982955|11167875|FG004|STARTED|Overall Study||15
10042759|NCT01982955|11167871|FG000|Treated|Overall Study||6
10042760|NCT01982955|11167872|FG001|Treated|Overall Study||12
10042761|NCT01982955|11167873|FG002|Treated|Overall Study||31
10042762|NCT01982955|11167874|FG003|Treated|Overall Study||23
10042763|NCT01982955|11167875|FG004|Treated|Overall Study||15
10042764|NCT01982955|11167871|FG000|COMPLETED|Overall Study||6
10042765|NCT01982955|11167872|FG001|COMPLETED|Overall Study||12
10042766|NCT01982955|11167873|FG002|COMPLETED|Overall Study||27
10042767|NCT01982955|11167874|FG003|COMPLETED|Overall Study||23
10042768|NCT01982955|11167875|FG004|COMPLETED|Overall Study||15
10042769|NCT01982955|11167871|FG000|NOT COMPLETED|Overall Study||0
10042770|NCT01982955|11167872|FG001|NOT COMPLETED|Overall Study||0
10042771|NCT01982955|11167873|FG002|NOT COMPLETED|Overall Study||4
10042772|NCT01982955|11167874|FG003|NOT COMPLETED|Overall Study||1
10042773|NCT01982955|11167875|FG004|NOT COMPLETED|Overall Study||0
10042774|NCT01982968|11167890|FG000|STARTED|Overall Study||29
10042775|NCT01982968|11167891|FG001|STARTED|Overall Study||29
10042776|NCT01982968|11167890|FG000|COMPLETED|Overall Study||21
10042777|NCT01982968|11167891|FG001|COMPLETED|Overall Study||27
10042778|NCT01982968|11167890|FG000|NOT COMPLETED|Overall Study||8
10042779|NCT01982968|11167891|FG001|NOT COMPLETED|Overall Study||2
10042780|NCT01983020|11167901|FG000|STARTED|Overall Study||12
10042781|NCT01983020|11167902|FG001|STARTED|Overall Study||11
10042782|NCT01983020|11167903|FG002|STARTED|Overall Study||12
10117173|NCT02536404|11247879|FG000|STARTED|Overall Study||112
10117174|NCT02536404|11247880|FG001|STARTED|Overall Study||6
10117175|NCT02536404|11247879|FG000|COMPLETED|Overall Study||92
10117176|NCT02536404|11247880|FG001|COMPLETED|Overall Study||5
10117177|NCT02536404|11247879|FG000|NOT COMPLETED|Overall Study||20
10117178|NCT02536404|11247880|FG001|NOT COMPLETED|Overall Study||1
10117179|NCT02536508|11247889|FG000|STARTED|Overall Study||194
10117180|NCT02536508|11247890|FG001|STARTED|Overall Study||174
10117181|NCT02536508|11247891|FG002|STARTED|Overall Study||88
10117182|NCT02536508|11247889|FG000|COMPLETED|Overall Study||142
10117183|NCT02536508|11247890|FG001|COMPLETED|Overall Study||130
10117184|NCT02536508|11247891|FG002|COMPLETED|Overall Study||65
10117185|NCT02536508|11247889|FG000|NOT COMPLETED|Overall Study||52
10117186|NCT02536508|11247890|FG001|NOT COMPLETED|Overall Study||44
10117187|NCT02536508|11247891|FG002|NOT COMPLETED|Overall Study||23
10117188|NCT02536664|11247901|FG000|STARTED|Overall Study||312
10117189|NCT02536664|11247902|FG001|STARTED|Overall Study||177
10117190|NCT02536664|11247901|FG000|COMPLETED|Overall Study||205
10117191|NCT02536664|11247902|FG001|COMPLETED|Overall Study||97
10117192|NCT02536664|11247901|FG000|NOT COMPLETED|Overall Study||107
10117193|NCT02536664|11247902|FG001|NOT COMPLETED|Overall Study||80
10117194|NCT02536781|11247910|FG000|STARTED|Overall Study||36
10117195|NCT02536781|11247911|FG001|STARTED|Overall Study||34
10117196|NCT02536781|11247910|FG000|COMPLETED|Overall Study||34
10117197|NCT02536781|11247911|FG001|COMPLETED|Overall Study||34
10117198|NCT02536781|11247910|FG000|NOT COMPLETED|Overall Study||2
10117199|NCT02536781|11247911|FG001|NOT COMPLETED|Overall Study||0
10117200|NCT02536833|11247921|FG000|STARTED|Overall Study||112
10117201|NCT02536833|11247922|FG001|STARTED|Overall Study||117
10042783|NCT01983020|11167904|FG003|STARTED|Overall Study||11
10042784|NCT01983020|11167901|FG000|COMPLETED|Overall Study||12
10042785|NCT01983020|11167902|FG001|COMPLETED|Overall Study||11
10042786|NCT01983020|11167903|FG002|COMPLETED|Overall Study||12
10042787|NCT01983020|11167904|FG003|COMPLETED|Overall Study||11
10042788|NCT01983020|11167901|FG000|NOT COMPLETED|Overall Study||0
10042789|NCT01983020|11167902|FG001|NOT COMPLETED|Overall Study||0
10042790|NCT01983020|11167903|FG002|NOT COMPLETED|Overall Study||0
10042791|NCT01983020|11167904|FG003|NOT COMPLETED|Overall Study||0
10042792|NCT01983111|11167916|FG000|STARTED|Overall Study||70
10042793|NCT01983111|11167917|FG001|STARTED|Overall Study||66
10042794|NCT01983111|11167916|FG000|COMPLETED|Overall Study||58
10042795|NCT01983111|11167917|FG001|COMPLETED|Overall Study||59
10042796|NCT01983111|11167916|FG000|NOT COMPLETED|Overall Study||12
10042797|NCT01983111|11167917|FG001|NOT COMPLETED|Overall Study||7
10042798|NCT01983228|11167925|FG000|STARTED|Overall Study||249
10042799|NCT01983228|11167926|FG001|STARTED|Overall Study||251
10042800|NCT01983228|11167925|FG000|COMPLETED|Overall Study||211
10042801|NCT01983228|11167926|FG001|COMPLETED|Overall Study||189
10117202|NCT02536833|11247923|FG002|STARTED|Overall Study||110
10117203|NCT02536833|11247924|FG003|STARTED|Overall Study||116
10117204|NCT02536833|11247921|FG000|COMPLETED|Overall Study||103
10117205|NCT02536833|11247922|FG001|COMPLETED|Overall Study||107
10117206|NCT02536833|11247923|FG002|COMPLETED|Overall Study||95
10117207|NCT02536833|11247924|FG003|COMPLETED|Overall Study||97
10117208|NCT02536833|11247921|FG000|NOT COMPLETED|Overall Study||9
10117209|NCT02536833|11247922|FG001|NOT COMPLETED|Overall Study||10
10042802|NCT01983228|11167925|FG000|NOT COMPLETED|Overall Study||38
10042803|NCT01983228|11167926|FG001|NOT COMPLETED|Overall Study||62
10042804|NCT01983254|11167936|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125
10042805|NCT01983254|11167937|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136
10042806|NCT01983254|11167936|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125
10042807|NCT01983254|11167937|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136
10042808|NCT01983254|11167936|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95
10042809|NCT01983254|11167937|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110
10042810|NCT01983254|11167936|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91
10042811|NCT01983254|11167937|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106
10042812|NCT01983254|11167936|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91
10117210|NCT02536833|11247923|FG002|NOT COMPLETED|Overall Study||15
10117211|NCT02536833|11247924|FG003|NOT COMPLETED|Overall Study||19
10117212|NCT02536846|11247935|FG000|STARTED|Overall Study||10
10117213|NCT02536846|11247935|FG000|COMPLETED|Overall Study||9
10117214|NCT02536846|11247935|FG000|NOT COMPLETED|Overall Study||1
10117215|NCT02536963|11247940|FG000|STARTED|Overall Study||318
10117216|NCT02536963|11247940|FG000|COMPLETED|Overall Study||300
10117217|NCT02536963|11247940|FG000|NOT COMPLETED|Overall Study||18
10117218|NCT02536976|11247946|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3
10117219|NCT02536976|11247947|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
10117220|NCT02536976|11247946|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3
10117221|NCT02536976|11247947|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
10117222|NCT02536976|11247946|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
10117223|NCT02536976|11247947|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
10117224|NCT02536976|11247946|FG000|Washout|Overall Study||3
10117225|NCT02536976|11247947|FG001|Washout|Overall Study||1
10117226|NCT02536976|11247946|FG000|COMPLETED|Overall Study||3
10117227|NCT02536976|11247947|FG001|COMPLETED|Overall Study||1
10117228|NCT02536976|11247946|FG000|NOT COMPLETED|Overall Study||0
10117229|NCT02536976|11247947|FG001|NOT COMPLETED|Overall Study||1
10117230|NCT02537015|11247955|FG000|STARTED|Overall Study||81
10117231|NCT02537015|11247955|FG000|COMPLETED|Overall Study||75
10117232|NCT02537015|11247955|FG000|NOT COMPLETED|Overall Study||6
10117233|NCT02537431|11247959|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
10117234|NCT02537431|11247959|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
10117235|NCT02537431|11247959|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
10117236|NCT02537431|11247959|FG000|STARTED|Treatment Extension Period I||13
10117237|NCT02537431|11247959|FG000|COMPLETED|Treatment Extension Period I||13
10117238|NCT02537431|11247959|FG000|NOT COMPLETED|Treatment Extension Period I||0
10117239|NCT02537431|11247959|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
10117240|NCT02537431|11247959|FG000|COMPLETED|Treatment Extension Period II||8
10117241|NCT02537431|11247959|FG000|NOT COMPLETED|Treatment Extension Period II||0
10117242|NCT02537444|11247965|FG000|STARTED|Overall Study||39
10117243|NCT02537444|11247966|FG001|STARTED|Overall Study||39
10117244|NCT02537444|11247965|FG000|Enrolled|Overall Study||39
10117245|NCT02537444|11247966|FG001|Enrolled|Overall Study||39
10117246|NCT02537444|11247965|FG000|Received Study Medication|Overall Study||38
10117247|NCT02537444|11247966|FG001|Received Study Medication|Overall Study||39
10117248|NCT02537444|11247965|FG000|Discontinued Study|Overall Study||39
10117249|NCT02537444|11247966|FG001|Discontinued Study|Overall Study||39
10117250|NCT02537444|11247965|FG000|COMPLETED|Overall Study||0
10117251|NCT02537444|11247966|FG001|COMPLETED|Overall Study||0
10117252|NCT02537444|11247965|FG000|NOT COMPLETED|Overall Study||39
10117253|NCT02537444|11247966|FG001|NOT COMPLETED|Overall Study||39
10117254|NCT02537522|11247972|FG000|STARTED|Phase I - Contralateral||34
10117255|NCT02537522|11247973|FG001|STARTED|Phase I - Contralateral||37
10117256|NCT02537522|11247974|FG002|STARTED|Phase I - Contralateral||0
10117257|NCT02537522|11247975|FG003|STARTED|Phase I - Contralateral||0
10117258|NCT02537522|11247972|FG000|COMPLETED|Phase I - Contralateral||19
10117259|NCT02537522|11247973|FG001|COMPLETED|Phase I - Contralateral||27
10117260|NCT02537522|11247974|FG002|COMPLETED|Phase I - Contralateral||0
10117261|NCT02537522|11247975|FG003|COMPLETED|Phase I - Contralateral||0
10117262|NCT02537522|11247972|FG000|NOT COMPLETED|Phase I - Contralateral||15
10117263|NCT02537522|11247973|FG001|NOT COMPLETED|Phase I - Contralateral||10
10117264|NCT02537522|11247974|FG002|NOT COMPLETED|Phase I - Contralateral||0
10117265|NCT02537522|11247975|FG003|NOT COMPLETED|Phase I - Contralateral||0
10117266|NCT02537522|11247972|FG000|STARTED|Phase II - Period 1 Bilateral||0
10117267|NCT02537522|11247973|FG001|STARTED|Phase II - Period 1 Bilateral||0
10117268|NCT02537522|11247974|FG002|STARTED|Phase II - Period 1 Bilateral||23
10117269|NCT02537522|11247975|FG003|STARTED|Phase II - Period 1 Bilateral||23
10042813|NCT01983254|11167937|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106
10042814|NCT01983254|11167936|FG000|NOT COMPLETED|Overall Study||34
10042815|NCT01983254|11167937|FG001|NOT COMPLETED|Overall Study||30
10042816|NCT01983293|11167945|FG000|STARTED|Overall Study||161
10042817|NCT01983293|11167946|FG001|STARTED|Overall Study||81
10042818|NCT01983293|11167945|FG000|COMPLETED|Overall Study||128
10042819|NCT01983293|11167946|FG001|COMPLETED|Overall Study||62
10042820|NCT01983293|11167945|FG000|NOT COMPLETED|Overall Study||33
10042821|NCT01983293|11167946|FG001|NOT COMPLETED|Overall Study||19
10042822|NCT01983566|11167956|FG000|STARTED|Test Period 1||4
10042823|NCT01983566|11167957|FG001|STARTED|Test Period 1||4
10042824|NCT01983566|11167958|FG002|STARTED|Test Period 1||4
10042825|NCT01983566|11167959|FG003|STARTED|Test Period 1||4
10042826|NCT01983566|11167956|FG000|COMPLETED|Test Period 1||4
10042827|NCT01983566|11167957|FG001|COMPLETED|Test Period 1||4
10042828|NCT01983566|11167958|FG002|COMPLETED|Test Period 1||4
10042829|NCT01983566|11167959|FG003|COMPLETED|Test Period 1||4
10042830|NCT01983566|11167956|FG000|NOT COMPLETED|Test Period 1||0
10042831|NCT01983566|11167957|FG001|NOT COMPLETED|Test Period 1||0
10042832|NCT01983566|11167958|FG002|NOT COMPLETED|Test Period 1||0
10042833|NCT01983566|11167959|FG003|NOT COMPLETED|Test Period 1||0
10042834|NCT01983566|11167956|FG000|STARTED|Wash-Out 1||4
10117270|NCT02537522|11247972|FG000|COMPLETED|Phase II - Period 1 Bilateral||0
10117271|NCT02537522|11247973|FG001|COMPLETED|Phase II - Period 1 Bilateral||0
10117272|NCT02537522|11247974|FG002|COMPLETED|Phase II - Period 1 Bilateral||23
10117273|NCT02537522|11247975|FG003|COMPLETED|Phase II - Period 1 Bilateral||22
10117274|NCT02537522|11247972|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0
10117275|NCT02537522|11247973|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0
10117276|NCT02537522|11247974|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0
10117277|NCT02537522|11247975|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1
10117278|NCT02537522|11247972|FG000|STARTED|Phase II - Period 2 Bilateral||0
10042835|NCT01983566|11167957|FG001|STARTED|Wash-Out 1||4
10042836|NCT01983566|11167958|FG002|STARTED|Wash-Out 1||4
10042837|NCT01983566|11167959|FG003|STARTED|Wash-Out 1||4
10042838|NCT01983566|11167956|FG000|COMPLETED|Wash-Out 1||4
10042839|NCT01983566|11167957|FG001|COMPLETED|Wash-Out 1||4
10042840|NCT01983566|11167958|FG002|COMPLETED|Wash-Out 1||4
10042841|NCT01983566|11167959|FG003|COMPLETED|Wash-Out 1||4
10042842|NCT01983566|11167956|FG000|NOT COMPLETED|Wash-Out 1||0
10042843|NCT01983566|11167957|FG001|NOT COMPLETED|Wash-Out 1||0
10042844|NCT01983566|11167958|FG002|NOT COMPLETED|Wash-Out 1||0
10042845|NCT01983566|11167959|FG003|NOT COMPLETED|Wash-Out 1||0
10042846|NCT01983566|11167956|FG000|STARTED|Test Period 2||4
10117279|NCT02537522|11247973|FG001|STARTED|Phase II - Period 2 Bilateral||0
10117280|NCT02537522|11247974|FG002|STARTED|Phase II - Period 2 Bilateral||23
10117281|NCT02537522|11247975|FG003|STARTED|Phase II - Period 2 Bilateral||22
10117282|NCT02537522|11247972|FG000|COMPLETED|Phase II - Period 2 Bilateral||0
10117283|NCT02537522|11247973|FG001|COMPLETED|Phase II - Period 2 Bilateral||0
10117284|NCT02537522|11247974|FG002|COMPLETED|Phase II - Period 2 Bilateral||23
10117285|NCT02537522|11247975|FG003|COMPLETED|Phase II - Period 2 Bilateral||22
10117286|NCT02537522|11247972|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10042847|NCT01983566|11167957|FG001|STARTED|Test Period 2||4
10042848|NCT01983566|11167958|FG002|STARTED|Test Period 2||4
10042849|NCT01983566|11167959|FG003|STARTED|Test Period 2||4
10042850|NCT01983566|11167956|FG000|COMPLETED|Test Period 2||4
10042851|NCT01983566|11167957|FG001|COMPLETED|Test Period 2||4
10042852|NCT01983566|11167958|FG002|COMPLETED|Test Period 2||4
10042853|NCT01983566|11167959|FG003|COMPLETED|Test Period 2||4
10042854|NCT01983566|11167956|FG000|NOT COMPLETED|Test Period 2||0
10042855|NCT01983566|11167957|FG001|NOT COMPLETED|Test Period 2||0
10042856|NCT01983566|11167958|FG002|NOT COMPLETED|Test Period 2||0
10042857|NCT01983566|11167959|FG003|NOT COMPLETED|Test Period 2||0
10042858|NCT01983566|11167956|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
10042859|NCT01983566|11167957|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
10042860|NCT01983566|11167958|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
10042861|NCT01983566|11167959|FG003|STARTED|Wash-Out 2||4
10042862|NCT01983566|11167956|FG000|COMPLETED|Wash-Out 2||2
10042863|NCT01983566|11167957|FG001|COMPLETED|Wash-Out 2||3
10042864|NCT01983566|11167958|FG002|COMPLETED|Wash-Out 2||2
10042865|NCT01983566|11167959|FG003|COMPLETED|Wash-Out 2||4
10042866|NCT01983566|11167956|FG000|NOT COMPLETED|Wash-Out 2||0
10042867|NCT01983566|11167957|FG001|NOT COMPLETED|Wash-Out 2||0
10042868|NCT01983566|11167958|FG002|NOT COMPLETED|Wash-Out 2||0
10042869|NCT01983566|11167959|FG003|NOT COMPLETED|Wash-Out 2||0
10042870|NCT01983566|11167956|FG000|STARTED|Test Period 3||2
10042871|NCT01983566|11167957|FG001|STARTED|Test Period 3||3
10042872|NCT01983566|11167958|FG002|STARTED|Test Period 3||2
10042873|NCT01983566|11167959|FG003|STARTED|Test Period 3||4
10042874|NCT01983566|11167956|FG000|COMPLETED|Test Period 3||2
10042875|NCT01983566|11167957|FG001|COMPLETED|Test Period 3||3
10042876|NCT01983566|11167958|FG002|COMPLETED|Test Period 3||2
10042877|NCT01983566|11167959|FG003|COMPLETED|Test Period 3||4
10042878|NCT01983566|11167956|FG000|NOT COMPLETED|Test Period 3||0
10042879|NCT01983566|11167957|FG001|NOT COMPLETED|Test Period 3||0
10042880|NCT01983566|11167958|FG002|NOT COMPLETED|Test Period 3||0
10042881|NCT01983566|11167959|FG003|NOT COMPLETED|Test Period 3||0
10042882|NCT01983566|11167956|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10042883|NCT01983566|11167957|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10042884|NCT01983566|11167958|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10117287|NCT02537522|11247973|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10117288|NCT02537522|11247974|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10042885|NCT01983566|11167959|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10042886|NCT01983566|11167956|FG000|COMPLETED|Wash-Out 3||0
10042887|NCT01983566|11167957|FG001|COMPLETED|Wash-Out 3||0
10042888|NCT01983566|11167958|FG002|COMPLETED|Wash-Out 3||0
10042889|NCT01983566|11167959|FG003|COMPLETED|Wash-Out 3||0
10042890|NCT01983566|11167956|FG000|NOT COMPLETED|Wash-Out 3||0
10042891|NCT01983566|11167957|FG001|NOT COMPLETED|Wash-Out 3||0
10042892|NCT01983566|11167958|FG002|NOT COMPLETED|Wash-Out 3||0
10042893|NCT01983566|11167959|FG003|NOT COMPLETED|Wash-Out 3||0
10042894|NCT01983566|11167956|FG000|STARTED|Test Period 4||0
10042895|NCT01983566|11167957|FG001|STARTED|Test Period 4||0
10042896|NCT01983566|11167958|FG002|STARTED|Test Period 4||0
10042897|NCT01983566|11167959|FG003|STARTED|Test Period 4||0
10042898|NCT01983566|11167956|FG000|COMPLETED|Test Period 4||0
10042899|NCT01983566|11167957|FG001|COMPLETED|Test Period 4||0
10042900|NCT01983566|11167958|FG002|COMPLETED|Test Period 4||0
10042901|NCT01983566|11167959|FG003|COMPLETED|Test Period 4||0
10042902|NCT01983566|11167956|FG000|NOT COMPLETED|Test Period 4||0
10042903|NCT01983566|11167957|FG001|NOT COMPLETED|Test Period 4||0
10042904|NCT01983566|11167958|FG002|NOT COMPLETED|Test Period 4||0
10042905|NCT01983566|11167959|FG003|NOT COMPLETED|Test Period 4||0
10042906|NCT01983683|11167972|FG000|STARTED|Overall Study||298
10042907|NCT01983683|11167973|FG001|STARTED|Overall Study||311
10042908|NCT01983683|11167972|FG000|COMPLETED|Overall Study||260
10042909|NCT01983683|11167973|FG001|COMPLETED|Overall Study||260
10042910|NCT01983683|11167972|FG000|NOT COMPLETED|Overall Study||38
10042911|NCT01983683|11167973|FG001|NOT COMPLETED|Overall Study||51
10042912|NCT01983787|11167979|FG000|STARTED|Overall Study||10
10042913|NCT01983787|11167979|FG000|COMPLETED|Overall Study||10
10042914|NCT01983787|11167979|FG000|NOT COMPLETED|Overall Study||0
10042915|NCT01983826|11168004|FG000|STARTED|Overall Study||13
10042916|NCT01983826|11168005|FG001|STARTED|Overall Study||8
10042917|NCT01983826|11168004|FG000|COMPLETED|Overall Study||13
10042918|NCT01983826|11168005|FG001|COMPLETED|Overall Study||8
10042919|NCT01983826|11168004|FG000|NOT COMPLETED|Overall Study||0
10042920|NCT01983826|11168005|FG001|NOT COMPLETED|Overall Study||0
10042921|NCT01983839|11168015|FG000|STARTED|Overall Study||18
10042922|NCT01983839|11168015|FG000|COMPLETED|Overall Study||18
10042923|NCT01983839|11168015|FG000|NOT COMPLETED|Overall Study||0
10117289|NCT02537522|11247975|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10117290|NCT02537574|11247984|FG000|STARTED|Overall Study||126
10117291|NCT02537574|11247985|FG001|STARTED|Overall Study||126
10117292|NCT02537574|11247986|FG002|STARTED|Overall Study||126
10117293|NCT02537574|11247984|FG000|COMPLETED|Overall Study||27
10117294|NCT02537574|11247985|FG001|COMPLETED|Overall Study||23
10117295|NCT02537574|11247986|FG002|COMPLETED|Overall Study||18
10117296|NCT02537574|11247984|FG000|NOT COMPLETED|Overall Study||99
10117297|NCT02537574|11247985|FG001|NOT COMPLETED|Overall Study||103
10117298|NCT02537574|11247986|FG002|NOT COMPLETED|Overall Study||108
10117299|NCT02537717|11247994|FG000|STARTED|Overall Study||17
10117300|NCT02537717|11247994|FG000|COMPLETED|Overall Study||17
10117301|NCT02537717|11247994|FG000|NOT COMPLETED|Overall Study||0
10117302|NCT02537730|11248001|FG000|STARTED|First Intervention (7 Days)||17
10117303|NCT02537730|11248002|FG001|STARTED|First Intervention (7 Days)||16
10117304|NCT02537730|11248001|FG000|COMPLETED|First Intervention (7 Days)||17
10117305|NCT02537730|11248002|FG001|COMPLETED|First Intervention (7 Days)||16
10117306|NCT02537730|11248001|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10117307|NCT02537730|11248002|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10117308|NCT02537730|11248001|FG000|STARTED|Second Intervention (7 Days)||17
10117309|NCT02537730|11248002|FG001|STARTED|Second Intervention (7 Days)||16
10117310|NCT02537730|11248001|FG000|COMPLETED|Second Intervention (7 Days)||17
10117311|NCT02537730|11248002|FG001|COMPLETED|Second Intervention (7 Days)||16
10117312|NCT02537730|11248001|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10117313|NCT02537730|11248002|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10117314|NCT02537873|11248010|FG000|STARTED|Overall Study||17
10117315|NCT02537873|11248011|FG001|STARTED|Overall Study||8
10117316|NCT02537873|11248010|FG000|COMPLETED|Overall Study||9
10117317|NCT02537873|11248011|FG001|COMPLETED|Overall Study||4
10117318|NCT02537873|11248010|FG000|NOT COMPLETED|Overall Study||8
10117319|NCT02537873|11248011|FG001|NOT COMPLETED|Overall Study||4
10117320|NCT02537951|11248018|FG000|STARTED|Overall Study||10
10117321|NCT02537951|11248018|FG000|COMPLETED|Overall Study||10
10117322|NCT02537951|11248018|FG000|NOT COMPLETED|Overall Study||0
10117323|NCT02538016|11248026|FG000|STARTED|Overall Study||4
10117324|NCT02538016|11248026|FG000|COMPLETED|Overall Study||4
10117325|NCT02538016|11248026|FG000|NOT COMPLETED|Overall Study||0
10117326|NCT02538029|11248033|FG000|STARTED|Overall Study||24
10117327|NCT02538029|11248034|FG001|STARTED|Overall Study||10
10117328|NCT02538029|11248035|FG002|STARTED|Overall Study||11
10117329|NCT02538029|11248033|FG000|COMPLETED|Overall Study||23
10117330|NCT02538029|11248034|FG001|COMPLETED|Overall Study||10
10117331|NCT02538029|11248035|FG002|COMPLETED|Overall Study||10
10042924|NCT01983878|11168019|FG000|STARTED|Overall Study||36
10042925|NCT01983878|11168019|FG000|Received At Least One Dose of Study Drug|Overall Study||36
10042926|NCT01983878|11168019|FG000|COMPLETED|Overall Study||36
10042927|NCT01983878|11168019|FG000|NOT COMPLETED|Overall Study||0
10042928|NCT01983930|11168026|FG000|STARTED|Overall Study||41
10117332|NCT02538029|11248033|FG000|NOT COMPLETED|Overall Study||1
10117333|NCT02538029|11248034|FG001|NOT COMPLETED|Overall Study||0
10117334|NCT02538029|11248035|FG002|NOT COMPLETED|Overall Study||1
10042929|NCT01983930|11168027|FG001|STARTED|Overall Study||38
10042930|NCT01983930|11168026|FG000|COMPLETED|Overall Study||32
10042931|NCT01983930|11168027|FG001|COMPLETED|Overall Study||29
10042932|NCT01983930|11168026|FG000|NOT COMPLETED|Overall Study||9
10042933|NCT01983930|11168027|FG001|NOT COMPLETED|Overall Study||9
10042934|NCT01983969|11168037|FG000|STARTED|Overall Study||37
10042935|NCT01983969|11168038|FG001|STARTED|Overall Study||19
10042936|NCT01983969|11168039|FG002|STARTED|Overall Study||5
10042937|NCT01983969|11168037|FG000|COMPLETED|Overall Study||37
10042938|NCT01983969|11168038|FG001|COMPLETED|Overall Study||18
10042939|NCT01983969|11168039|FG002|COMPLETED|Overall Study||5
10042940|NCT01983969|11168037|FG000|NOT COMPLETED|Overall Study||0
10042941|NCT01983969|11168038|FG001|NOT COMPLETED|Overall Study||1
10042942|NCT01983969|11168039|FG002|NOT COMPLETED|Overall Study||0
10042943|NCT01984164|11168053|FG000|STARTED|Overall Study||87
10042944|NCT01984164|11168054|FG001|STARTED|Overall Study||89
10042945|NCT01984164|11168053|FG000|COMPLETED|Overall Study||77
10042946|NCT01984164|11168054|FG001|COMPLETED|Overall Study||64
10042947|NCT01984164|11168053|FG000|NOT COMPLETED|Overall Study||10
10042948|NCT01984164|11168054|FG001|NOT COMPLETED|Overall Study||25
10042949|NCT01984229|11168062|FG000|STARTED|Period 1||6
10042950|NCT01984229|11168063|FG001|STARTED|Period 1||17
10042951|NCT01984229|11168062|FG000|COMPLETED|Period 1||6
10042952|NCT01984229|11168063|FG001|COMPLETED|Period 1||17
10042953|NCT01984229|11168062|FG000|NOT COMPLETED|Period 1||0
10042954|NCT01984229|11168063|FG001|NOT COMPLETED|Period 1||0
10042955|NCT01984229|11168062|FG000|STARTED|Period 2||6
10042956|NCT01984229|11168063|FG001|STARTED|Period 2||17
10042957|NCT01984229|11168062|FG000|COMPLETED|Period 2||6
10042958|NCT01984229|11168063|FG001|COMPLETED|Period 2||17
10042959|NCT01984229|11168062|FG000|NOT COMPLETED|Period 2||0
10042960|NCT01984229|11168063|FG001|NOT COMPLETED|Period 2||0
10042961|NCT01984229|11168062|FG000|STARTED|Period 3||6
10042962|NCT01984229|11168063|FG001|STARTED|Period 3||17
10042963|NCT01984229|11168062|FG000|COMPLETED|Period 3||6
10042964|NCT01984229|11168063|FG001|COMPLETED|Period 3||17
10042965|NCT01984229|11168062|FG000|NOT COMPLETED|Period 3||0
10042966|NCT01984229|11168063|FG001|NOT COMPLETED|Period 3||0
10042967|NCT01984229|11168062|FG000|STARTED|Safety Follow-up Period||6
10042968|NCT01984229|11168063|FG001|STARTED|Safety Follow-up Period||17
10042969|NCT01984229|11168062|FG000|COMPLETED|Safety Follow-up Period||4
10042970|NCT01984229|11168063|FG001|COMPLETED|Safety Follow-up Period||16
10042971|NCT01984229|11168062|FG000|NOT COMPLETED|Safety Follow-up Period||2
10042972|NCT01984229|11168063|FG001|NOT COMPLETED|Safety Follow-up Period||1
10042973|NCT01984242|11168078|FG000|STARTED|Overall Study||101
10042974|NCT01984242|11168079|FG001|STARTED|Overall Study||103
10042975|NCT01984242|11168080|FG002|STARTED|Overall Study||101
10042976|NCT01984242|11168078|FG000|Treated|Overall Study||101
10042977|NCT01984242|11168079|FG001|Treated|Overall Study||103
10042978|NCT01984242|11168080|FG002|Treated|Overall Study||100
10042979|NCT01984242|11168078|FG000|COMPLETED|Overall Study||0
10042980|NCT01984242|11168079|FG001|COMPLETED|Overall Study||0
10042981|NCT01984242|11168080|FG002|COMPLETED|Overall Study||0
10042982|NCT01984242|11168078|FG000|NOT COMPLETED|Overall Study||101
10042983|NCT01984242|11168079|FG001|NOT COMPLETED|Overall Study||103
10042984|NCT01984242|11168080|FG002|NOT COMPLETED|Overall Study||101
10042985|NCT01984294|11168099|FG000|STARTED|Overall Study||35
10042986|NCT01984294|11168100|FG001|STARTED|Overall Study||32
10042987|NCT01984294|11168101|FG002|STARTED|Overall Study||34
10042988|NCT01984294|11168099|FG000|COMPLETED|Overall Study||31
10042989|NCT01984294|11168100|FG001|COMPLETED|Overall Study||29
10042990|NCT01984294|11168101|FG002|COMPLETED|Overall Study||27
10042991|NCT01984294|11168099|FG000|NOT COMPLETED|Overall Study||4
10042992|NCT01984294|11168100|FG001|NOT COMPLETED|Overall Study||3
10042993|NCT01984294|11168101|FG002|NOT COMPLETED|Overall Study||7
10042994|NCT01984398|11168111|FG000|STARTED|Treatment Period 1||4
10042995|NCT01984398|11168112|FG001|STARTED|Treatment Period 1||4
10042996|NCT01984398|11168113|FG002|STARTED|Treatment Period 1||4
10042997|NCT01984398|11168114|FG003|STARTED|Treatment Period 1||4
10042998|NCT01984398|11168111|FG000|COMPLETED|Treatment Period 1||4
10042999|NCT01984398|11168112|FG001|COMPLETED|Treatment Period 1||4
10043000|NCT01984398|11168113|FG002|COMPLETED|Treatment Period 1||4
10043001|NCT01984398|11168114|FG003|COMPLETED|Treatment Period 1||4
10043002|NCT01984398|11168111|FG000|NOT COMPLETED|Treatment Period 1||0
10043003|NCT01984398|11168112|FG001|NOT COMPLETED|Treatment Period 1||0
10043004|NCT01984398|11168113|FG002|NOT COMPLETED|Treatment Period 1||0
10043005|NCT01984398|11168114|FG003|NOT COMPLETED|Treatment Period 1||0
10043006|NCT01984398|11168111|FG000|STARTED|Washout Period of 5 to 7 Days||4
10043007|NCT01984398|11168112|FG001|STARTED|Washout Period of 5 to 7 Days||4
10043008|NCT01984398|11168113|FG002|STARTED|Washout Period of 5 to 7 Days||4
10043009|NCT01984398|11168114|FG003|STARTED|Washout Period of 5 to 7 Days||4
10043010|NCT01984398|11168111|FG000|COMPLETED|Washout Period of 5 to 7 Days||4
10043011|NCT01984398|11168112|FG001|COMPLETED|Washout Period of 5 to 7 Days||4
10043012|NCT01984398|11168113|FG002|COMPLETED|Washout Period of 5 to 7 Days||4
10043013|NCT01984398|11168114|FG003|COMPLETED|Washout Period of 5 to 7 Days||4
10043014|NCT01984398|11168111|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10043015|NCT01984398|11168112|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10043016|NCT01984398|11168113|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10043017|NCT01984398|11168114|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10043018|NCT01984398|11168111|FG000|STARTED|Treatment Period 2||4
10043019|NCT01984398|11168112|FG001|STARTED|Treatment Period 2||4
10043020|NCT01984398|11168113|FG002|STARTED|Treatment Period 2||4
10043021|NCT01984398|11168114|FG003|STARTED|Treatment Period 2||4
10043022|NCT01984398|11168111|FG000|COMPLETED|Treatment Period 2||4
10043023|NCT01984398|11168112|FG001|COMPLETED|Treatment Period 2||4
10043024|NCT01984398|11168113|FG002|COMPLETED|Treatment Period 2||4
10043025|NCT01984398|11168114|FG003|COMPLETED|Treatment Period 2||4
10043026|NCT01984398|11168111|FG000|NOT COMPLETED|Treatment Period 2||0
10043027|NCT01984398|11168112|FG001|NOT COMPLETED|Treatment Period 2||0
10043028|NCT01984398|11168113|FG002|NOT COMPLETED|Treatment Period 2||0
10043029|NCT01984398|11168114|FG003|NOT COMPLETED|Treatment Period 2||0
10043030|NCT01984424|11168126|FG000|STARTED|Overall Study||73
10043031|NCT01984424|11168127|FG001|STARTED|Overall Study||145
10043032|NCT01984424|11168126|FG000|COMPLETED|Overall Study||70
10043033|NCT01984424|11168127|FG001|COMPLETED|Overall Study||138
10043034|NCT01984424|11168126|FG000|NOT COMPLETED|Overall Study||3
10043035|NCT01984424|11168127|FG001|NOT COMPLETED|Overall Study||7
10043036|NCT01984515|11168133|FG000|STARTED|Overall Study||59
10043037|NCT01984515|11168133|FG000|Received CBT Session|Overall Study||40
10043038|NCT01984515|11168133|FG000|COMPLETED|Overall Study||40
10043039|NCT01984515|11168133|FG000|NOT COMPLETED|Overall Study||19
10043040|NCT01984684|11168139|FG000|STARTED|Overall Study||423
10043041|NCT01984684|11168140|FG001|STARTED|Overall Study||427
10043042|NCT01984684|11168139|FG000|COMPLETED|Overall Study||366
10043043|NCT01984684|11168140|FG001|COMPLETED|Overall Study||368
10043044|NCT01984684|11168139|FG000|NOT COMPLETED|Overall Study||57
10043045|NCT01984684|11168140|FG001|NOT COMPLETED|Overall Study||59
10043046|NCT01984697|11168151|FG000|STARTED|Overall Study||301
10043047|NCT01984697|11168152|FG001|STARTED|Overall Study||301
10043048|NCT01984697|11168153|FG002|STARTED|Overall Study||301
10043049|NCT01984697|11168154|FG003|STARTED|Overall Study||301
10043050|NCT01984697|11168155|FG004|STARTED|Overall Study||314
10043051|NCT01984697|11168151|FG000|Vaccination 1|Overall Study||301
10043052|NCT01984697|11168152|FG001|Vaccination 1|Overall Study||301
10043053|NCT01984697|11168153|FG002|Vaccination 1|Overall Study||300
10043054|NCT01984697|11168154|FG003|Vaccination 1|Overall Study||300
10043055|NCT01984697|11168155|FG004|Vaccination 1|Overall Study||314
10043056|NCT01984697|11168151|FG000|Vaccination 2|Overall Study||293
10043057|NCT01984697|11168152|FG001|Vaccination 2|Overall Study||296
10043058|NCT01984697|11168153|FG002|Vaccination 2|Overall Study||291
10043059|NCT01984697|11168154|FG003|Vaccination 2|Overall Study||298
10043060|NCT01984697|11168155|FG004|Vaccination 2|Overall Study||313
10043061|NCT01984697|11168151|FG000|Vaccination 3|Overall Study||0
10043062|NCT01984697|11168152|FG001|Vaccination 3|Overall Study||0
10043063|NCT01984697|11168153|FG002|Vaccination 3|Overall Study||0
10043064|NCT01984697|11168154|FG003|Vaccination 3|Overall Study||293
10043065|NCT01984697|11168155|FG004|Vaccination 3|Overall Study||311
10043066|NCT01984697|11168151|FG000|Month 36 Vaccination|Overall Study||270
10043067|NCT01984697|11168152|FG001|Month 36 Vaccination|Overall Study||281
10043068|NCT01984697|11168153|FG002|Month 36 Vaccination|Overall Study||280
10043069|NCT01984697|11168154|FG003|Month 36 Vaccination|Overall Study||9
10043070|NCT01984697|11168155|FG004|Month 36 Vaccination|Overall Study||31
10043071|NCT01984697|11168151|FG000|COMPLETED|Overall Study||258
10043072|NCT01984697|11168152|FG001|COMPLETED|Overall Study||270
10043073|NCT01984697|11168153|FG002|COMPLETED|Overall Study||272
10043074|NCT01984697|11168154|FG003|COMPLETED|Overall Study||280
10043075|NCT01984697|11168155|FG004|COMPLETED|Overall Study||279
10043076|NCT01984697|11168151|FG000|NOT COMPLETED|Overall Study||43
10043077|NCT01984697|11168152|FG001|NOT COMPLETED|Overall Study||31
10043078|NCT01984697|11168153|FG002|NOT COMPLETED|Overall Study||29
10043079|NCT01984697|11168154|FG003|NOT COMPLETED|Overall Study||21
10043080|NCT01984697|11168155|FG004|NOT COMPLETED|Overall Study||35
10043081|NCT01984892|11168167|FG000|STARTED|Overall Study||8
10043082|NCT01984892|11168167|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
10043083|NCT01984892|11168167|FG000|NOT COMPLETED|Overall Study||7
10043084|NCT01985126|11168173|FG000|STARTED|Overall Study||18
10043085|NCT01985126|11168174|FG001|STARTED|Overall Study||106
10043086|NCT01985126|11168173|FG000|COMPLETED|Overall Study||0
10043087|NCT01985126|11168174|FG001|COMPLETED|Overall Study||0
10043088|NCT01985126|11168173|FG000|NOT COMPLETED|Overall Study||18
10043089|NCT01985126|11168174|FG001|NOT COMPLETED|Overall Study||106
10043090|NCT01985321|11168182|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
10043091|NCT01985321|11168183|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83
10043092|NCT01985321|11168182|FG000|COMPLETED|Overall Study||79
10043093|NCT01985321|11168183|FG001|COMPLETED|Overall Study||78
10043094|NCT01985321|11168182|FG000|NOT COMPLETED|Overall Study||11
10043095|NCT01985321|11168183|FG001|NOT COMPLETED|Overall Study||5
10043096|NCT01985334|11168197|FG000|STARTED|Overall Study||130
10043097|NCT01985334|11168198|FG001|STARTED|Overall Study||387
10043098|NCT01985334|11168199|FG002|STARTED|Overall Study||420
10043099|NCT01985334|11168200|FG003|STARTED|Overall Study||1262
10043100|NCT01985334|11168201|FG004|STARTED|Overall Study||274
10043101|NCT01985334|11168202|FG005|STARTED|Overall Study||822
10043102|NCT01985334|11168203|FG006|STARTED|Overall Study||274
10043103|NCT01985334|11168204|FG007|STARTED|Overall Study||820
10043104|NCT01985334|11168197|FG000|The Intention-to-treat (ITT) Population|Overall Study||122
10043105|NCT01985334|11168198|FG001|The Intention-to-treat (ITT) Population|Overall Study||369
10043106|NCT01985334|11168199|FG002|The Intention-to-treat (ITT) Population|Overall Study||420
10043107|NCT01985334|11168200|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254
10043108|NCT01985334|11168201|FG004|The Intention-to-treat (ITT) Population|Overall Study||269
10043109|NCT01985334|11168202|FG005|The Intention-to-treat (ITT) Population|Overall Study||811
10043110|NCT01985334|11168203|FG006|The Intention-to-treat (ITT) Population|Overall Study||268
10043111|NCT01985334|11168204|FG007|The Intention-to-treat (ITT) Population|Overall Study||811
10043112|NCT01985334|11168197|FG000|COMPLETED|Overall Study||107
10043113|NCT01985334|11168198|FG001|COMPLETED|Overall Study||303
10043114|NCT01985334|11168199|FG002|COMPLETED|Overall Study||367
10043115|NCT01985334|11168200|FG003|COMPLETED|Overall Study||1033
10043116|NCT01985334|11168201|FG004|COMPLETED|Overall Study||234
10043117|NCT01985334|11168202|FG005|COMPLETED|Overall Study||666
10043118|NCT01985334|11168203|FG006|COMPLETED|Overall Study||237
10043119|NCT01985334|11168204|FG007|COMPLETED|Overall Study||699
10043120|NCT01985334|11168197|FG000|NOT COMPLETED|Overall Study||23
10043121|NCT01985334|11168198|FG001|NOT COMPLETED|Overall Study||84
10043122|NCT01985334|11168199|FG002|NOT COMPLETED|Overall Study||53
10043123|NCT01985334|11168200|FG003|NOT COMPLETED|Overall Study||229
10043124|NCT01985334|11168201|FG004|NOT COMPLETED|Overall Study||40
10043125|NCT01985334|11168202|FG005|NOT COMPLETED|Overall Study||156
10043126|NCT01985334|11168203|FG006|NOT COMPLETED|Overall Study||37
10043127|NCT01985334|11168204|FG007|NOT COMPLETED|Overall Study||121
10043128|NCT01985360|11168238|FG000|STARTED|Overall Study||388
10043129|NCT01985360|11168239|FG001|STARTED|Overall Study||389
10043130|NCT01985360|11168238|FG000|COMPLETED|Overall Study||379
10043131|NCT01985360|11168239|FG001|COMPLETED|Overall Study||386
10043132|NCT01985360|11168238|FG000|NOT COMPLETED|Overall Study||9
10043133|NCT01985360|11168239|FG001|NOT COMPLETED|Overall Study||3
10043134|NCT01985425|11168247|FG000|STARTED|Overall Study||49
10043135|NCT01985425|11168248|FG001|STARTED|Overall Study||51
10043136|NCT01985425|11168247|FG000|COMPLETED|Overall Study||49
10043137|NCT01985425|11168248|FG001|COMPLETED|Overall Study||51
10043138|NCT01985425|11168247|FG000|NOT COMPLETED|Overall Study||0
10043139|NCT01985425|11168248|FG001|NOT COMPLETED|Overall Study||0
10043140|NCT01985542|11168256|FG000|STARTED|Overall Study||7
10043141|NCT01985542|11168257|FG001|STARTED|Overall Study||9
10043142|NCT01985542|11168256|FG000|COMPLETED|Overall Study||3
10043143|NCT01985542|11168257|FG001|COMPLETED|Overall Study||3
10043144|NCT01985542|11168256|FG000|NOT COMPLETED|Overall Study||4
10043145|NCT01985542|11168257|FG001|NOT COMPLETED|Overall Study||6
10043146|NCT01985581|11168266|FG000|STARTED|First Intervention||25
10043147|NCT01985581|11168267|FG001|STARTED|First Intervention||25
10043148|NCT01985581|11168266|FG000|COMPLETED|First Intervention||22
10043149|NCT01985581|11168267|FG001|COMPLETED|First Intervention||23
10043150|NCT01985581|11168266|FG000|NOT COMPLETED|First Intervention||3
10043151|NCT01985581|11168267|FG001|NOT COMPLETED|First Intervention||2
10043152|NCT01985581|11168266|FG000|STARTED|Second Intervention||22
10043153|NCT01985581|11168267|FG001|STARTED|Second Intervention||23
10043154|NCT01985581|11168266|FG000|COMPLETED|Second Intervention||20
10043155|NCT01985581|11168267|FG001|COMPLETED|Second Intervention||19
10043156|NCT01985581|11168266|FG000|NOT COMPLETED|Second Intervention||2
10043157|NCT01985581|11168267|FG001|NOT COMPLETED|Second Intervention||4
10043158|NCT01985685|11168286|FG000|STARTED|Overall Study||27
10043159|NCT01985685|11168287|FG001|STARTED|Overall Study||29
10043160|NCT01985685|11168286|FG000|COMPLETED|Overall Study||27
10043161|NCT01985685|11168287|FG001|COMPLETED|Overall Study||29
10043162|NCT01985685|11168286|FG000|NOT COMPLETED|Overall Study||0
10043163|NCT01985685|11168287|FG001|NOT COMPLETED|Overall Study||0
10043164|NCT01985763|11168293|FG000|STARTED|Overall Study||13
10043165|NCT01985763|11168293|FG000|COMPLETED|Overall Study||13
10043166|NCT01985763|11168293|FG000|NOT COMPLETED|Overall Study||0
10043167|NCT01985932|11168298|FG000|STARTED|Overall Study||15
10043168|NCT01985932|11168298|FG000|COMPLETED|Overall Study||15
10043169|NCT01985932|11168298|FG000|NOT COMPLETED|Overall Study||0
10043170|NCT01985958|11168302|FG000|STARTED|Overall Study||4
10043171|NCT01985958|11168302|FG000|COMPLETED|Overall Study||3
10043172|NCT01985958|11168302|FG000|NOT COMPLETED|Overall Study||1
10043173|NCT01985971|11168306|FG000|STARTED|Overall Study||2
10043174|NCT01985971|11168306|FG000|COMPLETED|Overall Study||1
10043175|NCT01985971|11168306|FG000|NOT COMPLETED|Overall Study||1
10043176|NCT01986010|11168327|FG000|STARTED|Overall Study||13
10043177|NCT01986010|11168328|FG001|STARTED|Overall Study||14
10043178|NCT01986010|11168329|FG002|STARTED|Overall Study||14
10043179|NCT01986010|11168330|FG003|STARTED|Overall Study||10
10043180|NCT01986010|11168331|FG004|STARTED|Overall Study||11
10043181|NCT01986010|11168332|FG005|STARTED|Overall Study||19
10043182|NCT01986010|11168333|FG006|STARTED|Overall Study||10
10043183|NCT01986010|11168334|FG007|STARTED|Overall Study||4
10043184|NCT01986010|11168335|FG008|STARTED|Overall Study||12
10043185|NCT01986010|11168336|FG009|STARTED|Overall Study||10
10043186|NCT01986010|11168337|FG010|STARTED|Overall Study||10
10043187|NCT01986010|11168338|FG011|STARTED|Overall Study||11
10043188|NCT01986010|11168339|FG012|STARTED|Overall Study||10
10043189|NCT01986010|11168340|FG013|STARTED|Overall Study||11
10043190|NCT01986010|11168341|FG014|STARTED|Overall Study||16
10043191|NCT01986010|11168342|FG015|STARTED|Overall Study||11
10043192|NCT01986010|11168343|FG016|STARTED|Overall Study||4
10043193|NCT01986010|11168327|FG000|Vaccination 1|Overall Study||13
10043194|NCT01986010|11168328|FG001|Vaccination 1|Overall Study||14
10043195|NCT01986010|11168329|FG002|Vaccination 1|Overall Study||14
10043196|NCT01986010|11168330|FG003|Vaccination 1|Overall Study||10
10043197|NCT01986010|11168331|FG004|Vaccination 1|Overall Study||11
10043198|NCT01986010|11168332|FG005|Vaccination 1|Overall Study||19
10043199|NCT01986010|11168333|FG006|Vaccination 1|Overall Study||10
10043200|NCT01986010|11168334|FG007|Vaccination 1|Overall Study||4
10043201|NCT01986010|11168335|FG008|Vaccination 1|Overall Study||12
10043202|NCT01986010|11168336|FG009|Vaccination 1|Overall Study||10
10043203|NCT01986010|11168337|FG010|Vaccination 1|Overall Study||10
10043204|NCT01986010|11168338|FG011|Vaccination 1|Overall Study||11
10043205|NCT01986010|11168339|FG012|Vaccination 1|Overall Study||10
10043206|NCT01986010|11168340|FG013|Vaccination 1|Overall Study||11
10043207|NCT01986010|11168341|FG014|Vaccination 1|Overall Study||16
10043208|NCT01986010|11168342|FG015|Vaccination 1|Overall Study||11
10043209|NCT01986010|11168343|FG016|Vaccination 1|Overall Study||4
10043210|NCT01986010|11168327|FG000|Vaccination 2|Overall Study||12
10043211|NCT01986010|11168328|FG001|Vaccination 2|Overall Study||13
10043212|NCT01986010|11168329|FG002|Vaccination 2|Overall Study||12
10043213|NCT01986010|11168330|FG003|Vaccination 2|Overall Study||10
10043214|NCT01986010|11168331|FG004|Vaccination 2|Overall Study||9
10043215|NCT01986010|11168332|FG005|Vaccination 2|Overall Study||19
10043216|NCT01986010|11168333|FG006|Vaccination 2|Overall Study||10
10043217|NCT01986010|11168334|FG007|Vaccination 2|Overall Study||4
10043218|NCT01986010|11168335|FG008|Vaccination 2|Overall Study||11
10043219|NCT01986010|11168336|FG009|Vaccination 2|Overall Study||10
10043220|NCT01986010|11168337|FG010|Vaccination 2|Overall Study||10
10043221|NCT01986010|11168338|FG011|Vaccination 2|Overall Study||10
10043222|NCT01986010|11168339|FG012|Vaccination 2|Overall Study||10
10043223|NCT01986010|11168340|FG013|Vaccination 2|Overall Study||9
10043224|NCT01986010|11168341|FG014|Vaccination 2|Overall Study||16
10043225|NCT01986010|11168342|FG015|Vaccination 2|Overall Study||10
10043226|NCT01986010|11168343|FG016|Vaccination 2|Overall Study||4
10043227|NCT01986010|11168327|FG000|Vaccination 3|Overall Study||10
10043228|NCT01986010|11168328|FG001|Vaccination 3|Overall Study||10
10043229|NCT01986010|11168329|FG002|Vaccination 3|Overall Study||9
10043230|NCT01986010|11168330|FG003|Vaccination 3|Overall Study||10
10043231|NCT01986010|11168331|FG004|Vaccination 3|Overall Study||9
10043232|NCT01986010|11168332|FG005|Vaccination 3|Overall Study||15
10043233|NCT01986010|11168333|FG006|Vaccination 3|Overall Study||10
10043234|NCT01986010|11168334|FG007|Vaccination 3|Overall Study||4
10043235|NCT01986010|11168335|FG008|Vaccination 3|Overall Study||10
10043236|NCT01986010|11168336|FG009|Vaccination 3|Overall Study||10
10043237|NCT01986010|11168337|FG010|Vaccination 3|Overall Study||10
10043238|NCT01986010|11168338|FG011|Vaccination 3|Overall Study||8
10043239|NCT01986010|11168339|FG012|Vaccination 3|Overall Study||10
10043240|NCT01986010|11168340|FG013|Vaccination 3|Overall Study||9
10043241|NCT01986010|11168341|FG014|Vaccination 3|Overall Study||13
10043242|NCT01986010|11168342|FG015|Vaccination 3|Overall Study||10
10043243|NCT01986010|11168343|FG016|Vaccination 3|Overall Study||4
10043244|NCT01986010|11168327|FG000|COMPLETED|Overall Study||7
10043245|NCT01986010|11168328|FG001|COMPLETED|Overall Study||6
10043246|NCT01986010|11168329|FG002|COMPLETED|Overall Study||7
10043247|NCT01986010|11168330|FG003|COMPLETED|Overall Study||8
10043248|NCT01986010|11168331|FG004|COMPLETED|Overall Study||6
10043249|NCT01986010|11168332|FG005|COMPLETED|Overall Study||11
10043250|NCT01986010|11168333|FG006|COMPLETED|Overall Study||10
10043251|NCT01986010|11168334|FG007|COMPLETED|Overall Study||4
10043252|NCT01986010|11168335|FG008|COMPLETED|Overall Study||6
10043253|NCT01986010|11168336|FG009|COMPLETED|Overall Study||7
10043254|NCT01986010|11168337|FG010|COMPLETED|Overall Study||3
10043255|NCT01986010|11168338|FG011|COMPLETED|Overall Study||1
10043256|NCT01986010|11168339|FG012|COMPLETED|Overall Study||0
10043257|NCT01986010|11168340|FG013|COMPLETED|Overall Study||0
10043258|NCT01986010|11168341|FG014|COMPLETED|Overall Study||6
10043259|NCT01986010|11168342|FG015|COMPLETED|Overall Study||0
10043260|NCT01986010|11168343|FG016|COMPLETED|Overall Study||0
10043261|NCT01986010|11168327|FG000|NOT COMPLETED|Overall Study||6
10043262|NCT01986010|11168328|FG001|NOT COMPLETED|Overall Study||8
10043263|NCT01986010|11168329|FG002|NOT COMPLETED|Overall Study||7
10043264|NCT01986010|11168330|FG003|NOT COMPLETED|Overall Study||2
10043265|NCT01986010|11168331|FG004|NOT COMPLETED|Overall Study||5
10043266|NCT01986010|11168332|FG005|NOT COMPLETED|Overall Study||8
10043267|NCT01986010|11168333|FG006|NOT COMPLETED|Overall Study||0
10043268|NCT01986010|11168334|FG007|NOT COMPLETED|Overall Study||0
10043269|NCT01986010|11168335|FG008|NOT COMPLETED|Overall Study||6
10043270|NCT01986010|11168336|FG009|NOT COMPLETED|Overall Study||3
10043271|NCT01986010|11168337|FG010|NOT COMPLETED|Overall Study||7
10043272|NCT01986010|11168338|FG011|NOT COMPLETED|Overall Study||10
10043273|NCT01986010|11168339|FG012|NOT COMPLETED|Overall Study||10
10043274|NCT01986010|11168340|FG013|NOT COMPLETED|Overall Study||11
10043275|NCT01986010|11168341|FG014|NOT COMPLETED|Overall Study||10
10043276|NCT01986010|11168342|FG015|NOT COMPLETED|Overall Study||11
10043277|NCT01986010|11168343|FG016|NOT COMPLETED|Overall Study||4
10043278|NCT01986062|11168391|FG000|STARTED|Overall Study||47
10043279|NCT01986062|11168392|FG001|STARTED|Overall Study||50
10043280|NCT01986062|11168391|FG000|COMPLETED|Overall Study||46
10043281|NCT01986062|11168392|FG001|COMPLETED|Overall Study||49
10043282|NCT01986062|11168391|FG000|NOT COMPLETED|Overall Study||1
10043283|NCT01986062|11168392|FG001|NOT COMPLETED|Overall Study||1
10043284|NCT01986140|11168400|FG000|STARTED|Overall Study||157
10043285|NCT01986140|11168401|FG001|STARTED|Overall Study||79
10043286|NCT01986140|11168400|FG000|COMPLETED|Overall Study||122
10043287|NCT01986140|11168401|FG001|COMPLETED|Overall Study||51
10043288|NCT01986140|11168400|FG000|NOT COMPLETED|Overall Study||35
10043289|NCT01986140|11168401|FG001|NOT COMPLETED|Overall Study||28
10043290|NCT01986231|11168407|FG000|STARTED|Overall Study||12
10043291|NCT01986231|11168407|FG000|COMPLETED|Overall Study||11
10043292|NCT01986231|11168407|FG000|NOT COMPLETED|Overall Study||1
10043293|NCT01986348|11168415|FG000|STARTED|Overall Study||8
10043294|NCT01986348|11168416|FG001|STARTED|Overall Study||24
10043295|NCT01986348|11168417|FG002|STARTED|Overall Study||14
10043296|NCT01986348|11168418|FG003|STARTED|Overall Study||30
10043297|NCT01986348|11168415|FG000|COMPLETED|Overall Study||0
10043298|NCT01986348|11168416|FG001|COMPLETED|Overall Study||0
10043299|NCT01986348|11168417|FG002|COMPLETED|Overall Study||0
10043300|NCT01986348|11168418|FG003|COMPLETED|Overall Study||0
10043301|NCT01986348|11168415|FG000|NOT COMPLETED|Overall Study||8
10043302|NCT01986348|11168416|FG001|NOT COMPLETED|Overall Study||24
10043303|NCT01986348|11168417|FG002|NOT COMPLETED|Overall Study||14
10043304|NCT01986348|11168418|FG003|NOT COMPLETED|Overall Study||30
10043305|NCT01986361|11168433|FG000|STARTED|Overall Study||101
10043306|NCT01986361|11168434|FG001|STARTED|Overall Study||21
10043307|NCT01986361|11168433|FG000|COMPLETED|Overall Study||101
10043308|NCT01986361|11168434|FG001|COMPLETED|Overall Study||21
10043309|NCT01986361|11168433|FG000|NOT COMPLETED|Overall Study||0
10043310|NCT01986361|11168434|FG001|NOT COMPLETED|Overall Study||0
10043311|NCT01986647|11168444|FG000|STARTED|Overall Study||152
10043312|NCT01986647|11168445|FG001|STARTED|Overall Study||146
10043313|NCT01986647|11168446|FG002|STARTED|Overall Study||49
10043314|NCT01986647|11168447|FG003|STARTED|Overall Study||77
10043315|NCT01986647|11168444|FG000|COMPLETED|Overall Study||142
10043316|NCT01986647|11168445|FG001|COMPLETED|Overall Study||139
10043317|NCT01986647|11168446|FG002|COMPLETED|Overall Study||37
10043318|NCT01986647|11168447|FG003|COMPLETED|Overall Study||66
10043319|NCT01986647|11168444|FG000|NOT COMPLETED|Overall Study||10
10043320|NCT01986647|11168445|FG001|NOT COMPLETED|Overall Study||7
10043321|NCT01986647|11168446|FG002|NOT COMPLETED|Overall Study||12
10043322|NCT01986647|11168447|FG003|NOT COMPLETED|Overall Study||11
10043323|NCT01986686|11168463|FG000|STARTED|Overall Study||81
10043324|NCT01986686|11168464|FG001|STARTED|Overall Study||26
10043325|NCT01986686|11168463|FG000|COMPLETED|Overall Study||81
10043326|NCT01986686|11168464|FG001|COMPLETED|Overall Study||26
10043327|NCT01986686|11168463|FG000|NOT COMPLETED|Overall Study||0
10043328|NCT01986686|11168464|FG001|NOT COMPLETED|Overall Study||0
10043329|NCT01986790|11168473|FG000|STARTED|Overall Study||91
10043330|NCT01986790|11168474|FG001|STARTED|Overall Study||154
10043331|NCT01986790|11168475|FG002|STARTED|Overall Study||98
10043332|NCT01986790|11168473|FG000|COMPLETED|Overall Study||91
10043333|NCT01986790|11168474|FG001|COMPLETED|Overall Study||154
10043334|NCT01986790|11168475|FG002|COMPLETED|Overall Study||98
10043335|NCT01986790|11168473|FG000|NOT COMPLETED|Overall Study||0
10043336|NCT01986790|11168474|FG001|NOT COMPLETED|Overall Study||0
10043337|NCT01986790|11168475|FG002|NOT COMPLETED|Overall Study||0
10043338|NCT01986829|11168483|FG000|STARTED|Overall Study||9
10043339|NCT01986829|11168483|FG000|COMPLETED|Overall Study||8
10043340|NCT01986829|11168483|FG000|NOT COMPLETED|Overall Study||1
10043341|NCT01986855|11168493|FG000|STARTED|Overall Study||158
10043342|NCT01986855|11168494|FG001|STARTED|Overall Study||156
10043343|NCT01986855|11168495|FG002|STARTED|Overall Study||154
10043344|NCT01986855|11168493|FG000|Treated|Overall Study||158
10043345|NCT01986855|11168494|FG001|Treated|Overall Study||155
10043346|NCT01986855|11168495|FG002|Treated|Overall Study||154
10043347|NCT01986855|11168493|FG000|COMPLETED|Overall Study||145
10043348|NCT01986855|11168494|FG001|COMPLETED|Overall Study||142
10043349|NCT01986855|11168495|FG002|COMPLETED|Overall Study||143
10043350|NCT01986855|11168493|FG000|NOT COMPLETED|Overall Study||13
10043351|NCT01986855|11168494|FG001|NOT COMPLETED|Overall Study||14
10043352|NCT01986855|11168495|FG002|NOT COMPLETED|Overall Study||11
10043353|NCT01986881|11168506|FG000|STARTED|Overall Study||2752
10043354|NCT01986881|11168507|FG001|STARTED|Overall Study||2747
10043355|NCT01986881|11168508|FG002|STARTED|Overall Study||2747
10043356|NCT01986881|11168506|FG000|Treated|Overall Study||2746
10043357|NCT01986881|11168507|FG001|Treated|Overall Study||2747
10043358|NCT01986881|11168508|FG002|Treated|Overall Study||2745
10043359|NCT01986881|11168506|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
10043360|NCT01986881|11168507|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
10043361|NCT01986881|11168508|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
10043362|NCT01986881|11168506|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
10043363|NCT01986881|11168507|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
10043364|NCT01986881|11168508|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
10043365|NCT01986881|11168506|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
10043366|NCT01986881|11168507|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
10117335|NCT02538042|11248047|FG000|STARTED|Overall Study||17
10117336|NCT02538042|11248048|FG001|STARTED|Overall Study||17
10043367|NCT01986881|11168508|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
10043368|NCT01986881|11168506|FG000|COMPLETED|Overall Study||2422
10043369|NCT01986881|11168507|FG001|COMPLETED|Overall Study||2401
10043370|NCT01986881|11168508|FG002|COMPLETED|Overall Study||2389
10043371|NCT01986881|11168506|FG000|NOT COMPLETED|Overall Study||330
10043372|NCT01986881|11168507|FG001|NOT COMPLETED|Overall Study||346
10117337|NCT02538042|11248047|FG000|Completed All MCE Sessions|Overall Study||15
10043373|NCT01986881|11168508|FG002|NOT COMPLETED|Overall Study||358
10043374|NCT01986907|11168539|FG000|STARTED|Overall Study||936
10043375|NCT01986907|11168539|FG000|COMPLETED|Overall Study||774
10043376|NCT01986907|11168539|FG000|NOT COMPLETED|Overall Study||162
10043377|NCT01986920|11168546|FG000|STARTED|A- 101 25%||35
10043378|NCT01986920|11168547|FG001|STARTED|A- 101 25%||0
10043379|NCT01986920|11168548|FG002|STARTED|A- 101 25%||0
10043380|NCT01986920|11168549|FG003|STARTED|A- 101 25%||0
10043381|NCT01986920|11168546|FG000|COMPLETED|A- 101 25%||34
10043382|NCT01986920|11168547|FG001|COMPLETED|A- 101 25%||0
10043383|NCT01986920|11168548|FG002|COMPLETED|A- 101 25%||0
10043384|NCT01986920|11168549|FG003|COMPLETED|A- 101 25%||0
10043385|NCT01986920|11168546|FG000|NOT COMPLETED|A- 101 25%||1
10043386|NCT01986920|11168547|FG001|NOT COMPLETED|A- 101 25%||0
10043387|NCT01986920|11168548|FG002|NOT COMPLETED|A- 101 25%||0
10043388|NCT01986920|11168549|FG003|NOT COMPLETED|A- 101 25%||0
10043389|NCT01986920|11168546|FG000|STARTED|A-101 32.5%||0
10043390|NCT01986920|11168547|FG001|STARTED|A-101 32.5%||35
10043391|NCT01986920|11168548|FG002|STARTED|A-101 32.5%||0
10043392|NCT01986920|11168549|FG003|STARTED|A-101 32.5%||0
10043393|NCT01986920|11168546|FG000|COMPLETED|A-101 32.5%||0
10043394|NCT01986920|11168547|FG001|COMPLETED|A-101 32.5%||34
10043395|NCT01986920|11168548|FG002|COMPLETED|A-101 32.5%||0
10043396|NCT01986920|11168549|FG003|COMPLETED|A-101 32.5%||0
10043397|NCT01986920|11168546|FG000|NOT COMPLETED|A-101 32.5%||0
10043398|NCT01986920|11168547|FG001|NOT COMPLETED|A-101 32.5%||1
10043399|NCT01986920|11168548|FG002|NOT COMPLETED|A-101 32.5%||0
10043400|NCT01986920|11168549|FG003|NOT COMPLETED|A-101 32.5%||0
10043401|NCT01986920|11168546|FG000|STARTED|A-101 40%||0
10043402|NCT01986920|11168547|FG001|STARTED|A-101 40%||0
10043403|NCT01986920|11168548|FG002|STARTED|A-101 40%||35
10043404|NCT01986920|11168549|FG003|STARTED|A-101 40%||0
10043405|NCT01986920|11168546|FG000|COMPLETED|A-101 40%||0
10043406|NCT01986920|11168547|FG001|COMPLETED|A-101 40%||0
10043407|NCT01986920|11168548|FG002|COMPLETED|A-101 40%||34
10043408|NCT01986920|11168549|FG003|COMPLETED|A-101 40%||0
10043409|NCT01986920|11168546|FG000|NOT COMPLETED|A-101 40%||0
10043410|NCT01986920|11168547|FG001|NOT COMPLETED|A-101 40%||0
10043411|NCT01986920|11168548|FG002|NOT COMPLETED|A-101 40%||1
10043412|NCT01986920|11168549|FG003|NOT COMPLETED|A-101 40%||0
10043413|NCT01986920|11168546|FG000|STARTED|Placebo||0
10043414|NCT01986920|11168547|FG001|STARTED|Placebo||0
10043415|NCT01986920|11168548|FG002|STARTED|Placebo||0
10043416|NCT01986920|11168549|FG003|STARTED|Placebo||35
10043417|NCT01986920|11168546|FG000|COMPLETED|Placebo||0
10043418|NCT01986920|11168547|FG001|COMPLETED|Placebo||0
10043419|NCT01986920|11168548|FG002|COMPLETED|Placebo||0
10043420|NCT01986920|11168549|FG003|COMPLETED|Placebo||34
10043421|NCT01986920|11168546|FG000|NOT COMPLETED|Placebo||0
10043422|NCT01986920|11168547|FG001|NOT COMPLETED|Placebo||0
10043423|NCT01986920|11168548|FG002|NOT COMPLETED|Placebo||0
10117338|NCT02538042|11248048|FG001|Completed All MCE Sessions|Overall Study||15
10117339|NCT02538042|11248047|FG000|Attended Post-Quit Visit|Overall Study||15
10117340|NCT02538042|11248048|FG001|Attended Post-Quit Visit|Overall Study||14
10043424|NCT01986920|11168549|FG003|NOT COMPLETED|Placebo||1
10043425|NCT01986946|11168561|FG000|STARTED|Overall Study||5
10043426|NCT01986946|11168562|FG001|STARTED|Overall Study||9
10043427|NCT01986946|11168561|FG000|COMPLETED|Overall Study||5
10043428|NCT01986946|11168562|FG001|COMPLETED|Overall Study||9
10043429|NCT01986946|11168561|FG000|NOT COMPLETED|Overall Study||0
10043430|NCT01986946|11168562|FG001|NOT COMPLETED|Overall Study||0
10043431|NCT01986985|11168568|FG000|STARTED|Overall Study||58
10043432|NCT01986985|11168568|FG000|COMPLETED|Overall Study||51
10043433|NCT01986985|11168568|FG000|NOT COMPLETED|Overall Study||7
10043434|NCT01987089|11168574|FG000|STARTED|Overall Study||31
10043435|NCT01987089|11168575|FG001|STARTED|Overall Study||32
10043436|NCT01987089|11168574|FG000|COMPLETED|Overall Study||30
10043437|NCT01987089|11168575|FG001|COMPLETED|Overall Study||28
10043438|NCT01987089|11168574|FG000|NOT COMPLETED|Overall Study||1
10043439|NCT01987089|11168575|FG001|NOT COMPLETED|Overall Study||4
10043440|NCT01987102|11168583|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8
10043441|NCT01987102|11168584|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10
10043442|NCT01987102|11168583|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
10043443|NCT01987102|11168584|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
10043444|NCT01987102|11168583|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
10043445|NCT01987102|11168584|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
10043446|NCT01987102|11168583|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4
10043447|NCT01987102|11168584|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4
10043448|NCT01987102|11168583|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
10043449|NCT01987102|11168584|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
10043450|NCT01987102|11168583|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
10043451|NCT01987102|11168584|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
10043452|NCT01987219|11168597|FG000|STARTED|Overall Study||2
10043453|NCT01987219|11168598|FG001|STARTED|Overall Study||2
10043454|NCT01987219|11168599|FG002|STARTED|Overall Study||7
10043455|NCT01987219|11168600|FG003|STARTED|Overall Study||2
10043456|NCT01987219|11168601|FG004|STARTED|Overall Study||1
10043457|NCT01987219|11168602|FG005|STARTED|Overall Study||1
10043458|NCT01987219|11168597|FG000|COMPLETED|Overall Study||2
10043459|NCT01987219|11168598|FG001|COMPLETED|Overall Study||2
10043460|NCT01987219|11168599|FG002|COMPLETED|Overall Study||6
10043461|NCT01987219|11168600|FG003|COMPLETED|Overall Study||2
10043462|NCT01987219|11168601|FG004|COMPLETED|Overall Study||1
10043463|NCT01987219|11168602|FG005|COMPLETED|Overall Study||1
10043464|NCT01987219|11168597|FG000|NOT COMPLETED|Overall Study||0
10043465|NCT01987219|11168598|FG001|NOT COMPLETED|Overall Study||0
10043466|NCT01987219|11168599|FG002|NOT COMPLETED|Overall Study||1
10043467|NCT01987219|11168600|FG003|NOT COMPLETED|Overall Study||0
10043468|NCT01987219|11168601|FG004|NOT COMPLETED|Overall Study||0
10043469|NCT01987219|11168602|FG005|NOT COMPLETED|Overall Study||0
10043470|NCT01987232|11168615|FG000|STARTED|Overall Study||5
10043471|NCT01987232|11168616|FG001|STARTED|Overall Study||3
10043472|NCT01987232|11168617|FG002|STARTED|Overall Study||3
10043473|NCT01987232|11168618|FG003|STARTED|Overall Study||15
10043474|NCT01987232|11168619|FG004|STARTED|Overall Study||6
10043475|NCT01987232|11168615|FG000|COMPLETED|Overall Study||5
10043476|NCT01987232|11168616|FG001|COMPLETED|Overall Study||3
10043477|NCT01987232|11168617|FG002|COMPLETED|Overall Study||3
10043478|NCT01987232|11168618|FG003|COMPLETED|Overall Study||14
10043479|NCT01987232|11168619|FG004|COMPLETED|Overall Study||6
10043480|NCT01987232|11168615|FG000|NOT COMPLETED|Overall Study||0
10043481|NCT01987232|11168616|FG001|NOT COMPLETED|Overall Study||0
10043482|NCT01987232|11168617|FG002|NOT COMPLETED|Overall Study||0
10043483|NCT01987232|11168618|FG003|NOT COMPLETED|Overall Study||1
10043484|NCT01987232|11168619|FG004|NOT COMPLETED|Overall Study||0
10043485|NCT01987349|11168641|FG000|STARTED|Overall Study||6
10043486|NCT01987349|11168642|FG001|STARTED|Overall Study||6
10043487|NCT01987349|11168643|FG002|STARTED|Overall Study||8
10043488|NCT01987349|11168644|FG003|STARTED|Overall Study||6
10043489|NCT01987349|11168645|FG004|STARTED|Overall Study||6
10043490|NCT01987349|11168646|FG005|STARTED|Overall Study||6
10043491|NCT01987349|11168647|FG006|STARTED|Overall Study||10
10043492|NCT01987349|11168648|FG007|STARTED|Overall Study||25
10043493|NCT01987349|11168641|FG000|COMPLETED|Overall Study||6
10043494|NCT01987349|11168642|FG001|COMPLETED|Overall Study||6
10043495|NCT01987349|11168643|FG002|COMPLETED|Overall Study||8
10043496|NCT01987349|11168644|FG003|COMPLETED|Overall Study||6
10043497|NCT01987349|11168645|FG004|COMPLETED|Overall Study||6
10043498|NCT01987349|11168646|FG005|COMPLETED|Overall Study||6
10043499|NCT01987349|11168647|FG006|COMPLETED|Overall Study||10
10043500|NCT01987349|11168648|FG007|COMPLETED|Overall Study||24
10043501|NCT01987349|11168641|FG000|NOT COMPLETED|Overall Study||0
10043502|NCT01987349|11168642|FG001|NOT COMPLETED|Overall Study||0
10043503|NCT01987349|11168643|FG002|NOT COMPLETED|Overall Study||0
10043504|NCT01987349|11168644|FG003|NOT COMPLETED|Overall Study||0
10043505|NCT01987349|11168645|FG004|NOT COMPLETED|Overall Study||0
10043506|NCT01987349|11168646|FG005|NOT COMPLETED|Overall Study||0
10043507|NCT01987349|11168647|FG006|NOT COMPLETED|Overall Study||0
10043508|NCT01987349|11168648|FG007|NOT COMPLETED|Overall Study||1
10043509|NCT01987401|11168673|FG000|STARTED|Overall Study||591
10043510|NCT01987401|11168674|FG001|STARTED|Overall Study||591
10043511|NCT01987401|11168675|FG002|STARTED|Overall Study||60
10043512|NCT01987401|11168673|FG000|COMPLETED|Overall Study||137
10043513|NCT01987401|11168674|FG001|COMPLETED|Overall Study||121
10043514|NCT01987401|11168675|FG002|COMPLETED|Overall Study||16
10043515|NCT01987401|11168673|FG000|NOT COMPLETED|Overall Study||454
10043516|NCT01987401|11168674|FG001|NOT COMPLETED|Overall Study||470
10043517|NCT01987401|11168675|FG002|NOT COMPLETED|Overall Study||44
10043518|NCT01987414|11168685|FG000|STARTED|Overall Study||10
10043519|NCT01987414|11168686|FG001|STARTED|Overall Study||8
10043520|NCT01987414|11168685|FG000|COMPLETED|Overall Study||8
10043521|NCT01987414|11168686|FG001|COMPLETED|Overall Study||6
10043522|NCT01987414|11168685|FG000|NOT COMPLETED|Overall Study||2
10043523|NCT01987414|11168686|FG001|NOT COMPLETED|Overall Study||2
10043524|NCT01987427|11168695|FG000|STARTED|Overall Study||78
10043525|NCT01987427|11168696|FG001|STARTED|Overall Study||78
10043526|NCT01987427|11168697|FG002|STARTED|Overall Study||79
10043527|NCT01987427|11168695|FG000|COMPLETED|Overall Study||64
10043528|NCT01987427|11168696|FG001|COMPLETED|Overall Study||68
10043529|NCT01987427|11168697|FG002|COMPLETED|Overall Study||59
10043530|NCT01987427|11168695|FG000|NOT COMPLETED|Overall Study||14
10043531|NCT01987427|11168696|FG001|NOT COMPLETED|Overall Study||10
10043532|NCT01987427|11168697|FG002|NOT COMPLETED|Overall Study||20
10043533|NCT01987453|11168708|FG000|STARTED|Overall Study||51
10043534|NCT01987453|11168709|FG001|STARTED|Overall Study||41
10043535|NCT01987453|11168710|FG002|STARTED|Overall Study||8
10043536|NCT01987453|11168708|FG000|COMPLETED|Overall Study||50
10043537|NCT01987453|11168709|FG001|COMPLETED|Overall Study||29
10043538|NCT01987453|11168710|FG002|COMPLETED|Overall Study||7
10043539|NCT01987453|11168708|FG000|NOT COMPLETED|Overall Study||1
10043540|NCT01987453|11168709|FG001|NOT COMPLETED|Overall Study||12
10043541|NCT01987453|11168710|FG002|NOT COMPLETED|Overall Study||1
10043542|NCT01987479|11168722|FG000|STARTED|Overall Study||150
10043543|NCT01987479|11168722|FG000|COMPLETED|Overall Study||133
10043544|NCT01987479|11168722|FG000|NOT COMPLETED|Overall Study||17
10043545|NCT01987505|11168728|FG000|STARTED|Overall Study||140
10043546|NCT01987505|11168728|FG000|COMPLETED|Overall Study||106
10043547|NCT01987505|11168728|FG000|NOT COMPLETED|Overall Study||34
10043548|NCT01987557|11168737|FG000|STARTED|Overall Study||16
10043549|NCT01987557|11168738|FG001|STARTED|Overall Study||16
10043550|NCT01987557|11168739|FG002|STARTED|Overall Study||16
10043551|NCT01987557|11168737|FG000|COMPLETED|Overall Study||13
10043552|NCT01987557|11168738|FG001|COMPLETED|Overall Study||13
10043553|NCT01987557|11168739|FG002|COMPLETED|Overall Study||13
10043554|NCT01987557|11168737|FG000|NOT COMPLETED|Overall Study||3
10043555|NCT01987557|11168738|FG001|NOT COMPLETED|Overall Study||3
10043556|NCT01987557|11168739|FG002|NOT COMPLETED|Overall Study||3
10043557|NCT01987583|11168749|FG000|STARTED|Overall Study||40
10043558|NCT01987583|11168750|FG001|STARTED|Overall Study||40
10043559|NCT01987583|11168749|FG000|COMPLETED|Overall Study||37
10043560|NCT01987583|11168750|FG001|COMPLETED|Overall Study||38
10043561|NCT01987583|11168749|FG000|NOT COMPLETED|Overall Study||3
10043562|NCT01987583|11168750|FG001|NOT COMPLETED|Overall Study||2
10043563|NCT01987596|11168758|FG000|STARTED|Overall Study||12
10043564|NCT01987596|11168759|FG001|STARTED|Overall Study||11
10043565|NCT01987596|11168758|FG000|COMPLETED|Overall Study||11
10043566|NCT01987596|11168759|FG001|COMPLETED|Overall Study||10
10043567|NCT01987596|11168758|FG000|NOT COMPLETED|Overall Study||1
10043568|NCT01987596|11168759|FG001|NOT COMPLETED|Overall Study||1
10043569|NCT01987609|11168771|FG000|STARTED|Overall Study|one arm on one patient|7
9706410|NCT03617523|10805434|FG004|NOT COMPLETED|Overall Study||0
9706411|NCT03546192|10805453|FG000|STARTED|Overall Study||60
9706412|NCT03546192|10805454|FG001|STARTED|Overall Study||60
9706413|NCT03546192|10805453|FG000|COMPLETED|Overall Study||60
9706414|NCT03546192|10805454|FG001|COMPLETED|Overall Study||60
9706415|NCT03546192|10805453|FG000|NOT COMPLETED|Overall Study||0
9706416|NCT03546192|10805454|FG001|NOT COMPLETED|Overall Study||0
10043570|NCT01987609|11168771|FG000|Hylenex Injected in Arm|Overall Study||6
10043571|NCT01987609|11168771|FG000|Normal Saline Injected in Arm|Overall Study||6
10043572|NCT01987609|11168771|FG000|COMPLETED|Overall Study||6
10043573|NCT01987609|11168771|FG000|NOT COMPLETED|Overall Study||1
10043574|NCT01987752|11168785|FG000|STARTED|Overall Study||732
10043575|NCT01987752|11168785|FG000|COMPLETED|Overall Study||732
10043576|NCT01987752|11168785|FG000|NOT COMPLETED|Overall Study||0
10043577|NCT01987765|11168789|FG000|STARTED|Overall Study||847
10043578|NCT01987765|11168789|FG000|COMPLETED|Overall Study||745
10043579|NCT01987765|11168789|FG000|NOT COMPLETED|Overall Study||102
10043580|NCT01987817|11168795|FG000|STARTED|Overall Study||29
10043581|NCT01987817|11168796|FG001|STARTED|Overall Study||27
10043582|NCT01987817|11168795|FG000|COMPLETED|Overall Study||23
10043583|NCT01987817|11168796|FG001|COMPLETED|Overall Study||26
10043584|NCT01987817|11168795|FG000|NOT COMPLETED|Overall Study||6
10043585|NCT01987817|11168796|FG001|NOT COMPLETED|Overall Study||1
10043586|NCT01987830|11168803|FG000|STARTED|Overall Study||13
10043587|NCT01987830|11168803|FG000|COMPLETED|Overall Study||12
10043588|NCT01987830|11168803|FG000|NOT COMPLETED|Overall Study||1
10043589|NCT01987895|11168809|FG000|STARTED|Overall Study||306
10043590|NCT01987895|11168810|FG001|STARTED|Overall Study||326
10043591|NCT01987895|11168809|FG000|COMPLETED|Overall Study||276
10043592|NCT01987895|11168810|FG001|COMPLETED|Overall Study||296
10043593|NCT01987895|11168809|FG000|NOT COMPLETED|Overall Study||30
10043594|NCT01987895|11168810|FG001|NOT COMPLETED|Overall Study||30
10043595|NCT01987908|11168816|FG000|STARTED|Placebo Lead-in Period||23
10043596|NCT01987908|11168817|FG001|STARTED|Placebo Lead-in Period||0
10043597|NCT01987908|11168818|FG002|STARTED|Placebo Lead-in Period||0
10043598|NCT01987908|11168816|FG000|COMPLETED|Placebo Lead-in Period||14
10043599|NCT01987908|11168817|FG001|COMPLETED|Placebo Lead-in Period||0
10043600|NCT01987908|11168818|FG002|COMPLETED|Placebo Lead-in Period||0
10043601|NCT01987908|11168816|FG000|NOT COMPLETED|Placebo Lead-in Period||9
10043602|NCT01987908|11168817|FG001|NOT COMPLETED|Placebo Lead-in Period||0
10043603|NCT01987908|11168818|FG002|NOT COMPLETED|Placebo Lead-in Period||0
10043604|NCT01987908|11168816|FG000|STARTED|Treatment Period||0
10043605|NCT01987908|11168817|FG001|STARTED|Treatment Period||11
10043606|NCT01987908|11168818|FG002|STARTED|Treatment Period||3
10043607|NCT01987908|11168816|FG000|COMPLETED|Treatment Period||0
10043608|NCT01987908|11168817|FG001|COMPLETED|Treatment Period||10
10043609|NCT01987908|11168818|FG002|COMPLETED|Treatment Period||2
10043610|NCT01987908|11168816|FG000|NOT COMPLETED|Treatment Period||0
10043611|NCT01987908|11168817|FG001|NOT COMPLETED|Treatment Period||1
10043612|NCT01987908|11168818|FG002|NOT COMPLETED|Treatment Period||1
10043613|NCT01987908|11168816|FG000|STARTED|Post-Treatment Observation Period||0
10043614|NCT01987908|11168817|FG001|STARTED|Post-Treatment Observation Period||10
10043615|NCT01987908|11168818|FG002|STARTED|Post-Treatment Observation Period||2
10043616|NCT01987908|11168816|FG000|COMPLETED|Post-Treatment Observation Period||0
10043617|NCT01987908|11168817|FG001|COMPLETED|Post-Treatment Observation Period||7
10043618|NCT01987908|11168818|FG002|COMPLETED|Post-Treatment Observation Period||2
10043619|NCT01987908|11168816|FG000|NOT COMPLETED|Post-Treatment Observation Period||0
10043620|NCT01987908|11168817|FG001|NOT COMPLETED|Post-Treatment Observation Period||3
10043621|NCT01987908|11168818|FG002|NOT COMPLETED|Post-Treatment Observation Period||0
10043622|NCT01987960|11168844|FG000|STARTED|Period 1||417
10043623|NCT01987960|11168845|FG001|STARTED|Period 1||0
10043624|NCT01987960|11168846|FG002|STARTED|Period 1||0
9706417|NCT03517449|10805462|FG000|STARTED|Overall Study||411
9706418|NCT03517449|10805463|FG001|STARTED|Overall Study||416
9706419|NCT03517449|10805462|FG000|Treated|Overall Study||406
9706420|NCT03517449|10805463|FG001|Treated|Overall Study||388
9706421|NCT03517449|10805462|FG000|COMPLETED|Overall Study||0
9706422|NCT03517449|10805463|FG001|COMPLETED|Overall Study||0
9706423|NCT03517449|10805462|FG000|NOT COMPLETED|Overall Study||411
9706424|NCT03517449|10805463|FG001|NOT COMPLETED|Overall Study||416
9706425|NCT03470922|10805471|FG000|STARTED|Overall Study||355
9706426|NCT03470922|10805472|FG001|STARTED|Overall Study||359
9706427|NCT03470922|10805471|FG000|COMPLETED|Overall Study||237
9706428|NCT03470922|10805472|FG001|COMPLETED|Overall Study||227
9706429|NCT03470922|10805471|FG000|NOT COMPLETED|Overall Study||118
10043625|NCT01987960|11168847|FG003|STARTED|Period 1||0
10043626|NCT01987960|11168844|FG000|COMPLETED|Period 1||231
10043627|NCT01987960|11168845|FG001|COMPLETED|Period 1||0
10043628|NCT01987960|11168846|FG002|COMPLETED|Period 1||0
10043629|NCT01987960|11168847|FG003|COMPLETED|Period 1||0
10043630|NCT01987960|11168844|FG000|NOT COMPLETED|Period 1||186
10043631|NCT01987960|11168845|FG001|NOT COMPLETED|Period 1||0
10043632|NCT01987960|11168846|FG002|NOT COMPLETED|Period 1||0
10043633|NCT01987960|11168847|FG003|NOT COMPLETED|Period 1||0
10043634|NCT01987960|11168844|FG000|STARTED|Period 2||0
10043635|NCT01987960|11168845|FG001|STARTED|Period 2||17
10043636|NCT01987960|11168846|FG002|STARTED|Period 2||23
10043637|NCT01987960|11168847|FG003|STARTED|Period 2||0
10043638|NCT01987960|11168844|FG000|COMPLETED|Period 2||0
10043639|NCT01987960|11168845|FG001|COMPLETED|Period 2||12
10043640|NCT01987960|11168846|FG002|COMPLETED|Period 2||14
10043641|NCT01987960|11168847|FG003|COMPLETED|Period 2||0
10043642|NCT01987960|11168844|FG000|NOT COMPLETED|Period 2||0
10043643|NCT01987960|11168845|FG001|NOT COMPLETED|Period 2||5
10043644|NCT01987960|11168846|FG002|NOT COMPLETED|Period 2||9
10043645|NCT01987960|11168847|FG003|NOT COMPLETED|Period 2||0
10043646|NCT01987960|11168844|FG000|STARTED|Period 3||0
10043647|NCT01987960|11168845|FG001|STARTED|Period 3||0
10043648|NCT01987960|11168846|FG002|STARTED|Period 3||0
10043649|NCT01987960|11168847|FG003|STARTED|Period 3||190
10043650|NCT01987960|11168844|FG000|COMPLETED|Period 3||0
10043651|NCT01987960|11168845|FG001|COMPLETED|Period 3||0
10043652|NCT01987960|11168846|FG002|COMPLETED|Period 3||0
10043653|NCT01987960|11168847|FG003|COMPLETED|Period 3||119
10043654|NCT01987960|11168844|FG000|NOT COMPLETED|Period 3||0
10043655|NCT01987960|11168845|FG001|NOT COMPLETED|Period 3||0
10043656|NCT01987960|11168846|FG002|NOT COMPLETED|Period 3||0
10043657|NCT01987960|11168847|FG003|NOT COMPLETED|Period 3||71
10043658|NCT01987986|11168861|FG000|STARTED|Overall Study||43
10043659|NCT01987986|11168862|FG001|STARTED|Overall Study||43
10043660|NCT01987986|11168863|FG002|STARTED|Overall Study||40
10043661|NCT01987986|11168864|FG003|STARTED|Overall Study||24
10043662|NCT01987986|11168861|FG000|COMPLETED|Overall Study||41
10043663|NCT01987986|11168862|FG001|COMPLETED|Overall Study||43
10043664|NCT01987986|11168863|FG002|COMPLETED|Overall Study||38
10043665|NCT01987986|11168864|FG003|COMPLETED|Overall Study||24
10043666|NCT01987986|11168861|FG000|NOT COMPLETED|Overall Study||2
10043667|NCT01987986|11168862|FG001|NOT COMPLETED|Overall Study||0
10043668|NCT01987986|11168863|FG002|NOT COMPLETED|Overall Study||2
10043669|NCT01987986|11168864|FG003|NOT COMPLETED|Overall Study||0
10043670|NCT01988012|11168874|FG000|STARTED|Overall Study||100
10043671|NCT01988012|11168874|FG000|COMPLETED|Overall Study||85
10043672|NCT01988012|11168874|FG000|NOT COMPLETED|Overall Study||15
10043673|NCT01988090|11168880|FG000|STARTED|Start Treament After Randomization||46
10043674|NCT01988090|11168881|FG001|STARTED|Start Treament After Randomization||47
10043675|NCT01988090|11168880|FG000|COMPLETED|Start Treament After Randomization||44
10043676|NCT01988090|11168881|FG001|COMPLETED|Start Treament After Randomization||43
10043677|NCT01988090|11168880|FG000|NOT COMPLETED|Start Treament After Randomization||2
10043678|NCT01988090|11168881|FG001|NOT COMPLETED|Start Treament After Randomization||4
10043679|NCT01988090|11168880|FG000|STARTED|Complete Study After Start||44
10043680|NCT01988090|11168881|FG001|STARTED|Complete Study After Start||43
10043681|NCT01988090|11168880|FG000|COMPLETED|Complete Study After Start||41
10043682|NCT01988090|11168881|FG001|COMPLETED|Complete Study After Start||42
10043683|NCT01988090|11168880|FG000|NOT COMPLETED|Complete Study After Start||3
10043684|NCT01988090|11168881|FG001|NOT COMPLETED|Complete Study After Start||1
10043685|NCT01988103|11168890|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84
10043686|NCT01988103|11168891|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85
10043687|NCT01988103|11168892|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85
10043688|NCT01988103|11168893|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0
10043689|NCT01988103|11168894|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0
10043690|NCT01988103|11168890|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72
10043691|NCT01988103|11168891|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69
10043692|NCT01988103|11168892|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76
10043693|NCT01988103|11168893|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0
10043694|NCT01988103|11168894|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0
10043695|NCT01988103|11168890|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
10043696|NCT01988103|11168891|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
10043697|NCT01988103|11168892|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
10043698|NCT01988103|11168893|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
10043699|NCT01988103|11168894|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
10043700|NCT01988103|11168890|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0
10043701|NCT01988103|11168891|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69
10043702|NCT01988103|11168892|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76
10043703|NCT01988103|11168893|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36
10043704|NCT01988103|11168894|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35
10043705|NCT01988103|11168890|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
10043706|NCT01988103|11168891|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
10043707|NCT01988103|11168892|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
10043708|NCT01988103|11168893|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
10043709|NCT01988103|11168894|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
10043710|NCT01988103|11168890|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
10043711|NCT01988103|11168891|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
10043712|NCT01988103|11168892|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
10043713|NCT01988103|11168893|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
10043714|NCT01988103|11168894|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
10043715|NCT01988103|11168890|FG000|STARTED|Observational Follow-up Phase||12
10043716|NCT01988103|11168891|FG001|STARTED|Observational Follow-up Phase||82
10043717|NCT01988103|11168892|FG002|STARTED|Observational Follow-up Phase||83
10043718|NCT01988103|11168893|FG003|STARTED|Observational Follow-up Phase||36
10043719|NCT01988103|11168894|FG004|STARTED|Observational Follow-up Phase||33
10043720|NCT01988103|11168890|FG000|COMPLETED|Observational Follow-up Phase||12
10043721|NCT01988103|11168891|FG001|COMPLETED|Observational Follow-up Phase||79
10043722|NCT01988103|11168892|FG002|COMPLETED|Observational Follow-up Phase||82
10043723|NCT01988103|11168893|FG003|COMPLETED|Observational Follow-up Phase||36
10043724|NCT01988103|11168894|FG004|COMPLETED|Observational Follow-up Phase||33
10043725|NCT01988103|11168890|FG000|NOT COMPLETED|Observational Follow-up Phase||0
10043726|NCT01988103|11168891|FG001|NOT COMPLETED|Observational Follow-up Phase||3
10043727|NCT01988103|11168892|FG002|NOT COMPLETED|Observational Follow-up Phase||1
10043728|NCT01988103|11168893|FG003|NOT COMPLETED|Observational Follow-up Phase||0
10043729|NCT01988103|11168894|FG004|NOT COMPLETED|Observational Follow-up Phase||0
10043730|NCT01988129|11168911|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
10043731|NCT01988129|11168912|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
10043732|NCT01988129|11168911|FG000|Attended Education Session|Overall Study||542
10043733|NCT01988129|11168912|FG001|Attended Education Session|Overall Study||18
10043734|NCT01988129|11168911|FG000|Screened for Sleep Disorders|Overall Study||416
10043735|NCT01988129|11168912|FG001|Screened for Sleep Disorders|Overall Study||15
10043736|NCT01988129|11168911|FG000|Completed 1-year Follow-up Survey|Overall Study||100
10043737|NCT01988129|11168912|FG001|Completed 1-year Follow-up Survey|Overall Study||4
10043738|NCT01988129|11168911|FG000|COMPLETED|Overall Study||601
10043739|NCT01988129|11168912|FG001|COMPLETED|Overall Study||588
10043740|NCT01988129|11168911|FG000|NOT COMPLETED|Overall Study||0
10043741|NCT01988129|11168912|FG001|NOT COMPLETED|Overall Study||0
10043742|NCT01988246|11168923|FG000|STARTED|Overall Study||15
10043743|NCT01988246|11168924|FG001|STARTED|Overall Study||15
10043744|NCT01988246|11168923|FG000|COMPLETED|Overall Study||14
10043745|NCT01988246|11168924|FG001|COMPLETED|Overall Study||15
10043746|NCT01988246|11168923|FG000|NOT COMPLETED|Overall Study||1
10043747|NCT01988246|11168924|FG001|NOT COMPLETED|Overall Study||0
10043748|NCT01988376|11168932|FG000|STARTED|Overall Study||129
10043749|NCT01988376|11168933|FG001|STARTED|Overall Study||129
10043750|NCT01988376|11168932|FG000|COMPLETED|Overall Study||129
10043751|NCT01988376|11168933|FG001|COMPLETED|Overall Study||129
10043752|NCT01988376|11168932|FG000|NOT COMPLETED|Overall Study||0
10043753|NCT01988376|11168933|FG001|NOT COMPLETED|Overall Study||0
10043754|NCT01988402|11168941|FG000|STARTED|Overall Study||16
10043755|NCT01988402|11168942|FG001|STARTED|Overall Study||19
10043756|NCT01988402|11168941|FG000|COMPLETED|Overall Study||14
10043757|NCT01988402|11168942|FG001|COMPLETED|Overall Study||17
10043758|NCT01988402|11168941|FG000|NOT COMPLETED|Overall Study||2
10043759|NCT01988402|11168942|FG001|NOT COMPLETED|Overall Study||2
10043760|NCT01988415|11168948|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
10043761|NCT01988415|11168948|FG000|COMPLETED|Overall Study||26
10043762|NCT01988415|11168948|FG000|NOT COMPLETED|Overall Study||0
10117341|NCT02538042|11248047|FG000|Completed All Post-Quit Visits|Overall Study||12
10117342|NCT02538042|11248048|FG001|Completed All Post-Quit Visits|Overall Study||12
10117343|NCT02538042|11248047|FG000|COMPLETED|Overall Study||6
10117344|NCT02538042|11248048|FG001|COMPLETED|Overall Study||6
10117345|NCT02538042|11248047|FG000|NOT COMPLETED|Overall Study||11
10117346|NCT02538042|11248048|FG001|NOT COMPLETED|Overall Study||11
10117347|NCT02538094|11248056|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2
10117348|NCT02538094|11248057|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5
10117349|NCT02538094|11248056|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2
10117350|NCT02538094|11248057|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4
10117351|NCT02538094|11248056|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
10117352|NCT02538094|11248057|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
10117353|NCT02538094|11248056|FG000|STARTED|Washout (4 Weeks)||2
10117354|NCT02538094|11248057|FG001|STARTED|Washout (4 Weeks)||4
10117355|NCT02538094|11248056|FG000|COMPLETED|Washout (4 Weeks)||2
10117356|NCT02538094|11248057|FG001|COMPLETED|Washout (4 Weeks)||3
10117357|NCT02538094|11248056|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10117358|NCT02538094|11248057|FG001|NOT COMPLETED|Washout (4 Weeks)||1
10117359|NCT02538094|11248056|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2
10117360|NCT02538094|11248057|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3
10117361|NCT02538094|11248056|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2
10117362|NCT02538094|11248057|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3
10117363|NCT02538094|11248056|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
10117364|NCT02538094|11248057|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
10117365|NCT02538107|11248063|FG000|STARTED|Overall Study||290
10117366|NCT02538107|11248063|FG000|COMPLETED|Overall Study||180
10117367|NCT02538107|11248063|FG000|NOT COMPLETED|Overall Study||110
10117368|NCT02538341|11248079|FG000|STARTED|Overall Study||310
10117369|NCT02538341|11248080|FG001|STARTED|Overall Study||307
10043763|NCT01988662|11168956|FG000|STARTED|Overall Study||104
10043764|NCT01988662|11168957|FG001|STARTED|Overall Study||101
10043765|NCT01988662|11168956|FG000|COMPLETED|Overall Study||100
10043766|NCT01988662|11168957|FG001|COMPLETED|Overall Study||99
10043767|NCT01988662|11168956|FG000|NOT COMPLETED|Overall Study||4
10043768|NCT01988662|11168957|FG001|NOT COMPLETED|Overall Study||2
10043769|NCT01988779|11168966|FG000|STARTED|Overall Study||12
10043770|NCT01988779|11168967|FG001|STARTED|Overall Study||13
10043771|NCT01988779|11168966|FG000|COMPLETED|Overall Study||9
10043772|NCT01988779|11168967|FG001|COMPLETED|Overall Study||11
10043773|NCT01988779|11168966|FG000|NOT COMPLETED|Overall Study||3
10043774|NCT01988779|11168967|FG001|NOT COMPLETED|Overall Study||2
10043775|NCT01988857|11168973|FG000|STARTED|Overall Study||300
10043776|NCT01988857|11168973|FG000|COMPLETED|Overall Study||300
10043777|NCT01988857|11168973|FG000|NOT COMPLETED|Overall Study||0
10043778|NCT01988922|11168980|FG000|STARTED|Overall Study||10
10043779|NCT01988922|11168981|FG001|STARTED|Overall Study||10
10043780|NCT01988922|11168982|FG002|STARTED|Overall Study||10
10043781|NCT01988922|11168980|FG000|COMPLETED|Overall Study||10
10043782|NCT01988922|11168981|FG001|COMPLETED|Overall Study||10
10043783|NCT01988922|11168982|FG002|COMPLETED|Overall Study||10
10043784|NCT01988922|11168980|FG000|NOT COMPLETED|Overall Study||0
10043785|NCT01988922|11168981|FG001|NOT COMPLETED|Overall Study||0
10043786|NCT01988922|11168982|FG002|NOT COMPLETED|Overall Study||0
10043787|NCT01989130|11168995|FG000|STARTED|Overall Study||43
10043788|NCT01989130|11168996|FG001|STARTED|Overall Study||27
10043789|NCT01989130|11168995|FG000|COMPLETED|Overall Study||43
10043790|NCT01989130|11168996|FG001|COMPLETED|Overall Study||27
10043791|NCT01989130|11168995|FG000|NOT COMPLETED|Overall Study||0
10043792|NCT01989130|11168996|FG001|NOT COMPLETED|Overall Study||0
10043793|NCT01989156|11169005|FG000|STARTED|Confinement Period (Population at Day 5)||80
10043794|NCT01989156|11169006|FG001|STARTED|Confinement Period (Population at Day 5)||41
10043795|NCT01989156|11169007|FG002|STARTED|Confinement Period (Population at Day 5)||39
10043796|NCT01989156|11169005|FG000|COMPLETED|Confinement Period (Population at Day 5)||80
10043797|NCT01989156|11169006|FG001|COMPLETED|Confinement Period (Population at Day 5)||40
10043798|NCT01989156|11169007|FG002|COMPLETED|Confinement Period (Population at Day 5)||34
10043799|NCT01989156|11169005|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0
10043800|NCT01989156|11169006|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10043801|NCT01989156|11169007|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5
10043802|NCT01989156|11169005|FG000|STARTED|End of Study (Population at Day 90)||80
10043803|NCT01989156|11169006|FG001|STARTED|End of Study (Population at Day 90)||40
10043804|NCT01989156|11169007|FG002|STARTED|End of Study (Population at Day 90)||34
10043805|NCT01989156|11169005|FG000|COMPLETED|End of Study (Population at Day 90)||73
10043806|NCT01989156|11169006|FG001|COMPLETED|End of Study (Population at Day 90)||35
10043807|NCT01989156|11169007|FG002|COMPLETED|End of Study (Population at Day 90)||31
10043808|NCT01989156|11169005|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7
10043809|NCT01989156|11169006|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5
10043810|NCT01989156|11169007|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3
10043811|NCT01989169|11169017|FG000|STARTED|Period 1||15
10043812|NCT01989169|11169018|FG001|STARTED|Period 1||15
10043813|NCT01989169|11169017|FG000|COMPLETED|Period 1||15
10043814|NCT01989169|11169018|FG001|COMPLETED|Period 1||15
10043815|NCT01989169|11169017|FG000|NOT COMPLETED|Period 1||0
10043816|NCT01989169|11169018|FG001|NOT COMPLETED|Period 1||0
10043817|NCT01989169|11169017|FG000|STARTED|Period 2||15
10043818|NCT01989169|11169018|FG001|STARTED|Period 2||15
10043819|NCT01989169|11169017|FG000|COMPLETED|Period 2||15
10043820|NCT01989169|11169018|FG001|COMPLETED|Period 2||14
10117370|NCT02538341|11248079|FG000|Week 6 (Primary Outcome)|Overall Study||303
10117371|NCT02538341|11248080|FG001|Week 6 (Primary Outcome)|Overall Study||299
10117372|NCT02538341|11248079|FG000|Month 6 (Safety Outcome)|Overall Study||276
10117373|NCT02538341|11248080|FG001|Month 6 (Safety Outcome)|Overall Study||260
10117374|NCT02538341|11248079|FG000|1 Year Visit|Overall Study||254
10117375|NCT02538341|11248080|FG001|1 Year Visit|Overall Study||0
10117376|NCT02538341|11248079|FG000|COMPLETED|Overall Study||254
10117377|NCT02538341|11248080|FG001|COMPLETED|Overall Study||260
10117378|NCT02538341|11248079|FG000|NOT COMPLETED|Overall Study||56
10117379|NCT02538341|11248080|FG001|NOT COMPLETED|Overall Study||47
10117380|NCT02538354|11248088|FG000|STARTED|Overall Study||40
10117381|NCT02538354|11248089|FG001|STARTED|Overall Study||30
10117382|NCT02538354|11248088|FG000|COMPLETED|Overall Study||40
10117383|NCT02538354|11248089|FG001|COMPLETED|Overall Study||30
10117384|NCT02538354|11248088|FG000|NOT COMPLETED|Overall Study||0
10117385|NCT02538354|11248089|FG001|NOT COMPLETED|Overall Study||0
10117386|NCT02538419|11248097|FG000|STARTED|Overall Study||20
10117387|NCT02538419|11248098|FG001|STARTED|Overall Study||20
10117388|NCT02538419|11248097|FG000|COMPLETED|Overall Study||20
10043821|NCT01989169|11169017|FG000|NOT COMPLETED|Period 2||0
10043822|NCT01989169|11169018|FG001|NOT COMPLETED|Period 2||1
10043823|NCT01989195|11169024|FG000|STARTED|Overall Study||6
10043824|NCT01989195|11169024|FG000|COMPLETED|Overall Study||6
10043825|NCT01989195|11169024|FG000|NOT COMPLETED|Overall Study||0
10043826|NCT01989208|11169033|FG000|STARTED|200 mg (7 Days)||4
10043827|NCT01989208|11169034|FG001|STARTED|200 mg (7 Days)||12
10043828|NCT01989208|11169033|FG000|COMPLETED|200 mg (7 Days)||4
10117389|NCT02538419|11248098|FG001|COMPLETED|Overall Study||20
10117390|NCT02538419|11248097|FG000|NOT COMPLETED|Overall Study||0
10117391|NCT02538419|11248098|FG001|NOT COMPLETED|Overall Study||0
10117392|NCT02538471|11248104|FG000|STARTED|Overall Study||3
10043829|NCT01989208|11169034|FG001|COMPLETED|200 mg (7 Days)||11
10043830|NCT01989208|11169033|FG000|NOT COMPLETED|200 mg (7 Days)||0
10043831|NCT01989208|11169034|FG001|NOT COMPLETED|200 mg (7 Days)||1
10043832|NCT01989208|11169033|FG000|STARTED|400 mg (7 Days)||4
10043833|NCT01989208|11169034|FG001|STARTED|400 mg (7 Days)||11
10043834|NCT01989208|11169033|FG000|COMPLETED|400 mg (7 Days)||4
10043835|NCT01989208|11169034|FG001|COMPLETED|400 mg (7 Days)||11
10043836|NCT01989208|11169033|FG000|NOT COMPLETED|400 mg (7 Days)||0
10043837|NCT01989208|11169034|FG001|NOT COMPLETED|400 mg (7 Days)||0
10043838|NCT01989208|11169033|FG000|STARTED|800 mg (7 Days)||4
10043839|NCT01989208|11169034|FG001|STARTED|800 mg (7 Days)||11
10043840|NCT01989208|11169033|FG000|COMPLETED|800 mg (7 Days)||4
10043841|NCT01989208|11169034|FG001|COMPLETED|800 mg (7 Days)||11
10043842|NCT01989208|11169033|FG000|NOT COMPLETED|800 mg (7 Days)||0
10043843|NCT01989208|11169034|FG001|NOT COMPLETED|800 mg (7 Days)||0
10043844|NCT01989221|11169052|FG000|STARTED|Overall Study||14
10043845|NCT01989221|11169052|FG000|COMPLETED|Overall Study||14
10043846|NCT01989221|11169052|FG000|NOT COMPLETED|Overall Study||0
10043847|NCT01989455|11169061|FG000|STARTED|Overall Study||14
10043848|NCT01989455|11169062|FG001|STARTED|Overall Study||14
10043849|NCT01989455|11169063|FG002|STARTED|Overall Study||14
10043850|NCT01989455|11169064|FG003|STARTED|Overall Study||14
10043851|NCT01989455|11169065|FG004|STARTED|Overall Study||8
10043852|NCT01989455|11169061|FG000|COMPLETED|Overall Study||14
10043853|NCT01989455|11169062|FG001|COMPLETED|Overall Study||12
10043854|NCT01989455|11169063|FG002|COMPLETED|Overall Study||13
10043855|NCT01989455|11169064|FG003|COMPLETED|Overall Study||14
10043856|NCT01989455|11169065|FG004|COMPLETED|Overall Study||7
10043857|NCT01989455|11169061|FG000|NOT COMPLETED|Overall Study||0
10043858|NCT01989455|11169062|FG001|NOT COMPLETED|Overall Study||2
10043859|NCT01989455|11169063|FG002|NOT COMPLETED|Overall Study||1
10043860|NCT01989455|11169064|FG003|NOT COMPLETED|Overall Study||0
10043861|NCT01989455|11169065|FG004|NOT COMPLETED|Overall Study||1
10043862|NCT01989468|11169084|FG000|STARTED|Overall Study||138
10043863|NCT01989468|11169085|FG001|STARTED|Overall Study||139
10043864|NCT01989468|11169086|FG002|STARTED|Overall Study||64
10043865|NCT01989468|11169087|FG003|STARTED|Overall Study||65
10043866|NCT01989468|11169088|FG004|STARTED|Overall Study||8
10043867|NCT01989468|11169084|FG000|COMPLETED|Overall Study||91
10043868|NCT01989468|11169085|FG001|COMPLETED|Overall Study||102
10043869|NCT01989468|11169086|FG002|COMPLETED|Overall Study||45
10043870|NCT01989468|11169087|FG003|COMPLETED|Overall Study||49
10043871|NCT01989468|11169088|FG004|COMPLETED|Overall Study||0
10043872|NCT01989468|11169084|FG000|NOT COMPLETED|Overall Study||47
10043873|NCT01989468|11169085|FG001|NOT COMPLETED|Overall Study||37
10043874|NCT01989468|11169086|FG002|NOT COMPLETED|Overall Study||19
10043875|NCT01989468|11169087|FG003|NOT COMPLETED|Overall Study||16
10043876|NCT01989468|11169088|FG004|NOT COMPLETED|Overall Study||8
10043877|NCT01989546|11169101|FG000|STARTED|Overall Study||9
10043878|NCT01989546|11169101|FG000|COMPLETED|Overall Study||0
10043879|NCT01989546|11169101|FG000|NOT COMPLETED|Overall Study||9
10043880|NCT01989572|11169111|FG000|STARTED|Overall Study||109
10043881|NCT01989572|11169112|FG001|STARTED|Overall Study||111
10043882|NCT01989572|11169113|FG002|STARTED|Overall Study||109
10043883|NCT01989572|11169114|FG003|STARTED|Overall Study||107
10043884|NCT01989572|11169115|FG004|STARTED|Overall Study||190
10043885|NCT01989572|11169116|FG005|STARTED|Overall Study||189
10043886|NCT01989572|11169111|FG000|Treated|Overall Study||104
10043887|NCT01989572|11169112|FG001|Treated|Overall Study||110
10043888|NCT01989572|11169113|FG002|Treated|Overall Study||107
10043889|NCT01989572|11169114|FG003|Treated|Overall Study||104
10043890|NCT01989572|11169115|FG004|Treated|Overall Study||186
10043891|NCT01989572|11169116|FG005|Treated|Overall Study||171
10043892|NCT01989572|11169111|FG000|COMPLETED|Overall Study||54
10043893|NCT01989572|11169112|FG001|COMPLETED|Overall Study||53
10043894|NCT01989572|11169113|FG002|COMPLETED|Overall Study||47
10043895|NCT01989572|11169114|FG003|COMPLETED|Overall Study||56
10043896|NCT01989572|11169115|FG004|COMPLETED|Overall Study||92
10043897|NCT01989572|11169116|FG005|COMPLETED|Overall Study||79
10043898|NCT01989572|11169111|FG000|NOT COMPLETED|Overall Study||55
10043899|NCT01989572|11169112|FG001|NOT COMPLETED|Overall Study||58
10043900|NCT01989572|11169113|FG002|NOT COMPLETED|Overall Study||62
10043901|NCT01989572|11169114|FG003|NOT COMPLETED|Overall Study||51
10043902|NCT01989572|11169115|FG004|NOT COMPLETED|Overall Study||98
10043903|NCT01989572|11169116|FG005|NOT COMPLETED|Overall Study||110
10043904|NCT01989689|11169136|FG000|STARTED|Baseline||11
10043905|NCT01989689|11169137|FG001|STARTED|Baseline||13
10043906|NCT01989689|11169136|FG000|COMPLETED|Baseline||11
10043907|NCT01989689|11169137|FG001|COMPLETED|Baseline||13
10043908|NCT01989689|11169136|FG000|NOT COMPLETED|Baseline||0
10043909|NCT01989689|11169137|FG001|NOT COMPLETED|Baseline||0
10043910|NCT01989689|11169136|FG000|STARTED|Treatment Period 1 ( 3 Months)||11
10043911|NCT01989689|11169137|FG001|STARTED|Treatment Period 1 ( 3 Months)||13
10043912|NCT01989689|11169136|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11
10043913|NCT01989689|11169137|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10
10043914|NCT01989689|11169136|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
10043915|NCT01989689|11169137|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
10043916|NCT01989689|11169136|FG000|STARTED|Treatment Period ( 3 Months)||11
10043917|NCT01989689|11169137|FG001|STARTED|Treatment Period ( 3 Months)||10
10043918|NCT01989689|11169136|FG000|COMPLETED|Treatment Period ( 3 Months)||11
10043919|NCT01989689|11169137|FG001|COMPLETED|Treatment Period ( 3 Months)||10
10043920|NCT01989689|11169136|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0
10043921|NCT01989689|11169137|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0
10043922|NCT01989754|11169147|FG000|STARTED|Overall Study||2905
10043923|NCT01989754|11169148|FG001|STARTED|Overall Study||2907
10043924|NCT01989754|11169147|FG000|Treated|Overall Study||2903
10043925|NCT01989754|11169148|FG001|Treated|Overall Study||2904
10043926|NCT01989754|11169147|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866
10043927|NCT01989754|11169148|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872
10043928|NCT01989754|11169147|FG000|NOT COMPLETED|Overall Study||39
10043929|NCT01989754|11169148|FG001|NOT COMPLETED|Overall Study||35
10043930|NCT01989793|11169156|FG000|STARTED|Overall Study||18
10043931|NCT01989793|11169157|FG001|STARTED|Overall Study||19
10043932|NCT01989793|11169156|FG000|COMPLETED|Overall Study||10
10043933|NCT01989793|11169157|FG001|COMPLETED|Overall Study||15
10043934|NCT01989793|11169156|FG000|NOT COMPLETED|Overall Study||8
10043935|NCT01989793|11169157|FG001|NOT COMPLETED|Overall Study||4
10043936|NCT01989910|11169165|FG000|STARTED|Overall Study||53
10043937|NCT01989910|11169166|FG001|STARTED|Overall Study||54
10043938|NCT01989910|11169165|FG000|COMPLETED|Overall Study||51
10043939|NCT01989910|11169166|FG001|COMPLETED|Overall Study||54
10043940|NCT01989910|11169165|FG000|NOT COMPLETED|Overall Study||2
10043941|NCT01989910|11169166|FG001|NOT COMPLETED|Overall Study||0
10043942|NCT01989975|11169172|FG000|STARTED|Overall Study||40
10043943|NCT01989975|11169172|FG000|COMPLETED|Overall Study||40
10043944|NCT01989975|11169172|FG000|NOT COMPLETED|Overall Study||0
10043945|NCT01990261|11169176|FG000|STARTED|Overall Study||33
10043946|NCT01990261|11169176|FG000|Treated|Overall Study||29
10043947|NCT01990261|11169176|FG000|COMPLETED|Overall Study||8
10043948|NCT01990261|11169176|FG000|NOT COMPLETED|Overall Study||25
10043949|NCT01990300|11169180|FG000|STARTED|Overall Study||3281
10043950|NCT01990300|11169180|FG000|COMPLETED|Overall Study||3139
10043951|NCT01990300|11169180|FG000|NOT COMPLETED|Overall Study||142
10043952|NCT01990313|11169184|FG000|STARTED|Overall Study||15
10043953|NCT01990313|11169184|FG000|COMPLETED|Overall Study||14
10043954|NCT01990313|11169184|FG000|NOT COMPLETED|Overall Study||1
10043955|NCT01990339|11169188|FG000|STARTED|Overall Study||14965
10043956|NCT01990339|11169188|FG000|COMPLETED|Overall Study||12653
10043957|NCT01990339|11169188|FG000|NOT COMPLETED|Overall Study||2312
10043958|NCT01990495|11169194|FG000|STARTED|Overall Study||18
10043959|NCT01990495|11169195|FG001|STARTED|Overall Study||19
10043960|NCT01990495|11169194|FG000|COMPLETED|Overall Study||13
10043961|NCT01990495|11169195|FG001|COMPLETED|Overall Study||15
10043962|NCT01990495|11169194|FG000|NOT COMPLETED|Overall Study||5
10043963|NCT01990495|11169195|FG001|NOT COMPLETED|Overall Study||4
10043964|NCT01990534|11169203|FG000|STARTED|Overall Study||60
10043965|NCT01990534|11169203|FG000|COMPLETED|Overall Study||25
10043966|NCT01990534|11169203|FG000|NOT COMPLETED|Overall Study||35
10043967|NCT01990560|11169207|FG000|STARTED|Overall Study||8
10043968|NCT01990560|11169207|FG000|COMPLETED|Overall Study||7
10043969|NCT01990560|11169207|FG000|NOT COMPLETED|Overall Study||1
10043970|NCT01990573|11169214|FG000|STARTED|Overall Study||20
10043971|NCT01990573|11169215|FG001|STARTED|Overall Study||14
10043972|NCT01990573|11169216|FG002|STARTED|Overall Study||17
10043973|NCT01990573|11169214|FG000|COMPLETED|Overall Study||20
10043974|NCT01990573|11169215|FG001|COMPLETED|Overall Study||14
10043975|NCT01990573|11169216|FG002|COMPLETED|Overall Study||16
10043976|NCT01990573|11169214|FG000|NOT COMPLETED|Overall Study||0
10043977|NCT01990573|11169215|FG001|NOT COMPLETED|Overall Study||0
10043978|NCT01990573|11169216|FG002|NOT COMPLETED|Overall Study||1
10043979|NCT01990612|11169226|FG000|STARTED|Overall Study||3044
10043980|NCT01990612|11169227|FG001|STARTED|Overall Study||3062
10043981|NCT01990612|11169226|FG000|COMPLETED|Overall Study||3037
10043982|NCT01990612|11169227|FG001|COMPLETED|Overall Study||3059
10043983|NCT01990612|11169226|FG000|NOT COMPLETED|Overall Study||7
10043984|NCT01990612|11169227|FG001|NOT COMPLETED|Overall Study||3
10043985|NCT01990664|11169235|FG000|STARTED|Overall Study||102
10043986|NCT01990664|11169236|FG001|STARTED|Overall Study||90
10043987|NCT01990664|11169235|FG000|COMPLETED|Overall Study||95
10043988|NCT01990664|11169236|FG001|COMPLETED|Overall Study||79
10043989|NCT01990664|11169235|FG000|NOT COMPLETED|Overall Study||7
10117393|NCT02538471|11248104|FG000|COMPLETED|Overall Study||1
10117394|NCT02538471|11248104|FG000|NOT COMPLETED|Overall Study||2
10117395|NCT02538523|11248110|FG000|STARTED|Overall Study||29
10117396|NCT02538523|11248111|FG001|STARTED|Overall Study||29
10117397|NCT02538523|11248110|FG000|COMPLETED|Overall Study||29
10117398|NCT02538523|11248111|FG001|COMPLETED|Overall Study||29
10117399|NCT02538523|11248110|FG000|NOT COMPLETED|Overall Study||0
10117400|NCT02538523|11248111|FG001|NOT COMPLETED|Overall Study||0
10117401|NCT02538614|11248117|FG000|STARTED|Overall Study||2
10117402|NCT02538614|11248117|FG000|COMPLETED|Overall Study||0
10117403|NCT02538614|11248117|FG000|NOT COMPLETED|Overall Study||2
10117404|NCT02538679|11248126|FG000|STARTED|Overall Study||24
10117405|NCT02538679|11248127|FG001|STARTED|Overall Study||54
10117406|NCT02538679|11248128|FG002|STARTED|Overall Study||49
10117407|NCT02538679|11248126|FG000|COMPLETED|Overall Study||21
10117408|NCT02538679|11248127|FG001|COMPLETED|Overall Study||45
10117409|NCT02538679|11248128|FG002|COMPLETED|Overall Study||41
10117410|NCT02538679|11248126|FG000|NOT COMPLETED|Overall Study||3
10117411|NCT02538679|11248127|FG001|NOT COMPLETED|Overall Study||9
10117412|NCT02538679|11248128|FG002|NOT COMPLETED|Overall Study||8
10043990|NCT01990664|11169236|FG001|NOT COMPLETED|Overall Study||11
10117413|NCT02538783|11248138|FG000|STARTED|Overall Study||130
10117414|NCT02538783|11248139|FG001|STARTED|Overall Study||129
10043991|NCT01990677|11169244|FG000|STARTED|Overall Study||12
10043992|NCT01990677|11169245|FG001|STARTED|Overall Study||6
10043993|NCT01990677|11169244|FG000|COMPLETED|Overall Study||10
10043994|NCT01990677|11169245|FG001|COMPLETED|Overall Study||5
10043995|NCT01990677|11169244|FG000|NOT COMPLETED|Overall Study||2
10043996|NCT01990677|11169245|FG001|NOT COMPLETED|Overall Study||1
10043997|NCT01990703|11169253|FG000|STARTED|Overall Study||147
10043998|NCT01990703|11169254|FG001|STARTED|Overall Study||138
10043999|NCT01990703|11169253|FG000|COMPLETED|Overall Study||108
10044000|NCT01990703|11169254|FG001|COMPLETED|Overall Study||93
10044001|NCT01990703|11169253|FG000|NOT COMPLETED|Overall Study||39
10044002|NCT01990703|11169254|FG001|NOT COMPLETED|Overall Study||45
10044003|NCT01990742|11169262|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
10044004|NCT01990742|11169263|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
10044005|NCT01990742|11169262|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
10044006|NCT01990742|11169263|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
10044007|NCT01990742|11169262|FG000|NOT COMPLETED|Overall Study||407
10044008|NCT01990742|11169263|FG001|NOT COMPLETED|Overall Study||1353
10044009|NCT01990768|11169272|FG000|STARTED|Intervention Started||345
10044010|NCT01990768|11169273|FG001|STARTED|Intervention Started||345
10044011|NCT01990768|11169274|FG002|STARTED|Intervention Started||373
10044012|NCT01990768|11169272|FG000|COMPLETED|Intervention Started||309
10044013|NCT01990768|11169273|FG001|COMPLETED|Intervention Started||312
10044014|NCT01990768|11169274|FG002|COMPLETED|Intervention Started||346
10044015|NCT01990768|11169272|FG000|NOT COMPLETED|Intervention Started||36
10044016|NCT01990768|11169273|FG001|NOT COMPLETED|Intervention Started||33
10044017|NCT01990768|11169274|FG002|NOT COMPLETED|Intervention Started||27
10044018|NCT01990768|11169272|FG000|STARTED|Prehospital Study Drug Infusion||309
10044019|NCT01990768|11169273|FG001|STARTED|Prehospital Study Drug Infusion||312
10044020|NCT01990768|11169274|FG002|STARTED|Prehospital Study Drug Infusion||346
10044021|NCT01990768|11169272|FG000|COMPLETED|Prehospital Study Drug Infusion||290
10044022|NCT01990768|11169273|FG001|COMPLETED|Prehospital Study Drug Infusion||285
10044023|NCT01990768|11169274|FG002|COMPLETED|Prehospital Study Drug Infusion||327
10044024|NCT01990768|11169272|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19
10044025|NCT01990768|11169273|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27
10044026|NCT01990768|11169274|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19
10044027|NCT01990768|11169272|FG000|STARTED|In-Hospital Study Drug Infusion||309
10044028|NCT01990768|11169273|FG001|STARTED|In-Hospital Study Drug Infusion||312
10044029|NCT01990768|11169274|FG002|STARTED|In-Hospital Study Drug Infusion||346
10044030|NCT01990768|11169272|FG000|COMPLETED|In-Hospital Study Drug Infusion||214
10044031|NCT01990768|11169273|FG001|COMPLETED|In-Hospital Study Drug Infusion||229
10044032|NCT01990768|11169274|FG002|COMPLETED|In-Hospital Study Drug Infusion||266
10044033|NCT01990768|11169272|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95
10044034|NCT01990768|11169273|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83
10044035|NCT01990768|11169274|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80
10044036|NCT01990768|11169272|FG000|STARTED|6-Month Follow-up||309
10044037|NCT01990768|11169273|FG001|STARTED|6-Month Follow-up||312
10044038|NCT01990768|11169274|FG002|STARTED|6-Month Follow-up||346
10044039|NCT01990768|11169272|FG000|COMPLETED|6-Month Follow-up||270
10044040|NCT01990768|11169273|FG001|COMPLETED|6-Month Follow-up||261
10044041|NCT01990768|11169274|FG002|COMPLETED|6-Month Follow-up||288
10044042|NCT01990768|11169272|FG000|NOT COMPLETED|6-Month Follow-up||39
10044043|NCT01990768|11169273|FG001|NOT COMPLETED|6-Month Follow-up||51
10044044|NCT01990768|11169274|FG002|NOT COMPLETED|6-Month Follow-up||58
10044045|NCT01990794|11169283|FG000|STARTED|Overall Study||13
10044046|NCT01990794|11169283|FG000|One Month Into Study|Overall Study||10
10044047|NCT01990794|11169283|FG000|COMPLETED|Overall Study||10
10044048|NCT01990794|11169283|FG000|NOT COMPLETED|Overall Study||3
10044049|NCT01990820|11169372|FG000|STARTED|Overall Study||13
10044050|NCT01990820|11169373|FG001|STARTED|Overall Study||12
10044051|NCT01990820|11169372|FG000|COMPLETED|Overall Study||13
10044052|NCT01990820|11169373|FG001|COMPLETED|Overall Study||12
10044053|NCT01990820|11169372|FG000|NOT COMPLETED|Overall Study||0
10044054|NCT01990820|11169373|FG001|NOT COMPLETED|Overall Study||0
10044055|NCT01990859|11169379|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20
10044056|NCT01990859|11169379|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
10044057|NCT01990859|11169379|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
10044058|NCT01990859|11169379|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
10044059|NCT01990859|11169379|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
10044060|NCT01990859|11169379|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
10044061|NCT01990859|11169379|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
10044062|NCT01990859|11169379|FG000|COMPLETED|90 Day Follow Up for All Participants||20
10044063|NCT01990859|11169379|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0
10044064|NCT01990898|11169384|FG000|STARTED|Overall Study||26
10044065|NCT01990898|11169384|FG000|3 Months|Overall Study||22
10044066|NCT01990898|11169384|FG000|COMPLETED|Overall Study||22
10117415|NCT02538783|11248138|FG000|COMPLETED|Overall Study||130
10044067|NCT01990898|11169384|FG000|NOT COMPLETED|Overall Study||4
10044068|NCT01990950|11169388|FG000|STARTED|Overall Study||21
10044069|NCT01990950|11169388|FG000|COMPLETED|Overall Study||10
10117416|NCT02538783|11248139|FG001|COMPLETED|Overall Study||128
10044070|NCT01990950|11169388|FG000|NOT COMPLETED|Overall Study||11
10044071|NCT01991197|11169394|FG000|STARTED|Overall Study||9
10044072|NCT01991197|11169395|FG001|STARTED|Overall Study||11
10044073|NCT01991197|11169394|FG000|COMPLETED|Overall Study||6
10044074|NCT01991197|11169395|FG001|COMPLETED|Overall Study||8
10044075|NCT01991197|11169394|FG000|NOT COMPLETED|Overall Study||3
10044076|NCT01991197|11169395|FG001|NOT COMPLETED|Overall Study||3
10044077|NCT01991314|11169408|FG000|STARTED|Overall Study||45
10044078|NCT01991314|11169409|FG001|STARTED|Overall Study||43
10044079|NCT01991314|11169408|FG000|COMPLETED|Overall Study||34
10044080|NCT01991314|11169409|FG001|COMPLETED|Overall Study||32
10044081|NCT01991314|11169408|FG000|NOT COMPLETED|Overall Study||11
10044082|NCT01991314|11169409|FG001|NOT COMPLETED|Overall Study||11
10044083|NCT01991470|11169415|FG000|STARTED|Enlite 1 Period||161
10044084|NCT01991470|11169415|FG000|COMPLETED|Enlite 1 Period||141
10044085|NCT01991470|11169415|FG000|NOT COMPLETED|Enlite 1 Period||20
10044086|NCT01991470|11169415|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
10044087|NCT01991470|11169415|FG000|COMPLETED|Enlite 3 Period||146
10044088|NCT01991470|11169415|FG000|NOT COMPLETED|Enlite 3 Period||12
10044089|NCT01991483|11169431|FG000|STARTED|Dose Level: Placebo||7
10044090|NCT01991483|11169432|FG001|STARTED|Dose Level: Placebo||0
10044091|NCT01991483|11169433|FG002|STARTED|Dose Level: Placebo||0
10044092|NCT01991483|11169434|FG003|STARTED|Dose Level: Placebo||0
10044093|NCT01991483|11169431|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
10044094|NCT01991483|11169432|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
10044095|NCT01991483|11169433|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
10044096|NCT01991483|11169434|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
10044097|NCT01991483|11169431|FG000|COMPLETED|Dose Level: Placebo||7
10044098|NCT01991483|11169432|FG001|COMPLETED|Dose Level: Placebo||0
10044099|NCT01991483|11169433|FG002|COMPLETED|Dose Level: Placebo||0
10044100|NCT01991483|11169434|FG003|COMPLETED|Dose Level: Placebo||0
10044101|NCT01991483|11169431|FG000|NOT COMPLETED|Dose Level: Placebo||0
10044102|NCT01991483|11169432|FG001|NOT COMPLETED|Dose Level: Placebo||0
10044103|NCT01991483|11169433|FG002|NOT COMPLETED|Dose Level: Placebo||0
10044104|NCT01991483|11169434|FG003|NOT COMPLETED|Dose Level: Placebo||0
10044105|NCT01991483|11169431|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
10044106|NCT01991483|11169432|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
10044107|NCT01991483|11169433|FG002|STARTED|Dose Level 300 mg||0
10044108|NCT01991483|11169434|FG003|STARTED|Dose Level 300 mg||0
10044109|NCT01991483|11169431|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
10044110|NCT01991483|11169432|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
10044111|NCT01991483|11169433|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
10044112|NCT01991483|11169434|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
10044113|NCT01991483|11169431|FG000|COMPLETED|Dose Level 300 mg||0
10044114|NCT01991483|11169432|FG001|COMPLETED|Dose Level 300 mg||6
10044115|NCT01991483|11169433|FG002|COMPLETED|Dose Level 300 mg||0
10044116|NCT01991483|11169434|FG003|COMPLETED|Dose Level 300 mg||0
10044117|NCT01991483|11169431|FG000|NOT COMPLETED|Dose Level 300 mg||0
10044118|NCT01991483|11169432|FG001|NOT COMPLETED|Dose Level 300 mg||0
10044119|NCT01991483|11169433|FG002|NOT COMPLETED|Dose Level 300 mg||0
10044120|NCT01991483|11169434|FG003|NOT COMPLETED|Dose Level 300 mg||0
10044121|NCT01991483|11169431|FG000|STARTED|Dose Level 600 mg||0
10044122|NCT01991483|11169432|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
10044123|NCT01991483|11169433|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
10044124|NCT01991483|11169434|FG003|STARTED|Dose Level 600 mg||0
10044125|NCT01991483|11169431|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
10044126|NCT01991483|11169432|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
10044127|NCT01991483|11169433|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
10044128|NCT01991483|11169434|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
10044129|NCT01991483|11169431|FG000|COMPLETED|Dose Level 600 mg||0
10044130|NCT01991483|11169432|FG001|COMPLETED|Dose Level 600 mg||0
10044131|NCT01991483|11169433|FG002|COMPLETED|Dose Level 600 mg||9
10044132|NCT01991483|11169434|FG003|COMPLETED|Dose Level 600 mg||0
10044133|NCT01991483|11169431|FG000|NOT COMPLETED|Dose Level 600 mg||0
10044134|NCT01991483|11169432|FG001|NOT COMPLETED|Dose Level 600 mg||0
10044135|NCT01991483|11169433|FG002|NOT COMPLETED|Dose Level 600 mg||2
10044136|NCT01991483|11169434|FG003|NOT COMPLETED|Dose Level 600 mg||0
10044137|NCT01991483|11169431|FG000|STARTED|Dose Level 1000 mg||0
10044138|NCT01991483|11169432|FG001|STARTED|Dose Level 1000 mg||0
10044139|NCT01991483|11169433|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
10044140|NCT01991483|11169434|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
10044141|NCT01991483|11169431|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
10044142|NCT01991483|11169432|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
10044143|NCT01991483|11169433|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
10044144|NCT01991483|11169434|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
10044145|NCT01991483|11169431|FG000|COMPLETED|Dose Level 1000 mg||0
10044146|NCT01991483|11169432|FG001|COMPLETED|Dose Level 1000 mg||0
10044147|NCT01991483|11169433|FG002|COMPLETED|Dose Level 1000 mg||0
10044148|NCT01991483|11169434|FG003|COMPLETED|Dose Level 1000 mg||3
10044149|NCT01991483|11169431|FG000|NOT COMPLETED|Dose Level 1000 mg||0
10044150|NCT01991483|11169432|FG001|NOT COMPLETED|Dose Level 1000 mg||0
10044151|NCT01991483|11169433|FG002|NOT COMPLETED|Dose Level 1000 mg||0
10044152|NCT01991483|11169434|FG003|NOT COMPLETED|Dose Level 1000 mg||1
10044153|NCT01991522|11169449|FG000|STARTED|Overall Study||16
10044154|NCT01991522|11169450|FG001|STARTED|Overall Study||17
10044155|NCT01991522|11169449|FG000|COMPLETED|Overall Study||16
10044156|NCT01991522|11169450|FG001|COMPLETED|Overall Study||17
10044157|NCT01991522|11169449|FG000|NOT COMPLETED|Overall Study||0
10044158|NCT01991522|11169450|FG001|NOT COMPLETED|Overall Study||0
10044159|NCT01991548|11169456|FG000|STARTED|Overall Study||40
10044160|NCT01991548|11169456|FG000|COMPLETED|Overall Study||39
10044161|NCT01991548|11169456|FG000|NOT COMPLETED|Overall Study||1
10044162|NCT01991743|11169464|FG000|STARTED|Overall Study||60
10044163|NCT01991743|11169465|FG001|STARTED|Overall Study||60
10044164|NCT01991743|11169466|FG002|STARTED|Overall Study||60
10044165|NCT01991743|11169467|FG003|STARTED|Overall Study||60
10044166|NCT01991743|11169464|FG000|COMPLETED|Overall Study||60
10044167|NCT01991743|11169465|FG001|COMPLETED|Overall Study||60
10044168|NCT01991743|11169466|FG002|COMPLETED|Overall Study||59
10044169|NCT01991743|11169467|FG003|COMPLETED|Overall Study||60
10044170|NCT01991743|11169464|FG000|NOT COMPLETED|Overall Study||0
10044171|NCT01991743|11169465|FG001|NOT COMPLETED|Overall Study||0
10044172|NCT01991743|11169466|FG002|NOT COMPLETED|Overall Study||1
10044173|NCT01991743|11169467|FG003|NOT COMPLETED|Overall Study||0
10044174|NCT01991795|11169479|FG000|STARTED|Overall Study||9645
10044175|NCT01991795|11169480|FG001|STARTED|Overall Study||9626
10044176|NCT01991795|11169479|FG000|COMPLETED|Overall Study||9496
10044177|NCT01991795|11169480|FG001|COMPLETED|Overall Study||9503
10044178|NCT01991795|11169479|FG000|NOT COMPLETED|Overall Study||149
10044179|NCT01991795|11169480|FG001|NOT COMPLETED|Overall Study||123
10044180|NCT01991808|11169486|FG000|STARTED|Overall Study||16
10044181|NCT01991808|11169486|FG000|COMPLETED|Overall Study||16
10044182|NCT01991808|11169486|FG000|NOT COMPLETED|Overall Study||0
10044183|NCT01991821|11169492|FG000|STARTED|Overall Study||169
10044184|NCT01991821|11169493|FG001|STARTED|Overall Study||178
10044185|NCT01991821|11169492|FG000|COMPLETED|Overall Study||6
10044186|NCT01991821|11169493|FG001|COMPLETED|Overall Study||11
10044187|NCT01991821|11169492|FG000|NOT COMPLETED|Overall Study||163
10044188|NCT01991821|11169493|FG001|NOT COMPLETED|Overall Study||167
10044189|NCT01991860|11169503|FG000|STARTED|Overall Study||176
10044190|NCT01991860|11169504|FG001|STARTED|Overall Study||166
10044191|NCT01991860|11169503|FG000|COMPLETED|Overall Study||172
10044192|NCT01991860|11169504|FG001|COMPLETED|Overall Study||164
10044193|NCT01991860|11169503|FG000|NOT COMPLETED|Overall Study||4
10044194|NCT01991860|11169504|FG001|NOT COMPLETED|Overall Study||2
10044195|NCT01991977|11169510|FG000|STARTED|Overall Study||91
10044196|NCT01991977|11169510|FG000|Received PET Tracer|Overall Study||84
10044197|NCT01991977|11169510|FG000|Received IMRT Treatment|Overall Study||79
10044198|NCT01991977|11169510|FG000|Evaluable for the Primary Outcome|Overall Study||39
10044199|NCT01991977|11169510|FG000|COMPLETED|Overall Study||79
10044200|NCT01991977|11169510|FG000|NOT COMPLETED|Overall Study||12
10044201|NCT01991990|11169516|FG000|STARTED|Overall Study||6
10044202|NCT01991990|11169517|FG001|STARTED|Overall Study||12
10044203|NCT01991990|11169516|FG000|COMPLETED|Overall Study||6
10044204|NCT01991990|11169517|FG001|COMPLETED|Overall Study||12
10044205|NCT01991990|11169516|FG000|NOT COMPLETED|Overall Study||0
10044206|NCT01991990|11169517|FG001|NOT COMPLETED|Overall Study||0
10044207|NCT01992016|11169529|FG000|STARTED|Overall Study||4
10044208|NCT01992016|11169530|FG001|STARTED|Overall Study||7
10044209|NCT01992016|11169529|FG000|COMPLETED|Overall Study||4
10044210|NCT01992016|11169530|FG001|COMPLETED|Overall Study||7
10044211|NCT01992016|11169529|FG000|NOT COMPLETED|Overall Study||0
10044212|NCT01992016|11169530|FG001|NOT COMPLETED|Overall Study||0
10044213|NCT01992094|11169539|FG000|STARTED|Overall Study||1335
10044214|NCT01992094|11169540|FG001|STARTED|Overall Study||676
10044215|NCT01992094|11169541|FG002|STARTED|Overall Study||669
10044216|NCT01992094|11169539|FG000|COMPLETED|Overall Study||1285
10044217|NCT01992094|11169540|FG001|COMPLETED|Overall Study||652
10044218|NCT01992094|11169541|FG002|COMPLETED|Overall Study||648
10044219|NCT01992094|11169539|FG000|NOT COMPLETED|Overall Study||50
10044220|NCT01992094|11169540|FG001|NOT COMPLETED|Overall Study||24
10044221|NCT01992094|11169541|FG002|NOT COMPLETED|Overall Study||21
10044222|NCT01992107|11169568|FG000|STARTED|Overall Study||1159
10044223|NCT01992107|11169569|FG001|STARTED|Overall Study||593
10044224|NCT01992107|11169570|FG002|STARTED|Overall Study||581
10044225|NCT01992107|11169568|FG000|COMPLETED|Overall Study||1091
10044226|NCT01992107|11169569|FG001|COMPLETED|Overall Study||560
10044227|NCT01992107|11169570|FG002|COMPLETED|Overall Study||545
10044228|NCT01992107|11169568|FG000|NOT COMPLETED|Overall Study||68
10044229|NCT01992107|11169569|FG001|NOT COMPLETED|Overall Study||33
10044230|NCT01992107|11169570|FG002|NOT COMPLETED|Overall Study||36
10044231|NCT01992159|11169599|FG000|STARTED|Overall Study||63
10044232|NCT01992159|11169600|FG001|STARTED|Overall Study||63
10044233|NCT01992159|11169601|FG002|STARTED|Overall Study||63
10044234|NCT01992159|11169602|FG003|STARTED|Overall Study||63
10044235|NCT01992159|11169599|FG000|Received Treatment|Overall Study||63
10044236|NCT01992159|11169600|FG001|Received Treatment|Overall Study||63
10044237|NCT01992159|11169601|FG002|Received Treatment|Overall Study||63
10044238|NCT01992159|11169602|FG003|Received Treatment|Overall Study||63
10044239|NCT01992159|11169599|FG000|Completed First 12 Months of Study|Overall Study||59
10044240|NCT01992159|11169600|FG001|Completed First 12 Months of Study|Overall Study||56
10044241|NCT01992159|11169601|FG002|Completed First 12 Months of Study|Overall Study||63
10044242|NCT01992159|11169602|FG003|Completed First 12 Months of Study|Overall Study||59
10044243|NCT01992159|11169599|FG000|COMPLETED|Overall Study||59
10044244|NCT01992159|11169600|FG001|COMPLETED|Overall Study||55
10044245|NCT01992159|11169601|FG002|COMPLETED|Overall Study||62
10044246|NCT01992159|11169602|FG003|COMPLETED|Overall Study||59
10044247|NCT01992159|11169599|FG000|NOT COMPLETED|Overall Study||4
10044248|NCT01992159|11169600|FG001|NOT COMPLETED|Overall Study||8
10044249|NCT01992159|11169601|FG002|NOT COMPLETED|Overall Study||1
10044250|NCT01992159|11169602|FG003|NOT COMPLETED|Overall Study||4
10044251|NCT01992172|11169614|FG000|STARTED|Overall Study||7
10044252|NCT01992172|11169615|FG001|STARTED|Overall Study||0
10044253|NCT01992172|11169614|FG000|COMPLETED|Overall Study||7
10044254|NCT01992172|11169615|FG001|COMPLETED|Overall Study||0
10117417|NCT02538783|11248138|FG000|NOT COMPLETED|Overall Study||0
10117418|NCT02538783|11248139|FG001|NOT COMPLETED|Overall Study||1
10117419|NCT02538900|11248148|FG000|STARTED|Overall Study||116
10117420|NCT02538900|11248149|FG001|STARTED|Overall Study||124
10117421|NCT02538900|11248150|FG002|STARTED|Overall Study||65
10117422|NCT02538900|11248148|FG000|COMPLETED|Overall Study||96
10117423|NCT02538900|11248149|FG001|COMPLETED|Overall Study||106
10117424|NCT02538900|11248150|FG002|COMPLETED|Overall Study||48
10117425|NCT02538900|11248148|FG000|NOT COMPLETED|Overall Study||20
10117426|NCT02538900|11248149|FG001|NOT COMPLETED|Overall Study||18
10117427|NCT02538900|11248150|FG002|NOT COMPLETED|Overall Study||17
9706430|NCT03470922|10805472|FG001|NOT COMPLETED|Overall Study||132
9706431|NCT03308825|10805482|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
9706432|NCT03308825|10805483|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
9706433|NCT03308825|10805484|FG002|STARTED|Overall Study||60
9706434|NCT03308825|10805485|FG003|STARTED|Overall Study||60
9706435|NCT03308825|10805482|FG000|COMPLETED|Overall Study||57
9706436|NCT03308825|10805483|FG001|COMPLETED|Overall Study||57
9706437|NCT03308825|10805484|FG002|COMPLETED|Overall Study||59
9706438|NCT03308825|10805485|FG003|COMPLETED|Overall Study||60
9706439|NCT03308825|10805482|FG000|NOT COMPLETED|Overall Study||2
9706440|NCT03308825|10805483|FG001|NOT COMPLETED|Overall Study||4
9706441|NCT03308825|10805484|FG002|NOT COMPLETED|Overall Study||1
9706442|NCT03308825|10805485|FG003|NOT COMPLETED|Overall Study||0
9706443|NCT02915302|10805501|FG000|STARTED|Overall Study||955
9706444|NCT02915302|10805502|FG001|STARTED|Overall Study||995
9706445|NCT02915302|10805501|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949
9706446|NCT02915302|10805502|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992
9706447|NCT02915302|10805501|FG000|COMPLETED|Overall Study||890
9706448|NCT02915302|10805502|FG001|COMPLETED|Overall Study||917
9706449|NCT02915302|10805501|FG000|NOT COMPLETED|Overall Study||65
9706450|NCT02915302|10805502|FG001|NOT COMPLETED|Overall Study||78
9706451|NCT02908269|10805511|FG000|STARTED|Overall Study||60
9706452|NCT02908269|10805512|FG001|STARTED|Overall Study||60
9706453|NCT02908269|10805513|FG002|STARTED|Overall Study||60
9706454|NCT02908269|10805511|FG000|COMPLETED|Overall Study||60
9706455|NCT02908269|10805512|FG001|COMPLETED|Overall Study||60
9706456|NCT02908269|10805513|FG002|COMPLETED|Overall Study||60
9706457|NCT02908269|10805511|FG000|NOT COMPLETED|Overall Study||0
9706458|NCT02908269|10805512|FG001|NOT COMPLETED|Overall Study||0
9706459|NCT02908269|10805513|FG002|NOT COMPLETED|Overall Study||0
9706460|NCT02744040|10805525|FG000|STARTED|Overall Study||28
9706461|NCT02744040|10805526|FG001|STARTED|Overall Study||51
9706462|NCT02744040|10805527|FG002|STARTED|Overall Study||72
9706463|NCT02744040|10805525|FG000|COMPLETED|Overall Study||22
9706464|NCT02744040|10805526|FG001|COMPLETED|Overall Study||40
9706465|NCT02744040|10805527|FG002|COMPLETED|Overall Study||50
9706466|NCT02744040|10805525|FG000|NOT COMPLETED|Overall Study||6
9706467|NCT02744040|10805526|FG001|NOT COMPLETED|Overall Study||11
9706468|NCT02744040|10805527|FG002|NOT COMPLETED|Overall Study||22
9729092|NCT00116753|10828706|FG002|STARTED|Overall Study||152
9729093|NCT00116753|10828704|FG000|ITT Population|Overall Study||150
9729094|NCT00116753|10828705|FG001|ITT Population|Overall Study||150
9729095|NCT00116753|10828706|FG002|ITT Population|Overall Study||147
9729096|NCT00116753|10828704|FG000|COMPLETED|Overall Study||121
9729097|NCT00116753|10828705|FG001|COMPLETED|Overall Study||125
9729098|NCT00116753|10828706|FG002|COMPLETED|Overall Study||128
9729099|NCT00116753|10828704|FG000|NOT COMPLETED|Overall Study||32
9729100|NCT00116753|10828705|FG001|NOT COMPLETED|Overall Study||30
9729101|NCT00116753|10828706|FG002|NOT COMPLETED|Overall Study||24
9729102|NCT00116779|10828716|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
9729103|NCT00116779|10828717|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
10117428|NCT02538965|11248158|FG000|STARTED|Treatment Period||17
9729104|NCT00116779|10828716|FG000|COMPLETED|Overall Study||42
9729105|NCT00116779|10828717|FG001|COMPLETED|Overall Study||45
9729106|NCT00116779|10828716|FG000|NOT COMPLETED|Overall Study||21
9729107|NCT00116779|10828717|FG001|NOT COMPLETED|Overall Study||19
9729108|NCT00116805|10828725|FG000|STARTED|Double-blind Period Through Week 48||176
9729109|NCT00116805|10828726|FG001|STARTED|Double-blind Period Through Week 48||90
9729110|NCT00116805|10828725|FG000|COMPLETED|Double-blind Period Through Week 48||165
9729111|NCT00116805|10828726|FG001|COMPLETED|Double-blind Period Through Week 48||85
9729112|NCT00116805|10828725|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11
9706469|NCT02698826|10805535|FG000|STARTED|Overall Study||16
9706470|NCT02698826|10805535|FG000|COMPLETED|Overall Study||2
9706471|NCT02698826|10805535|FG000|NOT COMPLETED|Overall Study||14
9706472|NCT02617589|10805543|FG000|STARTED|All Randomized||280
9706473|NCT02617589|10805544|FG001|STARTED|All Randomized||280
9706474|NCT02617589|10805543|FG000|COMPLETED|All Randomized||278
9706475|NCT02617589|10805544|FG001|COMPLETED|All Randomized||275
9706476|NCT02617589|10805543|FG000|NOT COMPLETED|All Randomized||2
9706477|NCT02617589|10805544|FG001|NOT COMPLETED|All Randomized||5
9706478|NCT02617589|10805543|FG000|STARTED|Treatment Period||278
9706479|NCT02617589|10805544|FG001|STARTED|Treatment Period||275
9706480|NCT02617589|10805543|FG000|COMPLETED|Treatment Period||4
9706481|NCT02617589|10805544|FG001|COMPLETED|Treatment Period||1
9706482|NCT02617589|10805543|FG000|NOT COMPLETED|Treatment Period||274
9706483|NCT02617589|10805544|FG001|NOT COMPLETED|Treatment Period||274
9706484|NCT02614859|10805552|FG000|STARTED|Overall Study||9
9706485|NCT02614859|10805553|FG001|STARTED|Overall Study||20
9706486|NCT02614859|10805552|FG000|COMPLETED|Overall Study||9
9706487|NCT02614859|10805553|FG001|COMPLETED|Overall Study||19
9706488|NCT02614859|10805552|FG000|NOT COMPLETED|Overall Study||0
9706489|NCT02614859|10805553|FG001|NOT COMPLETED|Overall Study||1
9706490|NCT02614066|10805565|FG000|STARTED|Overall Study||6
9706491|NCT02614066|10805566|FG001|STARTED|Overall Study||28
9706492|NCT02614066|10805567|FG002|STARTED|Overall Study||20
9706493|NCT02614066|10805568|FG003|STARTED|Overall Study||71
9706494|NCT02614066|10805565|FG000|COMPLETED|Overall Study||0
9706495|NCT02614066|10805566|FG001|COMPLETED|Overall Study||0
10044255|NCT01992172|11169614|FG000|NOT COMPLETED|Overall Study||0
10044256|NCT01992172|11169615|FG001|NOT COMPLETED|Overall Study||0
10044257|NCT01992185|11169623|FG000|STARTED|Overall Study||7
10044258|NCT01992185|11169624|FG001|STARTED|Overall Study||8
10044259|NCT01992185|11169623|FG000|COMPLETED|Overall Study||7
10044260|NCT01992185|11169624|FG001|COMPLETED|Overall Study||8
10044261|NCT01992185|11169623|FG000|NOT COMPLETED|Overall Study||0
10044262|NCT01992185|11169624|FG001|NOT COMPLETED|Overall Study||0
10044263|NCT01992354|11169630|FG000|STARTED|Overall Study||4
10044264|NCT01992354|11169630|FG000|COMPLETED|Overall Study||4
10044265|NCT01992354|11169630|FG000|NOT COMPLETED|Overall Study||0
10044266|NCT01992380|11169638|FG000|STARTED|Overall Study||6
10044267|NCT01992380|11169639|FG001|STARTED|Overall Study||8
10044268|NCT01992380|11169640|FG002|STARTED|Overall Study||10
10044269|NCT01992380|11169638|FG000|COMPLETED|Overall Study||6
10044270|NCT01992380|11169639|FG001|COMPLETED|Overall Study||8
10044271|NCT01992380|11169640|FG002|COMPLETED|Overall Study||10
10044272|NCT01992380|11169638|FG000|NOT COMPLETED|Overall Study||0
10044273|NCT01992380|11169639|FG001|NOT COMPLETED|Overall Study||0
10044274|NCT01992380|11169640|FG002|NOT COMPLETED|Overall Study||0
10044275|NCT01992523|11169648|FG000|STARTED|Overall Study||41
10044276|NCT01992523|11169649|FG001|STARTED|Overall Study||41
10044277|NCT01992523|11169648|FG000|COMPLETED|Overall Study||41
10044278|NCT01992523|11169649|FG001|COMPLETED|Overall Study||41
10044279|NCT01992523|11169648|FG000|NOT COMPLETED|Overall Study||0
10044280|NCT01992523|11169649|FG001|NOT COMPLETED|Overall Study||0
10044281|NCT01992536|11169667|FG000|STARTED|Overall Study||26
10044282|NCT01992536|11169668|FG001|STARTED|Overall Study||25
10044283|NCT01992536|11169669|FG002|STARTED|Overall Study||17
10044284|NCT01992536|11169670|FG003|STARTED|Overall Study||24
10044285|NCT01992536|11169671|FG004|STARTED|Overall Study||11
10044286|NCT01992536|11169672|FG005|STARTED|Overall Study||21
10044287|NCT01992536|11169673|FG006|STARTED|Overall Study||7
10044288|NCT01992536|11169674|FG007|STARTED|Overall Study||21
10044289|NCT01992536|11169675|FG008|STARTED|Overall Study||19
10044290|NCT01992536|11169676|FG009|STARTED|Overall Study||19
10044291|NCT01992536|11169667|FG000|COMPLETED|Overall Study||22
10044292|NCT01992536|11169668|FG001|COMPLETED|Overall Study||22
10044293|NCT01992536|11169669|FG002|COMPLETED|Overall Study||16
10044294|NCT01992536|11169670|FG003|COMPLETED|Overall Study||22
10044295|NCT01992536|11169671|FG004|COMPLETED|Overall Study||11
10044296|NCT01992536|11169672|FG005|COMPLETED|Overall Study||20
10044297|NCT01992536|11169673|FG006|COMPLETED|Overall Study||0
10044298|NCT01992536|11169674|FG007|COMPLETED|Overall Study||21
10044299|NCT01992536|11169675|FG008|COMPLETED|Overall Study||18
10044300|NCT01992536|11169676|FG009|COMPLETED|Overall Study||18
10044301|NCT01992536|11169667|FG000|NOT COMPLETED|Overall Study||4
10044302|NCT01992536|11169668|FG001|NOT COMPLETED|Overall Study||3
10044303|NCT01992536|11169669|FG002|NOT COMPLETED|Overall Study||1
10044304|NCT01992536|11169670|FG003|NOT COMPLETED|Overall Study||2
9706496|NCT02614066|10805567|FG002|COMPLETED|Overall Study||0
9706497|NCT02614066|10805568|FG003|COMPLETED|Overall Study||0
9706498|NCT02614066|10805565|FG000|NOT COMPLETED|Overall Study||6
9706499|NCT02614066|10805566|FG001|NOT COMPLETED|Overall Study||28
9706500|NCT02614066|10805567|FG002|NOT COMPLETED|Overall Study||20
9706501|NCT02614066|10805568|FG003|NOT COMPLETED|Overall Study||71
9706502|NCT02519348|10805585|FG000|STARTED|Overall Study||40
9706503|NCT02519348|10805586|FG001|STARTED|Overall Study||104
9706504|NCT02519348|10805587|FG002|STARTED|Overall Study||75
10044305|NCT01992536|11169671|FG004|NOT COMPLETED|Overall Study||0
10044306|NCT01992536|11169672|FG005|NOT COMPLETED|Overall Study||1
10044307|NCT01992536|11169673|FG006|NOT COMPLETED|Overall Study||7
10044308|NCT01992536|11169674|FG007|NOT COMPLETED|Overall Study||0
10044309|NCT01992536|11169675|FG008|NOT COMPLETED|Overall Study||1
10044310|NCT01992536|11169676|FG009|NOT COMPLETED|Overall Study||1
10044311|NCT01992549|11169718|FG000|STARTED|Overall Study||48
10044312|NCT01992549|11169718|FG000|SAF Population|Overall Study||48
10044313|NCT01992549|11169718|FG000|ITT Population|Overall Study||47
10044314|NCT01992549|11169718|FG000|PROPH Population|Overall Study||47
10044315|NCT01992549|11169718|FG000|BLEED Population|Overall Study||29
10044316|NCT01992549|11169718|FG000|SURG Population|Overall Study||3
10044317|NCT01992549|11169718|FG000|COMPLETED|Overall Study||44
10044318|NCT01992549|11169718|FG000|NOT COMPLETED|Overall Study||4
10044319|NCT01992757|11169728|FG000|STARTED|Overall Study||51
10044320|NCT01992757|11169728|FG000|COMPLETED|Overall Study||49
10044321|NCT01992757|11169728|FG000|NOT COMPLETED|Overall Study||2
10044322|NCT01992874|11169733|FG000|STARTED|Part A||21
10044323|NCT01992874|11169734|FG001|STARTED|Part A||17
10044324|NCT01992874|11169735|FG002|STARTED|Part A||0
10044325|NCT01992874|11169733|FG000|COMPLETED|Part A||21
10044326|NCT01992874|11169734|FG001|COMPLETED|Part A||17
10044327|NCT01992874|11169735|FG002|COMPLETED|Part A||0
10044328|NCT01992874|11169733|FG000|NOT COMPLETED|Part A||0
10044329|NCT01992874|11169734|FG001|NOT COMPLETED|Part A||0
10044330|NCT01992874|11169735|FG002|NOT COMPLETED|Part A||0
10044331|NCT01992874|11169733|FG000|STARTED|Part B||0
10044332|NCT01992874|11169734|FG001|STARTED|Part B||0
10044333|NCT01992874|11169735|FG002|STARTED|Part B||38
10044334|NCT01992874|11169733|FG000|COMPLETED|Part B||0
10044335|NCT01992874|11169734|FG001|COMPLETED|Part B||0
10044336|NCT01992874|11169735|FG002|COMPLETED|Part B||38
10044337|NCT01992874|11169733|FG000|NOT COMPLETED|Part B||0
10044338|NCT01992874|11169734|FG001|NOT COMPLETED|Part B||0
10044339|NCT01992874|11169735|FG002|NOT COMPLETED|Part B||0
10044340|NCT01993017|11169748|FG000|STARTED|Overall Study||499
10044341|NCT01993017|11169749|FG001|STARTED|Overall Study||501
10044342|NCT01993017|11169750|FG002|STARTED|Overall Study||500
10044343|NCT01993017|11169748|FG000|COMPLETED|Overall Study||393
10044344|NCT01993017|11169749|FG001|COMPLETED|Overall Study||411
10044345|NCT01993017|11169750|FG002|COMPLETED|Overall Study||421
10044346|NCT01993017|11169748|FG000|NOT COMPLETED|Overall Study||106
10044347|NCT01993017|11169749|FG001|NOT COMPLETED|Overall Study||90
10044348|NCT01993017|11169750|FG002|NOT COMPLETED|Overall Study||79
10044349|NCT01993030|11169761|FG000|STARTED|Overall Study||36
10044350|NCT01993030|11169762|FG001|STARTED|Overall Study||35
10044351|NCT01993030|11169761|FG000|COMPLETED|Overall Study||36
10044352|NCT01993030|11169762|FG001|COMPLETED|Overall Study||31
10044353|NCT01993030|11169761|FG000|NOT COMPLETED|Overall Study||0
10044354|NCT01993030|11169762|FG001|NOT COMPLETED|Overall Study||4
10044355|NCT01993108|11169770|FG000|STARTED|Overall Study||11
10044356|NCT01993108|11169771|FG001|STARTED|Overall Study||12
10044357|NCT01993108|11169770|FG000|COMPLETED|Overall Study||11
10044358|NCT01993108|11169771|FG001|COMPLETED|Overall Study||12
10044359|NCT01993108|11169770|FG000|NOT COMPLETED|Overall Study||0
10044360|NCT01993108|11169771|FG001|NOT COMPLETED|Overall Study||0
10044361|NCT01993186|11169791|FG000|STARTED|Double-Blind Placebo-Controlled Period||25
10044362|NCT01993186|11169792|FG001|STARTED|Double-Blind Placebo-Controlled Period||11
10044363|NCT01993186|11169791|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23
10044364|NCT01993186|11169792|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11
10044365|NCT01993186|11169791|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
10044366|NCT01993186|11169792|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
10044367|NCT01993186|11169791|FG000|STARTED|Open-Label Extension Period||23
10044368|NCT01993186|11169792|FG001|STARTED|Open-Label Extension Period||11
10044369|NCT01993186|11169791|FG000|COMPLETED|Open-Label Extension Period||16
10044370|NCT01993186|11169792|FG001|COMPLETED|Open-Label Extension Period||5
10044371|NCT01993186|11169791|FG000|NOT COMPLETED|Open-Label Extension Period||7
10044372|NCT01993186|11169792|FG001|NOT COMPLETED|Open-Label Extension Period||6
10044373|NCT01993238|11169799|FG000|STARTED|Overall Study||11
10044374|NCT01993238|11169799|FG000|COMPLETED|Overall Study||11
10044375|NCT01993238|11169799|FG000|NOT COMPLETED|Overall Study||0
10044376|NCT01993329|11169809|FG000|STARTED|Period 1||3
10044377|NCT01993329|11169810|FG001|STARTED|Period 1||4
10044378|NCT01993329|11169811|FG002|STARTED|Period 1||3
10044379|NCT01993329|11169812|FG003|STARTED|Period 1||3
10044380|NCT01993329|11169813|FG004|STARTED|Period 1||3
10044381|NCT01993329|11169814|FG005|STARTED|Period 1||4
10044382|NCT01993329|11169809|FG000|COMPLETED|Period 1||3
10044383|NCT01993329|11169810|FG001|COMPLETED|Period 1||4
10044384|NCT01993329|11169811|FG002|COMPLETED|Period 1||3
10044385|NCT01993329|11169812|FG003|COMPLETED|Period 1||3
10044386|NCT01993329|11169813|FG004|COMPLETED|Period 1||3
10044387|NCT01993329|11169814|FG005|COMPLETED|Period 1||4
10044388|NCT01993329|11169809|FG000|NOT COMPLETED|Period 1||0
10044389|NCT01993329|11169810|FG001|NOT COMPLETED|Period 1||0
10044390|NCT01993329|11169811|FG002|NOT COMPLETED|Period 1||0
10044391|NCT01993329|11169812|FG003|NOT COMPLETED|Period 1||0
10044392|NCT01993329|11169813|FG004|NOT COMPLETED|Period 1||0
10044393|NCT01993329|11169814|FG005|NOT COMPLETED|Period 1||0
10044394|NCT01993329|11169809|FG000|STARTED|Wash-out||3
10044395|NCT01993329|11169810|FG001|STARTED|Wash-out||4
10044396|NCT01993329|11169811|FG002|STARTED|Wash-out||3
10044397|NCT01993329|11169812|FG003|STARTED|Wash-out||3
10044398|NCT01993329|11169813|FG004|STARTED|Wash-out||3
10044399|NCT01993329|11169814|FG005|STARTED|Wash-out||4
10044400|NCT01993329|11169809|FG000|COMPLETED|Wash-out||3
10044401|NCT01993329|11169810|FG001|COMPLETED|Wash-out||4
10044402|NCT01993329|11169811|FG002|COMPLETED|Wash-out||3
10044403|NCT01993329|11169812|FG003|COMPLETED|Wash-out||3
10044404|NCT01993329|11169813|FG004|COMPLETED|Wash-out||3
10044405|NCT01993329|11169814|FG005|COMPLETED|Wash-out||4
10044406|NCT01993329|11169809|FG000|NOT COMPLETED|Wash-out||0
10044407|NCT01993329|11169810|FG001|NOT COMPLETED|Wash-out||0
10044408|NCT01993329|11169811|FG002|NOT COMPLETED|Wash-out||0
10044409|NCT01993329|11169812|FG003|NOT COMPLETED|Wash-out||0
10044410|NCT01993329|11169813|FG004|NOT COMPLETED|Wash-out||0
10044411|NCT01993329|11169814|FG005|NOT COMPLETED|Wash-out||0
10044412|NCT01993329|11169809|FG000|STARTED|Period 2||3
10044413|NCT01993329|11169810|FG001|STARTED|Period 2||4
10044414|NCT01993329|11169811|FG002|STARTED|Period 2||3
10044415|NCT01993329|11169812|FG003|STARTED|Period 2||3
10044416|NCT01993329|11169813|FG004|STARTED|Period 2||3
10044417|NCT01993329|11169814|FG005|STARTED|Period 2||4
10044418|NCT01993329|11169809|FG000|COMPLETED|Period 2||3
10044419|NCT01993329|11169810|FG001|COMPLETED|Period 2||4
10044420|NCT01993329|11169811|FG002|COMPLETED|Period 2||3
10044421|NCT01993329|11169812|FG003|COMPLETED|Period 2||3
10044422|NCT01993329|11169813|FG004|COMPLETED|Period 2||3
10044423|NCT01993329|11169814|FG005|COMPLETED|Period 2||3
10044424|NCT01993329|11169809|FG000|NOT COMPLETED|Period 2||0
10044425|NCT01993329|11169810|FG001|NOT COMPLETED|Period 2||0
10044426|NCT01993329|11169811|FG002|NOT COMPLETED|Period 2||0
10044427|NCT01993329|11169812|FG003|NOT COMPLETED|Period 2||0
10044428|NCT01993329|11169813|FG004|NOT COMPLETED|Period 2||0
10044429|NCT01993329|11169814|FG005|NOT COMPLETED|Period 2||1
10044430|NCT01993329|11169809|FG000|STARTED|Wash-out||3
10044431|NCT01993329|11169810|FG001|STARTED|Wash-out||4
10044432|NCT01993329|11169811|FG002|STARTED|Wash-out||3
10044433|NCT01993329|11169812|FG003|STARTED|Wash-out||3
10044434|NCT01993329|11169813|FG004|STARTED|Wash-out||3
10044435|NCT01993329|11169814|FG005|STARTED|Wash-out||3
10044436|NCT01993329|11169809|FG000|COMPLETED|Wash-out||3
10044437|NCT01993329|11169810|FG001|COMPLETED|Wash-out||3
10044438|NCT01993329|11169811|FG002|COMPLETED|Wash-out||3
10044439|NCT01993329|11169812|FG003|COMPLETED|Wash-out||3
10044440|NCT01993329|11169813|FG004|COMPLETED|Wash-out||3
10044441|NCT01993329|11169814|FG005|COMPLETED|Wash-out||3
10044442|NCT01993329|11169809|FG000|NOT COMPLETED|Wash-out||0
10044443|NCT01993329|11169810|FG001|NOT COMPLETED|Wash-out||1
10044444|NCT01993329|11169811|FG002|NOT COMPLETED|Wash-out||0
10044445|NCT01993329|11169812|FG003|NOT COMPLETED|Wash-out||0
10044446|NCT01993329|11169813|FG004|NOT COMPLETED|Wash-out||0
10044447|NCT01993329|11169814|FG005|NOT COMPLETED|Wash-out||0
10044448|NCT01993329|11169809|FG000|STARTED|Period 3||3
10044449|NCT01993329|11169810|FG001|STARTED|Period 3||3
10044450|NCT01993329|11169811|FG002|STARTED|Period 3||3
10044451|NCT01993329|11169812|FG003|STARTED|Period 3||3
10044452|NCT01993329|11169813|FG004|STARTED|Period 3||3
10044453|NCT01993329|11169814|FG005|STARTED|Period 3||3
10044454|NCT01993329|11169809|FG000|COMPLETED|Period 3||3
10044455|NCT01993329|11169810|FG001|COMPLETED|Period 3||3
10044456|NCT01993329|11169811|FG002|COMPLETED|Period 3||3
10044457|NCT01993329|11169812|FG003|COMPLETED|Period 3||3
10044458|NCT01993329|11169813|FG004|COMPLETED|Period 3||3
10044459|NCT01993329|11169814|FG005|COMPLETED|Period 3||3
10117429|NCT02538965|11248158|FG000|COMPLETED|Treatment Period||0
10117430|NCT02538965|11248158|FG000|NOT COMPLETED|Treatment Period||17
10117431|NCT02538965|11248158|FG000|STARTED|Follow-Up Period||17
10117432|NCT02538965|11248158|FG000|COMPLETED|Follow-Up Period||0
10117433|NCT02538965|11248158|FG000|NOT COMPLETED|Follow-Up Period||17
10117434|NCT02539108|11248164|FG000|STARTED|Overall Study||30
10117435|NCT02539108|11248165|FG001|STARTED|Overall Study||30
10117436|NCT02539108|11248164|FG000|COMPLETED|Overall Study||30
10117437|NCT02539108|11248165|FG001|COMPLETED|Overall Study||30
10117438|NCT02539108|11248164|FG000|NOT COMPLETED|Overall Study||0
10117439|NCT02539108|11248165|FG001|NOT COMPLETED|Overall Study||0
10117440|NCT02539134|11248177|FG000|STARTED|Overall Study||10
10117441|NCT02539134|11248178|FG001|STARTED|Overall Study||6
10117442|NCT02539134|11248179|FG002|STARTED|Overall Study||6
10117443|NCT02539134|11248180|FG003|STARTED|Overall Study||6
10117444|NCT02539134|11248181|FG004|STARTED|Overall Study||6
10117445|NCT02539134|11248182|FG005|STARTED|Overall Study||6
10117446|NCT02539134|11248177|FG000|COMPLETED|Overall Study||9
10117447|NCT02539134|11248178|FG001|COMPLETED|Overall Study||6
10117448|NCT02539134|11248179|FG002|COMPLETED|Overall Study||6
10044460|NCT01993329|11169809|FG000|NOT COMPLETED|Period 3||0
10044461|NCT01993329|11169810|FG001|NOT COMPLETED|Period 3||0
10044462|NCT01993329|11169811|FG002|NOT COMPLETED|Period 3||0
10044463|NCT01993329|11169812|FG003|NOT COMPLETED|Period 3||0
10044464|NCT01993329|11169813|FG004|NOT COMPLETED|Period 3||0
10044465|NCT01993329|11169814|FG005|NOT COMPLETED|Period 3||0
10044466|NCT01993615|11169828|FG000|STARTED|Overall Study||40
10044467|NCT01993615|11169829|FG001|STARTED|Overall Study||40
10044468|NCT01993615|11169828|FG000|COMPLETED|Overall Study||39
10044469|NCT01993615|11169829|FG001|COMPLETED|Overall Study||40
10044470|NCT01993615|11169828|FG000|NOT COMPLETED|Overall Study||1
10044471|NCT01993615|11169829|FG001|NOT COMPLETED|Overall Study||0
10044472|NCT01993667|11169837|FG000|STARTED|Overall Study||64
10044473|NCT01993667|11169838|FG001|STARTED|Overall Study||66
10044474|NCT01993667|11169837|FG000|COMPLETED|Overall Study||43
10117449|NCT02539134|11248180|FG003|COMPLETED|Overall Study||6
10117450|NCT02539134|11248181|FG004|COMPLETED|Overall Study||6
10117451|NCT02539134|11248182|FG005|COMPLETED|Overall Study||6
10117452|NCT02539134|11248177|FG000|NOT COMPLETED|Overall Study||1
10117453|NCT02539134|11248178|FG001|NOT COMPLETED|Overall Study||0
10117454|NCT02539134|11248179|FG002|NOT COMPLETED|Overall Study||0
10044475|NCT01993667|11169838|FG001|COMPLETED|Overall Study||47
10044476|NCT01993667|11169837|FG000|NOT COMPLETED|Overall Study||21
10044477|NCT01993667|11169838|FG001|NOT COMPLETED|Overall Study||19
10044478|NCT01993823|11169846|FG000|STARTED|Overall Study||95
10044479|NCT01993823|11169847|FG001|STARTED|Overall Study||95
10044480|NCT01993823|11169846|FG000|COMPLETED|Overall Study||88
10044481|NCT01993823|11169847|FG001|COMPLETED|Overall Study||79
10044482|NCT01993823|11169846|FG000|NOT COMPLETED|Overall Study||7
10044483|NCT01993823|11169847|FG001|NOT COMPLETED|Overall Study||16
10044484|NCT01993836|11169856|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
10044485|NCT01993836|11169857|FG001|STARTED|Overall Study||68
10044486|NCT01993836|11169858|FG002|STARTED|Overall Study||51
10044487|NCT01993836|11169856|FG000|COMPLETED|Overall Study||55
10044488|NCT01993836|11169857|FG001|COMPLETED|Overall Study||55
10044489|NCT01993836|11169858|FG002|COMPLETED|Overall Study||46
10044490|NCT01993836|11169856|FG000|NOT COMPLETED|Overall Study||17
10044491|NCT01993836|11169857|FG001|NOT COMPLETED|Overall Study||13
10044492|NCT01993836|11169858|FG002|NOT COMPLETED|Overall Study||5
10044493|NCT01993849|11169868|FG000|STARTED|Overall Study||12
10044494|NCT01993849|11169869|FG001|STARTED|Overall Study||11
10044495|NCT01993849|11169868|FG000|COMPLETED|Overall Study||9
10044496|NCT01993849|11169869|FG001|COMPLETED|Overall Study||9
10044497|NCT01993849|11169868|FG000|NOT COMPLETED|Overall Study||3
10044498|NCT01993849|11169869|FG001|NOT COMPLETED|Overall Study||2
10044499|NCT01993875|11169879|FG000|STARTED|Overall Study||82
10044500|NCT01993875|11169880|FG001|STARTED|Overall Study||82
10044501|NCT01993875|11169879|FG000|COMPLETED|Overall Study||75
10044502|NCT01993875|11169880|FG001|COMPLETED|Overall Study||76
10044503|NCT01993875|11169879|FG000|NOT COMPLETED|Overall Study||7
10044504|NCT01993875|11169880|FG001|NOT COMPLETED|Overall Study||6
10044505|NCT01993888|11169889|FG000|STARTED|Overall Study||50
10044506|NCT01993888|11169890|FG001|STARTED|Overall Study||52
10044507|NCT01993888|11169889|FG000|COMPLETED|Overall Study||48
10044508|NCT01993888|11169890|FG001|COMPLETED|Overall Study||49
10044509|NCT01993888|11169889|FG000|NOT COMPLETED|Overall Study||2
10044510|NCT01993888|11169890|FG001|NOT COMPLETED|Overall Study||3
10044511|NCT01993927|11169896|FG000|STARTED|Overall Study||742
10044512|NCT01993927|11169896|FG000|COMPLETED|Overall Study||713
10044513|NCT01993927|11169896|FG000|NOT COMPLETED|Overall Study||29
10044514|NCT01993940|11169902|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
10044515|NCT01993940|11169903|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
10044516|NCT01993940|11169902|FG000|Received Treatment|Overall Study||272
10044517|NCT01993940|11169903|FG001|Received Treatment|Overall Study||276
10044518|NCT01993940|11169902|FG000|COMPLETED|Overall Study||237
10044519|NCT01993940|11169903|FG001|COMPLETED|Overall Study||232
10044520|NCT01993940|11169902|FG000|NOT COMPLETED|Overall Study||40
10044521|NCT01993940|11169903|FG001|NOT COMPLETED|Overall Study||44
10044522|NCT01994109|11169912|FG000|STARTED|Double-blind Phase (Part A)||63
10044523|NCT01994109|11169913|FG001|STARTED|Double-blind Phase (Part A)||64
10044524|NCT01994109|11169914|FG002|STARTED|Double-blind Phase (Part A)||60
10044525|NCT01994109|11169915|FG003|STARTED|Double-blind Phase (Part A)||0
10044526|NCT01994109|11169912|FG000|COMPLETED|Double-blind Phase (Part A)||62
10044527|NCT01994109|11169913|FG001|COMPLETED|Double-blind Phase (Part A)||61
10044528|NCT01994109|11169914|FG002|COMPLETED|Double-blind Phase (Part A)||53
10044529|NCT01994109|11169915|FG003|COMPLETED|Double-blind Phase (Part A)||0
10044530|NCT01994109|11169912|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1
10044531|NCT01994109|11169913|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3
10044532|NCT01994109|11169914|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7
10044533|NCT01994109|11169915|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0
10044534|NCT01994109|11169912|FG000|STARTED|Open-label Phase (Part B)||0
10044535|NCT01994109|11169913|FG001|STARTED|Open-label Phase (Part B)||0
10044536|NCT01994109|11169914|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
10044537|NCT01994109|11169915|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
10044538|NCT01994109|11169912|FG000|COMPLETED|Open-label Phase (Part B)||0
10044539|NCT01994109|11169913|FG001|COMPLETED|Open-label Phase (Part B)||0
10044540|NCT01994109|11169914|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
10044541|NCT01994109|11169915|FG003|COMPLETED|Open-label Phase (Part B)||128
10044542|NCT01994109|11169912|FG000|NOT COMPLETED|Open-label Phase (Part B)||0
10044543|NCT01994109|11169913|FG001|NOT COMPLETED|Open-label Phase (Part B)||0
10044544|NCT01994109|11169914|FG002|NOT COMPLETED|Open-label Phase (Part B)||0
10044545|NCT01994109|11169915|FG003|NOT COMPLETED|Open-label Phase (Part B)||42
10044546|NCT01994226|11169927|FG000|STARTED|Overall Study||199
10044547|NCT01994226|11169928|FG001|STARTED|Overall Study||200
10044548|NCT01994226|11169927|FG000|COMPLETED|Overall Study||180
10044549|NCT01994226|11169928|FG001|COMPLETED|Overall Study||179
10044550|NCT01994226|11169927|FG000|NOT COMPLETED|Overall Study||19
10044551|NCT01994226|11169928|FG001|NOT COMPLETED|Overall Study||21
10117455|NCT02539134|11248180|FG003|NOT COMPLETED|Overall Study||0
10044552|NCT01994291|11169937|FG000|STARTED|Overall Study||99
10044553|NCT01994291|11169938|FG001|STARTED|Overall Study||43
10044554|NCT01994291|11169939|FG002|STARTED|Overall Study||56
10044555|NCT01994291|11169937|FG000|Received Treatment|Overall Study||99
10044556|NCT01994291|11169938|FG001|Received Treatment|Overall Study||43
10044557|NCT01994291|11169939|FG002|Received Treatment|Overall Study||56
10044558|NCT01994291|11169937|FG000|COMPLETED|Overall Study||84
10044559|NCT01994291|11169938|FG001|COMPLETED|Overall Study||36
10044560|NCT01994291|11169939|FG002|COMPLETED|Overall Study||47
10044561|NCT01994291|11169937|FG000|NOT COMPLETED|Overall Study||15
10044562|NCT01994291|11169938|FG001|NOT COMPLETED|Overall Study||7
10044563|NCT01994291|11169939|FG002|NOT COMPLETED|Overall Study||9
10044564|NCT01994395|11169950|FG000|STARTED|Overall Study||26
10044565|NCT01994395|11169951|FG001|STARTED|Overall Study||27
10044566|NCT01994395|11169950|FG000|COMPLETED|Overall Study||25
10044567|NCT01994395|11169951|FG001|COMPLETED|Overall Study||25
10044568|NCT01994395|11169950|FG000|NOT COMPLETED|Overall Study||1
10044569|NCT01994395|11169951|FG001|NOT COMPLETED|Overall Study||2
10044570|NCT01994486|11169957|FG000|STARTED|Overall Study||20
10044571|NCT01994486|11169957|FG000|COMPLETED|Overall Study||20
10044572|NCT01994486|11169957|FG000|NOT COMPLETED|Overall Study||0
10044573|NCT01994538|11169965|FG000|STARTED|Overall Study||136
10044574|NCT01994538|11169966|FG001|STARTED|Overall Study||136
10044575|NCT01994538|11169965|FG000|COMPLETED|Overall Study||136
10044576|NCT01994538|11169966|FG001|COMPLETED|Overall Study||136
10044577|NCT01994538|11169965|FG000|NOT COMPLETED|Overall Study||0
10044578|NCT01994538|11169966|FG001|NOT COMPLETED|Overall Study||0
10044579|NCT01994590|11169972|FG000|STARTED|Overall Study||4
10044580|NCT01994590|11169972|FG000|COMPLETED|Overall Study||2
10044581|NCT01994590|11169972|FG000|NOT COMPLETED|Overall Study||2
10044582|NCT01994629|11169978|FG000|STARTED|Overall Study||100
10044583|NCT01994629|11169979|FG001|STARTED|Overall Study||102
10044584|NCT01994629|11169978|FG000|COMPLETED|Overall Study||99
10044585|NCT01994629|11169979|FG001|COMPLETED|Overall Study||99
10044586|NCT01994629|11169978|FG000|NOT COMPLETED|Overall Study||1
10044587|NCT01994629|11169979|FG001|NOT COMPLETED|Overall Study||3
10044588|NCT01994720|11169987|FG000|STARTED|Overall Study||6589
10044589|NCT01994720|11169988|FG001|STARTED|Overall Study||6610
10044590|NCT01994720|11169987|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
10044591|NCT01994720|11169988|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
10044592|NCT01994720|11169987|FG000|NOT COMPLETED|Overall Study||46
10044593|NCT01994720|11169988|FG001|NOT COMPLETED|Overall Study||56
10044594|NCT01994746|11169994|FG000|STARTED|First Visit||39
10044595|NCT01994746|11169995|FG001|STARTED|First Visit||38
10044596|NCT01994746|11169994|FG000|Received At Least 1 Dose|First Visit||39
10044597|NCT01994746|11169995|FG001|Received At Least 1 Dose|First Visit||38
10044598|NCT01994746|11169994|FG000|COMPLETED|First Visit||39
10044599|NCT01994746|11169995|FG001|COMPLETED|First Visit||38
10044600|NCT01994746|11169994|FG000|NOT COMPLETED|First Visit||0
10044601|NCT01994746|11169995|FG001|NOT COMPLETED|First Visit||0
10044602|NCT01994746|11169994|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
10044603|NCT01994746|11169995|FG001|STARTED|Second Visit||38
10044604|NCT01994746|11169994|FG000|Completed Both Dosing Visits|Second Visit||38
10044605|NCT01994746|11169995|FG001|Completed Both Dosing Visits|Second Visit||38
10044606|NCT01994746|11169994|FG000|COMPLETED|Second Visit||38
10044607|NCT01994746|11169995|FG001|COMPLETED|Second Visit||38
10044608|NCT01994746|11169994|FG000|NOT COMPLETED|Second Visit||0
10044609|NCT01994746|11169995|FG001|NOT COMPLETED|Second Visit||0
10044610|NCT01994785|11170005|FG000|STARTED|Overall Study||109
10044611|NCT01994785|11170006|FG001|STARTED|Overall Study||109
10044612|NCT01994785|11170007|FG002|STARTED|Overall Study||117
10044613|NCT01994785|11170008|FG003|STARTED|Overall Study||117
10044614|NCT01994785|11170005|FG000|COMPLETED|Overall Study||101
10044615|NCT01994785|11170006|FG001|COMPLETED|Overall Study||108
10044616|NCT01994785|11170007|FG002|COMPLETED|Overall Study||117
10044617|NCT01994785|11170008|FG003|COMPLETED|Overall Study||114
10044618|NCT01994785|11170005|FG000|NOT COMPLETED|Overall Study||8
10044619|NCT01994785|11170006|FG001|NOT COMPLETED|Overall Study||1
10044620|NCT01994785|11170007|FG002|NOT COMPLETED|Overall Study||0
10044621|NCT01994785|11170008|FG003|NOT COMPLETED|Overall Study||3
10044622|NCT01994837|11170018|FG000|STARTED|Overall Study||32
10044623|NCT01994837|11170018|FG000|Treated|Overall Study||32
10044624|NCT01994837|11170018|FG000|COMPLETED|Overall Study||0
10044625|NCT01994837|11170018|FG000|NOT COMPLETED|Overall Study||32
10044626|NCT01994850|11170022|FG000|STARTED|Overall Study||32
10044627|NCT01994850|11170022|FG000|COMPLETED|Overall Study||30
10044628|NCT01994850|11170022|FG000|NOT COMPLETED|Overall Study||2
10044629|NCT01994863|11170026|FG000|STARTED|Period 1||11
10044630|NCT01994863|11170027|FG001|STARTED|Period 1||12
10044631|NCT01994863|11170026|FG000|COMPLETED|Period 1||4
10044632|NCT01994863|11170027|FG001|COMPLETED|Period 1||9
10044633|NCT01994863|11170026|FG000|NOT COMPLETED|Period 1||7
10044634|NCT01994863|11170027|FG001|NOT COMPLETED|Period 1||3
10044635|NCT01994863|11170026|FG000|STARTED|Period 2||8
10044636|NCT01994863|11170027|FG001|STARTED|Period 2||9
10044637|NCT01994863|11170026|FG000|COMPLETED|Period 2||7
10044638|NCT01994863|11170027|FG001|COMPLETED|Period 2||5
10044639|NCT01994863|11170026|FG000|NOT COMPLETED|Period 2||1
10044640|NCT01994863|11170027|FG001|NOT COMPLETED|Period 2||4
10044641|NCT01994876|11170033|FG000|STARTED|Baseline - Own Product||9
10044642|NCT01994876|11170034|FG001|STARTED|Baseline - Own Product||9
10044643|NCT01994876|11170033|FG000|COMPLETED|Baseline - Own Product||9
10044644|NCT01994876|11170034|FG001|COMPLETED|Baseline - Own Product||9
10044645|NCT01994876|11170033|FG000|NOT COMPLETED|Baseline - Own Product||0
10044646|NCT01994876|11170034|FG001|NOT COMPLETED|Baseline - Own Product||0
10044647|NCT01994876|11170033|FG000|STARTED|Test Period 1||9
10044648|NCT01994876|11170034|FG001|STARTED|Test Period 1||9
10044649|NCT01994876|11170033|FG000|COMPLETED|Test Period 1||9
10044650|NCT01994876|11170034|FG001|COMPLETED|Test Period 1||7
10044651|NCT01994876|11170033|FG000|NOT COMPLETED|Test Period 1||0
10044652|NCT01994876|11170034|FG001|NOT COMPLETED|Test Period 1||2
10044653|NCT01994876|11170033|FG000|STARTED|Test Period 2||9
10044654|NCT01994876|11170034|FG001|STARTED|Test Period 2||7
10044655|NCT01994876|11170033|FG000|COMPLETED|Test Period 2||8
10044656|NCT01994876|11170034|FG001|COMPLETED|Test Period 2||6
10044657|NCT01994876|11170033|FG000|NOT COMPLETED|Test Period 2||1
10117456|NCT02539134|11248181|FG004|NOT COMPLETED|Overall Study||0
10117457|NCT02539134|11248182|FG005|NOT COMPLETED|Overall Study||0
10117458|NCT02539342|11248203|FG000|STARTED|Overall Study||1
10117459|NCT02539342|11248204|FG001|STARTED|Overall Study||0
10117460|NCT02539342|11248203|FG000|COMPLETED|Overall Study||1
10117461|NCT02539342|11248204|FG001|COMPLETED|Overall Study||0
10117462|NCT02539342|11248203|FG000|NOT COMPLETED|Overall Study||0
10117463|NCT02539342|11248204|FG001|NOT COMPLETED|Overall Study||0
9706505|NCT02519348|10805588|FG003|STARTED|Overall Study||69
9706506|NCT02519348|10805589|FG004|STARTED|Overall Study||84
10044658|NCT01994876|11170034|FG001|NOT COMPLETED|Test Period 2||1
10044659|NCT01994889|11170045|FG000|STARTED|Overall Study||88
10044660|NCT01994889|11170046|FG001|STARTED|Overall Study||176
10044661|NCT01994889|11170047|FG002|STARTED|Overall Study||177
10044662|NCT01994889|11170045|FG000|COMPLETED|Overall Study||60
10044663|NCT01994889|11170046|FG001|COMPLETED|Overall Study||113
10044664|NCT01994889|11170047|FG002|COMPLETED|Overall Study||85
10044665|NCT01994889|11170045|FG000|NOT COMPLETED|Overall Study||28
10044666|NCT01994889|11170046|FG001|NOT COMPLETED|Overall Study||63
10044667|NCT01994889|11170047|FG002|NOT COMPLETED|Overall Study||92
10044668|NCT01994902|11170054|FG000|STARTED|Test Period 1||63
10044669|NCT01994902|11170055|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
10044670|NCT01994902|11170054|FG000|COMPLETED|Test Period 1||57
10044671|NCT01994902|11170055|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
10044672|NCT01994902|11170054|FG000|NOT COMPLETED|Test Period 1||6
10044673|NCT01994902|11170055|FG001|NOT COMPLETED|Test Period 1||3
10044674|NCT01994902|11170054|FG000|STARTED|Test Period 2||57
10044675|NCT01994902|11170055|FG001|STARTED|Test Period 2||61
10044676|NCT01994902|11170054|FG000|COMPLETED|Test Period 2||57
10044677|NCT01994902|11170055|FG001|COMPLETED|Test Period 2||55
10044678|NCT01994902|11170054|FG000|NOT COMPLETED|Test Period 2||0
10044679|NCT01994902|11170055|FG001|NOT COMPLETED|Test Period 2||6
10044680|NCT01994954|11170063|FG000|STARTED|Overall Study||99
10044681|NCT01994954|11170064|FG001|STARTED|Overall Study||97
10044682|NCT01994954|11170063|FG000|COMPLETED|Overall Study||74
10044683|NCT01994954|11170064|FG001|COMPLETED|Overall Study||67
10044684|NCT01994954|11170063|FG000|NOT COMPLETED|Overall Study||25
10044685|NCT01994954|11170064|FG001|NOT COMPLETED|Overall Study||30
10044686|NCT01994993|11170081|FG000|STARTED|Overall Study||63
10044687|NCT01994993|11170082|FG001|STARTED|Overall Study||47
10044688|NCT01994993|11170083|FG002|STARTED|Overall Study||70
10044689|NCT01994993|11170084|FG003|STARTED|Overall Study||55
10044690|NCT01994993|11170085|FG004|STARTED|Overall Study||24
10044691|NCT01994993|11170081|FG000|COMPLETED|Overall Study||28
10044692|NCT01994993|11170082|FG001|COMPLETED|Overall Study||12
10044693|NCT01994993|11170083|FG002|COMPLETED|Overall Study||23
10044694|NCT01994993|11170084|FG003|COMPLETED|Overall Study||9
10044695|NCT01994993|11170085|FG004|COMPLETED|Overall Study||22
10044696|NCT01994993|11170081|FG000|NOT COMPLETED|Overall Study||35
10044697|NCT01994993|11170082|FG001|NOT COMPLETED|Overall Study||35
10044698|NCT01994993|11170083|FG002|NOT COMPLETED|Overall Study||47
10044699|NCT01994993|11170084|FG003|NOT COMPLETED|Overall Study||46
10044700|NCT01994993|11170085|FG004|NOT COMPLETED|Overall Study||2
10044701|NCT01995045|11170099|FG000|STARTED|Overall Study||29
10044702|NCT01995045|11170100|FG001|STARTED|Overall Study||28
10044703|NCT01995045|11170099|FG000|COMPLETED|Overall Study||29
10044704|NCT01995045|11170100|FG001|COMPLETED|Overall Study||28
10044705|NCT01995045|11170099|FG000|NOT COMPLETED|Overall Study||0
10044706|NCT01995045|11170100|FG001|NOT COMPLETED|Overall Study||0
10044707|NCT01995071|11170118|FG000|STARTED|Overall Study||8
10044708|NCT01995071|11170119|FG001|STARTED|Overall Study||8
10044709|NCT01995071|11170120|FG002|STARTED|Overall Study||9
10044710|NCT01995071|11170121|FG003|STARTED|Overall Study||8
10044711|NCT01995071|11170122|FG004|STARTED|Overall Study||8
10044712|NCT01995071|11170123|FG005|STARTED|Overall Study||8
10044713|NCT01995071|11170124|FG006|STARTED|Overall Study||8
10044714|NCT01995071|11170125|FG007|STARTED|Overall Study||8
10044715|NCT01995071|11170126|FG008|STARTED|Overall Study||8
10044716|NCT01995071|11170127|FG009|STARTED|Overall Study||8
10044717|NCT01995071|11170128|FG010|STARTED|Overall Study||8
9706507|NCT02519348|10805590|FG005|STARTED|Overall Study||47
9706508|NCT02519348|10805591|FG006|STARTED|Overall Study||3
9706509|NCT02519348|10805592|FG007|STARTED|Overall Study||5
9706510|NCT02519348|10805593|FG008|STARTED|Overall Study||6
10044718|NCT01995071|11170129|FG011|STARTED|Overall Study||0
10044719|NCT01995071|11170118|FG000|COMPLETED|Overall Study||7
10117464|NCT02539368|11248215|FG000|STARTED|Overall Study||1522
10117465|NCT02539368|11248216|FG001|STARTED|Overall Study||494
9706511|NCT02519348|10805585|FG000|Treated|Overall Study||40
10044720|NCT01995071|11170119|FG001|COMPLETED|Overall Study||8
10117466|NCT02539368|11248217|FG002|STARTED|Overall Study||358
10044721|NCT01995071|11170120|FG002|COMPLETED|Overall Study||8
10044722|NCT01995071|11170121|FG003|COMPLETED|Overall Study||8
9706512|NCT02519348|10805586|FG001|Treated|Overall Study||101
9706513|NCT02519348|10805587|FG002|Treated|Overall Study||74
9706514|NCT02519348|10805588|FG003|Treated|Overall Study||69
9706515|NCT02519348|10805589|FG004|Treated|Overall Study||82
9706516|NCT02519348|10805590|FG005|Treated|Overall Study||47
9706517|NCT02519348|10805591|FG006|Treated|Overall Study||3
9706518|NCT02519348|10805592|FG007|Treated|Overall Study||5
9706519|NCT02519348|10805593|FG008|Treated|Overall Study||5
9706520|NCT02519348|10805585|FG000|COMPLETED|Overall Study||0
9706521|NCT02519348|10805586|FG001|COMPLETED|Overall Study||0
9706522|NCT02519348|10805587|FG002|COMPLETED|Overall Study||0
9706523|NCT02519348|10805588|FG003|COMPLETED|Overall Study||0
9706524|NCT02519348|10805589|FG004|COMPLETED|Overall Study||0
9706525|NCT02519348|10805590|FG005|COMPLETED|Overall Study||0
9706526|NCT02519348|10805591|FG006|COMPLETED|Overall Study||0
9706527|NCT02519348|10805592|FG007|COMPLETED|Overall Study||0
9706528|NCT02519348|10805593|FG008|COMPLETED|Overall Study||0
9706529|NCT02519348|10805585|FG000|NOT COMPLETED|Overall Study||40
9706530|NCT02519348|10805586|FG001|NOT COMPLETED|Overall Study||104
9706531|NCT02519348|10805587|FG002|NOT COMPLETED|Overall Study||75
9706532|NCT02519348|10805588|FG003|NOT COMPLETED|Overall Study||69
9706533|NCT02519348|10805589|FG004|NOT COMPLETED|Overall Study||84
9706534|NCT02519348|10805590|FG005|NOT COMPLETED|Overall Study||47
9706535|NCT02519348|10805591|FG006|NOT COMPLETED|Overall Study||3
9706536|NCT02519348|10805592|FG007|NOT COMPLETED|Overall Study||5
9706537|NCT02519348|10805593|FG008|NOT COMPLETED|Overall Study||6
9706538|NCT02429414|10805616|FG000|STARTED|Overall Study||42
9706539|NCT02429414|10805617|FG001|STARTED|Overall Study||38
9706540|NCT02429414|10805616|FG000|COMPLETED|Overall Study||42
9706541|NCT02429414|10805617|FG001|COMPLETED|Overall Study||37
9706542|NCT02429414|10805616|FG000|NOT COMPLETED|Overall Study||0
9706543|NCT02429414|10805617|FG001|NOT COMPLETED|Overall Study||1
9706544|NCT02267603|10805623|FG000|STARTED|Overall Study||50
9706545|NCT02267603|10805623|FG000|COMPLETED|Overall Study||6
9706546|NCT02267603|10805623|FG000|NOT COMPLETED|Overall Study||44
9706547|NCT02258659|10805627|FG000|STARTED|Overall Study||62
9706548|NCT02258659|10805627|FG000|COMPLETED|Overall Study||61
9706549|NCT02258659|10805627|FG000|NOT COMPLETED|Overall Study||1
9706550|NCT02111850|10805642|FG000|STARTED|Phase 1 Dose Escalation||1
9706551|NCT02111850|10805643|FG001|STARTED|Phase 1 Dose Escalation||1
9706552|NCT02111850|10805644|FG002|STARTED|Phase 1 Dose Escalation||1
9706553|NCT02111850|10805645|FG003|STARTED|Phase 1 Dose Escalation||1
9706554|NCT02111850|10805646|FG004|STARTED|Phase 1 Dose Escalation||2
9706555|NCT02111850|10805647|FG005|STARTED|Phase 1 Dose Escalation||1
9706556|NCT02111850|10805648|FG006|STARTED|Phase 1 Dose Escalation||1
9706557|NCT02111850|10805649|FG007|STARTED|Phase 1 Dose Escalation||1
9706558|NCT02111850|10805650|FG008|STARTED|Phase 1 Dose Escalation||6
9706559|NCT02111850|10805651|FG009|STARTED|Phase 1 Dose Escalation||0
9706560|NCT02111850|10805652|FG010|STARTED|Phase 1 Dose Escalation||0
9706561|NCT02111850|10805642|FG000|COMPLETED|Phase 1 Dose Escalation||1
10044723|NCT01995071|11170122|FG004|COMPLETED|Overall Study||7
10044724|NCT01995071|11170123|FG005|COMPLETED|Overall Study||8
10044725|NCT01995071|11170124|FG006|COMPLETED|Overall Study||7
10044726|NCT01995071|11170125|FG007|COMPLETED|Overall Study||6
10044727|NCT01995071|11170126|FG008|COMPLETED|Overall Study||7
10044728|NCT01995071|11170127|FG009|COMPLETED|Overall Study||8
10044729|NCT01995071|11170128|FG010|COMPLETED|Overall Study||7
10044730|NCT01995071|11170129|FG011|COMPLETED|Overall Study||0
10044731|NCT01995071|11170118|FG000|NOT COMPLETED|Overall Study||1
10044732|NCT01995071|11170119|FG001|NOT COMPLETED|Overall Study||0
10044733|NCT01995071|11170120|FG002|NOT COMPLETED|Overall Study||1
10044734|NCT01995071|11170121|FG003|NOT COMPLETED|Overall Study||0
10044735|NCT01995071|11170122|FG004|NOT COMPLETED|Overall Study||1
10044736|NCT01995071|11170123|FG005|NOT COMPLETED|Overall Study||0
10044737|NCT01995071|11170124|FG006|NOT COMPLETED|Overall Study||1
10044738|NCT01995071|11170125|FG007|NOT COMPLETED|Overall Study||2
10044739|NCT01995071|11170126|FG008|NOT COMPLETED|Overall Study||1
10044740|NCT01995071|11170127|FG009|NOT COMPLETED|Overall Study||0
10044741|NCT01995071|11170128|FG010|NOT COMPLETED|Overall Study||1
10044742|NCT01995071|11170129|FG011|NOT COMPLETED|Overall Study||0
10117467|NCT02539368|11248218|FG003|STARTED|Overall Study||67
9706562|NCT02111850|10805643|FG001|COMPLETED|Phase 1 Dose Escalation||1
9706563|NCT02111850|10805644|FG002|COMPLETED|Phase 1 Dose Escalation||1
9706564|NCT02111850|10805645|FG003|COMPLETED|Phase 1 Dose Escalation||1
9706565|NCT02111850|10805646|FG004|COMPLETED|Phase 1 Dose Escalation||1
9706566|NCT02111850|10805647|FG005|COMPLETED|Phase 1 Dose Escalation||1
9706567|NCT02111850|10805648|FG006|COMPLETED|Phase 1 Dose Escalation||1
9706568|NCT02111850|10805649|FG007|COMPLETED|Phase 1 Dose Escalation||1
9706569|NCT02111850|10805650|FG008|COMPLETED|Phase 1 Dose Escalation||6
9706570|NCT02111850|10805651|FG009|COMPLETED|Phase 1 Dose Escalation||0
9706571|NCT02111850|10805652|FG010|COMPLETED|Phase 1 Dose Escalation||0
9706572|NCT02111850|10805642|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0
9706573|NCT02111850|10805643|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0
9706574|NCT02111850|10805644|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0
10117468|NCT02539368|11248219|FG004|STARTED|Overall Study||102
10117469|NCT02539368|11248215|FG000|COMPLETED|Overall Study||1117
9706575|NCT02111850|10805645|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0
9706576|NCT02111850|10805646|FG004|NOT COMPLETED|Phase 1 Dose Escalation||1
10117470|NCT02539368|11248216|FG001|COMPLETED|Overall Study||393
10117471|NCT02539368|11248217|FG002|COMPLETED|Overall Study||291
10117472|NCT02539368|11248218|FG003|COMPLETED|Overall Study||60
10044743|NCT01995123|11170163|FG000|STARTED|Overall Study||63
10044744|NCT01995123|11170164|FG001|STARTED|Overall Study||61
10044745|NCT01995123|11170163|FG000|COMPLETED|Overall Study||45
10044746|NCT01995123|11170164|FG001|COMPLETED|Overall Study||46
10044747|NCT01995123|11170163|FG000|NOT COMPLETED|Overall Study||18
10044748|NCT01995123|11170164|FG001|NOT COMPLETED|Overall Study||15
10044749|NCT01995136|11170170|FG000|STARTED|Overall Study||32
10044750|NCT01995136|11170170|FG000|COMPLETED|Overall Study||31
10044751|NCT01995136|11170170|FG000|NOT COMPLETED|Overall Study||1
10044752|NCT01995201|11170176|FG000|STARTED|From Baseline Until Week 24||74
10044753|NCT01995201|11170177|FG001|STARTED|From Baseline Until Week 24||327
10044754|NCT01995201|11170178|FG002|STARTED|From Baseline Until Week 24||0
10044755|NCT01995201|11170179|FG003|STARTED|From Baseline Until Week 24||0
10044756|NCT01995201|11170180|FG004|STARTED|From Baseline Until Week 24||0
10044757|NCT01995201|11170181|FG005|STARTED|From Baseline Until Week 24||0
10044758|NCT01995201|11170182|FG006|STARTED|From Baseline Until Week 24||0
10044759|NCT01995201|11170176|FG000|COMPLETED|From Baseline Until Week 24||64
10044760|NCT01995201|11170177|FG001|COMPLETED|From Baseline Until Week 24||281
10044761|NCT01995201|11170178|FG002|COMPLETED|From Baseline Until Week 24||0
10044762|NCT01995201|11170179|FG003|COMPLETED|From Baseline Until Week 24||0
10044763|NCT01995201|11170180|FG004|COMPLETED|From Baseline Until Week 24||0
10044764|NCT01995201|11170181|FG005|COMPLETED|From Baseline Until Week 24||0
10044765|NCT01995201|11170182|FG006|COMPLETED|From Baseline Until Week 24||0
10044766|NCT01995201|11170176|FG000|NOT COMPLETED|From Baseline Until Week 24||10
10044767|NCT01995201|11170177|FG001|NOT COMPLETED|From Baseline Until Week 24||46
10044768|NCT01995201|11170178|FG002|NOT COMPLETED|From Baseline Until Week 24||0
10044769|NCT01995201|11170179|FG003|NOT COMPLETED|From Baseline Until Week 24||0
10044770|NCT01995201|11170180|FG004|NOT COMPLETED|From Baseline Until Week 24||0
10044771|NCT01995201|11170181|FG005|NOT COMPLETED|From Baseline Until Week 24||0
10044772|NCT01995201|11170182|FG006|NOT COMPLETED|From Baseline Until Week 24||0
10044773|NCT01995201|11170176|FG000|STARTED|From Week 24 Until Week 48||0
10044774|NCT01995201|11170177|FG001|STARTED|From Week 24 Until Week 48||0
10044775|NCT01995201|11170178|FG002|STARTED|From Week 24 Until Week 48||89
10044776|NCT01995201|11170179|FG003|STARTED|From Week 24 Until Week 48||90
10044777|NCT01995201|11170180|FG004|STARTED|From Week 24 Until Week 48||95
10044778|NCT01995201|11170181|FG005|STARTED|From Week 24 Until Week 48||67
10044779|NCT01995201|11170182|FG006|STARTED|From Week 24 Until Week 48||2
10044780|NCT01995201|11170176|FG000|COMPLETED|From Week 24 Until Week 48||0
10044781|NCT01995201|11170177|FG001|COMPLETED|From Week 24 Until Week 48||0
10044782|NCT01995201|11170178|FG002|COMPLETED|From Week 24 Until Week 48||84
10044783|NCT01995201|11170179|FG003|COMPLETED|From Week 24 Until Week 48||89
10044784|NCT01995201|11170180|FG004|COMPLETED|From Week 24 Until Week 48||89
10044785|NCT01995201|11170181|FG005|COMPLETED|From Week 24 Until Week 48||59
10044786|NCT01995201|11170182|FG006|COMPLETED|From Week 24 Until Week 48||0
10044787|NCT01995201|11170176|FG000|NOT COMPLETED|From Week 24 Until Week 48||0
10044788|NCT01995201|11170177|FG001|NOT COMPLETED|From Week 24 Until Week 48||0
10044789|NCT01995201|11170178|FG002|NOT COMPLETED|From Week 24 Until Week 48||5
10044790|NCT01995201|11170179|FG003|NOT COMPLETED|From Week 24 Until Week 48||1
10044791|NCT01995201|11170180|FG004|NOT COMPLETED|From Week 24 Until Week 48||6
10044792|NCT01995201|11170181|FG005|NOT COMPLETED|From Week 24 Until Week 48||8
10044793|NCT01995201|11170182|FG006|NOT COMPLETED|From Week 24 Until Week 48||2
10044794|NCT01995266|11170203|FG000|STARTED|Overall Study||159
10044795|NCT01995266|11170203|FG000|COMPLETED|Overall Study||150
10044796|NCT01995266|11170203|FG000|NOT COMPLETED|Overall Study||9
10044797|NCT01995357|11170207|FG000|STARTED|Period 1||4
10044798|NCT01995357|11170208|FG001|STARTED|Period 1||3
10044799|NCT01995357|11170209|FG002|STARTED|Period 1||4
10044800|NCT01995357|11170210|FG003|STARTED|Period 1||3
10044801|NCT01995357|11170211|FG004|STARTED|Period 1||4
10044802|NCT01995357|11170212|FG005|STARTED|Period 1||4
10044803|NCT01995357|11170207|FG000|COMPLETED|Period 1||4
10044804|NCT01995357|11170208|FG001|COMPLETED|Period 1||3
10044805|NCT01995357|11170209|FG002|COMPLETED|Period 1||4
10044806|NCT01995357|11170210|FG003|COMPLETED|Period 1||3
10044807|NCT01995357|11170211|FG004|COMPLETED|Period 1||4
10044808|NCT01995357|11170212|FG005|COMPLETED|Period 1||4
10044809|NCT01995357|11170207|FG000|NOT COMPLETED|Period 1||0
10044810|NCT01995357|11170208|FG001|NOT COMPLETED|Period 1||0
10044811|NCT01995357|11170209|FG002|NOT COMPLETED|Period 1||0
10044812|NCT01995357|11170210|FG003|NOT COMPLETED|Period 1||0
10044813|NCT01995357|11170211|FG004|NOT COMPLETED|Period 1||0
10044814|NCT01995357|11170212|FG005|NOT COMPLETED|Period 1||0
10044815|NCT01995357|11170207|FG000|STARTED|Period 2||4
10044816|NCT01995357|11170208|FG001|STARTED|Period 2||3
10044817|NCT01995357|11170209|FG002|STARTED|Period 2||4
10044818|NCT01995357|11170210|FG003|STARTED|Period 2||3
10044819|NCT01995357|11170211|FG004|STARTED|Period 2||4
10044820|NCT01995357|11170212|FG005|STARTED|Period 2||4
10044821|NCT01995357|11170207|FG000|COMPLETED|Period 2||4
10044822|NCT01995357|11170208|FG001|COMPLETED|Period 2||3
10044823|NCT01995357|11170209|FG002|COMPLETED|Period 2||4
10044824|NCT01995357|11170210|FG003|COMPLETED|Period 2||3
10044825|NCT01995357|11170211|FG004|COMPLETED|Period 2||4
10044826|NCT01995357|11170212|FG005|COMPLETED|Period 2||4
10044827|NCT01995357|11170207|FG000|NOT COMPLETED|Period 2||0
10044828|NCT01995357|11170208|FG001|NOT COMPLETED|Period 2||0
10044829|NCT01995357|11170209|FG002|NOT COMPLETED|Period 2||0
10044830|NCT01995357|11170210|FG003|NOT COMPLETED|Period 2||0
10044831|NCT01995357|11170211|FG004|NOT COMPLETED|Period 2||0
10044832|NCT01995357|11170212|FG005|NOT COMPLETED|Period 2||0
10044833|NCT01995357|11170207|FG000|STARTED|Period 3||4
10044834|NCT01995357|11170208|FG001|STARTED|Period 3||3
10044835|NCT01995357|11170209|FG002|STARTED|Period 3||4
10044836|NCT01995357|11170210|FG003|STARTED|Period 3||3
10044837|NCT01995357|11170211|FG004|STARTED|Period 3||4
10044838|NCT01995357|11170212|FG005|STARTED|Period 3||4
10044839|NCT01995357|11170207|FG000|COMPLETED|Period 3||4
10044840|NCT01995357|11170208|FG001|COMPLETED|Period 3||3
10044841|NCT01995357|11170209|FG002|COMPLETED|Period 3||4
10044842|NCT01995357|11170210|FG003|COMPLETED|Period 3||3
10044843|NCT01995357|11170211|FG004|COMPLETED|Period 3||4
10044844|NCT01995357|11170212|FG005|COMPLETED|Period 3||4
10044845|NCT01995357|11170207|FG000|NOT COMPLETED|Period 3||0
10044846|NCT01995357|11170208|FG001|NOT COMPLETED|Period 3||0
10044847|NCT01995357|11170209|FG002|NOT COMPLETED|Period 3||0
10044848|NCT01995357|11170210|FG003|NOT COMPLETED|Period 3||0
10044849|NCT01995357|11170211|FG004|NOT COMPLETED|Period 3||0
10044850|NCT01995357|11170212|FG005|NOT COMPLETED|Period 3||0
10044851|NCT01995357|11170207|FG000|STARTED|Period 4||4
10044852|NCT01995357|11170208|FG001|STARTED|Period 4||3
10044853|NCT01995357|11170209|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
10044854|NCT01995357|11170210|FG003|STARTED|Period 4||3
10044855|NCT01995357|11170211|FG004|STARTED|Period 4||4
10044856|NCT01995357|11170212|FG005|STARTED|Period 4||4
10044857|NCT01995357|11170207|FG000|COMPLETED|Period 4||4
10044858|NCT01995357|11170208|FG001|COMPLETED|Period 4||3
10044859|NCT01995357|11170209|FG002|COMPLETED|Period 4||4
10044860|NCT01995357|11170210|FG003|COMPLETED|Period 4||3
10044861|NCT01995357|11170211|FG004|COMPLETED|Period 4||4
10044862|NCT01995357|11170212|FG005|COMPLETED|Period 4||4
10044863|NCT01995357|11170207|FG000|NOT COMPLETED|Period 4||0
10044864|NCT01995357|11170208|FG001|NOT COMPLETED|Period 4||0
10044865|NCT01995357|11170209|FG002|NOT COMPLETED|Period 4||0
10044866|NCT01995357|11170210|FG003|NOT COMPLETED|Period 4||0
10044867|NCT01995357|11170211|FG004|NOT COMPLETED|Period 4||0
10044868|NCT01995357|11170212|FG005|NOT COMPLETED|Period 4||0
10044869|NCT01995357|11170207|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
10044870|NCT01995357|11170208|FG001|STARTED|Period 5||3
10044871|NCT01995357|11170209|FG002|STARTED|Period 5||4
10044872|NCT01995357|11170210|FG003|STARTED|Period 5||3
10044873|NCT01995357|11170211|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
10044874|NCT01995357|11170212|FG005|STARTED|Period 5||4
10044875|NCT01995357|11170207|FG000|COMPLETED|Period 5||2
10044876|NCT01995357|11170208|FG001|COMPLETED|Period 5||3
10044877|NCT01995357|11170209|FG002|COMPLETED|Period 5||3
10044878|NCT01995357|11170210|FG003|COMPLETED|Period 5||3
10044879|NCT01995357|11170211|FG004|COMPLETED|Period 5||4
10044880|NCT01995357|11170212|FG005|COMPLETED|Period 5||4
10044881|NCT01995357|11170207|FG000|NOT COMPLETED|Period 5||2
10044882|NCT01995357|11170208|FG001|NOT COMPLETED|Period 5||0
10044883|NCT01995357|11170209|FG002|NOT COMPLETED|Period 5||1
10044884|NCT01995357|11170210|FG003|NOT COMPLETED|Period 5||0
10044885|NCT01995357|11170211|FG004|NOT COMPLETED|Period 5||0
10044886|NCT01995357|11170212|FG005|NOT COMPLETED|Period 5||0
10044887|NCT01995461|11170228|FG000|STARTED|Overall Study||26
10044888|NCT01995461|11170228|FG000|COMPLETED|Overall Study||21
10044889|NCT01995461|11170228|FG000|NOT COMPLETED|Overall Study||5
10044890|NCT01995487|11170234|FG000|STARTED|Overall Study||958
10117473|NCT02539368|11248219|FG004|COMPLETED|Overall Study||88
10117474|NCT02539368|11248215|FG000|NOT COMPLETED|Overall Study||405
10117475|NCT02539368|11248216|FG001|NOT COMPLETED|Overall Study||101
10117476|NCT02539368|11248217|FG002|NOT COMPLETED|Overall Study||67
10117477|NCT02539368|11248218|FG003|NOT COMPLETED|Overall Study||7
10117478|NCT02539368|11248219|FG004|NOT COMPLETED|Overall Study||14
10117479|NCT02539459|11248234|FG000|STARTED|Overall Study||20
10117480|NCT02539459|11248234|FG000|COMPLETED|Overall Study||18
10117481|NCT02539459|11248234|FG000|NOT COMPLETED|Overall Study||2
10117482|NCT02539511|11248240|FG000|STARTED|Overall Study||23
10117483|NCT02539511|11248241|FG001|STARTED|Overall Study||17
10117484|NCT02539511|11248240|FG000|COMPLETED|Overall Study||17
10117485|NCT02539511|11248241|FG001|COMPLETED|Overall Study||17
10117486|NCT02539511|11248240|FG000|NOT COMPLETED|Overall Study||6
10117487|NCT02539511|11248241|FG001|NOT COMPLETED|Overall Study||0
10117488|NCT02539654|11248247|FG000|STARTED|Overall Study||14
10117489|NCT02539654|11248247|FG000|COMPLETED|Overall Study||14
10117490|NCT02539654|11248247|FG000|NOT COMPLETED|Overall Study||0
10117491|NCT02539797|11248252|FG000|STARTED|Overall Study||12
10044891|NCT01995487|11170235|FG001|STARTED|Overall Study||961
10044892|NCT01995487|11170234|FG000|COMPLETED|Overall Study||884
10044893|NCT01995487|11170235|FG001|COMPLETED|Overall Study||878
10044894|NCT01995487|11170234|FG000|NOT COMPLETED|Overall Study||74
10044895|NCT01995487|11170235|FG001|NOT COMPLETED|Overall Study||83
10044896|NCT01995513|11170241|FG000|STARTED|Open Label Treatment Period||509
10044897|NCT01995513|11170242|FG001|STARTED|Open Label Treatment Period||0
10044898|NCT01995513|11170243|FG002|STARTED|Open Label Treatment Period||0
10117492|NCT02539797|11248253|FG001|STARTED|Overall Study||13
10117493|NCT02539797|11248254|FG002|STARTED|Overall Study||13
10117494|NCT02539797|11248252|FG000|COMPLETED|Overall Study||12
10044899|NCT01995513|11170241|FG000|COMPLETED|Open Label Treatment Period||251
10044900|NCT01995513|11170242|FG001|COMPLETED|Open Label Treatment Period||0
10044901|NCT01995513|11170243|FG002|COMPLETED|Open Label Treatment Period||0
10117495|NCT02539797|11248253|FG001|COMPLETED|Overall Study||12
10044902|NCT01995513|11170241|FG000|NOT COMPLETED|Open Label Treatment Period||258
10044903|NCT01995513|11170242|FG001|NOT COMPLETED|Open Label Treatment Period||0
10044904|NCT01995513|11170243|FG002|NOT COMPLETED|Open Label Treatment Period||0
10044905|NCT01995513|11170241|FG000|STARTED|Double Blind Treatment Period||0
10044906|NCT01995513|11170242|FG001|STARTED|Double Blind Treatment Period||126
10044907|NCT01995513|11170243|FG002|STARTED|Double Blind Treatment Period||125
10044908|NCT01995513|11170241|FG000|Treated|Double Blind Treatment Period||0
10044909|NCT01995513|11170242|FG001|Treated|Double Blind Treatment Period||125
10044910|NCT01995513|11170243|FG002|Treated|Double Blind Treatment Period||124
10044911|NCT01995513|11170241|FG000|COMPLETED|Double Blind Treatment Period||0
10044912|NCT01995513|11170242|FG001|COMPLETED|Double Blind Treatment Period||0
10044913|NCT01995513|11170243|FG002|COMPLETED|Double Blind Treatment Period||0
10044914|NCT01995513|11170241|FG000|NOT COMPLETED|Double Blind Treatment Period||0
10044915|NCT01995513|11170242|FG001|NOT COMPLETED|Double Blind Treatment Period||126
10044916|NCT01995513|11170243|FG002|NOT COMPLETED|Double Blind Treatment Period||125
10044917|NCT01995526|11170253|FG000|STARTED|Overall Study||11
10044918|NCT01995526|11170253|FG000|Received One Dose of Study Drug|Overall Study||11
10044919|NCT01995526|11170253|FG000|COMPLETED|Overall Study||10
10044920|NCT01995526|11170253|FG000|NOT COMPLETED|Overall Study||1
10044921|NCT01995539|11170257|FG000|STARTED|Overall Study||181
10044922|NCT01995539|11170257|FG000|COMPLETED|Overall Study||148
10044923|NCT01995539|11170257|FG000|NOT COMPLETED|Overall Study||33
10044924|NCT01995552|11170261|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
10044925|NCT01995552|11170261|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
10044926|NCT01995552|11170261|FG000|NOT COMPLETED|Overall Study||17
10044927|NCT01995825|11170269|FG000|STARTED|Overall Study||18
10044928|NCT01995825|11170270|FG001|STARTED|Overall Study||17
10044929|NCT01995825|11170269|FG000|COMPLETED|Overall Study||17
10044930|NCT01995825|11170270|FG001|COMPLETED|Overall Study||17
10044931|NCT01995825|11170269|FG000|NOT COMPLETED|Overall Study||1
10044932|NCT01995825|11170270|FG001|NOT COMPLETED|Overall Study||0
10044933|NCT01995838|11170283|FG000|STARTED|Overall Study||56
10044934|NCT01995838|11170284|FG001|STARTED|Overall Study||32
10044935|NCT01995838|11170285|FG002|STARTED|Overall Study||27
10044936|NCT01995838|11170286|FG003|STARTED|Overall Study||38
10044937|NCT01995838|11170287|FG004|STARTED|Overall Study||32
10044938|NCT01995838|11170288|FG005|STARTED|Overall Study||56
10044939|NCT01995838|11170289|FG006|STARTED|Overall Study||50
10044940|NCT01995838|11170283|FG000|COMPLETED|Overall Study||51
10044941|NCT01995838|11170284|FG001|COMPLETED|Overall Study||30
10044942|NCT01995838|11170285|FG002|COMPLETED|Overall Study||27
10044943|NCT01995838|11170286|FG003|COMPLETED|Overall Study||36
10044944|NCT01995838|11170287|FG004|COMPLETED|Overall Study||30
10044945|NCT01995838|11170288|FG005|COMPLETED|Overall Study||54
10044946|NCT01995838|11170289|FG006|COMPLETED|Overall Study||45
10044947|NCT01995838|11170283|FG000|NOT COMPLETED|Overall Study||5
10044948|NCT01995838|11170284|FG001|NOT COMPLETED|Overall Study||2
10044949|NCT01995838|11170285|FG002|NOT COMPLETED|Overall Study||0
10044950|NCT01995838|11170286|FG003|NOT COMPLETED|Overall Study||2
10044951|NCT01995838|11170287|FG004|NOT COMPLETED|Overall Study||2
10044952|NCT01995838|11170288|FG005|NOT COMPLETED|Overall Study||2
10044953|NCT01995838|11170289|FG006|NOT COMPLETED|Overall Study||5
10044954|NCT01996033|11170306|FG000|STARTED|Overall Study||25
10044955|NCT01996033|11170306|FG000|COMPLETED|Overall Study||16
10044956|NCT01996033|11170306|FG000|NOT COMPLETED|Overall Study||9
10044957|NCT01996241|11170312|FG000|STARTED|Overall Study||1164
10044958|NCT01996241|11170313|FG001|STARTED|Overall Study||1111
10044959|NCT01996241|11170312|FG000|COMPLETED|Overall Study||912
10044960|NCT01996241|11170313|FG001|COMPLETED|Overall Study||876
10044961|NCT01996241|11170312|FG000|NOT COMPLETED|Overall Study||252
10044962|NCT01996241|11170313|FG001|NOT COMPLETED|Overall Study||235
10044963|NCT01996254|11170323|FG000|STARTED|Overall Study||5
10044964|NCT01996254|11170324|FG001|STARTED|Overall Study||14
10044965|NCT01996254|11170325|FG002|STARTED|Overall Study||14
10044966|NCT01996254|11170323|FG000|Safety Set|Overall Study||5
10044967|NCT01996254|11170324|FG001|Safety Set|Overall Study||14
10044968|NCT01996254|11170325|FG002|Safety Set|Overall Study||14
10044969|NCT01996254|11170323|FG000|Full Analysis Set|Overall Study||0
10044970|NCT01996254|11170324|FG001|Full Analysis Set|Overall Study||12
10044971|NCT01996254|11170325|FG002|Full Analysis Set|Overall Study||14
10044972|NCT01996254|11170323|FG000|Long Term Analysis Set|Overall Study||0
10044973|NCT01996254|11170324|FG001|Long Term Analysis Set|Overall Study||12
10044974|NCT01996254|11170325|FG002|Long Term Analysis Set|Overall Study||14
10044975|NCT01996254|11170323|FG000|Per Protocol Set|Overall Study||0
10044976|NCT01996254|11170324|FG001|Per Protocol Set|Overall Study||10
10044977|NCT01996254|11170325|FG002|Per Protocol Set|Overall Study||13
10044978|NCT01996254|11170323|FG000|COMPLETED|Overall Study||4
10044979|NCT01996254|11170324|FG001|COMPLETED|Overall Study||9
10044980|NCT01996254|11170325|FG002|COMPLETED|Overall Study||6
10044981|NCT01996254|11170323|FG000|NOT COMPLETED|Overall Study||1
10044982|NCT01996254|11170324|FG001|NOT COMPLETED|Overall Study||5
10044983|NCT01996254|11170325|FG002|NOT COMPLETED|Overall Study||8
10044984|NCT01996319|11170337|FG000|STARTED|Overall Study||96
10044985|NCT01996319|11170338|FG001|STARTED|Overall Study||98
10044986|NCT01996319|11170337|FG000|COMPLETED|Overall Study||88
10044987|NCT01996319|11170338|FG001|COMPLETED|Overall Study||95
10044988|NCT01996319|11170337|FG000|NOT COMPLETED|Overall Study||8
10044989|NCT01996319|11170338|FG001|NOT COMPLETED|Overall Study||3
10044990|NCT01996332|11170344|FG000|STARTED|Overall Study||1805
10044991|NCT01996332|11170344|FG000|COMPLETED|Overall Study||0
10044992|NCT01996332|11170344|FG000|NOT COMPLETED|Overall Study||1805
10044993|NCT01996592|11170348|FG000|STARTED|Overall Study||575
10044994|NCT01996592|11170348|FG000|COMPLETED|Overall Study||530
10044995|NCT01996592|11170348|FG000|NOT COMPLETED|Overall Study||45
10044996|NCT01996644|11170359|FG000|STARTED|Overall Study||20
10044997|NCT01996644|11170360|FG001|STARTED|Overall Study||16
10044998|NCT01996644|11170359|FG000|COMPLETED|Overall Study||20
10044999|NCT01996644|11170360|FG001|COMPLETED|Overall Study||16
10045000|NCT01996644|11170359|FG000|NOT COMPLETED|Overall Study||0
10045001|NCT01996644|11170360|FG001|NOT COMPLETED|Overall Study||0
10045002|NCT01996657|11170372|FG000|STARTED|Overall Study||250
10045003|NCT01996657|11170373|FG001|STARTED|Overall Study||250
10045004|NCT01996657|11170374|FG002|STARTED|Overall Study||248
10045005|NCT01996657|11170372|FG000|COMPLETED|Overall Study||237
10045006|NCT01996657|11170373|FG001|COMPLETED|Overall Study||239
10045007|NCT01996657|11170374|FG002|COMPLETED|Overall Study||234
10045008|NCT01996657|11170372|FG000|NOT COMPLETED|Overall Study||13
10045009|NCT01996657|11170373|FG001|NOT COMPLETED|Overall Study||11
10045010|NCT01996657|11170374|FG002|NOT COMPLETED|Overall Study||14
10045011|NCT01996709|11170384|FG000|STARTED|Overall Study||66
10045012|NCT01996709|11170385|FG001|STARTED|Overall Study||68
10045013|NCT01996709|11170384|FG000|COMPLETED|Overall Study||61
10045014|NCT01996709|11170385|FG001|COMPLETED|Overall Study||67
10045015|NCT01996709|11170384|FG000|NOT COMPLETED|Overall Study||5
10045016|NCT01996709|11170385|FG001|NOT COMPLETED|Overall Study||1
10045017|NCT01996748|11170397|FG000|STARTED|Overall Study||66
10045018|NCT01996748|11170398|FG001|STARTED|Overall Study||69
10045019|NCT01996748|11170397|FG000|COMPLETED|Overall Study||58
10045020|NCT01996748|11170398|FG001|COMPLETED|Overall Study||63
10045021|NCT01996748|11170397|FG000|NOT COMPLETED|Overall Study||8
10045022|NCT01996748|11170398|FG001|NOT COMPLETED|Overall Study||6
10045023|NCT01996813|11170408|FG000|STARTED|Overall Study||23
10045024|NCT01996813|11170409|FG001|STARTED|Overall Study||24
10045025|NCT01996813|11170408|FG000|COMPLETED|Overall Study||23
10045026|NCT01996813|11170409|FG001|COMPLETED|Overall Study||24
10045027|NCT01996813|11170408|FG000|NOT COMPLETED|Overall Study||0
10045028|NCT01996813|11170409|FG001|NOT COMPLETED|Overall Study||0
10045029|NCT01996826|11170417|FG000|STARTED|Overall Study||39
10045030|NCT01996826|11170418|FG001|STARTED|Overall Study||36
10045031|NCT01996826|11170417|FG000|COMPLETED|Overall Study||32
10045032|NCT01996826|11170418|FG001|COMPLETED|Overall Study||33
10045033|NCT01996826|11170417|FG000|NOT COMPLETED|Overall Study||7
10045034|NCT01996826|11170418|FG001|NOT COMPLETED|Overall Study||3
10045035|NCT01996839|11170427|FG000|STARTED|Overall Study||172
10045036|NCT01996839|11170428|FG001|STARTED|Overall Study||171
10045037|NCT01996839|11170429|FG002|STARTED|Overall Study||171
10045038|NCT01996839|11170427|FG000|COMPLETED|Overall Study||80
10045039|NCT01996839|11170428|FG001|COMPLETED|Overall Study||133
10045040|NCT01996839|11170429|FG002|COMPLETED|Overall Study||139
10045041|NCT01996839|11170427|FG000|NOT COMPLETED|Overall Study||92
10045042|NCT01996839|11170428|FG001|NOT COMPLETED|Overall Study||38
10045043|NCT01996839|11170429|FG002|NOT COMPLETED|Overall Study||32
10045044|NCT01996904|11170439|FG000|STARTED|Overall Study||139
10045045|NCT01996904|11170440|FG001|STARTED|Overall Study||117
10045046|NCT01996904|11170439|FG000|COMPLETED|Overall Study||101
10045047|NCT01996904|11170440|FG001|COMPLETED|Overall Study||90
10045048|NCT01996904|11170439|FG000|NOT COMPLETED|Overall Study||38
10045049|NCT01996904|11170440|FG001|NOT COMPLETED|Overall Study||27
10045050|NCT01996917|11170446|FG000|STARTED|Overall Study||21
10045051|NCT01996917|11170446|FG000|COMPLETED|Overall Study||21
10045052|NCT01996917|11170446|FG000|NOT COMPLETED|Overall Study||0
10045053|NCT01996943|11170453|FG000|STARTED|Overall Study||50
10045054|NCT01996943|11170454|FG001|STARTED|Overall Study||50
10045055|NCT01996943|11170453|FG000|COMPLETED|Overall Study||50
10045056|NCT01996943|11170454|FG001|COMPLETED|Overall Study||50
10045057|NCT01996943|11170453|FG000|NOT COMPLETED|Overall Study||0
10045058|NCT01996943|11170454|FG001|NOT COMPLETED|Overall Study||0
10045059|NCT01997125|11170460|FG000|STARTED|Overall Study||1
10045060|NCT01997125|11170460|FG000|COMPLETED|Overall Study||1
10045061|NCT01997125|11170460|FG000|NOT COMPLETED|Overall Study||0
10045062|NCT01997216|11170464|FG000|STARTED|First 9 Hours||18
10045063|NCT01997216|11170465|FG001|STARTED|First 9 Hours||21
10045064|NCT01997216|11170464|FG000|COMPLETED|First 9 Hours||18
10045065|NCT01997216|11170465|FG001|COMPLETED|First 9 Hours||21
10045066|NCT01997216|11170464|FG000|NOT COMPLETED|First 9 Hours||0
10045067|NCT01997216|11170465|FG001|NOT COMPLETED|First 9 Hours||0
10045068|NCT01997216|11170464|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
10045069|NCT01997216|11170465|FG001|STARTED|Second 9 Hours||21
10045070|NCT01997216|11170464|FG000|COMPLETED|Second 9 Hours||19
10045071|NCT01997216|11170465|FG001|COMPLETED|Second 9 Hours||21
10045072|NCT01997216|11170464|FG000|NOT COMPLETED|Second 9 Hours||0
10045073|NCT01997216|11170465|FG001|NOT COMPLETED|Second 9 Hours||0
10045074|NCT01997229|11170473|FG000|STARTED|Overall Study||62
10045075|NCT01997229|11170474|FG001|STARTED|Overall Study||63
10045076|NCT01997229|11170473|FG000|COMPLETED|Overall Study||57
10045077|NCT01997229|11170474|FG001|COMPLETED|Overall Study||61
10045078|NCT01997229|11170473|FG000|NOT COMPLETED|Overall Study||5
10045079|NCT01997229|11170474|FG001|NOT COMPLETED|Overall Study||2
10045080|NCT01997281|11170482|FG000|STARTED|Overall Study||7
10045081|NCT01997281|11170483|FG001|STARTED|Overall Study||7
10045082|NCT01997281|11170482|FG000|Withdrawal|Overall Study||1
10045083|NCT01997281|11170483|FG001|Withdrawal|Overall Study||0
10045084|NCT01997281|11170482|FG000|COMPLETED|Overall Study||6
10045085|NCT01997281|11170483|FG001|COMPLETED|Overall Study||7
10045086|NCT01997281|11170482|FG000|NOT COMPLETED|Overall Study||1
10045087|NCT01997281|11170483|FG001|NOT COMPLETED|Overall Study||0
10045088|NCT01997333|11170491|FG000|STARTED|Randomization and Treatment||109
10045089|NCT01997333|11170492|FG001|STARTED|Randomization and Treatment||218
10045090|NCT01997333|11170491|FG000|COMPLETED|Randomization and Treatment||6
10045091|NCT01997333|11170492|FG001|COMPLETED|Randomization and Treatment||15
10045092|NCT01997333|11170491|FG000|NOT COMPLETED|Randomization and Treatment||103
10045093|NCT01997333|11170492|FG001|NOT COMPLETED|Randomization and Treatment||203
10045094|NCT01997333|11170491|FG000|STARTED|Survival Follow up||92
10045095|NCT01997333|11170492|FG001|STARTED|Survival Follow up||213
10045096|NCT01997333|11170491|FG000|COMPLETED|Survival Follow up||76
10045097|NCT01997333|11170492|FG001|COMPLETED|Survival Follow up||199
10045098|NCT01997333|11170491|FG000|NOT COMPLETED|Survival Follow up||16
10045099|NCT01997333|11170492|FG001|NOT COMPLETED|Survival Follow up||14
10045100|NCT01997398|11170500|FG000|STARTED|Overall Study||35
10045101|NCT01997398|11170500|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
10045102|NCT01997398|11170500|FG000|NOT COMPLETED|Overall Study||1
10045103|NCT01997411|11170514|FG000|STARTED|Overall Study||6
10045104|NCT01997411|11170515|FG001|STARTED|Overall Study||6
10045105|NCT01997411|11170516|FG002|STARTED|Overall Study||6
10045106|NCT01997411|11170517|FG003|STARTED|Overall Study||6
10045107|NCT01997411|11170518|FG004|STARTED|Overall Study||6
10045108|NCT01997411|11170519|FG005|STARTED|Overall Study||6
10045109|NCT01997411|11170520|FG006|STARTED|Overall Study||6
10045110|NCT01997411|11170521|FG007|STARTED|Overall Study||6
10045111|NCT01997411|11170514|FG000|COMPLETED|Overall Study||6
10045112|NCT01997411|11170515|FG001|COMPLETED|Overall Study||6
10045113|NCT01997411|11170516|FG002|COMPLETED|Overall Study||6
10045114|NCT01997411|11170517|FG003|COMPLETED|Overall Study||6
10045115|NCT01997411|11170518|FG004|COMPLETED|Overall Study||6
10045116|NCT01997411|11170519|FG005|COMPLETED|Overall Study||5
10045117|NCT01997411|11170520|FG006|COMPLETED|Overall Study||6
10045118|NCT01997411|11170521|FG007|COMPLETED|Overall Study||6
10045119|NCT01997411|11170514|FG000|NOT COMPLETED|Overall Study||0
10045120|NCT01997411|11170515|FG001|NOT COMPLETED|Overall Study||0
10045121|NCT01997411|11170516|FG002|NOT COMPLETED|Overall Study||0
10045122|NCT01997411|11170517|FG003|NOT COMPLETED|Overall Study||0
10045123|NCT01997411|11170518|FG004|NOT COMPLETED|Overall Study||0
10045124|NCT01997411|11170519|FG005|NOT COMPLETED|Overall Study||1
10045125|NCT01997411|11170520|FG006|NOT COMPLETED|Overall Study||0
10045126|NCT01997411|11170521|FG007|NOT COMPLETED|Overall Study||0
10045127|NCT01997437|11170539|FG000|STARTED|Overall Study||6
10045128|NCT01997437|11170539|FG000|COMPLETED|Overall Study||6
10045129|NCT01997437|11170539|FG000|NOT COMPLETED|Overall Study||0
10045130|NCT01997515|11170545|FG000|STARTED|Overall Study||40
10045131|NCT01997515|11170546|FG001|STARTED|Overall Study||40
10045132|NCT01997515|11170545|FG000|COMPLETED|Overall Study||36
10045133|NCT01997515|11170546|FG001|COMPLETED|Overall Study||35
10045134|NCT01997515|11170545|FG000|NOT COMPLETED|Overall Study||4
10045135|NCT01997515|11170546|FG001|NOT COMPLETED|Overall Study||5
10045136|NCT01997723|11170552|FG000|STARTED|Overall Study||75
10045137|NCT01997723|11170552|FG000|COMPLETED|Overall Study||75
10045138|NCT01997723|11170552|FG000|NOT COMPLETED|Overall Study||0
10045139|NCT01997892|11170556|FG000|STARTED|Overall Study||1027
10045140|NCT01997892|11170556|FG000|Received Darbepoetin Alfa|Overall Study||987
10045141|NCT01997892|11170556|FG000|COMPLETED|Overall Study||959
10045142|NCT01997892|11170556|FG000|NOT COMPLETED|Overall Study||68
10045143|NCT01997905|11170565|FG000|STARTED|Overall Study||13
10045144|NCT01997905|11170565|FG000|Baseline Completed|Overall Study||11
10045145|NCT01997905|11170565|FG000|COMPLETED|Overall Study||10
10045146|NCT01997905|11170565|FG000|NOT COMPLETED|Overall Study||3
10045147|NCT01998243|11170571|FG000|STARTED|Overall Study||42
10045148|NCT01998243|11170572|FG001|STARTED|Overall Study||39
10045149|NCT01998243|11170571|FG000|COMPLETED|Overall Study||34
10045150|NCT01998243|11170572|FG001|COMPLETED|Overall Study||32
10045151|NCT01998243|11170571|FG000|NOT COMPLETED|Overall Study||8
10045152|NCT01998243|11170572|FG001|NOT COMPLETED|Overall Study||7
10045153|NCT01998269|11170580|FG000|STARTED|Overall Study||193
10045154|NCT01998269|11170580|FG000|COMPLETED|Overall Study||193
10045155|NCT01998269|11170580|FG000|NOT COMPLETED|Overall Study||0
10045156|NCT01998360|11170586|FG000|STARTED|Overall Study||50
10045157|NCT01998360|11170587|FG001|STARTED|Overall Study||50
10045158|NCT01998360|11170586|FG000|COMPLETED|Overall Study||50
10045159|NCT01998360|11170587|FG001|COMPLETED|Overall Study||50
10045160|NCT01998360|11170586|FG000|NOT COMPLETED|Overall Study||0
10045161|NCT01998360|11170587|FG001|NOT COMPLETED|Overall Study||0
10045162|NCT01998399|11170595|FG000|STARTED|Overall Study||12
10045163|NCT01998399|11170596|FG001|STARTED|Overall Study||13
10045164|NCT01998399|11170595|FG000|COMPLETED|Overall Study||4
10045165|NCT01998399|11170596|FG001|COMPLETED|Overall Study||4
10045166|NCT01998399|11170595|FG000|NOT COMPLETED|Overall Study||8
10045167|NCT01998399|11170596|FG001|NOT COMPLETED|Overall Study||9
10045168|NCT01998438|11170605|FG000|STARTED|Overall Study||319
10045169|NCT01998438|11170606|FG001|STARTED|Overall Study||318
10045170|NCT01998438|11170607|FG002|STARTED|Overall Study||318
10045171|NCT01998438|11170605|FG000|COMPLETED|Overall Study||319
10045172|NCT01998438|11170606|FG001|COMPLETED|Overall Study||318
10045173|NCT01998438|11170607|FG002|COMPLETED|Overall Study||318
10045174|NCT01998438|11170605|FG000|NOT COMPLETED|Overall Study||0
10045175|NCT01998438|11170606|FG001|NOT COMPLETED|Overall Study||0
10045176|NCT01998438|11170607|FG002|NOT COMPLETED|Overall Study||0
10045177|NCT01998477|11170617|FG000|STARTED|Overall Study||282
10045178|NCT01998477|11170618|FG001|STARTED|Overall Study||148
10045179|NCT01998477|11170617|FG000|COMPLETED|Overall Study||272
10045180|NCT01998477|11170618|FG001|COMPLETED|Overall Study||143
10045181|NCT01998477|11170617|FG000|NOT COMPLETED|Overall Study||10
10045182|NCT01998477|11170618|FG001|NOT COMPLETED|Overall Study||5
10045183|NCT01998581|11170651|FG000|STARTED|Overall Study||169
10117496|NCT02539797|11248254|FG002|COMPLETED|Overall Study||13
10117497|NCT02539797|11248252|FG000|NOT COMPLETED|Overall Study||0
10117498|NCT02539797|11248253|FG001|NOT COMPLETED|Overall Study||1
10117499|NCT02539797|11248254|FG002|NOT COMPLETED|Overall Study||0
10117500|NCT02539992|11248265|FG000|STARTED|Overall Study||15
10117501|NCT02539992|11248266|FG001|STARTED|Overall Study||11
10117502|NCT02539992|11248267|FG002|STARTED|Overall Study||18
10117503|NCT02539992|11248265|FG000|COMPLETED|Overall Study||15
10117504|NCT02539992|11248266|FG001|COMPLETED|Overall Study||7
10117505|NCT02539992|11248267|FG002|COMPLETED|Overall Study||14
10117506|NCT02539992|11248265|FG000|NOT COMPLETED|Overall Study||0
10117507|NCT02539992|11248266|FG001|NOT COMPLETED|Overall Study||4
10117508|NCT02539992|11248267|FG002|NOT COMPLETED|Overall Study||4
10117509|NCT02540083|11248277|FG000|STARTED|Overall Study||94
10117510|NCT02540083|11248277|FG000|COMPLETED|Overall Study||78
10117511|NCT02540083|11248277|FG000|NOT COMPLETED|Overall Study||16
10117512|NCT02540161|11248285|FG000|STARTED|Overall Study||20
10117513|NCT02540161|11248286|FG001|STARTED|Overall Study||7
10117514|NCT02540161|11248287|FG002|STARTED|Overall Study||5
10117515|NCT02540161|11248288|FG003|STARTED|Overall Study||7
10117516|NCT02540161|11248285|FG000|COMPLETED|Overall Study||20
10117517|NCT02540161|11248286|FG001|COMPLETED|Overall Study||7
10117518|NCT02540161|11248287|FG002|COMPLETED|Overall Study||5
10117519|NCT02540161|11248288|FG003|COMPLETED|Overall Study||7
10117520|NCT02540161|11248285|FG000|NOT COMPLETED|Overall Study||0
10117521|NCT02540161|11248286|FG001|NOT COMPLETED|Overall Study||0
10117522|NCT02540161|11248287|FG002|NOT COMPLETED|Overall Study||0
10117523|NCT02540161|11248288|FG003|NOT COMPLETED|Overall Study||0
10117524|NCT02540213|11248298|FG000|STARTED|Overall Study||240
10117525|NCT02540213|11248298|FG000|COMPLETED|Overall Study||201
10117526|NCT02540213|11248298|FG000|NOT COMPLETED|Overall Study||39
10117527|NCT02540226|11248304|FG000|STARTED|Overall Study||33
10117528|NCT02540226|11248305|FG001|STARTED|Overall Study||33
10117529|NCT02540226|11248304|FG000|COMPLETED|Overall Study||31
10117530|NCT02540226|11248305|FG001|COMPLETED|Overall Study||32
10117531|NCT02540226|11248304|FG000|NOT COMPLETED|Overall Study||2
10117532|NCT02540226|11248305|FG001|NOT COMPLETED|Overall Study||1
10117533|NCT02540265|11248314|FG000|STARTED|Overall Study||20
10117534|NCT02540265|11248315|FG001|STARTED|Overall Study||20
10117535|NCT02540265|11248316|FG002|STARTED|Overall Study||19
10117536|NCT02540265|11248314|FG000|Treatment Completion|Overall Study||20
10117537|NCT02540265|11248315|FG001|Treatment Completion|Overall Study||19
10117538|NCT02540265|11248316|FG002|Treatment Completion|Overall Study||18
10117539|NCT02540265|11248314|FG000|COMPLETED|Overall Study||20
10117540|NCT02540265|11248315|FG001|COMPLETED|Overall Study||20
10117541|NCT02540265|11248316|FG002|COMPLETED|Overall Study||18
10117542|NCT02540265|11248314|FG000|NOT COMPLETED|Overall Study||0
10117543|NCT02540265|11248315|FG001|NOT COMPLETED|Overall Study||0
10117544|NCT02540265|11248316|FG002|NOT COMPLETED|Overall Study||1
10117545|NCT02540291|11248328|FG000|STARTED|Overall Study||8
10117546|NCT02540291|11248329|FG001|STARTED|Overall Study||8
10117547|NCT02540291|11248330|FG002|STARTED|Overall Study||7
10117548|NCT02540291|11248331|FG003|STARTED|Overall Study||7
10117549|NCT02540291|11248328|FG000|COMPLETED|Overall Study||0
10117550|NCT02540291|11248329|FG001|COMPLETED|Overall Study||0
10117551|NCT02540291|11248330|FG002|COMPLETED|Overall Study||0
10117552|NCT02540291|11248331|FG003|COMPLETED|Overall Study||0
10117553|NCT02540291|11248328|FG000|NOT COMPLETED|Overall Study||8
10117554|NCT02540291|11248329|FG001|NOT COMPLETED|Overall Study||8
10117555|NCT02540291|11248330|FG002|NOT COMPLETED|Overall Study||7
10117556|NCT02540291|11248331|FG003|NOT COMPLETED|Overall Study||7
10117557|NCT02540356|11248345|FG000|STARTED|Overall Study||1
10117558|NCT02540356|11248346|FG001|STARTED|Overall Study||0
10117559|NCT02540356|11248345|FG000|COMPLETED|Overall Study||0
10117560|NCT02540356|11248346|FG001|COMPLETED|Overall Study||0
10117561|NCT02540356|11248345|FG000|NOT COMPLETED|Overall Study||1
10117562|NCT02540356|11248346|FG001|NOT COMPLETED|Overall Study||0
10117563|NCT02540447|11248353|FG000|STARTED|Overall Study||40
10117564|NCT02540447|11248354|FG001|STARTED|Overall Study||40
10045184|NCT01998581|11170652|FG001|STARTED|Overall Study||56
10045185|NCT01998581|11170651|FG000|COMPLETED|Overall Study||123
10117565|NCT02540447|11248353|FG000|COMPLETED|Overall Study||40
10117566|NCT02540447|11248354|FG001|COMPLETED|Overall Study||40
10117567|NCT02540447|11248353|FG000|NOT COMPLETED|Overall Study||0
10045186|NCT01998581|11170652|FG001|COMPLETED|Overall Study||44
10117568|NCT02540447|11248354|FG001|NOT COMPLETED|Overall Study||0
10117569|NCT02540538|11248363|FG000|STARTED|Overall Study||12
10117570|NCT02540538|11248364|FG001|STARTED|Overall Study||12
10117571|NCT02540538|11248365|FG002|STARTED|Overall Study||10
10117572|NCT02540538|11248363|FG000|COMPLETED|Overall Study||12
10045187|NCT01998581|11170651|FG000|NOT COMPLETED|Overall Study||46
10117573|NCT02540538|11248364|FG001|COMPLETED|Overall Study||11
10045188|NCT01998581|11170652|FG001|NOT COMPLETED|Overall Study||12
10045189|NCT01998633|11170661|FG000|STARTED|Overall Study||47
10045190|NCT01998633|11170661|FG000|COMPLETED|Overall Study||46
10045191|NCT01998633|11170661|FG000|NOT COMPLETED|Overall Study||1
10045192|NCT01998737|11170671|FG000|STARTED|Overall Study||911
10045193|NCT01998737|11170672|FG001|STARTED|Overall Study||100
10045194|NCT01998737|11170671|FG000|COMPLETED|Overall Study||888
10045195|NCT01998737|11170672|FG001|COMPLETED|Overall Study||100
10045196|NCT01998737|11170671|FG000|NOT COMPLETED|Overall Study||23
10045197|NCT01998737|11170672|FG001|NOT COMPLETED|Overall Study||0
10045198|NCT01998880|11170680|FG000|STARTED|Overall Study||233
10045199|NCT01998880|11170681|FG001|STARTED|Overall Study||118
10045200|NCT01998880|11170680|FG000|Received Study Drug|Overall Study||230
10045201|NCT01998880|11170681|FG001|Received Study Drug|Overall Study||116
10045202|NCT01998880|11170680|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205
10045203|NCT01998880|11170681|FG001|COMPLETED|Overall Study||78
10045204|NCT01998880|11170680|FG000|NOT COMPLETED|Overall Study||28
10045205|NCT01998880|11170681|FG001|NOT COMPLETED|Overall Study||40
10045206|NCT01998893|11170687|FG000|STARTED|Overall Study||38
10045207|NCT01998893|11170687|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
10045208|NCT01998893|11170687|FG000|2nd Treatment Cycle Started|Overall Study||5
10045209|NCT01998893|11170687|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3
10045210|NCT01998893|11170687|FG000|COMPLETED|Overall Study||21
10045211|NCT01998893|11170687|FG000|NOT COMPLETED|Overall Study||17
10045212|NCT01998906|11170694|FG000|STARTED|Overall Study||115
10045213|NCT01998906|11170695|FG001|STARTED|Overall Study||116
10045214|NCT01998906|11170696|FG002|STARTED|Overall Study||99
10045215|NCT01998906|11170694|FG000|COMPLETED|Overall Study||1
10045216|NCT01998906|11170695|FG001|COMPLETED|Overall Study||2
10045217|NCT01998906|11170696|FG002|COMPLETED|Overall Study||1
10045218|NCT01998906|11170694|FG000|NOT COMPLETED|Overall Study||114
10045219|NCT01998906|11170695|FG001|NOT COMPLETED|Overall Study||114
10045220|NCT01998906|11170696|FG002|NOT COMPLETED|Overall Study||98
10045221|NCT01998919|11170709|FG000|STARTED|Overall Study||79
10045222|NCT01998919|11170710|FG001|STARTED|Overall Study||74
10045223|NCT01998919|11170709|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
10045224|NCT01998919|11170710|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
10045225|NCT01998919|11170709|FG000|COMPLETED|Overall Study||37
10045226|NCT01998919|11170710|FG001|COMPLETED|Overall Study||39
10045227|NCT01998919|11170709|FG000|NOT COMPLETED|Overall Study||42
10045228|NCT01998919|11170710|FG001|NOT COMPLETED|Overall Study||35
10045229|NCT01998958|11170723|FG000|STARTED|Period 1 (Panel A and B)||33
10045230|NCT01998958|11170724|FG001|STARTED|Period 1 (Panel A and B)||11
10045231|NCT01998958|11170725|FG002|STARTED|Period 1 (Panel A and B)||11
10045232|NCT01998958|11170726|FG003|STARTED|Period 1 (Panel A and B)||12
10045233|NCT01998958|11170727|FG004|STARTED|Period 1 (Panel A and B)||21
10045234|NCT01998958|11170728|FG005|STARTED|Period 1 (Panel A and B)||11
10045235|NCT01998958|11170729|FG006|STARTED|Period 1 (Panel A and B)||9
10045236|NCT01998958|11170730|FG007|STARTED|Period 1 (Panel A and B)||0
10045237|NCT01998958|11170731|FG008|STARTED|Period 1 (Panel A and B)||0
10045238|NCT01998958|11170732|FG009|STARTED|Period 1 (Panel A and B)||0
10045239|NCT01998958|11170733|FG010|STARTED|Period 1 (Panel A and B)||0
10045240|NCT01998958|11170734|FG011|STARTED|Period 1 (Panel A and B)||0
10045241|NCT01998958|11170735|FG012|STARTED|Period 1 (Panel A and B)||0
10045242|NCT01998958|11170736|FG013|STARTED|Period 1 (Panel A and B)||0
10045243|NCT01998958|11170737|FG014|STARTED|Period 1 (Panel A and B)||0
10045244|NCT01998958|11170738|FG015|STARTED|Period 1 (Panel A and B)||0
10045245|NCT01998958|11170739|FG016|STARTED|Period 1 (Panel A and B)||0
10045246|NCT01998958|11170740|FG017|STARTED|Period 1 (Panel A and B)||0
10045247|NCT01998958|11170741|FG018|STARTED|Period 1 (Panel A and B)||0
10045248|NCT01998958|11170742|FG019|STARTED|Period 1 (Panel A and B)||0
10045249|NCT01998958|11170743|FG020|STARTED|Period 1 (Panel A and B)||0
10045250|NCT01998958|11170744|FG021|STARTED|Period 1 (Panel A and B)||0
10045251|NCT01998958|11170745|FG022|STARTED|Period 1 (Panel A and B)||0
10045252|NCT01998958|11170746|FG023|STARTED|Period 1 (Panel A and B)||0
10045253|NCT01998958|11170747|FG024|STARTED|Period 1 (Panel A and B)||0
10045254|NCT01998958|11170748|FG025|STARTED|Period 1 (Panel A and B)||0
10045255|NCT01998958|11170749|FG026|STARTED|Period 1 (Panel A and B)||0
10045256|NCT01998958|11170750|FG027|STARTED|Period 1 (Panel A and B)||0
10045257|NCT01998958|11170751|FG028|STARTED|Period 1 (Panel A and B)||0
10045258|NCT01998958|11170752|FG029|STARTED|Period 1 (Panel A and B)||0
10045259|NCT01998958|11170753|FG030|STARTED|Period 1 (Panel A and B)||0
10045260|NCT01998958|11170754|FG031|STARTED|Period 1 (Panel A and B)||0
10045261|NCT01998958|11170723|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
10045262|NCT01998958|11170724|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045263|NCT01998958|11170725|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045264|NCT01998958|11170726|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045265|NCT01998958|11170727|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045266|NCT01998958|11170728|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045267|NCT01998958|11170729|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045268|NCT01998958|11170730|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045269|NCT01998958|11170731|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045270|NCT01998958|11170732|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10117574|NCT02540538|11248365|FG002|COMPLETED|Overall Study||10
10045271|NCT01998958|11170733|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045272|NCT01998958|11170734|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045273|NCT01998958|11170735|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045274|NCT01998958|11170736|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045275|NCT01998958|11170737|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045276|NCT01998958|11170738|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045277|NCT01998958|11170739|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045278|NCT01998958|11170740|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045279|NCT01998958|11170741|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045280|NCT01998958|11170742|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045281|NCT01998958|11170743|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045282|NCT01998958|11170744|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045283|NCT01998958|11170745|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045284|NCT01998958|11170746|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045285|NCT01998958|11170747|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045286|NCT01998958|11170748|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045287|NCT01998958|11170749|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045288|NCT01998958|11170750|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045289|NCT01998958|11170751|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045290|NCT01998958|11170752|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045291|NCT01998958|11170753|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045292|NCT01998958|11170754|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10045293|NCT01998958|11170723|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
10045294|NCT01998958|11170724|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045295|NCT01998958|11170725|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045296|NCT01998958|11170726|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045297|NCT01998958|11170727|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045298|NCT01998958|11170728|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045299|NCT01998958|11170729|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045300|NCT01998958|11170730|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045301|NCT01998958|11170731|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045302|NCT01998958|11170732|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045303|NCT01998958|11170733|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045304|NCT01998958|11170734|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045305|NCT01998958|11170735|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045306|NCT01998958|11170736|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045307|NCT01998958|11170737|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045308|NCT01998958|11170738|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045309|NCT01998958|11170739|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045310|NCT01998958|11170740|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045311|NCT01998958|11170741|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045312|NCT01998958|11170742|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045313|NCT01998958|11170743|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045314|NCT01998958|11170744|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045315|NCT01998958|11170745|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045316|NCT01998958|11170746|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045317|NCT01998958|11170747|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045318|NCT01998958|11170748|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045319|NCT01998958|11170749|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045320|NCT01998958|11170750|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045321|NCT01998958|11170751|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045322|NCT01998958|11170752|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045323|NCT01998958|11170753|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045324|NCT01998958|11170754|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10045325|NCT01998958|11170723|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
10045326|NCT01998958|11170724|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045327|NCT01998958|11170725|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045328|NCT01998958|11170726|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045329|NCT01998958|11170727|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045330|NCT01998958|11170728|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045331|NCT01998958|11170729|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045332|NCT01998958|11170730|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045333|NCT01998958|11170731|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045334|NCT01998958|11170732|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045335|NCT01998958|11170733|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045336|NCT01998958|11170734|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045337|NCT01998958|11170735|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045338|NCT01998958|11170736|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045339|NCT01998958|11170737|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045340|NCT01998958|11170738|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045341|NCT01998958|11170739|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045342|NCT01998958|11170740|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045343|NCT01998958|11170741|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045344|NCT01998958|11170742|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045345|NCT01998958|11170743|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045346|NCT01998958|11170744|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045347|NCT01998958|11170745|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045348|NCT01998958|11170746|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045349|NCT01998958|11170747|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045350|NCT01998958|11170748|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045351|NCT01998958|11170749|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045352|NCT01998958|11170750|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045353|NCT01998958|11170751|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045354|NCT01998958|11170752|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045355|NCT01998958|11170753|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045356|NCT01998958|11170754|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10045357|NCT01998958|11170723|FG000|COMPLETED|Period 1 (Panel A and B)||32
10045358|NCT01998958|11170724|FG001|COMPLETED|Period 1 (Panel A and B)||8
10045359|NCT01998958|11170725|FG002|COMPLETED|Period 1 (Panel A and B)||11
10045360|NCT01998958|11170726|FG003|COMPLETED|Period 1 (Panel A and B)||12
10045361|NCT01998958|11170727|FG004|COMPLETED|Period 1 (Panel A and B)||21
10045362|NCT01998958|11170728|FG005|COMPLETED|Period 1 (Panel A and B)||11
10045363|NCT01998958|11170729|FG006|COMPLETED|Period 1 (Panel A and B)||9
10045364|NCT01998958|11170730|FG007|COMPLETED|Period 1 (Panel A and B)||0
10045365|NCT01998958|11170731|FG008|COMPLETED|Period 1 (Panel A and B)||0
10045366|NCT01998958|11170732|FG009|COMPLETED|Period 1 (Panel A and B)||0
10045367|NCT01998958|11170733|FG010|COMPLETED|Period 1 (Panel A and B)||0
10045368|NCT01998958|11170734|FG011|COMPLETED|Period 1 (Panel A and B)||0
10045369|NCT01998958|11170735|FG012|COMPLETED|Period 1 (Panel A and B)||0
10045370|NCT01998958|11170736|FG013|COMPLETED|Period 1 (Panel A and B)||0
10045371|NCT01998958|11170737|FG014|COMPLETED|Period 1 (Panel A and B)||0
10045372|NCT01998958|11170738|FG015|COMPLETED|Period 1 (Panel A and B)||0
10045373|NCT01998958|11170739|FG016|COMPLETED|Period 1 (Panel A and B)||0
10045374|NCT01998958|11170740|FG017|COMPLETED|Period 1 (Panel A and B)||0
10045375|NCT01998958|11170741|FG018|COMPLETED|Period 1 (Panel A and B)||0
10045376|NCT01998958|11170742|FG019|COMPLETED|Period 1 (Panel A and B)||0
10045377|NCT01998958|11170743|FG020|COMPLETED|Period 1 (Panel A and B)||0
10045378|NCT01998958|11170744|FG021|COMPLETED|Period 1 (Panel A and B)||0
10045379|NCT01998958|11170745|FG022|COMPLETED|Period 1 (Panel A and B)||0
10045380|NCT01998958|11170746|FG023|COMPLETED|Period 1 (Panel A and B)||0
10045381|NCT01998958|11170747|FG024|COMPLETED|Period 1 (Panel A and B)||0
10045382|NCT01998958|11170748|FG025|COMPLETED|Period 1 (Panel A and B)||0
10045383|NCT01998958|11170749|FG026|COMPLETED|Period 1 (Panel A and B)||0
10045384|NCT01998958|11170750|FG027|COMPLETED|Period 1 (Panel A and B)||0
10045385|NCT01998958|11170751|FG028|COMPLETED|Period 1 (Panel A and B)||0
10045386|NCT01998958|11170752|FG029|COMPLETED|Period 1 (Panel A and B)||0
10045387|NCT01998958|11170753|FG030|COMPLETED|Period 1 (Panel A and B)||0
10045388|NCT01998958|11170754|FG031|COMPLETED|Period 1 (Panel A and B)||0
10045389|NCT01998958|11170723|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1
10045390|NCT01998958|11170724|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3
10045391|NCT01998958|11170725|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0
10045392|NCT01998958|11170726|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0
10045393|NCT01998958|11170727|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0
10045394|NCT01998958|11170728|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0
10045395|NCT01998958|11170729|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0
10045396|NCT01998958|11170730|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0
10045397|NCT01998958|11170731|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0
10045398|NCT01998958|11170732|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0
10045399|NCT01998958|11170733|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0
10045400|NCT01998958|11170734|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0
10045401|NCT01998958|11170735|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0
10045402|NCT01998958|11170736|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0
10045403|NCT01998958|11170737|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0
10045404|NCT01998958|11170738|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0
10045405|NCT01998958|11170739|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0
10045406|NCT01998958|11170740|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0
10045407|NCT01998958|11170741|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0
10045408|NCT01998958|11170742|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0
10045409|NCT01998958|11170743|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0
10045410|NCT01998958|11170744|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0
10045411|NCT01998958|11170745|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0
10045412|NCT01998958|11170746|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0
10045413|NCT01998958|11170747|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0
10045414|NCT01998958|11170748|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0
10045415|NCT01998958|11170749|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0
10045416|NCT01998958|11170750|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0
10045417|NCT01998958|11170751|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0
10045418|NCT01998958|11170752|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0
10045419|NCT01998958|11170753|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0
10045420|NCT01998958|11170754|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0
10045421|NCT01998958|11170723|FG000|STARTED|Period 2 (Panel A and B)||0
10045422|NCT01998958|11170724|FG001|STARTED|Period 2 (Panel A and B)||0
10045423|NCT01998958|11170725|FG002|STARTED|Period 2 (Panel A and B)||0
10045424|NCT01998958|11170726|FG003|STARTED|Period 2 (Panel A and B)||0
10045425|NCT01998958|11170727|FG004|STARTED|Period 2 (Panel A and B)||0
10117575|NCT02540538|11248363|FG000|NOT COMPLETED|Overall Study||0
10117576|NCT02540538|11248364|FG001|NOT COMPLETED|Overall Study||1
10117577|NCT02540538|11248365|FG002|NOT COMPLETED|Overall Study||0
10117578|NCT02540629|11248375|FG000|STARTED|Overall Study||6201
10117579|NCT02540629|11248376|FG001|STARTED|Overall Study||6469
10117580|NCT02540629|11248375|FG000|COMPLETED|Overall Study||6201
10117581|NCT02540629|11248376|FG001|COMPLETED|Overall Study||6469
10117582|NCT02540629|11248375|FG000|NOT COMPLETED|Overall Study||0
10117583|NCT02540629|11248376|FG001|NOT COMPLETED|Overall Study||0
10117584|NCT02540668|11248383|FG000|STARTED|Period 1 - Warfarin Single Dose||15
10117585|NCT02540668|11248384|FG001|STARTED|Period 1 - Warfarin Single Dose||0
10117586|NCT02540668|11248383|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
10117587|NCT02540668|11248384|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
10117588|NCT02540668|11248383|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15
10117589|NCT02540668|11248384|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0
10117590|NCT02540668|11248383|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
10117591|NCT02540668|11248384|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
10117592|NCT02540668|11248383|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
10117593|NCT02540668|11248384|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
10117594|NCT02540668|11248383|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0
10117595|NCT02540668|11248384|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14
10117596|NCT02540668|11248383|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
10117597|NCT02540668|11248384|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
10117598|NCT02540772|11248393|FG000|STARTED|Overall Study||10
10117599|NCT02540772|11248394|FG001|STARTED|Overall Study||10
10117600|NCT02540772|11248393|FG000|COMPLETED|Overall Study||10
10117601|NCT02540772|11248394|FG001|COMPLETED|Overall Study||10
10117602|NCT02540772|11248393|FG000|NOT COMPLETED|Overall Study||0
10117603|NCT02540772|11248394|FG001|NOT COMPLETED|Overall Study||0
10117604|NCT02540850|11248403|FG000|STARTED|Overall Study||360
10117605|NCT02540850|11248404|FG001|STARTED|Overall Study||396
10117606|NCT02540850|11248405|FG002|STARTED|Overall Study||444
10117607|NCT02540850|11248403|FG000|COMPLETED|Overall Study||291
10117608|NCT02540850|11248404|FG001|COMPLETED|Overall Study||330
10117609|NCT02540850|11248405|FG002|COMPLETED|Overall Study||410
10117610|NCT02540850|11248403|FG000|NOT COMPLETED|Overall Study||69
10117611|NCT02540850|11248404|FG001|NOT COMPLETED|Overall Study||66
10117612|NCT02540850|11248405|FG002|NOT COMPLETED|Overall Study||34
10117613|NCT02540954|11248415|FG000|STARTED|Overall Study||168
10117614|NCT02540954|11248416|FG001|STARTED|Overall Study||168
9706577|NCT02111850|10805647|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0
9706578|NCT02111850|10805648|FG006|NOT COMPLETED|Phase 1 Dose Escalation||0
9706579|NCT02111850|10805649|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
9706580|NCT02111850|10805650|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
9706581|NCT02111850|10805651|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
9706582|NCT02111850|10805652|FG010|NOT COMPLETED|Phase 1 Dose Escalation||0
9706583|NCT02111850|10805642|FG000|STARTED|Phase 2 Maximum Tolerated Dose||0
9706584|NCT02111850|10805643|FG001|STARTED|Phase 2 Maximum Tolerated Dose||0
9706585|NCT02111850|10805644|FG002|STARTED|Phase 2 Maximum Tolerated Dose||0
9706586|NCT02111850|10805645|FG003|STARTED|Phase 2 Maximum Tolerated Dose||0
9706587|NCT02111850|10805646|FG004|STARTED|Phase 2 Maximum Tolerated Dose||0
9706588|NCT02111850|10805647|FG005|STARTED|Phase 2 Maximum Tolerated Dose||0
9706589|NCT02111850|10805648|FG006|STARTED|Phase 2 Maximum Tolerated Dose||0
9706590|NCT02111850|10805649|FG007|STARTED|Phase 2 Maximum Tolerated Dose||0
9706591|NCT02111850|10805650|FG008|STARTED|Phase 2 Maximum Tolerated Dose||0
10117615|NCT02540954|11248415|FG000|Treated|Overall Study||167
10117616|NCT02540954|11248416|FG001|Treated|Overall Study||168
10117617|NCT02540954|11248415|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165
10117618|NCT02540954|11248416|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167
9706592|NCT02111850|10805651|FG009|STARTED|Phase 2 Maximum Tolerated Dose||5
10117619|NCT02540954|11248415|FG000|COMPLETED|Overall Study|Completed treatment|149
10117620|NCT02540954|11248416|FG001|COMPLETED|Overall Study|Completed treatment|154
10117621|NCT02540954|11248415|FG000|NOT COMPLETED|Overall Study||19
10117622|NCT02540954|11248416|FG001|NOT COMPLETED|Overall Study||14
10117623|NCT02540993|11248424|FG000|STARTED|Overall Study||2866
9706593|NCT02111850|10805652|FG010|STARTED|Phase 2 Maximum Tolerated Dose||1
10045426|NCT01998958|11170728|FG005|STARTED|Period 2 (Panel A and B)||0
10045427|NCT01998958|11170729|FG006|STARTED|Period 2 (Panel A and B)||0
10117624|NCT02540993|11248425|FG001|STARTED|Overall Study||2868
10117625|NCT02540993|11248424|FG000|Included in FAS|Overall Study||2833
10045428|NCT01998958|11170730|FG007|STARTED|Period 2 (Panel A and B)||6
10045429|NCT01998958|11170731|FG008|STARTED|Period 2 (Panel A and B)||4
10045430|NCT01998958|11170732|FG009|STARTED|Period 2 (Panel A and B)||8
10045431|NCT01998958|11170733|FG010|STARTED|Period 2 (Panel A and B)||9
10045432|NCT01998958|11170734|FG011|STARTED|Period 2 (Panel A and B)||5
10045433|NCT01998958|11170735|FG012|STARTED|Period 2 (Panel A and B)||8
10045434|NCT01998958|11170736|FG013|STARTED|Period 2 (Panel A and B)||11
10045435|NCT01998958|11170737|FG014|STARTED|Period 2 (Panel A and B)||12
10045436|NCT01998958|11170738|FG015|STARTED|Period 2 (Panel A and B)||5
10045437|NCT01998958|11170739|FG016|STARTED|Period 2 (Panel A and B)||8
10045438|NCT01998958|11170740|FG017|STARTED|Period 2 (Panel A and B)||5
10045439|NCT01998958|11170741|FG018|STARTED|Period 2 (Panel A and B)||3
10045440|NCT01998958|11170742|FG019|STARTED|Period 2 (Panel A and B)||11
10045441|NCT01998958|11170743|FG020|STARTED|Period 2 (Panel A and B)||9
10045442|NCT01998958|11170744|FG021|STARTED|Period 2 (Panel A and B)||0
10045443|NCT01998958|11170745|FG022|STARTED|Period 2 (Panel A and B)||0
10045444|NCT01998958|11170746|FG023|STARTED|Period 2 (Panel A and B)||0
10045445|NCT01998958|11170747|FG024|STARTED|Period 2 (Panel A and B)||0
10045446|NCT01998958|11170748|FG025|STARTED|Period 2 (Panel A and B)||0
10045447|NCT01998958|11170749|FG026|STARTED|Period 2 (Panel A and B)||0
10045448|NCT01998958|11170750|FG027|STARTED|Period 2 (Panel A and B)||0
10045449|NCT01998958|11170751|FG028|STARTED|Period 2 (Panel A and B)||0
10045450|NCT01998958|11170752|FG029|STARTED|Period 2 (Panel A and B)||0
10045451|NCT01998958|11170753|FG030|STARTED|Period 2 (Panel A and B)||0
10045452|NCT01998958|11170754|FG031|STARTED|Period 2 (Panel A and B)||0
10045453|NCT01998958|11170723|FG000|COMPLETED|Period 2 (Panel A and B)||0
10045454|NCT01998958|11170724|FG001|COMPLETED|Period 2 (Panel A and B)||0
10045455|NCT01998958|11170725|FG002|COMPLETED|Period 2 (Panel A and B)||0
10045456|NCT01998958|11170726|FG003|COMPLETED|Period 2 (Panel A and B)||0
10045457|NCT01998958|11170727|FG004|COMPLETED|Period 2 (Panel A and B)||0
10045458|NCT01998958|11170728|FG005|COMPLETED|Period 2 (Panel A and B)||0
10045459|NCT01998958|11170729|FG006|COMPLETED|Period 2 (Panel A and B)||0
10045460|NCT01998958|11170730|FG007|COMPLETED|Period 2 (Panel A and B)||6
10045461|NCT01998958|11170731|FG008|COMPLETED|Period 2 (Panel A and B)||4
10045462|NCT01998958|11170732|FG009|COMPLETED|Period 2 (Panel A and B)||8
10045463|NCT01998958|11170733|FG010|COMPLETED|Period 2 (Panel A and B)||8
10045464|NCT01998958|11170734|FG011|COMPLETED|Period 2 (Panel A and B)||5
10045465|NCT01998958|11170735|FG012|COMPLETED|Period 2 (Panel A and B)||8
10045466|NCT01998958|11170736|FG013|COMPLETED|Period 2 (Panel A and B)||11
10045467|NCT01998958|11170737|FG014|COMPLETED|Period 2 (Panel A and B)||10
10045468|NCT01998958|11170738|FG015|COMPLETED|Period 2 (Panel A and B)||5
10045469|NCT01998958|11170739|FG016|COMPLETED|Period 2 (Panel A and B)||8
10045470|NCT01998958|11170740|FG017|COMPLETED|Period 2 (Panel A and B)||5
10045471|NCT01998958|11170741|FG018|COMPLETED|Period 2 (Panel A and B)||2
10045472|NCT01998958|11170742|FG019|COMPLETED|Period 2 (Panel A and B)||11
10045473|NCT01998958|11170743|FG020|COMPLETED|Period 2 (Panel A and B)||9
10045474|NCT01998958|11170744|FG021|COMPLETED|Period 2 (Panel A and B)||0
10045475|NCT01998958|11170745|FG022|COMPLETED|Period 2 (Panel A and B)||0
10045476|NCT01998958|11170746|FG023|COMPLETED|Period 2 (Panel A and B)||0
10045477|NCT01998958|11170747|FG024|COMPLETED|Period 2 (Panel A and B)||0
10045478|NCT01998958|11170748|FG025|COMPLETED|Period 2 (Panel A and B)||0
10045479|NCT01998958|11170749|FG026|COMPLETED|Period 2 (Panel A and B)||0
10045480|NCT01998958|11170750|FG027|COMPLETED|Period 2 (Panel A and B)||0
10045481|NCT01998958|11170751|FG028|COMPLETED|Period 2 (Panel A and B)||0
10045482|NCT01998958|11170752|FG029|COMPLETED|Period 2 (Panel A and B)||0
10045483|NCT01998958|11170753|FG030|COMPLETED|Period 2 (Panel A and B)||0
10045484|NCT01998958|11170754|FG031|COMPLETED|Period 2 (Panel A and B)||0
10045485|NCT01998958|11170723|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0
10045486|NCT01998958|11170724|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0
10045487|NCT01998958|11170725|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0
10045488|NCT01998958|11170726|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0
10045489|NCT01998958|11170727|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0
10045490|NCT01998958|11170728|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0
10045491|NCT01998958|11170729|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0
10045492|NCT01998958|11170730|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0
10045493|NCT01998958|11170731|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0
10045494|NCT01998958|11170732|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0
10045495|NCT01998958|11170733|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1
10045496|NCT01998958|11170734|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0
10045497|NCT01998958|11170735|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0
10045498|NCT01998958|11170736|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0
10045499|NCT01998958|11170737|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2
10045500|NCT01998958|11170738|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0
10045501|NCT01998958|11170739|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0
10045502|NCT01998958|11170740|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0
10045503|NCT01998958|11170741|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1
10045504|NCT01998958|11170742|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0
10045505|NCT01998958|11170743|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0
10045506|NCT01998958|11170744|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0
10045507|NCT01998958|11170745|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0
10045508|NCT01998958|11170746|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0
10045509|NCT01998958|11170747|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0
10045510|NCT01998958|11170748|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0
10045511|NCT01998958|11170749|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0
10045512|NCT01998958|11170750|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0
10045513|NCT01998958|11170751|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0
10045514|NCT01998958|11170752|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0
10045515|NCT01998958|11170753|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0
10045516|NCT01998958|11170754|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0
10045517|NCT01998958|11170723|FG000|STARTED|Open Label Phase (Optional)||0
10045518|NCT01998958|11170724|FG001|STARTED|Open Label Phase (Optional)||0
10045519|NCT01998958|11170725|FG002|STARTED|Open Label Phase (Optional)||0
10045520|NCT01998958|11170726|FG003|STARTED|Open Label Phase (Optional)||0
10045521|NCT01998958|11170727|FG004|STARTED|Open Label Phase (Optional)||0
10045522|NCT01998958|11170728|FG005|STARTED|Open Label Phase (Optional)||0
10045523|NCT01998958|11170729|FG006|STARTED|Open Label Phase (Optional)||0
10045524|NCT01998958|11170730|FG007|STARTED|Open Label Phase (Optional)||0
10045525|NCT01998958|11170731|FG008|STARTED|Open Label Phase (Optional)||0
10045526|NCT01998958|11170732|FG009|STARTED|Open Label Phase (Optional)||0
10045527|NCT01998958|11170733|FG010|STARTED|Open Label Phase (Optional)||0
10045528|NCT01998958|11170734|FG011|STARTED|Open Label Phase (Optional)||0
10045529|NCT01998958|11170735|FG012|STARTED|Open Label Phase (Optional)||0
10045530|NCT01998958|11170736|FG013|STARTED|Open Label Phase (Optional)||0
10045531|NCT01998958|11170737|FG014|STARTED|Open Label Phase (Optional)||0
10045532|NCT01998958|11170738|FG015|STARTED|Open Label Phase (Optional)||0
10045533|NCT01998958|11170739|FG016|STARTED|Open Label Phase (Optional)||0
10045534|NCT01998958|11170740|FG017|STARTED|Open Label Phase (Optional)||0
10045535|NCT01998958|11170741|FG018|STARTED|Open Label Phase (Optional)||0
10045536|NCT01998958|11170742|FG019|STARTED|Open Label Phase (Optional)||0
10045537|NCT01998958|11170743|FG020|STARTED|Open Label Phase (Optional)||0
10045538|NCT01998958|11170744|FG021|STARTED|Open Label Phase (Optional)||10
10045539|NCT01998958|11170745|FG022|STARTED|Open Label Phase (Optional)||20
10045540|NCT01998958|11170746|FG023|STARTED|Open Label Phase (Optional)||27
10045541|NCT01998958|11170747|FG024|STARTED|Open Label Phase (Optional)||13
10045542|NCT01998958|11170748|FG025|STARTED|Open Label Phase (Optional)||7
10045543|NCT01998958|11170749|FG026|STARTED|Open Label Phase (Optional)||19
10045544|NCT01998958|11170750|FG027|STARTED|Open Label Phase (Optional)||0
10045545|NCT01998958|11170751|FG028|STARTED|Open Label Phase (Optional)||0
10045546|NCT01998958|11170752|FG029|STARTED|Open Label Phase (Optional)||0
10045547|NCT01998958|11170753|FG030|STARTED|Open Label Phase (Optional)||0
10045548|NCT01998958|11170754|FG031|STARTED|Open Label Phase (Optional)||0
10045549|NCT01998958|11170723|FG000|COMPLETED|Open Label Phase (Optional)||0
10045550|NCT01998958|11170724|FG001|COMPLETED|Open Label Phase (Optional)||0
10045551|NCT01998958|11170725|FG002|COMPLETED|Open Label Phase (Optional)||0
10045552|NCT01998958|11170726|FG003|COMPLETED|Open Label Phase (Optional)||0
10045553|NCT01998958|11170727|FG004|COMPLETED|Open Label Phase (Optional)||0
10045554|NCT01998958|11170728|FG005|COMPLETED|Open Label Phase (Optional)||0
10045555|NCT01998958|11170729|FG006|COMPLETED|Open Label Phase (Optional)||0
10045556|NCT01998958|11170730|FG007|COMPLETED|Open Label Phase (Optional)||0
10045557|NCT01998958|11170731|FG008|COMPLETED|Open Label Phase (Optional)||0
10045558|NCT01998958|11170732|FG009|COMPLETED|Open Label Phase (Optional)||0
10045559|NCT01998958|11170733|FG010|COMPLETED|Open Label Phase (Optional)||0
10045560|NCT01998958|11170734|FG011|COMPLETED|Open Label Phase (Optional)||0
10045561|NCT01998958|11170735|FG012|COMPLETED|Open Label Phase (Optional)||0
10045562|NCT01998958|11170736|FG013|COMPLETED|Open Label Phase (Optional)||0
10045563|NCT01998958|11170737|FG014|COMPLETED|Open Label Phase (Optional)||0
10045564|NCT01998958|11170738|FG015|COMPLETED|Open Label Phase (Optional)||0
10045565|NCT01998958|11170739|FG016|COMPLETED|Open Label Phase (Optional)||0
10045566|NCT01998958|11170740|FG017|COMPLETED|Open Label Phase (Optional)||0
10045567|NCT01998958|11170741|FG018|COMPLETED|Open Label Phase (Optional)||0
10045568|NCT01998958|11170742|FG019|COMPLETED|Open Label Phase (Optional)||0
10045569|NCT01998958|11170743|FG020|COMPLETED|Open Label Phase (Optional)||0
10045570|NCT01998958|11170744|FG021|COMPLETED|Open Label Phase (Optional)||7
10045571|NCT01998958|11170745|FG022|COMPLETED|Open Label Phase (Optional)||11
10045572|NCT01998958|11170746|FG023|COMPLETED|Open Label Phase (Optional)||23
10045573|NCT01998958|11170747|FG024|COMPLETED|Open Label Phase (Optional)||13
10045574|NCT01998958|11170748|FG025|COMPLETED|Open Label Phase (Optional)||7
10045575|NCT01998958|11170749|FG026|COMPLETED|Open Label Phase (Optional)||19
10045576|NCT01998958|11170750|FG027|COMPLETED|Open Label Phase (Optional)||0
10045577|NCT01998958|11170751|FG028|COMPLETED|Open Label Phase (Optional)||0
10045578|NCT01998958|11170752|FG029|COMPLETED|Open Label Phase (Optional)||0
10045579|NCT01998958|11170753|FG030|COMPLETED|Open Label Phase (Optional)||0
10045580|NCT01998958|11170754|FG031|COMPLETED|Open Label Phase (Optional)||0
10045581|NCT01998958|11170723|FG000|NOT COMPLETED|Open Label Phase (Optional)||0
10117626|NCT02540993|11248425|FG001|Included in FAS|Overall Study||2841
10045582|NCT01998958|11170724|FG001|NOT COMPLETED|Open Label Phase (Optional)||0
10045583|NCT01998958|11170725|FG002|NOT COMPLETED|Open Label Phase (Optional)||0
10045584|NCT01998958|11170726|FG003|NOT COMPLETED|Open Label Phase (Optional)||0
10045585|NCT01998958|11170727|FG004|NOT COMPLETED|Open Label Phase (Optional)||0
10045586|NCT01998958|11170728|FG005|NOT COMPLETED|Open Label Phase (Optional)||0
10045587|NCT01998958|11170729|FG006|NOT COMPLETED|Open Label Phase (Optional)||0
10045588|NCT01998958|11170730|FG007|NOT COMPLETED|Open Label Phase (Optional)||0
10045589|NCT01998958|11170731|FG008|NOT COMPLETED|Open Label Phase (Optional)||0
10045590|NCT01998958|11170732|FG009|NOT COMPLETED|Open Label Phase (Optional)||0
10045591|NCT01998958|11170733|FG010|NOT COMPLETED|Open Label Phase (Optional)||0
10045592|NCT01998958|11170734|FG011|NOT COMPLETED|Open Label Phase (Optional)||0
10045593|NCT01998958|11170735|FG012|NOT COMPLETED|Open Label Phase (Optional)||0
10045594|NCT01998958|11170736|FG013|NOT COMPLETED|Open Label Phase (Optional)||0
10045595|NCT01998958|11170737|FG014|NOT COMPLETED|Open Label Phase (Optional)||0
10045596|NCT01998958|11170738|FG015|NOT COMPLETED|Open Label Phase (Optional)||0
10045597|NCT01998958|11170739|FG016|NOT COMPLETED|Open Label Phase (Optional)||0
10045598|NCT01998958|11170740|FG017|NOT COMPLETED|Open Label Phase (Optional)||0
10045599|NCT01998958|11170741|FG018|NOT COMPLETED|Open Label Phase (Optional)||0
10045600|NCT01998958|11170742|FG019|NOT COMPLETED|Open Label Phase (Optional)||0
10045601|NCT01998958|11170743|FG020|NOT COMPLETED|Open Label Phase (Optional)||0
10045602|NCT01998958|11170744|FG021|NOT COMPLETED|Open Label Phase (Optional)||3
10045603|NCT01998958|11170745|FG022|NOT COMPLETED|Open Label Phase (Optional)||9
10045604|NCT01998958|11170746|FG023|NOT COMPLETED|Open Label Phase (Optional)||4
10045605|NCT01998958|11170747|FG024|NOT COMPLETED|Open Label Phase (Optional)||0
10045606|NCT01998958|11170748|FG025|NOT COMPLETED|Open Label Phase (Optional)||0
10045607|NCT01998958|11170749|FG026|NOT COMPLETED|Open Label Phase (Optional)||0
10045608|NCT01998958|11170750|FG027|NOT COMPLETED|Open Label Phase (Optional)||0
10045609|NCT01998958|11170751|FG028|NOT COMPLETED|Open Label Phase (Optional)||0
10045610|NCT01998958|11170752|FG029|NOT COMPLETED|Open Label Phase (Optional)||0
10045611|NCT01998958|11170753|FG030|NOT COMPLETED|Open Label Phase (Optional)||0
10045612|NCT01998958|11170754|FG031|NOT COMPLETED|Open Label Phase (Optional)||0
10045613|NCT01998958|11170723|FG000|STARTED|Follow-up Phase||0
10045614|NCT01998958|11170724|FG001|STARTED|Follow-up Phase||0
10045615|NCT01998958|11170725|FG002|STARTED|Follow-up Phase||0
10045616|NCT01998958|11170726|FG003|STARTED|Follow-up Phase||0
10045617|NCT01998958|11170727|FG004|STARTED|Follow-up Phase||0
10045618|NCT01998958|11170728|FG005|STARTED|Follow-up Phase||0
10045619|NCT01998958|11170729|FG006|STARTED|Follow-up Phase||0
10045620|NCT01998958|11170730|FG007|STARTED|Follow-up Phase||0
10045621|NCT01998958|11170731|FG008|STARTED|Follow-up Phase||0
10045622|NCT01998958|11170732|FG009|STARTED|Follow-up Phase||0
10045623|NCT01998958|11170733|FG010|STARTED|Follow-up Phase||0
10045624|NCT01998958|11170734|FG011|STARTED|Follow-up Phase||0
10045625|NCT01998958|11170735|FG012|STARTED|Follow-up Phase||0
10045626|NCT01998958|11170736|FG013|STARTED|Follow-up Phase||0
10045627|NCT01998958|11170737|FG014|STARTED|Follow-up Phase||0
10045628|NCT01998958|11170738|FG015|STARTED|Follow-up Phase||0
10045629|NCT01998958|11170739|FG016|STARTED|Follow-up Phase||0
10045630|NCT01998958|11170740|FG017|STARTED|Follow-up Phase||0
10045631|NCT01998958|11170741|FG018|STARTED|Follow-up Phase||0
10045632|NCT01998958|11170742|FG019|STARTED|Follow-up Phase||0
10045633|NCT01998958|11170743|FG020|STARTED|Follow-up Phase||0
10045634|NCT01998958|11170744|FG021|STARTED|Follow-up Phase||0
10045635|NCT01998958|11170745|FG022|STARTED|Follow-up Phase||0
10045636|NCT01998958|11170746|FG023|STARTED|Follow-up Phase||0
10045637|NCT01998958|11170747|FG024|STARTED|Follow-up Phase||0
10045638|NCT01998958|11170748|FG025|STARTED|Follow-up Phase||0
10045639|NCT01998958|11170749|FG026|STARTED|Follow-up Phase||0
10045640|NCT01998958|11170750|FG027|STARTED|Follow-up Phase||1
10045641|NCT01998958|11170751|FG028|STARTED|Follow-up Phase||4
10045642|NCT01998958|11170752|FG029|STARTED|Follow-up Phase||12
10045643|NCT01998958|11170753|FG030|STARTED|Follow-up Phase||39
10045644|NCT01998958|11170754|FG031|STARTED|Follow-up Phase||42
10045645|NCT01998958|11170723|FG000|COMPLETED|Follow-up Phase||0
10045646|NCT01998958|11170724|FG001|COMPLETED|Follow-up Phase||0
10045647|NCT01998958|11170725|FG002|COMPLETED|Follow-up Phase||0
10045648|NCT01998958|11170726|FG003|COMPLETED|Follow-up Phase||0
10045649|NCT01998958|11170727|FG004|COMPLETED|Follow-up Phase||0
10045650|NCT01998958|11170728|FG005|COMPLETED|Follow-up Phase||0
10045651|NCT01998958|11170729|FG006|COMPLETED|Follow-up Phase||0
10045652|NCT01998958|11170730|FG007|COMPLETED|Follow-up Phase||0
10045653|NCT01998958|11170731|FG008|COMPLETED|Follow-up Phase||0
10045654|NCT01998958|11170732|FG009|COMPLETED|Follow-up Phase||0
10045655|NCT01998958|11170733|FG010|COMPLETED|Follow-up Phase||0
10045656|NCT01998958|11170734|FG011|COMPLETED|Follow-up Phase||0
10045657|NCT01998958|11170735|FG012|COMPLETED|Follow-up Phase||0
10045658|NCT01998958|11170736|FG013|COMPLETED|Follow-up Phase||0
10045659|NCT01998958|11170737|FG014|COMPLETED|Follow-up Phase||0
10045660|NCT01998958|11170738|FG015|COMPLETED|Follow-up Phase||0
10045661|NCT01998958|11170739|FG016|COMPLETED|Follow-up Phase||0
10045662|NCT01998958|11170740|FG017|COMPLETED|Follow-up Phase||0
10045663|NCT01998958|11170741|FG018|COMPLETED|Follow-up Phase||0
10045664|NCT01998958|11170742|FG019|COMPLETED|Follow-up Phase||0
10045665|NCT01998958|11170743|FG020|COMPLETED|Follow-up Phase||0
10045666|NCT01998958|11170744|FG021|COMPLETED|Follow-up Phase||0
10045667|NCT01998958|11170745|FG022|COMPLETED|Follow-up Phase||0
10045668|NCT01998958|11170746|FG023|COMPLETED|Follow-up Phase||0
10045669|NCT01998958|11170747|FG024|COMPLETED|Follow-up Phase||0
10045670|NCT01998958|11170748|FG025|COMPLETED|Follow-up Phase||0
10045671|NCT01998958|11170749|FG026|COMPLETED|Follow-up Phase||0
10045672|NCT01998958|11170750|FG027|COMPLETED|Follow-up Phase||1
10045673|NCT01998958|11170751|FG028|COMPLETED|Follow-up Phase||4
10045674|NCT01998958|11170752|FG029|COMPLETED|Follow-up Phase||12
10045675|NCT01998958|11170753|FG030|COMPLETED|Follow-up Phase||39
10045676|NCT01998958|11170754|FG031|COMPLETED|Follow-up Phase||42
10045677|NCT01998958|11170723|FG000|NOT COMPLETED|Follow-up Phase||0
10045678|NCT01998958|11170724|FG001|NOT COMPLETED|Follow-up Phase||0
10045679|NCT01998958|11170725|FG002|NOT COMPLETED|Follow-up Phase||0
10045680|NCT01998958|11170726|FG003|NOT COMPLETED|Follow-up Phase||0
10045681|NCT01998958|11170727|FG004|NOT COMPLETED|Follow-up Phase||0
10045682|NCT01998958|11170728|FG005|NOT COMPLETED|Follow-up Phase||0
10045683|NCT01998958|11170729|FG006|NOT COMPLETED|Follow-up Phase||0
10045684|NCT01998958|11170730|FG007|NOT COMPLETED|Follow-up Phase||0
10045685|NCT01998958|11170731|FG008|NOT COMPLETED|Follow-up Phase||0
10045686|NCT01998958|11170732|FG009|NOT COMPLETED|Follow-up Phase||0
10045687|NCT01998958|11170733|FG010|NOT COMPLETED|Follow-up Phase||0
10045688|NCT01998958|11170734|FG011|NOT COMPLETED|Follow-up Phase||0
10045689|NCT01998958|11170735|FG012|NOT COMPLETED|Follow-up Phase||0
10045690|NCT01998958|11170736|FG013|NOT COMPLETED|Follow-up Phase||0
10045691|NCT01998958|11170737|FG014|NOT COMPLETED|Follow-up Phase||0
10045692|NCT01998958|11170738|FG015|NOT COMPLETED|Follow-up Phase||0
10045693|NCT01998958|11170739|FG016|NOT COMPLETED|Follow-up Phase||0
10045694|NCT01998958|11170740|FG017|NOT COMPLETED|Follow-up Phase||0
10045695|NCT01998958|11170741|FG018|NOT COMPLETED|Follow-up Phase||0
10045696|NCT01998958|11170742|FG019|NOT COMPLETED|Follow-up Phase||0
10045697|NCT01998958|11170743|FG020|NOT COMPLETED|Follow-up Phase||0
10045698|NCT01998958|11170744|FG021|NOT COMPLETED|Follow-up Phase||0
10045699|NCT01998958|11170745|FG022|NOT COMPLETED|Follow-up Phase||0
10045700|NCT01998958|11170746|FG023|NOT COMPLETED|Follow-up Phase||0
10045701|NCT01998958|11170747|FG024|NOT COMPLETED|Follow-up Phase||0
10045702|NCT01998958|11170748|FG025|NOT COMPLETED|Follow-up Phase||0
10045703|NCT01998958|11170749|FG026|NOT COMPLETED|Follow-up Phase||0
10045704|NCT01998958|11170750|FG027|NOT COMPLETED|Follow-up Phase||0
10045705|NCT01998958|11170751|FG028|NOT COMPLETED|Follow-up Phase||0
10045706|NCT01998958|11170752|FG029|NOT COMPLETED|Follow-up Phase||0
10045707|NCT01998958|11170753|FG030|NOT COMPLETED|Follow-up Phase||0
10045708|NCT01998958|11170754|FG031|NOT COMPLETED|Follow-up Phase||0
10045709|NCT01998984|11170808|FG000|STARTED|Overall Study||55
10045710|NCT01998984|11170809|FG001|STARTED|Overall Study||59
10045711|NCT01998984|11170810|FG002|STARTED|Overall Study||49
10045712|NCT01998984|11170811|FG003|STARTED|Overall Study||61
10045713|NCT01998984|11170808|FG000|COMPLETED|Overall Study||55
10045714|NCT01998984|11170809|FG001|COMPLETED|Overall Study||58
10045715|NCT01998984|11170810|FG002|COMPLETED|Overall Study||48
10045716|NCT01998984|11170811|FG003|COMPLETED|Overall Study||58
10045717|NCT01998984|11170808|FG000|NOT COMPLETED|Overall Study||0
10045718|NCT01998984|11170809|FG001|NOT COMPLETED|Overall Study||1
10045719|NCT01998984|11170810|FG002|NOT COMPLETED|Overall Study||1
10045720|NCT01998984|11170811|FG003|NOT COMPLETED|Overall Study||3
10045721|NCT01999114|11170826|FG000|STARTED|Overall Study||66
10045722|NCT01999114|11170827|FG001|STARTED|Overall Study||66
10045723|NCT01999114|11170828|FG002|STARTED|Overall Study||66
10045724|NCT01999114|11170829|FG003|STARTED|Overall Study||65
10045725|NCT01999114|11170830|FG004|STARTED|Overall Study||65
10045726|NCT01999114|11170826|FG000|COMPLETED|Overall Study||58
10045727|NCT01999114|11170827|FG001|COMPLETED|Overall Study||59
10045728|NCT01999114|11170828|FG002|COMPLETED|Overall Study||61
10045729|NCT01999114|11170829|FG003|COMPLETED|Overall Study||62
10117627|NCT02540993|11248424|FG000|Treated|Overall Study||2827
10117628|NCT02540993|11248425|FG001|Treated|Overall Study||2831
10117629|NCT02540993|11248424|FG000|COMPLETED|Overall Study||2824
10117630|NCT02540993|11248425|FG001|COMPLETED|Overall Study||2832
10117631|NCT02540993|11248424|FG000|NOT COMPLETED|Overall Study||42
10117632|NCT02540993|11248425|FG001|NOT COMPLETED|Overall Study||36
10117633|NCT02541409|11248433|FG000|STARTED|Overall Study||25
10117634|NCT02541409|11248434|FG001|STARTED|Overall Study||25
10117635|NCT02541409|11248433|FG000|COMPLETED|Overall Study||22
10117636|NCT02541409|11248434|FG001|COMPLETED|Overall Study||22
10117637|NCT02541409|11248433|FG000|NOT COMPLETED|Overall Study||3
10117638|NCT02541409|11248434|FG001|NOT COMPLETED|Overall Study||3
10045730|NCT01999114|11170830|FG004|COMPLETED|Overall Study||61
10045731|NCT01999114|11170826|FG000|NOT COMPLETED|Overall Study||8
10045732|NCT01999114|11170827|FG001|NOT COMPLETED|Overall Study||7
10045733|NCT01999114|11170828|FG002|NOT COMPLETED|Overall Study||5
10045734|NCT01999114|11170829|FG003|NOT COMPLETED|Overall Study||3
10045735|NCT01999114|11170830|FG004|NOT COMPLETED|Overall Study||4
10045736|NCT01999192|11170860|FG000|STARTED|Main Phase I||83
10045737|NCT01999192|11170861|FG001|STARTED|Main Phase I||80
10045738|NCT01999192|11170862|FG002|STARTED|Main Phase I||78
10045739|NCT01999192|11170863|FG003|STARTED|Main Phase I||80
10045740|NCT01999192|11170860|FG000|COMPLETED|Main Phase I||72
10045741|NCT01999192|11170861|FG001|COMPLETED|Main Phase I||70
10045742|NCT01999192|11170862|FG002|COMPLETED|Main Phase I||70
10045743|NCT01999192|11170863|FG003|COMPLETED|Main Phase I||72
10045744|NCT01999192|11170860|FG000|NOT COMPLETED|Main Phase I||11
10045745|NCT01999192|11170861|FG001|NOT COMPLETED|Main Phase I||10
10045746|NCT01999192|11170862|FG002|NOT COMPLETED|Main Phase I||8
10045747|NCT01999192|11170863|FG003|NOT COMPLETED|Main Phase I||8
10045748|NCT01999192|11170860|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
10045749|NCT01999192|11170861|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
10045750|NCT01999192|11170862|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
10117639|NCT02541422|11248440|FG000|STARTED|First Intervention||23
10117640|NCT02541422|11248441|FG001|STARTED|First Intervention||26
10117641|NCT02541422|11248440|FG000|COMPLETED|First Intervention||23
10045751|NCT01999192|11170863|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
10045752|NCT01999192|11170860|FG000|COMPLETED|Main Phase II||55
10045753|NCT01999192|11170861|FG001|COMPLETED|Main Phase II||66
10045754|NCT01999192|11170862|FG002|COMPLETED|Main Phase II||76
10045755|NCT01999192|11170863|FG003|COMPLETED|Main Phase II||43
10045756|NCT01999192|11170860|FG000|NOT COMPLETED|Main Phase II||9
10045757|NCT01999192|11170861|FG001|NOT COMPLETED|Main Phase II||9
10045758|NCT01999192|11170862|FG002|NOT COMPLETED|Main Phase II||22
10045759|NCT01999192|11170863|FG003|NOT COMPLETED|Main Phase II||1
10045760|NCT01999192|11170860|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
10045761|NCT01999192|11170861|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
10045762|NCT01999192|11170862|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
10045763|NCT01999192|11170863|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
10045764|NCT01999192|11170860|FG000|COMPLETED|Extension Phase||41
10045765|NCT01999192|11170861|FG001|COMPLETED|Extension Phase||38
10045766|NCT01999192|11170862|FG002|COMPLETED|Extension Phase||44
10045767|NCT01999192|11170863|FG003|COMPLETED|Extension Phase||0
10045768|NCT01999192|11170860|FG000|NOT COMPLETED|Extension Phase||13
10045769|NCT01999192|11170861|FG001|NOT COMPLETED|Extension Phase||18
10045770|NCT01999192|11170862|FG002|NOT COMPLETED|Extension Phase||24
10045771|NCT01999192|11170863|FG003|NOT COMPLETED|Extension Phase||0
10045772|NCT01999218|11170876|FG000|STARTED|Overall Study||448
10045773|NCT01999218|11170877|FG001|STARTED|Overall Study||441
10045774|NCT01999218|11170878|FG002|STARTED|Overall Study||437
10045775|NCT01999218|11170876|FG000|Treated|Overall Study||448
10045776|NCT01999218|11170877|FG001|Treated|Overall Study||440
10045777|NCT01999218|11170878|FG002|Treated|Overall Study||437
10045778|NCT01999218|11170876|FG000|Site Issue|Overall Study||445
10045779|NCT01999218|11170877|FG001|Site Issue|Overall Study||435
10045780|NCT01999218|11170878|FG002|Site Issue|Overall Study||435
10045781|NCT01999218|11170876|FG000|COMPLETED|Overall Study||339
10045782|NCT01999218|11170877|FG001|COMPLETED|Overall Study||340
10045783|NCT01999218|11170878|FG002|COMPLETED|Overall Study||327
10045784|NCT01999218|11170876|FG000|NOT COMPLETED|Overall Study||109
10045785|NCT01999218|11170877|FG001|NOT COMPLETED|Overall Study||101
10045786|NCT01999218|11170878|FG002|NOT COMPLETED|Overall Study||110
10045787|NCT01999231|11170890|FG000|STARTED|Overall Study||6
10045788|NCT01999231|11170891|FG001|STARTED|Overall Study||6
10045789|NCT01999231|11170892|FG002|STARTED|Overall Study||6
10045790|NCT01999231|11170893|FG003|STARTED|Overall Study||6
10045791|NCT01999231|11170890|FG000|COMPLETED|Overall Study||6
10045792|NCT01999231|11170891|FG001|COMPLETED|Overall Study||6
10045793|NCT01999231|11170892|FG002|COMPLETED|Overall Study||6
10045794|NCT01999231|11170893|FG003|COMPLETED|Overall Study||6
10045795|NCT01999231|11170890|FG000|NOT COMPLETED|Overall Study||0
10045796|NCT01999231|11170891|FG001|NOT COMPLETED|Overall Study||0
10045797|NCT01999231|11170892|FG002|NOT COMPLETED|Overall Study||0
10045798|NCT01999231|11170893|FG003|NOT COMPLETED|Overall Study||0
10045799|NCT01999322|11170907|FG000|STARTED|Overall Study||25
10045800|NCT01999322|11170908|FG001|STARTED|Overall Study||12
10045801|NCT01999322|11170907|FG000|COMPLETED|Overall Study||24
10045802|NCT01999322|11170908|FG001|COMPLETED|Overall Study||12
10045803|NCT01999322|11170907|FG000|NOT COMPLETED|Overall Study||1
10045804|NCT01999322|11170908|FG001|NOT COMPLETED|Overall Study||0
10045805|NCT01999335|11170919|FG000|STARTED|Overall Study||3
10045806|NCT01999335|11170920|FG001|STARTED|Overall Study||1
10045807|NCT01999335|11170921|FG002|STARTED|Overall Study||7
10045808|NCT01999335|11170922|FG003|STARTED|Overall Study||10
10045809|NCT01999335|11170923|FG004|STARTED|Overall Study||12
10045810|NCT01999335|11170919|FG000|Received Study Treatment|Overall Study||3
10045811|NCT01999335|11170920|FG001|Received Study Treatment|Overall Study||1
10045812|NCT01999335|11170921|FG002|Received Study Treatment|Overall Study||7
10045813|NCT01999335|11170922|FG003|Received Study Treatment|Overall Study||10
10045814|NCT01999335|11170923|FG004|Received Study Treatment|Overall Study||10
10045815|NCT01999335|11170919|FG000|COMPLETED|Overall Study||3
10045816|NCT01999335|11170920|FG001|COMPLETED|Overall Study||1
10045817|NCT01999335|11170921|FG002|COMPLETED|Overall Study||7
10045818|NCT01999335|11170922|FG003|COMPLETED|Overall Study||10
10045819|NCT01999335|11170923|FG004|COMPLETED|Overall Study||10
10045820|NCT01999335|11170919|FG000|NOT COMPLETED|Overall Study||0
10045821|NCT01999335|11170920|FG001|NOT COMPLETED|Overall Study||0
10045822|NCT01999335|11170921|FG002|NOT COMPLETED|Overall Study||0
10045823|NCT01999335|11170922|FG003|NOT COMPLETED|Overall Study||0
10045824|NCT01999335|11170923|FG004|NOT COMPLETED|Overall Study||2
10045825|NCT01999348|11170938|FG000|STARTED|Overall Study||1553
10045826|NCT01999348|11170938|FG000|COMPLETED|Overall Study||1433
10045827|NCT01999348|11170938|FG000|NOT COMPLETED|Overall Study||120
10045828|NCT01999400|11170942|FG000|STARTED|First Intervention (1 Day)||6
10045829|NCT01999400|11170943|FG001|STARTED|First Intervention (1 Day)||6
10045830|NCT01999400|11170944|FG002|STARTED|First Intervention (1 Day)||5
10045831|NCT01999400|11170945|FG003|STARTED|First Intervention (1 Day)||5
10045832|NCT01999400|11170946|FG004|STARTED|First Intervention (1 Day)||4
10045833|NCT01999400|11170947|FG005|STARTED|First Intervention (1 Day)||4
10045834|NCT01999400|11170942|FG000|COMPLETED|First Intervention (1 Day)||4
10045835|NCT01999400|11170943|FG001|COMPLETED|First Intervention (1 Day)||4
10045836|NCT01999400|11170944|FG002|COMPLETED|First Intervention (1 Day)||3
10045837|NCT01999400|11170945|FG003|COMPLETED|First Intervention (1 Day)||2
10045838|NCT01999400|11170946|FG004|COMPLETED|First Intervention (1 Day)||4
10045839|NCT01999400|11170947|FG005|COMPLETED|First Intervention (1 Day)||3
10045840|NCT01999400|11170942|FG000|NOT COMPLETED|First Intervention (1 Day)||2
10045841|NCT01999400|11170943|FG001|NOT COMPLETED|First Intervention (1 Day)||2
10045842|NCT01999400|11170944|FG002|NOT COMPLETED|First Intervention (1 Day)||2
10045843|NCT01999400|11170945|FG003|NOT COMPLETED|First Intervention (1 Day)||3
10045844|NCT01999400|11170946|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10045845|NCT01999400|11170947|FG005|NOT COMPLETED|First Intervention (1 Day)||1
10045846|NCT01999400|11170942|FG000|STARTED|Washout (10 Days)||5
10045847|NCT01999400|11170943|FG001|STARTED|Washout (10 Days)||4
10045848|NCT01999400|11170944|FG002|STARTED|Washout (10 Days)||3
10045849|NCT01999400|11170945|FG003|STARTED|Washout (10 Days)||2
10045850|NCT01999400|11170946|FG004|STARTED|Washout (10 Days)||3
10045851|NCT01999400|11170947|FG005|STARTED|Washout (10 Days)||3
10045852|NCT01999400|11170942|FG000|COMPLETED|Washout (10 Days)||5
10045853|NCT01999400|11170943|FG001|COMPLETED|Washout (10 Days)||4
10045854|NCT01999400|11170944|FG002|COMPLETED|Washout (10 Days)||3
10045855|NCT01999400|11170945|FG003|COMPLETED|Washout (10 Days)||2
10045856|NCT01999400|11170946|FG004|COMPLETED|Washout (10 Days)||3
10045857|NCT01999400|11170947|FG005|COMPLETED|Washout (10 Days)||3
10045858|NCT01999400|11170942|FG000|NOT COMPLETED|Washout (10 Days)||0
10045859|NCT01999400|11170943|FG001|NOT COMPLETED|Washout (10 Days)||0
10045860|NCT01999400|11170944|FG002|NOT COMPLETED|Washout (10 Days)||0
10045861|NCT01999400|11170945|FG003|NOT COMPLETED|Washout (10 Days)||0
10045862|NCT01999400|11170946|FG004|NOT COMPLETED|Washout (10 Days)||0
10045863|NCT01999400|11170947|FG005|NOT COMPLETED|Washout (10 Days)||0
10045864|NCT01999400|11170942|FG000|STARTED|Second Intervention (1 Day)||5
10045865|NCT01999400|11170943|FG001|STARTED|Second Intervention (1 Day)||4
10045866|NCT01999400|11170944|FG002|STARTED|Second Intervention (1 Day)||3
10045867|NCT01999400|11170945|FG003|STARTED|Second Intervention (1 Day)||2
10045868|NCT01999400|11170946|FG004|STARTED|Second Intervention (1 Day)||3
10045869|NCT01999400|11170947|FG005|STARTED|Second Intervention (1 Day)||3
10045870|NCT01999400|11170942|FG000|COMPLETED|Second Intervention (1 Day)||5
10045871|NCT01999400|11170943|FG001|COMPLETED|Second Intervention (1 Day)||4
10045872|NCT01999400|11170944|FG002|COMPLETED|Second Intervention (1 Day)||3
10045873|NCT01999400|11170945|FG003|COMPLETED|Second Intervention (1 Day)||2
10045874|NCT01999400|11170946|FG004|COMPLETED|Second Intervention (1 Day)||3
10045875|NCT01999400|11170947|FG005|COMPLETED|Second Intervention (1 Day)||3
10045876|NCT01999400|11170942|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10045877|NCT01999400|11170943|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10045878|NCT01999400|11170944|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10045879|NCT01999400|11170945|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10045880|NCT01999400|11170946|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10045881|NCT01999400|11170947|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10045882|NCT01999400|11170942|FG000|STARTED|Washout (10 Days)||2
10045883|NCT01999400|11170943|FG001|STARTED|Washout (10 Days)||0
10045884|NCT01999400|11170944|FG002|STARTED|Washout (10 Days)||1
10045885|NCT01999400|11170945|FG003|STARTED|Washout (10 Days)||1
10045886|NCT01999400|11170946|FG004|STARTED|Washout (10 Days)||1
10045887|NCT01999400|11170947|FG005|STARTED|Washout (10 Days)||1
10045888|NCT01999400|11170942|FG000|COMPLETED|Washout (10 Days)||2
10045889|NCT01999400|11170943|FG001|COMPLETED|Washout (10 Days)||0
10045890|NCT01999400|11170944|FG002|COMPLETED|Washout (10 Days)||1
10045891|NCT01999400|11170945|FG003|COMPLETED|Washout (10 Days)||1
10045892|NCT01999400|11170946|FG004|COMPLETED|Washout (10 Days)||1
10045893|NCT01999400|11170947|FG005|COMPLETED|Washout (10 Days)||1
10045894|NCT01999400|11170942|FG000|NOT COMPLETED|Washout (10 Days)||0
10045895|NCT01999400|11170943|FG001|NOT COMPLETED|Washout (10 Days)||0
10045896|NCT01999400|11170944|FG002|NOT COMPLETED|Washout (10 Days)||0
10045897|NCT01999400|11170945|FG003|NOT COMPLETED|Washout (10 Days)||0
10045898|NCT01999400|11170946|FG004|NOT COMPLETED|Washout (10 Days)||0
10045899|NCT01999400|11170947|FG005|NOT COMPLETED|Washout (10 Days)||0
10045900|NCT01999400|11170942|FG000|STARTED|Third Intervention (1 Day)||2
10045901|NCT01999400|11170943|FG001|STARTED|Third Intervention (1 Day)||0
10045902|NCT01999400|11170944|FG002|STARTED|Third Intervention (1 Day)||1
10045903|NCT01999400|11170945|FG003|STARTED|Third Intervention (1 Day)||1
10045904|NCT01999400|11170946|FG004|STARTED|Third Intervention (1 Day)||1
10045905|NCT01999400|11170947|FG005|STARTED|Third Intervention (1 Day)||1
10045906|NCT01999400|11170942|FG000|COMPLETED|Third Intervention (1 Day)||2
10045907|NCT01999400|11170943|FG001|COMPLETED|Third Intervention (1 Day)||0
10045908|NCT01999400|11170944|FG002|COMPLETED|Third Intervention (1 Day)||1
10045909|NCT01999400|11170945|FG003|COMPLETED|Third Intervention (1 Day)||1
10045910|NCT01999400|11170946|FG004|COMPLETED|Third Intervention (1 Day)||1
10045911|NCT01999400|11170947|FG005|COMPLETED|Third Intervention (1 Day)||0
10045912|NCT01999400|11170942|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10045913|NCT01999400|11170943|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10045914|NCT01999400|11170944|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10045915|NCT01999400|11170945|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10045916|NCT01999400|11170946|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10045917|NCT01999400|11170947|FG005|NOT COMPLETED|Third Intervention (1 Day)||1
10045918|NCT01999400|11170942|FG000|STARTED|Washout (10 Days)||1
10045919|NCT01999400|11170943|FG001|STARTED|Washout (10 Days)||0
10045920|NCT01999400|11170944|FG002|STARTED|Washout (10 Days)||1
10045921|NCT01999400|11170945|FG003|STARTED|Washout (10 Days)||0
10045922|NCT01999400|11170946|FG004|STARTED|Washout (10 Days)||0
10045923|NCT01999400|11170947|FG005|STARTED|Washout (10 Days)||0
10045924|NCT01999400|11170942|FG000|COMPLETED|Washout (10 Days)||1
10045925|NCT01999400|11170943|FG001|COMPLETED|Washout (10 Days)||0
10045926|NCT01999400|11170944|FG002|COMPLETED|Washout (10 Days)||1
10045927|NCT01999400|11170945|FG003|COMPLETED|Washout (10 Days)||0
10045928|NCT01999400|11170946|FG004|COMPLETED|Washout (10 Days)||0
10045929|NCT01999400|11170947|FG005|COMPLETED|Washout (10 Days)||0
10045930|NCT01999400|11170942|FG000|NOT COMPLETED|Washout (10 Days)||0
10045931|NCT01999400|11170943|FG001|NOT COMPLETED|Washout (10 Days)||0
10045932|NCT01999400|11170944|FG002|NOT COMPLETED|Washout (10 Days)||0
10045933|NCT01999400|11170945|FG003|NOT COMPLETED|Washout (10 Days)||0
10045934|NCT01999400|11170946|FG004|NOT COMPLETED|Washout (10 Days)||0
10045935|NCT01999400|11170947|FG005|NOT COMPLETED|Washout (10 Days)||0
10045936|NCT01999400|11170942|FG000|STARTED|Fourth Intervention (1 Day)||1
10045937|NCT01999400|11170943|FG001|STARTED|Fourth Intervention (1 Day)||0
10045938|NCT01999400|11170944|FG002|STARTED|Fourth Intervention (1 Day)||1
10045939|NCT01999400|11170945|FG003|STARTED|Fourth Intervention (1 Day)||0
10045940|NCT01999400|11170946|FG004|STARTED|Fourth Intervention (1 Day)||0
10045941|NCT01999400|11170947|FG005|STARTED|Fourth Intervention (1 Day)||0
10045942|NCT01999400|11170942|FG000|COMPLETED|Fourth Intervention (1 Day)||1
10045943|NCT01999400|11170943|FG001|COMPLETED|Fourth Intervention (1 Day)||0
10045944|NCT01999400|11170944|FG002|COMPLETED|Fourth Intervention (1 Day)||1
10045945|NCT01999400|11170945|FG003|COMPLETED|Fourth Intervention (1 Day)||0
10045946|NCT01999400|11170946|FG004|COMPLETED|Fourth Intervention (1 Day)||0
10045947|NCT01999400|11170947|FG005|COMPLETED|Fourth Intervention (1 Day)||0
10045948|NCT01999400|11170942|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10045949|NCT01999400|11170943|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10045950|NCT01999400|11170944|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
10045951|NCT01999400|11170945|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
10045952|NCT01999400|11170946|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
10045953|NCT01999400|11170947|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
10045954|NCT01999465|11170959|FG000|STARTED|Overall Study||10
10045955|NCT01999465|11170960|FG001|STARTED|Overall Study||10
10045956|NCT01999465|11170959|FG000|COMPLETED|Overall Study||10
10045957|NCT01999465|11170960|FG001|COMPLETED|Overall Study||7
10045958|NCT01999465|11170959|FG000|NOT COMPLETED|Overall Study||0
10045959|NCT01999465|11170960|FG001|NOT COMPLETED|Overall Study||3
10045960|NCT01999517|11170968|FG000|STARTED|Overall Study||68
10045961|NCT01999517|11170969|FG001|STARTED|Overall Study||54
10045962|NCT01999517|11170968|FG000|COMPLETED|Overall Study||68
10045963|NCT01999517|11170969|FG001|COMPLETED|Overall Study||54
10117642|NCT02541422|11248441|FG001|COMPLETED|First Intervention||26
10117643|NCT02541422|11248440|FG000|NOT COMPLETED|First Intervention||0
10117644|NCT02541422|11248441|FG001|NOT COMPLETED|First Intervention||0
10117645|NCT02541422|11248440|FG000|STARTED|Second Intervention||23
10117646|NCT02541422|11248441|FG001|STARTED|Second Intervention||26
10117647|NCT02541422|11248440|FG000|COMPLETED|Second Intervention||23
10117648|NCT02541422|11248441|FG001|COMPLETED|Second Intervention||26
10117649|NCT02541422|11248440|FG000|NOT COMPLETED|Second Intervention||0
10117650|NCT02541422|11248441|FG001|NOT COMPLETED|Second Intervention||0
10117651|NCT02541565|11248447|FG000|STARTED|Overall Study||30
10117652|NCT02541565|11248447|FG000|COMPLETED|Overall Study||27
10117653|NCT02541565|11248447|FG000|NOT COMPLETED|Overall Study||3
10117654|NCT02541604|11248463|FG000|STARTED|Overall Study||11
10117655|NCT02541604|11248464|FG001|STARTED|Overall Study||9
10117656|NCT02541604|11248465|FG002|STARTED|Overall Study||11
10117657|NCT02541604|11248466|FG003|STARTED|Overall Study||3
10117658|NCT02541604|11248467|FG004|STARTED|Overall Study||10
10117659|NCT02541604|11248468|FG005|STARTED|Overall Study||10
10117660|NCT02541604|11248469|FG006|STARTED|Overall Study||10
10117661|NCT02541604|11248470|FG007|STARTED|Overall Study||10
10117662|NCT02541604|11248471|FG008|STARTED|Overall Study||4
10117663|NCT02541604|11248472|FG009|STARTED|Overall Study||4
10117664|NCT02541604|11248473|FG010|STARTED|Overall Study||2
10117665|NCT02541604|11248474|FG011|STARTED|Overall Study||3
10117666|NCT02541604|11248463|FG000|COMPLETED|Overall Study||0
10117667|NCT02541604|11248464|FG001|COMPLETED|Overall Study||0
10117668|NCT02541604|11248465|FG002|COMPLETED|Overall Study||0
10117669|NCT02541604|11248466|FG003|COMPLETED|Overall Study||0
10117670|NCT02541604|11248467|FG004|COMPLETED|Overall Study||0
10117671|NCT02541604|11248468|FG005|COMPLETED|Overall Study||0
10117672|NCT02541604|11248469|FG006|COMPLETED|Overall Study||0
10117673|NCT02541604|11248470|FG007|COMPLETED|Overall Study||0
10117674|NCT02541604|11248471|FG008|COMPLETED|Overall Study||0
10117675|NCT02541604|11248472|FG009|COMPLETED|Overall Study||0
10117676|NCT02541604|11248473|FG010|COMPLETED|Overall Study||0
10117677|NCT02541604|11248474|FG011|COMPLETED|Overall Study||0
10117678|NCT02541604|11248463|FG000|NOT COMPLETED|Overall Study||11
10117679|NCT02541604|11248464|FG001|NOT COMPLETED|Overall Study||9
10117680|NCT02541604|11248465|FG002|NOT COMPLETED|Overall Study||11
10117681|NCT02541604|11248466|FG003|NOT COMPLETED|Overall Study||3
10117682|NCT02541604|11248467|FG004|NOT COMPLETED|Overall Study||10
10117683|NCT02541604|11248468|FG005|NOT COMPLETED|Overall Study||10
10117684|NCT02541604|11248469|FG006|NOT COMPLETED|Overall Study||10
10117685|NCT02541604|11248470|FG007|NOT COMPLETED|Overall Study||10
10117686|NCT02541604|11248471|FG008|NOT COMPLETED|Overall Study||4
10117687|NCT02541604|11248472|FG009|NOT COMPLETED|Overall Study||4
10117688|NCT02541604|11248473|FG010|NOT COMPLETED|Overall Study||2
10045964|NCT01999517|11170968|FG000|NOT COMPLETED|Overall Study||0
10045965|NCT01999517|11170969|FG001|NOT COMPLETED|Overall Study||0
10045966|NCT01999530|11170975|FG000|STARTED|Overall Study||20
10045967|NCT01999530|11170975|FG000|COMPLETED|Overall Study||7
10117689|NCT02541604|11248474|FG011|NOT COMPLETED|Overall Study||3
10117690|NCT02541669|11248528|FG000|STARTED|Open Label Treatment Period||8
10117691|NCT02541669|11248529|FG001|STARTED|Open Label Treatment Period||8
10045968|NCT01999530|11170975|FG000|NOT COMPLETED|Overall Study||13
10045969|NCT01999777|11170981|FG000|STARTED|Overall Study||31
10045970|NCT01999777|11170982|FG001|STARTED|Overall Study||31
10045971|NCT01999777|11170981|FG000|COMPLETED|Overall Study||31
10045972|NCT01999777|11170982|FG001|COMPLETED|Overall Study||31
10045973|NCT01999777|11170981|FG000|NOT COMPLETED|Overall Study||0
10045974|NCT01999777|11170982|FG001|NOT COMPLETED|Overall Study||0
10045975|NCT01999868|11170991|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45
10045976|NCT01999868|11170992|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46
10045977|NCT01999868|11170993|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17
10045978|NCT01999868|11170991|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45
10045979|NCT01999868|11170992|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46
10045980|NCT01999868|11170993|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12
10045981|NCT01999868|11170991|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
10045982|NCT01999868|11170992|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
10045983|NCT01999868|11170993|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
10045984|NCT01999868|11170991|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
10045985|NCT01999868|11170992|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
10045986|NCT01999868|11170993|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
10045987|NCT01999868|11170991|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
10045988|NCT01999868|11170992|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
10045989|NCT01999868|11170993|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
10045990|NCT01999868|11170991|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
10045991|NCT01999868|11170992|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
10045992|NCT01999868|11170993|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
10045993|NCT01999868|11170991|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27
10045994|NCT01999868|11170992|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35
10045995|NCT01999868|11170993|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0
10045996|NCT01999868|11170991|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
10045997|NCT01999868|11170992|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
10045998|NCT01999868|11170993|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
10045999|NCT01999868|11170991|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
10046000|NCT01999868|11170992|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
10046001|NCT01999868|11170993|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
10046002|NCT01999894|11171001|FG000|STARTED|Overall Study||102
10046003|NCT01999894|11171001|FG000|COMPLETED|Overall Study||66
10046004|NCT01999894|11171001|FG000|NOT COMPLETED|Overall Study||36
10046005|NCT01999920|11171008|FG000|STARTED|Overall Study||13
10046006|NCT01999920|11171009|FG001|STARTED|Overall Study||11
10046007|NCT01999920|11171008|FG000|COMPLETED|Overall Study||7
10046008|NCT01999920|11171009|FG001|COMPLETED|Overall Study||9
10046009|NCT01999920|11171008|FG000|NOT COMPLETED|Overall Study||6
10046010|NCT01999920|11171009|FG001|NOT COMPLETED|Overall Study||2
10046011|NCT01999946|11171018|FG000|STARTED|Overall Study||61
10046012|NCT01999946|11171019|FG001|STARTED|Overall Study||58
10046013|NCT01999946|11171020|FG002|STARTED|Overall Study||79
10046014|NCT01999946|11171018|FG000|COMPLETED|Overall Study||59
10046015|NCT01999946|11171019|FG001|COMPLETED|Overall Study||56
10046016|NCT01999946|11171020|FG002|COMPLETED|Overall Study||0
10046017|NCT01999946|11171018|FG000|NOT COMPLETED|Overall Study||2
10046018|NCT01999946|11171019|FG001|NOT COMPLETED|Overall Study||2
10046019|NCT01999946|11171020|FG002|NOT COMPLETED|Overall Study||79
10046020|NCT01999972|11171033|FG000|STARTED|Dose Escalation Part||5
10046021|NCT01999972|11171034|FG001|STARTED|Dose Escalation Part||3
10046022|NCT01999972|11171035|FG002|STARTED|Dose Escalation Part||5
10046023|NCT01999972|11171036|FG003|STARTED|Dose Escalation Part||11
10046024|NCT01999972|11171037|FG004|STARTED|Dose Escalation Part||0
10046025|NCT01999972|11171038|FG005|STARTED|Dose Escalation Part||0
10046026|NCT01999972|11171033|FG000|Treated|Dose Escalation Part||5
10046027|NCT01999972|11171034|FG001|Treated|Dose Escalation Part||3
10046028|NCT01999972|11171035|FG002|Treated|Dose Escalation Part||4
10046029|NCT01999972|11171036|FG003|Treated|Dose Escalation Part||10
10046030|NCT01999972|11171037|FG004|Treated|Dose Escalation Part||0
10046031|NCT01999972|11171038|FG005|Treated|Dose Escalation Part||0
10046032|NCT01999972|11171033|FG000|COMPLETED|Dose Escalation Part||0
10046033|NCT01999972|11171034|FG001|COMPLETED|Dose Escalation Part||0
10046034|NCT01999972|11171035|FG002|COMPLETED|Dose Escalation Part||0
10046035|NCT01999972|11171036|FG003|COMPLETED|Dose Escalation Part||0
10046036|NCT01999972|11171037|FG004|COMPLETED|Dose Escalation Part||0
10046037|NCT01999972|11171038|FG005|COMPLETED|Dose Escalation Part||0
10046038|NCT01999972|11171033|FG000|NOT COMPLETED|Dose Escalation Part||5
10046039|NCT01999972|11171034|FG001|NOT COMPLETED|Dose Escalation Part||3
10046040|NCT01999972|11171035|FG002|NOT COMPLETED|Dose Escalation Part||5
10046041|NCT01999972|11171036|FG003|NOT COMPLETED|Dose Escalation Part||11
10046042|NCT01999972|11171037|FG004|NOT COMPLETED|Dose Escalation Part||0
10046043|NCT01999972|11171038|FG005|NOT COMPLETED|Dose Escalation Part||0
10046044|NCT01999972|11171033|FG000|STARTED|Dose Expansion Part||0
10046045|NCT01999972|11171034|FG001|STARTED|Dose Expansion Part||0
10046046|NCT01999972|11171035|FG002|STARTED|Dose Expansion Part||0
10046047|NCT01999972|11171036|FG003|STARTED|Dose Expansion Part||0
10046048|NCT01999972|11171037|FG004|STARTED|Dose Expansion Part||21
10046049|NCT01999972|11171038|FG005|STARTED|Dose Expansion Part||7
10046050|NCT01999972|11171033|FG000|Treated|Dose Expansion Part||0
10046051|NCT01999972|11171034|FG001|Treated|Dose Expansion Part||0
10046052|NCT01999972|11171035|FG002|Treated|Dose Expansion Part||0
10046053|NCT01999972|11171036|FG003|Treated|Dose Expansion Part||0
10046054|NCT01999972|11171037|FG004|Treated|Dose Expansion Part||21
10046055|NCT01999972|11171038|FG005|Treated|Dose Expansion Part||7
10046056|NCT01999972|11171033|FG000|COMPLETED|Dose Expansion Part||0
10046057|NCT01999972|11171034|FG001|COMPLETED|Dose Expansion Part||0
10046058|NCT01999972|11171035|FG002|COMPLETED|Dose Expansion Part||0
10046059|NCT01999972|11171036|FG003|COMPLETED|Dose Expansion Part||0
10046060|NCT01999972|11171037|FG004|COMPLETED|Dose Expansion Part||0
10046061|NCT01999972|11171038|FG005|COMPLETED|Dose Expansion Part||0
10046062|NCT01999972|11171033|FG000|NOT COMPLETED|Dose Expansion Part||0
10046063|NCT01999972|11171034|FG001|NOT COMPLETED|Dose Expansion Part||0
10046064|NCT01999972|11171035|FG002|NOT COMPLETED|Dose Expansion Part||0
10046065|NCT01999972|11171036|FG003|NOT COMPLETED|Dose Expansion Part||0
10046066|NCT01999972|11171037|FG004|NOT COMPLETED|Dose Expansion Part||21
10046067|NCT01999972|11171038|FG005|NOT COMPLETED|Dose Expansion Part||7
10046068|NCT01999985|11171054|FG000|STARTED|Overall Study||8
10046069|NCT01999985|11171055|FG001|STARTED|Overall Study||3
10046070|NCT01999985|11171056|FG002|STARTED|Overall Study||14
10046071|NCT01999985|11171054|FG000|COMPLETED|Overall Study||8
10046072|NCT01999985|11171055|FG001|COMPLETED|Overall Study||3
10046073|NCT01999985|11171056|FG002|COMPLETED|Overall Study||14
10046074|NCT01999985|11171054|FG000|NOT COMPLETED|Overall Study||0
10046075|NCT01999985|11171055|FG001|NOT COMPLETED|Overall Study||0
10046076|NCT01999985|11171056|FG002|NOT COMPLETED|Overall Study||0
10046077|NCT02000154|11171062|FG000|STARTED|Overall Study||1
10046078|NCT02000154|11171062|FG000|COMPLETED|Overall Study||1
10046079|NCT02000154|11171062|FG000|NOT COMPLETED|Overall Study||0
10046080|NCT02000180|11171068|FG000|STARTED|Overall Study||18
10046081|NCT02000180|11171069|FG001|STARTED|Overall Study||19
10046082|NCT02000180|11171068|FG000|COMPLETED|Overall Study||18
10046083|NCT02000180|11171069|FG001|COMPLETED|Overall Study||19
10046084|NCT02000180|11171068|FG000|NOT COMPLETED|Overall Study||0
10046085|NCT02000180|11171069|FG001|NOT COMPLETED|Overall Study||0
10046086|NCT02000440|11171075|FG000|STARTED|Overall Study||17
10046087|NCT02000440|11171075|FG000|COMPLETED|Overall Study||13
10046088|NCT02000440|11171075|FG000|NOT COMPLETED|Overall Study||4
10046089|NCT02000531|11171081|FG000|STARTED|Overall Study||21
10046090|NCT02000531|11171082|FG001|STARTED|Overall Study||24
10046091|NCT02000531|11171081|FG000|Safety Population|Overall Study||21
10046092|NCT02000531|11171082|FG001|Safety Population|Overall Study||24
10046093|NCT02000531|11171081|FG000|COMPLETED|Overall Study||17
10046094|NCT02000531|11171082|FG001|COMPLETED|Overall Study||16
10046095|NCT02000531|11171081|FG000|NOT COMPLETED|Overall Study||4
10046096|NCT02000531|11171082|FG001|NOT COMPLETED|Overall Study||8
10046097|NCT02000583|11171090|FG000|STARTED|Overall Study||78
10046098|NCT02000583|11171091|FG001|STARTED|Overall Study||39
10046099|NCT02000583|11171090|FG000|COMPLETED|Overall Study||75
10046100|NCT02000583|11171091|FG001|COMPLETED|Overall Study||34
10046101|NCT02000583|11171090|FG000|NOT COMPLETED|Overall Study||3
10046102|NCT02000583|11171091|FG001|NOT COMPLETED|Overall Study||5
10046103|NCT02000752|11171099|FG000|STARTED|Overall Study||60
10046104|NCT02000752|11171100|FG001|STARTED|Overall Study||60
10046105|NCT02000752|11171099|FG000|COMPLETED|Overall Study||29
10046106|NCT02000752|11171100|FG001|COMPLETED|Overall Study||47
10046107|NCT02000752|11171099|FG000|NOT COMPLETED|Overall Study||31
10046108|NCT02000752|11171100|FG001|NOT COMPLETED|Overall Study||13
10046109|NCT02000817|11171110|FG000|STARTED|Overall Study||6
10046110|NCT02000817|11171111|FG001|STARTED|Overall Study||9
10046111|NCT02000817|11171112|FG002|STARTED|Overall Study||8
10046112|NCT02000817|11171113|FG003|STARTED|Overall Study||7
10046113|NCT02000817|11171110|FG000|COMPLETED|Overall Study||4
10046114|NCT02000817|11171111|FG001|COMPLETED|Overall Study||8
10046115|NCT02000817|11171112|FG002|COMPLETED|Overall Study||7
10046116|NCT02000817|11171113|FG003|COMPLETED|Overall Study||7
10046117|NCT02000817|11171110|FG000|NOT COMPLETED|Overall Study||2
10046118|NCT02000817|11171111|FG001|NOT COMPLETED|Overall Study||1
10046119|NCT02000817|11171112|FG002|NOT COMPLETED|Overall Study||1
10046120|NCT02000817|11171113|FG003|NOT COMPLETED|Overall Study||0
10046121|NCT02000908|11171128|FG000|STARTED|Overall Study||30
10046122|NCT02000908|11171129|FG001|STARTED|Overall Study||40
10046123|NCT02000908|11171128|FG000|COMPLETED|Overall Study||28
10046124|NCT02000908|11171129|FG001|COMPLETED|Overall Study||36
10117692|NCT02541669|11248530|FG002|STARTED|Open Label Treatment Period||0
10046125|NCT02000908|11171128|FG000|NOT COMPLETED|Overall Study||2
10046126|NCT02000908|11171129|FG001|NOT COMPLETED|Overall Study||4
10046127|NCT02000921|11171138|FG000|STARTED|Overall Study||27
10046128|NCT02000921|11171139|FG001|STARTED|Overall Study||53
10046129|NCT02000921|11171140|FG002|STARTED|Overall Study||56
10046130|NCT02000921|11171138|FG000|COMPLETED|Overall Study||22
10046131|NCT02000921|11171139|FG001|COMPLETED|Overall Study||37
10046132|NCT02000921|11171140|FG002|COMPLETED|Overall Study||46
10046133|NCT02000921|11171138|FG000|NOT COMPLETED|Overall Study||5
10046134|NCT02000921|11171139|FG001|NOT COMPLETED|Overall Study||16
10046135|NCT02000921|11171140|FG002|NOT COMPLETED|Overall Study||10
10046136|NCT02000973|11171152|FG000|STARTED|Overall Study||20
10046137|NCT02000973|11171153|FG001|STARTED|Overall Study||20
10046138|NCT02000973|11171154|FG002|STARTED|Overall Study||20
10046139|NCT02000973|11171155|FG003|STARTED|Overall Study||20
10046140|NCT02000973|11171152|FG000|COMPLETED|Overall Study||20
10046141|NCT02000973|11171153|FG001|COMPLETED|Overall Study||20
10046142|NCT02000973|11171154|FG002|COMPLETED|Overall Study||20
10046143|NCT02000973|11171155|FG003|COMPLETED|Overall Study||20
10046144|NCT02000973|11171152|FG000|NOT COMPLETED|Overall Study||0
10046145|NCT02000973|11171153|FG001|NOT COMPLETED|Overall Study||0
10046146|NCT02000973|11171154|FG002|NOT COMPLETED|Overall Study||0
10046147|NCT02000973|11171155|FG003|NOT COMPLETED|Overall Study||0
10046148|NCT02001051|11171167|FG000|STARTED|Overall Study||2
10046149|NCT02001051|11171168|FG001|STARTED|Overall Study||2
10046150|NCT02001051|11171167|FG000|COMPLETED|Overall Study||2
10046151|NCT02001051|11171168|FG001|COMPLETED|Overall Study||1
10046152|NCT02001051|11171167|FG000|NOT COMPLETED|Overall Study||0
10046153|NCT02001051|11171168|FG001|NOT COMPLETED|Overall Study||1
10046154|NCT02001064|11171176|FG000|STARTED|Overall Study||30
10046155|NCT02001064|11171177|FG001|STARTED|Overall Study||30
10046156|NCT02001064|11171176|FG000|COMPLETED|Overall Study||28
10046157|NCT02001064|11171177|FG001|COMPLETED|Overall Study||29
10046158|NCT02001064|11171176|FG000|NOT COMPLETED|Overall Study||2
10046159|NCT02001064|11171177|FG001|NOT COMPLETED|Overall Study||1
10046160|NCT02001181|11171185|FG000|STARTED|Overall Study||35
10046161|NCT02001181|11171186|FG001|STARTED|Overall Study||34
10046162|NCT02001181|11171185|FG000|COMPLETED|Overall Study||34
10046163|NCT02001181|11171186|FG001|COMPLETED|Overall Study||31
10046164|NCT02001181|11171185|FG000|NOT COMPLETED|Overall Study||1
10046165|NCT02001181|11171186|FG001|NOT COMPLETED|Overall Study||3
10046166|NCT02001194|11171196|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68
10046167|NCT02001194|11171197|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80
10046168|NCT02001194|11171198|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76
10046169|NCT02001194|11171199|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80
10046170|NCT02001194|11171196|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
10046171|NCT02001194|11171197|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
10046172|NCT02001194|11171198|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
10046173|NCT02001194|11171199|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
10046174|NCT02001194|11171196|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1
10046175|NCT02001194|11171197|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0
10046176|NCT02001194|11171198|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2
10046177|NCT02001194|11171199|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2
10046178|NCT02001194|11171196|FG000|STARTED|Follow-Up Period (13 Weeks)||67
10046179|NCT02001194|11171197|FG001|STARTED|Follow-Up Period (13 Weeks)||80
10046180|NCT02001194|11171198|FG002|STARTED|Follow-Up Period (13 Weeks)||74
10046181|NCT02001194|11171199|FG003|STARTED|Follow-Up Period (13 Weeks)||78
10046182|NCT02001194|11171196|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64
10046183|NCT02001194|11171197|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78
10046184|NCT02001194|11171198|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73
10046185|NCT02001194|11171199|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78
10046186|NCT02001194|11171196|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
10046187|NCT02001194|11171197|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
10046188|NCT02001194|11171198|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
10046189|NCT02001194|11171199|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
10046190|NCT02001558|11171211|FG000|STARTED|Overall Study||32
10046191|NCT02001558|11171212|FG001|STARTED|Overall Study||33
10046192|NCT02001558|11171211|FG000|COMPLETED|Overall Study||24
10046193|NCT02001558|11171212|FG001|COMPLETED|Overall Study||19
10046194|NCT02001558|11171211|FG000|NOT COMPLETED|Overall Study||8
10046195|NCT02001558|11171212|FG001|NOT COMPLETED|Overall Study||14
10046196|NCT02001688|11171221|FG000|STARTED|Overall Study||12
10046197|NCT02001688|11171222|FG001|STARTED|Overall Study||12
10046198|NCT02001688|11171223|FG002|STARTED|Overall Study||12
10046199|NCT02001688|11171221|FG000|COMPLETED|Overall Study||12
10046200|NCT02001688|11171222|FG001|COMPLETED|Overall Study||11
10046201|NCT02001688|11171223|FG002|COMPLETED|Overall Study||11
10046202|NCT02001688|11171221|FG000|NOT COMPLETED|Overall Study||0
10046203|NCT02001688|11171222|FG001|NOT COMPLETED|Overall Study||1
10046204|NCT02001688|11171223|FG002|NOT COMPLETED|Overall Study||1
10046205|NCT02001714|11171234|FG000|STARTED|Overall Study||232
10046206|NCT02001714|11171235|FG001|STARTED|Overall Study||231
10046207|NCT02001714|11171234|FG000|COMPLETED|Overall Study||210
10046208|NCT02001714|11171235|FG001|COMPLETED|Overall Study||219
10046209|NCT02001714|11171234|FG000|NOT COMPLETED|Overall Study||22
10046210|NCT02001714|11171235|FG001|NOT COMPLETED|Overall Study||12
10046211|NCT02001987|11171241|FG000|STARTED|Core Study Period (24 Weeks)||139
10046212|NCT02001987|11171241|FG000|COMPLETED|Core Study Period (24 Weeks)||116
10046213|NCT02001987|11171241|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23
10046214|NCT02001987|11171241|FG000|STARTED|LTE Period (52 Weeks)||116
10046215|NCT02001987|11171241|FG000|COMPLETED|LTE Period (52 Weeks)||107
10046216|NCT02001987|11171241|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9
10046217|NCT02002091|11171252|FG000|STARTED|Screening||122
10046218|NCT02002091|11171253|FG001|STARTED|Screening||205
10046219|NCT02002091|11171252|FG000|COMPLETED|Screening||109
10046220|NCT02002091|11171253|FG001|COMPLETED|Screening||191
10046221|NCT02002091|11171252|FG000|NOT COMPLETED|Screening||13
10046222|NCT02002091|11171253|FG001|NOT COMPLETED|Screening||14
10046223|NCT02002091|11171252|FG000|STARTED|One Year Follow up||109
10046224|NCT02002091|11171253|FG001|STARTED|One Year Follow up||191
10046225|NCT02002091|11171252|FG000|COMPLETED|One Year Follow up||109
10046226|NCT02002091|11171253|FG001|COMPLETED|One Year Follow up||191
10046227|NCT02002091|11171252|FG000|NOT COMPLETED|One Year Follow up||0
10046228|NCT02002091|11171253|FG001|NOT COMPLETED|One Year Follow up||0
10046229|NCT02002182|11171290|FG000|STARTED|Overall Study||9
10046230|NCT02002182|11171291|FG001|STARTED|Overall Study||6
10046231|NCT02002182|11171290|FG000|COMPLETED|Overall Study||4
10046232|NCT02002182|11171291|FG001|COMPLETED|Overall Study||5
10046233|NCT02002182|11171290|FG000|NOT COMPLETED|Overall Study||5
10046234|NCT02002182|11171291|FG001|NOT COMPLETED|Overall Study||1
10046235|NCT02002208|11171299|FG000|STARTED|Overall Study||69
10046236|NCT02002208|11171300|FG001|STARTED|Overall Study||70
10046237|NCT02002208|11171299|FG000|COMPLETED|Overall Study||32
10046238|NCT02002208|11171300|FG001|COMPLETED|Overall Study||30
10046239|NCT02002208|11171299|FG000|NOT COMPLETED|Overall Study||37
10046240|NCT02002208|11171300|FG001|NOT COMPLETED|Overall Study||40
10046241|NCT02002221|11171308|FG000|STARTED|Overall Study||78
10046242|NCT02002221|11171309|FG001|STARTED|Overall Study||78
10046243|NCT02002221|11171308|FG000|COMPLETED|Overall Study||76
10046244|NCT02002221|11171309|FG001|COMPLETED|Overall Study||75
10046245|NCT02002221|11171308|FG000|NOT COMPLETED|Overall Study||2
10046246|NCT02002221|11171309|FG001|NOT COMPLETED|Overall Study||3
10046247|NCT02002494|11171315|FG000|STARTED|Overall Study||27
10046248|NCT02002494|11171315|FG000|COMPLETED|Overall Study||27
10046249|NCT02002494|11171315|FG000|NOT COMPLETED|Overall Study||0
10046250|NCT02002533|11171332|FG000|STARTED|Overall Study||34
10046251|NCT02002533|11171333|FG001|STARTED|Overall Study||37
10046252|NCT02002533|11171332|FG000|COMPLETED|Overall Study||28
10046253|NCT02002533|11171333|FG001|COMPLETED|Overall Study||19
10046254|NCT02002533|11171332|FG000|NOT COMPLETED|Overall Study||6
10046255|NCT02002533|11171333|FG001|NOT COMPLETED|Overall Study||18
10046256|NCT02002650|11171342|FG000|STARTED|Overall Study||1297
10046257|NCT02002650|11171343|FG001|STARTED|Overall Study||1303
10046258|NCT02002650|11171342|FG000|COMPLETED|Overall Study||1297
10046259|NCT02002650|11171343|FG001|COMPLETED|Overall Study||1303
10046260|NCT02002650|11171342|FG000|NOT COMPLETED|Overall Study||0
10046261|NCT02002650|11171343|FG001|NOT COMPLETED|Overall Study||0
10046262|NCT02002689|11171350|FG000|STARTED|Overall Study||10
10046263|NCT02002689|11171350|FG000|COMPLETED|Overall Study||0
10046264|NCT02002689|11171350|FG000|NOT COMPLETED|Overall Study||10
10117693|NCT02541669|11248531|FG003|STARTED|Open Label Treatment Period||0
10117694|NCT02541669|11248532|FG004|STARTED|Open Label Treatment Period||0
10117695|NCT02541669|11248528|FG000|COMPLETED|Open Label Treatment Period||8
10117696|NCT02541669|11248529|FG001|COMPLETED|Open Label Treatment Period||8
10117697|NCT02541669|11248530|FG002|COMPLETED|Open Label Treatment Period||0
10117698|NCT02541669|11248531|FG003|COMPLETED|Open Label Treatment Period||0
10117699|NCT02541669|11248532|FG004|COMPLETED|Open Label Treatment Period||0
10117700|NCT02541669|11248528|FG000|NOT COMPLETED|Open Label Treatment Period||0
10117701|NCT02541669|11248529|FG001|NOT COMPLETED|Open Label Treatment Period||0
10117702|NCT02541669|11248530|FG002|NOT COMPLETED|Open Label Treatment Period||0
10117703|NCT02541669|11248531|FG003|NOT COMPLETED|Open Label Treatment Period||0
10117704|NCT02541669|11248532|FG004|NOT COMPLETED|Open Label Treatment Period||0
10117705|NCT02541669|11248528|FG000|STARTED|Double-Blinded Treatment Period||0
10117706|NCT02541669|11248529|FG001|STARTED|Double-Blinded Treatment Period||0
10117707|NCT02541669|11248530|FG002|STARTED|Double-Blinded Treatment Period||16
10117708|NCT02541669|11248531|FG003|STARTED|Double-Blinded Treatment Period||16
10117709|NCT02541669|11248532|FG004|STARTED|Double-Blinded Treatment Period||16
10117710|NCT02541669|11248528|FG000|COMPLETED|Double-Blinded Treatment Period||0
10117711|NCT02541669|11248529|FG001|COMPLETED|Double-Blinded Treatment Period||0
10117712|NCT02541669|11248530|FG002|COMPLETED|Double-Blinded Treatment Period||15
10117713|NCT02541669|11248531|FG003|COMPLETED|Double-Blinded Treatment Period||16
10117714|NCT02541669|11248532|FG004|COMPLETED|Double-Blinded Treatment Period||15
10117715|NCT02541669|11248528|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0
10117716|NCT02541669|11248529|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0
10117717|NCT02541669|11248530|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1
10117718|NCT02541669|11248531|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0
10117719|NCT02541669|11248532|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1
10117720|NCT02541812|11248545|FG000|STARTED|Overall Study||10
10117721|NCT02541812|11248546|FG001|STARTED|Overall Study||10
10117722|NCT02541812|11248545|FG000|COMPLETED|Overall Study||10
10117723|NCT02541812|11248546|FG001|COMPLETED|Overall Study||10
10117724|NCT02541812|11248545|FG000|NOT COMPLETED|Overall Study||0
10117725|NCT02541812|11248546|FG001|NOT COMPLETED|Overall Study||0
10117726|NCT02541864|11248555|FG000|STARTED|Overall Study||164
10117727|NCT02541864|11248556|FG001|STARTED|Overall Study||166
10117728|NCT02541864|11248555|FG000|COMPLETED|Overall Study||164
10117729|NCT02541864|11248556|FG001|COMPLETED|Overall Study||166
10117730|NCT02541864|11248555|FG000|NOT COMPLETED|Overall Study||0
10117731|NCT02541864|11248556|FG001|NOT COMPLETED|Overall Study||0
10117732|NCT02541903|11248562|FG000|STARTED|Overall Study||8
10117733|NCT02541903|11248562|FG000|COMPLETED|Overall Study||7
10117734|NCT02541903|11248562|FG000|NOT COMPLETED|Overall Study||1
10117735|NCT02541942|11248566|FG000|STARTED|Overall Study||19
10117736|NCT02541942|11248566|FG000|COMPLETED|Overall Study||19
10117737|NCT02541942|11248566|FG000|NOT COMPLETED|Overall Study||0
10117738|NCT02542046|11248573|FG000|STARTED|Overall Study||300
10117739|NCT02542046|11248574|FG001|STARTED|Overall Study||300
10117740|NCT02542046|11248575|FG002|STARTED|Overall Study||300
10117741|NCT02542046|11248573|FG000|COMPLETED|Overall Study||300
10117742|NCT02542046|11248574|FG001|COMPLETED|Overall Study||300
10117743|NCT02542046|11248575|FG002|COMPLETED|Overall Study||300
10117744|NCT02542046|11248573|FG000|NOT COMPLETED|Overall Study||0
10117745|NCT02542046|11248574|FG001|NOT COMPLETED|Overall Study||0
10117746|NCT02542046|11248575|FG002|NOT COMPLETED|Overall Study||0
10046265|NCT02002702|11171357|FG000|STARTED|Overall Study||16
10046266|NCT02002702|11171358|FG001|STARTED|Overall Study||15
10046267|NCT02002702|11171359|FG002|STARTED|Overall Study||15
10046268|NCT02002702|11171357|FG000|COMPLETED|Overall Study||16
10046269|NCT02002702|11171358|FG001|COMPLETED|Overall Study||15
10046270|NCT02002702|11171359|FG002|COMPLETED|Overall Study||15
10046271|NCT02002702|11171357|FG000|NOT COMPLETED|Overall Study||0
10046272|NCT02002702|11171358|FG001|NOT COMPLETED|Overall Study||0
10046273|NCT02002702|11171359|FG002|NOT COMPLETED|Overall Study||0
10046274|NCT02002767|11171369|FG000|STARTED|Overall Study||9
10046275|NCT02002767|11171370|FG001|STARTED|Overall Study||10
10046276|NCT02002767|11171369|FG000|COMPLETED|Overall Study||9
10046277|NCT02002767|11171370|FG001|COMPLETED|Overall Study||10
10046278|NCT02002767|11171369|FG000|NOT COMPLETED|Overall Study||0
10046279|NCT02002767|11171370|FG001|NOT COMPLETED|Overall Study||0
10046280|NCT02002832|11171378|FG000|STARTED|Overall Study||194
10046281|NCT02002832|11171379|FG001|STARTED|Overall Study||194
10046282|NCT02002832|11171378|FG000|COMPLETED|Overall Study||166
10046283|NCT02002832|11171379|FG001|COMPLETED|Overall Study||168
10046284|NCT02002832|11171378|FG000|NOT COMPLETED|Overall Study||28
10046285|NCT02002832|11171379|FG001|NOT COMPLETED|Overall Study||26
10046286|NCT02002871|11171386|FG000|STARTED|Overall Study||21
10046287|NCT02002871|11171386|FG000|COMPLETED|Overall Study||20
10046288|NCT02002871|11171386|FG000|NOT COMPLETED|Overall Study||1
10046289|NCT02002884|11171394|FG000|STARTED|Main Period (MP)||87
10046290|NCT02002884|11171395|FG001|STARTED|Main Period (MP)||88
10046291|NCT02002884|11171396|FG002|STARTED|Main Period (MP)||176
10046292|NCT02002884|11171397|FG003|STARTED|Main Period (MP)||0
10046293|NCT02002884|11171394|FG000|Treated|Main Period (MP)||87
10046294|NCT02002884|11171395|FG001|Treated|Main Period (MP)||87
10046295|NCT02002884|11171396|FG002|Treated|Main Period (MP)||176
10046296|NCT02002884|11171397|FG003|Treated|Main Period (MP)||0
10046297|NCT02002884|11171394|FG000|COMPLETED|Main Period (MP)||81
10046298|NCT02002884|11171395|FG001|COMPLETED|Main Period (MP)||82
10046299|NCT02002884|11171396|FG002|COMPLETED|Main Period (MP)||168
10046300|NCT02002884|11171397|FG003|COMPLETED|Main Period (MP)||0
10046301|NCT02002884|11171394|FG000|NOT COMPLETED|Main Period (MP)||6
10046302|NCT02002884|11171395|FG001|NOT COMPLETED|Main Period (MP)||6
10046303|NCT02002884|11171396|FG002|NOT COMPLETED|Main Period (MP)||8
10046304|NCT02002884|11171397|FG003|NOT COMPLETED|Main Period (MP)||0
10046305|NCT02002884|11171394|FG000|STARTED|Open-Label Extension Period (OLEX)||0
10046306|NCT02002884|11171395|FG001|STARTED|Open-Label Extension Period (OLEX)||0
10046307|NCT02002884|11171396|FG002|STARTED|Open-Label Extension Period (OLEX)||0
10046308|NCT02002884|11171397|FG003|STARTED|Open-Label Extension Period (OLEX)||331
10046309|NCT02002884|11171394|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0
10046310|NCT02002884|11171395|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0
10046311|NCT02002884|11171396|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0
10046312|NCT02002884|11171397|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281
10046313|NCT02002884|11171394|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
10046314|NCT02002884|11171395|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
10046315|NCT02002884|11171396|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
10046316|NCT02002884|11171397|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
10046317|NCT02002936|11171407|FG000|STARTED|Overall Study||1
10046318|NCT02002936|11171407|FG000|COMPLETED|Overall Study||1
10046319|NCT02002936|11171407|FG000|NOT COMPLETED|Overall Study||0
10046320|NCT02002975|11171411|FG000|STARTED|Overall Study||18223
10046321|NCT02002975|11171411|FG000|COMPLETED|Overall Study||17651
10046322|NCT02002975|11171411|FG000|NOT COMPLETED|Overall Study||572
10046323|NCT02003014|11171415|FG000|STARTED|Overall Study||899
10046324|NCT02003014|11171415|FG000|COMPLETED|Overall Study||880
10046325|NCT02003014|11171415|FG000|NOT COMPLETED|Overall Study||19
10046326|NCT02003053|11171421|FG000|STARTED|Overall Study||4
10046327|NCT02003053|11171422|FG001|STARTED|Overall Study||3
10046328|NCT02003053|11171421|FG000|COMPLETED|Overall Study||4
10046329|NCT02003053|11171422|FG001|COMPLETED|Overall Study||3
10046330|NCT02003053|11171421|FG000|NOT COMPLETED|Overall Study||0
10046331|NCT02003053|11171422|FG001|NOT COMPLETED|Overall Study||0
10046332|NCT02003183|11171430|FG000|STARTED|Overall Study||7
10046333|NCT02003183|11171431|FG001|STARTED|Overall Study||17
10046334|NCT02003183|11171430|FG000|COMPLETED|Overall Study||7
10046335|NCT02003183|11171431|FG001|COMPLETED|Overall Study||15
10046336|NCT02003183|11171430|FG000|NOT COMPLETED|Overall Study||0
10046337|NCT02003183|11171431|FG001|NOT COMPLETED|Overall Study||2
10046338|NCT02003352|11171437|FG000|STARTED|Overall Study||98
10046339|NCT02003352|11171437|FG000|COMPLETED|Overall Study||98
10046340|NCT02003352|11171437|FG000|NOT COMPLETED|Overall Study||0
10046341|NCT02003365|11171444|FG000|STARTED|Overall Study||10
10046342|NCT02003365|11171445|FG001|STARTED|Overall Study||30
10046343|NCT02003365|11171446|FG002|STARTED|Overall Study||10
10046344|NCT02003365|11171444|FG000|COMPLETED|Overall Study||10
10046345|NCT02003365|11171445|FG001|COMPLETED|Overall Study||30
10046346|NCT02003365|11171446|FG002|COMPLETED|Overall Study||9
10046347|NCT02003365|11171444|FG000|NOT COMPLETED|Overall Study||0
10046348|NCT02003365|11171445|FG001|NOT COMPLETED|Overall Study||0
10046349|NCT02003365|11171446|FG002|NOT COMPLETED|Overall Study||1
10046350|NCT02003391|11171456|FG000|STARTED|Overall Study||81
10046351|NCT02003391|11171457|FG001|STARTED|Overall Study||75
10046352|NCT02003391|11171456|FG000|Safety Population|Overall Study||81
10046353|NCT02003391|11171457|FG001|Safety Population|Overall Study||75
10046354|NCT02003391|11171456|FG000|Intent to Treat Population|Overall Study||78
10046355|NCT02003391|11171457|FG001|Intent to Treat Population|Overall Study||73
10046356|NCT02003391|11171456|FG000|COMPLETED|Overall Study||78
10046357|NCT02003391|11171457|FG001|COMPLETED|Overall Study||73
10046358|NCT02003391|11171456|FG000|NOT COMPLETED|Overall Study||3
10046359|NCT02003391|11171457|FG001|NOT COMPLETED|Overall Study||2
10046360|NCT02003404|11171463|FG000|STARTED|Overall Study||17
10046361|NCT02003404|11171463|FG000|COMPLETED|Overall Study||17
10046362|NCT02003404|11171463|FG000|NOT COMPLETED|Overall Study||0
10046363|NCT02003508|11171471|FG000|STARTED|Overall Study||179
10046364|NCT02003508|11171472|FG001|STARTED|Overall Study||166
10046365|NCT02003508|11171471|FG000|COMPLETED|Overall Study||179
10046366|NCT02003508|11171472|FG001|COMPLETED|Overall Study||166
10046367|NCT02003508|11171471|FG000|NOT COMPLETED|Overall Study||0
10046368|NCT02003508|11171472|FG001|NOT COMPLETED|Overall Study||0
10046369|NCT02003534|11171478|FG000|STARTED|Overall Study||376
10046370|NCT02003534|11171478|FG000|COMPLETED|Overall Study||329
10046371|NCT02003534|11171478|FG000|NOT COMPLETED|Overall Study||47
10046372|NCT02003573|11171485|FG000|STARTED|Overall Study|Started are treated patients|3
10046373|NCT02003573|11171486|FG001|STARTED|Overall Study|Started are treated patients|4
10046374|NCT02003573|11171487|FG002|STARTED|Overall Study|Started are treated patients|6
10046375|NCT02003573|11171485|FG000|COMPLETED|Overall Study||0
10046376|NCT02003573|11171486|FG001|COMPLETED|Overall Study||0
10046377|NCT02003573|11171487|FG002|COMPLETED|Overall Study||0
10046378|NCT02003573|11171485|FG000|NOT COMPLETED|Overall Study||3
10046379|NCT02003573|11171486|FG001|NOT COMPLETED|Overall Study||4
10046380|NCT02003573|11171487|FG002|NOT COMPLETED|Overall Study||6
10046381|NCT02003625|11171499|FG000|STARTED|Overall Study||15
10046382|NCT02003625|11171500|FG001|STARTED|Overall Study||15
10046383|NCT02003625|11171499|FG000|Received Transplant|Overall Study||14
10046384|NCT02003625|11171500|FG001|Received Transplant|Overall Study||12
10046385|NCT02003625|11171499|FG000|COMPLETED|Overall Study||14
10046386|NCT02003625|11171500|FG001|COMPLETED|Overall Study||12
10046387|NCT02003625|11171499|FG000|NOT COMPLETED|Overall Study||1
10046388|NCT02003625|11171500|FG001|NOT COMPLETED|Overall Study||3
10046389|NCT02003638|11171508|FG000|STARTED|Overall Study||6
10046390|NCT02003638|11171509|FG001|STARTED|Overall Study||3
10046391|NCT02003638|11171508|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
10046392|NCT02003638|11171509|FG001|COMPLETED|Overall Study||3
10046393|NCT02003638|11171508|FG000|NOT COMPLETED|Overall Study||1
10046394|NCT02003638|11171509|FG001|NOT COMPLETED|Overall Study||0
10046395|NCT02003898|11171515|FG000|STARTED|Overall Study||372
10046396|NCT02003898|11171515|FG000|COMPLETED|Overall Study||305
10046397|NCT02003898|11171515|FG000|NOT COMPLETED|Overall Study||67
10046398|NCT02003911|11171521|FG000|STARTED|Overall Study||80
10046399|NCT02003911|11171522|FG001|STARTED|Overall Study||79
10046400|NCT02003911|11171521|FG000|COMPLETED|Overall Study||78
10046401|NCT02003911|11171522|FG001|COMPLETED|Overall Study||72
10046402|NCT02003911|11171521|FG000|NOT COMPLETED|Overall Study||2
10046403|NCT02003911|11171522|FG001|NOT COMPLETED|Overall Study||7
10046404|NCT02003963|11171530|FG000|STARTED|Overall Study||22
10046405|NCT02003963|11171531|FG001|STARTED|Overall Study||19
10046406|NCT02003963|11171530|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
10046407|NCT02003963|11171531|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
10046408|NCT02003963|11171530|FG000|NOT COMPLETED|Overall Study||2
10046409|NCT02003963|11171531|FG001|NOT COMPLETED|Overall Study||1
10046410|NCT02004093|11171541|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
10046411|NCT02004093|11171542|FG001|STARTED|Overall Study||74
10046412|NCT02004093|11171541|FG000|COMPLETED|Overall Study||1
10046413|NCT02004093|11171542|FG001|COMPLETED|Overall Study||1
10046414|NCT02004093|11171541|FG000|NOT COMPLETED|Overall Study||74
10046415|NCT02004093|11171542|FG001|NOT COMPLETED|Overall Study||73
10046416|NCT02004132|11171551|FG000|STARTED|Overall Study||12
10046417|NCT02004132|11171551|FG000|Received Study Drug|Overall Study||12
10046418|NCT02004132|11171551|FG000|COMPLETED|Overall Study||12
10046419|NCT02004132|11171551|FG000|NOT COMPLETED|Overall Study||0
10046420|NCT02004158|11171555|FG000|STARTED|Overall Study||23
10046421|NCT02004158|11171555|FG000|COMPLETED|Overall Study||20
10046422|NCT02004158|11171555|FG000|NOT COMPLETED|Overall Study||3
10046423|NCT02004236|11171564|FG000|STARTED|Overall Study||75
10046424|NCT02004236|11171565|FG001|STARTED|Overall Study||75
10046425|NCT02004236|11171566|FG002|STARTED|Overall Study||75
10046426|NCT02004236|11171564|FG000|COMPLETED|Overall Study||75
10046427|NCT02004236|11171565|FG001|COMPLETED|Overall Study||75
10046428|NCT02004236|11171566|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
10046429|NCT02004236|11171564|FG000|NOT COMPLETED|Overall Study||0
10046430|NCT02004236|11171565|FG001|NOT COMPLETED|Overall Study||0
10046431|NCT02004236|11171566|FG002|NOT COMPLETED|Overall Study||16
10046432|NCT02004262|11171581|FG000|STARTED|Overall Study||73
10046433|NCT02004262|11171582|FG001|STARTED|Overall Study||68
10046434|NCT02004262|11171583|FG002|STARTED|Overall Study||72
10046435|NCT02004262|11171584|FG003|STARTED|Overall Study||29
10046436|NCT02004262|11171585|FG004|STARTED|Overall Study||31
10046437|NCT02004262|11171586|FG005|STARTED|Overall Study||30
10046438|NCT02004262|11171581|FG000|Treated|Overall Study||68
10046439|NCT02004262|11171582|FG001|Treated|Overall Study||58
10046440|NCT02004262|11171583|FG002|Treated|Overall Study||43
10046441|NCT02004262|11171584|FG003|Treated|Overall Study||26
10046442|NCT02004262|11171585|FG004|Treated|Overall Study||29
10046443|NCT02004262|11171586|FG005|Treated|Overall Study||11
10046444|NCT02004262|11171581|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10046445|NCT02004262|11171582|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10046446|NCT02004262|11171583|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10046447|NCT02004262|11171584|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10046448|NCT02004262|11171585|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10046449|NCT02004262|11171586|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10046450|NCT02004262|11171581|FG000|NOT COMPLETED|Overall Study||73
10046451|NCT02004262|11171582|FG001|NOT COMPLETED|Overall Study||68
10046452|NCT02004262|11171583|FG002|NOT COMPLETED|Overall Study||72
10046453|NCT02004262|11171584|FG003|NOT COMPLETED|Overall Study||29
10046454|NCT02004262|11171585|FG004|NOT COMPLETED|Overall Study||31
10046455|NCT02004262|11171586|FG005|NOT COMPLETED|Overall Study||30
10046456|NCT02004288|11171602|FG000|STARTED|Overall Study||15
10046457|NCT02004288|11171603|FG001|STARTED|Overall Study||16
10046458|NCT02004288|11171602|FG000|COMPLETED|Overall Study||14
10046459|NCT02004288|11171603|FG001|COMPLETED|Overall Study||15
10046460|NCT02004288|11171602|FG000|NOT COMPLETED|Overall Study||1
10046461|NCT02004288|11171603|FG001|NOT COMPLETED|Overall Study||1
10046462|NCT02004353|11171609|FG000|STARTED|Overall Study||1518
10046463|NCT02004353|11171609|FG000|COMPLETED|Overall Study||184
10046464|NCT02004353|11171609|FG000|NOT COMPLETED|Overall Study||1334
10046465|NCT02004366|11171618|FG000|STARTED|In-hospital||128
10046466|NCT02004366|11171619|FG001|STARTED|In-hospital||122
10046467|NCT02004366|11171620|FG002|STARTED|In-hospital||0
10046468|NCT02004366|11171621|FG003|STARTED|In-hospital||0
10046469|NCT02004366|11171622|FG004|STARTED|In-hospital||0
10046470|NCT02004366|11171618|FG000|COMPLETED|In-hospital||128
10046471|NCT02004366|11171619|FG001|COMPLETED|In-hospital||122
10046472|NCT02004366|11171620|FG002|COMPLETED|In-hospital||0
10046473|NCT02004366|11171621|FG003|COMPLETED|In-hospital||0
10046474|NCT02004366|11171622|FG004|COMPLETED|In-hospital||0
10046475|NCT02004366|11171618|FG000|NOT COMPLETED|In-hospital||0
10046476|NCT02004366|11171619|FG001|NOT COMPLETED|In-hospital||0
10046477|NCT02004366|11171620|FG002|NOT COMPLETED|In-hospital||0
10046478|NCT02004366|11171621|FG003|NOT COMPLETED|In-hospital||0
10046479|NCT02004366|11171622|FG004|NOT COMPLETED|In-hospital||0
10046480|NCT02004366|11171618|FG000|STARTED|On Discharge||0
10046481|NCT02004366|11171619|FG001|STARTED|On Discharge||0
10046482|NCT02004366|11171620|FG002|STARTED|On Discharge||92
10046483|NCT02004366|11171621|FG003|STARTED|On Discharge||93
10046484|NCT02004366|11171622|FG004|STARTED|On Discharge||39
10046485|NCT02004366|11171618|FG000|COMPLETED|On Discharge||0
10046486|NCT02004366|11171619|FG001|COMPLETED|On Discharge||0
10046487|NCT02004366|11171620|FG002|COMPLETED|On Discharge||92
10046488|NCT02004366|11171621|FG003|COMPLETED|On Discharge||93
10046489|NCT02004366|11171622|FG004|COMPLETED|On Discharge||39
10046490|NCT02004366|11171618|FG000|NOT COMPLETED|On Discharge||0
10046491|NCT02004366|11171619|FG001|NOT COMPLETED|On Discharge||0
10046492|NCT02004366|11171620|FG002|NOT COMPLETED|On Discharge||0
10046493|NCT02004366|11171621|FG003|NOT COMPLETED|On Discharge||0
10046494|NCT02004366|11171622|FG004|NOT COMPLETED|On Discharge||0
10046495|NCT02004613|11171637|FG000|STARTED|Overall Study||400
10046496|NCT02004613|11171638|FG001|STARTED|Overall Study||398
10046497|NCT02004613|11171637|FG000|COMPLETED|Overall Study||398
10046498|NCT02004613|11171638|FG001|COMPLETED|Overall Study||396
10046499|NCT02004613|11171637|FG000|NOT COMPLETED|Overall Study||2
10046500|NCT02004613|11171638|FG001|NOT COMPLETED|Overall Study||2
10046501|NCT02004847|11171646|FG000|STARTED|Overall Study||24
10046502|NCT02004847|11171647|FG001|STARTED|Overall Study||23
10046503|NCT02004847|11171646|FG000|COMPLETED|Overall Study||23
10046504|NCT02004847|11171647|FG001|COMPLETED|Overall Study||22
10046505|NCT02004847|11171646|FG000|NOT COMPLETED|Overall Study||1
10046506|NCT02004847|11171647|FG001|NOT COMPLETED|Overall Study||1
10046507|NCT02004873|11171662|FG000|STARTED|Overall Study|Micra Implant Attempt|725
10046508|NCT02004873|11171662|FG000|Micra Implant Success|Overall Study||719
10046509|NCT02004873|11171662|FG000|COMPLETED|Overall Study|6-Month Follow-up|301
10046510|NCT02004873|11171662|FG000|NOT COMPLETED|Overall Study||424
10046511|NCT02004886|11171673|FG000|STARTED|Overall Study||19
10046512|NCT02004886|11171674|FG001|STARTED|Overall Study||18
10046513|NCT02004886|11171675|FG002|STARTED|Overall Study||18
10046514|NCT02004886|11171676|FG003|STARTED|Overall Study||19
10046515|NCT02004886|11171673|FG000|COMPLETED|Overall Study||18
10046516|NCT02004886|11171674|FG001|COMPLETED|Overall Study||17
10046517|NCT02004886|11171675|FG002|COMPLETED|Overall Study||18
10046518|NCT02004886|11171676|FG003|COMPLETED|Overall Study||19
10046519|NCT02004886|11171673|FG000|NOT COMPLETED|Overall Study||1
10046520|NCT02004886|11171674|FG001|NOT COMPLETED|Overall Study||1
10046521|NCT02004886|11171675|FG002|NOT COMPLETED|Overall Study||0
10046522|NCT02004886|11171676|FG003|NOT COMPLETED|Overall Study||0
10046523|NCT02004977|11171688|FG000|STARTED|Overall Study||463
10046524|NCT02004977|11171689|FG001|STARTED|Overall Study||441
10046525|NCT02004977|11171688|FG000|COMPLETED|Overall Study||409
10046526|NCT02004977|11171689|FG001|COMPLETED|Overall Study||436
10046527|NCT02004977|11171688|FG000|NOT COMPLETED|Overall Study||54
10046528|NCT02004977|11171689|FG001|NOT COMPLETED|Overall Study||5
10046529|NCT02004990|11171695|FG000|STARTED|Overall Study||12
10046530|NCT02004990|11171695|FG000|COMPLETED|Overall Study||12
10046531|NCT02004990|11171695|FG000|NOT COMPLETED|Overall Study||0
10046532|NCT02005016|11171699|FG000|STARTED|Overall Study||46
10046533|NCT02005016|11171699|FG000|COMPLETED|Overall Study||44
10046534|NCT02005016|11171699|FG000|NOT COMPLETED|Overall Study||2
10046535|NCT02005029|11171705|FG000|STARTED|First Intervention (1 Day)||5
10046536|NCT02005029|11171706|FG001|STARTED|First Intervention (1 Day)||5
10046537|NCT02005029|11171705|FG000|COMPLETED|First Intervention (1 Day)||4
10046538|NCT02005029|11171706|FG001|COMPLETED|First Intervention (1 Day)||5
10046539|NCT02005029|11171705|FG000|NOT COMPLETED|First Intervention (1 Day)||1
10046540|NCT02005029|11171706|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10046541|NCT02005029|11171705|FG000|STARTED|Washout (2 Weeks)||4
10046542|NCT02005029|11171706|FG001|STARTED|Washout (2 Weeks)||5
10046543|NCT02005029|11171705|FG000|COMPLETED|Washout (2 Weeks)||4
10046544|NCT02005029|11171706|FG001|COMPLETED|Washout (2 Weeks)||5
10046545|NCT02005029|11171705|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10046546|NCT02005029|11171706|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10046547|NCT02005029|11171705|FG000|STARTED|Second Intervention (1 Day)||4
10046548|NCT02005029|11171706|FG001|STARTED|Second Intervention (1 Day)||5
10046549|NCT02005029|11171705|FG000|COMPLETED|Second Intervention (1 Day)||4
10046550|NCT02005029|11171706|FG001|COMPLETED|Second Intervention (1 Day)||5
10046551|NCT02005029|11171705|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10046552|NCT02005029|11171706|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10046553|NCT02005211|11171737|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046554|NCT02005211|11171738|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046555|NCT02005211|11171739|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046556|NCT02005211|11171740|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046557|NCT02005211|11171741|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046558|NCT02005211|11171742|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046559|NCT02005211|11171743|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046560|NCT02005211|11171737|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046561|NCT02005211|11171738|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046562|NCT02005211|11171739|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046563|NCT02005211|11171740|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10046564|NCT02005211|11171741|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046565|NCT02005211|11171742|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046566|NCT02005211|11171743|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046567|NCT02005211|11171737|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046568|NCT02005211|11171738|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046569|NCT02005211|11171739|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046570|NCT02005211|11171740|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046571|NCT02005211|11171741|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046572|NCT02005211|11171742|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046573|NCT02005211|11171743|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10046574|NCT02005211|11171737|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046575|NCT02005211|11171738|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046576|NCT02005211|11171739|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046577|NCT02005211|11171740|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046578|NCT02005211|11171741|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
10046579|NCT02005211|11171742|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
10046580|NCT02005211|11171743|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
10046581|NCT02005211|11171737|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046582|NCT02005211|11171738|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046583|NCT02005211|11171739|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046584|NCT02005211|11171740|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046585|NCT02005211|11171741|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
10046586|NCT02005211|11171742|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
10046587|NCT02005211|11171743|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
10046588|NCT02005211|11171737|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046589|NCT02005211|11171738|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046590|NCT02005211|11171739|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046591|NCT02005211|11171740|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046592|NCT02005211|11171741|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
10046593|NCT02005211|11171742|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046594|NCT02005211|11171743|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10046595|NCT02005250|11171768|FG000|STARTED|Overall Study||61
10046596|NCT02005250|11171769|FG001|STARTED|Overall Study||32
10046597|NCT02005250|11171768|FG000|COMPLETED|Overall Study||46
10046598|NCT02005250|11171769|FG001|COMPLETED|Overall Study||27
10046599|NCT02005250|11171768|FG000|NOT COMPLETED|Overall Study||15
10046600|NCT02005250|11171769|FG001|NOT COMPLETED|Overall Study||5
10046601|NCT02005276|11171779|FG000|STARTED|Overall Study||65
10046602|NCT02005276|11171780|FG001|STARTED|Overall Study||41
10046603|NCT02005276|11171781|FG002|STARTED|Overall Study||59
10046604|NCT02005276|11171782|FG003|STARTED|Overall Study||44
10046605|NCT02005276|11171779|FG000|Completed Intervention|Overall Study||61
10046606|NCT02005276|11171780|FG001|Completed Intervention|Overall Study||39
10046607|NCT02005276|11171781|FG002|Completed Intervention|Overall Study||56
10046608|NCT02005276|11171782|FG003|Completed Intervention|Overall Study||42
10046609|NCT02005276|11171779|FG000|COMPLETED|Overall Study||60
10046610|NCT02005276|11171780|FG001|COMPLETED|Overall Study||39
10046611|NCT02005276|11171781|FG002|COMPLETED|Overall Study||56
10046612|NCT02005276|11171782|FG003|COMPLETED|Overall Study||41
10046613|NCT02005276|11171779|FG000|NOT COMPLETED|Overall Study||5
10046614|NCT02005276|11171780|FG001|NOT COMPLETED|Overall Study||2
10046615|NCT02005276|11171781|FG002|NOT COMPLETED|Overall Study||3
10046616|NCT02005276|11171782|FG003|NOT COMPLETED|Overall Study||3
10046617|NCT02005354|11171796|FG000|STARTED|Overall Study||35
10046618|NCT02005354|11171797|FG001|STARTED|Overall Study||35
10046619|NCT02005354|11171796|FG000|COMPLETED|Overall Study||35
10046620|NCT02005354|11171797|FG001|COMPLETED|Overall Study||35
10046621|NCT02005354|11171796|FG000|NOT COMPLETED|Overall Study||0
10046622|NCT02005354|11171797|FG001|NOT COMPLETED|Overall Study||0
10046623|NCT02005393|11171803|FG000|STARTED|Overall Study||20
10046624|NCT02005393|11171803|FG000|COMPLETED|Overall Study||20
10046625|NCT02005393|11171803|FG000|NOT COMPLETED|Overall Study||0
10046626|NCT02005484|11171807|FG000|STARTED|Overall Study||6
10046627|NCT02005484|11171807|FG000|COMPLETED|Overall Study||2
10046628|NCT02005484|11171807|FG000|NOT COMPLETED|Overall Study||4
10117747|NCT02542072|11248585|FG000|STARTED|First Intervention (1 Month)||44
10117748|NCT02542072|11248586|FG001|STARTED|First Intervention (1 Month)||46
10117749|NCT02542072|11248585|FG000|COMPLETED|First Intervention (1 Month)||39
10117750|NCT02542072|11248586|FG001|COMPLETED|First Intervention (1 Month)||43
10117751|NCT02542072|11248585|FG000|NOT COMPLETED|First Intervention (1 Month)||5
10117752|NCT02542072|11248586|FG001|NOT COMPLETED|First Intervention (1 Month)||3
10117753|NCT02542072|11248585|FG000|STARTED|Second Intervention (1 Month)||39
10117754|NCT02542072|11248586|FG001|STARTED|Second Intervention (1 Month)||43
10046629|NCT02005510|11171813|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
10046630|NCT02005510|11171814|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
10046631|NCT02005510|11171813|FG000|COMPLETED|Randomized (Round 1)||8120
10046632|NCT02005510|11171814|FG001|COMPLETED|Randomized (Round 1)||8111
10046633|NCT02005510|11171813|FG000|NOT COMPLETED|Randomized (Round 1)||0
10046634|NCT02005510|11171814|FG001|NOT COMPLETED|Randomized (Round 1)||0
10046635|NCT02005510|11171813|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
10046636|NCT02005510|11171814|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
10046637|NCT02005510|11171813|FG000|COMPLETED|Rerandomized (Round 2)||1631
10046638|NCT02005510|11171814|FG001|COMPLETED|Rerandomized (Round 2)||1585
10046639|NCT02005510|11171813|FG000|NOT COMPLETED|Rerandomized (Round 2)||0
10046640|NCT02005510|11171814|FG001|NOT COMPLETED|Rerandomized (Round 2)||0
10046641|NCT02005510|11171813|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
10046642|NCT02005510|11171814|FG001|STARTED|Rerandomized (Round 3)||195
10046643|NCT02005510|11171813|FG000|COMPLETED|Rerandomized (Round 3)||209
10046644|NCT02005510|11171814|FG001|COMPLETED|Rerandomized (Round 3)||195
10046645|NCT02005510|11171813|FG000|NOT COMPLETED|Rerandomized (Round 3)||0
10046646|NCT02005510|11171814|FG001|NOT COMPLETED|Rerandomized (Round 3)||0
10046647|NCT02005536|11171820|FG000|STARTED|Overall Study||60
10046648|NCT02005536|11171820|FG000|COMPLETED|Overall Study||60
10046649|NCT02005536|11171820|FG000|NOT COMPLETED|Overall Study||0
10046650|NCT02005549|11171824|FG000|STARTED|Overall Study||18
10046651|NCT02005549|11171824|FG000|COMPLETED|Overall Study||18
10046652|NCT02005549|11171824|FG000|NOT COMPLETED|Overall Study||0
10046653|NCT02005562|11171830|FG000|STARTED|Overall Study||127
10046654|NCT02005562|11171831|FG001|STARTED|Overall Study||125
10046655|NCT02005562|11171830|FG000|Transplanted|Overall Study||126
10046656|NCT02005562|11171831|FG001|Transplanted|Overall Study||121
10046657|NCT02005562|11171830|FG000|COMPLETED|Overall Study||115
10046658|NCT02005562|11171831|FG001|COMPLETED|Overall Study||110
10046659|NCT02005562|11171830|FG000|NOT COMPLETED|Overall Study||12
10046660|NCT02005562|11171831|FG001|NOT COMPLETED|Overall Study||15
10046661|NCT02005601|11171839|FG000|STARTED|Overall Study||53
10046662|NCT02005601|11171840|FG001|STARTED|Overall Study||53
10046663|NCT02005601|11171839|FG000|COMPLETED|Overall Study||53
10046664|NCT02005601|11171840|FG001|COMPLETED|Overall Study||53
10046665|NCT02005601|11171839|FG000|NOT COMPLETED|Overall Study||0
10046666|NCT02005601|11171840|FG001|NOT COMPLETED|Overall Study||0
10046667|NCT02005627|11171848|FG000|STARTED|Overall Study||23
10046668|NCT02005627|11171849|FG001|STARTED|Overall Study||23
10046669|NCT02005627|11171848|FG000|COMPLETED|Overall Study||21
10046670|NCT02005627|11171849|FG001|COMPLETED|Overall Study||19
10046671|NCT02005627|11171848|FG000|NOT COMPLETED|Overall Study||2
10046672|NCT02005627|11171849|FG001|NOT COMPLETED|Overall Study||4
10046673|NCT02005666|11171859|FG000|STARTED|Overall Study||338
10046674|NCT02005666|11171860|FG001|STARTED|Overall Study||343
10046675|NCT02005666|11171861|FG002|STARTED|Overall Study||169
10046676|NCT02005666|11171859|FG000|COMPLETED|Overall Study||311
10046677|NCT02005666|11171860|FG001|COMPLETED|Overall Study||299
10046678|NCT02005666|11171861|FG002|COMPLETED|Overall Study||160
10046679|NCT02005666|11171859|FG000|NOT COMPLETED|Overall Study||27
10117755|NCT02542072|11248585|FG000|COMPLETED|Second Intervention (1 Month)||37
10046680|NCT02005666|11171860|FG001|NOT COMPLETED|Overall Study||44
10046681|NCT02005666|11171861|FG002|NOT COMPLETED|Overall Study||9
10046682|NCT02005692|11171869|FG000|STARTED|Overall Study||70
10046683|NCT02005692|11171869|FG000|COMPLETED|Overall Study||63
10046684|NCT02005692|11171869|FG000|NOT COMPLETED|Overall Study||7
10046685|NCT02005887|11171876|FG000|STARTED|Overall Study||26
10046686|NCT02005887|11171877|FG001|STARTED|Overall Study||25
10046687|NCT02005887|11171876|FG000|COMPLETED|Overall Study||26
10046688|NCT02005887|11171877|FG001|COMPLETED|Overall Study||23
10046689|NCT02005887|11171876|FG000|NOT COMPLETED|Overall Study||0
10046690|NCT02005887|11171877|FG001|NOT COMPLETED|Overall Study||2
10046691|NCT02006056|11171885|FG000|STARTED|Overall Study||26
10046692|NCT02006056|11171886|FG001|STARTED|Overall Study||4
10046693|NCT02006056|11171885|FG000|COMPLETED|Overall Study||26
10046694|NCT02006056|11171886|FG001|COMPLETED|Overall Study||4
10046695|NCT02006056|11171885|FG000|NOT COMPLETED|Overall Study||0
10046696|NCT02006056|11171886|FG001|NOT COMPLETED|Overall Study||0
10046697|NCT02006108|11171892|FG000|STARTED|Overall Study||21
10046698|NCT02006108|11171892|FG000|MR Imaging|Overall Study||19
10046699|NCT02006108|11171892|FG000|COMPLETED|Overall Study||19
10046700|NCT02006108|11171892|FG000|NOT COMPLETED|Overall Study||2
10046701|NCT02006121|11171898|FG000|STARTED|Double Blind Phase||54
10046702|NCT02006121|11171899|FG001|STARTED|Double Blind Phase||53
10046703|NCT02006121|11171898|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
10046704|NCT02006121|11171899|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
10046705|NCT02006121|11171898|FG000|NOT COMPLETED|Double Blind Phase||12
10046706|NCT02006121|11171899|FG001|NOT COMPLETED|Double Blind Phase||24
10046707|NCT02006121|11171898|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
10046708|NCT02006121|11171899|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
10046709|NCT02006121|11171898|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
10046710|NCT02006121|11171899|FG001|COMPLETED|Open Label Phase||0
10046711|NCT02006121|11171898|FG000|NOT COMPLETED|Open Label Phase||25
10046712|NCT02006121|11171899|FG001|NOT COMPLETED|Open Label Phase||0
10046713|NCT02006160|11171911|FG000|STARTED|Overall Study||45
10046714|NCT02006160|11171912|FG001|STARTED|Overall Study||16
10046715|NCT02006160|11171911|FG000|COMPLETED|Overall Study||41
10046716|NCT02006160|11171912|FG001|COMPLETED|Overall Study||16
10046717|NCT02006160|11171911|FG000|NOT COMPLETED|Overall Study||4
10046718|NCT02006160|11171912|FG001|NOT COMPLETED|Overall Study||0
10046719|NCT02006264|11171920|FG000|STARTED|Overall Study||15
10046720|NCT02006264|11171921|FG001|STARTED|Overall Study||15
10046721|NCT02006264|11171920|FG000|COMPLETED|Overall Study||14
10046722|NCT02006264|11171921|FG001|COMPLETED|Overall Study||15
10046723|NCT02006264|11171920|FG000|NOT COMPLETED|Overall Study||1
10046724|NCT02006264|11171921|FG001|NOT COMPLETED|Overall Study||0
10046725|NCT02006342|11171929|FG000|STARTED|Overall Study||20
10046726|NCT02006342|11171930|FG001|STARTED|Overall Study||20
10046727|NCT02006342|11171929|FG000|COMPLETED|Overall Study||19
10046728|NCT02006342|11171930|FG001|COMPLETED|Overall Study||20
10046729|NCT02006342|11171929|FG000|NOT COMPLETED|Overall Study||1
10046730|NCT02006342|11171930|FG001|NOT COMPLETED|Overall Study||0
10046731|NCT02006420|11171938|FG000|STARTED|Overall Study||24
10046732|NCT02006420|11171939|FG001|STARTED|Overall Study||21
10046733|NCT02006420|11171938|FG000|COMPLETED|Overall Study||24
10046734|NCT02006420|11171939|FG001|COMPLETED|Overall Study||21
10046735|NCT02006420|11171938|FG000|NOT COMPLETED|Overall Study||0
10046736|NCT02006420|11171939|FG001|NOT COMPLETED|Overall Study||0
10046737|NCT02006472|11171956|FG000|STARTED|Period 1 (Through Week 26)||82
10046738|NCT02006472|11171957|FG001|STARTED|Period 1 (Through Week 26)||81
10046739|NCT02006472|11171958|FG002|STARTED|Period 1 (Through Week 26)||82
10046740|NCT02006472|11171959|FG003|STARTED|Period 1 (Through Week 26)||81
10046741|NCT02006472|11171960|FG004|STARTED|Period 1 (Through Week 26)||82
10046742|NCT02006472|11171956|FG000|ITT|Period 1 (Through Week 26)||82
10046743|NCT02006472|11171957|FG001|ITT|Period 1 (Through Week 26)||81
10046744|NCT02006472|11171958|FG002|ITT|Period 1 (Through Week 26)||82
10046745|NCT02006472|11171959|FG003|ITT|Period 1 (Through Week 26)||81
10046746|NCT02006472|11171960|FG004|ITT|Period 1 (Through Week 26)||82
10046747|NCT02006472|11171956|FG000|FAS|Period 1 (Through Week 26)||81
10046748|NCT02006472|11171957|FG001|FAS|Period 1 (Through Week 26)||75
10046749|NCT02006472|11171958|FG002|FAS|Period 1 (Through Week 26)||79
10046750|NCT02006472|11171959|FG003|FAS|Period 1 (Through Week 26)||81
10046751|NCT02006472|11171960|FG004|FAS|Period 1 (Through Week 26)||81
10046752|NCT02006472|11171956|FG000|Safety Set|Period 1 (Through Week 26)||82
10046753|NCT02006472|11171957|FG001|Safety Set|Period 1 (Through Week 26)||81
10046754|NCT02006472|11171958|FG002|Safety Set|Period 1 (Through Week 26)||82
10046755|NCT02006472|11171959|FG003|Safety Set|Period 1 (Through Week 26)||81
10046756|NCT02006472|11171960|FG004|Safety Set|Period 1 (Through Week 26)||82
10046757|NCT02006472|11171956|FG000|COMPLETED|Period 1 (Through Week 26)||70
10046758|NCT02006472|11171957|FG001|COMPLETED|Period 1 (Through Week 26)||59
10046759|NCT02006472|11171958|FG002|COMPLETED|Period 1 (Through Week 26)||65
10046760|NCT02006472|11171959|FG003|COMPLETED|Period 1 (Through Week 26)||67
10046761|NCT02006472|11171960|FG004|COMPLETED|Period 1 (Through Week 26)||62
10046762|NCT02006472|11171956|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12
10046763|NCT02006472|11171957|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22
10046764|NCT02006472|11171958|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17
10046765|NCT02006472|11171959|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14
10046766|NCT02006472|11171960|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20
10046767|NCT02006472|11171956|FG000|STARTED|Period 2 (Through Week 52)||57
10046768|NCT02006472|11171957|FG001|STARTED|Period 2 (Through Week 52)||49
10046769|NCT02006472|11171958|FG002|STARTED|Period 2 (Through Week 52)||54
10046770|NCT02006472|11171959|FG003|STARTED|Period 2 (Through Week 52)||56
10046771|NCT02006472|11171960|FG004|STARTED|Period 2 (Through Week 52)||46
10046772|NCT02006472|11171956|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57
10046773|NCT02006472|11171957|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49
10046774|NCT02006472|11171958|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52
10046775|NCT02006472|11171959|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56
10046776|NCT02006472|11171960|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46
10046777|NCT02006472|11171956|FG000|COMPLETED|Period 2 (Through Week 52)||52
10046778|NCT02006472|11171957|FG001|COMPLETED|Period 2 (Through Week 52)||43
10046779|NCT02006472|11171958|FG002|COMPLETED|Period 2 (Through Week 52)||44
10046780|NCT02006472|11171959|FG003|COMPLETED|Period 2 (Through Week 52)||53
10046781|NCT02006472|11171960|FG004|COMPLETED|Period 2 (Through Week 52)||44
10046782|NCT02006472|11171956|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5
10046783|NCT02006472|11171957|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6
10046784|NCT02006472|11171958|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10
10046785|NCT02006472|11171959|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3
10046786|NCT02006472|11171960|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2
10046787|NCT02006576|11171980|FG000|STARTED|Overall Study||35
10046788|NCT02006576|11171981|FG001|STARTED|Overall Study||51
10046789|NCT02006576|11171982|FG002|STARTED|Overall Study||32
10046790|NCT02006576|11171980|FG000|COMPLETED|Overall Study||17
10046791|NCT02006576|11171981|FG001|COMPLETED|Overall Study||44
10046792|NCT02006576|11171982|FG002|COMPLETED|Overall Study||15
10046793|NCT02006576|11171980|FG000|NOT COMPLETED|Overall Study||18
10046794|NCT02006576|11171981|FG001|NOT COMPLETED|Overall Study||7
10046795|NCT02006576|11171982|FG002|NOT COMPLETED|Overall Study||17
10046796|NCT02006628|11171992|FG000|STARTED|Overall Study||43
10046797|NCT02006628|11171993|FG001|STARTED|Overall Study||45
10046798|NCT02006628|11171992|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43
10046799|NCT02006628|11171993|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
10046800|NCT02006628|11171992|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42
10046801|NCT02006628|11171993|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44
10046802|NCT02006628|11171992|FG000|COMPLETED|Overall Study||40
10046803|NCT02006628|11171993|FG001|COMPLETED|Overall Study||43
10046804|NCT02006628|11171992|FG000|NOT COMPLETED|Overall Study||3
10046805|NCT02006628|11171993|FG001|NOT COMPLETED|Overall Study||2
10046806|NCT02006641|11172002|FG000|STARTED|Overall Study||284
10046807|NCT02006641|11172003|FG001|STARTED|Overall Study||290
10046808|NCT02006641|11172004|FG002|STARTED|Overall Study||284
10046809|NCT02006641|11172002|FG000|Treated|Overall Study||282
10046810|NCT02006641|11172003|FG001|Treated|Overall Study||285
10046811|NCT02006641|11172004|FG002|Treated|Overall Study||281
10046812|NCT02006641|11172002|FG000|COMPLETED|Overall Study||258
10046813|NCT02006641|11172003|FG001|COMPLETED|Overall Study||257
10046814|NCT02006641|11172004|FG002|COMPLETED|Overall Study||248
10046815|NCT02006641|11172002|FG000|NOT COMPLETED|Overall Study||26
10046816|NCT02006641|11172003|FG001|NOT COMPLETED|Overall Study||33
10046817|NCT02006641|11172004|FG002|NOT COMPLETED|Overall Study||36
10046818|NCT02006654|11172014|FG000|STARTED|Overall Study||369
10046819|NCT02006654|11172015|FG001|STARTED|Overall Study||365
10046820|NCT02006654|11172014|FG000|Treated|Overall Study||365
10046821|NCT02006654|11172015|FG001|Treated|Overall Study||363
10046822|NCT02006654|11172014|FG000|COMPLETED|Overall Study||324
10046823|NCT02006654|11172015|FG001|COMPLETED|Overall Study||321
10046824|NCT02006654|11172014|FG000|NOT COMPLETED|Overall Study||45
10046825|NCT02006654|11172015|FG001|NOT COMPLETED|Overall Study||44
10046826|NCT02006667|11172022|FG000|STARTED|Overall Study||13
10046827|NCT02006667|11172022|FG000|COMPLETED|Overall Study||7
10046828|NCT02006667|11172022|FG000|NOT COMPLETED|Overall Study||6
10046829|NCT02006693|11172028|FG000|STARTED|Overall Study||112
10046830|NCT02006693|11172029|FG001|STARTED|Overall Study||87
10046831|NCT02006693|11172028|FG000|COMPLETED|Overall Study||84
10046832|NCT02006693|11172029|FG001|COMPLETED|Overall Study||74
10046833|NCT02006693|11172028|FG000|NOT COMPLETED|Overall Study||28
10046834|NCT02006693|11172029|FG001|NOT COMPLETED|Overall Study||13
10046835|NCT02006706|11172035|FG000|STARTED|Overall Study||15
10046836|NCT02006706|11172035|FG000|COMPLETED|Overall Study||14
10046837|NCT02006706|11172035|FG000|NOT COMPLETED|Overall Study||1
10046838|NCT02006719|11172041|FG000|STARTED|Overall Study||237
10046839|NCT02006719|11172042|FG001|STARTED|Overall Study||85
10046840|NCT02006719|11172041|FG000|COMPLETED|Overall Study||219
10046841|NCT02006719|11172042|FG001|COMPLETED|Overall Study||80
10046842|NCT02006719|11172041|FG000|NOT COMPLETED|Overall Study||18
10046843|NCT02006719|11172042|FG001|NOT COMPLETED|Overall Study||5
10046844|NCT02006732|11172052|FG000|STARTED|Overall Study||202
10046845|NCT02006732|11172053|FG001|STARTED|Overall Study||203
10046846|NCT02006732|11172054|FG002|STARTED|Overall Study||202
10046847|NCT02006732|11172055|FG003|STARTED|Overall Study||202
10046848|NCT02006732|11172052|FG000|COMPLETED|Overall Study||182
10046849|NCT02006732|11172053|FG001|COMPLETED|Overall Study||191
10046850|NCT02006732|11172054|FG002|COMPLETED|Overall Study||193
10046851|NCT02006732|11172055|FG003|COMPLETED|Overall Study||198
10046852|NCT02006732|11172052|FG000|NOT COMPLETED|Overall Study||20
10046853|NCT02006732|11172053|FG001|NOT COMPLETED|Overall Study||12
10046854|NCT02006732|11172054|FG002|NOT COMPLETED|Overall Study||9
10046855|NCT02006732|11172055|FG003|NOT COMPLETED|Overall Study||4
10046856|NCT02006758|11172065|FG000|STARTED|Overall Study|Total number of enrolled participants|68
10046857|NCT02006758|11172065|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
10046858|NCT02006758|11172065|FG000|1-month Follow up|Overall Study|1-month follow up completed|66
10046859|NCT02006758|11172065|FG000|6-month Follow up|Overall Study|6-month follow up completed|60
10046860|NCT02006758|11172065|FG000|12-month Follow up|Overall Study|12-month follow up completed|55
10046861|NCT02006758|11172065|FG000|COMPLETED|Overall Study||55
10117756|NCT02542072|11248586|FG001|COMPLETED|Second Intervention (1 Month)||43
10117757|NCT02542072|11248585|FG000|NOT COMPLETED|Second Intervention (1 Month)||2
10117758|NCT02542072|11248586|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
10117759|NCT02542150|11248614|FG000|STARTED|Overall Study||12
10117760|NCT02542150|11248615|FG001|STARTED|Overall Study||12
10117761|NCT02542150|11248614|FG000|Completed Placebo|Overall Study||12
10117762|NCT02542150|11248615|FG001|Completed Placebo|Overall Study||12
10117763|NCT02542150|11248614|FG000|Started Intervention|Overall Study||12
10117764|NCT02542150|11248615|FG001|Started Intervention|Overall Study||12
10117765|NCT02542150|11248614|FG000|COMPLETED|Overall Study||12
10117766|NCT02542150|11248615|FG001|COMPLETED|Overall Study||12
10117767|NCT02542150|11248614|FG000|NOT COMPLETED|Overall Study||0
10117768|NCT02542150|11248615|FG001|NOT COMPLETED|Overall Study||0
10117769|NCT02542280|11248627|FG000|STARTED|Overall Study||174
10117770|NCT02542280|11248628|FG001|STARTED|Overall Study||175
10117771|NCT02542280|11248627|FG000|COMPLETED|Overall Study||162
10117772|NCT02542280|11248628|FG001|COMPLETED|Overall Study||167
10117773|NCT02542280|11248627|FG000|NOT COMPLETED|Overall Study||12
10117774|NCT02542280|11248628|FG001|NOT COMPLETED|Overall Study||8
10117775|NCT02542410|11248636|FG000|STARTED|Overall Study||5
10117776|NCT02542410|11248637|FG001|STARTED|Overall Study||5
10117777|NCT02542410|11248636|FG000|COMPLETED|Overall Study||3
10117778|NCT02542410|11248637|FG001|COMPLETED|Overall Study||4
10046862|NCT02006758|11172065|FG000|NOT COMPLETED|Overall Study||13
10046863|NCT02006836|11172073|FG000|STARTED|Case-control Period: Month 1- Month 6||20
10046864|NCT02006836|11172074|FG001|STARTED|Case-control Period: Month 1- Month 6||20
10046865|NCT02006836|11172075|FG002|STARTED|Case-control Period: Month 1- Month 6||0
10046866|NCT02006836|11172073|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20
10046867|NCT02006836|11172074|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20
10046868|NCT02006836|11172075|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0
10046869|NCT02006836|11172073|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
10046870|NCT02006836|11172074|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
10046871|NCT02006836|11172075|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
10046872|NCT02006836|11172073|FG000|STARTED|Self-control Period: Month 7-month 12||0
10046873|NCT02006836|11172074|FG001|STARTED|Self-control Period: Month 7-month 12||0
10046874|NCT02006836|11172075|FG002|STARTED|Self-control Period: Month 7-month 12||19
10046875|NCT02006836|11172073|FG000|COMPLETED|Self-control Period: Month 7-month 12||0
10046876|NCT02006836|11172074|FG001|COMPLETED|Self-control Period: Month 7-month 12||0
10046877|NCT02006836|11172075|FG002|COMPLETED|Self-control Period: Month 7-month 12||19
10046878|NCT02006836|11172073|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0
10046879|NCT02006836|11172074|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0
10046880|NCT02006836|11172075|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0
10046881|NCT02006888|11172088|FG000|STARTED|Overall Study||158
10046882|NCT02006888|11172089|FG001|STARTED|Overall Study||156
10046883|NCT02006888|11172090|FG002|STARTED|Overall Study||80
10046884|NCT02006888|11172088|FG000|COMPLETED|Overall Study||122
10046885|NCT02006888|11172089|FG001|COMPLETED|Overall Study||122
10046886|NCT02006888|11172090|FG002|COMPLETED|Overall Study||58
10046887|NCT02006888|11172088|FG000|NOT COMPLETED|Overall Study||36
10046888|NCT02006888|11172089|FG001|NOT COMPLETED|Overall Study||34
10046889|NCT02006888|11172090|FG002|NOT COMPLETED|Overall Study||22
10046890|NCT02006979|11172100|FG000|STARTED|Overall Study||14
10046891|NCT02006979|11172101|FG001|STARTED|Overall Study||13
10046892|NCT02006979|11172100|FG000|COMPLETED|Overall Study||13
10046893|NCT02006979|11172101|FG001|COMPLETED|Overall Study||11
10046894|NCT02006979|11172100|FG000|NOT COMPLETED|Overall Study||1
10046895|NCT02006979|11172101|FG001|NOT COMPLETED|Overall Study||2
10046896|NCT02007070|11172107|FG000|STARTED|Overall Study||38
10046897|NCT02007070|11172107|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5
10046898|NCT02007070|11172107|FG000|NOT COMPLETED|Overall Study||33
10046899|NCT02007096|11172113|FG000|STARTED|Overall Study||63
10046900|NCT02007096|11172114|FG001|STARTED|Overall Study||64
10046901|NCT02007096|11172113|FG000|COMPLETED|Overall Study||52
10046902|NCT02007096|11172114|FG001|COMPLETED|Overall Study||48
10046903|NCT02007096|11172113|FG000|NOT COMPLETED|Overall Study||11
10046904|NCT02007096|11172114|FG001|NOT COMPLETED|Overall Study||16
10046905|NCT02007109|11172120|FG000|STARTED|Overall Study||193
10046906|NCT02007109|11172120|FG000|PACU Analysis|Overall Study||184
10046907|NCT02007109|11172120|FG000|COMPLETED|Overall Study||82
10117779|NCT02542410|11248636|FG000|NOT COMPLETED|Overall Study||2
10117780|NCT02542410|11248637|FG001|NOT COMPLETED|Overall Study||1
10117781|NCT02542462|11248647|FG000|STARTED|Overall Study||25
10046908|NCT02007109|11172120|FG000|NOT COMPLETED|Overall Study||111
10046909|NCT02007200|11172127|FG000|STARTED|Overall Study||55
10046910|NCT02007200|11172127|FG000|COMPLETED|Overall Study||55
10046911|NCT02007200|11172127|FG000|NOT COMPLETED|Overall Study||0
10046912|NCT02007252|11172133|FG000|STARTED|Overall Study||31
10046913|NCT02007252|11172134|FG001|STARTED|Overall Study||33
10046914|NCT02007252|11172133|FG000|Safety Analysis Set|Overall Study||31
10046915|NCT02007252|11172134|FG001|Safety Analysis Set|Overall Study||33
10046916|NCT02007252|11172133|FG000|Pharmacodynamic Analysis Set|Overall Study||31
10046917|NCT02007252|11172134|FG001|Pharmacodynamic Analysis Set|Overall Study||33
10046918|NCT02007252|11172133|FG000|COMPLETED|Overall Study||20
10046919|NCT02007252|11172134|FG001|COMPLETED|Overall Study||22
10046920|NCT02007252|11172133|FG000|NOT COMPLETED|Overall Study||11
10046921|NCT02007252|11172134|FG001|NOT COMPLETED|Overall Study||11
10046922|NCT02007278|11172142|FG000|STARTED|Overall Study||20
10046923|NCT02007278|11172143|FG001|STARTED|Overall Study||20
10046924|NCT02007278|11172142|FG000|COMPLETED|Overall Study||18
10046925|NCT02007278|11172143|FG001|COMPLETED|Overall Study||17
10046926|NCT02007278|11172142|FG000|NOT COMPLETED|Overall Study||2
10046927|NCT02007278|11172143|FG001|NOT COMPLETED|Overall Study||3
10046928|NCT02007291|11172149|FG000|STARTED|Overall Study||48
10046929|NCT02007291|11172150|FG001|STARTED|Overall Study||23
10046930|NCT02007291|11172149|FG000|COMPLETED|Overall Study||48
10046931|NCT02007291|11172150|FG001|COMPLETED|Overall Study||23
10046932|NCT02007291|11172149|FG000|NOT COMPLETED|Overall Study||0
10046933|NCT02007291|11172150|FG001|NOT COMPLETED|Overall Study||0
10046934|NCT02007369|11172159|FG000|STARTED|Overall Study||42
10046935|NCT02007369|11172160|FG001|STARTED|Overall Study||40
10046936|NCT02007369|11172161|FG002|STARTED|Overall Study||54
10046937|NCT02007369|11172159|FG000|COMPLETED|Overall Study||42
10046938|NCT02007369|11172160|FG001|COMPLETED|Overall Study||40
10046939|NCT02007369|11172161|FG002|COMPLETED|Overall Study||54
10046940|NCT02007369|11172159|FG000|NOT COMPLETED|Overall Study||0
10046941|NCT02007369|11172160|FG001|NOT COMPLETED|Overall Study||0
10046942|NCT02007369|11172161|FG002|NOT COMPLETED|Overall Study||0
10046943|NCT02007434|11172177|FG000|STARTED|Overall Study||17
10046944|NCT02007434|11172178|FG001|STARTED|Overall Study||4
10046945|NCT02007434|11172179|FG002|STARTED|Overall Study||17
10046946|NCT02007434|11172180|FG003|STARTED|Overall Study||4
10046947|NCT02007434|11172181|FG004|STARTED|Overall Study||16
10046948|NCT02007434|11172182|FG005|STARTED|Overall Study||4
10046949|NCT02007434|11172183|FG006|STARTED|Overall Study||18
10046950|NCT02007434|11172184|FG007|STARTED|Overall Study||4
10046951|NCT02007434|11172177|FG000|Received Treatment|Overall Study||17
10046952|NCT02007434|11172178|FG001|Received Treatment|Overall Study||3
10046953|NCT02007434|11172179|FG002|Received Treatment|Overall Study||17
10046954|NCT02007434|11172180|FG003|Received Treatment|Overall Study||4
10046955|NCT02007434|11172181|FG004|Received Treatment|Overall Study||16
10046956|NCT02007434|11172182|FG005|Received Treatment|Overall Study||4
10046957|NCT02007434|11172183|FG006|Received Treatment|Overall Study||18
10046958|NCT02007434|11172184|FG007|Received Treatment|Overall Study||4
10046959|NCT02007434|11172177|FG000|COMPLETED|Overall Study||16
10046960|NCT02007434|11172178|FG001|COMPLETED|Overall Study||3
10046961|NCT02007434|11172179|FG002|COMPLETED|Overall Study||16
10046962|NCT02007434|11172180|FG003|COMPLETED|Overall Study||4
10046963|NCT02007434|11172181|FG004|COMPLETED|Overall Study||16
10046964|NCT02007434|11172182|FG005|COMPLETED|Overall Study||4
10046965|NCT02007434|11172183|FG006|COMPLETED|Overall Study||18
10046966|NCT02007434|11172184|FG007|COMPLETED|Overall Study||4
10046967|NCT02007434|11172177|FG000|NOT COMPLETED|Overall Study||1
10046968|NCT02007434|11172178|FG001|NOT COMPLETED|Overall Study||1
10046969|NCT02007434|11172179|FG002|NOT COMPLETED|Overall Study||1
10046970|NCT02007434|11172180|FG003|NOT COMPLETED|Overall Study||0
10046971|NCT02007434|11172181|FG004|NOT COMPLETED|Overall Study||0
10046972|NCT02007434|11172182|FG005|NOT COMPLETED|Overall Study||0
10046973|NCT02007434|11172183|FG006|NOT COMPLETED|Overall Study||0
10046974|NCT02007434|11172184|FG007|NOT COMPLETED|Overall Study||0
10046975|NCT02007577|11172205|FG000|STARTED|Overall Study||27
10046976|NCT02007577|11172206|FG001|STARTED|Overall Study||14
10046977|NCT02007577|11172205|FG000|COMPLETED|Overall Study||26
10046978|NCT02007577|11172206|FG001|COMPLETED|Overall Study||13
10046979|NCT02007577|11172205|FG000|NOT COMPLETED|Overall Study||1
10046980|NCT02007577|11172206|FG001|NOT COMPLETED|Overall Study||1
10046981|NCT02007720|11172214|FG000|STARTED|Overall Study||436
10046982|NCT02007720|11172215|FG001|STARTED|Overall Study||440
10046983|NCT02007720|11172214|FG000|Full Analysis Set|Overall Study||433
10046984|NCT02007720|11172215|FG001|Full Analysis Set|Overall Study||437
10046985|NCT02007720|11172214|FG000|Safety Set|Overall Study||426
10046986|NCT02007720|11172215|FG001|Safety Set|Overall Study||432
10046987|NCT02007720|11172214|FG000|COMPLETED|Overall Study||354
10046988|NCT02007720|11172215|FG001|COMPLETED|Overall Study||368
10046989|NCT02007720|11172214|FG000|NOT COMPLETED|Overall Study||82
10046990|NCT02007720|11172215|FG001|NOT COMPLETED|Overall Study||72
10046991|NCT02007863|11172222|FG000|STARTED|Overall Study||2
10046992|NCT02007863|11172222|FG000|COMPLETED|Overall Study||2
10046993|NCT02007863|11172222|FG000|NOT COMPLETED|Overall Study||0
10046994|NCT02007954|11172226|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
10046995|NCT02007954|11172226|FG000|Completed First TACE|Overall Study||24
10046996|NCT02007954|11172226|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
10046997|NCT02007954|11172226|FG000|COMPLETED|Overall Study||17
10046998|NCT02007954|11172226|FG000|NOT COMPLETED|Overall Study||7
10046999|NCT02008149|11172233|FG000|STARTED|Overall Study||7
10047000|NCT02008149|11172234|FG001|STARTED|Overall Study||1
10047001|NCT02008149|11172235|FG002|STARTED|Overall Study||1
10047002|NCT02008149|11172233|FG000|COMPLETED|Overall Study||4
10047003|NCT02008149|11172234|FG001|COMPLETED|Overall Study||0
10047004|NCT02008149|11172235|FG002|COMPLETED|Overall Study||1
10047005|NCT02008149|11172233|FG000|NOT COMPLETED|Overall Study||3
10047006|NCT02008149|11172234|FG001|NOT COMPLETED|Overall Study||1
10047007|NCT02008149|11172235|FG002|NOT COMPLETED|Overall Study||0
10047008|NCT02008227|11172245|FG000|STARTED|Overall Study||612
10047009|NCT02008227|11172246|FG001|STARTED|Overall Study||613
10047010|NCT02008227|11172245|FG000|Treated|Overall Study||579
10047011|NCT02008227|11172246|FG001|Treated|Overall Study||608
10047012|NCT02008227|11172245|FG000|COMPLETED|Overall Study||0
10047013|NCT02008227|11172246|FG001|COMPLETED|Overall Study||0
10047014|NCT02008227|11172245|FG000|NOT COMPLETED|Overall Study||612
10047015|NCT02008227|11172246|FG001|NOT COMPLETED|Overall Study||613
10047016|NCT02008318|11172255|FG000|STARTED|Overall Study||41
10047017|NCT02008318|11172256|FG001|STARTED|Overall Study||2
10047018|NCT02008318|11172255|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
10047019|NCT02008318|11172256|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
10047020|NCT02008318|11172255|FG000|COMPLETED|Overall Study||29
10047021|NCT02008318|11172256|FG001|COMPLETED|Overall Study||1
10047022|NCT02008318|11172255|FG000|NOT COMPLETED|Overall Study||12
10047023|NCT02008318|11172256|FG001|NOT COMPLETED|Overall Study||1
10047024|NCT02008526|11172268|FG000|STARTED|Overall Study||94
10047025|NCT02008526|11172269|FG001|STARTED|Overall Study||99
10047026|NCT02008526|11172270|FG002|STARTED|Overall Study||93
10047027|NCT02008526|11172268|FG000|COMPLETED|Overall Study||86
10047028|NCT02008526|11172269|FG001|COMPLETED|Overall Study||85
10047029|NCT02008526|11172270|FG002|COMPLETED|Overall Study||84
10047030|NCT02008526|11172268|FG000|NOT COMPLETED|Overall Study||8
10047031|NCT02008526|11172269|FG001|NOT COMPLETED|Overall Study||14
10047032|NCT02008526|11172270|FG002|NOT COMPLETED|Overall Study||9
10047033|NCT02008565|11172282|FG000|STARTED|Overall Study||86
10047034|NCT02008565|11172283|FG001|STARTED|Overall Study||84
10047035|NCT02008565|11172284|FG002|STARTED|Overall Study||88
10047036|NCT02008565|11172285|FG003|STARTED|Overall Study||42
10047037|NCT02008565|11172282|FG000|COMPLETED|Overall Study||85
10047038|NCT02008565|11172283|FG001|COMPLETED|Overall Study||83
10047039|NCT02008565|11172284|FG002|COMPLETED|Overall Study||86
10047040|NCT02008565|11172285|FG003|COMPLETED|Overall Study||42
10047041|NCT02008565|11172282|FG000|NOT COMPLETED|Overall Study||1
10117782|NCT02542462|11248648|FG001|STARTED|Overall Study||25
10117783|NCT02542462|11248649|FG002|STARTED|Overall Study||25
10117784|NCT02542462|11248650|FG003|STARTED|Overall Study||26
10117785|NCT02542462|11248647|FG000|COMPLETED|Overall Study||25
10117786|NCT02542462|11248648|FG001|COMPLETED|Overall Study||25
10117787|NCT02542462|11248649|FG002|COMPLETED|Overall Study||25
10117788|NCT02542462|11248650|FG003|COMPLETED|Overall Study||25
10117789|NCT02542462|11248647|FG000|NOT COMPLETED|Overall Study||0
10117790|NCT02542462|11248648|FG001|NOT COMPLETED|Overall Study||0
10117791|NCT02542462|11248649|FG002|NOT COMPLETED|Overall Study||0
10117792|NCT02542462|11248650|FG003|NOT COMPLETED|Overall Study||1
10117793|NCT02542605|11248661|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12
10117794|NCT02542605|11248662|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0
10117795|NCT02542605|11248663|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0
10117796|NCT02542605|11248661|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
10117797|NCT02542605|11248662|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
10117798|NCT02542605|11248663|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
10117799|NCT02542605|11248661|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
10117800|NCT02542605|11248662|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
10117801|NCT02542605|11248663|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
10117802|NCT02542605|11248661|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
10047042|NCT02008565|11172283|FG001|NOT COMPLETED|Overall Study||1
10047043|NCT02008565|11172284|FG002|NOT COMPLETED|Overall Study||2
10047044|NCT02008565|11172285|FG003|NOT COMPLETED|Overall Study||0
10047045|NCT02008617|11172299|FG000|STARTED|Overall Study||8
10047046|NCT02008617|11172300|FG001|STARTED|Overall Study||10
10047047|NCT02008617|11172299|FG000|COMPLETED|Overall Study||8
10047048|NCT02008617|11172300|FG001|COMPLETED|Overall Study||10
10047049|NCT02008617|11172299|FG000|NOT COMPLETED|Overall Study||0
10047050|NCT02008617|11172300|FG001|NOT COMPLETED|Overall Study||0
10047051|NCT02008682|11172308|FG000|STARTED|Overall Study||184
10047052|NCT02008682|11172309|FG001|STARTED|Overall Study||184
10047053|NCT02008682|11172308|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
10047054|NCT02008682|11172309|FG001|Exposed|Overall Study||184
10047055|NCT02008682|11172308|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
10047056|NCT02008682|11172309|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
10047057|NCT02008682|11172308|FG000|NOT COMPLETED|Overall Study||27
10047058|NCT02008682|11172309|FG001|NOT COMPLETED|Overall Study||14
10047059|NCT02008773|11172319|FG000|STARTED|Overall Study||40
10047060|NCT02008773|11172320|FG001|STARTED|Overall Study||34
10047061|NCT02008773|11172321|FG002|STARTED|Overall Study||46
10047062|NCT02008773|11172322|FG003|STARTED|Overall Study||50
10117803|NCT02542605|11248662|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10047063|NCT02008773|11172319|FG000|COMPLETED|Overall Study||27
10047064|NCT02008773|11172320|FG001|COMPLETED|Overall Study||25
10047065|NCT02008773|11172321|FG002|COMPLETED|Overall Study||32
10047066|NCT02008773|11172322|FG003|COMPLETED|Overall Study||38
10047067|NCT02008773|11172319|FG000|NOT COMPLETED|Overall Study||13
10047068|NCT02008773|11172320|FG001|NOT COMPLETED|Overall Study||9
10047069|NCT02008773|11172321|FG002|NOT COMPLETED|Overall Study||14
10047070|NCT02008773|11172322|FG003|NOT COMPLETED|Overall Study||12
10047071|NCT02008877|11172330|FG000|STARTED|Overall Study||3
10047072|NCT02008877|11172331|FG001|STARTED|Overall Study||7
10047073|NCT02008877|11172332|FG002|STARTED|Overall Study||10
10047074|NCT02008877|11172330|FG000|COMPLETED|Overall Study||3
10047075|NCT02008877|11172331|FG001|COMPLETED|Overall Study||6
10047076|NCT02008877|11172332|FG002|COMPLETED|Overall Study||10
10047077|NCT02008877|11172330|FG000|NOT COMPLETED|Overall Study||0
10047078|NCT02008877|11172331|FG001|NOT COMPLETED|Overall Study||1
10047079|NCT02008877|11172332|FG002|NOT COMPLETED|Overall Study||0
10047080|NCT02008890|11172344|FG000|STARTED|Period 1||80
10047081|NCT02008890|11172345|FG001|STARTED|Period 1||79
10047082|NCT02008890|11172346|FG002|STARTED|Period 1||78
10047083|NCT02008890|11172347|FG003|STARTED|Period 1||0
10047084|NCT02008890|11172348|FG004|STARTED|Period 1||0
10047085|NCT02008890|11172344|FG000|COMPLETED|Period 1||65
10047086|NCT02008890|11172345|FG001|COMPLETED|Period 1||64
10047087|NCT02008890|11172346|FG002|COMPLETED|Period 1||66
10047088|NCT02008890|11172347|FG003|COMPLETED|Period 1||0
10047089|NCT02008890|11172348|FG004|COMPLETED|Period 1||0
10047090|NCT02008890|11172344|FG000|NOT COMPLETED|Period 1||15
10047091|NCT02008890|11172345|FG001|NOT COMPLETED|Period 1||15
10047092|NCT02008890|11172346|FG002|NOT COMPLETED|Period 1||12
10047093|NCT02008890|11172347|FG003|NOT COMPLETED|Period 1||0
10047094|NCT02008890|11172348|FG004|NOT COMPLETED|Period 1||0
10047095|NCT02008890|11172344|FG000|STARTED|Period 2||65
10047096|NCT02008890|11172345|FG001|STARTED|Period 2||64
10047097|NCT02008890|11172346|FG002|STARTED|Period 2||10
10047098|NCT02008890|11172347|FG003|STARTED|Period 2||27
10047099|NCT02008890|11172348|FG004|STARTED|Period 2||28
10047100|NCT02008890|11172344|FG000|COMPLETED|Period 2||38
10047101|NCT02008890|11172345|FG001|COMPLETED|Period 2||49
10047102|NCT02008890|11172346|FG002|COMPLETED|Period 2||9
10047103|NCT02008890|11172347|FG003|COMPLETED|Period 2||13
10047104|NCT02008890|11172348|FG004|COMPLETED|Period 2||20
10047105|NCT02008890|11172344|FG000|NOT COMPLETED|Period 2||27
10047106|NCT02008890|11172345|FG001|NOT COMPLETED|Period 2||15
10047107|NCT02008890|11172346|FG002|NOT COMPLETED|Period 2||1
10047108|NCT02008890|11172347|FG003|NOT COMPLETED|Period 2||14
10047109|NCT02008890|11172348|FG004|NOT COMPLETED|Period 2||8
10047110|NCT02008890|11172344|FG000|STARTED|Extension Period||31
10047111|NCT02008890|11172345|FG001|STARTED|Extension Period||36
10047112|NCT02008890|11172346|FG002|STARTED|Extension Period||0
10047113|NCT02008890|11172347|FG003|STARTED|Extension Period||10
10117804|NCT02542605|11248663|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10117805|NCT02542605|11248661|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10117806|NCT02542605|11248662|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10117807|NCT02542605|11248663|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10117808|NCT02542605|11248661|FG000|STARTED|Part B: Challenge Phase||23
10117809|NCT02542605|11248662|FG001|STARTED|Part B: Challenge Phase||0
10117810|NCT02542605|11248663|FG002|STARTED|Part B: Challenge Phase||0
9706594|NCT02111850|10805642|FG000|COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706595|NCT02111850|10805643|FG001|COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706596|NCT02111850|10805644|FG002|COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706597|NCT02111850|10805645|FG003|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10117811|NCT02542605|11248661|FG000|Received PACAP-38|Part B: Challenge Phase||23
10117812|NCT02542605|11248662|FG001|Received PACAP-38|Part B: Challenge Phase||0
10117813|NCT02542605|11248663|FG002|Received PACAP-38|Part B: Challenge Phase||0
10117814|NCT02542605|11248661|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15
10117815|NCT02542605|11248662|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0
10117816|NCT02542605|11248663|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0
10117817|NCT02542605|11248661|FG000|COMPLETED|Part B: Challenge Phase||22
10117818|NCT02542605|11248662|FG001|COMPLETED|Part B: Challenge Phase||0
10117819|NCT02542605|11248663|FG002|COMPLETED|Part B: Challenge Phase||0
10117820|NCT02542605|11248661|FG000|NOT COMPLETED|Part B: Challenge Phase||1
10117821|NCT02542605|11248662|FG001|NOT COMPLETED|Part B: Challenge Phase||0
10117822|NCT02542605|11248663|FG002|NOT COMPLETED|Part B: Challenge Phase||0
10117823|NCT02542605|11248661|FG000|STARTED|Part B: Randomization Phase||0
10117824|NCT02542605|11248662|FG001|STARTED|Part B: Randomization Phase||9
9706598|NCT02111850|10805646|FG004|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10047114|NCT02008890|11172348|FG004|STARTED|Extension Period||17
10047115|NCT02008890|11172344|FG000|COMPLETED|Extension Period||26
10047116|NCT02008890|11172345|FG001|COMPLETED|Extension Period||31
10047117|NCT02008890|11172346|FG002|COMPLETED|Extension Period||0
10047118|NCT02008890|11172347|FG003|COMPLETED|Extension Period||6
10047119|NCT02008890|11172348|FG004|COMPLETED|Extension Period||13
10047120|NCT02008890|11172344|FG000|NOT COMPLETED|Extension Period||5
10047121|NCT02008890|11172345|FG001|NOT COMPLETED|Extension Period||5
10047122|NCT02008890|11172346|FG002|NOT COMPLETED|Extension Period||0
10047123|NCT02008890|11172347|FG003|NOT COMPLETED|Extension Period||4
10047124|NCT02008890|11172348|FG004|NOT COMPLETED|Extension Period||4
10117825|NCT02542605|11248663|FG002|STARTED|Part B: Randomization Phase||8
10047125|NCT02008916|11172366|FG000|STARTED|Primary Assessment (up to Week 16)||74
10047126|NCT02008916|11172367|FG001|STARTED|Primary Assessment (up to Week 16)||76
10047127|NCT02008916|11172368|FG002|STARTED|Primary Assessment (up to Week 16)||76
10047128|NCT02008916|11172366|FG000|FAS|Primary Assessment (up to Week 16)||74
10047129|NCT02008916|11172367|FG001|FAS|Primary Assessment (up to Week 16)||76
10047130|NCT02008916|11172368|FG002|FAS|Primary Assessment (up to Week 16)||76
10047131|NCT02008916|11172366|FG000|Safety Set|Primary Assessment (up to Week 16)||74
10047132|NCT02008916|11172367|FG001|Safety Set|Primary Assessment (up to Week 16)||76
10047133|NCT02008916|11172368|FG002|Safety Set|Primary Assessment (up to Week 16)||75
10047134|NCT02008916|11172366|FG000|COMPLETED|Primary Assessment (up to Week 16)||74
10047135|NCT02008916|11172367|FG001|COMPLETED|Primary Assessment (up to Week 16)||75
10047136|NCT02008916|11172368|FG002|COMPLETED|Primary Assessment (up to Week 16)||73
10047137|NCT02008916|11172366|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0
10047138|NCT02008916|11172367|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1
10047139|NCT02008916|11172368|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3
10047140|NCT02008916|11172366|FG000|STARTED|Week 16 - 156||74
10047141|NCT02008916|11172367|FG001|STARTED|Week 16 - 156||75
10047142|NCT02008916|11172368|FG002|STARTED|Week 16 - 156||73
10047143|NCT02008916|11172366|FG000|COMPLETED|Week 16 - 156||55
10047144|NCT02008916|11172367|FG001|COMPLETED|Week 16 - 156||62
10047145|NCT02008916|11172368|FG002|COMPLETED|Week 16 - 156||63
10047146|NCT02008916|11172366|FG000|NOT COMPLETED|Week 16 - 156||19
10047147|NCT02008916|11172367|FG001|NOT COMPLETED|Week 16 - 156||13
10047148|NCT02008916|11172368|FG002|NOT COMPLETED|Week 16 - 156||10
10047149|NCT02008942|11172377|FG000|STARTED|First Intervention||27
10047150|NCT02008942|11172378|FG001|STARTED|First Intervention||30
10047151|NCT02008942|11172377|FG000|COMPLETED|First Intervention||27
10047152|NCT02008942|11172378|FG001|COMPLETED|First Intervention||30
10047153|NCT02008942|11172377|FG000|NOT COMPLETED|First Intervention||0
10047154|NCT02008942|11172378|FG001|NOT COMPLETED|First Intervention||0
10047155|NCT02008942|11172377|FG000|STARTED|Second Intervention||26
10047156|NCT02008942|11172378|FG001|STARTED|Second Intervention||30
10047157|NCT02008942|11172377|FG000|COMPLETED|Second Intervention||25
10047158|NCT02008942|11172378|FG001|COMPLETED|Second Intervention||30
10047159|NCT02008942|11172377|FG000|NOT COMPLETED|Second Intervention||1
10047160|NCT02008942|11172378|FG001|NOT COMPLETED|Second Intervention||0
10047161|NCT02009046|11172386|FG000|STARTED|Overall Study||1025
10047162|NCT02009046|11172387|FG001|STARTED|Overall Study||884
10047163|NCT02009046|11172386|FG000|SEI Curriculum Only|Overall Study||461
10047164|NCT02009046|11172387|FG001|SEI Curriculum Only|Overall Study||0
10047165|NCT02009046|11172386|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
10047166|NCT02009046|11172387|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
10047167|NCT02009046|11172386|FG000|Ctrl Curriculum Only|Overall Study||0
10047168|NCT02009046|11172387|FG001|Ctrl Curriculum Only|Overall Study||456
10047169|NCT02009046|11172386|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
10047170|NCT02009046|11172387|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
10047171|NCT02009046|11172386|FG000|COMPLETED|Overall Study||769
10047172|NCT02009046|11172387|FG001|COMPLETED|Overall Study||678
10047173|NCT02009046|11172386|FG000|NOT COMPLETED|Overall Study||256
10047174|NCT02009046|11172387|FG001|NOT COMPLETED|Overall Study||206
10117826|NCT02542605|11248661|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
10117827|NCT02542605|11248662|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
10117828|NCT02542605|11248663|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
10117829|NCT02542605|11248661|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0
10117830|NCT02542605|11248662|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7
10117831|NCT02542605|11248663|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8
10117832|NCT02542605|11248661|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0
10117833|NCT02542605|11248662|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9
10117834|NCT02542605|11248663|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7
10117835|NCT02542605|11248661|FG000|COMPLETED|Part B: Randomization Phase||0
10117836|NCT02542605|11248662|FG001|COMPLETED|Part B: Randomization Phase||9
10117837|NCT02542605|11248663|FG002|COMPLETED|Part B: Randomization Phase||7
10117838|NCT02542605|11248661|FG000|NOT COMPLETED|Part B: Randomization Phase||0
10117839|NCT02542605|11248662|FG001|NOT COMPLETED|Part B: Randomization Phase||0
10117840|NCT02542605|11248663|FG002|NOT COMPLETED|Part B: Randomization Phase||1
10117841|NCT02542631|11248674|FG000|STARTED|Overall Study||139
10117842|NCT02542631|11248675|FG001|STARTED|Overall Study||139
10117843|NCT02542631|11248674|FG000|COMPLETED|Overall Study||108
10117844|NCT02542631|11248675|FG001|COMPLETED|Overall Study||108
10117845|NCT02542631|11248674|FG000|NOT COMPLETED|Overall Study||31
10117846|NCT02542631|11248675|FG001|NOT COMPLETED|Overall Study||31
10117847|NCT02542761|11248681|FG000|STARTED|Acclimation Period 1||5
10117848|NCT02542761|11248682|FG001|STARTED|Acclimation Period 1||5
10117849|NCT02542761|11248681|FG000|COMPLETED|Acclimation Period 1||5
10117850|NCT02542761|11248682|FG001|COMPLETED|Acclimation Period 1||5
10117851|NCT02542761|11248681|FG000|NOT COMPLETED|Acclimation Period 1||0
10117852|NCT02542761|11248682|FG001|NOT COMPLETED|Acclimation Period 1||0
10117853|NCT02542761|11248681|FG000|STARTED|First Intervention||5
10117854|NCT02542761|11248682|FG001|STARTED|First Intervention||5
10117855|NCT02542761|11248681|FG000|COMPLETED|First Intervention||5
10117856|NCT02542761|11248682|FG001|COMPLETED|First Intervention||5
10117857|NCT02542761|11248681|FG000|NOT COMPLETED|First Intervention||0
10047175|NCT02009163|11172401|FG000|STARTED|Open-label Period (Non-randomized)||418
10047176|NCT02009163|11172402|FG001|STARTED|Open-label Period (Non-randomized)||0
10047177|NCT02009163|11172403|FG002|STARTED|Open-label Period (Non-randomized)||0
10047178|NCT02009163|11172401|FG000|COMPLETED|Open-label Period (Non-randomized)||275
10047179|NCT02009163|11172402|FG001|COMPLETED|Open-label Period (Non-randomized)||0
10047180|NCT02009163|11172403|FG002|COMPLETED|Open-label Period (Non-randomized)||0
10047181|NCT02009163|11172401|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143
10047182|NCT02009163|11172402|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0
10047183|NCT02009163|11172403|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0
10047184|NCT02009163|11172401|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
10047185|NCT02009163|11172402|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
10047186|NCT02009163|11172403|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
10047187|NCT02009163|11172401|FG000|COMPLETED|Randomized-withdrawal Period||0
10047188|NCT02009163|11172402|FG001|COMPLETED|Randomized-withdrawal Period||50
10047189|NCT02009163|11172403|FG002|COMPLETED|Randomized-withdrawal Period||102
10047190|NCT02009163|11172401|FG000|NOT COMPLETED|Randomized-withdrawal Period||0
10047191|NCT02009163|11172402|FG001|NOT COMPLETED|Randomized-withdrawal Period||88
10047192|NCT02009163|11172403|FG002|NOT COMPLETED|Randomized-withdrawal Period||35
10047193|NCT02009332|11172419|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
10047194|NCT02009332|11172420|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047195|NCT02009332|11172421|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047196|NCT02009332|11172422|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047197|NCT02009332|11172423|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047198|NCT02009332|11172424|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047199|NCT02009332|11172419|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
10047200|NCT02009332|11172420|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047201|NCT02009332|11172421|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047202|NCT02009332|11172422|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047203|NCT02009332|11172423|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047204|NCT02009332|11172424|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047205|NCT02009332|11172419|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047206|NCT02009332|11172420|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047207|NCT02009332|11172421|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047208|NCT02009332|11172422|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047209|NCT02009332|11172423|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047210|NCT02009332|11172424|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10047211|NCT02009332|11172419|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047212|NCT02009332|11172420|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
10047213|NCT02009332|11172421|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
10047214|NCT02009332|11172422|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047215|NCT02009332|11172423|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047216|NCT02009332|11172424|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047217|NCT02009332|11172419|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047218|NCT02009332|11172420|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
10047219|NCT02009332|11172421|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
10047220|NCT02009332|11172422|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047221|NCT02009332|11172423|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047222|NCT02009332|11172424|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047223|NCT02009332|11172419|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047224|NCT02009332|11172420|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
10047225|NCT02009332|11172421|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047226|NCT02009332|11172422|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047227|NCT02009332|11172423|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047228|NCT02009332|11172424|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10047229|NCT02009332|11172419|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047230|NCT02009332|11172420|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047231|NCT02009332|11172421|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047232|NCT02009332|11172422|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
10047233|NCT02009332|11172423|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047234|NCT02009332|11172424|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047235|NCT02009332|11172419|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047236|NCT02009332|11172420|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047237|NCT02009332|11172421|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047238|NCT02009332|11172422|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
10047239|NCT02009332|11172423|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047240|NCT02009332|11172424|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047241|NCT02009332|11172419|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047242|NCT02009332|11172420|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047243|NCT02009332|11172421|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047244|NCT02009332|11172422|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047245|NCT02009332|11172423|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047246|NCT02009332|11172424|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10047247|NCT02009332|11172419|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047248|NCT02009332|11172420|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047249|NCT02009332|11172421|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047250|NCT02009332|11172422|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047251|NCT02009332|11172423|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
10047252|NCT02009332|11172424|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047253|NCT02009332|11172419|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047254|NCT02009332|11172420|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047255|NCT02009332|11172421|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047256|NCT02009332|11172422|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047257|NCT02009332|11172423|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
10047258|NCT02009332|11172424|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047259|NCT02009332|11172419|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047260|NCT02009332|11172420|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047261|NCT02009332|11172421|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047262|NCT02009332|11172422|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047263|NCT02009332|11172423|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
10047264|NCT02009332|11172424|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10047265|NCT02009332|11172419|FG000|STARTED|Phase 2 (Weeks 206-252)||0
10047266|NCT02009332|11172420|FG001|STARTED|Phase 2 (Weeks 206-252)||0
10047267|NCT02009332|11172421|FG002|STARTED|Phase 2 (Weeks 206-252)||0
10047268|NCT02009332|11172422|FG003|STARTED|Phase 2 (Weeks 206-252)||0
10047269|NCT02009332|11172423|FG004|STARTED|Phase 2 (Weeks 206-252)||0
10047270|NCT02009332|11172424|FG005|STARTED|Phase 2 (Weeks 206-252)||6
10047271|NCT02009332|11172419|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0
10047272|NCT02009332|11172420|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0
10047273|NCT02009332|11172421|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0
10047274|NCT02009332|11172422|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0
10047275|NCT02009332|11172423|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0
10047276|NCT02009332|11172424|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
10047277|NCT02009332|11172419|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10047278|NCT02009332|11172420|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10047279|NCT02009332|11172421|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10047280|NCT02009332|11172422|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10047281|NCT02009332|11172423|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10047282|NCT02009332|11172424|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
10047283|NCT02009397|11172438|FG000|STARTED|Overall Study||26
10047284|NCT02009397|11172438|FG000|COMPLETED|Overall Study||6
10047285|NCT02009397|11172438|FG000|NOT COMPLETED|Overall Study||20
10047286|NCT02009501|11172444|FG000|STARTED|Overall Study||9
10047287|NCT02009501|11172445|FG001|STARTED|Overall Study||11
10047288|NCT02009501|11172444|FG000|COMPLETED|Overall Study||9
10047289|NCT02009501|11172445|FG001|COMPLETED|Overall Study||11
10047290|NCT02009501|11172444|FG000|NOT COMPLETED|Overall Study||0
10047291|NCT02009501|11172445|FG001|NOT COMPLETED|Overall Study||0
10047292|NCT02009696|11172451|FG000|STARTED|Overall Study||221
10047293|NCT02009696|11172451|FG000|COMPLETED|Overall Study||219
10047294|NCT02009696|11172451|FG000|NOT COMPLETED|Overall Study||2
10047295|NCT02009722|11172457|FG000|STARTED|Overall Study||41
10047296|NCT02009722|11172458|FG001|STARTED|Overall Study||43
10047297|NCT02009722|11172457|FG000|Received Intervention|Overall Study||41
10047298|NCT02009722|11172458|FG001|Received Intervention|Overall Study||42
10047299|NCT02009722|11172457|FG000|COMPLETED|Overall Study||40
10047300|NCT02009722|11172458|FG001|COMPLETED|Overall Study||40
10047301|NCT02009722|11172457|FG000|NOT COMPLETED|Overall Study||1
10047302|NCT02009722|11172458|FG001|NOT COMPLETED|Overall Study||3
10047303|NCT02009865|11172466|FG000|STARTED|Overall Study||81
10047304|NCT02009865|11172467|FG001|STARTED|Overall Study||81
10047305|NCT02009865|11172466|FG000|COMPLETED|Overall Study||80
10047306|NCT02009865|11172467|FG001|COMPLETED|Overall Study||76
10047307|NCT02009865|11172466|FG000|NOT COMPLETED|Overall Study||1
10047308|NCT02009865|11172467|FG001|NOT COMPLETED|Overall Study||5
10047309|NCT02009878|11172476|FG000|STARTED|Overall Study||10
10047310|NCT02009878|11172477|FG001|STARTED|Overall Study||11
10047311|NCT02009878|11172478|FG002|STARTED|Overall Study||9
10047312|NCT02009878|11172476|FG000|COMPLETED|Overall Study||10
10047313|NCT02009878|11172477|FG001|COMPLETED|Overall Study||10
10047314|NCT02009878|11172478|FG002|COMPLETED|Overall Study||9
10047315|NCT02009878|11172476|FG000|NOT COMPLETED|Overall Study||0
10047316|NCT02009878|11172477|FG001|NOT COMPLETED|Overall Study||1
10047317|NCT02009878|11172478|FG002|NOT COMPLETED|Overall Study||0
10047318|NCT02009930|11172486|FG000|STARTED|Overall Study|5 withdrawn|112
10047319|NCT02009930|11172486|FG000|COMPLETED|Overall Study||107
10047320|NCT02009930|11172486|FG000|NOT COMPLETED|Overall Study||5
10047321|NCT02010021|11172499|FG000|STARTED|Overall Study||10
10047322|NCT02010021|11172500|FG001|STARTED|Overall Study||7
10047323|NCT02010021|11172499|FG000|COMPLETED|Overall Study||10
10047324|NCT02010021|11172500|FG001|COMPLETED|Overall Study||7
10047325|NCT02010021|11172499|FG000|NOT COMPLETED|Overall Study||0
10047326|NCT02010021|11172500|FG001|NOT COMPLETED|Overall Study||0
10047327|NCT02010151|11172508|FG000|STARTED|Overall Study|January 2013 to December 2017|1498
10047328|NCT02010151|11172509|FG001|STARTED|Overall Study|January 2013 to December 2017|1696
10047329|NCT02010151|11172508|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
10047330|NCT02010151|11172509|FG001|COMPLETED|Overall Study|TM sent: 598|1696
10047331|NCT02010151|11172508|FG000|NOT COMPLETED|Overall Study||0
10047332|NCT02010151|11172509|FG001|NOT COMPLETED|Overall Study||0
10047333|NCT02010203|11172520|FG000|STARTED|Overall Study||10
10047334|NCT02010203|11172521|FG001|STARTED|Overall Study||26
10047335|NCT02010203|11172522|FG002|STARTED|Overall Study||26
10047336|NCT02010203|11172523|FG003|STARTED|Overall Study||26
10047337|NCT02010203|11172524|FG004|STARTED|Overall Study||16
10047338|NCT02010203|11172520|FG000|COMPLETED|Overall Study||10
10047339|NCT02010203|11172521|FG001|COMPLETED|Overall Study||17
10047340|NCT02010203|11172522|FG002|COMPLETED|Overall Study||16
10047341|NCT02010203|11172523|FG003|COMPLETED|Overall Study||23
10047342|NCT02010203|11172524|FG004|COMPLETED|Overall Study||3
10047343|NCT02010203|11172520|FG000|NOT COMPLETED|Overall Study||0
10047344|NCT02010203|11172521|FG001|NOT COMPLETED|Overall Study||9
10047345|NCT02010203|11172522|FG002|NOT COMPLETED|Overall Study||10
10047346|NCT02010203|11172523|FG003|NOT COMPLETED|Overall Study||3
10047347|NCT02010203|11172524|FG004|NOT COMPLETED|Overall Study||13
10047348|NCT02010216|11172536|FG000|STARTED|Overall Study||23
10047349|NCT02010216|11172536|FG000|COMPLETED|Overall Study||23
10047350|NCT02010216|11172536|FG000|NOT COMPLETED|Overall Study||0
10047351|NCT02010255|11172554|FG000|STARTED|Overall Study||28
10047352|NCT02010255|11172555|FG001|STARTED|Overall Study||28
10047353|NCT02010255|11172556|FG002|STARTED|Overall Study||25
10047354|NCT02010255|11172557|FG003|STARTED|Overall Study||26
10047355|NCT02010255|11172558|FG004|STARTED|Overall Study||52
10047356|NCT02010255|11172559|FG005|STARTED|Overall Study||49
10047357|NCT02010255|11172560|FG006|STARTED|Overall Study||34
10047358|NCT02010255|11172561|FG007|STARTED|Overall Study||33
10047359|NCT02010255|11172562|FG008|STARTED|Overall Study||22
10047360|NCT02010255|11172563|FG009|STARTED|Overall Study||23
10047361|NCT02010255|11172564|FG010|STARTED|Overall Study||3
10047362|NCT02010255|11172565|FG011|STARTED|Overall Study||5
10047363|NCT02010255|11172566|FG012|STARTED|Overall Study||3
10047364|NCT02010255|11172567|FG013|STARTED|Overall Study||3
10047365|NCT02010255|11172554|FG000|COMPLETED|Overall Study||22
10047366|NCT02010255|11172555|FG001|COMPLETED|Overall Study||26
10047367|NCT02010255|11172556|FG002|COMPLETED|Overall Study||18
10047368|NCT02010255|11172557|FG003|COMPLETED|Overall Study||20
10047369|NCT02010255|11172558|FG004|COMPLETED|Overall Study||48
10047370|NCT02010255|11172559|FG005|COMPLETED|Overall Study||49
10047371|NCT02010255|11172560|FG006|COMPLETED|Overall Study||33
10047372|NCT02010255|11172561|FG007|COMPLETED|Overall Study||32
10047373|NCT02010255|11172562|FG008|COMPLETED|Overall Study||21
10047374|NCT02010255|11172563|FG009|COMPLETED|Overall Study||23
10047375|NCT02010255|11172564|FG010|COMPLETED|Overall Study||1
10047376|NCT02010255|11172565|FG011|COMPLETED|Overall Study||4
10047377|NCT02010255|11172566|FG012|COMPLETED|Overall Study||3
10047378|NCT02010255|11172567|FG013|COMPLETED|Overall Study||2
10047379|NCT02010255|11172554|FG000|NOT COMPLETED|Overall Study||6
10047380|NCT02010255|11172555|FG001|NOT COMPLETED|Overall Study||2
10047381|NCT02010255|11172556|FG002|NOT COMPLETED|Overall Study||7
10047382|NCT02010255|11172557|FG003|NOT COMPLETED|Overall Study||6
10047383|NCT02010255|11172558|FG004|NOT COMPLETED|Overall Study||4
10047384|NCT02010255|11172559|FG005|NOT COMPLETED|Overall Study||0
10047385|NCT02010255|11172560|FG006|NOT COMPLETED|Overall Study||1
10047386|NCT02010255|11172561|FG007|NOT COMPLETED|Overall Study||1
10047387|NCT02010255|11172562|FG008|NOT COMPLETED|Overall Study||1
10047388|NCT02010255|11172563|FG009|NOT COMPLETED|Overall Study||0
10047389|NCT02010255|11172564|FG010|NOT COMPLETED|Overall Study||2
10047390|NCT02010255|11172565|FG011|NOT COMPLETED|Overall Study||1
10047391|NCT02010255|11172566|FG012|NOT COMPLETED|Overall Study||0
10047392|NCT02010255|11172567|FG013|NOT COMPLETED|Overall Study||1
10047393|NCT02010359|11172624|FG000|STARTED|Overall Study||15
10047394|NCT02010359|11172625|FG001|STARTED|Overall Study||14
10047395|NCT02010359|11172624|FG000|COMPLETED|Overall Study||13
10047396|NCT02010359|11172625|FG001|COMPLETED|Overall Study||12
10047397|NCT02010359|11172624|FG000|NOT COMPLETED|Overall Study||2
10047398|NCT02010359|11172625|FG001|NOT COMPLETED|Overall Study||2
10047399|NCT02010567|11172636|FG000|STARTED|Overall Study||3
10047400|NCT02010567|11172637|FG001|STARTED|Overall Study||6
10047401|NCT02010567|11172638|FG002|STARTED|Overall Study||14
10047402|NCT02010567|11172639|FG003|STARTED|Overall Study||3
10047403|NCT02010567|11172640|FG004|STARTED|Overall Study||6
10047404|NCT02010567|11172636|FG000|COMPLETED|Overall Study||3
10047405|NCT02010567|11172637|FG001|COMPLETED|Overall Study||6
10047406|NCT02010567|11172638|FG002|COMPLETED|Overall Study||13
10047407|NCT02010567|11172639|FG003|COMPLETED|Overall Study||3
10047408|NCT02010567|11172640|FG004|COMPLETED|Overall Study||5
10047409|NCT02010567|11172636|FG000|NOT COMPLETED|Overall Study||0
10047410|NCT02010567|11172637|FG001|NOT COMPLETED|Overall Study||0
10047411|NCT02010567|11172638|FG002|NOT COMPLETED|Overall Study||1
10047412|NCT02010567|11172639|FG003|NOT COMPLETED|Overall Study||0
10047413|NCT02010567|11172640|FG004|NOT COMPLETED|Overall Study||1
10047414|NCT02010632|11172650|FG000|STARTED|First Intervention (7 Days)||16
10047415|NCT02010632|11172651|FG001|STARTED|First Intervention (7 Days)||16
10047416|NCT02010632|11172650|FG000|COMPLETED|First Intervention (7 Days)||16
10047417|NCT02010632|11172651|FG001|COMPLETED|First Intervention (7 Days)||16
10047418|NCT02010632|11172650|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10047419|NCT02010632|11172651|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10047420|NCT02010632|11172650|FG000|STARTED|Wash Out Period (14 Days)||16
10047421|NCT02010632|11172651|FG001|STARTED|Wash Out Period (14 Days)||16
10047422|NCT02010632|11172650|FG000|COMPLETED|Wash Out Period (14 Days)||16
10047423|NCT02010632|11172651|FG001|COMPLETED|Wash Out Period (14 Days)||16
10047424|NCT02010632|11172650|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0
10047425|NCT02010632|11172651|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0
10047426|NCT02010632|11172650|FG000|STARTED|Second Intervention (7 Days)||16
10047427|NCT02010632|11172651|FG001|STARTED|Second Intervention (7 Days)||16
10047428|NCT02010632|11172650|FG000|COMPLETED|Second Intervention (7 Days)||15
10047429|NCT02010632|11172651|FG001|COMPLETED|Second Intervention (7 Days)||16
10047430|NCT02010632|11172650|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
10047431|NCT02010632|11172651|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10047432|NCT02010645|11172657|FG000|STARTED|Overall Study||6
10047433|NCT02010645|11172657|FG000|COMPLETED|Overall Study||6
10047434|NCT02010645|11172657|FG000|NOT COMPLETED|Overall Study||0
10047435|NCT02010684|11172663|FG000|STARTED|Overall Study||39
10047436|NCT02010684|11172664|FG001|STARTED|Overall Study||82
10047437|NCT02010684|11172663|FG000|COMPLETED|Overall Study||27
10047438|NCT02010684|11172664|FG001|COMPLETED|Overall Study||59
10047439|NCT02010684|11172663|FG000|NOT COMPLETED|Overall Study||12
10047440|NCT02010684|11172664|FG001|NOT COMPLETED|Overall Study||23
10047441|NCT02010697|11172673|FG000|STARTED|Overall Study||1044
10047442|NCT02010697|11172674|FG001|STARTED|Overall Study||1038
10047443|NCT02010697|11172675|FG002|STARTED|Overall Study||1043
10047444|NCT02010697|11172673|FG000|COMPLETED|Overall Study||1044
10047445|NCT02010697|11172674|FG001|COMPLETED|Overall Study||1038
10047446|NCT02010697|11172675|FG002|COMPLETED|Overall Study||1043
10047447|NCT02010697|11172673|FG000|NOT COMPLETED|Overall Study||0
10047448|NCT02010697|11172674|FG001|NOT COMPLETED|Overall Study||0
10047449|NCT02010697|11172675|FG002|NOT COMPLETED|Overall Study||0
10047450|NCT02010775|11172688|FG000|STARTED|Overall Study||38
10047451|NCT02010775|11172689|FG001|STARTED|Overall Study||38
10047452|NCT02010775|11172690|FG002|STARTED|Overall Study||37
10047453|NCT02010775|11172691|FG003|STARTED|Overall Study||37
10047454|NCT02010775|11172692|FG004|STARTED|Overall Study||37
10047455|NCT02010775|11172688|FG000|COMPLETED|Overall Study||33
10047456|NCT02010775|11172689|FG001|COMPLETED|Overall Study||35
10047457|NCT02010775|11172690|FG002|COMPLETED|Overall Study||34
10047458|NCT02010775|11172691|FG003|COMPLETED|Overall Study||34
10047459|NCT02010775|11172692|FG004|COMPLETED|Overall Study||31
10047460|NCT02010775|11172688|FG000|NOT COMPLETED|Overall Study||5
10047461|NCT02010775|11172689|FG001|NOT COMPLETED|Overall Study||3
10047462|NCT02010775|11172690|FG002|NOT COMPLETED|Overall Study||3
10047463|NCT02010775|11172691|FG003|NOT COMPLETED|Overall Study||3
10047464|NCT02010775|11172692|FG004|NOT COMPLETED|Overall Study||6
10047465|NCT02010996|11172706|FG000|STARTED|Overall Study||36
10047466|NCT02010996|11172707|FG001|STARTED|Overall Study||36
10047467|NCT02010996|11172706|FG000|COMPLETED|Overall Study||36
10047468|NCT02010996|11172707|FG001|COMPLETED|Overall Study||36
10047469|NCT02010996|11172706|FG000|NOT COMPLETED|Overall Study||0
10047470|NCT02010996|11172707|FG001|NOT COMPLETED|Overall Study||0
10047471|NCT02011113|11172717|FG000|STARTED|Overall Study||36
10047472|NCT02011113|11172717|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
10047473|NCT02011113|11172717|FG000|NOT COMPLETED|Overall Study||36
10047474|NCT02011386|11172722|FG000|STARTED|Overall Study||53
10047475|NCT02011386|11172722|FG000|COMPLETED|Overall Study||48
10047476|NCT02011386|11172722|FG000|NOT COMPLETED|Overall Study||5
10047477|NCT02011464|11172728|FG000|STARTED|Overall Study||10
10047478|NCT02011464|11172729|FG001|STARTED|Overall Study||10
10047479|NCT02011464|11172728|FG000|COMPLETED|Overall Study||10
10047480|NCT02011464|11172729|FG001|COMPLETED|Overall Study||10
10047481|NCT02011464|11172728|FG000|NOT COMPLETED|Overall Study||0
10047482|NCT02011464|11172729|FG001|NOT COMPLETED|Overall Study||0
10047483|NCT02011490|11172750|FG000|STARTED|Part 1||8
10047484|NCT02011490|11172751|FG001|STARTED|Part 1||8
10047485|NCT02011490|11172752|FG002|STARTED|Part 1||8
10047486|NCT02011490|11172753|FG003|STARTED|Part 1||0
10047487|NCT02011490|11172754|FG004|STARTED|Part 1||0
10047488|NCT02011490|11172755|FG005|STARTED|Part 1||0
10047489|NCT02011490|11172750|FG000|COMPLETED|Part 1||8
10047490|NCT02011490|11172751|FG001|COMPLETED|Part 1||8
10047491|NCT02011490|11172752|FG002|COMPLETED|Part 1||8
10047492|NCT02011490|11172753|FG003|COMPLETED|Part 1||0
10047493|NCT02011490|11172754|FG004|COMPLETED|Part 1||0
10047494|NCT02011490|11172755|FG005|COMPLETED|Part 1||0
10047495|NCT02011490|11172750|FG000|NOT COMPLETED|Part 1||0
10047496|NCT02011490|11172751|FG001|NOT COMPLETED|Part 1||0
10047497|NCT02011490|11172752|FG002|NOT COMPLETED|Part 1||0
10047498|NCT02011490|11172753|FG003|NOT COMPLETED|Part 1||0
10047499|NCT02011490|11172754|FG004|NOT COMPLETED|Part 1||0
10047500|NCT02011490|11172755|FG005|NOT COMPLETED|Part 1||0
10047501|NCT02011490|11172750|FG000|STARTED|Part 2||0
10047502|NCT02011490|11172751|FG001|STARTED|Part 2||0
10047503|NCT02011490|11172752|FG002|STARTED|Part 2||0
10047504|NCT02011490|11172753|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
10047505|NCT02011490|11172754|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
10047506|NCT02011490|11172755|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
10047507|NCT02011490|11172750|FG000|COMPLETED|Part 2||0
10047508|NCT02011490|11172751|FG001|COMPLETED|Part 2||0
10047509|NCT02011490|11172752|FG002|COMPLETED|Part 2||0
10047510|NCT02011490|11172753|FG003|COMPLETED|Part 2||6
10047511|NCT02011490|11172754|FG004|COMPLETED|Part 2||6
10047512|NCT02011490|11172755|FG005|COMPLETED|Part 2||6
10047513|NCT02011490|11172750|FG000|NOT COMPLETED|Part 2||0
10047514|NCT02011490|11172751|FG001|NOT COMPLETED|Part 2||0
10047515|NCT02011490|11172752|FG002|NOT COMPLETED|Part 2||0
10047516|NCT02011490|11172753|FG003|NOT COMPLETED|Part 2||0
10047517|NCT02011490|11172754|FG004|NOT COMPLETED|Part 2||0
10047518|NCT02011490|11172755|FG005|NOT COMPLETED|Part 2||0
10047519|NCT02011516|11172771|FG000|STARTED|Overall Study||8
10047520|NCT02011516|11172772|FG001|STARTED|Overall Study||8
10047521|NCT02011516|11172771|FG000|COMPLETED|Overall Study||4
10047522|NCT02011516|11172772|FG001|COMPLETED|Overall Study||6
10047523|NCT02011516|11172771|FG000|NOT COMPLETED|Overall Study||4
10047524|NCT02011516|11172772|FG001|NOT COMPLETED|Overall Study||2
10047525|NCT02011893|11172778|FG000|STARTED|Enrollment to Randomization||173
10047526|NCT02011893|11172779|FG001|STARTED|Enrollment to Randomization||0
10047527|NCT02011893|11172780|FG002|STARTED|Enrollment to Randomization||0
10047528|NCT02011893|11172778|FG000|Baseline|Enrollment to Randomization||141
10047529|NCT02011893|11172779|FG001|Baseline|Enrollment to Randomization||0
10047530|NCT02011893|11172780|FG002|Baseline|Enrollment to Randomization||0
10047531|NCT02011893|11172778|FG000|Trial Stimulation Implant|Enrollment to Randomization||121
10047532|NCT02011893|11172779|FG001|Trial Stimulation Implant|Enrollment to Randomization||0
10047533|NCT02011893|11172780|FG002|Trial Stimulation Implant|Enrollment to Randomization||0
10047534|NCT02011893|11172778|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101
10047535|NCT02011893|11172779|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0
10047536|NCT02011893|11172780|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0
10047537|NCT02011893|11172778|FG000|Randomization|Enrollment to Randomization||100
10047538|NCT02011893|11172779|FG001|Randomization|Enrollment to Randomization||0
10047539|NCT02011893|11172780|FG002|Randomization|Enrollment to Randomization||0
10047540|NCT02011893|11172778|FG000|COMPLETED|Enrollment to Randomization||100
10047541|NCT02011893|11172779|FG001|COMPLETED|Enrollment to Randomization||0
10047542|NCT02011893|11172780|FG002|COMPLETED|Enrollment to Randomization||0
10047543|NCT02011893|11172778|FG000|NOT COMPLETED|Enrollment to Randomization||73
10047544|NCT02011893|11172779|FG001|NOT COMPLETED|Enrollment to Randomization||0
10047545|NCT02011893|11172780|FG002|NOT COMPLETED|Enrollment to Randomization||0
10047546|NCT02011893|11172778|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0
10047547|NCT02011893|11172779|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45
10047548|NCT02011893|11172780|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55
10047549|NCT02011893|11172778|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
10047550|NCT02011893|11172779|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
10047551|NCT02011893|11172780|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
10047552|NCT02011893|11172778|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
10047553|NCT02011893|11172779|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
10047554|NCT02011893|11172780|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
10047555|NCT02011893|11172778|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
10047556|NCT02011893|11172779|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
10047557|NCT02011893|11172780|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
10047558|NCT02011893|11172778|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
10047559|NCT02011893|11172779|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
10047560|NCT02011893|11172780|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
10047561|NCT02011893|11172778|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
10047562|NCT02011893|11172779|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
10047563|NCT02011893|11172780|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
10047564|NCT02011893|11172778|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
10047565|NCT02011893|11172779|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
10047566|NCT02011893|11172780|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
10047567|NCT02011893|11172778|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
10047568|NCT02011893|11172779|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
10047569|NCT02011893|11172780|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
10047570|NCT02011893|11172778|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
10047571|NCT02011893|11172779|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
10047572|NCT02011893|11172780|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
10047573|NCT02011893|11172778|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
10047574|NCT02011893|11172779|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
10047575|NCT02011893|11172780|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
10047576|NCT02011945|11172788|FG000|STARTED|Overall Study||2
10047577|NCT02011945|11172789|FG001|STARTED|Overall Study||13
10047578|NCT02011945|11172790|FG002|STARTED|Overall Study||16
10047579|NCT02011945|11172788|FG000|COMPLETED|Overall Study||0
10047580|NCT02011945|11172789|FG001|COMPLETED|Overall Study||3
10047581|NCT02011945|11172790|FG002|COMPLETED|Overall Study||6
10047582|NCT02011945|11172788|FG000|NOT COMPLETED|Overall Study||2
10047583|NCT02011945|11172789|FG001|NOT COMPLETED|Overall Study||10
10047584|NCT02011945|11172790|FG002|NOT COMPLETED|Overall Study||10
10047585|NCT02012192|11172800|FG000|STARTED|Overall Study||90
10047586|NCT02012192|11172801|FG001|STARTED|Overall Study||43
10047587|NCT02012192|11172800|FG000|COMPLETED|Overall Study||63
10047588|NCT02012192|11172801|FG001|COMPLETED|Overall Study||43
10047589|NCT02012192|11172800|FG000|NOT COMPLETED|Overall Study||27
10047590|NCT02012192|11172801|FG001|NOT COMPLETED|Overall Study||0
10047591|NCT02012218|11172812|FG000|STARTED|Overall Study||12
10047592|NCT02012218|11172813|FG001|STARTED|Overall Study||11
10117858|NCT02542761|11248682|FG001|NOT COMPLETED|First Intervention||0
10047593|NCT02012218|11172814|FG002|STARTED|Overall Study||13
10047594|NCT02012218|11172815|FG003|STARTED|Overall Study||19
10047595|NCT02012218|11172816|FG004|STARTED|Overall Study||6
10047596|NCT02012218|11172812|FG000|COMPLETED|Overall Study||8
10047597|NCT02012218|11172813|FG001|COMPLETED|Overall Study||10
10047598|NCT02012218|11172814|FG002|COMPLETED|Overall Study||11
10047599|NCT02012218|11172815|FG003|COMPLETED|Overall Study||17
10047600|NCT02012218|11172816|FG004|COMPLETED|Overall Study||5
10047601|NCT02012218|11172812|FG000|NOT COMPLETED|Overall Study||4
10047602|NCT02012218|11172813|FG001|NOT COMPLETED|Overall Study||1
10047603|NCT02012218|11172814|FG002|NOT COMPLETED|Overall Study||2
10047604|NCT02012218|11172815|FG003|NOT COMPLETED|Overall Study||2
10047605|NCT02012218|11172816|FG004|NOT COMPLETED|Overall Study||1
10047606|NCT02012283|11172830|FG000|STARTED|First Intervention||10
10047607|NCT02012283|11172831|FG001|STARTED|First Intervention||10
10047608|NCT02012283|11172830|FG000|COMPLETED|First Intervention||10
10047609|NCT02012283|11172831|FG001|COMPLETED|First Intervention||10
10047610|NCT02012283|11172830|FG000|NOT COMPLETED|First Intervention||0
10047611|NCT02012283|11172831|FG001|NOT COMPLETED|First Intervention||0
10047612|NCT02012283|11172830|FG000|STARTED|Second Intervention||10
10047613|NCT02012283|11172831|FG001|STARTED|Second Intervention||10
10047614|NCT02012283|11172830|FG000|COMPLETED|Second Intervention||10
10047615|NCT02012283|11172831|FG001|COMPLETED|Second Intervention||10
10047616|NCT02012283|11172830|FG000|NOT COMPLETED|Second Intervention||0
10047617|NCT02012283|11172831|FG001|NOT COMPLETED|Second Intervention||0
10047618|NCT02012283|11172830|FG000|STARTED|Third Intervention||10
10047619|NCT02012283|11172831|FG001|STARTED|Third Intervention||10
10047620|NCT02012283|11172830|FG000|COMPLETED|Third Intervention||10
10047621|NCT02012283|11172831|FG001|COMPLETED|Third Intervention||10
10047622|NCT02012283|11172830|FG000|NOT COMPLETED|Third Intervention||0
10047623|NCT02012283|11172831|FG001|NOT COMPLETED|Third Intervention||0
10047624|NCT02012348|11172845|FG000|STARTED|Overall Study||10
10047625|NCT02012348|11172846|FG001|STARTED|Overall Study||10
10047626|NCT02012348|11172847|FG002|STARTED|Overall Study||10
10047627|NCT02012348|11172845|FG000|COMPLETED|Overall Study||10
10047628|NCT02012348|11172846|FG001|COMPLETED|Overall Study||10
10047629|NCT02012348|11172847|FG002|COMPLETED|Overall Study||10
10047630|NCT02012348|11172845|FG000|NOT COMPLETED|Overall Study||0
10047631|NCT02012348|11172846|FG001|NOT COMPLETED|Overall Study||0
10047632|NCT02012348|11172847|FG002|NOT COMPLETED|Overall Study||0
10047633|NCT02012452|11172857|FG000|STARTED|Overall Study||7
10047634|NCT02012452|11172858|FG001|STARTED|Overall Study||2
10047635|NCT02012452|11172857|FG000|COMPLETED|Overall Study||1
10047636|NCT02012452|11172858|FG001|COMPLETED|Overall Study||1
10047637|NCT02012452|11172857|FG000|NOT COMPLETED|Overall Study||6
10047638|NCT02012452|11172858|FG001|NOT COMPLETED|Overall Study||1
10047639|NCT02012491|11172866|FG000|STARTED|Overall Study||151
10047640|NCT02012491|11172867|FG001|STARTED|Overall Study||149
10047641|NCT02012491|11172866|FG000|COMPLETED|Overall Study||149
10047642|NCT02012491|11172867|FG001|COMPLETED|Overall Study||148
10047643|NCT02012491|11172866|FG000|NOT COMPLETED|Overall Study||2
10047644|NCT02012491|11172867|FG001|NOT COMPLETED|Overall Study||1
10047645|NCT02012582|11172877|FG000|STARTED|Overall Study||8
10047646|NCT02012582|11172878|FG001|STARTED|Overall Study||8
10047647|NCT02012582|11172879|FG002|STARTED|Overall Study||8
10047648|NCT02012582|11172880|FG003|STARTED|Overall Study||8
10047649|NCT02012582|11172877|FG000|COMPLETED|Overall Study||8
10047650|NCT02012582|11172878|FG001|COMPLETED|Overall Study||8
10047651|NCT02012582|11172879|FG002|COMPLETED|Overall Study||8
10047652|NCT02012582|11172880|FG003|COMPLETED|Overall Study||7
10047653|NCT02012582|11172877|FG000|NOT COMPLETED|Overall Study||0
10047654|NCT02012582|11172878|FG001|NOT COMPLETED|Overall Study||0
10047655|NCT02012582|11172879|FG002|NOT COMPLETED|Overall Study||0
10047656|NCT02012582|11172880|FG003|NOT COMPLETED|Overall Study||1
10047657|NCT02012621|11172890|FG000|STARTED|Overall Study||807
10047658|NCT02012621|11172890|FG000|Visit 1 Completed|Overall Study||807
10047659|NCT02012621|11172890|FG000|Visit 2 Completed|Overall Study||688
10047660|NCT02012621|11172890|FG000|Visit 3 Completed|Overall Study||444
10047661|NCT02012621|11172890|FG000|COMPLETED|Overall Study||807
10047662|NCT02012621|11172890|FG000|NOT COMPLETED|Overall Study||0
10047663|NCT02012686|11172896|FG000|STARTED|Overall Study||50
10047664|NCT02012686|11172897|FG001|STARTED|Overall Study||50
10047665|NCT02012686|11172896|FG000|COMPLETED|Overall Study||50
10047666|NCT02012686|11172897|FG001|COMPLETED|Overall Study||48
10047667|NCT02012686|11172896|FG000|NOT COMPLETED|Overall Study||0
10047668|NCT02012686|11172897|FG001|NOT COMPLETED|Overall Study||2
10047669|NCT02012959|11172903|FG000|STARTED|Treatment Phase A||9
10047670|NCT02012959|11172904|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10047671|NCT02012959|11172905|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10047672|NCT02012959|11172906|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10047673|NCT02012959|11172907|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10047674|NCT02012959|11172903|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
10047675|NCT02012959|11172904|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10047676|NCT02012959|11172905|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10047677|NCT02012959|11172906|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10047678|NCT02012959|11172907|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10047679|NCT02012959|11172903|FG000|COMPLETED|Treatment Phase A||7
10047680|NCT02012959|11172904|FG001|COMPLETED|Treatment Phase A||0
10047681|NCT02012959|11172905|FG002|COMPLETED|Treatment Phase A||0
10047682|NCT02012959|11172906|FG003|COMPLETED|Treatment Phase A||0
10047683|NCT02012959|11172907|FG004|COMPLETED|Treatment Phase A||0
10047684|NCT02012959|11172903|FG000|NOT COMPLETED|Treatment Phase A||2
10047685|NCT02012959|11172904|FG001|NOT COMPLETED|Treatment Phase A||0
10047686|NCT02012959|11172905|FG002|NOT COMPLETED|Treatment Phase A||0
10047687|NCT02012959|11172906|FG003|NOT COMPLETED|Treatment Phase A||0
10047688|NCT02012959|11172907|FG004|NOT COMPLETED|Treatment Phase A||0
10047689|NCT02012959|11172903|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
10047690|NCT02012959|11172904|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
10047691|NCT02012959|11172905|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
10047692|NCT02012959|11172906|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
10047693|NCT02012959|11172907|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
10047694|NCT02012959|11172903|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
10047695|NCT02012959|11172904|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
10047696|NCT02012959|11172905|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
10047697|NCT02012959|11172906|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
10047698|NCT02012959|11172907|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
10047699|NCT02012959|11172903|FG000|COMPLETED|Treatment Phase B||0
10047700|NCT02012959|11172904|FG001|COMPLETED|Treatment Phase B||2
10047701|NCT02012959|11172905|FG002|COMPLETED|Treatment Phase B||3
10047702|NCT02012959|11172906|FG003|COMPLETED|Treatment Phase B||1
10047703|NCT02012959|11172907|FG004|COMPLETED|Treatment Phase B||1
10047704|NCT02012959|11172903|FG000|NOT COMPLETED|Treatment Phase B||0
10047705|NCT02012959|11172904|FG001|NOT COMPLETED|Treatment Phase B||0
10047706|NCT02012959|11172905|FG002|NOT COMPLETED|Treatment Phase B||0
10047707|NCT02012959|11172906|FG003|NOT COMPLETED|Treatment Phase B||0
10047708|NCT02012959|11172907|FG004|NOT COMPLETED|Treatment Phase B||0
10047709|NCT02013037|11172917|FG000|STARTED|Overall Study||36
10047710|NCT02013037|11172917|FG000|COMPLETED|Overall Study||20
10047711|NCT02013037|11172917|FG000|NOT COMPLETED|Overall Study||16
10047712|NCT02013050|11172926|FG000|STARTED|Overall Study||42
10047713|NCT02013050|11172927|FG001|STARTED|Overall Study||41
10047714|NCT02013050|11172928|FG002|STARTED|Overall Study||3
10047715|NCT02013050|11172929|FG003|STARTED|Overall Study||23
10047716|NCT02013050|11172926|FG000|COMPLETED|Overall Study||38
10047717|NCT02013050|11172927|FG001|COMPLETED|Overall Study||36
10047718|NCT02013050|11172928|FG002|COMPLETED|Overall Study||3
10047719|NCT02013050|11172929|FG003|COMPLETED|Overall Study||19
10047720|NCT02013050|11172926|FG000|NOT COMPLETED|Overall Study||4
10047721|NCT02013050|11172927|FG001|NOT COMPLETED|Overall Study||5
10047722|NCT02013050|11172928|FG002|NOT COMPLETED|Overall Study||0
10047723|NCT02013050|11172929|FG003|NOT COMPLETED|Overall Study||4
10047724|NCT02013180|11172941|FG000|STARTED|Overall Study||119
10117859|NCT02542761|11248681|FG000|STARTED|Acclimation Period 2||5
10117860|NCT02542761|11248682|FG001|STARTED|Acclimation Period 2||5
10117861|NCT02542761|11248681|FG000|COMPLETED|Acclimation Period 2||5
10117862|NCT02542761|11248682|FG001|COMPLETED|Acclimation Period 2||5
10117863|NCT02542761|11248681|FG000|NOT COMPLETED|Acclimation Period 2||0
10117864|NCT02542761|11248682|FG001|NOT COMPLETED|Acclimation Period 2||0
10117865|NCT02542761|11248681|FG000|STARTED|Second Intervention||5
10117866|NCT02542761|11248682|FG001|STARTED|Second Intervention||5
10117867|NCT02542761|11248681|FG000|COMPLETED|Second Intervention||5
10117868|NCT02542761|11248682|FG001|COMPLETED|Second Intervention||5
10117869|NCT02542761|11248681|FG000|NOT COMPLETED|Second Intervention||0
10117870|NCT02542761|11248682|FG001|NOT COMPLETED|Second Intervention||0
10117871|NCT02542865|11248690|FG000|STARTED|Overall Study||462
10117872|NCT02542865|11248691|FG001|STARTED|Overall Study||462
10117873|NCT02542865|11248690|FG000|Treated|Overall Study||460
10117874|NCT02542865|11248691|FG001|Treated|Overall Study||462
10117875|NCT02542865|11248690|FG000|COMPLETED|Overall Study||445
10117876|NCT02542865|11248691|FG001|COMPLETED|Overall Study||462
10117877|NCT02542865|11248690|FG000|NOT COMPLETED|Overall Study||17
10117878|NCT02542865|11248691|FG001|NOT COMPLETED|Overall Study||0
10117879|NCT02542943|11248700|FG000|STARTED|Overall Study||79
10117880|NCT02542943|11248701|FG001|STARTED|Overall Study||80
10117881|NCT02542943|11248702|FG002|STARTED|Overall Study||81
10117882|NCT02542943|11248700|FG000|COMPLETED|Overall Study||78
10117883|NCT02542943|11248701|FG001|COMPLETED|Overall Study||79
10117884|NCT02542943|11248702|FG002|COMPLETED|Overall Study||81
10117885|NCT02542943|11248700|FG000|NOT COMPLETED|Overall Study||1
10047725|NCT02013180|11172942|FG001|STARTED|Overall Study||361
10047726|NCT02013180|11172941|FG000|COMPLETED|Overall Study||119
10047727|NCT02013180|11172942|FG001|COMPLETED|Overall Study||361
10047728|NCT02013180|11172941|FG000|NOT COMPLETED|Overall Study||0
10047729|NCT02013180|11172942|FG001|NOT COMPLETED|Overall Study||0
10117886|NCT02542943|11248701|FG001|NOT COMPLETED|Overall Study||1
10117887|NCT02542943|11248702|FG002|NOT COMPLETED|Overall Study||0
10117888|NCT02543203|11248713|FG000|STARTED|Overall Study||13
10117889|NCT02543203|11248714|FG001|STARTED|Overall Study||15
10117890|NCT02543203|11248713|FG000|COMPLETED|Overall Study||7
10117891|NCT02543203|11248714|FG001|COMPLETED|Overall Study||10
10117892|NCT02543203|11248713|FG000|NOT COMPLETED|Overall Study||6
10117893|NCT02543203|11248714|FG001|NOT COMPLETED|Overall Study||5
10047730|NCT02013206|11172950|FG000|STARTED|Overall Study||29
10047731|NCT02013206|11172951|FG001|STARTED|Overall Study||23
10047732|NCT02013206|11172950|FG000|Received Study Drug|Overall Study||26
10047733|NCT02013206|11172951|FG001|Received Study Drug|Overall Study||23
10047734|NCT02013206|11172950|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
10047735|NCT02013206|11172951|FG001|COMPLETED|Overall Study||1
10047736|NCT02013206|11172950|FG000|NOT COMPLETED|Overall Study||27
10047737|NCT02013206|11172951|FG001|NOT COMPLETED|Overall Study||22
10047738|NCT02013245|11172961|FG000|STARTED|Overall Study||9
10047739|NCT02013245|11172962|FG001|STARTED|Overall Study||9
10047740|NCT02013245|11172963|FG002|STARTED|Overall Study||9
10047741|NCT02013245|11172964|FG003|STARTED|Overall Study||9
10047742|NCT02013245|11172961|FG000|COMPLETED|Overall Study||9
10047743|NCT02013245|11172962|FG001|COMPLETED|Overall Study||8
10047744|NCT02013245|11172963|FG002|COMPLETED|Overall Study||9
10047745|NCT02013245|11172964|FG003|COMPLETED|Overall Study||9
10047746|NCT02013245|11172961|FG000|NOT COMPLETED|Overall Study||0
10047747|NCT02013245|11172962|FG001|NOT COMPLETED|Overall Study||1
10047748|NCT02013245|11172963|FG002|NOT COMPLETED|Overall Study||0
10047749|NCT02013245|11172964|FG003|NOT COMPLETED|Overall Study||0
10047750|NCT02013375|11172974|FG000|STARTED|Overall Study||2
10047751|NCT02013375|11172974|FG000|COMPLETED|Overall Study||0
10047752|NCT02013375|11172974|FG000|NOT COMPLETED|Overall Study||2
10047753|NCT02013388|11172987|FG000|STARTED|Overall Study||9
10047754|NCT02013388|11172988|FG001|STARTED|Overall Study||6
10047755|NCT02013388|11172989|FG002|STARTED|Overall Study||6
10047756|NCT02013388|11172990|FG003|STARTED|Overall Study||6
10047757|NCT02013388|11172991|FG004|STARTED|Overall Study||6
10047758|NCT02013388|11172992|FG005|STARTED|Overall Study||6
10047759|NCT02013388|11172993|FG006|STARTED|Overall Study||6
10047760|NCT02013388|11172994|FG007|STARTED|Overall Study||4
10047761|NCT02013388|11172987|FG000|COMPLETED|Overall Study||8
10047762|NCT02013388|11172988|FG001|COMPLETED|Overall Study||6
10047763|NCT02013388|11172989|FG002|COMPLETED|Overall Study||6
10047764|NCT02013388|11172990|FG003|COMPLETED|Overall Study||6
10047765|NCT02013388|11172991|FG004|COMPLETED|Overall Study||5
10047766|NCT02013388|11172992|FG005|COMPLETED|Overall Study||6
10047767|NCT02013388|11172993|FG006|COMPLETED|Overall Study||6
10047768|NCT02013388|11172994|FG007|COMPLETED|Overall Study||4
10047769|NCT02013388|11172987|FG000|NOT COMPLETED|Overall Study||1
10047770|NCT02013388|11172988|FG001|NOT COMPLETED|Overall Study||0
10047771|NCT02013388|11172989|FG002|NOT COMPLETED|Overall Study||0
10047772|NCT02013388|11172990|FG003|NOT COMPLETED|Overall Study||0
10047773|NCT02013388|11172991|FG004|NOT COMPLETED|Overall Study||1
10047774|NCT02013388|11172992|FG005|NOT COMPLETED|Overall Study||0
10047775|NCT02013388|11172993|FG006|NOT COMPLETED|Overall Study||0
10047776|NCT02013388|11172994|FG007|NOT COMPLETED|Overall Study||0
10047777|NCT02013531|11173016|FG000|STARTED|Overall Study||37
10047778|NCT02013531|11173016|FG000|COMPLETED|Overall Study||32
10047779|NCT02013531|11173016|FG000|NOT COMPLETED|Overall Study||5
10047780|NCT02013544|11173022|FG000|STARTED|Overall Study||182
10047781|NCT02013544|11173023|FG001|STARTED|Overall Study||376
10047782|NCT02013544|11173022|FG000|Safety Population|Overall Study||180
10047783|NCT02013544|11173023|FG001|Safety Population|Overall Study||374
10047784|NCT02013544|11173022|FG000|ITT Population|Overall Study||157
10047785|NCT02013544|11173023|FG001|ITT Population|Overall Study||325
10047786|NCT02013544|11173022|FG000|COMPLETED|Overall Study||171
10047787|NCT02013544|11173023|FG001|COMPLETED|Overall Study||356
10047788|NCT02013544|11173022|FG000|NOT COMPLETED|Overall Study||11
10047789|NCT02013544|11173023|FG001|NOT COMPLETED|Overall Study||20
10047790|NCT02013609|11173029|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
10047791|NCT02013609|11173029|FG000|COMPLETED|Overall Study||29
10047792|NCT02013609|11173029|FG000|NOT COMPLETED|Overall Study||18
10047793|NCT02013622|11173033|FG000|STARTED|Overall Study||49
10047794|NCT02013622|11173033|FG000|COMPLETED|Overall Study||25
10047795|NCT02013622|11173033|FG000|NOT COMPLETED|Overall Study||24
10047796|NCT02013674|11173039|FG000|STARTED|Overall Study||15
10047797|NCT02013674|11173040|FG001|STARTED|Overall Study||15
10047798|NCT02013674|11173039|FG000|COMPLETED|Overall Study||14
10047799|NCT02013674|11173040|FG001|COMPLETED|Overall Study||14
10047800|NCT02013674|11173039|FG000|NOT COMPLETED|Overall Study||1
10047801|NCT02013674|11173040|FG001|NOT COMPLETED|Overall Study||1
10047802|NCT02013687|11173050|FG000|STARTED|Overall Study||6
10047803|NCT02013687|11173051|FG001|STARTED|Overall Study||6
10047804|NCT02013687|11173052|FG002|STARTED|Overall Study||16
10047805|NCT02013687|11173053|FG003|STARTED|Overall Study||16
10047806|NCT02013687|11173050|FG000|COMPLETED|Overall Study||6
10047807|NCT02013687|11173051|FG001|COMPLETED|Overall Study||6
10047808|NCT02013687|11173052|FG002|COMPLETED|Overall Study||14
10047809|NCT02013687|11173053|FG003|COMPLETED|Overall Study||14
10047810|NCT02013687|11173050|FG000|NOT COMPLETED|Overall Study||0
10047811|NCT02013687|11173051|FG001|NOT COMPLETED|Overall Study||0
10047812|NCT02013687|11173052|FG002|NOT COMPLETED|Overall Study||2
10047813|NCT02013687|11173053|FG003|NOT COMPLETED|Overall Study||2
10047814|NCT02013765|11173067|FG000|STARTED|Overall Study||5
10047815|NCT02013765|11173067|FG000|COMPLETED|Overall Study||4
10047816|NCT02013765|11173067|FG000|NOT COMPLETED|Overall Study||1
10047817|NCT02013778|11173071|FG000|STARTED|Overall Study||8
10047818|NCT02013778|11173071|FG000|COMPLETED|Overall Study||1
10047819|NCT02013778|11173071|FG000|NOT COMPLETED|Overall Study||7
10047820|NCT02013791|11173084|FG000|STARTED|Period 1||8
10047821|NCT02013791|11173085|FG001|STARTED|Period 1||8
10047822|NCT02013791|11173086|FG002|STARTED|Period 1||4
10047823|NCT02013791|11173087|FG003|STARTED|Period 1||8
10047824|NCT02013791|11173088|FG004|STARTED|Period 1||4
10047825|NCT02013791|11173089|FG005|STARTED|Period 1||8
10047826|NCT02013791|11173090|FG006|STARTED|Period 1||4
10047827|NCT02013791|11173091|FG007|STARTED|Period 1||8
10047828|NCT02013791|11173092|FG008|STARTED|Period 1||3
10047829|NCT02013791|11173084|FG000|COMPLETED|Period 1||8
10117894|NCT02543294|11248728|FG000|STARTED|Overall Study||20
10117895|NCT02543294|11248728|FG000|COMPLETED|Overall Study||8
10117896|NCT02543294|11248728|FG000|NOT COMPLETED|Overall Study||12
10117897|NCT02543346|11248733|FG000|STARTED|First Priming Visit||26
10117898|NCT02543346|11248734|FG001|STARTED|First Priming Visit||25
10117899|NCT02543346|11248735|FG002|STARTED|First Priming Visit||24
10117900|NCT02543346|11248736|FG003|STARTED|First Priming Visit||23
10117901|NCT02543346|11248733|FG000|COMPLETED|First Priming Visit||26
10117902|NCT02543346|11248734|FG001|COMPLETED|First Priming Visit||25
10117903|NCT02543346|11248735|FG002|COMPLETED|First Priming Visit||24
10117904|NCT02543346|11248736|FG003|COMPLETED|First Priming Visit||23
10117905|NCT02543346|11248733|FG000|NOT COMPLETED|First Priming Visit||0
10117906|NCT02543346|11248734|FG001|NOT COMPLETED|First Priming Visit||0
10117907|NCT02543346|11248735|FG002|NOT COMPLETED|First Priming Visit||0
10117908|NCT02543346|11248736|FG003|NOT COMPLETED|First Priming Visit||0
10117909|NCT02543346|11248733|FG000|STARTED|First Treatment Visit||26
10117910|NCT02543346|11248734|FG001|STARTED|First Treatment Visit||25
10117911|NCT02543346|11248735|FG002|STARTED|First Treatment Visit||24
10047830|NCT02013791|11173085|FG001|COMPLETED|Period 1||6
10047831|NCT02013791|11173086|FG002|COMPLETED|Period 1||4
10047832|NCT02013791|11173087|FG003|COMPLETED|Period 1||7
10047833|NCT02013791|11173088|FG004|COMPLETED|Period 1||4
10047834|NCT02013791|11173089|FG005|COMPLETED|Period 1||8
10047835|NCT02013791|11173090|FG006|COMPLETED|Period 1||3
10047836|NCT02013791|11173091|FG007|COMPLETED|Period 1||7
10047837|NCT02013791|11173092|FG008|COMPLETED|Period 1||3
10047838|NCT02013791|11173084|FG000|NOT COMPLETED|Period 1||0
10047839|NCT02013791|11173085|FG001|NOT COMPLETED|Period 1||2
10047840|NCT02013791|11173086|FG002|NOT COMPLETED|Period 1||0
10047841|NCT02013791|11173087|FG003|NOT COMPLETED|Period 1||1
10047842|NCT02013791|11173088|FG004|NOT COMPLETED|Period 1||0
10047843|NCT02013791|11173089|FG005|NOT COMPLETED|Period 1||0
10047844|NCT02013791|11173090|FG006|NOT COMPLETED|Period 1||1
10047845|NCT02013791|11173091|FG007|NOT COMPLETED|Period 1||1
10047846|NCT02013791|11173092|FG008|NOT COMPLETED|Period 1||0
10047847|NCT02013791|11173084|FG000|STARTED|Period 2||0
10047848|NCT02013791|11173085|FG001|STARTED|Period 2||0
10047849|NCT02013791|11173086|FG002|STARTED|Period 2||2
10047850|NCT02013791|11173087|FG003|STARTED|Period 2||0
10047851|NCT02013791|11173088|FG004|STARTED|Period 2||0
10047852|NCT02013791|11173089|FG005|STARTED|Period 2||0
10047853|NCT02013791|11173090|FG006|STARTED|Period 2||3
10047854|NCT02013791|11173091|FG007|STARTED|Period 2||0
10047855|NCT02013791|11173092|FG008|STARTED|Period 2||0
10047856|NCT02013791|11173084|FG000|COMPLETED|Period 2||0
10047857|NCT02013791|11173085|FG001|COMPLETED|Period 2||0
10047858|NCT02013791|11173086|FG002|COMPLETED|Period 2||2
10047859|NCT02013791|11173087|FG003|COMPLETED|Period 2||0
10047860|NCT02013791|11173088|FG004|COMPLETED|Period 2||0
10047861|NCT02013791|11173089|FG005|COMPLETED|Period 2||0
10047862|NCT02013791|11173090|FG006|COMPLETED|Period 2||3
10117912|NCT02543346|11248736|FG003|STARTED|First Treatment Visit||23
10117913|NCT02543346|11248733|FG000|COMPLETED|First Treatment Visit||26
10117914|NCT02543346|11248734|FG001|COMPLETED|First Treatment Visit||25
10117915|NCT02543346|11248735|FG002|COMPLETED|First Treatment Visit||24
10117916|NCT02543346|11248736|FG003|COMPLETED|First Treatment Visit||23
10117917|NCT02543346|11248733|FG000|NOT COMPLETED|First Treatment Visit||0
10117918|NCT02543346|11248734|FG001|NOT COMPLETED|First Treatment Visit||0
10117919|NCT02543346|11248735|FG002|NOT COMPLETED|First Treatment Visit||0
10047863|NCT02013791|11173091|FG007|COMPLETED|Period 2||0
10047864|NCT02013791|11173092|FG008|COMPLETED|Period 2||0
10047865|NCT02013791|11173084|FG000|NOT COMPLETED|Period 2||0
10047866|NCT02013791|11173085|FG001|NOT COMPLETED|Period 2||0
10047867|NCT02013791|11173086|FG002|NOT COMPLETED|Period 2||0
10047868|NCT02013791|11173087|FG003|NOT COMPLETED|Period 2||0
10047869|NCT02013791|11173088|FG004|NOT COMPLETED|Period 2||0
10047870|NCT02013791|11173089|FG005|NOT COMPLETED|Period 2||0
10047871|NCT02013791|11173090|FG006|NOT COMPLETED|Period 2||0
10047872|NCT02013791|11173091|FG007|NOT COMPLETED|Period 2||0
10047873|NCT02013791|11173092|FG008|NOT COMPLETED|Period 2||0
10047874|NCT02013817|11173113|FG000|STARTED|Overall Study||43
10047875|NCT02013817|11173113|FG000|COMPLETED|Overall Study||16
10047876|NCT02013817|11173113|FG000|NOT COMPLETED|Overall Study||27
10047877|NCT02013830|11173117|FG000|STARTED|Overall Study||45
10047878|NCT02013830|11173117|FG000|COMPLETED|Overall Study||15
10047879|NCT02013830|11173117|FG000|NOT COMPLETED|Overall Study||30
10047880|NCT02014051|11173121|FG000|STARTED|Overall Study||3
10117920|NCT02543346|11248736|FG003|NOT COMPLETED|First Treatment Visit||0
10117921|NCT02543346|11248733|FG000|STARTED|Washout (at Least 14 Days)||26
10117922|NCT02543346|11248734|FG001|STARTED|Washout (at Least 14 Days)||25
10117923|NCT02543346|11248735|FG002|STARTED|Washout (at Least 14 Days)||24
10117924|NCT02543346|11248736|FG003|STARTED|Washout (at Least 14 Days)||23
10047881|NCT02014051|11173122|FG001|STARTED|Overall Study||6
10047882|NCT02014051|11173121|FG000|COMPLETED|Overall Study||2
10047883|NCT02014051|11173122|FG001|COMPLETED|Overall Study||5
10047884|NCT02014051|11173121|FG000|NOT COMPLETED|Overall Study||1
10047885|NCT02014051|11173122|FG001|NOT COMPLETED|Overall Study||1
10047886|NCT02014116|11173138|FG000|STARTED|Overall Study||3
10047887|NCT02014116|11173139|FG001|STARTED|Overall Study||4
10047888|NCT02014116|11173140|FG002|STARTED|Overall Study||3
10047889|NCT02014116|11173141|FG003|STARTED|Overall Study||7
10047890|NCT02014116|11173142|FG004|STARTED|Overall Study||2
10047891|NCT02014116|11173143|FG005|STARTED|Overall Study||16
10047892|NCT02014116|11173144|FG006|STARTED|Overall Study||1
10047893|NCT02014116|11173145|FG007|STARTED|Overall Study||5
10047894|NCT02014116|11173146|FG008|STARTED|Overall Study||10
10047895|NCT02014116|11173138|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10047896|NCT02014116|11173139|FG001|Received at Least One Dose of Study Drug|Overall Study||4
10047897|NCT02014116|11173140|FG002|Received at Least One Dose of Study Drug|Overall Study||3
10047898|NCT02014116|11173141|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10047899|NCT02014116|11173142|FG004|Received at Least One Dose of Study Drug|Overall Study||2
10047900|NCT02014116|11173143|FG005|Received at Least One Dose of Study Drug|Overall Study||16
10047901|NCT02014116|11173144|FG006|Received at Least One Dose of Study Drug|Overall Study||1
10047902|NCT02014116|11173145|FG007|Received at Least One Dose of Study Drug|Overall Study||5
10047903|NCT02014116|11173146|FG008|Received at Least One Dose of Study Drug|Overall Study||10
10047904|NCT02014116|11173138|FG000|COMPLETED|Overall Study||0
10047905|NCT02014116|11173139|FG001|COMPLETED|Overall Study||0
10047906|NCT02014116|11173140|FG002|COMPLETED|Overall Study||0
10047907|NCT02014116|11173141|FG003|COMPLETED|Overall Study||0
10047908|NCT02014116|11173142|FG004|COMPLETED|Overall Study||0
10047909|NCT02014116|11173143|FG005|COMPLETED|Overall Study||0
10047910|NCT02014116|11173144|FG006|COMPLETED|Overall Study||0
10047911|NCT02014116|11173145|FG007|COMPLETED|Overall Study||0
10047912|NCT02014116|11173146|FG008|COMPLETED|Overall Study||0
10047913|NCT02014116|11173138|FG000|NOT COMPLETED|Overall Study||3
10047914|NCT02014116|11173139|FG001|NOT COMPLETED|Overall Study||4
10047915|NCT02014116|11173140|FG002|NOT COMPLETED|Overall Study||3
10047916|NCT02014116|11173141|FG003|NOT COMPLETED|Overall Study||7
10047917|NCT02014116|11173142|FG004|NOT COMPLETED|Overall Study||2
10047918|NCT02014116|11173143|FG005|NOT COMPLETED|Overall Study||16
10047919|NCT02014116|11173144|FG006|NOT COMPLETED|Overall Study||1
10047920|NCT02014116|11173145|FG007|NOT COMPLETED|Overall Study||5
10047921|NCT02014116|11173146|FG008|NOT COMPLETED|Overall Study||10
10047922|NCT02014129|11173172|FG000|STARTED|Overall Study||3
10047923|NCT02014129|11173173|FG001|STARTED|Overall Study||3
10047924|NCT02014129|11173174|FG002|STARTED|Overall Study||6
10047925|NCT02014129|11173172|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10047926|NCT02014129|11173173|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10047927|NCT02014129|11173174|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10047928|NCT02014129|11173172|FG000|COMPLETED|Overall Study||3
10047929|NCT02014129|11173173|FG001|COMPLETED|Overall Study||3
10047930|NCT02014129|11173174|FG002|COMPLETED|Overall Study||6
10047931|NCT02014129|11173172|FG000|NOT COMPLETED|Overall Study||0
10047932|NCT02014129|11173173|FG001|NOT COMPLETED|Overall Study||0
10047933|NCT02014129|11173174|FG002|NOT COMPLETED|Overall Study||0
10047934|NCT02014272|11173182|FG000|STARTED|Intervention Period 1||14
10047935|NCT02014272|11173183|FG001|STARTED|Intervention Period 1||14
10047936|NCT02014272|11173182|FG000|COMPLETED|Intervention Period 1||13
10047937|NCT02014272|11173183|FG001|COMPLETED|Intervention Period 1||13
10047938|NCT02014272|11173182|FG000|NOT COMPLETED|Intervention Period 1||1
10047939|NCT02014272|11173183|FG001|NOT COMPLETED|Intervention Period 1||1
10047940|NCT02014272|11173182|FG000|STARTED|Washout Period 1 (7 Days)||13
10047941|NCT02014272|11173183|FG001|STARTED|Washout Period 1 (7 Days)||13
10047942|NCT02014272|11173182|FG000|COMPLETED|Washout Period 1 (7 Days)||13
10047943|NCT02014272|11173183|FG001|COMPLETED|Washout Period 1 (7 Days)||13
10047944|NCT02014272|11173182|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10047945|NCT02014272|11173183|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10047946|NCT02014272|11173182|FG000|STARTED|Intervention Period 2||13
10047947|NCT02014272|11173183|FG001|STARTED|Intervention Period 2||13
10047948|NCT02014272|11173182|FG000|COMPLETED|Intervention Period 2||13
10047949|NCT02014272|11173183|FG001|COMPLETED|Intervention Period 2||13
10047950|NCT02014272|11173182|FG000|NOT COMPLETED|Intervention Period 2||0
10047951|NCT02014272|11173183|FG001|NOT COMPLETED|Intervention Period 2||0
10047952|NCT02014363|11173192|FG000|STARTED|Overall Study||55
10047953|NCT02014363|11173193|FG001|STARTED|Overall Study||54
10047954|NCT02014363|11173194|FG002|STARTED|Overall Study||55
10047955|NCT02014363|11173192|FG000|COMPLETED|Overall Study||38
10047956|NCT02014363|11173193|FG001|COMPLETED|Overall Study||35
10047957|NCT02014363|11173194|FG002|COMPLETED|Overall Study||31
10047958|NCT02014363|11173192|FG000|NOT COMPLETED|Overall Study||17
10047959|NCT02014363|11173193|FG001|NOT COMPLETED|Overall Study||19
10047960|NCT02014363|11173194|FG002|NOT COMPLETED|Overall Study||24
10047961|NCT02014376|11173205|FG000|STARTED|Overall Study||15
10047962|NCT02014376|11173206|FG001|STARTED|Overall Study||16
10047963|NCT02014376|11173207|FG002|STARTED|Overall Study||17
10047964|NCT02014376|11173205|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10047965|NCT02014376|11173206|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10047966|NCT02014376|11173207|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17
10047967|NCT02014376|11173205|FG000|COMPLETED|Overall Study||12
10047968|NCT02014376|11173206|FG001|COMPLETED|Overall Study||15
10047969|NCT02014376|11173207|FG002|COMPLETED|Overall Study||17
10047970|NCT02014376|11173205|FG000|NOT COMPLETED|Overall Study||3
10047971|NCT02014376|11173206|FG001|NOT COMPLETED|Overall Study||1
10047972|NCT02014376|11173207|FG002|NOT COMPLETED|Overall Study||0
10047973|NCT02014402|11173219|FG000|STARTED|Overall Study||31
10047974|NCT02014402|11173220|FG001|STARTED|Overall Study||30
10047975|NCT02014402|11173221|FG002|STARTED|Overall Study||35
10047976|NCT02014402|11173222|FG003|STARTED|Overall Study||85
10047977|NCT02014402|11173219|FG000|Human Thrombin|Overall Study||20
9706599|NCT02111850|10805647|FG005|COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706600|NCT02111850|10805648|FG006|COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706601|NCT02111850|10805649|FG007|COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706602|NCT02111850|10805650|FG008|COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706603|NCT02111850|10805651|FG009|COMPLETED|Phase 2 Maximum Tolerated Dose||5
10047978|NCT02014402|11173220|FG001|Human Thrombin|Overall Study||20
10047979|NCT02014402|11173221|FG002|Human Thrombin|Overall Study||23
10047980|NCT02014402|11173222|FG003|Human Thrombin|Overall Study||57
10047981|NCT02014402|11173219|FG000|Bovine Thrombin|Overall Study||11
10117925|NCT02543346|11248733|FG000|COMPLETED|Washout (at Least 14 Days)||26
10117926|NCT02543346|11248734|FG001|COMPLETED|Washout (at Least 14 Days)||25
10117927|NCT02543346|11248735|FG002|COMPLETED|Washout (at Least 14 Days)||24
10117928|NCT02543346|11248736|FG003|COMPLETED|Washout (at Least 14 Days)||23
10117929|NCT02543346|11248733|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
10047982|NCT02014402|11173220|FG001|Bovine Thrombin|Overall Study||10
10047983|NCT02014402|11173221|FG002|Bovine Thrombin|Overall Study||12
10047984|NCT02014402|11173222|FG003|Bovine Thrombin|Overall Study||28
10047985|NCT02014402|11173219|FG000|COMPLETED|Overall Study||29
10047986|NCT02014402|11173220|FG001|COMPLETED|Overall Study||27
10047987|NCT02014402|11173221|FG002|COMPLETED|Overall Study||32
10047988|NCT02014402|11173222|FG003|COMPLETED|Overall Study||82
10047989|NCT02014402|11173219|FG000|NOT COMPLETED|Overall Study||2
10047990|NCT02014402|11173220|FG001|NOT COMPLETED|Overall Study||3
10047991|NCT02014402|11173221|FG002|NOT COMPLETED|Overall Study||3
10047992|NCT02014402|11173222|FG003|NOT COMPLETED|Overall Study||3
10047993|NCT02014441|11173239|FG000|STARTED|Overall Study||61
10047994|NCT02014441|11173239|FG000|Received Treatment|Overall Study||60
10047995|NCT02014441|11173239|FG000|COMPLETED|Overall Study||49
10047996|NCT02014441|11173239|FG000|NOT COMPLETED|Overall Study||12
10047997|NCT02014467|11173247|FG000|STARTED|Overall Study||365
10047998|NCT02014467|11173248|FG001|STARTED|Overall Study||119
10047999|NCT02014467|11173247|FG000|COMPLETED|Overall Study||340
10048000|NCT02014467|11173248|FG001|COMPLETED|Overall Study||112
10048001|NCT02014467|11173247|FG000|NOT COMPLETED|Overall Study||25
10048002|NCT02014467|11173248|FG001|NOT COMPLETED|Overall Study||7
10048003|NCT02014480|11173254|FG000|STARTED|Treatment Period 1 (14 Days)||35
10048004|NCT02014480|11173255|FG001|STARTED|Treatment Period 1 (14 Days)||35
10048005|NCT02014480|11173256|FG002|STARTED|Treatment Period 1 (14 Days)||34
10048006|NCT02014480|11173257|FG003|STARTED|Treatment Period 1 (14 Days)||34
10048007|NCT02014480|11173258|FG004|STARTED|Treatment Period 1 (14 Days)||35
10048008|NCT02014480|11173259|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
10048009|NCT02014480|11173254|FG000|COMPLETED|Treatment Period 1 (14 Days)||35
10048010|NCT02014480|11173255|FG001|COMPLETED|Treatment Period 1 (14 Days)||34
10048011|NCT02014480|11173256|FG002|COMPLETED|Treatment Period 1 (14 Days)||33
10048012|NCT02014480|11173257|FG003|COMPLETED|Treatment Period 1 (14 Days)||32
10048013|NCT02014480|11173258|FG004|COMPLETED|Treatment Period 1 (14 Days)||34
10048014|NCT02014480|11173259|FG005|COMPLETED|Treatment Period 1 (14 Days)||34
10048015|NCT02014480|11173254|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10048016|NCT02014480|11173255|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10048017|NCT02014480|11173256|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10048018|NCT02014480|11173257|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10048019|NCT02014480|11173258|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10048020|NCT02014480|11173259|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10048021|NCT02014480|11173254|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35
10048022|NCT02014480|11173255|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34
10048023|NCT02014480|11173256|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33
10048024|NCT02014480|11173257|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32
10048025|NCT02014480|11173258|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34
10048026|NCT02014480|11173259|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34
10048027|NCT02014480|11173254|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35
10048028|NCT02014480|11173255|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34
10048029|NCT02014480|11173256|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32
10048030|NCT02014480|11173257|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32
10048031|NCT02014480|11173258|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34
10048032|NCT02014480|11173259|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34
10048033|NCT02014480|11173254|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10048034|NCT02014480|11173255|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
9706604|NCT02111850|10805652|FG010|COMPLETED|Phase 2 Maximum Tolerated Dose||1
10048035|NCT02014480|11173256|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
10048036|NCT02014480|11173257|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10048037|NCT02014480|11173258|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10117930|NCT02543346|11248734|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
10048038|NCT02014480|11173259|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10048039|NCT02014480|11173254|FG000|STARTED|Treatment Period 2 (14 Days)||35
10048040|NCT02014480|11173255|FG001|STARTED|Treatment Period 2 (14 Days)||34
10048041|NCT02014480|11173256|FG002|STARTED|Treatment Period 2 (14 Days)||32
10048042|NCT02014480|11173257|FG003|STARTED|Treatment Period 2 (14 Days)||32
10048043|NCT02014480|11173258|FG004|STARTED|Treatment Period 2 (14 Days)||34
10048044|NCT02014480|11173259|FG005|STARTED|Treatment Period 2 (14 Days)||34
10048045|NCT02014480|11173254|FG000|COMPLETED|Treatment Period 2 (14 Days)||34
10048046|NCT02014480|11173255|FG001|COMPLETED|Treatment Period 2 (14 Days)||33
10048047|NCT02014480|11173256|FG002|COMPLETED|Treatment Period 2 (14 Days)||30
10048048|NCT02014480|11173257|FG003|COMPLETED|Treatment Period 2 (14 Days)||31
10048049|NCT02014480|11173258|FG004|COMPLETED|Treatment Period 2 (14 Days)||34
10048050|NCT02014480|11173259|FG005|COMPLETED|Treatment Period 2 (14 Days)||34
10048051|NCT02014480|11173254|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10048052|NCT02014480|11173255|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10048053|NCT02014480|11173256|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
10048054|NCT02014480|11173257|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10048055|NCT02014480|11173258|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10048056|NCT02014480|11173259|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10048057|NCT02014480|11173254|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34
10048058|NCT02014480|11173255|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33
10048059|NCT02014480|11173256|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30
10048060|NCT02014480|11173257|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31
10048061|NCT02014480|11173258|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34
10048062|NCT02014480|11173259|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34
10048063|NCT02014480|11173254|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34
10048064|NCT02014480|11173255|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33
10048065|NCT02014480|11173256|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30
10048066|NCT02014480|11173257|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31
10048067|NCT02014480|11173258|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34
10048068|NCT02014480|11173259|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34
10048069|NCT02014480|11173254|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10048070|NCT02014480|11173255|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10048071|NCT02014480|11173256|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10048072|NCT02014480|11173257|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10048073|NCT02014480|11173258|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10048074|NCT02014480|11173259|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10048075|NCT02014480|11173254|FG000|STARTED|Treatment Period 3 (14 Days)||34
10048076|NCT02014480|11173255|FG001|STARTED|Treatment Period 3 (14 Days)||33
10048077|NCT02014480|11173256|FG002|STARTED|Treatment Period 3 (14 Days)||30
10048078|NCT02014480|11173257|FG003|STARTED|Treatment Period 3 (14 Days)||31
10048079|NCT02014480|11173258|FG004|STARTED|Treatment Period 3 (14 Days)||34
10048080|NCT02014480|11173259|FG005|STARTED|Treatment Period 3 (14 Days)||34
10048081|NCT02014480|11173254|FG000|COMPLETED|Treatment Period 3 (14 Days)||34
10048082|NCT02014480|11173255|FG001|COMPLETED|Treatment Period 3 (14 Days)||32
10048083|NCT02014480|11173256|FG002|COMPLETED|Treatment Period 3 (14 Days)||29
10048084|NCT02014480|11173257|FG003|COMPLETED|Treatment Period 3 (14 Days)||31
10048085|NCT02014480|11173258|FG004|COMPLETED|Treatment Period 3 (14 Days)||34
10048086|NCT02014480|11173259|FG005|COMPLETED|Treatment Period 3 (14 Days)||32
10048087|NCT02014480|11173254|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10048088|NCT02014480|11173255|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10048089|NCT02014480|11173256|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10048090|NCT02014480|11173257|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10048091|NCT02014480|11173258|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10048092|NCT02014480|11173259|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
10048093|NCT02014519|11173267|FG000|STARTED|Overall Study||2000
10048094|NCT02014519|11173267|FG000|COMPLETED|Overall Study||2000
10048095|NCT02014519|11173267|FG000|NOT COMPLETED|Overall Study||0
10048096|NCT02014584|11173281|FG000|STARTED|Double-Blind Period (24 Weeks)||59
10048097|NCT02014584|11173282|FG001|STARTED|Double-Blind Period (24 Weeks)||58
10048098|NCT02014584|11173283|FG002|STARTED|Double-Blind Period (24 Weeks)||0
10048099|NCT02014584|11173284|FG003|STARTED|Double-Blind Period (24 Weeks)||0
10048100|NCT02014584|11173285|FG004|STARTED|Double-Blind Period (24 Weeks)||0
10048101|NCT02014584|11173286|FG005|STARTED|Double-Blind Period (24 Weeks)||0
10048102|NCT02014584|11173281|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57
10048103|NCT02014584|11173282|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52
10048104|NCT02014584|11173283|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0
10048105|NCT02014584|11173284|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0
10048106|NCT02014584|11173285|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0
10048107|NCT02014584|11173286|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0
10048108|NCT02014584|11173281|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
10048109|NCT02014584|11173282|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
10048110|NCT02014584|11173283|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10048111|NCT02014584|11173284|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10048112|NCT02014584|11173285|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10048113|NCT02014584|11173286|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10048114|NCT02014584|11173281|FG000|STARTED|Open-Label Period (24 Weeks)||0
10048115|NCT02014584|11173282|FG001|STARTED|Open-Label Period (24 Weeks)||0
10048116|NCT02014584|11173283|FG002|STARTED|Open-Label Period (24 Weeks)||49
10117931|NCT02543346|11248735|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
10117932|NCT02543346|11248736|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
10117933|NCT02543346|11248733|FG000|STARTED|Second Priming Visit||26
10117934|NCT02543346|11248734|FG001|STARTED|Second Priming Visit||25
10117935|NCT02543346|11248735|FG002|STARTED|Second Priming Visit||24
10117936|NCT02543346|11248736|FG003|STARTED|Second Priming Visit||23
10048117|NCT02014584|11173284|FG003|STARTED|Open-Label Period (24 Weeks)||48
10048118|NCT02014584|11173285|FG004|STARTED|Open-Label Period (24 Weeks)||0
10048119|NCT02014584|11173286|FG005|STARTED|Open-Label Period (24 Weeks)||0
10048120|NCT02014584|11173281|FG000|COMPLETED|Open-Label Period (24 Weeks)||0
10048121|NCT02014584|11173282|FG001|COMPLETED|Open-Label Period (24 Weeks)||0
10048122|NCT02014584|11173283|FG002|COMPLETED|Open-Label Period (24 Weeks)||44
10048123|NCT02014584|11173284|FG003|COMPLETED|Open-Label Period (24 Weeks)||47
10048124|NCT02014584|11173285|FG004|COMPLETED|Open-Label Period (24 Weeks)||0
10048125|NCT02014584|11173286|FG005|COMPLETED|Open-Label Period (24 Weeks)||0
10048126|NCT02014584|11173281|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10048127|NCT02014584|11173282|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10048128|NCT02014584|11173283|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5
10048129|NCT02014584|11173284|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1
10048130|NCT02014584|11173285|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10048131|NCT02014584|11173286|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10048132|NCT02014584|11173281|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10048133|NCT02014584|11173282|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10048134|NCT02014584|11173283|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10048135|NCT02014584|11173284|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10048136|NCT02014584|11173285|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
10048137|NCT02014584|11173286|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
10048138|NCT02014584|11173281|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048139|NCT02014584|11173282|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048140|NCT02014584|11173283|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048141|NCT02014584|11173284|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048142|NCT02014584|11173285|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
10048143|NCT02014584|11173286|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
10048144|NCT02014584|11173281|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048145|NCT02014584|11173282|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048146|NCT02014584|11173283|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048147|NCT02014584|11173284|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048148|NCT02014584|11173285|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
10048149|NCT02014584|11173286|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10048150|NCT02014597|11173300|FG000|STARTED|Overall Study||12
10117937|NCT02543346|11248733|FG000|COMPLETED|Second Priming Visit||25
10117938|NCT02543346|11248734|FG001|COMPLETED|Second Priming Visit||23
10117939|NCT02543346|11248735|FG002|COMPLETED|Second Priming Visit||22
10117940|NCT02543346|11248736|FG003|COMPLETED|Second Priming Visit||21
10117941|NCT02543346|11248733|FG000|NOT COMPLETED|Second Priming Visit||1
10117942|NCT02543346|11248734|FG001|NOT COMPLETED|Second Priming Visit||2
10117943|NCT02543346|11248735|FG002|NOT COMPLETED|Second Priming Visit||2
10117944|NCT02543346|11248736|FG003|NOT COMPLETED|Second Priming Visit||2
10117945|NCT02543346|11248733|FG000|STARTED|Second Treatment Visit||25
10117946|NCT02543346|11248734|FG001|STARTED|Second Treatment Visit||23
10117947|NCT02543346|11248735|FG002|STARTED|Second Treatment Visit||22
10117948|NCT02543346|11248736|FG003|STARTED|Second Treatment Visit||21
10117949|NCT02543346|11248733|FG000|COMPLETED|Second Treatment Visit||25
10117950|NCT02543346|11248734|FG001|COMPLETED|Second Treatment Visit||23
10117951|NCT02543346|11248735|FG002|COMPLETED|Second Treatment Visit||22
10117952|NCT02543346|11248736|FG003|COMPLETED|Second Treatment Visit||21
10117953|NCT02543346|11248733|FG000|NOT COMPLETED|Second Treatment Visit||0
10117954|NCT02543346|11248734|FG001|NOT COMPLETED|Second Treatment Visit||0
10117955|NCT02543346|11248735|FG002|NOT COMPLETED|Second Treatment Visit||0
10117956|NCT02543346|11248736|FG003|NOT COMPLETED|Second Treatment Visit||0
10117957|NCT02543398|11248748|FG000|STARTED|Overall Study||20
10117958|NCT02543398|11248749|FG001|STARTED|Overall Study||20
10117959|NCT02543398|11248748|FG000|COMPLETED|Overall Study||20
10117960|NCT02543398|11248749|FG001|COMPLETED|Overall Study||20
10117961|NCT02543398|11248748|FG000|NOT COMPLETED|Overall Study||0
10117962|NCT02543398|11248749|FG001|NOT COMPLETED|Overall Study||0
10117963|NCT02543437|11248755|FG000|STARTED|Overall Study||117
10048151|NCT02014597|11173301|FG001|STARTED|Overall Study||11
10048152|NCT02014597|11173300|FG000|COMPLETED|Overall Study||10
10048153|NCT02014597|11173301|FG001|COMPLETED|Overall Study||10
10048154|NCT02014597|11173300|FG000|NOT COMPLETED|Overall Study||2
10117964|NCT02543437|11248755|FG000|COMPLETED|Overall Study||117
10117965|NCT02543437|11248755|FG000|NOT COMPLETED|Overall Study||0
10117966|NCT02543528|11248759|FG000|STARTED|Adaptation Period||0
10117967|NCT02543528|11248760|FG001|STARTED|Adaptation Period||0
10117968|NCT02543528|11248761|FG002|STARTED|Adaptation Period||0
10117969|NCT02543528|11248762|FG003|STARTED|Adaptation Period||0
10117970|NCT02543528|11248763|FG004|STARTED|Adaptation Period||168
10117971|NCT02543528|11248759|FG000|COMPLETED|Adaptation Period||0
10048155|NCT02014597|11173301|FG001|NOT COMPLETED|Overall Study||1
10048156|NCT02014740|11173309|FG000|STARTED|Overall Study||55
10048157|NCT02014740|11173310|FG001|STARTED|Overall Study||45
10048158|NCT02014740|11173309|FG000|COMPLETED|Overall Study||49
10048159|NCT02014740|11173310|FG001|COMPLETED|Overall Study||40
10048160|NCT02014740|11173309|FG000|NOT COMPLETED|Overall Study||6
10048161|NCT02014740|11173310|FG001|NOT COMPLETED|Overall Study||5
10048162|NCT02015039|11173318|FG000|STARTED|Overall Study||6
10048163|NCT02015039|11173319|FG001|STARTED|Overall Study||7
10048164|NCT02015039|11173318|FG000|COMPLETED|Overall Study||6
10048165|NCT02015039|11173319|FG001|COMPLETED|Overall Study||6
10048166|NCT02015039|11173318|FG000|NOT COMPLETED|Overall Study||0
10048167|NCT02015039|11173319|FG001|NOT COMPLETED|Overall Study||1
10048168|NCT02015065|11173328|FG000|STARTED|Overall Study||2
10048169|NCT02015065|11173329|FG001|STARTED|Overall Study||5
10048170|NCT02015065|11173330|FG002|STARTED|Overall Study||2
10048171|NCT02015065|11173328|FG000|COMPLETED|Overall Study||1
10048172|NCT02015065|11173329|FG001|COMPLETED|Overall Study||3
10048173|NCT02015065|11173330|FG002|COMPLETED|Overall Study||1
10048174|NCT02015065|11173328|FG000|NOT COMPLETED|Overall Study||1
10048175|NCT02015065|11173329|FG001|NOT COMPLETED|Overall Study||2
10048176|NCT02015065|11173330|FG002|NOT COMPLETED|Overall Study||1
10048177|NCT02015104|11173340|FG000|STARTED|Overall Study||16
10048178|NCT02015104|11173341|FG001|STARTED|Overall Study||16
10048179|NCT02015104|11173340|FG000|COMPLETED|Overall Study||15
10048180|NCT02015104|11173341|FG001|COMPLETED|Overall Study||15
10048181|NCT02015104|11173340|FG000|NOT COMPLETED|Overall Study||1
10048182|NCT02015104|11173341|FG001|NOT COMPLETED|Overall Study||1
10048183|NCT02015195|11173357|FG000|STARTED|Overall Study||16
10048184|NCT02015195|11173358|FG001|STARTED|Overall Study||16
10048185|NCT02015195|11173359|FG002|STARTED|Overall Study||16
10048186|NCT02015195|11173360|FG003|STARTED|Overall Study||1
10048187|NCT02015195|11173361|FG004|STARTED|Overall Study||16
10048188|NCT02015195|11173362|FG005|STARTED|Overall Study||16
10048189|NCT02015195|11173363|FG006|STARTED|Overall Study||16
10048190|NCT02015195|11173357|FG000|COMPLETED|Overall Study||16
10048191|NCT02015195|11173358|FG001|COMPLETED|Overall Study||16
10048192|NCT02015195|11173359|FG002|COMPLETED|Overall Study||16
10048193|NCT02015195|11173360|FG003|COMPLETED|Overall Study||0
10048194|NCT02015195|11173361|FG004|COMPLETED|Overall Study||16
10048195|NCT02015195|11173362|FG005|COMPLETED|Overall Study||16
10048196|NCT02015195|11173363|FG006|COMPLETED|Overall Study||16
10048197|NCT02015195|11173357|FG000|NOT COMPLETED|Overall Study||0
10048198|NCT02015195|11173358|FG001|NOT COMPLETED|Overall Study||0
10048199|NCT02015195|11173359|FG002|NOT COMPLETED|Overall Study||0
10048200|NCT02015195|11173360|FG003|NOT COMPLETED|Overall Study||1
10048201|NCT02015195|11173361|FG004|NOT COMPLETED|Overall Study||0
10048202|NCT02015195|11173362|FG005|NOT COMPLETED|Overall Study||0
10048203|NCT02015195|11173363|FG006|NOT COMPLETED|Overall Study||0
10117972|NCT02543528|11248760|FG001|COMPLETED|Adaptation Period||0
10117973|NCT02543528|11248761|FG002|COMPLETED|Adaptation Period||0
10117974|NCT02543528|11248762|FG003|COMPLETED|Adaptation Period||0
10117975|NCT02543528|11248763|FG004|COMPLETED|Adaptation Period||142
10117976|NCT02543528|11248759|FG000|NOT COMPLETED|Adaptation Period||0
10117977|NCT02543528|11248760|FG001|NOT COMPLETED|Adaptation Period||0
10117978|NCT02543528|11248761|FG002|NOT COMPLETED|Adaptation Period||0
10117979|NCT02543528|11248762|FG003|NOT COMPLETED|Adaptation Period||0
9706605|NCT02111850|10805642|FG000|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10048204|NCT02015221|11173380|FG000|STARTED|Overall Study||41
10048205|NCT02015221|11173381|FG001|STARTED|Overall Study||40
10048206|NCT02015221|11173380|FG000|COMPLETED|Overall Study||32
10048207|NCT02015221|11173381|FG001|COMPLETED|Overall Study||34
10048208|NCT02015221|11173380|FG000|NOT COMPLETED|Overall Study||9
10048209|NCT02015221|11173381|FG001|NOT COMPLETED|Overall Study||6
10048210|NCT02015234|11173389|FG000|STARTED|Overall Study||79
10048211|NCT02015234|11173390|FG001|STARTED|Overall Study||79
10048212|NCT02015234|11173389|FG000|COMPLETED|Overall Study||43
10048213|NCT02015234|11173390|FG001|COMPLETED|Overall Study||54
10048214|NCT02015234|11173389|FG000|NOT COMPLETED|Overall Study||36
10117980|NCT02543528|11248763|FG004|NOT COMPLETED|Adaptation Period||26
10048215|NCT02015234|11173390|FG001|NOT COMPLETED|Overall Study||25
10048216|NCT02015390|11173400|FG000|STARTED|Overall Study||9
10048217|NCT02015390|11173401|FG001|STARTED|Overall Study||7
10048218|NCT02015390|11173400|FG000|COMPLETED|Overall Study||8
10048219|NCT02015390|11173401|FG001|COMPLETED|Overall Study||3
10048220|NCT02015390|11173400|FG000|NOT COMPLETED|Overall Study||1
10048221|NCT02015390|11173401|FG001|NOT COMPLETED|Overall Study||4
10048222|NCT02015442|11173408|FG000|STARTED|First Intervention (7 Days)||5
10048223|NCT02015442|11173409|FG001|STARTED|First Intervention (7 Days)||4
10048224|NCT02015442|11173408|FG000|COMPLETED|First Intervention (7 Days)||5
10048225|NCT02015442|11173409|FG001|COMPLETED|First Intervention (7 Days)||4
10048226|NCT02015442|11173408|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10048227|NCT02015442|11173409|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10048228|NCT02015442|11173408|FG000|STARTED|Wash-out (4 Weeks)||5
10048229|NCT02015442|11173409|FG001|STARTED|Wash-out (4 Weeks)||4
10048230|NCT02015442|11173408|FG000|COMPLETED|Wash-out (4 Weeks)||5
10048231|NCT02015442|11173409|FG001|COMPLETED|Wash-out (4 Weeks)||4
10048232|NCT02015442|11173408|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
10048233|NCT02015442|11173409|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
10048234|NCT02015442|11173408|FG000|STARTED|Second Intervention (7 Days)||5
10048235|NCT02015442|11173409|FG001|STARTED|Second Intervention (7 Days)||4
10048236|NCT02015442|11173408|FG000|COMPLETED|Second Intervention (7 Days)||5
10048237|NCT02015442|11173409|FG001|COMPLETED|Second Intervention (7 Days)||4
10048238|NCT02015442|11173408|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10048239|NCT02015442|11173409|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10048240|NCT02015481|11173415|FG000|STARTED|Overall Study||25
10048241|NCT02015481|11173415|FG000|COMPLETED|Overall Study||24
10048242|NCT02015481|11173415|FG000|NOT COMPLETED|Overall Study||1
10048243|NCT02015520|11173424|FG000|STARTED|Overall Study||40
10048244|NCT02015520|11173425|FG001|STARTED|Overall Study||21
10048245|NCT02015520|11173426|FG002|STARTED|Overall Study||42
10048246|NCT02015520|11173427|FG003|STARTED|Overall Study||40
10048247|NCT02015520|11173424|FG000|COMPLETED|Overall Study||35
10048248|NCT02015520|11173425|FG001|COMPLETED|Overall Study||17
10048249|NCT02015520|11173426|FG002|COMPLETED|Overall Study||35
10048250|NCT02015520|11173427|FG003|COMPLETED|Overall Study||36
10048251|NCT02015520|11173424|FG000|NOT COMPLETED|Overall Study||5
10048252|NCT02015520|11173425|FG001|NOT COMPLETED|Overall Study||4
10048253|NCT02015520|11173426|FG002|NOT COMPLETED|Overall Study||7
10048254|NCT02015520|11173427|FG003|NOT COMPLETED|Overall Study||4
10048255|NCT02015546|11173440|FG000|STARTED|Overall Study||23
10048256|NCT02015546|11173441|FG001|STARTED|Overall Study||21
10048257|NCT02015546|11173442|FG002|STARTED|Overall Study||26
10048258|NCT02015546|11173440|FG000|COMPLETED|Overall Study||20
10048259|NCT02015546|11173441|FG001|COMPLETED|Overall Study||19
10048260|NCT02015546|11173442|FG002|COMPLETED|Overall Study||22
10048261|NCT02015546|11173440|FG000|NOT COMPLETED|Overall Study||3
10048262|NCT02015546|11173441|FG001|NOT COMPLETED|Overall Study||2
10048263|NCT02015546|11173442|FG002|NOT COMPLETED|Overall Study||4
10048264|NCT02015637|11173452|FG000|STARTED|Overall Study||306
10048265|NCT02015637|11173453|FG001|STARTED|Overall Study||154
10048266|NCT02015637|11173452|FG000|COMPLETED|Overall Study||298
10048267|NCT02015637|11173453|FG001|COMPLETED|Overall Study||149
10048268|NCT02015637|11173452|FG000|NOT COMPLETED|Overall Study||8
10048269|NCT02015637|11173453|FG001|NOT COMPLETED|Overall Study||5
10048270|NCT02015676|11173462|FG000|STARTED|Overall Study||15
10048271|NCT02015676|11173463|FG001|STARTED|Overall Study||48
10048272|NCT02015676|11173464|FG002|STARTED|Overall Study||6
10048273|NCT02015676|11173462|FG000|COMPLETED|Overall Study||6
10048274|NCT02015676|11173463|FG001|COMPLETED|Overall Study||14
10048275|NCT02015676|11173464|FG002|COMPLETED|Overall Study||3
10048276|NCT02015676|11173462|FG000|NOT COMPLETED|Overall Study||9
10048277|NCT02015676|11173463|FG001|NOT COMPLETED|Overall Study||34
10048278|NCT02015676|11173464|FG002|NOT COMPLETED|Overall Study||3
10048279|NCT02015754|11173468|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
10048280|NCT02015754|11173468|FG000|Completed First TACE|Overall Study||14
10048281|NCT02015754|11173468|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
10048282|NCT02015754|11173468|FG000|COMPLETED|Overall Study||3
10048283|NCT02015754|11173468|FG000|NOT COMPLETED|Overall Study||11
10048284|NCT02015793|11173474|FG000|STARTED|Overall Study||15
10048285|NCT02015793|11173475|FG001|STARTED|Overall Study||15
10048286|NCT02015793|11173474|FG000|Completed Double-Blind Period|Overall Study||14
10048287|NCT02015793|11173475|FG001|Completed Double-Blind Period|Overall Study||14
10048288|NCT02015793|11173474|FG000|Entered Open-label Extension Period|Overall Study||13
10048289|NCT02015793|11173475|FG001|Entered Open-label Extension Period|Overall Study||14
10048290|NCT02015793|11173474|FG000|COMPLETED|Overall Study||11
10048291|NCT02015793|11173475|FG001|COMPLETED|Overall Study||11
10048292|NCT02015793|11173474|FG000|NOT COMPLETED|Overall Study||4
10048293|NCT02015793|11173475|FG001|NOT COMPLETED|Overall Study||4
10048294|NCT02015819|11173491|FG000|STARTED|Overall Study||3
10048295|NCT02015819|11173492|FG001|STARTED|Overall Study||3
10048296|NCT02015819|11173493|FG002|STARTED|Overall Study||3
10048297|NCT02015819|11173494|FG003|STARTED|Overall Study||7
10048298|NCT02015819|11173491|FG000|COMPLETED|Overall Study||3
10048299|NCT02015819|11173492|FG001|COMPLETED|Overall Study||3
10048300|NCT02015819|11173493|FG002|COMPLETED|Overall Study||3
10048301|NCT02015819|11173494|FG003|COMPLETED|Overall Study||6
10048302|NCT02015819|11173491|FG000|NOT COMPLETED|Overall Study||0
10048303|NCT02015819|11173492|FG001|NOT COMPLETED|Overall Study||0
10048304|NCT02015819|11173493|FG002|NOT COMPLETED|Overall Study||0
10048305|NCT02015819|11173494|FG003|NOT COMPLETED|Overall Study||1
10048306|NCT02016105|11173510|FG000|STARTED|TREATMENT PERIOD 1||231
10048307|NCT02016105|11173511|FG001|STARTED|TREATMENT PERIOD 1||234
10048308|NCT02016105|11173512|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10048309|NCT02016105|11173513|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10048310|NCT02016105|11173514|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10048311|NCT02016105|11173515|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10048312|NCT02016105|11173510|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
10048313|NCT02016105|11173511|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
10048314|NCT02016105|11173512|FG002|COMPLETED|TREATMENT PERIOD 1||0
10048315|NCT02016105|11173513|FG003|COMPLETED|TREATMENT PERIOD 1||0
10048316|NCT02016105|11173514|FG004|COMPLETED|TREATMENT PERIOD 1||0
10048317|NCT02016105|11173515|FG005|COMPLETED|TREATMENT PERIOD 1||0
10048318|NCT02016105|11173510|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30
10048319|NCT02016105|11173511|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33
10048320|NCT02016105|11173512|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0
10048321|NCT02016105|11173513|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0
10048322|NCT02016105|11173514|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0
10048323|NCT02016105|11173515|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0
10048324|NCT02016105|11173510|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10048325|NCT02016105|11173511|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10048326|NCT02016105|11173512|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
10048327|NCT02016105|11173513|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
10048328|NCT02016105|11173514|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
10048329|NCT02016105|11173515|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
10048330|NCT02016105|11173510|FG000|COMPLETED|TREATMENT PERIOD 2||0
10048331|NCT02016105|11173511|FG001|COMPLETED|TREATMENT PERIOD 2||0
10048332|NCT02016105|11173512|FG002|COMPLETED|TREATMENT PERIOD 2||57
10048333|NCT02016105|11173513|FG003|COMPLETED|TREATMENT PERIOD 2||116
10048334|NCT02016105|11173514|FG004|COMPLETED|TREATMENT PERIOD 2||59
10048335|NCT02016105|11173515|FG005|COMPLETED|TREATMENT PERIOD 2||112
10048336|NCT02016105|11173510|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0
10048337|NCT02016105|11173511|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0
10048338|NCT02016105|11173512|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6
10048339|NCT02016105|11173513|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11
10048340|NCT02016105|11173514|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4
10048341|NCT02016105|11173515|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14
10048342|NCT02016105|11173510|FG000|STARTED|EXTENSION PERIOD||0
10048343|NCT02016105|11173511|FG001|STARTED|EXTENSION PERIOD||0
10048344|NCT02016105|11173512|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
10048345|NCT02016105|11173513|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
10048346|NCT02016105|11173514|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
10048347|NCT02016105|11173515|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
10048348|NCT02016105|11173510|FG000|COMPLETED|EXTENSION PERIOD||0
10048349|NCT02016105|11173511|FG001|COMPLETED|EXTENSION PERIOD||0
10048350|NCT02016105|11173512|FG002|COMPLETED|EXTENSION PERIOD||47
10048351|NCT02016105|11173513|FG003|COMPLETED|EXTENSION PERIOD||104
10048352|NCT02016105|11173514|FG004|COMPLETED|EXTENSION PERIOD||50
10048353|NCT02016105|11173515|FG005|COMPLETED|EXTENSION PERIOD||100
10048354|NCT02016105|11173510|FG000|NOT COMPLETED|EXTENSION PERIOD||0
10048355|NCT02016105|11173511|FG001|NOT COMPLETED|EXTENSION PERIOD||0
10048356|NCT02016105|11173512|FG002|NOT COMPLETED|EXTENSION PERIOD||5
10048357|NCT02016105|11173513|FG003|NOT COMPLETED|EXTENSION PERIOD||5
10048358|NCT02016105|11173514|FG004|NOT COMPLETED|EXTENSION PERIOD||6
10048359|NCT02016105|11173515|FG005|NOT COMPLETED|EXTENSION PERIOD||6
10048360|NCT02016170|11173532|FG000|STARTED|Overall Study||27
10048361|NCT02016170|11173533|FG001|STARTED|Overall Study||28
10048362|NCT02016170|11173534|FG002|STARTED|Overall Study||27
10048363|NCT02016170|11173532|FG000|COMPLETED|Overall Study||25
10048364|NCT02016170|11173533|FG001|COMPLETED|Overall Study||27
10048365|NCT02016170|11173534|FG002|COMPLETED|Overall Study||27
10048366|NCT02016170|11173532|FG000|NOT COMPLETED|Overall Study||2
10048367|NCT02016170|11173533|FG001|NOT COMPLETED|Overall Study||1
10048368|NCT02016170|11173534|FG002|NOT COMPLETED|Overall Study||0
10048369|NCT02016183|11173541|FG000|STARTED|Overall Study||3222
10048370|NCT02016183|11173541|FG000|COMPLETED|Overall Study||3157
10048371|NCT02016183|11173541|FG000|NOT COMPLETED|Overall Study||65
10048372|NCT02016235|11173548|FG000|STARTED|Overall Study||10
10048373|NCT02016235|11173549|FG001|STARTED|Overall Study||10
10048374|NCT02016235|11173550|FG002|STARTED|Overall Study||10
10048375|NCT02016235|11173548|FG000|COMPLETED|Overall Study||10
10048376|NCT02016235|11173549|FG001|COMPLETED|Overall Study||10
10117981|NCT02543528|11248759|FG000|STARTED|Extended Wear Period||36
10117982|NCT02543528|11248760|FG001|STARTED|Extended Wear Period||35
10117983|NCT02543528|11248761|FG002|STARTED|Extended Wear Period||36
10117984|NCT02543528|11248762|FG003|STARTED|Extended Wear Period||35
10117985|NCT02543528|11248763|FG004|STARTED|Extended Wear Period||0
10117986|NCT02543528|11248759|FG000|COMPLETED|Extended Wear Period||8
10117987|NCT02543528|11248760|FG001|COMPLETED|Extended Wear Period||14
10117988|NCT02543528|11248761|FG002|COMPLETED|Extended Wear Period||13
10117989|NCT02543528|11248762|FG003|COMPLETED|Extended Wear Period||23
10117990|NCT02543528|11248763|FG004|COMPLETED|Extended Wear Period||0
10117991|NCT02543528|11248759|FG000|NOT COMPLETED|Extended Wear Period||28
10117992|NCT02543528|11248760|FG001|NOT COMPLETED|Extended Wear Period||21
10117993|NCT02543528|11248761|FG002|NOT COMPLETED|Extended Wear Period||23
10117994|NCT02543528|11248762|FG003|NOT COMPLETED|Extended Wear Period||12
10048377|NCT02016235|11173550|FG002|COMPLETED|Overall Study||10
10048378|NCT02016235|11173548|FG000|NOT COMPLETED|Overall Study||0
10048379|NCT02016235|11173549|FG001|NOT COMPLETED|Overall Study||0
10048380|NCT02016235|11173550|FG002|NOT COMPLETED|Overall Study||0
10048381|NCT02016300|11173560|FG000|STARTED|Overall Study||12
10048382|NCT02016300|11173561|FG001|STARTED|Overall Study||12
10048383|NCT02016300|11173560|FG000|COMPLETED|Overall Study||12
10048384|NCT02016300|11173561|FG001|COMPLETED|Overall Study||9
10048385|NCT02016300|11173560|FG000|NOT COMPLETED|Overall Study||0
10048386|NCT02016300|11173561|FG001|NOT COMPLETED|Overall Study||3
10048387|NCT02016482|11173569|FG000|STARTED|Period A||108
10048388|NCT02016482|11173570|FG001|STARTED|Period A||109
10048389|NCT02016482|11173569|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
10048390|NCT02016482|11173570|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
10048391|NCT02016482|11173569|FG000|NOT COMPLETED|Period A||14
10048392|NCT02016482|11173570|FG001|NOT COMPLETED|Period A||15
10048393|NCT02016482|11173569|FG000|STARTED|Period B||94
10048394|NCT02016482|11173570|FG001|STARTED|Period B||94
10048395|NCT02016482|11173569|FG000|COMPLETED|Period B||81
10048396|NCT02016482|11173570|FG001|COMPLETED|Period B||87
10048397|NCT02016482|11173569|FG000|NOT COMPLETED|Period B||13
10048398|NCT02016482|11173570|FG001|NOT COMPLETED|Period B||7
10048399|NCT02016560|11173584|FG000|STARTED|Exploratory Phase||16
10048400|NCT02016560|11173585|FG001|STARTED|Exploratory Phase||58
10048401|NCT02016560|11173586|FG002|STARTED|Exploratory Phase||98
10048402|NCT02016560|11173587|FG003|STARTED|Exploratory Phase||51
10048403|NCT02016560|11173588|FG004|STARTED|Exploratory Phase||0
10048404|NCT02016560|11173589|FG005|STARTED|Exploratory Phase||0
10048405|NCT02016560|11173584|FG000|COMPLETED|Exploratory Phase||16
10048406|NCT02016560|11173585|FG001|COMPLETED|Exploratory Phase||54
10048407|NCT02016560|11173586|FG002|COMPLETED|Exploratory Phase||62
10048408|NCT02016560|11173587|FG003|COMPLETED|Exploratory Phase||35
10048409|NCT02016560|11173588|FG004|COMPLETED|Exploratory Phase||0
10048410|NCT02016560|11173589|FG005|COMPLETED|Exploratory Phase||0
10048411|NCT02016560|11173584|FG000|NOT COMPLETED|Exploratory Phase||0
10048412|NCT02016560|11173585|FG001|NOT COMPLETED|Exploratory Phase||4
10048413|NCT02016560|11173586|FG002|NOT COMPLETED|Exploratory Phase||36
10048414|NCT02016560|11173587|FG003|NOT COMPLETED|Exploratory Phase||16
10048415|NCT02016560|11173588|FG004|NOT COMPLETED|Exploratory Phase||0
10048416|NCT02016560|11173589|FG005|NOT COMPLETED|Exploratory Phase||0
10048417|NCT02016560|11173584|FG000|STARTED|Confirmatory Phase||0
10048418|NCT02016560|11173585|FG001|STARTED|Confirmatory Phase||0
10048419|NCT02016560|11173586|FG002|STARTED|Confirmatory Phase||0
10048420|NCT02016560|11173587|FG003|STARTED|Confirmatory Phase||0
10048421|NCT02016560|11173588|FG004|STARTED|Confirmatory Phase||98
10048422|NCT02016560|11173589|FG005|STARTED|Confirmatory Phase||62
10048423|NCT02016560|11173584|FG000|COMPLETED|Confirmatory Phase||0
10048424|NCT02016560|11173585|FG001|COMPLETED|Confirmatory Phase||0
10048425|NCT02016560|11173586|FG002|COMPLETED|Confirmatory Phase||0
10048426|NCT02016560|11173587|FG003|COMPLETED|Confirmatory Phase||0
10048427|NCT02016560|11173588|FG004|COMPLETED|Confirmatory Phase||76
10048428|NCT02016560|11173589|FG005|COMPLETED|Confirmatory Phase||35
10048429|NCT02016560|11173584|FG000|NOT COMPLETED|Confirmatory Phase||0
10048430|NCT02016560|11173585|FG001|NOT COMPLETED|Confirmatory Phase||0
10048431|NCT02016560|11173586|FG002|NOT COMPLETED|Confirmatory Phase||0
10048432|NCT02016560|11173587|FG003|NOT COMPLETED|Confirmatory Phase||0
10048433|NCT02016560|11173588|FG004|NOT COMPLETED|Confirmatory Phase||22
10048434|NCT02016560|11173589|FG005|NOT COMPLETED|Confirmatory Phase||27
10048435|NCT02016612|11173615|FG000|STARTED|Overall Study||25
10048436|NCT02016612|11173616|FG001|STARTED|Overall Study||25
10048437|NCT02016612|11173617|FG002|STARTED|Overall Study||26
10048438|NCT02016612|11173618|FG003|STARTED|Overall Study||61
10048439|NCT02016612|11173615|FG000|COMPLETED|Overall Study||25
10048440|NCT02016612|11173616|FG001|COMPLETED|Overall Study||25
10048441|NCT02016612|11173617|FG002|COMPLETED|Overall Study||26
10048442|NCT02016612|11173618|FG003|COMPLETED|Overall Study||61
10048443|NCT02016612|11173615|FG000|NOT COMPLETED|Overall Study||0
10048444|NCT02016612|11173616|FG001|NOT COMPLETED|Overall Study||0
10048445|NCT02016612|11173617|FG002|NOT COMPLETED|Overall Study||0
10048446|NCT02016612|11173618|FG003|NOT COMPLETED|Overall Study||0
10048447|NCT02016625|11173630|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
10117995|NCT02543528|11248763|FG004|NOT COMPLETED|Extended Wear Period||0
10117996|NCT02543554|11248779|FG000|STARTED|Overall Study||1192
10117997|NCT02543554|11248780|FG001|STARTED|Overall Study||513
10117998|NCT02543554|11248779|FG000|COMPLETED|Overall Study||1192
10048448|NCT02016625|11173631|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
10048449|NCT02016625|11173630|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
10048450|NCT02016625|11173631|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
10048451|NCT02016625|11173630|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
10048452|NCT02016625|11173631|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
10048453|NCT02016625|11173630|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
10048454|NCT02016625|11173631|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
10048455|NCT02016625|11173630|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
10048456|NCT02016625|11173631|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
10048457|NCT02016625|11173630|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
10048458|NCT02016625|11173631|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
10048459|NCT02016690|11173647|FG000|STARTED|Overall Study||312
10048460|NCT02016690|11173647|FG000|Treated|Overall Study||312
10048461|NCT02016690|11173647|FG000|Safety Analysis Set (SAS)|Overall Study||304
10048462|NCT02016690|11173647|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288
10048463|NCT02016690|11173647|FG000|NOT COMPLETED|Overall Study||24
10048464|NCT02016716|11173654|FG000|STARTED|Overall Study||53
10048465|NCT02016716|11173655|FG001|STARTED|Overall Study||118
10048466|NCT02016716|11173656|FG002|STARTED|Overall Study||123
10048467|NCT02016716|11173654|FG000|Received Study Treatment|Overall Study||53
10048468|NCT02016716|11173655|FG001|Received Study Treatment|Overall Study||118
10048469|NCT02016716|11173656|FG002|Received Study Treatment|Overall Study||123
10048470|NCT02016716|11173654|FG000|COMPLETED|Overall Study||47
10048471|NCT02016716|11173655|FG001|COMPLETED|Overall Study||110
10117999|NCT02543554|11248780|FG001|COMPLETED|Overall Study||513
10118000|NCT02543554|11248779|FG000|NOT COMPLETED|Overall Study||0
10118001|NCT02543554|11248780|FG001|NOT COMPLETED|Overall Study||0
10118002|NCT02543658|11248788|FG000|STARTED|Overall Study||40
10118003|NCT02543658|11248789|FG001|STARTED|Overall Study||40
10118004|NCT02543658|11248788|FG000|COMPLETED|Overall Study||40
10118005|NCT02543658|11248789|FG001|COMPLETED|Overall Study||36
10118006|NCT02543658|11248788|FG000|NOT COMPLETED|Overall Study||0
10118007|NCT02543658|11248789|FG001|NOT COMPLETED|Overall Study||4
10118008|NCT02543723|11248798|FG000|STARTED|Overall Study||65
10118009|NCT02543723|11248799|FG001|STARTED|Overall Study||63
10118010|NCT02543723|11248798|FG000|COMPLETED|Overall Study||65
10118011|NCT02543723|11248799|FG001|COMPLETED|Overall Study||63
10118012|NCT02543723|11248798|FG000|NOT COMPLETED|Overall Study||0
10118013|NCT02543723|11248799|FG001|NOT COMPLETED|Overall Study||0
10118014|NCT02543801|11248811|FG000|STARTED|Overall Study||61
10118015|NCT02543801|11248812|FG001|STARTED|Overall Study||60
10118016|NCT02543801|11248813|FG002|STARTED|Overall Study||59
10118017|NCT02543801|11248814|FG003|STARTED|Overall Study||59
10118018|NCT02543801|11248811|FG000|COMPLETED|Overall Study||60
10118019|NCT02543801|11248812|FG001|COMPLETED|Overall Study||58
10118020|NCT02543801|11248813|FG002|COMPLETED|Overall Study||59
10118021|NCT02543801|11248814|FG003|COMPLETED|Overall Study||59
10118022|NCT02543801|11248811|FG000|NOT COMPLETED|Overall Study||1
10118023|NCT02543801|11248812|FG001|NOT COMPLETED|Overall Study||2
10118024|NCT02543801|11248813|FG002|NOT COMPLETED|Overall Study||0
10118025|NCT02543801|11248814|FG003|NOT COMPLETED|Overall Study||0
10118026|NCT02543840|11248826|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
10118027|NCT02543840|11248827|FG001|STARTED|Overall Study||62
10118028|NCT02543840|11248826|FG000|0 Month Timepoint (t0)|Overall Study||593
10118029|NCT02543840|11248827|FG001|0 Month Timepoint (t0)|Overall Study||40
10118030|NCT02543840|11248826|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
10118031|NCT02543840|11248827|FG001|6 Month Timepoint (t6)|Overall Study||0
10118032|NCT02543840|11248826|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
10118033|NCT02543840|11248827|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
10118034|NCT02543840|11248826|FG000|COMPLETED|Overall Study||1050
10118035|NCT02543840|11248827|FG001|COMPLETED|Overall Study||62
10118036|NCT02543840|11248826|FG000|NOT COMPLETED|Overall Study||0
10118037|NCT02543840|11248827|FG001|NOT COMPLETED|Overall Study||0
10118038|NCT02543892|11248842|FG000|STARTED|Received Vaccination 1||12
10118039|NCT02543892|11248843|FG001|STARTED|Received Vaccination 1||12
10118040|NCT02543892|11248844|FG002|STARTED|Received Vaccination 1||12
10118041|NCT02543892|11248845|FG003|STARTED|Received Vaccination 1||12
10118042|NCT02543892|11248846|FG004|STARTED|Received Vaccination 1||50
10118043|NCT02543892|11248847|FG005|STARTED|Received Vaccination 1||50
10118044|NCT02543892|11248848|FG006|STARTED|Received Vaccination 1||50
10118045|NCT02543892|11248849|FG007|STARTED|Received Vaccination 1||50
10118046|NCT02543892|11248842|FG000|COMPLETED|Received Vaccination 1||12
10118047|NCT02543892|11248843|FG001|COMPLETED|Received Vaccination 1||12
10118048|NCT02543892|11248844|FG002|COMPLETED|Received Vaccination 1||12
10118049|NCT02543892|11248845|FG003|COMPLETED|Received Vaccination 1||12
10118050|NCT02543892|11248846|FG004|COMPLETED|Received Vaccination 1||50
10118051|NCT02543892|11248847|FG005|COMPLETED|Received Vaccination 1||50
10118052|NCT02543892|11248848|FG006|COMPLETED|Received Vaccination 1||50
10118053|NCT02543892|11248849|FG007|COMPLETED|Received Vaccination 1||50
10118054|NCT02543892|11248842|FG000|NOT COMPLETED|Received Vaccination 1||0
10118055|NCT02543892|11248843|FG001|NOT COMPLETED|Received Vaccination 1||0
10118056|NCT02543892|11248844|FG002|NOT COMPLETED|Received Vaccination 1||0
10048472|NCT02016716|11173656|FG002|COMPLETED|Overall Study||117
10048473|NCT02016716|11173654|FG000|NOT COMPLETED|Overall Study||6
10048474|NCT02016716|11173655|FG001|NOT COMPLETED|Overall Study||8
10048475|NCT02016716|11173656|FG002|NOT COMPLETED|Overall Study||6
10048476|NCT02016755|11173665|FG000|STARTED|Overall Study||10
10048477|NCT02016755|11173665|FG000|Completed Month 18 Clinic Visit|Overall Study||5
10048478|NCT02016755|11173665|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3
10048479|NCT02016755|11173665|FG000|COMPLETED|Overall Study||3
10048480|NCT02016755|11173665|FG000|NOT COMPLETED|Overall Study||7
10048481|NCT02016885|11173674|FG000|STARTED|Overall Study||38
10048482|NCT02016885|11173675|FG001|STARTED|Overall Study||40
10048483|NCT02016885|11173676|FG002|STARTED|Overall Study||40
10048484|NCT02016885|11173677|FG003|STARTED|Overall Study||40
10048485|NCT02016885|11173678|FG004|STARTED|Overall Study||40
10048486|NCT02016885|11173674|FG000|COMPLETED|Overall Study||34
10048487|NCT02016885|11173675|FG001|COMPLETED|Overall Study||36
10048488|NCT02016885|11173676|FG002|COMPLETED|Overall Study||39
10048489|NCT02016885|11173677|FG003|COMPLETED|Overall Study||30
10048490|NCT02016885|11173678|FG004|COMPLETED|Overall Study||39
10048491|NCT02016885|11173674|FG000|NOT COMPLETED|Overall Study||4
10048492|NCT02016885|11173675|FG001|NOT COMPLETED|Overall Study||4
10048493|NCT02016885|11173676|FG002|NOT COMPLETED|Overall Study||1
10048494|NCT02016885|11173677|FG003|NOT COMPLETED|Overall Study||10
10048495|NCT02016885|11173678|FG004|NOT COMPLETED|Overall Study||1
10118057|NCT02543892|11248845|FG003|NOT COMPLETED|Received Vaccination 1||0
10118058|NCT02543892|11248846|FG004|NOT COMPLETED|Received Vaccination 1||0
10118059|NCT02543892|11248847|FG005|NOT COMPLETED|Received Vaccination 1||0
10118060|NCT02543892|11248848|FG006|NOT COMPLETED|Received Vaccination 1||0
10118061|NCT02543892|11248849|FG007|NOT COMPLETED|Received Vaccination 1||0
10118062|NCT02543892|11248842|FG000|STARTED|Received Vaccination 2||12
10118063|NCT02543892|11248843|FG001|STARTED|Received Vaccination 2||12
10118064|NCT02543892|11248844|FG002|STARTED|Received Vaccination 2||12
10118065|NCT02543892|11248845|FG003|STARTED|Received Vaccination 2||12
10118066|NCT02543892|11248846|FG004|STARTED|Received Vaccination 2||50
10118067|NCT02543892|11248847|FG005|STARTED|Received Vaccination 2||50
10118068|NCT02543892|11248848|FG006|STARTED|Received Vaccination 2||50
10118069|NCT02543892|11248849|FG007|STARTED|Received Vaccination 2||50
10118070|NCT02543892|11248842|FG000|COMPLETED|Received Vaccination 2||11
10118071|NCT02543892|11248843|FG001|COMPLETED|Received Vaccination 2||11
10118072|NCT02543892|11248844|FG002|COMPLETED|Received Vaccination 2||12
10118073|NCT02543892|11248845|FG003|COMPLETED|Received Vaccination 2||12
10118074|NCT02543892|11248846|FG004|COMPLETED|Received Vaccination 2||50
10118075|NCT02543892|11248847|FG005|COMPLETED|Received Vaccination 2||49
10118076|NCT02543892|11248848|FG006|COMPLETED|Received Vaccination 2||50
10118077|NCT02543892|11248849|FG007|COMPLETED|Received Vaccination 2||49
10118078|NCT02543892|11248842|FG000|NOT COMPLETED|Received Vaccination 2||1
10118079|NCT02543892|11248843|FG001|NOT COMPLETED|Received Vaccination 2||1
10118080|NCT02543892|11248844|FG002|NOT COMPLETED|Received Vaccination 2||0
10118081|NCT02543892|11248845|FG003|NOT COMPLETED|Received Vaccination 2||0
10118082|NCT02543892|11248846|FG004|NOT COMPLETED|Received Vaccination 2||0
10118083|NCT02543892|11248847|FG005|NOT COMPLETED|Received Vaccination 2||1
10118084|NCT02543892|11248848|FG006|NOT COMPLETED|Received Vaccination 2||0
10118085|NCT02543892|11248849|FG007|NOT COMPLETED|Received Vaccination 2||1
10118086|NCT02543892|11248842|FG000|STARTED|Had Immunology Data||11
10118087|NCT02543892|11248843|FG001|STARTED|Had Immunology Data||11
10118088|NCT02543892|11248844|FG002|STARTED|Had Immunology Data||12
10118089|NCT02543892|11248845|FG003|STARTED|Had Immunology Data||12
10118090|NCT02543892|11248846|FG004|STARTED|Had Immunology Data||50
10118091|NCT02543892|11248847|FG005|STARTED|Had Immunology Data||49
10118092|NCT02543892|11248848|FG006|STARTED|Had Immunology Data||50
10118093|NCT02543892|11248849|FG007|STARTED|Had Immunology Data||49
10118094|NCT02543892|11248842|FG000|COMPLETED|Had Immunology Data||11
10118095|NCT02543892|11248843|FG001|COMPLETED|Had Immunology Data||11
10118096|NCT02543892|11248844|FG002|COMPLETED|Had Immunology Data||12
10118097|NCT02543892|11248845|FG003|COMPLETED|Had Immunology Data||12
10118098|NCT02543892|11248846|FG004|COMPLETED|Had Immunology Data||50
10118099|NCT02543892|11248847|FG005|COMPLETED|Had Immunology Data||49
10118100|NCT02543892|11248848|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
10118101|NCT02543892|11248849|FG007|COMPLETED|Had Immunology Data||49
10118102|NCT02543892|11248842|FG000|NOT COMPLETED|Had Immunology Data||0
10118103|NCT02543892|11248843|FG001|NOT COMPLETED|Had Immunology Data||0
10118104|NCT02543892|11248844|FG002|NOT COMPLETED|Had Immunology Data||0
10118105|NCT02543892|11248845|FG003|NOT COMPLETED|Had Immunology Data||0
10118106|NCT02543892|11248846|FG004|NOT COMPLETED|Had Immunology Data||0
10118107|NCT02543892|11248847|FG005|NOT COMPLETED|Had Immunology Data||0
10118108|NCT02543892|11248848|FG006|NOT COMPLETED|Had Immunology Data||1
10118109|NCT02543892|11248849|FG007|NOT COMPLETED|Had Immunology Data||0
10118110|NCT02543918|11248874|FG000|STARTED|Overall Study||41
10118111|NCT02543918|11248875|FG001|STARTED|Overall Study||43
10118112|NCT02543918|11248874|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
10118113|NCT02543918|11248875|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
10118114|NCT02543918|11248874|FG000|COMPLETED|Overall Study||38
10118115|NCT02543918|11248875|FG001|COMPLETED|Overall Study||39
10118116|NCT02543918|11248874|FG000|NOT COMPLETED|Overall Study||3
10118117|NCT02543918|11248875|FG001|NOT COMPLETED|Overall Study||4
10118118|NCT02544113|11248883|FG000|STARTED|Overall Study||55
10118119|NCT02544113|11248884|FG001|STARTED|Overall Study||55
10048496|NCT02016898|11173692|FG000|STARTED|Overall Study||50
10048497|NCT02016898|11173693|FG001|STARTED|Overall Study||45
10048498|NCT02016898|11173692|FG000|COMPLETED|Overall Study||45
10048499|NCT02016898|11173693|FG001|COMPLETED|Overall Study||40
10048500|NCT02016898|11173692|FG000|NOT COMPLETED|Overall Study||5
10048501|NCT02016898|11173693|FG001|NOT COMPLETED|Overall Study||5
10048502|NCT02016963|11173699|FG000|STARTED|Overall Study||20
10048503|NCT02016963|11173699|FG000|COMPLETED|Overall Study||20
10048504|NCT02016963|11173699|FG000|NOT COMPLETED|Overall Study||0
10048505|NCT02017015|11173704|FG000|STARTED|Overall Study||83
10048506|NCT02017015|11173704|FG000|Safety Population|Overall Study||83
10048507|NCT02017015|11173704|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
10048508|NCT02017015|11173704|FG000|NOT COMPLETED|Overall Study||69
10048509|NCT02017093|11173711|FG000|STARTED|Overall Study||4
10048510|NCT02017093|11173712|FG001|STARTED|Overall Study||3
10048511|NCT02017093|11173711|FG000|COMPLETED|Overall Study||4
10048512|NCT02017093|11173712|FG001|COMPLETED|Overall Study||3
10048513|NCT02017093|11173711|FG000|NOT COMPLETED|Overall Study||0
10048514|NCT02017093|11173712|FG001|NOT COMPLETED|Overall Study||0
10048515|NCT02017171|11173722|FG000|STARTED|Overall Study||267
10048516|NCT02017171|11173723|FG001|STARTED|Overall Study||263
10048517|NCT02017171|11173722|FG000|COMPLETED|Overall Study||205
10048518|NCT02017171|11173723|FG001|COMPLETED|Overall Study||217
10048519|NCT02017171|11173722|FG000|NOT COMPLETED|Overall Study||62
10048520|NCT02017171|11173723|FG001|NOT COMPLETED|Overall Study||46
10048521|NCT02017210|11173733|FG000|STARTED|Overall Study||17
10048522|NCT02017210|11173734|FG001|STARTED|Overall Study||20
10048523|NCT02017210|11173735|FG002|STARTED|Overall Study||20
10048524|NCT02017210|11173733|FG000|COMPLETED|Overall Study||17
10048525|NCT02017210|11173734|FG001|COMPLETED|Overall Study||20
10048526|NCT02017210|11173735|FG002|COMPLETED|Overall Study||20
10048527|NCT02017210|11173733|FG000|NOT COMPLETED|Overall Study||0
10048528|NCT02017210|11173734|FG001|NOT COMPLETED|Overall Study||0
10048529|NCT02017210|11173735|FG002|NOT COMPLETED|Overall Study||0
10048530|NCT02017223|11173746|FG000|STARTED|Overall Study||12
10048531|NCT02017223|11173746|FG000|COMPLETED|Overall Study||10
10048532|NCT02017223|11173746|FG000|NOT COMPLETED|Overall Study||2
10048533|NCT02017327|11173753|FG000|STARTED|Overall Study||122
10048534|NCT02017327|11173754|FG001|STARTED|Overall Study||125
10048535|NCT02017327|11173755|FG002|STARTED|Overall Study||132
10048536|NCT02017327|11173753|FG000|COMPLETED|Overall Study||106
10048537|NCT02017327|11173754|FG001|COMPLETED|Overall Study||113
10048538|NCT02017327|11173755|FG002|COMPLETED|Overall Study||117
10048539|NCT02017327|11173753|FG000|NOT COMPLETED|Overall Study||16
10048540|NCT02017327|11173754|FG001|NOT COMPLETED|Overall Study||12
10048541|NCT02017327|11173755|FG002|NOT COMPLETED|Overall Study||15
10048542|NCT02017444|11173765|FG000|STARTED|Overall Study||14
10048543|NCT02017444|11173766|FG001|STARTED|Overall Study||17
10048544|NCT02017444|11173765|FG000|COMPLETED|Overall Study||12
10048545|NCT02017444|11173766|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17
10048546|NCT02017444|11173765|FG000|NOT COMPLETED|Overall Study||2
10048547|NCT02017444|11173766|FG001|NOT COMPLETED|Overall Study||0
10048548|NCT02017535|11173776|FG000|STARTED|Overall Study||9
10048549|NCT02017535|11173777|FG001|STARTED|Overall Study||3
10048550|NCT02017535|11173778|FG002|STARTED|Overall Study||2
10048551|NCT02017535|11173779|FG003|STARTED|Overall Study||1
10048552|NCT02017535|11173776|FG000|COMPLETED|Overall Study||8
10048553|NCT02017535|11173777|FG001|COMPLETED|Overall Study||3
10048554|NCT02017535|11173778|FG002|COMPLETED|Overall Study||2
10048555|NCT02017535|11173779|FG003|COMPLETED|Overall Study||1
10048556|NCT02017535|11173776|FG000|NOT COMPLETED|Overall Study||1
10048557|NCT02017535|11173777|FG001|NOT COMPLETED|Overall Study||0
10048558|NCT02017535|11173778|FG002|NOT COMPLETED|Overall Study||0
10048559|NCT02017535|11173779|FG003|NOT COMPLETED|Overall Study||0
10048560|NCT02017574|11173791|FG000|STARTED|Overall Study||12
10048561|NCT02017574|11173792|FG001|STARTED|Overall Study||12
10048562|NCT02017574|11173791|FG000|COMPLETED|Overall Study||12
10048563|NCT02017574|11173792|FG001|COMPLETED|Overall Study||12
10048564|NCT02017574|11173791|FG000|NOT COMPLETED|Overall Study||0
10048565|NCT02017574|11173792|FG001|NOT COMPLETED|Overall Study||0
10048566|NCT02017860|11173798|FG000|STARTED|Overall Study||4
10048567|NCT02017860|11173798|FG000|COMPLETED|Overall Study||2
10048568|NCT02017860|11173798|FG000|NOT COMPLETED|Overall Study||2
10048569|NCT02017899|11173808|FG000|STARTED|Overall Study||8
10048570|NCT02017899|11173809|FG001|STARTED|Overall Study||9
10048571|NCT02017899|11173810|FG002|STARTED|Overall Study||8
10048572|NCT02017899|11173811|FG003|STARTED|Overall Study||8
10048573|NCT02017899|11173812|FG004|STARTED|Overall Study||9
10048574|NCT02017899|11173813|FG005|STARTED|Overall Study||8
10048575|NCT02017899|11173808|FG000|COMPLETED|Overall Study||8
10048576|NCT02017899|11173809|FG001|COMPLETED|Overall Study||9
10048577|NCT02017899|11173810|FG002|COMPLETED|Overall Study||8
10048578|NCT02017899|11173811|FG003|COMPLETED|Overall Study||7
10048579|NCT02017899|11173812|FG004|COMPLETED|Overall Study||8
10048580|NCT02017899|11173813|FG005|COMPLETED|Overall Study||8
10048581|NCT02017899|11173808|FG000|NOT COMPLETED|Overall Study||0
10048582|NCT02017899|11173809|FG001|NOT COMPLETED|Overall Study||0
10048583|NCT02017899|11173810|FG002|NOT COMPLETED|Overall Study||0
10048584|NCT02017899|11173811|FG003|NOT COMPLETED|Overall Study||1
10048585|NCT02017899|11173812|FG004|NOT COMPLETED|Overall Study||1
10048586|NCT02017899|11173813|FG005|NOT COMPLETED|Overall Study||0
10048587|NCT02018042|11173827|FG000|STARTED|Overall Study||15
10048588|NCT02018042|11173827|FG000|COMPLETED|Overall Study||14
10048589|NCT02018042|11173827|FG000|NOT COMPLETED|Overall Study||1
10048590|NCT02018107|11173831|FG000|STARTED|Overall Study||27
10048591|NCT02018107|11173831|FG000|COMPLETED|Overall Study||27
10048592|NCT02018107|11173831|FG000|NOT COMPLETED|Overall Study||0
10048593|NCT02018315|11173835|FG000|STARTED|Overall Study||14
10048594|NCT02018315|11173835|FG000|COMPLETED|Overall Study||14
10048595|NCT02018315|11173835|FG000|NOT COMPLETED|Overall Study||0
10048596|NCT02018445|11173839|FG000|STARTED|Overall Study||36
10048597|NCT02018445|11173839|FG000|COMPLETED|Overall Study||29
10048598|NCT02018445|11173839|FG000|NOT COMPLETED|Overall Study||7
10048599|NCT02018458|11173846|FG000|STARTED|Overall Study||10
10048600|NCT02018458|11173846|FG000|COMPLETED|Overall Study||6
10048601|NCT02018458|11173846|FG000|NOT COMPLETED|Overall Study||4
10048602|NCT02018562|11173852|FG000|STARTED|Overall Study||25
10048603|NCT02018562|11173853|FG001|STARTED|Overall Study||25
10048604|NCT02018562|11173852|FG000|COMPLETED|Overall Study||22
10048605|NCT02018562|11173853|FG001|COMPLETED|Overall Study||25
10048606|NCT02018562|11173852|FG000|NOT COMPLETED|Overall Study||3
10048607|NCT02018562|11173853|FG001|NOT COMPLETED|Overall Study||0
10048608|NCT02018627|11173861|FG000|STARTED|Overall Study||7
10048609|NCT02018627|11173862|FG001|STARTED|Overall Study||6
10048610|NCT02018627|11173861|FG000|COMPLETED|Overall Study||7
10048611|NCT02018627|11173862|FG001|COMPLETED|Overall Study||6
10048612|NCT02018627|11173861|FG000|NOT COMPLETED|Overall Study||0
10048613|NCT02018627|11173862|FG001|NOT COMPLETED|Overall Study||0
10048614|NCT02018653|11173870|FG000|STARTED|Overall Study||1
10048615|NCT02018653|11173871|FG001|STARTED|Overall Study||1
10048616|NCT02018653|11173870|FG000|COMPLETED|Overall Study||1
10048617|NCT02018653|11173871|FG001|COMPLETED|Overall Study||0
10048618|NCT02018653|11173870|FG000|NOT COMPLETED|Overall Study||0
10048619|NCT02018653|11173871|FG001|NOT COMPLETED|Overall Study||1
10048620|NCT02018809|11173881|FG000|STARTED|Overall Study||50
10048621|NCT02018809|11173882|FG001|STARTED|Overall Study||50
10048622|NCT02018809|11173883|FG002|STARTED|Overall Study||50
10048623|NCT02018809|11173884|FG003|STARTED|Overall Study||50
10048624|NCT02018809|11173881|FG000|COMPLETED|Overall Study||50
10048625|NCT02018809|11173882|FG001|COMPLETED|Overall Study||50
10048626|NCT02018809|11173883|FG002|COMPLETED|Overall Study||50
10048627|NCT02018809|11173884|FG003|COMPLETED|Overall Study||50
10048628|NCT02018809|11173881|FG000|NOT COMPLETED|Overall Study||0
10048629|NCT02018809|11173882|FG001|NOT COMPLETED|Overall Study||0
10048630|NCT02018809|11173883|FG002|NOT COMPLETED|Overall Study||0
10048631|NCT02018809|11173884|FG003|NOT COMPLETED|Overall Study||0
10048632|NCT02018822|11173896|FG000|STARTED|Overall Study||50
10048633|NCT02018822|11173897|FG001|STARTED|Overall Study||50
10048634|NCT02018822|11173898|FG002|STARTED|Overall Study||35
10048635|NCT02018822|11173896|FG000|COMPLETED|Overall Study||44
10048636|NCT02018822|11173897|FG001|COMPLETED|Overall Study||42
10048637|NCT02018822|11173898|FG002|COMPLETED|Overall Study||29
10048638|NCT02018822|11173896|FG000|NOT COMPLETED|Overall Study||6
10048639|NCT02018822|11173897|FG001|NOT COMPLETED|Overall Study||8
10048640|NCT02018822|11173898|FG002|NOT COMPLETED|Overall Study||6
10048641|NCT02018887|11173917|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9
10048642|NCT02018887|11173918|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9
10048643|NCT02018887|11173919|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
10048644|NCT02018887|11173920|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10048645|NCT02018887|11173921|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10048646|NCT02018887|11173922|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10048647|NCT02018887|11173923|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10048648|NCT02018887|11173924|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10048649|NCT02018887|11173925|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
10048650|NCT02018887|11173926|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10048651|NCT02018887|11173927|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10048652|NCT02018887|11173917|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
10048653|NCT02018887|11173918|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
10048654|NCT02018887|11173919|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048655|NCT02018887|11173920|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048656|NCT02018887|11173921|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048657|NCT02018887|11173922|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048658|NCT02018887|11173923|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048659|NCT02018887|11173924|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048660|NCT02018887|11173925|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048661|NCT02018887|11173926|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048662|NCT02018887|11173927|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10048663|NCT02018887|11173917|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9
10048664|NCT02018887|11173918|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9
10048665|NCT02018887|11173919|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048666|NCT02018887|11173920|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048667|NCT02018887|11173921|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048668|NCT02018887|11173922|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048669|NCT02018887|11173923|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048670|NCT02018887|11173924|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048671|NCT02018887|11173925|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048672|NCT02018887|11173926|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048673|NCT02018887|11173927|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048674|NCT02018887|11173917|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048675|NCT02018887|11173918|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048676|NCT02018887|11173919|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048677|NCT02018887|11173920|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048678|NCT02018887|11173921|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048679|NCT02018887|11173922|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048680|NCT02018887|11173923|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048681|NCT02018887|11173924|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048682|NCT02018887|11173925|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048683|NCT02018887|11173926|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048684|NCT02018887|11173927|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10048685|NCT02018887|11173917|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9
10048686|NCT02018887|11173918|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9
10048687|NCT02018887|11173919|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
10048688|NCT02018887|11173920|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10048689|NCT02018887|11173921|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10048690|NCT02018887|11173922|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10048691|NCT02018887|11173923|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10048692|NCT02018887|11173924|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10048693|NCT02018887|11173925|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
10048694|NCT02018887|11173926|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10048695|NCT02018887|11173927|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10048696|NCT02018887|11173917|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
10048697|NCT02018887|11173918|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
10048698|NCT02018887|11173919|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048699|NCT02018887|11173920|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048700|NCT02018887|11173921|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048701|NCT02018887|11173922|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048702|NCT02018887|11173923|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048703|NCT02018887|11173924|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048704|NCT02018887|11173925|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048705|NCT02018887|11173926|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048706|NCT02018887|11173927|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10048707|NCT02018887|11173917|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9
10048708|NCT02018887|11173918|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9
10118120|NCT02544113|11248883|FG000|COMPLETED|Overall Study||52
10118121|NCT02544113|11248884|FG001|COMPLETED|Overall Study||51
10118122|NCT02544113|11248883|FG000|NOT COMPLETED|Overall Study||3
10118123|NCT02544113|11248884|FG001|NOT COMPLETED|Overall Study||4
10118124|NCT02544152|11248892|FG000|STARTED|Overall Study||34
10118125|NCT02544152|11248893|FG001|STARTED|Overall Study||37
10118126|NCT02544152|11248892|FG000|Modified Intent to Treat (mITT)|Overall Study||34
10118127|NCT02544152|11248893|FG001|Modified Intent to Treat (mITT)|Overall Study||37
10118128|NCT02544152|11248892|FG000|Safety Analysis Set (SAS)|Overall Study||34
10118129|NCT02544152|11248893|FG001|Safety Analysis Set (SAS)|Overall Study||37
10118130|NCT02544152|11248892|FG000|COMPLETED|Overall Study||33
10118131|NCT02544152|11248893|FG001|COMPLETED|Overall Study||30
10118132|NCT02544152|11248892|FG000|NOT COMPLETED|Overall Study||1
10118133|NCT02544152|11248893|FG001|NOT COMPLETED|Overall Study||7
10118134|NCT02544217|11248905|FG000|STARTED|Overall Study||7
10118135|NCT02544217|11248906|FG001|STARTED|Overall Study||7
10118136|NCT02544217|11248907|FG002|STARTED|Overall Study||4
10118137|NCT02544217|11248908|FG003|STARTED|Overall Study||4
10118138|NCT02544217|11248909|FG004|STARTED|Overall Study||4
10118139|NCT02544217|11248910|FG005|STARTED|Overall Study||6
10118140|NCT02544217|11248905|FG000|COMPLETED|Overall Study||6
10118141|NCT02544217|11248906|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
10118142|NCT02544217|11248907|FG002|COMPLETED|Overall Study||4
10118143|NCT02544217|11248908|FG003|COMPLETED|Overall Study||4
10118144|NCT02544217|11248909|FG004|COMPLETED|Overall Study||4
10118145|NCT02544217|11248910|FG005|COMPLETED|Overall Study||6
10118146|NCT02544217|11248905|FG000|NOT COMPLETED|Overall Study||1
10118147|NCT02544217|11248906|FG001|NOT COMPLETED|Overall Study||1
10118148|NCT02544217|11248907|FG002|NOT COMPLETED|Overall Study||0
9706606|NCT02111850|10805643|FG001|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10048709|NCT02018887|11173919|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048710|NCT02018887|11173920|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048711|NCT02018887|11173921|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048712|NCT02018887|11173922|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048713|NCT02018887|11173923|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048714|NCT02018887|11173924|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048715|NCT02018887|11173925|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048716|NCT02018887|11173926|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048717|NCT02018887|11173927|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048718|NCT02018887|11173917|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048719|NCT02018887|11173918|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048720|NCT02018887|11173919|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048721|NCT02018887|11173920|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048722|NCT02018887|11173921|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048723|NCT02018887|11173922|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048724|NCT02018887|11173923|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048725|NCT02018887|11173924|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048726|NCT02018887|11173925|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048727|NCT02018887|11173926|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048728|NCT02018887|11173927|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10048729|NCT02018887|11173917|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9
10048730|NCT02018887|11173918|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9
10048731|NCT02018887|11173919|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
10048732|NCT02018887|11173920|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10048733|NCT02018887|11173921|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10048734|NCT02018887|11173922|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10048735|NCT02018887|11173923|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10048736|NCT02018887|11173924|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10048737|NCT02018887|11173925|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
10048738|NCT02018887|11173926|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10048739|NCT02018887|11173927|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10048740|NCT02018887|11173917|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
10048741|NCT02018887|11173918|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
10048742|NCT02018887|11173919|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048743|NCT02018887|11173920|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048744|NCT02018887|11173921|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048745|NCT02018887|11173922|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048746|NCT02018887|11173923|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048747|NCT02018887|11173924|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048748|NCT02018887|11173925|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048749|NCT02018887|11173926|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048750|NCT02018887|11173927|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10048751|NCT02018887|11173917|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8
10048752|NCT02018887|11173918|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9
10048753|NCT02018887|11173919|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048754|NCT02018887|11173920|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048755|NCT02018887|11173921|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048756|NCT02018887|11173922|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048757|NCT02018887|11173923|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048758|NCT02018887|11173924|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048759|NCT02018887|11173925|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048760|NCT02018887|11173926|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048761|NCT02018887|11173927|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048762|NCT02018887|11173917|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
10048763|NCT02018887|11173918|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048764|NCT02018887|11173919|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048765|NCT02018887|11173920|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048766|NCT02018887|11173921|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048767|NCT02018887|11173922|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048768|NCT02018887|11173923|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048769|NCT02018887|11173924|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048770|NCT02018887|11173925|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048771|NCT02018887|11173926|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048772|NCT02018887|11173927|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10048773|NCT02018887|11173917|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
10048774|NCT02018887|11173918|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
10048775|NCT02018887|11173919|FG002|STARTED|Part B: Cohorts 3-7 Overall||15
10048776|NCT02018887|11173920|FG003|STARTED|Part B: Cohorts 3-7 Overall||9
10048777|NCT02018887|11173921|FG004|STARTED|Part B: Cohorts 3-7 Overall||9
10048778|NCT02018887|11173922|FG005|STARTED|Part B: Cohorts 3-7 Overall||9
10048779|NCT02018887|11173923|FG006|STARTED|Part B: Cohorts 3-7 Overall||9
10048780|NCT02018887|11173924|FG007|STARTED|Part B: Cohorts 3-7 Overall||9
10048781|NCT02018887|11173925|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
10048782|NCT02018887|11173926|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
10048783|NCT02018887|11173927|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
10048784|NCT02018887|11173917|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10048785|NCT02018887|11173918|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10048786|NCT02018887|11173919|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
10048787|NCT02018887|11173920|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10048788|NCT02018887|11173921|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10048789|NCT02018887|11173922|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10048790|NCT02018887|11173923|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10048791|NCT02018887|11173924|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10048792|NCT02018887|11173925|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10048793|NCT02018887|11173926|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10048794|NCT02018887|11173927|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10048795|NCT02018887|11173917|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0
10048796|NCT02018887|11173918|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0
10048797|NCT02018887|11173919|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15
10048798|NCT02018887|11173920|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9
10048799|NCT02018887|11173921|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8
10048800|NCT02018887|11173922|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9
10048801|NCT02018887|11173923|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8
10048802|NCT02018887|11173924|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5
10048803|NCT02018887|11173925|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0
10048804|NCT02018887|11173926|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0
10048805|NCT02018887|11173927|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0
10048806|NCT02018887|11173917|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048807|NCT02018887|11173918|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048808|NCT02018887|11173919|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048809|NCT02018887|11173920|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048810|NCT02018887|11173921|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
10048811|NCT02018887|11173922|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048812|NCT02018887|11173923|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
10048813|NCT02018887|11173924|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
10048814|NCT02018887|11173925|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048815|NCT02018887|11173926|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048816|NCT02018887|11173927|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10048817|NCT02018887|11173917|FG000|STARTED|Part C: Cohort 8 Overall||0
10048818|NCT02018887|11173918|FG001|STARTED|Part C: Cohort 8 Overall||0
10048819|NCT02018887|11173919|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
10048820|NCT02018887|11173920|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10048821|NCT02018887|11173921|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10048822|NCT02018887|11173922|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10118149|NCT02544217|11248908|FG003|NOT COMPLETED|Overall Study||0
10118150|NCT02544217|11248909|FG004|NOT COMPLETED|Overall Study||0
10118151|NCT02544217|11248910|FG005|NOT COMPLETED|Overall Study||0
10118152|NCT02544321|11248979|FG000|STARTED|Overall Study||43
10118153|NCT02544321|11248980|FG001|STARTED|Overall Study||43
10118154|NCT02544321|11248979|FG000|Completed First Treatment|Overall Study||43
10118155|NCT02544321|11248980|FG001|Completed First Treatment|Overall Study||41
10118156|NCT02544321|11248979|FG000|Completed Washout|Overall Study||43
10118157|NCT02544321|11248980|FG001|Completed Washout|Overall Study||41
10118158|NCT02544321|11248979|FG000|Started Second Treatment|Overall Study||42
10118159|NCT02544321|11248980|FG001|Started Second Treatment|Overall Study||40
10118160|NCT02544321|11248979|FG000|COMPLETED|Overall Study||41
10118161|NCT02544321|11248980|FG001|COMPLETED|Overall Study||39
10118162|NCT02544321|11248979|FG000|NOT COMPLETED|Overall Study||2
10118163|NCT02544321|11248980|FG001|NOT COMPLETED|Overall Study||4
10118164|NCT02544451|11248998|FG000|STARTED|Treatment Period 1 (96 Weeks)||143
10118165|NCT02544451|11248999|FG001|STARTED|Treatment Period 1 (96 Weeks)||96
10118166|NCT02544451|11249000|FG002|STARTED|Treatment Period 1 (96 Weeks)||6
10118167|NCT02544451|11249001|FG003|STARTED|Treatment Period 1 (96 Weeks)||0
10118168|NCT02544451|11248998|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129
10118169|NCT02544451|11248999|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84
10118170|NCT02544451|11249000|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5
10118171|NCT02544451|11249001|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0
10118172|NCT02544451|11248998|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
10118173|NCT02544451|11248999|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
10118174|NCT02544451|11249000|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
10118175|NCT02544451|11249001|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
10118176|NCT02544451|11248998|FG000|STARTED|Treatment Period 2 (168 Weeks)||0
10118177|NCT02544451|11248999|FG001|STARTED|Treatment Period 2 (168 Weeks)||0
10118178|NCT02544451|11249000|FG002|STARTED|Treatment Period 2 (168 Weeks)||0
10118179|NCT02544451|11249001|FG003|STARTED|Treatment Period 2 (168 Weeks)||10
10118180|NCT02544451|11248998|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0
10118181|NCT02544451|11248999|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0
10118182|NCT02544451|11249000|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0
10118183|NCT02544451|11249001|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0
10118184|NCT02544451|11248998|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
10118185|NCT02544451|11248999|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
10048823|NCT02018887|11173923|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10048824|NCT02018887|11173924|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10048825|NCT02018887|11173925|FG008|STARTED|Part C: Cohort 8 Overall||10
10048826|NCT02018887|11173926|FG009|STARTED|Part C: Cohort 8 Overall||4
10048827|NCT02018887|11173927|FG010|STARTED|Part C: Cohort 8 Overall||7
10048828|NCT02018887|11173917|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048829|NCT02018887|11173918|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048830|NCT02018887|11173919|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048831|NCT02018887|11173920|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048832|NCT02018887|11173921|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048833|NCT02018887|11173922|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048834|NCT02018887|11173923|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048835|NCT02018887|11173924|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10048836|NCT02018887|11173925|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
10048837|NCT02018887|11173926|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
10048838|NCT02018887|11173927|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
10048839|NCT02018887|11173917|FG000|COMPLETED|Part C: Cohort 8 Overall||0
10048840|NCT02018887|11173918|FG001|COMPLETED|Part C: Cohort 8 Overall||0
10048841|NCT02018887|11173919|FG002|COMPLETED|Part C: Cohort 8 Overall||0
10048842|NCT02018887|11173920|FG003|COMPLETED|Part C: Cohort 8 Overall||0
10048843|NCT02018887|11173921|FG004|COMPLETED|Part C: Cohort 8 Overall||0
10048844|NCT02018887|11173922|FG005|COMPLETED|Part C: Cohort 8 Overall||0
10048845|NCT02018887|11173923|FG006|COMPLETED|Part C: Cohort 8 Overall||0
10048846|NCT02018887|11173924|FG007|COMPLETED|Part C: Cohort 8 Overall||0
10048847|NCT02018887|11173925|FG008|COMPLETED|Part C: Cohort 8 Overall||7
10048848|NCT02018887|11173926|FG009|COMPLETED|Part C: Cohort 8 Overall||1
10048849|NCT02018887|11173927|FG010|COMPLETED|Part C: Cohort 8 Overall||6
10048850|NCT02018887|11173917|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048851|NCT02018887|11173918|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048852|NCT02018887|11173919|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048853|NCT02018887|11173920|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048854|NCT02018887|11173921|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048855|NCT02018887|11173922|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048856|NCT02018887|11173923|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048857|NCT02018887|11173924|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0
10048858|NCT02018887|11173925|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3
10048859|NCT02018887|11173926|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3
10048860|NCT02018887|11173927|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1
10048861|NCT02019069|11173993|FG000|STARTED|Overall Study||11
10048862|NCT02019069|11173993|FG000|COMPLETED|Overall Study||11
10048863|NCT02019069|11173993|FG000|NOT COMPLETED|Overall Study||0
10048864|NCT02019108|11173999|FG000|STARTED|Overall Study||40
10048865|NCT02019108|11174000|FG001|STARTED|Overall Study||39
10048866|NCT02019108|11173999|FG000|Baseline (Week 0)|Overall Study||40
10048867|NCT02019108|11174000|FG001|Baseline (Week 0)|Overall Study||39
10048868|NCT02019108|11173999|FG000|Follow-up (Week 17)|Overall Study||38
10048869|NCT02019108|11174000|FG001|Follow-up (Week 17)|Overall Study||36
10048870|NCT02019108|11173999|FG000|Retention (Week 21)|Overall Study||35
10048871|NCT02019108|11174000|FG001|Retention (Week 21)|Overall Study||32
10048872|NCT02019108|11173999|FG000|COMPLETED|Overall Study||35
10048873|NCT02019108|11174000|FG001|COMPLETED|Overall Study||32
10048874|NCT02019108|11173999|FG000|NOT COMPLETED|Overall Study||5
10048875|NCT02019108|11174000|FG001|NOT COMPLETED|Overall Study||7
10048876|NCT02019264|11174008|FG000|STARTED|Overall Study||6000
10048877|NCT02019264|11174009|FG001|STARTED|Overall Study||6000
10048878|NCT02019264|11174008|FG000|Safety Analysis Set|Overall Study||5992
10048879|NCT02019264|11174009|FG001|Safety Analysis Set|Overall Study||5995
10048880|NCT02019264|11174008|FG000|COMPLETED|Overall Study||5752
10048881|NCT02019264|11174009|FG001|COMPLETED|Overall Study||5793
10048882|NCT02019264|11174008|FG000|NOT COMPLETED|Overall Study||248
10048883|NCT02019264|11174009|FG001|NOT COMPLETED|Overall Study||207
10048884|NCT02019277|11174015|FG000|STARTED|Overall Study||50
10048885|NCT02019277|11174015|FG000|COMPLETED|Overall Study||38
10048886|NCT02019277|11174015|FG000|NOT COMPLETED|Overall Study||12
10048887|NCT02019420|11174021|FG000|STARTED|Overall Study||366
10048888|NCT02019420|11174022|FG001|STARTED|Overall Study||360
10048889|NCT02019420|11174021|FG000|Treated|Overall Study||361
10048890|NCT02019420|11174022|FG001|Treated|Overall Study||357
10048891|NCT02019420|11174021|FG000|COMPLETED|Overall Study||258
10048892|NCT02019420|11174022|FG001|COMPLETED|Overall Study||254
10048893|NCT02019420|11174021|FG000|NOT COMPLETED|Overall Study||108
10048894|NCT02019420|11174022|FG001|NOT COMPLETED|Overall Study||106
10048895|NCT02019472|11174031|FG000|STARTED|Overall Study||186
10048896|NCT02019472|11174032|FG001|STARTED|Overall Study||186
10048897|NCT02019472|11174033|FG002|STARTED|Overall Study||187
10048898|NCT02019472|11174031|FG000|COMPLETED|Overall Study||149
10048899|NCT02019472|11174032|FG001|COMPLETED|Overall Study||134
10048900|NCT02019472|11174033|FG002|COMPLETED|Overall Study||145
10048901|NCT02019472|11174031|FG000|NOT COMPLETED|Overall Study||37
10048902|NCT02019472|11174032|FG001|NOT COMPLETED|Overall Study||52
10048903|NCT02019472|11174033|FG002|NOT COMPLETED|Overall Study||42
10048904|NCT02019550|11174047|FG000|STARTED|Treatment Period 1 (4 Weeks)||46
10048905|NCT02019550|11174048|FG001|STARTED|Treatment Period 1 (4 Weeks)||51
10048906|NCT02019550|11174047|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46
10048907|NCT02019550|11174048|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50
10048908|NCT02019550|11174047|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10048909|NCT02019550|11174048|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
10048910|NCT02019550|11174047|FG000|STARTED|Treatment Period 2 (4 Weeks)||46
10048911|NCT02019550|11174048|FG001|STARTED|Treatment Period 2 (4 Weeks)||50
10048912|NCT02019550|11174047|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46
10048913|NCT02019550|11174048|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50
10048914|NCT02019550|11174047|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10048915|NCT02019550|11174048|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10048916|NCT02019563|11174058|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
10048917|NCT02019563|11174059|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30
10048918|NCT02019563|11174058|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
10048919|NCT02019563|11174059|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
10048920|NCT02019563|11174058|FG000|NOT COMPLETED|Overall Study||0
10048921|NCT02019563|11174059|FG001|NOT COMPLETED|Overall Study||0
10048922|NCT02019602|11174069|FG000|STARTED|Screening Period||21
10048923|NCT02019602|11174070|FG001|STARTED|Screening Period||16
10048924|NCT02019602|11174069|FG000|COMPLETED|Screening Period||16
10048925|NCT02019602|11174070|FG001|COMPLETED|Screening Period||16
10048926|NCT02019602|11174069|FG000|NOT COMPLETED|Screening Period||5
10048927|NCT02019602|11174070|FG001|NOT COMPLETED|Screening Period||0
10048928|NCT02019602|11174069|FG000|STARTED|Sampling Period||16
10048929|NCT02019602|11174070|FG001|STARTED|Sampling Period||16
10048930|NCT02019602|11174069|FG000|COMPLETED|Sampling Period||16
10048931|NCT02019602|11174070|FG001|COMPLETED|Sampling Period||16
10048932|NCT02019602|11174069|FG000|NOT COMPLETED|Sampling Period||0
10048933|NCT02019602|11174070|FG001|NOT COMPLETED|Sampling Period||0
10048934|NCT02019667|11174077|FG000|STARTED|First Intervention (6 Months)||10
10048935|NCT02019667|11174078|FG001|STARTED|First Intervention (6 Months)||9
10048936|NCT02019667|11174077|FG000|COMPLETED|First Intervention (6 Months)||10
10048937|NCT02019667|11174078|FG001|COMPLETED|First Intervention (6 Months)||8
10048938|NCT02019667|11174077|FG000|NOT COMPLETED|First Intervention (6 Months)||0
10048939|NCT02019667|11174078|FG001|NOT COMPLETED|First Intervention (6 Months)||1
10048940|NCT02019667|11174077|FG000|STARTED|Washout Period (9 Weeks)||10
10048941|NCT02019667|11174078|FG001|STARTED|Washout Period (9 Weeks)||8
10048942|NCT02019667|11174077|FG000|COMPLETED|Washout Period (9 Weeks)||10
10048943|NCT02019667|11174078|FG001|COMPLETED|Washout Period (9 Weeks)||8
10048944|NCT02019667|11174077|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
10048945|NCT02019667|11174078|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
10048946|NCT02019667|11174077|FG000|STARTED|2nd Intervention (6 Months)||10
10048947|NCT02019667|11174078|FG001|STARTED|2nd Intervention (6 Months)||8
10048948|NCT02019667|11174077|FG000|COMPLETED|2nd Intervention (6 Months)||10
10048949|NCT02019667|11174078|FG001|COMPLETED|2nd Intervention (6 Months)||6
10048950|NCT02019667|11174077|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0
10048951|NCT02019667|11174078|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2
10048952|NCT02019667|11174077|FG000|STARTED|Washout Period (9 Weeks)||10
10048953|NCT02019667|11174078|FG001|STARTED|Washout Period (9 Weeks)||6
10048954|NCT02019667|11174077|FG000|COMPLETED|Washout Period (9 Weeks)||10
10048955|NCT02019667|11174078|FG001|COMPLETED|Washout Period (9 Weeks)||6
10048956|NCT02019667|11174077|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
10048957|NCT02019667|11174078|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
10048958|NCT02019719|11174091|FG000|STARTED|Overall Study||19
10048959|NCT02019719|11174092|FG001|STARTED|Overall Study||19
10048960|NCT02019719|11174093|FG002|STARTED|Overall Study||20
10048961|NCT02019719|11174094|FG003|STARTED|Overall Study||19
10048962|NCT02019719|11174095|FG004|STARTED|Overall Study||20
10048963|NCT02019719|11174091|FG000|COMPLETED|Overall Study||13
10048964|NCT02019719|11174092|FG001|COMPLETED|Overall Study||18
10048965|NCT02019719|11174093|FG002|COMPLETED|Overall Study||20
10048966|NCT02019719|11174094|FG003|COMPLETED|Overall Study||17
10048967|NCT02019719|11174095|FG004|COMPLETED|Overall Study||18
10048968|NCT02019719|11174091|FG000|NOT COMPLETED|Overall Study||6
10048969|NCT02019719|11174092|FG001|NOT COMPLETED|Overall Study||1
10048970|NCT02019719|11174093|FG002|NOT COMPLETED|Overall Study||0
10048971|NCT02019719|11174094|FG003|NOT COMPLETED|Overall Study||2
10048972|NCT02019719|11174095|FG004|NOT COMPLETED|Overall Study||2
10048973|NCT02019758|11174116|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
10048974|NCT02019758|11174117|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
10048975|NCT02019758|11174116|FG000|Received Intervention|Overall Study||64
10048976|NCT02019758|11174117|FG001|Received Intervention|Overall Study||63
10048977|NCT02019758|11174116|FG000|Did Not Receive Intervention|Overall Study||1
10048978|NCT02019758|11174117|FG001|Did Not Receive Intervention|Overall Study||1
10048979|NCT02019758|11174116|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
10048980|NCT02019758|11174117|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
10048981|NCT02019758|11174116|FG000|COMPLETED|Overall Study||56
10048982|NCT02019758|11174117|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
10048983|NCT02019758|11174116|FG000|NOT COMPLETED|Overall Study||9
10048984|NCT02019758|11174117|FG001|NOT COMPLETED|Overall Study||9
10048985|NCT02019888|11174126|FG000|STARTED|Overall Study||148
10048986|NCT02019888|11174127|FG001|STARTED|Overall Study||113
10048987|NCT02019888|11174128|FG002|STARTED|Overall Study||59
10048988|NCT02019888|11174126|FG000|COMPLETED|Overall Study||108
10048989|NCT02019888|11174127|FG001|COMPLETED|Overall Study||83
10048990|NCT02019888|11174128|FG002|COMPLETED|Overall Study||54
10048991|NCT02019888|11174126|FG000|NOT COMPLETED|Overall Study||40
10048992|NCT02019888|11174127|FG001|NOT COMPLETED|Overall Study||30
10048993|NCT02019888|11174128|FG002|NOT COMPLETED|Overall Study||5
10048994|NCT02019927|11174142|FG000|STARTED|Overall Study||46
10048995|NCT02019927|11174143|FG001|STARTED|Overall Study||23
10048996|NCT02019927|11174144|FG002|STARTED|Overall Study||9
10048997|NCT02019927|11174145|FG003|STARTED|Overall Study||5
10048998|NCT02019927|11174146|FG004|STARTED|Overall Study||10
10048999|NCT02019927|11174147|FG005|STARTED|Overall Study||4
10049000|NCT02019927|11174142|FG000|COMPLETED|Overall Study||44
10049001|NCT02019927|11174143|FG001|COMPLETED|Overall Study||19
10049002|NCT02019927|11174144|FG002|COMPLETED|Overall Study||8
10049003|NCT02019927|11174145|FG003|COMPLETED|Overall Study||3
10049004|NCT02019927|11174146|FG004|COMPLETED|Overall Study||7
10049005|NCT02019927|11174147|FG005|COMPLETED|Overall Study||3
10049006|NCT02019927|11174142|FG000|NOT COMPLETED|Overall Study||2
10049007|NCT02019927|11174143|FG001|NOT COMPLETED|Overall Study||4
10049008|NCT02019927|11174144|FG002|NOT COMPLETED|Overall Study||1
10049009|NCT02019927|11174145|FG003|NOT COMPLETED|Overall Study||2
10049010|NCT02019927|11174146|FG004|NOT COMPLETED|Overall Study||3
10049011|NCT02019927|11174147|FG005|NOT COMPLETED|Overall Study||1
10049012|NCT02019940|11174165|FG000|STARTED|Overall Study||18
10049013|NCT02019940|11174165|FG000|COMPLETED|Overall Study||8
10049014|NCT02019940|11174165|FG000|NOT COMPLETED|Overall Study||10
10049015|NCT02019979|11174169|FG000|STARTED|Overall Study||14
10049016|NCT02019979|11174169|FG000|COMPLETED|Overall Study||0
10049017|NCT02019979|11174169|FG000|NOT COMPLETED|Overall Study||14
10049018|NCT02020018|11174175|FG000|STARTED|Overall Study||272
10049019|NCT02020018|11174176|FG001|STARTED|Overall Study||1597
10049020|NCT02020018|11174175|FG000|COMPLETED|Overall Study||272
10049021|NCT02020018|11174176|FG001|COMPLETED|Overall Study||1597
10049022|NCT02020018|11174175|FG000|NOT COMPLETED|Overall Study||0
10049023|NCT02020018|11174176|FG001|NOT COMPLETED|Overall Study||0
10049024|NCT02020031|11174184|FG000|STARTED|Overall Study||11
10049025|NCT02020031|11174185|FG001|STARTED|Overall Study||11
10049026|NCT02020031|11174184|FG000|COMPLETED|Overall Study||10
10049027|NCT02020031|11174185|FG001|COMPLETED|Overall Study||10
10049028|NCT02020031|11174184|FG000|NOT COMPLETED|Overall Study||1
10049029|NCT02020031|11174185|FG001|NOT COMPLETED|Overall Study||1
10049030|NCT02020135|11174193|FG000|STARTED|Overall Study||9
10049031|NCT02020135|11174193|FG000|COMPLETED|Overall Study||0
10049032|NCT02020135|11174193|FG000|NOT COMPLETED|Overall Study||9
10049033|NCT02020252|11174199|FG000|STARTED|Overall Study||120
10049034|NCT02020252|11174199|FG000|COMPLETED|Overall Study||120
10049035|NCT02020252|11174199|FG000|NOT COMPLETED|Overall Study||0
10049036|NCT02020278|11174203|FG000|STARTED|Core Safety Follow-up Component||3
10049037|NCT02020278|11174203|FG000|COMPLETED|Core Safety Follow-up Component||3
10049038|NCT02020278|11174203|FG000|NOT COMPLETED|Core Safety Follow-up Component||0
10049039|NCT02020278|11174203|FG000|STARTED|Optional Tolvaptan Treatment Component||0
10049040|NCT02020278|11174203|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0
10049041|NCT02020278|11174203|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
10049042|NCT02020304|11174211|FG000|STARTED|Overall Study||30
10049043|NCT02020304|11174212|FG001|STARTED|Overall Study||28
10049044|NCT02020304|11174211|FG000|COMPLETED|Overall Study||27
10049045|NCT02020304|11174212|FG001|COMPLETED|Overall Study||26
10049046|NCT02020304|11174211|FG000|NOT COMPLETED|Overall Study||3
10049047|NCT02020304|11174212|FG001|NOT COMPLETED|Overall Study||2
10049048|NCT02020369|11174220|FG000|STARTED|Overall Study||14
10049049|NCT02020369|11174221|FG001|STARTED|Overall Study||13
10049050|NCT02020369|11174220|FG000|COMPLETED|Overall Study||11
10049051|NCT02020369|11174221|FG001|COMPLETED|Overall Study||11
10049052|NCT02020369|11174220|FG000|NOT COMPLETED|Overall Study||3
10049053|NCT02020369|11174221|FG001|NOT COMPLETED|Overall Study||2
10049054|NCT02020408|11174230|FG000|STARTED|Overall Study||88
10049055|NCT02020408|11174230|FG000|COMPLETED|Overall Study||85
10049056|NCT02020408|11174230|FG000|NOT COMPLETED|Overall Study||3
10049057|NCT02020512|11174240|FG000|STARTED|Overall Study||87
10049058|NCT02020512|11174240|FG000|COMPLETED|Overall Study||79
10049059|NCT02020512|11174240|FG000|NOT COMPLETED|Overall Study||8
10049060|NCT02020577|11174246|FG000|STARTED|Overall Study||3
10049061|NCT02020577|11174247|FG001|STARTED|Overall Study||55
10049062|NCT02020577|11174246|FG000|COMPLETED|Overall Study||0
10049063|NCT02020577|11174247|FG001|COMPLETED|Overall Study||0
10049064|NCT02020577|11174246|FG000|NOT COMPLETED|Overall Study||3
10049065|NCT02020577|11174247|FG001|NOT COMPLETED|Overall Study||55
10049066|NCT02020590|11174255|FG000|STARTED|Overall Study||22
10049067|NCT02020590|11174255|FG000|COMPLETED|Overall Study||22
10049068|NCT02020590|11174255|FG000|NOT COMPLETED|Overall Study||0
10049069|NCT02020616|11174266|FG000|STARTED|Overall Study||10
10049070|NCT02020616|11174267|FG001|STARTED|Overall Study||8
10049071|NCT02020616|11174268|FG002|STARTED|Overall Study||8
10049072|NCT02020616|11174269|FG003|STARTED|Overall Study||8
10049073|NCT02020616|11174270|FG004|STARTED|Overall Study||8
10049074|NCT02020616|11174271|FG005|STARTED|Overall Study||8
10049075|NCT02020616|11174272|FG006|STARTED|Overall Study||10
10049076|NCT02020616|11174266|FG000|Received at Least One Dose of Study Drug|Overall Study||10
10049077|NCT02020616|11174267|FG001|Received at Least One Dose of Study Drug|Overall Study||8
10049078|NCT02020616|11174268|FG002|Received at Least One Dose of Study Drug|Overall Study||8
10049079|NCT02020616|11174269|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10049080|NCT02020616|11174270|FG004|Received at Least One Dose of Study Drug|Overall Study||8
10049081|NCT02020616|11174271|FG005|Received at Least One Dose of Study Drug|Overall Study||8
10049082|NCT02020616|11174272|FG006|Received at Least One Dose of Study Drug|Overall Study||10
10049083|NCT02020616|11174266|FG000|COMPLETED|Overall Study||10
10049084|NCT02020616|11174267|FG001|COMPLETED|Overall Study||7
10049085|NCT02020616|11174268|FG002|COMPLETED|Overall Study||6
10049086|NCT02020616|11174269|FG003|COMPLETED|Overall Study||6
10049087|NCT02020616|11174270|FG004|COMPLETED|Overall Study||6
10049088|NCT02020616|11174271|FG005|COMPLETED|Overall Study||3
10049089|NCT02020616|11174272|FG006|COMPLETED|Overall Study||6
10049090|NCT02020616|11174266|FG000|NOT COMPLETED|Overall Study||0
10049091|NCT02020616|11174267|FG001|NOT COMPLETED|Overall Study||1
10049092|NCT02020616|11174268|FG002|NOT COMPLETED|Overall Study||2
10049093|NCT02020616|11174269|FG003|NOT COMPLETED|Overall Study||2
10049094|NCT02020616|11174270|FG004|NOT COMPLETED|Overall Study||2
10049095|NCT02020616|11174271|FG005|NOT COMPLETED|Overall Study||5
10049096|NCT02020616|11174272|FG006|NOT COMPLETED|Overall Study||4
10049097|NCT02020785|11174304|FG000|STARTED|First Intervention (3 Weeks)||15
10049098|NCT02020785|11174305|FG001|STARTED|First Intervention (3 Weeks)||16
10049099|NCT02020785|11174304|FG000|COMPLETED|First Intervention (3 Weeks)||15
10049100|NCT02020785|11174305|FG001|COMPLETED|First Intervention (3 Weeks)||16
10049101|NCT02020785|11174304|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10049102|NCT02020785|11174305|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10049103|NCT02020785|11174304|FG000|STARTED|Second Intervention (3 Weeks)||15
10049104|NCT02020785|11174305|FG001|STARTED|Second Intervention (3 Weeks)||16
10049105|NCT02020785|11174304|FG000|COMPLETED|Second Intervention (3 Weeks)||15
10049106|NCT02020785|11174305|FG001|COMPLETED|Second Intervention (3 Weeks)||16
10049107|NCT02020785|11174304|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10049108|NCT02020785|11174305|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10049109|NCT02020863|11174311|FG000|STARTED|Overall Study||40
10049110|NCT02020863|11174311|FG000|COMPLETED|Overall Study||35
10049111|NCT02020863|11174311|FG000|NOT COMPLETED|Overall Study||5
10049112|NCT02020889|11174317|FG000|STARTED|Overall Study||68
10049113|NCT02020889|11174318|FG001|STARTED|Overall Study||68
10049114|NCT02020889|11174317|FG000|COMPLETED|Overall Study||61
10049115|NCT02020889|11174318|FG001|COMPLETED|Overall Study||65
10049116|NCT02020889|11174317|FG000|NOT COMPLETED|Overall Study||7
10049117|NCT02020889|11174318|FG001|NOT COMPLETED|Overall Study||3
10049118|NCT02020941|11174324|FG000|STARTED|Overall Study||10
10049119|NCT02020941|11174324|FG000|COMPLETED|Overall Study||2
10049120|NCT02020941|11174324|FG000|NOT COMPLETED|Overall Study||8
10049121|NCT02020967|11174330|FG000|STARTED|Overall Study||367
10049122|NCT02020967|11174330|FG000|Examined Participants|Overall Study||329
10049123|NCT02020967|11174330|FG000|COMPLETED|Overall Study||316
10049124|NCT02020967|11174330|FG000|NOT COMPLETED|Overall Study||51
10049125|NCT02021292|11174338|FG000|STARTED|Overall Study||40
10049126|NCT02021292|11174339|FG001|STARTED|Overall Study||40
10049127|NCT02021292|11174338|FG000|COMPLETED|Overall Study||40
10049128|NCT02021292|11174339|FG001|COMPLETED|Overall Study||37
10049129|NCT02021292|11174338|FG000|NOT COMPLETED|Overall Study||0
10049130|NCT02021292|11174339|FG001|NOT COMPLETED|Overall Study||3
10049131|NCT02021318|11174349|FG000|STARTED|Overall Study||323
10049132|NCT02021318|11174350|FG001|STARTED|Overall Study||293
10049133|NCT02021318|11174349|FG000|COMPLETED|Overall Study||250
10049134|NCT02021318|11174350|FG001|COMPLETED|Overall Study||230
10049135|NCT02021318|11174349|FG000|NOT COMPLETED|Overall Study||73
10049136|NCT02021318|11174350|FG001|NOT COMPLETED|Overall Study||63
10049137|NCT02021331|11174359|FG000|STARTED|Overall Study||2
10049138|NCT02021331|11174360|FG001|STARTED|Overall Study||3
10049139|NCT02021331|11174359|FG000|COMPLETED|Overall Study||2
10049140|NCT02021331|11174360|FG001|COMPLETED|Overall Study||1
10049141|NCT02021331|11174359|FG000|NOT COMPLETED|Overall Study||0
10049142|NCT02021331|11174360|FG001|NOT COMPLETED|Overall Study||2
10049143|NCT02021461|11174366|FG000|STARTED|Overall Study||38
10049144|NCT02021461|11174366|FG000|COMPLETED|Overall Study||38
10049145|NCT02021461|11174366|FG000|NOT COMPLETED|Overall Study||0
10049146|NCT02021565|11174374|FG000|STARTED|Baseline Through Intervention||72
10049147|NCT02021565|11174375|FG001|STARTED|Baseline Through Intervention||54
10049148|NCT02021565|11174374|FG000|Caregivers|Baseline Through Intervention||36
10049149|NCT02021565|11174375|FG001|Caregivers|Baseline Through Intervention||27
10049150|NCT02021565|11174374|FG000|Care Recipients|Baseline Through Intervention||36
10049151|NCT02021565|11174375|FG001|Care Recipients|Baseline Through Intervention||27
10049152|NCT02021565|11174374|FG000|COMPLETED|Baseline Through Intervention||60
10049153|NCT02021565|11174375|FG001|COMPLETED|Baseline Through Intervention||36
10049154|NCT02021565|11174374|FG000|NOT COMPLETED|Baseline Through Intervention||12
10049155|NCT02021565|11174375|FG001|NOT COMPLETED|Baseline Through Intervention||18
10049156|NCT02021565|11174374|FG000|STARTED|3-month Follow-up||60
10049157|NCT02021565|11174375|FG001|STARTED|3-month Follow-up||36
10049158|NCT02021565|11174374|FG000|Caregivers|3-month Follow-up||30
10049159|NCT02021565|11174375|FG001|Caregivers|3-month Follow-up||18
10049160|NCT02021565|11174374|FG000|Care Recipients|3-month Follow-up||30
10049161|NCT02021565|11174375|FG001|Care Recipients|3-month Follow-up||18
10049162|NCT02021565|11174374|FG000|COMPLETED|3-month Follow-up||50
10049163|NCT02021565|11174375|FG001|COMPLETED|3-month Follow-up||34
10049164|NCT02021565|11174374|FG000|NOT COMPLETED|3-month Follow-up||10
10049165|NCT02021565|11174375|FG001|NOT COMPLETED|3-month Follow-up||2
10049166|NCT02021643|11174389|FG000|STARTED|Overall Study||156
10049167|NCT02021643|11174390|FG001|STARTED|Overall Study||290
10049168|NCT02021643|11174391|FG002|STARTED|Overall Study||11
10049169|NCT02021643|11174392|FG003|STARTED|Overall Study||230
10049170|NCT02021643|11174389|FG000|COMPLETED|Overall Study||147
10049171|NCT02021643|11174390|FG001|COMPLETED|Overall Study||280
10049172|NCT02021643|11174391|FG002|COMPLETED|Overall Study||11
10049173|NCT02021643|11174392|FG003|COMPLETED|Overall Study||218
10049174|NCT02021643|11174389|FG000|NOT COMPLETED|Overall Study||9
10049175|NCT02021643|11174390|FG001|NOT COMPLETED|Overall Study||10
10049176|NCT02021643|11174391|FG002|NOT COMPLETED|Overall Study||0
10049177|NCT02021643|11174392|FG003|NOT COMPLETED|Overall Study||12
10049178|NCT02021656|11174408|FG000|STARTED|Overall Study||384
10049179|NCT02021656|11174408|FG000|COMPLETED|Overall Study||378
10049180|NCT02021656|11174408|FG000|NOT COMPLETED|Overall Study||6
10049181|NCT02021669|11174418|FG000|STARTED|Overall Study||71
10049182|NCT02021669|11174419|FG001|STARTED|Overall Study||73
10049183|NCT02021669|11174418|FG000|COMPLETED|Overall Study||64
10049184|NCT02021669|11174419|FG001|COMPLETED|Overall Study||70
10049185|NCT02021669|11174418|FG000|NOT COMPLETED|Overall Study||7
10049186|NCT02021669|11174419|FG001|NOT COMPLETED|Overall Study||3
10049190|NCT02021929|11174431|FG000|STARTED|Overall Study||16
10049191|NCT02021929|11174432|FG001|STARTED|Overall Study||12
10049192|NCT02021929|11174431|FG000|COMPLETED|Overall Study||14
10049193|NCT02021929|11174432|FG001|COMPLETED|Overall Study||11
10049194|NCT02021929|11174431|FG000|NOT COMPLETED|Overall Study||2
10049195|NCT02021929|11174432|FG001|NOT COMPLETED|Overall Study||1
10049196|NCT02021942|11174438|FG000|STARTED|Overall Study||16
10049197|NCT02021942|11174438|FG000|COMPLETED|Overall Study||16
10049198|NCT02021942|11174438|FG000|NOT COMPLETED|Overall Study||0
10049199|NCT02021955|11174445|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
10049200|NCT02021955|11174446|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
10049201|NCT02021955|11174445|FG000|COMPLETED|Step 0||210
10049202|NCT02021955|11174446|FG001|COMPLETED|Step 0||0
10049203|NCT02021955|11174445|FG000|NOT COMPLETED|Step 0||0
10049204|NCT02021955|11174446|FG001|NOT COMPLETED|Step 0||0
10049205|NCT02021955|11174445|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
10049206|NCT02021955|11174446|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
10049207|NCT02021955|11174445|FG000|COMPLETED|Step 1||193
10049208|NCT02021955|11174446|FG001|COMPLETED|Step 1||18
10049209|NCT02021955|11174445|FG000|NOT COMPLETED|Step 1||0
10049210|NCT02021955|11174446|FG001|NOT COMPLETED|Step 1||0
10049211|NCT02021955|11174445|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
10049212|NCT02021955|11174446|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
10049213|NCT02021955|11174445|FG000|COMPLETED|Step 2||165
10049214|NCT02021955|11174446|FG001|COMPLETED|Step 2||21
10049215|NCT02021955|11174445|FG000|NOT COMPLETED|Step 2||0
10049216|NCT02021955|11174446|FG001|NOT COMPLETED|Step 2||0
10049217|NCT02021955|11174445|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
10049218|NCT02021955|11174446|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
10049219|NCT02021955|11174445|FG000|COMPLETED|Step 3||175
10049220|NCT02021955|11174446|FG001|COMPLETED|Step 3||30
10049221|NCT02021955|11174445|FG000|NOT COMPLETED|Step 3||0
10049222|NCT02021955|11174446|FG001|NOT COMPLETED|Step 3||0
10049223|NCT02021955|11174445|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
10049224|NCT02021955|11174446|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
10049225|NCT02021955|11174445|FG000|COMPLETED|Step 4||173
10049226|NCT02021955|11174446|FG001|COMPLETED|Step 4||37
10049227|NCT02021955|11174445|FG000|NOT COMPLETED|Step 4||0
10049228|NCT02021955|11174446|FG001|NOT COMPLETED|Step 4||0
10049229|NCT02021955|11174445|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
10049230|NCT02021955|11174446|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
10049231|NCT02021955|11174445|FG000|COMPLETED|Step 5||174
10049232|NCT02021955|11174446|FG001|COMPLETED|Step 5||40
10049233|NCT02021955|11174445|FG000|NOT COMPLETED|Step 5||0
10049234|NCT02021955|11174446|FG001|NOT COMPLETED|Step 5||0
10049235|NCT02021955|11174445|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
10118186|NCT02544451|11249000|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
10049236|NCT02021955|11174446|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
10049237|NCT02021955|11174445|FG000|COMPLETED|Step 6||158
10049238|NCT02021955|11174446|FG001|COMPLETED|Step 6||53
10049239|NCT02021955|11174445|FG000|NOT COMPLETED|Step 6||0
10049240|NCT02021955|11174446|FG001|NOT COMPLETED|Step 6||0
10049241|NCT02021955|11174445|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
10049242|NCT02021955|11174446|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
10049243|NCT02021955|11174445|FG000|COMPLETED|Step 7||157
10049244|NCT02021955|11174446|FG001|COMPLETED|Step 7||57
10049245|NCT02021955|11174445|FG000|NOT COMPLETED|Step 7||0
10049246|NCT02021955|11174446|FG001|NOT COMPLETED|Step 7||0
10049247|NCT02021955|11174445|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
10049248|NCT02021955|11174446|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
10049249|NCT02021955|11174445|FG000|COMPLETED|Step 8||144
10049250|NCT02021955|11174446|FG001|COMPLETED|Step 8||73
10049251|NCT02021955|11174445|FG000|NOT COMPLETED|Step 8||0
10049252|NCT02021955|11174446|FG001|NOT COMPLETED|Step 8||0
10049253|NCT02021955|11174445|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
10049254|NCT02021955|11174446|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
10049255|NCT02021955|11174445|FG000|COMPLETED|Step 9||139
10049256|NCT02021955|11174446|FG001|COMPLETED|Step 9||77
10049257|NCT02021955|11174445|FG000|NOT COMPLETED|Step 9||0
10049258|NCT02021955|11174446|FG001|NOT COMPLETED|Step 9||0
10049259|NCT02021955|11174445|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
10049260|NCT02021955|11174446|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
10049261|NCT02021955|11174445|FG000|COMPLETED|Step 10||135
10049262|NCT02021955|11174446|FG001|COMPLETED|Step 10||79
10049263|NCT02021955|11174445|FG000|NOT COMPLETED|Step 10||0
10049264|NCT02021955|11174446|FG001|NOT COMPLETED|Step 10||0
10049265|NCT02021955|11174445|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
10049266|NCT02021955|11174446|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
10049267|NCT02021955|11174445|FG000|COMPLETED|Step 11||126
10049268|NCT02021955|11174446|FG001|COMPLETED|Step 11||88
10049269|NCT02021955|11174445|FG000|NOT COMPLETED|Step 11||0
10049270|NCT02021955|11174446|FG001|NOT COMPLETED|Step 11||0
10049271|NCT02021955|11174445|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
10049272|NCT02021955|11174446|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
10049273|NCT02021955|11174445|FG000|COMPLETED|Step 12||123
10049274|NCT02021955|11174446|FG001|COMPLETED|Step 12||90
10049275|NCT02021955|11174445|FG000|NOT COMPLETED|Step 12||0
10049276|NCT02021955|11174446|FG001|NOT COMPLETED|Step 12||0
10049277|NCT02021955|11174445|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
10049278|NCT02021955|11174446|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
10049279|NCT02021955|11174445|FG000|COMPLETED|Step 13||118
10049280|NCT02021955|11174446|FG001|COMPLETED|Step 13||96
10049281|NCT02021955|11174445|FG000|NOT COMPLETED|Step 13||0
10049282|NCT02021955|11174446|FG001|NOT COMPLETED|Step 13||0
10049283|NCT02021955|11174445|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
10049284|NCT02021955|11174446|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
10049285|NCT02021955|11174445|FG000|COMPLETED|Step 14||105
10049286|NCT02021955|11174446|FG001|COMPLETED|Step 14||95
10118187|NCT02544451|11249001|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
10118188|NCT02544607|11249019|FG000|STARTED|Overall Study||16
10118189|NCT02544607|11249019|FG000|COMPLETED|Overall Study||16
10118190|NCT02544607|11249019|FG000|NOT COMPLETED|Overall Study||0
10118191|NCT02544633|11249028|FG000|STARTED|Treatment Period||28
10118192|NCT02544633|11249029|FG001|STARTED|Treatment Period||20
10118193|NCT02544633|11249030|FG002|STARTED|Treatment Period||8
10118194|NCT02544633|11249031|FG003|STARTED|Treatment Period||12
10118195|NCT02544633|11249028|FG000|COMPLETED|Treatment Period||0
10118196|NCT02544633|11249029|FG001|COMPLETED|Treatment Period||0
10118197|NCT02544633|11249030|FG002|COMPLETED|Treatment Period||0
10118198|NCT02544633|11249031|FG003|COMPLETED|Treatment Period||0
10118199|NCT02544633|11249028|FG000|NOT COMPLETED|Treatment Period||28
10118200|NCT02544633|11249029|FG001|NOT COMPLETED|Treatment Period||20
10118201|NCT02544633|11249030|FG002|NOT COMPLETED|Treatment Period||8
10118202|NCT02544633|11249031|FG003|NOT COMPLETED|Treatment Period||12
10118203|NCT02544633|11249028|FG000|STARTED|Survival Follow-up Period||28
10118204|NCT02544633|11249029|FG001|STARTED|Survival Follow-up Period||19
10118205|NCT02544633|11249030|FG002|STARTED|Survival Follow-up Period||7
10118206|NCT02544633|11249031|FG003|STARTED|Survival Follow-up Period||12
10118207|NCT02544633|11249028|FG000|COMPLETED|Survival Follow-up Period||0
10118208|NCT02544633|11249029|FG001|COMPLETED|Survival Follow-up Period||0
10118209|NCT02544633|11249030|FG002|COMPLETED|Survival Follow-up Period||0
10118210|NCT02544633|11249031|FG003|COMPLETED|Survival Follow-up Period||0
10118211|NCT02544633|11249028|FG000|NOT COMPLETED|Survival Follow-up Period||28
10118212|NCT02544633|11249029|FG001|NOT COMPLETED|Survival Follow-up Period||19
10118213|NCT02544633|11249030|FG002|NOT COMPLETED|Survival Follow-up Period||7
10118214|NCT02544633|11249031|FG003|NOT COMPLETED|Survival Follow-up Period||12
10118215|NCT02544763|11249056|FG000|STARTED|Overall Study||75
10118216|NCT02544763|11249057|FG001|STARTED|Overall Study||73
10118217|NCT02544763|11249058|FG002|STARTED|Overall Study||76
10118218|NCT02544763|11249056|FG000|COMPLETED|Overall Study||65
10118219|NCT02544763|11249057|FG001|COMPLETED|Overall Study||61
10118220|NCT02544763|11249058|FG002|COMPLETED|Overall Study||75
10118221|NCT02544763|11249056|FG000|NOT COMPLETED|Overall Study||10
10118222|NCT02544763|11249057|FG001|NOT COMPLETED|Overall Study||12
10049287|NCT02021955|11174445|FG000|NOT COMPLETED|Step 14||0
10049288|NCT02021955|11174446|FG001|NOT COMPLETED|Step 14||0
10049289|NCT02021955|11174445|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
10118223|NCT02544763|11249058|FG002|NOT COMPLETED|Overall Study||1
10118224|NCT02544984|11249068|FG000|STARTED|Overall Study||30
10118225|NCT02544984|11249069|FG001|STARTED|Overall Study||30
10118226|NCT02544984|11249068|FG000|COMPLETED|Overall Study||28
10118227|NCT02544984|11249069|FG001|COMPLETED|Overall Study||28
10049290|NCT02021955|11174446|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
10049291|NCT02021955|11174445|FG000|COMPLETED|Step 15||110
10049292|NCT02021955|11174446|FG001|COMPLETED|Step 15||102
10049293|NCT02021955|11174445|FG000|NOT COMPLETED|Step 15||0
10049294|NCT02021955|11174446|FG001|NOT COMPLETED|Step 15||0
10049295|NCT02021955|11174445|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
10049296|NCT02021955|11174446|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
10049297|NCT02021955|11174445|FG000|COMPLETED|Step 16||103
10049298|NCT02021955|11174446|FG001|COMPLETED|Step 16||114
10049299|NCT02021955|11174445|FG000|NOT COMPLETED|Step 16||0
10049300|NCT02021955|11174446|FG001|NOT COMPLETED|Step 16||0
10049301|NCT02021955|11174445|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
10049302|NCT02021955|11174446|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
10049303|NCT02021955|11174445|FG000|COMPLETED|Step 17||99
10049304|NCT02021955|11174446|FG001|COMPLETED|Step 17||121
10049305|NCT02021955|11174445|FG000|NOT COMPLETED|Step 17||0
10049306|NCT02021955|11174446|FG001|NOT COMPLETED|Step 17||0
10049307|NCT02021955|11174445|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
10049308|NCT02021955|11174446|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
10049309|NCT02021955|11174445|FG000|COMPLETED|Step 18||96
10049310|NCT02021955|11174446|FG001|COMPLETED|Step 18||124
10049311|NCT02021955|11174445|FG000|NOT COMPLETED|Step 18||0
10049312|NCT02021955|11174446|FG001|NOT COMPLETED|Step 18||0
10049313|NCT02021955|11174445|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
10049314|NCT02021955|11174446|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
10049315|NCT02021955|11174445|FG000|COMPLETED|Step 19||94
10049316|NCT02021955|11174446|FG001|COMPLETED|Step 19||126
10049317|NCT02021955|11174445|FG000|NOT COMPLETED|Step 19||0
10049318|NCT02021955|11174446|FG001|NOT COMPLETED|Step 19||0
10049319|NCT02021955|11174445|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
10049320|NCT02021955|11174446|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
10049321|NCT02021955|11174445|FG000|COMPLETED|Step 20||92
10049322|NCT02021955|11174446|FG001|COMPLETED|Step 20||128
10049323|NCT02021955|11174445|FG000|NOT COMPLETED|Step 20||0
10049324|NCT02021955|11174446|FG001|NOT COMPLETED|Step 20||0
10049325|NCT02021955|11174445|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
10049326|NCT02021955|11174446|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
10049327|NCT02021955|11174445|FG000|COMPLETED|Step 21||88
10049328|NCT02021955|11174446|FG001|COMPLETED|Step 21||134
10049329|NCT02021955|11174445|FG000|NOT COMPLETED|Step 21||0
10049330|NCT02021955|11174446|FG001|NOT COMPLETED|Step 21||0
10049331|NCT02021955|11174445|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
10049332|NCT02021955|11174446|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
10049333|NCT02021955|11174445|FG000|COMPLETED|Step 22||89
10049334|NCT02021955|11174446|FG001|COMPLETED|Step 22||152
10049335|NCT02021955|11174445|FG000|NOT COMPLETED|Step 22||0
10049336|NCT02021955|11174446|FG001|NOT COMPLETED|Step 22||0
10049337|NCT02021955|11174445|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
10049338|NCT02021955|11174446|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
10049339|NCT02021955|11174445|FG000|COMPLETED|Step 23||69
10049340|NCT02021955|11174446|FG001|COMPLETED|Step 23||175
10049341|NCT02021955|11174445|FG000|NOT COMPLETED|Step 23||0
10049342|NCT02021955|11174446|FG001|NOT COMPLETED|Step 23||0
10049343|NCT02021955|11174445|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
10049344|NCT02021955|11174446|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
10049345|NCT02021955|11174445|FG000|COMPLETED|Step 24||62
10049346|NCT02021955|11174446|FG001|COMPLETED|Step 24||183
10049347|NCT02021955|11174445|FG000|NOT COMPLETED|Step 24||0
10049348|NCT02021955|11174446|FG001|NOT COMPLETED|Step 24||0
10049349|NCT02021955|11174445|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
10049350|NCT02021955|11174446|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
10049351|NCT02021955|11174445|FG000|COMPLETED|Step 25||37
10049352|NCT02021955|11174446|FG001|COMPLETED|Step 25||208
10049353|NCT02021955|11174445|FG000|NOT COMPLETED|Step 25||0
10049354|NCT02021955|11174446|FG001|NOT COMPLETED|Step 25||0
10049355|NCT02021955|11174445|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
10049356|NCT02021955|11174446|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
10049357|NCT02021955|11174445|FG000|COMPLETED|Step 26||30
10049358|NCT02021955|11174446|FG001|COMPLETED|Step 26||215
10049359|NCT02021955|11174445|FG000|NOT COMPLETED|Step 26||0
10049360|NCT02021955|11174446|FG001|NOT COMPLETED|Step 26||0
10049361|NCT02021955|11174445|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
10049362|NCT02021955|11174446|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
10049363|NCT02021955|11174445|FG000|COMPLETED|Step 27||25
10049364|NCT02021955|11174446|FG001|COMPLETED|Step 27||243
10049365|NCT02021955|11174445|FG000|NOT COMPLETED|Step 27||0
10049366|NCT02021955|11174446|FG001|NOT COMPLETED|Step 27||0
10049367|NCT02021955|11174445|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
10049368|NCT02021955|11174446|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
10049369|NCT02021955|11174445|FG000|COMPLETED|Step 28||15
10049370|NCT02021955|11174446|FG001|COMPLETED|Step 28||256
10049371|NCT02021955|11174445|FG000|NOT COMPLETED|Step 28||0
10049372|NCT02021955|11174446|FG001|NOT COMPLETED|Step 28||0
10049373|NCT02021955|11174445|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
10049374|NCT02021955|11174446|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
10049375|NCT02021955|11174445|FG000|COMPLETED|Step 29||10
10049376|NCT02021955|11174446|FG001|COMPLETED|Step 29||266
10049377|NCT02021955|11174445|FG000|NOT COMPLETED|Step 29||0
10049378|NCT02021955|11174446|FG001|NOT COMPLETED|Step 29||0
10049379|NCT02021955|11174445|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
10049380|NCT02021955|11174446|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
10049381|NCT02021955|11174445|FG000|COMPLETED|Step 30||0
10049382|NCT02021955|11174446|FG001|COMPLETED|Step 30||277
10049383|NCT02021955|11174445|FG000|NOT COMPLETED|Step 30||0
10049384|NCT02021955|11174446|FG001|NOT COMPLETED|Step 30||0
10049385|NCT02022007|11174455|FG000|STARTED|Overall Study||13
10049386|NCT02022007|11174456|FG001|STARTED|Overall Study||12
10049387|NCT02022007|11174457|FG002|STARTED|Overall Study||13
10049388|NCT02022007|11174455|FG000|COMPLETED|Overall Study||12
10049389|NCT02022007|11174456|FG001|COMPLETED|Overall Study||11
10049390|NCT02022007|11174457|FG002|COMPLETED|Overall Study||11
10049391|NCT02022007|11174455|FG000|NOT COMPLETED|Overall Study||1
10049392|NCT02022007|11174456|FG001|NOT COMPLETED|Overall Study||1
10049393|NCT02022007|11174457|FG002|NOT COMPLETED|Overall Study||2
10049394|NCT02022020|11174465|FG000|STARTED|Overall Study||220
10049395|NCT02022020|11174465|FG000|COMPLETED|Overall Study||220
10049396|NCT02022020|11174465|FG000|NOT COMPLETED|Overall Study||0
10049397|NCT02022085|11174469|FG000|STARTED|Overall Study||54
10049398|NCT02022085|11174469|FG000|COMPLETED|Overall Study||53
10049399|NCT02022085|11174469|FG000|NOT COMPLETED|Overall Study||1
10049400|NCT02022111|11174475|FG000|STARTED|Overall Study||196
10049401|NCT02022111|11174476|FG001|STARTED|Overall Study||208
10049402|NCT02022111|11174475|FG000|COMPLETED|Overall Study||186
10049403|NCT02022111|11174476|FG001|COMPLETED|Overall Study||193
10049404|NCT02022111|11174475|FG000|NOT COMPLETED|Overall Study||10
10049405|NCT02022111|11174476|FG001|NOT COMPLETED|Overall Study||15
10049406|NCT02022657|11174484|FG000|STARTED|Overall Study||10
10049407|NCT02022657|11174485|FG001|STARTED|Overall Study||8
10049408|NCT02022657|11174486|FG002|STARTED|Overall Study||9
10049409|NCT02022657|11174487|FG003|STARTED|Overall Study||8
10049410|NCT02022657|11174488|FG004|STARTED|Overall Study||8
10049411|NCT02022657|11174489|FG005|STARTED|Overall Study||9
10049412|NCT02022657|11174484|FG000|COMPLETED|Overall Study||8
10049413|NCT02022657|11174485|FG001|COMPLETED|Overall Study||8
10049414|NCT02022657|11174486|FG002|COMPLETED|Overall Study||8
10049415|NCT02022657|11174487|FG003|COMPLETED|Overall Study||8
10049416|NCT02022657|11174488|FG004|COMPLETED|Overall Study||8
10049417|NCT02022657|11174489|FG005|COMPLETED|Overall Study||8
10049418|NCT02022657|11174484|FG000|NOT COMPLETED|Overall Study||2
10049419|NCT02022657|11174485|FG001|NOT COMPLETED|Overall Study||0
10049420|NCT02022657|11174486|FG002|NOT COMPLETED|Overall Study||1
10049421|NCT02022657|11174487|FG003|NOT COMPLETED|Overall Study||0
10049422|NCT02022657|11174488|FG004|NOT COMPLETED|Overall Study||0
10049423|NCT02022657|11174489|FG005|NOT COMPLETED|Overall Study||1
10049424|NCT02022670|11174498|FG000|STARTED|Overall Study||11
10049425|NCT02022670|11174499|FG001|STARTED|Overall Study||10
10049426|NCT02022670|11174500|FG002|STARTED|Overall Study||12
10049427|NCT02022670|11174498|FG000|COMPLETED|Overall Study||10
10049428|NCT02022670|11174499|FG001|COMPLETED|Overall Study||10
10049429|NCT02022670|11174500|FG002|COMPLETED|Overall Study||11
10049430|NCT02022670|11174498|FG000|NOT COMPLETED|Overall Study||1
10049431|NCT02022670|11174499|FG001|NOT COMPLETED|Overall Study||0
10049432|NCT02022670|11174500|FG002|NOT COMPLETED|Overall Study||1
10049433|NCT02022735|11174509|FG000|STARTED|Overall Study||22
10049434|NCT02022735|11174509|FG000|COMPLETED|Overall Study||22
10049435|NCT02022735|11174509|FG000|NOT COMPLETED|Overall Study||0
10049436|NCT02022748|11174521|FG000|STARTED|Overall Study||8
10049437|NCT02022748|11174522|FG001|STARTED|Overall Study||6
10049438|NCT02022748|11174523|FG002|STARTED|Overall Study||13
10049439|NCT02022748|11174521|FG000|Subject Who Started Treatment|Overall Study||8
10049440|NCT02022748|11174522|FG001|Subject Who Started Treatment|Overall Study||6
10049441|NCT02022748|11174523|FG002|Subject Who Started Treatment|Overall Study||13
10049442|NCT02022748|11174521|FG000|Subjects Who Completed Treatment|Overall Study||7
10049443|NCT02022748|11174522|FG001|Subjects Who Completed Treatment|Overall Study||4
10049444|NCT02022748|11174523|FG002|Subjects Who Completed Treatment|Overall Study||13
10049445|NCT02022748|11174521|FG000|COMPLETED|Overall Study||7
10049446|NCT02022748|11174522|FG001|COMPLETED|Overall Study||4
10049447|NCT02022748|11174523|FG002|COMPLETED|Overall Study||13
10049448|NCT02022748|11174521|FG000|NOT COMPLETED|Overall Study||1
10049449|NCT02022748|11174522|FG001|NOT COMPLETED|Overall Study||2
10049450|NCT02022748|11174523|FG002|NOT COMPLETED|Overall Study||0
10049451|NCT02022826|11174531|FG000|STARTED|Overall Study||167
10049452|NCT02022826|11174531|FG000|COMPLETED|Overall Study||139
10049453|NCT02022826|11174531|FG000|NOT COMPLETED|Overall Study||28
10049454|NCT02023099|11174538|FG000|STARTED|Overall Study||215
10049455|NCT02023099|11174539|FG001|STARTED|Overall Study||106
10049456|NCT02023099|11174540|FG002|STARTED|Overall Study||42
10049457|NCT02023099|11174538|FG000|COMPLETED|Overall Study||212
10049458|NCT02023099|11174539|FG001|COMPLETED|Overall Study||106
10049459|NCT02023099|11174540|FG002|COMPLETED|Overall Study||39
10049460|NCT02023099|11174538|FG000|NOT COMPLETED|Overall Study||3
10049461|NCT02023099|11174539|FG001|NOT COMPLETED|Overall Study||0
10049462|NCT02023099|11174540|FG002|NOT COMPLETED|Overall Study||3
10049463|NCT02023112|11174550|FG000|STARTED|Overall Study||85
10049464|NCT02023112|11174551|FG001|STARTED|Overall Study||86
10049465|NCT02023112|11174550|FG000|COMPLETED|Overall Study||83
10049466|NCT02023112|11174551|FG001|COMPLETED|Overall Study||85
10049467|NCT02023112|11174550|FG000|NOT COMPLETED|Overall Study||2
10049468|NCT02023112|11174551|FG001|NOT COMPLETED|Overall Study||1
10049469|NCT02023125|11174561|FG000|STARTED|Period 1||9
10049470|NCT02023125|11174562|FG001|STARTED|Period 1||9
10049471|NCT02023125|11174563|FG002|STARTED|Period 1||24
10049472|NCT02023125|11174561|FG000|COMPLETED|Period 1||9
10049473|NCT02023125|11174562|FG001|COMPLETED|Period 1||9
10049474|NCT02023125|11174563|FG002|COMPLETED|Period 1||24
10049475|NCT02023125|11174561|FG000|NOT COMPLETED|Period 1||0
10049476|NCT02023125|11174562|FG001|NOT COMPLETED|Period 1||0
10049477|NCT02023125|11174563|FG002|NOT COMPLETED|Period 1||0
10049478|NCT02023125|11174561|FG000|STARTED|Washout Period||9
10049479|NCT02023125|11174562|FG001|STARTED|Washout Period||9
10049480|NCT02023125|11174563|FG002|STARTED|Washout Period||24
10049481|NCT02023125|11174561|FG000|COMPLETED|Washout Period||9
10049482|NCT02023125|11174562|FG001|COMPLETED|Washout Period||9
10049483|NCT02023125|11174563|FG002|COMPLETED|Washout Period||24
10049484|NCT02023125|11174561|FG000|NOT COMPLETED|Washout Period||0
10049485|NCT02023125|11174562|FG001|NOT COMPLETED|Washout Period||0
10049486|NCT02023125|11174563|FG002|NOT COMPLETED|Washout Period||0
10049487|NCT02023125|11174561|FG000|STARTED|Period 2||9
10049488|NCT02023125|11174562|FG001|STARTED|Period 2||9
10049489|NCT02023125|11174563|FG002|STARTED|Period 2||24
10049490|NCT02023125|11174561|FG000|COMPLETED|Period 2||9
10049491|NCT02023125|11174562|FG001|COMPLETED|Period 2||9
10049492|NCT02023125|11174563|FG002|COMPLETED|Period 2||24
10049493|NCT02023125|11174561|FG000|NOT COMPLETED|Period 2||0
10049494|NCT02023125|11174562|FG001|NOT COMPLETED|Period 2||0
10049495|NCT02023125|11174563|FG002|NOT COMPLETED|Period 2||0
10049496|NCT02023151|11174575|FG000|STARTED|Overall Study||17
10049497|NCT02023151|11174575|FG000|COMPLETED|Overall Study||13
10049498|NCT02023151|11174575|FG000|NOT COMPLETED|Overall Study||4
10049499|NCT02023242|11174581|FG000|STARTED|Overall Study||75
10049500|NCT02023242|11174582|FG001|STARTED|Overall Study||77
10049501|NCT02023242|11174581|FG000|COMPLETED|Overall Study||72
10049502|NCT02023242|11174582|FG001|COMPLETED|Overall Study||75
10049503|NCT02023242|11174581|FG000|NOT COMPLETED|Overall Study||3
10049504|NCT02023242|11174582|FG001|NOT COMPLETED|Overall Study||2
10049505|NCT02023268|11174590|FG000|STARTED|Overall Study||52
10049506|NCT02023268|11174591|FG001|STARTED|Overall Study||53
10049507|NCT02023268|11174590|FG000|COMPLETED|Overall Study||52
10049508|NCT02023268|11174591|FG001|COMPLETED|Overall Study||49
10049509|NCT02023268|11174590|FG000|NOT COMPLETED|Overall Study||0
10049510|NCT02023268|11174591|FG001|NOT COMPLETED|Overall Study||4
10049511|NCT02023411|11174599|FG000|STARTED|Overall Study||10
10049512|NCT02023411|11174600|FG001|STARTED|Overall Study||10
10049513|NCT02023411|11174599|FG000|COMPLETED|Overall Study||10
10049514|NCT02023411|11174600|FG001|COMPLETED|Overall Study||10
10049515|NCT02023411|11174599|FG000|NOT COMPLETED|Overall Study||0
10049516|NCT02023411|11174600|FG001|NOT COMPLETED|Overall Study||0
10049517|NCT02023515|11174609|FG000|STARTED|Overall Study||24
10049518|NCT02023515|11174610|FG001|STARTED|Overall Study||25
10049519|NCT02023515|11174609|FG000|COMPLETED|Overall Study||23
10049520|NCT02023515|11174610|FG001|COMPLETED|Overall Study||22
10049521|NCT02023515|11174609|FG000|NOT COMPLETED|Overall Study||1
10049522|NCT02023515|11174610|FG001|NOT COMPLETED|Overall Study||3
10049523|NCT02023697|11174619|FG000|STARTED|Treatment Period||130
10049524|NCT02023697|11174620|FG001|STARTED|Treatment Period||130
10049525|NCT02023697|11174621|FG002|STARTED|Treatment Period||131
10049526|NCT02023697|11174619|FG000|Received Treatment|Treatment Period||125
10049527|NCT02023697|11174620|FG001|Received Treatment|Treatment Period||124
10049528|NCT02023697|11174621|FG002|Received Treatment|Treatment Period||121
10049529|NCT02023697|11174619|FG000|COMPLETED|Treatment Period||84
10049530|NCT02023697|11174620|FG001|COMPLETED|Treatment Period||67
10049531|NCT02023697|11174621|FG002|COMPLETED|Treatment Period||29
10049532|NCT02023697|11174619|FG000|NOT COMPLETED|Treatment Period||46
10049533|NCT02023697|11174620|FG001|NOT COMPLETED|Treatment Period||63
10049534|NCT02023697|11174621|FG002|NOT COMPLETED|Treatment Period||102
10049535|NCT02023697|11174619|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
10049536|NCT02023697|11174620|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
10049537|NCT02023697|11174621|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
10049538|NCT02023697|11174619|FG000|COMPLETED|Active Follow-up Period||28
10049539|NCT02023697|11174620|FG001|COMPLETED|Active Follow-up Period||21
10049540|NCT02023697|11174621|FG002|COMPLETED|Active Follow-up Period||17
10049541|NCT02023697|11174619|FG000|NOT COMPLETED|Active Follow-up Period||92
10049542|NCT02023697|11174620|FG001|NOT COMPLETED|Active Follow-up Period||99
10049543|NCT02023697|11174621|FG002|NOT COMPLETED|Active Follow-up Period||99
10049544|NCT02023697|11174619|FG000|STARTED|Long-term Follow-up Period||28
10049545|NCT02023697|11174620|FG001|STARTED|Long-term Follow-up Period||21
10049546|NCT02023697|11174621|FG002|STARTED|Long-term Follow-up Period||17
10049547|NCT02023697|11174619|FG000|COMPLETED|Long-term Follow-up Period||0
10049548|NCT02023697|11174620|FG001|COMPLETED|Long-term Follow-up Period||0
10049549|NCT02023697|11174621|FG002|COMPLETED|Long-term Follow-up Period||0
10049550|NCT02023697|11174619|FG000|NOT COMPLETED|Long-term Follow-up Period||28
10049551|NCT02023697|11174620|FG001|NOT COMPLETED|Long-term Follow-up Period||21
10049552|NCT02023697|11174621|FG002|NOT COMPLETED|Long-term Follow-up Period||17
10049553|NCT02023801|11174636|FG000|STARTED|Overall Study|Treatment Attempted|24
10049554|NCT02023801|11174636|FG000|Treated|Overall Study|Treatment Completed|24
10049555|NCT02023801|11174636|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
10049556|NCT02023801|11174636|FG000|NOT COMPLETED|Overall Study||0
10049557|NCT02023866|11174640|FG000|STARTED|Overall Study||36
10049558|NCT02023866|11174640|FG000|COMPLETED|Overall Study||30
10049559|NCT02023866|11174640|FG000|NOT COMPLETED|Overall Study||6
10049560|NCT02023879|11174647|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58
10049561|NCT02023879|11174648|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116
10049562|NCT02023879|11174649|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59
10049563|NCT02023879|11174647|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58
10049564|NCT02023879|11174648|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115
10118228|NCT02544984|11249068|FG000|NOT COMPLETED|Overall Study||2
10118229|NCT02544984|11249069|FG001|NOT COMPLETED|Overall Study||2
10118230|NCT02545075|11249077|FG000|STARTED|Randomization||122
10118231|NCT02545075|11249078|FG001|STARTED|Randomization||60
10118232|NCT02545075|11249077|FG000|COMPLETED|Randomization||122
10118233|NCT02545075|11249078|FG001|COMPLETED|Randomization||53
10118234|NCT02545075|11249077|FG000|NOT COMPLETED|Randomization||0
10118235|NCT02545075|11249078|FG001|NOT COMPLETED|Randomization||7
10118236|NCT02545075|11249077|FG000|STARTED|Treatment||122
10118237|NCT02545075|11249078|FG001|STARTED|Treatment||53
10118238|NCT02545075|11249077|FG000|COMPLETED|Treatment||0
10118239|NCT02545075|11249078|FG001|COMPLETED|Treatment||0
10118240|NCT02545075|11249077|FG000|NOT COMPLETED|Treatment||122
10118241|NCT02545075|11249078|FG001|NOT COMPLETED|Treatment||53
10118242|NCT02545101|11249084|FG000|STARTED|Overall Study||100
10118243|NCT02545101|11249084|FG000|COMPLETED|Overall Study||100
10118244|NCT02545101|11249084|FG000|NOT COMPLETED|Overall Study||0
10196158|NCT03358407|11324486|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196159|NCT03358407|11324477|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196160|NCT03358407|11324478|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196161|NCT03358407|11324479|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196162|NCT03358407|11324480|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10196163|NCT03358407|11324481|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
10196164|NCT03358407|11324482|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196165|NCT03358407|11324483|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196166|NCT03358407|11324484|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196167|NCT03358407|11324485|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196168|NCT03358407|11324486|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196169|NCT03358407|11324477|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196170|NCT03358407|11324478|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10049565|NCT02023879|11174649|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58
10049566|NCT02023879|11174647|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
10049567|NCT02023879|11174648|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
10049568|NCT02023879|11174649|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
10049569|NCT02023879|11174647|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
10049570|NCT02023879|11174648|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
10049571|NCT02023879|11174649|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
10049572|NCT02023879|11174647|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
10196171|NCT03358407|11324479|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196172|NCT03358407|11324480|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196173|NCT03358407|11324481|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
10049573|NCT02023879|11174648|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
10049574|NCT02023879|11174649|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
10049575|NCT02023879|11174647|FG000|COMPLETED|Extension Open Label Treatment||46
10049576|NCT02023879|11174648|FG001|COMPLETED|Extension Open Label Treatment||89
10049577|NCT02023879|11174649|FG002|COMPLETED|Extension Open Label Treatment||43
10049578|NCT02023879|11174647|FG000|NOT COMPLETED|Extension Open Label Treatment||5
10049579|NCT02023879|11174648|FG001|NOT COMPLETED|Extension Open Label Treatment||17
10049580|NCT02023879|11174649|FG002|NOT COMPLETED|Extension Open Label Treatment||5
10049581|NCT02023918|11174664|FG000|STARTED|Overall Study||6
10049582|NCT02023918|11174664|FG000|COMPLETED|Overall Study||6
10049583|NCT02023918|11174664|FG000|NOT COMPLETED|Overall Study||0
10049584|NCT02023944|11174670|FG000|STARTED|Overall Study||25
10049585|NCT02023944|11174671|FG001|STARTED|Overall Study||25
10049586|NCT02023944|11174670|FG000|COMPLETED|Overall Study||25
10049587|NCT02023944|11174671|FG001|COMPLETED|Overall Study||24
10049588|NCT02023944|11174670|FG000|NOT COMPLETED|Overall Study||0
10049589|NCT02023944|11174671|FG001|NOT COMPLETED|Overall Study||1
10049590|NCT02023983|11174680|FG000|STARTED|Overall Study||76
10049591|NCT02023983|11174681|FG001|STARTED|Overall Study||75
10049592|NCT02023983|11174680|FG000|COMPLETED|Overall Study||76
10049593|NCT02023983|11174681|FG001|COMPLETED|Overall Study||75
10049594|NCT02023983|11174680|FG000|NOT COMPLETED|Overall Study||0
10049595|NCT02023983|11174681|FG001|NOT COMPLETED|Overall Study||0
10049596|NCT02024087|11174689|FG000|STARTED|Overall Study||5
10049597|NCT02024087|11174690|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
10049598|NCT02024087|11174689|FG000|COMPLETED|Overall Study||5
10049599|NCT02024087|11174690|FG001|COMPLETED|Overall Study||16
10049600|NCT02024087|11174689|FG000|NOT COMPLETED|Overall Study||0
10049601|NCT02024087|11174690|FG001|NOT COMPLETED|Overall Study||0
10049602|NCT02024165|11174697|FG000|STARTED|Overall Study||71
10049603|NCT02024165|11174697|FG000|COMPLETED|Overall Study||71
10049604|NCT02024165|11174697|FG000|NOT COMPLETED|Overall Study||0
10049605|NCT02024204|11174704|FG000|STARTED|Overall Study||49
10049606|NCT02024204|11174705|FG001|STARTED|Overall Study||11
10049607|NCT02024204|11174704|FG000|COMPLETED|Overall Study||49
10049608|NCT02024204|11174705|FG001|COMPLETED|Overall Study||11
10049609|NCT02024204|11174704|FG000|NOT COMPLETED|Overall Study||0
10049610|NCT02024204|11174705|FG001|NOT COMPLETED|Overall Study||0
10049611|NCT02024386|11174714|FG000|STARTED|Overall Study||6
10049612|NCT02024386|11174715|FG001|STARTED|Overall Study||11
10049613|NCT02024386|11174716|FG002|STARTED|Overall Study||5
10049614|NCT02024386|11174714|FG000|COMPLETED|Overall Study||6
10049615|NCT02024386|11174715|FG001|COMPLETED|Overall Study||11
10049616|NCT02024386|11174716|FG002|COMPLETED|Overall Study||5
10049617|NCT02024386|11174714|FG000|NOT COMPLETED|Overall Study||0
10049618|NCT02024386|11174715|FG001|NOT COMPLETED|Overall Study||0
10049619|NCT02024386|11174716|FG002|NOT COMPLETED|Overall Study||0
10049620|NCT02024477|11174727|FG000|STARTED|Overall Study||21
10049621|NCT02024477|11174728|FG001|STARTED|Overall Study||21
10049622|NCT02024477|11174727|FG000|COMPLETED|Overall Study||21
10049623|NCT02024477|11174728|FG001|COMPLETED|Overall Study||21
10049624|NCT02024477|11174727|FG000|NOT COMPLETED|Overall Study||0
10049625|NCT02024477|11174728|FG001|NOT COMPLETED|Overall Study||0
10049626|NCT02024646|11174737|FG000|STARTED|Overall Study||163
10049627|NCT02024646|11174738|FG001|STARTED|Overall Study||160
10049628|NCT02024646|11174739|FG002|STARTED|Overall Study||161
10049629|NCT02024646|11174737|FG000|COMPLETED|Overall Study||131
10049630|NCT02024646|11174738|FG001|COMPLETED|Overall Study||135
10049631|NCT02024646|11174739|FG002|COMPLETED|Overall Study||133
10049632|NCT02024646|11174737|FG000|NOT COMPLETED|Overall Study||32
10049633|NCT02024646|11174738|FG001|NOT COMPLETED|Overall Study||25
10049634|NCT02024646|11174739|FG002|NOT COMPLETED|Overall Study||28
10049635|NCT02024698|11174747|FG000|STARTED|First Intervention (7 Days)||16
10049636|NCT02024698|11174748|FG001|STARTED|First Intervention (7 Days)||27
10049637|NCT02024698|11174747|FG000|COMPLETED|First Intervention (7 Days)||16
10049638|NCT02024698|11174748|FG001|COMPLETED|First Intervention (7 Days)||26
10049639|NCT02024698|11174747|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10049640|NCT02024698|11174748|FG001|NOT COMPLETED|First Intervention (7 Days)||1
10049641|NCT02024698|11174747|FG000|STARTED|Second Intervention (7 Days)||16
10049642|NCT02024698|11174748|FG001|STARTED|Second Intervention (7 Days)||26
10049643|NCT02024698|11174747|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1
10049644|NCT02024698|11174748|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0
10049645|NCT02024698|11174747|FG000|COMPLETED|Second Intervention (7 Days)||16
10049646|NCT02024698|11174748|FG001|COMPLETED|Second Intervention (7 Days)||26
10049647|NCT02024698|11174747|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10049648|NCT02024698|11174748|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10118245|NCT02545270|11249091|FG000|STARTED|Overall Study||6
10118246|NCT02545270|11249092|FG001|STARTED|Overall Study||5
10118247|NCT02545270|11249093|FG002|STARTED|Overall Study||5
10118248|NCT02545270|11249091|FG000|COMPLETED|Overall Study||6
10118249|NCT02545270|11249092|FG001|COMPLETED|Overall Study||4
10118250|NCT02545270|11249093|FG002|COMPLETED|Overall Study||3
10118251|NCT02545270|11249091|FG000|NOT COMPLETED|Overall Study||0
10118252|NCT02545270|11249092|FG001|NOT COMPLETED|Overall Study||1
10118253|NCT02545270|11249093|FG002|NOT COMPLETED|Overall Study||2
10118254|NCT02545322|11249102|FG000|STARTED|Overall Study||18
10049649|NCT02024711|11174756|FG000|STARTED|Overall Study||130
10049650|NCT02024711|11174757|FG001|STARTED|Overall Study||132
10049651|NCT02024711|11174756|FG000|COMPLETED|Overall Study||129
10049652|NCT02024711|11174757|FG001|COMPLETED|Overall Study||128
10049653|NCT02024711|11174756|FG000|NOT COMPLETED|Overall Study||1
10049654|NCT02024711|11174757|FG001|NOT COMPLETED|Overall Study||4
10049655|NCT02024724|11174765|FG000|STARTED|Overall Study||30
10049656|NCT02024724|11174766|FG001|STARTED|Overall Study||30
10049657|NCT02024724|11174765|FG000|COMPLETED|Overall Study||29
10049658|NCT02024724|11174766|FG001|COMPLETED|Overall Study||30
10049659|NCT02024724|11174765|FG000|NOT COMPLETED|Overall Study||1
10049660|NCT02024724|11174766|FG001|NOT COMPLETED|Overall Study||0
10049661|NCT02024750|11174774|FG000|STARTED|Overall Study||106
10049662|NCT02024750|11174775|FG001|STARTED|Overall Study||108
10049663|NCT02024750|11174774|FG000|COMPLETED|Overall Study||104
10049664|NCT02024750|11174775|FG001|COMPLETED|Overall Study||107
10049665|NCT02024750|11174774|FG000|NOT COMPLETED|Overall Study||2
10049666|NCT02024750|11174775|FG001|NOT COMPLETED|Overall Study||1
10049667|NCT02024867|11174783|FG000|STARTED|Overall Study||134
10049668|NCT02024867|11174784|FG001|STARTED|Overall Study||131
10049669|NCT02024867|11174783|FG000|COMPLETED|Overall Study||125
10049670|NCT02024867|11174784|FG001|COMPLETED|Overall Study||124
10049671|NCT02024867|11174783|FG000|NOT COMPLETED|Overall Study||9
10049672|NCT02024867|11174784|FG001|NOT COMPLETED|Overall Study||7
10049673|NCT02024932|11174796|FG000|STARTED|Overall Study||2
10049674|NCT02024932|11174797|FG001|STARTED|Overall Study||4
10049675|NCT02024932|11174798|FG002|STARTED|Overall Study||2
10049676|NCT02024932|11174799|FG003|STARTED|Overall Study||2
10049677|NCT02024932|11174800|FG004|STARTED|Overall Study||18
10049678|NCT02024932|11174801|FG005|STARTED|Overall Study||9
10049679|NCT02024932|11174796|FG000|Safety Analysis Set|Overall Study||2
10049680|NCT02024932|11174797|FG001|Safety Analysis Set|Overall Study||4
10049681|NCT02024932|11174798|FG002|Safety Analysis Set|Overall Study||2
10049682|NCT02024932|11174799|FG003|Safety Analysis Set|Overall Study||2
10049683|NCT02024932|11174800|FG004|Safety Analysis Set|Overall Study||18
10049684|NCT02024932|11174801|FG005|Safety Analysis Set|Overall Study||9
10049685|NCT02024932|11174796|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2
10049686|NCT02024932|11174797|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10049687|NCT02024932|11174798|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10049688|NCT02024932|11174799|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2
10049689|NCT02024932|11174800|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18
10049690|NCT02024932|11174801|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10049691|NCT02024932|11174796|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10049692|NCT02024932|11174797|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
10049693|NCT02024932|11174798|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10049694|NCT02024932|11174799|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10049695|NCT02024932|11174800|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18
10049696|NCT02024932|11174801|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9
10049697|NCT02024932|11174796|FG000|COMPLETED|Overall Study||0
10049698|NCT02024932|11174797|FG001|COMPLETED|Overall Study||1
10049699|NCT02024932|11174798|FG002|COMPLETED|Overall Study||2
10049700|NCT02024932|11174799|FG003|COMPLETED|Overall Study||0
10049701|NCT02024932|11174800|FG004|COMPLETED|Overall Study||16
10049702|NCT02024932|11174801|FG005|COMPLETED|Overall Study||9
10049703|NCT02024932|11174796|FG000|NOT COMPLETED|Overall Study||2
10049704|NCT02024932|11174797|FG001|NOT COMPLETED|Overall Study||3
10049705|NCT02024932|11174798|FG002|NOT COMPLETED|Overall Study||0
10049706|NCT02024932|11174799|FG003|NOT COMPLETED|Overall Study||2
10049707|NCT02024932|11174800|FG004|NOT COMPLETED|Overall Study||2
10049708|NCT02024932|11174801|FG005|NOT COMPLETED|Overall Study||0
10049709|NCT02024971|11174821|FG000|STARTED|Overall Study||1103
10049710|NCT02024971|11174821|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
10049711|NCT02024971|11174821|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
10049712|NCT02024971|11174821|FG000|NOT COMPLETED|Overall Study||36
10049713|NCT02025075|11174827|FG000|STARTED|Overall Study||16
10049714|NCT02025075|11174828|FG001|STARTED|Overall Study||21
10049715|NCT02025075|11174827|FG000|COMPLETED|Overall Study||16
10049716|NCT02025075|11174828|FG001|COMPLETED|Overall Study||19
10049717|NCT02025075|11174827|FG000|NOT COMPLETED|Overall Study||0
10049718|NCT02025075|11174828|FG001|NOT COMPLETED|Overall Study||2
10049719|NCT02025179|11174843|FG000|STARTED|Overall Study||8
10049720|NCT02025179|11174844|FG001|STARTED|Overall Study||9
10049721|NCT02025179|11174845|FG002|STARTED|Overall Study||8
10049722|NCT02025179|11174843|FG000|COMPLETED|Overall Study||8
10049723|NCT02025179|11174844|FG001|COMPLETED|Overall Study||9
10049724|NCT02025179|11174845|FG002|COMPLETED|Overall Study||7
10049725|NCT02025179|11174843|FG000|NOT COMPLETED|Overall Study||0
10049726|NCT02025179|11174844|FG001|NOT COMPLETED|Overall Study||0
10049727|NCT02025179|11174845|FG002|NOT COMPLETED|Overall Study||1
10049728|NCT02025205|11174855|FG000|STARTED|Overall Study||43
10049729|NCT02025205|11174856|FG001|STARTED|Overall Study||50
10049730|NCT02025205|11174855|FG000|COMPLETED|Overall Study||40
10049731|NCT02025205|11174856|FG001|COMPLETED|Overall Study||47
10049732|NCT02025205|11174855|FG000|NOT COMPLETED|Overall Study||3
10049733|NCT02025205|11174856|FG001|NOT COMPLETED|Overall Study||3
10049734|NCT02025426|11174864|FG000|STARTED|Overall Study||9
10049735|NCT02025426|11174865|FG001|STARTED|Overall Study||4
10049736|NCT02025426|11174864|FG000|COMPLETED|Overall Study||9
10049737|NCT02025426|11174865|FG001|COMPLETED|Overall Study||4
10049738|NCT02025426|11174864|FG000|NOT COMPLETED|Overall Study||0
10049739|NCT02025426|11174865|FG001|NOT COMPLETED|Overall Study||0
10049740|NCT02025439|11174873|FG000|STARTED|Overall Study||2
10049741|NCT02025439|11174874|FG001|STARTED|Overall Study||2
10049742|NCT02025439|11174873|FG000|COMPLETED|Overall Study||2
10049743|NCT02025439|11174874|FG001|COMPLETED|Overall Study||2
10049744|NCT02025439|11174873|FG000|NOT COMPLETED|Overall Study||0
10049745|NCT02025439|11174874|FG001|NOT COMPLETED|Overall Study||0
10049746|NCT02025530|11174884|FG000|STARTED|Overall Study||296
10049747|NCT02025530|11174885|FG001|STARTED|Overall Study||734
10049748|NCT02025530|11174884|FG000|COMPLETED|Overall Study||291
10049749|NCT02025530|11174885|FG001|COMPLETED|Overall Study||733
10049750|NCT02025530|11174884|FG000|NOT COMPLETED|Overall Study||5
10049751|NCT02025530|11174885|FG001|NOT COMPLETED|Overall Study||1
10049752|NCT02025621|11174893|FG000|STARTED|Overall Study||442
10049753|NCT02025621|11174894|FG001|STARTED|Overall Study||440
10049754|NCT02025621|11174893|FG000|COMPLETED|Overall Study||428
10049755|NCT02025621|11174894|FG001|COMPLETED|Overall Study||421
10049756|NCT02025621|11174893|FG000|NOT COMPLETED|Overall Study||14
10049757|NCT02025621|11174894|FG001|NOT COMPLETED|Overall Study||19
10049758|NCT02025634|11174902|FG000|STARTED|Overall Study||65
10049759|NCT02025634|11174903|FG001|STARTED|Overall Study||54
10049760|NCT02025634|11174902|FG000|COMPLETED|Overall Study||65
10049761|NCT02025634|11174903|FG001|COMPLETED|Overall Study||54
10049762|NCT02025634|11174902|FG000|NOT COMPLETED|Overall Study||0
10049763|NCT02025634|11174903|FG001|NOT COMPLETED|Overall Study||0
10049764|NCT02025647|11174909|FG000|STARTED|Overall Study||139
10049765|NCT02025647|11174909|FG000|Session 1 (Narrative Module)|Overall Study||139
10049766|NCT02025647|11174909|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
10049767|NCT02025647|11174909|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
10049768|NCT02025647|11174909|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
10049769|NCT02025647|11174909|FG000|COMPLETED|Overall Study||139
9706607|NCT02111850|10805644|FG002|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706608|NCT02111850|10805645|FG003|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706609|NCT02111850|10805646|FG004|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706610|NCT02111850|10805647|FG005|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706611|NCT02111850|10805648|FG006|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706612|NCT02111850|10805649|FG007|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706613|NCT02111850|10805650|FG008|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10049770|NCT02025647|11174909|FG000|NOT COMPLETED|Overall Study||0
10049771|NCT02025725|11174915|FG000|STARTED|Overall Study||102
10049772|NCT02025725|11174916|FG001|STARTED|Overall Study||103
10049773|NCT02025725|11174915|FG000|COMPLETED|Overall Study||91
10049774|NCT02025725|11174916|FG001|COMPLETED|Overall Study||99
10049775|NCT02025725|11174915|FG000|NOT COMPLETED|Overall Study||11
10049776|NCT02025725|11174916|FG001|NOT COMPLETED|Overall Study||4
10049777|NCT02025751|11174926|FG000|STARTED|Overall Study||26
10049778|NCT02025751|11174927|FG001|STARTED|Overall Study||27
10049779|NCT02025751|11174926|FG000|COMPLETED|Overall Study||25
10049780|NCT02025751|11174927|FG001|COMPLETED|Overall Study||24
10049781|NCT02025751|11174926|FG000|NOT COMPLETED|Overall Study||1
10049782|NCT02025751|11174927|FG001|NOT COMPLETED|Overall Study||3
10049783|NCT02025829|11174935|FG000|STARTED|Overall Study||3
10049784|NCT02025829|11174936|FG001|STARTED|Overall Study||11
10049785|NCT02025829|11174935|FG000|COMPLETED|Overall Study||3
10049786|NCT02025829|11174936|FG001|COMPLETED|Overall Study||11
10049787|NCT02025829|11174935|FG000|NOT COMPLETED|Overall Study||0
10049788|NCT02025829|11174936|FG001|NOT COMPLETED|Overall Study||0
10049789|NCT02025907|11174945|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108
10049790|NCT02025907|11174946|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108
10049791|NCT02025907|11174945|FG000|COMPLETED|Overall Study||81
10049792|NCT02025907|11174946|FG001|COMPLETED|Overall Study||96
10049793|NCT02025907|11174945|FG000|NOT COMPLETED|Overall Study||27
10049794|NCT02025907|11174946|FG001|NOT COMPLETED|Overall Study||12
10049795|NCT02025985|11174957|FG000|STARTED|Overall Study||25
10049796|NCT02025985|11174958|FG001|STARTED|Overall Study||23
10049797|NCT02025985|11174959|FG002|STARTED|Overall Study||25
10049798|NCT02025985|11174960|FG003|STARTED|Overall Study||21
10049799|NCT02025985|11174961|FG004|STARTED|Overall Study||20
10049800|NCT02025985|11174957|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23
10049801|NCT02025985|11174958|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22
10049802|NCT02025985|11174959|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25
10049803|NCT02025985|11174960|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21
10049804|NCT02025985|11174961|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20
10049805|NCT02025985|11174957|FG000|COMPLETED|Overall Study||0
10049806|NCT02025985|11174958|FG001|COMPLETED|Overall Study||0
10049807|NCT02025985|11174959|FG002|COMPLETED|Overall Study||0
10049808|NCT02025985|11174960|FG003|COMPLETED|Overall Study||0
10049809|NCT02025985|11174961|FG004|COMPLETED|Overall Study||0
10049810|NCT02025985|11174957|FG000|NOT COMPLETED|Overall Study||25
10049811|NCT02025985|11174958|FG001|NOT COMPLETED|Overall Study||23
10049812|NCT02025985|11174959|FG002|NOT COMPLETED|Overall Study||25
10049813|NCT02025985|11174960|FG003|NOT COMPLETED|Overall Study||21
10049814|NCT02025985|11174961|FG004|NOT COMPLETED|Overall Study||20
10049815|NCT02026011|11174977|FG000|STARTED|Allocation 1 (First Set of Medication)||46
10049816|NCT02026011|11174978|FG001|STARTED|Allocation 1 (First Set of Medication)||41
10049817|NCT02026011|11174977|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38
10049818|NCT02026011|11174978|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39
10049819|NCT02026011|11174977|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
10049820|NCT02026011|11174978|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
10049821|NCT02026011|11174977|FG000|STARTED|Allocation 2 (Second Set of Medication)||38
10049822|NCT02026011|11174978|FG001|STARTED|Allocation 2 (Second Set of Medication)||37
10049823|NCT02026011|11174977|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37
10049824|NCT02026011|11174978|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35
10049825|NCT02026011|11174977|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
10049826|NCT02026011|11174978|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
10049827|NCT02026063|11174989|FG000|STARTED|Overall Study||22
10049828|NCT02026063|11174990|FG001|STARTED|Overall Study||102
10049829|NCT02026063|11174989|FG000|COMPLETED|Overall Study||13
10049830|NCT02026063|11174990|FG001|COMPLETED|Overall Study||53
10049831|NCT02026063|11174989|FG000|NOT COMPLETED|Overall Study||9
10049832|NCT02026063|11174990|FG001|NOT COMPLETED|Overall Study||49
10049833|NCT02026141|11174999|FG000|STARTED|Overall Study||20
10049834|NCT02026141|11175000|FG001|STARTED|Overall Study||20
10049835|NCT02026141|11174999|FG000|COMPLETED|Overall Study||20
10049836|NCT02026141|11175000|FG001|COMPLETED|Overall Study||19
10049837|NCT02026141|11174999|FG000|NOT COMPLETED|Overall Study||0
10049838|NCT02026141|11175000|FG001|NOT COMPLETED|Overall Study||1
10049839|NCT02026193|11175008|FG000|STARTED|Overall Study||3
10049840|NCT02026193|11175009|FG001|STARTED|Overall Study||8
10049841|NCT02026193|11175008|FG000|COMPLETED|Overall Study||3
10049842|NCT02026193|11175009|FG001|COMPLETED|Overall Study||8
10049843|NCT02026193|11175008|FG000|NOT COMPLETED|Overall Study||0
10049844|NCT02026193|11175009|FG001|NOT COMPLETED|Overall Study||0
10049845|NCT02026206|11175017|FG000|STARTED|Overall Study||44
10049846|NCT02026206|11175018|FG001|STARTED|Overall Study||44
10049847|NCT02026206|11175017|FG000|COMPLETED|Overall Study||40
10049848|NCT02026206|11175018|FG001|COMPLETED|Overall Study||36
10049849|NCT02026206|11175017|FG000|NOT COMPLETED|Overall Study||4
10049850|NCT02026206|11175018|FG001|NOT COMPLETED|Overall Study||8
10049851|NCT02026258|11175026|FG000|STARTED|Randomized||20
10049852|NCT02026258|11175027|FG001|STARTED|Randomized||21
10049853|NCT02026258|11175026|FG000|COMPLETED|Randomized||16
10049854|NCT02026258|11175027|FG001|COMPLETED|Randomized||19
10049855|NCT02026258|11175026|FG000|NOT COMPLETED|Randomized||4
10049856|NCT02026258|11175027|FG001|NOT COMPLETED|Randomized||2
10049857|NCT02026258|11175026|FG000|STARTED|Recieved Allocated Intervention||16
10049858|NCT02026258|11175027|FG001|STARTED|Recieved Allocated Intervention||19
10049859|NCT02026258|11175026|FG000|COMPLETED|Recieved Allocated Intervention||15
10049860|NCT02026258|11175027|FG001|COMPLETED|Recieved Allocated Intervention||17
10049861|NCT02026258|11175026|FG000|NOT COMPLETED|Recieved Allocated Intervention||1
10049862|NCT02026258|11175027|FG001|NOT COMPLETED|Recieved Allocated Intervention||2
10049863|NCT02026297|11175036|FG000|STARTED|Overall Study||7
10049864|NCT02026297|11175037|FG001|STARTED|Overall Study||13
10049865|NCT02026297|11175036|FG000|COMPLETED|Overall Study||7
10049866|NCT02026297|11175037|FG001|COMPLETED|Overall Study||13
10049867|NCT02026297|11175036|FG000|NOT COMPLETED|Overall Study||0
10049868|NCT02026297|11175037|FG001|NOT COMPLETED|Overall Study||0
10049869|NCT02026453|11175046|FG000|STARTED|Overall Study||101
10049870|NCT02026453|11175047|FG001|STARTED|Overall Study||103
10049871|NCT02026453|11175048|FG002|STARTED|Overall Study||102
10049872|NCT02026453|11175046|FG000|COMPLETED|Overall Study||95
10049873|NCT02026453|11175047|FG001|COMPLETED|Overall Study||94
10049874|NCT02026453|11175048|FG002|COMPLETED|Overall Study||89
10049875|NCT02026453|11175046|FG000|NOT COMPLETED|Overall Study||6
10049876|NCT02026453|11175047|FG001|NOT COMPLETED|Overall Study||9
10049877|NCT02026453|11175048|FG002|NOT COMPLETED|Overall Study||13
10049878|NCT02026687|11175058|FG000|STARTED|Overall Study||40
10049879|NCT02026687|11175059|FG001|STARTED|Overall Study||40
10049880|NCT02026687|11175058|FG000|COMPLETED|Overall Study||39
10049881|NCT02026687|11175059|FG001|COMPLETED|Overall Study||38
10049882|NCT02026687|11175058|FG000|NOT COMPLETED|Overall Study||1
10049883|NCT02026687|11175059|FG001|NOT COMPLETED|Overall Study||2
10049884|NCT02027025|11175068|FG000|STARTED|Overall Study||48
10049885|NCT02027025|11175069|FG001|STARTED|Overall Study||47
10049886|NCT02027025|11175070|FG002|STARTED|Overall Study||47
10049887|NCT02027025|11175068|FG000|COMPLETED|Overall Study||47
10049888|NCT02027025|11175069|FG001|COMPLETED|Overall Study||42
10049889|NCT02027025|11175070|FG002|COMPLETED|Overall Study||46
10049890|NCT02027025|11175068|FG000|NOT COMPLETED|Overall Study||1
10049891|NCT02027025|11175069|FG001|NOT COMPLETED|Overall Study||5
10049892|NCT02027025|11175070|FG002|NOT COMPLETED|Overall Study||1
10049893|NCT02027311|11175091|FG000|STARTED|Overall Study||33
10049894|NCT02027311|11175092|FG001|STARTED|Overall Study||35
10049895|NCT02027311|11175091|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
10049896|NCT02027311|11175092|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
10049897|NCT02027311|11175091|FG000|NOT COMPLETED|Overall Study||3
10049898|NCT02027311|11175092|FG001|NOT COMPLETED|Overall Study||2
10049899|NCT02027376|11175100|FG000|STARTED|Overall Study||5
10049900|NCT02027376|11175101|FG001|STARTED|Overall Study||4
10049901|NCT02027376|11175102|FG002|STARTED|Overall Study||3
10049902|NCT02027376|11175100|FG000|COMPLETED|Overall Study||4
10049903|NCT02027376|11175101|FG001|COMPLETED|Overall Study||4
10049904|NCT02027376|11175102|FG002|COMPLETED|Overall Study||3
10049905|NCT02027376|11175100|FG000|NOT COMPLETED|Overall Study||1
10049906|NCT02027376|11175101|FG001|NOT COMPLETED|Overall Study||0
10049907|NCT02027376|11175102|FG002|NOT COMPLETED|Overall Study||0
10049908|NCT02027402|11175114|FG000|STARTED|Overall Study||98
10049909|NCT02027402|11175115|FG001|STARTED|Overall Study||100
10049910|NCT02027402|11175114|FG000|COMPLETED|Overall Study||94
10049911|NCT02027402|11175115|FG001|COMPLETED|Overall Study||99
10049912|NCT02027402|11175114|FG000|NOT COMPLETED|Overall Study||4
10049913|NCT02027402|11175115|FG001|NOT COMPLETED|Overall Study||1
10049914|NCT02027428|11175125|FG000|STARTED|Induction||427
10049915|NCT02027428|11175126|FG001|STARTED|Induction||0
10049916|NCT02027428|11175127|FG002|STARTED|Induction||0
10049917|NCT02027428|11175125|FG000|Received Study Drug|Induction||420
10049918|NCT02027428|11175126|FG001|Received Study Drug|Induction||0
10049919|NCT02027428|11175127|FG002|Received Study Drug|Induction||0
10049920|NCT02027428|11175125|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
10049921|NCT02027428|11175126|FG001|COMPLETED|Induction||0
10049922|NCT02027428|11175127|FG002|COMPLETED|Induction||0
10049923|NCT02027428|11175125|FG000|NOT COMPLETED|Induction||225
10049924|NCT02027428|11175126|FG001|NOT COMPLETED|Induction||0
10049925|NCT02027428|11175127|FG002|NOT COMPLETED|Induction||0
10049926|NCT02027428|11175125|FG000|STARTED|Maintenance||0
10049927|NCT02027428|11175126|FG001|STARTED|Maintenance||136
10049928|NCT02027428|11175127|FG002|STARTED|Maintenance||66
10049929|NCT02027428|11175125|FG000|COMPLETED|Maintenance||0
10049930|NCT02027428|11175126|FG001|COMPLETED|Maintenance||12
10049931|NCT02027428|11175127|FG002|COMPLETED|Maintenance||6
10049932|NCT02027428|11175125|FG000|NOT COMPLETED|Maintenance||0
10049933|NCT02027428|11175126|FG001|NOT COMPLETED|Maintenance||124
10049934|NCT02027428|11175127|FG002|NOT COMPLETED|Maintenance||60
10049935|NCT02027428|11175125|FG000|STARTED|Survival Follow-up||0
10049936|NCT02027428|11175126|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
10049937|NCT02027428|11175127|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
10049938|NCT02027428|11175125|FG000|COMPLETED|Survival Follow-up||0
10049939|NCT02027428|11175126|FG001|COMPLETED|Survival Follow-up||38
10049940|NCT02027428|11175127|FG002|COMPLETED|Survival Follow-up||9
10049941|NCT02027428|11175125|FG000|NOT COMPLETED|Survival Follow-up||0
10049942|NCT02027428|11175126|FG001|NOT COMPLETED|Survival Follow-up||79
10049943|NCT02027428|11175127|FG002|NOT COMPLETED|Survival Follow-up||46
10049944|NCT02027545|11175152|FG000|STARTED|Overall Study||261
10049945|NCT02027545|11175153|FG001|STARTED|Overall Study||175
10049946|NCT02027545|11175152|FG000|COMPLETED|Overall Study||259
10049947|NCT02027545|11175153|FG001|COMPLETED|Overall Study||173
10049948|NCT02027545|11175152|FG000|NOT COMPLETED|Overall Study||2
10049949|NCT02027545|11175153|FG001|NOT COMPLETED|Overall Study||2
10049950|NCT02027558|11175161|FG000|STARTED|Overall Study||62
10049951|NCT02027558|11175162|FG001|STARTED|Overall Study||63
10049952|NCT02027558|11175161|FG000|Post-treatment|Overall Study||49
10049953|NCT02027558|11175162|FG001|Post-treatment|Overall Study||60
10049954|NCT02027558|11175161|FG000|3-month Follow-up|Overall Study||53
10049955|NCT02027558|11175162|FG001|3-month Follow-up|Overall Study||58
10049956|NCT02027558|11175161|FG000|6-month Follow-up|Overall Study||53
10049957|NCT02027558|11175162|FG001|6-month Follow-up|Overall Study||61
10049958|NCT02027558|11175161|FG000|COMPLETED|Overall Study||53
10049959|NCT02027558|11175162|FG001|COMPLETED|Overall Study||61
10049960|NCT02027558|11175161|FG000|NOT COMPLETED|Overall Study||9
10049961|NCT02027558|11175162|FG001|NOT COMPLETED|Overall Study||2
10049962|NCT02027623|11175172|FG000|STARTED|Overall Study||77
10049963|NCT02027623|11175173|FG001|STARTED|Overall Study||77
10049964|NCT02027623|11175172|FG000|COMPLETED|Overall Study||68
10049965|NCT02027623|11175173|FG001|COMPLETED|Overall Study||65
10049966|NCT02027623|11175172|FG000|NOT COMPLETED|Overall Study||9
10049967|NCT02027623|11175173|FG001|NOT COMPLETED|Overall Study||12
10049968|NCT02027701|11175180|FG000|STARTED|Overall Study||82
10049969|NCT02027701|11175180|FG000|COMPLETED|Overall Study||66
10049970|NCT02027701|11175180|FG000|NOT COMPLETED|Overall Study||16
10049971|NCT02027844|11175189|FG000|STARTED|Overall Study||39
10049972|NCT02027844|11175190|FG001|STARTED|Overall Study||39
10049973|NCT02027844|11175191|FG002|STARTED|Overall Study||39
10049974|NCT02027844|11175189|FG000|COMPLETED|Overall Study||34
10049975|NCT02027844|11175190|FG001|COMPLETED|Overall Study||33
10049976|NCT02027844|11175191|FG002|COMPLETED|Overall Study||37
10049977|NCT02027844|11175189|FG000|NOT COMPLETED|Overall Study||5
10049978|NCT02027844|11175190|FG001|NOT COMPLETED|Overall Study||6
10049979|NCT02027844|11175191|FG002|NOT COMPLETED|Overall Study||2
10049980|NCT02027883|11175201|FG000|STARTED|Overall Study||50
10049981|NCT02027883|11175202|FG001|STARTED|Overall Study||50
10049982|NCT02027883|11175201|FG000|COMPLETED|Overall Study||50
10049983|NCT02027883|11175202|FG001|COMPLETED|Overall Study||50
10049984|NCT02027883|11175201|FG000|NOT COMPLETED|Overall Study||0
10049985|NCT02027883|11175202|FG001|NOT COMPLETED|Overall Study||0
10049986|NCT02028065|11175215|FG000|STARTED|Randomization Through Start Treatment|Randomized|76
10049987|NCT02028065|11175216|FG001|STARTED|Randomization Through Start Treatment|Randomized|154
10049988|NCT02028065|11175217|FG002|STARTED|Randomization Through Start Treatment|Randomized|152
10049989|NCT02028065|11175215|FG000|COMPLETED|Randomization Through Start Treatment||75
10049990|NCT02028065|11175216|FG001|COMPLETED|Randomization Through Start Treatment||151
10049991|NCT02028065|11175217|FG002|COMPLETED|Randomization Through Start Treatment||149
10049992|NCT02028065|11175215|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
10049993|NCT02028065|11175216|FG001|NOT COMPLETED|Randomization Through Start Treatment||3
10049994|NCT02028065|11175217|FG002|NOT COMPLETED|Randomization Through Start Treatment||3
10049995|NCT02028065|11175215|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
10049996|NCT02028065|11175216|FG001|STARTED|Treatment Through Study Completion||151
10049997|NCT02028065|11175217|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
10049998|NCT02028065|11175215|FG000|Received First Dose|Treatment Through Study Completion||76
10049999|NCT02028065|11175216|FG001|Received First Dose|Treatment Through Study Completion||151
10050000|NCT02028065|11175217|FG002|Received First Dose|Treatment Through Study Completion||148
10050001|NCT02028065|11175215|FG000|Received Second Dose|Treatment Through Study Completion||69
10050002|NCT02028065|11175216|FG001|Received Second Dose|Treatment Through Study Completion||140
10050003|NCT02028065|11175217|FG002|Received Second Dose|Treatment Through Study Completion||138
10050004|NCT02028065|11175215|FG000|Received Third Dose|Treatment Through Study Completion||64
10050005|NCT02028065|11175216|FG001|Received Third Dose|Treatment Through Study Completion||136
10050006|NCT02028065|11175217|FG002|Received Third Dose|Treatment Through Study Completion||134
10050007|NCT02028065|11175215|FG000|COMPLETED|Treatment Through Study Completion||64
10050008|NCT02028065|11175216|FG001|COMPLETED|Treatment Through Study Completion||136
10050009|NCT02028065|11175217|FG002|COMPLETED|Treatment Through Study Completion||134
10050010|NCT02028065|11175215|FG000|NOT COMPLETED|Treatment Through Study Completion||12
10050011|NCT02028065|11175216|FG001|NOT COMPLETED|Treatment Through Study Completion||15
10050012|NCT02028065|11175217|FG002|NOT COMPLETED|Treatment Through Study Completion||14
10050013|NCT02028169|11175225|FG000|STARTED|Overall Study||120
10050014|NCT02028169|11175225|FG000|COMPLETED|Overall Study||92
10050015|NCT02028169|11175225|FG000|NOT COMPLETED|Overall Study||28
10050016|NCT02028182|11175229|FG000|STARTED|Overall Study||22
10050017|NCT02028182|11175229|FG000|COMPLETED|Overall Study||20
10050018|NCT02028182|11175229|FG000|NOT COMPLETED|Overall Study||2
10050019|NCT02028208|11175237|FG000|STARTED|Overall Study||21
10050020|NCT02028208|11175238|FG001|STARTED|Overall Study||13
10050021|NCT02028208|11175239|FG002|STARTED|Overall Study||22
10050022|NCT02028208|11175237|FG000|COMPLETED|Overall Study||21
10050023|NCT02028208|11175238|FG001|COMPLETED|Overall Study||13
10050024|NCT02028208|11175239|FG002|COMPLETED|Overall Study||21
10050025|NCT02028208|11175237|FG000|NOT COMPLETED|Overall Study||0
10050026|NCT02028208|11175238|FG001|NOT COMPLETED|Overall Study||0
10050027|NCT02028208|11175239|FG002|NOT COMPLETED|Overall Study||1
10050028|NCT02028221|11175249|FG000|STARTED|Overall Study||75
10050029|NCT02028221|11175250|FG001|STARTED|Overall Study||76
10050030|NCT02028221|11175249|FG000|COMPLETED|Overall Study||62
10050031|NCT02028221|11175250|FG001|COMPLETED|Overall Study||56
10050032|NCT02028221|11175249|FG000|NOT COMPLETED|Overall Study||13
10050033|NCT02028221|11175250|FG001|NOT COMPLETED|Overall Study||20
10050034|NCT02028247|11175259|FG000|STARTED|Overall Study||77
10050035|NCT02028247|11175260|FG001|STARTED|Overall Study||71
10050036|NCT02028247|11175261|FG002|STARTED|Overall Study||19
10050037|NCT02028247|11175259|FG000|COMPLETED|Overall Study||67
10050038|NCT02028247|11175260|FG001|COMPLETED|Overall Study||59
10050039|NCT02028247|11175261|FG002|COMPLETED|Overall Study||15
10050040|NCT02028247|11175259|FG000|NOT COMPLETED|Overall Study||10
10050041|NCT02028247|11175260|FG001|NOT COMPLETED|Overall Study||12
10050042|NCT02028247|11175261|FG002|NOT COMPLETED|Overall Study||4
10050043|NCT02028325|11175269|FG000|STARTED|Overall Study||136
10050044|NCT02028325|11175269|FG000|COMPLETED|Overall Study||126
10050045|NCT02028325|11175269|FG000|NOT COMPLETED|Overall Study||10
10050046|NCT02028676|11175282|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
10050047|NCT02028676|11175283|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
10050048|NCT02028676|11175284|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
10050049|NCT02028676|11175285|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
10050050|NCT02028676|11175286|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
10050051|NCT02028676|11175287|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10050052|NCT02028676|11175288|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10050053|NCT02028676|11175289|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10050054|NCT02028676|11175290|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10050055|NCT02028676|11175282|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606
10050056|NCT02028676|11175283|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600
10050057|NCT02028676|11175284|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0
10050058|NCT02028676|11175285|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0
10050059|NCT02028676|11175286|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0
10050060|NCT02028676|11175287|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0
10050061|NCT02028676|11175288|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0
10050062|NCT02028676|11175289|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0
10050063|NCT02028676|11175290|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0
10050064|NCT02028676|11175282|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050065|NCT02028676|11175283|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050066|NCT02028676|11175284|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050067|NCT02028676|11175285|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050068|NCT02028676|11175286|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050069|NCT02028676|11175287|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050070|NCT02028676|11175288|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050071|NCT02028676|11175289|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050072|NCT02028676|11175290|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10050073|NCT02028676|11175282|FG000|STARTED|Initial Enrolment: Induction ART||0
10050074|NCT02028676|11175283|FG001|STARTED|Initial Enrolment: Induction ART||0
10050075|NCT02028676|11175284|FG002|STARTED|Initial Enrolment: Induction ART||397
10050076|NCT02028676|11175285|FG003|STARTED|Initial Enrolment: Induction ART||404
10050077|NCT02028676|11175286|FG004|STARTED|Initial Enrolment: Induction ART||405
10050078|NCT02028676|11175287|FG005|STARTED|Initial Enrolment: Induction ART||0
10050079|NCT02028676|11175288|FG006|STARTED|Initial Enrolment: Induction ART||0
10050080|NCT02028676|11175289|FG007|STARTED|Initial Enrolment: Induction ART||0
10050081|NCT02028676|11175290|FG008|STARTED|Initial Enrolment: Induction ART||0
10050082|NCT02028676|11175282|FG000|COMPLETED|Initial Enrolment: Induction ART||0
10050083|NCT02028676|11175283|FG001|COMPLETED|Initial Enrolment: Induction ART||0
10050084|NCT02028676|11175284|FG002|COMPLETED|Initial Enrolment: Induction ART||397
10050085|NCT02028676|11175285|FG003|COMPLETED|Initial Enrolment: Induction ART||404
10050086|NCT02028676|11175286|FG004|COMPLETED|Initial Enrolment: Induction ART||405
10050087|NCT02028676|11175287|FG005|COMPLETED|Initial Enrolment: Induction ART||0
10050088|NCT02028676|11175288|FG006|COMPLETED|Initial Enrolment: Induction ART||0
10050089|NCT02028676|11175289|FG007|COMPLETED|Initial Enrolment: Induction ART||0
10050090|NCT02028676|11175290|FG008|COMPLETED|Initial Enrolment: Induction ART||0
10050091|NCT02028676|11175282|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050092|NCT02028676|11175283|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050093|NCT02028676|11175284|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050094|NCT02028676|11175285|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050095|NCT02028676|11175286|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050096|NCT02028676|11175287|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050097|NCT02028676|11175288|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050098|NCT02028676|11175289|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050099|NCT02028676|11175290|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0
10050100|NCT02028676|11175282|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10050101|NCT02028676|11175283|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10050102|NCT02028676|11175284|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10050103|NCT02028676|11175285|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10050104|NCT02028676|11175286|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10050105|NCT02028676|11175287|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
10050106|NCT02028676|11175288|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
10050107|NCT02028676|11175289|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10050108|NCT02028676|11175290|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10050109|NCT02028676|11175282|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050110|NCT02028676|11175283|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050111|NCT02028676|11175284|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050112|NCT02028676|11175285|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050113|NCT02028676|11175286|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050114|NCT02028676|11175287|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
10050115|NCT02028676|11175288|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
10050116|NCT02028676|11175289|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050117|NCT02028676|11175290|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050118|NCT02028676|11175282|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050119|NCT02028676|11175283|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050120|NCT02028676|11175284|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050121|NCT02028676|11175285|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050122|NCT02028676|11175286|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050123|NCT02028676|11175287|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050124|NCT02028676|11175288|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050125|NCT02028676|11175289|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050126|NCT02028676|11175290|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10050127|NCT02028676|11175282|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0
10050128|NCT02028676|11175283|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0
10050129|NCT02028676|11175284|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0
10050130|NCT02028676|11175285|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0
10050131|NCT02028676|11175286|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0
10050132|NCT02028676|11175287|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0
10050133|NCT02028676|11175288|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0
10050134|NCT02028676|11175289|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376
10050135|NCT02028676|11175290|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382
10050136|NCT02028676|11175282|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050137|NCT02028676|11175283|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050138|NCT02028676|11175284|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050139|NCT02028676|11175285|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050140|NCT02028676|11175286|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050141|NCT02028676|11175287|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050142|NCT02028676|11175288|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050143|NCT02028676|11175289|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376
10050144|NCT02028676|11175290|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382
10050145|NCT02028676|11175282|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050146|NCT02028676|11175283|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050147|NCT02028676|11175284|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050148|NCT02028676|11175285|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050149|NCT02028676|11175286|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050150|NCT02028676|11175287|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050151|NCT02028676|11175288|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050152|NCT02028676|11175289|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050153|NCT02028676|11175290|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10050154|NCT02028715|11175316|FG000|STARTED|Overall Study||34
10118255|NCT02545322|11249102|FG000|COMPLETED|Overall Study||15
10118256|NCT02545322|11249102|FG000|NOT COMPLETED|Overall Study||3
10118257|NCT02545504|11249108|FG000|STARTED|Overall Study||218
10118258|NCT02545504|11249109|FG001|STARTED|Overall Study||214
10118259|NCT02545504|11249108|FG000|COMPLETED|Overall Study||0
10118260|NCT02545504|11249109|FG001|COMPLETED|Overall Study||0
10118261|NCT02545504|11249108|FG000|NOT COMPLETED|Overall Study||218
10118262|NCT02545504|11249109|FG001|NOT COMPLETED|Overall Study||214
10118263|NCT02545543|11249121|FG000|STARTED|Overall Study||1709
10118264|NCT02545543|11249122|FG001|STARTED|Overall Study||569
10118265|NCT02545543|11249121|FG000|COMPLETED|Overall Study||1628
10118266|NCT02545543|11249122|FG001|COMPLETED|Overall Study||535
10118267|NCT02545543|11249121|FG000|NOT COMPLETED|Overall Study||81
10118268|NCT02545543|11249122|FG001|NOT COMPLETED|Overall Study||34
10118269|NCT02545608|11249132|FG000|STARTED|Overall Study||9
10118270|NCT02545608|11249133|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
10118271|NCT02545608|11249132|FG000|COMPLETED|Overall Study||9
10118272|NCT02545608|11249133|FG001|COMPLETED|Overall Study||93
10118273|NCT02545608|11249132|FG000|NOT COMPLETED|Overall Study||0
10118274|NCT02545608|11249133|FG001|NOT COMPLETED|Overall Study||7
10118275|NCT02545907|11249142|FG000|STARTED|Overall Study||3
10118276|NCT02545907|11249143|FG001|STARTED|Overall Study||3
10118277|NCT02545907|11249144|FG002|STARTED|Overall Study||4
10118278|NCT02545907|11249142|FG000|COMPLETED|Overall Study||3
10118279|NCT02545907|11249143|FG001|COMPLETED|Overall Study||3
10118280|NCT02545907|11249144|FG002|COMPLETED|Overall Study||4
10118281|NCT02545907|11249142|FG000|NOT COMPLETED|Overall Study||0
10118282|NCT02545907|11249143|FG001|NOT COMPLETED|Overall Study||0
10118283|NCT02545907|11249144|FG002|NOT COMPLETED|Overall Study||0
10118284|NCT02545933|11249156|FG000|STARTED|Overall Study||44
10118285|NCT02545933|11249157|FG001|STARTED|Overall Study||43
10118286|NCT02545933|11249158|FG002|STARTED|Overall Study||43
10118287|NCT02545933|11249156|FG000|COMPLETED|Overall Study||38
10118288|NCT02545933|11249157|FG001|COMPLETED|Overall Study||40
10118289|NCT02545933|11249158|FG002|COMPLETED|Overall Study||39
10118290|NCT02545933|11249156|FG000|NOT COMPLETED|Overall Study||6
10118291|NCT02545933|11249157|FG001|NOT COMPLETED|Overall Study||3
10118292|NCT02545933|11249158|FG002|NOT COMPLETED|Overall Study||4
10118293|NCT02546193|11249168|FG000|STARTED|Overall Study||10
10118294|NCT02546193|11249169|FG001|STARTED|Overall Study||10
10118295|NCT02546193|11249170|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
10118296|NCT02546193|11249171|FG003|STARTED|Overall Study||0
10118297|NCT02546193|11249168|FG000|COMPLETED|Overall Study||4
10050155|NCT02028715|11175317|FG001|STARTED|Overall Study||34
10050156|NCT02028715|11175316|FG000|COMPLETED|Overall Study||29
10050157|NCT02028715|11175317|FG001|COMPLETED|Overall Study||30
10050158|NCT02028715|11175316|FG000|NOT COMPLETED|Overall Study||5
10050159|NCT02028715|11175317|FG001|NOT COMPLETED|Overall Study||4
10050160|NCT02028754|11175325|FG000|STARTED|Overall Study||90
10050161|NCT02028754|11175326|FG001|STARTED|Overall Study||90
10050162|NCT02028754|11175325|FG000|COMPLETED|Overall Study||83
10050163|NCT02028754|11175326|FG001|COMPLETED|Overall Study||82
10050164|NCT02028754|11175325|FG000|NOT COMPLETED|Overall Study||7
10050165|NCT02028754|11175326|FG001|NOT COMPLETED|Overall Study||8
10050166|NCT02028767|11175332|FG000|STARTED|Treatment Period 1||16
10050167|NCT02028767|11175333|FG001|STARTED|Treatment Period 1||16
10050168|NCT02028767|11175332|FG000|COMPLETED|Treatment Period 1||16
10050169|NCT02028767|11175333|FG001|COMPLETED|Treatment Period 1||16
10050170|NCT02028767|11175332|FG000|NOT COMPLETED|Treatment Period 1||0
10050171|NCT02028767|11175333|FG001|NOT COMPLETED|Treatment Period 1||0
10050172|NCT02028767|11175332|FG000|STARTED|Treatment Period 2||16
10050173|NCT02028767|11175333|FG001|STARTED|Treatment Period 2||16
10050174|NCT02028767|11175332|FG000|COMPLETED|Treatment Period 2||14
10050175|NCT02028767|11175333|FG001|COMPLETED|Treatment Period 2||16
10050176|NCT02028767|11175332|FG000|NOT COMPLETED|Treatment Period 2||2
10050177|NCT02028767|11175333|FG001|NOT COMPLETED|Treatment Period 2||0
10050178|NCT02028780|11175351|FG000|STARTED|Observation Phase||6
10050179|NCT02028780|11175352|FG001|STARTED|Observation Phase||2
10050180|NCT02028780|11175353|FG002|STARTED|Observation Phase||6
9848408|NCT00858832|10961067|FG001|STARTED|Overall Study||23
9848409|NCT00858832|10961066|FG000|COMPLETED|Overall Study||20
9848410|NCT00858832|10961067|FG001|COMPLETED|Overall Study||22
9848411|NCT00858832|10961066|FG000|NOT COMPLETED|Overall Study||1
9848412|NCT00858832|10961067|FG001|NOT COMPLETED|Overall Study||1
9848413|NCT00858845|10961075|FG000|STARTED|Overall Study||5
9848414|NCT00858845|10961076|FG001|STARTED|Overall Study||6
9848415|NCT00858845|10961075|FG000|COMPLETED|Overall Study||5
9848416|NCT00858845|10961076|FG001|COMPLETED|Overall Study||5
9848417|NCT00858845|10961075|FG000|NOT COMPLETED|Overall Study||0
9848418|NCT00858845|10961076|FG001|NOT COMPLETED|Overall Study||1
9848419|NCT00858858|10961082|FG000|STARTED|Overall Study||60
9848420|NCT00858858|10961082|FG000|COMPLETED|Overall Study||42
10118298|NCT02546193|11249169|FG001|COMPLETED|Overall Study||4
10118299|NCT02546193|11249170|FG002|COMPLETED|Overall Study||0
10118300|NCT02546193|11249171|FG003|COMPLETED|Overall Study||0
10118301|NCT02546193|11249168|FG000|NOT COMPLETED|Overall Study||6
10118302|NCT02546193|11249169|FG001|NOT COMPLETED|Overall Study||6
10118303|NCT02546193|11249170|FG002|NOT COMPLETED|Overall Study||2
10118304|NCT02546193|11249171|FG003|NOT COMPLETED|Overall Study||0
10118305|NCT02546323|11249179|FG000|STARTED|Overall Study||272
10118306|NCT02546323|11249180|FG001|STARTED|Overall Study||271
10118307|NCT02546323|11249179|FG000|Received Treatment|Overall Study||272
10118308|NCT02546323|11249180|FG001|Received Treatment|Overall Study||268
10118309|NCT02546323|11249179|FG000|COMPLETED|Overall Study||212
10118310|NCT02546323|11249180|FG001|COMPLETED|Overall Study||205
10118311|NCT02546323|11249179|FG000|NOT COMPLETED|Overall Study||60
10118312|NCT02546323|11249180|FG001|NOT COMPLETED|Overall Study||66
10118313|NCT02546362|11249186|FG000|STARTED|4-week Treatment Period||50
10118314|NCT02546362|11249186|FG000|COMPLETED|4-week Treatment Period||47
10118315|NCT02546362|11249186|FG000|NOT COMPLETED|4-week Treatment Period||3
10118316|NCT02546362|11249186|FG000|STARTED|12-week Treatment Period||47
10118317|NCT02546362|11249186|FG000|COMPLETED|12-week Treatment Period||38
10118318|NCT02546362|11249186|FG000|NOT COMPLETED|12-week Treatment Period||9
10118319|NCT02546375|11249190|FG000|STARTED|Overall Study||87
10118320|NCT02546375|11249190|FG000|COMPLETED|Overall Study||87
10118321|NCT02546375|11249190|FG000|NOT COMPLETED|Overall Study||0
10118322|NCT02546388|11249196|FG000|STARTED|Overall Study||4
10118323|NCT02546388|11249197|FG001|STARTED|Overall Study||13
10118324|NCT02546388|11249196|FG000|COMPLETED|Overall Study||4
10118325|NCT02546388|11249197|FG001|COMPLETED|Overall Study||13
10118326|NCT02546388|11249196|FG000|NOT COMPLETED|Overall Study||0
10118327|NCT02546388|11249197|FG001|NOT COMPLETED|Overall Study||0
10118328|NCT02546544|11249204|FG000|STARTED|Overall Study||16
10118329|NCT02546544|11249204|FG000|Received Allocated Intervention|Overall Study||16
10118330|NCT02546544|11249204|FG000|COMPLETED|Overall Study||0
10118331|NCT02546544|11249204|FG000|NOT COMPLETED|Overall Study||16
10118332|NCT02546570|11249210|FG000|STARTED|Overall Study||9
10118333|NCT02546570|11249211|FG001|STARTED|Overall Study||2
10118334|NCT02546570|11249210|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6
10118335|NCT02546570|11249211|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2
10118336|NCT02546570|11249210|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3
10118337|NCT02546570|11249211|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0
10118338|NCT02546570|11249210|FG000|COMPLETED|Overall Study||9
10118339|NCT02546570|11249211|FG001|COMPLETED|Overall Study||2
10118340|NCT02546570|11249210|FG000|NOT COMPLETED|Overall Study||0
10118341|NCT02546570|11249211|FG001|NOT COMPLETED|Overall Study||0
9848421|NCT00858858|10961082|FG000|NOT COMPLETED|Overall Study||18
9848422|NCT00858962|10961086|FG000|STARTED|Overall Study||12
9848423|NCT00858962|10961086|FG000|COMPLETED|Overall Study||12
9848424|NCT00858962|10961086|FG000|NOT COMPLETED|Overall Study||0
9848425|NCT00858988|10961092|FG000|STARTED|Randomized and Allocation||74
10050181|NCT02028780|11175354|FG003|STARTED|Observation Phase||6
10050182|NCT02028780|11175355|FG004|STARTED|Observation Phase||6
10050183|NCT02028780|11175356|FG005|STARTED|Observation Phase||6
10050184|NCT02028780|11175357|FG006|STARTED|Observation Phase||9
9848426|NCT00858988|10961093|FG001|STARTED|Randomized and Allocation||73
9848427|NCT00858988|10961092|FG000|COMPLETED|Randomized and Allocation||74
9848428|NCT00858988|10961093|FG001|COMPLETED|Randomized and Allocation||73
9848429|NCT00858988|10961092|FG000|NOT COMPLETED|Randomized and Allocation||0
9848430|NCT00858988|10961093|FG001|NOT COMPLETED|Randomized and Allocation||0
9848431|NCT00858988|10961092|FG000|STARTED|Analysis||74
9848432|NCT00858988|10961093|FG001|STARTED|Analysis||73
9848433|NCT00858988|10961092|FG000|COMPLETED|Analysis||72
9848434|NCT00858988|10961093|FG001|COMPLETED|Analysis||72
9848435|NCT00858988|10961092|FG000|NOT COMPLETED|Analysis||2
9848436|NCT00858988|10961093|FG001|NOT COMPLETED|Analysis||1
9848437|NCT00859014|10961099|FG000|STARTED|Overall Study||25
9848438|NCT00859014|10961099|FG000|COMPLETED|Overall Study||20
9848439|NCT00859014|10961099|FG000|NOT COMPLETED|Overall Study||5
9848440|NCT00859027|10961105|FG000|STARTED|Overall Study||25
9848441|NCT00859027|10961106|FG001|STARTED|Overall Study||25
9848442|NCT00859027|10961105|FG000|COMPLETED|Overall Study||20
9848443|NCT00859027|10961106|FG001|COMPLETED|Overall Study||20
9848444|NCT00859027|10961105|FG000|NOT COMPLETED|Overall Study||5
9848445|NCT00859027|10961106|FG001|NOT COMPLETED|Overall Study||5
9848446|NCT00859040|10961114|FG000|STARTED|Overall Study||18
9848447|NCT00859040|10961115|FG001|STARTED|Overall Study||16
9848448|NCT00859040|10961114|FG000|COMPLETED|Overall Study||18
9848449|NCT00859040|10961115|FG001|COMPLETED|Overall Study||16
9848450|NCT00859040|10961114|FG000|NOT COMPLETED|Overall Study||0
9848451|NCT00859040|10961115|FG001|NOT COMPLETED|Overall Study||0
9848452|NCT00859053|10961125|FG000|STARTED|Overall Study||6
9848453|NCT00859053|10961126|FG001|STARTED|Overall Study||6
9848454|NCT00859053|10961127|FG002|STARTED|Overall Study||6
9848455|NCT00859053|10961128|FG003|STARTED|Overall Study||12
9848456|NCT00859053|10961125|FG000|COMPLETED|Overall Study||6
9848457|NCT00859053|10961126|FG001|COMPLETED|Overall Study||6
9848458|NCT00859053|10961127|FG002|COMPLETED|Overall Study||6
9848459|NCT00859053|10961128|FG003|COMPLETED|Overall Study||12
9848460|NCT00859053|10961125|FG000|NOT COMPLETED|Overall Study||0
9848461|NCT00859053|10961126|FG001|NOT COMPLETED|Overall Study||0
9848462|NCT00859053|10961127|FG002|NOT COMPLETED|Overall Study||0
9848463|NCT00859053|10961128|FG003|NOT COMPLETED|Overall Study||0
9848464|NCT00859131|10961140|FG000|STARTED|Overall Study||102
9848465|NCT00859131|10961141|FG001|STARTED|Overall Study||98
9848466|NCT00859131|10961140|FG000|COMPLETED|Overall Study||102
9848467|NCT00859131|10961141|FG001|COMPLETED|Overall Study||98
9848468|NCT00859131|10961140|FG000|NOT COMPLETED|Overall Study||0
9848469|NCT00859131|10961141|FG001|NOT COMPLETED|Overall Study||0
9848470|NCT00859222|10961150|FG000|STARTED|Overall Study||3
9848471|NCT00859222|10961151|FG001|STARTED|Overall Study||3
9848472|NCT00859222|10961152|FG002|STARTED|Overall Study||6
9848473|NCT00859222|10961153|FG003|STARTED|Overall Study||24
9848474|NCT00859222|10961154|FG004|STARTED|Overall Study||15
9848475|NCT00859222|10961150|FG000|COMPLETED|Overall Study||0
9848476|NCT00859222|10961151|FG001|COMPLETED|Overall Study||0
9848477|NCT00859222|10961152|FG002|COMPLETED|Overall Study||0
9848478|NCT00859222|10961153|FG003|COMPLETED|Overall Study||0
9848479|NCT00859222|10961154|FG004|COMPLETED|Overall Study||0
9848480|NCT00859222|10961150|FG000|NOT COMPLETED|Overall Study||3
9848481|NCT00859222|10961151|FG001|NOT COMPLETED|Overall Study||3
9848482|NCT00859222|10961152|FG002|NOT COMPLETED|Overall Study||6
9848483|NCT00859222|10961153|FG003|NOT COMPLETED|Overall Study||24
9848484|NCT00859222|10961154|FG004|NOT COMPLETED|Overall Study||15
9848485|NCT00859313|10961169|FG000|STARTED|Overall Study||30
9848486|NCT00859313|10961169|FG000|COMPLETED|Overall Study||26
9848487|NCT00859313|10961169|FG000|NOT COMPLETED|Overall Study||4
9848488|NCT00859339|10961173|FG000|STARTED|Overall Study||9
9848489|NCT00859339|10961173|FG000|COMPLETED|Overall Study||9
9848490|NCT00859339|10961173|FG000|NOT COMPLETED|Overall Study||0
9848491|NCT00859456|10961177|FG000|STARTED|Overall Study||9
9848492|NCT00859456|10961177|FG000|COMPLETED|Overall Study||1
9848493|NCT00859456|10961177|FG000|NOT COMPLETED|Overall Study||8
9848494|NCT00859469|10961181|FG000|STARTED|Overall Study||29
9848495|NCT00859469|10961181|FG000|6 Cycles|Overall Study||16
9848496|NCT00859469|10961181|FG000|COMPLETED|Overall Study||1
9848497|NCT00859469|10961181|FG000|NOT COMPLETED|Overall Study||28
9848498|NCT00859495|10961185|FG000|STARTED|Overall Study||9
9848499|NCT00859495|10961185|FG000|COMPLETED|Overall Study||9
9848500|NCT00859495|10961185|FG000|NOT COMPLETED|Overall Study||0
9848501|NCT00859508|10961191|FG000|STARTED|Overall Study||68
9848502|NCT00859508|10961192|FG001|STARTED|Overall Study||37
9848503|NCT00859508|10961191|FG000|COMPLETED|Overall Study||62
9848504|NCT00859508|10961192|FG001|COMPLETED|Overall Study||37
9848505|NCT00859508|10961191|FG000|NOT COMPLETED|Overall Study||6
9848506|NCT00859508|10961192|FG001|NOT COMPLETED|Overall Study||0
9963838|NCT01488877|11083635|FG002|STARTED|Initial Randomization||0
9963839|NCT01488877|11083633|FG000|COMPLETED|Initial Randomization||1
9963840|NCT01488877|11083634|FG001|COMPLETED|Initial Randomization||5
9963841|NCT01488877|11083635|FG002|COMPLETED|Initial Randomization||0
9963842|NCT01488877|11083633|FG000|NOT COMPLETED|Initial Randomization||0
9963843|NCT01488877|11083634|FG001|NOT COMPLETED|Initial Randomization||0
9963844|NCT01488877|11083635|FG002|NOT COMPLETED|Initial Randomization||0
9963845|NCT01488877|11083633|FG000|STARTED|Re-randomization||0
9963846|NCT01488877|11083634|FG001|STARTED|Re-randomization||0
9963847|NCT01488877|11083635|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
9963848|NCT01488877|11083633|FG000|COMPLETED|Re-randomization||0
9848507|NCT00859547|10961198|FG000|STARTED|Overall Study||30
9848508|NCT00859547|10961198|FG000|COMPLETED|Overall Study||28
9848509|NCT00859547|10961198|FG000|NOT COMPLETED|Overall Study||2
9848510|NCT00859573|10961204|FG000|STARTED|Overall Study||6
9848511|NCT00859573|10961205|FG001|STARTED|Overall Study||3
9848512|NCT00859573|10961204|FG000|COMPLETED|Overall Study||1
9848513|NCT00859573|10961205|FG001|COMPLETED|Overall Study||1
9848514|NCT00859573|10961204|FG000|NOT COMPLETED|Overall Study||5
9848515|NCT00859573|10961205|FG001|NOT COMPLETED|Overall Study||2
9848516|NCT00859586|10961211|FG000|STARTED|Overall Study||8
9848517|NCT00859586|10961211|FG000|COMPLETED|Overall Study||4
9848518|NCT00859586|10961211|FG000|NOT COMPLETED|Overall Study||4
9848519|NCT00859638|10961217|FG000|STARTED|Overall Study||65
9848520|NCT00859638|10961218|FG001|STARTED|Overall Study||59
9848521|NCT00859638|10961217|FG000|COMPLETED|Overall Study||55
9848522|NCT00859638|10961218|FG001|COMPLETED|Overall Study||55
9848523|NCT00859638|10961217|FG000|NOT COMPLETED|Overall Study||10
9848524|NCT00859638|10961218|FG001|NOT COMPLETED|Overall Study||4
9848525|NCT00859651|10961226|FG000|STARTED|Overall Study||18
9848526|NCT00859651|10961227|FG001|STARTED|Overall Study||22
9848527|NCT00859651|10961226|FG000|COMPLETED|Overall Study||18
9848528|NCT00859651|10961227|FG001|COMPLETED|Overall Study||22
9848529|NCT00859651|10961226|FG000|NOT COMPLETED|Overall Study||0
9848530|NCT00859651|10961227|FG001|NOT COMPLETED|Overall Study||0
9848531|NCT00859833|10961233|FG000|STARTED|Overall Study||30
9848532|NCT00859833|10961233|FG000|COMPLETED|Overall Study||30
9848533|NCT00859833|10961233|FG000|NOT COMPLETED|Overall Study||0
9848534|NCT00859898|10961241|FG000|STARTED|Overall Study||211
9848535|NCT00859898|10961242|FG001|STARTED|Overall Study||219
9848536|NCT00859898|10961243|FG002|STARTED|Overall Study||208
9848537|NCT00859898|10961241|FG000|COMPLETED|Overall Study||183
9848538|NCT00859898|10961242|FG001|COMPLETED|Overall Study||188
9848539|NCT00859898|10961243|FG002|COMPLETED|Overall Study||181
9848540|NCT00859898|10961241|FG000|NOT COMPLETED|Overall Study||28
9848541|NCT00859898|10961242|FG001|NOT COMPLETED|Overall Study||31
9848542|NCT00859898|10961243|FG002|NOT COMPLETED|Overall Study||27
9848543|NCT00859937|10961254|FG000|STARTED|Overall Study||41
9848544|NCT00859937|10961255|FG001|STARTED|Overall Study||14
9848545|NCT00859937|10961254|FG000|COMPLETED|Overall Study||40
9848546|NCT00859937|10961255|FG001|COMPLETED|Overall Study||14
9848547|NCT00859937|10961254|FG000|NOT COMPLETED|Overall Study||1
9848548|NCT00859937|10961255|FG001|NOT COMPLETED|Overall Study||0
9848549|NCT00859950|10961263|FG000|STARTED|Overall Study||49
9848550|NCT00859950|10961264|FG001|STARTED|Overall Study||21
9848551|NCT00859950|10961263|FG000|COMPLETED|Overall Study||49
9848552|NCT00859950|10961264|FG001|COMPLETED|Overall Study||21
9848553|NCT00859950|10961263|FG000|NOT COMPLETED|Overall Study||0
9848554|NCT00859950|10961264|FG001|NOT COMPLETED|Overall Study||0
9848555|NCT00859976|10961272|FG000|STARTED|Overall Study||82
9848556|NCT00859976|10961273|FG001|STARTED|Overall Study||85
9848557|NCT00859976|10961272|FG000|COMPLETED|Overall Study||66
9848558|NCT00859976|10961273|FG001|COMPLETED|Overall Study||67
9848559|NCT00859976|10961272|FG000|NOT COMPLETED|Overall Study||16
9848560|NCT00859976|10961273|FG001|NOT COMPLETED|Overall Study||18
9848561|NCT00860015|10961279|FG000|STARTED|Overall Study||12
9848562|NCT00860015|10961279|FG000|COMPLETED|Overall Study||12
9848563|NCT00860015|10961279|FG000|NOT COMPLETED|Overall Study||0
9848564|NCT00860028|10961285|FG000|STARTED|Placebo Controlled Pretreatment Period||15
9848565|NCT00860028|10961286|FG001|STARTED|Placebo Controlled Pretreatment Period||15
9848566|NCT00860028|10961285|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13
9848567|NCT00860028|10961286|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14
9848568|NCT00860028|10961285|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
9848569|NCT00860028|10961286|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
9848570|NCT00860028|10961285|FG000|STARTED|Smoking Cessation Phase||13
9848571|NCT00860028|10961286|FG001|STARTED|Smoking Cessation Phase||14
9848572|NCT00860028|10961285|FG000|COMPLETED|Smoking Cessation Phase||13
9848573|NCT00860028|10961286|FG001|COMPLETED|Smoking Cessation Phase||12
9848574|NCT00860028|10961285|FG000|NOT COMPLETED|Smoking Cessation Phase||0
9848575|NCT00860028|10961286|FG001|NOT COMPLETED|Smoking Cessation Phase||2
9848576|NCT00860067|10961297|FG000|STARTED|Overall Study||1200
9848577|NCT00860067|10961298|FG001|STARTED|Overall Study||299
9848578|NCT00860067|10961299|FG002|STARTED|Overall Study||301
9848579|NCT00860067|10961297|FG000|COMPLETED|Overall Study||1149
9848580|NCT00860067|10961298|FG001|COMPLETED|Overall Study||290
9848581|NCT00860067|10961299|FG002|COMPLETED|Overall Study||292
9848582|NCT00860067|10961297|FG000|NOT COMPLETED|Overall Study||51
9848583|NCT00860067|10961298|FG001|NOT COMPLETED|Overall Study||9
9848584|NCT00860067|10961299|FG002|NOT COMPLETED|Overall Study||9
9848585|NCT00860171|10961310|FG000|STARTED|Overall Study||16
9848586|NCT00860171|10961310|FG000|COMPLETED|Overall Study||16
9848587|NCT00860171|10961310|FG000|NOT COMPLETED|Overall Study||0
9848588|NCT00860262|10961317|FG000|STARTED|Overall Study||421
9848589|NCT00860262|10961318|FG001|STARTED|Overall Study||217
9848590|NCT00860262|10961319|FG002|STARTED|Overall Study||220
9848591|NCT00860262|10961317|FG000|COMPLETED|Overall Study||401
9848592|NCT00860262|10961318|FG001|COMPLETED|Overall Study||195
9848593|NCT00860262|10961319|FG002|COMPLETED|Overall Study||202
9848594|NCT00860262|10961317|FG000|NOT COMPLETED|Overall Study||20
9848595|NCT00860262|10961318|FG001|NOT COMPLETED|Overall Study||22
9848596|NCT00860262|10961319|FG002|NOT COMPLETED|Overall Study||18
9848597|NCT00860314|10961331|FG000|STARTED|Overall Study||48
9848598|NCT00860314|10961332|FG001|STARTED|Overall Study||48
9848599|NCT00860314|10961331|FG000|COMPLETED|Overall Study||48
9848600|NCT00860314|10961332|FG001|COMPLETED|Overall Study||48
9848601|NCT00860314|10961331|FG000|NOT COMPLETED|Overall Study||0
9848602|NCT00860314|10961332|FG001|NOT COMPLETED|Overall Study||0
9848603|NCT00860379|10961341|FG000|STARTED|Overall Study||4
9848604|NCT00860379|10961342|FG001|STARTED|Overall Study||6
9848605|NCT00860379|10961343|FG002|STARTED|Overall Study||4
9848606|NCT00860379|10961341|FG000|COMPLETED|Overall Study||4
9848607|NCT00860379|10961342|FG001|COMPLETED|Overall Study||6
9848608|NCT00860379|10961343|FG002|COMPLETED|Overall Study||4
9848609|NCT00860379|10961341|FG000|NOT COMPLETED|Overall Study||0
9848610|NCT00860379|10961342|FG001|NOT COMPLETED|Overall Study||0
9848611|NCT00860379|10961343|FG002|NOT COMPLETED|Overall Study||0
9848612|NCT00860405|10961353|FG000|STARTED|Overall Study||31
9848613|NCT00860405|10961354|FG001|STARTED|Overall Study||30
9848614|NCT00860405|10961353|FG000|Completed Treatment|Overall Study||31
9848615|NCT00860405|10961354|FG001|Completed Treatment|Overall Study||29
9848616|NCT00860405|10961353|FG000|Day 28 Follow-up Performed|Overall Study||31
9848617|NCT00860405|10961354|FG001|Day 28 Follow-up Performed|Overall Study||29
9848618|NCT00860405|10961353|FG000|COMPLETED|Overall Study|completed overall study|26
9848619|NCT00860405|10961354|FG001|COMPLETED|Overall Study||26
9848620|NCT00860405|10961353|FG000|NOT COMPLETED|Overall Study||5
9848621|NCT00860405|10961354|FG001|NOT COMPLETED|Overall Study||4
9848622|NCT00860457|10961360|FG000|STARTED|Overall Study||22
9848623|NCT00860457|10961360|FG000|COMPLETED|Overall Study||11
9848624|NCT00860457|10961360|FG000|NOT COMPLETED|Overall Study||11
9848625|NCT00860470|10961366|FG000|STARTED|Overall Study||22162
9848626|NCT00860470|10961367|FG001|STARTED|Overall Study||22405
9848627|NCT00860470|10961366|FG000|COMPLETED|Overall Study||22114
9848628|NCT00860470|10961367|FG001|COMPLETED|Overall Study||22346
9848629|NCT00860470|10961366|FG000|NOT COMPLETED|Overall Study||48
9848630|NCT00860470|10961367|FG001|NOT COMPLETED|Overall Study||59
9848631|NCT00860535|10961373|FG000|STARTED|Overall Study||9
9848632|NCT00860535|10961373|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
9848633|NCT00860535|10961373|FG000|COMPLETED|Overall Study||8
9848634|NCT00860535|10961373|FG000|NOT COMPLETED|Overall Study||1
10050185|NCT02028780|11175358|FG007|STARTED|Observation Phase||3
10050186|NCT02028780|11175359|FG008|STARTED|Observation Phase||9
10050187|NCT02028780|11175360|FG009|STARTED|Observation Phase||9
10050188|NCT02028780|11175361|FG010|STARTED|Observation Phase||9
10050189|NCT02028780|11175362|FG011|STARTED|Observation Phase||9
10050190|NCT02028780|11175351|FG000|COMPLETED|Observation Phase||6
10050191|NCT02028780|11175352|FG001|COMPLETED|Observation Phase||2
10050192|NCT02028780|11175353|FG002|COMPLETED|Observation Phase||6
10050193|NCT02028780|11175354|FG003|COMPLETED|Observation Phase||6
10050194|NCT02028780|11175355|FG004|COMPLETED|Observation Phase||6
10050195|NCT02028780|11175356|FG005|COMPLETED|Observation Phase||6
10050196|NCT02028780|11175357|FG006|COMPLETED|Observation Phase||9
10050197|NCT02028780|11175358|FG007|COMPLETED|Observation Phase||3
10050198|NCT02028780|11175359|FG008|COMPLETED|Observation Phase||9
10050199|NCT02028780|11175360|FG009|COMPLETED|Observation Phase||9
10050200|NCT02028780|11175361|FG010|COMPLETED|Observation Phase||9
10050201|NCT02028780|11175362|FG011|COMPLETED|Observation Phase||9
10050202|NCT02028780|11175351|FG000|NOT COMPLETED|Observation Phase||0
10050203|NCT02028780|11175352|FG001|NOT COMPLETED|Observation Phase||0
10050204|NCT02028780|11175353|FG002|NOT COMPLETED|Observation Phase||0
10050205|NCT02028780|11175354|FG003|NOT COMPLETED|Observation Phase||0
10050206|NCT02028780|11175355|FG004|NOT COMPLETED|Observation Phase||0
10050207|NCT02028780|11175356|FG005|NOT COMPLETED|Observation Phase||0
10050208|NCT02028780|11175357|FG006|NOT COMPLETED|Observation Phase||0
10050209|NCT02028780|11175358|FG007|NOT COMPLETED|Observation Phase||0
10050210|NCT02028780|11175359|FG008|NOT COMPLETED|Observation Phase||0
10050211|NCT02028780|11175360|FG009|NOT COMPLETED|Observation Phase||0
10050212|NCT02028780|11175361|FG010|NOT COMPLETED|Observation Phase||0
10050213|NCT02028780|11175362|FG011|NOT COMPLETED|Observation Phase||0
10050214|NCT02028780|11175351|FG000|STARTED|Follow up Phase||6
10050215|NCT02028780|11175352|FG001|STARTED|Follow up Phase||2
10050216|NCT02028780|11175353|FG002|STARTED|Follow up Phase||6
10050217|NCT02028780|11175354|FG003|STARTED|Follow up Phase||6
10050218|NCT02028780|11175355|FG004|STARTED|Follow up Phase||6
10050219|NCT02028780|11175356|FG005|STARTED|Follow up Phase||6
10050220|NCT02028780|11175357|FG006|STARTED|Follow up Phase||9
10050221|NCT02028780|11175358|FG007|STARTED|Follow up Phase||3
10050222|NCT02028780|11175359|FG008|STARTED|Follow up Phase||9
10050223|NCT02028780|11175360|FG009|STARTED|Follow up Phase||9
10050224|NCT02028780|11175361|FG010|STARTED|Follow up Phase||9
10050225|NCT02028780|11175362|FG011|STARTED|Follow up Phase||9
10050226|NCT02028780|11175351|FG000|COMPLETED|Follow up Phase||6
10050227|NCT02028780|11175352|FG001|COMPLETED|Follow up Phase||2
10050228|NCT02028780|11175353|FG002|COMPLETED|Follow up Phase||6
10050229|NCT02028780|11175354|FG003|COMPLETED|Follow up Phase||6
10050230|NCT02028780|11175355|FG004|COMPLETED|Follow up Phase||6
10050231|NCT02028780|11175356|FG005|COMPLETED|Follow up Phase||6
10050232|NCT02028780|11175357|FG006|COMPLETED|Follow up Phase||9
9848635|NCT00860574|10961377|FG000|STARTED|Overall Study||96
9848636|NCT00860574|10961377|FG000|COMPLETED|Overall Study||93
9848637|NCT00860574|10961377|FG000|NOT COMPLETED|Overall Study||3
9848638|NCT00860743|10961387|FG000|STARTED|Overall Study||40
9848639|NCT00860743|10961388|FG001|STARTED|Overall Study||23
9848640|NCT00860743|10961387|FG000|COMPLETED|Overall Study||37
10050233|NCT02028780|11175358|FG007|COMPLETED|Follow up Phase||3
10050234|NCT02028780|11175359|FG008|COMPLETED|Follow up Phase||9
10050235|NCT02028780|11175360|FG009|COMPLETED|Follow up Phase||9
10050236|NCT02028780|11175361|FG010|COMPLETED|Follow up Phase||9
10050237|NCT02028780|11175362|FG011|COMPLETED|Follow up Phase||9
10050238|NCT02028780|11175351|FG000|NOT COMPLETED|Follow up Phase||0
10050239|NCT02028780|11175352|FG001|NOT COMPLETED|Follow up Phase||0
10050240|NCT02028780|11175353|FG002|NOT COMPLETED|Follow up Phase||0
10050241|NCT02028780|11175354|FG003|NOT COMPLETED|Follow up Phase||0
10050242|NCT02028780|11175355|FG004|NOT COMPLETED|Follow up Phase||0
10050243|NCT02028780|11175356|FG005|NOT COMPLETED|Follow up Phase||0
10050244|NCT02028780|11175357|FG006|NOT COMPLETED|Follow up Phase||0
10050245|NCT02028780|11175358|FG007|NOT COMPLETED|Follow up Phase||0
10050246|NCT02028780|11175359|FG008|NOT COMPLETED|Follow up Phase||0
10050247|NCT02028780|11175360|FG009|NOT COMPLETED|Follow up Phase||0
10050248|NCT02028780|11175361|FG010|NOT COMPLETED|Follow up Phase||0
10050249|NCT02028780|11175362|FG011|NOT COMPLETED|Follow up Phase||0
10050250|NCT02028871|11175408|FG000|STARTED|Overall Study||14
10050251|NCT02028871|11175409|FG001|STARTED|Overall Study||12
10050252|NCT02028871|11175408|FG000|COMPLETED|Overall Study||10
10050253|NCT02028871|11175409|FG001|COMPLETED|Overall Study||9
10050254|NCT02028871|11175408|FG000|NOT COMPLETED|Overall Study||4
10050255|NCT02028871|11175409|FG001|NOT COMPLETED|Overall Study||3
10050256|NCT02029040|11175420|FG000|STARTED|Overall Study||27
10050257|NCT02029040|11175421|FG001|STARTED|Overall Study||25
10050258|NCT02029040|11175420|FG000|COMPLETED|Overall Study||27
10050259|NCT02029040|11175421|FG001|COMPLETED|Overall Study||25
10050260|NCT02029040|11175420|FG000|NOT COMPLETED|Overall Study||0
10050261|NCT02029040|11175421|FG001|NOT COMPLETED|Overall Study||0
10050262|NCT02029196|11175429|FG000|STARTED|Overall Study||306
10050263|NCT02029196|11175430|FG001|STARTED|Overall Study||102
10050264|NCT02029196|11175429|FG000|COMPLETED|Overall Study||286
10050265|NCT02029196|11175430|FG001|COMPLETED|Overall Study||101
10050266|NCT02029196|11175429|FG000|NOT COMPLETED|Overall Study||20
10050267|NCT02029196|11175430|FG001|NOT COMPLETED|Overall Study||1
10050268|NCT02029235|11175438|FG000|STARTED|Overall Study||34
10050269|NCT02029235|11175439|FG001|STARTED|Overall Study||31
10050270|NCT02029235|11175438|FG000|COMPLETED|Overall Study||30
10050271|NCT02029235|11175439|FG001|COMPLETED|Overall Study||30
10050272|NCT02029235|11175438|FG000|NOT COMPLETED|Overall Study||4
10050273|NCT02029235|11175439|FG001|NOT COMPLETED|Overall Study||1
10050274|NCT02029274|11175449|FG000|STARTED|Overall Study||5
10050275|NCT02029274|11175450|FG001|STARTED|Overall Study||4
10050276|NCT02029274|11175451|FG002|STARTED|Overall Study||4
10050277|NCT02029274|11175452|FG003|STARTED|Overall Study||4
10050278|NCT02029274|11175449|FG000|Fixed Dose Period 2|Overall Study||5
10050279|NCT02029274|11175450|FG001|Fixed Dose Period 2|Overall Study||4
10050280|NCT02029274|11175451|FG002|Fixed Dose Period 2|Overall Study||4
10050281|NCT02029274|11175452|FG003|Fixed Dose Period 2|Overall Study||4
10050282|NCT02029274|11175449|FG000|COMPLETED|Overall Study||4
10050283|NCT02029274|11175450|FG001|COMPLETED|Overall Study||4
10050284|NCT02029274|11175451|FG002|COMPLETED|Overall Study||2
10050285|NCT02029274|11175452|FG003|COMPLETED|Overall Study||2
10050286|NCT02029274|11175449|FG000|NOT COMPLETED|Overall Study||1
10050287|NCT02029274|11175450|FG001|NOT COMPLETED|Overall Study||0
10050288|NCT02029274|11175451|FG002|NOT COMPLETED|Overall Study||2
10050289|NCT02029274|11175452|FG003|NOT COMPLETED|Overall Study||2
10050290|NCT02029417|11175466|FG000|STARTED|Overall Study||2
10050291|NCT02029417|11175466|FG000|COMPLETED|Overall Study||0
10050292|NCT02029417|11175466|FG000|NOT COMPLETED|Overall Study||2
10050293|NCT02029495|11175473|FG000|STARTED|Overall Study||159
10050294|NCT02029495|11175474|FG001|STARTED|Overall Study||158
10050295|NCT02029495|11175475|FG002|STARTED|Overall Study||161
10050296|NCT02029495|11175473|FG000|COMPLETED|Overall Study||158
10050297|NCT02029495|11175474|FG001|COMPLETED|Overall Study||158
10050298|NCT02029495|11175475|FG002|COMPLETED|Overall Study||159
10050299|NCT02029495|11175473|FG000|NOT COMPLETED|Overall Study||1
10050300|NCT02029495|11175474|FG001|NOT COMPLETED|Overall Study||0
10050301|NCT02029495|11175475|FG002|NOT COMPLETED|Overall Study||2
10050302|NCT02029521|11175485|FG000|STARTED|Overall Study||24
10050303|NCT02029521|11175486|FG001|STARTED|Overall Study||23
10050304|NCT02029521|11175485|FG000|COMPLETED|Overall Study||22
10050305|NCT02029521|11175486|FG001|COMPLETED|Overall Study||22
10050306|NCT02029521|11175485|FG000|NOT COMPLETED|Overall Study||2
10050307|NCT02029521|11175486|FG001|NOT COMPLETED|Overall Study||1
10050308|NCT02029638|11175498|FG000|STARTED|Overall Study||2
10050309|NCT02029638|11175499|FG001|STARTED|Overall Study||1
10050310|NCT02029638|11175500|FG002|STARTED|Overall Study||1
10050311|NCT02029638|11175498|FG000|COMPLETED|Overall Study||0
10050312|NCT02029638|11175499|FG001|COMPLETED|Overall Study||1
10050313|NCT02029638|11175500|FG002|COMPLETED|Overall Study||0
10050314|NCT02029638|11175498|FG000|NOT COMPLETED|Overall Study||2
10050315|NCT02029638|11175499|FG001|NOT COMPLETED|Overall Study||0
10050316|NCT02029638|11175500|FG002|NOT COMPLETED|Overall Study||1
10050317|NCT02029703|11175510|FG000|STARTED|Overall Study||20
10050318|NCT02029703|11175511|FG001|STARTED|Overall Study||22
10050319|NCT02029703|11175510|FG000|COMPLETED|Overall Study||20
10050320|NCT02029703|11175511|FG001|COMPLETED|Overall Study||22
10050321|NCT02029703|11175510|FG000|NOT COMPLETED|Overall Study||0
10050322|NCT02029703|11175511|FG001|NOT COMPLETED|Overall Study||0
10050323|NCT02029755|11175520|FG000|STARTED|Overall Study||36
10050324|NCT02029755|11175521|FG001|STARTED|Overall Study||36
10050325|NCT02029755|11175522|FG002|STARTED|Overall Study||36
10050326|NCT02029755|11175520|FG000|COMPLETED|Overall Study||36
10050327|NCT02029755|11175521|FG001|COMPLETED|Overall Study||36
10050328|NCT02029755|11175522|FG002|COMPLETED|Overall Study||36
10050329|NCT02029755|11175520|FG000|NOT COMPLETED|Overall Study||0
10050330|NCT02029755|11175521|FG001|NOT COMPLETED|Overall Study||0
10050331|NCT02029755|11175522|FG002|NOT COMPLETED|Overall Study||0
10050332|NCT02029872|11175532|FG000|STARTED|Overall Study||9
10050333|NCT02029872|11175533|FG001|STARTED|Overall Study||9
10050334|NCT02029872|11175532|FG000|COMPLETED|Overall Study||7
10050335|NCT02029872|11175533|FG001|COMPLETED|Overall Study||6
10050336|NCT02029872|11175532|FG000|NOT COMPLETED|Overall Study||2
10050337|NCT02029872|11175533|FG001|NOT COMPLETED|Overall Study||3
10050338|NCT02029911|11175539|FG000|STARTED|Overall Study|Treatment Attempted|60
10050339|NCT02029911|11175539|FG000|Treated|Overall Study|Treatment Completed|60
10050340|NCT02029911|11175539|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
10050341|NCT02029911|11175539|FG000|NOT COMPLETED|Overall Study||0
10050342|NCT02029976|11175545|FG000|STARTED|YR-1 Post Intervention vs Baseline||132
10050343|NCT02029976|11175546|FG001|STARTED|YR-1 Post Intervention vs Baseline||132
10050344|NCT02029976|11175545|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120
10050345|NCT02029976|11175546|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124
10050346|NCT02029976|11175545|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
10050347|NCT02029976|11175546|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
10050348|NCT02029976|11175545|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
10050349|NCT02029976|11175546|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
10050350|NCT02029976|11175545|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122
10050351|NCT02029976|11175546|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124
10050352|NCT02029976|11175545|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
10050353|NCT02029976|11175546|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
10050354|NCT02029989|11175554|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
10050355|NCT02029989|11175555|FG001|STARTED|Overall Study||60
10050356|NCT02029989|11175554|FG000|COMPLETED|Overall Study||45
10050357|NCT02029989|11175555|FG001|COMPLETED|Overall Study||49
10050358|NCT02029989|11175554|FG000|NOT COMPLETED|Overall Study||16
10050359|NCT02029989|11175555|FG001|NOT COMPLETED|Overall Study||11
10050360|NCT02030002|11175561|FG000|STARTED|Enrollment||49
10050361|NCT02030002|11175561|FG000|COMPLETED|Enrollment||44
10050362|NCT02030002|11175561|FG000|NOT COMPLETED|Enrollment||5
10050363|NCT02030002|11175561|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44
10050364|NCT02030002|11175561|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
10050365|NCT02030002|11175561|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
10050366|NCT02030002|11175561|FG000|STARTED|APC II Adhesive Coated Appliance System||44
10050367|NCT02030002|11175561|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44
10050368|NCT02030002|11175561|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
10050369|NCT02030002|11175561|FG000|STARTED|Follow-up||44
10050370|NCT02030002|11175561|FG000|COMPLETED|Follow-up||42
10050371|NCT02030002|11175561|FG000|NOT COMPLETED|Follow-up||2
10050372|NCT02030041|11175570|FG000|STARTED|Overall Study||11
10050373|NCT02030041|11175571|FG001|STARTED|Overall Study||11
10050374|NCT02030041|11175572|FG002|STARTED|Overall Study||11
10050375|NCT02030041|11175570|FG000|COMPLETED|Overall Study||9
10050376|NCT02030041|11175571|FG001|COMPLETED|Overall Study||9
10050377|NCT02030041|11175572|FG002|COMPLETED|Overall Study||10
10050378|NCT02030041|11175570|FG000|NOT COMPLETED|Overall Study||2
10050379|NCT02030041|11175571|FG001|NOT COMPLETED|Overall Study||2
10050380|NCT02030041|11175572|FG002|NOT COMPLETED|Overall Study||1
10050381|NCT02030080|11175584|FG000|STARTED|Overall Study|25 teams|100
10050382|NCT02030080|11175585|FG001|STARTED|Overall Study|16 teams|64
10050383|NCT02030080|11175586|FG002|STARTED|Overall Study|20 teams|80
10050384|NCT02030080|11175587|FG003|STARTED|Overall Study|11 teams|44
10050385|NCT02030080|11175584|FG000|COMPLETED|Overall Study||100
10050386|NCT02030080|11175585|FG001|COMPLETED|Overall Study||64
10050387|NCT02030080|11175586|FG002|COMPLETED|Overall Study||80
10050388|NCT02030080|11175587|FG003|COMPLETED|Overall Study||42
10050389|NCT02030080|11175584|FG000|NOT COMPLETED|Overall Study||0
10050390|NCT02030080|11175585|FG001|NOT COMPLETED|Overall Study||0
10050391|NCT02030080|11175586|FG002|NOT COMPLETED|Overall Study||0
10050392|NCT02030080|11175587|FG003|NOT COMPLETED|Overall Study||2
10050393|NCT02030119|11175601|FG000|STARTED|Overall Study||70
10050394|NCT02030119|11175602|FG001|STARTED|Overall Study||70
10050395|NCT02030119|11175603|FG002|STARTED|Overall Study||71
10050396|NCT02030119|11175604|FG003|STARTED|Overall Study||70
10050397|NCT02030119|11175601|FG000|COMPLETED|Overall Study||67
10050398|NCT02030119|11175602|FG001|COMPLETED|Overall Study||68
10050399|NCT02030119|11175603|FG002|COMPLETED|Overall Study||65
10050400|NCT02030119|11175604|FG003|COMPLETED|Overall Study||67
10050401|NCT02030119|11175601|FG000|NOT COMPLETED|Overall Study||3
10050402|NCT02030119|11175602|FG001|NOT COMPLETED|Overall Study||2
10050403|NCT02030119|11175603|FG002|NOT COMPLETED|Overall Study||6
10050404|NCT02030119|11175604|FG003|NOT COMPLETED|Overall Study||3
10050405|NCT02030288|11175616|FG000|STARTED|Overall Study||89
10050406|NCT02030288|11175617|FG001|STARTED|Overall Study||89
10050407|NCT02030288|11175616|FG000|COMPLETED|Overall Study||89
10050408|NCT02030288|11175617|FG001|COMPLETED|Overall Study||89
10050409|NCT02030288|11175616|FG000|NOT COMPLETED|Overall Study||0
10050410|NCT02030288|11175617|FG001|NOT COMPLETED|Overall Study||0
10050411|NCT02030405|11175627|FG000|STARTED|Overall Study||4
10050412|NCT02030405|11175627|FG000|COMPLETED|Overall Study||2
10050413|NCT02030405|11175627|FG000|NOT COMPLETED|Overall Study||2
10050414|NCT02030535|11175632|FG000|STARTED|Treatment Period 1 (1 Day)||53
10050415|NCT02030535|11175632|FG000|COMPLETED|Treatment Period 1 (1 Day)||53
10118342|NCT02546609|11249224|FG000|STARTED|Overall Study||24
10118343|NCT02546609|11249225|FG001|STARTED|Overall Study||35
10118344|NCT02546609|11249226|FG002|STARTED|Overall Study||32
10118345|NCT02546609|11249224|FG000|COMPLETED|Overall Study||22
10118346|NCT02546609|11249225|FG001|COMPLETED|Overall Study||24
10118347|NCT02546609|11249226|FG002|COMPLETED|Overall Study||25
10118348|NCT02546609|11249224|FG000|NOT COMPLETED|Overall Study||2
10118349|NCT02546609|11249225|FG001|NOT COMPLETED|Overall Study||11
10118350|NCT02546609|11249226|FG002|NOT COMPLETED|Overall Study||7
10118351|NCT02546765|11249238|FG000|STARTED|Overall Study||31
10118352|NCT02546765|11249239|FG001|STARTED|Overall Study||30
10118353|NCT02546765|11249240|FG002|STARTED|Overall Study||30
10118354|NCT02546765|11249241|FG003|STARTED|Overall Study||30
10050416|NCT02030535|11175632|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10050417|NCT02030535|11175632|FG000|STARTED|Washout Period 1 (21 Days)||53
10050418|NCT02030535|11175632|FG000|COMPLETED|Washout Period 1 (21 Days)||52
10050419|NCT02030535|11175632|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1
10050420|NCT02030535|11175632|FG000|STARTED|Treatment Period 2 (1 Day)||52
10050421|NCT02030535|11175632|FG000|COMPLETED|Treatment Period 2 (1 Day)||52
10050422|NCT02030535|11175632|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10050423|NCT02030535|11175632|FG000|STARTED|Washout Period 2 (21 Days)||52
10050424|NCT02030535|11175632|FG000|COMPLETED|Washout Period 2 (21 Days)||52
10050425|NCT02030535|11175632|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0
10050426|NCT02030535|11175632|FG000|STARTED|Treatment Period 3 (1 Day)||52
10050427|NCT02030535|11175632|FG000|COMPLETED|Treatment Period 3 (1 Day)||52
10050428|NCT02030535|11175632|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10050429|NCT02030574|11175646|FG000|STARTED|Overall Study||2
10050430|NCT02030574|11175646|FG000|COMPLETED|Overall Study||2
10050431|NCT02030574|11175646|FG000|NOT COMPLETED|Overall Study||0
10050432|NCT02030600|11175652|FG000|STARTED|Treatment Period 1||361
10050433|NCT02030600|11175653|FG001|STARTED|Treatment Period 1||360
10050434|NCT02030600|11175652|FG000|Exposed|Treatment Period 1||356
10050435|NCT02030600|11175653|FG001|Exposed|Treatment Period 1||357
10050436|NCT02030600|11175652|FG000|COMPLETED|Treatment Period 1||308
10050437|NCT02030600|11175653|FG001|COMPLETED|Treatment Period 1||315
10050438|NCT02030600|11175652|FG000|NOT COMPLETED|Treatment Period 1||53
10050439|NCT02030600|11175653|FG001|NOT COMPLETED|Treatment Period 1||45
10050440|NCT02030600|11175652|FG000|STARTED|Treatment Period 2||308
10050441|NCT02030600|11175653|FG001|STARTED|Treatment Period 2||315
10050442|NCT02030600|11175652|FG000|COMPLETED|Treatment Period 2||283
10050443|NCT02030600|11175653|FG001|COMPLETED|Treatment Period 2||297
10050444|NCT02030600|11175652|FG000|NOT COMPLETED|Treatment Period 2||25
10050445|NCT02030600|11175653|FG001|NOT COMPLETED|Treatment Period 2||18
10050446|NCT02030821|11175665|FG000|STARTED|Overall Study||48
10050447|NCT02030821|11175666|FG001|STARTED|Overall Study||46
10050448|NCT02030821|11175667|FG002|STARTED|Overall Study||78
10050449|NCT02030821|11175668|FG003|STARTED|Overall Study||74
10050450|NCT02030821|11175665|FG000|COMPLETED|Overall Study||46
10050451|NCT02030821|11175666|FG001|COMPLETED|Overall Study||44
10050452|NCT02030821|11175667|FG002|COMPLETED|Overall Study||73
10050453|NCT02030821|11175668|FG003|COMPLETED|Overall Study||72
10050454|NCT02030821|11175665|FG000|NOT COMPLETED|Overall Study||2
10050455|NCT02030821|11175666|FG001|NOT COMPLETED|Overall Study||2
10050456|NCT02030821|11175667|FG002|NOT COMPLETED|Overall Study||5
10050457|NCT02030821|11175668|FG003|NOT COMPLETED|Overall Study||2
10050458|NCT02030834|11175681|FG000|STARTED|Overall Study||50
10050459|NCT02030834|11175682|FG001|STARTED|Overall Study||3
10050460|NCT02030834|11175683|FG002|STARTED|Overall Study||10
10050461|NCT02030834|11175681|FG000|COMPLETED|Overall Study||39
10050462|NCT02030834|11175682|FG001|COMPLETED|Overall Study||3
10050463|NCT02030834|11175683|FG002|COMPLETED|Overall Study||7
10118355|NCT02546765|11249238|FG000|COMPLETED|Overall Study||31
10118356|NCT02546765|11249239|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
10118357|NCT02546765|11249240|FG002|COMPLETED|Overall Study||30
10118358|NCT02546765|11249241|FG003|COMPLETED|Overall Study||30
10118359|NCT02546765|11249238|FG000|NOT COMPLETED|Overall Study||0
10118360|NCT02546765|11249239|FG001|NOT COMPLETED|Overall Study||1
10118361|NCT02546765|11249240|FG002|NOT COMPLETED|Overall Study||0
10118362|NCT02546765|11249241|FG003|NOT COMPLETED|Overall Study||0
10118363|NCT02546856|11249264|FG000|STARTED|4 Months Evaluation||164
10118364|NCT02546856|11249265|FG001|STARTED|4 Months Evaluation||156
10118365|NCT02546856|11249264|FG000|COMPLETED|4 Months Evaluation||144
10118366|NCT02546856|11249265|FG001|COMPLETED|4 Months Evaluation||145
10118367|NCT02546856|11249264|FG000|NOT COMPLETED|4 Months Evaluation||20
10118368|NCT02546856|11249265|FG001|NOT COMPLETED|4 Months Evaluation||11
10118369|NCT02546856|11249264|FG000|STARTED|6 Months Evaluation||144
10118370|NCT02546856|11249265|FG001|STARTED|6 Months Evaluation||145
10050464|NCT02030834|11175681|FG000|NOT COMPLETED|Overall Study||11
10050465|NCT02030834|11175682|FG001|NOT COMPLETED|Overall Study||0
10050466|NCT02030834|11175683|FG002|NOT COMPLETED|Overall Study||3
10118371|NCT02546856|11249264|FG000|COMPLETED|6 Months Evaluation||136
10118372|NCT02546856|11249265|FG001|COMPLETED|6 Months Evaluation||138
10050467|NCT02030847|11175691|FG000|STARTED|Overall Study||42
10050468|NCT02030847|11175691|FG000|COMPLETED|Overall Study||5
10050469|NCT02030847|11175691|FG000|NOT COMPLETED|Overall Study||37
10050470|NCT02030886|11175698|FG000|STARTED|Overall Study||14
10050471|NCT02030886|11175699|FG001|STARTED|Overall Study||6
10050472|NCT02030886|11175698|FG000|COMPLETED|Overall Study||14
10050473|NCT02030886|11175699|FG001|COMPLETED|Overall Study||6
10050474|NCT02030886|11175698|FG000|NOT COMPLETED|Overall Study||0
10050475|NCT02030886|11175699|FG001|NOT COMPLETED|Overall Study||0
10050476|NCT02031146|11175709|FG000|STARTED|Overall Study||11
10050477|NCT02031146|11175710|FG001|STARTED|Overall Study||3
10050478|NCT02031146|11175711|FG002|STARTED|Overall Study||18
10050479|NCT02031146|11175712|FG003|STARTED|Overall Study||148
10050480|NCT02031146|11175713|FG004|STARTED|Overall Study||42
10050481|NCT02031146|11175714|FG005|STARTED|Overall Study||4
10050482|NCT02031146|11175715|FG006|STARTED|Overall Study||5
10050483|NCT02031146|11175709|FG000|Considered in Analysis|Overall Study||11
10050484|NCT02031146|11175710|FG001|Considered in Analysis|Overall Study||3
10050485|NCT02031146|11175711|FG002|Considered in Analysis|Overall Study||18
10050486|NCT02031146|11175712|FG003|Considered in Analysis|Overall Study||48
10050487|NCT02031146|11175713|FG004|Considered in Analysis|Overall Study||16
10050488|NCT02031146|11175714|FG005|Considered in Analysis|Overall Study||0
10050489|NCT02031146|11175715|FG006|Considered in Analysis|Overall Study||0
10050490|NCT02031146|11175709|FG000|COMPLETED|Overall Study||11
10050491|NCT02031146|11175710|FG001|COMPLETED|Overall Study||3
10050492|NCT02031146|11175711|FG002|COMPLETED|Overall Study||18
10050493|NCT02031146|11175712|FG003|COMPLETED|Overall Study||48
10050494|NCT02031146|11175713|FG004|COMPLETED|Overall Study||16
10050495|NCT02031146|11175714|FG005|COMPLETED|Overall Study||0
10050496|NCT02031146|11175715|FG006|COMPLETED|Overall Study||0
10050497|NCT02031146|11175709|FG000|NOT COMPLETED|Overall Study||0
10050498|NCT02031146|11175710|FG001|NOT COMPLETED|Overall Study||0
10050499|NCT02031146|11175711|FG002|NOT COMPLETED|Overall Study||0
10050500|NCT02031146|11175712|FG003|NOT COMPLETED|Overall Study||100
10050501|NCT02031146|11175713|FG004|NOT COMPLETED|Overall Study||26
10050502|NCT02031146|11175714|FG005|NOT COMPLETED|Overall Study||4
10050503|NCT02031146|11175715|FG006|NOT COMPLETED|Overall Study||5
10050504|NCT02031237|11175727|FG000|STARTED|Overall Study||14
10050505|NCT02031237|11175728|FG001|STARTED|Overall Study||35
10050506|NCT02031237|11175729|FG002|STARTED|Overall Study||3
10050507|NCT02031237|11175727|FG000|COMPLETED|Overall Study||9
10050508|NCT02031237|11175728|FG001|COMPLETED|Overall Study||21
10050509|NCT02031237|11175729|FG002|COMPLETED|Overall Study||0
10050510|NCT02031237|11175727|FG000|NOT COMPLETED|Overall Study||5
10050511|NCT02031237|11175728|FG001|NOT COMPLETED|Overall Study||14
10050512|NCT02031237|11175729|FG002|NOT COMPLETED|Overall Study||3
10050513|NCT02031276|11175739|FG000|STARTED|Period 1 Double-blind IV||39
10050514|NCT02031276|11175740|FG001|STARTED|Period 1 Double-blind IV||41
10050515|NCT02031276|11175741|FG002|STARTED|Period 1 Double-blind IV||41
10050516|NCT02031276|11175739|FG000|COMPLETED|Period 1 Double-blind IV||33
10050517|NCT02031276|11175740|FG001|COMPLETED|Period 1 Double-blind IV||35
10050518|NCT02031276|11175741|FG002|COMPLETED|Period 1 Double-blind IV||40
10050519|NCT02031276|11175739|FG000|NOT COMPLETED|Period 1 Double-blind IV||6
10050520|NCT02031276|11175740|FG001|NOT COMPLETED|Period 1 Double-blind IV||6
10050521|NCT02031276|11175741|FG002|NOT COMPLETED|Period 1 Double-blind IV||1
10050522|NCT02031276|11175739|FG000|STARTED|Period 2 Open-label Risankizumab IV||33
10050523|NCT02031276|11175740|FG001|STARTED|Period 2 Open-label Risankizumab IV||35
10050524|NCT02031276|11175741|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
10050525|NCT02031276|11175739|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29
10050526|NCT02031276|11175740|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33
10050527|NCT02031276|11175741|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38
10050528|NCT02031276|11175739|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
10050529|NCT02031276|11175740|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
10050530|NCT02031276|11175741|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
10050531|NCT02031276|11175739|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
10050532|NCT02031276|11175740|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
10050533|NCT02031276|11175741|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
10050534|NCT02031276|11175739|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16
10050535|NCT02031276|11175740|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19
10050536|NCT02031276|11175741|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19
10050537|NCT02031276|11175739|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
10050538|NCT02031276|11175740|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
10050539|NCT02031276|11175741|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
10050540|NCT02031302|11175755|FG000|STARTED|Overall Study||1014
10050541|NCT02031302|11175756|FG001|STARTED|Overall Study||50
10050542|NCT02031302|11175755|FG000|COMPLETED|Overall Study||850
10050543|NCT02031302|11175756|FG001|COMPLETED|Overall Study||50
10050544|NCT02031302|11175755|FG000|NOT COMPLETED|Overall Study||164
10050545|NCT02031302|11175756|FG001|NOT COMPLETED|Overall Study||0
10050546|NCT02031432|11175763|FG000|STARTED|Overall Study||76
10050547|NCT02031432|11175763|FG000|Completing the Titration Phase|Overall Study||67
10050548|NCT02031432|11175763|FG000|Completing the Treatment|Overall Study||39
10050549|NCT02031432|11175763|FG000|COMPLETED|Overall Study||38
10050550|NCT02031432|11175763|FG000|NOT COMPLETED|Overall Study||38
10050551|NCT02031458|11175770|FG000|STARTED|May 8, 2015 to January 11, 2019||138
10050552|NCT02031458|11175771|FG001|STARTED|May 8, 2015 to January 11, 2019||269
10050553|NCT02031458|11175772|FG002|STARTED|May 8, 2015 to January 11, 2019||252
10050554|NCT02031458|11175770|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0
10050555|NCT02031458|11175771|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0
10050556|NCT02031458|11175772|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0
10050557|NCT02031458|11175770|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
10050558|NCT02031458|11175771|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
10050559|NCT02031458|11175772|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
10050560|NCT02031458|11175770|FG000|STARTED|Baseline to May 8, 2015||139
10050561|NCT02031458|11175771|FG001|STARTED|Baseline to May 8, 2015||267
10050562|NCT02031458|11175772|FG002|STARTED|Baseline to May 8, 2015||253
10050563|NCT02031458|11175770|FG000|COMPLETED|Baseline to May 8, 2015||0
10050564|NCT02031458|11175771|FG001|COMPLETED|Baseline to May 8, 2015||0
10050565|NCT02031458|11175772|FG002|COMPLETED|Baseline to May 8, 2015||0
10050566|NCT02031458|11175770|FG000|NOT COMPLETED|Baseline to May 8, 2015||139
10050567|NCT02031458|11175771|FG001|NOT COMPLETED|Baseline to May 8, 2015||267
10050568|NCT02031458|11175772|FG002|NOT COMPLETED|Baseline to May 8, 2015||253
10050569|NCT02031471|11175782|FG000|STARTED|24 Week Treatment Period||57
10050570|NCT02031471|11175782|FG000|COMPLETED|24 Week Treatment Period||46
10050571|NCT02031471|11175782|FG000|NOT COMPLETED|24 Week Treatment Period||11
10050572|NCT02031471|11175782|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
10050573|NCT02031471|11175782|FG000|COMPLETED|Long Term Extension (LTE) Period||37
10050574|NCT02031471|11175782|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2
10050575|NCT02031536|11175788|FG000|STARTED|Overall Study||2
10050576|NCT02031536|11175789|FG001|STARTED|Overall Study||0
10050577|NCT02031536|11175788|FG000|COMPLETED|Overall Study||1
10050578|NCT02031536|11175789|FG001|COMPLETED|Overall Study||0
10050579|NCT02031536|11175788|FG000|NOT COMPLETED|Overall Study||1
10050580|NCT02031536|11175789|FG001|NOT COMPLETED|Overall Study||0
10050581|NCT02031627|11175798|FG000|STARTED|Overall Study||7
10050582|NCT02031627|11175799|FG001|STARTED|Overall Study||7
10050583|NCT02031627|11175800|FG002|STARTED|Overall Study||7
10050584|NCT02031627|11175798|FG000|COMPLETED|Overall Study||7
10050585|NCT02031627|11175799|FG001|COMPLETED|Overall Study||7
10050586|NCT02031627|11175800|FG002|COMPLETED|Overall Study||7
10050587|NCT02031627|11175798|FG000|NOT COMPLETED|Overall Study||0
10050588|NCT02031627|11175799|FG001|NOT COMPLETED|Overall Study||0
10050589|NCT02031627|11175800|FG002|NOT COMPLETED|Overall Study||0
10050590|NCT02031640|11175813|FG000|STARTED|Screening Period|Consented|1113
10050591|NCT02031640|11175814|FG001|STARTED|Screening Period||0
10050592|NCT02031640|11175815|FG002|STARTED|Screening Period||0
10050593|NCT02031640|11175816|FG003|STARTED|Screening Period||0
10050594|NCT02031640|11175817|FG004|STARTED|Screening Period||0
10050595|NCT02031640|11175818|FG005|STARTED|Screening Period||0
10050596|NCT02031640|11175813|FG000|COMPLETED|Screening Period||701
10050597|NCT02031640|11175814|FG001|COMPLETED|Screening Period||0
10050598|NCT02031640|11175815|FG002|COMPLETED|Screening Period||0
10050599|NCT02031640|11175816|FG003|COMPLETED|Screening Period||0
10050600|NCT02031640|11175817|FG004|COMPLETED|Screening Period||0
10050601|NCT02031640|11175818|FG005|COMPLETED|Screening Period||0
10050602|NCT02031640|11175813|FG000|NOT COMPLETED|Screening Period||412
10050603|NCT02031640|11175814|FG001|NOT COMPLETED|Screening Period||0
10050604|NCT02031640|11175815|FG002|NOT COMPLETED|Screening Period||0
10050605|NCT02031640|11175816|FG003|NOT COMPLETED|Screening Period||0
10050606|NCT02031640|11175817|FG004|NOT COMPLETED|Screening Period||0
10050607|NCT02031640|11175818|FG005|NOT COMPLETED|Screening Period||0
10050608|NCT02031640|11175813|FG000|STARTED|Run-In Period||701
10050609|NCT02031640|11175814|FG001|STARTED|Run-In Period||0
10050610|NCT02031640|11175815|FG002|STARTED|Run-In Period||0
10050611|NCT02031640|11175816|FG003|STARTED|Run-In Period||0
10050612|NCT02031640|11175817|FG004|STARTED|Run-In Period||0
10050613|NCT02031640|11175818|FG005|STARTED|Run-In Period||0
10050614|NCT02031640|11175813|FG000|COMPLETED|Run-In Period||532
10050615|NCT02031640|11175814|FG001|COMPLETED|Run-In Period||0
10050616|NCT02031640|11175815|FG002|COMPLETED|Run-In Period||0
10050617|NCT02031640|11175816|FG003|COMPLETED|Run-In Period||0
10050618|NCT02031640|11175817|FG004|COMPLETED|Run-In Period||0
10050619|NCT02031640|11175818|FG005|COMPLETED|Run-In Period||0
10050620|NCT02031640|11175813|FG000|NOT COMPLETED|Run-In Period||169
10118373|NCT02546856|11249264|FG000|NOT COMPLETED|6 Months Evaluation||8
10050621|NCT02031640|11175814|FG001|NOT COMPLETED|Run-In Period||0
10050622|NCT02031640|11175815|FG002|NOT COMPLETED|Run-In Period||0
10050623|NCT02031640|11175816|FG003|NOT COMPLETED|Run-In Period||0
10050624|NCT02031640|11175817|FG004|NOT COMPLETED|Run-In Period||0
10050625|NCT02031640|11175818|FG005|NOT COMPLETED|Run-In Period||0
10050626|NCT02031640|11175813|FG000|STARTED|Double-blind Treatment Period||0
10050627|NCT02031640|11175814|FG001|STARTED|Double-blind Treatment Period||106
10050628|NCT02031640|11175815|FG002|STARTED|Double-blind Treatment Period||106
10050629|NCT02031640|11175816|FG003|STARTED|Double-blind Treatment Period||106
10050630|NCT02031640|11175817|FG004|STARTED|Double-blind Treatment Period||107
10050631|NCT02031640|11175818|FG005|STARTED|Double-blind Treatment Period||107
10050632|NCT02031640|11175813|FG000|Full Analysis Set|Double-blind Treatment Period||0
10050633|NCT02031640|11175814|FG001|Full Analysis Set|Double-blind Treatment Period||106
10050634|NCT02031640|11175815|FG002|Full Analysis Set|Double-blind Treatment Period||104
10050635|NCT02031640|11175816|FG003|Full Analysis Set|Double-blind Treatment Period||106
10050636|NCT02031640|11175817|FG004|Full Analysis Set|Double-blind Treatment Period||106
10050637|NCT02031640|11175818|FG005|Full Analysis Set|Double-blind Treatment Period||107
10050638|NCT02031640|11175813|FG000|COMPLETED|Double-blind Treatment Period||0
10050639|NCT02031640|11175814|FG001|COMPLETED|Double-blind Treatment Period||84
10050640|NCT02031640|11175815|FG002|COMPLETED|Double-blind Treatment Period||100
10050641|NCT02031640|11175816|FG003|COMPLETED|Double-blind Treatment Period||99
10050642|NCT02031640|11175817|FG004|COMPLETED|Double-blind Treatment Period||96
10050643|NCT02031640|11175818|FG005|COMPLETED|Double-blind Treatment Period||104
10050644|NCT02031640|11175813|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10050645|NCT02031640|11175814|FG001|NOT COMPLETED|Double-blind Treatment Period||22
10050646|NCT02031640|11175815|FG002|NOT COMPLETED|Double-blind Treatment Period||6
10050647|NCT02031640|11175816|FG003|NOT COMPLETED|Double-blind Treatment Period||7
10050648|NCT02031640|11175817|FG004|NOT COMPLETED|Double-blind Treatment Period||11
10050649|NCT02031640|11175818|FG005|NOT COMPLETED|Double-blind Treatment Period||3
10050650|NCT02031679|11175839|FG000|STARTED|Overall Study||14
10050651|NCT02031679|11175840|FG001|STARTED|Overall Study||14
10050652|NCT02031679|11175839|FG000|COMPLETED|Overall Study||14
10050653|NCT02031679|11175840|FG001|COMPLETED|Overall Study||12
10050654|NCT02031679|11175839|FG000|NOT COMPLETED|Overall Study||0
10050655|NCT02031679|11175840|FG001|NOT COMPLETED|Overall Study||2
10050656|NCT02031770|11175846|FG000|STARTED|Overall Study||10
10050657|NCT02031770|11175847|FG001|STARTED|Overall Study||10
10050658|NCT02031770|11175846|FG000|COMPLETED|Overall Study||9
10050659|NCT02031770|11175847|FG001|COMPLETED|Overall Study||9
10050660|NCT02031770|11175846|FG000|NOT COMPLETED|Overall Study||1
10050661|NCT02031770|11175847|FG001|NOT COMPLETED|Overall Study||1
10050662|NCT02032173|11175853|FG000|STARTED|Overall Study||31
10050663|NCT02032173|11175853|FG000|Included Population - Main Group|Overall Study||31
10050664|NCT02032173|11175853|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
10050665|NCT02032173|11175853|FG000|COMPLETED|Overall Study||0
10050666|NCT02032173|11175853|FG000|NOT COMPLETED|Overall Study||31
10050667|NCT02032212|11175861|FG000|STARTED|Overall Study||3
10050668|NCT02032212|11175862|FG001|STARTED|Overall Study||3
10050669|NCT02032212|11175863|FG002|STARTED|Overall Study||3
10050670|NCT02032212|11175864|FG003|STARTED|Overall Study||3
10050671|NCT02032212|11175861|FG000|COMPLETED|Overall Study||3
10050672|NCT02032212|11175862|FG001|COMPLETED|Overall Study||3
10050673|NCT02032212|11175863|FG002|COMPLETED|Overall Study||3
10050674|NCT02032212|11175864|FG003|COMPLETED|Overall Study||3
10050675|NCT02032212|11175861|FG000|NOT COMPLETED|Overall Study||0
10050676|NCT02032212|11175862|FG001|NOT COMPLETED|Overall Study||0
10050677|NCT02032212|11175863|FG002|NOT COMPLETED|Overall Study||0
10050678|NCT02032212|11175864|FG003|NOT COMPLETED|Overall Study||0
10050679|NCT02032238|11175876|FG000|STARTED|Overall Study||12
10050680|NCT02032238|11175877|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
10050681|NCT02032238|11175876|FG000|COMPLETED|Overall Study||10
10050682|NCT02032238|11175877|FG001|COMPLETED|Overall Study||0
10050683|NCT02032238|11175876|FG000|NOT COMPLETED|Overall Study||2
10050684|NCT02032238|11175877|FG001|NOT COMPLETED|Overall Study||0
10050685|NCT02032407|11175883|FG000|STARTED|Overall Study||68
10050686|NCT02032407|11175883|FG000|COMPLETED|Overall Study||63
10050687|NCT02032407|11175883|FG000|NOT COMPLETED|Overall Study||5
10050688|NCT02032420|11175889|FG000|STARTED|Overall Study||18
10050689|NCT02032420|11175890|FG001|STARTED|Overall Study||17
10050690|NCT02032420|11175889|FG000|COMPLETED|Overall Study||18
10050691|NCT02032420|11175890|FG001|COMPLETED|Overall Study||17
10050692|NCT02032420|11175889|FG000|NOT COMPLETED|Overall Study||0
10050693|NCT02032420|11175890|FG001|NOT COMPLETED|Overall Study||0
10050694|NCT02032433|11175898|FG000|STARTED|Overall Study||283
10050695|NCT02032433|11175899|FG001|STARTED|Overall Study||287
10050696|NCT02032433|11175898|FG000|COMPLETED|Overall Study||205
10118374|NCT02546856|11249265|FG001|NOT COMPLETED|6 Months Evaluation||7
10118375|NCT02547012|11249285|FG000|STARTED|Overall Study||24
10118376|NCT02547012|11249286|FG001|STARTED|Overall Study||27
10118377|NCT02547012|11249285|FG000|COMPLETED|Overall Study||24
10118378|NCT02547012|11249286|FG001|COMPLETED|Overall Study||27
10118379|NCT02547012|11249285|FG000|NOT COMPLETED|Overall Study||0
10118380|NCT02547012|11249286|FG001|NOT COMPLETED|Overall Study||0
10118381|NCT02547038|11249294|FG000|STARTED|Overall Study||176
10118382|NCT02547038|11249295|FG001|STARTED|Overall Study||176
10118383|NCT02547038|11249294|FG000|COMPLETED|Overall Study||173
10050697|NCT02032433|11175899|FG001|COMPLETED|Overall Study||225
10050698|NCT02032433|11175898|FG000|NOT COMPLETED|Overall Study||78
10050699|NCT02032433|11175899|FG001|NOT COMPLETED|Overall Study||62
10050700|NCT02032550|11175907|FG000|STARTED|Overall Study||371
10050701|NCT02032550|11175908|FG001|STARTED|Overall Study||372
10050702|NCT02032550|11175907|FG000|COMPLETED|Overall Study||343
10050703|NCT02032550|11175908|FG001|COMPLETED|Overall Study||350
10050704|NCT02032550|11175907|FG000|NOT COMPLETED|Overall Study||28
10050705|NCT02032550|11175908|FG001|NOT COMPLETED|Overall Study||22
10050706|NCT02032641|11175914|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9
10050707|NCT02032641|11175914|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
10050708|NCT02032641|11175914|FG000|NOT COMPLETED|Overall Study||1
10118384|NCT02547038|11249295|FG001|COMPLETED|Overall Study||174
10118385|NCT02547038|11249294|FG000|NOT COMPLETED|Overall Study||3
10050709|NCT02032680|11175922|FG000|STARTED|Overall Study||22
10050710|NCT02032680|11175923|FG001|STARTED|Overall Study||8
10050711|NCT02032680|11175922|FG000|COMPLETED|Overall Study||16
10050712|NCT02032680|11175923|FG001|COMPLETED|Overall Study||7
10050713|NCT02032680|11175922|FG000|NOT COMPLETED|Overall Study||6
10050714|NCT02032680|11175923|FG001|NOT COMPLETED|Overall Study||1
10050715|NCT02032706|11175929|FG000|STARTED|Overall Study||36
10050716|NCT02032706|11175929|FG000|COMPLETED|Overall Study||30
10050717|NCT02032706|11175929|FG000|NOT COMPLETED|Overall Study||6
10050718|NCT02032758|11175935|FG000|STARTED|Overall Study||27
10050719|NCT02032758|11175936|FG001|STARTED|Overall Study||11
10050720|NCT02032758|11175935|FG000|COMPLETED|Overall Study||27
10050721|NCT02032758|11175936|FG001|COMPLETED|Overall Study||11
10050722|NCT02032758|11175935|FG000|NOT COMPLETED|Overall Study||0
10050723|NCT02032758|11175936|FG001|NOT COMPLETED|Overall Study||0
10050724|NCT02032875|11175944|FG000|STARTED|Treatment Period||53
10050725|NCT02032875|11175945|FG001|STARTED|Treatment Period||60
10050726|NCT02032875|11175944|FG000|COMPLETED|Treatment Period||52
10050727|NCT02032875|11175945|FG001|COMPLETED|Treatment Period||56
10050728|NCT02032875|11175944|FG000|NOT COMPLETED|Treatment Period||1
10050729|NCT02032875|11175945|FG001|NOT COMPLETED|Treatment Period||4
10050730|NCT02032875|11175944|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
10050731|NCT02032875|11175945|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
10050732|NCT02032875|11175944|FG000|COMPLETED|Follow-up Period||50
10050733|NCT02032875|11175945|FG001|COMPLETED|Follow-up Period||46
10050734|NCT02032875|11175944|FG000|NOT COMPLETED|Follow-up Period||3
10050735|NCT02032875|11175945|FG001|NOT COMPLETED|Follow-up Period||11
10050736|NCT02032888|11175955|FG000|STARTED|Treatment Period||101
10050737|NCT02032888|11175956|FG001|STARTED|Treatment Period||50
10050738|NCT02032888|11175957|FG002|STARTED|Treatment Period||52
10050739|NCT02032888|11175955|FG000|COMPLETED|Treatment Period||99
10050740|NCT02032888|11175956|FG001|COMPLETED|Treatment Period||48
10050741|NCT02032888|11175957|FG002|COMPLETED|Treatment Period||52
10050742|NCT02032888|11175955|FG000|NOT COMPLETED|Treatment Period||2
10050743|NCT02032888|11175956|FG001|NOT COMPLETED|Treatment Period||2
10050744|NCT02032888|11175957|FG002|NOT COMPLETED|Treatment Period||0
10050745|NCT02032888|11175955|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
10050746|NCT02032888|11175956|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
10050747|NCT02032888|11175957|FG002|STARTED|Follow-up Period||52
10050748|NCT02032888|11175955|FG000|COMPLETED|Follow-up Period||97
10050749|NCT02032888|11175956|FG001|COMPLETED|Follow-up Period||47
10050750|NCT02032888|11175957|FG002|COMPLETED|Follow-up Period||52
10050751|NCT02032888|11175955|FG000|NOT COMPLETED|Follow-up Period||3
10050752|NCT02032888|11175956|FG001|NOT COMPLETED|Follow-up Period||2
10050753|NCT02032888|11175957|FG002|NOT COMPLETED|Follow-up Period||0
10050754|NCT02032901|11175976|FG000|STARTED|Treatment Period (12 Weeks)||101
10050755|NCT02032901|11175977|FG001|STARTED|Treatment Period (12 Weeks)||51
10050756|NCT02032901|11175976|FG000|COMPLETED|Treatment Period (12 Weeks)||100
10050757|NCT02032901|11175977|FG001|COMPLETED|Treatment Period (12 Weeks)||51
10050758|NCT02032901|11175976|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1
10050759|NCT02032901|11175977|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
10050760|NCT02032901|11175976|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
10050761|NCT02032901|11175977|FG001|STARTED|Follow-Up Period (24 Weeks)||51
10050762|NCT02032901|11175976|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101
10050763|NCT02032901|11175977|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50
10050764|NCT02032901|11175976|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
10050765|NCT02032901|11175977|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
10050766|NCT02033005|11175988|FG000|STARTED|Overall Study||80
10050767|NCT02033005|11175989|FG001|STARTED|Overall Study||9
10050768|NCT02033005|11175990|FG002|STARTED|Overall Study||35
10050769|NCT02033005|11175988|FG000|COMPLETED|Overall Study||36
10050770|NCT02033005|11175989|FG001|COMPLETED|Overall Study||9
10050771|NCT02033005|11175990|FG002|COMPLETED|Overall Study||25
10050772|NCT02033005|11175988|FG000|NOT COMPLETED|Overall Study||44
10050773|NCT02033005|11175989|FG001|NOT COMPLETED|Overall Study||0
10050774|NCT02033005|11175990|FG002|NOT COMPLETED|Overall Study||10
9706614|NCT02111850|10805651|FG009|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706615|NCT02111850|10805652|FG010|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
9706616|NCT01983553|10805680|FG000|STARTED|Overall Study||2131
9706617|NCT01983553|10805681|FG001|STARTED|Overall Study||1072
9706618|NCT01983553|10805680|FG000|COMPLETED|Overall Study||2131
9706619|NCT01983553|10805681|FG001|COMPLETED|Overall Study||1072
10050775|NCT02033083|11176001|FG000|STARTED|Overall Study||90
10050776|NCT02033083|11176002|FG001|STARTED|Overall Study||90
10050777|NCT02033083|11176001|FG000|COMPLETED|Overall Study||89
9706620|NCT01983553|10805680|FG000|NOT COMPLETED|Overall Study||0
9706621|NCT01983553|10805681|FG001|NOT COMPLETED|Overall Study||0
10050778|NCT02033083|11176002|FG001|COMPLETED|Overall Study||89
10050779|NCT02033083|11176001|FG000|NOT COMPLETED|Overall Study||1
9706622|NCT01760291|10805687|FG000|STARTED|Overall Study||576
10050780|NCT02033083|11176002|FG001|NOT COMPLETED|Overall Study||1
10050781|NCT02033174|11176008|FG000|STARTED|First Intervention||8
10050782|NCT02033174|11176009|FG001|STARTED|First Intervention||8
10050783|NCT02033174|11176008|FG000|COMPLETED|First Intervention||8
10050784|NCT02033174|11176009|FG001|COMPLETED|First Intervention||8
10050785|NCT02033174|11176008|FG000|NOT COMPLETED|First Intervention||0
10050786|NCT02033174|11176009|FG001|NOT COMPLETED|First Intervention||0
10050787|NCT02033174|11176008|FG000|STARTED|Washout (1 Week)||8
10050788|NCT02033174|11176009|FG001|STARTED|Washout (1 Week)||8
10050789|NCT02033174|11176008|FG000|COMPLETED|Washout (1 Week)||8
10050790|NCT02033174|11176009|FG001|COMPLETED|Washout (1 Week)||8
10050791|NCT02033174|11176008|FG000|NOT COMPLETED|Washout (1 Week)||0
10050792|NCT02033174|11176009|FG001|NOT COMPLETED|Washout (1 Week)||0
10050793|NCT02033174|11176008|FG000|STARTED|Second Intervention||8
10050794|NCT02033174|11176009|FG001|STARTED|Second Intervention||8
10050795|NCT02033174|11176008|FG000|COMPLETED|Second Intervention||8
10050796|NCT02033174|11176009|FG001|COMPLETED|Second Intervention||8
10050797|NCT02033174|11176008|FG000|NOT COMPLETED|Second Intervention||0
10050798|NCT02033174|11176009|FG001|NOT COMPLETED|Second Intervention||0
10050799|NCT02033200|11176017|FG000|STARTED|Overall Study||40
10050800|NCT02033200|11176018|FG001|STARTED|Overall Study||40
10050801|NCT02033200|11176017|FG000|COMPLETED|Overall Study||40
10050802|NCT02033200|11176018|FG001|COMPLETED|Overall Study||40
10050803|NCT02033200|11176017|FG000|NOT COMPLETED|Overall Study||0
10050804|NCT02033200|11176018|FG001|NOT COMPLETED|Overall Study||0
10050805|NCT02033213|11176026|FG000|STARTED|Overall Study||8
10050806|NCT02033213|11176027|FG001|STARTED|Overall Study||8
10050807|NCT02033213|11176026|FG000|COMPLETED|Overall Study||8
10050808|NCT02033213|11176027|FG001|COMPLETED|Overall Study||8
10050809|NCT02033213|11176026|FG000|NOT COMPLETED|Overall Study||0
10050810|NCT02033213|11176027|FG001|NOT COMPLETED|Overall Study||0
10050811|NCT02033317|11176035|FG000|STARTED|Overall Study||6
10050812|NCT02033317|11176035|FG000|COMPLETED|Overall Study||6
10050813|NCT02033317|11176035|FG000|NOT COMPLETED|Overall Study||0
10050814|NCT02033369|11176041|FG000|STARTED|Overall Study||26
10050815|NCT02033369|11176042|FG001|STARTED|Overall Study||26
10050816|NCT02033369|11176041|FG000|COMPLETED|Overall Study||21
10050817|NCT02033369|11176042|FG001|COMPLETED|Overall Study||21
10050818|NCT02033369|11176041|FG000|NOT COMPLETED|Overall Study||5
10050819|NCT02033369|11176042|FG001|NOT COMPLETED|Overall Study||5
10050820|NCT02033382|11176048|FG000|STARTED|Overall Study||83
10050821|NCT02033382|11176049|FG001|STARTED|Overall Study||82
10050822|NCT02033382|11176048|FG000|COMPLETED|Overall Study||32
10050823|NCT02033382|11176049|FG001|COMPLETED|Overall Study||36
10050824|NCT02033382|11176048|FG000|NOT COMPLETED|Overall Study||51
10050825|NCT02033382|11176049|FG001|NOT COMPLETED|Overall Study||46
10050826|NCT02033499|11176062|FG000|STARTED|Overall Study||152
10050827|NCT02033499|11176063|FG001|STARTED|Overall Study||150
10050828|NCT02033499|11176064|FG002|STARTED|Overall Study||148
10050829|NCT02033499|11176062|FG000|COMPLETED|Overall Study||147
10050830|NCT02033499|11176063|FG001|COMPLETED|Overall Study||142
10050831|NCT02033499|11176064|FG002|COMPLETED|Overall Study||139
10050832|NCT02033499|11176062|FG000|NOT COMPLETED|Overall Study||5
10050833|NCT02033499|11176063|FG001|NOT COMPLETED|Overall Study||8
10050834|NCT02033499|11176064|FG002|NOT COMPLETED|Overall Study||9
10050835|NCT02033694|11176073|FG000|STARTED|Overall Study||1271
10050836|NCT02033694|11176073|FG000|COMPLETED|Overall Study||1271
10050837|NCT02033694|11176073|FG000|NOT COMPLETED|Overall Study||0
10050838|NCT02033759|11176080|FG000|STARTED|Overall Study||22
10050839|NCT02033759|11176081|FG001|STARTED|Overall Study||21
10050840|NCT02033759|11176080|FG000|COMPLETED|Overall Study||19
10050841|NCT02033759|11176081|FG001|COMPLETED|Overall Study||19
10050842|NCT02033759|11176080|FG000|NOT COMPLETED|Overall Study||3
10050843|NCT02033759|11176081|FG001|NOT COMPLETED|Overall Study||2
10118386|NCT02547038|11249295|FG001|NOT COMPLETED|Overall Study||2
10118387|NCT02547064|11249303|FG000|STARTED|Overall Study||81
10118388|NCT02547064|11249304|FG001|STARTED|Overall Study||81
10118389|NCT02547064|11249303|FG000|COMPLETED|Overall Study||78
10118390|NCT02547064|11249304|FG001|COMPLETED|Overall Study||79
10118391|NCT02547064|11249303|FG000|NOT COMPLETED|Overall Study||3
10118392|NCT02547064|11249304|FG001|NOT COMPLETED|Overall Study||2
10118393|NCT02547220|11249312|FG000|STARTED|Overall Study||19
10118394|NCT02547220|11249313|FG001|STARTED|Overall Study||20
10118395|NCT02547220|11249312|FG000|COMPLETED|Overall Study||0
10118396|NCT02547220|11249313|FG001|COMPLETED|Overall Study||0
10118397|NCT02547220|11249312|FG000|NOT COMPLETED|Overall Study||19
10118398|NCT02547220|11249313|FG001|NOT COMPLETED|Overall Study||20
10118399|NCT02547233|11249321|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
10118400|NCT02547233|11249322|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
10118401|NCT02547233|11249321|FG000|Treated|3-day Treatment and 8-week Follow-up||205
10118402|NCT02547233|11249322|FG001|Treated|3-day Treatment and 8-week Follow-up||100
10050844|NCT02033850|11176089|FG000|STARTED|Overall Study||23
10050845|NCT02033850|11176090|FG001|STARTED|Overall Study||23
10050846|NCT02033850|11176089|FG000|COMPLETED|Overall Study||21
10050847|NCT02033850|11176090|FG001|COMPLETED|Overall Study||22
10050848|NCT02033850|11176089|FG000|NOT COMPLETED|Overall Study||2
10050849|NCT02033850|11176090|FG001|NOT COMPLETED|Overall Study||1
10050850|NCT02033876|11176098|FG000|STARTED|Overall Study||12
10050851|NCT02033876|11176099|FG001|STARTED|Overall Study||12
10118403|NCT02547233|11249321|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203
10118404|NCT02547233|11249322|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92
10118405|NCT02547233|11249321|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
10118406|NCT02547233|11249322|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
10118407|NCT02547233|11249321|FG000|STARTED|12-month Follow-up||199
10118408|NCT02547233|11249322|FG001|STARTED|12-month Follow-up||84
10050852|NCT02033876|11176098|FG000|COMPLETED|Overall Study||12
10050853|NCT02033876|11176099|FG001|COMPLETED|Overall Study||12
10050854|NCT02033876|11176098|FG000|NOT COMPLETED|Overall Study||0
10050855|NCT02033876|11176099|FG001|NOT COMPLETED|Overall Study||0
10050856|NCT02033889|11176108|FG000|STARTED|Overall Study||209
10050857|NCT02033889|11176109|FG001|STARTED|Overall Study||207
10050858|NCT02033889|11176110|FG002|STARTED|Overall Study||205
10050859|NCT02033889|11176108|FG000|COMPLETED|Overall Study||175
10050860|NCT02033889|11176109|FG001|COMPLETED|Overall Study||187
10050861|NCT02033889|11176110|FG002|COMPLETED|Overall Study||180
10050862|NCT02033889|11176108|FG000|NOT COMPLETED|Overall Study||34
10050863|NCT02033889|11176109|FG001|NOT COMPLETED|Overall Study||20
10050864|NCT02033889|11176110|FG002|NOT COMPLETED|Overall Study||25
10050865|NCT02033993|11176120|FG000|STARTED|Overall Study||99
10050866|NCT02033993|11176121|FG001|STARTED|Overall Study||100
10050867|NCT02033993|11176120|FG000|COMPLETED|Overall Study||96
10050868|NCT02033993|11176121|FG001|COMPLETED|Overall Study||91
10050869|NCT02033993|11176120|FG000|NOT COMPLETED|Overall Study||3
10050870|NCT02033993|11176121|FG001|NOT COMPLETED|Overall Study||9
10050871|NCT02034006|11176129|FG000|STARTED|Overall Study||200
10050872|NCT02034006|11176129|FG000|Once Treated Patients|Overall Study||70
10118409|NCT02547233|11249321|FG000|COMPLETED|12-month Follow-up||185
10118410|NCT02547233|11249322|FG001|COMPLETED|12-month Follow-up||67
10118411|NCT02547233|11249321|FG000|NOT COMPLETED|12-month Follow-up||14
10118412|NCT02547233|11249322|FG001|NOT COMPLETED|12-month Follow-up||17
10118413|NCT02547363|11249332|FG000|STARTED|3-day Treatment and 8-week Follow-up||211
10118414|NCT02547363|11249333|FG001|STARTED|3-day Treatment and 8-week Follow-up||105
10118415|NCT02547363|11249332|FG000|Treated|3-day Treatment and 8-week Follow-up||209
10118416|NCT02547363|11249333|FG001|Treated|3-day Treatment and 8-week Follow-up||104
10118417|NCT02547363|11249332|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
10118418|NCT02547363|11249333|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94
10118419|NCT02547363|11249332|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
10118420|NCT02547363|11249333|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
10118421|NCT02547363|11249332|FG000|STARTED|12-month Follow-up||204
10118422|NCT02547363|11249333|FG001|STARTED|12-month Follow-up||86
10118423|NCT02547363|11249332|FG000|COMPLETED|12-month Follow-up||194
10118424|NCT02547363|11249333|FG001|COMPLETED|12-month Follow-up||81
10118425|NCT02547363|11249332|FG000|NOT COMPLETED|12-month Follow-up||10
10118426|NCT02547363|11249333|FG001|NOT COMPLETED|12-month Follow-up||5
10118427|NCT02547428|11249343|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42
10118428|NCT02547428|11249344|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43
10118429|NCT02547428|11249343|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42
10118430|NCT02547428|11249344|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43
10118431|NCT02547428|11249343|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31
10118432|NCT02547428|11249344|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37
10118433|NCT02547428|11249343|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11
10118434|NCT02547428|11249344|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6
10118435|NCT02547428|11249343|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31
10118436|NCT02547428|11249344|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37
10118437|NCT02547428|11249343|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
10118438|NCT02547428|11249344|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
10118439|NCT02547428|11249343|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1
10118440|NCT02547428|11249344|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7
10118441|NCT02547454|11249357|FG000|STARTED|Overall Study||393
10118442|NCT02547454|11249357|FG000|COMPLETED|Overall Study||221
10118443|NCT02547454|11249357|FG000|NOT COMPLETED|Overall Study||172
10118444|NCT02547623|11249363|FG000|STARTED|Overall Study||126
10118445|NCT02547623|11249364|FG001|STARTED|Overall Study||55
10118446|NCT02547623|11249363|FG000|COMPLETED|Overall Study||122
10118447|NCT02547623|11249364|FG001|COMPLETED|Overall Study||52
10050873|NCT02034006|11176129|FG000|Re-treated Patients|Overall Study||130
10050874|NCT02034006|11176129|FG000|COMPLETED|Overall Study||186
10050875|NCT02034006|11176129|FG000|NOT COMPLETED|Overall Study||14
10050876|NCT02034019|11176138|FG000|STARTED|Overall Study||164
10050877|NCT02034019|11176139|FG001|STARTED|Overall Study||83
10050878|NCT02034019|11176138|FG000|COMPLETED|Overall Study||163
10050879|NCT02034019|11176139|FG001|COMPLETED|Overall Study||81
10050880|NCT02034019|11176138|FG000|NOT COMPLETED|Overall Study||1
10050881|NCT02034019|11176139|FG001|NOT COMPLETED|Overall Study||2
10050882|NCT02034058|11176145|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
10050883|NCT02034058|11176145|FG000|COMPLETED|Overall Study||149
10050884|NCT02034058|11176145|FG000|NOT COMPLETED|Overall Study||3
10050885|NCT02034162|11176151|FG000|STARTED|Double-blind||146
10050886|NCT02034162|11176152|FG001|STARTED|Double-blind||149
10050887|NCT02034162|11176153|FG002|STARTED|Double-blind||0
10050888|NCT02034162|11176151|FG000|COMPLETED|Double-blind||137
10050889|NCT02034162|11176152|FG001|COMPLETED|Double-blind||141
10050890|NCT02034162|11176153|FG002|COMPLETED|Double-blind||0
10050891|NCT02034162|11176151|FG000|NOT COMPLETED|Double-blind||9
10050892|NCT02034162|11176152|FG001|NOT COMPLETED|Double-blind||8
10050893|NCT02034162|11176153|FG002|NOT COMPLETED|Double-blind||0
10050894|NCT02034162|11176151|FG000|STARTED|Open-label||0
10050895|NCT02034162|11176152|FG001|STARTED|Open-label||0
10050896|NCT02034162|11176153|FG002|STARTED|Open-label||278
10050897|NCT02034162|11176151|FG000|COMPLETED|Open-label||0
10050898|NCT02034162|11176152|FG001|COMPLETED|Open-label||0
10050899|NCT02034162|11176153|FG002|COMPLETED|Open-label||278
10050900|NCT02034162|11176151|FG000|NOT COMPLETED|Open-label||0
10050901|NCT02034162|11176152|FG001|NOT COMPLETED|Open-label||0
10050902|NCT02034162|11176153|FG002|NOT COMPLETED|Open-label||0
10050903|NCT02034175|11176164|FG000|STARTED|Overall Study||190
10050904|NCT02034175|11176164|FG000|COMPLETED|Overall Study||190
10050905|NCT02034175|11176164|FG000|NOT COMPLETED|Overall Study||0
10050906|NCT02034409|11176170|FG000|STARTED|Sham Run-in Period||140
10050907|NCT02034409|11176171|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
10050908|NCT02034409|11176170|FG000|COMPLETED|Sham Run-in Period||136
10050909|NCT02034409|11176171|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
10050910|NCT02034409|11176170|FG000|NOT COMPLETED|Sham Run-in Period||4
10050911|NCT02034409|11176171|FG001|NOT COMPLETED|Sham Run-in Period||0
10050912|NCT02034409|11176170|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67
10050913|NCT02034409|11176171|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69
10050914|NCT02034409|11176170|FG000|COMPLETED|Sham-Controlled Treatment Period||55
10050915|NCT02034409|11176171|FG001|COMPLETED|Sham-Controlled Treatment Period||54
10050916|NCT02034409|11176170|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12
10050917|NCT02034409|11176171|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15
10050918|NCT02034435|11176179|FG000|STARTED|Overall Study||13
10050919|NCT02034435|11176180|FG001|STARTED|Overall Study||15
10050920|NCT02034435|11176181|FG002|STARTED|Overall Study||7
10050921|NCT02034435|11176182|FG003|STARTED|Overall Study||9
10050922|NCT02034435|11176179|FG000|Aim 1|Overall Study||13
10050923|NCT02034435|11176180|FG001|Aim 1|Overall Study||15
10050924|NCT02034435|11176181|FG002|Aim 1|Overall Study||0
10050925|NCT02034435|11176182|FG003|Aim 1|Overall Study||0
10050926|NCT02034435|11176179|FG000|Aim 2|Overall Study||0
10050927|NCT02034435|11176180|FG001|Aim 2|Overall Study||0
10050928|NCT02034435|11176181|FG002|Aim 2|Overall Study||7
10050929|NCT02034435|11176182|FG003|Aim 2|Overall Study||9
10050930|NCT02034435|11176179|FG000|COMPLETED|Overall Study||11
10050931|NCT02034435|11176180|FG001|COMPLETED|Overall Study||13
10050932|NCT02034435|11176181|FG002|COMPLETED|Overall Study||7
10050933|NCT02034435|11176182|FG003|COMPLETED|Overall Study||8
10050934|NCT02034435|11176179|FG000|NOT COMPLETED|Overall Study||2
10050935|NCT02034435|11176180|FG001|NOT COMPLETED|Overall Study||2
10050936|NCT02034435|11176181|FG002|NOT COMPLETED|Overall Study||0
10050937|NCT02034435|11176182|FG003|NOT COMPLETED|Overall Study||1
10050938|NCT02034474|11176194|FG000|STARTED|Overall Study||19
10050939|NCT02034474|11176195|FG001|STARTED|Overall Study||17
10050940|NCT02034474|11176194|FG000|1 Dose|Overall Study||2
10050941|NCT02034474|11176195|FG001|1 Dose|Overall Study||4
10050942|NCT02034474|11176194|FG000|2 Doses|Overall Study||2
10050943|NCT02034474|11176195|FG001|2 Doses|Overall Study||0
10050944|NCT02034474|11176194|FG000|3 Doses|Overall Study||15
10050945|NCT02034474|11176195|FG001|3 Doses|Overall Study||13
9848641|NCT00860743|10961388|FG001|COMPLETED|Overall Study||23
9848642|NCT00860743|10961387|FG000|NOT COMPLETED|Overall Study||3
9848643|NCT00860743|10961388|FG001|NOT COMPLETED|Overall Study||0
10050946|NCT02034474|11176194|FG000|COMPLETED|Overall Study||15
10050947|NCT02034474|11176195|FG001|COMPLETED|Overall Study||13
10050948|NCT02034474|11176194|FG000|NOT COMPLETED|Overall Study||4
10050949|NCT02034474|11176195|FG001|NOT COMPLETED|Overall Study||4
10050950|NCT02034513|11176205|FG000|STARTED|Overall Study||249
10050951|NCT02034513|11176206|FG001|STARTED|Overall Study||252
10050952|NCT02034513|11176205|FG000|Exposed|Overall Study||249
10050953|NCT02034513|11176206|FG001|Exposed|Overall Study||251
10050954|NCT02034513|11176205|FG000|COMPLETED|Overall Study||200
10050955|NCT02034513|11176206|FG001|COMPLETED|Overall Study||195
10050956|NCT02034513|11176205|FG000|NOT COMPLETED|Overall Study||49
10050957|NCT02034513|11176206|FG001|NOT COMPLETED|Overall Study||57
10050958|NCT02034552|11176217|FG000|STARTED|Overall Study||22
10050959|NCT02034552|11176218|FG001|STARTED|Overall Study||24
10050960|NCT02034552|11176219|FG002|STARTED|Overall Study||22
10050961|NCT02034552|11176217|FG000|Received Treatment|Overall Study||19
10050962|NCT02034552|11176218|FG001|Received Treatment|Overall Study||22
10050963|NCT02034552|11176219|FG002|Received Treatment|Overall Study||22
10050964|NCT02034552|11176217|FG000|COMPLETED|Overall Study||8
10050965|NCT02034552|11176218|FG001|COMPLETED|Overall Study||4
10050966|NCT02034552|11176219|FG002|COMPLETED|Overall Study||5
10050967|NCT02034552|11176217|FG000|NOT COMPLETED|Overall Study||14
10050968|NCT02034552|11176218|FG001|NOT COMPLETED|Overall Study||20
10050969|NCT02034552|11176219|FG002|NOT COMPLETED|Overall Study||17
10050970|NCT02034565|11176227|FG000|STARTED|Overall Study||7
10050971|NCT02034565|11176228|FG001|STARTED|Overall Study||7
10050972|NCT02034565|11176227|FG000|COMPLETED|Overall Study||6
10050973|NCT02034565|11176228|FG001|COMPLETED|Overall Study||7
10050974|NCT02034565|11176227|FG000|NOT COMPLETED|Overall Study||1
10050975|NCT02034565|11176228|FG001|NOT COMPLETED|Overall Study||0
10050976|NCT02034578|11176236|FG000|STARTED|Overall Study||4
10050977|NCT02034578|11176237|FG001|STARTED|Overall Study||3
10050978|NCT02034578|11176238|FG002|STARTED|Overall Study||4
10050979|NCT02034578|11176239|FG003|STARTED|Overall Study||3
10050980|NCT02034578|11176240|FG004|STARTED|Overall Study||4
10050981|NCT02034578|11176241|FG005|STARTED|Overall Study||3
10050982|NCT02034578|11176236|FG000|COMPLETED|Overall Study||4
10050983|NCT02034578|11176237|FG001|COMPLETED|Overall Study||3
10050984|NCT02034578|11176238|FG002|COMPLETED|Overall Study||4
10050985|NCT02034578|11176239|FG003|COMPLETED|Overall Study||3
10050986|NCT02034578|11176240|FG004|COMPLETED|Overall Study||4
10050987|NCT02034578|11176241|FG005|COMPLETED|Overall Study||3
10050988|NCT02034578|11176236|FG000|NOT COMPLETED|Overall Study||0
10050989|NCT02034578|11176237|FG001|NOT COMPLETED|Overall Study||0
10050990|NCT02034578|11176238|FG002|NOT COMPLETED|Overall Study||0
10050991|NCT02034578|11176239|FG003|NOT COMPLETED|Overall Study||0
10050992|NCT02034578|11176240|FG004|NOT COMPLETED|Overall Study||0
10050993|NCT02034578|11176241|FG005|NOT COMPLETED|Overall Study||0
10050994|NCT02034591|11176250|FG000|STARTED|Overall Study||4
10050995|NCT02034591|11176251|FG001|STARTED|Overall Study||3
10050996|NCT02034591|11176252|FG002|STARTED|Overall Study||4
10050997|NCT02034591|11176253|FG003|STARTED|Overall Study||3
10050998|NCT02034591|11176254|FG004|STARTED|Overall Study||4
10050999|NCT02034591|11176255|FG005|STARTED|Overall Study||3
10051000|NCT02034591|11176250|FG000|COMPLETED|Overall Study||4
10051001|NCT02034591|11176251|FG001|COMPLETED|Overall Study||3
10051002|NCT02034591|11176252|FG002|COMPLETED|Overall Study||4
10051003|NCT02034591|11176253|FG003|COMPLETED|Overall Study||3
10051004|NCT02034591|11176254|FG004|COMPLETED|Overall Study||3
10051005|NCT02034591|11176255|FG005|COMPLETED|Overall Study||3
10051006|NCT02034591|11176250|FG000|NOT COMPLETED|Overall Study||0
10051007|NCT02034591|11176251|FG001|NOT COMPLETED|Overall Study||0
10051008|NCT02034591|11176252|FG002|NOT COMPLETED|Overall Study||0
10051009|NCT02034591|11176253|FG003|NOT COMPLETED|Overall Study||0
10051010|NCT02034591|11176254|FG004|NOT COMPLETED|Overall Study||1
10051011|NCT02034591|11176255|FG005|NOT COMPLETED|Overall Study||0
10051012|NCT02034708|11176266|FG000|STARTED|First Contrast Agent Injection (1 Day)||138
10051013|NCT02034708|11176267|FG001|STARTED|First Contrast Agent Injection (1 Day)||130
10051014|NCT02034708|11176266|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138
10051015|NCT02034708|11176267|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130
10051016|NCT02034708|11176266|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
10051017|NCT02034708|11176267|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
10051018|NCT02034708|11176266|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138
10051019|NCT02034708|11176267|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130
10051020|NCT02034708|11176266|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
10051021|NCT02034708|11176267|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
10051022|NCT02034708|11176266|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
10051023|NCT02034708|11176267|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
10051024|NCT02034708|11176266|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129
10051025|NCT02034708|11176267|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120
10051026|NCT02034708|11176266|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129
10051027|NCT02034708|11176267|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120
10051028|NCT02034708|11176266|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
10051029|NCT02034708|11176267|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
10051030|NCT02034799|11176280|FG000|STARTED|Overall Study||129
10051031|NCT02034799|11176281|FG001|STARTED|Overall Study||127
10051032|NCT02034799|11176280|FG000|COMPLETED|Overall Study||127
10051033|NCT02034799|11176281|FG001|COMPLETED|Overall Study||123
10051034|NCT02034799|11176280|FG000|NOT COMPLETED|Overall Study||2
10051035|NCT02034799|11176281|FG001|NOT COMPLETED|Overall Study||4
10051036|NCT02034877|11176289|FG000|STARTED|Overall Study||200
10051037|NCT02034877|11176290|FG001|STARTED|Overall Study||999
10051038|NCT02034877|11176289|FG000|COMPLETED|Overall Study||200
10051039|NCT02034877|11176290|FG001|COMPLETED|Overall Study||993
10051040|NCT02034877|11176289|FG000|NOT COMPLETED|Overall Study||0
10051041|NCT02034877|11176290|FG001|NOT COMPLETED|Overall Study||6
10051042|NCT02034916|11176298|FG000|STARTED|Overall Study||49
10051043|NCT02034916|11176299|FG001|STARTED|Overall Study||35
10051044|NCT02034916|11176298|FG000|Treated|Overall Study||48
10051045|NCT02034916|11176299|FG001|Treated|Overall Study||35
10051046|NCT02034916|11176298|FG000|COMPLETED|Overall Study||0
10051047|NCT02034916|11176299|FG001|COMPLETED|Overall Study||0
10051048|NCT02034916|11176298|FG000|NOT COMPLETED|Overall Study||49
10051049|NCT02034916|11176299|FG001|NOT COMPLETED|Overall Study||35
10051050|NCT02035202|11176309|FG000|STARTED|Overall Study||85
10051051|NCT02035202|11176310|FG001|STARTED|Overall Study||85
10051052|NCT02035202|11176311|FG002|STARTED|Overall Study||85
10051053|NCT02035202|11176309|FG000|COMPLETED|Overall Study||77
10051054|NCT02035202|11176310|FG001|COMPLETED|Overall Study||69
10051055|NCT02035202|11176311|FG002|COMPLETED|Overall Study||83
10051056|NCT02035202|11176309|FG000|NOT COMPLETED|Overall Study||8
10051057|NCT02035202|11176310|FG001|NOT COMPLETED|Overall Study||16
10051058|NCT02035202|11176311|FG002|NOT COMPLETED|Overall Study||2
10051059|NCT02035267|11176323|FG000|STARTED|Overall Study||31
10051060|NCT02035267|11176324|FG001|STARTED|Overall Study||16
10051061|NCT02035267|11176325|FG002|STARTED|Overall Study||30
10051062|NCT02035267|11176326|FG003|STARTED|Overall Study||16
10051063|NCT02035267|11176323|FG000|COMPLETED|Overall Study||31
10051064|NCT02035267|11176324|FG001|COMPLETED|Overall Study||15
10051065|NCT02035267|11176325|FG002|COMPLETED|Overall Study||28
10051066|NCT02035267|11176326|FG003|COMPLETED|Overall Study||15
10051067|NCT02035267|11176323|FG000|NOT COMPLETED|Overall Study||0
10051068|NCT02035267|11176324|FG001|NOT COMPLETED|Overall Study||1
10051069|NCT02035267|11176325|FG002|NOT COMPLETED|Overall Study||2
10051070|NCT02035267|11176326|FG003|NOT COMPLETED|Overall Study||1
10051071|NCT02035332|11176338|FG000|STARTED|Overall Study|Treatment Attempted|21
10051072|NCT02035332|11176338|FG000|Treated|Overall Study|Treatment Completed|20
10051073|NCT02035332|11176338|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
10051074|NCT02035332|11176338|FG000|NOT COMPLETED|Overall Study||1
10051075|NCT02035345|11176342|FG000|STARTED|Overall Study||15
10051076|NCT02035345|11176342|FG000|COMPLETED|Overall Study||15
10051077|NCT02035345|11176342|FG000|NOT COMPLETED|Overall Study||0
10051078|NCT02035475|11176347|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
10051079|NCT02035475|11176347|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
10051080|NCT02035475|11176347|FG000|NOT COMPLETED|Overall Study||6
10051081|NCT02035553|11176355|FG000|STARTED|Overall Study||91
10051082|NCT02035553|11176356|FG001|STARTED|Overall Study||90
10051083|NCT02035553|11176355|FG000|COMPLETED|Overall Study||73
10051084|NCT02035553|11176356|FG001|COMPLETED|Overall Study||67
10051085|NCT02035553|11176355|FG000|NOT COMPLETED|Overall Study||18
10051086|NCT02035553|11176356|FG001|NOT COMPLETED|Overall Study||23
10051087|NCT02035696|11176366|FG000|STARTED|Overall Study||174
10051088|NCT02035696|11176367|FG001|STARTED|Overall Study||166
10051089|NCT02035696|11176368|FG002|STARTED|Overall Study||167
10051090|NCT02035696|11176369|FG003|STARTED|Overall Study||164
10051091|NCT02035696|11176366|FG000|COMPLETED|Overall Study||171
10051092|NCT02035696|11176367|FG001|COMPLETED|Overall Study||163
10051093|NCT02035696|11176368|FG002|COMPLETED|Overall Study||164
10051094|NCT02035696|11176369|FG003|COMPLETED|Overall Study||161
10051095|NCT02035696|11176366|FG000|NOT COMPLETED|Overall Study||3
10051096|NCT02035696|11176367|FG001|NOT COMPLETED|Overall Study||3
10051097|NCT02035696|11176368|FG002|NOT COMPLETED|Overall Study||3
10051098|NCT02035696|11176369|FG003|NOT COMPLETED|Overall Study||3
10051099|NCT02035748|11176383|FG000|STARTED|Overall Study||468
10051100|NCT02035748|11176383|FG000|COMPLETED|Overall Study||448
10051101|NCT02035748|11176383|FG000|NOT COMPLETED|Overall Study||20
10051102|NCT02036294|11176390|FG000|STARTED|Overall Study||120
10051103|NCT02036294|11176391|FG001|STARTED|Overall Study||120
10051104|NCT02036294|11176390|FG000|COMPLETED|Overall Study||111
10051105|NCT02036294|11176391|FG001|COMPLETED|Overall Study||109
10051106|NCT02036294|11176390|FG000|NOT COMPLETED|Overall Study||9
10051107|NCT02036294|11176391|FG001|NOT COMPLETED|Overall Study||11
10051108|NCT02036320|11176397|FG000|STARTED|Period 1||95
10051109|NCT02036320|11176398|FG001|STARTED|Period 1||95
10051110|NCT02036320|11176397|FG000|COMPLETED|Period 1||95
10051111|NCT02036320|11176398|FG001|COMPLETED|Period 1||95
10051112|NCT02036320|11176397|FG000|NOT COMPLETED|Period 1||0
10051113|NCT02036320|11176398|FG001|NOT COMPLETED|Period 1||0
10051114|NCT02036320|11176397|FG000|STARTED|Period 2||95
10051115|NCT02036320|11176398|FG001|STARTED|Period 2||95
10051116|NCT02036320|11176397|FG000|COMPLETED|Period 2||95
10051117|NCT02036320|11176398|FG001|COMPLETED|Period 2||95
10051118|NCT02036320|11176397|FG000|NOT COMPLETED|Period 2||0
10051119|NCT02036320|11176398|FG001|NOT COMPLETED|Period 2||0
10051120|NCT02036424|11176406|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23
10051121|NCT02036424|11176407|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27
10051122|NCT02036424|11176406|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
10051123|NCT02036424|11176407|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
10051124|NCT02036424|11176406|FG000|NOT COMPLETED|Overall Study||0
10051125|NCT02036424|11176407|FG001|NOT COMPLETED|Overall Study||0
10051126|NCT02036502|11176421|FG000|STARTED|Part 1:Dose Determination/Escalation||6
10051127|NCT02036502|11176422|FG001|STARTED|Part 1:Dose Determination/Escalation||4
10051128|NCT02036502|11176423|FG002|STARTED|Part 1:Dose Determination/Escalation||0
10051129|NCT02036502|11176424|FG003|STARTED|Part 1:Dose Determination/Escalation||0
10051130|NCT02036502|11176425|FG004|STARTED|Part 1:Dose Determination/Escalation||0
10051131|NCT02036502|11176426|FG005|STARTED|Part 1:Dose Determination/Escalation||0
10051132|NCT02036502|11176427|FG006|STARTED|Part 1:Dose Determination/Escalation||0
10051133|NCT02036502|11176428|FG007|STARTED|Part 1:Dose Determination/Escalation||0
10051134|NCT02036502|11176421|FG000|Treated|Part 1:Dose Determination/Escalation||6
10051135|NCT02036502|11176422|FG001|Treated|Part 1:Dose Determination/Escalation||3
10051136|NCT02036502|11176423|FG002|Treated|Part 1:Dose Determination/Escalation||0
10051137|NCT02036502|11176424|FG003|Treated|Part 1:Dose Determination/Escalation||0
10051138|NCT02036502|11176425|FG004|Treated|Part 1:Dose Determination/Escalation||0
10051139|NCT02036502|11176426|FG005|Treated|Part 1:Dose Determination/Escalation||0
10051140|NCT02036502|11176427|FG006|Treated|Part 1:Dose Determination/Escalation||0
10051141|NCT02036502|11176428|FG007|Treated|Part 1:Dose Determination/Escalation||0
10051142|NCT02036502|11176421|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0
10051143|NCT02036502|11176422|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0
10051144|NCT02036502|11176423|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0
10051145|NCT02036502|11176424|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0
10051146|NCT02036502|11176425|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0
10051147|NCT02036502|11176426|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0
10051148|NCT02036502|11176427|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0
10051149|NCT02036502|11176428|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0
10051150|NCT02036502|11176421|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
10051151|NCT02036502|11176422|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
10051152|NCT02036502|11176423|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10051153|NCT02036502|11176424|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10051154|NCT02036502|11176425|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10051155|NCT02036502|11176426|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10051156|NCT02036502|11176427|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10051157|NCT02036502|11176428|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10051158|NCT02036502|11176421|FG000|STARTED|Part 2:Dose Confirmation||0
10051159|NCT02036502|11176422|FG001|STARTED|Part 2:Dose Confirmation||0
10051160|NCT02036502|11176423|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
10051161|NCT02036502|11176424|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
10051162|NCT02036502|11176425|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
10051163|NCT02036502|11176426|FG005|STARTED|Part 2:Dose Confirmation||0
10051164|NCT02036502|11176427|FG006|STARTED|Part 2:Dose Confirmation||0
10051165|NCT02036502|11176428|FG007|STARTED|Part 2:Dose Confirmation||0
10051166|NCT02036502|11176421|FG000|Treated|Part 2:Dose Confirmation||0
10051167|NCT02036502|11176422|FG001|Treated|Part 2:Dose Confirmation||0
10051168|NCT02036502|11176423|FG002|Treated|Part 2:Dose Confirmation||6
10051169|NCT02036502|11176424|FG003|Treated|Part 2:Dose Confirmation||1
10051170|NCT02036502|11176425|FG004|Treated|Part 2:Dose Confirmation||1
10051171|NCT02036502|11176426|FG005|Treated|Part 2:Dose Confirmation||0
10051172|NCT02036502|11176427|FG006|Treated|Part 2:Dose Confirmation||0
10051173|NCT02036502|11176428|FG007|Treated|Part 2:Dose Confirmation||0
10051174|NCT02036502|11176421|FG000|COMPLETED|Part 2:Dose Confirmation||0
10051175|NCT02036502|11176422|FG001|COMPLETED|Part 2:Dose Confirmation||0
10051176|NCT02036502|11176423|FG002|COMPLETED|Part 2:Dose Confirmation||0
10051177|NCT02036502|11176424|FG003|COMPLETED|Part 2:Dose Confirmation||0
10051178|NCT02036502|11176425|FG004|COMPLETED|Part 2:Dose Confirmation||0
10051179|NCT02036502|11176426|FG005|COMPLETED|Part 2:Dose Confirmation||0
10051180|NCT02036502|11176427|FG006|COMPLETED|Part 2:Dose Confirmation||0
10051181|NCT02036502|11176428|FG007|COMPLETED|Part 2:Dose Confirmation||0
10051182|NCT02036502|11176421|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0
10051183|NCT02036502|11176422|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0
10051184|NCT02036502|11176423|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6
10051185|NCT02036502|11176424|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2
10051186|NCT02036502|11176425|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1
10051187|NCT02036502|11176426|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0
10051188|NCT02036502|11176427|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0
10051189|NCT02036502|11176428|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0
10051190|NCT02036502|11176421|FG000|STARTED|Part 3:Dose Expansion||0
10051191|NCT02036502|11176422|FG001|STARTED|Part 3:Dose Expansion||0
10051192|NCT02036502|11176423|FG002|STARTED|Part 3:Dose Expansion||0
10051193|NCT02036502|11176424|FG003|STARTED|Part 3:Dose Expansion||0
10051194|NCT02036502|11176425|FG004|STARTED|Part 3:Dose Expansion||0
10051195|NCT02036502|11176426|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
10051196|NCT02036502|11176427|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
10051197|NCT02036502|11176428|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
10051198|NCT02036502|11176421|FG000|Treated|Part 3:Dose Expansion||0
10051199|NCT02036502|11176422|FG001|Treated|Part 3:Dose Expansion||0
10051200|NCT02036502|11176423|FG002|Treated|Part 3:Dose Expansion||0
10051201|NCT02036502|11176424|FG003|Treated|Part 3:Dose Expansion||0
10051202|NCT02036502|11176425|FG004|Treated|Part 3:Dose Expansion||0
10051203|NCT02036502|11176426|FG005|Treated|Part 3:Dose Expansion||45
10051204|NCT02036502|11176427|FG006|Treated|Part 3:Dose Expansion||1
10051205|NCT02036502|11176428|FG007|Treated|Part 3:Dose Expansion||10
10051206|NCT02036502|11176421|FG000|COMPLETED|Part 3:Dose Expansion||0
10118448|NCT02547623|11249363|FG000|NOT COMPLETED|Overall Study||4
10051207|NCT02036502|11176422|FG001|COMPLETED|Part 3:Dose Expansion||0
10051208|NCT02036502|11176423|FG002|COMPLETED|Part 3:Dose Expansion||0
10051209|NCT02036502|11176424|FG003|COMPLETED|Part 3:Dose Expansion||0
10051210|NCT02036502|11176425|FG004|COMPLETED|Part 3:Dose Expansion||0
10051211|NCT02036502|11176426|FG005|COMPLETED|Part 3:Dose Expansion||0
10051212|NCT02036502|11176427|FG006|COMPLETED|Part 3:Dose Expansion||0
10051213|NCT02036502|11176428|FG007|COMPLETED|Part 3:Dose Expansion||0
10051214|NCT02036502|11176421|FG000|NOT COMPLETED|Part 3:Dose Expansion||0
10051215|NCT02036502|11176422|FG001|NOT COMPLETED|Part 3:Dose Expansion||0
10051216|NCT02036502|11176423|FG002|NOT COMPLETED|Part 3:Dose Expansion||0
10051217|NCT02036502|11176424|FG003|NOT COMPLETED|Part 3:Dose Expansion||0
10051218|NCT02036502|11176425|FG004|NOT COMPLETED|Part 3:Dose Expansion||0
10051219|NCT02036502|11176426|FG005|NOT COMPLETED|Part 3:Dose Expansion||47
10051220|NCT02036502|11176427|FG006|NOT COMPLETED|Part 3:Dose Expansion||1
10051221|NCT02036502|11176428|FG007|NOT COMPLETED|Part 3:Dose Expansion||10
10051222|NCT02036515|11176451|FG000|STARTED|Overall Study||156
10051223|NCT02036515|11176452|FG001|STARTED|Overall Study||155
10051224|NCT02036515|11176453|FG002|STARTED|Overall Study||153
10051225|NCT02036515|11176451|FG000|Treated|Overall Study||156
10051226|NCT02036515|11176452|FG001|Treated|Overall Study||153
10051227|NCT02036515|11176453|FG002|Treated|Overall Study||153
10051228|NCT02036515|11176451|FG000|COMPLETED|Overall Study||151
10051229|NCT02036515|11176452|FG001|COMPLETED|Overall Study||143
10051230|NCT02036515|11176453|FG002|COMPLETED|Overall Study||139
10051231|NCT02036515|11176451|FG000|NOT COMPLETED|Overall Study||5
10051232|NCT02036515|11176452|FG001|NOT COMPLETED|Overall Study||12
10051233|NCT02036515|11176453|FG002|NOT COMPLETED|Overall Study||14
10051234|NCT02036541|11176461|FG000|STARTED|Overall Study||65
10051235|NCT02036541|11176461|FG000|Completed Endpoint Visit|Overall Study||54
10051236|NCT02036541|11176461|FG000|COMPLETED|Overall Study||49
10051237|NCT02036541|11176461|FG000|NOT COMPLETED|Overall Study||16
10051238|NCT02036580|11176468|FG000|STARTED|Overall Study||8
10051239|NCT02036580|11176469|FG001|STARTED|Overall Study||8
10051240|NCT02036580|11176470|FG002|STARTED|Overall Study||4
10051241|NCT02036580|11176468|FG000|COMPLETED|Overall Study||7
10051242|NCT02036580|11176469|FG001|COMPLETED|Overall Study||7
10051243|NCT02036580|11176470|FG002|COMPLETED|Overall Study||4
10051244|NCT02036580|11176468|FG000|NOT COMPLETED|Overall Study||1
10051245|NCT02036580|11176469|FG001|NOT COMPLETED|Overall Study||1
10051246|NCT02036580|11176470|FG002|NOT COMPLETED|Overall Study||0
10051247|NCT02036645|11176490|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
10051248|NCT02036645|11176491|FG001|STARTED|SAD Cohorts : Study Part 1||3
10051249|NCT02036645|11176492|FG002|STARTED|SAD Cohorts : Study Part 1||6
10051250|NCT02036645|11176493|FG003|STARTED|SAD Cohorts : Study Part 1||6
10051251|NCT02036645|11176494|FG004|STARTED|SAD Cohorts : Study Part 1||6
10051252|NCT02036645|11176495|FG005|STARTED|SAD Cohorts : Study Part 1||6
10051253|NCT02036645|11176496|FG006|STARTED|SAD Cohorts : Study Part 1||6
10051254|NCT02036645|11176497|FG007|STARTED|SAD Cohorts : Study Part 1||0
10051255|NCT02036645|11176498|FG008|STARTED|SAD Cohorts : Study Part 1||0
10051256|NCT02036645|11176499|FG009|STARTED|SAD Cohorts : Study Part 1||0
10051257|NCT02036645|11176500|FG010|STARTED|SAD Cohorts : Study Part 1||0
10051258|NCT02036645|11176501|FG011|STARTED|SAD Cohorts : Study Part 1||0
10051259|NCT02036645|11176490|FG000|COMPLETED|SAD Cohorts : Study Part 1||12
10051260|NCT02036645|11176491|FG001|COMPLETED|SAD Cohorts : Study Part 1||3
10051261|NCT02036645|11176492|FG002|COMPLETED|SAD Cohorts : Study Part 1||6
10051262|NCT02036645|11176493|FG003|COMPLETED|SAD Cohorts : Study Part 1||5
10051263|NCT02036645|11176494|FG004|COMPLETED|SAD Cohorts : Study Part 1||6
10051264|NCT02036645|11176495|FG005|COMPLETED|SAD Cohorts : Study Part 1||6
10051265|NCT02036645|11176496|FG006|COMPLETED|SAD Cohorts : Study Part 1||5
10051266|NCT02036645|11176497|FG007|COMPLETED|SAD Cohorts : Study Part 1||0
10051267|NCT02036645|11176498|FG008|COMPLETED|SAD Cohorts : Study Part 1||0
10051268|NCT02036645|11176499|FG009|COMPLETED|SAD Cohorts : Study Part 1||0
10051269|NCT02036645|11176500|FG010|COMPLETED|SAD Cohorts : Study Part 1||0
10051270|NCT02036645|11176501|FG011|COMPLETED|SAD Cohorts : Study Part 1||0
10051271|NCT02036645|11176490|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051272|NCT02036645|11176491|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051273|NCT02036645|11176492|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051274|NCT02036645|11176493|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1
10051275|NCT02036645|11176494|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051276|NCT02036645|11176495|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051277|NCT02036645|11176496|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1
10051278|NCT02036645|11176497|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051279|NCT02036645|11176498|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051280|NCT02036645|11176499|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051281|NCT02036645|11176500|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051282|NCT02036645|11176501|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10051283|NCT02036645|11176490|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
10051284|NCT02036645|11176491|FG001|STARTED|MAD Cohorts: Study Part 2||0
10051285|NCT02036645|11176492|FG002|STARTED|MAD Cohorts: Study Part 2||0
10051286|NCT02036645|11176493|FG003|STARTED|MAD Cohorts: Study Part 2||0
10051287|NCT02036645|11176494|FG004|STARTED|MAD Cohorts: Study Part 2||0
10051288|NCT02036645|11176495|FG005|STARTED|MAD Cohorts: Study Part 2||0
10051289|NCT02036645|11176496|FG006|STARTED|MAD Cohorts: Study Part 2||0
10051290|NCT02036645|11176497|FG007|STARTED|MAD Cohorts: Study Part 2||8
10051291|NCT02036645|11176498|FG008|STARTED|MAD Cohorts: Study Part 2||6
10118449|NCT02547623|11249364|FG001|NOT COMPLETED|Overall Study||3
10118450|NCT02547649|11249373|FG000|STARTED|Overall Study||231
10118451|NCT02547649|11249374|FG001|STARTED|Overall Study||231
10118452|NCT02547649|11249375|FG002|STARTED|Overall Study||228
10051292|NCT02036645|11176499|FG009|STARTED|MAD Cohorts: Study Part 2||6
10051293|NCT02036645|11176500|FG010|STARTED|MAD Cohorts: Study Part 2||6
10051294|NCT02036645|11176501|FG011|STARTED|MAD Cohorts: Study Part 2||6
10051295|NCT02036645|11176490|FG000|COMPLETED|MAD Cohorts: Study Part 2||0
10051296|NCT02036645|11176491|FG001|COMPLETED|MAD Cohorts: Study Part 2||0
10051297|NCT02036645|11176492|FG002|COMPLETED|MAD Cohorts: Study Part 2||0
10051298|NCT02036645|11176493|FG003|COMPLETED|MAD Cohorts: Study Part 2||0
10051299|NCT02036645|11176494|FG004|COMPLETED|MAD Cohorts: Study Part 2||0
10051300|NCT02036645|11176495|FG005|COMPLETED|MAD Cohorts: Study Part 2||0
10051301|NCT02036645|11176496|FG006|COMPLETED|MAD Cohorts: Study Part 2||0
10051302|NCT02036645|11176497|FG007|COMPLETED|MAD Cohorts: Study Part 2||8
10051303|NCT02036645|11176498|FG008|COMPLETED|MAD Cohorts: Study Part 2||6
10051304|NCT02036645|11176499|FG009|COMPLETED|MAD Cohorts: Study Part 2||6
10051305|NCT02036645|11176500|FG010|COMPLETED|MAD Cohorts: Study Part 2||6
10051306|NCT02036645|11176501|FG011|COMPLETED|MAD Cohorts: Study Part 2||6
10051307|NCT02036645|11176490|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051308|NCT02036645|11176491|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051309|NCT02036645|11176492|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051310|NCT02036645|11176493|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051311|NCT02036645|11176494|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051312|NCT02036645|11176495|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051313|NCT02036645|11176496|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051314|NCT02036645|11176497|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051315|NCT02036645|11176498|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051316|NCT02036645|11176499|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051317|NCT02036645|11176500|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051318|NCT02036645|11176501|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10051319|NCT02036775|11176539|FG000|STARTED|Treatment Period 1 (6 Days)||4
10051320|NCT02036775|11176540|FG001|STARTED|Treatment Period 1 (6 Days)||4
10051321|NCT02036775|11176541|FG002|STARTED|Treatment Period 1 (6 Days)||4
10051322|NCT02036775|11176542|FG003|STARTED|Treatment Period 1 (6 Days)||4
10051323|NCT02036775|11176543|FG004|STARTED|Treatment Period 1 (6 Days)||4
10051324|NCT02036775|11176544|FG005|STARTED|Treatment Period 1 (6 Days)||4
10051325|NCT02036775|11176539|FG000|COMPLETED|Treatment Period 1 (6 Days)||4
10051326|NCT02036775|11176540|FG001|COMPLETED|Treatment Period 1 (6 Days)||4
10051327|NCT02036775|11176541|FG002|COMPLETED|Treatment Period 1 (6 Days)||4
10051328|NCT02036775|11176542|FG003|COMPLETED|Treatment Period 1 (6 Days)||4
10051329|NCT02036775|11176543|FG004|COMPLETED|Treatment Period 1 (6 Days)||4
10051330|NCT02036775|11176544|FG005|COMPLETED|Treatment Period 1 (6 Days)||4
10051331|NCT02036775|11176539|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10051332|NCT02036775|11176540|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10051333|NCT02036775|11176541|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10051334|NCT02036775|11176542|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10051335|NCT02036775|11176543|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10051336|NCT02036775|11176544|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10051337|NCT02036775|11176539|FG000|STARTED|Treatment Period 2 (6 Days)||4
10051338|NCT02036775|11176540|FG001|STARTED|Treatment Period 2 (6 Days)||4
10051339|NCT02036775|11176541|FG002|STARTED|Treatment Period 2 (6 Days)||4
10051340|NCT02036775|11176542|FG003|STARTED|Treatment Period 2 (6 Days)||4
10051341|NCT02036775|11176543|FG004|STARTED|Treatment Period 2 (6 Days)||4
10051342|NCT02036775|11176544|FG005|STARTED|Treatment Period 2 (6 Days)||4
10051343|NCT02036775|11176539|FG000|COMPLETED|Treatment Period 2 (6 Days)||4
10051344|NCT02036775|11176540|FG001|COMPLETED|Treatment Period 2 (6 Days)||4
10051345|NCT02036775|11176541|FG002|COMPLETED|Treatment Period 2 (6 Days)||4
10051346|NCT02036775|11176542|FG003|COMPLETED|Treatment Period 2 (6 Days)||4
10051347|NCT02036775|11176543|FG004|COMPLETED|Treatment Period 2 (6 Days)||4
10051348|NCT02036775|11176544|FG005|COMPLETED|Treatment Period 2 (6 Days)||3
10051349|NCT02036775|11176539|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10051350|NCT02036775|11176540|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10051351|NCT02036775|11176541|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10051352|NCT02036775|11176542|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10051353|NCT02036775|11176543|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10051354|NCT02036775|11176544|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1
10051355|NCT02036775|11176539|FG000|STARTED|Treatment Period 3 (6 Days)||4
10051356|NCT02036775|11176540|FG001|STARTED|Treatment Period 3 (6 Days)||4
10051357|NCT02036775|11176541|FG002|STARTED|Treatment Period 3 (6 Days)||4
10051358|NCT02036775|11176542|FG003|STARTED|Treatment Period 3 (6 Days)||4
10051359|NCT02036775|11176543|FG004|STARTED|Treatment Period 3 (6 Days)||4
10051360|NCT02036775|11176544|FG005|STARTED|Treatment Period 3 (6 Days)||3
10051361|NCT02036775|11176539|FG000|COMPLETED|Treatment Period 3 (6 Days)||4
10051362|NCT02036775|11176540|FG001|COMPLETED|Treatment Period 3 (6 Days)||4
10051363|NCT02036775|11176541|FG002|COMPLETED|Treatment Period 3 (6 Days)||4
10051364|NCT02036775|11176542|FG003|COMPLETED|Treatment Period 3 (6 Days)||4
10051365|NCT02036775|11176543|FG004|COMPLETED|Treatment Period 3 (6 Days)||4
10051366|NCT02036775|11176544|FG005|COMPLETED|Treatment Period 3 (6 Days)||3
10051367|NCT02036775|11176539|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10051368|NCT02036775|11176540|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10051369|NCT02036775|11176541|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10051370|NCT02036775|11176542|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10051371|NCT02036775|11176543|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10051372|NCT02036775|11176544|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10051373|NCT02036840|11176552|FG000|STARTED|Overall Study||513
10051374|NCT02036840|11176552|FG000|COMPLETED|Overall Study||513
10051375|NCT02036840|11176552|FG000|NOT COMPLETED|Overall Study||0
10051376|NCT02036853|11176558|FG000|STARTED|Overall Study||6
10051377|NCT02036853|11176559|FG001|STARTED|Overall Study||14
10051378|NCT02036853|11176558|FG000|COMPLETED|Overall Study||6
10051379|NCT02036853|11176559|FG001|COMPLETED|Overall Study||8
10051380|NCT02036853|11176558|FG000|NOT COMPLETED|Overall Study||0
10051381|NCT02036853|11176559|FG001|NOT COMPLETED|Overall Study||6
10051382|NCT02037061|11176567|FG000|STARTED|Overall Study||22
10051383|NCT02037061|11176568|FG001|STARTED|Overall Study||24
10051384|NCT02037061|11176567|FG000|COMPLETED|Overall Study||22
10051385|NCT02037061|11176568|FG001|COMPLETED|Overall Study||24
10051386|NCT02037061|11176567|FG000|NOT COMPLETED|Overall Study||0
10051387|NCT02037061|11176568|FG001|NOT COMPLETED|Overall Study||0
10051388|NCT02037165|11176581|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5
10051389|NCT02037165|11176582|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5
10051390|NCT02037165|11176583|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5
10051391|NCT02037165|11176584|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5
10051392|NCT02037165|11176585|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5
10051393|NCT02037165|11176581|FG000|COMPLETED|Period 1 (2 Days)||5
10051394|NCT02037165|11176582|FG001|COMPLETED|Period 1 (2 Days)||5
10051395|NCT02037165|11176583|FG002|COMPLETED|Period 1 (2 Days)||5
10051396|NCT02037165|11176584|FG003|COMPLETED|Period 1 (2 Days)||5
10051397|NCT02037165|11176585|FG004|COMPLETED|Period 1 (2 Days)||5
10051398|NCT02037165|11176581|FG000|NOT COMPLETED|Period 1 (2 Days)||0
10051399|NCT02037165|11176582|FG001|NOT COMPLETED|Period 1 (2 Days)||0
10051400|NCT02037165|11176583|FG002|NOT COMPLETED|Period 1 (2 Days)||0
10051401|NCT02037165|11176584|FG003|NOT COMPLETED|Period 1 (2 Days)||0
10051402|NCT02037165|11176585|FG004|NOT COMPLETED|Period 1 (2 Days)||0
10051403|NCT02037165|11176581|FG000|STARTED|Washout Period 1 (6 Days)||5
10051404|NCT02037165|11176582|FG001|STARTED|Washout Period 1 (6 Days)||5
10051405|NCT02037165|11176583|FG002|STARTED|Washout Period 1 (6 Days)||5
10051406|NCT02037165|11176584|FG003|STARTED|Washout Period 1 (6 Days)||5
10051407|NCT02037165|11176585|FG004|STARTED|Washout Period 1 (6 Days)||5
10051408|NCT02037165|11176581|FG000|COMPLETED|Washout Period 1 (6 Days)||5
10051409|NCT02037165|11176582|FG001|COMPLETED|Washout Period 1 (6 Days)||5
10051410|NCT02037165|11176583|FG002|COMPLETED|Washout Period 1 (6 Days)||5
10051411|NCT02037165|11176584|FG003|COMPLETED|Washout Period 1 (6 Days)||5
10051412|NCT02037165|11176585|FG004|COMPLETED|Washout Period 1 (6 Days)||5
10051413|NCT02037165|11176581|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0
10051414|NCT02037165|11176582|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0
10051415|NCT02037165|11176583|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0
10051416|NCT02037165|11176584|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0
10051417|NCT02037165|11176585|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0
10051418|NCT02037165|11176581|FG000|STARTED|Period 2 (2 Days)||5
10051419|NCT02037165|11176582|FG001|STARTED|Period 2 (2 Days)||5
10051420|NCT02037165|11176583|FG002|STARTED|Period 2 (2 Days)||5
10051421|NCT02037165|11176584|FG003|STARTED|Period 2 (2 Days)||5
10051422|NCT02037165|11176585|FG004|STARTED|Period 2 (2 Days)||5
10051423|NCT02037165|11176581|FG000|COMPLETED|Period 2 (2 Days)||5
10051424|NCT02037165|11176582|FG001|COMPLETED|Period 2 (2 Days)||5
10051425|NCT02037165|11176583|FG002|COMPLETED|Period 2 (2 Days)||5
10051426|NCT02037165|11176584|FG003|COMPLETED|Period 2 (2 Days)||5
10051427|NCT02037165|11176585|FG004|COMPLETED|Period 2 (2 Days)||5
10051428|NCT02037165|11176581|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10051429|NCT02037165|11176582|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10051430|NCT02037165|11176583|FG002|NOT COMPLETED|Period 2 (2 Days)||0
10118453|NCT02547649|11249373|FG000|Vaccinated|Overall Study||231
10118454|NCT02547649|11249374|FG001|Vaccinated|Overall Study||231
10118455|NCT02547649|11249375|FG002|Vaccinated|Overall Study||227
10118456|NCT02547649|11249373|FG000|COMPLETED|Overall Study||228
10118457|NCT02547649|11249374|FG001|COMPLETED|Overall Study||226
10118458|NCT02547649|11249375|FG002|COMPLETED|Overall Study||224
10051431|NCT02037165|11176584|FG003|NOT COMPLETED|Period 2 (2 Days)||0
10051432|NCT02037165|11176585|FG004|NOT COMPLETED|Period 2 (2 Days)||0
10051433|NCT02037165|11176581|FG000|STARTED|Washout Period 2 (6 Days)||5
10051434|NCT02037165|11176582|FG001|STARTED|Washout Period 2 (6 Days)||5
10051435|NCT02037165|11176583|FG002|STARTED|Washout Period 2 (6 Days)||5
10051436|NCT02037165|11176584|FG003|STARTED|Washout Period 2 (6 Days)||5
10051437|NCT02037165|11176585|FG004|STARTED|Washout Period 2 (6 Days)||5
10051438|NCT02037165|11176581|FG000|COMPLETED|Washout Period 2 (6 Days)||5
10118459|NCT02547649|11249373|FG000|NOT COMPLETED|Overall Study||3
10118460|NCT02547649|11249374|FG001|NOT COMPLETED|Overall Study||5
10118461|NCT02547649|11249375|FG002|NOT COMPLETED|Overall Study||4
10118462|NCT02547714|11249383|FG000|STARTED|Overall Study||34
10118463|NCT02547714|11249383|FG000|COMPLETED|Overall Study||34
10118464|NCT02547714|11249383|FG000|NOT COMPLETED|Overall Study||0
10118465|NCT02547766|11249388|FG000|STARTED|Overall Study||10
10118466|NCT02547766|11249388|FG000|COMPLETED|Overall Study||9
10118467|NCT02547766|11249388|FG000|NOT COMPLETED|Overall Study||1
10118468|NCT02547779|11249394|FG000|STARTED|Overall Study||5214
10118469|NCT02547779|11249395|FG001|STARTED|Overall Study||5207
10118470|NCT02547779|11249394|FG000|COMPLETED|Overall Study||5214
10051439|NCT02037165|11176582|FG001|COMPLETED|Washout Period 2 (6 Days)||5
10051440|NCT02037165|11176583|FG002|COMPLETED|Washout Period 2 (6 Days)||5
10051441|NCT02037165|11176584|FG003|COMPLETED|Washout Period 2 (6 Days)||5
10118471|NCT02547779|11249395|FG001|COMPLETED|Overall Study||5207
10118472|NCT02547779|11249394|FG000|NOT COMPLETED|Overall Study||0
10051442|NCT02037165|11176585|FG004|COMPLETED|Washout Period 2 (6 Days)||5
10051443|NCT02037165|11176581|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0
10051444|NCT02037165|11176582|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0
10051445|NCT02037165|11176583|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0
10051446|NCT02037165|11176584|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0
10051447|NCT02037165|11176585|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0
10051448|NCT02037165|11176581|FG000|STARTED|Period 3 (2 Days)||5
10051449|NCT02037165|11176582|FG001|STARTED|Period 3 (2 Days)||5
10051450|NCT02037165|11176583|FG002|STARTED|Period 3 (2 Days)||5
10051451|NCT02037165|11176584|FG003|STARTED|Period 3 (2 Days)||5
10051452|NCT02037165|11176585|FG004|STARTED|Period 3 (2 Days)||5
10051453|NCT02037165|11176581|FG000|COMPLETED|Period 3 (2 Days)||5
10051454|NCT02037165|11176582|FG001|COMPLETED|Period 3 (2 Days)||5
10051455|NCT02037165|11176583|FG002|COMPLETED|Period 3 (2 Days)||5
10051456|NCT02037165|11176584|FG003|COMPLETED|Period 3 (2 Days)||5
10051457|NCT02037165|11176585|FG004|COMPLETED|Period 3 (2 Days)||5
10051458|NCT02037165|11176581|FG000|NOT COMPLETED|Period 3 (2 Days)||0
10051459|NCT02037165|11176582|FG001|NOT COMPLETED|Period 3 (2 Days)||0
10051460|NCT02037165|11176583|FG002|NOT COMPLETED|Period 3 (2 Days)||0
10051461|NCT02037165|11176584|FG003|NOT COMPLETED|Period 3 (2 Days)||0
10051462|NCT02037165|11176585|FG004|NOT COMPLETED|Period 3 (2 Days)||0
10051463|NCT02037165|11176581|FG000|STARTED|Washout Period 3 (6 Days)||5
10051464|NCT02037165|11176582|FG001|STARTED|Washout Period 3 (6 Days)||5
10051465|NCT02037165|11176583|FG002|STARTED|Washout Period 3 (6 Days)||5
10051466|NCT02037165|11176584|FG003|STARTED|Washout Period 3 (6 Days)||5
10051467|NCT02037165|11176585|FG004|STARTED|Washout Period 3 (6 Days)||5
10051468|NCT02037165|11176581|FG000|COMPLETED|Washout Period 3 (6 Days)||5
10051469|NCT02037165|11176582|FG001|COMPLETED|Washout Period 3 (6 Days)||5
10051470|NCT02037165|11176583|FG002|COMPLETED|Washout Period 3 (6 Days)||5
10051471|NCT02037165|11176584|FG003|COMPLETED|Washout Period 3 (6 Days)||5
10051472|NCT02037165|11176585|FG004|COMPLETED|Washout Period 3 (6 Days)||5
10051473|NCT02037165|11176581|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0
10051474|NCT02037165|11176582|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0
10051475|NCT02037165|11176583|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0
10051476|NCT02037165|11176584|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0
10051477|NCT02037165|11176585|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0
10051478|NCT02037165|11176581|FG000|STARTED|Period 4 (2 Days)||5
10051479|NCT02037165|11176582|FG001|STARTED|Period 4 (2 Days)||5
10051480|NCT02037165|11176583|FG002|STARTED|Period 4 (2 Days)||5
10051481|NCT02037165|11176584|FG003|STARTED|Period 4 (2 Days)||5
10051482|NCT02037165|11176585|FG004|STARTED|Period 4 (2 Days)||5
10051483|NCT02037165|11176581|FG000|COMPLETED|Period 4 (2 Days)||5
10051484|NCT02037165|11176582|FG001|COMPLETED|Period 4 (2 Days)||5
10051485|NCT02037165|11176583|FG002|COMPLETED|Period 4 (2 Days)||5
10051486|NCT02037165|11176584|FG003|COMPLETED|Period 4 (2 Days)||5
10051487|NCT02037165|11176585|FG004|COMPLETED|Period 4 (2 Days)||5
10051488|NCT02037165|11176581|FG000|NOT COMPLETED|Period 4 (2 Days)||0
10051489|NCT02037165|11176582|FG001|NOT COMPLETED|Period 4 (2 Days)||0
10051490|NCT02037165|11176583|FG002|NOT COMPLETED|Period 4 (2 Days)||0
10051491|NCT02037165|11176584|FG003|NOT COMPLETED|Period 4 (2 Days)||0
10051492|NCT02037165|11176585|FG004|NOT COMPLETED|Period 4 (2 Days)||0
10051493|NCT02037165|11176581|FG000|STARTED|Washout Period 4 (6 Days)||5
10051494|NCT02037165|11176582|FG001|STARTED|Washout Period 4 (6 Days)||5
10051495|NCT02037165|11176583|FG002|STARTED|Washout Period 4 (6 Days)||5
10051496|NCT02037165|11176584|FG003|STARTED|Washout Period 4 (6 Days)||5
10051497|NCT02037165|11176585|FG004|STARTED|Washout Period 4 (6 Days)||5
10051498|NCT02037165|11176581|FG000|COMPLETED|Washout Period 4 (6 Days)||5
10051499|NCT02037165|11176582|FG001|COMPLETED|Washout Period 4 (6 Days)||5
10051500|NCT02037165|11176583|FG002|COMPLETED|Washout Period 4 (6 Days)||5
10051501|NCT02037165|11176584|FG003|COMPLETED|Washout Period 4 (6 Days)||5
10051502|NCT02037165|11176585|FG004|COMPLETED|Washout Period 4 (6 Days)||4
10051503|NCT02037165|11176581|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0
10051504|NCT02037165|11176582|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0
10051505|NCT02037165|11176583|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0
10051506|NCT02037165|11176584|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0
10051507|NCT02037165|11176585|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1
10051508|NCT02037165|11176581|FG000|STARTED|Period 5 (2 Days)||5
10051509|NCT02037165|11176582|FG001|STARTED|Period 5 (2 Days)||5
10051510|NCT02037165|11176583|FG002|STARTED|Period 5 (2 Days)||5
10051511|NCT02037165|11176584|FG003|STARTED|Period 5 (2 Days)||5
10051512|NCT02037165|11176585|FG004|STARTED|Period 5 (2 Days)||4
10051513|NCT02037165|11176581|FG000|COMPLETED|Period 5 (2 Days)||5
10051514|NCT02037165|11176582|FG001|COMPLETED|Period 5 (2 Days)||5
10051515|NCT02037165|11176583|FG002|COMPLETED|Period 5 (2 Days)||5
10051516|NCT02037165|11176584|FG003|COMPLETED|Period 5 (2 Days)||5
10051517|NCT02037165|11176585|FG004|COMPLETED|Period 5 (2 Days)||4
10051518|NCT02037165|11176581|FG000|NOT COMPLETED|Period 5 (2 Days)||0
10051519|NCT02037165|11176582|FG001|NOT COMPLETED|Period 5 (2 Days)||0
10051520|NCT02037165|11176583|FG002|NOT COMPLETED|Period 5 (2 Days)||0
10051521|NCT02037165|11176584|FG003|NOT COMPLETED|Period 5 (2 Days)||0
10051522|NCT02037165|11176585|FG004|NOT COMPLETED|Period 5 (2 Days)||0
10051523|NCT02037204|11176601|FG000|STARTED|Overall Study||35
10051524|NCT02037204|11176601|FG000|COMPLETED|Overall Study||35
10051525|NCT02037204|11176601|FG000|NOT COMPLETED|Overall Study||0
10051526|NCT02037230|11176610|FG000|STARTED|Overall Study||1
10051527|NCT02037230|11176611|FG001|STARTED|Overall Study||13
10051528|NCT02037230|11176612|FG002|STARTED|Overall Study||9
10051529|NCT02037230|11176613|FG003|STARTED|Overall Study||11
10051530|NCT02037230|11176610|FG000|Completed 4 Cycles of Treatment|Overall Study||1
10051531|NCT02037230|11176611|FG001|Completed 4 Cycles of Treatment|Overall Study||9
10051532|NCT02037230|11176612|FG002|Completed 4 Cycles of Treatment|Overall Study||7
10051533|NCT02037230|11176613|FG003|Completed 4 Cycles of Treatment|Overall Study||9
10051534|NCT02037230|11176610|FG000|COMPLETED|Overall Study||0
10051535|NCT02037230|11176611|FG001|COMPLETED|Overall Study||7
10051536|NCT02037230|11176612|FG002|COMPLETED|Overall Study||3
10051537|NCT02037230|11176613|FG003|COMPLETED|Overall Study||5
10051538|NCT02037230|11176610|FG000|NOT COMPLETED|Overall Study||1
10051539|NCT02037230|11176611|FG001|NOT COMPLETED|Overall Study||6
10051540|NCT02037230|11176612|FG002|NOT COMPLETED|Overall Study||6
10051541|NCT02037230|11176613|FG003|NOT COMPLETED|Overall Study||6
10051542|NCT02037256|11176626|FG000|STARTED|Overall Study||3
10051543|NCT02037256|11176627|FG001|STARTED|Overall Study||20
10051544|NCT02037256|11176626|FG000|COMPLETED|Overall Study||3
10051545|NCT02037256|11176627|FG001|COMPLETED|Overall Study||17
10051546|NCT02037256|11176626|FG000|NOT COMPLETED|Overall Study||0
10051547|NCT02037256|11176627|FG001|NOT COMPLETED|Overall Study||3
10051548|NCT02037295|11176639|FG000|STARTED|Phase 1: Crossover UF and OF||9
10051549|NCT02037295|11176640|FG001|STARTED|Phase 1: Crossover UF and OF||7
10051550|NCT02037295|11176641|FG002|STARTED|Phase 1: Crossover UF and OF||4
10051551|NCT02037295|11176642|FG003|STARTED|Phase 1: Crossover UF and OF||7
10051552|NCT02037295|11176639|FG000|COMPLETED|Phase 1: Crossover UF and OF||9
10051553|NCT02037295|11176640|FG001|COMPLETED|Phase 1: Crossover UF and OF||7
10051554|NCT02037295|11176641|FG002|COMPLETED|Phase 1: Crossover UF and OF||4
10051555|NCT02037295|11176642|FG003|COMPLETED|Phase 1: Crossover UF and OF||7
9706623|NCT01760291|10805687|FG000|COMPLETED|Overall Study||340
9706624|NCT01760291|10805687|FG000|NOT COMPLETED|Overall Study||236
9706625|NCT01483027|10805693|FG000|STARTED|Overall Study||215
9706626|NCT01483027|10805694|FG001|STARTED|Overall Study||213
9706627|NCT01483027|10805693|FG000|COMPLETED|Overall Study||169
9706628|NCT01483027|10805694|FG001|COMPLETED|Overall Study||153
9706629|NCT01483027|10805693|FG000|NOT COMPLETED|Overall Study||46
9706630|NCT01483027|10805694|FG001|NOT COMPLETED|Overall Study||60
9706631|NCT01472562|10805700|FG000|STARTED|Induction Phase (Week 1- 48)||38
9706632|NCT01472562|10805700|FG000|COMPLETED|Induction Phase (Week 1- 48)||27
9706633|NCT01472562|10805700|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11
9706634|NCT01472562|10805700|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27
9706635|NCT01472562|10805700|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4
9706636|NCT01472562|10805700|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
9706637|NCT01379781|10805706|FG000|STARTED|Overall Study||27
9706638|NCT01379781|10805707|FG001|STARTED|Overall Study||27
9706639|NCT01379781|10805706|FG000|COMPLETED|Overall Study||16
9706640|NCT01379781|10805707|FG001|COMPLETED|Overall Study||19
9706641|NCT01379781|10805706|FG000|NOT COMPLETED|Overall Study||11
9706642|NCT01379781|10805707|FG001|NOT COMPLETED|Overall Study||8
9706643|NCT00135200|10805713|FG000|STARTED|Overall Study||16
9706644|NCT00135200|10805713|FG000|COMPLETED|Overall Study||16
9706645|NCT00135200|10805713|FG000|NOT COMPLETED|Overall Study||0
9729113|NCT00116805|10828726|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5
9729114|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
9729115|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
9729116|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144
9729117|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83
9729118|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
9729119|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
9729120|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 97 - 144||144
9729121|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 97 - 144||83
9729122|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133
9729123|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74
10051556|NCT02037295|11176639|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10051557|NCT02037295|11176640|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10051558|NCT02037295|11176641|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10051559|NCT02037295|11176642|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10051560|NCT02037295|11176639|FG000|STARTED|Phase 2: Vancomycin and Placebo||9
10051561|NCT02037295|11176640|FG001|STARTED|Phase 2: Vancomycin and Placebo||7
10051562|NCT02037295|11176641|FG002|STARTED|Phase 2: Vancomycin and Placebo||4
10051563|NCT02037295|11176642|FG003|STARTED|Phase 2: Vancomycin and Placebo||7
10051564|NCT02037295|11176639|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8
10051565|NCT02037295|11176640|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7
10051566|NCT02037295|11176641|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4
10051567|NCT02037295|11176642|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6
10051568|NCT02037295|11176639|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
10051569|NCT02037295|11176640|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
10051570|NCT02037295|11176641|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
10051571|NCT02037295|11176642|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
10051572|NCT02037347|11176654|FG000|STARTED|Overall Study||1
10051573|NCT02037347|11176654|FG000|COMPLETED|Overall Study||1
10051574|NCT02037347|11176654|FG000|NOT COMPLETED|Overall Study||0
10051575|NCT02037425|11176658|FG000|STARTED|Overall Study||44
10051576|NCT02037425|11176658|FG000|Randomized to Treatment|Overall Study||32
10051577|NCT02037425|11176658|FG000|COMPLETED|Overall Study||18
10051578|NCT02037425|11176658|FG000|NOT COMPLETED|Overall Study||26
10051579|NCT02037438|11176666|FG000|STARTED|Overall Study||920
10051580|NCT02037438|11176667|FG001|STARTED|Overall Study||916
10051581|NCT02037438|11176666|FG000|COMPLETED|Overall Study||574
10051582|NCT02037438|11176667|FG001|COMPLETED|Overall Study||561
10051583|NCT02037438|11176666|FG000|NOT COMPLETED|Overall Study||346
10051584|NCT02037438|11176667|FG001|NOT COMPLETED|Overall Study||355
10051585|NCT02037477|11176677|FG000|STARTED|Treatment Period 1||5
10051586|NCT02037477|11176678|FG001|STARTED|Treatment Period 1||5
10051587|NCT02037477|11176679|FG002|STARTED|Treatment Period 1||5
10051588|NCT02037477|11176680|FG003|STARTED|Treatment Period 1||5
10051589|NCT02037477|11176677|FG000|COMPLETED|Treatment Period 1||5
10051590|NCT02037477|11176678|FG001|COMPLETED|Treatment Period 1||5
10051591|NCT02037477|11176679|FG002|COMPLETED|Treatment Period 1||4
10051592|NCT02037477|11176680|FG003|COMPLETED|Treatment Period 1||5
10051593|NCT02037477|11176677|FG000|NOT COMPLETED|Treatment Period 1||0
10051594|NCT02037477|11176678|FG001|NOT COMPLETED|Treatment Period 1||0
10051595|NCT02037477|11176679|FG002|NOT COMPLETED|Treatment Period 1||1
10051596|NCT02037477|11176680|FG003|NOT COMPLETED|Treatment Period 1||0
10051597|NCT02037477|11176677|FG000|STARTED|Treatment Period 2||5
10051598|NCT02037477|11176678|FG001|STARTED|Treatment Period 2||5
10051599|NCT02037477|11176679|FG002|STARTED|Treatment Period 2||4
10051600|NCT02037477|11176680|FG003|STARTED|Treatment Period 2||5
10051601|NCT02037477|11176677|FG000|COMPLETED|Treatment Period 2||5
10051602|NCT02037477|11176678|FG001|COMPLETED|Treatment Period 2||5
10051603|NCT02037477|11176679|FG002|COMPLETED|Treatment Period 2||4
10051604|NCT02037477|11176680|FG003|COMPLETED|Treatment Period 2||5
10051605|NCT02037477|11176677|FG000|NOT COMPLETED|Treatment Period 2||0
10051606|NCT02037477|11176678|FG001|NOT COMPLETED|Treatment Period 2||0
10051607|NCT02037477|11176679|FG002|NOT COMPLETED|Treatment Period 2||0
10051608|NCT02037477|11176680|FG003|NOT COMPLETED|Treatment Period 2||0
10051609|NCT02037555|11176692|FG000|STARTED|Overall Study||213
10051610|NCT02037555|11176693|FG001|STARTED|Overall Study||212
10051611|NCT02037555|11176692|FG000|Dosed|Overall Study||201
10051612|NCT02037555|11176693|FG001|Dosed|Overall Study||198
10051613|NCT02037555|11176692|FG000|Dosed and Operated On|Overall Study||200
10051614|NCT02037555|11176693|FG001|Dosed and Operated On|Overall Study||196
10051615|NCT02037555|11176692|FG000|COMPLETED|Overall Study||190
10051616|NCT02037555|11176693|FG001|COMPLETED|Overall Study||191
10051617|NCT02037555|11176692|FG000|NOT COMPLETED|Overall Study||23
10051618|NCT02037555|11176693|FG001|NOT COMPLETED|Overall Study||21
10051619|NCT02037568|11176701|FG000|STARTED|Overall Study||83
10051620|NCT02037568|11176702|FG001|STARTED|Overall Study||76
10051621|NCT02037568|11176701|FG000|Month 1.5 (Post Transplantation)|Overall Study||79
10051622|NCT02037568|11176702|FG001|Month 1.5 (Post Transplantation)|Overall Study||76
10051623|NCT02037568|11176701|FG000|Month 3 (Post Transplantation)|Overall Study||66
10051624|NCT02037568|11176702|FG001|Month 3 (Post Transplantation)|Overall Study||62
10051625|NCT02037568|11176701|FG000|Month 6 (Post Transplantation)|Overall Study||63
10051626|NCT02037568|11176702|FG001|Month 6 (Post Transplantation)|Overall Study||52
10051627|NCT02037568|11176701|FG000|COMPLETED|Overall Study||47
10051628|NCT02037568|11176702|FG001|COMPLETED|Overall Study||37
10051629|NCT02037568|11176701|FG000|NOT COMPLETED|Overall Study||36
10051630|NCT02037568|11176702|FG001|NOT COMPLETED|Overall Study||39
10051631|NCT02037607|11176708|FG000|STARTED|Overall Study||100
10051632|NCT02037607|11176708|FG000|COMPLETED|Overall Study||91
10051633|NCT02037607|11176708|FG000|NOT COMPLETED|Overall Study||9
10051634|NCT02037776|11176714|FG000|STARTED|Overall Study||61
10051635|NCT02037776|11176715|FG001|STARTED|Overall Study||64
10051636|NCT02037776|11176714|FG000|COMPLETED|Overall Study||56
10051637|NCT02037776|11176715|FG001|COMPLETED|Overall Study||60
10051638|NCT02037776|11176714|FG000|NOT COMPLETED|Overall Study||5
10051639|NCT02037776|11176715|FG001|NOT COMPLETED|Overall Study||4
10051640|NCT02037893|11176725|FG000|STARTED|Overall Study||32
10051641|NCT02037893|11176726|FG001|STARTED|Overall Study||25
10051642|NCT02037893|11176727|FG002|STARTED|Overall Study||27
10051643|NCT02037893|11176728|FG003|STARTED|Overall Study||28
10051644|NCT02037893|11176725|FG000|COMPLETED|Overall Study||32
10051645|NCT02037893|11176726|FG001|COMPLETED|Overall Study||25
10051646|NCT02037893|11176727|FG002|COMPLETED|Overall Study||26
10051647|NCT02037893|11176728|FG003|COMPLETED|Overall Study||28
10051648|NCT02037893|11176725|FG000|NOT COMPLETED|Overall Study||0
10051649|NCT02037893|11176726|FG001|NOT COMPLETED|Overall Study||0
10051650|NCT02037893|11176727|FG002|NOT COMPLETED|Overall Study||1
10051651|NCT02037893|11176728|FG003|NOT COMPLETED|Overall Study||0
10051652|NCT02037984|11176746|FG000|STARTED|Overall Study||20
10051653|NCT02037984|11176747|FG001|STARTED|Overall Study||20
10051654|NCT02037984|11176748|FG002|STARTED|Overall Study||50
10051655|NCT02037984|11176749|FG003|STARTED|Overall Study||51
10051656|NCT02037984|11176750|FG004|STARTED|Overall Study||50
10051657|NCT02037984|11176751|FG005|STARTED|Overall Study||49
10051658|NCT02037984|11176752|FG006|STARTED|Overall Study||50
10051659|NCT02037984|11176753|FG007|STARTED|Overall Study||51
10051660|NCT02037984|11176746|FG000|COMPLETED|Overall Study||19
10051661|NCT02037984|11176747|FG001|COMPLETED|Overall Study||20
10051662|NCT02037984|11176748|FG002|COMPLETED|Overall Study||38
10051663|NCT02037984|11176749|FG003|COMPLETED|Overall Study||30
10051664|NCT02037984|11176750|FG004|COMPLETED|Overall Study||38
10051665|NCT02037984|11176751|FG005|COMPLETED|Overall Study||37
10051666|NCT02037984|11176752|FG006|COMPLETED|Overall Study||33
10051667|NCT02037984|11176753|FG007|COMPLETED|Overall Study||39
10051668|NCT02037984|11176746|FG000|NOT COMPLETED|Overall Study||1
10051669|NCT02037984|11176747|FG001|NOT COMPLETED|Overall Study||0
10051670|NCT02037984|11176748|FG002|NOT COMPLETED|Overall Study||12
10051671|NCT02037984|11176749|FG003|NOT COMPLETED|Overall Study||21
10051672|NCT02037984|11176750|FG004|NOT COMPLETED|Overall Study||12
10051673|NCT02037984|11176751|FG005|NOT COMPLETED|Overall Study||12
10051674|NCT02037984|11176752|FG006|NOT COMPLETED|Overall Study||17
10051675|NCT02037984|11176753|FG007|NOT COMPLETED|Overall Study||12
10051676|NCT02038010|11176781|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11
10051677|NCT02038010|11176782|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6
10051678|NCT02038010|11176783|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
10051679|NCT02038010|11176784|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
10051680|NCT02038010|11176781|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
10051681|NCT02038010|11176782|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
10051682|NCT02038010|11176783|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
10051683|NCT02038010|11176784|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
10051684|NCT02038010|11176781|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
10051685|NCT02038010|11176782|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
10051686|NCT02038010|11176783|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
10051687|NCT02038010|11176784|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
10051688|NCT02038010|11176781|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
10051689|NCT02038010|11176782|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
10051690|NCT02038010|11176783|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10051691|NCT02038010|11176784|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10051692|NCT02038010|11176781|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
10051693|NCT02038010|11176782|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
10051694|NCT02038010|11176783|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10051695|NCT02038010|11176784|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10051696|NCT02038010|11176781|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10
10051697|NCT02038010|11176782|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4
10051698|NCT02038010|11176783|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0
10051699|NCT02038010|11176784|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0
10051700|NCT02038010|11176781|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
10051701|NCT02038010|11176782|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
10051702|NCT02038010|11176783|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
10051703|NCT02038010|11176784|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
10051704|NCT02038010|11176781|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
10051705|NCT02038010|11176782|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
10051706|NCT02038010|11176783|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
10051707|NCT02038010|11176784|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
10051708|NCT02038010|11176781|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
10051709|NCT02038010|11176782|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
10051710|NCT02038010|11176783|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10051711|NCT02038010|11176784|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10051712|NCT02038010|11176781|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
10051713|NCT02038010|11176782|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
10051714|NCT02038010|11176783|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10051715|NCT02038010|11176784|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10051716|NCT02038010|11176781|FG000|STARTED|Follow Up||11
10051717|NCT02038010|11176782|FG001|STARTED|Follow Up||6
10051718|NCT02038010|11176783|FG002|STARTED|Follow Up||0
10051719|NCT02038010|11176784|FG003|STARTED|Follow Up||0
10051720|NCT02038010|11176781|FG000|COMPLETED|Follow Up||4
10051721|NCT02038010|11176782|FG001|COMPLETED|Follow Up||3
10051722|NCT02038010|11176783|FG002|COMPLETED|Follow Up||0
10051723|NCT02038010|11176784|FG003|COMPLETED|Follow Up||0
10118473|NCT02547779|11249395|FG001|NOT COMPLETED|Overall Study||0
10051724|NCT02038010|11176781|FG000|NOT COMPLETED|Follow Up||7
10051725|NCT02038010|11176782|FG001|NOT COMPLETED|Follow Up||3
10051726|NCT02038010|11176783|FG002|NOT COMPLETED|Follow Up||0
10051727|NCT02038010|11176784|FG003|NOT COMPLETED|Follow Up||0
10051728|NCT02038023|11176792|FG000|STARTED|Overall Study||74
10051729|NCT02038023|11176792|FG000|COMPLETED|Overall Study||73
10051730|NCT02038023|11176792|FG000|NOT COMPLETED|Overall Study||1
10051731|NCT02038036|11176800|FG000|STARTED|Core Study||74
10051732|NCT02038036|11176801|FG001|STARTED|Core Study||75
10051733|NCT02038036|11176800|FG000|Full Analysis Set|Core Study||74
10051734|NCT02038036|11176801|FG001|Full Analysis Set|Core Study||75
10051735|NCT02038036|11176800|FG000|Crossover Set|Core Study||0
10051736|NCT02038036|11176801|FG001|Crossover Set|Core Study||58
10051737|NCT02038036|11176800|FG000|COMPLETED|Core Study||59
10051738|NCT02038036|11176801|FG001|COMPLETED|Core Study||61
10051739|NCT02038036|11176800|FG000|NOT COMPLETED|Core Study||15
10051740|NCT02038036|11176801|FG001|NOT COMPLETED|Core Study||14
10051741|NCT02038036|11176800|FG000|STARTED|Crossover Period||0
10051742|NCT02038036|11176801|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
10051743|NCT02038036|11176800|FG000|COMPLETED|Crossover Period||0
10051744|NCT02038036|11176801|FG001|COMPLETED|Crossover Period||38
10051745|NCT02038036|11176800|FG000|NOT COMPLETED|Crossover Period||0
10051746|NCT02038036|11176801|FG001|NOT COMPLETED|Crossover Period||20
10051747|NCT02038049|11176812|FG000|STARTED|Overall Study||4
10051748|NCT02038049|11176813|FG001|STARTED|Overall Study||4
10051749|NCT02038049|11176812|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4
10051750|NCT02038049|11176813|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
10051751|NCT02038049|11176812|FG000|COMPLETED|Overall Study||3
10051752|NCT02038049|11176813|FG001|COMPLETED|Overall Study||4
10051753|NCT02038049|11176812|FG000|NOT COMPLETED|Overall Study||1
10051754|NCT02038049|11176813|FG001|NOT COMPLETED|Overall Study||0
10051755|NCT02038075|11176825|FG000|STARTED|Overall Study||76
10051756|NCT02038075|11176826|FG001|STARTED|Overall Study||76
10051757|NCT02038075|11176825|FG000|COMPLETED|Overall Study||73
10051758|NCT02038075|11176826|FG001|COMPLETED|Overall Study||76
10051759|NCT02038075|11176825|FG000|NOT COMPLETED|Overall Study||3
10051760|NCT02038075|11176826|FG001|NOT COMPLETED|Overall Study||0
10051761|NCT02038179|11176832|FG000|STARTED|Phase 1 (4 Weeks)||52
10051762|NCT02038179|11176833|FG001|STARTED|Phase 1 (4 Weeks)||47
10051763|NCT02038179|11176832|FG000|COMPLETED|Phase 1 (4 Weeks)||48
10051764|NCT02038179|11176833|FG001|COMPLETED|Phase 1 (4 Weeks)||42
10051765|NCT02038179|11176832|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4
10051766|NCT02038179|11176833|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
10051767|NCT02038179|11176832|FG000|STARTED|Washout (2-4 Weeks)||48
10051768|NCT02038179|11176833|FG001|STARTED|Washout (2-4 Weeks)||42
10051769|NCT02038179|11176832|FG000|COMPLETED|Washout (2-4 Weeks)||46
10051770|NCT02038179|11176833|FG001|COMPLETED|Washout (2-4 Weeks)||40
10051771|NCT02038179|11176832|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2
10051772|NCT02038179|11176833|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2
10051773|NCT02038179|11176832|FG000|STARTED|Phase 2 (4 Weeks)||46
10051774|NCT02038179|11176833|FG001|STARTED|Phase 2 (4 Weeks)||40
10051775|NCT02038179|11176832|FG000|COMPLETED|Phase 2 (4 Weeks)||44
10051776|NCT02038179|11176833|FG001|COMPLETED|Phase 2 (4 Weeks)||38
10051777|NCT02038179|11176832|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2
10051778|NCT02038179|11176833|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2
10051779|NCT02038218|11176841|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
10051780|NCT02038218|11176842|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
10051781|NCT02038218|11176841|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
10051782|NCT02038218|11176842|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
10051783|NCT02038218|11176841|FG000|NOT COMPLETED|Overall Study||0
10051784|NCT02038218|11176842|FG001|NOT COMPLETED|Overall Study||0
10051785|NCT02038543|11176852|FG000|STARTED|Overall Study||7
10051786|NCT02038543|11176853|FG001|STARTED|Overall Study||4
10051787|NCT02038543|11176854|FG002|STARTED|Overall Study||8
10051788|NCT02038543|11176855|FG003|STARTED|Overall Study||3
10051789|NCT02038543|11176852|FG000|COMPLETED|Overall Study||7
10051790|NCT02038543|11176853|FG001|COMPLETED|Overall Study||4
10051791|NCT02038543|11176854|FG002|COMPLETED|Overall Study||8
10051792|NCT02038543|11176855|FG003|COMPLETED|Overall Study||1
10051793|NCT02038543|11176852|FG000|NOT COMPLETED|Overall Study||0
10051794|NCT02038543|11176853|FG001|NOT COMPLETED|Overall Study||0
10051795|NCT02038543|11176854|FG002|NOT COMPLETED|Overall Study||0
10051796|NCT02038543|11176855|FG003|NOT COMPLETED|Overall Study||2
10051797|NCT02038569|11176865|FG000|STARTED|Overall Study||107
10051798|NCT02038569|11176865|FG000|COMPLETED|Overall Study||102
10051799|NCT02038569|11176865|FG000|NOT COMPLETED|Overall Study||5
10051800|NCT02038647|11176872|FG000|STARTED|Overall Study||89
10051801|NCT02038647|11176873|FG001|STARTED|Overall Study||89
10051802|NCT02038647|11176872|FG000|COMPLETED|Overall Study||0
10051803|NCT02038647|11176873|FG001|COMPLETED|Overall Study||0
10051804|NCT02038647|11176872|FG000|NOT COMPLETED|Overall Study||89
10051805|NCT02038647|11176873|FG001|NOT COMPLETED|Overall Study||89
10051806|NCT02038764|11176884|FG000|STARTED|Overall Study||7
10051807|NCT02038764|11176885|FG001|STARTED|Overall Study||8
10051808|NCT02038764|11176886|FG002|STARTED|Overall Study||9
10051809|NCT02038764|11176887|FG003|STARTED|Overall Study||5
10051810|NCT02038764|11176888|FG004|STARTED|Overall Study||8
10051811|NCT02038764|11176884|FG000|COMPLETED|Overall Study||6
10051812|NCT02038764|11176885|FG001|COMPLETED|Overall Study||7
10051813|NCT02038764|11176886|FG002|COMPLETED|Overall Study||7
10051814|NCT02038764|11176887|FG003|COMPLETED|Overall Study||5
10051815|NCT02038764|11176888|FG004|COMPLETED|Overall Study||7
10051816|NCT02038764|11176884|FG000|NOT COMPLETED|Overall Study||1
10051817|NCT02038764|11176885|FG001|NOT COMPLETED|Overall Study||1
10051818|NCT02038764|11176886|FG002|NOT COMPLETED|Overall Study||2
10051819|NCT02038764|11176887|FG003|NOT COMPLETED|Overall Study||0
10051820|NCT02038764|11176888|FG004|NOT COMPLETED|Overall Study||1
10051821|NCT02038790|11176904|FG000|STARTED|Day 0 - First Treatment||16
10051822|NCT02038790|11176905|FG001|STARTED|Day 0 - First Treatment||17
10051823|NCT02038790|11176904|FG000|COMPLETED|Day 0 - First Treatment||15
10051824|NCT02038790|11176905|FG001|COMPLETED|Day 0 - First Treatment||16
10118474|NCT02547922|11249404|FG000|STARTED|Overall Study||46
10118475|NCT02547922|11249405|FG001|STARTED|Overall Study||52
10118476|NCT02547922|11249406|FG002|STARTED|Overall Study||49
10118477|NCT02547922|11249404|FG000|FAS (Full Analysis Set)|Overall Study||45
10118478|NCT02547922|11249405|FG001|FAS (Full Analysis Set)|Overall Study||51
10118479|NCT02547922|11249406|FG002|FAS (Full Analysis Set)|Overall Study||49
10118480|NCT02547922|11249404|FG000|COMPLETED|Overall Study||18
10118481|NCT02547922|11249405|FG001|COMPLETED|Overall Study||28
10118482|NCT02547922|11249406|FG002|COMPLETED|Overall Study||20
10118483|NCT02547922|11249404|FG000|NOT COMPLETED|Overall Study||28
10118484|NCT02547922|11249405|FG001|NOT COMPLETED|Overall Study||24
10118485|NCT02547922|11249406|FG002|NOT COMPLETED|Overall Study||29
10118486|NCT02547935|11249423|FG000|STARTED|Overall Study||155
10118487|NCT02547935|11249424|FG001|STARTED|Overall Study||145
10118488|NCT02547935|11249425|FG002|STARTED|Overall Study||148
10118489|NCT02547935|11249423|FG000|Received Treatment|Overall Study||152
10118490|NCT02547935|11249424|FG001|Received Treatment|Overall Study||145
10118491|NCT02547935|11249425|FG002|Received Treatment|Overall Study||148
10118492|NCT02547935|11249423|FG000|Full Analysis Set|Overall Study||152
10118493|NCT02547935|11249424|FG001|Full Analysis Set|Overall Study||144
10118494|NCT02547935|11249425|FG002|Full Analysis Set|Overall Study||148
10118495|NCT02547935|11249423|FG000|Safety Analysis Set|Overall Study||152
10118496|NCT02547935|11249424|FG001|Safety Analysis Set|Overall Study||145
10118497|NCT02547935|11249425|FG002|Safety Analysis Set|Overall Study||148
10118498|NCT02547935|11249423|FG000|COMPLETED|Overall Study||150
10118499|NCT02547935|11249424|FG001|COMPLETED|Overall Study||137
10118500|NCT02547935|11249425|FG002|COMPLETED|Overall Study||143
10118501|NCT02547935|11249423|FG000|NOT COMPLETED|Overall Study||5
10118502|NCT02547935|11249424|FG001|NOT COMPLETED|Overall Study||8
10118503|NCT02547935|11249425|FG002|NOT COMPLETED|Overall Study||5
10118504|NCT02547974|11249439|FG000|STARTED|Overall Study||15
10118505|NCT02547974|11249440|FG001|STARTED|Overall Study||31
10118506|NCT02547974|11249441|FG002|STARTED|Overall Study||30
10118507|NCT02547974|11249442|FG003|STARTED|Overall Study||44
10118508|NCT02547974|11249439|FG000|COMPLETED|Overall Study||14
10118509|NCT02547974|11249440|FG001|COMPLETED|Overall Study||31
10118510|NCT02547974|11249441|FG002|COMPLETED|Overall Study||30
10118511|NCT02547974|11249442|FG003|COMPLETED|Overall Study||44
10118512|NCT02547974|11249439|FG000|NOT COMPLETED|Overall Study||1
10118513|NCT02547974|11249440|FG001|NOT COMPLETED|Overall Study||0
10118514|NCT02547974|11249441|FG002|NOT COMPLETED|Overall Study||0
10118515|NCT02547974|11249442|FG003|NOT COMPLETED|Overall Study||0
10118516|NCT02547987|11249455|FG000|STARTED|Overall Study||25
10118517|NCT02547987|11249455|FG000|COMPLETED|Overall Study||22
10118518|NCT02547987|11249455|FG000|NOT COMPLETED|Overall Study||3
10118519|NCT02548078|11249461|FG000|STARTED|Overall Study||300
10118520|NCT02548078|11249462|FG001|STARTED|Overall Study||300
10118521|NCT02548078|11249461|FG000|COMPLETED|Overall Study||295
10118522|NCT02548078|11249462|FG001|COMPLETED|Overall Study||294
10118523|NCT02548078|11249461|FG000|NOT COMPLETED|Overall Study||5
10118524|NCT02548078|11249462|FG001|NOT COMPLETED|Overall Study||6
10118525|NCT02548156|11249475|FG000|STARTED|Period 1||5
10118526|NCT02548156|11249476|FG001|STARTED|Period 1||5
10118527|NCT02548156|11249477|FG002|STARTED|Period 1||4
10118528|NCT02548156|11249478|FG003|STARTED|Period 1||5
10118529|NCT02548156|11249479|FG004|STARTED|Period 1||5
10118530|NCT02548156|11249480|FG005|STARTED|Period 1||5
10118531|NCT02548156|11249475|FG000|COMPLETED|Period 1||5
10118532|NCT02548156|11249476|FG001|COMPLETED|Period 1||5
10118533|NCT02548156|11249477|FG002|COMPLETED|Period 1||4
10118534|NCT02548156|11249478|FG003|COMPLETED|Period 1||5
10118535|NCT02548156|11249479|FG004|COMPLETED|Period 1||5
10118536|NCT02548156|11249480|FG005|COMPLETED|Period 1||5
10118537|NCT02548156|11249475|FG000|NOT COMPLETED|Period 1||0
10118538|NCT02548156|11249476|FG001|NOT COMPLETED|Period 1||0
10118539|NCT02548156|11249477|FG002|NOT COMPLETED|Period 1||0
10118540|NCT02548156|11249478|FG003|NOT COMPLETED|Period 1||0
10118541|NCT02548156|11249479|FG004|NOT COMPLETED|Period 1||0
10118542|NCT02548156|11249480|FG005|NOT COMPLETED|Period 1||0
10051825|NCT02038790|11176904|FG000|NOT COMPLETED|Day 0 - First Treatment||1
10118543|NCT02548156|11249475|FG000|STARTED|Washout Period 1||5
10118544|NCT02548156|11249476|FG001|STARTED|Washout Period 1||5
10118545|NCT02548156|11249477|FG002|STARTED|Washout Period 1||4
10118546|NCT02548156|11249478|FG003|STARTED|Washout Period 1||5
10118547|NCT02548156|11249479|FG004|STARTED|Washout Period 1||5
10118548|NCT02548156|11249480|FG005|STARTED|Washout Period 1||5
10118549|NCT02548156|11249475|FG000|COMPLETED|Washout Period 1||5
10118550|NCT02548156|11249476|FG001|COMPLETED|Washout Period 1||5
10118551|NCT02548156|11249477|FG002|COMPLETED|Washout Period 1||4
10118552|NCT02548156|11249478|FG003|COMPLETED|Washout Period 1||5
10051826|NCT02038790|11176905|FG001|NOT COMPLETED|Day 0 - First Treatment||1
10051827|NCT02038790|11176904|FG000|STARTED|Day 1 - Second Treatment||15
10051828|NCT02038790|11176905|FG001|STARTED|Day 1 - Second Treatment||16
10051829|NCT02038790|11176904|FG000|COMPLETED|Day 1 - Second Treatment||15
10051830|NCT02038790|11176905|FG001|COMPLETED|Day 1 - Second Treatment||16
10051831|NCT02038790|11176904|FG000|NOT COMPLETED|Day 1 - Second Treatment||0
10051832|NCT02038790|11176905|FG001|NOT COMPLETED|Day 1 - Second Treatment||0
10051833|NCT02038829|11176912|FG000|STARTED|Treatment Period 1||8
10051834|NCT02038829|11176913|FG001|STARTED|Treatment Period 1||8
10051835|NCT02038829|11176914|FG002|STARTED|Treatment Period 1||8
10051836|NCT02038829|11176915|FG003|STARTED|Treatment Period 1||8
10051837|NCT02038829|11176916|FG004|STARTED|Treatment Period 1||8
10051838|NCT02038829|11176917|FG005|STARTED|Treatment Period 1||8
10051839|NCT02038829|11176918|FG006|STARTED|Treatment Period 1||8
10051840|NCT02038829|11176919|FG007|STARTED|Treatment Period 1||8
10051841|NCT02038829|11176920|FG008|STARTED|Treatment Period 1||8
10051842|NCT02038829|11176921|FG009|STARTED|Treatment Period 1||8
10118553|NCT02548156|11249479|FG004|COMPLETED|Washout Period 1||4
10118554|NCT02548156|11249480|FG005|COMPLETED|Washout Period 1||5
10118555|NCT02548156|11249475|FG000|NOT COMPLETED|Washout Period 1||0
10118556|NCT02548156|11249476|FG001|NOT COMPLETED|Washout Period 1||0
10118557|NCT02548156|11249477|FG002|NOT COMPLETED|Washout Period 1||0
10118558|NCT02548156|11249478|FG003|NOT COMPLETED|Washout Period 1||0
10118559|NCT02548156|11249479|FG004|NOT COMPLETED|Washout Period 1||1
10118560|NCT02548156|11249480|FG005|NOT COMPLETED|Washout Period 1||0
10118561|NCT02548156|11249475|FG000|STARTED|Period 2||5
10118562|NCT02548156|11249476|FG001|STARTED|Period 2||5
10118563|NCT02548156|11249477|FG002|STARTED|Period 2||4
10118564|NCT02548156|11249478|FG003|STARTED|Period 2||5
10118565|NCT02548156|11249479|FG004|STARTED|Period 2||4
10118566|NCT02548156|11249480|FG005|STARTED|Period 2||5
10118567|NCT02548156|11249475|FG000|COMPLETED|Period 2||5
10118568|NCT02548156|11249476|FG001|COMPLETED|Period 2||5
10118569|NCT02548156|11249477|FG002|COMPLETED|Period 2||4
10118570|NCT02548156|11249478|FG003|COMPLETED|Period 2||5
10118571|NCT02548156|11249479|FG004|COMPLETED|Period 2||4
10118572|NCT02548156|11249480|FG005|COMPLETED|Period 2||5
10118573|NCT02548156|11249475|FG000|NOT COMPLETED|Period 2||0
10118574|NCT02548156|11249476|FG001|NOT COMPLETED|Period 2||0
10118575|NCT02548156|11249477|FG002|NOT COMPLETED|Period 2||0
10118576|NCT02548156|11249478|FG003|NOT COMPLETED|Period 2||0
10118577|NCT02548156|11249479|FG004|NOT COMPLETED|Period 2||0
10118578|NCT02548156|11249480|FG005|NOT COMPLETED|Period 2||0
10118579|NCT02548156|11249475|FG000|STARTED|Washout Period 2||5
10118580|NCT02548156|11249476|FG001|STARTED|Washout Period 2||5
10118581|NCT02548156|11249477|FG002|STARTED|Washout Period 2||4
10118582|NCT02548156|11249478|FG003|STARTED|Washout Period 2||5
10118583|NCT02548156|11249479|FG004|STARTED|Washout Period 2||4
10118584|NCT02548156|11249480|FG005|STARTED|Washout Period 2||5
10118585|NCT02548156|11249475|FG000|COMPLETED|Washout Period 2||5
10118586|NCT02548156|11249476|FG001|COMPLETED|Washout Period 2||5
10118587|NCT02548156|11249477|FG002|COMPLETED|Washout Period 2||4
10118588|NCT02548156|11249478|FG003|COMPLETED|Washout Period 2||5
10118589|NCT02548156|11249479|FG004|COMPLETED|Washout Period 2||4
10118590|NCT02548156|11249480|FG005|COMPLETED|Washout Period 2||5
10118591|NCT02548156|11249475|FG000|NOT COMPLETED|Washout Period 2||0
10118592|NCT02548156|11249476|FG001|NOT COMPLETED|Washout Period 2||0
10118593|NCT02548156|11249477|FG002|NOT COMPLETED|Washout Period 2||0
10118594|NCT02548156|11249478|FG003|NOT COMPLETED|Washout Period 2||0
10118595|NCT02548156|11249479|FG004|NOT COMPLETED|Washout Period 2||0
10118596|NCT02548156|11249480|FG005|NOT COMPLETED|Washout Period 2||0
10118597|NCT02548156|11249475|FG000|STARTED|Period 3||5
10118598|NCT02548156|11249476|FG001|STARTED|Period 3||5
10118599|NCT02548156|11249477|FG002|STARTED|Period 3||4
10118600|NCT02548156|11249478|FG003|STARTED|Period 3||5
10118601|NCT02548156|11249479|FG004|STARTED|Period 3||4
10118602|NCT02548156|11249480|FG005|STARTED|Period 3||5
10118603|NCT02548156|11249475|FG000|COMPLETED|Period 3||5
10118604|NCT02548156|11249476|FG001|COMPLETED|Period 3||5
10118605|NCT02548156|11249477|FG002|COMPLETED|Period 3||4
10118606|NCT02548156|11249478|FG003|COMPLETED|Period 3||5
10118607|NCT02548156|11249479|FG004|COMPLETED|Period 3||4
10118608|NCT02548156|11249480|FG005|COMPLETED|Period 3||5
10118609|NCT02548156|11249475|FG000|NOT COMPLETED|Period 3||0
10118610|NCT02548156|11249476|FG001|NOT COMPLETED|Period 3||0
10118611|NCT02548156|11249477|FG002|NOT COMPLETED|Period 3||0
10118612|NCT02548156|11249478|FG003|NOT COMPLETED|Period 3||0
10118613|NCT02548156|11249479|FG004|NOT COMPLETED|Period 3||0
10118614|NCT02548156|11249480|FG005|NOT COMPLETED|Period 3||0
10118615|NCT02548312|11249496|FG000|STARTED|Overall Study||133
10118616|NCT02548312|11249497|FG001|STARTED|Overall Study||133
10118617|NCT02548312|11249498|FG002|STARTED|Overall Study||134
10118618|NCT02548312|11249499|FG003|STARTED|Overall Study||133
10118619|NCT02548312|11249500|FG004|STARTED|Overall Study||133
10118620|NCT02548312|11249501|FG005|STARTED|Overall Study||133
10118621|NCT02548312|11249502|FG006|STARTED|Overall Study||133
10118622|NCT02548312|11249503|FG007|STARTED|Overall Study||133
10118623|NCT02548312|11249496|FG000|COMPLETED|Overall Study||100
10118624|NCT02548312|11249497|FG001|COMPLETED|Overall Study||90
10118625|NCT02548312|11249498|FG002|COMPLETED|Overall Study||96
10118626|NCT02548312|11249499|FG003|COMPLETED|Overall Study||87
10118627|NCT02548312|11249500|FG004|COMPLETED|Overall Study||99
10118628|NCT02548312|11249501|FG005|COMPLETED|Overall Study||93
10118629|NCT02548312|11249502|FG006|COMPLETED|Overall Study||93
10051843|NCT02038829|11176922|FG010|STARTED|Treatment Period 1||8
10051844|NCT02038829|11176923|FG011|STARTED|Treatment Period 1||8
10051845|NCT02038829|11176912|FG000|COMPLETED|Treatment Period 1||8
10051846|NCT02038829|11176913|FG001|COMPLETED|Treatment Period 1||8
10051847|NCT02038829|11176914|FG002|COMPLETED|Treatment Period 1||8
10051848|NCT02038829|11176915|FG003|COMPLETED|Treatment Period 1||8
10051849|NCT02038829|11176916|FG004|COMPLETED|Treatment Period 1||8
10051850|NCT02038829|11176917|FG005|COMPLETED|Treatment Period 1||8
10051851|NCT02038829|11176918|FG006|COMPLETED|Treatment Period 1||8
10051852|NCT02038829|11176919|FG007|COMPLETED|Treatment Period 1||8
10051853|NCT02038829|11176920|FG008|COMPLETED|Treatment Period 1||8
10051854|NCT02038829|11176921|FG009|COMPLETED|Treatment Period 1||8
10051855|NCT02038829|11176922|FG010|COMPLETED|Treatment Period 1||8
10051856|NCT02038829|11176923|FG011|COMPLETED|Treatment Period 1||8
10051857|NCT02038829|11176912|FG000|NOT COMPLETED|Treatment Period 1||0
10051858|NCT02038829|11176913|FG001|NOT COMPLETED|Treatment Period 1||0
10051859|NCT02038829|11176914|FG002|NOT COMPLETED|Treatment Period 1||0
10051860|NCT02038829|11176915|FG003|NOT COMPLETED|Treatment Period 1||0
10051861|NCT02038829|11176916|FG004|NOT COMPLETED|Treatment Period 1||0
10051862|NCT02038829|11176917|FG005|NOT COMPLETED|Treatment Period 1||0
10051863|NCT02038829|11176918|FG006|NOT COMPLETED|Treatment Period 1||0
10051864|NCT02038829|11176919|FG007|NOT COMPLETED|Treatment Period 1||0
10051865|NCT02038829|11176920|FG008|NOT COMPLETED|Treatment Period 1||0
10051866|NCT02038829|11176921|FG009|NOT COMPLETED|Treatment Period 1||0
10051867|NCT02038829|11176922|FG010|NOT COMPLETED|Treatment Period 1||0
10051868|NCT02038829|11176923|FG011|NOT COMPLETED|Treatment Period 1||0
10051869|NCT02038829|11176912|FG000|STARTED|Washout Period 1||8
10051870|NCT02038829|11176913|FG001|STARTED|Washout Period 1||8
10051871|NCT02038829|11176914|FG002|STARTED|Washout Period 1||8
10051872|NCT02038829|11176915|FG003|STARTED|Washout Period 1||8
10051873|NCT02038829|11176916|FG004|STARTED|Washout Period 1||8
10051874|NCT02038829|11176917|FG005|STARTED|Washout Period 1||8
10051875|NCT02038829|11176918|FG006|STARTED|Washout Period 1||8
10051876|NCT02038829|11176919|FG007|STARTED|Washout Period 1||8
10051877|NCT02038829|11176920|FG008|STARTED|Washout Period 1||8
10051878|NCT02038829|11176921|FG009|STARTED|Washout Period 1||8
10051879|NCT02038829|11176922|FG010|STARTED|Washout Period 1||8
10051880|NCT02038829|11176923|FG011|STARTED|Washout Period 1||8
10051881|NCT02038829|11176912|FG000|COMPLETED|Washout Period 1||8
10051882|NCT02038829|11176913|FG001|COMPLETED|Washout Period 1||8
10051883|NCT02038829|11176914|FG002|COMPLETED|Washout Period 1||8
10051884|NCT02038829|11176915|FG003|COMPLETED|Washout Period 1||8
10051885|NCT02038829|11176916|FG004|COMPLETED|Washout Period 1||7
10051886|NCT02038829|11176917|FG005|COMPLETED|Washout Period 1||8
10051887|NCT02038829|11176918|FG006|COMPLETED|Washout Period 1||8
10051888|NCT02038829|11176919|FG007|COMPLETED|Washout Period 1||8
10118630|NCT02548312|11249503|FG007|COMPLETED|Overall Study||91
10118631|NCT02548312|11249496|FG000|NOT COMPLETED|Overall Study||33
10118632|NCT02548312|11249497|FG001|NOT COMPLETED|Overall Study||43
10118633|NCT02548312|11249498|FG002|NOT COMPLETED|Overall Study||38
10118634|NCT02548312|11249499|FG003|NOT COMPLETED|Overall Study||46
10051889|NCT02038829|11176920|FG008|COMPLETED|Washout Period 1||8
10051890|NCT02038829|11176921|FG009|COMPLETED|Washout Period 1||8
10051891|NCT02038829|11176922|FG010|COMPLETED|Washout Period 1||8
10051892|NCT02038829|11176923|FG011|COMPLETED|Washout Period 1||8
10051893|NCT02038829|11176912|FG000|NOT COMPLETED|Washout Period 1||0
10051894|NCT02038829|11176913|FG001|NOT COMPLETED|Washout Period 1||0
10051895|NCT02038829|11176914|FG002|NOT COMPLETED|Washout Period 1||0
10051896|NCT02038829|11176915|FG003|NOT COMPLETED|Washout Period 1||0
10051897|NCT02038829|11176916|FG004|NOT COMPLETED|Washout Period 1||1
10051898|NCT02038829|11176917|FG005|NOT COMPLETED|Washout Period 1||0
10051899|NCT02038829|11176918|FG006|NOT COMPLETED|Washout Period 1||0
10051900|NCT02038829|11176919|FG007|NOT COMPLETED|Washout Period 1||0
10051901|NCT02038829|11176920|FG008|NOT COMPLETED|Washout Period 1||0
10051902|NCT02038829|11176921|FG009|NOT COMPLETED|Washout Period 1||0
10051903|NCT02038829|11176922|FG010|NOT COMPLETED|Washout Period 1||0
10051904|NCT02038829|11176923|FG011|NOT COMPLETED|Washout Period 1||0
10051905|NCT02038829|11176912|FG000|STARTED|Treatment Period 2||8
10051906|NCT02038829|11176913|FG001|STARTED|Treatment Period 2||8
10051907|NCT02038829|11176914|FG002|STARTED|Treatment Period 2||8
10051908|NCT02038829|11176915|FG003|STARTED|Treatment Period 2||8
10051909|NCT02038829|11176916|FG004|STARTED|Treatment Period 2||7
10051910|NCT02038829|11176917|FG005|STARTED|Treatment Period 2||8
10051911|NCT02038829|11176918|FG006|STARTED|Treatment Period 2||8
10051912|NCT02038829|11176919|FG007|STARTED|Treatment Period 2||8
10051913|NCT02038829|11176920|FG008|STARTED|Treatment Period 2||8
10118635|NCT02548312|11249500|FG004|NOT COMPLETED|Overall Study||34
10118636|NCT02548312|11249501|FG005|NOT COMPLETED|Overall Study||40
10051914|NCT02038829|11176921|FG009|STARTED|Treatment Period 2||8
10051915|NCT02038829|11176922|FG010|STARTED|Treatment Period 2||8
10051916|NCT02038829|11176923|FG011|STARTED|Treatment Period 2||8
9706646|NCT02513394|10805719|FG000|STARTED|Overall Study||2896
9706647|NCT02513394|10805720|FG001|STARTED|Overall Study||2900
10051917|NCT02038829|11176912|FG000|COMPLETED|Treatment Period 2||7
10051918|NCT02038829|11176913|FG001|COMPLETED|Treatment Period 2||8
10051919|NCT02038829|11176914|FG002|COMPLETED|Treatment Period 2||8
10051920|NCT02038829|11176915|FG003|COMPLETED|Treatment Period 2||8
10051921|NCT02038829|11176916|FG004|COMPLETED|Treatment Period 2||7
10051922|NCT02038829|11176917|FG005|COMPLETED|Treatment Period 2||8
10051923|NCT02038829|11176918|FG006|COMPLETED|Treatment Period 2||8
10051924|NCT02038829|11176919|FG007|COMPLETED|Treatment Period 2||8
10051925|NCT02038829|11176920|FG008|COMPLETED|Treatment Period 2||8
10051926|NCT02038829|11176921|FG009|COMPLETED|Treatment Period 2||8
10051927|NCT02038829|11176922|FG010|COMPLETED|Treatment Period 2||7
10051928|NCT02038829|11176923|FG011|COMPLETED|Treatment Period 2||8
10051929|NCT02038829|11176912|FG000|NOT COMPLETED|Treatment Period 2||1
10051930|NCT02038829|11176913|FG001|NOT COMPLETED|Treatment Period 2||0
10051931|NCT02038829|11176914|FG002|NOT COMPLETED|Treatment Period 2||0
10051932|NCT02038829|11176915|FG003|NOT COMPLETED|Treatment Period 2||0
10051933|NCT02038829|11176916|FG004|NOT COMPLETED|Treatment Period 2||0
10051934|NCT02038829|11176917|FG005|NOT COMPLETED|Treatment Period 2||0
10051935|NCT02038829|11176918|FG006|NOT COMPLETED|Treatment Period 2||0
10051936|NCT02038829|11176919|FG007|NOT COMPLETED|Treatment Period 2||0
10051937|NCT02038829|11176920|FG008|NOT COMPLETED|Treatment Period 2||0
10051938|NCT02038829|11176921|FG009|NOT COMPLETED|Treatment Period 2||0
10051939|NCT02038829|11176922|FG010|NOT COMPLETED|Treatment Period 2||1
10051940|NCT02038829|11176923|FG011|NOT COMPLETED|Treatment Period 2||0
10051941|NCT02038829|11176912|FG000|STARTED|Washout Period 2||7
10051942|NCT02038829|11176913|FG001|STARTED|Washout Period 2||8
10051943|NCT02038829|11176914|FG002|STARTED|Washout Period 2||8
10051944|NCT02038829|11176915|FG003|STARTED|Washout Period 2||8
10051945|NCT02038829|11176916|FG004|STARTED|Washout Period 2||7
10051946|NCT02038829|11176917|FG005|STARTED|Washout Period 2||8
10051947|NCT02038829|11176918|FG006|STARTED|Washout Period 2||8
10051948|NCT02038829|11176919|FG007|STARTED|Washout Period 2||8
10051949|NCT02038829|11176920|FG008|STARTED|Washout Period 2||8
10051950|NCT02038829|11176921|FG009|STARTED|Washout Period 2||8
10051951|NCT02038829|11176922|FG010|STARTED|Washout Period 2||7
10051952|NCT02038829|11176923|FG011|STARTED|Washout Period 2||8
10051953|NCT02038829|11176912|FG000|COMPLETED|Washout Period 2||7
10051954|NCT02038829|11176913|FG001|COMPLETED|Washout Period 2||8
10051955|NCT02038829|11176914|FG002|COMPLETED|Washout Period 2||8
10051956|NCT02038829|11176915|FG003|COMPLETED|Washout Period 2||8
10051957|NCT02038829|11176916|FG004|COMPLETED|Washout Period 2||7
10051958|NCT02038829|11176917|FG005|COMPLETED|Washout Period 2||7
10051959|NCT02038829|11176918|FG006|COMPLETED|Washout Period 2||8
10051960|NCT02038829|11176919|FG007|COMPLETED|Washout Period 2||8
10051961|NCT02038829|11176920|FG008|COMPLETED|Washout Period 2||7
10051962|NCT02038829|11176921|FG009|COMPLETED|Washout Period 2||8
10051963|NCT02038829|11176922|FG010|COMPLETED|Washout Period 2||7
10051964|NCT02038829|11176923|FG011|COMPLETED|Washout Period 2||8
10051965|NCT02038829|11176912|FG000|NOT COMPLETED|Washout Period 2||0
10051966|NCT02038829|11176913|FG001|NOT COMPLETED|Washout Period 2||0
10051967|NCT02038829|11176914|FG002|NOT COMPLETED|Washout Period 2||0
10051968|NCT02038829|11176915|FG003|NOT COMPLETED|Washout Period 2||0
10051969|NCT02038829|11176916|FG004|NOT COMPLETED|Washout Period 2||0
10051970|NCT02038829|11176917|FG005|NOT COMPLETED|Washout Period 2||1
10051971|NCT02038829|11176918|FG006|NOT COMPLETED|Washout Period 2||0
10051972|NCT02038829|11176919|FG007|NOT COMPLETED|Washout Period 2||0
10051973|NCT02038829|11176920|FG008|NOT COMPLETED|Washout Period 2||1
10051974|NCT02038829|11176921|FG009|NOT COMPLETED|Washout Period 2||0
10051975|NCT02038829|11176922|FG010|NOT COMPLETED|Washout Period 2||0
10051976|NCT02038829|11176923|FG011|NOT COMPLETED|Washout Period 2||0
10051977|NCT02038829|11176912|FG000|STARTED|Treatment Period 3||7
10051978|NCT02038829|11176913|FG001|STARTED|Treatment Period 3||8
10051979|NCT02038829|11176914|FG002|STARTED|Treatment Period 3||8
10051980|NCT02038829|11176915|FG003|STARTED|Treatment Period 3||8
10051981|NCT02038829|11176916|FG004|STARTED|Treatment Period 3||7
10051982|NCT02038829|11176917|FG005|STARTED|Treatment Period 3||7
10051983|NCT02038829|11176918|FG006|STARTED|Treatment Period 3||8
10051984|NCT02038829|11176919|FG007|STARTED|Treatment Period 3||8
10051985|NCT02038829|11176920|FG008|STARTED|Treatment Period 3||7
10051986|NCT02038829|11176921|FG009|STARTED|Treatment Period 3||8
10051987|NCT02038829|11176922|FG010|STARTED|Treatment Period 3||7
10051988|NCT02038829|11176923|FG011|STARTED|Treatment Period 3||8
10051989|NCT02038829|11176912|FG000|COMPLETED|Treatment Period 3||7
10051990|NCT02038829|11176913|FG001|COMPLETED|Treatment Period 3||8
10051991|NCT02038829|11176914|FG002|COMPLETED|Treatment Period 3||8
10051992|NCT02038829|11176915|FG003|COMPLETED|Treatment Period 3||8
10051993|NCT02038829|11176916|FG004|COMPLETED|Treatment Period 3||7
10051994|NCT02038829|11176917|FG005|COMPLETED|Treatment Period 3||7
10051995|NCT02038829|11176918|FG006|COMPLETED|Treatment Period 3||8
10051996|NCT02038829|11176919|FG007|COMPLETED|Treatment Period 3||8
10051997|NCT02038829|11176920|FG008|COMPLETED|Treatment Period 3||7
10051998|NCT02038829|11176921|FG009|COMPLETED|Treatment Period 3||8
10051999|NCT02038829|11176922|FG010|COMPLETED|Treatment Period 3||7
10052000|NCT02038829|11176923|FG011|COMPLETED|Treatment Period 3||8
10052001|NCT02038829|11176912|FG000|NOT COMPLETED|Treatment Period 3||0
10052002|NCT02038829|11176913|FG001|NOT COMPLETED|Treatment Period 3||0
10052003|NCT02038829|11176914|FG002|NOT COMPLETED|Treatment Period 3||0
10052004|NCT02038829|11176915|FG003|NOT COMPLETED|Treatment Period 3||0
10052005|NCT02038829|11176916|FG004|NOT COMPLETED|Treatment Period 3||0
10118637|NCT02548312|11249502|FG006|NOT COMPLETED|Overall Study||40
10118638|NCT02548312|11249503|FG007|NOT COMPLETED|Overall Study||42
10118639|NCT02548455|11249521|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
10052006|NCT02038829|11176917|FG005|NOT COMPLETED|Treatment Period 3||0
10052007|NCT02038829|11176918|FG006|NOT COMPLETED|Treatment Period 3||0
10052008|NCT02038829|11176919|FG007|NOT COMPLETED|Treatment Period 3||0
10052009|NCT02038829|11176920|FG008|NOT COMPLETED|Treatment Period 3||0
10052010|NCT02038829|11176921|FG009|NOT COMPLETED|Treatment Period 3||0
10052011|NCT02038829|11176922|FG010|NOT COMPLETED|Treatment Period 3||0
10052012|NCT02038829|11176923|FG011|NOT COMPLETED|Treatment Period 3||0
10052013|NCT02038829|11176912|FG000|STARTED|Washout Period 3||7
10052014|NCT02038829|11176913|FG001|STARTED|Washout Period 3||8
10052015|NCT02038829|11176914|FG002|STARTED|Washout Period 3||8
10052016|NCT02038829|11176915|FG003|STARTED|Washout Period 3||8
10052017|NCT02038829|11176916|FG004|STARTED|Washout Period 3||7
10052018|NCT02038829|11176917|FG005|STARTED|Washout Period 3||7
10052019|NCT02038829|11176918|FG006|STARTED|Washout Period 3||8
10052020|NCT02038829|11176919|FG007|STARTED|Washout Period 3||8
10052021|NCT02038829|11176920|FG008|STARTED|Washout Period 3||7
10052022|NCT02038829|11176921|FG009|STARTED|Washout Period 3||8
10052023|NCT02038829|11176922|FG010|STARTED|Washout Period 3||7
10052024|NCT02038829|11176923|FG011|STARTED|Washout Period 3||8
10052025|NCT02038829|11176912|FG000|COMPLETED|Washout Period 3||7
10052026|NCT02038829|11176913|FG001|COMPLETED|Washout Period 3||8
10052027|NCT02038829|11176914|FG002|COMPLETED|Washout Period 3||8
10052028|NCT02038829|11176915|FG003|COMPLETED|Washout Period 3||8
10052029|NCT02038829|11176916|FG004|COMPLETED|Washout Period 3||7
10052030|NCT02038829|11176917|FG005|COMPLETED|Washout Period 3||7
10052031|NCT02038829|11176918|FG006|COMPLETED|Washout Period 3||8
10052032|NCT02038829|11176919|FG007|COMPLETED|Washout Period 3||8
10052033|NCT02038829|11176920|FG008|COMPLETED|Washout Period 3||7
10052034|NCT02038829|11176921|FG009|COMPLETED|Washout Period 3||8
10052035|NCT02038829|11176922|FG010|COMPLETED|Washout Period 3||7
10052036|NCT02038829|11176923|FG011|COMPLETED|Washout Period 3||8
10052037|NCT02038829|11176912|FG000|NOT COMPLETED|Washout Period 3||0
10052038|NCT02038829|11176913|FG001|NOT COMPLETED|Washout Period 3||0
10052039|NCT02038829|11176914|FG002|NOT COMPLETED|Washout Period 3||0
10052040|NCT02038829|11176915|FG003|NOT COMPLETED|Washout Period 3||0
10052041|NCT02038829|11176916|FG004|NOT COMPLETED|Washout Period 3||0
10052042|NCT02038829|11176917|FG005|NOT COMPLETED|Washout Period 3||0
10052043|NCT02038829|11176918|FG006|NOT COMPLETED|Washout Period 3||0
10052044|NCT02038829|11176919|FG007|NOT COMPLETED|Washout Period 3||0
10052045|NCT02038829|11176920|FG008|NOT COMPLETED|Washout Period 3||0
10052046|NCT02038829|11176921|FG009|NOT COMPLETED|Washout Period 3||0
10052047|NCT02038829|11176922|FG010|NOT COMPLETED|Washout Period 3||0
10052048|NCT02038829|11176923|FG011|NOT COMPLETED|Washout Period 3||0
10052049|NCT02038829|11176912|FG000|STARTED|Treatment Period 4||7
10052050|NCT02038829|11176913|FG001|STARTED|Treatment Period 4||8
10052051|NCT02038829|11176914|FG002|STARTED|Treatment Period 4||8
10052052|NCT02038829|11176915|FG003|STARTED|Treatment Period 4||8
10052053|NCT02038829|11176916|FG004|STARTED|Treatment Period 4||7
10052054|NCT02038829|11176917|FG005|STARTED|Treatment Period 4||7
10052055|NCT02038829|11176918|FG006|STARTED|Treatment Period 4||8
10052056|NCT02038829|11176919|FG007|STARTED|Treatment Period 4||8
10052057|NCT02038829|11176920|FG008|STARTED|Treatment Period 4||7
10052058|NCT02038829|11176921|FG009|STARTED|Treatment Period 4||8
10052059|NCT02038829|11176922|FG010|STARTED|Treatment Period 4||7
10052060|NCT02038829|11176923|FG011|STARTED|Treatment Period 4||8
10052061|NCT02038829|11176912|FG000|COMPLETED|Treatment Period 4||7
10052062|NCT02038829|11176913|FG001|COMPLETED|Treatment Period 4||7
10052063|NCT02038829|11176914|FG002|COMPLETED|Treatment Period 4||8
10052064|NCT02038829|11176915|FG003|COMPLETED|Treatment Period 4||8
10052065|NCT02038829|11176916|FG004|COMPLETED|Treatment Period 4||7
10052066|NCT02038829|11176917|FG005|COMPLETED|Treatment Period 4||7
10052067|NCT02038829|11176918|FG006|COMPLETED|Treatment Period 4||8
10052068|NCT02038829|11176919|FG007|COMPLETED|Treatment Period 4||8
10052069|NCT02038829|11176920|FG008|COMPLETED|Treatment Period 4||7
10052070|NCT02038829|11176921|FG009|COMPLETED|Treatment Period 4||8
10052071|NCT02038829|11176922|FG010|COMPLETED|Treatment Period 4||7
10052072|NCT02038829|11176923|FG011|COMPLETED|Treatment Period 4||8
10052073|NCT02038829|11176912|FG000|NOT COMPLETED|Treatment Period 4||0
10052074|NCT02038829|11176913|FG001|NOT COMPLETED|Treatment Period 4||1
10052075|NCT02038829|11176914|FG002|NOT COMPLETED|Treatment Period 4||0
10052076|NCT02038829|11176915|FG003|NOT COMPLETED|Treatment Period 4||0
10052077|NCT02038829|11176916|FG004|NOT COMPLETED|Treatment Period 4||0
10052078|NCT02038829|11176917|FG005|NOT COMPLETED|Treatment Period 4||0
10052079|NCT02038829|11176918|FG006|NOT COMPLETED|Treatment Period 4||0
10052080|NCT02038829|11176919|FG007|NOT COMPLETED|Treatment Period 4||0
10052081|NCT02038829|11176920|FG008|NOT COMPLETED|Treatment Period 4||0
10052082|NCT02038829|11176921|FG009|NOT COMPLETED|Treatment Period 4||0
10052083|NCT02038829|11176922|FG010|NOT COMPLETED|Treatment Period 4||0
10052084|NCT02038829|11176923|FG011|NOT COMPLETED|Treatment Period 4||0
10052085|NCT02038829|11176912|FG000|STARTED|Washout Period 4||7
10052086|NCT02038829|11176913|FG001|STARTED|Washout Period 4||7
10052087|NCT02038829|11176914|FG002|STARTED|Washout Period 4||8
10052088|NCT02038829|11176915|FG003|STARTED|Washout Period 4||8
10052089|NCT02038829|11176916|FG004|STARTED|Washout Period 4||7
10052090|NCT02038829|11176917|FG005|STARTED|Washout Period 4||7
10052091|NCT02038829|11176918|FG006|STARTED|Washout Period 4||8
10052092|NCT02038829|11176919|FG007|STARTED|Washout Period 4||8
10052093|NCT02038829|11176920|FG008|STARTED|Washout Period 4||7
10052094|NCT02038829|11176921|FG009|STARTED|Washout Period 4||8
10052095|NCT02038829|11176922|FG010|STARTED|Washout Period 4||7
10052096|NCT02038829|11176923|FG011|STARTED|Washout Period 4||8
10052097|NCT02038829|11176912|FG000|COMPLETED|Washout Period 4||7
10052098|NCT02038829|11176913|FG001|COMPLETED|Washout Period 4||7
10052099|NCT02038829|11176914|FG002|COMPLETED|Washout Period 4||8
10052100|NCT02038829|11176915|FG003|COMPLETED|Washout Period 4||8
10052101|NCT02038829|11176916|FG004|COMPLETED|Washout Period 4||7
10052102|NCT02038829|11176917|FG005|COMPLETED|Washout Period 4||7
10052103|NCT02038829|11176918|FG006|COMPLETED|Washout Period 4||7
10052104|NCT02038829|11176919|FG007|COMPLETED|Washout Period 4||8
10052105|NCT02038829|11176920|FG008|COMPLETED|Washout Period 4||7
10052106|NCT02038829|11176921|FG009|COMPLETED|Washout Period 4||8
10052107|NCT02038829|11176922|FG010|COMPLETED|Washout Period 4||7
10052108|NCT02038829|11176923|FG011|COMPLETED|Washout Period 4||8
10052109|NCT02038829|11176912|FG000|NOT COMPLETED|Washout Period 4||0
10052110|NCT02038829|11176913|FG001|NOT COMPLETED|Washout Period 4||0
10052111|NCT02038829|11176914|FG002|NOT COMPLETED|Washout Period 4||0
10052112|NCT02038829|11176915|FG003|NOT COMPLETED|Washout Period 4||0
10052113|NCT02038829|11176916|FG004|NOT COMPLETED|Washout Period 4||0
10052114|NCT02038829|11176917|FG005|NOT COMPLETED|Washout Period 4||0
10052115|NCT02038829|11176918|FG006|NOT COMPLETED|Washout Period 4||1
10052116|NCT02038829|11176919|FG007|NOT COMPLETED|Washout Period 4||0
10052117|NCT02038829|11176920|FG008|NOT COMPLETED|Washout Period 4||0
10052118|NCT02038829|11176921|FG009|NOT COMPLETED|Washout Period 4||0
10052119|NCT02038829|11176922|FG010|NOT COMPLETED|Washout Period 4||0
10052120|NCT02038829|11176923|FG011|NOT COMPLETED|Washout Period 4||0
10052121|NCT02038829|11176912|FG000|STARTED|Treatment Period 5||7
10052122|NCT02038829|11176913|FG001|STARTED|Treatment Period 5||7
10052123|NCT02038829|11176914|FG002|STARTED|Treatment Period 5||8
10052124|NCT02038829|11176915|FG003|STARTED|Treatment Period 5||8
10052125|NCT02038829|11176916|FG004|STARTED|Treatment Period 5||7
10052126|NCT02038829|11176917|FG005|STARTED|Treatment Period 5||7
10052127|NCT02038829|11176918|FG006|STARTED|Treatment Period 5||7
10052128|NCT02038829|11176919|FG007|STARTED|Treatment Period 5||8
10052129|NCT02038829|11176920|FG008|STARTED|Treatment Period 5||7
10052130|NCT02038829|11176921|FG009|STARTED|Treatment Period 5||8
10052131|NCT02038829|11176922|FG010|STARTED|Treatment Period 5||7
10052132|NCT02038829|11176923|FG011|STARTED|Treatment Period 5||8
10052133|NCT02038829|11176912|FG000|COMPLETED|Treatment Period 5||7
10052134|NCT02038829|11176913|FG001|COMPLETED|Treatment Period 5||7
10052135|NCT02038829|11176914|FG002|COMPLETED|Treatment Period 5||8
10052136|NCT02038829|11176915|FG003|COMPLETED|Treatment Period 5||8
10052137|NCT02038829|11176916|FG004|COMPLETED|Treatment Period 5||7
10052138|NCT02038829|11176917|FG005|COMPLETED|Treatment Period 5||7
10052139|NCT02038829|11176918|FG006|COMPLETED|Treatment Period 5||7
10052140|NCT02038829|11176919|FG007|COMPLETED|Treatment Period 5||8
10052141|NCT02038829|11176920|FG008|COMPLETED|Treatment Period 5||7
10052142|NCT02038829|11176921|FG009|COMPLETED|Treatment Period 5||8
10052143|NCT02038829|11176922|FG010|COMPLETED|Treatment Period 5||7
10052144|NCT02038829|11176923|FG011|COMPLETED|Treatment Period 5||8
10052145|NCT02038829|11176912|FG000|NOT COMPLETED|Treatment Period 5||0
10052146|NCT02038829|11176913|FG001|NOT COMPLETED|Treatment Period 5||0
10052147|NCT02038829|11176914|FG002|NOT COMPLETED|Treatment Period 5||0
10052148|NCT02038829|11176915|FG003|NOT COMPLETED|Treatment Period 5||0
10052149|NCT02038829|11176916|FG004|NOT COMPLETED|Treatment Period 5||0
10052150|NCT02038829|11176917|FG005|NOT COMPLETED|Treatment Period 5||0
10052151|NCT02038829|11176918|FG006|NOT COMPLETED|Treatment Period 5||0
10052152|NCT02038829|11176919|FG007|NOT COMPLETED|Treatment Period 5||0
10052153|NCT02038829|11176920|FG008|NOT COMPLETED|Treatment Period 5||0
10052154|NCT02038829|11176921|FG009|NOT COMPLETED|Treatment Period 5||0
10052155|NCT02038829|11176922|FG010|NOT COMPLETED|Treatment Period 5||0
10052156|NCT02038829|11176923|FG011|NOT COMPLETED|Treatment Period 5||0
10052157|NCT02038829|11176912|FG000|STARTED|Washout Period 5||7
10052158|NCT02038829|11176913|FG001|STARTED|Washout Period 5||7
10052159|NCT02038829|11176914|FG002|STARTED|Washout Period 5||8
10052160|NCT02038829|11176915|FG003|STARTED|Washout Period 5||8
10052161|NCT02038829|11176916|FG004|STARTED|Washout Period 5||7
10052162|NCT02038829|11176917|FG005|STARTED|Washout Period 5||7
10052163|NCT02038829|11176918|FG006|STARTED|Washout Period 5||7
10052164|NCT02038829|11176919|FG007|STARTED|Washout Period 5||8
10052165|NCT02038829|11176920|FG008|STARTED|Washout Period 5||7
10052166|NCT02038829|11176921|FG009|STARTED|Washout Period 5||8
10052167|NCT02038829|11176922|FG010|STARTED|Washout Period 5||7
10052168|NCT02038829|11176923|FG011|STARTED|Washout Period 5||8
10118640|NCT02548455|11249521|FG000|Completed Pre-Discharge|Overall Study||484
10052169|NCT02038829|11176912|FG000|COMPLETED|Washout Period 5||7
10052170|NCT02038829|11176913|FG001|COMPLETED|Washout Period 5||7
10052171|NCT02038829|11176914|FG002|COMPLETED|Washout Period 5||8
10052172|NCT02038829|11176915|FG003|COMPLETED|Washout Period 5||8
10052173|NCT02038829|11176916|FG004|COMPLETED|Washout Period 5||7
10052174|NCT02038829|11176917|FG005|COMPLETED|Washout Period 5||7
10052175|NCT02038829|11176918|FG006|COMPLETED|Washout Period 5||7
10052176|NCT02038829|11176919|FG007|COMPLETED|Washout Period 5||8
10052177|NCT02038829|11176920|FG008|COMPLETED|Washout Period 5||7
10052178|NCT02038829|11176921|FG009|COMPLETED|Washout Period 5||8
10052179|NCT02038829|11176922|FG010|COMPLETED|Washout Period 5||7
10052180|NCT02038829|11176923|FG011|COMPLETED|Washout Period 5||8
10052181|NCT02038829|11176912|FG000|NOT COMPLETED|Washout Period 5||0
10052182|NCT02038829|11176913|FG001|NOT COMPLETED|Washout Period 5||0
10052183|NCT02038829|11176914|FG002|NOT COMPLETED|Washout Period 5||0
10052184|NCT02038829|11176915|FG003|NOT COMPLETED|Washout Period 5||0
10052185|NCT02038829|11176916|FG004|NOT COMPLETED|Washout Period 5||0
10052186|NCT02038829|11176917|FG005|NOT COMPLETED|Washout Period 5||0
10052187|NCT02038829|11176918|FG006|NOT COMPLETED|Washout Period 5||0
10052188|NCT02038829|11176919|FG007|NOT COMPLETED|Washout Period 5||0
10052189|NCT02038829|11176920|FG008|NOT COMPLETED|Washout Period 5||0
10052190|NCT02038829|11176921|FG009|NOT COMPLETED|Washout Period 5||0
10052191|NCT02038829|11176922|FG010|NOT COMPLETED|Washout Period 5||0
10052192|NCT02038829|11176923|FG011|NOT COMPLETED|Washout Period 5||0
10052193|NCT02038829|11176912|FG000|STARTED|Treatment Period 6||7
10052194|NCT02038829|11176913|FG001|STARTED|Treatment Period 6||7
10052195|NCT02038829|11176914|FG002|STARTED|Treatment Period 6||8
10118641|NCT02548455|11249521|FG000|Completed 6-Month Follow-up|Overall Study||259
10118642|NCT02548455|11249521|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
10118643|NCT02548455|11249521|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
10118644|NCT02548455|11249521|FG000|NOT COMPLETED|Overall Study||240
10118645|NCT02548585|11249532|FG000|STARTED|Overall Study||45
10118646|NCT02548585|11249533|FG001|STARTED|Overall Study||6
10118647|NCT02548585|11249534|FG002|STARTED|Overall Study||6
10118648|NCT02548585|11249535|FG003|STARTED|Overall Study||7
10118649|NCT02548585|11249536|FG004|STARTED|Overall Study||25
10118650|NCT02548585|11249537|FG005|STARTED|Overall Study||12
10118651|NCT02548585|11249538|FG006|STARTED|Overall Study||12
10118652|NCT02548585|11249532|FG000|Treated|Overall Study||45
10118653|NCT02548585|11249533|FG001|Treated|Overall Study||6
10118654|NCT02548585|11249534|FG002|Treated|Overall Study||6
10118655|NCT02548585|11249535|FG003|Treated|Overall Study||7
10118656|NCT02548585|11249536|FG004|Treated|Overall Study||25
10118657|NCT02548585|11249537|FG005|Treated|Overall Study||11
10118658|NCT02548585|11249538|FG006|Treated|Overall Study||12
10118659|NCT02548585|11249532|FG000|COMPLETED|Overall Study||43
10118660|NCT02548585|11249533|FG001|COMPLETED|Overall Study||6
10118661|NCT02548585|11249534|FG002|COMPLETED|Overall Study||6
10118662|NCT02548585|11249535|FG003|COMPLETED|Overall Study||5
10118663|NCT02548585|11249536|FG004|COMPLETED|Overall Study||22
10118664|NCT02548585|11249537|FG005|COMPLETED|Overall Study||10
10118665|NCT02548585|11249538|FG006|COMPLETED|Overall Study||11
10118666|NCT02548585|11249532|FG000|NOT COMPLETED|Overall Study||2
10118667|NCT02548585|11249533|FG001|NOT COMPLETED|Overall Study||0
10118668|NCT02548585|11249534|FG002|NOT COMPLETED|Overall Study||0
10118669|NCT02548585|11249535|FG003|NOT COMPLETED|Overall Study||2
10118670|NCT02548585|11249536|FG004|NOT COMPLETED|Overall Study||3
10118671|NCT02548585|11249537|FG005|NOT COMPLETED|Overall Study||2
10118672|NCT02548585|11249538|FG006|NOT COMPLETED|Overall Study||1
10118673|NCT02548650|11249581|FG000|STARTED|Triple Therapy||30
10118674|NCT02548650|11249582|FG001|STARTED|Triple Therapy||36
10118675|NCT02548650|11249581|FG000|COMPLETED|Triple Therapy||29
10118676|NCT02548650|11249582|FG001|COMPLETED|Triple Therapy||32
10118677|NCT02548650|11249581|FG000|NOT COMPLETED|Triple Therapy||1
10118678|NCT02548650|11249582|FG001|NOT COMPLETED|Triple Therapy||4
10118679|NCT02548650|11249581|FG000|STARTED|Double Therapy||29
10118680|NCT02548650|11249582|FG001|STARTED|Double Therapy||32
10118681|NCT02548650|11249581|FG000|COMPLETED|Double Therapy||28
10118682|NCT02548650|11249582|FG001|COMPLETED|Double Therapy||30
10118683|NCT02548650|11249581|FG000|NOT COMPLETED|Double Therapy||1
10118684|NCT02548650|11249582|FG001|NOT COMPLETED|Double Therapy||2
10118685|NCT02548728|11249590|FG000|STARTED|Overall Study||6
10118686|NCT02548728|11249591|FG001|STARTED|Overall Study||6
10118687|NCT02548728|11249590|FG000|COMPLETED|Overall Study||6
10052196|NCT02038829|11176915|FG003|STARTED|Treatment Period 6||8
10052197|NCT02038829|11176916|FG004|STARTED|Treatment Period 6||7
10052198|NCT02038829|11176917|FG005|STARTED|Treatment Period 6||7
10052199|NCT02038829|11176918|FG006|STARTED|Treatment Period 6||7
10052200|NCT02038829|11176919|FG007|STARTED|Treatment Period 6||8
10052201|NCT02038829|11176920|FG008|STARTED|Treatment Period 6||7
10052202|NCT02038829|11176921|FG009|STARTED|Treatment Period 6||8
10118688|NCT02548728|11249591|FG001|COMPLETED|Overall Study||6
10052203|NCT02038829|11176922|FG010|STARTED|Treatment Period 6||7
10052204|NCT02038829|11176923|FG011|STARTED|Treatment Period 6||8
10052205|NCT02038829|11176912|FG000|COMPLETED|Treatment Period 6||7
10052206|NCT02038829|11176913|FG001|COMPLETED|Treatment Period 6||7
10052207|NCT02038829|11176914|FG002|COMPLETED|Treatment Period 6||7
10052208|NCT02038829|11176915|FG003|COMPLETED|Treatment Period 6||8
10052209|NCT02038829|11176916|FG004|COMPLETED|Treatment Period 6||7
10052210|NCT02038829|11176917|FG005|COMPLETED|Treatment Period 6||7
10052211|NCT02038829|11176918|FG006|COMPLETED|Treatment Period 6||7
10052212|NCT02038829|11176919|FG007|COMPLETED|Treatment Period 6||8
10052213|NCT02038829|11176920|FG008|COMPLETED|Treatment Period 6||7
10052214|NCT02038829|11176921|FG009|COMPLETED|Treatment Period 6||8
10052215|NCT02038829|11176922|FG010|COMPLETED|Treatment Period 6||7
10052216|NCT02038829|11176923|FG011|COMPLETED|Treatment Period 6||8
10052217|NCT02038829|11176912|FG000|NOT COMPLETED|Treatment Period 6||0
10052218|NCT02038829|11176913|FG001|NOT COMPLETED|Treatment Period 6||0
10052219|NCT02038829|11176914|FG002|NOT COMPLETED|Treatment Period 6||1
10052220|NCT02038829|11176915|FG003|NOT COMPLETED|Treatment Period 6||0
10052221|NCT02038829|11176916|FG004|NOT COMPLETED|Treatment Period 6||0
10052222|NCT02038829|11176917|FG005|NOT COMPLETED|Treatment Period 6||0
10052223|NCT02038829|11176918|FG006|NOT COMPLETED|Treatment Period 6||0
10052224|NCT02038829|11176919|FG007|NOT COMPLETED|Treatment Period 6||0
10052225|NCT02038829|11176920|FG008|NOT COMPLETED|Treatment Period 6||0
10052226|NCT02038829|11176921|FG009|NOT COMPLETED|Treatment Period 6||0
10052227|NCT02038829|11176922|FG010|NOT COMPLETED|Treatment Period 6||0
10052228|NCT02038829|11176923|FG011|NOT COMPLETED|Treatment Period 6||0
10052229|NCT02038881|11176941|FG000|STARTED|Overall Study||27
10052230|NCT02038881|11176942|FG001|STARTED|Overall Study||29
10052231|NCT02038881|11176943|FG002|STARTED|Overall Study||31
10052232|NCT02038881|11176941|FG000|COMPLETED|Overall Study||24
10052233|NCT02038881|11176942|FG001|COMPLETED|Overall Study||29
10052234|NCT02038881|11176943|FG002|COMPLETED|Overall Study||30
10052235|NCT02038881|11176941|FG000|NOT COMPLETED|Overall Study||3
10052236|NCT02038881|11176942|FG001|NOT COMPLETED|Overall Study||0
10052237|NCT02038881|11176943|FG002|NOT COMPLETED|Overall Study||1
10052238|NCT02038894|11176956|FG000|STARTED|Overall Study||60
10052239|NCT02038894|11176957|FG001|STARTED|Overall Study||58
10052240|NCT02038894|11176958|FG002|STARTED|Overall Study||61
10052241|NCT02038894|11176956|FG000|COMPLETED|Overall Study||60
10052242|NCT02038894|11176957|FG001|COMPLETED|Overall Study||58
10052243|NCT02038894|11176958|FG002|COMPLETED|Overall Study||61
10052244|NCT02038894|11176956|FG000|NOT COMPLETED|Overall Study||0
10052245|NCT02038894|11176957|FG001|NOT COMPLETED|Overall Study||0
10052246|NCT02038894|11176958|FG002|NOT COMPLETED|Overall Study||0
10052247|NCT02038907|11176984|FG000|STARTED|Overall Study||30
10052248|NCT02038907|11176985|FG001|STARTED|Overall Study||30
10052249|NCT02038907|11176986|FG002|STARTED|Overall Study||30
10052250|NCT02038907|11176987|FG003|STARTED|Overall Study||31
10052251|NCT02038907|11176988|FG004|STARTED|Overall Study||30
10052252|NCT02038907|11176989|FG005|STARTED|Overall Study||31
10052253|NCT02038907|11176990|FG006|STARTED|Overall Study||30
10052254|NCT02038907|11176991|FG007|STARTED|Overall Study||32
10052255|NCT02038907|11176992|FG008|STARTED|Overall Study||29
10052256|NCT02038907|11176993|FG009|STARTED|Overall Study||30
10052257|NCT02038907|11176994|FG010|STARTED|Overall Study||29
10052258|NCT02038907|11176995|FG011|STARTED|Overall Study||28
10052259|NCT02038907|11176996|FG012|STARTED|Overall Study||29
10052260|NCT02038907|11176997|FG013|STARTED|Overall Study||31
10052261|NCT02038907|11176984|FG000|COMPLETED|Overall Study||30
10052262|NCT02038907|11176985|FG001|COMPLETED|Overall Study||30
10052263|NCT02038907|11176986|FG002|COMPLETED|Overall Study||30
10052264|NCT02038907|11176987|FG003|COMPLETED|Overall Study||31
10052265|NCT02038907|11176988|FG004|COMPLETED|Overall Study||30
10052266|NCT02038907|11176989|FG005|COMPLETED|Overall Study||31
10052267|NCT02038907|11176990|FG006|COMPLETED|Overall Study||30
10052268|NCT02038907|11176991|FG007|COMPLETED|Overall Study||32
10052269|NCT02038907|11176992|FG008|COMPLETED|Overall Study||29
10052270|NCT02038907|11176993|FG009|COMPLETED|Overall Study||30
10052271|NCT02038907|11176994|FG010|COMPLETED|Overall Study||27
10052272|NCT02038907|11176995|FG011|COMPLETED|Overall Study||28
10052273|NCT02038907|11176996|FG012|COMPLETED|Overall Study||29
10052274|NCT02038907|11176997|FG013|COMPLETED|Overall Study||31
10052275|NCT02038907|11176984|FG000|NOT COMPLETED|Overall Study||0
10052276|NCT02038907|11176985|FG001|NOT COMPLETED|Overall Study||0
10052277|NCT02038907|11176986|FG002|NOT COMPLETED|Overall Study||0
10052278|NCT02038907|11176987|FG003|NOT COMPLETED|Overall Study||0
10052279|NCT02038907|11176988|FG004|NOT COMPLETED|Overall Study||0
10052280|NCT02038907|11176989|FG005|NOT COMPLETED|Overall Study||0
10052281|NCT02038907|11176990|FG006|NOT COMPLETED|Overall Study||0
10052282|NCT02038907|11176991|FG007|NOT COMPLETED|Overall Study||0
10052283|NCT02038907|11176992|FG008|NOT COMPLETED|Overall Study||0
10052284|NCT02038907|11176993|FG009|NOT COMPLETED|Overall Study||0
10052285|NCT02038907|11176994|FG010|NOT COMPLETED|Overall Study||2
10052286|NCT02038907|11176995|FG011|NOT COMPLETED|Overall Study||0
10052287|NCT02038907|11176996|FG012|NOT COMPLETED|Overall Study||0
10052288|NCT02038907|11176997|FG013|NOT COMPLETED|Overall Study||0
10052289|NCT02038920|11177031|FG000|STARTED|Induction Phase (Week 0 to 14)||79
10052290|NCT02038920|11177032|FG001|STARTED|Induction Phase (Week 0 to 14)||78
10052291|NCT02038920|11177033|FG002|STARTED|Induction Phase (Week 0 to 14)||0
10052292|NCT02038920|11177034|FG003|STARTED|Induction Phase (Week 0 to 14)||0
10052293|NCT02038920|11177035|FG004|STARTED|Induction Phase (Week 0 to 14)||0
10052294|NCT02038920|11177036|FG005|STARTED|Induction Phase (Week 0 to 14)||0
10052295|NCT02038920|11177031|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73
10052296|NCT02038920|11177032|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66
10052297|NCT02038920|11177033|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0
10052298|NCT02038920|11177034|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0
10052299|NCT02038920|11177035|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0
10052300|NCT02038920|11177036|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0
10052301|NCT02038920|11177031|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
10052302|NCT02038920|11177032|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
10052303|NCT02038920|11177033|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10052304|NCT02038920|11177034|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10052305|NCT02038920|11177035|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10052306|NCT02038920|11177036|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10052307|NCT02038920|11177031|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0
10052308|NCT02038920|11177032|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0
10052309|NCT02038920|11177033|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12
10052310|NCT02038920|11177034|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12
10052311|NCT02038920|11177035|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17
10052312|NCT02038920|11177036|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0
10052313|NCT02038920|11177031|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0
10052314|NCT02038920|11177032|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0
10052315|NCT02038920|11177033|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7
10052316|NCT02038920|11177034|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4
10052317|NCT02038920|11177035|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5
10052318|NCT02038920|11177036|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0
10052319|NCT02038920|11177031|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
10052320|NCT02038920|11177032|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
10052321|NCT02038920|11177033|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
10052322|NCT02038920|11177034|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
10052323|NCT02038920|11177035|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
10052324|NCT02038920|11177036|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
10052325|NCT02038920|11177031|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0
10052326|NCT02038920|11177032|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0
10052327|NCT02038920|11177033|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0
10052328|NCT02038920|11177034|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0
10052329|NCT02038920|11177035|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0
10052330|NCT02038920|11177036|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134
10052331|NCT02038920|11177031|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052332|NCT02038920|11177032|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052333|NCT02038920|11177033|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052334|NCT02038920|11177034|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052335|NCT02038920|11177035|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052336|NCT02038920|11177036|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57
10052337|NCT02038920|11177031|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052338|NCT02038920|11177032|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052339|NCT02038920|11177033|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052340|NCT02038920|11177034|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052341|NCT02038920|11177035|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10052342|NCT02038920|11177036|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
10052343|NCT02038933|11177055|FG000|STARTED|Overall Study||121
10052344|NCT02038933|11177055|FG000|COMPLETED|Overall Study||0
10052345|NCT02038933|11177055|FG000|NOT COMPLETED|Overall Study||121
10052346|NCT02038959|11177062|FG000|STARTED|Overall Study||98
10052347|NCT02038959|11177063|FG001|STARTED|Overall Study||97
10052348|NCT02038959|11177062|FG000|COMPLETED|Overall Study||92
10052349|NCT02038959|11177063|FG001|COMPLETED|Overall Study||89
10052350|NCT02038959|11177062|FG000|NOT COMPLETED|Overall Study||6
10052351|NCT02038959|11177063|FG001|NOT COMPLETED|Overall Study||8
10052352|NCT02039115|11177071|FG000|STARTED|Overall Study||1
10052353|NCT02039115|11177072|FG001|STARTED|Overall Study||0
10052354|NCT02039115|11177071|FG000|COMPLETED|Overall Study||1
10052355|NCT02039115|11177072|FG001|COMPLETED|Overall Study||0
10052356|NCT02039115|11177071|FG000|NOT COMPLETED|Overall Study||0
10052357|NCT02039115|11177072|FG001|NOT COMPLETED|Overall Study||0
10052358|NCT02039219|11177080|FG000|STARTED|Treatment||11
10052359|NCT02039219|11177081|FG001|STARTED|Treatment||8
10052360|NCT02039219|11177080|FG000|COMPLETED|Treatment||7
10052361|NCT02039219|11177081|FG001|COMPLETED|Treatment||6
10052362|NCT02039219|11177080|FG000|NOT COMPLETED|Treatment||4
10052363|NCT02039219|11177081|FG001|NOT COMPLETED|Treatment||2
10052364|NCT02039219|11177080|FG000|STARTED|Follow up||7
10052365|NCT02039219|11177081|FG001|STARTED|Follow up||6
10052366|NCT02039219|11177080|FG000|COMPLETED|Follow up||7
10052367|NCT02039219|11177081|FG001|COMPLETED|Follow up||5
10052368|NCT02039219|11177080|FG000|NOT COMPLETED|Follow up||0
10052369|NCT02039219|11177081|FG001|NOT COMPLETED|Follow up||1
10052370|NCT02039375|11177087|FG000|STARTED|Overall Study||35
10052371|NCT02039375|11177087|FG000|COMPLETED|Overall Study||33
10052372|NCT02039375|11177087|FG000|NOT COMPLETED|Overall Study||2
10052373|NCT02039414|11177093|FG000|STARTED|Overall Study||22
10052374|NCT02039414|11177094|FG001|STARTED|Overall Study||18
10052375|NCT02039414|11177093|FG000|COMPLETED|Overall Study||16
10052376|NCT02039414|11177094|FG001|COMPLETED|Overall Study||16
10052377|NCT02039414|11177093|FG000|NOT COMPLETED|Overall Study||6
10052378|NCT02039414|11177094|FG001|NOT COMPLETED|Overall Study||2
10052379|NCT02039427|11177104|FG000|STARTED|Overall Study||48
10052380|NCT02039427|11177105|FG001|STARTED|Overall Study||48
10052381|NCT02039427|11177106|FG002|STARTED|Overall Study||48
10052382|NCT02039427|11177107|FG003|STARTED|Overall Study||48
10052383|NCT02039427|11177104|FG000|COMPLETED|Overall Study||45
10052384|NCT02039427|11177105|FG001|COMPLETED|Overall Study||47
10052385|NCT02039427|11177106|FG002|COMPLETED|Overall Study||45
10052386|NCT02039427|11177107|FG003|COMPLETED|Overall Study||43
10052387|NCT02039427|11177104|FG000|NOT COMPLETED|Overall Study||3
10052388|NCT02039427|11177105|FG001|NOT COMPLETED|Overall Study||1
10052389|NCT02039427|11177106|FG002|NOT COMPLETED|Overall Study||3
10052390|NCT02039427|11177107|FG003|NOT COMPLETED|Overall Study||5
10052391|NCT02039505|11177124|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82
10052392|NCT02039505|11177125|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164
10052393|NCT02039505|11177126|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46
10052394|NCT02039505|11177127|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0
10052395|NCT02039505|11177128|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0
10052396|NCT02039505|11177129|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0
10052397|NCT02039505|11177130|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0
10052398|NCT02039505|11177124|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78
10052399|NCT02039505|11177125|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155
10052400|NCT02039505|11177126|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36
10052401|NCT02039505|11177127|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052402|NCT02039505|11177128|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052403|NCT02039505|11177129|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052404|NCT02039505|11177130|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052405|NCT02039505|11177124|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
10052406|NCT02039505|11177125|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
10052407|NCT02039505|11177126|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
10052408|NCT02039505|11177127|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052409|NCT02039505|11177128|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052410|NCT02039505|11177129|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052411|NCT02039505|11177130|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10052412|NCT02039505|11177124|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10052413|NCT02039505|11177125|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10052414|NCT02039505|11177126|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10052415|NCT02039505|11177127|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42
10052416|NCT02039505|11177128|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41
10052417|NCT02039505|11177129|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26
10052418|NCT02039505|11177130|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10052419|NCT02039505|11177124|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052420|NCT02039505|11177125|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052421|NCT02039505|11177126|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052422|NCT02039505|11177127|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
10052423|NCT02039505|11177128|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
10052424|NCT02039505|11177129|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
10052425|NCT02039505|11177130|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052426|NCT02039505|11177124|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052427|NCT02039505|11177125|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052428|NCT02039505|11177126|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052429|NCT02039505|11177127|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
10052430|NCT02039505|11177128|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
10052431|NCT02039505|11177129|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
10052432|NCT02039505|11177130|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10052433|NCT02039505|11177124|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0
10052434|NCT02039505|11177125|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0
10052435|NCT02039505|11177126|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0
10052436|NCT02039505|11177127|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0
10052437|NCT02039505|11177128|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0
10052438|NCT02039505|11177129|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0
10052439|NCT02039505|11177130|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259
10052440|NCT02039505|11177124|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052441|NCT02039505|11177125|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052442|NCT02039505|11177126|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052443|NCT02039505|11177127|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052444|NCT02039505|11177128|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052445|NCT02039505|11177129|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052446|NCT02039505|11177130|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188
10052447|NCT02039505|11177124|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052448|NCT02039505|11177125|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052449|NCT02039505|11177126|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052450|NCT02039505|11177127|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052451|NCT02039505|11177128|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052452|NCT02039505|11177129|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10052453|NCT02039505|11177130|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
10052454|NCT02039674|11177164|FG000|STARTED|Overall Study||13
10052455|NCT02039674|11177165|FG001|STARTED|Overall Study||12
10052456|NCT02039674|11177166|FG002|STARTED|Overall Study||12
10052457|NCT02039674|11177167|FG003|STARTED|Overall Study||13
10052458|NCT02039674|11177168|FG004|STARTED|Overall Study||12
10052459|NCT02039674|11177169|FG005|STARTED|Overall Study||12
10052460|NCT02039674|11177170|FG006|STARTED|Overall Study||3
10052461|NCT02039674|11177171|FG007|STARTED|Overall Study||3
10052462|NCT02039674|11177172|FG008|STARTED|Overall Study||12
10052463|NCT02039674|11177173|FG009|STARTED|Overall Study||12
10052464|NCT02039674|11177174|FG010|STARTED|Overall Study||7
10052465|NCT02039674|11177175|FG011|STARTED|Overall Study||60
10052466|NCT02039674|11177176|FG012|STARTED|Overall Study||63
10052467|NCT02039674|11177177|FG013|STARTED|Overall Study||33
10052468|NCT02039674|11177164|FG000|Treated|Overall Study||13
10052469|NCT02039674|11177165|FG001|Treated|Overall Study||12
10052470|NCT02039674|11177166|FG002|Treated|Overall Study||11
10052471|NCT02039674|11177167|FG003|Treated|Overall Study||13
10052472|NCT02039674|11177168|FG004|Treated|Overall Study||12
10052473|NCT02039674|11177169|FG005|Treated|Overall Study||12
10052474|NCT02039674|11177170|FG006|Treated|Overall Study||3
10052475|NCT02039674|11177171|FG007|Treated|Overall Study||3
10052476|NCT02039674|11177172|FG008|Treated|Overall Study||12
10052477|NCT02039674|11177173|FG009|Treated|Overall Study||12
10052478|NCT02039674|11177174|FG010|Treated|Overall Study||7
10052479|NCT02039674|11177175|FG011|Treated|Overall Study||59
10052480|NCT02039674|11177176|FG012|Treated|Overall Study||62
10052481|NCT02039674|11177177|FG013|Treated|Overall Study||33
10052482|NCT02039674|11177164|FG000|COMPLETED|Overall Study||1
10052483|NCT02039674|11177165|FG001|COMPLETED|Overall Study||0
10052484|NCT02039674|11177166|FG002|COMPLETED|Overall Study||0
10052485|NCT02039674|11177167|FG003|COMPLETED|Overall Study||0
10052486|NCT02039674|11177168|FG004|COMPLETED|Overall Study||0
10052487|NCT02039674|11177169|FG005|COMPLETED|Overall Study||0
10052488|NCT02039674|11177170|FG006|COMPLETED|Overall Study||0
10052489|NCT02039674|11177171|FG007|COMPLETED|Overall Study||0
10052490|NCT02039674|11177172|FG008|COMPLETED|Overall Study||0
10052491|NCT02039674|11177173|FG009|COMPLETED|Overall Study||0
10052492|NCT02039674|11177174|FG010|COMPLETED|Overall Study||0
10052493|NCT02039674|11177175|FG011|COMPLETED|Overall Study||0
10052494|NCT02039674|11177176|FG012|COMPLETED|Overall Study||0
10052495|NCT02039674|11177177|FG013|COMPLETED|Overall Study||0
10052496|NCT02039674|11177164|FG000|NOT COMPLETED|Overall Study||12
10052497|NCT02039674|11177165|FG001|NOT COMPLETED|Overall Study||12
10052498|NCT02039674|11177166|FG002|NOT COMPLETED|Overall Study||12
10052499|NCT02039674|11177167|FG003|NOT COMPLETED|Overall Study||13
10052500|NCT02039674|11177168|FG004|NOT COMPLETED|Overall Study||12
10052501|NCT02039674|11177169|FG005|NOT COMPLETED|Overall Study||12
10052502|NCT02039674|11177170|FG006|NOT COMPLETED|Overall Study||3
10052503|NCT02039674|11177171|FG007|NOT COMPLETED|Overall Study||3
10052504|NCT02039674|11177172|FG008|NOT COMPLETED|Overall Study||12
10052505|NCT02039674|11177173|FG009|NOT COMPLETED|Overall Study||12
10052506|NCT02039674|11177174|FG010|NOT COMPLETED|Overall Study||7
10052507|NCT02039674|11177175|FG011|NOT COMPLETED|Overall Study||60
10052508|NCT02039674|11177176|FG012|NOT COMPLETED|Overall Study||63
10052509|NCT02039674|11177177|FG013|NOT COMPLETED|Overall Study||33
10052510|NCT02039687|11177214|FG000|STARTED|Overall Study||16
10052511|NCT02039687|11177215|FG001|STARTED|Overall Study||16
10052512|NCT02039687|11177216|FG002|STARTED|Overall Study||16
10052513|NCT02039687|11177217|FG003|STARTED|Overall Study||16
10052514|NCT02039687|11177214|FG000|COMPLETED|Overall Study||16
10052515|NCT02039687|11177215|FG001|COMPLETED|Overall Study||15
10052516|NCT02039687|11177216|FG002|COMPLETED|Overall Study||13
10052517|NCT02039687|11177217|FG003|COMPLETED|Overall Study||16
10052518|NCT02039687|11177214|FG000|NOT COMPLETED|Overall Study||0
10052519|NCT02039687|11177215|FG001|NOT COMPLETED|Overall Study||1
10052520|NCT02039687|11177216|FG002|NOT COMPLETED|Overall Study||3
10118689|NCT02548728|11249590|FG000|NOT COMPLETED|Overall Study||0
10052521|NCT02039687|11177217|FG003|NOT COMPLETED|Overall Study||0
10118690|NCT02548728|11249591|FG001|NOT COMPLETED|Overall Study||0
10118691|NCT02548845|11249597|FG000|STARTED|Overall Study||70
10118692|NCT02548845|11249597|FG000|COMPLETED|Overall Study||70
10118693|NCT02548845|11249597|FG000|NOT COMPLETED|Overall Study||0
10118694|NCT02548910|11249607|FG000|STARTED|Overall Study||31
10118695|NCT02548910|11249608|FG001|STARTED|Overall Study||31
10118696|NCT02548910|11249607|FG000|COMPLETED|Overall Study||31
10118697|NCT02548910|11249608|FG001|COMPLETED|Overall Study||31
10118698|NCT02548910|11249607|FG000|NOT COMPLETED|Overall Study||0
10118699|NCT02548910|11249608|FG001|NOT COMPLETED|Overall Study||0
10118700|NCT02548949|11249615|FG000|STARTED|Overall Study||700
10118701|NCT02548949|11249615|FG000|COMPLETED|Overall Study||700
10118702|NCT02548949|11249615|FG000|NOT COMPLETED|Overall Study||0
10118703|NCT02548962|11249621|FG000|STARTED|Overall Study||8
10118704|NCT02548962|11249622|FG001|STARTED|Overall Study||3
10118705|NCT02548962|11249621|FG000|COMPLETED|Overall Study||7
10118706|NCT02548962|11249622|FG001|COMPLETED|Overall Study||3
10118707|NCT02548962|11249621|FG000|NOT COMPLETED|Overall Study||1
10118708|NCT02548962|11249622|FG001|NOT COMPLETED|Overall Study||0
10118709|NCT02549014|11249632|FG000|STARTED|Overall Study||8
10118710|NCT02549014|11249633|FG001|STARTED|Overall Study||8
10052522|NCT02039726|11177229|FG000|STARTED|Overall Study||245
10052523|NCT02039726|11177230|FG001|STARTED|Overall Study||122
10052524|NCT02039726|11177229|FG000|Ongoing (as of Data Cutoff)|Overall Study||45
10052525|NCT02039726|11177230|FG001|Ongoing (as of Data Cutoff)|Overall Study||16
10052526|NCT02039726|11177229|FG000|Did Not Receive Treatment|Overall Study||4
10052527|NCT02039726|11177230|FG001|Did Not Receive Treatment|Overall Study||28
10052528|NCT02039726|11177229|FG000|COMPLETED|Overall Study||200
10052529|NCT02039726|11177230|FG001|COMPLETED|Overall Study||106
10052530|NCT02039726|11177229|FG000|NOT COMPLETED|Overall Study||45
10052531|NCT02039726|11177230|FG001|NOT COMPLETED|Overall Study||16
10052532|NCT02039778|11177236|FG000|STARTED|Overall Study||4
10052533|NCT02039778|11177236|FG000|COMPLETED|Overall Study||0
10052534|NCT02039778|11177236|FG000|NOT COMPLETED|Overall Study||4
10052535|NCT02039817|11177242|FG000|STARTED|Overall Study||8
10052536|NCT02039817|11177243|FG001|STARTED|Overall Study||8
10052537|NCT02039817|11177242|FG000|COMPLETED|Overall Study||8
10052538|NCT02039817|11177243|FG001|COMPLETED|Overall Study||8
10052539|NCT02039817|11177242|FG000|NOT COMPLETED|Overall Study||0
10052540|NCT02039817|11177243|FG001|NOT COMPLETED|Overall Study||0
10052541|NCT02039856|11177250|FG000|STARTED|Overall Study||2720
10052542|NCT02039856|11177251|FG001|STARTED|Overall Study||1180
10052543|NCT02039856|11177250|FG000|Baseline Started - Patients|Overall Study||2183
10052544|NCT02039856|11177251|FG001|Baseline Started - Patients|Overall Study||919
10052545|NCT02039856|11177250|FG000|Baseline Completed - Patients|Overall Study||953
10052546|NCT02039856|11177251|FG001|Baseline Completed - Patients|Overall Study||442
10052547|NCT02039856|11177250|FG000|Baseline Started - Providers/Staff|Overall Study||537
10052548|NCT02039856|11177251|FG001|Baseline Started - Providers/Staff|Overall Study||261
10052549|NCT02039856|11177250|FG000|Baseline Completed -Providers/Staff|Overall Study||194
10052550|NCT02039856|11177251|FG001|Baseline Completed -Providers/Staff|Overall Study||94
10052551|NCT02039856|11177250|FG000|Total Baseline Completed|Overall Study||1147
10052552|NCT02039856|11177251|FG001|Total Baseline Completed|Overall Study||536
10052553|NCT02039856|11177250|FG000|12-month Started-patients|Overall Study||953
10052554|NCT02039856|11177251|FG001|12-month Started-patients|Overall Study||442
10052555|NCT02039856|11177250|FG000|12-month Completed- Patients|Overall Study||580
10052556|NCT02039856|11177251|FG001|12-month Completed- Patients|Overall Study||241
10052557|NCT02039856|11177250|FG000|12-month Providers/Staff|Overall Study||0
10052558|NCT02039856|11177251|FG001|12-month Providers/Staff|Overall Study||0
10052559|NCT02039856|11177250|FG000|24-month Started|Overall Study||1518
10052560|NCT02039856|11177251|FG001|24-month Started|Overall Study||746
10052561|NCT02039856|11177250|FG000|24-month Started - Patients|Overall Study||953
10052562|NCT02039856|11177251|FG001|24-month Started - Patients|Overall Study||442
10052563|NCT02039856|11177250|FG000|24-month Completed - Patients|Overall Study||519
10052564|NCT02039856|11177251|FG001|24-month Completed - Patients|Overall Study||222
10052565|NCT02039856|11177250|FG000|24-month Started Providers/Staff|Overall Study||565
10052566|NCT02039856|11177251|FG001|24-month Started Providers/Staff|Overall Study||304
10052567|NCT02039856|11177250|FG000|24-month Completed Providers/Staff|Overall Study||174
10052568|NCT02039856|11177251|FG001|24-month Completed Providers/Staff|Overall Study||105
10052569|NCT02039856|11177250|FG000|Total 24-month Completed|Overall Study||693
10052570|NCT02039856|11177251|FG001|Total 24-month Completed|Overall Study||327
10052571|NCT02039856|11177250|FG000|COMPLETED|Overall Study||693
10052572|NCT02039856|11177251|FG001|COMPLETED|Overall Study||327
10052573|NCT02039856|11177250|FG000|NOT COMPLETED|Overall Study||2027
10052574|NCT02039856|11177251|FG001|NOT COMPLETED|Overall Study||853
10052575|NCT02039908|11177259|FG000|STARTED|Phase 1-Summer||129
10052576|NCT02039908|11177260|FG001|STARTED|Phase 1-Summer||138
10052577|NCT02039908|11177261|FG002|STARTED|Phase 1-Summer||0
10052578|NCT02039908|11177262|FG003|STARTED|Phase 1-Summer||0
10052579|NCT02039908|11177259|FG000|COMPLETED|Phase 1-Summer||116
10052580|NCT02039908|11177260|FG001|COMPLETED|Phase 1-Summer||132
10052581|NCT02039908|11177261|FG002|COMPLETED|Phase 1-Summer||0
10052582|NCT02039908|11177262|FG003|COMPLETED|Phase 1-Summer||0
10052583|NCT02039908|11177259|FG000|NOT COMPLETED|Phase 1-Summer||13
10052584|NCT02039908|11177260|FG001|NOT COMPLETED|Phase 1-Summer||6
10052585|NCT02039908|11177261|FG002|NOT COMPLETED|Phase 1-Summer||0
10052586|NCT02039908|11177262|FG003|NOT COMPLETED|Phase 1-Summer||0
10052587|NCT02039908|11177259|FG000|STARTED|Phase 2-School Year||0
10052588|NCT02039908|11177260|FG001|STARTED|Phase 2-School Year||0
10052589|NCT02039908|11177261|FG002|STARTED|Phase 2-School Year||121
10052590|NCT02039908|11177262|FG003|STARTED|Phase 2-School Year||124
10052591|NCT02039908|11177259|FG000|COMPLETED|Phase 2-School Year||0
10052592|NCT02039908|11177260|FG001|COMPLETED|Phase 2-School Year||0
10052593|NCT02039908|11177261|FG002|COMPLETED|Phase 2-School Year||109
10052594|NCT02039908|11177262|FG003|COMPLETED|Phase 2-School Year||116
10052595|NCT02039908|11177259|FG000|NOT COMPLETED|Phase 2-School Year||0
10052596|NCT02039908|11177260|FG001|NOT COMPLETED|Phase 2-School Year||0
10052597|NCT02039908|11177261|FG002|NOT COMPLETED|Phase 2-School Year||12
10052598|NCT02039908|11177262|FG003|NOT COMPLETED|Phase 2-School Year||8
10052599|NCT02039947|11177274|FG000|STARTED|Overall Study||76
10052600|NCT02039947|11177275|FG001|STARTED|Overall Study||16
10052601|NCT02039947|11177276|FG002|STARTED|Overall Study||16
10052602|NCT02039947|11177277|FG003|STARTED|Overall Study||17
10052603|NCT02039947|11177274|FG000|COMPLETED|Overall Study||76
10052604|NCT02039947|11177275|FG001|COMPLETED|Overall Study||16
10052605|NCT02039947|11177276|FG002|COMPLETED|Overall Study||16
10052606|NCT02039947|11177277|FG003|COMPLETED|Overall Study||17
10052607|NCT02039947|11177274|FG000|NOT COMPLETED|Overall Study||0
10052608|NCT02039947|11177275|FG001|NOT COMPLETED|Overall Study||0
10052609|NCT02039947|11177276|FG002|NOT COMPLETED|Overall Study||0
10052610|NCT02039947|11177277|FG003|NOT COMPLETED|Overall Study||0
10052611|NCT02040077|11177294|FG000|STARTED|Overall Study||27
10052612|NCT02040077|11177295|FG001|STARTED|Overall Study||24
10052613|NCT02040077|11177296|FG002|STARTED|Overall Study||25
10052614|NCT02040077|11177294|FG000|COMPLETED|Overall Study||27
10052615|NCT02040077|11177295|FG001|COMPLETED|Overall Study||24
10052616|NCT02040077|11177296|FG002|COMPLETED|Overall Study||25
10052617|NCT02040077|11177294|FG000|NOT COMPLETED|Overall Study||0
10052618|NCT02040077|11177295|FG001|NOT COMPLETED|Overall Study||0
10052619|NCT02040077|11177296|FG002|NOT COMPLETED|Overall Study||0
10052620|NCT02040090|11177307|FG000|STARTED|Overall Study||59
10052621|NCT02040090|11177308|FG001|STARTED|Overall Study||59
10052622|NCT02040090|11177307|FG000|COMPLETED|Overall Study||56
10052623|NCT02040090|11177308|FG001|COMPLETED|Overall Study||57
10052624|NCT02040090|11177307|FG000|NOT COMPLETED|Overall Study||3
10052625|NCT02040090|11177308|FG001|NOT COMPLETED|Overall Study||2
10052626|NCT02040116|11177314|FG000|STARTED|Overall Study||19
10052627|NCT02040116|11177314|FG000|COMPLETED|Overall Study||19
10052628|NCT02040116|11177314|FG000|NOT COMPLETED|Overall Study||0
10052629|NCT02040259|11177322|FG000|STARTED|Overall Study||2008
10052630|NCT02040259|11177322|FG000|COMPLETED|Overall Study||1645
10052631|NCT02040259|11177322|FG000|NOT COMPLETED|Overall Study||363
10052632|NCT02040298|11177330|FG000|STARTED|First Intervention (3 Months)||25
10052633|NCT02040298|11177331|FG001|STARTED|First Intervention (3 Months)||25
10052634|NCT02040298|11177330|FG000|COMPLETED|First Intervention (3 Months)||25
10052635|NCT02040298|11177331|FG001|COMPLETED|First Intervention (3 Months)||25
10052636|NCT02040298|11177330|FG000|NOT COMPLETED|First Intervention (3 Months)||0
10052637|NCT02040298|11177331|FG001|NOT COMPLETED|First Intervention (3 Months)||0
10052638|NCT02040298|11177330|FG000|STARTED|Second Intervention (2 Months)||25
10052639|NCT02040298|11177331|FG001|STARTED|Second Intervention (2 Months)||25
10052640|NCT02040298|11177330|FG000|COMPLETED|Second Intervention (2 Months)||25
10052641|NCT02040298|11177331|FG001|COMPLETED|Second Intervention (2 Months)||25
10052642|NCT02040298|11177330|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
10052643|NCT02040298|11177331|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
10052644|NCT02040428|11177345|FG000|STARTED|Overall Study||75
10052645|NCT02040428|11177346|FG001|STARTED|Overall Study||81
10052646|NCT02040428|11177345|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76
10052647|NCT02040428|11177346|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80
10052648|NCT02040428|11177345|FG000|COMPLETED|Overall Study||70
10052649|NCT02040428|11177346|FG001|COMPLETED|Overall Study||77
10052650|NCT02040428|11177345|FG000|NOT COMPLETED|Overall Study||5
10052651|NCT02040428|11177346|FG001|NOT COMPLETED|Overall Study||4
10052652|NCT02040532|11177352|FG000|STARTED|Overall Study||32
10052653|NCT02040532|11177352|FG000|Received at Least One Dose of Medication|Overall Study||26
10052654|NCT02040532|11177352|FG000|COMPLETED|Overall Study||20
10052655|NCT02040532|11177352|FG000|NOT COMPLETED|Overall Study||12
10052656|NCT02040623|11177359|FG000|STARTED|Overall Study||11
10052657|NCT02040623|11177360|FG001|STARTED|Overall Study||12
10052658|NCT02040623|11177361|FG002|STARTED|Overall Study||12
10052659|NCT02040623|11177359|FG000|COMPLETED|Overall Study||7
10052660|NCT02040623|11177360|FG001|COMPLETED|Overall Study||6
10052661|NCT02040623|11177361|FG002|COMPLETED|Overall Study||10
10052662|NCT02040623|11177359|FG000|NOT COMPLETED|Overall Study||4
10052663|NCT02040623|11177360|FG001|NOT COMPLETED|Overall Study||6
10052664|NCT02040623|11177361|FG002|NOT COMPLETED|Overall Study||2
10052665|NCT02040766|11177374|FG000|STARTED|Overall Study||127
10052666|NCT02040766|11177375|FG001|STARTED|Overall Study||126
10052667|NCT02040766|11177376|FG002|STARTED|Overall Study||125
10052668|NCT02040766|11177377|FG003|STARTED|Overall Study||125
10052669|NCT02040766|11177378|FG004|STARTED|Overall Study||125
10052670|NCT02040766|11177374|FG000|COMPLETED|Overall Study||109
10052671|NCT02040766|11177375|FG001|COMPLETED|Overall Study||116
10052672|NCT02040766|11177376|FG002|COMPLETED|Overall Study||113
10052673|NCT02040766|11177377|FG003|COMPLETED|Overall Study||112
10052674|NCT02040766|11177378|FG004|COMPLETED|Overall Study||112
10052675|NCT02040766|11177374|FG000|NOT COMPLETED|Overall Study||18
10052676|NCT02040766|11177375|FG001|NOT COMPLETED|Overall Study||10
10052677|NCT02040766|11177376|FG002|NOT COMPLETED|Overall Study||12
10052678|NCT02040766|11177377|FG003|NOT COMPLETED|Overall Study||13
10052679|NCT02040766|11177378|FG004|NOT COMPLETED|Overall Study||13
10052680|NCT02040779|11177394|FG000|STARTED|Overall Study||91
10052681|NCT02040779|11177395|FG001|STARTED|Overall Study||90
10052682|NCT02040779|11177396|FG002|STARTED|Overall Study||92
10052683|NCT02040779|11177394|FG000|Full Analysis Set (FAS)|Overall Study||90
10052684|NCT02040779|11177395|FG001|Full Analysis Set (FAS)|Overall Study||88
10052685|NCT02040779|11177396|FG002|Full Analysis Set (FAS)|Overall Study||92
10052686|NCT02040779|11177394|FG000|COMPLETED|Overall Study||79
10052687|NCT02040779|11177395|FG001|COMPLETED|Overall Study||83
10052688|NCT02040779|11177396|FG002|COMPLETED|Overall Study||88
10052689|NCT02040779|11177394|FG000|NOT COMPLETED|Overall Study||12
10052690|NCT02040779|11177395|FG001|NOT COMPLETED|Overall Study||7
10052691|NCT02040779|11177396|FG002|NOT COMPLETED|Overall Study||4
10052692|NCT02040805|11177406|FG000|STARTED|Overall Study||160
10052693|NCT02040805|11177407|FG001|STARTED|Overall Study||163
10052694|NCT02040805|11177406|FG000|COMPLETED|Overall Study||118
10052695|NCT02040805|11177407|FG001|COMPLETED|Overall Study||113
10052696|NCT02040805|11177406|FG000|NOT COMPLETED|Overall Study||42
10052697|NCT02040805|11177407|FG001|NOT COMPLETED|Overall Study||50
10052698|NCT02040844|11177416|FG000|STARTED|Overall Study||138
10052699|NCT02040844|11177417|FG001|STARTED|Overall Study||148
10052700|NCT02040844|11177418|FG002|STARTED|Overall Study||144
10052701|NCT02040844|11177416|FG000|COMPLETED|Overall Study||88
10052702|NCT02040844|11177417|FG001|COMPLETED|Overall Study||109
10052703|NCT02040844|11177418|FG002|COMPLETED|Overall Study||97
10052704|NCT02040844|11177416|FG000|NOT COMPLETED|Overall Study||50
10052705|NCT02040844|11177417|FG001|NOT COMPLETED|Overall Study||39
10052706|NCT02040844|11177418|FG002|NOT COMPLETED|Overall Study||47
10052707|NCT02040870|11177426|FG000|STARTED|Overall Study||103
10052708|NCT02040870|11177426|FG000|Entered Post-treatment Follow-up|Overall Study||2
10052709|NCT02040870|11177426|FG000|Entered Survival Follow-up|Overall Study||75
10052710|NCT02040870|11177426|FG000|Discontinue From Study|Overall Study||26
10052711|NCT02040870|11177426|FG000|COMPLETED|Overall Study||0
10052712|NCT02040870|11177426|FG000|NOT COMPLETED|Overall Study||103
10052713|NCT02041091|11177432|FG000|STARTED|Treatment||112
10052714|NCT02041091|11177433|FG001|STARTED|Treatment||114
10052715|NCT02041091|11177432|FG000|Received At Least One Dose of Study Drug|Treatment||112
10052716|NCT02041091|11177433|FG001|Received At Least One Dose of Study Drug|Treatment||114
10052717|NCT02041091|11177432|FG000|Participated in Follow Up|Treatment||106
10052718|NCT02041091|11177433|FG001|Participated in Follow Up|Treatment||96
10052719|NCT02041091|11177432|FG000|COMPLETED|Treatment||90
10052720|NCT02041091|11177433|FG001|COMPLETED|Treatment||91
10052721|NCT02041091|11177432|FG000|NOT COMPLETED|Treatment||22
10052722|NCT02041091|11177433|FG001|NOT COMPLETED|Treatment||23
10052723|NCT02041091|11177432|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
10052724|NCT02041091|11177433|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
10052725|NCT02041091|11177432|FG000|COMPLETED|Optional Safety Extension Period||0
10052726|NCT02041091|11177433|FG001|COMPLETED|Optional Safety Extension Period||0
10052727|NCT02041091|11177432|FG000|NOT COMPLETED|Optional Safety Extension Period||85
10052728|NCT02041091|11177433|FG001|NOT COMPLETED|Optional Safety Extension Period||82
10052729|NCT02041104|11177447|FG000|STARTED|Overall Study||28
10052730|NCT02041104|11177448|FG001|STARTED|Overall Study||23
10052731|NCT02041104|11177447|FG000|COMPLETED|Overall Study||27
10052732|NCT02041104|11177448|FG001|COMPLETED|Overall Study||16
10052733|NCT02041104|11177447|FG000|NOT COMPLETED|Overall Study||1
10052734|NCT02041104|11177448|FG001|NOT COMPLETED|Overall Study||7
10052735|NCT02041221|11177462|FG000|STARTED|Part 1||6
10052736|NCT02041221|11177463|FG001|STARTED|Part 1||6
10052737|NCT02041221|11177464|FG002|STARTED|Part 1||6
10052738|NCT02041221|11177465|FG003|STARTED|Part 1||6
10052739|NCT02041221|11177466|FG004|STARTED|Part 1||6
10052740|NCT02041221|11177467|FG005|STARTED|Part 1||10
10052741|NCT02041221|11177462|FG000|COMPLETED|Part 1||6
10052742|NCT02041221|11177463|FG001|COMPLETED|Part 1||6
10052743|NCT02041221|11177464|FG002|COMPLETED|Part 1||6
10052744|NCT02041221|11177465|FG003|COMPLETED|Part 1||6
10052745|NCT02041221|11177466|FG004|COMPLETED|Part 1||6
10052746|NCT02041221|11177467|FG005|COMPLETED|Part 1||10
10052747|NCT02041221|11177462|FG000|NOT COMPLETED|Part 1||0
10052748|NCT02041221|11177463|FG001|NOT COMPLETED|Part 1||0
10052749|NCT02041221|11177464|FG002|NOT COMPLETED|Part 1||0
10052750|NCT02041221|11177465|FG003|NOT COMPLETED|Part 1||0
10052751|NCT02041221|11177466|FG004|NOT COMPLETED|Part 1||0
10052752|NCT02041221|11177467|FG005|NOT COMPLETED|Part 1||0
10052753|NCT02041221|11177462|FG000|STARTED|Part 2||6
10052754|NCT02041221|11177463|FG001|STARTED|Part 2||6
10052755|NCT02041221|11177464|FG002|STARTED|Part 2||6
10052756|NCT02041221|11177465|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
10052757|NCT02041221|11177466|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
10052758|NCT02041221|11177467|FG005|STARTED|Part 2||6
10052759|NCT02041221|11177462|FG000|COMPLETED|Part 2||6
10052760|NCT02041221|11177463|FG001|COMPLETED|Part 2||6
10052761|NCT02041221|11177464|FG002|COMPLETED|Part 2||5
10052762|NCT02041221|11177465|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
10052763|NCT02041221|11177466|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
10052764|NCT02041221|11177467|FG005|COMPLETED|Part 2||6
10052765|NCT02041221|11177462|FG000|NOT COMPLETED|Part 2||0
10052766|NCT02041221|11177463|FG001|NOT COMPLETED|Part 2||0
10052767|NCT02041221|11177464|FG002|NOT COMPLETED|Part 2||1
10052768|NCT02041221|11177465|FG003|NOT COMPLETED|Part 2||0
10118711|NCT02549014|11249632|FG000|COMPLETED|Overall Study||8
10118712|NCT02549014|11249633|FG001|COMPLETED|Overall Study||8
10118713|NCT02549014|11249632|FG000|NOT COMPLETED|Overall Study||0
10118714|NCT02549014|11249633|FG001|NOT COMPLETED|Overall Study||0
10118715|NCT02549027|11249657|FG000|STARTED|Period 1 - MK-1064 or Placebo||5
10118716|NCT02549027|11249658|FG001|STARTED|Period 1 - MK-1064 or Placebo||5
10052769|NCT02041221|11177466|FG004|NOT COMPLETED|Part 2||0
10052770|NCT02041221|11177467|FG005|NOT COMPLETED|Part 2||0
10052771|NCT02041286|11177481|FG000|STARTED|Overall Study||136
10052772|NCT02041286|11177481|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
10052773|NCT02041286|11177481|FG000|NOT COMPLETED|Overall Study||1
10052774|NCT02041299|11177489|FG000|STARTED|Overall Study||152
10052775|NCT02041299|11177490|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
10118717|NCT02549027|11249659|FG002|STARTED|Period 1 - MK-1064 or Placebo||5
10118718|NCT02549027|11249660|FG003|STARTED|Period 1 - MK-1064 or Placebo||5
10118719|NCT02549027|11249661|FG004|STARTED|Period 1 - MK-1064 or Placebo||0
10118720|NCT02549027|11249662|FG005|STARTED|Period 1 - MK-1064 or Placebo||0
10118721|NCT02549027|11249657|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5
10118722|NCT02549027|11249658|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5
10118723|NCT02549027|11249659|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5
10118724|NCT02549027|11249660|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5
10118725|NCT02549027|11249661|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0
10118726|NCT02549027|11249662|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0
10118727|NCT02549027|11249657|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10118728|NCT02549027|11249658|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10118729|NCT02549027|11249659|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10118730|NCT02549027|11249660|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10118731|NCT02549027|11249661|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10118732|NCT02549027|11249662|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10118733|NCT02549027|11249657|FG000|STARTED|Washout After Period 1||5
10118734|NCT02549027|11249658|FG001|STARTED|Washout After Period 1||5
10118735|NCT02549027|11249659|FG002|STARTED|Washout After Period 1||5
10118736|NCT02549027|11249660|FG003|STARTED|Washout After Period 1||5
10118737|NCT02549027|11249661|FG004|STARTED|Washout After Period 1||0
10118738|NCT02549027|11249662|FG005|STARTED|Washout After Period 1||0
10118739|NCT02549027|11249657|FG000|COMPLETED|Washout After Period 1||5
10118740|NCT02549027|11249658|FG001|COMPLETED|Washout After Period 1||5
10118741|NCT02549027|11249659|FG002|COMPLETED|Washout After Period 1||5
10118742|NCT02549027|11249660|FG003|COMPLETED|Washout After Period 1||5
10118743|NCT02549027|11249661|FG004|COMPLETED|Washout After Period 1||0
10118744|NCT02549027|11249662|FG005|COMPLETED|Washout After Period 1||0
10118745|NCT02549027|11249657|FG000|NOT COMPLETED|Washout After Period 1||0
10118746|NCT02549027|11249658|FG001|NOT COMPLETED|Washout After Period 1||0
10118747|NCT02549027|11249659|FG002|NOT COMPLETED|Washout After Period 1||0
10118748|NCT02549027|11249660|FG003|NOT COMPLETED|Washout After Period 1||0
10118749|NCT02549027|11249661|FG004|NOT COMPLETED|Washout After Period 1||0
10118750|NCT02549027|11249662|FG005|NOT COMPLETED|Washout After Period 1||0
10118751|NCT02549027|11249657|FG000|STARTED|Period 2 - MK-1064 or Placebo||5
10118752|NCT02549027|11249658|FG001|STARTED|Period 2 - MK-1064 or Placebo||5
10118753|NCT02549027|11249659|FG002|STARTED|Period 2 - MK-1064 or Placebo||5
10118754|NCT02549027|11249660|FG003|STARTED|Period 2 - MK-1064 or Placebo||5
10118755|NCT02549027|11249661|FG004|STARTED|Period 2 - MK-1064 or Placebo||0
10118756|NCT02549027|11249662|FG005|STARTED|Period 2 - MK-1064 or Placebo||0
10118757|NCT02549027|11249657|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5
10118758|NCT02549027|11249658|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5
10118759|NCT02549027|11249659|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5
10118760|NCT02549027|11249660|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5
10118761|NCT02549027|11249661|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0
10118762|NCT02549027|11249662|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0
10118763|NCT02549027|11249657|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10118764|NCT02549027|11249658|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10118765|NCT02549027|11249659|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10118766|NCT02549027|11249660|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10118767|NCT02549027|11249661|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10118768|NCT02549027|11249662|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10118769|NCT02549027|11249657|FG000|STARTED|Washout After Period 2||5
10118770|NCT02549027|11249658|FG001|STARTED|Washout After Period 2||5
10118771|NCT02549027|11249659|FG002|STARTED|Washout After Period 2||5
10118772|NCT02549027|11249660|FG003|STARTED|Washout After Period 2||5
10118773|NCT02549027|11249661|FG004|STARTED|Washout After Period 2||0
10118774|NCT02549027|11249662|FG005|STARTED|Washout After Period 2||0
10118775|NCT02549027|11249657|FG000|COMPLETED|Washout After Period 2||5
10118776|NCT02549027|11249658|FG001|COMPLETED|Washout After Period 2||5
10118777|NCT02549027|11249659|FG002|COMPLETED|Washout After Period 2||5
10118778|NCT02549027|11249660|FG003|COMPLETED|Washout After Period 2||5
10118779|NCT02549027|11249661|FG004|COMPLETED|Washout After Period 2||0
10118780|NCT02549027|11249662|FG005|COMPLETED|Washout After Period 2||0
10118781|NCT02549027|11249657|FG000|NOT COMPLETED|Washout After Period 2||0
10118782|NCT02549027|11249658|FG001|NOT COMPLETED|Washout After Period 2||0
10118783|NCT02549027|11249659|FG002|NOT COMPLETED|Washout After Period 2||0
10118784|NCT02549027|11249660|FG003|NOT COMPLETED|Washout After Period 2||0
10118785|NCT02549027|11249661|FG004|NOT COMPLETED|Washout After Period 2||0
10118786|NCT02549027|11249662|FG005|NOT COMPLETED|Washout After Period 2||0
10118787|NCT02549027|11249657|FG000|STARTED|Period 3 - MK-1064 or Placebo||5
10118788|NCT02549027|11249658|FG001|STARTED|Period 3 - MK-1064 or Placebo||5
10118789|NCT02549027|11249659|FG002|STARTED|Period 3 - MK-1064 or Placebo||5
10118790|NCT02549027|11249660|FG003|STARTED|Period 3 - MK-1064 or Placebo||5
10118791|NCT02549027|11249661|FG004|STARTED|Period 3 - MK-1064 or Placebo||0
10118792|NCT02549027|11249662|FG005|STARTED|Period 3 - MK-1064 or Placebo||0
10118793|NCT02549027|11249657|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5
10118794|NCT02549027|11249658|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5
10118795|NCT02549027|11249659|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5
10118796|NCT02549027|11249660|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5
10118797|NCT02549027|11249661|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0
10118798|NCT02549027|11249662|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0
10118799|NCT02549027|11249657|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10052776|NCT02041299|11177489|FG000|COMPLETED|Overall Study||106
10052777|NCT02041299|11177490|FG001|COMPLETED|Overall Study||58
10052778|NCT02041299|11177489|FG000|NOT COMPLETED|Overall Study||46
10052779|NCT02041299|11177490|FG001|NOT COMPLETED|Overall Study||20
10052780|NCT02041325|11177502|FG000|STARTED|Overall Study||22
10052781|NCT02041325|11177503|FG001|STARTED|Overall Study||16
10052782|NCT02041325|11177502|FG000|COMPLETED|Overall Study||19
10052783|NCT02041325|11177503|FG001|COMPLETED|Overall Study||13
10052784|NCT02041325|11177502|FG000|NOT COMPLETED|Overall Study||3
10052785|NCT02041325|11177503|FG001|NOT COMPLETED|Overall Study||3
10052786|NCT02041377|11177513|FG000|STARTED|Overall Study||134
10052787|NCT02041377|11177513|FG000|COMPLETED|Overall Study||134
10052788|NCT02041377|11177513|FG000|NOT COMPLETED|Overall Study||0
10052789|NCT02041429|11177521|FG000|STARTED|Overall Study||3
10052790|NCT02041429|11177522|FG001|STARTED|Overall Study||4
10052791|NCT02041429|11177523|FG002|STARTED|Overall Study||7
10052792|NCT02041429|11177524|FG003|STARTED|Overall Study||6
10052793|NCT02041429|11177521|FG000|Treated|Overall Study||3
10052794|NCT02041429|11177522|FG001|Treated|Overall Study||3
10052795|NCT02041429|11177523|FG002|Treated|Overall Study||7
10052796|NCT02041429|11177524|FG003|Treated|Overall Study||6
10052797|NCT02041429|11177521|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3
10052798|NCT02041429|11177522|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3
10052799|NCT02041429|11177523|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6
10052800|NCT02041429|11177524|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6
10052801|NCT02041429|11177521|FG000|COMPLETED|Overall Study||0
10052802|NCT02041429|11177522|FG001|COMPLETED|Overall Study||0
10052803|NCT02041429|11177523|FG002|COMPLETED|Overall Study||0
10052804|NCT02041429|11177524|FG003|COMPLETED|Overall Study||0
10052805|NCT02041429|11177521|FG000|NOT COMPLETED|Overall Study||3
10052806|NCT02041429|11177522|FG001|NOT COMPLETED|Overall Study||4
10052807|NCT02041429|11177523|FG002|NOT COMPLETED|Overall Study||7
10052808|NCT02041429|11177524|FG003|NOT COMPLETED|Overall Study||6
10052809|NCT02041494|11177541|FG000|STARTED|Overall Study||82
10052810|NCT02041494|11177542|FG001|STARTED|Overall Study||83
10052811|NCT02041494|11177541|FG000|COMPLETED|Overall Study||63
10052812|NCT02041494|11177542|FG001|COMPLETED|Overall Study||63
10052813|NCT02041494|11177541|FG000|NOT COMPLETED|Overall Study||19
10052814|NCT02041494|11177542|FG001|NOT COMPLETED|Overall Study||20
10052815|NCT02041520|11177551|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
10052816|NCT02041520|11177552|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35
10052817|NCT02041520|11177551|FG000|COMPLETED|Overall Study||29
10052818|NCT02041520|11177552|FG001|COMPLETED|Overall Study||28
10052819|NCT02041520|11177551|FG000|NOT COMPLETED|Overall Study||6
10052820|NCT02041520|11177552|FG001|NOT COMPLETED|Overall Study||7
10052821|NCT02041702|11177562|FG000|STARTED|Overall Study||140
10052822|NCT02041702|11177563|FG001|STARTED|Overall Study||143
10052823|NCT02041702|11177562|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129
10052824|NCT02041702|11177563|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140
10052825|NCT02041702|11177562|FG000|Post MRI Scan/ Post Waiting|Overall Study||129
10052826|NCT02041702|11177563|FG001|Post MRI Scan/ Post Waiting|Overall Study||140
10052827|NCT02041702|11177562|FG000|COMPLETED|Overall Study||129
10052828|NCT02041702|11177563|FG001|COMPLETED|Overall Study||134
10052829|NCT02041702|11177562|FG000|NOT COMPLETED|Overall Study||11
10052830|NCT02041702|11177563|FG001|NOT COMPLETED|Overall Study||9
10052831|NCT02041923|11177571|FG000|STARTED|Overall Study||102
10052832|NCT02041923|11177572|FG001|STARTED|Overall Study||96
10052833|NCT02041923|11177571|FG000|COMPLETED|Overall Study||76
10052834|NCT02041923|11177572|FG001|COMPLETED|Overall Study||66
10052835|NCT02041923|11177571|FG000|NOT COMPLETED|Overall Study||26
10052836|NCT02041923|11177572|FG001|NOT COMPLETED|Overall Study||30
10052837|NCT02041962|11177582|FG000|STARTED|Overall Study||123
10052838|NCT02041962|11177583|FG001|STARTED|Overall Study||115
10052839|NCT02041962|11177582|FG000|Participants Completing 6 mo. f/up|Overall Study||69
10052840|NCT02041962|11177583|FG001|Participants Completing 6 mo. f/up|Overall Study||44
10052841|NCT02041962|11177582|FG000|Participants Completing 12 mo. f/up|Overall Study||42
10052842|NCT02041962|11177583|FG001|Participants Completing 12 mo. f/up|Overall Study||31
10052843|NCT02041962|11177582|FG000|COMPLETED|Overall Study||42
10052844|NCT02041962|11177583|FG001|COMPLETED|Overall Study||31
10052845|NCT02041962|11177582|FG000|NOT COMPLETED|Overall Study||81
10052846|NCT02041962|11177583|FG001|NOT COMPLETED|Overall Study||84
10052847|NCT02042014|11177589|FG000|STARTED|Overall Study||8
10052848|NCT02042014|11177589|FG000|COMPLETED|Overall Study||0
10052849|NCT02042014|11177589|FG000|NOT COMPLETED|Overall Study||8
10052850|NCT02042131|11177596|FG000|STARTED|Overall Study||32
10052851|NCT02042131|11177597|FG001|STARTED|Overall Study||32
10052852|NCT02042131|11177598|FG002|STARTED|Overall Study||33
10052853|NCT02042131|11177596|FG000|COMPLETED|Overall Study||32
10052854|NCT02042131|11177597|FG001|COMPLETED|Overall Study||32
10052855|NCT02042131|11177598|FG002|COMPLETED|Overall Study||33
10052856|NCT02042131|11177596|FG000|NOT COMPLETED|Overall Study||0
10052857|NCT02042131|11177597|FG001|NOT COMPLETED|Overall Study||0
10052858|NCT02042131|11177598|FG002|NOT COMPLETED|Overall Study||0
10052859|NCT02042183|11177610|FG000|STARTED|Overall Study||404
10052860|NCT02042183|11177611|FG001|STARTED|Overall Study||202
10052861|NCT02042183|11177610|FG000|Safety Population|Overall Study||400
10052862|NCT02042183|11177611|FG001|Safety Population|Overall Study||195
10052863|NCT02042183|11177610|FG000|Modified Intent-to-treat (mITT)|Overall Study||399
10052864|NCT02042183|11177611|FG001|Modified Intent-to-treat (mITT)|Overall Study||195
10052865|NCT02042183|11177610|FG000|COMPLETED|Overall Study||339
10052866|NCT02042183|11177611|FG001|COMPLETED|Overall Study||166
10052867|NCT02042183|11177610|FG000|NOT COMPLETED|Overall Study||65
10052868|NCT02042183|11177611|FG001|NOT COMPLETED|Overall Study||36
10052869|NCT02042274|11177619|FG000|STARTED|Overall Study||12
10052870|NCT02042274|11177619|FG000|COMPLETED|Overall Study||12
10052871|NCT02042274|11177619|FG000|NOT COMPLETED|Overall Study||0
10052872|NCT02042404|11177623|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
10052873|NCT02042404|11177624|FG001|STARTED|Overall Study||5
10052874|NCT02042404|11177623|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
10052875|NCT02042404|11177624|FG001|COMPLETED|Overall Study||5
10052876|NCT02042404|11177623|FG000|NOT COMPLETED|Overall Study||5
10052877|NCT02042404|11177624|FG001|NOT COMPLETED|Overall Study||0
10052878|NCT02042443|11177633|FG000|STARTED|Overall Study||27
10052879|NCT02042443|11177634|FG001|STARTED|Overall Study||26
10052880|NCT02042443|11177633|FG000|Eligible and Analyzable|Overall Study||24
10052881|NCT02042443|11177634|FG001|Eligible and Analyzable|Overall Study||20
10052882|NCT02042443|11177633|FG000|COMPLETED|Overall Study||0
10052883|NCT02042443|11177634|FG001|COMPLETED|Overall Study||0
10052884|NCT02042443|11177633|FG000|NOT COMPLETED|Overall Study||27
10052885|NCT02042443|11177634|FG001|NOT COMPLETED|Overall Study||26
10052886|NCT02042534|11177643|FG000|STARTED|Overall Study||101
10052887|NCT02042534|11177644|FG001|STARTED|Overall Study||94
10052888|NCT02042534|11177643|FG000|COMPLETED|Overall Study||101
10052889|NCT02042534|11177644|FG001|COMPLETED|Overall Study||94
10052890|NCT02042534|11177643|FG000|NOT COMPLETED|Overall Study||0
10052891|NCT02042534|11177644|FG001|NOT COMPLETED|Overall Study||0
10052892|NCT02042872|11177652|FG000|STARTED|Overall Study||8
10052893|NCT02042872|11177653|FG001|STARTED|Overall Study||13
10052894|NCT02042872|11177652|FG000|COMPLETED|Overall Study||8
10052895|NCT02042872|11177653|FG001|COMPLETED|Overall Study||8
10052896|NCT02042872|11177652|FG000|NOT COMPLETED|Overall Study||0
10052897|NCT02042872|11177653|FG001|NOT COMPLETED|Overall Study||5
10052898|NCT02042911|11177659|FG000|STARTED|Overall Study||10
10052899|NCT02042911|11177659|FG000|COMPLETED|Overall Study||9
10052900|NCT02042911|11177659|FG000|NOT COMPLETED|Overall Study||1
10052901|NCT02043015|11177663|FG000|STARTED|Overall Study||115
10052902|NCT02043015|11177663|FG000|COMPLETED|Overall Study||87
10052903|NCT02043015|11177663|FG000|NOT COMPLETED|Overall Study||28
10052904|NCT02043132|11177671|FG000|STARTED|Overall Study||58
10052905|NCT02043132|11177672|FG001|STARTED|Overall Study||58
10052906|NCT02043132|11177671|FG000|COMPLETED|Overall Study||53
10052907|NCT02043132|11177672|FG001|COMPLETED|Overall Study||49
10052908|NCT02043132|11177671|FG000|NOT COMPLETED|Overall Study||5
10052909|NCT02043132|11177672|FG001|NOT COMPLETED|Overall Study||9
10052910|NCT02043145|11177681|FG000|STARTED|Overall Study||55
10052911|NCT02043145|11177682|FG001|STARTED|Overall Study||247
10052912|NCT02043145|11177683|FG002|STARTED|Overall Study||425
10052913|NCT02043145|11177681|FG000|COMPLETED|Overall Study||55
10052914|NCT02043145|11177682|FG001|COMPLETED|Overall Study||247
10052915|NCT02043145|11177683|FG002|COMPLETED|Overall Study||425
10052916|NCT02043145|11177681|FG000|NOT COMPLETED|Overall Study||0
10052917|NCT02043145|11177682|FG001|NOT COMPLETED|Overall Study||0
10052918|NCT02043145|11177683|FG002|NOT COMPLETED|Overall Study||0
10052919|NCT02043197|11177693|FG000|STARTED|Overall Study||300
10052920|NCT02043197|11177693|FG000|COMPLETED|Overall Study||292
10118800|NCT02549027|11249658|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10118801|NCT02549027|11249659|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10118802|NCT02549027|11249660|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10118803|NCT02549027|11249661|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10118804|NCT02549027|11249662|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10118805|NCT02549027|11249657|FG000|STARTED|Washout After Period 3||5
10118806|NCT02549027|11249658|FG001|STARTED|Washout After Period 3||5
10118807|NCT02549027|11249659|FG002|STARTED|Washout After Period 3||5
10118808|NCT02549027|11249660|FG003|STARTED|Washout After Period 3||5
10118809|NCT02549027|11249661|FG004|STARTED|Washout After Period 3||0
10118810|NCT02549027|11249662|FG005|STARTED|Washout After Period 3||0
10118811|NCT02549027|11249657|FG000|COMPLETED|Washout After Period 3||5
10118812|NCT02549027|11249658|FG001|COMPLETED|Washout After Period 3||5
10118813|NCT02549027|11249659|FG002|COMPLETED|Washout After Period 3||5
10118814|NCT02549027|11249660|FG003|COMPLETED|Washout After Period 3||5
10118815|NCT02549027|11249661|FG004|COMPLETED|Washout After Period 3||0
10118816|NCT02549027|11249662|FG005|COMPLETED|Washout After Period 3||0
10118817|NCT02549027|11249657|FG000|NOT COMPLETED|Washout After Period 3||0
10118818|NCT02549027|11249658|FG001|NOT COMPLETED|Washout After Period 3||0
10118819|NCT02549027|11249659|FG002|NOT COMPLETED|Washout After Period 3||0
10118820|NCT02549027|11249660|FG003|NOT COMPLETED|Washout After Period 3||0
10052921|NCT02043197|11177693|FG000|NOT COMPLETED|Overall Study||8
10052922|NCT02043301|11177700|FG000|STARTED|Overall Study||25
10118821|NCT02549027|11249661|FG004|NOT COMPLETED|Washout After Period 3||0
10118822|NCT02549027|11249662|FG005|NOT COMPLETED|Washout After Period 3||0
10052923|NCT02043301|11177701|FG001|STARTED|Overall Study||25
10052924|NCT02043301|11177702|FG002|STARTED|Overall Study||25
10052925|NCT02043301|11177700|FG000|COMPLETED|Overall Study||25
10052926|NCT02043301|11177701|FG001|COMPLETED|Overall Study||24
10052927|NCT02043301|11177702|FG002|COMPLETED|Overall Study||25
10052928|NCT02043301|11177700|FG000|NOT COMPLETED|Overall Study||0
10052929|NCT02043301|11177701|FG001|NOT COMPLETED|Overall Study||1
10052930|NCT02043301|11177702|FG002|NOT COMPLETED|Overall Study||0
10052931|NCT02043366|11177716|FG000|STARTED|Overall Study||30
10052932|NCT02043366|11177717|FG001|STARTED|Overall Study||30
10052933|NCT02043366|11177718|FG002|STARTED|Overall Study||30
10052934|NCT02043366|11177719|FG003|STARTED|Overall Study||30
10052935|NCT02043366|11177720|FG004|STARTED|Overall Study||30
10052936|NCT02043366|11177721|FG005|STARTED|Overall Study||30
10052937|NCT02043366|11177716|FG000|COMPLETED|Overall Study||28
10052938|NCT02043366|11177717|FG001|COMPLETED|Overall Study||28
10052939|NCT02043366|11177718|FG002|COMPLETED|Overall Study||28
10052940|NCT02043366|11177719|FG003|COMPLETED|Overall Study||28
10052941|NCT02043366|11177720|FG004|COMPLETED|Overall Study||28
10052942|NCT02043366|11177721|FG005|COMPLETED|Overall Study||28
10052943|NCT02043366|11177716|FG000|NOT COMPLETED|Overall Study||2
10052944|NCT02043366|11177717|FG001|NOT COMPLETED|Overall Study||2
10052945|NCT02043366|11177718|FG002|NOT COMPLETED|Overall Study||2
10052946|NCT02043366|11177719|FG003|NOT COMPLETED|Overall Study||2
10052947|NCT02043366|11177720|FG004|NOT COMPLETED|Overall Study||2
10052948|NCT02043366|11177721|FG005|NOT COMPLETED|Overall Study||2
10052949|NCT02043379|11177739|FG000|STARTED|Overall Study||30
10052950|NCT02043379|11177740|FG001|STARTED|Overall Study||20
10052951|NCT02043379|11177739|FG000|COMPLETED|Overall Study||30
10052952|NCT02043379|11177740|FG001|COMPLETED|Overall Study||20
10052953|NCT02043379|11177739|FG000|NOT COMPLETED|Overall Study||0
10052954|NCT02043379|11177740|FG001|NOT COMPLETED|Overall Study||0
10052955|NCT02043509|11177748|FG000|STARTED|Baseline to 1st Follow-up||203
10052956|NCT02043509|11177749|FG001|STARTED|Baseline to 1st Follow-up||204
10052957|NCT02043509|11177748|FG000|COMPLETED|Baseline to 1st Follow-up||138
10052958|NCT02043509|11177749|FG001|COMPLETED|Baseline to 1st Follow-up||157
10052959|NCT02043509|11177748|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65
10052960|NCT02043509|11177749|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47
10052961|NCT02043509|11177748|FG000|STARTED|Baseline to 2nd Follow-up||203
10052962|NCT02043509|11177749|FG001|STARTED|Baseline to 2nd Follow-up||204
10052963|NCT02043509|11177748|FG000|COMPLETED|Baseline to 2nd Follow-up||129
10052964|NCT02043509|11177749|FG001|COMPLETED|Baseline to 2nd Follow-up||132
10052965|NCT02043509|11177748|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74
10052966|NCT02043509|11177749|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72
10052967|NCT02043548|11177757|FG000|STARTED|Overall Study||18
10052968|NCT02043548|11177758|FG001|STARTED|Overall Study||18
10052969|NCT02043548|11177757|FG000|COMPLETED|Overall Study||17
10052970|NCT02043548|11177758|FG001|COMPLETED|Overall Study||17
10052971|NCT02043548|11177757|FG000|NOT COMPLETED|Overall Study||1
10052972|NCT02043548|11177758|FG001|NOT COMPLETED|Overall Study||1
10052973|NCT02043574|11177766|FG000|STARTED|Overall Study||25
10052974|NCT02043574|11177767|FG001|STARTED|Overall Study||26
10052975|NCT02043574|11177766|FG000|COMPLETED|Overall Study||19
10052976|NCT02043574|11177767|FG001|COMPLETED|Overall Study||20
10052977|NCT02043574|11177766|FG000|NOT COMPLETED|Overall Study||6
10052978|NCT02043574|11177767|FG001|NOT COMPLETED|Overall Study||6
10052979|NCT02043652|11177774|FG000|STARTED|Overall Study||119
10052980|NCT02043652|11177774|FG000|COMPLETED|Overall Study||93
10052981|NCT02043652|11177774|FG000|NOT COMPLETED|Overall Study||26
10052982|NCT02043704|11177780|FG000|STARTED|Overall Study||50
10052983|NCT02043704|11177781|FG001|STARTED|Overall Study||50
10052984|NCT02043704|11177780|FG000|COMPLETED|Overall Study||47
10052985|NCT02043704|11177781|FG001|COMPLETED|Overall Study||43
10052986|NCT02043704|11177780|FG000|NOT COMPLETED|Overall Study||3
10052987|NCT02043704|11177781|FG001|NOT COMPLETED|Overall Study||7
10052988|NCT02043782|11177787|FG000|STARTED|Period 1||7
10052989|NCT02043782|11177788|FG001|STARTED|Period 1||6
10052990|NCT02043782|11177789|FG002|STARTED|Period 1||7
10052991|NCT02043782|11177790|FG003|STARTED|Period 1||6
10052992|NCT02043782|11177791|FG004|STARTED|Period 1||6
10052993|NCT02043782|11177792|FG005|STARTED|Period 1||6
10052994|NCT02043782|11177787|FG000|COMPLETED|Period 1||7
10052995|NCT02043782|11177788|FG001|COMPLETED|Period 1||6
10052996|NCT02043782|11177789|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
10052997|NCT02043782|11177790|FG003|COMPLETED|Period 1||6
10052998|NCT02043782|11177791|FG004|COMPLETED|Period 1||6
10052999|NCT02043782|11177792|FG005|COMPLETED|Period 1||6
10053000|NCT02043782|11177787|FG000|NOT COMPLETED|Period 1||0
10053001|NCT02043782|11177788|FG001|NOT COMPLETED|Period 1||0
10053002|NCT02043782|11177789|FG002|NOT COMPLETED|Period 1||1
10053003|NCT02043782|11177790|FG003|NOT COMPLETED|Period 1||0
10053004|NCT02043782|11177791|FG004|NOT COMPLETED|Period 1||0
10053005|NCT02043782|11177792|FG005|NOT COMPLETED|Period 1||0
10053006|NCT02043782|11177787|FG000|STARTED|Period 2||7
10053007|NCT02043782|11177788|FG001|STARTED|Period 2||6
10053008|NCT02043782|11177789|FG002|STARTED|Period 2||6
10053009|NCT02043782|11177790|FG003|STARTED|Period 2||6
10053010|NCT02043782|11177791|FG004|STARTED|Period 2||6
10053011|NCT02043782|11177792|FG005|STARTED|Period 2||6
10053012|NCT02043782|11177787|FG000|COMPLETED|Period 2||7
10053013|NCT02043782|11177788|FG001|COMPLETED|Period 2||6
10053014|NCT02043782|11177789|FG002|COMPLETED|Period 2||6
10053015|NCT02043782|11177790|FG003|COMPLETED|Period 2||6
10053016|NCT02043782|11177791|FG004|COMPLETED|Period 2||6
10053017|NCT02043782|11177792|FG005|COMPLETED|Period 2||6
10053018|NCT02043782|11177787|FG000|NOT COMPLETED|Period 2||0
10053019|NCT02043782|11177788|FG001|NOT COMPLETED|Period 2||0
10053020|NCT02043782|11177789|FG002|NOT COMPLETED|Period 2||0
10053021|NCT02043782|11177790|FG003|NOT COMPLETED|Period 2||0
10053022|NCT02043782|11177791|FG004|NOT COMPLETED|Period 2||0
10053023|NCT02043782|11177792|FG005|NOT COMPLETED|Period 2||0
10053024|NCT02043782|11177787|FG000|STARTED|Period 3||7
10053025|NCT02043782|11177788|FG001|STARTED|Period 3||6
10053026|NCT02043782|11177789|FG002|STARTED|Period 3||6
10053027|NCT02043782|11177790|FG003|STARTED|Period 3||6
10053028|NCT02043782|11177791|FG004|STARTED|Period 3||6
10053029|NCT02043782|11177792|FG005|STARTED|Period 3||6
10053030|NCT02043782|11177787|FG000|COMPLETED|Period 3||7
10053031|NCT02043782|11177788|FG001|COMPLETED|Period 3||6
10053032|NCT02043782|11177789|FG002|COMPLETED|Period 3||6
10053033|NCT02043782|11177790|FG003|COMPLETED|Period 3||6
10053034|NCT02043782|11177791|FG004|COMPLETED|Period 3||6
10053035|NCT02043782|11177792|FG005|COMPLETED|Period 3||6
10053036|NCT02043782|11177787|FG000|NOT COMPLETED|Period 3||0
10053037|NCT02043782|11177788|FG001|NOT COMPLETED|Period 3||0
10053038|NCT02043782|11177789|FG002|NOT COMPLETED|Period 3||0
10053039|NCT02043782|11177790|FG003|NOT COMPLETED|Period 3||0
10053040|NCT02043782|11177791|FG004|NOT COMPLETED|Period 3||0
10053041|NCT02043782|11177792|FG005|NOT COMPLETED|Period 3||0
10053042|NCT02043808|11177802|FG000|STARTED|Overall Study||12793
10053043|NCT02043808|11177803|FG001|STARTED|Overall Study||12793
10053044|NCT02043808|11177802|FG000|COMPLETED|Overall Study||12793
10053045|NCT02043808|11177803|FG001|COMPLETED|Overall Study||12793
10053046|NCT02043808|11177802|FG000|NOT COMPLETED|Overall Study||0
10053047|NCT02043808|11177803|FG001|NOT COMPLETED|Overall Study||0
10053048|NCT02043899|11177809|FG000|STARTED|Overall Study||36
10053049|NCT02043899|11177809|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
10053050|NCT02043899|11177809|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
10053051|NCT02043899|11177809|FG000|COMPLETED|Overall Study||9
10053052|NCT02043899|11177809|FG000|NOT COMPLETED|Overall Study||27
10053053|NCT02043938|11177813|FG000|STARTED|Overall Study||46
10053054|NCT02043938|11177813|FG000|COMPLETED|Overall Study||36
10053055|NCT02043938|11177813|FG000|NOT COMPLETED|Overall Study||10
10053056|NCT02044094|11177820|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
10053057|NCT02044094|11177820|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
10053058|NCT02044094|11177820|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
10053059|NCT02044094|11177820|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
10053060|NCT02044094|11177820|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
10053061|NCT02044094|11177820|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
10053062|NCT02044094|11177820|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
10053063|NCT02044094|11177820|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
10053064|NCT02044159|11177837|FG000|STARTED|Overall Study||27
10053065|NCT02044159|11177838|FG001|STARTED|Overall Study||30
10053066|NCT02044159|11177837|FG000|COMPLETED|Overall Study||23
10053067|NCT02044159|11177838|FG001|COMPLETED|Overall Study||26
10053068|NCT02044159|11177837|FG000|NOT COMPLETED|Overall Study||4
10053069|NCT02044159|11177838|FG001|NOT COMPLETED|Overall Study||4
10053070|NCT02044367|11177847|FG000|STARTED|Overall Study||9
10053071|NCT02044367|11177848|FG001|STARTED|Overall Study||9
10053072|NCT02044367|11177849|FG002|STARTED|Overall Study||9
10053073|NCT02044367|11177850|FG003|STARTED|Overall Study||9
10053074|NCT02044367|11177851|FG004|STARTED|Overall Study||9
10053075|NCT02044367|11177852|FG005|STARTED|Overall Study||9
10053076|NCT02044367|11177847|FG000|COMPLETED|Overall Study||9
10053077|NCT02044367|11177848|FG001|COMPLETED|Overall Study||9
10053078|NCT02044367|11177849|FG002|COMPLETED|Overall Study||9
10053079|NCT02044367|11177850|FG003|COMPLETED|Overall Study||9
10053080|NCT02044367|11177851|FG004|COMPLETED|Overall Study||9
10053081|NCT02044367|11177852|FG005|COMPLETED|Overall Study||9
10053082|NCT02044367|11177847|FG000|NOT COMPLETED|Overall Study||0
10053083|NCT02044367|11177848|FG001|NOT COMPLETED|Overall Study||0
10053084|NCT02044367|11177849|FG002|NOT COMPLETED|Overall Study||0
10053085|NCT02044367|11177850|FG003|NOT COMPLETED|Overall Study||0
10053086|NCT02044367|11177851|FG004|NOT COMPLETED|Overall Study||0
10053087|NCT02044367|11177852|FG005|NOT COMPLETED|Overall Study||0
10053088|NCT02044380|11177864|FG000|STARTED|Overall Study|Started are the treated patients|14
10053089|NCT02044380|11177864|FG000|COMPLETED|Overall Study||14
10053090|NCT02044380|11177864|FG000|NOT COMPLETED|Overall Study||0
10053091|NCT02044393|11177870|FG000|STARTED|Period 1||10
10053092|NCT02044393|11177871|FG001|STARTED|Period 1||10
10053093|NCT02044393|11177870|FG000|COMPLETED|Period 1||10
10053094|NCT02044393|11177871|FG001|COMPLETED|Period 1||10
10053095|NCT02044393|11177870|FG000|NOT COMPLETED|Period 1||0
10053096|NCT02044393|11177871|FG001|NOT COMPLETED|Period 1||0
10053097|NCT02044393|11177870|FG000|STARTED|Period 2||10
10053098|NCT02044393|11177871|FG001|STARTED|Period 2||10
10053099|NCT02044393|11177870|FG000|COMPLETED|Period 2||10
10053100|NCT02044393|11177871|FG001|COMPLETED|Period 2||10
10053101|NCT02044393|11177870|FG000|NOT COMPLETED|Period 2||0
10053102|NCT02044393|11177871|FG001|NOT COMPLETED|Period 2||0
10053103|NCT02044419|11177884|FG000|STARTED|First Intervention||11
10053104|NCT02044419|11177885|FG001|STARTED|First Intervention||10
10053105|NCT02044419|11177886|FG002|STARTED|First Intervention||11
10053106|NCT02044419|11177884|FG000|COMPLETED|First Intervention||11
10053107|NCT02044419|11177885|FG001|COMPLETED|First Intervention||9
10053108|NCT02044419|11177886|FG002|COMPLETED|First Intervention||10
10053109|NCT02044419|11177884|FG000|NOT COMPLETED|First Intervention||0
10053110|NCT02044419|11177885|FG001|NOT COMPLETED|First Intervention||1
10053111|NCT02044419|11177886|FG002|NOT COMPLETED|First Intervention||1
10053112|NCT02044419|11177884|FG000|STARTED|Second Intervention||11
10053113|NCT02044419|11177885|FG001|STARTED|Second Intervention||9
10053114|NCT02044419|11177886|FG002|STARTED|Second Intervention||10
10053115|NCT02044419|11177884|FG000|COMPLETED|Second Intervention||11
10053116|NCT02044419|11177885|FG001|COMPLETED|Second Intervention||9
10053117|NCT02044419|11177886|FG002|COMPLETED|Second Intervention||10
10053118|NCT02044419|11177884|FG000|NOT COMPLETED|Second Intervention||0
10053119|NCT02044419|11177885|FG001|NOT COMPLETED|Second Intervention||0
10053120|NCT02044419|11177886|FG002|NOT COMPLETED|Second Intervention||0
10053121|NCT02044419|11177884|FG000|STARTED|Third Intervention||11
10053122|NCT02044419|11177885|FG001|STARTED|Third Intervention||9
10053123|NCT02044419|11177886|FG002|STARTED|Third Intervention||10
10053124|NCT02044419|11177884|FG000|COMPLETED|Third Intervention||11
10053125|NCT02044419|11177885|FG001|COMPLETED|Third Intervention||9
10053126|NCT02044419|11177886|FG002|COMPLETED|Third Intervention||10
10053127|NCT02044419|11177884|FG000|NOT COMPLETED|Third Intervention||0
10118823|NCT02549027|11249657|FG000|STARTED|Period 4 - MK-1064 or Placebo||5
10118824|NCT02549027|11249658|FG001|STARTED|Period 4 - MK-1064 or Placebo||5
10118825|NCT02549027|11249659|FG002|STARTED|Period 4 - MK-1064 or Placebo||5
10118826|NCT02549027|11249660|FG003|STARTED|Period 4 - MK-1064 or Placebo||5
10118827|NCT02549027|11249661|FG004|STARTED|Period 4 - MK-1064 or Placebo||0
10053128|NCT02044419|11177885|FG001|NOT COMPLETED|Third Intervention||0
10053129|NCT02044419|11177886|FG002|NOT COMPLETED|Third Intervention||0
10053130|NCT02044458|11177896|FG000|STARTED|Overall Study||65
10053131|NCT02044458|11177897|FG001|STARTED|Overall Study||69
10053132|NCT02044458|11177896|FG000|COMPLETED|Overall Study||62
10053133|NCT02044458|11177897|FG001|COMPLETED|Overall Study||61
10053134|NCT02044458|11177896|FG000|NOT COMPLETED|Overall Study||3
10053135|NCT02044458|11177897|FG001|NOT COMPLETED|Overall Study||8
10053136|NCT02044510|11177905|FG000|STARTED|Overall Study||16
10053137|NCT02044510|11177906|FG001|STARTED|Overall Study||16
10053138|NCT02044510|11177905|FG000|COMPLETED|Overall Study||15
10053139|NCT02044510|11177906|FG001|COMPLETED|Overall Study||14
10053140|NCT02044510|11177905|FG000|NOT COMPLETED|Overall Study||1
10053141|NCT02044510|11177906|FG001|NOT COMPLETED|Overall Study||2
10053142|NCT02044796|11177914|FG000|STARTED|Overall Study||9
10053143|NCT02044796|11177915|FG001|STARTED|Overall Study||9
10053144|NCT02044796|11177916|FG002|STARTED|Overall Study||9
10053145|NCT02044796|11177917|FG003|STARTED|Overall Study||6
10053146|NCT02044796|11177918|FG004|STARTED|Overall Study||10
10053147|NCT02044796|11177919|FG005|STARTED|Overall Study||6
10053148|NCT02044796|11177920|FG006|STARTED|Overall Study||6
10053149|NCT02044796|11177921|FG007|STARTED|Overall Study||4
10053150|NCT02044796|11177922|FG008|STARTED|Overall Study||106
10053151|NCT02044796|11177923|FG009|STARTED|Overall Study||34
10053152|NCT02044796|11177914|FG000|COMPLETED|Overall Study||9
10053153|NCT02044796|11177915|FG001|COMPLETED|Overall Study||9
10053154|NCT02044796|11177916|FG002|COMPLETED|Overall Study||9
10053155|NCT02044796|11177917|FG003|COMPLETED|Overall Study||6
10053156|NCT02044796|11177918|FG004|COMPLETED|Overall Study||10
10053157|NCT02044796|11177919|FG005|COMPLETED|Overall Study||6
10053158|NCT02044796|11177920|FG006|COMPLETED|Overall Study||6
10053159|NCT02044796|11177921|FG007|COMPLETED|Overall Study||4
10053160|NCT02044796|11177922|FG008|COMPLETED|Overall Study||106
10053161|NCT02044796|11177923|FG009|COMPLETED|Overall Study||34
10053162|NCT02044796|11177914|FG000|NOT COMPLETED|Overall Study||0
10053163|NCT02044796|11177915|FG001|NOT COMPLETED|Overall Study||0
10053164|NCT02044796|11177916|FG002|NOT COMPLETED|Overall Study||0
10053165|NCT02044796|11177917|FG003|NOT COMPLETED|Overall Study||0
10053166|NCT02044796|11177918|FG004|NOT COMPLETED|Overall Study||0
10053167|NCT02044796|11177919|FG005|NOT COMPLETED|Overall Study||0
10053168|NCT02044796|11177920|FG006|NOT COMPLETED|Overall Study||0
10053169|NCT02044796|11177921|FG007|NOT COMPLETED|Overall Study||0
10053170|NCT02044796|11177922|FG008|NOT COMPLETED|Overall Study||0
10053171|NCT02044796|11177923|FG009|NOT COMPLETED|Overall Study||0
10053172|NCT02044874|11177944|FG000|STARTED|Overall Study||201
10053173|NCT02044874|11177945|FG001|STARTED|Overall Study||202
10053174|NCT02044874|11177946|FG002|STARTED|Overall Study||200
10053175|NCT02044874|11177944|FG000|COMPLETED|Overall Study||171
10053176|NCT02044874|11177945|FG001|COMPLETED|Overall Study||147
10053177|NCT02044874|11177946|FG002|COMPLETED|Overall Study||140
10053178|NCT02044874|11177944|FG000|NOT COMPLETED|Overall Study||30
10053179|NCT02044874|11177945|FG001|NOT COMPLETED|Overall Study||55
10053180|NCT02044874|11177946|FG002|NOT COMPLETED|Overall Study||60
10053181|NCT02044991|11177958|FG000|STARTED|Overall Study||2
10053182|NCT02044991|11177959|FG001|STARTED|Overall Study||0
10053183|NCT02044991|11177958|FG000|COMPLETED|Overall Study||2
10053184|NCT02044991|11177959|FG001|COMPLETED|Overall Study||0
10053185|NCT02044991|11177958|FG000|NOT COMPLETED|Overall Study||0
10053186|NCT02044991|11177959|FG001|NOT COMPLETED|Overall Study||0
10053187|NCT02045095|11177965|FG000|STARTED|Overall Study||3
10053188|NCT02045095|11177966|FG001|STARTED|Overall Study||4
10053189|NCT02045095|11177967|FG002|STARTED|Overall Study||4
10053190|NCT02045095|11177968|FG003|STARTED|Overall Study||4
10053191|NCT02045095|11177969|FG004|STARTED|Overall Study||5
10053192|NCT02045095|11177970|FG005|STARTED|Overall Study||8
10053193|NCT02045095|11177971|FG006|STARTED|Overall Study||1
10053194|NCT02045095|11177965|FG000|COMPLETED|Overall Study||0
10053195|NCT02045095|11177966|FG001|COMPLETED|Overall Study||0
10053196|NCT02045095|11177967|FG002|COMPLETED|Overall Study||0
10053197|NCT02045095|11177968|FG003|COMPLETED|Overall Study||0
10053198|NCT02045095|11177969|FG004|COMPLETED|Overall Study||0
10053199|NCT02045095|11177970|FG005|COMPLETED|Overall Study||0
10053200|NCT02045095|11177971|FG006|COMPLETED|Overall Study||0
10053201|NCT02045095|11177965|FG000|NOT COMPLETED|Overall Study||3
10053202|NCT02045095|11177966|FG001|NOT COMPLETED|Overall Study||4
10053203|NCT02045095|11177967|FG002|NOT COMPLETED|Overall Study||4
10053204|NCT02045095|11177968|FG003|NOT COMPLETED|Overall Study||4
10053205|NCT02045095|11177969|FG004|NOT COMPLETED|Overall Study||5
10053206|NCT02045095|11177970|FG005|NOT COMPLETED|Overall Study||8
10053207|NCT02045095|11177971|FG006|NOT COMPLETED|Overall Study||1
10053208|NCT02045108|11177991|FG000|STARTED|Overall Study||22
10053209|NCT02045108|11177992|FG001|STARTED|Overall Study||15
10053210|NCT02045108|11177993|FG002|STARTED|Overall Study||20
10053211|NCT02045108|11177994|FG003|STARTED|Overall Study||20
10053212|NCT02045108|11177991|FG000|COMPLETED|Overall Study||21
10053213|NCT02045108|11177992|FG001|COMPLETED|Overall Study||12
10053214|NCT02045108|11177993|FG002|COMPLETED|Overall Study||18
10053215|NCT02045108|11177994|FG003|COMPLETED|Overall Study||19
10053216|NCT02045108|11177991|FG000|NOT COMPLETED|Overall Study||1
10053217|NCT02045108|11177992|FG001|NOT COMPLETED|Overall Study||3
10053218|NCT02045108|11177993|FG002|NOT COMPLETED|Overall Study||2
10053219|NCT02045108|11177994|FG003|NOT COMPLETED|Overall Study||1
10053220|NCT02045212|11178006|FG000|STARTED|Overall Study||13
10053221|NCT02045212|11178007|FG001|STARTED|Overall Study||9
10053222|NCT02045212|11178006|FG000|COMPLETED|Overall Study||11
10053223|NCT02045212|11178007|FG001|COMPLETED|Overall Study||8
10053224|NCT02045212|11178006|FG000|NOT COMPLETED|Overall Study||2
10053225|NCT02045212|11178007|FG001|NOT COMPLETED|Overall Study||1
10053226|NCT02045238|11178019|FG000|STARTED|Overall Study||16
10053227|NCT02045238|11178020|FG001|STARTED|Overall Study||15
10053228|NCT02045238|11178019|FG000|COMPLETED|Overall Study||9
10053229|NCT02045238|11178020|FG001|COMPLETED|Overall Study||14
10053230|NCT02045238|11178019|FG000|NOT COMPLETED|Overall Study||7
10053231|NCT02045238|11178020|FG001|NOT COMPLETED|Overall Study||1
10053232|NCT02045264|11178026|FG000|STARTED|Overall Study||12
10053233|NCT02045264|11178026|FG000|COMPLETED|Overall Study||12
10053234|NCT02045264|11178026|FG000|NOT COMPLETED|Overall Study||0
10053235|NCT02045277|11178034|FG000|STARTED|Overall Study||59
10053236|NCT02045277|11178035|FG001|STARTED|Overall Study||63
10053237|NCT02045277|11178036|FG002|STARTED|Overall Study||59
10053238|NCT02045277|11178037|FG003|STARTED|Overall Study||31
10053239|NCT02045277|11178034|FG000|COMPLETED|Overall Study||55
10053240|NCT02045277|11178035|FG001|COMPLETED|Overall Study||62
10053241|NCT02045277|11178036|FG002|COMPLETED|Overall Study||47
10053242|NCT02045277|11178037|FG003|COMPLETED|Overall Study||29
10053243|NCT02045277|11178034|FG000|NOT COMPLETED|Overall Study||4
10053244|NCT02045277|11178035|FG001|NOT COMPLETED|Overall Study||1
10053245|NCT02045277|11178036|FG002|NOT COMPLETED|Overall Study||12
10053246|NCT02045277|11178037|FG003|NOT COMPLETED|Overall Study||2
10053247|NCT02045433|11178047|FG000|STARTED|Overall Study||16
10053248|NCT02045433|11178047|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
10053249|NCT02045433|11178047|FG000|NOT COMPLETED|Overall Study||1
10053250|NCT02045511|11178053|FG000|STARTED|Overall Study||8
10053251|NCT02045511|11178054|FG001|STARTED|Overall Study||7
10053252|NCT02045511|11178053|FG000|COMPLETED|Overall Study||8
10053253|NCT02045511|11178054|FG001|COMPLETED|Overall Study||7
10053254|NCT02045511|11178053|FG000|NOT COMPLETED|Overall Study||0
10053255|NCT02045511|11178054|FG001|NOT COMPLETED|Overall Study||0
10053256|NCT02045732|11178062|FG000|STARTED|Overall Study||1
10053257|NCT02045732|11178063|FG001|STARTED|Overall Study||3
10053258|NCT02045732|11178062|FG000|COMPLETED|Overall Study||0
10053259|NCT02045732|11178063|FG001|COMPLETED|Overall Study||2
10053260|NCT02045732|11178062|FG000|NOT COMPLETED|Overall Study||1
10053261|NCT02045732|11178063|FG001|NOT COMPLETED|Overall Study||1
10053262|NCT02045836|11178071|FG000|STARTED|Overall Study||432
10053263|NCT02045836|11178072|FG001|STARTED|Overall Study||433
10053264|NCT02045836|11178071|FG000|COMPLETED|Overall Study||423
10053265|NCT02045836|11178072|FG001|COMPLETED|Overall Study||419
10053266|NCT02045836|11178071|FG000|NOT COMPLETED|Overall Study||9
10053267|NCT02045836|11178072|FG001|NOT COMPLETED|Overall Study||14
10053268|NCT02045862|11178082|FG000|STARTED|Overall Study||306
10053269|NCT02045862|11178083|FG001|STARTED|Overall Study||305
10053270|NCT02045862|11178084|FG002|STARTED|Overall Study||1218
10053271|NCT02045862|11178082|FG000|Treated|Overall Study||306
10053272|NCT02045862|11178083|FG001|Treated|Overall Study||303
10053273|NCT02045862|11178084|FG002|Treated|Overall Study||1210
10053274|NCT02045862|11178082|FG000|COMPLETED|Overall Study||267
10053275|NCT02045862|11178083|FG001|COMPLETED|Overall Study||265
10053276|NCT02045862|11178084|FG002|COMPLETED|Overall Study||1092
10053277|NCT02045862|11178082|FG000|NOT COMPLETED|Overall Study||39
10053278|NCT02045862|11178083|FG001|NOT COMPLETED|Overall Study||40
10053279|NCT02045862|11178084|FG002|NOT COMPLETED|Overall Study||126
10053280|NCT02045875|11178094|FG000|STARTED|Overall Study||27
10053281|NCT02045875|11178095|FG001|STARTED|Overall Study||23
10053282|NCT02045875|11178094|FG000|COMPLETED|Overall Study||20
10053283|NCT02045875|11178095|FG001|COMPLETED|Overall Study||20
10053284|NCT02045875|11178094|FG000|NOT COMPLETED|Overall Study||7
10053285|NCT02045875|11178095|FG001|NOT COMPLETED|Overall Study||3
10053286|NCT02045979|11178104|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
10053287|NCT02045979|11178105|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
10053288|NCT02045979|11178106|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
10053289|NCT02045979|11178104|FG000|COMPLETED|Overall Study||106
10053290|NCT02045979|11178105|FG001|COMPLETED|Overall Study||107
10053291|NCT02045979|11178106|FG002|COMPLETED|Overall Study||107
10053292|NCT02045979|11178104|FG000|NOT COMPLETED|Overall Study||2
10053293|NCT02045979|11178105|FG001|NOT COMPLETED|Overall Study||1
10053294|NCT02045979|11178106|FG002|NOT COMPLETED|Overall Study||1
10053295|NCT02046005|11178117|FG000|STARTED|Overall Study||80
10053296|NCT02046005|11178118|FG001|STARTED|Overall Study||78
10053297|NCT02046005|11178119|FG002|STARTED|Overall Study||80
10053298|NCT02046005|11178117|FG000|COMPLETED|Overall Study||72
10053299|NCT02046005|11178118|FG001|COMPLETED|Overall Study||71
10053300|NCT02046005|11178119|FG002|COMPLETED|Overall Study||70
10053301|NCT02046005|11178117|FG000|NOT COMPLETED|Overall Study||8
10053302|NCT02046005|11178118|FG001|NOT COMPLETED|Overall Study||7
10053303|NCT02046005|11178119|FG002|NOT COMPLETED|Overall Study||10
10053304|NCT02046070|11178130|FG000|STARTED|Overall Study||36
10053305|NCT02046070|11178131|FG001|STARTED|Overall Study||34
10053306|NCT02046070|11178132|FG002|STARTED|Overall Study||78
10053307|NCT02046070|11178130|FG000|COMPLETED|Overall Study||4
10053308|NCT02046070|11178131|FG001|COMPLETED|Overall Study||6
10053309|NCT02046070|11178132|FG002|COMPLETED|Overall Study||8
10053310|NCT02046070|11178130|FG000|NOT COMPLETED|Overall Study||32
10053311|NCT02046070|11178131|FG001|NOT COMPLETED|Overall Study||28
10053312|NCT02046070|11178132|FG002|NOT COMPLETED|Overall Study||70
10053313|NCT02046122|11178140|FG000|STARTED|Overall Study||17
10053314|NCT02046122|11178140|FG000|COMPLETED|Overall Study||8
10053315|NCT02046122|11178140|FG000|NOT COMPLETED|Overall Study||9
10053316|NCT02046135|11178146|FG000|STARTED|Overall Study||26
10053317|NCT02046135|11178147|FG001|STARTED|Overall Study||25
10053318|NCT02046135|11178146|FG000|COMPLETED|Overall Study||26
10053319|NCT02046135|11178147|FG001|COMPLETED|Overall Study||25
10053320|NCT02046135|11178146|FG000|NOT COMPLETED|Overall Study||0
10053321|NCT02046135|11178147|FG001|NOT COMPLETED|Overall Study||0
10053322|NCT02046148|11178155|FG000|STARTED|Overall Study||49
10053323|NCT02046148|11178156|FG001|STARTED|Overall Study||26
10053324|NCT02046148|11178155|FG000|COMPLETED|Overall Study||48
10053325|NCT02046148|11178156|FG001|COMPLETED|Overall Study||23
10053326|NCT02046148|11178155|FG000|NOT COMPLETED|Overall Study||1
10053327|NCT02046148|11178156|FG001|NOT COMPLETED|Overall Study||3
10053328|NCT02046174|11178162|FG000|STARTED|Overall Study||42
10053329|NCT02046174|11178163|FG001|STARTED|Overall Study||3
10053330|NCT02046174|11178162|FG000|COMPLETED|Overall Study||41
10053331|NCT02046174|11178163|FG001|COMPLETED|Overall Study||3
10053332|NCT02046174|11178162|FG000|NOT COMPLETED|Overall Study||1
10053333|NCT02046174|11178163|FG001|NOT COMPLETED|Overall Study||0
10053334|NCT02046200|11178248|FG000|STARTED|First Intervention (1 Day)||5
10053335|NCT02046200|11178249|FG001|STARTED|First Intervention (1 Day)||6
10053336|NCT02046200|11178248|FG000|COMPLETED|First Intervention (1 Day)||5
10053337|NCT02046200|11178249|FG001|COMPLETED|First Intervention (1 Day)||6
10053338|NCT02046200|11178248|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10053339|NCT02046200|11178249|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10053340|NCT02046200|11178248|FG000|STARTED|Second Intervention (1 Day)||5
10053341|NCT02046200|11178249|FG001|STARTED|Second Intervention (1 Day)||6
10053342|NCT02046200|11178248|FG000|COMPLETED|Second Intervention (1 Day)||5
10053343|NCT02046200|11178249|FG001|COMPLETED|Second Intervention (1 Day)||6
10053344|NCT02046200|11178248|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10053345|NCT02046200|11178249|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10053346|NCT02046265|11178267|FG000|STARTED|Overall Study||17
10053347|NCT02046265|11178268|FG001|STARTED|Overall Study||17
10053348|NCT02046265|11178269|FG002|STARTED|Overall Study||12
10053349|NCT02046265|11178270|FG003|STARTED|Overall Study||14
10053350|NCT02046265|11178267|FG000|COMPLETED|Overall Study||16
10053351|NCT02046265|11178268|FG001|COMPLETED|Overall Study||15
10053352|NCT02046265|11178269|FG002|COMPLETED|Overall Study||10
10053353|NCT02046265|11178270|FG003|COMPLETED|Overall Study||12
10053354|NCT02046265|11178267|FG000|NOT COMPLETED|Overall Study||1
10053355|NCT02046265|11178268|FG001|NOT COMPLETED|Overall Study||2
10053356|NCT02046265|11178269|FG002|NOT COMPLETED|Overall Study||2
10053357|NCT02046265|11178270|FG003|NOT COMPLETED|Overall Study||2
10053358|NCT02046317|11178282|FG000|STARTED|Overall Study||4
10053359|NCT02046317|11178283|FG001|STARTED|Overall Study||8
10053360|NCT02046317|11178282|FG000|COMPLETED|Overall Study||4
10053361|NCT02046317|11178283|FG001|COMPLETED|Overall Study||8
10053362|NCT02046317|11178282|FG000|NOT COMPLETED|Overall Study||0
10053363|NCT02046317|11178283|FG001|NOT COMPLETED|Overall Study||0
10053364|NCT02046369|11178291|FG000|STARTED|Overall Study||176
10053365|NCT02046369|11178292|FG001|STARTED|Overall Study||174
10053366|NCT02046369|11178291|FG000|COMPLETED|Overall Study||162
10053367|NCT02046369|11178292|FG001|COMPLETED|Overall Study||156
10053368|NCT02046369|11178291|FG000|NOT COMPLETED|Overall Study||14
10053369|NCT02046369|11178292|FG001|NOT COMPLETED|Overall Study||18
10053370|NCT02046382|11178300|FG000|STARTED|Overall Study||65
10053371|NCT02046382|11178301|FG001|STARTED|Overall Study||67
10053372|NCT02046382|11178300|FG000|COMPLETED|Overall Study||57
10053373|NCT02046382|11178301|FG001|COMPLETED|Overall Study||47
10053374|NCT02046382|11178300|FG000|NOT COMPLETED|Overall Study||8
10053375|NCT02046382|11178301|FG001|NOT COMPLETED|Overall Study||20
10053376|NCT02046525|11178309|FG000|STARTED|Overall Study||5
10053377|NCT02046525|11178310|FG001|STARTED|Overall Study||5
10053378|NCT02046525|11178309|FG000|COMPLETED|Overall Study||5
10053379|NCT02046525|11178310|FG001|COMPLETED|Overall Study||5
10053380|NCT02046525|11178309|FG000|NOT COMPLETED|Overall Study||0
10053381|NCT02046525|11178310|FG001|NOT COMPLETED|Overall Study||0
10053382|NCT02046564|11178318|FG000|STARTED|Overall Study||209
10053383|NCT02046564|11178319|FG001|STARTED|Overall Study||203
10053384|NCT02046564|11178318|FG000|COMPLETED|Overall Study||194
10053385|NCT02046564|11178319|FG001|COMPLETED|Overall Study||183
10053386|NCT02046564|11178318|FG000|NOT COMPLETED|Overall Study||15
10053387|NCT02046564|11178319|FG001|NOT COMPLETED|Overall Study||20
10053388|NCT02046603|11178327|FG000|STARTED|Overall Study||22
10053389|NCT02046603|11178328|FG001|STARTED|Overall Study||140
10053390|NCT02046603|11178327|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21
10053391|NCT02046603|11178328|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140
10053392|NCT02046603|11178327|FG000|COMPLETED|Overall Study||7
10053393|NCT02046603|11178328|FG001|COMPLETED|Overall Study||65
10053394|NCT02046603|11178327|FG000|NOT COMPLETED|Overall Study||15
10053395|NCT02046603|11178328|FG001|NOT COMPLETED|Overall Study||75
10053396|NCT02046616|11178335|FG000|STARTED|24-Week Treatment Period||133
10053397|NCT02046616|11178335|FG000|COMPLETED|24-Week Treatment Period||114
10053398|NCT02046616|11178335|FG000|NOT COMPLETED|24-Week Treatment Period||19
10053399|NCT02046616|11178335|FG000|STARTED|8-Week FU Period||114
10053400|NCT02046616|11178335|FG000|COMPLETED|8-Week FU Period||113
10053401|NCT02046616|11178335|FG000|NOT COMPLETED|8-Week FU Period||1
10053402|NCT02046772|11178341|FG000|STARTED|Overall Study||30
10053403|NCT02046772|11178342|FG001|STARTED|Overall Study||33
10053404|NCT02046772|11178341|FG000|COMPLETED|Overall Study||30
10053405|NCT02046772|11178342|FG001|COMPLETED|Overall Study||33
10053406|NCT02046772|11178341|FG000|NOT COMPLETED|Overall Study||0
10053407|NCT02046772|11178342|FG001|NOT COMPLETED|Overall Study||0
10053408|NCT02046863|11178348|FG000|STARTED|Overall Study||7
10053409|NCT02046863|11178348|FG000|COMPLETED|Overall Study||7
10053410|NCT02046863|11178348|FG000|NOT COMPLETED|Overall Study||0
10053411|NCT02046902|11178355|FG000|STARTED|Overall Study||336
10053412|NCT02046902|11178356|FG001|STARTED|Overall Study||113
10053413|NCT02046902|11178357|FG002|STARTED|Overall Study||137
10053414|NCT02046902|11178355|FG000|COMPLETED|Overall Study||336
10053415|NCT02046902|11178356|FG001|COMPLETED|Overall Study||113
10053416|NCT02046902|11178357|FG002|COMPLETED|Overall Study||137
10053417|NCT02046902|11178355|FG000|NOT COMPLETED|Overall Study||0
10053418|NCT02046902|11178356|FG001|NOT COMPLETED|Overall Study||0
10053419|NCT02046902|11178357|FG002|NOT COMPLETED|Overall Study||0
10053420|NCT02046941|11178365|FG000|STARTED|Overall Study||17
10053421|NCT02046941|11178365|FG000|COMPLETED|Overall Study||10
10053422|NCT02046941|11178365|FG000|NOT COMPLETED|Overall Study||7
10118828|NCT02549027|11249662|FG005|STARTED|Period 4 - MK-1064 or Placebo||0
10118829|NCT02549027|11249657|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5
10118830|NCT02549027|11249658|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5
10118831|NCT02549027|11249659|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5
10118832|NCT02549027|11249660|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5
10118833|NCT02549027|11249661|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0
10118834|NCT02549027|11249662|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0
10118835|NCT02549027|11249657|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10118836|NCT02549027|11249658|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10118837|NCT02549027|11249659|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10118838|NCT02549027|11249660|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10118839|NCT02549027|11249661|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10118840|NCT02549027|11249662|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10118841|NCT02549027|11249657|FG000|STARTED|Washout After Period 4||5
10118842|NCT02549027|11249658|FG001|STARTED|Washout After Period 4||5
10118843|NCT02549027|11249659|FG002|STARTED|Washout After Period 4||5
10118844|NCT02549027|11249660|FG003|STARTED|Washout After Period 4||5
10118845|NCT02549027|11249661|FG004|STARTED|Washout After Period 4||0
10118846|NCT02549027|11249662|FG005|STARTED|Washout After Period 4||0
10118847|NCT02549027|11249657|FG000|COMPLETED|Washout After Period 4||5
10118848|NCT02549027|11249658|FG001|COMPLETED|Washout After Period 4||4
10118849|NCT02549027|11249659|FG002|COMPLETED|Washout After Period 4||4
10118850|NCT02549027|11249660|FG003|COMPLETED|Washout After Period 4||4
10118851|NCT02549027|11249661|FG004|COMPLETED|Washout After Period 4||0
10118852|NCT02549027|11249662|FG005|COMPLETED|Washout After Period 4||0
10118853|NCT02549027|11249657|FG000|NOT COMPLETED|Washout After Period 4||0
10118854|NCT02549027|11249658|FG001|NOT COMPLETED|Washout After Period 4||1
10118855|NCT02549027|11249659|FG002|NOT COMPLETED|Washout After Period 4||1
10118856|NCT02549027|11249660|FG003|NOT COMPLETED|Washout After Period 4||1
10118857|NCT02549027|11249661|FG004|NOT COMPLETED|Washout After Period 4||0
10118858|NCT02549027|11249662|FG005|NOT COMPLETED|Washout After Period 4||0
10118859|NCT02549027|11249657|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
10118860|NCT02549027|11249658|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
10118861|NCT02549027|11249659|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
10118862|NCT02549027|11249660|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
10118863|NCT02549027|11249661|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
10118864|NCT02549027|11249662|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
10053423|NCT02046980|11178372|FG000|STARTED|Overall Study||72
10053424|NCT02046980|11178373|FG001|STARTED|Overall Study||72
10053425|NCT02046980|11178374|FG002|STARTED|Overall Study||73
10053426|NCT02046980|11178372|FG000|COMPLETED|Overall Study||70
10053427|NCT02046980|11178373|FG001|COMPLETED|Overall Study||67
10053428|NCT02046980|11178374|FG002|COMPLETED|Overall Study||72
10053429|NCT02046980|11178372|FG000|NOT COMPLETED|Overall Study||2
10053430|NCT02046980|11178373|FG001|NOT COMPLETED|Overall Study||5
10053431|NCT02046980|11178374|FG002|NOT COMPLETED|Overall Study||1
10053432|NCT02046993|11178384|FG000|STARTED|Overall Study||105
10053433|NCT02046993|11178385|FG001|STARTED|Overall Study||105
10053434|NCT02046993|11178384|FG000|3rd Month|Overall Study||104
10053435|NCT02046993|11178385|FG001|3rd Month|Overall Study||97
10053436|NCT02046993|11178384|FG000|6th Month|Overall Study||102
10053437|NCT02046993|11178385|FG001|6th Month|Overall Study||94
10053438|NCT02046993|11178384|FG000|COMPLETED|Overall Study||102
10053439|NCT02046993|11178385|FG001|COMPLETED|Overall Study||94
10053440|NCT02046993|11178384|FG000|NOT COMPLETED|Overall Study||3
10053441|NCT02046993|11178385|FG001|NOT COMPLETED|Overall Study||11
10053442|NCT02047032|11178395|FG000|STARTED|Overall Study||250
10053443|NCT02047032|11178396|FG001|STARTED|Overall Study||250
10053444|NCT02047032|11178395|FG000|COMPLETED|Overall Study||245
10053445|NCT02047032|11178396|FG001|COMPLETED|Overall Study||235
10053446|NCT02047032|11178395|FG000|NOT COMPLETED|Overall Study||5
10053447|NCT02047032|11178396|FG001|NOT COMPLETED|Overall Study||15
10053448|NCT02047045|11178406|FG000|STARTED|Baseline||280
10053449|NCT02047045|11178407|FG001|STARTED|Baseline||280
10053450|NCT02047045|11178406|FG000|COMPLETED|Baseline||277
10053451|NCT02047045|11178407|FG001|COMPLETED|Baseline||278
10053452|NCT02047045|11178406|FG000|NOT COMPLETED|Baseline||3
10053453|NCT02047045|11178407|FG001|NOT COMPLETED|Baseline||2
10053454|NCT02047045|11178406|FG000|STARTED|Treatment Period (8 Weeks )||277
10053455|NCT02047045|11178407|FG001|STARTED|Treatment Period (8 Weeks )||278
10053456|NCT02047045|11178406|FG000|COMPLETED|Treatment Period (8 Weeks )||266
10053457|NCT02047045|11178407|FG001|COMPLETED|Treatment Period (8 Weeks )||263
10053458|NCT02047045|11178406|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11
10053459|NCT02047045|11178407|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15
10053460|NCT02047045|11178406|FG000|STARTED|Follow-up Period (24 Weeks)||266
10053461|NCT02047045|11178407|FG001|STARTED|Follow-up Period (24 Weeks)||263
10053462|NCT02047045|11178406|FG000|COMPLETED|Follow-up Period (24 Weeks)||265
10053463|NCT02047045|11178407|FG001|COMPLETED|Follow-up Period (24 Weeks)||262
10053464|NCT02047045|11178406|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
10053465|NCT02047045|11178407|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1
10053466|NCT02047110|11178417|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
10053467|NCT02047110|11178418|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
10053468|NCT02047110|11178419|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
10053469|NCT02047110|11178420|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
10053470|NCT02047110|11178417|FG000|COMPLETED|DB Treatment Period up to Week 24||35
10053471|NCT02047110|11178418|FG001|COMPLETED|DB Treatment Period up to Week 24||38
10053472|NCT02047110|11178419|FG002|COMPLETED|DB Treatment Period up to Week 24||36
10053473|NCT02047110|11178420|FG003|COMPLETED|DB Treatment Period up to Week 24||38
10053474|NCT02047110|11178417|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5
10053475|NCT02047110|11178418|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2
10053476|NCT02047110|11178419|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3
10053477|NCT02047110|11178420|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2
10053478|NCT02047110|11178417|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
10053479|NCT02047110|11178418|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
10053480|NCT02047110|11178419|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
10053481|NCT02047110|11178420|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
10053482|NCT02047110|11178417|FG000|COMPLETED|DB (Week 12 up to Week 24)||9
10053483|NCT02047110|11178418|FG001|COMPLETED|DB (Week 12 up to Week 24)||15
10053484|NCT02047110|11178419|FG002|COMPLETED|DB (Week 12 up to Week 24)||12
10053485|NCT02047110|11178420|FG003|COMPLETED|DB (Week 12 up to Week 24)||12
10053486|NCT02047110|11178417|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0
10053487|NCT02047110|11178418|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2
10053488|NCT02047110|11178419|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1
10053489|NCT02047110|11178420|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0
10053490|NCT02047110|11178417|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
10053491|NCT02047110|11178418|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
10053492|NCT02047110|11178419|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
10053493|NCT02047110|11178420|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
10053494|NCT02047110|11178417|FG000|COMPLETED|Escape Treatment Period||23
10053495|NCT02047110|11178418|FG001|COMPLETED|Escape Treatment Period||15
10053496|NCT02047110|11178419|FG002|COMPLETED|Escape Treatment Period||20
10053497|NCT02047110|11178420|FG003|COMPLETED|Escape Treatment Period||24
10053498|NCT02047110|11178417|FG000|NOT COMPLETED|Escape Treatment Period||3
10053499|NCT02047110|11178418|FG001|NOT COMPLETED|Escape Treatment Period||6
10053500|NCT02047110|11178419|FG002|NOT COMPLETED|Escape Treatment Period||3
10053501|NCT02047110|11178420|FG003|NOT COMPLETED|Escape Treatment Period||2
10053502|NCT02047110|11178417|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
10053503|NCT02047110|11178418|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
10053504|NCT02047110|11178419|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
10053505|NCT02047110|11178420|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
10053506|NCT02047110|11178417|FG000|COMPLETED|OLE Treatment Period||4
10053507|NCT02047110|11178418|FG001|COMPLETED|OLE Treatment Period||8
10053508|NCT02047110|11178419|FG002|COMPLETED|OLE Treatment Period||4
10053509|NCT02047110|11178420|FG003|COMPLETED|OLE Treatment Period||9
10053510|NCT02047110|11178417|FG000|NOT COMPLETED|OLE Treatment Period||0
10053511|NCT02047110|11178418|FG001|NOT COMPLETED|OLE Treatment Period||0
10053512|NCT02047110|11178419|FG002|NOT COMPLETED|OLE Treatment Period||1
10118865|NCT02549027|11249657|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0
10118866|NCT02549027|11249658|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0
10118867|NCT02549027|11249659|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0
10118868|NCT02549027|11249660|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0
9706648|NCT02513394|10805719|FG000|COMPLETED|Overall Study||2884
10118869|NCT02549027|11249661|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
10118870|NCT02549027|11249662|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1
10118871|NCT02549027|11249657|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10118872|NCT02549027|11249658|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10118873|NCT02549027|11249659|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10118874|NCT02549027|11249660|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10118875|NCT02549027|11249661|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
10118876|NCT02549027|11249662|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10118877|NCT02549040|11249677|FG000|STARTED|Period 1||16
10118878|NCT02549040|11249677|FG000|COMPLETED|Period 1||16
10118879|NCT02549040|11249677|FG000|NOT COMPLETED|Period 1||0
10118880|NCT02549040|11249677|FG000|STARTED|Period 2||16
10118881|NCT02549040|11249677|FG000|COMPLETED|Period 2||16
10118882|NCT02549040|11249677|FG000|NOT COMPLETED|Period 2||0
10118883|NCT02549040|11249677|FG000|STARTED|Period 3||16
10118884|NCT02549040|11249677|FG000|COMPLETED|Period 3||16
10118885|NCT02549040|11249677|FG000|NOT COMPLETED|Period 3||0
10118886|NCT02549040|11249677|FG000|STARTED|Period 4||16
10118887|NCT02549040|11249677|FG000|COMPLETED|Period 4||16
10118888|NCT02549040|11249677|FG000|NOT COMPLETED|Period 4||0
10118889|NCT02549040|11249677|FG000|STARTED|Period 5||16
10118890|NCT02549040|11249677|FG000|COMPLETED|Period 5||16
10118891|NCT02549040|11249677|FG000|NOT COMPLETED|Period 5||0
10118892|NCT02549196|11249693|FG000|STARTED|Overall Study||8
10118893|NCT02549196|11249694|FG001|STARTED|Overall Study||1
10118894|NCT02549196|11249695|FG002|STARTED|Overall Study||6
10118895|NCT02549196|11249696|FG003|STARTED|Overall Study||13
10053513|NCT02047110|11178420|FG003|NOT COMPLETED|OLE Treatment Period||0
10053514|NCT02047227|11178439|FG000|STARTED|Overall Study||462
10053515|NCT02047227|11178440|FG001|STARTED|Overall Study||477
10053516|NCT02047227|11178439|FG000|Completed Ovarian Stimulation Phase|Overall Study||424
10053517|NCT02047227|11178440|FG001|Completed Ovarian Stimulation Phase|Overall Study||440
10053518|NCT02047227|11178439|FG000|COMPLETED|Overall Study||318
10053519|NCT02047227|11178440|FG001|COMPLETED|Overall Study||347
10053520|NCT02047227|11178439|FG000|NOT COMPLETED|Overall Study||144
10053521|NCT02047227|11178440|FG001|NOT COMPLETED|Overall Study||130
10053522|NCT02047253|11178446|FG000|STARTED|Overall Study||28
10053523|NCT02047253|11178446|FG000|COMPLETED|Overall Study||20
10053524|NCT02047253|11178446|FG000|NOT COMPLETED|Overall Study||8
10053525|NCT02047305|11178450|FG000|STARTED|Overall Study||96
10053526|NCT02047305|11178450|FG000|COMPLETED|Overall Study||96
10053527|NCT02047305|11178450|FG000|NOT COMPLETED|Overall Study||0
10053528|NCT02047318|11178454|FG000|STARTED|Core Study Period||19
10053529|NCT02047318|11178454|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6
10053530|NCT02047318|11178454|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6
10053531|NCT02047318|11178454|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6
10053532|NCT02047318|11178454|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11
10053533|NCT02047318|11178454|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19
10053534|NCT02047318|11178454|FG000|COMPLETED|Core Study Period||7
10053535|NCT02047318|11178454|FG000|NOT COMPLETED|Core Study Period||12
10053536|NCT02047318|11178454|FG000|STARTED|52-week Follow-up Treatment Period||6
10053537|NCT02047318|11178454|FG000|COMPLETED|52-week Follow-up Treatment Period||6
10053538|NCT02047318|11178454|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0
10053539|NCT02047318|11178454|FG000|STARTED|Long-term Follow-up Treatment Period||7
10053540|NCT02047318|11178454|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7
10053541|NCT02047318|11178454|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5
10053542|NCT02047318|11178454|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5
10053543|NCT02047318|11178454|FG000|COMPLETED|Long-term Follow-up Treatment Period||6
10053544|NCT02047318|11178454|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1
10053545|NCT02047344|11178471|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
10053546|NCT02047344|11178472|FG001|STARTED|Overall Study||15
10053547|NCT02047344|11178471|FG000|COMPLETED|Overall Study||16
10053548|NCT02047344|11178472|FG001|COMPLETED|Overall Study||15
10053549|NCT02047344|11178471|FG000|NOT COMPLETED|Overall Study||0
10053550|NCT02047344|11178472|FG001|NOT COMPLETED|Overall Study||0
10053551|NCT02047500|11178484|FG000|STARTED|Overall Study||19
10053552|NCT02047500|11178484|FG000|COMPLETED|Overall Study||0
10053553|NCT02047500|11178484|FG000|NOT COMPLETED|Overall Study||19
10053554|NCT02047604|11178494|FG000|STARTED|Overall Study||6
10053555|NCT02047604|11178495|FG001|STARTED|Overall Study||7
10053556|NCT02047604|11178496|FG002|STARTED|Overall Study||6
10053557|NCT02047604|11178497|FG003|STARTED|Overall Study||6
10053558|NCT02047604|11178498|FG004|STARTED|Overall Study||6
10053559|NCT02047604|11178499|FG005|STARTED|Overall Study||10
10053560|NCT02047604|11178494|FG000|COMPLETED|Overall Study||6
10053561|NCT02047604|11178495|FG001|COMPLETED|Overall Study||7
10053562|NCT02047604|11178496|FG002|COMPLETED|Overall Study||6
10053563|NCT02047604|11178497|FG003|COMPLETED|Overall Study||6
10053564|NCT02047604|11178498|FG004|COMPLETED|Overall Study||5
10053565|NCT02047604|11178499|FG005|COMPLETED|Overall Study||9
10053566|NCT02047604|11178494|FG000|NOT COMPLETED|Overall Study||0
10053567|NCT02047604|11178495|FG001|NOT COMPLETED|Overall Study||0
10053568|NCT02047604|11178496|FG002|NOT COMPLETED|Overall Study||0
10053569|NCT02047604|11178497|FG003|NOT COMPLETED|Overall Study||0
10053570|NCT02047604|11178498|FG004|NOT COMPLETED|Overall Study||1
10053571|NCT02047604|11178499|FG005|NOT COMPLETED|Overall Study||1
10053572|NCT02047643|11178513|FG000|STARTED|Overall Study||9
10053573|NCT02047643|11178514|FG001|STARTED|Overall Study||9
10053574|NCT02047643|11178513|FG000|COMPLETED|Overall Study||9
10053575|NCT02047643|11178514|FG001|COMPLETED|Overall Study||9
10053576|NCT02047643|11178513|FG000|NOT COMPLETED|Overall Study||0
10053577|NCT02047643|11178514|FG001|NOT COMPLETED|Overall Study||0
10053578|NCT02047734|11178523|FG000|STARTED|Overall Study||443
10053579|NCT02047734|11178524|FG001|STARTED|Overall Study||443
10053580|NCT02047734|11178525|FG002|STARTED|Overall Study||434
10053581|NCT02047734|11178523|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
10053582|NCT02047734|11178524|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
10053583|NCT02047734|11178525|FG002|Received Treatment|Overall Study||433
10053584|NCT02047734|11178523|FG000|COMPLETED|Overall Study||376
10053585|NCT02047734|11178524|FG001|COMPLETED|Overall Study||374
10053586|NCT02047734|11178525|FG002|COMPLETED|Overall Study||388
10053587|NCT02047734|11178523|FG000|NOT COMPLETED|Overall Study||67
10053588|NCT02047734|11178524|FG001|NOT COMPLETED|Overall Study||69
10053589|NCT02047734|11178525|FG002|NOT COMPLETED|Overall Study||46
10053590|NCT02047903|11178533|FG000|STARTED|Overall Study||161
10053591|NCT02047903|11178533|FG000|Treated|Overall Study||152
10053592|NCT02047903|11178533|FG000|COMPLETED|Overall Study||102
10053593|NCT02047903|11178533|FG000|NOT COMPLETED|Overall Study||59
10053594|NCT02047981|11178539|FG000|STARTED|MORDOR Stage I Year 1-2||97047
10053595|NCT02047981|11178540|FG001|STARTED|MORDOR Stage I Year 1-2||93191
10053596|NCT02047981|11178539|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650
10053597|NCT02047981|11178540|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474
10053598|NCT02047981|11178539|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
10053599|NCT02047981|11178540|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
10053600|NCT02047981|11178539|FG000|STARTED|MORDOR Stage II Year 3||37497
10053601|NCT02047981|11178540|FG001|STARTED|MORDOR Stage II Year 3||33294
10053602|NCT02047981|11178539|FG000|COMPLETED|MORDOR Stage II Year 3||34611
10053603|NCT02047981|11178540|FG001|COMPLETED|MORDOR Stage II Year 3||30931
10053604|NCT02047981|11178539|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886
10053605|NCT02047981|11178540|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363
10053606|NCT02048072|11178546|FG000|STARTED|Overall Study||33
10053607|NCT02048072|11178546|FG000|COMPLETED|Overall Study||29
10053608|NCT02048072|11178546|FG000|NOT COMPLETED|Overall Study||4
10053609|NCT02048241|11178552|FG000|STARTED|Overall Study||5
10053610|NCT02048241|11178553|FG001|STARTED|Overall Study||6
10053611|NCT02048241|11178552|FG000|COMPLETED|Overall Study||5
10053612|NCT02048241|11178553|FG001|COMPLETED|Overall Study||5
10053613|NCT02048241|11178552|FG000|NOT COMPLETED|Overall Study||0
10053614|NCT02048241|11178553|FG001|NOT COMPLETED|Overall Study||1
10053615|NCT02048670|11178561|FG000|STARTED|Overall Study||6
10053616|NCT02048670|11178562|FG001|STARTED|Overall Study||6
10053617|NCT02048670|11178561|FG000|COMPLETED|Overall Study||6
10053618|NCT02048670|11178562|FG001|COMPLETED|Overall Study||6
10053619|NCT02048670|11178561|FG000|NOT COMPLETED|Overall Study||0
10053620|NCT02048670|11178562|FG001|NOT COMPLETED|Overall Study||0
10053621|NCT02048826|11178570|FG000|STARTED|Overall Study||16
10053622|NCT02048826|11178571|FG001|STARTED|Overall Study||15
10053623|NCT02048826|11178570|FG000|COMPLETED|Overall Study||15
10053624|NCT02048826|11178571|FG001|COMPLETED|Overall Study||15
10053625|NCT02048826|11178570|FG000|NOT COMPLETED|Overall Study||1
10053626|NCT02048826|11178571|FG001|NOT COMPLETED|Overall Study||0
10053627|NCT02048878|11178579|FG000|STARTED|Overall Study||13
10053628|NCT02048878|11178580|FG001|STARTED|Overall Study||15
10053629|NCT02048878|11178579|FG000|COMPLETED|Overall Study||12
10053630|NCT02048878|11178580|FG001|COMPLETED|Overall Study||12
10053631|NCT02048878|11178579|FG000|NOT COMPLETED|Overall Study||1
10053632|NCT02048878|11178580|FG001|NOT COMPLETED|Overall Study||3
10053633|NCT02048891|11178588|FG000|STARTED|Overall Study||2
10053634|NCT02048891|11178589|FG001|STARTED|Overall Study||1
10053635|NCT02048891|11178588|FG000|COMPLETED|Overall Study||2
10053636|NCT02048891|11178589|FG001|COMPLETED|Overall Study||1
10053637|NCT02048891|11178588|FG000|NOT COMPLETED|Overall Study||0
10053638|NCT02048891|11178589|FG001|NOT COMPLETED|Overall Study||0
10053639|NCT02049151|11178597|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15
10053640|NCT02049151|11178598|FG001|STARTED|Overall Study|1 subject did not receive treatment|17
10053641|NCT02049151|11178597|FG000|COMPLETED|Overall Study||15
10053642|NCT02049151|11178598|FG001|COMPLETED|Overall Study||17
10053643|NCT02049151|11178597|FG000|NOT COMPLETED|Overall Study||0
10053644|NCT02049151|11178598|FG001|NOT COMPLETED|Overall Study||0
10053645|NCT02049307|11178606|FG000|STARTED|Overall Study||52
10053646|NCT02049307|11178607|FG001|STARTED|Overall Study||56
10053647|NCT02049307|11178606|FG000|COMPLETED|Overall Study||50
10053648|NCT02049307|11178607|FG001|COMPLETED|Overall Study||55
10053649|NCT02049307|11178606|FG000|NOT COMPLETED|Overall Study||2
10053650|NCT02049307|11178607|FG001|NOT COMPLETED|Overall Study||1
10053651|NCT02049385|11178615|FG000|STARTED|First Intervention||4
10053652|NCT02049385|11178616|FG001|STARTED|First Intervention||2
10053653|NCT02049385|11178615|FG000|COMPLETED|First Intervention||1
10053654|NCT02049385|11178616|FG001|COMPLETED|First Intervention||2
10053655|NCT02049385|11178615|FG000|NOT COMPLETED|First Intervention||3
10053656|NCT02049385|11178616|FG001|NOT COMPLETED|First Intervention||0
10053657|NCT02049385|11178615|FG000|STARTED|Second Intervention||1
10053658|NCT02049385|11178616|FG001|STARTED|Second Intervention||2
10053659|NCT02049385|11178615|FG000|COMPLETED|Second Intervention||1
10053660|NCT02049385|11178616|FG001|COMPLETED|Second Intervention||0
10053661|NCT02049385|11178615|FG000|NOT COMPLETED|Second Intervention||0
10053662|NCT02049385|11178616|FG001|NOT COMPLETED|Second Intervention||2
10053663|NCT02049437|11178624|FG000|STARTED|Period 1||17
10053664|NCT02049437|11178625|FG001|STARTED|Period 1||17
10053665|NCT02049437|11178624|FG000|COMPLETED|Period 1||15
10053666|NCT02049437|11178625|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16
10053667|NCT02049437|11178624|FG000|NOT COMPLETED|Period 1||2
10053668|NCT02049437|11178625|FG001|NOT COMPLETED|Period 1||1
10053669|NCT02049437|11178624|FG000|STARTED|Washout 1||15
10053670|NCT02049437|11178625|FG001|STARTED|Washout 1||16
10053671|NCT02049437|11178624|FG000|COMPLETED|Washout 1||15
10053672|NCT02049437|11178625|FG001|COMPLETED|Washout 1||16
10053673|NCT02049437|11178624|FG000|NOT COMPLETED|Washout 1||0
10053674|NCT02049437|11178625|FG001|NOT COMPLETED|Washout 1||0
10053675|NCT02049437|11178624|FG000|STARTED|Period 2||15
10053676|NCT02049437|11178625|FG001|STARTED|Period 2||16
10053677|NCT02049437|11178624|FG000|COMPLETED|Period 2||15
10053678|NCT02049437|11178625|FG001|COMPLETED|Period 2||16
10053679|NCT02049437|11178624|FG000|NOT COMPLETED|Period 2||0
10053680|NCT02049437|11178625|FG001|NOT COMPLETED|Period 2||0
10053681|NCT02049437|11178624|FG000|STARTED|Washout 2||15
10053682|NCT02049437|11178625|FG001|STARTED|Washout 2||16
10053683|NCT02049437|11178624|FG000|COMPLETED|Washout 2||15
10053684|NCT02049437|11178625|FG001|COMPLETED|Washout 2||16
10053685|NCT02049437|11178624|FG000|NOT COMPLETED|Washout 2||0
10053686|NCT02049437|11178625|FG001|NOT COMPLETED|Washout 2||0
10053687|NCT02049450|11178631|FG000|STARTED|Overall Study||30
10053688|NCT02049450|11178631|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4
10118896|NCT02549196|11249693|FG000|COMPLETED|Overall Study||7
10053689|NCT02049450|11178631|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
10053690|NCT02049450|11178631|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
10053691|NCT02049450|11178631|FG000|NOT COMPLETED|Overall Study||4
10053692|NCT02049476|11178642|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
10053693|NCT02049476|11178642|FG000|COMPLETED|Overall Study|20th patient completed the study|20
10053694|NCT02049476|11178642|FG000|NOT COMPLETED|Overall Study||0
10053695|NCT02049502|11178646|FG000|STARTED|Overall Study||8
10053696|NCT02049502|11178646|FG000|COMPLETED|Overall Study||8
10053697|NCT02049502|11178646|FG000|NOT COMPLETED|Overall Study||0
10053698|NCT02049749|11178652|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80
10053699|NCT02049749|11178653|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160
10053700|NCT02049749|11178652|FG000|COMPLETED|Overall Study||80
10053701|NCT02049749|11178653|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160
10053702|NCT02049749|11178652|FG000|NOT COMPLETED|Overall Study||0
10053703|NCT02049749|11178653|FG001|NOT COMPLETED|Overall Study||0
10053704|NCT02049814|11178662|FG000|STARTED|Overall Study||248
10053705|NCT02049814|11178663|FG001|STARTED|Overall Study||246
10053706|NCT02049814|11178662|FG000|Safety Set|Overall Study||248
10053707|NCT02049814|11178663|FG001|Safety Set|Overall Study||245
10053708|NCT02049814|11178662|FG000|COMPLETED|Overall Study||219
10053709|NCT02049814|11178663|FG001|COMPLETED|Overall Study||219
10053710|NCT02049814|11178662|FG000|NOT COMPLETED|Overall Study||29
10053711|NCT02049814|11178663|FG001|NOT COMPLETED|Overall Study||27
10053712|NCT02049866|11178669|FG000|STARTED|Overall Study||33
10053713|NCT02049866|11178669|FG000|COMPLETED|Overall Study||32
10053714|NCT02049866|11178669|FG000|NOT COMPLETED|Overall Study||1
10053715|NCT02049931|11178676|FG000|STARTED|Overall Study||20
10053716|NCT02049931|11178677|FG001|STARTED|Overall Study||20
10053717|NCT02049931|11178678|FG002|STARTED|Overall Study||20
10053718|NCT02049931|11178676|FG000|COMPLETED|Overall Study||17
10053719|NCT02049931|11178677|FG001|COMPLETED|Overall Study||15
10053720|NCT02049931|11178678|FG002|COMPLETED|Overall Study||17
10053721|NCT02049931|11178676|FG000|NOT COMPLETED|Overall Study||3
10053722|NCT02049931|11178677|FG001|NOT COMPLETED|Overall Study||5
10053723|NCT02049931|11178678|FG002|NOT COMPLETED|Overall Study||3
10053724|NCT02049944|11178686|FG000|STARTED|Overall Study||30
10053725|NCT02049944|11178686|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14
10053726|NCT02049944|11178686|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
10053727|NCT02049944|11178686|FG000|COMPLETED|Overall Study||28
10053728|NCT02049944|11178686|FG000|NOT COMPLETED|Overall Study||2
10053729|NCT02049957|11178699|FG000|STARTED|Overall Study||6
10053730|NCT02049957|11178700|FG001|STARTED|Overall Study||6
10053731|NCT02049957|11178701|FG002|STARTED|Overall Study||3
10053732|NCT02049957|11178702|FG003|STARTED|Overall Study||3
10053733|NCT02049957|11178703|FG004|STARTED|Overall Study||6
10053734|NCT02049957|11178704|FG005|STARTED|Overall Study||43
10053735|NCT02049957|11178705|FG006|STARTED|Overall Study||8
10053736|NCT02049957|11178706|FG007|STARTED|Overall Study||35
10053737|NCT02049957|11178707|FG008|STARTED|Overall Study||8
10053738|NCT02049957|11178699|FG000|COMPLETED|Overall Study||0
10053739|NCT02049957|11178700|FG001|COMPLETED|Overall Study||0
10053740|NCT02049957|11178701|FG002|COMPLETED|Overall Study||0
10053741|NCT02049957|11178702|FG003|COMPLETED|Overall Study||0
10053742|NCT02049957|11178703|FG004|COMPLETED|Overall Study||0
10053743|NCT02049957|11178704|FG005|COMPLETED|Overall Study||0
10053744|NCT02049957|11178705|FG006|COMPLETED|Overall Study||0
10053745|NCT02049957|11178706|FG007|COMPLETED|Overall Study||0
10053746|NCT02049957|11178707|FG008|COMPLETED|Overall Study||0
10053747|NCT02049957|11178699|FG000|NOT COMPLETED|Overall Study||6
10053748|NCT02049957|11178700|FG001|NOT COMPLETED|Overall Study||6
10053749|NCT02049957|11178701|FG002|NOT COMPLETED|Overall Study||3
10053750|NCT02049957|11178702|FG003|NOT COMPLETED|Overall Study||3
10053751|NCT02049957|11178703|FG004|NOT COMPLETED|Overall Study||6
10053752|NCT02049957|11178704|FG005|NOT COMPLETED|Overall Study||43
10053753|NCT02049957|11178705|FG006|NOT COMPLETED|Overall Study||8
10118897|NCT02549196|11249694|FG001|COMPLETED|Overall Study||1
10118898|NCT02549196|11249695|FG002|COMPLETED|Overall Study||5
10118899|NCT02549196|11249696|FG003|COMPLETED|Overall Study||12
10118900|NCT02549196|11249693|FG000|NOT COMPLETED|Overall Study||1
10118901|NCT02549196|11249694|FG001|NOT COMPLETED|Overall Study||0
10118902|NCT02549196|11249695|FG002|NOT COMPLETED|Overall Study||1
10118903|NCT02549196|11249696|FG003|NOT COMPLETED|Overall Study||1
10118904|NCT02549287|11249708|FG000|STARTED|Overall Study||193
10053754|NCT02049957|11178706|FG007|NOT COMPLETED|Overall Study||35
10053755|NCT02049957|11178707|FG008|NOT COMPLETED|Overall Study||8
10053756|NCT02050048|11178729|FG000|STARTED|Overall Study||14
10053757|NCT02050048|11178730|FG001|STARTED|Overall Study||12
10053758|NCT02050048|11178729|FG000|COMPLETED|Overall Study||9
10053759|NCT02050048|11178730|FG001|COMPLETED|Overall Study||10
10053760|NCT02050048|11178729|FG000|NOT COMPLETED|Overall Study||5
10053761|NCT02050048|11178730|FG001|NOT COMPLETED|Overall Study||2
10053762|NCT02050321|11178736|FG000|STARTED|Overall Study||2
10053763|NCT02050321|11178736|FG000|COMPLETED|Overall Study||0
10053764|NCT02050321|11178736|FG000|NOT COMPLETED|Overall Study||2
10053765|NCT02050334|11178742|FG000|STARTED|Overall Study||9
10053766|NCT02050334|11178743|FG001|STARTED|Overall Study||9
10053767|NCT02050334|11178742|FG000|COMPLETED|Overall Study||9
10053768|NCT02050334|11178743|FG001|COMPLETED|Overall Study||9
10053769|NCT02050334|11178742|FG000|NOT COMPLETED|Overall Study||0
10053770|NCT02050334|11178743|FG001|NOT COMPLETED|Overall Study||0
10053771|NCT02050373|11178752|FG000|STARTED|Overall Study||34
10053772|NCT02050373|11178753|FG001|STARTED|Overall Study||34
10053773|NCT02050373|11178752|FG000|COMPLETED|Overall Study||27
10053774|NCT02050373|11178753|FG001|COMPLETED|Overall Study||24
10053775|NCT02050373|11178752|FG000|NOT COMPLETED|Overall Study||7
10053776|NCT02050373|11178753|FG001|NOT COMPLETED|Overall Study||10
10053777|NCT02050841|11178760|FG000|STARTED|Overall Study||50
10053778|NCT02050841|11178760|FG000|COMPLETED|Overall Study||49
10053779|NCT02050841|11178760|FG000|NOT COMPLETED|Overall Study||1
10053780|NCT02051296|11178772|FG000|STARTED|Overall Study||66
10053781|NCT02051296|11178773|FG001|STARTED|Overall Study||65
10053782|NCT02051296|11178772|FG000|Received Allocated Intervention|Overall Study||59
10053783|NCT02051296|11178773|FG001|Received Allocated Intervention|Overall Study||58
10053784|NCT02051296|11178772|FG000|COMPLETED|Overall Study||58
10053785|NCT02051296|11178773|FG001|COMPLETED|Overall Study||56
10053786|NCT02051296|11178772|FG000|NOT COMPLETED|Overall Study||8
10053787|NCT02051296|11178773|FG001|NOT COMPLETED|Overall Study||9
10053788|NCT02051335|11178783|FG000|STARTED|Period 1||7
10053789|NCT02051335|11178784|FG001|STARTED|Period 1||7
10053790|NCT02051335|11178785|FG002|STARTED|Period 1||7
10053791|NCT02051335|11178786|FG003|STARTED|Period 1||6
10053792|NCT02051335|11178783|FG000|COMPLETED|Period 1||7
10053793|NCT02051335|11178784|FG001|COMPLETED|Period 1||7
10053794|NCT02051335|11178785|FG002|COMPLETED|Period 1||7
10053795|NCT02051335|11178786|FG003|COMPLETED|Period 1||6
10053796|NCT02051335|11178783|FG000|NOT COMPLETED|Period 1||0
10053797|NCT02051335|11178784|FG001|NOT COMPLETED|Period 1||0
10053798|NCT02051335|11178785|FG002|NOT COMPLETED|Period 1||0
10053799|NCT02051335|11178786|FG003|NOT COMPLETED|Period 1||0
10053800|NCT02051335|11178783|FG000|STARTED|Period 2||7
10053801|NCT02051335|11178784|FG001|STARTED|Period 2||7
10053802|NCT02051335|11178785|FG002|STARTED|Period 2||7
10053803|NCT02051335|11178786|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
10053804|NCT02051335|11178783|FG000|COMPLETED|Period 2||7
10053805|NCT02051335|11178784|FG001|COMPLETED|Period 2||7
10053806|NCT02051335|11178785|FG002|COMPLETED|Period 2||7
10053807|NCT02051335|11178786|FG003|COMPLETED|Period 2||4
10053808|NCT02051335|11178783|FG000|NOT COMPLETED|Period 2||0
10118905|NCT02549287|11249709|FG001|STARTED|Overall Study||96
10118906|NCT02549287|11249708|FG000|COMPLETED|Overall Study||113
10118907|NCT02549287|11249709|FG001|COMPLETED|Overall Study||64
10118908|NCT02549287|11249708|FG000|NOT COMPLETED|Overall Study||80
10118909|NCT02549287|11249709|FG001|NOT COMPLETED|Overall Study||32
10118910|NCT02549339|11249717|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
10118911|NCT02549339|11249718|FG001|STARTED|3-day Treatment and 8-week Follow-up||104
10118912|NCT02549339|11249717|FG000|Treated|3-day Treatment and 8-week Follow-up||202
10118913|NCT02549339|11249718|FG001|Treated|3-day Treatment and 8-week Follow-up||104
10118914|NCT02549339|11249717|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201
10118915|NCT02549339|11249718|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99
10118916|NCT02549339|11249717|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
10118917|NCT02549339|11249718|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
10118918|NCT02549339|11249717|FG000|STARTED|12-month Follow-up||201
10118919|NCT02549339|11249718|FG001|STARTED|12-month Follow-up||98
10118920|NCT02549339|11249717|FG000|COMPLETED|12-month Follow-up||192
10118921|NCT02549339|11249718|FG001|COMPLETED|12-month Follow-up||87
10118922|NCT02549339|11249717|FG000|NOT COMPLETED|12-month Follow-up||9
10118923|NCT02549339|11249718|FG001|NOT COMPLETED|12-month Follow-up||11
10118924|NCT02549352|11249728|FG000|STARTED|3-day Treatment and 8-week Follow-up||209
10118925|NCT02549352|11249729|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
10118926|NCT02549352|11249728|FG000|Treated|3-day Treatment and 8-week Follow-up||209
10118927|NCT02549352|11249729|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
10118928|NCT02549352|11249728|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
10118929|NCT02549352|11249729|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96
10118930|NCT02549352|11249728|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
10118931|NCT02549352|11249729|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
10118932|NCT02549352|11249728|FG000|STARTED|12-month Follow-up||207
10118933|NCT02549352|11249729|FG001|STARTED|12-month Follow-up||93
10118934|NCT02549352|11249728|FG000|COMPLETED|12-month Follow-up||199
10118935|NCT02549352|11249729|FG001|COMPLETED|12-month Follow-up||81
10118936|NCT02549352|11249728|FG000|NOT COMPLETED|12-month Follow-up||8
10118937|NCT02549352|11249729|FG001|NOT COMPLETED|12-month Follow-up||12
10118938|NCT02549365|11249739|FG000|STARTED|Overall Study||164
10118939|NCT02549365|11249740|FG001|STARTED|Overall Study||112
10053809|NCT02051335|11178784|FG001|NOT COMPLETED|Period 2||0
10053810|NCT02051335|11178785|FG002|NOT COMPLETED|Period 2||0
10053811|NCT02051335|11178786|FG003|NOT COMPLETED|Period 2||0
10053812|NCT02051335|11178783|FG000|STARTED|Period 3||7
10053813|NCT02051335|11178784|FG001|STARTED|Period 3||7
10053814|NCT02051335|11178785|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
10053815|NCT02051335|11178786|FG003|STARTED|Period 3||4
10053816|NCT02051335|11178783|FG000|COMPLETED|Period 3||7
10053817|NCT02051335|11178784|FG001|COMPLETED|Period 3||7
10053818|NCT02051335|11178785|FG002|COMPLETED|Period 3||5
10053819|NCT02051335|11178786|FG003|COMPLETED|Period 3||4
10053820|NCT02051335|11178783|FG000|NOT COMPLETED|Period 3||0
10053821|NCT02051335|11178784|FG001|NOT COMPLETED|Period 3||0
10053822|NCT02051335|11178785|FG002|NOT COMPLETED|Period 3||0
10053823|NCT02051335|11178786|FG003|NOT COMPLETED|Period 3||0
10053824|NCT02051335|11178783|FG000|STARTED|Period 4||7
10053825|NCT02051335|11178784|FG001|STARTED|Period 4||7
10053826|NCT02051335|11178785|FG002|STARTED|Period 4||5
10053827|NCT02051335|11178786|FG003|STARTED|Period 4||4
10053828|NCT02051335|11178783|FG000|COMPLETED|Period 4||7
10053829|NCT02051335|11178784|FG001|COMPLETED|Period 4||7
10053830|NCT02051335|11178785|FG002|COMPLETED|Period 4||5
10053831|NCT02051335|11178786|FG003|COMPLETED|Period 4||4
10053832|NCT02051335|11178783|FG000|NOT COMPLETED|Period 4||0
10053833|NCT02051335|11178784|FG001|NOT COMPLETED|Period 4||0
10053834|NCT02051335|11178785|FG002|NOT COMPLETED|Period 4||0
10053835|NCT02051335|11178786|FG003|NOT COMPLETED|Period 4||0
10053836|NCT02051426|11178798|FG000|STARTED|First Intervention||16
10053837|NCT02051426|11178799|FG001|STARTED|First Intervention||19
10053838|NCT02051426|11178798|FG000|COMPLETED|First Intervention||16
10053839|NCT02051426|11178799|FG001|COMPLETED|First Intervention||19
10053840|NCT02051426|11178798|FG000|NOT COMPLETED|First Intervention||0
10053841|NCT02051426|11178799|FG001|NOT COMPLETED|First Intervention||0
10053842|NCT02051426|11178798|FG000|STARTED|Washout Period of 1 Month||16
10053843|NCT02051426|11178799|FG001|STARTED|Washout Period of 1 Month||19
10053844|NCT02051426|11178798|FG000|COMPLETED|Washout Period of 1 Month||16
10053845|NCT02051426|11178799|FG001|COMPLETED|Washout Period of 1 Month||19
10053846|NCT02051426|11178798|FG000|NOT COMPLETED|Washout Period of 1 Month||0
10053847|NCT02051426|11178799|FG001|NOT COMPLETED|Washout Period of 1 Month||0
10053848|NCT02051426|11178798|FG000|STARTED|Second Intervention||16
10118940|NCT02549365|11249739|FG000|COMPLETED|Overall Study||164
10118941|NCT02549365|11249740|FG001|COMPLETED|Overall Study||112
10118942|NCT02549365|11249739|FG000|NOT COMPLETED|Overall Study||0
10118943|NCT02549365|11249740|FG001|NOT COMPLETED|Overall Study||0
10118944|NCT02549508|11249748|FG000|STARTED|Overall Study||47
10118945|NCT02549508|11249749|FG001|STARTED|Overall Study||38
10118946|NCT02549508|11249748|FG000|COMPLETED|Overall Study||33
10118947|NCT02549508|11249749|FG001|COMPLETED|Overall Study||21
10118948|NCT02549508|11249748|FG000|NOT COMPLETED|Overall Study||14
10118949|NCT02549508|11249749|FG001|NOT COMPLETED|Overall Study||17
10118950|NCT02549573|11249759|FG000|STARTED|Overall Study||6
10118951|NCT02549573|11249760|FG001|STARTED|Overall Study||7
10118952|NCT02549573|11249759|FG000|COMPLETED|Overall Study||6
10118953|NCT02549573|11249760|FG001|COMPLETED|Overall Study||4
10118954|NCT02549573|11249759|FG000|NOT COMPLETED|Overall Study||0
10118955|NCT02549573|11249760|FG001|NOT COMPLETED|Overall Study||3
10118956|NCT02549859|11249766|FG000|STARTED|Visit 1||11
10118957|NCT02549859|11249766|FG000|COMPLETED|Visit 1||11
10118958|NCT02549859|11249766|FG000|NOT COMPLETED|Visit 1||0
10118959|NCT02549859|11249766|FG000|STARTED|Long-term 60 Hz DBS||11
10118960|NCT02549859|11249766|FG000|COMPLETED|Long-term 60 Hz DBS||10
10118961|NCT02549859|11249766|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1
10118962|NCT02549859|11249766|FG000|STARTED|Visit 2||10
10118963|NCT02549859|11249766|FG000|COMPLETED|Visit 2||10
10118964|NCT02549859|11249766|FG000|NOT COMPLETED|Visit 2||0
10118965|NCT02550106|11249774|FG000|STARTED|Overall Study||136
10118966|NCT02550106|11249774|FG000|COMPLETED|Overall Study||124
10118967|NCT02550106|11249774|FG000|NOT COMPLETED|Overall Study||12
10118968|NCT02550132|11249780|FG000|STARTED|Overall Study||25
10118969|NCT02550132|11249780|FG000|COMPLETED|Overall Study||25
10118970|NCT02550132|11249780|FG000|NOT COMPLETED|Overall Study||0
10118971|NCT02550210|11249784|FG000|STARTED|Overall Study||23
10118972|NCT02550210|11249784|FG000|COMPLETED|Overall Study||19
10118973|NCT02550210|11249784|FG000|NOT COMPLETED|Overall Study||4
10118974|NCT02550743|11249792|FG000|STARTED|Overall Study||3
10118975|NCT02550743|11249793|FG001|STARTED|Overall Study||3
10118976|NCT02550743|11249794|FG002|STARTED|Overall Study||1
10118977|NCT02550743|11249795|FG003|STARTED|Overall Study||0
10053849|NCT02051426|11178799|FG001|STARTED|Second Intervention||19
10053850|NCT02051426|11178798|FG000|COMPLETED|Second Intervention||16
10118978|NCT02550743|11249792|FG000|COMPLETED|Overall Study||3
10118979|NCT02550743|11249793|FG001|COMPLETED|Overall Study||3
10118980|NCT02550743|11249794|FG002|COMPLETED|Overall Study||1
10118981|NCT02550743|11249795|FG003|COMPLETED|Overall Study||0
10118982|NCT02550743|11249792|FG000|NOT COMPLETED|Overall Study||0
10118983|NCT02550743|11249793|FG001|NOT COMPLETED|Overall Study||0
10118984|NCT02550743|11249794|FG002|NOT COMPLETED|Overall Study||0
10118985|NCT02550743|11249795|FG003|NOT COMPLETED|Overall Study||0
10118986|NCT02550795|11249809|FG000|STARTED|Overall Study||50
10118987|NCT02550795|11249810|FG001|STARTED|Overall Study||50
10118988|NCT02550795|11249811|FG002|STARTED|Overall Study||50
10118989|NCT02550795|11249809|FG000|COMPLETED|Overall Study||50
10118990|NCT02550795|11249810|FG001|COMPLETED|Overall Study||49
10118991|NCT02550795|11249811|FG002|COMPLETED|Overall Study||50
10118992|NCT02550795|11249809|FG000|NOT COMPLETED|Overall Study||0
10118993|NCT02550795|11249810|FG001|NOT COMPLETED|Overall Study||1
10118994|NCT02550795|11249811|FG002|NOT COMPLETED|Overall Study||0
10118995|NCT02550938|11249823|FG000|STARTED|Overall Study||44
10118996|NCT02550938|11249824|FG001|STARTED|Overall Study||85
10118997|NCT02550938|11249825|FG002|STARTED|Overall Study||43
10053851|NCT02051426|11178799|FG001|COMPLETED|Second Intervention||19
10053852|NCT02051426|11178798|FG000|NOT COMPLETED|Second Intervention||0
10118998|NCT02550938|11249826|FG003|STARTED|Overall Study||81
10118999|NCT02550938|11249823|FG000|COMPLETED|Overall Study||36
10119000|NCT02550938|11249824|FG001|COMPLETED|Overall Study||78
10053853|NCT02051426|11178799|FG001|NOT COMPLETED|Second Intervention||0
10053854|NCT02051452|11178807|FG000|STARTED|Overall Study||16
10053855|NCT02051452|11178808|FG001|STARTED|Overall Study||16
10053856|NCT02051452|11178807|FG000|COMPLETED|Overall Study||16
10053857|NCT02051452|11178808|FG001|COMPLETED|Overall Study||16
10053858|NCT02051452|11178807|FG000|NOT COMPLETED|Overall Study||0
10053859|NCT02051452|11178808|FG001|NOT COMPLETED|Overall Study||0
10053860|NCT02051595|11178814|FG000|STARTED|Overall Study||25
10053861|NCT02051595|11178814|FG000|COMPLETED|Overall Study||25
10053862|NCT02051595|11178814|FG000|NOT COMPLETED|Overall Study||0
10053863|NCT02051686|11178820|FG000|STARTED|Overall Study||42
10053864|NCT02051686|11178821|FG001|STARTED|Overall Study||46
10053865|NCT02051686|11178820|FG000|COMPLETED|Overall Study||42
10053866|NCT02051686|11178821|FG001|COMPLETED|Overall Study||46
10053867|NCT02051686|11178820|FG000|NOT COMPLETED|Overall Study||0
10053868|NCT02051686|11178821|FG001|NOT COMPLETED|Overall Study||0
10053869|NCT02051764|11178829|FG000|STARTED|Overall Study||16
10053870|NCT02051764|11178830|FG001|STARTED|Overall Study||28
10053871|NCT02051764|11178829|FG000|COMPLETED|Overall Study||16
10053872|NCT02051764|11178830|FG001|COMPLETED|Overall Study||21
10053873|NCT02051764|11178829|FG000|NOT COMPLETED|Overall Study||0
10053874|NCT02051764|11178830|FG001|NOT COMPLETED|Overall Study||7
10053875|NCT02051790|11178836|FG000|STARTED|Overall Study||241
10053876|NCT02051790|11178836|FG000|COMPLETED|Overall Study||241
10053877|NCT02051790|11178836|FG000|NOT COMPLETED|Overall Study||0
10053878|NCT02051816|11178844|FG000|STARTED|Overall Study||37
10053879|NCT02051816|11178845|FG001|STARTED|Overall Study||40
10053880|NCT02051816|11178846|FG002|STARTED|Overall Study||37
10053881|NCT02051816|11178847|FG003|STARTED|Overall Study||36
10053882|NCT02051816|11178844|FG000|COMPLETED|Overall Study||37
10053883|NCT02051816|11178845|FG001|COMPLETED|Overall Study||40
10053884|NCT02051816|11178846|FG002|COMPLETED|Overall Study||37
10053885|NCT02051816|11178847|FG003|COMPLETED|Overall Study||36
10053886|NCT02051816|11178844|FG000|NOT COMPLETED|Overall Study||0
10053887|NCT02051816|11178845|FG001|NOT COMPLETED|Overall Study||0
10053888|NCT02051816|11178846|FG002|NOT COMPLETED|Overall Study||0
10053889|NCT02051816|11178847|FG003|NOT COMPLETED|Overall Study||0
10053890|NCT02052011|11178863|FG000|STARTED|Overall Study||21
10053891|NCT02052011|11178864|FG001|STARTED|Overall Study||10
10053892|NCT02052011|11178863|FG000|COMPLETED|Overall Study||17
10053893|NCT02052011|11178864|FG001|COMPLETED|Overall Study||8
10053894|NCT02052011|11178863|FG000|NOT COMPLETED|Overall Study||4
10053895|NCT02052011|11178864|FG001|NOT COMPLETED|Overall Study||2
10053896|NCT02052141|11178872|FG000|STARTED|Intervention Period 1||5
10053897|NCT02052141|11178873|FG001|STARTED|Intervention Period 1||7
10053898|NCT02052141|11178872|FG000|COMPLETED|Intervention Period 1||5
10053899|NCT02052141|11178873|FG001|COMPLETED|Intervention Period 1||7
10053900|NCT02052141|11178872|FG000|NOT COMPLETED|Intervention Period 1||0
10053901|NCT02052141|11178873|FG001|NOT COMPLETED|Intervention Period 1||0
10053902|NCT02052141|11178872|FG000|STARTED|Intervention Period 2||5
10053903|NCT02052141|11178873|FG001|STARTED|Intervention Period 2||7
10053904|NCT02052141|11178872|FG000|COMPLETED|Intervention Period 2||5
10053905|NCT02052141|11178873|FG001|COMPLETED|Intervention Period 2||7
10053906|NCT02052141|11178872|FG000|NOT COMPLETED|Intervention Period 2||0
10053907|NCT02052141|11178873|FG001|NOT COMPLETED|Intervention Period 2||0
10053908|NCT02052310|11178881|FG000|STARTED|Overall Study||522
10053909|NCT02052310|11178882|FG001|STARTED|Overall Study||521
10053910|NCT02052310|11178881|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522
10053911|NCT02052310|11178882|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517
10053912|NCT02052310|11178881|FG000|COMPLETED|Overall Study||307
10053913|NCT02052310|11178882|FG001|COMPLETED|Overall Study||309
10053914|NCT02052310|11178881|FG000|NOT COMPLETED|Overall Study||215
10053915|NCT02052310|11178882|FG001|NOT COMPLETED|Overall Study||212
10053916|NCT02052414|11178888|FG000|STARTED|Overall Study||34
10053917|NCT02052414|11178888|FG000|COMPLETED|Overall Study||17
10053918|NCT02052414|11178888|FG000|NOT COMPLETED|Overall Study||17
10053919|NCT02052440|11178895|FG000|STARTED|Overall Study||50
10053920|NCT02052440|11178896|FG001|STARTED|Overall Study||52
10053921|NCT02052440|11178895|FG000|COMPLETED|Overall Study||50
10053922|NCT02052440|11178896|FG001|COMPLETED|Overall Study||51
10053923|NCT02052440|11178895|FG000|NOT COMPLETED|Overall Study||0
10053924|NCT02052440|11178896|FG001|NOT COMPLETED|Overall Study||1
10053925|NCT02052466|11178902|FG000|STARTED|Overall Study||32
10053926|NCT02052466|11178902|FG000|COMPLETED|Overall Study||30
10053927|NCT02052466|11178902|FG000|NOT COMPLETED|Overall Study||2
10053928|NCT02052544|11178906|FG000|STARTED|Overall Study|First Subject In|123
10053929|NCT02052544|11178906|FG000|COMPLETED|Overall Study|Last Subject Out|123
10053930|NCT02052544|11178906|FG000|NOT COMPLETED|Overall Study||0
10053931|NCT02052557|11178913|FG000|STARTED|Overall Study||26
10053932|NCT02052557|11178914|FG001|STARTED|Overall Study||25
10053933|NCT02052557|11178913|FG000|COMPLETED|Overall Study||26
10053934|NCT02052557|11178914|FG001|COMPLETED|Overall Study||25
10053935|NCT02052557|11178913|FG000|NOT COMPLETED|Overall Study||0
10053936|NCT02052557|11178914|FG001|NOT COMPLETED|Overall Study||0
10053937|NCT02052596|11178924|FG000|STARTED|Active Phase||412
10053938|NCT02052596|11178925|FG001|STARTED|Active Phase||418
10053939|NCT02052596|11178924|FG000|COMPLETED|Active Phase||396
10053940|NCT02052596|11178925|FG001|COMPLETED|Active Phase||398
10053941|NCT02052596|11178924|FG000|NOT COMPLETED|Active Phase||16
10053942|NCT02052596|11178925|FG001|NOT COMPLETED|Active Phase||20
10053943|NCT02052596|11178924|FG000|STARTED|Safety Phase||412
10053944|NCT02052596|11178925|FG001|STARTED|Safety Phase||418
10053945|NCT02052596|11178924|FG000|COMPLETED|Safety Phase||385
10053946|NCT02052596|11178925|FG001|COMPLETED|Safety Phase||383
10053947|NCT02052596|11178924|FG000|NOT COMPLETED|Safety Phase||27
10053948|NCT02052596|11178925|FG001|NOT COMPLETED|Safety Phase||35
10053949|NCT02052635|11178933|FG000|STARTED|Overall Study||7
10053950|NCT02052635|11178934|FG001|STARTED|Overall Study||6
10053951|NCT02052635|11178933|FG000|COMPLETED|Overall Study||7
10053952|NCT02052635|11178934|FG001|COMPLETED|Overall Study||6
10053953|NCT02052635|11178933|FG000|NOT COMPLETED|Overall Study||0
10053954|NCT02052635|11178934|FG001|NOT COMPLETED|Overall Study||0
10053955|NCT02052661|11178940|FG000|STARTED|Overall Study||300
10053956|NCT02052661|11178940|FG000|COMPLETED|Overall Study||300
10053957|NCT02052661|11178940|FG000|NOT COMPLETED|Overall Study||0
10053958|NCT02052752|11178947|FG000|STARTED|Overall Study||30
10053959|NCT02052752|11178948|FG001|STARTED|Overall Study||30
10053960|NCT02052752|11178949|FG002|STARTED|Overall Study||30
10053961|NCT02052752|11178947|FG000|COMPLETED|Overall Study||30
10119001|NCT02550938|11249825|FG002|COMPLETED|Overall Study||31
10119002|NCT02550938|11249826|FG003|COMPLETED|Overall Study||70
10119003|NCT02550938|11249823|FG000|NOT COMPLETED|Overall Study||8
10119004|NCT02550938|11249824|FG001|NOT COMPLETED|Overall Study||7
10119005|NCT02550938|11249825|FG002|NOT COMPLETED|Overall Study||12
10119006|NCT02550938|11249826|FG003|NOT COMPLETED|Overall Study||11
10119007|NCT02551055|11249843|FG000|STARTED|Overall Study||4
10119008|NCT02551055|11249844|FG001|STARTED|Overall Study||6
10119009|NCT02551055|11249845|FG002|STARTED|Overall Study||3
10119010|NCT02551055|11249846|FG003|STARTED|Overall Study||6
10119011|NCT02551055|11249847|FG004|STARTED|Overall Study||7
10119012|NCT02551055|11249848|FG005|STARTED|Overall Study||2
10119013|NCT02551055|11249849|FG006|STARTED|Overall Study||4
10119014|NCT02551055|11249850|FG007|STARTED|Overall Study||0
10119015|NCT02551055|11249843|FG000|COMPLETED|Overall Study||0
10119016|NCT02551055|11249844|FG001|COMPLETED|Overall Study||0
10119017|NCT02551055|11249845|FG002|COMPLETED|Overall Study||1
10119018|NCT02551055|11249846|FG003|COMPLETED|Overall Study||1
10119019|NCT02551055|11249847|FG004|COMPLETED|Overall Study||0
10119020|NCT02551055|11249848|FG005|COMPLETED|Overall Study||1
10119021|NCT02551055|11249849|FG006|COMPLETED|Overall Study||1
10119022|NCT02551055|11249850|FG007|COMPLETED|Overall Study||0
10119023|NCT02551055|11249843|FG000|NOT COMPLETED|Overall Study||4
10119024|NCT02551055|11249844|FG001|NOT COMPLETED|Overall Study||6
10119025|NCT02551055|11249845|FG002|NOT COMPLETED|Overall Study||2
10119026|NCT02551055|11249846|FG003|NOT COMPLETED|Overall Study||5
10119027|NCT02551055|11249847|FG004|NOT COMPLETED|Overall Study||7
10119028|NCT02551055|11249848|FG005|NOT COMPLETED|Overall Study||1
10119029|NCT02551055|11249849|FG006|NOT COMPLETED|Overall Study||3
10119030|NCT02551055|11249850|FG007|NOT COMPLETED|Overall Study||0
10119031|NCT02551094|11249870|FG000|STARTED|Overall Study||2366
10119032|NCT02551094|11249871|FG001|STARTED|Overall Study||2379
10053962|NCT02052752|11178948|FG001|COMPLETED|Overall Study||30
10053963|NCT02052752|11178949|FG002|COMPLETED|Overall Study||30
10119033|NCT02551094|11249870|FG000|COMPLETED|Overall Study||2226
10119034|NCT02551094|11249871|FG001|COMPLETED|Overall Study||2232
10119035|NCT02551094|11249870|FG000|NOT COMPLETED|Overall Study||140
10119036|NCT02551094|11249871|FG001|NOT COMPLETED|Overall Study||147
10119037|NCT02551159|11249880|FG000|STARTED|Overall Study||413
10119038|NCT02551159|11249881|FG001|STARTED|Overall Study||204
10119039|NCT02551159|11249882|FG002|STARTED|Overall Study||206
10119040|NCT02551159|11249880|FG000|Full Analysis Set|Overall Study||413
10119041|NCT02551159|11249881|FG001|Full Analysis Set|Overall Study||204
10119042|NCT02551159|11249882|FG002|Full Analysis Set|Overall Study||206
10119043|NCT02551159|11249880|FG000|Safety Analysis Set|Overall Study||408
10119044|NCT02551159|11249881|FG001|Safety Analysis Set|Overall Study||202
10119045|NCT02551159|11249882|FG002|Safety Analysis Set|Overall Study||196
10119046|NCT02551159|11249880|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190
10119047|NCT02551159|11249881|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99
10119048|NCT02551159|11249882|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94
10119049|NCT02551159|11249880|FG000|COMPLETED|Overall Study||0
10119050|NCT02551159|11249881|FG001|COMPLETED|Overall Study||0
10053964|NCT02052752|11178947|FG000|NOT COMPLETED|Overall Study||0
10053965|NCT02052752|11178948|FG001|NOT COMPLETED|Overall Study||0
10053966|NCT02052752|11178949|FG002|NOT COMPLETED|Overall Study||0
10053967|NCT02052895|11178961|FG000|STARTED|Overall Study||196
10119051|NCT02551159|11249882|FG002|COMPLETED|Overall Study||0
10119052|NCT02551159|11249880|FG000|NOT COMPLETED|Overall Study||413
10119053|NCT02551159|11249881|FG001|NOT COMPLETED|Overall Study||204
10119054|NCT02551159|11249882|FG002|NOT COMPLETED|Overall Study||206
10119055|NCT02551224|11249890|FG000|STARTED|First Intervention||50
10119056|NCT02551224|11249891|FG001|STARTED|First Intervention||50
10119057|NCT02551224|11249890|FG000|COMPLETED|First Intervention||50
10119058|NCT02551224|11249891|FG001|COMPLETED|First Intervention||50
10053968|NCT02052895|11178962|FG001|STARTED|Overall Study||15
10053969|NCT02052895|11178963|FG002|STARTED|Overall Study||15
10053970|NCT02052895|11178961|FG000|COMPLETED|Overall Study||196
10053971|NCT02052895|11178962|FG001|COMPLETED|Overall Study||15
10053972|NCT02052895|11178963|FG002|COMPLETED|Overall Study||15
10053973|NCT02052895|11178961|FG000|NOT COMPLETED|Overall Study||0
10053974|NCT02052895|11178962|FG001|NOT COMPLETED|Overall Study||0
10053975|NCT02052895|11178963|FG002|NOT COMPLETED|Overall Study||0
10053976|NCT02052960|11178972|FG000|STARTED|Overall Study||117
10053977|NCT02052960|11178973|FG001|STARTED|Overall Study||123
10053978|NCT02052960|11178972|FG000|Treated Patients|Overall Study||115
10053979|NCT02052960|11178973|FG001|Treated Patients|Overall Study||122
10053980|NCT02052960|11178972|FG000|COMPLETED|Overall Study||63
10053981|NCT02052960|11178973|FG001|COMPLETED|Overall Study||77
10053982|NCT02052960|11178972|FG000|NOT COMPLETED|Overall Study||54
10053983|NCT02052960|11178973|FG001|NOT COMPLETED|Overall Study||46
10053984|NCT02053077|11178982|FG000|STARTED|Overall Study||150
10053985|NCT02053077|11178982|FG000|COMPLETED|Overall Study||150
10053986|NCT02053077|11178982|FG000|NOT COMPLETED|Overall Study||0
10053987|NCT02053168|11178986|FG000|STARTED|Overall Study||25
10053988|NCT02053168|11178986|FG000|COMPLETED|Overall Study||22
10053989|NCT02053168|11178986|FG000|NOT COMPLETED|Overall Study||3
10053990|NCT02053259|11178994|FG000|STARTED|Overall Study||25
10053991|NCT02053259|11178995|FG001|STARTED|Overall Study||24
10053992|NCT02053259|11178996|FG002|STARTED|Overall Study||24
10053993|NCT02053259|11178997|FG003|STARTED|Overall Study||23
10053994|NCT02053259|11178994|FG000|COMPLETED|Overall Study||25
10119059|NCT02551224|11249890|FG000|NOT COMPLETED|First Intervention||0
10119060|NCT02551224|11249891|FG001|NOT COMPLETED|First Intervention||0
10119061|NCT02551224|11249890|FG000|STARTED|Second Intervention (5 Min After First )||50
10053995|NCT02053259|11178995|FG001|COMPLETED|Overall Study||24
10053996|NCT02053259|11178996|FG002|COMPLETED|Overall Study||24
10053997|NCT02053259|11178997|FG003|COMPLETED|Overall Study||23
10053998|NCT02053259|11178994|FG000|NOT COMPLETED|Overall Study||0
10053999|NCT02053259|11178995|FG001|NOT COMPLETED|Overall Study||0
10054000|NCT02053259|11178996|FG002|NOT COMPLETED|Overall Study||0
10054001|NCT02053259|11178997|FG003|NOT COMPLETED|Overall Study||0
10054002|NCT02053376|11179007|FG000|STARTED|Overall Study||43
10054003|NCT02053376|11179007|FG000|COMPLETED|Overall Study||43
10054004|NCT02053376|11179007|FG000|NOT COMPLETED|Overall Study||0
10054005|NCT02053493|11179013|FG000|STARTED|Overall Study||51
10054006|NCT02053493|11179014|FG001|STARTED|Overall Study||59
10054007|NCT02053493|11179013|FG000|COMPLETED|Overall Study||50
10054008|NCT02053493|11179014|FG001|COMPLETED|Overall Study||58
10054009|NCT02053493|11179013|FG000|NOT COMPLETED|Overall Study||1
10054010|NCT02053493|11179014|FG001|NOT COMPLETED|Overall Study||1
10054011|NCT02053610|11179022|FG000|STARTED|Overall Study||330
10054012|NCT02053610|11179023|FG001|STARTED|Overall Study||333
10054013|NCT02053610|11179022|FG000|Received Study Drug|Overall Study||326
10119062|NCT02551224|11249891|FG001|STARTED|Second Intervention (5 Min After First )||50
10119063|NCT02551224|11249890|FG000|COMPLETED|Second Intervention (5 Min After First )||50
10119064|NCT02551224|11249891|FG001|COMPLETED|Second Intervention (5 Min After First )||50
10119065|NCT02551224|11249890|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0
10119066|NCT02551224|11249891|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0
10119067|NCT02551432|11249897|FG000|STARTED|Overall Study||26
10119068|NCT02551432|11249897|FG000|COMPLETED|Overall Study||26
10119069|NCT02551432|11249897|FG000|NOT COMPLETED|Overall Study||0
10119070|NCT02551653|11249903|FG000|STARTED|Overall Study||5
10119071|NCT02551653|11249904|FG001|STARTED|Overall Study||5
10119072|NCT02551653|11249903|FG000|COMPLETED|Overall Study||5
10119073|NCT02551653|11249904|FG001|COMPLETED|Overall Study||5
10119074|NCT02551653|11249903|FG000|NOT COMPLETED|Overall Study||0
10119075|NCT02551653|11249904|FG001|NOT COMPLETED|Overall Study||0
10119076|NCT02551666|11249912|FG000|STARTED|Overall Study||16
10119077|NCT02551666|11249913|FG001|STARTED|Overall Study||19
10119078|NCT02551666|11249912|FG000|COMPLETED|Overall Study||15
10119079|NCT02551666|11249913|FG001|COMPLETED|Overall Study||16
10119080|NCT02551666|11249912|FG000|NOT COMPLETED|Overall Study||1
10119081|NCT02551666|11249913|FG001|NOT COMPLETED|Overall Study||3
10054014|NCT02053610|11179023|FG001|Received Study Drug|Overall Study||331
10054015|NCT02053610|11179022|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288
10054016|NCT02053610|11179023|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266
10054017|NCT02053610|11179022|FG000|NOT COMPLETED|Overall Study||42
10054018|NCT02053610|11179023|FG001|NOT COMPLETED|Overall Study||67
10054019|NCT02053753|11179031|FG000|STARTED|Overall Study||72
10054020|NCT02053753|11179032|FG001|STARTED|Overall Study||74
10054021|NCT02053753|11179031|FG000|Received Treatment|Overall Study||71
10054022|NCT02053753|11179032|FG001|Received Treatment|Overall Study||71
10054023|NCT02053753|11179031|FG000|COMPLETED|Overall Study||65
10054024|NCT02053753|11179032|FG001|COMPLETED|Overall Study||66
10054025|NCT02053753|11179031|FG000|NOT COMPLETED|Overall Study||7
10119082|NCT02551692|11249922|FG000|STARTED|Overall Study||31
10119083|NCT02551692|11249923|FG001|STARTED|Overall Study||27
10119084|NCT02551692|11249924|FG002|STARTED|Overall Study||30
10054026|NCT02053753|11179032|FG001|NOT COMPLETED|Overall Study||8
10054027|NCT02054130|11179042|FG000|STARTED|Overall Study||138
10054028|NCT02054130|11179043|FG001|STARTED|Overall Study||138
10054029|NCT02054130|11179044|FG002|STARTED|Overall Study||137
10054030|NCT02054130|11179045|FG003|STARTED|Overall Study||137
10054031|NCT02054130|11179042|FG000|COMPLETED|Overall Study||130
10054032|NCT02054130|11179043|FG001|COMPLETED|Overall Study||127
10054033|NCT02054130|11179044|FG002|COMPLETED|Overall Study||122
10054034|NCT02054130|11179045|FG003|COMPLETED|Overall Study||115
10054035|NCT02054130|11179042|FG000|NOT COMPLETED|Overall Study||8
10054036|NCT02054130|11179043|FG001|NOT COMPLETED|Overall Study||11
10054037|NCT02054130|11179044|FG002|NOT COMPLETED|Overall Study||15
10054038|NCT02054130|11179045|FG003|NOT COMPLETED|Overall Study||22
10054039|NCT02054156|11179060|FG000|STARTED|Overall Study||110
10054040|NCT02054156|11179061|FG001|STARTED|Overall Study||111
10054041|NCT02054156|11179060|FG000|COMPLETED|Overall Study||35
10054042|NCT02054156|11179061|FG001|COMPLETED|Overall Study||30
10054043|NCT02054156|11179060|FG000|NOT COMPLETED|Overall Study||75
10054044|NCT02054156|11179061|FG001|NOT COMPLETED|Overall Study||81
10054045|NCT02054325|11179069|FG000|STARTED|Overall Study||51
10054046|NCT02054325|11179070|FG001|STARTED|Overall Study||55
10054047|NCT02054325|11179069|FG000|COMPLETED|Overall Study||43
10054048|NCT02054325|11179070|FG001|COMPLETED|Overall Study||50
10054049|NCT02054325|11179069|FG000|NOT COMPLETED|Overall Study||8
10054050|NCT02054325|11179070|FG001|NOT COMPLETED|Overall Study||5
10054051|NCT02054338|11179078|FG000|STARTED|Overall Study||503
10054052|NCT02054338|11179079|FG001|STARTED|Overall Study||501
10054053|NCT02054338|11179078|FG000|COMPLETED|Overall Study||0
10054054|NCT02054338|11179079|FG001|COMPLETED|Overall Study||0
10054055|NCT02054338|11179078|FG000|NOT COMPLETED|Overall Study||503
10054056|NCT02054338|11179079|FG001|NOT COMPLETED|Overall Study||501
10054057|NCT02054481|11179089|FG000|STARTED|Overall Study||43
10054058|NCT02054481|11179090|FG001|STARTED|Overall Study||41
10054059|NCT02054481|11179091|FG002|STARTED|Overall Study||42
10054060|NCT02054481|11179092|FG003|STARTED|Overall Study||40
10054061|NCT02054481|11179089|FG000|COMPLETED|Overall Study||39
10054062|NCT02054481|11179090|FG001|COMPLETED|Overall Study||39
10054063|NCT02054481|11179091|FG002|COMPLETED|Overall Study||40
10054064|NCT02054481|11179092|FG003|COMPLETED|Overall Study||39
10054065|NCT02054481|11179089|FG000|NOT COMPLETED|Overall Study||4
10054066|NCT02054481|11179090|FG001|NOT COMPLETED|Overall Study||2
10054067|NCT02054481|11179091|FG002|NOT COMPLETED|Overall Study||2
10054068|NCT02054481|11179092|FG003|NOT COMPLETED|Overall Study||1
10054069|NCT02054520|11179109|FG000|STARTED|Overall Study||11
10054070|NCT02054520|11179110|FG001|STARTED|Overall Study||16
10054071|NCT02054520|11179111|FG002|STARTED|Overall Study||6
10054072|NCT02054520|11179112|FG003|STARTED|Overall Study||6
10054073|NCT02054520|11179113|FG004|STARTED|Overall Study||5
10054074|NCT02054520|11179114|FG005|STARTED|Overall Study||3
10054075|NCT02054520|11179109|FG000|COMPLETED|Overall Study||2
10054076|NCT02054520|11179110|FG001|COMPLETED|Overall Study||11
10054077|NCT02054520|11179111|FG002|COMPLETED|Overall Study||0
10054078|NCT02054520|11179112|FG003|COMPLETED|Overall Study||0
10054079|NCT02054520|11179113|FG004|COMPLETED|Overall Study||0
10054080|NCT02054520|11179114|FG005|COMPLETED|Overall Study||0
10054081|NCT02054520|11179109|FG000|NOT COMPLETED|Overall Study||9
10054082|NCT02054520|11179110|FG001|NOT COMPLETED|Overall Study||5
10054083|NCT02054520|11179111|FG002|NOT COMPLETED|Overall Study||6
10054084|NCT02054520|11179112|FG003|NOT COMPLETED|Overall Study||6
10054085|NCT02054520|11179113|FG004|NOT COMPLETED|Overall Study||5
10054086|NCT02054520|11179114|FG005|NOT COMPLETED|Overall Study||3
10054087|NCT02054572|11179128|FG000|STARTED|Overall Study||6
10054088|NCT02054572|11179128|FG000|COMPLETED|Overall Study||6
10054089|NCT02054572|11179128|FG000|NOT COMPLETED|Overall Study||0
10054090|NCT02054702|11179134|FG000|STARTED|Overall Study||64
10054091|NCT02054702|11179135|FG001|STARTED|Overall Study||33
10054092|NCT02054702|11179134|FG000|COMPLETED|Overall Study||40
10054093|NCT02054702|11179135|FG001|COMPLETED|Overall Study||21
10054094|NCT02054702|11179134|FG000|NOT COMPLETED|Overall Study||24
10054095|NCT02054702|11179135|FG001|NOT COMPLETED|Overall Study||12
10054096|NCT02054715|11179143|FG000|STARTED|Baseline/Follow-up 1||219
10054097|NCT02054715|11179144|FG001|STARTED|Baseline/Follow-up 1||199
10054098|NCT02054715|11179143|FG000|COMPLETED|Baseline/Follow-up 1||211
10054099|NCT02054715|11179144|FG001|COMPLETED|Baseline/Follow-up 1||192
10054100|NCT02054715|11179143|FG000|NOT COMPLETED|Baseline/Follow-up 1||8
10054101|NCT02054715|11179144|FG001|NOT COMPLETED|Baseline/Follow-up 1||7
10054102|NCT02054715|11179143|FG000|STARTED|Follow-up 2||211
10054103|NCT02054715|11179144|FG001|STARTED|Follow-up 2||192
10054104|NCT02054715|11179143|FG000|COMPLETED|Follow-up 2||192
10054105|NCT02054715|11179144|FG001|COMPLETED|Follow-up 2||173
10054106|NCT02054715|11179143|FG000|NOT COMPLETED|Follow-up 2||19
10054107|NCT02054715|11179144|FG001|NOT COMPLETED|Follow-up 2||19
10054108|NCT02054754|11179152|FG000|STARTED|Overall Study||6
10054109|NCT02054754|11179153|FG001|STARTED|Overall Study||6
10054110|NCT02054754|11179154|FG002|STARTED|Overall Study||6
10054111|NCT02054754|11179155|FG003|STARTED|Overall Study||6
10119085|NCT02551692|11249922|FG000|COMPLETED|Overall Study||30
10119086|NCT02551692|11249923|FG001|COMPLETED|Overall Study||26
10119087|NCT02551692|11249924|FG002|COMPLETED|Overall Study||25
10119088|NCT02551692|11249922|FG000|NOT COMPLETED|Overall Study||1
10054112|NCT02054754|11179156|FG004|STARTED|Overall Study||6
10054113|NCT02054754|11179157|FG005|STARTED|Overall Study||10
10054114|NCT02054754|11179152|FG000|COMPLETED|Overall Study||6
10054115|NCT02054754|11179153|FG001|COMPLETED|Overall Study||6
10054116|NCT02054754|11179154|FG002|COMPLETED|Overall Study||6
10054117|NCT02054754|11179155|FG003|COMPLETED|Overall Study||6
10054118|NCT02054754|11179156|FG004|COMPLETED|Overall Study||6
10054119|NCT02054754|11179157|FG005|COMPLETED|Overall Study||10
10054120|NCT02054754|11179152|FG000|NOT COMPLETED|Overall Study||0
10054121|NCT02054754|11179153|FG001|NOT COMPLETED|Overall Study||0
10054122|NCT02054754|11179154|FG002|NOT COMPLETED|Overall Study||0
10054123|NCT02054754|11179155|FG003|NOT COMPLETED|Overall Study||0
10054124|NCT02054754|11179156|FG004|NOT COMPLETED|Overall Study||0
10054125|NCT02054754|11179157|FG005|NOT COMPLETED|Overall Study||0
10054126|NCT02054897|11179175|FG000|STARTED|Overall Study||129
10054127|NCT02054897|11179176|FG001|STARTED|Overall Study||130
10054128|NCT02054897|11179177|FG002|STARTED|Overall Study||129
10054129|NCT02054897|11179175|FG000|Exposed|Overall Study||128
10054130|NCT02054897|11179176|FG001|Exposed|Overall Study||130
10054131|NCT02054897|11179177|FG002|Exposed|Overall Study||129
10054132|NCT02054897|11179175|FG000|COMPLETED|Overall Study||119
10054133|NCT02054897|11179176|FG001|COMPLETED|Overall Study||123
10054134|NCT02054897|11179177|FG002|COMPLETED|Overall Study||117
10054135|NCT02054897|11179175|FG000|NOT COMPLETED|Overall Study||10
10054136|NCT02054897|11179176|FG001|NOT COMPLETED|Overall Study||7
10054137|NCT02054897|11179177|FG002|NOT COMPLETED|Overall Study||12
10054138|NCT02055118|11179188|FG000|STARTED|Overall Study||15
10054139|NCT02055118|11179189|FG001|STARTED|Overall Study||34
10054140|NCT02055118|11179190|FG002|STARTED|Overall Study||9
10054141|NCT02055118|11179188|FG000|COMPLETED|Overall Study||15
10054142|NCT02055118|11179189|FG001|COMPLETED|Overall Study||32
10054143|NCT02055118|11179190|FG002|COMPLETED|Overall Study||9
10054144|NCT02055118|11179188|FG000|NOT COMPLETED|Overall Study||0
10054145|NCT02055118|11179189|FG001|NOT COMPLETED|Overall Study||2
10054146|NCT02055118|11179190|FG002|NOT COMPLETED|Overall Study||0
10054147|NCT02055157|11179203|FG000|STARTED|Initial 6 Months||8
10054148|NCT02055157|11179204|FG001|STARTED|Initial 6 Months||8
10054149|NCT02055157|11179205|FG002|STARTED|Initial 6 Months||10
10054150|NCT02055157|11179206|FG003|STARTED|Initial 6 Months||9
10054151|NCT02055157|11179203|FG000|COMPLETED|Initial 6 Months||7
10054152|NCT02055157|11179204|FG001|COMPLETED|Initial 6 Months||7
10054153|NCT02055157|11179205|FG002|COMPLETED|Initial 6 Months||10
10054154|NCT02055157|11179206|FG003|COMPLETED|Initial 6 Months||8
10054155|NCT02055157|11179203|FG000|NOT COMPLETED|Initial 6 Months||1
10054156|NCT02055157|11179204|FG001|NOT COMPLETED|Initial 6 Months||1
10054157|NCT02055157|11179205|FG002|NOT COMPLETED|Initial 6 Months||0
10054158|NCT02055157|11179206|FG003|NOT COMPLETED|Initial 6 Months||1
10054159|NCT02055157|11179203|FG000|STARTED|18-month Extension||7
10054160|NCT02055157|11179204|FG001|STARTED|18-month Extension||7
10054161|NCT02055157|11179205|FG002|STARTED|18-month Extension||10
10054162|NCT02055157|11179206|FG003|STARTED|18-month Extension||8
10054163|NCT02055157|11179203|FG000|COMPLETED|18-month Extension||6
10054164|NCT02055157|11179204|FG001|COMPLETED|18-month Extension||6
10054165|NCT02055157|11179205|FG002|COMPLETED|18-month Extension||10
10054166|NCT02055157|11179206|FG003|COMPLETED|18-month Extension||8
10054167|NCT02055157|11179203|FG000|NOT COMPLETED|18-month Extension||1
10119089|NCT02551692|11249923|FG001|NOT COMPLETED|Overall Study||1
10119090|NCT02551692|11249924|FG002|NOT COMPLETED|Overall Study||5
10119091|NCT02551731|11249932|FG000|STARTED|Overall Study||9
10119092|NCT02551731|11249932|FG000|COMPLETED|Overall Study||7
10119093|NCT02551731|11249932|FG000|NOT COMPLETED|Overall Study||2
10119094|NCT02551744|11249938|FG000|STARTED|Overall Study||50
10119095|NCT02551744|11249939|FG001|STARTED|Overall Study||51
10119096|NCT02551744|11249938|FG000|COMPLETED|Overall Study||50
10119097|NCT02551744|11249939|FG001|COMPLETED|Overall Study||51
10119098|NCT02551744|11249938|FG000|NOT COMPLETED|Overall Study||0
10119099|NCT02551744|11249939|FG001|NOT COMPLETED|Overall Study||0
10119100|NCT02551757|11249947|FG000|STARTED|Overall Study||20
10119101|NCT02551757|11249948|FG001|STARTED|Overall Study||20
10119102|NCT02551757|11249947|FG000|COMPLETED|Overall Study||13
10119103|NCT02551757|11249948|FG001|COMPLETED|Overall Study||17
10119104|NCT02551757|11249947|FG000|NOT COMPLETED|Overall Study||7
10119105|NCT02551757|11249948|FG001|NOT COMPLETED|Overall Study||3
10119106|NCT02551770|11249958|FG000|STARTED|Overall Study||51
10119107|NCT02551770|11249959|FG001|STARTED|Overall Study||51
10119108|NCT02551770|11249958|FG000|COMPLETED|Overall Study||48
10119109|NCT02551770|11249959|FG001|COMPLETED|Overall Study||48
10119110|NCT02551770|11249958|FG000|NOT COMPLETED|Overall Study||3
10119111|NCT02551770|11249959|FG001|NOT COMPLETED|Overall Study||3
10119112|NCT02551809|11249967|FG000|STARTED|Overall Study||14
10119113|NCT02551809|11249968|FG001|STARTED|Overall Study||15
10119114|NCT02551809|11249969|FG002|STARTED|Overall Study||14
10119115|NCT02551809|11249967|FG000|COMPLETED|Overall Study||14
10119116|NCT02551809|11249968|FG001|COMPLETED|Overall Study||14
10119117|NCT02551809|11249969|FG002|COMPLETED|Overall Study||13
10054168|NCT02055157|11179204|FG001|NOT COMPLETED|18-month Extension||1
10054169|NCT02055157|11179205|FG002|NOT COMPLETED|18-month Extension||0
10054170|NCT02055157|11179206|FG003|NOT COMPLETED|18-month Extension||0
10054171|NCT02055352|11179229|FG000|STARTED|Overall Study||109
10054172|NCT02055352|11179230|FG001|STARTED|Overall Study||113
10054173|NCT02055352|11179229|FG000|Per-Protocol Set (PPS)|Overall Study||108
10054174|NCT02055352|11179230|FG001|Per-Protocol Set (PPS)|Overall Study||111
10054175|NCT02055352|11179229|FG000|COMPLETED|Overall Study||103
10054176|NCT02055352|11179230|FG001|COMPLETED|Overall Study||96
10054177|NCT02055352|11179229|FG000|NOT COMPLETED|Overall Study||6
10054178|NCT02055352|11179230|FG001|NOT COMPLETED|Overall Study||17
10054179|NCT02055365|11179236|FG000|STARTED|Overall Study||10
10054180|NCT02055365|11179236|FG000|COMPLETED|Overall Study||9
10119118|NCT02551809|11249967|FG000|NOT COMPLETED|Overall Study||0
10054181|NCT02055365|11179236|FG000|NOT COMPLETED|Overall Study||1
10054182|NCT02055404|11179247|FG000|STARTED|Overall Study||3
10119119|NCT02551809|11249968|FG001|NOT COMPLETED|Overall Study||1
10054183|NCT02055404|11179247|FG000|COMPLETED|Overall Study||3
10054184|NCT02055404|11179247|FG000|NOT COMPLETED|Overall Study||0
10054185|NCT02055430|11179262|FG000|STARTED|Overall Study||45
10054186|NCT02055430|11179263|FG001|STARTED|Overall Study||45
10054187|NCT02055430|11179262|FG000|COMPLETED|Overall Study||45
10054188|NCT02055430|11179263|FG001|COMPLETED|Overall Study||45
10054189|NCT02055430|11179262|FG000|NOT COMPLETED|Overall Study||0
10054190|NCT02055430|11179263|FG001|NOT COMPLETED|Overall Study||0
10054191|NCT02055638|11179271|FG000|STARTED|Overall Study||49
10054192|NCT02055638|11179272|FG001|STARTED|Overall Study||48
10054193|NCT02055638|11179271|FG000|COMPLETED|Overall Study||39
10054194|NCT02055638|11179272|FG001|COMPLETED|Overall Study||40
10054195|NCT02055638|11179271|FG000|NOT COMPLETED|Overall Study||10
10054196|NCT02055638|11179272|FG001|NOT COMPLETED|Overall Study||8
10054197|NCT02055781|11179281|FG000|STARTED|Overall Study||104
10054198|NCT02055781|11179282|FG001|STARTED|Overall Study||107
10054199|NCT02055781|11179283|FG002|STARTED|Overall Study||100
10054200|NCT02055781|11179281|FG000|COMPLETED|Overall Study||62
10054201|NCT02055781|11179282|FG001|COMPLETED|Overall Study||79
10054202|NCT02055781|11179283|FG002|COMPLETED|Overall Study||63
10054203|NCT02055781|11179281|FG000|NOT COMPLETED|Overall Study||42
10054204|NCT02055781|11179282|FG001|NOT COMPLETED|Overall Study||28
10054205|NCT02055781|11179283|FG002|NOT COMPLETED|Overall Study||37
10054206|NCT02055820|11179301|FG000|STARTED|Phase I: Dose-Finding||7
10054207|NCT02055820|11179302|FG001|STARTED|Phase I: Dose-Finding||3
10054208|NCT02055820|11179303|FG002|STARTED|Phase I: Dose-Finding||8
10054209|NCT02055820|11179304|FG003|STARTED|Phase I: Dose-Finding||6
10054210|NCT02055820|11179305|FG004|STARTED|Phase I: Dose-Finding||0
10054211|NCT02055820|11179306|FG005|STARTED|Phase I: Dose-Finding||7
10054212|NCT02055820|11179307|FG006|STARTED|Phase I: Dose-Finding||7
10054213|NCT02055820|11179308|FG007|STARTED|Phase I: Dose-Finding||6
10054214|NCT02055820|11179309|FG008|STARTED|Phase I: Dose-Finding||6
10054215|NCT02055820|11179310|FG009|STARTED|Phase I: Dose-Finding||6
10054216|NCT02055820|11179301|FG000|COMPLETED|Phase I: Dose-Finding||6
10054217|NCT02055820|11179302|FG001|COMPLETED|Phase I: Dose-Finding||3
10054218|NCT02055820|11179303|FG002|COMPLETED|Phase I: Dose-Finding||7
10054219|NCT02055820|11179304|FG003|COMPLETED|Phase I: Dose-Finding||3
10054220|NCT02055820|11179305|FG004|COMPLETED|Phase I: Dose-Finding||0
10054221|NCT02055820|11179306|FG005|COMPLETED|Phase I: Dose-Finding||5
10054222|NCT02055820|11179307|FG006|COMPLETED|Phase I: Dose-Finding||5
10054223|NCT02055820|11179308|FG007|COMPLETED|Phase I: Dose-Finding||6
10054224|NCT02055820|11179309|FG008|COMPLETED|Phase I: Dose-Finding||6
10054225|NCT02055820|11179310|FG009|COMPLETED|Phase I: Dose-Finding||6
10054226|NCT02055820|11179301|FG000|NOT COMPLETED|Phase I: Dose-Finding||1
10054227|NCT02055820|11179302|FG001|NOT COMPLETED|Phase I: Dose-Finding||0
10054228|NCT02055820|11179303|FG002|NOT COMPLETED|Phase I: Dose-Finding||1
10054229|NCT02055820|11179304|FG003|NOT COMPLETED|Phase I: Dose-Finding||3
10054230|NCT02055820|11179305|FG004|NOT COMPLETED|Phase I: Dose-Finding||0
10054231|NCT02055820|11179306|FG005|NOT COMPLETED|Phase I: Dose-Finding||2
10054232|NCT02055820|11179307|FG006|NOT COMPLETED|Phase I: Dose-Finding||2
10054233|NCT02055820|11179308|FG007|NOT COMPLETED|Phase I: Dose-Finding||0
10054234|NCT02055820|11179309|FG008|NOT COMPLETED|Phase I: Dose-Finding||0
10054235|NCT02055820|11179310|FG009|NOT COMPLETED|Phase I: Dose-Finding||0
10054236|NCT02055820|11179301|FG000|STARTED|Phase II: Expansion||0
10054237|NCT02055820|11179302|FG001|STARTED|Phase II: Expansion||0
10054238|NCT02055820|11179303|FG002|STARTED|Phase II: Expansion||0
10054239|NCT02055820|11179304|FG003|STARTED|Phase II: Expansion||0
10054240|NCT02055820|11179305|FG004|STARTED|Phase II: Expansion||208
10054241|NCT02055820|11179306|FG005|STARTED|Phase II: Expansion||0
10054242|NCT02055820|11179307|FG006|STARTED|Phase II: Expansion||0
10054243|NCT02055820|11179308|FG007|STARTED|Phase II: Expansion||0
10054244|NCT02055820|11179309|FG008|STARTED|Phase II: Expansion||0
10054245|NCT02055820|11179310|FG009|STARTED|Phase II: Expansion||0
10054246|NCT02055820|11179301|FG000|COMPLETED|Phase II: Expansion||0
10054247|NCT02055820|11179302|FG001|COMPLETED|Phase II: Expansion||0
10054248|NCT02055820|11179303|FG002|COMPLETED|Phase II: Expansion||0
10054249|NCT02055820|11179304|FG003|COMPLETED|Phase II: Expansion||0
10054250|NCT02055820|11179305|FG004|COMPLETED|Phase II: Expansion||159
10054251|NCT02055820|11179306|FG005|COMPLETED|Phase II: Expansion||0
10054252|NCT02055820|11179307|FG006|COMPLETED|Phase II: Expansion||0
10054253|NCT02055820|11179308|FG007|COMPLETED|Phase II: Expansion||0
10054254|NCT02055820|11179309|FG008|COMPLETED|Phase II: Expansion||0
10054255|NCT02055820|11179310|FG009|COMPLETED|Phase II: Expansion||0
10054256|NCT02055820|11179301|FG000|NOT COMPLETED|Phase II: Expansion||0
10054257|NCT02055820|11179302|FG001|NOT COMPLETED|Phase II: Expansion||0
10054258|NCT02055820|11179303|FG002|NOT COMPLETED|Phase II: Expansion||0
10054259|NCT02055820|11179304|FG003|NOT COMPLETED|Phase II: Expansion||0
10054260|NCT02055820|11179305|FG004|NOT COMPLETED|Phase II: Expansion||49
10054261|NCT02055820|11179306|FG005|NOT COMPLETED|Phase II: Expansion||0
10054262|NCT02055820|11179307|FG006|NOT COMPLETED|Phase II: Expansion||0
10054263|NCT02055820|11179308|FG007|NOT COMPLETED|Phase II: Expansion||0
10054264|NCT02055820|11179309|FG008|NOT COMPLETED|Phase II: Expansion||0
10054265|NCT02055820|11179310|FG009|NOT COMPLETED|Phase II: Expansion||0
10054266|NCT02055898|11179354|FG000|STARTED|First Intervention (5 Days)||7
10054267|NCT02055898|11179355|FG001|STARTED|First Intervention (5 Days)||6
10054268|NCT02055898|11179354|FG000|COMPLETED|First Intervention (5 Days)||5
10054269|NCT02055898|11179355|FG001|COMPLETED|First Intervention (5 Days)||5
10054270|NCT02055898|11179354|FG000|NOT COMPLETED|First Intervention (5 Days)||2
10054271|NCT02055898|11179355|FG001|NOT COMPLETED|First Intervention (5 Days)||1
10054272|NCT02055898|11179354|FG000|STARTED|Washout (at Least 14 Days)||5
10054273|NCT02055898|11179355|FG001|STARTED|Washout (at Least 14 Days)||5
10054274|NCT02055898|11179354|FG000|COMPLETED|Washout (at Least 14 Days)||5
10054275|NCT02055898|11179355|FG001|COMPLETED|Washout (at Least 14 Days)||5
10054276|NCT02055898|11179354|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
10054277|NCT02055898|11179355|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
10054278|NCT02055898|11179354|FG000|STARTED|Second Intervention (5 Days)||5
10054279|NCT02055898|11179355|FG001|STARTED|Second Intervention (5 Days)||5
10054280|NCT02055898|11179354|FG000|COMPLETED|Second Intervention (5 Days)||5
10054281|NCT02055898|11179355|FG001|COMPLETED|Second Intervention (5 Days)||5
10054282|NCT02055898|11179354|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
10054283|NCT02055898|11179355|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
10054284|NCT02055976|11179370|FG000|STARTED|Overall Study||25
10054285|NCT02055976|11179371|FG001|STARTED|Overall Study||24
10054286|NCT02055976|11179372|FG002|STARTED|Overall Study||24
10054287|NCT02055976|11179373|FG003|STARTED|Overall Study||26
10054288|NCT02055976|11179374|FG004|STARTED|Overall Study||22
10054289|NCT02055976|11179375|FG005|STARTED|Overall Study||25
10054290|NCT02055976|11179376|FG006|STARTED|Overall Study||25
10054291|NCT02055976|11179377|FG007|STARTED|Overall Study||24
10054292|NCT02055976|11179378|FG008|STARTED|Overall Study||23
10054293|NCT02055976|11179370|FG000|COMPLETED|Overall Study||25
10054294|NCT02055976|11179371|FG001|COMPLETED|Overall Study||24
10054295|NCT02055976|11179372|FG002|COMPLETED|Overall Study||23
10054296|NCT02055976|11179373|FG003|COMPLETED|Overall Study||25
10054297|NCT02055976|11179374|FG004|COMPLETED|Overall Study||22
10054298|NCT02055976|11179375|FG005|COMPLETED|Overall Study||24
10054299|NCT02055976|11179376|FG006|COMPLETED|Overall Study||23
10054300|NCT02055976|11179377|FG007|COMPLETED|Overall Study||24
10054301|NCT02055976|11179378|FG008|COMPLETED|Overall Study||23
10054302|NCT02055976|11179370|FG000|NOT COMPLETED|Overall Study||0
10054303|NCT02055976|11179371|FG001|NOT COMPLETED|Overall Study||0
10054304|NCT02055976|11179372|FG002|NOT COMPLETED|Overall Study||1
10054305|NCT02055976|11179373|FG003|NOT COMPLETED|Overall Study||1
10054306|NCT02055976|11179374|FG004|NOT COMPLETED|Overall Study||0
10054307|NCT02055976|11179375|FG005|NOT COMPLETED|Overall Study||1
10054308|NCT02055976|11179376|FG006|NOT COMPLETED|Overall Study||2
10054309|NCT02055976|11179377|FG007|NOT COMPLETED|Overall Study||0
10054310|NCT02055976|11179378|FG008|NOT COMPLETED|Overall Study||0
10054311|NCT02056171|11179407|FG000|STARTED|Overall Study||3
10054312|NCT02056171|11179408|FG001|STARTED|Overall Study||3
10054313|NCT02056171|11179407|FG000|COMPLETED|Overall Study||3
10054314|NCT02056171|11179408|FG001|COMPLETED|Overall Study||3
10054315|NCT02056171|11179407|FG000|NOT COMPLETED|Overall Study||0
10054316|NCT02056171|11179408|FG001|NOT COMPLETED|Overall Study||0
10054317|NCT02056288|11179416|FG000|STARTED|In-Hospital Data||40
10054318|NCT02056288|11179417|FG001|STARTED|In-Hospital Data||38
10054319|NCT02056288|11179416|FG000|COMPLETED|In-Hospital Data||35
10054320|NCT02056288|11179417|FG001|COMPLETED|In-Hospital Data||38
10054321|NCT02056288|11179416|FG000|NOT COMPLETED|In-Hospital Data||5
10054322|NCT02056288|11179417|FG001|NOT COMPLETED|In-Hospital Data||0
10054323|NCT02056288|11179416|FG000|STARTED|48-Hour Post-Discharge Data||35
10054324|NCT02056288|11179417|FG001|STARTED|48-Hour Post-Discharge Data||38
10054325|NCT02056288|11179416|FG000|COMPLETED|48-Hour Post-Discharge Data||21
10054326|NCT02056288|11179417|FG001|COMPLETED|48-Hour Post-Discharge Data||18
10054327|NCT02056288|11179416|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14
10054328|NCT02056288|11179417|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20
10054329|NCT02056301|11179425|FG000|STARTED|Overall Study||33
10054330|NCT02056301|11179426|FG001|STARTED|Overall Study||29
10054331|NCT02056301|11179425|FG000|COMPLETED|Overall Study||31
10054332|NCT02056301|11179426|FG001|COMPLETED|Overall Study||23
10054333|NCT02056301|11179425|FG000|NOT COMPLETED|Overall Study||2
10054334|NCT02056301|11179426|FG001|NOT COMPLETED|Overall Study||6
10054335|NCT02056340|11179434|FG000|STARTED|Overall Study||59
10054336|NCT02056340|11179435|FG001|STARTED|Overall Study||57
10054337|NCT02056340|11179434|FG000|COMPLETED|Overall Study||52
10054338|NCT02056340|11179435|FG001|COMPLETED|Overall Study||46
10054339|NCT02056340|11179434|FG000|NOT COMPLETED|Overall Study||7
10119120|NCT02551809|11249969|FG002|NOT COMPLETED|Overall Study||1
10119121|NCT02551822|11249979|FG000|STARTED|Overall Study||11
10119122|NCT02551822|11249980|FG001|STARTED|Overall Study||12
10119123|NCT02551822|11249979|FG000|COMPLETED|Overall Study||9
10119124|NCT02551822|11249980|FG001|COMPLETED|Overall Study||10
10119125|NCT02551822|11249979|FG000|NOT COMPLETED|Overall Study||2
10119126|NCT02551822|11249980|FG001|NOT COMPLETED|Overall Study||2
10119127|NCT02551874|11249988|FG000|STARTED|Overall Study||324
10119128|NCT02551874|11249989|FG001|STARTED|Overall Study||326
10119129|NCT02551874|11249988|FG000|Received Treatment in Short-term Study|Overall Study||324
10119130|NCT02551874|11249989|FG001|Received Treatment in Short-term Study|Overall Study||319
10119131|NCT02551874|11249988|FG000|Entered Long-term Study|Overall Study||306
10119132|NCT02551874|11249989|FG001|Entered Long-term Study|Overall Study||294
10054340|NCT02056340|11179435|FG001|NOT COMPLETED|Overall Study||11
10054341|NCT02056392|11179447|FG000|STARTED|Overall Study||10
10054342|NCT02056392|11179448|FG001|STARTED|Overall Study||9
10054343|NCT02056392|11179449|FG002|STARTED|Overall Study||9
10054344|NCT02056392|11179450|FG003|STARTED|Overall Study||9
10054345|NCT02056392|11179451|FG004|STARTED|Overall Study||8
10054346|NCT02056392|11179452|FG005|STARTED|Overall Study||9
10054347|NCT02056392|11179447|FG000|COMPLETED|Overall Study||8
10054348|NCT02056392|11179448|FG001|COMPLETED|Overall Study||8
10054349|NCT02056392|11179449|FG002|COMPLETED|Overall Study||6
10054350|NCT02056392|11179450|FG003|COMPLETED|Overall Study||9
10054351|NCT02056392|11179451|FG004|COMPLETED|Overall Study||7
10054352|NCT02056392|11179452|FG005|COMPLETED|Overall Study||9
10054353|NCT02056392|11179447|FG000|NOT COMPLETED|Overall Study||2
10054354|NCT02056392|11179448|FG001|NOT COMPLETED|Overall Study||1
10054355|NCT02056392|11179449|FG002|NOT COMPLETED|Overall Study||3
10054356|NCT02056392|11179450|FG003|NOT COMPLETED|Overall Study||0
10054357|NCT02056392|11179451|FG004|NOT COMPLETED|Overall Study||1
10054358|NCT02056392|11179452|FG005|NOT COMPLETED|Overall Study||0
10054359|NCT02056431|11179462|FG000|STARTED|Overall Study||604
10054360|NCT02056431|11179463|FG001|STARTED|Overall Study||666
10054361|NCT02056431|11179462|FG000|COMPLETED|Overall Study||560
10054362|NCT02056431|11179463|FG001|COMPLETED|Overall Study||619
10054363|NCT02056431|11179462|FG000|NOT COMPLETED|Overall Study||44
10054364|NCT02056431|11179463|FG001|NOT COMPLETED|Overall Study||47
10054365|NCT02056626|11179475|FG000|STARTED|Overall Study||13
10054366|NCT02056626|11179476|FG001|STARTED|Overall Study||13
10054367|NCT02056626|11179477|FG002|STARTED|Overall Study||4
10054368|NCT02056626|11179478|FG003|STARTED|Overall Study||14
10054369|NCT02056626|11179475|FG000|COMPLETED|Overall Study||10
10054370|NCT02056626|11179476|FG001|COMPLETED|Overall Study||12
10054371|NCT02056626|11179477|FG002|COMPLETED|Overall Study||4
10054372|NCT02056626|11179478|FG003|COMPLETED|Overall Study||14
10054373|NCT02056626|11179475|FG000|NOT COMPLETED|Overall Study||3
10054374|NCT02056626|11179476|FG001|NOT COMPLETED|Overall Study||1
10054375|NCT02056626|11179477|FG002|NOT COMPLETED|Overall Study||0
10054376|NCT02056626|11179478|FG003|NOT COMPLETED|Overall Study||0
10054377|NCT02056639|11179490|FG000|STARTED|Overall Study||23
10054378|NCT02056639|11179491|FG001|STARTED|Overall Study||23
10054379|NCT02056639|11179490|FG000|COMPLETED|Overall Study||23
10054380|NCT02056639|11179491|FG001|COMPLETED|Overall Study||23
10054381|NCT02056639|11179490|FG000|NOT COMPLETED|Overall Study||0
10054382|NCT02056639|11179491|FG001|NOT COMPLETED|Overall Study||0
10119133|NCT02551874|11249988|FG000|Received Treatment in Long-term Study|Overall Study||295
10119134|NCT02551874|11249989|FG001|Received Treatment in Long-term Study|Overall Study||284
10119135|NCT02551874|11249988|FG000|COMPLETED|Overall Study||296
10119136|NCT02551874|11249989|FG001|COMPLETED|Overall Study||287
10119137|NCT02551874|11249988|FG000|NOT COMPLETED|Overall Study||28
10119138|NCT02551874|11249989|FG001|NOT COMPLETED|Overall Study||39
10119139|NCT02551887|11249998|FG000|STARTED|Overall Study||301
10119140|NCT02551887|11249999|FG001|STARTED|Overall Study||124
10119141|NCT02551887|11250000|FG002|STARTED|Overall Study||222
10119142|NCT02551887|11249998|FG000|COMPLETED|Overall Study||301
10119143|NCT02551887|11249999|FG001|COMPLETED|Overall Study||124
10119144|NCT02551887|11250000|FG002|COMPLETED|Overall Study||222
10119145|NCT02551887|11249998|FG000|NOT COMPLETED|Overall Study||0
10119146|NCT02551887|11249999|FG001|NOT COMPLETED|Overall Study||0
10119147|NCT02551887|11250000|FG002|NOT COMPLETED|Overall Study||0
10119148|NCT02552121|11250016|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
10119149|NCT02552121|11250017|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119150|NCT02552121|11250018|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119151|NCT02552121|11250019|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119152|NCT02552121|11250020|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119153|NCT02552121|11250021|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119154|NCT02552121|11250022|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119155|NCT02552121|11250023|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119156|NCT02552121|11250016|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119157|NCT02552121|11250017|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119158|NCT02552121|11250018|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119159|NCT02552121|11250019|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119160|NCT02552121|11250020|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119161|NCT02552121|11250021|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119162|NCT02552121|11250022|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119163|NCT02552121|11250023|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119164|NCT02552121|11250016|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
10119165|NCT02552121|11250017|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119166|NCT02552121|11250018|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119167|NCT02552121|11250019|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119168|NCT02552121|11250020|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119169|NCT02552121|11250021|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119170|NCT02552121|11250022|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119171|NCT02552121|11250023|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10119172|NCT02552121|11250016|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10119173|NCT02552121|11250017|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
10119174|NCT02552121|11250018|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10119175|NCT02552121|11250019|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10119176|NCT02552121|11250020|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10119177|NCT02552121|11250021|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10119178|NCT02552121|11250022|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10119179|NCT02552121|11250023|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10119180|NCT02552121|11250016|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119181|NCT02552121|11250017|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10054383|NCT02056652|11179501|FG000|STARTED|Overall Study||61
10054384|NCT02056652|11179502|FG001|STARTED|Overall Study||61
10054385|NCT02056652|11179501|FG000|COMPLETED|Overall Study||60
10054386|NCT02056652|11179502|FG001|COMPLETED|Overall Study||58
10054387|NCT02056652|11179501|FG000|NOT COMPLETED|Overall Study||1
10054388|NCT02056652|11179502|FG001|NOT COMPLETED|Overall Study||3
10054389|NCT02056834|11179508|FG000|STARTED|Overall Study||36
10054390|NCT02056834|11179508|FG000|6 Weeks|Overall Study||34
10054391|NCT02056834|11179508|FG000|6 Months|Overall Study||31
10054392|NCT02056834|11179508|FG000|COMPLETED|Overall Study||29
10054393|NCT02056834|11179508|FG000|NOT COMPLETED|Overall Study||7
10054394|NCT02057042|11179515|FG000|STARTED|Overall Study||163
10054395|NCT02057042|11179516|FG001|STARTED|Overall Study||167
10054396|NCT02057042|11179515|FG000|COMPLETED|Overall Study||118
10054397|NCT02057042|11179516|FG001|COMPLETED|Overall Study||101
10054398|NCT02057042|11179515|FG000|NOT COMPLETED|Overall Study||45
10054399|NCT02057042|11179516|FG001|NOT COMPLETED|Overall Study||66
10054400|NCT02057068|11179524|FG000|STARTED|Overall Study||60
10054401|NCT02057068|11179525|FG001|STARTED|Overall Study||36
10054402|NCT02057068|11179524|FG000|COMPLETED|Overall Study||52
10054403|NCT02057068|11179525|FG001|COMPLETED|Overall Study||28
10054404|NCT02057068|11179524|FG000|NOT COMPLETED|Overall Study||8
10054405|NCT02057068|11179525|FG001|NOT COMPLETED|Overall Study||8
10054406|NCT02057081|11179535|FG000|STARTED|Overall Study||136
10054407|NCT02057081|11179536|FG001|STARTED|Overall Study||112
10054408|NCT02057081|11179535|FG000|Completed Baseline|Overall Study||88
10054409|NCT02057081|11179536|FG001|Completed Baseline|Overall Study||80
10054410|NCT02057081|11179535|FG000|Post-Treatment Assessment|Overall Study||58
10054411|NCT02057081|11179536|FG001|Post-Treatment Assessment|Overall Study||52
10054412|NCT02057081|11179535|FG000|COMPLETED|Overall Study||46
10054413|NCT02057081|11179536|FG001|COMPLETED|Overall Study||44
10054414|NCT02057081|11179535|FG000|NOT COMPLETED|Overall Study||90
10054415|NCT02057081|11179536|FG001|NOT COMPLETED|Overall Study||68
10054416|NCT02057198|11179545|FG000|STARTED|Overall Study||11
10054417|NCT02057198|11179546|FG001|STARTED|Overall Study||11
10054418|NCT02057198|11179547|FG002|STARTED|Overall Study||11
10054419|NCT02057198|11179545|FG000|COMPLETED|Overall Study||11
10054420|NCT02057198|11179546|FG001|COMPLETED|Overall Study||10
10054421|NCT02057198|11179547|FG002|COMPLETED|Overall Study||10
10054422|NCT02057198|11179545|FG000|NOT COMPLETED|Overall Study||0
10054423|NCT02057198|11179546|FG001|NOT COMPLETED|Overall Study||1
10054424|NCT02057198|11179547|FG002|NOT COMPLETED|Overall Study||1
10054425|NCT02057250|11179559|FG000|STARTED|AID Assessment Phase||56
10054426|NCT02057250|11179560|FG001|STARTED|AID Assessment Phase||53
10054427|NCT02057250|11179561|FG002|STARTED|AID Assessment Phase||52
10054428|NCT02057250|11179562|FG003|STARTED|AID Assessment Phase||56
10054429|NCT02057250|11179563|FG004|STARTED|AID Assessment Phase||0
10054430|NCT02057250|11179559|FG000|COMPLETED|AID Assessment Phase||52
10054431|NCT02057250|11179560|FG001|COMPLETED|AID Assessment Phase||50
10054432|NCT02057250|11179561|FG002|COMPLETED|AID Assessment Phase||45
10054433|NCT02057250|11179562|FG003|COMPLETED|AID Assessment Phase||54
10054434|NCT02057250|11179563|FG004|COMPLETED|AID Assessment Phase||0
10054435|NCT02057250|11179559|FG000|NOT COMPLETED|AID Assessment Phase||4
10054436|NCT02057250|11179560|FG001|NOT COMPLETED|AID Assessment Phase||3
10054437|NCT02057250|11179561|FG002|NOT COMPLETED|AID Assessment Phase||7
10054438|NCT02057250|11179562|FG003|NOT COMPLETED|AID Assessment Phase||2
10054439|NCT02057250|11179563|FG004|NOT COMPLETED|AID Assessment Phase||0
10054440|NCT02057250|11179559|FG000|STARTED|Extension Phase||0
10054441|NCT02057250|11179560|FG001|STARTED|Extension Phase||0
10054442|NCT02057250|11179561|FG002|STARTED|Extension Phase||0
10054443|NCT02057250|11179562|FG003|STARTED|Extension Phase||0
10054444|NCT02057250|11179563|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
10054445|NCT02057250|11179559|FG000|Treated|Extension Phase||0
10054446|NCT02057250|11179560|FG001|Treated|Extension Phase||0
10054447|NCT02057250|11179561|FG002|Treated|Extension Phase||0
10054448|NCT02057250|11179562|FG003|Treated|Extension Phase||0
10054449|NCT02057250|11179563|FG004|Treated|Extension Phase||188
10054450|NCT02057250|11179559|FG000|COMPLETED|Extension Phase||0
10054451|NCT02057250|11179560|FG001|COMPLETED|Extension Phase||0
10054452|NCT02057250|11179561|FG002|COMPLETED|Extension Phase||0
10054453|NCT02057250|11179562|FG003|COMPLETED|Extension Phase||0
10054454|NCT02057250|11179563|FG004|COMPLETED|Extension Phase||156
10054455|NCT02057250|11179559|FG000|NOT COMPLETED|Extension Phase||0
10054456|NCT02057250|11179560|FG001|NOT COMPLETED|Extension Phase||0
10054457|NCT02057250|11179561|FG002|NOT COMPLETED|Extension Phase||0
10054458|NCT02057250|11179562|FG003|NOT COMPLETED|Extension Phase||0
10054459|NCT02057250|11179563|FG004|NOT COMPLETED|Extension Phase||36
10054460|NCT02057393|11179575|FG000|STARTED|Overall Study||89
10054461|NCT02057393|11179575|FG000|COMPLETED|Overall Study||87
10054462|NCT02057393|11179575|FG000|NOT COMPLETED|Overall Study||2
10054463|NCT02057406|11179582|FG000|STARTED|Overall Study||36
10054464|NCT02057406|11179583|FG001|STARTED|Overall Study||36
10054465|NCT02057406|11179584|FG002|STARTED|Overall Study||36
10054466|NCT02057406|11179582|FG000|COMPLETED|Overall Study||35
10054467|NCT02057406|11179583|FG001|COMPLETED|Overall Study||33
10054468|NCT02057406|11179584|FG002|COMPLETED|Overall Study||32
10054469|NCT02057406|11179582|FG000|NOT COMPLETED|Overall Study||1
10054470|NCT02057406|11179583|FG001|NOT COMPLETED|Overall Study||3
10054471|NCT02057406|11179584|FG002|NOT COMPLETED|Overall Study||4
10054472|NCT02057458|11179592|FG000|STARTED|Recruited for Participation||8
10054473|NCT02057458|11179593|FG001|STARTED|Recruited for Participation||8
10054474|NCT02057458|11179594|FG002|STARTED|Recruited for Participation||3
10054475|NCT02057458|11179592|FG000|COMPLETED|Recruited for Participation||8
10054476|NCT02057458|11179593|FG001|COMPLETED|Recruited for Participation||8
10054477|NCT02057458|11179594|FG002|COMPLETED|Recruited for Participation||3
10054478|NCT02057458|11179592|FG000|NOT COMPLETED|Recruited for Participation||0
10054479|NCT02057458|11179593|FG001|NOT COMPLETED|Recruited for Participation||0
10054480|NCT02057458|11179594|FG002|NOT COMPLETED|Recruited for Participation||0
10054481|NCT02057458|11179592|FG000|STARTED|Met Inclusion Criteria||8
10054482|NCT02057458|11179593|FG001|STARTED|Met Inclusion Criteria||8
10054483|NCT02057458|11179594|FG002|STARTED|Met Inclusion Criteria||3
10054484|NCT02057458|11179592|FG000|COMPLETED|Met Inclusion Criteria||8
10054485|NCT02057458|11179593|FG001|COMPLETED|Met Inclusion Criteria||7
10054486|NCT02057458|11179594|FG002|COMPLETED|Met Inclusion Criteria||3
10054487|NCT02057458|11179592|FG000|NOT COMPLETED|Met Inclusion Criteria||0
10054488|NCT02057458|11179593|FG001|NOT COMPLETED|Met Inclusion Criteria||1
10054489|NCT02057458|11179594|FG002|NOT COMPLETED|Met Inclusion Criteria||0
10054490|NCT02057458|11179592|FG000|STARTED|Acute Study (1 Hour): First Intervention||8
10054491|NCT02057458|11179593|FG001|STARTED|Acute Study (1 Hour): First Intervention||7
10054492|NCT02057458|11179594|FG002|STARTED|Acute Study (1 Hour): First Intervention||0
10054493|NCT02057458|11179592|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6
10054494|NCT02057458|11179593|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7
10054495|NCT02057458|11179594|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0
10054496|NCT02057458|11179592|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
10054497|NCT02057458|11179593|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
10054498|NCT02057458|11179594|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
10054499|NCT02057458|11179592|FG000|STARTED|Acute Study (1 Hour): Second Int.||6
10054500|NCT02057458|11179593|FG001|STARTED|Acute Study (1 Hour): Second Int.||7
10054501|NCT02057458|11179594|FG002|STARTED|Acute Study (1 Hour): Second Int.||0
10054502|NCT02057458|11179592|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6
10054503|NCT02057458|11179593|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7
10054504|NCT02057458|11179594|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0
10054505|NCT02057458|11179592|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
10054506|NCT02057458|11179593|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
10054507|NCT02057458|11179594|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
10054508|NCT02057458|11179592|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6
10054509|NCT02057458|11179593|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7
10054510|NCT02057458|11179594|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3
10054511|NCT02057458|11179592|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5
10054512|NCT02057458|11179593|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7
10054513|NCT02057458|11179594|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3
10054514|NCT02057458|11179592|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
10054515|NCT02057458|11179593|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
10054516|NCT02057458|11179594|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
10054517|NCT02057523|11179624|FG000|STARTED|Overall Study||2
10054518|NCT02057523|11179624|FG000|COMPLETED|Overall Study||0
10054519|NCT02057523|11179624|FG000|NOT COMPLETED|Overall Study||2
10054520|NCT02057549|11179630|FG000|STARTED|Overall Study||18
10054521|NCT02057549|11179631|FG001|STARTED|Overall Study||18
10054522|NCT02057549|11179630|FG000|COMPLETED|Overall Study||15
10054523|NCT02057549|11179631|FG001|COMPLETED|Overall Study||18
10054524|NCT02057549|11179630|FG000|NOT COMPLETED|Overall Study||3
10054525|NCT02057549|11179631|FG001|NOT COMPLETED|Overall Study||0
10054526|NCT02057575|11179641|FG000|STARTED|Overall Study||74
10054527|NCT02057575|11179642|FG001|STARTED|Overall Study||73
10054528|NCT02057575|11179643|FG002|STARTED|Overall Study||78
10054529|NCT02057575|11179644|FG003|STARTED|Overall Study||73
10054530|NCT02057575|11179641|FG000|COMPLETED|Overall Study||73
10054531|NCT02057575|11179642|FG001|COMPLETED|Overall Study||69
10054532|NCT02057575|11179643|FG002|COMPLETED|Overall Study||78
10054533|NCT02057575|11179644|FG003|COMPLETED|Overall Study||72
10054534|NCT02057575|11179641|FG000|NOT COMPLETED|Overall Study||1
10054535|NCT02057575|11179642|FG001|NOT COMPLETED|Overall Study||4
10054536|NCT02057575|11179643|FG002|NOT COMPLETED|Overall Study||0
10054537|NCT02057575|11179644|FG003|NOT COMPLETED|Overall Study||1
10054538|NCT02057640|11179656|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
10054539|NCT02057640|11179657|FG001|STARTED|Weeks 1-4||3
10054540|NCT02057640|11179656|FG000|COMPLETED|Weeks 1-4||4
10054541|NCT02057640|11179657|FG001|COMPLETED|Weeks 1-4||3
10054542|NCT02057640|11179656|FG000|NOT COMPLETED|Weeks 1-4||0
10054543|NCT02057640|11179657|FG001|NOT COMPLETED|Weeks 1-4||0
10054544|NCT02057640|11179656|FG000|STARTED|Phase II Portion of Study at DL2||0
10054545|NCT02057640|11179657|FG001|STARTED|Phase II Portion of Study at DL2||9
10054546|NCT02057640|11179656|FG000|COMPLETED|Phase II Portion of Study at DL2||0
10054547|NCT02057640|11179657|FG001|COMPLETED|Phase II Portion of Study at DL2||9
10054548|NCT02057640|11179656|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0
10054549|NCT02057640|11179657|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0
10054550|NCT02057666|11179666|FG000|STARTED|Double Blind Treatment Period||96
10054551|NCT02057666|11179667|FG001|STARTED|Double Blind Treatment Period||50
10054552|NCT02057666|11179666|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
10054553|NCT02057666|11179667|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
10054554|NCT02057666|11179666|FG000|NOT COMPLETED|Double Blind Treatment Period||96
10054555|NCT02057666|11179667|FG001|NOT COMPLETED|Double Blind Treatment Period||44
10054556|NCT02057666|11179666|FG000|STARTED|Open-Label Treatment Period||0
10054557|NCT02057666|11179667|FG001|STARTED|Open-Label Treatment Period||6
10054558|NCT02057666|11179666|FG000|COMPLETED|Open-Label Treatment Period||0
10054559|NCT02057666|11179667|FG001|COMPLETED|Open-Label Treatment Period||0
10054560|NCT02057666|11179666|FG000|NOT COMPLETED|Open-Label Treatment Period||0
10054561|NCT02057666|11179667|FG001|NOT COMPLETED|Open-Label Treatment Period||6
10054562|NCT02057692|11179677|FG000|STARTED|Overall Study||8
10054563|NCT02057692|11179678|FG001|STARTED|Overall Study||11
10054564|NCT02057692|11179679|FG002|STARTED|Overall Study||6
10054565|NCT02057692|11179680|FG003|STARTED|Overall Study||12
10054566|NCT02057692|11179677|FG000|COMPLETED|Overall Study||7
10054567|NCT02057692|11179678|FG001|COMPLETED|Overall Study||11
10054568|NCT02057692|11179679|FG002|COMPLETED|Overall Study||6
10054569|NCT02057692|11179680|FG003|COMPLETED|Overall Study||11
10054570|NCT02057692|11179677|FG000|NOT COMPLETED|Overall Study||1
10054571|NCT02057692|11179678|FG001|NOT COMPLETED|Overall Study||0
10054572|NCT02057692|11179679|FG002|NOT COMPLETED|Overall Study||0
10054573|NCT02057692|11179680|FG003|NOT COMPLETED|Overall Study||1
10054574|NCT02057718|11179698|FG000|STARTED|Completed Study Treatment Through Wk. 72||8
10054575|NCT02057718|11179699|FG001|STARTED|Completed Study Treatment Through Wk. 72||25
10054576|NCT02057718|11179698|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
10054577|NCT02057718|11179699|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
10054578|NCT02057718|11179698|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6
10054579|NCT02057718|11179699|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16
10054580|NCT02057718|11179698|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
10054581|NCT02057718|11179699|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
10054582|NCT02057718|11179698|FG000|STARTED|Optional Follow-up Treatment Period||6
10054583|NCT02057718|11179699|FG001|STARTED|Optional Follow-up Treatment Period||16
10054584|NCT02057718|11179698|FG000|COMPLETED|Optional Follow-up Treatment Period||4
10054585|NCT02057718|11179699|FG001|COMPLETED|Optional Follow-up Treatment Period||8
10054586|NCT02057718|11179698|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2
10054587|NCT02057718|11179699|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8
10054588|NCT02057757|11179707|FG000|STARTED|Overall Study||131
10054589|NCT02057757|11179708|FG001|STARTED|Overall Study||129
10054590|NCT02057757|11179707|FG000|Intent to Treat|Overall Study||130
10054591|NCT02057757|11179708|FG001|Intent to Treat|Overall Study||127
10054592|NCT02057757|11179707|FG000|COMPLETED|Overall Study||117
10054593|NCT02057757|11179708|FG001|COMPLETED|Overall Study||121
10054594|NCT02057757|11179707|FG000|NOT COMPLETED|Overall Study||14
10054595|NCT02057757|11179708|FG001|NOT COMPLETED|Overall Study||8
10054596|NCT02057835|11179728|FG000|STARTED|Overall Study||8
10054597|NCT02057835|11179729|FG001|STARTED|Overall Study||6
10054598|NCT02057835|11179730|FG002|STARTED|Overall Study||6
10054599|NCT02057835|11179731|FG003|STARTED|Overall Study||6
10054600|NCT02057835|11179732|FG004|STARTED|Overall Study||6
10054601|NCT02057835|11179733|FG005|STARTED|Overall Study||8
10054602|NCT02057835|11179734|FG006|STARTED|Overall Study||6
10054603|NCT02057835|11179735|FG007|STARTED|Overall Study||6
10054604|NCT02057835|11179736|FG008|STARTED|Overall Study||6
10054605|NCT02057835|11179737|FG009|STARTED|Overall Study||6
10054606|NCT02057835|11179728|FG000|COMPLETED|Overall Study||8
10054607|NCT02057835|11179729|FG001|COMPLETED|Overall Study||4
10054608|NCT02057835|11179730|FG002|COMPLETED|Overall Study||6
10054609|NCT02057835|11179731|FG003|COMPLETED|Overall Study||6
10054610|NCT02057835|11179732|FG004|COMPLETED|Overall Study||6
10054611|NCT02057835|11179733|FG005|COMPLETED|Overall Study||8
10054612|NCT02057835|11179734|FG006|COMPLETED|Overall Study||6
10054613|NCT02057835|11179735|FG007|COMPLETED|Overall Study||6
10054614|NCT02057835|11179736|FG008|COMPLETED|Overall Study||6
10054615|NCT02057835|11179737|FG009|COMPLETED|Overall Study||6
10054616|NCT02057835|11179728|FG000|NOT COMPLETED|Overall Study||0
10054617|NCT02057835|11179729|FG001|NOT COMPLETED|Overall Study||2
10054618|NCT02057835|11179730|FG002|NOT COMPLETED|Overall Study||0
10054619|NCT02057835|11179731|FG003|NOT COMPLETED|Overall Study||0
10054620|NCT02057835|11179732|FG004|NOT COMPLETED|Overall Study||0
10054621|NCT02057835|11179733|FG005|NOT COMPLETED|Overall Study||0
10054622|NCT02057835|11179734|FG006|NOT COMPLETED|Overall Study||0
10054623|NCT02057835|11179735|FG007|NOT COMPLETED|Overall Study||0
10054624|NCT02057835|11179736|FG008|NOT COMPLETED|Overall Study||0
10054625|NCT02057835|11179737|FG009|NOT COMPLETED|Overall Study||0
10054626|NCT02057939|11179766|FG000|STARTED|Overall Study||38
10054627|NCT02057939|11179766|FG000|COMPLETED|Overall Study||37
10054628|NCT02057939|11179766|FG000|NOT COMPLETED|Overall Study||1
10054629|NCT02057952|11179773|FG000|STARTED|Overall Study||51
10054630|NCT02057952|11179774|FG001|STARTED|Overall Study||49
10054631|NCT02057952|11179775|FG002|STARTED|Overall Study||50
10054632|NCT02057952|11179773|FG000|COMPLETED|Overall Study||43
10054633|NCT02057952|11179774|FG001|COMPLETED|Overall Study||39
10054634|NCT02057952|11179775|FG002|COMPLETED|Overall Study||28
10054635|NCT02057952|11179773|FG000|NOT COMPLETED|Overall Study||8
10054636|NCT02057952|11179774|FG001|NOT COMPLETED|Overall Study||10
10054637|NCT02057952|11179775|FG002|NOT COMPLETED|Overall Study||22
10054638|NCT02058069|11179783|FG000|STARTED|Overall Study||100
10054639|NCT02058069|11179783|FG000|COMPLETED|Overall Study||89
10054640|NCT02058069|11179783|FG000|NOT COMPLETED|Overall Study||11
10054641|NCT02058095|11179789|FG000|STARTED|Overall Study||15
10054642|NCT02058095|11179790|FG001|STARTED|Overall Study||7
10054643|NCT02058095|11179789|FG000|COMPLETED|Overall Study||14
10054644|NCT02058095|11179790|FG001|COMPLETED|Overall Study||7
10054645|NCT02058095|11179789|FG000|NOT COMPLETED|Overall Study||1
10054646|NCT02058095|11179790|FG001|NOT COMPLETED|Overall Study||0
10054647|NCT02058108|11179798|FG000|STARTED|Overall Study||43
10054648|NCT02058108|11179799|FG001|STARTED|Overall Study||10
10054649|NCT02058108|11179798|FG000|Switched to Telbivudine After Week 24|Overall Study||0
10054650|NCT02058108|11179799|FG001|Switched to Telbivudine After Week 24|Overall Study||5
10054651|NCT02058108|11179798|FG000|COMPLETED|Overall Study||2
10054652|NCT02058108|11179799|FG001|COMPLETED|Overall Study||0
10054653|NCT02058108|11179798|FG000|NOT COMPLETED|Overall Study||41
10054654|NCT02058108|11179799|FG001|NOT COMPLETED|Overall Study||10
10054655|NCT02058147|11179810|FG000|STARTED|Overall Study||469
10054656|NCT02058147|11179811|FG001|STARTED|Overall Study||467
10054657|NCT02058147|11179812|FG002|STARTED|Overall Study||234
10054658|NCT02058147|11179810|FG000|Treated|Overall Study||469
10054659|NCT02058147|11179811|FG001|Treated|Overall Study||467
10054660|NCT02058147|11179812|FG002|Treated|Overall Study||233
10054661|NCT02058147|11179810|FG000|COMPLETED|Overall Study||440
10054662|NCT02058147|11179811|FG001|COMPLETED|Overall Study||440
10054663|NCT02058147|11179812|FG002|COMPLETED|Overall Study||205
10054664|NCT02058147|11179810|FG000|NOT COMPLETED|Overall Study||29
10054665|NCT02058147|11179811|FG001|NOT COMPLETED|Overall Study||27
10054666|NCT02058147|11179812|FG002|NOT COMPLETED|Overall Study||29
10054667|NCT02058160|11179822|FG000|STARTED|Overall Study||367
10054668|NCT02058160|11179823|FG001|STARTED|Overall Study||369
10054669|NCT02058160|11179822|FG000|Treated|Overall Study||365
10054670|NCT02058160|11179823|FG001|Treated|Overall Study||365
10054671|NCT02058160|11179822|FG000|COMPLETED|Overall Study||336
10054672|NCT02058160|11179823|FG001|COMPLETED|Overall Study||355
10054673|NCT02058160|11179822|FG000|NOT COMPLETED|Overall Study||31
10119182|NCT02552121|11250018|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119183|NCT02552121|11250019|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119184|NCT02552121|11250020|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119185|NCT02552121|11250021|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119186|NCT02552121|11250022|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119187|NCT02552121|11250023|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119188|NCT02552121|11250016|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119189|NCT02552121|11250017|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
10119190|NCT02552121|11250018|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119191|NCT02552121|11250019|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119192|NCT02552121|11250020|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119193|NCT02552121|11250021|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119194|NCT02552121|11250022|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119195|NCT02552121|11250023|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10119196|NCT02552121|11250016|FG000|STARTED|Part 2: Cohort Expansion||0
10119197|NCT02552121|11250017|FG001|STARTED|Part 2: Cohort Expansion||0
10119198|NCT02552121|11250018|FG002|STARTED|Part 2: Cohort Expansion||11
10119199|NCT02552121|11250019|FG003|STARTED|Part 2: Cohort Expansion||3
10119200|NCT02552121|11250020|FG004|STARTED|Part 2: Cohort Expansion||1
10119201|NCT02552121|11250021|FG005|STARTED|Part 2: Cohort Expansion||5
10119202|NCT02552121|11250022|FG006|STARTED|Part 2: Cohort Expansion||1
10119203|NCT02552121|11250023|FG007|STARTED|Part 2: Cohort Expansion||3
10119204|NCT02552121|11250016|FG000|COMPLETED|Part 2: Cohort Expansion||0
10119205|NCT02552121|11250017|FG001|COMPLETED|Part 2: Cohort Expansion||0
10119206|NCT02552121|11250018|FG002|COMPLETED|Part 2: Cohort Expansion||0
10119207|NCT02552121|11250019|FG003|COMPLETED|Part 2: Cohort Expansion||0
10119208|NCT02552121|11250020|FG004|COMPLETED|Part 2: Cohort Expansion||0
10119209|NCT02552121|11250021|FG005|COMPLETED|Part 2: Cohort Expansion||1
10119210|NCT02552121|11250022|FG006|COMPLETED|Part 2: Cohort Expansion||0
10119211|NCT02552121|11250023|FG007|COMPLETED|Part 2: Cohort Expansion||0
10119212|NCT02552121|11250016|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0
10119213|NCT02552121|11250017|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0
10119214|NCT02552121|11250018|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11
10119215|NCT02552121|11250019|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3
10119216|NCT02552121|11250020|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1
10119217|NCT02552121|11250021|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4
10119218|NCT02552121|11250022|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1
10054674|NCT02058160|11179823|FG001|NOT COMPLETED|Overall Study||14
10054675|NCT02058251|11179831|FG000|STARTED|Overall Study||35
10054676|NCT02058251|11179832|FG001|STARTED|Overall Study||38
10054677|NCT02058251|11179831|FG000|COMPLETED|Overall Study||35
10054678|NCT02058251|11179832|FG001|COMPLETED|Overall Study||38
10054679|NCT02058251|11179831|FG000|NOT COMPLETED|Overall Study||0
10054680|NCT02058251|11179832|FG001|NOT COMPLETED|Overall Study||0
10054681|NCT02058290|11179840|FG000|STARTED|Overall Study||77
10054682|NCT02058290|11179841|FG001|STARTED|Overall Study||45
10054683|NCT02058290|11179840|FG000|COMPLETED|Overall Study||66
10054684|NCT02058290|11179841|FG001|COMPLETED|Overall Study||36
10054685|NCT02058290|11179840|FG000|NOT COMPLETED|Overall Study||11
10054686|NCT02058290|11179841|FG001|NOT COMPLETED|Overall Study||9
10054687|NCT02058368|11179849|FG000|STARTED|Overall Study||302
10054688|NCT02058368|11179850|FG001|STARTED|Overall Study||305
10054689|NCT02058368|11179849|FG000|COMPLETED|Overall Study||261
10054690|NCT02058368|11179850|FG001|COMPLETED|Overall Study||251
10054691|NCT02058368|11179849|FG000|NOT COMPLETED|Overall Study||41
10054692|NCT02058368|11179850|FG001|NOT COMPLETED|Overall Study||54
10054693|NCT02058498|11179856|FG000|STARTED|Overall Study||12
10054694|NCT02058498|11179856|FG000|6 Weeks|Overall Study||8
10054695|NCT02058498|11179856|FG000|COMPLETED|Overall Study||8
10054696|NCT02058498|11179856|FG000|NOT COMPLETED|Overall Study||4
10054697|NCT02058511|11179860|FG000|STARTED|Overall Study||24
10054698|NCT02058511|11179860|FG000|COMPLETED|Overall Study||24
10054699|NCT02058511|11179860|FG000|NOT COMPLETED|Overall Study||0
10054700|NCT02058563|11179866|FG000|STARTED|Overall Study||454
10054701|NCT02058563|11179867|FG001|STARTED|Overall Study||457
10054702|NCT02058563|11179866|FG000|COMPLETED|Overall Study||426
10054703|NCT02058563|11179867|FG001|COMPLETED|Overall Study||433
10054704|NCT02058563|11179866|FG000|NOT COMPLETED|Overall Study||28
10119219|NCT02552121|11250023|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3
10119220|NCT02552147|11250055|FG000|STARTED|First Intervention (7 Days)||4
10119221|NCT02552147|11250056|FG001|STARTED|First Intervention (7 Days)||4
10054705|NCT02058563|11179867|FG001|NOT COMPLETED|Overall Study||24
10054706|NCT02058589|11179875|FG000|STARTED|Overall Study||132
10054707|NCT02058589|11179876|FG001|STARTED|Overall Study||132
10054708|NCT02058589|11179875|FG000|COMPLETED|Overall Study||130
10054709|NCT02058589|11179876|FG001|COMPLETED|Overall Study||130
10054710|NCT02058589|11179875|FG000|NOT COMPLETED|Overall Study||2
10054711|NCT02058589|11179876|FG001|NOT COMPLETED|Overall Study||2
10054712|NCT02058628|11179886|FG000|STARTED|Overall Study||111
10054713|NCT02058628|11179887|FG001|STARTED|Overall Study||110
10054714|NCT02058628|11179886|FG000|COMPLETED|Overall Study||104
10054715|NCT02058628|11179887|FG001|COMPLETED|Overall Study||102
10054716|NCT02058628|11179886|FG000|NOT COMPLETED|Overall Study||7
10054717|NCT02058628|11179887|FG001|NOT COMPLETED|Overall Study||8
10054718|NCT02058836|11179898|FG000|STARTED|Overall Study||4
10054719|NCT02058836|11179899|FG001|STARTED|Overall Study||4
10054720|NCT02058836|11179898|FG000|COMPLETED|Overall Study||3
10054721|NCT02058836|11179899|FG001|COMPLETED|Overall Study||3
10054722|NCT02058836|11179898|FG000|NOT COMPLETED|Overall Study||1
10054723|NCT02058836|11179899|FG001|NOT COMPLETED|Overall Study||1
10054724|NCT02058849|11179907|FG000|STARTED|Overall Study||11
10054725|NCT02058849|11179908|FG001|STARTED|Overall Study||2
10054726|NCT02058849|11179907|FG000|COMPLETED|Overall Study||4
10054727|NCT02058849|11179908|FG001|COMPLETED|Overall Study||1
10054728|NCT02058849|11179907|FG000|NOT COMPLETED|Overall Study||7
10054729|NCT02058849|11179908|FG001|NOT COMPLETED|Overall Study||1
10054730|NCT02058940|11179914|FG000|STARTED|Overall Study||8
10054731|NCT02058940|11179914|FG000|COMPLETED|Overall Study||7
10054732|NCT02058940|11179914|FG000|NOT COMPLETED|Overall Study||1
10054733|NCT02058966|11179918|FG000|STARTED|Open-Label Methamphetamine||19
10119222|NCT02552147|11250055|FG000|COMPLETED|First Intervention (7 Days)||3
10054734|NCT02058966|11179918|FG000|Received Methamphetamine|Open-Label Methamphetamine||18
10054735|NCT02058966|11179918|FG000|COMPLETED|Open-Label Methamphetamine||18
10054736|NCT02058966|11179918|FG000|NOT COMPLETED|Open-Label Methamphetamine||1
10054737|NCT02058966|11179918|FG000|STARTED|First Intervention||15
10054738|NCT02058966|11179918|FG000|Received Placebo-Placebo|First Intervention||3
10054739|NCT02058966|11179918|FG000|Received Placebo-Meth|First Intervention||4
10054740|NCT02058966|11179918|FG000|Received Entacapone-Placebo|First Intervention||2
10054741|NCT02058966|11179918|FG000|Received Entacapone-Meth|First Intervention||5
10054742|NCT02058966|11179918|FG000|COMPLETED|First Intervention||14
10054743|NCT02058966|11179918|FG000|NOT COMPLETED|First Intervention||1
10054744|NCT02058966|11179918|FG000|STARTED|Second Intervention||13
10119223|NCT02552147|11250056|FG001|COMPLETED|First Intervention (7 Days)||4
10054745|NCT02058966|11179918|FG000|Received Placebo-Placebo|Second Intervention||2
10054746|NCT02058966|11179918|FG000|Received Placebo-Meth|Second Intervention||2
10054747|NCT02058966|11179918|FG000|Received Entacapone-Placebo|Second Intervention||6
10054748|NCT02058966|11179918|FG000|Received Entacapone-Meth|Second Intervention||3
10054749|NCT02058966|11179918|FG000|COMPLETED|Second Intervention||13
10054750|NCT02058966|11179918|FG000|NOT COMPLETED|Second Intervention||0
10054751|NCT02058966|11179918|FG000|STARTED|Third Intervention||12
10054752|NCT02058966|11179918|FG000|Received Placebo-Placebo|Third Intervention||4
10054753|NCT02058966|11179918|FG000|Received Placebo-Meth|Third Intervention||4
10054754|NCT02058966|11179918|FG000|Received Entacapone-Placebo|Third Intervention||1
10054755|NCT02058966|11179918|FG000|Received Entacapone-Meth|Third Intervention||3
10054756|NCT02058966|11179918|FG000|COMPLETED|Third Intervention||12
10054757|NCT02058966|11179918|FG000|NOT COMPLETED|Third Intervention||0
10054758|NCT02058966|11179918|FG000|STARTED|Fourth Intervention||12
10054759|NCT02058966|11179918|FG000|Received Placebo-Placebo|Fourth Intervention||4
10054760|NCT02058966|11179918|FG000|Received Placebo-Meth|Fourth Intervention||3
10054761|NCT02058966|11179918|FG000|Received Entacapone-Placebo|Fourth Intervention||3
10054762|NCT02058966|11179918|FG000|Received Entacapone-Meth|Fourth Intervention||2
10054763|NCT02058966|11179918|FG000|COMPLETED|Fourth Intervention||12
10054764|NCT02058966|11179918|FG000|NOT COMPLETED|Fourth Intervention||0
10054765|NCT02058992|11179930|FG000|STARTED|Overall Study||3339
10054766|NCT02058992|11179930|FG000|COMPLETED|Overall Study||3223
10054767|NCT02058992|11179930|FG000|NOT COMPLETED|Overall Study||116
10054768|NCT02059005|11179936|FG000|STARTED|Overall Study||49
10054769|NCT02059005|11179937|FG001|STARTED|Overall Study||48
10054770|NCT02059005|11179936|FG000|3 Month Assessment|Overall Study||37
10054771|NCT02059005|11179937|FG001|3 Month Assessment|Overall Study||33
10054772|NCT02059005|11179936|FG000|6 Month Assessment|Overall Study||29
10054773|NCT02059005|11179937|FG001|6 Month Assessment|Overall Study||24
10054774|NCT02059005|11179936|FG000|COMPLETED|Overall Study||29
10054775|NCT02059005|11179937|FG001|COMPLETED|Overall Study||24
10054776|NCT02059005|11179936|FG000|NOT COMPLETED|Overall Study||20
10054777|NCT02059005|11179937|FG001|NOT COMPLETED|Overall Study||24
10054778|NCT02059057|11179945|FG000|STARTED|Overall Study||102
10054779|NCT02059057|11179945|FG000|COMPLETED|Overall Study||87
10054780|NCT02059057|11179945|FG000|NOT COMPLETED|Overall Study||15
10054781|NCT02059070|11179952|FG000|STARTED|Overall Study||19
10054782|NCT02059070|11179953|FG001|STARTED|Overall Study||20
10054783|NCT02059070|11179952|FG000|COMPLETED|Overall Study||14
10054784|NCT02059070|11179953|FG001|COMPLETED|Overall Study||16
10054785|NCT02059070|11179952|FG000|NOT COMPLETED|Overall Study||5
10054786|NCT02059070|11179953|FG001|NOT COMPLETED|Overall Study||4
10054787|NCT02059135|11179961|FG000|STARTED|Maternal Follow-up (ITT Population)||62
10054788|NCT02059135|11179962|FG001|STARTED|Maternal Follow-up (ITT Population)||58
10054789|NCT02059135|11179961|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59
10054790|NCT02059135|11179962|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51
10054791|NCT02059135|11179961|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
10054792|NCT02059135|11179962|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
10054793|NCT02059135|11179961|FG000|STARTED|Neonatal Follow-up (Safety Population)||60
10054794|NCT02059135|11179962|FG001|STARTED|Neonatal Follow-up (Safety Population)||54
10054795|NCT02059135|11179961|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56
10054796|NCT02059135|11179962|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50
10054797|NCT02059135|11179961|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
10054798|NCT02059135|11179962|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
10054799|NCT02059148|11179970|FG000|STARTED|Treatment 1||4
10054800|NCT02059148|11179971|FG001|STARTED|Treatment 1||4
10054801|NCT02059148|11179972|FG002|STARTED|Treatment 1||4
10054802|NCT02059148|11179973|FG003|STARTED|Treatment 1||4
10054803|NCT02059148|11179974|FG004|STARTED|Treatment 1||4
10054804|NCT02059148|11179975|FG005|STARTED|Treatment 1||4
10054805|NCT02059148|11179970|FG000|COMPLETED|Treatment 1||4
10054806|NCT02059148|11179971|FG001|COMPLETED|Treatment 1||4
10054807|NCT02059148|11179972|FG002|COMPLETED|Treatment 1||4
10054808|NCT02059148|11179973|FG003|COMPLETED|Treatment 1||4
10054809|NCT02059148|11179974|FG004|COMPLETED|Treatment 1||4
10054810|NCT02059148|11179975|FG005|COMPLETED|Treatment 1||3
10054811|NCT02059148|11179970|FG000|NOT COMPLETED|Treatment 1||0
10054812|NCT02059148|11179971|FG001|NOT COMPLETED|Treatment 1||0
10054813|NCT02059148|11179972|FG002|NOT COMPLETED|Treatment 1||0
10054814|NCT02059148|11179973|FG003|NOT COMPLETED|Treatment 1||0
10054815|NCT02059148|11179974|FG004|NOT COMPLETED|Treatment 1||0
10054816|NCT02059148|11179975|FG005|NOT COMPLETED|Treatment 1||1
10054817|NCT02059148|11179970|FG000|STARTED|Treatment 2||4
10054818|NCT02059148|11179971|FG001|STARTED|Treatment 2||4
10054819|NCT02059148|11179972|FG002|STARTED|Treatment 2||4
10054820|NCT02059148|11179973|FG003|STARTED|Treatment 2||4
10054821|NCT02059148|11179974|FG004|STARTED|Treatment 2||4
10054822|NCT02059148|11179975|FG005|STARTED|Treatment 2||3
10054823|NCT02059148|11179970|FG000|COMPLETED|Treatment 2||4
10054824|NCT02059148|11179971|FG001|COMPLETED|Treatment 2||4
10054825|NCT02059148|11179972|FG002|COMPLETED|Treatment 2||4
10054826|NCT02059148|11179973|FG003|COMPLETED|Treatment 2||4
10054827|NCT02059148|11179974|FG004|COMPLETED|Treatment 2||4
10054828|NCT02059148|11179975|FG005|COMPLETED|Treatment 2||3
10054829|NCT02059148|11179970|FG000|NOT COMPLETED|Treatment 2||0
10054830|NCT02059148|11179971|FG001|NOT COMPLETED|Treatment 2||0
10054831|NCT02059148|11179972|FG002|NOT COMPLETED|Treatment 2||0
10054832|NCT02059148|11179973|FG003|NOT COMPLETED|Treatment 2||0
10054833|NCT02059148|11179974|FG004|NOT COMPLETED|Treatment 2||0
10054834|NCT02059148|11179975|FG005|NOT COMPLETED|Treatment 2||0
10054835|NCT02059148|11179970|FG000|STARTED|Treatment 3||4
10054836|NCT02059148|11179971|FG001|STARTED|Treatment 3||4
10054837|NCT02059148|11179972|FG002|STARTED|Treatment 3||4
10054838|NCT02059148|11179973|FG003|STARTED|Treatment 3||4
10054839|NCT02059148|11179974|FG004|STARTED|Treatment 3||4
10054840|NCT02059148|11179975|FG005|STARTED|Treatment 3||3
10054841|NCT02059148|11179970|FG000|COMPLETED|Treatment 3||4
10054842|NCT02059148|11179971|FG001|COMPLETED|Treatment 3||4
10054843|NCT02059148|11179972|FG002|COMPLETED|Treatment 3||4
10054844|NCT02059148|11179973|FG003|COMPLETED|Treatment 3||4
10054845|NCT02059148|11179974|FG004|COMPLETED|Treatment 3||4
10054846|NCT02059148|11179975|FG005|COMPLETED|Treatment 3||3
10054847|NCT02059148|11179970|FG000|NOT COMPLETED|Treatment 3||0
10054848|NCT02059148|11179971|FG001|NOT COMPLETED|Treatment 3||0
10054849|NCT02059148|11179972|FG002|NOT COMPLETED|Treatment 3||0
10054850|NCT02059148|11179973|FG003|NOT COMPLETED|Treatment 3||0
10054851|NCT02059148|11179974|FG004|NOT COMPLETED|Treatment 3||0
10054852|NCT02059148|11179975|FG005|NOT COMPLETED|Treatment 3||0
10054853|NCT02059161|11179988|FG000|STARTED|Overall Study||245
10054854|NCT02059161|11179989|FG001|STARTED|Overall Study||263
10054855|NCT02059161|11179988|FG000|Treated|Overall Study||241
10054856|NCT02059161|11179989|FG001|Treated|Overall Study||258
10054857|NCT02059161|11179988|FG000|COMPLETED|Overall Study||196
10054858|NCT02059161|11179989|FG001|COMPLETED|Overall Study||222
10054859|NCT02059161|11179988|FG000|NOT COMPLETED|Overall Study||49
10054860|NCT02059161|11179989|FG001|NOT COMPLETED|Overall Study||41
10054861|NCT02059174|11179995|FG000|STARTED|Period 1||37
10054862|NCT02059174|11179996|FG001|STARTED|Period 1||39
10054863|NCT02059174|11179995|FG000|COMPLETED|Period 1||37
10054864|NCT02059174|11179996|FG001|COMPLETED|Period 1||37
10119224|NCT02552147|11250055|FG000|NOT COMPLETED|First Intervention (7 Days)||1
10119225|NCT02552147|11250056|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10119226|NCT02552147|11250055|FG000|STARTED|Washout (7 Days)||3
10119227|NCT02552147|11250056|FG001|STARTED|Washout (7 Days)||4
10119228|NCT02552147|11250055|FG000|COMPLETED|Washout (7 Days)||3
10119229|NCT02552147|11250056|FG001|COMPLETED|Washout (7 Days)||4
10119230|NCT02552147|11250055|FG000|NOT COMPLETED|Washout (7 Days)||0
10119231|NCT02552147|11250056|FG001|NOT COMPLETED|Washout (7 Days)||0
10119232|NCT02552147|11250055|FG000|STARTED|Second Intervention (7 Days)||3
10119233|NCT02552147|11250056|FG001|STARTED|Second Intervention (7 Days)||4
10119234|NCT02552147|11250055|FG000|COMPLETED|Second Intervention (7 Days)||1
10119235|NCT02552147|11250056|FG001|COMPLETED|Second Intervention (7 Days)||4
10119236|NCT02552147|11250055|FG000|NOT COMPLETED|Second Intervention (7 Days)||2
10119237|NCT02552147|11250056|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10119238|NCT02552225|11250064|FG000|STARTED|Overall Study||3
10119239|NCT02552225|11250065|FG001|STARTED|Overall Study||3
10119240|NCT02552225|11250064|FG000|COMPLETED|Overall Study||2
10119241|NCT02552225|11250065|FG001|COMPLETED|Overall Study||3
10119242|NCT02552225|11250064|FG000|NOT COMPLETED|Overall Study||1
10119243|NCT02552225|11250065|FG001|NOT COMPLETED|Overall Study||0
10119244|NCT02552238|11250071|FG000|STARTED|Overall Study||174
10119245|NCT02552238|11250071|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
10119246|NCT02552238|11250071|FG000|NOT COMPLETED|Overall Study||4
10119247|NCT02552303|11250086|FG000|STARTED|Allocation||10
10119248|NCT02552303|11250087|FG001|STARTED|Allocation||10
10119249|NCT02552303|11250088|FG002|STARTED|Allocation||8
10119250|NCT02552303|11250089|FG003|STARTED|Allocation||11
10119251|NCT02552303|11250086|FG000|COMPLETED|Allocation||7
10119252|NCT02552303|11250087|FG001|COMPLETED|Allocation||8
10119253|NCT02552303|11250088|FG002|COMPLETED|Allocation||7
10119254|NCT02552303|11250089|FG003|COMPLETED|Allocation||10
10119255|NCT02552303|11250086|FG000|NOT COMPLETED|Allocation||3
10119256|NCT02552303|11250087|FG001|NOT COMPLETED|Allocation||2
10119257|NCT02552303|11250088|FG002|NOT COMPLETED|Allocation||1
10119258|NCT02552303|11250089|FG003|NOT COMPLETED|Allocation||1
10119259|NCT02552303|11250086|FG000|STARTED|Follow-Up||7
10119260|NCT02552303|11250087|FG001|STARTED|Follow-Up||8
10119261|NCT02552303|11250088|FG002|STARTED|Follow-Up||7
10119262|NCT02552303|11250089|FG003|STARTED|Follow-Up||10
10119263|NCT02552303|11250086|FG000|COMPLETED|Follow-Up||7
10119264|NCT02552303|11250087|FG001|COMPLETED|Follow-Up||6
10119265|NCT02552303|11250088|FG002|COMPLETED|Follow-Up||6
10119266|NCT02552303|11250089|FG003|COMPLETED|Follow-Up||10
10119267|NCT02552303|11250086|FG000|NOT COMPLETED|Follow-Up||0
10119268|NCT02552303|11250087|FG001|NOT COMPLETED|Follow-Up||2
10119269|NCT02552303|11250088|FG002|NOT COMPLETED|Follow-Up||1
10119270|NCT02552303|11250089|FG003|NOT COMPLETED|Follow-Up||0
10119271|NCT02552316|11250099|FG000|STARTED|Overall Study||34
10119272|NCT02552316|11250099|FG000|COMPLETED|Overall Study||32
10119273|NCT02552316|11250099|FG000|NOT COMPLETED|Overall Study||2
10119274|NCT02552355|11250151|FG000|STARTED|Overall Study||14
10054865|NCT02059174|11179995|FG000|NOT COMPLETED|Period 1||0
10054866|NCT02059174|11179996|FG001|NOT COMPLETED|Period 1||2
10054867|NCT02059174|11179995|FG000|STARTED|Period 2||37
10054868|NCT02059174|11179996|FG001|STARTED|Period 2||37
10054869|NCT02059174|11179995|FG000|COMPLETED|Period 2||36
10054870|NCT02059174|11179996|FG001|COMPLETED|Period 2||35
10054871|NCT02059174|11179995|FG000|NOT COMPLETED|Period 2||1
10054872|NCT02059174|11179996|FG001|NOT COMPLETED|Period 2||2
10054873|NCT02059174|11179995|FG000|STARTED|Period 3||36
10054874|NCT02059174|11179996|FG001|STARTED|Period 3||35
10054875|NCT02059174|11179995|FG000|COMPLETED|Period 3||35
10054876|NCT02059174|11179996|FG001|COMPLETED|Period 3||35
10054877|NCT02059174|11179995|FG000|NOT COMPLETED|Period 3||1
10054878|NCT02059174|11179996|FG001|NOT COMPLETED|Period 3||0
10054879|NCT02059174|11179995|FG000|STARTED|Period 4||35
10054880|NCT02059174|11179996|FG001|STARTED|Period 4||35
10054881|NCT02059174|11179995|FG000|COMPLETED|Period 4||35
10054882|NCT02059174|11179996|FG001|COMPLETED|Period 4||35
10054883|NCT02059174|11179995|FG000|NOT COMPLETED|Period 4||0
10054884|NCT02059174|11179996|FG001|NOT COMPLETED|Period 4||0
10054885|NCT02059187|11180004|FG000|STARTED|Overall Study||265
10054886|NCT02059187|11180005|FG001|STARTED|Overall Study||266
10054887|NCT02059187|11180004|FG000|COMPLETED|Overall Study||240
10054888|NCT02059187|11180005|FG001|COMPLETED|Overall Study||244
10054889|NCT02059187|11180004|FG000|NOT COMPLETED|Overall Study||25
10119275|NCT02552355|11250152|FG001|STARTED|Overall Study||13
10119276|NCT02552355|11250153|FG002|STARTED|Overall Study||14
10119277|NCT02552355|11250154|FG003|STARTED|Overall Study||15
10119278|NCT02552355|11250151|FG000|COMPLETED|Overall Study||14
10119279|NCT02552355|11250152|FG001|COMPLETED|Overall Study||11
10119280|NCT02552355|11250153|FG002|COMPLETED|Overall Study||12
10119281|NCT02552355|11250154|FG003|COMPLETED|Overall Study||14
10119282|NCT02552355|11250151|FG000|NOT COMPLETED|Overall Study||0
10119283|NCT02552355|11250152|FG001|NOT COMPLETED|Overall Study||2
10119284|NCT02552355|11250153|FG002|NOT COMPLETED|Overall Study||2
10119285|NCT02552355|11250154|FG003|NOT COMPLETED|Overall Study||1
10119286|NCT02552368|11250164|FG000|STARTED|Overall Study||23
10119287|NCT02552368|11250164|FG000|COMPLETED|Overall Study||10
10119288|NCT02552368|11250164|FG000|NOT COMPLETED|Overall Study||13
10119289|NCT02552732|11250169|FG000|STARTED|Overall Study||29
10119290|NCT02552732|11250169|FG000|Used Device|Overall Study||23
10119291|NCT02552732|11250169|FG000|Completed Week 1|Overall Study||21
10119292|NCT02552732|11250169|FG000|Completed Week 2|Overall Study||20
10119293|NCT02552732|11250169|FG000|Completed Week 3|Overall Study||19
10119294|NCT02552732|11250169|FG000|Completed Week 4|Overall Study||19
10119295|NCT02552732|11250169|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12
10119296|NCT02552732|11250169|FG000|COMPLETED|Overall Study||19
10119297|NCT02552732|11250169|FG000|NOT COMPLETED|Overall Study||10
10119298|NCT02552810|11250176|FG000|STARTED|Overall Study||15
10119299|NCT02552810|11250177|FG001|STARTED|Overall Study||15
10119300|NCT02552810|11250176|FG000|COMPLETED|Overall Study||15
10119301|NCT02552810|11250177|FG001|COMPLETED|Overall Study||15
10119302|NCT02552810|11250176|FG000|NOT COMPLETED|Overall Study||0
10119303|NCT02552810|11250177|FG001|NOT COMPLETED|Overall Study||0
10119304|NCT02552888|11250185|FG000|STARTED|Overall Study|35 participants were enrolled.|35
10119305|NCT02552888|11250186|FG001|STARTED|Overall Study|35 participants were enrolled.|35
10119306|NCT02552888|11250185|FG000|COMPLETED|Overall Study|34 participants completed the study.|34
10119307|NCT02552888|11250186|FG001|COMPLETED|Overall Study|34 participants completed the study|34
10119308|NCT02552888|11250185|FG000|NOT COMPLETED|Overall Study||1
10119309|NCT02552888|11250186|FG001|NOT COMPLETED|Overall Study||1
10119310|NCT02552966|11250196|FG000|STARTED|Overall Study||20
10119311|NCT02552966|11250196|FG000|COMPLETED|Overall Study||15
10119312|NCT02552966|11250196|FG000|NOT COMPLETED|Overall Study||5
10119313|NCT02553135|11250200|FG000|STARTED|Overall Study||6
10119314|NCT02553135|11250200|FG000|COMPLETED|Overall Study||6
10119315|NCT02553135|11250200|FG000|NOT COMPLETED|Overall Study||0
10119316|NCT02553317|11250206|FG000|STARTED|Overall Treatment Period + Follow-up||72
10119317|NCT02553317|11250207|FG001|STARTED|Overall Treatment Period + Follow-up||73
10119318|NCT02553317|11250206|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71
10119319|NCT02553317|11250207|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73
10119320|NCT02553317|11250206|FG000|COMPLETED|Overall Treatment Period + Follow-up||58
10119321|NCT02553317|11250207|FG001|COMPLETED|Overall Treatment Period + Follow-up||50
10119322|NCT02553317|11250206|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14
10119323|NCT02553317|11250207|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23
10119324|NCT02553317|11250206|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
10119325|NCT02553317|11250207|FG001|STARTED|Double-blind (DB) Treatment Period||73
10119326|NCT02553317|11250206|FG000|COMPLETED|Double-blind (DB) Treatment Period||68
10119327|NCT02553317|11250207|FG001|COMPLETED|Double-blind (DB) Treatment Period||65
10119328|NCT02553317|11250206|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3
10119329|NCT02553317|11250207|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8
10119330|NCT02553317|11250206|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
10119331|NCT02553317|11250207|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
10119332|NCT02553317|11250206|FG000|COMPLETED|Open-label (OL) Treatment Period||2
10119333|NCT02553317|11250207|FG001|COMPLETED|Open-label (OL) Treatment Period||22
10119334|NCT02553317|11250206|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0
10119335|NCT02553317|11250207|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4
10119336|NCT02553330|11250217|FG000|STARTED|Overall Study||12
10119337|NCT02553330|11250218|FG001|STARTED|Overall Study||39
10119338|NCT02553330|11250219|FG002|STARTED|Overall Study||39
10119339|NCT02553330|11250217|FG000|COMPLETED|Overall Study||7
10119340|NCT02553330|11250218|FG001|COMPLETED|Overall Study||0
10054890|NCT02059187|11180005|FG001|NOT COMPLETED|Overall Study||22
10054891|NCT02059213|11180013|FG000|STARTED|Overall Study||20
10054892|NCT02059213|11180014|FG001|STARTED|Overall Study||42
10054893|NCT02059213|11180013|FG000|Initiated Treatment|Overall Study||20
10119341|NCT02553330|11250219|FG002|COMPLETED|Overall Study||2
10119342|NCT02553330|11250217|FG000|NOT COMPLETED|Overall Study||5
10119343|NCT02553330|11250218|FG001|NOT COMPLETED|Overall Study||39
10054894|NCT02059213|11180014|FG001|Initiated Treatment|Overall Study||40
10054895|NCT02059213|11180013|FG000|COMPLETED|Overall Study||20
10054896|NCT02059213|11180014|FG001|COMPLETED|Overall Study||40
10054897|NCT02059213|11180013|FG000|NOT COMPLETED|Overall Study||0
10054898|NCT02059213|11180014|FG001|NOT COMPLETED|Overall Study||2
10054899|NCT02059239|11180025|FG000|STARTED|Overall Study||18
10054900|NCT02059239|11180026|FG001|STARTED|Overall Study||16
10054901|NCT02059239|11180025|FG000|COMPLETED|Overall Study||16
10054902|NCT02059239|11180026|FG001|COMPLETED|Overall Study||13
10054903|NCT02059239|11180025|FG000|NOT COMPLETED|Overall Study||2
10054904|NCT02059239|11180026|FG001|NOT COMPLETED|Overall Study||3
10054905|NCT02059278|11180035|FG000|STARTED|Overall Study||165
10054906|NCT02059278|11180036|FG001|STARTED|Overall Study||170
10054907|NCT02059278|11180035|FG000|COMPLETED|Overall Study||162
10054908|NCT02059278|11180036|FG001|COMPLETED|Overall Study||166
10054909|NCT02059278|11180035|FG000|NOT COMPLETED|Overall Study||3
10054910|NCT02059278|11180036|FG001|NOT COMPLETED|Overall Study||4
10054911|NCT02059291|11180051|FG000|STARTED|Epoch 2||31
10054912|NCT02059291|11180052|FG001|STARTED|Epoch 2||32
10054913|NCT02059291|11180053|FG002|STARTED|Epoch 2||37
10054914|NCT02059291|11180054|FG003|STARTED|Epoch 2||35
10054915|NCT02059291|11180055|FG004|STARTED|Epoch 2||22
10054916|NCT02059291|11180056|FG005|STARTED|Epoch 2||24
10054917|NCT02059291|11180057|FG006|STARTED|Epoch 2||2
10054918|NCT02059291|11180058|FG007|STARTED|Epoch 2||2
10054919|NCT02059291|11180059|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
10054920|NCT02059291|11180060|FG009|STARTED|Epoch 2||0
10054921|NCT02059291|11180061|FG010|STARTED|Epoch 2||0
10054922|NCT02059291|11180062|FG011|STARTED|Epoch 2||0
10054923|NCT02059291|11180063|FG012|STARTED|Epoch 2||0
10054924|NCT02059291|11180064|FG013|STARTED|Epoch 2||0
10054925|NCT02059291|11180065|FG014|STARTED|Epoch 2||0
10054926|NCT02059291|11180066|FG015|STARTED|Epoch 2||0
10054927|NCT02059291|11180067|FG016|STARTED|Epoch 2||0
10054928|NCT02059291|11180068|FG017|STARTED|Epoch 2||0
10054929|NCT02059291|11180069|FG018|STARTED|Epoch 2||0
10054930|NCT02059291|11180070|FG019|STARTED|Epoch 2||0
10054931|NCT02059291|11180071|FG020|STARTED|Epoch 2||0
10054932|NCT02059291|11180072|FG021|STARTED|Epoch 2||0
10054933|NCT02059291|11180073|FG022|STARTED|Epoch 2||0
10054934|NCT02059291|11180074|FG023|STARTED|Epoch 2||0
10054935|NCT02059291|11180075|FG024|STARTED|Epoch 2||0
10054936|NCT02059291|11180051|FG000|COMPLETED|Epoch 2||31
10054937|NCT02059291|11180052|FG001|COMPLETED|Epoch 2||31
10054938|NCT02059291|11180053|FG002|COMPLETED|Epoch 2||36
10054939|NCT02059291|11180054|FG003|COMPLETED|Epoch 2||33
10054940|NCT02059291|11180055|FG004|COMPLETED|Epoch 2||22
10054941|NCT02059291|11180056|FG005|COMPLETED|Epoch 2||22
10054942|NCT02059291|11180057|FG006|COMPLETED|Epoch 2||2
10054943|NCT02059291|11180058|FG007|COMPLETED|Epoch 2||1
10054944|NCT02059291|11180059|FG008|COMPLETED|Epoch 2||16
10054945|NCT02059291|11180060|FG009|COMPLETED|Epoch 2||0
10054946|NCT02059291|11180061|FG010|COMPLETED|Epoch 2||0
10054947|NCT02059291|11180062|FG011|COMPLETED|Epoch 2||0
10054948|NCT02059291|11180063|FG012|COMPLETED|Epoch 2||0
10054949|NCT02059291|11180064|FG013|COMPLETED|Epoch 2||0
10054950|NCT02059291|11180065|FG014|COMPLETED|Epoch 2||0
10054951|NCT02059291|11180066|FG015|COMPLETED|Epoch 2||0
10054952|NCT02059291|11180067|FG016|COMPLETED|Epoch 2||0
10054953|NCT02059291|11180068|FG017|COMPLETED|Epoch 2||0
10054954|NCT02059291|11180069|FG018|COMPLETED|Epoch 2||0
10054955|NCT02059291|11180070|FG019|COMPLETED|Epoch 2||0
10054956|NCT02059291|11180071|FG020|COMPLETED|Epoch 2||0
10054957|NCT02059291|11180072|FG021|COMPLETED|Epoch 2||0
10054958|NCT02059291|11180073|FG022|COMPLETED|Epoch 2||0
10054959|NCT02059291|11180074|FG023|COMPLETED|Epoch 2||0
10054960|NCT02059291|11180075|FG024|COMPLETED|Epoch 2||0
10054961|NCT02059291|11180051|FG000|NOT COMPLETED|Epoch 2||0
10054962|NCT02059291|11180052|FG001|NOT COMPLETED|Epoch 2||1
10054963|NCT02059291|11180053|FG002|NOT COMPLETED|Epoch 2||1
10054964|NCT02059291|11180054|FG003|NOT COMPLETED|Epoch 2||2
10054965|NCT02059291|11180055|FG004|NOT COMPLETED|Epoch 2||0
10054966|NCT02059291|11180056|FG005|NOT COMPLETED|Epoch 2||2
10054967|NCT02059291|11180057|FG006|NOT COMPLETED|Epoch 2||0
10054968|NCT02059291|11180058|FG007|NOT COMPLETED|Epoch 2||1
10054969|NCT02059291|11180059|FG008|NOT COMPLETED|Epoch 2||2
10054970|NCT02059291|11180060|FG009|NOT COMPLETED|Epoch 2||0
10054971|NCT02059291|11180061|FG010|NOT COMPLETED|Epoch 2||0
10054972|NCT02059291|11180062|FG011|NOT COMPLETED|Epoch 2||0
10054973|NCT02059291|11180063|FG012|NOT COMPLETED|Epoch 2||0
10054974|NCT02059291|11180064|FG013|NOT COMPLETED|Epoch 2||0
10054975|NCT02059291|11180065|FG014|NOT COMPLETED|Epoch 2||0
10054976|NCT02059291|11180066|FG015|NOT COMPLETED|Epoch 2||0
10054977|NCT02059291|11180067|FG016|NOT COMPLETED|Epoch 2||0
10054978|NCT02059291|11180068|FG017|NOT COMPLETED|Epoch 2||0
10054979|NCT02059291|11180069|FG018|NOT COMPLETED|Epoch 2||0
10054980|NCT02059291|11180070|FG019|NOT COMPLETED|Epoch 2||0
10054981|NCT02059291|11180071|FG020|NOT COMPLETED|Epoch 2||0
10054982|NCT02059291|11180072|FG021|NOT COMPLETED|Epoch 2||0
10054983|NCT02059291|11180073|FG022|NOT COMPLETED|Epoch 2||0
10054984|NCT02059291|11180074|FG023|NOT COMPLETED|Epoch 2||0
10054985|NCT02059291|11180075|FG024|NOT COMPLETED|Epoch 2||0
10054986|NCT02059291|11180051|FG000|STARTED|Epoch 3||0
10054987|NCT02059291|11180052|FG001|STARTED|Epoch 3||0
10054988|NCT02059291|11180053|FG002|STARTED|Epoch 3||0
10054989|NCT02059291|11180054|FG003|STARTED|Epoch 3||0
10054990|NCT02059291|11180055|FG004|STARTED|Epoch 3||0
10054991|NCT02059291|11180056|FG005|STARTED|Epoch 3||0
10054992|NCT02059291|11180057|FG006|STARTED|Epoch 3||2
10054993|NCT02059291|11180058|FG007|STARTED|Epoch 3||1
10054994|NCT02059291|11180059|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0
10054995|NCT02059291|11180060|FG009|STARTED|Epoch 3||9
10054996|NCT02059291|11180061|FG010|STARTED|Epoch 3||10
10054997|NCT02059291|11180062|FG011|STARTED|Epoch 3||6
10054998|NCT02059291|11180063|FG012|STARTED|Epoch 3||7
10054999|NCT02059291|11180064|FG013|STARTED|Epoch 3||4
10055000|NCT02059291|11180065|FG014|STARTED|Epoch 3||5
10055001|NCT02059291|11180066|FG015|STARTED|Epoch 3||126
10055002|NCT02059291|11180067|FG016|STARTED|Epoch 3||0
10055003|NCT02059291|11180068|FG017|STARTED|Epoch 3||0
10055004|NCT02059291|11180069|FG018|STARTED|Epoch 3||0
10055005|NCT02059291|11180070|FG019|STARTED|Epoch 3||0
10055006|NCT02059291|11180071|FG020|STARTED|Epoch 3||0
10055007|NCT02059291|11180072|FG021|STARTED|Epoch 3||0
10055008|NCT02059291|11180073|FG022|STARTED|Epoch 3||0
10055009|NCT02059291|11180074|FG023|STARTED|Epoch 3||0
10055010|NCT02059291|11180075|FG024|STARTED|Epoch 3||0
10055011|NCT02059291|11180051|FG000|COMPLETED|Epoch 3||0
10055012|NCT02059291|11180052|FG001|COMPLETED|Epoch 3||0
10055013|NCT02059291|11180053|FG002|COMPLETED|Epoch 3||0
10055014|NCT02059291|11180054|FG003|COMPLETED|Epoch 3||0
10055015|NCT02059291|11180055|FG004|COMPLETED|Epoch 3||0
10055016|NCT02059291|11180056|FG005|COMPLETED|Epoch 3||0
10055017|NCT02059291|11180057|FG006|COMPLETED|Epoch 3||2
10055018|NCT02059291|11180058|FG007|COMPLETED|Epoch 3||1
10055019|NCT02059291|11180059|FG008|COMPLETED|Epoch 3||0
10055020|NCT02059291|11180060|FG009|COMPLETED|Epoch 3||9
10055021|NCT02059291|11180061|FG010|COMPLETED|Epoch 3||10
10055022|NCT02059291|11180062|FG011|COMPLETED|Epoch 3||6
10055023|NCT02059291|11180063|FG012|COMPLETED|Epoch 3||7
10055024|NCT02059291|11180064|FG013|COMPLETED|Epoch 3||3
10055025|NCT02059291|11180065|FG014|COMPLETED|Epoch 3||5
10055026|NCT02059291|11180066|FG015|COMPLETED|Epoch 3||120
10055027|NCT02059291|11180067|FG016|COMPLETED|Epoch 3||0
10055028|NCT02059291|11180068|FG017|COMPLETED|Epoch 3||0
10055029|NCT02059291|11180069|FG018|COMPLETED|Epoch 3||0
10055030|NCT02059291|11180070|FG019|COMPLETED|Epoch 3||0
10055031|NCT02059291|11180071|FG020|COMPLETED|Epoch 3||0
10055032|NCT02059291|11180072|FG021|COMPLETED|Epoch 3||0
10055033|NCT02059291|11180073|FG022|COMPLETED|Epoch 3||0
10055034|NCT02059291|11180074|FG023|COMPLETED|Epoch 3||0
10055035|NCT02059291|11180075|FG024|COMPLETED|Epoch 3||0
10055036|NCT02059291|11180051|FG000|NOT COMPLETED|Epoch 3||0
10055037|NCT02059291|11180052|FG001|NOT COMPLETED|Epoch 3||0
10055038|NCT02059291|11180053|FG002|NOT COMPLETED|Epoch 3||0
10055039|NCT02059291|11180054|FG003|NOT COMPLETED|Epoch 3||0
10055040|NCT02059291|11180055|FG004|NOT COMPLETED|Epoch 3||0
10055041|NCT02059291|11180056|FG005|NOT COMPLETED|Epoch 3||0
10055042|NCT02059291|11180057|FG006|NOT COMPLETED|Epoch 3||0
10055043|NCT02059291|11180058|FG007|NOT COMPLETED|Epoch 3||0
10055044|NCT02059291|11180059|FG008|NOT COMPLETED|Epoch 3||0
10055045|NCT02059291|11180060|FG009|NOT COMPLETED|Epoch 3||0
10055046|NCT02059291|11180061|FG010|NOT COMPLETED|Epoch 3||0
10055047|NCT02059291|11180062|FG011|NOT COMPLETED|Epoch 3||0
10055048|NCT02059291|11180063|FG012|NOT COMPLETED|Epoch 3||0
10055049|NCT02059291|11180064|FG013|NOT COMPLETED|Epoch 3||1
10055050|NCT02059291|11180065|FG014|NOT COMPLETED|Epoch 3||0
10055051|NCT02059291|11180066|FG015|NOT COMPLETED|Epoch 3||6
10055052|NCT02059291|11180067|FG016|NOT COMPLETED|Epoch 3||0
10055053|NCT02059291|11180068|FG017|NOT COMPLETED|Epoch 3||0
10055054|NCT02059291|11180069|FG018|NOT COMPLETED|Epoch 3||0
10055055|NCT02059291|11180070|FG019|NOT COMPLETED|Epoch 3||0
10055056|NCT02059291|11180071|FG020|NOT COMPLETED|Epoch 3||0
10055057|NCT02059291|11180072|FG021|NOT COMPLETED|Epoch 3||0
10055058|NCT02059291|11180073|FG022|NOT COMPLETED|Epoch 3||0
10055059|NCT02059291|11180074|FG023|NOT COMPLETED|Epoch 3||0
10055060|NCT02059291|11180075|FG024|NOT COMPLETED|Epoch 3||0
10055061|NCT02059291|11180051|FG000|STARTED|Epoch 4||0
10055062|NCT02059291|11180052|FG001|STARTED|Epoch 4||0
10055063|NCT02059291|11180053|FG002|STARTED|Epoch 4||0
10055064|NCT02059291|11180054|FG003|STARTED|Epoch 4||0
10055065|NCT02059291|11180055|FG004|STARTED|Epoch 4||0
10055066|NCT02059291|11180056|FG005|STARTED|Epoch 4||0
10055067|NCT02059291|11180057|FG006|STARTED|Epoch 4||0
10055068|NCT02059291|11180058|FG007|STARTED|Epoch 4||0
10055069|NCT02059291|11180059|FG008|STARTED|Epoch 4||0
10055070|NCT02059291|11180060|FG009|STARTED|Epoch 4||0
10055071|NCT02059291|11180061|FG010|STARTED|Epoch 4||0
10055072|NCT02059291|11180062|FG011|STARTED|Epoch 4||0
10055073|NCT02059291|11180063|FG012|STARTED|Epoch 4||0
10055074|NCT02059291|11180064|FG013|STARTED|Epoch 4||0
10055075|NCT02059291|11180065|FG014|STARTED|Epoch 4||0
10055076|NCT02059291|11180066|FG015|STARTED|Epoch 4||0
10055077|NCT02059291|11180067|FG016|STARTED|Epoch 4||43
10055078|NCT02059291|11180068|FG017|STARTED|Epoch 4||14
10055079|NCT02059291|11180069|FG018|STARTED|Epoch 4||2
10055080|NCT02059291|11180070|FG019|STARTED|Epoch 4||18
10055081|NCT02059291|11180071|FG020|STARTED|Epoch 4||34
10055082|NCT02059291|11180072|FG021|STARTED|Epoch 4||14
10055083|NCT02059291|11180073|FG022|STARTED|Epoch 4||31
10055084|NCT02059291|11180074|FG023|STARTED|Epoch 4||22
10055085|NCT02059291|11180075|FG024|STARTED|Epoch 4||0
10055086|NCT02059291|11180051|FG000|COMPLETED|Epoch 4||0
10055087|NCT02059291|11180052|FG001|COMPLETED|Epoch 4||0
10055088|NCT02059291|11180053|FG002|COMPLETED|Epoch 4||0
10055089|NCT02059291|11180054|FG003|COMPLETED|Epoch 4||0
10055090|NCT02059291|11180055|FG004|COMPLETED|Epoch 4||0
10055091|NCT02059291|11180056|FG005|COMPLETED|Epoch 4||0
10055092|NCT02059291|11180057|FG006|COMPLETED|Epoch 4||0
10055093|NCT02059291|11180058|FG007|COMPLETED|Epoch 4||0
10055094|NCT02059291|11180059|FG008|COMPLETED|Epoch 4||0
10055095|NCT02059291|11180060|FG009|COMPLETED|Epoch 4||0
10055096|NCT02059291|11180061|FG010|COMPLETED|Epoch 4||0
10055097|NCT02059291|11180062|FG011|COMPLETED|Epoch 4||0
10055098|NCT02059291|11180063|FG012|COMPLETED|Epoch 4||0
10055099|NCT02059291|11180064|FG013|COMPLETED|Epoch 4||0
10055100|NCT02059291|11180065|FG014|COMPLETED|Epoch 4||0
10055101|NCT02059291|11180066|FG015|COMPLETED|Epoch 4||0
10055102|NCT02059291|11180067|FG016|COMPLETED|Epoch 4||41
10055103|NCT02059291|11180068|FG017|COMPLETED|Epoch 4||14
10055104|NCT02059291|11180069|FG018|COMPLETED|Epoch 4||2
10055105|NCT02059291|11180070|FG019|COMPLETED|Epoch 4||18
10055106|NCT02059291|11180071|FG020|COMPLETED|Epoch 4||33
10119344|NCT02553330|11250219|FG002|NOT COMPLETED|Overall Study||37
10119345|NCT02553395|11250230|FG000|STARTED|First Intervention||12
10119346|NCT02553395|11250231|FG001|STARTED|First Intervention||18
10119347|NCT02553395|11250230|FG000|COMPLETED|First Intervention||12
10119348|NCT02553395|11250231|FG001|COMPLETED|First Intervention||18
10119349|NCT02553395|11250230|FG000|NOT COMPLETED|First Intervention||0
10119350|NCT02553395|11250231|FG001|NOT COMPLETED|First Intervention||0
10119351|NCT02553395|11250230|FG000|STARTED|Second Intervention||12
10119352|NCT02553395|11250231|FG001|STARTED|Second Intervention||18
10119353|NCT02553395|11250230|FG000|COMPLETED|Second Intervention||12
10119354|NCT02553395|11250231|FG001|COMPLETED|Second Intervention||18
10119355|NCT02553395|11250230|FG000|NOT COMPLETED|Second Intervention||0
10119356|NCT02553395|11250231|FG001|NOT COMPLETED|Second Intervention||0
10119357|NCT02553421|11250240|FG000|STARTED|Overall Study||185
10119358|NCT02553421|11250241|FG001|STARTED|Overall Study||58
10119359|NCT02553421|11250240|FG000|COMPLETED|Overall Study||156
10119360|NCT02553421|11250241|FG001|COMPLETED|Overall Study||57
10119361|NCT02553421|11250240|FG000|NOT COMPLETED|Overall Study||29
10119362|NCT02553421|11250241|FG001|NOT COMPLETED|Overall Study||1
10119363|NCT02553499|11250262|FG000|STARTED|Overall Study||2
10119364|NCT02553499|11250263|FG001|STARTED|Overall Study||2
10119365|NCT02553499|11250264|FG002|STARTED|Overall Study||2
10119366|NCT02553499|11250265|FG003|STARTED|Overall Study||2
10119367|NCT02553499|11250266|FG004|STARTED|Overall Study||3
10119368|NCT02553499|11250267|FG005|STARTED|Overall Study||3
10119369|NCT02553499|11250268|FG006|STARTED|Overall Study||3
10119370|NCT02553499|11250269|FG007|STARTED|Overall Study||3
10119371|NCT02553499|11250270|FG008|STARTED|Overall Study||3
10119372|NCT02553499|11250271|FG009|STARTED|Overall Study||3
10119373|NCT02553499|11250272|FG010|STARTED|Overall Study||3
10119374|NCT02553499|11250273|FG011|STARTED|Overall Study||3
10119375|NCT02553499|11250274|FG012|STARTED|Overall Study||3
10119376|NCT02553499|11250275|FG013|STARTED|Overall Study||2
10119377|NCT02553499|11250262|FG000|COMPLETED|Overall Study||0
10119378|NCT02553499|11250263|FG001|COMPLETED|Overall Study||0
10119379|NCT02553499|11250264|FG002|COMPLETED|Overall Study||0
10119380|NCT02553499|11250265|FG003|COMPLETED|Overall Study||0
10119381|NCT02553499|11250266|FG004|COMPLETED|Overall Study||0
10119382|NCT02553499|11250267|FG005|COMPLETED|Overall Study||0
10119383|NCT02553499|11250268|FG006|COMPLETED|Overall Study||0
10119384|NCT02553499|11250269|FG007|COMPLETED|Overall Study||0
10119385|NCT02553499|11250270|FG008|COMPLETED|Overall Study||0
10119386|NCT02553499|11250271|FG009|COMPLETED|Overall Study||0
10119387|NCT02553499|11250272|FG010|COMPLETED|Overall Study||0
10119388|NCT02553499|11250273|FG011|COMPLETED|Overall Study||0
10119389|NCT02553499|11250274|FG012|COMPLETED|Overall Study||0
10119390|NCT02553499|11250275|FG013|COMPLETED|Overall Study||0
10119391|NCT02553499|11250262|FG000|NOT COMPLETED|Overall Study||2
10119392|NCT02553499|11250263|FG001|NOT COMPLETED|Overall Study||2
10119393|NCT02553499|11250264|FG002|NOT COMPLETED|Overall Study||2
10119394|NCT02553499|11250265|FG003|NOT COMPLETED|Overall Study||2
10119395|NCT02553499|11250266|FG004|NOT COMPLETED|Overall Study||3
10119396|NCT02553499|11250267|FG005|NOT COMPLETED|Overall Study||3
10119397|NCT02553499|11250268|FG006|NOT COMPLETED|Overall Study||3
10119398|NCT02553499|11250269|FG007|NOT COMPLETED|Overall Study||3
10119399|NCT02553499|11250270|FG008|NOT COMPLETED|Overall Study||3
10119400|NCT02553499|11250271|FG009|NOT COMPLETED|Overall Study||3
10119401|NCT02553499|11250272|FG010|NOT COMPLETED|Overall Study||3
10119402|NCT02553499|11250273|FG011|NOT COMPLETED|Overall Study||3
10119403|NCT02553499|11250274|FG012|NOT COMPLETED|Overall Study||3
10119404|NCT02553499|11250275|FG013|NOT COMPLETED|Overall Study||2
10119405|NCT02553512|11250306|FG000|STARTED|Overall Study||167
10119406|NCT02553512|11250306|FG000|COMPLETED|Overall Study||144
10119407|NCT02553512|11250306|FG000|NOT COMPLETED|Overall Study||23
10119408|NCT02553538|11250312|FG000|STARTED|Overall Study||792
10119409|NCT02553538|11250313|FG001|STARTED|Overall Study||820
10119410|NCT02553538|11250312|FG000|COMPLETED|Overall Study||605
10119411|NCT02553538|11250313|FG001|COMPLETED|Overall Study||764
10055107|NCT02059291|11180072|FG021|COMPLETED|Epoch 4||14
10119412|NCT02553538|11250312|FG000|NOT COMPLETED|Overall Study||187
10119413|NCT02553538|11250313|FG001|NOT COMPLETED|Overall Study||56
10055108|NCT02059291|11180073|FG022|COMPLETED|Epoch 4||30
10055109|NCT02059291|11180074|FG023|COMPLETED|Epoch 4||21
10119414|NCT02553629|11250321|FG000|STARTED|Overall Study||53
10119415|NCT02553629|11250322|FG001|STARTED|Overall Study||56
10119416|NCT02553629|11250321|FG000|COMPLETED|Overall Study||50
10055110|NCT02059291|11180075|FG024|COMPLETED|Epoch 4||0
10055111|NCT02059291|11180051|FG000|NOT COMPLETED|Epoch 4||0
10055112|NCT02059291|11180052|FG001|NOT COMPLETED|Epoch 4||0
10119417|NCT02553629|11250322|FG001|COMPLETED|Overall Study||50
10119418|NCT02553629|11250321|FG000|NOT COMPLETED|Overall Study||3
10119419|NCT02553629|11250322|FG001|NOT COMPLETED|Overall Study||6
10055113|NCT02059291|11180053|FG002|NOT COMPLETED|Epoch 4||0
10055114|NCT02059291|11180054|FG003|NOT COMPLETED|Epoch 4||0
10055115|NCT02059291|11180055|FG004|NOT COMPLETED|Epoch 4||0
10055116|NCT02059291|11180056|FG005|NOT COMPLETED|Epoch 4||0
10055117|NCT02059291|11180057|FG006|NOT COMPLETED|Epoch 4||0
10055118|NCT02059291|11180058|FG007|NOT COMPLETED|Epoch 4||0
10055119|NCT02059291|11180059|FG008|NOT COMPLETED|Epoch 4||0
10055120|NCT02059291|11180060|FG009|NOT COMPLETED|Epoch 4||0
10055121|NCT02059291|11180061|FG010|NOT COMPLETED|Epoch 4||0
10055122|NCT02059291|11180062|FG011|NOT COMPLETED|Epoch 4||0
10055123|NCT02059291|11180063|FG012|NOT COMPLETED|Epoch 4||0
10055124|NCT02059291|11180064|FG013|NOT COMPLETED|Epoch 4||0
10055125|NCT02059291|11180065|FG014|NOT COMPLETED|Epoch 4||0
10055126|NCT02059291|11180066|FG015|NOT COMPLETED|Epoch 4||0
10055127|NCT02059291|11180067|FG016|NOT COMPLETED|Epoch 4||2
10055128|NCT02059291|11180068|FG017|NOT COMPLETED|Epoch 4||0
10055129|NCT02059291|11180069|FG018|NOT COMPLETED|Epoch 4||0
10055130|NCT02059291|11180070|FG019|NOT COMPLETED|Epoch 4||0
10055131|NCT02059291|11180071|FG020|NOT COMPLETED|Epoch 4||1
10055132|NCT02059291|11180072|FG021|NOT COMPLETED|Epoch 4||0
10055133|NCT02059291|11180073|FG022|NOT COMPLETED|Epoch 4||1
10055134|NCT02059291|11180074|FG023|NOT COMPLETED|Epoch 4||1
10055135|NCT02059291|11180075|FG024|NOT COMPLETED|Epoch 4||0
10055136|NCT02059395|11180105|FG000|STARTED|Overall Study||22
10055137|NCT02059395|11180106|FG001|STARTED|Overall Study||27
10055138|NCT02059395|11180105|FG000|COMPLETED|Overall Study||20
10055139|NCT02059395|11180106|FG001|COMPLETED|Overall Study||23
10055140|NCT02059395|11180105|FG000|NOT COMPLETED|Overall Study||2
10055141|NCT02059395|11180106|FG001|NOT COMPLETED|Overall Study||4
10055142|NCT02059408|11180115|FG000|STARTED|Overall Study||604
10055143|NCT02059408|11180116|FG001|STARTED|Overall Study||599
10055144|NCT02059408|11180117|FG002|STARTED|Overall Study||616
10055145|NCT02059408|11180115|FG000|COMPLETED|Overall Study||604
10055146|NCT02059408|11180116|FG001|COMPLETED|Overall Study||269
10055147|NCT02059408|11180117|FG002|COMPLETED|Overall Study||258
10055148|NCT02059408|11180115|FG000|NOT COMPLETED|Overall Study||0
10055149|NCT02059408|11180116|FG001|NOT COMPLETED|Overall Study||330
10055150|NCT02059408|11180117|FG002|NOT COMPLETED|Overall Study||358
10055151|NCT02059434|11180136|FG000|STARTED|Period 1 (After Screening/run-in Period)||2
10055152|NCT02059434|11180137|FG001|STARTED|Period 1 (After Screening/run-in Period)||2
10055153|NCT02059434|11180138|FG002|STARTED|Period 1 (After Screening/run-in Period)||2
10055154|NCT02059434|11180139|FG003|STARTED|Period 1 (After Screening/run-in Period)||2
10055155|NCT02059434|11180140|FG004|STARTED|Period 1 (After Screening/run-in Period)||2
10055156|NCT02059434|11180141|FG005|STARTED|Period 1 (After Screening/run-in Period)||2
10055157|NCT02059434|11180142|FG006|STARTED|Period 1 (After Screening/run-in Period)||2
10055158|NCT02059434|11180143|FG007|STARTED|Period 1 (After Screening/run-in Period)||3
10055159|NCT02059434|11180144|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055160|NCT02059434|11180136|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2
10055161|NCT02059434|11180137|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2
10055162|NCT02059434|11180138|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2
10055163|NCT02059434|11180139|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2
10055164|NCT02059434|11180140|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2
10055165|NCT02059434|11180141|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2
10055166|NCT02059434|11180142|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2
10055167|NCT02059434|11180143|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3
10055168|NCT02059434|11180144|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055169|NCT02059434|11180136|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055170|NCT02059434|11180137|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055171|NCT02059434|11180138|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055172|NCT02059434|11180139|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055173|NCT02059434|11180140|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055174|NCT02059434|11180141|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055175|NCT02059434|11180142|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055176|NCT02059434|11180143|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055177|NCT02059434|11180144|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10055178|NCT02059434|11180136|FG000|STARTED|Washout Between Periods 1 and 2||2
10055179|NCT02059434|11180137|FG001|STARTED|Washout Between Periods 1 and 2||2
10055180|NCT02059434|11180138|FG002|STARTED|Washout Between Periods 1 and 2||2
10055181|NCT02059434|11180139|FG003|STARTED|Washout Between Periods 1 and 2||2
10055182|NCT02059434|11180140|FG004|STARTED|Washout Between Periods 1 and 2||2
10055183|NCT02059434|11180141|FG005|STARTED|Washout Between Periods 1 and 2||2
10055184|NCT02059434|11180142|FG006|STARTED|Washout Between Periods 1 and 2||2
10055185|NCT02059434|11180143|FG007|STARTED|Washout Between Periods 1 and 2||3
10055186|NCT02059434|11180144|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055187|NCT02059434|11180136|FG000|COMPLETED|Washout Between Periods 1 and 2||2
10055188|NCT02059434|11180137|FG001|COMPLETED|Washout Between Periods 1 and 2||2
10055189|NCT02059434|11180138|FG002|COMPLETED|Washout Between Periods 1 and 2||2
10055190|NCT02059434|11180139|FG003|COMPLETED|Washout Between Periods 1 and 2||2
10055191|NCT02059434|11180140|FG004|COMPLETED|Washout Between Periods 1 and 2||2
10055192|NCT02059434|11180141|FG005|COMPLETED|Washout Between Periods 1 and 2||2
10055193|NCT02059434|11180142|FG006|COMPLETED|Washout Between Periods 1 and 2||2
10055194|NCT02059434|11180143|FG007|COMPLETED|Washout Between Periods 1 and 2||2
10055195|NCT02059434|11180144|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055196|NCT02059434|11180136|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055197|NCT02059434|11180137|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055198|NCT02059434|11180138|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055199|NCT02059434|11180139|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055200|NCT02059434|11180140|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055201|NCT02059434|11180141|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055202|NCT02059434|11180142|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055203|NCT02059434|11180143|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1
10055204|NCT02059434|11180144|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0
10055205|NCT02059434|11180136|FG000|STARTED|Period 2||2
10055206|NCT02059434|11180137|FG001|STARTED|Period 2||2
10055207|NCT02059434|11180138|FG002|STARTED|Period 2||2
10055208|NCT02059434|11180139|FG003|STARTED|Period 2||2
10055209|NCT02059434|11180140|FG004|STARTED|Period 2||2
10055210|NCT02059434|11180141|FG005|STARTED|Period 2||2
10055211|NCT02059434|11180142|FG006|STARTED|Period 2||2
10055212|NCT02059434|11180143|FG007|STARTED|Period 2||2
10055213|NCT02059434|11180144|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055214|NCT02059434|11180136|FG000|COMPLETED|Period 2||2
10055215|NCT02059434|11180137|FG001|COMPLETED|Period 2||2
10055216|NCT02059434|11180138|FG002|COMPLETED|Period 2||2
10055217|NCT02059434|11180139|FG003|COMPLETED|Period 2||2
10119420|NCT02553746|11250330|FG000|STARTED|Overall Study||80
10119421|NCT02553746|11250331|FG001|STARTED|Overall Study||66
10119422|NCT02553746|11250330|FG000|COMPLETED|Overall Study||77
10119423|NCT02553746|11250331|FG001|COMPLETED|Overall Study||64
10119424|NCT02553746|11250330|FG000|NOT COMPLETED|Overall Study||3
10055218|NCT02059434|11180140|FG004|COMPLETED|Period 2||2
10055219|NCT02059434|11180141|FG005|COMPLETED|Period 2||2
10055220|NCT02059434|11180142|FG006|COMPLETED|Period 2||2
10055221|NCT02059434|11180143|FG007|COMPLETED|Period 2||2
10055222|NCT02059434|11180144|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055223|NCT02059434|11180136|FG000|NOT COMPLETED|Period 2||0
10055224|NCT02059434|11180137|FG001|NOT COMPLETED|Period 2||0
10055225|NCT02059434|11180138|FG002|NOT COMPLETED|Period 2||0
10055226|NCT02059434|11180139|FG003|NOT COMPLETED|Period 2||0
10055227|NCT02059434|11180140|FG004|NOT COMPLETED|Period 2||0
10055228|NCT02059434|11180141|FG005|NOT COMPLETED|Period 2||0
10055229|NCT02059434|11180142|FG006|NOT COMPLETED|Period 2||0
10055230|NCT02059434|11180143|FG007|NOT COMPLETED|Period 2||0
10055231|NCT02059434|11180144|FG008|NOT COMPLETED|Period 2||0
10055232|NCT02059434|11180136|FG000|STARTED|Washout Between Periods 2 and 3||2
10055233|NCT02059434|11180137|FG001|STARTED|Washout Between Periods 2 and 3||2
10055234|NCT02059434|11180138|FG002|STARTED|Washout Between Periods 2 and 3||2
10055235|NCT02059434|11180139|FG003|STARTED|Washout Between Periods 2 and 3||2
10055236|NCT02059434|11180140|FG004|STARTED|Washout Between Periods 2 and 3||2
10055237|NCT02059434|11180141|FG005|STARTED|Washout Between Periods 2 and 3||2
10055238|NCT02059434|11180142|FG006|STARTED|Washout Between Periods 2 and 3||2
10055239|NCT02059434|11180143|FG007|STARTED|Washout Between Periods 2 and 3||2
10055240|NCT02059434|11180144|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055241|NCT02059434|11180136|FG000|COMPLETED|Washout Between Periods 2 and 3||2
10055242|NCT02059434|11180137|FG001|COMPLETED|Washout Between Periods 2 and 3||2
10055243|NCT02059434|11180138|FG002|COMPLETED|Washout Between Periods 2 and 3||2
10055244|NCT02059434|11180139|FG003|COMPLETED|Washout Between Periods 2 and 3||2
10055245|NCT02059434|11180140|FG004|COMPLETED|Washout Between Periods 2 and 3||2
10055246|NCT02059434|11180141|FG005|COMPLETED|Washout Between Periods 2 and 3||2
10055247|NCT02059434|11180142|FG006|COMPLETED|Washout Between Periods 2 and 3||2
10055248|NCT02059434|11180143|FG007|COMPLETED|Washout Between Periods 2 and 3||2
10055249|NCT02059434|11180144|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055250|NCT02059434|11180136|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055251|NCT02059434|11180137|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055252|NCT02059434|11180138|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055253|NCT02059434|11180139|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055254|NCT02059434|11180140|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055255|NCT02059434|11180141|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055256|NCT02059434|11180142|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055257|NCT02059434|11180143|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055258|NCT02059434|11180144|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0
10055259|NCT02059434|11180136|FG000|STARTED|Period 3||2
10055260|NCT02059434|11180137|FG001|STARTED|Period 3||2
10055261|NCT02059434|11180138|FG002|STARTED|Period 3||2
10055262|NCT02059434|11180139|FG003|STARTED|Period 3||2
10055263|NCT02059434|11180140|FG004|STARTED|Period 3||2
10055264|NCT02059434|11180141|FG005|STARTED|Period 3||2
10055265|NCT02059434|11180142|FG006|STARTED|Period 3||2
10055266|NCT02059434|11180143|FG007|STARTED|Period 3||2
10055267|NCT02059434|11180144|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10119425|NCT02553746|11250331|FG001|NOT COMPLETED|Overall Study||2
10196174|NCT03358407|11324482|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196175|NCT03358407|11324483|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196176|NCT03358407|11324484|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10119426|NCT02553772|11250339|FG000|STARTED|Overall Study||120
10119427|NCT02553772|11250340|FG001|STARTED|Overall Study||122
10119428|NCT02553772|11250339|FG000|COMPLETED|Overall Study||114
10119429|NCT02553772|11250340|FG001|COMPLETED|Overall Study||116
10119430|NCT02553772|11250339|FG000|NOT COMPLETED|Overall Study||6
10119431|NCT02553772|11250340|FG001|NOT COMPLETED|Overall Study||6
10055268|NCT02059434|11180136|FG000|COMPLETED|Period 3||2
10055269|NCT02059434|11180137|FG001|COMPLETED|Period 3||2
9706649|NCT02513394|10805720|FG001|COMPLETED|Overall Study||2877
9706650|NCT02513394|10805719|FG000|NOT COMPLETED|Overall Study||12
9706651|NCT02513394|10805720|FG001|NOT COMPLETED|Overall Study||23
9729124|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
9729125|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
9729126|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 145 - 192||133
10119432|NCT02553798|11250346|FG000|STARTED|Overall Study||564
10119433|NCT02553798|11250346|FG000|COMPLETED|Overall Study||226
10119434|NCT02553798|11250346|FG000|NOT COMPLETED|Overall Study||338
10119435|NCT02553928|11250352|FG000|STARTED|Overall Study||30
10119436|NCT02553928|11250353|FG001|STARTED|Overall Study||32
10119437|NCT02553928|11250352|FG000|COMPLETED|Overall Study||28
10119438|NCT02553928|11250353|FG001|COMPLETED|Overall Study||29
10119439|NCT02553928|11250352|FG000|NOT COMPLETED|Overall Study||2
10119440|NCT02553928|11250353|FG001|NOT COMPLETED|Overall Study||3
10119441|NCT02554019|11250363|FG000|STARTED|Overall Study||12
9729127|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 145 - 192||74
9729128|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123
9729129|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68
9729130|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
10055270|NCT02059434|11180138|FG002|COMPLETED|Period 3||2
10055271|NCT02059434|11180139|FG003|COMPLETED|Period 3||2
10055272|NCT02059434|11180140|FG004|COMPLETED|Period 3||2
10055273|NCT02059434|11180141|FG005|COMPLETED|Period 3||2
10055274|NCT02059434|11180142|FG006|COMPLETED|Period 3||2
10055275|NCT02059434|11180143|FG007|COMPLETED|Period 3||2
10055276|NCT02059434|11180144|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10055277|NCT02059434|11180136|FG000|NOT COMPLETED|Period 3||0
10055278|NCT02059434|11180137|FG001|NOT COMPLETED|Period 3||0
10055279|NCT02059434|11180138|FG002|NOT COMPLETED|Period 3||0
10055280|NCT02059434|11180139|FG003|NOT COMPLETED|Period 3||0
10055281|NCT02059434|11180140|FG004|NOT COMPLETED|Period 3||0
10055282|NCT02059434|11180141|FG005|NOT COMPLETED|Period 3||0
10055283|NCT02059434|11180142|FG006|NOT COMPLETED|Period 3||0
10055284|NCT02059434|11180143|FG007|NOT COMPLETED|Period 3||0
10055285|NCT02059434|11180144|FG008|NOT COMPLETED|Period 3||0
10055286|NCT02059434|11180136|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055287|NCT02059434|11180137|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055288|NCT02059434|11180138|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055289|NCT02059434|11180139|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055290|NCT02059434|11180140|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055291|NCT02059434|11180141|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055292|NCT02059434|11180142|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055293|NCT02059434|11180143|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055294|NCT02059434|11180144|FG008|STARTED|Period 4 (After Screening/run-in Period)||38
10055295|NCT02059434|11180136|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055296|NCT02059434|11180137|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055297|NCT02059434|11180138|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055298|NCT02059434|11180139|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055299|NCT02059434|11180140|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055300|NCT02059434|11180141|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10119442|NCT02554019|11250364|FG001|STARTED|Overall Study||12
10119443|NCT02554019|11250365|FG002|STARTED|Overall Study||12
10119444|NCT02554019|11250363|FG000|COMPLETED|Overall Study||10
10119445|NCT02554019|11250364|FG001|COMPLETED|Overall Study||12
10119446|NCT02554019|11250365|FG002|COMPLETED|Overall Study||10
10119447|NCT02554019|11250363|FG000|NOT COMPLETED|Overall Study||2
10119448|NCT02554019|11250364|FG001|NOT COMPLETED|Overall Study||0
10055301|NCT02059434|11180142|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055302|NCT02059434|11180143|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10055303|NCT02059434|11180144|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38
10055304|NCT02059434|11180136|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055305|NCT02059434|11180137|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055306|NCT02059434|11180138|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055307|NCT02059434|11180139|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055308|NCT02059434|11180140|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055309|NCT02059434|11180141|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055310|NCT02059434|11180142|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055311|NCT02059434|11180143|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055312|NCT02059434|11180144|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10055313|NCT02059434|11180136|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055314|NCT02059434|11180137|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055315|NCT02059434|11180138|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055316|NCT02059434|11180139|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055317|NCT02059434|11180140|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055318|NCT02059434|11180141|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10119449|NCT02554019|11250365|FG002|NOT COMPLETED|Overall Study||2
10119450|NCT02554279|11250375|FG000|STARTED|Overall Study||311
10119451|NCT02554279|11250376|FG001|STARTED|Overall Study||309
10119452|NCT02554279|11250375|FG000|Treated|Overall Study||310
10119453|NCT02554279|11250376|FG001|Treated|Overall Study||309
10119454|NCT02554279|11250375|FG000|Completed Day 6 of Stimulation|Overall Study||308
10119455|NCT02554279|11250376|FG001|Completed Day 6 of Stimulation|Overall Study||309
10119456|NCT02554279|11250375|FG000|Received Trigger|Overall Study||293
10119457|NCT02554279|11250376|FG001|Received Trigger|Overall Study||307
10119458|NCT02554279|11250375|FG000|Completed Oocyte Retrieval|Overall Study||292
10119459|NCT02554279|11250376|FG001|Completed Oocyte Retrieval|Overall Study||306
10119460|NCT02554279|11250375|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201
10119461|NCT02554279|11250376|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191
10119462|NCT02554279|11250375|FG000|COMPLETED|Overall Study||279
10119463|NCT02554279|11250376|FG001|COMPLETED|Overall Study||291
10119464|NCT02554279|11250375|FG000|NOT COMPLETED|Overall Study||32
10119465|NCT02554279|11250376|FG001|NOT COMPLETED|Overall Study||18
10119466|NCT02554435|11250391|FG000|STARTED|Overall Study||20
10119467|NCT02554435|11250392|FG001|STARTED|Overall Study||20
10119468|NCT02554435|11250391|FG000|COMPLETED|Overall Study||14
10119469|NCT02554435|11250392|FG001|COMPLETED|Overall Study||19
10119470|NCT02554435|11250391|FG000|NOT COMPLETED|Overall Study||6
10119471|NCT02554435|11250392|FG001|NOT COMPLETED|Overall Study||1
10119472|NCT02554513|11250399|FG000|STARTED|First Treatment Phase (7 Weeks)||3
10119473|NCT02554513|11250400|FG001|STARTED|First Treatment Phase (7 Weeks)||3
10119474|NCT02554513|11250399|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3
10119475|NCT02554513|11250400|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2
10119476|NCT02554513|11250399|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
10119477|NCT02554513|11250400|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1
10119478|NCT02554513|11250399|FG000|STARTED|Washout (2 Weeks)||3
10119479|NCT02554513|11250400|FG001|STARTED|Washout (2 Weeks)||2
10119480|NCT02554513|11250399|FG000|COMPLETED|Washout (2 Weeks)||3
10119481|NCT02554513|11250400|FG001|COMPLETED|Washout (2 Weeks)||2
10119482|NCT02554513|11250399|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10119483|NCT02554513|11250400|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10119484|NCT02554513|11250399|FG000|STARTED|Second Treatment Phase (7 Weeks)||3
10119485|NCT02554513|11250400|FG001|STARTED|Second Treatment Phase (7 Weeks)||2
10119486|NCT02554513|11250399|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3
10119487|NCT02554513|11250400|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2
10119488|NCT02554513|11250399|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
10119489|NCT02554513|11250400|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
10119490|NCT02554656|11250412|FG000|STARTED|Overall Study||89
10119491|NCT02554656|11250412|FG000|COMPLETED|Overall Study||86
10119492|NCT02554656|11250412|FG000|NOT COMPLETED|Overall Study||3
10119493|NCT02554682|11250426|FG000|STARTED|Overall Study||40
10119494|NCT02554682|11250427|FG001|STARTED|Overall Study||40
10119495|NCT02554682|11250428|FG002|STARTED|Overall Study||40
10119496|NCT02554682|11250429|FG003|STARTED|Overall Study||40
10119497|NCT02554682|11250430|FG004|STARTED|Overall Study||40
10119498|NCT02554682|11250431|FG005|STARTED|Overall Study||40
10119499|NCT02554682|11250432|FG006|STARTED|Overall Study||28
10119500|NCT02554682|11250433|FG007|STARTED|Overall Study||28
10119501|NCT02554682|11250434|FG008|STARTED|Overall Study||26
10119502|NCT02554682|11250435|FG009|STARTED|Overall Study||26
10119503|NCT02554682|11250426|FG000|COMPLETED|Overall Study||25
10119504|NCT02554682|11250427|FG001|COMPLETED|Overall Study||28
10119505|NCT02554682|11250428|FG002|COMPLETED|Overall Study||36
10119506|NCT02554682|11250429|FG003|COMPLETED|Overall Study||37
10119507|NCT02554682|11250430|FG004|COMPLETED|Overall Study||38
10119508|NCT02554682|11250431|FG005|COMPLETED|Overall Study||39
10119509|NCT02554682|11250432|FG006|COMPLETED|Overall Study||22
10119510|NCT02554682|11250433|FG007|COMPLETED|Overall Study||22
10119511|NCT02554682|11250434|FG008|COMPLETED|Overall Study||24
10055319|NCT02059434|11180142|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10119512|NCT02554682|11250435|FG009|COMPLETED|Overall Study||24
10119513|NCT02554682|11250426|FG000|NOT COMPLETED|Overall Study||15
10119514|NCT02554682|11250427|FG001|NOT COMPLETED|Overall Study||12
10119515|NCT02554682|11250428|FG002|NOT COMPLETED|Overall Study||4
10119516|NCT02554682|11250429|FG003|NOT COMPLETED|Overall Study||3
10055320|NCT02059434|11180143|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055321|NCT02059434|11180144|FG008|STARTED|Washout Between Periods 4 and 5||38
10055322|NCT02059434|11180136|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055323|NCT02059434|11180137|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055324|NCT02059434|11180138|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055325|NCT02059434|11180139|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055326|NCT02059434|11180140|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055327|NCT02059434|11180141|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055328|NCT02059434|11180142|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055329|NCT02059434|11180143|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10055330|NCT02059434|11180144|FG008|COMPLETED|Washout Between Periods 4 and 5||37
10055331|NCT02059434|11180136|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055332|NCT02059434|11180137|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055333|NCT02059434|11180138|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055334|NCT02059434|11180139|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055335|NCT02059434|11180140|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055336|NCT02059434|11180141|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055337|NCT02059434|11180142|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055338|NCT02059434|11180143|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0
10055339|NCT02059434|11180144|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1
10055340|NCT02059434|11180136|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055341|NCT02059434|11180137|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055342|NCT02059434|11180138|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055343|NCT02059434|11180139|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055344|NCT02059434|11180140|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055345|NCT02059434|11180141|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055346|NCT02059434|11180142|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055347|NCT02059434|11180143|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10055348|NCT02059434|11180144|FG008|STARTED|Period 5||37
10055349|NCT02059434|11180136|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055350|NCT02059434|11180137|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055351|NCT02059434|11180138|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055352|NCT02059434|11180139|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055353|NCT02059434|11180140|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055354|NCT02059434|11180141|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055355|NCT02059434|11180142|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055356|NCT02059434|11180143|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10055357|NCT02059434|11180144|FG008|COMPLETED|Period 5||37
10055358|NCT02059434|11180136|FG000|NOT COMPLETED|Period 5||0
10055359|NCT02059434|11180137|FG001|NOT COMPLETED|Period 5||0
10055360|NCT02059434|11180138|FG002|NOT COMPLETED|Period 5||0
10055361|NCT02059434|11180139|FG003|NOT COMPLETED|Period 5||0
10055362|NCT02059434|11180140|FG004|NOT COMPLETED|Period 5||0
10055363|NCT02059434|11180141|FG005|NOT COMPLETED|Period 5||0
10055364|NCT02059434|11180142|FG006|NOT COMPLETED|Period 5||0
10055365|NCT02059434|11180143|FG007|NOT COMPLETED|Period 5||0
10055366|NCT02059434|11180144|FG008|NOT COMPLETED|Period 5||0
10119517|NCT02554682|11250430|FG004|NOT COMPLETED|Overall Study||2
10119518|NCT02554682|11250431|FG005|NOT COMPLETED|Overall Study||1
10119519|NCT02554682|11250432|FG006|NOT COMPLETED|Overall Study||6
10119520|NCT02554682|11250433|FG007|NOT COMPLETED|Overall Study||6
10119521|NCT02554682|11250434|FG008|NOT COMPLETED|Overall Study||2
10119522|NCT02554682|11250435|FG009|NOT COMPLETED|Overall Study||2
10119523|NCT02554721|11250465|FG000|STARTED|Overall Study||20
10119524|NCT02554721|11250466|FG001|STARTED|Overall Study||19
10119525|NCT02554721|11250467|FG002|STARTED|Overall Study||19
10119526|NCT02554721|11250468|FG003|STARTED|Overall Study||17
10119527|NCT02554721|11250469|FG004|STARTED|Overall Study||2
10119528|NCT02554721|11250465|FG000|COMPLETED|Overall Study||19
10119529|NCT02554721|11250466|FG001|COMPLETED|Overall Study||19
10119530|NCT02554721|11250467|FG002|COMPLETED|Overall Study||19
10119531|NCT02554721|11250468|FG003|COMPLETED|Overall Study||17
10119532|NCT02554721|11250469|FG004|COMPLETED|Overall Study||0
10119533|NCT02554721|11250465|FG000|NOT COMPLETED|Overall Study||1
10119534|NCT02554721|11250466|FG001|NOT COMPLETED|Overall Study||0
10119535|NCT02554721|11250467|FG002|NOT COMPLETED|Overall Study||0
10119536|NCT02554721|11250468|FG003|NOT COMPLETED|Overall Study||0
10119537|NCT02554721|11250469|FG004|NOT COMPLETED|Overall Study||2
10119538|NCT02554760|11250478|FG000|STARTED|Overall Study||9
10119539|NCT02554760|11250479|FG001|STARTED|Overall Study||10
10119540|NCT02554760|11250478|FG000|COMPLETED|Overall Study||9
10055367|NCT02059434|11180136|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10119541|NCT02554760|11250479|FG001|COMPLETED|Overall Study||10
10119542|NCT02554760|11250478|FG000|NOT COMPLETED|Overall Study||0
10119543|NCT02554760|11250479|FG001|NOT COMPLETED|Overall Study||0
10119544|NCT02554786|11250493|FG000|STARTED|Overall Study||445
10119545|NCT02554786|11250494|FG001|STARTED|Overall Study||439
10119546|NCT02554786|11250495|FG002|STARTED|Overall Study||442
10119547|NCT02554786|11250496|FG003|STARTED|Overall Study||444
10119548|NCT02554786|11250497|FG004|STARTED|Overall Study||446
10119549|NCT02554786|11250493|FG000|COMPLETED|Overall Study||410
10119550|NCT02554786|11250494|FG001|COMPLETED|Overall Study||413
10119551|NCT02554786|11250495|FG002|COMPLETED|Overall Study||412
10119552|NCT02554786|11250496|FG003|COMPLETED|Overall Study||403
10119553|NCT02554786|11250497|FG004|COMPLETED|Overall Study||416
10119554|NCT02554786|11250493|FG000|NOT COMPLETED|Overall Study||35
10119555|NCT02554786|11250494|FG001|NOT COMPLETED|Overall Study||26
10119556|NCT02554786|11250495|FG002|NOT COMPLETED|Overall Study||30
10119557|NCT02554786|11250496|FG003|NOT COMPLETED|Overall Study||41
10119558|NCT02554786|11250497|FG004|NOT COMPLETED|Overall Study||30
10119559|NCT02554799|11250515|FG000|STARTED|Overall Study||9
10119560|NCT02554799|11250516|FG001|STARTED|Overall Study||9
10119561|NCT02554799|11250515|FG000|COMPLETED|Overall Study||9
10119562|NCT02554799|11250516|FG001|COMPLETED|Overall Study||9
10119563|NCT02554799|11250515|FG000|NOT COMPLETED|Overall Study||0
10119564|NCT02554799|11250516|FG001|NOT COMPLETED|Overall Study||0
10119565|NCT02554877|11250526|FG000|STARTED|Overall Study||51
10119566|NCT02554877|11250527|FG001|STARTED|Overall Study||51
10119567|NCT02554877|11250528|FG002|STARTED|Overall Study||52
10119568|NCT02554877|11250529|FG003|STARTED|Overall Study||52
10119569|NCT02554877|11250526|FG000|COMPLETED|Overall Study||39
10119570|NCT02554877|11250527|FG001|COMPLETED|Overall Study||44
10119571|NCT02554877|11250528|FG002|COMPLETED|Overall Study||46
10119572|NCT02554877|11250529|FG003|COMPLETED|Overall Study||45
10119573|NCT02554877|11250526|FG000|NOT COMPLETED|Overall Study||12
10119574|NCT02554877|11250527|FG001|NOT COMPLETED|Overall Study||7
10119575|NCT02554877|11250528|FG002|NOT COMPLETED|Overall Study||6
10119576|NCT02554877|11250529|FG003|NOT COMPLETED|Overall Study||7
10119577|NCT02554890|11250541|FG000|STARTED|Double-blind||444
10119578|NCT02554890|11250542|FG001|STARTED|Double-blind||443
10119579|NCT02554890|11250541|FG000|Treated Patients|Double-blind||436
10119580|NCT02554890|11250542|FG001|Treated Patients|Double-blind||439
10119581|NCT02554890|11250541|FG000|COMPLETED|Double-blind||348
10119582|NCT02554890|11250542|FG001|COMPLETED|Double-blind||352
10119583|NCT02554890|11250541|FG000|NOT COMPLETED|Double-blind||96
10119584|NCT02554890|11250542|FG001|NOT COMPLETED|Double-blind||91
10119585|NCT02554890|11250541|FG000|STARTED|Open-label||0
10119586|NCT02554890|11250542|FG001|STARTED|Open-label||887
10119587|NCT02554890|11250541|FG000|COMPLETED|Open-label||0
10119588|NCT02554890|11250542|FG001|COMPLETED|Open-label||835
10119589|NCT02554890|11250541|FG000|NOT COMPLETED|Open-label||0
10119590|NCT02554890|11250542|FG001|NOT COMPLETED|Open-label||52
10119591|NCT02554903|11250552|FG000|STARTED|Overall Study||28
10119592|NCT02554903|11250553|FG001|STARTED|Overall Study||29
10119593|NCT02554903|11250552|FG000|COMPLETED|Overall Study||24
10119594|NCT02554903|11250553|FG001|COMPLETED|Overall Study||24
10119595|NCT02554903|11250552|FG000|NOT COMPLETED|Overall Study||4
10119596|NCT02554903|11250553|FG001|NOT COMPLETED|Overall Study||5
10119597|NCT02554929|11250562|FG000|STARTED|Overall Study||46
10119598|NCT02554929|11250563|FG001|STARTED|Overall Study||44
10119599|NCT02554929|11250562|FG000|Per Protocol Received Intervention|Overall Study||44
10119600|NCT02554929|11250563|FG001|Per Protocol Received Intervention|Overall Study||36
10119601|NCT02554929|11250562|FG000|Per Protocol Post-Intervention|Overall Study||42
10055368|NCT02059434|11180137|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055369|NCT02059434|11180138|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055370|NCT02059434|11180139|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055371|NCT02059434|11180140|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055372|NCT02059434|11180141|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055373|NCT02059434|11180142|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055374|NCT02059434|11180143|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055375|NCT02059434|11180144|FG008|STARTED|Washout Between Periods 5 and 6||37
10055376|NCT02059434|11180136|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10119602|NCT02554929|11250563|FG001|Per Protocol Post-Intervention|Overall Study||36
10119603|NCT02554929|11250562|FG000|Per Protocol 6 Month Follow-up|Overall Study||40
10119604|NCT02554929|11250563|FG001|Per Protocol 6 Month Follow-up|Overall Study||32
10119605|NCT02554929|11250562|FG000|COMPLETED|Overall Study||40
10119606|NCT02554929|11250563|FG001|COMPLETED|Overall Study||32
10119607|NCT02554929|11250562|FG000|NOT COMPLETED|Overall Study||6
10119608|NCT02554929|11250563|FG001|NOT COMPLETED|Overall Study||12
10119609|NCT02554981|11250569|FG000|STARTED|Overall Study||51
10119610|NCT02554981|11250569|FG000|COMPLETED|Overall Study||46
10119611|NCT02554981|11250569|FG000|NOT COMPLETED|Overall Study||5
10119612|NCT02555098|11250573|FG000|STARTED|First Intervention||12
10119613|NCT02555098|11250574|FG001|STARTED|First Intervention||11
10119614|NCT02555098|11250573|FG000|COMPLETED|First Intervention||12
10119615|NCT02555098|11250574|FG001|COMPLETED|First Intervention||11
10119616|NCT02555098|11250573|FG000|NOT COMPLETED|First Intervention||0
10055377|NCT02059434|11180137|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055378|NCT02059434|11180138|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055379|NCT02059434|11180139|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055380|NCT02059434|11180140|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055381|NCT02059434|11180141|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055382|NCT02059434|11180142|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055383|NCT02059434|11180143|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10055384|NCT02059434|11180144|FG008|COMPLETED|Washout Between Periods 5 and 6||37
10055385|NCT02059434|11180136|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055386|NCT02059434|11180137|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055387|NCT02059434|11180138|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055388|NCT02059434|11180139|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055389|NCT02059434|11180140|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055390|NCT02059434|11180141|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055391|NCT02059434|11180142|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055392|NCT02059434|11180143|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055393|NCT02059434|11180144|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0
10055394|NCT02059434|11180136|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055395|NCT02059434|11180137|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055396|NCT02059434|11180138|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055397|NCT02059434|11180139|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055398|NCT02059434|11180140|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055399|NCT02059434|11180141|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055400|NCT02059434|11180142|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055401|NCT02059434|11180143|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10055402|NCT02059434|11180144|FG008|STARTED|Period 6||37
10055403|NCT02059434|11180136|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055404|NCT02059434|11180137|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055405|NCT02059434|11180138|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055406|NCT02059434|11180139|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055407|NCT02059434|11180140|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055408|NCT02059434|11180141|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055409|NCT02059434|11180142|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055410|NCT02059434|11180143|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10055411|NCT02059434|11180144|FG008|COMPLETED|Period 6||37
10055412|NCT02059434|11180136|FG000|NOT COMPLETED|Period 6||0
10055413|NCT02059434|11180137|FG001|NOT COMPLETED|Period 6||0
10055414|NCT02059434|11180138|FG002|NOT COMPLETED|Period 6||0
10055415|NCT02059434|11180139|FG003|NOT COMPLETED|Period 6||0
10055416|NCT02059434|11180140|FG004|NOT COMPLETED|Period 6||0
10055417|NCT02059434|11180141|FG005|NOT COMPLETED|Period 6||0
10055418|NCT02059434|11180142|FG006|NOT COMPLETED|Period 6||0
10055419|NCT02059434|11180143|FG007|NOT COMPLETED|Period 6||0
10055420|NCT02059434|11180144|FG008|NOT COMPLETED|Period 6||0
10055421|NCT02059434|11180136|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055422|NCT02059434|11180137|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055423|NCT02059434|11180138|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055424|NCT02059434|11180139|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055425|NCT02059434|11180140|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055426|NCT02059434|11180141|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055427|NCT02059434|11180142|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055428|NCT02059434|11180143|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055429|NCT02059434|11180144|FG008|STARTED|Washout Between Periods 6 and 7||37
10119617|NCT02555098|11250574|FG001|NOT COMPLETED|First Intervention||0
10119618|NCT02555098|11250573|FG000|STARTED|Second Intervention||12
10119619|NCT02555098|11250574|FG001|STARTED|Second Intervention||11
10119620|NCT02555098|11250573|FG000|COMPLETED|Second Intervention||12
10119621|NCT02555098|11250574|FG001|COMPLETED|Second Intervention||11
10119622|NCT02555098|11250573|FG000|NOT COMPLETED|Second Intervention||0
10119623|NCT02555098|11250574|FG001|NOT COMPLETED|Second Intervention||0
10119624|NCT02555215|11250584|FG000|STARTED|Overall Study||20
10119625|NCT02555215|11250584|FG000|COMPLETED|Overall Study||17
10119626|NCT02555215|11250584|FG000|NOT COMPLETED|Overall Study||3
10119627|NCT02555228|11250590|FG000|STARTED|Overall Study|20th August 2015|27
10119628|NCT02555228|11250591|FG001|STARTED|Overall Study|14th August 2015|27
10119629|NCT02555228|11250590|FG000|COMPLETED|Overall Study|19th November 2015|27
10119630|NCT02555228|11250591|FG001|COMPLETED|Overall Study|29th October 2015|27
10119631|NCT02555228|11250590|FG000|NOT COMPLETED|Overall Study||0
10119632|NCT02555228|11250591|FG001|NOT COMPLETED|Overall Study||0
10119633|NCT02555306|11250601|FG000|STARTED|Overall Study||3
10119634|NCT02555306|11250602|FG001|STARTED|Overall Study||3
10119635|NCT02555306|11250603|FG002|STARTED|Overall Study||3
10119636|NCT02555306|11250604|FG003|STARTED|Overall Study||3
10055430|NCT02059434|11180136|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055431|NCT02059434|11180137|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055432|NCT02059434|11180138|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055433|NCT02059434|11180139|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055434|NCT02059434|11180140|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055435|NCT02059434|11180141|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055436|NCT02059434|11180142|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055437|NCT02059434|11180143|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10055438|NCT02059434|11180144|FG008|COMPLETED|Washout Between Periods 6 and 7||36
10055439|NCT02059434|11180136|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055440|NCT02059434|11180137|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055441|NCT02059434|11180138|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055442|NCT02059434|11180139|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055443|NCT02059434|11180140|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055444|NCT02059434|11180141|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055445|NCT02059434|11180142|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055446|NCT02059434|11180143|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0
10055447|NCT02059434|11180144|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1
10055448|NCT02059434|11180136|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055449|NCT02059434|11180137|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055450|NCT02059434|11180138|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055451|NCT02059434|11180139|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055452|NCT02059434|11180140|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055453|NCT02059434|11180141|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055454|NCT02059434|11180142|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055455|NCT02059434|11180143|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10055456|NCT02059434|11180144|FG008|STARTED|Period 7||36
10055457|NCT02059434|11180136|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055458|NCT02059434|11180137|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055459|NCT02059434|11180138|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055460|NCT02059434|11180139|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055461|NCT02059434|11180140|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055462|NCT02059434|11180141|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055463|NCT02059434|11180142|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055464|NCT02059434|11180143|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10055465|NCT02059434|11180144|FG008|COMPLETED|Period 7||36
10055466|NCT02059434|11180136|FG000|NOT COMPLETED|Period 7||0
10055467|NCT02059434|11180137|FG001|NOT COMPLETED|Period 7||0
10055468|NCT02059434|11180138|FG002|NOT COMPLETED|Period 7||0
10055469|NCT02059434|11180139|FG003|NOT COMPLETED|Period 7||0
10055470|NCT02059434|11180140|FG004|NOT COMPLETED|Period 7||0
10055471|NCT02059434|11180141|FG005|NOT COMPLETED|Period 7||0
10055472|NCT02059434|11180142|FG006|NOT COMPLETED|Period 7||0
10055473|NCT02059434|11180143|FG007|NOT COMPLETED|Period 7||0
10055474|NCT02059434|11180144|FG008|NOT COMPLETED|Period 7||0
10055475|NCT02059434|11180136|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055476|NCT02059434|11180137|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055477|NCT02059434|11180138|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055478|NCT02059434|11180139|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055479|NCT02059434|11180140|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055480|NCT02059434|11180141|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055481|NCT02059434|11180142|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055482|NCT02059434|11180143|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055483|NCT02059434|11180144|FG008|STARTED|Washout Between Periods 7 and 8||36
10055484|NCT02059434|11180136|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055485|NCT02059434|11180137|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055486|NCT02059434|11180138|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055487|NCT02059434|11180139|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055488|NCT02059434|11180140|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055489|NCT02059434|11180141|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055490|NCT02059434|11180142|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055491|NCT02059434|11180143|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10055492|NCT02059434|11180144|FG008|COMPLETED|Washout Between Periods 7 and 8||34
10055493|NCT02059434|11180136|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055494|NCT02059434|11180137|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055495|NCT02059434|11180138|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055496|NCT02059434|11180139|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055497|NCT02059434|11180140|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055498|NCT02059434|11180141|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055499|NCT02059434|11180142|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055500|NCT02059434|11180143|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0
10055501|NCT02059434|11180144|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2
10055502|NCT02059434|11180136|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055503|NCT02059434|11180137|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055504|NCT02059434|11180138|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055505|NCT02059434|11180139|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055506|NCT02059434|11180140|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055507|NCT02059434|11180141|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055508|NCT02059434|11180142|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055509|NCT02059434|11180143|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10055510|NCT02059434|11180144|FG008|STARTED|Period 8||34
10055511|NCT02059434|11180136|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10119637|NCT02555306|11250601|FG000|COMPLETED|Overall Study||3
10119638|NCT02555306|11250602|FG001|COMPLETED|Overall Study||3
10119639|NCT02555306|11250603|FG002|COMPLETED|Overall Study||3
10119640|NCT02555306|11250604|FG003|COMPLETED|Overall Study||3
10119641|NCT02555306|11250601|FG000|NOT COMPLETED|Overall Study||0
10119642|NCT02555306|11250602|FG001|NOT COMPLETED|Overall Study||0
10119643|NCT02555306|11250603|FG002|NOT COMPLETED|Overall Study||0
10119644|NCT02555306|11250604|FG003|NOT COMPLETED|Overall Study||0
10119645|NCT02555371|11250614|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
10119646|NCT02555371|11250615|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119647|NCT02555371|11250616|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119648|NCT02555371|11250617|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119649|NCT02555371|11250618|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119650|NCT02555371|11250614|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
10119651|NCT02555371|11250615|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119652|NCT02555371|11250616|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119653|NCT02555371|11250617|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119654|NCT02555371|11250618|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119655|NCT02555371|11250614|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
10119656|NCT02555371|11250615|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119657|NCT02555371|11250616|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119658|NCT02555371|11250617|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119659|NCT02555371|11250618|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10119660|NCT02555371|11250614|FG000|STARTED|Part C (DB Period: Up to 52W)||0
10119661|NCT02555371|11250615|FG001|STARTED|Part C (DB Period: Up to 52W)||151
10119662|NCT02555371|11250616|FG002|STARTED|Part C (DB Period: Up to 52W)||144
10119663|NCT02555371|11250617|FG003|STARTED|Part C (DB Period: Up to 52W)||0
10119664|NCT02555371|11250618|FG004|STARTED|Part C (DB Period: Up to 52W)||0
10119665|NCT02555371|11250614|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0
10119666|NCT02555371|11250615|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62
10119667|NCT02555371|11250616|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96
10119668|NCT02555371|11250617|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0
10119669|NCT02555371|11250618|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0
10119670|NCT02555371|11250614|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
10119671|NCT02555371|11250615|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
10119672|NCT02555371|11250616|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
10119673|NCT02555371|11250617|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
10119674|NCT02555371|11250618|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
10119675|NCT02555371|11250614|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0
10119676|NCT02555371|11250615|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0
10119677|NCT02555371|11250616|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0
10119678|NCT02555371|11250617|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84
10119679|NCT02555371|11250618|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45
10119680|NCT02555371|11250614|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10119681|NCT02555371|11250615|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10119682|NCT02555371|11250616|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10119683|NCT02555371|11250617|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
10119684|NCT02555371|11250618|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
10119685|NCT02555371|11250614|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10119686|NCT02555371|11250615|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10119687|NCT02555371|11250616|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10119688|NCT02555371|11250617|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
10119689|NCT02555371|11250618|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
10119690|NCT02555449|11250627|FG000|STARTED|Overall Study||6
10119691|NCT02555449|11250627|FG000|COMPLETED|Overall Study||6
10119692|NCT02555449|11250627|FG000|NOT COMPLETED|Overall Study||0
10119693|NCT02555618|11250633|FG000|STARTED|Overall Study||200
10119694|NCT02555618|11250634|FG001|STARTED|Overall Study||200
10119695|NCT02555618|11250633|FG000|COMPLETED|Overall Study||199
10119696|NCT02555618|11250634|FG001|COMPLETED|Overall Study||200
10119697|NCT02555618|11250633|FG000|NOT COMPLETED|Overall Study||1
10119698|NCT02555618|11250634|FG001|NOT COMPLETED|Overall Study||0
10055512|NCT02059434|11180137|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10055513|NCT02059434|11180138|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10055514|NCT02059434|11180139|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10055515|NCT02059434|11180140|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10055516|NCT02059434|11180141|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10055517|NCT02059434|11180142|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10055518|NCT02059434|11180143|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10055519|NCT02059434|11180144|FG008|COMPLETED|Period 8||34
10055520|NCT02059434|11180136|FG000|NOT COMPLETED|Period 8||0
10055521|NCT02059434|11180137|FG001|NOT COMPLETED|Period 8||0
10055522|NCT02059434|11180138|FG002|NOT COMPLETED|Period 8||0
10055523|NCT02059434|11180139|FG003|NOT COMPLETED|Period 8||0
10055524|NCT02059434|11180140|FG004|NOT COMPLETED|Period 8||0
10055525|NCT02059434|11180141|FG005|NOT COMPLETED|Period 8||0
10055526|NCT02059434|11180142|FG006|NOT COMPLETED|Period 8||0
10055527|NCT02059434|11180143|FG007|NOT COMPLETED|Period 8||0
10055528|NCT02059434|11180144|FG008|NOT COMPLETED|Period 8||0
10055529|NCT02059512|11180175|FG000|STARTED|Overall Study||46
10055530|NCT02059512|11180176|FG001|STARTED|Overall Study||34
10055531|NCT02059512|11180177|FG002|STARTED|Overall Study||37
10055532|NCT02059512|11180175|FG000|COMPLETED|Overall Study||37
10055533|NCT02059512|11180176|FG001|COMPLETED|Overall Study||25
10055534|NCT02059512|11180177|FG002|COMPLETED|Overall Study||23
10055535|NCT02059512|11180175|FG000|NOT COMPLETED|Overall Study||9
10055536|NCT02059512|11180176|FG001|NOT COMPLETED|Overall Study||9
10119699|NCT02555631|11250640|FG000|STARTED|Overall Study||29
10119700|NCT02555631|11250640|FG000|COMPLETED|Overall Study||25
10119701|NCT02555631|11250640|FG000|NOT COMPLETED|Overall Study||4
10119702|NCT02555683|11250647|FG000|STARTED|Overall Study||301
10119703|NCT02555683|11250648|FG001|STARTED|Overall Study||295
10119704|NCT02555683|11250649|FG002|STARTED|Overall Study||298
10119705|NCT02555683|11250647|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
10119706|NCT02555683|11250648|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
10119707|NCT02555683|11250649|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
10119708|NCT02555683|11250647|FG000|FAS/SAF: Overall Population|Overall Study||299
10119709|NCT02555683|11250648|FG001|FAS/SAF: Overall Population|Overall Study||293
10119710|NCT02555683|11250649|FG002|FAS/SAF: Overall Population|Overall Study||298
10119711|NCT02555683|11250647|FG000|COMPLETED|Overall Study||282
10119712|NCT02555683|11250648|FG001|COMPLETED|Overall Study||278
10119713|NCT02555683|11250649|FG002|COMPLETED|Overall Study||269
10119714|NCT02555683|11250647|FG000|NOT COMPLETED|Overall Study||19
10119715|NCT02555683|11250648|FG001|NOT COMPLETED|Overall Study||17
10119716|NCT02555683|11250649|FG002|NOT COMPLETED|Overall Study||29
10119717|NCT02555722|11250659|FG000|STARTED|Lens Dispensed||60
10119718|NCT02555722|11250660|FG001|STARTED|Lens Dispensed||30
10119719|NCT02555722|11250659|FG000|COMPLETED|Lens Dispensed||60
10119720|NCT02555722|11250660|FG001|COMPLETED|Lens Dispensed||30
10119721|NCT02555722|11250659|FG000|NOT COMPLETED|Lens Dispensed||0
10119722|NCT02555722|11250660|FG001|NOT COMPLETED|Lens Dispensed||0
10119723|NCT02555722|11250659|FG000|STARTED|Week 1||60
10119724|NCT02555722|11250660|FG001|STARTED|Week 1||30
10119725|NCT02555722|11250659|FG000|COMPLETED|Week 1||60
10119726|NCT02555722|11250660|FG001|COMPLETED|Week 1||30
10119727|NCT02555722|11250659|FG000|NOT COMPLETED|Week 1||0
10119728|NCT02555722|11250660|FG001|NOT COMPLETED|Week 1||0
10119729|NCT02555722|11250659|FG000|STARTED|Week 2||60
10119730|NCT02555722|11250660|FG001|STARTED|Week 2||30
10119731|NCT02555722|11250659|FG000|COMPLETED|Week 2||59
10119732|NCT02555722|11250660|FG001|COMPLETED|Week 2||29
10119733|NCT02555722|11250659|FG000|NOT COMPLETED|Week 2||1
10119734|NCT02555722|11250660|FG001|NOT COMPLETED|Week 2||1
10119735|NCT02555722|11250659|FG000|STARTED|Month 1||59
10119736|NCT02555722|11250660|FG001|STARTED|Month 1||29
10119737|NCT02555722|11250659|FG000|COMPLETED|Month 1||58
10119738|NCT02555722|11250660|FG001|COMPLETED|Month 1||29
10119739|NCT02555722|11250659|FG000|NOT COMPLETED|Month 1||1
10119740|NCT02555722|11250660|FG001|NOT COMPLETED|Month 1||0
10119741|NCT02555722|11250659|FG000|STARTED|Month 2||58
10119742|NCT02555722|11250660|FG001|STARTED|Month 2||29
10119743|NCT02555722|11250659|FG000|COMPLETED|Month 2||54
10119744|NCT02555722|11250660|FG001|COMPLETED|Month 2||29
10119745|NCT02555722|11250659|FG000|NOT COMPLETED|Month 2||4
10119746|NCT02555722|11250660|FG001|NOT COMPLETED|Month 2||0
10119747|NCT02555722|11250659|FG000|STARTED|Month 3||54
10119748|NCT02555722|11250660|FG001|STARTED|Month 3||29
10119749|NCT02555722|11250659|FG000|COMPLETED|Month 3||54
10119750|NCT02555722|11250660|FG001|COMPLETED|Month 3||29
10119751|NCT02555722|11250659|FG000|NOT COMPLETED|Month 3||0
10055537|NCT02059512|11180177|FG002|NOT COMPLETED|Overall Study||14
10055538|NCT02059642|11180203|FG000|STARTED|Overall Study||148
10055539|NCT02059642|11180204|FG001|STARTED|Overall Study||152
10119752|NCT02555722|11250660|FG001|NOT COMPLETED|Month 3||0
10119753|NCT02555878|11250691|FG000|STARTED|Overall Study||421
10119754|NCT02555878|11250692|FG001|STARTED|Overall Study||420
10119755|NCT02555878|11250691|FG000|Treated|Overall Study||404
10119756|NCT02555878|11250692|FG001|Treated|Overall Study||405
10119757|NCT02555878|11250691|FG000|COMPLETED|Overall Study||255
10119758|NCT02555878|11250692|FG001|COMPLETED|Overall Study||270
10119759|NCT02555878|11250691|FG000|NOT COMPLETED|Overall Study||166
10119760|NCT02555878|11250692|FG001|NOT COMPLETED|Overall Study||150
10119761|NCT02555930|11250698|FG000|STARTED|Overall Study||148
10119762|NCT02555930|11250698|FG000|COMPLETED|Overall Study||148
10055540|NCT02059642|11180203|FG000|COMPLETED|Overall Study||121
10055541|NCT02059642|11180204|FG001|COMPLETED|Overall Study||128
10055542|NCT02059642|11180203|FG000|NOT COMPLETED|Overall Study||27
10055543|NCT02059642|11180204|FG001|NOT COMPLETED|Overall Study||24
10055544|NCT02059902|11180212|FG000|STARTED|Overall Study||18
10055545|NCT02059902|11180213|FG001|STARTED|Overall Study||18
10055546|NCT02059902|11180212|FG000|COMPLETED|Overall Study||14
10055547|NCT02059902|11180213|FG001|COMPLETED|Overall Study||14
10055548|NCT02059902|11180212|FG000|NOT COMPLETED|Overall Study||4
10055549|NCT02059902|11180213|FG001|NOT COMPLETED|Overall Study||4
10055550|NCT02059928|11180219|FG000|STARTED|Overall Study||20
10055551|NCT02059928|11180219|FG000|COMPLETED|Overall Study||20
10055552|NCT02059928|11180219|FG000|NOT COMPLETED|Overall Study||0
10055553|NCT02059980|11180225|FG000|STARTED|Overall Study||18
10055554|NCT02059980|11180226|FG001|STARTED|Overall Study||15
10055555|NCT02059980|11180225|FG000|COMPLETED|Overall Study||16
10119763|NCT02555930|11250698|FG000|NOT COMPLETED|Overall Study||0
10119764|NCT02556112|11250706|FG000|STARTED|Overall Study||40
10119765|NCT02556112|11250707|FG001|STARTED|Overall Study||40
10119766|NCT02556112|11250708|FG002|STARTED|Overall Study||42
10119767|NCT02556112|11250706|FG000|COMPLETED|Overall Study||30
10119768|NCT02556112|11250707|FG001|COMPLETED|Overall Study||23
10119769|NCT02556112|11250708|FG002|COMPLETED|Overall Study||30
10119770|NCT02556112|11250706|FG000|NOT COMPLETED|Overall Study||10
10119771|NCT02556112|11250707|FG001|NOT COMPLETED|Overall Study||17
10119772|NCT02556112|11250708|FG002|NOT COMPLETED|Overall Study||12
10119773|NCT02556138|11250717|FG000|STARTED|Overall Study||8
10119774|NCT02556138|11250717|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
10119775|NCT02556138|11250717|FG000|NOT COMPLETED|Overall Study||1
10119776|NCT02556177|11250723|FG000|STARTED|Overall Study||325
10119777|NCT02556177|11250724|FG001|STARTED|Overall Study||152
10119778|NCT02556177|11250723|FG000|COMPLETED|Overall Study||42
10119779|NCT02556177|11250724|FG001|COMPLETED|Overall Study||91
10119780|NCT02556177|11250723|FG000|NOT COMPLETED|Overall Study||283
10119781|NCT02556177|11250724|FG001|NOT COMPLETED|Overall Study||61
10119782|NCT02556203|11250732|FG000|STARTED|Overall Study||826
10119783|NCT02556203|11250733|FG001|STARTED|Overall Study||818
10119784|NCT02556203|11250732|FG000|Received Treatment|Overall Study||801
10119785|NCT02556203|11250733|FG001|Received Treatment|Overall Study||807
10119786|NCT02556203|11250732|FG000|COMPLETED|Overall Study||799
10119787|NCT02556203|11250733|FG001|COMPLETED|Overall Study||792
10119788|NCT02556203|11250732|FG000|NOT COMPLETED|Overall Study||27
10119789|NCT02556203|11250733|FG001|NOT COMPLETED|Overall Study||26
10119790|NCT02556255|11250739|FG000|STARTED|Overall Study||50
10119791|NCT02556255|11250739|FG000|COMPLETED|Overall Study||46
10119792|NCT02556255|11250739|FG000|NOT COMPLETED|Overall Study||4
10119793|NCT02556307|11250743|FG000|STARTED|Overall Study||270
10119794|NCT02556307|11250743|FG000|Treated|Overall Study||268
10119795|NCT02556307|11250743|FG000|COMPLETED|Overall Study||217
10119796|NCT02556307|11250743|FG000|NOT COMPLETED|Overall Study||53
10119797|NCT02556333|11250747|FG000|STARTED|Overall Study||1
10119798|NCT02556333|11250747|FG000|COMPLETED|Overall Study||1
10119799|NCT02556333|11250747|FG000|NOT COMPLETED|Overall Study||0
10119800|NCT02556554|11250754|FG000|STARTED|Overall Study||8
10119801|NCT02556554|11250755|FG001|STARTED|Overall Study||14
10119802|NCT02556554|11250756|FG002|STARTED|Overall Study||19
10119803|NCT02556554|11250757|FG003|STARTED|Overall Study||12
10119804|NCT02556554|11250758|FG004|STARTED|Overall Study||14
10119805|NCT02556554|11250754|FG000|COMPLETED|Overall Study||8
10119806|NCT02556554|11250755|FG001|COMPLETED|Overall Study||13
10119807|NCT02556554|11250756|FG002|COMPLETED|Overall Study||15
10119808|NCT02556554|11250757|FG003|COMPLETED|Overall Study||12
10119809|NCT02556554|11250758|FG004|COMPLETED|Overall Study||14
10119810|NCT02556554|11250754|FG000|NOT COMPLETED|Overall Study||0
10119811|NCT02556554|11250755|FG001|NOT COMPLETED|Overall Study||1
10119812|NCT02556554|11250756|FG002|NOT COMPLETED|Overall Study||4
10119813|NCT02556554|11250757|FG003|NOT COMPLETED|Overall Study||0
10119814|NCT02556554|11250758|FG004|NOT COMPLETED|Overall Study||0
10119815|NCT02556632|11250772|FG000|STARTED|Overall Study||64
10119816|NCT02556632|11250773|FG001|STARTED|Overall Study||65
10119817|NCT02556632|11250774|FG002|STARTED|Overall Study||62
10119818|NCT02556632|11250772|FG000|COMPLETED|Overall Study||59
10119819|NCT02556632|11250773|FG001|COMPLETED|Overall Study||59
10119820|NCT02556632|11250774|FG002|COMPLETED|Overall Study||53
10119821|NCT02556632|11250772|FG000|NOT COMPLETED|Overall Study||5
10119822|NCT02556632|11250773|FG001|NOT COMPLETED|Overall Study||6
10119823|NCT02556632|11250774|FG002|NOT COMPLETED|Overall Study||9
10119824|NCT02556775|11250786|FG000|STARTED|Overall Study||7
10119825|NCT02556775|11250787|FG001|STARTED|Overall Study||2
10055556|NCT02059980|11180226|FG001|COMPLETED|Overall Study||14
10055557|NCT02059980|11180225|FG000|NOT COMPLETED|Overall Study||2
10055558|NCT02059980|11180226|FG001|NOT COMPLETED|Overall Study||1
10055559|NCT02059993|11180234|FG000|STARTED|Overall Study||42
10119826|NCT02556775|11250788|FG002|STARTED|Overall Study||5
10119827|NCT02556775|11250789|FG003|STARTED|Overall Study||2
10119828|NCT02556775|11250786|FG000|COMPLETED|Overall Study||5
10055560|NCT02059993|11180235|FG001|STARTED|Overall Study||41
10119829|NCT02556775|11250787|FG001|COMPLETED|Overall Study||2
10119830|NCT02556775|11250788|FG002|COMPLETED|Overall Study||4
10119831|NCT02556775|11250789|FG003|COMPLETED|Overall Study||2
10119832|NCT02556775|11250786|FG000|NOT COMPLETED|Overall Study||2
10119833|NCT02556775|11250787|FG001|NOT COMPLETED|Overall Study||0
10055561|NCT02059993|11180234|FG000|COMPLETED|Overall Study||40
10055562|NCT02059993|11180235|FG001|COMPLETED|Overall Study||37
10055563|NCT02059993|11180234|FG000|NOT COMPLETED|Overall Study||2
10055564|NCT02059993|11180235|FG001|NOT COMPLETED|Overall Study||4
10119834|NCT02556775|11250788|FG002|NOT COMPLETED|Overall Study||1
10119835|NCT02556775|11250789|FG003|NOT COMPLETED|Overall Study||0
10119836|NCT02556788|11250803|FG000|STARTED|Overall Study||602
10119837|NCT02556788|11250804|FG001|STARTED|Overall Study||610
10055565|NCT02060058|11180244|FG000|STARTED|Overall Study||4
10055566|NCT02060058|11180245|FG001|STARTED|Overall Study||0
10055567|NCT02060058|11180246|FG002|STARTED|Overall Study||8
10055568|NCT02060058|11180244|FG000|COMPLETED|Overall Study||4
10055569|NCT02060058|11180245|FG001|COMPLETED|Overall Study||0
10055570|NCT02060058|11180246|FG002|COMPLETED|Overall Study||8
10055571|NCT02060058|11180244|FG000|NOT COMPLETED|Overall Study||0
10055572|NCT02060058|11180245|FG001|NOT COMPLETED|Overall Study||0
10055573|NCT02060058|11180246|FG002|NOT COMPLETED|Overall Study||0
10055574|NCT02060370|11180255|FG000|STARTED|Overall Study||60
10055575|NCT02060370|11180255|FG000|COMPLETED|Overall Study||59
10055576|NCT02060370|11180255|FG000|NOT COMPLETED|Overall Study||1
10055577|NCT02060383|11180264|FG000|STARTED|Core Phase||38
10055578|NCT02060383|11180265|FG001|STARTED|Core Phase||43
10055579|NCT02060383|11180266|FG002|STARTED|Core Phase||19
10055580|NCT02060383|11180267|FG003|STARTED|Core Phase||46
10055581|NCT02060383|11180268|FG004|STARTED|Core Phase||103
10055582|NCT02060383|11180264|FG000|Completed Core/Entered Extension|Core Phase||17
10055583|NCT02060383|11180265|FG001|Completed Core/Entered Extension|Core Phase||17
10055584|NCT02060383|11180266|FG002|Completed Core/Entered Extension|Core Phase||10
10055585|NCT02060383|11180267|FG003|Completed Core/Entered Extension|Core Phase||21
10055586|NCT02060383|11180268|FG004|Completed Core/Entered Extension|Core Phase||53
10055587|NCT02060383|11180264|FG000|Completed Core/Did Not Enter Extension|Core Phase||18
10055588|NCT02060383|11180265|FG001|Completed Core/Did Not Enter Extension|Core Phase||20
10055589|NCT02060383|11180266|FG002|Completed Core/Did Not Enter Extension|Core Phase||9
10055590|NCT02060383|11180267|FG003|Completed Core/Did Not Enter Extension|Core Phase||18
10055591|NCT02060383|11180268|FG004|Completed Core/Did Not Enter Extension|Core Phase||42
10055592|NCT02060383|11180264|FG000|COMPLETED|Core Phase||35
10055593|NCT02060383|11180265|FG001|COMPLETED|Core Phase||37
10055594|NCT02060383|11180266|FG002|COMPLETED|Core Phase||19
10055595|NCT02060383|11180267|FG003|COMPLETED|Core Phase||39
10055596|NCT02060383|11180268|FG004|COMPLETED|Core Phase||95
10055597|NCT02060383|11180264|FG000|NOT COMPLETED|Core Phase||3
10055598|NCT02060383|11180265|FG001|NOT COMPLETED|Core Phase||6
10055599|NCT02060383|11180266|FG002|NOT COMPLETED|Core Phase||0
10055600|NCT02060383|11180267|FG003|NOT COMPLETED|Core Phase||7
10055601|NCT02060383|11180268|FG004|NOT COMPLETED|Core Phase||8
10055602|NCT02060383|11180264|FG000|STARTED|Extension Phase||17
10055603|NCT02060383|11180265|FG001|STARTED|Extension Phase||17
10055604|NCT02060383|11180266|FG002|STARTED|Extension Phase||10
10055605|NCT02060383|11180267|FG003|STARTED|Extension Phase||21
10055606|NCT02060383|11180268|FG004|STARTED|Extension Phase||53
10055607|NCT02060383|11180264|FG000|COMPLETED|Extension Phase||14
10055608|NCT02060383|11180265|FG001|COMPLETED|Extension Phase||14
10055609|NCT02060383|11180266|FG002|COMPLETED|Extension Phase||7
10055610|NCT02060383|11180267|FG003|COMPLETED|Extension Phase||19
10055611|NCT02060383|11180268|FG004|COMPLETED|Extension Phase||46
10055612|NCT02060383|11180264|FG000|NOT COMPLETED|Extension Phase||3
10055613|NCT02060383|11180265|FG001|NOT COMPLETED|Extension Phase||3
10055614|NCT02060383|11180266|FG002|NOT COMPLETED|Extension Phase||3
10055615|NCT02060383|11180267|FG003|NOT COMPLETED|Extension Phase||2
10055616|NCT02060383|11180268|FG004|NOT COMPLETED|Extension Phase||7
10055617|NCT02060461|11180280|FG000|STARTED|Overall Study||33
10055618|NCT02060461|11180280|FG000|COMPLETED|Overall Study||33
10055619|NCT02060461|11180280|FG000|NOT COMPLETED|Overall Study||0
10055620|NCT02060526|11180289|FG000|STARTED|Overall Study||7
10055621|NCT02060526|11180290|FG001|STARTED|Overall Study||7
10055622|NCT02060526|11180291|FG002|STARTED|Overall Study||7
10055623|NCT02060526|11180289|FG000|COMPLETED|Overall Study||7
10055624|NCT02060526|11180290|FG001|COMPLETED|Overall Study||7
10055625|NCT02060526|11180291|FG002|COMPLETED|Overall Study||7
10055626|NCT02060526|11180289|FG000|NOT COMPLETED|Overall Study||0
10055627|NCT02060526|11180290|FG001|NOT COMPLETED|Overall Study||0
10055628|NCT02060526|11180291|FG002|NOT COMPLETED|Overall Study||0
10055629|NCT02060539|11180301|FG000|STARTED|Overall Study||19
10055630|NCT02060539|11180301|FG000|COMPLETED|Overall Study||19
10055631|NCT02060539|11180301|FG000|NOT COMPLETED|Overall Study||0
10055632|NCT02060838|11180307|FG000|STARTED|Overall Study||28
10055633|NCT02060838|11180308|FG001|STARTED|Overall Study||22
10119838|NCT02556788|11250803|FG000|COMPLETED|Overall Study||558
10055634|NCT02060838|11180307|FG000|COMPLETED|Overall Study||28
10055635|NCT02060838|11180308|FG001|COMPLETED|Overall Study||22
10055636|NCT02060838|11180307|FG000|NOT COMPLETED|Overall Study||0
10055637|NCT02060838|11180308|FG001|NOT COMPLETED|Overall Study||0
10055638|NCT02060890|11180314|FG000|STARTED|Overall Study||20
10055639|NCT02060890|11180314|FG000|COMPLETED|Overall Study||16
10055640|NCT02060890|11180314|FG000|NOT COMPLETED|Overall Study||4
10055641|NCT02060903|11180321|FG000|STARTED|Overall Study||187
10055642|NCT02060903|11180322|FG001|STARTED|Overall Study||192
10055643|NCT02060903|11180321|FG000|COMPLETED|Overall Study||183
10055644|NCT02060903|11180322|FG001|COMPLETED|Overall Study||185
10055645|NCT02060903|11180321|FG000|NOT COMPLETED|Overall Study||4
10055646|NCT02060903|11180322|FG001|NOT COMPLETED|Overall Study||7
10055647|NCT02061202|11180330|FG000|STARTED|Overall Study||36
10055648|NCT02061202|11180331|FG001|STARTED|Overall Study||18
10055649|NCT02061202|11180330|FG000|COMPLETED|Overall Study||35
10055650|NCT02061202|11180331|FG001|COMPLETED|Overall Study||17
10055651|NCT02061202|11180330|FG000|NOT COMPLETED|Overall Study||1
10055652|NCT02061202|11180331|FG001|NOT COMPLETED|Overall Study||1
10055653|NCT02061280|11180339|FG000|STARTED|Overall Study||71
10055654|NCT02061280|11180340|FG001|STARTED|Overall Study||37
10055655|NCT02061280|11180339|FG000|Randomized to Treatment|Overall Study||54
10055656|NCT02061280|11180340|FG001|Randomized to Treatment|Overall Study||25
10055657|NCT02061280|11180339|FG000|COMPLETED|Overall Study||53
10055658|NCT02061280|11180340|FG001|COMPLETED|Overall Study||25
10055659|NCT02061280|11180339|FG000|NOT COMPLETED|Overall Study||18
10055660|NCT02061280|11180340|FG001|NOT COMPLETED|Overall Study||12
10055661|NCT02061358|11180358|FG000|STARTED|Overall Study||6
10055662|NCT02061358|11180359|FG001|STARTED|Overall Study||6
10055663|NCT02061358|11180360|FG002|STARTED|Overall Study||6
10055664|NCT02061358|11180361|FG003|STARTED|Overall Study||6
10055665|NCT02061358|11180362|FG004|STARTED|Overall Study||6
10055666|NCT02061358|11180363|FG005|STARTED|Overall Study||6
10055667|NCT02061358|11180364|FG006|STARTED|Overall Study||6
10055668|NCT02061358|11180365|FG007|STARTED|Overall Study||6
10055669|NCT02061358|11180366|FG008|STARTED|Overall Study||16
10055670|NCT02061358|11180358|FG000|COMPLETED|Overall Study||6
10055671|NCT02061358|11180359|FG001|COMPLETED|Overall Study||6
10119839|NCT02556788|11250804|FG001|COMPLETED|Overall Study||573
10119840|NCT02556788|11250803|FG000|NOT COMPLETED|Overall Study||44
10119841|NCT02556788|11250804|FG001|NOT COMPLETED|Overall Study||37
10119842|NCT02556801|11250814|FG000|STARTED|Overall Study||42
10119843|NCT02556801|11250815|FG001|STARTED|Overall Study||42
10119844|NCT02556801|11250816|FG002|STARTED|Overall Study||42
10119845|NCT02556801|11250817|FG003|STARTED|Overall Study||42
10119846|NCT02556801|11250814|FG000|COMPLETED|Overall Study||40
10119847|NCT02556801|11250815|FG001|COMPLETED|Overall Study||35
10119848|NCT02556801|11250816|FG002|COMPLETED|Overall Study||38
10119849|NCT02556801|11250817|FG003|COMPLETED|Overall Study||37
10119850|NCT02556801|11250814|FG000|NOT COMPLETED|Overall Study||2
10119851|NCT02556801|11250815|FG001|NOT COMPLETED|Overall Study||7
10119852|NCT02556801|11250816|FG002|NOT COMPLETED|Overall Study||4
10119853|NCT02556801|11250817|FG003|NOT COMPLETED|Overall Study||5
10119854|NCT02556918|11250829|FG000|STARTED|Overall Study||100
10119855|NCT02556918|11250830|FG001|STARTED|Overall Study||101
10119856|NCT02556918|11250829|FG000|COMPLETED|Overall Study||91
10119857|NCT02556918|11250830|FG001|COMPLETED|Overall Study||91
10119858|NCT02556918|11250829|FG000|NOT COMPLETED|Overall Study||9
10119859|NCT02556918|11250830|FG001|NOT COMPLETED|Overall Study||10
10119860|NCT02557035|11250839|FG000|STARTED|Overall Study||225
10119861|NCT02557035|11250840|FG001|STARTED|Overall Study||215
10119862|NCT02557035|11250839|FG000|COMPLETED|Overall Study||218
10119863|NCT02557035|11250840|FG001|COMPLETED|Overall Study||206
10119864|NCT02557035|11250839|FG000|NOT COMPLETED|Overall Study||7
10119865|NCT02557035|11250840|FG001|NOT COMPLETED|Overall Study||9
10119866|NCT02557100|11250849|FG000|STARTED|Single Blind Treatment Period||40
10119867|NCT02557100|11250850|FG001|STARTED|Single Blind Treatment Period||40
10119868|NCT02557100|11250851|FG002|STARTED|Single Blind Treatment Period||0
10119869|NCT02557100|11250849|FG000|COMPLETED|Single Blind Treatment Period||40
10119870|NCT02557100|11250850|FG001|COMPLETED|Single Blind Treatment Period||36
10119871|NCT02557100|11250851|FG002|COMPLETED|Single Blind Treatment Period||0
10119872|NCT02557100|11250849|FG000|NOT COMPLETED|Single Blind Treatment Period||0
10119873|NCT02557100|11250850|FG001|NOT COMPLETED|Single Blind Treatment Period||4
10119874|NCT02557100|11250851|FG002|NOT COMPLETED|Single Blind Treatment Period||0
10119875|NCT02557100|11250849|FG000|STARTED|Transition to Open Label||40
10119876|NCT02557100|11250850|FG001|STARTED|Transition to Open Label||36
10119877|NCT02557100|11250851|FG002|STARTED|Transition to Open Label||0
10119878|NCT02557100|11250849|FG000|COMPLETED|Transition to Open Label||0
10119879|NCT02557100|11250850|FG001|COMPLETED|Transition to Open Label||0
10119880|NCT02557100|11250851|FG002|COMPLETED|Transition to Open Label||0
10119881|NCT02557100|11250849|FG000|NOT COMPLETED|Transition to Open Label||40
10119882|NCT02557100|11250850|FG001|NOT COMPLETED|Transition to Open Label||36
10119883|NCT02557100|11250851|FG002|NOT COMPLETED|Transition to Open Label||0
10119884|NCT02557100|11250849|FG000|STARTED|Cumulative Abatacept Period||0
10119885|NCT02557100|11250850|FG001|STARTED|Cumulative Abatacept Period||0
10119886|NCT02557100|11250851|FG002|STARTED|Cumulative Abatacept Period||76
10119887|NCT02557100|11250849|FG000|COMPLETED|Cumulative Abatacept Period||0
10119888|NCT02557100|11250850|FG001|COMPLETED|Cumulative Abatacept Period||0
10119889|NCT02557100|11250851|FG002|COMPLETED|Cumulative Abatacept Period||72
10119890|NCT02557100|11250849|FG000|NOT COMPLETED|Cumulative Abatacept Period||0
10119891|NCT02557100|11250850|FG001|NOT COMPLETED|Cumulative Abatacept Period||0
10055672|NCT02061358|11180360|FG002|COMPLETED|Overall Study||6
10055673|NCT02061358|11180361|FG003|COMPLETED|Overall Study||6
10055674|NCT02061358|11180362|FG004|COMPLETED|Overall Study||6
10055675|NCT02061358|11180363|FG005|COMPLETED|Overall Study||6
10055676|NCT02061358|11180364|FG006|COMPLETED|Overall Study||6
10055677|NCT02061358|11180365|FG007|COMPLETED|Overall Study||6
10055678|NCT02061358|11180366|FG008|COMPLETED|Overall Study||16
10055679|NCT02061358|11180358|FG000|NOT COMPLETED|Overall Study||0
10055680|NCT02061358|11180359|FG001|NOT COMPLETED|Overall Study||0
10055681|NCT02061358|11180360|FG002|NOT COMPLETED|Overall Study||0
10055682|NCT02061358|11180361|FG003|NOT COMPLETED|Overall Study||0
10055683|NCT02061358|11180362|FG004|NOT COMPLETED|Overall Study||0
10055684|NCT02061358|11180363|FG005|NOT COMPLETED|Overall Study||0
10055685|NCT02061358|11180364|FG006|NOT COMPLETED|Overall Study||0
10055686|NCT02061358|11180365|FG007|NOT COMPLETED|Overall Study||0
10055687|NCT02061358|11180366|FG008|NOT COMPLETED|Overall Study||0
10055688|NCT02061384|11180388|FG000|STARTED|Overall Study||10
10055689|NCT02061384|11180389|FG001|STARTED|Overall Study||10
10055690|NCT02061384|11180388|FG000|COMPLETED|Overall Study||10
10055691|NCT02061384|11180389|FG001|COMPLETED|Overall Study||10
10055692|NCT02061384|11180388|FG000|NOT COMPLETED|Overall Study||0
10055693|NCT02061384|11180389|FG001|NOT COMPLETED|Overall Study||0
10055694|NCT02061397|11180395|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
10055695|NCT02061397|11180395|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
10055696|NCT02061397|11180395|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
10055697|NCT02061397|11180395|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
10055698|NCT02061397|11180395|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
10055699|NCT02061397|11180395|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
10055700|NCT02061540|11180399|FG000|STARTED|Overall Study||27
10055701|NCT02061540|11180399|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5
10055702|NCT02061540|11180399|FG000|COMPLETED|Overall Study||23
10055703|NCT02061540|11180399|FG000|NOT COMPLETED|Overall Study||4
10055704|NCT02061592|11180410|FG000|STARTED|Period 1||66
10119892|NCT02557100|11250851|FG002|NOT COMPLETED|Cumulative Abatacept Period||4
10119893|NCT02557178|11250861|FG000|STARTED|Overall Study||72
10119894|NCT02557178|11250862|FG001|STARTED|Overall Study||74
10119895|NCT02557178|11250861|FG000|COMPLETED|Overall Study||56
10119896|NCT02557178|11250862|FG001|COMPLETED|Overall Study||63
10119897|NCT02557178|11250861|FG000|NOT COMPLETED|Overall Study||16
10119898|NCT02557178|11250862|FG001|NOT COMPLETED|Overall Study||11
10119899|NCT02557399|11250870|FG000|STARTED|Overall Study||172
10119900|NCT02557399|11250871|FG001|STARTED|Overall Study||177
10119901|NCT02557399|11250870|FG000|COMPLETED|Overall Study||165
10119902|NCT02557399|11250871|FG001|COMPLETED|Overall Study||169
10119903|NCT02557399|11250870|FG000|NOT COMPLETED|Overall Study||7
10119904|NCT02557399|11250871|FG001|NOT COMPLETED|Overall Study||8
10119905|NCT02557516|11250884|FG000|STARTED|Overall Study||3
10119906|NCT02557516|11250885|FG001|STARTED|Overall Study||6
10119907|NCT02557516|11250886|FG002|STARTED|Overall Study||4
10119908|NCT02557516|11250887|FG003|STARTED|Overall Study||9
10119909|NCT02557516|11250884|FG000|COMPLETED|Overall Study||2
10119910|NCT02557516|11250885|FG001|COMPLETED|Overall Study||1
10119911|NCT02557516|11250886|FG002|COMPLETED|Overall Study||0
10119912|NCT02557516|11250887|FG003|COMPLETED|Overall Study||0
10119913|NCT02557516|11250884|FG000|NOT COMPLETED|Overall Study||1
10119914|NCT02557516|11250885|FG001|NOT COMPLETED|Overall Study||5
10119915|NCT02557516|11250886|FG002|NOT COMPLETED|Overall Study||4
10119916|NCT02557516|11250887|FG003|NOT COMPLETED|Overall Study||9
10119917|NCT02557555|11250906|FG000|STARTED|Overall Study||100
10119918|NCT02557555|11250906|FG000|COMPLETED|Overall Study||100
10119919|NCT02557555|11250906|FG000|NOT COMPLETED|Overall Study||0
10119920|NCT02557646|11250911|FG000|STARTED|Overall Study||693
10119921|NCT02557646|11250911|FG000|COMPLETED|Overall Study||417
10119922|NCT02557646|11250911|FG000|NOT COMPLETED|Overall Study||276
10119923|NCT02557698|11250917|FG000|STARTED|Overall Study||30
10119924|NCT02557698|11250918|FG001|STARTED|Overall Study||30
10119925|NCT02557698|11250917|FG000|COMPLETED|Overall Study||30
10119926|NCT02557698|11250918|FG001|COMPLETED|Overall Study||30
10119927|NCT02557698|11250917|FG000|NOT COMPLETED|Overall Study||0
10119928|NCT02557698|11250918|FG001|NOT COMPLETED|Overall Study||0
10119929|NCT02558231|11250926|FG000|STARTED|Overall Study||123
10119930|NCT02558231|11250927|FG001|STARTED|Overall Study||124
10119931|NCT02558231|11250926|FG000|Treated|Overall Study||123
10119932|NCT02558231|11250927|FG001|Treated|Overall Study||123
10119933|NCT02558231|11250926|FG000|COMPLETED|Overall Study||98
10119934|NCT02558231|11250927|FG001|COMPLETED|Overall Study||98
10119935|NCT02558231|11250926|FG000|NOT COMPLETED|Overall Study||25
10119936|NCT02558231|11250927|FG001|NOT COMPLETED|Overall Study||26
10119937|NCT02558296|11250935|FG000|STARTED|Completed the Study Through Week 24||1133
10119938|NCT02558296|11250936|FG001|STARTED|Completed the Study Through Week 24||567
10119939|NCT02558296|11250935|FG000|COMPLETED|Completed the Study Through Week 24||1089
10119940|NCT02558296|11250936|FG001|COMPLETED|Completed the Study Through Week 24||542
10119941|NCT02558296|11250935|FG000|NOT COMPLETED|Completed the Study Through Week 24||44
10119942|NCT02558296|11250936|FG001|NOT COMPLETED|Completed the Study Through Week 24||25
10119943|NCT02558296|11250935|FG000|STARTED|Completed the Study||1133
10119944|NCT02558296|11250936|FG001|STARTED|Completed the Study||567
10119945|NCT02558296|11250935|FG000|COMPLETED|Completed the Study||987
10119946|NCT02558296|11250936|FG001|COMPLETED|Completed the Study||482
10119947|NCT02558296|11250935|FG000|NOT COMPLETED|Completed the Study||146
10119948|NCT02558296|11250936|FG001|NOT COMPLETED|Completed the Study||85
10119949|NCT02558374|11250948|FG000|STARTED|Overall Study||351
10119950|NCT02558374|11250949|FG001|STARTED|Overall Study||357
10119951|NCT02558374|11250948|FG000|COMPLETED|Overall Study||243
10119952|NCT02558374|11250949|FG001|COMPLETED|Overall Study||314
10119953|NCT02558374|11250948|FG000|NOT COMPLETED|Overall Study||108
10119954|NCT02558374|11250949|FG001|NOT COMPLETED|Overall Study||43
10119955|NCT02558400|11250958|FG000|STARTED|Overall Study||238
10119956|NCT02558400|11250959|FG001|STARTED|Overall Study||244
10119957|NCT02558400|11250960|FG002|STARTED|Overall Study||236
10119958|NCT02558400|11250958|FG000|COMPLETED|Overall Study||159
10119959|NCT02558400|11250959|FG001|COMPLETED|Overall Study||148
10055705|NCT02061592|11180411|FG001|STARTED|Period 1||62
10055706|NCT02061592|11180410|FG000|COMPLETED|Period 1||64
10055707|NCT02061592|11180411|FG001|COMPLETED|Period 1||62
10055708|NCT02061592|11180410|FG000|NOT COMPLETED|Period 1||2
10055709|NCT02061592|11180411|FG001|NOT COMPLETED|Period 1||0
10055710|NCT02061592|11180410|FG000|STARTED|Period 2||64
10055711|NCT02061592|11180411|FG001|STARTED|Period 2||62
10055712|NCT02061592|11180410|FG000|COMPLETED|Period 2||64
10055713|NCT02061592|11180411|FG001|COMPLETED|Period 2||61
10055714|NCT02061592|11180410|FG000|NOT COMPLETED|Period 2||0
10055715|NCT02061592|11180411|FG001|NOT COMPLETED|Period 2||1
10055716|NCT02061683|11180419|FG000|STARTED|Overall Study||263
10055717|NCT02061683|11180419|FG000|COMPLETED|Overall Study||203
10055718|NCT02061683|11180419|FG000|NOT COMPLETED|Overall Study||60
10055719|NCT02061696|11180425|FG000|STARTED|Overall Study||17
10055720|NCT02061696|11180426|FG001|STARTED|Overall Study||22
10055721|NCT02061696|11180425|FG000|COMPLETED|Overall Study||17
10055722|NCT02061696|11180426|FG001|COMPLETED|Overall Study||22
10055723|NCT02061696|11180425|FG000|NOT COMPLETED|Overall Study||0
10055724|NCT02061696|11180426|FG001|NOT COMPLETED|Overall Study||0
10055725|NCT02061748|11180434|FG000|STARTED|Overall Study||7646
10055726|NCT02061748|11180435|FG001|STARTED|Overall Study||30853
10055727|NCT02061748|11180434|FG000|COMPLETED|Overall Study||7646
10055728|NCT02061748|11180435|FG001|COMPLETED|Overall Study||30853
10055729|NCT02061748|11180434|FG000|NOT COMPLETED|Overall Study||0
10055730|NCT02061748|11180435|FG001|NOT COMPLETED|Overall Study||0
10119960|NCT02558400|11250960|FG002|COMPLETED|Overall Study||203
10119961|NCT02558400|11250958|FG000|NOT COMPLETED|Overall Study||79
10119962|NCT02558400|11250959|FG001|NOT COMPLETED|Overall Study||96
10055731|NCT02061774|11180443|FG000|STARTED|Overall Study||10
10055732|NCT02061774|11180444|FG001|STARTED|Overall Study||11
10055733|NCT02061774|11180443|FG000|COMPLETED|Overall Study||10
10055734|NCT02061774|11180444|FG001|COMPLETED|Overall Study||11
10055735|NCT02061774|11180443|FG000|NOT COMPLETED|Overall Study||0
10055736|NCT02061774|11180444|FG001|NOT COMPLETED|Overall Study||0
10055737|NCT02061813|11180450|FG000|STARTED|Overall Study||40
10055738|NCT02061813|11180450|FG000|Abametapir Lotion|Overall Study||40
10055739|NCT02061813|11180450|FG000|Vehicle Lotion|Overall Study||40
10055740|NCT02061813|11180450|FG000|Saline 0.9%|Overall Study||40
10055741|NCT02061813|11180450|FG000|SLS 0.2%|Overall Study||40
10055742|NCT02061813|11180450|FG000|COMPLETED|Overall Study||37
10055743|NCT02061813|11180450|FG000|NOT COMPLETED|Overall Study||3
10055744|NCT02061969|11180459|FG000|STARTED|Overall Study||73
10055745|NCT02061969|11180460|FG001|STARTED|Overall Study||67
10055746|NCT02061969|11180459|FG000|COMPLETED|Overall Study||73
10055747|NCT02061969|11180460|FG001|COMPLETED|Overall Study||67
10055748|NCT02061969|11180459|FG000|NOT COMPLETED|Overall Study||0
10055749|NCT02061969|11180460|FG001|NOT COMPLETED|Overall Study||0
10055750|NCT02062008|11180466|FG000|STARTED|Overall Study||2
10055751|NCT02062008|11180466|FG000|COMPLETED|Overall Study||2
10055752|NCT02062008|11180466|FG000|NOT COMPLETED|Overall Study||0
10055753|NCT02062151|11180470|FG000|STARTED|Overall Study||21
10055754|NCT02062151|11180470|FG000|COMPLETED|Overall Study||20
10055755|NCT02062151|11180470|FG000|NOT COMPLETED|Overall Study||1
10055756|NCT02062177|11180476|FG000|STARTED|Overall Study||70
10055757|NCT02062177|11180477|FG001|STARTED|Overall Study||70
10119963|NCT02558400|11250960|FG002|NOT COMPLETED|Overall Study||33
10119964|NCT02558790|11250971|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
10119965|NCT02558790|11250971|FG000|Treated|Overall Study||15
10119966|NCT02558790|11250971|FG000|COMPLETED|Overall Study||13
10119967|NCT02558790|11250971|FG000|NOT COMPLETED|Overall Study||7
10119968|NCT02558829|11250979|FG000|STARTED|Overall Study||21
10119969|NCT02558829|11250980|FG001|STARTED|Overall Study||21
10119970|NCT02558829|11250981|FG002|STARTED|Overall Study||24
10055758|NCT02062177|11180476|FG000|COMPLETED|Overall Study||70
10055759|NCT02062177|11180477|FG001|COMPLETED|Overall Study||70
10055760|NCT02062177|11180476|FG000|NOT COMPLETED|Overall Study||0
10055761|NCT02062177|11180477|FG001|NOT COMPLETED|Overall Study||0
10055762|NCT02062294|11180483|FG000|STARTED|Overall Study||14
10055763|NCT02062294|11180483|FG000|COMPLETED|Overall Study||14
10055764|NCT02062294|11180483|FG000|NOT COMPLETED|Overall Study||0
10055765|NCT02062359|11180487|FG000|STARTED|Overall Study||2
10055766|NCT02062359|11180487|FG000|COMPLETED|Overall Study||2
10055767|NCT02062359|11180487|FG000|NOT COMPLETED|Overall Study||0
10055768|NCT02062385|11180495|FG000|STARTED|Overall Study||1620
10119971|NCT02558829|11250982|FG003|STARTED|Overall Study||18
10055769|NCT02062385|11180496|FG001|STARTED|Overall Study||1620
10055770|NCT02062385|11180497|FG002|STARTED|Overall Study||400
10055771|NCT02062385|11180498|FG003|STARTED|Overall Study||400
10055772|NCT02062385|11180495|FG000|Received Vaccination 1|Overall Study||1618
10055773|NCT02062385|11180496|FG001|Received Vaccination 1|Overall Study||1619
10055774|NCT02062385|11180497|FG002|Received Vaccination 1|Overall Study||400
10055775|NCT02062385|11180498|FG003|Received Vaccination 1|Overall Study||400
10055776|NCT02062385|11180495|FG000|Received Vaccination 2|Overall Study||1554
10055777|NCT02062385|11180496|FG001|Received Vaccination 2|Overall Study||1566
10119972|NCT02558829|11250983|FG004|STARTED|Overall Study||18
10119973|NCT02558829|11250984|FG005|STARTED|Overall Study||26
10055778|NCT02062385|11180497|FG002|Received Vaccination 2|Overall Study||392
10055779|NCT02062385|11180498|FG003|Received Vaccination 2|Overall Study||393
10055780|NCT02062385|11180495|FG000|Received Vaccination 3|Overall Study||1543
10055781|NCT02062385|11180496|FG001|Received Vaccination 3|Overall Study||1554
10055782|NCT02062385|11180497|FG002|Received Vaccination 3|Overall Study||389
10055783|NCT02062385|11180498|FG003|Received Vaccination 3|Overall Study||392
10055784|NCT02062385|11180495|FG000|COMPLETED|Overall Study||1542
10055785|NCT02062385|11180496|FG001|COMPLETED|Overall Study||1555
10055786|NCT02062385|11180497|FG002|COMPLETED|Overall Study||388
10055787|NCT02062385|11180498|FG003|COMPLETED|Overall Study||391
10055788|NCT02062385|11180495|FG000|NOT COMPLETED|Overall Study||78
10055789|NCT02062385|11180496|FG001|NOT COMPLETED|Overall Study||65
10055790|NCT02062385|11180497|FG002|NOT COMPLETED|Overall Study||12
10055791|NCT02062385|11180498|FG003|NOT COMPLETED|Overall Study||9
10055792|NCT02062398|11180506|FG000|STARTED|Overall Study||13
10055793|NCT02062398|11180506|FG000|COMPLETED|Overall Study||12
10055794|NCT02062398|11180506|FG000|NOT COMPLETED|Overall Study||1
10055795|NCT02062437|11180510|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
10055796|NCT02062437|11180510|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
10055797|NCT02062437|11180510|FG000|NOT COMPLETED|Overall Study||52
10055798|NCT02062450|11180516|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
10055799|NCT02062450|11180516|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
10055800|NCT02062450|11180516|FG000|COMPLETED|Overall Study||255
10055801|NCT02062450|11180516|FG000|NOT COMPLETED|Overall Study||124
10055802|NCT02062502|11180526|FG000|STARTED|Overall Study||306
10055803|NCT02062502|11180527|FG001|STARTED|Overall Study||305
10055804|NCT02062502|11180526|FG000|Vaccinated Dose 1|Overall Study||306
10055805|NCT02062502|11180527|FG001|Vaccinated Dose 1|Overall Study||305
10055806|NCT02062502|11180526|FG000|COMPLETED|Overall Study||263
10055807|NCT02062502|11180527|FG001|COMPLETED|Overall Study||270
10055808|NCT02062502|11180526|FG000|NOT COMPLETED|Overall Study||43
10055809|NCT02062502|11180527|FG001|NOT COMPLETED|Overall Study||35
10055810|NCT02062580|11180535|FG000|STARTED|Overall Study||71
10055811|NCT02062580|11180536|FG001|STARTED|Overall Study||78
10055812|NCT02062580|11180535|FG000|COMPLETED|Overall Study||59
10055813|NCT02062580|11180536|FG001|COMPLETED|Overall Study||65
10055814|NCT02062580|11180535|FG000|NOT COMPLETED|Overall Study||12
10055815|NCT02062580|11180536|FG001|NOT COMPLETED|Overall Study||13
10055816|NCT02062593|11180544|FG000|STARTED|Overall Study||105
10055817|NCT02062593|11180545|FG001|STARTED|Overall Study||95
10055818|NCT02062593|11180544|FG000|COMPLETED|Overall Study||105
10055819|NCT02062593|11180545|FG001|COMPLETED|Overall Study||91
10055820|NCT02062593|11180544|FG000|NOT COMPLETED|Overall Study||0
10055821|NCT02062593|11180545|FG001|NOT COMPLETED|Overall Study||4
10055822|NCT02062606|11180551|FG000|STARTED|Overall Study||188
10055823|NCT02062606|11180551|FG000|COMPLETED|Overall Study||99
10055824|NCT02062606|11180551|FG000|NOT COMPLETED|Overall Study||89
10055825|NCT02062632|11180584|FG000|STARTED|Overall Study||3
10055826|NCT02062632|11180584|FG000|COMPLETED|Overall Study||2
10055827|NCT02062632|11180584|FG000|NOT COMPLETED|Overall Study||1
10055828|NCT02062645|11180588|FG000|STARTED|Overall Study||115
10055829|NCT02062645|11180588|FG000|COMPLETED|Overall Study||100
10055830|NCT02062645|11180588|FG000|NOT COMPLETED|Overall Study||15
10055831|NCT02062658|11180592|FG000|STARTED|Overall Study||10
10055832|NCT02062658|11180592|FG000|COMPLETED|Overall Study||8
10055833|NCT02062658|11180592|FG000|NOT COMPLETED|Overall Study||2
10055834|NCT02062710|11180596|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
10055835|NCT02062710|11180597|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
10055836|NCT02062710|11180598|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
10055837|NCT02062710|11180599|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
10055838|NCT02062710|11180600|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
10055839|NCT02062710|11180601|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
10055840|NCT02062710|11180596|FG000|COMPLETED|Overall Study||3
10055841|NCT02062710|11180597|FG001|COMPLETED|Overall Study||4
10055842|NCT02062710|11180598|FG002|COMPLETED|Overall Study||5
10055843|NCT02062710|11180599|FG003|COMPLETED|Overall Study||3
10055844|NCT02062710|11180600|FG004|COMPLETED|Overall Study||3
10055845|NCT02062710|11180601|FG005|COMPLETED|Overall Study||4
10055846|NCT02062710|11180596|FG000|NOT COMPLETED|Overall Study||0
10055847|NCT02062710|11180597|FG001|NOT COMPLETED|Overall Study||0
10055848|NCT02062710|11180598|FG002|NOT COMPLETED|Overall Study||0
10055849|NCT02062710|11180599|FG003|NOT COMPLETED|Overall Study||0
10055850|NCT02062710|11180600|FG004|NOT COMPLETED|Overall Study||0
10055851|NCT02062710|11180601|FG005|NOT COMPLETED|Overall Study||0
10119974|NCT02558829|11250985|FG006|STARTED|Overall Study||18
10119975|NCT02558829|11250986|FG007|STARTED|Overall Study||11
10119976|NCT02558829|11250979|FG000|COMPLETED|Overall Study||20
10119977|NCT02558829|11250980|FG001|COMPLETED|Overall Study||18
10119978|NCT02558829|11250981|FG002|COMPLETED|Overall Study||21
10119979|NCT02558829|11250982|FG003|COMPLETED|Overall Study||16
10119980|NCT02558829|11250983|FG004|COMPLETED|Overall Study||16
10119981|NCT02558829|11250984|FG005|COMPLETED|Overall Study||24
10119982|NCT02558829|11250985|FG006|COMPLETED|Overall Study||17
10119983|NCT02558829|11250986|FG007|COMPLETED|Overall Study||8
10119984|NCT02558829|11250979|FG000|NOT COMPLETED|Overall Study||1
10119985|NCT02558829|11250980|FG001|NOT COMPLETED|Overall Study||3
10119986|NCT02558829|11250981|FG002|NOT COMPLETED|Overall Study||3
10119987|NCT02558829|11250982|FG003|NOT COMPLETED|Overall Study||2
10119988|NCT02558829|11250983|FG004|NOT COMPLETED|Overall Study||2
10055852|NCT02062801|11180611|FG000|STARTED|Overall Study||301
10055853|NCT02062801|11180612|FG001|STARTED|Overall Study||301
10055854|NCT02062801|11180611|FG000|COMPLETED|Overall Study||299
10055855|NCT02062801|11180612|FG001|COMPLETED|Overall Study||297
10055856|NCT02062801|11180611|FG000|NOT COMPLETED|Overall Study||2
10055857|NCT02062801|11180612|FG001|NOT COMPLETED|Overall Study||4
10119989|NCT02558829|11250984|FG005|NOT COMPLETED|Overall Study||2
10119990|NCT02558829|11250985|FG006|NOT COMPLETED|Overall Study||1
10119991|NCT02558829|11250986|FG007|NOT COMPLETED|Overall Study||3
10119992|NCT02558894|11251010|FG000|STARTED|Overall Study||32
10119993|NCT02558894|11251011|FG001|STARTED|Overall Study||33
10119994|NCT02558894|11251010|FG000|Patients Who Received IP|Overall Study||32
10119995|NCT02558894|11251011|FG001|Patients Who Received IP|Overall Study||32
10119996|NCT02558894|11251010|FG000|COMPLETED|Overall Study||0
10119997|NCT02558894|11251011|FG001|COMPLETED|Overall Study||0
10119998|NCT02558894|11251010|FG000|NOT COMPLETED|Overall Study||32
10119999|NCT02558894|11251011|FG001|NOT COMPLETED|Overall Study||33
10120000|NCT02559115|11251017|FG000|STARTED|Overall Study||19
10120001|NCT02559115|11251017|FG000|COMPLETED|Overall Study||16
10120002|NCT02559115|11251017|FG000|NOT COMPLETED|Overall Study||3
10120003|NCT02559206|11251029|FG000|STARTED|Overall Study||66
10120004|NCT02559206|11251030|FG001|STARTED|Overall Study||66
10120005|NCT02559206|11251031|FG002|STARTED|Overall Study||67
10120006|NCT02559206|11251032|FG003|STARTED|Overall Study||67
10120007|NCT02559206|11251033|FG004|STARTED|Overall Study||67
10120008|NCT02559206|11251034|FG005|STARTED|Overall Study||67
10120009|NCT02559206|11251035|FG006|STARTED|Overall Study||66
10120010|NCT02559206|11251036|FG007|STARTED|Overall Study||66
10120011|NCT02559206|11251029|FG000|COMPLETED|Overall Study||58
10120012|NCT02559206|11251030|FG001|COMPLETED|Overall Study||54
10120013|NCT02559206|11251031|FG002|COMPLETED|Overall Study||58
10120014|NCT02559206|11251032|FG003|COMPLETED|Overall Study||53
10120015|NCT02559206|11251033|FG004|COMPLETED|Overall Study||55
10120016|NCT02559206|11251034|FG005|COMPLETED|Overall Study||53
10120017|NCT02559206|11251035|FG006|COMPLETED|Overall Study||60
10120018|NCT02559206|11251036|FG007|COMPLETED|Overall Study||57
10120019|NCT02559206|11251029|FG000|NOT COMPLETED|Overall Study||8
10120020|NCT02559206|11251030|FG001|NOT COMPLETED|Overall Study||12
10120021|NCT02559206|11251031|FG002|NOT COMPLETED|Overall Study||9
10120022|NCT02559206|11251032|FG003|NOT COMPLETED|Overall Study||14
10120023|NCT02559206|11251033|FG004|NOT COMPLETED|Overall Study||12
10120024|NCT02559206|11251034|FG005|NOT COMPLETED|Overall Study||14
10120025|NCT02559206|11251035|FG006|NOT COMPLETED|Overall Study||6
10120026|NCT02559206|11251036|FG007|NOT COMPLETED|Overall Study||9
10120027|NCT02559310|11251056|FG000|STARTED|Overall Study||276
10120028|NCT02559310|11251057|FG001|STARTED|Overall Study||275
10120029|NCT02559310|11251056|FG000|COMPLETED|Overall Study||249
10120030|NCT02559310|11251057|FG001|COMPLETED|Overall Study||256
10120031|NCT02559310|11251056|FG000|NOT COMPLETED|Overall Study||27
10120032|NCT02559310|11251057|FG001|NOT COMPLETED|Overall Study||19
10120033|NCT02559414|11251066|FG000|STARTED|Overall Study||11
10120034|NCT02559414|11251067|FG001|STARTED|Overall Study||22
10120035|NCT02559414|11251068|FG002|STARTED|Overall Study||22
10120036|NCT02559414|11251066|FG000|COMPLETED|Overall Study||10
10120037|NCT02559414|11251067|FG001|COMPLETED|Overall Study||20
10120038|NCT02559414|11251068|FG002|COMPLETED|Overall Study||20
10120039|NCT02559414|11251066|FG000|NOT COMPLETED|Overall Study||1
10120040|NCT02559414|11251067|FG001|NOT COMPLETED|Overall Study||2
10120041|NCT02559414|11251068|FG002|NOT COMPLETED|Overall Study||2
10120042|NCT02559505|11251093|FG000|STARTED|Overall Study||49
10120043|NCT02559505|11251094|FG001|STARTED|Overall Study||84
10120044|NCT02559505|11251093|FG000|COMPLETED|Overall Study||22
10120045|NCT02559505|11251094|FG001|COMPLETED|Overall Study||62
10120046|NCT02559505|11251093|FG000|NOT COMPLETED|Overall Study||27
10120047|NCT02559505|11251094|FG001|NOT COMPLETED|Overall Study||22
10120048|NCT02559570|11251117|FG000|STARTED|Overall Study||41
10120049|NCT02559570|11251118|FG001|STARTED|Overall Study||36
10120050|NCT02559570|11251119|FG002|STARTED|Overall Study||41
10120051|NCT02559570|11251120|FG003|STARTED|Overall Study||39
10120052|NCT02559570|11251121|FG004|STARTED|Overall Study||16
10120053|NCT02559570|11251117|FG000|COMPLETED|Overall Study||39
10120054|NCT02559570|11251118|FG001|COMPLETED|Overall Study||34
10120055|NCT02559570|11251119|FG002|COMPLETED|Overall Study||39
10120056|NCT02559570|11251120|FG003|COMPLETED|Overall Study||36
10120057|NCT02559570|11251121|FG004|COMPLETED|Overall Study||14
10120058|NCT02559570|11251117|FG000|NOT COMPLETED|Overall Study||2
10120059|NCT02559570|11251118|FG001|NOT COMPLETED|Overall Study||2
10120060|NCT02559570|11251119|FG002|NOT COMPLETED|Overall Study||2
10120061|NCT02559570|11251120|FG003|NOT COMPLETED|Overall Study||3
10120062|NCT02559570|11251121|FG004|NOT COMPLETED|Overall Study||2
10120063|NCT02559622|11251136|FG000|STARTED|Overall Study||48
10120064|NCT02559622|11251137|FG001|STARTED|Overall Study||54
10120065|NCT02559622|11251138|FG002|STARTED|Overall Study||26
10120066|NCT02559622|11251139|FG003|STARTED|Overall Study||23
10120067|NCT02559622|11251136|FG000|COMPLETED|Overall Study||47
10120068|NCT02559622|11251137|FG001|COMPLETED|Overall Study||49
10055858|NCT02062879|11180620|FG000|STARTED|Overall Study||10
10055859|NCT02062879|11180621|FG001|STARTED|Overall Study||10
10055860|NCT02062879|11180620|FG000|COMPLETED|Overall Study||6
10055861|NCT02062879|11180621|FG001|COMPLETED|Overall Study||9
10055862|NCT02062879|11180620|FG000|NOT COMPLETED|Overall Study||4
10055863|NCT02062879|11180621|FG001|NOT COMPLETED|Overall Study||1
10055864|NCT02062905|11180629|FG000|STARTED|Overall Study||35
10055865|NCT02062905|11180630|FG001|STARTED|Overall Study||33
10055866|NCT02062905|11180629|FG000|COMPLETED|Overall Study||28
10055867|NCT02062905|11180630|FG001|COMPLETED|Overall Study||31
10055868|NCT02062905|11180629|FG000|NOT COMPLETED|Overall Study||7
10055869|NCT02062905|11180630|FG001|NOT COMPLETED|Overall Study||2
10055870|NCT02063035|11180638|FG000|STARTED|Overall Study||12
10055871|NCT02063035|11180639|FG001|STARTED|Overall Study||17
10055872|NCT02063035|11180638|FG000|COMPLETED|Overall Study||12
10055873|NCT02063035|11180639|FG001|COMPLETED|Overall Study||17
10055874|NCT02063035|11180638|FG000|NOT COMPLETED|Overall Study||0
10055875|NCT02063035|11180639|FG001|NOT COMPLETED|Overall Study||0
10055876|NCT02063087|11180647|FG000|STARTED|Emergency Department Intervention||493
10055877|NCT02063087|11180648|FG001|STARTED|Emergency Department Intervention||478
10055878|NCT02063087|11180647|FG000|COMPLETED|Emergency Department Intervention||493
10055879|NCT02063087|11180648|FG001|COMPLETED|Emergency Department Intervention||478
10055880|NCT02063087|11180647|FG000|NOT COMPLETED|Emergency Department Intervention||0
10120069|NCT02559622|11251138|FG002|COMPLETED|Overall Study||24
10120070|NCT02559622|11251139|FG003|COMPLETED|Overall Study||20
10120071|NCT02559622|11251136|FG000|NOT COMPLETED|Overall Study||1
10120072|NCT02559622|11251137|FG001|NOT COMPLETED|Overall Study||5
10120073|NCT02559622|11251138|FG002|NOT COMPLETED|Overall Study||2
10120074|NCT02559622|11251139|FG003|NOT COMPLETED|Overall Study||3
10120075|NCT02559687|11251153|FG000|STARTED|Overall Study||121
10120076|NCT02559687|11251153|FG000|COMPLETED|Overall Study||0
10120077|NCT02559687|11251153|FG000|NOT COMPLETED|Overall Study||121
10120078|NCT02559713|11251157|FG000|STARTED|Overall Study||11
10120079|NCT02559713|11251157|FG000|Safety Set|Overall Study||11
10120080|NCT02559713|11251157|FG000|Pharmacokinetic Set|Overall Study||11
10120081|NCT02559713|11251157|FG000|COMPLETED|Overall Study||10
10120082|NCT02559713|11251157|FG000|NOT COMPLETED|Overall Study||1
10120083|NCT02559817|11251166|FG000|STARTED|Treatment Period||19
10120084|NCT02559817|11251167|FG001|STARTED|Treatment Period||29
10120085|NCT02559817|11251168|FG002|STARTED|Treatment Period||21
10120086|NCT02559817|11251169|FG003|STARTED|Treatment Period||24
10120087|NCT02559817|11251170|FG004|STARTED|Treatment Period||8
10120088|NCT02559817|11251166|FG000|COMPLETED|Treatment Period||18
10120089|NCT02559817|11251167|FG001|COMPLETED|Treatment Period||27
10120090|NCT02559817|11251168|FG002|COMPLETED|Treatment Period||19
10120091|NCT02559817|11251169|FG003|COMPLETED|Treatment Period||22
10120092|NCT02559817|11251170|FG004|COMPLETED|Treatment Period||8
10120093|NCT02559817|11251166|FG000|NOT COMPLETED|Treatment Period||1
10120094|NCT02559817|11251167|FG001|NOT COMPLETED|Treatment Period||2
10120095|NCT02559817|11251168|FG002|NOT COMPLETED|Treatment Period||2
10120096|NCT02559817|11251169|FG003|NOT COMPLETED|Treatment Period||2
10120097|NCT02559817|11251170|FG004|NOT COMPLETED|Treatment Period||0
10120098|NCT02559817|11251166|FG000|STARTED|Post-treatment Period||18
10120099|NCT02559817|11251167|FG001|STARTED|Post-treatment Period||27
10120100|NCT02559817|11251168|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
10120101|NCT02559817|11251169|FG003|STARTED|Post-treatment Period||22
10120102|NCT02559817|11251170|FG004|STARTED|Post-treatment Period||8
10120103|NCT02559817|11251166|FG000|COMPLETED|Post-treatment Period||18
10120104|NCT02559817|11251167|FG001|COMPLETED|Post-treatment Period||27
10120105|NCT02559817|11251168|FG002|COMPLETED|Post-treatment Period||20
10120106|NCT02559817|11251169|FG003|COMPLETED|Post-treatment Period||22
10120107|NCT02559817|11251170|FG004|COMPLETED|Post-treatment Period||8
10120108|NCT02559817|11251166|FG000|NOT COMPLETED|Post-treatment Period||0
10120109|NCT02559817|11251167|FG001|NOT COMPLETED|Post-treatment Period||0
10120110|NCT02559817|11251168|FG002|NOT COMPLETED|Post-treatment Period||0
10120111|NCT02559817|11251169|FG003|NOT COMPLETED|Post-treatment Period||0
10120112|NCT02559817|11251170|FG004|NOT COMPLETED|Post-treatment Period||0
10120113|NCT02559895|11251186|FG000|STARTED|Overall Study||224
10120114|NCT02559895|11251187|FG001|STARTED|Overall Study||225
10120115|NCT02559895|11251188|FG002|STARTED|Overall Study||224
10120116|NCT02559895|11251189|FG003|STARTED|Overall Study||225
10120117|NCT02559895|11251186|FG000|Participants Treated|Overall Study||222
10120118|NCT02559895|11251187|FG001|Participants Treated|Overall Study||221
10120119|NCT02559895|11251188|FG002|Participants Treated|Overall Study||223
10120120|NCT02559895|11251189|FG003|Participants Treated|Overall Study||222
10120121|NCT02559895|11251186|FG000|COMPLETED|Overall Study||169
10120122|NCT02559895|11251187|FG001|COMPLETED|Overall Study||172
10120123|NCT02559895|11251188|FG002|COMPLETED|Overall Study||170
10120124|NCT02559895|11251189|FG003|COMPLETED|Overall Study||165
10120125|NCT02559895|11251186|FG000|NOT COMPLETED|Overall Study||55
10120126|NCT02559895|11251187|FG001|NOT COMPLETED|Overall Study||53
10120127|NCT02559895|11251188|FG002|NOT COMPLETED|Overall Study||54
10120128|NCT02559895|11251189|FG003|NOT COMPLETED|Overall Study||60
10120129|NCT02560012|11251199|FG000|STARTED|Overall Study||3
10055881|NCT02063087|11180648|FG001|NOT COMPLETED|Emergency Department Intervention||0
10055882|NCT02063087|11180647|FG000|STARTED|7 Day Follow-up||493
10120130|NCT02560012|11251199|FG000|COMPLETED|Overall Study||1
10120131|NCT02560012|11251199|FG000|NOT COMPLETED|Overall Study||2
10055883|NCT02063087|11180648|FG001|STARTED|7 Day Follow-up||478
10055884|NCT02063087|11180647|FG000|COMPLETED|7 Day Follow-up||493
10055885|NCT02063087|11180648|FG001|COMPLETED|7 Day Follow-up||478
10055886|NCT02063087|11180647|FG000|NOT COMPLETED|7 Day Follow-up||0
10055887|NCT02063087|11180648|FG001|NOT COMPLETED|7 Day Follow-up||0
10055888|NCT02063178|11180656|FG000|STARTED|Overall Study||124
10055889|NCT02063178|11180657|FG001|STARTED|Overall Study||124
10055890|NCT02063178|11180656|FG000|COMPLETED|Overall Study||95
10055891|NCT02063178|11180657|FG001|COMPLETED|Overall Study||77
10055892|NCT02063178|11180656|FG000|NOT COMPLETED|Overall Study||29
10055893|NCT02063178|11180657|FG001|NOT COMPLETED|Overall Study||47
10055894|NCT02063217|11180670|FG000|STARTED|Overall Study||12
10055895|NCT02063217|11180671|FG001|STARTED|Overall Study||12
10055896|NCT02063217|11180672|FG002|STARTED|Overall Study||12
10055897|NCT02063217|11180670|FG000|COMPLETED|Overall Study||11
10055898|NCT02063217|11180671|FG001|COMPLETED|Overall Study||12
10055899|NCT02063217|11180672|FG002|COMPLETED|Overall Study||12
10055900|NCT02063217|11180670|FG000|NOT COMPLETED|Overall Study||1
10055901|NCT02063217|11180671|FG001|NOT COMPLETED|Overall Study||0
10055902|NCT02063217|11180672|FG002|NOT COMPLETED|Overall Study||0
10055903|NCT02063230|11180684|FG000|STARTED|Overall Study||8
10055904|NCT02063230|11180685|FG001|STARTED|Overall Study||8
10055905|NCT02063230|11180686|FG002|STARTED|Overall Study||8
10055906|NCT02063230|11180687|FG003|STARTED|Overall Study||8
10055907|NCT02063230|11180684|FG000|Received Treatment|Overall Study||8
10055908|NCT02063230|11180685|FG001|Received Treatment|Overall Study||8
10055909|NCT02063230|11180686|FG002|Received Treatment|Overall Study||8
10055910|NCT02063230|11180687|FG003|Received Treatment|Overall Study||8
10055911|NCT02063230|11180684|FG000|COMPLETED|Overall Study||8
10055912|NCT02063230|11180685|FG001|COMPLETED|Overall Study||8
10055913|NCT02063230|11180686|FG002|COMPLETED|Overall Study||8
10055914|NCT02063230|11180687|FG003|COMPLETED|Overall Study||8
10055915|NCT02063230|11180684|FG000|NOT COMPLETED|Overall Study||0
10055916|NCT02063230|11180685|FG001|NOT COMPLETED|Overall Study||0
10055917|NCT02063230|11180686|FG002|NOT COMPLETED|Overall Study||0
10055918|NCT02063230|11180687|FG003|NOT COMPLETED|Overall Study||0
10055919|NCT02063516|11180699|FG000|STARTED|Overall Study||40
10055920|NCT02063516|11180700|FG001|STARTED|Overall Study||40
10055921|NCT02063516|11180699|FG000|COMPLETED|Overall Study||40
10055922|NCT02063516|11180700|FG001|COMPLETED|Overall Study||40
10055923|NCT02063516|11180699|FG000|NOT COMPLETED|Overall Study||0
10055924|NCT02063516|11180700|FG001|NOT COMPLETED|Overall Study||0
10055925|NCT02063659|11180709|FG000|STARTED|Double-Blind Treatment Period||26
10055926|NCT02063659|11180710|FG001|STARTED|Double-Blind Treatment Period||25
10055927|NCT02063659|11180711|FG002|STARTED|Double-Blind Treatment Period||25
10055928|NCT02063659|11180712|FG003|STARTED|Double-Blind Treatment Period||0
10055929|NCT02063659|11180709|FG000|COMPLETED|Double-Blind Treatment Period||24
10055930|NCT02063659|11180710|FG001|COMPLETED|Double-Blind Treatment Period||22
10055931|NCT02063659|11180711|FG002|COMPLETED|Double-Blind Treatment Period||22
10055932|NCT02063659|11180712|FG003|COMPLETED|Double-Blind Treatment Period||0
10055933|NCT02063659|11180709|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
10055934|NCT02063659|11180710|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
10055935|NCT02063659|11180711|FG002|NOT COMPLETED|Double-Blind Treatment Period||3
10055936|NCT02063659|11180712|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
10055937|NCT02063659|11180709|FG000|STARTED|Open-Label Extension Period (OLE)||0
10055938|NCT02063659|11180710|FG001|STARTED|Open-Label Extension Period (OLE)||0
10055939|NCT02063659|11180711|FG002|STARTED|Open-Label Extension Period (OLE)||0
10055940|NCT02063659|11180712|FG003|STARTED|Open-Label Extension Period (OLE)||67
10055941|NCT02063659|11180709|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
10055942|NCT02063659|11180710|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
10055943|NCT02063659|11180711|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
10055944|NCT02063659|11180712|FG003|COMPLETED|Open-Label Extension Period (OLE)||47
10055945|NCT02063659|11180709|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10055946|NCT02063659|11180710|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10055947|NCT02063659|11180711|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10055948|NCT02063659|11180712|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20
10055949|NCT02063672|11180728|FG000|STARTED|Overall Study||53
10120132|NCT02560025|11251203|FG000|STARTED|Overall Study||42
10120133|NCT02560025|11251203|FG000|COMPLETED|Overall Study||39
10120134|NCT02560025|11251203|FG000|NOT COMPLETED|Overall Study||3
10120135|NCT02560038|11251207|FG000|STARTED|Overall Study||3
10120136|NCT02560038|11251207|FG000|COMPLETED|Overall Study||1
10120137|NCT02560038|11251207|FG000|NOT COMPLETED|Overall Study||2
10120138|NCT02560051|11251214|FG000|STARTED|Overall Study||6
10120139|NCT02560051|11251215|FG001|STARTED|Overall Study||8
10055950|NCT02063672|11180729|FG001|STARTED|Overall Study||29
10055951|NCT02063672|11180728|FG000|COMPLETED|Overall Study||18
10120140|NCT02560051|11251216|FG002|STARTED|Overall Study||5
10120141|NCT02560051|11251214|FG000|COMPLETED|Overall Study||3
10055952|NCT02063672|11180729|FG001|COMPLETED|Overall Study||7
10055953|NCT02063672|11180728|FG000|NOT COMPLETED|Overall Study||35
10055954|NCT02063672|11180729|FG001|NOT COMPLETED|Overall Study||22
10055955|NCT02063698|11180737|FG000|STARTED|Overall Study||15
10055956|NCT02063698|11180738|FG001|STARTED|Overall Study||15
10055957|NCT02063698|11180737|FG000|COMPLETED|Overall Study||14
10055958|NCT02063698|11180738|FG001|COMPLETED|Overall Study||13
10055959|NCT02063698|11180737|FG000|NOT COMPLETED|Overall Study||1
10120142|NCT02560051|11251215|FG001|COMPLETED|Overall Study||4
10120143|NCT02560051|11251216|FG002|COMPLETED|Overall Study||4
10055960|NCT02063698|11180738|FG001|NOT COMPLETED|Overall Study||2
10055961|NCT02063737|11180746|FG000|STARTED|Overall Study||52
10055962|NCT02063737|11180747|FG001|STARTED|Overall Study||48
10055963|NCT02063737|11180746|FG000|COMPLETED|Overall Study||41
10055964|NCT02063737|11180747|FG001|COMPLETED|Overall Study||44
10055965|NCT02063737|11180746|FG000|NOT COMPLETED|Overall Study||11
10055966|NCT02063737|11180747|FG001|NOT COMPLETED|Overall Study||4
10055967|NCT02063828|11180756|FG000|STARTED|Overall Study||14
10055968|NCT02063828|11180757|FG001|STARTED|Overall Study||14
10055969|NCT02063828|11180758|FG002|STARTED|Overall Study||18
10055970|NCT02063828|11180756|FG000|Week 6|Overall Study||11
10055971|NCT02063828|11180757|FG001|Week 6|Overall Study||9
10055972|NCT02063828|11180758|FG002|Week 6|Overall Study||14
10055973|NCT02063828|11180756|FG000|COMPLETED|Overall Study||10
10055974|NCT02063828|11180757|FG001|COMPLETED|Overall Study||8
10055975|NCT02063828|11180758|FG002|COMPLETED|Overall Study||14
10055976|NCT02063828|11180756|FG000|NOT COMPLETED|Overall Study||4
10055977|NCT02063828|11180757|FG001|NOT COMPLETED|Overall Study||6
10055978|NCT02063828|11180758|FG002|NOT COMPLETED|Overall Study||4
10055979|NCT02063854|11180773|FG000|STARTED|Overall Study||199
10055980|NCT02063854|11180774|FG001|STARTED|Overall Study||66
10055981|NCT02063854|11180775|FG002|STARTED|Overall Study||206
10055982|NCT02063854|11180776|FG003|STARTED|Overall Study||68
10055983|NCT02063854|11180777|FG004|STARTED|Overall Study||65
10055984|NCT02063854|11180778|FG005|STARTED|Overall Study||201
10055985|NCT02063854|11180779|FG006|STARTED|Overall Study||66
10055986|NCT02063854|11180773|FG000|Full Analysis Set: Received Study Drug|Overall Study||199
10055987|NCT02063854|11180774|FG001|Full Analysis Set: Received Study Drug|Overall Study||66
10055988|NCT02063854|11180775|FG002|Full Analysis Set: Received Study Drug|Overall Study||206
10055989|NCT02063854|11180776|FG003|Full Analysis Set: Received Study Drug|Overall Study||68
10055990|NCT02063854|11180777|FG004|Full Analysis Set: Received Study Drug|Overall Study||65
10055991|NCT02063854|11180778|FG005|Full Analysis Set: Received Study Drug|Overall Study||200
10055992|NCT02063854|11180779|FG006|Full Analysis Set: Received Study Drug|Overall Study||66
10055993|NCT02063854|11180773|FG000|COMPLETED|Overall Study||178
10055994|NCT02063854|11180774|FG001|COMPLETED|Overall Study||54
10055995|NCT02063854|11180775|FG002|COMPLETED|Overall Study||176
10055996|NCT02063854|11180776|FG003|COMPLETED|Overall Study||58
10055997|NCT02063854|11180777|FG004|COMPLETED|Overall Study||54
10055998|NCT02063854|11180778|FG005|COMPLETED|Overall Study||170
10055999|NCT02063854|11180779|FG006|COMPLETED|Overall Study||60
10120144|NCT02560051|11251214|FG000|NOT COMPLETED|Overall Study||3
10120145|NCT02560051|11251215|FG001|NOT COMPLETED|Overall Study||4
10120146|NCT02560051|11251216|FG002|NOT COMPLETED|Overall Study||1
10120147|NCT02560324|11251226|FG000|STARTED|Period 1 (2 Weeks)||35
10120148|NCT02560324|11251227|FG001|STARTED|Period 1 (2 Weeks)||34
10120149|NCT02560324|11251226|FG000|COMPLETED|Period 1 (2 Weeks)||23
10120150|NCT02560324|11251227|FG001|COMPLETED|Period 1 (2 Weeks)||25
10120151|NCT02560324|11251226|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12
10120152|NCT02560324|11251227|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9
10120153|NCT02560324|11251226|FG000|STARTED|Washout (2 Weeks)||23
10120154|NCT02560324|11251227|FG001|STARTED|Washout (2 Weeks)||25
10120155|NCT02560324|11251226|FG000|COMPLETED|Washout (2 Weeks)||23
10120156|NCT02560324|11251227|FG001|COMPLETED|Washout (2 Weeks)||23
10120157|NCT02560324|11251226|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10120158|NCT02560324|11251227|FG001|NOT COMPLETED|Washout (2 Weeks)||2
10120159|NCT02560324|11251226|FG000|STARTED|Period 2 (2 Weeks)||23
10120160|NCT02560324|11251227|FG001|STARTED|Period 2 (2 Weeks)||23
10120161|NCT02560324|11251226|FG000|COMPLETED|Period 2 (2 Weeks)||22
10120162|NCT02560324|11251227|FG001|COMPLETED|Period 2 (2 Weeks)||21
10120163|NCT02560324|11251226|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1
10120164|NCT02560324|11251227|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2
10120165|NCT02560389|11251240|FG000|STARTED|Overall Study||34
10120166|NCT02560389|11251241|FG001|STARTED|Overall Study||28
10120167|NCT02560389|11251242|FG002|STARTED|Overall Study||29
10120168|NCT02560389|11251240|FG000|COMPLETED|Overall Study||33
10120169|NCT02560389|11251241|FG001|COMPLETED|Overall Study||25
10120170|NCT02560389|11251242|FG002|COMPLETED|Overall Study||27
10120171|NCT02560389|11251240|FG000|NOT COMPLETED|Overall Study||1
10120172|NCT02560389|11251241|FG001|NOT COMPLETED|Overall Study||3
10120173|NCT02560389|11251242|FG002|NOT COMPLETED|Overall Study||2
10120174|NCT02560493|11251252|FG000|STARTED|Overall Study||23
10120175|NCT02560493|11251253|FG001|STARTED|Overall Study||23
10056000|NCT02063854|11180773|FG000|NOT COMPLETED|Overall Study||21
10056001|NCT02063854|11180774|FG001|NOT COMPLETED|Overall Study||12
10056002|NCT02063854|11180775|FG002|NOT COMPLETED|Overall Study||30
10120176|NCT02560493|11251252|FG000|COMPLETED|Overall Study||22
10056003|NCT02063854|11180776|FG003|NOT COMPLETED|Overall Study||10
10056004|NCT02063854|11180777|FG004|NOT COMPLETED|Overall Study||11
10120177|NCT02560493|11251253|FG001|COMPLETED|Overall Study||23
10120178|NCT02560493|11251252|FG000|NOT COMPLETED|Overall Study||1
10120179|NCT02560493|11251253|FG001|NOT COMPLETED|Overall Study||0
10120180|NCT02560558|11251261|FG000|STARTED|Overall Study||84
10120181|NCT02560558|11251262|FG001|STARTED|Overall Study||82
10120182|NCT02560558|11251261|FG000|COMPLETED|Overall Study||77
10120183|NCT02560558|11251262|FG001|COMPLETED|Overall Study||76
10120184|NCT02560558|11251261|FG000|NOT COMPLETED|Overall Study||7
10120185|NCT02560558|11251262|FG001|NOT COMPLETED|Overall Study||6
10056005|NCT02063854|11180778|FG005|NOT COMPLETED|Overall Study||31
10056006|NCT02063854|11180779|FG006|NOT COMPLETED|Overall Study||6
10056007|NCT02063867|11180799|FG000|STARTED|Overall Study||156889
10056008|NCT02063867|11180800|FG001|STARTED|Overall Study||183013
10056009|NCT02063867|11180799|FG000|COMPLETED|Overall Study||152598
10056010|NCT02063867|11180800|FG001|COMPLETED|Overall Study||180048
10056011|NCT02063867|11180799|FG000|NOT COMPLETED|Overall Study||4291
10056012|NCT02063867|11180800|FG001|NOT COMPLETED|Overall Study||2965
10056013|NCT02063880|11180808|FG000|STARTED|Overall Study||90
10056014|NCT02063880|11180809|FG001|STARTED|Overall Study||93
10056015|NCT02063880|11180808|FG000|COMPLETED|Overall Study||62
10056016|NCT02063880|11180809|FG001|COMPLETED|Overall Study||66
10056017|NCT02063880|11180808|FG000|NOT COMPLETED|Overall Study||28
10056018|NCT02063880|11180809|FG001|NOT COMPLETED|Overall Study||27
10056019|NCT02063984|11180817|FG000|STARTED|Overall Study||29
10056020|NCT02063984|11180818|FG001|STARTED|Overall Study||30
10056021|NCT02063984|11180817|FG000|COMPLETED|Overall Study||23
10056022|NCT02063984|11180818|FG001|COMPLETED|Overall Study||25
10056023|NCT02063984|11180817|FG000|NOT COMPLETED|Overall Study||6
10056024|NCT02063984|11180818|FG001|NOT COMPLETED|Overall Study||5
10056025|NCT02064166|11180830|FG000|STARTED|Overall Study||9
10056026|NCT02064166|11180831|FG001|STARTED|Overall Study||6
10056027|NCT02064166|11180830|FG000|COMPLETED|Overall Study||8
10056028|NCT02064166|11180831|FG001|COMPLETED|Overall Study||6
10056029|NCT02064166|11180830|FG000|NOT COMPLETED|Overall Study||1
10056030|NCT02064166|11180831|FG001|NOT COMPLETED|Overall Study||0
10056031|NCT02064205|11180859|FG000|STARTED|Overall Study||32
10056032|NCT02064205|11180859|FG000|Condition A|Overall Study||32
10056033|NCT02064205|11180859|FG000|Condition B|Overall Study||32
10056034|NCT02064205|11180859|FG000|Condition C|Overall Study||31
10056035|NCT02064205|11180859|FG000|Condition D|Overall Study||32
10056036|NCT02064205|11180859|FG000|COMPLETED|Overall Study||31
10056037|NCT02064205|11180859|FG000|NOT COMPLETED|Overall Study||1
10056038|NCT02064231|11180875|FG000|STARTED|First Test Period (Test A or Test C)||14
10056039|NCT02064231|11180876|FG001|STARTED|First Test Period (Test A or Test C)||12
10056040|NCT02064231|11180877|FG002|STARTED|First Test Period (Test A or Test C)||1
10056041|NCT02064231|11180878|FG003|STARTED|First Test Period (Test A or Test C)||1
10056042|NCT02064231|11180875|FG000|COMPLETED|First Test Period (Test A or Test C)||7
10056043|NCT02064231|11180876|FG001|COMPLETED|First Test Period (Test A or Test C)||8
10056044|NCT02064231|11180877|FG002|COMPLETED|First Test Period (Test A or Test C)||0
10056045|NCT02064231|11180878|FG003|COMPLETED|First Test Period (Test A or Test C)||1
10056046|NCT02064231|11180875|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7
10056047|NCT02064231|11180876|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4
10056048|NCT02064231|11180877|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1
10056049|NCT02064231|11180878|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0
10056050|NCT02064231|11180875|FG000|STARTED|Second Test Period (Test B or Test D)||7
10056051|NCT02064231|11180876|FG001|STARTED|Second Test Period (Test B or Test D)||8
10056052|NCT02064231|11180877|FG002|STARTED|Second Test Period (Test B or Test D)||0
10056053|NCT02064231|11180878|FG003|STARTED|Second Test Period (Test B or Test D)||1
10120186|NCT02560584|11251268|FG000|STARTED|Overall Study||304
10056054|NCT02064231|11180875|FG000|COMPLETED|Second Test Period (Test B or Test D)||6
10056055|NCT02064231|11180876|FG001|COMPLETED|Second Test Period (Test B or Test D)||7
10056056|NCT02064231|11180877|FG002|COMPLETED|Second Test Period (Test B or Test D)||0
10056057|NCT02064231|11180878|FG003|COMPLETED|Second Test Period (Test B or Test D)||1
10056058|NCT02064231|11180875|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1
10056059|NCT02064231|11180876|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1
10056060|NCT02064231|11180877|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0
10056061|NCT02064231|11180878|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0
10056062|NCT02064231|11180875|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
10056063|NCT02064231|11180876|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
10056064|NCT02064231|11180877|FG002|STARTED|Third Test Period (Own Product)||0
10056065|NCT02064231|11180878|FG003|STARTED|Third Test Period (Own Product)||1
10056066|NCT02064231|11180875|FG000|COMPLETED|Third Test Period (Own Product)||8
10056067|NCT02064231|11180876|FG001|COMPLETED|Third Test Period (Own Product)||8
10056068|NCT02064231|11180877|FG002|COMPLETED|Third Test Period (Own Product)||0
10056069|NCT02064231|11180878|FG003|COMPLETED|Third Test Period (Own Product)||1
10056070|NCT02064231|11180875|FG000|NOT COMPLETED|Third Test Period (Own Product)||0
10056071|NCT02064231|11180876|FG001|NOT COMPLETED|Third Test Period (Own Product)||0
10056072|NCT02064231|11180877|FG002|NOT COMPLETED|Third Test Period (Own Product)||0
10056073|NCT02064231|11180878|FG003|NOT COMPLETED|Third Test Period (Own Product)||0
10056074|NCT02064270|11180892|FG000|STARTED|Overall Study||263
10056075|NCT02064270|11180893|FG001|STARTED|Overall Study||263
10056076|NCT02064270|11180892|FG000|COMPLETED|Overall Study||201
10056077|NCT02064270|11180893|FG001|COMPLETED|Overall Study||231
10056078|NCT02064270|11180892|FG000|NOT COMPLETED|Overall Study||62
10056079|NCT02064270|11180893|FG001|NOT COMPLETED|Overall Study||32
10056080|NCT02064439|11180902|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
10056081|NCT02064439|11180903|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107
10056082|NCT02064439|11180904|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131
10056083|NCT02064439|11180902|FG000|COMPLETED|Overall Study||984
10056084|NCT02064439|11180903|FG001|COMPLETED|Overall Study||969
10056085|NCT02064439|11180904|FG002|COMPLETED|Overall Study||949
10056086|NCT02064439|11180902|FG000|NOT COMPLETED|Overall Study||143
10056087|NCT02064439|11180903|FG001|NOT COMPLETED|Overall Study||138
10056088|NCT02064439|11180904|FG002|NOT COMPLETED|Overall Study||182
10056089|NCT02064582|11180912|FG000|STARTED|Overall Study||7
10056090|NCT02064582|11180912|FG000|COMPLETED|Overall Study||7
10056091|NCT02064582|11180912|FG000|NOT COMPLETED|Overall Study||0
10056092|NCT02064816|11180918|FG000|STARTED|Overall Study||104
10056093|NCT02064816|11180919|FG001|STARTED|Overall Study||96
10056094|NCT02064816|11180918|FG000|COMPLETED|Overall Study||96
10056095|NCT02064816|11180919|FG001|COMPLETED|Overall Study||88
10056096|NCT02064816|11180918|FG000|NOT COMPLETED|Overall Study||8
10056097|NCT02064816|11180919|FG001|NOT COMPLETED|Overall Study||8
10056098|NCT02064855|11180925|FG000|STARTED|Overall Study||108
10056099|NCT02064855|11180925|FG000|COMPLETED|Overall Study||53
10056100|NCT02064855|11180925|FG000|NOT COMPLETED|Overall Study||55
10056101|NCT02064868|11180974|FG000|STARTED|Overall Study||1756
10056102|NCT02064868|11180975|FG001|STARTED|Overall Study||894
10056103|NCT02064868|11180974|FG000|Full Analysis Set|Overall Study||1756
10056104|NCT02064868|11180975|FG001|Full Analysis Set|Overall Study||894
10056105|NCT02064868|11180974|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
10056106|NCT02064868|11180975|FG001|Safety Set|Overall Study||894
10056107|NCT02064868|11180974|FG000|Per Protocol Set|Overall Study||1155
10056108|NCT02064868|11180975|FG001|Per Protocol Set|Overall Study||627
10056109|NCT02064868|11180974|FG000|COMPLETED|Overall Study||1722
10056110|NCT02064868|11180975|FG001|COMPLETED|Overall Study||881
10056111|NCT02064868|11180974|FG000|NOT COMPLETED|Overall Study||34
10056112|NCT02064868|11180975|FG001|NOT COMPLETED|Overall Study||13
10056113|NCT02064894|11180984|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
10056114|NCT02064894|11180985|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
10056115|NCT02064894|11180986|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
10056116|NCT02064894|11180984|FG000|Available at T-60|Overall Study||91
10056117|NCT02064894|11180985|FG001|Available at T-60|Overall Study||188
10056118|NCT02064894|11180986|FG002|Available at T-60|Overall Study||177
10056119|NCT02064894|11180984|FG000|Avalaible at T-90|Overall Study||74
10056120|NCT02064894|11180985|FG001|Avalaible at T-90|Overall Study||134
10056121|NCT02064894|11180986|FG002|Avalaible at T-90|Overall Study||129
10056122|NCT02064894|11180984|FG000|COMPLETED|Overall Study||56
10056123|NCT02064894|11180985|FG001|COMPLETED|Overall Study||99
10056124|NCT02064894|11180986|FG002|COMPLETED|Overall Study||86
10056125|NCT02064894|11180984|FG000|NOT COMPLETED|Overall Study||43
10056126|NCT02064894|11180985|FG001|NOT COMPLETED|Overall Study||102
10056127|NCT02064894|11180986|FG002|NOT COMPLETED|Overall Study||115
10056128|NCT02064907|11180996|FG000|STARTED|Period 1||26
10056129|NCT02064907|11180997|FG001|STARTED|Period 1||26
10056130|NCT02064907|11180996|FG000|COMPLETED|Period 1||26
10056131|NCT02064907|11180997|FG001|COMPLETED|Period 1||26
10056132|NCT02064907|11180996|FG000|NOT COMPLETED|Period 1||0
10056133|NCT02064907|11180997|FG001|NOT COMPLETED|Period 1||0
10056134|NCT02064907|11180996|FG000|STARTED|Period 2||26
10056135|NCT02064907|11180997|FG001|STARTED|Period 2||26
10056136|NCT02064907|11180996|FG000|COMPLETED|Period 2||26
10056137|NCT02064907|11180997|FG001|COMPLETED|Period 2||26
10056138|NCT02064907|11180996|FG000|NOT COMPLETED|Period 2||0
10056139|NCT02064907|11180997|FG001|NOT COMPLETED|Period 2||0
10056140|NCT02064920|11181005|FG000|STARTED|Overall Study||6
10056141|NCT02064920|11181006|FG001|STARTED|Overall Study||30
10056142|NCT02064920|11181005|FG000|Treated|Overall Study||6
10056143|NCT02064920|11181006|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
10056144|NCT02064920|11181005|FG000|COMPLETED|Overall Study||5
10056145|NCT02064920|11181006|FG001|COMPLETED|Overall Study||21
10056146|NCT02064920|11181005|FG000|NOT COMPLETED|Overall Study||1
10056147|NCT02064920|11181006|FG001|NOT COMPLETED|Overall Study||9
10056148|NCT02064959|11181014|FG000|STARTED|Overall Study||16
10056149|NCT02064959|11181015|FG001|STARTED|Overall Study||16
10056150|NCT02064959|11181014|FG000|COMPLETED|Overall Study||16
10056151|NCT02064959|11181015|FG001|COMPLETED|Overall Study||16
10056152|NCT02064959|11181014|FG000|NOT COMPLETED|Overall Study||0
10056153|NCT02064959|11181015|FG001|NOT COMPLETED|Overall Study||0
10056154|NCT02064985|11181024|FG000|STARTED|Overall Study||12
10056155|NCT02064985|11181025|FG001|STARTED|Overall Study||12
10056156|NCT02064985|11181026|FG002|STARTED|Overall Study||12
10056157|NCT02064985|11181024|FG000|COMPLETED|Overall Study||12
10056158|NCT02064985|11181025|FG001|COMPLETED|Overall Study||12
10056159|NCT02064985|11181026|FG002|COMPLETED|Overall Study||12
10056160|NCT02064985|11181024|FG000|NOT COMPLETED|Overall Study||0
10056161|NCT02064985|11181025|FG001|NOT COMPLETED|Overall Study||0
10056162|NCT02064985|11181026|FG002|NOT COMPLETED|Overall Study||0
10056163|NCT02065245|11181041|FG000|STARTED|Infusion 1||5
10056164|NCT02065245|11181042|FG001|STARTED|Infusion 1||5
10056165|NCT02065245|11181043|FG002|STARTED|Infusion 1||5
10056166|NCT02065245|11181044|FG003|STARTED|Infusion 1||10
10056167|NCT02065245|11181045|FG004|STARTED|Infusion 1||10
10056168|NCT02065245|11181046|FG005|STARTED|Infusion 1||10
10056169|NCT02065245|11181047|FG006|STARTED|Infusion 1||20
10056170|NCT02065245|11181041|FG000|COMPLETED|Infusion 1||5
10056171|NCT02065245|11181042|FG001|COMPLETED|Infusion 1||5
10056172|NCT02065245|11181043|FG002|COMPLETED|Infusion 1||4
10056173|NCT02065245|11181044|FG003|COMPLETED|Infusion 1||10
10056174|NCT02065245|11181045|FG004|COMPLETED|Infusion 1||9
10056175|NCT02065245|11181046|FG005|COMPLETED|Infusion 1||10
10056176|NCT02065245|11181047|FG006|COMPLETED|Infusion 1||19
10056177|NCT02065245|11181041|FG000|NOT COMPLETED|Infusion 1||0
10056178|NCT02065245|11181042|FG001|NOT COMPLETED|Infusion 1||0
10056179|NCT02065245|11181043|FG002|NOT COMPLETED|Infusion 1||1
10056180|NCT02065245|11181044|FG003|NOT COMPLETED|Infusion 1||0
10056181|NCT02065245|11181045|FG004|NOT COMPLETED|Infusion 1||1
10056182|NCT02065245|11181046|FG005|NOT COMPLETED|Infusion 1||0
10056183|NCT02065245|11181047|FG006|NOT COMPLETED|Infusion 1||1
10056184|NCT02065245|11181041|FG000|STARTED|Infusion 2||5
10056185|NCT02065245|11181042|FG001|STARTED|Infusion 2||5
10056186|NCT02065245|11181043|FG002|STARTED|Infusion 2||2
10056187|NCT02065245|11181044|FG003|STARTED|Infusion 2||0
10056188|NCT02065245|11181045|FG004|STARTED|Infusion 2||0
10056189|NCT02065245|11181046|FG005|STARTED|Infusion 2||6
10056190|NCT02065245|11181047|FG006|STARTED|Infusion 2||12
10056191|NCT02065245|11181041|FG000|COMPLETED|Infusion 2||5
10056192|NCT02065245|11181042|FG001|COMPLETED|Infusion 2||5
10056193|NCT02065245|11181043|FG002|COMPLETED|Infusion 2||2
10056194|NCT02065245|11181044|FG003|COMPLETED|Infusion 2||0
10056195|NCT02065245|11181045|FG004|COMPLETED|Infusion 2||0
10056196|NCT02065245|11181046|FG005|COMPLETED|Infusion 2||6
10056197|NCT02065245|11181047|FG006|COMPLETED|Infusion 2||11
10056198|NCT02065245|11181041|FG000|NOT COMPLETED|Infusion 2||0
10056199|NCT02065245|11181042|FG001|NOT COMPLETED|Infusion 2||0
10056200|NCT02065245|11181043|FG002|NOT COMPLETED|Infusion 2||0
10056201|NCT02065245|11181044|FG003|NOT COMPLETED|Infusion 2||0
10056202|NCT02065245|11181045|FG004|NOT COMPLETED|Infusion 2||0
10056203|NCT02065245|11181046|FG005|NOT COMPLETED|Infusion 2||0
10056204|NCT02065245|11181047|FG006|NOT COMPLETED|Infusion 2||1
10056205|NCT02065245|11181041|FG000|STARTED|Infusion 3||3
10056206|NCT02065245|11181042|FG001|STARTED|Infusion 3||5
10056207|NCT02065245|11181043|FG002|STARTED|Infusion 3||1
10056208|NCT02065245|11181044|FG003|STARTED|Infusion 3||0
10056209|NCT02065245|11181045|FG004|STARTED|Infusion 3||0
10056210|NCT02065245|11181046|FG005|STARTED|Infusion 3||0
10056211|NCT02065245|11181047|FG006|STARTED|Infusion 3||0
10056212|NCT02065245|11181041|FG000|COMPLETED|Infusion 3||2
10056213|NCT02065245|11181042|FG001|COMPLETED|Infusion 3||4
10056214|NCT02065245|11181043|FG002|COMPLETED|Infusion 3||1
10056215|NCT02065245|11181044|FG003|COMPLETED|Infusion 3||0
10056216|NCT02065245|11181045|FG004|COMPLETED|Infusion 3||0
10056217|NCT02065245|11181046|FG005|COMPLETED|Infusion 3||0
10056218|NCT02065245|11181047|FG006|COMPLETED|Infusion 3||0
10056219|NCT02065245|11181041|FG000|NOT COMPLETED|Infusion 3||1
10056220|NCT02065245|11181042|FG001|NOT COMPLETED|Infusion 3||1
10056221|NCT02065245|11181043|FG002|NOT COMPLETED|Infusion 3||0
10056222|NCT02065245|11181044|FG003|NOT COMPLETED|Infusion 3||0
10056223|NCT02065245|11181045|FG004|NOT COMPLETED|Infusion 3||0
10056224|NCT02065245|11181046|FG005|NOT COMPLETED|Infusion 3||0
10056225|NCT02065245|11181047|FG006|NOT COMPLETED|Infusion 3||0
10056226|NCT02065245|11181041|FG000|STARTED|Infusion 4||1
10056227|NCT02065245|11181042|FG001|STARTED|Infusion 4||2
10056228|NCT02065245|11181043|FG002|STARTED|Infusion 4||1
10056229|NCT02065245|11181044|FG003|STARTED|Infusion 4||0
10056230|NCT02065245|11181045|FG004|STARTED|Infusion 4||0
10056231|NCT02065245|11181046|FG005|STARTED|Infusion 4||0
10056232|NCT02065245|11181047|FG006|STARTED|Infusion 4||0
10056233|NCT02065245|11181041|FG000|COMPLETED|Infusion 4||1
10056234|NCT02065245|11181042|FG001|COMPLETED|Infusion 4||2
10056235|NCT02065245|11181043|FG002|COMPLETED|Infusion 4||1
10056236|NCT02065245|11181044|FG003|COMPLETED|Infusion 4||0
10056237|NCT02065245|11181045|FG004|COMPLETED|Infusion 4||0
10056238|NCT02065245|11181046|FG005|COMPLETED|Infusion 4||0
10056239|NCT02065245|11181047|FG006|COMPLETED|Infusion 4||0
10056240|NCT02065245|11181041|FG000|NOT COMPLETED|Infusion 4||0
10056241|NCT02065245|11181042|FG001|NOT COMPLETED|Infusion 4||0
10056242|NCT02065245|11181043|FG002|NOT COMPLETED|Infusion 4||0
10056243|NCT02065245|11181044|FG003|NOT COMPLETED|Infusion 4||0
10056244|NCT02065245|11181045|FG004|NOT COMPLETED|Infusion 4||0
10056245|NCT02065245|11181046|FG005|NOT COMPLETED|Infusion 4||0
10056246|NCT02065245|11181047|FG006|NOT COMPLETED|Infusion 4||0
10056247|NCT02065336|11181071|FG000|STARTED|Main Study||6
10056248|NCT02065336|11181072|FG001|STARTED|Main Study||6
10056249|NCT02065336|11181073|FG002|STARTED|Main Study||6
10056250|NCT02065336|11181074|FG003|STARTED|Main Study||6
10056251|NCT02065336|11181075|FG004|STARTED|Main Study||6
10056252|NCT02065336|11181076|FG005|STARTED|Main Study||6
10056253|NCT02065336|11181077|FG006|STARTED|Main Study||12
10056254|NCT02065336|11181078|FG007|STARTED|Main Study||10
10056255|NCT02065336|11181079|FG008|STARTED|Main Study||0
10056256|NCT02065336|11181080|FG009|STARTED|Main Study||0
10056257|NCT02065336|11181071|FG000|COMPLETED|Main Study||6
10056258|NCT02065336|11181072|FG001|COMPLETED|Main Study||6
10056259|NCT02065336|11181073|FG002|COMPLETED|Main Study||6
10056260|NCT02065336|11181074|FG003|COMPLETED|Main Study||6
10056261|NCT02065336|11181075|FG004|COMPLETED|Main Study||6
10056262|NCT02065336|11181076|FG005|COMPLETED|Main Study||6
10056263|NCT02065336|11181077|FG006|COMPLETED|Main Study||12
10056264|NCT02065336|11181078|FG007|COMPLETED|Main Study||10
10056265|NCT02065336|11181079|FG008|COMPLETED|Main Study||0
10056266|NCT02065336|11181080|FG009|COMPLETED|Main Study||0
10056267|NCT02065336|11181071|FG000|NOT COMPLETED|Main Study||0
10056268|NCT02065336|11181072|FG001|NOT COMPLETED|Main Study||0
10056269|NCT02065336|11181073|FG002|NOT COMPLETED|Main Study||0
10056270|NCT02065336|11181074|FG003|NOT COMPLETED|Main Study||0
10056271|NCT02065336|11181075|FG004|NOT COMPLETED|Main Study||0
10056272|NCT02065336|11181076|FG005|NOT COMPLETED|Main Study||0
10056273|NCT02065336|11181077|FG006|NOT COMPLETED|Main Study||0
10056274|NCT02065336|11181078|FG007|NOT COMPLETED|Main Study||0
10056275|NCT02065336|11181079|FG008|NOT COMPLETED|Main Study||0
10056276|NCT02065336|11181080|FG009|NOT COMPLETED|Main Study||0
10056277|NCT02065336|11181071|FG000|STARTED|Extension Phase||0
10056278|NCT02065336|11181072|FG001|STARTED|Extension Phase||0
10056279|NCT02065336|11181073|FG002|STARTED|Extension Phase||0
10056280|NCT02065336|11181074|FG003|STARTED|Extension Phase||0
10056281|NCT02065336|11181075|FG004|STARTED|Extension Phase||0
10056282|NCT02065336|11181076|FG005|STARTED|Extension Phase||0
10056283|NCT02065336|11181077|FG006|STARTED|Extension Phase||0
10056284|NCT02065336|11181078|FG007|STARTED|Extension Phase||0
10056285|NCT02065336|11181079|FG008|STARTED|Extension Phase||2
10056286|NCT02065336|11181080|FG009|STARTED|Extension Phase||8
10056287|NCT02065336|11181071|FG000|COMPLETED|Extension Phase||0
10056288|NCT02065336|11181072|FG001|COMPLETED|Extension Phase||0
10056289|NCT02065336|11181073|FG002|COMPLETED|Extension Phase||0
10056290|NCT02065336|11181074|FG003|COMPLETED|Extension Phase||0
10056291|NCT02065336|11181075|FG004|COMPLETED|Extension Phase||0
10056292|NCT02065336|11181076|FG005|COMPLETED|Extension Phase||0
10056293|NCT02065336|11181077|FG006|COMPLETED|Extension Phase||0
10056294|NCT02065336|11181078|FG007|COMPLETED|Extension Phase||0
10056295|NCT02065336|11181079|FG008|COMPLETED|Extension Phase||0
10056296|NCT02065336|11181080|FG009|COMPLETED|Extension Phase||0
10056297|NCT02065336|11181071|FG000|NOT COMPLETED|Extension Phase||0
10056298|NCT02065336|11181072|FG001|NOT COMPLETED|Extension Phase||0
10056299|NCT02065336|11181073|FG002|NOT COMPLETED|Extension Phase||0
10056300|NCT02065336|11181074|FG003|NOT COMPLETED|Extension Phase||0
10056301|NCT02065336|11181075|FG004|NOT COMPLETED|Extension Phase||0
10056302|NCT02065336|11181076|FG005|NOT COMPLETED|Extension Phase||0
10056303|NCT02065336|11181077|FG006|NOT COMPLETED|Extension Phase||0
10056304|NCT02065336|11181078|FG007|NOT COMPLETED|Extension Phase||0
10056305|NCT02065336|11181079|FG008|NOT COMPLETED|Extension Phase||2
10056306|NCT02065336|11181080|FG009|NOT COMPLETED|Extension Phase||8
10056307|NCT02065453|11181113|FG000|STARTED|Overall Study||27
10056308|NCT02065453|11181114|FG001|STARTED|Overall Study||25
10056309|NCT02065453|11181113|FG000|COMPLETED|Overall Study||24
10056310|NCT02065453|11181114|FG001|COMPLETED|Overall Study||21
10056311|NCT02065453|11181113|FG000|NOT COMPLETED|Overall Study||3
10056312|NCT02065453|11181114|FG001|NOT COMPLETED|Overall Study||4
10056313|NCT02065479|11181121|FG000|STARTED|Overall Study||33
10056314|NCT02065479|11181122|FG001|STARTED|Overall Study||32
10056315|NCT02065479|11181121|FG000|COMPLETED|Overall Study||33
10056316|NCT02065479|11181122|FG001|COMPLETED|Overall Study||32
10056317|NCT02065479|11181121|FG000|NOT COMPLETED|Overall Study||0
10056318|NCT02065479|11181122|FG001|NOT COMPLETED|Overall Study||0
10056319|NCT02065518|11181132|FG000|STARTED|Overall Study||19
10056320|NCT02065518|11181133|FG001|STARTED|Overall Study||19
10120187|NCT02560584|11251268|FG000|COMPLETED|Overall Study||304
10120188|NCT02560584|11251268|FG000|NOT COMPLETED|Overall Study||0
10120189|NCT02560701|11251276|FG000|STARTED|Overall Study||8060
10120190|NCT02560701|11251277|FG001|STARTED|Overall Study||89242
10120191|NCT02560701|11251276|FG000|Carve Out|Overall Study||8060
10120192|NCT02560701|11251277|FG001|Carve Out|Overall Study||88729
10120193|NCT02560701|11251276|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598
10120194|NCT02560701|11251277|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367
10120195|NCT02560701|11251276|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533
10120196|NCT02560701|11251277|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427
10120197|NCT02560701|11251276|FG000|Matched Cohort|Overall Study||3517
10120198|NCT02560701|11251277|FG001|Matched Cohort|Overall Study||37776
10120199|NCT02560701|11251276|FG000|COMPLETED|Overall Study||3517
10120200|NCT02560701|11251277|FG001|COMPLETED|Overall Study||37776
10120201|NCT02560701|11251276|FG000|NOT COMPLETED|Overall Study||4543
10120202|NCT02560701|11251277|FG001|NOT COMPLETED|Overall Study||51466
10120203|NCT02560753|11251287|FG000|STARTED|Overall Study||9
10120204|NCT02560753|11251288|FG001|STARTED|Overall Study||9
10120205|NCT02560753|11251289|FG002|STARTED|Overall Study||10
10120206|NCT02560753|11251290|FG003|STARTED|Overall Study||8
10120207|NCT02560753|11251287|FG000|COMPLETED|Overall Study||8
10120208|NCT02560753|11251288|FG001|COMPLETED|Overall Study||9
10120209|NCT02560753|11251289|FG002|COMPLETED|Overall Study||9
10120210|NCT02560753|11251290|FG003|COMPLETED|Overall Study||8
10120211|NCT02560753|11251287|FG000|NOT COMPLETED|Overall Study||1
10120212|NCT02560753|11251288|FG001|NOT COMPLETED|Overall Study||0
10120213|NCT02560753|11251289|FG002|NOT COMPLETED|Overall Study||1
10120214|NCT02560753|11251290|FG003|NOT COMPLETED|Overall Study||0
10120215|NCT02560779|11251302|FG000|STARTED|Overall Study||14
10120216|NCT02560779|11251303|FG001|STARTED|Overall Study||13
10120217|NCT02560779|11251302|FG000|COMPLETED|Overall Study||14
10120218|NCT02560779|11251303|FG001|COMPLETED|Overall Study||13
10120219|NCT02560779|11251302|FG000|NOT COMPLETED|Overall Study||0
10120220|NCT02560779|11251303|FG001|NOT COMPLETED|Overall Study||0
10120221|NCT02560922|11251311|FG000|STARTED|Overall Study||124
10120222|NCT02560922|11251312|FG001|STARTED|Overall Study||124
10120223|NCT02560922|11251311|FG000|COMPLETED|Overall Study||98
10120224|NCT02560922|11251312|FG001|COMPLETED|Overall Study||112
10120225|NCT02560922|11251311|FG000|NOT COMPLETED|Overall Study||26
10120226|NCT02560922|11251312|FG001|NOT COMPLETED|Overall Study||12
10120227|NCT02561000|11251321|FG000|STARTED|Overall Study||34
10120228|NCT02561000|11251322|FG001|STARTED|Overall Study||35
10120229|NCT02561000|11251323|FG002|STARTED|Overall Study||31
10120230|NCT02561000|11251321|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
10120231|NCT02561000|11251322|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
10056321|NCT02065518|11181134|FG002|STARTED|Overall Study||20
10056322|NCT02065518|11181135|FG003|STARTED|Overall Study||20
10056323|NCT02065518|11181132|FG000|COMPLETED|Overall Study||13
10056324|NCT02065518|11181133|FG001|COMPLETED|Overall Study||11
10056325|NCT02065518|11181134|FG002|COMPLETED|Overall Study||11
10056326|NCT02065518|11181135|FG003|COMPLETED|Overall Study||15
10056327|NCT02065518|11181132|FG000|NOT COMPLETED|Overall Study||6
10120232|NCT02561000|11251323|FG002|Safety Population|Overall Study||31
10120233|NCT02561000|11251321|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
10120234|NCT02561000|11251322|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
10120235|NCT02561000|11251323|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
10196177|NCT03358407|11324485|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10056328|NCT02065518|11181133|FG001|NOT COMPLETED|Overall Study||8
10056329|NCT02065518|11181134|FG002|NOT COMPLETED|Overall Study||9
10056330|NCT02065518|11181135|FG003|NOT COMPLETED|Overall Study||5
10056331|NCT02065557|11181148|FG000|STARTED|Induction Period||32
10056332|NCT02065557|11181149|FG001|STARTED|Induction Period||51
10056333|NCT02065557|11181150|FG002|STARTED|Induction Period||18
10056334|NCT02065557|11181151|FG003|STARTED|Induction Period||0
10056335|NCT02065557|11181152|FG004|STARTED|Induction Period||0
10056336|NCT02065557|11181153|FG005|STARTED|Induction Period||0
10056337|NCT02065557|11181148|FG000|Enrolled in Main Study|Induction Period||30
10056338|NCT02065557|11181149|FG001|Enrolled in Main Study|Induction Period||47
10056339|NCT02065557|11181150|FG002|Enrolled in Main Study|Induction Period||16
10056340|NCT02065557|11181151|FG003|Enrolled in Main Study|Induction Period||0
10056341|NCT02065557|11181152|FG004|Enrolled in Main Study|Induction Period||0
10056342|NCT02065557|11181153|FG005|Enrolled in Main Study|Induction Period||0
10056343|NCT02065557|11181148|FG000|Enrolled in Japan Sub-study|Induction Period||2
10056344|NCT02065557|11181149|FG001|Enrolled in Japan Sub-study|Induction Period||4
10056345|NCT02065557|11181150|FG002|Enrolled in Japan Sub-study|Induction Period||2
10056346|NCT02065557|11181151|FG003|Enrolled in Japan Sub-study|Induction Period||0
10056347|NCT02065557|11181152|FG004|Enrolled in Japan Sub-study|Induction Period||0
10056348|NCT02065557|11181153|FG005|Enrolled in Japan Sub-study|Induction Period||0
10056349|NCT02065557|11181148|FG000|COMPLETED|Induction Period||22
10056350|NCT02065557|11181149|FG001|COMPLETED|Induction Period||43
10056351|NCT02065557|11181150|FG002|COMPLETED|Induction Period||16
10056352|NCT02065557|11181151|FG003|COMPLETED|Induction Period||0
10056353|NCT02065557|11181152|FG004|COMPLETED|Induction Period||0
10056354|NCT02065557|11181153|FG005|COMPLETED|Induction Period||0
10056355|NCT02065557|11181148|FG000|NOT COMPLETED|Induction Period||10
10056356|NCT02065557|11181149|FG001|NOT COMPLETED|Induction Period||8
10056357|NCT02065557|11181150|FG002|NOT COMPLETED|Induction Period||2
10056358|NCT02065557|11181151|FG003|NOT COMPLETED|Induction Period||0
10056359|NCT02065557|11181152|FG004|NOT COMPLETED|Induction Period||0
10056360|NCT02065557|11181153|FG005|NOT COMPLETED|Induction Period||0
10120236|NCT02561000|11251321|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
10120237|NCT02561000|11251322|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
10120238|NCT02561000|11251323|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
10120239|NCT02561000|11251321|FG000|COMPLETED|Overall Study||32
10120240|NCT02561000|11251322|FG001|COMPLETED|Overall Study||31
10120241|NCT02561000|11251323|FG002|COMPLETED|Overall Study||31
10120242|NCT02561000|11251321|FG000|NOT COMPLETED|Overall Study||2
10120243|NCT02561000|11251322|FG001|NOT COMPLETED|Overall Study||4
10120244|NCT02561000|11251323|FG002|NOT COMPLETED|Overall Study||0
10120245|NCT02561078|11251333|FG000|STARTED|Overall Study||209
10120246|NCT02561078|11251334|FG001|STARTED|Overall Study||211
10120247|NCT02561078|11251333|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208
10120248|NCT02561078|11251334|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
10120249|NCT02561078|11251333|FG000|COMPLETED|Overall Study||179
10120250|NCT02561078|11251334|FG001|COMPLETED|Overall Study||186
10120251|NCT02561078|11251333|FG000|NOT COMPLETED|Overall Study||30
10120252|NCT02561078|11251334|FG001|NOT COMPLETED|Overall Study||25
10120253|NCT02561130|11251342|FG000|STARTED|Overall Study||77
10120254|NCT02561130|11251343|FG001|STARTED|Overall Study||77
10120255|NCT02561130|11251342|FG000|COMPLETED|Overall Study||76
10120256|NCT02561130|11251343|FG001|COMPLETED|Overall Study||76
10120257|NCT02561130|11251342|FG000|NOT COMPLETED|Overall Study||1
10120258|NCT02561130|11251343|FG001|NOT COMPLETED|Overall Study||1
10120259|NCT02561156|11251362|FG000|STARTED|Part 1||12
10120260|NCT02561156|11251363|FG001|STARTED|Part 1||6
10120261|NCT02561156|11251364|FG002|STARTED|Part 1||6
10120262|NCT02561156|11251365|FG003|STARTED|Part 1||6
10120263|NCT02561156|11251366|FG004|STARTED|Part 1||6
10120264|NCT02561156|11251367|FG005|STARTED|Part 1||6
10120265|NCT02561156|11251368|FG006|STARTED|Part 1||6
10120266|NCT02561156|11251369|FG007|STARTED|Part 1||0
10120267|NCT02561156|11251370|FG008|STARTED|Part 1||0
10120268|NCT02561156|11251371|FG009|STARTED|Part 1||0
10120269|NCT02561156|11251372|FG010|STARTED|Part 1||0
10120270|NCT02561156|11251373|FG011|STARTED|Part 1||0
10120271|NCT02561156|11251374|FG012|STARTED|Part 1||0
10120272|NCT02561156|11251362|FG000|COMPLETED|Part 1||12
10120273|NCT02561156|11251363|FG001|COMPLETED|Part 1||6
10120274|NCT02561156|11251364|FG002|COMPLETED|Part 1||6
10120275|NCT02561156|11251365|FG003|COMPLETED|Part 1||6
10120276|NCT02561156|11251366|FG004|COMPLETED|Part 1||6
10120277|NCT02561156|11251367|FG005|COMPLETED|Part 1||6
10120278|NCT02561156|11251368|FG006|COMPLETED|Part 1||6
10120279|NCT02561156|11251369|FG007|COMPLETED|Part 1||0
10120280|NCT02561156|11251370|FG008|COMPLETED|Part 1||0
10120281|NCT02561156|11251371|FG009|COMPLETED|Part 1||0
10120282|NCT02561156|11251372|FG010|COMPLETED|Part 1||0
10120283|NCT02561156|11251373|FG011|COMPLETED|Part 1||0
10120284|NCT02561156|11251374|FG012|COMPLETED|Part 1||0
10120285|NCT02561156|11251362|FG000|NOT COMPLETED|Part 1||0
10120286|NCT02561156|11251363|FG001|NOT COMPLETED|Part 1||0
10120287|NCT02561156|11251364|FG002|NOT COMPLETED|Part 1||0
10120288|NCT02561156|11251365|FG003|NOT COMPLETED|Part 1||0
10120289|NCT02561156|11251366|FG004|NOT COMPLETED|Part 1||0
10120290|NCT02561156|11251367|FG005|NOT COMPLETED|Part 1||0
10120291|NCT02561156|11251368|FG006|NOT COMPLETED|Part 1||0
10120292|NCT02561156|11251369|FG007|NOT COMPLETED|Part 1||0
10120293|NCT02561156|11251370|FG008|NOT COMPLETED|Part 1||0
10120294|NCT02561156|11251371|FG009|NOT COMPLETED|Part 1||0
10120295|NCT02561156|11251372|FG010|NOT COMPLETED|Part 1||0
10120296|NCT02561156|11251373|FG011|NOT COMPLETED|Part 1||0
10056361|NCT02065557|11181148|FG000|STARTED|Maintenance Period||0
10056362|NCT02065557|11181149|FG001|STARTED|Maintenance Period||0
10056363|NCT02065557|11181150|FG002|STARTED|Maintenance Period||0
10056364|NCT02065557|11181151|FG003|STARTED|Maintenance Period||12
10056365|NCT02065557|11181152|FG004|STARTED|Maintenance Period||33
10056366|NCT02065557|11181153|FG005|STARTED|Maintenance Period||36
10056367|NCT02065557|11181148|FG000|COMPLETED|Maintenance Period||0
10056368|NCT02065557|11181149|FG001|COMPLETED|Maintenance Period||0
10056369|NCT02065557|11181150|FG002|COMPLETED|Maintenance Period||0
10056370|NCT02065557|11181151|FG003|COMPLETED|Maintenance Period||11
10056371|NCT02065557|11181152|FG004|COMPLETED|Maintenance Period||25
10056372|NCT02065557|11181153|FG005|COMPLETED|Maintenance Period||32
10056373|NCT02065557|11181148|FG000|NOT COMPLETED|Maintenance Period||0
10056374|NCT02065557|11181149|FG001|NOT COMPLETED|Maintenance Period||0
10056375|NCT02065557|11181150|FG002|NOT COMPLETED|Maintenance Period||0
10056376|NCT02065557|11181151|FG003|NOT COMPLETED|Maintenance Period||1
10056377|NCT02065557|11181152|FG004|NOT COMPLETED|Maintenance Period||8
10056378|NCT02065557|11181153|FG005|NOT COMPLETED|Maintenance Period||4
10056379|NCT02065570|11181180|FG000|STARTED|Induction Study||206
10056380|NCT02065570|11181181|FG001|STARTED|Induction Study||308
10056381|NCT02065570|11181182|FG002|STARTED|Induction Study||0
10056382|NCT02065570|11181183|FG003|STARTED|Induction Study||0
10056383|NCT02065570|11181180|FG000|COMPLETED|Induction Study||192
10056384|NCT02065570|11181181|FG001|COMPLETED|Induction Study||287
10056385|NCT02065570|11181182|FG002|COMPLETED|Induction Study||0
10056386|NCT02065570|11181183|FG003|COMPLETED|Induction Study||0
10056387|NCT02065570|11181180|FG000|NOT COMPLETED|Induction Study||14
10056388|NCT02065570|11181181|FG001|NOT COMPLETED|Induction Study||21
10056389|NCT02065570|11181182|FG002|NOT COMPLETED|Induction Study||0
10056390|NCT02065570|11181183|FG003|NOT COMPLETED|Induction Study||0
10056391|NCT02065570|11181180|FG000|STARTED|Maintenance Study||0
10120297|NCT02561156|11251374|FG012|NOT COMPLETED|Part 1||0
10120298|NCT02561156|11251362|FG000|STARTED|Part 2||0
10120299|NCT02561156|11251363|FG001|STARTED|Part 2||0
10120300|NCT02561156|11251364|FG002|STARTED|Part 2||0
10120301|NCT02561156|11251365|FG003|STARTED|Part 2||0
10120302|NCT02561156|11251366|FG004|STARTED|Part 2||0
10120303|NCT02561156|11251367|FG005|STARTED|Part 2||0
10120304|NCT02561156|11251368|FG006|STARTED|Part 2||0
10120305|NCT02561156|11251369|FG007|STARTED|Part 2||10
10120306|NCT02561156|11251370|FG008|STARTED|Part 2||6
10120307|NCT02561156|11251371|FG009|STARTED|Part 2||6
10120308|NCT02561156|11251372|FG010|STARTED|Part 2||6
10120309|NCT02561156|11251373|FG011|STARTED|Part 2||6
10120310|NCT02561156|11251374|FG012|STARTED|Part 2||6
10120311|NCT02561156|11251362|FG000|COMPLETED|Part 2||0
10120312|NCT02561156|11251363|FG001|COMPLETED|Part 2||0
10120313|NCT02561156|11251364|FG002|COMPLETED|Part 2||0
10120314|NCT02561156|11251365|FG003|COMPLETED|Part 2||0
10120315|NCT02561156|11251366|FG004|COMPLETED|Part 2||0
10120316|NCT02561156|11251367|FG005|COMPLETED|Part 2||0
10120317|NCT02561156|11251368|FG006|COMPLETED|Part 2||0
10120318|NCT02561156|11251369|FG007|COMPLETED|Part 2||10
10120319|NCT02561156|11251370|FG008|COMPLETED|Part 2||6
10120320|NCT02561156|11251371|FG009|COMPLETED|Part 2||6
10120321|NCT02561156|11251372|FG010|COMPLETED|Part 2||6
10120322|NCT02561156|11251373|FG011|COMPLETED|Part 2||5
10120323|NCT02561156|11251374|FG012|COMPLETED|Part 2||6
10120324|NCT02561156|11251362|FG000|NOT COMPLETED|Part 2||0
10120325|NCT02561156|11251363|FG001|NOT COMPLETED|Part 2||0
10120326|NCT02561156|11251364|FG002|NOT COMPLETED|Part 2||0
10120327|NCT02561156|11251365|FG003|NOT COMPLETED|Part 2||0
10120328|NCT02561156|11251366|FG004|NOT COMPLETED|Part 2||0
10120329|NCT02561156|11251367|FG005|NOT COMPLETED|Part 2||0
10120330|NCT02561156|11251368|FG006|NOT COMPLETED|Part 2||0
10120331|NCT02561156|11251369|FG007|NOT COMPLETED|Part 2||0
10120332|NCT02561156|11251370|FG008|NOT COMPLETED|Part 2||0
10120333|NCT02561156|11251371|FG009|NOT COMPLETED|Part 2||0
10120334|NCT02561156|11251372|FG010|NOT COMPLETED|Part 2||0
10120335|NCT02561156|11251373|FG011|NOT COMPLETED|Part 2||1
10120336|NCT02561156|11251374|FG012|NOT COMPLETED|Part 2||0
10120337|NCT02561195|11251424|FG000|STARTED|Vaccination 1 to 3||183
10120338|NCT02561195|11251425|FG001|STARTED|Vaccination 1 to 3||184
10120339|NCT02561195|11251426|FG002|STARTED|Vaccination 1 to 3||61
10120340|NCT02561195|11251427|FG003|STARTED|Vaccination 1 to 3||183
10120341|NCT02561195|11251428|FG004|STARTED|Vaccination 1 to 3||183
10120342|NCT02561195|11251429|FG005|STARTED|Vaccination 1 to 3||61
10120343|NCT02561195|11251430|FG006|STARTED|Vaccination 1 to 3||0
10120344|NCT02561195|11251431|FG007|STARTED|Vaccination 1 to 3||0
10120345|NCT02561195|11251432|FG008|STARTED|Vaccination 1 to 3||0
10120346|NCT02561195|11251433|FG009|STARTED|Vaccination 1 to 3||0
10056392|NCT02065570|11181181|FG001|STARTED|Maintenance Study||0
10056393|NCT02065570|11181182|FG002|STARTED|Maintenance Study||109
10056394|NCT02065570|11181183|FG003|STARTED|Maintenance Study||109
10056395|NCT02065570|11181180|FG000|COMPLETED|Maintenance Study||0
10120347|NCT02561195|11251434|FG010|STARTED|Vaccination 1 to 3||0
10120348|NCT02561195|11251435|FG011|STARTED|Vaccination 1 to 3||0
10120349|NCT02561195|11251436|FG012|STARTED|Vaccination 1 to 3||0
10120350|NCT02561195|11251437|FG013|STARTED|Vaccination 1 to 3||0
10120351|NCT02561195|11251424|FG000|Treated|Vaccination 1 to 3||182
10120352|NCT02561195|11251425|FG001|Treated|Vaccination 1 to 3||184
10120353|NCT02561195|11251426|FG002|Treated|Vaccination 1 to 3||61
10120354|NCT02561195|11251427|FG003|Treated|Vaccination 1 to 3||183
10120355|NCT02561195|11251428|FG004|Treated|Vaccination 1 to 3||183
10120356|NCT02561195|11251429|FG005|Treated|Vaccination 1 to 3||61
10056396|NCT02065570|11181181|FG001|COMPLETED|Maintenance Study||0
10056397|NCT02065570|11181182|FG002|COMPLETED|Maintenance Study||87
10056398|NCT02065570|11181183|FG003|COMPLETED|Maintenance Study||90
10056399|NCT02065570|11181180|FG000|NOT COMPLETED|Maintenance Study||0
10056400|NCT02065570|11181181|FG001|NOT COMPLETED|Maintenance Study||0
10056401|NCT02065570|11181182|FG002|NOT COMPLETED|Maintenance Study||22
10056402|NCT02065570|11181183|FG003|NOT COMPLETED|Maintenance Study||19
10056403|NCT02065622|11181196|FG000|STARTED|Induction Study||379
10056404|NCT02065622|11181197|FG001|STARTED|Induction Study||573
10056405|NCT02065622|11181198|FG002|STARTED|Induction Study||0
10056406|NCT02065622|11181199|FG003|STARTED|Induction Study||0
10056407|NCT02065622|11181200|FG004|STARTED|Induction Study||0
10056408|NCT02065622|11181196|FG000|Enrolled in Main Study|Induction Study||340
10056409|NCT02065622|11181197|FG001|Enrolled in Main Study|Induction Study||512
10056410|NCT02065622|11181198|FG002|Enrolled in Main Study|Induction Study||0
10056411|NCT02065622|11181199|FG003|Enrolled in Main Study|Induction Study||0
10056412|NCT02065622|11181200|FG004|Enrolled in Main Study|Induction Study||0
10056413|NCT02065622|11181196|FG000|Enrolled in Japan Sub-Study|Induction Study||39
10056414|NCT02065622|11181197|FG001|Enrolled in Japan Sub-Study|Induction Study||61
10056415|NCT02065622|11181198|FG002|Enrolled in Japan Sub-Study|Induction Study||0
10056416|NCT02065622|11181199|FG003|Enrolled in Japan Sub-Study|Induction Study||0
10056417|NCT02065622|11181200|FG004|Enrolled in Japan Sub-Study|Induction Study||0
10056418|NCT02065622|11181196|FG000|COMPLETED|Induction Study||332
10056419|NCT02065622|11181197|FG001|COMPLETED|Induction Study||514
10056420|NCT02065622|11181198|FG002|COMPLETED|Induction Study||0
10056421|NCT02065622|11181199|FG003|COMPLETED|Induction Study||0
10056422|NCT02065622|11181200|FG004|COMPLETED|Induction Study||0
10056423|NCT02065622|11181196|FG000|NOT COMPLETED|Induction Study||47
10120357|NCT02561195|11251430|FG006|Treated|Vaccination 1 to 3||0
10120358|NCT02561195|11251431|FG007|Treated|Vaccination 1 to 3||0
10120359|NCT02561195|11251432|FG008|Treated|Vaccination 1 to 3||0
10120360|NCT02561195|11251433|FG009|Treated|Vaccination 1 to 3||0
10120361|NCT02561195|11251434|FG010|Treated|Vaccination 1 to 3||0
10120362|NCT02561195|11251435|FG011|Treated|Vaccination 1 to 3||0
10120363|NCT02561195|11251436|FG012|Treated|Vaccination 1 to 3||0
10120364|NCT02561195|11251437|FG013|Treated|Vaccination 1 to 3||0
10120365|NCT02561195|11251424|FG000|COMPLETED|Vaccination 1 to 3||160
10120366|NCT02561195|11251425|FG001|COMPLETED|Vaccination 1 to 3||162
10120367|NCT02561195|11251426|FG002|COMPLETED|Vaccination 1 to 3||55
10120368|NCT02561195|11251427|FG003|COMPLETED|Vaccination 1 to 3||157
10120369|NCT02561195|11251428|FG004|COMPLETED|Vaccination 1 to 3||155
10120370|NCT02561195|11251429|FG005|COMPLETED|Vaccination 1 to 3||51
10120371|NCT02561195|11251430|FG006|COMPLETED|Vaccination 1 to 3||0
10120372|NCT02561195|11251431|FG007|COMPLETED|Vaccination 1 to 3||0
10120373|NCT02561195|11251432|FG008|COMPLETED|Vaccination 1 to 3||0
10120374|NCT02561195|11251433|FG009|COMPLETED|Vaccination 1 to 3||0
10120375|NCT02561195|11251434|FG010|COMPLETED|Vaccination 1 to 3||0
10120376|NCT02561195|11251435|FG011|COMPLETED|Vaccination 1 to 3||0
10120377|NCT02561195|11251436|FG012|COMPLETED|Vaccination 1 to 3||0
10120378|NCT02561195|11251437|FG013|COMPLETED|Vaccination 1 to 3||0
10120379|NCT02561195|11251424|FG000|NOT COMPLETED|Vaccination 1 to 3||23
10120380|NCT02561195|11251425|FG001|NOT COMPLETED|Vaccination 1 to 3||22
10120381|NCT02561195|11251426|FG002|NOT COMPLETED|Vaccination 1 to 3||6
10120382|NCT02561195|11251427|FG003|NOT COMPLETED|Vaccination 1 to 3||26
10120383|NCT02561195|11251428|FG004|NOT COMPLETED|Vaccination 1 to 3||28
10120384|NCT02561195|11251429|FG005|NOT COMPLETED|Vaccination 1 to 3||10
10120385|NCT02561195|11251430|FG006|NOT COMPLETED|Vaccination 1 to 3||0
10056424|NCT02065622|11181197|FG001|NOT COMPLETED|Induction Study||59
10056425|NCT02065622|11181198|FG002|NOT COMPLETED|Induction Study||0
10120386|NCT02561195|11251431|FG007|NOT COMPLETED|Vaccination 1 to 3||0
10120387|NCT02561195|11251432|FG008|NOT COMPLETED|Vaccination 1 to 3||0
10120388|NCT02561195|11251433|FG009|NOT COMPLETED|Vaccination 1 to 3||0
10120389|NCT02561195|11251434|FG010|NOT COMPLETED|Vaccination 1 to 3||0
10120390|NCT02561195|11251435|FG011|NOT COMPLETED|Vaccination 1 to 3||0
10120391|NCT02561195|11251436|FG012|NOT COMPLETED|Vaccination 1 to 3||0
10120392|NCT02561195|11251437|FG013|NOT COMPLETED|Vaccination 1 to 3||0
10056426|NCT02065622|11181199|FG003|NOT COMPLETED|Induction Study||0
10056427|NCT02065622|11181200|FG004|NOT COMPLETED|Induction Study||0
10056428|NCT02065622|11181196|FG000|STARTED|Maintenance Study||0
10056429|NCT02065622|11181197|FG001|STARTED|Maintenance Study||0
10056430|NCT02065622|11181198|FG002|STARTED|Maintenance Study||345
10056431|NCT02065622|11181199|FG003|STARTED|Maintenance Study||350
10056432|NCT02065622|11181200|FG004|STARTED|Maintenance Study||151
10056433|NCT02065622|11181196|FG000|COMPLETED|Maintenance Study||0
10056434|NCT02065622|11181197|FG001|COMPLETED|Maintenance Study||0
10056435|NCT02065622|11181198|FG002|COMPLETED|Maintenance Study||221
10056436|NCT02065622|11181199|FG003|COMPLETED|Maintenance Study||246
10056437|NCT02065622|11181200|FG004|COMPLETED|Maintenance Study||105
10056438|NCT02065622|11181196|FG000|NOT COMPLETED|Maintenance Study||0
10056439|NCT02065622|11181197|FG001|NOT COMPLETED|Maintenance Study||0
10056440|NCT02065622|11181198|FG002|NOT COMPLETED|Maintenance Study||124
10056441|NCT02065622|11181199|FG003|NOT COMPLETED|Maintenance Study||104
10056442|NCT02065622|11181200|FG004|NOT COMPLETED|Maintenance Study||46
10056443|NCT02065687|11181217|FG000|STARTED|Overall Study||234
10056444|NCT02065687|11181218|FG001|STARTED|Overall Study||235
10056445|NCT02065687|11181217|FG000|COMPLETED|Overall Study||234
10056446|NCT02065687|11181218|FG001|COMPLETED|Overall Study||235
10056447|NCT02065687|11181217|FG000|NOT COMPLETED|Overall Study||0
10056448|NCT02065687|11181218|FG001|NOT COMPLETED|Overall Study||0
10056449|NCT02065713|11181226|FG000|STARTED|Overall Study||23
10056450|NCT02065713|11181227|FG001|STARTED|Overall Study||21
10056451|NCT02065713|11181226|FG000|COMPLETED|Overall Study||22
10056452|NCT02065713|11181227|FG001|COMPLETED|Overall Study||20
10056453|NCT02065713|11181226|FG000|NOT COMPLETED|Overall Study||1
10056454|NCT02065713|11181227|FG001|NOT COMPLETED|Overall Study||1
10056455|NCT02065791|11181235|FG000|STARTED|Overall Study||2199
10056456|NCT02065791|11181236|FG001|STARTED|Overall Study||2202
10056457|NCT02065791|11181235|FG000|Treated|Overall Study||2197
10056458|NCT02065791|11181236|FG001|Treated|Overall Study||2200
10056459|NCT02065791|11181235|FG000|COMPLETED|Overall Study||2174
10056460|NCT02065791|11181236|FG001|COMPLETED|Overall Study||2187
10056461|NCT02065791|11181235|FG000|NOT COMPLETED|Overall Study||25
10056462|NCT02065791|11181236|FG001|NOT COMPLETED|Overall Study||15
10056463|NCT02065895|11181242|FG000|STARTED|Overall Study||1
10056464|NCT02065895|11181243|FG001|STARTED|Overall Study||3
10056465|NCT02065895|11181244|FG002|STARTED|Overall Study||1
10056466|NCT02065895|11181245|FG003|STARTED|Overall Study||1
10056467|NCT02065895|11181246|FG004|STARTED|Overall Study||1
10056468|NCT02065895|11181247|FG005|STARTED|Overall Study||1
10056469|NCT02065895|11181242|FG000|COMPLETED|Overall Study||0
10056470|NCT02065895|11181243|FG001|COMPLETED|Overall Study||2
10056471|NCT02065895|11181244|FG002|COMPLETED|Overall Study||1
10056472|NCT02065895|11181245|FG003|COMPLETED|Overall Study||0
10056473|NCT02065895|11181246|FG004|COMPLETED|Overall Study||1
10056474|NCT02065895|11181247|FG005|COMPLETED|Overall Study||1
10056475|NCT02065895|11181242|FG000|NOT COMPLETED|Overall Study||1
10056476|NCT02065895|11181243|FG001|NOT COMPLETED|Overall Study||1
10056477|NCT02065895|11181244|FG002|NOT COMPLETED|Overall Study||0
10056478|NCT02065895|11181245|FG003|NOT COMPLETED|Overall Study||1
10056479|NCT02065895|11181246|FG004|NOT COMPLETED|Overall Study||0
10056480|NCT02065895|11181247|FG005|NOT COMPLETED|Overall Study||0
10056481|NCT02066051|11181264|FG000|STARTED|Overall Study||8
10056482|NCT02066051|11181264|FG000|COMPLETED|Overall Study||7
10056483|NCT02066051|11181264|FG000|NOT COMPLETED|Overall Study||1
10056484|NCT02066129|11181270|FG000|STARTED|Overall Study||127
10056485|NCT02066129|11181271|FG001|STARTED|Overall Study||127
10056486|NCT02066129|11181270|FG000|COMPLETED|Overall Study||98
10056487|NCT02066129|11181271|FG001|COMPLETED|Overall Study||94
10056488|NCT02066129|11181270|FG000|NOT COMPLETED|Overall Study||29
10056489|NCT02066129|11181271|FG001|NOT COMPLETED|Overall Study||33
10056490|NCT02066233|11181279|FG000|STARTED|EG Scan II (Day 1)||50
10056491|NCT02066233|11181280|FG001|STARTED|EG Scan II (Day 1)||50
10056492|NCT02066233|11181279|FG000|COMPLETED|EG Scan II (Day 1)||44
10056493|NCT02066233|11181280|FG001|COMPLETED|EG Scan II (Day 1)||44
10056494|NCT02066233|11181279|FG000|NOT COMPLETED|EG Scan II (Day 1)||6
10056495|NCT02066233|11181280|FG001|NOT COMPLETED|EG Scan II (Day 1)||6
10056496|NCT02066233|11181279|FG000|STARTED|Standard Endoscopy (Day 2)||44
10056497|NCT02066233|11181280|FG001|STARTED|Standard Endoscopy (Day 2)||44
10056498|NCT02066233|11181279|FG000|COMPLETED|Standard Endoscopy (Day 2)||44
10056499|NCT02066233|11181280|FG001|COMPLETED|Standard Endoscopy (Day 2)||44
10056500|NCT02066233|11181279|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0
10056501|NCT02066233|11181280|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0
10056502|NCT02066298|11181292|FG000|STARTED|Overall Study||49
10120393|NCT02561195|11251424|FG000|STARTED|Extension Stage (Vaccination 4)||0
10120394|NCT02561195|11251425|FG001|STARTED|Extension Stage (Vaccination 4)||0
10120395|NCT02561195|11251426|FG002|STARTED|Extension Stage (Vaccination 4)||0
10120396|NCT02561195|11251427|FG003|STARTED|Extension Stage (Vaccination 4)||0
10120397|NCT02561195|11251428|FG004|STARTED|Extension Stage (Vaccination 4)||0
10120398|NCT02561195|11251429|FG005|STARTED|Extension Stage (Vaccination 4)||0
10120399|NCT02561195|11251430|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
10120400|NCT02561195|11251431|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
10120401|NCT02561195|11251432|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
10120402|NCT02561195|11251433|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
10120403|NCT02561195|11251434|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
10056503|NCT02066298|11181293|FG001|STARTED|Overall Study||48
10056504|NCT02066298|11181294|FG002|STARTED|Overall Study||50
10056505|NCT02066298|11181295|FG003|STARTED|Overall Study||51
10056506|NCT02066298|11181296|FG004|STARTED|Overall Study||47
10056507|NCT02066298|11181297|FG005|STARTED|Overall Study||50
10056508|NCT02066298|11181292|FG000|Completed 1st Period|Overall Study||44
10056509|NCT02066298|11181293|FG001|Completed 1st Period|Overall Study||47
10056510|NCT02066298|11181294|FG002|Completed 1st Period|Overall Study||45
10056511|NCT02066298|11181295|FG003|Completed 1st Period|Overall Study||48
10056512|NCT02066298|11181296|FG004|Completed 1st Period|Overall Study||46
10056513|NCT02066298|11181297|FG005|Completed 1st Period|Overall Study||45
10056514|NCT02066298|11181292|FG000|Completed 2nd Period|Overall Study||41
10056515|NCT02066298|11181293|FG001|Completed 2nd Period|Overall Study||41
10056516|NCT02066298|11181294|FG002|Completed 2nd Period|Overall Study||41
10056517|NCT02066298|11181295|FG003|Completed 2nd Period|Overall Study||46
10056518|NCT02066298|11181296|FG004|Completed 2nd Period|Overall Study||42
10056519|NCT02066298|11181297|FG005|Completed 2nd Period|Overall Study||41
10056520|NCT02066298|11181292|FG000|Completed 3rd Period|Overall Study||40
10056521|NCT02066298|11181293|FG001|Completed 3rd Period|Overall Study||40
10056522|NCT02066298|11181294|FG002|Completed 3rd Period|Overall Study||40
10056523|NCT02066298|11181295|FG003|Completed 3rd Period|Overall Study||45
10056524|NCT02066298|11181296|FG004|Completed 3rd Period|Overall Study||38
10056525|NCT02066298|11181297|FG005|Completed 3rd Period|Overall Study||38
10056526|NCT02066298|11181292|FG000|COMPLETED|Overall Study||40
10056527|NCT02066298|11181293|FG001|COMPLETED|Overall Study||40
10056528|NCT02066298|11181294|FG002|COMPLETED|Overall Study||40
10056529|NCT02066298|11181295|FG003|COMPLETED|Overall Study||45
10056530|NCT02066298|11181296|FG004|COMPLETED|Overall Study||38
10120404|NCT02561195|11251435|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
10120405|NCT02561195|11251436|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
10120406|NCT02561195|11251437|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
10120407|NCT02561195|11251424|FG000|COMPLETED|Extension Stage (Vaccination 4)||0
10120408|NCT02561195|11251425|FG001|COMPLETED|Extension Stage (Vaccination 4)||0
10120409|NCT02561195|11251426|FG002|COMPLETED|Extension Stage (Vaccination 4)||0
10120410|NCT02561195|11251427|FG003|COMPLETED|Extension Stage (Vaccination 4)||0
10120411|NCT02561195|11251428|FG004|COMPLETED|Extension Stage (Vaccination 4)||0
10120412|NCT02561195|11251429|FG005|COMPLETED|Extension Stage (Vaccination 4)||0
10120413|NCT02561195|11251430|FG006|COMPLETED|Extension Stage (Vaccination 4)||14
10120414|NCT02561195|11251431|FG007|COMPLETED|Extension Stage (Vaccination 4)||17
10120415|NCT02561195|11251432|FG008|COMPLETED|Extension Stage (Vaccination 4)||21
10120416|NCT02561195|11251433|FG009|COMPLETED|Extension Stage (Vaccination 4)||20
10120417|NCT02561195|11251434|FG010|COMPLETED|Extension Stage (Vaccination 4)||43
10120418|NCT02561195|11251435|FG011|COMPLETED|Extension Stage (Vaccination 4)||45
10120419|NCT02561195|11251436|FG012|COMPLETED|Extension Stage (Vaccination 4)||51
10120420|NCT02561195|11251437|FG013|COMPLETED|Extension Stage (Vaccination 4)||54
10120421|NCT02561195|11251424|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10120422|NCT02561195|11251425|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10120423|NCT02561195|11251426|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10120424|NCT02561195|11251427|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10120425|NCT02561195|11251428|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10120426|NCT02561195|11251429|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10120427|NCT02561195|11251430|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2
10120428|NCT02561195|11251431|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1
10120429|NCT02561195|11251432|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3
10120430|NCT02561195|11251433|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2
10120431|NCT02561195|11251434|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8
10120432|NCT02561195|11251435|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7
10120433|NCT02561195|11251436|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7
10120434|NCT02561195|11251437|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5
10120435|NCT02561221|11251471|FG000|STARTED|Overall Study||452
10120436|NCT02561221|11251472|FG001|STARTED|Overall Study||351
10120437|NCT02561221|11251471|FG000|Month 6|Overall Study||386
10120438|NCT02561221|11251472|FG001|Month 6|Overall Study||340
10120439|NCT02561221|11251471|FG000|Month 12|Overall Study||365
10120440|NCT02561221|11251472|FG001|Month 12|Overall Study||326
10120441|NCT02561221|11251471|FG000|Month 18|Overall Study||357
10120442|NCT02561221|11251472|FG001|Month 18|Overall Study||316
10120443|NCT02561221|11251471|FG000|COMPLETED|Overall Study||362
10120444|NCT02561221|11251472|FG001|COMPLETED|Overall Study||308
10056531|NCT02066298|11181297|FG005|COMPLETED|Overall Study||38
10056532|NCT02066298|11181292|FG000|NOT COMPLETED|Overall Study||9
10056533|NCT02066298|11181293|FG001|NOT COMPLETED|Overall Study||8
10056534|NCT02066298|11181294|FG002|NOT COMPLETED|Overall Study||10
10056535|NCT02066298|11181295|FG003|NOT COMPLETED|Overall Study||6
9848644|NCT00860795|10961396|FG000|STARTED|Overall Study||10
9848645|NCT00860795|10961397|FG001|STARTED|Overall Study||10
10056536|NCT02066298|11181296|FG004|NOT COMPLETED|Overall Study||9
10056537|NCT02066298|11181297|FG005|NOT COMPLETED|Overall Study||12
10056538|NCT02066311|11181309|FG000|STARTED|Overall Study||15
10056539|NCT02066311|11181309|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
10056540|NCT02066311|11181309|FG000|NOT COMPLETED|Overall Study||5
10056541|NCT02066389|11181319|FG000|STARTED|Overall Study||50
10056542|NCT02066389|11181320|FG001|STARTED|Overall Study||50
10056543|NCT02066389|11181321|FG002|STARTED|Overall Study||50
10056544|NCT02066389|11181322|FG003|STARTED|Overall Study||50
10056545|NCT02066389|11181323|FG004|STARTED|Overall Study||50
10056546|NCT02066389|11181324|FG005|STARTED|Overall Study||50
10056547|NCT02066389|11181319|FG000|Received Study Drug|Overall Study||50
10056548|NCT02066389|11181320|FG001|Received Study Drug|Overall Study||50
10056549|NCT02066389|11181321|FG002|Received Study Drug|Overall Study||50
10056550|NCT02066389|11181322|FG003|Received Study Drug|Overall Study||50
10056551|NCT02066389|11181323|FG004|Received Study Drug|Overall Study||50
10056552|NCT02066389|11181324|FG005|Received Study Drug|Overall Study||49
10056553|NCT02066389|11181319|FG000|COMPLETED|Overall Study||45
10056554|NCT02066389|11181320|FG001|COMPLETED|Overall Study||49
10056555|NCT02066389|11181321|FG002|COMPLETED|Overall Study||44
10056556|NCT02066389|11181322|FG003|COMPLETED|Overall Study||47
10056557|NCT02066389|11181323|FG004|COMPLETED|Overall Study||43
10056558|NCT02066389|11181324|FG005|COMPLETED|Overall Study||45
10056559|NCT02066389|11181319|FG000|NOT COMPLETED|Overall Study||5
10056560|NCT02066389|11181320|FG001|NOT COMPLETED|Overall Study||1
10056561|NCT02066389|11181321|FG002|NOT COMPLETED|Overall Study||6
10056562|NCT02066389|11181322|FG003|NOT COMPLETED|Overall Study||3
10056563|NCT02066389|11181323|FG004|NOT COMPLETED|Overall Study||7
10056564|NCT02066389|11181324|FG005|NOT COMPLETED|Overall Study||5
10056565|NCT02066402|11181340|FG000|STARTED|Overall Study||300
10056566|NCT02066402|11181341|FG001|STARTED|Overall Study||298
10056567|NCT02066402|11181340|FG000|Participants Received Treatment|Overall Study||292
10056568|NCT02066402|11181341|FG001|Participants Received Treatment|Overall Study||297
10056569|NCT02066402|11181340|FG000|Completed Study Treatment Period|Overall Study||261
10056570|NCT02066402|11181341|FG001|Completed Study Treatment Period|Overall Study||256
10056571|NCT02066402|11181340|FG000|COMPLETED|Overall Study||274
10056572|NCT02066402|11181341|FG001|COMPLETED|Overall Study||275
10056573|NCT02066402|11181340|FG000|NOT COMPLETED|Overall Study||26
10056574|NCT02066402|11181341|FG001|NOT COMPLETED|Overall Study||23
10056575|NCT02066467|11181347|FG000|STARTED|Overall Study||863
10056576|NCT02066467|11181347|FG000|COMPLETED|Overall Study||648
10056577|NCT02066467|11181347|FG000|NOT COMPLETED|Overall Study||215
10056578|NCT02066727|11181353|FG000|STARTED|Overall Study||30
10056579|NCT02066727|11181354|FG001|STARTED|Overall Study||30
10056580|NCT02066727|11181353|FG000|COMPLETED|Overall Study||30
10056581|NCT02066727|11181354|FG001|COMPLETED|Overall Study||30
10056582|NCT02066727|11181353|FG000|NOT COMPLETED|Overall Study||0
10056583|NCT02066727|11181354|FG001|NOT COMPLETED|Overall Study||0
10056584|NCT02066740|11181360|FG000|STARTED|Overall Study||34
10056585|NCT02066740|11181360|FG000|COMPLETED|Overall Study||32
10056586|NCT02066740|11181360|FG000|NOT COMPLETED|Overall Study||2
10056587|NCT02066792|11181368|FG000|STARTED|Overall Study||40
10056588|NCT02066792|11181369|FG001|STARTED|Overall Study||38
10056589|NCT02066792|11181370|FG002|STARTED|Overall Study||38
10056590|NCT02066792|11181371|FG003|STARTED|Overall Study||36
10056591|NCT02066792|11181368|FG000|COMPLETED|Overall Study||33
10056592|NCT02066792|11181369|FG001|COMPLETED|Overall Study||33
10056593|NCT02066792|11181370|FG002|COMPLETED|Overall Study||30
10056594|NCT02066792|11181371|FG003|COMPLETED|Overall Study||27
10056595|NCT02066792|11181368|FG000|NOT COMPLETED|Overall Study||7
10120445|NCT02561221|11251471|FG000|NOT COMPLETED|Overall Study||90
10120446|NCT02561221|11251472|FG001|NOT COMPLETED|Overall Study||43
10120447|NCT02561247|11251478|FG000|STARTED|Overall Study||23
10120448|NCT02561247|11251478|FG000|COMPLETED|Overall Study||17
10120449|NCT02561247|11251478|FG000|NOT COMPLETED|Overall Study||6
10120450|NCT02561273|11251484|FG000|STARTED|Overall Study||40
10120451|NCT02561273|11251485|FG001|STARTED|Overall Study||4
10120452|NCT02561273|11251484|FG000|COMPLETED|Overall Study||39
10120453|NCT02561273|11251485|FG001|COMPLETED|Overall Study||4
10120454|NCT02561273|11251484|FG000|NOT COMPLETED|Overall Study||1
10120455|NCT02561273|11251485|FG001|NOT COMPLETED|Overall Study||0
10120456|NCT02561338|11251498|FG000|STARTED|Overall Study||53
10120457|NCT02561338|11251499|FG001|STARTED|Overall Study||50
10120458|NCT02561338|11251500|FG002|STARTED|Overall Study||51
10120459|NCT02561338|11251501|FG003|STARTED|Overall Study||51
10120460|NCT02561338|11251502|FG004|STARTED|Overall Study||53
9706652|NCT02498132|10805729|FG000|STARTED|Overall Study||24
10056596|NCT02066792|11181369|FG001|NOT COMPLETED|Overall Study||5
10056597|NCT02066792|11181370|FG002|NOT COMPLETED|Overall Study||8
10056598|NCT02066792|11181371|FG003|NOT COMPLETED|Overall Study||9
10056599|NCT02066857|11181383|FG000|STARTED|Overall Study||1
10120461|NCT02561338|11251498|FG000|COMPLETED|Overall Study||45
10120462|NCT02561338|11251499|FG001|COMPLETED|Overall Study||44
10120463|NCT02561338|11251500|FG002|COMPLETED|Overall Study||42
10120464|NCT02561338|11251501|FG003|COMPLETED|Overall Study||46
9706653|NCT02498132|10805730|FG001|STARTED|Overall Study||19
9706654|NCT02498132|10805731|FG002|STARTED|Overall Study||9
9706655|NCT02498132|10805729|FG000|COMPLETED|Overall Study||22
9706656|NCT02498132|10805730|FG001|COMPLETED|Overall Study||18
9706657|NCT02498132|10805731|FG002|COMPLETED|Overall Study||9
9706658|NCT02498132|10805729|FG000|NOT COMPLETED|Overall Study||2
9706659|NCT02498132|10805730|FG001|NOT COMPLETED|Overall Study||1
9706660|NCT02498132|10805731|FG002|NOT COMPLETED|Overall Study||0
9706661|NCT02450760|10805741|FG000|STARTED|Overall Study||15
9706662|NCT02450760|10805742|FG001|STARTED|Overall Study||18
10056600|NCT02066857|11181384|FG001|STARTED|Overall Study||4
10056601|NCT02066857|11181383|FG000|COMPLETED|Overall Study||0
10056602|NCT02066857|11181384|FG001|COMPLETED|Overall Study||3
10056603|NCT02066857|11181383|FG000|NOT COMPLETED|Overall Study||1
10056604|NCT02066857|11181384|FG001|NOT COMPLETED|Overall Study||1
10056605|NCT02066896|11181393|FG000|STARTED|Overall Study||33
10056606|NCT02066896|11181394|FG001|STARTED|Overall Study||33
10056607|NCT02066896|11181393|FG000|COMPLETED|Overall Study||33
10056608|NCT02066896|11181394|FG001|COMPLETED|Overall Study||33
10056609|NCT02066896|11181393|FG000|NOT COMPLETED|Overall Study||0
10056610|NCT02066896|11181394|FG001|NOT COMPLETED|Overall Study||0
10056611|NCT02066922|11181400|FG000|STARTED|Overall Study||15
10056612|NCT02066922|11181400|FG000|COMPLETED|Overall Study||14
10056613|NCT02066922|11181400|FG000|NOT COMPLETED|Overall Study||1
10056614|NCT02067000|11181407|FG000|STARTED|Overall Study||217
10056615|NCT02067000|11181407|FG000|COMPLETED|Overall Study||167
10056616|NCT02067000|11181407|FG000|NOT COMPLETED|Overall Study||50
10056617|NCT02067039|11181413|FG000|STARTED|Overall Study||1325
10056618|NCT02067039|11181414|FG001|STARTED|Overall Study||1340
10056619|NCT02067039|11181413|FG000|3 Month Survey|Overall Study||824
10056620|NCT02067039|11181414|FG001|3 Month Survey|Overall Study||766
10056621|NCT02067039|11181413|FG000|6 Month Survey|Overall Study||735
10056622|NCT02067039|11181414|FG001|6 Month Survey|Overall Study||756
10056623|NCT02067039|11181413|FG000|9 Month Survey|Overall Study||748
10056624|NCT02067039|11181414|FG001|9 Month Survey|Overall Study||838
10056625|NCT02067039|11181413|FG000|COMPLETED|Overall Study||752
10056626|NCT02067039|11181414|FG001|COMPLETED|Overall Study||832
10056627|NCT02067039|11181413|FG000|NOT COMPLETED|Overall Study||573
10056628|NCT02067039|11181414|FG001|NOT COMPLETED|Overall Study||508
10056629|NCT02067273|11181424|FG000|STARTED|Overall Study||5
10056630|NCT02067273|11181425|FG001|STARTED|Overall Study||15
10056631|NCT02067273|11181424|FG000|COMPLETED|Overall Study||5
10056632|NCT02067273|11181425|FG001|COMPLETED|Overall Study||12
10056633|NCT02067273|11181424|FG000|NOT COMPLETED|Overall Study||0
10056634|NCT02067273|11181425|FG001|NOT COMPLETED|Overall Study||3
10056635|NCT02067468|11181434|FG000|STARTED|Overall Study||882
10056636|NCT02067468|11181435|FG001|STARTED|Overall Study||890
10056637|NCT02067468|11181436|FG002|STARTED|Overall Study||889
10056638|NCT02067468|11181434|FG000|Followed-up Through Medical Records|Overall Study||882
10056639|NCT02067468|11181435|FG001|Followed-up Through Medical Records|Overall Study||890
10056640|NCT02067468|11181436|FG002|Followed-up Through Medical Records|Overall Study||889
10056641|NCT02067468|11181434|FG000|Had at Least One Routine Colposcopy|Overall Study||772
10056642|NCT02067468|11181435|FG001|Had at Least One Routine Colposcopy|Overall Study||372
10056643|NCT02067468|11181436|FG002|Had at Least One Routine Colposcopy|Overall Study||462
10056644|NCT02067468|11181434|FG000|COMPLETED|Overall Study||882
10056645|NCT02067468|11181435|FG001|COMPLETED|Overall Study||890
10056646|NCT02067468|11181436|FG002|COMPLETED|Overall Study||889
10056647|NCT02067468|11181434|FG000|NOT COMPLETED|Overall Study||0
10056648|NCT02067468|11181435|FG001|NOT COMPLETED|Overall Study||0
10056649|NCT02067468|11181436|FG002|NOT COMPLETED|Overall Study||0
10056650|NCT02067533|11181446|FG000|STARTED|Overall Study||45
10056651|NCT02067533|11181447|FG001|STARTED|Overall Study||46
10056652|NCT02067533|11181446|FG000|COMPLETED|Overall Study||41
10056653|NCT02067533|11181447|FG001|COMPLETED|Overall Study||44
10056654|NCT02067533|11181446|FG000|NOT COMPLETED|Overall Study||4
10056655|NCT02067533|11181447|FG001|NOT COMPLETED|Overall Study||2
10056656|NCT02067585|11181456|FG000|STARTED|Overall Study||16
10056657|NCT02067585|11181457|FG001|STARTED|Overall Study||16
10056658|NCT02067585|11181458|FG002|STARTED|Overall Study||16
10056659|NCT02067585|11181456|FG000|COMPLETED|Overall Study||16
10056660|NCT02067585|11181457|FG001|COMPLETED|Overall Study||16
10056661|NCT02067585|11181458|FG002|COMPLETED|Overall Study||16
10056662|NCT02067585|11181456|FG000|NOT COMPLETED|Overall Study||0
10056663|NCT02067585|11181457|FG001|NOT COMPLETED|Overall Study||0
10056664|NCT02067585|11181458|FG002|NOT COMPLETED|Overall Study||0
10056665|NCT02067663|11181468|FG000|STARTED|Overall Study||68
10056666|NCT02067663|11181469|FG001|STARTED|Overall Study||55
10120465|NCT02561338|11251502|FG004|COMPLETED|Overall Study||51
10120466|NCT02561338|11251498|FG000|NOT COMPLETED|Overall Study||8
10120467|NCT02561338|11251499|FG001|NOT COMPLETED|Overall Study||6
10120468|NCT02561338|11251500|FG002|NOT COMPLETED|Overall Study||9
10056667|NCT02067663|11181468|FG000|COMPLETED|Overall Study||55
10056668|NCT02067663|11181469|FG001|COMPLETED|Overall Study||41
10056669|NCT02067663|11181468|FG000|NOT COMPLETED|Overall Study||13
10056670|NCT02067663|11181469|FG001|NOT COMPLETED|Overall Study||14
10056671|NCT02067676|11181481|FG000|STARTED|Overall Study||8
10056672|NCT02067676|11181482|FG001|STARTED|Overall Study||8
10056673|NCT02067676|11181483|FG002|STARTED|Overall Study||8
10056674|NCT02067676|11181484|FG003|STARTED|Overall Study||8
10056675|NCT02067676|11181485|FG004|STARTED|Overall Study||8
10056676|NCT02067676|11181486|FG005|STARTED|Overall Study||8
10056677|NCT02067676|11181481|FG000|COMPLETED|Overall Study||7
10056678|NCT02067676|11181482|FG001|COMPLETED|Overall Study||8
10056679|NCT02067676|11181483|FG002|COMPLETED|Overall Study||8
10056680|NCT02067676|11181484|FG003|COMPLETED|Overall Study||8
10056681|NCT02067676|11181485|FG004|COMPLETED|Overall Study||8
10056682|NCT02067676|11181486|FG005|COMPLETED|Overall Study||8
10056683|NCT02067676|11181481|FG000|NOT COMPLETED|Overall Study||1
10056684|NCT02067676|11181482|FG001|NOT COMPLETED|Overall Study||0
10056685|NCT02067676|11181483|FG002|NOT COMPLETED|Overall Study||0
10056686|NCT02067676|11181484|FG003|NOT COMPLETED|Overall Study||0
10056687|NCT02067676|11181485|FG004|NOT COMPLETED|Overall Study||0
10056688|NCT02067676|11181486|FG005|NOT COMPLETED|Overall Study||0
10056689|NCT02067728|11181507|FG000|STARTED|Baseline - 1 Month Follow up Survey||220
10056690|NCT02067728|11181508|FG001|STARTED|Baseline - 1 Month Follow up Survey||210
10056691|NCT02067728|11181507|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
10056692|NCT02067728|11181508|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
10056693|NCT02067728|11181507|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
10056694|NCT02067728|11181508|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
10056695|NCT02067728|11181507|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
10056696|NCT02067728|11181508|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
10056697|NCT02067728|11181507|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
10056698|NCT02067728|11181508|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
10056699|NCT02067728|11181507|FG000|NOT COMPLETED|6 Month Follow up Survey||48
10056700|NCT02067728|11181508|FG001|NOT COMPLETED|6 Month Follow up Survey||60
10056701|NCT02067728|11181507|FG000|STARTED|6 Month Measurements||220
10056702|NCT02067728|11181508|FG001|STARTED|6 Month Measurements||210
10056703|NCT02067728|11181507|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
10056704|NCT02067728|11181508|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
10056705|NCT02067728|11181507|FG000|NOT COMPLETED|6 Month Measurements||114
10056706|NCT02067728|11181508|FG001|NOT COMPLETED|6 Month Measurements||97
10056707|NCT02067806|11181514|FG000|STARTED|Overall Study||394
10056708|NCT02067806|11181514|FG000|COMPLETED|Overall Study||387
10056709|NCT02067806|11181514|FG000|NOT COMPLETED|Overall Study||7
10056710|NCT02067858|11181519|FG000|STARTED|Overall Study||6
10056711|NCT02067858|11181519|FG000|COMPLETED|Overall Study||6
10056712|NCT02067858|11181519|FG000|NOT COMPLETED|Overall Study||0
10056713|NCT02068027|11181525|FG000|STARTED|Overall Study||130
10056714|NCT02068027|11181526|FG001|STARTED|Overall Study||130
10056715|NCT02068027|11181525|FG000|COMPLETED|Overall Study||117
10056716|NCT02068027|11181526|FG001|COMPLETED|Overall Study||114
10056717|NCT02068027|11181525|FG000|NOT COMPLETED|Overall Study||13
10056718|NCT02068027|11181526|FG001|NOT COMPLETED|Overall Study||16
10056719|NCT02068118|11181534|FG000|STARTED|18-month Comparative Study Period||455
10056720|NCT02068118|11181535|FG001|STARTED|18-month Comparative Study Period||482
10056721|NCT02068118|11181534|FG000|COMPLETED|18-month Comparative Study Period||327
10056722|NCT02068118|11181535|FG001|COMPLETED|18-month Comparative Study Period||305
10056723|NCT02068118|11181534|FG000|NOT COMPLETED|18-month Comparative Study Period||128
10056724|NCT02068118|11181535|FG001|NOT COMPLETED|18-month Comparative Study Period||177
10056725|NCT02068118|11181534|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7
10056726|NCT02068118|11181535|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13
10056727|NCT02068118|11181534|FG000|COMPLETED|Extension Period||5
10056728|NCT02068118|11181535|FG001|COMPLETED|Extension Period||10
10056729|NCT02068118|11181534|FG000|NOT COMPLETED|Extension Period||2
10056730|NCT02068118|11181535|FG001|NOT COMPLETED|Extension Period||3
10056731|NCT02068157|11181543|FG000|STARTED|Overall Study||3
10056732|NCT02068157|11181543|FG000|COMPLETED|Overall Study||3
10056733|NCT02068157|11181543|FG000|NOT COMPLETED|Overall Study||0
10056734|NCT02068222|11181547|FG000|STARTED|Overall Study||10
10056735|NCT02068222|11181547|FG000|COMPLETED|Overall Study||9
10056736|NCT02068222|11181547|FG000|NOT COMPLETED|Overall Study||1
10056737|NCT02068352|11181554|FG000|STARTED|Overall Study||41
10056738|NCT02068352|11181555|FG001|STARTED|Overall Study||43
10056739|NCT02068352|11181556|FG002|STARTED|Overall Study||37
10056740|NCT02068352|11181554|FG000|COMPLETED|Overall Study||31
10056741|NCT02068352|11181555|FG001|COMPLETED|Overall Study||35
10056742|NCT02068352|11181556|FG002|COMPLETED|Overall Study||28
10056743|NCT02068352|11181554|FG000|NOT COMPLETED|Overall Study||10
10056744|NCT02068352|11181555|FG001|NOT COMPLETED|Overall Study||8
10056745|NCT02068352|11181556|FG002|NOT COMPLETED|Overall Study||9
10056746|NCT02068443|11181567|FG000|STARTED|Overall Study||71
10056747|NCT02068443|11181568|FG001|STARTED|Overall Study||152
10056748|NCT02068443|11181569|FG002|STARTED|Overall Study||151
10056749|NCT02068443|11181567|FG000|COMPLETED|Overall Study||64
10056750|NCT02068443|11181568|FG001|COMPLETED|Overall Study||146
10056751|NCT02068443|11181569|FG002|COMPLETED|Overall Study||148
10056752|NCT02068443|11181567|FG000|NOT COMPLETED|Overall Study||7
10056753|NCT02068443|11181568|FG001|NOT COMPLETED|Overall Study||6
10056754|NCT02068443|11181569|FG002|NOT COMPLETED|Overall Study||3
10120469|NCT02561338|11251501|FG003|NOT COMPLETED|Overall Study||5
10120470|NCT02561338|11251502|FG004|NOT COMPLETED|Overall Study||2
10056755|NCT02068495|11181577|FG000|STARTED|Overall Study||3409
10056756|NCT02068495|11181577|FG000|COMPLETED|Overall Study||3300
10056757|NCT02068495|11181577|FG000|NOT COMPLETED|Overall Study||109
10056758|NCT02068508|11181581|FG000|STARTED|Overall Study||1067
10120471|NCT02561455|11251520|FG000|STARTED|Overall Study||2
10120472|NCT02561455|11251521|FG001|STARTED|Overall Study||3
10056759|NCT02068508|11181581|FG000|COMPLETED|Overall Study||1035
10056760|NCT02068508|11181581|FG000|NOT COMPLETED|Overall Study||32
10056761|NCT02068599|11181588|FG000|STARTED|Overall Study||130
10056762|NCT02068599|11181589|FG001|STARTED|Overall Study||129
10056763|NCT02068599|11181590|FG002|STARTED|Overall Study||130
10056764|NCT02068599|11181588|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
10056765|NCT02068599|11181589|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
10056766|NCT02068599|11181590|FG002|Safety Analysis Set|Overall Study||130
10056767|NCT02068599|11181588|FG000|Full Analysis Set|Overall Study||129
10056768|NCT02068599|11181589|FG001|Full Analysis Set|Overall Study||128
10056769|NCT02068599|11181590|FG002|Full Analysis Set|Overall Study||130
10056770|NCT02068599|11181588|FG000|COMPLETED|Overall Study||119
10056771|NCT02068599|11181589|FG001|COMPLETED|Overall Study||119
10056772|NCT02068599|11181590|FG002|COMPLETED|Overall Study||117
10056773|NCT02068599|11181588|FG000|NOT COMPLETED|Overall Study||11
10056774|NCT02068599|11181589|FG001|NOT COMPLETED|Overall Study||10
10056775|NCT02068599|11181590|FG002|NOT COMPLETED|Overall Study||13
10056776|NCT02068729|11181598|FG000|STARTED|Overall Study||131
10056777|NCT02068729|11181598|FG000|COMPLETED|Overall Study||56
10056778|NCT02068729|11181598|FG000|NOT COMPLETED|Overall Study||75
10056779|NCT02068768|11181657|FG000|STARTED|Overall Study||13
10056780|NCT02068768|11181657|FG000|COMPLETED|Overall Study||6
10056781|NCT02068768|11181657|FG000|NOT COMPLETED|Overall Study||7
10056782|NCT02068820|11181663|FG000|STARTED|Overall Study||20
10056783|NCT02068820|11181664|FG001|STARTED|Overall Study||180
10056784|NCT02068820|11181663|FG000|COMPLETED|Overall Study||20
10056785|NCT02068820|11181664|FG001|COMPLETED|Overall Study||180
10056786|NCT02068820|11181663|FG000|NOT COMPLETED|Overall Study||0
10056787|NCT02068820|11181664|FG001|NOT COMPLETED|Overall Study||0
10056788|NCT02068846|11181677|FG000|STARTED|Overall Study||9
10056789|NCT02068846|11181678|FG001|STARTED|Overall Study||8
10056790|NCT02068846|11181677|FG000|COMPLETED|Overall Study||8
10056791|NCT02068846|11181678|FG001|COMPLETED|Overall Study||7
10056792|NCT02068846|11181677|FG000|NOT COMPLETED|Overall Study||1
10056793|NCT02068846|11181678|FG001|NOT COMPLETED|Overall Study||1
10056794|NCT02068885|11181687|FG000|STARTED|Overall Study||57
10056795|NCT02068885|11181688|FG001|STARTED|Overall Study||53
10056796|NCT02068885|11181689|FG002|STARTED|Overall Study||54
10056797|NCT02068885|11181687|FG000|Provided Data at Midpoint Test Phase|Overall Study||56
10056798|NCT02068885|11181688|FG001|Provided Data at Midpoint Test Phase|Overall Study||50
10056799|NCT02068885|11181689|FG002|Provided Data at Midpoint Test Phase|Overall Study||48
10056800|NCT02068885|11181687|FG000|Provided Data at End of Test Phase|Overall Study||54
10056801|NCT02068885|11181688|FG001|Provided Data at End of Test Phase|Overall Study||48
10056802|NCT02068885|11181689|FG002|Provided Data at End of Test Phase|Overall Study||46
10056803|NCT02068885|11181687|FG000|Included in Intention-to-treat Analysis|Overall Study||56
10056804|NCT02068885|11181688|FG001|Included in Intention-to-treat Analysis|Overall Study||52
10056805|NCT02068885|11181689|FG002|Included in Intention-to-treat Analysis|Overall Study||54
10056806|NCT02068885|11181687|FG000|COMPLETED|Overall Study||54
10056807|NCT02068885|11181688|FG001|COMPLETED|Overall Study||48
10056808|NCT02068885|11181689|FG002|COMPLETED|Overall Study||46
10056809|NCT02068885|11181687|FG000|NOT COMPLETED|Overall Study||3
10056810|NCT02068885|11181688|FG001|NOT COMPLETED|Overall Study||5
10056811|NCT02068885|11181689|FG002|NOT COMPLETED|Overall Study||8
10056812|NCT02069015|11181700|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
10056813|NCT02069015|11181701|FG001|STARTED|Overall Study||68
10056814|NCT02069015|11181700|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
10056815|NCT02069015|11181701|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45
10056816|NCT02069015|11181700|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38
10056817|NCT02069015|11181701|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43
10056818|NCT02069015|11181700|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32
10056819|NCT02069015|11181701|FG001|90 Day|Overall Study|90 day post ED discharge|35
10056820|NCT02069015|11181700|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31
10056821|NCT02069015|11181701|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
10056822|NCT02069015|11181700|FG000|NOT COMPLETED|Overall Study||40
10056823|NCT02069015|11181701|FG001|NOT COMPLETED|Overall Study||33
10056824|NCT02069041|11181708|FG000|STARTED|Overall Study||8
10056825|NCT02069041|11181708|FG000|Received at Least One Dose of Study Drug|Overall Study||8
10056826|NCT02069041|11181708|FG000|COMPLETED|Overall Study||8
10056827|NCT02069041|11181708|FG000|NOT COMPLETED|Overall Study||0
10056828|NCT02069093|11181712|FG000|STARTED|Overall Study||86
10056829|NCT02069093|11181712|FG000|Pharmacokinetic Analysis Set|Overall Study||50
10056830|NCT02069093|11181712|FG000|COMPLETED|Overall Study||56
10056831|NCT02069093|11181712|FG000|NOT COMPLETED|Overall Study||30
10056832|NCT02069119|11181720|FG000|STARTED|Overall Study||20
10056833|NCT02069119|11181721|FG001|STARTED|Overall Study||4
10056834|NCT02069119|11181722|FG002|STARTED|Overall Study||20
10056835|NCT02069119|11181723|FG003|STARTED|Overall Study||4
10056836|NCT02069119|11181720|FG000|COMPLETED|Overall Study||20
10056837|NCT02069119|11181721|FG001|COMPLETED|Overall Study||4
10056838|NCT02069119|11181722|FG002|COMPLETED|Overall Study||20
10056839|NCT02069119|11181723|FG003|COMPLETED|Overall Study||4
10056840|NCT02069119|11181720|FG000|NOT COMPLETED|Overall Study||0
10056841|NCT02069119|11181721|FG001|NOT COMPLETED|Overall Study||0
10056842|NCT02069119|11181722|FG002|NOT COMPLETED|Overall Study||0
10056843|NCT02069119|11181723|FG003|NOT COMPLETED|Overall Study||0
10056844|NCT02069184|11181737|FG000|STARTED|Overall Study||33
10056845|NCT02069184|11181738|FG001|STARTED|Overall Study||33
10056846|NCT02069184|11181737|FG000|COMPLETED|Overall Study||27
10056847|NCT02069184|11181738|FG001|COMPLETED|Overall Study||31
10056848|NCT02069184|11181737|FG000|NOT COMPLETED|Overall Study||6
10056849|NCT02069184|11181738|FG001|NOT COMPLETED|Overall Study||2
10056850|NCT02069353|11181744|FG000|STARTED|Overall Study||4
10056851|NCT02069353|11181744|FG000|COMPLETED|Overall Study||4
10056852|NCT02069353|11181744|FG000|NOT COMPLETED|Overall Study||0
10056853|NCT02069379|11181750|FG000|STARTED|Baseline Measurements||30
10056854|NCT02069379|11181751|FG001|STARTED|Baseline Measurements||4
10120473|NCT02561455|11251522|FG002|STARTED|Overall Study||3
10120474|NCT02561455|11251523|FG003|STARTED|Overall Study||1
10120475|NCT02561455|11251520|FG000|COMPLETED|Overall Study||0
10120476|NCT02561455|11251521|FG001|COMPLETED|Overall Study||1
10120477|NCT02561455|11251522|FG002|COMPLETED|Overall Study||0
10120478|NCT02561455|11251523|FG003|COMPLETED|Overall Study||0
9848646|NCT00860795|10961396|FG000|Number to Complete Study Medication|Overall Study||9
9848647|NCT00860795|10961397|FG001|Number to Complete Study Medication|Overall Study||10
9848648|NCT00860795|10961396|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
9848649|NCT00860795|10961397|FG001|COMPLETED|Overall Study||10
9848650|NCT00860795|10961396|FG000|NOT COMPLETED|Overall Study||0
9848651|NCT00860795|10961397|FG001|NOT COMPLETED|Overall Study||0
9848652|NCT00860847|10961405|FG000|STARTED|Overall Study||32
10056855|NCT02069379|11181752|FG002|STARTED|Baseline Measurements||2
10120479|NCT02561455|11251520|FG000|NOT COMPLETED|Overall Study||2
10120480|NCT02561455|11251521|FG001|NOT COMPLETED|Overall Study||2
10120481|NCT02561455|11251522|FG002|NOT COMPLETED|Overall Study||3
10120482|NCT02561455|11251523|FG003|NOT COMPLETED|Overall Study||1
10120483|NCT02561481|11251535|FG000|STARTED|Pilot Trial||10
10120484|NCT02561481|11251536|FG001|STARTED|Pilot Trial||0
10120485|NCT02561481|11251535|FG000|COMPLETED|Pilot Trial||10
10120486|NCT02561481|11251536|FG001|COMPLETED|Pilot Trial||0
10120487|NCT02561481|11251535|FG000|NOT COMPLETED|Pilot Trial||0
10120488|NCT02561481|11251536|FG001|NOT COMPLETED|Pilot Trial||0
10120489|NCT02561481|11251535|FG000|STARTED|Main Trial - Double Blind Phase||25
10120490|NCT02561481|11251536|FG001|STARTED|Main Trial - Double Blind Phase||25
10120491|NCT02561481|11251535|FG000|COMPLETED|Main Trial - Double Blind Phase||22
10120492|NCT02561481|11251536|FG001|COMPLETED|Main Trial - Double Blind Phase||23
10120493|NCT02561481|11251535|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3
10120494|NCT02561481|11251536|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2
10120495|NCT02561481|11251535|FG000|STARTED|Main Trial - Open Label Phase||45
10120496|NCT02561481|11251536|FG001|STARTED|Main Trial - Open Label Phase||0
10120497|NCT02561481|11251535|FG000|COMPLETED|Main Trial - Open Label Phase||32
10120498|NCT02561481|11251536|FG001|COMPLETED|Main Trial - Open Label Phase||0
10120499|NCT02561481|11251535|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13
10120500|NCT02561481|11251536|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0
10120501|NCT02561572|11251547|FG000|STARTED|Overall Study||64
10120502|NCT02561572|11251548|FG001|STARTED|Overall Study||64
10120503|NCT02561572|11251547|FG000|COMPLETED|Overall Study||62
10120504|NCT02561572|11251548|FG001|COMPLETED|Overall Study||62
10120505|NCT02561572|11251547|FG000|NOT COMPLETED|Overall Study||2
10120506|NCT02561572|11251548|FG001|NOT COMPLETED|Overall Study||2
10120507|NCT02561585|11251556|FG000|STARTED|Overall Study||20
10120508|NCT02561585|11251557|FG001|STARTED|Overall Study||11
10120509|NCT02561585|11251556|FG000|COMPLETED|Overall Study||17
10120510|NCT02561585|11251557|FG001|COMPLETED|Overall Study||6
10120511|NCT02561585|11251556|FG000|NOT COMPLETED|Overall Study||3
10120512|NCT02561585|11251557|FG001|NOT COMPLETED|Overall Study||5
10120513|NCT02561702|11251567|FG000|STARTED|First Intervention||2
10120514|NCT02561702|11251568|FG001|STARTED|First Intervention||2
10120515|NCT02561702|11251567|FG000|COMPLETED|First Intervention||2
10120516|NCT02561702|11251568|FG001|COMPLETED|First Intervention||2
10120517|NCT02561702|11251567|FG000|NOT COMPLETED|First Intervention||0
10120518|NCT02561702|11251568|FG001|NOT COMPLETED|First Intervention||0
10120519|NCT02561702|11251567|FG000|STARTED|Washout||2
10120520|NCT02561702|11251568|FG001|STARTED|Washout||2
10120521|NCT02561702|11251567|FG000|COMPLETED|Washout||2
10120522|NCT02561702|11251568|FG001|COMPLETED|Washout||2
10056856|NCT02069379|11181753|FG003|STARTED|Baseline Measurements||6
10120523|NCT02561702|11251567|FG000|NOT COMPLETED|Washout||0
10120524|NCT02561702|11251568|FG001|NOT COMPLETED|Washout||0
10120525|NCT02561702|11251567|FG000|STARTED|Second Intervention||2
10120526|NCT02561702|11251568|FG001|STARTED|Second Intervention||2
10120527|NCT02561702|11251567|FG000|COMPLETED|Second Intervention||2
10120528|NCT02561702|11251568|FG001|COMPLETED|Second Intervention||2
10120529|NCT02561702|11251567|FG000|NOT COMPLETED|Second Intervention||0
10120530|NCT02561702|11251568|FG001|NOT COMPLETED|Second Intervention||0
10120531|NCT02561806|11251576|FG000|STARTED|Induction Period||166
10120532|NCT02561806|11251577|FG001|STARTED|Induction Period||136
10120533|NCT02561806|11251576|FG000|Received At Least One Dose of Study Drug|Induction Period||166
10120534|NCT02561806|11251577|FG001|Received At Least One Dose of Study Drug|Induction Period||135
10056857|NCT02069379|11181750|FG000|Baseline Measurements Taken|Baseline Measurements||30
10120535|NCT02561806|11251576|FG000|COMPLETED|Induction Period||164
10120536|NCT02561806|11251577|FG001|COMPLETED|Induction Period||131
10120537|NCT02561806|11251576|FG000|NOT COMPLETED|Induction Period||2
10120538|NCT02561806|11251577|FG001|NOT COMPLETED|Induction Period||5
10120539|NCT02561806|11251576|FG000|STARTED|Maintenance Period||164
10120540|NCT02561806|11251577|FG001|STARTED|Maintenance Period||131
10056858|NCT02069379|11181751|FG001|Baseline Measurements Taken|Baseline Measurements||4
10056859|NCT02069379|11181752|FG002|Baseline Measurements Taken|Baseline Measurements||2
10056860|NCT02069379|11181753|FG003|Baseline Measurements Taken|Baseline Measurements||6
10056861|NCT02069379|11181750|FG000|COMPLETED|Baseline Measurements||27
10056862|NCT02069379|11181751|FG001|COMPLETED|Baseline Measurements||4
10056863|NCT02069379|11181752|FG002|COMPLETED|Baseline Measurements||2
10056864|NCT02069379|11181753|FG003|COMPLETED|Baseline Measurements||4
10056865|NCT02069379|11181750|FG000|NOT COMPLETED|Baseline Measurements||3
10056866|NCT02069379|11181751|FG001|NOT COMPLETED|Baseline Measurements||0
10056867|NCT02069379|11181752|FG002|NOT COMPLETED|Baseline Measurements||0
10056868|NCT02069379|11181753|FG003|NOT COMPLETED|Baseline Measurements||2
10056869|NCT02069379|11181750|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
10056870|NCT02069379|11181751|FG001|STARTED|First Treatment Arm||4
10056871|NCT02069379|11181752|FG002|STARTED|First Treatment Arm||2
10056872|NCT02069379|11181753|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
10056873|NCT02069379|11181750|FG000|COMPLETED|First Treatment Arm||0
10056874|NCT02069379|11181751|FG001|COMPLETED|First Treatment Arm||3
10056875|NCT02069379|11181752|FG002|COMPLETED|First Treatment Arm||1
10056876|NCT02069379|11181753|FG003|COMPLETED|First Treatment Arm||0
10056877|NCT02069379|11181750|FG000|NOT COMPLETED|First Treatment Arm||0
10056878|NCT02069379|11181751|FG001|NOT COMPLETED|First Treatment Arm||1
10056879|NCT02069379|11181752|FG002|NOT COMPLETED|First Treatment Arm||1
10056880|NCT02069379|11181753|FG003|NOT COMPLETED|First Treatment Arm||0
10056881|NCT02069379|11181750|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
10056882|NCT02069379|11181751|FG001|STARTED|Washout Period (4 Weeks)||3
10056883|NCT02069379|11181752|FG002|STARTED|Washout Period (4 Weeks)||1
10056884|NCT02069379|11181753|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
10056885|NCT02069379|11181750|FG000|COMPLETED|Washout Period (4 Weeks)||0
10056886|NCT02069379|11181751|FG001|COMPLETED|Washout Period (4 Weeks)||1
10056887|NCT02069379|11181752|FG002|COMPLETED|Washout Period (4 Weeks)||1
10056888|NCT02069379|11181753|FG003|COMPLETED|Washout Period (4 Weeks)||0
10056889|NCT02069379|11181750|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
10056890|NCT02069379|11181751|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2
10056891|NCT02069379|11181752|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0
10056892|NCT02069379|11181753|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0
10056893|NCT02069379|11181750|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
10056894|NCT02069379|11181751|FG001|STARTED|Second Treatment Arm||1
10056895|NCT02069379|11181752|FG002|STARTED|Second Treatment Arm||1
10056896|NCT02069379|11181753|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
10056897|NCT02069379|11181750|FG000|COMPLETED|Second Treatment Arm||0
10056898|NCT02069379|11181751|FG001|COMPLETED|Second Treatment Arm||1
10056899|NCT02069379|11181752|FG002|COMPLETED|Second Treatment Arm||0
10056900|NCT02069379|11181753|FG003|COMPLETED|Second Treatment Arm||0
10056901|NCT02069379|11181750|FG000|NOT COMPLETED|Second Treatment Arm||0
10056902|NCT02069379|11181751|FG001|NOT COMPLETED|Second Treatment Arm||0
10056903|NCT02069379|11181752|FG002|NOT COMPLETED|Second Treatment Arm||1
10056904|NCT02069379|11181753|FG003|NOT COMPLETED|Second Treatment Arm||0
10056905|NCT02069392|11181765|FG000|STARTED|Overall Study||14
10056906|NCT02069392|11181766|FG001|STARTED|Overall Study||17
10056907|NCT02069392|11181765|FG000|COMPLETED|Overall Study||10
10056908|NCT02069392|11181766|FG001|COMPLETED|Overall Study||15
10056909|NCT02069392|11181765|FG000|NOT COMPLETED|Overall Study||4
10056910|NCT02069392|11181766|FG001|NOT COMPLETED|Overall Study||2
10056911|NCT02069704|11181776|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
10056912|NCT02069704|11181777|FG001|STARTED|Overall Study||71
10056913|NCT02069704|11181776|FG000|COMPLETED|Overall Study||69
10056914|NCT02069704|11181777|FG001|COMPLETED|Overall Study||71
10056915|NCT02069704|11181776|FG000|NOT COMPLETED|Overall Study||0
10056916|NCT02069704|11181777|FG001|NOT COMPLETED|Overall Study||0
10056917|NCT02069847|11181792|FG000|STARTED|Overall Study||22
10056918|NCT02069847|11181793|FG001|STARTED|Overall Study||68
10056919|NCT02069847|11181792|FG000|COMPLETED|Overall Study||22
10056920|NCT02069847|11181793|FG001|COMPLETED|Overall Study||68
10056921|NCT02069847|11181792|FG000|NOT COMPLETED|Overall Study||0
10056922|NCT02069847|11181793|FG001|NOT COMPLETED|Overall Study||0
10056923|NCT02070237|11181800|FG000|STARTED|Overall Study||45
10056924|NCT02070237|11181801|FG001|STARTED|Overall Study||45
10056925|NCT02070237|11181800|FG000|COMPLETED|Overall Study||42
10056926|NCT02070237|11181801|FG001|COMPLETED|Overall Study||42
10056927|NCT02070237|11181800|FG000|NOT COMPLETED|Overall Study||3
10056928|NCT02070237|11181801|FG001|NOT COMPLETED|Overall Study||3
10056929|NCT02070276|11181810|FG000|STARTED|Overall Study||149
10056930|NCT02070276|11181811|FG001|STARTED|Overall Study||132
10056931|NCT02070276|11181812|FG002|STARTED|Overall Study||148
10056932|NCT02070276|11181810|FG000|COMPLETED|Overall Study||149
10056933|NCT02070276|11181811|FG001|COMPLETED|Overall Study||132
10056934|NCT02070276|11181812|FG002|COMPLETED|Overall Study||148
10056935|NCT02070276|11181810|FG000|NOT COMPLETED|Overall Study||0
10120541|NCT02561806|11251576|FG000|COMPLETED|Maintenance Period||151
10120542|NCT02561806|11251577|FG001|COMPLETED|Maintenance Period||123
10120543|NCT02561806|11251576|FG000|NOT COMPLETED|Maintenance Period||13
10120544|NCT02561806|11251577|FG001|NOT COMPLETED|Maintenance Period||8
10056936|NCT02070276|11181811|FG001|NOT COMPLETED|Overall Study||0
10056937|NCT02070276|11181812|FG002|NOT COMPLETED|Overall Study||0
10056938|NCT02070302|11181822|FG000|STARTED|Overall Study||5
10056939|NCT02070302|11181823|FG001|STARTED|Overall Study||5
10056940|NCT02070302|11181822|FG000|COMPLETED|Overall Study||5
10056941|NCT02070302|11181823|FG001|COMPLETED|Overall Study||5
10056942|NCT02070302|11181822|FG000|NOT COMPLETED|Overall Study||0
10056943|NCT02070302|11181823|FG001|NOT COMPLETED|Overall Study||0
10056944|NCT02070380|11181833|FG000|STARTED|First Injection||31
10056945|NCT02070380|11181834|FG001|STARTED|First Injection||39
10056946|NCT02070380|11181835|FG002|STARTED|First Injection||53
10056947|NCT02070380|11181836|FG003|STARTED|First Injection||54
10056948|NCT02070380|11181833|FG000|COMPLETED|First Injection||31
10056949|NCT02070380|11181834|FG001|COMPLETED|First Injection||39
10056950|NCT02070380|11181835|FG002|COMPLETED|First Injection||53
10056951|NCT02070380|11181836|FG003|COMPLETED|First Injection||54
10056952|NCT02070380|11181833|FG000|NOT COMPLETED|First Injection||0
10056953|NCT02070380|11181834|FG001|NOT COMPLETED|First Injection||0
10056954|NCT02070380|11181835|FG002|NOT COMPLETED|First Injection||0
10056955|NCT02070380|11181836|FG003|NOT COMPLETED|First Injection||0
10056956|NCT02070380|11181833|FG000|STARTED|Washout (no Second Injection/MRI)||31
10056957|NCT02070380|11181834|FG001|STARTED|Washout (no Second Injection/MRI)||39
10056958|NCT02070380|11181835|FG002|STARTED|Washout (no Second Injection/MRI)||53
10056959|NCT02070380|11181836|FG003|STARTED|Washout (no Second Injection/MRI)||54
10056960|NCT02070380|11181833|FG000|COMPLETED|Washout (no Second Injection/MRI)||31
10056961|NCT02070380|11181834|FG001|COMPLETED|Washout (no Second Injection/MRI)||34
10056962|NCT02070380|11181835|FG002|COMPLETED|Washout (no Second Injection/MRI)||51
10056963|NCT02070380|11181836|FG003|COMPLETED|Washout (no Second Injection/MRI)||51
10056964|NCT02070380|11181833|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0
10056965|NCT02070380|11181834|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5
10056966|NCT02070380|11181835|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2
10056967|NCT02070380|11181836|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3
10056968|NCT02070380|11181833|FG000|STARTED|Second Injection||31
10056969|NCT02070380|11181834|FG001|STARTED|Second Injection||34
10056970|NCT02070380|11181835|FG002|STARTED|Second Injection||51
10056971|NCT02070380|11181836|FG003|STARTED|Second Injection||51
10056972|NCT02070380|11181833|FG000|COMPLETED|Second Injection||31
10056973|NCT02070380|11181834|FG001|COMPLETED|Second Injection||32
10056974|NCT02070380|11181835|FG002|COMPLETED|Second Injection||50
10056975|NCT02070380|11181836|FG003|COMPLETED|Second Injection||46
10056976|NCT02070380|11181833|FG000|NOT COMPLETED|Second Injection||0
10056977|NCT02070380|11181834|FG001|NOT COMPLETED|Second Injection||2
10056978|NCT02070380|11181835|FG002|NOT COMPLETED|Second Injection||1
10056979|NCT02070380|11181836|FG003|NOT COMPLETED|Second Injection||5
10056980|NCT02070484|11181850|FG000|STARTED|Overall Study||3
10056981|NCT02070484|11181851|FG001|STARTED|Overall Study||3
10056982|NCT02070484|11181850|FG000|COMPLETED|Overall Study||2
10056983|NCT02070484|11181851|FG001|COMPLETED|Overall Study||3
10056984|NCT02070484|11181850|FG000|NOT COMPLETED|Overall Study||1
10056985|NCT02070484|11181851|FG001|NOT COMPLETED|Overall Study||0
10056986|NCT02070588|11181860|FG000|STARTED|Overall Study||86
10056987|NCT02070588|11181861|FG001|STARTED|Overall Study||26
10056988|NCT02070588|11181862|FG002|STARTED|Overall Study||0
10056989|NCT02070588|11181860|FG000|COMPLETED|Overall Study||47
10056990|NCT02070588|11181861|FG001|COMPLETED|Overall Study||25
10056991|NCT02070588|11181862|FG002|COMPLETED|Overall Study||0
10056992|NCT02070588|11181860|FG000|NOT COMPLETED|Overall Study||39
10056993|NCT02070588|11181861|FG001|NOT COMPLETED|Overall Study||1
10056994|NCT02070588|11181862|FG002|NOT COMPLETED|Overall Study||0
10056995|NCT02070640|11181872|FG000|STARTED|Overall Study||93
10056996|NCT02070640|11181873|FG001|STARTED|Overall Study||6
10056997|NCT02070640|11181872|FG000|COMPLETED|Overall Study||82
10056998|NCT02070640|11181873|FG001|COMPLETED|Overall Study||6
10056999|NCT02070640|11181872|FG000|NOT COMPLETED|Overall Study||11
10057000|NCT02070640|11181873|FG001|NOT COMPLETED|Overall Study||0
10057001|NCT02070692|11181882|FG000|STARTED|Overall Study||28
10057002|NCT02070692|11181883|FG001|STARTED|Overall Study||28
10057003|NCT02070692|11181882|FG000|COMPLETED|Overall Study||18
10057004|NCT02070692|11181883|FG001|COMPLETED|Overall Study||16
10057005|NCT02070692|11181882|FG000|NOT COMPLETED|Overall Study||10
10057006|NCT02070692|11181883|FG001|NOT COMPLETED|Overall Study||12
10120545|NCT02561806|11251576|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
10120546|NCT02561806|11251577|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
10120547|NCT02561806|11251576|FG000|COMPLETED|Post-Treatment Follow-up||155
10120548|NCT02561806|11251577|FG001|COMPLETED|Post-Treatment Follow-up||59
10120549|NCT02561806|11251576|FG000|NOT COMPLETED|Post-Treatment Follow-up||2
10120550|NCT02561806|11251577|FG001|NOT COMPLETED|Post-Treatment Follow-up||1
10120551|NCT02561832|11251600|FG000|STARTED|Overall Study||8
10120552|NCT02561832|11251601|FG001|STARTED|Overall Study||7
10120553|NCT02561832|11251600|FG000|INFORMED CONSENT OBTAINED|Overall Study||8
10120554|NCT02561832|11251601|FG001|INFORMED CONSENT OBTAINED|Overall Study||7
10120555|NCT02561832|11251600|FG000|COMPLETED|Overall Study||1
10120556|NCT02561832|11251601|FG001|COMPLETED|Overall Study||3
10120557|NCT02561832|11251600|FG000|NOT COMPLETED|Overall Study||7
10120558|NCT02561832|11251601|FG001|NOT COMPLETED|Overall Study||4
10120559|NCT02561897|11251609|FG000|STARTED|Overall Study||2
10120560|NCT02561897|11251610|FG001|STARTED|Overall Study||3
10057007|NCT02070744|11181893|FG000|STARTED|PC Phase (12 Weeks)||6
10057008|NCT02070744|11181894|FG001|STARTED|PC Phase (12 Weeks)||5
10057009|NCT02070744|11181895|FG002|STARTED|PC Phase (12 Weeks)||15
10057010|NCT02070744|11181896|FG003|STARTED|PC Phase (12 Weeks)||14
10057011|NCT02070744|11181897|FG004|STARTED|PC Phase (12 Weeks)||0
10057012|NCT02070744|11181893|FG000|Treated|PC Phase (12 Weeks)||6
10057013|NCT02070744|11181894|FG001|Treated|PC Phase (12 Weeks)||5
10057014|NCT02070744|11181895|FG002|Treated|PC Phase (12 Weeks)||15
10057015|NCT02070744|11181896|FG003|Treated|PC Phase (12 Weeks)||13
10057016|NCT02070744|11181897|FG004|Treated|PC Phase (12 Weeks)||0
10057017|NCT02070744|11181893|FG000|COMPLETED|PC Phase (12 Weeks)||6
10057018|NCT02070744|11181894|FG001|COMPLETED|PC Phase (12 Weeks)||5
10057019|NCT02070744|11181895|FG002|COMPLETED|PC Phase (12 Weeks)||15
10057020|NCT02070744|11181896|FG003|COMPLETED|PC Phase (12 Weeks)||13
10057021|NCT02070744|11181897|FG004|COMPLETED|PC Phase (12 Weeks)||0
10057022|NCT02070744|11181893|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0
10057023|NCT02070744|11181894|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0
10057024|NCT02070744|11181895|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0
10057025|NCT02070744|11181896|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1
10057026|NCT02070744|11181897|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0
10057027|NCT02070744|11181893|FG000|STARTED|OLE Phase (48 Weeks)||0
10057028|NCT02070744|11181894|FG001|STARTED|OLE Phase (48 Weeks)||0
10057029|NCT02070744|11181895|FG002|STARTED|OLE Phase (48 Weeks)||0
10057030|NCT02070744|11181896|FG003|STARTED|OLE Phase (48 Weeks)||0
10057031|NCT02070744|11181897|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
10057032|NCT02070744|11181893|FG000|COMPLETED|OLE Phase (48 Weeks)||0
10057033|NCT02070744|11181894|FG001|COMPLETED|OLE Phase (48 Weeks)||0
10057034|NCT02070744|11181895|FG002|COMPLETED|OLE Phase (48 Weeks)||0
10057035|NCT02070744|11181896|FG003|COMPLETED|OLE Phase (48 Weeks)||0
10057036|NCT02070744|11181897|FG004|COMPLETED|OLE Phase (48 Weeks)||24
10057037|NCT02070744|11181893|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0
10057038|NCT02070744|11181894|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0
10057039|NCT02070744|11181895|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0
10057040|NCT02070744|11181896|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0
10057041|NCT02070744|11181897|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3
10057042|NCT02070757|11181914|FG000|STARTED|Overall Study||362
10057043|NCT02070757|11181915|FG001|STARTED|Overall Study||364
10057044|NCT02070757|11181914|FG000|Treated Participants|Overall Study||361
10057045|NCT02070757|11181915|FG001|Treated Participants|Overall Study||359
10057046|NCT02070757|11181914|FG000|COMPLETED|Overall Study||245
10057047|NCT02070757|11181915|FG001|COMPLETED|Overall Study||250
10057048|NCT02070757|11181914|FG000|NOT COMPLETED|Overall Study||117
10057049|NCT02070757|11181915|FG001|NOT COMPLETED|Overall Study||114
10057050|NCT02070965|11181924|FG000|STARTED|Overall Study||27
10057051|NCT02070965|11181925|FG001|STARTED|Overall Study||23
10057052|NCT02070965|11181926|FG002|STARTED|Overall Study||25
10057053|NCT02070965|11181924|FG000|COMPLETED|Overall Study||25
10057054|NCT02070965|11181925|FG001|COMPLETED|Overall Study||21
10057055|NCT02070965|11181926|FG002|COMPLETED|Overall Study||24
10057056|NCT02070965|11181924|FG000|NOT COMPLETED|Overall Study||2
10057057|NCT02070965|11181925|FG001|NOT COMPLETED|Overall Study||2
10057058|NCT02070965|11181926|FG002|NOT COMPLETED|Overall Study||1
10057059|NCT02070978|11181937|FG000|STARTED|Overall Study||83
10057060|NCT02070978|11181938|FG001|STARTED|Overall Study||82
10057061|NCT02070978|11181939|FG002|STARTED|Overall Study||88
10057062|NCT02070978|11181937|FG000|COMPLETED|Overall Study||36
10057063|NCT02070978|11181938|FG001|COMPLETED|Overall Study||29
10057064|NCT02070978|11181939|FG002|COMPLETED|Overall Study||35
10057065|NCT02070978|11181937|FG000|NOT COMPLETED|Overall Study||47
10057066|NCT02070978|11181938|FG001|NOT COMPLETED|Overall Study||53
10057067|NCT02070978|11181939|FG002|NOT COMPLETED|Overall Study||53
10057068|NCT02070991|11181949|FG000|STARTED|Overall Study||31
10057069|NCT02070991|11181950|FG001|STARTED|Overall Study||32
10120561|NCT02561897|11251609|FG000|COMPLETED|Overall Study||2
10120562|NCT02561897|11251610|FG001|COMPLETED|Overall Study||3
10120563|NCT02561897|11251609|FG000|NOT COMPLETED|Overall Study||0
10120564|NCT02561897|11251610|FG001|NOT COMPLETED|Overall Study||0
10120565|NCT02562066|11251620|FG000|STARTED|Overall Study||8
10120566|NCT02562066|11251621|FG001|STARTED|Overall Study||8
10120567|NCT02562066|11251622|FG002|STARTED|Overall Study||4
10120568|NCT02562066|11251620|FG000|COMPLETED|Overall Study||7
10120569|NCT02562066|11251621|FG001|COMPLETED|Overall Study||7
10120570|NCT02562066|11251622|FG002|COMPLETED|Overall Study||0
10120571|NCT02562066|11251620|FG000|NOT COMPLETED|Overall Study||1
10120572|NCT02562066|11251621|FG001|NOT COMPLETED|Overall Study||1
10120573|NCT02562066|11251622|FG002|NOT COMPLETED|Overall Study||4
10196178|NCT03358407|11324486|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10196179|NCT03358407|11324477|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196180|NCT03358407|11324478|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196181|NCT03358407|11324479|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196182|NCT03358407|11324480|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196183|NCT03358407|11324481|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
10196184|NCT03358407|11324482|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196185|NCT03358407|11324483|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196186|NCT03358407|11324484|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196187|NCT03358407|11324485|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10057070|NCT02070991|11181949|FG000|COMPLETED|Overall Study||28
10057071|NCT02070991|11181950|FG001|COMPLETED|Overall Study||32
10057072|NCT02070991|11181949|FG000|NOT COMPLETED|Overall Study||3
10057073|NCT02070991|11181950|FG001|NOT COMPLETED|Overall Study||0
10057074|NCT02071082|11181958|FG000|STARTED|Overall Study||4
10120574|NCT02562482|11251630|FG000|STARTED|Overall Study||201
10120575|NCT02562482|11251631|FG001|STARTED|Overall Study||199
10120576|NCT02562482|11251630|FG000|Received 1st Injection|Overall Study||197
10120577|NCT02562482|11251631|FG001|Received 1st Injection|Overall Study||199
10120578|NCT02562482|11251630|FG000|Received 2nd Injection|Overall Study||192
10120579|NCT02562482|11251631|FG001|Received 2nd Injection|Overall Study||192
10120580|NCT02562482|11251630|FG000|COMPLETED|Overall Study||180
10120581|NCT02562482|11251631|FG001|COMPLETED|Overall Study||183
10120582|NCT02562482|11251630|FG000|NOT COMPLETED|Overall Study||21
10120583|NCT02562482|11251631|FG001|NOT COMPLETED|Overall Study||16
10120584|NCT02562521|11251639|FG000|STARTED|Overall Study||18
10120585|NCT02562521|11251640|FG001|STARTED|Overall Study||7
10120586|NCT02562521|11251639|FG000|COMPLETED|Overall Study||18
10120587|NCT02562521|11251640|FG001|COMPLETED|Overall Study||7
10120588|NCT02562521|11251639|FG000|NOT COMPLETED|Overall Study||0
10120589|NCT02562521|11251640|FG001|NOT COMPLETED|Overall Study||0
10120590|NCT02562755|11251648|FG000|STARTED|Overall Study||234
10120591|NCT02562755|11251649|FG001|STARTED|Overall Study||225
10120592|NCT02562755|11251648|FG000|Safety Population|Overall Study||218
10120593|NCT02562755|11251649|FG001|Safety Population|Overall Study||217
10120594|NCT02562755|11251648|FG000|COMPLETED|Overall Study||161
10120595|NCT02562755|11251649|FG001|COMPLETED|Overall Study||153
10120596|NCT02562755|11251648|FG000|NOT COMPLETED|Overall Study||73
10120597|NCT02562755|11251649|FG001|NOT COMPLETED|Overall Study||72
10120598|NCT02562898|11251657|FG000|STARTED|Overall Study||10
10120599|NCT02562898|11251658|FG001|STARTED|Overall Study||8
10120600|NCT02562898|11251657|FG000|COMPLETED|Overall Study||10
10120601|NCT02562898|11251658|FG001|COMPLETED|Overall Study||8
10120602|NCT02562898|11251657|FG000|NOT COMPLETED|Overall Study||0
10120603|NCT02562898|11251658|FG001|NOT COMPLETED|Overall Study||0
10120604|NCT02562924|11251667|FG000|STARTED|Overall Study||13
10120605|NCT02562924|11251668|FG001|STARTED|Overall Study||12
10120606|NCT02562924|11251669|FG002|STARTED|Overall Study||12
10120607|NCT02562924|11251667|FG000|COMPLETED|Overall Study||12
10120608|NCT02562924|11251668|FG001|COMPLETED|Overall Study||1
10120609|NCT02562924|11251669|FG002|COMPLETED|Overall Study||8
10120610|NCT02562924|11251667|FG000|NOT COMPLETED|Overall Study||1
10120611|NCT02562924|11251668|FG001|NOT COMPLETED|Overall Study||11
10120612|NCT02562924|11251669|FG002|NOT COMPLETED|Overall Study||4
10120613|NCT02562989|11251683|FG000|STARTED|Overall Study||3
10120614|NCT02562989|11251684|FG001|STARTED|Overall Study||4
10120615|NCT02562989|11251685|FG002|STARTED|Overall Study||6
10120616|NCT02562989|11251683|FG000|COMPLETED|Overall Study||3
10120617|NCT02562989|11251684|FG001|COMPLETED|Overall Study||4
10120618|NCT02562989|11251685|FG002|COMPLETED|Overall Study||6
10120619|NCT02562989|11251683|FG000|NOT COMPLETED|Overall Study||0
10120620|NCT02562989|11251684|FG001|NOT COMPLETED|Overall Study||0
10120621|NCT02562989|11251685|FG002|NOT COMPLETED|Overall Study||0
10120622|NCT02563067|11251696|FG000|STARTED|Overall Study||296
10120623|NCT02563067|11251697|FG001|STARTED|Overall Study||294
10120624|NCT02563067|11251698|FG002|STARTED|Overall Study||287
10120625|NCT02563067|11251696|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
10120626|NCT02563067|11251697|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
10120627|NCT02563067|11251698|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
10120628|NCT02563067|11251696|FG000|FAS/SAF: Overall Population|Overall Study||296
10120629|NCT02563067|11251697|FG001|FAS/SAF: Overall Population|Overall Study||293
10120630|NCT02563067|11251698|FG002|FAS/SAF: Overall Population|Overall Study||287
10120631|NCT02563067|11251696|FG000|COMPLETED|Overall Study||277
10120632|NCT02563067|11251697|FG001|COMPLETED|Overall Study||268
10120633|NCT02563067|11251698|FG002|COMPLETED|Overall Study||267
10120634|NCT02563067|11251696|FG000|NOT COMPLETED|Overall Study||19
10120635|NCT02563067|11251697|FG001|NOT COMPLETED|Overall Study||26
10120636|NCT02563067|11251698|FG002|NOT COMPLETED|Overall Study||20
10120637|NCT02563093|11251710|FG000|STARTED|Overall Study||52
10120638|NCT02563093|11251711|FG001|STARTED|Overall Study||52
10120639|NCT02563093|11251712|FG002|STARTED|Overall Study||53
10120640|NCT02563093|11251713|FG003|STARTED|Overall Study||51
10120641|NCT02563093|11251710|FG000|COMPLETED|Overall Study||52
10057075|NCT02071082|11181959|FG001|STARTED|Overall Study||75
10057076|NCT02071082|11181958|FG000|COMPLETED|Overall Study||2
10057077|NCT02071082|11181959|FG001|COMPLETED|Overall Study||68
10057078|NCT02071082|11181958|FG000|NOT COMPLETED|Overall Study||2
10057079|NCT02071082|11181959|FG001|NOT COMPLETED|Overall Study||7
10120642|NCT02563093|11251711|FG001|COMPLETED|Overall Study||52
10120643|NCT02563093|11251712|FG002|COMPLETED|Overall Study||53
10120644|NCT02563093|11251713|FG003|COMPLETED|Overall Study||51
10120645|NCT02563093|11251710|FG000|NOT COMPLETED|Overall Study||0
10057080|NCT02071095|11181967|FG000|STARTED|Overall Study||12
10120646|NCT02563093|11251711|FG001|NOT COMPLETED|Overall Study||0
10120647|NCT02563093|11251712|FG002|NOT COMPLETED|Overall Study||0
10120648|NCT02563093|11251713|FG003|NOT COMPLETED|Overall Study||0
10057081|NCT02071095|11181968|FG001|STARTED|Overall Study||3
10057082|NCT02071095|11181967|FG000|COMPLETED|Overall Study||12
10057083|NCT02071095|11181968|FG001|COMPLETED|Overall Study||3
10057084|NCT02071095|11181967|FG000|NOT COMPLETED|Overall Study||0
10057085|NCT02071095|11181968|FG001|NOT COMPLETED|Overall Study||0
10057086|NCT02071108|11181974|FG000|STARTED|Overall Study||35
10057087|NCT02071108|11181974|FG000|COMPLETED|Overall Study||35
10057088|NCT02071108|11181974|FG000|NOT COMPLETED|Overall Study||0
10057089|NCT02071173|11181978|FG000|STARTED|Overall Study||2244
10057090|NCT02071173|11181978|FG000|Implanted/Attempted With a Study Device|Overall Study||2200
10057091|NCT02071173|11181978|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
10057092|NCT02071173|11181978|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
10057093|NCT02071173|11181978|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
10057094|NCT02071173|11181978|FG000|NOT COMPLETED|Overall Study||1835
10057095|NCT02071225|11181983|FG000|STARTED|Overall Study||72
10057096|NCT02071225|11181983|FG000|COMPLETED|Overall Study||42
10057097|NCT02071225|11181983|FG000|NOT COMPLETED|Overall Study||30
10057098|NCT02071290|11181989|FG000|STARTED|Overall Study||25
10057099|NCT02071290|11181990|FG001|STARTED|Overall Study||25
10057100|NCT02071290|11181989|FG000|COMPLETED|Overall Study||21
10057101|NCT02071290|11181990|FG001|COMPLETED|Overall Study||18
10057102|NCT02071290|11181989|FG000|NOT COMPLETED|Overall Study||4
10057103|NCT02071290|11181990|FG001|NOT COMPLETED|Overall Study||7
10057104|NCT02071420|11181998|FG000|STARTED|Overall Study||30
10057105|NCT02071420|11181999|FG001|STARTED|Overall Study||30
10057106|NCT02071420|11181998|FG000|COMPLETED|Overall Study||27
10057107|NCT02071420|11181999|FG001|COMPLETED|Overall Study||27
10057108|NCT02071420|11181998|FG000|NOT COMPLETED|Overall Study||3
10057109|NCT02071420|11181999|FG001|NOT COMPLETED|Overall Study||3
10057110|NCT02071706|11182005|FG000|STARTED|Overall Study||62
10057111|NCT02071706|11182005|FG000|COMPLETED|Overall Study||59
10057112|NCT02071706|11182005|FG000|NOT COMPLETED|Overall Study||3
10057113|NCT02071771|11182009|FG000|STARTED|Period 1: First 10 Days||41
10057114|NCT02071771|11182010|FG001|STARTED|Period 1: First 10 Days||39
10057115|NCT02071771|11182009|FG000|Dispensed|Period 1: First 10 Days||39
10057116|NCT02071771|11182010|FG001|Dispensed|Period 1: First 10 Days||39
10057117|NCT02071771|11182009|FG000|COMPLETED|Period 1: First 10 Days||39
10057118|NCT02071771|11182010|FG001|COMPLETED|Period 1: First 10 Days||39
10057119|NCT02071771|11182009|FG000|NOT COMPLETED|Period 1: First 10 Days||2
10057120|NCT02071771|11182010|FG001|NOT COMPLETED|Period 1: First 10 Days||0
10057121|NCT02071771|11182009|FG000|STARTED|Period 2: Second 10 Days||39
10057122|NCT02071771|11182010|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
10057123|NCT02071771|11182009|FG000|COMPLETED|Period 2: Second 10 Days||39
10057124|NCT02071771|11182010|FG001|COMPLETED|Period 2: Second 10 Days||38
10057125|NCT02071771|11182009|FG000|NOT COMPLETED|Period 2: Second 10 Days||0
10057126|NCT02071771|11182010|FG001|NOT COMPLETED|Period 2: Second 10 Days||0
10057127|NCT02071810|11182021|FG000|STARTED|Overall Study||6
10057128|NCT02071810|11182022|FG001|STARTED|Overall Study||6
10057129|NCT02071810|11182023|FG002|STARTED|Overall Study||6
10057130|NCT02071810|11182024|FG003|STARTED|Overall Study||7
10057131|NCT02071810|11182025|FG004|STARTED|Overall Study||9
10057132|NCT02071810|11182021|FG000|COMPLETED|Overall Study||6
10057133|NCT02071810|11182022|FG001|COMPLETED|Overall Study||6
10057134|NCT02071810|11182023|FG002|COMPLETED|Overall Study||6
10057135|NCT02071810|11182024|FG003|COMPLETED|Overall Study||6
10057136|NCT02071810|11182025|FG004|COMPLETED|Overall Study||8
10057137|NCT02071810|11182021|FG000|NOT COMPLETED|Overall Study||0
10057138|NCT02071810|11182022|FG001|NOT COMPLETED|Overall Study||0
10057139|NCT02071810|11182023|FG002|NOT COMPLETED|Overall Study||0
10057140|NCT02071810|11182024|FG003|NOT COMPLETED|Overall Study||1
10057141|NCT02071810|11182025|FG004|NOT COMPLETED|Overall Study||1
10057142|NCT02071823|11182039|FG000|STARTED|Overall Study||6
10057143|NCT02071823|11182040|FG001|STARTED|Overall Study||6
10057144|NCT02071823|11182039|FG000|COMPLETED|Overall Study||5
10057145|NCT02071823|11182040|FG001|COMPLETED|Overall Study||6
10057146|NCT02071823|11182039|FG000|NOT COMPLETED|Overall Study||1
10057147|NCT02071823|11182040|FG001|NOT COMPLETED|Overall Study||0
10057148|NCT02071849|11182048|FG000|STARTED|6-month Primary Endpoint||20
10057149|NCT02071849|11182048|FG000|COMPLETED|6-month Primary Endpoint||15
10057150|NCT02071849|11182048|FG000|NOT COMPLETED|6-month Primary Endpoint||5
10057151|NCT02071849|11182048|FG000|STARTED|2-year Extended Follow-up||15
10057152|NCT02071849|11182048|FG000|COMPLETED|2-year Extended Follow-up||14
10057153|NCT02071849|11182048|FG000|NOT COMPLETED|2-year Extended Follow-up||1
10057154|NCT02071914|11182055|FG000|STARTED|Overall Study||27
10057155|NCT02071914|11182056|FG001|STARTED|Overall Study||27
10057156|NCT02071914|11182057|FG002|STARTED|Overall Study||27
10057157|NCT02071914|11182055|FG000|COMPLETED|Overall Study||27
10057158|NCT02071914|11182056|FG001|COMPLETED|Overall Study||27
10057159|NCT02071914|11182057|FG002|COMPLETED|Overall Study||27
10057160|NCT02071914|11182055|FG000|NOT COMPLETED|Overall Study||0
10057161|NCT02071914|11182056|FG001|NOT COMPLETED|Overall Study||0
10057162|NCT02071914|11182057|FG002|NOT COMPLETED|Overall Study||0
10057163|NCT02072096|11182067|FG000|STARTED|Overall Study||99
10057164|NCT02072096|11182068|FG001|STARTED|Overall Study||93
10057165|NCT02072096|11182067|FG000|Received at Least One Dose of Study Drug|Overall Study||98
10057166|NCT02072096|11182068|FG001|Received at Least One Dose of Study Drug|Overall Study||93
10057167|NCT02072096|11182067|FG000|COMPLETED|Overall Study||14
10057168|NCT02072096|11182068|FG001|COMPLETED|Overall Study||15
10057169|NCT02072096|11182067|FG000|NOT COMPLETED|Overall Study||85
10057170|NCT02072096|11182068|FG001|NOT COMPLETED|Overall Study||78
10057171|NCT02072174|11182077|FG000|STARTED|Overall Study||290
10057172|NCT02072174|11182078|FG001|STARTED|Overall Study||279
10057173|NCT02072174|11182077|FG000|COMPLETED|Overall Study||258
10057174|NCT02072174|11182078|FG001|COMPLETED|Overall Study||240
10057175|NCT02072174|11182077|FG000|NOT COMPLETED|Overall Study||32
10057176|NCT02072174|11182078|FG001|NOT COMPLETED|Overall Study||39
10057177|NCT02072200|11182086|FG000|STARTED|Overall Study||147
10057178|NCT02072200|11182086|FG000|COMPLETED|Overall Study||145
10057179|NCT02072200|11182086|FG000|NOT COMPLETED|Overall Study||2
10057180|NCT02072226|11182092|FG000|STARTED|Overall Study||156
10057181|NCT02072226|11182093|FG001|STARTED|Overall Study||157
10057182|NCT02072226|11182092|FG000|COMPLETED|Overall Study||141
10057183|NCT02072226|11182093|FG001|COMPLETED|Overall Study||147
10057184|NCT02072226|11182092|FG000|NOT COMPLETED|Overall Study||15
10057185|NCT02072226|11182093|FG001|NOT COMPLETED|Overall Study||10
10057186|NCT02072421|11182099|FG000|STARTED|Overall Study||2879
10057187|NCT02072421|11182099|FG000|COMPLETED|Overall Study||2489
10057188|NCT02072421|11182099|FG000|NOT COMPLETED|Overall Study||390
10057189|NCT02072434|11182106|FG000|STARTED|Overall Study||1095
10057190|NCT02072434|11182107|FG001|STARTED|Overall Study||1104
10057191|NCT02072434|11182106|FG000|Intent to Treat Analysis Set|Overall Study||1095
10057192|NCT02072434|11182107|FG001|Intent to Treat Analysis Set|Overall Study||1104
10057193|NCT02072434|11182106|FG000|Received Study Drug|Overall Study||1067
10057194|NCT02072434|11182107|FG001|Received Study Drug|Overall Study||1082
10057195|NCT02072434|11182106|FG000|Safety Analysis Set|Overall Study||1067
10057196|NCT02072434|11182107|FG001|Safety Analysis Set|Overall Study||1082
10057197|NCT02072434|11182106|FG000|COMPLETED|Overall Study||1041
10057198|NCT02072434|11182107|FG001|COMPLETED|Overall Study||1014
10057199|NCT02072434|11182106|FG000|NOT COMPLETED|Overall Study||54
10057200|NCT02072434|11182107|FG001|NOT COMPLETED|Overall Study||90
10057201|NCT02072668|11182113|FG000|STARTED|First Intervention||7
10057202|NCT02072668|11182114|FG001|STARTED|First Intervention||7
10057203|NCT02072668|11182113|FG000|COMPLETED|First Intervention||7
10057204|NCT02072668|11182114|FG001|COMPLETED|First Intervention||7
10057205|NCT02072668|11182113|FG000|NOT COMPLETED|First Intervention||0
10057206|NCT02072668|11182114|FG001|NOT COMPLETED|First Intervention||0
10057207|NCT02072668|11182113|FG000|STARTED|Washout (2 Weeks)||7
10057208|NCT02072668|11182114|FG001|STARTED|Washout (2 Weeks)||7
10057209|NCT02072668|11182113|FG000|COMPLETED|Washout (2 Weeks)||7
10057210|NCT02072668|11182114|FG001|COMPLETED|Washout (2 Weeks)||7
10120649|NCT02563106|11251726|FG000|STARTED|Overall Study||206
10120650|NCT02563106|11251727|FG001|STARTED|Overall Study||207
10120651|NCT02563106|11251726|FG000|COMPLETED|Overall Study||172
10120652|NCT02563106|11251727|FG001|COMPLETED|Overall Study||178
10120653|NCT02563106|11251726|FG000|NOT COMPLETED|Overall Study||34
10120654|NCT02563106|11251727|FG001|NOT COMPLETED|Overall Study||29
10120655|NCT02563496|11251738|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
10120656|NCT02563496|11251739|FG001|STARTED|Overall Study||14
10120657|NCT02563496|11251740|FG002|STARTED|Overall Study||5
10120658|NCT02563496|11251741|FG003|STARTED|Overall Study||22
10120659|NCT02563496|11251742|FG004|STARTED|Overall Study||19
10120660|NCT02563496|11251738|FG000|COMPLETED|Overall Study||0
10120661|NCT02563496|11251739|FG001|COMPLETED|Overall Study||14
10120662|NCT02563496|11251740|FG002|COMPLETED|Overall Study||5
10120663|NCT02563496|11251741|FG003|COMPLETED|Overall Study||22
10120664|NCT02563496|11251742|FG004|COMPLETED|Overall Study||19
10120665|NCT02563496|11251738|FG000|NOT COMPLETED|Overall Study||0
10120666|NCT02563496|11251739|FG001|NOT COMPLETED|Overall Study||0
10120667|NCT02563496|11251740|FG002|NOT COMPLETED|Overall Study||0
10120668|NCT02563496|11251741|FG003|NOT COMPLETED|Overall Study||0
10120669|NCT02563496|11251742|FG004|NOT COMPLETED|Overall Study||0
10120670|NCT02563548|11251756|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3
10120671|NCT02563548|11251757|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2
10120672|NCT02563548|11251758|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7
10120673|NCT02563548|11251759|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2
10120674|NCT02563548|11251760|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0
10120675|NCT02563548|11251761|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0
10120676|NCT02563548|11251756|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
10120677|NCT02563548|11251757|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
10120678|NCT02563548|11251758|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
10120679|NCT02563548|11251759|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
10120680|NCT02563548|11251760|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
10120681|NCT02563548|11251761|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
10120682|NCT02563548|11251756|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10120683|NCT02563548|11251757|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10057211|NCT02072668|11182113|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10057212|NCT02072668|11182114|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10057213|NCT02072668|11182113|FG000|STARTED|Second Intervention||7
10120684|NCT02563548|11251758|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10120685|NCT02563548|11251759|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10057214|NCT02072668|11182114|FG001|STARTED|Second Intervention||7
10057215|NCT02072668|11182113|FG000|COMPLETED|Second Intervention||6
10057216|NCT02072668|11182114|FG001|COMPLETED|Second Intervention||7
10057217|NCT02072668|11182113|FG000|NOT COMPLETED|Second Intervention||1
10057218|NCT02072668|11182114|FG001|NOT COMPLETED|Second Intervention||0
10057219|NCT02072824|11182125|FG000|STARTED|Overall Study||71
10057220|NCT02072824|11182126|FG001|STARTED|Overall Study||34
10057221|NCT02072824|11182127|FG002|STARTED|Overall Study||70
10057222|NCT02072824|11182125|FG000|COMPLETED|Overall Study||69
10057223|NCT02072824|11182126|FG001|COMPLETED|Overall Study||33
10057224|NCT02072824|11182127|FG002|COMPLETED|Overall Study||67
10057225|NCT02072824|11182125|FG000|NOT COMPLETED|Overall Study||2
10057226|NCT02072824|11182126|FG001|NOT COMPLETED|Overall Study||1
10057227|NCT02072824|11182127|FG002|NOT COMPLETED|Overall Study||3
10057228|NCT02072928|11182135|FG000|STARTED|Overall Study||55
10057229|NCT02072928|11182135|FG000|COMPLETED|Overall Study||55
10057230|NCT02072928|11182135|FG000|NOT COMPLETED|Overall Study||0
10057231|NCT02072941|11182141|FG000|STARTED|Overall Study||219
10057232|NCT02072941|11182142|FG001|STARTED|Overall Study||226
10057233|NCT02072941|11182141|FG000|COMPLETED|Overall Study||181
10057234|NCT02072941|11182142|FG001|COMPLETED|Overall Study||197
10057235|NCT02072941|11182141|FG000|NOT COMPLETED|Overall Study||38
10057236|NCT02072941|11182142|FG001|NOT COMPLETED|Overall Study||29
10057237|NCT02072980|11182148|FG000|STARTED|Period 1, First Wear||7
10057238|NCT02072980|11182149|FG001|STARTED|Period 1, First Wear||8
10057239|NCT02072980|11182148|FG000|COMPLETED|Period 1, First Wear||7
10057240|NCT02072980|11182149|FG001|COMPLETED|Period 1, First Wear||8
10057241|NCT02072980|11182148|FG000|NOT COMPLETED|Period 1, First Wear||0
10057242|NCT02072980|11182149|FG001|NOT COMPLETED|Period 1, First Wear||0
10057243|NCT02072980|11182148|FG000|STARTED|Period 2, Second Wear||7
10057244|NCT02072980|11182149|FG001|STARTED|Period 2, Second Wear||8
10057245|NCT02072980|11182148|FG000|COMPLETED|Period 2, Second Wear||7
10057246|NCT02072980|11182149|FG001|COMPLETED|Period 2, Second Wear||7
10057247|NCT02072980|11182148|FG000|NOT COMPLETED|Period 2, Second Wear||0
10057248|NCT02072980|11182149|FG001|NOT COMPLETED|Period 2, Second Wear||1
10057249|NCT02073162|11182157|FG000|STARTED|Overall Study||1499
10057250|NCT02073162|11182158|FG001|STARTED|Overall Study||1501
10057251|NCT02073162|11182157|FG000|COMPLETED|Overall Study||1493
10057252|NCT02073162|11182158|FG001|COMPLETED|Overall Study||1490
10057253|NCT02073162|11182157|FG000|NOT COMPLETED|Overall Study||6
10057254|NCT02073162|11182158|FG001|NOT COMPLETED|Overall Study||11
10057255|NCT02073331|11182164|FG000|STARTED|Overall Study||1420
10057256|NCT02073331|11182164|FG000|COMPLETED|Overall Study||1420
10057257|NCT02073331|11182164|FG000|NOT COMPLETED|Overall Study||0
10057258|NCT02073435|11182170|FG000|STARTED|Overall Study||81
10057259|NCT02073435|11182171|FG001|STARTED|Overall Study||96
10057260|NCT02073435|11182170|FG000|COMPLETED|Overall Study||81
10057261|NCT02073435|11182171|FG001|COMPLETED|Overall Study||96
10057262|NCT02073435|11182170|FG000|NOT COMPLETED|Overall Study||0
10057263|NCT02073435|11182171|FG001|NOT COMPLETED|Overall Study||0
10057264|NCT02073448|11182180|FG000|STARTED|Overall Study||101
10057265|NCT02073448|11182181|FG001|STARTED|Overall Study||212
10057266|NCT02073448|11182182|FG002|STARTED|Overall Study||104
10057267|NCT02073448|11182180|FG000|COMPLETED|Overall Study||99
10057268|NCT02073448|11182181|FG001|COMPLETED|Overall Study||200
10057269|NCT02073448|11182182|FG002|COMPLETED|Overall Study||99
10057270|NCT02073448|11182180|FG000|NOT COMPLETED|Overall Study||2
10057271|NCT02073448|11182181|FG001|NOT COMPLETED|Overall Study||12
10057272|NCT02073448|11182182|FG002|NOT COMPLETED|Overall Study||5
10057273|NCT02073461|11182195|FG000|STARTED|Overall Study||79
10057274|NCT02073461|11182196|FG001|STARTED|Overall Study||78
10057275|NCT02073461|11182197|FG002|STARTED|Overall Study||79
10120686|NCT02563548|11251760|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10120687|NCT02563548|11251761|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10120688|NCT02563548|11251756|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
10120689|NCT02563548|11251757|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
10120690|NCT02563548|11251758|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
10120691|NCT02563548|11251759|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
10120692|NCT02563548|11251760|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10120693|NCT02563548|11251761|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10120694|NCT02563548|11251756|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0
10120695|NCT02563548|11251757|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0
10120696|NCT02563548|11251758|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0
10120697|NCT02563548|11251759|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0
10120698|NCT02563548|11251760|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25
10120699|NCT02563548|11251761|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17
10120700|NCT02563548|11251756|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10120701|NCT02563548|11251757|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10120702|NCT02563548|11251758|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10057276|NCT02073461|11182195|FG000|COMPLETED|Overall Study||75
10120703|NCT02563548|11251759|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10120704|NCT02563548|11251760|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
10120705|NCT02563548|11251761|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
10120706|NCT02563548|11251756|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10057277|NCT02073461|11182196|FG001|COMPLETED|Overall Study||77
10057278|NCT02073461|11182197|FG002|COMPLETED|Overall Study||78
10057279|NCT02073461|11182195|FG000|NOT COMPLETED|Overall Study||4
10057280|NCT02073461|11182196|FG001|NOT COMPLETED|Overall Study||1
10057281|NCT02073461|11182197|FG002|NOT COMPLETED|Overall Study||1
10057282|NCT02073487|11182207|FG000|STARTED|Overall Study||16
10057283|NCT02073487|11182208|FG001|STARTED|Overall Study||16
10057284|NCT02073487|11182207|FG000|COMPLETED|Overall Study||14
10120707|NCT02563548|11251757|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120708|NCT02563548|11251758|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120709|NCT02563548|11251759|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120710|NCT02563548|11251760|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120711|NCT02563548|11251761|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120712|NCT02563548|11251756|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120713|NCT02563548|11251757|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120714|NCT02563548|11251758|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120715|NCT02563548|11251759|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10120716|NCT02563548|11251760|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
10120717|NCT02563548|11251761|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
10120718|NCT02563561|11251784|FG000|STARTED|Overall Study||19
10120719|NCT02563561|11251785|FG001|STARTED|Overall Study||23
10120720|NCT02563561|11251786|FG002|STARTED|Overall Study||20
10120721|NCT02563561|11251784|FG000|Safety Population|Overall Study||19
10120722|NCT02563561|11251785|FG001|Safety Population|Overall Study||21
10120723|NCT02563561|11251786|FG002|Safety Population|Overall Study||17
10120724|NCT02563561|11251784|FG000|COMPLETED|Overall Study||1
10120725|NCT02563561|11251785|FG001|COMPLETED|Overall Study||2
10120726|NCT02563561|11251786|FG002|COMPLETED|Overall Study||3
10120727|NCT02563561|11251784|FG000|NOT COMPLETED|Overall Study||18
10120728|NCT02563561|11251785|FG001|NOT COMPLETED|Overall Study||21
10120729|NCT02563561|11251786|FG002|NOT COMPLETED|Overall Study||17
10120730|NCT02563808|11251796|FG000|STARTED|Overall Study||96
10120731|NCT02563808|11251797|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
10120732|NCT02563808|11251796|FG000|COMPLETED|Overall Study||96
10120733|NCT02563808|11251797|FG001|COMPLETED|Overall Study||88
10120734|NCT02563808|11251796|FG000|NOT COMPLETED|Overall Study||0
10057285|NCT02073487|11182208|FG001|COMPLETED|Overall Study||16
10057286|NCT02073487|11182207|FG000|NOT COMPLETED|Overall Study||2
10057287|NCT02073487|11182208|FG001|NOT COMPLETED|Overall Study||0
10057288|NCT02073643|11182215|FG000|STARTED|Overall Study||204
10057289|NCT02073643|11182215|FG000|COMPLETED|Overall Study||180
10057290|NCT02073643|11182215|FG000|NOT COMPLETED|Overall Study||24
10057291|NCT02073656|11182219|FG000|STARTED|Primary Study||335
10057292|NCT02073656|11182219|FG000|COMPLETED|Primary Study||327
10057293|NCT02073656|11182219|FG000|NOT COMPLETED|Primary Study||8
10057294|NCT02073656|11182219|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
10120735|NCT02563808|11251797|FG001|NOT COMPLETED|Overall Study||0
10120736|NCT02563834|11251805|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10
10120737|NCT02563834|11251806|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8
10120738|NCT02563834|11251805|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10
10120739|NCT02563834|11251806|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8
10120740|NCT02563834|11251805|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
10057295|NCT02073656|11182219|FG000|COMPLETED|Retreatment Substudy||9
10057296|NCT02073656|11182219|FG000|NOT COMPLETED|Retreatment Substudy||0
10057297|NCT02073682|11182227|FG000|STARTED|Overall Study||522
10057298|NCT02073682|11182228|FG001|STARTED|Overall Study||524
10057299|NCT02073682|11182227|FG000|COMPLETED|Overall Study||200
10057300|NCT02073682|11182228|FG001|COMPLETED|Overall Study||154
10120741|NCT02563834|11251806|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
10120742|NCT02563834|11251805|FG000|STARTED|Insulin Infusion (*Day 2)||10
10120743|NCT02563834|11251806|FG001|STARTED|Insulin Infusion (*Day 2)||8
10120744|NCT02563834|11251805|FG000|COMPLETED|Insulin Infusion (*Day 2)||10
10120745|NCT02563834|11251806|FG001|COMPLETED|Insulin Infusion (*Day 2)||8
10120746|NCT02563834|11251805|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0
10120747|NCT02563834|11251806|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0
10120748|NCT02563860|11251814|FG000|STARTED|Overall Study||20
10120749|NCT02563860|11251814|FG000|COMPLETED|Overall Study||19
10120750|NCT02563860|11251814|FG000|NOT COMPLETED|Overall Study||1
10120751|NCT02563899|11251822|FG000|STARTED|Overall Study||18
10120752|NCT02563899|11251823|FG001|STARTED|Overall Study||5
10120753|NCT02563899|11251824|FG002|STARTED|Overall Study||10
10120754|NCT02563899|11251825|FG003|STARTED|Overall Study||6
10120755|NCT02563899|11251822|FG000|COMPLETED|Overall Study||17
10120756|NCT02563899|11251823|FG001|COMPLETED|Overall Study||5
10120757|NCT02563899|11251824|FG002|COMPLETED|Overall Study||9
10120758|NCT02563899|11251825|FG003|COMPLETED|Overall Study||6
10120759|NCT02563899|11251822|FG000|NOT COMPLETED|Overall Study||1
10120760|NCT02563899|11251823|FG001|NOT COMPLETED|Overall Study||0
10120761|NCT02563899|11251824|FG002|NOT COMPLETED|Overall Study||1
10120762|NCT02563899|11251825|FG003|NOT COMPLETED|Overall Study||0
10120763|NCT02563990|11251838|FG000|STARTED|Overall Study||12
10120764|NCT02563990|11251839|FG001|STARTED|Overall Study||14
10120765|NCT02563990|11251838|FG000|COMPLETED|Overall Study||12
10120766|NCT02563990|11251839|FG001|COMPLETED|Overall Study||14
10120767|NCT02563990|11251838|FG000|NOT COMPLETED|Overall Study||0
10120768|NCT02563990|11251839|FG001|NOT COMPLETED|Overall Study||0
10120769|NCT02564016|11251849|FG000|STARTED|Overall Study||22
10120770|NCT02564016|11251850|FG001|STARTED|Overall Study||14
10120771|NCT02564016|11251849|FG000|COMPLETED|Overall Study||4
10120772|NCT02564016|11251850|FG001|COMPLETED|Overall Study||4
10120773|NCT02564016|11251849|FG000|NOT COMPLETED|Overall Study||18
10120774|NCT02564016|11251850|FG001|NOT COMPLETED|Overall Study||10
10120775|NCT02564029|11251856|FG000|STARTED|Overall Study||7
10120776|NCT02564029|11251856|FG000|COMPLETED|Overall Study||7
10120777|NCT02564029|11251856|FG000|NOT COMPLETED|Overall Study||0
10120778|NCT02564042|11251873|FG000|STARTED|Overall Study||38
10120779|NCT02564042|11251874|FG001|STARTED|Overall Study||38
10120780|NCT02564042|11251875|FG002|STARTED|Overall Study||38
10120781|NCT02564042|11251876|FG003|STARTED|Overall Study||38
10120782|NCT02564042|11251877|FG004|STARTED|Overall Study||37
10120783|NCT02564042|11251878|FG005|STARTED|Overall Study||38
10120784|NCT02564042|11251873|FG000|COMPLETED|Overall Study||27
10120785|NCT02564042|11251874|FG001|COMPLETED|Overall Study||30
10120786|NCT02564042|11251875|FG002|COMPLETED|Overall Study||32
10120787|NCT02564042|11251876|FG003|COMPLETED|Overall Study||35
10120788|NCT02564042|11251877|FG004|COMPLETED|Overall Study||26
10120789|NCT02564042|11251878|FG005|COMPLETED|Overall Study||24
10120790|NCT02564042|11251873|FG000|NOT COMPLETED|Overall Study||11
10120791|NCT02564042|11251874|FG001|NOT COMPLETED|Overall Study||8
10120792|NCT02564042|11251875|FG002|NOT COMPLETED|Overall Study||6
10120793|NCT02564042|11251876|FG003|NOT COMPLETED|Overall Study||3
10120794|NCT02564042|11251877|FG004|NOT COMPLETED|Overall Study||11
10120795|NCT02564042|11251878|FG005|NOT COMPLETED|Overall Study||14
10120796|NCT02564055|11251898|FG000|STARTED|Overall Study||40
10120797|NCT02564055|11251899|FG001|STARTED|Overall Study||41
10120798|NCT02564055|11251900|FG002|STARTED|Overall Study||43
10120799|NCT02564055|11251901|FG003|STARTED|Overall Study||41
10120800|NCT02564055|11251902|FG004|STARTED|Overall Study||42
10120801|NCT02564055|11251903|FG005|STARTED|Overall Study||40
10120802|NCT02564055|11251898|FG000|COMPLETED|Overall Study||34
10120803|NCT02564055|11251899|FG001|COMPLETED|Overall Study||36
10120804|NCT02564055|11251900|FG002|COMPLETED|Overall Study||31
10120805|NCT02564055|11251901|FG003|COMPLETED|Overall Study||35
10120806|NCT02564055|11251902|FG004|COMPLETED|Overall Study||27
10120807|NCT02564055|11251903|FG005|COMPLETED|Overall Study||28
10120808|NCT02564055|11251898|FG000|NOT COMPLETED|Overall Study||6
10120809|NCT02564055|11251899|FG001|NOT COMPLETED|Overall Study||5
10120810|NCT02564055|11251900|FG002|NOT COMPLETED|Overall Study||12
10057301|NCT02073682|11182227|FG000|NOT COMPLETED|Overall Study||322
10057302|NCT02073682|11182228|FG001|NOT COMPLETED|Overall Study||370
10057303|NCT02073747|11182236|FG000|STARTED|Overall Study||15
10057304|NCT02073747|11182237|FG001|STARTED|Overall Study||15
10120811|NCT02564055|11251901|FG003|NOT COMPLETED|Overall Study||6
10120812|NCT02564055|11251902|FG004|NOT COMPLETED|Overall Study||15
10120813|NCT02564055|11251903|FG005|NOT COMPLETED|Overall Study||12
10120814|NCT02564120|11251922|FG000|STARTED|Overall Study||1556
10057305|NCT02073747|11182236|FG000|COMPLETED|Overall Study||14
10057306|NCT02073747|11182237|FG001|COMPLETED|Overall Study||14
10057307|NCT02073747|11182236|FG000|NOT COMPLETED|Overall Study||1
10057308|NCT02073747|11182237|FG001|NOT COMPLETED|Overall Study||1
10057309|NCT02073929|11182245|FG000|STARTED|Overall Study||48
10057310|NCT02073929|11182246|FG001|STARTED|Overall Study||24
10057311|NCT02073929|11182245|FG000|COMPLETED|Overall Study||44
10057312|NCT02073929|11182246|FG001|COMPLETED|Overall Study||21
10057313|NCT02073929|11182245|FG000|NOT COMPLETED|Overall Study||4
10057314|NCT02073929|11182246|FG001|NOT COMPLETED|Overall Study||3
10057315|NCT02074059|11182258|FG000|STARTED|Overall Study||8
10057316|NCT02074059|11182259|FG001|STARTED|Overall Study||8
10057317|NCT02074059|11182260|FG002|STARTED|Overall Study||8
10057318|NCT02074059|11182261|FG003|STARTED|Overall Study||8
10057319|NCT02074059|11182262|FG004|STARTED|Overall Study||8
10057320|NCT02074059|11182263|FG005|STARTED|Overall Study||40
10057321|NCT02074059|11182258|FG000|COMPLETED|Overall Study||8
10057322|NCT02074059|11182259|FG001|COMPLETED|Overall Study||8
10057323|NCT02074059|11182260|FG002|COMPLETED|Overall Study||8
10057324|NCT02074059|11182261|FG003|COMPLETED|Overall Study||8
10057325|NCT02074059|11182262|FG004|COMPLETED|Overall Study||7
10057326|NCT02074059|11182263|FG005|COMPLETED|Overall Study||39
10057327|NCT02074059|11182258|FG000|NOT COMPLETED|Overall Study||0
10057328|NCT02074059|11182259|FG001|NOT COMPLETED|Overall Study||0
10057329|NCT02074059|11182260|FG002|NOT COMPLETED|Overall Study||0
10057330|NCT02074059|11182261|FG003|NOT COMPLETED|Overall Study||0
10057331|NCT02074059|11182262|FG004|NOT COMPLETED|Overall Study||1
10057332|NCT02074059|11182263|FG005|NOT COMPLETED|Overall Study||1
10057333|NCT02074345|11182278|FG000|STARTED|Overall Study||31
10057334|NCT02074345|11182278|FG000|COMPLETED|Overall Study||31
10057335|NCT02074345|11182278|FG000|NOT COMPLETED|Overall Study||0
10057336|NCT02074358|11182282|FG000|STARTED|Overall Study||3
10057337|NCT02074358|11182283|FG001|STARTED|Overall Study||3
10057338|NCT02074358|11182284|FG002|STARTED|Overall Study||2
10057339|NCT02074358|11182285|FG003|STARTED|Overall Study||2
10057340|NCT02074358|11182286|FG004|STARTED|Overall Study||3
10057341|NCT02074358|11182287|FG005|STARTED|Overall Study||2
10057342|NCT02074358|11182282|FG000|COMPLETED|Overall Study||3
10057343|NCT02074358|11182283|FG001|COMPLETED|Overall Study||3
10057344|NCT02074358|11182284|FG002|COMPLETED|Overall Study||2
10057345|NCT02074358|11182285|FG003|COMPLETED|Overall Study||2
10057346|NCT02074358|11182286|FG004|COMPLETED|Overall Study||3
10057347|NCT02074358|11182287|FG005|COMPLETED|Overall Study||2
10057348|NCT02074358|11182282|FG000|NOT COMPLETED|Overall Study||0
10057349|NCT02074358|11182283|FG001|NOT COMPLETED|Overall Study||0
10057350|NCT02074358|11182284|FG002|NOT COMPLETED|Overall Study||0
10057351|NCT02074358|11182285|FG003|NOT COMPLETED|Overall Study||0
10057352|NCT02074358|11182286|FG004|NOT COMPLETED|Overall Study||0
10057353|NCT02074358|11182287|FG005|NOT COMPLETED|Overall Study||0
10057354|NCT02074384|11182298|FG000|STARTED|Overall Study||74
10057355|NCT02074384|11182299|FG001|STARTED|Overall Study||70
10057356|NCT02074384|11182300|FG002|STARTED|Overall Study||17
10057357|NCT02074384|11182298|FG000|COMPLETED|Overall Study||74
10057358|NCT02074384|11182299|FG001|COMPLETED|Overall Study||70
10057359|NCT02074384|11182300|FG002|COMPLETED|Overall Study||17
10057360|NCT02074384|11182298|FG000|NOT COMPLETED|Overall Study||0
10057361|NCT02074384|11182299|FG001|NOT COMPLETED|Overall Study||0
10057362|NCT02074384|11182300|FG002|NOT COMPLETED|Overall Study||0
10057363|NCT02074514|11182312|FG000|STARTED|Overall Study||59
10057364|NCT02074514|11182313|FG001|STARTED|Overall Study||58
10057365|NCT02074514|11182312|FG000|COMPLETED|Overall Study||56
10057366|NCT02074514|11182313|FG001|COMPLETED|Overall Study||54
10057367|NCT02074514|11182312|FG000|NOT COMPLETED|Overall Study||3
10057368|NCT02074514|11182313|FG001|NOT COMPLETED|Overall Study||4
10057369|NCT02074553|11182325|FG000|STARTED|Intervention Period 1||12
10057370|NCT02074553|11182326|FG001|STARTED|Intervention Period 1||12
10057371|NCT02074553|11182327|FG002|STARTED|Intervention Period 1||12
10057372|NCT02074553|11182328|FG003|STARTED|Intervention Period 1||13
10057373|NCT02074553|11182329|FG004|STARTED|Intervention Period 1||12
10057374|NCT02074553|11182330|FG005|STARTED|Intervention Period 1||12
10057375|NCT02074553|11182331|FG006|STARTED|Intervention Period 1||12
10120815|NCT02564120|11251922|FG000|COMPLETED|Overall Study||1110
10120816|NCT02564120|11251922|FG000|NOT COMPLETED|Overall Study||446
10057376|NCT02074553|11182332|FG007|STARTED|Intervention Period 1||12
10057377|NCT02074553|11182325|FG000|COMPLETED|Intervention Period 1||12
10057378|NCT02074553|11182326|FG001|COMPLETED|Intervention Period 1||12
10057379|NCT02074553|11182327|FG002|COMPLETED|Intervention Period 1||12
10057380|NCT02074553|11182328|FG003|COMPLETED|Intervention Period 1||12
10057381|NCT02074553|11182329|FG004|COMPLETED|Intervention Period 1||12
10057382|NCT02074553|11182330|FG005|COMPLETED|Intervention Period 1||12
10057383|NCT02074553|11182331|FG006|COMPLETED|Intervention Period 1||12
10057384|NCT02074553|11182332|FG007|COMPLETED|Intervention Period 1||12
10057385|NCT02074553|11182325|FG000|NOT COMPLETED|Intervention Period 1||0
10057386|NCT02074553|11182326|FG001|NOT COMPLETED|Intervention Period 1||0
10057387|NCT02074553|11182327|FG002|NOT COMPLETED|Intervention Period 1||0
10120817|NCT02564198|11251939|FG000|STARTED|Overall Study||8
10120818|NCT02564198|11251940|FG001|STARTED|Overall Study||15
10057388|NCT02074553|11182328|FG003|NOT COMPLETED|Intervention Period 1||1
10057389|NCT02074553|11182329|FG004|NOT COMPLETED|Intervention Period 1||0
10057390|NCT02074553|11182330|FG005|NOT COMPLETED|Intervention Period 1||0
10057391|NCT02074553|11182331|FG006|NOT COMPLETED|Intervention Period 1||0
10057392|NCT02074553|11182332|FG007|NOT COMPLETED|Intervention Period 1||0
10057393|NCT02074553|11182325|FG000|STARTED|Washout Period 1||12
10057394|NCT02074553|11182326|FG001|STARTED|Washout Period 1||12
10057395|NCT02074553|11182327|FG002|STARTED|Washout Period 1||12
10057396|NCT02074553|11182328|FG003|STARTED|Washout Period 1||12
10057397|NCT02074553|11182329|FG004|STARTED|Washout Period 1||12
10057398|NCT02074553|11182330|FG005|STARTED|Washout Period 1||12
10057399|NCT02074553|11182331|FG006|STARTED|Washout Period 1||12
10057400|NCT02074553|11182332|FG007|STARTED|Washout Period 1||12
10057401|NCT02074553|11182325|FG000|COMPLETED|Washout Period 1||11
10057402|NCT02074553|11182326|FG001|COMPLETED|Washout Period 1||12
10057403|NCT02074553|11182327|FG002|COMPLETED|Washout Period 1||12
10057404|NCT02074553|11182328|FG003|COMPLETED|Washout Period 1||11
10057405|NCT02074553|11182329|FG004|COMPLETED|Washout Period 1||12
10057406|NCT02074553|11182330|FG005|COMPLETED|Washout Period 1||11
10057407|NCT02074553|11182331|FG006|COMPLETED|Washout Period 1||12
10057408|NCT02074553|11182332|FG007|COMPLETED|Washout Period 1||12
10057409|NCT02074553|11182325|FG000|NOT COMPLETED|Washout Period 1||1
10057410|NCT02074553|11182326|FG001|NOT COMPLETED|Washout Period 1||0
10057411|NCT02074553|11182327|FG002|NOT COMPLETED|Washout Period 1||0
10057412|NCT02074553|11182328|FG003|NOT COMPLETED|Washout Period 1||1
10057413|NCT02074553|11182329|FG004|NOT COMPLETED|Washout Period 1||0
10057414|NCT02074553|11182330|FG005|NOT COMPLETED|Washout Period 1||1
10057415|NCT02074553|11182331|FG006|NOT COMPLETED|Washout Period 1||0
10057416|NCT02074553|11182332|FG007|NOT COMPLETED|Washout Period 1||0
10057417|NCT02074553|11182325|FG000|STARTED|Intervention Period 2||11
10057418|NCT02074553|11182326|FG001|STARTED|Intervention Period 2||12
10057419|NCT02074553|11182327|FG002|STARTED|Intervention Period 2||12
10057420|NCT02074553|11182328|FG003|STARTED|Intervention Period 2||11
10057421|NCT02074553|11182329|FG004|STARTED|Intervention Period 2||12
10057422|NCT02074553|11182330|FG005|STARTED|Intervention Period 2||11
10057423|NCT02074553|11182331|FG006|STARTED|Intervention Period 2||12
10057424|NCT02074553|11182332|FG007|STARTED|Intervention Period 2||12
10057425|NCT02074553|11182325|FG000|COMPLETED|Intervention Period 2||11
10057426|NCT02074553|11182326|FG001|COMPLETED|Intervention Period 2||12
10057427|NCT02074553|11182327|FG002|COMPLETED|Intervention Period 2||12
10057428|NCT02074553|11182328|FG003|COMPLETED|Intervention Period 2||11
10057429|NCT02074553|11182329|FG004|COMPLETED|Intervention Period 2||12
10057430|NCT02074553|11182330|FG005|COMPLETED|Intervention Period 2||11
10057431|NCT02074553|11182331|FG006|COMPLETED|Intervention Period 2||12
10057432|NCT02074553|11182332|FG007|COMPLETED|Intervention Period 2||12
10057433|NCT02074553|11182325|FG000|NOT COMPLETED|Intervention Period 2||0
10057434|NCT02074553|11182326|FG001|NOT COMPLETED|Intervention Period 2||0
10057435|NCT02074553|11182327|FG002|NOT COMPLETED|Intervention Period 2||0
10057436|NCT02074553|11182328|FG003|NOT COMPLETED|Intervention Period 2||0
10057437|NCT02074553|11182329|FG004|NOT COMPLETED|Intervention Period 2||0
10057438|NCT02074553|11182330|FG005|NOT COMPLETED|Intervention Period 2||0
10057439|NCT02074553|11182331|FG006|NOT COMPLETED|Intervention Period 2||0
10057440|NCT02074553|11182332|FG007|NOT COMPLETED|Intervention Period 2||0
10057441|NCT02074553|11182325|FG000|STARTED|Washout Period 2||11
10057442|NCT02074553|11182326|FG001|STARTED|Washout Period 2||12
10057443|NCT02074553|11182327|FG002|STARTED|Washout Period 2||12
10057444|NCT02074553|11182328|FG003|STARTED|Washout Period 2||11
10057445|NCT02074553|11182329|FG004|STARTED|Washout Period 2||12
10057446|NCT02074553|11182330|FG005|STARTED|Washout Period 2||11
10057447|NCT02074553|11182331|FG006|STARTED|Washout Period 2||12
10057448|NCT02074553|11182332|FG007|STARTED|Washout Period 2||12
10057449|NCT02074553|11182325|FG000|COMPLETED|Washout Period 2||11
10057450|NCT02074553|11182326|FG001|COMPLETED|Washout Period 2||12
10057451|NCT02074553|11182327|FG002|COMPLETED|Washout Period 2||11
10057452|NCT02074553|11182328|FG003|COMPLETED|Washout Period 2||11
10057453|NCT02074553|11182329|FG004|COMPLETED|Washout Period 2||12
10057454|NCT02074553|11182330|FG005|COMPLETED|Washout Period 2||10
10057455|NCT02074553|11182331|FG006|COMPLETED|Washout Period 2||11
10057456|NCT02074553|11182332|FG007|COMPLETED|Washout Period 2||12
10057457|NCT02074553|11182325|FG000|NOT COMPLETED|Washout Period 2||0
10057458|NCT02074553|11182326|FG001|NOT COMPLETED|Washout Period 2||0
10057459|NCT02074553|11182327|FG002|NOT COMPLETED|Washout Period 2||1
10057460|NCT02074553|11182328|FG003|NOT COMPLETED|Washout Period 2||0
10057461|NCT02074553|11182329|FG004|NOT COMPLETED|Washout Period 2||0
10057462|NCT02074553|11182330|FG005|NOT COMPLETED|Washout Period 2||1
10057463|NCT02074553|11182331|FG006|NOT COMPLETED|Washout Period 2||1
10057464|NCT02074553|11182332|FG007|NOT COMPLETED|Washout Period 2||0
10120819|NCT02564198|11251941|FG002|STARTED|Overall Study||6
10057465|NCT02074553|11182325|FG000|STARTED|Intervention Period 3||11
10057466|NCT02074553|11182326|FG001|STARTED|Intervention Period 3||12
10057467|NCT02074553|11182327|FG002|STARTED|Intervention Period 3||11
10057468|NCT02074553|11182328|FG003|STARTED|Intervention Period 3||11
10057469|NCT02074553|11182329|FG004|STARTED|Intervention Period 3||12
10057470|NCT02074553|11182330|FG005|STARTED|Intervention Period 3||10
10057471|NCT02074553|11182331|FG006|STARTED|Intervention Period 3||11
10057472|NCT02074553|11182332|FG007|STARTED|Intervention Period 3||12
10057473|NCT02074553|11182325|FG000|COMPLETED|Intervention Period 3||11
10057474|NCT02074553|11182326|FG001|COMPLETED|Intervention Period 3||12
10057475|NCT02074553|11182327|FG002|COMPLETED|Intervention Period 3||11
10057476|NCT02074553|11182328|FG003|COMPLETED|Intervention Period 3||11
10057477|NCT02074553|11182329|FG004|COMPLETED|Intervention Period 3||12
10057478|NCT02074553|11182330|FG005|COMPLETED|Intervention Period 3||10
10057479|NCT02074553|11182331|FG006|COMPLETED|Intervention Period 3||11
10057480|NCT02074553|11182332|FG007|COMPLETED|Intervention Period 3||12
10057481|NCT02074553|11182325|FG000|NOT COMPLETED|Intervention Period 3||0
10120820|NCT02564198|11251939|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10120821|NCT02564198|11251940|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
10120822|NCT02564198|11251941|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10057482|NCT02074553|11182326|FG001|NOT COMPLETED|Intervention Period 3||0
10057483|NCT02074553|11182327|FG002|NOT COMPLETED|Intervention Period 3||0
10057484|NCT02074553|11182328|FG003|NOT COMPLETED|Intervention Period 3||0
10057485|NCT02074553|11182329|FG004|NOT COMPLETED|Intervention Period 3||0
10057486|NCT02074553|11182330|FG005|NOT COMPLETED|Intervention Period 3||0
10057487|NCT02074553|11182331|FG006|NOT COMPLETED|Intervention Period 3||0
10057488|NCT02074553|11182332|FG007|NOT COMPLETED|Intervention Period 3||0
10057489|NCT02074553|11182325|FG000|STARTED|Washout Period 3||11
10057490|NCT02074553|11182326|FG001|STARTED|Washout Period 3||12
10057491|NCT02074553|11182327|FG002|STARTED|Washout Period 3||11
10057492|NCT02074553|11182328|FG003|STARTED|Washout Period 3||11
10057493|NCT02074553|11182329|FG004|STARTED|Washout Period 3||12
10057494|NCT02074553|11182330|FG005|STARTED|Washout Period 3||10
10057495|NCT02074553|11182331|FG006|STARTED|Washout Period 3||11
10120823|NCT02564198|11251939|FG000|COMPLETED|Overall Study||6
10120824|NCT02564198|11251940|FG001|COMPLETED|Overall Study||10
10120825|NCT02564198|11251941|FG002|COMPLETED|Overall Study||6
10120826|NCT02564198|11251939|FG000|NOT COMPLETED|Overall Study||2
10120827|NCT02564198|11251940|FG001|NOT COMPLETED|Overall Study||5
10120828|NCT02564198|11251941|FG002|NOT COMPLETED|Overall Study||0
10120829|NCT02564211|11251951|FG000|STARTED|Overall Study||77
10120830|NCT02564211|11251951|FG000|COMPLETED|Overall Study||73
10120831|NCT02564211|11251951|FG000|NOT COMPLETED|Overall Study||4
10120832|NCT02564354|11251957|FG000|STARTED|Overall Study||10
10120833|NCT02564354|11251958|FG001|STARTED|Overall Study||8
10120834|NCT02564354|11251957|FG000|COMPLETED|Overall Study||10
10120835|NCT02564354|11251958|FG001|COMPLETED|Overall Study||8
10120836|NCT02564354|11251957|FG000|NOT COMPLETED|Overall Study||0
10120837|NCT02564354|11251958|FG001|NOT COMPLETED|Overall Study||0
10120838|NCT02564432|11251964|FG000|STARTED|Overall Study||10
10120839|NCT02564432|11251964|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
10120840|NCT02564432|11251964|FG000|NOT COMPLETED|Overall Study||2
10120841|NCT02564471|11251974|FG000|STARTED|Overall Study||25
10120842|NCT02564471|11251975|FG001|STARTED|Overall Study||26
10120843|NCT02564471|11251976|FG002|STARTED|Overall Study||27
10120844|NCT02564471|11251977|FG003|STARTED|Overall Study||25
10120845|NCT02564471|11251974|FG000|COMPLETED|Overall Study||22
10120846|NCT02564471|11251975|FG001|COMPLETED|Overall Study||23
10120847|NCT02564471|11251976|FG002|COMPLETED|Overall Study||24
10120848|NCT02564471|11251977|FG003|COMPLETED|Overall Study||25
10120849|NCT02564471|11251974|FG000|NOT COMPLETED|Overall Study||3
10120850|NCT02564471|11251975|FG001|NOT COMPLETED|Overall Study||3
10120851|NCT02564471|11251976|FG002|NOT COMPLETED|Overall Study||3
10120852|NCT02564471|11251977|FG003|NOT COMPLETED|Overall Study||0
10120853|NCT02564497|11251989|FG000|STARTED|Overall Study||74
10120854|NCT02564497|11251990|FG001|STARTED|Overall Study||72
10120855|NCT02564497|11251989|FG000|COMPLETED|Overall Study||74
10120856|NCT02564497|11251990|FG001|COMPLETED|Overall Study||72
10120857|NCT02564497|11251989|FG000|NOT COMPLETED|Overall Study||0
10120858|NCT02564497|11251990|FG001|NOT COMPLETED|Overall Study||0
10120859|NCT02564718|11251998|FG000|STARTED|Overall Study||5
10120860|NCT02564718|11251999|FG001|STARTED|Overall Study||5
10120861|NCT02564718|11251998|FG000|COMPLETED|Overall Study||5
10120862|NCT02564718|11251999|FG001|COMPLETED|Overall Study||4
10120863|NCT02564718|11251998|FG000|NOT COMPLETED|Overall Study||0
10120864|NCT02564718|11251999|FG001|NOT COMPLETED|Overall Study||1
10120865|NCT02564887|11252007|FG000|STARTED|Overall Study||16
10120866|NCT02564887|11252008|FG001|STARTED|Overall Study||10
10120867|NCT02564887|11252007|FG000|COMPLETED|Overall Study||10
10120868|NCT02564887|11252008|FG001|COMPLETED|Overall Study||10
10120869|NCT02564887|11252007|FG000|NOT COMPLETED|Overall Study||6
10120870|NCT02564887|11252008|FG001|NOT COMPLETED|Overall Study||0
10120871|NCT02564926|11252018|FG000|STARTED|Overall Study||60
10120872|NCT02564926|11252019|FG001|STARTED|Overall Study||61
10120873|NCT02564926|11252018|FG000|COMPLETED|Overall Study||52
10120874|NCT02564926|11252019|FG001|COMPLETED|Overall Study||54
10120875|NCT02564926|11252018|FG000|NOT COMPLETED|Overall Study||8
10120876|NCT02564926|11252019|FG001|NOT COMPLETED|Overall Study||7
10120877|NCT02564952|11252025|FG000|STARTED|Overall Study||18
10120878|NCT02564952|11252025|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
10120879|NCT02564952|11252025|FG000|Completed OLE Titration Period|Overall Study||16
10120880|NCT02564952|11252025|FG000|COMPLETED|Overall Study||7
10120881|NCT02564952|11252025|FG000|NOT COMPLETED|Overall Study||11
10120882|NCT02565108|11252031|FG000|STARTED|Overall Study||16
10120883|NCT02565108|11252032|FG001|STARTED|Overall Study||4
10120884|NCT02565108|11252031|FG000|Safety Set|Overall Study||16
10120885|NCT02565108|11252032|FG001|Safety Set|Overall Study||4
10120886|NCT02565108|11252031|FG000|Pharmacokinetic (PK) Set|Overall Study||10
10120887|NCT02565108|11252032|FG001|Pharmacokinetic (PK) Set|Overall Study||3
10120888|NCT02565108|11252031|FG000|COMPLETED|Overall Study||14
10120889|NCT02565108|11252032|FG001|COMPLETED|Overall Study||4
10120890|NCT02565108|11252031|FG000|NOT COMPLETED|Overall Study||2
10120891|NCT02565108|11252032|FG001|NOT COMPLETED|Overall Study||0
10120892|NCT02565147|11252040|FG000|STARTED|Overall Study||38
10120893|NCT02565147|11252041|FG001|STARTED|Overall Study||40
10120894|NCT02565147|11252040|FG000|Received Study Drug|Overall Study||38
10057496|NCT02074553|11182332|FG007|STARTED|Washout Period 3||12
10057497|NCT02074553|11182325|FG000|COMPLETED|Washout Period 3||11
10057498|NCT02074553|11182326|FG001|COMPLETED|Washout Period 3||12
10057499|NCT02074553|11182327|FG002|COMPLETED|Washout Period 3||11
10057500|NCT02074553|11182328|FG003|COMPLETED|Washout Period 3||11
10057501|NCT02074553|11182329|FG004|COMPLETED|Washout Period 3||12
10057502|NCT02074553|11182330|FG005|COMPLETED|Washout Period 3||10
10057503|NCT02074553|11182331|FG006|COMPLETED|Washout Period 3||11
10057504|NCT02074553|11182332|FG007|COMPLETED|Washout Period 3||11
10057505|NCT02074553|11182325|FG000|NOT COMPLETED|Washout Period 3||0
10057506|NCT02074553|11182326|FG001|NOT COMPLETED|Washout Period 3||0
10057507|NCT02074553|11182327|FG002|NOT COMPLETED|Washout Period 3||0
10057508|NCT02074553|11182328|FG003|NOT COMPLETED|Washout Period 3||0
10120895|NCT02565147|11252041|FG001|Received Study Drug|Overall Study||40
10120896|NCT02565147|11252040|FG000|Per-Protocol Population|Overall Study||28
10120897|NCT02565147|11252041|FG001|Per-Protocol Population|Overall Study||36
10120898|NCT02565147|11252040|FG000|COMPLETED|Overall Study||32
10120899|NCT02565147|11252041|FG001|COMPLETED|Overall Study||37
10120900|NCT02565147|11252040|FG000|NOT COMPLETED|Overall Study||6
10120901|NCT02565147|11252041|FG001|NOT COMPLETED|Overall Study||3
10120902|NCT02565186|11252049|FG000|STARTED|Overall Study||1046
10120903|NCT02565186|11252050|FG001|STARTED|Overall Study||1125
10120904|NCT02565186|11252049|FG000|Received at Least One Dose of Study Drug|Overall Study||991
10120905|NCT02565186|11252050|FG001|Received at Least One Dose of Study Drug|Overall Study||1039
10120906|NCT02565186|11252049|FG000|COMPLETED|Overall Study||466
10120907|NCT02565186|11252050|FG001|COMPLETED|Overall Study||504
10120908|NCT02565186|11252049|FG000|NOT COMPLETED|Overall Study||580
10120909|NCT02565186|11252050|FG001|NOT COMPLETED|Overall Study||621
10120910|NCT02565381|11252059|FG000|STARTED|Overall Study||25
10120911|NCT02565381|11252060|FG001|STARTED|Overall Study||25
10120912|NCT02565381|11252061|FG002|STARTED|Overall Study||25
10120913|NCT02565381|11252059|FG000|COMPLETED|Overall Study||24
10120914|NCT02565381|11252060|FG001|COMPLETED|Overall Study||25
10120915|NCT02565381|11252061|FG002|COMPLETED|Overall Study||24
10120916|NCT02565381|11252059|FG000|NOT COMPLETED|Overall Study||1
10120917|NCT02565381|11252060|FG001|NOT COMPLETED|Overall Study||0
10120918|NCT02565381|11252061|FG002|NOT COMPLETED|Overall Study||1
10120919|NCT02565485|11252071|FG000|STARTED|Overall Study||139
10120920|NCT02565485|11252072|FG001|STARTED|Overall Study||137
10120921|NCT02565485|11252071|FG000|COMPLETED|Overall Study||139
10120922|NCT02565485|11252072|FG001|COMPLETED|Overall Study||137
10120923|NCT02565485|11252071|FG000|NOT COMPLETED|Overall Study||0
10120924|NCT02565485|11252072|FG001|NOT COMPLETED|Overall Study||0
10120925|NCT02565511|11252082|FG000|STARTED|Overall Study||42
10120926|NCT02565511|11252083|FG001|STARTED|Overall Study||23
10120927|NCT02565511|11252084|FG002|STARTED|Overall Study||251
10120928|NCT02565511|11252085|FG003|STARTED|Overall Study||164
10120929|NCT02565511|11252082|FG000|3 Patients Were Mis-randomized|Overall Study||0
10120930|NCT02565511|11252083|FG001|3 Patients Were Mis-randomized|Overall Study||0
10120931|NCT02565511|11252084|FG002|3 Patients Were Mis-randomized|Overall Study||2
10120932|NCT02565511|11252085|FG003|3 Patients Were Mis-randomized|Overall Study||1
10120933|NCT02565511|11252082|FG000|COMPLETED|Overall Study||0
10120934|NCT02565511|11252083|FG001|COMPLETED|Overall Study||0
10120935|NCT02565511|11252084|FG002|COMPLETED|Overall Study||0
10120936|NCT02565511|11252085|FG003|COMPLETED|Overall Study||0
10120937|NCT02565511|11252082|FG000|NOT COMPLETED|Overall Study||42
10120938|NCT02565511|11252083|FG001|NOT COMPLETED|Overall Study||23
10120939|NCT02565511|11252084|FG002|NOT COMPLETED|Overall Study||251
10120940|NCT02565511|11252085|FG003|NOT COMPLETED|Overall Study||164
10120941|NCT02565576|11252097|FG000|STARTED|Overall Study||22
10120942|NCT02565576|11252098|FG001|STARTED|Overall Study||22
10120943|NCT02565576|11252097|FG000|COMPLETED|Overall Study||17
10120944|NCT02565576|11252098|FG001|COMPLETED|Overall Study||17
10120945|NCT02565576|11252097|FG000|NOT COMPLETED|Overall Study||5
10120946|NCT02565576|11252098|FG001|NOT COMPLETED|Overall Study||5
10120947|NCT02565615|11252109|FG000|STARTED|Overall Study||291
10120948|NCT02565615|11252110|FG001|STARTED|Overall Study||3080
10120949|NCT02565615|11252111|FG002|STARTED|Overall Study||21
10120950|NCT02565615|11252112|FG003|STARTED|Overall Study||101
10120951|NCT02565615|11252113|FG004|STARTED|Overall Study||1622
10120952|NCT02565615|11252109|FG000|Treated|Overall Study||291
10120953|NCT02565615|11252110|FG001|Treated|Overall Study||3080
10120954|NCT02565615|11252111|FG002|Treated|Overall Study||21
10120955|NCT02565615|11252112|FG003|Treated|Overall Study||101
10120956|NCT02565615|11252113|FG004|Treated|Overall Study||1055
10120957|NCT02565615|11252109|FG000|COMPLETED|Overall Study||288
10120958|NCT02565615|11252110|FG001|COMPLETED|Overall Study||3044
10120959|NCT02565615|11252111|FG002|COMPLETED|Overall Study||21
10120960|NCT02565615|11252112|FG003|COMPLETED|Overall Study||98
10120961|NCT02565615|11252113|FG004|COMPLETED|Overall Study||21
10120962|NCT02565615|11252109|FG000|NOT COMPLETED|Overall Study||3
10120963|NCT02565615|11252110|FG001|NOT COMPLETED|Overall Study||36
10120964|NCT02565615|11252111|FG002|NOT COMPLETED|Overall Study||0
10120965|NCT02565615|11252112|FG003|NOT COMPLETED|Overall Study||3
10120966|NCT02565615|11252113|FG004|NOT COMPLETED|Overall Study||1601
10120967|NCT02565628|11252127|FG000|STARTED|Overall Study||10
10120968|NCT02565628|11252128|FG001|STARTED|Overall Study||9
10120969|NCT02565628|11252127|FG000|Received Treatment|Overall Study||10
10057509|NCT02074553|11182329|FG004|NOT COMPLETED|Washout Period 3||0
10057510|NCT02074553|11182330|FG005|NOT COMPLETED|Washout Period 3||0
10057511|NCT02074553|11182331|FG006|NOT COMPLETED|Washout Period 3||0
10057512|NCT02074553|11182332|FG007|NOT COMPLETED|Washout Period 3||1
10057513|NCT02074553|11182325|FG000|STARTED|Intervention Period 4||11
10120970|NCT02565628|11252128|FG001|Received Treatment|Overall Study||9
10120971|NCT02565628|11252127|FG000|COMPLETED|Overall Study||10
10057514|NCT02074553|11182326|FG001|STARTED|Intervention Period 4||12
10057515|NCT02074553|11182327|FG002|STARTED|Intervention Period 4||11
10057516|NCT02074553|11182328|FG003|STARTED|Intervention Period 4||11
10057517|NCT02074553|11182329|FG004|STARTED|Intervention Period 4||12
10057518|NCT02074553|11182330|FG005|STARTED|Intervention Period 4||10
10057519|NCT02074553|11182331|FG006|STARTED|Intervention Period 4||11
10057520|NCT02074553|11182332|FG007|STARTED|Intervention Period 4||11
10057521|NCT02074553|11182325|FG000|COMPLETED|Intervention Period 4||11
10057522|NCT02074553|11182326|FG001|COMPLETED|Intervention Period 4||12
10057523|NCT02074553|11182327|FG002|COMPLETED|Intervention Period 4||11
10057524|NCT02074553|11182328|FG003|COMPLETED|Intervention Period 4||11
10057525|NCT02074553|11182329|FG004|COMPLETED|Intervention Period 4||12
10057526|NCT02074553|11182330|FG005|COMPLETED|Intervention Period 4||10
10057527|NCT02074553|11182331|FG006|COMPLETED|Intervention Period 4||11
10057528|NCT02074553|11182332|FG007|COMPLETED|Intervention Period 4||11
10057529|NCT02074553|11182325|FG000|NOT COMPLETED|Intervention Period 4||0
10057530|NCT02074553|11182326|FG001|NOT COMPLETED|Intervention Period 4||0
10057531|NCT02074553|11182327|FG002|NOT COMPLETED|Intervention Period 4||0
10057532|NCT02074553|11182328|FG003|NOT COMPLETED|Intervention Period 4||0
10057533|NCT02074553|11182329|FG004|NOT COMPLETED|Intervention Period 4||0
10057534|NCT02074553|11182330|FG005|NOT COMPLETED|Intervention Period 4||0
10057535|NCT02074553|11182331|FG006|NOT COMPLETED|Intervention Period 4||0
10057536|NCT02074553|11182332|FG007|NOT COMPLETED|Intervention Period 4||0
10057537|NCT02074709|11182352|FG000|STARTED|Overall Study||30
10057538|NCT02074709|11182353|FG001|STARTED|Overall Study||30
10057539|NCT02074709|11182352|FG000|COMPLETED|Overall Study||29
10057540|NCT02074709|11182353|FG001|COMPLETED|Overall Study||29
10057541|NCT02074709|11182352|FG000|NOT COMPLETED|Overall Study||1
10057542|NCT02074709|11182353|FG001|NOT COMPLETED|Overall Study||1
10057543|NCT02074735|11182361|FG000|STARTED|Overall Study||29
10057544|NCT02074735|11182362|FG001|STARTED|Overall Study||33
10057545|NCT02074735|11182361|FG000|COMPLETED|Overall Study||26
10057546|NCT02074735|11182362|FG001|COMPLETED|Overall Study||29
10057547|NCT02074735|11182361|FG000|NOT COMPLETED|Overall Study||3
10057548|NCT02074735|11182362|FG001|NOT COMPLETED|Overall Study||4
10057549|NCT02074982|11182370|FG000|STARTED|Overall Study||337
10057550|NCT02074982|11182371|FG001|STARTED|Overall Study||339
10057551|NCT02074982|11182370|FG000|Full Analysis Set (FAS)|Overall Study||336
10057552|NCT02074982|11182371|FG001|Full Analysis Set (FAS)|Overall Study||339
10057553|NCT02074982|11182370|FG000|Safety Set (SF)|Overall Study||335
10057554|NCT02074982|11182371|FG001|Safety Set (SF)|Overall Study||336
10057555|NCT02074982|11182370|FG000|COMPLETED|Overall Study||286
10057556|NCT02074982|11182371|FG001|COMPLETED|Overall Study||285
10120972|NCT02565628|11252128|FG001|COMPLETED|Overall Study||9
10120973|NCT02565628|11252127|FG000|NOT COMPLETED|Overall Study||0
10120974|NCT02565628|11252128|FG001|NOT COMPLETED|Overall Study||0
10120975|NCT02565706|11252138|FG000|STARTED|Overall Study||178
10120976|NCT02565706|11252139|FG001|STARTED|Overall Study||172
10120977|NCT02565706|11252140|FG002|STARTED|Overall Study||193
10120978|NCT02565706|11252141|FG003|STARTED|Overall Study||201
10120979|NCT02565706|11252138|FG000|COMPLETED|Overall Study||101
10120980|NCT02565706|11252139|FG001|COMPLETED|Overall Study||90
10120981|NCT02565706|11252140|FG002|COMPLETED|Overall Study||104
10120982|NCT02565706|11252141|FG003|COMPLETED|Overall Study||116
10120983|NCT02565706|11252138|FG000|NOT COMPLETED|Overall Study||77
10120984|NCT02565706|11252139|FG001|NOT COMPLETED|Overall Study||82
10120985|NCT02565706|11252140|FG002|NOT COMPLETED|Overall Study||89
10120986|NCT02565706|11252141|FG003|NOT COMPLETED|Overall Study||85
10120987|NCT02565784|11252156|FG000|STARTED|First Treatment||100
10120988|NCT02565784|11252156|FG000|6 Months Follow-up|First Treatment||99
10120989|NCT02565784|11252156|FG000|12 Months Follow-up|First Treatment||98
10120990|NCT02565784|11252156|FG000|COMPLETED|First Treatment||98
10120991|NCT02565784|11252156|FG000|NOT COMPLETED|First Treatment||2
10057557|NCT02074982|11182370|FG000|NOT COMPLETED|Overall Study||51
10057558|NCT02074982|11182371|FG001|NOT COMPLETED|Overall Study||54
10057559|NCT02074995|11182377|FG000|STARTED|Overall Study||1
10057560|NCT02074995|11182378|FG001|STARTED|Overall Study||0
10057561|NCT02074995|11182379|FG002|STARTED|Overall Study||0
10057562|NCT02074995|11182377|FG000|COMPLETED|Overall Study||1
10120992|NCT02565784|11252156|FG000|STARTED|Second Treatment||98
10120993|NCT02565784|11252156|FG000|6 Months Follow-up|Second Treatment||97
10120994|NCT02565784|11252156|FG000|12 Months Follow-up|Second Treatment||96
10120995|NCT02565784|11252156|FG000|COMPLETED|Second Treatment||96
10120996|NCT02565784|11252156|FG000|NOT COMPLETED|Second Treatment||2
10120997|NCT02565810|11252164|FG000|STARTED|Overall Study||49
10057563|NCT02074995|11182378|FG001|COMPLETED|Overall Study||0
10057564|NCT02074995|11182379|FG002|COMPLETED|Overall Study||0
10057565|NCT02074995|11182377|FG000|NOT COMPLETED|Overall Study||0
10057566|NCT02074995|11182378|FG001|NOT COMPLETED|Overall Study||0
10057567|NCT02074995|11182379|FG002|NOT COMPLETED|Overall Study||0
10057568|NCT02075008|11182383|FG000|STARTED|Overall Study||270
10057569|NCT02075008|11182383|FG000|COMPLETED|Overall Study||94
10057570|NCT02075008|11182383|FG000|NOT COMPLETED|Overall Study||176
10057571|NCT02075047|11182389|FG000|STARTED|Treatment Phase (4 Weeks)||86
10057572|NCT02075047|11182390|FG001|STARTED|Treatment Phase (4 Weeks)||85
10057573|NCT02075047|11182389|FG000|COMPLETED|Treatment Phase (4 Weeks)||63
10057574|NCT02075047|11182390|FG001|COMPLETED|Treatment Phase (4 Weeks)||75
10057575|NCT02075047|11182389|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23
10057576|NCT02075047|11182390|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10
10120998|NCT02565810|11252164|FG000|COMPLETED|Overall Study||48
10057577|NCT02075047|11182389|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
10057578|NCT02075047|11182390|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
10057579|NCT02075047|11182389|FG000|COMPLETED|Follow up Phase (5 Weeks)||60
10057580|NCT02075047|11182390|FG001|COMPLETED|Follow up Phase (5 Weeks)||72
10057581|NCT02075047|11182389|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26
10057582|NCT02075047|11182390|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13
10057583|NCT02075073|11182399|FG000|STARTED|Overall Study||36
10057584|NCT02075073|11182400|FG001|STARTED|Overall Study||37
10057585|NCT02075073|11182401|FG002|STARTED|Overall Study||36
10057586|NCT02075073|11182399|FG000|COMPLETED|Overall Study||36
10057587|NCT02075073|11182400|FG001|COMPLETED|Overall Study||36
10057588|NCT02075073|11182401|FG002|COMPLETED|Overall Study||36
10057589|NCT02075073|11182399|FG000|NOT COMPLETED|Overall Study||0
10057590|NCT02075073|11182400|FG001|NOT COMPLETED|Overall Study||1
10057591|NCT02075073|11182401|FG002|NOT COMPLETED|Overall Study||0
10057592|NCT02075125|11182411|FG000|STARTED|Overall Study||19
10057593|NCT02075125|11182412|FG001|STARTED|Overall Study||20
10057594|NCT02075125|11182411|FG000|COMPLETED|Overall Study||19
10057595|NCT02075125|11182412|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
10057596|NCT02075125|11182411|FG000|NOT COMPLETED|Overall Study||0
10057597|NCT02075125|11182412|FG001|NOT COMPLETED|Overall Study||1
10057598|NCT02075203|11182421|FG000|STARTED|Overall Study||330
10057599|NCT02075203|11182422|FG001|STARTED|Overall Study||330
10057600|NCT02075203|11182423|FG002|STARTED|Overall Study||329
10057601|NCT02075203|11182421|FG000|COMPLETED|Overall Study||327
10057602|NCT02075203|11182422|FG001|COMPLETED|Overall Study||330
10057603|NCT02075203|11182423|FG002|COMPLETED|Overall Study||328
10057604|NCT02075203|11182421|FG000|NOT COMPLETED|Overall Study||3
10057605|NCT02075203|11182422|FG001|NOT COMPLETED|Overall Study||0
10057606|NCT02075203|11182423|FG002|NOT COMPLETED|Overall Study||1
10057607|NCT02075255|11182434|FG000|STARTED|Overall Study||72
10057608|NCT02075255|11182435|FG001|STARTED|Overall Study||73
10057609|NCT02075255|11182436|FG002|STARTED|Overall Study||75
10057610|NCT02075255|11182434|FG000|COMPLETED|Overall Study||68
10057611|NCT02075255|11182435|FG001|COMPLETED|Overall Study||69
10057612|NCT02075255|11182436|FG002|COMPLETED|Overall Study||72
10057613|NCT02075255|11182434|FG000|NOT COMPLETED|Overall Study||4
10057614|NCT02075255|11182435|FG001|NOT COMPLETED|Overall Study||4
10057615|NCT02075255|11182436|FG002|NOT COMPLETED|Overall Study||3
10057616|NCT02075463|11182444|FG000|STARTED|Overall Study||15
10057617|NCT02075463|11182444|FG000|COMPLETED|Overall Study||7
10057618|NCT02075463|11182444|FG000|NOT COMPLETED|Overall Study||8
10057619|NCT02075476|11182451|FG000|STARTED|Overall Study||20
10057620|NCT02075476|11182452|FG001|STARTED|Overall Study||20
10057621|NCT02075476|11182451|FG000|COMPLETED|Overall Study||17
10057622|NCT02075476|11182452|FG001|COMPLETED|Overall Study||15
10057623|NCT02075476|11182451|FG000|NOT COMPLETED|Overall Study||3
10057624|NCT02075476|11182452|FG001|NOT COMPLETED|Overall Study||5
10057625|NCT02075515|11182461|FG000|STARTED|Overall Study||218
10057626|NCT02075515|11182462|FG001|STARTED|Overall Study||217
10057627|NCT02075515|11182463|FG002|STARTED|Overall Study||216
10057628|NCT02075515|11182461|FG000|COMPLETED|Overall Study||214
10057629|NCT02075515|11182462|FG001|COMPLETED|Overall Study||212
10057630|NCT02075515|11182463|FG002|COMPLETED|Overall Study||208
10057631|NCT02075515|11182461|FG000|NOT COMPLETED|Overall Study||4
10057632|NCT02075515|11182462|FG001|NOT COMPLETED|Overall Study||5
10057633|NCT02075515|11182463|FG002|NOT COMPLETED|Overall Study||8
10057634|NCT02075541|11182474|FG000|STARTED|Overall Study||73
10057635|NCT02075541|11182475|FG001|STARTED|Overall Study||72
10057636|NCT02075541|11182474|FG000|COMPLETED|Overall Study||69
10057637|NCT02075541|11182475|FG001|COMPLETED|Overall Study||64
10057638|NCT02075541|11182474|FG000|NOT COMPLETED|Overall Study||4
10057639|NCT02075541|11182475|FG001|NOT COMPLETED|Overall Study||8
10057640|NCT02075554|11182481|FG000|STARTED|Overall Study||58
10057641|NCT02075554|11182481|FG000|COMPLETED|Overall Study||43
10057642|NCT02075554|11182481|FG000|NOT COMPLETED|Overall Study||15
10057643|NCT02075606|11182485|FG000|STARTED|Overall Study||50
10057644|NCT02075606|11182485|FG000|COMPLETED|Overall Study||40
10057645|NCT02075606|11182485|FG000|NOT COMPLETED|Overall Study||10
10057646|NCT02075632|11182496|FG000|STARTED|Overall Study||162
10057647|NCT02075632|11182497|FG001|STARTED|Overall Study||148
10057648|NCT02075632|11182496|FG000|COMPLETED|Overall Study||161
10057649|NCT02075632|11182497|FG001|COMPLETED|Overall Study||143
10057650|NCT02075632|11182496|FG000|NOT COMPLETED|Overall Study||1
10057651|NCT02075632|11182497|FG001|NOT COMPLETED|Overall Study||5
10057652|NCT02075658|11182505|FG000|STARTED|Overall Study||30
10057653|NCT02075658|11182506|FG001|STARTED|Overall Study||30
10057654|NCT02075658|11182505|FG000|COMPLETED|Overall Study||28
10057655|NCT02075658|11182506|FG001|COMPLETED|Overall Study||28
10057656|NCT02075658|11182505|FG000|NOT COMPLETED|Overall Study||2
10057657|NCT02075658|11182506|FG001|NOT COMPLETED|Overall Study||2
10057658|NCT02076022|11182514|FG000|STARTED|Overall Study||7
10120999|NCT02565810|11252164|FG000|NOT COMPLETED|Overall Study||1
10057659|NCT02076022|11182515|FG001|STARTED|Overall Study||3
10057660|NCT02076022|11182514|FG000|COMPLETED|Overall Study||5
10057661|NCT02076022|11182515|FG001|COMPLETED|Overall Study||3
10057662|NCT02076022|11182514|FG000|NOT COMPLETED|Overall Study||2
10057663|NCT02076022|11182515|FG001|NOT COMPLETED|Overall Study||0
10057664|NCT02076100|11182528|FG000|STARTED|Overall Study||3
10057665|NCT02076100|11182529|FG001|STARTED|Overall Study||3
10057666|NCT02076100|11182530|FG002|STARTED|Overall Study||3
10057667|NCT02076100|11182531|FG003|STARTED|Overall Study||3
10057668|NCT02076100|11182532|FG004|STARTED|Overall Study||3
10057669|NCT02076100|11182533|FG005|STARTED|Overall Study||3
10057670|NCT02076100|11182534|FG006|STARTED|Overall Study||4
10057671|NCT02076100|11182528|FG000|COMPLETED|Overall Study||3
10057672|NCT02076100|11182529|FG001|COMPLETED|Overall Study||3
10057673|NCT02076100|11182530|FG002|COMPLETED|Overall Study||3
10057674|NCT02076100|11182531|FG003|COMPLETED|Overall Study||3
10057675|NCT02076100|11182532|FG004|COMPLETED|Overall Study||3
10057676|NCT02076100|11182533|FG005|COMPLETED|Overall Study||3
10057677|NCT02076100|11182534|FG006|COMPLETED|Overall Study||4
10057678|NCT02076100|11182528|FG000|NOT COMPLETED|Overall Study||0
10057679|NCT02076100|11182529|FG001|NOT COMPLETED|Overall Study||0
10057680|NCT02076100|11182530|FG002|NOT COMPLETED|Overall Study||0
10057681|NCT02076100|11182531|FG003|NOT COMPLETED|Overall Study||0
10057682|NCT02076100|11182532|FG004|NOT COMPLETED|Overall Study||0
10121000|NCT02565901|11252176|FG000|STARTED|Overall Study||11
10121001|NCT02565901|11252177|FG001|STARTED|Overall Study||11
10121002|NCT02565901|11252178|FG002|STARTED|Overall Study||6
10121003|NCT02565901|11252176|FG000|COMPLETED|Overall Study||11
10121004|NCT02565901|11252177|FG001|COMPLETED|Overall Study||11
10121005|NCT02565901|11252178|FG002|COMPLETED|Overall Study||6
10121006|NCT02565901|11252176|FG000|NOT COMPLETED|Overall Study||0
10121007|NCT02565901|11252177|FG001|NOT COMPLETED|Overall Study||0
10121008|NCT02565901|11252178|FG002|NOT COMPLETED|Overall Study||0
10121009|NCT02566005|11252189|FG000|STARTED|Overall Study||100
10121010|NCT02566005|11252190|FG001|STARTED|Overall Study||100
10121011|NCT02566005|11252189|FG000|COMPLETED|Overall Study||92
10121012|NCT02566005|11252190|FG001|COMPLETED|Overall Study||94
10121013|NCT02566005|11252189|FG000|NOT COMPLETED|Overall Study||8
10121014|NCT02566005|11252190|FG001|NOT COMPLETED|Overall Study||6
10121015|NCT02566031|11252198|FG000|STARTED|Overall Study||189
10121016|NCT02566031|11252199|FG001|STARTED|Overall Study||190
10121017|NCT02566031|11252198|FG000|COMPLETED|Overall Study||169
10121018|NCT02566031|11252199|FG001|COMPLETED|Overall Study||178
10121019|NCT02566031|11252198|FG000|NOT COMPLETED|Overall Study||20
10121020|NCT02566031|11252199|FG001|NOT COMPLETED|Overall Study||12
10121021|NCT02566044|11252209|FG000|STARTED|Overall Study||6
10121022|NCT02566044|11252210|FG001|STARTED|Overall Study||6
10121023|NCT02566044|11252211|FG002|STARTED|Overall Study||4
10121024|NCT02566044|11252209|FG000|COMPLETED|Overall Study||6
10121025|NCT02566044|11252210|FG001|COMPLETED|Overall Study||6
10121026|NCT02566044|11252211|FG002|COMPLETED|Overall Study||4
10121027|NCT02566044|11252209|FG000|NOT COMPLETED|Overall Study||0
10121028|NCT02566044|11252210|FG001|NOT COMPLETED|Overall Study||0
10121029|NCT02566044|11252211|FG002|NOT COMPLETED|Overall Study||0
10121030|NCT02566083|11252226|FG000|STARTED|Overall Study||214
10121031|NCT02566083|11252227|FG001|STARTED|Overall Study||151
10121032|NCT02566083|11252226|FG000|COMPLETED|Overall Study||198
10121033|NCT02566083|11252227|FG001|COMPLETED|Overall Study||141
10121034|NCT02566083|11252226|FG000|NOT COMPLETED|Overall Study||16
10121035|NCT02566083|11252227|FG001|NOT COMPLETED|Overall Study||10
10121036|NCT02566109|11252233|FG000|STARTED|Overall Study||6
10121037|NCT02566109|11252233|FG000|COMPLETED|Overall Study||5
10121038|NCT02566109|11252233|FG000|NOT COMPLETED|Overall Study||1
10121039|NCT02566135|11252239|FG000|STARTED|Overall Study||29
10121040|NCT02566135|11252240|FG001|STARTED|Overall Study||29
10121041|NCT02566135|11252239|FG000|COMPLETED|Overall Study||29
10121042|NCT02566135|11252240|FG001|COMPLETED|Overall Study||29
10121043|NCT02566135|11252239|FG000|NOT COMPLETED|Overall Study||0
10121044|NCT02566135|11252240|FG001|NOT COMPLETED|Overall Study||0
10121045|NCT02566239|11252248|FG000|STARTED|Overall Study||43
10121046|NCT02566239|11252249|FG001|STARTED|Overall Study||48
10121047|NCT02566239|11252248|FG000|COMPLETED|Overall Study||39
10121048|NCT02566239|11252249|FG001|COMPLETED|Overall Study||44
10121049|NCT02566239|11252248|FG000|NOT COMPLETED|Overall Study||4
10121050|NCT02566239|11252249|FG001|NOT COMPLETED|Overall Study||4
10121051|NCT02566265|11252257|FG000|STARTED|Overall Study||81
10121052|NCT02566265|11252258|FG001|STARTED|Overall Study||41
10121053|NCT02566265|11252257|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
10121054|NCT02566265|11252258|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
10121055|NCT02566265|11252257|FG000|Day of Second Vaccine|Overall Study||74
10057683|NCT02076100|11182533|FG005|NOT COMPLETED|Overall Study||0
10057684|NCT02076100|11182534|FG006|NOT COMPLETED|Overall Study||0
10057685|NCT02076113|11182556|FG000|STARTED|Overall Study||63
10057686|NCT02076113|11182557|FG001|STARTED|Overall Study||100
10057687|NCT02076113|11182556|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
10057688|NCT02076113|11182557|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
10057689|NCT02076113|11182556|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
10121056|NCT02566265|11252258|FG001|Day of Second Vaccine|Overall Study||41
10121057|NCT02566265|11252257|FG000|30 Days Following 2nd Vaccine|Overall Study||72
10121058|NCT02566265|11252258|FG001|30 Days Following 2nd Vaccine|Overall Study||35
10121059|NCT02566265|11252257|FG000|End of Study Visit (Optional)|Overall Study||38
10121060|NCT02566265|11252258|FG001|End of Study Visit (Optional)|Overall Study||18
10121061|NCT02566265|11252257|FG000|COMPLETED|Overall Study||72
10121062|NCT02566265|11252258|FG001|COMPLETED|Overall Study||35
10121063|NCT02566265|11252257|FG000|NOT COMPLETED|Overall Study||9
10121064|NCT02566265|11252258|FG001|NOT COMPLETED|Overall Study||6
10121065|NCT02566317|11252266|FG000|STARTED|Overall Study||276
10057690|NCT02076113|11182557|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
10057691|NCT02076113|11182556|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
10057692|NCT02076113|11182557|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
10057693|NCT02076113|11182556|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60
10057694|NCT02076113|11182557|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
10057695|NCT02076113|11182556|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
10057696|NCT02076113|11182557|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
10057697|NCT02076113|11182556|FG000|COMPLETED|Overall Study||56
10057698|NCT02076113|11182557|FG001|COMPLETED|Overall Study||93
10057699|NCT02076113|11182556|FG000|NOT COMPLETED|Overall Study||7
10057700|NCT02076113|11182557|FG001|NOT COMPLETED|Overall Study||7
10057701|NCT02076152|11182568|FG000|STARTED|Overall Study||2
10057702|NCT02076152|11182569|FG001|STARTED|Overall Study||9
10057703|NCT02076152|11182568|FG000|COMPLETED|Overall Study||2
10057704|NCT02076152|11182569|FG001|COMPLETED|Overall Study||9
10057705|NCT02076152|11182568|FG000|NOT COMPLETED|Overall Study||0
10057706|NCT02076152|11182569|FG001|NOT COMPLETED|Overall Study||0
10057707|NCT02076165|11182576|FG000|STARTED|Overall Study||74
10057708|NCT02076165|11182577|FG001|STARTED|Overall Study||75
10057709|NCT02076165|11182576|FG000|COMPLETED|Overall Study||66
10057710|NCT02076165|11182577|FG001|COMPLETED|Overall Study||69
10057711|NCT02076165|11182576|FG000|NOT COMPLETED|Overall Study||8
10057712|NCT02076165|11182577|FG001|NOT COMPLETED|Overall Study||6
10057713|NCT02076243|11182583|FG000|STARTED|Overall Study||2
10057714|NCT02076243|11182583|FG000|COMPLETED|Overall Study||0
10057715|NCT02076243|11182583|FG000|NOT COMPLETED|Overall Study||2
10057716|NCT02076321|11182589|FG000|STARTED|Overall Study||51
10057717|NCT02076321|11182590|FG001|STARTED|Overall Study||51
10057718|NCT02076321|11182589|FG000|COMPLETED|Overall Study||46
10057719|NCT02076321|11182590|FG001|COMPLETED|Overall Study||49
10057720|NCT02076321|11182589|FG000|NOT COMPLETED|Overall Study||5
10057721|NCT02076321|11182590|FG001|NOT COMPLETED|Overall Study||2
10057722|NCT02076334|11182600|FG000|STARTED|Overall Study||21
10057723|NCT02076334|11182601|FG001|STARTED|Overall Study||21
10057724|NCT02076334|11182602|FG002|STARTED|Overall Study||21
10057725|NCT02076334|11182603|FG003|STARTED|Overall Study||21
10057726|NCT02076334|11182600|FG000|COMPLETED|Overall Study||20
10057727|NCT02076334|11182601|FG001|COMPLETED|Overall Study||20
10057728|NCT02076334|11182602|FG002|COMPLETED|Overall Study||20
10057729|NCT02076334|11182603|FG003|COMPLETED|Overall Study||20
10057730|NCT02076334|11182600|FG000|NOT COMPLETED|Overall Study||1
10057731|NCT02076334|11182601|FG001|NOT COMPLETED|Overall Study||1
10057732|NCT02076334|11182602|FG002|NOT COMPLETED|Overall Study||1
10057733|NCT02076334|11182603|FG003|NOT COMPLETED|Overall Study||1
10057734|NCT02076399|11182615|FG000|STARTED|Overall Study||51
10057735|NCT02076399|11182616|FG001|STARTED|Overall Study||25
10057736|NCT02076399|11182615|FG000|COMPLETED|Overall Study||12
10057737|NCT02076399|11182616|FG001|COMPLETED|Overall Study||1
10057738|NCT02076399|11182615|FG000|NOT COMPLETED|Overall Study||39
10057739|NCT02076399|11182616|FG001|NOT COMPLETED|Overall Study||24
10057740|NCT02076412|11182624|FG000|STARTED|Overall Study||50
10057741|NCT02076412|11182625|FG001|STARTED|Overall Study||24
10057742|NCT02076412|11182624|FG000|COMPLETED|Overall Study||13
10057743|NCT02076412|11182625|FG001|COMPLETED|Overall Study||2
10057744|NCT02076412|11182624|FG000|NOT COMPLETED|Overall Study||37
10057745|NCT02076412|11182625|FG001|NOT COMPLETED|Overall Study||22
10057746|NCT02076425|11182633|FG000|STARTED|Overall Study||114
10057747|NCT02076425|11182634|FG001|STARTED|Overall Study||115
10057748|NCT02076425|11182633|FG000|COMPLETED|Overall Study||100
10057749|NCT02076425|11182634|FG001|COMPLETED|Overall Study||91
10057750|NCT02076425|11182633|FG000|NOT COMPLETED|Overall Study||14
10057751|NCT02076425|11182634|FG001|NOT COMPLETED|Overall Study||24
10057752|NCT02076776|11182643|FG000|STARTED|Overall Study||6
10057753|NCT02076776|11182644|FG001|STARTED|Overall Study||8
10057754|NCT02076776|11182645|FG002|STARTED|Overall Study||6
10057755|NCT02076776|11182643|FG000|COMPLETED|Overall Study||5
10057756|NCT02076776|11182644|FG001|COMPLETED|Overall Study||6
10057757|NCT02076776|11182645|FG002|COMPLETED|Overall Study||6
10057758|NCT02076776|11182643|FG000|NOT COMPLETED|Overall Study||1
10057759|NCT02076776|11182644|FG001|NOT COMPLETED|Overall Study||2
10057760|NCT02076776|11182645|FG002|NOT COMPLETED|Overall Study||0
10057761|NCT02076919|11182665|FG000|STARTED|Overall Study||24
10057762|NCT02076919|11182666|FG001|STARTED|Overall Study||8
10057763|NCT02076919|11182667|FG002|STARTED|Overall Study||36
10057764|NCT02076919|11182668|FG003|STARTED|Overall Study||12
10057765|NCT02076919|11182665|FG000|COMPLETED|Overall Study||24
10057766|NCT02076919|11182666|FG001|COMPLETED|Overall Study||8
10057767|NCT02076919|11182667|FG002|COMPLETED|Overall Study||36
10057768|NCT02076919|11182668|FG003|COMPLETED|Overall Study||12
10057769|NCT02076919|11182665|FG000|NOT COMPLETED|Overall Study||0
10057770|NCT02076919|11182666|FG001|NOT COMPLETED|Overall Study||0
10057771|NCT02076919|11182667|FG002|NOT COMPLETED|Overall Study||0
10057772|NCT02076919|11182668|FG003|NOT COMPLETED|Overall Study||0
10057773|NCT02076997|11182695|FG000|STARTED|Overall Study||23
10057774|NCT02076997|11182695|FG000|COMPLETED|Overall Study||22
10057775|NCT02076997|11182695|FG000|NOT COMPLETED|Overall Study||1
10057776|NCT02077140|11182704|FG000|STARTED|Overall Study||36
10057777|NCT02077140|11182705|FG001|STARTED|Overall Study||36
10057778|NCT02077140|11182706|FG002|STARTED|Overall Study||36
10057779|NCT02077140|11182707|FG003|STARTED|Overall Study||36
10057780|NCT02077140|11182708|FG004|STARTED|Overall Study||48
10057781|NCT02077140|11182704|FG000|COMPLETED|Overall Study||32
10057782|NCT02077140|11182705|FG001|COMPLETED|Overall Study||34
10057783|NCT02077140|11182706|FG002|COMPLETED|Overall Study||34
10057784|NCT02077140|11182707|FG003|COMPLETED|Overall Study||32
10057785|NCT02077140|11182708|FG004|COMPLETED|Overall Study||43
10057786|NCT02077140|11182704|FG000|NOT COMPLETED|Overall Study||4
10057787|NCT02077140|11182705|FG001|NOT COMPLETED|Overall Study||2
10057788|NCT02077140|11182706|FG002|NOT COMPLETED|Overall Study||2
10057789|NCT02077140|11182707|FG003|NOT COMPLETED|Overall Study||4
10057790|NCT02077140|11182708|FG004|NOT COMPLETED|Overall Study||5
10057791|NCT02077374|11182725|FG000|STARTED|Overall Study||19
10057792|NCT02077374|11182726|FG001|STARTED|Overall Study||19
10057793|NCT02077374|11182725|FG000|COMPLETED|Overall Study||19
10057794|NCT02077374|11182726|FG001|COMPLETED|Overall Study||17
10057795|NCT02077374|11182725|FG000|NOT COMPLETED|Overall Study||0
10057796|NCT02077374|11182726|FG001|NOT COMPLETED|Overall Study||2
10057797|NCT02077465|11182737|FG000|STARTED|Overall Study||8
10057798|NCT02077465|11182738|FG001|STARTED|Overall Study||3
10057799|NCT02077465|11182737|FG000|COMPLETED|Overall Study||7
10121066|NCT02566317|11252267|FG001|STARTED|Overall Study||354
10121067|NCT02566317|11252266|FG000|COMPLETED|Overall Study||247
10121068|NCT02566317|11252267|FG001|COMPLETED|Overall Study||292
10121069|NCT02566317|11252266|FG000|NOT COMPLETED|Overall Study||29
10121070|NCT02566317|11252267|FG001|NOT COMPLETED|Overall Study||62
10121071|NCT02566369|11252275|FG000|STARTED|Overall Study||612
10121072|NCT02566369|11252276|FG001|STARTED|Overall Study||596
10121073|NCT02566369|11252275|FG000|COMPLETED|Overall Study||540
10121074|NCT02566369|11252276|FG001|COMPLETED|Overall Study||535
10121075|NCT02566369|11252275|FG000|NOT COMPLETED|Overall Study||72
10121076|NCT02566369|11252276|FG001|NOT COMPLETED|Overall Study||61
10121077|NCT02566525|11252284|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
10121078|NCT02566525|11252285|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
10121079|NCT02566525|11252284|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
10121080|NCT02566525|11252285|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
10121081|NCT02566525|11252284|FG000|NOT COMPLETED|Overall Study||3
10121082|NCT02566525|11252285|FG001|NOT COMPLETED|Overall Study||5
10121083|NCT02566577|11252295|FG000|STARTED|Overall Study||9
10121084|NCT02566577|11252296|FG001|STARTED|Overall Study||6
10121085|NCT02566577|11252295|FG000|COMPLETED|Overall Study||6
10121086|NCT02566577|11252296|FG001|COMPLETED|Overall Study||4
10121087|NCT02566577|11252295|FG000|NOT COMPLETED|Overall Study||3
10121088|NCT02566577|11252296|FG001|NOT COMPLETED|Overall Study||2
10121089|NCT02566590|11252306|FG000|STARTED|Overall Study||10
10121090|NCT02566590|11252307|FG001|STARTED|Overall Study||10
10121091|NCT02566590|11252306|FG000|COMPLETED|Overall Study||10
10121092|NCT02566590|11252307|FG001|COMPLETED|Overall Study||10
10121093|NCT02566590|11252306|FG000|NOT COMPLETED|Overall Study||0
10121094|NCT02566590|11252307|FG001|NOT COMPLETED|Overall Study||0
10121095|NCT02566759|11252330|FG000|STARTED|All Parts||12
10121096|NCT02566759|11252331|FG001|STARTED|All Parts||6
10121097|NCT02566759|11252332|FG002|STARTED|All Parts||6
10121098|NCT02566759|11252333|FG003|STARTED|All Parts||6
10121099|NCT02566759|11252334|FG004|STARTED|All Parts||6
10121100|NCT02566759|11252335|FG005|STARTED|All Parts||6
10121101|NCT02566759|11252336|FG006|STARTED|All Parts||6
10121102|NCT02566759|11252337|FG007|STARTED|All Parts||8
10121103|NCT02566759|11252338|FG008|STARTED|All Parts||6
10121104|NCT02566759|11252339|FG009|STARTED|All Parts||6
10121105|NCT02566759|11252340|FG010|STARTED|All Parts||6
10121106|NCT02566759|11252341|FG011|STARTED|All Parts||6
10121107|NCT02566759|11252342|FG012|STARTED|All Parts||1
10121108|NCT02566759|11252343|FG013|STARTED|All Parts||5
10121109|NCT02566759|11252344|FG014|STARTED|All Parts||8
10121110|NCT02566759|11252345|FG015|STARTED|All Parts||8
10057800|NCT02077465|11182738|FG001|COMPLETED|Overall Study||2
10057801|NCT02077465|11182737|FG000|NOT COMPLETED|Overall Study||1
10057802|NCT02077465|11182738|FG001|NOT COMPLETED|Overall Study||1
10121111|NCT02566759|11252346|FG016|STARTED|All Parts||8
10121112|NCT02566759|11252330|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
10121113|NCT02566759|11252331|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
10121114|NCT02566759|11252332|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10057803|NCT02078102|11182746|FG000|STARTED|Overall Study||25
10057804|NCT02078102|11182747|FG001|STARTED|Overall Study||13
10057805|NCT02078102|11182746|FG000|COMPLETED|Overall Study||23
10057806|NCT02078102|11182747|FG001|COMPLETED|Overall Study||12
10057807|NCT02078102|11182746|FG000|NOT COMPLETED|Overall Study||2
10057808|NCT02078102|11182747|FG001|NOT COMPLETED|Overall Study||1
10057809|NCT02078180|11182754|FG000|STARTED|Overall Study||34
10057810|NCT02078180|11182754|FG000|IR75|Overall Study||30
10057811|NCT02078180|11182754|FG000|IR100|Overall Study||31
10057812|NCT02078180|11182754|FG000|SR100|Overall Study||31
10057813|NCT02078180|11182754|FG000|SR150|Overall Study||32
10057814|NCT02078180|11182754|FG000|XL 150|Overall Study||31
10057815|NCT02078180|11182754|FG000|XL 300|Overall Study||32
10057816|NCT02078180|11182754|FG000|COMPLETED|Overall Study||29
10057817|NCT02078180|11182754|FG000|NOT COMPLETED|Overall Study||5
10057818|NCT02078193|11182763|FG000|STARTED|Overall Study||3
10057819|NCT02078193|11182763|FG000|COMPLETED|Overall Study||3
10057820|NCT02078193|11182763|FG000|NOT COMPLETED|Overall Study||0
10057821|NCT02078219|11182773|FG000|STARTED|Overall Study||41
10057822|NCT02078219|11182774|FG001|STARTED|Overall Study||40
10057823|NCT02078219|11182775|FG002|STARTED|Overall Study||41
10057824|NCT02078219|11182776|FG003|STARTED|Overall Study||41
10057825|NCT02078219|11182777|FG004|STARTED|Overall Study||41
10057826|NCT02078219|11182773|FG000|COMPLETED|Overall Study||38
10057827|NCT02078219|11182774|FG001|COMPLETED|Overall Study||36
10057828|NCT02078219|11182775|FG002|COMPLETED|Overall Study||35
10057829|NCT02078219|11182776|FG003|COMPLETED|Overall Study||37
10057830|NCT02078219|11182777|FG004|COMPLETED|Overall Study||39
10057831|NCT02078219|11182773|FG000|NOT COMPLETED|Overall Study||3
10057832|NCT02078219|11182774|FG001|NOT COMPLETED|Overall Study||4
10057833|NCT02078219|11182775|FG002|NOT COMPLETED|Overall Study||6
10057834|NCT02078219|11182776|FG003|NOT COMPLETED|Overall Study||4
10057835|NCT02078219|11182777|FG004|NOT COMPLETED|Overall Study||2
10057836|NCT02078284|11182794|FG000|STARTED|Overall Study||5
10057837|NCT02078284|11182795|FG001|STARTED|Overall Study||7
10057838|NCT02078284|11182796|FG002|STARTED|Overall Study||6
10057839|NCT02078284|11182797|FG003|STARTED|Overall Study||6
10057840|NCT02078284|11182798|FG004|STARTED|Overall Study||4
10057841|NCT02078284|11182794|FG000|COMPLETED|Overall Study||5
10057842|NCT02078284|11182795|FG001|COMPLETED|Overall Study||7
10057843|NCT02078284|11182796|FG002|COMPLETED|Overall Study||6
10057844|NCT02078284|11182797|FG003|COMPLETED|Overall Study||6
10057845|NCT02078284|11182798|FG004|COMPLETED|Overall Study||4
10057846|NCT02078284|11182794|FG000|NOT COMPLETED|Overall Study||0
10057847|NCT02078284|11182795|FG001|NOT COMPLETED|Overall Study||0
10057848|NCT02078284|11182796|FG002|NOT COMPLETED|Overall Study||0
10057849|NCT02078284|11182797|FG003|NOT COMPLETED|Overall Study||0
10057850|NCT02078284|11182798|FG004|NOT COMPLETED|Overall Study||0
10057851|NCT02078492|11182813|FG000|STARTED|Overall Study||80
10057852|NCT02078492|11182814|FG001|STARTED|Overall Study||80
10057853|NCT02078492|11182815|FG002|STARTED|Overall Study||80
10057854|NCT02078492|11182813|FG000|COMPLETED|Overall Study||80
10057855|NCT02078492|11182814|FG001|COMPLETED|Overall Study||80
10057856|NCT02078492|11182815|FG002|COMPLETED|Overall Study||80
10057857|NCT02078492|11182813|FG000|NOT COMPLETED|Overall Study||0
10057858|NCT02078492|11182814|FG001|NOT COMPLETED|Overall Study||0
10057859|NCT02078492|11182815|FG002|NOT COMPLETED|Overall Study||0
10057860|NCT02078557|11182823|FG000|STARTED|Overall Study||4
10057861|NCT02078557|11182823|FG000|COMPLETED|Overall Study||4
10057862|NCT02078557|11182823|FG000|NOT COMPLETED|Overall Study||0
10057863|NCT02078713|11182831|FG000|STARTED|Overall Study||407
10057864|NCT02078713|11182832|FG001|STARTED|Overall Study||351
10057865|NCT02078713|11182833|FG002|STARTED|Overall Study||15
10057866|NCT02078713|11182834|FG003|STARTED|Overall Study||13
10057867|NCT02078713|11182831|FG000|COMPLETED|Overall Study||355
10057868|NCT02078713|11182832|FG001|COMPLETED|Overall Study||290
10057869|NCT02078713|11182833|FG002|COMPLETED|Overall Study||15
10057870|NCT02078713|11182834|FG003|COMPLETED|Overall Study||13
10057871|NCT02078713|11182831|FG000|NOT COMPLETED|Overall Study||52
10057872|NCT02078713|11182832|FG001|NOT COMPLETED|Overall Study||61
10057873|NCT02078713|11182833|FG002|NOT COMPLETED|Overall Study||0
10057874|NCT02078713|11182834|FG003|NOT COMPLETED|Overall Study||0
10057875|NCT02078726|11182848|FG000|STARTED|Overall Study||64
10057876|NCT02078726|11182849|FG001|STARTED|Overall Study||36
10057877|NCT02078726|11182848|FG000|COMPLETED|Overall Study||64
10057878|NCT02078726|11182849|FG001|COMPLETED|Overall Study||36
10057879|NCT02078726|11182848|FG000|NOT COMPLETED|Overall Study||0
10057880|NCT02078726|11182849|FG001|NOT COMPLETED|Overall Study||0
10057881|NCT02078752|11182865|FG000|STARTED|Overall Study||3
10057882|NCT02078752|11182866|FG001|STARTED|Overall Study||13
10057883|NCT02078752|11182867|FG002|STARTED|Overall Study||2
10057884|NCT02078752|11182868|FG003|STARTED|Overall Study||7
10057885|NCT02078752|11182869|FG004|STARTED|Overall Study||3
10057886|NCT02078752|11182870|FG005|STARTED|Overall Study||9
10057887|NCT02078752|11182871|FG006|STARTED|Overall Study||3
10057888|NCT02078752|11182872|FG007|STARTED|Overall Study||6
10057889|NCT02078752|11182873|FG008|STARTED|Overall Study||2
10057890|NCT02078752|11182874|FG009|STARTED|Overall Study||12
10057891|NCT02078752|11182865|FG000|COMPLETED|Overall Study||1
10057892|NCT02078752|11182866|FG001|COMPLETED|Overall Study||6
10057893|NCT02078752|11182867|FG002|COMPLETED|Overall Study||1
10057894|NCT02078752|11182868|FG003|COMPLETED|Overall Study||5
10057895|NCT02078752|11182869|FG004|COMPLETED|Overall Study||2
10057896|NCT02078752|11182870|FG005|COMPLETED|Overall Study||5
10057897|NCT02078752|11182871|FG006|COMPLETED|Overall Study||1
10057898|NCT02078752|11182872|FG007|COMPLETED|Overall Study||3
10057899|NCT02078752|11182873|FG008|COMPLETED|Overall Study||2
10057900|NCT02078752|11182874|FG009|COMPLETED|Overall Study||2
10057901|NCT02078752|11182865|FG000|NOT COMPLETED|Overall Study||2
10057902|NCT02078752|11182866|FG001|NOT COMPLETED|Overall Study||7
10057903|NCT02078752|11182867|FG002|NOT COMPLETED|Overall Study||1
10057904|NCT02078752|11182868|FG003|NOT COMPLETED|Overall Study||2
10057905|NCT02078752|11182869|FG004|NOT COMPLETED|Overall Study||1
10057906|NCT02078752|11182870|FG005|NOT COMPLETED|Overall Study||4
10057907|NCT02078752|11182871|FG006|NOT COMPLETED|Overall Study||2
10057908|NCT02078752|11182872|FG007|NOT COMPLETED|Overall Study||3
10057909|NCT02078752|11182873|FG008|NOT COMPLETED|Overall Study||0
10057910|NCT02078752|11182874|FG009|NOT COMPLETED|Overall Study||10
10057911|NCT02078817|11182905|FG000|STARTED|Overall Study||14
10057912|NCT02078817|11182905|FG000|COMPLETED|Overall Study||13
10057913|NCT02078817|11182905|FG000|NOT COMPLETED|Overall Study||1
10057914|NCT02078882|11182909|FG000|STARTED|Overall Study||16
10057915|NCT02078882|11182909|FG000|COMPLETED|Overall Study||16
10057916|NCT02078882|11182909|FG000|NOT COMPLETED|Overall Study||0
10057917|NCT02078960|11182916|FG000|STARTED|Treatment Period||2
10057918|NCT02078960|11182917|FG001|STARTED|Treatment Period||4
10057919|NCT02078960|11182918|FG002|STARTED|Treatment Period||4
10057920|NCT02078960|11182916|FG000|COMPLETED|Treatment Period||0
10057921|NCT02078960|11182917|FG001|COMPLETED|Treatment Period||1
10057922|NCT02078960|11182918|FG002|COMPLETED|Treatment Period||1
10057923|NCT02078960|11182916|FG000|NOT COMPLETED|Treatment Period||2
10057924|NCT02078960|11182917|FG001|NOT COMPLETED|Treatment Period||3
10057925|NCT02078960|11182918|FG002|NOT COMPLETED|Treatment Period||3
10057926|NCT02078960|11182916|FG000|STARTED|Follow-up Period||2
10057927|NCT02078960|11182917|FG001|STARTED|Follow-up Period||2
10121115|NCT02566759|11252333|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121116|NCT02566759|11252334|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121117|NCT02566759|11252335|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121118|NCT02566759|11252336|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121119|NCT02566759|11252337|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
10121120|NCT02566759|11252338|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121121|NCT02566759|11252339|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121122|NCT02566759|11252340|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121123|NCT02566759|11252341|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10121124|NCT02566759|11252342|FG012|COMPLETED|All Parts||0
10121125|NCT02566759|11252343|FG013|COMPLETED|All Parts||0
10121126|NCT02566759|11252344|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
10121127|NCT02566759|11252345|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
10121128|NCT02566759|11252346|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
10121129|NCT02566759|11252330|FG000|NOT COMPLETED|All Parts||0
10121130|NCT02566759|11252331|FG001|NOT COMPLETED|All Parts||1
10121131|NCT02566759|11252332|FG002|NOT COMPLETED|All Parts||0
10121132|NCT02566759|11252333|FG003|NOT COMPLETED|All Parts||0
10121133|NCT02566759|11252334|FG004|NOT COMPLETED|All Parts||0
10121134|NCT02566759|11252335|FG005|NOT COMPLETED|All Parts||0
10121135|NCT02566759|11252336|FG006|NOT COMPLETED|All Parts||0
10121136|NCT02566759|11252337|FG007|NOT COMPLETED|All Parts||0
10121137|NCT02566759|11252338|FG008|NOT COMPLETED|All Parts||0
10057928|NCT02078960|11182918|FG002|STARTED|Follow-up Period||1
10057929|NCT02078960|11182916|FG000|COMPLETED|Follow-up Period||0
10057930|NCT02078960|11182917|FG001|COMPLETED|Follow-up Period||1
10057931|NCT02078960|11182918|FG002|COMPLETED|Follow-up Period||1
10057932|NCT02078960|11182916|FG000|NOT COMPLETED|Follow-up Period||2
10057933|NCT02078960|11182917|FG001|NOT COMPLETED|Follow-up Period||1
10057934|NCT02078960|11182918|FG002|NOT COMPLETED|Follow-up Period||0
10057935|NCT02079025|11182930|FG000|STARTED|Overall Study||839
10057936|NCT02079025|11182931|FG001|STARTED|Overall Study||837
10057937|NCT02079025|11182930|FG000|COMPLETED|Overall Study||839
10057938|NCT02079025|11182931|FG001|COMPLETED|Overall Study||837
10057939|NCT02079025|11182930|FG000|NOT COMPLETED|Overall Study||0
10057940|NCT02079025|11182931|FG001|NOT COMPLETED|Overall Study||0
10057941|NCT02079038|11182940|FG000|STARTED|Modified Intent to Treat Population||112
10057942|NCT02079038|11182941|FG001|STARTED|Modified Intent to Treat Population||56
10057943|NCT02079038|11182940|FG000|COMPLETED|Modified Intent to Treat Population||105
10057944|NCT02079038|11182941|FG001|COMPLETED|Modified Intent to Treat Population||51
10057945|NCT02079038|11182940|FG000|NOT COMPLETED|Modified Intent to Treat Population||7
10057946|NCT02079038|11182941|FG001|NOT COMPLETED|Modified Intent to Treat Population||5
10057947|NCT02079038|11182940|FG000|STARTED|Completed 6 Months||105
10057948|NCT02079038|11182941|FG001|STARTED|Completed 6 Months||51
10057949|NCT02079038|11182940|FG000|COMPLETED|Completed 6 Months||103
10057950|NCT02079038|11182941|FG001|COMPLETED|Completed 6 Months||50
10057951|NCT02079038|11182940|FG000|NOT COMPLETED|Completed 6 Months||2
10057952|NCT02079038|11182941|FG001|NOT COMPLETED|Completed 6 Months||1
10057953|NCT02079077|11182949|FG000|STARTED|Overall Study||43
10057954|NCT02079077|11182950|FG001|STARTED|Overall Study||48
10057955|NCT02079077|11182949|FG000|COMPLETED|Overall Study||37
10057956|NCT02079077|11182950|FG001|COMPLETED|Overall Study||39
10057957|NCT02079077|11182949|FG000|NOT COMPLETED|Overall Study||6
10057958|NCT02079077|11182950|FG001|NOT COMPLETED|Overall Study||9
10057959|NCT02079246|11182956|FG000|STARTED|OLEX||1463
10057960|NCT02079246|11182957|FG001|STARTED|OLEX||0
10057961|NCT02079246|11182956|FG000|COMPLETED|OLEX||1235
10057962|NCT02079246|11182957|FG001|COMPLETED|OLEX||0
10057963|NCT02079246|11182956|FG000|NOT COMPLETED|OLEX||228
10057964|NCT02079246|11182957|FG001|NOT COMPLETED|OLEX||0
10057965|NCT02079246|11182956|FG000|STARTED|OLEX-MEM||0
10057966|NCT02079246|11182957|FG001|STARTED|OLEX-MEM||101
10057967|NCT02079246|11182956|FG000|COMPLETED|OLEX-MEM||0
10057968|NCT02079246|11182957|FG001|COMPLETED|OLEX-MEM||82
10057969|NCT02079246|11182956|FG000|NOT COMPLETED|OLEX-MEM||0
10057970|NCT02079246|11182957|FG001|NOT COMPLETED|OLEX-MEM||19
10057971|NCT02079311|11182968|FG000|STARTED|Overall Study||28
10057972|NCT02079311|11182969|FG001|STARTED|Overall Study||27
10057973|NCT02079311|11182968|FG000|COMPLETED|Overall Study||28
10057974|NCT02079311|11182969|FG001|COMPLETED|Overall Study||26
10057975|NCT02079311|11182968|FG000|NOT COMPLETED|Overall Study||0
10057976|NCT02079311|11182969|FG001|NOT COMPLETED|Overall Study||1
10057977|NCT02079519|11182975|FG000|STARTED|Overall Study||10
10121138|NCT02566759|11252339|FG009|NOT COMPLETED|All Parts||0
10121139|NCT02566759|11252340|FG010|NOT COMPLETED|All Parts||0
10121140|NCT02566759|11252341|FG011|NOT COMPLETED|All Parts||0
10121141|NCT02566759|11252342|FG012|NOT COMPLETED|All Parts||1
10121142|NCT02566759|11252343|FG013|NOT COMPLETED|All Parts||5
10121143|NCT02566759|11252344|FG014|NOT COMPLETED|All Parts||0
10121144|NCT02566759|11252345|FG015|NOT COMPLETED|All Parts||0
10121145|NCT02566759|11252346|FG016|NOT COMPLETED|All Parts||0
10121146|NCT02566759|11252330|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121147|NCT02566759|11252331|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121148|NCT02566759|11252332|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121149|NCT02566759|11252333|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121150|NCT02566759|11252334|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121151|NCT02566759|11252335|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121152|NCT02566759|11252336|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121153|NCT02566759|11252337|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121154|NCT02566759|11252338|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121155|NCT02566759|11252339|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121156|NCT02566759|11252340|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121157|NCT02566759|11252341|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121158|NCT02566759|11252342|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121159|NCT02566759|11252343|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121160|NCT02566759|11252344|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10121161|NCT02566759|11252345|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10121162|NCT02566759|11252346|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10121163|NCT02566759|11252330|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121164|NCT02566759|11252331|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121165|NCT02566759|11252332|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121166|NCT02566759|11252333|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121167|NCT02566759|11252334|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121168|NCT02566759|11252335|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121169|NCT02566759|11252336|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121170|NCT02566759|11252337|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121171|NCT02566759|11252338|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121172|NCT02566759|11252339|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121173|NCT02566759|11252340|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10057978|NCT02079519|11182975|FG000|COMPLETED|Overall Study||0
10057979|NCT02079519|11182975|FG000|NOT COMPLETED|Overall Study||10
10057980|NCT02079532|11182979|FG000|STARTED|Overall Study||302
10057981|NCT02079532|11182979|FG000|COMPLETED|Overall Study||273
10057982|NCT02079532|11182979|FG000|NOT COMPLETED|Overall Study||29
10057983|NCT02079610|11182985|FG000|STARTED|Overall Study||19
10057984|NCT02079610|11182986|FG001|STARTED|Overall Study||17
10057985|NCT02079610|11182985|FG000|COMPLETED|Overall Study||18
10057986|NCT02079610|11182986|FG001|COMPLETED|Overall Study||16
10057987|NCT02079610|11182985|FG000|NOT COMPLETED|Overall Study||1
10057988|NCT02079610|11182986|FG001|NOT COMPLETED|Overall Study||1
10057989|NCT02079636|11183007|FG000|STARTED|Overall Study||8
10057990|NCT02079636|11183008|FG001|STARTED|Overall Study||15
10057991|NCT02079636|11183009|FG002|STARTED|Overall Study||3
10057992|NCT02079636|11183010|FG003|STARTED|Overall Study||21
10057993|NCT02079636|11183011|FG004|STARTED|Overall Study||4
10057994|NCT02079636|11183012|FG005|STARTED|Overall Study||19
10057995|NCT02079636|11183013|FG006|STARTED|Overall Study||12
10057996|NCT02079636|11183014|FG007|STARTED|Overall Study||4
10057997|NCT02079636|11183015|FG008|STARTED|Overall Study||3
10057998|NCT02079636|11183016|FG009|STARTED|Overall Study||9
10057999|NCT02079636|11183017|FG010|STARTED|Overall Study||10
10058000|NCT02079636|11183018|FG011|STARTED|Overall Study||6
10058001|NCT02079636|11183019|FG012|STARTED|Overall Study||8
10058002|NCT02079636|11183020|FG013|STARTED|Overall Study||3
10121174|NCT02566759|11252341|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121175|NCT02566759|11252342|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121176|NCT02566759|11252343|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121177|NCT02566759|11252344|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10121178|NCT02566759|11252345|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10121179|NCT02566759|11252346|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10121180|NCT02566759|11252330|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121181|NCT02566759|11252331|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121182|NCT02566759|11252332|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121183|NCT02566759|11252333|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121184|NCT02566759|11252334|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121185|NCT02566759|11252335|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121186|NCT02566759|11252336|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121187|NCT02566759|11252337|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121188|NCT02566759|11252338|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121189|NCT02566759|11252339|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121190|NCT02566759|11252340|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121191|NCT02566759|11252341|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121192|NCT02566759|11252342|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121193|NCT02566759|11252343|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121194|NCT02566759|11252344|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121195|NCT02566759|11252345|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121196|NCT02566759|11252346|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121197|NCT02566759|11252330|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121198|NCT02566759|11252331|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121199|NCT02566759|11252332|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121200|NCT02566759|11252333|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121201|NCT02566759|11252334|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121202|NCT02566759|11252335|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121203|NCT02566759|11252336|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121204|NCT02566759|11252337|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121205|NCT02566759|11252338|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121206|NCT02566759|11252339|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121207|NCT02566759|11252340|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121208|NCT02566759|11252341|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121209|NCT02566759|11252342|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121210|NCT02566759|11252343|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121211|NCT02566759|11252344|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10121212|NCT02566759|11252345|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10121213|NCT02566759|11252346|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10121214|NCT02566759|11252330|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121215|NCT02566759|11252331|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121216|NCT02566759|11252332|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121217|NCT02566759|11252333|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121218|NCT02566759|11252334|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121219|NCT02566759|11252335|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121220|NCT02566759|11252336|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121221|NCT02566759|11252337|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121222|NCT02566759|11252338|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121223|NCT02566759|11252339|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121224|NCT02566759|11252340|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10058003|NCT02079636|11183021|FG014|STARTED|Overall Study||17
10058004|NCT02079636|11183007|FG000|Received at Least One Dose of Study Drug|Overall Study||8
10058005|NCT02079636|11183008|FG001|Received at Least One Dose of Study Drug|Overall Study||15
10058006|NCT02079636|11183009|FG002|Received at Least One Dose of Study Drug|Overall Study||3
10058007|NCT02079636|11183010|FG003|Received at Least One Dose of Study Drug|Overall Study||21
10058008|NCT02079636|11183011|FG004|Received at Least One Dose of Study Drug|Overall Study||4
10058009|NCT02079636|11183012|FG005|Received at Least One Dose of Study Drug|Overall Study||19
10058010|NCT02079636|11183013|FG006|Received at Least One Dose of Study Drug|Overall Study||12
10058011|NCT02079636|11183014|FG007|Received at Least One Dose of Study Drug|Overall Study||4
10058012|NCT02079636|11183015|FG008|Received at Least One Dose of Study Drug|Overall Study||3
10058013|NCT02079636|11183016|FG009|Received at Least One Dose of Study Drug|Overall Study||9
10058014|NCT02079636|11183017|FG010|Received at Least One Dose of Study Drug|Overall Study||10
10058015|NCT02079636|11183018|FG011|Received at Least One Dose of Study Drug|Overall Study||6
10058016|NCT02079636|11183019|FG012|Received at Least One Dose of Study Drug|Overall Study||8
10058017|NCT02079636|11183020|FG013|Received at Least One Dose of Study Drug|Overall Study||3
10058018|NCT02079636|11183021|FG014|Received at Least One Dose of Study Drug|Overall Study||17
10058019|NCT02079636|11183007|FG000|COMPLETED|Overall Study||5
10058020|NCT02079636|11183008|FG001|COMPLETED|Overall Study||13
10058021|NCT02079636|11183009|FG002|COMPLETED|Overall Study||3
10121225|NCT02566759|11252341|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121226|NCT02566759|11252342|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121227|NCT02566759|11252343|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121228|NCT02566759|11252344|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10121229|NCT02566759|11252345|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10121230|NCT02566759|11252346|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
10121231|NCT02566759|11252330|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121232|NCT02566759|11252331|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121233|NCT02566759|11252332|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121234|NCT02566759|11252333|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121235|NCT02566759|11252334|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121236|NCT02566759|11252335|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121237|NCT02566759|11252336|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121238|NCT02566759|11252337|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121239|NCT02566759|11252338|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121240|NCT02566759|11252339|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121241|NCT02566759|11252340|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121242|NCT02566759|11252341|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121243|NCT02566759|11252342|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121244|NCT02566759|11252343|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121245|NCT02566759|11252344|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121246|NCT02566759|11252345|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121247|NCT02566759|11252346|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
10121248|NCT02566759|11252330|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121249|NCT02566759|11252331|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121250|NCT02566759|11252332|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121251|NCT02566759|11252333|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121252|NCT02566759|11252334|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121253|NCT02566759|11252335|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121254|NCT02566759|11252336|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121255|NCT02566759|11252337|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121256|NCT02566759|11252338|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121257|NCT02566759|11252339|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121258|NCT02566759|11252340|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121259|NCT02566759|11252341|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121260|NCT02566759|11252342|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121261|NCT02566759|11252343|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10121262|NCT02566759|11252344|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10121263|NCT02566759|11252345|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10121264|NCT02566759|11252346|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7
10121265|NCT02566759|11252330|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121266|NCT02566759|11252331|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121267|NCT02566759|11252332|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121268|NCT02566759|11252333|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121269|NCT02566759|11252334|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121270|NCT02566759|11252335|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121271|NCT02566759|11252336|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121272|NCT02566759|11252337|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121273|NCT02566759|11252338|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121274|NCT02566759|11252339|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121275|NCT02566759|11252340|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121276|NCT02566759|11252341|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121277|NCT02566759|11252342|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121278|NCT02566759|11252343|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10058022|NCT02079636|11183010|FG003|COMPLETED|Overall Study||9
10058023|NCT02079636|11183011|FG004|COMPLETED|Overall Study||2
10058024|NCT02079636|11183012|FG005|COMPLETED|Overall Study||13
10058025|NCT02079636|11183013|FG006|COMPLETED|Overall Study||11
10058026|NCT02079636|11183014|FG007|COMPLETED|Overall Study||3
10058027|NCT02079636|11183015|FG008|COMPLETED|Overall Study||3
10058028|NCT02079636|11183016|FG009|COMPLETED|Overall Study||6
10058029|NCT02079636|11183017|FG010|COMPLETED|Overall Study||8
10058030|NCT02079636|11183018|FG011|COMPLETED|Overall Study||4
10058031|NCT02079636|11183019|FG012|COMPLETED|Overall Study||5
10058032|NCT02079636|11183020|FG013|COMPLETED|Overall Study||3
10121279|NCT02566759|11252344|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10121280|NCT02566759|11252345|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10121281|NCT02566759|11252346|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
10121282|NCT02566759|11252330|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121283|NCT02566759|11252331|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121284|NCT02566759|11252332|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121285|NCT02566759|11252333|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121286|NCT02566759|11252334|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121287|NCT02566759|11252335|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121288|NCT02566759|11252336|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121289|NCT02566759|11252337|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121290|NCT02566759|11252338|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121291|NCT02566759|11252339|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121292|NCT02566759|11252340|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121293|NCT02566759|11252341|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121294|NCT02566759|11252342|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121295|NCT02566759|11252343|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121296|NCT02566759|11252344|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121297|NCT02566759|11252345|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121298|NCT02566759|11252346|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10121299|NCT02566759|11252330|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121300|NCT02566759|11252331|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121301|NCT02566759|11252332|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121302|NCT02566759|11252333|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121303|NCT02566759|11252334|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121304|NCT02566759|11252335|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121305|NCT02566759|11252336|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121306|NCT02566759|11252337|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121307|NCT02566759|11252338|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121308|NCT02566759|11252339|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121309|NCT02566759|11252340|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121310|NCT02566759|11252341|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121311|NCT02566759|11252342|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121312|NCT02566759|11252343|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10121313|NCT02566759|11252344|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10121314|NCT02566759|11252345|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10121315|NCT02566759|11252346|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7
10121316|NCT02566759|11252330|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121317|NCT02566759|11252331|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121318|NCT02566759|11252332|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121319|NCT02566759|11252333|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121320|NCT02566759|11252334|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121321|NCT02566759|11252335|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121322|NCT02566759|11252336|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121323|NCT02566759|11252337|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121324|NCT02566759|11252338|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121325|NCT02566759|11252339|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121326|NCT02566759|11252340|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121327|NCT02566759|11252341|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121328|NCT02566759|11252342|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121329|NCT02566759|11252343|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121330|NCT02566759|11252344|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10121331|NCT02566759|11252345|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10121332|NCT02566759|11252346|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
10121333|NCT02566759|11252330|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121334|NCT02566759|11252331|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121335|NCT02566759|11252332|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121336|NCT02566759|11252333|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121337|NCT02566759|11252334|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121338|NCT02566759|11252335|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121339|NCT02566759|11252336|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121340|NCT02566759|11252337|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10058033|NCT02079636|11183021|FG014|COMPLETED|Overall Study||12
10058034|NCT02079636|11183007|FG000|NOT COMPLETED|Overall Study||3
10121341|NCT02566759|11252338|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121342|NCT02566759|11252339|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121343|NCT02566759|11252340|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121344|NCT02566759|11252341|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121345|NCT02566759|11252342|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121346|NCT02566759|11252343|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121347|NCT02566759|11252344|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121348|NCT02566759|11252345|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121349|NCT02566759|11252346|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10121350|NCT02566785|11252407|FG000|STARTED|Overall Study||15
10121351|NCT02566785|11252408|FG001|STARTED|Overall Study||18
10121352|NCT02566785|11252407|FG000|COMPLETED|Overall Study||14
10121353|NCT02566785|11252408|FG001|COMPLETED|Overall Study||15
10121354|NCT02566785|11252407|FG000|NOT COMPLETED|Overall Study||1
10121355|NCT02566785|11252408|FG001|NOT COMPLETED|Overall Study||3
10121356|NCT02566889|11252416|FG000|STARTED|Overall Study||45
10121357|NCT02566889|11252417|FG001|STARTED|Overall Study||8
10121358|NCT02566889|11252416|FG000|Cross-over to Dose Escalation Group|Overall Study||1
10121359|NCT02566889|11252417|FG001|Cross-over to Dose Escalation Group|Overall Study||0
10121360|NCT02566889|11252416|FG000|COMPLETED|Overall Study||32
10121361|NCT02566889|11252417|FG001|COMPLETED|Overall Study||3
10121362|NCT02566889|11252416|FG000|NOT COMPLETED|Overall Study||13
10121363|NCT02566889|11252417|FG001|NOT COMPLETED|Overall Study||5
10121364|NCT02566902|11252424|FG000|STARTED|Overall Study||60
10121365|NCT02566902|11252425|FG001|STARTED|Overall Study||58
10121366|NCT02566902|11252424|FG000|COMPLETED|Overall Study||58
10121367|NCT02566902|11252425|FG001|COMPLETED|Overall Study||57
10121368|NCT02566902|11252424|FG000|NOT COMPLETED|Overall Study||2
10121369|NCT02566902|11252425|FG001|NOT COMPLETED|Overall Study||1
10121370|NCT02566993|11252433|FG000|STARTED|Overall Study||307
10121371|NCT02566993|11252434|FG001|STARTED|Overall Study||306
10121372|NCT02566993|11252433|FG000|COMPLETED|Overall Study||0
10121373|NCT02566993|11252434|FG001|COMPLETED|Overall Study||0
10121374|NCT02566993|11252433|FG000|NOT COMPLETED|Overall Study||307
10121375|NCT02566993|11252434|FG001|NOT COMPLETED|Overall Study||306
10121376|NCT02567188|11252442|FG000|STARTED|Overall Study||144
10121377|NCT02567188|11252442|FG000|COMPLETED|Overall Study||109
10121378|NCT02567188|11252442|FG000|NOT COMPLETED|Overall Study||35
10121379|NCT02567227|11252449|FG000|STARTED|9 Weeks||192
10121380|NCT02567227|11252450|FG001|STARTED|9 Weeks||191
10121381|NCT02567227|11252449|FG000|COMPLETED|9 Weeks||158
10058035|NCT02079636|11183008|FG001|NOT COMPLETED|Overall Study||2
10058036|NCT02079636|11183009|FG002|NOT COMPLETED|Overall Study||0
10058037|NCT02079636|11183010|FG003|NOT COMPLETED|Overall Study||12
10058038|NCT02079636|11183011|FG004|NOT COMPLETED|Overall Study||2
10058039|NCT02079636|11183012|FG005|NOT COMPLETED|Overall Study||6
10058040|NCT02079636|11183013|FG006|NOT COMPLETED|Overall Study||1
10058041|NCT02079636|11183014|FG007|NOT COMPLETED|Overall Study||1
10058042|NCT02079636|11183015|FG008|NOT COMPLETED|Overall Study||0
10058043|NCT02079636|11183016|FG009|NOT COMPLETED|Overall Study||3
10058044|NCT02079636|11183017|FG010|NOT COMPLETED|Overall Study||2
10058045|NCT02079636|11183018|FG011|NOT COMPLETED|Overall Study||2
10121382|NCT02567227|11252450|FG001|COMPLETED|9 Weeks||167
10121383|NCT02567227|11252449|FG000|NOT COMPLETED|9 Weeks||34
10121384|NCT02567227|11252450|FG001|NOT COMPLETED|9 Weeks||24
10121385|NCT02567227|11252449|FG000|STARTED|6 Month||158
10058046|NCT02079636|11183019|FG012|NOT COMPLETED|Overall Study||3
10121386|NCT02567227|11252450|FG001|STARTED|6 Month||167
10121387|NCT02567227|11252449|FG000|COMPLETED|6 Month||113
10121388|NCT02567227|11252450|FG001|COMPLETED|6 Month||127
10121389|NCT02567227|11252449|FG000|NOT COMPLETED|6 Month||45
10121390|NCT02567227|11252450|FG001|NOT COMPLETED|6 Month||40
10121391|NCT02567227|11252449|FG000|STARTED|12 Months||113
10058047|NCT02079636|11183020|FG013|NOT COMPLETED|Overall Study||0
10058048|NCT02079636|11183021|FG014|NOT COMPLETED|Overall Study||5
10058049|NCT02079649|11183089|FG000|STARTED|Overall Study||42
10058050|NCT02079649|11183090|FG001|STARTED|Overall Study||41
10058051|NCT02079649|11183091|FG002|STARTED|Overall Study||41
10058052|NCT02079649|11183092|FG003|STARTED|Overall Study||40
10058053|NCT02079649|11183089|FG000|Treated|Overall Study||41
10058054|NCT02079649|11183090|FG001|Treated|Overall Study||41
10058055|NCT02079649|11183091|FG002|Treated|Overall Study||40
10058056|NCT02079649|11183092|FG003|Treated|Overall Study||40
10058057|NCT02079649|11183089|FG000|COMPLETED|Overall Study||41
10058058|NCT02079649|11183090|FG001|COMPLETED|Overall Study||41
10058059|NCT02079649|11183091|FG002|COMPLETED|Overall Study||40
10058060|NCT02079649|11183092|FG003|COMPLETED|Overall Study||38
10058061|NCT02079649|11183089|FG000|NOT COMPLETED|Overall Study||1
10058062|NCT02079649|11183090|FG001|NOT COMPLETED|Overall Study||0
10058063|NCT02079649|11183091|FG002|NOT COMPLETED|Overall Study||1
10058064|NCT02079649|11183092|FG003|NOT COMPLETED|Overall Study||2
10058065|NCT02079805|11183105|FG000|STARTED|Overall Study||16
10058066|NCT02079805|11183106|FG001|STARTED|Overall Study||17
10058067|NCT02079805|11183105|FG000|COMPLETED|Overall Study||16
10058068|NCT02079805|11183106|FG001|COMPLETED|Overall Study||15
10058069|NCT02079805|11183105|FG000|NOT COMPLETED|Overall Study||0
10058070|NCT02079805|11183106|FG001|NOT COMPLETED|Overall Study||2
10058071|NCT02079844|11183115|FG000|STARTED|Treatment Period 1||6
10058072|NCT02079844|11183116|FG001|STARTED|Treatment Period 1||7
10058073|NCT02079844|11183117|FG002|STARTED|Treatment Period 1||7
10058074|NCT02079844|11183115|FG000|COMPLETED|Treatment Period 1||6
10058075|NCT02079844|11183116|FG001|COMPLETED|Treatment Period 1||7
10058076|NCT02079844|11183117|FG002|COMPLETED|Treatment Period 1||5
10058077|NCT02079844|11183115|FG000|NOT COMPLETED|Treatment Period 1||0
10058078|NCT02079844|11183116|FG001|NOT COMPLETED|Treatment Period 1||0
10058079|NCT02079844|11183117|FG002|NOT COMPLETED|Treatment Period 1||2
10058080|NCT02079844|11183115|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
10058081|NCT02079844|11183116|FG001|STARTED|Treatment Period 2||7
10058082|NCT02079844|11183117|FG002|STARTED|Treatment Period 2||5
10058083|NCT02079844|11183115|FG000|COMPLETED|Treatment Period 2||5
10058084|NCT02079844|11183116|FG001|COMPLETED|Treatment Period 2||6
10058085|NCT02079844|11183117|FG002|COMPLETED|Treatment Period 2||5
10058086|NCT02079844|11183115|FG000|NOT COMPLETED|Treatment Period 2||0
10058087|NCT02079844|11183116|FG001|NOT COMPLETED|Treatment Period 2||1
10058088|NCT02079844|11183117|FG002|NOT COMPLETED|Treatment Period 2||0
10058089|NCT02079844|11183115|FG000|STARTED|Treatment Period 3||5
10058090|NCT02079844|11183116|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
10058091|NCT02079844|11183117|FG002|STARTED|Treatment Period 3||5
10058092|NCT02079844|11183115|FG000|COMPLETED|Treatment Period 3||5
10058093|NCT02079844|11183116|FG001|COMPLETED|Treatment Period 3||5
10058094|NCT02079844|11183117|FG002|COMPLETED|Treatment Period 3||5
10058095|NCT02079844|11183115|FG000|NOT COMPLETED|Treatment Period 3||0
10058096|NCT02079844|11183116|FG001|NOT COMPLETED|Treatment Period 3||0
10058097|NCT02079844|11183117|FG002|NOT COMPLETED|Treatment Period 3||0
10058098|NCT02079909|11183131|FG000|STARTED|Overall Study||158
10058099|NCT02079909|11183132|FG001|STARTED|Overall Study||166
10058100|NCT02079909|11183133|FG002|STARTED|Overall Study||158
10058101|NCT02079909|11183131|FG000|COMPLETED|Overall Study||120
10058102|NCT02079909|11183132|FG001|COMPLETED|Overall Study||117
10058103|NCT02079909|11183133|FG002|COMPLETED|Overall Study||140
10058104|NCT02079909|11183131|FG000|NOT COMPLETED|Overall Study||38
10058105|NCT02079909|11183132|FG001|NOT COMPLETED|Overall Study||49
10058106|NCT02079909|11183133|FG002|NOT COMPLETED|Overall Study||18
10058107|NCT02079987|11183143|FG000|STARTED|Overall Study||557
10058108|NCT02079987|11183144|FG001|STARTED|Overall Study||544
10058109|NCT02079987|11183143|FG000|COMPLETED|Overall Study||557
10058110|NCT02079987|11183144|FG001|COMPLETED|Overall Study||544
10058111|NCT02079987|11183143|FG000|NOT COMPLETED|Overall Study||0
10058112|NCT02079987|11183144|FG001|NOT COMPLETED|Overall Study||0
10058113|NCT02080091|11183151|FG000|STARTED|Overall Study||25
10058114|NCT02080091|11183151|FG000|COMPLETED|Overall Study||0
10058115|NCT02080091|11183151|FG000|NOT COMPLETED|Overall Study||25
10058116|NCT02080195|11183155|FG000|STARTED|Overall Study||1
10058117|NCT02080195|11183155|FG000|COMPLETED|Overall Study||1
10058118|NCT02080195|11183155|FG000|NOT COMPLETED|Overall Study||0
10058119|NCT02080221|11183159|FG000|STARTED|Overall Study||50
10058120|NCT02080221|11183159|FG000|COMPLETED|Overall Study||48
10058121|NCT02080221|11183159|FG000|NOT COMPLETED|Overall Study||2
10058122|NCT02080273|11183166|FG000|STARTED|Overall Study||45
10058123|NCT02080273|11183167|FG001|STARTED|Overall Study||45
10058124|NCT02080273|11183168|FG002|STARTED|Overall Study||45
10058125|NCT02080273|11183166|FG000|COMPLETED|Overall Study||45
10058126|NCT02080273|11183167|FG001|COMPLETED|Overall Study||45
10058127|NCT02080273|11183168|FG002|COMPLETED|Overall Study||45
10058128|NCT02080273|11183166|FG000|NOT COMPLETED|Overall Study||0
10058129|NCT02080273|11183167|FG001|NOT COMPLETED|Overall Study||0
10058130|NCT02080273|11183168|FG002|NOT COMPLETED|Overall Study||0
10058131|NCT02080312|11183176|FG000|STARTED|Overall Study||6
10058132|NCT02080312|11183176|FG000|COMPLETED|Overall Study||6
10058133|NCT02080312|11183176|FG000|NOT COMPLETED|Overall Study||0
10058134|NCT02080364|11183185|FG000|STARTED|Baseline Period||197
10058135|NCT02080364|11183186|FG001|STARTED|Baseline Period||208
10058136|NCT02080364|11183187|FG002|STARTED|Baseline Period||247
10058137|NCT02080364|11183188|FG003|STARTED|Baseline Period||228
10058138|NCT02080364|11183185|FG000|COMPLETED|Baseline Period||195
10058139|NCT02080364|11183186|FG001|COMPLETED|Baseline Period||206
10058140|NCT02080364|11183187|FG002|COMPLETED|Baseline Period||246
10058141|NCT02080364|11183188|FG003|COMPLETED|Baseline Period||228
10058142|NCT02080364|11183185|FG000|NOT COMPLETED|Baseline Period||2
10058143|NCT02080364|11183186|FG001|NOT COMPLETED|Baseline Period||2
10058144|NCT02080364|11183187|FG002|NOT COMPLETED|Baseline Period||1
10058145|NCT02080364|11183188|FG003|NOT COMPLETED|Baseline Period||0
10058146|NCT02080364|11183185|FG000|STARTED|Treatment Period||195
10058147|NCT02080364|11183186|FG001|STARTED|Treatment Period||206
10058148|NCT02080364|11183187|FG002|STARTED|Treatment Period||246
10058149|NCT02080364|11183188|FG003|STARTED|Treatment Period||228
10058150|NCT02080364|11183185|FG000|COMPLETED|Treatment Period||148
10058151|NCT02080364|11183186|FG001|COMPLETED|Treatment Period||157
10058152|NCT02080364|11183187|FG002|COMPLETED|Treatment Period||9
10058153|NCT02080364|11183188|FG003|COMPLETED|Treatment Period||4
10058154|NCT02080364|11183185|FG000|NOT COMPLETED|Treatment Period||47
10058155|NCT02080364|11183186|FG001|NOT COMPLETED|Treatment Period||49
10058156|NCT02080364|11183187|FG002|NOT COMPLETED|Treatment Period||237
10058157|NCT02080364|11183188|FG003|NOT COMPLETED|Treatment Period||224
10058158|NCT02080403|11183200|FG000|STARTED|Overall Study||146
10058159|NCT02080403|11183201|FG001|STARTED|Overall Study||144
10058160|NCT02080403|11183200|FG000|COMPLETED|Overall Study||131
10058161|NCT02080403|11183201|FG001|COMPLETED|Overall Study||132
10058162|NCT02080403|11183200|FG000|NOT COMPLETED|Overall Study||15
10058163|NCT02080403|11183201|FG001|NOT COMPLETED|Overall Study||12
10058164|NCT02080455|11183209|FG000|STARTED|Overall Study||16
10058165|NCT02080455|11183210|FG001|STARTED|Overall Study||16
10058166|NCT02080455|11183209|FG000|COMPLETED|Overall Study||16
10058167|NCT02080455|11183210|FG001|COMPLETED|Overall Study||16
10058168|NCT02080455|11183209|FG000|NOT COMPLETED|Overall Study||0
10058169|NCT02080455|11183210|FG001|NOT COMPLETED|Overall Study||0
10058170|NCT02080468|11183226|FG000|STARTED|Overall Study||16
10058171|NCT02080468|11183227|FG001|STARTED|Overall Study||16
10058172|NCT02080468|11183226|FG000|COMPLETED|Overall Study||14
10058173|NCT02080468|11183227|FG001|COMPLETED|Overall Study||14
10058174|NCT02080468|11183226|FG000|NOT COMPLETED|Overall Study||2
10058175|NCT02080468|11183227|FG001|NOT COMPLETED|Overall Study||2
10058176|NCT02080481|11183242|FG000|STARTED|Overall Study||68
10058177|NCT02080481|11183243|FG001|STARTED|Overall Study||67
10058178|NCT02080481|11183242|FG000|COMPLETED|Overall Study||67
10058179|NCT02080481|11183243|FG001|COMPLETED|Overall Study||67
10058180|NCT02080481|11183242|FG000|NOT COMPLETED|Overall Study||1
10058181|NCT02080481|11183243|FG001|NOT COMPLETED|Overall Study||0
10058182|NCT02080507|11183251|FG000|STARTED|Overall Study||5
10058183|NCT02080507|11183252|FG001|STARTED|Overall Study||7
10058184|NCT02080507|11183251|FG000|COMPLETED|Overall Study||5
10058185|NCT02080507|11183252|FG001|COMPLETED|Overall Study||7
10058186|NCT02080507|11183251|FG000|NOT COMPLETED|Overall Study||0
10058187|NCT02080507|11183252|FG001|NOT COMPLETED|Overall Study||0
10058188|NCT02080546|11183260|FG000|STARTED|Overall Study||57
10058189|NCT02080546|11183261|FG001|STARTED|Overall Study||63
10058190|NCT02080546|11183260|FG000|COMPLETED|Overall Study||49
10058191|NCT02080546|11183261|FG001|COMPLETED|Overall Study||52
10058192|NCT02080546|11183260|FG000|NOT COMPLETED|Overall Study||8
10058193|NCT02080546|11183261|FG001|NOT COMPLETED|Overall Study||11
10058194|NCT02080637|11183269|FG000|STARTED|Overall Study||13
10058195|NCT02080637|11183270|FG001|STARTED|Overall Study||3
10058196|NCT02080637|11183269|FG000|COMPLETED|Overall Study||13
10058197|NCT02080637|11183270|FG001|COMPLETED|Overall Study||3
10058198|NCT02080637|11183269|FG000|NOT COMPLETED|Overall Study||0
10058199|NCT02080637|11183270|FG001|NOT COMPLETED|Overall Study||0
10058200|NCT02080780|11183276|FG000|STARTED|Overall Study||24
10058201|NCT02080780|11183276|FG000|COMPLETED|Overall Study||24
10058202|NCT02080780|11183276|FG000|NOT COMPLETED|Overall Study||0
10058203|NCT02080819|11183286|FG000|STARTED|Overall Study||63
10058204|NCT02080819|11183287|FG001|STARTED|Overall Study||35
10058205|NCT02080819|11183288|FG002|STARTED|Overall Study||33
10058206|NCT02080819|11183286|FG000|COMPLETED|Overall Study||38
10058207|NCT02080819|11183287|FG001|COMPLETED|Overall Study||9
10058208|NCT02080819|11183288|FG002|COMPLETED|Overall Study||11
10058209|NCT02080819|11183286|FG000|NOT COMPLETED|Overall Study||25
10058210|NCT02080819|11183287|FG001|NOT COMPLETED|Overall Study||26
10058211|NCT02080819|11183288|FG002|NOT COMPLETED|Overall Study||22
10058212|NCT02080832|11183299|FG000|STARTED|Overall Study||15
10058213|NCT02080832|11183300|FG001|STARTED|Overall Study||17
10058214|NCT02080832|11183301|FG002|STARTED|Overall Study||22
10058215|NCT02080832|11183299|FG000|COMPLETED|Overall Study||6
10058216|NCT02080832|11183300|FG001|COMPLETED|Overall Study||5
10058217|NCT02080832|11183301|FG002|COMPLETED|Overall Study||6
10058218|NCT02080832|11183299|FG000|NOT COMPLETED|Overall Study||9
10058219|NCT02080832|11183300|FG001|NOT COMPLETED|Overall Study||12
10058220|NCT02080832|11183301|FG002|NOT COMPLETED|Overall Study||16
10058221|NCT02080871|11183311|FG000|STARTED|Overall Study||134
10058222|NCT02080871|11183311|FG000|COMPLETED|Overall Study||132
10058223|NCT02080871|11183311|FG000|NOT COMPLETED|Overall Study||2
10058224|NCT02081001|11183317|FG000|STARTED|Overall Study||2
10058225|NCT02081001|11183318|FG001|STARTED|Overall Study||1
10058226|NCT02081001|11183319|FG002|STARTED|Overall Study||2
10058227|NCT02081001|11183320|FG003|STARTED|Overall Study||1
10058228|NCT02081001|11183321|FG004|STARTED|Overall Study||3
10058229|NCT02081001|11183322|FG005|STARTED|Overall Study||1
10058230|NCT02081001|11183323|FG006|STARTED|Overall Study||2
10058231|NCT02081001|11183324|FG007|STARTED|Overall Study||1
10058232|NCT02081001|11183325|FG008|STARTED|Overall Study||2
10058233|NCT02081001|11183326|FG009|STARTED|Overall Study||1
10058234|NCT02081001|11183327|FG010|STARTED|Overall Study||2
10058235|NCT02081001|11183328|FG011|STARTED|Overall Study||1
10058236|NCT02081001|11183317|FG000|COMPLETED|Overall Study||2
10058237|NCT02081001|11183318|FG001|COMPLETED|Overall Study||1
10058238|NCT02081001|11183319|FG002|COMPLETED|Overall Study||2
10058239|NCT02081001|11183320|FG003|COMPLETED|Overall Study||1
10058240|NCT02081001|11183321|FG004|COMPLETED|Overall Study||2
10058241|NCT02081001|11183322|FG005|COMPLETED|Overall Study||1
10058242|NCT02081001|11183323|FG006|COMPLETED|Overall Study||2
10058243|NCT02081001|11183324|FG007|COMPLETED|Overall Study||1
10058244|NCT02081001|11183325|FG008|COMPLETED|Overall Study||2
10058245|NCT02081001|11183326|FG009|COMPLETED|Overall Study||1
10058246|NCT02081001|11183327|FG010|COMPLETED|Overall Study||2
10058247|NCT02081001|11183328|FG011|COMPLETED|Overall Study||1
10058248|NCT02081001|11183317|FG000|NOT COMPLETED|Overall Study||0
10058249|NCT02081001|11183318|FG001|NOT COMPLETED|Overall Study||0
10058250|NCT02081001|11183319|FG002|NOT COMPLETED|Overall Study||0
10058251|NCT02081001|11183320|FG003|NOT COMPLETED|Overall Study||0
10058252|NCT02081001|11183321|FG004|NOT COMPLETED|Overall Study||1
10058253|NCT02081001|11183322|FG005|NOT COMPLETED|Overall Study||0
10058254|NCT02081001|11183323|FG006|NOT COMPLETED|Overall Study||0
10058255|NCT02081001|11183324|FG007|NOT COMPLETED|Overall Study||0
10058256|NCT02081001|11183325|FG008|NOT COMPLETED|Overall Study||0
10058257|NCT02081001|11183326|FG009|NOT COMPLETED|Overall Study||0
10058258|NCT02081001|11183327|FG010|NOT COMPLETED|Overall Study||0
10058259|NCT02081001|11183328|FG011|NOT COMPLETED|Overall Study||0
10058260|NCT02081014|11183339|FG000|STARTED|Overall Study||2
10058261|NCT02081014|11183340|FG001|STARTED|Overall Study||2
10058262|NCT02081014|11183341|FG002|STARTED|Overall Study||2
10058263|NCT02081014|11183342|FG003|STARTED|Overall Study||2
10058264|NCT02081014|11183343|FG004|STARTED|Overall Study||2
10058265|NCT02081014|11183344|FG005|STARTED|Overall Study||2
10058266|NCT02081014|11183339|FG000|COMPLETED|Overall Study||2
10058267|NCT02081014|11183340|FG001|COMPLETED|Overall Study||2
10058268|NCT02081014|11183341|FG002|COMPLETED|Overall Study||2
10058269|NCT02081014|11183342|FG003|COMPLETED|Overall Study||2
10058270|NCT02081014|11183343|FG004|COMPLETED|Overall Study||2
10058271|NCT02081014|11183344|FG005|COMPLETED|Overall Study||2
10058272|NCT02081014|11183339|FG000|NOT COMPLETED|Overall Study||0
10058273|NCT02081014|11183340|FG001|NOT COMPLETED|Overall Study||0
10058274|NCT02081014|11183341|FG002|NOT COMPLETED|Overall Study||0
10058275|NCT02081014|11183342|FG003|NOT COMPLETED|Overall Study||0
10058276|NCT02081014|11183343|FG004|NOT COMPLETED|Overall Study||0
10058277|NCT02081014|11183344|FG005|NOT COMPLETED|Overall Study||0
10058278|NCT02081079|11183365|FG000|STARTED|Overall Study||44
10058279|NCT02081079|11183366|FG001|STARTED|Overall Study||41
10058280|NCT02081079|11183365|FG000|COMPLETED|Overall Study||40
10058281|NCT02081079|11183366|FG001|COMPLETED|Overall Study||39
10058282|NCT02081079|11183365|FG000|NOT COMPLETED|Overall Study||4
10058283|NCT02081079|11183366|FG001|NOT COMPLETED|Overall Study||2
10058284|NCT02081196|11183376|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
10058285|NCT02081196|11183376|FG000|Untreated Control Flank|Overall Study||45
10058286|NCT02081196|11183376|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
10058287|NCT02081196|11183376|FG000|NOT COMPLETED|Overall Study||1
10058288|NCT02081248|11183384|FG000|STARTED|Overall Study||98
10058289|NCT02081248|11183385|FG001|STARTED|Overall Study||100
10058290|NCT02081248|11183384|FG000|COMPLETED|Overall Study||76
10058291|NCT02081248|11183385|FG001|COMPLETED|Overall Study||87
10058292|NCT02081248|11183384|FG000|NOT COMPLETED|Overall Study||22
10058293|NCT02081248|11183385|FG001|NOT COMPLETED|Overall Study||13
10058294|NCT02081365|11183393|FG000|STARTED|Overall Study||74
10058295|NCT02081365|11183394|FG001|STARTED|Overall Study||77
10058296|NCT02081365|11183393|FG000|Received Allocated Intervention|Overall Study||46
10058297|NCT02081365|11183394|FG001|Received Allocated Intervention|Overall Study||59
10058298|NCT02081365|11183393|FG000|COMPLETED|Overall Study||44
10058299|NCT02081365|11183394|FG001|COMPLETED|Overall Study||54
10058300|NCT02081365|11183393|FG000|NOT COMPLETED|Overall Study||30
10058301|NCT02081365|11183394|FG001|NOT COMPLETED|Overall Study||23
10058302|NCT02081417|11183402|FG000|STARTED|Overall Study|Randomized to intervention|163
10058303|NCT02081417|11183403|FG001|STARTED|Overall Study||166
10058304|NCT02081417|11183402|FG000|1st Interview Completed|Overall Study||146
10058305|NCT02081417|11183403|FG001|1st Interview Completed|Overall Study||145
10058306|NCT02081417|11183402|FG000|3-Month Follow-Up|Overall Study||94
10058307|NCT02081417|11183403|FG001|3-Month Follow-Up|Overall Study||95
10058308|NCT02081417|11183402|FG000|6-Month Follow-Up|Overall Study||82
10058309|NCT02081417|11183403|FG001|6-Month Follow-Up|Overall Study||92
10058310|NCT02081417|11183402|FG000|COMPLETED|Overall Study||107
10058311|NCT02081417|11183403|FG001|COMPLETED|Overall Study||115
10058312|NCT02081417|11183402|FG000|NOT COMPLETED|Overall Study||56
10058313|NCT02081417|11183403|FG001|NOT COMPLETED|Overall Study||51
10058314|NCT02081443|11183411|FG000|STARTED|Overall Study||30
10058315|NCT02081443|11183412|FG001|STARTED|Overall Study||30
10058316|NCT02081443|11183411|FG000|COMPLETED|Overall Study||30
10058317|NCT02081443|11183412|FG001|COMPLETED|Overall Study||30
10058318|NCT02081443|11183411|FG000|NOT COMPLETED|Overall Study||0
10058319|NCT02081443|11183412|FG001|NOT COMPLETED|Overall Study||0
10058320|NCT02081456|11183420|FG000|STARTED|Overall Study||11
10121392|NCT02567227|11252450|FG001|STARTED|12 Months||127
10121393|NCT02567227|11252449|FG000|COMPLETED|12 Months||82
10121394|NCT02567227|11252450|FG001|COMPLETED|12 Months||93
10121395|NCT02567227|11252449|FG000|NOT COMPLETED|12 Months||31
10121396|NCT02567227|11252450|FG001|NOT COMPLETED|12 Months||34
10121397|NCT02567266|11252459|FG000|STARTED|Overall Study||68
10121398|NCT02567266|11252460|FG001|STARTED|Overall Study||60
10121399|NCT02567266|11252461|FG002|STARTED|Overall Study||68
10121400|NCT02567266|11252459|FG000|Midpoint (8 Weeks)|Overall Study||54
10121401|NCT02567266|11252460|FG001|Midpoint (8 Weeks)|Overall Study||52
10121402|NCT02567266|11252461|FG002|Midpoint (8 Weeks)|Overall Study||55
10121403|NCT02567266|11252459|FG000|Post (16 Weeks)|Overall Study||49
10121404|NCT02567266|11252460|FG001|Post (16 Weeks)|Overall Study||43
10121405|NCT02567266|11252461|FG002|Post (16 Weeks)|Overall Study||53
10121406|NCT02567266|11252459|FG000|Follow-up (28 Weeks)|Overall Study||45
10121407|NCT02567266|11252460|FG001|Follow-up (28 Weeks)|Overall Study||45
10121408|NCT02567266|11252461|FG002|Follow-up (28 Weeks)|Overall Study||52
10121409|NCT02567266|11252459|FG000|COMPLETED|Overall Study||45
10121410|NCT02567266|11252460|FG001|COMPLETED|Overall Study||45
10121411|NCT02567266|11252461|FG002|COMPLETED|Overall Study||52
10121412|NCT02567266|11252459|FG000|NOT COMPLETED|Overall Study||23
10121413|NCT02567266|11252460|FG001|NOT COMPLETED|Overall Study||15
10121414|NCT02567266|11252461|FG002|NOT COMPLETED|Overall Study||16
10121415|NCT02567552|11252471|FG000|STARTED|Overall Study||12
10121416|NCT02567552|11252472|FG001|STARTED|Overall Study||12
10121417|NCT02567552|11252471|FG000|COMPLETED|Overall Study||12
10121418|NCT02567552|11252472|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11
10121419|NCT02567552|11252471|FG000|NOT COMPLETED|Overall Study||0
10121420|NCT02567552|11252472|FG001|NOT COMPLETED|Overall Study||1
10121421|NCT02567656|11252484|FG000|STARTED|Overall Study||4
10121422|NCT02567656|11252485|FG001|STARTED|Overall Study||4
10121423|NCT02567656|11252486|FG002|STARTED|Overall Study||5
10121424|NCT02567656|11252487|FG003|STARTED|Overall Study||6
10121425|NCT02567656|11252488|FG004|STARTED|Overall Study||19
10121426|NCT02567656|11252489|FG005|STARTED|Overall Study||20
10121427|NCT02567656|11252484|FG000|COMPLETED|Overall Study||3
10121428|NCT02567656|11252485|FG001|COMPLETED|Overall Study||3
10121429|NCT02567656|11252486|FG002|COMPLETED|Overall Study||3
10121430|NCT02567656|11252487|FG003|COMPLETED|Overall Study||6
10121431|NCT02567656|11252488|FG004|COMPLETED|Overall Study||19
10121432|NCT02567656|11252489|FG005|COMPLETED|Overall Study||20
10121433|NCT02567656|11252484|FG000|NOT COMPLETED|Overall Study||1
10121434|NCT02567656|11252485|FG001|NOT COMPLETED|Overall Study||1
10121435|NCT02567656|11252486|FG002|NOT COMPLETED|Overall Study||2
10121436|NCT02567656|11252487|FG003|NOT COMPLETED|Overall Study||0
10121437|NCT02567656|11252488|FG004|NOT COMPLETED|Overall Study||0
10121438|NCT02567656|11252489|FG005|NOT COMPLETED|Overall Study||0
10121439|NCT02567708|11252503|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
10121440|NCT02567708|11252504|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
10121441|NCT02567708|11252503|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
10121442|NCT02567708|11252504|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
10121443|NCT02567708|11252503|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
10121444|NCT02567708|11252504|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
10121445|NCT02567708|11252503|FG000|STARTED|Washout Period (Up to 4 Weeks)||22
10121446|NCT02567708|11252504|FG001|STARTED|Washout Period (Up to 4 Weeks)||23
10121447|NCT02567708|11252503|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22
10121448|NCT02567708|11252504|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23
10121449|NCT02567708|11252503|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10121450|NCT02567708|11252504|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10121451|NCT02567708|11252503|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
10121452|NCT02567708|11252504|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
10058321|NCT02081456|11183421|FG001|STARTED|Overall Study||12
10058322|NCT02081456|11183420|FG000|COMPLETED|Overall Study||11
10058323|NCT02081456|11183421|FG001|COMPLETED|Overall Study||12
10058324|NCT02081456|11183420|FG000|NOT COMPLETED|Overall Study||0
10058325|NCT02081456|11183421|FG001|NOT COMPLETED|Overall Study||0
10058326|NCT02081534|11183434|FG000|STARTED|Overall Study||23
10058327|NCT02081534|11183435|FG001|STARTED|Overall Study||21
10058328|NCT02081534|11183436|FG002|STARTED|Overall Study||23
10058329|NCT02081534|11183437|FG003|STARTED|Overall Study||26
10121453|NCT02567708|11252503|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
10121454|NCT02567708|11252504|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
10121455|NCT02567708|11252503|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
10058330|NCT02081534|11183438|FG004|STARTED|Overall Study||22
10058331|NCT02081534|11183439|FG005|STARTED|Overall Study||21
10058332|NCT02081534|11183440|FG006|STARTED|Overall Study||26
10058333|NCT02081534|11183434|FG000|COMPLETED|Overall Study||18
10058334|NCT02081534|11183435|FG001|COMPLETED|Overall Study||13
10121456|NCT02567708|11252504|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
10121457|NCT02567968|11252511|FG000|STARTED|First Intervention||4
10121458|NCT02567968|11252512|FG001|STARTED|First Intervention||4
10121459|NCT02567968|11252511|FG000|COMPLETED|First Intervention||4
10121460|NCT02567968|11252512|FG001|COMPLETED|First Intervention||4
10121461|NCT02567968|11252511|FG000|NOT COMPLETED|First Intervention||0
10058335|NCT02081534|11183436|FG002|COMPLETED|Overall Study||19
10058336|NCT02081534|11183437|FG003|COMPLETED|Overall Study||13
10058337|NCT02081534|11183438|FG004|COMPLETED|Overall Study||18
10058338|NCT02081534|11183439|FG005|COMPLETED|Overall Study||12
10058339|NCT02081534|11183440|FG006|COMPLETED|Overall Study||22
10058340|NCT02081534|11183434|FG000|NOT COMPLETED|Overall Study||5
10058341|NCT02081534|11183435|FG001|NOT COMPLETED|Overall Study||8
10058342|NCT02081534|11183436|FG002|NOT COMPLETED|Overall Study||4
10058343|NCT02081534|11183437|FG003|NOT COMPLETED|Overall Study||13
10058344|NCT02081534|11183438|FG004|NOT COMPLETED|Overall Study||4
10058345|NCT02081534|11183439|FG005|NOT COMPLETED|Overall Study||9
10058346|NCT02081534|11183440|FG006|NOT COMPLETED|Overall Study||4
10058347|NCT02081573|11183456|FG000|STARTED|Overall Study||10
10058348|NCT02081573|11183456|FG000|COMPLETED|Overall Study||10
10058349|NCT02081573|11183456|FG000|NOT COMPLETED|Overall Study||0
10058350|NCT02081586|11183464|FG000|STARTED|Overall Study||3
10058351|NCT02081586|11183465|FG001|STARTED|Overall Study||3
10058352|NCT02081586|11183466|FG002|STARTED|Overall Study||4
10058353|NCT02081586|11183467|FG003|STARTED|Overall Study||3
10058354|NCT02081586|11183464|FG000|COMPLETED|Overall Study||3
10058355|NCT02081586|11183465|FG001|COMPLETED|Overall Study||2
10058356|NCT02081586|11183466|FG002|COMPLETED|Overall Study||3
10058357|NCT02081586|11183467|FG003|COMPLETED|Overall Study||2
10058358|NCT02081586|11183464|FG000|NOT COMPLETED|Overall Study||0
10058359|NCT02081586|11183465|FG001|NOT COMPLETED|Overall Study||1
10058360|NCT02081586|11183466|FG002|NOT COMPLETED|Overall Study||1
10058361|NCT02081586|11183467|FG003|NOT COMPLETED|Overall Study||1
10058362|NCT02081599|11183481|FG000|STARTED|Period 1：Double-blind Period||71
10058363|NCT02081599|11183482|FG001|STARTED|Period 1：Double-blind Period||77
10058364|NCT02081599|11183481|FG000|COMPLETED|Period 1：Double-blind Period||63
10058365|NCT02081599|11183482|FG001|COMPLETED|Period 1：Double-blind Period||75
10058366|NCT02081599|11183481|FG000|NOT COMPLETED|Period 1：Double-blind Period||8
10058367|NCT02081599|11183482|FG001|NOT COMPLETED|Period 1：Double-blind Period||2
10058368|NCT02081599|11183481|FG000|STARTED|Period 2：Open-label Period||63
10058369|NCT02081599|11183482|FG001|STARTED|Period 2：Open-label Period||75
10058370|NCT02081599|11183481|FG000|COMPLETED|Period 2：Open-label Period||57
10058371|NCT02081599|11183482|FG001|COMPLETED|Period 2：Open-label Period||71
10058372|NCT02081599|11183481|FG000|NOT COMPLETED|Period 2：Open-label Period||6
10058373|NCT02081599|11183482|FG001|NOT COMPLETED|Period 2：Open-label Period||4
10058374|NCT02081638|11183492|FG000|STARTED|Overall Study||26
10058375|NCT02081638|11183493|FG001|STARTED|Overall Study||27
10058376|NCT02081638|11183492|FG000|COMPLETED|Overall Study||24
10058377|NCT02081638|11183493|FG001|COMPLETED|Overall Study||20
10058378|NCT02081638|11183492|FG000|NOT COMPLETED|Overall Study||2
10058379|NCT02081638|11183493|FG001|NOT COMPLETED|Overall Study||7
10058380|NCT02081677|11183507|FG000|STARTED|Overall Study||19
10058381|NCT02081677|11183508|FG001|STARTED|Overall Study||19
10058382|NCT02081677|11183509|FG002|STARTED|Overall Study||19
10058383|NCT02081677|11183510|FG003|STARTED|Overall Study||19
10058384|NCT02081677|11183507|FG000|COMPLETED|Overall Study||18
10058385|NCT02081677|11183508|FG001|COMPLETED|Overall Study||18
10058386|NCT02081677|11183509|FG002|COMPLETED|Overall Study||17
10058387|NCT02081677|11183510|FG003|COMPLETED|Overall Study||19
10058388|NCT02081677|11183507|FG000|NOT COMPLETED|Overall Study||1
10058389|NCT02081677|11183508|FG001|NOT COMPLETED|Overall Study||1
10058390|NCT02081677|11183509|FG002|NOT COMPLETED|Overall Study||2
10058391|NCT02081677|11183510|FG003|NOT COMPLETED|Overall Study||0
10058392|NCT02081690|11183520|FG000|STARTED|Overall Study||88
10058393|NCT02081690|11183520|FG000|COMPLETED|Overall Study||81
10058394|NCT02081690|11183520|FG000|NOT COMPLETED|Overall Study||7
10058395|NCT02081807|11183532|FG000|STARTED|Overall Study||7668
10058396|NCT02081807|11183533|FG001|STARTED|Overall Study||26149
10058397|NCT02081807|11183534|FG002|STARTED|Overall Study||14852
10058398|NCT02081807|11183535|FG003|STARTED|Overall Study||9112
10058399|NCT02081807|11183536|FG004|STARTED|Overall Study||27456
10058400|NCT02081807|11183537|FG005|STARTED|Overall Study||76055
10058401|NCT02081807|11183538|FG006|STARTED|Overall Study||40207
10058402|NCT02081807|11183539|FG007|STARTED|Overall Study||19729
10058403|NCT02081807|11183532|FG000|COMPLETED|Overall Study||7668
10058404|NCT02081807|11183533|FG001|COMPLETED|Overall Study||26149
10058405|NCT02081807|11183534|FG002|COMPLETED|Overall Study||14852
10058406|NCT02081807|11183535|FG003|COMPLETED|Overall Study||9112
10058407|NCT02081807|11183536|FG004|COMPLETED|Overall Study||27456
10058408|NCT02081807|11183537|FG005|COMPLETED|Overall Study||76055
10058409|NCT02081807|11183538|FG006|COMPLETED|Overall Study||40207
10058410|NCT02081807|11183539|FG007|COMPLETED|Overall Study||19729
10058411|NCT02081807|11183532|FG000|NOT COMPLETED|Overall Study||0
10058412|NCT02081807|11183533|FG001|NOT COMPLETED|Overall Study||0
10058413|NCT02081807|11183534|FG002|NOT COMPLETED|Overall Study||0
10058414|NCT02081807|11183535|FG003|NOT COMPLETED|Overall Study||0
10058415|NCT02081807|11183536|FG004|NOT COMPLETED|Overall Study||0
10058416|NCT02081807|11183537|FG005|NOT COMPLETED|Overall Study||0
10058417|NCT02081807|11183538|FG006|NOT COMPLETED|Overall Study||0
10058418|NCT02081807|11183539|FG007|NOT COMPLETED|Overall Study||0
10058419|NCT02081846|11183569|FG000|STARTED|Overall Study||751
10058420|NCT02081846|11183570|FG001|STARTED|Overall Study||749
10058421|NCT02081846|11183569|FG000|COMPLETED|Overall Study||749
10058422|NCT02081846|11183570|FG001|COMPLETED|Overall Study||749
10058423|NCT02081846|11183569|FG000|NOT COMPLETED|Overall Study||2
10058424|NCT02081846|11183570|FG001|NOT COMPLETED|Overall Study||0
10058425|NCT02081859|11183578|FG000|STARTED|Overall Study||150
10058426|NCT02081859|11183579|FG001|STARTED|Overall Study||150
10058427|NCT02081859|11183578|FG000|COMPLETED|Overall Study||116
10058428|NCT02081859|11183579|FG001|COMPLETED|Overall Study||119
10058429|NCT02081859|11183578|FG000|NOT COMPLETED|Overall Study||34
10058430|NCT02081859|11183579|FG001|NOT COMPLETED|Overall Study||31
10058431|NCT02081950|11183585|FG000|STARTED|Treatment Period 1||14
10058432|NCT02081950|11183585|FG000|COMPLETED|Treatment Period 1||14
10058433|NCT02081950|11183585|FG000|NOT COMPLETED|Treatment Period 1||0
10058434|NCT02081950|11183585|FG000|STARTED|Treatment Period 2||14
10058435|NCT02081950|11183585|FG000|COMPLETED|Treatment Period 2||14
10058436|NCT02081950|11183585|FG000|NOT COMPLETED|Treatment Period 2||0
10058437|NCT02081963|11183593|FG000|STARTED|Overall Study||79
10058438|NCT02081963|11183594|FG001|STARTED|Overall Study||73
10058439|NCT02081963|11183593|FG000|COMPLETED|Overall Study||74
10058440|NCT02081963|11183594|FG001|COMPLETED|Overall Study||69
10058441|NCT02081963|11183593|FG000|NOT COMPLETED|Overall Study||5
10058442|NCT02081963|11183594|FG001|NOT COMPLETED|Overall Study||4
10058443|NCT02082119|11183600|FG000|STARTED|Overall Study||82
10058444|NCT02082119|11183600|FG000|COMPLETED|Overall Study||82
10058445|NCT02082119|11183600|FG000|NOT COMPLETED|Overall Study||0
10058446|NCT02082145|11183606|FG000|STARTED|Overall Study||5
10058447|NCT02082145|11183607|FG001|STARTED|Overall Study||9
10058448|NCT02082145|11183606|FG000|COMPLETED|Overall Study||5
10058449|NCT02082145|11183607|FG001|COMPLETED|Overall Study||9
10058450|NCT02082145|11183606|FG000|NOT COMPLETED|Overall Study||0
10058451|NCT02082145|11183607|FG001|NOT COMPLETED|Overall Study||0
10058452|NCT02082158|11183621|FG000|STARTED|Overall Study||66
10058453|NCT02082158|11183622|FG001|STARTED|Overall Study||61
10058454|NCT02082158|11183623|FG002|STARTED|Overall Study||52
10058455|NCT02082158|11183624|FG003|STARTED|Overall Study||72
10058456|NCT02082158|11183625|FG004|STARTED|Overall Study||68
10058457|NCT02082158|11183626|FG005|STARTED|Overall Study||63
10058458|NCT02082158|11183621|FG000|COMPLETED|Overall Study||58
10058459|NCT02082158|11183622|FG001|COMPLETED|Overall Study||53
10058460|NCT02082158|11183623|FG002|COMPLETED|Overall Study||38
10058461|NCT02082158|11183624|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
10058462|NCT02082158|11183625|FG004|COMPLETED|Overall Study||64
10058463|NCT02082158|11183626|FG005|COMPLETED|Overall Study||56
10058464|NCT02082158|11183621|FG000|NOT COMPLETED|Overall Study||8
10058465|NCT02082158|11183622|FG001|NOT COMPLETED|Overall Study||8
10058466|NCT02082158|11183623|FG002|NOT COMPLETED|Overall Study||14
10058467|NCT02082158|11183624|FG003|NOT COMPLETED|Overall Study||4
10058468|NCT02082158|11183625|FG004|NOT COMPLETED|Overall Study||4
10058469|NCT02082158|11183626|FG005|NOT COMPLETED|Overall Study||7
10058470|NCT02082184|11183648|FG000|STARTED|Overall Study||149
10058471|NCT02082184|11183649|FG001|STARTED|Overall Study||75
10058472|NCT02082184|11183648|FG000|COMPLETED|Overall Study||139
10058473|NCT02082184|11183649|FG001|COMPLETED|Overall Study||62
10058474|NCT02082184|11183648|FG000|NOT COMPLETED|Overall Study||10
10058475|NCT02082184|11183649|FG001|NOT COMPLETED|Overall Study||13
10058476|NCT02082210|11183661|FG000|STARTED|Overall Study||3
10058477|NCT02082210|11183662|FG001|STARTED|Overall Study||3
10058478|NCT02082210|11183663|FG002|STARTED|Overall Study||16
10058479|NCT02082210|11183664|FG003|STARTED|Overall Study||45
10058480|NCT02082210|11183665|FG004|STARTED|Overall Study||15
10058481|NCT02082210|11183666|FG005|STARTED|Overall Study||15
10121462|NCT02567968|11252512|FG001|NOT COMPLETED|First Intervention||0
10121463|NCT02567968|11252511|FG000|STARTED|Washout (2 Weeks)||4
10121464|NCT02567968|11252512|FG001|STARTED|Washout (2 Weeks)||4
10121465|NCT02567968|11252511|FG000|COMPLETED|Washout (2 Weeks)||4
10121466|NCT02567968|11252512|FG001|COMPLETED|Washout (2 Weeks)||4
10121467|NCT02567968|11252511|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10121468|NCT02567968|11252512|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10121469|NCT02567968|11252511|FG000|STARTED|Second Intervention||4
10121470|NCT02567968|11252512|FG001|STARTED|Second Intervention||4
10121471|NCT02567968|11252511|FG000|COMPLETED|Second Intervention||4
10121472|NCT02567968|11252512|FG001|COMPLETED|Second Intervention||4
10121473|NCT02567968|11252511|FG000|NOT COMPLETED|Second Intervention||0
10121474|NCT02567968|11252512|FG001|NOT COMPLETED|Second Intervention||0
10121475|NCT02568046|11252520|FG000|STARTED|Overall Study||5
10121476|NCT02568046|11252521|FG001|STARTED|Overall Study||5
10121477|NCT02568046|11252520|FG000|COMPLETED|Overall Study||0
10121478|NCT02568046|11252521|FG001|COMPLETED|Overall Study||2
10121479|NCT02568046|11252520|FG000|NOT COMPLETED|Overall Study||5
10058482|NCT02082210|11183661|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10058483|NCT02082210|11183662|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10058484|NCT02082210|11183663|FG002|Received at Least One Dose of Study Drug|Overall Study||16
10058485|NCT02082210|11183664|FG003|Received at Least One Dose of Study Drug|Overall Study||45
10058486|NCT02082210|11183665|FG004|Received at Least One Dose of Study Drug|Overall Study||15
10058487|NCT02082210|11183666|FG005|Received at Least One Dose of Study Drug|Overall Study||15
10058488|NCT02082210|11183661|FG000|COMPLETED|Overall Study||3
10058489|NCT02082210|11183662|FG001|COMPLETED|Overall Study||3
10121480|NCT02568046|11252521|FG001|NOT COMPLETED|Overall Study||3
10121481|NCT02568072|11252527|FG000|STARTED|Overall Study||120
10121482|NCT02568072|11252527|FG000|COMPLETED|Overall Study||68
10121483|NCT02568072|11252527|FG000|NOT COMPLETED|Overall Study||52
10121484|NCT02568254|11252532|FG000|STARTED|Period 1||13
10121485|NCT02568254|11252533|FG001|STARTED|Period 1||12
10058490|NCT02082210|11183663|FG002|COMPLETED|Overall Study||13
10058491|NCT02082210|11183664|FG003|COMPLETED|Overall Study||39
10058492|NCT02082210|11183665|FG004|COMPLETED|Overall Study||12
10058493|NCT02082210|11183666|FG005|COMPLETED|Overall Study||13
10058494|NCT02082210|11183661|FG000|NOT COMPLETED|Overall Study||0
10058495|NCT02082210|11183662|FG001|NOT COMPLETED|Overall Study||0
10058496|NCT02082210|11183663|FG002|NOT COMPLETED|Overall Study||3
10058497|NCT02082210|11183664|FG003|NOT COMPLETED|Overall Study||6
10058498|NCT02082210|11183665|FG004|NOT COMPLETED|Overall Study||3
10058499|NCT02082210|11183666|FG005|NOT COMPLETED|Overall Study||2
10058500|NCT02082262|11183692|FG000|STARTED|Overall Study||140
10058501|NCT02082262|11183692|FG000|COMPLETED|Overall Study||89
10058502|NCT02082262|11183692|FG000|NOT COMPLETED|Overall Study||51
10058503|NCT02082288|11183696|FG000|STARTED|Overall Study||243
10058504|NCT02082288|11183696|FG000|COMPLETED|Overall Study||243
10058505|NCT02082288|11183696|FG000|NOT COMPLETED|Overall Study||0
10058506|NCT02082340|11183702|FG000|STARTED|Overall Study||194
10058507|NCT02082340|11183703|FG001|STARTED|Overall Study||198
10058508|NCT02082340|11183702|FG000|COMPLETED|Overall Study||193
10058509|NCT02082340|11183703|FG001|COMPLETED|Overall Study||197
10058510|NCT02082340|11183702|FG000|NOT COMPLETED|Overall Study||1
10058511|NCT02082340|11183703|FG001|NOT COMPLETED|Overall Study||1
10058512|NCT02082392|11183711|FG000|STARTED|Overall Study||2
10058513|NCT02082392|11183712|FG001|STARTED|Overall Study||1
10058514|NCT02082392|11183711|FG000|COMPLETED|Overall Study||2
10058515|NCT02082392|11183712|FG001|COMPLETED|Overall Study||1
10058516|NCT02082392|11183711|FG000|NOT COMPLETED|Overall Study||0
10058517|NCT02082392|11183712|FG001|NOT COMPLETED|Overall Study||0
10058518|NCT02082483|11183720|FG000|STARTED|Overall Study||71
10058519|NCT02082483|11183721|FG001|STARTED|Overall Study||73
10058520|NCT02082483|11183720|FG000|COMPLETED|Overall Study||65
10058521|NCT02082483|11183721|FG001|COMPLETED|Overall Study||67
10058522|NCT02082483|11183720|FG000|NOT COMPLETED|Overall Study||6
10058523|NCT02082483|11183721|FG001|NOT COMPLETED|Overall Study||6
10058524|NCT02082522|11183730|FG000|STARTED|Overall Study||15
10058525|NCT02082522|11183731|FG001|STARTED|Overall Study||13
10058526|NCT02082522|11183730|FG000|COMPLETED|Overall Study||0
10058527|NCT02082522|11183731|FG001|COMPLETED|Overall Study||0
10058528|NCT02082522|11183730|FG000|NOT COMPLETED|Overall Study||15
10058529|NCT02082522|11183731|FG001|NOT COMPLETED|Overall Study||13
10058530|NCT02082678|11183739|FG000|STARTED|Overall Study||35
10058531|NCT02082678|11183740|FG001|STARTED|Overall Study||35
10058532|NCT02082678|11183739|FG000|COMPLETED|Overall Study||23
10058533|NCT02082678|11183740|FG001|COMPLETED|Overall Study||21
10058534|NCT02082678|11183739|FG000|NOT COMPLETED|Overall Study||12
10058535|NCT02082678|11183740|FG001|NOT COMPLETED|Overall Study||14
10058536|NCT02082717|11183748|FG000|STARTED|Overall Study||8
10058537|NCT02082717|11183749|FG001|STARTED|Overall Study||9
10058538|NCT02082717|11183748|FG000|COMPLETED|Overall Study||8
10058539|NCT02082717|11183749|FG001|COMPLETED|Overall Study||9
10058540|NCT02082717|11183748|FG000|NOT COMPLETED|Overall Study||0
10058541|NCT02082717|11183749|FG001|NOT COMPLETED|Overall Study||0
10058542|NCT02082769|11183762|FG000|STARTED|Overall Study||168
10058543|NCT02082769|11183763|FG001|STARTED|Overall Study||168
10058544|NCT02082769|11183764|FG002|STARTED|Overall Study||168
10121486|NCT02568254|11252534|FG002|STARTED|Period 1||13
10121487|NCT02568254|11252535|FG003|STARTED|Period 1||12
10121488|NCT02568254|11252536|FG004|STARTED|Period 1||12
10121489|NCT02568254|11252537|FG005|STARTED|Period 1||12
10121490|NCT02568254|11252532|FG000|COMPLETED|Period 1||13
10058545|NCT02082769|11183762|FG000|COMPLETED|Overall Study||144
10058546|NCT02082769|11183763|FG001|COMPLETED|Overall Study||141
10058547|NCT02082769|11183764|FG002|COMPLETED|Overall Study||132
10058548|NCT02082769|11183762|FG000|NOT COMPLETED|Overall Study||24
10058549|NCT02082769|11183763|FG001|NOT COMPLETED|Overall Study||27
10058550|NCT02082769|11183764|FG002|NOT COMPLETED|Overall Study||36
10058551|NCT02082912|11183774|FG000|STARTED|Overall Study||7
10058552|NCT02082912|11183775|FG001|STARTED|Overall Study||7
10058553|NCT02082912|11183774|FG000|COMPLETED|Overall Study||7
10058554|NCT02082912|11183775|FG001|COMPLETED|Overall Study||6
10058555|NCT02082912|11183774|FG000|NOT COMPLETED|Overall Study||0
10058556|NCT02082912|11183775|FG001|NOT COMPLETED|Overall Study||1
10121491|NCT02568254|11252533|FG001|COMPLETED|Period 1||12
10121492|NCT02568254|11252534|FG002|COMPLETED|Period 1||13
10058557|NCT02082977|11183791|FG000|STARTED|Part 1 (Up to 3.2 Years)||2
10058558|NCT02082977|11183792|FG001|STARTED|Part 1 (Up to 3.2 Years)||1
10058559|NCT02082977|11183793|FG002|STARTED|Part 1 (Up to 3.2 Years)||1
10058560|NCT02082977|11183794|FG003|STARTED|Part 1 (Up to 3.2 Years)||1
10058561|NCT02082977|11183795|FG004|STARTED|Part 1 (Up to 3.2 Years)||3
10058562|NCT02082977|11183796|FG005|STARTED|Part 1 (Up to 3.2 Years)||4
10058563|NCT02082977|11183797|FG006|STARTED|Part 1 (Up to 3.2 Years)||10
10058564|NCT02082977|11183798|FG007|STARTED|Part 1 (Up to 3.2 Years)||12
10058565|NCT02082977|11183799|FG008|STARTED|Part 1 (Up to 3.2 Years)||7
10058566|NCT02082977|11183800|FG009|STARTED|Part 1 (Up to 3.2 Years)||0
10058567|NCT02082977|11183791|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1
10058568|NCT02082977|11183792|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1
10058569|NCT02082977|11183793|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1
10058570|NCT02082977|11183794|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1
10058571|NCT02082977|11183795|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2
10058572|NCT02082977|11183796|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1
10058573|NCT02082977|11183797|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4
10058574|NCT02082977|11183798|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7
10058575|NCT02082977|11183799|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4
10058576|NCT02082977|11183800|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0
10058577|NCT02082977|11183791|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
10058578|NCT02082977|11183792|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10058579|NCT02082977|11183793|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10058580|NCT02082977|11183794|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10058581|NCT02082977|11183795|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
10058582|NCT02082977|11183796|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
10058583|NCT02082977|11183797|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
10058584|NCT02082977|11183798|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
10058585|NCT02082977|11183799|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
10058586|NCT02082977|11183800|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10058587|NCT02082977|11183791|FG000|STARTED|Part 2 (Up to 3.2 Years)||0
10058588|NCT02082977|11183792|FG001|STARTED|Part 2 (Up to 3.2 Years)||0
10058589|NCT02082977|11183793|FG002|STARTED|Part 2 (Up to 3.2 Years)||0
10058590|NCT02082977|11183794|FG003|STARTED|Part 2 (Up to 3.2 Years)||0
10058591|NCT02082977|11183795|FG004|STARTED|Part 2 (Up to 3.2 Years)||0
10058592|NCT02082977|11183796|FG005|STARTED|Part 2 (Up to 3.2 Years)||0
10058593|NCT02082977|11183797|FG006|STARTED|Part 2 (Up to 3.2 Years)||0
10058594|NCT02082977|11183798|FG007|STARTED|Part 2 (Up to 3.2 Years)||0
10058595|NCT02082977|11183799|FG008|STARTED|Part 2 (Up to 3.2 Years)||0
10058596|NCT02082977|11183800|FG009|STARTED|Part 2 (Up to 3.2 Years)||0
10058597|NCT02082977|11183791|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058598|NCT02082977|11183792|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058599|NCT02082977|11183793|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058600|NCT02082977|11183794|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058601|NCT02082977|11183795|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058602|NCT02082977|11183796|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058603|NCT02082977|11183797|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058604|NCT02082977|11183798|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058605|NCT02082977|11183799|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058606|NCT02082977|11183800|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0
10058607|NCT02082977|11183791|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058608|NCT02082977|11183792|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058609|NCT02082977|11183793|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058610|NCT02082977|11183794|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058611|NCT02082977|11183795|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058612|NCT02082977|11183796|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058613|NCT02082977|11183797|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058614|NCT02082977|11183798|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058615|NCT02082977|11183799|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058616|NCT02082977|11183800|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10058617|NCT02083107|11183835|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
10058618|NCT02083107|11183836|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
10058619|NCT02083107|11183837|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
10058620|NCT02083107|11183835|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
10058621|NCT02083107|11183836|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
10121493|NCT02568254|11252535|FG003|COMPLETED|Period 1||12
10121494|NCT02568254|11252536|FG004|COMPLETED|Period 1||12
10121495|NCT02568254|11252537|FG005|COMPLETED|Period 1||12
10121496|NCT02568254|11252532|FG000|NOT COMPLETED|Period 1||0
10121497|NCT02568254|11252533|FG001|NOT COMPLETED|Period 1||0
10121498|NCT02568254|11252534|FG002|NOT COMPLETED|Period 1||0
10121499|NCT02568254|11252535|FG003|NOT COMPLETED|Period 1||0
10121500|NCT02568254|11252536|FG004|NOT COMPLETED|Period 1||0
10121501|NCT02568254|11252537|FG005|NOT COMPLETED|Period 1||0
10121502|NCT02568254|11252532|FG000|STARTED|Period 2||13
10121503|NCT02568254|11252533|FG001|STARTED|Period 2||12
10121504|NCT02568254|11252534|FG002|STARTED|Period 2||13
10121505|NCT02568254|11252535|FG003|STARTED|Period 2||12
10121506|NCT02568254|11252536|FG004|STARTED|Period 2||12
10058622|NCT02083107|11183837|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
10058623|NCT02083107|11183835|FG000|NOT COMPLETED|Overall Study||0
10058624|NCT02083107|11183836|FG001|NOT COMPLETED|Overall Study||0
10058625|NCT02083107|11183837|FG002|NOT COMPLETED|Overall Study||0
10058626|NCT02083185|11183848|FG000|STARTED|Overall Study||56
10058627|NCT02083185|11183849|FG001|STARTED|Overall Study||56
10058628|NCT02083185|11183850|FG002|STARTED|Overall Study||24
10058629|NCT02083185|11183848|FG000|Safety Population|Overall Study||56
10058630|NCT02083185|11183849|FG001|Safety Population|Overall Study||54
10058631|NCT02083185|11183850|FG002|Safety Population|Overall Study||24
10058632|NCT02083185|11183848|FG000|COMPLETED|Overall Study||36
10058633|NCT02083185|11183849|FG001|COMPLETED|Overall Study||27
10058634|NCT02083185|11183850|FG002|COMPLETED|Overall Study||17
10058635|NCT02083185|11183848|FG000|NOT COMPLETED|Overall Study||20
10058636|NCT02083185|11183849|FG001|NOT COMPLETED|Overall Study||29
10058637|NCT02083185|11183850|FG002|NOT COMPLETED|Overall Study||7
10058638|NCT02083263|11183860|FG000|STARTED|Overall Study||16
10058639|NCT02083263|11183861|FG001|STARTED|Overall Study||16
10058640|NCT02083263|11183860|FG000|COMPLETED|Overall Study||16
10058641|NCT02083263|11183861|FG001|COMPLETED|Overall Study||16
10058642|NCT02083263|11183860|FG000|NOT COMPLETED|Overall Study||0
10058643|NCT02083263|11183861|FG001|NOT COMPLETED|Overall Study||0
10058644|NCT02083380|11183870|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
10058645|NCT02083380|11183871|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
10058646|NCT02083380|11183872|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
10058647|NCT02083380|11183870|FG000|COMPLETED|Overall Study||57
10058648|NCT02083380|11183871|FG001|COMPLETED|Overall Study||56
10058649|NCT02083380|11183872|FG002|COMPLETED|Overall Study||65
10058650|NCT02083380|11183870|FG000|NOT COMPLETED|Overall Study||91
10058651|NCT02083380|11183871|FG001|NOT COMPLETED|Overall Study||95
10058652|NCT02083380|11183872|FG002|NOT COMPLETED|Overall Study||84
10058653|NCT02083406|11183888|FG000|STARTED|Overall Study||7
10058654|NCT02083406|11183889|FG001|STARTED|Overall Study||8
10058655|NCT02083406|11183890|FG002|STARTED|Overall Study||7
10058656|NCT02083406|11183888|FG000|COMPLETED|Overall Study||7
10058657|NCT02083406|11183889|FG001|COMPLETED|Overall Study||8
10058658|NCT02083406|11183890|FG002|COMPLETED|Overall Study||7
10058659|NCT02083406|11183888|FG000|NOT COMPLETED|Overall Study||0
10058660|NCT02083406|11183889|FG001|NOT COMPLETED|Overall Study||0
10058661|NCT02083406|11183890|FG002|NOT COMPLETED|Overall Study||0
10058662|NCT02083653|11183901|FG000|STARTED|Overall Study||83
10058663|NCT02083653|11183902|FG001|STARTED|Overall Study||86
10058664|NCT02083653|11183903|FG002|STARTED|Overall Study||85
10058665|NCT02083653|11183901|FG000|COMPLETED|Overall Study||1
10058666|NCT02083653|11183902|FG001|COMPLETED|Overall Study||1
10058667|NCT02083653|11183903|FG002|COMPLETED|Overall Study||1
10058668|NCT02083653|11183901|FG000|NOT COMPLETED|Overall Study||82
10058669|NCT02083653|11183902|FG001|NOT COMPLETED|Overall Study||85
10058670|NCT02083653|11183903|FG002|NOT COMPLETED|Overall Study||84
10058671|NCT02083679|11183915|FG000|STARTED|Overall Study||3
10058672|NCT02083679|11183916|FG001|STARTED|Overall Study||6
10058673|NCT02083679|11183917|FG002|STARTED|Overall Study||3
10058674|NCT02083679|11183918|FG003|STARTED|Overall Study||3
10058675|NCT02083679|11183915|FG000|COMPLETED|Overall Study||3
10058676|NCT02083679|11183916|FG001|COMPLETED|Overall Study||6
10058677|NCT02083679|11183917|FG002|COMPLETED|Overall Study||3
10058678|NCT02083679|11183918|FG003|COMPLETED|Overall Study||3
10058679|NCT02083679|11183915|FG000|NOT COMPLETED|Overall Study||0
10058680|NCT02083679|11183916|FG001|NOT COMPLETED|Overall Study||0
10058681|NCT02083679|11183917|FG002|NOT COMPLETED|Overall Study||0
10058682|NCT02083679|11183918|FG003|NOT COMPLETED|Overall Study||0
10058683|NCT02083783|11183930|FG000|STARTED|Overall Study||52
10058684|NCT02083783|11183931|FG001|STARTED|Overall Study||48
10058685|NCT02083783|11183930|FG000|COMPLETED|Overall Study||51
10058686|NCT02083783|11183931|FG001|COMPLETED|Overall Study||48
10058687|NCT02083783|11183930|FG000|NOT COMPLETED|Overall Study||1
10058688|NCT02083783|11183931|FG001|NOT COMPLETED|Overall Study||0
10058689|NCT02083809|11183941|FG000|STARTED|Overall Study||82
10058690|NCT02083809|11183942|FG001|STARTED|Overall Study||84
10058691|NCT02083809|11183941|FG000|COMPLETED|Overall Study||78
10058692|NCT02083809|11183942|FG001|COMPLETED|Overall Study||82
10058693|NCT02083809|11183941|FG000|NOT COMPLETED|Overall Study||4
10058694|NCT02083809|11183942|FG001|NOT COMPLETED|Overall Study||2
10058695|NCT02083861|11183950|FG000|STARTED|Overall Study||57
10058696|NCT02083861|11183951|FG001|STARTED|Overall Study||36
10058697|NCT02083861|11183950|FG000|Treated|Overall Study||55
10058698|NCT02083861|11183951|FG001|Treated|Overall Study||35
10058699|NCT02083861|11183950|FG000|COMPLETED|Overall Study||51
10058700|NCT02083861|11183951|FG001|COMPLETED|Overall Study||33
10058701|NCT02083861|11183950|FG000|NOT COMPLETED|Overall Study||6
10058702|NCT02083861|11183951|FG001|NOT COMPLETED|Overall Study||3
10058703|NCT02083926|11183961|FG000|STARTED|Overall Study||9
10058704|NCT02083926|11183962|FG001|STARTED|Overall Study||9
10058705|NCT02083926|11183961|FG000|COMPLETED|Overall Study||8
10058706|NCT02083926|11183962|FG001|COMPLETED|Overall Study||9
10058707|NCT02083926|11183961|FG000|NOT COMPLETED|Overall Study||1
10058708|NCT02083926|11183962|FG001|NOT COMPLETED|Overall Study||0
10058709|NCT02083965|11183971|FG000|STARTED|PK Period 1||10
10058710|NCT02083965|11183972|FG001|STARTED|PK Period 1||9
10058711|NCT02083965|11183971|FG000|COMPLETED|PK Period 1||10
10058712|NCT02083965|11183972|FG001|COMPLETED|PK Period 1||9
10058713|NCT02083965|11183971|FG000|NOT COMPLETED|PK Period 1||0
10058714|NCT02083965|11183972|FG001|NOT COMPLETED|PK Period 1||0
10058715|NCT02083965|11183971|FG000|STARTED|Washout Period||10
10058716|NCT02083965|11183972|FG001|STARTED|Washout Period||9
10058717|NCT02083965|11183971|FG000|COMPLETED|Washout Period||10
10058718|NCT02083965|11183972|FG001|COMPLETED|Washout Period||9
10058719|NCT02083965|11183971|FG000|NOT COMPLETED|Washout Period||0
10058720|NCT02083965|11183972|FG001|NOT COMPLETED|Washout Period||0
10058721|NCT02083965|11183971|FG000|STARTED|PK Period 2||10
10058722|NCT02083965|11183972|FG001|STARTED|PK Period 2||9
10058723|NCT02083965|11183971|FG000|COMPLETED|PK Period 2||10
10058724|NCT02083965|11183972|FG001|COMPLETED|PK Period 2||9
10058725|NCT02083965|11183971|FG000|NOT COMPLETED|PK Period 2||0
10058726|NCT02083965|11183972|FG001|NOT COMPLETED|PK Period 2||0
10058727|NCT02083965|11183971|FG000|STARTED|Treatment Period||10
10058728|NCT02083965|11183972|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
10058729|NCT02083965|11183971|FG000|COMPLETED|Treatment Period||9
10058730|NCT02083965|11183972|FG001|COMPLETED|Treatment Period||8
10058731|NCT02083965|11183971|FG000|NOT COMPLETED|Treatment Period||1
10058732|NCT02083965|11183972|FG001|NOT COMPLETED|Treatment Period||0
10058733|NCT02084056|11183982|FG000|STARTED|Treatment Period 1 (4 Days)||28
10058734|NCT02084056|11183983|FG001|STARTED|Treatment Period 1 (4 Days)||30
10058735|NCT02084056|11183984|FG002|STARTED|Treatment Period 1 (4 Days)||8
10058736|NCT02084056|11183985|FG003|STARTED|Treatment Period 1 (4 Days)||8
10058737|NCT02084056|11183982|FG000|COMPLETED|Treatment Period 1 (4 Days)||27
10058738|NCT02084056|11183983|FG001|COMPLETED|Treatment Period 1 (4 Days)||30
10058739|NCT02084056|11183984|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
10058740|NCT02084056|11183985|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
10058741|NCT02084056|11183982|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1
10058742|NCT02084056|11183983|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10058743|NCT02084056|11183984|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10058744|NCT02084056|11183985|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10058745|NCT02084056|11183982|FG000|STARTED|Washout Period 1 (35 Days)||27
10058746|NCT02084056|11183983|FG001|STARTED|Washout Period 1 (35 Days)||30
10058747|NCT02084056|11183984|FG002|STARTED|Washout Period 1 (35 Days)||8
10058748|NCT02084056|11183985|FG003|STARTED|Washout Period 1 (35 Days)||8
10058749|NCT02084056|11183982|FG000|COMPLETED|Washout Period 1 (35 Days)||26
10121507|NCT02568254|11252537|FG005|STARTED|Period 2||12
10121508|NCT02568254|11252532|FG000|COMPLETED|Period 2||13
10121509|NCT02568254|11252533|FG001|COMPLETED|Period 2||12
10121510|NCT02568254|11252534|FG002|COMPLETED|Period 2||12
10121511|NCT02568254|11252535|FG003|COMPLETED|Period 2||12
10121512|NCT02568254|11252536|FG004|COMPLETED|Period 2||12
10121513|NCT02568254|11252537|FG005|COMPLETED|Period 2||12
10121514|NCT02568254|11252532|FG000|NOT COMPLETED|Period 2||0
10121515|NCT02568254|11252533|FG001|NOT COMPLETED|Period 2||0
10121516|NCT02568254|11252534|FG002|NOT COMPLETED|Period 2||1
10121517|NCT02568254|11252535|FG003|NOT COMPLETED|Period 2||0
10121518|NCT02568254|11252536|FG004|NOT COMPLETED|Period 2||0
10121519|NCT02568254|11252537|FG005|NOT COMPLETED|Period 2||0
10121520|NCT02568254|11252532|FG000|STARTED|Period 3||13
10121521|NCT02568254|11252533|FG001|STARTED|Period 3||12
10121522|NCT02568254|11252534|FG002|STARTED|Period 3||12
10121523|NCT02568254|11252535|FG003|STARTED|Period 3||12
10121524|NCT02568254|11252536|FG004|STARTED|Period 3||12
10121525|NCT02568254|11252537|FG005|STARTED|Period 3||12
10121526|NCT02568254|11252532|FG000|COMPLETED|Period 3||13
10121527|NCT02568254|11252533|FG001|COMPLETED|Period 3||12
10121528|NCT02568254|11252534|FG002|COMPLETED|Period 3||12
10121529|NCT02568254|11252535|FG003|COMPLETED|Period 3||12
10121530|NCT02568254|11252536|FG004|COMPLETED|Period 3||11
10121531|NCT02568254|11252537|FG005|COMPLETED|Period 3||12
10121532|NCT02568254|11252532|FG000|NOT COMPLETED|Period 3||0
10121533|NCT02568254|11252533|FG001|NOT COMPLETED|Period 3||0
10121534|NCT02568254|11252534|FG002|NOT COMPLETED|Period 3||0
10121535|NCT02568254|11252535|FG003|NOT COMPLETED|Period 3||0
10121536|NCT02568254|11252536|FG004|NOT COMPLETED|Period 3||1
10121537|NCT02568254|11252537|FG005|NOT COMPLETED|Period 3||0
10121538|NCT02568345|11252545|FG000|STARTED|Overall Study||31
10058750|NCT02084056|11183983|FG001|COMPLETED|Washout Period 1 (35 Days)||30
10058751|NCT02084056|11183984|FG002|COMPLETED|Washout Period 1 (35 Days)||8
10058752|NCT02084056|11183985|FG003|COMPLETED|Washout Period 1 (35 Days)||8
10058753|NCT02084056|11183982|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1
10058754|NCT02084056|11183983|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
10058755|NCT02084056|11183984|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0
10058756|NCT02084056|11183985|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0
10121539|NCT02568345|11252545|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
10121540|NCT02568345|11252545|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
10121541|NCT02568345|11252545|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
10121542|NCT02568345|11252545|FG000|COMPLETED|Overall Study||31
10121543|NCT02568345|11252545|FG000|NOT COMPLETED|Overall Study||0
10121544|NCT02568384|11252549|FG000|STARTED|Overall Study||45
10121545|NCT02568384|11252549|FG000|COMPLETED|Overall Study||43
10121546|NCT02568384|11252549|FG000|NOT COMPLETED|Overall Study||2
10121547|NCT02568397|11252553|FG000|STARTED|Period 1||60
10058757|NCT02084056|11183982|FG000|STARTED|Treatment Period 2 (4 Days)||26
10058758|NCT02084056|11183983|FG001|STARTED|Treatment Period 2 (4 Days)||30
10058759|NCT02084056|11183984|FG002|STARTED|Treatment Period 2 (4 Days)||8
10058760|NCT02084056|11183985|FG003|STARTED|Treatment Period 2 (4 Days)||8
10058761|NCT02084056|11183982|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
10058762|NCT02084056|11183983|FG001|COMPLETED|Treatment Period 2 (4 Days)||30
10058763|NCT02084056|11183984|FG002|COMPLETED|Treatment Period 2 (4 Days)||8
10058764|NCT02084056|11183985|FG003|COMPLETED|Treatment Period 2 (4 Days)||8
10058765|NCT02084056|11183982|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058766|NCT02084056|11183983|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058767|NCT02084056|11183984|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058768|NCT02084056|11183985|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058769|NCT02084069|11183997|FG000|STARTED|Overall Study||29
10058770|NCT02084069|11183998|FG001|STARTED|Overall Study||29
10058771|NCT02084069|11183997|FG000|COMPLETED|Overall Study||29
10058772|NCT02084069|11183998|FG001|COMPLETED|Overall Study||29
10058773|NCT02084069|11183997|FG000|NOT COMPLETED|Overall Study||0
10058774|NCT02084069|11183998|FG001|NOT COMPLETED|Overall Study||0
10058775|NCT02084082|11184006|FG000|STARTED|Treatment Period 1 (4 Days)||26
10058776|NCT02084082|11184007|FG001|STARTED|Treatment Period 1 (4 Days)||26
10058777|NCT02084082|11184008|FG002|STARTED|Treatment Period 1 (4 Days)||8
10058778|NCT02084082|11184009|FG003|STARTED|Treatment Period 1 (4 Days)||8
10058779|NCT02084082|11184006|FG000|COMPLETED|Treatment Period 1 (4 Days)||26
10058780|NCT02084082|11184007|FG001|COMPLETED|Treatment Period 1 (4 Days)||26
10058781|NCT02084082|11184008|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
10058782|NCT02084082|11184009|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
10058783|NCT02084082|11184006|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10058784|NCT02084082|11184007|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10058785|NCT02084082|11184008|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10058786|NCT02084082|11184009|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10058787|NCT02084082|11184006|FG000|STARTED|Washout Period 1 (35 Days)||26
10058788|NCT02084082|11184007|FG001|STARTED|Washout Period 1 (35 Days)||26
10058789|NCT02084082|11184008|FG002|STARTED|Washout Period 1 (35 Days)||8
10058790|NCT02084082|11184009|FG003|STARTED|Washout Period 1 (35 Days)||8
10058791|NCT02084082|11184006|FG000|COMPLETED|Washout Period 1 (35 Days)||26
10058792|NCT02084082|11184007|FG001|COMPLETED|Washout Period 1 (35 Days)||26
10058793|NCT02084082|11184008|FG002|COMPLETED|Washout Period 1 (35 Days)||7
10058794|NCT02084082|11184009|FG003|COMPLETED|Washout Period 1 (35 Days)||6
10058795|NCT02084082|11184006|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0
10058796|NCT02084082|11184007|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
10058797|NCT02084082|11184008|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1
10058798|NCT02084082|11184009|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2
10058799|NCT02084082|11184006|FG000|STARTED|Treatment Period 2 (4 Days)||26
10058800|NCT02084082|11184007|FG001|STARTED|Treatment Period 2 (4 Days)||26
10058801|NCT02084082|11184008|FG002|STARTED|Treatment Period 2 (4 Days)||7
10058802|NCT02084082|11184009|FG003|STARTED|Treatment Period 2 (4 Days)||6
10058803|NCT02084082|11184006|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
10058804|NCT02084082|11184007|FG001|COMPLETED|Treatment Period 2 (4 Days)||26
10058805|NCT02084082|11184008|FG002|COMPLETED|Treatment Period 2 (4 Days)||7
10058806|NCT02084082|11184009|FG003|COMPLETED|Treatment Period 2 (4 Days)||6
10058807|NCT02084082|11184006|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058808|NCT02084082|11184007|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058809|NCT02084082|11184008|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058810|NCT02084082|11184009|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10058811|NCT02084134|11184021|FG000|STARTED|Overall Study||23
10121548|NCT02568397|11252554|FG001|STARTED|Period 1||0
10121549|NCT02568397|11252553|FG000|Received at Least 1 Dose of Study Drug|Period 1||60
10121550|NCT02568397|11252554|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
10121551|NCT02568397|11252553|FG000|COMPLETED|Period 1||60
10121552|NCT02568397|11252554|FG001|COMPLETED|Period 1||0
10121553|NCT02568397|11252553|FG000|NOT COMPLETED|Period 1||0
10121554|NCT02568397|11252554|FG001|NOT COMPLETED|Period 1||0
10121555|NCT02568397|11252553|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
10121556|NCT02568397|11252554|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
10121557|NCT02568397|11252553|FG000|COMPLETED|Period 2||0
10121558|NCT02568397|11252554|FG001|COMPLETED|Period 2||58
10121559|NCT02568397|11252553|FG000|NOT COMPLETED|Period 2||0
10121560|NCT02568397|11252554|FG001|NOT COMPLETED|Period 2||2
10121561|NCT02568475|11252571|FG000|STARTED|Overall Study||97
10121562|NCT02568475|11252572|FG001|STARTED|Overall Study||95
10121563|NCT02568475|11252571|FG000|Post-test|Overall Study||85
10121564|NCT02568475|11252572|FG001|Post-test|Overall Study||82
10121565|NCT02568475|11252571|FG000|COMPLETED|Overall Study||46
10121566|NCT02568475|11252572|FG001|COMPLETED|Overall Study||52
10058812|NCT02084134|11184022|FG001|STARTED|Overall Study||20
10058813|NCT02084134|11184021|FG000|COMPLETED|Overall Study||19
10058814|NCT02084134|11184022|FG001|COMPLETED|Overall Study||17
10058815|NCT02084134|11184021|FG000|NOT COMPLETED|Overall Study||4
10058816|NCT02084134|11184022|FG001|NOT COMPLETED|Overall Study||3
10058817|NCT02084160|11184028|FG000|STARTED|Overall Study||579
10058818|NCT02084160|11184028|FG000|COMPLETED|Overall Study||579
10058819|NCT02084160|11184028|FG000|NOT COMPLETED|Overall Study||0
10121567|NCT02568475|11252571|FG000|NOT COMPLETED|Overall Study||51
10121568|NCT02568475|11252572|FG001|NOT COMPLETED|Overall Study||43
10058820|NCT02084238|11184032|FG000|STARTED|Overall Study||40
10058821|NCT02084238|11184032|FG000|COMPLETED|Overall Study||38
10058822|NCT02084238|11184032|FG000|NOT COMPLETED|Overall Study||2
10058823|NCT02084511|11184047|FG000|STARTED|Overall Study||20
10058824|NCT02084511|11184048|FG001|STARTED|Overall Study||20
10058825|NCT02084511|11184049|FG002|STARTED|Overall Study||20
10058826|NCT02084511|11184050|FG003|STARTED|Overall Study||20
10058827|NCT02084511|11184047|FG000|COMPLETED|Overall Study||20
10058828|NCT02084511|11184048|FG001|COMPLETED|Overall Study||20
10058829|NCT02084511|11184049|FG002|COMPLETED|Overall Study||20
10058830|NCT02084511|11184050|FG003|COMPLETED|Overall Study||20
10058831|NCT02084511|11184047|FG000|NOT COMPLETED|Overall Study||0
10058832|NCT02084511|11184048|FG001|NOT COMPLETED|Overall Study||0
10058833|NCT02084511|11184049|FG002|NOT COMPLETED|Overall Study||0
10058834|NCT02084511|11184050|FG003|NOT COMPLETED|Overall Study||0
10121569|NCT02568644|11252580|FG000|STARTED|Overall Study||30
10121570|NCT02568644|11252581|FG001|STARTED|Overall Study||30
10121571|NCT02568644|11252580|FG000|COMPLETED|Overall Study||30
10121572|NCT02568644|11252581|FG001|COMPLETED|Overall Study||30
10121573|NCT02568644|11252580|FG000|NOT COMPLETED|Overall Study||0
10121574|NCT02568644|11252581|FG001|NOT COMPLETED|Overall Study||0
10121575|NCT02568683|11252591|FG000|STARTED|Overall Study||6
10121576|NCT02568683|11252592|FG001|STARTED|Overall Study||4
10121577|NCT02568683|11252591|FG000|COMPLETED|Overall Study||0
10121578|NCT02568683|11252592|FG001|COMPLETED|Overall Study||0
10121579|NCT02568683|11252591|FG000|NOT COMPLETED|Overall Study||6
10121580|NCT02568683|11252592|FG001|NOT COMPLETED|Overall Study||4
10121581|NCT02568852|11252600|FG000|STARTED|Overall Study||25
10121582|NCT02568852|11252601|FG001|STARTED|Overall Study||25
10121583|NCT02568852|11252600|FG000|COMPLETED|Overall Study||25
10121584|NCT02568852|11252601|FG001|COMPLETED|Overall Study||25
10121585|NCT02568852|11252600|FG000|NOT COMPLETED|Overall Study||0
10121586|NCT02568852|11252601|FG001|NOT COMPLETED|Overall Study||0
10121587|NCT02569086|11252607|FG000|STARTED|Overall Study||22
10121588|NCT02569086|11252607|FG000|COMPLETED|Overall Study||22
10121589|NCT02569086|11252607|FG000|NOT COMPLETED|Overall Study||0
10121590|NCT02569112|11252611|FG000|STARTED|Overall Study||10
10121591|NCT02569112|11252612|FG001|STARTED|Overall Study||10
10121592|NCT02569112|11252611|FG000|COMPLETED|Overall Study||10
10121593|NCT02569112|11252612|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
10121594|NCT02569112|11252611|FG000|NOT COMPLETED|Overall Study||0
10121595|NCT02569112|11252612|FG001|NOT COMPLETED|Overall Study||0
10121596|NCT02569398|11252620|FG000|STARTED|Overall Study||185
10121597|NCT02569398|11252621|FG001|STARTED|Overall Study||189
10121598|NCT02569398|11252622|FG002|STARTED|Overall Study||183
10121599|NCT02569398|11252620|FG000|COMPLETED|Overall Study||0
10121600|NCT02569398|11252621|FG001|COMPLETED|Overall Study||0
10121601|NCT02569398|11252622|FG002|COMPLETED|Overall Study||0
10121602|NCT02569398|11252620|FG000|NOT COMPLETED|Overall Study||185
10121603|NCT02569398|11252621|FG001|NOT COMPLETED|Overall Study||189
10121604|NCT02569398|11252622|FG002|NOT COMPLETED|Overall Study||183
10121605|NCT02569411|11252632|FG000|STARTED|Overall Study||65
10121606|NCT02569411|11252633|FG001|STARTED|Overall Study||64
10121607|NCT02569411|11252632|FG000|COMPLETED|Overall Study||0
10121608|NCT02569411|11252633|FG001|COMPLETED|Overall Study||0
10121609|NCT02569411|11252632|FG000|NOT COMPLETED|Overall Study||65
10121610|NCT02569411|11252633|FG001|NOT COMPLETED|Overall Study||64
10121611|NCT02569437|11252641|FG000|STARTED|Overall Study||24
10121612|NCT02569437|11252642|FG001|STARTED|Overall Study||25
10121613|NCT02569437|11252641|FG000|COMPLETED|Overall Study||12
10121614|NCT02569437|11252642|FG001|COMPLETED|Overall Study||11
10121615|NCT02569437|11252641|FG000|NOT COMPLETED|Overall Study||12
10121616|NCT02569437|11252642|FG001|NOT COMPLETED|Overall Study||14
10121617|NCT02569541|11252648|FG000|STARTED|Overall Study||30
10121618|NCT02569541|11252648|FG000|COMPLETED|Overall Study||9
10121619|NCT02569541|11252648|FG000|NOT COMPLETED|Overall Study||21
10121620|NCT02569632|11252652|FG000|STARTED|Overall Study||18
10121621|NCT02569632|11252652|FG000|COMPLETED|Overall Study||17
10121622|NCT02569632|11252652|FG000|NOT COMPLETED|Overall Study||1
10121623|NCT02569658|11252658|FG000|STARTED|Overall Study||53
10121624|NCT02569658|11252659|FG001|STARTED|Overall Study||57
10121625|NCT02569658|11252658|FG000|COMPLETED|Overall Study||52
10121626|NCT02569658|11252659|FG001|COMPLETED|Overall Study||56
10121627|NCT02569658|11252658|FG000|NOT COMPLETED|Overall Study||1
9848653|NCT00860847|10961406|FG001|STARTED|Overall Study||33
9848654|NCT00860847|10961405|FG000|COMPLETED|Overall Study||28
10058835|NCT02084628|11184060|FG000|STARTED|Overall Study||1
10058836|NCT02084628|11184060|FG000|COMPLETED|Overall Study||1
10058837|NCT02084628|11184060|FG000|NOT COMPLETED|Overall Study||0
10121628|NCT02569658|11252659|FG001|NOT COMPLETED|Overall Study||1
10121629|NCT02569710|11252675|FG000|STARTED|Overall Study||20
10121630|NCT02569710|11252676|FG001|STARTED|Overall Study||25
10058838|NCT02084706|11184066|FG000|STARTED|Overall Study||29
10058839|NCT02084706|11184067|FG001|STARTED|Overall Study||31
10058840|NCT02084706|11184066|FG000|COMPLETED|Overall Study||29
10121631|NCT02569710|11252677|FG002|STARTED|Overall Study||20
10121632|NCT02569710|11252678|FG003|STARTED|Overall Study||20
10121633|NCT02569710|11252679|FG004|STARTED|Overall Study||8
10121634|NCT02569710|11252680|FG005|STARTED|Overall Study||5
10121635|NCT02569710|11252681|FG006|STARTED|Overall Study||14
10121636|NCT02569710|11252682|FG007|STARTED|Overall Study||30
10121637|NCT02569710|11252683|FG008|STARTED|Overall Study||15
10121638|NCT02569710|11252684|FG009|STARTED|Overall Study||4
10058841|NCT02084706|11184067|FG001|COMPLETED|Overall Study||31
10058842|NCT02084706|11184066|FG000|NOT COMPLETED|Overall Study||0
10058843|NCT02084706|11184067|FG001|NOT COMPLETED|Overall Study||0
10058844|NCT02084797|11184073|FG000|STARTED|Overall Study||10
10058845|NCT02084797|11184073|FG000|COMPLETED|Overall Study||10
10058846|NCT02084797|11184073|FG000|NOT COMPLETED|Overall Study||0
10058847|NCT02085070|11184079|FG000|STARTED|Overall Study||23
10058848|NCT02085070|11184080|FG001|STARTED|Overall Study||42
10058849|NCT02085070|11184079|FG000|COMPLETED|Overall Study||23
10058850|NCT02085070|11184080|FG001|COMPLETED|Overall Study||42
10058851|NCT02085070|11184079|FG000|NOT COMPLETED|Overall Study||0
10058852|NCT02085070|11184080|FG001|NOT COMPLETED|Overall Study||0
10058853|NCT02085135|11184088|FG000|STARTED|Overall Study||34
10058854|NCT02085135|11184089|FG001|STARTED|Overall Study||32
10058855|NCT02085135|11184088|FG000|COMPLETED|Overall Study||23
10058856|NCT02085135|11184089|FG001|COMPLETED|Overall Study||23
10058857|NCT02085135|11184088|FG000|NOT COMPLETED|Overall Study||11
10058858|NCT02085135|11184089|FG001|NOT COMPLETED|Overall Study||9
10058859|NCT02085161|11184099|FG000|STARTED|Overall Study||76
10058860|NCT02085161|11184100|FG001|STARTED|Overall Study||76
10058861|NCT02085161|11184101|FG002|STARTED|Overall Study||76
10058862|NCT02085161|11184102|FG003|STARTED|Overall Study||76
10058863|NCT02085161|11184099|FG000|COMPLETED|Overall Study||64
10058864|NCT02085161|11184100|FG001|COMPLETED|Overall Study||66
10058865|NCT02085161|11184101|FG002|COMPLETED|Overall Study||71
10058866|NCT02085161|11184102|FG003|COMPLETED|Overall Study||66
10058867|NCT02085161|11184099|FG000|NOT COMPLETED|Overall Study||12
10058868|NCT02085161|11184100|FG001|NOT COMPLETED|Overall Study||10
10058869|NCT02085161|11184101|FG002|NOT COMPLETED|Overall Study||5
10058870|NCT02085161|11184102|FG003|NOT COMPLETED|Overall Study||10
10058871|NCT02085252|11184115|FG000|STARTED|Overall Study||58
10058872|NCT02085252|11184116|FG001|STARTED|Overall Study||57
10058873|NCT02085252|11184115|FG000|COMPLETED|Overall Study||57
10058874|NCT02085252|11184116|FG001|COMPLETED|Overall Study||53
10058875|NCT02085252|11184115|FG000|NOT COMPLETED|Overall Study||1
10058876|NCT02085252|11184116|FG001|NOT COMPLETED|Overall Study||4
10058877|NCT02085356|11184126|FG000|STARTED|Overall Study||577
10058878|NCT02085356|11184127|FG001|STARTED|Overall Study||348
10058879|NCT02085356|11184128|FG002|STARTED|Overall Study||681
10058880|NCT02085356|11184129|FG003|STARTED|Overall Study||361
10058881|NCT02085356|11184126|FG000|COMPLETED|Overall Study||577
10058882|NCT02085356|11184127|FG001|COMPLETED|Overall Study||348
10058883|NCT02085356|11184128|FG002|COMPLETED|Overall Study||681
10058884|NCT02085356|11184129|FG003|COMPLETED|Overall Study||361
10058885|NCT02085356|11184126|FG000|NOT COMPLETED|Overall Study||0
10058886|NCT02085356|11184127|FG001|NOT COMPLETED|Overall Study||0
10121639|NCT02569710|11252675|FG000|COMPLETED|Overall Study||19
10121640|NCT02569710|11252676|FG001|COMPLETED|Overall Study||25
9848655|NCT00860847|10961406|FG001|COMPLETED|Overall Study||28
9848656|NCT00860847|10961405|FG000|NOT COMPLETED|Overall Study||4
9848657|NCT00860847|10961406|FG001|NOT COMPLETED|Overall Study||5
9848658|NCT00860938|10961414|FG000|STARTED|Overall Study||45
9848659|NCT00860938|10961415|FG001|STARTED|Overall Study||45
9848660|NCT00860938|10961414|FG000|COMPLETED|Overall Study||31
9848661|NCT00860938|10961415|FG001|COMPLETED|Overall Study||37
9848662|NCT00860938|10961414|FG000|NOT COMPLETED|Overall Study||14
9848663|NCT00860938|10961415|FG001|NOT COMPLETED|Overall Study||8
9848664|NCT00860951|10961421|FG000|STARTED|Overall Study||29
10121641|NCT02569710|11252677|FG002|COMPLETED|Overall Study||20
10121642|NCT02569710|11252678|FG003|COMPLETED|Overall Study||20
10121643|NCT02569710|11252679|FG004|COMPLETED|Overall Study||7
10121644|NCT02569710|11252680|FG005|COMPLETED|Overall Study||4
10121645|NCT02569710|11252681|FG006|COMPLETED|Overall Study||12
10121646|NCT02569710|11252682|FG007|COMPLETED|Overall Study||30
10121647|NCT02569710|11252683|FG008|COMPLETED|Overall Study||14
10121648|NCT02569710|11252684|FG009|COMPLETED|Overall Study||4
10121649|NCT02569710|11252675|FG000|NOT COMPLETED|Overall Study||1
10121650|NCT02569710|11252676|FG001|NOT COMPLETED|Overall Study||0
10121651|NCT02569710|11252677|FG002|NOT COMPLETED|Overall Study||0
10121652|NCT02569710|11252678|FG003|NOT COMPLETED|Overall Study||0
10121653|NCT02569710|11252679|FG004|NOT COMPLETED|Overall Study||1
10121654|NCT02569710|11252680|FG005|NOT COMPLETED|Overall Study||1
10121655|NCT02569710|11252681|FG006|NOT COMPLETED|Overall Study||2
10121656|NCT02569710|11252682|FG007|NOT COMPLETED|Overall Study||0
10121657|NCT02569710|11252683|FG008|NOT COMPLETED|Overall Study||1
10121658|NCT02569710|11252684|FG009|NOT COMPLETED|Overall Study||0
10121659|NCT02569723|11252717|FG000|STARTED|Overall Study||6
10121660|NCT02569723|11252717|FG000|COMPLETED|Overall Study||6
10121661|NCT02569723|11252717|FG000|NOT COMPLETED|Overall Study||0
10121662|NCT02569801|11252723|FG000|STARTED|Overall Study||36
10121663|NCT02569801|11252724|FG001|STARTED|Overall Study||35
10121664|NCT02569801|11252723|FG000|Received Treatment|Overall Study||35
10121665|NCT02569801|11252724|FG001|Received Treatment|Overall Study||35
10121666|NCT02569801|11252723|FG000|COMPLETED|Overall Study||0
10121667|NCT02569801|11252724|FG001|COMPLETED|Overall Study||0
10058887|NCT02085356|11184128|FG002|NOT COMPLETED|Overall Study||0
10058888|NCT02085356|11184129|FG003|NOT COMPLETED|Overall Study||0
10058889|NCT02085447|11184139|FG000|STARTED|Overall Study||30
10121668|NCT02569801|11252723|FG000|NOT COMPLETED|Overall Study||36
10121669|NCT02569801|11252724|FG001|NOT COMPLETED|Overall Study||35
10121670|NCT02569853|11252732|FG000|STARTED|Overall Study||131
10121671|NCT02569853|11252733|FG001|STARTED|Overall Study||137
10058890|NCT02085447|11184139|FG000|COMPLETED|Overall Study||26
10058891|NCT02085447|11184139|FG000|NOT COMPLETED|Overall Study||4
10058892|NCT02085460|11184147|FG000|STARTED|Overall Study||31
10058893|NCT02085460|11184148|FG001|STARTED|Overall Study||32
10058894|NCT02085460|11184149|FG002|STARTED|Overall Study||31
10058895|NCT02085460|11184147|FG000|COMPLETED|Overall Study||17
10058896|NCT02085460|11184148|FG001|COMPLETED|Overall Study||24
10058897|NCT02085460|11184149|FG002|COMPLETED|Overall Study||21
10058898|NCT02085460|11184147|FG000|NOT COMPLETED|Overall Study||14
10058899|NCT02085460|11184148|FG001|NOT COMPLETED|Overall Study||8
10058900|NCT02085460|11184149|FG002|NOT COMPLETED|Overall Study||10
10058901|NCT02085473|11184161|FG000|STARTED|Overall Study||15
10058902|NCT02085473|11184162|FG001|STARTED|Overall Study||15
10058903|NCT02085473|11184163|FG002|STARTED|Overall Study||15
10058904|NCT02085473|11184164|FG003|STARTED|Overall Study||15
10058905|NCT02085473|11184161|FG000|COMPLETED|Overall Study||15
10058906|NCT02085473|11184162|FG001|COMPLETED|Overall Study||15
10058907|NCT02085473|11184163|FG002|COMPLETED|Overall Study||15
10121672|NCT02569853|11252732|FG000|COMPLETED|Overall Study||111
10121673|NCT02569853|11252733|FG001|COMPLETED|Overall Study||123
10121674|NCT02569853|11252732|FG000|NOT COMPLETED|Overall Study||20
10121675|NCT02569853|11252733|FG001|NOT COMPLETED|Overall Study||14
10121676|NCT02569892|11252741|FG000|STARTED|Overall Study||10
10121677|NCT02569892|11252742|FG001|STARTED|Overall Study||9
10121678|NCT02569892|11252741|FG000|COMPLETED|Overall Study||10
10121679|NCT02569892|11252742|FG001|COMPLETED|Overall Study||8
10121680|NCT02569892|11252741|FG000|NOT COMPLETED|Overall Study||0
10121681|NCT02569892|11252742|FG001|NOT COMPLETED|Overall Study||1
10121682|NCT02569996|11252748|FG000|STARTED|Overall Study||124
10121683|NCT02569996|11252748|FG000|COMPLETED|Overall Study||69
10121684|NCT02569996|11252748|FG000|NOT COMPLETED|Overall Study||55
10121685|NCT02570022|11252754|FG000|STARTED|Overall Study||26
10121686|NCT02570022|11252755|FG001|STARTED|Overall Study||31
10121687|NCT02570022|11252754|FG000|COMPLETED|Overall Study||26
10121688|NCT02570022|11252755|FG001|COMPLETED|Overall Study||31
10121689|NCT02570022|11252754|FG000|NOT COMPLETED|Overall Study||0
10121690|NCT02570022|11252755|FG001|NOT COMPLETED|Overall Study||0
10121691|NCT02570074|11252763|FG000|STARTED|Period 1 (First Dosing Regimen)||9
10121692|NCT02570074|11252764|FG001|STARTED|Period 1 (First Dosing Regimen)||10
10121693|NCT02570074|11252763|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9
10121694|NCT02570074|11252764|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10
10121695|NCT02570074|11252763|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
10121696|NCT02570074|11252764|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
10121697|NCT02570074|11252763|FG000|STARTED|Period 2 (Second Dosing Regimen)||9
10121698|NCT02570074|11252764|FG001|STARTED|Period 2 (Second Dosing Regimen)||10
10121699|NCT02570074|11252763|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8
10121700|NCT02570074|11252764|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10
10121701|NCT02570074|11252763|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
10121702|NCT02570074|11252764|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
10121703|NCT02570126|11252784|FG000|STARTED|Overall Study||615
10121704|NCT02570126|11252785|FG001|STARTED|Overall Study||616
10121705|NCT02570126|11252784|FG000|COMPLETED|Overall Study||609
10121706|NCT02570126|11252785|FG001|COMPLETED|Overall Study||607
10121707|NCT02570126|11252784|FG000|NOT COMPLETED|Overall Study||6
10121708|NCT02570126|11252785|FG001|NOT COMPLETED|Overall Study||9
10121709|NCT02570139|11252793|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
10121710|NCT02570139|11252794|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
10121711|NCT02570139|11252793|FG000|COMPLETED|Overall Study||24
10121712|NCT02570139|11252794|FG001|COMPLETED|Overall Study||21
10121713|NCT02570139|11252793|FG000|NOT COMPLETED|Overall Study||0
10121714|NCT02570139|11252794|FG001|NOT COMPLETED|Overall Study||0
10121715|NCT02570152|11252800|FG000|STARTED|Overall Study||2004
10121716|NCT02570152|11252800|FG000|COMPLETED|Overall Study||1989
10121717|NCT02570152|11252800|FG000|NOT COMPLETED|Overall Study||15
10121718|NCT02570165|11252811|FG000|STARTED|Overall Study||46
10121719|NCT02570165|11252812|FG001|STARTED|Overall Study||46
10121720|NCT02570165|11252813|FG002|STARTED|Overall Study||46
10121721|NCT02570165|11252814|FG003|STARTED|Overall Study||45
10121722|NCT02570165|11252815|FG004|STARTED|Overall Study||47
10121723|NCT02570165|11252816|FG005|STARTED|Overall Study||46
10121724|NCT02570165|11252817|FG006|STARTED|Overall Study||47
10121725|NCT02570165|11252811|FG000|COMPLETED|Overall Study||44
10121726|NCT02570165|11252812|FG001|COMPLETED|Overall Study||43
10121727|NCT02570165|11252813|FG002|COMPLETED|Overall Study||41
10121728|NCT02570165|11252814|FG003|COMPLETED|Overall Study||40
10121729|NCT02570165|11252815|FG004|COMPLETED|Overall Study||41
10121730|NCT02570165|11252816|FG005|COMPLETED|Overall Study||44
10121731|NCT02570165|11252817|FG006|COMPLETED|Overall Study||47
10121732|NCT02570165|11252811|FG000|NOT COMPLETED|Overall Study||2
10121733|NCT02570165|11252812|FG001|NOT COMPLETED|Overall Study||3
10121734|NCT02570165|11252813|FG002|NOT COMPLETED|Overall Study||5
10121735|NCT02570165|11252814|FG003|NOT COMPLETED|Overall Study||5
10121736|NCT02570165|11252815|FG004|NOT COMPLETED|Overall Study||6
10121737|NCT02570165|11252816|FG005|NOT COMPLETED|Overall Study||2
10121738|NCT02570165|11252817|FG006|NOT COMPLETED|Overall Study||0
10196188|NCT03358407|11324486|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196189|NCT03358407|11324477|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10058908|NCT02085473|11184164|FG003|COMPLETED|Overall Study||15
10058909|NCT02085473|11184161|FG000|NOT COMPLETED|Overall Study||0
10058910|NCT02085473|11184162|FG001|NOT COMPLETED|Overall Study||0
10058911|NCT02085473|11184163|FG002|NOT COMPLETED|Overall Study||0
10058912|NCT02085473|11184164|FG003|NOT COMPLETED|Overall Study||0
10058913|NCT02085551|11184174|FG000|STARTED|Overall Study||85
10058914|NCT02085551|11184174|FG000|COMPLETED|Overall Study||85
10058915|NCT02085551|11184174|FG000|NOT COMPLETED|Overall Study||0
10058916|NCT02085720|11184178|FG000|STARTED|Overall Study||819
10058917|NCT02085720|11184178|FG000|COMPLETED|Overall Study||819
10058918|NCT02085720|11184178|FG000|NOT COMPLETED|Overall Study||0
10058919|NCT02085785|11184188|FG000|STARTED|Overall Study||7
10058920|NCT02085785|11184189|FG001|STARTED|Overall Study||8
10058921|NCT02085785|11184188|FG000|COMPLETED|Overall Study||5
10058922|NCT02085785|11184189|FG001|COMPLETED|Overall Study||6
10058923|NCT02085785|11184188|FG000|NOT COMPLETED|Overall Study||2
10058924|NCT02085785|11184189|FG001|NOT COMPLETED|Overall Study||2
10058925|NCT02085980|11184197|FG000|STARTED|Overall Study||30
10058926|NCT02085980|11184197|FG000|COMPLETED|Overall Study||27
10058927|NCT02085980|11184197|FG000|NOT COMPLETED|Overall Study||3
10058928|NCT02086110|11184203|FG000|STARTED|Overall Study||5
10058929|NCT02086110|11184204|FG001|STARTED|Overall Study||6
10058930|NCT02086110|11184203|FG000|COMPLETED|Overall Study||4
10058931|NCT02086110|11184204|FG001|COMPLETED|Overall Study||5
10058932|NCT02086110|11184203|FG000|NOT COMPLETED|Overall Study||1
10058933|NCT02086110|11184204|FG001|NOT COMPLETED|Overall Study||1
10058934|NCT02086162|11184213|FG000|STARTED|Overall Study||78
10058935|NCT02086162|11184214|FG001|STARTED|Overall Study||84
10058936|NCT02086162|11184213|FG000|COMPLETED|Overall Study||68
10058937|NCT02086162|11184214|FG001|COMPLETED|Overall Study||77
10058938|NCT02086162|11184213|FG000|NOT COMPLETED|Overall Study||10
10121739|NCT02570295|11252835|FG000|STARTED|Overall Study||375
10121740|NCT02570295|11252836|FG001|STARTED|Overall Study||347
10121741|NCT02570295|11252835|FG000|COMPLETED|Overall Study||364
10121742|NCT02570295|11252836|FG001|COMPLETED|Overall Study||289
10121743|NCT02570295|11252835|FG000|NOT COMPLETED|Overall Study||11
10121744|NCT02570295|11252836|FG001|NOT COMPLETED|Overall Study||58
10058939|NCT02086162|11184214|FG001|NOT COMPLETED|Overall Study||7
10058940|NCT02086331|11184224|FG000|STARTED|Overall Study||5
10058941|NCT02086331|11184224|FG000|COMPLETED|Overall Study||5
10058942|NCT02086331|11184224|FG000|NOT COMPLETED|Overall Study||0
10058943|NCT02086500|11184239|FG000|STARTED|Overall Study||447
10058944|NCT02086500|11184240|FG001|STARTED|Overall Study||456
10058945|NCT02086500|11184239|FG000|COMPLETED|Overall Study||447
10058946|NCT02086500|11184240|FG001|COMPLETED|Overall Study||456
10058947|NCT02086500|11184239|FG000|NOT COMPLETED|Overall Study||0
10058948|NCT02086500|11184240|FG001|NOT COMPLETED|Overall Study||0
10121745|NCT02570425|11252844|FG000|STARTED|Visit 1||274
10121746|NCT02570425|11252845|FG001|STARTED|Visit 1||242
10121747|NCT02570425|11252844|FG000|COMPLETED|Visit 1||274
10121748|NCT02570425|11252845|FG001|COMPLETED|Visit 1||242
10121749|NCT02570425|11252844|FG000|NOT COMPLETED|Visit 1||0
10121750|NCT02570425|11252845|FG001|NOT COMPLETED|Visit 1||0
10121751|NCT02570425|11252844|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
10121752|NCT02570425|11252845|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
10121753|NCT02570425|11252844|FG000|COMPLETED|Visit 2||251
10121754|NCT02570425|11252845|FG001|COMPLETED|Visit 2||247
10121755|NCT02570425|11252844|FG000|NOT COMPLETED|Visit 2||0
10121756|NCT02570425|11252845|FG001|NOT COMPLETED|Visit 2||0
10121757|NCT02570425|11252844|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
10121758|NCT02570425|11252845|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
10121759|NCT02570425|11252844|FG000|COMPLETED|Visit 3||229
10121760|NCT02570425|11252845|FG001|COMPLETED|Visit 3||231
10121761|NCT02570425|11252844|FG000|NOT COMPLETED|Visit 3||0
10121762|NCT02570425|11252845|FG001|NOT COMPLETED|Visit 3||0
10121763|NCT02570711|11252856|FG000|STARTED|Overall Study||1
10121764|NCT02570711|11252857|FG001|STARTED|Overall Study||2
10121765|NCT02570711|11252856|FG000|COMPLETED|Overall Study||0
10121766|NCT02570711|11252857|FG001|COMPLETED|Overall Study||0
10121767|NCT02570711|11252856|FG000|NOT COMPLETED|Overall Study||1
10121768|NCT02570711|11252857|FG001|NOT COMPLETED|Overall Study||2
10121769|NCT02570750|11252865|FG000|STARTED|Overall Study||110
10121770|NCT02570750|11252866|FG001|STARTED|Overall Study||73
10121771|NCT02570750|11252865|FG000|COMPLETED|Overall Study||96
10121772|NCT02570750|11252866|FG001|COMPLETED|Overall Study||68
10121773|NCT02570750|11252865|FG000|NOT COMPLETED|Overall Study||14
10121774|NCT02570750|11252866|FG001|NOT COMPLETED|Overall Study||5
10121775|NCT02571049|11252872|FG000|STARTED|Screening||10
10121776|NCT02571049|11252873|FG001|STARTED|Screening||14
10121777|NCT02571049|11252872|FG000|COMPLETED|Screening||8
10121778|NCT02571049|11252873|FG001|COMPLETED|Screening||12
10121779|NCT02571049|11252872|FG000|NOT COMPLETED|Screening||2
10121780|NCT02571049|11252873|FG001|NOT COMPLETED|Screening||2
10121781|NCT02571049|11252872|FG000|STARTED|Randomization||8
10121782|NCT02571049|11252873|FG001|STARTED|Randomization||12
10121783|NCT02571049|11252872|FG000|COMPLETED|Randomization||8
10121784|NCT02571049|11252873|FG001|COMPLETED|Randomization||10
10121785|NCT02571049|11252872|FG000|NOT COMPLETED|Randomization||0
10121786|NCT02571049|11252873|FG001|NOT COMPLETED|Randomization||2
10121787|NCT02571075|11252881|FG000|STARTED|Overall Study||45
10121788|NCT02571075|11252882|FG001|STARTED|Overall Study||50
10121789|NCT02571075|11252881|FG000|COMPLETED|Overall Study||25
10121790|NCT02571075|11252882|FG001|COMPLETED|Overall Study||26
10058949|NCT02086565|11184248|FG000|STARTED|Overall Study||151
10058950|NCT02086565|11184249|FG001|STARTED|Overall Study||150
10058951|NCT02086565|11184248|FG000|COMPLETED|Overall Study||135
10058952|NCT02086565|11184249|FG001|COMPLETED|Overall Study||138
10058953|NCT02086565|11184248|FG000|NOT COMPLETED|Overall Study||16
10058954|NCT02086565|11184249|FG001|NOT COMPLETED|Overall Study||12
10058955|NCT02086591|11184255|FG000|STARTED|Overall Study||7
10058956|NCT02086591|11184255|FG000|COMPLETED|Overall Study||2
10058957|NCT02086591|11184255|FG000|NOT COMPLETED|Overall Study||5
10058958|NCT02086682|11184261|FG000|STARTED|Overall Study||156
10058959|NCT02086682|11184262|FG001|STARTED|Overall Study||182
10058960|NCT02086682|11184261|FG000|COMPLETED|Overall Study||156
10058961|NCT02086682|11184262|FG001|COMPLETED|Overall Study||182
10058962|NCT02086682|11184261|FG000|NOT COMPLETED|Overall Study||0
10058963|NCT02086682|11184262|FG001|NOT COMPLETED|Overall Study||0
10058964|NCT02086708|11184268|FG000|STARTED|Overall Study||24
10058965|NCT02086708|11184268|FG000|COMPLETED|Overall Study||24
10058966|NCT02086708|11184268|FG000|NOT COMPLETED|Overall Study||0
10058967|NCT02086786|11184282|FG000|STARTED|Overall Study||35
10058968|NCT02086786|11184283|FG001|STARTED|Overall Study||35
10058969|NCT02086786|11184282|FG000|COMPLETED|Overall Study||17
10058970|NCT02086786|11184283|FG001|COMPLETED|Overall Study||19
10058971|NCT02086786|11184282|FG000|NOT COMPLETED|Overall Study||18
10058972|NCT02086786|11184283|FG001|NOT COMPLETED|Overall Study||16
10058973|NCT02086968|11184293|FG000|STARTED|Overall Study||100
10058974|NCT02086968|11184294|FG001|STARTED|Overall Study||98
10058975|NCT02086968|11184293|FG000|COMPLETED|Overall Study||92
10058976|NCT02086968|11184294|FG001|COMPLETED|Overall Study||85
10058977|NCT02086968|11184293|FG000|NOT COMPLETED|Overall Study||8
10058978|NCT02086968|11184294|FG001|NOT COMPLETED|Overall Study||13
10058979|NCT02087046|11184300|FG000|STARTED|Overall Study||127
10058980|NCT02087046|11184300|FG000|Primary Endpoint|Overall Study||121
10058981|NCT02087046|11184300|FG000|COMPLETED|Overall Study||116
10058982|NCT02087046|11184300|FG000|NOT COMPLETED|Overall Study||11
10058983|NCT02087059|11184305|FG000|STARTED|Overall Study||51
10058984|NCT02087059|11184305|FG000|COMPLETED|Overall Study||44
10058985|NCT02087059|11184305|FG000|NOT COMPLETED|Overall Study||7
10058986|NCT02087085|11184311|FG000|STARTED|Overall Study||154
10058987|NCT02087085|11184312|FG001|STARTED|Overall Study||156
10058988|NCT02087085|11184311|FG000|COMPLETED|Overall Study||34
10058989|NCT02087085|11184312|FG001|COMPLETED|Overall Study||40
10058990|NCT02087085|11184311|FG000|NOT COMPLETED|Overall Study||120
10058991|NCT02087085|11184312|FG001|NOT COMPLETED|Overall Study||116
10058992|NCT02087150|11184321|FG000|STARTED|Overall Study||81
10058993|NCT02087150|11184322|FG001|STARTED|Overall Study||162
10058994|NCT02087150|11184323|FG002|STARTED|Overall Study||80
10058995|NCT02087150|11184321|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
10058996|NCT02087150|11184322|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
10058997|NCT02087150|11184323|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
10058998|NCT02087150|11184321|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0
10058999|NCT02087150|11184322|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0
10059000|NCT02087150|11184323|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70
10059001|NCT02087150|11184321|FG000|COMPLETED|Overall Study||71
10059002|NCT02087150|11184322|FG001|COMPLETED|Overall Study||128
10059003|NCT02087150|11184323|FG002|COMPLETED|Overall Study||69
10059004|NCT02087150|11184321|FG000|NOT COMPLETED|Overall Study||10
10059005|NCT02087150|11184322|FG001|NOT COMPLETED|Overall Study||34
10059006|NCT02087150|11184323|FG002|NOT COMPLETED|Overall Study||11
10059007|NCT02087163|11184332|FG000|STARTED|Overall Study||90
10059008|NCT02087163|11184332|FG000|COMPLETED|Overall Study||73
10059009|NCT02087163|11184332|FG000|NOT COMPLETED|Overall Study||17
10059010|NCT02087176|11184336|FG000|STARTED|Overall Study||32
10059011|NCT02087176|11184336|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0
10059012|NCT02087176|11184336|FG000|NOT COMPLETED|Overall Study||32
10059013|NCT02087241|11184344|FG000|STARTED|Overall Study||3
10059014|NCT02087241|11184345|FG001|STARTED|Overall Study||3
10059015|NCT02087241|11184346|FG002|STARTED|Overall Study||1
10059016|NCT02087241|11184347|FG003|STARTED|Overall Study||7
10059017|NCT02087241|11184344|FG000|COMPLETED|Overall Study||0
10059018|NCT02087241|11184345|FG001|COMPLETED|Overall Study||0
10059019|NCT02087241|11184346|FG002|COMPLETED|Overall Study||0
10059020|NCT02087241|11184347|FG003|COMPLETED|Overall Study||0
10059021|NCT02087241|11184344|FG000|NOT COMPLETED|Overall Study||3
10059022|NCT02087241|11184345|FG001|NOT COMPLETED|Overall Study||3
10059023|NCT02087241|11184346|FG002|NOT COMPLETED|Overall Study||1
10059024|NCT02087241|11184347|FG003|NOT COMPLETED|Overall Study||7
10059025|NCT02087306|11184364|FG000|STARTED|Overall Study||65
10059026|NCT02087306|11184365|FG001|STARTED|Overall Study||93
10059027|NCT02087306|11184366|FG002|STARTED|Overall Study||43
10059028|NCT02087306|11184364|FG000|COMPLETED|Overall Study||29
10059029|NCT02087306|11184365|FG001|COMPLETED|Overall Study||29
10059030|NCT02087306|11184366|FG002|COMPLETED|Overall Study||16
10059031|NCT02087306|11184364|FG000|NOT COMPLETED|Overall Study||36
10059032|NCT02087306|11184365|FG001|NOT COMPLETED|Overall Study||64
10059033|NCT02087306|11184366|FG002|NOT COMPLETED|Overall Study||27
10059034|NCT02087514|11184379|FG000|STARTED|Overall Study||10
10059035|NCT02087514|11184380|FG001|STARTED|Overall Study||10
10059036|NCT02087514|11184381|FG002|STARTED|Overall Study||10
10059037|NCT02087514|11184382|FG003|STARTED|Overall Study||10
10059038|NCT02087514|11184383|FG004|STARTED|Overall Study||10
10059039|NCT02087514|11184384|FG005|STARTED|Overall Study||10
10059040|NCT02087514|11184379|FG000|COMPLETED|Overall Study||8
10059041|NCT02087514|11184380|FG001|COMPLETED|Overall Study||10
10059042|NCT02087514|11184381|FG002|COMPLETED|Overall Study||7
10059043|NCT02087514|11184382|FG003|COMPLETED|Overall Study||8
10059044|NCT02087514|11184383|FG004|COMPLETED|Overall Study||10
10059045|NCT02087514|11184384|FG005|COMPLETED|Overall Study||9
10059046|NCT02087514|11184379|FG000|NOT COMPLETED|Overall Study||2
10059047|NCT02087514|11184380|FG001|NOT COMPLETED|Overall Study||0
10059048|NCT02087514|11184381|FG002|NOT COMPLETED|Overall Study||3
10059049|NCT02087514|11184382|FG003|NOT COMPLETED|Overall Study||2
10059050|NCT02087514|11184383|FG004|NOT COMPLETED|Overall Study||0
10059051|NCT02087514|11184384|FG005|NOT COMPLETED|Overall Study||1
10059052|NCT02087670|11184400|FG000|STARTED|Overall Study||20
10059053|NCT02087670|11184401|FG001|STARTED|Overall Study||22
10059054|NCT02087670|11184400|FG000|COMPLETED|Overall Study||17
10059055|NCT02087670|11184401|FG001|COMPLETED|Overall Study||20
10059056|NCT02087670|11184400|FG000|NOT COMPLETED|Overall Study||3
10059057|NCT02087670|11184401|FG001|NOT COMPLETED|Overall Study||2
10059058|NCT02087748|11184407|FG000|STARTED|Overall Study||24
10059059|NCT02087748|11184407|FG000|COMPLETED|Overall Study||24
10059060|NCT02087748|11184407|FG000|NOT COMPLETED|Overall Study||0
10059061|NCT02087774|11184417|FG000|STARTED|Overall Study||150
10059062|NCT02087774|11184418|FG001|STARTED|Overall Study||150
10059063|NCT02087774|11184417|FG000|COMPLETED|Overall Study||142
10059064|NCT02087774|11184418|FG001|COMPLETED|Overall Study||130
10059065|NCT02087774|11184417|FG000|NOT COMPLETED|Overall Study||8
10059066|NCT02087774|11184418|FG001|NOT COMPLETED|Overall Study||20
10059067|NCT02087904|11184428|FG000|STARTED|Overall Study||85
10059068|NCT02087904|11184429|FG001|STARTED|Overall Study||89
10059069|NCT02087904|11184430|FG002|STARTED|Overall Study||87
10059070|NCT02087904|11184431|FG003|STARTED|Overall Study||89
10059071|NCT02087904|11184428|FG000|COMPLETED|Overall Study||60
10059072|NCT02087904|11184429|FG001|COMPLETED|Overall Study||70
10059073|NCT02087904|11184430|FG002|COMPLETED|Overall Study||65
10059074|NCT02087904|11184431|FG003|COMPLETED|Overall Study||64
10059075|NCT02087904|11184428|FG000|NOT COMPLETED|Overall Study||25
10059076|NCT02087904|11184429|FG001|NOT COMPLETED|Overall Study||19
10059077|NCT02087904|11184430|FG002|NOT COMPLETED|Overall Study||22
10059078|NCT02087904|11184431|FG003|NOT COMPLETED|Overall Study||25
10059079|NCT02087943|11184444|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64
10059080|NCT02087943|11184445|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58
10059081|NCT02087943|11184446|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63
10059082|NCT02087943|11184447|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0
10059083|NCT02087943|11184448|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0
10059084|NCT02087943|11184444|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
10059085|NCT02087943|11184445|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
10059086|NCT02087943|11184446|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
10059087|NCT02087943|11184447|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0
10059088|NCT02087943|11184448|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0
10059089|NCT02087943|11184444|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
10059090|NCT02087943|11184445|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46
10059091|NCT02087943|11184446|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
10059092|NCT02087943|11184447|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0
10059093|NCT02087943|11184448|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0
10059094|NCT02087943|11184444|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
10059095|NCT02087943|11184445|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
10059096|NCT02087943|11184446|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
10059097|NCT02087943|11184447|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
10059098|NCT02087943|11184448|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
10059099|NCT02087943|11184444|FG000|STARTED|Active Treatment Phase Week 12-24||0
10059100|NCT02087943|11184445|FG001|STARTED|Active Treatment Phase Week 12-24||46
10059101|NCT02087943|11184446|FG002|STARTED|Active Treatment Phase Week 12-24||49
10059102|NCT02087943|11184447|FG003|STARTED|Active Treatment Phase Week 12-24||24
10059103|NCT02087943|11184448|FG004|STARTED|Active Treatment Phase Week 12-24||23
10059104|NCT02087943|11184444|FG000|COMPLETED|Active Treatment Phase Week 12-24||0
10059105|NCT02087943|11184445|FG001|COMPLETED|Active Treatment Phase Week 12-24||42
10059106|NCT02087943|11184446|FG002|COMPLETED|Active Treatment Phase Week 12-24||44
10059107|NCT02087943|11184447|FG003|COMPLETED|Active Treatment Phase Week 12-24||22
10059108|NCT02087943|11184448|FG004|COMPLETED|Active Treatment Phase Week 12-24||21
10059109|NCT02087943|11184444|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0
10059110|NCT02087943|11184445|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4
10059111|NCT02087943|11184446|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5
10059112|NCT02087943|11184447|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2
10059113|NCT02087943|11184448|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2
10059114|NCT02087943|11184444|FG000|STARTED|Observational Follow-up Phase Week 24-30||0
10059115|NCT02087943|11184445|FG001|STARTED|Observational Follow-up Phase Week 24-30||46
10059116|NCT02087943|11184446|FG002|STARTED|Observational Follow-up Phase Week 24-30||48
10059117|NCT02087943|11184447|FG003|STARTED|Observational Follow-up Phase Week 24-30||24
10059118|NCT02087943|11184448|FG004|STARTED|Observational Follow-up Phase Week 24-30||23
10059119|NCT02087943|11184444|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0
10059120|NCT02087943|11184445|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46
10059121|NCT02087943|11184446|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45
10059122|NCT02087943|11184447|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23
10059123|NCT02087943|11184448|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22
10059124|NCT02087943|11184444|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
10059125|NCT02087943|11184445|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
10059126|NCT02087943|11184446|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
10059127|NCT02087943|11184447|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
10059128|NCT02087943|11184448|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
10059129|NCT02087956|11184462|FG000|STARTED|Overall Study||111
10059130|NCT02087956|11184463|FG001|STARTED|Overall Study||112
10059131|NCT02087956|11184462|FG000|COMPLETED|Overall Study||105
10059132|NCT02087956|11184463|FG001|COMPLETED|Overall Study||107
10059133|NCT02087956|11184462|FG000|NOT COMPLETED|Overall Study||6
10059134|NCT02087956|11184463|FG001|NOT COMPLETED|Overall Study||5
10059135|NCT02087995|11184471|FG000|STARTED|Overall Study||51
10059136|NCT02087995|11184471|FG000|COMPLETED|Overall Study||51
10059137|NCT02087995|11184471|FG000|NOT COMPLETED|Overall Study||0
10059138|NCT02088034|11184478|FG000|STARTED|Overall Study||33
10059139|NCT02088034|11184479|FG001|STARTED|Overall Study||30
10059140|NCT02088034|11184480|FG002|STARTED|Overall Study||29
10059141|NCT02088034|11184478|FG000|COMPLETED|Overall Study||30
10059142|NCT02088034|11184479|FG001|COMPLETED|Overall Study||28
10059143|NCT02088034|11184480|FG002|COMPLETED|Overall Study||27
10059144|NCT02088034|11184478|FG000|NOT COMPLETED|Overall Study||3
10059145|NCT02088034|11184479|FG001|NOT COMPLETED|Overall Study||2
10059146|NCT02088034|11184480|FG002|NOT COMPLETED|Overall Study||2
10059147|NCT02088047|11184490|FG000|STARTED|Overall Study||3
10059148|NCT02088047|11184491|FG001|STARTED|Overall Study||1
10059149|NCT02088047|11184490|FG000|COMPLETED|Overall Study||2
10059150|NCT02088047|11184491|FG001|COMPLETED|Overall Study||1
10059151|NCT02088047|11184490|FG000|NOT COMPLETED|Overall Study||1
10059152|NCT02088047|11184491|FG001|NOT COMPLETED|Overall Study||0
10059153|NCT02088073|11184502|FG000|STARTED|Acute Phase||258
10059154|NCT02088073|11184503|FG001|STARTED|Acute Phase||0
10059155|NCT02088073|11184504|FG002|STARTED|Acute Phase||0
10059156|NCT02088073|11184505|FG003|STARTED|Acute Phase||0
10059157|NCT02088073|11184506|FG004|STARTED|Acute Phase||0
10059158|NCT02088073|11184502|FG000|COMPLETED|Acute Phase||251
10059159|NCT02088073|11184503|FG001|COMPLETED|Acute Phase||0
10059160|NCT02088073|11184504|FG002|COMPLETED|Acute Phase||0
10059161|NCT02088073|11184505|FG003|COMPLETED|Acute Phase||0
10059162|NCT02088073|11184506|FG004|COMPLETED|Acute Phase||0
10059163|NCT02088073|11184502|FG000|NOT COMPLETED|Acute Phase||7
10059164|NCT02088073|11184503|FG001|NOT COMPLETED|Acute Phase||0
10059165|NCT02088073|11184504|FG002|NOT COMPLETED|Acute Phase||0
10059166|NCT02088073|11184505|FG003|NOT COMPLETED|Acute Phase||0
10059167|NCT02088073|11184506|FG004|NOT COMPLETED|Acute Phase||0
10059168|NCT02088073|11184502|FG000|STARTED|Maintanance Phase||0
10059169|NCT02088073|11184503|FG001|STARTED|Maintanance Phase||85
10059170|NCT02088073|11184504|FG002|STARTED|Maintanance Phase||45
10059171|NCT02088073|11184505|FG003|STARTED|Maintanance Phase||51
10059172|NCT02088073|11184506|FG004|STARTED|Maintanance Phase||56
10059173|NCT02088073|11184502|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
10059174|NCT02088073|11184503|FG001|COMPLETED|Maintanance Phase||75
10059175|NCT02088073|11184504|FG002|COMPLETED|Maintanance Phase||40
10059176|NCT02088073|11184505|FG003|COMPLETED|Maintanance Phase||44
10059177|NCT02088073|11184506|FG004|COMPLETED|Maintanance Phase||49
10059178|NCT02088073|11184502|FG000|NOT COMPLETED|Maintanance Phase||0
10059179|NCT02088073|11184503|FG001|NOT COMPLETED|Maintanance Phase||10
10059180|NCT02088073|11184504|FG002|NOT COMPLETED|Maintanance Phase||5
10059181|NCT02088073|11184505|FG003|NOT COMPLETED|Maintanance Phase||7
10059182|NCT02088073|11184506|FG004|NOT COMPLETED|Maintanance Phase||7
10059183|NCT02088177|11184519|FG000|STARTED|Overall Study||12
10059184|NCT02088177|11184519|FG000|COMPLETED|Overall Study||9
10059185|NCT02088177|11184519|FG000|NOT COMPLETED|Overall Study||3
10059186|NCT02088216|11184525|FG000|STARTED|Overall Study||81
10059187|NCT02088216|11184526|FG001|STARTED|Overall Study||80
10059188|NCT02088216|11184525|FG000|COMPLETED|Overall Study||69
10059189|NCT02088216|11184526|FG001|COMPLETED|Overall Study||70
10059190|NCT02088216|11184525|FG000|NOT COMPLETED|Overall Study||12
10059191|NCT02088216|11184526|FG001|NOT COMPLETED|Overall Study||10
10059192|NCT02088385|11184534|FG000|STARTED|Overall Study||10
10059193|NCT02088385|11184535|FG001|STARTED|Overall Study||10
10059194|NCT02088385|11184534|FG000|COMPLETED|Overall Study||10
10059195|NCT02088385|11184535|FG001|COMPLETED|Overall Study||10
10059196|NCT02088385|11184534|FG000|NOT COMPLETED|Overall Study||0
10059197|NCT02088385|11184535|FG001|NOT COMPLETED|Overall Study||0
10059198|NCT02088541|11184546|FG000|STARTED|Overall Study||71
10059199|NCT02088541|11184547|FG001|STARTED|Overall Study||27
10059200|NCT02088541|11184548|FG002|STARTED|Overall Study||117
10059201|NCT02088541|11184549|FG003|STARTED|Overall Study||44
10059202|NCT02088541|11184550|FG004|STARTED|Overall Study||58
10059203|NCT02088541|11184546|FG000|Safety Population|Overall Study||71
10059204|NCT02088541|11184547|FG001|Safety Population|Overall Study||27
10059205|NCT02088541|11184548|FG002|Safety Population|Overall Study||115
10059206|NCT02088541|11184549|FG003|Safety Population|Overall Study||39
10059207|NCT02088541|11184550|FG004|Safety Population|Overall Study||45
10059208|NCT02088541|11184546|FG000|Intent-to-treat (ITT) Population|Overall Study||0
10059209|NCT02088541|11184547|FG001|Intent-to-treat (ITT) Population|Overall Study||0
10059210|NCT02088541|11184548|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
10059211|NCT02088541|11184549|FG003|Intent-to-treat (ITT) Population|Overall Study||0
10059212|NCT02088541|11184550|FG004|Intent-to-treat (ITT) Population|Overall Study||57
10059213|NCT02088541|11184546|FG000|COMPLETED|Overall Study||0
10059214|NCT02088541|11184547|FG001|COMPLETED|Overall Study||0
10059215|NCT02088541|11184548|FG002|COMPLETED|Overall Study||0
10059216|NCT02088541|11184549|FG003|COMPLETED|Overall Study||0
10059217|NCT02088541|11184550|FG004|COMPLETED|Overall Study||0
10059218|NCT02088541|11184546|FG000|NOT COMPLETED|Overall Study||71
10059219|NCT02088541|11184547|FG001|NOT COMPLETED|Overall Study||27
10059220|NCT02088541|11184548|FG002|NOT COMPLETED|Overall Study||117
10059221|NCT02088541|11184549|FG003|NOT COMPLETED|Overall Study||44
10059222|NCT02088541|11184550|FG004|NOT COMPLETED|Overall Study||58
10059223|NCT02088697|11184562|FG000|STARTED|Period I||25
10059224|NCT02088697|11184563|FG001|STARTED|Period I||25
10059225|NCT02088697|11184562|FG000|COMPLETED|Period I||24
10059226|NCT02088697|11184563|FG001|COMPLETED|Period I||21
10059227|NCT02088697|11184562|FG000|NOT COMPLETED|Period I||1
10059228|NCT02088697|11184563|FG001|NOT COMPLETED|Period I||4
10059229|NCT02088697|11184562|FG000|STARTED|Wash-out Period (at Least 10 Days)||24
10059230|NCT02088697|11184563|FG001|STARTED|Wash-out Period (at Least 10 Days)||21
10059231|NCT02088697|11184562|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23
10059232|NCT02088697|11184563|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21
10059233|NCT02088697|11184562|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
10059234|NCT02088697|11184563|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
10059235|NCT02088697|11184562|FG000|STARTED|Period II||23
10059236|NCT02088697|11184563|FG001|STARTED|Period II||21
10059237|NCT02088697|11184562|FG000|COMPLETED|Period II||23
10059238|NCT02088697|11184563|FG001|COMPLETED|Period II||21
10059239|NCT02088697|11184562|FG000|NOT COMPLETED|Period II||0
10059240|NCT02088697|11184563|FG001|NOT COMPLETED|Period II||0
10059241|NCT02088788|11184571|FG000|STARTED|Overall Study||135
10059242|NCT02088788|11184572|FG001|STARTED|Overall Study||130
10059243|NCT02088788|11184571|FG000|COMPLETED|Overall Study||105
10059244|NCT02088788|11184572|FG001|COMPLETED|Overall Study||89
10059245|NCT02088788|11184571|FG000|NOT COMPLETED|Overall Study||30
10059246|NCT02088788|11184572|FG001|NOT COMPLETED|Overall Study||41
10059247|NCT02088905|11184580|FG000|STARTED|Overall Study||13
10059248|NCT02088905|11184581|FG001|STARTED|Overall Study||10
10059249|NCT02088905|11184580|FG000|Week 9|Overall Study||10
10059250|NCT02088905|11184581|FG001|Week 9|Overall Study||9
10059251|NCT02088905|11184580|FG000|COMPLETED|Overall Study||8
10059252|NCT02088905|11184581|FG001|COMPLETED|Overall Study||9
10059253|NCT02088905|11184580|FG000|NOT COMPLETED|Overall Study||5
10059254|NCT02088905|11184581|FG001|NOT COMPLETED|Overall Study||1
10059255|NCT02089113|11184589|FG000|STARTED|Overall Study||161
10059256|NCT02089113|11184590|FG001|STARTED|Overall Study||80
10059257|NCT02089113|11184589|FG000|COMPLETED|Overall Study||160
10059258|NCT02089113|11184590|FG001|COMPLETED|Overall Study||80
10059259|NCT02089113|11184589|FG000|NOT COMPLETED|Overall Study||1
10059260|NCT02089113|11184590|FG001|NOT COMPLETED|Overall Study||0
10059261|NCT02089191|11184596|FG000|STARTED|Period 1, First 12 Hours||16
10059262|NCT02089191|11184597|FG001|STARTED|Period 1, First 12 Hours||15
10059263|NCT02089191|11184596|FG000|COMPLETED|Period 1, First 12 Hours||16
10059264|NCT02089191|11184597|FG001|COMPLETED|Period 1, First 12 Hours||15
10059265|NCT02089191|11184596|FG000|NOT COMPLETED|Period 1, First 12 Hours||0
10059266|NCT02089191|11184597|FG001|NOT COMPLETED|Period 1, First 12 Hours||0
10059267|NCT02089191|11184596|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
10059268|NCT02089191|11184597|FG001|STARTED|Period 2, Second 12 Hours||15
10059269|NCT02089191|11184596|FG000|COMPLETED|Period 2, Second 12 Hours||15
10059270|NCT02089191|11184597|FG001|COMPLETED|Period 2, Second 12 Hours||15
10059271|NCT02089191|11184596|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0
10059272|NCT02089191|11184597|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0
10059273|NCT02089230|11184606|FG000|STARTED|Overall Study||3
10059274|NCT02089230|11184607|FG001|STARTED|Overall Study||4
10059275|NCT02089230|11184608|FG002|STARTED|Overall Study||12
10059276|NCT02089230|11184606|FG000|COMPLETED|Overall Study||3
10059277|NCT02089230|11184607|FG001|COMPLETED|Overall Study||4
10059278|NCT02089230|11184608|FG002|COMPLETED|Overall Study||6
10059279|NCT02089230|11184606|FG000|NOT COMPLETED|Overall Study||0
10059280|NCT02089230|11184607|FG001|NOT COMPLETED|Overall Study||0
10059281|NCT02089230|11184608|FG002|NOT COMPLETED|Overall Study||6
10059282|NCT02089334|11184620|FG000|STARTED|Overall Study||3
10059283|NCT02089334|11184621|FG001|STARTED|Overall Study||4
10059284|NCT02089334|11184622|FG002|STARTED|Overall Study||4
10059285|NCT02089334|11184623|FG003|STARTED|Overall Study||13
10059286|NCT02089334|11184620|FG000|Received Study Drug|Overall Study||3
10059287|NCT02089334|11184621|FG001|Received Study Drug|Overall Study||4
10059288|NCT02089334|11184622|FG002|Received Study Drug|Overall Study||3
10059289|NCT02089334|11184623|FG003|Received Study Drug|Overall Study||11
10059290|NCT02089334|11184620|FG000|COMPLETED|Overall Study||3
10059291|NCT02089334|11184621|FG001|COMPLETED|Overall Study||4
10059292|NCT02089334|11184622|FG002|COMPLETED|Overall Study||3
10059293|NCT02089334|11184623|FG003|COMPLETED|Overall Study||6
10059294|NCT02089334|11184620|FG000|NOT COMPLETED|Overall Study||0
10059295|NCT02089334|11184621|FG001|NOT COMPLETED|Overall Study||0
10059296|NCT02089334|11184622|FG002|NOT COMPLETED|Overall Study||1
10059297|NCT02089334|11184623|FG003|NOT COMPLETED|Overall Study||7
10059298|NCT02089347|11184638|FG000|STARTED|Overall Study||356
10059299|NCT02089347|11184639|FG001|STARTED|Overall Study||178
10059300|NCT02089347|11184638|FG000|COMPLETED|Overall Study||355
10059301|NCT02089347|11184639|FG001|COMPLETED|Overall Study||178
10059302|NCT02089347|11184638|FG000|NOT COMPLETED|Overall Study||1
10059303|NCT02089347|11184639|FG001|NOT COMPLETED|Overall Study||0
10059304|NCT02089464|11184647|FG000|STARTED|Overall Study||132
10059305|NCT02089464|11184648|FG001|STARTED|Overall Study||67
10059306|NCT02089464|11184647|FG000|COMPLETED|Overall Study||104
10059307|NCT02089464|11184648|FG001|COMPLETED|Overall Study||51
10059308|NCT02089464|11184647|FG000|NOT COMPLETED|Overall Study||28
10059309|NCT02089464|11184648|FG001|NOT COMPLETED|Overall Study||16
10059310|NCT02089659|11184656|FG000|STARTED|Overall Study||8
10059311|NCT02089659|11184657|FG001|STARTED|Overall Study||8
10059312|NCT02089659|11184658|FG002|STARTED|Overall Study||0
10059313|NCT02089659|11184656|FG000|COMPLETED|Overall Study||8
10059314|NCT02089659|11184657|FG001|COMPLETED|Overall Study||8
10059315|NCT02089659|11184658|FG002|COMPLETED|Overall Study||0
10059316|NCT02089659|11184656|FG000|NOT COMPLETED|Overall Study||0
10059317|NCT02089659|11184657|FG001|NOT COMPLETED|Overall Study||0
10121791|NCT02571075|11252881|FG000|NOT COMPLETED|Overall Study||20
10121792|NCT02571075|11252882|FG001|NOT COMPLETED|Overall Study||24
10121793|NCT02571153|11252891|FG000|STARTED|Overall Study||45
10121794|NCT02571153|11252892|FG001|STARTED|Overall Study||45
10121795|NCT02571153|11252893|FG002|STARTED|Overall Study||45
10121796|NCT02571153|11252891|FG000|COMPLETED|Overall Study||39
10121797|NCT02571153|11252892|FG001|COMPLETED|Overall Study||37
10121798|NCT02571153|11252893|FG002|COMPLETED|Overall Study||43
10121799|NCT02571153|11252891|FG000|NOT COMPLETED|Overall Study||6
10121800|NCT02571153|11252892|FG001|NOT COMPLETED|Overall Study||8
10121801|NCT02571153|11252893|FG002|NOT COMPLETED|Overall Study||2
10121802|NCT02571218|11252903|FG000|STARTED|Overall Study||40
10121803|NCT02571218|11252904|FG001|STARTED|Overall Study||41
10121804|NCT02571218|11252903|FG000|COMPLETED|Overall Study||40
10121805|NCT02571218|11252904|FG001|COMPLETED|Overall Study||41
10121806|NCT02571218|11252903|FG000|NOT COMPLETED|Overall Study||0
10121807|NCT02571218|11252904|FG001|NOT COMPLETED|Overall Study||0
10121808|NCT02571244|11252912|FG000|STARTED|Overall Study||44
10121809|NCT02571244|11252913|FG001|STARTED|Overall Study||22
10121810|NCT02571244|11252912|FG000|COMPLETED|Overall Study||41
10121811|NCT02571244|11252913|FG001|COMPLETED|Overall Study||21
10121812|NCT02571244|11252912|FG000|NOT COMPLETED|Overall Study||3
10121813|NCT02571244|11252913|FG001|NOT COMPLETED|Overall Study||1
10121814|NCT02571439|11252924|FG000|STARTED|Overall Study||20
10121815|NCT02571439|11252925|FG001|STARTED|Overall Study||21
10121816|NCT02571439|11252924|FG000|COMPLETED|Overall Study||20
10121817|NCT02571439|11252925|FG001|COMPLETED|Overall Study||21
10121818|NCT02571439|11252924|FG000|NOT COMPLETED|Overall Study||0
10121819|NCT02571439|11252925|FG001|NOT COMPLETED|Overall Study||0
10121820|NCT02571452|11252933|FG000|STARTED|Overall Study Treatment||47
10121821|NCT02571452|11252934|FG001|STARTED|Overall Study Treatment||46
10121822|NCT02571452|11252933|FG000|COMPLETED|Overall Study Treatment||47
10121823|NCT02571452|11252934|FG001|COMPLETED|Overall Study Treatment||45
10121824|NCT02571452|11252933|FG000|NOT COMPLETED|Overall Study Treatment||0
10121825|NCT02571452|11252934|FG001|NOT COMPLETED|Overall Study Treatment||1
10121826|NCT02571452|11252933|FG000|STARTED|Overall Study 6-Month Follow-up||47
10121827|NCT02571452|11252934|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
10121828|NCT02571452|11252933|FG000|COMPLETED|Overall Study 6-Month Follow-up||42
10121829|NCT02571452|11252934|FG001|COMPLETED|Overall Study 6-Month Follow-up||0
10121830|NCT02571452|11252933|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5
10121831|NCT02571452|11252934|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0
10121832|NCT02571634|11252940|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
10121833|NCT02571634|11252940|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
10121834|NCT02571634|11252940|FG000|NOT COMPLETED|Overall Study||0
10121835|NCT02571777|11252950|FG000|STARTED|Overall Study||619
10121836|NCT02571777|11252951|FG001|STARTED|Overall Study||620
10121837|NCT02571777|11252952|FG002|STARTED|Overall Study||618
10121838|NCT02571777|11252953|FG003|STARTED|Overall Study||617
10121839|NCT02571777|11252954|FG004|STARTED|Overall Study||618
10121840|NCT02571777|11252950|FG000|Full Analysis Set (FAS)|Overall Study||615
10121841|NCT02571777|11252951|FG001|Full Analysis Set (FAS)|Overall Study||616
10121842|NCT02571777|11252952|FG002|Full Analysis Set (FAS)|Overall Study||611
10059318|NCT02089659|11184658|FG002|NOT COMPLETED|Overall Study||0
10059319|NCT02089737|11184664|FG000|STARTED|Overall Study||3091
10059320|NCT02089737|11184664|FG000|COMPLETED|Overall Study||3085
10121843|NCT02571777|11252953|FG003|Full Analysis Set (FAS)|Overall Study||607
10121844|NCT02571777|11252954|FG004|Full Analysis Set (FAS)|Overall Study||612
10059321|NCT02089737|11184664|FG000|NOT COMPLETED|Overall Study||6
10059322|NCT02089997|11184669|FG000|STARTED|Overall Study||3304
10059323|NCT02089997|11184669|FG000|COMPLETED|Overall Study||3058
10059324|NCT02089997|11184669|FG000|NOT COMPLETED|Overall Study||246
10059325|NCT02090075|11184675|FG000|STARTED|Overall Study||33
10059326|NCT02090075|11184676|FG001|STARTED|Overall Study||33
10059327|NCT02090075|11184675|FG000|COMPLETED|Overall Study||26
10059328|NCT02090075|11184676|FG001|COMPLETED|Overall Study||30
10059329|NCT02090075|11184675|FG000|NOT COMPLETED|Overall Study||7
10059330|NCT02090075|11184676|FG001|NOT COMPLETED|Overall Study||3
10059331|NCT02090088|11184682|FG000|STARTED|Overall Study||4
10059332|NCT02090088|11184682|FG000|Gave Birth|Overall Study||4
10059333|NCT02090088|11184682|FG000|COMPLETED|Overall Study||4
10059334|NCT02090088|11184682|FG000|NOT COMPLETED|Overall Study||0
10059335|NCT02090283|11184690|FG000|STARTED|Overall Study||17
10059336|NCT02090283|11184691|FG001|STARTED|Overall Study||15
10059337|NCT02090283|11184692|FG002|STARTED|Overall Study||10
10059338|NCT02090283|11184690|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17
10059339|NCT02090283|11184691|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15
10059340|NCT02090283|11184692|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10
10059341|NCT02090283|11184690|FG000|COMPLETED|Overall Study||0
10059342|NCT02090283|11184691|FG001|COMPLETED|Overall Study||0
10059343|NCT02090283|11184692|FG002|COMPLETED|Overall Study||0
10059344|NCT02090283|11184690|FG000|NOT COMPLETED|Overall Study||17
10059345|NCT02090283|11184691|FG001|NOT COMPLETED|Overall Study||15
10059346|NCT02090283|11184692|FG002|NOT COMPLETED|Overall Study||10
10059347|NCT02090374|11184708|FG000|STARTED|Overall Study||8
10121845|NCT02571777|11252950|FG000|Safety Set (SAF)|Overall Study||616
10121846|NCT02571777|11252951|FG001|Safety Set (SAF)|Overall Study||617
10121847|NCT02571777|11252952|FG002|Safety Set (SAF)|Overall Study||613
10121848|NCT02571777|11252953|FG003|Safety Set (SAF)|Overall Study||608
10121849|NCT02571777|11252954|FG004|Safety Set (SAF)|Overall Study||618
10121850|NCT02571777|11252950|FG000|COMPLETED|Overall Study||580
10121851|NCT02571777|11252951|FG001|COMPLETED|Overall Study||582
10121852|NCT02571777|11252952|FG002|COMPLETED|Overall Study||577
10121853|NCT02571777|11252953|FG003|COMPLETED|Overall Study||580
10121854|NCT02571777|11252954|FG004|COMPLETED|Overall Study||582
10121855|NCT02571777|11252950|FG000|NOT COMPLETED|Overall Study||39
10121856|NCT02571777|11252951|FG001|NOT COMPLETED|Overall Study||38
10121857|NCT02571777|11252952|FG002|NOT COMPLETED|Overall Study||41
10121858|NCT02571777|11252953|FG003|NOT COMPLETED|Overall Study||37
10121859|NCT02571777|11252954|FG004|NOT COMPLETED|Overall Study||36
10121860|NCT02571972|11252966|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
10121861|NCT02571972|11252966|FG000|COMPLETED|Overall Study||10
10121862|NCT02571972|11252966|FG000|NOT COMPLETED|Overall Study||4
10121863|NCT02572076|11252970|FG000|STARTED|Overall Study||10
10121864|NCT02572076|11252970|FG000|COMPLETED|Overall Study||9
10121865|NCT02572076|11252970|FG000|NOT COMPLETED|Overall Study||1
10121866|NCT02572167|11252977|FG000|STARTED|Overall Study||6
10121867|NCT02572167|11252978|FG001|STARTED|Overall Study||56
10121868|NCT02572167|11252979|FG002|STARTED|Overall Study||31
10121869|NCT02572167|11252977|FG000|COMPLETED|Overall Study||0
10121870|NCT02572167|11252978|FG001|COMPLETED|Overall Study||0
10121871|NCT02572167|11252979|FG002|COMPLETED|Overall Study||0
10121872|NCT02572167|11252977|FG000|NOT COMPLETED|Overall Study||6
10121873|NCT02572167|11252978|FG001|NOT COMPLETED|Overall Study||56
10121874|NCT02572167|11252979|FG002|NOT COMPLETED|Overall Study||31
10121875|NCT02572388|11252991|FG000|STARTED|Overall Study||11
10121876|NCT02572388|11252992|FG001|STARTED|Overall Study||4
10121877|NCT02572388|11252993|FG002|STARTED|Overall Study||10
10121878|NCT02572388|11252994|FG003|STARTED|Overall Study||6
10121879|NCT02572388|11252991|FG000|COMPLETED|Overall Study||10
10121880|NCT02572388|11252992|FG001|COMPLETED|Overall Study||3
10121881|NCT02572388|11252993|FG002|COMPLETED|Overall Study||8
10121882|NCT02572388|11252994|FG003|COMPLETED|Overall Study||4
10121883|NCT02572388|11252991|FG000|NOT COMPLETED|Overall Study||1
10121884|NCT02572388|11252992|FG001|NOT COMPLETED|Overall Study||1
10121885|NCT02572388|11252993|FG002|NOT COMPLETED|Overall Study||2
10121886|NCT02572388|11252994|FG003|NOT COMPLETED|Overall Study||2
10121887|NCT02572401|11253008|FG000|STARTED|Overall Study||97
10121888|NCT02572401|11253009|FG001|STARTED|Overall Study||98
10121889|NCT02572401|11253010|FG002|STARTED|Overall Study||98
10121890|NCT02572401|11253011|FG003|STARTED|Overall Study||98
10121891|NCT02572401|11253008|FG000|COMPLETED|Overall Study||92
10121892|NCT02572401|11253009|FG001|COMPLETED|Overall Study||90
10121893|NCT02572401|11253010|FG002|COMPLETED|Overall Study||89
10121894|NCT02572401|11253011|FG003|COMPLETED|Overall Study||88
10121895|NCT02572401|11253008|FG000|NOT COMPLETED|Overall Study||5
10121896|NCT02572401|11253009|FG001|NOT COMPLETED|Overall Study||8
10121897|NCT02572401|11253010|FG002|NOT COMPLETED|Overall Study||9
10059348|NCT02090374|11184709|FG001|STARTED|Overall Study||4
10121898|NCT02572401|11253011|FG003|NOT COMPLETED|Overall Study||10
10121899|NCT02572427|11253023|FG000|STARTED|Overall Study||37
10121900|NCT02572427|11253024|FG001|STARTED|Overall Study||45
10059349|NCT02090374|11184710|FG002|STARTED|Overall Study||4
10059350|NCT02090374|11184711|FG003|STARTED|Overall Study||9
10059351|NCT02090374|11184712|FG004|STARTED|Overall Study||35
10121901|NCT02572427|11253023|FG000|COMPLETED|Overall Study||31
10121902|NCT02572427|11253024|FG001|COMPLETED|Overall Study||36
10059352|NCT02090374|11184713|FG005|STARTED|Overall Study||15
10059353|NCT02090374|11184714|FG006|STARTED|Overall Study||16
10059354|NCT02090374|11184715|FG007|STARTED|Overall Study||2
10059355|NCT02090374|11184708|FG000|COMPLETED|Overall Study||8
10059356|NCT02090374|11184709|FG001|COMPLETED|Overall Study||4
10059357|NCT02090374|11184710|FG002|COMPLETED|Overall Study||4
10121903|NCT02572427|11253023|FG000|NOT COMPLETED|Overall Study||6
10121904|NCT02572427|11253024|FG001|NOT COMPLETED|Overall Study||9
10121905|NCT02572570|11253030|FG000|STARTED|Overall Study||27
10121906|NCT02572570|11253030|FG000|Filtek Bulk Fill Posterior|Overall Study||27
10121907|NCT02572570|11253030|FG000|Filtek Supreme Ultra|Overall Study||27
10121908|NCT02572570|11253030|FG000|1 Year Follow-Up|Overall Study||20
10121909|NCT02572570|11253030|FG000|2 Year Follow-Up|Overall Study||13
10121910|NCT02572570|11253030|FG000|3 Year Follow-Up|Overall Study||5
10121911|NCT02572570|11253030|FG000|5 Year Follow-Up|Overall Study||0
10121912|NCT02572570|11253030|FG000|COMPLETED|Overall Study||0
10121913|NCT02572570|11253030|FG000|NOT COMPLETED|Overall Study||27
10121914|NCT02572609|11253039|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18
10121915|NCT02572609|11253040|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18
10121916|NCT02572609|11253039|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18
10121917|NCT02572609|11253040|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18
10121918|NCT02572609|11253039|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10121919|NCT02572609|11253040|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10121920|NCT02572609|11253039|FG000|STARTED|Period 2: Treatment Period 2||18
10121921|NCT02572609|11253040|FG001|STARTED|Period 2: Treatment Period 2||18
10121922|NCT02572609|11253039|FG000|COMPLETED|Period 2: Treatment Period 2||18
10121923|NCT02572609|11253040|FG001|COMPLETED|Period 2: Treatment Period 2||18
10121924|NCT02572609|11253039|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0
10121925|NCT02572609|11253040|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0
10121926|NCT02572752|11253049|FG000|STARTED|Period 1 Including Washout||23
10121927|NCT02572752|11253050|FG001|STARTED|Period 1 Including Washout||23
10121928|NCT02572752|11253051|FG002|STARTED|Period 1 Including Washout||24
10121929|NCT02572752|11253049|FG000|COMPLETED|Period 1 Including Washout||23
10121930|NCT02572752|11253050|FG001|COMPLETED|Period 1 Including Washout||23
10121931|NCT02572752|11253051|FG002|COMPLETED|Period 1 Including Washout||24
10121932|NCT02572752|11253049|FG000|NOT COMPLETED|Period 1 Including Washout||0
10121933|NCT02572752|11253050|FG001|NOT COMPLETED|Period 1 Including Washout||0
10121934|NCT02572752|11253051|FG002|NOT COMPLETED|Period 1 Including Washout||0
10121935|NCT02572752|11253049|FG000|STARTED|Period 2 Including Washout||23
10121936|NCT02572752|11253050|FG001|STARTED|Period 2 Including Washout||23
10121937|NCT02572752|11253051|FG002|STARTED|Period 2 Including Washout||24
10121938|NCT02572752|11253049|FG000|COMPLETED|Period 2 Including Washout||23
10121939|NCT02572752|11253050|FG001|COMPLETED|Period 2 Including Washout||23
10121940|NCT02572752|11253051|FG002|COMPLETED|Period 2 Including Washout||24
10121941|NCT02572752|11253049|FG000|NOT COMPLETED|Period 2 Including Washout||0
10121942|NCT02572752|11253050|FG001|NOT COMPLETED|Period 2 Including Washout||0
10121943|NCT02572752|11253051|FG002|NOT COMPLETED|Period 2 Including Washout||0
10121944|NCT02572752|11253049|FG000|STARTED|Period 3 Including Washout||23
10121945|NCT02572752|11253050|FG001|STARTED|Period 3 Including Washout||23
10121946|NCT02572752|11253051|FG002|STARTED|Period 3 Including Washout||24
10121947|NCT02572752|11253049|FG000|COMPLETED|Period 3 Including Washout||23
10121948|NCT02572752|11253050|FG001|COMPLETED|Period 3 Including Washout||23
10121949|NCT02572752|11253051|FG002|COMPLETED|Period 3 Including Washout||24
10121950|NCT02572752|11253049|FG000|NOT COMPLETED|Period 3 Including Washout||0
10121951|NCT02572752|11253050|FG001|NOT COMPLETED|Period 3 Including Washout||0
10121952|NCT02572752|11253051|FG002|NOT COMPLETED|Period 3 Including Washout||0
10121953|NCT02572817|11253060|FG000|STARTED|Overall Study||91
10121954|NCT02572817|11253061|FG001|STARTED|Overall Study||47
10121955|NCT02572817|11253060|FG000|COMPLETED|Overall Study||82
10121956|NCT02572817|11253061|FG001|COMPLETED|Overall Study||41
10121957|NCT02572817|11253060|FG000|NOT COMPLETED|Overall Study||9
10121958|NCT02572817|11253061|FG001|NOT COMPLETED|Overall Study||6
10121959|NCT02573012|11253069|FG000|STARTED|Overall Study||131
10121960|NCT02573012|11253070|FG001|STARTED|Overall Study||128
10121961|NCT02573012|11253069|FG000|COMPLETED|Overall Study||116
10121962|NCT02573012|11253070|FG001|COMPLETED|Overall Study||113
10121963|NCT02573012|11253069|FG000|NOT COMPLETED|Overall Study||15
10121964|NCT02573012|11253070|FG001|NOT COMPLETED|Overall Study||15
10121965|NCT02573155|11253078|FG000|STARTED|Treatment Period 1||16
10121966|NCT02573155|11253079|FG001|STARTED|Treatment Period 1||38
10121967|NCT02573155|11253078|FG000|COMPLETED|Treatment Period 1||16
10121968|NCT02573155|11253079|FG001|COMPLETED|Treatment Period 1||38
10059358|NCT02090374|11184711|FG003|COMPLETED|Overall Study||9
10059359|NCT02090374|11184712|FG004|COMPLETED|Overall Study||35
10059360|NCT02090374|11184713|FG005|COMPLETED|Overall Study||15
10059361|NCT02090374|11184714|FG006|COMPLETED|Overall Study||16
10059362|NCT02090374|11184715|FG007|COMPLETED|Overall Study||2
10059363|NCT02090374|11184708|FG000|NOT COMPLETED|Overall Study||0
10121969|NCT02573155|11253078|FG000|NOT COMPLETED|Treatment Period 1||0
10121970|NCT02573155|11253079|FG001|NOT COMPLETED|Treatment Period 1||0
10121971|NCT02573155|11253078|FG000|STARTED|Washout Between Treatment Period 1 and 2||16
10121972|NCT02573155|11253079|FG001|STARTED|Washout Between Treatment Period 1 and 2||38
10059364|NCT02090374|11184709|FG001|NOT COMPLETED|Overall Study||0
10059365|NCT02090374|11184710|FG002|NOT COMPLETED|Overall Study||0
10059366|NCT02090374|11184711|FG003|NOT COMPLETED|Overall Study||0
10059367|NCT02090374|11184712|FG004|NOT COMPLETED|Overall Study||0
10059368|NCT02090374|11184713|FG005|NOT COMPLETED|Overall Study||0
10059369|NCT02090374|11184714|FG006|NOT COMPLETED|Overall Study||0
10059370|NCT02090374|11184715|FG007|NOT COMPLETED|Overall Study||0
10059371|NCT02090413|11184736|FG000|STARTED|Overall Study||81
10059372|NCT02090413|11184737|FG001|STARTED|Overall Study||80
10059373|NCT02090413|11184738|FG002|STARTED|Overall Study||80
10059374|NCT02090413|11184736|FG000|COMPLETED|Overall Study||62
10059375|NCT02090413|11184737|FG001|COMPLETED|Overall Study||60
10059376|NCT02090413|11184738|FG002|COMPLETED|Overall Study||57
10059377|NCT02090413|11184736|FG000|NOT COMPLETED|Overall Study||19
10059378|NCT02090413|11184737|FG001|NOT COMPLETED|Overall Study||20
10059379|NCT02090413|11184738|FG002|NOT COMPLETED|Overall Study||23
10059380|NCT02090426|11184749|FG000|STARTED|Overall Study||401
10059381|NCT02090426|11184750|FG001|STARTED|Overall Study||399
10059382|NCT02090426|11184749|FG000|Analysis Population|Overall Study||389
10059383|NCT02090426|11184750|FG001|Analysis Population|Overall Study||393
10059384|NCT02090426|11184749|FG000|COMPLETED|Overall Study||389
10059385|NCT02090426|11184750|FG001|COMPLETED|Overall Study||393
10059386|NCT02090426|11184749|FG000|NOT COMPLETED|Overall Study||12
10059387|NCT02090426|11184750|FG001|NOT COMPLETED|Overall Study||6
10059388|NCT02090634|11184758|FG000|STARTED|Overall Study||30
10059389|NCT02090634|11184759|FG001|STARTED|Overall Study||28
10059390|NCT02090634|11184758|FG000|COMPLETED|Overall Study||25
10059391|NCT02090634|11184759|FG001|COMPLETED|Overall Study||25
10059392|NCT02090634|11184758|FG000|NOT COMPLETED|Overall Study||5
10059393|NCT02090634|11184759|FG001|NOT COMPLETED|Overall Study||3
10059394|NCT02090725|11184765|FG000|STARTED|Overall Study||4
10059395|NCT02090725|11184765|FG000|COMPLETED|Overall Study||0
10059396|NCT02090725|11184765|FG000|NOT COMPLETED|Overall Study||4
10059397|NCT02090764|11184771|FG000|STARTED|Overall Study||206
10059398|NCT02090764|11184772|FG001|STARTED|Overall Study||206
10059399|NCT02090764|11184771|FG000|COMPLETED|Overall Study||200
10059400|NCT02090764|11184772|FG001|COMPLETED|Overall Study||186
10059401|NCT02090764|11184771|FG000|NOT COMPLETED|Overall Study||6
10059402|NCT02090764|11184772|FG001|NOT COMPLETED|Overall Study||20
10059403|NCT02090777|11184778|FG000|STARTED|Overall Study||4
10059404|NCT02090777|11184778|FG000|COMPLETED|Overall Study||4
10059405|NCT02090777|11184778|FG000|NOT COMPLETED|Overall Study||0
10059406|NCT02090855|11184782|FG000|STARTED|Overall Study||108
10059407|NCT02090855|11184782|FG000|COMPLETED|Overall Study||106
10059408|NCT02090855|11184782|FG000|NOT COMPLETED|Overall Study||2
10059409|NCT02090894|11184789|FG000|STARTED|Overall Study||11
10059410|NCT02090894|11184789|FG000|COMPLETED|Overall Study||11
10059411|NCT02090894|11184789|FG000|NOT COMPLETED|Overall Study||0
10059412|NCT02090959|11184793|FG000|STARTED|Overall Study||219
10059413|NCT02090959|11184793|FG000|As-treated Population|Overall Study||218
10059414|NCT02090959|11184793|FG000|COMPLETED|Overall Study||68
10059415|NCT02090959|11184793|FG000|NOT COMPLETED|Overall Study||151
10059416|NCT02091089|11184797|FG000|STARTED|Overall Study||20
10059417|NCT02091089|11184797|FG000|COMPLETED|Overall Study||18
10059418|NCT02091089|11184797|FG000|NOT COMPLETED|Overall Study||2
10059419|NCT02091102|11184801|FG000|STARTED|Overall Study||20
10059420|NCT02091102|11184801|FG000|COMPLETED|Overall Study||20
10059421|NCT02091102|11184801|FG000|NOT COMPLETED|Overall Study||0
10059422|NCT02091167|11184807|FG000|STARTED|Overall Study||19
10059423|NCT02091167|11184808|FG001|STARTED|Overall Study||16
10059424|NCT02091167|11184807|FG000|COMPLETED|Overall Study||19
10059425|NCT02091167|11184808|FG001|COMPLETED|Overall Study||14
10059426|NCT02091167|11184807|FG000|NOT COMPLETED|Overall Study||0
10059427|NCT02091167|11184808|FG001|NOT COMPLETED|Overall Study||2
10059428|NCT02091206|11184818|FG000|STARTED|Treatment Period||10
10059429|NCT02091206|11184819|FG001|STARTED|Treatment Period||8
10059430|NCT02091206|11184820|FG002|STARTED|Treatment Period||9
10059431|NCT02091206|11184821|FG003|STARTED|Treatment Period||7
10059432|NCT02091206|11184818|FG000|Safety Analysis Set|Treatment Period||10
10059433|NCT02091206|11184819|FG001|Safety Analysis Set|Treatment Period||8
10059434|NCT02091206|11184820|FG002|Safety Analysis Set|Treatment Period||9
10059435|NCT02091206|11184821|FG003|Safety Analysis Set|Treatment Period||7
10059436|NCT02091206|11184818|FG000|COMPLETED|Treatment Period||10
10059437|NCT02091206|11184819|FG001|COMPLETED|Treatment Period||7
10059438|NCT02091206|11184820|FG002|COMPLETED|Treatment Period||8
10059439|NCT02091206|11184821|FG003|COMPLETED|Treatment Period||7
10059440|NCT02091206|11184818|FG000|NOT COMPLETED|Treatment Period||0
10059441|NCT02091206|11184819|FG001|NOT COMPLETED|Treatment Period||1
10059442|NCT02091206|11184820|FG002|NOT COMPLETED|Treatment Period||1
10059443|NCT02091206|11184821|FG003|NOT COMPLETED|Treatment Period||0
10059444|NCT02091206|11184818|FG000|STARTED|Taper Period||10
10059445|NCT02091206|11184819|FG001|STARTED|Taper Period||7
10059446|NCT02091206|11184820|FG002|STARTED|Taper Period||8
10059447|NCT02091206|11184821|FG003|STARTED|Taper Period||7
10059448|NCT02091206|11184818|FG000|COMPLETED|Taper Period||9
10059449|NCT02091206|11184819|FG001|COMPLETED|Taper Period||7
10059450|NCT02091206|11184820|FG002|COMPLETED|Taper Period||8
10059451|NCT02091206|11184821|FG003|COMPLETED|Taper Period||5
10059452|NCT02091206|11184818|FG000|NOT COMPLETED|Taper Period||1
10059453|NCT02091206|11184819|FG001|NOT COMPLETED|Taper Period||0
10059454|NCT02091206|11184820|FG002|NOT COMPLETED|Taper Period||0
10059455|NCT02091206|11184821|FG003|NOT COMPLETED|Taper Period||2
10059456|NCT02091284|11184833|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
10059457|NCT02091284|11184834|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23
10059458|NCT02091284|11184833|FG000|COMPLETED|Overall Study||23
10059459|NCT02091284|11184834|FG001|COMPLETED|Overall Study||22
10059460|NCT02091284|11184833|FG000|NOT COMPLETED|Overall Study||3
10059461|NCT02091284|11184834|FG001|NOT COMPLETED|Overall Study||1
10059462|NCT02091362|11184844|FG000|STARTED|Period 1||133
10059463|NCT02091362|11184845|FG001|STARTED|Period 1||137
10059464|NCT02091362|11184844|FG000|COMPLETED|Period 1||128
10059465|NCT02091362|11184845|FG001|COMPLETED|Period 1||133
10059466|NCT02091362|11184844|FG000|NOT COMPLETED|Period 1||5
10059467|NCT02091362|11184845|FG001|NOT COMPLETED|Period 1||4
10059468|NCT02091362|11184844|FG000|STARTED|Wash-out||128
10059469|NCT02091362|11184845|FG001|STARTED|Wash-out||133
10059470|NCT02091362|11184844|FG000|COMPLETED|Wash-out||127
10059471|NCT02091362|11184845|FG001|COMPLETED|Wash-out||130
10059472|NCT02091362|11184844|FG000|NOT COMPLETED|Wash-out||1
10059473|NCT02091362|11184845|FG001|NOT COMPLETED|Wash-out||3
10059474|NCT02091362|11184844|FG000|STARTED|Period 2||127
10059475|NCT02091362|11184845|FG001|STARTED|Period 2||130
10059476|NCT02091362|11184844|FG000|COMPLETED|Period 2||125
10059477|NCT02091362|11184845|FG001|COMPLETED|Period 2||128
10059478|NCT02091362|11184844|FG000|NOT COMPLETED|Period 2||2
10059479|NCT02091362|11184845|FG001|NOT COMPLETED|Period 2||2
10059480|NCT02091375|11184857|FG000|STARTED|Overall Study||61
10121973|NCT02573155|11253078|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16
10121974|NCT02573155|11253079|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33
10121975|NCT02573155|11253078|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
10121976|NCT02573155|11253079|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
10121977|NCT02573155|11253078|FG000|STARTED|Period 2||16
10121978|NCT02573155|11253079|FG001|STARTED|Period 2||33
10121979|NCT02573155|11253078|FG000|COMPLETED|Period 2||16
10121980|NCT02573155|11253079|FG001|COMPLETED|Period 2||33
10121981|NCT02573155|11253078|FG000|NOT COMPLETED|Period 2||0
10121982|NCT02573155|11253079|FG001|NOT COMPLETED|Period 2||0
10121983|NCT02573155|11253078|FG000|STARTED|Washout Between Treatment Period 2 and 3||16
10121984|NCT02573155|11253079|FG001|STARTED|Washout Between Treatment Period 2 and 3||33
10121985|NCT02573155|11253078|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15
10121986|NCT02573155|11253079|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31
10121987|NCT02573155|11253078|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
10121988|NCT02573155|11253079|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
10121989|NCT02573155|11253078|FG000|STARTED|Period 3||15
10121990|NCT02573155|11253079|FG001|STARTED|Period 3||31
10121991|NCT02573155|11253078|FG000|COMPLETED|Period 3||15
10121992|NCT02573155|11253079|FG001|COMPLETED|Period 3||31
10121993|NCT02573155|11253078|FG000|NOT COMPLETED|Period 3||0
10121994|NCT02573155|11253079|FG001|NOT COMPLETED|Period 3||0
10121995|NCT02573155|11253078|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
10121996|NCT02573155|11253079|FG001|STARTED|Washout Between Treatment Period 3 and 4||31
10121997|NCT02573155|11253078|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
10121998|NCT02573155|11253079|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29
10121999|NCT02573155|11253078|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
10122000|NCT02573155|11253079|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
10122001|NCT02573155|11253078|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
10122002|NCT02573155|11253079|FG001|STARTED|Period 4||29
10122003|NCT02573155|11253078|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
10122004|NCT02573155|11253079|FG001|COMPLETED|Period 4||29
10122005|NCT02573155|11253078|FG000|NOT COMPLETED|Period 4||0
10122006|NCT02573155|11253079|FG001|NOT COMPLETED|Period 4||0
10122007|NCT02573155|11253078|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
10122008|NCT02573155|11253079|FG001|STARTED|Washout Between Treatment Period 4 and 5||29
10122009|NCT02573155|11253078|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
10122010|NCT02573155|11253079|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28
10122011|NCT02573155|11253078|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
10122012|NCT02573155|11253079|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
10122013|NCT02573155|11253078|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10122014|NCT02573155|11253079|FG001|STARTED|Period 5||28
10122015|NCT02573155|11253078|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10122016|NCT02573155|11253079|FG001|COMPLETED|Period 5||28
10122017|NCT02573155|11253078|FG000|NOT COMPLETED|Period 5||0
10059481|NCT02091375|11184858|FG001|STARTED|Overall Study||59
10059482|NCT02091375|11184857|FG000|Safety Analysis Set|Overall Study||61
10059483|NCT02091375|11184858|FG001|Safety Analysis Set|Overall Study||59
10059484|NCT02091375|11184857|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61
10059485|NCT02091375|11184858|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59
10059486|NCT02091375|11184857|FG000|COMPLETED|Overall Study||52
10059487|NCT02091375|11184858|FG001|COMPLETED|Overall Study||56
10122018|NCT02573155|11253079|FG001|NOT COMPLETED|Period 5||0
10122019|NCT02573181|11253107|FG000|STARTED|Overall Study||127
10059488|NCT02091375|11184857|FG000|NOT COMPLETED|Overall Study||9
10059489|NCT02091375|11184858|FG001|NOT COMPLETED|Overall Study||3
10059490|NCT02091414|11184864|FG000|STARTED|Overall Study||36
10059491|NCT02091414|11184864|FG000|COMPLETED|Overall Study||32
10059492|NCT02091414|11184864|FG000|NOT COMPLETED|Overall Study||4
10059493|NCT02091440|11184868|FG000|STARTED|Overall Study||6
10059494|NCT02091440|11184868|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6
10059495|NCT02091440|11184868|FG000|Overall Survival at 180 Days|Overall Study||6
10059496|NCT02091440|11184868|FG000|COMPLETED|Overall Study||4
10059497|NCT02091440|11184868|FG000|NOT COMPLETED|Overall Study||2
10059498|NCT02091466|11184874|FG000|STARTED|Overall Study||20
10059499|NCT02091466|11184875|FG001|STARTED|Overall Study||20
10059500|NCT02091466|11184874|FG000|COMPLETED|Overall Study||20
10059501|NCT02091466|11184875|FG001|COMPLETED|Overall Study||20
10059502|NCT02091466|11184874|FG000|NOT COMPLETED|Overall Study||0
10059503|NCT02091466|11184875|FG001|NOT COMPLETED|Overall Study||0
10059504|NCT02091531|11184881|FG000|STARTED|Overall Study||9
10059505|NCT02091531|11184881|FG000|COMPLETED|Overall Study||9
10059506|NCT02091531|11184881|FG000|NOT COMPLETED|Overall Study||0
10059507|NCT02091726|11184885|FG000|STARTED|Overall Study||110
10059508|NCT02091726|11184885|FG000|1 Week Followup|Overall Study||110
10059509|NCT02091726|11184885|FG000|4 Week Followup|Overall Study||104
10059510|NCT02091726|11184885|FG000|COMPLETED|Overall Study||104
10059511|NCT02091726|11184885|FG000|NOT COMPLETED|Overall Study||6
10059512|NCT02091739|11184892|FG000|STARTED|MP: 16 Weeks||36
10059513|NCT02091739|11184893|FG001|STARTED|MP: 16 Weeks||74
10059514|NCT02091739|11184894|FG002|STARTED|MP: 16 Weeks||74
10059515|NCT02091739|11184895|FG003|STARTED|MP: 16 Weeks||0
10059516|NCT02091739|11184896|FG004|STARTED|MP: 16 Weeks||0
10059517|NCT02091739|11184892|FG000|COMPLETED|MP: 16 Weeks||32
10059518|NCT02091739|11184893|FG001|COMPLETED|MP: 16 Weeks||69
10059519|NCT02091739|11184894|FG002|COMPLETED|MP: 16 Weeks||72
10059520|NCT02091739|11184895|FG003|COMPLETED|MP: 16 Weeks||0
10059521|NCT02091739|11184896|FG004|COMPLETED|MP: 16 Weeks||0
10059522|NCT02091739|11184892|FG000|NOT COMPLETED|MP: 16 Weeks||4
10059523|NCT02091739|11184893|FG001|NOT COMPLETED|MP: 16 Weeks||5
10059524|NCT02091739|11184894|FG002|NOT COMPLETED|MP: 16 Weeks||2
10059525|NCT02091739|11184895|FG003|NOT COMPLETED|MP: 16 Weeks||0
10059526|NCT02091739|11184896|FG004|NOT COMPLETED|MP: 16 Weeks||0
10059527|NCT02091739|11184892|FG000|STARTED|EP: 48 Weeks||0
10059528|NCT02091739|11184893|FG001|STARTED|EP: 48 Weeks||0
10059529|NCT02091739|11184894|FG002|STARTED|EP: 48 Weeks||0
10059530|NCT02091739|11184895|FG003|STARTED|EP: 48 Weeks||84
10059531|NCT02091739|11184896|FG004|STARTED|EP: 48 Weeks||89
10059532|NCT02091739|11184892|FG000|COMPLETED|EP: 48 Weeks||0
10059533|NCT02091739|11184893|FG001|COMPLETED|EP: 48 Weeks||0
10059534|NCT02091739|11184894|FG002|COMPLETED|EP: 48 Weeks||0
10059535|NCT02091739|11184895|FG003|COMPLETED|EP: 48 Weeks||76
10059536|NCT02091739|11184896|FG004|COMPLETED|EP: 48 Weeks||75
10059537|NCT02091739|11184892|FG000|NOT COMPLETED|EP: 48 Weeks||0
10059538|NCT02091739|11184893|FG001|NOT COMPLETED|EP: 48 Weeks||0
10059539|NCT02091739|11184894|FG002|NOT COMPLETED|EP: 48 Weeks||0
10059540|NCT02091739|11184895|FG003|NOT COMPLETED|EP: 48 Weeks||8
10059541|NCT02091739|11184896|FG004|NOT COMPLETED|EP: 48 Weeks||14
10059542|NCT02091778|11184906|FG000|STARTED|Overall Study||21
10059543|NCT02091778|11184906|FG000|COMPLETED|Overall Study||20
10059544|NCT02091778|11184906|FG000|NOT COMPLETED|Overall Study||1
10059545|NCT02091856|11184913|FG000|STARTED|Active Intervention Interval||34
10059546|NCT02091856|11184914|FG001|STARTED|Active Intervention Interval||19
10059547|NCT02091856|11184915|FG002|STARTED|Active Intervention Interval||26
10059548|NCT02091856|11184913|FG000|COMPLETED|Active Intervention Interval||15
10059549|NCT02091856|11184914|FG001|COMPLETED|Active Intervention Interval||12
10059550|NCT02091856|11184915|FG002|COMPLETED|Active Intervention Interval||19
10059551|NCT02091856|11184913|FG000|NOT COMPLETED|Active Intervention Interval||19
10059552|NCT02091856|11184914|FG001|NOT COMPLETED|Active Intervention Interval||7
10059553|NCT02091856|11184915|FG002|NOT COMPLETED|Active Intervention Interval||7
10059554|NCT02091856|11184913|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
10059555|NCT02091856|11184914|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
10059556|NCT02091856|11184915|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
10059557|NCT02091856|11184913|FG000|COMPLETED|Follow-up Assessment||10
10059558|NCT02091856|11184914|FG001|COMPLETED|Follow-up Assessment||9
10059559|NCT02091856|11184915|FG002|COMPLETED|Follow-up Assessment||0
10059560|NCT02091856|11184913|FG000|NOT COMPLETED|Follow-up Assessment||5
10059561|NCT02091856|11184914|FG001|NOT COMPLETED|Follow-up Assessment||3
10059562|NCT02091856|11184915|FG002|NOT COMPLETED|Follow-up Assessment||0
10059563|NCT02091869|11184925|FG000|STARTED|Overall Study||17
10059564|NCT02091869|11184926|FG001|STARTED|Overall Study||17
10059565|NCT02091869|11184925|FG000|COMPLETED|Overall Study||17
10059566|NCT02091869|11184926|FG001|COMPLETED|Overall Study||14
10059567|NCT02091869|11184925|FG000|NOT COMPLETED|Overall Study||0
10059568|NCT02091869|11184926|FG001|NOT COMPLETED|Overall Study||3
10059569|NCT02091882|11184932|FG000|STARTED|Overall Study||30
10059570|NCT02091882|11184932|FG000|COMPLETED|Overall Study||30
10059571|NCT02091882|11184932|FG000|NOT COMPLETED|Overall Study||0
10059572|NCT02091921|11184936|FG000|STARTED|Overall Study||53
10059573|NCT02091921|11184936|FG000|COMPLETED|Overall Study||50
10059574|NCT02091921|11184936|FG000|NOT COMPLETED|Overall Study||3
10059575|NCT02091986|11184946|FG000|STARTED|Overall Study||92
10059576|NCT02091986|11184947|FG001|STARTED|Overall Study||95
10059577|NCT02091986|11184948|FG002|STARTED|Overall Study||92
10059578|NCT02091986|11184946|FG000|COMPLETED|Overall Study||85
10059579|NCT02091986|11184947|FG001|COMPLETED|Overall Study||84
10059580|NCT02091986|11184948|FG002|COMPLETED|Overall Study||84
10059581|NCT02091986|11184946|FG000|NOT COMPLETED|Overall Study||7
10059582|NCT02091986|11184947|FG001|NOT COMPLETED|Overall Study||11
10059583|NCT02091986|11184948|FG002|NOT COMPLETED|Overall Study||8
10059584|NCT02092025|11184956|FG000|STARTED|Overall Study||3437
10059585|NCT02092025|11184956|FG000|COMPLETED|Overall Study||3369
10059586|NCT02092025|11184956|FG000|NOT COMPLETED|Overall Study||68
10059587|NCT02092116|11184962|FG000|STARTED|Overall Study||6
10059588|NCT02092116|11184963|FG001|STARTED|Overall Study||20
10059589|NCT02092116|11184962|FG000|COMPLETED|Overall Study||6
10059590|NCT02092116|11184963|FG001|COMPLETED|Overall Study||16
10059591|NCT02092116|11184962|FG000|NOT COMPLETED|Overall Study||0
10059592|NCT02092116|11184963|FG001|NOT COMPLETED|Overall Study||4
10059593|NCT02092168|11184971|FG000|STARTED|Overall Study||12
10059594|NCT02092168|11184972|FG001|STARTED|Overall Study||12
10059595|NCT02092168|11184971|FG000|COMPLETED|Overall Study||12
10059596|NCT02092168|11184972|FG001|COMPLETED|Overall Study||12
10059597|NCT02092168|11184971|FG000|NOT COMPLETED|Overall Study||0
10059598|NCT02092168|11184972|FG001|NOT COMPLETED|Overall Study||0
10059599|NCT02092181|11184980|FG000|STARTED|Overall Study||15
10059600|NCT02092181|11184981|FG001|STARTED|Overall Study||15
10059601|NCT02092181|11184980|FG000|COMPLETED|Overall Study||12
10059602|NCT02092181|11184981|FG001|COMPLETED|Overall Study||14
10059603|NCT02092181|11184980|FG000|NOT COMPLETED|Overall Study||3
10059604|NCT02092181|11184981|FG001|NOT COMPLETED|Overall Study||1
10059605|NCT02092220|11184987|FG000|STARTED|Period 1||21
10059606|NCT02092220|11184988|FG001|STARTED|Period 1||22
10059607|NCT02092220|11184987|FG000|COMPLETED|Period 1||21
10059608|NCT02092220|11184988|FG001|COMPLETED|Period 1||20
10059609|NCT02092220|11184987|FG000|NOT COMPLETED|Period 1||0
10059610|NCT02092220|11184988|FG001|NOT COMPLETED|Period 1||2
10059611|NCT02092220|11184987|FG000|STARTED|Period 2||21
10059612|NCT02092220|11184988|FG001|STARTED|Period 2||20
10059613|NCT02092220|11184987|FG000|COMPLETED|Period 2||20
10059614|NCT02092220|11184988|FG001|COMPLETED|Period 2||19
10059615|NCT02092220|11184987|FG000|NOT COMPLETED|Period 2||1
10059616|NCT02092220|11184988|FG001|NOT COMPLETED|Period 2||1
10059617|NCT02092285|11184996|FG000|STARTED|Induction Phase||205
10059618|NCT02092285|11184996|FG000|COMPLETED|Induction Phase||170
10059619|NCT02092285|11184996|FG000|NOT COMPLETED|Induction Phase||35
10059620|NCT02092285|11184996|FG000|STARTED|Maintenance Phase & Follow-up||170
10122020|NCT02573181|11253108|FG001|STARTED|Overall Study||126
10122021|NCT02573181|11253107|FG000|Vaccinated|Overall Study||127
10059621|NCT02092285|11184996|FG000|COMPLETED|Maintenance Phase & Follow-up||60
10059622|NCT02092285|11184996|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110
10122022|NCT02573181|11253108|FG001|Vaccinated|Overall Study||126
10122023|NCT02573181|11253107|FG000|COMPLETED|Overall Study||127
10059623|NCT02092298|11185000|FG000|STARTED|Overall Study||19
10059624|NCT02092298|11185000|FG000|COMPLETED|Overall Study||19
10059625|NCT02092298|11185000|FG000|NOT COMPLETED|Overall Study||0
10059626|NCT02092311|11185006|FG000|STARTED|Overall Study||285
10059627|NCT02092311|11185007|FG001|STARTED|Overall Study||285
10059628|NCT02092311|11185006|FG000|COMPLETED|Overall Study||285
10059629|NCT02092311|11185007|FG001|COMPLETED|Overall Study||285
10059630|NCT02092311|11185006|FG000|NOT COMPLETED|Overall Study||0
10059631|NCT02092311|11185007|FG001|NOT COMPLETED|Overall Study||0
10059632|NCT02092324|11185015|FG000|STARTED|Overall Study||51
10059633|NCT02092324|11185015|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
10059634|NCT02092324|11185015|FG000|Wildtype CSF3R|Overall Study||23
10059635|NCT02092324|11185015|FG000|Mutant CSF3R|Overall Study||26
10059636|NCT02092324|11185015|FG000|COMPLETED|Overall Study||32
10059637|NCT02092324|11185015|FG000|NOT COMPLETED|Overall Study||19
10059638|NCT02092350|11185024|FG000|STARTED|Overall Study||123
10059639|NCT02092350|11185025|FG001|STARTED|Overall Study||114
10059640|NCT02092350|11185024|FG000|COMPLETED|Overall Study||113
10059641|NCT02092350|11185025|FG001|COMPLETED|Overall Study||102
10059642|NCT02092350|11185024|FG000|NOT COMPLETED|Overall Study||10
10059643|NCT02092350|11185025|FG001|NOT COMPLETED|Overall Study||12
10059644|NCT02092389|11185033|FG000|STARTED|Overall Study||10
10059645|NCT02092389|11185033|FG000|COMPLETED|Overall Study||4
10059646|NCT02092389|11185033|FG000|NOT COMPLETED|Overall Study||6
10059647|NCT02092415|11185037|FG000|STARTED|Overall Study||10
10059648|NCT02092415|11185037|FG000|COMPLETED|Overall Study||10
10059649|NCT02092415|11185037|FG000|NOT COMPLETED|Overall Study||0
10059650|NCT02092441|11185044|FG000|STARTED|Overall Study||37
10059651|NCT02092441|11185045|FG001|STARTED|Overall Study||43
10059652|NCT02092441|11185044|FG000|COMPLETED|Overall Study||37
10059653|NCT02092441|11185045|FG001|COMPLETED|Overall Study||43
10059654|NCT02092441|11185044|FG000|NOT COMPLETED|Overall Study||0
10059655|NCT02092441|11185045|FG001|NOT COMPLETED|Overall Study||0
10059656|NCT02092467|11185054|FG000|STARTED|Overall Study||1457
10059657|NCT02092467|11185055|FG001|STARTED|Overall Study||1457
10059658|NCT02092467|11185056|FG002|STARTED|Overall Study||1458
10059659|NCT02092467|11185054|FG000|Treated|Overall Study||1455
10059660|NCT02092467|11185055|FG001|Treated|Overall Study||1456
10059661|NCT02092467|11185056|FG002|Treated|Overall Study||1451
10059662|NCT02092467|11185054|FG000|COMPLETED|Overall Study||1053
10059663|NCT02092467|11185055|FG001|COMPLETED|Overall Study||998
10059664|NCT02092467|11185056|FG002|COMPLETED|Overall Study||1060
10059665|NCT02092467|11185054|FG000|NOT COMPLETED|Overall Study||404
10059666|NCT02092467|11185055|FG001|NOT COMPLETED|Overall Study||459
10059667|NCT02092467|11185056|FG002|NOT COMPLETED|Overall Study||398
10059668|NCT02092610|11185068|FG000|STARTED|Overall Study||25
10059669|NCT02092610|11185069|FG001|STARTED|Overall Study||52
10059670|NCT02092610|11185068|FG000|COMPLETED|Overall Study||17
10059671|NCT02092610|11185069|FG001|COMPLETED|Overall Study||40
10059672|NCT02092610|11185068|FG000|NOT COMPLETED|Overall Study||8
10059673|NCT02092610|11185069|FG001|NOT COMPLETED|Overall Study||12
10059674|NCT02092649|11185077|FG000|STARTED|Overall Study|13 participants recruited|13
10059675|NCT02092649|11185078|FG001|STARTED|Overall Study|13 participants recruited|13
10059676|NCT02092649|11185077|FG000|COMPLETED|Overall Study|13 participants finished study|13
10059677|NCT02092649|11185078|FG001|COMPLETED|Overall Study|13 participants finished study|13
10059678|NCT02092649|11185077|FG000|NOT COMPLETED|Overall Study||0
10059679|NCT02092649|11185078|FG001|NOT COMPLETED|Overall Study||0
10059680|NCT02092662|11185086|FG000|STARTED|Overall Study||38
10059681|NCT02092662|11185087|FG001|STARTED|Overall Study||19
10059682|NCT02092662|11185086|FG000|Recruited|Overall Study||38
10059683|NCT02092662|11185087|FG001|Recruited|Overall Study||19
10059684|NCT02092662|11185086|FG000|COMPLETED|Overall Study||25
10059685|NCT02092662|11185087|FG001|COMPLETED|Overall Study||19
10059686|NCT02092662|11185086|FG000|NOT COMPLETED|Overall Study||13
10059687|NCT02092662|11185087|FG001|NOT COMPLETED|Overall Study||0
10059688|NCT02092857|11185097|FG000|STARTED|Overall Study||30
10059689|NCT02092857|11185098|FG001|STARTED|Overall Study||30
10059690|NCT02092857|11185099|FG002|STARTED|Overall Study||29
10059691|NCT02092857|11185097|FG000|COMPLETED|Overall Study||20
10059692|NCT02092857|11185098|FG001|COMPLETED|Overall Study||18
10059693|NCT02092857|11185099|FG002|COMPLETED|Overall Study||16
10059694|NCT02092857|11185097|FG000|NOT COMPLETED|Overall Study||10
10059695|NCT02092857|11185098|FG001|NOT COMPLETED|Overall Study||12
10122024|NCT02573181|11253108|FG001|COMPLETED|Overall Study||126
10122025|NCT02573181|11253107|FG000|NOT COMPLETED|Overall Study||0
10059696|NCT02092857|11185099|FG002|NOT COMPLETED|Overall Study||13
10059697|NCT02092909|11185111|FG000|STARTED|Overall Study||6
10059698|NCT02092909|11185112|FG001|STARTED|Overall Study||5
10059699|NCT02092909|11185113|FG002|STARTED|Overall Study||14
10059700|NCT02092909|11185114|FG003|STARTED|Overall Study||6
10059701|NCT02092909|11185111|FG000|COMPLETED|Overall Study||5
10059702|NCT02092909|11185112|FG001|COMPLETED|Overall Study||2
10059703|NCT02092909|11185113|FG002|COMPLETED|Overall Study||5
10059704|NCT02092909|11185114|FG003|COMPLETED|Overall Study||0
10059705|NCT02092909|11185111|FG000|NOT COMPLETED|Overall Study||1
10059706|NCT02092909|11185112|FG001|NOT COMPLETED|Overall Study||3
10059707|NCT02092909|11185113|FG002|NOT COMPLETED|Overall Study||9
10059708|NCT02092909|11185114|FG003|NOT COMPLETED|Overall Study||6
10122026|NCT02573181|11253108|FG001|NOT COMPLETED|Overall Study||0
10122027|NCT02573246|11253119|FG000|STARTED|Overall Study||14
10059709|NCT02092961|11185127|FG000|STARTED|Overall Study|Patients who received treatment|33
10059710|NCT02092961|11185128|FG001|STARTED|Overall Study|Patients who received treatment|28
10059711|NCT02092961|11185129|FG002|STARTED|Overall Study|Patients who received treatment|29
10059712|NCT02092961|11185127|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
10059713|NCT02092961|11185128|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
10059714|NCT02092961|11185129|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
10059715|NCT02092961|11185127|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
10059716|NCT02092961|11185128|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
10059717|NCT02092961|11185129|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
10059718|NCT02092961|11185127|FG000|NOT COMPLETED|Overall Study||21
10059719|NCT02092961|11185128|FG001|NOT COMPLETED|Overall Study||14
10059720|NCT02092961|11185129|FG002|NOT COMPLETED|Overall Study||16
10059721|NCT02092987|11185140|FG000|STARTED|Overall Study||110
10059722|NCT02092987|11185141|FG001|STARTED|Overall Study||111
10059723|NCT02092987|11185140|FG000|COMPLETED|Overall Study||106
10059724|NCT02092987|11185141|FG001|COMPLETED|Overall Study||103
10059725|NCT02092987|11185140|FG000|NOT COMPLETED|Overall Study||4
10059726|NCT02092987|11185141|FG001|NOT COMPLETED|Overall Study||8
10059727|NCT02093026|11185150|FG000|STARTED|Overall Study||465
10122028|NCT02573246|11253120|FG001|STARTED|Overall Study||15
10122029|NCT02573246|11253121|FG002|STARTED|Overall Study||18
10122030|NCT02573246|11253122|FG003|STARTED|Overall Study||16
10122031|NCT02573246|11253123|FG004|STARTED|Overall Study||15
10122032|NCT02573246|11253119|FG000|COMPLETED|Overall Study||11
10122033|NCT02573246|11253120|FG001|COMPLETED|Overall Study||14
10122034|NCT02573246|11253121|FG002|COMPLETED|Overall Study||15
10122035|NCT02573246|11253122|FG003|COMPLETED|Overall Study||14
10122036|NCT02573246|11253123|FG004|COMPLETED|Overall Study||11
10122037|NCT02573246|11253119|FG000|NOT COMPLETED|Overall Study||3
10122038|NCT02573246|11253120|FG001|NOT COMPLETED|Overall Study||1
10122039|NCT02573246|11253121|FG002|NOT COMPLETED|Overall Study||3
10122040|NCT02573246|11253122|FG003|NOT COMPLETED|Overall Study||2
10122041|NCT02573246|11253123|FG004|NOT COMPLETED|Overall Study||4
10122042|NCT02573311|11253142|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
10122043|NCT02573311|11253143|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
10122044|NCT02573311|11253142|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
10122045|NCT02573311|11253143|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
10122046|NCT02573311|11253142|FG000|NOT COMPLETED|Disposition for Part 1||7
10122047|NCT02573311|11253143|FG001|NOT COMPLETED|Disposition for Part 1||3
10122048|NCT02573311|11253142|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
10122049|NCT02573311|11253143|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
10122050|NCT02573311|11253142|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
10122051|NCT02573311|11253143|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
10122052|NCT02573311|11253142|FG000|NOT COMPLETED|Disposition for Part 2||210
10122053|NCT02573311|11253143|FG001|NOT COMPLETED|Disposition for Part 2||26
10122054|NCT02573350|11253151|FG000|STARTED|Overall Study||137
10122055|NCT02573350|11253152|FG001|STARTED|Overall Study||76
10122056|NCT02573350|11253151|FG000|Efficacy Analysis Population|Overall Study||132
10122057|NCT02573350|11253152|FG001|Efficacy Analysis Population|Overall Study||73
10122058|NCT02573350|11253151|FG000|Safety Population|Overall Study||137
10122059|NCT02573350|11253152|FG001|Safety Population|Overall Study||76
10122060|NCT02573350|11253151|FG000|COMPLETED|Overall Study||121
10122061|NCT02573350|11253152|FG001|COMPLETED|Overall Study||67
10122062|NCT02573350|11253151|FG000|NOT COMPLETED|Overall Study||16
10122063|NCT02573350|11253152|FG001|NOT COMPLETED|Overall Study||9
10122064|NCT02573402|11253163|FG000|STARTED|Overall Study||12
10122065|NCT02573402|11253164|FG001|STARTED|Overall Study||7
10122066|NCT02573402|11253163|FG000|COMPLETED|Overall Study||12
10122067|NCT02573402|11253164|FG001|COMPLETED|Overall Study||7
10122068|NCT02573402|11253163|FG000|NOT COMPLETED|Overall Study||0
10122069|NCT02573402|11253164|FG001|NOT COMPLETED|Overall Study||0
10122070|NCT02573467|11253174|FG000|STARTED|Double-blind Treatment Epoch||53
10122071|NCT02573467|11253175|FG001|STARTED|Double-blind Treatment Epoch||52
10122072|NCT02573467|11253176|FG002|STARTED|Double-blind Treatment Epoch||51
10122073|NCT02573467|11253177|FG003|STARTED|Double-blind Treatment Epoch||55
10122074|NCT02573467|11253174|FG000|Full Analysis Set|Double-blind Treatment Epoch||53
10122075|NCT02573467|11253175|FG001|Full Analysis Set|Double-blind Treatment Epoch||52
10122076|NCT02573467|11253176|FG002|Full Analysis Set|Double-blind Treatment Epoch||51
10122077|NCT02573467|11253177|FG003|Full Analysis Set|Double-blind Treatment Epoch||55
10122078|NCT02573467|11253174|FG000|COMPLETED|Double-blind Treatment Epoch||0
10122079|NCT02573467|11253175|FG001|COMPLETED|Double-blind Treatment Epoch||0
10122080|NCT02573467|11253176|FG002|COMPLETED|Double-blind Treatment Epoch||0
10122081|NCT02573467|11253177|FG003|COMPLETED|Double-blind Treatment Epoch||0
10122082|NCT02573467|11253174|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53
10122083|NCT02573467|11253175|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52
10122084|NCT02573467|11253176|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51
10122085|NCT02573467|11253177|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55
10122086|NCT02573467|11253174|FG000|STARTED|Post-treatment Follow up Epoch||41
10122087|NCT02573467|11253175|FG001|STARTED|Post-treatment Follow up Epoch||46
10059728|NCT02093026|11185150|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
10122088|NCT02573467|11253176|FG002|STARTED|Post-treatment Follow up Epoch||44
10122089|NCT02573467|11253177|FG003|STARTED|Post-treatment Follow up Epoch||47
10122090|NCT02573467|11253174|FG000|COMPLETED|Post-treatment Follow up Epoch||35
10059729|NCT02093026|11185150|FG000|NOT COMPLETED|Overall Study||193
10059730|NCT02093221|11185160|FG000|STARTED|Overall Study||15
10059731|NCT02093221|11185161|FG001|STARTED|Overall Study||16
10059732|NCT02093221|11185162|FG002|STARTED|Overall Study||15
10059733|NCT02093221|11185163|FG003|STARTED|Overall Study||15
10059734|NCT02093221|11185164|FG004|STARTED|Overall Study||15
10059735|NCT02093221|11185160|FG000|COMPLETED|Overall Study||5
10059736|NCT02093221|11185161|FG001|COMPLETED|Overall Study||8
10059737|NCT02093221|11185162|FG002|COMPLETED|Overall Study||6
10059738|NCT02093221|11185163|FG003|COMPLETED|Overall Study||7
10059739|NCT02093221|11185164|FG004|COMPLETED|Overall Study||7
10059740|NCT02093221|11185160|FG000|NOT COMPLETED|Overall Study||10
10059741|NCT02093221|11185161|FG001|NOT COMPLETED|Overall Study||8
10059742|NCT02093221|11185162|FG002|NOT COMPLETED|Overall Study||9
10059743|NCT02093221|11185163|FG003|NOT COMPLETED|Overall Study||8
10059744|NCT02093221|11185164|FG004|NOT COMPLETED|Overall Study||8
10059745|NCT02093234|11185179|FG000|STARTED|Overall Study||56
10059746|NCT02093234|11185180|FG001|STARTED|Overall Study||56
10059747|NCT02093234|11185181|FG002|STARTED|Overall Study||54
10059748|NCT02093234|11185179|FG000|COMPLETED|Overall Study||53
10059749|NCT02093234|11185180|FG001|COMPLETED|Overall Study||52
10059750|NCT02093234|11185181|FG002|COMPLETED|Overall Study||50
10059751|NCT02093234|11185179|FG000|NOT COMPLETED|Overall Study||3
10059752|NCT02093234|11185180|FG001|NOT COMPLETED|Overall Study||4
10059753|NCT02093234|11185181|FG002|NOT COMPLETED|Overall Study||4
10059754|NCT02093351|11185192|FG000|STARTED|Part A||30
10059755|NCT02093351|11185193|FG001|STARTED|Part A||23
10059756|NCT02093351|11185194|FG002|STARTED|Part A||26
10059757|NCT02093351|11185195|FG003|STARTED|Part A||0
10059758|NCT02093351|11185192|FG000|Completing Treatment Period 1|Part A||29
10059759|NCT02093351|11185193|FG001|Completing Treatment Period 1|Part A||22
10059760|NCT02093351|11185194|FG002|Completing Treatment Period 1|Part A||23
10059761|NCT02093351|11185195|FG003|Completing Treatment Period 1|Part A||0
10059762|NCT02093351|11185192|FG000|Completing Treatment Period 2|Part A||29
10059763|NCT02093351|11185193|FG001|Completing Treatment Period 2|Part A||21
10059764|NCT02093351|11185194|FG002|Completing Treatment Period 2|Part A||23
10059765|NCT02093351|11185195|FG003|Completing Treatment Period 2|Part A||0
10059766|NCT02093351|11185192|FG000|Completing Treatment Period 3|Part A||28
10059767|NCT02093351|11185193|FG001|Completing Treatment Period 3|Part A||21
10059768|NCT02093351|11185194|FG002|Completing Treatment Period 3|Part A||23
10059769|NCT02093351|11185195|FG003|Completing Treatment Period 3|Part A||0
10122091|NCT02573467|11253175|FG001|COMPLETED|Post-treatment Follow up Epoch||41
10122092|NCT02573467|11253176|FG002|COMPLETED|Post-treatment Follow up Epoch||34
10122093|NCT02573467|11253177|FG003|COMPLETED|Post-treatment Follow up Epoch||44
10122094|NCT02573467|11253174|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6
10122095|NCT02573467|11253175|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5
10122096|NCT02573467|11253176|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10
10122097|NCT02573467|11253177|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3
10122098|NCT02573857|11253190|FG000|STARTED|Overall Study||8
10122099|NCT02573857|11253191|FG001|STARTED|Overall Study||8
10122100|NCT02573857|11253190|FG000|COMPLETED|Overall Study||8
10122101|NCT02573857|11253191|FG001|COMPLETED|Overall Study||8
10122102|NCT02573857|11253190|FG000|NOT COMPLETED|Overall Study||0
10122103|NCT02573857|11253191|FG001|NOT COMPLETED|Overall Study||0
10122104|NCT02573870|11253199|FG000|STARTED|Overall Study||20
10122105|NCT02573870|11253200|FG001|STARTED|Overall Study||42
10122106|NCT02573870|11253199|FG000|COMPLETED|Overall Study||20
10122107|NCT02573870|11253200|FG001|COMPLETED|Overall Study||35
10122108|NCT02573870|11253199|FG000|NOT COMPLETED|Overall Study||0
10122109|NCT02573870|11253200|FG001|NOT COMPLETED|Overall Study||7
10122110|NCT02573883|11253208|FG000|STARTED|Six Month Follow Up||25
10122111|NCT02573883|11253209|FG001|STARTED|Six Month Follow Up||27
10122112|NCT02573883|11253210|FG002|STARTED|Six Month Follow Up||0
10122113|NCT02573883|11253211|FG003|STARTED|Six Month Follow Up||0
10122114|NCT02573883|11253208|FG000|COMPLETED|Six Month Follow Up||24
10122115|NCT02573883|11253209|FG001|COMPLETED|Six Month Follow Up||27
10122116|NCT02573883|11253210|FG002|COMPLETED|Six Month Follow Up||0
10122117|NCT02573883|11253211|FG003|COMPLETED|Six Month Follow Up||0
10122118|NCT02573883|11253208|FG000|NOT COMPLETED|Six Month Follow Up||1
10059770|NCT02093351|11185192|FG000|COMPLETED|Part A||28
10059771|NCT02093351|11185193|FG001|COMPLETED|Part A||21
10059772|NCT02093351|11185194|FG002|COMPLETED|Part A||23
10059773|NCT02093351|11185195|FG003|COMPLETED|Part A||0
10059774|NCT02093351|11185192|FG000|NOT COMPLETED|Part A||2
10059775|NCT02093351|11185193|FG001|NOT COMPLETED|Part A||2
10059776|NCT02093351|11185194|FG002|NOT COMPLETED|Part A||3
10059777|NCT02093351|11185195|FG003|NOT COMPLETED|Part A||0
10059778|NCT02093351|11185192|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
10122119|NCT02573883|11253209|FG001|NOT COMPLETED|Six Month Follow Up||0
10122120|NCT02573883|11253210|FG002|NOT COMPLETED|Six Month Follow Up||0
10122121|NCT02573883|11253211|FG003|NOT COMPLETED|Six Month Follow Up||0
10122122|NCT02573883|11253208|FG000|STARTED|One Year Follow Up||13
10122123|NCT02573883|11253209|FG001|STARTED|One Year Follow Up||17
10122124|NCT02573883|11253210|FG002|STARTED|One Year Follow Up||11
10122125|NCT02573883|11253211|FG003|STARTED|One Year Follow Up||10
10122126|NCT02573883|11253208|FG000|COMPLETED|One Year Follow Up||11
10059779|NCT02093351|11185193|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
10059780|NCT02093351|11185194|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
10059781|NCT02093351|11185195|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
10059782|NCT02093351|11185192|FG000|COMPLETED|Part B||0
10059783|NCT02093351|11185193|FG001|COMPLETED|Part B||0
10059784|NCT02093351|11185194|FG002|COMPLETED|Part B||0
10059785|NCT02093351|11185195|FG003|COMPLETED|Part B||6
10122127|NCT02573883|11253209|FG001|COMPLETED|One Year Follow Up||16
10122128|NCT02573883|11253210|FG002|COMPLETED|One Year Follow Up||11
10122129|NCT02573883|11253211|FG003|COMPLETED|One Year Follow Up||10
10122130|NCT02573883|11253208|FG000|NOT COMPLETED|One Year Follow Up||2
10122131|NCT02573883|11253209|FG001|NOT COMPLETED|One Year Follow Up||1
10122132|NCT02573883|11253210|FG002|NOT COMPLETED|One Year Follow Up||0
10122133|NCT02573883|11253211|FG003|NOT COMPLETED|One Year Follow Up||0
10122134|NCT02573948|11253226|FG000|STARTED|RDS||603
10122135|NCT02573948|11253226|FG000|COMPLETED|RDS||603
10122136|NCT02573948|11253226|FG000|NOT COMPLETED|RDS||0
10122137|NCT02573948|11253226|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
10122138|NCT02573948|11253226|FG000|COMPLETED|Longitudinal Cohort||194
10122139|NCT02573948|11253226|FG000|NOT COMPLETED|Longitudinal Cohort||56
10122140|NCT02574078|11253246|FG000|STARTED|Pre-Treatment Period||13
10122141|NCT02574078|11253247|FG001|STARTED|Pre-Treatment Period||6
10122142|NCT02574078|11253248|FG002|STARTED|Pre-Treatment Period||9
10122143|NCT02574078|11253249|FG003|STARTED|Pre-Treatment Period||35
10122144|NCT02574078|11253250|FG004|STARTED|Pre-Treatment Period||34
10122145|NCT02574078|11253251|FG005|STARTED|Pre-Treatment Period||35
10122146|NCT02574078|11253252|FG006|STARTED|Pre-Treatment Period||18
10122147|NCT02574078|11253253|FG007|STARTED|Pre-Treatment Period||17
10122148|NCT02574078|11253254|FG008|STARTED|Pre-Treatment Period||26
10122149|NCT02574078|11253255|FG009|STARTED|Pre-Treatment Period||26
10122150|NCT02574078|11253256|FG010|STARTED|Pre-Treatment Period||53
10122151|NCT02574078|11253257|FG011|STARTED|Pre-Treatment Period||56
10122152|NCT02574078|11253258|FG012|STARTED|Pre-Treatment Period||13
10122153|NCT02574078|11253246|FG000|COMPLETED|Pre-Treatment Period||13
10122154|NCT02574078|11253247|FG001|COMPLETED|Pre-Treatment Period||6
10122155|NCT02574078|11253248|FG002|COMPLETED|Pre-Treatment Period||9
10122156|NCT02574078|11253249|FG003|COMPLETED|Pre-Treatment Period||35
10122157|NCT02574078|11253250|FG004|COMPLETED|Pre-Treatment Period||34
10122158|NCT02574078|11253251|FG005|COMPLETED|Pre-Treatment Period||34
10122159|NCT02574078|11253252|FG006|COMPLETED|Pre-Treatment Period||14
10122160|NCT02574078|11253253|FG007|COMPLETED|Pre-Treatment Period||14
10122161|NCT02574078|11253254|FG008|COMPLETED|Pre-Treatment Period||25
10122162|NCT02574078|11253255|FG009|COMPLETED|Pre-Treatment Period||26
9848665|NCT00860951|10961421|FG000|COMPLETED|Overall Study||22
9848666|NCT00860951|10961421|FG000|NOT COMPLETED|Overall Study||7
9848667|NCT00861146|10961429|FG000|STARTED|Overall Study||105
9848668|NCT00861146|10961430|FG001|STARTED|Overall Study||46
9848669|NCT00861146|10961429|FG000|Week 2 Assessment|Overall Study||97
10059786|NCT02093351|11185192|FG000|NOT COMPLETED|Part B||0
10122163|NCT02574078|11253256|FG010|COMPLETED|Pre-Treatment Period||49
10122164|NCT02574078|11253257|FG011|COMPLETED|Pre-Treatment Period||55
10122165|NCT02574078|11253258|FG012|COMPLETED|Pre-Treatment Period||13
10122166|NCT02574078|11253246|FG000|NOT COMPLETED|Pre-Treatment Period||0
10122167|NCT02574078|11253247|FG001|NOT COMPLETED|Pre-Treatment Period||0
10122168|NCT02574078|11253248|FG002|NOT COMPLETED|Pre-Treatment Period||0
10122169|NCT02574078|11253249|FG003|NOT COMPLETED|Pre-Treatment Period||0
10122170|NCT02574078|11253250|FG004|NOT COMPLETED|Pre-Treatment Period||0
10122171|NCT02574078|11253251|FG005|NOT COMPLETED|Pre-Treatment Period||1
10122172|NCT02574078|11253252|FG006|NOT COMPLETED|Pre-Treatment Period||4
10122173|NCT02574078|11253253|FG007|NOT COMPLETED|Pre-Treatment Period||3
10122174|NCT02574078|11253254|FG008|NOT COMPLETED|Pre-Treatment Period||1
10122175|NCT02574078|11253255|FG009|NOT COMPLETED|Pre-Treatment Period||0
10122176|NCT02574078|11253256|FG010|NOT COMPLETED|Pre-Treatment Period||4
10122177|NCT02574078|11253257|FG011|NOT COMPLETED|Pre-Treatment Period||1
10122178|NCT02574078|11253258|FG012|NOT COMPLETED|Pre-Treatment Period||0
10122179|NCT02574078|11253246|FG000|STARTED|Treatment Period||13
10122180|NCT02574078|11253247|FG001|STARTED|Treatment Period||6
10122181|NCT02574078|11253248|FG002|STARTED|Treatment Period||9
10122182|NCT02574078|11253249|FG003|STARTED|Treatment Period||35
10122183|NCT02574078|11253250|FG004|STARTED|Treatment Period||34
10122184|NCT02574078|11253251|FG005|STARTED|Treatment Period||34
10122185|NCT02574078|11253252|FG006|STARTED|Treatment Period||14
10122186|NCT02574078|11253253|FG007|STARTED|Treatment Period||14
10122187|NCT02574078|11253254|FG008|STARTED|Treatment Period||25
9848670|NCT00861146|10961430|FG001|Week 2 Assessment|Overall Study||45
10059787|NCT02093351|11185193|FG001|NOT COMPLETED|Part B||0
10122188|NCT02574078|11253255|FG009|STARTED|Treatment Period||26
10122189|NCT02574078|11253256|FG010|STARTED|Treatment Period||49
10122190|NCT02574078|11253257|FG011|STARTED|Treatment Period||55
10122191|NCT02574078|11253258|FG012|STARTED|Treatment Period||13
10122192|NCT02574078|11253246|FG000|COMPLETED|Treatment Period||3
10122193|NCT02574078|11253247|FG001|COMPLETED|Treatment Period||0
10122194|NCT02574078|11253248|FG002|COMPLETED|Treatment Period||0
10122195|NCT02574078|11253249|FG003|COMPLETED|Treatment Period||7
10122196|NCT02574078|11253250|FG004|COMPLETED|Treatment Period||3
10122197|NCT02574078|11253251|FG005|COMPLETED|Treatment Period||1
10122198|NCT02574078|11253252|FG006|COMPLETED|Treatment Period||2
10059788|NCT02093351|11185194|FG002|NOT COMPLETED|Part B||0
10059789|NCT02093351|11185195|FG003|NOT COMPLETED|Part B||63
10059790|NCT02093390|11185212|FG000|STARTED|Overall Study||20
10059791|NCT02093390|11185213|FG001|STARTED|Overall Study||20
10059792|NCT02093390|11185212|FG000|COMPLETED|Overall Study||20
10059793|NCT02093390|11185213|FG001|COMPLETED|Overall Study||19
10059794|NCT02093390|11185212|FG000|NOT COMPLETED|Overall Study||0
10059795|NCT02093390|11185213|FG001|NOT COMPLETED|Overall Study||1
10059796|NCT02093520|11185222|FG000|STARTED|Overall Study||149
10059797|NCT02093520|11185223|FG001|STARTED|Overall Study||153
10059798|NCT02093520|11185222|FG000|COMPLETED|Overall Study||143
10059799|NCT02093520|11185223|FG001|COMPLETED|Overall Study||131
10059800|NCT02093520|11185222|FG000|NOT COMPLETED|Overall Study||6
10059801|NCT02093520|11185223|FG001|NOT COMPLETED|Overall Study||22
10122199|NCT02574078|11253253|FG007|COMPLETED|Treatment Period||2
10122200|NCT02574078|11253254|FG008|COMPLETED|Treatment Period||1
10122201|NCT02574078|11253255|FG009|COMPLETED|Treatment Period||9
10122202|NCT02574078|11253256|FG010|COMPLETED|Treatment Period||4
10122203|NCT02574078|11253257|FG011|COMPLETED|Treatment Period||8
10122204|NCT02574078|11253258|FG012|COMPLETED|Treatment Period||0
10122205|NCT02574078|11253246|FG000|NOT COMPLETED|Treatment Period||10
10122206|NCT02574078|11253247|FG001|NOT COMPLETED|Treatment Period||6
10122207|NCT02574078|11253248|FG002|NOT COMPLETED|Treatment Period||9
10122208|NCT02574078|11253249|FG003|NOT COMPLETED|Treatment Period||28
10122209|NCT02574078|11253250|FG004|NOT COMPLETED|Treatment Period||31
10122210|NCT02574078|11253251|FG005|NOT COMPLETED|Treatment Period||33
10122211|NCT02574078|11253252|FG006|NOT COMPLETED|Treatment Period||12
10122212|NCT02574078|11253253|FG007|NOT COMPLETED|Treatment Period||12
10122213|NCT02574078|11253254|FG008|NOT COMPLETED|Treatment Period||24
10122214|NCT02574078|11253255|FG009|NOT COMPLETED|Treatment Period||17
10122215|NCT02574078|11253256|FG010|NOT COMPLETED|Treatment Period||45
10122216|NCT02574078|11253257|FG011|NOT COMPLETED|Treatment Period||47
10122217|NCT02574078|11253258|FG012|NOT COMPLETED|Treatment Period||13
10122218|NCT02574247|11253292|FG000|STARTED|Overall Study||10
10122219|NCT02574247|11253293|FG001|STARTED|Overall Study||8
10122220|NCT02574247|11253294|FG002|STARTED|Overall Study||10
10122221|NCT02574247|11253292|FG000|COMPLETED|Overall Study||5
10122222|NCT02574247|11253293|FG001|COMPLETED|Overall Study||5
10122223|NCT02574247|11253294|FG002|COMPLETED|Overall Study||5
10122224|NCT02574247|11253292|FG000|NOT COMPLETED|Overall Study||5
10122225|NCT02574247|11253293|FG001|NOT COMPLETED|Overall Study||3
10122226|NCT02574247|11253294|FG002|NOT COMPLETED|Overall Study||5
10122227|NCT02574260|11253304|FG000|STARTED|Overall Study||3
10122228|NCT02574260|11253304|FG000|COMPLETED|Overall Study||2
10122229|NCT02574260|11253304|FG000|NOT COMPLETED|Overall Study||1
10122230|NCT02574312|11253310|FG000|STARTED|Pre-Operative||44
10122231|NCT02574312|11253311|FG001|STARTED|Pre-Operative||44
10122232|NCT02574312|11253310|FG000|COMPLETED|Pre-Operative||44
10122233|NCT02574312|11253311|FG001|COMPLETED|Pre-Operative||44
10122234|NCT02574312|11253310|FG000|NOT COMPLETED|Pre-Operative||0
10122235|NCT02574312|11253311|FG001|NOT COMPLETED|Pre-Operative||0
10122236|NCT02574312|11253310|FG000|STARTED|3 Months Follow-up||44
10122237|NCT02574312|11253311|FG001|STARTED|3 Months Follow-up||44
10122238|NCT02574312|11253310|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
10122239|NCT02574312|11253311|FG001|COMPLETED|3 Months Follow-up||44
10122240|NCT02574312|11253310|FG000|NOT COMPLETED|3 Months Follow-up||1
10122241|NCT02574312|11253311|FG001|NOT COMPLETED|3 Months Follow-up||0
10122242|NCT02574520|11253321|FG000|STARTED|Overall Study||48
10122243|NCT02574520|11253322|FG001|STARTED|Overall Study||46
10122244|NCT02574520|11253323|FG002|STARTED|Overall Study||153
10122245|NCT02574520|11253324|FG003|STARTED|Overall Study||152
10122246|NCT02574520|11253321|FG000|Dosed|Overall Study||46
10122247|NCT02574520|11253322|FG001|Dosed|Overall Study||46
10122248|NCT02574520|11253323|FG002|Dosed|Overall Study||148
10122249|NCT02574520|11253324|FG003|Dosed|Overall Study||148
10122250|NCT02574520|11253321|FG000|COMPLETED|Overall Study||46
10122251|NCT02574520|11253322|FG001|COMPLETED|Overall Study||46
10122252|NCT02574520|11253323|FG002|COMPLETED|Overall Study||148
10122253|NCT02574520|11253324|FG003|COMPLETED|Overall Study||144
10122254|NCT02574520|11253321|FG000|NOT COMPLETED|Overall Study||2
10122255|NCT02574520|11253322|FG001|NOT COMPLETED|Overall Study||0
10122256|NCT02574520|11253323|FG002|NOT COMPLETED|Overall Study||5
10122257|NCT02574520|11253324|FG003|NOT COMPLETED|Overall Study||8
10122258|NCT02574598|11253336|FG000|STARTED|Overall Study||40
10122259|NCT02574598|11253337|FG001|STARTED|Overall Study||38
10122260|NCT02574598|11253336|FG000|COMPLETED|Overall Study||40
10122261|NCT02574598|11253337|FG001|COMPLETED|Overall Study||38
10122262|NCT02574598|11253336|FG000|NOT COMPLETED|Overall Study||0
10122263|NCT02574598|11253337|FG001|NOT COMPLETED|Overall Study||0
10122264|NCT02574637|11253348|FG000|STARTED|Double-blind Period||5
10122265|NCT02574637|11253349|FG001|STARTED|Double-blind Period||5
10122266|NCT02574637|11253350|FG002|STARTED|Double-blind Period||9
10122267|NCT02574637|11253351|FG003|STARTED|Double-blind Period||7
10122268|NCT02574637|11253352|FG004|STARTED|Double-blind Period||3
10122269|NCT02574637|11253353|FG005|STARTED|Double-blind Period||0
10122270|NCT02574637|11253354|FG006|STARTED|Double-blind Period||0
10122271|NCT02574637|11253355|FG007|STARTED|Double-blind Period||0
10122272|NCT02574637|11253356|FG008|STARTED|Double-blind Period||0
10122273|NCT02574637|11253357|FG009|STARTED|Double-blind Period||0
10122274|NCT02574637|11253348|FG000|COMPLETED|Double-blind Period||2
10122275|NCT02574637|11253349|FG001|COMPLETED|Double-blind Period||4
10059802|NCT02093663|11185229|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27
10059803|NCT02093663|11185230|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26
10059804|NCT02093663|11185231|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0
10059805|NCT02093663|11185232|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0
10059806|NCT02093663|11185233|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0
10059807|NCT02093663|11185229|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
10059808|NCT02093663|11185230|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
10059809|NCT02093663|11185231|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10059810|NCT02093663|11185232|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10059811|NCT02093663|11185233|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10059812|NCT02093663|11185229|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
10059813|NCT02093663|11185230|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
10059814|NCT02093663|11185231|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10059815|NCT02093663|11185232|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10059816|NCT02093663|11185233|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10059817|NCT02093663|11185229|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0
10059818|NCT02093663|11185230|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0
10059819|NCT02093663|11185231|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18
10059820|NCT02093663|11185232|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0
10059821|NCT02093663|11185233|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0
10059822|NCT02093663|11185229|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10059823|NCT02093663|11185230|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10059824|NCT02093663|11185231|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
10059825|NCT02093663|11185232|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10059826|NCT02093663|11185233|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10059827|NCT02093663|11185229|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059828|NCT02093663|11185230|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059829|NCT02093663|11185231|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12
10059830|NCT02093663|11185232|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059831|NCT02093663|11185233|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059832|NCT02093663|11185229|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059833|NCT02093663|11185230|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059834|NCT02093663|11185231|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
10059835|NCT02093663|11185232|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059836|NCT02093663|11185233|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10059837|NCT02093663|11185229|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
10059838|NCT02093663|11185230|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
10059839|NCT02093663|11185231|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
10059840|NCT02093663|11185232|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
10059841|NCT02093663|11185233|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
10059842|NCT02093663|11185229|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
10059843|NCT02093663|11185230|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
10059844|NCT02093663|11185231|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
10059845|NCT02093663|11185232|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
10059846|NCT02093663|11185233|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
10059847|NCT02093663|11185229|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
10059848|NCT02093663|11185230|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
10059849|NCT02093663|11185231|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
10059850|NCT02093663|11185232|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
10059851|NCT02093663|11185233|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
10059852|NCT02093663|11185229|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
10059853|NCT02093663|11185230|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
10059854|NCT02093663|11185231|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
10059855|NCT02093663|11185232|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
10059856|NCT02093663|11185233|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
10059857|NCT02093663|11185229|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10059858|NCT02093663|11185230|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10059859|NCT02093663|11185231|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10059860|NCT02093663|11185232|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
10059861|NCT02093663|11185233|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
10059862|NCT02093663|11185229|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10059863|NCT02093663|11185230|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10059864|NCT02093663|11185231|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10059865|NCT02093663|11185232|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
10059866|NCT02093663|11185233|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
10059867|NCT02093702|11185252|FG000|STARTED|Overall Study||2
10059868|NCT02093702|11185253|FG001|STARTED|Overall Study||3
10059869|NCT02093702|11185252|FG000|COMPLETED|Overall Study||2
10059870|NCT02093702|11185253|FG001|COMPLETED|Overall Study||3
10059871|NCT02093702|11185252|FG000|NOT COMPLETED|Overall Study||0
10059872|NCT02093702|11185253|FG001|NOT COMPLETED|Overall Study||0
10059873|NCT02093793|11185263|FG000|STARTED|Overall Study||98
10059874|NCT02093793|11185264|FG001|STARTED|Overall Study||90
10059875|NCT02093793|11185265|FG002|STARTED|Overall Study||68
10059876|NCT02093793|11185263|FG000|COMPLETED|Overall Study||91
10059877|NCT02093793|11185264|FG001|COMPLETED|Overall Study||80
10059878|NCT02093793|11185265|FG002|COMPLETED|Overall Study||65
10059879|NCT02093793|11185263|FG000|NOT COMPLETED|Overall Study||7
10059880|NCT02093793|11185264|FG001|NOT COMPLETED|Overall Study||10
10059881|NCT02093793|11185265|FG002|NOT COMPLETED|Overall Study||3
10059882|NCT02093819|11185281|FG000|STARTED|Overall Study||15
10059883|NCT02093819|11185282|FG001|STARTED|Overall Study||6
10059884|NCT02093819|11185283|FG002|STARTED|Overall Study||10
10059885|NCT02093819|11185284|FG003|STARTED|Overall Study||6
10059886|NCT02093819|11185285|FG004|STARTED|Overall Study||6
10059887|NCT02093819|11185286|FG005|STARTED|Overall Study||6
10059888|NCT02093819|11185287|FG006|STARTED|Overall Study||5
10059889|NCT02093819|11185288|FG007|STARTED|Overall Study||6
10059890|NCT02093819|11185281|FG000|COMPLETED|Overall Study||15
10059891|NCT02093819|11185282|FG001|COMPLETED|Overall Study||6
10059892|NCT02093819|11185283|FG002|COMPLETED|Overall Study||10
10059893|NCT02093819|11185284|FG003|COMPLETED|Overall Study||6
10059894|NCT02093819|11185285|FG004|COMPLETED|Overall Study||6
10059895|NCT02093819|11185286|FG005|COMPLETED|Overall Study||6
10059896|NCT02093819|11185287|FG006|COMPLETED|Overall Study||5
10059897|NCT02093819|11185288|FG007|COMPLETED|Overall Study||6
10059898|NCT02093819|11185281|FG000|NOT COMPLETED|Overall Study||0
10059899|NCT02093819|11185282|FG001|NOT COMPLETED|Overall Study||0
10059900|NCT02093819|11185283|FG002|NOT COMPLETED|Overall Study||0
10059901|NCT02093819|11185284|FG003|NOT COMPLETED|Overall Study||0
10059902|NCT02093819|11185285|FG004|NOT COMPLETED|Overall Study||0
10059903|NCT02093819|11185286|FG005|NOT COMPLETED|Overall Study||0
10059904|NCT02093819|11185287|FG006|NOT COMPLETED|Overall Study||0
10059905|NCT02093819|11185288|FG007|NOT COMPLETED|Overall Study||0
10059906|NCT02093897|11185315|FG000|STARTED|Overall Study||84
10059907|NCT02093897|11185315|FG000|COMPLETED|Overall Study||65
10059908|NCT02093897|11185315|FG000|NOT COMPLETED|Overall Study||19
10059909|NCT02093923|11185331|FG000|STARTED|Overall Study||4
10059910|NCT02093923|11185332|FG001|STARTED|Overall Study||4
10059911|NCT02093923|11185333|FG002|STARTED|Overall Study||5
10059912|NCT02093923|11185334|FG003|STARTED|Overall Study||12
10059913|NCT02093923|11185335|FG004|STARTED|Overall Study||13
10059914|NCT02093923|11185331|FG000|Total Treated|Overall Study||4
10059915|NCT02093923|11185332|FG001|Total Treated|Overall Study||4
10059916|NCT02093923|11185333|FG002|Total Treated|Overall Study||5
10059917|NCT02093923|11185334|FG003|Total Treated|Overall Study||11
10059918|NCT02093923|11185335|FG004|Total Treated|Overall Study||13
10059919|NCT02093923|11185331|FG000|Treated - 1 Dose Only:|Overall Study||0
10059920|NCT02093923|11185332|FG001|Treated - 1 Dose Only:|Overall Study||0
10059921|NCT02093923|11185333|FG002|Treated - 1 Dose Only:|Overall Study||0
10059922|NCT02093923|11185334|FG003|Treated - 1 Dose Only:|Overall Study||1
10059923|NCT02093923|11185335|FG004|Treated - 1 Dose Only:|Overall Study||0
10059924|NCT02093923|11185331|FG000|Treated - 2 Doses:|Overall Study||4
10059925|NCT02093923|11185332|FG001|Treated - 2 Doses:|Overall Study||4
10059926|NCT02093923|11185333|FG002|Treated - 2 Doses:|Overall Study||5
10059927|NCT02093923|11185334|FG003|Treated - 2 Doses:|Overall Study||10
10059928|NCT02093923|11185335|FG004|Treated - 2 Doses:|Overall Study||13
10059929|NCT02093923|11185331|FG000|COMPLETED|Overall Study||4
10059930|NCT02093923|11185332|FG001|COMPLETED|Overall Study||4
10059931|NCT02093923|11185333|FG002|COMPLETED|Overall Study||5
10059932|NCT02093923|11185334|FG003|COMPLETED|Overall Study||10
10059933|NCT02093923|11185335|FG004|COMPLETED|Overall Study||13
10059934|NCT02093923|11185331|FG000|NOT COMPLETED|Overall Study||0
10059935|NCT02093923|11185332|FG001|NOT COMPLETED|Overall Study||0
10059936|NCT02093923|11185333|FG002|NOT COMPLETED|Overall Study||0
10059937|NCT02093923|11185334|FG003|NOT COMPLETED|Overall Study||2
10059938|NCT02093923|11185335|FG004|NOT COMPLETED|Overall Study||0
10059939|NCT02093949|11185353|FG000|STARTED|Overall Study||105
10122276|NCT02574637|11253350|FG002|COMPLETED|Double-blind Period||2
10122277|NCT02574637|11253351|FG003|COMPLETED|Double-blind Period||3
10122278|NCT02574637|11253352|FG004|COMPLETED|Double-blind Period||1
10122279|NCT02574637|11253353|FG005|COMPLETED|Double-blind Period||0
10122280|NCT02574637|11253354|FG006|COMPLETED|Double-blind Period||0
10122281|NCT02574637|11253355|FG007|COMPLETED|Double-blind Period||0
10122282|NCT02574637|11253356|FG008|COMPLETED|Double-blind Period||0
10122283|NCT02574637|11253357|FG009|COMPLETED|Double-blind Period||0
10122284|NCT02574637|11253348|FG000|NOT COMPLETED|Double-blind Period||3
10122285|NCT02574637|11253349|FG001|NOT COMPLETED|Double-blind Period||1
10122286|NCT02574637|11253350|FG002|NOT COMPLETED|Double-blind Period||7
10122287|NCT02574637|11253351|FG003|NOT COMPLETED|Double-blind Period||4
10122288|NCT02574637|11253352|FG004|NOT COMPLETED|Double-blind Period||2
10122289|NCT02574637|11253353|FG005|NOT COMPLETED|Double-blind Period||0
10122290|NCT02574637|11253354|FG006|NOT COMPLETED|Double-blind Period||0
10059940|NCT02093949|11185354|FG001|STARTED|Overall Study||47
10059941|NCT02093949|11185353|FG000|COMPLETED|Overall Study||105
10059942|NCT02093949|11185354|FG001|COMPLETED|Overall Study||47
10059943|NCT02093949|11185353|FG000|NOT COMPLETED|Overall Study||0
10059944|NCT02093949|11185354|FG001|NOT COMPLETED|Overall Study||0
10059945|NCT02093962|11185370|FG000|STARTED|Overall Study||134
10059946|NCT02093962|11185371|FG001|STARTED|Overall Study||131
10059947|NCT02093962|11185370|FG000|Received Treatment|Overall Study||130
10059948|NCT02093962|11185371|FG001|Received Treatment|Overall Study||130
10059949|NCT02093962|11185370|FG000|COMPLETED|Overall Study||0
10059950|NCT02093962|11185371|FG001|COMPLETED|Overall Study||0
10059951|NCT02093962|11185370|FG000|NOT COMPLETED|Overall Study||134
10059952|NCT02093962|11185371|FG001|NOT COMPLETED|Overall Study||131
10122291|NCT02574637|11253355|FG007|NOT COMPLETED|Double-blind Period||0
10122292|NCT02574637|11253356|FG008|NOT COMPLETED|Double-blind Period||0
10122293|NCT02574637|11253357|FG009|NOT COMPLETED|Double-blind Period||0
10122294|NCT02574637|11253348|FG000|STARTED|Open-label (OL) Period||0
10122295|NCT02574637|11253349|FG001|STARTED|Open-label (OL) Period||0
10122296|NCT02574637|11253350|FG002|STARTED|Open-label (OL) Period||0
10122297|NCT02574637|11253351|FG003|STARTED|Open-label (OL) Period||0
10122298|NCT02574637|11253352|FG004|STARTED|Open-label (OL) Period||0
10122299|NCT02574637|11253353|FG005|STARTED|Open-label (OL) Period||2
10122300|NCT02574637|11253354|FG006|STARTED|Open-label (OL) Period||3
10122301|NCT02574637|11253355|FG007|STARTED|Open-label (OL) Period||2
10122302|NCT02574637|11253356|FG008|STARTED|Open-label (OL) Period||3
10122303|NCT02574637|11253357|FG009|STARTED|Open-label (OL) Period||1
10122304|NCT02574637|11253348|FG000|COMPLETED|Open-label (OL) Period||0
10122305|NCT02574637|11253349|FG001|COMPLETED|Open-label (OL) Period||0
10122306|NCT02574637|11253350|FG002|COMPLETED|Open-label (OL) Period||0
10122307|NCT02574637|11253351|FG003|COMPLETED|Open-label (OL) Period||0
10122308|NCT02574637|11253352|FG004|COMPLETED|Open-label (OL) Period||0
10122309|NCT02574637|11253353|FG005|COMPLETED|Open-label (OL) Period||0
10122310|NCT02574637|11253354|FG006|COMPLETED|Open-label (OL) Period||1
10122311|NCT02574637|11253355|FG007|COMPLETED|Open-label (OL) Period||1
10122312|NCT02574637|11253356|FG008|COMPLETED|Open-label (OL) Period||1
10122313|NCT02574637|11253357|FG009|COMPLETED|Open-label (OL) Period||0
10122314|NCT02574637|11253348|FG000|NOT COMPLETED|Open-label (OL) Period||0
10122315|NCT02574637|11253349|FG001|NOT COMPLETED|Open-label (OL) Period||0
10122316|NCT02574637|11253350|FG002|NOT COMPLETED|Open-label (OL) Period||0
10122317|NCT02574637|11253351|FG003|NOT COMPLETED|Open-label (OL) Period||0
10122318|NCT02574637|11253352|FG004|NOT COMPLETED|Open-label (OL) Period||0
10122319|NCT02574637|11253353|FG005|NOT COMPLETED|Open-label (OL) Period||2
10122320|NCT02574637|11253354|FG006|NOT COMPLETED|Open-label (OL) Period||2
10122321|NCT02574637|11253355|FG007|NOT COMPLETED|Open-label (OL) Period||1
10122322|NCT02574637|11253356|FG008|NOT COMPLETED|Open-label (OL) Period||2
10122323|NCT02574637|11253357|FG009|NOT COMPLETED|Open-label (OL) Period||1
10122324|NCT02574832|11253378|FG000|STARTED|Overall Study||2
10122325|NCT02574832|11253378|FG000|COMPLETED|Overall Study||2
10122326|NCT02574832|11253378|FG000|NOT COMPLETED|Overall Study||0
10122327|NCT02574845|11253388|FG000|STARTED|Overall Study||3
10122328|NCT02574845|11253389|FG001|STARTED|Overall Study||3
10122329|NCT02574845|11253390|FG002|STARTED|Overall Study||3
10122330|NCT02574845|11253391|FG003|STARTED|Overall Study||3
10122331|NCT02574845|11253392|FG004|STARTED|Overall Study||3
10122332|NCT02574845|11253393|FG005|STARTED|Overall Study||3
10122333|NCT02574845|11253388|FG000|Received T1|Overall Study||3
10122334|NCT02574845|11253389|FG001|Received T1|Overall Study||2
10122335|NCT02574845|11253390|FG002|Received T1|Overall Study||3
10122336|NCT02574845|11253391|FG003|Received T1|Overall Study||3
10122337|NCT02574845|11253392|FG004|Received T1|Overall Study||2
10122338|NCT02574845|11253393|FG005|Received T1|Overall Study|one subject missed treatment period 2|2
10122339|NCT02574845|11253388|FG000|Received T2|Overall Study||3
10122340|NCT02574845|11253389|FG001|Received T2|Overall Study||3
10122341|NCT02574845|11253390|FG002|Received T2|Overall Study||3
10122342|NCT02574845|11253391|FG003|Received T2|Overall Study||3
10122343|NCT02574845|11253392|FG004|Received T2|Overall Study||2
10122344|NCT02574845|11253393|FG005|Received T2|Overall Study||3
10122345|NCT02574845|11253388|FG000|Received T3|Overall Study|one subject missed treatment period 2|2
10122346|NCT02574845|11253389|FG001|Received T3|Overall Study||2
10122347|NCT02574845|11253390|FG002|Received T3|Overall Study||3
10122348|NCT02574845|11253391|FG003|Received T3|Overall Study||3
10122349|NCT02574845|11253392|FG004|Received T3|Overall Study||2
10122350|NCT02574845|11253393|FG005|Received T3|Overall Study||3
10122351|NCT02574845|11253388|FG000|Received T4|Overall Study||3
10122352|NCT02574845|11253389|FG001|Received T4|Overall Study||2
10122353|NCT02574845|11253390|FG002|Received T4|Overall Study||3
10122354|NCT02574845|11253391|FG003|Received T4|Overall Study||3
10122355|NCT02574845|11253392|FG004|Received T4|Overall Study||2
10122356|NCT02574845|11253393|FG005|Received T4|Overall Study||2
10122357|NCT02574845|11253388|FG000|Received T5|Overall Study||3
10122358|NCT02574845|11253389|FG001|Received T5|Overall Study||2
10122359|NCT02574845|11253390|FG002|Received T5|Overall Study||3
10059953|NCT02094118|11185379|FG000|STARTED|Overall Study||85
10059954|NCT02094118|11185380|FG001|STARTED|Overall Study||86
10122360|NCT02574845|11253391|FG003|Received T5|Overall Study||3
10059955|NCT02094118|11185379|FG000|COMPLETED|Overall Study||73
10059956|NCT02094118|11185380|FG001|COMPLETED|Overall Study||81
10122361|NCT02574845|11253392|FG004|Received T5|Overall Study||3
10122362|NCT02574845|11253393|FG005|Received T5|Overall Study||2
10122363|NCT02574845|11253388|FG000|Received R|Overall Study||3
10122364|NCT02574845|11253389|FG001|Received R|Overall Study||2
10122365|NCT02574845|11253390|FG002|Received R|Overall Study||3
10059957|NCT02094118|11185379|FG000|NOT COMPLETED|Overall Study||12
10059958|NCT02094118|11185380|FG001|NOT COMPLETED|Overall Study||5
10059959|NCT02094300|11185390|FG000|STARTED|Overall Study||26
10059960|NCT02094300|11185390|FG000|30 Days|Overall Study||24
10059961|NCT02094300|11185390|FG000|COMPLETED|Overall Study||6
10059962|NCT02094300|11185390|FG000|NOT COMPLETED|Overall Study||20
10059963|NCT02094326|11185394|FG000|STARTED|Overall Study||301
10059964|NCT02094326|11185394|FG000|COMPLETED|Overall Study||301
10059965|NCT02094326|11185394|FG000|NOT COMPLETED|Overall Study||0
10059966|NCT02094417|11185403|FG000|STARTED|Overall Study||7
10059967|NCT02094417|11185404|FG001|STARTED|Overall Study||9
10059968|NCT02094417|11185405|FG002|STARTED|Overall Study||9
10059969|NCT02094417|11185406|FG003|STARTED|Overall Study||10
10059970|NCT02094417|11185403|FG000|COMPLETED|Overall Study||2
10059971|NCT02094417|11185404|FG001|COMPLETED|Overall Study||1
10059972|NCT02094417|11185405|FG002|COMPLETED|Overall Study||4
10059973|NCT02094417|11185406|FG003|COMPLETED|Overall Study||3
10059974|NCT02094417|11185403|FG000|NOT COMPLETED|Overall Study||5
10059975|NCT02094417|11185404|FG001|NOT COMPLETED|Overall Study||8
10059976|NCT02094417|11185405|FG002|NOT COMPLETED|Overall Study||5
10059977|NCT02094417|11185406|FG003|NOT COMPLETED|Overall Study||7
10059978|NCT02094443|11185418|FG000|STARTED|Overall Study||26
10059979|NCT02094443|11185419|FG001|STARTED|Overall Study||26
10059980|NCT02094443|11185418|FG000|Completed at Week 12|Overall Study||0
10059981|NCT02094443|11185419|FG001|Completed at Week 12|Overall Study||1
10059982|NCT02094443|11185418|FG000|Completed at Week 24|Overall Study||11
10059983|NCT02094443|11185419|FG001|Completed at Week 24|Overall Study||8
10059984|NCT02094443|11185418|FG000|COMPLETED|Overall Study||11
10059985|NCT02094443|11185419|FG001|COMPLETED|Overall Study||9
10059986|NCT02094443|11185418|FG000|NOT COMPLETED|Overall Study||15
10059987|NCT02094443|11185419|FG001|NOT COMPLETED|Overall Study||17
10059988|NCT02094534|11185427|FG000|STARTED|Overall Study||15
10059989|NCT02094534|11185428|FG001|STARTED|Overall Study||10
10059990|NCT02094534|11185427|FG000|COMPLETED|Overall Study||15
10059991|NCT02094534|11185428|FG001|COMPLETED|Overall Study||10
10059992|NCT02094534|11185427|FG000|NOT COMPLETED|Overall Study||0
10059993|NCT02094534|11185428|FG001|NOT COMPLETED|Overall Study||0
10059994|NCT02094573|11185436|FG000|STARTED|Overall Study||112
10059995|NCT02094573|11185437|FG001|STARTED|Overall Study||110
10059996|NCT02094573|11185436|FG000|Treated|Overall Study||109
10059997|NCT02094573|11185437|FG001|Treated|Overall Study||110
10059998|NCT02094573|11185436|FG000|COMPLETED|Overall Study||0
10059999|NCT02094573|11185437|FG001|COMPLETED|Overall Study||0
10060000|NCT02094573|11185436|FG000|NOT COMPLETED|Overall Study||112
10060001|NCT02094573|11185437|FG001|NOT COMPLETED|Overall Study||110
10060002|NCT02094586|11185447|FG000|STARTED|Overall Study||927
10060003|NCT02094586|11185448|FG001|STARTED|Overall Study||933
10060004|NCT02094586|11185449|FG002|STARTED|Overall Study||935
10060005|NCT02094586|11185450|FG003|STARTED|Overall Study||351
10060006|NCT02094586|11185447|FG000|COMPLETED|Overall Study||848
10060007|NCT02094586|11185448|FG001|COMPLETED|Overall Study||866
10060008|NCT02094586|11185449|FG002|COMPLETED|Overall Study||876
10060009|NCT02094586|11185450|FG003|COMPLETED|Overall Study||331
10122366|NCT02574845|11253391|FG003|Received R|Overall Study||3
10122367|NCT02574845|11253392|FG004|Received R|Overall Study||2
10122368|NCT02574845|11253393|FG005|Received R|Overall Study||3
10122369|NCT02574845|11253388|FG000|COMPLETED|Overall Study||3
10122370|NCT02574845|11253389|FG001|COMPLETED|Overall Study||2
10122371|NCT02574845|11253390|FG002|COMPLETED|Overall Study||3
10122372|NCT02574845|11253391|FG003|COMPLETED|Overall Study||3
10122373|NCT02574845|11253392|FG004|COMPLETED|Overall Study||2
10122374|NCT02574845|11253393|FG005|COMPLETED|Overall Study||2
10122375|NCT02574845|11253388|FG000|NOT COMPLETED|Overall Study||0
10122376|NCT02574845|11253389|FG001|NOT COMPLETED|Overall Study||1
10122377|NCT02574845|11253390|FG002|NOT COMPLETED|Overall Study||0
10122378|NCT02574845|11253391|FG003|NOT COMPLETED|Overall Study||0
10122379|NCT02574845|11253392|FG004|NOT COMPLETED|Overall Study||1
10122380|NCT02574845|11253393|FG005|NOT COMPLETED|Overall Study||1
10122381|NCT02574858|11253407|FG000|STARTED|Overall Study||25
10122382|NCT02574858|11253407|FG000|COMPLETED|Overall Study||25
10122383|NCT02574858|11253407|FG000|NOT COMPLETED|Overall Study||0
10122384|NCT02575079|11253413|FG000|STARTED|Overall Study||48
10122385|NCT02575079|11253414|FG001|STARTED|Overall Study||71
10122386|NCT02575079|11253413|FG000|COMPLETED|Overall Study||42
10122387|NCT02575079|11253414|FG001|COMPLETED|Overall Study||71
10122388|NCT02575079|11253413|FG000|NOT COMPLETED|Overall Study||6
10122389|NCT02575079|11253414|FG001|NOT COMPLETED|Overall Study||0
10122390|NCT02575300|11253419|FG000|STARTED|Overall Study||20
10122391|NCT02575300|11253419|FG000|COMPLETED|Overall Study||20
10122392|NCT02575300|11253419|FG000|NOT COMPLETED|Overall Study||0
10122393|NCT02575807|11253428|FG000|STARTED|Overall Study||9
10122394|NCT02575807|11253429|FG001|STARTED|Overall Study||4
10122395|NCT02575807|11253430|FG002|STARTED|Overall Study||16
10122396|NCT02575807|11253431|FG003|STARTED|Overall Study||2
10122397|NCT02575807|11253432|FG004|STARTED|Overall Study||4
10060010|NCT02094586|11185447|FG000|NOT COMPLETED|Overall Study||79
10060011|NCT02094586|11185448|FG001|NOT COMPLETED|Overall Study||67
10060012|NCT02094586|11185449|FG002|NOT COMPLETED|Overall Study||59
10060013|NCT02094586|11185450|FG003|NOT COMPLETED|Overall Study||20
10060014|NCT02094612|11185474|FG000|STARTED|Overall Study||112
10122398|NCT02575807|11253428|FG000|Treated|Overall Study||8
10122399|NCT02575807|11253429|FG001|Treated|Overall Study||4
10060015|NCT02094612|11185475|FG001|STARTED|Overall Study||95
10060016|NCT02094612|11185474|FG000|1 Month Follow up|Overall Study||67
10060017|NCT02094612|11185475|FG001|1 Month Follow up|Overall Study||50
10122400|NCT02575807|11253430|FG002|Treated|Overall Study||16
10122401|NCT02575807|11253431|FG003|Treated|Overall Study||1
10122402|NCT02575807|11253432|FG004|Treated|Overall Study||3
10122403|NCT02575807|11253428|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10122404|NCT02575807|11253429|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10122405|NCT02575807|11253430|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10122406|NCT02575807|11253431|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10122407|NCT02575807|11253432|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10122408|NCT02575807|11253428|FG000|NOT COMPLETED|Overall Study||9
10122409|NCT02575807|11253429|FG001|NOT COMPLETED|Overall Study||4
10122410|NCT02575807|11253430|FG002|NOT COMPLETED|Overall Study||16
10122411|NCT02575807|11253431|FG003|NOT COMPLETED|Overall Study||2
10122412|NCT02575807|11253432|FG004|NOT COMPLETED|Overall Study||4
10122413|NCT02575833|11253448|FG000|STARTED|Overall Study||44
10122414|NCT02575833|11253449|FG001|STARTED|Overall Study||45
10122415|NCT02575833|11253448|FG000|Received Study Drug|Overall Study||44
10122416|NCT02575833|11253449|FG001|Received Study Drug|Overall Study||44
10122417|NCT02575833|11253448|FG000|COMPLETED|Overall Study||43
10122418|NCT02575833|11253449|FG001|COMPLETED|Overall Study||44
10122419|NCT02575833|11253448|FG000|NOT COMPLETED|Overall Study||1
10122420|NCT02575833|11253449|FG001|NOT COMPLETED|Overall Study||1
10122421|NCT02575911|11253455|FG000|STARTED|Overall Study||30
10122422|NCT02575911|11253455|FG000|COMPLETED|Overall Study||29
10122423|NCT02575911|11253455|FG000|NOT COMPLETED|Overall Study||1
10122424|NCT02575950|11253467|FG000|STARTED|Overall Study||3
10122425|NCT02575950|11253468|FG001|STARTED|Overall Study||6
10122426|NCT02575950|11253469|FG002|STARTED|Overall Study||6
10122427|NCT02575950|11253470|FG003|STARTED|Overall Study||25
10122428|NCT02575950|11253467|FG000|COMPLETED|Overall Study||3
10122429|NCT02575950|11253468|FG001|COMPLETED|Overall Study||5
10122430|NCT02575950|11253469|FG002|COMPLETED|Overall Study||6
10060018|NCT02094612|11185474|FG000|3 Month Follow up|Overall Study||50
10060019|NCT02094612|11185475|FG001|3 Month Follow up|Overall Study||43
10060020|NCT02094612|11185474|FG000|6 Month Follow up|Overall Study||33
10060021|NCT02094612|11185475|FG001|6 Month Follow up|Overall Study||25
10060022|NCT02094612|11185474|FG000|COMPLETED|Overall Study||33
10060023|NCT02094612|11185475|FG001|COMPLETED|Overall Study||25
10060024|NCT02094612|11185474|FG000|NOT COMPLETED|Overall Study||79
10060025|NCT02094612|11185475|FG001|NOT COMPLETED|Overall Study||70
10122431|NCT02575950|11253470|FG003|COMPLETED|Overall Study||20
10122432|NCT02575950|11253467|FG000|NOT COMPLETED|Overall Study||0
10122433|NCT02575950|11253468|FG001|NOT COMPLETED|Overall Study||1
10122434|NCT02575950|11253469|FG002|NOT COMPLETED|Overall Study||0
10122435|NCT02575950|11253470|FG003|NOT COMPLETED|Overall Study||5
10122436|NCT02576041|11253478|FG000|STARTED|Placebo (run-in)||18
10122437|NCT02576041|11253478|FG000|COMPLETED|Placebo (run-in)||18
10122438|NCT02576041|11253478|FG000|NOT COMPLETED|Placebo (run-in)||0
10122439|NCT02576041|11253478|FG000|STARTED|Bilastine (Active Treatement)||18
10122440|NCT02576041|11253478|FG000|COMPLETED|Bilastine (Active Treatement)||18
10122441|NCT02576041|11253478|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0
10122442|NCT02576054|11253482|FG000|STARTED|Overall Study||101
10122443|NCT02576054|11253482|FG000|Vaccination 1|Overall Study||100
10122444|NCT02576054|11253482|FG000|Vaccination 2|Overall Study||100
10122445|NCT02576054|11253482|FG000|Vaccination 3|Overall Study||100
10122446|NCT02576054|11253482|FG000|COMPLETED|Overall Study||100
10122447|NCT02576054|11253482|FG000|NOT COMPLETED|Overall Study||1
10122448|NCT02576067|11253490|FG000|STARTED|Overall Study||60
10122449|NCT02576067|11253491|FG001|STARTED|Overall Study||63
10122450|NCT02576067|11253490|FG000|COMPLETED|Overall Study||26
10122451|NCT02576067|11253491|FG001|COMPLETED|Overall Study||27
10122452|NCT02576067|11253490|FG000|NOT COMPLETED|Overall Study||34
10122453|NCT02576067|11253491|FG001|NOT COMPLETED|Overall Study||36
10122454|NCT02576145|11253499|FG000|STARTED|Overall Study||6
10122455|NCT02576145|11253500|FG001|STARTED|Overall Study||5
10122456|NCT02576145|11253499|FG000|COMPLETED|Overall Study||3
10122457|NCT02576145|11253500|FG001|COMPLETED|Overall Study||4
10122458|NCT02576145|11253499|FG000|NOT COMPLETED|Overall Study||3
10122459|NCT02576145|11253500|FG001|NOT COMPLETED|Overall Study||1
10122460|NCT02576249|11253508|FG000|STARTED|Overall Study||15
10122461|NCT02576249|11253509|FG001|STARTED|Overall Study||14
10122462|NCT02576249|11253508|FG000|COMPLETED|Overall Study||15
10122463|NCT02576249|11253509|FG001|COMPLETED|Overall Study||14
10122464|NCT02576249|11253508|FG000|NOT COMPLETED|Overall Study||0
10122465|NCT02576249|11253509|FG001|NOT COMPLETED|Overall Study||0
10122466|NCT02576535|11253515|FG000|STARTED|Overall Study||18
10122467|NCT02576535|11253515|FG000|COMPLETED|Overall Study||16
10122468|NCT02576535|11253515|FG000|NOT COMPLETED|Overall Study||2
10122469|NCT02576587|11253521|FG000|STARTED|Baseline|Total cases baseline visit|161
10060026|NCT02094664|11185483|FG000|STARTED|Overall Study||16
10060027|NCT02094664|11185484|FG001|STARTED|Overall Study||16
10060028|NCT02094664|11185483|FG000|COMPLETED|Overall Study||16
10122470|NCT02576587|11253522|FG001|STARTED|Baseline|Total controls baseline visit|156
10122471|NCT02576587|11253521|FG000|COMPLETED|Baseline|Baseline visit completed|161
10060029|NCT02094664|11185484|FG001|COMPLETED|Overall Study||16
10060030|NCT02094664|11185483|FG000|NOT COMPLETED|Overall Study||0
10060031|NCT02094664|11185484|FG001|NOT COMPLETED|Overall Study||0
10060032|NCT02094677|11185492|FG000|STARTED|Overall Study||43
10060033|NCT02094677|11185493|FG001|STARTED|Overall Study||31
10060034|NCT02094677|11185492|FG000|COMPLETED|Overall Study||40
10060035|NCT02094677|11185493|FG001|COMPLETED|Overall Study||30
10060036|NCT02094677|11185492|FG000|NOT COMPLETED|Overall Study||3
10060037|NCT02094677|11185493|FG001|NOT COMPLETED|Overall Study||1
10060038|NCT02094755|11185506|FG000|STARTED|Overall Study||100
10060039|NCT02094755|11185506|FG000|COMPLETED|Overall Study||100
10060040|NCT02094755|11185506|FG000|NOT COMPLETED|Overall Study||0
10060041|NCT02094872|11185510|FG000|STARTED|Overall Study||49
10060042|NCT02094872|11185510|FG000|Received Biopsy|Overall Study||37
10060043|NCT02094872|11185510|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
10060044|NCT02094872|11185510|FG000|Received Targeted Therapy|Overall Study||20
10060045|NCT02094872|11185510|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
10060046|NCT02094872|11185510|FG000|Patients Treated With MEK162|Overall Study||20
10060047|NCT02094872|11185510|FG000|COMPLETED|Overall Study||20
10060048|NCT02094872|11185510|FG000|NOT COMPLETED|Overall Study||29
10060049|NCT02094885|11185516|FG000|STARTED|Overall Study||125
10060050|NCT02094885|11185517|FG001|STARTED|Overall Study||127
10060051|NCT02094885|11185516|FG000|COMPLETED|Overall Study||123
10060052|NCT02094885|11185517|FG001|COMPLETED|Overall Study||122
10060053|NCT02094885|11185516|FG000|NOT COMPLETED|Overall Study||2
10060054|NCT02094885|11185517|FG001|NOT COMPLETED|Overall Study||5
10060055|NCT02094898|11185523|FG000|STARTED|Overall Study||12
10060056|NCT02094898|11185523|FG000|COMPLETED|Overall Study||7
10060057|NCT02094898|11185523|FG000|NOT COMPLETED|Overall Study||5
10060058|NCT02094937|11185529|FG000|STARTED|8 Weeks in Period 1||430
10060059|NCT02094937|11185530|FG001|STARTED|8 Weeks in Period 1||0
10060060|NCT02094937|11185531|FG002|STARTED|8 Weeks in Period 1||0
10060061|NCT02094937|11185532|FG003|STARTED|8 Weeks in Period 1||0
10060062|NCT02094937|11185529|FG000|COMPLETED|8 Weeks in Period 1||370
10060063|NCT02094937|11185530|FG001|COMPLETED|8 Weeks in Period 1||0
10060064|NCT02094937|11185531|FG002|COMPLETED|8 Weeks in Period 1||0
10060065|NCT02094937|11185532|FG003|COMPLETED|8 Weeks in Period 1||0
10060066|NCT02094937|11185529|FG000|NOT COMPLETED|8 Weeks in Period 1||60
10060067|NCT02094937|11185530|FG001|NOT COMPLETED|8 Weeks in Period 1||0
10060068|NCT02094937|11185531|FG002|NOT COMPLETED|8 Weeks in Period 1||0
10060069|NCT02094937|11185532|FG003|NOT COMPLETED|8 Weeks in Period 1||0
10060070|NCT02094937|11185529|FG000|STARTED|12 Weeks in Period 2||0
10060071|NCT02094937|11185530|FG001|STARTED|12 Weeks in Period 2||123
10060072|NCT02094937|11185531|FG002|STARTED|12 Weeks in Period 2||124
10060073|NCT02094937|11185532|FG003|STARTED|12 Weeks in Period 2||124
10060074|NCT02094937|11185529|FG000|COMPLETED|12 Weeks in Period 2||0
10060075|NCT02094937|11185530|FG001|COMPLETED|12 Weeks in Period 2||112
10060076|NCT02094937|11185531|FG002|COMPLETED|12 Weeks in Period 2||112
10060077|NCT02094937|11185532|FG003|COMPLETED|12 Weeks in Period 2||112
10060078|NCT02094937|11185529|FG000|NOT COMPLETED|12 Weeks in Period 2||0
10060079|NCT02094937|11185530|FG001|NOT COMPLETED|12 Weeks in Period 2||11
10060080|NCT02094937|11185531|FG002|NOT COMPLETED|12 Weeks in Period 2||12
10060081|NCT02094937|11185532|FG003|NOT COMPLETED|12 Weeks in Period 2||12
10060082|NCT02095106|11185543|FG000|STARTED|First Intervention (14 Days)||14
10060083|NCT02095106|11185544|FG001|STARTED|First Intervention (14 Days)||13
10060084|NCT02095106|11185543|FG000|COMPLETED|First Intervention (14 Days)||14
10060085|NCT02095106|11185544|FG001|COMPLETED|First Intervention (14 Days)||13
10060086|NCT02095106|11185543|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10060087|NCT02095106|11185544|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10060088|NCT02095106|11185543|FG000|STARTED|Second Intervention (14 Days)||14
10060089|NCT02095106|11185544|FG001|STARTED|Second Intervention (14 Days)||13
10060090|NCT02095106|11185543|FG000|COMPLETED|Second Intervention (14 Days)||14
10060091|NCT02095106|11185544|FG001|COMPLETED|Second Intervention (14 Days)||12
10060092|NCT02095106|11185543|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10060093|NCT02095106|11185544|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
10060094|NCT02095145|11185556|FG000|STARTED|Overall Study||15
10060095|NCT02095145|11185557|FG001|STARTED|Overall Study||15
10060096|NCT02095145|11185556|FG000|COMPLETED|Overall Study||14
10060097|NCT02095145|11185557|FG001|COMPLETED|Overall Study||15
10060098|NCT02095145|11185556|FG000|NOT COMPLETED|Overall Study||1
10060099|NCT02095145|11185557|FG001|NOT COMPLETED|Overall Study||0
10060100|NCT02095158|11185565|FG000|STARTED|Overall Study||440
10060101|NCT02095158|11185565|FG000|COMPLETED|Overall Study||365
10060102|NCT02095158|11185565|FG000|NOT COMPLETED|Overall Study||75
10060103|NCT02095197|11185571|FG000|STARTED|Overall Study||40
10060104|NCT02095197|11185572|FG001|STARTED|Overall Study||39
10060105|NCT02095197|11185571|FG000|COMPLETED|Overall Study||40
10060106|NCT02095197|11185572|FG001|COMPLETED|Overall Study||36
10060107|NCT02095197|11185571|FG000|NOT COMPLETED|Overall Study||0
10060108|NCT02095197|11185572|FG001|NOT COMPLETED|Overall Study||3
10060109|NCT02095223|11185580|FG000|STARTED|Overall Study||2
10060110|NCT02095223|11185581|FG001|STARTED|Overall Study||2
10060111|NCT02095223|11185580|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
10060112|NCT02095223|11185581|FG001|COMPLETED|Overall Study||2
10060113|NCT02095223|11185580|FG000|NOT COMPLETED|Overall Study||1
10060114|NCT02095223|11185581|FG001|NOT COMPLETED|Overall Study||0
10060115|NCT02095340|11185590|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51
10060116|NCT02095340|11185591|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54
10060117|NCT02095340|11185592|FG002|STARTED|Overall Study||105
10060118|NCT02095340|11185590|FG000|COMPLETED|Overall Study||51
10060119|NCT02095340|11185591|FG001|COMPLETED|Overall Study||54
10060120|NCT02095340|11185592|FG002|COMPLETED|Overall Study||105
10060121|NCT02095340|11185590|FG000|NOT COMPLETED|Overall Study||0
10060122|NCT02095340|11185591|FG001|NOT COMPLETED|Overall Study||0
10060123|NCT02095340|11185592|FG002|NOT COMPLETED|Overall Study||0
10060124|NCT02095535|11185601|FG000|STARTED|Recruitment||20
10060125|NCT02095535|11185601|FG000|COMPLETED|Recruitment||18
10060126|NCT02095535|11185601|FG000|NOT COMPLETED|Recruitment||2
10060127|NCT02095535|11185601|FG000|STARTED|Analysis||18
10060128|NCT02095535|11185601|FG000|COMPLETED|Analysis||18
10060129|NCT02095535|11185601|FG000|NOT COMPLETED|Analysis||0
10060130|NCT02095561|11185607|FG000|STARTED|Overall Study||3049
10060131|NCT02095561|11185608|FG001|STARTED|Overall Study||2964
10060132|NCT02095561|11185607|FG000|Self-testing Acceptability|Overall Study||2616
10060133|NCT02095561|11185608|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
10060134|NCT02095561|11185607|FG000|HPV Self-tested Women|Overall Study||2519
10060135|NCT02095561|11185608|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
10060136|NCT02095561|11185607|FG000|HPV Tested at Health Centers|Overall Study||99
10060137|NCT02095561|11185608|FG001|HPV Tested at Health Centers|Overall Study||599
10060138|NCT02095561|11185607|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
10060139|NCT02095561|11185608|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
10060140|NCT02095561|11185607|FG000|NOT COMPLETED|Overall Study||0
10060141|NCT02095561|11185608|FG001|NOT COMPLETED|Overall Study||0
10122472|NCT02576587|11253522|FG001|COMPLETED|Baseline|Baseline visit completed|155
10122473|NCT02576587|11253521|FG000|NOT COMPLETED|Baseline||0
10122474|NCT02576587|11253522|FG001|NOT COMPLETED|Baseline||1
10122475|NCT02576587|11253521|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161
10122476|NCT02576587|11253522|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
10122477|NCT02576587|11253521|FG000|Selected for Follow up|Follow up Period (Case Only)||61
10122478|NCT02576587|11253522|FG001|Selected for Follow up|Follow up Period (Case Only)||0
10122479|NCT02576587|11253521|FG000|COMPLETED|Follow up Period (Case Only)||44
10122480|NCT02576587|11253522|FG001|COMPLETED|Follow up Period (Case Only)||0
10122481|NCT02576587|11253521|FG000|NOT COMPLETED|Follow up Period (Case Only)||117
10122482|NCT02576587|11253522|FG001|NOT COMPLETED|Follow up Period (Case Only)||155
10122483|NCT02576639|11253535|FG000|STARTED|Overall Study||24
10122484|NCT02576639|11253536|FG001|STARTED|Overall Study||25
10122485|NCT02576639|11253537|FG002|STARTED|Overall Study||25
10122486|NCT02576639|11253538|FG003|STARTED|Overall Study||26
10122487|NCT02576639|11253539|FG004|STARTED|Overall Study||24
10122488|NCT02576639|11253535|FG000|Pharmacodynamic Analysis Set|Overall Study||24
10122489|NCT02576639|11253536|FG001|Pharmacodynamic Analysis Set|Overall Study||24
10122490|NCT02576639|11253537|FG002|Pharmacodynamic Analysis Set|Overall Study||25
10122491|NCT02576639|11253538|FG003|Pharmacodynamic Analysis Set|Overall Study||25
10122492|NCT02576639|11253539|FG004|Pharmacodynamic Analysis Set|Overall Study||25
10122493|NCT02576639|11253535|FG000|Pharmacokinetic Analysis Set|Overall Study||0
10122494|NCT02576639|11253536|FG001|Pharmacokinetic Analysis Set|Overall Study||25
10122495|NCT02576639|11253537|FG002|Pharmacokinetic Analysis Set|Overall Study||25
10122496|NCT02576639|11253538|FG003|Pharmacokinetic Analysis Set|Overall Study||26
10122497|NCT02576639|11253539|FG004|Pharmacokinetic Analysis Set|Overall Study||24
10122498|NCT02576639|11253535|FG000|Safety Analysis Set|Overall Study||24
10122499|NCT02576639|11253536|FG001|Safety Analysis Set|Overall Study||25
10122500|NCT02576639|11253537|FG002|Safety Analysis Set|Overall Study||25
10122501|NCT02576639|11253538|FG003|Safety Analysis Set|Overall Study||26
10122502|NCT02576639|11253539|FG004|Safety Analysis Set|Overall Study||24
10122503|NCT02576639|11253535|FG000|COMPLETED|Overall Study||22
10122504|NCT02576639|11253536|FG001|COMPLETED|Overall Study||23
10122505|NCT02576639|11253537|FG002|COMPLETED|Overall Study||23
10122506|NCT02576639|11253538|FG003|COMPLETED|Overall Study||25
10122507|NCT02576639|11253539|FG004|COMPLETED|Overall Study||20
10122508|NCT02576639|11253535|FG000|NOT COMPLETED|Overall Study||2
10122509|NCT02576639|11253536|FG001|NOT COMPLETED|Overall Study||2
10122510|NCT02576639|11253537|FG002|NOT COMPLETED|Overall Study||2
10122511|NCT02576639|11253538|FG003|NOT COMPLETED|Overall Study||1
10122512|NCT02576639|11253539|FG004|NOT COMPLETED|Overall Study||4
10122513|NCT02576652|11253555|FG000|STARTED|Overall Study||6
10122514|NCT02576652|11253555|FG000|COMPLETED|Overall Study||4
10122515|NCT02576652|11253555|FG000|NOT COMPLETED|Overall Study||2
10122516|NCT02576678|11253562|FG000|STARTED|Overall Study||13
10122517|NCT02576678|11253563|FG001|STARTED|Overall Study||8
10122518|NCT02576678|11253564|FG002|STARTED|Overall Study||21
10122519|NCT02576678|11253562|FG000|Pharmacokinetic (PK) Population|Overall Study||12
10122520|NCT02576678|11253563|FG001|Pharmacokinetic (PK) Population|Overall Study||8
10060148|NCT02095691|11185626|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
10060149|NCT02095691|11185626|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
10060150|NCT02095691|11185626|FG000|NOT COMPLETED|Overall Study||1
10060151|NCT02095873|11185644|FG000|STARTED|First Intervention (8 Weeks)||16
10060152|NCT02095873|11185645|FG001|STARTED|First Intervention (8 Weeks)||16
10060153|NCT02095873|11185644|FG000|COMPLETED|First Intervention (8 Weeks)||15
10060154|NCT02095873|11185645|FG001|COMPLETED|First Intervention (8 Weeks)||16
10060155|NCT02095873|11185644|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1
10060156|NCT02095873|11185645|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
10060157|NCT02095873|11185644|FG000|STARTED|Second Intervention (8 Weeks)||15
10060158|NCT02095873|11185645|FG001|STARTED|Second Intervention (8 Weeks)||16
10060159|NCT02095873|11185644|FG000|COMPLETED|Second Intervention (8 Weeks)||13
10060160|NCT02095873|11185645|FG001|COMPLETED|Second Intervention (8 Weeks)||16
10060161|NCT02095873|11185644|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
10060162|NCT02095873|11185645|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10060163|NCT02095951|11185655|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
10060164|NCT02095951|11185656|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
10060165|NCT02095951|11185655|FG000|COMPLETED|Overall Study||4
10060166|NCT02095951|11185656|FG001|COMPLETED|Overall Study||8
10060167|NCT02095951|11185655|FG000|NOT COMPLETED|Overall Study||9
10060168|NCT02095951|11185656|FG001|NOT COMPLETED|Overall Study||6
10060169|NCT02096003|11185668|FG000|STARTED|Overall Study||40
10060170|NCT02096003|11185669|FG001|STARTED|Overall Study||40
10060171|NCT02096003|11185668|FG000|COMPLETED|Overall Study||38
10060172|NCT02096003|11185669|FG001|COMPLETED|Overall Study||37
10060173|NCT02096003|11185668|FG000|NOT COMPLETED|Overall Study||2
10060174|NCT02096003|11185669|FG001|NOT COMPLETED|Overall Study||3
10060175|NCT02096029|11185677|FG000|STARTED|Overall Study||652
10060176|NCT02096029|11185678|FG001|STARTED|Overall Study||593
10060177|NCT02096029|11185677|FG000|COMPLETED|Overall Study||652
10060178|NCT02096029|11185678|FG001|COMPLETED|Overall Study||593
10060179|NCT02096029|11185677|FG000|NOT COMPLETED|Overall Study||0
10060180|NCT02096029|11185678|FG001|NOT COMPLETED|Overall Study||0
10060181|NCT02096081|11185686|FG000|STARTED|Overall Study||122
10060182|NCT02096081|11185687|FG001|STARTED|Overall Study||128
10060183|NCT02096081|11185686|FG000|COMPLETED|Overall Study||119
10060184|NCT02096081|11185687|FG001|COMPLETED|Overall Study||124
10060185|NCT02096081|11185686|FG000|NOT COMPLETED|Overall Study||3
10060186|NCT02096081|11185687|FG001|NOT COMPLETED|Overall Study||4
10060187|NCT02096107|11185695|FG000|STARTED|Overall Study||30
10060188|NCT02096107|11185696|FG001|STARTED|Overall Study||30
10060189|NCT02096107|11185695|FG000|COMPLETED|Overall Study||30
10060190|NCT02096107|11185696|FG001|COMPLETED|Overall Study||30
10060191|NCT02096107|11185695|FG000|NOT COMPLETED|Overall Study||0
10060192|NCT02096107|11185696|FG001|NOT COMPLETED|Overall Study||0
10060193|NCT02096263|11185705|FG000|STARTED|Overall Study||195
10060194|NCT02096263|11185706|FG001|STARTED|Overall Study||194
10060195|NCT02096263|11185707|FG002|STARTED|Overall Study||196
10060196|NCT02096263|11185705|FG000|COMPLETED|Overall Study||161
10060197|NCT02096263|11185706|FG001|COMPLETED|Overall Study||158
10060198|NCT02096263|11185707|FG002|COMPLETED|Overall Study||157
10060199|NCT02096263|11185705|FG000|NOT COMPLETED|Overall Study||34
10060200|NCT02096263|11185706|FG001|NOT COMPLETED|Overall Study||36
10060201|NCT02096263|11185707|FG002|NOT COMPLETED|Overall Study||39
10060202|NCT02096276|11185717|FG000|STARTED|Overall Study||250
10060203|NCT02096276|11185718|FG001|STARTED|Overall Study||55
10060204|NCT02096276|11185717|FG000|COMPLETED|Overall Study||250
10060205|NCT02096276|11185718|FG001|COMPLETED|Overall Study||55
10060206|NCT02096276|11185717|FG000|NOT COMPLETED|Overall Study||0
10060207|NCT02096276|11185718|FG001|NOT COMPLETED|Overall Study||0
10060208|NCT02096458|11185724|FG000|STARTED|Overall Study||8
10060209|NCT02096458|11185724|FG000|COMPLETED|Overall Study||8
10060210|NCT02096458|11185724|FG000|NOT COMPLETED|Overall Study||0
10060211|NCT02096471|11185728|FG000|STARTED|Overall Study||19
10060212|NCT02096471|11185728|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
10060213|NCT02096471|11185728|FG000|NOT COMPLETED|Overall Study||13
10060214|NCT02096575|11185734|FG000|STARTED|Overall Study||68
10060215|NCT02096575|11185735|FG001|STARTED|Overall Study||67
10060216|NCT02096575|11185736|FG002|STARTED|Overall Study||5
10060217|NCT02096575|11185734|FG000|COMPLETED|Overall Study||68
10060218|NCT02096575|11185735|FG001|COMPLETED|Overall Study||67
10060219|NCT02096575|11185736|FG002|COMPLETED|Overall Study||0
10060220|NCT02096575|11185734|FG000|NOT COMPLETED|Overall Study||0
10060221|NCT02096575|11185735|FG001|NOT COMPLETED|Overall Study||0
10060222|NCT02096575|11185736|FG002|NOT COMPLETED|Overall Study||5
10060223|NCT02096679|11185743|FG000|STARTED|Overall Study||8
10060224|NCT02096679|11185743|FG000|COMPLETED|Overall Study||8
10060225|NCT02096679|11185743|FG000|NOT COMPLETED|Overall Study||0
10060226|NCT02096692|11185747|FG000|STARTED|Overall Study||154
10060227|NCT02096692|11185747|FG000|COMPLETED|Overall Study||150
10060228|NCT02096692|11185747|FG000|NOT COMPLETED|Overall Study||4
10060229|NCT02096705|11185753|FG000|STARTED|Treatment||133
10060230|NCT02096705|11185754|FG001|STARTED|Treatment||139
10060231|NCT02096705|11185753|FG000|COMPLETED|Treatment||124
10060232|NCT02096705|11185754|FG001|COMPLETED|Treatment||134
10060233|NCT02096705|11185753|FG000|NOT COMPLETED|Treatment||9
10060234|NCT02096705|11185754|FG001|NOT COMPLETED|Treatment||5
10060235|NCT02096705|11185753|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
10060236|NCT02096705|11185754|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
10060237|NCT02096705|11185753|FG000|COMPLETED|Follow-up||125
10060238|NCT02096705|11185754|FG001|COMPLETED|Follow-up||135
10060239|NCT02096705|11185753|FG000|NOT COMPLETED|Follow-up||4
10060240|NCT02096705|11185754|FG001|NOT COMPLETED|Follow-up||4
10060241|NCT02096718|11185763|FG000|STARTED|Overall Study||8
10060242|NCT02096718|11185764|FG001|STARTED|Overall Study||8
10060243|NCT02096718|11185765|FG002|STARTED|Overall Study||14
10060244|NCT02096718|11185763|FG000|COMPLETED|Overall Study||8
10060245|NCT02096718|11185764|FG001|COMPLETED|Overall Study||8
10060246|NCT02096718|11185765|FG002|COMPLETED|Overall Study||14
10060247|NCT02096718|11185763|FG000|NOT COMPLETED|Overall Study||0
10060248|NCT02096718|11185764|FG001|NOT COMPLETED|Overall Study||0
10060249|NCT02096718|11185765|FG002|NOT COMPLETED|Overall Study||0
10060250|NCT02096731|11185776|FG000|STARTED|Overall Study||26442
10060251|NCT02096731|11185777|FG001|STARTED|Overall Study||88955
10060252|NCT02096731|11185776|FG000|COMPLETED|Overall Study||26442
10060253|NCT02096731|11185777|FG001|COMPLETED|Overall Study||88955
10060254|NCT02096731|11185776|FG000|NOT COMPLETED|Overall Study||0
10060255|NCT02096731|11185777|FG001|NOT COMPLETED|Overall Study||0
10060256|NCT02096744|11185786|FG000|STARTED|Treatment Period 1(7 Days)||29
10060257|NCT02096744|11185787|FG001|STARTED|Treatment Period 1(7 Days)||29
10060258|NCT02096744|11185786|FG000|COMPLETED|Treatment Period 1(7 Days)||28
10060259|NCT02096744|11185787|FG001|COMPLETED|Treatment Period 1(7 Days)||28
10060260|NCT02096744|11185786|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1
10060261|NCT02096744|11185787|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1
10060262|NCT02096744|11185786|FG000|STARTED|Washout Period 1(7 Days)||28
10060263|NCT02096744|11185787|FG001|STARTED|Washout Period 1(7 Days)||28
10060264|NCT02096744|11185786|FG000|COMPLETED|Washout Period 1(7 Days)||28
10060265|NCT02096744|11185787|FG001|COMPLETED|Washout Period 1(7 Days)||28
10060266|NCT02096744|11185786|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0
10060267|NCT02096744|11185787|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0
10060268|NCT02096744|11185786|FG000|STARTED|Treatment Period 2 (7 Days)||28
10060269|NCT02096744|11185787|FG001|STARTED|Treatment Period 2 (7 Days)||28
10060270|NCT02096744|11185786|FG000|COMPLETED|Treatment Period 2 (7 Days)||28
10060271|NCT02096744|11185787|FG001|COMPLETED|Treatment Period 2 (7 Days)||28
10060272|NCT02096744|11185786|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10060273|NCT02096744|11185787|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10060274|NCT02096744|11185786|FG000|STARTED|Washout Period 2 (3 Days)||28
10060275|NCT02096744|11185787|FG001|STARTED|Washout Period 2 (3 Days)||28
10060276|NCT02096744|11185786|FG000|COMPLETED|Washout Period 2 (3 Days)||28
10060277|NCT02096744|11185787|FG001|COMPLETED|Washout Period 2 (3 Days)||28
10060278|NCT02096744|11185786|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
10060279|NCT02096744|11185787|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
10060280|NCT02096744|11185786|FG000|STARTED|Treatment Period 3 (7 Days)||28
10060281|NCT02096744|11185787|FG001|STARTED|Treatment Period 3 (7 Days)||28
10060282|NCT02096744|11185786|FG000|COMPLETED|Treatment Period 3 (7 Days)||28
10060283|NCT02096744|11185787|FG001|COMPLETED|Treatment Period 3 (7 Days)||27
10060284|NCT02096744|11185786|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10060285|NCT02096744|11185787|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1
10060286|NCT02096835|11185798|FG000|STARTED|Overall Study||53
10060287|NCT02096835|11185799|FG001|STARTED|Overall Study||53
10060288|NCT02096835|11185800|FG002|STARTED|Overall Study||51
10060289|NCT02096835|11185798|FG000|COMPLETED|Overall Study||50
10060290|NCT02096835|11185799|FG001|COMPLETED|Overall Study||53
10060291|NCT02096835|11185800|FG002|COMPLETED|Overall Study||50
10060292|NCT02096835|11185798|FG000|NOT COMPLETED|Overall Study||3
10060293|NCT02096835|11185799|FG001|NOT COMPLETED|Overall Study||0
10060294|NCT02096835|11185800|FG002|NOT COMPLETED|Overall Study||1
10060295|NCT02096861|11185812|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
10060296|NCT02096861|11185813|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
10060297|NCT02096861|11185814|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
10060298|NCT02096861|11185815|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
10060299|NCT02096861|11185812|FG000|Drug Switching at Week 30|Overall Study||48
10060300|NCT02096861|11185813|FG001|Drug Switching at Week 30|Overall Study||44
10060301|NCT02096861|11185814|FG002|Drug Switching at Week 30|Overall Study||41
10060302|NCT02096861|11185815|FG003|Drug Switching at Week 30|Overall Study||47
10060303|NCT02096861|11185812|FG000|COMPLETED|Overall Study||44
10060304|NCT02096861|11185813|FG001|COMPLETED|Overall Study||40
10060305|NCT02096861|11185814|FG002|COMPLETED|Overall Study||37
10060306|NCT02096861|11185815|FG003|COMPLETED|Overall Study||45
10060307|NCT02096861|11185812|FG000|NOT COMPLETED|Overall Study||12
10060308|NCT02096861|11185813|FG001|NOT COMPLETED|Overall Study||15
10060309|NCT02096861|11185814|FG002|NOT COMPLETED|Overall Study||17
10060310|NCT02096861|11185815|FG003|NOT COMPLETED|Overall Study||10
10060311|NCT02096900|11185829|FG000|STARTED|Overall Study|Allocated to Midazolam|42
10060312|NCT02096900|11185830|FG001|STARTED|Overall Study|Allocated to Zolpidem|44
10060313|NCT02096900|11185829|FG000|COMPLETED|Overall Study||38
10060314|NCT02096900|11185830|FG001|COMPLETED|Overall Study||42
10060315|NCT02096900|11185829|FG000|NOT COMPLETED|Overall Study||4
10060316|NCT02096900|11185830|FG001|NOT COMPLETED|Overall Study||2
10060317|NCT02096952|11185836|FG000|STARTED|Overall Study||15
10060318|NCT02096952|11185836|FG000|COMPLETED|Overall Study||14
10060319|NCT02096952|11185836|FG000|NOT COMPLETED|Overall Study||1
10060320|NCT02097030|11185842|FG000|STARTED|First Intervention (3 Days)||15
10060321|NCT02097030|11185843|FG001|STARTED|First Intervention (3 Days)||17
10060322|NCT02097030|11185842|FG000|COMPLETED|First Intervention (3 Days)||14
10060323|NCT02097030|11185843|FG001|COMPLETED|First Intervention (3 Days)||16
10060324|NCT02097030|11185842|FG000|NOT COMPLETED|First Intervention (3 Days)||1
10060325|NCT02097030|11185843|FG001|NOT COMPLETED|First Intervention (3 Days)||1
10060326|NCT02097030|11185842|FG000|STARTED|Second Intervention (3 Days)||14
10060327|NCT02097030|11185843|FG001|STARTED|Second Intervention (3 Days)||16
10060328|NCT02097030|11185842|FG000|COMPLETED|Second Intervention (3 Days)||14
10060329|NCT02097030|11185843|FG001|COMPLETED|Second Intervention (3 Days)||16
10060330|NCT02097030|11185842|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
10060331|NCT02097030|11185843|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
10060332|NCT02097056|11185853|FG000|STARTED|Overall Study||171
10060333|NCT02097056|11185853|FG000|ParticipantsTreated|Overall Study||170
10060334|NCT02097056|11185853|FG000|COMPLETED|Overall Study||113
10060335|NCT02097056|11185853|FG000|NOT COMPLETED|Overall Study||58
10060336|NCT02097108|11185857|FG000|STARTED|Overall Study||11
10060337|NCT02097108|11185857|FG000|COMPLETED|Overall Study||9
10060338|NCT02097108|11185857|FG000|NOT COMPLETED|Overall Study||2
10060339|NCT02097238|11185861|FG000|STARTED|Overall Study||19
10060340|NCT02097238|11185861|FG000|COMPLETED|Overall Study||0
10060341|NCT02097238|11185861|FG000|NOT COMPLETED|Overall Study||19
10060342|NCT02097277|11185871|FG000|STARTED|Overall Study||24
10060343|NCT02097277|11185872|FG001|STARTED|Overall Study||24
10060344|NCT02097277|11185873|FG002|STARTED|Overall Study||24
10060345|NCT02097277|11185874|FG003|STARTED|Overall Study||24
10060346|NCT02097277|11185875|FG004|STARTED|Overall Study||24
10060347|NCT02097277|11185871|FG000|COMPLETED|Overall Study||22
10060348|NCT02097277|11185872|FG001|COMPLETED|Overall Study||21
10060349|NCT02097277|11185873|FG002|COMPLETED|Overall Study||22
10060350|NCT02097277|11185874|FG003|COMPLETED|Overall Study||20
10060351|NCT02097277|11185875|FG004|COMPLETED|Overall Study||23
10060352|NCT02097277|11185871|FG000|NOT COMPLETED|Overall Study||2
10060353|NCT02097277|11185872|FG001|NOT COMPLETED|Overall Study||3
10060354|NCT02097277|11185873|FG002|NOT COMPLETED|Overall Study||2
10060355|NCT02097277|11185874|FG003|NOT COMPLETED|Overall Study||4
10060356|NCT02097277|11185875|FG004|NOT COMPLETED|Overall Study||1
10060357|NCT02097290|11185891|FG000|STARTED|Overall Study||210
10060358|NCT02097290|11185891|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
10122521|NCT02576678|11253564|FG002|Pharmacokinetic (PK) Population|Overall Study||18
10122522|NCT02576678|11253562|FG000|COMPLETED|Overall Study||8
10122523|NCT02576678|11253563|FG001|COMPLETED|Overall Study||7
10122524|NCT02576678|11253564|FG002|COMPLETED|Overall Study||16
10122525|NCT02576678|11253562|FG000|NOT COMPLETED|Overall Study||5
10122526|NCT02576678|11253563|FG001|NOT COMPLETED|Overall Study||1
10122527|NCT02576678|11253564|FG002|NOT COMPLETED|Overall Study||5
10122528|NCT02576899|11253574|FG000|STARTED|Overall Study||16
10122529|NCT02576899|11253575|FG001|STARTED|Overall Study||20
10122530|NCT02576899|11253574|FG000|COMPLETED|Overall Study||5
10122531|NCT02576899|11253575|FG001|COMPLETED|Overall Study||7
10122532|NCT02576899|11253574|FG000|NOT COMPLETED|Overall Study||11
10122533|NCT02576899|11253575|FG001|NOT COMPLETED|Overall Study||13
10122534|NCT02576938|11253585|FG000|STARTED|Overall Study||49
10122535|NCT02576938|11253586|FG001|STARTED|Overall Study||37
10122536|NCT02576938|11253587|FG002|STARTED|Overall Study||38
10122537|NCT02576938|11253585|FG000|Received at Least One Dose of Study Drug|Overall Study||49
10122538|NCT02576938|11253586|FG001|Received at Least One Dose of Study Drug|Overall Study||37
10122539|NCT02576938|11253587|FG002|Received at Least One Dose of Study Drug|Overall Study||38
10122540|NCT02576938|11253585|FG000|COMPLETED|Overall Study||29
10122541|NCT02576938|11253586|FG001|COMPLETED|Overall Study||25
10122542|NCT02576938|11253587|FG002|COMPLETED|Overall Study||26
10122543|NCT02576938|11253585|FG000|NOT COMPLETED|Overall Study||20
10122544|NCT02576938|11253586|FG001|NOT COMPLETED|Overall Study||12
10122545|NCT02576938|11253587|FG002|NOT COMPLETED|Overall Study||12
10122546|NCT02576951|11253601|FG000|STARTED|Overall Study||15
10122547|NCT02576951|11253602|FG001|STARTED|Overall Study||3
10122548|NCT02576951|11253603|FG002|STARTED|Overall Study||80
10122549|NCT02576951|11253604|FG003|STARTED|Overall Study||80
10122550|NCT02576951|11253601|FG000|Received at Least One Dose of Study Drug|Overall Study||15
10122551|NCT02576951|11253602|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10122552|NCT02576951|11253603|FG002|Received at Least One Dose of Study Drug|Overall Study||80
10122553|NCT02576951|11253604|FG003|Received at Least One Dose of Study Drug|Overall Study||80
10122554|NCT02576951|11253601|FG000|COMPLETED|Overall Study||14
10122555|NCT02576951|11253602|FG001|COMPLETED|Overall Study||3
10122556|NCT02576951|11253603|FG002|COMPLETED|Overall Study||78
10122557|NCT02576951|11253604|FG003|COMPLETED|Overall Study||75
10122558|NCT02576951|11253601|FG000|NOT COMPLETED|Overall Study||1
10060359|NCT02097290|11185891|FG000|NOT COMPLETED|Overall Study||17
10060360|NCT02097303|11185895|FG000|STARTED|Overall Study||36
10060361|NCT02097303|11185895|FG000|COMPLETED|Overall Study||31
10122559|NCT02576951|11253602|FG001|NOT COMPLETED|Overall Study||0
10122560|NCT02576951|11253603|FG002|NOT COMPLETED|Overall Study||2
10122561|NCT02576951|11253604|FG003|NOT COMPLETED|Overall Study||5
10122562|NCT02576977|11253618|FG000|STARTED|Overall Study||126
10122563|NCT02576977|11253619|FG001|STARTED|Overall Study||125
10122564|NCT02576977|11253618|FG000|Treated|Overall Study||122
10122565|NCT02576977|11253619|FG001|Treated|Overall Study||123
10122566|NCT02576977|11253618|FG000|COMPLETED|Overall Study||0
10122567|NCT02576977|11253619|FG001|COMPLETED|Overall Study||0
10122568|NCT02576977|11253618|FG000|NOT COMPLETED|Overall Study||126
10122569|NCT02576977|11253619|FG001|NOT COMPLETED|Overall Study||125
10122570|NCT02576990|11253627|FG000|STARTED|Overall Study||56
10122571|NCT02576990|11253628|FG001|STARTED|Overall Study||24
10122572|NCT02576990|11253627|FG000|Treated|Overall Study||53
10122573|NCT02576990|11253628|FG001|Treated|Overall Study||23
10122574|NCT02576990|11253627|FG000|COMPLETED|Overall Study||0
10122575|NCT02576990|11253628|FG001|COMPLETED|Overall Study||0
10122576|NCT02576990|11253627|FG000|NOT COMPLETED|Overall Study||56
10122577|NCT02576990|11253628|FG001|NOT COMPLETED|Overall Study||24
10122578|NCT02577003|11253636|FG000|STARTED|Overall Study||73
10122579|NCT02577003|11253637|FG001|STARTED|Overall Study||70
10122580|NCT02577003|11253636|FG000|COMPLETED|Overall Study||71
10122581|NCT02577003|11253637|FG001|COMPLETED|Overall Study||65
10122582|NCT02577003|11253636|FG000|NOT COMPLETED|Overall Study||2
10122583|NCT02577003|11253637|FG001|NOT COMPLETED|Overall Study||5
10122584|NCT02577016|11253645|FG000|STARTED|Overall Study||70
10122585|NCT02577016|11253646|FG001|STARTED|Overall Study||71
10122586|NCT02577016|11253645|FG000|COMPLETED|Overall Study||68
10122587|NCT02577016|11253646|FG001|COMPLETED|Overall Study||69
10122588|NCT02577016|11253645|FG000|NOT COMPLETED|Overall Study||2
10122589|NCT02577016|11253646|FG001|NOT COMPLETED|Overall Study||2
10122590|NCT02577029|11253660|FG000|STARTED|Overall Study||10
10122591|NCT02577029|11253661|FG001|STARTED|Overall Study||2
10122592|NCT02577029|11253662|FG002|STARTED|Overall Study||7
10122593|NCT02577029|11253663|FG003|STARTED|Overall Study||12
10122594|NCT02577029|11253664|FG004|STARTED|Overall Study||11
10122595|NCT02577029|11253665|FG005|STARTED|Overall Study||13
10122596|NCT02577029|11253666|FG006|STARTED|Overall Study||12
10122597|NCT02577029|11253667|FG007|STARTED|Overall Study||12
10122598|NCT02577029|11253660|FG000|COMPLETED|Overall Study||0
10122599|NCT02577029|11253661|FG001|COMPLETED|Overall Study||0
10122600|NCT02577029|11253662|FG002|COMPLETED|Overall Study||0
10122601|NCT02577029|11253663|FG003|COMPLETED|Overall Study||0
10122602|NCT02577029|11253664|FG004|COMPLETED|Overall Study||0
10122603|NCT02577029|11253665|FG005|COMPLETED|Overall Study||0
10122604|NCT02577029|11253666|FG006|COMPLETED|Overall Study||0
10122605|NCT02577029|11253667|FG007|COMPLETED|Overall Study||0
10122606|NCT02577029|11253660|FG000|NOT COMPLETED|Overall Study||10
10122607|NCT02577029|11253661|FG001|NOT COMPLETED|Overall Study||2
10122608|NCT02577029|11253662|FG002|NOT COMPLETED|Overall Study||7
10122609|NCT02577029|11253663|FG003|NOT COMPLETED|Overall Study||12
10122610|NCT02577029|11253664|FG004|NOT COMPLETED|Overall Study||11
10122611|NCT02577029|11253665|FG005|NOT COMPLETED|Overall Study||13
10122612|NCT02577029|11253666|FG006|NOT COMPLETED|Overall Study||12
10122613|NCT02577029|11253667|FG007|NOT COMPLETED|Overall Study||12
10122614|NCT02577042|11253687|FG000|STARTED|Overall Study||20
10122615|NCT02577042|11253688|FG001|STARTED|Overall Study||22
10122616|NCT02577042|11253687|FG000|COMPLETED|Overall Study||15
10122617|NCT02577042|11253688|FG001|COMPLETED|Overall Study||19
10122618|NCT02577042|11253687|FG000|NOT COMPLETED|Overall Study||5
10122619|NCT02577042|11253688|FG001|NOT COMPLETED|Overall Study||3
10122620|NCT02577107|11253697|FG000|STARTED|Overall Study||6
10122621|NCT02577107|11253698|FG001|STARTED|Overall Study||6
10122622|NCT02577107|11253697|FG000|COMPLETED|Overall Study||6
10122623|NCT02577107|11253698|FG001|COMPLETED|Overall Study||5
10122624|NCT02577107|11253697|FG000|NOT COMPLETED|Overall Study||0
10122625|NCT02577107|11253698|FG001|NOT COMPLETED|Overall Study||1
10122626|NCT02577146|11253704|FG000|STARTED|Overall Study||74
10122627|NCT02577146|11253704|FG000|COMPLETED|Overall Study||46
10122628|NCT02577146|11253704|FG000|NOT COMPLETED|Overall Study||28
10122629|NCT02577315|11253710|FG000|STARTED|Treatment Period 1 (4 Days)||12
10122630|NCT02577315|11253711|FG001|STARTED|Treatment Period 1 (4 Days)||13
10122631|NCT02577315|11253710|FG000|COMPLETED|Treatment Period 1 (4 Days)||12
10122632|NCT02577315|11253711|FG001|COMPLETED|Treatment Period 1 (4 Days)||12
10122633|NCT02577315|11253710|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10122634|NCT02577315|11253711|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
10122635|NCT02577315|11253710|FG000|STARTED|Washout Period (5 Days)||12
10122636|NCT02577315|11253711|FG001|STARTED|Washout Period (5 Days)||12
10122637|NCT02577315|11253710|FG000|COMPLETED|Washout Period (5 Days)||12
10122638|NCT02577315|11253711|FG001|COMPLETED|Washout Period (5 Days)||12
10122639|NCT02577315|11253710|FG000|NOT COMPLETED|Washout Period (5 Days)||0
10122640|NCT02577315|11253711|FG001|NOT COMPLETED|Washout Period (5 Days)||0
10122641|NCT02577315|11253710|FG000|STARTED|Treatment Period 2 (4 Days)||12
10122642|NCT02577315|11253711|FG001|STARTED|Treatment Period 2 (4 Days)||12
10122643|NCT02577315|11253710|FG000|COMPLETED|Treatment Period 2 (4 Days)||12
10122644|NCT02577315|11253711|FG001|COMPLETED|Treatment Period 2 (4 Days)||12
10122645|NCT02577315|11253710|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10122646|NCT02577315|11253711|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10122647|NCT02577445|11253719|FG000|STARTED|Overall Study||14
10122648|NCT02577445|11253720|FG001|STARTED|Overall Study||17
10122649|NCT02577445|11253719|FG000|COMPLETED|Overall Study|study terminated prematurely|0
10122650|NCT02577445|11253720|FG001|COMPLETED|Overall Study|study terminated prematurely|0
10122651|NCT02577445|11253719|FG000|NOT COMPLETED|Overall Study||14
10122652|NCT02577445|11253720|FG001|NOT COMPLETED|Overall Study||17
10122653|NCT02577510|11253727|FG000|STARTED|Overall Study||21
10122654|NCT02577510|11253728|FG001|STARTED|Overall Study||21
10122655|NCT02577510|11253727|FG000|COMPLETED|Overall Study||21
10122656|NCT02577510|11253728|FG001|COMPLETED|Overall Study||21
10122657|NCT02577510|11253727|FG000|NOT COMPLETED|Overall Study||0
10122658|NCT02577510|11253728|FG001|NOT COMPLETED|Overall Study||0
10122659|NCT02577601|11253737|FG000|STARTED|UPA Only (1 Month)||36
10122660|NCT02577601|11253737|FG000|COMPLETED|UPA Only (1 Month)||36
10122661|NCT02577601|11253737|FG000|NOT COMPLETED|UPA Only (1 Month)||0
10122662|NCT02577601|11253737|FG000|STARTED|Washout (1 Month)||33
10122663|NCT02577601|11253737|FG000|COMPLETED|Washout (1 Month)||33
10122664|NCT02577601|11253737|FG000|NOT COMPLETED|Washout (1 Month)||0
10122665|NCT02577601|11253737|FG000|STARTED|UPA+COC (1 Month)||33
10122666|NCT02577601|11253737|FG000|COMPLETED|UPA+COC (1 Month)||33
10122667|NCT02577601|11253737|FG000|NOT COMPLETED|UPA+COC (1 Month)||0
10122668|NCT02577640|11253748|FG000|STARTED|Dose Escalation Group 1||4
10122669|NCT02577640|11253749|FG001|STARTED|Dose Escalation Group 1||0
10122670|NCT02577640|11253750|FG002|STARTED|Dose Escalation Group 1||0
10122671|NCT02577640|11253751|FG003|STARTED|Dose Escalation Group 1||0
10122672|NCT02577640|11253748|FG000|COMPLETED|Dose Escalation Group 1||3
10122673|NCT02577640|11253749|FG001|COMPLETED|Dose Escalation Group 1||0
10122674|NCT02577640|11253750|FG002|COMPLETED|Dose Escalation Group 1||0
10122675|NCT02577640|11253751|FG003|COMPLETED|Dose Escalation Group 1||0
10122676|NCT02577640|11253748|FG000|NOT COMPLETED|Dose Escalation Group 1||1
10122677|NCT02577640|11253749|FG001|NOT COMPLETED|Dose Escalation Group 1||0
10122678|NCT02577640|11253750|FG002|NOT COMPLETED|Dose Escalation Group 1||0
10122679|NCT02577640|11253751|FG003|NOT COMPLETED|Dose Escalation Group 1||0
10122680|NCT02577640|11253748|FG000|STARTED|Dose Escalation Group 2||0
10122681|NCT02577640|11253749|FG001|STARTED|Dose Escalation Group 2||3
10122682|NCT02577640|11253750|FG002|STARTED|Dose Escalation Group 2||0
10122683|NCT02577640|11253751|FG003|STARTED|Dose Escalation Group 2||0
10122684|NCT02577640|11253748|FG000|COMPLETED|Dose Escalation Group 2||0
10122685|NCT02577640|11253749|FG001|COMPLETED|Dose Escalation Group 2||3
10122686|NCT02577640|11253750|FG002|COMPLETED|Dose Escalation Group 2||0
10122687|NCT02577640|11253751|FG003|COMPLETED|Dose Escalation Group 2||0
10122688|NCT02577640|11253748|FG000|NOT COMPLETED|Dose Escalation Group 2||0
10122689|NCT02577640|11253749|FG001|NOT COMPLETED|Dose Escalation Group 2||0
10122690|NCT02577640|11253750|FG002|NOT COMPLETED|Dose Escalation Group 2||0
10122691|NCT02577640|11253751|FG003|NOT COMPLETED|Dose Escalation Group 2||0
10122692|NCT02577640|11253748|FG000|STARTED|Dose Escalation Group 3||0
10122693|NCT02577640|11253749|FG001|STARTED|Dose Escalation Group 3||0
10122694|NCT02577640|11253750|FG002|STARTED|Dose Escalation Group 3||3
10122695|NCT02577640|11253751|FG003|STARTED|Dose Escalation Group 3||0
10122696|NCT02577640|11253748|FG000|COMPLETED|Dose Escalation Group 3||0
10122697|NCT02577640|11253749|FG001|COMPLETED|Dose Escalation Group 3||0
10122698|NCT02577640|11253750|FG002|COMPLETED|Dose Escalation Group 3||3
10122699|NCT02577640|11253751|FG003|COMPLETED|Dose Escalation Group 3||0
10122700|NCT02577640|11253748|FG000|NOT COMPLETED|Dose Escalation Group 3||0
10122701|NCT02577640|11253749|FG001|NOT COMPLETED|Dose Escalation Group 3||0
10122702|NCT02577640|11253750|FG002|NOT COMPLETED|Dose Escalation Group 3||0
10122703|NCT02577640|11253751|FG003|NOT COMPLETED|Dose Escalation Group 3||0
10122704|NCT02577640|11253748|FG000|STARTED|Maximally Tolerated Dose||0
10122705|NCT02577640|11253749|FG001|STARTED|Maximally Tolerated Dose||0
10122706|NCT02577640|11253750|FG002|STARTED|Maximally Tolerated Dose||0
10122707|NCT02577640|11253751|FG003|STARTED|Maximally Tolerated Dose||1
10122708|NCT02577640|11253748|FG000|COMPLETED|Maximally Tolerated Dose||0
10122709|NCT02577640|11253749|FG001|COMPLETED|Maximally Tolerated Dose||0
10122710|NCT02577640|11253750|FG002|COMPLETED|Maximally Tolerated Dose||0
10122711|NCT02577640|11253751|FG003|COMPLETED|Maximally Tolerated Dose||1
10122712|NCT02577640|11253748|FG000|NOT COMPLETED|Maximally Tolerated Dose||0
10122713|NCT02577640|11253749|FG001|NOT COMPLETED|Maximally Tolerated Dose||0
10122714|NCT02577640|11253750|FG002|NOT COMPLETED|Maximally Tolerated Dose||0
10122715|NCT02577640|11253751|FG003|NOT COMPLETED|Maximally Tolerated Dose||0
10122716|NCT02577718|11253763|FG000|STARTED|Overall Study||60
10122717|NCT02577718|11253763|FG000|COMPLETED|Overall Study||52
10122718|NCT02577718|11253763|FG000|NOT COMPLETED|Overall Study||8
10122719|NCT02577822|11253771|FG000|STARTED|Overall Study||27
10122720|NCT02577822|11253772|FG001|STARTED|Overall Study||33
10122721|NCT02577822|11253771|FG000|COMPLETED|Overall Study||21
10122722|NCT02577822|11253772|FG001|COMPLETED|Overall Study||20
10122723|NCT02577822|11253771|FG000|NOT COMPLETED|Overall Study||6
10122724|NCT02577822|11253772|FG001|NOT COMPLETED|Overall Study||13
10122725|NCT02577887|11253778|FG000|STARTED|Overall Study||2101
10122726|NCT02577887|11253778|FG000|6 Month Follow-up|Overall Study||1938
10122727|NCT02577887|11253778|FG000|COMPLETED|Overall Study||1803
10122728|NCT02577887|11253778|FG000|NOT COMPLETED|Overall Study||298
10122729|NCT02577900|11253785|FG000|STARTED|Overall Study||11
10122730|NCT02577900|11253786|FG001|STARTED|Overall Study||10
10122731|NCT02577900|11253787|FG002|STARTED|Overall Study||10
10122732|NCT02577900|11253785|FG000|COMPLETED|Overall Study||11
10122733|NCT02577900|11253786|FG001|COMPLETED|Overall Study||10
10122734|NCT02577900|11253787|FG002|COMPLETED|Overall Study||10
10122735|NCT02577900|11253785|FG000|NOT COMPLETED|Overall Study||0
10122736|NCT02577900|11253786|FG001|NOT COMPLETED|Overall Study||0
10122737|NCT02577900|11253787|FG002|NOT COMPLETED|Overall Study||0
10122738|NCT02577978|11253797|FG000|STARTED|Overall Study||32
10122739|NCT02577978|11253798|FG001|STARTED|Overall Study||29
10122740|NCT02577978|11253797|FG000|COMPLETED|Overall Study||25
10122741|NCT02577978|11253798|FG001|COMPLETED|Overall Study||25
10122742|NCT02577978|11253797|FG000|NOT COMPLETED|Overall Study||7
10122743|NCT02577978|11253798|FG001|NOT COMPLETED|Overall Study||4
10122744|NCT02577991|11253807|FG000|STARTED|Overall Study||24
10122745|NCT02577991|11253808|FG001|STARTED|Overall Study||27
10122746|NCT02577991|11253809|FG002|STARTED|Overall Study||29
10122747|NCT02577991|11253807|FG000|COMPLETED|Overall Study||21
10122748|NCT02577991|11253808|FG001|COMPLETED|Overall Study||25
10122749|NCT02577991|11253809|FG002|COMPLETED|Overall Study||29
10122750|NCT02577991|11253807|FG000|NOT COMPLETED|Overall Study||3
10122751|NCT02577991|11253808|FG001|NOT COMPLETED|Overall Study||2
10122752|NCT02577991|11253809|FG002|NOT COMPLETED|Overall Study||0
10122753|NCT02578186|11253817|FG000|STARTED|Period 1 (First of Crossover)||17
10122754|NCT02578186|11253818|FG001|STARTED|Period 1 (First of Crossover)||18
10122755|NCT02578186|11253817|FG000|COMPLETED|Period 1 (First of Crossover)||12
10122756|NCT02578186|11253818|FG001|COMPLETED|Period 1 (First of Crossover)||13
10122757|NCT02578186|11253817|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5
10122758|NCT02578186|11253818|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5
10122759|NCT02578186|11253817|FG000|STARTED|Period 2 (Second of Crossover)||12
10122760|NCT02578186|11253818|FG001|STARTED|Period 2 (Second of Crossover)||13
10122761|NCT02578186|11253817|FG000|COMPLETED|Period 2 (Second of Crossover)||12
10122762|NCT02578186|11253818|FG001|COMPLETED|Period 2 (Second of Crossover)||13
10122763|NCT02578186|11253817|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0
10122764|NCT02578186|11253818|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0
10122765|NCT02578199|11253824|FG000|STARTED|Overall Study||31
10122766|NCT02578199|11253824|FG000|COMPLETED|Overall Study||27
10122767|NCT02578199|11253824|FG000|NOT COMPLETED|Overall Study||4
10122768|NCT02578238|11253828|FG000|STARTED|Overall Study||143
10122769|NCT02578238|11253828|FG000|COMPLETED|Overall Study||143
10122770|NCT02578238|11253828|FG000|NOT COMPLETED|Overall Study||0
10122771|NCT02578316|11253832|FG000|STARTED|Study Phase||6
10122772|NCT02578316|11253832|FG000|COMPLETED|Study Phase||6
10122773|NCT02578316|11253832|FG000|NOT COMPLETED|Study Phase||0
10122774|NCT02578316|11253832|FG000|STARTED|Extension Phase||6
10122775|NCT02578316|11253832|FG000|COMPLETED|Extension Phase||0
10122776|NCT02578316|11253832|FG000|NOT COMPLETED|Extension Phase||6
10122777|NCT02578706|11253843|FG000|STARTED|Overall Study||9
10122778|NCT02578706|11253844|FG001|STARTED|Overall Study||10
10122779|NCT02578706|11253845|FG002|STARTED|Overall Study||8
10122780|NCT02578706|11253843|FG000|COMPLETED|Overall Study||8
10122781|NCT02578706|11253844|FG001|COMPLETED|Overall Study||5
10122782|NCT02578706|11253845|FG002|COMPLETED|Overall Study||8
10122783|NCT02578706|11253843|FG000|NOT COMPLETED|Overall Study||1
10122784|NCT02578706|11253844|FG001|NOT COMPLETED|Overall Study||5
10122785|NCT02578706|11253845|FG002|NOT COMPLETED|Overall Study||0
10122786|NCT02578745|11253855|FG000|STARTED|Overall Study||60
10122787|NCT02578745|11253856|FG001|STARTED|Overall Study||60
10122788|NCT02578745|11253855|FG000|COMPLETED|Overall Study||60
10122789|NCT02578745|11253856|FG001|COMPLETED|Overall Study||60
10122790|NCT02578745|11253855|FG000|NOT COMPLETED|Overall Study||0
10122791|NCT02578745|11253856|FG001|NOT COMPLETED|Overall Study||0
10122792|NCT02578862|11253865|FG000|STARTED|Overall Study||37
10122793|NCT02578862|11253866|FG001|STARTED|Overall Study||35
10122794|NCT02578862|11253865|FG000|COMPLETED|Overall Study||37
10122795|NCT02578862|11253866|FG001|COMPLETED|Overall Study||33
10122796|NCT02578862|11253865|FG000|NOT COMPLETED|Overall Study||0
10122797|NCT02578862|11253866|FG001|NOT COMPLETED|Overall Study||2
10122798|NCT02578901|11253874|FG000|STARTED|Overall Study||165
10122799|NCT02578901|11253875|FG001|STARTED|Overall Study||165
10122800|NCT02578901|11253874|FG000|COMPLETED|Overall Study||145
10122801|NCT02578901|11253875|FG001|COMPLETED|Overall Study||144
10122802|NCT02578901|11253874|FG000|NOT COMPLETED|Overall Study||20
10122803|NCT02578901|11253875|FG001|NOT COMPLETED|Overall Study||21
10122804|NCT02578940|11253881|FG000|STARTED|Overall Study||109
10122805|NCT02578940|11253881|FG000|Received 18F-fluciclovine|Overall Study||104
10122806|NCT02578940|11253881|FG000|COMPLETED|Overall Study||103
10122807|NCT02578940|11253881|FG000|NOT COMPLETED|Overall Study||6
10122808|NCT02578992|11253889|FG000|STARTED|Overall Study|November 2014|65
10122809|NCT02578992|11253890|FG001|STARTED|Overall Study|November 2014|65
10122810|NCT02578992|11253889|FG000|COMPLETED|Overall Study|October 2015|62
10122811|NCT02578992|11253890|FG001|COMPLETED|Overall Study|October 2015|62
10122812|NCT02578992|11253889|FG000|NOT COMPLETED|Overall Study||3
10122813|NCT02578992|11253890|FG001|NOT COMPLETED|Overall Study||3
10122814|NCT02579057|11253904|FG000|STARTED|Overall Study||19
10122815|NCT02579057|11253905|FG001|STARTED|Overall Study||21
10122816|NCT02579057|11253904|FG000|COMPLETED|Overall Study||19
10122817|NCT02579057|11253905|FG001|COMPLETED|Overall Study||21
10122818|NCT02579057|11253904|FG000|NOT COMPLETED|Overall Study||0
10122819|NCT02579057|11253905|FG001|NOT COMPLETED|Overall Study||0
10122820|NCT02579135|11253913|FG000|STARTED|Overall Study||107
10122821|NCT02579135|11253914|FG001|STARTED|Overall Study||115
10122822|NCT02579135|11253913|FG000|COMPLETED|Overall Study||105
10122823|NCT02579135|11253914|FG001|COMPLETED|Overall Study||106
10122824|NCT02579135|11253913|FG000|NOT COMPLETED|Overall Study||2
10122825|NCT02579135|11253914|FG001|NOT COMPLETED|Overall Study||9
10122826|NCT02579343|11253922|FG000|STARTED|Overall Study||7
10122827|NCT02579343|11253923|FG001|STARTED|Overall Study||6
10122828|NCT02579343|11253922|FG000|COMPLETED|Overall Study||7
10122829|NCT02579343|11253923|FG001|COMPLETED|Overall Study||6
10122830|NCT02579343|11253922|FG000|NOT COMPLETED|Overall Study||0
10122831|NCT02579343|11253923|FG001|NOT COMPLETED|Overall Study||0
10122832|NCT02579382|11253933|FG000|STARTED|Main Study Phase||28
10122833|NCT02579382|11253934|FG001|STARTED|Main Study Phase||53
10122834|NCT02579382|11253935|FG002|STARTED|Main Study Phase||56
10122835|NCT02579382|11253936|FG003|STARTED|Main Study Phase||55
10122836|NCT02579382|11253933|FG000|COMPLETED|Main Study Phase||28
10122837|NCT02579382|11253934|FG001|COMPLETED|Main Study Phase||53
10122838|NCT02579382|11253935|FG002|COMPLETED|Main Study Phase||54
10122839|NCT02579382|11253936|FG003|COMPLETED|Main Study Phase||52
10122840|NCT02579382|11253933|FG000|NOT COMPLETED|Main Study Phase||0
10122841|NCT02579382|11253934|FG001|NOT COMPLETED|Main Study Phase||0
10122842|NCT02579382|11253935|FG002|NOT COMPLETED|Main Study Phase||2
10122843|NCT02579382|11253936|FG003|NOT COMPLETED|Main Study Phase||3
10122844|NCT02579382|11253933|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
10122845|NCT02579382|11253934|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
10122846|NCT02579382|11253935|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54
10122847|NCT02579382|11253936|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
10122848|NCT02579382|11253933|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
10122849|NCT02579382|11253934|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
10122850|NCT02579382|11253935|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
10122851|NCT02579382|11253936|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
10122852|NCT02579382|11253933|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
10122853|NCT02579382|11253934|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
10122854|NCT02579382|11253935|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
10122855|NCT02579382|11253936|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
10122856|NCT02579421|11253958|FG000|STARTED|Overall Study||23
10122857|NCT02579421|11253959|FG001|STARTED|Overall Study||23
10122858|NCT02579421|11253960|FG002|STARTED|Overall Study||6
10122859|NCT02579421|11253961|FG003|STARTED|Overall Study||6
10122860|NCT02579421|11253958|FG000|COMPLETED|Overall Study||17
10122861|NCT02579421|11253959|FG001|COMPLETED|Overall Study||18
10122862|NCT02579421|11253960|FG002|COMPLETED|Overall Study||5
10122863|NCT02579421|11253961|FG003|COMPLETED|Overall Study||3
10122864|NCT02579421|11253958|FG000|NOT COMPLETED|Overall Study||6
10122865|NCT02579421|11253959|FG001|NOT COMPLETED|Overall Study||5
10122866|NCT02579421|11253960|FG002|NOT COMPLETED|Overall Study||1
10122867|NCT02579421|11253961|FG003|NOT COMPLETED|Overall Study||3
10122868|NCT02579603|11253973|FG000|STARTED|Overall Study|Started are the randomised patients|52
10122869|NCT02579603|11253974|FG001|STARTED|Overall Study|Started are the randomised patients|53
10122870|NCT02579603|11253973|FG000|Number of Patients Treated|Overall Study||51
10122871|NCT02579603|11253974|FG001|Number of Patients Treated|Overall Study||53
10122872|NCT02579603|11253973|FG000|COMPLETED|Overall Study||48
10122873|NCT02579603|11253974|FG001|COMPLETED|Overall Study||51
10122874|NCT02579603|11253973|FG000|NOT COMPLETED|Overall Study||4
10122875|NCT02579603|11253974|FG001|NOT COMPLETED|Overall Study||2
10122876|NCT02579616|11253981|FG000|STARTED|Overall Study||29
10122877|NCT02579616|11253981|FG000|Treated|Overall Study||26
10122878|NCT02579616|11253981|FG000|COMPLETED|Overall Study||26
10122879|NCT02579616|11253981|FG000|NOT COMPLETED|Overall Study||3
10196190|NCT03358407|11324478|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196191|NCT03358407|11324479|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196192|NCT03358407|11324480|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196193|NCT03358407|11324481|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10196194|NCT03358407|11324482|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196195|NCT03358407|11324483|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196196|NCT03358407|11324484|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196197|NCT03358407|11324485|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196198|NCT03358407|11324486|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196199|NCT03358407|11324477|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196200|NCT03358407|11324478|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196201|NCT03358407|11324479|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196202|NCT03358407|11324480|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196203|NCT03358407|11324481|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196204|NCT03358407|11324482|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196205|NCT03358407|11324483|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196206|NCT03358407|11324484|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196207|NCT03358407|11324485|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196208|NCT03358407|11324486|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10196209|NCT03358407|11324477|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196210|NCT03358407|11324478|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196211|NCT03358407|11324479|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196212|NCT03358407|11324480|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196213|NCT03358407|11324481|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196214|NCT03358407|11324482|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10196215|NCT03358407|11324483|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10196216|NCT03358407|11324484|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
10122880|NCT02579629|11253988|FG000|STARTED|Overall Study||22
10122881|NCT02579629|11253989|FG001|STARTED|Overall Study||20
10122882|NCT02579629|11253990|FG002|STARTED|Overall Study||22
10122883|NCT02579629|11253988|FG000|COMPLETED|Overall Study||20
10122884|NCT02579629|11253989|FG001|COMPLETED|Overall Study||19
10122885|NCT02579629|11253990|FG002|COMPLETED|Overall Study||20
10122886|NCT02579629|11253988|FG000|NOT COMPLETED|Overall Study||2
10122887|NCT02579629|11253989|FG001|NOT COMPLETED|Overall Study||1
10122888|NCT02579629|11253990|FG002|NOT COMPLETED|Overall Study||2
10122889|NCT02579759|11254001|FG000|STARTED|Overall Study||109
10122890|NCT02579759|11254002|FG001|STARTED|Overall Study||113
10122891|NCT02579759|11254003|FG002|STARTED|Overall Study||101
10122892|NCT02579759|11254001|FG000|COMPLETED|Overall Study||85
10122893|NCT02579759|11254002|FG001|COMPLETED|Overall Study||49
10122894|NCT02579759|11254003|FG002|COMPLETED|Overall Study||80
10122895|NCT02579759|11254001|FG000|NOT COMPLETED|Overall Study||24
10122896|NCT02579759|11254002|FG001|NOT COMPLETED|Overall Study||64
10122897|NCT02579759|11254003|FG002|NOT COMPLETED|Overall Study||21
10122898|NCT02579772|11254013|FG000|STARTED|Overall Study||8
10122899|NCT02579772|11254014|FG001|STARTED|Overall Study||5
10122900|NCT02579772|11254013|FG000|COMPLETED|Overall Study||6
10122901|NCT02579772|11254014|FG001|COMPLETED|Overall Study||3
10122902|NCT02579772|11254013|FG000|NOT COMPLETED|Overall Study||2
10122903|NCT02579772|11254014|FG001|NOT COMPLETED|Overall Study||2
10122904|NCT02579863|11254022|FG000|STARTED|Overall Study||156
10122905|NCT02579863|11254023|FG001|STARTED|Overall Study||154
10122906|NCT02579863|11254022|FG000|Treated|Overall Study||154
10122907|NCT02579863|11254023|FG001|Treated|Overall Study||148
10122908|NCT02579863|11254022|FG000|COMPLETED|Overall Study||0
10122909|NCT02579863|11254023|FG001|COMPLETED|Overall Study||0
10122910|NCT02579863|11254022|FG000|NOT COMPLETED|Overall Study||156
10122911|NCT02579863|11254023|FG001|NOT COMPLETED|Overall Study||154
10122912|NCT02579876|11254031|FG000|STARTED|Overall Study||15
10122913|NCT02579876|11254032|FG001|STARTED|Overall Study||5
10122914|NCT02579876|11254031|FG000|COMPLETED|Overall Study||14
10122915|NCT02579876|11254032|FG001|COMPLETED|Overall Study||5
10122916|NCT02579876|11254031|FG000|NOT COMPLETED|Overall Study||1
10122917|NCT02579876|11254032|FG001|NOT COMPLETED|Overall Study||0
10122918|NCT02579915|11254040|FG000|STARTED|Overall Study||19
10122919|NCT02579915|11254041|FG001|STARTED|Overall Study||21
10122920|NCT02579915|11254040|FG000|COMPLETED|Overall Study||9
10122921|NCT02579915|11254041|FG001|COMPLETED|Overall Study||16
10122922|NCT02579915|11254040|FG000|NOT COMPLETED|Overall Study||10
10122923|NCT02579915|11254041|FG001|NOT COMPLETED|Overall Study||5
10122924|NCT02579928|11254049|FG000|STARTED|Overall Study||6
10122925|NCT02579928|11254050|FG001|STARTED|Overall Study||11
10122926|NCT02579928|11254049|FG000|COMPLETED|Overall Study||5
10122927|NCT02579928|11254050|FG001|COMPLETED|Overall Study||11
10122928|NCT02579928|11254049|FG000|NOT COMPLETED|Overall Study||1
10122929|NCT02579928|11254050|FG001|NOT COMPLETED|Overall Study||0
10122930|NCT02580188|11254058|FG000|STARTED|Overall Study||35
10122931|NCT02580188|11254059|FG001|STARTED|Overall Study||35
10122932|NCT02580188|11254058|FG000|COMPLETED|Overall Study||32
10122933|NCT02580188|11254059|FG001|COMPLETED|Overall Study||32
10122934|NCT02580188|11254058|FG000|NOT COMPLETED|Overall Study||3
10122935|NCT02580188|11254059|FG001|NOT COMPLETED|Overall Study||3
10122936|NCT02580201|11254068|FG000|STARTED|Overall Study||50
10122937|NCT02580201|11254069|FG001|STARTED|Overall Study||104
10122938|NCT02580201|11254068|FG000|COMPLETED|Overall Study||50
10122939|NCT02580201|11254069|FG001|COMPLETED|Overall Study||104
10122940|NCT02580201|11254068|FG000|NOT COMPLETED|Overall Study||0
10122941|NCT02580201|11254069|FG001|NOT COMPLETED|Overall Study||0
10122942|NCT02580240|11254078|FG000|STARTED|Overall Study||62
10122943|NCT02580240|11254079|FG001|STARTED|Overall Study||58
10122944|NCT02580240|11254078|FG000|COMPLETED|Overall Study||60
10122945|NCT02580240|11254079|FG001|COMPLETED|Overall Study||58
10122946|NCT02580240|11254078|FG000|NOT COMPLETED|Overall Study||2
10122947|NCT02580240|11254079|FG001|NOT COMPLETED|Overall Study||0
10122948|NCT02580318|11254085|FG000|STARTED|Overall Study||54
10122949|NCT02580318|11254085|FG000|Poor Effort|Overall Study||53
10122950|NCT02580318|11254085|FG000|Hyperventilation (Immediate)|Overall Study||54
10122951|NCT02580318|11254085|FG000|Hyperventilation (5 Minutes)|Overall Study||54
10122952|NCT02580318|11254085|FG000|Hyperventilation (10 Minutes)|Overall Study||54
10122953|NCT02580318|11254085|FG000|Drinking Water (Immediate)|Overall Study||51
10122954|NCT02580318|11254085|FG000|Drinking Water (5 Minutes)|Overall Study||54
10122955|NCT02580318|11254085|FG000|COMPLETED|Overall Study||54
10122956|NCT02580318|11254085|FG000|NOT COMPLETED|Overall Study||0
10122957|NCT02580357|11254092|FG000|STARTED|Overall Study||18
10122958|NCT02580357|11254093|FG001|STARTED|Overall Study||18
10122959|NCT02580357|11254094|FG002|STARTED|Overall Study||18
10122960|NCT02580357|11254092|FG000|COMPLETED|Overall Study||15
10122961|NCT02580357|11254093|FG001|COMPLETED|Overall Study||18
10122962|NCT02580357|11254094|FG002|COMPLETED|Overall Study||18
10122963|NCT02580357|11254092|FG000|NOT COMPLETED|Overall Study||3
10122964|NCT02580357|11254093|FG001|NOT COMPLETED|Overall Study||0
10122965|NCT02580357|11254094|FG002|NOT COMPLETED|Overall Study||0
10122966|NCT02580591|11254106|FG000|STARTED|Overall Study||242
10122967|NCT02580591|11254107|FG001|STARTED|Overall Study||242
10122968|NCT02580591|11254108|FG002|STARTED|Overall Study||248
10122969|NCT02580591|11254109|FG003|STARTED|Overall Study||245
10122970|NCT02580591|11254106|FG000|Treated|Overall Study||241
10122971|NCT02580591|11254107|FG001|Treated|Overall Study||241
10122972|NCT02580591|11254108|FG002|Treated|Overall Study||248
10122973|NCT02580591|11254109|FG003|Treated|Overall Study||245
10122974|NCT02580591|11254106|FG000|COMPLETED|Overall Study||224
10122975|NCT02580591|11254107|FG001|COMPLETED|Overall Study||232
10122976|NCT02580591|11254108|FG002|COMPLETED|Overall Study||235
10122977|NCT02580591|11254109|FG003|COMPLETED|Overall Study||233
10122978|NCT02580591|11254106|FG000|NOT COMPLETED|Overall Study||18
10122979|NCT02580591|11254107|FG001|NOT COMPLETED|Overall Study||10
10122980|NCT02580591|11254108|FG002|NOT COMPLETED|Overall Study||13
10122981|NCT02580591|11254109|FG003|NOT COMPLETED|Overall Study||12
10122982|NCT02580799|11254119|FG000|STARTED|Overall Study||30
10122983|NCT02580799|11254119|FG000|COMPLETED|Overall Study||30
10122984|NCT02580799|11254119|FG000|NOT COMPLETED|Overall Study||0
10122985|NCT02580877|11254125|FG000|STARTED|Overall Study||45
10122986|NCT02580877|11254126|FG001|STARTED|Overall Study||47
10122987|NCT02580877|11254125|FG000|COMPLETED|Overall Study||44
10122988|NCT02580877|11254126|FG001|COMPLETED|Overall Study||43
10122989|NCT02580877|11254125|FG000|NOT COMPLETED|Overall Study||1
10122990|NCT02580877|11254126|FG001|NOT COMPLETED|Overall Study||4
10122991|NCT02581111|11254135|FG000|STARTED|Overall Study||98
10122992|NCT02581111|11254136|FG001|STARTED|Overall Study||101
10122993|NCT02581111|11254135|FG000|COMPLETED|Overall Study||96
10122994|NCT02581111|11254136|FG001|COMPLETED|Overall Study||94
10122995|NCT02581111|11254135|FG000|NOT COMPLETED|Overall Study||2
10122996|NCT02581111|11254136|FG001|NOT COMPLETED|Overall Study||7
10122997|NCT02581163|11254142|FG000|STARTED|Overall Study||311
10122998|NCT02581163|11254142|FG000|COMPLETED|Overall Study||282
10122999|NCT02581163|11254142|FG000|NOT COMPLETED|Overall Study||29
10123000|NCT02581189|11254149|FG000|STARTED|Overall Study||534
10123001|NCT02581189|11254149|FG000|COMPLETED|Overall Study||481
10123002|NCT02581189|11254149|FG000|NOT COMPLETED|Overall Study||53
10123003|NCT02581202|11254156|FG000|STARTED|Overall Study||216
10123004|NCT02581202|11254156|FG000|COMPLETED|Overall Study||202
10123005|NCT02581202|11254156|FG000|NOT COMPLETED|Overall Study||14
10123006|NCT02581345|11254163|FG000|STARTED|Part 1: up to Week 16||286
10123007|NCT02581345|11254164|FG001|STARTED|Part 1: up to Week 16||286
10123008|NCT02581345|11254165|FG002|STARTED|Part 1: up to Week 16||0
10123009|NCT02581345|11254166|FG003|STARTED|Part 1: up to Week 16||0
10123010|NCT02581345|11254163|FG000|COMPLETED|Part 1: up to Week 16||271
10123011|NCT02581345|11254164|FG001|COMPLETED|Part 1: up to Week 16||263
10123012|NCT02581345|11254165|FG002|COMPLETED|Part 1: up to Week 16||0
10123013|NCT02581345|11254166|FG003|COMPLETED|Part 1: up to Week 16||0
10123014|NCT02581345|11254163|FG000|NOT COMPLETED|Part 1: up to Week 16||15
10123015|NCT02581345|11254164|FG001|NOT COMPLETED|Part 1: up to Week 16||23
10123016|NCT02581345|11254165|FG002|NOT COMPLETED|Part 1: up to Week 16||0
10123017|NCT02581345|11254166|FG003|NOT COMPLETED|Part 1: up to Week 16||0
10123018|NCT02581345|11254163|FG000|STARTED|Part 2: Week 17 to Week 47||271
10123019|NCT02581345|11254164|FG001|STARTED|Part 2: Week 17 to Week 47||0
10123020|NCT02581345|11254165|FG002|STARTED|Part 2: Week 17 to Week 47||132
10123021|NCT02581345|11254166|FG003|STARTED|Part 2: Week 17 to Week 47||131
10123022|NCT02581345|11254163|FG000|COMPLETED|Part 2: Week 17 to Week 47||242
10123023|NCT02581345|11254164|FG001|COMPLETED|Part 2: Week 17 to Week 47||0
10123024|NCT02581345|11254165|FG002|COMPLETED|Part 2: Week 17 to Week 47||117
9706663|NCT02450760|10805741|FG000|COMPLETED|Overall Study||15
10123025|NCT02581345|11254166|FG003|COMPLETED|Part 2: Week 17 to Week 47||119
10123026|NCT02581345|11254163|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29
10123027|NCT02581345|11254164|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0
10123028|NCT02581345|11254165|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15
10123029|NCT02581345|11254166|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12
10123030|NCT02581384|11254184|FG000|STARTED|Overall Study||3
10123031|NCT02581384|11254185|FG001|STARTED|Overall Study||2
10123032|NCT02581384|11254184|FG000|COMPLETED|Overall Study||3
10123033|NCT02581384|11254185|FG001|COMPLETED|Overall Study||2
10123034|NCT02581384|11254184|FG000|NOT COMPLETED|Overall Study||0
10123035|NCT02581384|11254185|FG001|NOT COMPLETED|Overall Study||0
10123036|NCT02581410|11254194|FG000|STARTED|Vaccination Phase||215
10123037|NCT02581410|11254195|FG001|STARTED|Vaccination Phase||215
10123038|NCT02581410|11254194|FG000|COMPLETED|Vaccination Phase||213
10123039|NCT02581410|11254195|FG001|COMPLETED|Vaccination Phase||212
10123040|NCT02581410|11254194|FG000|NOT COMPLETED|Vaccination Phase||2
10123041|NCT02581410|11254195|FG001|NOT COMPLETED|Vaccination Phase||3
10123042|NCT02581410|11254194|FG000|STARTED|End of Study Phase||215
10123043|NCT02581410|11254195|FG001|STARTED|End of Study Phase||215
10123044|NCT02581410|11254194|FG000|COMPLETED|End of Study Phase||210
10123045|NCT02581410|11254195|FG001|COMPLETED|End of Study Phase||204
10123046|NCT02581410|11254194|FG000|NOT COMPLETED|End of Study Phase||5
10123047|NCT02581410|11254195|FG001|NOT COMPLETED|End of Study Phase||11
10123048|NCT02581475|11254204|FG000|STARTED|Overall Study||193
10123049|NCT02581475|11254205|FG001|STARTED|Overall Study||193
10123050|NCT02581475|11254204|FG000|COMPLETED|Overall Study||182
10123051|NCT02581475|11254205|FG001|COMPLETED|Overall Study||178
10123052|NCT02581475|11254204|FG000|NOT COMPLETED|Overall Study||11
10123053|NCT02581475|11254205|FG001|NOT COMPLETED|Overall Study||15
10123054|NCT02581488|11254213|FG000|STARTED|Overall Study||51
10123055|NCT02581488|11254214|FG001|STARTED|Overall Study||51
10123056|NCT02581488|11254213|FG000|COMPLETED|Overall Study||42
10123057|NCT02581488|11254214|FG001|COMPLETED|Overall Study||40
10123058|NCT02581488|11254213|FG000|NOT COMPLETED|Overall Study||9
10123059|NCT02581488|11254214|FG001|NOT COMPLETED|Overall Study||11
10123060|NCT02581839|11254220|FG000|STARTED|Overall Study||9
10123061|NCT02581839|11254220|FG000|COMPLETED|Overall Study||9
10123062|NCT02581839|11254220|FG000|NOT COMPLETED|Overall Study||0
10123063|NCT02581865|11254227|FG000|STARTED|Overall Study||40
10123064|NCT02581865|11254228|FG001|STARTED|Overall Study||42
10123065|NCT02581865|11254229|FG002|STARTED|Overall Study||42
10123066|NCT02581865|11254227|FG000|COMPLETED|Overall Study||36
10123067|NCT02581865|11254228|FG001|COMPLETED|Overall Study||35
10123068|NCT02581865|11254229|FG002|COMPLETED|Overall Study||26
10123069|NCT02581865|11254227|FG000|NOT COMPLETED|Overall Study||4
10123070|NCT02581865|11254228|FG001|NOT COMPLETED|Overall Study||7
10123071|NCT02581865|11254229|FG002|NOT COMPLETED|Overall Study||16
10123072|NCT02581891|11254242|FG000|STARTED|Overall Study||135
10123073|NCT02581891|11254243|FG001|STARTED|Overall Study||136
10123074|NCT02581891|11254242|FG000|Completed Treatment|Overall Study||120
10123075|NCT02581891|11254243|FG001|Completed Treatment|Overall Study||117
10123076|NCT02581891|11254242|FG000|COMPLETED|Overall Study||119
10123077|NCT02581891|11254243|FG001|COMPLETED|Overall Study||117
10123078|NCT02581891|11254242|FG000|NOT COMPLETED|Overall Study||16
10123079|NCT02581891|11254243|FG001|NOT COMPLETED|Overall Study||19
10123080|NCT02581995|11254250|FG000|STARTED|Overall Study||560
10123081|NCT02581995|11254250|FG000|Treated|Overall Study||560
10123082|NCT02581995|11254250|FG000|COMPLETED|Overall Study||529
10123083|NCT02581995|11254250|FG000|NOT COMPLETED|Overall Study||31
10123084|NCT02582151|11254256|FG000|STARTED|Overall Study||14
10123085|NCT02582151|11254257|FG001|STARTED|Overall Study||16
10123086|NCT02582151|11254256|FG000|COMPLETED|Overall Study||12
10123087|NCT02582151|11254257|FG001|COMPLETED|Overall Study||16
10123088|NCT02582151|11254256|FG000|NOT COMPLETED|Overall Study||2
10123089|NCT02582151|11254257|FG001|NOT COMPLETED|Overall Study||0
10123090|NCT02582216|11254263|FG000|STARTED|Overall Study||22
10123091|NCT02582216|11254263|FG000|COMPLETED|Overall Study||22
10123092|NCT02582216|11254263|FG000|NOT COMPLETED|Overall Study||0
10123093|NCT02582242|11254270|FG000|STARTED|Overall Study||220
10123094|NCT02582242|11254271|FG001|STARTED|Overall Study||217
10123095|NCT02582242|11254270|FG000|COMPLETED|Overall Study||200
10123096|NCT02582242|11254271|FG001|COMPLETED|Overall Study||200
10123097|NCT02582242|11254270|FG000|NOT COMPLETED|Overall Study||20
10123098|NCT02582242|11254271|FG001|NOT COMPLETED|Overall Study||17
10123099|NCT02582255|11254279|FG000|STARTED|Overall Study||50
10123100|NCT02582255|11254280|FG001|STARTED|Overall Study||50
10123101|NCT02582255|11254279|FG000|COMPLETED|Overall Study||50
10123102|NCT02582255|11254280|FG001|COMPLETED|Overall Study||47
10123103|NCT02582255|11254279|FG000|NOT COMPLETED|Overall Study||0
10123104|NCT02582255|11254280|FG001|NOT COMPLETED|Overall Study||3
10123105|NCT02582515|11254289|FG000|STARTED|Overall Study||9
10123106|NCT02582515|11254290|FG001|STARTED|Overall Study||11
10123107|NCT02582515|11254289|FG000|Received Study Intervention|Overall Study||9
10123108|NCT02582515|11254290|FG001|Received Study Intervention|Overall Study||10
10123109|NCT02582515|11254289|FG000|COMPLETED|Overall Study||9
10123110|NCT02582515|11254290|FG001|COMPLETED|Overall Study||10
10123111|NCT02582515|11254289|FG000|NOT COMPLETED|Overall Study||0
10123112|NCT02582515|11254290|FG001|NOT COMPLETED|Overall Study||1
10123113|NCT02582632|11254296|FG000|STARTED|Overall Study||166
10123114|NCT02582632|11254296|FG000|COMPLETED|Overall Study||165
10123115|NCT02582632|11254296|FG000|NOT COMPLETED|Overall Study||1
10123116|NCT02582658|11254300|FG000|STARTED|Overall Study||171
10123117|NCT02582658|11254300|FG000|COMPLETED|Overall Study||146
10123118|NCT02582658|11254300|FG000|NOT COMPLETED|Overall Study||25
10123119|NCT02582671|11254304|FG000|STARTED|Overall Study||101
10123120|NCT02582671|11254304|FG000|COMPLETED|Overall Study||99
10123121|NCT02582671|11254304|FG000|NOT COMPLETED|Overall Study||2
10123122|NCT02582684|11254309|FG000|STARTED|Overall Study||122
10123123|NCT02582684|11254309|FG000|COMPLETED|Overall Study||105
10123124|NCT02582684|11254309|FG000|NOT COMPLETED|Overall Study||17
10123125|NCT02582814|11254315|FG000|STARTED|Overall Study||76
10123126|NCT02582814|11254316|FG001|STARTED|Overall Study||75
10123127|NCT02582814|11254315|FG000|COMPLETED|Overall Study||67
10123128|NCT02582814|11254316|FG001|COMPLETED|Overall Study||68
10123129|NCT02582814|11254315|FG000|NOT COMPLETED|Overall Study||9
10123130|NCT02582814|11254316|FG001|NOT COMPLETED|Overall Study||7
10123131|NCT02582840|11254325|FG000|STARTED|Overall Study||14
10123132|NCT02582840|11254326|FG001|STARTED|Overall Study||14
10123133|NCT02582840|11254327|FG002|STARTED|Overall Study||14
10123134|NCT02582840|11254325|FG000|COMPLETED|Overall Study||14
10123135|NCT02582840|11254326|FG001|COMPLETED|Overall Study||14
10123136|NCT02582840|11254327|FG002|COMPLETED|Overall Study||14
10123137|NCT02582840|11254325|FG000|NOT COMPLETED|Overall Study||0
10123138|NCT02582840|11254326|FG001|NOT COMPLETED|Overall Study||0
10123139|NCT02582840|11254327|FG002|NOT COMPLETED|Overall Study||0
10123140|NCT02582866|11254337|FG000|STARTED|Overall Study||106
10123141|NCT02582866|11254337|FG000|COMPLETED|Overall Study||84
10123142|NCT02582866|11254337|FG000|NOT COMPLETED|Overall Study||22
10123143|NCT02582970|11254341|FG000|STARTED|Overall Study||40
10123144|NCT02582970|11254341|FG000|COMPLETED|Overall Study||40
10123145|NCT02582970|11254341|FG000|NOT COMPLETED|Overall Study||0
10123146|NCT02582983|11254345|FG000|STARTED|Overall Study||23
10123147|NCT02582983|11254345|FG000|COMPLETED|Overall Study||17
10123148|NCT02582983|11254345|FG000|NOT COMPLETED|Overall Study||6
10123149|NCT02583230|11254349|FG000|STARTED|Overall Study||11
10123150|NCT02583230|11254349|FG000|COMPLETED|Overall Study||11
10123151|NCT02583230|11254349|FG000|NOT COMPLETED|Overall Study||0
10123152|NCT02583256|11254357|FG000|STARTED|Overall Study||403
10123153|NCT02583256|11254358|FG001|STARTED|Overall Study||403
10123154|NCT02583256|11254359|FG002|STARTED|Overall Study||402
10123155|NCT02583256|11254360|FG003|STARTED|Overall Study||393
10123156|NCT02583256|11254357|FG000|Exposed|Overall Study||403
10123157|NCT02583256|11254358|FG001|Exposed|Overall Study||403
10123158|NCT02583256|11254359|FG002|Exposed|Overall Study||402
10123159|NCT02583256|11254360|FG003|Exposed|Overall Study||393
10123160|NCT02583256|11254357|FG000|COMPLETED|Overall Study||400
10123161|NCT02583256|11254358|FG001|COMPLETED|Overall Study||401
10123162|NCT02583256|11254359|FG002|COMPLETED|Overall Study||400
10123163|NCT02583256|11254360|FG003|COMPLETED|Overall Study||390
10123164|NCT02583256|11254357|FG000|NOT COMPLETED|Overall Study||3
10123165|NCT02583256|11254358|FG001|NOT COMPLETED|Overall Study||2
10123166|NCT02583256|11254359|FG002|NOT COMPLETED|Overall Study||2
10123167|NCT02583256|11254360|FG003|NOT COMPLETED|Overall Study||3
10123168|NCT02583360|11254374|FG000|STARTED|Overall Study||60
10123169|NCT02583360|11254375|FG001|STARTED|Overall Study||49
10123170|NCT02583360|11254374|FG000|COMPLETED|Overall Study||60
10123171|NCT02583360|11254375|FG001|COMPLETED|Overall Study||49
10123172|NCT02583360|11254374|FG000|NOT COMPLETED|Overall Study||0
10123173|NCT02583360|11254375|FG001|NOT COMPLETED|Overall Study||0
10123174|NCT02583399|11254381|FG000|STARTED|Overall Study||30
10123175|NCT02583399|11254381|FG000|COMPLETED|Overall Study||24
10123176|NCT02583399|11254381|FG000|NOT COMPLETED|Overall Study||6
10123177|NCT02583425|11254385|FG000|STARTED|Screening||27
10123178|NCT02583425|11254385|FG000|COMPLETED|Screening||15
10123179|NCT02583425|11254385|FG000|NOT COMPLETED|Screening||12
10123180|NCT02583425|11254385|FG000|STARTED|Baseline||15
10123181|NCT02583425|11254385|FG000|COMPLETED|Baseline||10
10123182|NCT02583425|11254385|FG000|NOT COMPLETED|Baseline||5
10123183|NCT02583425|11254385|FG000|STARTED|Treatment Period||10
10123184|NCT02583425|11254385|FG000|COMPLETED|Treatment Period||9
10123185|NCT02583425|11254385|FG000|NOT COMPLETED|Treatment Period||1
10123186|NCT02583477|11254392|FG000|STARTED|Overall Study||3
10123187|NCT02583477|11254393|FG001|STARTED|Overall Study||20
10123188|NCT02583477|11254392|FG000|Received Treatment|Overall Study||3
10123189|NCT02583477|11254393|FG001|Received Treatment|Overall Study||20
10123190|NCT02583477|11254392|FG000|Completed Treatment|Overall Study||0
10123191|NCT02583477|11254393|FG001|Completed Treatment|Overall Study||0
10123192|NCT02583477|11254392|FG000|COMPLETED|Overall Study||0
10123193|NCT02583477|11254393|FG001|COMPLETED|Overall Study||0
10123194|NCT02583477|11254392|FG000|NOT COMPLETED|Overall Study||3
10123195|NCT02583477|11254393|FG001|NOT COMPLETED|Overall Study||20
10123196|NCT02583711|11254403|FG000|STARTED|Overall Study||11
10123197|NCT02583711|11254404|FG001|STARTED|Overall Study||38
10123198|NCT02583711|11254405|FG002|STARTED|Overall Study||10
10123199|NCT02583711|11254403|FG000|COMPLETED|Overall Study||11
10123200|NCT02583711|11254404|FG001|COMPLETED|Overall Study||28
10123201|NCT02583711|11254405|FG002|COMPLETED|Overall Study||10
10123202|NCT02583711|11254403|FG000|NOT COMPLETED|Overall Study||0
10123203|NCT02583711|11254404|FG001|NOT COMPLETED|Overall Study||10
10123204|NCT02583711|11254405|FG002|NOT COMPLETED|Overall Study||0
10123205|NCT02584140|11254415|FG000|STARTED|Overall Study||136
10123206|NCT02584140|11254415|FG000|COMPLETED|Overall Study||83
10123207|NCT02584140|11254415|FG000|NOT COMPLETED|Overall Study||53
10123208|NCT02584257|11254419|FG000|STARTED|Period 1||9
10123209|NCT02584257|11254420|FG001|STARTED|Period 1||9
10123210|NCT02584257|11254421|FG002|STARTED|Period 1||9
10123211|NCT02584257|11254422|FG003|STARTED|Period 1||8
10123212|NCT02584257|11254423|FG004|STARTED|Period 1||10
10123213|NCT02584257|11254424|FG005|STARTED|Period 1||10
10123214|NCT02584257|11254425|FG006|STARTED|Period 1||18
10123215|NCT02584257|11254426|FG007|STARTED|Period 1||9
10123216|NCT02584257|11254427|FG008|STARTED|Period 1||9
10123217|NCT02584257|11254419|FG000|COMPLETED|Period 1||9
10123218|NCT02584257|11254420|FG001|COMPLETED|Period 1||9
10123219|NCT02584257|11254421|FG002|COMPLETED|Period 1||9
10123220|NCT02584257|11254422|FG003|COMPLETED|Period 1||8
10123221|NCT02584257|11254423|FG004|COMPLETED|Period 1||10
10123222|NCT02584257|11254424|FG005|COMPLETED|Period 1||10
10123223|NCT02584257|11254425|FG006|COMPLETED|Period 1||17
10123224|NCT02584257|11254426|FG007|COMPLETED|Period 1||9
10123225|NCT02584257|11254427|FG008|COMPLETED|Period 1||9
10123226|NCT02584257|11254419|FG000|NOT COMPLETED|Period 1||0
10123227|NCT02584257|11254420|FG001|NOT COMPLETED|Period 1||0
10123228|NCT02584257|11254421|FG002|NOT COMPLETED|Period 1||0
10123229|NCT02584257|11254422|FG003|NOT COMPLETED|Period 1||0
10123230|NCT02584257|11254423|FG004|NOT COMPLETED|Period 1||0
10123231|NCT02584257|11254424|FG005|NOT COMPLETED|Period 1||0
10123232|NCT02584257|11254425|FG006|NOT COMPLETED|Period 1||1
10123233|NCT02584257|11254426|FG007|NOT COMPLETED|Period 1||0
10123234|NCT02584257|11254427|FG008|NOT COMPLETED|Period 1||0
10123235|NCT02584257|11254419|FG000|STARTED|Period 2||9
10123236|NCT02584257|11254420|FG001|STARTED|Period 2||9
10123237|NCT02584257|11254421|FG002|STARTED|Period 2||9
10123238|NCT02584257|11254422|FG003|STARTED|Period 2||8
10123239|NCT02584257|11254423|FG004|STARTED|Period 2||10
10123240|NCT02584257|11254424|FG005|STARTED|Period 2||10
10123241|NCT02584257|11254425|FG006|STARTED|Period 2||17
10123242|NCT02584257|11254426|FG007|STARTED|Period 2||9
10123243|NCT02584257|11254427|FG008|STARTED|Period 2||9
10123244|NCT02584257|11254419|FG000|COMPLETED|Period 2||8
10123245|NCT02584257|11254420|FG001|COMPLETED|Period 2||8
10123246|NCT02584257|11254421|FG002|COMPLETED|Period 2||9
10123247|NCT02584257|11254422|FG003|COMPLETED|Period 2||8
10123248|NCT02584257|11254423|FG004|COMPLETED|Period 2||10
10123249|NCT02584257|11254424|FG005|COMPLETED|Period 2||10
10123250|NCT02584257|11254425|FG006|COMPLETED|Period 2||17
10123251|NCT02584257|11254426|FG007|COMPLETED|Period 2||9
10123252|NCT02584257|11254427|FG008|COMPLETED|Period 2||9
10123253|NCT02584257|11254419|FG000|NOT COMPLETED|Period 2||1
10123254|NCT02584257|11254420|FG001|NOT COMPLETED|Period 2||1
10123255|NCT02584257|11254421|FG002|NOT COMPLETED|Period 2||0
10123256|NCT02584257|11254422|FG003|NOT COMPLETED|Period 2||0
10123257|NCT02584257|11254423|FG004|NOT COMPLETED|Period 2||0
10123258|NCT02584257|11254424|FG005|NOT COMPLETED|Period 2||0
10123259|NCT02584257|11254425|FG006|NOT COMPLETED|Period 2||0
10123260|NCT02584257|11254426|FG007|NOT COMPLETED|Period 2||0
10123261|NCT02584257|11254427|FG008|NOT COMPLETED|Period 2||0
10123262|NCT02584257|11254419|FG000|STARTED|Period 3||8
10123263|NCT02584257|11254420|FG001|STARTED|Period 3||8
10123264|NCT02584257|11254421|FG002|STARTED|Period 3||9
10123265|NCT02584257|11254422|FG003|STARTED|Period 3||8
10123266|NCT02584257|11254423|FG004|STARTED|Period 3||10
10123267|NCT02584257|11254424|FG005|STARTED|Period 3||10
10123268|NCT02584257|11254425|FG006|STARTED|Period 3||17
10123269|NCT02584257|11254426|FG007|STARTED|Period 3||9
10123270|NCT02584257|11254427|FG008|STARTED|Period 3||9
10123271|NCT02584257|11254419|FG000|COMPLETED|Period 3||8
10123272|NCT02584257|11254420|FG001|COMPLETED|Period 3||8
10123273|NCT02584257|11254421|FG002|COMPLETED|Period 3||9
10123274|NCT02584257|11254422|FG003|COMPLETED|Period 3||8
10123275|NCT02584257|11254423|FG004|COMPLETED|Period 3||10
10123276|NCT02584257|11254424|FG005|COMPLETED|Period 3||10
10123277|NCT02584257|11254425|FG006|COMPLETED|Period 3||17
10123278|NCT02584257|11254426|FG007|COMPLETED|Period 3||9
10123279|NCT02584257|11254427|FG008|COMPLETED|Period 3||9
10123280|NCT02584257|11254419|FG000|NOT COMPLETED|Period 3||0
10123281|NCT02584257|11254420|FG001|NOT COMPLETED|Period 3||0
10123282|NCT02584257|11254421|FG002|NOT COMPLETED|Period 3||0
10123283|NCT02584257|11254422|FG003|NOT COMPLETED|Period 3||0
10123284|NCT02584257|11254423|FG004|NOT COMPLETED|Period 3||0
9706664|NCT02450760|10805742|FG001|COMPLETED|Overall Study||18
10123285|NCT02584257|11254424|FG005|NOT COMPLETED|Period 3||0
10123286|NCT02584257|11254425|FG006|NOT COMPLETED|Period 3||0
10123287|NCT02584257|11254426|FG007|NOT COMPLETED|Period 3||0
10123288|NCT02584257|11254427|FG008|NOT COMPLETED|Period 3||0
10123289|NCT02584257|11254419|FG000|STARTED|Period 4||8
10123290|NCT02584257|11254420|FG001|STARTED|Period 4||8
10123291|NCT02584257|11254421|FG002|STARTED|Period 4||9
10123292|NCT02584257|11254422|FG003|STARTED|Period 4||8
10123293|NCT02584257|11254423|FG004|STARTED|Period 4||10
10123294|NCT02584257|11254424|FG005|STARTED|Period 4||10
10123295|NCT02584257|11254425|FG006|STARTED|Period 4||17
10123296|NCT02584257|11254426|FG007|STARTED|Period 4||9
10123297|NCT02584257|11254427|FG008|STARTED|Period 4||9
10123298|NCT02584257|11254419|FG000|COMPLETED|Period 4||8
10123299|NCT02584257|11254420|FG001|COMPLETED|Period 4||8
10123300|NCT02584257|11254421|FG002|COMPLETED|Period 4||9
10123301|NCT02584257|11254422|FG003|COMPLETED|Period 4||8
10123302|NCT02584257|11254423|FG004|COMPLETED|Period 4||10
10123303|NCT02584257|11254424|FG005|COMPLETED|Period 4||10
10123304|NCT02584257|11254425|FG006|COMPLETED|Period 4||17
10123305|NCT02584257|11254426|FG007|COMPLETED|Period 4||9
10123306|NCT02584257|11254427|FG008|COMPLETED|Period 4||9
10123307|NCT02584257|11254419|FG000|NOT COMPLETED|Period 4||0
10123308|NCT02584257|11254420|FG001|NOT COMPLETED|Period 4||0
10123309|NCT02584257|11254421|FG002|NOT COMPLETED|Period 4||0
10123310|NCT02584257|11254422|FG003|NOT COMPLETED|Period 4||0
10123311|NCT02584257|11254423|FG004|NOT COMPLETED|Period 4||0
10123312|NCT02584257|11254424|FG005|NOT COMPLETED|Period 4||0
10123313|NCT02584257|11254425|FG006|NOT COMPLETED|Period 4||0
10123314|NCT02584257|11254426|FG007|NOT COMPLETED|Period 4||0
10123315|NCT02584257|11254427|FG008|NOT COMPLETED|Period 4||0
10123316|NCT02584257|11254419|FG000|STARTED|Period 5||8
10123317|NCT02584257|11254420|FG001|STARTED|Period 5||8
10123318|NCT02584257|11254421|FG002|STARTED|Period 5||9
10123319|NCT02584257|11254422|FG003|STARTED|Period 5||8
10123320|NCT02584257|11254423|FG004|STARTED|Period 5||10
10123321|NCT02584257|11254424|FG005|STARTED|Period 5||10
10123322|NCT02584257|11254425|FG006|STARTED|Period 5||17
10123323|NCT02584257|11254426|FG007|STARTED|Period 5||9
10123324|NCT02584257|11254427|FG008|STARTED|Period 5||9
10123325|NCT02584257|11254419|FG000|COMPLETED|Period 5||8
10123326|NCT02584257|11254420|FG001|COMPLETED|Period 5||8
10123327|NCT02584257|11254421|FG002|COMPLETED|Period 5||9
10123328|NCT02584257|11254422|FG003|COMPLETED|Period 5||8
10123329|NCT02584257|11254423|FG004|COMPLETED|Period 5||10
10123330|NCT02584257|11254424|FG005|COMPLETED|Period 5||10
10123331|NCT02584257|11254425|FG006|COMPLETED|Period 5||17
10123332|NCT02584257|11254426|FG007|COMPLETED|Period 5||9
10123333|NCT02584257|11254427|FG008|COMPLETED|Period 5||9
10123334|NCT02584257|11254419|FG000|NOT COMPLETED|Period 5||0
10123335|NCT02584257|11254420|FG001|NOT COMPLETED|Period 5||0
10123336|NCT02584257|11254421|FG002|NOT COMPLETED|Period 5||0
10123337|NCT02584257|11254422|FG003|NOT COMPLETED|Period 5||0
10123338|NCT02584257|11254423|FG004|NOT COMPLETED|Period 5||0
10123339|NCT02584257|11254424|FG005|NOT COMPLETED|Period 5||0
10123340|NCT02584257|11254425|FG006|NOT COMPLETED|Period 5||0
10123341|NCT02584257|11254426|FG007|NOT COMPLETED|Period 5||0
10123342|NCT02584257|11254427|FG008|NOT COMPLETED|Period 5||0
10123343|NCT02584452|11254441|FG000|STARTED|Overall Study||34
10123344|NCT02584452|11254442|FG001|STARTED|Overall Study||23
10123345|NCT02584452|11254441|FG000|COMPLETED|Overall Study||32
10123346|NCT02584452|11254442|FG001|COMPLETED|Overall Study||21
10123347|NCT02584452|11254441|FG000|NOT COMPLETED|Overall Study||2
10123348|NCT02584452|11254442|FG001|NOT COMPLETED|Overall Study||2
10123349|NCT02584504|11254452|FG000|STARTED|Double-blind Treatment|Randomized|54
10123350|NCT02584504|11254453|FG001|STARTED|Double-blind Treatment|Randomized|53
10123351|NCT02584504|11254454|FG002|STARTED|Double-blind Treatment|Randomized|56
10123352|NCT02584504|11254452|FG000|ITT Population|Double-blind Treatment||54
10123353|NCT02584504|11254453|FG001|ITT Population|Double-blind Treatment||53
10123354|NCT02584504|11254454|FG002|ITT Population|Double-blind Treatment||56
10123355|NCT02584504|11254452|FG000|mITT Population|Double-blind Treatment||54
10123356|NCT02584504|11254453|FG001|mITT Population|Double-blind Treatment||53
10123357|NCT02584504|11254454|FG002|mITT Population|Double-blind Treatment||56
10123358|NCT02584504|11254452|FG000|Safety Population|Double-blind Treatment||54
10123359|NCT02584504|11254453|FG001|Safety Population|Double-blind Treatment||53
10123360|NCT02584504|11254454|FG002|Safety Population|Double-blind Treatment||56
10123361|NCT02584504|11254452|FG000|COMPLETED|Double-blind Treatment||54
10123362|NCT02584504|11254453|FG001|COMPLETED|Double-blind Treatment||51
10123363|NCT02584504|11254454|FG002|COMPLETED|Double-blind Treatment||55
10123364|NCT02584504|11254452|FG000|NOT COMPLETED|Double-blind Treatment||0
10123365|NCT02584504|11254453|FG001|NOT COMPLETED|Double-blind Treatment||2
10123366|NCT02584504|11254454|FG002|NOT COMPLETED|Double-blind Treatment||1
10123367|NCT02584504|11254452|FG000|STARTED|Open-label Treatment||54
10123368|NCT02584504|11254453|FG001|STARTED|Open-label Treatment||51
10123369|NCT02584504|11254454|FG002|STARTED|Open-label Treatment||55
10123370|NCT02584504|11254452|FG000|Treated|Open-label Treatment||54
10123371|NCT02584504|11254453|FG001|Treated|Open-label Treatment||50
10123372|NCT02584504|11254454|FG002|Treated|Open-label Treatment||54
10123373|NCT02584504|11254452|FG000|COMPLETED|Open-label Treatment||52
10123374|NCT02584504|11254453|FG001|COMPLETED|Open-label Treatment||47
10123375|NCT02584504|11254454|FG002|COMPLETED|Open-label Treatment||47
10123376|NCT02584504|11254452|FG000|NOT COMPLETED|Open-label Treatment||2
10123377|NCT02584504|11254453|FG001|NOT COMPLETED|Open-label Treatment||4
10123378|NCT02584504|11254454|FG002|NOT COMPLETED|Open-label Treatment||8
10123379|NCT02584608|11254466|FG000|STARTED|Overall Study||12
10123380|NCT02584608|11254466|FG000|COMPLETED|Overall Study||12
10123381|NCT02584608|11254466|FG000|NOT COMPLETED|Overall Study||0
10123382|NCT02584660|11254472|FG000|STARTED|Overall Study||51
10123383|NCT02584660|11254473|FG001|STARTED|Overall Study||63
10123384|NCT02584660|11254472|FG000|Treated|Overall Study||49
10123385|NCT02584660|11254473|FG001|Treated|Overall Study||63
10123386|NCT02584660|11254472|FG000|COMPLETED|Overall Study||44
10123387|NCT02584660|11254473|FG001|COMPLETED|Overall Study||55
10123388|NCT02584660|11254472|FG000|NOT COMPLETED|Overall Study||7
10123389|NCT02584660|11254473|FG001|NOT COMPLETED|Overall Study||8
10123390|NCT02584673|11254481|FG000|STARTED|Overall Study||15
10123391|NCT02584673|11254482|FG001|STARTED|Overall Study||15
10123392|NCT02584673|11254481|FG000|COMPLETED|Overall Study||15
10123393|NCT02584673|11254482|FG001|COMPLETED|Overall Study||15
10123394|NCT02584673|11254481|FG000|NOT COMPLETED|Overall Study||0
10123395|NCT02584673|11254482|FG001|NOT COMPLETED|Overall Study||0
10123396|NCT02584686|11254490|FG000|STARTED|Overall Study||12
10123397|NCT02584686|11254491|FG001|STARTED|Overall Study||12
10123398|NCT02584686|11254490|FG000|COMPLETED|Overall Study||12
10123399|NCT02584686|11254491|FG001|COMPLETED|Overall Study||12
10123400|NCT02584686|11254490|FG000|NOT COMPLETED|Overall Study||0
10123401|NCT02584686|11254491|FG001|NOT COMPLETED|Overall Study||0
10123402|NCT02584725|11254501|FG000|STARTED|Overall Study||28
10123403|NCT02584725|11254502|FG001|STARTED|Overall Study||28
10123404|NCT02584725|11254503|FG002|STARTED|Overall Study||28
10123405|NCT02584725|11254501|FG000|COMPLETED|Overall Study||28
10123406|NCT02584725|11254502|FG001|COMPLETED|Overall Study||28
10123407|NCT02584725|11254503|FG002|COMPLETED|Overall Study||28
10123408|NCT02584725|11254501|FG000|NOT COMPLETED|Overall Study||0
10123409|NCT02584725|11254502|FG001|NOT COMPLETED|Overall Study||0
10123410|NCT02584725|11254503|FG002|NOT COMPLETED|Overall Study||0
10123411|NCT02584790|11254511|FG000|STARTED|Overall Study||55
10123412|NCT02584790|11254511|FG000|COMPLETED|Overall Study||40
10123413|NCT02584790|11254511|FG000|NOT COMPLETED|Overall Study||15
10123414|NCT02584855|11254515|FG000|STARTED|Open-Label Treatment Period||394
10123415|NCT02584855|11254516|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
10123416|NCT02584855|11254517|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
10123417|NCT02584855|11254518|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
10123418|NCT02584855|11254519|FG004|STARTED|Open-Label Treatment Period||0
10123419|NCT02584855|11254520|FG005|STARTED|Open-Label Treatment Period||0
10123420|NCT02584855|11254515|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
10123421|NCT02584855|11254516|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10123422|NCT02584855|11254517|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10123423|NCT02584855|11254518|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10123424|NCT02584855|11254519|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10123425|NCT02584855|11254520|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10123426|NCT02584855|11254515|FG000|Met Randomization Criteria|Open-Label Treatment Period||158
10123427|NCT02584855|11254516|FG001|Met Randomization Criteria|Open-Label Treatment Period||0
10123428|NCT02584855|11254517|FG002|Met Randomization Criteria|Open-Label Treatment Period||0
10123429|NCT02584855|11254518|FG003|Met Randomization Criteria|Open-Label Treatment Period||0
10123430|NCT02584855|11254519|FG004|Met Randomization Criteria|Open-Label Treatment Period||0
10123431|NCT02584855|11254520|FG005|Met Randomization Criteria|Open-Label Treatment Period||0
10123432|NCT02584855|11254515|FG000|Non-randomized|Open-Label Treatment Period||133
10123433|NCT02584855|11254516|FG001|Non-randomized|Open-Label Treatment Period||0
10123434|NCT02584855|11254517|FG002|Non-randomized|Open-Label Treatment Period||0
10123435|NCT02584855|11254518|FG003|Non-randomized|Open-Label Treatment Period||0
10123436|NCT02584855|11254519|FG004|Non-randomized|Open-Label Treatment Period||0
10123437|NCT02584855|11254520|FG005|Non-randomized|Open-Label Treatment Period||0
10123438|NCT02584855|11254515|FG000|COMPLETED|Open-Label Treatment Period||291
10123439|NCT02584855|11254516|FG001|COMPLETED|Open-Label Treatment Period||0
10123440|NCT02584855|11254517|FG002|COMPLETED|Open-Label Treatment Period||0
10123441|NCT02584855|11254518|FG003|COMPLETED|Open-Label Treatment Period||0
10123442|NCT02584855|11254519|FG004|COMPLETED|Open-Label Treatment Period||0
10123443|NCT02584855|11254520|FG005|COMPLETED|Open-Label Treatment Period||0
10123444|NCT02584855|11254515|FG000|NOT COMPLETED|Open-Label Treatment Period||103
10123445|NCT02584855|11254516|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10123446|NCT02584855|11254517|FG002|NOT COMPLETED|Open-Label Treatment Period||0
10123447|NCT02584855|11254518|FG003|NOT COMPLETED|Open-Label Treatment Period||0
10123448|NCT02584855|11254519|FG004|NOT COMPLETED|Open-Label Treatment Period||0
10123449|NCT02584855|11254520|FG005|NOT COMPLETED|Open-Label Treatment Period||0
10123450|NCT02584855|11254515|FG000|STARTED|Double-Blind Withdrawal Period||0
10123451|NCT02584855|11254516|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
10123452|NCT02584855|11254517|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
10123453|NCT02584855|11254518|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
10123454|NCT02584855|11254519|FG004|STARTED|Double-Blind Withdrawal Period||0
10123455|NCT02584855|11254520|FG005|STARTED|Double-Blind Withdrawal Period||0
10123456|NCT02584855|11254515|FG000|Relapsed|Double-Blind Withdrawal Period||0
10123457|NCT02584855|11254516|FG001|Relapsed|Double-Blind Withdrawal Period||0
10123458|NCT02584855|11254517|FG002|Relapsed|Double-Blind Withdrawal Period||67
10123459|NCT02584855|11254518|FG003|Relapsed|Double-Blind Withdrawal Period||30
10123460|NCT02584855|11254519|FG004|Relapsed|Double-Blind Withdrawal Period||0
10123461|NCT02584855|11254520|FG005|Relapsed|Double-Blind Withdrawal Period||0
10123462|NCT02584855|11254515|FG000|COMPLETED|Double-Blind Withdrawal Period||0
10123463|NCT02584855|11254516|FG001|COMPLETED|Double-Blind Withdrawal Period||118
10123464|NCT02584855|11254517|FG002|COMPLETED|Double-Blind Withdrawal Period||77
10123465|NCT02584855|11254518|FG003|COMPLETED|Double-Blind Withdrawal Period||78
10123466|NCT02584855|11254519|FG004|COMPLETED|Double-Blind Withdrawal Period||0
10123467|NCT02584855|11254520|FG005|COMPLETED|Double-Blind Withdrawal Period||0
10123468|NCT02584855|11254515|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0
10123469|NCT02584855|11254516|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15
10123470|NCT02584855|11254517|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2
10123471|NCT02584855|11254518|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1
10123472|NCT02584855|11254519|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0
10123473|NCT02584855|11254520|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0
10123474|NCT02584855|11254515|FG000|STARTED|Post Treatment Follow-up Period||0
10123475|NCT02584855|11254516|FG001|STARTED|Post Treatment Follow-up Period||0
10123476|NCT02584855|11254517|FG002|STARTED|Post Treatment Follow-up Period||0
10123477|NCT02584855|11254518|FG003|STARTED|Post Treatment Follow-up Period||0
10123478|NCT02584855|11254519|FG004|STARTED|Post Treatment Follow-up Period||355
10123479|NCT02584855|11254520|FG005|STARTED|Post Treatment Follow-up Period||12
10123480|NCT02584855|11254515|FG000|COMPLETED|Post Treatment Follow-up Period||0
10123481|NCT02584855|11254516|FG001|COMPLETED|Post Treatment Follow-up Period||0
10123482|NCT02584855|11254517|FG002|COMPLETED|Post Treatment Follow-up Period||0
10123483|NCT02584855|11254518|FG003|COMPLETED|Post Treatment Follow-up Period||0
10123484|NCT02584855|11254519|FG004|COMPLETED|Post Treatment Follow-up Period||347
10123485|NCT02584855|11254520|FG005|COMPLETED|Post Treatment Follow-up Period||12
10123486|NCT02584855|11254515|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
10123487|NCT02584855|11254516|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
10123488|NCT02584855|11254517|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
10123489|NCT02584855|11254518|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
10123490|NCT02584855|11254519|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8
10123491|NCT02584855|11254520|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0
10123492|NCT02584868|11254535|FG000|STARTED|Overall Study||44
10123493|NCT02584868|11254536|FG001|STARTED|Overall Study||44
10123494|NCT02584868|11254535|FG000|COMPLETED|Overall Study||44
10123495|NCT02584868|11254536|FG001|COMPLETED|Overall Study||44
10123496|NCT02584868|11254535|FG000|NOT COMPLETED|Overall Study||0
10123497|NCT02584868|11254536|FG001|NOT COMPLETED|Overall Study||0
10123498|NCT02584959|11254545|FG000|STARTED|Period 1||31
10123499|NCT02584959|11254546|FG001|STARTED|Period 1||29
10123500|NCT02584959|11254547|FG002|STARTED|Period 1||15
10123501|NCT02584959|11254545|FG000|COMPLETED|Period 1||28
10123502|NCT02584959|11254546|FG001|COMPLETED|Period 1||25
10123503|NCT02584959|11254547|FG002|COMPLETED|Period 1||15
10123504|NCT02584959|11254545|FG000|NOT COMPLETED|Period 1||3
10123505|NCT02584959|11254546|FG001|NOT COMPLETED|Period 1||4
10123506|NCT02584959|11254547|FG002|NOT COMPLETED|Period 1||0
10123507|NCT02584959|11254545|FG000|STARTED|Period 2||28
10123508|NCT02584959|11254546|FG001|STARTED|Period 2||25
10123509|NCT02584959|11254547|FG002|STARTED|Period 2||15
10123510|NCT02584959|11254545|FG000|COMPLETED|Period 2||22
10123511|NCT02584959|11254546|FG001|COMPLETED|Period 2||24
10123512|NCT02584959|11254547|FG002|COMPLETED|Period 2||13
10123513|NCT02584959|11254545|FG000|NOT COMPLETED|Period 2||6
10123514|NCT02584959|11254546|FG001|NOT COMPLETED|Period 2||1
10123515|NCT02584959|11254547|FG002|NOT COMPLETED|Period 2||2
10123516|NCT02584998|11254567|FG000|STARTED|Overall Study||260
10123517|NCT02584998|11254568|FG001|STARTED|Overall Study||261
10123518|NCT02584998|11254569|FG002|STARTED|Overall Study||261
10123519|NCT02584998|11254567|FG000|COMPLETED|Overall Study||260
10123520|NCT02584998|11254568|FG001|COMPLETED|Overall Study||261
10123521|NCT02584998|11254569|FG002|COMPLETED|Overall Study||261
10123522|NCT02584998|11254567|FG000|NOT COMPLETED|Overall Study||0
10123523|NCT02584998|11254568|FG001|NOT COMPLETED|Overall Study||0
10123524|NCT02584998|11254569|FG002|NOT COMPLETED|Overall Study||0
10123525|NCT02585245|11254577|FG000|STARTED|Overall Study||607
10123526|NCT02585245|11254577|FG000|COMPLETED|Overall Study||594
10123527|NCT02585245|11254577|FG000|NOT COMPLETED|Overall Study||13
10123528|NCT02585700|11254584|FG000|STARTED|Overall Study||30
10123529|NCT02585700|11254585|FG001|STARTED|Overall Study||30
10123530|NCT02585700|11254584|FG000|COMPLETED|Overall Study||30
10123531|NCT02585700|11254585|FG001|COMPLETED|Overall Study||30
10123532|NCT02585700|11254584|FG000|NOT COMPLETED|Overall Study||0
10123533|NCT02585700|11254585|FG001|NOT COMPLETED|Overall Study||0
10123534|NCT02585713|11254593|FG000|STARTED|Overall Study||150
10123535|NCT02585713|11254594|FG001|STARTED|Overall Study||150
10123536|NCT02585713|11254593|FG000|COMPLETED|Overall Study||145
10123537|NCT02585713|11254594|FG001|COMPLETED|Overall Study||142
10123538|NCT02585713|11254593|FG000|NOT COMPLETED|Overall Study||5
10123539|NCT02585713|11254594|FG001|NOT COMPLETED|Overall Study||8
10123540|NCT02585778|11254604|FG000|STARTED|Overall Study|Randomized|345
10123541|NCT02585778|11254605|FG001|STARTED|Overall Study|Randomized|172
10123542|NCT02585778|11254604|FG000|Treated (Safety Population)|Overall Study||344
10123543|NCT02585778|11254605|FG001|Treated (Safety Population)|Overall Study||170
10123544|NCT02585778|11254604|FG000|ITT Population|Overall Study||336
10123545|NCT02585778|11254605|FG001|ITT Population|Overall Study||167
10123546|NCT02585778|11254604|FG000|mITT Population|Overall Study||333
10123547|NCT02585778|11254605|FG001|mITT Population|Overall Study||164
10123548|NCT02585778|11254604|FG000|T1DM Participants|Overall Study||51
10123549|NCT02585778|11254605|FG001|T1DM Participants|Overall Study||25
10123550|NCT02585778|11254604|FG000|T2DM Participants|Overall Study||294
10123551|NCT02585778|11254605|FG001|T2DM Participants|Overall Study||147
10123552|NCT02585778|11254604|FG000|COMPLETED|Overall Study||312
10123553|NCT02585778|11254605|FG001|COMPLETED|Overall Study||157
10123554|NCT02585778|11254604|FG000|NOT COMPLETED|Overall Study||33
10123555|NCT02585778|11254605|FG001|NOT COMPLETED|Overall Study||15
10123556|NCT02585830|11254615|FG000|STARTED|Overall Study||25
10123557|NCT02585830|11254615|FG000|COMPLETED|Overall Study||22
10123558|NCT02585830|11254615|FG000|NOT COMPLETED|Overall Study||3
10123559|NCT02585843|11254621|FG000|STARTED|Overall Study||10
10123560|NCT02585843|11254622|FG001|STARTED|Overall Study||10
10123561|NCT02585843|11254621|FG000|COMPLETED|Overall Study||9
10123562|NCT02585843|11254622|FG001|COMPLETED|Overall Study||10
10123563|NCT02585843|11254621|FG000|NOT COMPLETED|Overall Study||1
10123564|NCT02585843|11254622|FG001|NOT COMPLETED|Overall Study||0
10123565|NCT02585895|11254630|FG000|STARTED|Primary Period||20
10123566|NCT02585895|11254631|FG001|STARTED|Primary Period||19
10123567|NCT02585895|11254630|FG000|COMPLETED|Primary Period||20
10123568|NCT02585895|11254631|FG001|COMPLETED|Primary Period||19
10123569|NCT02585895|11254630|FG000|NOT COMPLETED|Primary Period||0
10123570|NCT02585895|11254631|FG001|NOT COMPLETED|Primary Period||0
10123571|NCT02585895|11254630|FG000|STARTED|Post-primary Period||20
10123572|NCT02585895|11254631|FG001|STARTED|Post-primary Period||19
10123573|NCT02585895|11254630|FG000|COMPLETED|Post-primary Period||20
10123574|NCT02585895|11254631|FG001|COMPLETED|Post-primary Period||19
10123575|NCT02585895|11254630|FG000|NOT COMPLETED|Post-primary Period||0
10123576|NCT02585895|11254631|FG001|NOT COMPLETED|Post-primary Period||0
10123577|NCT02585934|11254642|FG000|STARTED|Overall Study||661
10123578|NCT02585934|11254643|FG001|STARTED|Overall Study||654
10123579|NCT02585934|11254642|FG000|Safety Population|Overall Study||656
10123580|NCT02585934|11254643|FG001|Safety Population|Overall Study||651
10123581|NCT02585934|11254642|FG000|Intent to Treat (ITT)|Overall Study||643
10123582|NCT02585934|11254643|FG001|Intent to Treat (ITT)|Overall Study||633
10123583|NCT02585934|11254642|FG000|Per Protocol (PP)|Overall Study||603
10123584|NCT02585934|11254643|FG001|Per Protocol (PP)|Overall Study||582
10123585|NCT02585934|11254642|FG000|COMPLETED|Overall Study||592
10123586|NCT02585934|11254643|FG001|COMPLETED|Overall Study||581
10123587|NCT02585934|11254642|FG000|NOT COMPLETED|Overall Study||69
10123588|NCT02585934|11254643|FG001|NOT COMPLETED|Overall Study||73
10123589|NCT02585960|11254657|FG000|STARTED|PK/Safety Assessment Period||57
10123590|NCT02585960|11254658|FG001|STARTED|PK/Safety Assessment Period||58
10123591|NCT02585960|11254659|FG002|STARTED|PK/Safety Assessment Period||6
10123592|NCT02585960|11254657|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
10123593|NCT02585960|11254658|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
10123594|NCT02585960|11254659|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
10123595|NCT02585960|11254657|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
10123596|NCT02585960|11254658|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
10123597|NCT02585960|11254659|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
10123598|NCT02585960|11254657|FG000|COMPLETED|PK/Safety Assessment Period||52
10123599|NCT02585960|11254658|FG001|COMPLETED|PK/Safety Assessment Period||48
10123600|NCT02585960|11254659|FG002|COMPLETED|PK/Safety Assessment Period||0
10123601|NCT02585960|11254657|FG000|NOT COMPLETED|PK/Safety Assessment Period||5
10123602|NCT02585960|11254658|FG001|NOT COMPLETED|PK/Safety Assessment Period||10
10123603|NCT02585960|11254659|FG002|NOT COMPLETED|PK/Safety Assessment Period||6
10123604|NCT02585960|11254657|FG000|STARTED|Prophylactic Treatment Period||52
10123605|NCT02585960|11254658|FG001|STARTED|Prophylactic Treatment Period||48
10123606|NCT02585960|11254659|FG002|STARTED|Prophylactic Treatment Period||0
10123607|NCT02585960|11254657|FG000|COMPLETED|Prophylactic Treatment Period||52
10123608|NCT02585960|11254658|FG001|COMPLETED|Prophylactic Treatment Period||43
10123609|NCT02585960|11254659|FG002|COMPLETED|Prophylactic Treatment Period||0
10123610|NCT02585960|11254657|FG000|NOT COMPLETED|Prophylactic Treatment Period||0
10123611|NCT02585960|11254658|FG001|NOT COMPLETED|Prophylactic Treatment Period||5
10123612|NCT02585960|11254659|FG002|NOT COMPLETED|Prophylactic Treatment Period||0
10123613|NCT02585999|11254670|FG000|STARTED|Overall Study||28
10123614|NCT02585999|11254670|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
10123615|NCT02585999|11254670|FG000|NOT COMPLETED|Overall Study||2
10123616|NCT02586012|11254675|FG000|STARTED|Overall Study||5
10123617|NCT02586012|11254676|FG001|STARTED|Overall Study||5
10123618|NCT02586012|11254677|FG002|STARTED|Overall Study||5
10123619|NCT02586012|11254678|FG003|STARTED|Overall Study||5
10123620|NCT02586012|11254679|FG004|STARTED|Overall Study||5
10123621|NCT02586012|11254680|FG005|STARTED|Overall Study||5
10123622|NCT02586012|11254675|FG000|COMPLETED|Overall Study||4
10123623|NCT02586012|11254676|FG001|COMPLETED|Overall Study||2
10123624|NCT02586012|11254677|FG002|COMPLETED|Overall Study||4
10123625|NCT02586012|11254678|FG003|COMPLETED|Overall Study||3
10123626|NCT02586012|11254679|FG004|COMPLETED|Overall Study||4
10123627|NCT02586012|11254680|FG005|COMPLETED|Overall Study||2
10123628|NCT02586012|11254675|FG000|NOT COMPLETED|Overall Study||1
10123629|NCT02586012|11254676|FG001|NOT COMPLETED|Overall Study||3
10123630|NCT02586012|11254677|FG002|NOT COMPLETED|Overall Study||1
10123631|NCT02586012|11254678|FG003|NOT COMPLETED|Overall Study||2
10123632|NCT02586012|11254679|FG004|NOT COMPLETED|Overall Study||1
10123633|NCT02586012|11254680|FG005|NOT COMPLETED|Overall Study||3
10123634|NCT02586064|11254691|FG000|STARTED|Overall Study||61
10123635|NCT02586064|11254692|FG001|STARTED|Overall Study||54
10123636|NCT02586064|11254691|FG000|COMPLETED|Overall Study||43
10123637|NCT02586064|11254692|FG001|COMPLETED|Overall Study||26
10123638|NCT02586064|11254691|FG000|NOT COMPLETED|Overall Study||18
10123639|NCT02586064|11254692|FG001|NOT COMPLETED|Overall Study||28
10123640|NCT02586077|11254701|FG000|STARTED|Overall Study||36
10123641|NCT02586077|11254701|FG000|COMPLETED|Overall Study||28
10123642|NCT02586077|11254701|FG000|NOT COMPLETED|Overall Study||8
10123643|NCT02586155|11254708|FG000|STARTED|Overall Study||1215
10123644|NCT02586155|11254709|FG001|STARTED|Overall Study||1210
10123645|NCT02586155|11254708|FG000|Final Number Randomized|Overall Study||1212
10123646|NCT02586155|11254709|FG001|Final Number Randomized|Overall Study||1206
10123647|NCT02586155|11254708|FG000|COMPLETED|Overall Study||1088
10123648|NCT02586155|11254709|FG001|COMPLETED|Overall Study||1083
10123649|NCT02586155|11254708|FG000|NOT COMPLETED|Overall Study||127
10123650|NCT02586155|11254709|FG001|NOT COMPLETED|Overall Study||127
10123651|NCT02586233|11254722|FG000|STARTED|Overall Study||7
10123652|NCT02586233|11254723|FG001|STARTED|Overall Study||7
10123653|NCT02586233|11254724|FG002|STARTED|Overall Study||13
10123654|NCT02586233|11254725|FG003|STARTED|Overall Study||17
10123655|NCT02586233|11254726|FG004|STARTED|Overall Study||18
10123656|NCT02586233|11254727|FG005|STARTED|Overall Study||18
10123657|NCT02586233|11254728|FG006|STARTED|Overall Study||26
10123658|NCT02586233|11254722|FG000|COMPLETED|Overall Study||7
10123659|NCT02586233|11254723|FG001|COMPLETED|Overall Study||5
10123660|NCT02586233|11254724|FG002|COMPLETED|Overall Study||13
10123661|NCT02586233|11254725|FG003|COMPLETED|Overall Study||17
10123662|NCT02586233|11254726|FG004|COMPLETED|Overall Study||16
10123663|NCT02586233|11254727|FG005|COMPLETED|Overall Study||16
10123664|NCT02586233|11254728|FG006|COMPLETED|Overall Study||24
10123665|NCT02586233|11254722|FG000|NOT COMPLETED|Overall Study||0
10123666|NCT02586233|11254723|FG001|NOT COMPLETED|Overall Study||2
10123667|NCT02586233|11254724|FG002|NOT COMPLETED|Overall Study||0
10123668|NCT02586233|11254725|FG003|NOT COMPLETED|Overall Study||0
10123669|NCT02586233|11254726|FG004|NOT COMPLETED|Overall Study||2
10123670|NCT02586233|11254727|FG005|NOT COMPLETED|Overall Study||2
10123671|NCT02586233|11254728|FG006|NOT COMPLETED|Overall Study||2
10123672|NCT02586415|11254750|FG000|STARTED|Overall Study||92
10123673|NCT02586415|11254751|FG001|STARTED|Overall Study||90
10123674|NCT02586415|11254750|FG000|24 Hour Assessment|Overall Study||91
10123675|NCT02586415|11254751|FG001|24 Hour Assessment|Overall Study||90
10123676|NCT02586415|11254750|FG000|Day 30 Assessment|Overall Study||81
10123677|NCT02586415|11254751|FG001|Day 30 Assessment|Overall Study||70
10123678|NCT02586415|11254750|FG000|Day 90 Assessment|Overall Study||78
10123679|NCT02586415|11254751|FG001|Day 90 Assessment|Overall Study||65
10123680|NCT02586415|11254750|FG000|COMPLETED|Overall Study||78
10123681|NCT02586415|11254751|FG001|COMPLETED|Overall Study||65
10123682|NCT02586415|11254750|FG000|NOT COMPLETED|Overall Study||14
10123683|NCT02586415|11254751|FG001|NOT COMPLETED|Overall Study||25
10123684|NCT02586493|11254758|FG000|STARTED|Overall Study||278
10123685|NCT02586493|11254758|FG000|COMPLETED|Overall Study||266
10123686|NCT02586493|11254758|FG000|NOT COMPLETED|Overall Study||12
10123687|NCT02586506|11254762|FG000|STARTED|Overall Study||259
10123688|NCT02586506|11254762|FG000|COMPLETED|Overall Study||250
10123689|NCT02586506|11254762|FG000|NOT COMPLETED|Overall Study||9
10123690|NCT02586727|11254768|FG000|STARTED|Overall Study||20
10123691|NCT02586727|11254769|FG001|STARTED|Overall Study||20
10123692|NCT02586727|11254768|FG000|COMPLETED|Overall Study||19
10123693|NCT02586727|11254769|FG001|COMPLETED|Overall Study||20
10123694|NCT02586727|11254768|FG000|NOT COMPLETED|Overall Study||1
10123695|NCT02586727|11254769|FG001|NOT COMPLETED|Overall Study||0
10123696|NCT02586805|11254779|FG000|STARTED|Overall Study||41
10123697|NCT02586805|11254780|FG001|STARTED|Overall Study||28
10123698|NCT02586805|11254781|FG002|STARTED|Overall Study||29
10123699|NCT02586805|11254782|FG003|STARTED|Overall Study||27
10123700|NCT02586805|11254779|FG000|COMPLETED|Overall Study||35
10123701|NCT02586805|11254780|FG001|COMPLETED|Overall Study||27
10123702|NCT02586805|11254781|FG002|COMPLETED|Overall Study||26
10123703|NCT02586805|11254782|FG003|COMPLETED|Overall Study||25
10123704|NCT02586805|11254779|FG000|NOT COMPLETED|Overall Study||6
10123705|NCT02586805|11254780|FG001|NOT COMPLETED|Overall Study||1
10123706|NCT02586805|11254781|FG002|NOT COMPLETED|Overall Study||3
10123707|NCT02586805|11254782|FG003|NOT COMPLETED|Overall Study||2
10123708|NCT02586896|11254794|FG000|STARTED|Overall Study||150
10123709|NCT02586896|11254795|FG001|STARTED|Overall Study||150
10123710|NCT02586896|11254794|FG000|3-Month Follow-up|Overall Study||126
10123711|NCT02586896|11254795|FG001|3-Month Follow-up|Overall Study||123
10123712|NCT02586896|11254794|FG000|COMPLETED|Overall Study||131
10123713|NCT02586896|11254795|FG001|COMPLETED|Overall Study||133
10123714|NCT02586896|11254794|FG000|NOT COMPLETED|Overall Study||19
10123715|NCT02586896|11254795|FG001|NOT COMPLETED|Overall Study||17
10123716|NCT02586909|11254801|FG000|STARTED|Overall Study||1099
10123717|NCT02586909|11254801|FG000|COMPLETED|Overall Study||151
10123718|NCT02586909|11254801|FG000|NOT COMPLETED|Overall Study||948
10123719|NCT02586974|11254807|FG000|STARTED|Overall Study||32
10123720|NCT02586974|11254808|FG001|STARTED|Overall Study||32
10123721|NCT02586974|11254807|FG000|COMPLETED|Overall Study||32
10123722|NCT02586974|11254808|FG001|COMPLETED|Overall Study||32
10123723|NCT02586974|11254807|FG000|NOT COMPLETED|Overall Study||0
10123724|NCT02586974|11254808|FG001|NOT COMPLETED|Overall Study||0
10123725|NCT02587065|11254816|FG000|STARTED|Overall Study||193
10123726|NCT02587065|11254816|FG000|COMPLETED|Overall Study||166
10123727|NCT02587065|11254816|FG000|NOT COMPLETED|Overall Study||27
10123728|NCT02587117|11254822|FG000|STARTED|Overall Study||13
10123729|NCT02587117|11254823|FG001|STARTED|Overall Study||15
10123730|NCT02587117|11254822|FG000|COMPLETED|Overall Study||13
10123731|NCT02587117|11254823|FG001|COMPLETED|Overall Study||15
10123732|NCT02587117|11254822|FG000|NOT COMPLETED|Overall Study||0
10123733|NCT02587117|11254823|FG001|NOT COMPLETED|Overall Study||0
10123734|NCT02587143|11254831|FG000|STARTED|Overall Study||66
10123735|NCT02587143|11254832|FG001|STARTED|Overall Study||60
10123736|NCT02587143|11254831|FG000|COMPLETED|Overall Study||65
10123737|NCT02587143|11254832|FG001|COMPLETED|Overall Study||60
10123738|NCT02587143|11254831|FG000|NOT COMPLETED|Overall Study||1
10123739|NCT02587143|11254832|FG001|NOT COMPLETED|Overall Study||0
10123740|NCT02587221|11254840|FG000|STARTED|Overall Study||3394
10123741|NCT02587221|11254841|FG001|STARTED|Overall Study||3396
10123742|NCT02587221|11254840|FG000|Treated|Overall Study||3379
10123743|NCT02587221|11254841|FG001|Treated|Overall Study||3382
10123744|NCT02587221|11254840|FG000|COMPLETED|Overall Study||3263
10123745|NCT02587221|11254841|FG001|COMPLETED|Overall Study||3273
10123746|NCT02587221|11254840|FG000|NOT COMPLETED|Overall Study||131
10123747|NCT02587221|11254841|FG001|NOT COMPLETED|Overall Study||123
10123748|NCT02587234|11254849|FG000|STARTED|Overall Study||11
10123749|NCT02587234|11254850|FG001|STARTED|Overall Study||10
10123750|NCT02587234|11254849|FG000|COMPLETED|Overall Study||10
10123751|NCT02587234|11254850|FG001|COMPLETED|Overall Study||7
10123752|NCT02587234|11254849|FG000|NOT COMPLETED|Overall Study||1
10123753|NCT02587234|11254850|FG001|NOT COMPLETED|Overall Study||3
10123754|NCT02587351|11254858|FG000|STARTED|Overall Study||268
10123755|NCT02587351|11254859|FG001|STARTED|Overall Study||264
10123756|NCT02587351|11254858|FG000|COMPLETED|Overall Study||268
10123757|NCT02587351|11254859|FG001|COMPLETED|Overall Study||264
10123758|NCT02587351|11254858|FG000|NOT COMPLETED|Overall Study||0
10123759|NCT02587351|11254859|FG001|NOT COMPLETED|Overall Study||0
10123760|NCT02587819|11254865|FG000|STARTED|Overall Study||21
10123761|NCT02587819|11254865|FG000|Exposed|Overall Study||21
10123762|NCT02587819|11254865|FG000|COMPLETED|Overall Study||19
10123763|NCT02587819|11254865|FG000|NOT COMPLETED|Overall Study||2
10123764|NCT02587962|11254875|FG000|STARTED|Overall Study||3
10123765|NCT02587962|11254876|FG001|STARTED|Overall Study||3
10123766|NCT02587962|11254877|FG002|STARTED|Overall Study||6
10123767|NCT02587962|11254878|FG003|STARTED|Overall Study||7
10123768|NCT02587962|11254879|FG004|STARTED|Overall Study||15
10123769|NCT02587962|11254875|FG000|COMPLETED|Overall Study||1
10123770|NCT02587962|11254876|FG001|COMPLETED|Overall Study||0
10123771|NCT02587962|11254877|FG002|COMPLETED|Overall Study||0
10123772|NCT02587962|11254878|FG003|COMPLETED|Overall Study||1
10123773|NCT02587962|11254879|FG004|COMPLETED|Overall Study||0
10123774|NCT02587962|11254875|FG000|NOT COMPLETED|Overall Study||2
10123775|NCT02587962|11254876|FG001|NOT COMPLETED|Overall Study||3
10123776|NCT02587962|11254877|FG002|NOT COMPLETED|Overall Study||6
10123777|NCT02587962|11254878|FG003|NOT COMPLETED|Overall Study||6
10123778|NCT02587962|11254879|FG004|NOT COMPLETED|Overall Study||15
10123779|NCT02588092|11254904|FG000|STARTED|Overall Study||4
10123780|NCT02588092|11254905|FG001|STARTED|Overall Study||3
10123781|NCT02588092|11254906|FG002|STARTED|Overall Study||3
10123782|NCT02588092|11254907|FG003|STARTED|Overall Study||3
10123783|NCT02588092|11254908|FG004|STARTED|Overall Study||3
10123784|NCT02588092|11254909|FG005|STARTED|Overall Study||3
10123785|NCT02588092|11254910|FG006|STARTED|Overall Study||3
10123786|NCT02588092|11254911|FG007|STARTED|Overall Study||4
10123787|NCT02588092|11254912|FG008|STARTED|Overall Study||6
10123788|NCT02588092|11254913|FG009|STARTED|Overall Study||3
10123789|NCT02588092|11254904|FG000|COMPLETED|Overall Study||0
10123790|NCT02588092|11254905|FG001|COMPLETED|Overall Study||0
10123791|NCT02588092|11254906|FG002|COMPLETED|Overall Study||0
10123792|NCT02588092|11254907|FG003|COMPLETED|Overall Study||0
10123793|NCT02588092|11254908|FG004|COMPLETED|Overall Study||0
10123794|NCT02588092|11254909|FG005|COMPLETED|Overall Study||0
10123795|NCT02588092|11254910|FG006|COMPLETED|Overall Study||0
10123796|NCT02588092|11254911|FG007|COMPLETED|Overall Study||0
10123797|NCT02588092|11254912|FG008|COMPLETED|Overall Study||0
10123798|NCT02588092|11254913|FG009|COMPLETED|Overall Study||0
10123799|NCT02588092|11254904|FG000|NOT COMPLETED|Overall Study||4
10123800|NCT02588092|11254905|FG001|NOT COMPLETED|Overall Study||3
10123801|NCT02588092|11254906|FG002|NOT COMPLETED|Overall Study||3
10123802|NCT02588092|11254907|FG003|NOT COMPLETED|Overall Study||3
10123803|NCT02588092|11254908|FG004|NOT COMPLETED|Overall Study||3
10123804|NCT02588092|11254909|FG005|NOT COMPLETED|Overall Study||3
10123805|NCT02588092|11254910|FG006|NOT COMPLETED|Overall Study||3
10123806|NCT02588092|11254911|FG007|NOT COMPLETED|Overall Study||4
10123807|NCT02588092|11254912|FG008|NOT COMPLETED|Overall Study||6
10123808|NCT02588092|11254913|FG009|NOT COMPLETED|Overall Study||3
10196217|NCT03358407|11324485|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196218|NCT03358407|11324486|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196219|NCT03358407|11324477|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196220|NCT03358407|11324478|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196221|NCT03358407|11324479|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196222|NCT03358407|11324480|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196223|NCT03358407|11324481|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196224|NCT03358407|11324482|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196225|NCT03358407|11324483|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
10123809|NCT04960228|11254941|FG000|STARTED|Overall Study||1098
10123810|NCT04960228|11254942|FG001|STARTED|Overall Study||999
10123811|NCT04960228|11254941|FG000|COMPLETED|Overall Study||810
10123812|NCT04960228|11254942|FG001|COMPLETED|Overall Study||813
10123813|NCT04960228|11254941|FG000|NOT COMPLETED|Overall Study||288
10123814|NCT04960228|11254942|FG001|NOT COMPLETED|Overall Study||186
10123815|NCT03922477|11254948|FG000|STARTED|Overall Study||13
10123816|NCT03922477|11254948|FG000|COMPLETED|Overall Study||0
10123817|NCT03922477|11254948|FG000|NOT COMPLETED|Overall Study||13
10123859|NCT02859558|11254980|FG001|COMPLETED|Step 2||0
10123860|NCT02859558|11254981|FG002|COMPLETED|Step 2||0
10123861|NCT02859558|11254982|FG003|COMPLETED|Step 2||0
10123862|NCT02859558|11254983|FG004|COMPLETED|Step 2||0
10123863|NCT02859558|11254979|FG000|NOT COMPLETED|Step 2||25
10123864|NCT02859558|11254980|FG001|NOT COMPLETED|Step 2||39
10123865|NCT02859558|11254981|FG002|NOT COMPLETED|Step 2||21
10123866|NCT02859558|11254982|FG003|NOT COMPLETED|Step 2||0
10123867|NCT02859558|11254983|FG004|NOT COMPLETED|Step 2||0
10123868|NCT02818920|11254993|FG000|STARTED|Overall Study||30
10123869|NCT02818920|11254993|FG000|Completed Surgery|Overall Study||25
10123870|NCT02818920|11254993|FG000|Received Adjuvant Therapy|Overall Study||17
10123871|NCT02818920|11254993|FG000|COMPLETED|Overall Study||12
10123872|NCT02818920|11254993|FG000|NOT COMPLETED|Overall Study||18
10123873|NCT02481310|11255000|FG000|STARTED|Induction Treatment (6 Cycles)||1
10123874|NCT02481310|11255001|FG001|STARTED|Induction Treatment (6 Cycles)||36
10123875|NCT02481310|11255002|FG002|STARTED|Induction Treatment (6 Cycles)||1
10123876|NCT02481310|11255000|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
10123877|NCT02481310|11255001|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34
10123878|NCT02481310|11255002|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
10123879|NCT02481310|11255000|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
10123880|NCT02481310|11255001|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30
10123881|NCT02481310|11255002|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
10123882|NCT02481310|11255000|FG000|COMPLETED|Induction Treatment (6 Cycles)||1
10123883|NCT02481310|11255001|FG001|COMPLETED|Induction Treatment (6 Cycles)||30
10123884|NCT02481310|11255002|FG002|COMPLETED|Induction Treatment (6 Cycles)||1
10123885|NCT02481310|11255000|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0
10123886|NCT02481310|11255001|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6
10123887|NCT02481310|11255002|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0
10123888|NCT02481310|11255000|FG000|STARTED|Maintenance Treatment||1
10123889|NCT02481310|11255001|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21
10123890|NCT02481310|11255002|FG002|STARTED|Maintenance Treatment||1
10123891|NCT02481310|11255000|FG000|Started Maintenance Treatment|Maintenance Treatment||1
10123892|NCT02481310|11255001|FG001|Started Maintenance Treatment|Maintenance Treatment||21
10123893|NCT02481310|11255002|FG002|Started Maintenance Treatment|Maintenance Treatment||1
10123894|NCT02481310|11255000|FG000|COMPLETED|Maintenance Treatment||1
10123895|NCT02481310|11255001|FG001|COMPLETED|Maintenance Treatment||21
10123896|NCT02481310|11255002|FG002|COMPLETED|Maintenance Treatment||1
10123897|NCT02481310|11255000|FG000|NOT COMPLETED|Maintenance Treatment||0
10123898|NCT02481310|11255001|FG001|NOT COMPLETED|Maintenance Treatment||0
10123899|NCT02481310|11255002|FG002|NOT COMPLETED|Maintenance Treatment||0
10123900|NCT02481310|11255000|FG000|STARTED|Follow up||1
10123901|NCT02481310|11255001|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32
10123902|NCT02481310|11255002|FG002|STARTED|Follow up||1
10123903|NCT02481310|11255000|FG000|COMPLETED|Follow up||1
10123904|NCT02481310|11255001|FG001|COMPLETED|Follow up||29
10123905|NCT02481310|11255002|FG002|COMPLETED|Follow up||1
10123906|NCT02481310|11255000|FG000|NOT COMPLETED|Follow up||0
10123907|NCT02481310|11255001|FG001|NOT COMPLETED|Follow up||3
10123908|NCT02481310|11255002|FG002|NOT COMPLETED|Follow up||0
10196226|NCT03358407|11324484|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10196227|NCT03358407|11324485|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196228|NCT03358407|11324486|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196229|NCT03358407|11324477|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196230|NCT03358407|11324478|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196231|NCT03358407|11324479|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196232|NCT03358407|11324480|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196233|NCT03358407|11324481|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196234|NCT03358407|11324482|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10196235|NCT03358407|11324483|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
10196236|NCT03358407|11324484|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10196237|NCT03358407|11324485|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196238|NCT03358407|11324486|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10196239|NCT03358407|11324477|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196240|NCT03358407|11324478|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196241|NCT03358407|11324479|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196242|NCT03358407|11324480|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196243|NCT03358407|11324481|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196244|NCT03358407|11324482|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
10196245|NCT03358407|11324483|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
10123818|NCT03688074|11254954|FG000|STARTED|Overall Study||59
10123819|NCT03688074|11254955|FG001|STARTED|Overall Study||57
10123820|NCT03688074|11254954|FG000|COMPLETED|Overall Study||58
10060362|NCT02097303|11185895|FG000|NOT COMPLETED|Overall Study||5
10060363|NCT02097472|11185907|FG000|STARTED|Received Vaccination 1||18
10060364|NCT02097472|11185908|FG001|STARTED|Received Vaccination 1||18
9706665|NCT02450760|10805741|FG000|NOT COMPLETED|Overall Study||0
9706666|NCT02450760|10805742|FG001|NOT COMPLETED|Overall Study||0
9729131|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
9729132|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 193 - 240||123
9729133|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 193 - 240||68
9729134|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110
9729135|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64
9729136|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
9729137|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
9729138|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 241 - 288||110
9729139|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 241 - 288||64
9729140|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104
9729141|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64
9729142|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
9729143|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
9729144|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 289 - 336||104
9729145|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 289 - 336||64
9729146|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98
9729147|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57
9729148|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
9729149|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
9729150|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 337 - 384||98
9729151|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 337 - 384||57
9729152|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90
9729153|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56
9729154|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
9729155|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
9729156|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
10060365|NCT02097472|11185909|FG002|STARTED|Received Vaccination 1||18
10060366|NCT02097472|11185910|FG003|STARTED|Received Vaccination 1||50
10060367|NCT02097472|11185911|FG004|STARTED|Received Vaccination 1||50
10060368|NCT02097472|11185912|FG005|STARTED|Received Vaccination 1||50
10060369|NCT02097472|11185913|FG006|STARTED|Received Vaccination 1||50
10060370|NCT02097472|11185914|FG007|STARTED|Received Vaccination 1||50
10060371|NCT02097472|11185907|FG000|COMPLETED|Received Vaccination 1||18
10123821|NCT03688074|11254955|FG001|COMPLETED|Overall Study||56
10123822|NCT03688074|11254954|FG000|NOT COMPLETED|Overall Study||1
10123823|NCT03688074|11254955|FG001|NOT COMPLETED|Overall Study||1
10123824|NCT03342001|11254961|FG000|STARTED|Overall Study||11
10123825|NCT03342001|11254961|FG000|COMPLETED|Overall Study||9
10123826|NCT03342001|11254961|FG000|NOT COMPLETED|Overall Study||2
10123827|NCT02871934|11254967|FG000|STARTED|Overall Study||193
10123828|NCT02871934|11254968|FG001|STARTED|Overall Study||215
10123829|NCT02871934|11254967|FG000|COMPLETED|Overall Study||193
10123830|NCT02871934|11254968|FG001|COMPLETED|Overall Study||215
10123831|NCT02871934|11254967|FG000|NOT COMPLETED|Overall Study||0
10123832|NCT02871934|11254968|FG001|NOT COMPLETED|Overall Study||0
10123833|NCT02859558|11254979|FG000|STARTED|Step 1||49
10123834|NCT02859558|11254980|FG001|STARTED|Step 1||79
10123835|NCT02859558|11254981|FG002|STARTED|Step 1||60
10123836|NCT02859558|11254982|FG003|STARTED|Step 1||4
10123837|NCT02859558|11254983|FG004|STARTED|Step 1||3
10123838|NCT02859558|11254979|FG000|Completed Week 48|Step 1||41
10123839|NCT02859558|11254980|FG001|Completed Week 48|Step 1||68
10123840|NCT02859558|11254981|FG002|Completed Week 48|Step 1||50
10123841|NCT02859558|11254982|FG003|Completed Week 48|Step 1||0
10123842|NCT02859558|11254983|FG004|Completed Week 48|Step 1||0
10123843|NCT02859558|11254979|FG000|COMPLETED|Step 1||37
10123844|NCT02859558|11254980|FG001|COMPLETED|Step 1||67
10123845|NCT02859558|11254981|FG002|COMPLETED|Step 1||49
10123846|NCT02859558|11254982|FG003|COMPLETED|Step 1||4
10123847|NCT02859558|11254983|FG004|COMPLETED|Step 1||0
10123848|NCT02859558|11254979|FG000|NOT COMPLETED|Step 1||12
10123849|NCT02859558|11254980|FG001|NOT COMPLETED|Step 1||12
10123850|NCT02859558|11254981|FG002|NOT COMPLETED|Step 1||11
10123851|NCT02859558|11254982|FG003|NOT COMPLETED|Step 1||0
10060372|NCT02097472|11185908|FG001|COMPLETED|Received Vaccination 1||18
10060373|NCT02097472|11185909|FG002|COMPLETED|Received Vaccination 1||18
10060374|NCT02097472|11185910|FG003|COMPLETED|Received Vaccination 1||50
10060375|NCT02097472|11185911|FG004|COMPLETED|Received Vaccination 1||50
10060376|NCT02097472|11185912|FG005|COMPLETED|Received Vaccination 1||50
10060377|NCT02097472|11185913|FG006|COMPLETED|Received Vaccination 1||50
10060378|NCT02097472|11185914|FG007|COMPLETED|Received Vaccination 1||50
10123852|NCT02859558|11254983|FG004|NOT COMPLETED|Step 1||3
10123853|NCT02859558|11254979|FG000|STARTED|Step 2||25
10123854|NCT02859558|11254980|FG001|STARTED|Step 2||39
10123855|NCT02859558|11254981|FG002|STARTED|Step 2||21
10123856|NCT02859558|11254982|FG003|STARTED|Step 2||0
10123857|NCT02859558|11254983|FG004|STARTED|Step 2||0
10123858|NCT02859558|11254979|FG000|COMPLETED|Step 2||0
10123909|NCT02343952|11255006|FG000|STARTED|Study Treatment||93
10123910|NCT02343952|11255006|FG000|COMPLETED|Study Treatment||40
10123911|NCT02343952|11255006|FG000|NOT COMPLETED|Study Treatment||53
10123912|NCT02343952|11255006|FG000|STARTED|Follow up||83
10123913|NCT02343952|11255006|FG000|COMPLETED|Follow up||38
10123914|NCT02343952|11255006|FG000|NOT COMPLETED|Follow up||45
10123915|NCT02326155|11255012|FG000|STARTED|Overall Study||407
10123916|NCT02326155|11255013|FG001|STARTED|Overall Study||63
10123917|NCT02326155|11255012|FG000|COMPLETED|Overall Study||13
10123918|NCT02326155|11255013|FG001|COMPLETED|Overall Study||1
10123919|NCT02326155|11255012|FG000|NOT COMPLETED|Overall Study||394
10123920|NCT02326155|11255013|FG001|NOT COMPLETED|Overall Study||62
10123921|NCT02304367|11255019|FG000|STARTED|Overall Study|14 participants with TIO; 1 participant with ENS; 2 participants with XLH|17
10123922|NCT02304367|11255019|FG000|Completed 48 Weeks of Study Drug|Overall Study||16
10123923|NCT02304367|11255019|FG000|Completed 144 Weeks of Study Drug|Overall Study||12
10123924|NCT02304367|11255019|FG000|COMPLETED|Overall Study||9
10123925|NCT02304367|11255019|FG000|NOT COMPLETED|Overall Study||8
10123926|NCT01810705|11255032|FG000|STARTED|Overall Study||83
10123927|NCT01810705|11255033|FG001|STARTED|Overall Study||40
10123928|NCT01810705|11255032|FG000|COMPLETED|Overall Study||10
10123929|NCT01810705|11255033|FG001|COMPLETED|Overall Study||5
10123930|NCT01810705|11255032|FG000|NOT COMPLETED|Overall Study||73
10123931|NCT01810705|11255033|FG001|NOT COMPLETED|Overall Study||35
10123932|NCT02588261|11255041|FG000|STARTED|Overall Study||267
10123933|NCT02588261|11255042|FG001|STARTED|Overall Study||263
10123934|NCT02588261|11255041|FG000|Treated|Overall Study||265
10123935|NCT02588261|11255042|FG001|Treated|Overall Study||262
10123936|NCT02588261|11255041|FG000|COMPLETED|Overall Study||0
10123937|NCT02588261|11255042|FG001|COMPLETED|Overall Study||0
10123938|NCT02588261|11255041|FG000|NOT COMPLETED|Overall Study||267
10123939|NCT02588261|11255042|FG001|NOT COMPLETED|Overall Study||263
10123940|NCT02588339|11255048|FG000|STARTED|Overall Study||42
10123941|NCT02588339|11255048|FG000|COMPLETED|Overall Study||39
10123942|NCT02588339|11255048|FG000|NOT COMPLETED|Overall Study||3
10123943|NCT02588573|11255054|FG000|STARTED|Overall Study||45
10123944|NCT02588573|11255055|FG001|STARTED|Overall Study||45
10123945|NCT02588573|11255054|FG000|Randomized Eye Etafilcon A|Overall Study||45
10123946|NCT02588573|11255055|FG001|Randomized Eye Etafilcon A|Overall Study||45
10123947|NCT02588573|11255054|FG000|Randomized Eye Somofilcon A|Overall Study||45
10123948|NCT02588573|11255055|FG001|Randomized Eye Somofilcon A|Overall Study||45
10123949|NCT02588573|11255054|FG000|COMPLETED|Overall Study||45
10123950|NCT02588573|11255055|FG001|COMPLETED|Overall Study||45
10123951|NCT02588573|11255054|FG000|NOT COMPLETED|Overall Study||0
10123952|NCT02588573|11255055|FG001|NOT COMPLETED|Overall Study||0
10123953|NCT02588586|11255073|FG000|STARTED|Overall Study||17
10123954|NCT02588586|11255073|FG000|COMPLETED|Overall Study||15
10123955|NCT02588586|11255073|FG000|NOT COMPLETED|Overall Study||2
10123956|NCT02588599|11255077|FG000|STARTED|Overall Study||54
10123957|NCT02588599|11255077|FG000|COMPLETED|Overall Study||54
10123958|NCT02588599|11255077|FG000|NOT COMPLETED|Overall Study||0
10123959|NCT02588612|11255081|FG000|STARTED|Overall Study||10
10123960|NCT02588612|11255081|FG000|Received T-cell Infusion|Overall Study||5
10123961|NCT02588612|11255081|FG000|COMPLETED|Overall Study||5
10123962|NCT02588612|11255081|FG000|NOT COMPLETED|Overall Study||5
10123963|NCT02588664|11255087|FG000|STARTED|Overall Study||3193
10123964|NCT02588664|11255088|FG001|STARTED|Overall Study||2689
10123965|NCT02588664|11255087|FG000|COMPLETED|Overall Study||1832
10123966|NCT02588664|11255088|FG001|COMPLETED|Overall Study||1644
10123967|NCT02588664|11255087|FG000|NOT COMPLETED|Overall Study||1361
10123968|NCT02588664|11255088|FG001|NOT COMPLETED|Overall Study||1045
10123969|NCT02588833|11255096|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
10123970|NCT02588833|11255097|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
10123971|NCT02588833|11255096|FG000|COMPLETED|Part 1||2
10123972|NCT02588833|11255097|FG001|COMPLETED|Part 1||20
10123973|NCT02588833|11255096|FG000|NOT COMPLETED|Part 1||1
10123974|NCT02588833|11255097|FG001|NOT COMPLETED|Part 1||0
10123975|NCT02588833|11255096|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
10123976|NCT02588833|11255097|FG001|STARTED|Part 2A||20
10123977|NCT02588833|11255096|FG000|COMPLETED|Part 2A||0
10123978|NCT02588833|11255097|FG001|COMPLETED|Part 2A||18
10123979|NCT02588833|11255096|FG000|NOT COMPLETED|Part 2A||0
10123980|NCT02588833|11255097|FG001|NOT COMPLETED|Part 2A||2
10123981|NCT02588833|11255096|FG000|STARTED|Part 2B||0
10123982|NCT02588833|11255097|FG001|STARTED|Part 2B||18
10123983|NCT02588833|11255096|FG000|COMPLETED|Part 2B||0
10123984|NCT02588833|11255097|FG001|COMPLETED|Part 2B||17
10123985|NCT02588833|11255096|FG000|NOT COMPLETED|Part 2B||0
10123986|NCT02588833|11255097|FG001|NOT COMPLETED|Part 2B||1
10123987|NCT02588833|11255096|FG000|STARTED|Part 2C||0
10123988|NCT02588833|11255097|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
10123989|NCT02588833|11255096|FG000|COMPLETED|Part 2C||0
10123990|NCT02588833|11255097|FG001|COMPLETED|Part 2C||12
10123991|NCT02588833|11255096|FG000|NOT COMPLETED|Part 2C||0
10123992|NCT02588833|11255097|FG001|NOT COMPLETED|Part 2C||2
10123993|NCT02588833|11255096|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
10123994|NCT02588833|11255097|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
10123995|NCT02588833|11255096|FG000|COMPLETED|Part 3 (Safety Follow-up)||3
10123996|NCT02588833|11255097|FG001|COMPLETED|Part 3 (Safety Follow-up)||2
10123997|NCT02588833|11255096|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0
10123998|NCT02588833|11255097|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2
10123999|NCT02588872|11255106|FG000|STARTED|Overall Study||59
10124000|NCT02588872|11255107|FG001|STARTED|Overall Study||52
10124001|NCT02588872|11255106|FG000|COMPLETED|Overall Study||59
10124002|NCT02588872|11255107|FG001|COMPLETED|Overall Study||52
10124003|NCT02588872|11255106|FG000|NOT COMPLETED|Overall Study||0
10124004|NCT02588872|11255107|FG001|NOT COMPLETED|Overall Study||0
10124005|NCT02588976|11255113|FG000|STARTED|Overall Study||30
10124006|NCT02588976|11255113|FG000|COMPLETED|Overall Study||30
10124007|NCT02588976|11255113|FG000|NOT COMPLETED|Overall Study||0
10124008|NCT02589067|11255120|FG000|STARTED|Overall Study||33
10124009|NCT02589067|11255121|FG001|STARTED|Overall Study||34
10124010|NCT02589067|11255120|FG000|COMPLETED|Overall Study||28
10124011|NCT02589067|11255121|FG001|COMPLETED|Overall Study||28
10124012|NCT02589067|11255120|FG000|NOT COMPLETED|Overall Study||5
10124013|NCT02589067|11255121|FG001|NOT COMPLETED|Overall Study||6
10124014|NCT02589171|11255130|FG000|STARTED|Overall Study||35
10124015|NCT02589171|11255131|FG001|STARTED|Overall Study||35
10124016|NCT02589171|11255130|FG000|Day 1 Follow up|Overall Study||35
10124017|NCT02589171|11255131|FG001|Day 1 Follow up|Overall Study||35
10124018|NCT02589171|11255130|FG000|Week 1 Follow up|Overall Study||35
10124019|NCT02589171|11255131|FG001|Week 1 Follow up|Overall Study||34
10124020|NCT02589171|11255130|FG000|Week 6 Follow up|Overall Study||28
10124021|NCT02589171|11255131|FG001|Week 6 Follow up|Overall Study||30
10124022|NCT02589171|11255130|FG000|COMPLETED|Overall Study||28
10124023|NCT02589171|11255131|FG001|COMPLETED|Overall Study||30
10124024|NCT02589171|11255130|FG000|NOT COMPLETED|Overall Study||7
10124025|NCT02589171|11255131|FG001|NOT COMPLETED|Overall Study||5
10124026|NCT02589405|11255137|FG000|STARTED|Overall Study||50
10124027|NCT02589405|11255137|FG000|COMPLETED|Overall Study||46
10124028|NCT02589405|11255137|FG000|NOT COMPLETED|Overall Study||4
10124029|NCT02589626|11255143|FG000|STARTED|Overall Study|Entered are treated patients|32
10124030|NCT02589626|11255144|FG001|STARTED|Overall Study|Entered are treated patients|33
10124031|NCT02589626|11255143|FG000|COMPLETED|Overall Study||29
10124032|NCT02589626|11255144|FG001|COMPLETED|Overall Study||31
10124033|NCT02589626|11255143|FG000|NOT COMPLETED|Overall Study||3
10124034|NCT02589626|11255144|FG001|NOT COMPLETED|Overall Study||2
10124035|NCT02589639|11255153|FG000|STARTED|Overall Study||90
10124036|NCT02589639|11255154|FG001|STARTED|Overall Study||89
10124037|NCT02589639|11255155|FG002|STARTED|Overall Study||90
10124038|NCT02589639|11255153|FG000|Treated|Overall Study||90
10124039|NCT02589639|11255154|FG001|Treated|Overall Study||86
10124040|NCT02589639|11255155|FG002|Treated|Overall Study||90
10124041|NCT02589639|11255153|FG000|COMPLETED|Overall Study||80
10124042|NCT02589639|11255154|FG001|COMPLETED|Overall Study||79
10124043|NCT02589639|11255155|FG002|COMPLETED|Overall Study||86
10124044|NCT02589639|11255153|FG000|NOT COMPLETED|Overall Study||10
10124045|NCT02589639|11255154|FG001|NOT COMPLETED|Overall Study||10
10124046|NCT02589639|11255155|FG002|NOT COMPLETED|Overall Study||4
10124047|NCT02589665|11255167|FG000|STARTED|Induction Period||63
10124048|NCT02589665|11255168|FG001|STARTED|Induction Period||63
10124049|NCT02589665|11255169|FG002|STARTED|Induction Period||62
10124050|NCT02589665|11255170|FG003|STARTED|Induction Period||61
10124051|NCT02589665|11255171|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
10124052|NCT02589665|11255172|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
10124053|NCT02589665|11255173|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
10124054|NCT02589665|11255174|FG007|STARTED|Induction Period||0
10124055|NCT02589665|11255175|FG008|STARTED|Induction Period||0
10124056|NCT02589665|11255176|FG009|STARTED|Induction Period||0
10124057|NCT02589665|11255167|FG000|Received at Least One Dose of Study Drug|Induction Period||63
10124058|NCT02589665|11255168|FG001|Received at Least One Dose of Study Drug|Induction Period||63
10124059|NCT02589665|11255169|FG002|Received at Least One Dose of Study Drug|Induction Period||62
10124060|NCT02589665|11255170|FG003|Received at Least One Dose of Study Drug|Induction Period||60
10124061|NCT02589665|11255171|FG004|Received at Least One Dose of Study Drug|Induction Period||0
10124062|NCT02589665|11255172|FG005|Received at Least One Dose of Study Drug|Induction Period||0
10124063|NCT02589665|11255173|FG006|Received at Least One Dose of Study Drug|Induction Period||0
10124064|NCT02589665|11255174|FG007|Received at Least One Dose of Study Drug|Induction Period||0
10124065|NCT02589665|11255175|FG008|Received at Least One Dose of Study Drug|Induction Period||0
10124066|NCT02589665|11255176|FG009|Received at Least One Dose of Study Drug|Induction Period||0
10124067|NCT02589665|11255167|FG000|COMPLETED|Induction Period||60
10124068|NCT02589665|11255168|FG001|COMPLETED|Induction Period||61
10124069|NCT02589665|11255169|FG002|COMPLETED|Induction Period||60
10124070|NCT02589665|11255170|FG003|COMPLETED|Induction Period||57
10124071|NCT02589665|11255171|FG004|COMPLETED|Induction Period||0
10124072|NCT02589665|11255172|FG005|COMPLETED|Induction Period||0
10124073|NCT02589665|11255173|FG006|COMPLETED|Induction Period||0
10124074|NCT02589665|11255174|FG007|COMPLETED|Induction Period||0
10124075|NCT02589665|11255175|FG008|COMPLETED|Induction Period||0
10124076|NCT02589665|11255176|FG009|COMPLETED|Induction Period||0
10124077|NCT02589665|11255167|FG000|NOT COMPLETED|Induction Period||3
10124078|NCT02589665|11255168|FG001|NOT COMPLETED|Induction Period||2
10124079|NCT02589665|11255169|FG002|NOT COMPLETED|Induction Period||2
10124080|NCT02589665|11255170|FG003|NOT COMPLETED|Induction Period||4
10124081|NCT02589665|11255171|FG004|NOT COMPLETED|Induction Period||0
10124082|NCT02589665|11255172|FG005|NOT COMPLETED|Induction Period||0
10124083|NCT02589665|11255173|FG006|NOT COMPLETED|Induction Period||0
10124084|NCT02589665|11255174|FG007|NOT COMPLETED|Induction Period||0
10124085|NCT02589665|11255175|FG008|NOT COMPLETED|Induction Period||0
10124086|NCT02589665|11255176|FG009|NOT COMPLETED|Induction Period||0
10124087|NCT02589665|11255167|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10124088|NCT02589665|11255168|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10124089|NCT02589665|11255169|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10124090|NCT02589665|11255170|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10124091|NCT02589665|11255171|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
10124092|NCT02589665|11255172|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
10124093|NCT02589665|11255173|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
10124094|NCT02589665|11255174|FG007|STARTED|Maintenance Period||0
10124095|NCT02589665|11255175|FG008|STARTED|Maintenance Period||0
10124096|NCT02589665|11255176|FG009|STARTED|Maintenance Period||0
10124097|NCT02589665|11255167|FG000|COMPLETED|Maintenance Period||0
10124098|NCT02589665|11255168|FG001|COMPLETED|Maintenance Period||0
10124099|NCT02589665|11255169|FG002|COMPLETED|Maintenance Period||0
10124100|NCT02589665|11255170|FG003|COMPLETED|Maintenance Period||0
10124101|NCT02589665|11255171|FG004|COMPLETED|Maintenance Period||0
10124102|NCT02589665|11255172|FG005|COMPLETED|Maintenance Period||0
10124103|NCT02589665|11255173|FG006|COMPLETED|Maintenance Period||0
10124104|NCT02589665|11255174|FG007|COMPLETED|Maintenance Period||0
10124105|NCT02589665|11255175|FG008|COMPLETED|Maintenance Period||0
10124106|NCT02589665|11255176|FG009|COMPLETED|Maintenance Period||0
10124107|NCT02589665|11255167|FG000|NOT COMPLETED|Maintenance Period||0
10124108|NCT02589665|11255168|FG001|NOT COMPLETED|Maintenance Period||0
10124109|NCT02589665|11255169|FG002|NOT COMPLETED|Maintenance Period||0
10124110|NCT02589665|11255170|FG003|NOT COMPLETED|Maintenance Period||0
10124111|NCT02589665|11255171|FG004|NOT COMPLETED|Maintenance Period||13
10124112|NCT02589665|11255172|FG005|NOT COMPLETED|Maintenance Period||47
10124113|NCT02589665|11255173|FG006|NOT COMPLETED|Maintenance Period||46
10124114|NCT02589665|11255174|FG007|NOT COMPLETED|Maintenance Period||0
10124115|NCT02589665|11255175|FG008|NOT COMPLETED|Maintenance Period||0
10124116|NCT02589665|11255176|FG009|NOT COMPLETED|Maintenance Period||0
10124117|NCT02589665|11255167|FG000|STARTED|Induction Extension Period||0
10124118|NCT02589665|11255168|FG001|STARTED|Induction Extension Period||0
10124119|NCT02589665|11255169|FG002|STARTED|Induction Extension Period||0
10124120|NCT02589665|11255170|FG003|STARTED|Induction Extension Period||0
10124121|NCT02589665|11255171|FG004|STARTED|Induction Extension Period||0
10124122|NCT02589665|11255172|FG005|STARTED|Induction Extension Period||0
10124123|NCT02589665|11255173|FG006|STARTED|Induction Extension Period||0
10124124|NCT02589665|11255174|FG007|STARTED|Induction Extension Period||32
10124125|NCT02589665|11255175|FG008|STARTED|Induction Extension Period||96
10124126|NCT02589665|11255176|FG009|STARTED|Induction Extension Period||0
10124127|NCT02589665|11255167|FG000|COMPLETED|Induction Extension Period||0
10124128|NCT02589665|11255168|FG001|COMPLETED|Induction Extension Period||0
10124129|NCT02589665|11255169|FG002|COMPLETED|Induction Extension Period||0
10124130|NCT02589665|11255170|FG003|COMPLETED|Induction Extension Period||0
10124131|NCT02589665|11255171|FG004|COMPLETED|Induction Extension Period||0
10124132|NCT02589665|11255172|FG005|COMPLETED|Induction Extension Period||0
10124133|NCT02589665|11255173|FG006|COMPLETED|Induction Extension Period||0
10124134|NCT02589665|11255174|FG007|COMPLETED|Induction Extension Period||30
10124135|NCT02589665|11255175|FG008|COMPLETED|Induction Extension Period||84
10124136|NCT02589665|11255176|FG009|COMPLETED|Induction Extension Period||0
10124137|NCT02589665|11255167|FG000|NOT COMPLETED|Induction Extension Period||0
10124138|NCT02589665|11255168|FG001|NOT COMPLETED|Induction Extension Period||0
10124139|NCT02589665|11255169|FG002|NOT COMPLETED|Induction Extension Period||0
10124140|NCT02589665|11255170|FG003|NOT COMPLETED|Induction Extension Period||0
10124141|NCT02589665|11255171|FG004|NOT COMPLETED|Induction Extension Period||0
10124142|NCT02589665|11255172|FG005|NOT COMPLETED|Induction Extension Period||0
10124143|NCT02589665|11255173|FG006|NOT COMPLETED|Induction Extension Period||0
10124144|NCT02589665|11255174|FG007|NOT COMPLETED|Induction Extension Period||2
10124145|NCT02589665|11255175|FG008|NOT COMPLETED|Induction Extension Period||12
10124146|NCT02589665|11255176|FG009|NOT COMPLETED|Induction Extension Period||0
10124147|NCT02589665|11255167|FG000|STARTED|Maintenance Extension Period||0
10124148|NCT02589665|11255168|FG001|STARTED|Maintenance Extension Period||0
10124149|NCT02589665|11255169|FG002|STARTED|Maintenance Extension Period||0
10124150|NCT02589665|11255170|FG003|STARTED|Maintenance Extension Period||0
10124151|NCT02589665|11255171|FG004|STARTED|Maintenance Extension Period||0
10124152|NCT02589665|11255172|FG005|STARTED|Maintenance Extension Period||0
10124153|NCT02589665|11255173|FG006|STARTED|Maintenance Extension Period||0
10124154|NCT02589665|11255174|FG007|STARTED|Maintenance Extension Period||0
10124155|NCT02589665|11255175|FG008|STARTED|Maintenance Extension Period||0
10124156|NCT02589665|11255176|FG009|STARTED|Maintenance Extension Period||68
10124157|NCT02589665|11255167|FG000|COMPLETED|Maintenance Extension Period||0
10124158|NCT02589665|11255168|FG001|COMPLETED|Maintenance Extension Period||0
10124159|NCT02589665|11255169|FG002|COMPLETED|Maintenance Extension Period||0
10124160|NCT02589665|11255170|FG003|COMPLETED|Maintenance Extension Period||0
10124161|NCT02589665|11255171|FG004|COMPLETED|Maintenance Extension Period||0
10124162|NCT02589665|11255172|FG005|COMPLETED|Maintenance Extension Period||0
10124163|NCT02589665|11255173|FG006|COMPLETED|Maintenance Extension Period||0
10124164|NCT02589665|11255174|FG007|COMPLETED|Maintenance Extension Period||0
10124165|NCT02589665|11255175|FG008|COMPLETED|Maintenance Extension Period||0
10124166|NCT02589665|11255176|FG009|COMPLETED|Maintenance Extension Period||0
10124167|NCT02589665|11255167|FG000|NOT COMPLETED|Maintenance Extension Period||0
10124168|NCT02589665|11255168|FG001|NOT COMPLETED|Maintenance Extension Period||0
10124169|NCT02589665|11255169|FG002|NOT COMPLETED|Maintenance Extension Period||0
10124170|NCT02589665|11255170|FG003|NOT COMPLETED|Maintenance Extension Period||0
10124171|NCT02589665|11255171|FG004|NOT COMPLETED|Maintenance Extension Period||0
10124172|NCT02589665|11255172|FG005|NOT COMPLETED|Maintenance Extension Period||0
10124173|NCT02589665|11255173|FG006|NOT COMPLETED|Maintenance Extension Period||0
10124174|NCT02589665|11255174|FG007|NOT COMPLETED|Maintenance Extension Period||0
10124175|NCT02589665|11255175|FG008|NOT COMPLETED|Maintenance Extension Period||0
10124176|NCT02589665|11255176|FG009|NOT COMPLETED|Maintenance Extension Period||68
10124177|NCT02589808|11255200|FG000|STARTED|Overall Study||76
10124178|NCT02589808|11255200|FG000|COMPLETED|Overall Study||76
10124179|NCT02589808|11255200|FG000|NOT COMPLETED|Overall Study||0
10124180|NCT02589847|11255206|FG000|STARTED|Overall Study||162
10124181|NCT02589847|11255207|FG001|STARTED|Overall Study||110
10124182|NCT02589847|11255206|FG000|Safety Population|Overall Study||149
10124183|NCT02589847|11255207|FG001|Safety Population|Overall Study||0
10124184|NCT02589847|11255206|FG000|Full Analysis Set (FAS)|Overall Study||149
10124185|NCT02589847|11255207|FG001|Full Analysis Set (FAS)|Overall Study||104
10124186|NCT02589847|11255206|FG000|Evaluable|Overall Study||142
10124187|NCT02589847|11255207|FG001|Evaluable|Overall Study||75
10124188|NCT02589847|11255206|FG000|COMPLETED|Overall Study||107
10124189|NCT02589847|11255207|FG001|COMPLETED|Overall Study||39
10124190|NCT02589847|11255206|FG000|NOT COMPLETED|Overall Study||55
10124191|NCT02589847|11255207|FG001|NOT COMPLETED|Overall Study||71
10124192|NCT02589977|11255217|FG000|STARTED|Overall Study||23
10124193|NCT02589977|11255218|FG001|STARTED|Overall Study||20
10124194|NCT02589977|11255219|FG002|STARTED|Overall Study||12
10124195|NCT02589977|11255217|FG000|COMPLETED|Overall Study||17
10124196|NCT02589977|11255218|FG001|COMPLETED|Overall Study||15
10124197|NCT02589977|11255219|FG002|COMPLETED|Overall Study||8
10124198|NCT02589977|11255217|FG000|NOT COMPLETED|Overall Study||6
10124199|NCT02589977|11255218|FG001|NOT COMPLETED|Overall Study||5
10124200|NCT02589977|11255219|FG002|NOT COMPLETED|Overall Study||4
10124201|NCT02590003|11255229|FG000|STARTED|Overall Study||1
10124202|NCT02590003|11255230|FG001|STARTED|Overall Study||2
10124203|NCT02590003|11255229|FG000|COMPLETED|Overall Study||0
10124204|NCT02590003|11255230|FG001|COMPLETED|Overall Study||0
10124205|NCT02590003|11255229|FG000|NOT COMPLETED|Overall Study||1
10124206|NCT02590003|11255230|FG001|NOT COMPLETED|Overall Study||2
10124207|NCT02590354|11255236|FG000|STARTED|Phase 1||114
10124208|NCT02590354|11255236|FG000|COMPLETED|Phase 1||16
10124209|NCT02590354|11255236|FG000|NOT COMPLETED|Phase 1||98
10124210|NCT02590354|11255236|FG000|STARTED|Phase 2 - Treatment Interruption||16
10124211|NCT02590354|11255236|FG000|COMPLETED|Phase 2 - Treatment Interruption||14
10124212|NCT02590354|11255236|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2
10124213|NCT02590406|11255243|FG000|STARTED|Overall Study||25
10124214|NCT02590406|11255244|FG001|STARTED|Overall Study||25
10124215|NCT02590406|11255243|FG000|COMPLETED|Overall Study||24
9706667|NCT02445339|10805755|FG000|STARTED|Overall Study||25
9706668|NCT02445339|10805756|FG001|STARTED|Overall Study||25
9706669|NCT02445339|10805755|FG000|COMPLETED|Overall Study||13
9706670|NCT02445339|10805756|FG001|COMPLETED|Overall Study||10
9706671|NCT02445339|10805755|FG000|NOT COMPLETED|Overall Study||12
9706672|NCT02445339|10805756|FG001|NOT COMPLETED|Overall Study||15
9706673|NCT03618056|10805762|FG000|STARTED|Overall Study||1
9706674|NCT03618056|10805762|FG000|COMPLETED|Overall Study||1
9706675|NCT03618056|10805762|FG000|NOT COMPLETED|Overall Study||0
9706676|NCT03503617|10805768|FG000|STARTED|Overall Study||14
9706677|NCT03503617|10805769|FG001|STARTED|Overall Study||13
10124216|NCT02590406|11255244|FG001|COMPLETED|Overall Study||24
10124217|NCT02590406|11255243|FG000|NOT COMPLETED|Overall Study||1
10124218|NCT02590406|11255244|FG001|NOT COMPLETED|Overall Study||1
10124219|NCT02590432|11255252|FG000|STARTED|Open-label Treatment Period||508
10124220|NCT02590432|11255253|FG001|STARTED|Open-label Treatment Period||318
10124221|NCT02590432|11255254|FG002|STARTED|Open-label Treatment Period||0
10124222|NCT02590432|11255255|FG003|STARTED|Open-label Treatment Period||0
10124223|NCT02590432|11255256|FG004|STARTED|Open-label Treatment Period||0
10124224|NCT02590432|11255257|FG005|STARTED|Open-label Treatment Period||0
10124225|NCT02590432|11255258|FG006|STARTED|Open-label Treatment Period||0
10124226|NCT02590432|11255259|FG007|STARTED|Open-label Treatment Period||0
10124227|NCT02590432|11255260|FG008|STARTED|Open-label Treatment Period||0
10124228|NCT02590432|11255252|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
10124229|NCT02590432|11255253|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
10124230|NCT02590432|11255254|FG002|COMPLETED|Open-label Treatment Period||0
10124231|NCT02590432|11255255|FG003|COMPLETED|Open-label Treatment Period||0
10124232|NCT02590432|11255256|FG004|COMPLETED|Open-label Treatment Period||0
10124233|NCT02590432|11255257|FG005|COMPLETED|Open-label Treatment Period||0
10124234|NCT02590432|11255258|FG006|COMPLETED|Open-label Treatment Period||0
10124235|NCT02590432|11255259|FG007|COMPLETED|Open-label Treatment Period||0
10124236|NCT02590432|11255260|FG008|COMPLETED|Open-label Treatment Period||0
10124237|NCT02590432|11255252|FG000|NOT COMPLETED|Open-label Treatment Period||232
10124238|NCT02590432|11255253|FG001|NOT COMPLETED|Open-label Treatment Period||152
10124239|NCT02590432|11255254|FG002|NOT COMPLETED|Open-label Treatment Period||0
10124240|NCT02590432|11255255|FG003|NOT COMPLETED|Open-label Treatment Period||0
10124241|NCT02590432|11255256|FG004|NOT COMPLETED|Open-label Treatment Period||0
10124242|NCT02590432|11255257|FG005|NOT COMPLETED|Open-label Treatment Period||0
10124243|NCT02590432|11255258|FG006|NOT COMPLETED|Open-label Treatment Period||0
10124244|NCT02590432|11255259|FG007|NOT COMPLETED|Open-label Treatment Period||0
10124245|NCT02590432|11255260|FG008|NOT COMPLETED|Open-label Treatment Period||0
10124246|NCT02590432|11255252|FG000|STARTED|Double-blind Treatment Period||0
10124247|NCT02590432|11255253|FG001|STARTED|Double-blind Treatment Period||0
10124248|NCT02590432|11255254|FG002|STARTED|Double-blind Treatment Period||18
10124249|NCT02590432|11255255|FG003|STARTED|Double-blind Treatment Period||18
10124250|NCT02590432|11255256|FG004|STARTED|Double-blind Treatment Period||16
10124251|NCT02590432|11255257|FG005|STARTED|Double-blind Treatment Period||32
10124252|NCT02590432|11255258|FG006|STARTED|Double-blind Treatment Period||30
10124253|NCT02590432|11255259|FG007|STARTED|Double-blind Treatment Period||0
10124254|NCT02590432|11255260|FG008|STARTED|Double-blind Treatment Period||0
10124255|NCT02590432|11255252|FG000|COMPLETED|Double-blind Treatment Period||0
10124256|NCT02590432|11255253|FG001|COMPLETED|Double-blind Treatment Period||0
10124257|NCT02590432|11255254|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
10124258|NCT02590432|11255255|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
10124259|NCT02590432|11255256|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
10124260|NCT02590432|11255257|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
10124261|NCT02590432|11255258|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
10124262|NCT02590432|11255259|FG007|COMPLETED|Double-blind Treatment Period||0
10124263|NCT02590432|11255260|FG008|COMPLETED|Double-blind Treatment Period||0
10124264|NCT02590432|11255252|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10124265|NCT02590432|11255253|FG001|NOT COMPLETED|Double-blind Treatment Period||0
10124266|NCT02590432|11255254|FG002|NOT COMPLETED|Double-blind Treatment Period||17
10124267|NCT02590432|11255255|FG003|NOT COMPLETED|Double-blind Treatment Period||15
10124268|NCT02590432|11255256|FG004|NOT COMPLETED|Double-blind Treatment Period||9
10124269|NCT02590432|11255257|FG005|NOT COMPLETED|Double-blind Treatment Period||26
10124270|NCT02590432|11255258|FG006|NOT COMPLETED|Double-blind Treatment Period||21
10124271|NCT02590432|11255259|FG007|NOT COMPLETED|Double-blind Treatment Period||0
10124272|NCT02590432|11255260|FG008|NOT COMPLETED|Double-blind Treatment Period||0
10124273|NCT02590432|11255252|FG000|STARTED|Dose-reduced Open Label Treatment Period||0
10124274|NCT02590432|11255253|FG001|STARTED|Dose-reduced Open Label Treatment Period||0
10124275|NCT02590432|11255254|FG002|STARTED|Dose-reduced Open Label Treatment Period||0
10124276|NCT02590432|11255255|FG003|STARTED|Dose-reduced Open Label Treatment Period||0
10124277|NCT02590432|11255256|FG004|STARTED|Dose-reduced Open Label Treatment Period||0
10124278|NCT02590432|11255257|FG005|STARTED|Dose-reduced Open Label Treatment Period||0
10124279|NCT02590432|11255258|FG006|STARTED|Dose-reduced Open Label Treatment Period||0
10124280|NCT02590432|11255259|FG007|STARTED|Dose-reduced Open Label Treatment Period||31
10124281|NCT02590432|11255260|FG008|STARTED|Dose-reduced Open Label Treatment Period||26
10124282|NCT02590432|11255252|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0
10124283|NCT02590432|11255253|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0
10124284|NCT02590432|11255254|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0
10124285|NCT02590432|11255255|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0
10124286|NCT02590432|11255256|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0
10124287|NCT02590432|11255257|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0
10124288|NCT02590432|11255258|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0
10124289|NCT02590432|11255259|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13
10124290|NCT02590432|11255260|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8
10124291|NCT02590432|11255252|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10124292|NCT02590432|11255253|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10124293|NCT02590432|11255254|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10124294|NCT02590432|11255255|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10124295|NCT02590432|11255256|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10124296|NCT02590432|11255257|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10124297|NCT02590432|11255258|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10124298|NCT02590432|11255259|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
10124299|NCT02590432|11255260|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
10124300|NCT02590562|11255272|FG000|STARTED|Overall Study||808
10124301|NCT02590562|11255272|FG000|COMPLETED|Overall Study||802
10124302|NCT02590562|11255272|FG000|NOT COMPLETED|Overall Study||6
10124303|NCT02590588|11255282|FG000|STARTED|Overall Study||1
10124304|NCT02590588|11255282|FG000|COMPLETED|Overall Study||0
10124305|NCT02590588|11255282|FG000|NOT COMPLETED|Overall Study||1
10124306|NCT02590939|11255288|FG000|STARTED|Overall Study||52
10124307|NCT02590939|11255289|FG001|STARTED|Overall Study||54
10124308|NCT02590939|11255288|FG000|COMPLETED|Overall Study||47
10124309|NCT02590939|11255289|FG001|COMPLETED|Overall Study||52
10124310|NCT02590939|11255288|FG000|NOT COMPLETED|Overall Study||5
10124311|NCT02590939|11255289|FG001|NOT COMPLETED|Overall Study||2
10124312|NCT02591056|11255295|FG000|STARTED|Overall Study||27
10124313|NCT02591056|11255295|FG000|COMPLETED|Overall Study||27
10124314|NCT02591056|11255295|FG000|NOT COMPLETED|Overall Study||0
10124315|NCT02591238|11255303|FG000|STARTED|Overall Study||16
10124316|NCT02591238|11255304|FG001|STARTED|Overall Study||17
10124317|NCT02591238|11255305|FG002|STARTED|Overall Study||17
10124318|NCT02591238|11255306|FG003|STARTED|Overall Study||18
10124319|NCT02591238|11255303|FG000|COMPLETED|Overall Study||15
10124320|NCT02591238|11255304|FG001|COMPLETED|Overall Study||16
10124321|NCT02591238|11255305|FG002|COMPLETED|Overall Study||17
10124322|NCT02591238|11255306|FG003|COMPLETED|Overall Study||15
10124323|NCT02591238|11255303|FG000|NOT COMPLETED|Overall Study||1
10124324|NCT02591238|11255304|FG001|NOT COMPLETED|Overall Study||1
10124325|NCT02591238|11255305|FG002|NOT COMPLETED|Overall Study||0
10124326|NCT02591238|11255306|FG003|NOT COMPLETED|Overall Study||3
10124327|NCT02591290|11255316|FG000|STARTED|Overall Study||60
10124328|NCT02591290|11255316|FG000|Vaccinated Dose 1|Overall Study||60
10124329|NCT02591290|11255316|FG000|Vaccinated Dose 2|Overall Study||58
10124330|NCT02591290|11255316|FG000|COMPLETED|Overall Study||58
10124331|NCT02591290|11255316|FG000|NOT COMPLETED|Overall Study||2
10124332|NCT02591511|11255322|FG000|STARTED|Overall Study||30
10124333|NCT02591511|11255323|FG001|STARTED|Overall Study||33
10124334|NCT02591511|11255322|FG000|COMPLETED|Overall Study||30
10124335|NCT02591511|11255323|FG001|COMPLETED|Overall Study||33
10124336|NCT02591511|11255322|FG000|NOT COMPLETED|Overall Study||0
10124337|NCT02591511|11255323|FG001|NOT COMPLETED|Overall Study||0
10124338|NCT02591537|11255331|FG000|STARTED|Overall Study||8
10124339|NCT02591537|11255332|FG001|STARTED|Overall Study||8
10124340|NCT02591537|11255331|FG000|COMPLETED|Overall Study||8
10124341|NCT02591537|11255332|FG001|COMPLETED|Overall Study||8
10124342|NCT02591537|11255331|FG000|NOT COMPLETED|Overall Study||0
10124343|NCT02591537|11255332|FG001|NOT COMPLETED|Overall Study||0
10124344|NCT02592018|11255339|FG000|STARTED|Overall Study||15
10124345|NCT02592018|11255339|FG000|COMPLETED|Overall Study||13
10124346|NCT02592018|11255339|FG000|NOT COMPLETED|Overall Study||2
10124347|NCT02592421|11255345|FG000|STARTED|Study 1||20
10124348|NCT02592421|11255346|FG001|STARTED|Study 1||10
10124349|NCT02592421|11255345|FG000|COMPLETED|Study 1||20
10124350|NCT02592421|11255346|FG001|COMPLETED|Study 1||10
10124351|NCT02592421|11255345|FG000|NOT COMPLETED|Study 1||0
10124352|NCT02592421|11255346|FG001|NOT COMPLETED|Study 1||0
10124353|NCT02592421|11255345|FG000|STARTED|Study 2: Glucose Clamp Conditions||20
10124354|NCT02592421|11255346|FG001|STARTED|Study 2: Glucose Clamp Conditions||10
10124355|NCT02592421|11255345|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20
10124356|NCT02592421|11255346|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10
10124357|NCT02592421|11255345|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
10124358|NCT02592421|11255346|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
10124359|NCT02592421|11255345|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20
10124360|NCT02592421|11255346|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10
10124361|NCT02592421|11255345|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
10124362|NCT02592421|11255346|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
10124363|NCT02592421|11255345|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
10124364|NCT02592421|11255346|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
10124365|NCT02592434|11255352|FG000|STARTED|Open-Label Phase (18 Weeks)||225
10124366|NCT02592434|11255353|FG001|STARTED|Open-Label Phase (18 Weeks)||0
10124367|NCT02592434|11255354|FG002|STARTED|Open-Label Phase (18 Weeks)||0
10124368|NCT02592434|11255352|FG000|Treated|Open-Label Phase (18 Weeks)||225
10124369|NCT02592434|11255353|FG001|Treated|Open-Label Phase (18 Weeks)||0
10124370|NCT02592434|11255354|FG002|Treated|Open-Label Phase (18 Weeks)||0
10124371|NCT02592434|11255352|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185
10124372|NCT02592434|11255353|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0
10124373|NCT02592434|11255354|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0
10124374|NCT02592434|11255352|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
10124375|NCT02592434|11255353|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
10124376|NCT02592434|11255354|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
10124377|NCT02592434|11255352|FG000|STARTED|Double Blind Phase (26 Weeks)||0
10124378|NCT02592434|11255353|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
10124379|NCT02592434|11255354|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
10124380|NCT02592434|11255352|FG000|Treated|Double Blind Phase (26 Weeks)||0
10124381|NCT02592434|11255353|FG001|Treated|Double Blind Phase (26 Weeks)||88
10124382|NCT02592434|11255354|FG002|Treated|Double Blind Phase (26 Weeks)||85
10124383|NCT02592434|11255352|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0
10124384|NCT02592434|11255353|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61
10124385|NCT02592434|11255354|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38
10124386|NCT02592434|11255352|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
10124387|NCT02592434|11255353|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
10124388|NCT02592434|11255354|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
10124389|NCT02592447|11255364|FG000|STARTED|Overall Study||29
10124390|NCT02592447|11255365|FG001|STARTED|Overall Study||15
10124391|NCT02592447|11255364|FG000|COMPLETED|Overall Study||27
10124392|NCT02592447|11255365|FG001|COMPLETED|Overall Study||14
10124393|NCT02592447|11255364|FG000|NOT COMPLETED|Overall Study||2
10124394|NCT02592447|11255365|FG001|NOT COMPLETED|Overall Study||1
10124395|NCT02592486|11255373|FG000|STARTED|Overall Study||81
10124396|NCT02592486|11255374|FG001|STARTED|Overall Study||81
10124397|NCT02592486|11255373|FG000|COMPLETED|Overall Study||81
10124398|NCT02592486|11255374|FG001|COMPLETED|Overall Study||76
10124399|NCT02592486|11255373|FG000|NOT COMPLETED|Overall Study||0
10124400|NCT02592486|11255374|FG001|NOT COMPLETED|Overall Study||5
10124401|NCT02592629|11255383|FG000|STARTED|Overall Study||5
10124402|NCT02592629|11255384|FG001|STARTED|Overall Study||9
10124403|NCT02592629|11255385|FG002|STARTED|Overall Study||5
10124404|NCT02592629|11255383|FG000|COMPLETED|Overall Study||5
10124405|NCT02592629|11255384|FG001|COMPLETED|Overall Study||9
10124406|NCT02592629|11255385|FG002|COMPLETED|Overall Study||5
10124407|NCT02592629|11255383|FG000|NOT COMPLETED|Overall Study||0
10124408|NCT02592629|11255384|FG001|NOT COMPLETED|Overall Study||0
10124409|NCT02592629|11255385|FG002|NOT COMPLETED|Overall Study||0
10124410|NCT02592655|11255395|FG000|STARTED|First Tourniquet, Left Thigh.||19
10124411|NCT02592655|11255395|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
10124412|NCT02592655|11255395|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
10124413|NCT02592655|11255395|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
10124414|NCT02592655|11255395|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
10124415|NCT02592655|11255395|FG000|COMPLETED|First Tourniquet, Left Thigh.||19
10124416|NCT02592655|11255395|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0
10124417|NCT02592655|11255395|FG000|STARTED|Second Tourniquet Right Thigh.||19
10124418|NCT02592655|11255395|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
10124419|NCT02592655|11255395|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
10124420|NCT02592655|11255395|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
10124421|NCT02592655|11255395|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
10124422|NCT02592655|11255395|FG000|COMPLETED|Second Tourniquet Right Thigh.||19
10124423|NCT02592655|11255395|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0
10124424|NCT02592655|11255395|FG000|STARTED|Third Tourniquet, Left Thigh.||19
10124425|NCT02592655|11255395|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
10124426|NCT02592655|11255395|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
10124427|NCT02592655|11255395|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
10124428|NCT02592655|11255395|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
10124429|NCT02592655|11255395|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19
10124430|NCT02592655|11255395|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
10124431|NCT02592655|11255395|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
10124432|NCT02592655|11255395|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
10124433|NCT02592655|11255395|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
10124434|NCT02592655|11255395|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
10124435|NCT02592655|11255395|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
10124436|NCT02592655|11255395|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4
10124437|NCT02592655|11255395|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
10124438|NCT02592798|11255412|FG000|STARTED|Double-Blind Period 1 (DB1)||17
10124439|NCT02592798|11255413|FG001|STARTED|Double-Blind Period 1 (DB1)||19
10124440|NCT02592798|11255412|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14
10124441|NCT02592798|11255413|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13
10124442|NCT02592798|11255412|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
10124443|NCT02592798|11255413|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
10124444|NCT02592798|11255412|FG000|STARTED|Transition From DB1 to DB2||14
10124445|NCT02592798|11255413|FG001|STARTED|Transition From DB1 to DB2||13
10124446|NCT02592798|11255412|FG000|COMPLETED|Transition From DB1 to DB2||11
10124447|NCT02592798|11255413|FG001|COMPLETED|Transition From DB1 to DB2||11
10124448|NCT02592798|11255412|FG000|NOT COMPLETED|Transition From DB1 to DB2||3
10124449|NCT02592798|11255413|FG001|NOT COMPLETED|Transition From DB1 to DB2||2
10124450|NCT02592798|11255412|FG000|STARTED|Double-Blind Period 2 (DB2)||11
10124451|NCT02592798|11255413|FG001|STARTED|Double-Blind Period 2 (DB2)||11
10124452|NCT02592798|11255412|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6
10124453|NCT02592798|11255413|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9
10124454|NCT02592798|11255412|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
10124455|NCT02592798|11255413|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
10124456|NCT02592798|11255412|FG000|STARTED|Transition From DB2 to OLE||6
10124457|NCT02592798|11255413|FG001|STARTED|Transition From DB2 to OLE||9
10124458|NCT02592798|11255412|FG000|COMPLETED|Transition From DB2 to OLE||5
10124459|NCT02592798|11255413|FG001|COMPLETED|Transition From DB2 to OLE||9
10124460|NCT02592798|11255412|FG000|NOT COMPLETED|Transition From DB2 to OLE||1
10124461|NCT02592798|11255413|FG001|NOT COMPLETED|Transition From DB2 to OLE||0
10124462|NCT02592798|11255412|FG000|STARTED|Open Label Period (OLE)||10
10124463|NCT02592798|11255413|FG001|STARTED|Open Label Period (OLE)||13
10124464|NCT02592798|11255412|FG000|COMPLETED|Open Label Period (OLE)||6
10124465|NCT02592798|11255413|FG001|COMPLETED|Open Label Period (OLE)||4
10124466|NCT02592798|11255412|FG000|NOT COMPLETED|Open Label Period (OLE)||4
10124467|NCT02592798|11255413|FG001|NOT COMPLETED|Open Label Period (OLE)||9
10124468|NCT02592876|11255428|FG000|STARTED|Overall Study||41
10124469|NCT02592876|11255429|FG001|STARTED|Overall Study||40
10124470|NCT02592876|11255428|FG000|Received Study Drug|Overall Study||40
10124471|NCT02592876|11255429|FG001|Received Study Drug|Overall Study||40
10124472|NCT02592876|11255428|FG000|Completed Treatment|Overall Study||34
10124473|NCT02592876|11255429|FG001|Completed Treatment|Overall Study||32
10124474|NCT02592876|11255428|FG000|COMPLETED|Overall Study||0
10124475|NCT02592876|11255429|FG001|COMPLETED|Overall Study||0
10124476|NCT02592876|11255428|FG000|NOT COMPLETED|Overall Study||41
10124477|NCT02592876|11255429|FG001|NOT COMPLETED|Overall Study||40
10124478|NCT02593006|11255438|FG000|STARTED|Overall Study||257
10124479|NCT02593006|11255439|FG001|STARTED|Overall Study||100
10124480|NCT02593006|11255440|FG002|STARTED|Overall Study||43
10124481|NCT02593006|11255438|FG000|COMPLETED|Overall Study||250
10124482|NCT02593006|11255439|FG001|COMPLETED|Overall Study||93
10124483|NCT02593006|11255440|FG002|COMPLETED|Overall Study||38
10124484|NCT02593006|11255438|FG000|NOT COMPLETED|Overall Study||7
10124485|NCT02593006|11255439|FG001|NOT COMPLETED|Overall Study||7
10124486|NCT02593006|11255440|FG002|NOT COMPLETED|Overall Study||5
10124487|NCT02593032|11255451|FG000|STARTED|Overall Study||17
10124488|NCT02593032|11255452|FG001|STARTED|Overall Study||33
10124489|NCT02593032|11255451|FG000|COMPLETED|Overall Study||17
10124490|NCT02593032|11255452|FG001|COMPLETED|Overall Study||33
10124491|NCT02593032|11255451|FG000|NOT COMPLETED|Overall Study||0
10124492|NCT02593032|11255452|FG001|NOT COMPLETED|Overall Study||0
10124493|NCT02593097|11255460|FG000|STARTED|First Intervention (12 Weeks)||14
10124494|NCT02593097|11255461|FG001|STARTED|First Intervention (12 Weeks)||20
10124495|NCT02593097|11255460|FG000|Received Intervention|First Intervention (12 Weeks)||14
10124496|NCT02593097|11255461|FG001|Received Intervention|First Intervention (12 Weeks)||20
10124497|NCT02593097|11255460|FG000|COMPLETED|First Intervention (12 Weeks)||12
10124498|NCT02593097|11255461|FG001|COMPLETED|First Intervention (12 Weeks)||16
10124499|NCT02593097|11255460|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2
10124500|NCT02593097|11255461|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4
10124501|NCT02593097|11255460|FG000|STARTED|Washout (4 Weeks)||12
10124502|NCT02593097|11255461|FG001|STARTED|Washout (4 Weeks)||16
10124503|NCT02593097|11255460|FG000|COMPLETED|Washout (4 Weeks)||12
10124504|NCT02593097|11255461|FG001|COMPLETED|Washout (4 Weeks)||16
10124505|NCT02593097|11255460|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10124506|NCT02593097|11255461|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10124507|NCT02593097|11255460|FG000|STARTED|Second Intervention (12 Weeks)||12
10124508|NCT02593097|11255461|FG001|STARTED|Second Intervention (12 Weeks)||16
10124509|NCT02593097|11255460|FG000|COMPLETED|Second Intervention (12 Weeks)||9
10124510|NCT02593097|11255461|FG001|COMPLETED|Second Intervention (12 Weeks)||15
10124511|NCT02593097|11255460|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3
10124512|NCT02593097|11255461|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1
10124513|NCT02593149|11255469|FG000|STARTED|Run-In||340
10124514|NCT02593149|11255470|FG001|STARTED|Run-In||361
10124515|NCT02593149|11255469|FG000|COMPLETED|Run-In||304
10124516|NCT02593149|11255470|FG001|COMPLETED|Run-In||323
10124517|NCT02593149|11255469|FG000|NOT COMPLETED|Run-In||36
10124518|NCT02593149|11255470|FG001|NOT COMPLETED|Run-In||38
10124519|NCT02593149|11255469|FG000|STARTED|Intervention||942
10124520|NCT02593149|11255470|FG001|STARTED|Intervention||960
10124521|NCT02593149|11255469|FG000|COMPLETED|Intervention||826
10124522|NCT02593149|11255470|FG001|COMPLETED|Intervention||845
10124523|NCT02593149|11255469|FG000|NOT COMPLETED|Intervention||116
10124524|NCT02593149|11255470|FG001|NOT COMPLETED|Intervention||115
10124525|NCT02593305|11255479|FG000|STARTED|Baseline 1||7
10124526|NCT02593305|11255480|FG001|STARTED|Baseline 1||6
10124527|NCT02593305|11255481|FG002|STARTED|Baseline 1||10
10124528|NCT02593305|11255479|FG000|COMPLETED|Baseline 1||7
10124529|NCT02593305|11255480|FG001|COMPLETED|Baseline 1||6
10124530|NCT02593305|11255481|FG002|COMPLETED|Baseline 1||10
10124531|NCT02593305|11255479|FG000|NOT COMPLETED|Baseline 1||0
10124532|NCT02593305|11255480|FG001|NOT COMPLETED|Baseline 1||0
10124533|NCT02593305|11255481|FG002|NOT COMPLETED|Baseline 1||0
10124534|NCT02593305|11255479|FG000|STARTED|Post 1||7
10124535|NCT02593305|11255480|FG001|STARTED|Post 1||6
10124536|NCT02593305|11255481|FG002|STARTED|Post 1||10
10124537|NCT02593305|11255479|FG000|COMPLETED|Post 1||7
10124538|NCT02593305|11255480|FG001|COMPLETED|Post 1||6
10124539|NCT02593305|11255481|FG002|COMPLETED|Post 1||0
10124540|NCT02593305|11255479|FG000|NOT COMPLETED|Post 1||0
10124541|NCT02593305|11255480|FG001|NOT COMPLETED|Post 1||0
10124542|NCT02593305|11255481|FG002|NOT COMPLETED|Post 1||10
10124543|NCT02593305|11255479|FG000|STARTED|Baseline 2||7
10124544|NCT02593305|11255480|FG001|STARTED|Baseline 2||6
10124545|NCT02593305|11255481|FG002|STARTED|Baseline 2||0
10124546|NCT02593305|11255479|FG000|COMPLETED|Baseline 2||7
10124547|NCT02593305|11255480|FG001|COMPLETED|Baseline 2||6
10124548|NCT02593305|11255481|FG002|COMPLETED|Baseline 2||0
10124549|NCT02593305|11255479|FG000|NOT COMPLETED|Baseline 2||0
10124550|NCT02593305|11255480|FG001|NOT COMPLETED|Baseline 2||0
10124551|NCT02593305|11255481|FG002|NOT COMPLETED|Baseline 2||0
10124552|NCT02593305|11255479|FG000|STARTED|Post 2||7
10124553|NCT02593305|11255480|FG001|STARTED|Post 2||6
10124554|NCT02593305|11255481|FG002|STARTED|Post 2||0
10124555|NCT02593305|11255479|FG000|COMPLETED|Post 2||7
10124556|NCT02593305|11255480|FG001|COMPLETED|Post 2||6
10124557|NCT02593305|11255481|FG002|COMPLETED|Post 2||0
10124558|NCT02593305|11255479|FG000|NOT COMPLETED|Post 2||0
10124559|NCT02593305|11255480|FG001|NOT COMPLETED|Post 2||0
10124560|NCT02593305|11255481|FG002|NOT COMPLETED|Post 2||0
10124561|NCT02593318|11255492|FG000|STARTED|Overall Study||16
10124562|NCT02593318|11255493|FG001|STARTED|Overall Study||16
10124563|NCT02593318|11255492|FG000|COMPLETED|Overall Study||15
10124564|NCT02593318|11255493|FG001|COMPLETED|Overall Study||15
10124565|NCT02593318|11255492|FG000|NOT COMPLETED|Overall Study||1
10124566|NCT02593318|11255493|FG001|NOT COMPLETED|Overall Study||1
10124567|NCT02593396|11255507|FG000|STARTED|Overall Study||40
10124568|NCT02593396|11255508|FG001|STARTED|Overall Study||40
10124569|NCT02593396|11255507|FG000|At Least Done One Efficacy Assessment|Overall Study||36
10124570|NCT02593396|11255508|FG001|At Least Done One Efficacy Assessment|Overall Study||36
10124571|NCT02593396|11255507|FG000|COMPLETED|Overall Study||25
10124572|NCT02593396|11255508|FG001|COMPLETED|Overall Study||26
10124573|NCT02593396|11255507|FG000|NOT COMPLETED|Overall Study||15
10124574|NCT02593396|11255508|FG001|NOT COMPLETED|Overall Study||14
10124575|NCT02593539|11255514|FG000|STARTED|Overall Study||5
10124576|NCT02593539|11255514|FG000|COMPLETED|Overall Study||4
10124577|NCT02593539|11255514|FG000|NOT COMPLETED|Overall Study||1
10124578|NCT02593630|11255521|FG000|STARTED|Overall Study||54
10124579|NCT02593630|11255521|FG000|COMPLETED|Overall Study||53
10124580|NCT02593630|11255521|FG000|NOT COMPLETED|Overall Study||1
10124581|NCT02593773|11255526|FG000|STARTED|Overall Study||86
10124582|NCT02593773|11255526|FG000|COMPLETED|Overall Study||51
10124583|NCT02593773|11255526|FG000|NOT COMPLETED|Overall Study||35
10124584|NCT02593825|11255532|FG000|STARTED|Intervention||67
10124585|NCT02593825|11255533|FG001|STARTED|Intervention||67
10124586|NCT02593825|11255532|FG000|COMPLETED|Intervention||57
10124587|NCT02593825|11255533|FG001|COMPLETED|Intervention||55
10124588|NCT02593825|11255532|FG000|NOT COMPLETED|Intervention||10
10124589|NCT02593825|11255533|FG001|NOT COMPLETED|Intervention||12
10124590|NCT02593825|11255532|FG000|STARTED|Follow-up||57
10124591|NCT02593825|11255533|FG001|STARTED|Follow-up||55
10124592|NCT02593825|11255532|FG000|COMPLETED|Follow-up||57
10124593|NCT02593825|11255533|FG001|COMPLETED|Follow-up||55
10124594|NCT02593825|11255532|FG000|NOT COMPLETED|Follow-up||0
10124595|NCT02593825|11255533|FG001|NOT COMPLETED|Follow-up||0
10124596|NCT02593864|11255541|FG000|STARTED|Overall Study||25
10124597|NCT02593864|11255541|FG000|COMPLETED|Overall Study||19
10124598|NCT02593864|11255541|FG000|NOT COMPLETED|Overall Study||6
10196246|NCT03358407|11324484|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
10196247|NCT03358407|11324485|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196248|NCT03358407|11324486|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196249|NCT03358407|11324477|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196250|NCT03358407|11324478|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196251|NCT03358407|11324479|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196252|NCT03358407|11324480|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196253|NCT03358407|11324481|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196254|NCT03358407|11324482|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196255|NCT03358407|11324483|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196256|NCT03358407|11324484|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196257|NCT03358407|11324485|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196258|NCT03358407|11324486|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196259|NCT03358407|11324477|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196260|NCT03358407|11324478|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196261|NCT03358407|11324479|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196262|NCT03358407|11324480|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196263|NCT03358407|11324481|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196264|NCT03358407|11324482|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
10196265|NCT03358407|11324483|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
10196266|NCT03358407|11324484|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
10196267|NCT03358407|11324485|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196268|NCT03358407|11324486|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10196269|NCT03358407|11324477|FG000|STARTED|Part B: Overall Period (11 Weeks)||0
10196270|NCT03358407|11324478|FG001|STARTED|Part B: Overall Period (11 Weeks)||0
10196271|NCT03358407|11324479|FG002|STARTED|Part B: Overall Period (11 Weeks)||0
10196272|NCT03358407|11324480|FG003|STARTED|Part B: Overall Period (11 Weeks)||0
10196273|NCT03358407|11324481|FG004|STARTED|Part B: Overall Period (11 Weeks)||0
10196274|NCT03358407|11324482|FG005|STARTED|Part B: Overall Period (11 Weeks)||0
10196275|NCT03358407|11324483|FG006|STARTED|Part B: Overall Period (11 Weeks)||0
10196276|NCT03358407|11324484|FG007|STARTED|Part B: Overall Period (11 Weeks)||0
10196277|NCT03358407|11324485|FG008|STARTED|Part B: Overall Period (11 Weeks)||0
10196278|NCT03358407|11324486|FG009|STARTED|Part B: Overall Period (11 Weeks)||0
10196279|NCT03358407|11324477|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196280|NCT03358407|11324478|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196281|NCT03358407|11324479|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196282|NCT03358407|11324480|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196283|NCT03358407|11324481|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196284|NCT03358407|11324482|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196285|NCT03358407|11324483|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196286|NCT03358407|11324484|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196287|NCT03358407|11324485|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196288|NCT03358407|11324486|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0
10196289|NCT03358407|11324477|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196290|NCT03358407|11324478|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196291|NCT03358407|11324479|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196292|NCT03358407|11324480|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196293|NCT03358407|11324481|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196294|NCT03358407|11324482|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196295|NCT03358407|11324483|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196296|NCT03358407|11324484|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196297|NCT03358407|11324485|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196298|NCT03358407|11324486|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10196299|NCT03358576|11324516|FG000|STARTED|Overall Study||338
10196300|NCT03358576|11324517|FG001|STARTED|Overall Study||336
10196301|NCT03358576|11324516|FG000|COMPLETED|Overall Study||312
10196302|NCT03358576|11324517|FG001|COMPLETED|Overall Study||311
10196303|NCT03358576|11324516|FG000|NOT COMPLETED|Overall Study||26
10196304|NCT03358576|11324517|FG001|NOT COMPLETED|Overall Study||25
10196305|NCT03359395|11324525|FG000|STARTED|First Intervention A / B||49
10196306|NCT03359395|11324526|FG001|STARTED|First Intervention A / B||50
10196307|NCT03359395|11324525|FG000|COMPLETED|First Intervention A / B||46
10196308|NCT03359395|11324526|FG001|COMPLETED|First Intervention A / B||47
10196309|NCT03359395|11324525|FG000|NOT COMPLETED|First Intervention A / B||3
10196310|NCT03359395|11324526|FG001|NOT COMPLETED|First Intervention A / B||3
10196311|NCT03359395|11324525|FG000|STARTED|Second Intervention B/A||46
10124599|NCT04142242|11255551|FG000|STARTED|Overall Study||139
10124600|NCT04142242|11255552|FG001|STARTED|Overall Study||176
10124601|NCT04142242|11255553|FG002|STARTED|Overall Study||31
10124602|NCT04142242|11255554|FG003|STARTED|Overall Study||39
10124603|NCT04142242|11255555|FG004|STARTED|Overall Study||26
10124604|NCT04142242|11255556|FG005|STARTED|Overall Study||60
10124605|NCT04142242|11255551|FG000|Vaccinated|Overall Study||138
10124606|NCT04142242|11255552|FG001|Vaccinated|Overall Study||175
10124607|NCT04142242|11255553|FG002|Vaccinated|Overall Study||0
10124608|NCT04142242|11255554|FG003|Vaccinated|Overall Study||0
10124609|NCT04142242|11255555|FG004|Vaccinated|Overall Study||0
10124610|NCT04142242|11255556|FG005|Vaccinated|Overall Study||0
10124611|NCT04142242|11255551|FG000|Full Analysis Set (FAS)|Overall Study||138
10124612|NCT04142242|11255552|FG001|Full Analysis Set (FAS)|Overall Study||175
10124613|NCT04142242|11255553|FG002|Full Analysis Set (FAS)|Overall Study||31
10124614|NCT04142242|11255554|FG003|Full Analysis Set (FAS)|Overall Study||39
10124615|NCT04142242|11255555|FG004|Full Analysis Set (FAS)|Overall Study||26
10124616|NCT04142242|11255556|FG005|Full Analysis Set (FAS)|Overall Study||59
10124617|NCT04142242|11255551|FG000|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
10124618|NCT04142242|11255552|FG001|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
10124619|NCT04142242|11255553|FG002|Safety Analysis Set (SAfAS)|Overall Study||0
10124620|NCT04142242|11255554|FG003|Safety Analysis Set (SAfAS)|Overall Study||0
10124621|NCT04142242|11255555|FG004|Safety Analysis Set (SAfAS)|Overall Study||0
10124622|NCT04142242|11255556|FG005|Safety Analysis Set (SAfAS)|Overall Study||0
10124623|NCT04142242|11255551|FG000|COMPLETED|Overall Study||138
10124624|NCT04142242|11255552|FG001|COMPLETED|Overall Study||175
10124625|NCT04142242|11255553|FG002|COMPLETED|Overall Study||0
10124626|NCT04142242|11255554|FG003|COMPLETED|Overall Study||0
10124627|NCT04142242|11255555|FG004|COMPLETED|Overall Study||26
10124628|NCT04142242|11255556|FG005|COMPLETED|Overall Study||59
10124629|NCT04142242|11255551|FG000|NOT COMPLETED|Overall Study||1
10124630|NCT04142242|11255552|FG001|NOT COMPLETED|Overall Study||1
10124631|NCT04142242|11255553|FG002|NOT COMPLETED|Overall Study||31
10124632|NCT04142242|11255554|FG003|NOT COMPLETED|Overall Study||39
10124633|NCT04142242|11255555|FG004|NOT COMPLETED|Overall Study||0
10124634|NCT04142242|11255556|FG005|NOT COMPLETED|Overall Study||1
10124635|NCT04087122|11255569|FG000|STARTED|Overall Study||20
10124636|NCT04087122|11255569|FG000|COMPLETED|Overall Study||20
10124637|NCT04087122|11255569|FG000|NOT COMPLETED|Overall Study||0
10124638|NCT03990389|11255577|FG000|STARTED|Overall Study||15
10124639|NCT03990389|11255578|FG001|STARTED|Overall Study||16
10124640|NCT03990389|11255577|FG000|COMPLETED|Overall Study||12
10124641|NCT03990389|11255578|FG001|COMPLETED|Overall Study||16
10124642|NCT03990389|11255577|FG000|NOT COMPLETED|Overall Study||3
10124643|NCT03990389|11255578|FG001|NOT COMPLETED|Overall Study||0
10124644|NCT03939312|11255584|FG000|STARTED|OL Treatment Period (40 Weeks)||685
10124645|NCT03939312|11255584|FG000|COMPLETED|OL Treatment Period (40 Weeks)||511
10124646|NCT03939312|11255584|FG000|NOT COMPLETED|OL Treatment Period (40 Weeks)||174
10124647|NCT03939312|11255584|FG000|STARTED|Safety Follow-up 4 Weeks (Up to Week 44)|Out of 685 participants, 640 participants who received treatment including 511 participants who completed the treatment entered safety follow-up period.|640
10124648|NCT03939312|11255584|FG000|COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||624
10124649|NCT03939312|11255584|FG000|NOT COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||16
10124650|NCT03934541|11255594|FG000|STARTED|Overall Study||5
10124651|NCT03934541|11255595|FG001|STARTED|Overall Study||15
10124652|NCT03934541|11255596|FG002|STARTED|Overall Study||1
10124653|NCT03934541|11255597|FG003|STARTED|Overall Study||3
10124654|NCT03934541|11255594|FG000|COMPLETED|Overall Study||5
10124655|NCT03934541|11255595|FG001|COMPLETED|Overall Study||14
10124656|NCT03934541|11255596|FG002|COMPLETED|Overall Study||1
10124657|NCT03934541|11255597|FG003|COMPLETED|Overall Study||3
10124658|NCT03934541|11255594|FG000|NOT COMPLETED|Overall Study||0
10124659|NCT03934541|11255595|FG001|NOT COMPLETED|Overall Study||1
10124660|NCT03934541|11255596|FG002|NOT COMPLETED|Overall Study||0
10124661|NCT03934541|11255597|FG003|NOT COMPLETED|Overall Study||0
10124662|NCT03895034|11255607|FG000|STARTED|Overall Study||66
10124663|NCT03895034|11255607|FG000|COMPLETED|Overall Study||64
10124664|NCT03895034|11255607|FG000|NOT COMPLETED|Overall Study||2
10124665|NCT03870477|11255611|FG000|STARTED|Overall Study||1
10124666|NCT03870477|11255611|FG000|COMPLETED|Overall Study||0
10124667|NCT03870477|11255611|FG000|NOT COMPLETED|Overall Study||1
10124668|NCT03351244|11255618|FG000|STARTED|Overall Study||89
10124669|NCT03351244|11255619|FG001|STARTED|Overall Study||88
10124670|NCT03351244|11255620|FG002|STARTED|Overall Study||87
10124671|NCT03351244|11255618|FG000|COMPLETED|Overall Study||62
10124672|NCT03351244|11255619|FG001|COMPLETED|Overall Study||48
10124673|NCT03351244|11255620|FG002|COMPLETED|Overall Study||53
10124674|NCT03351244|11255618|FG000|NOT COMPLETED|Overall Study||27
10124675|NCT03351244|11255619|FG001|NOT COMPLETED|Overall Study||40
10124676|NCT03351244|11255620|FG002|NOT COMPLETED|Overall Study||34
10124677|NCT03292926|11255632|FG000|STARTED|Overall Study||39
10124678|NCT03292926|11255633|FG001|STARTED|Overall Study||39
10124679|NCT03292926|11255632|FG000|COMPLETED|Overall Study||39
10124680|NCT03292926|11255633|FG001|COMPLETED|Overall Study||39
10124681|NCT03292926|11255632|FG000|NOT COMPLETED|Overall Study||0
10124682|NCT03292926|11255633|FG001|NOT COMPLETED|Overall Study||0
10124683|NCT03084666|11255641|FG000|STARTED|Overall Study||20
10124684|NCT03084666|11255642|FG001|STARTED|Overall Study||20
10124685|NCT03084666|11255641|FG000|COMPLETED|Overall Study||20
10124686|NCT03084666|11255642|FG001|COMPLETED|Overall Study||20
10124687|NCT03084666|11255641|FG000|NOT COMPLETED|Overall Study||0
10124688|NCT03084666|11255642|FG001|NOT COMPLETED|Overall Study||0
10124689|NCT02982954|11255652|FG000|STARTED|Treatment Period||106
10124690|NCT02982954|11255653|FG001|STARTED|Treatment Period||52
10124691|NCT02982954|11255654|FG002|STARTED|Treatment Period||28
10124692|NCT02982954|11255655|FG003|STARTED|Treatment Period||25
10124693|NCT02982954|11255652|FG000|COMPLETED|Treatment Period||0
10124694|NCT02982954|11255653|FG001|COMPLETED|Treatment Period||0
10124695|NCT02982954|11255654|FG002|COMPLETED|Treatment Period||0
10124696|NCT02982954|11255655|FG003|COMPLETED|Treatment Period||0
10124697|NCT02982954|11255652|FG000|NOT COMPLETED|Treatment Period||106
10124698|NCT02982954|11255653|FG001|NOT COMPLETED|Treatment Period||52
10124699|NCT02982954|11255654|FG002|NOT COMPLETED|Treatment Period||28
10124700|NCT02982954|11255655|FG003|NOT COMPLETED|Treatment Period||25
10124701|NCT02982954|11255652|FG000|STARTED|Continuing in Study||106
10124702|NCT02982954|11255653|FG001|STARTED|Continuing in Study||52
10124703|NCT02982954|11255654|FG002|STARTED|Continuing in Study||28
10124704|NCT02982954|11255655|FG003|STARTED|Continuing in Study||25
10124705|NCT02982954|11255652|FG000|COMPLETED|Continuing in Study||52
10124706|NCT02982954|11255653|FG001|COMPLETED|Continuing in Study||19
10124707|NCT02982954|11255654|FG002|COMPLETED|Continuing in Study||17
10124708|NCT02982954|11255655|FG003|COMPLETED|Continuing in Study||7
10124709|NCT02982954|11255652|FG000|NOT COMPLETED|Continuing in Study||54
10124710|NCT02982954|11255653|FG001|NOT COMPLETED|Continuing in Study||33
10124711|NCT02982954|11255654|FG002|NOT COMPLETED|Continuing in Study||11
10124712|NCT02982954|11255655|FG003|NOT COMPLETED|Continuing in Study||18
10124713|NCT02903914|11255673|FG000|STARTED|Overall Study||8
10124714|NCT02903914|11255674|FG001|STARTED|Overall Study||7
10124715|NCT02903914|11255675|FG002|STARTED|Overall Study||85
10124716|NCT02903914|11255676|FG003|STARTED|Overall Study||7
10124717|NCT02903914|11255677|FG004|STARTED|Overall Study||10
10124718|NCT02903914|11255678|FG005|STARTED|Overall Study||14
10124719|NCT02903914|11255679|FG006|STARTED|Overall Study||123
10124720|NCT02903914|11255680|FG007|STARTED|Overall Study||6
10124721|NCT02903914|11255673|FG000|COMPLETED|Overall Study||0
10124722|NCT02903914|11255674|FG001|COMPLETED|Overall Study||0
10124723|NCT02903914|11255675|FG002|COMPLETED|Overall Study||0
10124724|NCT02903914|11255676|FG003|COMPLETED|Overall Study||0
10124725|NCT02903914|11255677|FG004|COMPLETED|Overall Study||0
10124726|NCT02903914|11255678|FG005|COMPLETED|Overall Study||0
10124727|NCT02903914|11255679|FG006|COMPLETED|Overall Study||6
10124728|NCT02903914|11255680|FG007|COMPLETED|Overall Study||1
10124729|NCT02903914|11255673|FG000|NOT COMPLETED|Overall Study||8
10124730|NCT02903914|11255674|FG001|NOT COMPLETED|Overall Study||7
10124731|NCT02903914|11255675|FG002|NOT COMPLETED|Overall Study||85
10124732|NCT02903914|11255676|FG003|NOT COMPLETED|Overall Study||7
10124733|NCT02903914|11255677|FG004|NOT COMPLETED|Overall Study||10
10124734|NCT02903914|11255678|FG005|NOT COMPLETED|Overall Study||14
10124735|NCT02903914|11255679|FG006|NOT COMPLETED|Overall Study||117
10124736|NCT02903914|11255680|FG007|NOT COMPLETED|Overall Study||5
10124737|NCT02727699|11255702|FG000|STARTED|Overall Study||91
10124738|NCT02727699|11255703|FG001|STARTED|Overall Study||94
10124739|NCT02727699|11255702|FG000|COMPLETED|Overall Study||82
10124740|NCT02727699|11255703|FG001|COMPLETED|Overall Study||89
10124741|NCT02727699|11255702|FG000|NOT COMPLETED|Overall Study||9
10124742|NCT02727699|11255703|FG001|NOT COMPLETED|Overall Study||5
10124743|NCT02429375|11255712|FG000|STARTED|Overall Study||3
10124744|NCT02429375|11255713|FG001|STARTED|Overall Study||3
10124745|NCT02429375|11255714|FG002|STARTED|Overall Study||1
10124746|NCT02429375|11255712|FG000|COMPLETED|Overall Study||3
10124747|NCT02429375|11255713|FG001|COMPLETED|Overall Study||3
10124748|NCT02429375|11255714|FG002|COMPLETED|Overall Study||1
10124749|NCT02429375|11255712|FG000|NOT COMPLETED|Overall Study||0
10124750|NCT02429375|11255713|FG001|NOT COMPLETED|Overall Study||0
10124751|NCT02429375|11255714|FG002|NOT COMPLETED|Overall Study||0
10196312|NCT03359395|11324526|FG001|STARTED|Second Intervention B/A||47
10196313|NCT03359395|11324525|FG000|COMPLETED|Second Intervention B/A||43
10196314|NCT03359395|11324526|FG001|COMPLETED|Second Intervention B/A||44
10196315|NCT03359395|11324525|FG000|NOT COMPLETED|Second Intervention B/A||3
10196316|NCT03359395|11324526|FG001|NOT COMPLETED|Second Intervention B/A||3
10196317|NCT03359473|11324536|FG000|STARTED|Overall Study||23
10196318|NCT03359473|11324537|FG001|STARTED|Overall Study||24
10196319|NCT03359473|11324538|FG002|STARTED|Overall Study||24
10196320|NCT03359473|11324539|FG003|STARTED|Overall Study||25
10196321|NCT03359473|11324536|FG000|COMPLETED|Overall Study||21
10196322|NCT03359473|11324537|FG001|COMPLETED|Overall Study||18
10196323|NCT03359473|11324538|FG002|COMPLETED|Overall Study||18
10196324|NCT03359473|11324539|FG003|COMPLETED|Overall Study||20
10196325|NCT03359473|11324536|FG000|NOT COMPLETED|Overall Study||2
10196326|NCT03359473|11324537|FG001|NOT COMPLETED|Overall Study||6
10196327|NCT03359473|11324538|FG002|NOT COMPLETED|Overall Study||6
10196328|NCT03359473|11324539|FG003|NOT COMPLETED|Overall Study||5
10196329|NCT03359590|11324552|FG000|STARTED|First Intervention||10
10196330|NCT03359590|11324553|FG001|STARTED|First Intervention||10
10196331|NCT03359590|11324552|FG000|Exposed|First Intervention||9
10196332|NCT03359590|11324553|FG001|Exposed|First Intervention||10
10196333|NCT03359590|11324552|FG000|Discontinued|First Intervention||1
10196334|NCT03359590|11324553|FG001|Discontinued|First Intervention||2
10124752|NCT02230254|11255723|FG000|STARTED|Overall Study||101
10124753|NCT02230254|11255723|FG000|COMPLETED|Overall Study||98
10124754|NCT02230254|11255723|FG000|NOT COMPLETED|Overall Study||3
10124755|NCT01909453|11255732|FG000|STARTED|Overall Study||192
10124756|NCT01909453|11255733|FG001|STARTED|Overall Study||194
10124757|NCT01909453|11255734|FG002|STARTED|Overall Study||191
10124758|NCT01909453|11255735|FG003|STARTED|Overall Study||258
10124759|NCT01909453|11255736|FG004|STARTED|Overall Study||86
10124760|NCT01909453|11255732|FG000|COMPLETED|Overall Study||0
10124761|NCT01909453|11255733|FG001|COMPLETED|Overall Study||0
10124762|NCT01909453|11255734|FG002|COMPLETED|Overall Study||0
10124763|NCT01909453|11255735|FG003|COMPLETED|Overall Study||0
10124764|NCT01909453|11255736|FG004|COMPLETED|Overall Study||0
10124765|NCT01909453|11255732|FG000|NOT COMPLETED|Overall Study||192
10124766|NCT01909453|11255733|FG001|NOT COMPLETED|Overall Study||194
10124767|NCT01909453|11255734|FG002|NOT COMPLETED|Overall Study||191
10124768|NCT01909453|11255735|FG003|NOT COMPLETED|Overall Study||258
10124769|NCT01909453|11255736|FG004|NOT COMPLETED|Overall Study||86
10124770|NCT01891396|11255757|FG000|STARTED|Overall Study||149
10124771|NCT01891396|11255758|FG001|STARTED|Overall Study||150
10124772|NCT01891396|11255759|FG002|STARTED|Overall Study||69
10124773|NCT01891396|11255757|FG000|Received Study Injection|Overall Study||149
10124774|NCT01891396|11255758|FG001|Received Study Injection|Overall Study||150
10124775|NCT01891396|11255759|FG002|Received Study Injection|Overall Study||69
10124776|NCT01891396|11255757|FG000|COMPLETED|Overall Study||145
10124777|NCT01891396|11255758|FG001|COMPLETED|Overall Study||145
10124778|NCT01891396|11255759|FG002|COMPLETED|Overall Study||66
10124779|NCT01891396|11255757|FG000|NOT COMPLETED|Overall Study||4
10124780|NCT01891396|11255758|FG001|NOT COMPLETED|Overall Study||5
10124781|NCT01891396|11255759|FG002|NOT COMPLETED|Overall Study||3
10124782|NCT01525901|11255775|FG000|STARTED|Period 1: 12 Weeks||5
10124783|NCT01525901|11255776|FG001|STARTED|Period 1: 12 Weeks||4
10124784|NCT01525901|11255777|FG002|STARTED|Period 1: 12 Weeks||5
10124785|NCT01525901|11255778|FG003|STARTED|Period 1: 12 Weeks||5
10124786|NCT01525901|11255775|FG000|COMPLETED|Period 1: 12 Weeks||5
10124787|NCT01525901|11255776|FG001|COMPLETED|Period 1: 12 Weeks||4
10124788|NCT01525901|11255777|FG002|COMPLETED|Period 1: 12 Weeks||5
10124789|NCT01525901|11255778|FG003|COMPLETED|Period 1: 12 Weeks||5
10124790|NCT01525901|11255775|FG000|NOT COMPLETED|Period 1: 12 Weeks||0
10124791|NCT01525901|11255776|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
10124792|NCT01525901|11255777|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
10124793|NCT01525901|11255778|FG003|NOT COMPLETED|Period 1: 12 Weeks||0
10124794|NCT01525901|11255775|FG000|STARTED|Washout 4 Weeks||5
10124795|NCT01525901|11255776|FG001|STARTED|Washout 4 Weeks||4
10124796|NCT01525901|11255777|FG002|STARTED|Washout 4 Weeks||5
10124797|NCT01525901|11255778|FG003|STARTED|Washout 4 Weeks||5
10124798|NCT01525901|11255775|FG000|COMPLETED|Washout 4 Weeks||5
10124799|NCT01525901|11255776|FG001|COMPLETED|Washout 4 Weeks||4
10124800|NCT01525901|11255777|FG002|COMPLETED|Washout 4 Weeks||5
10124801|NCT01525901|11255778|FG003|COMPLETED|Washout 4 Weeks||5
10124802|NCT01525901|11255775|FG000|NOT COMPLETED|Washout 4 Weeks||0
10124803|NCT01525901|11255776|FG001|NOT COMPLETED|Washout 4 Weeks||0
10124804|NCT01525901|11255777|FG002|NOT COMPLETED|Washout 4 Weeks||0
10124805|NCT01525901|11255778|FG003|NOT COMPLETED|Washout 4 Weeks||0
9706678|NCT03503617|10805768|FG000|COMPLETED|Overall Study||14
9706679|NCT03503617|10805769|FG001|COMPLETED|Overall Study||10
9706680|NCT03503617|10805768|FG000|NOT COMPLETED|Overall Study||0
9706681|NCT03503617|10805769|FG001|NOT COMPLETED|Overall Study||3
9706682|NCT03298867|10805777|FG000|STARTED|Double-Masked 24-Week Treatment Period||42
9706683|NCT03298867|10805778|FG001|STARTED|Double-Masked 24-Week Treatment Period||41
9706684|NCT03298867|10805777|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40
9706685|NCT03298867|10805778|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39
9706686|NCT03298867|10805777|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
9706687|NCT03298867|10805778|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
9706688|NCT03298867|10805777|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4
9706689|NCT03298867|10805778|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36
10124806|NCT01525901|11255775|FG000|STARTED|Period 2: 12 Weeks||5
10124807|NCT01525901|11255776|FG001|STARTED|Period 2: 12 Weeks||4
10124808|NCT01525901|11255777|FG002|STARTED|Period 2: 12 Weeks||5
10124809|NCT01525901|11255778|FG003|STARTED|Period 2: 12 Weeks||5
10124810|NCT01525901|11255775|FG000|COMPLETED|Period 2: 12 Weeks||5
10124811|NCT01525901|11255776|FG001|COMPLETED|Period 2: 12 Weeks||3
10124812|NCT01525901|11255777|FG002|COMPLETED|Period 2: 12 Weeks||5
10124813|NCT01525901|11255778|FG003|COMPLETED|Period 2: 12 Weeks||5
10124814|NCT01525901|11255775|FG000|NOT COMPLETED|Period 2: 12 Weeks||0
10124815|NCT01525901|11255776|FG001|NOT COMPLETED|Period 2: 12 Weeks||1
10124816|NCT01525901|11255777|FG002|NOT COMPLETED|Period 2: 12 Weeks||0
10124817|NCT01525901|11255778|FG003|NOT COMPLETED|Period 2: 12 Weeks||0
10124818|NCT01354431|11255791|FG000|STARTED|Pre-Treatment Period||60
10124819|NCT01354431|11255792|FG001|STARTED|Pre-Treatment Period||54
10124820|NCT01354431|11255793|FG002|STARTED|Pre-Treatment Period||54
10124821|NCT01354431|11255791|FG000|COMPLETED|Pre-Treatment Period||59
10124822|NCT01354431|11255792|FG001|COMPLETED|Pre-Treatment Period||54
10124823|NCT01354431|11255793|FG002|COMPLETED|Pre-Treatment Period||54
10124824|NCT01354431|11255791|FG000|NOT COMPLETED|Pre-Treatment Period||1
10124825|NCT01354431|11255792|FG001|NOT COMPLETED|Pre-Treatment Period||0
10124826|NCT01354431|11255793|FG002|NOT COMPLETED|Pre-Treatment Period||0
10124827|NCT01354431|11255791|FG000|STARTED|Treatment Period||59
10124828|NCT01354431|11255792|FG001|STARTED|Treatment Period||54
10124829|NCT01354431|11255793|FG002|STARTED|Treatment Period||54
10124830|NCT01354431|11255791|FG000|COMPLETED|Treatment Period||0
10124831|NCT01354431|11255792|FG001|COMPLETED|Treatment Period||0
10124832|NCT01354431|11255793|FG002|COMPLETED|Treatment Period||0
10124833|NCT01354431|11255791|FG000|NOT COMPLETED|Treatment Period||59
10124834|NCT01354431|11255792|FG001|NOT COMPLETED|Treatment Period||54
10124835|NCT01354431|11255793|FG002|NOT COMPLETED|Treatment Period||54
10124836|NCT01003691|11255805|FG000|STARTED|Overall Study||6
10124837|NCT01003691|11255806|FG001|STARTED|Overall Study||6
10124838|NCT01003691|11255807|FG002|STARTED|Overall Study||6
10124839|NCT01003691|11255808|FG003|STARTED|Overall Study||6
10124840|NCT01003691|11255805|FG000|COMPLETED|Overall Study||6
10124841|NCT01003691|11255806|FG001|COMPLETED|Overall Study||6
10124842|NCT01003691|11255807|FG002|COMPLETED|Overall Study||6
10124843|NCT01003691|11255808|FG003|COMPLETED|Overall Study||5
10124844|NCT01003691|11255805|FG000|NOT COMPLETED|Overall Study||0
10124845|NCT01003691|11255806|FG001|NOT COMPLETED|Overall Study||0
10124846|NCT01003691|11255807|FG002|NOT COMPLETED|Overall Study||0
10124847|NCT01003691|11255808|FG003|NOT COMPLETED|Overall Study||1
10124848|NCT02593903|11255821|FG000|STARTED|Overall Study||35
10124849|NCT02593903|11255822|FG001|STARTED|Overall Study||32
10124850|NCT02593903|11255821|FG000|COMPLETED|Overall Study||35
10124851|NCT02593903|11255822|FG001|COMPLETED|Overall Study||31
10124852|NCT02593903|11255821|FG000|NOT COMPLETED|Overall Study||0
10124853|NCT02593903|11255822|FG001|NOT COMPLETED|Overall Study||1
10124854|NCT02594098|11255830|FG000|STARTED|Overall Study||27
10124855|NCT02594098|11255831|FG001|STARTED|Overall Study||14
10124856|NCT02594098|11255830|FG000|COMPLETED|Overall Study||1
10124857|NCT02594098|11255831|FG001|COMPLETED|Overall Study||1
10124858|NCT02594098|11255830|FG000|NOT COMPLETED|Overall Study||26
10124859|NCT02594098|11255831|FG001|NOT COMPLETED|Overall Study||13
10124860|NCT02594111|11255841|FG000|STARTED|Overall Study||366
10124861|NCT02594111|11255842|FG001|STARTED|Overall Study||348
10124862|NCT02594111|11255841|FG000|COMPLETED|Overall Study||366
10124863|NCT02594111|11255842|FG001|COMPLETED|Overall Study||348
10124864|NCT02594111|11255841|FG000|NOT COMPLETED|Overall Study||0
10124865|NCT02594111|11255842|FG001|NOT COMPLETED|Overall Study||0
10124866|NCT02594163|11255850|FG000|STARTED|Treatment Period||12
10124867|NCT02594163|11255851|FG001|STARTED|Treatment Period||13
10124868|NCT02594163|11255850|FG000|COMPLETED|Treatment Period||5
10124869|NCT02594163|11255851|FG001|COMPLETED|Treatment Period||1
10124870|NCT02594163|11255850|FG000|NOT COMPLETED|Treatment Period||7
10124871|NCT02594163|11255851|FG001|NOT COMPLETED|Treatment Period||12
10124872|NCT02594163|11255850|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12
10124873|NCT02594163|11255851|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13
10124874|NCT02594163|11255850|FG000|COMPLETED|Follow-up Period||1
10124875|NCT02594163|11255851|FG001|COMPLETED|Follow-up Period||1
10124876|NCT02594163|11255850|FG000|NOT COMPLETED|Follow-up Period||11
10124877|NCT02594163|11255851|FG001|NOT COMPLETED|Follow-up Period||12
10124878|NCT02594644|11255859|FG000|STARTED|Overall Study||16
10124879|NCT02594644|11255860|FG001|STARTED|Overall Study||16
10124880|NCT02594644|11255859|FG000|COMPLETED|Overall Study||16
10124881|NCT02594644|11255860|FG001|COMPLETED|Overall Study||15
10124882|NCT02594644|11255859|FG000|NOT COMPLETED|Overall Study||0
10124883|NCT02594644|11255860|FG001|NOT COMPLETED|Overall Study||1
10124884|NCT02594826|11255878|FG000|STARTED|Overall Study||347
10124885|NCT02594826|11255879|FG001|STARTED|Overall Study||358
10124886|NCT02594826|11255878|FG000|COMPLETED|Overall Study||290
10124887|NCT02594826|11255879|FG001|COMPLETED|Overall Study||298
10124888|NCT02594826|11255878|FG000|NOT COMPLETED|Overall Study||57
10124889|NCT02594826|11255879|FG001|NOT COMPLETED|Overall Study||60
10124890|NCT02595008|11255887|FG000|STARTED|Overall Study||20
10124891|NCT02595008|11255888|FG001|STARTED|Overall Study||4
10124892|NCT02595008|11255887|FG000|COMPLETED|Overall Study||19
10124893|NCT02595008|11255888|FG001|COMPLETED|Overall Study||4
10124894|NCT02595008|11255887|FG000|NOT COMPLETED|Overall Study||1
10124895|NCT02595008|11255888|FG001|NOT COMPLETED|Overall Study||0
10124896|NCT02595073|11255896|FG000|STARTED|Overall Study||61
10124897|NCT02595073|11255897|FG001|STARTED|Overall Study||63
10124898|NCT02595073|11255896|FG000|COMPLETED|Overall Study||59
10124899|NCT02595073|11255897|FG001|COMPLETED|Overall Study||62
10124900|NCT02595073|11255896|FG000|NOT COMPLETED|Overall Study||2
10124901|NCT02595073|11255897|FG001|NOT COMPLETED|Overall Study||1
10124902|NCT02595398|11255905|FG000|STARTED|Overall Study||96
10124903|NCT02595398|11255906|FG001|STARTED|Overall Study||64
10124904|NCT02595398|11255905|FG000|Intention-to-Treat (ITT) Population|Overall Study||96
10124905|NCT02595398|11255906|FG001|Intention-to-Treat (ITT) Population|Overall Study||64
10124906|NCT02595398|11255905|FG000|Safety Population|Overall Study||96
10124907|NCT02595398|11255906|FG001|Safety Population|Overall Study||64
10124908|NCT02595398|11255905|FG000|COMPLETED|Overall Study||92
10124909|NCT02595398|11255906|FG001|COMPLETED|Overall Study||63
10124910|NCT02595398|11255905|FG000|NOT COMPLETED|Overall Study||4
10124911|NCT02595398|11255906|FG001|NOT COMPLETED|Overall Study||1
10124912|NCT02595437|11255912|FG000|STARTED|Triferic Via IV||22
10124913|NCT02595437|11255912|FG000|COMPLETED|Triferic Via IV||21
10124914|NCT02595437|11255912|FG000|NOT COMPLETED|Triferic Via IV||1
10124915|NCT02595437|11255912|FG000|STARTED|Triferic Via Hemodialysate||21
10124916|NCT02595437|11255912|FG000|COMPLETED|Triferic Via Hemodialysate||21
10124917|NCT02595437|11255912|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0
10124918|NCT02595450|11255924|FG000|STARTED|Overall Study||299
10124919|NCT02595450|11255924|FG000|Treated|Overall Study||291
10124920|NCT02595450|11255924|FG000|COMPLETED|Overall Study||218
10124921|NCT02595450|11255924|FG000|NOT COMPLETED|Overall Study||81
10124922|NCT02595502|11255928|FG000|STARTED|Period 1||143
10124923|NCT02595502|11255929|FG001|STARTED|Period 1||142
10124924|NCT02595502|11255928|FG000|COMPLETED|Period 1||142
10124925|NCT02595502|11255929|FG001|COMPLETED|Period 1||140
10124926|NCT02595502|11255928|FG000|NOT COMPLETED|Period 1||1
10124927|NCT02595502|11255929|FG001|NOT COMPLETED|Period 1||2
10124928|NCT02595502|11255928|FG000|STARTED|Period 2||142
10124929|NCT02595502|11255929|FG001|STARTED|Period 2||140
10124930|NCT02595502|11255928|FG000|COMPLETED|Period 2||141
10124931|NCT02595502|11255929|FG001|COMPLETED|Period 2||138
10124932|NCT02595502|11255928|FG000|NOT COMPLETED|Period 2||1
10124933|NCT02595502|11255929|FG001|NOT COMPLETED|Period 2||2
10124934|NCT02595502|11255928|FG000|STARTED|Period 3||141
10124935|NCT02595502|11255929|FG001|STARTED|Period 3||138
10124936|NCT02595502|11255928|FG000|COMPLETED|Period 3||140
10124937|NCT02595502|11255929|FG001|COMPLETED|Period 3||136
10124938|NCT02595502|11255928|FG000|NOT COMPLETED|Period 3||1
10124939|NCT02595502|11255929|FG001|NOT COMPLETED|Period 3||2
10124940|NCT02595528|11255939|FG000|STARTED|Overall Study||41
10124941|NCT02595528|11255940|FG001|STARTED|Overall Study||40
10124942|NCT02595528|11255941|FG002|STARTED|Overall Study||42
10124943|NCT02595528|11255942|FG003|STARTED|Overall Study||40
10124944|NCT02595528|11255939|FG000|COMPLETED|Overall Study||39
10124945|NCT02595528|11255940|FG001|COMPLETED|Overall Study||37
10124946|NCT02595528|11255941|FG002|COMPLETED|Overall Study||41
10124947|NCT02595528|11255942|FG003|COMPLETED|Overall Study||36
10124948|NCT02595528|11255939|FG000|NOT COMPLETED|Overall Study||2
10124949|NCT02595528|11255940|FG001|NOT COMPLETED|Overall Study||3
10124950|NCT02595528|11255941|FG002|NOT COMPLETED|Overall Study||1
10124951|NCT02595528|11255942|FG003|NOT COMPLETED|Overall Study||4
10124952|NCT02595567|11255952|FG000|STARTED|Overall Study||25
10124953|NCT02595567|11255952|FG000|COMPLETED|Overall Study||25
10124954|NCT02595567|11255952|FG000|NOT COMPLETED|Overall Study||0
10124955|NCT02595684|11255958|FG000|STARTED|Overall Study||9
10124956|NCT02595684|11255959|FG001|STARTED|Overall Study||9
10124957|NCT02595684|11255958|FG000|COMPLETED|Overall Study||9
10124958|NCT02595684|11255959|FG001|COMPLETED|Overall Study||9
10124959|NCT02595684|11255958|FG000|NOT COMPLETED|Overall Study||0
10124960|NCT02595684|11255959|FG001|NOT COMPLETED|Overall Study||0
10124961|NCT02595723|11255968|FG000|STARTED|First Intervention (4 Days)||8
10124962|NCT02595723|11255969|FG001|STARTED|First Intervention (4 Days)||6
10124963|NCT02595723|11255970|FG002|STARTED|First Intervention (4 Days)||7
10124964|NCT02595723|11255968|FG000|COMPLETED|First Intervention (4 Days)||8
10124965|NCT02595723|11255969|FG001|COMPLETED|First Intervention (4 Days)||6
10124966|NCT02595723|11255970|FG002|COMPLETED|First Intervention (4 Days)||7
10124967|NCT02595723|11255968|FG000|NOT COMPLETED|First Intervention (4 Days)||0
10124968|NCT02595723|11255969|FG001|NOT COMPLETED|First Intervention (4 Days)||0
10124969|NCT02595723|11255970|FG002|NOT COMPLETED|First Intervention (4 Days)||0
10124970|NCT02595723|11255968|FG000|STARTED|First Washout (21 Days)||8
10124971|NCT02595723|11255969|FG001|STARTED|First Washout (21 Days)||6
10124972|NCT02595723|11255970|FG002|STARTED|First Washout (21 Days)||7
10124973|NCT02595723|11255968|FG000|COMPLETED|First Washout (21 Days)||6
10124974|NCT02595723|11255969|FG001|COMPLETED|First Washout (21 Days)||6
10124975|NCT02595723|11255970|FG002|COMPLETED|First Washout (21 Days)||7
10124976|NCT02595723|11255968|FG000|NOT COMPLETED|First Washout (21 Days)||2
10124977|NCT02595723|11255969|FG001|NOT COMPLETED|First Washout (21 Days)||0
10124978|NCT02595723|11255970|FG002|NOT COMPLETED|First Washout (21 Days)||0
10124979|NCT02595723|11255968|FG000|STARTED|Second Intervention (4 Days)||6
10124980|NCT02595723|11255969|FG001|STARTED|Second Intervention (4 Days)||6
10124981|NCT02595723|11255970|FG002|STARTED|Second Intervention (4 Days)||7
10124982|NCT02595723|11255968|FG000|COMPLETED|Second Intervention (4 Days)||6
10124983|NCT02595723|11255969|FG001|COMPLETED|Second Intervention (4 Days)||6
10124984|NCT02595723|11255970|FG002|COMPLETED|Second Intervention (4 Days)||7
10124985|NCT02595723|11255968|FG000|NOT COMPLETED|Second Intervention (4 Days)||0
10124986|NCT02595723|11255969|FG001|NOT COMPLETED|Second Intervention (4 Days)||0
10124987|NCT02595723|11255970|FG002|NOT COMPLETED|Second Intervention (4 Days)||0
10124988|NCT02595723|11255968|FG000|STARTED|Second Washout (21 Days)||6
10124989|NCT02595723|11255969|FG001|STARTED|Second Washout (21 Days)||6
10124990|NCT02595723|11255970|FG002|STARTED|Second Washout (21 Days)||7
10124991|NCT02595723|11255968|FG000|COMPLETED|Second Washout (21 Days)||6
10124992|NCT02595723|11255969|FG001|COMPLETED|Second Washout (21 Days)||5
10124993|NCT02595723|11255970|FG002|COMPLETED|Second Washout (21 Days)||7
10124994|NCT02595723|11255968|FG000|NOT COMPLETED|Second Washout (21 Days)||0
10124995|NCT02595723|11255969|FG001|NOT COMPLETED|Second Washout (21 Days)||1
10124996|NCT02595723|11255970|FG002|NOT COMPLETED|Second Washout (21 Days)||0
10124997|NCT02595723|11255968|FG000|STARTED|Third Intervention (4 Days)||6
10124998|NCT02595723|11255969|FG001|STARTED|Third Intervention (4 Days)||5
9706690|NCT03298867|10805777|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3
9706691|NCT03298867|10805778|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20
10124999|NCT02595723|11255970|FG002|STARTED|Third Intervention (4 Days)||7
10125000|NCT02595723|11255968|FG000|COMPLETED|Third Intervention (4 Days)||6
10125001|NCT02595723|11255969|FG001|COMPLETED|Third Intervention (4 Days)||5
10125002|NCT02595723|11255970|FG002|COMPLETED|Third Intervention (4 Days)||7
10125003|NCT02595723|11255968|FG000|NOT COMPLETED|Third Intervention (4 Days)||0
10125004|NCT02595723|11255969|FG001|NOT COMPLETED|Third Intervention (4 Days)||0
10125005|NCT02595723|11255970|FG002|NOT COMPLETED|Third Intervention (4 Days)||0
10125006|NCT02595749|11255980|FG000|STARTED|Overall Study||45
10125007|NCT02595749|11255981|FG001|STARTED|Overall Study||38
10125008|NCT02595749|11255980|FG000|COMPLETED|Overall Study||33
10125009|NCT02595749|11255981|FG001|COMPLETED|Overall Study||31
10125010|NCT02595749|11255980|FG000|NOT COMPLETED|Overall Study||12
10125011|NCT02595749|11255981|FG001|NOT COMPLETED|Overall Study||7
10125012|NCT02595970|11255987|FG000|STARTED|Overall Study||120
10125013|NCT02595970|11255987|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
10125014|NCT02595970|11255987|FG000|NOT COMPLETED|Overall Study||20
10125015|NCT02595983|11255991|FG000|STARTED|Overall Study||12
10125016|NCT02595983|11255991|FG000|COMPLETED|Overall Study||8
10125017|NCT02595983|11255991|FG000|NOT COMPLETED|Overall Study||4
10125018|NCT02596009|11255996|FG000|STARTED|Overall Study||14
10125019|NCT02596009|11255997|FG001|STARTED|Overall Study||16
10125020|NCT02596009|11255998|FG002|STARTED|Overall Study||16
10125021|NCT02596009|11255999|FG003|STARTED|Overall Study||16
10125022|NCT02596009|11256000|FG004|STARTED|Overall Study||18
10125023|NCT02596009|11256001|FG005|STARTED|Overall Study||17
10125024|NCT02596009|11255996|FG000|COMPLETED|Overall Study||14
10125025|NCT02596009|11255997|FG001|COMPLETED|Overall Study||15
10125026|NCT02596009|11255998|FG002|COMPLETED|Overall Study||16
10125027|NCT02596009|11255999|FG003|COMPLETED|Overall Study||16
10125028|NCT02596009|11256000|FG004|COMPLETED|Overall Study||18
10125029|NCT02596009|11256001|FG005|COMPLETED|Overall Study||17
10125030|NCT02596009|11255996|FG000|NOT COMPLETED|Overall Study||0
10125031|NCT02596009|11255997|FG001|NOT COMPLETED|Overall Study||1
10125032|NCT02596009|11255998|FG002|NOT COMPLETED|Overall Study||0
10125033|NCT02596009|11255999|FG003|NOT COMPLETED|Overall Study||0
10125034|NCT02596009|11256000|FG004|NOT COMPLETED|Overall Study||0
10125035|NCT02596009|11256001|FG005|NOT COMPLETED|Overall Study||0
10125036|NCT02596022|11256009|FG000|STARTED|Overall Study||10
10125037|NCT02596022|11256010|FG001|STARTED|Overall Study||8
10125038|NCT02596022|11256009|FG000|COMPLETED|Overall Study||10
10060379|NCT02097472|11185907|FG000|NOT COMPLETED|Received Vaccination 1||0
10060380|NCT02097472|11185908|FG001|NOT COMPLETED|Received Vaccination 1||0
10060381|NCT02097472|11185909|FG002|NOT COMPLETED|Received Vaccination 1||0
10060382|NCT02097472|11185910|FG003|NOT COMPLETED|Received Vaccination 1||0
10060383|NCT02097472|11185911|FG004|NOT COMPLETED|Received Vaccination 1||0
10060384|NCT02097472|11185912|FG005|NOT COMPLETED|Received Vaccination 1||0
10060385|NCT02097472|11185913|FG006|NOT COMPLETED|Received Vaccination 1||0
10125039|NCT02596022|11256010|FG001|COMPLETED|Overall Study||8
10125040|NCT02596022|11256009|FG000|NOT COMPLETED|Overall Study||0
10125041|NCT02596022|11256010|FG001|NOT COMPLETED|Overall Study||0
10125042|NCT02596230|11256021|FG000|STARTED|Objective 1, One Visit During 14 Days||3714
10125043|NCT02596230|11256022|FG001|STARTED|Objective 1, One Visit During 14 Days||1006
10125044|NCT02596230|11256023|FG002|STARTED|Objective 1, One Visit During 14 Days||0
10125045|NCT02596230|11256024|FG003|STARTED|Objective 1, One Visit During 14 Days||1375
10125046|NCT02596230|11256025|FG004|STARTED|Objective 1, One Visit During 14 Days||0
10125047|NCT02596230|11256021|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714
10125048|NCT02596230|11256022|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006
10125049|NCT02596230|11256023|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0
10125050|NCT02596230|11256024|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375
10125051|NCT02596230|11256025|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0
10125052|NCT02596230|11256021|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10125053|NCT02596230|11256022|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10125054|NCT02596230|11256023|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
9848671|NCT00861146|10961429|FG000|Week 13 Assessment|Overall Study||85
9848672|NCT00861146|10961430|FG001|Week 13 Assessment|Overall Study||38
9848673|NCT00861146|10961429|FG000|COMPLETED|Overall Study||85
9848674|NCT00861146|10961430|FG001|COMPLETED|Overall Study||38
9848675|NCT00861146|10961429|FG000|NOT COMPLETED|Overall Study||20
9848676|NCT00861146|10961430|FG001|NOT COMPLETED|Overall Study||8
9848677|NCT00861198|10961436|FG000|STARTED|Overall Study||75
9848678|NCT00861198|10961436|FG000|COMPLETED|Overall Study||70
9848679|NCT00861198|10961436|FG000|NOT COMPLETED|Overall Study||5
9848680|NCT00861263|10961440|FG000|STARTED|Overall Study||193
9848681|NCT00861263|10961440|FG000|COMPLETED|Overall Study||193
9848682|NCT00861263|10961440|FG000|NOT COMPLETED|Overall Study||0
9848683|NCT00861341|10961444|FG000|STARTED|Overall Study||40
9848684|NCT00861341|10961444|FG000|COMPLETED|Overall Study||38
9848685|NCT00861341|10961444|FG000|NOT COMPLETED|Overall Study||2
9848686|NCT00861380|10961455|FG000|STARTED|Overall Study||8427
9848687|NCT00861380|10961456|FG001|STARTED|Overall Study||9112
9848688|NCT00861380|10961457|FG002|STARTED|Overall Study||8872
9848689|NCT00861380|10961458|FG003|STARTED|Overall Study||3689
9848690|NCT00861380|10961459|FG004|STARTED|Overall Study||1812
9848691|NCT00861380|10961460|FG005|STARTED|Overall Study||6249
9848692|NCT00861380|10961461|FG006|STARTED|Overall Study||3020
10060386|NCT02097472|11185914|FG007|NOT COMPLETED|Received Vaccination 1||0
10060387|NCT02097472|11185907|FG000|STARTED|Received Vaccination 2||18
10060388|NCT02097472|11185908|FG001|STARTED|Received Vaccination 2||18
10060389|NCT02097472|11185909|FG002|STARTED|Received Vaccination 2||18
10060390|NCT02097472|11185910|FG003|STARTED|Received Vaccination 2||50
10060391|NCT02097472|11185911|FG004|STARTED|Received Vaccination 2||50
10125055|NCT02596230|11256024|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10125056|NCT02596230|11256025|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10125057|NCT02596230|11256021|FG000|STARTED|Screening Period for Objective 2||3714
10125058|NCT02596230|11256022|FG001|STARTED|Screening Period for Objective 2||1006
10125059|NCT02596230|11256023|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
10125060|NCT02596230|11256024|FG003|STARTED|Screening Period for Objective 2||1375
10125061|NCT02596230|11256025|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
10125062|NCT02596230|11256021|FG000|COMPLETED|Screening Period for Objective 2||0
10125063|NCT02596230|11256022|FG001|COMPLETED|Screening Period for Objective 2||778
10125064|NCT02596230|11256023|FG002|COMPLETED|Screening Period for Objective 2||910
10125065|NCT02596230|11256024|FG003|COMPLETED|Screening Period for Objective 2||529
10125066|NCT02596230|11256025|FG004|COMPLETED|Screening Period for Objective 2||792
10125067|NCT02596230|11256021|FG000|NOT COMPLETED|Screening Period for Objective 2||3714
10125068|NCT02596230|11256022|FG001|NOT COMPLETED|Screening Period for Objective 2||228
10125069|NCT02596230|11256023|FG002|NOT COMPLETED|Screening Period for Objective 2||0
10125070|NCT02596230|11256024|FG003|NOT COMPLETED|Screening Period for Objective 2||846
10125071|NCT02596230|11256025|FG004|NOT COMPLETED|Screening Period for Objective 2||0
10125072|NCT02596230|11256021|FG000|STARTED|Objective 2, One Year||0
10125073|NCT02596230|11256022|FG001|STARTED|Objective 2, One Year||778
10125074|NCT02596230|11256023|FG002|STARTED|Objective 2, One Year||910
10125075|NCT02596230|11256024|FG003|STARTED|Objective 2, One Year||529
10125076|NCT02596230|11256025|FG004|STARTED|Objective 2, One Year||792
10125077|NCT02596230|11256021|FG000|COMPLETED|Objective 2, One Year||0
10125078|NCT02596230|11256022|FG001|COMPLETED|Objective 2, One Year||710
10125079|NCT02596230|11256023|FG002|COMPLETED|Objective 2, One Year||812
10125080|NCT02596230|11256024|FG003|COMPLETED|Objective 2, One Year||471
10125081|NCT02596230|11256025|FG004|COMPLETED|Objective 2, One Year||714
10125082|NCT02596230|11256021|FG000|NOT COMPLETED|Objective 2, One Year||0
10125083|NCT02596230|11256022|FG001|NOT COMPLETED|Objective 2, One Year||68
10125084|NCT02596230|11256023|FG002|NOT COMPLETED|Objective 2, One Year||98
10125085|NCT02596230|11256024|FG003|NOT COMPLETED|Objective 2, One Year||58
10125086|NCT02596230|11256025|FG004|NOT COMPLETED|Objective 2, One Year||78
10125087|NCT02596321|11256037|FG000|STARTED|Overall Study||56
10125088|NCT02596321|11256038|FG001|STARTED|Overall Study||56
10125089|NCT02596321|11256037|FG000|COMPLETED|Overall Study||53
10125090|NCT02596321|11256038|FG001|COMPLETED|Overall Study||56
10125091|NCT02596321|11256037|FG000|NOT COMPLETED|Overall Study||3
10125092|NCT02596321|11256038|FG001|NOT COMPLETED|Overall Study||0
10125093|NCT02596451|11256047|FG000|STARTED|Overall Study||385
10125094|NCT02596451|11256048|FG001|STARTED|Overall Study||392
10125095|NCT02596451|11256049|FG002|STARTED|Overall Study||387
10125096|NCT02596451|11256047|FG000|COMPLETED|Overall Study||381
10125097|NCT02596451|11256048|FG001|COMPLETED|Overall Study||374
10125098|NCT02596451|11256049|FG002|COMPLETED|Overall Study||373
10125099|NCT02596451|11256047|FG000|NOT COMPLETED|Overall Study||4
10125100|NCT02596451|11256048|FG001|NOT COMPLETED|Overall Study||18
10125101|NCT02596451|11256049|FG002|NOT COMPLETED|Overall Study||14
10125102|NCT02596620|11256058|FG000|STARTED|Overall Study|Started from 1st October 2013|82
10125103|NCT02596620|11256059|FG001|STARTED|Overall Study|Started from 1st October 2013|82
10125104|NCT02596620|11256058|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81
10125105|NCT02596620|11256059|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81
10125106|NCT02596620|11256058|FG000|NOT COMPLETED|Overall Study||1
10125107|NCT02596620|11256059|FG001|NOT COMPLETED|Overall Study||1
10125108|NCT02596711|11256068|FG000|STARTED|Overall Study||9
10125109|NCT02596711|11256069|FG001|STARTED|Overall Study||8
10125110|NCT02596711|11256070|FG002|STARTED|Overall Study||8
10125111|NCT02596711|11256068|FG000|Visit 2|Overall Study||9
10125112|NCT02596711|11256069|FG001|Visit 2|Overall Study||7
10125113|NCT02596711|11256070|FG002|Visit 2|Overall Study||6
10125114|NCT02596711|11256068|FG000|Visit 3|Overall Study||7
10125115|NCT02596711|11256069|FG001|Visit 3|Overall Study||8
10125116|NCT02596711|11256070|FG002|Visit 3|Overall Study||6
10125117|NCT02596711|11256068|FG000|3 Month Follow-up|Overall Study||8
10125118|NCT02596711|11256069|FG001|3 Month Follow-up|Overall Study||6
10125119|NCT02596711|11256070|FG002|3 Month Follow-up|Overall Study||6
10125120|NCT02596711|11256068|FG000|6 Month Follow-up|Overall Study||8
10125121|NCT02596711|11256069|FG001|6 Month Follow-up|Overall Study||6
10125122|NCT02596711|11256070|FG002|6 Month Follow-up|Overall Study||5
10125123|NCT02596711|11256068|FG000|COMPLETED|Overall Study||8
10125124|NCT02596711|11256069|FG001|COMPLETED|Overall Study||6
10125125|NCT02596711|11256070|FG002|COMPLETED|Overall Study||5
10125126|NCT02596711|11256068|FG000|NOT COMPLETED|Overall Study||1
10125127|NCT02596711|11256069|FG001|NOT COMPLETED|Overall Study||2
10125128|NCT02596711|11256070|FG002|NOT COMPLETED|Overall Study||3
10125129|NCT02596750|11256080|FG000|STARTED|Baseline||21
10125130|NCT02596750|11256081|FG001|STARTED|Baseline||21
10125131|NCT02596750|11256080|FG000|COMPLETED|Baseline||21
10125132|NCT02596750|11256081|FG001|COMPLETED|Baseline||21
10125133|NCT02596750|11256080|FG000|NOT COMPLETED|Baseline||0
10125134|NCT02596750|11256081|FG001|NOT COMPLETED|Baseline||0
10125135|NCT02596750|11256080|FG000|STARTED|2 Minutes||21
10125136|NCT02596750|11256081|FG001|STARTED|2 Minutes||21
10125137|NCT02596750|11256080|FG000|COMPLETED|2 Minutes||21
10125138|NCT02596750|11256081|FG001|COMPLETED|2 Minutes||21
10125139|NCT02596750|11256080|FG000|NOT COMPLETED|2 Minutes||0
10125140|NCT02596750|11256081|FG001|NOT COMPLETED|2 Minutes||0
10125141|NCT02596750|11256080|FG000|STARTED|5 Minutes||21
10125142|NCT02596750|11256081|FG001|STARTED|5 Minutes||21
10125143|NCT02596750|11256080|FG000|COMPLETED|5 Minutes||21
10125144|NCT02596750|11256081|FG001|COMPLETED|5 Minutes||21
10125145|NCT02596750|11256080|FG000|NOT COMPLETED|5 Minutes||0
10125146|NCT02596750|11256081|FG001|NOT COMPLETED|5 Minutes||0
10125147|NCT02596750|11256080|FG000|STARTED|10 Minutes||21
10125148|NCT02596750|11256081|FG001|STARTED|10 Minutes||21
10125149|NCT02596750|11256080|FG000|COMPLETED|10 Minutes||21
10125150|NCT02596750|11256081|FG001|COMPLETED|10 Minutes||21
10125151|NCT02596750|11256080|FG000|NOT COMPLETED|10 Minutes||0
10125152|NCT02596750|11256081|FG001|NOT COMPLETED|10 Minutes||0
10125153|NCT02596750|11256080|FG000|STARTED|30 Minutes||21
10125154|NCT02596750|11256081|FG001|STARTED|30 Minutes||21
10125155|NCT02596750|11256080|FG000|COMPLETED|30 Minutes||21
10125156|NCT02596750|11256081|FG001|COMPLETED|30 Minutes||21
10125157|NCT02596750|11256080|FG000|NOT COMPLETED|30 Minutes||0
10125158|NCT02596750|11256081|FG001|NOT COMPLETED|30 Minutes||0
10125159|NCT02596854|11256088|FG000|STARTED|Overall Study||117
10125160|NCT02596854|11256088|FG000|COMPLETED|Overall Study||109
10125161|NCT02596854|11256088|FG000|NOT COMPLETED|Overall Study||8
10125162|NCT02596867|11256092|FG000|STARTED|Overall Study||2
10125163|NCT02596867|11256092|FG000|2 Patients Prospectively Recruited|Overall Study||2
10125164|NCT02596867|11256092|FG000|COMPLETED|Overall Study||2
10125165|NCT02596867|11256092|FG000|NOT COMPLETED|Overall Study||0
10125166|NCT02596893|11256101|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174
10125167|NCT02596893|11256102|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176
10125168|NCT02596893|11256103|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176
10125169|NCT02596893|11256104|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175
10125170|NCT02596893|11256101|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
10125171|NCT02596893|11256102|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
10125172|NCT02596893|11256103|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
10125173|NCT02596893|11256104|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
10125174|NCT02596893|11256101|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
10125175|NCT02596893|11256102|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
10125176|NCT02596893|11256103|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
10125177|NCT02596893|11256104|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
10125178|NCT02596893|11256101|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57
10125179|NCT02596893|11256102|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51
10125180|NCT02596893|11256103|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56
10125181|NCT02596893|11256104|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47
10125182|NCT02596893|11256101|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57
10125183|NCT02596893|11256102|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51
10125184|NCT02596893|11256103|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56
10125185|NCT02596893|11256104|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47
10125186|NCT02596893|11256101|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10125187|NCT02596893|11256102|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10125188|NCT02596893|11256103|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10125189|NCT02596893|11256104|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10125190|NCT02596906|11256116|FG000|STARTED|Overall Study||12
10125191|NCT02596906|11256117|FG001|STARTED|Overall Study||10
10125192|NCT02596906|11256116|FG000|COMPLETED|Overall Study||8
10125193|NCT02596906|11256117|FG001|COMPLETED|Overall Study||7
10125194|NCT02596906|11256116|FG000|NOT COMPLETED|Overall Study||4
10125195|NCT02596906|11256117|FG001|NOT COMPLETED|Overall Study||3
10125196|NCT02596945|11256123|FG000|STARTED|Overall Study||223
10125197|NCT02596945|11256123|FG000|Treated|Overall Study||220
10125198|NCT02596945|11256123|FG000|COMPLETED|Overall Study||167
10125199|NCT02596945|11256123|FG000|NOT COMPLETED|Overall Study||56
10125200|NCT02596958|11256127|FG000|STARTED|Overall Study||996
10125201|NCT02596958|11256127|FG000|COMPLETED|Overall Study||0
10125202|NCT02596958|11256127|FG000|NOT COMPLETED|Overall Study||996
10125203|NCT02596971|11256134|FG000|STARTED|Overall Study||42
10125204|NCT02596971|11256135|FG001|STARTED|Overall Study||7
10125205|NCT02596971|11256136|FG002|STARTED|Overall Study||42
10125206|NCT02596971|11256134|FG000|COMPLETED|Overall Study||32
10125207|NCT02596971|11256135|FG001|COMPLETED|Overall Study||5
10125208|NCT02596971|11256136|FG002|COMPLETED|Overall Study||33
10125209|NCT02596971|11256134|FG000|NOT COMPLETED|Overall Study||10
10125210|NCT02596971|11256135|FG001|NOT COMPLETED|Overall Study||2
10125211|NCT02596971|11256136|FG002|NOT COMPLETED|Overall Study||9
10125212|NCT02597049|11256150|FG000|STARTED|Overall Study||142
10125213|NCT02597049|11256151|FG001|STARTED|Overall Study||142
10125214|NCT02597049|11256152|FG002|STARTED|Overall Study||140
10125215|NCT02597049|11256150|FG000|Received at Least One Dose of Study Drug|Overall Study||142
10125216|NCT02597049|11256151|FG001|Received at Least One Dose of Study Drug|Overall Study||141
10125217|NCT02597049|11256152|FG002|Received at Least One Dose of Study Drug|Overall Study||140
10125218|NCT02597049|11256150|FG000|COMPLETED|Overall Study||135
10125219|NCT02597049|11256151|FG001|COMPLETED|Overall Study||137
10125220|NCT02597049|11256152|FG002|COMPLETED|Overall Study||137
10125221|NCT02597049|11256150|FG000|NOT COMPLETED|Overall Study||7
10125222|NCT02597049|11256151|FG001|NOT COMPLETED|Overall Study||5
10125223|NCT02597049|11256152|FG002|NOT COMPLETED|Overall Study||3
10125224|NCT02597101|11256162|FG000|STARTED|Overall Study||4
10125225|NCT02597101|11256163|FG001|STARTED|Overall Study||5
10125226|NCT02597101|11256162|FG000|COMPLETED|Overall Study||4
10125227|NCT02597101|11256163|FG001|COMPLETED|Overall Study||5
10125228|NCT02597101|11256162|FG000|NOT COMPLETED|Overall Study||0
10125229|NCT02597101|11256163|FG001|NOT COMPLETED|Overall Study||0
10125230|NCT02597127|11256177|FG000|STARTED|Overall Study||60
10125231|NCT02597127|11256178|FG001|STARTED|Overall Study||62
10125232|NCT02597127|11256179|FG002|STARTED|Overall Study||66
10125233|NCT02597127|11256180|FG003|STARTED|Overall Study||65
10125234|NCT02597127|11256181|FG004|STARTED|Overall Study||62
10125235|NCT02597127|11256182|FG005|STARTED|Overall Study||63
10125236|NCT02597127|11256183|FG006|STARTED|Overall Study||61
10125237|NCT02597127|11256184|FG007|STARTED|Overall Study||62
10125238|NCT02597127|11256177|FG000|Treated|Overall Study||60
10125239|NCT02597127|11256178|FG001|Treated|Overall Study||61
10125240|NCT02597127|11256179|FG002|Treated|Overall Study||65
10125241|NCT02597127|11256180|FG003|Treated|Overall Study||65
10125242|NCT02597127|11256181|FG004|Treated|Overall Study||61
10125243|NCT02597127|11256182|FG005|Treated|Overall Study||62
10125244|NCT02597127|11256183|FG006|Treated|Overall Study||61
10125245|NCT02597127|11256184|FG007|Treated|Overall Study||62
10125246|NCT02597127|11256177|FG000|COMPLETED|Overall Study||59
10125247|NCT02597127|11256178|FG001|COMPLETED|Overall Study||59
10125248|NCT02597127|11256179|FG002|COMPLETED|Overall Study||58
10125249|NCT02597127|11256180|FG003|COMPLETED|Overall Study||60
10125250|NCT02597127|11256181|FG004|COMPLETED|Overall Study||57
10125251|NCT02597127|11256182|FG005|COMPLETED|Overall Study||59
10125252|NCT02597127|11256183|FG006|COMPLETED|Overall Study||57
10125253|NCT02597127|11256184|FG007|COMPLETED|Overall Study||60
10125254|NCT02597127|11256177|FG000|NOT COMPLETED|Overall Study||1
10125255|NCT02597127|11256178|FG001|NOT COMPLETED|Overall Study||3
10125256|NCT02597127|11256179|FG002|NOT COMPLETED|Overall Study||8
10125257|NCT02597127|11256180|FG003|NOT COMPLETED|Overall Study||5
10125258|NCT02597127|11256181|FG004|NOT COMPLETED|Overall Study||5
10125259|NCT02597127|11256182|FG005|NOT COMPLETED|Overall Study||4
10125260|NCT02597127|11256183|FG006|NOT COMPLETED|Overall Study||4
10125261|NCT02597127|11256184|FG007|NOT COMPLETED|Overall Study||2
10125262|NCT02597452|11256223|FG000|STARTED|Overall Study||516
10125263|NCT02597452|11256223|FG000|COMPLETED|Overall Study||486
10125264|NCT02597452|11256223|FG000|NOT COMPLETED|Overall Study||30
10125265|NCT02597478|11256229|FG000|STARTED|Overall Study||16
10125266|NCT02597478|11256230|FG001|STARTED|Overall Study||18
10125267|NCT02597478|11256229|FG000|COMPLETED|Overall Study||13
10125268|NCT02597478|11256230|FG001|COMPLETED|Overall Study||17
10125269|NCT02597478|11256229|FG000|NOT COMPLETED|Overall Study||3
10125270|NCT02597478|11256230|FG001|NOT COMPLETED|Overall Study||1
10125271|NCT02597543|11256238|FG000|STARTED|Overall Study||6
10125272|NCT02597543|11256239|FG001|STARTED|Overall Study||8
10125273|NCT02597543|11256238|FG000|COMPLETED|Overall Study||6
10125274|NCT02597543|11256239|FG001|COMPLETED|Overall Study||8
10125275|NCT02597543|11256238|FG000|NOT COMPLETED|Overall Study||0
10125276|NCT02597543|11256239|FG001|NOT COMPLETED|Overall Study||0
10125277|NCT02597582|11256247|FG000|STARTED|Overall Study||21
10125278|NCT02597582|11256248|FG001|STARTED|Overall Study||20
10125279|NCT02597582|11256247|FG000|COMPLETED|Overall Study||21
10125280|NCT02597582|11256248|FG001|COMPLETED|Overall Study||20
10125281|NCT02597582|11256247|FG000|NOT COMPLETED|Overall Study||0
10125282|NCT02597582|11256248|FG001|NOT COMPLETED|Overall Study||0
10125283|NCT02597673|11256260|FG000|STARTED|Overall Study||34
10125284|NCT02597673|11256261|FG001|STARTED|Overall Study||33
10125285|NCT02597673|11256262|FG002|STARTED|Overall Study||33
10125286|NCT02597673|11256263|FG003|STARTED|Overall Study||30
10125287|NCT02597673|11256260|FG000|COMPLETED|Overall Study||31
10125288|NCT02597673|11256261|FG001|COMPLETED|Overall Study||27
10125289|NCT02597673|11256262|FG002|COMPLETED|Overall Study||28
10125290|NCT02597673|11256263|FG003|COMPLETED|Overall Study||25
10125291|NCT02597673|11256260|FG000|NOT COMPLETED|Overall Study||3
10125292|NCT02597673|11256261|FG001|NOT COMPLETED|Overall Study||6
10125293|NCT02597673|11256262|FG002|NOT COMPLETED|Overall Study||5
10125294|NCT02597673|11256263|FG003|NOT COMPLETED|Overall Study||5
10125295|NCT02597712|11256276|FG000|STARTED|Overall Study||13
10125296|NCT02597712|11256277|FG001|STARTED|Overall Study||11
10125297|NCT02597712|11256276|FG000|COMPLETED|Overall Study||10
10125298|NCT02597712|11256277|FG001|COMPLETED|Overall Study||10
10125299|NCT02597712|11256276|FG000|NOT COMPLETED|Overall Study||3
10125300|NCT02597712|11256277|FG001|NOT COMPLETED|Overall Study||1
10125301|NCT02597855|11256285|FG000|STARTED|Overall Study||18
10125302|NCT02597855|11256286|FG001|STARTED|Overall Study||14
10125303|NCT02597855|11256285|FG000|COMPLETED|Overall Study||16
10125304|NCT02597855|11256286|FG001|COMPLETED|Overall Study||13
10125305|NCT02597855|11256285|FG000|NOT COMPLETED|Overall Study||2
10125306|NCT02597855|11256286|FG001|NOT COMPLETED|Overall Study||1
10125307|NCT02597907|11256294|FG000|STARTED|Overall Study||44
10125308|NCT02597907|11256295|FG001|STARTED|Overall Study||44
10125309|NCT02597907|11256294|FG000|COMPLETED|Overall Study||44
10125310|NCT02597907|11256295|FG001|COMPLETED|Overall Study||44
10125311|NCT02597907|11256294|FG000|NOT COMPLETED|Overall Study||0
10125312|NCT02597907|11256295|FG001|NOT COMPLETED|Overall Study||0
10125313|NCT02597920|11256304|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
10125314|NCT02597920|11256305|FG001|STARTED|Overall Study||1159
10125315|NCT02597920|11256306|FG002|STARTED|Overall Study||78
10125316|NCT02597920|11256304|FG000|COMPLETED|Overall Study||544
10125317|NCT02597920|11256305|FG001|COMPLETED|Overall Study||1075
10125318|NCT02597920|11256306|FG002|COMPLETED|Overall Study||72
10125319|NCT02597920|11256304|FG000|NOT COMPLETED|Overall Study||41
10125320|NCT02597920|11256305|FG001|NOT COMPLETED|Overall Study||84
10125321|NCT02597920|11256306|FG002|NOT COMPLETED|Overall Study||6
10125322|NCT02597933|11256318|FG000|STARTED|Overall Study|Started are randomised|290
10125323|NCT02597933|11256319|FG001|STARTED|Overall Study|Started are randomised|290
10125324|NCT02597933|11256318|FG000|Treated Patients|Overall Study||288
10125325|NCT02597933|11256319|FG001|Treated Patients|Overall Study||288
10125326|NCT02597933|11256318|FG000|COMPLETED|Overall Study||252
10125327|NCT02597933|11256319|FG001|COMPLETED|Overall Study||239
10125328|NCT02597933|11256318|FG000|NOT COMPLETED|Overall Study||38
10125329|NCT02597933|11256319|FG001|NOT COMPLETED|Overall Study||51
10125330|NCT02597946|11256325|FG000|STARTED|Overall Study||18
10125331|NCT02597946|11256325|FG000|COMPLETED|Overall Study||0
10125332|NCT02597946|11256325|FG000|NOT COMPLETED|Overall Study||18
10125333|NCT02598076|11256331|FG000|STARTED|Overall Study||31
10125334|NCT02598076|11256332|FG001|STARTED|Overall Study||29
10125335|NCT02598076|11256331|FG000|COMPLETED|Overall Study||29
10125336|NCT02598076|11256332|FG001|COMPLETED|Overall Study||26
10125337|NCT02598076|11256331|FG000|NOT COMPLETED|Overall Study||2
10125338|NCT02598076|11256332|FG001|NOT COMPLETED|Overall Study||3
10125339|NCT02598089|11256340|FG000|STARTED|Overall Study||30
10125340|NCT02598089|11256341|FG001|STARTED|Overall Study||30
10125341|NCT02598089|11256340|FG000|COMPLETED|Overall Study||30
10125342|NCT02598089|11256341|FG001|COMPLETED|Overall Study||30
10125343|NCT02598089|11256340|FG000|NOT COMPLETED|Overall Study||0
10125344|NCT02598089|11256341|FG001|NOT COMPLETED|Overall Study||0
10125345|NCT02598128|11256354|FG000|STARTED|Period A: Days -7 to -1||34
10125346|NCT02598128|11256355|FG001|STARTED|Period A: Days -7 to -1||0
10125347|NCT02598128|11256356|FG002|STARTED|Period A: Days -7 to -1||0
10125348|NCT02598128|11256357|FG003|STARTED|Period A: Days -7 to -1||0
10125349|NCT02598128|11256354|FG000|COMPLETED|Period A: Days -7 to -1||33
10125350|NCT02598128|11256355|FG001|COMPLETED|Period A: Days -7 to -1||0
10125351|NCT02598128|11256356|FG002|COMPLETED|Period A: Days -7 to -1||0
10125352|NCT02598128|11256357|FG003|COMPLETED|Period A: Days -7 to -1||0
10125353|NCT02598128|11256354|FG000|NOT COMPLETED|Period A: Days -7 to -1||1
10125354|NCT02598128|11256355|FG001|NOT COMPLETED|Period A: Days -7 to -1||0
10125355|NCT02598128|11256356|FG002|NOT COMPLETED|Period A: Days -7 to -1||0
10125356|NCT02598128|11256357|FG003|NOT COMPLETED|Period A: Days -7 to -1||0
10125357|NCT02598128|11256354|FG000|STARTED|Period B: Days 1 to 11||0
10125358|NCT02598128|11256355|FG001|STARTED|Period B: Days 1 to 11||17
10125359|NCT02598128|11256356|FG002|STARTED|Period B: Days 1 to 11||16
10125360|NCT02598128|11256357|FG003|STARTED|Period B: Days 1 to 11||0
10125361|NCT02598128|11256354|FG000|COMPLETED|Period B: Days 1 to 11||0
10125362|NCT02598128|11256355|FG001|COMPLETED|Period B: Days 1 to 11||17
10125363|NCT02598128|11256356|FG002|COMPLETED|Period B: Days 1 to 11||16
10125364|NCT02598128|11256357|FG003|COMPLETED|Period B: Days 1 to 11||0
10125365|NCT02598128|11256354|FG000|NOT COMPLETED|Period B: Days 1 to 11||0
10125366|NCT02598128|11256355|FG001|NOT COMPLETED|Period B: Days 1 to 11||0
10125367|NCT02598128|11256356|FG002|NOT COMPLETED|Period B: Days 1 to 11||0
10125368|NCT02598128|11256357|FG003|NOT COMPLETED|Period B: Days 1 to 11||0
10125369|NCT02598128|11256354|FG000|STARTED|Period C: Days 12 to 20||0
10125370|NCT02598128|11256355|FG001|STARTED|Period C: Days 12 to 20||0
10125371|NCT02598128|11256356|FG002|STARTED|Period C: Days 12 to 20||0
10125372|NCT02598128|11256357|FG003|STARTED|Period C: Days 12 to 20||33
10125373|NCT02598128|11256354|FG000|COMPLETED|Period C: Days 12 to 20||0
10125374|NCT02598128|11256355|FG001|COMPLETED|Period C: Days 12 to 20||0
10125375|NCT02598128|11256356|FG002|COMPLETED|Period C: Days 12 to 20||0
10125376|NCT02598128|11256357|FG003|COMPLETED|Period C: Days 12 to 20||33
10125377|NCT02598128|11256354|FG000|NOT COMPLETED|Period C: Days 12 to 20||0
10125378|NCT02598128|11256355|FG001|NOT COMPLETED|Period C: Days 12 to 20||0
10125379|NCT02598128|11256356|FG002|NOT COMPLETED|Period C: Days 12 to 20||0
10125380|NCT02598128|11256357|FG003|NOT COMPLETED|Period C: Days 12 to 20||0
10125381|NCT02598193|11256369|FG000|STARTED|Overall Study||89
10125382|NCT02598193|11256369|FG000|COMPLETED|Overall Study||73
10125383|NCT02598193|11256369|FG000|NOT COMPLETED|Overall Study||16
10125384|NCT02598297|11256375|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
10125385|NCT02598297|11256376|FG001|STARTED|Overall Study||24
10125386|NCT02598297|11256375|FG000|Not Treted Wit Study Drug|Overall Study||1
10125387|NCT02598297|11256376|FG001|Not Treted Wit Study Drug|Overall Study||0
10125388|NCT02598297|11256375|FG000|Subjects Followed for Survival|Overall Study||1
10125389|NCT02598297|11256376|FG001|Subjects Followed for Survival|Overall Study||0
10125390|NCT02598297|11256375|FG000|COMPLETED|Overall Study||0
10125391|NCT02598297|11256376|FG001|COMPLETED|Overall Study||0
10125392|NCT02598297|11256375|FG000|NOT COMPLETED|Overall Study||25
10125393|NCT02598297|11256376|FG001|NOT COMPLETED|Overall Study||24
10125394|NCT02598934|11256384|FG000|STARTED|Overall Study||154
10125395|NCT02598934|11256385|FG001|STARTED|Overall Study||154
10125396|NCT02598934|11256384|FG000|COMPLETED|Overall Study||135
10125397|NCT02598934|11256385|FG001|COMPLETED|Overall Study||132
10125398|NCT02598934|11256384|FG000|NOT COMPLETED|Overall Study||19
10125399|NCT02598934|11256385|FG001|NOT COMPLETED|Overall Study||22
10125400|NCT02599129|11256393|FG000|STARTED|Overall Study||7
10125401|NCT02599129|11256394|FG001|STARTED|Overall Study||4
10125402|NCT02599129|11256393|FG000|COMPLETED|Overall Study||2
10125403|NCT02599129|11256394|FG001|COMPLETED|Overall Study||1
10125404|NCT02599129|11256393|FG000|NOT COMPLETED|Overall Study||5
10125405|NCT02599129|11256394|FG001|NOT COMPLETED|Overall Study||3
10125406|NCT02599194|11256400|FG000|STARTED|Overall Study||7
10125407|NCT02599194|11256400|FG000|COMPLETED|Overall Study||7
10125408|NCT02599194|11256400|FG000|NOT COMPLETED|Overall Study||0
10125409|NCT02599402|11256406|FG000|STARTED|Overall Study||533
10125410|NCT02599402|11256406|FG000|COMPLETED|Overall Study||0
10125411|NCT02599402|11256406|FG000|NOT COMPLETED|Overall Study||533
10125412|NCT02599441|11256436|FG000|STARTED|Overall Study||9
10125413|NCT02599441|11256436|FG000|COMPLETED|Overall Study||9
10125414|NCT02599441|11256436|FG000|NOT COMPLETED|Overall Study||0
10125415|NCT02599649|11256444|FG000|STARTED|Overall Study||2
10125416|NCT02599649|11256445|FG001|STARTED|Overall Study||0
10125417|NCT02599649|11256446|FG002|STARTED|Overall Study||8
10125418|NCT02599649|11256447|FG003|STARTED|Overall Study||0
10125419|NCT02599649|11256444|FG000|COMPLETED|Overall Study||2
10125420|NCT02599649|11256445|FG001|COMPLETED|Overall Study||0
10125421|NCT02599649|11256446|FG002|COMPLETED|Overall Study||8
10125422|NCT02599649|11256447|FG003|COMPLETED|Overall Study||0
10125423|NCT02599649|11256444|FG000|NOT COMPLETED|Overall Study||0
10125424|NCT02599649|11256445|FG001|NOT COMPLETED|Overall Study||0
10125425|NCT02599649|11256446|FG002|NOT COMPLETED|Overall Study||0
10125426|NCT02599649|11256447|FG003|NOT COMPLETED|Overall Study||0
10125427|NCT02599688|11256457|FG000|STARTED|Overall Study||18
10125428|NCT02599688|11256457|FG000|COMPLETED|Overall Study||14
10125429|NCT02599688|11256457|FG000|NOT COMPLETED|Overall Study||4
10125430|NCT02599766|11256461|FG000|STARTED|Overall Study||22
10125431|NCT02599766|11256461|FG000|COMPLETED|Overall Study||19
10125432|NCT02599766|11256461|FG000|NOT COMPLETED|Overall Study||3
10125433|NCT02599961|11256469|FG000|STARTED|Overall Study||15
10125434|NCT02599961|11256469|FG000|COMPLETED|Overall Study||0
10125435|NCT02599961|11256469|FG000|NOT COMPLETED|Overall Study||15
10125436|NCT02600325|11256473|FG000|STARTED|Overall Study||80
10125437|NCT02600325|11256473|FG000|COMPLETED|Overall Study||80
10125438|NCT02600325|11256473|FG000|NOT COMPLETED|Overall Study||0
10125439|NCT02600351|11256481|FG000|STARTED|Overall Study||17
10125440|NCT02600351|11256482|FG001|STARTED|Overall Study||17
10125441|NCT02600351|11256483|FG002|STARTED|Overall Study||26
10125442|NCT02600351|11256484|FG003|STARTED|Overall Study||27
10125443|NCT02600351|11256481|FG000|COMPLETED|Overall Study||12
10125444|NCT02600351|11256482|FG001|COMPLETED|Overall Study||17
10125445|NCT02600351|11256483|FG002|COMPLETED|Overall Study||20
10125446|NCT02600351|11256484|FG003|COMPLETED|Overall Study||22
10125447|NCT02600351|11256481|FG000|NOT COMPLETED|Overall Study||5
10125448|NCT02600351|11256482|FG001|NOT COMPLETED|Overall Study||0
10125449|NCT02600351|11256483|FG002|NOT COMPLETED|Overall Study||6
10125450|NCT02600351|11256484|FG003|NOT COMPLETED|Overall Study||5
10125451|NCT02600403|11256499|FG000|STARTED|Overall Study||44
10125452|NCT02600403|11256500|FG001|STARTED|Overall Study||6
10125453|NCT02600403|11256501|FG002|STARTED|Overall Study||11
10125454|NCT02600403|11256499|FG000|COMPLETED|Overall Study||44
10125455|NCT02600403|11256500|FG001|COMPLETED|Overall Study||6
10125456|NCT02600403|11256501|FG002|COMPLETED|Overall Study||11
10125457|NCT02600403|11256499|FG000|NOT COMPLETED|Overall Study||0
10125458|NCT02600403|11256500|FG001|NOT COMPLETED|Overall Study||0
10125459|NCT02600403|11256501|FG002|NOT COMPLETED|Overall Study||0
10125460|NCT02600559|11256512|FG000|STARTED|Overall Study||501
10125461|NCT02600559|11256512|FG000|COMPLETED|Overall Study||478
10125462|NCT02600559|11256512|FG000|NOT COMPLETED|Overall Study||23
10125463|NCT02600611|11256518|FG000|STARTED|Overall Study||300
10125464|NCT02600611|11256519|FG001|STARTED|Overall Study||300
10125465|NCT02600611|11256518|FG000|COMPLETED|Overall Study||298
10125466|NCT02600611|11256519|FG001|COMPLETED|Overall Study||300
10125467|NCT02600611|11256518|FG000|NOT COMPLETED|Overall Study||2
10125468|NCT02600611|11256519|FG001|NOT COMPLETED|Overall Study||0
10125469|NCT02600637|11256527|FG000|STARTED|Overall Study||19
10125470|NCT02600637|11256528|FG001|STARTED|Overall Study||18
10125471|NCT02600637|11256527|FG000|COMPLETED|Overall Study||14
10125472|NCT02600637|11256528|FG001|COMPLETED|Overall Study||13
10125473|NCT02600637|11256527|FG000|NOT COMPLETED|Overall Study||5
10125474|NCT02600637|11256528|FG001|NOT COMPLETED|Overall Study||5
10125475|NCT02600715|11256536|FG000|STARTED|Overall Study||13
10125476|NCT02600715|11256537|FG001|STARTED|Overall Study||13
10125477|NCT02600715|11256536|FG000|Allocated to Randomization|Overall Study||13
10125478|NCT02600715|11256537|FG001|Allocated to Randomization|Overall Study||13
10125479|NCT02600715|11256536|FG000|Received Treatment and Suppository|Overall Study||13
10125480|NCT02600715|11256537|FG001|Received Treatment and Suppository|Overall Study||13
10125481|NCT02600715|11256536|FG000|Completed 2-week Follow-up Appointment|Overall Study||13
10125482|NCT02600715|11256537|FG001|Completed 2-week Follow-up Appointment|Overall Study||12
10125483|NCT02600715|11256536|FG000|COMPLETED|Overall Study||13
10125484|NCT02600715|11256537|FG001|COMPLETED|Overall Study||13
10125485|NCT02600715|11256536|FG000|NOT COMPLETED|Overall Study||0
10125486|NCT02600715|11256537|FG001|NOT COMPLETED|Overall Study||0
10196335|NCT03359590|11324552|FG000|COMPLETED|First Intervention||9
10196336|NCT03359590|11324553|FG001|COMPLETED|First Intervention||8
10196337|NCT03359590|11324552|FG000|NOT COMPLETED|First Intervention||1
10196338|NCT03359590|11324553|FG001|NOT COMPLETED|First Intervention||2
10196339|NCT03359590|11324552|FG000|STARTED|Second Intervention||9
10196340|NCT03359590|11324553|FG001|STARTED|Second Intervention||8
10125487|NCT02600767|11256546|FG000|STARTED|Overall Study||79
10125488|NCT02600767|11256546|FG000|COMPLETED|Overall Study||74
10125489|NCT02600767|11256546|FG000|NOT COMPLETED|Overall Study||5
10125490|NCT02600819|11256550|FG000|STARTED|GEN Phase||55
10125491|NCT02600819|11256551|FG001|STARTED|GEN Phase||0
10125492|NCT02600819|11256550|FG000|COMPLETED|GEN Phase||39
10125493|NCT02600819|11256551|FG001|COMPLETED|GEN Phase||0
10125494|NCT02600819|11256550|FG000|NOT COMPLETED|GEN Phase||16
10125495|NCT02600819|11256551|FG001|NOT COMPLETED|GEN Phase||0
10125496|NCT02600819|11256550|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
10125497|NCT02600819|11256551|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
10125498|NCT02600819|11256550|FG000|COMPLETED|BVY OL Extension Phase||0
10125499|NCT02600819|11256551|FG001|COMPLETED|BVY OL Extension Phase||10
10125500|NCT02600819|11256550|FG000|NOT COMPLETED|BVY OL Extension Phase||0
10125501|NCT02600819|11256551|FG001|NOT COMPLETED|BVY OL Extension Phase||0
10125502|NCT02600845|11256557|FG000|STARTED|Overall Study||122
10125503|NCT02600845|11256557|FG000|COMPLETED|Overall Study||104
10125504|NCT02600845|11256557|FG000|NOT COMPLETED|Overall Study||18
10125505|NCT02600871|11256563|FG000|STARTED|Overall Study||52
10125506|NCT02600871|11256564|FG001|STARTED|Overall Study||49
10125507|NCT02600871|11256563|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
10125508|NCT02600871|11256564|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
10125509|NCT02600871|11256563|FG000|NOT COMPLETED|Overall Study||13
10125510|NCT02600871|11256564|FG001|NOT COMPLETED|Overall Study||10
10125511|NCT02601001|11256574|FG000|STARTED|Dosing Period 1||10
10125512|NCT02601001|11256575|FG001|STARTED|Dosing Period 1||20
10125513|NCT02601001|11256576|FG002|STARTED|Dosing Period 1||20
10125514|NCT02601001|11256577|FG003|STARTED|Dosing Period 1||0
10125515|NCT02601001|11256578|FG004|STARTED|Dosing Period 1||0
10125516|NCT02601001|11256579|FG005|STARTED|Dosing Period 1||0
10125517|NCT02601001|11256580|FG006|STARTED|Dosing Period 1||0
10125518|NCT02601001|11256574|FG000|COMPLETED|Dosing Period 1||10
10125519|NCT02601001|11256575|FG001|COMPLETED|Dosing Period 1||20
10125520|NCT02601001|11256576|FG002|COMPLETED|Dosing Period 1||20
10125521|NCT02601001|11256577|FG003|COMPLETED|Dosing Period 1||0
10125522|NCT02601001|11256578|FG004|COMPLETED|Dosing Period 1||0
10125523|NCT02601001|11256579|FG005|COMPLETED|Dosing Period 1||0
10125524|NCT02601001|11256580|FG006|COMPLETED|Dosing Period 1||0
10125525|NCT02601001|11256574|FG000|NOT COMPLETED|Dosing Period 1||0
10125526|NCT02601001|11256575|FG001|NOT COMPLETED|Dosing Period 1||0
10125527|NCT02601001|11256576|FG002|NOT COMPLETED|Dosing Period 1||0
10125528|NCT02601001|11256577|FG003|NOT COMPLETED|Dosing Period 1||0
10125529|NCT02601001|11256578|FG004|NOT COMPLETED|Dosing Period 1||0
10125530|NCT02601001|11256579|FG005|NOT COMPLETED|Dosing Period 1||0
10125531|NCT02601001|11256580|FG006|NOT COMPLETED|Dosing Period 1||0
10125532|NCT02601001|11256574|FG000|STARTED|Dosing Period 2||10
10125533|NCT02601001|11256575|FG001|STARTED|Dosing Period 2||0
10125534|NCT02601001|11256576|FG002|STARTED|Dosing Period 2||0
10125535|NCT02601001|11256577|FG003|STARTED|Dosing Period 2||7
10125536|NCT02601001|11256578|FG004|STARTED|Dosing Period 2||13
10125537|NCT02601001|11256579|FG005|STARTED|Dosing Period 2||7
10125538|NCT02601001|11256580|FG006|STARTED|Dosing Period 2||13
10125539|NCT02601001|11256574|FG000|COMPLETED|Dosing Period 2||10
10125540|NCT02601001|11256575|FG001|COMPLETED|Dosing Period 2||0
10125541|NCT02601001|11256576|FG002|COMPLETED|Dosing Period 2||0
10125542|NCT02601001|11256577|FG003|COMPLETED|Dosing Period 2||7
10125543|NCT02601001|11256578|FG004|COMPLETED|Dosing Period 2||13
10125544|NCT02601001|11256579|FG005|COMPLETED|Dosing Period 2||7
10125545|NCT02601001|11256580|FG006|COMPLETED|Dosing Period 2||12
10125546|NCT02601001|11256574|FG000|NOT COMPLETED|Dosing Period 2||0
10125547|NCT02601001|11256575|FG001|NOT COMPLETED|Dosing Period 2||0
10125548|NCT02601001|11256576|FG002|NOT COMPLETED|Dosing Period 2||0
10125549|NCT02601001|11256577|FG003|NOT COMPLETED|Dosing Period 2||0
10125550|NCT02601001|11256578|FG004|NOT COMPLETED|Dosing Period 2||0
10125551|NCT02601001|11256579|FG005|NOT COMPLETED|Dosing Period 2||0
10125552|NCT02601001|11256580|FG006|NOT COMPLETED|Dosing Period 2||1
10125553|NCT02601027|11256603|FG000|STARTED|Registration to Surgery||64
10125554|NCT02601027|11256604|FG001|STARTED|Registration to Surgery||56
10125555|NCT02601027|11256603|FG000|COMPLETED|Registration to Surgery||44
10125556|NCT02601027|11256604|FG001|COMPLETED|Registration to Surgery||46
10125557|NCT02601027|11256603|FG000|NOT COMPLETED|Registration to Surgery||20
10125558|NCT02601027|11256604|FG001|NOT COMPLETED|Registration to Surgery||10
10125559|NCT02601027|11256603|FG000|STARTED|Surgery to Assessments||44
10125560|NCT02601027|11256604|FG001|STARTED|Surgery to Assessments||46
10125561|NCT02601027|11256603|FG000|COMPLETED|Surgery to Assessments||44
10125562|NCT02601027|11256604|FG001|COMPLETED|Surgery to Assessments||46
10125563|NCT02601027|11256603|FG000|NOT COMPLETED|Surgery to Assessments||0
10125564|NCT02601027|11256604|FG001|NOT COMPLETED|Surgery to Assessments||0
10125565|NCT02601105|11256610|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
10125566|NCT02601105|11256610|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
10125567|NCT02601105|11256610|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
10125568|NCT02601105|11256610|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15
10125569|NCT02601105|11256610|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
10125570|NCT02601105|11256610|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
10125571|NCT02601105|11256610|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15
10125572|NCT02601105|11256610|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
10125573|NCT02601105|11256610|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
10125574|NCT02601170|11256618|FG000|STARTED|Overall Study||11
10125575|NCT02601170|11256619|FG001|STARTED|Overall Study||11
10125576|NCT02601170|11256618|FG000|COMPLETED|Overall Study||11
10125577|NCT02601170|11256619|FG001|COMPLETED|Overall Study||11
10125578|NCT02601170|11256618|FG000|NOT COMPLETED|Overall Study||0
10125579|NCT02601170|11256619|FG001|NOT COMPLETED|Overall Study||0
10125580|NCT02601300|11256625|FG000|STARTED|Induction Phase||41
10125581|NCT02601300|11256625|FG000|COMPLETED|Induction Phase||38
10125582|NCT02601300|11256625|FG000|NOT COMPLETED|Induction Phase||3
10125583|NCT02601300|11256625|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
10125584|NCT02601300|11256625|FG000|Treated With IP|Extension Phase||34
10125585|NCT02601300|11256625|FG000|COMPLETED|Extension Phase||18
10125586|NCT02601300|11256625|FG000|NOT COMPLETED|Extension Phase||17
10125587|NCT02601469|11256633|FG000|STARTED|Overall Study||25
10125588|NCT02601469|11256634|FG001|STARTED|Overall Study||1
10125589|NCT02601469|11256633|FG000|COMPLETED|Overall Study||24
10125590|NCT02601469|11256634|FG001|COMPLETED|Overall Study||1
10125591|NCT02601469|11256633|FG000|NOT COMPLETED|Overall Study||1
10125592|NCT02601469|11256634|FG001|NOT COMPLETED|Overall Study||0
10125593|NCT02601560|11256648|FG000|STARTED|Overall Study||8
10125594|NCT02601560|11256649|FG001|STARTED|Overall Study||6
10125595|NCT02601560|11256650|FG002|STARTED|Overall Study||6
10125596|NCT02601560|11256651|FG003|STARTED|Overall Study||6
10125597|NCT02601560|11256652|FG004|STARTED|Overall Study||6
10125598|NCT02601560|11256653|FG005|STARTED|Overall Study||4
10125599|NCT02601560|11256654|FG006|STARTED|Overall Study||6
10125600|NCT02601560|11256655|FG007|STARTED|Overall Study||6
10125601|NCT02601560|11256648|FG000|COMPLETED|Overall Study||8
10125602|NCT02601560|11256649|FG001|COMPLETED|Overall Study||6
10125603|NCT02601560|11256650|FG002|COMPLETED|Overall Study||6
10125604|NCT02601560|11256651|FG003|COMPLETED|Overall Study||6
10125605|NCT02601560|11256652|FG004|COMPLETED|Overall Study||6
10125606|NCT02601560|11256653|FG005|COMPLETED|Overall Study||4
10125607|NCT02601560|11256654|FG006|COMPLETED|Overall Study||5
10125608|NCT02601560|11256655|FG007|COMPLETED|Overall Study||6
10125609|NCT02601560|11256648|FG000|NOT COMPLETED|Overall Study||0
10125610|NCT02601560|11256649|FG001|NOT COMPLETED|Overall Study||0
10125611|NCT02601560|11256650|FG002|NOT COMPLETED|Overall Study||0
10125612|NCT02601560|11256651|FG003|NOT COMPLETED|Overall Study||0
10125613|NCT02601560|11256652|FG004|NOT COMPLETED|Overall Study||0
10125614|NCT02601560|11256653|FG005|NOT COMPLETED|Overall Study||0
10125615|NCT02601560|11256654|FG006|NOT COMPLETED|Overall Study||1
10125616|NCT02601560|11256655|FG007|NOT COMPLETED|Overall Study||0
10125617|NCT02601573|11256685|FG000|STARTED|Overall Study|Number randomized and treated.|23
10125618|NCT02601573|11256686|FG001|STARTED|Overall Study|Number randomized and treated.|24
10125619|NCT02601573|11256687|FG002|STARTED|Overall Study|Number randomized and treated.|17
10125620|NCT02601573|11256688|FG003|STARTED|Overall Study|Number randomized and treated.|18
10125621|NCT02601573|11256689|FG004|STARTED|Overall Study|Number randomized and treated.|18
10125622|NCT02601573|11256685|FG000|COMPLETED|Overall Study||23
10125623|NCT02601573|11256686|FG001|COMPLETED|Overall Study||20
10125624|NCT02601573|11256687|FG002|COMPLETED|Overall Study||16
10125625|NCT02601573|11256688|FG003|COMPLETED|Overall Study||17
10125626|NCT02601573|11256689|FG004|COMPLETED|Overall Study||16
10125627|NCT02601573|11256685|FG000|NOT COMPLETED|Overall Study||0
10125628|NCT02601573|11256686|FG001|NOT COMPLETED|Overall Study||4
10125629|NCT02601573|11256687|FG002|NOT COMPLETED|Overall Study||1
10125630|NCT02601573|11256688|FG003|NOT COMPLETED|Overall Study||1
10125631|NCT02601573|11256689|FG004|NOT COMPLETED|Overall Study||2
10125632|NCT02601625|11256705|FG000|STARTED|Overall Study||6
10125633|NCT02601625|11256706|FG001|STARTED|Overall Study||6
10125634|NCT02601625|11256707|FG002|STARTED|Overall Study||6
10125635|NCT02601625|11256708|FG003|STARTED|Overall Study||12
10125636|NCT02601625|11256705|FG000|COMPLETED|Overall Study||6
10125637|NCT02601625|11256706|FG001|COMPLETED|Overall Study||6
10125638|NCT02601625|11256707|FG002|COMPLETED|Overall Study||5
10125639|NCT02601625|11256708|FG003|COMPLETED|Overall Study||11
10125640|NCT02601625|11256705|FG000|NOT COMPLETED|Overall Study||0
10125641|NCT02601625|11256706|FG001|NOT COMPLETED|Overall Study||0
10125642|NCT02601625|11256707|FG002|NOT COMPLETED|Overall Study||1
10125643|NCT02601625|11256708|FG003|NOT COMPLETED|Overall Study||1
10125644|NCT02601820|11256732|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
10125645|NCT02601820|11256732|FG000|COMPLETED|Pre-Treatment (T1)||1601
10125646|NCT02601820|11256732|FG000|NOT COMPLETED|Pre-Treatment (T1)||0
10125647|NCT02601820|11256732|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
10125648|NCT02601820|11256732|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
10125649|NCT02601820|11256732|FG000|NOT COMPLETED|Early On-Treatment (T2)||51
10125650|NCT02601820|11256732|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
10125651|NCT02601820|11256732|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
10125652|NCT02601820|11256732|FG000|NOT COMPLETED|Late On-Treatment (T3)||49
10125653|NCT02601820|11256732|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
10196341|NCT03359590|11324552|FG000|Exposed|Second Intervention||9
10125654|NCT02601820|11256732|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
10125655|NCT02601820|11256732|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
10125656|NCT02601820|11256732|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
10125657|NCT02601820|11256732|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
10125658|NCT02601820|11256732|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
10125659|NCT02601833|11256751|FG000|STARTED|Overall Study||56
10125660|NCT02601833|11256752|FG001|STARTED|Overall Study||42
10125661|NCT02601833|11256751|FG000|COMPLETED|Overall Study||40
10125662|NCT02601833|11256752|FG001|COMPLETED|Overall Study||29
10125663|NCT02601833|11256751|FG000|NOT COMPLETED|Overall Study||16
10125664|NCT02601833|11256752|FG001|NOT COMPLETED|Overall Study||13
10125665|NCT02601976|11256761|FG000|STARTED|Overall Study||64
10125666|NCT02601976|11256761|FG000|COMPLETED|Overall Study||64
10125667|NCT02601976|11256761|FG000|NOT COMPLETED|Overall Study||0
10125668|NCT02602080|11256768|FG000|STARTED|Overall Study||21
10125669|NCT02602080|11256769|FG001|STARTED|Overall Study||16
10125670|NCT02602080|11256770|FG002|STARTED|Overall Study||18
10125671|NCT02602080|11256768|FG000|COMPLETED|Overall Study||15
10125672|NCT02602080|11256769|FG001|COMPLETED|Overall Study||15
10125673|NCT02602080|11256770|FG002|COMPLETED|Overall Study||15
10125674|NCT02602080|11256768|FG000|NOT COMPLETED|Overall Study||6
10125675|NCT02602080|11256769|FG001|NOT COMPLETED|Overall Study||1
10125676|NCT02602080|11256770|FG002|NOT COMPLETED|Overall Study||3
10125677|NCT02602223|11256778|FG000|STARTED|Overall Study||9
10125678|NCT02602223|11256778|FG000|COMPLETED|Overall Study||9
10125679|NCT02602223|11256778|FG000|NOT COMPLETED|Overall Study||0
10125680|NCT02602496|11256787|FG000|STARTED|Overall Study||15
10125681|NCT02602496|11256788|FG001|STARTED|Overall Study||20
10125682|NCT02602496|11256789|FG002|STARTED|Overall Study||17
10125683|NCT02602496|11256787|FG000|COMPLETED|Overall Study||14
10125684|NCT02602496|11256788|FG001|COMPLETED|Overall Study||18
10125685|NCT02602496|11256789|FG002|COMPLETED|Overall Study||17
10125686|NCT02602496|11256787|FG000|NOT COMPLETED|Overall Study||1
10125687|NCT02602496|11256788|FG001|NOT COMPLETED|Overall Study||2
10125688|NCT02602496|11256789|FG002|NOT COMPLETED|Overall Study||0
10125689|NCT02603107|11256799|FG000|STARTED|Randomized Phase||290
10125690|NCT02603107|11256800|FG001|STARTED|Randomized Phase||287
10125691|NCT02603107|11256799|FG000|COMPLETED|Randomized Phase||275
10125692|NCT02603107|11256800|FG001|COMPLETED|Randomized Phase||266
10125693|NCT02603107|11256799|FG000|NOT COMPLETED|Randomized Phase||15
10125694|NCT02603107|11256800|FG001|NOT COMPLETED|Randomized Phase||21
10125695|NCT02603107|11256799|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
10125696|NCT02603107|11256800|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
10125697|NCT02603107|11256799|FG000|COMPLETED|Optional Extension Phase||263
10125698|NCT02603107|11256800|FG001|COMPLETED|Optional Extension Phase||232
10125699|NCT02603107|11256799|FG000|NOT COMPLETED|Optional Extension Phase||9
10125700|NCT02603107|11256800|FG001|NOT COMPLETED|Optional Extension Phase||13
10125701|NCT02603120|11256810|FG000|STARTED|Double-Blind Treatment Phase||284
10125702|NCT02603120|11256811|FG001|STARTED|Double-Blind Treatment Phase||283
10125703|NCT02603120|11256810|FG000|COMPLETED|Double-Blind Treatment Phase||265
10125704|NCT02603120|11256811|FG001|COMPLETED|Double-Blind Treatment Phase||267
10125705|NCT02603120|11256810|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19
10125706|NCT02603120|11256811|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16
10125707|NCT02603120|11256810|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259
10125708|NCT02603120|11256811|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265
10125709|NCT02603120|11256810|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
10125710|NCT02603120|11256811|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
10125711|NCT02603120|11256810|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
10125712|NCT02603120|11256811|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
10125713|NCT02603172|11256827|FG000|STARTED|Part A (Approximately 16 Weeks)||7
10125714|NCT02603172|11256828|FG001|STARTED|Part A (Approximately 16 Weeks)||1
10125715|NCT02603172|11256829|FG002|STARTED|Part A (Approximately 16 Weeks)||8
10125716|NCT02603172|11256830|FG003|STARTED|Part A (Approximately 16 Weeks)||1
10125717|NCT02603172|11256831|FG004|STARTED|Part A (Approximately 16 Weeks)||0
10125718|NCT02603172|11256832|FG005|STARTED|Part A (Approximately 16 Weeks)||0
10125719|NCT02603172|11256833|FG006|STARTED|Part A (Approximately 16 Weeks)||0
10125720|NCT02603172|11256834|FG007|STARTED|Part A (Approximately 16 Weeks)||0
10125721|NCT02603172|11256827|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7
10125722|NCT02603172|11256828|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1
10125723|NCT02603172|11256829|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7
10125724|NCT02603172|11256830|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1
10125725|NCT02603172|11256831|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0
10125726|NCT02603172|11256832|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0
10125727|NCT02603172|11256833|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0
10125728|NCT02603172|11256834|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0
10125729|NCT02603172|11256827|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10125730|NCT02603172|11256828|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10125731|NCT02603172|11256829|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
10125732|NCT02603172|11256830|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10125733|NCT02603172|11256831|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10125734|NCT02603172|11256832|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10125735|NCT02603172|11256833|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10125736|NCT02603172|11256834|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10125737|NCT02603172|11256827|FG000|STARTED|Part B (Approximately 7 Weeks)||0
10125738|NCT02603172|11256828|FG001|STARTED|Part B (Approximately 7 Weeks)||1
10125739|NCT02603172|11256829|FG002|STARTED|Part B (Approximately 7 Weeks)||0
10125740|NCT02603172|11256830|FG003|STARTED|Part B (Approximately 7 Weeks)||1
10125741|NCT02603172|11256831|FG004|STARTED|Part B (Approximately 7 Weeks)||6
10125742|NCT02603172|11256832|FG005|STARTED|Part B (Approximately 7 Weeks)||0
10125743|NCT02603172|11256833|FG006|STARTED|Part B (Approximately 7 Weeks)||0
10125744|NCT02603172|11256834|FG007|STARTED|Part B (Approximately 7 Weeks)||0
10125745|NCT02603172|11256827|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0
10125746|NCT02603172|11256828|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1
10125747|NCT02603172|11256829|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0
10125748|NCT02603172|11256830|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1
10125749|NCT02603172|11256831|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6
10125750|NCT02603172|11256832|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0
10125751|NCT02603172|11256833|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0
10125752|NCT02603172|11256834|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0
10125753|NCT02603172|11256827|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125754|NCT02603172|11256828|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125755|NCT02603172|11256829|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125756|NCT02603172|11256830|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125757|NCT02603172|11256831|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125758|NCT02603172|11256832|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125759|NCT02603172|11256833|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125760|NCT02603172|11256834|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10125761|NCT02603172|11256827|FG000|STARTED|Part C (Approximately 13 Weeks)||0
10125762|NCT02603172|11256828|FG001|STARTED|Part C (Approximately 13 Weeks)||0
10125763|NCT02603172|11256829|FG002|STARTED|Part C (Approximately 13 Weeks)||0
10125764|NCT02603172|11256830|FG003|STARTED|Part C (Approximately 13 Weeks)||0
10125765|NCT02603172|11256831|FG004|STARTED|Part C (Approximately 13 Weeks)||0
10125766|NCT02603172|11256832|FG005|STARTED|Part C (Approximately 13 Weeks)||0
10125767|NCT02603172|11256833|FG006|STARTED|Part C (Approximately 13 Weeks)||0
10125768|NCT02603172|11256834|FG007|STARTED|Part C (Approximately 13 Weeks)||0
10125769|NCT02603172|11256827|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0
10125770|NCT02603172|11256828|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0
10125771|NCT02603172|11256829|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0
10125772|NCT02603172|11256830|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0
10125773|NCT02603172|11256831|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0
10125774|NCT02603172|11256832|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0
10125775|NCT02603172|11256833|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0
10125776|NCT02603172|11256834|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0
10125777|NCT02603172|11256827|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125778|NCT02603172|11256828|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125779|NCT02603172|11256829|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125780|NCT02603172|11256830|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125781|NCT02603172|11256831|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125782|NCT02603172|11256832|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125783|NCT02603172|11256833|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125784|NCT02603172|11256834|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10125785|NCT02603211|11256850|FG000|STARTED|Overall Study||20
10125786|NCT02603211|11256850|FG000|COMPLETED|Overall Study||20
10125787|NCT02603211|11256850|FG000|NOT COMPLETED|Overall Study||0
10125788|NCT02603393|11256857|FG000|STARTED|Overall Study||527
10125789|NCT02603393|11256858|FG001|STARTED|Overall Study||526
10125790|NCT02603393|11256857|FG000|COMPLETED|Overall Study||456
10125791|NCT02603393|11256858|FG001|COMPLETED|Overall Study||472
10125792|NCT02603393|11256857|FG000|NOT COMPLETED|Overall Study||71
10125793|NCT02603393|11256858|FG001|NOT COMPLETED|Overall Study||54
10125794|NCT02603419|11256870|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
10125795|NCT02603419|11256871|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
10125796|NCT02603419|11256872|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
10125797|NCT02603419|11256873|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
10125798|NCT02603419|11256874|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
9706692|NCT03298867|10805777|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1
9706693|NCT03298867|10805778|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16
9706694|NCT03298867|10805777|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3
9706695|NCT03298867|10805778|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20
9706696|NCT03298867|10805777|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3
10125799|NCT02603419|11256875|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125800|NCT02603419|11256870|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10125801|NCT02603419|11256871|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10125802|NCT02603419|11256872|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10125803|NCT02603419|11256873|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10125804|NCT02603419|11256874|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10125805|NCT02603419|11256875|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
10196342|NCT03359590|11324553|FG001|Exposed|Second Intervention||8
10125806|NCT02603419|11256870|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125807|NCT02603419|11256871|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125808|NCT02603419|11256872|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125809|NCT02603419|11256873|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125810|NCT02603419|11256874|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125811|NCT02603419|11256875|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125812|NCT02603419|11256870|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10125813|NCT02603419|11256871|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
10125814|NCT02603419|11256872|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10125815|NCT02603419|11256873|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10125816|NCT02603419|11256874|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10125817|NCT02603419|11256875|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10125818|NCT02603419|11256870|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10125819|NCT02603419|11256871|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10125820|NCT02603419|11256872|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10125821|NCT02603419|11256873|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10125822|NCT02603419|11256874|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10125823|NCT02603419|11256875|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
10125824|NCT02603419|11256870|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125825|NCT02603419|11256871|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125826|NCT02603419|11256872|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125827|NCT02603419|11256873|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125828|NCT02603419|11256874|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125829|NCT02603419|11256875|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125830|NCT02603419|11256870|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125831|NCT02603419|11256871|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125832|NCT02603419|11256872|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125833|NCT02603419|11256873|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125834|NCT02603419|11256874|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10125835|NCT02603419|11256875|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
10125836|NCT02603666|11256890|FG000|STARTED|Overall Study||130
10125837|NCT02603666|11256890|FG000|COMPLETED|Overall Study||130
10125838|NCT02603666|11256890|FG000|NOT COMPLETED|Overall Study||0
10125839|NCT02603809|11256900|FG000|STARTED|Overall Study||82
9848693|NCT00861380|10961455|FG000|COMPLETED|Overall Study||0
9848694|NCT00861380|10961456|FG001|COMPLETED|Overall Study||0
9848695|NCT00861380|10961457|FG002|COMPLETED|Overall Study||0
9848696|NCT00861380|10961458|FG003|COMPLETED|Overall Study||0
9848697|NCT00861380|10961459|FG004|COMPLETED|Overall Study||0
9848698|NCT00861380|10961460|FG005|COMPLETED|Overall Study||0
10125840|NCT02603809|11256901|FG001|STARTED|Overall Study||82
10125841|NCT02603809|11256902|FG002|STARTED|Overall Study||82
10125842|NCT02603809|11256903|FG003|STARTED|Overall Study||82
10125843|NCT02603809|11256904|FG004|STARTED|Overall Study||81
10125844|NCT02603809|11256905|FG005|STARTED|Overall Study||81
10125845|NCT02603809|11256900|FG000|Per-protocol Set|Overall Study||67
10125846|NCT02603809|11256901|FG001|Per-protocol Set|Overall Study||68
10125847|NCT02603809|11256902|FG002|Per-protocol Set|Overall Study||71
10125848|NCT02603809|11256903|FG003|Per-protocol Set|Overall Study||67
10125849|NCT02603809|11256904|FG004|Per-protocol Set|Overall Study||68
10125850|NCT02603809|11256905|FG005|Per-protocol Set|Overall Study||69
10125851|NCT02603809|11256900|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
10125852|NCT02603809|11256901|FG001|Modified Per-Protocol Set|Overall Study||68
10125853|NCT02603809|11256902|FG002|Modified Per-Protocol Set|Overall Study||71
10125854|NCT02603809|11256903|FG003|Modified Per-Protocol Set|Overall Study||67
10125855|NCT02603809|11256904|FG004|Modified Per-Protocol Set|Overall Study||68
10125856|NCT02603809|11256905|FG005|Modified Per-Protocol Set|Overall Study||69
10125857|NCT02603809|11256900|FG000|Completed Study|Overall Study||75
10125858|NCT02603809|11256901|FG001|Completed Study|Overall Study||79
10125859|NCT02603809|11256902|FG002|Completed Study|Overall Study||79
10125860|NCT02603809|11256903|FG003|Completed Study|Overall Study||76
10125861|NCT02603809|11256904|FG004|Completed Study|Overall Study||78
10125862|NCT02603809|11256905|FG005|Completed Study|Overall Study||75
10125863|NCT02603809|11256900|FG000|COMPLETED|Overall Study||70
10125864|NCT02603809|11256901|FG001|COMPLETED|Overall Study||74
10125865|NCT02603809|11256902|FG002|COMPLETED|Overall Study||75
10125866|NCT02603809|11256903|FG003|COMPLETED|Overall Study||70
10125867|NCT02603809|11256904|FG004|COMPLETED|Overall Study||70
10125868|NCT02603809|11256905|FG005|COMPLETED|Overall Study||71
10125869|NCT02603809|11256900|FG000|NOT COMPLETED|Overall Study||12
10125870|NCT02603809|11256901|FG001|NOT COMPLETED|Overall Study||8
10125871|NCT02603809|11256902|FG002|NOT COMPLETED|Overall Study||7
10125872|NCT02603809|11256903|FG003|NOT COMPLETED|Overall Study||12
10125873|NCT02603809|11256904|FG004|NOT COMPLETED|Overall Study||11
10125874|NCT02603809|11256905|FG005|NOT COMPLETED|Overall Study||10
10125875|NCT02603926|11256921|FG000|STARTED|Overall Study||6
10125876|NCT02603926|11256921|FG000|COMPLETED|Overall Study||6
10125877|NCT02603926|11256921|FG000|NOT COMPLETED|Overall Study||0
10125878|NCT02603952|11256930|FG000|STARTED|Overall Study||32
10125879|NCT02603952|11256931|FG001|STARTED|Overall Study||31
10125880|NCT02603952|11256932|FG002|STARTED|Overall Study||31
10125881|NCT02603952|11256933|FG003|STARTED|Overall Study||32
10125882|NCT02603952|11256930|FG000|Treated|Overall Study||32
10125883|NCT02603952|11256931|FG001|Treated|Overall Study||31
10125884|NCT02603952|11256932|FG002|Treated|Overall Study||31
10125885|NCT02603952|11256933|FG003|Treated|Overall Study||31
10125886|NCT02603952|11256930|FG000|COMPLETED|Overall Study||31
10125887|NCT02603952|11256931|FG001|COMPLETED|Overall Study||31
10125888|NCT02603952|11256932|FG002|COMPLETED|Overall Study||31
10125889|NCT02603952|11256933|FG003|COMPLETED|Overall Study||31
10125890|NCT02603952|11256930|FG000|NOT COMPLETED|Overall Study||1
10125891|NCT02603952|11256931|FG001|NOT COMPLETED|Overall Study||0
10125892|NCT02603952|11256932|FG002|NOT COMPLETED|Overall Study||0
10125893|NCT02603952|11256933|FG003|NOT COMPLETED|Overall Study||1
10125894|NCT02604017|11256948|FG000|STARTED|Overall Study||352
10125895|NCT02604017|11256949|FG001|STARTED|Overall Study||351
10125896|NCT02604017|11256948|FG000|COMPLETED|Overall Study||346
10125897|NCT02604017|11256949|FG001|COMPLETED|Overall Study||343
10125898|NCT02604017|11256948|FG000|NOT COMPLETED|Overall Study||6
10125899|NCT02604017|11256949|FG001|NOT COMPLETED|Overall Study||8
10125900|NCT02604160|11256957|FG000|STARTED|Overall Study||2
10125901|NCT02604160|11256958|FG001|STARTED|Overall Study||5
10125902|NCT02604160|11256957|FG000|Received at Least One Dose of Study Drug|Overall Study||2
10125903|NCT02604160|11256958|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10125904|NCT02604160|11256957|FG000|COMPLETED|Overall Study||2
10125905|NCT02604160|11256958|FG001|COMPLETED|Overall Study||3
10125906|NCT02604160|11256957|FG000|NOT COMPLETED|Overall Study||0
10125907|NCT02604160|11256958|FG001|NOT COMPLETED|Overall Study||2
10125908|NCT02604173|11256969|FG000|STARTED|Overall Study||33
10125909|NCT02604173|11256970|FG001|STARTED|Overall Study||35
10125910|NCT02604173|11256971|FG002|STARTED|Overall Study||35
10125911|NCT02604173|11256969|FG000|COMPLETED|Overall Study||33
10125912|NCT02604173|11256970|FG001|COMPLETED|Overall Study||35
10125913|NCT02604173|11256971|FG002|COMPLETED|Overall Study||35
10125914|NCT02604173|11256969|FG000|NOT COMPLETED|Overall Study||0
10125915|NCT02604173|11256970|FG001|NOT COMPLETED|Overall Study||0
10125916|NCT02604173|11256971|FG002|NOT COMPLETED|Overall Study||0
10125917|NCT02604199|11256983|FG000|STARTED|Overall Study||9
10125918|NCT02604199|11256984|FG001|STARTED|Overall Study||11
10125919|NCT02604199|11256985|FG002|STARTED|Overall Study||17
10125920|NCT02604199|11256986|FG003|STARTED|Overall Study||21
10125921|NCT02604199|11256983|FG000|COMPLETED|Overall Study||9
10125922|NCT02604199|11256984|FG001|COMPLETED|Overall Study||8
10125923|NCT02604199|11256985|FG002|COMPLETED|Overall Study||17
10125924|NCT02604199|11256986|FG003|COMPLETED|Overall Study||18
10125925|NCT02604199|11256983|FG000|NOT COMPLETED|Overall Study||0
10125926|NCT02604199|11256984|FG001|NOT COMPLETED|Overall Study||3
10125927|NCT02604199|11256985|FG002|NOT COMPLETED|Overall Study||0
10125928|NCT02604199|11256986|FG003|NOT COMPLETED|Overall Study||3
10125929|NCT02604212|11257003|FG000|STARTED|Overall Study||6
10125930|NCT02604212|11257004|FG001|STARTED|Overall Study||5
10125931|NCT02604212|11257005|FG002|STARTED|Overall Study||10
10125932|NCT02604212|11257006|FG003|STARTED|Overall Study||11
10125933|NCT02604212|11257003|FG000|COMPLETED|Overall Study||4
10125934|NCT02604212|11257004|FG001|COMPLETED|Overall Study||4
10125935|NCT02604212|11257005|FG002|COMPLETED|Overall Study||6
10125936|NCT02604212|11257006|FG003|COMPLETED|Overall Study||8
10125937|NCT02604212|11257003|FG000|NOT COMPLETED|Overall Study||2
10125938|NCT02604212|11257004|FG001|NOT COMPLETED|Overall Study||1
10125939|NCT02604212|11257005|FG002|NOT COMPLETED|Overall Study||4
10125940|NCT02604212|11257006|FG003|NOT COMPLETED|Overall Study||3
10125941|NCT02604264|11257023|FG000|STARTED|Run-In||618
10125942|NCT02604264|11257024|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
10125943|NCT02604264|11257023|FG000|COMPLETED|Run-In||618
10125944|NCT02604264|11257024|FG001|COMPLETED|Run-In||611
10125945|NCT02604264|11257023|FG000|NOT COMPLETED|Run-In||0
10125946|NCT02604264|11257024|FG001|NOT COMPLETED|Run-In||0
10125947|NCT02604264|11257023|FG000|STARTED|Intervention||1445
10125948|NCT02604264|11257024|FG001|STARTED|Intervention||1467
10125949|NCT02604264|11257023|FG000|COMPLETED|Intervention||1245
10125950|NCT02604264|11257024|FG001|COMPLETED|Intervention||1225
10125951|NCT02604264|11257023|FG000|NOT COMPLETED|Intervention||200
10125952|NCT02604264|11257024|FG001|NOT COMPLETED|Intervention||242
10125953|NCT02604342|11257032|FG000|STARTED|Overall Study||79
10125954|NCT02604342|11257033|FG001|STARTED|Overall Study||40
10125955|NCT02604342|11257032|FG000|COMPLETED|Overall Study||36
10125956|NCT02604342|11257033|FG001|COMPLETED|Overall Study||17
10125957|NCT02604342|11257032|FG000|NOT COMPLETED|Overall Study||43
10125958|NCT02604342|11257033|FG001|NOT COMPLETED|Overall Study||23
10125959|NCT02604407|11257042|FG000|STARTED|Overall Study||91
10125960|NCT02604407|11257043|FG001|STARTED|Overall Study||92
10125961|NCT02604407|11257044|FG002|STARTED|Overall Study||92
10125962|NCT02604407|11257042|FG000|TREATED|Overall Study||89
10125963|NCT02604407|11257043|FG001|TREATED|Overall Study||92
10125964|NCT02604407|11257044|FG002|TREATED|Overall Study||90
10125965|NCT02604407|11257042|FG000|COMPLETED|Overall Study||80
10125966|NCT02604407|11257043|FG001|COMPLETED|Overall Study||80
10125967|NCT02604407|11257044|FG002|COMPLETED|Overall Study||76
10125968|NCT02604407|11257042|FG000|NOT COMPLETED|Overall Study||11
10125969|NCT02604407|11257043|FG001|NOT COMPLETED|Overall Study||12
10125970|NCT02604407|11257044|FG002|NOT COMPLETED|Overall Study||16
10125971|NCT02604550|11257054|FG000|STARTED|Overall Study||56
10125972|NCT02604550|11257055|FG001|STARTED|Overall Study||59
10125973|NCT02604550|11257054|FG000|COMPLETED|Overall Study||31
10125974|NCT02604550|11257055|FG001|COMPLETED|Overall Study||33
10125975|NCT02604550|11257054|FG000|NOT COMPLETED|Overall Study||25
10125976|NCT02604550|11257055|FG001|NOT COMPLETED|Overall Study||26
10125977|NCT02604589|11257064|FG000|STARTED|Overall Study||3
10125978|NCT02604589|11257065|FG001|STARTED|Overall Study||5
10125979|NCT02604589|11257066|FG002|STARTED|Overall Study||2
10125980|NCT02604589|11257064|FG000|COMPLETED|Overall Study||3
10125981|NCT02604589|11257065|FG001|COMPLETED|Overall Study||5
10125982|NCT02604589|11257066|FG002|COMPLETED|Overall Study||1
10125983|NCT02604589|11257064|FG000|NOT COMPLETED|Overall Study||0
10125984|NCT02604589|11257065|FG001|NOT COMPLETED|Overall Study||0
10125985|NCT02604589|11257066|FG002|NOT COMPLETED|Overall Study||1
10125986|NCT02604810|11257074|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52
10125987|NCT02604810|11257074|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
10125988|NCT02604810|11257074|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
10125989|NCT02604810|11257074|FG000|STARTED|IGSC 20%, 24 Weeks||49
10125990|NCT02604810|11257074|FG000|COMPLETED|IGSC 20%, 24 Weeks||42
10125991|NCT02604810|11257074|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7
10125992|NCT02605122|11257082|FG000|STARTED|Overall Study||73
10125993|NCT02605122|11257083|FG001|STARTED|Overall Study||24
10125994|NCT02605122|11257082|FG000|Received Study Drug|Overall Study||70
10125995|NCT02605122|11257083|FG001|Received Study Drug|Overall Study||24
10125996|NCT02605122|11257082|FG000|COMPLETED|Overall Study||68
10125997|NCT02605122|11257083|FG001|COMPLETED|Overall Study||22
10125998|NCT02605122|11257082|FG000|NOT COMPLETED|Overall Study||5
10125999|NCT02605122|11257083|FG001|NOT COMPLETED|Overall Study||2
10126000|NCT02605174|11257093|FG000|STARTED|Overall Study||501
10126001|NCT02605174|11257094|FG001|STARTED|Overall Study||249
10126002|NCT02605174|11257095|FG002|STARTED|Overall Study||502
10126003|NCT02605174|11257096|FG003|STARTED|Overall Study||252
10126004|NCT02605174|11257097|FG004|STARTED|Overall Study||501
10126005|NCT02605174|11257098|FG005|STARTED|Overall Study||249
10126006|NCT02605174|11257099|FG006|STARTED|Overall Study||751
10126007|NCT02605174|11257093|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429
10126008|NCT02605174|11257094|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225
10126009|NCT02605174|11257095|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423
10126010|NCT02605174|11257096|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212
10126011|NCT02605174|11257097|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434
10126012|NCT02605174|11257098|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215
10126013|NCT02605174|11257099|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645
10126014|NCT02605174|11257093|FG000|Received Optional 2nd Dose|Overall Study||206
10126015|NCT02605174|11257094|FG001|Received Optional 2nd Dose|Overall Study||96
10126016|NCT02605174|11257095|FG002|Received Optional 2nd Dose|Overall Study||177
10126017|NCT02605174|11257096|FG003|Received Optional 2nd Dose|Overall Study||83
10126018|NCT02605174|11257097|FG004|Received Optional 2nd Dose|Overall Study||144
10126019|NCT02605174|11257098|FG005|Received Optional 2nd Dose|Overall Study||74
10126020|NCT02605174|11257099|FG006|Received Optional 2nd Dose|Overall Study||361
10126021|NCT02605174|11257093|FG000|COMPLETED|Overall Study||437
10126022|NCT02605174|11257094|FG001|COMPLETED|Overall Study||226
10126023|NCT02605174|11257095|FG002|COMPLETED|Overall Study||426
10126024|NCT02605174|11257096|FG003|COMPLETED|Overall Study||216
10126025|NCT02605174|11257097|FG004|COMPLETED|Overall Study||448
10126026|NCT02605174|11257098|FG005|COMPLETED|Overall Study||217
10126027|NCT02605174|11257099|FG006|COMPLETED|Overall Study||662
10126028|NCT02605174|11257093|FG000|NOT COMPLETED|Overall Study||64
10126029|NCT02605174|11257094|FG001|NOT COMPLETED|Overall Study||23
10126030|NCT02605174|11257095|FG002|NOT COMPLETED|Overall Study||76
10126031|NCT02605174|11257096|FG003|NOT COMPLETED|Overall Study||36
10126032|NCT02605174|11257097|FG004|NOT COMPLETED|Overall Study||53
10126033|NCT02605174|11257098|FG005|NOT COMPLETED|Overall Study||32
10126034|NCT02605174|11257099|FG006|NOT COMPLETED|Overall Study||89
10126035|NCT02605187|11257129|FG000|STARTED|Overall Study||40
10126036|NCT02605187|11257130|FG001|STARTED|Overall Study||21
10126037|NCT02605187|11257131|FG002|STARTED|Overall Study||83
10126038|NCT02605187|11257132|FG003|STARTED|Overall Study||16
10126039|NCT02605187|11257129|FG000|COMPLETED|Overall Study||32
10126040|NCT02605187|11257130|FG001|COMPLETED|Overall Study||19
10126041|NCT02605187|11257131|FG002|COMPLETED|Overall Study||72
10126042|NCT02605187|11257132|FG003|COMPLETED|Overall Study||15
10126043|NCT02605187|11257129|FG000|NOT COMPLETED|Overall Study||8
10126044|NCT02605187|11257130|FG001|NOT COMPLETED|Overall Study||2
10126045|NCT02605187|11257131|FG002|NOT COMPLETED|Overall Study||11
10126046|NCT02605187|11257132|FG003|NOT COMPLETED|Overall Study||1
10126047|NCT02605304|11257144|FG000|STARTED|Overall Study||4
10126048|NCT02605304|11257145|FG001|STARTED|Overall Study||3
10126049|NCT02605304|11257144|FG000|COMPLETED|Overall Study||4
10126050|NCT02605304|11257145|FG001|COMPLETED|Overall Study||3
10126051|NCT02605304|11257144|FG000|NOT COMPLETED|Overall Study||0
10126052|NCT02605304|11257145|FG001|NOT COMPLETED|Overall Study||0
10126053|NCT02605395|11257151|FG000|STARTED|Period 1, Day 1||35
10126054|NCT02605395|11257152|FG001|STARTED|Period 1, Day 1||35
10126055|NCT02605395|11257151|FG000|COMPLETED|Period 1, Day 1||35
10126056|NCT02605395|11257152|FG001|COMPLETED|Period 1, Day 1||35
10126057|NCT02605395|11257151|FG000|NOT COMPLETED|Period 1, Day 1||0
10126058|NCT02605395|11257152|FG001|NOT COMPLETED|Period 1, Day 1||0
10126059|NCT02605395|11257151|FG000|STARTED|Washout Period, Day 2 to Day 7||35
10126060|NCT02605395|11257152|FG001|STARTED|Washout Period, Day 2 to Day 7||35
10126061|NCT02605395|11257151|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35
10126062|NCT02605395|11257152|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35
10126063|NCT02605395|11257151|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
10126064|NCT02605395|11257152|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
10126065|NCT02605395|11257151|FG000|STARTED|Period 2, Day 8||35
10126066|NCT02605395|11257152|FG001|STARTED|Period 2, Day 8||35
10126067|NCT02605395|11257151|FG000|COMPLETED|Period 2, Day 8||35
10126068|NCT02605395|11257152|FG001|COMPLETED|Period 2, Day 8||35
10126069|NCT02605395|11257151|FG000|NOT COMPLETED|Period 2, Day 8||0
10126070|NCT02605395|11257152|FG001|NOT COMPLETED|Period 2, Day 8||0
10126071|NCT02605447|11257158|FG000|STARTED|Overall Study||1487
10126072|NCT02605447|11257158|FG000|COMPLETED|Overall Study||1385
10126073|NCT02605447|11257158|FG000|NOT COMPLETED|Overall Study||102
10126074|NCT02605642|11257165|FG000|STARTED|Overall Study||227
10126075|NCT02605642|11257166|FG001|STARTED|Overall Study||107
10126076|NCT02605642|11257165|FG000|Safety Set|Overall Study||221
10126077|NCT02605642|11257166|FG001|Safety Set|Overall Study||107
10126078|NCT02605642|11257165|FG000|COMPLETED|Overall Study||131
10126079|NCT02605642|11257166|FG001|COMPLETED|Overall Study||86
10126080|NCT02605642|11257165|FG000|NOT COMPLETED|Overall Study||96
10126081|NCT02605642|11257166|FG001|NOT COMPLETED|Overall Study||21
10126082|NCT02605837|11257174|FG000|STARTED|Overall Study||105
10126083|NCT02605837|11257175|FG001|STARTED|Overall Study||213
10126084|NCT02605837|11257174|FG000|COMPLETED|Overall Study||94
10126085|NCT02605837|11257175|FG001|COMPLETED|Overall Study||202
10126086|NCT02605837|11257174|FG000|NOT COMPLETED|Overall Study||11
10126087|NCT02605837|11257175|FG001|NOT COMPLETED|Overall Study||11
10126088|NCT02605863|11257184|FG000|STARTED|Overall Study||1
10126089|NCT02605863|11257185|FG001|STARTED|Overall Study||0
10126090|NCT02605863|11257184|FG000|COMPLETED|Overall Study||1
10126091|NCT02605863|11257185|FG001|COMPLETED|Overall Study||0
10126092|NCT02605863|11257184|FG000|NOT COMPLETED|Overall Study||0
10126093|NCT02605863|11257185|FG001|NOT COMPLETED|Overall Study||0
10126094|NCT02605876|11257194|FG000|STARTED|Overall Study||25
10126095|NCT02605876|11257195|FG001|STARTED|Overall Study||25
10126096|NCT02605876|11257196|FG002|STARTED|Overall Study||25
10126097|NCT02605876|11257194|FG000|COMPLETED|Overall Study||25
10126098|NCT02605876|11257195|FG001|COMPLETED|Overall Study||25
10126099|NCT02605876|11257196|FG002|COMPLETED|Overall Study||25
10126100|NCT02605876|11257194|FG000|NOT COMPLETED|Overall Study||0
10126101|NCT02605876|11257195|FG001|NOT COMPLETED|Overall Study||0
10126102|NCT02605876|11257196|FG002|NOT COMPLETED|Overall Study||0
10126103|NCT02605928|11257204|FG000|STARTED|Overall Study||79
10126104|NCT02605928|11257204|FG000|Pivotal Phase, Statistical Phase|Overall Study||51
10126105|NCT02605928|11257204|FG000|COMPLETED|Overall Study||46
10126106|NCT02605928|11257204|FG000|NOT COMPLETED|Overall Study||33
10126107|NCT02605954|11257210|FG000|STARTED|Overall Study||183
10126108|NCT02605954|11257211|FG001|STARTED|Overall Study||92
10126109|NCT02605954|11257210|FG000|COMPLETED|Overall Study||171
10126110|NCT02605954|11257211|FG001|COMPLETED|Overall Study||88
10126111|NCT02605954|11257210|FG000|NOT COMPLETED|Overall Study||12
10126112|NCT02605954|11257211|FG001|NOT COMPLETED|Overall Study||4
10126113|NCT02606253|11257223|FG000|STARTED|Overall Study||20
10126114|NCT02606253|11257224|FG001|STARTED|Overall Study||20
10126115|NCT02606253|11257225|FG002|STARTED|Overall Study||20
10126116|NCT02606253|11257223|FG000|COMPLETED|Overall Study||15
10126117|NCT02606253|11257224|FG001|COMPLETED|Overall Study||18
10126118|NCT02606253|11257225|FG002|COMPLETED|Overall Study||20
10126119|NCT02606253|11257223|FG000|NOT COMPLETED|Overall Study||5
10126120|NCT02606253|11257224|FG001|NOT COMPLETED|Overall Study||2
10126121|NCT02606253|11257225|FG002|NOT COMPLETED|Overall Study||0
10126122|NCT02606500|11257235|FG000|STARTED|Overall Study||35
10126123|NCT02606500|11257236|FG001|STARTED|Overall Study||35
10126124|NCT02606500|11257235|FG000|COMPLETED|Overall Study||35
10126125|NCT02606500|11257236|FG001|COMPLETED|Overall Study||35
10126126|NCT02606500|11257235|FG000|NOT COMPLETED|Overall Study||0
10126127|NCT02606500|11257236|FG001|NOT COMPLETED|Overall Study||0
10126128|NCT02606604|11257244|FG000|STARTED|Overall Study||8
10126129|NCT02606604|11257245|FG001|STARTED|Overall Study||7
10126130|NCT02606604|11257244|FG000|COMPLETED|Overall Study||7
10126131|NCT02606604|11257245|FG001|COMPLETED|Overall Study||7
10126132|NCT02606604|11257244|FG000|NOT COMPLETED|Overall Study||1
10126133|NCT02606604|11257245|FG001|NOT COMPLETED|Overall Study||0
10126134|NCT02606643|11257255|FG000|STARTED|Overall Study||68
10126135|NCT02606643|11257256|FG001|STARTED|Overall Study||76
10126136|NCT02606643|11257255|FG000|COMPLETED|Overall Study||67
10126137|NCT02606643|11257256|FG001|COMPLETED|Overall Study||73
10126138|NCT02606643|11257255|FG000|NOT COMPLETED|Overall Study||1
10126139|NCT02606643|11257256|FG001|NOT COMPLETED|Overall Study||3
10126140|NCT02606708|11257266|FG000|STARTED|Overall Study||314
10126141|NCT02606708|11257266|FG000|COMPLETED|Overall Study||314
10126142|NCT02606708|11257266|FG000|NOT COMPLETED|Overall Study||0
10126143|NCT02606734|11257270|FG000|STARTED|Overall Study||44
10126144|NCT02606734|11257270|FG000|COMPLETED|Overall Study||44
10126145|NCT02606734|11257270|FG000|NOT COMPLETED|Overall Study||0
10126146|NCT02606838|11257274|FG000|STARTED|Overall Study||119
10126147|NCT02606838|11257274|FG000|COMPLETED|Overall Study||119
10126148|NCT02606838|11257274|FG000|NOT COMPLETED|Overall Study||0
10126149|NCT02606877|11257284|FG000|STARTED|Overall Study||20
10126150|NCT02606877|11257285|FG001|STARTED|Overall Study||17
10126151|NCT02606877|11257284|FG000|COMPLETED|Overall Study||16
10126152|NCT02606877|11257285|FG001|COMPLETED|Overall Study||16
10126153|NCT02606877|11257284|FG000|NOT COMPLETED|Overall Study||4
10126154|NCT02606877|11257285|FG001|NOT COMPLETED|Overall Study||1
10126155|NCT02606903|11257295|FG000|STARTED|Overall Study||35
10126156|NCT02606903|11257296|FG001|STARTED|Overall Study||36
10126157|NCT02606903|11257295|FG000|COMPLETED|Overall Study||35
10126158|NCT02606903|11257296|FG001|COMPLETED|Overall Study||36
10126159|NCT02606903|11257295|FG000|NOT COMPLETED|Overall Study||0
10126160|NCT02606903|11257296|FG001|NOT COMPLETED|Overall Study||0
10126161|NCT02607124|11257302|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
10126162|NCT02607124|11257302|FG000|COMPLETED|Overall Study||10
10126163|NCT02607124|11257302|FG000|NOT COMPLETED|Overall Study||0
10126164|NCT02607228|11257314|FG000|STARTED|Overall Study||5
10126165|NCT02607228|11257315|FG001|STARTED|Overall Study||4
10126166|NCT02607228|11257316|FG002|STARTED|Overall Study||3
10126167|NCT02607228|11257317|FG003|STARTED|Overall Study||6
10126168|NCT02607228|11257318|FG004|STARTED|Overall Study||5
10126169|NCT02607228|11257319|FG005|STARTED|Overall Study||6
10126170|NCT02607228|11257320|FG006|STARTED|Overall Study||2
10126171|NCT02607228|11257314|FG000|COMPLETED|Overall Study||0
10126172|NCT02607228|11257315|FG001|COMPLETED|Overall Study||0
10126173|NCT02607228|11257316|FG002|COMPLETED|Overall Study||0
10126174|NCT02607228|11257317|FG003|COMPLETED|Overall Study||0
10126175|NCT02607228|11257318|FG004|COMPLETED|Overall Study||0
10126176|NCT02607228|11257319|FG005|COMPLETED|Overall Study||0
10126177|NCT02607228|11257320|FG006|COMPLETED|Overall Study||0
10126178|NCT02607228|11257314|FG000|NOT COMPLETED|Overall Study||5
10126179|NCT02607228|11257315|FG001|NOT COMPLETED|Overall Study||4
10126180|NCT02607228|11257316|FG002|NOT COMPLETED|Overall Study||3
10126181|NCT02607228|11257317|FG003|NOT COMPLETED|Overall Study||6
10126182|NCT02607228|11257318|FG004|NOT COMPLETED|Overall Study||5
10126183|NCT02607228|11257319|FG005|NOT COMPLETED|Overall Study||6
10126184|NCT02607228|11257320|FG006|NOT COMPLETED|Overall Study||2
10126185|NCT02607254|11257340|FG000|STARTED|Overall Study||3
10126186|NCT02607254|11257341|FG001|STARTED|Overall Study||3
10126187|NCT02607254|11257342|FG002|STARTED|Overall Study||5
10126188|NCT02607254|11257340|FG000|COMPLETED|Overall Study||3
10126189|NCT02607254|11257341|FG001|COMPLETED|Overall Study||3
10126190|NCT02607254|11257342|FG002|COMPLETED|Overall Study||5
10126191|NCT02607254|11257340|FG000|NOT COMPLETED|Overall Study||0
10126192|NCT02607254|11257341|FG001|NOT COMPLETED|Overall Study||0
10126193|NCT02607254|11257342|FG002|NOT COMPLETED|Overall Study||0
10126194|NCT02607280|11257358|FG000|STARTED|Overall Study||30
10126195|NCT02607280|11257359|FG001|STARTED|Overall Study||5
10126196|NCT02607280|11257358|FG000|Received Study Drug|Overall Study||30
10126197|NCT02607280|11257359|FG001|Received Study Drug|Overall Study||5
10126198|NCT02607280|11257358|FG000|COMPLETED|Overall Study||26
10126199|NCT02607280|11257359|FG001|COMPLETED|Overall Study||4
10126200|NCT02607280|11257358|FG000|NOT COMPLETED|Overall Study||4
10126201|NCT02607280|11257359|FG001|NOT COMPLETED|Overall Study||1
10126202|NCT02607306|11257368|FG000|STARTED|Overall Study||275
10126203|NCT02607306|11257369|FG001|STARTED|Overall Study||271
10126204|NCT02607306|11257370|FG002|STARTED|Overall Study||273
10126205|NCT02607306|11257368|FG000|COMPLETED|Overall Study||254
10126206|NCT02607306|11257369|FG001|COMPLETED|Overall Study||248
10126207|NCT02607306|11257370|FG002|COMPLETED|Overall Study||263
10126208|NCT02607306|11257368|FG000|NOT COMPLETED|Overall Study||21
10126209|NCT02607306|11257369|FG001|NOT COMPLETED|Overall Study||23
10126210|NCT02607306|11257370|FG002|NOT COMPLETED|Overall Study||10
10126211|NCT02607618|11257381|FG000|STARTED|Overall Study||306
10126212|NCT02607618|11257382|FG001|STARTED|Overall Study||307
10126213|NCT02607618|11257381|FG000|COMPLETED|Overall Study||295
10126214|NCT02607618|11257382|FG001|COMPLETED|Overall Study||305
10126215|NCT02607618|11257381|FG000|NOT COMPLETED|Overall Study||11
10126216|NCT02607618|11257382|FG001|NOT COMPLETED|Overall Study||2
10126217|NCT02607735|11257390|FG000|STARTED|Primary Study||264
10126218|NCT02607735|11257391|FG001|STARTED|Primary Study||152
10126219|NCT02607735|11257392|FG002|STARTED|Primary Study||0
10126220|NCT02607735|11257390|FG000|COMPLETED|Primary Study||257
10126221|NCT02607735|11257391|FG001|COMPLETED|Primary Study||152
10126222|NCT02607735|11257392|FG002|COMPLETED|Primary Study||0
10126223|NCT02607735|11257390|FG000|NOT COMPLETED|Primary Study||7
10126224|NCT02607735|11257391|FG001|NOT COMPLETED|Primary Study||0
10126225|NCT02607735|11257392|FG002|NOT COMPLETED|Primary Study||0
10126226|NCT02607735|11257390|FG000|STARTED|Deferred Treatment Substudy||0
10126227|NCT02607735|11257391|FG001|STARTED|Deferred Treatment Substudy||0
10126228|NCT02607735|11257392|FG002|STARTED|Deferred Treatment Substudy||147
10126229|NCT02607735|11257390|FG000|COMPLETED|Deferred Treatment Substudy||0
10126230|NCT02607735|11257391|FG001|COMPLETED|Deferred Treatment Substudy||0
10126231|NCT02607735|11257392|FG002|COMPLETED|Deferred Treatment Substudy||142
10126232|NCT02607735|11257390|FG000|NOT COMPLETED|Deferred Treatment Substudy||0
10126233|NCT02607735|11257391|FG001|NOT COMPLETED|Deferred Treatment Substudy||0
10126234|NCT02607735|11257392|FG002|NOT COMPLETED|Deferred Treatment Substudy||5
10126235|NCT02607800|11257402|FG000|STARTED|Overall Study||502
10126236|NCT02607800|11257403|FG001|STARTED|Overall Study||441
10126237|NCT02607800|11257402|FG000|COMPLETED|Overall Study||492
10126238|NCT02607800|11257403|FG001|COMPLETED|Overall Study||430
10126239|NCT02607800|11257402|FG000|NOT COMPLETED|Overall Study||10
10126240|NCT02607800|11257403|FG001|NOT COMPLETED|Overall Study||11
10126241|NCT02607865|11257414|FG000|STARTED|Overall Study||466
10126242|NCT02607865|11257415|FG001|STARTED|Overall Study||466
10126243|NCT02607865|11257416|FG002|STARTED|Overall Study||465
10126244|NCT02607865|11257417|FG003|STARTED|Overall Study||467
10126245|NCT02607865|11257414|FG000|Full Analysis Set (FAS)|Overall Study||466
10126246|NCT02607865|11257415|FG001|Full Analysis Set (FAS)|Overall Study||465
10126247|NCT02607865|11257416|FG002|Full Analysis Set (FAS)|Overall Study||465
10126248|NCT02607865|11257417|FG003|Full Analysis Set (FAS)|Overall Study||467
10126249|NCT02607865|11257414|FG000|Safety Analysis Set (SAS)|Overall Study||466
10126250|NCT02607865|11257415|FG001|Safety Analysis Set (SAS)|Overall Study||464
10126251|NCT02607865|11257416|FG002|Safety Analysis Set (SAS)|Overall Study||465
10126252|NCT02607865|11257417|FG003|Safety Analysis Set (SAS)|Overall Study||466
10126253|NCT02607865|11257414|FG000|COMPLETED|Overall Study||433
10126254|NCT02607865|11257415|FG001|COMPLETED|Overall Study||436
10126255|NCT02607865|11257416|FG002|COMPLETED|Overall Study||438
10126256|NCT02607865|11257417|FG003|COMPLETED|Overall Study||451
10126257|NCT02607865|11257414|FG000|NOT COMPLETED|Overall Study||33
10126258|NCT02607865|11257415|FG001|NOT COMPLETED|Overall Study||30
10126259|NCT02607865|11257416|FG002|NOT COMPLETED|Overall Study||27
10126260|NCT02607865|11257417|FG003|NOT COMPLETED|Overall Study||16
10126261|NCT02608099|11257429|FG000|STARTED|Overall Study||148
10126262|NCT02608099|11257430|FG001|STARTED|Overall Study||152
10126263|NCT02608099|11257429|FG000|Safety|Overall Study||149
10126264|NCT02608099|11257430|FG001|Safety|Overall Study||151
10126265|NCT02608099|11257429|FG000|COMPLETED|Overall Study||145
10126266|NCT02608099|11257430|FG001|COMPLETED|Overall Study||150
10126267|NCT02608099|11257429|FG000|NOT COMPLETED|Overall Study||3
10126268|NCT02608099|11257430|FG001|NOT COMPLETED|Overall Study||2
10126269|NCT02608177|11257438|FG000|STARTED|Overall Study||2
10126270|NCT02608177|11257439|FG001|STARTED|Overall Study||1
10126271|NCT02608177|11257438|FG000|COMPLETED|Overall Study||2
10126272|NCT02608177|11257439|FG001|COMPLETED|Overall Study||1
10126273|NCT02608177|11257438|FG000|NOT COMPLETED|Overall Study||0
10126274|NCT02608177|11257439|FG001|NOT COMPLETED|Overall Study||0
10126275|NCT02608229|11257449|FG000|STARTED|Overall Study||10
10126276|NCT02608229|11257450|FG001|STARTED|Overall Study||8
10126277|NCT02608229|11257449|FG000|600 mg BVD-523|Overall Study||10
10126278|NCT02608229|11257450|FG001|600 mg BVD-523|Overall Study||2
10126279|NCT02608229|11257449|FG000|450 mg BVD-523|Overall Study||0
10126280|NCT02608229|11257450|FG001|450 mg BVD-523|Overall Study||6
10126281|NCT02608229|11257449|FG000|COMPLETED|Overall Study||10
10126282|NCT02608229|11257450|FG001|COMPLETED|Overall Study||8
10126283|NCT02608229|11257449|FG000|NOT COMPLETED|Overall Study||0
10126284|NCT02608229|11257450|FG001|NOT COMPLETED|Overall Study||0
10126285|NCT02608450|11257460|FG000|STARTED|Overall Study||353
10126286|NCT02608450|11257461|FG001|STARTED|Overall Study||355
10126287|NCT02608450|11257460|FG000|COMPLETED|Overall Study||287
10126288|NCT02608450|11257461|FG001|COMPLETED|Overall Study||290
10126289|NCT02608450|11257460|FG000|NOT COMPLETED|Overall Study||66
10126290|NCT02608450|11257461|FG001|NOT COMPLETED|Overall Study||65
10126291|NCT02608463|11257470|FG000|STARTED|Overall Study||10
10126292|NCT02608463|11257471|FG001|STARTED|Overall Study||5
10126293|NCT02608463|11257472|FG002|STARTED|Overall Study||0
10126294|NCT02608463|11257473|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0
10126295|NCT02608463|11257470|FG000|COMPLETED|Overall Study||10
10126296|NCT02608463|11257471|FG001|COMPLETED|Overall Study||5
10126297|NCT02608463|11257472|FG002|COMPLETED|Overall Study||0
10126298|NCT02608463|11257473|FG003|COMPLETED|Overall Study||0
10126299|NCT02608463|11257470|FG000|NOT COMPLETED|Overall Study||0
10126300|NCT02608463|11257471|FG001|NOT COMPLETED|Overall Study||0
10126301|NCT02608463|11257472|FG002|NOT COMPLETED|Overall Study||0
10126302|NCT02608463|11257473|FG003|NOT COMPLETED|Overall Study||0
10126303|NCT02608476|11257483|FG000|STARTED|Overall Study||369
10126304|NCT02608476|11257484|FG001|STARTED|Overall Study||363
10126305|NCT02608476|11257483|FG000|COMPLETED|Overall Study||302
10126306|NCT02608476|11257484|FG001|COMPLETED|Overall Study||282
10126307|NCT02608476|11257483|FG000|NOT COMPLETED|Overall Study||67
10126308|NCT02608476|11257484|FG001|NOT COMPLETED|Overall Study||81
10126309|NCT02608489|11257492|FG000|STARTED|Overall Study||43
10126310|NCT02608489|11257493|FG001|STARTED|Overall Study||43
10126311|NCT02608489|11257492|FG000|COMPLETED|Overall Study||30
10126312|NCT02608489|11257493|FG001|COMPLETED|Overall Study||33
10126313|NCT02608489|11257492|FG000|NOT COMPLETED|Overall Study||13
10126314|NCT02608489|11257493|FG001|NOT COMPLETED|Overall Study||10
10126315|NCT02608879|11257502|FG000|STARTED|Overall Study||10
10126316|NCT02608879|11257503|FG001|STARTED|Overall Study||6
10126317|NCT02608879|11257504|FG002|STARTED|Overall Study||3
10126318|NCT02608879|11257502|FG000|COMPLETED|Overall Study||9
10126319|NCT02608879|11257503|FG001|COMPLETED|Overall Study||6
10126320|NCT02608879|11257504|FG002|COMPLETED|Overall Study||0
10126321|NCT02608879|11257502|FG000|NOT COMPLETED|Overall Study||1
10126322|NCT02608879|11257503|FG001|NOT COMPLETED|Overall Study||0
10126323|NCT02608879|11257504|FG002|NOT COMPLETED|Overall Study||3
10126324|NCT02608892|11257514|FG000|STARTED|Overall Study||51
10126325|NCT02608892|11257515|FG001|STARTED|Overall Study||49
10126326|NCT02608892|11257514|FG000|COMPLETED|Overall Study||50
10126327|NCT02608892|11257515|FG001|COMPLETED|Overall Study||49
10126328|NCT02608892|11257514|FG000|NOT COMPLETED|Overall Study||1
10126329|NCT02608892|11257515|FG001|NOT COMPLETED|Overall Study||0
10126330|NCT02609100|11257524|FG000|STARTED|Overall Study||2
10126331|NCT02609100|11257525|FG001|STARTED|Overall Study||2
10126332|NCT02609100|11257524|FG000|COMPLETED|Overall Study||2
10126333|NCT02609100|11257525|FG001|COMPLETED|Overall Study||2
10126334|NCT02609100|11257524|FG000|NOT COMPLETED|Overall Study||0
10126335|NCT02609100|11257525|FG001|NOT COMPLETED|Overall Study||0
10126336|NCT02609113|11257535|FG000|STARTED|Overall Study||11
10126337|NCT02609113|11257536|FG001|STARTED|Overall Study||11
10126338|NCT02609113|11257535|FG000|COMPLETED|Overall Study||9
10126339|NCT02609113|11257536|FG001|COMPLETED|Overall Study||9
10126340|NCT02609113|11257535|FG000|NOT COMPLETED|Overall Study||2
10126341|NCT02609113|11257536|FG001|NOT COMPLETED|Overall Study||2
10126342|NCT02609178|11257542|FG000|STARTED|First Crown||0
10126343|NCT02609178|11257543|FG001|STARTED|First Crown||1
10126344|NCT02609178|11257544|FG002|STARTED|First Crown||6
10126345|NCT02609178|11257545|FG003|STARTED|First Crown||3
10126346|NCT02609178|11257546|FG004|STARTED|First Crown||0
10126347|NCT02609178|11257547|FG005|STARTED|First Crown||2
10126348|NCT02609178|11257542|FG000|COMPLETED|First Crown||0
10126349|NCT02609178|11257543|FG001|COMPLETED|First Crown||1
10126350|NCT02609178|11257544|FG002|COMPLETED|First Crown||5
10126351|NCT02609178|11257545|FG003|COMPLETED|First Crown||2
10126352|NCT02609178|11257546|FG004|COMPLETED|First Crown||0
10126353|NCT02609178|11257547|FG005|COMPLETED|First Crown||2
10126354|NCT02609178|11257542|FG000|NOT COMPLETED|First Crown||0
10126355|NCT02609178|11257543|FG001|NOT COMPLETED|First Crown||0
10126356|NCT02609178|11257544|FG002|NOT COMPLETED|First Crown||1
10126357|NCT02609178|11257545|FG003|NOT COMPLETED|First Crown||1
10126358|NCT02609178|11257546|FG004|NOT COMPLETED|First Crown||0
10126359|NCT02609178|11257547|FG005|NOT COMPLETED|First Crown||0
10126360|NCT02609178|11257542|FG000|STARTED|5-minute Washout Time||0
9706697|NCT03298867|10805778|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19
9706698|NCT03298867|10805777|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0
9706699|NCT03298867|10805778|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1
9706700|NCT03227224|10805788|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138
9706701|NCT03227224|10805789|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33
9706702|NCT03227224|10805790|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63
9706703|NCT03227224|10805791|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53
9706704|NCT03227224|10805788|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137
9706705|NCT03227224|10805789|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33
9706706|NCT03227224|10805790|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61
9706707|NCT03227224|10805791|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52
9706708|NCT03227224|10805788|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123
10126361|NCT02609178|11257543|FG001|STARTED|5-minute Washout Time||1
10126362|NCT02609178|11257544|FG002|STARTED|5-minute Washout Time||5
10126363|NCT02609178|11257545|FG003|STARTED|5-minute Washout Time||2
10126364|NCT02609178|11257546|FG004|STARTED|5-minute Washout Time||0
10126365|NCT02609178|11257547|FG005|STARTED|5-minute Washout Time||2
10126366|NCT02609178|11257542|FG000|COMPLETED|5-minute Washout Time||0
10126367|NCT02609178|11257543|FG001|COMPLETED|5-minute Washout Time||1
10126368|NCT02609178|11257544|FG002|COMPLETED|5-minute Washout Time||5
10126369|NCT02609178|11257545|FG003|COMPLETED|5-minute Washout Time||2
10126370|NCT02609178|11257546|FG004|COMPLETED|5-minute Washout Time||0
10126371|NCT02609178|11257547|FG005|COMPLETED|5-minute Washout Time||2
10126372|NCT02609178|11257542|FG000|NOT COMPLETED|5-minute Washout Time||0
10126373|NCT02609178|11257543|FG001|NOT COMPLETED|5-minute Washout Time||0
10126374|NCT02609178|11257544|FG002|NOT COMPLETED|5-minute Washout Time||0
10126375|NCT02609178|11257545|FG003|NOT COMPLETED|5-minute Washout Time||0
10126376|NCT02609178|11257546|FG004|NOT COMPLETED|5-minute Washout Time||0
10126377|NCT02609178|11257547|FG005|NOT COMPLETED|5-minute Washout Time||0
10126378|NCT02609178|11257542|FG000|STARTED|Second Crown||0
10126379|NCT02609178|11257543|FG001|STARTED|Second Crown||1
10126380|NCT02609178|11257544|FG002|STARTED|Second Crown||5
10126381|NCT02609178|11257545|FG003|STARTED|Second Crown||2
10126382|NCT02609178|11257546|FG004|STARTED|Second Crown||0
10126383|NCT02609178|11257547|FG005|STARTED|Second Crown||2
10126384|NCT02609178|11257542|FG000|COMPLETED|Second Crown||0
10126385|NCT02609178|11257543|FG001|COMPLETED|Second Crown||1
10126386|NCT02609178|11257544|FG002|COMPLETED|Second Crown||5
10126387|NCT02609178|11257545|FG003|COMPLETED|Second Crown||2
10126388|NCT02609178|11257546|FG004|COMPLETED|Second Crown||0
10126389|NCT02609178|11257547|FG005|COMPLETED|Second Crown||2
10126390|NCT02609178|11257542|FG000|NOT COMPLETED|Second Crown||0
10126391|NCT02609178|11257543|FG001|NOT COMPLETED|Second Crown||0
10126392|NCT02609178|11257544|FG002|NOT COMPLETED|Second Crown||0
10126393|NCT02609178|11257545|FG003|NOT COMPLETED|Second Crown||0
10126394|NCT02609178|11257546|FG004|NOT COMPLETED|Second Crown||0
10126395|NCT02609178|11257547|FG005|NOT COMPLETED|Second Crown||0
10126396|NCT02609178|11257542|FG000|STARTED|5-minute Washout Time||0
10126397|NCT02609178|11257543|FG001|STARTED|5-minute Washout Time||1
10126398|NCT02609178|11257544|FG002|STARTED|5-minute Washout Time||5
10126399|NCT02609178|11257545|FG003|STARTED|5-minute Washout Time||2
10126400|NCT02609178|11257546|FG004|STARTED|5-minute Washout Time||0
10126401|NCT02609178|11257547|FG005|STARTED|5-minute Washout Time||2
10126402|NCT02609178|11257542|FG000|COMPLETED|5-minute Washout Time||0
10126403|NCT02609178|11257543|FG001|COMPLETED|5-minute Washout Time||1
10126404|NCT02609178|11257544|FG002|COMPLETED|5-minute Washout Time||5
10126405|NCT02609178|11257545|FG003|COMPLETED|5-minute Washout Time||2
10126406|NCT02609178|11257546|FG004|COMPLETED|5-minute Washout Time||0
10126407|NCT02609178|11257547|FG005|COMPLETED|5-minute Washout Time||2
10126408|NCT02609178|11257542|FG000|NOT COMPLETED|5-minute Washout Time||0
10126409|NCT02609178|11257543|FG001|NOT COMPLETED|5-minute Washout Time||0
10126410|NCT02609178|11257544|FG002|NOT COMPLETED|5-minute Washout Time||0
10126411|NCT02609178|11257545|FG003|NOT COMPLETED|5-minute Washout Time||0
10126412|NCT02609178|11257546|FG004|NOT COMPLETED|5-minute Washout Time||0
10126413|NCT02609178|11257547|FG005|NOT COMPLETED|5-minute Washout Time||0
10126414|NCT02609178|11257542|FG000|STARTED|Third Crown||0
10126415|NCT02609178|11257543|FG001|STARTED|Third Crown||1
10126416|NCT02609178|11257544|FG002|STARTED|Third Crown||5
10126417|NCT02609178|11257545|FG003|STARTED|Third Crown||2
10126418|NCT02609178|11257546|FG004|STARTED|Third Crown||0
10126419|NCT02609178|11257547|FG005|STARTED|Third Crown||2
10126420|NCT02609178|11257542|FG000|COMPLETED|Third Crown||0
10126421|NCT02609178|11257543|FG001|COMPLETED|Third Crown||1
10126422|NCT02609178|11257544|FG002|COMPLETED|Third Crown||5
10126423|NCT02609178|11257545|FG003|COMPLETED|Third Crown||2
10126424|NCT02609178|11257546|FG004|COMPLETED|Third Crown||0
10126425|NCT02609178|11257547|FG005|COMPLETED|Third Crown||2
10126426|NCT02609178|11257542|FG000|NOT COMPLETED|Third Crown||0
10126427|NCT02609178|11257543|FG001|NOT COMPLETED|Third Crown||0
10126428|NCT02609178|11257544|FG002|NOT COMPLETED|Third Crown||0
10126429|NCT02609178|11257545|FG003|NOT COMPLETED|Third Crown||0
10126430|NCT02609178|11257546|FG004|NOT COMPLETED|Third Crown||0
10126431|NCT02609178|11257547|FG005|NOT COMPLETED|Third Crown||0
10126432|NCT02609204|11257553|FG000|STARTED|Overall Study||51
10126433|NCT02609204|11257553|FG000|COMPLETED|Overall Study||51
10126434|NCT02609204|11257553|FG000|NOT COMPLETED|Overall Study||0
10126435|NCT02609308|11257560|FG000|STARTED|Overall Study||10
10126436|NCT02609308|11257561|FG001|STARTED|Overall Study||11
10126437|NCT02609308|11257560|FG000|COMPLETED|Overall Study||10
10126438|NCT02609308|11257561|FG001|COMPLETED|Overall Study||11
10126439|NCT02609308|11257560|FG000|NOT COMPLETED|Overall Study||0
10126440|NCT02609308|11257561|FG001|NOT COMPLETED|Overall Study||0
10126441|NCT02609399|11257569|FG000|STARTED|Influenza Season 2015-2016||27
10126442|NCT02609399|11257570|FG001|STARTED|Influenza Season 2015-2016||31
10126443|NCT02609399|11257569|FG000|COMPLETED|Influenza Season 2015-2016||24
10126444|NCT02609399|11257570|FG001|COMPLETED|Influenza Season 2015-2016||29
10126445|NCT02609399|11257569|FG000|NOT COMPLETED|Influenza Season 2015-2016||3
10126446|NCT02609399|11257570|FG001|NOT COMPLETED|Influenza Season 2015-2016||2
10126447|NCT02609399|11257569|FG000|STARTED|Influenza Season 2016-2017||58
10126448|NCT02609399|11257570|FG001|STARTED|Influenza Season 2016-2017||64
10126449|NCT02609399|11257569|FG000|COMPLETED|Influenza Season 2016-2017||49
10126450|NCT02609399|11257570|FG001|COMPLETED|Influenza Season 2016-2017||59
10126451|NCT02609399|11257569|FG000|NOT COMPLETED|Influenza Season 2016-2017||9
10126452|NCT02609399|11257570|FG001|NOT COMPLETED|Influenza Season 2016-2017||5
10126453|NCT02609607|11257580|FG000|STARTED|Overall Study||6
10126454|NCT02609607|11257581|FG001|STARTED|Overall Study||5
10126455|NCT02609607|11257580|FG000|COMPLETED|Overall Study||6
10126456|NCT02609607|11257581|FG001|COMPLETED|Overall Study||4
10126457|NCT02609607|11257580|FG000|NOT COMPLETED|Overall Study||0
10126458|NCT02609607|11257581|FG001|NOT COMPLETED|Overall Study||1
10126459|NCT02609633|11257589|FG000|STARTED|Overall Study||42
10126460|NCT02609633|11257590|FG001|STARTED|Overall Study||56
10126461|NCT02609633|11257589|FG000|Full Analysis Set (FAS)|Overall Study||32
10126462|NCT02609633|11257590|FG001|Full Analysis Set (FAS)|Overall Study||46
10126463|NCT02609633|11257589|FG000|COMPLETED|Overall Study||37
10126464|NCT02609633|11257590|FG001|COMPLETED|Overall Study||54
10126465|NCT02609633|11257589|FG000|NOT COMPLETED|Overall Study||5
10126466|NCT02609633|11257590|FG001|NOT COMPLETED|Overall Study||2
10126467|NCT02609659|11257597|FG000|STARTED|Overall Study||105
10126468|NCT02609659|11257597|FG000|COMPLETED|Overall Study||97
10126469|NCT02609659|11257597|FG000|NOT COMPLETED|Overall Study||8
10126470|NCT02609672|11257603|FG000|STARTED|Overall Study||12
10126471|NCT02609672|11257604|FG001|STARTED|Overall Study||12
10126472|NCT02609672|11257603|FG000|COMPLETED|Overall Study||9
10126473|NCT02609672|11257604|FG001|COMPLETED|Overall Study||11
10126474|NCT02609672|11257603|FG000|NOT COMPLETED|Overall Study||3
10126475|NCT02609672|11257604|FG001|NOT COMPLETED|Overall Study||1
10126476|NCT02609841|11257612|FG000|STARTED|Overall Study||240
10126477|NCT02609841|11257612|FG000|COMPLETED|Overall Study||212
10126478|NCT02609841|11257612|FG000|NOT COMPLETED|Overall Study||28
10126479|NCT02609984|11257620|FG000|STARTED|Overall Study||45
10126480|NCT02609984|11257621|FG001|STARTED|Overall Study||44
10126481|NCT02609984|11257620|FG000|Treated|Overall Study||45
10126482|NCT02609984|11257621|FG001|Treated|Overall Study||43
10126483|NCT02609984|11257620|FG000|COMPLETED|Overall Study||1
10126484|NCT02609984|11257621|FG001|COMPLETED|Overall Study||5
10126485|NCT02609984|11257620|FG000|NOT COMPLETED|Overall Study||44
10126486|NCT02609984|11257621|FG001|NOT COMPLETED|Overall Study||39
10126487|NCT02610140|11257629|FG000|STARTED|Randomization and Treatment Period||166
10126488|NCT02610140|11257630|FG001|STARTED|Randomization and Treatment Period||82
10126489|NCT02610140|11257629|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
10126490|NCT02610140|11257630|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
10126491|NCT02610140|11257629|FG000|COMPLETED|Randomization and Treatment Period||0
10126492|NCT02610140|11257630|FG001|COMPLETED|Randomization and Treatment Period||0
10126493|NCT02610140|11257629|FG000|NOT COMPLETED|Randomization and Treatment Period||166
10126494|NCT02610140|11257630|FG001|NOT COMPLETED|Randomization and Treatment Period||82
10126495|NCT02610140|11257629|FG000|STARTED|Safety Follow-up||102
10126496|NCT02610140|11257630|FG001|STARTED|Safety Follow-up||45
10126497|NCT02610140|11257629|FG000|COMPLETED|Safety Follow-up||57
10126498|NCT02610140|11257630|FG001|COMPLETED|Safety Follow-up||21
10126499|NCT02610140|11257629|FG000|NOT COMPLETED|Safety Follow-up||45
10126500|NCT02610140|11257630|FG001|NOT COMPLETED|Safety Follow-up||24
10126501|NCT02610140|11257629|FG000|STARTED|Active Follow-up||48
10126502|NCT02610140|11257630|FG001|STARTED|Active Follow-up||26
10126503|NCT02610140|11257629|FG000|COMPLETED|Active Follow-up||0
10126504|NCT02610140|11257630|FG001|COMPLETED|Active Follow-up||0
10126505|NCT02610140|11257629|FG000|NOT COMPLETED|Active Follow-up||48
10126506|NCT02610140|11257630|FG001|NOT COMPLETED|Active Follow-up||26
10126507|NCT02610140|11257629|FG000|STARTED|Long-term Follow-up||123
10126508|NCT02610140|11257630|FG001|STARTED|Long-term Follow-up||66
10126509|NCT02610140|11257629|FG000|COMPLETED|Long-term Follow-up||0
10126510|NCT02610140|11257630|FG001|COMPLETED|Long-term Follow-up||0
10126511|NCT02610140|11257629|FG000|NOT COMPLETED|Long-term Follow-up||123
10126512|NCT02610140|11257630|FG001|NOT COMPLETED|Long-term Follow-up||66
10126513|NCT02610192|11257636|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
10126514|NCT02610192|11257636|FG000|COMPLETED|Overall Study||41
10126515|NCT02610192|11257636|FG000|NOT COMPLETED|Overall Study||9
10126516|NCT02610231|11257640|FG000|STARTED|Overall Study||239
10126517|NCT02610231|11257640|FG000|COMPLETED|Overall Study||179
10126518|NCT02610231|11257640|FG000|NOT COMPLETED|Overall Study||60
10126519|NCT02610634|11257649|FG000|STARTED|Overall Study||60
10126520|NCT02610634|11257650|FG001|STARTED|Overall Study||40
10126521|NCT02610634|11257649|FG000|COMPLETED|Overall Study||60
10126522|NCT02610634|11257650|FG001|COMPLETED|Overall Study||40
10126523|NCT02610634|11257649|FG000|NOT COMPLETED|Overall Study||0
10126524|NCT02610634|11257650|FG001|NOT COMPLETED|Overall Study||0
10126525|NCT02610725|11257656|FG000|STARTED|Overall Study||281
10126526|NCT02610725|11257656|FG000|COMPLETED|Overall Study||75
10126527|NCT02610725|11257656|FG000|NOT COMPLETED|Overall Study||206
10126528|NCT02610816|11257662|FG000|STARTED|Phase 1||38
10126529|NCT02610816|11257663|FG001|STARTED|Phase 1||25
10126530|NCT02610816|11257664|FG002|STARTED|Phase 1||0
10126531|NCT02610816|11257665|FG003|STARTED|Phase 1||0
10126532|NCT02610816|11257662|FG000|COMPLETED|Phase 1||34
10126533|NCT02610816|11257663|FG001|COMPLETED|Phase 1||17
10126534|NCT02610816|11257664|FG002|COMPLETED|Phase 1||0
10126535|NCT02610816|11257665|FG003|COMPLETED|Phase 1||0
10126536|NCT02610816|11257662|FG000|NOT COMPLETED|Phase 1||4
10126537|NCT02610816|11257663|FG001|NOT COMPLETED|Phase 1||8
10126538|NCT02610816|11257664|FG002|NOT COMPLETED|Phase 1||0
10126539|NCT02610816|11257665|FG003|NOT COMPLETED|Phase 1||0
10126540|NCT02610816|11257662|FG000|STARTED|Phase 2||0
10126541|NCT02610816|11257663|FG001|STARTED|Phase 2||0
10126542|NCT02610816|11257664|FG002|STARTED|Phase 2||19
10126543|NCT02610816|11257665|FG003|STARTED|Phase 2||10
10126544|NCT02610816|11257662|FG000|COMPLETED|Phase 2||0
10126545|NCT02610816|11257663|FG001|COMPLETED|Phase 2||0
10126546|NCT02610816|11257664|FG002|COMPLETED|Phase 2||8
10126547|NCT02610816|11257665|FG003|COMPLETED|Phase 2||4
10126548|NCT02610816|11257662|FG000|NOT COMPLETED|Phase 2||0
10126549|NCT02610816|11257663|FG001|NOT COMPLETED|Phase 2||0
10126550|NCT02610816|11257664|FG002|NOT COMPLETED|Phase 2||11
10126551|NCT02610816|11257665|FG003|NOT COMPLETED|Phase 2||6
10126552|NCT02610842|11257675|FG000|STARTED|Overall Study||27
10126553|NCT02610842|11257675|FG000|COMPLETED|Overall Study||22
10126554|NCT02610842|11257675|FG000|NOT COMPLETED|Overall Study||5
10126555|NCT02610868|11257681|FG000|STARTED|MYOBLOC: Treatment Session 1||187
10126556|NCT02610868|11257681|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180
10126557|NCT02610868|11257681|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
10126558|NCT02610868|11257681|FG000|STARTED|MYOBLOC: Treatment Session 2||177
10126559|NCT02610868|11257681|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165
10126560|NCT02610868|11257681|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
10126561|NCT02610868|11257681|FG000|STARTED|MYOBLOC: Treatment Session 3||50
10126562|NCT02610868|11257681|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43
10126563|NCT02610868|11257681|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
10126564|NCT02610868|11257681|FG000|STARTED|MYOBLOC: Treatment Session 4||24
10126565|NCT02610868|11257681|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22
10126566|NCT02610868|11257681|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
10126567|NCT02610972|11257703|FG000|STARTED|Overall Study||100
10126568|NCT02610972|11257704|FG001|STARTED|Overall Study||50
10126569|NCT02610972|11257703|FG000|COMPLETED|Overall Study||100
10126570|NCT02610972|11257704|FG001|COMPLETED|Overall Study||50
10126571|NCT02610972|11257703|FG000|NOT COMPLETED|Overall Study||0
10126572|NCT02610972|11257704|FG001|NOT COMPLETED|Overall Study||0
10196343|NCT03359590|11324552|FG000|Discontinued|Second Intervention||0
10196344|NCT03359590|11324553|FG001|Discontinued|Second Intervention||0
10196345|NCT03359590|11324552|FG000|COMPLETED|Second Intervention||9
10196346|NCT03359590|11324553|FG001|COMPLETED|Second Intervention||8
10196347|NCT03359590|11324552|FG000|NOT COMPLETED|Second Intervention||0
10196348|NCT03359590|11324553|FG001|NOT COMPLETED|Second Intervention||0
10196349|NCT03359629|11324561|FG000|STARTED|Overall Study||200
10196350|NCT03359629|11324562|FG001|STARTED|Overall Study||10
10196351|NCT03359629|11324561|FG000|COMPLETED|Overall Study||200
10196352|NCT03359629|11324562|FG001|COMPLETED|Overall Study||10
10196353|NCT03359629|11324561|FG000|NOT COMPLETED|Overall Study||0
10196354|NCT03359629|11324562|FG001|NOT COMPLETED|Overall Study||0
10196355|NCT03359850|11324570|FG000|STARTED|PK Phase (Up to Day 8)||9
10196356|NCT03359850|11324571|FG001|STARTED|PK Phase (Up to Day 8)||8
10196357|NCT03359850|11324570|FG000|COMPLETED|PK Phase (Up to Day 8)||8
10196358|NCT03359850|11324571|FG001|COMPLETED|PK Phase (Up to Day 8)||7
10196359|NCT03359850|11324570|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1
10196360|NCT03359850|11324571|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1
10196361|NCT03359850|11324570|FG000|STARTED|Extension Phase (Up to 28 Months)||8
10196362|NCT03359850|11324571|FG001|STARTED|Extension Phase (Up to 28 Months)||7
10196363|NCT03359850|11324570|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0
10196364|NCT03359850|11324571|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1
10196365|NCT03359850|11324570|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
10196366|NCT03359850|11324571|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
10196367|NCT03359889|11324579|FG000|STARTED|Overall Study||5
10196368|NCT03359889|11324579|FG000|COMPLETED|Overall Study||5
10196369|NCT03359889|11324579|FG000|NOT COMPLETED|Overall Study||0
10196370|NCT03360071|11324585|FG000|STARTED|Overall Study||17
10196371|NCT03360071|11324586|FG001|STARTED|Overall Study||14
10196372|NCT03360071|11324585|FG000|COMPLETED|Overall Study||16
10196373|NCT03360071|11324586|FG001|COMPLETED|Overall Study||14
10196374|NCT03360071|11324585|FG000|NOT COMPLETED|Overall Study||1
10196375|NCT03360071|11324586|FG001|NOT COMPLETED|Overall Study||0
10196376|NCT03360110|11324592|FG000|STARTED|First Intervention||27
10196377|NCT03360110|11324593|FG001|STARTED|First Intervention||26
10196378|NCT03360110|11324592|FG000|COMPLETED|First Intervention||27
10196379|NCT03360110|11324593|FG001|COMPLETED|First Intervention||26
10196380|NCT03360110|11324592|FG000|NOT COMPLETED|First Intervention||0
10196381|NCT03360110|11324593|FG001|NOT COMPLETED|First Intervention||0
10196382|NCT03360110|11324592|FG000|STARTED|Second Intervention||27
10196383|NCT03360110|11324593|FG001|STARTED|Second Intervention||26
10196384|NCT03360110|11324592|FG000|COMPLETED|Second Intervention||27
10196385|NCT03360110|11324593|FG001|COMPLETED|Second Intervention||26
10196386|NCT03360110|11324592|FG000|NOT COMPLETED|Second Intervention||0
10196387|NCT03360110|11324593|FG001|NOT COMPLETED|Second Intervention||0
10196388|NCT03360344|11324614|FG000|STARTED|Overall Study||15
10196389|NCT03360344|11324615|FG001|STARTED|Overall Study||16
10196390|NCT03360344|11324616|FG002|STARTED|Overall Study||13
10196391|NCT03360344|11324614|FG000|COMPLETED|Overall Study||15
10196392|NCT03360344|11324615|FG001|COMPLETED|Overall Study||15
10196393|NCT03360344|11324616|FG002|COMPLETED|Overall Study||12
10196394|NCT03360344|11324614|FG000|NOT COMPLETED|Overall Study||0
10196395|NCT03360344|11324615|FG001|NOT COMPLETED|Overall Study||1
10196396|NCT03360344|11324616|FG002|NOT COMPLETED|Overall Study||1
10196397|NCT03360747|11324624|FG000|STARTED|Overall Study||3
10196398|NCT03360747|11324624|FG000|COMPLETED|Overall Study||2
10196399|NCT03360747|11324624|FG000|NOT COMPLETED|Overall Study||1
10196400|NCT03361137|11324633|FG000|STARTED|Overall Study||1
10196401|NCT03361137|11324634|FG001|STARTED|Overall Study||9
10196402|NCT03361137|11324635|FG002|STARTED|Overall Study||1
10196403|NCT03361137|11324636|FG003|STARTED|Overall Study||2
10196404|NCT03361137|11324637|FG004|STARTED|Overall Study||1
10196405|NCT03361137|11324633|FG000|COMPLETED|Overall Study||0
10196406|NCT03361137|11324634|FG001|COMPLETED|Overall Study||9
10196407|NCT03361137|11324635|FG002|COMPLETED|Overall Study||1
10196408|NCT03361137|11324636|FG003|COMPLETED|Overall Study||2
10196409|NCT03361137|11324637|FG004|COMPLETED|Overall Study||1
10196410|NCT03361137|11324633|FG000|NOT COMPLETED|Overall Study||1
10196411|NCT03361137|11324634|FG001|NOT COMPLETED|Overall Study||0
10196412|NCT03361137|11324635|FG002|NOT COMPLETED|Overall Study||0
10196413|NCT03361137|11324636|FG003|NOT COMPLETED|Overall Study||0
10196414|NCT03361137|11324637|FG004|NOT COMPLETED|Overall Study||0
10196415|NCT03361176|11324653|FG000|STARTED|Overall Study||10
10196416|NCT03361176|11324654|FG001|STARTED|Overall Study||20
10196417|NCT03361176|11324653|FG000|COMPLETED|Overall Study||9
10196418|NCT03361176|11324654|FG001|COMPLETED|Overall Study||15
10196419|NCT03361176|11324653|FG000|NOT COMPLETED|Overall Study||1
10196420|NCT03361176|11324654|FG001|NOT COMPLETED|Overall Study||5
10196421|NCT03361293|11324662|FG000|STARTED|Overall Study||20
10196422|NCT03361293|11324663|FG001|STARTED|Overall Study||24
10196423|NCT03361293|11324662|FG000|COMPLETED|Overall Study||19
10196424|NCT03361293|11324663|FG001|COMPLETED|Overall Study||19
10196425|NCT03361293|11324662|FG000|NOT COMPLETED|Overall Study||1
10196426|NCT03361293|11324663|FG001|NOT COMPLETED|Overall Study||5
10196427|NCT03361423|11324671|FG000|STARTED|Overall Study||126
10196428|NCT03361423|11324672|FG001|STARTED|Overall Study||126
10196429|NCT03361423|11324671|FG000|COMPLETED|Overall Study||99
10196430|NCT03361423|11324672|FG001|COMPLETED|Overall Study||103
10196431|NCT03361423|11324671|FG000|NOT COMPLETED|Overall Study||27
10126573|NCT02611154|11257710|FG000|STARTED|Overall Study||5
10126574|NCT02611154|11257710|FG000|COMPLETED|Overall Study||5
10126575|NCT02611154|11257710|FG000|NOT COMPLETED|Overall Study||0
10126576|NCT02611362|11257731|FG000|STARTED|Overall Study||41
10126577|NCT02611362|11257732|FG001|STARTED|Overall Study||41
10126578|NCT02611362|11257731|FG000|Immediate Posttest (3 Months)|Overall Study||33
10126579|NCT02611362|11257732|FG001|Immediate Posttest (3 Months)|Overall Study||34
10126580|NCT02611362|11257731|FG000|6-month Follow-up|Overall Study||32
10126581|NCT02611362|11257732|FG001|6-month Follow-up|Overall Study||35
10126582|NCT02611362|11257731|FG000|COMPLETED|Overall Study||32
10126583|NCT02611362|11257732|FG001|COMPLETED|Overall Study||35
10126584|NCT02611362|11257731|FG000|NOT COMPLETED|Overall Study||9
10126585|NCT02611362|11257732|FG001|NOT COMPLETED|Overall Study||6
10126586|NCT02611479|11257739|FG000|STARTED|Baseline Enrollment||184
10126587|NCT02611479|11257739|FG000|COMPLETED|Baseline Enrollment||171
10126588|NCT02611479|11257739|FG000|NOT COMPLETED|Baseline Enrollment||13
10126589|NCT02611479|11257739|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171
10126590|NCT02611479|11257739|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
10126591|NCT02611479|11257739|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
10126592|NCT02611479|11257739|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169
10126593|NCT02611479|11257739|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151
10126594|NCT02611479|11257739|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
10126595|NCT02611479|11257739|FG000|STARTED|Data Cleaning||151
10126596|NCT02611479|11257739|FG000|COMPLETED|Data Cleaning||149
10126597|NCT02611479|11257739|FG000|NOT COMPLETED|Data Cleaning||2
10126598|NCT02611752|11257745|FG000|STARTED|Overall Study||22
10126599|NCT02611752|11257746|FG001|STARTED|Overall Study||25
10126600|NCT02611752|11257745|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
10126601|NCT02611752|11257746|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
10126602|NCT02611752|11257745|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
10126603|NCT02611752|11257746|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
10126604|NCT02611752|11257745|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
10126605|NCT02611752|11257746|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
10126606|NCT02611752|11257745|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
10126607|NCT02611752|11257746|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
10126608|NCT02611752|11257745|FG000|COMPLETED|Overall Study||22
10126609|NCT02611752|11257746|FG001|COMPLETED|Overall Study||24
10126610|NCT02611752|11257745|FG000|NOT COMPLETED|Overall Study||0
10126611|NCT02611752|11257746|FG001|NOT COMPLETED|Overall Study||1
10126612|NCT02611765|11257767|FG000|STARTED|Overall Study||29
10126613|NCT02611765|11257768|FG001|STARTED|Overall Study||35
10126614|NCT02611765|11257767|FG000|COMPLETED|Overall Study||27
10126615|NCT02611765|11257768|FG001|COMPLETED|Overall Study||29
10126616|NCT02611765|11257767|FG000|NOT COMPLETED|Overall Study||2
10126617|NCT02611765|11257768|FG001|NOT COMPLETED|Overall Study||6
10126618|NCT02611778|11257776|FG000|STARTED|Overall Study||238
10126619|NCT02611778|11257777|FG001|STARTED|Overall Study||239
10126620|NCT02611778|11257776|FG000|COMPLETED|Overall Study||226
10126621|NCT02611778|11257777|FG001|COMPLETED|Overall Study||226
10126622|NCT02611778|11257776|FG000|NOT COMPLETED|Overall Study||12
10126623|NCT02611778|11257777|FG001|NOT COMPLETED|Overall Study||13
10126624|NCT02611882|11257787|FG000|STARTED|Overall Study||75
10126625|NCT02611882|11257788|FG001|STARTED|Overall Study||150
10126626|NCT02611882|11257789|FG002|STARTED|Overall Study||0
10126627|NCT02611882|11257787|FG000|Completed Surgery Per Protocol|Overall Study||42
10126628|NCT02611882|11257788|FG001|Completed Surgery Per Protocol|Overall Study||0
10126629|NCT02611882|11257789|FG002|Completed Surgery Per Protocol|Overall Study||0
10126630|NCT02611882|11257787|FG000|COMPLETED|Overall Study||42
10126631|NCT02611882|11257788|FG001|COMPLETED|Overall Study||150
10126632|NCT02611882|11257789|FG002|COMPLETED|Overall Study||0
10126633|NCT02611882|11257787|FG000|NOT COMPLETED|Overall Study||33
10126634|NCT02611882|11257788|FG001|NOT COMPLETED|Overall Study||0
10126635|NCT02611882|11257789|FG002|NOT COMPLETED|Overall Study||0
10126636|NCT02612064|11257798|FG000|STARTED|Overall Study||115
10126637|NCT02612064|11257799|FG001|STARTED|Overall Study||115
10126638|NCT02612064|11257798|FG000|COMPLETED|Overall Study||114
10126639|NCT02612064|11257799|FG001|COMPLETED|Overall Study||112
10126640|NCT02612064|11257798|FG000|NOT COMPLETED|Overall Study||1
10126641|NCT02612064|11257799|FG001|NOT COMPLETED|Overall Study||3
10126642|NCT02612077|11257805|FG000|STARTED|Overall Study||765
10126643|NCT02612077|11257805|FG000|Did Not Receive Study Product|Overall Study||5
10126644|NCT02612077|11257805|FG000|Safety Analysis Set|Overall Study||760
10126645|NCT02612077|11257805|FG000|Efficacy Analysis Set|Overall Study||737
10126646|NCT02612077|11257805|FG000|COMPLETED|Overall Study||299
10126647|NCT02612077|11257805|FG000|NOT COMPLETED|Overall Study||466
10126648|NCT02612155|11257814|FG000|STARTED|Overall Study||17
10126649|NCT02612155|11257815|FG001|STARTED|Overall Study||18
10126650|NCT02612155|11257814|FG000|COMPLETED|Overall Study||14
10126651|NCT02612155|11257815|FG001|COMPLETED|Overall Study||15
10126652|NCT02612155|11257814|FG000|NOT COMPLETED|Overall Study||3
10126653|NCT02612155|11257815|FG001|NOT COMPLETED|Overall Study||3
10126654|NCT02612428|11257823|FG000|STARTED|VTL-308||78
10126655|NCT02612428|11257824|FG001|STARTED|VTL-308||73
10126656|NCT02612428|11257823|FG000|COMPLETED|VTL-308||64
10126657|NCT02612428|11257824|FG001|COMPLETED|VTL-308||56
10126658|NCT02612428|11257823|FG000|NOT COMPLETED|VTL-308||14
10126659|NCT02612428|11257824|FG001|NOT COMPLETED|VTL-308||17
10126660|NCT02612428|11257823|FG000|STARTED|VTL-308E||64
10126661|NCT02612428|11257824|FG001|STARTED|VTL-308E||56
10126662|NCT02612428|11257823|FG000|COMPLETED|VTL-308E||53
10126663|NCT02612428|11257824|FG001|COMPLETED|VTL-308E||49
10126664|NCT02612428|11257823|FG000|NOT COMPLETED|VTL-308E||11
10126665|NCT02612428|11257824|FG001|NOT COMPLETED|VTL-308E||7
10126666|NCT02612610|11257834|FG000|STARTED|Overall Study||63
10126667|NCT02612610|11257835|FG001|STARTED|Overall Study||64
10126668|NCT02612610|11257836|FG002|STARTED|Overall Study||63
10126669|NCT02612610|11257837|FG003|STARTED|Overall Study||63
10126670|NCT02612610|11257834|FG000|Treated|Overall Study||63
10126671|NCT02612610|11257835|FG001|Treated|Overall Study||63
10126672|NCT02612610|11257836|FG002|Treated|Overall Study||63
10126673|NCT02612610|11257837|FG003|Treated|Overall Study||63
10126674|NCT02612610|11257834|FG000|COMPLETED|Overall Study||58
10126675|NCT02612610|11257835|FG001|COMPLETED|Overall Study||56
10126676|NCT02612610|11257836|FG002|COMPLETED|Overall Study||58
10126677|NCT02612610|11257837|FG003|COMPLETED|Overall Study||50
10126678|NCT02612610|11257834|FG000|NOT COMPLETED|Overall Study||5
10126679|NCT02612610|11257835|FG001|NOT COMPLETED|Overall Study||8
10126680|NCT02612610|11257836|FG002|NOT COMPLETED|Overall Study||5
10126681|NCT02612610|11257837|FG003|NOT COMPLETED|Overall Study||13
10126682|NCT02612623|11257851|FG000|STARTED|Overall Study||8
10126683|NCT02612623|11257852|FG001|STARTED|Overall Study||6
10126684|NCT02612623|11257853|FG002|STARTED|Overall Study||6
10126685|NCT02612623|11257854|FG003|STARTED|Overall Study||4
10126686|NCT02612623|11257851|FG000|Treated|Overall Study||8
10126687|NCT02612623|11257852|FG001|Treated|Overall Study||5
10126688|NCT02612623|11257853|FG002|Treated|Overall Study||6
10126689|NCT02612623|11257854|FG003|Treated|Overall Study||4
10126690|NCT02612623|11257851|FG000|COMPLETED|Overall Study||7
10126691|NCT02612623|11257852|FG001|COMPLETED|Overall Study||5
10126692|NCT02612623|11257853|FG002|COMPLETED|Overall Study||5
10126693|NCT02612623|11257854|FG003|COMPLETED|Overall Study||4
10126694|NCT02612623|11257851|FG000|NOT COMPLETED|Overall Study||1
10126695|NCT02612623|11257852|FG001|NOT COMPLETED|Overall Study||1
10126696|NCT02612623|11257853|FG002|NOT COMPLETED|Overall Study||1
10126697|NCT02612623|11257854|FG003|NOT COMPLETED|Overall Study||0
10126698|NCT02612688|11257866|FG000|STARTED|Overall Study||33035
10126699|NCT02612688|11257867|FG001|STARTED|Overall Study||70013
10126700|NCT02612688|11257866|FG000|COMPLETED|Overall Study||33035
10126701|NCT02612688|11257867|FG001|COMPLETED|Overall Study||70013
10126702|NCT02612688|11257866|FG000|NOT COMPLETED|Overall Study||0
10126703|NCT02612688|11257867|FG001|NOT COMPLETED|Overall Study||0
10126704|NCT02612727|11257877|FG000|STARTED|Overall Study||87
10126705|NCT02612727|11257878|FG001|STARTED|Overall Study||87
10126706|NCT02612727|11257877|FG000|COMPLETED|Overall Study||82
10126707|NCT02612727|11257878|FG001|COMPLETED|Overall Study||83
10126708|NCT02612727|11257877|FG000|NOT COMPLETED|Overall Study||5
10126709|NCT02612727|11257878|FG001|NOT COMPLETED|Overall Study||4
10126710|NCT02612779|11257886|FG000|STARTED|Overall Study||68
10126711|NCT02612779|11257887|FG001|STARTED|Overall Study||6
10126712|NCT02612779|11257886|FG000|COMPLETED|Overall Study||0
10126713|NCT02612779|11257887|FG001|COMPLETED|Overall Study||0
10126714|NCT02612779|11257886|FG000|NOT COMPLETED|Overall Study||68
10126715|NCT02612779|11257887|FG001|NOT COMPLETED|Overall Study||6
10126716|NCT02612857|11257897|FG000|STARTED|Overall Study||11
10126717|NCT02612857|11257898|FG001|STARTED|Overall Study||9
10126718|NCT02612857|11257899|FG002|STARTED|Overall Study||10
10126719|NCT02612857|11257897|FG000|COMPLETED|Overall Study||8
10126720|NCT02612857|11257898|FG001|COMPLETED|Overall Study||5
10126721|NCT02612857|11257899|FG002|COMPLETED|Overall Study||6
10126722|NCT02612857|11257897|FG000|NOT COMPLETED|Overall Study||3
10126723|NCT02612857|11257898|FG001|NOT COMPLETED|Overall Study||4
10126724|NCT02612857|11257899|FG002|NOT COMPLETED|Overall Study||4
10126725|NCT02612909|11257912|FG000|STARTED|Phase 2||100
10126726|NCT02612909|11257913|FG001|STARTED|Phase 2||100
10126727|NCT02612909|11257914|FG002|STARTED|Phase 2||100
10126728|NCT02612909|11257915|FG003|STARTED|Phase 2||0
10126729|NCT02612909|11257916|FG004|STARTED|Phase 2||0
10126730|NCT02612909|11257912|FG000|Received Injection 1|Phase 2||100
10126731|NCT02612909|11257913|FG001|Received Injection 1|Phase 2||100
10126732|NCT02612909|11257914|FG002|Received Injection 1|Phase 2||100
10126733|NCT02612909|11257915|FG003|Received Injection 1|Phase 2||0
10126734|NCT02612909|11257916|FG004|Received Injection 1|Phase 2||0
10126735|NCT02612909|11257912|FG000|Received Injection 2|Phase 2||98
10126736|NCT02612909|11257913|FG001|Received Injection 2|Phase 2||95
10126737|NCT02612909|11257914|FG002|Received Injection 2|Phase 2||99
10126738|NCT02612909|11257915|FG003|Received Injection 2|Phase 2||0
10126739|NCT02612909|11257916|FG004|Received Injection 2|Phase 2||0
10126740|NCT02612909|11257912|FG000|Completed Day 29 Clinic Visit|Phase 2||98
10126741|NCT02612909|11257913|FG001|Completed Day 29 Clinic Visit|Phase 2||95
10126742|NCT02612909|11257914|FG002|Completed Day 29 Clinic Visit|Phase 2||99
10126743|NCT02612909|11257915|FG003|Completed Day 29 Clinic Visit|Phase 2||0
10126744|NCT02612909|11257916|FG004|Completed Day 29 Clinic Visit|Phase 2||0
10126745|NCT02612909|11257912|FG000|Completed Day 43 Clinic Visit|Phase 2||97
10126746|NCT02612909|11257913|FG001|Completed Day 43 Clinic Visit|Phase 2||94
10126747|NCT02612909|11257914|FG002|Completed Day 43 Clinic Visit|Phase 2||99
10126748|NCT02612909|11257915|FG003|Completed Day 43 Clinic Visit|Phase 2||0
10126749|NCT02612909|11257916|FG004|Completed Day 43 Clinic Visit|Phase 2||0
10126750|NCT02612909|11257912|FG000|COMPLETED|Phase 2||98
10126751|NCT02612909|11257913|FG001|COMPLETED|Phase 2||95
10126752|NCT02612909|11257914|FG002|COMPLETED|Phase 2||99
10126753|NCT02612909|11257915|FG003|COMPLETED|Phase 2||0
10126754|NCT02612909|11257916|FG004|COMPLETED|Phase 2||0
10126755|NCT02612909|11257912|FG000|NOT COMPLETED|Phase 2||2
10126756|NCT02612909|11257913|FG001|NOT COMPLETED|Phase 2||5
10126757|NCT02612909|11257914|FG002|NOT COMPLETED|Phase 2||1
10126758|NCT02612909|11257915|FG003|NOT COMPLETED|Phase 2||0
10126759|NCT02612909|11257916|FG004|NOT COMPLETED|Phase 2||0
10126760|NCT02612909|11257912|FG000|STARTED|Phase 3||0
10126761|NCT02612909|11257913|FG001|STARTED|Phase 3||0
10126762|NCT02612909|11257914|FG002|STARTED|Phase 3||0
10126763|NCT02612909|11257915|FG003|STARTED|Phase 3||105
10126764|NCT02612909|11257916|FG004|STARTED|Phase 3||525
10126765|NCT02612909|11257912|FG000|Received Injection 1|Phase 3||0
10126766|NCT02612909|11257913|FG001|Received Injection 1|Phase 3||0
10126767|NCT02612909|11257914|FG002|Received Injection 1|Phase 3||0
10126768|NCT02612909|11257915|FG003|Received Injection 1|Phase 3||105
10126769|NCT02612909|11257916|FG004|Received Injection 1|Phase 3||525
10126770|NCT02612909|11257912|FG000|Received Injection 2|Phase 3||0
10126771|NCT02612909|11257913|FG001|Received Injection 2|Phase 3||0
10126772|NCT02612909|11257914|FG002|Received Injection 2|Phase 3||0
10126773|NCT02612909|11257915|FG003|Received Injection 2|Phase 3||103
10126774|NCT02612909|11257916|FG004|Received Injection 2|Phase 3||520
10126775|NCT02612909|11257912|FG000|Completed Day 29 Clinic Visit|Phase 3||0
10126776|NCT02612909|11257913|FG001|Completed Day 29 Clinic Visit|Phase 3||0
10126777|NCT02612909|11257914|FG002|Completed Day 29 Clinic Visit|Phase 3||0
10126778|NCT02612909|11257915|FG003|Completed Day 29 Clinic Visit|Phase 3||104
10126779|NCT02612909|11257916|FG004|Completed Day 29 Clinic Visit|Phase 3||525
10126780|NCT02612909|11257912|FG000|Completed Day 43 Clinic Visit|Phase 3||0
10126781|NCT02612909|11257913|FG001|Completed Day 43 Clinic Visit|Phase 3||0
10126782|NCT02612909|11257914|FG002|Completed Day 43 Clinic Visit|Phase 3||0
10126783|NCT02612909|11257915|FG003|Completed Day 43 Clinic Visit|Phase 3||104
10126784|NCT02612909|11257916|FG004|Completed Day 43 Clinic Visit|Phase 3||524
10126785|NCT02612909|11257912|FG000|COMPLETED|Phase 3||0
10126786|NCT02612909|11257913|FG001|COMPLETED|Phase 3||0
10126787|NCT02612909|11257914|FG002|COMPLETED|Phase 3||0
10126788|NCT02612909|11257915|FG003|COMPLETED|Phase 3||104
10126789|NCT02612909|11257916|FG004|COMPLETED|Phase 3||525
10126790|NCT02612909|11257912|FG000|NOT COMPLETED|Phase 3||0
10126791|NCT02612909|11257913|FG001|NOT COMPLETED|Phase 3||0
10126792|NCT02612909|11257914|FG002|NOT COMPLETED|Phase 3||0
10126793|NCT02612909|11257915|FG003|NOT COMPLETED|Phase 3||1
10126794|NCT02612909|11257916|FG004|NOT COMPLETED|Phase 3||0
10126795|NCT02613117|11257932|FG000|STARTED|Overall Study||57
10126796|NCT02613117|11257933|FG001|STARTED|Overall Study||47
10126797|NCT02613117|11257932|FG000|COMPLETED|Overall Study||57
10126798|NCT02613117|11257933|FG001|COMPLETED|Overall Study||47
10126799|NCT02613117|11257932|FG000|NOT COMPLETED|Overall Study||0
10126800|NCT02613117|11257933|FG001|NOT COMPLETED|Overall Study||0
10126801|NCT02613169|11257941|FG000|STARTED|Overall Study||150
10126802|NCT02613169|11257942|FG001|STARTED|Overall Study||150
10126803|NCT02613169|11257941|FG000|COMPLETED|Overall Study||132
10126804|NCT02613169|11257942|FG001|COMPLETED|Overall Study||133
10126805|NCT02613169|11257941|FG000|NOT COMPLETED|Overall Study||18
10126806|NCT02613169|11257942|FG001|NOT COMPLETED|Overall Study||17
10126807|NCT02613182|11257948|FG000|STARTED|Overall Study||34
10126808|NCT02613182|11257948|FG000|Number of Patients Dosed|Overall Study||34
10126809|NCT02613182|11257948|FG000|COMPLETED|Overall Study||0
10126810|NCT02613182|11257948|FG000|NOT COMPLETED|Overall Study||34
10126811|NCT02613208|11257952|FG000|STARTED|Overall Study||111
10126812|NCT02613208|11257952|FG000|COMPLETED|Overall Study||64
10126813|NCT02613208|11257952|FG000|NOT COMPLETED|Overall Study||47
10126814|NCT02613221|11257956|FG000|STARTED|Overall Study||56
10126815|NCT02613221|11257956|FG000|Safety Population: Received Study Drug|Overall Study||55
10126816|NCT02613221|11257956|FG000|COMPLETED|Overall Study||1
10126817|NCT02613221|11257956|FG000|NOT COMPLETED|Overall Study||55
10126818|NCT02613338|11257960|FG000|STARTED|Overall Study||30
10126819|NCT02613338|11257960|FG000|COMPLETED|Overall Study||30
10126820|NCT02613338|11257960|FG000|NOT COMPLETED|Overall Study||0
10126821|NCT02613364|11257967|FG000|STARTED|Overall Study||251
10126822|NCT02613364|11257968|FG001|STARTED|Overall Study||238
10126823|NCT02613364|11257969|FG002|STARTED|Overall Study||251
10126824|NCT02613364|11257967|FG000|COMPLETED|Overall Study||185
10126825|NCT02613364|11257968|FG001|COMPLETED|Overall Study||148
10126826|NCT02613364|11257969|FG002|COMPLETED|Overall Study||175
10126827|NCT02613364|11257967|FG000|NOT COMPLETED|Overall Study||66
10126828|NCT02613364|11257968|FG001|NOT COMPLETED|Overall Study||90
10126829|NCT02613364|11257969|FG002|NOT COMPLETED|Overall Study||76
10126830|NCT02613403|11257981|FG000|STARTED|Overall Study||36
10126831|NCT02613403|11257982|FG001|STARTED|Overall Study||36
10126832|NCT02613403|11257983|FG002|STARTED|Overall Study||9
10126833|NCT02613403|11257984|FG003|STARTED|Overall Study||13
10126834|NCT02613403|11257985|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
10126835|NCT02613403|11257981|FG000|Treated|Overall Study||35
10126836|NCT02613403|11257982|FG001|Treated|Overall Study||36
10126837|NCT02613403|11257983|FG002|Treated|Overall Study||9
10126838|NCT02613403|11257984|FG003|Treated|Overall Study||13
10126839|NCT02613403|11257985|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
10126840|NCT02613403|11257981|FG000|COMPLETED|Overall Study||34
10126841|NCT02613403|11257982|FG001|COMPLETED|Overall Study||35
10126842|NCT02613403|11257983|FG002|COMPLETED|Overall Study||9
10126843|NCT02613403|11257984|FG003|COMPLETED|Overall Study||13
10126844|NCT02613403|11257985|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
10126845|NCT02613403|11257981|FG000|NOT COMPLETED|Overall Study||2
10126846|NCT02613403|11257982|FG001|NOT COMPLETED|Overall Study||1
10126847|NCT02613403|11257983|FG002|NOT COMPLETED|Overall Study||0
10126848|NCT02613403|11257984|FG003|NOT COMPLETED|Overall Study||0
10126849|NCT02613403|11257985|FG004|NOT COMPLETED|Overall Study||0
10126850|NCT02613481|11257995|FG000|STARTED|Overall Study||50
10126851|NCT02613481|11257995|FG000|COMPLETED|Overall Study||41
10126852|NCT02613481|11257995|FG000|NOT COMPLETED|Overall Study||9
10126853|NCT02613572|11258002|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
10126854|NCT02613572|11258003|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
10126855|NCT02613572|11258004|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
10126856|NCT02613572|11258002|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
10126857|NCT02613572|11258003|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10126858|NCT02613572|11258004|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10126859|NCT02613572|11258002|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
10126860|NCT02613572|11258003|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10126861|NCT02613572|11258004|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10126862|NCT02613572|11258002|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
10126863|NCT02613572|11258003|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10126864|NCT02613572|11258004|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10126865|NCT02613572|11258002|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
10126866|NCT02613572|11258003|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10126867|NCT02613572|11258004|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10126868|NCT02613572|11258002|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
10126869|NCT02613572|11258003|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10126870|NCT02613572|11258004|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10126871|NCT02613572|11258002|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0
10126872|NCT02613572|11258003|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27
10126873|NCT02613572|11258004|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26
10196432|NCT03361423|11324672|FG001|NOT COMPLETED|Overall Study||23
10126874|NCT02613572|11258002|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
10126875|NCT02613572|11258003|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
10126876|NCT02613572|11258004|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
10126877|NCT02613572|11258002|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
10126878|NCT02613572|11258003|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
10126879|NCT02613572|11258004|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
10126880|NCT02613871|11258016|FG000|STARTED|Overall Study||111
10126881|NCT02613871|11258016|FG000|COMPLETED|Overall Study||108
10126882|NCT02613871|11258016|FG000|NOT COMPLETED|Overall Study||3
10126883|NCT02613884|11258020|FG000|STARTED|Overall Study||26
10126884|NCT02613884|11258020|FG000|Safety Endpoint 1|Overall Study||26
10126885|NCT02613884|11258020|FG000|Feasibility Questionnaire|Overall Study||26
10126886|NCT02613884|11258020|FG000|Safety Endpoint 2|Overall Study||26
10126887|NCT02613884|11258020|FG000|Efficacy Endpoint 1|Overall Study||25
10126888|NCT02613884|11258020|FG000|Efficacy Timepoint 2|Overall Study||25
10126889|NCT02613884|11258020|FG000|Efficacy Timepoint 3|Overall Study||24
10126890|NCT02613884|11258020|FG000|COMPLETED|Overall Study||24
10126891|NCT02613884|11258020|FG000|NOT COMPLETED|Overall Study||2
10126892|NCT02613897|11258028|FG000|STARTED|Overall Study||22
10126893|NCT02613897|11258029|FG001|STARTED|Overall Study||22
10126894|NCT02613897|11258030|FG002|STARTED|Overall Study||12
10126895|NCT02613897|11258028|FG000|COMPLETED|Overall Study||22
10126896|NCT02613897|11258029|FG001|COMPLETED|Overall Study||22
10126897|NCT02613897|11258030|FG002|COMPLETED|Overall Study||12
10126898|NCT02613897|11258028|FG000|NOT COMPLETED|Overall Study||0
10126899|NCT02613897|11258029|FG001|NOT COMPLETED|Overall Study||0
10126900|NCT02613897|11258030|FG002|NOT COMPLETED|Overall Study||0
10126901|NCT02613910|11258039|FG000|STARTED|Overall Study||1
10126902|NCT02613910|11258039|FG000|COMPLETED|Overall Study||0
10126903|NCT02613910|11258039|FG000|NOT COMPLETED|Overall Study||1
10126904|NCT02614079|11258043|FG000|STARTED|Overall Study||6
10126905|NCT02614079|11258043|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
10126906|NCT02614079|11258043|FG000|NOT COMPLETED|Overall Study||1
10126907|NCT02614131|11258054|FG000|STARTED|Overall Study||11
10126908|NCT02614131|11258055|FG001|STARTED|Overall Study||8
10126909|NCT02614131|11258056|FG002|STARTED|Overall Study||8
10126910|NCT02614131|11258057|FG003|STARTED|Overall Study||8
10126911|NCT02614131|11258058|FG004|STARTED|Overall Study||8
10126912|NCT02614131|11258059|FG005|STARTED|Overall Study||2
10126913|NCT02614131|11258060|FG006|STARTED|Overall Study||5
10126914|NCT02614131|11258054|FG000|Received at Least One Dose of Drug|Overall Study||11
10126915|NCT02614131|11258055|FG001|Received at Least One Dose of Drug|Overall Study||8
10126916|NCT02614131|11258056|FG002|Received at Least One Dose of Drug|Overall Study||8
10126917|NCT02614131|11258057|FG003|Received at Least One Dose of Drug|Overall Study||8
10126918|NCT02614131|11258058|FG004|Received at Least One Dose of Drug|Overall Study||8
10126919|NCT02614131|11258059|FG005|Received at Least One Dose of Drug|Overall Study||2
10126920|NCT02614131|11258060|FG006|Received at Least One Dose of Drug|Overall Study||5
10126921|NCT02614131|11258054|FG000|COMPLETED|Overall Study||10
10126922|NCT02614131|11258055|FG001|COMPLETED|Overall Study||8
10126923|NCT02614131|11258056|FG002|COMPLETED|Overall Study||8
10126924|NCT02614131|11258057|FG003|COMPLETED|Overall Study||8
10126925|NCT02614131|11258058|FG004|COMPLETED|Overall Study||8
10126926|NCT02614131|11258059|FG005|COMPLETED|Overall Study||2
10126927|NCT02614131|11258060|FG006|COMPLETED|Overall Study||4
10126928|NCT02614131|11258054|FG000|NOT COMPLETED|Overall Study||1
10126929|NCT02614131|11258055|FG001|NOT COMPLETED|Overall Study||0
10126930|NCT02614131|11258056|FG002|NOT COMPLETED|Overall Study||0
10126931|NCT02614131|11258057|FG003|NOT COMPLETED|Overall Study||0
10126932|NCT02614131|11258058|FG004|NOT COMPLETED|Overall Study||0
10126933|NCT02614131|11258059|FG005|NOT COMPLETED|Overall Study||0
10126934|NCT02614131|11258060|FG006|NOT COMPLETED|Overall Study||1
10126935|NCT02614183|11258085|FG000|STARTED|Double Blind Treatment Phase||434
10126936|NCT02614183|11258086|FG001|STARTED|Double Blind Treatment Phase||214
10126937|NCT02614183|11258087|FG002|STARTED|Double Blind Treatment Phase||214
10126938|NCT02614183|11258085|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
10126939|NCT02614183|11258086|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
10126940|NCT02614183|11258087|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
10126941|NCT02614183|11258085|FG000|Safety Population|Double Blind Treatment Phase||432
10126942|NCT02614183|11258086|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
10126943|NCT02614183|11258087|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
10126944|NCT02614183|11258085|FG000|COMPLETED|Double Blind Treatment Phase||351
10126945|NCT02614183|11258086|FG001|COMPLETED|Double Blind Treatment Phase||177
10126946|NCT02614183|11258087|FG002|COMPLETED|Double Blind Treatment Phase||175
10126947|NCT02614183|11258085|FG000|NOT COMPLETED|Double Blind Treatment Phase||83
10126948|NCT02614183|11258086|FG001|NOT COMPLETED|Double Blind Treatment Phase||37
10126949|NCT02614183|11258087|FG002|NOT COMPLETED|Double Blind Treatment Phase||39
10126950|NCT02614183|11258085|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
10196433|NCT03361605|11324678|FG000|STARTED|Overall Study||29
10196434|NCT03361605|11324678|FG000|COMPLETED|Overall Study||26
10126951|NCT02614183|11258086|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
10126952|NCT02614183|11258087|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
10126953|NCT02614183|11258085|FG000|Safety Population|Post Treatment Follow-up Phase||372
10126954|NCT02614183|11258086|FG001|Safety Population|Post Treatment Follow-up Phase||183
10126955|NCT02614183|11258087|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
10126956|NCT02614183|11258085|FG000|COMPLETED|Post Treatment Follow-up Phase||354
10126957|NCT02614183|11258086|FG001|COMPLETED|Post Treatment Follow-up Phase||179
10126958|NCT02614183|11258087|FG002|COMPLETED|Post Treatment Follow-up Phase||171
10126959|NCT02614183|11258085|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18
10126960|NCT02614183|11258086|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6
10126961|NCT02614183|11258087|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12
10126962|NCT02614196|11258107|FG000|STARTED|Double Blind Treatment Phase||463
10126963|NCT02614196|11258108|FG001|STARTED|Double Blind Treatment Phase||233
10126964|NCT02614196|11258109|FG002|STARTED|Double Blind Treatment Phase||226
10126965|NCT02614196|11258110|FG003|STARTED|Double Blind Treatment Phase||30
10126966|NCT02614196|11258111|FG004|STARTED|Double Blind Treatment Phase||15
10126967|NCT02614196|11258112|FG005|STARTED|Double Blind Treatment Phase||19
10126968|NCT02614196|11258107|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
10126969|NCT02614196|11258108|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
10126970|NCT02614196|11258109|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
10126971|NCT02614196|11258110|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
10126972|NCT02614196|11258111|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
10126973|NCT02614196|11258112|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
10126974|NCT02614196|11258107|FG000|COMPLETED|Double Blind Treatment Phase||387
10126975|NCT02614196|11258108|FG001|COMPLETED|Double Blind Treatment Phase||203
10126976|NCT02614196|11258109|FG002|COMPLETED|Double Blind Treatment Phase||195
10126977|NCT02614196|11258110|FG003|COMPLETED|Double Blind Treatment Phase||26
10126978|NCT02614196|11258111|FG004|COMPLETED|Double Blind Treatment Phase||14
10126979|NCT02614196|11258112|FG005|COMPLETED|Double Blind Treatment Phase||19
10126980|NCT02614196|11258107|FG000|NOT COMPLETED|Double Blind Treatment Phase||76
10126981|NCT02614196|11258108|FG001|NOT COMPLETED|Double Blind Treatment Phase||30
10126982|NCT02614196|11258109|FG002|NOT COMPLETED|Double Blind Treatment Phase||31
10126983|NCT02614196|11258110|FG003|NOT COMPLETED|Double Blind Treatment Phase||4
10126984|NCT02614196|11258111|FG004|NOT COMPLETED|Double Blind Treatment Phase||1
10126985|NCT02614196|11258112|FG005|NOT COMPLETED|Double Blind Treatment Phase||0
10126986|NCT02614196|11258107|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
10126987|NCT02614196|11258108|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
10126988|NCT02614196|11258109|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
10126989|NCT02614196|11258110|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
10126990|NCT02614196|11258111|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
10126991|NCT02614196|11258112|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
10126992|NCT02614196|11258107|FG000|COMPLETED|Post Treatment Follow-up Phase||390
10126993|NCT02614196|11258108|FG001|COMPLETED|Post Treatment Follow-up Phase||208
10126994|NCT02614196|11258109|FG002|COMPLETED|Post Treatment Follow-up Phase||199
10126995|NCT02614196|11258110|FG003|COMPLETED|Post Treatment Follow-up Phase||24
10126996|NCT02614196|11258111|FG004|COMPLETED|Post Treatment Follow-up Phase||13
10126997|NCT02614196|11258112|FG005|COMPLETED|Post Treatment Follow-up Phase||19
10126998|NCT02614196|11258107|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20
10126999|NCT02614196|11258108|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
10127000|NCT02614196|11258109|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8
10127001|NCT02614196|11258110|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1
10127002|NCT02614196|11258111|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2
10127003|NCT02614196|11258112|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0
10127004|NCT02614222|11258142|FG000|STARTED|Overall Study||13
10127005|NCT02614222|11258143|FG001|STARTED|Overall Study||14
10127006|NCT02614222|11258142|FG000|COMPLETED|Overall Study||13
10127007|NCT02614222|11258143|FG001|COMPLETED|Overall Study||14
10127008|NCT02614222|11258142|FG000|NOT COMPLETED|Overall Study||0
10127009|NCT02614222|11258143|FG001|NOT COMPLETED|Overall Study||0
10127010|NCT02614274|11258149|FG000|STARTED|Overall Study||9
10127011|NCT02614274|11258149|FG000|COMPLETED|Overall Study||5
10127012|NCT02614274|11258149|FG000|NOT COMPLETED|Overall Study||4
10127013|NCT02614287|11258155|FG000|STARTED|Open Label (OL) Treatment Phase||135
10127014|NCT02614287|11258156|FG001|STARTED|Open Label (OL) Treatment Phase||135
10127015|NCT02614287|11258155|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
10127016|NCT02614287|11258156|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
10127017|NCT02614287|11258155|FG000|COMPLETED|Open Label (OL) Treatment Phase||97
10127018|NCT02614287|11258156|FG001|COMPLETED|Open Label (OL) Treatment Phase||113
10127019|NCT02614287|11258155|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38
10127020|NCT02614287|11258156|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22
10127021|NCT02614287|11258155|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
10127022|NCT02614287|11258156|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
10127023|NCT02614287|11258155|FG000|COMPLETED|Post Treatment Follow-up Phase||103
10127024|NCT02614287|11258156|FG001|COMPLETED|Post Treatment Follow-up Phase||119
10127025|NCT02614287|11258155|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9
10127026|NCT02614287|11258156|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
10127027|NCT02614469|11258169|FG000|STARTED|Period 1||9
10127028|NCT02614469|11258170|FG001|STARTED|Period 1||9
10127029|NCT02614469|11258169|FG000|COMPLETED|Period 1||9
10127030|NCT02614469|11258170|FG001|COMPLETED|Period 1||9
10127031|NCT02614469|11258169|FG000|NOT COMPLETED|Period 1||0
10127032|NCT02614469|11258170|FG001|NOT COMPLETED|Period 1||0
10127033|NCT02614469|11258169|FG000|STARTED|Period 2||9
10127034|NCT02614469|11258170|FG001|STARTED|Period 2||9
10127035|NCT02614469|11258169|FG000|COMPLETED|Period 2||9
10127036|NCT02614469|11258170|FG001|COMPLETED|Period 2||9
10127037|NCT02614469|11258169|FG000|NOT COMPLETED|Period 2||0
10127038|NCT02614469|11258170|FG001|NOT COMPLETED|Period 2||0
10127039|NCT02614560|11258178|FG000|STARTED|Overall Study||6
10127040|NCT02614560|11258179|FG001|STARTED|Overall Study||8
10127041|NCT02614560|11258178|FG000|COMPLETED|Overall Study||0
10127042|NCT02614560|11258179|FG001|COMPLETED|Overall Study||6
10127043|NCT02614560|11258178|FG000|NOT COMPLETED|Overall Study||6
9706709|NCT03227224|10805789|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27
9706710|NCT03227224|10805790|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55
9706711|NCT03227224|10805791|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46
9706712|NCT03227224|10805788|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
9706713|NCT03227224|10805789|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6
9706714|NCT03227224|10805790|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8
9706715|NCT03227224|10805791|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7
9706716|NCT03227224|10805788|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|138
9706717|NCT03227224|10805789|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|33
9706718|NCT03227224|10805790|FG002|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|63
9706719|NCT03227224|10805791|FG003|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|53
9706720|NCT03227224|10805788|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134
9706721|NCT03227224|10805789|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29
9706722|NCT03227224|10805790|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57
9706723|NCT03227224|10805791|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50
9706724|NCT03227224|10805788|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
9706725|NCT03227224|10805789|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
9706726|NCT03227224|10805790|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6
9706727|NCT03227224|10805791|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3
9706728|NCT03220581|10805810|FG000|STARTED|Overall Study||28
9706729|NCT03220581|10805811|FG001|STARTED|Overall Study||32
10127044|NCT02614560|11258179|FG001|NOT COMPLETED|Overall Study||2
10127045|NCT02614703|11258187|FG000|STARTED|Overall Study||31
10127046|NCT02614703|11258188|FG001|STARTED|Overall Study||29
10127047|NCT02614703|11258187|FG000|COMPLETED|Overall Study||24
10127048|NCT02614703|11258188|FG001|COMPLETED|Overall Study||28
10127049|NCT02614703|11258187|FG000|NOT COMPLETED|Overall Study||7
10127050|NCT02614703|11258188|FG001|NOT COMPLETED|Overall Study||1
10127051|NCT02614729|11258196|FG000|STARTED|Overall Study||18
10127052|NCT02614729|11258197|FG001|STARTED|Overall Study||17
10127053|NCT02614729|11258196|FG000|COMPLETED|Overall Study||17
10127054|NCT02614729|11258197|FG001|COMPLETED|Overall Study||17
10127055|NCT02614729|11258196|FG000|NOT COMPLETED|Overall Study||1
10127056|NCT02614729|11258197|FG001|NOT COMPLETED|Overall Study||0
10127057|NCT02614924|11258207|FG000|STARTED|Overall Study||20
10127058|NCT02614924|11258208|FG001|STARTED|Overall Study||20
10127059|NCT02614924|11258207|FG000|COMPLETED|Overall Study||20
10127060|NCT02614924|11258208|FG001|COMPLETED|Overall Study||20
10127061|NCT02614924|11258207|FG000|NOT COMPLETED|Overall Study||0
10127062|NCT02614924|11258208|FG001|NOT COMPLETED|Overall Study||0
10127063|NCT02615145|11258218|FG000|STARTED|Overall Study||145
10127064|NCT02615145|11258219|FG001|STARTED|Overall Study||278
10127065|NCT02615145|11258220|FG002|STARTED|Overall Study||48
10127066|NCT02615145|11258221|FG003|STARTED|Overall Study||1
10127067|NCT02615145|11258218|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0
10127068|NCT02615145|11258219|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0
10127069|NCT02615145|11258220|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45
10127070|NCT02615145|11258221|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0
10127071|NCT02615145|11258218|FG000|3DAA|Overall Study||5
10127072|NCT02615145|11258219|FG001|3DAA|Overall Study||261
10127073|NCT02615145|11258220|FG002|3DAA|Overall Study||0
10127074|NCT02615145|11258221|FG003|3DAA|Overall Study||0
10127075|NCT02615145|11258218|FG000|3DAA + RBV|Overall Study||140
10127076|NCT02615145|11258219|FG001|3DAA + RBV|Overall Study||17
10127077|NCT02615145|11258220|FG002|3DAA + RBV|Overall Study||2
10127078|NCT02615145|11258221|FG003|3DAA + RBV|Overall Study||0
10127079|NCT02615145|11258218|FG000|COMPLETED|Overall Study||118
10127080|NCT02615145|11258219|FG001|COMPLETED|Overall Study||263
10127081|NCT02615145|11258220|FG002|COMPLETED|Overall Study||40
10127082|NCT02615145|11258221|FG003|COMPLETED|Overall Study||0
10127083|NCT02615145|11258218|FG000|NOT COMPLETED|Overall Study||27
10127084|NCT02615145|11258219|FG001|NOT COMPLETED|Overall Study||15
10127085|NCT02615145|11258220|FG002|NOT COMPLETED|Overall Study||8
10127086|NCT02615145|11258221|FG003|NOT COMPLETED|Overall Study||1
10127087|NCT02615158|11258250|FG000|STARTED|Overall Study||94
10127088|NCT02615158|11258251|FG001|STARTED|Overall Study||92
10127089|NCT02615158|11258252|FG002|STARTED|Overall Study||91
10127090|NCT02615158|11258250|FG000|COMPLETED|Overall Study||73
10127091|NCT02615158|11258251|FG001|COMPLETED|Overall Study||76
10127092|NCT02615158|11258252|FG002|COMPLETED|Overall Study||75
10127093|NCT02615158|11258250|FG000|NOT COMPLETED|Overall Study||21
10127094|NCT02615158|11258251|FG001|NOT COMPLETED|Overall Study||16
10127095|NCT02615158|11258252|FG002|NOT COMPLETED|Overall Study||16
10127096|NCT02615171|11258262|FG000|STARTED|Overall Study||32
10127097|NCT02615171|11258263|FG001|STARTED|Overall Study||32
10127098|NCT02615171|11258262|FG000|COMPLETED|Overall Study||30
10127099|NCT02615171|11258263|FG001|COMPLETED|Overall Study||31
10127100|NCT02615171|11258262|FG000|NOT COMPLETED|Overall Study||2
10127101|NCT02615171|11258263|FG001|NOT COMPLETED|Overall Study||1
10127102|NCT02615249|11258269|FG000|STARTED|Overall Study||122
10127103|NCT02615249|11258269|FG000|COMPLETED|Overall Study||121
10127104|NCT02615249|11258269|FG000|NOT COMPLETED|Overall Study||1
10127105|NCT02615470|11258276|FG000|STARTED|Overall Study||58
10127106|NCT02615470|11258277|FG001|STARTED|Overall Study||62
10127107|NCT02615470|11258276|FG000|Completed the Baseline Surveys|Overall Study||46
10127108|NCT02615470|11258277|FG001|Completed the Baseline Surveys|Overall Study||47
10127109|NCT02615470|11258276|FG000|COMPLETED|Overall Study||37
10127110|NCT02615470|11258277|FG001|COMPLETED|Overall Study||30
10127111|NCT02615470|11258276|FG000|NOT COMPLETED|Overall Study||21
10127112|NCT02615470|11258277|FG001|NOT COMPLETED|Overall Study||32
10127113|NCT02615509|11258283|FG000|STARTED|Overall Study||347
10127114|NCT02615509|11258283|FG000|COMPLETED|Overall Study||201
10127115|NCT02615509|11258283|FG000|NOT COMPLETED|Overall Study||146
10127116|NCT02615535|11258289|FG000|STARTED|Overall Study||14
10127117|NCT02615535|11258290|FG001|STARTED|Overall Study||11
10127118|NCT02615535|11258289|FG000|COMPLETED|Overall Study||10
10127119|NCT02615535|11258290|FG001|COMPLETED|Overall Study||10
10127120|NCT02615535|11258289|FG000|NOT COMPLETED|Overall Study||4
10127121|NCT02615535|11258290|FG001|NOT COMPLETED|Overall Study||1
10127122|NCT02615717|11258298|FG000|STARTED|Overall Study||3
10127123|NCT02615717|11258299|FG001|STARTED|Overall Study||3
10127124|NCT02615717|11258298|FG000|COMPLETED|Overall Study||3
10127125|NCT02615717|11258299|FG001|COMPLETED|Overall Study||3
10127126|NCT02615717|11258298|FG000|NOT COMPLETED|Overall Study||0
10127127|NCT02615717|11258299|FG001|NOT COMPLETED|Overall Study||0
10127128|NCT02615743|11258307|FG000|STARTED|Overall Study||21
10127129|NCT02615743|11258308|FG001|STARTED|Overall Study||20
10127130|NCT02615743|11258307|FG000|COMPLETED|Overall Study||15
10127131|NCT02615743|11258308|FG001|COMPLETED|Overall Study||17
10127132|NCT02615743|11258307|FG000|NOT COMPLETED|Overall Study||6
10127133|NCT02615743|11258308|FG001|NOT COMPLETED|Overall Study||3
10127134|NCT02616029|11258316|FG000|STARTED|Overall Study||38
10127135|NCT02616029|11258317|FG001|STARTED|Overall Study||28
10127136|NCT02616029|11258316|FG000|COMPLETED|Overall Study||34
10127137|NCT02616029|11258317|FG001|COMPLETED|Overall Study||26
10127138|NCT02616029|11258316|FG000|NOT COMPLETED|Overall Study||4
10127139|NCT02616029|11258317|FG001|NOT COMPLETED|Overall Study||2
10127140|NCT02616250|11258325|FG000|STARTED|Overall Study||95
10127141|NCT02616250|11258326|FG001|STARTED|Overall Study||95
10127142|NCT02616250|11258325|FG000|COMPLETED|Overall Study||85
10127143|NCT02616250|11258326|FG001|COMPLETED|Overall Study||86
10127144|NCT02616250|11258325|FG000|NOT COMPLETED|Overall Study||10
10127145|NCT02616250|11258326|FG001|NOT COMPLETED|Overall Study||9
10127146|NCT02616380|11258332|FG000|STARTED|Overall Study||100
10127147|NCT02616380|11258332|FG000|COMPLETED|Overall Study||97
10127148|NCT02616380|11258332|FG000|NOT COMPLETED|Overall Study||3
10127149|NCT02616523|11258339|FG000|STARTED|Overall Study|June 2014|20
10127150|NCT02616523|11258340|FG001|STARTED|Overall Study|June 2014|20
10127151|NCT02616523|11258341|FG002|STARTED|Overall Study|June 2014|20
10127152|NCT02616523|11258339|FG000|COMPLETED|Overall Study|April 2015|19
10127153|NCT02616523|11258340|FG001|COMPLETED|Overall Study|April 2015|20
10127154|NCT02616523|11258341|FG002|COMPLETED|Overall Study|April 2015|20
10127155|NCT02616523|11258339|FG000|NOT COMPLETED|Overall Study||1
10127156|NCT02616523|11258340|FG001|NOT COMPLETED|Overall Study||0
10127157|NCT02616523|11258341|FG002|NOT COMPLETED|Overall Study||0
10127158|NCT02616601|11258355|FG000|STARTED|Overall Study||140
10127159|NCT02616601|11258356|FG001|STARTED|Overall Study||140
10127160|NCT02616601|11258357|FG002|STARTED|Overall Study||142
10127161|NCT02616601|11258355|FG000|Safety Population|Overall Study||140
10127162|NCT02616601|11258356|FG001|Safety Population|Overall Study||140
10127163|NCT02616601|11258357|FG002|Safety Population|Overall Study||142
10127164|NCT02616601|11258355|FG000|mITT Population|Overall Study||137
10127165|NCT02616601|11258356|FG001|mITT Population|Overall Study||136
10127166|NCT02616601|11258357|FG002|mITT Population|Overall Study||138
10127167|NCT02616601|11258355|FG000|PP Population|Overall Study||112
10127168|NCT02616601|11258356|FG001|PP Population|Overall Study||121
10127169|NCT02616601|11258357|FG002|PP Population|Overall Study||123
10127170|NCT02616601|11258355|FG000|COMPLETED|Overall Study||131
10127171|NCT02616601|11258356|FG001|COMPLETED|Overall Study||136
10127172|NCT02616601|11258357|FG002|COMPLETED|Overall Study||135
10127173|NCT02616601|11258355|FG000|NOT COMPLETED|Overall Study||9
10127174|NCT02616601|11258356|FG001|NOT COMPLETED|Overall Study||4
10127175|NCT02616601|11258357|FG002|NOT COMPLETED|Overall Study||7
10127176|NCT02616614|11258368|FG000|STARTED|Overall Study||347
10127177|NCT02616614|11258369|FG001|STARTED|Overall Study||345
10127178|NCT02616614|11258370|FG002|STARTED|Overall Study||170
10127179|NCT02616614|11258368|FG000|Safety Population|Overall Study||329
10127180|NCT02616614|11258369|FG001|Safety Population|Overall Study||328
10127181|NCT02616614|11258370|FG002|Safety Population|Overall Study||161
10127182|NCT02616614|11258368|FG000|mITT Population|Overall Study||325
10127183|NCT02616614|11258369|FG001|mITT Population|Overall Study||325
10127184|NCT02616614|11258370|FG002|mITT Population|Overall Study||160
10127185|NCT02616614|11258368|FG000|PP Population|Overall Study||253
10127186|NCT02616614|11258369|FG001|PP Population|Overall Study||255
10127187|NCT02616614|11258370|FG002|PP Population|Overall Study||122
10127188|NCT02616614|11258368|FG000|COMPLETED|Overall Study||282
10127189|NCT02616614|11258369|FG001|COMPLETED|Overall Study||285
10127190|NCT02616614|11258370|FG002|COMPLETED|Overall Study||141
10127191|NCT02616614|11258368|FG000|NOT COMPLETED|Overall Study||65
10127192|NCT02616614|11258369|FG001|NOT COMPLETED|Overall Study||60
10127193|NCT02616614|11258370|FG002|NOT COMPLETED|Overall Study||29
10127194|NCT02616783|11258381|FG000|STARTED|Overall Study||111
10127195|NCT02616783|11258382|FG001|STARTED|Overall Study||56
10127196|NCT02616783|11258381|FG000|COMPLETED|Overall Study||105
10127197|NCT02616783|11258382|FG001|COMPLETED|Overall Study||54
10127198|NCT02616783|11258381|FG000|NOT COMPLETED|Overall Study||6
10127199|NCT02616783|11258382|FG001|NOT COMPLETED|Overall Study||2
10127200|NCT02616900|11258388|FG000|STARTED|Overall Study||74
10127201|NCT02616900|11258388|FG000|Completed 3mo Trial|Overall Study||57
10127202|NCT02616900|11258388|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
10127203|NCT02616900|11258388|FG000|NOT COMPLETED|Overall Study||23
10127204|NCT02617628|11258394|FG000|STARTED|Overall Study||74
10127205|NCT02617628|11258395|FG001|STARTED|Overall Study||72
10127206|NCT02617628|11258394|FG000|COMPLETED|Overall Study||12
10127207|NCT02617628|11258395|FG001|COMPLETED|Overall Study||11
10127208|NCT02617628|11258394|FG000|NOT COMPLETED|Overall Study||62
10127209|NCT02617628|11258395|FG001|NOT COMPLETED|Overall Study||61
10127210|NCT02617667|11258407|FG000|STARTED|Overall Study||51
10127211|NCT02617667|11258408|FG001|STARTED|Overall Study||51
10127212|NCT02617667|11258409|FG002|STARTED|Overall Study||52
10127213|NCT02617667|11258410|FG003|STARTED|Overall Study||53
10127214|NCT02617667|11258407|FG000|COMPLETED|Overall Study||50
10127215|NCT02617667|11258408|FG001|COMPLETED|Overall Study||50
10127216|NCT02617667|11258409|FG002|COMPLETED|Overall Study||48
10127217|NCT02617667|11258410|FG003|COMPLETED|Overall Study||52
10127218|NCT02617667|11258407|FG000|NOT COMPLETED|Overall Study||1
10127219|NCT02617667|11258408|FG001|NOT COMPLETED|Overall Study||1
10127220|NCT02617667|11258409|FG002|NOT COMPLETED|Overall Study||4
10127221|NCT02617667|11258410|FG003|NOT COMPLETED|Overall Study||1
10127222|NCT02617784|11258421|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
10127223|NCT02617784|11258422|FG001|STARTED|Overall Study||12
10127224|NCT02617784|11258421|FG000|First Dose Assessment Period|Overall Study||12
10127225|NCT02617784|11258422|FG001|First Dose Assessment Period|Overall Study||12
10127226|NCT02617784|11258421|FG000|Second Dose Assessment Period|Overall Study||11
10127227|NCT02617784|11258422|FG001|Second Dose Assessment Period|Overall Study||12
10127228|NCT02617784|11258421|FG000|COMPLETED|Overall Study||12
10127229|NCT02617784|11258422|FG001|COMPLETED|Overall Study||12
10127230|NCT02617784|11258421|FG000|NOT COMPLETED|Overall Study||0
10127231|NCT02617784|11258422|FG001|NOT COMPLETED|Overall Study||0
10127232|NCT02617888|11258431|FG000|STARTED|Overall Study||50
10127233|NCT02617888|11258432|FG001|STARTED|Overall Study||51
10127234|NCT02617888|11258433|FG002|STARTED|Overall Study||127
10127235|NCT02617888|11258431|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
10127236|NCT02617888|11258432|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
10127237|NCT02617888|11258433|FG002|COMPLETED|Overall Study||127
10127238|NCT02617888|11258431|FG000|NOT COMPLETED|Overall Study||1
10127239|NCT02617888|11258432|FG001|NOT COMPLETED|Overall Study||7
10127240|NCT02617888|11258433|FG002|NOT COMPLETED|Overall Study||0
10127241|NCT02617901|11258440|FG000|STARTED|Overall Study||20
10127242|NCT02617901|11258440|FG000|COMPLETED|Overall Study||20
10127243|NCT02617901|11258440|FG000|NOT COMPLETED|Overall Study||0
10127244|NCT02618031|11258446|FG000|STARTED|Overall Study||46
10127245|NCT02618031|11258447|FG001|STARTED|Overall Study||11
10127246|NCT02618031|11258446|FG000|COMPLETED|Overall Study||45
10127247|NCT02618031|11258447|FG001|COMPLETED|Overall Study||11
10127248|NCT02618031|11258446|FG000|NOT COMPLETED|Overall Study||1
10127249|NCT02618031|11258447|FG001|NOT COMPLETED|Overall Study||0
10127250|NCT02618187|11258461|FG000|STARTED|Overall Study||15
10127251|NCT02618187|11258462|FG001|STARTED|Overall Study||11
10127252|NCT02618187|11258463|FG002|STARTED|Overall Study||15
10127253|NCT02618187|11258464|FG003|STARTED|Overall Study||17
10127254|NCT02618187|11258461|FG000|Completed|Overall Study||13
10127255|NCT02618187|11258462|FG001|Completed|Overall Study||10
10127256|NCT02618187|11258463|FG002|Completed|Overall Study||13
10127257|NCT02618187|11258464|FG003|Completed|Overall Study||13
10127258|NCT02618187|11258461|FG000|COMPLETED|Overall Study||13
10127259|NCT02618187|11258462|FG001|COMPLETED|Overall Study||9
10127260|NCT02618187|11258463|FG002|COMPLETED|Overall Study||11
10127261|NCT02618187|11258464|FG003|COMPLETED|Overall Study||12
10127262|NCT02618187|11258461|FG000|NOT COMPLETED|Overall Study||2
10127263|NCT02618187|11258462|FG001|NOT COMPLETED|Overall Study||2
10127264|NCT02618187|11258463|FG002|NOT COMPLETED|Overall Study||4
10127265|NCT02618187|11258464|FG003|NOT COMPLETED|Overall Study||5
10127266|NCT02618343|11258476|FG000|STARTED|Overall Study||28
10127267|NCT02618343|11258477|FG001|STARTED|Overall Study||23
10127268|NCT02618343|11258476|FG000|COMPLETED|Overall Study||28
10127269|NCT02618343|11258477|FG001|COMPLETED|Overall Study||23
10127270|NCT02618343|11258476|FG000|NOT COMPLETED|Overall Study||0
10127271|NCT02618343|11258477|FG001|NOT COMPLETED|Overall Study||0
10127272|NCT02618382|11258483|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32
10127273|NCT02618382|11258483|FG000|COMPLETED|Overall Study|Completed Study treatment|29
10127274|NCT02618382|11258483|FG000|NOT COMPLETED|Overall Study||3
10127275|NCT02618512|11258487|FG000|STARTED|Overall Study||3
10127276|NCT02618512|11258487|FG000|COMPLETED|Overall Study||3
10127277|NCT02618512|11258487|FG000|NOT COMPLETED|Overall Study||0
10127278|NCT02618616|11258493|FG000|STARTED|Overall Study||87
10127279|NCT02618616|11258494|FG001|STARTED|Overall Study||42
10127280|NCT02618616|11258493|FG000|COMPLETED|Overall Study||66
10127281|NCT02618616|11258494|FG001|COMPLETED|Overall Study||35
10127282|NCT02618616|11258493|FG000|NOT COMPLETED|Overall Study||21
10127283|NCT02618616|11258494|FG001|NOT COMPLETED|Overall Study||7
10127284|NCT02618642|11258505|FG000|STARTED|Before 10 PILER Irradiation Treatments||15
10127285|NCT02618642|11258506|FG001|STARTED|Before 10 PILER Irradiation Treatments||15
10127286|NCT02618642|11258507|FG002|STARTED|Before 10 PILER Irradiation Treatments||15
10127287|NCT02618642|11258508|FG003|STARTED|Before 10 PILER Irradiation Treatments||15
10127288|NCT02618642|11258505|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15
10127289|NCT02618642|11258506|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15
10127290|NCT02618642|11258507|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15
10127291|NCT02618642|11258508|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15
10127292|NCT02618642|11258505|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10127293|NCT02618642|11258506|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10127294|NCT02618642|11258507|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10127295|NCT02618642|11258508|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10127296|NCT02618642|11258505|FG000|STARTED|After 10 PILER Irradiation Treatments||15
10127297|NCT02618642|11258506|FG001|STARTED|After 10 PILER Irradiation Treatments||15
10127298|NCT02618642|11258507|FG002|STARTED|After 10 PILER Irradiation Treatments||15
10127299|NCT02618642|11258508|FG003|STARTED|After 10 PILER Irradiation Treatments||15
10127300|NCT02618642|11258505|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15
10127301|NCT02618642|11258506|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15
10127302|NCT02618642|11258507|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15
10127303|NCT02618642|11258508|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15
10127304|NCT02618642|11258505|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10127305|NCT02618642|11258506|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10127306|NCT02618642|11258507|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10127307|NCT02618642|11258508|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10127308|NCT02618759|11258527|FG000|STARTED|Overall Study||60
10127309|NCT02618759|11258528|FG001|STARTED|Overall Study||59
10127310|NCT02618759|11258527|FG000|COMPLETED|Overall Study||58
10127311|NCT02618759|11258528|FG001|COMPLETED|Overall Study||54
10127312|NCT02618759|11258527|FG000|NOT COMPLETED|Overall Study||2
10127313|NCT02618759|11258528|FG001|NOT COMPLETED|Overall Study||5
10127314|NCT02618772|11258536|FG000|STARTED|Overall Study||39
10127315|NCT02618772|11258537|FG001|STARTED|Overall Study||40
10127316|NCT02618772|11258536|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
10127317|NCT02618772|11258537|FG001|Withdrawal by Subject|Overall Study||0
10127318|NCT02618772|11258536|FG000|COMPLETED|Overall Study||38
10127319|NCT02618772|11258537|FG001|COMPLETED|Overall Study||40
10127320|NCT02618772|11258536|FG000|NOT COMPLETED|Overall Study||1
10127321|NCT02618772|11258537|FG001|NOT COMPLETED|Overall Study||0
10127322|NCT02618915|11258545|FG000|STARTED|Overall Study||3
10127323|NCT02618915|11258546|FG001|STARTED|Overall Study||3
10127324|NCT02618915|11258545|FG000|COMPLETED|Overall Study||3
10127325|NCT02618915|11258546|FG001|COMPLETED|Overall Study||3
10127326|NCT02618915|11258545|FG000|NOT COMPLETED|Overall Study||0
10127327|NCT02618915|11258546|FG001|NOT COMPLETED|Overall Study||0
10127328|NCT02618928|11258554|FG000|STARTED|Overall Study||735
10127329|NCT02618928|11258554|FG000|Received Treatment|Overall Study||728
10127330|NCT02618928|11258554|FG000|COMPLETED|Overall Study||677
10127331|NCT02618928|11258554|FG000|NOT COMPLETED|Overall Study||58
10127332|NCT02618967|11258569|FG000|STARTED|Overall Study||6
10127333|NCT02618967|11258570|FG001|STARTED|Overall Study||6
10127334|NCT02618967|11258571|FG002|STARTED|Overall Study||6
10127335|NCT02618967|11258572|FG003|STARTED|Overall Study||6
10127336|NCT02618967|11258573|FG004|STARTED|Overall Study||6
10127337|NCT02618967|11258574|FG005|STARTED|Overall Study||6
10127338|NCT02618967|11258575|FG006|STARTED|Overall Study||6
10127339|NCT02618967|11258576|FG007|STARTED|Overall Study||14
10127340|NCT02618967|11258569|FG000|Received Treatment|Overall Study||6
10127341|NCT02618967|11258570|FG001|Received Treatment|Overall Study||6
10127342|NCT02618967|11258571|FG002|Received Treatment|Overall Study||6
10127343|NCT02618967|11258572|FG003|Received Treatment|Overall Study||6
10127344|NCT02618967|11258573|FG004|Received Treatment|Overall Study||6
10127345|NCT02618967|11258574|FG005|Received Treatment|Overall Study||6
10127346|NCT02618967|11258575|FG006|Received Treatment|Overall Study||6
10127347|NCT02618967|11258576|FG007|Received Treatment|Overall Study||14
10127348|NCT02618967|11258569|FG000|COMPLETED|Overall Study||5
10127349|NCT02618967|11258570|FG001|COMPLETED|Overall Study||6
10127350|NCT02618967|11258571|FG002|COMPLETED|Overall Study||5
10127351|NCT02618967|11258572|FG003|COMPLETED|Overall Study||6
10127352|NCT02618967|11258573|FG004|COMPLETED|Overall Study||4
10127353|NCT02618967|11258574|FG005|COMPLETED|Overall Study||6
10127354|NCT02618967|11258575|FG006|COMPLETED|Overall Study||6
10127355|NCT02618967|11258576|FG007|COMPLETED|Overall Study||14
10127356|NCT02618967|11258569|FG000|NOT COMPLETED|Overall Study||1
10127357|NCT02618967|11258570|FG001|NOT COMPLETED|Overall Study||0
10127358|NCT02618967|11258571|FG002|NOT COMPLETED|Overall Study||1
10127359|NCT02618967|11258572|FG003|NOT COMPLETED|Overall Study||0
10127360|NCT02618967|11258573|FG004|NOT COMPLETED|Overall Study||2
10127361|NCT02618967|11258574|FG005|NOT COMPLETED|Overall Study||0
10127362|NCT02618967|11258575|FG006|NOT COMPLETED|Overall Study||0
10127363|NCT02618967|11258576|FG007|NOT COMPLETED|Overall Study||0
10127364|NCT02619175|11258596|FG000|STARTED|Overall Study||18
10127365|NCT02619175|11258597|FG001|STARTED|Overall Study||16
10127366|NCT02619175|11258596|FG000|COMPLETED|Overall Study||16
10127367|NCT02619175|11258597|FG001|COMPLETED|Overall Study||16
10127368|NCT02619175|11258596|FG000|NOT COMPLETED|Overall Study||2
10127369|NCT02619175|11258597|FG001|NOT COMPLETED|Overall Study||0
10127370|NCT02619396|11258611|FG000|STARTED|Overall Study||20
10127371|NCT02619396|11258612|FG001|STARTED|Overall Study||20
10127372|NCT02619396|11258613|FG002|STARTED|Overall Study||20
10127373|NCT02619396|11258614|FG003|STARTED|Overall Study||20
10127374|NCT02619396|11258611|FG000|COMPLETED|Overall Study||20
10127375|NCT02619396|11258612|FG001|COMPLETED|Overall Study||20
10127376|NCT02619396|11258613|FG002|COMPLETED|Overall Study||20
10127377|NCT02619396|11258614|FG003|COMPLETED|Overall Study||20
10127378|NCT02619396|11258611|FG000|NOT COMPLETED|Overall Study||0
10127379|NCT02619396|11258612|FG001|NOT COMPLETED|Overall Study||0
10127380|NCT02619396|11258613|FG002|NOT COMPLETED|Overall Study||0
10127381|NCT02619396|11258614|FG003|NOT COMPLETED|Overall Study||0
10127382|NCT02619409|11258630|FG000|STARTED|Overall Study||6
10127383|NCT02619409|11258631|FG001|STARTED|Overall Study||6
10127384|NCT02619409|11258632|FG002|STARTED|Overall Study||6
10127385|NCT02619409|11258633|FG003|STARTED|Overall Study||6
10127386|NCT02619409|11258634|FG004|STARTED|Overall Study||6
10127387|NCT02619409|11258630|FG000|COMPLETED|Overall Study||6
10127388|NCT02619409|11258631|FG001|COMPLETED|Overall Study||6
10127389|NCT02619409|11258632|FG002|COMPLETED|Overall Study||6
10127390|NCT02619409|11258633|FG003|COMPLETED|Overall Study||6
10127391|NCT02619409|11258634|FG004|COMPLETED|Overall Study||6
10127392|NCT02619409|11258630|FG000|NOT COMPLETED|Overall Study||0
10127393|NCT02619409|11258631|FG001|NOT COMPLETED|Overall Study||0
10127394|NCT02619409|11258632|FG002|NOT COMPLETED|Overall Study||0
10127395|NCT02619409|11258633|FG003|NOT COMPLETED|Overall Study||0
10127396|NCT02619409|11258634|FG004|NOT COMPLETED|Overall Study||0
10127397|NCT02619591|11258648|FG000|STARTED|Overall Study||139
10127398|NCT02619591|11258649|FG001|STARTED|Overall Study||121
10127399|NCT02619591|11258648|FG000|COMPLETED|Overall Study||0
10127400|NCT02619591|11258649|FG001|COMPLETED|Overall Study||0
10127401|NCT02619591|11258648|FG000|NOT COMPLETED|Overall Study||139
10127402|NCT02619591|11258649|FG001|NOT COMPLETED|Overall Study||121
10127403|NCT02619617|11258655|FG000|STARTED|Period 1 Placebo - 1st AttacK||28
10127404|NCT02619617|11258656|FG001|STARTED|Period 1 Placebo - 1st AttacK||0
10127405|NCT02619617|11258655|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
10127406|NCT02619617|11258656|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
10127407|NCT02619617|11258655|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
10127408|NCT02619617|11258656|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
10127409|NCT02619617|11258655|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28
10127410|NCT02619617|11258656|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0
10127411|NCT02619617|11258655|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
10127412|NCT02619617|11258656|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
10127413|NCT02619617|11258655|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0
10127414|NCT02619617|11258656|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28
10127415|NCT02619617|11258655|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
10127416|NCT02619617|11258656|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
10127417|NCT02619617|11258655|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0
10127418|NCT02619617|11258656|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24
10127419|NCT02619617|11258655|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
10127420|NCT02619617|11258656|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
10127421|NCT02619799|11258666|FG000|STARTED|Overall Study||25
10127422|NCT02619799|11258667|FG001|STARTED|Overall Study||25
10127423|NCT02619799|11258666|FG000|COMPLETED|Overall Study||25
10127424|NCT02619799|11258667|FG001|COMPLETED|Overall Study||25
10127425|NCT02619799|11258666|FG000|NOT COMPLETED|Overall Study||0
10127426|NCT02619799|11258667|FG001|NOT COMPLETED|Overall Study||0
10127427|NCT02620020|11258677|FG000|STARTED|Overall Study||141
10127428|NCT02620020|11258678|FG001|STARTED|Overall Study||141
10127429|NCT02620020|11258679|FG002|STARTED|Overall Study||140
10127430|NCT02620020|11258680|FG003|STARTED|Overall Study||141
10127431|NCT02620020|11258677|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140
10127432|NCT02620020|11258678|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139
10127433|NCT02620020|11258679|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139
10127434|NCT02620020|11258680|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140
10127435|NCT02620020|11258677|FG000|COMPLETED|Overall Study||97
10127436|NCT02620020|11258678|FG001|COMPLETED|Overall Study||106
10127437|NCT02620020|11258679|FG002|COMPLETED|Overall Study||115
10127438|NCT02620020|11258680|FG003|COMPLETED|Overall Study||115
10127439|NCT02620020|11258677|FG000|NOT COMPLETED|Overall Study||44
10127440|NCT02620020|11258678|FG001|NOT COMPLETED|Overall Study||35
10127441|NCT02620020|11258679|FG002|NOT COMPLETED|Overall Study||25
10127442|NCT02620020|11258680|FG003|NOT COMPLETED|Overall Study||26
10127443|NCT02620384|11258692|FG000|STARTED|Overall Study||70
10127444|NCT02620384|11258693|FG001|STARTED|Overall Study||73
10127445|NCT02620384|11258692|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
10127446|NCT02620384|11258693|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
10127447|NCT02620384|11258692|FG000|NOT COMPLETED|Overall Study||4
10127448|NCT02620384|11258693|FG001|NOT COMPLETED|Overall Study||7
10127449|NCT02620683|11258699|FG000|STARTED|First Intervention (Visit 1)||12
10127450|NCT02620683|11258700|FG001|STARTED|First Intervention (Visit 1)||11
10127451|NCT02620683|11258699|FG000|COMPLETED|First Intervention (Visit 1)||12
10127452|NCT02620683|11258700|FG001|COMPLETED|First Intervention (Visit 1)||11
10127453|NCT02620683|11258699|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
10127454|NCT02620683|11258700|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
10127455|NCT02620683|11258699|FG000|STARTED|Washout (2 Weeks)||12
10127456|NCT02620683|11258700|FG001|STARTED|Washout (2 Weeks)||11
10127457|NCT02620683|11258699|FG000|COMPLETED|Washout (2 Weeks)||12
10127458|NCT02620683|11258700|FG001|COMPLETED|Washout (2 Weeks)||11
10127459|NCT02620683|11258699|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10127460|NCT02620683|11258700|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10127461|NCT02620683|11258699|FG000|STARTED|Second Intervention (Visit 2)||12
10127462|NCT02620683|11258700|FG001|STARTED|Second Intervention (Visit 2)||11
10127463|NCT02620683|11258699|FG000|COMPLETED|Second Intervention (Visit 2)||12
10127464|NCT02620683|11258700|FG001|COMPLETED|Second Intervention (Visit 2)||11
10127465|NCT02620683|11258699|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
10127466|NCT02620683|11258700|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
10127467|NCT02620774|11258707|FG000|STARTED|Overall Study||10
10127468|NCT02620774|11258708|FG001|STARTED|Overall Study||6
10127469|NCT02620774|11258707|FG000|COMPLETED|Overall Study||10
10127470|NCT02620774|11258708|FG001|COMPLETED|Overall Study||6
10127471|NCT02620774|11258707|FG000|NOT COMPLETED|Overall Study||0
10127472|NCT02620774|11258708|FG001|NOT COMPLETED|Overall Study||0
10127473|NCT02620787|11258716|FG000|STARTED|Overall Study||12
10127474|NCT02620787|11258717|FG001|STARTED|Overall Study||6
10127475|NCT02620787|11258716|FG000|COMPLETED|Overall Study||10
10127476|NCT02620787|11258717|FG001|COMPLETED|Overall Study||6
10127477|NCT02620787|11258716|FG000|NOT COMPLETED|Overall Study||2
10127478|NCT02620787|11258717|FG001|NOT COMPLETED|Overall Study||0
10127479|NCT02620878|11258723|FG000|STARTED|Overall Study||16
10127480|NCT02620878|11258724|FG001|STARTED|Overall Study||16
10127481|NCT02620878|11258723|FG000|COMPLETED|Overall Study||16
10127482|NCT02620878|11258724|FG001|COMPLETED|Overall Study||16
10127483|NCT02620878|11258723|FG000|NOT COMPLETED|Overall Study||0
10127484|NCT02620878|11258724|FG001|NOT COMPLETED|Overall Study||0
10127485|NCT02620904|11258732|FG000|STARTED|Overall Study||4
10127486|NCT02620904|11258733|FG001|STARTED|Overall Study||5
10127487|NCT02620904|11258732|FG000|COMPLETED|Overall Study||4
10127488|NCT02620904|11258733|FG001|COMPLETED|Overall Study||5
10127489|NCT02620904|11258732|FG000|NOT COMPLETED|Overall Study||0
10127490|NCT02620904|11258733|FG001|NOT COMPLETED|Overall Study||0
10127491|NCT02620917|11258739|FG000|STARTED|Overall Study||6623
10127492|NCT02620917|11258739|FG000|COMPLETED|Overall Study||6623
10127493|NCT02620917|11258739|FG000|NOT COMPLETED|Overall Study||0
10127494|NCT02621034|11258748|FG000|STARTED|Overall Study||53
10127495|NCT02621034|11258749|FG001|STARTED|Overall Study||52
10127496|NCT02621034|11258750|FG002|STARTED|Overall Study||55
10127497|NCT02621034|11258748|FG000|COMPLETED|Overall Study||50
10127498|NCT02621034|11258749|FG001|COMPLETED|Overall Study||50
10127499|NCT02621034|11258750|FG002|COMPLETED|Overall Study||50
10127500|NCT02621034|11258748|FG000|NOT COMPLETED|Overall Study||3
10127501|NCT02621034|11258749|FG001|NOT COMPLETED|Overall Study||2
10127502|NCT02621034|11258750|FG002|NOT COMPLETED|Overall Study||5
10127503|NCT02621047|11258763|FG000|STARTED|Overall Study||8
10127504|NCT02621047|11258764|FG001|STARTED|Overall Study||8
10127505|NCT02621047|11258765|FG002|STARTED|Overall Study||12
10127506|NCT02621047|11258763|FG000|COMPLETED|Overall Study||8
10127507|NCT02621047|11258764|FG001|COMPLETED|Overall Study||8
10127508|NCT02621047|11258765|FG002|COMPLETED|Overall Study||11
10127509|NCT02621047|11258763|FG000|NOT COMPLETED|Overall Study||0
10127510|NCT02621047|11258764|FG001|NOT COMPLETED|Overall Study||0
10127511|NCT02621047|11258765|FG002|NOT COMPLETED|Overall Study||1
10127512|NCT02621060|11258776|FG000|STARTED|Overall Study||15
9706730|NCT03220581|10805810|FG000|COMPLETED|Overall Study||25
9706731|NCT03220581|10805811|FG001|COMPLETED|Overall Study||25
9706732|NCT03220581|10805810|FG000|NOT COMPLETED|Overall Study||3
9706733|NCT03220581|10805811|FG001|NOT COMPLETED|Overall Study||7
9706734|NCT03099486|10805819|FG000|STARTED|Overall Study||2
10127513|NCT02621060|11258777|FG001|STARTED|Overall Study||15
10127514|NCT02621060|11258776|FG000|COMPLETED|Overall Study||12
9706735|NCT03099486|10805819|FG000|COMPLETED|Overall Study||2
9706736|NCT03099486|10805819|FG000|NOT COMPLETED|Overall Study||0
9706737|NCT02991482|10805825|FG000|STARTED|Overall Study||73
9706738|NCT02991482|10805826|FG001|STARTED|Overall Study||71
9706739|NCT02991482|10805825|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0
9706740|NCT02991482|10805826|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45
10127515|NCT02621060|11258777|FG001|COMPLETED|Overall Study||14
10127516|NCT02621060|11258776|FG000|NOT COMPLETED|Overall Study||3
10127517|NCT02621060|11258777|FG001|NOT COMPLETED|Overall Study||1
10127518|NCT02621073|11258785|FG000|STARTED|Overall Study||4
10127519|NCT02621073|11258786|FG001|STARTED|Overall Study||3
10127520|NCT02621073|11258785|FG000|COMPLETED|Overall Study||1
10127521|NCT02621073|11258786|FG001|COMPLETED|Overall Study||0
10127522|NCT02621073|11258785|FG000|NOT COMPLETED|Overall Study||3
10127523|NCT02621073|11258786|FG001|NOT COMPLETED|Overall Study||3
10127524|NCT02621463|11258792|FG000|STARTED|Overall Study||29
10127525|NCT02621463|11258792|FG000|COMPLETED|Overall Study||29
10127526|NCT02621463|11258792|FG000|NOT COMPLETED|Overall Study||0
10127527|NCT02621619|11258798|FG000|STARTED|Overall Study||80
10127528|NCT02621619|11258799|FG001|STARTED|Overall Study||79
10127529|NCT02621619|11258798|FG000|COMPLETED|Overall Study||80
10127530|NCT02621619|11258799|FG001|COMPLETED|Overall Study||79
10127531|NCT02621619|11258798|FG000|NOT COMPLETED|Overall Study||0
10127532|NCT02621619|11258799|FG001|NOT COMPLETED|Overall Study||0
10127533|NCT02621892|11258807|FG000|STARTED|Treatment Period||307
10127534|NCT02621892|11258808|FG001|STARTED|Treatment Period||299
10127535|NCT02621892|11258807|FG000|COMPLETED|Treatment Period||261
10127536|NCT02621892|11258808|FG001|COMPLETED|Treatment Period||272
10127537|NCT02621892|11258807|FG000|NOT COMPLETED|Treatment Period||46
10127538|NCT02621892|11258808|FG001|NOT COMPLETED|Treatment Period||27
10127539|NCT02621892|11258807|FG000|STARTED|Randomized Withdrawal Period||261
10127540|NCT02621892|11258808|FG001|STARTED|Randomized Withdrawal Period||272
10127541|NCT02621892|11258807|FG000|COMPLETED|Randomized Withdrawal Period||250
10127542|NCT02621892|11258808|FG001|COMPLETED|Randomized Withdrawal Period||260
10127543|NCT02621892|11258807|FG000|NOT COMPLETED|Randomized Withdrawal Period||11
10127544|NCT02621892|11258808|FG001|NOT COMPLETED|Randomized Withdrawal Period||12
10127545|NCT02621931|11258817|FG000|STARTED|Overall Study||375
10127546|NCT02621931|11258818|FG001|STARTED|Overall Study||376
10127547|NCT02621931|11258819|FG002|STARTED|Overall Study||379
10127548|NCT02621931|11258817|FG000|Safety and ITT Populations|Overall Study||375
10127549|NCT02621931|11258818|FG001|Safety and ITT Populations|Overall Study||376
10127550|NCT02621931|11258819|FG002|Safety and ITT Populations|Overall Study||379
10127551|NCT02621931|11258817|FG000|Full Analysis Set|Overall Study||371
10127552|NCT02621931|11258818|FG001|Full Analysis Set|Overall Study||375
10127553|NCT02621931|11258819|FG002|Full Analysis Set|Overall Study||375
10127554|NCT02621931|11258817|FG000|COMPLETED|Overall Study||342
10127555|NCT02621931|11258818|FG001|COMPLETED|Overall Study||349
10127556|NCT02621931|11258819|FG002|COMPLETED|Overall Study||343
10127557|NCT02621931|11258817|FG000|NOT COMPLETED|Overall Study||33
10127558|NCT02621931|11258818|FG001|NOT COMPLETED|Overall Study||27
10127559|NCT02621931|11258819|FG002|NOT COMPLETED|Overall Study||36
10196435|NCT03361605|11324678|FG000|NOT COMPLETED|Overall Study||3
10196436|NCT03361917|11324684|FG000|STARTED|Overall Study||99
10196437|NCT03361917|11324685|FG001|STARTED|Overall Study||101
10196438|NCT03361917|11324684|FG000|COMPLETED|Overall Study||99
10196439|NCT03361917|11324685|FG001|COMPLETED|Overall Study||101
10196440|NCT03361917|11324684|FG000|NOT COMPLETED|Overall Study||0
10196441|NCT03361917|11324685|FG001|NOT COMPLETED|Overall Study||0
10196442|NCT03362879|11324691|FG000|STARTED|Overall Study||409
10196443|NCT03362879|11324691|FG000|COMPLETED|Overall Study||409
10196444|NCT03362879|11324691|FG000|NOT COMPLETED|Overall Study||0
10196445|NCT03362944|11324696|FG000|STARTED|First Intervention||8
10196446|NCT03362944|11324697|FG001|STARTED|First Intervention||8
10196447|NCT03362944|11324696|FG000|COMPLETED|First Intervention||8
10196448|NCT03362944|11324697|FG001|COMPLETED|First Intervention||8
10196449|NCT03362944|11324696|FG000|NOT COMPLETED|First Intervention||0
10196450|NCT03362944|11324697|FG001|NOT COMPLETED|First Intervention||0
10196451|NCT03362944|11324696|FG000|STARTED|Single Week Washout Period||8
10196452|NCT03362944|11324697|FG001|STARTED|Single Week Washout Period||8
10196453|NCT03362944|11324696|FG000|COMPLETED|Single Week Washout Period||8
10196454|NCT03362944|11324697|FG001|COMPLETED|Single Week Washout Period||8
10196455|NCT03362944|11324696|FG000|NOT COMPLETED|Single Week Washout Period||0
10196456|NCT03362944|11324697|FG001|NOT COMPLETED|Single Week Washout Period||0
10196457|NCT03362944|11324696|FG000|STARTED|Second Intervention||8
9706741|NCT02991482|10805825|FG000|COMPLETED|Overall Study||8
10196458|NCT03362944|11324697|FG001|STARTED|Second Intervention||8
10196459|NCT03362944|11324696|FG000|COMPLETED|Second Intervention||8
10196460|NCT03362944|11324697|FG001|COMPLETED|Second Intervention||8
10196461|NCT03362944|11324696|FG000|NOT COMPLETED|Second Intervention||0
10196462|NCT03362944|11324697|FG001|NOT COMPLETED|Second Intervention||0
10196463|NCT03362957|11324705|FG000|STARTED|Overall Study||14
10196464|NCT03362957|11324706|FG001|STARTED|Overall Study||7
10196465|NCT03362957|11324705|FG000|Crossover to Receive GAE Procedure|Overall Study||0
10196466|NCT03362957|11324706|FG001|Crossover to Receive GAE Procedure|Overall Study||7
10196467|NCT03362957|11324705|FG000|COMPLETED|Overall Study||14
10196468|NCT03362957|11324706|FG001|COMPLETED|Overall Study||7
10196469|NCT03362957|11324705|FG000|NOT COMPLETED|Overall Study||0
10127560|NCT02621983|11258831|FG000|STARTED|Overall Study||21
10127561|NCT02621983|11258832|FG001|STARTED|Overall Study||17
10127562|NCT02621983|11258831|FG000|COMPLETED|Overall Study||9
10127563|NCT02621983|11258832|FG001|COMPLETED|Overall Study||6
10127564|NCT02621983|11258831|FG000|NOT COMPLETED|Overall Study||12
10127565|NCT02621983|11258832|FG001|NOT COMPLETED|Overall Study||11
10127566|NCT02622074|11258844|FG000|STARTED|Overall Study||10
10127567|NCT02622074|11258845|FG001|STARTED|Overall Study||10
10127568|NCT02622074|11258846|FG002|STARTED|Overall Study||10
10127569|NCT02622074|11258847|FG003|STARTED|Overall Study||10
10127570|NCT02622074|11258848|FG004|STARTED|Overall Study||10
10127571|NCT02622074|11258849|FG005|STARTED|Overall Study||10
10127572|NCT02622074|11258844|FG000|COMPLETED|Overall Study||6
10127573|NCT02622074|11258845|FG001|COMPLETED|Overall Study||9
10127574|NCT02622074|11258846|FG002|COMPLETED|Overall Study||10
10127575|NCT02622074|11258847|FG003|COMPLETED|Overall Study||9
10127576|NCT02622074|11258848|FG004|COMPLETED|Overall Study||9
10127577|NCT02622074|11258849|FG005|COMPLETED|Overall Study||10
10127578|NCT02622074|11258844|FG000|NOT COMPLETED|Overall Study||4
10127579|NCT02622074|11258845|FG001|NOT COMPLETED|Overall Study||1
10127580|NCT02622074|11258846|FG002|NOT COMPLETED|Overall Study||0
10127581|NCT02622074|11258847|FG003|NOT COMPLETED|Overall Study||1
10127582|NCT02622074|11258848|FG004|NOT COMPLETED|Overall Study||1
10127583|NCT02622074|11258849|FG005|NOT COMPLETED|Overall Study||0
10127584|NCT02622113|11258865|FG000|STARTED|Overall Study||67
10127585|NCT02622113|11258866|FG001|STARTED|Overall Study||76
10127586|NCT02622113|11258865|FG000|COMPLETED|Overall Study||62
10127587|NCT02622113|11258866|FG001|COMPLETED|Overall Study||66
10127588|NCT02622113|11258865|FG000|NOT COMPLETED|Overall Study||5
10127589|NCT02622113|11258866|FG001|NOT COMPLETED|Overall Study||10
10127590|NCT02622178|11258875|FG000|STARTED|Overall Study||42
10127591|NCT02622178|11258876|FG001|STARTED|Overall Study||45
10127592|NCT02622178|11258877|FG002|STARTED|Overall Study||49
9706742|NCT02991482|10805826|FG001|COMPLETED|Overall Study||5
9706743|NCT02991482|10805825|FG000|NOT COMPLETED|Overall Study||65
10127593|NCT02622178|11258875|FG000|COMPLETED|Overall Study||42
10127594|NCT02622178|11258876|FG001|COMPLETED|Overall Study||45
10127595|NCT02622178|11258877|FG002|COMPLETED|Overall Study||49
10127596|NCT02622178|11258875|FG000|NOT COMPLETED|Overall Study||0
10127597|NCT02622178|11258876|FG001|NOT COMPLETED|Overall Study||0
10127598|NCT02622178|11258877|FG002|NOT COMPLETED|Overall Study||0
10127599|NCT02622191|11258888|FG000|STARTED|Overall Study||19
10127600|NCT02622191|11258889|FG001|STARTED|Overall Study||14
10127601|NCT02622191|11258888|FG000|COMPLETED|Overall Study||19
10127602|NCT02622191|11258889|FG001|COMPLETED|Overall Study||14
10127603|NCT02622191|11258888|FG000|NOT COMPLETED|Overall Study||0
10127604|NCT02622191|11258889|FG001|NOT COMPLETED|Overall Study||0
10127605|NCT02622321|11258900|FG000|STARTED|Overall Study||35
10127606|NCT02622321|11258901|FG001|STARTED|Overall Study||18
10127607|NCT02622321|11258902|FG002|STARTED|Overall Study||49
10127608|NCT02622321|11258903|FG003|STARTED|Overall Study||11
10127609|NCT02622321|11258900|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
10127610|NCT02622321|11258901|FG001|Received at Least One Dose of Treatment|Overall Study||18
10127611|NCT02622321|11258902|FG002|Received at Least One Dose of Treatment|Overall Study||49
10127612|NCT02622321|11258903|FG003|Received at Least One Dose of Treatment|Overall Study||11
10127613|NCT02622321|11258900|FG000|Completed 24 Weeks in the Study|Overall Study||31
10127614|NCT02622321|11258901|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
10127615|NCT02622321|11258902|FG002|Completed 24 Weeks in the Study|Overall Study||49
10127616|NCT02622321|11258903|FG003|Completed 24 Weeks in the Study|Overall Study||11
10127617|NCT02622321|11258900|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
10127618|NCT02622321|11258901|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
10127619|NCT02622321|11258902|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
10127620|NCT02622321|11258903|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
10127621|NCT02622321|11258900|FG000|COMPLETED|Overall Study||32
10127622|NCT02622321|11258901|FG001|COMPLETED|Overall Study||18
10127623|NCT02622321|11258902|FG002|COMPLETED|Overall Study||48
10127624|NCT02622321|11258903|FG003|COMPLETED|Overall Study||11
10127625|NCT02622321|11258900|FG000|NOT COMPLETED|Overall Study||3
10127626|NCT02622321|11258901|FG001|NOT COMPLETED|Overall Study||0
10127627|NCT02622321|11258902|FG002|NOT COMPLETED|Overall Study||1
10127628|NCT02622321|11258903|FG003|NOT COMPLETED|Overall Study||0
10127629|NCT02622568|11258929|FG000|STARTED|Overall Study||14
10127630|NCT02622568|11258930|FG001|STARTED|Overall Study||14
10127631|NCT02622568|11258929|FG000|COMPLETED|Overall Study||9
10127632|NCT02622568|11258930|FG001|COMPLETED|Overall Study||9
10127633|NCT02622568|11258929|FG000|NOT COMPLETED|Overall Study||5
10127634|NCT02622568|11258930|FG001|NOT COMPLETED|Overall Study||5
10127635|NCT02622724|11258938|FG000|STARTED|Overall Study||144
10127636|NCT02622724|11258939|FG001|STARTED|Overall Study||152
10127637|NCT02622724|11258938|FG000|Subjects Randomised|Overall Study||146
10127638|NCT02622724|11258939|FG001|Subjects Randomised|Overall Study||155
10127639|NCT02622724|11258938|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105
10127640|NCT02622724|11258939|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115
10127641|NCT02622724|11258938|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96
10127642|NCT02622724|11258939|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101
10127643|NCT02622724|11258938|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73
10127644|NCT02622724|11258939|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74
10127645|NCT02622724|11258938|FG000|COMPLETED|Overall Study||51
10127646|NCT02622724|11258939|FG001|COMPLETED|Overall Study||49
10127647|NCT02622724|11258938|FG000|NOT COMPLETED|Overall Study||93
10127648|NCT02622724|11258939|FG001|NOT COMPLETED|Overall Study||103
10127649|NCT02623218|11258956|FG000|STARTED|Overall Study||5
10127650|NCT02623218|11258957|FG001|STARTED|Overall Study||4
10127651|NCT02623218|11258958|FG002|STARTED|Overall Study||4
10127652|NCT02623218|11258959|FG003|STARTED|Overall Study||4
10127653|NCT02623218|11258960|FG004|STARTED|Overall Study||4
10127654|NCT02623218|11258956|FG000|COMPLETED|Overall Study||5
10127655|NCT02623218|11258957|FG001|COMPLETED|Overall Study||3
10127656|NCT02623218|11258958|FG002|COMPLETED|Overall Study||4
10127657|NCT02623218|11258959|FG003|COMPLETED|Overall Study||4
10127658|NCT02623218|11258960|FG004|COMPLETED|Overall Study||4
10127659|NCT02623218|11258956|FG000|NOT COMPLETED|Overall Study||0
10127660|NCT02623218|11258957|FG001|NOT COMPLETED|Overall Study||1
10127661|NCT02623218|11258958|FG002|NOT COMPLETED|Overall Study||0
10127662|NCT02623218|11258959|FG003|NOT COMPLETED|Overall Study||0
10127663|NCT02623218|11258960|FG004|NOT COMPLETED|Overall Study||0
10127664|NCT02623322|11258975|FG000|STARTED|Overall Study||43
10127665|NCT02623322|11258976|FG001|STARTED|Overall Study||41
10127666|NCT02623322|11258977|FG002|STARTED|Overall Study||40
10127667|NCT02623322|11258975|FG000|COMPLETED|Overall Study||41
10127668|NCT02623322|11258976|FG001|COMPLETED|Overall Study||40
10127669|NCT02623322|11258977|FG002|COMPLETED|Overall Study||40
10127670|NCT02623322|11258975|FG000|NOT COMPLETED|Overall Study||2
10127671|NCT02623322|11258976|FG001|NOT COMPLETED|Overall Study||1
10127672|NCT02623322|11258977|FG002|NOT COMPLETED|Overall Study||0
10127673|NCT02623335|11258989|FG000|STARTED|Overall Study||223
10127674|NCT02623335|11258990|FG001|STARTED|Overall Study||223
10127675|NCT02623335|11258989|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223
10127676|NCT02623335|11258990|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222
10127677|NCT02623335|11258989|FG000|T1 Survey (24-48 Hours)|Overall Study||216
10127678|NCT02623335|11258990|FG001|T1 Survey (24-48 Hours)|Overall Study||214
10127679|NCT02623335|11258989|FG000|T2 Survey (6-8 Weeks)|Overall Study||199
10127680|NCT02623335|11258990|FG001|T2 Survey (6-8 Weeks)|Overall Study||192
10127681|NCT02623335|11258989|FG000|T3 Survey (12-14 Weeks)|Overall Study||196
10127682|NCT02623335|11258990|FG001|T3 Survey (12-14 Weeks)|Overall Study||187
10127683|NCT02623335|11258989|FG000|COMPLETED|Overall Study||196
10127684|NCT02623335|11258990|FG001|COMPLETED|Overall Study||187
10127685|NCT02623335|11258989|FG000|NOT COMPLETED|Overall Study||27
10127686|NCT02623335|11258990|FG001|NOT COMPLETED|Overall Study||36
10127687|NCT02623348|11258998|FG000|STARTED|Overall Study||30
10127688|NCT02623348|11258999|FG001|STARTED|Overall Study||30
10127689|NCT02623348|11258998|FG000|3-month Assessment|Overall Study||27
10127690|NCT02623348|11258999|FG001|3-month Assessment|Overall Study||26
10127691|NCT02623348|11258998|FG000|COMPLETED|Overall Study||27
10127692|NCT02623348|11258999|FG001|COMPLETED|Overall Study||28
10127693|NCT02623348|11258998|FG000|NOT COMPLETED|Overall Study||3
10127694|NCT02623348|11258999|FG001|NOT COMPLETED|Overall Study||2
10127695|NCT02623361|11259007|FG000|STARTED|Overall Study||40
10127696|NCT02623361|11259008|FG001|STARTED|Overall Study||40
10127697|NCT02623361|11259007|FG000|COMPLETED|Overall Study||40
10127698|NCT02623361|11259008|FG001|COMPLETED|Overall Study||38
10127699|NCT02623361|11259007|FG000|NOT COMPLETED|Overall Study||0
10127700|NCT02623361|11259008|FG001|NOT COMPLETED|Overall Study||2
10127701|NCT02623803|11259016|FG000|STARTED|Overall Study||25
10127702|NCT02623803|11259017|FG001|STARTED|Overall Study||23
10127703|NCT02623803|11259016|FG000|COMPLETED|Overall Study||25
10127704|NCT02623803|11259017|FG001|COMPLETED|Overall Study||23
10127705|NCT02623803|11259016|FG000|NOT COMPLETED|Overall Study||0
10127706|NCT02623803|11259017|FG001|NOT COMPLETED|Overall Study||0
10127707|NCT02623829|11259025|FG000|STARTED|Overall Study||21
10127708|NCT02623829|11259026|FG001|STARTED|Overall Study||21
10127709|NCT02623829|11259025|FG000|COMPLETED|Overall Study||20
10127710|NCT02623829|11259026|FG001|COMPLETED|Overall Study||20
10127711|NCT02623829|11259025|FG000|NOT COMPLETED|Overall Study||1
10127712|NCT02623829|11259026|FG001|NOT COMPLETED|Overall Study||1
10127713|NCT02623855|11259034|FG000|STARTED|Overall Study||56
10127714|NCT02623855|11259035|FG001|STARTED|Overall Study||100
10127715|NCT02623855|11259034|FG000|COMPLETED|Overall Study||46
10127716|NCT02623855|11259035|FG001|COMPLETED|Overall Study||84
10127717|NCT02623855|11259034|FG000|NOT COMPLETED|Overall Study||10
10127718|NCT02623855|11259035|FG001|NOT COMPLETED|Overall Study||16
10127719|NCT02624050|11259043|FG000|STARTED|Overall Study||26
10127720|NCT02624050|11259044|FG001|STARTED|Overall Study||25
10127721|NCT02624050|11259043|FG000|COMPLETED|Overall Study||20
10127722|NCT02624050|11259044|FG001|COMPLETED|Overall Study||25
10127723|NCT02624050|11259043|FG000|NOT COMPLETED|Overall Study||6
10127724|NCT02624050|11259044|FG001|NOT COMPLETED|Overall Study||0
10127725|NCT02624180|11259052|FG000|STARTED|Overall Study||43
10127726|NCT02624180|11259053|FG001|STARTED|Overall Study||38
10127727|NCT02624180|11259052|FG000|COMPLETED|Overall Study||37
10127728|NCT02624180|11259053|FG001|COMPLETED|Overall Study||34
10127729|NCT02624180|11259052|FG000|NOT COMPLETED|Overall Study||6
10127730|NCT02624180|11259053|FG001|NOT COMPLETED|Overall Study||4
10127731|NCT02624284|11259062|FG000|STARTED|Overall Study||49
10127732|NCT02624284|11259063|FG001|STARTED|Overall Study||53
10127733|NCT02624284|11259064|FG002|STARTED|Overall Study||47
10127734|NCT02624284|11259062|FG000|COMPLETED|Overall Study||35
10127735|NCT02624284|11259063|FG001|COMPLETED|Overall Study||35
10127736|NCT02624284|11259064|FG002|COMPLETED|Overall Study||36
10127737|NCT02624284|11259062|FG000|NOT COMPLETED|Overall Study||14
10127738|NCT02624284|11259063|FG001|NOT COMPLETED|Overall Study||18
10127739|NCT02624284|11259064|FG002|NOT COMPLETED|Overall Study||11
10127740|NCT02624375|11259072|FG000|STARTED|Overall Study||10
10127741|NCT02624375|11259072|FG000|COMPLETED|Overall Study||10
10127742|NCT02624375|11259072|FG000|NOT COMPLETED|Overall Study||0
10127743|NCT02624492|11259079|FG000|STARTED|Overall Study||5
10127744|NCT02624492|11259080|FG001|STARTED|Overall Study||8
10127745|NCT02624492|11259081|FG002|STARTED|Overall Study||8
10127746|NCT02624492|11259079|FG000|COMPLETED|Overall Study||3
10127747|NCT02624492|11259080|FG001|COMPLETED|Overall Study||4
10127748|NCT02624492|11259081|FG002|COMPLETED|Overall Study||3
10127749|NCT02624492|11259079|FG000|NOT COMPLETED|Overall Study||2
10127750|NCT02624492|11259080|FG001|NOT COMPLETED|Overall Study||4
10127751|NCT02624492|11259081|FG002|NOT COMPLETED|Overall Study||5
10127752|NCT02624687|11259091|FG000|STARTED|Overall Study||13
10127753|NCT02624687|11259092|FG001|STARTED|Overall Study||14
10127754|NCT02624687|11259091|FG000|COMPLETED|Overall Study||12
10127755|NCT02624687|11259092|FG001|COMPLETED|Overall Study||12
10127756|NCT02624687|11259091|FG000|NOT COMPLETED|Overall Study||1
10127757|NCT02624687|11259092|FG001|NOT COMPLETED|Overall Study||2
10127758|NCT02624700|11259100|FG000|STARTED|Overall Study||9
10127759|NCT02624700|11259101|FG001|STARTED|Overall Study||4
10127760|NCT02624700|11259100|FG000|COMPLETED|Overall Study||9
10127761|NCT02624700|11259101|FG001|COMPLETED|Overall Study||4
10127762|NCT02624700|11259100|FG000|NOT COMPLETED|Overall Study||0
10127763|NCT02624700|11259101|FG001|NOT COMPLETED|Overall Study||0
10127764|NCT02624713|11259111|FG000|STARTED|Overall Study||78
10127765|NCT02624713|11259112|FG001|STARTED|Overall Study||81
10127766|NCT02624713|11259111|FG000|COMPLETED|Overall Study||64
10127767|NCT02624713|11259112|FG001|COMPLETED|Overall Study||81
10127768|NCT02624713|11259111|FG000|NOT COMPLETED|Overall Study||14
10127769|NCT02624713|11259112|FG001|NOT COMPLETED|Overall Study||0
10127770|NCT02624791|11259119|FG000|STARTED|Overall Study||2
10127771|NCT02624791|11259120|FG001|STARTED|Overall Study||1
10127772|NCT02624791|11259121|FG002|STARTED|Overall Study||2
10127773|NCT02624791|11259122|FG003|STARTED|Overall Study||2
10127774|NCT02624791|11259123|FG004|STARTED|Overall Study||2
10127775|NCT02624791|11259124|FG005|STARTED|Overall Study||2
10127776|NCT02624791|11259119|FG000|COMPLETED|Overall Study||0
10127777|NCT02624791|11259120|FG001|COMPLETED|Overall Study||1
10127778|NCT02624791|11259121|FG002|COMPLETED|Overall Study||2
10127779|NCT02624791|11259122|FG003|COMPLETED|Overall Study||2
10127780|NCT02624791|11259123|FG004|COMPLETED|Overall Study||2
10127781|NCT02624791|11259124|FG005|COMPLETED|Overall Study||2
10127782|NCT02624791|11259119|FG000|NOT COMPLETED|Overall Study||2
10127783|NCT02624791|11259120|FG001|NOT COMPLETED|Overall Study||0
10127784|NCT02624791|11259121|FG002|NOT COMPLETED|Overall Study||0
10127785|NCT02624791|11259122|FG003|NOT COMPLETED|Overall Study||0
10127786|NCT02624791|11259123|FG004|NOT COMPLETED|Overall Study||0
10127787|NCT02624791|11259124|FG005|NOT COMPLETED|Overall Study||0
10127788|NCT02624843|11259131|FG000|STARTED|Overall Study||107
10127789|NCT02624843|11259132|FG001|STARTED|Overall Study||108
10127790|NCT02624843|11259133|FG002|STARTED|Overall Study||24
10127791|NCT02624843|11259131|FG000|COMPLETED|Overall Study||70
10127792|NCT02624843|11259132|FG001|COMPLETED|Overall Study||72
10127793|NCT02624843|11259133|FG002|COMPLETED|Overall Study||16
10127794|NCT02624843|11259131|FG000|NOT COMPLETED|Overall Study||37
10127795|NCT02624843|11259132|FG001|NOT COMPLETED|Overall Study||36
10127796|NCT02624843|11259133|FG002|NOT COMPLETED|Overall Study||8
10127797|NCT02624986|11259149|FG000|STARTED|Overall Study||2
10127798|NCT02624986|11259150|FG001|STARTED|Overall Study||3
10127799|NCT02624986|11259151|FG002|STARTED|Overall Study||2
10127800|NCT02624986|11259152|FG003|STARTED|Overall Study||3
10127801|NCT02624986|11259153|FG004|STARTED|Overall Study||4
10127802|NCT02624986|11259154|FG005|STARTED|Overall Study||2
10127803|NCT02624986|11259155|FG006|STARTED|Overall Study||4
10127804|NCT02624986|11259156|FG007|STARTED|Overall Study||5
10127805|NCT02624986|11259149|FG000|Received Any Study Treatment|Overall Study||1
10127806|NCT02624986|11259150|FG001|Received Any Study Treatment|Overall Study||3
10127807|NCT02624986|11259151|FG002|Received Any Study Treatment|Overall Study||2
10127808|NCT02624986|11259152|FG003|Received Any Study Treatment|Overall Study||3
10127809|NCT02624986|11259153|FG004|Received Any Study Treatment|Overall Study||4
10127810|NCT02624986|11259154|FG005|Received Any Study Treatment|Overall Study||2
10127811|NCT02624986|11259155|FG006|Received Any Study Treatment|Overall Study||4
10127812|NCT02624986|11259156|FG007|Received Any Study Treatment|Overall Study||5
10127813|NCT02624986|11259149|FG000|COMPLETED|Overall Study||0
10127814|NCT02624986|11259150|FG001|COMPLETED|Overall Study||0
10127815|NCT02624986|11259151|FG002|COMPLETED|Overall Study||0
10127816|NCT02624986|11259152|FG003|COMPLETED|Overall Study||0
10127817|NCT02624986|11259153|FG004|COMPLETED|Overall Study||0
10127818|NCT02624986|11259154|FG005|COMPLETED|Overall Study||0
10127819|NCT02624986|11259155|FG006|COMPLETED|Overall Study||0
10127820|NCT02624986|11259156|FG007|COMPLETED|Overall Study||0
10127821|NCT02624986|11259149|FG000|NOT COMPLETED|Overall Study||2
10127822|NCT02624986|11259150|FG001|NOT COMPLETED|Overall Study||3
10127823|NCT02624986|11259151|FG002|NOT COMPLETED|Overall Study||2
10127824|NCT02624986|11259152|FG003|NOT COMPLETED|Overall Study||3
10127825|NCT02624986|11259153|FG004|NOT COMPLETED|Overall Study||4
10127826|NCT02624986|11259154|FG005|NOT COMPLETED|Overall Study||2
10127827|NCT02624986|11259155|FG006|NOT COMPLETED|Overall Study||4
10127828|NCT02624986|11259156|FG007|NOT COMPLETED|Overall Study||5
10127829|NCT02625181|11259181|FG000|STARTED|Overall Study||1518
10127830|NCT02625181|11259182|FG001|STARTED|Overall Study||12809
10127831|NCT02625181|11259183|FG002|STARTED|Overall Study||12707
10127832|NCT02625181|11259181|FG000|COMPLETED|Overall Study||1518
10127833|NCT02625181|11259182|FG001|COMPLETED|Overall Study||12809
10127834|NCT02625181|11259183|FG002|COMPLETED|Overall Study||12707
10127835|NCT02625181|11259181|FG000|NOT COMPLETED|Overall Study||0
10127836|NCT02625181|11259182|FG001|NOT COMPLETED|Overall Study||0
10127837|NCT02625181|11259183|FG002|NOT COMPLETED|Overall Study||0
10127838|NCT02625207|11259193|FG000|STARTED|Part 1 (6 Days)||11
10127839|NCT02625207|11259194|FG001|STARTED|Part 1 (6 Days)||12
10127840|NCT02625207|11259195|FG002|STARTED|Part 1 (6 Days)||12
10127841|NCT02625207|11259196|FG003|STARTED|Part 1 (6 Days)||12
10127842|NCT02625207|11259193|FG000|COMPLETED|Part 1 (6 Days)||11
10127843|NCT02625207|11259194|FG001|COMPLETED|Part 1 (6 Days)||12
10127844|NCT02625207|11259195|FG002|COMPLETED|Part 1 (6 Days)||12
10127845|NCT02625207|11259196|FG003|COMPLETED|Part 1 (6 Days)||12
10127846|NCT02625207|11259193|FG000|NOT COMPLETED|Part 1 (6 Days)||0
10127847|NCT02625207|11259194|FG001|NOT COMPLETED|Part 1 (6 Days)||0
10127848|NCT02625207|11259195|FG002|NOT COMPLETED|Part 1 (6 Days)||0
10127849|NCT02625207|11259196|FG003|NOT COMPLETED|Part 1 (6 Days)||0
10127850|NCT02625207|11259193|FG000|STARTED|Part 2 (11 Days)||11
10127851|NCT02625207|11259194|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
10127852|NCT02625207|11259195|FG002|STARTED|Part 2 (11 Days)||12
10127853|NCT02625207|11259196|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
10127854|NCT02625207|11259193|FG000|COMPLETED|Part 2 (11 Days)||11
10127855|NCT02625207|11259194|FG001|COMPLETED|Part 2 (11 Days)||0
10127856|NCT02625207|11259195|FG002|COMPLETED|Part 2 (11 Days)||12
10127857|NCT02625207|11259196|FG003|COMPLETED|Part 2 (11 Days)||0
10127858|NCT02625207|11259193|FG000|NOT COMPLETED|Part 2 (11 Days)||0
10127859|NCT02625207|11259194|FG001|NOT COMPLETED|Part 2 (11 Days)||0
10127860|NCT02625207|11259195|FG002|NOT COMPLETED|Part 2 (11 Days)||0
10127861|NCT02625207|11259196|FG003|NOT COMPLETED|Part 2 (11 Days)||0
10127862|NCT02625220|11259212|FG000|STARTED|Overall Study||170
10127863|NCT02625220|11259212|FG000|COMPLETED|Overall Study||163
10127864|NCT02625220|11259212|FG000|NOT COMPLETED|Overall Study||7
10127865|NCT02625233|11259218|FG000|STARTED|Overall Study||49
10127866|NCT02625233|11259219|FG001|STARTED|Overall Study||56
10127867|NCT02625233|11259218|FG000|COMPLETED|Overall Study||47
10127868|NCT02625233|11259219|FG001|COMPLETED|Overall Study||56
10127869|NCT02625233|11259218|FG000|NOT COMPLETED|Overall Study||2
10127870|NCT02625233|11259219|FG001|NOT COMPLETED|Overall Study||0
10127871|NCT02625259|11259230|FG000|STARTED|First Intervention (Day 1)||11
10127872|NCT02625259|11259231|FG001|STARTED|First Intervention (Day 1)||9
10127873|NCT02625259|11259232|FG002|STARTED|First Intervention (Day 1)||8
10127874|NCT02625259|11259233|FG003|STARTED|First Intervention (Day 1)||10
10127875|NCT02625259|11259234|FG004|STARTED|First Intervention (Day 1)||16
10127876|NCT02625259|11259230|FG000|COMPLETED|First Intervention (Day 1)||9
10127877|NCT02625259|11259231|FG001|COMPLETED|First Intervention (Day 1)||8
10127878|NCT02625259|11259232|FG002|COMPLETED|First Intervention (Day 1)||7
10127879|NCT02625259|11259233|FG003|COMPLETED|First Intervention (Day 1)||9
10127880|NCT02625259|11259234|FG004|COMPLETED|First Intervention (Day 1)||16
10127881|NCT02625259|11259230|FG000|NOT COMPLETED|First Intervention (Day 1)||2
10127882|NCT02625259|11259231|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10127883|NCT02625259|11259232|FG002|NOT COMPLETED|First Intervention (Day 1)||1
10127884|NCT02625259|11259233|FG003|NOT COMPLETED|First Intervention (Day 1)||1
10127885|NCT02625259|11259234|FG004|NOT COMPLETED|First Intervention (Day 1)||0
10127886|NCT02625259|11259230|FG000|STARTED|Washout (Day 2 to Day 14)||9
10127887|NCT02625259|11259231|FG001|STARTED|Washout (Day 2 to Day 14)||8
10127888|NCT02625259|11259232|FG002|STARTED|Washout (Day 2 to Day 14)||7
10127889|NCT02625259|11259233|FG003|STARTED|Washout (Day 2 to Day 14)||9
10127890|NCT02625259|11259234|FG004|STARTED|Washout (Day 2 to Day 14)||0
10127891|NCT02625259|11259230|FG000|COMPLETED|Washout (Day 2 to Day 14)||9
10127892|NCT02625259|11259231|FG001|COMPLETED|Washout (Day 2 to Day 14)||8
10127893|NCT02625259|11259232|FG002|COMPLETED|Washout (Day 2 to Day 14)||7
10127894|NCT02625259|11259233|FG003|COMPLETED|Washout (Day 2 to Day 14)||9
10127895|NCT02625259|11259234|FG004|COMPLETED|Washout (Day 2 to Day 14)||0
10127896|NCT02625259|11259230|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10127897|NCT02625259|11259231|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10127898|NCT02625259|11259232|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10127899|NCT02625259|11259233|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10127900|NCT02625259|11259234|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10127901|NCT02625259|11259230|FG000|STARTED|Second Intervention (Day 15)||9
10127902|NCT02625259|11259231|FG001|STARTED|Second Intervention (Day 15)||8
10127903|NCT02625259|11259232|FG002|STARTED|Second Intervention (Day 15)||7
10127904|NCT02625259|11259233|FG003|STARTED|Second Intervention (Day 15)||9
10127905|NCT02625259|11259234|FG004|STARTED|Second Intervention (Day 15)||0
10127906|NCT02625259|11259230|FG000|COMPLETED|Second Intervention (Day 15)||9
10127907|NCT02625259|11259231|FG001|COMPLETED|Second Intervention (Day 15)||8
10127908|NCT02625259|11259232|FG002|COMPLETED|Second Intervention (Day 15)||7
10127909|NCT02625259|11259233|FG003|COMPLETED|Second Intervention (Day 15)||9
10127910|NCT02625259|11259234|FG004|COMPLETED|Second Intervention (Day 15)||0
10127911|NCT02625259|11259230|FG000|NOT COMPLETED|Second Intervention (Day 15)||0
10127912|NCT02625259|11259231|FG001|NOT COMPLETED|Second Intervention (Day 15)||0
10127913|NCT02625259|11259232|FG002|NOT COMPLETED|Second Intervention (Day 15)||0
10127914|NCT02625259|11259233|FG003|NOT COMPLETED|Second Intervention (Day 15)||0
10127915|NCT02625259|11259234|FG004|NOT COMPLETED|Second Intervention (Day 15)||0
10127916|NCT02625298|11259251|FG000|STARTED|Overall Study||11
10127917|NCT02625298|11259252|FG001|STARTED|Overall Study||13
10127918|NCT02625298|11259251|FG000|COMPLETED|Overall Study||10
10127919|NCT02625298|11259252|FG001|COMPLETED|Overall Study||13
10127920|NCT02625298|11259251|FG000|NOT COMPLETED|Overall Study||1
10127921|NCT02625298|11259252|FG001|NOT COMPLETED|Overall Study||0
10127922|NCT02625402|11259262|FG000|STARTED|Overall Study||42
10127923|NCT02625402|11259263|FG001|STARTED|Overall Study||37
10127924|NCT02625402|11259262|FG000|COMPLETED|Overall Study||33
10127925|NCT02625402|11259263|FG001|COMPLETED|Overall Study||25
10127926|NCT02625402|11259262|FG000|NOT COMPLETED|Overall Study||9
10127927|NCT02625402|11259263|FG001|NOT COMPLETED|Overall Study||12
10127928|NCT02625428|11259271|FG000|STARTED|Overall Study||20
10127929|NCT02625428|11259272|FG001|STARTED|Overall Study||20
10127930|NCT02625428|11259271|FG000|COMPLETED|Overall Study||20
10127931|NCT02625428|11259272|FG001|COMPLETED|Overall Study||20
10127932|NCT02625428|11259271|FG000|NOT COMPLETED|Overall Study||0
10127933|NCT02625428|11259272|FG001|NOT COMPLETED|Overall Study||0
10127934|NCT02625545|11259278|FG000|STARTED|Overall Study||45
10127935|NCT02625545|11259278|FG000|3 Month|Overall Study||45
10127936|NCT02625545|11259278|FG000|6 Month|Overall Study||45
10127937|NCT02625545|11259278|FG000|12 Month|Overall Study||45
10127938|NCT02625545|11259278|FG000|COMPLETED|Overall Study||45
10127939|NCT02625545|11259278|FG000|NOT COMPLETED|Overall Study||0
10127940|NCT02625571|11259282|FG000|STARTED|Overall Study||13
10127941|NCT02625571|11259282|FG000|COMPLETED|Overall Study||10
10127942|NCT02625571|11259282|FG000|NOT COMPLETED|Overall Study||3
10127943|NCT02625623|11259288|FG000|STARTED|Overall Study||186
10127944|NCT02625623|11259289|FG001|STARTED|Overall Study||185
10127945|NCT02625623|11259288|FG000|Treated|Overall Study||177
10127946|NCT02625623|11259289|FG001|Treated|Overall Study||184
10127947|NCT02625623|11259288|FG000|COMPLETED|Overall Study||177
10127948|NCT02625623|11259289|FG001|COMPLETED|Overall Study||184
10127949|NCT02625623|11259288|FG000|NOT COMPLETED|Overall Study||9
10127950|NCT02625623|11259289|FG001|NOT COMPLETED|Overall Study||1
10127951|NCT02625844|11259297|FG000|STARTED|Overall Study||110
10127952|NCT02625844|11259297|FG000|COMPLETED|Overall Study||110
10127953|NCT02625844|11259297|FG000|NOT COMPLETED|Overall Study||0
10127954|NCT02625909|11259303|FG000|STARTED|Overall Study||93
10127955|NCT02625909|11259304|FG001|STARTED|Overall Study||95
10127956|NCT02625909|11259303|FG000|COMPLETED|Overall Study||76
10127957|NCT02625909|11259304|FG001|COMPLETED|Overall Study||86
10127958|NCT02625909|11259303|FG000|NOT COMPLETED|Overall Study||17
10127959|NCT02625909|11259304|FG001|NOT COMPLETED|Overall Study||9
10127960|NCT02625922|11259312|FG000|STARTED|Overall Study||14
10127961|NCT02625922|11259313|FG001|STARTED|Overall Study||12
10127962|NCT02625922|11259312|FG000|Completed Treatment Period 1|Overall Study||12
10127963|NCT02625922|11259313|FG001|Completed Treatment Period 1|Overall Study||10
10127964|NCT02625922|11259312|FG000|Completed Treatment Period 2|Overall Study||11
10127965|NCT02625922|11259313|FG001|Completed Treatment Period 2|Overall Study||8
10127966|NCT02625922|11259312|FG000|COMPLETED|Overall Study||12
10127967|NCT02625922|11259313|FG001|COMPLETED|Overall Study||10
10127968|NCT02625922|11259312|FG000|NOT COMPLETED|Overall Study||2
10127969|NCT02625922|11259313|FG001|NOT COMPLETED|Overall Study||2
10127970|NCT02625974|11259324|FG000|STARTED|Overall Study||219
10127971|NCT02625974|11259325|FG001|STARTED|Overall Study||111
10127972|NCT02625974|11259324|FG000|Received Treatment|Overall Study||219
10127973|NCT02625974|11259325|FG001|Received Treatment|Overall Study||111
10127974|NCT02625974|11259324|FG000|COMPLETED|Overall Study||203
10127975|NCT02625974|11259325|FG001|COMPLETED|Overall Study||105
10127976|NCT02625974|11259324|FG000|NOT COMPLETED|Overall Study||16
10127977|NCT02625974|11259325|FG001|NOT COMPLETED|Overall Study||6
10127978|NCT02626000|11259367|FG000|STARTED|Overall Study||36
10127979|NCT02626000|11259367|FG000|COMPLETED|Overall Study||6
10127980|NCT02626000|11259367|FG000|NOT COMPLETED|Overall Study||30
10127981|NCT02626026|11259378|FG000|STARTED|Overall Study||8
10127982|NCT02626026|11259379|FG001|STARTED|Overall Study||2
10127983|NCT02626026|11259380|FG002|STARTED|Overall Study||8
10127984|NCT02626026|11259381|FG003|STARTED|Overall Study||2
10127985|NCT02626026|11259382|FG004|STARTED|Overall Study||17
10127986|NCT02626026|11259383|FG005|STARTED|Overall Study||5
10127987|NCT02626026|11259378|FG000|COMPLETED|Overall Study||8
10127988|NCT02626026|11259379|FG001|COMPLETED|Overall Study||2
10127989|NCT02626026|11259380|FG002|COMPLETED|Overall Study||8
10127990|NCT02626026|11259381|FG003|COMPLETED|Overall Study||2
10127991|NCT02626026|11259382|FG004|COMPLETED|Overall Study||16
10127992|NCT02626026|11259383|FG005|COMPLETED|Overall Study||5
10127993|NCT02626026|11259378|FG000|NOT COMPLETED|Overall Study||0
10127994|NCT02626026|11259379|FG001|NOT COMPLETED|Overall Study||0
10127995|NCT02626026|11259380|FG002|NOT COMPLETED|Overall Study||0
10127996|NCT02626026|11259381|FG003|NOT COMPLETED|Overall Study||0
10127997|NCT02626026|11259382|FG004|NOT COMPLETED|Overall Study||1
10127998|NCT02626026|11259383|FG005|NOT COMPLETED|Overall Study||0
10127999|NCT02626156|11259403|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29
10128000|NCT02626156|11259404|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29
10128001|NCT02626156|11259405|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42
10128002|NCT02626156|11259406|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40
10128003|NCT02626156|11259403|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23
10128004|NCT02626156|11259404|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22
10128005|NCT02626156|11259405|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37
10128006|NCT02626156|11259406|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35
10128007|NCT02626156|11259403|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
10128008|NCT02626156|11259404|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
10128009|NCT02626156|11259405|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
9706744|NCT02991482|10805826|FG001|NOT COMPLETED|Overall Study||66
9706745|NCT02768870|10805832|FG000|STARTED|Overall Study||26
9706746|NCT02768870|10805832|FG000|Implanted With Device|Overall Study||24
9706747|NCT02768870|10805832|FG000|COMPLETED|Overall Study||0
9706748|NCT02768870|10805832|FG000|NOT COMPLETED|Overall Study||26
9729157|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
9729158|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57
10128010|NCT02626156|11259406|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
10128011|NCT02626156|11259403|FG000|STARTED|Study Visit 3||23
10128012|NCT02626156|11259404|FG001|STARTED|Study Visit 3||22
10128013|NCT02626156|11259405|FG002|STARTED|Study Visit 3||37
10128014|NCT02626156|11259406|FG003|STARTED|Study Visit 3||35
10128015|NCT02626156|11259403|FG000|COMPLETED|Study Visit 3||15
10128016|NCT02626156|11259404|FG001|COMPLETED|Study Visit 3||17
10128017|NCT02626156|11259405|FG002|COMPLETED|Study Visit 3||33
10128018|NCT02626156|11259406|FG003|COMPLETED|Study Visit 3||33
10128019|NCT02626156|11259403|FG000|NOT COMPLETED|Study Visit 3||8
10128020|NCT02626156|11259404|FG001|NOT COMPLETED|Study Visit 3||5
10128021|NCT02626156|11259405|FG002|NOT COMPLETED|Study Visit 3||4
10128022|NCT02626156|11259406|FG003|NOT COMPLETED|Study Visit 3||2
10128023|NCT02626156|11259403|FG000|STARTED|Study Visit 4||15
10128024|NCT02626156|11259404|FG001|STARTED|Study Visit 4||17
10128025|NCT02626156|11259405|FG002|STARTED|Study Visit 4||33
10128026|NCT02626156|11259406|FG003|STARTED|Study Visit 4||33
10128027|NCT02626156|11259403|FG000|COMPLETED|Study Visit 4||12
10128028|NCT02626156|11259404|FG001|COMPLETED|Study Visit 4||15
10128029|NCT02626156|11259405|FG002|COMPLETED|Study Visit 4||24
9729159|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30
10128030|NCT02626156|11259406|FG003|COMPLETED|Study Visit 4||28
10128031|NCT02626156|11259403|FG000|NOT COMPLETED|Study Visit 4||3
10128032|NCT02626156|11259404|FG001|NOT COMPLETED|Study Visit 4||2
10128033|NCT02626156|11259405|FG002|NOT COMPLETED|Study Visit 4||9
10128034|NCT02626156|11259406|FG003|NOT COMPLETED|Study Visit 4||5
10128035|NCT02626182|11259424|FG000|STARTED|Overall Study||11
10128036|NCT02626182|11259425|FG001|STARTED|Overall Study||3
10128037|NCT02626182|11259424|FG000|COMPLETED|Overall Study||9
10128038|NCT02626182|11259425|FG001|COMPLETED|Overall Study||3
10128039|NCT02626182|11259424|FG000|NOT COMPLETED|Overall Study||2
10128040|NCT02626182|11259425|FG001|NOT COMPLETED|Overall Study||0
10128041|NCT02626611|11259434|FG000|STARTED|Overall Study||20
10128042|NCT02626611|11259435|FG001|STARTED|Overall Study||21
10128043|NCT02626611|11259436|FG002|STARTED|Overall Study||19
10128044|NCT02626611|11259434|FG000|COMPLETED|Overall Study||16
10128045|NCT02626611|11259435|FG001|COMPLETED|Overall Study||20
10128046|NCT02626611|11259436|FG002|COMPLETED|Overall Study||16
10128047|NCT02626611|11259434|FG000|NOT COMPLETED|Overall Study||4
10128048|NCT02626611|11259435|FG001|NOT COMPLETED|Overall Study||1
10128049|NCT02626611|11259436|FG002|NOT COMPLETED|Overall Study||3
10128050|NCT02626780|11259451|FG000|STARTED|Overall Study||7
10128051|NCT02626780|11259451|FG000|Withdrew From Study|Overall Study||3
10128052|NCT02626780|11259451|FG000|COMPLETED|Overall Study||4
10128053|NCT02626780|11259451|FG000|NOT COMPLETED|Overall Study||3
10128054|NCT02626819|11259457|FG000|STARTED|Overall Study||22
10128055|NCT02626819|11259458|FG001|STARTED|Overall Study||23
10128056|NCT02626819|11259457|FG000|COMPLETED|Overall Study||18
10128057|NCT02626819|11259458|FG001|COMPLETED|Overall Study||20
10128058|NCT02626819|11259457|FG000|NOT COMPLETED|Overall Study||4
10128059|NCT02626819|11259458|FG001|NOT COMPLETED|Overall Study||3
10128060|NCT02626910|11259468|FG000|STARTED|Overall Study||23
10128061|NCT02626910|11259469|FG001|STARTED|Overall Study||10
10128062|NCT02626910|11259470|FG002|STARTED|Overall Study||6
10128063|NCT02626910|11259471|FG003|STARTED|Overall Study||10
10128064|NCT02626910|11259468|FG000|COMPLETED|Overall Study||23
10128065|NCT02626910|11259469|FG001|COMPLETED|Overall Study||10
10128066|NCT02626910|11259470|FG002|COMPLETED|Overall Study||6
10128067|NCT02626910|11259471|FG003|COMPLETED|Overall Study||10
10128068|NCT02626910|11259468|FG000|NOT COMPLETED|Overall Study||0
10128069|NCT02626910|11259469|FG001|NOT COMPLETED|Overall Study||0
10128070|NCT02626910|11259470|FG002|NOT COMPLETED|Overall Study||0
10128071|NCT02626910|11259471|FG003|NOT COMPLETED|Overall Study||0
10128072|NCT02627001|11259483|FG000|STARTED|Overall Study||13
10128073|NCT02627001|11259484|FG001|STARTED|Overall Study||14
10128074|NCT02627001|11259483|FG000|COMPLETED|Overall Study||13
10128075|NCT02627001|11259484|FG001|COMPLETED|Overall Study||14
10128076|NCT02627001|11259483|FG000|NOT COMPLETED|Overall Study||0
10128077|NCT02627001|11259484|FG001|NOT COMPLETED|Overall Study||0
10128078|NCT02627118|11259490|FG000|STARTED|Overall Study||10
10128079|NCT02627118|11259490|FG000|COMPLETED|Overall Study||10
10128080|NCT02627118|11259490|FG000|NOT COMPLETED|Overall Study||0
10128081|NCT02627144|11259495|FG000|STARTED|Overall Study||365
10128082|NCT02627144|11259495|FG000|Treated|Overall Study||359
10128083|NCT02627144|11259495|FG000|COMPLETED|Overall Study||0
10128084|NCT02627144|11259495|FG000|NOT COMPLETED|Overall Study||365
10128085|NCT02627495|11259499|FG000|STARTED|Overall Study||9
10128086|NCT02627495|11259499|FG000|COMPLETED|Overall Study||5
10128087|NCT02627495|11259499|FG000|NOT COMPLETED|Overall Study||4
10128088|NCT02627677|11259506|FG000|STARTED|Overall Study||11
10128089|NCT02627677|11259507|FG001|STARTED|Overall Study||21
10128090|NCT02627677|11259508|FG002|STARTED|Overall Study||12
10128091|NCT02627677|11259506|FG000|COMPLETED|Overall Study||0
10128092|NCT02627677|11259507|FG001|COMPLETED|Overall Study||0
10128093|NCT02627677|11259508|FG002|COMPLETED|Overall Study||0
10128094|NCT02627677|11259506|FG000|NOT COMPLETED|Overall Study||11
10128095|NCT02627677|11259507|FG001|NOT COMPLETED|Overall Study||21
10128096|NCT02627677|11259508|FG002|NOT COMPLETED|Overall Study||12
10128097|NCT02627794|11259517|FG000|STARTED|Overall Study||3
10128098|NCT02627794|11259517|FG000|COMPLETED|Overall Study||3
10128099|NCT02627794|11259517|FG000|NOT COMPLETED|Overall Study||0
10128100|NCT02627924|11259524|FG000|STARTED|Overall Study||91
10128101|NCT02627924|11259524|FG000|COMPLETED|Overall Study||79
10128102|NCT02627924|11259524|FG000|NOT COMPLETED|Overall Study||12
10128103|NCT02628028|11259539|FG000|STARTED|Dosing Period||9
10128104|NCT02628028|11259540|FG001|STARTED|Dosing Period||9
10128105|NCT02628028|11259541|FG002|STARTED|Dosing Period||10
10128106|NCT02628028|11259542|FG003|STARTED|Dosing Period||8
10128107|NCT02628028|11259543|FG004|STARTED|Dosing Period||62
10128108|NCT02628028|11259544|FG005|STARTED|Dosing Period||63
10128109|NCT02628028|11259545|FG006|STARTED|Dosing Period||62
10128110|NCT02628028|11259546|FG007|STARTED|Dosing Period||63
10128111|NCT02628028|11259539|FG000|Received at Least 1dose of Study Drug|Dosing Period||9
10128112|NCT02628028|11259540|FG001|Received at Least 1dose of Study Drug|Dosing Period||9
10128113|NCT02628028|11259541|FG002|Received at Least 1dose of Study Drug|Dosing Period||10
10128114|NCT02628028|11259542|FG003|Received at Least 1dose of Study Drug|Dosing Period||8
10128115|NCT02628028|11259543|FG004|Received at Least 1dose of Study Drug|Dosing Period||62
10128116|NCT02628028|11259544|FG005|Received at Least 1dose of Study Drug|Dosing Period||63
10128117|NCT02628028|11259545|FG006|Received at Least 1dose of Study Drug|Dosing Period||62
10128118|NCT02628028|11259546|FG007|Received at Least 1dose of Study Drug|Dosing Period||63
10128119|NCT02628028|11259539|FG000|COMPLETED|Dosing Period||9
10128120|NCT02628028|11259540|FG001|COMPLETED|Dosing Period||9
10128121|NCT02628028|11259541|FG002|COMPLETED|Dosing Period||9
10128122|NCT02628028|11259542|FG003|COMPLETED|Dosing Period||8
10128123|NCT02628028|11259543|FG004|COMPLETED|Dosing Period||46
10128124|NCT02628028|11259544|FG005|COMPLETED|Dosing Period||49
10128125|NCT02628028|11259545|FG006|COMPLETED|Dosing Period||46
10128126|NCT02628028|11259546|FG007|COMPLETED|Dosing Period||48
10128127|NCT02628028|11259539|FG000|NOT COMPLETED|Dosing Period||0
10128128|NCT02628028|11259540|FG001|NOT COMPLETED|Dosing Period||0
10128129|NCT02628028|11259541|FG002|NOT COMPLETED|Dosing Period||1
10128130|NCT02628028|11259542|FG003|NOT COMPLETED|Dosing Period||0
10128131|NCT02628028|11259543|FG004|NOT COMPLETED|Dosing Period||16
10128132|NCT02628028|11259544|FG005|NOT COMPLETED|Dosing Period||14
10128133|NCT02628028|11259545|FG006|NOT COMPLETED|Dosing Period||16
10128134|NCT02628028|11259546|FG007|NOT COMPLETED|Dosing Period||15
10128135|NCT02628028|11259539|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10128136|NCT02628028|11259540|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10128137|NCT02628028|11259541|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10128138|NCT02628028|11259542|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10128139|NCT02628028|11259543|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
10128140|NCT02628028|11259544|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
10128141|NCT02628028|11259545|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
10128142|NCT02628028|11259546|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
10128143|NCT02628028|11259539|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10128144|NCT02628028|11259540|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10128145|NCT02628028|11259541|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10128146|NCT02628028|11259542|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10128147|NCT02628028|11259543|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10128148|NCT02628028|11259544|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
10128149|NCT02628028|11259545|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
10128150|NCT02628028|11259546|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
10128151|NCT02628028|11259539|FG000|COMPLETED|Long-term Extension (LTE) Period||0
10128152|NCT02628028|11259540|FG001|COMPLETED|Long-term Extension (LTE) Period||0
10128153|NCT02628028|11259541|FG002|COMPLETED|Long-term Extension (LTE) Period||0
10128154|NCT02628028|11259542|FG003|COMPLETED|Long-term Extension (LTE) Period||0
10128155|NCT02628028|11259543|FG004|COMPLETED|Long-term Extension (LTE) Period||0
10128156|NCT02628028|11259544|FG005|COMPLETED|Long-term Extension (LTE) Period||1
10128157|NCT02628028|11259545|FG006|COMPLETED|Long-term Extension (LTE) Period||0
10128158|NCT02628028|11259546|FG007|COMPLETED|Long-term Extension (LTE) Period||0
10128159|NCT02628028|11259539|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0
10128160|NCT02628028|11259540|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0
10128161|NCT02628028|11259541|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0
10128162|NCT02628028|11259542|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0
10128163|NCT02628028|11259543|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0
10128164|NCT02628028|11259544|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60
10128165|NCT02628028|11259545|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58
10128166|NCT02628028|11259546|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61
10128167|NCT02628093|11259570|FG000|STARTED|Overall Study||31
10128168|NCT02628093|11259571|FG001|STARTED|Overall Study||29
10128169|NCT02628093|11259570|FG000|COMPLETED|Overall Study||31
10128170|NCT02628093|11259571|FG001|COMPLETED|Overall Study||29
10128171|NCT02628093|11259570|FG000|NOT COMPLETED|Overall Study||0
10128172|NCT02628093|11259571|FG001|NOT COMPLETED|Overall Study||0
10128173|NCT02628106|11259577|FG000|STARTED|Overall Study||21
10128174|NCT02628106|11259577|FG000|COMPLETED|Overall Study||21
10128175|NCT02628106|11259577|FG000|NOT COMPLETED|Overall Study||0
10128176|NCT02628223|11259583|FG000|STARTED|Overall Study||38
10128177|NCT02628223|11259584|FG001|STARTED|Overall Study||38
10128178|NCT02628223|11259583|FG000|COMPLETED|Overall Study||38
10128179|NCT02628223|11259584|FG001|COMPLETED|Overall Study||36
10128180|NCT02628223|11259583|FG000|NOT COMPLETED|Overall Study||0
10128181|NCT02628223|11259584|FG001|NOT COMPLETED|Overall Study||2
10128182|NCT02628236|11259590|FG000|STARTED|Overall Study||14
10128183|NCT02628236|11259590|FG000|COMPLETED|Overall Study||14
10128184|NCT02628236|11259590|FG000|NOT COMPLETED|Overall Study||0
10128185|NCT02628418|11259596|FG000|STARTED|Overall Study||15
10128186|NCT02628418|11259597|FG001|STARTED|Overall Study||15
10128187|NCT02628418|11259596|FG000|COMPLETED|Overall Study||14
10128188|NCT02628418|11259597|FG001|COMPLETED|Overall Study||13
9706749|NCT02648698|10805838|FG000|STARTED|Overall Study||60
10128189|NCT02628418|11259596|FG000|NOT COMPLETED|Overall Study||1
10128190|NCT02628418|11259597|FG001|NOT COMPLETED|Overall Study||2
10128191|NCT02628600|11259611|FG000|STARTED|Overall Study||73
10128192|NCT02628600|11259612|FG001|STARTED|Overall Study||90
10128193|NCT02628600|11259611|FG000|Participant Discontinued the Study|Overall Study||24
10128194|NCT02628600|11259612|FG001|Participant Discontinued the Study|Overall Study||32
10128195|NCT02628600|11259611|FG000|COMPLETED|Overall Study||49
10128196|NCT02628600|11259612|FG001|COMPLETED|Overall Study||58
10128197|NCT02628600|11259611|FG000|NOT COMPLETED|Overall Study||24
10128198|NCT02628600|11259612|FG001|NOT COMPLETED|Overall Study||32
10128199|NCT02628743|11259618|FG000|STARTED|Overall Study||131
10128200|NCT02628743|11259618|FG000|COMPLETED|Overall Study||0
10128201|NCT02628743|11259618|FG000|NOT COMPLETED|Overall Study||131
10128202|NCT02628769|11259622|FG000|STARTED|First Intervention||3
10128203|NCT02628769|11259623|FG001|STARTED|First Intervention||3
10128204|NCT02628769|11259622|FG000|COMPLETED|First Intervention||2
10128205|NCT02628769|11259623|FG001|COMPLETED|First Intervention||2
10128206|NCT02628769|11259622|FG000|NOT COMPLETED|First Intervention||1
10128207|NCT02628769|11259623|FG001|NOT COMPLETED|First Intervention||1
10128208|NCT02628769|11259622|FG000|STARTED|Wash Out (28 Days)||2
10128209|NCT02628769|11259623|FG001|STARTED|Wash Out (28 Days)||2
10128210|NCT02628769|11259622|FG000|COMPLETED|Wash Out (28 Days)||2
10128211|NCT02628769|11259623|FG001|COMPLETED|Wash Out (28 Days)||2
10128212|NCT02628769|11259622|FG000|NOT COMPLETED|Wash Out (28 Days)||0
10128213|NCT02628769|11259623|FG001|NOT COMPLETED|Wash Out (28 Days)||0
10128214|NCT02628769|11259622|FG000|STARTED|Second Intervention||2
10128215|NCT02628769|11259623|FG001|STARTED|Second Intervention||2
10128216|NCT02628769|11259622|FG000|COMPLETED|Second Intervention||0
10128217|NCT02628769|11259623|FG001|COMPLETED|Second Intervention||1
10128218|NCT02628769|11259622|FG000|NOT COMPLETED|Second Intervention||2
10128219|NCT02628769|11259623|FG001|NOT COMPLETED|Second Intervention||1
10128220|NCT02628873|11259631|FG000|STARTED|First Test (1 Hour)||14
10128221|NCT02628873|11259632|FG001|STARTED|First Test (1 Hour)||7
10128222|NCT02628873|11259631|FG000|COMPLETED|First Test (1 Hour)||14
10128223|NCT02628873|11259632|FG001|COMPLETED|First Test (1 Hour)||7
10128224|NCT02628873|11259631|FG000|NOT COMPLETED|First Test (1 Hour)||0
10128225|NCT02628873|11259632|FG001|NOT COMPLETED|First Test (1 Hour)||0
10128226|NCT02628873|11259631|FG000|STARTED|Break (1 Hour)||14
10128227|NCT02628873|11259632|FG001|STARTED|Break (1 Hour)||7
10128228|NCT02628873|11259631|FG000|COMPLETED|Break (1 Hour)||14
10128229|NCT02628873|11259632|FG001|COMPLETED|Break (1 Hour)||6
10128230|NCT02628873|11259631|FG000|NOT COMPLETED|Break (1 Hour)||0
10128231|NCT02628873|11259632|FG001|NOT COMPLETED|Break (1 Hour)||1
10128232|NCT02628873|11259631|FG000|STARTED|Second Test (1 Hour)||14
10128233|NCT02628873|11259632|FG001|STARTED|Second Test (1 Hour)||6
10128234|NCT02628873|11259631|FG000|COMPLETED|Second Test (1 Hour)||13
10128235|NCT02628873|11259632|FG001|COMPLETED|Second Test (1 Hour)||6
10128236|NCT02628873|11259631|FG000|NOT COMPLETED|Second Test (1 Hour)||1
10128237|NCT02628873|11259632|FG001|NOT COMPLETED|Second Test (1 Hour)||0
10128238|NCT02628938|11259641|FG000|STARTED|Overall Study||15
10128239|NCT02628938|11259642|FG001|STARTED|Overall Study||15
10128240|NCT02628938|11259643|FG002|STARTED|Overall Study||15
10128241|NCT02628938|11259641|FG000|COMPLETED|Overall Study||10
10128242|NCT02628938|11259642|FG001|COMPLETED|Overall Study||13
10128243|NCT02628938|11259643|FG002|COMPLETED|Overall Study||11
10128244|NCT02628938|11259641|FG000|NOT COMPLETED|Overall Study||5
10128245|NCT02628938|11259642|FG001|NOT COMPLETED|Overall Study||2
10128246|NCT02628938|11259643|FG002|NOT COMPLETED|Overall Study||4
10128247|NCT02628964|11259653|FG000|STARTED|Overall Study||50
10128248|NCT02628964|11259654|FG001|STARTED|Overall Study||50
10128249|NCT02628964|11259653|FG000|COMPLETED|Overall Study||50
10128250|NCT02628964|11259654|FG001|COMPLETED|Overall Study||49
10128251|NCT02628964|11259653|FG000|NOT COMPLETED|Overall Study||0
10128252|NCT02628964|11259654|FG001|NOT COMPLETED|Overall Study||1
10128253|NCT02629094|11259660|FG000|STARTED|Overall Study||5
10128254|NCT02629094|11259660|FG000|COMPLETED|Overall Study||5
10128255|NCT02629094|11259660|FG000|NOT COMPLETED|Overall Study||0
10128256|NCT02629133|11259666|FG000|STARTED|Overall Study||25
10128257|NCT02629133|11259667|FG001|STARTED|Overall Study||25
10128258|NCT02629133|11259666|FG000|COMPLETED|Overall Study||21
10128259|NCT02629133|11259667|FG001|COMPLETED|Overall Study||23
10128260|NCT02629133|11259666|FG000|NOT COMPLETED|Overall Study||4
10128261|NCT02629133|11259667|FG001|NOT COMPLETED|Overall Study||2
10128262|NCT02629354|11259675|FG000|STARTED|Period 1||18
10128263|NCT02629354|11259676|FG001|STARTED|Period 1||18
10128264|NCT02629354|11259675|FG000|COMPLETED|Period 1||18
10128265|NCT02629354|11259676|FG001|COMPLETED|Period 1||18
10128266|NCT02629354|11259675|FG000|NOT COMPLETED|Period 1||0
10128267|NCT02629354|11259676|FG001|NOT COMPLETED|Period 1||0
10128268|NCT02629354|11259675|FG000|STARTED|Washout Period||18
9848699|NCT00861380|10961461|FG006|COMPLETED|Overall Study||0
10128269|NCT02629354|11259676|FG001|STARTED|Washout Period||18
10128270|NCT02629354|11259675|FG000|COMPLETED|Washout Period||18
10128271|NCT02629354|11259676|FG001|COMPLETED|Washout Period||18
10128272|NCT02629354|11259675|FG000|NOT COMPLETED|Washout Period||0
10128273|NCT02629354|11259676|FG001|NOT COMPLETED|Washout Period||0
10128274|NCT02629354|11259675|FG000|STARTED|Period 2||18
10128275|NCT02629354|11259676|FG001|STARTED|Period 2||18
10128276|NCT02629354|11259675|FG000|COMPLETED|Period 2||18
10128277|NCT02629354|11259676|FG001|COMPLETED|Period 2||18
10128278|NCT02629354|11259675|FG000|NOT COMPLETED|Period 2||0
10128279|NCT02629354|11259676|FG001|NOT COMPLETED|Period 2||0
10128280|NCT02629354|11259675|FG000|STARTED|Follow-up||18
10128281|NCT02629354|11259676|FG001|STARTED|Follow-up||18
10128282|NCT02629354|11259675|FG000|COMPLETED|Follow-up||18
10128283|NCT02629354|11259676|FG001|COMPLETED|Follow-up||18
10128284|NCT02629354|11259675|FG000|NOT COMPLETED|Follow-up||0
10128285|NCT02629354|11259676|FG001|NOT COMPLETED|Follow-up||0
10128286|NCT02629822|11259682|FG000|STARTED|Base Study||10
10128287|NCT02629822|11259682|FG000|COMPLETED|Base Study||7
10128288|NCT02629822|11259682|FG000|NOT COMPLETED|Base Study||3
10128289|NCT02629822|11259682|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
10128290|NCT02629822|11259682|FG000|COMPLETED|Extension Study||4
10128291|NCT02629822|11259682|FG000|NOT COMPLETED|Extension Study||2
10128292|NCT02629861|11259690|FG000|STARTED|Overall Study||294
10128293|NCT02629861|11259691|FG001|STARTED|Overall Study||291
10128294|NCT02629861|11259692|FG002|STARTED|Overall Study||290
10128295|NCT02629861|11259690|FG000|Intent to Treat (ITT)|Overall Study||294
10128296|NCT02629861|11259691|FG001|Intent to Treat (ITT)|Overall Study||291
10128297|NCT02629861|11259692|FG002|Intent to Treat (ITT)|Overall Study||290
10128298|NCT02629861|11259690|FG000|Safety Population|Overall Study||294
10128299|NCT02629861|11259691|FG001|Safety Population|Overall Study||291
10128300|NCT02629861|11259692|FG002|Safety Population|Overall Study||289
10128301|NCT02629861|11259690|FG000|Full Analysis Set|Overall Study||290
10128302|NCT02629861|11259691|FG001|Full Analysis Set|Overall Study||288
10128303|NCT02629861|11259692|FG002|Full Analysis Set|Overall Study||287
10128304|NCT02629861|11259690|FG000|COMPLETED|Overall Study||265
10128305|NCT02629861|11259691|FG001|COMPLETED|Overall Study||264
10128306|NCT02629861|11259692|FG002|COMPLETED|Overall Study||262
10128307|NCT02629861|11259690|FG000|NOT COMPLETED|Overall Study||29
10128308|NCT02629861|11259691|FG001|NOT COMPLETED|Overall Study||27
10128309|NCT02629861|11259692|FG002|NOT COMPLETED|Overall Study||28
10128310|NCT02629965|11259700|FG000|STARTED|Period 1||92
10128311|NCT02629965|11259701|FG001|STARTED|Period 1||92
10128312|NCT02629965|11259700|FG000|COMPLETED|Period 1||88
10128313|NCT02629965|11259701|FG001|COMPLETED|Period 1||90
10128314|NCT02629965|11259700|FG000|NOT COMPLETED|Period 1||4
10128315|NCT02629965|11259701|FG001|NOT COMPLETED|Period 1||2
10128316|NCT02629965|11259700|FG000|STARTED|Period 2||88
10128317|NCT02629965|11259701|FG001|STARTED|Period 2||90
10128318|NCT02629965|11259700|FG000|COMPLETED|Period 2||87
10128319|NCT02629965|11259701|FG001|COMPLETED|Period 2||90
10128320|NCT02629965|11259700|FG000|NOT COMPLETED|Period 2||1
10128321|NCT02629965|11259701|FG001|NOT COMPLETED|Period 2||0
10128322|NCT02629991|11259709|FG000|STARTED|Overall Study||11
10128323|NCT02629991|11259710|FG001|STARTED|Overall Study||12
10128324|NCT02629991|11259709|FG000|COMPLETED|Overall Study||10
10128325|NCT02629991|11259710|FG001|COMPLETED|Overall Study||11
10128326|NCT02629991|11259709|FG000|NOT COMPLETED|Overall Study||1
10128327|NCT02629991|11259710|FG001|NOT COMPLETED|Overall Study||1
10128328|NCT02630017|11259721|FG000|STARTED|Overall Study||13
10128329|NCT02630017|11259722|FG001|STARTED|Overall Study||12
10128330|NCT02630017|11259723|FG002|STARTED|Overall Study||13
10128331|NCT02630017|11259724|FG003|STARTED|Overall Study||13
10128332|NCT02630017|11259721|FG000|COMPLETED|Overall Study||12
10128333|NCT02630017|11259722|FG001|COMPLETED|Overall Study||11
10128334|NCT02630017|11259723|FG002|COMPLETED|Overall Study||11
10128335|NCT02630017|11259724|FG003|COMPLETED|Overall Study||12
10128336|NCT02630017|11259721|FG000|NOT COMPLETED|Overall Study||1
10128337|NCT02630017|11259722|FG001|NOT COMPLETED|Overall Study||1
10128338|NCT02630017|11259723|FG002|NOT COMPLETED|Overall Study||2
10128339|NCT02630017|11259724|FG003|NOT COMPLETED|Overall Study||1
10128340|NCT02630030|11259734|FG000|STARTED|Overall Study||3
10128341|NCT02630030|11259734|FG000|COMPLETED|Overall Study||3
10128342|NCT02630030|11259734|FG000|NOT COMPLETED|Overall Study||0
10128343|NCT02630186|11259738|FG000|STARTED|Overall Study||3
10128344|NCT02630186|11259738|FG000|COMPLETED|Overall Study||2
10128345|NCT02630186|11259738|FG000|NOT COMPLETED|Overall Study||1
10128346|NCT02630251|11259746|FG000|STARTED|Overall Study||2
10128347|NCT02630251|11259747|FG001|STARTED|Overall Study||1
10128348|NCT02630251|11259748|FG002|STARTED|Overall Study||1
10128349|NCT02630251|11259749|FG003|STARTED|Overall Study||1
10128350|NCT02630251|11259746|FG000|COMPLETED|Overall Study||2
10128351|NCT02630251|11259747|FG001|COMPLETED|Overall Study||1
10128352|NCT02630251|11259748|FG002|COMPLETED|Overall Study||0
10128353|NCT02630251|11259749|FG003|COMPLETED|Overall Study||1
10128354|NCT02630251|11259746|FG000|NOT COMPLETED|Overall Study||0
10128355|NCT02630251|11259747|FG001|NOT COMPLETED|Overall Study||0
10128356|NCT02630251|11259748|FG002|NOT COMPLETED|Overall Study||1
10128357|NCT02630251|11259749|FG003|NOT COMPLETED|Overall Study||0
10128358|NCT02630316|11259761|FG000|STARTED|Overall Study||163
10128359|NCT02630316|11259762|FG001|STARTED|Overall Study||163
10128360|NCT02630316|11259761|FG000|COMPLETED|Overall Study||128
10128361|NCT02630316|11259762|FG001|COMPLETED|Overall Study||130
10128362|NCT02630316|11259761|FG000|NOT COMPLETED|Overall Study||35
10128363|NCT02630316|11259762|FG001|NOT COMPLETED|Overall Study||33
10128364|NCT02630563|11259768|FG000|STARTED|Overall Study||9
10128365|NCT02630563|11259768|FG000|COMPLETED|Overall Study||8
10128366|NCT02630563|11259768|FG000|NOT COMPLETED|Overall Study||1
10128367|NCT02630693|11259775|FG000|STARTED|Overall Study||90
10128368|NCT02630693|11259776|FG001|STARTED|Overall Study||90
10128369|NCT02630693|11259775|FG000|COMPLETED|Overall Study||90
10128370|NCT02630693|11259776|FG001|COMPLETED|Overall Study||89
10128371|NCT02630693|11259775|FG000|NOT COMPLETED|Overall Study||0
10128372|NCT02630693|11259776|FG001|NOT COMPLETED|Overall Study||1
10128373|NCT02630706|11259785|FG000|STARTED|Overall Study||170
10128374|NCT02630706|11259786|FG001|STARTED|Overall Study||169
10128375|NCT02630706|11259787|FG002|STARTED|Overall Study||167
10128376|NCT02630706|11259785|FG000|Treated|Overall Study||170
10128377|NCT02630706|11259786|FG001|Treated|Overall Study||169
10128378|NCT02630706|11259787|FG002|Treated|Overall Study||167
10128379|NCT02630706|11259785|FG000|COMPLETED|Overall Study||163
10128380|NCT02630706|11259786|FG001|COMPLETED|Overall Study||160
10128381|NCT02630706|11259787|FG002|COMPLETED|Overall Study||157
10128382|NCT02630706|11259785|FG000|NOT COMPLETED|Overall Study||7
10128383|NCT02630706|11259786|FG001|NOT COMPLETED|Overall Study||9
10128384|NCT02630706|11259787|FG002|NOT COMPLETED|Overall Study||10
10128385|NCT02630719|11259797|FG000|STARTED|Overall Study||4
10128386|NCT02630719|11259798|FG001|STARTED|Overall Study||6
10128387|NCT02630719|11259797|FG000|COMPLETED|Overall Study||4
10128388|NCT02630719|11259798|FG001|COMPLETED|Overall Study||6
10128389|NCT02630719|11259797|FG000|NOT COMPLETED|Overall Study||0
10128390|NCT02630719|11259798|FG001|NOT COMPLETED|Overall Study||0
10128391|NCT02630953|11259806|FG000|STARTED|6 Month Assessment||97
10128392|NCT02630953|11259807|FG001|STARTED|6 Month Assessment||102
10128393|NCT02630953|11259806|FG000|COMPLETED|6 Month Assessment||83
10128394|NCT02630953|11259807|FG001|COMPLETED|6 Month Assessment||70
10128395|NCT02630953|11259806|FG000|NOT COMPLETED|6 Month Assessment||14
10128396|NCT02630953|11259807|FG001|NOT COMPLETED|6 Month Assessment||32
10128397|NCT02630953|11259806|FG000|STARTED|12 Month Assessment||97
10128398|NCT02630953|11259807|FG001|STARTED|12 Month Assessment||102
10128399|NCT02630953|11259806|FG000|COMPLETED|12 Month Assessment||73
10128400|NCT02630953|11259807|FG001|COMPLETED|12 Month Assessment||64
10128401|NCT02630953|11259806|FG000|NOT COMPLETED|12 Month Assessment||24
10128402|NCT02630953|11259807|FG001|NOT COMPLETED|12 Month Assessment||38
10128403|NCT02630966|11259815|FG000|STARTED|Overall Study||16
10128404|NCT02630966|11259816|FG001|STARTED|Overall Study||18
10128405|NCT02630966|11259815|FG000|COMPLETED|Overall Study||14
10128406|NCT02630966|11259816|FG001|COMPLETED|Overall Study||10
10128407|NCT02630966|11259815|FG000|NOT COMPLETED|Overall Study||2
10128408|NCT02630966|11259816|FG001|NOT COMPLETED|Overall Study||8
10128409|NCT02630992|11259822|FG000|STARTED|Overall Study||112
10128410|NCT02630992|11259822|FG000|COMPLETED|Overall Study||99
10128411|NCT02630992|11259822|FG000|NOT COMPLETED|Overall Study||13
10128412|NCT02631057|11259828|FG000|STARTED|Overall Study||899
10128413|NCT02631057|11259829|FG001|STARTED|Overall Study||3414
10128414|NCT02631057|11259828|FG000|COMPLETED|Overall Study||899
10128415|NCT02631057|11259829|FG001|COMPLETED|Overall Study||3414
10128416|NCT02631057|11259828|FG000|NOT COMPLETED|Overall Study||0
10128417|NCT02631057|11259829|FG001|NOT COMPLETED|Overall Study||0
10128418|NCT02631525|11259837|FG000|STARTED|Overall Study||20
10128419|NCT02631525|11259838|FG001|STARTED|Overall Study||20
10128420|NCT02631525|11259837|FG000|COMPLETED|Overall Study||20
10128421|NCT02631525|11259838|FG001|COMPLETED|Overall Study||20
10128422|NCT02631525|11259837|FG000|NOT COMPLETED|Overall Study||0
10128423|NCT02631525|11259838|FG001|NOT COMPLETED|Overall Study||0
10128424|NCT02631538|11259848|FG000|STARTED|Treatment Period (Up to Week 52)||13
10128425|NCT02631538|11259849|FG001|STARTED|Treatment Period (Up to Week 52)||24
10128426|NCT02631538|11259850|FG002|STARTED|Treatment Period (Up to Week 52)||24
10128427|NCT02631538|11259851|FG003|STARTED|Treatment Period (Up to Week 52)||25
10128428|NCT02631538|11259848|FG000|COMPLETED|Treatment Period (Up to Week 52)||9
10128429|NCT02631538|11259849|FG001|COMPLETED|Treatment Period (Up to Week 52)||17
10128430|NCT02631538|11259850|FG002|COMPLETED|Treatment Period (Up to Week 52)||19
10128431|NCT02631538|11259851|FG003|COMPLETED|Treatment Period (Up to Week 52)||17
10128432|NCT02631538|11259848|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4
10128433|NCT02631538|11259849|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7
10128434|NCT02631538|11259850|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5
10128435|NCT02631538|11259851|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8
10128436|NCT02631538|11259848|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9
10128437|NCT02631538|11259849|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17
10128438|NCT02631538|11259850|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19
10128439|NCT02631538|11259851|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17
10128440|NCT02631538|11259848|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
10128441|NCT02631538|11259849|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
10128442|NCT02631538|11259850|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
10128443|NCT02631538|11259851|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
10128444|NCT02631538|11259848|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
10128445|NCT02631538|11259849|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
10128446|NCT02631538|11259850|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
10128447|NCT02631538|11259851|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
10128448|NCT02631551|11259865|FG000|STARTED|Overall Study||302
10128449|NCT02631551|11259866|FG001|STARTED|Overall Study||297
10128450|NCT02631551|11259867|FG002|STARTED|Overall Study||294
10128451|NCT02631551|11259868|FG003|STARTED|Overall Study||287
10128452|NCT02631551|11259865|FG000|COMPLETED|Overall Study||289
10128453|NCT02631551|11259866|FG001|COMPLETED|Overall Study||278
10128454|NCT02631551|11259867|FG002|COMPLETED|Overall Study||283
10128455|NCT02631551|11259868|FG003|COMPLETED|Overall Study||276
10128456|NCT02631551|11259865|FG000|NOT COMPLETED|Overall Study||13
10128457|NCT02631551|11259866|FG001|NOT COMPLETED|Overall Study||19
10128458|NCT02631551|11259867|FG002|NOT COMPLETED|Overall Study||11
10128459|NCT02631551|11259868|FG003|NOT COMPLETED|Overall Study||11
10128460|NCT02631590|11259878|FG000|STARTED|Overall Study||24
10128461|NCT02631590|11259878|FG000|COMPLETED|Overall Study||24
10128462|NCT02631590|11259878|FG000|NOT COMPLETED|Overall Study||0
10128463|NCT02631746|11259882|FG000|STARTED|Overall Study||3
10128464|NCT02631746|11259882|FG000|COMPLETED|Overall Study||0
10128465|NCT02631746|11259882|FG000|NOT COMPLETED|Overall Study||3
10128466|NCT02631772|11259888|FG000|STARTED|Overall Study||16
10128467|NCT02631772|11259889|FG001|STARTED|Overall Study||16
10128468|NCT02631772|11259888|FG000|COMPLETED|Overall Study||16
10128469|NCT02631772|11259889|FG001|COMPLETED|Overall Study||16
10128470|NCT02631772|11259888|FG000|NOT COMPLETED|Overall Study||0
10128471|NCT02631772|11259889|FG001|NOT COMPLETED|Overall Study||0
10196470|NCT03362957|11324706|FG001|NOT COMPLETED|Overall Study||0
10196471|NCT03363321|11324719|FG000|STARTED|Overall Study||5
10196472|NCT03363321|11324720|FG001|STARTED|Overall Study||4
10128472|NCT02631850|11259899|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41
10128473|NCT02631850|11259900|FG001|STARTED|Treatment Period||44
10128474|NCT02631850|11259901|FG002|STARTED|Treatment Period||45
10128475|NCT02631850|11259902|FG003|STARTED|Treatment Period||38
10128476|NCT02631850|11259899|FG000|COMPLETED|Treatment Period||38
10128477|NCT02631850|11259900|FG001|COMPLETED|Treatment Period||38
10128478|NCT02631850|11259901|FG002|COMPLETED|Treatment Period||41
10128479|NCT02631850|11259902|FG003|COMPLETED|Treatment Period||33
10128480|NCT02631850|11259899|FG000|NOT COMPLETED|Treatment Period||3
10128481|NCT02631850|11259900|FG001|NOT COMPLETED|Treatment Period||6
10128482|NCT02631850|11259901|FG002|NOT COMPLETED|Treatment Period||4
10128483|NCT02631850|11259902|FG003|NOT COMPLETED|Treatment Period||5
10128484|NCT02631850|11259899|FG000|STARTED|6 Month Follow up||38
10128485|NCT02631850|11259900|FG001|STARTED|6 Month Follow up||38
10128486|NCT02631850|11259901|FG002|STARTED|6 Month Follow up||41
10128487|NCT02631850|11259902|FG003|STARTED|6 Month Follow up||33
10128488|NCT02631850|11259899|FG000|COMPLETED|6 Month Follow up||31
10128489|NCT02631850|11259900|FG001|COMPLETED|6 Month Follow up||25
10128490|NCT02631850|11259901|FG002|COMPLETED|6 Month Follow up||35
10128491|NCT02631850|11259902|FG003|COMPLETED|6 Month Follow up||22
10128492|NCT02631850|11259899|FG000|NOT COMPLETED|6 Month Follow up||7
10128493|NCT02631850|11259900|FG001|NOT COMPLETED|6 Month Follow up||13
10128494|NCT02631850|11259901|FG002|NOT COMPLETED|6 Month Follow up||6
10128495|NCT02631850|11259902|FG003|NOT COMPLETED|6 Month Follow up||11
10128496|NCT02631876|11259915|FG000|STARTED|Overall Study||248
10128497|NCT02631876|11259916|FG001|STARTED|Overall Study||118
10128498|NCT02631876|11259915|FG000|Safety Population|Overall Study||243
10128499|NCT02631876|11259916|FG001|Safety Population|Overall Study||109
10128500|NCT02631876|11259915|FG000|COMPLETED|Overall Study||129
10128501|NCT02631876|11259916|FG001|COMPLETED|Overall Study||55
10128502|NCT02631876|11259915|FG000|NOT COMPLETED|Overall Study||119
10128503|NCT02631876|11259916|FG001|NOT COMPLETED|Overall Study||63
10128504|NCT02631954|11259925|FG000|STARTED|Overall Study||12
10128505|NCT02631954|11259926|FG001|STARTED|Overall Study||12
10128506|NCT02631954|11259925|FG000|COMPLETED|Overall Study||12
10128507|NCT02631954|11259926|FG001|COMPLETED|Overall Study||12
10128508|NCT02631954|11259925|FG000|NOT COMPLETED|Overall Study||0
10128509|NCT02631954|11259926|FG001|NOT COMPLETED|Overall Study||0
10128510|NCT02632110|11259937|FG000|STARTED|Overall Study||25
10128511|NCT02632110|11259938|FG001|STARTED|Overall Study||25
10128512|NCT02632110|11259939|FG002|STARTED|Overall Study||27
10128513|NCT02632110|11259940|FG003|STARTED|Overall Study||27
9706750|NCT02648698|10805839|FG001|STARTED|Overall Study||60
9706751|NCT02648698|10805838|FG000|COMPLETED|Overall Study||59
10128514|NCT02632110|11259941|FG004|STARTED|Overall Study||29
10128515|NCT02632110|11259942|FG005|STARTED|Overall Study||29
10128516|NCT02632110|11259943|FG006|STARTED|Overall Study||26
10128517|NCT02632110|11259944|FG007|STARTED|Overall Study||26
10128518|NCT02632110|11259945|FG008|STARTED|Overall Study||30
10128519|NCT02632110|11259946|FG009|STARTED|Overall Study||30
10128520|NCT02632110|11259937|FG000|COMPLETED|Overall Study||24
10128521|NCT02632110|11259938|FG001|COMPLETED|Overall Study||24
10128522|NCT02632110|11259939|FG002|COMPLETED|Overall Study||27
10128523|NCT02632110|11259940|FG003|COMPLETED|Overall Study||27
10128524|NCT02632110|11259941|FG004|COMPLETED|Overall Study||28
10128525|NCT02632110|11259942|FG005|COMPLETED|Overall Study||28
10128526|NCT02632110|11259943|FG006|COMPLETED|Overall Study||23
10128527|NCT02632110|11259944|FG007|COMPLETED|Overall Study||23
10128528|NCT02632110|11259945|FG008|COMPLETED|Overall Study||29
10128529|NCT02632110|11259946|FG009|COMPLETED|Overall Study||29
10128530|NCT02632110|11259937|FG000|NOT COMPLETED|Overall Study||1
10128531|NCT02632110|11259938|FG001|NOT COMPLETED|Overall Study||1
10128532|NCT02632110|11259939|FG002|NOT COMPLETED|Overall Study||0
10128533|NCT02632110|11259940|FG003|NOT COMPLETED|Overall Study||0
10128534|NCT02632110|11259941|FG004|NOT COMPLETED|Overall Study||1
10128535|NCT02632110|11259942|FG005|NOT COMPLETED|Overall Study||1
10128536|NCT02632110|11259943|FG006|NOT COMPLETED|Overall Study||3
10128537|NCT02632110|11259944|FG007|NOT COMPLETED|Overall Study||3
10128538|NCT02632110|11259945|FG008|NOT COMPLETED|Overall Study||1
10128539|NCT02632110|11259946|FG009|NOT COMPLETED|Overall Study||1
10128540|NCT02632526|11259969|FG000|STARTED|Overall Study||36
10128541|NCT02632526|11259970|FG001|STARTED|Overall Study||12
10128542|NCT02632526|11259971|FG002|STARTED|Overall Study||24
10128543|NCT02632526|11259972|FG003|STARTED|Overall Study||12
10128544|NCT02632526|11259973|FG004|STARTED|Overall Study||4
10128545|NCT02632526|11259974|FG005|STARTED|Overall Study||8
10128546|NCT02632526|11259969|FG000|COMPLETED|Overall Study||36
10128547|NCT02632526|11259970|FG001|COMPLETED|Overall Study||12
10128548|NCT02632526|11259971|FG002|COMPLETED|Overall Study||24
10128549|NCT02632526|11259972|FG003|COMPLETED|Overall Study||12
10128550|NCT02632526|11259973|FG004|COMPLETED|Overall Study||4
10128551|NCT02632526|11259974|FG005|COMPLETED|Overall Study||8
10128552|NCT02632526|11259969|FG000|NOT COMPLETED|Overall Study||0
10128553|NCT02632526|11259970|FG001|NOT COMPLETED|Overall Study||0
10128554|NCT02632526|11259971|FG002|NOT COMPLETED|Overall Study||0
10128555|NCT02632526|11259972|FG003|NOT COMPLETED|Overall Study||0
10128556|NCT02632526|11259973|FG004|NOT COMPLETED|Overall Study||0
10128557|NCT02632526|11259974|FG005|NOT COMPLETED|Overall Study||0
10196473|NCT03363321|11324721|FG002|STARTED|Overall Study||4
10196474|NCT03363321|11324722|FG003|STARTED|Overall Study||5
10196475|NCT03363321|11324723|FG004|STARTED|Overall Study||2
10196476|NCT03363321|11324719|FG000|COMPLETED|Overall Study||5
10196477|NCT03363321|11324720|FG001|COMPLETED|Overall Study||3
10196478|NCT03363321|11324721|FG002|COMPLETED|Overall Study||4
10196479|NCT03363321|11324722|FG003|COMPLETED|Overall Study||4
10196480|NCT03363321|11324723|FG004|COMPLETED|Overall Study||2
10196481|NCT03363321|11324719|FG000|NOT COMPLETED|Overall Study||0
10196482|NCT03363321|11324720|FG001|NOT COMPLETED|Overall Study||1
10196483|NCT03363321|11324721|FG002|NOT COMPLETED|Overall Study||0
10196484|NCT03363321|11324722|FG003|NOT COMPLETED|Overall Study||1
10196485|NCT03363321|11324723|FG004|NOT COMPLETED|Overall Study||0
10196486|NCT03363776|11324739|FG000|STARTED|Overall Study||4
10196487|NCT03363776|11324740|FG001|STARTED|Overall Study||3
10196488|NCT03363776|11324741|FG002|STARTED|Overall Study||3
10196489|NCT03363776|11324739|FG000|COMPLETED|Overall Study||1
10196490|NCT03363776|11324740|FG001|COMPLETED|Overall Study||0
10196491|NCT03363776|11324741|FG002|COMPLETED|Overall Study||1
10196492|NCT03363776|11324739|FG000|NOT COMPLETED|Overall Study||3
10196493|NCT03363776|11324740|FG001|NOT COMPLETED|Overall Study||3
10196494|NCT03363776|11324741|FG002|NOT COMPLETED|Overall Study||2
10196495|NCT03363854|11324751|FG000|STARTED|Initial Treatment Period||253
10196496|NCT03363854|11324752|FG001|STARTED|Initial Treatment Period||127
10196497|NCT03363854|11324753|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10196498|NCT03363854|11324754|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10196499|NCT03363854|11324755|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10196500|NCT03363854|11324756|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10196501|NCT03363854|11324757|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10196502|NCT03363854|11324758|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
10196503|NCT03363854|11324751|FG000|COMPLETED|Initial Treatment Period||235
10196504|NCT03363854|11324752|FG001|COMPLETED|Initial Treatment Period||120
10196505|NCT03363854|11324753|FG002|COMPLETED|Initial Treatment Period||0
10196506|NCT03363854|11324754|FG003|COMPLETED|Initial Treatment Period||0
10196507|NCT03363854|11324755|FG004|COMPLETED|Initial Treatment Period||0
10196508|NCT03363854|11324756|FG005|COMPLETED|Initial Treatment Period||0
10196509|NCT03363854|11324757|FG006|COMPLETED|Initial Treatment Period||0
10196510|NCT03363854|11324758|FG007|COMPLETED|Initial Treatment Period||0
10196511|NCT03363854|11324751|FG000|NOT COMPLETED|Initial Treatment Period||18
10196512|NCT03363854|11324752|FG001|NOT COMPLETED|Initial Treatment Period||7
10196513|NCT03363854|11324753|FG002|NOT COMPLETED|Initial Treatment Period||0
10196514|NCT03363854|11324754|FG003|NOT COMPLETED|Initial Treatment Period||0
10196515|NCT03363854|11324755|FG004|NOT COMPLETED|Initial Treatment Period||0
10196516|NCT03363854|11324756|FG005|NOT COMPLETED|Initial Treatment Period||0
10196517|NCT03363854|11324757|FG006|NOT COMPLETED|Initial Treatment Period||0
10196518|NCT03363854|11324758|FG007|NOT COMPLETED|Initial Treatment Period||0
10196519|NCT03363854|11324751|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
10196520|NCT03363854|11324752|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
10196521|NCT03363854|11324753|FG002|STARTED|Continuation Treatment Period||69
10196522|NCT03363854|11324754|FG003|STARTED|Continuation Treatment Period||69
10128558|NCT02632552|11260021|FG000|STARTED|Overall Study||80
10128559|NCT02632552|11260022|FG001|STARTED|Overall Study||60
10128560|NCT02632552|11260021|FG000|COMPLETED|Overall Study||57
10128561|NCT02632552|11260022|FG001|COMPLETED|Overall Study||50
10128562|NCT02632552|11260021|FG000|NOT COMPLETED|Overall Study||23
10128563|NCT02632552|11260022|FG001|NOT COMPLETED|Overall Study||10
10128564|NCT02632747|11260031|FG000|STARTED|Treatment Period 1||16
10128565|NCT02632747|11260032|FG001|STARTED|Treatment Period 1||15
10128566|NCT02632747|11260031|FG000|COMPLETED|Treatment Period 1||16
10128567|NCT02632747|11260032|FG001|COMPLETED|Treatment Period 1||15
10128568|NCT02632747|11260031|FG000|NOT COMPLETED|Treatment Period 1||0
10128569|NCT02632747|11260032|FG001|NOT COMPLETED|Treatment Period 1||0
10128570|NCT02632747|11260031|FG000|STARTED|Wash-out Period||16
10128571|NCT02632747|11260032|FG001|STARTED|Wash-out Period||15
10128572|NCT02632747|11260031|FG000|COMPLETED|Wash-out Period||15
10128573|NCT02632747|11260032|FG001|COMPLETED|Wash-out Period||15
10128574|NCT02632747|11260031|FG000|NOT COMPLETED|Wash-out Period||1
10128575|NCT02632747|11260032|FG001|NOT COMPLETED|Wash-out Period||0
10128576|NCT02632747|11260031|FG000|STARTED|Treatment Period 2||15
10128577|NCT02632747|11260032|FG001|STARTED|Treatment Period 2||15
10128578|NCT02632747|11260031|FG000|COMPLETED|Treatment Period 2||15
10128579|NCT02632747|11260032|FG001|COMPLETED|Treatment Period 2||15
10128580|NCT02632747|11260031|FG000|NOT COMPLETED|Treatment Period 2||0
10128581|NCT02632747|11260032|FG001|NOT COMPLETED|Treatment Period 2||0
10128582|NCT02632786|11260040|FG000|STARTED|Overall Study||66
10128583|NCT02632786|11260041|FG001|STARTED|Overall Study||63
10128584|NCT02632786|11260040|FG000|Informed Consent Obtained|Overall Study||66
10128585|NCT02632786|11260041|FG001|Informed Consent Obtained|Overall Study||63
10128586|NCT02632786|11260040|FG000|Randomized and Dosed|Overall Study||66
10128587|NCT02632786|11260041|FG001|Randomized and Dosed|Overall Study||63
10128588|NCT02632786|11260040|FG000|COMPLETED|Overall Study||55
10128589|NCT02632786|11260041|FG001|COMPLETED|Overall Study||56
10128590|NCT02632786|11260040|FG000|NOT COMPLETED|Overall Study||11
10128591|NCT02632786|11260041|FG001|NOT COMPLETED|Overall Study||7
10128592|NCT02632812|11260050|FG000|STARTED|Overall Study||12
10128593|NCT02632812|11260051|FG001|STARTED|Overall Study||12
10128594|NCT02632812|11260050|FG000|COMPLETED|Overall Study||12
10128595|NCT02632812|11260051|FG001|COMPLETED|Overall Study||12
10128596|NCT02632812|11260050|FG000|NOT COMPLETED|Overall Study||0
10128597|NCT02632812|11260051|FG001|NOT COMPLETED|Overall Study||0
10128598|NCT02632838|11260059|FG000|STARTED|Overall Study||15
10128599|NCT02632838|11260060|FG001|STARTED|Overall Study||15
10128600|NCT02632838|11260059|FG000|COMPLETED|Overall Study||12
10128601|NCT02632838|11260060|FG001|COMPLETED|Overall Study||13
10128602|NCT02632838|11260059|FG000|NOT COMPLETED|Overall Study||3
10128603|NCT02632838|11260060|FG001|NOT COMPLETED|Overall Study||2
10128604|NCT02633020|11260072|FG000|STARTED|Overall Study||19
10128605|NCT02633020|11260073|FG001|STARTED|Overall Study||9
10128606|NCT02633020|11260072|FG000|COMPLETED|Overall Study||18
10128607|NCT02633020|11260073|FG001|COMPLETED|Overall Study||9
10128608|NCT02633020|11260072|FG000|NOT COMPLETED|Overall Study||1
10128609|NCT02633020|11260073|FG001|NOT COMPLETED|Overall Study||0
10128610|NCT02633046|11260079|FG000|STARTED|Overall Study||63
10128611|NCT02633046|11260079|FG000|Safety Population|Overall Study||63
10128612|NCT02633046|11260079|FG000|COMPLETED|Overall Study||36
10128613|NCT02633046|11260079|FG000|NOT COMPLETED|Overall Study||27
10128614|NCT02633215|11260085|FG000|STARTED|Overall Study||18
10128615|NCT02633215|11260086|FG001|STARTED|Overall Study||18
10128616|NCT02633215|11260085|FG000|COMPLETED|Overall Study||16
10128617|NCT02633215|11260086|FG001|COMPLETED|Overall Study||15
10128618|NCT02633215|11260085|FG000|NOT COMPLETED|Overall Study||2
10128619|NCT02633215|11260086|FG001|NOT COMPLETED|Overall Study||3
10128620|NCT02633306|11260092|FG000|STARTED|Overall Study||9
10128621|NCT02633306|11260092|FG000|COMPLETED|Overall Study||6
10128622|NCT02633306|11260092|FG000|NOT COMPLETED|Overall Study||3
10128623|NCT02633358|11260099|FG000|STARTED|Overall Study||87
10128624|NCT02633358|11260100|FG001|STARTED|Overall Study||54
10128625|NCT02633358|11260099|FG000|COMPLETED|Overall Study||87
10128626|NCT02633358|11260100|FG001|COMPLETED|Overall Study||54
10128627|NCT02633358|11260099|FG000|NOT COMPLETED|Overall Study||0
10128628|NCT02633358|11260100|FG001|NOT COMPLETED|Overall Study||0
10128629|NCT02633371|11260107|FG000|STARTED|Overall Study||10
10128630|NCT02633371|11260107|FG000|COMPLETED|Overall Study||7
10128631|NCT02633371|11260107|FG000|NOT COMPLETED|Overall Study||3
10128632|NCT02633488|11260113|FG000|STARTED|Overall Study||6
10128633|NCT02633488|11260114|FG001|STARTED|Overall Study||5
10128634|NCT02633488|11260113|FG000|COMPLETED|Overall Study||6
10128635|NCT02633488|11260114|FG001|COMPLETED|Overall Study||5
10128636|NCT02633488|11260113|FG000|NOT COMPLETED|Overall Study||0
10128637|NCT02633488|11260114|FG001|NOT COMPLETED|Overall Study||0
10128638|NCT02633501|11260126|FG000|STARTED|Overall Study||14
10128639|NCT02633501|11260127|FG001|STARTED|Overall Study||14
10128640|NCT02633501|11260128|FG002|STARTED|Overall Study||62
10128641|NCT02633501|11260129|FG003|STARTED|Overall Study||63
10128642|NCT02633501|11260130|FG004|STARTED|Overall Study||64
10128643|NCT02633501|11260131|FG005|STARTED|Overall Study||63
10128644|NCT02633501|11260126|FG000|COMPLETED|Overall Study||12
10128645|NCT02633501|11260127|FG001|COMPLETED|Overall Study||11
10128646|NCT02633501|11260128|FG002|COMPLETED|Overall Study||55
10128647|NCT02633501|11260129|FG003|COMPLETED|Overall Study||59
10128648|NCT02633501|11260130|FG004|COMPLETED|Overall Study||53
10128649|NCT02633501|11260131|FG005|COMPLETED|Overall Study||48
10128650|NCT02633501|11260126|FG000|NOT COMPLETED|Overall Study||2
10128651|NCT02633501|11260127|FG001|NOT COMPLETED|Overall Study||3
10128652|NCT02633501|11260128|FG002|NOT COMPLETED|Overall Study||7
10128653|NCT02633501|11260129|FG003|NOT COMPLETED|Overall Study||4
10128654|NCT02633501|11260130|FG004|NOT COMPLETED|Overall Study||11
10128655|NCT02633501|11260131|FG005|NOT COMPLETED|Overall Study||15
10128656|NCT02633527|11260155|FG000|STARTED|Overall Study||24
10128657|NCT02633527|11260156|FG001|STARTED|Overall Study||48
10128658|NCT02633527|11260157|FG002|STARTED|Overall Study||50
10128659|NCT02633527|11260158|FG003|STARTED|Overall Study||49
10128660|NCT02633527|11260159|FG004|STARTED|Overall Study||51
10128661|NCT02633527|11260155|FG000|COMPLETED|Overall Study||21
10128662|NCT02633527|11260156|FG001|COMPLETED|Overall Study||37
10128663|NCT02633527|11260157|FG002|COMPLETED|Overall Study||33
10128664|NCT02633527|11260158|FG003|COMPLETED|Overall Study||35
10128665|NCT02633527|11260159|FG004|COMPLETED|Overall Study||34
10128666|NCT02633527|11260155|FG000|NOT COMPLETED|Overall Study||3
10128667|NCT02633527|11260156|FG001|NOT COMPLETED|Overall Study||11
10128668|NCT02633527|11260157|FG002|NOT COMPLETED|Overall Study||17
10128669|NCT02633527|11260158|FG003|NOT COMPLETED|Overall Study||14
10128670|NCT02633527|11260159|FG004|NOT COMPLETED|Overall Study||17
10128671|NCT02633735|11260173|FG000|STARTED|Pre-implementation Phase||788
10128672|NCT02633735|11260174|FG001|STARTED|Pre-implementation Phase||1011
10128673|NCT02633735|11260173|FG000|COMPLETED|Pre-implementation Phase||788
10128674|NCT02633735|11260174|FG001|COMPLETED|Pre-implementation Phase||1011
10128675|NCT02633735|11260173|FG000|NOT COMPLETED|Pre-implementation Phase||0
10128676|NCT02633735|11260174|FG001|NOT COMPLETED|Pre-implementation Phase||0
10128677|NCT02633735|11260173|FG000|STARTED|Implementation Phase||1991
10128678|NCT02633735|11260174|FG001|STARTED|Implementation Phase||2150
10128679|NCT02633735|11260173|FG000|COMPLETED|Implementation Phase||1991
10128680|NCT02633735|11260174|FG001|COMPLETED|Implementation Phase||2150
10128681|NCT02633735|11260173|FG000|NOT COMPLETED|Implementation Phase||0
10128682|NCT02633735|11260174|FG001|NOT COMPLETED|Implementation Phase||0
10128683|NCT02633787|11260180|FG000|STARTED|Overall Study||110
10128684|NCT02633787|11260180|FG000|COMPLETED|Overall Study||109
10128685|NCT02633787|11260180|FG000|NOT COMPLETED|Overall Study||1
10128686|NCT02633800|11260186|FG000|STARTED|Overall Study||44
10128687|NCT02633800|11260187|FG001|STARTED|Overall Study||43
10128688|NCT02633800|11260186|FG000|COMPLETED|Overall Study||0
10128689|NCT02633800|11260187|FG001|COMPLETED|Overall Study||0
10128690|NCT02633800|11260186|FG000|NOT COMPLETED|Overall Study||44
10128691|NCT02633800|11260187|FG001|NOT COMPLETED|Overall Study||43
10128692|NCT02633956|11260197|FG000|STARTED|Overall Study||20
10128693|NCT02633956|11260198|FG001|STARTED|Overall Study||21
10128694|NCT02633956|11260199|FG002|STARTED|Overall Study||22
10128695|NCT02633956|11260200|FG003|STARTED|Overall Study||21
10128696|NCT02633956|11260197|FG000|COMPLETED|Overall Study||19
10128697|NCT02633956|11260198|FG001|COMPLETED|Overall Study||19
10128698|NCT02633956|11260199|FG002|COMPLETED|Overall Study||20
10128699|NCT02633956|11260200|FG003|COMPLETED|Overall Study||21
10128700|NCT02633956|11260197|FG000|NOT COMPLETED|Overall Study||1
10128701|NCT02633956|11260198|FG001|NOT COMPLETED|Overall Study||2
10128702|NCT02633956|11260199|FG002|NOT COMPLETED|Overall Study||2
10128703|NCT02633956|11260200|FG003|NOT COMPLETED|Overall Study||0
10128704|NCT02634073|11260214|FG000|STARTED|Overall Study||4
10128705|NCT02634073|11260215|FG001|STARTED|Overall Study||4
10128706|NCT02634073|11260216|FG002|STARTED|Overall Study||4
10128707|NCT02634073|11260217|FG003|STARTED|Overall Study||4
10128708|NCT02634073|11260214|FG000|COMPLETED|Overall Study||4
10128709|NCT02634073|11260215|FG001|COMPLETED|Overall Study||4
10128710|NCT02634073|11260216|FG002|COMPLETED|Overall Study||4
10128711|NCT02634073|11260217|FG003|COMPLETED|Overall Study||4
10128712|NCT02634073|11260214|FG000|NOT COMPLETED|Overall Study||0
10128713|NCT02634073|11260215|FG001|NOT COMPLETED|Overall Study||0
10128714|NCT02634073|11260216|FG002|NOT COMPLETED|Overall Study||0
10128715|NCT02634073|11260217|FG003|NOT COMPLETED|Overall Study||0
10128716|NCT02634151|11260229|FG000|STARTED|Overall Study||53
10128717|NCT02634151|11260230|FG001|STARTED|Overall Study||52
10128718|NCT02634151|11260229|FG000|Full Analysis Set|Overall Study||53
10128719|NCT02634151|11260230|FG001|Full Analysis Set|Overall Study||52
10128720|NCT02634151|11260229|FG000|Safety Set|Overall Study||54
10128721|NCT02634151|11260230|FG001|Safety Set|Overall Study||51
10128722|NCT02634151|11260229|FG000|COMPLETED|Overall Study||52
10128723|NCT02634151|11260230|FG001|COMPLETED|Overall Study||50
10128724|NCT02634151|11260229|FG000|NOT COMPLETED|Overall Study||1
10128725|NCT02634151|11260230|FG001|NOT COMPLETED|Overall Study||2
10128726|NCT02634177|11260238|FG000|STARTED|Overall Study||151
10128727|NCT02634177|11260239|FG001|STARTED|Overall Study||153
10128728|NCT02634177|11260238|FG000|COMPLETED|Overall Study||140
10128729|NCT02634177|11260239|FG001|COMPLETED|Overall Study||141
10128730|NCT02634177|11260238|FG000|NOT COMPLETED|Overall Study||11
10128731|NCT02634177|11260239|FG001|NOT COMPLETED|Overall Study||12
10128732|NCT02634320|11260245|FG000|STARTED|Overall Study||51
10128733|NCT02634320|11260245|FG000|COMPLETED|Overall Study||35
10128734|NCT02634320|11260245|FG000|NOT COMPLETED|Overall Study||16
10128735|NCT02634333|11260251|FG000|STARTED|Overall Study|Number of Eyes|200
10128736|NCT02634333|11260252|FG001|STARTED|Overall Study|Number of Eyes|199
10128737|NCT02634333|11260251|FG000|COMPLETED|Overall Study|Number of Eyes|160
10128738|NCT02634333|11260252|FG001|COMPLETED|Overall Study|Number of Eyes|167
10128739|NCT02634333|11260251|FG000|NOT COMPLETED|Overall Study||40
10128740|NCT02634333|11260252|FG001|NOT COMPLETED|Overall Study||32
10128741|NCT02634346|11260262|FG000|STARTED|Overall Study||134
10128742|NCT02634346|11260263|FG001|STARTED|Overall Study||133
10128743|NCT02634346|11260264|FG002|STARTED|Overall Study||134
10128744|NCT02634346|11260262|FG000|COMPLETED|Overall Study||122
10128745|NCT02634346|11260263|FG001|COMPLETED|Overall Study||119
10128746|NCT02634346|11260264|FG002|COMPLETED|Overall Study||111
10128747|NCT02634346|11260262|FG000|NOT COMPLETED|Overall Study||12
10128748|NCT02634346|11260263|FG001|NOT COMPLETED|Overall Study||14
10128749|NCT02634346|11260264|FG002|NOT COMPLETED|Overall Study||23
10128750|NCT02634580|11260276|FG000|STARTED|Double-blind Treatment Period||10
10128751|NCT02634580|11260277|FG001|STARTED|Double-blind Treatment Period||11
10128752|NCT02634580|11260278|FG002|STARTED|Double-blind Treatment Period||19
10128753|NCT02634580|11260279|FG003|STARTED|Double-blind Treatment Period||21
10128754|NCT02634580|11260276|FG000|COMPLETED|Double-blind Treatment Period||9
10128755|NCT02634580|11260277|FG001|COMPLETED|Double-blind Treatment Period||11
10128756|NCT02634580|11260278|FG002|COMPLETED|Double-blind Treatment Period||18
10128757|NCT02634580|11260279|FG003|COMPLETED|Double-blind Treatment Period||20
10128758|NCT02634580|11260276|FG000|NOT COMPLETED|Double-blind Treatment Period||1
10128759|NCT02634580|11260277|FG001|NOT COMPLETED|Double-blind Treatment Period||0
10128760|NCT02634580|11260278|FG002|NOT COMPLETED|Double-blind Treatment Period||1
10128761|NCT02634580|11260279|FG003|NOT COMPLETED|Double-blind Treatment Period||1
10128762|NCT02634580|11260276|FG000|STARTED|Open-label Extension Period||9
10128763|NCT02634580|11260277|FG001|STARTED|Open-label Extension Period||11
10128764|NCT02634580|11260278|FG002|STARTED|Open-label Extension Period||18
10128765|NCT02634580|11260279|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
10128766|NCT02634580|11260276|FG000|Received Open-label Treatment|Open-label Extension Period||9
10128767|NCT02634580|11260277|FG001|Received Open-label Treatment|Open-label Extension Period||11
10128768|NCT02634580|11260278|FG002|Received Open-label Treatment|Open-label Extension Period||18
10128769|NCT02634580|11260279|FG003|Received Open-label Treatment|Open-label Extension Period||20
10128770|NCT02634580|11260276|FG000|COMPLETED|Open-label Extension Period||9
10128771|NCT02634580|11260277|FG001|COMPLETED|Open-label Extension Period||10
10128772|NCT02634580|11260278|FG002|COMPLETED|Open-label Extension Period||18
10128773|NCT02634580|11260279|FG003|COMPLETED|Open-label Extension Period||20
10128774|NCT02634580|11260276|FG000|NOT COMPLETED|Open-label Extension Period||0
10128775|NCT02634580|11260277|FG001|NOT COMPLETED|Open-label Extension Period||1
10128776|NCT02634580|11260278|FG002|NOT COMPLETED|Open-label Extension Period||0
10128777|NCT02634580|11260279|FG003|NOT COMPLETED|Open-label Extension Period||1
10128778|NCT02634684|11260292|FG000|STARTED|Overall Study||19
10128779|NCT02634684|11260293|FG001|STARTED|Overall Study||19
10128780|NCT02634684|11260294|FG002|STARTED|Overall Study||21
10128781|NCT02634684|11260295|FG003|STARTED|Overall Study||23
10128782|NCT02634684|11260292|FG000|COMPLETED|Overall Study||19
10128783|NCT02634684|11260293|FG001|COMPLETED|Overall Study||19
10128784|NCT02634684|11260294|FG002|COMPLETED|Overall Study||21
10128785|NCT02634684|11260295|FG003|COMPLETED|Overall Study||23
10128786|NCT02634684|11260292|FG000|NOT COMPLETED|Overall Study||0
10128787|NCT02634684|11260293|FG001|NOT COMPLETED|Overall Study||0
10128788|NCT02634684|11260294|FG002|NOT COMPLETED|Overall Study||0
10128789|NCT02634684|11260295|FG003|NOT COMPLETED|Overall Study||0
10128790|NCT02634788|11260309|FG000|STARTED|Overall Study||79
10128791|NCT02634788|11260310|FG001|STARTED|Overall Study||81
10128792|NCT02634788|11260311|FG002|STARTED|Overall Study||80
10128793|NCT02634788|11260312|FG003|STARTED|Overall Study||82
10128794|NCT02634788|11260309|FG000|COMPLETED|Overall Study||75
10128795|NCT02634788|11260310|FG001|COMPLETED|Overall Study||71
10128796|NCT02634788|11260311|FG002|COMPLETED|Overall Study||75
10128797|NCT02634788|11260312|FG003|COMPLETED|Overall Study||77
10128798|NCT02634788|11260309|FG000|NOT COMPLETED|Overall Study||4
10128799|NCT02634788|11260310|FG001|NOT COMPLETED|Overall Study||10
10128800|NCT02634788|11260311|FG002|NOT COMPLETED|Overall Study||5
10128801|NCT02634788|11260312|FG003|NOT COMPLETED|Overall Study||5
10128802|NCT02634801|11260325|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54
10128803|NCT02634801|11260326|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54
10128804|NCT02634801|11260327|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54
10128805|NCT02634801|11260325|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
10128806|NCT02634801|11260326|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
10128807|NCT02634801|11260327|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
10128808|NCT02634801|11260325|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50
10128809|NCT02634801|11260326|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23
10128810|NCT02634801|11260327|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49
10128811|NCT02634801|11260325|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
10128812|NCT02634801|11260326|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
10128813|NCT02634801|11260327|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
10128814|NCT02634801|11260325|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
10128815|NCT02634801|11260326|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
10128816|NCT02634801|11260327|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
10128817|NCT02634801|11260325|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45
10128818|NCT02634801|11260326|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18
10128819|NCT02634801|11260327|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29
10128820|NCT02634801|11260325|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
10128821|NCT02634801|11260326|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
10128822|NCT02634801|11260327|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
10128823|NCT02634801|11260325|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
10128824|NCT02634801|11260326|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
10128825|NCT02634801|11260327|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
10128826|NCT02634801|11260325|FG000|COMPLETED|Follow-up Period||36
10128827|NCT02634801|11260326|FG001|COMPLETED|Follow-up Period||18
10128828|NCT02634801|11260327|FG002|COMPLETED|Follow-up Period||38
10128829|NCT02634801|11260325|FG000|NOT COMPLETED|Follow-up Period||5
10128830|NCT02634801|11260326|FG001|NOT COMPLETED|Follow-up Period||8
10128831|NCT02634801|11260327|FG002|NOT COMPLETED|Follow-up Period||8
10128832|NCT02634814|11260342|FG000|STARTED|Overall Study||32
10128833|NCT02634814|11260343|FG001|STARTED|Overall Study||29
10128834|NCT02634814|11260344|FG002|STARTED|Overall Study||29
10128835|NCT02634814|11260342|FG000|COMPLETED|Overall Study||30
10128836|NCT02634814|11260343|FG001|COMPLETED|Overall Study||23
10128837|NCT02634814|11260344|FG002|COMPLETED|Overall Study||29
10128838|NCT02634814|11260342|FG000|NOT COMPLETED|Overall Study||2
10128839|NCT02634814|11260343|FG001|NOT COMPLETED|Overall Study||6
10128840|NCT02634814|11260344|FG002|NOT COMPLETED|Overall Study||0
10128841|NCT02634983|11260352|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16
10128842|NCT02634983|11260353|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15
10128843|NCT02634983|11260352|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16
10128844|NCT02634983|11260353|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15
10128845|NCT02634983|11260352|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
10128846|NCT02634983|11260353|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
10128847|NCT02634983|11260352|FG000|STARTED|Washout (Approximately 7-14 Days)||16
10128848|NCT02634983|11260353|FG001|STARTED|Washout (Approximately 7-14 Days)||15
10128849|NCT02634983|11260352|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16
10128850|NCT02634983|11260353|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15
10128851|NCT02634983|11260352|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
10128852|NCT02634983|11260353|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
10128853|NCT02634983|11260352|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
10128854|NCT02634983|11260353|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
10128855|NCT02634983|11260352|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
10128856|NCT02634983|11260353|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
10128857|NCT02634983|11260352|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
10128858|NCT02634983|11260353|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
10128859|NCT02635035|11260361|FG000|STARTED|Overall Study||17
10128860|NCT02635035|11260362|FG001|STARTED|Overall Study||21
10128861|NCT02635035|11260361|FG000|COMPLETED|Overall Study||17
10128862|NCT02635035|11260362|FG001|COMPLETED|Overall Study||21
10128863|NCT02635035|11260361|FG000|NOT COMPLETED|Overall Study||0
10128864|NCT02635035|11260362|FG001|NOT COMPLETED|Overall Study||0
10128865|NCT02635204|11260370|FG000|STARTED|Overall Study||178
10128866|NCT02635204|11260371|FG001|STARTED|Overall Study||89
10128867|NCT02635204|11260370|FG000|COMPLETED|Overall Study||176
10128868|NCT02635204|11260371|FG001|COMPLETED|Overall Study||88
10128869|NCT02635204|11260370|FG000|NOT COMPLETED|Overall Study||2
10128870|NCT02635204|11260371|FG001|NOT COMPLETED|Overall Study||1
10128871|NCT02635347|11260379|FG000|STARTED|Overall Study||51
10128872|NCT02635347|11260380|FG001|STARTED|Overall Study||70
10128873|NCT02635347|11260379|FG000|Screening|Overall Study||51
10128874|NCT02635347|11260380|FG001|Screening|Overall Study||70
10128875|NCT02635347|11260379|FG000|Enrollment|Overall Study||31
10128876|NCT02635347|11260380|FG001|Enrollment|Overall Study||63
10128877|NCT02635347|11260379|FG000|Protocol Completion|Overall Study||22
10128878|NCT02635347|11260380|FG001|Protocol Completion|Overall Study||63
10128879|NCT02635347|11260379|FG000|Follow up|Overall Study||31
10128880|NCT02635347|11260380|FG001|Follow up|Overall Study||63
10128881|NCT02635347|11260379|FG000|Analyses|Overall Study||30
10128882|NCT02635347|11260380|FG001|Analyses|Overall Study||63
10128883|NCT02635347|11260379|FG000|COMPLETED|Overall Study||31
10128884|NCT02635347|11260380|FG001|COMPLETED|Overall Study||63
10128885|NCT02635347|11260379|FG000|NOT COMPLETED|Overall Study||20
10128886|NCT02635347|11260380|FG001|NOT COMPLETED|Overall Study||7
10128887|NCT02635386|11260392|FG000|STARTED|Overall Study||23
10128888|NCT02635386|11260393|FG001|STARTED|Overall Study||23
10128889|NCT02635386|11260394|FG002|STARTED|Overall Study||22
10128890|NCT02635386|11260395|FG003|STARTED|Overall Study||26
10128891|NCT02635386|11260396|FG004|STARTED|Overall Study||25
10128892|NCT02635386|11260392|FG000|COMPLETED|Overall Study||20
10128893|NCT02635386|11260393|FG001|COMPLETED|Overall Study||17
10128894|NCT02635386|11260394|FG002|COMPLETED|Overall Study||20
10128895|NCT02635386|11260395|FG003|COMPLETED|Overall Study||19
10128896|NCT02635386|11260396|FG004|COMPLETED|Overall Study||16
10128897|NCT02635386|11260392|FG000|NOT COMPLETED|Overall Study||3
10128898|NCT02635386|11260393|FG001|NOT COMPLETED|Overall Study||6
10128899|NCT02635386|11260394|FG002|NOT COMPLETED|Overall Study||2
10128900|NCT02635386|11260395|FG003|NOT COMPLETED|Overall Study||7
10128901|NCT02635386|11260396|FG004|NOT COMPLETED|Overall Study||9
10128902|NCT02635425|11260415|FG000|STARTED|Overall Study||15
10128903|NCT02635425|11260416|FG001|STARTED|Overall Study||15
10128904|NCT02635425|11260415|FG000|COMPLETED|Overall Study||15
10128905|NCT02635425|11260416|FG001|COMPLETED|Overall Study||15
10128906|NCT02635425|11260415|FG000|NOT COMPLETED|Overall Study||0
10128907|NCT02635425|11260416|FG001|NOT COMPLETED|Overall Study||0
10128908|NCT02635542|11260424|FG000|STARTED|Overall Study||50
10128909|NCT02635542|11260425|FG001|STARTED|Overall Study||50
10128910|NCT02635542|11260424|FG000|COMPLETED|Overall Study||50
10128911|NCT02635542|11260425|FG001|COMPLETED|Overall Study||50
10128912|NCT02635542|11260424|FG000|NOT COMPLETED|Overall Study||0
10128913|NCT02635542|11260425|FG001|NOT COMPLETED|Overall Study||0
10128914|NCT02635646|11260433|FG000|STARTED|Overall Study||57
10128915|NCT02635646|11260434|FG001|STARTED|Overall Study||65
10128916|NCT02635646|11260433|FG000|COMPLETED|Overall Study||32
10128917|NCT02635646|11260434|FG001|COMPLETED|Overall Study||39
10128918|NCT02635646|11260433|FG000|NOT COMPLETED|Overall Study||25
10128919|NCT02635646|11260434|FG001|NOT COMPLETED|Overall Study||26
10128920|NCT02635724|11260449|FG000|STARTED|Overall Study||41
10128921|NCT02635724|11260450|FG001|STARTED|Overall Study||26
10128922|NCT02635724|11260451|FG002|STARTED|Overall Study||7
10128923|NCT02635724|11260449|FG000|ITT Population|Overall Study||41
10128924|NCT02635724|11260450|FG001|ITT Population|Overall Study||26
10128925|NCT02635724|11260451|FG002|ITT Population|Overall Study||7
10128926|NCT02635724|11260449|FG000|Safety Population|Overall Study||41
10128927|NCT02635724|11260450|FG001|Safety Population|Overall Study||25
10128928|NCT02635724|11260451|FG002|Safety Population|Overall Study||7
10128929|NCT02635724|11260449|FG000|ITTI Population|Overall Study||28
10128930|NCT02635724|11260450|FG001|ITTI Population|Overall Study||19
10128931|NCT02635724|11260451|FG002|ITTI Population|Overall Study||5
10128932|NCT02635724|11260449|FG000|E-R Population|Overall Study||28
10128933|NCT02635724|11260450|FG001|E-R Population|Overall Study||19
10128934|NCT02635724|11260451|FG002|E-R Population|Overall Study||5
10128935|NCT02635724|11260449|FG000|COMPLETED|Overall Study||41
10128936|NCT02635724|11260450|FG001|COMPLETED|Overall Study||25
10128937|NCT02635724|11260451|FG002|COMPLETED|Overall Study||7
10128938|NCT02635724|11260449|FG000|NOT COMPLETED|Overall Study||0
10128939|NCT02635724|11260450|FG001|NOT COMPLETED|Overall Study||1
10128940|NCT02635724|11260451|FG002|NOT COMPLETED|Overall Study||0
10128941|NCT02635737|11260459|FG000|STARTED|Overall Study||29
10128942|NCT02635737|11260459|FG000|COMPLETED|Overall Study||28
10128943|NCT02635737|11260459|FG000|NOT COMPLETED|Overall Study||1
10128944|NCT02635828|11260463|FG000|STARTED|Overall Study||54
10128945|NCT02635828|11260463|FG000|COMPLETED|Overall Study||40
9706752|NCT02648698|10805839|FG001|COMPLETED|Overall Study||55
9706753|NCT02648698|10805838|FG000|NOT COMPLETED|Overall Study||1
10128946|NCT02635828|11260463|FG000|NOT COMPLETED|Overall Study||14
10128947|NCT02635880|11260467|FG000|STARTED|Overall Study||32
10128948|NCT02635880|11260467|FG000|COMPLETED|Overall Study||32
10128949|NCT02635880|11260467|FG000|NOT COMPLETED|Overall Study||0
10128950|NCT02635984|11260473|FG000|STARTED|Overall Study||53
10128951|NCT02635984|11260474|FG001|STARTED|Overall Study||55
10128952|NCT02635984|11260473|FG000|COMPLETED|Overall Study||50
10128953|NCT02635984|11260474|FG001|COMPLETED|Overall Study||51
10128954|NCT02635984|11260473|FG000|NOT COMPLETED|Overall Study||3
10128955|NCT02635984|11260474|FG001|NOT COMPLETED|Overall Study||4
10128956|NCT02636049|11260480|FG000|STARTED|Overall Study||12
10128957|NCT02636049|11260480|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12
10128958|NCT02636049|11260480|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12
10128959|NCT02636049|11260480|FG000|COMPLETED|Overall Study||12
10128960|NCT02636049|11260480|FG000|NOT COMPLETED|Overall Study||0
10128961|NCT02636361|11260486|FG000|STARTED|Period 1||5
10128962|NCT02636361|11260487|FG001|STARTED|Period 1||6
10128963|NCT02636361|11260488|FG002|STARTED|Period 1||5
9706754|NCT02648698|10805839|FG001|NOT COMPLETED|Overall Study||5
9706755|NCT02432196|10805845|FG000|STARTED|Overall Study||26
9706756|NCT02432196|10805845|FG000|Implanted With Device|Overall Study||25
9706757|NCT02432196|10805845|FG000|COMPLETED|Overall Study||0
9706758|NCT02432196|10805845|FG000|NOT COMPLETED|Overall Study||26
9706759|NCT02340676|10805849|FG000|STARTED|Overall Study||25
9706760|NCT02340676|10805849|FG000|COMPLETED|Overall Study||25
9706761|NCT02340676|10805849|FG000|NOT COMPLETED|Overall Study||0
10128964|NCT02636361|11260489|FG003|STARTED|Period 1||5
10128965|NCT02636361|11260490|FG004|STARTED|Period 1||5
10128966|NCT02636361|11260486|FG000|Received at Least One Dose of Study Drug|Period 1||5
10128967|NCT02636361|11260487|FG001|Received at Least One Dose of Study Drug|Period 1||5
10128968|NCT02636361|11260488|FG002|Received at Least One Dose of Study Drug|Period 1||5
10128969|NCT02636361|11260489|FG003|Received at Least One Dose of Study Drug|Period 1||5
10128970|NCT02636361|11260490|FG004|Received at Least One Dose of Study Drug|Period 1||4
10128971|NCT02636361|11260486|FG000|COMPLETED|Period 1||5
10128972|NCT02636361|11260487|FG001|COMPLETED|Period 1||5
10128973|NCT02636361|11260488|FG002|COMPLETED|Period 1||5
10128974|NCT02636361|11260489|FG003|COMPLETED|Period 1||5
10128975|NCT02636361|11260490|FG004|COMPLETED|Period 1||4
10128976|NCT02636361|11260486|FG000|NOT COMPLETED|Period 1||0
10128977|NCT02636361|11260487|FG001|NOT COMPLETED|Period 1||1
10128978|NCT02636361|11260488|FG002|NOT COMPLETED|Period 1||0
10128979|NCT02636361|11260489|FG003|NOT COMPLETED|Period 1||0
10128980|NCT02636361|11260490|FG004|NOT COMPLETED|Period 1||1
10128981|NCT02636361|11260486|FG000|STARTED|Period 2||5
10128982|NCT02636361|11260487|FG001|STARTED|Period 2||5
10128983|NCT02636361|11260488|FG002|STARTED|Period 2||5
10128984|NCT02636361|11260489|FG003|STARTED|Period 2||5
10128985|NCT02636361|11260490|FG004|STARTED|Period 2||4
10128986|NCT02636361|11260486|FG000|COMPLETED|Period 2||5
10128987|NCT02636361|11260487|FG001|COMPLETED|Period 2||5
10128988|NCT02636361|11260488|FG002|COMPLETED|Period 2||5
10128989|NCT02636361|11260489|FG003|COMPLETED|Period 2||5
10128990|NCT02636361|11260490|FG004|COMPLETED|Period 2||4
10128991|NCT02636361|11260486|FG000|NOT COMPLETED|Period 2||0
10128992|NCT02636361|11260487|FG001|NOT COMPLETED|Period 2||0
10128993|NCT02636361|11260488|FG002|NOT COMPLETED|Period 2||0
10128994|NCT02636361|11260489|FG003|NOT COMPLETED|Period 2||0
10128995|NCT02636361|11260490|FG004|NOT COMPLETED|Period 2||0
10128996|NCT02636361|11260486|FG000|STARTED|Period 3||5
10128997|NCT02636361|11260487|FG001|STARTED|Period 3||5
10128998|NCT02636361|11260488|FG002|STARTED|Period 3||5
10128999|NCT02636361|11260489|FG003|STARTED|Period 3||5
10129000|NCT02636361|11260490|FG004|STARTED|Period 3||4
10129001|NCT02636361|11260486|FG000|COMPLETED|Period 3||5
10129002|NCT02636361|11260487|FG001|COMPLETED|Period 3||5
10129003|NCT02636361|11260488|FG002|COMPLETED|Period 3||5
10129004|NCT02636361|11260489|FG003|COMPLETED|Period 3||5
10129005|NCT02636361|11260490|FG004|COMPLETED|Period 3||4
10129006|NCT02636361|11260486|FG000|NOT COMPLETED|Period 3||0
10129007|NCT02636361|11260487|FG001|NOT COMPLETED|Period 3||0
10129008|NCT02636361|11260488|FG002|NOT COMPLETED|Period 3||0
10129009|NCT02636361|11260489|FG003|NOT COMPLETED|Period 3||0
10129010|NCT02636361|11260490|FG004|NOT COMPLETED|Period 3||0
10129011|NCT02636361|11260486|FG000|STARTED|Period 4||5
10129012|NCT02636361|11260487|FG001|STARTED|Period 4||5
10129013|NCT02636361|11260488|FG002|STARTED|Period 4||5
10129014|NCT02636361|11260489|FG003|STARTED|Period 4||5
10129015|NCT02636361|11260490|FG004|STARTED|Period 4||4
10129016|NCT02636361|11260486|FG000|COMPLETED|Period 4||5
10129017|NCT02636361|11260487|FG001|COMPLETED|Period 4||5
10129018|NCT02636361|11260488|FG002|COMPLETED|Period 4||5
10129019|NCT02636361|11260489|FG003|COMPLETED|Period 4||4
10129020|NCT02636361|11260490|FG004|COMPLETED|Period 4||4
10129021|NCT02636361|11260486|FG000|NOT COMPLETED|Period 4||0
10129022|NCT02636361|11260487|FG001|NOT COMPLETED|Period 4||0
10129023|NCT02636361|11260488|FG002|NOT COMPLETED|Period 4||0
10129024|NCT02636361|11260489|FG003|NOT COMPLETED|Period 4||1
10129025|NCT02636361|11260490|FG004|NOT COMPLETED|Period 4||0
10129026|NCT02636361|11260486|FG000|STARTED|Period 5||5
10129027|NCT02636361|11260487|FG001|STARTED|Period 5||5
10129028|NCT02636361|11260488|FG002|STARTED|Period 5||5
10129029|NCT02636361|11260489|FG003|STARTED|Period 5||4
10129030|NCT02636361|11260490|FG004|STARTED|Period 5||4
10129031|NCT02636361|11260486|FG000|COMPLETED|Period 5||5
10129032|NCT02636361|11260487|FG001|COMPLETED|Period 5||5
10129033|NCT02636361|11260488|FG002|COMPLETED|Period 5||5
10129034|NCT02636361|11260489|FG003|COMPLETED|Period 5||4
10129035|NCT02636361|11260490|FG004|COMPLETED|Period 5||4
10129036|NCT02636361|11260486|FG000|NOT COMPLETED|Period 5||0
10129037|NCT02636361|11260487|FG001|NOT COMPLETED|Period 5||0
10129038|NCT02636361|11260488|FG002|NOT COMPLETED|Period 5||0
10129039|NCT02636361|11260489|FG003|NOT COMPLETED|Period 5||0
9706762|NCT02000882|10805853|FG000|STARTED|Overall Study||10
10129040|NCT02636361|11260490|FG004|NOT COMPLETED|Period 5||0
10129041|NCT02636595|11260504|FG000|STARTED|Overall Study||121
10129042|NCT02636595|11260504|FG000|COMPLETED|Overall Study||119
10129043|NCT02636595|11260504|FG000|NOT COMPLETED|Overall Study||2
10129044|NCT02636608|11260508|FG000|STARTED|Overall Study||244
10129045|NCT02636608|11260508|FG000|Received Treatment|Overall Study||243
9706763|NCT02000882|10805853|FG000|COMPLETED|Overall Study||4
10129046|NCT02636608|11260508|FG000|COMPLETED|Overall Study||233
10129047|NCT02636608|11260508|FG000|NOT COMPLETED|Overall Study||11
10129048|NCT02636699|11260517|FG000|STARTED|Overall Study||238
10129049|NCT02636699|11260518|FG001|STARTED|Overall Study||118
10129050|NCT02636699|11260517|FG000|COMPLETED|Overall Study||213
10129051|NCT02636699|11260518|FG001|COMPLETED|Overall Study||107
10129052|NCT02636699|11260517|FG000|NOT COMPLETED|Overall Study||25
10129053|NCT02636699|11260518|FG001|NOT COMPLETED|Overall Study||11
10129054|NCT02636712|11260524|FG000|STARTED|Overall Study||10
10129055|NCT02636712|11260524|FG000|COMPLETED|Overall Study||10
10129056|NCT02636712|11260524|FG000|NOT COMPLETED|Overall Study||0
10129057|NCT02636725|11260529|FG000|STARTED|Baseline||33
10129058|NCT02636725|11260529|FG000|COMPLETED|Baseline||30
10129059|NCT02636725|11260529|FG000|NOT COMPLETED|Baseline||3
10129060|NCT02636725|11260529|FG000|STARTED|Post-Baseline Imaging Assessment||30
10129061|NCT02636725|11260529|FG000|COMPLETED|Post-Baseline Imaging Assessment||30
10129062|NCT02636725|11260529|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0
10129063|NCT02636868|11260536|FG000|STARTED|Overall Study||73
10129064|NCT02636868|11260537|FG001|STARTED|Overall Study||76
10129065|NCT02636868|11260538|FG002|STARTED|Overall Study||72
10129066|NCT02636868|11260536|FG000|COMPLETED|Overall Study||73
10129067|NCT02636868|11260537|FG001|COMPLETED|Overall Study||75
10129068|NCT02636868|11260538|FG002|COMPLETED|Overall Study||70
10129069|NCT02636868|11260536|FG000|NOT COMPLETED|Overall Study||0
10129070|NCT02636868|11260537|FG001|NOT COMPLETED|Overall Study||1
10129071|NCT02636868|11260538|FG002|NOT COMPLETED|Overall Study||2
10129072|NCT02636907|11260546|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
10129073|NCT02636907|11260546|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
10129074|NCT02636907|11260546|FG000|NOT COMPLETED|Autoinjector Assessment Period||4
10129075|NCT02636907|11260546|FG000|STARTED|Extension Phase||72
10129076|NCT02636907|11260546|FG000|COMPLETED|Extension Phase||62
10129077|NCT02636907|11260546|FG000|NOT COMPLETED|Extension Phase||10
10129078|NCT02637037|11260552|FG000|STARTED|Overall Study||40
10129079|NCT02637037|11260553|FG001|STARTED|Overall Study||40
10129080|NCT02637037|11260552|FG000|COMPLETED|Overall Study||36
10129081|NCT02637037|11260553|FG001|COMPLETED|Overall Study||39
10129082|NCT02637037|11260552|FG000|NOT COMPLETED|Overall Study||4
10129083|NCT02637037|11260553|FG001|NOT COMPLETED|Overall Study||1
10129084|NCT02637063|11260574|FG000|STARTED|Overall Study||67
10129085|NCT02637063|11260575|FG001|STARTED|Overall Study||68
10129086|NCT02637063|11260576|FG002|STARTED|Overall Study||68
10129087|NCT02637063|11260574|FG000|COMPLETED|Overall Study||62
10129088|NCT02637063|11260575|FG001|COMPLETED|Overall Study||64
10129089|NCT02637063|11260576|FG002|COMPLETED|Overall Study||62
10129090|NCT02637063|11260574|FG000|NOT COMPLETED|Overall Study||5
10129091|NCT02637063|11260575|FG001|NOT COMPLETED|Overall Study||4
10129092|NCT02637063|11260576|FG002|NOT COMPLETED|Overall Study||6
10129093|NCT02637076|11260586|FG000|STARTED|Overall Study||2
10129094|NCT02637076|11260587|FG001|STARTED|Overall Study||15
9706764|NCT02000882|10805853|FG000|NOT COMPLETED|Overall Study||6
9706765|NCT01654315|10805860|FG000|STARTED|Overall Study||15
9706766|NCT01654315|10805861|FG001|STARTED|Overall Study||10
10129095|NCT02637076|11260586|FG000|COMPLETED|Overall Study||1
10129096|NCT02637076|11260587|FG001|COMPLETED|Overall Study||10
10129097|NCT02637076|11260586|FG000|NOT COMPLETED|Overall Study||1
10129098|NCT02637076|11260587|FG001|NOT COMPLETED|Overall Study||5
10129099|NCT02637141|11260596|FG000|STARTED|Overall Study||22
10129100|NCT02637141|11260597|FG001|STARTED|Overall Study||22
10129101|NCT02637141|11260598|FG002|STARTED|Overall Study||20
10129102|NCT02637141|11260596|FG000|Received Study Drug|Overall Study||22
10129103|NCT02637141|11260597|FG001|Received Study Drug|Overall Study||21
10129104|NCT02637141|11260598|FG002|Received Study Drug|Overall Study||19
10129105|NCT02637141|11260596|FG000|COMPLETED|Overall Study||20
10129106|NCT02637141|11260597|FG001|COMPLETED|Overall Study||20
10129107|NCT02637141|11260598|FG002|COMPLETED|Overall Study||19
10129108|NCT02637141|11260596|FG000|NOT COMPLETED|Overall Study||2
10129109|NCT02637141|11260597|FG001|NOT COMPLETED|Overall Study||2
10129110|NCT02637141|11260598|FG002|NOT COMPLETED|Overall Study||1
10129111|NCT02637232|11260606|FG000|STARTED|Overall Study||301
10129112|NCT02637232|11260606|FG000|COMPLETED|Overall Study||246
10129113|NCT02637232|11260606|FG000|NOT COMPLETED|Overall Study||55
10129114|NCT02637323|11260612|FG000|STARTED|Overall Study||63
10129115|NCT02637323|11260613|FG001|STARTED|Overall Study||18
10129116|NCT02637323|11260612|FG000|COMPLETED|Overall Study||61
10129117|NCT02637323|11260613|FG001|COMPLETED|Overall Study||17
10129118|NCT02637323|11260612|FG000|NOT COMPLETED|Overall Study||2
10129119|NCT02637323|11260613|FG001|NOT COMPLETED|Overall Study||1
10129120|NCT02637427|11260622|FG000|STARTED|Overall Study||27
10129121|NCT02637427|11260623|FG001|STARTED|Overall Study||30
10129122|NCT02637427|11260622|FG000|COMPLETED|Overall Study||27
10129123|NCT02637427|11260623|FG001|COMPLETED|Overall Study||30
10129124|NCT02637427|11260622|FG000|NOT COMPLETED|Overall Study||0
10129125|NCT02637427|11260623|FG001|NOT COMPLETED|Overall Study||0
10129126|NCT02637557|11260633|FG000|STARTED|Overall Study||71
10129127|NCT02637557|11260634|FG001|STARTED|Overall Study||71
10129128|NCT02637557|11260635|FG002|STARTED|Overall Study||71
10129129|NCT02637557|11260636|FG003|STARTED|Overall Study||69
9706767|NCT01654315|10805862|FG002|STARTED|Overall Study||9
9706768|NCT01654315|10805860|FG000|COMPLETED|Overall Study||15
9706769|NCT01654315|10805861|FG001|COMPLETED|Overall Study||10
10129130|NCT02637557|11260633|FG000|COMPLETED|Overall Study||63
10129131|NCT02637557|11260634|FG001|COMPLETED|Overall Study||66
10129132|NCT02637557|11260635|FG002|COMPLETED|Overall Study||62
10129133|NCT02637557|11260636|FG003|COMPLETED|Overall Study||62
10129134|NCT02637557|11260633|FG000|NOT COMPLETED|Overall Study||8
10129135|NCT02637557|11260634|FG001|NOT COMPLETED|Overall Study||5
10129136|NCT02637557|11260635|FG002|NOT COMPLETED|Overall Study||9
10129137|NCT02637557|11260636|FG003|NOT COMPLETED|Overall Study||7
10129138|NCT02637804|11260648|FG000|STARTED|First Intervention (1 Week)||27
10129139|NCT02637804|11260649|FG001|STARTED|First Intervention (1 Week)||28
10129140|NCT02637804|11260650|FG002|STARTED|First Intervention (1 Week)||25
10129141|NCT02637804|11260651|FG003|STARTED|First Intervention (1 Week)||26
10129142|NCT02637804|11260648|FG000|COMPLETED|First Intervention (1 Week)||27
10129143|NCT02637804|11260649|FG001|COMPLETED|First Intervention (1 Week)||28
10129144|NCT02637804|11260650|FG002|COMPLETED|First Intervention (1 Week)||25
10129145|NCT02637804|11260651|FG003|COMPLETED|First Intervention (1 Week)||26
10129146|NCT02637804|11260648|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10129147|NCT02637804|11260649|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10129148|NCT02637804|11260650|FG002|NOT COMPLETED|First Intervention (1 Week)||0
10129149|NCT02637804|11260651|FG003|NOT COMPLETED|First Intervention (1 Week)||0
10129150|NCT02637804|11260648|FG000|STARTED|Second Intervention (1 Week)||27
10129151|NCT02637804|11260649|FG001|STARTED|Second Intervention (1 Week)||28
10129152|NCT02637804|11260650|FG002|STARTED|Second Intervention (1 Week)||25
10129153|NCT02637804|11260651|FG003|STARTED|Second Intervention (1 Week)||26
10129154|NCT02637804|11260648|FG000|COMPLETED|Second Intervention (1 Week)||27
10129155|NCT02637804|11260649|FG001|COMPLETED|Second Intervention (1 Week)||28
10129156|NCT02637804|11260650|FG002|COMPLETED|Second Intervention (1 Week)||25
10129157|NCT02637804|11260651|FG003|COMPLETED|Second Intervention (1 Week)||26
10129158|NCT02637804|11260648|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10129159|NCT02637804|11260649|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10129160|NCT02637804|11260650|FG002|NOT COMPLETED|Second Intervention (1 Week)||0
10129161|NCT02637804|11260651|FG003|NOT COMPLETED|Second Intervention (1 Week)||0
10129162|NCT02637856|11260668|FG000|STARTED|Main Study (Baseline to Week 100)||608
10129163|NCT02637856|11260669|FG001|STARTED|Main Study (Baseline to Week 100)||0
10129164|NCT02637856|11260668|FG000|COMPLETED|Main Study (Baseline to Week 100)||389
10129165|NCT02637856|11260669|FG001|COMPLETED|Main Study (Baseline to Week 100)||0
10129166|NCT02637856|11260668|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219
10129167|NCT02637856|11260669|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0
10129168|NCT02637856|11260668|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0
10129169|NCT02637856|11260669|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129
10129170|NCT02637856|11260668|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0
10129171|NCT02637856|11260669|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125
10129172|NCT02637856|11260668|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
10129173|NCT02637856|11260669|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
10129174|NCT02637895|11260677|FG000|STARTED|Overall Study||21
10129175|NCT02637895|11260678|FG001|STARTED|Overall Study||20
10129176|NCT02637895|11260677|FG000|COMPLETED|Overall Study||15
10129177|NCT02637895|11260678|FG001|COMPLETED|Overall Study||17
10129178|NCT02637895|11260677|FG000|NOT COMPLETED|Overall Study||6
10129179|NCT02637895|11260678|FG001|NOT COMPLETED|Overall Study||3
10129180|NCT02637999|11260688|FG000|STARTED|Overall Study||8
10129181|NCT02637999|11260689|FG001|STARTED|Overall Study||8
10129182|NCT02637999|11260690|FG002|STARTED|Overall Study||8
10129183|NCT02637999|11260688|FG000|COMPLETED|Overall Study||7
10129184|NCT02637999|11260689|FG001|COMPLETED|Overall Study||6
10129185|NCT02637999|11260690|FG002|COMPLETED|Overall Study||6
10129186|NCT02637999|11260688|FG000|NOT COMPLETED|Overall Study||1
10129187|NCT02637999|11260689|FG001|NOT COMPLETED|Overall Study||2
10129188|NCT02637999|11260690|FG002|NOT COMPLETED|Overall Study||2
10129189|NCT02638012|11260698|FG000|STARTED|Overall Study||8
10129190|NCT02638012|11260698|FG000|COMPLETED|Overall Study||7
10129191|NCT02638012|11260698|FG000|NOT COMPLETED|Overall Study||1
10129192|NCT02638051|11260704|FG000|STARTED|Overall Study||130
10129193|NCT02638051|11260705|FG001|STARTED|Overall Study||130
10129194|NCT02638051|11260704|FG000|COMPLETED|Overall Study||130
10129195|NCT02638051|11260705|FG001|COMPLETED|Overall Study||130
10129196|NCT02638051|11260704|FG000|NOT COMPLETED|Overall Study||0
10129197|NCT02638051|11260705|FG001|NOT COMPLETED|Overall Study||0
10129198|NCT02638103|11260715|FG000|STARTED|Overall Study||419
10129199|NCT02638103|11260716|FG001|STARTED|Overall Study||526
10129200|NCT02638103|11260717|FG002|STARTED|Overall Study||420
10129201|NCT02638103|11260718|FG003|STARTED|Overall Study||525
10129202|NCT02638103|11260715|FG000|Safety Analysis Set|Overall Study||418
10129203|NCT02638103|11260716|FG001|Safety Analysis Set|Overall Study||526
10129204|NCT02638103|11260717|FG002|Safety Analysis Set|Overall Study||419
10129205|NCT02638103|11260718|FG003|Safety Analysis Set|Overall Study||525
10129206|NCT02638103|11260715|FG000|Full Analysis Set (FAS)|Overall Study||416
10129207|NCT02638103|11260716|FG001|Full Analysis Set (FAS)|Overall Study||520
10129208|NCT02638103|11260717|FG002|Full Analysis Set (FAS)|Overall Study||419
10129209|NCT02638103|11260718|FG003|Full Analysis Set (FAS)|Overall Study||523
10129210|NCT02638103|11260715|FG000|COMPLETED|Overall Study||313
10129211|NCT02638103|11260716|FG001|COMPLETED|Overall Study||408
10129212|NCT02638103|11260717|FG002|COMPLETED|Overall Study||335
10129213|NCT02638103|11260718|FG003|COMPLETED|Overall Study||383
10129214|NCT02638103|11260715|FG000|NOT COMPLETED|Overall Study||106
10129215|NCT02638103|11260716|FG001|NOT COMPLETED|Overall Study||118
10129216|NCT02638103|11260717|FG002|NOT COMPLETED|Overall Study||85
10129217|NCT02638103|11260718|FG003|NOT COMPLETED|Overall Study||142
10129218|NCT02638168|11260736|FG000|STARTED|Overall Study||3
10129219|NCT02638168|11260737|FG001|STARTED|Overall Study||0
10129220|NCT02638168|11260736|FG000|COMPLETED|Overall Study||3
10129221|NCT02638168|11260737|FG001|COMPLETED|Overall Study||0
10129222|NCT02638168|11260736|FG000|NOT COMPLETED|Overall Study||0
10129223|NCT02638168|11260737|FG001|NOT COMPLETED|Overall Study||0
10129224|NCT02638207|11260744|FG000|STARTED|Overall Study||35
10129225|NCT02638207|11260745|FG001|STARTED|Overall Study||69
10129226|NCT02638207|11260746|FG002|STARTED|Overall Study||38
10129227|NCT02638207|11260744|FG000|COMPLETED|Overall Study||28
10129228|NCT02638207|11260745|FG001|COMPLETED|Overall Study||61
10129229|NCT02638207|11260746|FG002|COMPLETED|Overall Study||34
10129230|NCT02638207|11260744|FG000|NOT COMPLETED|Overall Study||7
10129231|NCT02638207|11260745|FG001|NOT COMPLETED|Overall Study||8
10129232|NCT02638207|11260746|FG002|NOT COMPLETED|Overall Study||4
10129233|NCT02638259|11260758|FG000|STARTED|Treatment Period 1||186
10129234|NCT02638259|11260759|FG001|STARTED|Treatment Period 1||190
10129235|NCT02638259|11260758|FG000|COMPLETED|Treatment Period 1||181
10129236|NCT02638259|11260759|FG001|COMPLETED|Treatment Period 1||172
10129237|NCT02638259|11260758|FG000|NOT COMPLETED|Treatment Period 1||5
10129238|NCT02638259|11260759|FG001|NOT COMPLETED|Treatment Period 1||18
10129239|NCT02638259|11260758|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
10129240|NCT02638259|11260759|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
10129241|NCT02638259|11260758|FG000|COMPLETED|Treatment Period 2||169
10129242|NCT02638259|11260759|FG001|COMPLETED|Treatment Period 2||155
10129243|NCT02638259|11260758|FG000|NOT COMPLETED|Treatment Period 2||6
10129244|NCT02638259|11260759|FG001|NOT COMPLETED|Treatment Period 2||11
10129245|NCT02638337|11260771|FG000|STARTED|Overall Study||316
10129246|NCT02638337|11260772|FG001|STARTED|Overall Study||315
10129247|NCT02638337|11260771|FG000|Received Treatment|Overall Study||313
10129248|NCT02638337|11260772|FG001|Received Treatment|Overall Study||315
10129249|NCT02638337|11260771|FG000|COMPLETED|Overall Study||283
10129250|NCT02638337|11260772|FG001|COMPLETED|Overall Study||279
10129251|NCT02638337|11260771|FG000|NOT COMPLETED|Overall Study||33
10129252|NCT02638337|11260772|FG001|NOT COMPLETED|Overall Study||36
10129253|NCT02638493|11260781|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
10129254|NCT02638493|11260782|FG001|STARTED|Overall Study||8
10129255|NCT02638493|11260783|FG002|STARTED|Overall Study||8
10129256|NCT02638493|11260781|FG000|COMPLETED|Overall Study||8
10129257|NCT02638493|11260782|FG001|COMPLETED|Overall Study||8
10129258|NCT02638493|11260783|FG002|COMPLETED|Overall Study||8
10129259|NCT02638493|11260781|FG000|NOT COMPLETED|Overall Study||2
10129260|NCT02638493|11260782|FG001|NOT COMPLETED|Overall Study||0
10129261|NCT02638493|11260783|FG002|NOT COMPLETED|Overall Study||0
10129262|NCT02638597|11260793|FG000|STARTED|Overall Study||8
10129263|NCT02638597|11260794|FG001|STARTED|Overall Study||8
10129264|NCT02638597|11260793|FG000|COMPLETED|Overall Study||4
10129265|NCT02638597|11260794|FG001|COMPLETED|Overall Study||3
10129266|NCT02638597|11260793|FG000|NOT COMPLETED|Overall Study||4
10129267|NCT02638597|11260794|FG001|NOT COMPLETED|Overall Study||5
10129268|NCT02638623|11260804|FG000|STARTED|Overall Study||27
10129269|NCT02638623|11260805|FG001|STARTED|Overall Study||25
10129270|NCT02638623|11260804|FG000|COMPLETED|Overall Study||20
10129271|NCT02638623|11260805|FG001|COMPLETED|Overall Study||19
10129272|NCT02638623|11260804|FG000|NOT COMPLETED|Overall Study||7
10129273|NCT02638623|11260805|FG001|NOT COMPLETED|Overall Study||6
10129274|NCT02638948|11260815|FG000|STARTED|Overall Study||75
10129275|NCT02638948|11260816|FG001|STARTED|Overall Study||73
10129276|NCT02638948|11260817|FG002|STARTED|Overall Study||73
10129277|NCT02638948|11260818|FG003|STARTED|Overall Study||26
10129278|NCT02638948|11260815|FG000|COMPLETED|Overall Study||66
10129279|NCT02638948|11260816|FG001|COMPLETED|Overall Study||62
10129280|NCT02638948|11260817|FG002|COMPLETED|Overall Study||66
10129281|NCT02638948|11260818|FG003|COMPLETED|Overall Study||18
10129282|NCT02638948|11260815|FG000|NOT COMPLETED|Overall Study||9
10129283|NCT02638948|11260816|FG001|NOT COMPLETED|Overall Study||11
10129284|NCT02638948|11260817|FG002|NOT COMPLETED|Overall Study||7
10129285|NCT02638948|11260818|FG003|NOT COMPLETED|Overall Study||8
10129286|NCT02638974|11260833|FG000|STARTED|Overall Study||26
10129287|NCT02638974|11260834|FG001|STARTED|Overall Study||25
10129288|NCT02638974|11260833|FG000|COMPLETED|Overall Study||23
10129289|NCT02638974|11260834|FG001|COMPLETED|Overall Study||22
10129290|NCT02638974|11260833|FG000|NOT COMPLETED|Overall Study||3
10129291|NCT02638974|11260834|FG001|NOT COMPLETED|Overall Study||3
10129292|NCT02639052|11260840|FG000|STARTED|Overall Study||35
10129293|NCT02639052|11260840|FG000|Visit 1 (Baseline)|Overall Study||35
10129294|NCT02639052|11260840|FG000|Visit 2 (1-week Follow-up)|Overall Study||35
10129295|NCT02639052|11260840|FG000|Visit 3 (1-month Follow-up)|Overall Study||35
10129296|NCT02639052|11260840|FG000|Visit 4 (3-month Follow-up)|Overall Study||34
10129297|NCT02639052|11260840|FG000|COMPLETED|Overall Study||34
10129298|NCT02639052|11260840|FG000|NOT COMPLETED|Overall Study||1
10129299|NCT02639182|11260848|FG000|STARTED|Overall Study||67
10129300|NCT02639182|11260849|FG001|STARTED|Overall Study||66
10129301|NCT02639182|11260848|FG000|Treated|Overall Study||66
10129302|NCT02639182|11260849|FG001|Treated|Overall Study||65
10129303|NCT02639182|11260848|FG000|COMPLETED|Overall Study||0
10129304|NCT02639182|11260849|FG001|COMPLETED|Overall Study||0
10129305|NCT02639182|11260848|FG000|NOT COMPLETED|Overall Study||67
10129306|NCT02639182|11260849|FG001|NOT COMPLETED|Overall Study||66
10129307|NCT02639247|11260857|FG000|STARTED|Overall Study||182
10129308|NCT02639247|11260858|FG001|STARTED|Overall Study||151
10129309|NCT02639247|11260857|FG000|COMPLETED|Overall Study||177
10129310|NCT02639247|11260858|FG001|COMPLETED|Overall Study||149
10129311|NCT02639247|11260857|FG000|NOT COMPLETED|Overall Study||5
10129312|NCT02639247|11260858|FG001|NOT COMPLETED|Overall Study||2
10129313|NCT02639286|11260866|FG000|STARTED|Overall Study||3
10129314|NCT02639286|11260867|FG001|STARTED|Overall Study||2
10129315|NCT02639286|11260866|FG000|COMPLETED|Overall Study||3
10129316|NCT02639286|11260867|FG001|COMPLETED|Overall Study||2
10129317|NCT02639286|11260866|FG000|NOT COMPLETED|Overall Study||0
10129318|NCT02639286|11260867|FG001|NOT COMPLETED|Overall Study||0
10129319|NCT02639338|11260875|FG000|STARTED|Overall Study||110
10129320|NCT02639338|11260876|FG001|STARTED|Overall Study||110
10129321|NCT02639338|11260875|FG000|COMPLETED|Overall Study||106
10129322|NCT02639338|11260876|FG001|COMPLETED|Overall Study||105
10129323|NCT02639338|11260875|FG000|NOT COMPLETED|Overall Study||4
10129324|NCT02639338|11260876|FG001|NOT COMPLETED|Overall Study||5
10129325|NCT02639351|11260887|FG000|STARTED|Overall Study||16
10129326|NCT02639351|11260888|FG001|STARTED|Overall Study||16
10129327|NCT02639351|11260889|FG002|STARTED|Overall Study||16
10129328|NCT02639351|11260890|FG003|STARTED|Overall Study||16
10129329|NCT02639351|11260891|FG004|STARTED|Overall Study||16
10129330|NCT02639351|11260887|FG000|COMPLETED|Overall Study||16
10129331|NCT02639351|11260888|FG001|COMPLETED|Overall Study||16
10129332|NCT02639351|11260889|FG002|COMPLETED|Overall Study||16
10129333|NCT02639351|11260890|FG003|COMPLETED|Overall Study||16
10129334|NCT02639351|11260891|FG004|COMPLETED|Overall Study||16
10129335|NCT02639351|11260887|FG000|NOT COMPLETED|Overall Study||0
10129336|NCT02639351|11260888|FG001|NOT COMPLETED|Overall Study||0
10129337|NCT02639351|11260889|FG002|NOT COMPLETED|Overall Study||0
10129338|NCT02639351|11260890|FG003|NOT COMPLETED|Overall Study||0
10129339|NCT02639351|11260891|FG004|NOT COMPLETED|Overall Study||0
10129340|NCT02639429|11260907|FG000|STARTED|Overall Study||113
10129341|NCT02639429|11260908|FG001|STARTED|Overall Study||123
10129342|NCT02639429|11260907|FG000|COMPLETED|Overall Study||113
10129343|NCT02639429|11260908|FG001|COMPLETED|Overall Study||123
10129344|NCT02639429|11260907|FG000|NOT COMPLETED|Overall Study||0
10129345|NCT02639429|11260908|FG001|NOT COMPLETED|Overall Study||0
10129346|NCT02639494|11260914|FG000|STARTED|Overall Study||20
10129347|NCT02639494|11260914|FG000|COMPLETED|Overall Study||20
10129348|NCT02639494|11260914|FG000|NOT COMPLETED|Overall Study||0
10129349|NCT02639637|11260921|FG000|STARTED|Overall Study||7
10129350|NCT02639637|11260922|FG001|STARTED|Overall Study||6
10129351|NCT02639637|11260923|FG002|STARTED|Overall Study||2
10129352|NCT02639637|11260924|FG003|STARTED|Overall Study||3
10129353|NCT02639637|11260921|FG000|COMPLETED|Overall Study||7
10129354|NCT02639637|11260922|FG001|COMPLETED|Overall Study||6
10129355|NCT02639637|11260923|FG002|COMPLETED|Overall Study||2
10129356|NCT02639637|11260924|FG003|COMPLETED|Overall Study||3
10129357|NCT02639637|11260921|FG000|NOT COMPLETED|Overall Study||0
10129358|NCT02639637|11260922|FG001|NOT COMPLETED|Overall Study||0
10129359|NCT02639637|11260923|FG002|NOT COMPLETED|Overall Study||0
10129360|NCT02639637|11260924|FG003|NOT COMPLETED|Overall Study||0
10129361|NCT02639884|11260940|FG000|STARTED|Overall Study||51
10129362|NCT02639884|11260940|FG000|COMPLETED|Overall Study||47
10129363|NCT02639884|11260940|FG000|NOT COMPLETED|Overall Study||4
10129364|NCT02640053|11260947|FG000|STARTED|Overall Study||21
10129365|NCT02640053|11260948|FG001|STARTED|Overall Study||21
10129366|NCT02640053|11260947|FG000|COMPLETED|Overall Study||17
10129367|NCT02640053|11260948|FG001|COMPLETED|Overall Study||17
10129368|NCT02640053|11260947|FG000|NOT COMPLETED|Overall Study||4
10129369|NCT02640053|11260948|FG001|NOT COMPLETED|Overall Study||4
10129370|NCT02640157|11260957|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
10129371|NCT02640157|11260958|FG001|STARTED|Overall Study||116
10129372|NCT02640157|11260959|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
10129373|NCT02640157|11260957|FG000|Received Study Drug|Overall Study||233
10129374|NCT02640157|11260958|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
10129375|NCT02640157|11260959|FG002|Received Study Drug|Overall Study||157
10129376|NCT02640157|11260957|FG000|Completed Study Drug|Overall Study||225
10129377|NCT02640157|11260958|FG001|Completed Study Drug|Overall Study||112
10129378|NCT02640157|11260959|FG002|Completed Study Drug|Overall Study||154
10129379|NCT02640157|11260957|FG000|Discontinued Study Drug|Overall Study||8
10129380|NCT02640157|11260958|FG001|Discontinued Study Drug|Overall Study||3
10129381|NCT02640157|11260959|FG002|Discontinued Study Drug|Overall Study||3
10129382|NCT02640157|11260957|FG000|COMPLETED|Overall Study||220
10129383|NCT02640157|11260958|FG001|COMPLETED|Overall Study||111
10129384|NCT02640157|11260959|FG002|COMPLETED|Overall Study||147
10129385|NCT02640157|11260957|FG000|NOT COMPLETED|Overall Study||13
10129386|NCT02640157|11260958|FG001|NOT COMPLETED|Overall Study||5
10129387|NCT02640157|11260959|FG002|NOT COMPLETED|Overall Study||10
10129388|NCT02640235|11260970|FG000|STARTED|Overall Study||131
10129389|NCT02640235|11260971|FG001|STARTED|Overall Study||129
10129390|NCT02640235|11260970|FG000|COMPLETED|Overall Study||117
10129391|NCT02640235|11260971|FG001|COMPLETED|Overall Study||115
10129392|NCT02640235|11260970|FG000|NOT COMPLETED|Overall Study||14
10129393|NCT02640235|11260971|FG001|NOT COMPLETED|Overall Study||14
10129394|NCT02640404|11260979|FG000|STARTED|Overall Study||112
10129395|NCT02640404|11260980|FG001|STARTED|Overall Study||112
10129396|NCT02640404|11260979|FG000|COMPLETED|Overall Study||110
10129397|NCT02640404|11260980|FG001|COMPLETED|Overall Study||112
10129398|NCT02640404|11260979|FG000|NOT COMPLETED|Overall Study||2
10129399|NCT02640404|11260980|FG001|NOT COMPLETED|Overall Study||0
10129400|NCT02640482|11260988|FG000|STARTED|Overall Study||202
10129401|NCT02640482|11260989|FG001|STARTED|Overall Study||100
10129402|NCT02640482|11260988|FG000|COMPLETED|Overall Study||199
10129403|NCT02640482|11260989|FG001|COMPLETED|Overall Study||100
10129404|NCT02640482|11260988|FG000|NOT COMPLETED|Overall Study||3
10129405|NCT02640482|11260989|FG001|NOT COMPLETED|Overall Study||0
10129406|NCT02640547|11260995|FG000|STARTED|Overall Study||394
10129407|NCT02640547|11260995|FG000|COMPLETED|Overall Study||383
10129408|NCT02640547|11260995|FG000|NOT COMPLETED|Overall Study||11
10129409|NCT02640612|11261010|FG000|STARTED|Overall Study||225
10129410|NCT02640612|11261011|FG001|STARTED|Overall Study||103
10129411|NCT02640612|11261012|FG002|STARTED|Overall Study||102
10129412|NCT02640612|11261010|FG000|COMPLETED|Overall Study||203
10129413|NCT02640612|11261011|FG001|COMPLETED|Overall Study||89
10129414|NCT02640612|11261012|FG002|COMPLETED|Overall Study||96
10129415|NCT02640612|11261010|FG000|NOT COMPLETED|Overall Study||22
10129416|NCT02640612|11261011|FG001|NOT COMPLETED|Overall Study||14
10129417|NCT02640612|11261012|FG002|NOT COMPLETED|Overall Study||6
10129418|NCT02640716|11261022|FG000|STARTED|Overall Study||30
10129419|NCT02640716|11261023|FG001|STARTED|Overall Study||30
10129420|NCT02640716|11261022|FG000|Training Completion|Overall Study||27
10129421|NCT02640716|11261023|FG001|Training Completion|Overall Study||27
10129422|NCT02640716|11261022|FG000|COMPLETED|Overall Study||23
10129423|NCT02640716|11261023|FG001|COMPLETED|Overall Study||21
10129424|NCT02640716|11261022|FG000|NOT COMPLETED|Overall Study||7
10129425|NCT02640716|11261023|FG001|NOT COMPLETED|Overall Study||9
10129426|NCT02640755|11261031|FG000|STARTED|Single Dose Period (Day 1 - 8)||3
10129427|NCT02640755|11261032|FG001|STARTED|Single Dose Period (Day 1 - 8)||1
10129428|NCT02640755|11261031|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3
10129429|NCT02640755|11261032|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1
10129430|NCT02640755|11261031|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
10129431|NCT02640755|11261032|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
10129432|NCT02640755|11261031|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3
10129433|NCT02640755|11261032|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1
10129434|NCT02640755|11261031|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
10129435|NCT02640755|11261032|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
10129436|NCT02640755|11261031|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
10129437|NCT02640755|11261032|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
10129438|NCT02640807|11261042|FG000|STARTED|Overall Study||9
10129439|NCT02640807|11261043|FG001|STARTED|Overall Study||8
10129440|NCT02640807|11261044|FG002|STARTED|Overall Study||10
10129441|NCT02640807|11261042|FG000|COMPLETED|Overall Study||9
10129442|NCT02640807|11261043|FG001|COMPLETED|Overall Study||8
10129443|NCT02640807|11261044|FG002|COMPLETED|Overall Study||10
10129444|NCT02640807|11261042|FG000|NOT COMPLETED|Overall Study||0
9706770|NCT01654315|10805862|FG002|COMPLETED|Overall Study||9
9706771|NCT01654315|10805860|FG000|NOT COMPLETED|Overall Study||0
9706772|NCT01654315|10805861|FG001|NOT COMPLETED|Overall Study||0
9706773|NCT01654315|10805862|FG002|NOT COMPLETED|Overall Study||0
9706774|NCT01642004|10805872|FG000|STARTED|Randomization||135
9706775|NCT01642004|10805873|FG001|STARTED|Randomization||137
9706776|NCT01642004|10805872|FG000|COMPLETED|Randomization||131
9706777|NCT01642004|10805873|FG001|COMPLETED|Randomization||129
9706778|NCT01642004|10805872|FG000|NOT COMPLETED|Randomization||4
9706779|NCT01642004|10805873|FG001|NOT COMPLETED|Randomization||8
9706780|NCT01642004|10805872|FG000|STARTED|Treatment||131
9706781|NCT01642004|10805873|FG001|STARTED|Treatment||129
9706782|NCT01642004|10805872|FG000|COMPLETED|Treatment||21
9706783|NCT01642004|10805873|FG001|COMPLETED|Treatment||2
9706784|NCT01642004|10805872|FG000|NOT COMPLETED|Treatment||110
9706785|NCT01642004|10805873|FG001|NOT COMPLETED|Treatment||127
9706786|NCT01366092|10805879|FG000|STARTED|Overall Study||35
9706787|NCT01366092|10805879|FG000|COMPLETED|Overall Study||31
9706788|NCT01366092|10805879|FG000|NOT COMPLETED|Overall Study||4
9706789|NCT01326104|10805885|FG000|STARTED|Overall Study||7
9706790|NCT01326104|10805886|FG001|STARTED|Overall Study||19
9706791|NCT01326104|10805885|FG000|COMPLETED|Overall Study||7
9706792|NCT01326104|10805886|FG001|COMPLETED|Overall Study||15
9706793|NCT01326104|10805885|FG000|NOT COMPLETED|Overall Study||0
9706794|NCT01326104|10805886|FG001|NOT COMPLETED|Overall Study||4
9706795|NCT01244815|10805896|FG000|STARTED|Overall Study|Randomized|101
9848700|NCT00861380|10961455|FG000|NOT COMPLETED|Overall Study||8427
9848701|NCT00861380|10961456|FG001|NOT COMPLETED|Overall Study||9112
9848702|NCT00861380|10961457|FG002|NOT COMPLETED|Overall Study||8872
9848703|NCT00861380|10961458|FG003|NOT COMPLETED|Overall Study||3689
9848704|NCT00861380|10961459|FG004|NOT COMPLETED|Overall Study||1812
9848705|NCT00861380|10961460|FG005|NOT COMPLETED|Overall Study||6249
9848706|NCT00861380|10961461|FG006|NOT COMPLETED|Overall Study||3020
9848707|NCT00861471|10961494|FG000|STARTED|Overall Study||12
9848708|NCT00861471|10961494|FG000|COMPLETED|Overall Study||3
9848709|NCT00861471|10961494|FG000|NOT COMPLETED|Overall Study||9
9848710|NCT00861601|10961501|FG000|STARTED|Overall Study||12
9848711|NCT00861601|10961502|FG001|STARTED|Overall Study||14
9848712|NCT00861601|10961503|FG002|STARTED|Overall Study||12
9848713|NCT00861601|10961501|FG000|COMPLETED|Overall Study||12
9848714|NCT00861601|10961502|FG001|COMPLETED|Overall Study||14
9848715|NCT00861601|10961503|FG002|COMPLETED|Overall Study||12
9848716|NCT00861601|10961501|FG000|NOT COMPLETED|Overall Study||0
9848717|NCT00861601|10961502|FG001|NOT COMPLETED|Overall Study||0
9848718|NCT00861601|10961503|FG002|NOT COMPLETED|Overall Study||0
9848719|NCT00861614|10961516|FG000|STARTED|Overall Study||393
9848720|NCT00861614|10961517|FG001|STARTED|Overall Study||396
9848721|NCT00861614|10961516|FG000|COMPLETED|Overall Study||22
9848722|NCT00861614|10961517|FG001|COMPLETED|Overall Study||28
9848723|NCT00861614|10961516|FG000|NOT COMPLETED|Overall Study||371
9848724|NCT00861614|10961517|FG001|NOT COMPLETED|Overall Study||368
10129445|NCT02640807|11261043|FG001|NOT COMPLETED|Overall Study||0
9706796|NCT01244815|10805897|FG001|STARTED|Overall Study|Randomized|105
9706797|NCT01244815|10805898|FG002|STARTED|Overall Study|Randomized|99
9848725|NCT00861692|10961523|FG000|STARTED|Overall Study||20
9848726|NCT00861692|10961523|FG000|COMPLETED|Overall Study||14
10129446|NCT02640807|11261044|FG002|NOT COMPLETED|Overall Study||0
10129447|NCT02641067|11261054|FG000|STARTED|Overall Study||8
9706798|NCT01244815|10805899|FG003|STARTED|Overall Study|Randomized|99
9706799|NCT01244815|10805896|FG000|Treated|Overall Study||101
9706800|NCT01244815|10805897|FG001|Treated|Overall Study||104
9706801|NCT01244815|10805898|FG002|Treated|Overall Study||99
10129448|NCT02641067|11261055|FG001|STARTED|Overall Study||8
10129449|NCT02641067|11261054|FG000|COMPLETED|Overall Study||8
10129450|NCT02641067|11261055|FG001|COMPLETED|Overall Study||8
10129451|NCT02641067|11261054|FG000|NOT COMPLETED|Overall Study||0
10129452|NCT02641067|11261055|FG001|NOT COMPLETED|Overall Study||0
10129453|NCT02641080|11261063|FG000|STARTED|Overall Study||40
10129454|NCT02641080|11261064|FG001|STARTED|Overall Study||40
10129455|NCT02641080|11261063|FG000|COMPLETED|Overall Study||38
10129456|NCT02641080|11261064|FG001|COMPLETED|Overall Study||33
10129457|NCT02641080|11261063|FG000|NOT COMPLETED|Overall Study||2
10129458|NCT02641080|11261064|FG001|NOT COMPLETED|Overall Study||7
10129459|NCT02641249|11261070|FG000|STARTED|Overall Study||19
10129460|NCT02641249|11261070|FG000|COMPLETED|Overall Study||15
10129461|NCT02641249|11261070|FG000|NOT COMPLETED|Overall Study||4
10129462|NCT02641353|11261075|FG000|STARTED|Overall Study||5
10129463|NCT02641353|11261076|FG001|STARTED|Overall Study||5
10129464|NCT02641353|11261077|FG002|STARTED|Overall Study||6
10129465|NCT02641353|11261078|FG003|STARTED|Overall Study||6
10129466|NCT02641353|11261079|FG004|STARTED|Overall Study||6
10129467|NCT02641353|11261080|FG005|STARTED|Overall Study||6
10129468|NCT02641353|11261075|FG000|COMPLETED|Overall Study||5
10129469|NCT02641353|11261076|FG001|COMPLETED|Overall Study||5
10129470|NCT02641353|11261077|FG002|COMPLETED|Overall Study||6
10129471|NCT02641353|11261078|FG003|COMPLETED|Overall Study||6
10129472|NCT02641353|11261079|FG004|COMPLETED|Overall Study||6
10129473|NCT02641353|11261080|FG005|COMPLETED|Overall Study||6
10129474|NCT02641353|11261075|FG000|NOT COMPLETED|Overall Study||0
10129475|NCT02641353|11261076|FG001|NOT COMPLETED|Overall Study||0
10129476|NCT02641353|11261077|FG002|NOT COMPLETED|Overall Study||0
10129477|NCT02641353|11261078|FG003|NOT COMPLETED|Overall Study||0
10129478|NCT02641353|11261079|FG004|NOT COMPLETED|Overall Study||0
10129479|NCT02641353|11261080|FG005|NOT COMPLETED|Overall Study||0
10129480|NCT02641379|11261102|FG000|STARTED|Overall Study||142
10129481|NCT02641379|11261103|FG001|STARTED|Overall Study||152
10129482|NCT02641379|11261104|FG002|STARTED|Overall Study||78
10129483|NCT02641379|11261105|FG003|STARTED|Overall Study||156
10129484|NCT02641379|11261106|FG004|STARTED|Overall Study||17
10129485|NCT02641379|11261107|FG005|STARTED|Overall Study||36
10129486|NCT02641379|11261108|FG006|STARTED|Overall Study||25
10129487|NCT02641379|11261109|FG007|STARTED|Overall Study||20
10129488|NCT02641379|11261110|FG008|STARTED|Overall Study||42
10129489|NCT02641379|11261111|FG009|STARTED|Overall Study||45
10129490|NCT02641379|11261112|FG010|STARTED|Overall Study||8
10129491|NCT02641379|11261102|FG000|COMPLETED|Overall Study||107
10129492|NCT02641379|11261103|FG001|COMPLETED|Overall Study||101
10129493|NCT02641379|11261104|FG002|COMPLETED|Overall Study||7
10129494|NCT02641379|11261105|FG003|COMPLETED|Overall Study||139
10129495|NCT02641379|11261106|FG004|COMPLETED|Overall Study||0
10129496|NCT02641379|11261107|FG005|COMPLETED|Overall Study||20
10129497|NCT02641379|11261108|FG006|COMPLETED|Overall Study||12
10129498|NCT02641379|11261109|FG007|COMPLETED|Overall Study||1
10129499|NCT02641379|11261110|FG008|COMPLETED|Overall Study||36
10129500|NCT02641379|11261111|FG009|COMPLETED|Overall Study||36
10129501|NCT02641379|11261112|FG010|COMPLETED|Overall Study||0
10129502|NCT02641379|11261102|FG000|NOT COMPLETED|Overall Study||35
10129503|NCT02641379|11261103|FG001|NOT COMPLETED|Overall Study||51
10129504|NCT02641379|11261104|FG002|NOT COMPLETED|Overall Study||71
10129505|NCT02641379|11261105|FG003|NOT COMPLETED|Overall Study||17
10129506|NCT02641379|11261106|FG004|NOT COMPLETED|Overall Study||17
10129507|NCT02641379|11261107|FG005|NOT COMPLETED|Overall Study||16
10129508|NCT02641379|11261108|FG006|NOT COMPLETED|Overall Study||13
10129509|NCT02641379|11261109|FG007|NOT COMPLETED|Overall Study||19
10129510|NCT02641379|11261110|FG008|NOT COMPLETED|Overall Study||6
10129511|NCT02641379|11261111|FG009|NOT COMPLETED|Overall Study||9
10129512|NCT02641379|11261112|FG010|NOT COMPLETED|Overall Study||8
10196523|NCT03363854|11324755|FG004|STARTED|Continuation Treatment Period||95
10196524|NCT03363854|11324756|FG005|STARTED|Continuation Treatment Period||79
10196525|NCT03363854|11324757|FG006|STARTED|Continuation Treatment Period||41
10196526|NCT03363854|11324758|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
10196527|NCT03363854|11324751|FG000|COMPLETED|Continuation Treatment Period||0
10196528|NCT03363854|11324752|FG001|COMPLETED|Continuation Treatment Period||0
10196529|NCT03363854|11324753|FG002|COMPLETED|Continuation Treatment Period||68
10196530|NCT03363854|11324754|FG003|COMPLETED|Continuation Treatment Period||65
10196531|NCT03363854|11324755|FG004|COMPLETED|Continuation Treatment Period||87
10196532|NCT03363854|11324756|FG005|COMPLETED|Continuation Treatment Period||72
10196533|NCT03363854|11324757|FG006|COMPLETED|Continuation Treatment Period||38
10196534|NCT03363854|11324758|FG007|COMPLETED|Continuation Treatment Period||0
10196535|NCT03363854|11324751|FG000|NOT COMPLETED|Continuation Treatment Period||0
10196536|NCT03363854|11324752|FG001|NOT COMPLETED|Continuation Treatment Period||0
10196537|NCT03363854|11324753|FG002|NOT COMPLETED|Continuation Treatment Period||1
10196538|NCT03363854|11324754|FG003|NOT COMPLETED|Continuation Treatment Period||4
10196539|NCT03363854|11324755|FG004|NOT COMPLETED|Continuation Treatment Period||8
10196540|NCT03363854|11324756|FG005|NOT COMPLETED|Continuation Treatment Period||7
10196541|NCT03363854|11324757|FG006|NOT COMPLETED|Continuation Treatment Period||3
10196542|NCT03363854|11324758|FG007|NOT COMPLETED|Continuation Treatment Period||0
10196543|NCT03363854|11324751|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
10129513|NCT02641392|11261144|FG000|STARTED|Overall Study||4
10129514|NCT02641392|11261145|FG001|STARTED|Overall Study||13
10129515|NCT02641392|11261146|FG002|STARTED|Overall Study||293
10129516|NCT02641392|11261144|FG000|COMPLETED|Overall Study||0
10129517|NCT02641392|11261145|FG001|COMPLETED|Overall Study||0
10129518|NCT02641392|11261146|FG002|COMPLETED|Overall Study||0
10129519|NCT02641392|11261144|FG000|NOT COMPLETED|Overall Study||4
10129520|NCT02641392|11261145|FG001|NOT COMPLETED|Overall Study||13
10129521|NCT02641392|11261146|FG002|NOT COMPLETED|Overall Study||293
10129522|NCT02641522|11261154|FG000|STARTED|Overall Study||10
10129523|NCT02641522|11261154|FG000|COMPLETED|Overall Study||10
10129524|NCT02641522|11261154|FG000|NOT COMPLETED|Overall Study||0
10129525|NCT02641561|11261162|FG000|STARTED|Overall Study||48
10129526|NCT02641561|11261163|FG001|STARTED|Overall Study||48
10129527|NCT02641561|11261164|FG002|STARTED|Overall Study||48
10129528|NCT02641561|11261165|FG003|STARTED|Overall Study||48
10129529|NCT02641561|11261162|FG000|COMPLETED|Overall Study||48
10129530|NCT02641561|11261163|FG001|COMPLETED|Overall Study||48
10129531|NCT02641561|11261164|FG002|COMPLETED|Overall Study||48
10129532|NCT02641561|11261165|FG003|COMPLETED|Overall Study||48
10129533|NCT02641561|11261162|FG000|NOT COMPLETED|Overall Study||0
10129534|NCT02641561|11261163|FG001|NOT COMPLETED|Overall Study||0
10129535|NCT02641561|11261164|FG002|NOT COMPLETED|Overall Study||0
10129536|NCT02641561|11261165|FG003|NOT COMPLETED|Overall Study||0
10129537|NCT02641587|11261178|FG000|STARTED|Confinement Period||80
10129538|NCT02641587|11261179|FG001|STARTED|Confinement Period||40
10129539|NCT02641587|11261178|FG000|COMPLETED|Confinement Period||77
10129540|NCT02641587|11261179|FG001|COMPLETED|Confinement Period||39
10129541|NCT02641587|11261178|FG000|NOT COMPLETED|Confinement Period||3
10129542|NCT02641587|11261179|FG001|NOT COMPLETED|Confinement Period||1
10129543|NCT02641587|11261178|FG000|STARTED|Ambulatory Period||77
10129544|NCT02641587|11261179|FG001|STARTED|Ambulatory Period||39
10129545|NCT02641587|11261178|FG000|COMPLETED|Ambulatory Period||76
10129546|NCT02641587|11261179|FG001|COMPLETED|Ambulatory Period||39
10129547|NCT02641587|11261178|FG000|NOT COMPLETED|Ambulatory Period||1
10129548|NCT02641587|11261179|FG001|NOT COMPLETED|Ambulatory Period||0
10129549|NCT02641691|11261192|FG000|STARTED|Overall Study||20
10129550|NCT02641691|11261192|FG000|COMPLETED|Overall Study||20
10129551|NCT02641691|11261192|FG000|NOT COMPLETED|Overall Study||0
10129552|NCT02641730|11261205|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53
10129553|NCT02641730|11261206|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10129554|NCT02641730|11261207|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10129555|NCT02641730|11261208|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54
10129556|NCT02641730|11261209|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52
10129557|NCT02641730|11261205|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
10129558|NCT02641730|11261206|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10129559|NCT02641730|11261207|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10129560|NCT02641730|11261208|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
10129561|NCT02641730|11261209|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
10129562|NCT02641730|11261205|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
10129563|NCT02641730|11261206|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10129564|NCT02641730|11261207|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10129565|NCT02641730|11261208|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
10129566|NCT02641730|11261209|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
10129567|NCT02641730|11261205|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
10129568|NCT02641730|11261206|FG001|STARTED|After Controlled Period (Week 16 - 52)||25
10129569|NCT02641730|11261207|FG002|STARTED|After Controlled Period (Week 16 - 52)||26
10129570|NCT02641730|11261208|FG003|STARTED|After Controlled Period (Week 16 - 52)||53
10129571|NCT02641730|11261209|FG004|STARTED|After Controlled Period (Week 16 - 52)||50
10129572|NCT02641730|11261205|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
10129573|NCT02641730|11261206|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21
10129574|NCT02641730|11261207|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24
10129575|NCT02641730|11261208|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45
10129576|NCT02641730|11261209|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44
10129577|NCT02641730|11261205|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10129578|NCT02641730|11261206|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
10129579|NCT02641730|11261207|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
10129580|NCT02641730|11261208|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
10129581|NCT02641730|11261209|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
10129582|NCT02641730|11261205|FG000|STARTED|Observational Period (Week 60 - Week 84)||0
10129583|NCT02641730|11261206|FG001|STARTED|Observational Period (Week 60 - Week 84)||21
10129584|NCT02641730|11261207|FG002|STARTED|Observational Period (Week 60 - Week 84)||24
10129585|NCT02641730|11261208|FG003|STARTED|Observational Period (Week 60 - Week 84)||45
10129586|NCT02641730|11261209|FG004|STARTED|Observational Period (Week 60 - Week 84)||44
10129587|NCT02641730|11261205|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0
10129588|NCT02641730|11261206|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21
10129589|NCT02641730|11261207|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24
10129590|NCT02641730|11261208|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45
10129591|NCT02641730|11261209|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43
10129592|NCT02641730|11261205|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10129593|NCT02641730|11261206|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10129594|NCT02641730|11261207|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10129595|NCT02641730|11261208|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10129596|NCT02641730|11261209|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
10129597|NCT02641834|11261225|FG000|STARTED|Overall Study||60
10129598|NCT02641834|11261226|FG001|STARTED|Overall Study||58
10129599|NCT02641834|11261225|FG000|COMPLETED|Overall Study||50
10129600|NCT02641834|11261226|FG001|COMPLETED|Overall Study||50
10129601|NCT02641834|11261225|FG000|NOT COMPLETED|Overall Study||10
10129602|NCT02641834|11261226|FG001|NOT COMPLETED|Overall Study||8
10129603|NCT02641912|11261235|FG000|STARTED|Overall Study||53
10129604|NCT02641912|11261236|FG001|STARTED|Overall Study||47
10129605|NCT02641912|11261235|FG000|COMPLETED|Overall Study||53
10129606|NCT02641912|11261236|FG001|COMPLETED|Overall Study||47
10129607|NCT02641912|11261235|FG000|NOT COMPLETED|Overall Study||0
10129608|NCT02641912|11261236|FG001|NOT COMPLETED|Overall Study||0
10129609|NCT02642159|11261248|FG000|STARTED|Overall Study|Randomized|276
10129610|NCT02642159|11261249|FG001|STARTED|Overall Study|Randomized|137
10129611|NCT02642159|11261248|FG000|Treated (Safety Population)|Overall Study||275
10129612|NCT02642159|11261249|FG001|Treated (Safety Population)|Overall Study||137
10129613|NCT02642159|11261248|FG000|ITT Population|Overall Study||273
10129614|NCT02642159|11261249|FG001|ITT Population|Overall Study||136
10129615|NCT02642159|11261248|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
10129616|NCT02642159|11261249|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
10129617|NCT02642159|11261248|FG000|COMPLETED|Overall Study||245
10129618|NCT02642159|11261249|FG001|COMPLETED|Overall Study||129
10129619|NCT02642159|11261248|FG000|NOT COMPLETED|Overall Study||31
10129620|NCT02642159|11261249|FG001|NOT COMPLETED|Overall Study||8
10129621|NCT02642237|11261258|FG000|STARTED|Overall Study||15
10129622|NCT02642237|11261259|FG001|STARTED|Overall Study||15
10129623|NCT02642237|11261258|FG000|COMPLETED|Overall Study||15
10129624|NCT02642237|11261259|FG001|COMPLETED|Overall Study||15
10129625|NCT02642237|11261258|FG000|NOT COMPLETED|Overall Study||0
10129626|NCT02642237|11261259|FG001|NOT COMPLETED|Overall Study||0
10129627|NCT02642393|11261267|FG000|STARTED|Overall Study||149
10129628|NCT02642393|11261268|FG001|STARTED|Overall Study||149
10129629|NCT02642393|11261267|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
10129630|NCT02642393|11261268|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
10129631|NCT02642393|11261267|FG000|NOT COMPLETED|Overall Study||99
10129632|NCT02642393|11261268|FG001|NOT COMPLETED|Overall Study||92
10129633|NCT02642432|11261274|FG000|STARTED|Overall Study||146
10129634|NCT02642432|11261274|FG000|COMPLETED|Overall Study||138
10129635|NCT02642432|11261274|FG000|NOT COMPLETED|Overall Study||8
10129636|NCT02642536|11261280|FG000|STARTED|Overall Study||21
10129637|NCT02642536|11261281|FG001|STARTED|Overall Study||23
10129638|NCT02642536|11261280|FG000|COMPLETED|Overall Study||19
10129639|NCT02642536|11261281|FG001|COMPLETED|Overall Study||18
10129640|NCT02642536|11261280|FG000|NOT COMPLETED|Overall Study||2
10129641|NCT02642536|11261281|FG001|NOT COMPLETED|Overall Study||5
10129642|NCT02642575|11261287|FG000|STARTED|Overall Study||67
10129643|NCT02642575|11261287|FG000|COMPLETED|Overall Study||67
10129644|NCT02642575|11261287|FG000|NOT COMPLETED|Overall Study||0
10129645|NCT02642614|11261295|FG000|STARTED|Overall Study||30
10129646|NCT02642614|11261296|FG001|STARTED|Overall Study||30
10129647|NCT02642614|11261297|FG002|STARTED|Overall Study||30
10129648|NCT02642614|11261298|FG003|STARTED|Overall Study||30
10129649|NCT02642614|11261295|FG000|COMPLETED|Overall Study||27
10129650|NCT02642614|11261296|FG001|COMPLETED|Overall Study||28
10129651|NCT02642614|11261297|FG002|COMPLETED|Overall Study||28
10129652|NCT02642614|11261298|FG003|COMPLETED|Overall Study||28
10129653|NCT02642614|11261295|FG000|NOT COMPLETED|Overall Study||3
10129654|NCT02642614|11261296|FG001|NOT COMPLETED|Overall Study||2
10129655|NCT02642614|11261297|FG002|NOT COMPLETED|Overall Study||2
10129656|NCT02642614|11261298|FG003|NOT COMPLETED|Overall Study||2
10129657|NCT02642627|11261311|FG000|STARTED|Overall Study||42
10129658|NCT02642627|11261311|FG000|COMPLETED|Overall Study||39
10129659|NCT02642627|11261311|FG000|NOT COMPLETED|Overall Study||3
10129660|NCT02642653|11261318|FG000|STARTED|Overall Study||14
10129661|NCT02642653|11261319|FG001|STARTED|Overall Study||16
10129662|NCT02642653|11261318|FG000|COMPLETED|Overall Study||12
10129663|NCT02642653|11261319|FG001|COMPLETED|Overall Study||16
10129664|NCT02642653|11261318|FG000|NOT COMPLETED|Overall Study||2
10129665|NCT02642653|11261319|FG001|NOT COMPLETED|Overall Study||0
10129666|NCT02642679|11261325|FG000|STARTED|Overall Study||19
10129667|NCT02642679|11261325|FG000|COMPLETED|Overall Study||16
10129668|NCT02642679|11261325|FG000|NOT COMPLETED|Overall Study||3
10129669|NCT02642835|11261329|FG000|STARTED|Overall Study||48
10129670|NCT02642835|11261329|FG000|COMPLETED|Overall Study||48
10129671|NCT02642835|11261329|FG000|NOT COMPLETED|Overall Study||0
10129672|NCT02642952|11261335|FG000|STARTED|Overall Study||21
10129673|NCT02642952|11261336|FG001|STARTED|Overall Study||30
10129674|NCT02642952|11261335|FG000|COMPLETED|Overall Study||19
10129675|NCT02642952|11261336|FG001|COMPLETED|Overall Study||25
10129676|NCT02642952|11261335|FG000|NOT COMPLETED|Overall Study||2
10129677|NCT02642952|11261336|FG001|NOT COMPLETED|Overall Study||5
10129678|NCT02642991|11261342|FG000|STARTED|First Intervention||22
10129679|NCT02642991|11261343|FG001|STARTED|First Intervention||22
9848727|NCT00861692|10961523|FG000|NOT COMPLETED|Overall Study||6
9848728|NCT00861744|10961531|FG000|STARTED|Overall Study||304
9848729|NCT00861744|10961532|FG001|STARTED|Overall Study||304
9848730|NCT00861744|10961533|FG002|STARTED|Overall Study||304
9848731|NCT00861744|10961534|FG003|STARTED|Overall Study||308
9848732|NCT00861744|10961531|FG000|COMPLETED|Overall Study||287
9848733|NCT00861744|10961532|FG001|COMPLETED|Overall Study||275
9848734|NCT00861744|10961533|FG002|COMPLETED|Overall Study||280
9848735|NCT00861744|10961534|FG003|COMPLETED|Overall Study||275
9848736|NCT00861744|10961531|FG000|NOT COMPLETED|Overall Study||17
9848737|NCT00861744|10961532|FG001|NOT COMPLETED|Overall Study||29
9848738|NCT00861744|10961533|FG002|NOT COMPLETED|Overall Study||24
9848739|NCT00861744|10961534|FG003|NOT COMPLETED|Overall Study||33
9848740|NCT00861757|10961548|FG000|STARTED|Overall Study||154
9848741|NCT00861757|10961549|FG001|STARTED|Overall Study||151
9848742|NCT00861757|10961550|FG002|STARTED|Overall Study||155
9848743|NCT00861757|10961551|FG003|STARTED|Overall Study||152
9848744|NCT00861757|10961548|FG000|COMPLETED|Overall Study||145
9848745|NCT00861757|10961549|FG001|COMPLETED|Overall Study||136
9848746|NCT00861757|10961550|FG002|COMPLETED|Overall Study||137
9848747|NCT00861757|10961551|FG003|COMPLETED|Overall Study||143
9848748|NCT00861757|10961548|FG000|NOT COMPLETED|Overall Study||9
9848749|NCT00861757|10961549|FG001|NOT COMPLETED|Overall Study||15
9848750|NCT00861757|10961550|FG002|NOT COMPLETED|Overall Study||18
9848751|NCT00861757|10961551|FG003|NOT COMPLETED|Overall Study||9
9848752|NCT00861913|10961565|FG000|STARTED|Overall Study||13
9848753|NCT00861913|10961565|FG000|COMPLETED|Overall Study||13
9848754|NCT00861913|10961565|FG000|NOT COMPLETED|Overall Study||0
9848755|NCT00862082|10961571|FG000|STARTED|Overall Study||8
9848756|NCT00862082|10961572|FG001|STARTED|Overall Study||6
9848757|NCT00862082|10961571|FG000|COMPLETED|Overall Study||3
9848758|NCT00862082|10961572|FG001|COMPLETED|Overall Study||5
9848759|NCT00862082|10961571|FG000|NOT COMPLETED|Overall Study||5
9848760|NCT00862082|10961572|FG001|NOT COMPLETED|Overall Study||1
9848761|NCT00862121|10961587|FG000|STARTED|Overall Study||8
9848762|NCT00862121|10961588|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
9848763|NCT00862121|10961587|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
9848764|NCT00862121|10961588|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
9848765|NCT00862121|10961587|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
9848766|NCT00862121|10961588|FG001|Safety Analysis Set|Overall Study||11
9848767|NCT00862121|10961587|FG000|COMPLETED|Overall Study||7
9848768|NCT00862121|10961588|FG001|COMPLETED|Overall Study||4
9848769|NCT00862121|10961587|FG000|NOT COMPLETED|Overall Study||1
10060392|NCT02097472|11185912|FG005|STARTED|Received Vaccination 2||50
10060393|NCT02097472|11185913|FG006|STARTED|Received Vaccination 2||50
10060394|NCT02097472|11185914|FG007|STARTED|Received Vaccination 2||50
10060395|NCT02097472|11185907|FG000|COMPLETED|Received Vaccination 2||18
10060396|NCT02097472|11185908|FG001|COMPLETED|Received Vaccination 2||18
10060397|NCT02097472|11185909|FG002|COMPLETED|Received Vaccination 2||18
10060398|NCT02097472|11185910|FG003|COMPLETED|Received Vaccination 2||50
10060399|NCT02097472|11185911|FG004|COMPLETED|Received Vaccination 2||50
10060400|NCT02097472|11185912|FG005|COMPLETED|Received Vaccination 2||50
10060401|NCT02097472|11185913|FG006|COMPLETED|Received Vaccination 2||49
10060402|NCT02097472|11185914|FG007|COMPLETED|Received Vaccination 2||50
10060403|NCT02097472|11185907|FG000|NOT COMPLETED|Received Vaccination 2||0
10060404|NCT02097472|11185908|FG001|NOT COMPLETED|Received Vaccination 2||0
10060405|NCT02097472|11185909|FG002|NOT COMPLETED|Received Vaccination 2||0
10060406|NCT02097472|11185910|FG003|NOT COMPLETED|Received Vaccination 2||0
10060407|NCT02097472|11185911|FG004|NOT COMPLETED|Received Vaccination 2||0
10060408|NCT02097472|11185912|FG005|NOT COMPLETED|Received Vaccination 2||0
10060409|NCT02097472|11185913|FG006|NOT COMPLETED|Received Vaccination 2||1
10060410|NCT02097472|11185914|FG007|NOT COMPLETED|Received Vaccination 2||0
10060411|NCT02097472|11185907|FG000|STARTED|Assessed for Immunogenicity||18
10060412|NCT02097472|11185908|FG001|STARTED|Assessed for Immunogenicity||18
10060413|NCT02097472|11185909|FG002|STARTED|Assessed for Immunogenicity||18
10060414|NCT02097472|11185910|FG003|STARTED|Assessed for Immunogenicity||50
10060415|NCT02097472|11185911|FG004|STARTED|Assessed for Immunogenicity||50
10060416|NCT02097472|11185912|FG005|STARTED|Assessed for Immunogenicity||50
10060417|NCT02097472|11185913|FG006|STARTED|Assessed for Immunogenicity||49
10060418|NCT02097472|11185914|FG007|STARTED|Assessed for Immunogenicity||50
10060419|NCT02097472|11185907|FG000|COMPLETED|Assessed for Immunogenicity||18
10060420|NCT02097472|11185908|FG001|COMPLETED|Assessed for Immunogenicity||18
10060421|NCT02097472|11185909|FG002|COMPLETED|Assessed for Immunogenicity||17
9848770|NCT00862121|10961588|FG001|NOT COMPLETED|Overall Study||8
9848771|NCT00862134|10961596|FG000|STARTED|Overall Study||19
9848772|NCT00862134|10961597|FG001|STARTED|Overall Study||23
9848773|NCT00862134|10961596|FG000|COMPLETED|Overall Study||8
10129680|NCT02642991|11261342|FG000|COMPLETED|First Intervention||22
10129681|NCT02642991|11261343|FG001|COMPLETED|First Intervention||22
10129682|NCT02642991|11261342|FG000|NOT COMPLETED|First Intervention||0
10129683|NCT02642991|11261343|FG001|NOT COMPLETED|First Intervention||0
10129684|NCT02642991|11261342|FG000|STARTED|Second Intervention||22
10129685|NCT02642991|11261343|FG001|STARTED|Second Intervention||22
10129686|NCT02642991|11261342|FG000|COMPLETED|Second Intervention||22
10129687|NCT02642991|11261343|FG001|COMPLETED|Second Intervention||22
10129688|NCT02642991|11261342|FG000|NOT COMPLETED|Second Intervention||0
10129689|NCT02642991|11261343|FG001|NOT COMPLETED|Second Intervention||0
10129690|NCT02643004|11261352|FG000|STARTED|First Intervention (One Week)||35
10129691|NCT02643004|11261353|FG001|STARTED|First Intervention (One Week)||35
10129692|NCT02643004|11261352|FG000|COMPLETED|First Intervention (One Week)||35
10129693|NCT02643004|11261353|FG001|COMPLETED|First Intervention (One Week)||35
10129694|NCT02643004|11261352|FG000|NOT COMPLETED|First Intervention (One Week)||0
10129695|NCT02643004|11261353|FG001|NOT COMPLETED|First Intervention (One Week)||0
10129696|NCT02643004|11261352|FG000|STARTED|Second Intervention (One Week)||35
10129697|NCT02643004|11261353|FG001|STARTED|Second Intervention (One Week)||35
10129698|NCT02643004|11261352|FG000|COMPLETED|Second Intervention (One Week)||35
10129699|NCT02643004|11261353|FG001|COMPLETED|Second Intervention (One Week)||35
10129700|NCT02643004|11261352|FG000|NOT COMPLETED|Second Intervention (One Week)||0
10129701|NCT02643004|11261353|FG001|NOT COMPLETED|Second Intervention (One Week)||0
10129702|NCT02643082|11261359|FG000|STARTED|Period 1||10
10129703|NCT02643082|11261360|FG001|STARTED|Period 1||10
10129704|NCT02643082|11261359|FG000|COMPLETED|Period 1||9
10129705|NCT02643082|11261360|FG001|COMPLETED|Period 1||10
10129706|NCT02643082|11261359|FG000|NOT COMPLETED|Period 1||1
10129707|NCT02643082|11261360|FG001|NOT COMPLETED|Period 1||0
10129708|NCT02643082|11261359|FG000|STARTED|Washout||9
10129709|NCT02643082|11261360|FG001|STARTED|Washout||10
10129710|NCT02643082|11261359|FG000|COMPLETED|Washout||9
10129711|NCT02643082|11261360|FG001|COMPLETED|Washout||10
10129712|NCT02643082|11261359|FG000|NOT COMPLETED|Washout||0
10129713|NCT02643082|11261360|FG001|NOT COMPLETED|Washout||0
10129714|NCT02643082|11261359|FG000|STARTED|Period 2||9
10129715|NCT02643082|11261360|FG001|STARTED|Period 2||10
10129716|NCT02643082|11261359|FG000|COMPLETED|Period 2||9
10129717|NCT02643082|11261360|FG001|COMPLETED|Period 2||10
10129718|NCT02643082|11261359|FG000|NOT COMPLETED|Period 2||0
10129719|NCT02643082|11261360|FG001|NOT COMPLETED|Period 2||0
10129720|NCT02643095|11261367|FG000|STARTED|Overall Study||22
10129721|NCT02643095|11261367|FG000|COMPLETED|Overall Study||21
10129722|NCT02643095|11261367|FG000|NOT COMPLETED|Overall Study||1
10129723|NCT02643199|11261371|FG000|STARTED|Overall Study||90
10129724|NCT02643199|11261371|FG000|COMPLETED|Overall Study||90
10129725|NCT02643199|11261371|FG000|NOT COMPLETED|Overall Study||0
10129726|NCT02643225|11261377|FG000|STARTED|Overall Study||40
10129727|NCT02643225|11261378|FG001|STARTED|Overall Study||40
10129728|NCT02643225|11261377|FG000|COMPLETED|Overall Study||40
10129729|NCT02643225|11261378|FG001|COMPLETED|Overall Study||40
10129730|NCT02643225|11261377|FG000|NOT COMPLETED|Overall Study||0
10129731|NCT02643225|11261378|FG001|NOT COMPLETED|Overall Study||0
10129732|NCT02643251|11261387|FG000|STARTED|Overall Study||69
10129733|NCT02643251|11261388|FG001|STARTED|Overall Study||69
10129734|NCT02643251|11261387|FG000|COMPLETED|Overall Study||58
10129735|NCT02643251|11261388|FG001|COMPLETED|Overall Study||67
10129736|NCT02643251|11261387|FG000|NOT COMPLETED|Overall Study||11
10129737|NCT02643251|11261388|FG001|NOT COMPLETED|Overall Study||2
10129738|NCT02643355|11261396|FG000|STARTED|Overall Study||34
10129739|NCT02643355|11261397|FG001|STARTED|Overall Study||35
10129740|NCT02643355|11261396|FG000|COMPLETED|Overall Study||33
10129741|NCT02643355|11261397|FG001|COMPLETED|Overall Study||30
10129742|NCT02643355|11261396|FG000|NOT COMPLETED|Overall Study||1
10129743|NCT02643355|11261397|FG001|NOT COMPLETED|Overall Study||5
10129744|NCT02643394|11261405|FG000|STARTED|Overall Study||55
10129745|NCT02643394|11261406|FG001|STARTED|Overall Study||55
10129746|NCT02643394|11261405|FG000|COMPLETED|Overall Study||51
10129747|NCT02643394|11261406|FG001|COMPLETED|Overall Study||50
10129748|NCT02643394|11261405|FG000|NOT COMPLETED|Overall Study||4
10129749|NCT02643394|11261406|FG001|NOT COMPLETED|Overall Study||5
10129750|NCT02643459|11261414|FG000|STARTED|Overall Study||7901
10129751|NCT02643459|11261415|FG001|STARTED|Overall Study||8900
10129752|NCT02643459|11261414|FG000|COMPLETED|Overall Study||7901
10129753|NCT02643459|11261415|FG001|COMPLETED|Overall Study||8900
10129754|NCT02643459|11261414|FG000|NOT COMPLETED|Overall Study||0
10129755|NCT02643459|11261415|FG001|NOT COMPLETED|Overall Study||0
10129756|NCT02643472|11261424|FG000|STARTED|Overall Study||150
10129757|NCT02643472|11261425|FG001|STARTED|Overall Study||150
10129758|NCT02643472|11261424|FG000|COMPLETED|Overall Study||123
10129759|NCT02643472|11261425|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
10129760|NCT02643472|11261424|FG000|NOT COMPLETED|Overall Study||27
10129761|NCT02643472|11261425|FG001|NOT COMPLETED|Overall Study||34
10129762|NCT02643615|11261435|FG000|STARTED|Overall Study||9
10129763|NCT02643615|11261436|FG001|STARTED|Overall Study||11
10129764|NCT02643615|11261435|FG000|COMPLETED|Overall Study||9
10129765|NCT02643615|11261436|FG001|COMPLETED|Overall Study||11
10129766|NCT02643615|11261435|FG000|NOT COMPLETED|Overall Study||0
10129767|NCT02643615|11261436|FG001|NOT COMPLETED|Overall Study||0
10129768|NCT02643628|11261445|FG000|STARTED|Overall Study||21
10129769|NCT02643628|11261446|FG001|STARTED|Overall Study||23
10129770|NCT02643628|11261445|FG000|COMPLETED|Overall Study||20
10129771|NCT02643628|11261446|FG001|COMPLETED|Overall Study||17
10129772|NCT02643628|11261445|FG000|NOT COMPLETED|Overall Study||1
10129773|NCT02643628|11261446|FG001|NOT COMPLETED|Overall Study||6
10129774|NCT02643693|11261454|FG000|STARTED|Overall Study||4
10129775|NCT02643693|11261455|FG001|STARTED|Overall Study||4
10129776|NCT02643693|11261456|FG002|STARTED|Overall Study||4
10129777|NCT02643693|11261457|FG003|STARTED|Overall Study||4
10129778|NCT02643693|11261458|FG004|STARTED|Overall Study||4
10129779|NCT02643693|11261459|FG005|STARTED|Overall Study||4
10129780|NCT02643693|11261454|FG000|COMPLETED|Overall Study||2
10129781|NCT02643693|11261455|FG001|COMPLETED|Overall Study||2
10129782|NCT02643693|11261456|FG002|COMPLETED|Overall Study||3
10129783|NCT02643693|11261457|FG003|COMPLETED|Overall Study||4
10129784|NCT02643693|11261458|FG004|COMPLETED|Overall Study||4
10129785|NCT02643693|11261459|FG005|COMPLETED|Overall Study||3
10129786|NCT02643693|11261454|FG000|NOT COMPLETED|Overall Study||2
10129787|NCT02643693|11261455|FG001|NOT COMPLETED|Overall Study||2
10129788|NCT02643693|11261456|FG002|NOT COMPLETED|Overall Study||1
10129789|NCT02643693|11261457|FG003|NOT COMPLETED|Overall Study||0
10129790|NCT02643693|11261458|FG004|NOT COMPLETED|Overall Study||0
10129791|NCT02643693|11261459|FG005|NOT COMPLETED|Overall Study||1
10129792|NCT02643849|11261467|FG000|STARTED|Overall Study||107
10129793|NCT02643849|11261467|FG000|COMPLETED|Overall Study||82
10129794|NCT02643849|11261467|FG000|NOT COMPLETED|Overall Study||25
10129795|NCT02643862|11261473|FG000|STARTED|Overall Study||36
10129796|NCT02643862|11261474|FG001|STARTED|Overall Study||12
10129797|NCT02643862|11261473|FG000|COMPLETED|Overall Study||36
10129798|NCT02643862|11261474|FG001|COMPLETED|Overall Study||12
10129799|NCT02643862|11261473|FG000|NOT COMPLETED|Overall Study||0
10129800|NCT02643862|11261474|FG001|NOT COMPLETED|Overall Study||0
10129801|NCT02643875|11261480|FG000|STARTED|Overall Study||36
10129802|NCT02643875|11261480|FG000|Received 0.75|Overall Study||36
10129803|NCT02643875|11261480|FG000|Received 1.75 D|Overall Study||36
10129804|NCT02643875|11261480|FG000|COMPLETED|Overall Study||28
10129805|NCT02643875|11261480|FG000|NOT COMPLETED|Overall Study||8
10129806|NCT02643979|11261487|FG000|STARTED|Overall Study||11
10129807|NCT02643979|11261488|FG001|STARTED|Overall Study||11
10129808|NCT02643979|11261487|FG000|COMPLETED|Overall Study||11
10129809|NCT02643979|11261488|FG001|COMPLETED|Overall Study||11
10129810|NCT02643979|11261487|FG000|NOT COMPLETED|Overall Study||0
10129811|NCT02643979|11261488|FG001|NOT COMPLETED|Overall Study||0
10129812|NCT02644096|11261496|FG000|STARTED|Overall Study||93
10129813|NCT02644096|11261497|FG001|STARTED|Overall Study||82
10129814|NCT02644096|11261496|FG000|2 Week Interview|Overall Study|Not done in control group|0
10129815|NCT02644096|11261497|FG001|2 Week Interview|Overall Study||68
10129816|NCT02644096|11261496|FG000|10 Week Interview|Overall Study|Not done in control group|0
10129817|NCT02644096|11261497|FG001|10 Week Interview|Overall Study||59
10129818|NCT02644096|11261496|FG000|12 Week SF-36 Questionnaire|Overall Study||68
10129819|NCT02644096|11261497|FG001|12 Week SF-36 Questionnaire|Overall Study||59
10129820|NCT02644096|11261496|FG000|9 Month SF-36 Questionnaire|Overall Study||65
10129821|NCT02644096|11261497|FG001|9 Month SF-36 Questionnaire|Overall Study||57
10129822|NCT02644096|11261496|FG000|COMPLETED|Overall Study||65
10129823|NCT02644096|11261497|FG001|COMPLETED|Overall Study||57
10129824|NCT02644096|11261496|FG000|NOT COMPLETED|Overall Study||28
10129825|NCT02644096|11261497|FG001|NOT COMPLETED|Overall Study||25
10129826|NCT02644109|11261505|FG000|STARTED|Overall Study||24
10129827|NCT02644109|11261506|FG001|STARTED|Overall Study||28
10129828|NCT02644109|11261505|FG000|COMPLETED|Overall Study||24
10129829|NCT02644109|11261506|FG001|COMPLETED|Overall Study||24
10129830|NCT02644109|11261505|FG000|NOT COMPLETED|Overall Study||0
10129831|NCT02644109|11261506|FG001|NOT COMPLETED|Overall Study||4
10129832|NCT02644122|11261512|FG000|STARTED|Overall Study||1
10129833|NCT02644122|11261512|FG000|COMPLETED|Overall Study||0
10129834|NCT02644122|11261512|FG000|NOT COMPLETED|Overall Study||1
10129835|NCT02644278|11261521|FG000|STARTED|Overall Study||3
10129836|NCT02644278|11261522|FG001|STARTED|Overall Study||3
10129837|NCT02644278|11261523|FG002|STARTED|Overall Study||6
10129838|NCT02644278|11261524|FG003|STARTED|Overall Study||3
10129839|NCT02644278|11261521|FG000|COMPLETED|Overall Study||3
10129840|NCT02644278|11261522|FG001|COMPLETED|Overall Study||3
10129841|NCT02644278|11261523|FG002|COMPLETED|Overall Study||6
10129842|NCT02644278|11261524|FG003|COMPLETED|Overall Study||3
10129843|NCT02644278|11261521|FG000|NOT COMPLETED|Overall Study||0
10129844|NCT02644278|11261522|FG001|NOT COMPLETED|Overall Study||0
10129845|NCT02644278|11261523|FG002|NOT COMPLETED|Overall Study||0
10129846|NCT02644278|11261524|FG003|NOT COMPLETED|Overall Study||0
10129847|NCT02644343|11261534|FG000|STARTED|Overall Study||40
10129848|NCT02644343|11261534|FG000|COMPLETED|Overall Study||39
10129849|NCT02644343|11261534|FG000|NOT COMPLETED|Overall Study||1
10129850|NCT02644356|11261538|FG000|STARTED|Overall Study||51
10129851|NCT02644356|11261538|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
10129852|NCT02644356|11261538|FG000|NOT COMPLETED|Overall Study||2
10129853|NCT02644668|11261545|FG000|STARTED|Overall Study||26
10129854|NCT02644668|11261546|FG001|STARTED|Overall Study||24
10129855|NCT02644668|11261547|FG002|STARTED|Overall Study||20
10129856|NCT02644668|11261545|FG000|COMPLETED|Overall Study||24
10129857|NCT02644668|11261546|FG001|COMPLETED|Overall Study||24
10129858|NCT02644668|11261547|FG002|COMPLETED|Overall Study||17
10129859|NCT02644668|11261545|FG000|NOT COMPLETED|Overall Study||2
10129860|NCT02644668|11261546|FG001|NOT COMPLETED|Overall Study||0
10129861|NCT02644668|11261547|FG002|NOT COMPLETED|Overall Study||3
10129862|NCT02645019|11261562|FG000|STARTED|Overall Study||13
10129863|NCT02645019|11261563|FG001|STARTED|Overall Study||15
10129864|NCT02645019|11261564|FG002|STARTED|Overall Study||15
10129865|NCT02645019|11261565|FG003|STARTED|Overall Study||33
10129866|NCT02645019|11261566|FG004|STARTED|Overall Study||24
10129867|NCT02645019|11261562|FG000|COMPLETED|Overall Study||13
10129868|NCT02645019|11261563|FG001|COMPLETED|Overall Study||15
10129869|NCT02645019|11261564|FG002|COMPLETED|Overall Study||15
10129870|NCT02645019|11261565|FG003|COMPLETED|Overall Study||33
10129871|NCT02645019|11261566|FG004|COMPLETED|Overall Study||24
10129872|NCT02645019|11261562|FG000|NOT COMPLETED|Overall Study||0
10129873|NCT02645019|11261563|FG001|NOT COMPLETED|Overall Study||0
10129874|NCT02645019|11261564|FG002|NOT COMPLETED|Overall Study||0
10129875|NCT02645019|11261565|FG003|NOT COMPLETED|Overall Study||0
10129876|NCT02645019|11261566|FG004|NOT COMPLETED|Overall Study||0
10129877|NCT02645123|11261581|FG000|STARTED|Overall Study||25
10129878|NCT02645123|11261582|FG001|STARTED|Overall Study||25
10129879|NCT02645123|11261583|FG002|STARTED|Overall Study||25
10129880|NCT02645123|11261581|FG000|COMPLETED|Overall Study||25
10129881|NCT02645123|11261582|FG001|COMPLETED|Overall Study||25
10129882|NCT02645123|11261583|FG002|COMPLETED|Overall Study||25
10129883|NCT02645123|11261581|FG000|NOT COMPLETED|Overall Study||0
10129884|NCT02645123|11261582|FG001|NOT COMPLETED|Overall Study||0
10129885|NCT02645123|11261583|FG002|NOT COMPLETED|Overall Study||0
10129886|NCT02645253|11261595|FG000|STARTED|Overall Study||7
10129887|NCT02645253|11261596|FG001|STARTED|Overall Study||7
10129888|NCT02645253|11261597|FG002|STARTED|Overall Study||7
10129889|NCT02645253|11261598|FG003|STARTED|Overall Study||6
10129890|NCT02645253|11261595|FG000|COMPLETED|Overall Study||7
10129891|NCT02645253|11261596|FG001|COMPLETED|Overall Study||7
10129892|NCT02645253|11261597|FG002|COMPLETED|Overall Study||7
10129893|NCT02645253|11261598|FG003|COMPLETED|Overall Study||6
10129894|NCT02645253|11261595|FG000|NOT COMPLETED|Overall Study||0
10129895|NCT02645253|11261596|FG001|NOT COMPLETED|Overall Study||0
10129896|NCT02645253|11261597|FG002|NOT COMPLETED|Overall Study||0
10129897|NCT02645253|11261598|FG003|NOT COMPLETED|Overall Study||0
10129898|NCT02645409|11261615|FG000|STARTED|Overall Study||14
10129899|NCT02645409|11261616|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
10129900|NCT02645409|11261615|FG000|COMPLETED|Overall Study||10
10129901|NCT02645409|11261616|FG001|COMPLETED|Overall Study||0
10129902|NCT02645409|11261615|FG000|NOT COMPLETED|Overall Study||4
10129903|NCT02645409|11261616|FG001|NOT COMPLETED|Overall Study||0
10129904|NCT02645617|11261621|FG000|STARTED|Overall Study||12
10129905|NCT02645617|11261621|FG000|COMPLETED|Overall Study||12
10129906|NCT02645617|11261621|FG000|NOT COMPLETED|Overall Study||0
10129907|NCT02645760|11261627|FG000|STARTED|Overall Study||19
10129908|NCT02645760|11261628|FG001|STARTED|Overall Study||19
10129909|NCT02645760|11261627|FG000|COMPLETED|Overall Study||19
10129910|NCT02645760|11261628|FG001|COMPLETED|Overall Study||19
10129911|NCT02645760|11261627|FG000|NOT COMPLETED|Overall Study||0
10129912|NCT02645760|11261628|FG001|NOT COMPLETED|Overall Study||0
10129913|NCT02646124|11261637|FG000|STARTED|Overall Study||57
10129914|NCT02646124|11261638|FG001|STARTED|Overall Study||57
10129915|NCT02646124|11261637|FG000|COMPLETED|Overall Study||57
10129916|NCT02646124|11261638|FG001|COMPLETED|Overall Study||55
10129917|NCT02646124|11261637|FG000|NOT COMPLETED|Overall Study||0
10129918|NCT02646124|11261638|FG001|NOT COMPLETED|Overall Study||2
10129919|NCT02646332|11261646|FG000|STARTED|Overall Study||124
10129920|NCT02646332|11261647|FG001|STARTED|Overall Study||124
10129921|NCT02646332|11261646|FG000|COMPLETED|Overall Study||124
10129922|NCT02646332|11261647|FG001|COMPLETED|Overall Study||121
10129923|NCT02646332|11261646|FG000|NOT COMPLETED|Overall Study||0
10129924|NCT02646332|11261647|FG001|NOT COMPLETED|Overall Study||3
10129925|NCT02646371|11261655|FG000|STARTED|Overall Study||34
10129926|NCT02646371|11261656|FG001|STARTED|Overall Study||33
10129927|NCT02646371|11261655|FG000|COMPLETED|Overall Study||34
10129928|NCT02646371|11261656|FG001|COMPLETED|Overall Study||33
10129929|NCT02646371|11261655|FG000|NOT COMPLETED|Overall Study||0
10129930|NCT02646371|11261656|FG001|NOT COMPLETED|Overall Study||0
10129931|NCT02646423|11261664|FG000|STARTED|Overall Study||742
10129932|NCT02646423|11261665|FG001|STARTED|Overall Study||743
10129933|NCT02646423|11261664|FG000|COMPLETED|Overall Study||735
10129934|NCT02646423|11261665|FG001|COMPLETED|Overall Study||735
10129935|NCT02646423|11261664|FG000|NOT COMPLETED|Overall Study||7
10129936|NCT02646423|11261665|FG001|NOT COMPLETED|Overall Study||8
10129937|NCT02646449|11261673|FG000|STARTED|Overall Study||4
10129938|NCT02646449|11261674|FG001|STARTED|Overall Study||3
10129939|NCT02646449|11261673|FG000|COMPLETED|Overall Study||4
10129940|NCT02646449|11261674|FG001|COMPLETED|Overall Study||3
10129941|NCT02646449|11261673|FG000|NOT COMPLETED|Overall Study||0
10129942|NCT02646449|11261674|FG001|NOT COMPLETED|Overall Study||0
10129943|NCT02646566|11261683|FG000|STARTED|Overall Study||237
10129944|NCT02646566|11261684|FG001|STARTED|Overall Study||230
10129945|NCT02646566|11261685|FG002|STARTED|Overall Study||235
10129946|NCT02646566|11261683|FG000|COMPLETED|Overall Study||231
10129947|NCT02646566|11261684|FG001|COMPLETED|Overall Study||226
10129948|NCT02646566|11261685|FG002|COMPLETED|Overall Study||230
10129949|NCT02646566|11261683|FG000|NOT COMPLETED|Overall Study||6
10129950|NCT02646566|11261684|FG001|NOT COMPLETED|Overall Study||4
10129951|NCT02646566|11261685|FG002|NOT COMPLETED|Overall Study||5
10129952|NCT02646618|11261695|FG000|STARTED|Overall Study||167
10129953|NCT02646618|11261696|FG001|STARTED|Overall Study||162
10129954|NCT02646618|11261695|FG000|6 Month Follow-up|Overall Study||152
10129955|NCT02646618|11261696|FG001|6 Month Follow-up|Overall Study||150
10129956|NCT02646618|11261695|FG000|COMPLETED|Overall Study||157
10129957|NCT02646618|11261696|FG001|COMPLETED|Overall Study||148
10129958|NCT02646618|11261695|FG000|NOT COMPLETED|Overall Study||10
10129959|NCT02646618|11261696|FG001|NOT COMPLETED|Overall Study||14
10129960|NCT02646761|11261706|FG000|STARTED|Overall Study||18
10129961|NCT02646761|11261707|FG001|STARTED|Overall Study||20
10129962|NCT02646761|11261706|FG000|Subject Withdrew Before Baseline|Overall Study||5
10129963|NCT02646761|11261707|FG001|Subject Withdrew Before Baseline|Overall Study||8
10129964|NCT02646761|11261706|FG000|Baseline Assessment|Overall Study||13
10129965|NCT02646761|11261707|FG001|Baseline Assessment|Overall Study||12
10129966|NCT02646761|11261706|FG000|5-week Assessment|Overall Study||12
10129967|NCT02646761|11261707|FG001|5-week Assessment|Overall Study||10
10129968|NCT02646761|11261706|FG000|COMPLETED|Overall Study||10
10129969|NCT02646761|11261707|FG001|COMPLETED|Overall Study||10
10129970|NCT02646761|11261706|FG000|NOT COMPLETED|Overall Study||8
10129971|NCT02646761|11261707|FG001|NOT COMPLETED|Overall Study||10
10129972|NCT02646826|11261717|FG000|STARTED|Overall Study||21
10129973|NCT02646826|11261718|FG001|STARTED|Overall Study||22
10129974|NCT02646826|11261719|FG002|STARTED|Overall Study||21
10129975|NCT02646826|11261720|FG003|STARTED|Overall Study||22
10129976|NCT02646826|11261717|FG000|COMPLETED|Overall Study||19
10129977|NCT02646826|11261718|FG001|COMPLETED|Overall Study||22
10129978|NCT02646826|11261719|FG002|COMPLETED|Overall Study||20
10129979|NCT02646826|11261720|FG003|COMPLETED|Overall Study||21
10129980|NCT02646826|11261717|FG000|NOT COMPLETED|Overall Study||2
10129981|NCT02646826|11261718|FG001|NOT COMPLETED|Overall Study||0
10129982|NCT02646826|11261719|FG002|NOT COMPLETED|Overall Study||1
10129983|NCT02646826|11261720|FG003|NOT COMPLETED|Overall Study||1
10129984|NCT02646891|11261740|FG000|STARTED|Overall Study||6
10129985|NCT02646891|11261741|FG001|STARTED|Overall Study||12
10129986|NCT02646891|11261742|FG002|STARTED|Overall Study||12
10129987|NCT02646891|11261743|FG003|STARTED|Overall Study||6
10129988|NCT02646891|11261744|FG004|STARTED|Overall Study||12
10129989|NCT02646891|11261745|FG005|STARTED|Overall Study||12
10129990|NCT02646891|11261746|FG006|STARTED|Overall Study||139
10129991|NCT02646891|11261747|FG007|STARTED|Overall Study||140
10129992|NCT02646891|11261748|FG008|STARTED|Overall Study||140
10129993|NCT02646891|11261749|FG009|STARTED|Overall Study||139
10129994|NCT02646891|11261740|FG000|Received at Least 1 Dose|Overall Study||6
10129995|NCT02646891|11261741|FG001|Received at Least 1 Dose|Overall Study||12
10129996|NCT02646891|11261742|FG002|Received at Least 1 Dose|Overall Study||12
10129997|NCT02646891|11261743|FG003|Received at Least 1 Dose|Overall Study||6
10129998|NCT02646891|11261744|FG004|Received at Least 1 Dose|Overall Study||12
10129999|NCT02646891|11261745|FG005|Received at Least 1 Dose|Overall Study||12
10130000|NCT02646891|11261746|FG006|Received at Least 1 Dose|Overall Study||139
10130001|NCT02646891|11261747|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
10130002|NCT02646891|11261748|FG008|Received at Least 1 Dose|Overall Study||140
10130003|NCT02646891|11261749|FG009|Received at Least 1 Dose|Overall Study||139
10130004|NCT02646891|11261740|FG000|COMPLETED|Overall Study||4
10130005|NCT02646891|11261741|FG001|COMPLETED|Overall Study||11
10130006|NCT02646891|11261742|FG002|COMPLETED|Overall Study||11
10130007|NCT02646891|11261743|FG003|COMPLETED|Overall Study||6
10130008|NCT02646891|11261744|FG004|COMPLETED|Overall Study||12
10130009|NCT02646891|11261745|FG005|COMPLETED|Overall Study||12
10130010|NCT02646891|11261746|FG006|COMPLETED|Overall Study||130
10130011|NCT02646891|11261747|FG007|COMPLETED|Overall Study||127
10130012|NCT02646891|11261748|FG008|COMPLETED|Overall Study||130
10130013|NCT02646891|11261749|FG009|COMPLETED|Overall Study||134
10130014|NCT02646891|11261740|FG000|NOT COMPLETED|Overall Study||2
10130015|NCT02646891|11261741|FG001|NOT COMPLETED|Overall Study||1
10130016|NCT02646891|11261742|FG002|NOT COMPLETED|Overall Study||1
10130017|NCT02646891|11261743|FG003|NOT COMPLETED|Overall Study||0
10130018|NCT02646891|11261744|FG004|NOT COMPLETED|Overall Study||0
10130019|NCT02646891|11261745|FG005|NOT COMPLETED|Overall Study||0
10130020|NCT02646891|11261746|FG006|NOT COMPLETED|Overall Study||9
10130021|NCT02646891|11261747|FG007|NOT COMPLETED|Overall Study||13
10130022|NCT02646891|11261748|FG008|NOT COMPLETED|Overall Study||10
10130023|NCT02646891|11261749|FG009|NOT COMPLETED|Overall Study||5
10130024|NCT02646917|11261785|FG000|STARTED|Overall Study||21
10130025|NCT02646917|11261786|FG001|STARTED|Overall Study||20
10130026|NCT02646917|11261785|FG000|COMPLETED|Overall Study||21
10130027|NCT02646917|11261786|FG001|COMPLETED|Overall Study||20
10130028|NCT02646917|11261785|FG000|NOT COMPLETED|Overall Study||0
10130029|NCT02646917|11261786|FG001|NOT COMPLETED|Overall Study||0
10196544|NCT03363854|11324752|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
10196545|NCT03363854|11324753|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10196546|NCT03363854|11324754|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10196547|NCT03363854|11324755|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10196548|NCT03363854|11324756|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10196549|NCT03363854|11324757|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10196550|NCT03363854|11324758|FG007|STARTED|Safety Follow-up Period||278
10196551|NCT03363854|11324751|FG000|COMPLETED|Safety Follow-up Period||0
10196552|NCT03363854|11324752|FG001|COMPLETED|Safety Follow-up Period||0
10130030|NCT02647203|11261799|FG000|STARTED|12 Month Follow-up||173
10130031|NCT02647203|11261800|FG001|STARTED|12 Month Follow-up||172
10130032|NCT02647203|11261799|FG000|COMPLETED|12 Month Follow-up||148
10130033|NCT02647203|11261800|FG001|COMPLETED|12 Month Follow-up||149
10130034|NCT02647203|11261799|FG000|NOT COMPLETED|12 Month Follow-up||25
10130035|NCT02647203|11261800|FG001|NOT COMPLETED|12 Month Follow-up||23
10130036|NCT02647203|11261799|FG000|STARTED|24 Month Follow-up||148
10130037|NCT02647203|11261800|FG001|STARTED|24 Month Follow-up||149
10130038|NCT02647203|11261799|FG000|COMPLETED|24 Month Follow-up||142
10130039|NCT02647203|11261800|FG001|COMPLETED|24 Month Follow-up||138
10130040|NCT02647203|11261799|FG000|NOT COMPLETED|24 Month Follow-up||6
10130041|NCT02647203|11261800|FG001|NOT COMPLETED|24 Month Follow-up||11
10130042|NCT02647281|11261815|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
10130043|NCT02647281|11261816|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10130044|NCT02647281|11261817|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10130045|NCT02647281|11261818|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10130046|NCT02647281|11261819|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10130047|NCT02647281|11261820|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10130048|NCT02647281|11261821|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10130049|NCT02647281|11261822|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10130050|NCT02647281|11261823|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10130051|NCT02647281|11261815|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
10130052|NCT02647281|11261816|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10130053|NCT02647281|11261817|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10130054|NCT02647281|11261818|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10130055|NCT02647281|11261819|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10130056|NCT02647281|11261820|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130057|NCT02647281|11261821|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130058|NCT02647281|11261822|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130059|NCT02647281|11261823|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130060|NCT02647281|11261815|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130061|NCT02647281|11261816|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130062|NCT02647281|11261817|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130063|NCT02647281|11261818|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130064|NCT02647281|11261819|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130065|NCT02647281|11261820|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130066|NCT02647281|11261821|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130067|NCT02647281|11261822|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130068|NCT02647281|11261823|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10130069|NCT02647281|11261815|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130070|NCT02647281|11261816|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130071|NCT02647281|11261817|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130072|NCT02647281|11261818|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130073|NCT02647281|11261819|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130074|NCT02647281|11261820|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10130075|NCT02647281|11261821|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10130076|NCT02647281|11261822|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10130077|NCT02647281|11261823|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10130078|NCT02647281|11261815|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130079|NCT02647281|11261816|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130080|NCT02647281|11261817|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130081|NCT02647281|11261818|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130082|NCT02647281|11261819|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130083|NCT02647281|11261820|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
10130084|NCT02647281|11261821|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
10130085|NCT02647281|11261822|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
10130086|NCT02647281|11261823|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
10130087|NCT02647281|11261815|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130088|NCT02647281|11261816|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130089|NCT02647281|11261817|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130090|NCT02647281|11261818|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130091|NCT02647281|11261819|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130092|NCT02647281|11261820|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130093|NCT02647281|11261821|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130094|NCT02647281|11261822|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10130095|NCT02647281|11261823|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
10130096|NCT02647320|11261857|FG000|STARTED|Overall Study||46
10130097|NCT02647320|11261858|FG001|STARTED|Overall Study||46
10130098|NCT02647320|11261859|FG002|STARTED|Overall Study||69
10130099|NCT02647320|11261860|FG003|STARTED|Overall Study||68
10130100|NCT02647320|11261861|FG004|STARTED|Overall Study||69
10130101|NCT02647320|11261857|FG000|Inadvertently Randomized|Overall Study||0
10130102|NCT02647320|11261858|FG001|Inadvertently Randomized|Overall Study||0
10130103|NCT02647320|11261859|FG002|Inadvertently Randomized|Overall Study||0
10130104|NCT02647320|11261860|FG003|Inadvertently Randomized|Overall Study||1
10130105|NCT02647320|11261861|FG004|Inadvertently Randomized|Overall Study||0
10130106|NCT02647320|11261857|FG000|Safety Set|Overall Study||43
10130107|NCT02647320|11261858|FG001|Safety Set|Overall Study||44
10130108|NCT02647320|11261859|FG002|Safety Set|Overall Study||68
10130109|NCT02647320|11261860|FG003|Safety Set|Overall Study||68
10130110|NCT02647320|11261861|FG004|Safety Set|Overall Study||69
10130111|NCT02647320|11261857|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40
10130112|NCT02647320|11261858|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38
10130113|NCT02647320|11261859|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61
10130114|NCT02647320|11261860|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62
10130115|NCT02647320|11261861|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62
10130116|NCT02647320|11261857|FG000|COMPLETED|Overall Study||34
10130117|NCT02647320|11261858|FG001|COMPLETED|Overall Study||35
10130118|NCT02647320|11261859|FG002|COMPLETED|Overall Study||54
10130119|NCT02647320|11261860|FG003|COMPLETED|Overall Study||58
10130120|NCT02647320|11261861|FG004|COMPLETED|Overall Study||52
10130121|NCT02647320|11261857|FG000|NOT COMPLETED|Overall Study||12
10130122|NCT02647320|11261858|FG001|NOT COMPLETED|Overall Study||11
10130123|NCT02647320|11261859|FG002|NOT COMPLETED|Overall Study||15
10130124|NCT02647320|11261860|FG003|NOT COMPLETED|Overall Study||10
10130125|NCT02647320|11261861|FG004|NOT COMPLETED|Overall Study||17
10130126|NCT02647346|11261875|FG000|STARTED|Overall Study||132
10130127|NCT02647346|11261875|FG000|COMPLETED|Overall Study||129
10130128|NCT02647346|11261875|FG000|NOT COMPLETED|Overall Study||3
10130129|NCT02647645|11261881|FG000|STARTED|Overall Study||11
10130130|NCT02647645|11261882|FG001|STARTED|Overall Study||10
10130131|NCT02647645|11261881|FG000|COMPLETED|Overall Study||9
10130132|NCT02647645|11261882|FG001|COMPLETED|Overall Study||9
10130133|NCT02647645|11261881|FG000|NOT COMPLETED|Overall Study||2
10130134|NCT02647645|11261882|FG001|NOT COMPLETED|Overall Study||1
10130135|NCT02647658|11261890|FG000|STARTED|Overall Study||1207
10130136|NCT02647658|11261891|FG001|STARTED|Overall Study||1093
10130137|NCT02647658|11261890|FG000|6 Month Assessment|Overall Study||658
10130138|NCT02647658|11261891|FG001|6 Month Assessment|Overall Study||635
10130139|NCT02647658|11261890|FG000|COMPLETED|Overall Study||1192
9706802|NCT01244815|10805899|FG003|Treated|Overall Study||99
9706803|NCT01244815|10805896|FG000|COMPLETED|Overall Study||87
10130140|NCT02647658|11261891|FG001|COMPLETED|Overall Study||1069
10130141|NCT02647658|11261890|FG000|NOT COMPLETED|Overall Study||15
9706804|NCT01244815|10805897|FG001|COMPLETED|Overall Study||88
10130142|NCT02647658|11261891|FG001|NOT COMPLETED|Overall Study||24
10130143|NCT02647788|11261899|FG000|STARTED|Overall Study||70
10130144|NCT02647788|11261900|FG001|STARTED|Overall Study||70
10130145|NCT02647788|11261899|FG000|COMPLETED|Overall Study||54
10130146|NCT02647788|11261900|FG001|COMPLETED|Overall Study||57
10130147|NCT02647788|11261899|FG000|NOT COMPLETED|Overall Study||16
10130148|NCT02647788|11261900|FG001|NOT COMPLETED|Overall Study||13
10130149|NCT02647866|11261911|FG000|STARTED|Overall Study||9
10130150|NCT02647866|11261912|FG001|STARTED|Overall Study||10
10130151|NCT02647866|11261913|FG002|STARTED|Overall Study||9
10130152|NCT02647866|11261914|FG003|STARTED|Overall Study||21
10130153|NCT02647866|11261915|FG004|STARTED|Overall Study||17
10130154|NCT02647866|11261911|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
10130155|NCT02647866|11261912|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
10130156|NCT02647866|11261913|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
10130157|NCT02647866|11261914|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
10130158|NCT02647866|11261915|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
10130159|NCT02647866|11261911|FG000|Completed Induction Therapy Follow-Up|Overall Study||5
10130160|NCT02647866|11261912|FG001|Completed Induction Therapy Follow-Up|Overall Study||1
10130161|NCT02647866|11261913|FG002|Completed Induction Therapy Follow-Up|Overall Study||2
10130162|NCT02647866|11261914|FG003|Completed Induction Therapy Follow-Up|Overall Study||0
10130163|NCT02647866|11261915|FG004|Completed Induction Therapy Follow-Up|Overall Study||2
10130164|NCT02647866|11261911|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
10130165|NCT02647866|11261912|FG001|Completed Long-Term Extension Therapy|Overall Study||0
10130166|NCT02647866|11261913|FG002|Completed Long-Term Extension Therapy|Overall Study||0
10130167|NCT02647866|11261914|FG003|Completed Long-Term Extension Therapy|Overall Study||0
10130168|NCT02647866|11261915|FG004|Completed Long-Term Extension Therapy|Overall Study||0
10130169|NCT02647866|11261911|FG000|Completed LTE Follow-up|Overall Study||2
10130170|NCT02647866|11261912|FG001|Completed LTE Follow-up|Overall Study||0
10130171|NCT02647866|11261913|FG002|Completed LTE Follow-up|Overall Study||0
10130172|NCT02647866|11261914|FG003|Completed LTE Follow-up|Overall Study||0
10130173|NCT02647866|11261915|FG004|Completed LTE Follow-up|Overall Study||0
10130174|NCT02647866|11261911|FG000|Completed Open-Label Extension Therapy|Overall Study||0
10130175|NCT02647866|11261912|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
10130176|NCT02647866|11261913|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
10130177|NCT02647866|11261914|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
10130178|NCT02647866|11261915|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
10130179|NCT02647866|11261911|FG000|Completed OLE Follow-up|Overall Study||0
10130180|NCT02647866|11261912|FG001|Completed OLE Follow-up|Overall Study||6
10130181|NCT02647866|11261913|FG002|Completed OLE Follow-up|Overall Study||4
10130182|NCT02647866|11261914|FG003|Completed OLE Follow-up|Overall Study||14
10130183|NCT02647866|11261915|FG004|Completed OLE Follow-up|Overall Study||10
10130184|NCT02647866|11261911|FG000|Moved From LTE to OLE Therapy|Overall Study||0
10130185|NCT02647866|11261912|FG001|Moved From LTE to OLE Therapy|Overall Study||5
10130186|NCT02647866|11261913|FG002|Moved From LTE to OLE Therapy|Overall Study||0
10130187|NCT02647866|11261914|FG003|Moved From LTE to OLE Therapy|Overall Study||0
10130188|NCT02647866|11261915|FG004|Moved From LTE to OLE Therapy|Overall Study||2
10130189|NCT02647866|11261911|FG000|Discontinued the Treatment|Overall Study||4
10130190|NCT02647866|11261912|FG001|Discontinued the Treatment|Overall Study||5
10130191|NCT02647866|11261913|FG002|Discontinued the Treatment|Overall Study||5
10130192|NCT02647866|11261914|FG003|Discontinued the Treatment|Overall Study||5
10130193|NCT02647866|11261915|FG004|Discontinued the Treatment|Overall Study||8
10130194|NCT02647866|11261911|FG000|Discontinued the Study|Overall Study||5
10130195|NCT02647866|11261912|FG001|Discontinued the Study|Overall Study||4
10130196|NCT02647866|11261913|FG002|Discontinued the Study|Overall Study||5
10130197|NCT02647866|11261914|FG003|Discontinued the Study|Overall Study||6
10130198|NCT02647866|11261915|FG004|Discontinued the Study|Overall Study||8
10130199|NCT02647866|11261911|FG000|COMPLETED|Overall Study||4
10130200|NCT02647866|11261912|FG001|COMPLETED|Overall Study||6
9706805|NCT01244815|10805898|FG002|COMPLETED|Overall Study||88
9706806|NCT01244815|10805899|FG003|COMPLETED|Overall Study||87
9706807|NCT01244815|10805896|FG000|NOT COMPLETED|Overall Study||14
9706808|NCT01244815|10805897|FG001|NOT COMPLETED|Overall Study||17
9706809|NCT01244815|10805898|FG002|NOT COMPLETED|Overall Study||11
9706810|NCT01244815|10805899|FG003|NOT COMPLETED|Overall Study||12
10130201|NCT02647866|11261913|FG002|COMPLETED|Overall Study||4
10130202|NCT02647866|11261914|FG003|COMPLETED|Overall Study||15
10130203|NCT02647866|11261915|FG004|COMPLETED|Overall Study||9
10130204|NCT02647866|11261911|FG000|NOT COMPLETED|Overall Study||5
10130205|NCT02647866|11261912|FG001|NOT COMPLETED|Overall Study||4
10130206|NCT02647866|11261913|FG002|NOT COMPLETED|Overall Study||5
10130207|NCT02647866|11261914|FG003|NOT COMPLETED|Overall Study||6
10130208|NCT02647866|11261915|FG004|NOT COMPLETED|Overall Study||8
10130209|NCT02647905|11261935|FG000|STARTED|Overall Study||90
10130210|NCT02647905|11261935|FG000|COMPLETED|Overall Study||87
10130211|NCT02647905|11261935|FG000|NOT COMPLETED|Overall Study||3
10130212|NCT02647944|11261941|FG000|STARTED|Overall Study||19
10130213|NCT02647944|11261942|FG001|STARTED|Overall Study||21
10130214|NCT02647944|11261941|FG000|COMPLETED|Overall Study||17
10130215|NCT02647944|11261942|FG001|COMPLETED|Overall Study||18
10130216|NCT02647944|11261941|FG000|NOT COMPLETED|Overall Study||2
10130217|NCT02647944|11261942|FG001|NOT COMPLETED|Overall Study||3
10130218|NCT02648022|11261950|FG000|STARTED|Overall Study||40
10130219|NCT02648022|11261951|FG001|STARTED|Overall Study||39
10130220|NCT02648022|11261950|FG000|COMPLETED|Overall Study||40
10130221|NCT02648022|11261951|FG001|COMPLETED|Overall Study||39
10130222|NCT02648022|11261950|FG000|NOT COMPLETED|Overall Study||0
10130223|NCT02648022|11261951|FG001|NOT COMPLETED|Overall Study||0
10130224|NCT02648178|11261957|FG000|STARTED|Overall Study||19
10130225|NCT02648178|11261957|FG000|COMPLETED|Overall Study||10
10130226|NCT02648178|11261957|FG000|NOT COMPLETED|Overall Study||9
10130227|NCT02648204|11261965|FG000|STARTED|Overall Study||301
10130228|NCT02648204|11261966|FG001|STARTED|Overall Study||300
10130229|NCT02648204|11261967|FG002|STARTED|Overall Study||300
10130230|NCT02648204|11261968|FG003|STARTED|Overall Study||300
10130231|NCT02648204|11261965|FG000|Exposed|Overall Study||301
10130232|NCT02648204|11261966|FG001|Exposed|Overall Study||300
10130233|NCT02648204|11261967|FG002|Exposed|Overall Study||299
10130234|NCT02648204|11261968|FG003|Exposed|Overall Study||299
10130235|NCT02648204|11261965|FG000|COMPLETED|Overall Study||279
10130236|NCT02648204|11261966|FG001|COMPLETED|Overall Study||279
10130237|NCT02648204|11261967|FG002|COMPLETED|Overall Study||287
10130238|NCT02648204|11261968|FG003|COMPLETED|Overall Study||284
10130239|NCT02648204|11261965|FG000|NOT COMPLETED|Overall Study||22
10130240|NCT02648204|11261966|FG001|NOT COMPLETED|Overall Study||21
10130241|NCT02648204|11261967|FG002|NOT COMPLETED|Overall Study||13
10130242|NCT02648204|11261968|FG003|NOT COMPLETED|Overall Study||16
10130243|NCT02648217|11261980|FG000|STARTED|Overall Study||131
10130244|NCT02648217|11261981|FG001|STARTED|Overall Study||132
10130245|NCT02648217|11261980|FG000|Exposed|Overall Study||130
10130246|NCT02648217|11261981|FG001|Exposed|Overall Study||132
10130247|NCT02648217|11261980|FG000|COMPLETED|Overall Study||121
10130248|NCT02648217|11261981|FG001|COMPLETED|Overall Study||127
10130249|NCT02648217|11261980|FG000|NOT COMPLETED|Overall Study||10
10130250|NCT02648217|11261981|FG001|NOT COMPLETED|Overall Study||5
10130251|NCT02648230|11261987|FG000|STARTED|Overall Study||74
10130252|NCT02648230|11261987|FG000|COMPLETED|Overall Study||74
10130253|NCT02648230|11261987|FG000|NOT COMPLETED|Overall Study||0
10130254|NCT02648438|11261994|FG000|STARTED|Overall Study||12
10130255|NCT02648438|11261995|FG001|STARTED|Overall Study||12
10130256|NCT02648438|11261996|FG002|STARTED|Overall Study||6
10130257|NCT02648438|11261994|FG000|COMPLETED|Overall Study||9
10130258|NCT02648438|11261995|FG001|COMPLETED|Overall Study||9
10130259|NCT02648438|11261996|FG002|COMPLETED|Overall Study||6
10130260|NCT02648438|11261994|FG000|NOT COMPLETED|Overall Study||3
10130261|NCT02648438|11261995|FG001|NOT COMPLETED|Overall Study||3
10130262|NCT02648438|11261996|FG002|NOT COMPLETED|Overall Study||0
10130263|NCT02648646|11262012|FG000|STARTED|Overall Study||10
10130264|NCT02648646|11262012|FG000|COMPLETED|Overall Study||8
10130265|NCT02648646|11262012|FG000|NOT COMPLETED|Overall Study||2
10130266|NCT02648880|11262016|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3
10130267|NCT02648880|11262016|FG000|COMPLETED|Overall Study||3
10130268|NCT02648880|11262016|FG000|NOT COMPLETED|Overall Study||0
10130269|NCT02648919|11262020|FG000|STARTED|Overall Study||6
10130270|NCT02648919|11262020|FG000|COMPLETED|Overall Study||6
10130271|NCT02648919|11262020|FG000|NOT COMPLETED|Overall Study||0
10130272|NCT02648932|11262027|FG000|STARTED|Overall Study||5
10130273|NCT02648932|11262028|FG001|STARTED|Overall Study||4
10130274|NCT02648932|11262027|FG000|COMPLETED|Overall Study||2
10130275|NCT02648932|11262028|FG001|COMPLETED|Overall Study||3
10130276|NCT02648932|11262027|FG000|NOT COMPLETED|Overall Study||3
10130277|NCT02648932|11262028|FG001|NOT COMPLETED|Overall Study||1
10130278|NCT02648971|11262036|FG000|STARTED|Overall Study||18
10130279|NCT02648971|11262037|FG001|STARTED|Overall Study||18
10130280|NCT02648971|11262036|FG000|COMPLETED|Overall Study||18
10130281|NCT02648971|11262037|FG001|COMPLETED|Overall Study||18
10130282|NCT02648971|11262036|FG000|NOT COMPLETED|Overall Study||0
10130283|NCT02648971|11262037|FG001|NOT COMPLETED|Overall Study||0
10130284|NCT02649192|11262049|FG000|STARTED|Overall Study||5
10130285|NCT02649192|11262050|FG001|STARTED|Overall Study||4
10130286|NCT02649192|11262051|FG002|STARTED|Overall Study||22
10130287|NCT02649192|11262052|FG003|STARTED|Overall Study||22
10130288|NCT02649192|11262053|FG004|STARTED|Overall Study||12
10130289|NCT02649192|11262054|FG005|STARTED|Overall Study||14
10130290|NCT02649192|11262049|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
10130291|NCT02649192|11262050|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
10130292|NCT02649192|11262051|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
10130293|NCT02649192|11262052|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
10130294|NCT02649192|11262053|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
10130295|NCT02649192|11262054|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
10130296|NCT02649192|11262049|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
10130297|NCT02649192|11262050|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
10130298|NCT02649192|11262051|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
10130299|NCT02649192|11262052|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
10130300|NCT02649192|11262053|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
10130301|NCT02649192|11262054|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
10130302|NCT02649192|11262049|FG000|COMPLETED|Overall Study||5
10130303|NCT02649192|11262050|FG001|COMPLETED|Overall Study||4
10130304|NCT02649192|11262051|FG002|COMPLETED|Overall Study||21
10130305|NCT02649192|11262052|FG003|COMPLETED|Overall Study||20
10130306|NCT02649192|11262053|FG004|COMPLETED|Overall Study||11
10130307|NCT02649192|11262054|FG005|COMPLETED|Overall Study||14
10130308|NCT02649192|11262049|FG000|NOT COMPLETED|Overall Study||0
10130309|NCT02649192|11262050|FG001|NOT COMPLETED|Overall Study||0
10130310|NCT02649192|11262051|FG002|NOT COMPLETED|Overall Study||1
10130311|NCT02649192|11262052|FG003|NOT COMPLETED|Overall Study||2
10130312|NCT02649192|11262053|FG004|NOT COMPLETED|Overall Study||1
10130313|NCT02649192|11262054|FG005|NOT COMPLETED|Overall Study||0
10130314|NCT02649218|11262081|FG000|STARTED|Overall Study||226
10130315|NCT02649218|11262081|FG000|COMPLETED|Overall Study||201
10130316|NCT02649218|11262081|FG000|NOT COMPLETED|Overall Study||25
10130317|NCT02649231|11262090|FG000|STARTED|Overall Study||24
10130318|NCT02649231|11262091|FG001|STARTED|Overall Study||24
10130319|NCT02649231|11262092|FG002|STARTED|Overall Study||23
10130320|NCT02649231|11262093|FG003|STARTED|Overall Study||25
10130321|NCT02649231|11262090|FG000|COMPLETED|Overall Study||20
10130322|NCT02649231|11262091|FG001|COMPLETED|Overall Study||21
10130323|NCT02649231|11262092|FG002|COMPLETED|Overall Study||21
10130324|NCT02649231|11262093|FG003|COMPLETED|Overall Study||23
10130325|NCT02649231|11262090|FG000|NOT COMPLETED|Overall Study||4
10130326|NCT02649231|11262091|FG001|NOT COMPLETED|Overall Study||3
10130327|NCT02649231|11262092|FG002|NOT COMPLETED|Overall Study||2
10130328|NCT02649231|11262093|FG003|NOT COMPLETED|Overall Study||2
10130329|NCT02649322|11262105|FG000|STARTED|Overall Study||58
10130330|NCT02649322|11262106|FG001|STARTED|Overall Study||57
10130331|NCT02649322|11262105|FG000|COMPLETED|Overall Study||58
10130332|NCT02649322|11262106|FG001|COMPLETED|Overall Study||57
10130333|NCT02649322|11262105|FG000|NOT COMPLETED|Overall Study||0
10130334|NCT02649322|11262106|FG001|NOT COMPLETED|Overall Study||0
10130335|NCT02649556|11262116|FG000|STARTED|Overall Study||230
10130336|NCT02649556|11262117|FG001|STARTED|Overall Study||424
10130337|NCT02649556|11262118|FG002|STARTED|Overall Study||152
10130338|NCT02649556|11262119|FG003|STARTED|Overall Study||51
10130339|NCT02649556|11262116|FG000|COMPLETED|Overall Study||167
10130340|NCT02649556|11262117|FG001|COMPLETED|Overall Study||312
10130341|NCT02649556|11262118|FG002|COMPLETED|Overall Study||102
10130342|NCT02649556|11262119|FG003|COMPLETED|Overall Study||28
10130343|NCT02649556|11262116|FG000|NOT COMPLETED|Overall Study||63
10130344|NCT02649556|11262117|FG001|NOT COMPLETED|Overall Study||112
10130345|NCT02649556|11262118|FG002|NOT COMPLETED|Overall Study||50
10130346|NCT02649556|11262119|FG003|NOT COMPLETED|Overall Study||23
10130347|NCT02649608|11262129|FG000|STARTED|Overall Study||2
10130348|NCT02649608|11262130|FG001|STARTED|Overall Study||1
10130349|NCT02649608|11262131|FG002|STARTED|Overall Study||3
10130350|NCT02649608|11262132|FG003|STARTED|Overall Study||3
10130351|NCT02649608|11262133|FG004|STARTED|Overall Study||3
10130352|NCT02649608|11262134|FG005|STARTED|Overall Study||2
10130353|NCT02649608|11262135|FG006|STARTED|Overall Study||1
10130354|NCT02649608|11262129|FG000|COMPLETED|Overall Study||2
10130355|NCT02649608|11262130|FG001|COMPLETED|Overall Study||1
10130356|NCT02649608|11262131|FG002|COMPLETED|Overall Study||3
10130357|NCT02649608|11262132|FG003|COMPLETED|Overall Study||3
10130358|NCT02649608|11262133|FG004|COMPLETED|Overall Study||3
10130359|NCT02649608|11262134|FG005|COMPLETED|Overall Study||2
10130360|NCT02649608|11262135|FG006|COMPLETED|Overall Study||1
10130361|NCT02649608|11262129|FG000|NOT COMPLETED|Overall Study||0
10130362|NCT02649608|11262130|FG001|NOT COMPLETED|Overall Study||0
10130363|NCT02649608|11262131|FG002|NOT COMPLETED|Overall Study||0
10130364|NCT02649608|11262132|FG003|NOT COMPLETED|Overall Study||0
10130365|NCT02649608|11262133|FG004|NOT COMPLETED|Overall Study||0
10130366|NCT02649608|11262134|FG005|NOT COMPLETED|Overall Study||0
10130367|NCT02649608|11262135|FG006|NOT COMPLETED|Overall Study||0
10130368|NCT02649634|11262166|FG000|STARTED|Overall Study||69
10130369|NCT02649634|11262167|FG001|STARTED|Overall Study||66
10130370|NCT02649634|11262166|FG000|COMPLETED|Overall Study||66
10130371|NCT02649634|11262167|FG001|COMPLETED|Overall Study||60
10130372|NCT02649634|11262166|FG000|NOT COMPLETED|Overall Study||3
10130373|NCT02649634|11262167|FG001|NOT COMPLETED|Overall Study||6
10130374|NCT02649842|11262173|FG000|STARTED|Overall Study||101
10130375|NCT02649842|11262173|FG000|COMPLETED|Overall Study||101
10130376|NCT02649842|11262173|FG000|NOT COMPLETED|Overall Study||0
10130377|NCT02649894|11262181|FG000|STARTED|Overall Study||81
10130378|NCT02649894|11262182|FG001|STARTED|Overall Study||38
10130379|NCT02649894|11262181|FG000|Device Inserted|Overall Study||77
10130380|NCT02649894|11262182|FG001|Device Inserted|Overall Study||37
10130381|NCT02649894|11262181|FG000|Completed Day 30|Overall Study||56
10130382|NCT02649894|11262182|FG001|Completed Day 30|Overall Study||35
10130383|NCT02649894|11262181|FG000|COMPLETED|Overall Study||37
9706811|NCT01142596|10805911|FG000|STARTED|Overall Study||44
9706812|NCT01142596|10805912|FG001|STARTED|Overall Study||157
9706813|NCT01142596|10805911|FG000|COMPLETED|Overall Study||15
9706814|NCT01142596|10805912|FG001|COMPLETED|Overall Study||71
9706815|NCT01142596|10805911|FG000|NOT COMPLETED|Overall Study||29
9706816|NCT01142596|10805912|FG001|NOT COMPLETED|Overall Study||86
9706817|NCT01098110|10805921|FG000|STARTED|Overall Study|Randomized participants|176
9706818|NCT01098110|10805922|FG001|STARTED|Overall Study|Randomized participants|182
9706819|NCT01098110|10805923|FG002|STARTED|Overall Study|Randomized participants|174
9706820|NCT01098110|10805921|FG000|Treated|Overall Study|Received at least one dose of trial medication|175
9706821|NCT01098110|10805922|FG001|Treated|Overall Study|Received at least one dose of trial medication|181
9706822|NCT01098110|10805923|FG002|Treated|Overall Study|Received at least one dose of trial medication|174
9706823|NCT01098110|10805921|FG000|COMPLETED|Overall Study||114
9706824|NCT01098110|10805922|FG001|COMPLETED|Overall Study||109
9706825|NCT01098110|10805923|FG002|COMPLETED|Overall Study||80
9706826|NCT01098110|10805921|FG000|NOT COMPLETED|Overall Study||62
9706827|NCT01098110|10805922|FG001|NOT COMPLETED|Overall Study||73
9706828|NCT01098110|10805923|FG002|NOT COMPLETED|Overall Study||94
9706829|NCT01006265|10805935|FG000|STARTED|Overall Study||119
9706830|NCT01006265|10805936|FG001|STARTED|Overall Study||116
9706831|NCT01006265|10805937|FG002|STARTED|Overall Study||108
9706832|NCT01006265|10805938|FG003|STARTED|Overall Study||121
9706833|NCT01006265|10805935|FG000|Treated|Overall Study||119
9706834|NCT01006265|10805936|FG001|Treated|Overall Study||114
9706835|NCT01006265|10805937|FG002|Treated|Overall Study||108
9706836|NCT01006265|10805938|FG003|Treated|Overall Study||121
9706837|NCT01006265|10805935|FG000|COMPLETED|Overall Study||113
9706838|NCT01006265|10805936|FG001|COMPLETED|Overall Study||107
9706839|NCT01006265|10805937|FG002|COMPLETED|Overall Study||99
9706840|NCT01006265|10805938|FG003|COMPLETED|Overall Study||116
9706841|NCT01006265|10805935|FG000|NOT COMPLETED|Overall Study||6
9706842|NCT01006265|10805936|FG001|NOT COMPLETED|Overall Study||9
9706843|NCT01006265|10805937|FG002|NOT COMPLETED|Overall Study||9
9706844|NCT01006265|10805938|FG003|NOT COMPLETED|Overall Study||5
10130384|NCT02649894|11262182|FG001|COMPLETED|Overall Study||27
9706845|NCT00591227|10805950|FG000|STARTED|Overall Study||89
9706846|NCT00591227|10805951|FG001|STARTED|Overall Study||87
9706847|NCT00591227|10805950|FG000|COMPLETED|Overall Study||89
9706848|NCT00591227|10805951|FG001|COMPLETED|Overall Study||87
9706849|NCT00591227|10805950|FG000|NOT COMPLETED|Overall Study||0
9706850|NCT00591227|10805951|FG001|NOT COMPLETED|Overall Study||0
9706851|NCT00534976|10805960|FG000|STARTED|Period 1: Placebo Run-in||33
9706852|NCT00534976|10805961|FG001|STARTED|Period 1: Placebo Run-in||33
9706853|NCT00534976|10805960|FG000|COMPLETED|Period 1: Placebo Run-in||33
9706854|NCT00534976|10805961|FG001|COMPLETED|Period 1: Placebo Run-in||33
9706855|NCT00534976|10805960|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
10130385|NCT02649894|11262181|FG000|NOT COMPLETED|Overall Study||44
10130386|NCT02649894|11262182|FG001|NOT COMPLETED|Overall Study||11
10130387|NCT02650128|11262188|FG000|STARTED|Overall Study||60
10130388|NCT02650128|11262188|FG000|30 Day Primary and Safety Endpoint|Overall Study||60
10130389|NCT02650128|11262188|FG000|COMPLETED|Overall Study||58
10130390|NCT02650128|11262188|FG000|NOT COMPLETED|Overall Study||2
10130391|NCT02650193|11262196|FG000|STARTED|Overall Study||6
10130392|NCT02650193|11262197|FG001|STARTED|Overall Study||6
10130393|NCT02650193|11262198|FG002|STARTED|Overall Study||13
10130394|NCT02650193|11262196|FG000|COMPLETED|Overall Study||6
10130395|NCT02650193|11262197|FG001|COMPLETED|Overall Study||6
10130396|NCT02650193|11262198|FG002|COMPLETED|Overall Study||13
10130397|NCT02650193|11262196|FG000|NOT COMPLETED|Overall Study||0
10130398|NCT02650193|11262197|FG001|NOT COMPLETED|Overall Study||0
10130399|NCT02650193|11262198|FG002|NOT COMPLETED|Overall Study||0
10130400|NCT02650219|11262209|FG000|STARTED|Overall Study||40
10130401|NCT02650219|11262210|FG001|STARTED|Overall Study||20
10130402|NCT02650219|11262209|FG000|COMPLETED|Overall Study||40
10130403|NCT02650219|11262210|FG001|COMPLETED|Overall Study||20
10130404|NCT02650219|11262209|FG000|NOT COMPLETED|Overall Study||0
10130405|NCT02650219|11262210|FG001|NOT COMPLETED|Overall Study||0
10130406|NCT02650440|11262218|FG000|STARTED|Overall Study||10
10130407|NCT02650440|11262219|FG001|STARTED|Overall Study||10
10130408|NCT02650440|11262218|FG000|COMPLETED|Overall Study||10
10130409|NCT02650440|11262219|FG001|COMPLETED|Overall Study||8
10130410|NCT02650440|11262218|FG000|NOT COMPLETED|Overall Study||0
10130411|NCT02650440|11262219|FG001|NOT COMPLETED|Overall Study||2
10130412|NCT02650466|11262225|FG000|STARTED|Overall Study||24
10130413|NCT02650466|11262225|FG000|COMPLETED|Overall Study||17
10130414|NCT02650466|11262225|FG000|NOT COMPLETED|Overall Study||7
10130415|NCT02650856|11262233|FG000|STARTED|Overall Study||19
10130416|NCT02650856|11262234|FG001|STARTED|Overall Study||21
10130417|NCT02650856|11262233|FG000|Baseline|Overall Study||19
10130418|NCT02650856|11262234|FG001|Baseline|Overall Study||21
10130419|NCT02650856|11262233|FG000|24 Hours|Overall Study||19
10130420|NCT02650856|11262234|FG001|24 Hours|Overall Study||21
10130421|NCT02650856|11262233|FG000|48 Hours|Overall Study||19
10130422|NCT02650856|11262234|FG001|48 Hours|Overall Study||21
10130423|NCT02650856|11262233|FG000|72 Hours|Overall Study||19
10130424|NCT02650856|11262234|FG001|72 Hours|Overall Study||21
10130425|NCT02650856|11262233|FG000|COMPLETED|Overall Study||19
10130426|NCT02650856|11262234|FG001|COMPLETED|Overall Study||21
10130427|NCT02650856|11262233|FG000|NOT COMPLETED|Overall Study||0
10130428|NCT02650856|11262234|FG001|NOT COMPLETED|Overall Study||0
10130429|NCT02650895|11262246|FG000|STARTED|Overall Study||10
10130430|NCT02650895|11262247|FG001|STARTED|Overall Study||6
10130431|NCT02650895|11262248|FG002|STARTED|Overall Study||6
10130432|NCT02650895|11262249|FG003|STARTED|Overall Study||6
10130433|NCT02650895|11262250|FG004|STARTED|Overall Study||6
10130434|NCT02650895|11262251|FG005|STARTED|Overall Study||6
10130435|NCT02650895|11262246|FG000|COMPLETED|Overall Study||10
10130436|NCT02650895|11262247|FG001|COMPLETED|Overall Study||5
10130437|NCT02650895|11262248|FG002|COMPLETED|Overall Study||6
10130438|NCT02650895|11262249|FG003|COMPLETED|Overall Study||6
10130439|NCT02650895|11262250|FG004|COMPLETED|Overall Study||6
10130440|NCT02650895|11262251|FG005|COMPLETED|Overall Study||6
10130441|NCT02650895|11262246|FG000|NOT COMPLETED|Overall Study||0
10130442|NCT02650895|11262247|FG001|NOT COMPLETED|Overall Study||1
10130443|NCT02650895|11262248|FG002|NOT COMPLETED|Overall Study||0
10130444|NCT02650895|11262249|FG003|NOT COMPLETED|Overall Study||0
10130445|NCT02650895|11262250|FG004|NOT COMPLETED|Overall Study||0
10130446|NCT02650895|11262251|FG005|NOT COMPLETED|Overall Study||0
10130447|NCT02650921|11262270|FG000|STARTED|Overall Study||92
10130448|NCT02650921|11262270|FG000|COMPLETED|Overall Study||84
10130449|NCT02650921|11262270|FG000|NOT COMPLETED|Overall Study||8
10196553|NCT03363854|11324753|FG002|COMPLETED|Safety Follow-up Period||0
10196554|NCT03363854|11324754|FG003|COMPLETED|Safety Follow-up Period||0
10196555|NCT03363854|11324755|FG004|COMPLETED|Safety Follow-up Period||0
10196556|NCT03363854|11324756|FG005|COMPLETED|Safety Follow-up Period||0
10196557|NCT03363854|11324757|FG006|COMPLETED|Safety Follow-up Period||0
10196558|NCT03363854|11324758|FG007|COMPLETED|Safety Follow-up Period||62
10196559|NCT03363854|11324751|FG000|NOT COMPLETED|Safety Follow-up Period||0
10196560|NCT03363854|11324752|FG001|NOT COMPLETED|Safety Follow-up Period||0
10196561|NCT03363854|11324753|FG002|NOT COMPLETED|Safety Follow-up Period||0
10196562|NCT03363854|11324754|FG003|NOT COMPLETED|Safety Follow-up Period||0
10196563|NCT03363854|11324755|FG004|NOT COMPLETED|Safety Follow-up Period||0
10196564|NCT03363854|11324756|FG005|NOT COMPLETED|Safety Follow-up Period||0
10196565|NCT03363854|11324757|FG006|NOT COMPLETED|Safety Follow-up Period||0
10196566|NCT03363854|11324758|FG007|NOT COMPLETED|Safety Follow-up Period||216
10196567|NCT03363906|11324781|FG000|STARTED|Period 1 (Reference or Test)||15
10196568|NCT03363906|11324782|FG001|STARTED|Period 1 (Reference or Test)||12
10196569|NCT03363906|11324781|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
10196570|NCT03363906|11324782|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
10130450|NCT02650999|11262276|FG000|STARTED|Overall Study||12
10130451|NCT02650999|11262276|FG000|COMPLETED|Overall Study||12
10130452|NCT02650999|11262276|FG000|NOT COMPLETED|Overall Study||0
10130453|NCT02651103|11262280|FG000|STARTED|Overall Study||30
10130454|NCT02651103|11262280|FG000|COMPLETED|Overall Study||30
10130455|NCT02651103|11262280|FG000|NOT COMPLETED|Overall Study||0
10130456|NCT02651116|11262286|FG000|STARTED|Overall Study||68
10130457|NCT02651116|11262287|FG001|STARTED|Overall Study||63
10130458|NCT02651116|11262286|FG000|Treated|Overall Study||68
10130459|NCT02651116|11262287|FG001|Treated|Overall Study||63
10130460|NCT02651116|11262286|FG000|COMPLETED|Overall Study||67
10130461|NCT02651116|11262287|FG001|COMPLETED|Overall Study||62
10130462|NCT02651116|11262286|FG000|NOT COMPLETED|Overall Study||1
10130463|NCT02651116|11262287|FG001|NOT COMPLETED|Overall Study||1
10130464|NCT02651155|11262295|FG000|STARTED|Overall Study||99
10130465|NCT02651155|11262296|FG001|STARTED|Overall Study||105
10130466|NCT02651155|11262295|FG000|COMPLETED|Overall Study||93
10130467|NCT02651155|11262296|FG001|COMPLETED|Overall Study||103
10130468|NCT02651155|11262295|FG000|NOT COMPLETED|Overall Study||6
10130469|NCT02651155|11262296|FG001|NOT COMPLETED|Overall Study||2
10130470|NCT02651194|11262302|FG000|STARTED|Overall Study||104
10130471|NCT02651194|11262302|FG000|COMPLETED|Overall Study||99
10130472|NCT02651194|11262302|FG000|NOT COMPLETED|Overall Study||5
10130473|NCT02651220|11262309|FG000|STARTED|Overall Study||337
10130474|NCT02651220|11262310|FG001|STARTED|Overall Study||335
10130475|NCT02651220|11262311|FG002|STARTED|Overall Study||329
10130476|NCT02651220|11262309|FG000|COMPLETED|Overall Study||314
10130477|NCT02651220|11262310|FG001|COMPLETED|Overall Study||308
10130478|NCT02651220|11262311|FG002|COMPLETED|Overall Study||300
10130479|NCT02651220|11262309|FG000|NOT COMPLETED|Overall Study||23
10130480|NCT02651220|11262310|FG001|NOT COMPLETED|Overall Study||27
10130481|NCT02651220|11262311|FG002|NOT COMPLETED|Overall Study||29
10130482|NCT02651259|11262321|FG000|STARTED|Overall Study||25
10130483|NCT02651259|11262322|FG001|STARTED|Overall Study||25
10130484|NCT02651259|11262321|FG000|COMPLETED|Overall Study||25
10130485|NCT02651259|11262322|FG001|COMPLETED|Overall Study||25
10130486|NCT02651259|11262321|FG000|NOT COMPLETED|Overall Study||0
10130487|NCT02651259|11262322|FG001|NOT COMPLETED|Overall Study||0
10130488|NCT02651272|11262336|FG000|STARTED|Overall Study||4
10130489|NCT02651272|11262336|FG000|COMPLETED|Overall Study||1
10130490|NCT02651272|11262336|FG000|NOT COMPLETED|Overall Study||3
10130491|NCT02651337|11262340|FG000|STARTED|Overall Study||5
10130492|NCT02651337|11262340|FG000|COMPLETED|Overall Study||4
10130493|NCT02651337|11262340|FG000|NOT COMPLETED|Overall Study||1
10130494|NCT02651415|11262344|FG000|STARTED|Overall Study|12 patients were enrolled.|12
10130495|NCT02651415|11262344|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10
10130496|NCT02651415|11262344|FG000|NOT COMPLETED|Overall Study||2
10130497|NCT02651428|11262350|FG000|STARTED|Overall Study||403
10130498|NCT02651428|11262351|FG001|STARTED|Overall Study||403
10130499|NCT02651428|11262350|FG000|COMPLETED|Overall Study||359
10130500|NCT02651428|11262351|FG001|COMPLETED|Overall Study||359
10130501|NCT02651428|11262350|FG000|NOT COMPLETED|Overall Study||44
10130502|NCT02651428|11262351|FG001|NOT COMPLETED|Overall Study||44
10130503|NCT02651467|11262360|FG000|STARTED|Overall Study||74
10130504|NCT02651467|11262361|FG001|STARTED|Overall Study||74
10130505|NCT02651467|11262362|FG002|STARTED|Overall Study||73
10130506|NCT02651467|11262360|FG000|COMPLETED|Overall Study||73
10130507|NCT02651467|11262361|FG001|COMPLETED|Overall Study||74
10130508|NCT02651467|11262362|FG002|COMPLETED|Overall Study||69
10130509|NCT02651467|11262360|FG000|NOT COMPLETED|Overall Study||1
10130510|NCT02651467|11262361|FG001|NOT COMPLETED|Overall Study||0
10130511|NCT02651467|11262362|FG002|NOT COMPLETED|Overall Study||4
10130512|NCT02651545|11262373|FG000|STARTED|Overall Study||30
10130513|NCT02651545|11262374|FG001|STARTED|Overall Study||30
10130514|NCT02651545|11262373|FG000|COMPLETED|Overall Study||7
10130515|NCT02651545|11262374|FG001|COMPLETED|Overall Study||17
10130516|NCT02651545|11262373|FG000|NOT COMPLETED|Overall Study||23
10130517|NCT02651545|11262374|FG001|NOT COMPLETED|Overall Study||13
10130518|NCT02651584|11262382|FG000|STARTED|Overall Study||215
10130519|NCT02651584|11262383|FG001|STARTED|Overall Study||213
10130520|NCT02651584|11262382|FG000|COMPLETED|Overall Study||126
10130521|NCT02651584|11262383|FG001|COMPLETED|Overall Study||121
10130522|NCT02651584|11262382|FG000|NOT COMPLETED|Overall Study||89
10130523|NCT02651584|11262383|FG001|NOT COMPLETED|Overall Study||92
10130524|NCT02651688|11262395|FG000|STARTED|Overall Study||18
10130525|NCT02651688|11262396|FG001|STARTED|Overall Study||17
10130526|NCT02651688|11262397|FG002|STARTED|Overall Study||15
10130527|NCT02651688|11262395|FG000|COMPLETED|Overall Study||16
10130528|NCT02651688|11262396|FG001|COMPLETED|Overall Study||12
10130529|NCT02651688|11262397|FG002|COMPLETED|Overall Study||12
10130530|NCT02651688|11262395|FG000|NOT COMPLETED|Overall Study||2
10130531|NCT02651688|11262396|FG001|NOT COMPLETED|Overall Study||5
10130532|NCT02651688|11262397|FG002|NOT COMPLETED|Overall Study||3
10130533|NCT02651922|11262405|FG000|STARTED|Overall Study||156
10130534|NCT02651922|11262405|FG000|COMPLETED|Overall Study||154
10130535|NCT02651922|11262405|FG000|NOT COMPLETED|Overall Study||2
10130536|NCT02651987|11262411|FG000|STARTED|Overall Study||48
10130537|NCT02651987|11262412|FG001|STARTED|Overall Study||51
10130538|NCT02651987|11262411|FG000|COMPLETED|Overall Study||43
10130539|NCT02651987|11262412|FG001|COMPLETED|Overall Study||46
10130540|NCT02651987|11262411|FG000|NOT COMPLETED|Overall Study||5
10130541|NCT02651987|11262412|FG001|NOT COMPLETED|Overall Study||5
10130542|NCT02652156|11262424|FG000|STARTED|Overall Study||4
10130543|NCT02652156|11262425|FG001|STARTED|Overall Study||6
10130544|NCT02652156|11262426|FG002|STARTED|Overall Study||4
10130545|NCT02652156|11262424|FG000|COMPLETED|Overall Study||3
10130546|NCT02652156|11262425|FG001|COMPLETED|Overall Study||6
10130547|NCT02652156|11262426|FG002|COMPLETED|Overall Study||4
10130548|NCT02652156|11262424|FG000|NOT COMPLETED|Overall Study||1
10130549|NCT02652156|11262425|FG001|NOT COMPLETED|Overall Study||0
10130550|NCT02652156|11262426|FG002|NOT COMPLETED|Overall Study||0
10130551|NCT02652208|11262436|FG000|STARTED|Overall Study||17
10130552|NCT02652208|11262437|FG001|STARTED|Overall Study||17
10130553|NCT02652208|11262436|FG000|COMPLETED|Overall Study||13
10130554|NCT02652208|11262437|FG001|COMPLETED|Overall Study||15
10130555|NCT02652208|11262436|FG000|NOT COMPLETED|Overall Study||4
10130556|NCT02652208|11262437|FG001|NOT COMPLETED|Overall Study||2
10130557|NCT02652221|11262443|FG000|STARTED|Overall Study||55
10130558|NCT02652221|11262443|FG000|COMPLETED|Overall Study||55
10130559|NCT02652221|11262443|FG000|NOT COMPLETED|Overall Study||0
10130560|NCT02652260|11262450|FG000|STARTED|Overall Study||43
10130561|NCT02652260|11262451|FG001|STARTED|Overall Study||43
10130562|NCT02652260|11262450|FG000|COMPLETED|Overall Study||43
10130563|NCT02652260|11262451|FG001|COMPLETED|Overall Study||41
10130564|NCT02652260|11262450|FG000|NOT COMPLETED|Overall Study||0
10130565|NCT02652260|11262451|FG001|NOT COMPLETED|Overall Study||2
10130566|NCT02652390|11262463|FG000|STARTED|Overall Study||37
10130567|NCT02652390|11262464|FG001|STARTED|Overall Study||37
10130568|NCT02652390|11262465|FG002|STARTED|Overall Study||37
10130569|NCT02652390|11262463|FG000|COMPLETED|Overall Study||37
10130570|NCT02652390|11262464|FG001|COMPLETED|Overall Study||37
10130571|NCT02652390|11262465|FG002|COMPLETED|Overall Study||37
10130572|NCT02652390|11262463|FG000|NOT COMPLETED|Overall Study||0
10130573|NCT02652390|11262464|FG001|NOT COMPLETED|Overall Study||0
10130574|NCT02652390|11262465|FG002|NOT COMPLETED|Overall Study||0
10130575|NCT02652416|11262479|FG000|STARTED|Overall Study||18
10130576|NCT02652416|11262480|FG001|STARTED|Overall Study||18
10130577|NCT02652416|11262481|FG002|STARTED|Overall Study||18
10130578|NCT02652416|11262482|FG003|STARTED|Overall Study||18
10130579|NCT02652416|11262479|FG000|Subjects Who Participated in MD Part|Overall Study||6
10130580|NCT02652416|11262480|FG001|Subjects Who Participated in MD Part|Overall Study||0
10130581|NCT02652416|11262481|FG002|Subjects Who Participated in MD Part|Overall Study||0
10130582|NCT02652416|11262482|FG003|Subjects Who Participated in MD Part|Overall Study||18
10130583|NCT02652416|11262479|FG000|COMPLETED|Overall Study||18
10130584|NCT02652416|11262480|FG001|COMPLETED|Overall Study||18
10130585|NCT02652416|11262481|FG002|COMPLETED|Overall Study||18
10130586|NCT02652416|11262482|FG003|COMPLETED|Overall Study||18
10130587|NCT02652416|11262479|FG000|NOT COMPLETED|Overall Study||0
10130588|NCT02652416|11262480|FG001|NOT COMPLETED|Overall Study||0
10130589|NCT02652416|11262481|FG002|NOT COMPLETED|Overall Study||0
10130590|NCT02652416|11262482|FG003|NOT COMPLETED|Overall Study||0
10130591|NCT02652442|11262496|FG000|STARTED|Centrifugation - Distance||6
10130592|NCT02652442|11262496|FG000|COMPLETED|Centrifugation - Distance||5
10130593|NCT02652442|11262496|FG000|NOT COMPLETED|Centrifugation - Distance||1
10130594|NCT02652442|11262496|FG000|STARTED|Centrifugation - Duration||5
10130595|NCT02652442|11262496|FG000|COMPLETED|Centrifugation - Duration||5
10130596|NCT02652442|11262496|FG000|NOT COMPLETED|Centrifugation - Duration||0
10130597|NCT02652442|11262496|FG000|STARTED|Centrifugation - Schedule||5
10130598|NCT02652442|11262496|FG000|COMPLETED|Centrifugation - Schedule||5
10130599|NCT02652442|11262496|FG000|NOT COMPLETED|Centrifugation - Schedule||0
10130600|NCT02652481|11262508|FG000|STARTED|Phase 1||239
10130601|NCT02652481|11262508|FG000|COMPLETED|Phase 1||141
10130602|NCT02652481|11262508|FG000|NOT COMPLETED|Phase 1||98
10130603|NCT02652481|11262508|FG000|STARTED|Phase 2||261
10130604|NCT02652481|11262508|FG000|COMPLETED|Phase 2||243
10130605|NCT02652481|11262508|FG000|NOT COMPLETED|Phase 2||18
10130606|NCT02652624|11262514|FG000|STARTED|Randomized Phase||234
10130607|NCT02652624|11262515|FG001|STARTED|Randomized Phase||236
10130608|NCT02652624|11262514|FG000|COMPLETED|Randomized Phase||231
10130609|NCT02652624|11262515|FG001|COMPLETED|Randomized Phase||231
10130610|NCT02652624|11262514|FG000|NOT COMPLETED|Randomized Phase||3
10130611|NCT02652624|11262515|FG001|NOT COMPLETED|Randomized Phase||5
10130612|NCT02652624|11262514|FG000|STARTED|Extension Phase||231
10130613|NCT02652624|11262515|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
10130614|NCT02652624|11262514|FG000|COMPLETED|Extension Phase||227
10130615|NCT02652624|11262515|FG001|COMPLETED|Extension Phase||224
10130616|NCT02652624|11262514|FG000|NOT COMPLETED|Extension Phase||4
10130617|NCT02652624|11262515|FG001|NOT COMPLETED|Extension Phase||4
10130618|NCT02652767|11262523|FG000|STARTED|Overall Study||39
10130619|NCT02652767|11262523|FG000|Completed Week 48|Overall Study||38
10130620|NCT02652767|11262523|FG000|COMPLETED|Overall Study||35
10130621|NCT02652767|11262523|FG000|NOT COMPLETED|Overall Study||4
10130622|NCT02652780|11262529|FG000|STARTED|Overall Study||37
10130623|NCT02652780|11262529|FG000|COMPLETED|Overall Study||37
10130624|NCT02652780|11262529|FG000|NOT COMPLETED|Overall Study||0
10130625|NCT02653144|11262539|FG000|STARTED|Overall Study||30
10130626|NCT02653144|11262540|FG001|STARTED|Overall Study||28
10130627|NCT02653144|11262541|FG002|STARTED|Overall Study||31
10130628|NCT02653144|11262539|FG000|COMPLETED|Overall Study||30
10130629|NCT02653144|11262540|FG001|COMPLETED|Overall Study||28
10130630|NCT02653144|11262541|FG002|COMPLETED|Overall Study||31
10130631|NCT02653144|11262539|FG000|NOT COMPLETED|Overall Study||0
10130632|NCT02653144|11262540|FG001|NOT COMPLETED|Overall Study||0
10130633|NCT02653144|11262541|FG002|NOT COMPLETED|Overall Study||0
10130634|NCT02653170|11262552|FG000|STARTED|Overall Study||87
10130635|NCT02653170|11262553|FG001|STARTED|Overall Study||88
10130636|NCT02653170|11262554|FG002|STARTED|Overall Study||90
10130637|NCT02653170|11262552|FG000|COMPLETED|Overall Study||70
10130638|NCT02653170|11262553|FG001|COMPLETED|Overall Study||72
10130639|NCT02653170|11262554|FG002|COMPLETED|Overall Study||72
10130640|NCT02653170|11262552|FG000|NOT COMPLETED|Overall Study||17
10130641|NCT02653170|11262553|FG001|NOT COMPLETED|Overall Study||16
10130642|NCT02653170|11262554|FG002|NOT COMPLETED|Overall Study||18
10130643|NCT02653183|11262564|FG000|STARTED|Overall Study||53
10130644|NCT02653183|11262565|FG001|STARTED|Overall Study||50
10130645|NCT02653183|11262564|FG000|COMPLETED|Overall Study||49
10130646|NCT02653183|11262565|FG001|COMPLETED|Overall Study||46
10130647|NCT02653183|11262564|FG000|NOT COMPLETED|Overall Study||4
10130648|NCT02653183|11262565|FG001|NOT COMPLETED|Overall Study||4
10130649|NCT02653300|11262571|FG000|STARTED|Overall Study||10
10130650|NCT02653300|11262571|FG000|COMPLETED|Overall Study||8
10130651|NCT02653300|11262571|FG000|NOT COMPLETED|Overall Study||2
10130652|NCT02653326|11262577|FG000|STARTED|Overall Study||32
10130653|NCT02653326|11262578|FG001|STARTED|Overall Study||34
10130654|NCT02653326|11262577|FG000|COMPLETED|Overall Study||22
10130655|NCT02653326|11262578|FG001|COMPLETED|Overall Study||27
10130656|NCT02653326|11262577|FG000|NOT COMPLETED|Overall Study||10
10130657|NCT02653326|11262578|FG001|NOT COMPLETED|Overall Study||7
10130658|NCT02653391|11262587|FG000|STARTED|Overall Study||18
10130659|NCT02653391|11262588|FG001|STARTED|Overall Study||3
10130660|NCT02653391|11262589|FG002|STARTED|Overall Study||1
10130661|NCT02653391|11262587|FG000|COMPLETED|Overall Study||16
10130662|NCT02653391|11262588|FG001|COMPLETED|Overall Study||1
10130663|NCT02653391|11262589|FG002|COMPLETED|Overall Study||1
10130664|NCT02653391|11262587|FG000|NOT COMPLETED|Overall Study||2
10130665|NCT02653391|11262588|FG001|NOT COMPLETED|Overall Study||2
10130666|NCT02653391|11262589|FG002|NOT COMPLETED|Overall Study||0
10130667|NCT02653417|11262637|FG000|STARTED|Overall Study||38
10130668|NCT02653417|11262638|FG001|STARTED|Overall Study||34
10130669|NCT02653417|11262639|FG002|STARTED|Overall Study||29
10130670|NCT02653417|11262640|FG003|STARTED|Overall Study||38
10130671|NCT02653417|11262637|FG000|COMPLETED|Overall Study||37
10130672|NCT02653417|11262638|FG001|COMPLETED|Overall Study||32
10130673|NCT02653417|11262639|FG002|COMPLETED|Overall Study||26
10130674|NCT02653417|11262640|FG003|COMPLETED|Overall Study||33
10130675|NCT02653417|11262637|FG000|NOT COMPLETED|Overall Study||1
10130676|NCT02653417|11262638|FG001|NOT COMPLETED|Overall Study||2
10130677|NCT02653417|11262639|FG002|NOT COMPLETED|Overall Study||3
10130678|NCT02653417|11262640|FG003|NOT COMPLETED|Overall Study||5
10130679|NCT02653456|11262654|FG000|STARTED|Overall Study||64
10130680|NCT02653456|11262654|FG000|COMPLETED|Overall Study||59
10130681|NCT02653456|11262654|FG000|NOT COMPLETED|Overall Study||5
10130682|NCT02653560|11262659|FG000|STARTED|KMgCit Phase||30
10130683|NCT02653560|11262660|FG001|STARTED|KMgCit Phase||0
10130684|NCT02653560|11262661|FG002|STARTED|KMgCit Phase||0
10130685|NCT02653560|11262662|FG003|STARTED|KMgCit Phase||0
10130686|NCT02653560|11262659|FG000|COMPLETED|KMgCit Phase||30
10130687|NCT02653560|11262660|FG001|COMPLETED|KMgCit Phase||0
10130688|NCT02653560|11262661|FG002|COMPLETED|KMgCit Phase||0
10130689|NCT02653560|11262662|FG003|COMPLETED|KMgCit Phase||0
10130690|NCT02653560|11262659|FG000|NOT COMPLETED|KMgCit Phase||0
10130691|NCT02653560|11262660|FG001|NOT COMPLETED|KMgCit Phase||0
10130692|NCT02653560|11262661|FG002|NOT COMPLETED|KMgCit Phase||0
10130693|NCT02653560|11262662|FG003|NOT COMPLETED|KMgCit Phase||0
10130694|NCT02653560|11262659|FG000|STARTED|K Citrate Phase||0
10130695|NCT02653560|11262660|FG001|STARTED|K Citrate Phase||30
10130696|NCT02653560|11262661|FG002|STARTED|K Citrate Phase||0
10130697|NCT02653560|11262662|FG003|STARTED|K Citrate Phase||0
10130698|NCT02653560|11262659|FG000|COMPLETED|K Citrate Phase||0
10130699|NCT02653560|11262660|FG001|COMPLETED|K Citrate Phase||30
10130700|NCT02653560|11262661|FG002|COMPLETED|K Citrate Phase||0
10130701|NCT02653560|11262662|FG003|COMPLETED|K Citrate Phase||0
10130702|NCT02653560|11262659|FG000|NOT COMPLETED|K Citrate Phase||0
10130703|NCT02653560|11262660|FG001|NOT COMPLETED|K Citrate Phase||0
10130704|NCT02653560|11262661|FG002|NOT COMPLETED|K Citrate Phase||0
10130705|NCT02653560|11262662|FG003|NOT COMPLETED|K Citrate Phase||0
10130706|NCT02653560|11262659|FG000|STARTED|KCl Phase||0
10130707|NCT02653560|11262660|FG001|STARTED|KCl Phase||0
10130708|NCT02653560|11262661|FG002|STARTED|KCl Phase||30
10130709|NCT02653560|11262662|FG003|STARTED|KCl Phase||0
10130710|NCT02653560|11262659|FG000|COMPLETED|KCl Phase||0
10130711|NCT02653560|11262660|FG001|COMPLETED|KCl Phase||0
10130712|NCT02653560|11262661|FG002|COMPLETED|KCl Phase||30
10130713|NCT02653560|11262662|FG003|COMPLETED|KCl Phase||0
10130714|NCT02653560|11262659|FG000|NOT COMPLETED|KCl Phase||0
10130715|NCT02653560|11262660|FG001|NOT COMPLETED|KCl Phase||0
10130716|NCT02653560|11262661|FG002|NOT COMPLETED|KCl Phase||0
10130717|NCT02653560|11262662|FG003|NOT COMPLETED|KCl Phase||0
10130718|NCT02653560|11262659|FG000|STARTED|Placebo Phase||0
10130719|NCT02653560|11262660|FG001|STARTED|Placebo Phase||0
10130720|NCT02653560|11262661|FG002|STARTED|Placebo Phase||0
10130721|NCT02653560|11262662|FG003|STARTED|Placebo Phase||30
10130722|NCT02653560|11262659|FG000|COMPLETED|Placebo Phase||0
10130723|NCT02653560|11262660|FG001|COMPLETED|Placebo Phase||0
10130724|NCT02653560|11262661|FG002|COMPLETED|Placebo Phase||0
10130725|NCT02653560|11262662|FG003|COMPLETED|Placebo Phase||30
10130726|NCT02653560|11262659|FG000|NOT COMPLETED|Placebo Phase||0
10130727|NCT02653560|11262660|FG001|NOT COMPLETED|Placebo Phase||0
10130728|NCT02653560|11262661|FG002|NOT COMPLETED|Placebo Phase||0
10130729|NCT02653560|11262662|FG003|NOT COMPLETED|Placebo Phase||0
10130730|NCT02653625|11262672|FG000|STARTED|Overall Study||24
10130731|NCT02653625|11262672|FG000|COMPLETED|Overall Study||20
10130732|NCT02653625|11262672|FG000|NOT COMPLETED|Overall Study||4
10130733|NCT02653664|11262679|FG000|STARTED|Post-Treatment||110
10130734|NCT02653664|11262680|FG001|STARTED|Post-Treatment||110
10130735|NCT02653664|11262681|FG002|STARTED|Post-Treatment||108
10130736|NCT02653664|11262679|FG000|Primary and Secondary Data|Post-Treatment||93
10130737|NCT02653664|11262680|FG001|Primary and Secondary Data|Post-Treatment||104
10130738|NCT02653664|11262681|FG002|Primary and Secondary Data|Post-Treatment||91
10130739|NCT02653664|11262679|FG000|Primary Outcome Data Only|Post-Treatment||3
10130740|NCT02653664|11262680|FG001|Primary Outcome Data Only|Post-Treatment||0
10130741|NCT02653664|11262681|FG002|Primary Outcome Data Only|Post-Treatment||3
10130742|NCT02653664|11262679|FG000|COMPLETED|Post-Treatment||96
10130743|NCT02653664|11262680|FG001|COMPLETED|Post-Treatment||104
10130744|NCT02653664|11262681|FG002|COMPLETED|Post-Treatment||94
10130745|NCT02653664|11262679|FG000|NOT COMPLETED|Post-Treatment||14
10130746|NCT02653664|11262680|FG001|NOT COMPLETED|Post-Treatment||6
10130747|NCT02653664|11262681|FG002|NOT COMPLETED|Post-Treatment||14
10130748|NCT02653664|11262679|FG000|STARTED|3 Month Follow-Up||110
10130749|NCT02653664|11262680|FG001|STARTED|3 Month Follow-Up||110
10130750|NCT02653664|11262681|FG002|STARTED|3 Month Follow-Up||108
10130751|NCT02653664|11262679|FG000|Primary and Secondary Data|3 Month Follow-Up||83
10130752|NCT02653664|11262680|FG001|Primary and Secondary Data|3 Month Follow-Up||95
10130753|NCT02653664|11262681|FG002|Primary and Secondary Data|3 Month Follow-Up||82
10130754|NCT02653664|11262679|FG000|Primary Outcome Data Only|3 Month Follow-Up||6
10130755|NCT02653664|11262680|FG001|Primary Outcome Data Only|3 Month Follow-Up||0
10130756|NCT02653664|11262681|FG002|Primary Outcome Data Only|3 Month Follow-Up||1
10130757|NCT02653664|11262679|FG000|COMPLETED|3 Month Follow-Up||89
10130758|NCT02653664|11262680|FG001|COMPLETED|3 Month Follow-Up||95
10130759|NCT02653664|11262681|FG002|COMPLETED|3 Month Follow-Up||83
10130760|NCT02653664|11262679|FG000|NOT COMPLETED|3 Month Follow-Up||21
10130761|NCT02653664|11262680|FG001|NOT COMPLETED|3 Month Follow-Up||15
10130762|NCT02653664|11262681|FG002|NOT COMPLETED|3 Month Follow-Up||25
10130763|NCT02653664|11262679|FG000|STARTED|6 Month Follow-Up||110
10130764|NCT02653664|11262680|FG001|STARTED|6 Month Follow-Up||110
10130765|NCT02653664|11262681|FG002|STARTED|6 Month Follow-Up||108
10130766|NCT02653664|11262679|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85
10130767|NCT02653664|11262680|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87
10130768|NCT02653664|11262681|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83
10130769|NCT02653664|11262679|FG000|Primary Outcome Data Only|6 Month Follow-Up||2
10130770|NCT02653664|11262680|FG001|Primary Outcome Data Only|6 Month Follow-Up||2
10130771|NCT02653664|11262681|FG002|Primary Outcome Data Only|6 Month Follow-Up||2
10130772|NCT02653664|11262679|FG000|COMPLETED|6 Month Follow-Up||87
10130773|NCT02653664|11262680|FG001|COMPLETED|6 Month Follow-Up||89
10130774|NCT02653664|11262681|FG002|COMPLETED|6 Month Follow-Up||85
10130775|NCT02653664|11262679|FG000|NOT COMPLETED|6 Month Follow-Up||23
10130776|NCT02653664|11262680|FG001|NOT COMPLETED|6 Month Follow-Up||21
10130777|NCT02653664|11262681|FG002|NOT COMPLETED|6 Month Follow-Up||23
10130778|NCT02653768|11262694|FG000|STARTED|3-Month Follow-Up||230
10130779|NCT02653768|11262695|FG001|STARTED|3-Month Follow-Up||115
10130780|NCT02653768|11262694|FG000|COMPLETED|3-Month Follow-Up||164
10130781|NCT02653768|11262695|FG001|COMPLETED|3-Month Follow-Up||100
10130782|NCT02653768|11262694|FG000|NOT COMPLETED|3-Month Follow-Up||66
10130783|NCT02653768|11262695|FG001|NOT COMPLETED|3-Month Follow-Up||15
10130784|NCT02653768|11262694|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
10130785|NCT02653768|11262695|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
10130786|NCT02653768|11262694|FG000|COMPLETED|6-Month Follow-Up||164
10130787|NCT02653768|11262695|FG001|COMPLETED|6-Month Follow-Up||100
10130788|NCT02653768|11262694|FG000|NOT COMPLETED|6-Month Follow-Up||45
10130789|NCT02653768|11262695|FG001|NOT COMPLETED|6-Month Follow-Up||13
10130790|NCT02653768|11262694|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
10130791|NCT02653768|11262695|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
10130792|NCT02653768|11262694|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
10130793|NCT02653768|11262695|FG001|COMPLETED|9-Month Follow-Up (Primary)||95
10130794|NCT02653768|11262694|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33
10130795|NCT02653768|11262695|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16
10130796|NCT02653872|11262701|FG000|STARTED|Overall Study||15
10130797|NCT02653872|11262701|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
10130798|NCT02653872|11262701|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
10130799|NCT02653872|11262701|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
10130800|NCT02653872|11262701|FG000|COMPLETED|Overall Study||15
10130801|NCT02653872|11262701|FG000|NOT COMPLETED|Overall Study||0
10130802|NCT02654002|11262724|FG000|STARTED|Overall Study||12
10130803|NCT02654002|11262725|FG001|STARTED|Overall Study||12
10130804|NCT02654002|11262726|FG002|STARTED|Overall Study||12
10130805|NCT02654002|11262727|FG003|STARTED|Overall Study||12
10130806|NCT02654002|11262728|FG004|STARTED|Overall Study||12
10130807|NCT02654002|11262729|FG005|STARTED|Overall Study||12
10130808|NCT02654002|11262730|FG006|STARTED|Overall Study||12
10130809|NCT02654002|11262731|FG007|STARTED|Overall Study||12
10130810|NCT02654002|11262732|FG008|STARTED|Overall Study||24
10130811|NCT02654002|11262724|FG000|COMPLETED|Overall Study||12
10130812|NCT02654002|11262725|FG001|COMPLETED|Overall Study||12
10130813|NCT02654002|11262726|FG002|COMPLETED|Overall Study||12
10130814|NCT02654002|11262727|FG003|COMPLETED|Overall Study||12
10130815|NCT02654002|11262728|FG004|COMPLETED|Overall Study||12
10130816|NCT02654002|11262729|FG005|COMPLETED|Overall Study||11
10130817|NCT02654002|11262730|FG006|COMPLETED|Overall Study||11
10130818|NCT02654002|11262731|FG007|COMPLETED|Overall Study||11
10130819|NCT02654002|11262732|FG008|COMPLETED|Overall Study||24
10130820|NCT02654002|11262724|FG000|NOT COMPLETED|Overall Study||0
10130821|NCT02654002|11262725|FG001|NOT COMPLETED|Overall Study||0
10130822|NCT02654002|11262726|FG002|NOT COMPLETED|Overall Study||0
10130823|NCT02654002|11262727|FG003|NOT COMPLETED|Overall Study||0
10130824|NCT02654002|11262728|FG004|NOT COMPLETED|Overall Study||0
10130825|NCT02654002|11262729|FG005|NOT COMPLETED|Overall Study||1
10130826|NCT02654002|11262730|FG006|NOT COMPLETED|Overall Study||1
10130827|NCT02654002|11262731|FG007|NOT COMPLETED|Overall Study||1
10130828|NCT02654002|11262732|FG008|NOT COMPLETED|Overall Study||0
10130829|NCT02654054|11262770|FG000|STARTED|Treatment Period||102
10130830|NCT02654054|11262771|FG001|STARTED|Treatment Period||104
10130831|NCT02654054|11262772|FG002|STARTED|Treatment Period||207
10130832|NCT02654054|11262770|FG000|Randomized and Treated|Treatment Period||102
10130833|NCT02654054|11262771|FG001|Randomized and Treated|Treatment Period||104
10130834|NCT02654054|11262772|FG002|Randomized and Treated|Treatment Period||206
10130835|NCT02654054|11262770|FG000|COMPLETED|Treatment Period||83
10130836|NCT02654054|11262771|FG001|COMPLETED|Treatment Period||81
10130837|NCT02654054|11262772|FG002|COMPLETED|Treatment Period||164
10130838|NCT02654054|11262770|FG000|NOT COMPLETED|Treatment Period||19
10130839|NCT02654054|11262771|FG001|NOT COMPLETED|Treatment Period||23
10130840|NCT02654054|11262772|FG002|NOT COMPLETED|Treatment Period||43
10130841|NCT02654054|11262770|FG000|STARTED|Post-Treatment Follow-Up Period||25
10130842|NCT02654054|11262771|FG001|STARTED|Post-Treatment Follow-Up Period||32
10130843|NCT02654054|11262772|FG002|STARTED|Post-Treatment Follow-Up Period||59
10130844|NCT02654054|11262770|FG000|COMPLETED|Post-Treatment Follow-Up Period||17
10130845|NCT02654054|11262771|FG001|COMPLETED|Post-Treatment Follow-Up Period||24
10130846|NCT02654054|11262772|FG002|COMPLETED|Post-Treatment Follow-Up Period||29
10130847|NCT02654054|11262770|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8
10130848|NCT02654054|11262771|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8
10130849|NCT02654054|11262772|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30
10130850|NCT02654145|11262781|FG000|STARTED|Overall Study||145
10130851|NCT02654145|11262781|FG000|COMPLETED|Overall Study||138
10130852|NCT02654145|11262781|FG000|NOT COMPLETED|Overall Study||7
10130853|NCT02654483|11262787|FG000|STARTED|Double-blind||7
10130854|NCT02654483|11262788|FG001|STARTED|Double-blind||7
10130855|NCT02654483|11262787|FG000|COMPLETED|Double-blind||7
10130856|NCT02654483|11262788|FG001|COMPLETED|Double-blind||7
10130857|NCT02654483|11262787|FG000|NOT COMPLETED|Double-blind||0
10130858|NCT02654483|11262788|FG001|NOT COMPLETED|Double-blind||0
10130859|NCT02654483|11262787|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5
10130860|NCT02654483|11262788|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3
10130861|NCT02654483|11262787|FG000|COMPLETED|Open-label||5
10130862|NCT02654483|11262788|FG001|COMPLETED|Open-label||3
10130863|NCT02654483|11262787|FG000|NOT COMPLETED|Open-label||0
10130864|NCT02654483|11262788|FG001|NOT COMPLETED|Open-label||0
10130865|NCT02654652|11262802|FG000|STARTED|Overall Study||19
10130866|NCT02654652|11262803|FG001|STARTED|Overall Study||21
10130867|NCT02654652|11262802|FG000|COMPLETED|Overall Study||18
10130868|NCT02654652|11262803|FG001|COMPLETED|Overall Study||18
10130869|NCT02654652|11262802|FG000|NOT COMPLETED|Overall Study||1
10130870|NCT02654652|11262803|FG001|NOT COMPLETED|Overall Study||3
10130871|NCT02654691|11262809|FG000|STARTED|Overall Study||63
10130872|NCT02654691|11262809|FG000|COMPLETED|Overall Study||63
10130873|NCT02654691|11262809|FG000|NOT COMPLETED|Overall Study||0
10130874|NCT02654717|11262815|FG000|STARTED|Overall Study||56
10130875|NCT02654717|11262816|FG001|STARTED|Overall Study||55
10130876|NCT02654717|11262815|FG000|COMPLETED|Overall Study||50
10130877|NCT02654717|11262816|FG001|COMPLETED|Overall Study||50
10130878|NCT02654717|11262815|FG000|NOT COMPLETED|Overall Study||6
10130879|NCT02654717|11262816|FG001|NOT COMPLETED|Overall Study||5
10130880|NCT02654769|11262825|FG000|STARTED|Overall Study||149
10130881|NCT02654769|11262826|FG001|STARTED|Overall Study||149
10130882|NCT02654769|11262827|FG002|STARTED|Overall Study||143
10130883|NCT02654769|11262825|FG000|COMPLETED|Overall Study||145
10130884|NCT02654769|11262826|FG001|COMPLETED|Overall Study||148
10130885|NCT02654769|11262827|FG002|COMPLETED|Overall Study||142
10130886|NCT02654769|11262825|FG000|NOT COMPLETED|Overall Study||4
10130887|NCT02654769|11262826|FG001|NOT COMPLETED|Overall Study||1
10130888|NCT02654769|11262827|FG002|NOT COMPLETED|Overall Study||1
10130889|NCT02654808|11262839|FG000|STARTED|Overall Study||33
10130890|NCT02654808|11262840|FG001|STARTED|Overall Study||33
10130891|NCT02654808|11262841|FG002|STARTED|Overall Study||33
10130892|NCT02654808|11262842|FG003|STARTED|Overall Study||33
10130893|NCT02654808|11262839|FG000|COMPLETED|Overall Study||33
10130894|NCT02654808|11262840|FG001|COMPLETED|Overall Study||33
10130895|NCT02654808|11262841|FG002|COMPLETED|Overall Study||33
10130896|NCT02654808|11262842|FG003|COMPLETED|Overall Study||33
10130897|NCT02654808|11262839|FG000|NOT COMPLETED|Overall Study||0
10130898|NCT02654808|11262840|FG001|NOT COMPLETED|Overall Study||0
10130899|NCT02654808|11262841|FG002|NOT COMPLETED|Overall Study||0
10130900|NCT02654808|11262842|FG003|NOT COMPLETED|Overall Study||0
10130901|NCT02654860|11262860|FG000|STARTED|First Part||3
10130902|NCT02654860|11262861|FG001|STARTED|First Part||3
10130903|NCT02654860|11262862|FG002|STARTED|First Part||3
10130904|NCT02654860|11262863|FG003|STARTED|First Part||0
10130905|NCT02654860|11262860|FG000|COMPLETED|First Part||3
10130906|NCT02654860|11262861|FG001|COMPLETED|First Part||3
10130907|NCT02654860|11262862|FG002|COMPLETED|First Part||3
10130908|NCT02654860|11262863|FG003|COMPLETED|First Part||0
10130909|NCT02654860|11262860|FG000|NOT COMPLETED|First Part||0
10130910|NCT02654860|11262861|FG001|NOT COMPLETED|First Part||0
10130911|NCT02654860|11262862|FG002|NOT COMPLETED|First Part||0
10130912|NCT02654860|11262863|FG003|NOT COMPLETED|First Part||0
10130913|NCT02654860|11262860|FG000|STARTED|Second Part||15
10130914|NCT02654860|11262861|FG001|STARTED|Second Part||15
10130915|NCT02654860|11262862|FG002|STARTED|Second Part||15
10130916|NCT02654860|11262863|FG003|STARTED|Second Part||15
10130917|NCT02654860|11262860|FG000|COMPLETED|Second Part||15
10130918|NCT02654860|11262861|FG001|COMPLETED|Second Part||15
10130919|NCT02654860|11262862|FG002|COMPLETED|Second Part||15
10130920|NCT02654860|11262863|FG003|COMPLETED|Second Part||15
10130921|NCT02654860|11262860|FG000|NOT COMPLETED|Second Part||0
10130922|NCT02654860|11262861|FG001|NOT COMPLETED|Second Part||0
10130923|NCT02654860|11262862|FG002|NOT COMPLETED|Second Part||0
10130924|NCT02654860|11262863|FG003|NOT COMPLETED|Second Part||0
10130925|NCT02654977|11262873|FG000|STARTED|Overall Study||11
10130926|NCT02654977|11262873|FG000|COMPLETED|Overall Study||4
10130927|NCT02654977|11262873|FG000|NOT COMPLETED|Overall Study||7
10130928|NCT02655224|11262879|FG000|STARTED|Overall Study||33
10130929|NCT02655224|11262880|FG001|STARTED|Overall Study||32
10130930|NCT02655224|11262879|FG000|COMPLETED|Overall Study||32
10130931|NCT02655224|11262880|FG001|COMPLETED|Overall Study||31
10130932|NCT02655224|11262879|FG000|NOT COMPLETED|Overall Study||1
10130933|NCT02655224|11262880|FG001|NOT COMPLETED|Overall Study||1
10130934|NCT02655237|11262888|FG000|STARTED|Overall Study||139
10130935|NCT02655237|11262889|FG001|STARTED|Overall Study||142
10130936|NCT02655237|11262888|FG000|COMPLETED|Overall Study||122
10130937|NCT02655237|11262889|FG001|COMPLETED|Overall Study||131
10130938|NCT02655237|11262888|FG000|NOT COMPLETED|Overall Study||17
10130939|NCT02655237|11262889|FG001|NOT COMPLETED|Overall Study||11
10130940|NCT02655354|11262897|FG000|STARTED|Overall Study||265
10130941|NCT02655354|11262898|FG001|STARTED|Overall Study||370
10130942|NCT02655354|11262897|FG000|COMPLETED|Overall Study||188
10130943|NCT02655354|11262898|FG001|COMPLETED|Overall Study||289
10130944|NCT02655354|11262897|FG000|NOT COMPLETED|Overall Study||77
10130945|NCT02655354|11262898|FG001|NOT COMPLETED|Overall Study||81
10130946|NCT02655419|11262906|FG000|STARTED|Overall Study||17
10130947|NCT02655419|11262907|FG001|STARTED|Overall Study||23
10130948|NCT02655419|11262906|FG000|Treated|Overall Study||16
10130949|NCT02655419|11262907|FG001|Treated|Overall Study||18
10130950|NCT02655419|11262906|FG000|COMPLETED|Overall Study||12
10130951|NCT02655419|11262907|FG001|COMPLETED|Overall Study||16
10130952|NCT02655419|11262906|FG000|NOT COMPLETED|Overall Study||5
10130953|NCT02655419|11262907|FG001|NOT COMPLETED|Overall Study||7
10130954|NCT02655510|11262920|FG000|STARTED|Overall Study||6
10130955|NCT02655510|11262921|FG001|STARTED|Overall Study||6
10130956|NCT02655510|11262922|FG002|STARTED|Overall Study||6
10130957|NCT02655510|11262920|FG000|COMPLETED|Overall Study||6
10130958|NCT02655510|11262921|FG001|COMPLETED|Overall Study||6
9706856|NCT00534976|10805961|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
10130959|NCT02655510|11262922|FG002|COMPLETED|Overall Study||6
10130960|NCT02655510|11262920|FG000|NOT COMPLETED|Overall Study||0
10130961|NCT02655510|11262921|FG001|NOT COMPLETED|Overall Study||0
10130962|NCT02655510|11262922|FG002|NOT COMPLETED|Overall Study||0
10130963|NCT02655653|11262932|FG000|STARTED|Overall Study||56
10130964|NCT02655653|11262933|FG001|STARTED|Overall Study||58
10130965|NCT02655653|11262932|FG000|COMPLETED|Overall Study||56
10130966|NCT02655653|11262933|FG001|COMPLETED|Overall Study||58
10130967|NCT02655653|11262932|FG000|NOT COMPLETED|Overall Study||0
10130968|NCT02655653|11262933|FG001|NOT COMPLETED|Overall Study||0
10130969|NCT02655666|11262945|FG000|STARTED|Overall Study||16
10130970|NCT02655666|11262945|FG000|COMPLETED|Overall Study||4
10130971|NCT02655666|11262945|FG000|NOT COMPLETED|Overall Study||12
10130972|NCT02655679|11262954|FG000|STARTED|Overall Study||21
10130973|NCT02655679|11262955|FG001|STARTED|Overall Study||19
10130974|NCT02655679|11262956|FG002|STARTED|Overall Study||20
10130975|NCT02655679|11262957|FG003|STARTED|Overall Study||24
10130976|NCT02655679|11262958|FG004|STARTED|Overall Study||20
10130977|NCT02655679|11262954|FG000|Received Study Drug (Safety Population)|Overall Study||20
10130978|NCT02655679|11262955|FG001|Received Study Drug (Safety Population)|Overall Study||19
10130979|NCT02655679|11262956|FG002|Received Study Drug (Safety Population)|Overall Study||20
10130980|NCT02655679|11262957|FG003|Received Study Drug (Safety Population)|Overall Study||24
10130981|NCT02655679|11262958|FG004|Received Study Drug (Safety Population)|Overall Study||20
10130982|NCT02655679|11262954|FG000|COMPLETED|Overall Study||18
10130983|NCT02655679|11262955|FG001|COMPLETED|Overall Study||16
10130984|NCT02655679|11262956|FG002|COMPLETED|Overall Study||19
10130985|NCT02655679|11262957|FG003|COMPLETED|Overall Study||20
10130986|NCT02655679|11262958|FG004|COMPLETED|Overall Study||19
10130987|NCT02655679|11262954|FG000|NOT COMPLETED|Overall Study||3
10130988|NCT02655679|11262955|FG001|NOT COMPLETED|Overall Study||3
10130989|NCT02655679|11262956|FG002|NOT COMPLETED|Overall Study||1
10130990|NCT02655679|11262957|FG003|NOT COMPLETED|Overall Study||4
10130991|NCT02655679|11262958|FG004|NOT COMPLETED|Overall Study||1
10130992|NCT02655887|11262971|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170
10130993|NCT02655887|11262971|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156
10130994|NCT02655887|11262971|FG000|NOT COMPLETED|Overall Study||14
10130995|NCT02656069|11262977|FG000|STARTED|First Intervention||44
10130996|NCT02656069|11262978|FG001|STARTED|First Intervention||36
10130997|NCT02656069|11262977|FG000|COMPLETED|First Intervention||44
10130998|NCT02656069|11262978|FG001|COMPLETED|First Intervention||36
10130999|NCT02656069|11262977|FG000|NOT COMPLETED|First Intervention||0
10131000|NCT02656069|11262978|FG001|NOT COMPLETED|First Intervention||0
10131001|NCT02656069|11262977|FG000|STARTED|Second Intervention||44
10131002|NCT02656069|11262978|FG001|STARTED|Second Intervention||36
10131003|NCT02656069|11262977|FG000|COMPLETED|Second Intervention||43
10131004|NCT02656069|11262978|FG001|COMPLETED|Second Intervention||35
10131005|NCT02656069|11262977|FG000|NOT COMPLETED|Second Intervention||1
10131006|NCT02656069|11262978|FG001|NOT COMPLETED|Second Intervention||1
10131007|NCT02656160|11262984|FG000|STARTED|First Study Night||7
10131008|NCT02656160|11262985|FG001|STARTED|First Study Night||6
10131009|NCT02656160|11262984|FG000|COMPLETED|First Study Night||7
10131010|NCT02656160|11262985|FG001|COMPLETED|First Study Night||6
10131011|NCT02656160|11262984|FG000|NOT COMPLETED|First Study Night||0
10131012|NCT02656160|11262985|FG001|NOT COMPLETED|First Study Night||0
10131013|NCT02656160|11262984|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4
10131014|NCT02656160|11262985|FG001|STARTED|Second Study Night||6
10131015|NCT02656160|11262984|FG000|COMPLETED|Second Study Night||4
10131016|NCT02656160|11262985|FG001|COMPLETED|Second Study Night||6
10131017|NCT02656160|11262984|FG000|NOT COMPLETED|Second Study Night||0
10131018|NCT02656160|11262985|FG001|NOT COMPLETED|Second Study Night||0
10131019|NCT02656173|11262993|FG000|STARTED|Overall Study||285
10131020|NCT02656173|11262994|FG001|STARTED|Overall Study||283
10131021|NCT02656173|11262993|FG000|Received Treatment|Overall Study||284
10131022|NCT02656173|11262994|FG001|Received Treatment|Overall Study||282
10131023|NCT02656173|11262993|FG000|COMPLETED|Overall Study||272
10131024|NCT02656173|11262994|FG001|COMPLETED|Overall Study||272
10131025|NCT02656173|11262993|FG000|NOT COMPLETED|Overall Study||13
10131026|NCT02656173|11262994|FG001|NOT COMPLETED|Overall Study||11
10131027|NCT02656329|11263004|FG000|STARTED|Overall Study||164
10131028|NCT02656329|11263005|FG001|STARTED|Overall Study||157
10131029|NCT02656329|11263004|FG000|COMPLETED|Overall Study||0
10131030|NCT02656329|11263005|FG001|COMPLETED|Overall Study||0
10131031|NCT02656329|11263004|FG000|NOT COMPLETED|Overall Study||164
10131032|NCT02656329|11263005|FG001|NOT COMPLETED|Overall Study||157
10131033|NCT02656420|11263016|FG000|STARTED|Overall Study||55
10131034|NCT02656420|11263017|FG001|STARTED|Overall Study||25
10131035|NCT02656420|11263018|FG002|STARTED|Overall Study||35
10131036|NCT02656420|11263019|FG003|STARTED|Overall Study||55
10131037|NCT02656420|11263016|FG000|COMPLETED|Overall Study||55
10131038|NCT02656420|11263017|FG001|COMPLETED|Overall Study||24
10131039|NCT02656420|11263018|FG002|COMPLETED|Overall Study||35
10131040|NCT02656420|11263019|FG003|COMPLETED|Overall Study||55
10131041|NCT02656420|11263016|FG000|NOT COMPLETED|Overall Study||0
10131042|NCT02656420|11263017|FG001|NOT COMPLETED|Overall Study||1
10131043|NCT02656420|11263018|FG002|NOT COMPLETED|Overall Study||0
10131044|NCT02656420|11263019|FG003|NOT COMPLETED|Overall Study||0
10131045|NCT02656485|11263035|FG000|STARTED|Overall Study||9
10131046|NCT02656485|11263036|FG001|STARTED|Overall Study||9
10131047|NCT02656485|11263037|FG002|STARTED|Overall Study||9
10131048|NCT02656485|11263038|FG003|STARTED|Overall Study||9
10131049|NCT02656485|11263035|FG000|COMPLETED|Overall Study||7
10131050|NCT02656485|11263036|FG001|COMPLETED|Overall Study||6
10131051|NCT02656485|11263037|FG002|COMPLETED|Overall Study||7
10131052|NCT02656485|11263038|FG003|COMPLETED|Overall Study||7
10131053|NCT02656485|11263035|FG000|NOT COMPLETED|Overall Study||2
10131054|NCT02656485|11263036|FG001|NOT COMPLETED|Overall Study||3
10131055|NCT02656485|11263037|FG002|NOT COMPLETED|Overall Study||2
10131056|NCT02656485|11263038|FG003|NOT COMPLETED|Overall Study||2
10131057|NCT02656680|11263052|FG000|STARTED|Overall Study||40
10131058|NCT02656680|11263053|FG001|STARTED|Overall Study||40
10131059|NCT02656680|11263052|FG000|COMPLETED|Overall Study||40
10131060|NCT02656680|11263053|FG001|COMPLETED|Overall Study||39
10131061|NCT02656680|11263052|FG000|NOT COMPLETED|Overall Study||0
10131062|NCT02656680|11263053|FG001|NOT COMPLETED|Overall Study||1
10131063|NCT02656693|11263064|FG000|STARTED|Overall Study||326
10131064|NCT02656693|11263065|FG001|STARTED|Overall Study||216
10131065|NCT02656693|11263066|FG002|STARTED|Overall Study||298
10131066|NCT02656693|11263064|FG000|COMPLETED|Overall Study||325
10131067|NCT02656693|11263065|FG001|COMPLETED|Overall Study||214
10131068|NCT02656693|11263066|FG002|COMPLETED|Overall Study||295
10131069|NCT02656693|11263064|FG000|NOT COMPLETED|Overall Study||1
10131070|NCT02656693|11263065|FG001|NOT COMPLETED|Overall Study||2
10131071|NCT02656693|11263066|FG002|NOT COMPLETED|Overall Study||3
10131072|NCT02656745|11263074|FG000|STARTED|Overall Study||416
10131073|NCT02656745|11263074|FG000|COMPLETED|Overall Study||416
10131074|NCT02656745|11263074|FG000|NOT COMPLETED|Overall Study||0
10131075|NCT02656836|11263081|FG000|STARTED|Overall Study||9
10131076|NCT02656836|11263081|FG000|COMPLETED|Overall Study||6
10131077|NCT02656836|11263081|FG000|NOT COMPLETED|Overall Study||3
10131078|NCT02656875|11263085|FG000|STARTED|Overall Study||768
10131079|NCT02656875|11263085|FG000|COMPLETED|Overall Study||698
10131080|NCT02656875|11263085|FG000|NOT COMPLETED|Overall Study||70
10131081|NCT02657031|11263091|FG000|STARTED|Overall Study||29
10131082|NCT02657031|11263092|FG001|STARTED|Overall Study||25
10131083|NCT02657031|11263091|FG000|COMPLETED|Overall Study||28
10131084|NCT02657031|11263092|FG001|COMPLETED|Overall Study||23
10131085|NCT02657031|11263091|FG000|NOT COMPLETED|Overall Study||1
10131086|NCT02657031|11263092|FG001|NOT COMPLETED|Overall Study||2
10131087|NCT02657226|11263098|FG000|STARTED|Overall Study||15724
10131088|NCT02657226|11263098|FG000|COMPLETED|Overall Study||15724
10131089|NCT02657226|11263098|FG000|NOT COMPLETED|Overall Study||0
10131090|NCT02657252|11263107|FG000|STARTED|Overall Study||57
10131091|NCT02657252|11263108|FG001|STARTED|Overall Study||58
10131092|NCT02657252|11263107|FG000|COMPLETED|Overall Study||47
10131093|NCT02657252|11263108|FG001|COMPLETED|Overall Study||51
10131094|NCT02657252|11263107|FG000|NOT COMPLETED|Overall Study||10
10131095|NCT02657252|11263108|FG001|NOT COMPLETED|Overall Study||7
10131096|NCT02657369|11263114|FG000|STARTED|Overall Study||34
10131097|NCT02657369|11263114|FG000|COMPLETED|Overall Study||0
10131098|NCT02657369|11263114|FG000|NOT COMPLETED|Overall Study||34
10131099|NCT02657408|11263120|FG000|STARTED|Overall Study||28
10131100|NCT02657408|11263121|FG001|STARTED|Overall Study||29
10131101|NCT02657408|11263120|FG000|COMPLETED|Overall Study||25
10131102|NCT02657408|11263121|FG001|COMPLETED|Overall Study||22
10131103|NCT02657408|11263120|FG000|NOT COMPLETED|Overall Study||3
10131104|NCT02657408|11263121|FG001|NOT COMPLETED|Overall Study||7
10131105|NCT02657538|11263127|FG000|STARTED|Overall Study||35
10131106|NCT02657538|11263127|FG000|Received Near Infrared Transillumination|Overall Study||35
10131107|NCT02657538|11263127|FG000|Received Visual Caries Detection + Bite|Overall Study||35
10131108|NCT02657538|11263127|FG000|COMPLETED|Overall Study||31
10131109|NCT02657538|11263127|FG000|NOT COMPLETED|Overall Study||4
10131110|NCT02657564|11263134|FG000|STARTED|Overall Study||1237
10131111|NCT02657564|11263134|FG000|COMPLETED|Overall Study||1163
10131112|NCT02657564|11263134|FG000|NOT COMPLETED|Overall Study||74
10131113|NCT02657629|11263141|FG000|STARTED|Overall Study||14
10131114|NCT02657629|11263142|FG001|STARTED|Overall Study||14
10131115|NCT02657629|11263141|FG000|COMPLETED|Overall Study||12
10131116|NCT02657629|11263142|FG001|COMPLETED|Overall Study||14
10131117|NCT02657629|11263141|FG000|NOT COMPLETED|Overall Study||2
10131118|NCT02657629|11263142|FG001|NOT COMPLETED|Overall Study||0
10131119|NCT02657889|11263152|FG000|STARTED|Overall Study||7
10131120|NCT02657889|11263153|FG001|STARTED|Overall Study||7
10131121|NCT02657889|11263154|FG002|STARTED|Overall Study||53
10131122|NCT02657889|11263155|FG003|STARTED|Overall Study||55
10131123|NCT02657889|11263152|FG000|COMPLETED|Overall Study||0
10131124|NCT02657889|11263153|FG001|COMPLETED|Overall Study||0
10131125|NCT02657889|11263154|FG002|COMPLETED|Overall Study||0
10131126|NCT02657889|11263155|FG003|COMPLETED|Overall Study||0
10131127|NCT02657889|11263152|FG000|NOT COMPLETED|Overall Study||7
10131128|NCT02657889|11263153|FG001|NOT COMPLETED|Overall Study||7
10131129|NCT02657889|11263154|FG002|NOT COMPLETED|Overall Study||53
10131130|NCT02657889|11263155|FG003|NOT COMPLETED|Overall Study||55
10131131|NCT02657915|11263169|FG000|STARTED|Overall Study||24
10131132|NCT02657915|11263170|FG001|STARTED|Overall Study||28
10131133|NCT02657915|11263169|FG000|Intent-to Treat (ITT) Population|Overall Study||24
10131134|NCT02657915|11263170|FG001|Intent-to Treat (ITT) Population|Overall Study||28
10131135|NCT02657915|11263169|FG000|Per-protocol Population|Overall Study||23
10131136|NCT02657915|11263170|FG001|Per-protocol Population|Overall Study||24
10131137|NCT02657915|11263169|FG000|COMPLETED|Overall Study||24
10131138|NCT02657915|11263170|FG001|COMPLETED|Overall Study||28
10131139|NCT02657915|11263169|FG000|NOT COMPLETED|Overall Study||0
10131140|NCT02657915|11263170|FG001|NOT COMPLETED|Overall Study||0
10131141|NCT02657928|11263178|FG000|STARTED|Overall Study||20
10131142|NCT02657928|11263179|FG001|STARTED|Overall Study||20
10131143|NCT02657928|11263178|FG000|COMPLETED|Overall Study||20
10131144|NCT02657928|11263179|FG001|COMPLETED|Overall Study||20
10131145|NCT02657928|11263178|FG000|NOT COMPLETED|Overall Study||0
10131146|NCT02657928|11263179|FG001|NOT COMPLETED|Overall Study||0
10131147|NCT02658019|11263186|FG000|STARTED|Overall Study||29
10131148|NCT02658019|11263186|FG000|COMPLETED|Overall Study||28
10131149|NCT02658019|11263186|FG000|NOT COMPLETED|Overall Study||1
10131150|NCT02658084|11263192|FG000|STARTED|Overall Study||2
10131151|NCT02658084|11263193|FG001|STARTED|Overall Study||0
10131152|NCT02658084|11263192|FG000|COMPLETED|Overall Study||0
10131153|NCT02658084|11263193|FG001|COMPLETED|Overall Study||0
10131154|NCT02658084|11263192|FG000|NOT COMPLETED|Overall Study||2
10131155|NCT02658084|11263193|FG001|NOT COMPLETED|Overall Study||0
10131156|NCT02658149|11263200|FG000|STARTED|Overall Study||50
10131157|NCT02658149|11263201|FG001|STARTED|Overall Study||50
10131158|NCT02658149|11263200|FG000|COMPLETED|Overall Study||49
10131159|NCT02658149|11263201|FG001|COMPLETED|Overall Study||50
10131160|NCT02658149|11263200|FG000|NOT COMPLETED|Overall Study||1
10131161|NCT02658149|11263201|FG001|NOT COMPLETED|Overall Study||0
10131162|NCT02658175|11263210|FG000|STARTED|Treatment Period: Weeks 1 to 52||51
10131163|NCT02658175|11263211|FG001|STARTED|Treatment Period: Weeks 1 to 52||14
10131164|NCT02658175|11263212|FG002|STARTED|Treatment Period: Weeks 1 to 52||3
10131165|NCT02658175|11263210|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36
10131166|NCT02658175|11263211|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7
10131167|NCT02658175|11263212|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3
10131168|NCT02658175|11263210|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
10131169|NCT02658175|11263211|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
10131170|NCT02658175|11263212|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
10131171|NCT02658175|11263210|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36
10131172|NCT02658175|11263211|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7
10131173|NCT02658175|11263212|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3
10131174|NCT02658175|11263210|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
10131175|NCT02658175|11263211|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
10131176|NCT02658175|11263212|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
10131177|NCT02658175|11263210|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
10131178|NCT02658175|11263211|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
10131179|NCT02658175|11263212|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
10131180|NCT02658175|11263210|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1
10131181|NCT02658175|11263211|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0
10131182|NCT02658175|11263212|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1
10131183|NCT02658175|11263210|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10131184|NCT02658175|11263211|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10131185|NCT02658175|11263212|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10131186|NCT02658175|11263210|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
10131187|NCT02658175|11263211|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10131188|NCT02658175|11263212|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
10131189|NCT02658240|11263222|FG000|STARTED|Overall Study||30
10131190|NCT02658240|11263223|FG001|STARTED|Overall Study||30
10131191|NCT02658240|11263222|FG000|COMPLETED|Overall Study||30
10131192|NCT02658240|11263223|FG001|COMPLETED|Overall Study||30
10131193|NCT02658240|11263222|FG000|NOT COMPLETED|Overall Study||0
10131194|NCT02658240|11263223|FG001|NOT COMPLETED|Overall Study||0
10131195|NCT02658448|11263229|FG000|STARTED|Overall Study||19
10131196|NCT02658448|11263229|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
10131197|NCT02658448|11263229|FG000|NOT COMPLETED|Overall Study||1
10131198|NCT02658461|11263236|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
10131199|NCT02658461|11263237|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
10131200|NCT02658461|11263238|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
10131201|NCT02658461|11263236|FG000|COMPLETED|Overall Study||12
10131202|NCT02658461|11263237|FG001|COMPLETED|Overall Study||12
10131203|NCT02658461|11263238|FG002|COMPLETED|Overall Study||12
10131204|NCT02658461|11263236|FG000|NOT COMPLETED|Overall Study||0
10131205|NCT02658461|11263237|FG001|NOT COMPLETED|Overall Study||0
10131206|NCT02658461|11263238|FG002|NOT COMPLETED|Overall Study||0
10131207|NCT02658487|11263248|FG000|STARTED|Overall Study||42
10131208|NCT02658487|11263248|FG000|COMPLETED|Overall Study||26
10131209|NCT02658487|11263248|FG000|NOT COMPLETED|Overall Study||16
10131210|NCT02658630|11263253|FG000|STARTED|Overall Study||46
10131211|NCT02658630|11263253|FG000|COMPLETED|Overall Study||42
10131212|NCT02658630|11263253|FG000|NOT COMPLETED|Overall Study||4
10131213|NCT02658734|11263257|FG000|STARTED|Overall Study||70
10131214|NCT02658734|11263257|FG000|COMPLETED|Overall Study||13
10131215|NCT02658734|11263257|FG000|NOT COMPLETED|Overall Study||57
10131216|NCT02658851|11263261|FG000|STARTED|Overall Study||100
10131217|NCT02658851|11263261|FG000|COMPLETED|Overall Study||100
10131218|NCT02658851|11263261|FG000|NOT COMPLETED|Overall Study||0
10131219|NCT02658994|11263268|FG000|STARTED|Enrollment||287
10131220|NCT02658994|11263269|FG001|STARTED|Enrollment||283
10131221|NCT02658994|11263270|FG002|STARTED|Enrollment||584
10131222|NCT02658994|11263268|FG000|COMPLETED|Enrollment||287
10131223|NCT02658994|11263269|FG001|COMPLETED|Enrollment||283
10131224|NCT02658994|11263270|FG002|COMPLETED|Enrollment||584
10131225|NCT02658994|11263268|FG000|NOT COMPLETED|Enrollment||0
10131226|NCT02658994|11263269|FG001|NOT COMPLETED|Enrollment||0
10131227|NCT02658994|11263270|FG002|NOT COMPLETED|Enrollment||0
9706857|NCT00534976|10805960|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33
9706858|NCT00534976|10805961|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33
9706859|NCT00534976|10805960|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
9706860|NCT00534976|10805961|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
9706861|NCT00534976|10805960|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
9706862|NCT00534976|10805961|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
9706863|NCT00534976|10805960|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33
9706864|NCT00534976|10805961|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32
9706865|NCT00534976|10805960|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
9706866|NCT00534976|10805961|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
9706867|NCT00534976|10805960|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
9706868|NCT00534976|10805961|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
9706869|NCT00337675|10805970|FG000|STARTED|Overall Study||589
9706870|NCT00337675|10805971|FG001|STARTED|Overall Study||591
9706871|NCT00337675|10805972|FG002|STARTED|Overall Study||591
9706872|NCT00337675|10805970|FG000|COMPLETED|Overall Study||492
9706873|NCT00337675|10805971|FG001|COMPLETED|Overall Study||488
9706874|NCT00337675|10805972|FG002|COMPLETED|Overall Study||492
9706875|NCT00337675|10805970|FG000|NOT COMPLETED|Overall Study||97
9706876|NCT00337675|10805971|FG001|NOT COMPLETED|Overall Study||103
9706877|NCT00337675|10805972|FG002|NOT COMPLETED|Overall Study||99
9706878|NCT00317772|10805984|FG000|STARTED|Overall Study||3
9706879|NCT00317772|10805985|FG001|STARTED|Overall Study||3
9706880|NCT00317772|10805986|FG002|STARTED|Overall Study||3
9706881|NCT00317772|10805987|FG003|STARTED|Overall Study||10
9706882|NCT00317772|10805984|FG000|COMPLETED|Overall Study||1
9706883|NCT00317772|10805985|FG001|COMPLETED|Overall Study||1
9706884|NCT00317772|10805986|FG002|COMPLETED|Overall Study||2
9706885|NCT00317772|10805987|FG003|COMPLETED|Overall Study||1
9706886|NCT00317772|10805984|FG000|NOT COMPLETED|Overall Study||2
9706887|NCT00317772|10805985|FG001|NOT COMPLETED|Overall Study||2
9706888|NCT00317772|10805986|FG002|NOT COMPLETED|Overall Study||1
9706889|NCT00317772|10805987|FG003|NOT COMPLETED|Overall Study||9
9706890|NCT00291486|10806003|FG000|STARTED|Overall Study||3
9706891|NCT00291486|10806004|FG001|STARTED|Overall Study||6
9706892|NCT00291486|10806005|FG002|STARTED|Overall Study||3
9706893|NCT00291486|10806006|FG003|STARTED|Overall Study||3
9706894|NCT00291486|10806007|FG004|STARTED|Overall Study||4
9706895|NCT00291486|10806003|FG000|COMPLETED|Overall Study||2
9706896|NCT00291486|10806004|FG001|COMPLETED|Overall Study||3
9706897|NCT00291486|10806005|FG002|COMPLETED|Overall Study||2
9706898|NCT00291486|10806006|FG003|COMPLETED|Overall Study||2
9706899|NCT00291486|10806007|FG004|COMPLETED|Overall Study||3
9706900|NCT00291486|10806003|FG000|NOT COMPLETED|Overall Study||1
9706901|NCT00291486|10806004|FG001|NOT COMPLETED|Overall Study||3
9706902|NCT00291486|10806005|FG002|NOT COMPLETED|Overall Study||1
9706903|NCT00291486|10806006|FG003|NOT COMPLETED|Overall Study||1
9706904|NCT00291486|10806007|FG004|NOT COMPLETED|Overall Study||1
9706905|NCT00284856|10806031|FG000|STARTED|Overall Study||347
9706906|NCT00284856|10806032|FG001|STARTED|Overall Study||336
9706907|NCT00284856|10806033|FG002|STARTED|Overall Study||336
9706908|NCT00284856|10806031|FG000|COMPLETED|Overall Study||296
9706909|NCT00284856|10806032|FG001|COMPLETED|Overall Study||286
9706910|NCT00284856|10806033|FG002|COMPLETED|Overall Study||276
9706911|NCT00284856|10806031|FG000|NOT COMPLETED|Overall Study||51
9706912|NCT00284856|10806032|FG001|NOT COMPLETED|Overall Study||50
9706913|NCT00284856|10806033|FG002|NOT COMPLETED|Overall Study||60
9706914|NCT00070707|10806043|FG000|STARTED|Overall Study||113
9706915|NCT00070707|10806044|FG001|STARTED|Overall Study||75
9706916|NCT00070707|10806043|FG000|COMPLETED|Overall Study||99
9706917|NCT00070707|10806044|FG001|COMPLETED|Overall Study||68
9706918|NCT00070707|10806043|FG000|NOT COMPLETED|Overall Study||14
9706919|NCT00070707|10806044|FG001|NOT COMPLETED|Overall Study||7
9729160|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
9729161|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
9729162|NCT00116805|10828725|FG000|STARTED|Open-label Period Weeks 433 - 480||57
9729163|NCT00116805|10828726|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
9729164|NCT00116805|10828725|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53
9729165|NCT00116805|10828726|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29
9729166|NCT00116805|10828725|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
9729167|NCT00116805|10828726|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
9729168|NCT00116831|10828743|FG000|STARTED|Overall Study||337
9729169|NCT00116831|10828744|FG001|STARTED|Overall Study||331
10131228|NCT02658994|11263268|FG000|STARTED|3 Month Follow up||287
10131229|NCT02658994|11263269|FG001|STARTED|3 Month Follow up||283
10131230|NCT02658994|11263270|FG002|STARTED|3 Month Follow up||584
10131231|NCT02658994|11263268|FG000|COMPLETED|3 Month Follow up||221
10131232|NCT02658994|11263269|FG001|COMPLETED|3 Month Follow up||223
10131233|NCT02658994|11263270|FG002|COMPLETED|3 Month Follow up||451
10131234|NCT02658994|11263268|FG000|NOT COMPLETED|3 Month Follow up||66
10131235|NCT02658994|11263269|FG001|NOT COMPLETED|3 Month Follow up||60
10131236|NCT02658994|11263270|FG002|NOT COMPLETED|3 Month Follow up||133
10131237|NCT02658994|11263268|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
10131238|NCT02658994|11263269|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
10131239|NCT02658994|11263270|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
10131240|NCT02658994|11263268|FG000|COMPLETED|6 Month Follow up||228
10131241|NCT02658994|11263269|FG001|COMPLETED|6 Month Follow up||230
10131242|NCT02658994|11263270|FG002|COMPLETED|6 Month Follow up||471
10131243|NCT02658994|11263268|FG000|NOT COMPLETED|6 Month Follow up||59
10131244|NCT02658994|11263269|FG001|NOT COMPLETED|6 Month Follow up||53
10131245|NCT02658994|11263270|FG002|NOT COMPLETED|6 Month Follow up||113
10131246|NCT02658994|11263268|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
10131247|NCT02658994|11263269|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
10131248|NCT02658994|11263270|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
10131249|NCT02658994|11263268|FG000|COMPLETED|12 Month Follow up||228
10131250|NCT02658994|11263269|FG001|COMPLETED|12 Month Follow up||223
10131251|NCT02658994|11263270|FG002|COMPLETED|12 Month Follow up||489
10131252|NCT02658994|11263268|FG000|NOT COMPLETED|12 Month Follow up||59
10131253|NCT02658994|11263269|FG001|NOT COMPLETED|12 Month Follow up||60
10131254|NCT02658994|11263270|FG002|NOT COMPLETED|12 Month Follow up||95
10131255|NCT02658994|11263268|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
10131256|NCT02658994|11263269|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
10131257|NCT02658994|11263270|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
10131258|NCT02658994|11263268|FG000|COMPLETED|24 Month Follow up||220
10131259|NCT02658994|11263269|FG001|COMPLETED|24 Month Follow up||210
10131260|NCT02658994|11263270|FG002|COMPLETED|24 Month Follow up||473
10131261|NCT02658994|11263268|FG000|NOT COMPLETED|24 Month Follow up||67
10131262|NCT02658994|11263269|FG001|NOT COMPLETED|24 Month Follow up||73
10131263|NCT02658994|11263270|FG002|NOT COMPLETED|24 Month Follow up||111
10131264|NCT02658994|11263268|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
10131265|NCT02658994|11263269|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
10131266|NCT02658994|11263270|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
10131267|NCT02658994|11263268|FG000|COMPLETED|36 Month Follow up||216
10131268|NCT02658994|11263269|FG001|COMPLETED|36 Month Follow up||206
10131269|NCT02658994|11263270|FG002|COMPLETED|36 Month Follow up||467
10131270|NCT02658994|11263268|FG000|NOT COMPLETED|36 Month Follow up||71
10131271|NCT02658994|11263269|FG001|NOT COMPLETED|36 Month Follow up||77
10131272|NCT02658994|11263270|FG002|NOT COMPLETED|36 Month Follow up||117
10131273|NCT02659098|11263279|FG000|STARTED|Overall Study||21
10131274|NCT02659098|11263279|FG000|COMPLETED|Overall Study||14
10131275|NCT02659098|11263279|FG000|NOT COMPLETED|Overall Study||7
10131276|NCT02659150|11263283|FG000|STARTED|Subject Enrollment||16
10131277|NCT02659150|11263283|FG000|COMPLETED|Subject Enrollment||11
10131278|NCT02659150|11263283|FG000|NOT COMPLETED|Subject Enrollment||5
10131279|NCT02659150|11263283|FG000|STARTED|Baseline Imaging||11
10131280|NCT02659150|11263283|FG000|COMPLETED|Baseline Imaging||9
10131281|NCT02659150|11263283|FG000|NOT COMPLETED|Baseline Imaging||2
10131282|NCT02659150|11263283|FG000|STARTED|Study Drug Dosing||9
10131283|NCT02659150|11263283|FG000|COMPLETED|Study Drug Dosing||8
10131284|NCT02659150|11263283|FG000|NOT COMPLETED|Study Drug Dosing||1
10131285|NCT02659150|11263283|FG000|STARTED|Follow-up Imaging||8
10131286|NCT02659150|11263283|FG000|COMPLETED|Follow-up Imaging||8
10131287|NCT02659150|11263283|FG000|NOT COMPLETED|Follow-up Imaging||0
10131288|NCT02659501|11263290|FG000|STARTED|Overall Study||12
10131289|NCT02659501|11263291|FG001|STARTED|Overall Study||12
10131290|NCT02659501|11263290|FG000|COMPLETED|Overall Study||12
10131291|NCT02659501|11263291|FG001|COMPLETED|Overall Study||12
10131292|NCT02659501|11263290|FG000|NOT COMPLETED|Overall Study||0
10131293|NCT02659501|11263291|FG001|NOT COMPLETED|Overall Study||0
10131294|NCT02659540|11263299|FG000|STARTED|Overall Study||10
10131295|NCT02659540|11263300|FG001|STARTED|Overall Study||10
10131296|NCT02659540|11263299|FG000|COMPLETED|Overall Study||4
10131297|NCT02659540|11263300|FG001|COMPLETED|Overall Study||2
10131298|NCT02659540|11263299|FG000|NOT COMPLETED|Overall Study||6
10131299|NCT02659540|11263300|FG001|NOT COMPLETED|Overall Study||8
10131300|NCT02659631|11263316|FG000|STARTED|Overall Study||1
10131301|NCT02659631|11263317|FG001|STARTED|Overall Study||2
10131302|NCT02659631|11263318|FG002|STARTED|Overall Study||3
10131303|NCT02659631|11263319|FG003|STARTED|Overall Study||2
10131304|NCT02659631|11263320|FG004|STARTED|Overall Study||5
10131305|NCT02659631|11263321|FG005|STARTED|Overall Study||5
10131306|NCT02659631|11263322|FG006|STARTED|Overall Study||4
10131307|NCT02659631|11263323|FG007|STARTED|Overall Study||3
10131308|NCT02659631|11263324|FG008|STARTED|Overall Study||2
10131309|NCT02659631|11263325|FG009|STARTED|Overall Study||1
10131310|NCT02659631|11263316|FG000|COMPLETED|Overall Study||0
10131311|NCT02659631|11263317|FG001|COMPLETED|Overall Study||0
10131312|NCT02659631|11263318|FG002|COMPLETED|Overall Study||0
10131313|NCT02659631|11263319|FG003|COMPLETED|Overall Study||0
10131314|NCT02659631|11263320|FG004|COMPLETED|Overall Study||0
10131315|NCT02659631|11263321|FG005|COMPLETED|Overall Study||2
10131316|NCT02659631|11263322|FG006|COMPLETED|Overall Study||3
10131317|NCT02659631|11263323|FG007|COMPLETED|Overall Study||0
10131318|NCT02659631|11263324|FG008|COMPLETED|Overall Study||0
10131319|NCT02659631|11263325|FG009|COMPLETED|Overall Study||1
10131320|NCT02659631|11263316|FG000|NOT COMPLETED|Overall Study||1
10131321|NCT02659631|11263317|FG001|NOT COMPLETED|Overall Study||2
10131322|NCT02659631|11263318|FG002|NOT COMPLETED|Overall Study||3
10131323|NCT02659631|11263319|FG003|NOT COMPLETED|Overall Study||2
10131324|NCT02659631|11263320|FG004|NOT COMPLETED|Overall Study||5
10131325|NCT02659631|11263321|FG005|NOT COMPLETED|Overall Study||3
10131326|NCT02659631|11263322|FG006|NOT COMPLETED|Overall Study||1
10131327|NCT02659631|11263323|FG007|NOT COMPLETED|Overall Study||3
10131328|NCT02659631|11263324|FG008|NOT COMPLETED|Overall Study||2
10131329|NCT02659631|11263325|FG009|NOT COMPLETED|Overall Study||0
10196571|NCT03363906|11324781|FG000|COMPLETED|Period 1 (Reference or Test)||14
10196572|NCT03363906|11324782|FG001|COMPLETED|Period 1 (Reference or Test)||10
10196573|NCT03363906|11324781|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1
10196574|NCT03363906|11324782|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2
10196575|NCT03363906|11324781|FG000|STARTED|Period 2 (Test or Reference)||14
10196576|NCT03363906|11324782|FG001|STARTED|Period 2 (Test or Reference)||10
10196577|NCT03363906|11324781|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
10196578|NCT03363906|11324782|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
10196579|NCT03363906|11324781|FG000|COMPLETED|Period 2 (Test or Reference)||10
10196580|NCT03363906|11324782|FG001|COMPLETED|Period 2 (Test or Reference)||9
10196581|NCT03363906|11324781|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4
10196582|NCT03363906|11324782|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1
10131330|NCT02659709|11263349|FG000|STARTED|Overall Study||50
10131331|NCT02659709|11263349|FG000|COMPLETED|Overall Study||50
10131332|NCT02659709|11263349|FG000|NOT COMPLETED|Overall Study||0
10131333|NCT02659787|11263353|FG000|STARTED|First Intervention (1 Day)||19
10131334|NCT02659787|11263354|FG001|STARTED|First Intervention (1 Day)||19
10131335|NCT02659787|11263353|FG000|COMPLETED|First Intervention (1 Day)||19
10131336|NCT02659787|11263354|FG001|COMPLETED|First Intervention (1 Day)||19
10131337|NCT02659787|11263353|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10131338|NCT02659787|11263354|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10131339|NCT02659787|11263353|FG000|STARTED|Washout (3 Days)||19
10131340|NCT02659787|11263354|FG001|STARTED|Washout (3 Days)||19
10131341|NCT02659787|11263353|FG000|COMPLETED|Washout (3 Days)||19
10131342|NCT02659787|11263354|FG001|COMPLETED|Washout (3 Days)||19
10131343|NCT02659787|11263353|FG000|NOT COMPLETED|Washout (3 Days)||0
10131344|NCT02659787|11263354|FG001|NOT COMPLETED|Washout (3 Days)||0
10131345|NCT02659787|11263353|FG000|STARTED|Second Intervention (1 Day)||19
10131346|NCT02659787|11263354|FG001|STARTED|Second Intervention (1 Day)||19
10131347|NCT02659787|11263353|FG000|COMPLETED|Second Intervention (1 Day)||19
10131348|NCT02659787|11263354|FG001|COMPLETED|Second Intervention (1 Day)||19
10131349|NCT02659787|11263353|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10131350|NCT02659787|11263354|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10131351|NCT02659943|11263367|FG000|STARTED|Overall Study||3
10131352|NCT02659943|11263368|FG001|STARTED|Overall Study||2
10131353|NCT02659943|11263369|FG002|STARTED|Overall Study||1
10131354|NCT02659943|11263370|FG003|STARTED|Overall Study||4
10131355|NCT02659943|11263371|FG004|STARTED|Overall Study||2
10131356|NCT02659943|11263372|FG005|STARTED|Overall Study||9
10131357|NCT02659943|11263373|FG006|STARTED|Overall Study||6
10131358|NCT02659943|11263367|FG000|COMPLETED|Overall Study||2
10131359|NCT02659943|11263368|FG001|COMPLETED|Overall Study||0
10131360|NCT02659943|11263369|FG002|COMPLETED|Overall Study||0
10131361|NCT02659943|11263370|FG003|COMPLETED|Overall Study||1
10131362|NCT02659943|11263371|FG004|COMPLETED|Overall Study||0
10131363|NCT02659943|11263372|FG005|COMPLETED|Overall Study||4
10131364|NCT02659943|11263373|FG006|COMPLETED|Overall Study||0
10131365|NCT02659943|11263367|FG000|NOT COMPLETED|Overall Study||1
10131366|NCT02659943|11263368|FG001|NOT COMPLETED|Overall Study||2
10131367|NCT02659943|11263369|FG002|NOT COMPLETED|Overall Study||1
10131368|NCT02659943|11263370|FG003|NOT COMPLETED|Overall Study||3
10131369|NCT02659943|11263371|FG004|NOT COMPLETED|Overall Study||2
10131370|NCT02659943|11263372|FG005|NOT COMPLETED|Overall Study||5
10131371|NCT02659943|11263373|FG006|NOT COMPLETED|Overall Study||6
10131372|NCT02660112|11263394|FG000|STARTED|Overall Study||10
10131373|NCT02660112|11263394|FG000|COMPLETED|Overall Study||10
10131374|NCT02660112|11263394|FG000|NOT COMPLETED|Overall Study||0
10131375|NCT02660138|11263401|FG000|STARTED|Overall Study||76
10131376|NCT02660138|11263402|FG001|STARTED|Overall Study||76
10131377|NCT02660138|11263403|FG002|STARTED|Overall Study||75
10131378|NCT02660138|11263401|FG000|Subjects Treated in DBPC Cycle|Overall Study||76
10131379|NCT02660138|11263402|FG001|Subjects Treated in DBPC Cycle|Overall Study||75
10131380|NCT02660138|11263403|FG002|Subjects Treated in DBPC Cycle|Overall Study||75
10131381|NCT02660138|11263401|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49
10131382|NCT02660138|11263402|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75
10131383|NCT02660138|11263403|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75
10131384|NCT02660138|11263401|FG000|COMPLETED|Overall Study||6
10131385|NCT02660138|11263402|FG001|COMPLETED|Overall Study||2
10131386|NCT02660138|11263403|FG002|COMPLETED|Overall Study||3
10131387|NCT02660138|11263401|FG000|NOT COMPLETED|Overall Study||70
10131388|NCT02660138|11263402|FG001|NOT COMPLETED|Overall Study||74
10131389|NCT02660138|11263403|FG002|NOT COMPLETED|Overall Study||72
10131390|NCT02660229|11263416|FG000|STARTED|Overall Study|Randomization|34
10131391|NCT02660229|11263417|FG001|STARTED|Overall Study|Randomization|32
10131392|NCT02660229|11263416|FG000|Safety Analysis Set|Overall Study||34
10131393|NCT02660229|11263417|FG001|Safety Analysis Set|Overall Study||32
10131394|NCT02660229|11263416|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
10131395|NCT02660229|11263417|FG001|FAS Set|Overall Study||32
10131396|NCT02660229|11263416|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
10131397|NCT02660229|11263417|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
10131398|NCT02660229|11263416|FG000|COMPLETED|Overall Study||32
10131399|NCT02660229|11263417|FG001|COMPLETED|Overall Study||31
10131400|NCT02660229|11263416|FG000|NOT COMPLETED|Overall Study||2
10131401|NCT02660229|11263417|FG001|NOT COMPLETED|Overall Study||1
10131402|NCT02660242|11263423|FG000|STARTED|Control||16
10131403|NCT02660242|11263423|FG000|COMPLETED|Control||16
10131404|NCT02660242|11263423|FG000|NOT COMPLETED|Control||0
10131405|NCT02660242|11263423|FG000|STARTED|Basal Insulin Reduction||16
10131406|NCT02660242|11263423|FG000|COMPLETED|Basal Insulin Reduction||16
10131407|NCT02660242|11263423|FG000|NOT COMPLETED|Basal Insulin Reduction||0
10131408|NCT02660242|11263423|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
10131409|NCT02660242|11263423|FG000|COMPLETED|Glucose Tabs||15
10131410|NCT02660242|11263423|FG000|NOT COMPLETED|Glucose Tabs||1
10131411|NCT02660242|11263423|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
10131412|NCT02660242|11263423|FG000|COMPLETED|Glucagon Injection||15
10131413|NCT02660242|11263423|FG000|NOT COMPLETED|Glucagon Injection||1
10131414|NCT02660359|11263439|FG000|STARTED|Overall Study||86
10131415|NCT02660359|11263440|FG001|STARTED|Overall Study||86
10131416|NCT02660359|11263441|FG002|STARTED|Overall Study||85
10131417|NCT02660359|11263439|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56
10131418|NCT02660359|11263440|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86
10131419|NCT02660359|11263441|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85
10131420|NCT02660359|11263439|FG000|COMPLETED|Overall Study||0
10131421|NCT02660359|11263440|FG001|COMPLETED|Overall Study||0
10131422|NCT02660359|11263441|FG002|COMPLETED|Overall Study||1
10131423|NCT02660359|11263439|FG000|NOT COMPLETED|Overall Study||86
10131424|NCT02660359|11263440|FG001|NOT COMPLETED|Overall Study||86
10131425|NCT02660359|11263441|FG002|NOT COMPLETED|Overall Study||84
10131426|NCT02660489|11263451|FG000|STARTED|Overall Study||22
10131427|NCT02660489|11263452|FG001|STARTED|Overall Study||22
10131428|NCT02660489|11263451|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
10131429|NCT02660489|11263452|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
10131430|NCT02660489|11263451|FG000|NOT COMPLETED|Overall Study||6
10131431|NCT02660489|11263452|FG001|NOT COMPLETED|Overall Study||8
10131432|NCT02660580|11263460|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222
10131433|NCT02660580|11263461|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221
10131434|NCT02660580|11263462|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0
10131435|NCT02660580|11263463|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0
10131436|NCT02660580|11263464|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0
10131437|NCT02660580|11263460|FG000|Treated|Core Treatment Period (Week 1 to 16)||221
10131438|NCT02660580|11263461|FG001|Treated|Core Treatment Period (Week 1 to 16)||220
10131439|NCT02660580|11263462|FG002|Treated|Core Treatment Period (Week 1 to 16)||0
10131440|NCT02660580|11263463|FG003|Treated|Core Treatment Period (Week 1 to 16)||0
10131441|NCT02660580|11263464|FG004|Treated|Core Treatment Period (Week 1 to 16)||0
10131442|NCT02660580|11263460|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213
10131443|NCT02660580|11263461|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202
10131444|NCT02660580|11263462|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0
10131445|NCT02660580|11263463|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0
10131446|NCT02660580|11263464|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0
10131447|NCT02660580|11263460|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
10131448|NCT02660580|11263461|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
10131449|NCT02660580|11263462|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
10131450|NCT02660580|11263463|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
10131451|NCT02660580|11263464|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
10131452|NCT02660580|11263460|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0
10131453|NCT02660580|11263461|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0
10131454|NCT02660580|11263462|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213
10131455|NCT02660580|11263463|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101
10131456|NCT02660580|11263464|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101
10131457|NCT02660580|11263460|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10131458|NCT02660580|11263461|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10131459|NCT02660580|11263462|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
10131460|NCT02660580|11263463|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
10131461|NCT02660580|11263464|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
10131462|NCT02660580|11263460|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10131463|NCT02660580|11263461|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10131464|NCT02660580|11263462|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
10131465|NCT02660580|11263463|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
10131466|NCT02660580|11263464|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
10131467|NCT02660788|11263485|FG000|STARTED|Overall Study||2749
10131468|NCT02660788|11263486|FG001|STARTED|Overall Study||2749
10131469|NCT02660788|11263485|FG000|COMPLETED|Overall Study||2749
10131470|NCT02660788|11263486|FG001|COMPLETED|Overall Study||2749
10131471|NCT02660788|11263485|FG000|NOT COMPLETED|Overall Study||0
10131472|NCT02660788|11263486|FG001|NOT COMPLETED|Overall Study||0
10131473|NCT02660801|11263492|FG000|STARTED|Overall Study||11
10131474|NCT02660801|11263493|FG001|STARTED|Overall Study||15
10131475|NCT02660801|11263492|FG000|COMPLETED|Overall Study||11
10131476|NCT02660801|11263493|FG001|COMPLETED|Overall Study||15
10131477|NCT02660801|11263492|FG000|NOT COMPLETED|Overall Study||0
10131478|NCT02660801|11263493|FG001|NOT COMPLETED|Overall Study||0
10131479|NCT02660853|11263499|FG000|STARTED|Overall Study||25
10131480|NCT02660853|11263499|FG000|COMPLETED|Overall Study||25
10131481|NCT02660853|11263499|FG000|NOT COMPLETED|Overall Study||0
10131482|NCT02660918|11263505|FG000|STARTED|Overall Study||42
10131483|NCT02660918|11263506|FG001|STARTED|Overall Study||42
10131484|NCT02660918|11263505|FG000|COMPLETED|Overall Study|Age ineligible|41
10131485|NCT02660918|11263506|FG001|COMPLETED|Overall Study|Age ineligible|41
10131486|NCT02660918|11263505|FG000|NOT COMPLETED|Overall Study||1
10131487|NCT02660918|11263506|FG001|NOT COMPLETED|Overall Study||1
10131488|NCT02660944|11263515|FG000|STARTED|Overall Study||42
10131489|NCT02660944|11263516|FG001|STARTED|Overall Study||22
10131490|NCT02660944|11263515|FG000|COMPLETED|Overall Study||25
10131491|NCT02660944|11263516|FG001|COMPLETED|Overall Study||12
10131492|NCT02660944|11263515|FG000|NOT COMPLETED|Overall Study||17
10131493|NCT02660944|11263516|FG001|NOT COMPLETED|Overall Study||10
10131494|NCT02660983|11263524|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154
10131495|NCT02660983|11263525|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148
10131496|NCT02660983|11263524|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
10131497|NCT02660983|11263525|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
10131498|NCT02660983|11263524|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
10131499|NCT02660983|11263525|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
10131500|NCT02660983|11263524|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
10131501|NCT02660983|11263525|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
10131502|NCT02660983|11263524|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
10131503|NCT02660983|11263525|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
10131504|NCT02660983|11263524|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86
10131505|NCT02660983|11263525|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75
10131506|NCT02660983|11263524|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83
10131507|NCT02660983|11263525|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66
10131508|NCT02660983|11263524|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
10131509|NCT02660983|11263525|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
10131510|NCT02661061|11263534|FG000|STARTED|Overall Study||5
10131511|NCT02661061|11263535|FG001|STARTED|Overall Study||4
10131512|NCT02661061|11263534|FG000|COMPLETED|Overall Study||3
10131513|NCT02661061|11263535|FG001|COMPLETED|Overall Study||2
10131514|NCT02661061|11263534|FG000|NOT COMPLETED|Overall Study||2
10131515|NCT02661061|11263535|FG001|NOT COMPLETED|Overall Study||2
10131516|NCT02661126|11263543|FG000|STARTED|Overall Study||8
10131517|NCT02661126|11263544|FG001|STARTED|Overall Study||8
10131518|NCT02661126|11263543|FG000|COMPLETED|Overall Study||8
10131519|NCT02661126|11263544|FG001|COMPLETED|Overall Study||8
10131520|NCT02661126|11263543|FG000|NOT COMPLETED|Overall Study||0
10131521|NCT02661126|11263544|FG001|NOT COMPLETED|Overall Study||0
10131522|NCT02661178|11263565|FG000|STARTED|Part 1||1
10131523|NCT02661178|11263566|FG001|STARTED|Part 1||5
10131524|NCT02661178|11263567|FG002|STARTED|Part 1||6
10131525|NCT02661178|11263568|FG003|STARTED|Part 1||6
10131526|NCT02661178|11263569|FG004|STARTED|Part 1||5
10131527|NCT02661178|11263570|FG005|STARTED|Part 1||6
10131528|NCT02661178|11263571|FG006|STARTED|Part 1||6
10131529|NCT02661178|11263572|FG007|STARTED|Part 1||6
10131530|NCT02661178|11263573|FG008|STARTED|Part 1||6
10131531|NCT02661178|11263574|FG009|STARTED|Part 1||12
10131532|NCT02661178|11263575|FG010|STARTED|Part 1||4
10131533|NCT02661178|11263576|FG011|STARTED|Part 1||0
10131534|NCT02661178|11263577|FG012|STARTED|Part 1||0
10131535|NCT02661178|11263578|FG013|STARTED|Part 1||0
10131536|NCT02661178|11263579|FG014|STARTED|Part 1||0
10131537|NCT02661178|11263565|FG000|COMPLETED|Part 1||0
10131538|NCT02661178|11263566|FG001|COMPLETED|Part 1||5
10131539|NCT02661178|11263567|FG002|COMPLETED|Part 1||6
10131540|NCT02661178|11263568|FG003|COMPLETED|Part 1||6
10131541|NCT02661178|11263569|FG004|COMPLETED|Part 1||5
10131542|NCT02661178|11263570|FG005|COMPLETED|Part 1||6
10131543|NCT02661178|11263571|FG006|COMPLETED|Part 1||6
10131544|NCT02661178|11263572|FG007|COMPLETED|Part 1||6
10131545|NCT02661178|11263573|FG008|COMPLETED|Part 1||6
10131546|NCT02661178|11263574|FG009|COMPLETED|Part 1||12
10131547|NCT02661178|11263575|FG010|COMPLETED|Part 1||4
10131548|NCT02661178|11263576|FG011|COMPLETED|Part 1||0
10131549|NCT02661178|11263577|FG012|COMPLETED|Part 1||0
10131550|NCT02661178|11263578|FG013|COMPLETED|Part 1||0
10131551|NCT02661178|11263579|FG014|COMPLETED|Part 1||0
10131552|NCT02661178|11263565|FG000|NOT COMPLETED|Part 1||1
10131553|NCT02661178|11263566|FG001|NOT COMPLETED|Part 1||0
10131554|NCT02661178|11263567|FG002|NOT COMPLETED|Part 1||0
10131555|NCT02661178|11263568|FG003|NOT COMPLETED|Part 1||0
10131556|NCT02661178|11263569|FG004|NOT COMPLETED|Part 1||0
10131557|NCT02661178|11263570|FG005|NOT COMPLETED|Part 1||0
10131558|NCT02661178|11263571|FG006|NOT COMPLETED|Part 1||0
10131559|NCT02661178|11263572|FG007|NOT COMPLETED|Part 1||0
10131560|NCT02661178|11263573|FG008|NOT COMPLETED|Part 1||0
10131561|NCT02661178|11263574|FG009|NOT COMPLETED|Part 1||0
10131562|NCT02661178|11263575|FG010|NOT COMPLETED|Part 1||0
10131563|NCT02661178|11263576|FG011|NOT COMPLETED|Part 1||0
10131564|NCT02661178|11263577|FG012|NOT COMPLETED|Part 1||0
10131565|NCT02661178|11263578|FG013|NOT COMPLETED|Part 1||0
10131566|NCT02661178|11263579|FG014|NOT COMPLETED|Part 1||0
10131567|NCT02661178|11263565|FG000|STARTED|Part 2||0
10131568|NCT02661178|11263566|FG001|STARTED|Part 2||0
10131569|NCT02661178|11263567|FG002|STARTED|Part 2||0
10131570|NCT02661178|11263568|FG003|STARTED|Part 2||0
10131571|NCT02661178|11263569|FG004|STARTED|Part 2||0
10131572|NCT02661178|11263570|FG005|STARTED|Part 2||0
10131573|NCT02661178|11263571|FG006|STARTED|Part 2||0
10131574|NCT02661178|11263572|FG007|STARTED|Part 2||0
10131575|NCT02661178|11263573|FG008|STARTED|Part 2||0
10131576|NCT02661178|11263574|FG009|STARTED|Part 2||0
10131577|NCT02661178|11263575|FG010|STARTED|Part 2||0
10131578|NCT02661178|11263576|FG011|STARTED|Part 2||6
10131579|NCT02661178|11263577|FG012|STARTED|Part 2||6
10131580|NCT02661178|11263578|FG013|STARTED|Part 2||2
10131581|NCT02661178|11263579|FG014|STARTED|Part 2||2
10131582|NCT02661178|11263565|FG000|COMPLETED|Part 2||0
10131583|NCT02661178|11263566|FG001|COMPLETED|Part 2||0
10131584|NCT02661178|11263567|FG002|COMPLETED|Part 2||0
10131585|NCT02661178|11263568|FG003|COMPLETED|Part 2||0
10131586|NCT02661178|11263569|FG004|COMPLETED|Part 2||0
10131587|NCT02661178|11263570|FG005|COMPLETED|Part 2||0
10131588|NCT02661178|11263571|FG006|COMPLETED|Part 2||0
10131589|NCT02661178|11263572|FG007|COMPLETED|Part 2||0
10131590|NCT02661178|11263573|FG008|COMPLETED|Part 2||0
10131591|NCT02661178|11263574|FG009|COMPLETED|Part 2||0
10131592|NCT02661178|11263575|FG010|COMPLETED|Part 2||0
10131593|NCT02661178|11263576|FG011|COMPLETED|Part 2||6
10131594|NCT02661178|11263577|FG012|COMPLETED|Part 2||6
10131595|NCT02661178|11263578|FG013|COMPLETED|Part 2||2
10131596|NCT02661178|11263579|FG014|COMPLETED|Part 2||2
10131597|NCT02661178|11263565|FG000|NOT COMPLETED|Part 2||0
10131598|NCT02661178|11263566|FG001|NOT COMPLETED|Part 2||0
10131599|NCT02661178|11263567|FG002|NOT COMPLETED|Part 2||0
10131600|NCT02661178|11263568|FG003|NOT COMPLETED|Part 2||0
10131601|NCT02661178|11263569|FG004|NOT COMPLETED|Part 2||0
10131602|NCT02661178|11263570|FG005|NOT COMPLETED|Part 2||0
10131603|NCT02661178|11263571|FG006|NOT COMPLETED|Part 2||0
10131604|NCT02661178|11263572|FG007|NOT COMPLETED|Part 2||0
10131605|NCT02661178|11263573|FG008|NOT COMPLETED|Part 2||0
10131606|NCT02661178|11263574|FG009|NOT COMPLETED|Part 2||0
10131607|NCT02661178|11263575|FG010|NOT COMPLETED|Part 2||0
10131608|NCT02661178|11263576|FG011|NOT COMPLETED|Part 2||0
10131609|NCT02661178|11263577|FG012|NOT COMPLETED|Part 2||0
10131610|NCT02661178|11263578|FG013|NOT COMPLETED|Part 2||0
10131611|NCT02661178|11263579|FG014|NOT COMPLETED|Part 2||0
10131612|NCT02661217|11263631|FG000|STARTED|Overall Study||500
10131613|NCT02661217|11263632|FG001|STARTED|Overall Study||502
10131614|NCT02661217|11263631|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497
10131615|NCT02661217|11263632|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501
10131616|NCT02661217|11263631|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460
10131617|NCT02661217|11263632|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455
10131618|NCT02661217|11263631|FG000|COMPLETED|Overall Study||425
10131619|NCT02661217|11263632|FG001|COMPLETED|Overall Study||419
10131620|NCT02661217|11263631|FG000|NOT COMPLETED|Overall Study||75
10131621|NCT02661217|11263632|FG001|NOT COMPLETED|Overall Study||83
10131622|NCT02661256|11263639|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
10131623|NCT02661256|11263639|FG000|COMPLETED|Overall Study||7
10131624|NCT02661256|11263639|FG000|NOT COMPLETED|Overall Study||0
10131625|NCT02661490|11263650|FG000|STARTED|Overall Study||76
10131626|NCT02661490|11263651|FG001|STARTED|Overall Study||74
10131627|NCT02661490|11263652|FG002|STARTED|Overall Study||72
10131628|NCT02661490|11263653|FG003|STARTED|Overall Study||72
10131629|NCT02661490|11263654|FG004|STARTED|Overall Study||26
10131630|NCT02661490|11263650|FG000|COMPLETED|Overall Study||73
10131631|NCT02661490|11263651|FG001|COMPLETED|Overall Study||72
10131632|NCT02661490|11263652|FG002|COMPLETED|Overall Study||70
10131633|NCT02661490|11263653|FG003|COMPLETED|Overall Study||71
10131634|NCT02661490|11263654|FG004|COMPLETED|Overall Study||23
10131635|NCT02661490|11263650|FG000|NOT COMPLETED|Overall Study||3
10131636|NCT02661490|11263651|FG001|NOT COMPLETED|Overall Study||2
10131637|NCT02661490|11263652|FG002|NOT COMPLETED|Overall Study||2
10131638|NCT02661490|11263653|FG003|NOT COMPLETED|Overall Study||1
10131639|NCT02661490|11263654|FG004|NOT COMPLETED|Overall Study||3
10131640|NCT02661594|11263670|FG000|STARTED|Overall Study||10
10131641|NCT02661594|11263671|FG001|STARTED|Overall Study||11
10131642|NCT02661594|11263672|FG002|STARTED|Overall Study||10
10131643|NCT02661594|11263673|FG003|STARTED|Overall Study||9
10131644|NCT02661594|11263670|FG000|COMPLETED|Overall Study||9
10131645|NCT02661594|11263671|FG001|COMPLETED|Overall Study||11
10131646|NCT02661594|11263672|FG002|COMPLETED|Overall Study||9
10131647|NCT02661594|11263673|FG003|COMPLETED|Overall Study||9
10131648|NCT02661594|11263670|FG000|NOT COMPLETED|Overall Study||1
10131649|NCT02661594|11263671|FG001|NOT COMPLETED|Overall Study||0
10131650|NCT02661594|11263672|FG002|NOT COMPLETED|Overall Study||1
10131651|NCT02661594|11263673|FG003|NOT COMPLETED|Overall Study||0
10131652|NCT02661737|11263683|FG000|STARTED|Overall Study||503
10131653|NCT02661737|11263683|FG000|COMPLETED|Overall Study||469
10131654|NCT02661737|11263683|FG000|NOT COMPLETED|Overall Study||34
10131655|NCT02661815|11263691|FG000|STARTED|Overall Study||6
10131656|NCT02661815|11263692|FG001|STARTED|Overall Study||0
10131657|NCT02661815|11263693|FG002|STARTED|Overall Study||0
10131658|NCT02661815|11263694|FG003|STARTED|Overall Study||0
10131659|NCT02661815|11263691|FG000|COMPLETED|Overall Study||5
10131660|NCT02661815|11263692|FG001|COMPLETED|Overall Study||0
10131661|NCT02661815|11263693|FG002|COMPLETED|Overall Study||0
10131662|NCT02661815|11263694|FG003|COMPLETED|Overall Study||0
10131663|NCT02661815|11263691|FG000|NOT COMPLETED|Overall Study||1
10131664|NCT02661815|11263692|FG001|NOT COMPLETED|Overall Study||0
10131665|NCT02661815|11263693|FG002|NOT COMPLETED|Overall Study||0
10131666|NCT02661815|11263694|FG003|NOT COMPLETED|Overall Study||0
10131667|NCT02661828|11263710|FG000|STARTED|Overall Study||1
10131668|NCT02661828|11263711|FG001|STARTED|Overall Study||0
10131669|NCT02661828|11263710|FG000|COMPLETED|Overall Study||1
10131670|NCT02661828|11263711|FG001|COMPLETED|Overall Study||0
10131671|NCT02661828|11263710|FG000|NOT COMPLETED|Overall Study||0
10131672|NCT02661828|11263711|FG001|NOT COMPLETED|Overall Study||0
10131673|NCT02662023|11263718|FG000|STARTED|Overall Study||12
10131674|NCT02662023|11263719|FG001|STARTED|Overall Study||12
10131675|NCT02662023|11263718|FG000|COMPLETED|Overall Study||12
10131676|NCT02662023|11263719|FG001|COMPLETED|Overall Study||12
10131677|NCT02662023|11263718|FG000|NOT COMPLETED|Overall Study||0
10131678|NCT02662023|11263719|FG001|NOT COMPLETED|Overall Study||0
10131679|NCT02662036|11263727|FG000|STARTED|Overall Study||35
10131680|NCT02662036|11263728|FG001|STARTED|Overall Study||35
10131681|NCT02662036|11263727|FG000|COMPLETED|Overall Study||22
10131682|NCT02662036|11263728|FG001|COMPLETED|Overall Study||22
10131683|NCT02662036|11263727|FG000|NOT COMPLETED|Overall Study||13
10131684|NCT02662036|11263728|FG001|NOT COMPLETED|Overall Study||13
10131685|NCT02662244|11263734|FG000|STARTED|Overall Study||33
10131686|NCT02662244|11263734|FG000|COMPLETED|Overall Study||31
10131687|NCT02662244|11263734|FG000|NOT COMPLETED|Overall Study||2
10131688|NCT02662387|11263742|FG000|STARTED|Overall Study||27
10131689|NCT02662387|11263743|FG001|STARTED|Overall Study||28
10131690|NCT02662387|11263742|FG000|COMPLETED|Overall Study||27
10131691|NCT02662387|11263743|FG001|COMPLETED|Overall Study||28
10131692|NCT02662387|11263742|FG000|NOT COMPLETED|Overall Study||0
10131693|NCT02662387|11263743|FG001|NOT COMPLETED|Overall Study||0
10131694|NCT02662556|11263751|FG000|STARTED|Overall Study||140
10131695|NCT02662556|11263751|FG000|COMPLETED|Overall Study||132
10131696|NCT02662556|11263751|FG000|NOT COMPLETED|Overall Study||8
10131697|NCT02662569|11263760|FG000|STARTED|Overall Study||166
10131698|NCT02662569|11263761|FG001|STARTED|Overall Study||161
10131699|NCT02662569|11263762|FG002|STARTED|Overall Study||327
10131700|NCT02662569|11263763|FG003|STARTED|Overall Study||332
10131701|NCT02662569|11263760|FG000|Received Study Drug|Overall Study||164
10131702|NCT02662569|11263761|FG001|Received Study Drug|Overall Study||160
10131703|NCT02662569|11263762|FG002|Received Study Drug|Overall Study||325
10131704|NCT02662569|11263763|FG003|Received Study Drug|Overall Study||332
10131705|NCT02662569|11263760|FG000|COMPLETED|Overall Study||159
10131706|NCT02662569|11263761|FG001|COMPLETED|Overall Study||160
10131707|NCT02662569|11263762|FG002|COMPLETED|Overall Study||321
10131708|NCT02662569|11263763|FG003|COMPLETED|Overall Study||328
10131709|NCT02662569|11263760|FG000|NOT COMPLETED|Overall Study||7
10131710|NCT02662569|11263761|FG001|NOT COMPLETED|Overall Study||1
10131711|NCT02662569|11263762|FG002|NOT COMPLETED|Overall Study||6
10131712|NCT02662569|11263763|FG003|NOT COMPLETED|Overall Study||4
10131713|NCT02662582|11263775|FG000|STARTED|Treatment Period 1 (14 Days)||23
10131714|NCT02662582|11263776|FG001|STARTED|Treatment Period 1 (14 Days)||23
10131715|NCT02662582|11263775|FG000|COMPLETED|Treatment Period 1 (14 Days)||18
10131716|NCT02662582|11263776|FG001|COMPLETED|Treatment Period 1 (14 Days)||19
10131717|NCT02662582|11263775|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5
10131718|NCT02662582|11263776|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4
10131719|NCT02662582|11263775|FG000|STARTED|Washout Period (14 Days)||18
10131720|NCT02662582|11263776|FG001|STARTED|Washout Period (14 Days)||19
10131721|NCT02662582|11263775|FG000|COMPLETED|Washout Period (14 Days)||18
10131722|NCT02662582|11263776|FG001|COMPLETED|Washout Period (14 Days)||19
10131723|NCT02662582|11263775|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10131724|NCT02662582|11263776|FG001|NOT COMPLETED|Washout Period (14 Days)||0
10131725|NCT02662582|11263775|FG000|STARTED|Treatment Period 2 (14 Days)||18
10131726|NCT02662582|11263776|FG001|STARTED|Treatment Period 2 (14 Days)||19
10131727|NCT02662582|11263775|FG000|COMPLETED|Treatment Period 2 (14 Days)||18
10131728|NCT02662582|11263776|FG001|COMPLETED|Treatment Period 2 (14 Days)||19
10131729|NCT02662582|11263775|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10131730|NCT02662582|11263776|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10131731|NCT02662608|11263783|FG000|STARTED|Overall Study||1
10131732|NCT02662608|11263783|FG000|COMPLETED|Overall Study||1
10131733|NCT02662608|11263783|FG000|NOT COMPLETED|Overall Study||0
10131734|NCT02662764|11263787|FG000|STARTED|Overall Study||320
10131735|NCT02662764|11263787|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290
10131736|NCT02662764|11263787|FG000|NOT COMPLETED|Overall Study||30
10131737|NCT02663128|11263798|FG000|STARTED|Period 1||3
10131738|NCT02663128|11263799|FG001|STARTED|Period 1||3
10131739|NCT02663128|11263800|FG002|STARTED|Period 1||3
10131740|NCT02663128|11263801|FG003|STARTED|Period 1||3
10131741|NCT02663128|11263802|FG004|STARTED|Period 1||3
10131742|NCT02663128|11263803|FG005|STARTED|Period 1||3
10131743|NCT02663128|11263798|FG000|Received at Least One Dose of Study Drug|Period 1||3
10131744|NCT02663128|11263799|FG001|Received at Least One Dose of Study Drug|Period 1||3
10131745|NCT02663128|11263800|FG002|Received at Least One Dose of Study Drug|Period 1||3
10131746|NCT02663128|11263801|FG003|Received at Least One Dose of Study Drug|Period 1||3
10131747|NCT02663128|11263802|FG004|Received at Least One Dose of Study Drug|Period 1||3
10131748|NCT02663128|11263803|FG005|Received at Least One Dose of Study Drug|Period 1||3
10131749|NCT02663128|11263798|FG000|COMPLETED|Period 1||3
10131750|NCT02663128|11263799|FG001|COMPLETED|Period 1||3
10131751|NCT02663128|11263800|FG002|COMPLETED|Period 1||3
10131752|NCT02663128|11263801|FG003|COMPLETED|Period 1||3
10131753|NCT02663128|11263802|FG004|COMPLETED|Period 1||3
10131754|NCT02663128|11263803|FG005|COMPLETED|Period 1||3
10131755|NCT02663128|11263798|FG000|NOT COMPLETED|Period 1||0
10131756|NCT02663128|11263799|FG001|NOT COMPLETED|Period 1||0
10131757|NCT02663128|11263800|FG002|NOT COMPLETED|Period 1||0
10131758|NCT02663128|11263801|FG003|NOT COMPLETED|Period 1||0
10131759|NCT02663128|11263802|FG004|NOT COMPLETED|Period 1||0
10131760|NCT02663128|11263803|FG005|NOT COMPLETED|Period 1||0
10131761|NCT02663128|11263798|FG000|STARTED|Period 2||3
10131762|NCT02663128|11263799|FG001|STARTED|Period 2||3
10131763|NCT02663128|11263800|FG002|STARTED|Period 2||3
10131764|NCT02663128|11263801|FG003|STARTED|Period 2||3
10131765|NCT02663128|11263802|FG004|STARTED|Period 2||3
10131766|NCT02663128|11263803|FG005|STARTED|Period 2||3
10131767|NCT02663128|11263798|FG000|COMPLETED|Period 2||3
10131768|NCT02663128|11263799|FG001|COMPLETED|Period 2||3
10131769|NCT02663128|11263800|FG002|COMPLETED|Period 2||3
10131770|NCT02663128|11263801|FG003|COMPLETED|Period 2||3
10131771|NCT02663128|11263802|FG004|COMPLETED|Period 2||2
10131772|NCT02663128|11263803|FG005|COMPLETED|Period 2||3
10131773|NCT02663128|11263798|FG000|NOT COMPLETED|Period 2||0
10131774|NCT02663128|11263799|FG001|NOT COMPLETED|Period 2||0
10131775|NCT02663128|11263800|FG002|NOT COMPLETED|Period 2||0
10131776|NCT02663128|11263801|FG003|NOT COMPLETED|Period 2||0
10131777|NCT02663128|11263802|FG004|NOT COMPLETED|Period 2||1
10131778|NCT02663128|11263803|FG005|NOT COMPLETED|Period 2||0
10131779|NCT02663128|11263798|FG000|STARTED|Period 3||3
10131780|NCT02663128|11263799|FG001|STARTED|Period 3||3
10131781|NCT02663128|11263800|FG002|STARTED|Period 3||3
10131782|NCT02663128|11263801|FG003|STARTED|Period 3||3
10131783|NCT02663128|11263802|FG004|STARTED|Period 3||2
10131784|NCT02663128|11263803|FG005|STARTED|Period 3||3
10131785|NCT02663128|11263798|FG000|COMPLETED|Period 3||3
10131786|NCT02663128|11263799|FG001|COMPLETED|Period 3||3
10131787|NCT02663128|11263800|FG002|COMPLETED|Period 3||3
10131788|NCT02663128|11263801|FG003|COMPLETED|Period 3||3
10131789|NCT02663128|11263802|FG004|COMPLETED|Period 3||2
10131790|NCT02663128|11263803|FG005|COMPLETED|Period 3||3
10131791|NCT02663128|11263798|FG000|NOT COMPLETED|Period 3||0
10131792|NCT02663128|11263799|FG001|NOT COMPLETED|Period 3||0
10131793|NCT02663128|11263800|FG002|NOT COMPLETED|Period 3||0
10131794|NCT02663128|11263801|FG003|NOT COMPLETED|Period 3||0
10131795|NCT02663128|11263802|FG004|NOT COMPLETED|Period 3||0
10131796|NCT02663128|11263803|FG005|NOT COMPLETED|Period 3||0
10131797|NCT02663232|11263812|FG000|STARTED|Overall Study||264
10131798|NCT02663232|11263812|FG000|COMPLETED|Overall Study||264
10131799|NCT02663232|11263812|FG000|NOT COMPLETED|Overall Study||0
10131800|NCT02663453|11263818|FG000|STARTED|Overall Study||22
10131801|NCT02663453|11263819|FG001|STARTED|Overall Study||22
10131802|NCT02663453|11263818|FG000|COMPLETED|Overall Study||17
10131803|NCT02663453|11263819|FG001|COMPLETED|Overall Study||18
10131804|NCT02663453|11263818|FG000|NOT COMPLETED|Overall Study||5
10131805|NCT02663453|11263819|FG001|NOT COMPLETED|Overall Study||4
10131806|NCT02663674|11263827|FG000|STARTED|Overall Study||33
10131807|NCT02663674|11263828|FG001|STARTED|Overall Study||39
10131808|NCT02663674|11263827|FG000|COMPLETED|Overall Study||26
10131809|NCT02663674|11263828|FG001|COMPLETED|Overall Study||29
10131810|NCT02663674|11263827|FG000|NOT COMPLETED|Overall Study||7
10131811|NCT02663674|11263828|FG001|NOT COMPLETED|Overall Study||10
10131812|NCT02663687|11263839|FG000|STARTED|Overall Study||12
10131813|NCT02663687|11263840|FG001|STARTED|Overall Study||9
10131814|NCT02663687|11263841|FG002|STARTED|Overall Study||9
10131815|NCT02663687|11263842|FG003|STARTED|Overall Study||9
10131816|NCT02663687|11263843|FG004|STARTED|Overall Study||9
10131817|NCT02663687|11263839|FG000|Treatment Period 1 (IV)|Overall Study||12
10131818|NCT02663687|11263840|FG001|Treatment Period 1 (IV)|Overall Study||9
10131819|NCT02663687|11263841|FG002|Treatment Period 1 (IV)|Overall Study||9
10131820|NCT02663687|11263842|FG003|Treatment Period 1 (IV)|Overall Study||9
10131821|NCT02663687|11263843|FG004|Treatment Period 1 (IV)|Overall Study||9
10131822|NCT02663687|11263839|FG000|Treatment Period 2 (SC)|Overall Study||10
10131823|NCT02663687|11263840|FG001|Treatment Period 2 (SC)|Overall Study||9
10131824|NCT02663687|11263841|FG002|Treatment Period 2 (SC)|Overall Study||8
10131825|NCT02663687|11263842|FG003|Treatment Period 2 (SC)|Overall Study||9
10131826|NCT02663687|11263843|FG004|Treatment Period 2 (SC)|Overall Study||9
10131827|NCT02663687|11263839|FG000|COMPLETED|Overall Study||10
10131828|NCT02663687|11263840|FG001|COMPLETED|Overall Study||9
10131829|NCT02663687|11263841|FG002|COMPLETED|Overall Study||8
10131830|NCT02663687|11263842|FG003|COMPLETED|Overall Study||9
10131831|NCT02663687|11263843|FG004|COMPLETED|Overall Study||9
10131832|NCT02663687|11263839|FG000|NOT COMPLETED|Overall Study||2
10131833|NCT02663687|11263840|FG001|NOT COMPLETED|Overall Study||0
10131834|NCT02663687|11263841|FG002|NOT COMPLETED|Overall Study||1
10131835|NCT02663687|11263842|FG003|NOT COMPLETED|Overall Study||0
10131836|NCT02663687|11263843|FG004|NOT COMPLETED|Overall Study||0
10131837|NCT02663817|11263868|FG000|STARTED|Overall Study||52
10131838|NCT02663817|11263868|FG000|COMPLETED|Overall Study||50
10131839|NCT02663817|11263868|FG000|NOT COMPLETED|Overall Study||2
10131840|NCT02663882|11263876|FG000|STARTED|Overall Study||39
10131841|NCT02663882|11263877|FG001|STARTED|Overall Study||36
10131842|NCT02663882|11263876|FG000|COMPLETED|Overall Study||35
10131843|NCT02663882|11263877|FG001|COMPLETED|Overall Study||34
10131844|NCT02663882|11263876|FG000|NOT COMPLETED|Overall Study||4
10131845|NCT02663882|11263877|FG001|NOT COMPLETED|Overall Study||2
10131846|NCT02663895|11263883|FG000|STARTED|Overall Study||12
10131847|NCT02663895|11263883|FG000|COMPLETED|Overall Study||5
10131848|NCT02663895|11263883|FG000|NOT COMPLETED|Overall Study||7
10131849|NCT02664220|11263890|FG000|STARTED|Overall Study||50
10131850|NCT02664220|11263891|FG001|STARTED|Overall Study||50
10131851|NCT02664220|11263890|FG000|COMPLETED|Overall Study||50
10131852|NCT02664220|11263891|FG001|COMPLETED|Overall Study||50
10131853|NCT02664220|11263890|FG000|NOT COMPLETED|Overall Study||0
10131854|NCT02664220|11263891|FG001|NOT COMPLETED|Overall Study||0
10131855|NCT02664272|11263897|FG000|STARTED|Overall Study||40
10131856|NCT02664272|11263897|FG000|COMPLETED|Overall Study||38
10131857|NCT02664272|11263897|FG000|NOT COMPLETED|Overall Study||2
10131858|NCT02664311|11263903|FG000|STARTED|Overall Study||6
10131859|NCT02664311|11263904|FG001|STARTED|Overall Study||3
10131860|NCT02664311|11263903|FG000|COMPLETED|Overall Study||6
10131861|NCT02664311|11263904|FG001|COMPLETED|Overall Study||3
10131862|NCT02664311|11263903|FG000|NOT COMPLETED|Overall Study||0
10131863|NCT02664311|11263904|FG001|NOT COMPLETED|Overall Study||0
10131864|NCT02664363|11263910|FG000|STARTED|Overall Study||3
10131865|NCT02664363|11263910|FG000|COMPLETED|Overall Study||3
10131866|NCT02664363|11263910|FG000|NOT COMPLETED|Overall Study||0
10131867|NCT02664415|11263916|FG000|STARTED|Overall Study||14
10131868|NCT02664415|11263917|FG001|STARTED|Overall Study||5
10131869|NCT02664415|11263916|FG000|COMPLETED|Overall Study||13
10131870|NCT02664415|11263917|FG001|COMPLETED|Overall Study||5
10131871|NCT02664415|11263916|FG000|NOT COMPLETED|Overall Study||1
10131872|NCT02664415|11263917|FG001|NOT COMPLETED|Overall Study||0
10131873|NCT02664532|11263925|FG000|STARTED|Overall Study||75
10131874|NCT02664532|11263926|FG001|STARTED|Overall Study||75
10131875|NCT02664532|11263925|FG000|COMPLETED|Overall Study||75
10131876|NCT02664532|11263926|FG001|COMPLETED|Overall Study||75
10131877|NCT02664532|11263925|FG000|NOT COMPLETED|Overall Study||0
10131878|NCT02664532|11263926|FG001|NOT COMPLETED|Overall Study||0
10131879|NCT02664610|11263934|FG000|STARTED|Overall Study||46
10131880|NCT02664610|11263935|FG001|STARTED|Overall Study||48
10131881|NCT02664610|11263934|FG000|COMPLETED|Overall Study||32
10131882|NCT02664610|11263935|FG001|COMPLETED|Overall Study||41
10131883|NCT02664610|11263934|FG000|NOT COMPLETED|Overall Study||14
10131884|NCT02664610|11263935|FG001|NOT COMPLETED|Overall Study||7
10131885|NCT02664909|11263943|FG000|STARTED|Overall Study||17
10131886|NCT02664909|11263944|FG001|STARTED|Overall Study||19
10131887|NCT02664909|11263943|FG000|COMPLETED|Overall Study||15
10131888|NCT02664909|11263944|FG001|COMPLETED|Overall Study||16
10131889|NCT02664909|11263943|FG000|NOT COMPLETED|Overall Study||2
10131890|NCT02664909|11263944|FG001|NOT COMPLETED|Overall Study||3
10131891|NCT02664922|11263954|FG000|STARTED|Overall Study||11
10131892|NCT02664922|11263955|FG001|STARTED|Overall Study||12
10131893|NCT02664922|11263956|FG002|STARTED|Overall Study||7
10131894|NCT02664922|11263957|FG003|STARTED|Overall Study||5
10131895|NCT02664922|11263954|FG000|COMPLETED|Overall Study||10
10131896|NCT02664922|11263955|FG001|COMPLETED|Overall Study||12
10131897|NCT02664922|11263956|FG002|COMPLETED|Overall Study||7
10131898|NCT02664922|11263957|FG003|COMPLETED|Overall Study||5
10131899|NCT02664922|11263954|FG000|NOT COMPLETED|Overall Study||1
10131900|NCT02664922|11263955|FG001|NOT COMPLETED|Overall Study||0
10131901|NCT02664922|11263956|FG002|NOT COMPLETED|Overall Study||0
10131902|NCT02664922|11263957|FG003|NOT COMPLETED|Overall Study||0
10131903|NCT02664961|11263967|FG000|STARTED|Overall Study||3
10131904|NCT02664961|11263967|FG000|COMPLETED|Overall Study||3
10131905|NCT02664961|11263967|FG000|NOT COMPLETED|Overall Study||0
10131906|NCT02664987|11263971|FG000|STARTED|Overall Study||462
10131907|NCT02664987|11263971|FG000|COMPLETED|Overall Study||462
10131908|NCT02664987|11263971|FG000|NOT COMPLETED|Overall Study||0
10131909|NCT02665052|11263979|FG000|STARTED|Overall Study||11
10131910|NCT02665052|11263980|FG001|STARTED|Overall Study||9
10131911|NCT02665052|11263981|FG002|STARTED|Overall Study||9
10131912|NCT02665052|11263982|FG003|STARTED|Overall Study||19
10131913|NCT02665052|11263979|FG000|COMPLETED|Overall Study||8
10131914|NCT02665052|11263980|FG001|COMPLETED|Overall Study||7
10131915|NCT02665052|11263981|FG002|COMPLETED|Overall Study||9
10131916|NCT02665052|11263982|FG003|COMPLETED|Overall Study||14
10131917|NCT02665052|11263979|FG000|NOT COMPLETED|Overall Study||3
10131918|NCT02665052|11263980|FG001|NOT COMPLETED|Overall Study||2
10131919|NCT02665052|11263981|FG002|NOT COMPLETED|Overall Study||0
10131920|NCT02665052|11263982|FG003|NOT COMPLETED|Overall Study||5
10131921|NCT02665260|11263997|FG000|STARTED|Overall Study||24
10131922|NCT02665260|11263998|FG001|STARTED|Overall Study||23
10131923|NCT02665260|11263999|FG002|STARTED|Overall Study||25
10131924|NCT02665260|11264000|FG003|STARTED|Overall Study||22
10131925|NCT02665260|11263997|FG000|COMPLETED|Overall Study||22
10131926|NCT02665260|11263998|FG001|COMPLETED|Overall Study||22
10131927|NCT02665260|11263999|FG002|COMPLETED|Overall Study||21
10131928|NCT02665260|11264000|FG003|COMPLETED|Overall Study||21
10131929|NCT02665260|11263997|FG000|NOT COMPLETED|Overall Study||2
10131930|NCT02665260|11263998|FG001|NOT COMPLETED|Overall Study||1
10131931|NCT02665260|11263999|FG002|NOT COMPLETED|Overall Study||4
10131932|NCT02665260|11264000|FG003|NOT COMPLETED|Overall Study||1
10131933|NCT02665273|11264016|FG000|STARTED|Overall Study||13
10131934|NCT02665273|11264017|FG001|STARTED|Overall Study||15
10131935|NCT02665273|11264016|FG000|COMPLETED|Overall Study||13
10131936|NCT02665273|11264017|FG001|COMPLETED|Overall Study||15
10131937|NCT02665273|11264016|FG000|NOT COMPLETED|Overall Study||0
10131938|NCT02665273|11264017|FG001|NOT COMPLETED|Overall Study||0
10131939|NCT02665286|11264026|FG000|STARTED|Overall Study||79
10131940|NCT02665286|11264027|FG001|STARTED|Overall Study||80
10131941|NCT02665286|11264028|FG002|STARTED|Overall Study||81
10131942|NCT02665286|11264026|FG000|COMPLETED|Overall Study||76
10131943|NCT02665286|11264027|FG001|COMPLETED|Overall Study||78
10131944|NCT02665286|11264028|FG002|COMPLETED|Overall Study||80
10131945|NCT02665286|11264026|FG000|NOT COMPLETED|Overall Study||3
10131946|NCT02665286|11264027|FG001|NOT COMPLETED|Overall Study||2
10131947|NCT02665286|11264028|FG002|NOT COMPLETED|Overall Study||1
10131948|NCT02665364|11264038|FG000|STARTED|Overall Study||91
10131949|NCT02665364|11264039|FG001|STARTED|Overall Study||93
10131950|NCT02665364|11264038|FG000|COMPLETED|Overall Study||85
10131951|NCT02665364|11264039|FG001|COMPLETED|Overall Study||84
10131952|NCT02665364|11264038|FG000|NOT COMPLETED|Overall Study||6
10131953|NCT02665364|11264039|FG001|NOT COMPLETED|Overall Study||9
10131954|NCT02665455|11264045|FG000|STARTED|Overall Study||83
10131955|NCT02665455|11264045|FG000|COMPLETED|Overall Study||74
10131956|NCT02665455|11264045|FG000|NOT COMPLETED|Overall Study||9
10131957|NCT02665468|11264051|FG000|STARTED|Overall Study||595
10131958|NCT02665468|11264052|FG001|STARTED|Overall Study||601
10131959|NCT02665468|11264051|FG000|COMPLETED|Overall Study||595
10131960|NCT02665468|11264052|FG001|COMPLETED|Overall Study||601
10131961|NCT02665468|11264051|FG000|NOT COMPLETED|Overall Study||0
10131962|NCT02665468|11264052|FG001|NOT COMPLETED|Overall Study||0
10131963|NCT02665689|11264060|FG000|STARTED|Overall Study||2
10131964|NCT02665689|11264061|FG001|STARTED|Overall Study||2
10131965|NCT02665689|11264060|FG000|COMPLETED|Overall Study||0
10131966|NCT02665689|11264061|FG001|COMPLETED|Overall Study||0
10131967|NCT02665689|11264060|FG000|NOT COMPLETED|Overall Study||2
10131968|NCT02665689|11264061|FG001|NOT COMPLETED|Overall Study||2
10131969|NCT02665728|11264067|FG000|STARTED|Overall Study||33
10131970|NCT02665728|11264067|FG000|COMPLETED|Overall Study||33
10131971|NCT02665728|11264067|FG000|NOT COMPLETED|Overall Study||0
10131972|NCT02665741|11264074|FG000|STARTED|Overall Study||42
10131973|NCT02665741|11264075|FG001|STARTED|Overall Study||42
10131974|NCT02665741|11264076|FG002|STARTED|Overall Study||42
10131975|NCT02665741|11264074|FG000|COMPLETED|Overall Study||42
10131976|NCT02665741|11264075|FG001|COMPLETED|Overall Study||42
10131977|NCT02665741|11264076|FG002|COMPLETED|Overall Study||42
10131978|NCT02665741|11264074|FG000|NOT COMPLETED|Overall Study||0
10131979|NCT02665741|11264075|FG001|NOT COMPLETED|Overall Study||0
10131980|NCT02665741|11264076|FG002|NOT COMPLETED|Overall Study||0
10131981|NCT02665975|11264086|FG000|STARTED|Overall Study||46
10131982|NCT02665975|11264087|FG001|STARTED|Overall Study||46
10131983|NCT02665975|11264086|FG000|COMPLETED|Overall Study||37
10131984|NCT02665975|11264087|FG001|COMPLETED|Overall Study||37
10131985|NCT02665975|11264086|FG000|NOT COMPLETED|Overall Study||9
10131986|NCT02665975|11264087|FG001|NOT COMPLETED|Overall Study||9
10131987|NCT02666222|11264093|FG000|STARTED|Overall Study||51
10131988|NCT02666222|11264093|FG000|COMPLETED|Overall Study||49
10131989|NCT02666222|11264093|FG000|NOT COMPLETED|Overall Study||2
10131990|NCT02666352|11264100|FG000|STARTED|Overall Study||8
10131991|NCT02666352|11264101|FG001|STARTED|Overall Study||8
10131992|NCT02666352|11264102|FG002|STARTED|Overall Study||8
10131993|NCT02666352|11264100|FG000|COMPLETED|Overall Study||8
10131994|NCT02666352|11264101|FG001|COMPLETED|Overall Study||8
10131995|NCT02666352|11264102|FG002|COMPLETED|Overall Study||8
10131996|NCT02666352|11264100|FG000|NOT COMPLETED|Overall Study||0
10131997|NCT02666352|11264101|FG001|NOT COMPLETED|Overall Study||0
10131998|NCT02666352|11264102|FG002|NOT COMPLETED|Overall Study||0
10131999|NCT02666508|11264112|FG000|STARTED|Overall Study||31
10132000|NCT02666508|11264113|FG001|STARTED|Overall Study||30
10132001|NCT02666508|11264112|FG000|COMPLETED|Overall Study||31
10132002|NCT02666508|11264113|FG001|COMPLETED|Overall Study||30
10132003|NCT02666508|11264112|FG000|NOT COMPLETED|Overall Study||0
10132004|NCT02666508|11264113|FG001|NOT COMPLETED|Overall Study||0
10132005|NCT02666560|11264123|FG000|STARTED|Condition 1 (1 Day)||8
10132006|NCT02666560|11264124|FG001|STARTED|Condition 1 (1 Day)||11
10132007|NCT02666560|11264123|FG000|COMPLETED|Condition 1 (1 Day)||8
10132008|NCT02666560|11264124|FG001|COMPLETED|Condition 1 (1 Day)||11
10132009|NCT02666560|11264123|FG000|NOT COMPLETED|Condition 1 (1 Day)||0
10132010|NCT02666560|11264124|FG001|NOT COMPLETED|Condition 1 (1 Day)||0
10132011|NCT02666560|11264123|FG000|STARTED|Condition 2 (1 Day)||8
10132012|NCT02666560|11264124|FG001|STARTED|Condition 2 (1 Day)||11
10132013|NCT02666560|11264123|FG000|COMPLETED|Condition 2 (1 Day)||8
10132014|NCT02666560|11264124|FG001|COMPLETED|Condition 2 (1 Day)||11
10132015|NCT02666560|11264123|FG000|NOT COMPLETED|Condition 2 (1 Day)||0
10132016|NCT02666560|11264124|FG001|NOT COMPLETED|Condition 2 (1 Day)||0
10132017|NCT02666664|11264133|FG000|STARTED|Overall Study||742
10132018|NCT02666664|11264134|FG001|STARTED|Overall Study||1488
10132019|NCT02666664|11264133|FG000|COMPLETED|Overall Study||706
10132020|NCT02666664|11264134|FG001|COMPLETED|Overall Study||1404
10132021|NCT02666664|11264133|FG000|NOT COMPLETED|Overall Study||36
10132022|NCT02666664|11264134|FG001|NOT COMPLETED|Overall Study||84
10132023|NCT02666742|11264142|FG000|STARTED|Overall Study||123
10132024|NCT02666742|11264143|FG001|STARTED|Overall Study||123
10132025|NCT02666742|11264142|FG000|COMPLETED|Overall Study||123
10132026|NCT02666742|11264143|FG001|COMPLETED|Overall Study||123
10132027|NCT02666742|11264142|FG000|NOT COMPLETED|Overall Study||0
10132028|NCT02666742|11264143|FG001|NOT COMPLETED|Overall Study||0
10132029|NCT02666846|11264154|FG000|STARTED|Overall Study||20
10132030|NCT02666846|11264155|FG001|STARTED|Overall Study||20
10132031|NCT02666846|11264156|FG002|STARTED|Overall Study||20
10132032|NCT02666846|11264154|FG000|COMPLETED|Overall Study||20
10132033|NCT02666846|11264155|FG001|COMPLETED|Overall Study||20
10132034|NCT02666846|11264156|FG002|COMPLETED|Overall Study||20
10132035|NCT02666846|11264154|FG000|NOT COMPLETED|Overall Study||0
10132036|NCT02666846|11264155|FG001|NOT COMPLETED|Overall Study||0
10132037|NCT02666846|11264156|FG002|NOT COMPLETED|Overall Study||0
10132038|NCT02666950|11264186|FG000|STARTED|Overall Study||3
10132039|NCT02666950|11264186|FG000|COMPLETED|Overall Study||3
10132040|NCT02666950|11264186|FG000|NOT COMPLETED|Overall Study||0
10132041|NCT02667236|11264192|FG000|STARTED|Overall Study||223
10132042|NCT02667236|11264193|FG001|STARTED|Overall Study||227
10132043|NCT02667236|11264192|FG000|COMPLETED|Overall Study||220
10132044|NCT02667236|11264193|FG001|COMPLETED|Overall Study||226
10132045|NCT02667236|11264192|FG000|NOT COMPLETED|Overall Study||3
10132046|NCT02667236|11264193|FG001|NOT COMPLETED|Overall Study||1
10132047|NCT02667275|11264201|FG000|STARTED|Overall Study||244
10132048|NCT02667275|11264202|FG001|STARTED|Overall Study||243
10132049|NCT02667275|11264201|FG000|COMPLETED|Overall Study||233
10132050|NCT02667275|11264202|FG001|COMPLETED|Overall Study||228
10132051|NCT02667275|11264201|FG000|NOT COMPLETED|Overall Study||11
10132052|NCT02667275|11264202|FG001|NOT COMPLETED|Overall Study||15
10132053|NCT02667288|11264208|FG000|STARTED|Overall Study||147
10132054|NCT02667288|11264208|FG000|COMPLETED|Overall Study||134
10132055|NCT02667288|11264208|FG000|NOT COMPLETED|Overall Study||13
10132056|NCT02667301|11264212|FG000|STARTED|Overall Study||16
10132057|NCT02667301|11264212|FG000|COMPLETED|Overall Study||14
10132058|NCT02667301|11264212|FG000|NOT COMPLETED|Overall Study||2
10132059|NCT02667392|11264218|FG000|STARTED|Overall Study||11
10132060|NCT02667392|11264218|FG000|COMPLETED|Overall Study||11
10132061|NCT02667392|11264218|FG000|NOT COMPLETED|Overall Study||0
10132062|NCT02667457|11264224|FG000|STARTED|Overall Study||27
10132063|NCT02667457|11264225|FG001|STARTED|Overall Study||12
10132064|NCT02667457|11264224|FG000|Dosed Participants|Overall Study||26
10132065|NCT02667457|11264225|FG001|Dosed Participants|Overall Study||10
10132066|NCT02667457|11264224|FG000|Full Analysis Set Population (FAS)|Overall Study||25
10132067|NCT02667457|11264225|FG001|Full Analysis Set Population (FAS)|Overall Study||10
10132068|NCT02667457|11264224|FG000|COMPLETED|Overall Study||26
10132069|NCT02667457|11264225|FG001|COMPLETED|Overall Study||10
10132070|NCT02667457|11264224|FG000|NOT COMPLETED|Overall Study||1
10132071|NCT02667457|11264225|FG001|NOT COMPLETED|Overall Study||2
10132072|NCT02667626|11264234|FG000|STARTED|Overall Study||86
10132073|NCT02667626|11264235|FG001|STARTED|Overall Study||96
10132074|NCT02667626|11264234|FG000|COMPLETED|Overall Study||86
10132075|NCT02667626|11264235|FG001|COMPLETED|Overall Study||95
10132076|NCT02667626|11264234|FG000|NOT COMPLETED|Overall Study||0
10132077|NCT02667626|11264235|FG001|NOT COMPLETED|Overall Study||1
10132078|NCT02667704|11264244|FG000|STARTED|Treatment Period 1||13
10132079|NCT02667704|11264244|FG000|COMPLETED|Treatment Period 1||13
10132080|NCT02667704|11264244|FG000|NOT COMPLETED|Treatment Period 1||0
10132081|NCT02667704|11264244|FG000|STARTED|Treatment Period 2||13
10132082|NCT02667704|11264244|FG000|COMPLETED|Treatment Period 2||13
10132083|NCT02667704|11264244|FG000|NOT COMPLETED|Treatment Period 2||0
10132084|NCT02667821|11264251|FG000|STARTED|Overall Study||20
10132085|NCT02667821|11264251|FG000|COMPLETED|Overall Study||20
10132086|NCT02667821|11264251|FG000|NOT COMPLETED|Overall Study||0
10132087|NCT02667912|11264258|FG000|STARTED|Overall Study||28
10132088|NCT02667912|11264259|FG001|STARTED|Overall Study||27
10132089|NCT02667912|11264258|FG000|Six Months|Overall Study||27
10132090|NCT02667912|11264259|FG001|Six Months|Overall Study||24
10132091|NCT02667912|11264258|FG000|COMPLETED|Overall Study||23
10132092|NCT02667912|11264259|FG001|COMPLETED|Overall Study||24
10132093|NCT02667912|11264258|FG000|NOT COMPLETED|Overall Study||5
10132094|NCT02667912|11264259|FG001|NOT COMPLETED|Overall Study||3
10132095|NCT02667951|11264267|FG000|STARTED|Overall Study||66
10132096|NCT02667951|11264268|FG001|STARTED|Overall Study||63
10132097|NCT02667951|11264267|FG000|COMPLETED|Overall Study||45
10132098|NCT02667951|11264268|FG001|COMPLETED|Overall Study||40
10132099|NCT02667951|11264267|FG000|NOT COMPLETED|Overall Study||21
10132100|NCT02667951|11264268|FG001|NOT COMPLETED|Overall Study||23
10132101|NCT02668003|11264276|FG000|STARTED|Overall Study||501
10132102|NCT02668003|11264277|FG001|STARTED|Overall Study||501
10132103|NCT02668003|11264276|FG000|COMPLETED|Overall Study||500
10132104|NCT02668003|11264277|FG001|COMPLETED|Overall Study||496
10132105|NCT02668003|11264276|FG000|NOT COMPLETED|Overall Study||1
10132106|NCT02668003|11264277|FG001|NOT COMPLETED|Overall Study||5
10132107|NCT02668185|11264283|FG000|STARTED|Baseline Period (2 Weeks)||20
10132108|NCT02668185|11264284|FG001|STARTED|Baseline Period (2 Weeks)||17
10132109|NCT02668185|11264283|FG000|COMPLETED|Baseline Period (2 Weeks)||20
10132110|NCT02668185|11264284|FG001|COMPLETED|Baseline Period (2 Weeks)||17
10132111|NCT02668185|11264283|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0
10132112|NCT02668185|11264284|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0
10132113|NCT02668185|11264283|FG000|STARTED|First Intervention (4 Weeks)||20
10132114|NCT02668185|11264284|FG001|STARTED|First Intervention (4 Weeks)||17
10132115|NCT02668185|11264283|FG000|COMPLETED|First Intervention (4 Weeks)||18
10132116|NCT02668185|11264284|FG001|COMPLETED|First Intervention (4 Weeks)||17
10132117|NCT02668185|11264283|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10132118|NCT02668185|11264284|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10132119|NCT02668185|11264283|FG000|STARTED|Washout Period (2 Weeks)||18
10132120|NCT02668185|11264284|FG001|STARTED|Washout Period (2 Weeks)||17
10132121|NCT02668185|11264283|FG000|COMPLETED|Washout Period (2 Weeks)||17
10132122|NCT02668185|11264284|FG001|COMPLETED|Washout Period (2 Weeks)||15
10132123|NCT02668185|11264283|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
10132124|NCT02668185|11264284|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
10132125|NCT02668185|11264283|FG000|STARTED|Second Intervention (4 Weeks)||17
10132126|NCT02668185|11264284|FG001|STARTED|Second Intervention (4 Weeks)||15
10132127|NCT02668185|11264283|FG000|COMPLETED|Second Intervention (4 Weeks)||16
10132128|NCT02668185|11264284|FG001|COMPLETED|Second Intervention (4 Weeks)||12
10132129|NCT02668185|11264283|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10132130|NCT02668185|11264284|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
10132131|NCT02668185|11264283|FG000|STARTED|Moitoring Period (2 Weeks)||16
10132132|NCT02668185|11264284|FG001|STARTED|Moitoring Period (2 Weeks)||12
10132133|NCT02668185|11264283|FG000|COMPLETED|Moitoring Period (2 Weeks)||16
10132134|NCT02668185|11264284|FG001|COMPLETED|Moitoring Period (2 Weeks)||12
10132135|NCT02668185|11264283|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0
10132136|NCT02668185|11264284|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0
10132137|NCT02668198|11264290|FG000|STARTED|Overall Study||230
10132138|NCT02668198|11264290|FG000|COMPLETED|Overall Study||230
10132139|NCT02668198|11264290|FG000|NOT COMPLETED|Overall Study||0
10132140|NCT02668302|11264297|FG000|STARTED|Overall Study||20
10132141|NCT02668302|11264298|FG001|STARTED|Overall Study||20
10132142|NCT02668302|11264297|FG000|COMPLETED|Overall Study||19
10132143|NCT02668302|11264298|FG001|COMPLETED|Overall Study||20
10132144|NCT02668302|11264297|FG000|NOT COMPLETED|Overall Study||1
10132145|NCT02668302|11264298|FG001|NOT COMPLETED|Overall Study||0
10132146|NCT02668393|11264306|FG000|STARTED|Overall Study||7
10132147|NCT02668393|11264307|FG001|STARTED|Overall Study||7
10132148|NCT02668393|11264306|FG000|COMPLETED|Overall Study||0
10132149|NCT02668393|11264307|FG001|COMPLETED|Overall Study||1
10132150|NCT02668393|11264306|FG000|NOT COMPLETED|Overall Study||7
10132151|NCT02668393|11264307|FG001|NOT COMPLETED|Overall Study||6
10132152|NCT02668432|11264316|FG000|STARTED|Overall Study||5
10132153|NCT02668432|11264317|FG001|STARTED|Overall Study||4
10132154|NCT02668432|11264316|FG000|COMPLETED|Overall Study||5
10132155|NCT02668432|11264317|FG001|COMPLETED|Overall Study||4
10132156|NCT02668432|11264316|FG000|NOT COMPLETED|Overall Study||0
10132157|NCT02668432|11264317|FG001|NOT COMPLETED|Overall Study||0
10132158|NCT02668640|11264323|FG000|STARTED|Overall Study||55
10132159|NCT02668640|11264323|FG000|COMPLETED|Overall Study||41
10132160|NCT02668640|11264323|FG000|NOT COMPLETED|Overall Study||14
10132161|NCT02668692|11264329|FG000|STARTED|Overall Study||101
10132162|NCT02668692|11264330|FG001|STARTED|Overall Study||105
10132163|NCT02668692|11264329|FG000|COMPLETED|Overall Study||100
10132164|NCT02668692|11264330|FG001|COMPLETED|Overall Study||105
10132165|NCT02668692|11264329|FG000|NOT COMPLETED|Overall Study||1
10132166|NCT02668692|11264330|FG001|NOT COMPLETED|Overall Study||0
10132167|NCT02668952|11264338|FG000|STARTED|Overall Study||16
10132168|NCT02668952|11264339|FG001|STARTED|Overall Study||14
10132169|NCT02668952|11264338|FG000|COMPLETED|Overall Study||16
10132170|NCT02668952|11264339|FG001|COMPLETED|Overall Study||14
10132171|NCT02668952|11264338|FG000|NOT COMPLETED|Overall Study||0
10132172|NCT02668952|11264339|FG001|NOT COMPLETED|Overall Study||0
10132173|NCT02669017|11264354|FG000|STARTED|Overall Study||4
10132174|NCT02669017|11264355|FG001|STARTED|Overall Study||4
10132175|NCT02669017|11264356|FG002|STARTED|Overall Study||4
10132176|NCT02669017|11264357|FG003|STARTED|Overall Study||5
10132177|NCT02669017|11264358|FG004|STARTED|Overall Study||16
10132178|NCT02669017|11264359|FG005|STARTED|Overall Study||26
10132179|NCT02669017|11264360|FG006|STARTED|Overall Study||19
10132180|NCT02669017|11264361|FG007|STARTED|Overall Study||69
10132181|NCT02669017|11264362|FG008|STARTED|Overall Study||36
10132182|NCT02669017|11264354|FG000|COMPLETED|Overall Study||3
10132183|NCT02669017|11264355|FG001|COMPLETED|Overall Study||2
10132184|NCT02669017|11264356|FG002|COMPLETED|Overall Study||2
10132185|NCT02669017|11264357|FG003|COMPLETED|Overall Study||1
10132186|NCT02669017|11264358|FG004|COMPLETED|Overall Study||4
10132187|NCT02669017|11264359|FG005|COMPLETED|Overall Study||7
10132188|NCT02669017|11264360|FG006|COMPLETED|Overall Study||8
10132189|NCT02669017|11264361|FG007|COMPLETED|Overall Study||7
10132190|NCT02669017|11264362|FG008|COMPLETED|Overall Study||11
10132191|NCT02669017|11264354|FG000|NOT COMPLETED|Overall Study||1
10132192|NCT02669017|11264355|FG001|NOT COMPLETED|Overall Study||2
10132193|NCT02669017|11264356|FG002|NOT COMPLETED|Overall Study||2
10132194|NCT02669017|11264357|FG003|NOT COMPLETED|Overall Study||4
10132195|NCT02669017|11264358|FG004|NOT COMPLETED|Overall Study||12
10132196|NCT02669017|11264359|FG005|NOT COMPLETED|Overall Study||19
10132197|NCT02669017|11264360|FG006|NOT COMPLETED|Overall Study||11
10132198|NCT02669017|11264361|FG007|NOT COMPLETED|Overall Study||62
10132199|NCT02669017|11264362|FG008|NOT COMPLETED|Overall Study||25
10132200|NCT02669043|11264390|FG000|STARTED|Overall Study||8
10132201|NCT02669043|11264390|FG000|COMPLETED|Overall Study||4
10132202|NCT02669043|11264390|FG000|NOT COMPLETED|Overall Study||4
10132203|NCT02669082|11264394|FG000|STARTED|Overall Study||26
10132204|NCT02669082|11264394|FG000|COMPLETED|Overall Study||25
10132205|NCT02669082|11264394|FG000|NOT COMPLETED|Overall Study||1
10132206|NCT02669095|11264400|FG000|STARTED|Overall Study||75
10132207|NCT02669095|11264401|FG001|STARTED|Overall Study||75
10132208|NCT02669095|11264400|FG000|COMPLETED|Overall Study||74
10132209|NCT02669095|11264401|FG001|COMPLETED|Overall Study||72
10132210|NCT02669095|11264400|FG000|NOT COMPLETED|Overall Study||1
10132211|NCT02669095|11264401|FG001|NOT COMPLETED|Overall Study||3
10132212|NCT02669121|11264409|FG000|STARTED|Overall Study||2377
10132213|NCT02669121|11264410|FG001|STARTED|Overall Study||2371
10132214|NCT02669121|11264409|FG000|Treated (Safety Analysis Set)|Overall Study||2357
10132215|NCT02669121|11264410|FG001|Treated (Safety Analysis Set)|Overall Study||2355
10132216|NCT02669121|11264409|FG000|COMPLETED|Overall Study||2087
10132217|NCT02669121|11264410|FG001|COMPLETED|Overall Study||2089
10132218|NCT02669121|11264409|FG000|NOT COMPLETED|Overall Study||290
10132219|NCT02669121|11264410|FG001|NOT COMPLETED|Overall Study||282
10132220|NCT02669264|11264423|FG000|STARTED|Overall Study||5
10132221|NCT02669264|11264424|FG001|STARTED|Overall Study||7
10132222|NCT02669264|11264425|FG002|STARTED|Overall Study||3
10132223|NCT02669264|11264426|FG003|STARTED|Overall Study||4
10132224|NCT02669264|11264427|FG004|STARTED|Overall Study||5
10132225|NCT02669264|11264428|FG005|STARTED|Overall Study||6
10132226|NCT02669264|11264429|FG006|STARTED|Overall Study||5
10132227|NCT02669264|11264423|FG000|COMPLETED|Overall Study||0
10132228|NCT02669264|11264424|FG001|COMPLETED|Overall Study||1
10132229|NCT02669264|11264425|FG002|COMPLETED|Overall Study||0
10132230|NCT02669264|11264426|FG003|COMPLETED|Overall Study||1
10132231|NCT02669264|11264427|FG004|COMPLETED|Overall Study||0
10132232|NCT02669264|11264428|FG005|COMPLETED|Overall Study||0
10132233|NCT02669264|11264429|FG006|COMPLETED|Overall Study||0
10132234|NCT02669264|11264423|FG000|NOT COMPLETED|Overall Study||5
10132235|NCT02669264|11264424|FG001|NOT COMPLETED|Overall Study||6
10132236|NCT02669264|11264425|FG002|NOT COMPLETED|Overall Study||3
10132237|NCT02669264|11264426|FG003|NOT COMPLETED|Overall Study||3
10132238|NCT02669264|11264427|FG004|NOT COMPLETED|Overall Study||5
10132239|NCT02669264|11264428|FG005|NOT COMPLETED|Overall Study||6
10132240|NCT02669264|11264429|FG006|NOT COMPLETED|Overall Study||5
10132241|NCT02669329|11264447|FG000|STARTED|Overall Study||30
10132242|NCT02669329|11264447|FG000|COMPLETED|Overall Study||30
10132243|NCT02669329|11264447|FG000|NOT COMPLETED|Overall Study||0
10132244|NCT02669407|11264451|FG000|STARTED|Overall Study||14
10132245|NCT02669407|11264451|FG000|COMPLETED|Overall Study||11
10132246|NCT02669407|11264451|FG000|NOT COMPLETED|Overall Study||3
10132247|NCT02669433|11264458|FG000|STARTED|Overall Study||91
10132248|NCT02669433|11264459|FG001|STARTED|Overall Study||89
10132249|NCT02669433|11264460|FG002|STARTED|Overall Study||89
10132250|NCT02669433|11264458|FG000|Safety Population|Overall Study||91
10132251|NCT02669433|11264459|FG001|Safety Population|Overall Study||89
10132252|NCT02669433|11264460|FG002|Safety Population|Overall Study||88
10132253|NCT02669433|11264458|FG000|Intent to Treat (ITT) Population|Overall Study||89
10132254|NCT02669433|11264459|FG001|Intent to Treat (ITT) Population|Overall Study||89
10132255|NCT02669433|11264460|FG002|Intent to Treat (ITT) Population|Overall Study||87
10132256|NCT02669433|11264458|FG000|Per-Protocol Population|Overall Study||78
10132257|NCT02669433|11264459|FG001|Per-Protocol Population|Overall Study||79
10132258|NCT02669433|11264460|FG002|Per-Protocol Population|Overall Study||82
10132259|NCT02669433|11264458|FG000|Completers Population|Overall Study||73
10132260|NCT02669433|11264459|FG001|Completers Population|Overall Study||72
10132261|NCT02669433|11264460|FG002|Completers Population|Overall Study||69
10132262|NCT02669433|11264458|FG000|UPDRS Primary Population|Overall Study||87
10132263|NCT02669433|11264459|FG001|UPDRS Primary Population|Overall Study||87
10132264|NCT02669433|11264460|FG002|UPDRS Primary Population|Overall Study||84
10132265|NCT02669433|11264458|FG000|COMPLETED|Overall Study||76
10132266|NCT02669433|11264459|FG001|COMPLETED|Overall Study||75
10132267|NCT02669433|11264460|FG002|COMPLETED|Overall Study||74
10132268|NCT02669433|11264458|FG000|NOT COMPLETED|Overall Study||15
10132269|NCT02669433|11264459|FG001|NOT COMPLETED|Overall Study||14
10132270|NCT02669433|11264460|FG002|NOT COMPLETED|Overall Study||15
10132271|NCT02669615|11264468|FG000|STARTED|Overall Study||24
10132272|NCT02669615|11264468|FG000|COMPLETED|Overall Study||24
10132273|NCT02669615|11264468|FG000|NOT COMPLETED|Overall Study||0
10132274|NCT02669667|11264479|FG000|STARTED|Overall Study||12
10132275|NCT02669667|11264480|FG001|STARTED|Overall Study||4
10132276|NCT02669667|11264481|FG002|STARTED|Overall Study||4
10132277|NCT02669667|11264482|FG003|STARTED|Overall Study||6
10132278|NCT02669667|11264483|FG004|STARTED|Overall Study||6
10132279|NCT02669667|11264484|FG005|STARTED|Overall Study||6
10132280|NCT02669667|11264485|FG006|STARTED|Overall Study||6
10132281|NCT02669667|11264479|FG000|COMPLETED|Overall Study||12
10132282|NCT02669667|11264480|FG001|COMPLETED|Overall Study||4
10132283|NCT02669667|11264481|FG002|COMPLETED|Overall Study||4
10132284|NCT02669667|11264482|FG003|COMPLETED|Overall Study||6
10132285|NCT02669667|11264483|FG004|COMPLETED|Overall Study||6
10132286|NCT02669667|11264484|FG005|COMPLETED|Overall Study||5
10132287|NCT02669667|11264485|FG006|COMPLETED|Overall Study||6
10132288|NCT02669667|11264479|FG000|NOT COMPLETED|Overall Study||0
10132289|NCT02669667|11264480|FG001|NOT COMPLETED|Overall Study||0
10132290|NCT02669667|11264481|FG002|NOT COMPLETED|Overall Study||0
10132291|NCT02669667|11264482|FG003|NOT COMPLETED|Overall Study||0
10132292|NCT02669667|11264483|FG004|NOT COMPLETED|Overall Study||0
10132293|NCT02669667|11264484|FG005|NOT COMPLETED|Overall Study||1
10132294|NCT02669667|11264485|FG006|NOT COMPLETED|Overall Study||0
10132295|NCT02669758|11264507|FG000|STARTED|Overall Study||277
10132296|NCT02669758|11264507|FG000|COMPLETED|Overall Study||183
10132297|NCT02669758|11264507|FG000|NOT COMPLETED|Overall Study||94
10132298|NCT02669784|11264513|FG000|STARTED|Overall Study||18
10132299|NCT02669784|11264514|FG001|STARTED|Overall Study||16
10132300|NCT02669784|11264513|FG000|COMPLETED|Overall Study||18
10132301|NCT02669784|11264514|FG001|COMPLETED|Overall Study||16
10132302|NCT02669784|11264513|FG000|NOT COMPLETED|Overall Study||0
10132303|NCT02669784|11264514|FG001|NOT COMPLETED|Overall Study||0
10132304|NCT02669849|11264523|FG000|STARTED|Overall Study||29
10132305|NCT02669849|11264524|FG001|STARTED|Overall Study||6
10132306|NCT02669849|11264525|FG002|STARTED|Overall Study||32
10132307|NCT02669849|11264523|FG000|COMPLETED|Overall Study||11
10132308|NCT02669849|11264524|FG001|COMPLETED|Overall Study||4
10132309|NCT02669849|11264525|FG002|COMPLETED|Overall Study||8
10132310|NCT02669849|11264523|FG000|NOT COMPLETED|Overall Study||18
10132311|NCT02669849|11264524|FG001|NOT COMPLETED|Overall Study||2
10132312|NCT02669849|11264525|FG002|NOT COMPLETED|Overall Study||24
10132313|NCT02669862|11264536|FG000|STARTED|Overall Study||33
10132314|NCT02669862|11264537|FG001|STARTED|Overall Study||34
10132315|NCT02669862|11264538|FG002|STARTED|Overall Study||31
10132316|NCT02669862|11264536|FG000|COMPLETED|Overall Study||31
10132317|NCT02669862|11264537|FG001|COMPLETED|Overall Study||29
10132318|NCT02669862|11264538|FG002|COMPLETED|Overall Study||26
10132319|NCT02669862|11264536|FG000|NOT COMPLETED|Overall Study||2
10132320|NCT02669862|11264537|FG001|NOT COMPLETED|Overall Study||5
10132321|NCT02669862|11264538|FG002|NOT COMPLETED|Overall Study||5
10132322|NCT02669914|11264552|FG000|STARTED|Overall Study||4
10132323|NCT02669914|11264553|FG001|STARTED|Overall Study||0
10132324|NCT02669914|11264554|FG002|STARTED|Overall Study||0
10132325|NCT02669914|11264552|FG000|COMPLETED|Overall Study||4
10132326|NCT02669914|11264553|FG001|COMPLETED|Overall Study||0
10132327|NCT02669914|11264554|FG002|COMPLETED|Overall Study||0
10132328|NCT02669914|11264552|FG000|NOT COMPLETED|Overall Study||0
10132329|NCT02669914|11264553|FG001|NOT COMPLETED|Overall Study||0
10132330|NCT02669914|11264554|FG002|NOT COMPLETED|Overall Study||0
10132331|NCT02669940|11264564|FG000|STARTED|Overall Study||63
10132332|NCT02669940|11264565|FG001|STARTED|Overall Study||95
10132333|NCT02669940|11264564|FG000|COMPLETED|Overall Study||62
10132334|NCT02669940|11264565|FG001|COMPLETED|Overall Study||92
10132335|NCT02669940|11264564|FG000|NOT COMPLETED|Overall Study||1
10132336|NCT02669940|11264565|FG001|NOT COMPLETED|Overall Study||3
10132337|NCT02670083|11264580|FG000|STARTED|Overall Study||409
10132338|NCT02670083|11264581|FG001|STARTED|Overall Study||404
10132339|NCT02670083|11264580|FG000|COMPLETED|Overall Study||88
10132340|NCT02670083|11264581|FG001|COMPLETED|Overall Study||85
10132341|NCT02670083|11264580|FG000|NOT COMPLETED|Overall Study||321
10132342|NCT02670083|11264581|FG001|NOT COMPLETED|Overall Study||319
10132343|NCT02670122|11264588|FG000|STARTED|Overall Study||131
10132344|NCT02670122|11264588|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
10132345|NCT02670122|11264588|FG000|NOT COMPLETED|Overall Study||4
10132346|NCT02670330|11264601|FG000|STARTED|Overall Study||75
10132347|NCT02670330|11264602|FG001|STARTED|Overall Study||77
10132348|NCT02670330|11264601|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75
10132349|NCT02670330|11264602|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77
10132350|NCT02670330|11264601|FG000|COMPLETED|Overall Study||0
10132351|NCT02670330|11264602|FG001|COMPLETED|Overall Study||0
10132352|NCT02670330|11264601|FG000|NOT COMPLETED|Overall Study||75
10132353|NCT02670330|11264602|FG001|NOT COMPLETED|Overall Study||77
10132354|NCT02670343|11264608|FG000|STARTED|Overall Study||8
10132355|NCT02670343|11264608|FG000|COMPLETED|Overall Study||8
10132356|NCT02670343|11264608|FG000|NOT COMPLETED|Overall Study||0
10132357|NCT02670382|11264612|FG000|STARTED|Placebo lead-in Phase||12
10132358|NCT02670382|11264613|FG001|STARTED|Placebo lead-in Phase||12
10132359|NCT02670382|11264612|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
10132360|NCT02670382|11264613|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
10132361|NCT02670382|11264612|FG000|NOT COMPLETED|Placebo lead-in Phase||2
10132362|NCT02670382|11264613|FG001|NOT COMPLETED|Placebo lead-in Phase||1
10132363|NCT02670382|11264612|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
10132364|NCT02670382|11264613|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
10132365|NCT02670382|11264612|FG000|COMPLETED|First Active Intervention||10
10132366|NCT02670382|11264613|FG001|COMPLETED|First Active Intervention||11
10132367|NCT02670382|11264612|FG000|NOT COMPLETED|First Active Intervention||0
10132368|NCT02670382|11264613|FG001|NOT COMPLETED|First Active Intervention||0
10132369|NCT02670382|11264612|FG000|STARTED|Second Active Intervention||10
10132370|NCT02670382|11264613|FG001|STARTED|Second Active Intervention||11
10132371|NCT02670382|11264612|FG000|COMPLETED|Second Active Intervention||10
10132372|NCT02670382|11264613|FG001|COMPLETED|Second Active Intervention||11
10132373|NCT02670382|11264612|FG000|NOT COMPLETED|Second Active Intervention||0
10132374|NCT02670382|11264613|FG001|NOT COMPLETED|Second Active Intervention||0
10132375|NCT02670473|11264621|FG000|STARTED|Overall Study||35
10132376|NCT02670473|11264621|FG000|COMPLETED|Overall Study||34
10132377|NCT02670473|11264621|FG000|NOT COMPLETED|Overall Study||1
10132378|NCT02670538|11264637|FG000|STARTED|Overall Study||167
10132379|NCT02670538|11264638|FG001|STARTED|Overall Study||168
10132380|NCT02670538|11264639|FG002|STARTED|Overall Study||158
10132381|NCT02670538|11264637|FG000|Safety Population : Received Study Drug|Overall Study||165
10132382|NCT02670538|11264638|FG001|Safety Population : Received Study Drug|Overall Study||167
10132383|NCT02670538|11264639|FG002|Safety Population : Received Study Drug|Overall Study||158
10132384|NCT02670538|11264637|FG000|Intent-to-Treat Population|Overall Study||163
10132385|NCT02670538|11264638|FG001|Intent-to-Treat Population|Overall Study||162
10132386|NCT02670538|11264639|FG002|Intent-to-Treat Population|Overall Study||153
10132387|NCT02670538|11264637|FG000|COMPLETED|Overall Study||135
10132388|NCT02670538|11264638|FG001|COMPLETED|Overall Study||136
10132389|NCT02670538|11264639|FG002|COMPLETED|Overall Study||128
10132390|NCT02670538|11264637|FG000|NOT COMPLETED|Overall Study||32
10132391|NCT02670538|11264638|FG001|NOT COMPLETED|Overall Study||32
10132392|NCT02670538|11264639|FG002|NOT COMPLETED|Overall Study||30
10132393|NCT02670551|11264650|FG000|STARTED|Overall Study||163
10132394|NCT02670551|11264651|FG001|STARTED|Overall Study||160
10132395|NCT02670551|11264652|FG002|STARTED|Overall Study||165
10132396|NCT02670551|11264650|FG000|Received Treatment (Safety Population)|Overall Study||158
10132397|NCT02670551|11264651|FG001|Received Treatment (Safety Population)|Overall Study||157
10132398|NCT02670551|11264652|FG002|Received Treatment (Safety Population)|Overall Study||165
10132399|NCT02670551|11264650|FG000|COMPLETED|Overall Study||135
10132400|NCT02670551|11264651|FG001|COMPLETED|Overall Study||134
10132401|NCT02670551|11264652|FG002|COMPLETED|Overall Study||134
10132402|NCT02670551|11264650|FG000|NOT COMPLETED|Overall Study||28
10132403|NCT02670551|11264651|FG001|NOT COMPLETED|Overall Study||26
10132404|NCT02670551|11264652|FG002|NOT COMPLETED|Overall Study||31
10132405|NCT02670629|11264662|FG000|STARTED|Overall Study||29
10132406|NCT02670629|11264663|FG001|STARTED|Overall Study||29
10132407|NCT02670629|11264662|FG000|COMPLETED|Overall Study||29
10132408|NCT02670629|11264663|FG001|COMPLETED|Overall Study||29
10132409|NCT02670629|11264662|FG000|NOT COMPLETED|Overall Study||0
10132410|NCT02670629|11264663|FG001|NOT COMPLETED|Overall Study||0
10132411|NCT02670811|11264671|FG000|STARTED|Overall Study||18
10132412|NCT02670811|11264672|FG001|STARTED|Overall Study||18
10132413|NCT02670811|11264671|FG000|COMPLETED|Overall Study||17
10132414|NCT02670811|11264672|FG001|COMPLETED|Overall Study||18
10132415|NCT02670811|11264671|FG000|NOT COMPLETED|Overall Study||1
10132416|NCT02670811|11264672|FG001|NOT COMPLETED|Overall Study||0
10132417|NCT02670915|11264681|FG000|STARTED|Overall Study||260
10132418|NCT02670915|11264682|FG001|STARTED|Overall Study||259
10132419|NCT02670915|11264683|FG002|STARTED|Overall Study||258
10132420|NCT02670915|11264681|FG000|COMPLETED|Overall Study||256
10132421|NCT02670915|11264682|FG001|COMPLETED|Overall Study||251
10132422|NCT02670915|11264683|FG002|COMPLETED|Overall Study||253
10132423|NCT02670915|11264681|FG000|NOT COMPLETED|Overall Study||4
10132424|NCT02670915|11264682|FG001|NOT COMPLETED|Overall Study||8
10132425|NCT02670915|11264683|FG002|NOT COMPLETED|Overall Study||5
10132426|NCT02670928|11264693|FG000|STARTED|Overall Study||100
10132427|NCT02670928|11264694|FG001|STARTED|Overall Study||30
10132428|NCT02670928|11264693|FG000|COMPLETED|Overall Study||90
10132429|NCT02670928|11264694|FG001|COMPLETED|Overall Study||29
10132430|NCT02670928|11264693|FG000|NOT COMPLETED|Overall Study||10
10132431|NCT02670928|11264694|FG001|NOT COMPLETED|Overall Study||1
10132432|NCT02671032|11264700|FG000|STARTED|Overall Study||12
10132433|NCT02671032|11264700|FG000|COMPLETED|Overall Study||12
10132434|NCT02671032|11264700|FG000|NOT COMPLETED|Overall Study||0
10132435|NCT02671266|11264706|FG000|STARTED|Overall Study||20
10132436|NCT02671266|11264707|FG001|STARTED|Overall Study||21
10132437|NCT02671266|11264706|FG000|BDD Participants|Overall Study||9
10132438|NCT02671266|11264707|FG001|BDD Participants|Overall Study||9
10132439|NCT02671266|11264706|FG000|OCD Participants|Overall Study||2
10132440|NCT02671266|11264707|FG001|OCD Participants|Overall Study||3
10132441|NCT02671266|11264706|FG000|Healthy Participants|Overall Study||8
10132442|NCT02671266|11264707|FG001|Healthy Participants|Overall Study||8
10132443|NCT02671266|11264706|FG000|COMPLETED|Overall Study||19
10132444|NCT02671266|11264707|FG001|COMPLETED|Overall Study||20
10132445|NCT02671266|11264706|FG000|NOT COMPLETED|Overall Study||1
10132446|NCT02671266|11264707|FG001|NOT COMPLETED|Overall Study||1
10132447|NCT02671422|11264713|FG000|STARTED|Overall Study||260
10132448|NCT02671422|11264713|FG000|Not Treated With Vargatef®|Overall Study||3
10132449|NCT02671422|11264713|FG000|COMPLETED|Overall Study||0
10132450|NCT02671422|11264713|FG000|NOT COMPLETED|Overall Study||260
10132451|NCT02671500|11264717|FG000|STARTED|Overall Study||375
10132452|NCT02671500|11264717|FG000|COMPLETED|Overall Study||361
10132453|NCT02671500|11264717|FG000|NOT COMPLETED|Overall Study||14
10132454|NCT02671760|11264725|FG000|STARTED|Overall Study||13
10132455|NCT02671760|11264726|FG001|STARTED|Overall Study||13
10132456|NCT02671760|11264727|FG002|STARTED|Overall Study||13
10132457|NCT02671760|11264725|FG000|COMPLETED|Overall Study||13
10132458|NCT02671760|11264726|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
10132459|NCT02671760|11264727|FG002|COMPLETED|Overall Study||13
10132460|NCT02671760|11264725|FG000|NOT COMPLETED|Overall Study||0
10132461|NCT02671760|11264726|FG001|NOT COMPLETED|Overall Study||1
10132462|NCT02671760|11264727|FG002|NOT COMPLETED|Overall Study||0
10132463|NCT02672111|11264737|FG000|STARTED|Overall Study||190
10132464|NCT02672111|11264738|FG001|STARTED|Overall Study||37
10132465|NCT02672111|11264737|FG000|Completed Treatment|Overall Study||138
10132466|NCT02672111|11264738|FG001|Completed Treatment|Overall Study||29
10132467|NCT02672111|11264737|FG000|COMPLETED|Overall Study||132
10132468|NCT02672111|11264738|FG001|COMPLETED|Overall Study||25
10132469|NCT02672111|11264737|FG000|NOT COMPLETED|Overall Study||58
10132470|NCT02672111|11264738|FG001|NOT COMPLETED|Overall Study||12
10132471|NCT02672176|11264747|FG000|STARTED|Overall Study||161
10132472|NCT02672176|11264748|FG001|STARTED|Overall Study||158
10132473|NCT02672176|11264747|FG000|COMPLETED|Overall Study||155
10132474|NCT02672176|11264748|FG001|COMPLETED|Overall Study||132
10132475|NCT02672176|11264747|FG000|NOT COMPLETED|Overall Study||6
10132476|NCT02672176|11264748|FG001|NOT COMPLETED|Overall Study||26
10132477|NCT02672423|11264760|FG000|STARTED|Period 1||7
10132478|NCT02672423|11264761|FG001|STARTED|Period 1||7
10132479|NCT02672423|11264762|FG002|STARTED|Period 1||14
10132480|NCT02672423|11264763|FG003|STARTED|Period 1||15
10132481|NCT02672423|11264764|FG004|STARTED|Period 1||15
10132482|NCT02672423|11264765|FG005|STARTED|Period 1||15
10132483|NCT02672423|11264766|FG006|STARTED|Period 1||15
10132484|NCT02672423|11264767|FG007|STARTED|Period 1||15
10132485|NCT02672423|11264768|FG008|STARTED|Period 1||12
10132486|NCT02672423|11264769|FG009|STARTED|Period 1||12
10132487|NCT02672423|11264760|FG000|Received at Least One Dose of Study Drug|Period 1||7
10132488|NCT02672423|11264761|FG001|Received at Least One Dose of Study Drug|Period 1||7
10132489|NCT02672423|11264762|FG002|Received at Least One Dose of Study Drug|Period 1||14
10132490|NCT02672423|11264763|FG003|Received at Least One Dose of Study Drug|Period 1||15
10132491|NCT02672423|11264764|FG004|Received at Least One Dose of Study Drug|Period 1||15
10132492|NCT02672423|11264765|FG005|Received at Least One Dose of Study Drug|Period 1||15
10132493|NCT02672423|11264766|FG006|Received at Least One Dose of Study Drug|Period 1||15
10132494|NCT02672423|11264767|FG007|Received at Least One Dose of Study Drug|Period 1||15
10132495|NCT02672423|11264768|FG008|Received at Least One Dose of Study Drug|Period 1||12
10132496|NCT02672423|11264769|FG009|Received at Least One Dose of Study Drug|Period 1||12
10132497|NCT02672423|11264760|FG000|COMPLETED|Period 1||7
10132498|NCT02672423|11264761|FG001|COMPLETED|Period 1||7
10132499|NCT02672423|11264762|FG002|COMPLETED|Period 1||14
10132500|NCT02672423|11264763|FG003|COMPLETED|Period 1||15
10132501|NCT02672423|11264764|FG004|COMPLETED|Period 1||14
10132502|NCT02672423|11264765|FG005|COMPLETED|Period 1||15
10132503|NCT02672423|11264766|FG006|COMPLETED|Period 1||15
10132504|NCT02672423|11264767|FG007|COMPLETED|Period 1||15
10132505|NCT02672423|11264768|FG008|COMPLETED|Period 1||12
10132506|NCT02672423|11264769|FG009|COMPLETED|Period 1||12
10132507|NCT02672423|11264760|FG000|NOT COMPLETED|Period 1||0
10132508|NCT02672423|11264761|FG001|NOT COMPLETED|Period 1||0
10132509|NCT02672423|11264762|FG002|NOT COMPLETED|Period 1||0
10132510|NCT02672423|11264763|FG003|NOT COMPLETED|Period 1||0
10132511|NCT02672423|11264764|FG004|NOT COMPLETED|Period 1||1
10132512|NCT02672423|11264765|FG005|NOT COMPLETED|Period 1||0
10132513|NCT02672423|11264766|FG006|NOT COMPLETED|Period 1||0
10132514|NCT02672423|11264767|FG007|NOT COMPLETED|Period 1||0
10132515|NCT02672423|11264768|FG008|NOT COMPLETED|Period 1||0
10132516|NCT02672423|11264769|FG009|NOT COMPLETED|Period 1||0
10132517|NCT02672423|11264760|FG000|STARTED|Washout 1||7
10132518|NCT02672423|11264761|FG001|STARTED|Washout 1||7
10132519|NCT02672423|11264762|FG002|STARTED|Washout 1||14
10132520|NCT02672423|11264763|FG003|STARTED|Washout 1||15
10132521|NCT02672423|11264764|FG004|STARTED|Washout 1||14
10132522|NCT02672423|11264765|FG005|STARTED|Washout 1||15
10132523|NCT02672423|11264766|FG006|STARTED|Washout 1||15
10132524|NCT02672423|11264767|FG007|STARTED|Washout 1||15
10132525|NCT02672423|11264768|FG008|STARTED|Washout 1||12
10132526|NCT02672423|11264769|FG009|STARTED|Washout 1||12
10132527|NCT02672423|11264760|FG000|COMPLETED|Washout 1||7
10132528|NCT02672423|11264761|FG001|COMPLETED|Washout 1||7
10132529|NCT02672423|11264762|FG002|COMPLETED|Washout 1||14
10132530|NCT02672423|11264763|FG003|COMPLETED|Washout 1||15
10132531|NCT02672423|11264764|FG004|COMPLETED|Washout 1||14
10132532|NCT02672423|11264765|FG005|COMPLETED|Washout 1||15
10132533|NCT02672423|11264766|FG006|COMPLETED|Washout 1||15
10132534|NCT02672423|11264767|FG007|COMPLETED|Washout 1||15
10132535|NCT02672423|11264768|FG008|COMPLETED|Washout 1||12
10132536|NCT02672423|11264769|FG009|COMPLETED|Washout 1||12
10132537|NCT02672423|11264760|FG000|NOT COMPLETED|Washout 1||0
10132538|NCT02672423|11264761|FG001|NOT COMPLETED|Washout 1||0
10132539|NCT02672423|11264762|FG002|NOT COMPLETED|Washout 1||0
10132540|NCT02672423|11264763|FG003|NOT COMPLETED|Washout 1||0
10132541|NCT02672423|11264764|FG004|NOT COMPLETED|Washout 1||0
10132542|NCT02672423|11264765|FG005|NOT COMPLETED|Washout 1||0
10132543|NCT02672423|11264766|FG006|NOT COMPLETED|Washout 1||0
10132544|NCT02672423|11264767|FG007|NOT COMPLETED|Washout 1||0
10132545|NCT02672423|11264768|FG008|NOT COMPLETED|Washout 1||0
10132546|NCT02672423|11264769|FG009|NOT COMPLETED|Washout 1||0
10132547|NCT02672423|11264760|FG000|STARTED|Period 2||7
10132548|NCT02672423|11264761|FG001|STARTED|Period 2||7
10132549|NCT02672423|11264762|FG002|STARTED|Period 2||14
10132550|NCT02672423|11264763|FG003|STARTED|Period 2||15
10132551|NCT02672423|11264764|FG004|STARTED|Period 2||14
10132552|NCT02672423|11264765|FG005|STARTED|Period 2||15
10132553|NCT02672423|11264766|FG006|STARTED|Period 2||15
10132554|NCT02672423|11264767|FG007|STARTED|Period 2||15
10132555|NCT02672423|11264768|FG008|STARTED|Period 2||12
10132556|NCT02672423|11264769|FG009|STARTED|Period 2||12
10132557|NCT02672423|11264760|FG000|COMPLETED|Period 2||7
10132558|NCT02672423|11264761|FG001|COMPLETED|Period 2||7
10132559|NCT02672423|11264762|FG002|COMPLETED|Period 2||13
10132560|NCT02672423|11264763|FG003|COMPLETED|Period 2||15
10132561|NCT02672423|11264764|FG004|COMPLETED|Period 2||14
10132562|NCT02672423|11264765|FG005|COMPLETED|Period 2||15
10132563|NCT02672423|11264766|FG006|COMPLETED|Period 2||15
10132564|NCT02672423|11264767|FG007|COMPLETED|Period 2||15
10132565|NCT02672423|11264768|FG008|COMPLETED|Period 2||12
10132566|NCT02672423|11264769|FG009|COMPLETED|Period 2||12
10132567|NCT02672423|11264760|FG000|NOT COMPLETED|Period 2||0
10132568|NCT02672423|11264761|FG001|NOT COMPLETED|Period 2||0
10132569|NCT02672423|11264762|FG002|NOT COMPLETED|Period 2||1
10132570|NCT02672423|11264763|FG003|NOT COMPLETED|Period 2||0
10132571|NCT02672423|11264764|FG004|NOT COMPLETED|Period 2||0
10132572|NCT02672423|11264765|FG005|NOT COMPLETED|Period 2||0
10132573|NCT02672423|11264766|FG006|NOT COMPLETED|Period 2||0
10132574|NCT02672423|11264767|FG007|NOT COMPLETED|Period 2||0
10132575|NCT02672423|11264768|FG008|NOT COMPLETED|Period 2||0
10132576|NCT02672423|11264769|FG009|NOT COMPLETED|Period 2||0
10132577|NCT02672423|11264760|FG000|STARTED|Washout 2||7
10132578|NCT02672423|11264761|FG001|STARTED|Washout 2||7
10132579|NCT02672423|11264762|FG002|STARTED|Washout 2||13
10132580|NCT02672423|11264763|FG003|STARTED|Washout 2||15
10132581|NCT02672423|11264764|FG004|STARTED|Washout 2||14
10132582|NCT02672423|11264765|FG005|STARTED|Washout 2||15
10132583|NCT02672423|11264766|FG006|STARTED|Washout 2||15
10132584|NCT02672423|11264767|FG007|STARTED|Washout 2||15
10132585|NCT02672423|11264768|FG008|STARTED|Washout 2||12
10132586|NCT02672423|11264769|FG009|STARTED|Washout 2||12
10132587|NCT02672423|11264760|FG000|COMPLETED|Washout 2||7
10132588|NCT02672423|11264761|FG001|COMPLETED|Washout 2||7
10132589|NCT02672423|11264762|FG002|COMPLETED|Washout 2||13
10132590|NCT02672423|11264763|FG003|COMPLETED|Washout 2||15
10132591|NCT02672423|11264764|FG004|COMPLETED|Washout 2||14
10132592|NCT02672423|11264765|FG005|COMPLETED|Washout 2||15
10132593|NCT02672423|11264766|FG006|COMPLETED|Washout 2||15
10132594|NCT02672423|11264767|FG007|COMPLETED|Washout 2||15
10132595|NCT02672423|11264768|FG008|COMPLETED|Washout 2||12
10132596|NCT02672423|11264769|FG009|COMPLETED|Washout 2||12
10132597|NCT02672423|11264760|FG000|NOT COMPLETED|Washout 2||0
10132598|NCT02672423|11264761|FG001|NOT COMPLETED|Washout 2||0
10132599|NCT02672423|11264762|FG002|NOT COMPLETED|Washout 2||0
10132600|NCT02672423|11264763|FG003|NOT COMPLETED|Washout 2||0
10132601|NCT02672423|11264764|FG004|NOT COMPLETED|Washout 2||0
10132602|NCT02672423|11264765|FG005|NOT COMPLETED|Washout 2||0
10132603|NCT02672423|11264766|FG006|NOT COMPLETED|Washout 2||0
10132604|NCT02672423|11264767|FG007|NOT COMPLETED|Washout 2||0
10132605|NCT02672423|11264768|FG008|NOT COMPLETED|Washout 2||0
10132606|NCT02672423|11264769|FG009|NOT COMPLETED|Washout 2||0
10132607|NCT02672423|11264760|FG000|STARTED|Period 3|Part A was a 2-period study design.|0
10132608|NCT02672423|11264761|FG001|STARTED|Period 3|Part A was a 2-period study design.|0
10132609|NCT02672423|11264762|FG002|STARTED|Period 3||13
10132610|NCT02672423|11264763|FG003|STARTED|Period 3||15
10132611|NCT02672423|11264764|FG004|STARTED|Period 3||14
10132612|NCT02672423|11264765|FG005|STARTED|Period 3||15
10132613|NCT02672423|11264766|FG006|STARTED|Period 3||15
10132614|NCT02672423|11264767|FG007|STARTED|Period 3||15
10132615|NCT02672423|11264768|FG008|STARTED|Period 3|Part C was a 2-period study design.|0
10132616|NCT02672423|11264769|FG009|STARTED|Period 3|Part C was a 2-period study design.|0
10132617|NCT02672423|11264760|FG000|COMPLETED|Period 3||0
10132618|NCT02672423|11264761|FG001|COMPLETED|Period 3||0
10132619|NCT02672423|11264762|FG002|COMPLETED|Period 3||13
10132620|NCT02672423|11264763|FG003|COMPLETED|Period 3||15
10132621|NCT02672423|11264764|FG004|COMPLETED|Period 3||14
10132622|NCT02672423|11264765|FG005|COMPLETED|Period 3||14
10132623|NCT02672423|11264766|FG006|COMPLETED|Period 3||15
10132624|NCT02672423|11264767|FG007|COMPLETED|Period 3||14
10132625|NCT02672423|11264768|FG008|COMPLETED|Period 3||0
10132626|NCT02672423|11264769|FG009|COMPLETED|Period 3||0
10132627|NCT02672423|11264760|FG000|NOT COMPLETED|Period 3||0
10132628|NCT02672423|11264761|FG001|NOT COMPLETED|Period 3||0
10132629|NCT02672423|11264762|FG002|NOT COMPLETED|Period 3||0
10132630|NCT02672423|11264763|FG003|NOT COMPLETED|Period 3||0
10132631|NCT02672423|11264764|FG004|NOT COMPLETED|Period 3||0
10132632|NCT02672423|11264765|FG005|NOT COMPLETED|Period 3||1
10132633|NCT02672423|11264766|FG006|NOT COMPLETED|Period 3||0
10132634|NCT02672423|11264767|FG007|NOT COMPLETED|Period 3||1
10132635|NCT02672423|11264768|FG008|NOT COMPLETED|Period 3||0
10132636|NCT02672423|11264769|FG009|NOT COMPLETED|Period 3||0
10132637|NCT02672514|11264792|FG000|STARTED|Overall Study||53
10132638|NCT02672514|11264793|FG001|STARTED|Overall Study||51
10132639|NCT02672514|11264792|FG000|COMPLETED|Overall Study||53
10132640|NCT02672514|11264793|FG001|COMPLETED|Overall Study||51
10132641|NCT02672514|11264792|FG000|NOT COMPLETED|Overall Study||0
10132642|NCT02672514|11264793|FG001|NOT COMPLETED|Overall Study||0
10132643|NCT02672553|11264801|FG000|STARTED|Overall Study||51
10132644|NCT02672553|11264802|FG001|STARTED|Overall Study||49
10132645|NCT02672553|11264801|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
10132646|NCT02672553|11264802|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
10132647|NCT02672553|11264801|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46
10132648|NCT02672553|11264802|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51
10132649|NCT02672553|11264801|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46
10132650|NCT02672553|11264802|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48
10132651|NCT02672553|11264801|FG000|COMPLETED|Overall Study||39
10132652|NCT02672553|11264802|FG001|COMPLETED|Overall Study||41
10132653|NCT02672553|11264801|FG000|NOT COMPLETED|Overall Study||12
10132654|NCT02672553|11264802|FG001|NOT COMPLETED|Overall Study||8
10132655|NCT02672852|11264811|FG000|STARTED|Part A1||100
10132656|NCT02672852|11264812|FG001|STARTED|Part A1||407
10132657|NCT02672852|11264813|FG002|STARTED|Part A1||0
10132658|NCT02672852|11264814|FG003|STARTED|Part A1||0
10132659|NCT02672852|11264815|FG004|STARTED|Part A1||0
10132660|NCT02672852|11264816|FG005|STARTED|Part A1||0
10132661|NCT02672852|11264817|FG006|STARTED|Part A1||0
10132662|NCT02672852|11264811|FG000|COMPLETED|Part A1||97
10132663|NCT02672852|11264812|FG001|COMPLETED|Part A1||403
10132664|NCT02672852|11264813|FG002|COMPLETED|Part A1||0
10132665|NCT02672852|11264814|FG003|COMPLETED|Part A1||0
10132666|NCT02672852|11264815|FG004|COMPLETED|Part A1||0
10132667|NCT02672852|11264816|FG005|COMPLETED|Part A1||0
10132668|NCT02672852|11264817|FG006|COMPLETED|Part A1||0
10132669|NCT02672852|11264811|FG000|NOT COMPLETED|Part A1||3
10132670|NCT02672852|11264812|FG001|NOT COMPLETED|Part A1||4
10132671|NCT02672852|11264813|FG002|NOT COMPLETED|Part A1||0
10132672|NCT02672852|11264814|FG003|NOT COMPLETED|Part A1||0
10132673|NCT02672852|11264815|FG004|NOT COMPLETED|Part A1||0
10132674|NCT02672852|11264816|FG005|NOT COMPLETED|Part A1||0
10132675|NCT02672852|11264817|FG006|NOT COMPLETED|Part A1||0
10132676|NCT02672852|11264811|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
10132677|NCT02672852|11264812|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
10132678|NCT02672852|11264813|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
10132679|NCT02672852|11264814|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
10132680|NCT02672852|11264815|FG004|STARTED|Part A2||0
10132681|NCT02672852|11264816|FG005|STARTED|Part A2||0
10132682|NCT02672852|11264817|FG006|STARTED|Part A2||0
10132683|NCT02672852|11264811|FG000|COMPLETED|Part A2||0
10132684|NCT02672852|11264812|FG001|COMPLETED|Part A2||0
10132685|NCT02672852|11264813|FG002|COMPLETED|Part A2||83
10132686|NCT02672852|11264814|FG003|COMPLETED|Part A2||399
10132687|NCT02672852|11264815|FG004|COMPLETED|Part A2||0
10132688|NCT02672852|11264816|FG005|COMPLETED|Part A2||0
10132689|NCT02672852|11264817|FG006|COMPLETED|Part A2||0
10132690|NCT02672852|11264811|FG000|NOT COMPLETED|Part A2||0
10132691|NCT02672852|11264812|FG001|NOT COMPLETED|Part A2||0
10132692|NCT02672852|11264813|FG002|NOT COMPLETED|Part A2||10
10132693|NCT02672852|11264814|FG003|NOT COMPLETED|Part A2||4
10132694|NCT02672852|11264815|FG004|NOT COMPLETED|Part A2||0
10132695|NCT02672852|11264816|FG005|NOT COMPLETED|Part A2||0
10132696|NCT02672852|11264817|FG006|NOT COMPLETED|Part A2||0
10132697|NCT02672852|11264811|FG000|STARTED|Part B||0
10132698|NCT02672852|11264812|FG001|STARTED|Part B||0
10132699|NCT02672852|11264813|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
10132700|NCT02672852|11264814|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
10132701|NCT02672852|11264815|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
10132702|NCT02672852|11264816|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
10132703|NCT02672852|11264817|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
10132704|NCT02672852|11264811|FG000|COMPLETED|Part B||0
10132705|NCT02672852|11264812|FG001|COMPLETED|Part B||0
10132706|NCT02672852|11264813|FG002|COMPLETED|Part B||0
10132707|NCT02672852|11264814|FG003|COMPLETED|Part B||0
10132708|NCT02672852|11264815|FG004|COMPLETED|Part B||209
10132709|NCT02672852|11264816|FG005|COMPLETED|Part B||100
10132710|NCT02672852|11264817|FG006|COMPLETED|Part B||51
10132711|NCT02672852|11264811|FG000|NOT COMPLETED|Part B||0
10132712|NCT02672852|11264812|FG001|NOT COMPLETED|Part B||0
10132713|NCT02672852|11264813|FG002|NOT COMPLETED|Part B||0
10132714|NCT02672852|11264814|FG003|NOT COMPLETED|Part B||0
10132715|NCT02672852|11264815|FG004|NOT COMPLETED|Part B||16
10132716|NCT02672852|11264816|FG005|NOT COMPLETED|Part B||11
10132717|NCT02672852|11264817|FG006|NOT COMPLETED|Part B||12
10132718|NCT02673138|11264828|FG000|STARTED|Overall Study||10
10132719|NCT02673138|11264828|FG000|Started Day 1|Overall Study||10
10132720|NCT02673138|11264828|FG000|Ended Day 1|Overall Study||10
10132721|NCT02673138|11264828|FG000|Started Day 2|Overall Study||10
10132722|NCT02673138|11264828|FG000|Ended Day 2|Overall Study||10
10132723|NCT02673138|11264828|FG000|COMPLETED|Overall Study||10
10132724|NCT02673138|11264828|FG000|NOT COMPLETED|Overall Study||0
10132725|NCT02673372|11264836|FG000|STARTED|Overall Study||30
10132726|NCT02673372|11264837|FG001|STARTED|Overall Study||30
10132727|NCT02673372|11264836|FG000|COMPLETED|Overall Study||30
10132728|NCT02673372|11264837|FG001|COMPLETED|Overall Study||30
10132729|NCT02673372|11264836|FG000|NOT COMPLETED|Overall Study||0
10132730|NCT02673372|11264837|FG001|NOT COMPLETED|Overall Study||0
10132731|NCT02673489|11264845|FG000|STARTED|Treatment Period||54
10132732|NCT02673489|11264846|FG001|STARTED|Treatment Period||24
10132733|NCT02673489|11264845|FG000|COMPLETED|Treatment Period||49
10132734|NCT02673489|11264846|FG001|COMPLETED|Treatment Period||21
10132735|NCT02673489|11264845|FG000|NOT COMPLETED|Treatment Period||5
10132736|NCT02673489|11264846|FG001|NOT COMPLETED|Treatment Period||3
10132737|NCT02673489|11264845|FG000|STARTED|Follow Up Period||50
10132738|NCT02673489|11264846|FG001|STARTED|Follow Up Period||23
10132739|NCT02673489|11264845|FG000|COMPLETED|Follow Up Period||50
10132740|NCT02673489|11264846|FG001|COMPLETED|Follow Up Period||21
10132741|NCT02673489|11264845|FG000|NOT COMPLETED|Follow Up Period||0
10132742|NCT02673489|11264846|FG001|NOT COMPLETED|Follow Up Period||2
10132743|NCT02673515|11264855|FG000|STARTED|Overall Study||30
10132744|NCT02673515|11264856|FG001|STARTED|Overall Study||30
10132745|NCT02673515|11264855|FG000|COMPLETED|Overall Study||28
10132746|NCT02673515|11264856|FG001|COMPLETED|Overall Study||29
10132747|NCT02673515|11264855|FG000|NOT COMPLETED|Overall Study||2
10132748|NCT02673515|11264856|FG001|NOT COMPLETED|Overall Study||1
10132749|NCT02673541|11264864|FG000|STARTED|Overall Study||3
10132750|NCT02673541|11264865|FG001|STARTED|Overall Study||2
10132751|NCT02673541|11264864|FG000|COMPLETED|Overall Study||3
10132752|NCT02673541|11264865|FG001|COMPLETED|Overall Study||2
10132753|NCT02673541|11264864|FG000|NOT COMPLETED|Overall Study||0
10132754|NCT02673541|11264865|FG001|NOT COMPLETED|Overall Study||0
10132755|NCT02673619|11264875|FG000|STARTED|Overall Study||20
10132756|NCT02673619|11264876|FG001|STARTED|Overall Study||5
10132757|NCT02673619|11264877|FG002|STARTED|Overall Study||26
10132758|NCT02673619|11264878|FG003|STARTED|Overall Study||7
10132759|NCT02673619|11264875|FG000|COMPLETED|Overall Study||18
10132760|NCT02673619|11264876|FG001|COMPLETED|Overall Study||4
10132761|NCT02673619|11264877|FG002|COMPLETED|Overall Study||23
10132762|NCT02673619|11264878|FG003|COMPLETED|Overall Study||7
10132763|NCT02673619|11264875|FG000|NOT COMPLETED|Overall Study||2
10132764|NCT02673619|11264876|FG001|NOT COMPLETED|Overall Study||1
10132765|NCT02673619|11264877|FG002|NOT COMPLETED|Overall Study||3
10132766|NCT02673619|11264878|FG003|NOT COMPLETED|Overall Study||0
10132767|NCT02673918|11264891|FG000|STARTED|Overall Study||35
10132768|NCT02673918|11264892|FG001|STARTED|Overall Study||24
10132769|NCT02673918|11264891|FG000|COMPLETED|Overall Study||29
10132770|NCT02673918|11264892|FG001|COMPLETED|Overall Study||20
10132771|NCT02673918|11264891|FG000|NOT COMPLETED|Overall Study||6
10132772|NCT02673918|11264892|FG001|NOT COMPLETED|Overall Study||4
10132773|NCT02673944|11264900|FG000|STARTED|Overall Study||10
10132774|NCT02673944|11264900|FG000|COMPLETED|Overall Study||10
10132775|NCT02673944|11264900|FG000|NOT COMPLETED|Overall Study||0
10132776|NCT02674334|11264907|FG000|STARTED|Overall Study||47
10132777|NCT02674334|11264908|FG001|STARTED|Overall Study||43
10132778|NCT02674334|11264907|FG000|COMPLETED|Overall Study||40
10132779|NCT02674334|11264908|FG001|COMPLETED|Overall Study||40
10132780|NCT02674334|11264907|FG000|NOT COMPLETED|Overall Study||7
10132781|NCT02674334|11264908|FG001|NOT COMPLETED|Overall Study||3
10132782|NCT02674386|11264917|FG000|STARTED|Overall Study||20
10132783|NCT02674386|11264918|FG001|STARTED|Overall Study||117
10132784|NCT02674386|11264919|FG002|STARTED|Overall Study||17
10132785|NCT02674386|11264917|FG000|Safety Analysis Set|Overall Study||20
10132786|NCT02674386|11264918|FG001|Safety Analysis Set|Overall Study||113
10132787|NCT02674386|11264919|FG002|Safety Analysis Set|Overall Study||17
10132788|NCT02674386|11264917|FG000|COMPLETED|Overall Study||20
10132789|NCT02674386|11264918|FG001|COMPLETED|Overall Study||107
10132790|NCT02674386|11264919|FG002|COMPLETED|Overall Study||16
10132791|NCT02674386|11264917|FG000|NOT COMPLETED|Overall Study||0
10132792|NCT02674386|11264918|FG001|NOT COMPLETED|Overall Study||10
10132793|NCT02674386|11264919|FG002|NOT COMPLETED|Overall Study||1
10132794|NCT02674399|11264934|FG000|STARTED|Overall Study||19
10132795|NCT02674399|11264935|FG001|STARTED|Overall Study||9
10132796|NCT02674399|11264934|FG000|COMPLETED|Overall Study||17
10132797|NCT02674399|11264935|FG001|COMPLETED|Overall Study||9
10132798|NCT02674399|11264934|FG000|NOT COMPLETED|Overall Study||2
10132799|NCT02674399|11264935|FG001|NOT COMPLETED|Overall Study||0
10132800|NCT02674412|11264941|FG000|STARTED|Overall Study||5
10132801|NCT02674412|11264942|FG001|STARTED|Overall Study||5
10132802|NCT02674412|11264941|FG000|COMPLETED|Overall Study||5
10132803|NCT02674412|11264942|FG001|COMPLETED|Overall Study||5
10132804|NCT02674412|11264941|FG000|NOT COMPLETED|Overall Study||0
10132805|NCT02674412|11264942|FG001|NOT COMPLETED|Overall Study||0
10132806|NCT02674477|11264951|FG000|STARTED|Overall Study||48
10132807|NCT02674477|11264952|FG001|STARTED|Overall Study||47
10132808|NCT02674477|11264951|FG000|COMPLETED|Overall Study||40
10132809|NCT02674477|11264952|FG001|COMPLETED|Overall Study||45
10132810|NCT02674477|11264951|FG000|NOT COMPLETED|Overall Study||8
10132811|NCT02674477|11264952|FG001|NOT COMPLETED|Overall Study||2
10132812|NCT02674568|11264958|FG000|STARTED|Overall Study|Enrolled and dosed.|339
10132813|NCT02674568|11264958|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238
10132814|NCT02674568|11264958|FG000|DLL3 Positive|Overall Study||287
10132815|NCT02674568|11264958|FG000|COMPLETED|Overall Study||0
10132816|NCT02674568|11264958|FG000|NOT COMPLETED|Overall Study||339
10132817|NCT02674633|11264969|FG000|STARTED|Overall Study||180
10132818|NCT02674633|11264970|FG001|STARTED|Overall Study||168
10132819|NCT02674633|11264969|FG000|COMPLETED|Overall Study||175
10132820|NCT02674633|11264970|FG001|COMPLETED|Overall Study||164
10132821|NCT02674633|11264969|FG000|NOT COMPLETED|Overall Study||5
10132822|NCT02674633|11264970|FG001|NOT COMPLETED|Overall Study||4
10132823|NCT02674659|11264978|FG000|STARTED|Overall Study||43
10132824|NCT02674659|11264979|FG001|STARTED|Overall Study||44
10132825|NCT02674659|11264978|FG000|COMPLETED|Overall Study||39
10132826|NCT02674659|11264979|FG001|COMPLETED|Overall Study||40
10132827|NCT02674659|11264978|FG000|NOT COMPLETED|Overall Study||4
10132828|NCT02674659|11264979|FG001|NOT COMPLETED|Overall Study||4
10132829|NCT02674685|11264985|FG000|STARTED|Overall Study||237
10132830|NCT02674685|11264985|FG000|COMPLETED|Overall Study||233
10132831|NCT02674685|11264985|FG000|NOT COMPLETED|Overall Study||4
10132832|NCT02674854|11264992|FG000|STARTED|Overall Study||245
10132833|NCT02674854|11264993|FG001|STARTED|Overall Study||255
10132834|NCT02674854|11264994|FG002|STARTED|Overall Study||250
10132835|NCT02674854|11264992|FG000|COMPLETED|Overall Study||221
10132836|NCT02674854|11264993|FG001|COMPLETED|Overall Study||228
10132837|NCT02674854|11264994|FG002|COMPLETED|Overall Study||236
10132838|NCT02674854|11264992|FG000|NOT COMPLETED|Overall Study||24
10132839|NCT02674854|11264993|FG001|NOT COMPLETED|Overall Study||27
10132840|NCT02674854|11264994|FG002|NOT COMPLETED|Overall Study||14
10132841|NCT02675075|11265004|FG000|STARTED|Overall Study||15
10132842|NCT02675075|11265005|FG001|STARTED|Overall Study||19
10132843|NCT02675075|11265004|FG000|COMPLETED|Overall Study||12
10132844|NCT02675075|11265005|FG001|COMPLETED|Overall Study||19
10132845|NCT02675075|11265004|FG000|NOT COMPLETED|Overall Study||3
10132846|NCT02675075|11265005|FG001|NOT COMPLETED|Overall Study||0
10132847|NCT02675517|11265013|FG000|STARTED|Overall Study||1737
10132848|NCT02675517|11265013|FG000|COMPLETED|Overall Study||1578
10132849|NCT02675517|11265013|FG000|NOT COMPLETED|Overall Study||159
10132850|NCT02675543|11265019|FG000|STARTED|Overall Study||15
10132851|NCT02675543|11265020|FG001|STARTED|Overall Study||20
10132852|NCT02675543|11265019|FG000|COMPLETED|Overall Study||15
10132853|NCT02675543|11265020|FG001|COMPLETED|Overall Study||20
10132854|NCT02675543|11265019|FG000|NOT COMPLETED|Overall Study||0
10132855|NCT02675543|11265020|FG001|NOT COMPLETED|Overall Study||0
10132856|NCT02675634|11265026|FG000|STARTED|Test Period 1||10
10132857|NCT02675634|11265027|FG001|STARTED|Test Period 1||8
10132858|NCT02675634|11265028|FG002|STARTED|Test Period 1||9
10132859|NCT02675634|11265029|FG003|STARTED|Test Period 1||9
10132860|NCT02675634|11265030|FG004|STARTED|Test Period 1||10
10132861|NCT02675634|11265031|FG005|STARTED|Test Period 1||9
10132862|NCT02675634|11265026|FG000|COMPLETED|Test Period 1||10
10132863|NCT02675634|11265027|FG001|COMPLETED|Test Period 1||7
10132864|NCT02675634|11265028|FG002|COMPLETED|Test Period 1||8
10132865|NCT02675634|11265029|FG003|COMPLETED|Test Period 1||8
10132866|NCT02675634|11265030|FG004|COMPLETED|Test Period 1||10
10132867|NCT02675634|11265031|FG005|COMPLETED|Test Period 1||9
10132868|NCT02675634|11265026|FG000|NOT COMPLETED|Test Period 1||0
10132869|NCT02675634|11265027|FG001|NOT COMPLETED|Test Period 1||1
10132870|NCT02675634|11265028|FG002|NOT COMPLETED|Test Period 1||1
10132871|NCT02675634|11265029|FG003|NOT COMPLETED|Test Period 1||1
10132872|NCT02675634|11265030|FG004|NOT COMPLETED|Test Period 1||0
10132873|NCT02675634|11265031|FG005|NOT COMPLETED|Test Period 1||0
10132874|NCT02675634|11265026|FG000|STARTED|Test Period 2||10
10132875|NCT02675634|11265027|FG001|STARTED|Test Period 2||7
10132876|NCT02675634|11265028|FG002|STARTED|Test Period 2||8
10132877|NCT02675634|11265029|FG003|STARTED|Test Period 2||8
10132878|NCT02675634|11265030|FG004|STARTED|Test Period 2||10
10132879|NCT02675634|11265031|FG005|STARTED|Test Period 2||9
10132880|NCT02675634|11265026|FG000|COMPLETED|Test Period 2||9
10132881|NCT02675634|11265027|FG001|COMPLETED|Test Period 2||7
10132882|NCT02675634|11265028|FG002|COMPLETED|Test Period 2||8
10132883|NCT02675634|11265029|FG003|COMPLETED|Test Period 2||8
10132884|NCT02675634|11265030|FG004|COMPLETED|Test Period 2||10
10132885|NCT02675634|11265031|FG005|COMPLETED|Test Period 2||8
10132886|NCT02675634|11265026|FG000|NOT COMPLETED|Test Period 2||1
10132887|NCT02675634|11265027|FG001|NOT COMPLETED|Test Period 2||0
10132888|NCT02675634|11265028|FG002|NOT COMPLETED|Test Period 2||0
10132889|NCT02675634|11265029|FG003|NOT COMPLETED|Test Period 2||0
10132890|NCT02675634|11265030|FG004|NOT COMPLETED|Test Period 2||0
10132891|NCT02675634|11265031|FG005|NOT COMPLETED|Test Period 2||1
10132892|NCT02675634|11265026|FG000|STARTED|Test Period 3||9
10132893|NCT02675634|11265027|FG001|STARTED|Test Period 3||7
10132894|NCT02675634|11265028|FG002|STARTED|Test Period 3||8
10132895|NCT02675634|11265029|FG003|STARTED|Test Period 3||8
10132896|NCT02675634|11265030|FG004|STARTED|Test Period 3||10
10132897|NCT02675634|11265031|FG005|STARTED|Test Period 3||8
10132898|NCT02675634|11265026|FG000|COMPLETED|Test Period 3||9
10132899|NCT02675634|11265027|FG001|COMPLETED|Test Period 3||7
10132900|NCT02675634|11265028|FG002|COMPLETED|Test Period 3||8
10132901|NCT02675634|11265029|FG003|COMPLETED|Test Period 3||8
10132902|NCT02675634|11265030|FG004|COMPLETED|Test Period 3||10
10132903|NCT02675634|11265031|FG005|COMPLETED|Test Period 3||8
10132904|NCT02675634|11265026|FG000|NOT COMPLETED|Test Period 3||0
10132905|NCT02675634|11265027|FG001|NOT COMPLETED|Test Period 3||0
10132906|NCT02675634|11265028|FG002|NOT COMPLETED|Test Period 3||0
10132907|NCT02675634|11265029|FG003|NOT COMPLETED|Test Period 3||0
10132908|NCT02675634|11265030|FG004|NOT COMPLETED|Test Period 3||0
10132909|NCT02675634|11265031|FG005|NOT COMPLETED|Test Period 3||0
10132910|NCT02675764|11265041|FG000|STARTED|Overall Study||6
10132911|NCT02675764|11265042|FG001|STARTED|Overall Study||6
10132912|NCT02675764|11265041|FG000|COMPLETED|Overall Study||6
10132913|NCT02675764|11265042|FG001|COMPLETED|Overall Study||6
10132914|NCT02675764|11265041|FG000|NOT COMPLETED|Overall Study||0
10132915|NCT02675764|11265042|FG001|NOT COMPLETED|Overall Study||0
10132916|NCT02675907|11265050|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
10132917|NCT02675907|11265051|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
10132918|NCT02675907|11265050|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
10132919|NCT02675907|11265051|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
10132920|NCT02675907|11265050|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
10132921|NCT02675907|11265051|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
10132922|NCT02675907|11265050|FG000|STARTED|Study Overall||100
10132923|NCT02675907|11265051|FG001|STARTED|Study Overall||101
10132924|NCT02675907|11265050|FG000|COMPLETED|Study Overall||97
10132925|NCT02675907|11265051|FG001|COMPLETED|Study Overall||97
10132926|NCT02675907|11265050|FG000|NOT COMPLETED|Study Overall||3
10132927|NCT02675907|11265051|FG001|NOT COMPLETED|Study Overall||4
10132928|NCT02675998|11265061|FG000|STARTED|8-Week Treatment Period||74
10132929|NCT02675998|11265062|FG001|STARTED|8-Week Treatment Period||73
10132930|NCT02675998|11265063|FG002|STARTED|8-Week Treatment Period||72
10132931|NCT02675998|11265064|FG003|STARTED|8-Week Treatment Period||0
10132932|NCT02675998|11265061|FG000|COMPLETED|8-Week Treatment Period||57
10132933|NCT02675998|11265062|FG001|COMPLETED|8-Week Treatment Period||54
10132934|NCT02675998|11265063|FG002|COMPLETED|8-Week Treatment Period||53
10132935|NCT02675998|11265064|FG003|COMPLETED|8-Week Treatment Period||0
10132936|NCT02675998|11265061|FG000|NOT COMPLETED|8-Week Treatment Period||17
10132937|NCT02675998|11265062|FG001|NOT COMPLETED|8-Week Treatment Period||19
10132938|NCT02675998|11265063|FG002|NOT COMPLETED|8-Week Treatment Period||19
10132939|NCT02675998|11265064|FG003|NOT COMPLETED|8-Week Treatment Period||0
10132940|NCT02675998|11265061|FG000|STARTED|4-Week Randomized Withdrawal Period||25
10132941|NCT02675998|11265062|FG001|STARTED|4-Week Randomized Withdrawal Period||23
10132942|NCT02675998|11265063|FG002|STARTED|4-Week Randomized Withdrawal Period||34
10132943|NCT02675998|11265064|FG003|STARTED|4-Week Randomized Withdrawal Period||82
10132944|NCT02675998|11265061|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24
10132945|NCT02675998|11265062|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22
10132946|NCT02675998|11265063|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32
10132947|NCT02675998|11265064|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74
10132948|NCT02675998|11265061|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
10132949|NCT02675998|11265062|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
10132950|NCT02675998|11265063|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
10132951|NCT02675998|11265064|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
10132952|NCT02676375|11265077|FG000|STARTED|Overall Study||14
10132953|NCT02676375|11265078|FG001|STARTED|Overall Study||14
10132954|NCT02676375|11265079|FG002|STARTED|Overall Study||14
10132955|NCT02676375|11265077|FG000|COMPLETED|Overall Study||13
10132956|NCT02676375|11265078|FG001|COMPLETED|Overall Study||10
10132957|NCT02676375|11265079|FG002|COMPLETED|Overall Study||11
10132958|NCT02676375|11265077|FG000|NOT COMPLETED|Overall Study||1
10132959|NCT02676375|11265078|FG001|NOT COMPLETED|Overall Study||4
10132960|NCT02676375|11265079|FG002|NOT COMPLETED|Overall Study||3
10132961|NCT02676466|11265095|FG000|STARTED|Overall Study||109
10132962|NCT02676466|11265096|FG001|STARTED|Overall Study||71
10132963|NCT02676466|11265097|FG002|STARTED|Overall Study||26
10132964|NCT02676466|11265098|FG003|STARTED|Overall Study||17
10132965|NCT02676466|11265099|FG004|STARTED|Overall Study||26
10132966|NCT02676466|11265100|FG005|STARTED|Overall Study||13
10132967|NCT02676466|11265101|FG006|STARTED|Overall Study||13
10132968|NCT02676466|11265102|FG007|STARTED|Overall Study||14
10132969|NCT02676466|11265095|FG000|COMPLETED|Overall Study||105
10132970|NCT02676466|11265096|FG001|COMPLETED|Overall Study||66
10132971|NCT02676466|11265097|FG002|COMPLETED|Overall Study||24
10132972|NCT02676466|11265098|FG003|COMPLETED|Overall Study||17
10132973|NCT02676466|11265099|FG004|COMPLETED|Overall Study||23
10132974|NCT02676466|11265100|FG005|COMPLETED|Overall Study||12
10132975|NCT02676466|11265101|FG006|COMPLETED|Overall Study||12
10132976|NCT02676466|11265102|FG007|COMPLETED|Overall Study||13
10132977|NCT02676466|11265095|FG000|NOT COMPLETED|Overall Study||4
10132978|NCT02676466|11265096|FG001|NOT COMPLETED|Overall Study||5
10132979|NCT02676466|11265097|FG002|NOT COMPLETED|Overall Study||2
10132980|NCT02676466|11265098|FG003|NOT COMPLETED|Overall Study||0
10132981|NCT02676466|11265099|FG004|NOT COMPLETED|Overall Study||3
10132982|NCT02676466|11265100|FG005|NOT COMPLETED|Overall Study||1
10132983|NCT02676466|11265101|FG006|NOT COMPLETED|Overall Study||1
10132984|NCT02676466|11265102|FG007|NOT COMPLETED|Overall Study||1
10132985|NCT02676778|11265127|FG000|STARTED|Overall Study||17
10132986|NCT02676778|11265128|FG001|STARTED|Overall Study||19
10132987|NCT02676778|11265129|FG002|STARTED|Overall Study||1
10132988|NCT02676778|11265127|FG000|COMPLETED|Overall Study||0
10132989|NCT02676778|11265128|FG001|COMPLETED|Overall Study||7
10132990|NCT02676778|11265129|FG002|COMPLETED|Overall Study||0
10132991|NCT02676778|11265127|FG000|NOT COMPLETED|Overall Study||17
10132992|NCT02676778|11265128|FG001|NOT COMPLETED|Overall Study||12
10132993|NCT02676778|11265129|FG002|NOT COMPLETED|Overall Study||1
10132994|NCT02676843|11265138|FG000|STARTED|Overall Study||7
10132995|NCT02676843|11265138|FG000|COMPLETED|Overall Study||7
10132996|NCT02676843|11265138|FG000|NOT COMPLETED|Overall Study||0
10132997|NCT02676882|11265145|FG000|STARTED|Overall Study||13
10132998|NCT02676882|11265146|FG001|STARTED|Overall Study||7
10132999|NCT02676882|11265145|FG000|Evaluable|Overall Study||11
10133000|NCT02676882|11265146|FG001|Evaluable|Overall Study||6
10133001|NCT02676882|11265145|FG000|COMPLETED|Overall Study||10
10133002|NCT02676882|11265146|FG001|COMPLETED|Overall Study||5
10133003|NCT02676882|11265145|FG000|NOT COMPLETED|Overall Study||3
10133004|NCT02676882|11265146|FG001|NOT COMPLETED|Overall Study||2
10133005|NCT02676895|11265155|FG000|STARTED|Overall Study||22
10133006|NCT02676895|11265156|FG001|STARTED|Overall Study||26
10133007|NCT02676895|11265157|FG002|STARTED|Overall Study||24
10133008|NCT02676895|11265155|FG000|COMPLETED|Overall Study||20
10133009|NCT02676895|11265156|FG001|COMPLETED|Overall Study||23
10133010|NCT02676895|11265157|FG002|COMPLETED|Overall Study||21
10133011|NCT02676895|11265155|FG000|NOT COMPLETED|Overall Study||2
10133012|NCT02676895|11265156|FG001|NOT COMPLETED|Overall Study||3
10133013|NCT02676895|11265157|FG002|NOT COMPLETED|Overall Study||3
10133014|NCT02677116|11265175|FG000|STARTED|Overall Study||10
10133015|NCT02677116|11265176|FG001|STARTED|Overall Study||11
10133016|NCT02677116|11265177|FG002|STARTED|Overall Study||9
10133017|NCT02677116|11265178|FG003|STARTED|Overall Study||10
10133018|NCT02677116|11265179|FG004|STARTED|Overall Study||1
10133019|NCT02677116|11265180|FG005|STARTED|Overall Study||13
10133020|NCT02677116|11265181|FG006|STARTED|Overall Study||6
10133021|NCT02677116|11265182|FG007|STARTED|Overall Study||4
10133022|NCT02677116|11265183|FG008|STARTED|Overall Study||4
10133023|NCT02677116|11265175|FG000|Cycle 1 Olaratumab Alone|Overall Study||10
10133024|NCT02677116|11265176|FG001|Cycle 1 Olaratumab Alone|Overall Study||11
10133025|NCT02677116|11265177|FG002|Cycle 1 Olaratumab Alone|Overall Study||9
10133026|NCT02677116|11265178|FG003|Cycle 1 Olaratumab Alone|Overall Study||10
10133027|NCT02677116|11265179|FG004|Cycle 1 Olaratumab Alone|Overall Study||1
10133028|NCT02677116|11265180|FG005|Cycle 1 Olaratumab Alone|Overall Study||13
10133029|NCT02677116|11265181|FG006|Cycle 1 Olaratumab Alone|Overall Study||6
10133030|NCT02677116|11265182|FG007|Cycle 1 Olaratumab Alone|Overall Study||4
10133031|NCT02677116|11265183|FG008|Cycle 1 Olaratumab Alone|Overall Study||4
10133032|NCT02677116|11265175|FG000|Progressive Disease|Overall Study||7
10133033|NCT02677116|11265176|FG001|Progressive Disease|Overall Study||7
10133034|NCT02677116|11265177|FG002|Progressive Disease|Overall Study||6
10133035|NCT02677116|11265178|FG003|Progressive Disease|Overall Study||7
10133036|NCT02677116|11265179|FG004|Progressive Disease|Overall Study||0
10133037|NCT02677116|11265180|FG005|Progressive Disease|Overall Study||9
10133038|NCT02677116|11265181|FG006|Progressive Disease|Overall Study||2
10133039|NCT02677116|11265182|FG007|Progressive Disease|Overall Study||2
10133040|NCT02677116|11265183|FG008|Progressive Disease|Overall Study||2
10133041|NCT02677116|11265175|FG000|COMPLETED|Overall Study||7
10133042|NCT02677116|11265176|FG001|COMPLETED|Overall Study||7
10133043|NCT02677116|11265177|FG002|COMPLETED|Overall Study||6
10133044|NCT02677116|11265178|FG003|COMPLETED|Overall Study||7
10133045|NCT02677116|11265179|FG004|COMPLETED|Overall Study||0
10133046|NCT02677116|11265180|FG005|COMPLETED|Overall Study||9
10133047|NCT02677116|11265181|FG006|COMPLETED|Overall Study||2
10133048|NCT02677116|11265182|FG007|COMPLETED|Overall Study||2
10133049|NCT02677116|11265183|FG008|COMPLETED|Overall Study||2
10133050|NCT02677116|11265175|FG000|NOT COMPLETED|Overall Study||3
10133051|NCT02677116|11265176|FG001|NOT COMPLETED|Overall Study||4
10133052|NCT02677116|11265177|FG002|NOT COMPLETED|Overall Study||3
10133053|NCT02677116|11265178|FG003|NOT COMPLETED|Overall Study||3
10133054|NCT02677116|11265179|FG004|NOT COMPLETED|Overall Study||1
10133055|NCT02677116|11265180|FG005|NOT COMPLETED|Overall Study||4
10133056|NCT02677116|11265181|FG006|NOT COMPLETED|Overall Study||4
10133057|NCT02677116|11265182|FG007|NOT COMPLETED|Overall Study||2
10133058|NCT02677116|11265183|FG008|NOT COMPLETED|Overall Study||2
10133059|NCT02677220|11265226|FG000|STARTED|Overall Study||1
10133060|NCT02677220|11265226|FG000|COMPLETED|Overall Study||0
10133061|NCT02677220|11265226|FG000|NOT COMPLETED|Overall Study||1
10133062|NCT02677428|11265233|FG000|STARTED|Overall Study||63
10133063|NCT02677428|11265234|FG001|STARTED|Overall Study||55
10133064|NCT02677428|11265233|FG000|COMPLETED|Overall Study||63
10133065|NCT02677428|11265234|FG001|COMPLETED|Overall Study||55
10133066|NCT02677428|11265233|FG000|NOT COMPLETED|Overall Study||0
10133067|NCT02677428|11265234|FG001|NOT COMPLETED|Overall Study||0
10133068|NCT02677493|11265243|FG000|STARTED|Overall Study||1197
10133069|NCT02677493|11265244|FG001|STARTED|Overall Study||298
10133070|NCT02677493|11265245|FG002|STARTED|Overall Study||299
10133071|NCT02677493|11265243|FG000|COMPLETED|Overall Study||1186
10133072|NCT02677493|11265244|FG001|COMPLETED|Overall Study||296
10133073|NCT02677493|11265245|FG002|COMPLETED|Overall Study||296
10133074|NCT02677493|11265243|FG000|NOT COMPLETED|Overall Study||11
10133075|NCT02677493|11265244|FG001|NOT COMPLETED|Overall Study||2
10133076|NCT02677493|11265245|FG002|NOT COMPLETED|Overall Study||3
10133077|NCT02677623|11265260|FG000|STARTED|Overall Study||33
10133078|NCT02677623|11265261|FG001|STARTED|Overall Study||32
10133079|NCT02677623|11265262|FG002|STARTED|Overall Study||32
10133080|NCT02677623|11265263|FG003|STARTED|Overall Study||33
10133081|NCT02677623|11265260|FG000|COMPLETED|Overall Study||33
10133082|NCT02677623|11265261|FG001|COMPLETED|Overall Study||32
10133083|NCT02677623|11265262|FG002|COMPLETED|Overall Study||32
10133084|NCT02677623|11265263|FG003|COMPLETED|Overall Study||33
10133085|NCT02677623|11265260|FG000|NOT COMPLETED|Overall Study||0
10133086|NCT02677623|11265261|FG001|NOT COMPLETED|Overall Study||0
10133087|NCT02677623|11265262|FG002|NOT COMPLETED|Overall Study||0
10133088|NCT02677623|11265263|FG003|NOT COMPLETED|Overall Study||0
10133089|NCT02677701|11265275|FG000|STARTED|Overall Study||62
10133090|NCT02677701|11265276|FG001|STARTED|Overall Study||57
10133091|NCT02677701|11265275|FG000|Treated|Overall Study||61
10133092|NCT02677701|11265276|FG001|Treated|Overall Study||54
10133093|NCT02677701|11265275|FG000|COMPLETED|Overall Study||56
10133094|NCT02677701|11265276|FG001|COMPLETED|Overall Study||52
10133095|NCT02677701|11265275|FG000|NOT COMPLETED|Overall Study||6
10133096|NCT02677701|11265276|FG001|NOT COMPLETED|Overall Study||5
10133097|NCT02677714|11265284|FG000|STARTED|Overall Study||12
10133098|NCT02677714|11265285|FG001|STARTED|Overall Study||2
10133099|NCT02677714|11265284|FG000|COMPLETED|Overall Study||10
10133100|NCT02677714|11265285|FG001|COMPLETED|Overall Study||2
10133101|NCT02677714|11265284|FG000|NOT COMPLETED|Overall Study||2
10133102|NCT02677714|11265285|FG001|NOT COMPLETED|Overall Study||0
10133103|NCT02677740|11265293|FG000|STARTED|Overall Study||7
10133104|NCT02677740|11265294|FG001|STARTED|Overall Study||1
10133105|NCT02677740|11265293|FG000|COMPLETED|Overall Study||7
10133106|NCT02677740|11265294|FG001|COMPLETED|Overall Study||1
10133107|NCT02677740|11265293|FG000|NOT COMPLETED|Overall Study||0
10133108|NCT02677740|11265294|FG001|NOT COMPLETED|Overall Study||0
10133109|NCT02677753|11265302|FG000|STARTED|Overall Study||37
10133110|NCT02677753|11265303|FG001|STARTED|Overall Study||38
10133111|NCT02677753|11265302|FG000|COMPLETED|Overall Study||36
9706920|NCT02358993|10806052|FG000|STARTED|Overall Study||105
9706921|NCT02358993|10806053|FG001|STARTED|Overall Study||96
9706922|NCT02358993|10806052|FG000|COMPLETED|Overall Study||103
9706923|NCT02358993|10806053|FG001|COMPLETED|Overall Study||94
9706924|NCT02358993|10806052|FG000|NOT COMPLETED|Overall Study||2
9706925|NCT02358993|10806053|FG001|NOT COMPLETED|Overall Study||2
9706926|NCT03566199|10806059|FG000|STARTED|Overall Study||1
9706927|NCT03566199|10806060|FG001|STARTED|Overall Study||0
9706928|NCT03566199|10806061|FG002|STARTED|Overall Study||1
9706929|NCT03566199|10806062|FG003|STARTED|Overall Study||0
9706930|NCT03566199|10806063|FG004|STARTED|Overall Study||1
9706931|NCT03566199|10806064|FG005|STARTED|Overall Study||0
9706932|NCT03566199|10806065|FG006|STARTED|Overall Study||4
9706933|NCT03566199|10806066|FG007|STARTED|Overall Study||0
9706934|NCT03566199|10806059|FG000|COMPLETED|Overall Study||1
9706935|NCT03566199|10806060|FG001|COMPLETED|Overall Study||0
9706936|NCT03566199|10806061|FG002|COMPLETED|Overall Study||1
9706937|NCT03566199|10806062|FG003|COMPLETED|Overall Study||0
9706938|NCT03566199|10806063|FG004|COMPLETED|Overall Study||1
9706939|NCT03566199|10806064|FG005|COMPLETED|Overall Study||0
9706940|NCT03566199|10806065|FG006|COMPLETED|Overall Study||4
9706941|NCT03566199|10806066|FG007|COMPLETED|Overall Study||0
9706942|NCT03566199|10806059|FG000|NOT COMPLETED|Overall Study||0
9706943|NCT03566199|10806060|FG001|NOT COMPLETED|Overall Study||0
9706944|NCT03566199|10806061|FG002|NOT COMPLETED|Overall Study||0
9706945|NCT03566199|10806062|FG003|NOT COMPLETED|Overall Study||0
9706946|NCT03566199|10806063|FG004|NOT COMPLETED|Overall Study||0
9706947|NCT03566199|10806064|FG005|NOT COMPLETED|Overall Study||0
9706948|NCT03566199|10806065|FG006|NOT COMPLETED|Overall Study||0
9706949|NCT03566199|10806066|FG007|NOT COMPLETED|Overall Study||0
9706950|NCT04474197|10806074|FG000|STARTED|Overall Study||7
9706951|NCT04474197|10806075|FG001|STARTED|Overall Study||10
9706952|NCT04474197|10806076|FG002|STARTED|Overall Study||9
9706953|NCT04474197|10806077|FG003|STARTED|Overall Study||18
9706954|NCT04474197|10806074|FG000|COMPLETED|Overall Study||7
9706955|NCT04474197|10806075|FG001|COMPLETED|Overall Study||9
10133112|NCT02677753|11265303|FG001|COMPLETED|Overall Study||38
10133113|NCT02677753|11265302|FG000|NOT COMPLETED|Overall Study||1
10133114|NCT02677753|11265303|FG001|NOT COMPLETED|Overall Study||0
10133115|NCT02677766|11265311|FG000|STARTED|Overall Study||20
10133116|NCT02677766|11265312|FG001|STARTED|Overall Study||20
9706956|NCT04474197|10806076|FG002|COMPLETED|Overall Study||9
9706957|NCT04474197|10806077|FG003|COMPLETED|Overall Study||18
9706958|NCT04474197|10806074|FG000|NOT COMPLETED|Overall Study||0
9706959|NCT04474197|10806075|FG001|NOT COMPLETED|Overall Study||1
9706960|NCT04474197|10806076|FG002|NOT COMPLETED|Overall Study||0
9706961|NCT04474197|10806077|FG003|NOT COMPLETED|Overall Study||0
9706962|NCT04369950|10806094|FG000|STARTED|Overall Study||22
10133117|NCT02677766|11265311|FG000|COMPLETED|Overall Study||15
10133118|NCT02677766|11265312|FG001|COMPLETED|Overall Study||17
10133119|NCT02677766|11265311|FG000|NOT COMPLETED|Overall Study||5
10133120|NCT02677766|11265312|FG001|NOT COMPLETED|Overall Study||3
10133121|NCT02677779|11265320|FG000|STARTED|Overall Study||10
10133122|NCT02677779|11265321|FG001|STARTED|Overall Study||10
10133123|NCT02677779|11265320|FG000|COMPLETED|Overall Study||10
10133124|NCT02677779|11265321|FG001|COMPLETED|Overall Study||10
10133125|NCT02677779|11265320|FG000|NOT COMPLETED|Overall Study||0
10133126|NCT02677779|11265321|FG001|NOT COMPLETED|Overall Study||0
10133127|NCT02677844|11265329|FG000|STARTED|Period 1||5
10133128|NCT02677844|11265330|FG001|STARTED|Period 1||5
10133129|NCT02677844|11265331|FG002|STARTED|Period 1||5
10133130|NCT02677844|11265332|FG003|STARTED|Period 1||5
10133131|NCT02677844|11265333|FG004|STARTED|Period 1||0
10133132|NCT02677844|11265334|FG005|STARTED|Period 1||0
10133133|NCT02677844|11265335|FG006|STARTED|Period 1||0
10133134|NCT02677844|11265329|FG000|COMPLETED|Period 1||5
10133135|NCT02677844|11265330|FG001|COMPLETED|Period 1||5
10133136|NCT02677844|11265331|FG002|COMPLETED|Period 1||5
10133137|NCT02677844|11265332|FG003|COMPLETED|Period 1||5
10133138|NCT02677844|11265333|FG004|COMPLETED|Period 1||0
10133139|NCT02677844|11265334|FG005|COMPLETED|Period 1||0
10133140|NCT02677844|11265335|FG006|COMPLETED|Period 1||0
10133141|NCT02677844|11265329|FG000|NOT COMPLETED|Period 1||0
10133142|NCT02677844|11265330|FG001|NOT COMPLETED|Period 1||0
10133143|NCT02677844|11265331|FG002|NOT COMPLETED|Period 1||0
10133144|NCT02677844|11265332|FG003|NOT COMPLETED|Period 1||0
10133145|NCT02677844|11265333|FG004|NOT COMPLETED|Period 1||0
10133146|NCT02677844|11265334|FG005|NOT COMPLETED|Period 1||0
10133147|NCT02677844|11265335|FG006|NOT COMPLETED|Period 1||0
10133148|NCT02677844|11265329|FG000|STARTED|Period 2||5
10133149|NCT02677844|11265330|FG001|STARTED|Period 2||5
10133150|NCT02677844|11265331|FG002|STARTED|Period 2||5
10133151|NCT02677844|11265332|FG003|STARTED|Period 2||5
10133152|NCT02677844|11265333|FG004|STARTED|Period 2||0
10133153|NCT02677844|11265334|FG005|STARTED|Period 2||0
10133154|NCT02677844|11265335|FG006|STARTED|Period 2||0
10133155|NCT02677844|11265329|FG000|COMPLETED|Period 2||5
10133156|NCT02677844|11265330|FG001|COMPLETED|Period 2||5
10133157|NCT02677844|11265331|FG002|COMPLETED|Period 2||5
10133158|NCT02677844|11265332|FG003|COMPLETED|Period 2||5
10133159|NCT02677844|11265333|FG004|COMPLETED|Period 2||0
10133160|NCT02677844|11265334|FG005|COMPLETED|Period 2||0
10133161|NCT02677844|11265335|FG006|COMPLETED|Period 2||0
10133162|NCT02677844|11265329|FG000|NOT COMPLETED|Period 2||0
10133163|NCT02677844|11265330|FG001|NOT COMPLETED|Period 2||0
10133164|NCT02677844|11265331|FG002|NOT COMPLETED|Period 2||0
10133165|NCT02677844|11265332|FG003|NOT COMPLETED|Period 2||0
10133166|NCT02677844|11265333|FG004|NOT COMPLETED|Period 2||0
10133167|NCT02677844|11265334|FG005|NOT COMPLETED|Period 2||0
10133168|NCT02677844|11265335|FG006|NOT COMPLETED|Period 2||0
10133169|NCT02677844|11265329|FG000|STARTED|Period 3||5
10133170|NCT02677844|11265330|FG001|STARTED|Period 3||5
10133171|NCT02677844|11265331|FG002|STARTED|Period 3||5
10133172|NCT02677844|11265332|FG003|STARTED|Period 3||5
10133173|NCT02677844|11265333|FG004|STARTED|Period 3||0
10133174|NCT02677844|11265334|FG005|STARTED|Period 3||0
10133175|NCT02677844|11265335|FG006|STARTED|Period 3||0
10133176|NCT02677844|11265329|FG000|COMPLETED|Period 3||5
10133177|NCT02677844|11265330|FG001|COMPLETED|Period 3||5
10133178|NCT02677844|11265331|FG002|COMPLETED|Period 3||5
10133179|NCT02677844|11265332|FG003|COMPLETED|Period 3||4
10133180|NCT02677844|11265333|FG004|COMPLETED|Period 3||0
10133181|NCT02677844|11265334|FG005|COMPLETED|Period 3||0
10133182|NCT02677844|11265335|FG006|COMPLETED|Period 3||0
10133183|NCT02677844|11265329|FG000|NOT COMPLETED|Period 3||0
10133184|NCT02677844|11265330|FG001|NOT COMPLETED|Period 3||0
10133185|NCT02677844|11265331|FG002|NOT COMPLETED|Period 3||0
10133186|NCT02677844|11265332|FG003|NOT COMPLETED|Period 3||1
10133187|NCT02677844|11265333|FG004|NOT COMPLETED|Period 3||0
10133188|NCT02677844|11265334|FG005|NOT COMPLETED|Period 3||0
10133189|NCT02677844|11265335|FG006|NOT COMPLETED|Period 3||0
10133190|NCT02677844|11265329|FG000|STARTED|Period 4||5
10133191|NCT02677844|11265330|FG001|STARTED|Period 4||5
10133192|NCT02677844|11265331|FG002|STARTED|Period 4||5
10133193|NCT02677844|11265332|FG003|STARTED|Period 4||4
10133194|NCT02677844|11265333|FG004|STARTED|Period 4||0
10133195|NCT02677844|11265334|FG005|STARTED|Period 4||0
10133196|NCT02677844|11265335|FG006|STARTED|Period 4||0
10133197|NCT02677844|11265329|FG000|COMPLETED|Period 4||5
10133198|NCT02677844|11265330|FG001|COMPLETED|Period 4||5
10133199|NCT02677844|11265331|FG002|COMPLETED|Period 4||5
10133200|NCT02677844|11265332|FG003|COMPLETED|Period 4||4
10133201|NCT02677844|11265333|FG004|COMPLETED|Period 4||0
10133202|NCT02677844|11265334|FG005|COMPLETED|Period 4||0
10133203|NCT02677844|11265335|FG006|COMPLETED|Period 4||0
10133204|NCT02677844|11265329|FG000|NOT COMPLETED|Period 4||0
10133205|NCT02677844|11265330|FG001|NOT COMPLETED|Period 4||0
10133206|NCT02677844|11265331|FG002|NOT COMPLETED|Period 4||0
10133207|NCT02677844|11265332|FG003|NOT COMPLETED|Period 4||0
10133208|NCT02677844|11265333|FG004|NOT COMPLETED|Period 4||0
10133209|NCT02677844|11265334|FG005|NOT COMPLETED|Period 4||0
10133210|NCT02677844|11265335|FG006|NOT COMPLETED|Period 4||0
10133211|NCT02677844|11265329|FG000|STARTED|Period 4 (DDI)||0
10133212|NCT02677844|11265330|FG001|STARTED|Period 4 (DDI)||0
10133213|NCT02677844|11265331|FG002|STARTED|Period 4 (DDI)||0
10133214|NCT02677844|11265332|FG003|STARTED|Period 4 (DDI)||0
10133215|NCT02677844|11265333|FG004|STARTED|Period 4 (DDI)||7
10133216|NCT02677844|11265334|FG005|STARTED|Period 4 (DDI)||4
10133217|NCT02677844|11265335|FG006|STARTED|Period 4 (DDI)||4
10133218|NCT02677844|11265329|FG000|COMPLETED|Period 4 (DDI)||0
10133219|NCT02677844|11265330|FG001|COMPLETED|Period 4 (DDI)||0
10133220|NCT02677844|11265331|FG002|COMPLETED|Period 4 (DDI)||0
10133221|NCT02677844|11265332|FG003|COMPLETED|Period 4 (DDI)||0
10133222|NCT02677844|11265333|FG004|COMPLETED|Period 4 (DDI)||7
10133223|NCT02677844|11265334|FG005|COMPLETED|Period 4 (DDI)||4
10133224|NCT02677844|11265335|FG006|COMPLETED|Period 4 (DDI)||4
10133225|NCT02677844|11265329|FG000|NOT COMPLETED|Period 4 (DDI)||0
10133226|NCT02677844|11265330|FG001|NOT COMPLETED|Period 4 (DDI)||0
10133227|NCT02677844|11265331|FG002|NOT COMPLETED|Period 4 (DDI)||0
10133228|NCT02677844|11265332|FG003|NOT COMPLETED|Period 4 (DDI)||0
10133229|NCT02677844|11265333|FG004|NOT COMPLETED|Period 4 (DDI)||0
10133230|NCT02677844|11265334|FG005|NOT COMPLETED|Period 4 (DDI)||0
10133231|NCT02677844|11265335|FG006|NOT COMPLETED|Period 4 (DDI)||0
10133232|NCT02677844|11265329|FG000|STARTED|Period 5||0
10133233|NCT02677844|11265330|FG001|STARTED|Period 5||0
10133234|NCT02677844|11265331|FG002|STARTED|Period 5||0
10133235|NCT02677844|11265332|FG003|STARTED|Period 5||0
10133236|NCT02677844|11265333|FG004|STARTED|Period 5||7
10133237|NCT02677844|11265334|FG005|STARTED|Period 5||4
10133238|NCT02677844|11265335|FG006|STARTED|Period 5||4
10133239|NCT02677844|11265329|FG000|COMPLETED|Period 5||0
10133240|NCT02677844|11265330|FG001|COMPLETED|Period 5||0
10133241|NCT02677844|11265331|FG002|COMPLETED|Period 5||0
10133242|NCT02677844|11265332|FG003|COMPLETED|Period 5||0
10133243|NCT02677844|11265333|FG004|COMPLETED|Period 5||7
10133244|NCT02677844|11265334|FG005|COMPLETED|Period 5||4
10133245|NCT02677844|11265335|FG006|COMPLETED|Period 5||4
10133246|NCT02677844|11265329|FG000|NOT COMPLETED|Period 5||0
10133247|NCT02677844|11265330|FG001|NOT COMPLETED|Period 5||0
10133248|NCT02677844|11265331|FG002|NOT COMPLETED|Period 5||0
10133249|NCT02677844|11265332|FG003|NOT COMPLETED|Period 5||0
10133250|NCT02677844|11265333|FG004|NOT COMPLETED|Period 5||0
10133251|NCT02677844|11265334|FG005|NOT COMPLETED|Period 5||0
10133252|NCT02677844|11265335|FG006|NOT COMPLETED|Period 5||0
10133253|NCT02677844|11265329|FG000|STARTED|Period 6||0
10133254|NCT02677844|11265330|FG001|STARTED|Period 6||0
10133255|NCT02677844|11265331|FG002|STARTED|Period 6||0
10133256|NCT02677844|11265332|FG003|STARTED|Period 6||0
10133257|NCT02677844|11265333|FG004|STARTED|Period 6||7
10133258|NCT02677844|11265334|FG005|STARTED|Period 6||4
10133259|NCT02677844|11265335|FG006|STARTED|Period 6||4
10133260|NCT02677844|11265329|FG000|COMPLETED|Period 6||0
10133261|NCT02677844|11265330|FG001|COMPLETED|Period 6||0
10133262|NCT02677844|11265331|FG002|COMPLETED|Period 6||0
10133263|NCT02677844|11265332|FG003|COMPLETED|Period 6||0
10133264|NCT02677844|11265333|FG004|COMPLETED|Period 6||7
10133265|NCT02677844|11265334|FG005|COMPLETED|Period 6||4
10133266|NCT02677844|11265335|FG006|COMPLETED|Period 6||4
10133267|NCT02677844|11265329|FG000|NOT COMPLETED|Period 6||0
10133268|NCT02677844|11265330|FG001|NOT COMPLETED|Period 6||0
10133269|NCT02677844|11265331|FG002|NOT COMPLETED|Period 6||0
10133270|NCT02677844|11265332|FG003|NOT COMPLETED|Period 6||0
10133271|NCT02677844|11265333|FG004|NOT COMPLETED|Period 6||0
10133272|NCT02677844|11265334|FG005|NOT COMPLETED|Period 6||0
10133273|NCT02677844|11265335|FG006|NOT COMPLETED|Period 6||0
10133274|NCT02677844|11265329|FG000|STARTED|Period 7||0
10133275|NCT02677844|11265330|FG001|STARTED|Period 7||0
10133276|NCT02677844|11265331|FG002|STARTED|Period 7||0
10133277|NCT02677844|11265332|FG003|STARTED|Period 7||0
10133278|NCT02677844|11265333|FG004|STARTED|Period 7||7
10133279|NCT02677844|11265334|FG005|STARTED|Period 7||4
10133280|NCT02677844|11265335|FG006|STARTED|Period 7||4
10133281|NCT02677844|11265329|FG000|COMPLETED|Period 7||0
10133282|NCT02677844|11265330|FG001|COMPLETED|Period 7||0
10133283|NCT02677844|11265331|FG002|COMPLETED|Period 7||0
10133284|NCT02677844|11265332|FG003|COMPLETED|Period 7||0
10133285|NCT02677844|11265333|FG004|COMPLETED|Period 7||7
10133286|NCT02677844|11265334|FG005|COMPLETED|Period 7||4
10133287|NCT02677844|11265335|FG006|COMPLETED|Period 7||4
9848774|NCT00862134|10961597|FG001|COMPLETED|Overall Study||11
10133288|NCT02677844|11265329|FG000|NOT COMPLETED|Period 7||0
10133289|NCT02677844|11265330|FG001|NOT COMPLETED|Period 7||0
10133290|NCT02677844|11265331|FG002|NOT COMPLETED|Period 7||0
10133291|NCT02677844|11265332|FG003|NOT COMPLETED|Period 7||0
10133292|NCT02677844|11265333|FG004|NOT COMPLETED|Period 7||0
10133293|NCT02677844|11265334|FG005|NOT COMPLETED|Period 7||0
10133294|NCT02677844|11265335|FG006|NOT COMPLETED|Period 7||0
10133295|NCT02678000|11265359|FG000|STARTED|PART 1||7
10133296|NCT02678000|11265360|FG001|STARTED|PART 1||4
10133297|NCT02678000|11265361|FG002|STARTED|PART 1||0
10133298|NCT02678000|11265362|FG003|STARTED|PART 1||0
10133299|NCT02678000|11265363|FG004|STARTED|PART 1||0
10133300|NCT02678000|11265359|FG000|COMPLETED|PART 1||7
10133301|NCT02678000|11265360|FG001|COMPLETED|PART 1||4
10133302|NCT02678000|11265361|FG002|COMPLETED|PART 1||0
10133303|NCT02678000|11265362|FG003|COMPLETED|PART 1||0
10133304|NCT02678000|11265363|FG004|COMPLETED|PART 1||0
10133305|NCT02678000|11265359|FG000|NOT COMPLETED|PART 1||0
10133306|NCT02678000|11265360|FG001|NOT COMPLETED|PART 1||0
10133307|NCT02678000|11265361|FG002|NOT COMPLETED|PART 1||0
10133308|NCT02678000|11265362|FG003|NOT COMPLETED|PART 1||0
10133309|NCT02678000|11265363|FG004|NOT COMPLETED|PART 1||0
10133310|NCT02678000|11265359|FG000|STARTED|PART 2||0
10133311|NCT02678000|11265360|FG001|STARTED|PART 2||0
10133312|NCT02678000|11265361|FG002|STARTED|PART 2||28
10133313|NCT02678000|11265362|FG003|STARTED|PART 2||27
10133314|NCT02678000|11265363|FG004|STARTED|PART 2||18
9848775|NCT00862134|10961596|FG000|NOT COMPLETED|Overall Study||11
10133315|NCT02678000|11265359|FG000|COMPLETED|PART 2||0
10133316|NCT02678000|11265360|FG001|COMPLETED|PART 2||0
10133317|NCT02678000|11265361|FG002|COMPLETED|PART 2||25
10133318|NCT02678000|11265362|FG003|COMPLETED|PART 2||26
10133319|NCT02678000|11265363|FG004|COMPLETED|PART 2||18
10133320|NCT02678000|11265359|FG000|NOT COMPLETED|PART 2||0
10133321|NCT02678000|11265360|FG001|NOT COMPLETED|PART 2||0
10133322|NCT02678000|11265361|FG002|NOT COMPLETED|PART 2||3
10133323|NCT02678000|11265362|FG003|NOT COMPLETED|PART 2||1
10133324|NCT02678000|11265363|FG004|NOT COMPLETED|PART 2||0
10133325|NCT02678039|11265390|FG000|STARTED|Overall Study||53
10133326|NCT02678039|11265391|FG001|STARTED|Overall Study||47
10133327|NCT02678039|11265390|FG000|COMPLETED|Overall Study||53
10133328|NCT02678039|11265391|FG001|COMPLETED|Overall Study||47
10133329|NCT02678039|11265390|FG000|NOT COMPLETED|Overall Study||0
10133330|NCT02678039|11265391|FG001|NOT COMPLETED|Overall Study||0
10133331|NCT02678247|11265399|FG000|STARTED|First Intervention (7 Weeks)||15
10133332|NCT02678247|11265400|FG001|STARTED|First Intervention (7 Weeks)||15
10133333|NCT02678247|11265399|FG000|COMPLETED|First Intervention (7 Weeks)||13
10133334|NCT02678247|11265400|FG001|COMPLETED|First Intervention (7 Weeks)||11
10133335|NCT02678247|11265399|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2
10133336|NCT02678247|11265400|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4
10133337|NCT02678247|11265399|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
10133338|NCT02678247|11265400|FG001|STARTED|Second Intervention (7 Weeks)||11
10133339|NCT02678247|11265399|FG000|COMPLETED|Second Intervention (7 Weeks)||10
10133340|NCT02678247|11265400|FG001|COMPLETED|Second Intervention (7 Weeks)||9
10133341|NCT02678247|11265399|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4
10133342|NCT02678247|11265400|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2
10133343|NCT02678286|11265413|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
10133344|NCT02678286|11265414|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
10133345|NCT02678286|11265413|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
10133346|NCT02678286|11265414|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
10133347|NCT02678286|11265413|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
10133348|NCT02678286|11265414|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
10133349|NCT02678286|11265413|FG000|STARTED|Study Overall (28 Day Follow-Up)||110
10133350|NCT02678286|11265414|FG001|STARTED|Study Overall (28 Day Follow-Up)||109
10133351|NCT02678286|11265413|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104
10133352|NCT02678286|11265414|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105
10133353|NCT02678286|11265413|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
10133354|NCT02678286|11265414|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
10133355|NCT02678390|11265422|FG000|STARTED|Control (5 Days)||10
10133356|NCT02678390|11265423|FG001|STARTED|Control (5 Days)||10
10133357|NCT02678390|11265422|FG000|COMPLETED|Control (5 Days)||10
10133358|NCT02678390|11265423|FG001|COMPLETED|Control (5 Days)||10
10133359|NCT02678390|11265422|FG000|NOT COMPLETED|Control (5 Days)||0
10133360|NCT02678390|11265423|FG001|NOT COMPLETED|Control (5 Days)||0
10133361|NCT02678390|11265422|FG000|STARTED|MCT (5 Days)||10
10133362|NCT02678390|11265423|FG001|STARTED|MCT (5 Days)||10
10133363|NCT02678390|11265422|FG000|COMPLETED|MCT (5 Days)||10
10133364|NCT02678390|11265423|FG001|COMPLETED|MCT (5 Days)||10
10133365|NCT02678390|11265422|FG000|NOT COMPLETED|MCT (5 Days)||0
10133366|NCT02678390|11265423|FG001|NOT COMPLETED|MCT (5 Days)||0
10133367|NCT02678390|11265422|FG000|STARTED|AE (1 Day)||10
10133368|NCT02678390|11265423|FG001|STARTED|AE (1 Day)||10
10133369|NCT02678390|11265422|FG000|COMPLETED|AE (1 Day)||10
10133370|NCT02678390|11265423|FG001|COMPLETED|AE (1 Day)||9
10133371|NCT02678390|11265422|FG000|NOT COMPLETED|AE (1 Day)||0
10133372|NCT02678390|11265423|FG001|NOT COMPLETED|AE (1 Day)||1
10133373|NCT02678390|11265422|FG000|STARTED|MCT + AE (5 Days)||10
10133374|NCT02678390|11265423|FG001|STARTED|MCT + AE (5 Days)||9
10133375|NCT02678390|11265422|FG000|COMPLETED|MCT + AE (5 Days)||10
10133376|NCT02678390|11265423|FG001|COMPLETED|MCT + AE (5 Days)||9
10133377|NCT02678390|11265422|FG000|NOT COMPLETED|MCT + AE (5 Days)||0
10133378|NCT02678390|11265423|FG001|NOT COMPLETED|MCT + AE (5 Days)||0
10133379|NCT02678416|11265431|FG000|STARTED|Part 1||12
10133380|NCT02678416|11265431|FG000|Safety Population|Part 1||12
10133381|NCT02678416|11265431|FG000|Modified Intent to Treat (mITT)|Part 1||12
10133382|NCT02678416|11265431|FG000|Per Protocol Population|Part 1||8
10133383|NCT02678416|11265431|FG000|COMPLETED|Part 1||11
10133384|NCT02678416|11265431|FG000|NOT COMPLETED|Part 1||1
10133385|NCT02678416|11265431|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67
10133386|NCT02678416|11265431|FG000|Treated (Safety Population)|Part 2||66
10133387|NCT02678416|11265431|FG000|Modified Intent to Treat Population|Part 2||66
10133388|NCT02678416|11265431|FG000|Pharmacokinetic Population|Part 2||65
10133389|NCT02678416|11265431|FG000|Per Protocol Population|Part 2||64
10133390|NCT02678416|11265431|FG000|COMPLETED|Part 2||64
10133391|NCT02678416|11265431|FG000|NOT COMPLETED|Part 2||3
10133392|NCT02678442|11265451|FG000|STARTED|First Intervention||25
10133393|NCT02678442|11265452|FG001|STARTED|First Intervention||25
10133394|NCT02678442|11265451|FG000|COMPLETED|First Intervention||25
10133395|NCT02678442|11265452|FG001|COMPLETED|First Intervention||25
10133396|NCT02678442|11265451|FG000|NOT COMPLETED|First Intervention||0
10133397|NCT02678442|11265452|FG001|NOT COMPLETED|First Intervention||0
10133398|NCT02678442|11265451|FG000|STARTED|Second Intervention||25
10133399|NCT02678442|11265452|FG001|STARTED|Second Intervention||25
10133400|NCT02678442|11265451|FG000|COMPLETED|Second Intervention||23
10133401|NCT02678442|11265452|FG001|COMPLETED|Second Intervention||23
10133402|NCT02678442|11265451|FG000|NOT COMPLETED|Second Intervention||2
10133403|NCT02678442|11265452|FG001|NOT COMPLETED|Second Intervention||2
10133404|NCT02678676|11265460|FG000|STARTED|Overall Study||1820
10133405|NCT02678676|11265461|FG001|STARTED|Overall Study||1779
10133406|NCT02678676|11265460|FG000|COMPLETED|Overall Study||932
10133407|NCT02678676|11265461|FG001|COMPLETED|Overall Study||907
10133408|NCT02678676|11265460|FG000|NOT COMPLETED|Overall Study||888
10133409|NCT02678676|11265461|FG001|NOT COMPLETED|Overall Study||872
10133410|NCT02678923|11265469|FG000|STARTED|Overall Study||59
10133411|NCT02678923|11265470|FG001|STARTED|Overall Study||67
10133412|NCT02678923|11265469|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58
10133413|NCT02678923|11265470|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64
10133414|NCT02678923|11265469|FG000|mITT Population|Overall Study||52
10133415|NCT02678923|11265470|FG001|mITT Population|Overall Study||61
10133416|NCT02678923|11265469|FG000|COMPLETED|Overall Study||53
10133417|NCT02678923|11265470|FG001|COMPLETED|Overall Study||62
10133418|NCT02678923|11265469|FG000|NOT COMPLETED|Overall Study||6
10133419|NCT02678923|11265470|FG001|NOT COMPLETED|Overall Study||5
10133420|NCT02679079|11265479|FG000|STARTED|Overall Study||33
10133421|NCT02679079|11265480|FG001|STARTED|Overall Study||32
10133422|NCT02679079|11265481|FG002|STARTED|Overall Study||33
10133423|NCT02679079|11265479|FG000|ITT Analysis Set|Overall Study||31
9706963|NCT04369950|10806095|FG001|STARTED|Overall Study||22
9706964|NCT04369950|10806094|FG000|COMPLETED|Overall Study||20
9706965|NCT04369950|10806095|FG001|COMPLETED|Overall Study||20
9706966|NCT04369950|10806094|FG000|NOT COMPLETED|Overall Study||2
9706967|NCT04369950|10806095|FG001|NOT COMPLETED|Overall Study||2
9706968|NCT04070326|10806103|FG000|STARTED|Baseline Observation-12 Weeks Before TP||4
9706969|NCT04070326|10806104|FG001|STARTED|Baseline Observation-12 Weeks Before TP||17
9706970|NCT04070326|10806103|FG000|COMPLETED|Baseline Observation-12 Weeks Before TP||4
9706971|NCT04070326|10806104|FG001|COMPLETED|Baseline Observation-12 Weeks Before TP||17
9706972|NCT04070326|10806103|FG000|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
10133424|NCT02679079|11265480|FG001|ITT Analysis Set|Overall Study||32
10133425|NCT02679079|11265481|FG002|ITT Analysis Set|Overall Study||32
10133426|NCT02679079|11265479|FG000|COMPLETED|Overall Study||29
10133427|NCT02679079|11265480|FG001|COMPLETED|Overall Study||30
10133428|NCT02679079|11265481|FG002|COMPLETED|Overall Study||31
10133429|NCT02679079|11265479|FG000|NOT COMPLETED|Overall Study||4
10133430|NCT02679079|11265480|FG001|NOT COMPLETED|Overall Study||2
10133431|NCT02679079|11265481|FG002|NOT COMPLETED|Overall Study||2
10133432|NCT02679222|11265489|FG000|STARTED|Overall Study||10
10133433|NCT02679222|11265489|FG000|COMPLETED|Overall Study||9
10133434|NCT02679222|11265489|FG000|NOT COMPLETED|Overall Study||1
10133435|NCT02679235|11265501|FG000|STARTED|Overall Study||15
10133436|NCT02679235|11265501|FG000|COMPLETED|Overall Study||11
10133437|NCT02679235|11265501|FG000|NOT COMPLETED|Overall Study||4
10133438|NCT02679274|11265507|FG000|STARTED|Overall Study||2
10133439|NCT02679274|11265508|FG001|STARTED|Overall Study||1
10133440|NCT02679274|11265507|FG000|COMPLETED|Overall Study||1
10133441|NCT02679274|11265508|FG001|COMPLETED|Overall Study||1
10133442|NCT02679274|11265507|FG000|NOT COMPLETED|Overall Study||1
10133443|NCT02679274|11265508|FG001|NOT COMPLETED|Overall Study||0
10133444|NCT02679287|11265516|FG000|STARTED|Period 1: Randomization-Study Session 1||47
10133445|NCT02679287|11265517|FG001|STARTED|Period 1: Randomization-Study Session 1||46
10133446|NCT02679287|11265516|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43
10133447|NCT02679287|11265517|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40
10133448|NCT02679287|11265516|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
10133449|NCT02679287|11265517|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
10133450|NCT02679287|11265516|FG000|STARTED|Period 2||43
10133451|NCT02679287|11265517|FG001|STARTED|Period 2||40
10133452|NCT02679287|11265516|FG000|COMPLETED|Period 2||40
10133453|NCT02679287|11265517|FG001|COMPLETED|Period 2||40
10133454|NCT02679287|11265516|FG000|NOT COMPLETED|Period 2||3
10133455|NCT02679287|11265517|FG001|NOT COMPLETED|Period 2||0
10133456|NCT02679287|11265516|FG000|STARTED|Period 3||40
10133457|NCT02679287|11265517|FG001|STARTED|Period 3||40
10133458|NCT02679287|11265516|FG000|COMPLETED|Period 3||40
10133459|NCT02679287|11265517|FG001|COMPLETED|Period 3||39
10133460|NCT02679287|11265516|FG000|NOT COMPLETED|Period 3||0
10133461|NCT02679287|11265517|FG001|NOT COMPLETED|Period 3||1
10133462|NCT02679287|11265516|FG000|STARTED|Phase 4||40
10133463|NCT02679287|11265517|FG001|STARTED|Phase 4||39
10133464|NCT02679287|11265516|FG000|COMPLETED|Phase 4||40
10133465|NCT02679287|11265517|FG001|COMPLETED|Phase 4||39
10133466|NCT02679287|11265516|FG000|NOT COMPLETED|Phase 4||0
10133467|NCT02679287|11265517|FG001|NOT COMPLETED|Phase 4||0
10133468|NCT02679469|11265529|FG000|STARTED|Overall Study||7
10133469|NCT02679469|11265529|FG000|COMPLETED|Overall Study||7
10133470|NCT02679469|11265529|FG000|NOT COMPLETED|Overall Study||0
10133471|NCT02679573|11265535|FG000|STARTED|Overall Study||431
10133472|NCT02679573|11265536|FG001|STARTED|Overall Study||428
10133473|NCT02679573|11265535|FG000|COMPLETED|Overall Study||394
10133474|NCT02679573|11265536|FG001|COMPLETED|Overall Study||389
10133475|NCT02679573|11265535|FG000|NOT COMPLETED|Overall Study||37
10133476|NCT02679573|11265536|FG001|NOT COMPLETED|Overall Study||39
10133477|NCT02679690|11265542|FG000|STARTED|Overall Study||10
10133478|NCT02679690|11265542|FG000|COMPLETED|Overall Study||9
10133479|NCT02679690|11265542|FG000|NOT COMPLETED|Overall Study||1
10133480|NCT02679729|11265557|FG000|STARTED|Overall Study||6
10133481|NCT02679729|11265558|FG001|STARTED|Overall Study||7
10133482|NCT02679729|11265559|FG002|STARTED|Overall Study||6
10133483|NCT02679729|11265560|FG003|STARTED|Overall Study||6
10133484|NCT02679729|11265561|FG004|STARTED|Overall Study||6
10133485|NCT02679729|11265562|FG005|STARTED|Overall Study||6
10133486|NCT02679729|11265563|FG006|STARTED|Overall Study||6
10133487|NCT02679729|11265564|FG007|STARTED|Overall Study||14
10133488|NCT02679729|11265565|FG008|STARTED|Overall Study||6
10133489|NCT02679729|11265557|FG000|COMPLETED|Overall Study||6
10133490|NCT02679729|11265558|FG001|COMPLETED|Overall Study||5
10133491|NCT02679729|11265559|FG002|COMPLETED|Overall Study||6
10133492|NCT02679729|11265560|FG003|COMPLETED|Overall Study||6
10133493|NCT02679729|11265561|FG004|COMPLETED|Overall Study||5
10133494|NCT02679729|11265562|FG005|COMPLETED|Overall Study||6
10133495|NCT02679729|11265563|FG006|COMPLETED|Overall Study||5
10133496|NCT02679729|11265564|FG007|COMPLETED|Overall Study||14
10133497|NCT02679729|11265565|FG008|COMPLETED|Overall Study||6
10133498|NCT02679729|11265557|FG000|NOT COMPLETED|Overall Study||0
10133499|NCT02679729|11265558|FG001|NOT COMPLETED|Overall Study||2
10133500|NCT02679729|11265559|FG002|NOT COMPLETED|Overall Study||0
10133501|NCT02679729|11265560|FG003|NOT COMPLETED|Overall Study||0
10133502|NCT02679729|11265561|FG004|NOT COMPLETED|Overall Study||1
10133503|NCT02679729|11265562|FG005|NOT COMPLETED|Overall Study||0
10133504|NCT02679729|11265563|FG006|NOT COMPLETED|Overall Study||1
10133505|NCT02679729|11265564|FG007|NOT COMPLETED|Overall Study||0
10133506|NCT02679729|11265565|FG008|NOT COMPLETED|Overall Study||0
10133507|NCT02679755|11265599|FG000|STARTED|Overall Study||100
10133508|NCT02679755|11265600|FG001|STARTED|Overall Study||152
10133509|NCT02679755|11265599|FG000|COMPLETED|Overall Study||66
10133510|NCT02679755|11265600|FG001|COMPLETED|Overall Study||47
10133511|NCT02679755|11265599|FG000|NOT COMPLETED|Overall Study||34
10133512|NCT02679755|11265600|FG001|NOT COMPLETED|Overall Study||105
10133513|NCT02679807|11265611|FG000|STARTED|Overall Study||165
10133514|NCT02679807|11265612|FG001|STARTED|Overall Study||169
10133515|NCT02679807|11265611|FG000|COMPLETED|Overall Study||143
10133516|NCT02679807|11265612|FG001|COMPLETED|Overall Study||153
10133517|NCT02679807|11265611|FG000|NOT COMPLETED|Overall Study||22
10133518|NCT02679807|11265612|FG001|NOT COMPLETED|Overall Study||16
10133519|NCT02679911|11265618|FG000|STARTED|Overall Study|Intra-individual study|20
10133520|NCT02679911|11265618|FG000|COMPLETED|Overall Study||20
10133521|NCT02679911|11265618|FG000|NOT COMPLETED|Overall Study||0
10133522|NCT02679976|11265623|FG000|STARTED|Overall Study||30
10133523|NCT02679976|11265623|FG000|Hyperopes|Overall Study||16
10133524|NCT02679976|11265623|FG000|Myopes|Overall Study||14
10133525|NCT02679976|11265623|FG000|COMPLETED|Overall Study||30
10133526|NCT02679976|11265623|FG000|NOT COMPLETED|Overall Study||0
10133527|NCT02680002|11265634|FG000|STARTED|Overall Study||71
10133528|NCT02680002|11265635|FG001|STARTED|Overall Study||70
10133529|NCT02680002|11265636|FG002|STARTED|Overall Study||70
10133530|NCT02680002|11265637|FG003|STARTED|Overall Study||71
10133531|NCT02680002|11265638|FG004|STARTED|Overall Study||70
10133532|NCT02680002|11265639|FG005|STARTED|Overall Study||70
10133533|NCT02680002|11265634|FG000|Day 0 (Dose 1)|Overall Study||70
10133534|NCT02680002|11265635|FG001|Day 0 (Dose 1)|Overall Study||70
10133535|NCT02680002|11265636|FG002|Day 0 (Dose 1)|Overall Study||70
10133536|NCT02680002|11265637|FG003|Day 0 (Dose 1)|Overall Study||71
10133537|NCT02680002|11265638|FG004|Day 0 (Dose 1)|Overall Study||70
10133538|NCT02680002|11265639|FG005|Day 0 (Dose 1)|Overall Study||68
10133539|NCT02680002|11265634|FG000|Day 21 (Dose 2)|Overall Study||63
10133540|NCT02680002|11265635|FG001|Day 21 (Dose 2)|Overall Study||68
10133541|NCT02680002|11265636|FG002|Day 21 (Dose 2)|Overall Study||65
10133542|NCT02680002|11265637|FG003|Day 21 (Dose 2)|Overall Study||69
10133543|NCT02680002|11265638|FG004|Day 21 (Dose 2)|Overall Study||65
10133544|NCT02680002|11265639|FG005|Day 21 (Dose 2)|Overall Study||63
10133545|NCT02680002|11265634|FG000|Day 201|Overall Study||58
10133546|NCT02680002|11265635|FG001|Day 201|Overall Study||66
10133547|NCT02680002|11265636|FG002|Day 201|Overall Study||60
10133548|NCT02680002|11265637|FG003|Day 201|Overall Study||67
9706973|NCT04070326|10806104|FG001|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
9706974|NCT04070326|10806103|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||4
9706975|NCT04070326|10806104|FG001|STARTED|Treatment Period A (Weeks 1 to 26)||17
9706976|NCT04070326|10806103|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||3
10133549|NCT02680002|11265638|FG004|Day 201|Overall Study||59
10133550|NCT02680002|11265639|FG005|Day 201|Overall Study||61
10133551|NCT02680002|11265634|FG000|COMPLETED|Overall Study||58
10133552|NCT02680002|11265635|FG001|COMPLETED|Overall Study||66
10133553|NCT02680002|11265636|FG002|COMPLETED|Overall Study||60
10133554|NCT02680002|11265637|FG003|COMPLETED|Overall Study||67
10133555|NCT02680002|11265638|FG004|COMPLETED|Overall Study||59
10133556|NCT02680002|11265639|FG005|COMPLETED|Overall Study||61
10133557|NCT02680002|11265634|FG000|NOT COMPLETED|Overall Study||13
10133558|NCT02680002|11265635|FG001|NOT COMPLETED|Overall Study||4
10133559|NCT02680002|11265636|FG002|NOT COMPLETED|Overall Study||10
10133560|NCT02680002|11265637|FG003|NOT COMPLETED|Overall Study||4
10133561|NCT02680002|11265638|FG004|NOT COMPLETED|Overall Study||11
10133562|NCT02680002|11265639|FG005|NOT COMPLETED|Overall Study||9
10133563|NCT02680041|11265656|FG000|STARTED|Overall Study||221
10133564|NCT02680041|11265656|FG000|Received 18F-fluciclovine|Overall Study||213
10133565|NCT02680041|11265656|FG000|COMPLETED|Overall Study||211
10133566|NCT02680041|11265656|FG000|NOT COMPLETED|Overall Study||10
10196583|NCT03364023|11324788|FG000|STARTED|Overall Study||183
10196584|NCT03364023|11324788|FG000|COMPLETED|Overall Study||166
10196585|NCT03364023|11324788|FG000|NOT COMPLETED|Overall Study||17
10196586|NCT03364049|11324796|FG000|STARTED|Overall Study||6
10196587|NCT03364049|11324797|FG001|STARTED|Overall Study||6
10196588|NCT03364049|11324798|FG002|STARTED|Overall Study||6
10196589|NCT03364049|11324799|FG003|STARTED|Overall Study||15
10196590|NCT03364049|11324796|FG000|COMPLETED|Overall Study||0
10196591|NCT03364049|11324797|FG001|COMPLETED|Overall Study||0
10196592|NCT03364049|11324798|FG002|COMPLETED|Overall Study||0
10196593|NCT03364049|11324799|FG003|COMPLETED|Overall Study||0
10196594|NCT03364049|11324796|FG000|NOT COMPLETED|Overall Study||6
10196595|NCT03364049|11324797|FG001|NOT COMPLETED|Overall Study||6
10196596|NCT03364049|11324798|FG002|NOT COMPLETED|Overall Study||6
10196597|NCT03364049|11324799|FG003|NOT COMPLETED|Overall Study||15
10196598|NCT03364192|11324809|FG000|STARTED|Overall Study||28
10196599|NCT03364192|11324809|FG000|COMPLETED|Overall Study||12
10196600|NCT03364192|11324809|FG000|NOT COMPLETED|Overall Study||16
10196601|NCT03364309|11324817|FG000|STARTED|Induction Period||88
10196602|NCT03364309|11324818|FG001|STARTED|Induction Period||174
10133567|NCT02680054|11265661|FG000|STARTED|Overall Study||38
10133568|NCT02680054|11265661|FG000|COMPLETED|Overall Study||27
10133569|NCT02680054|11265661|FG000|NOT COMPLETED|Overall Study||11
10133570|NCT02680145|11265670|FG000|STARTED|Overall Study||58
10133571|NCT02680145|11265670|FG000|COMPLETED|Overall Study||47
10133572|NCT02680145|11265670|FG000|NOT COMPLETED|Overall Study||11
10133573|NCT02680158|11265674|FG000|STARTED|Overall Study||8
10133574|NCT02680158|11265675|FG001|STARTED|Overall Study||8
10133575|NCT02680158|11265676|FG002|STARTED|Overall Study||8
10133576|NCT02680158|11265677|FG003|STARTED|Overall Study||8
10133577|NCT02680158|11265678|FG004|STARTED|Overall Study||8
10133578|NCT02680158|11265679|FG005|STARTED|Overall Study||8
10133579|NCT02680158|11265674|FG000|COMPLETED|Overall Study||8
10133580|NCT02680158|11265675|FG001|COMPLETED|Overall Study||8
10133581|NCT02680158|11265676|FG002|COMPLETED|Overall Study||8
10133582|NCT02680158|11265677|FG003|COMPLETED|Overall Study||8
10133583|NCT02680158|11265678|FG004|COMPLETED|Overall Study||8
10133584|NCT02680158|11265679|FG005|COMPLETED|Overall Study||8
10133585|NCT02680158|11265674|FG000|NOT COMPLETED|Overall Study||0
10133586|NCT02680158|11265675|FG001|NOT COMPLETED|Overall Study||0
10133587|NCT02680158|11265676|FG002|NOT COMPLETED|Overall Study||0
10133588|NCT02680158|11265677|FG003|NOT COMPLETED|Overall Study||0
10133589|NCT02680158|11265678|FG004|NOT COMPLETED|Overall Study||0
10133590|NCT02680158|11265679|FG005|NOT COMPLETED|Overall Study||0
10133591|NCT02680301|11265689|FG000|STARTED|Overall Study||22
10133592|NCT02680301|11265690|FG001|STARTED|Overall Study||18
10133593|NCT02680301|11265689|FG000|COMPLETED|Overall Study||22
10133594|NCT02680301|11265690|FG001|COMPLETED|Overall Study||17
10133595|NCT02680301|11265689|FG000|NOT COMPLETED|Overall Study||0
10133596|NCT02680301|11265690|FG001|NOT COMPLETED|Overall Study||1
10133597|NCT02680314|11265699|FG000|STARTED|Overall Study||120
10133598|NCT02680314|11265700|FG001|STARTED|Overall Study||123
10133599|NCT02680314|11265699|FG000|COMPLETED|Overall Study||120
10133600|NCT02680314|11265700|FG001|COMPLETED|Overall Study||123
10133601|NCT02680314|11265699|FG000|NOT COMPLETED|Overall Study||0
10133602|NCT02680314|11265700|FG001|NOT COMPLETED|Overall Study||0
10133603|NCT02680457|11265706|FG000|STARTED|Initial Intervention||6
10133604|NCT02680457|11265707|FG001|STARTED|Initial Intervention||6
10133605|NCT02680457|11265706|FG000|COMPLETED|Initial Intervention||6
10133606|NCT02680457|11265707|FG001|COMPLETED|Initial Intervention||6
10133607|NCT02680457|11265706|FG000|NOT COMPLETED|Initial Intervention||0
10133608|NCT02680457|11265707|FG001|NOT COMPLETED|Initial Intervention||0
10133609|NCT02680457|11265706|FG000|STARTED|Washout Period||6
10133610|NCT02680457|11265707|FG001|STARTED|Washout Period||6
10133611|NCT02680457|11265706|FG000|COMPLETED|Washout Period||6
10133612|NCT02680457|11265707|FG001|COMPLETED|Washout Period||6
10133613|NCT02680457|11265706|FG000|NOT COMPLETED|Washout Period||0
10133614|NCT02680457|11265707|FG001|NOT COMPLETED|Washout Period||0
10133615|NCT02680457|11265706|FG000|STARTED|Cross-over Intervention||6
10133616|NCT02680457|11265707|FG001|STARTED|Cross-over Intervention||6
10133617|NCT02680457|11265706|FG000|COMPLETED|Cross-over Intervention||6
10133618|NCT02680457|11265707|FG001|COMPLETED|Cross-over Intervention||6
10133619|NCT02680457|11265706|FG000|NOT COMPLETED|Cross-over Intervention||0
10133620|NCT02680457|11265707|FG001|NOT COMPLETED|Cross-over Intervention||0
10133621|NCT02680639|11265713|FG000|STARTED|Screening Period||10
10133622|NCT02680639|11265714|FG001|STARTED|Screening Period||0
10133623|NCT02680639|11265715|FG002|STARTED|Screening Period||0
10133624|NCT02680639|11265713|FG000|COMPLETED|Screening Period||3
10133625|NCT02680639|11265714|FG001|COMPLETED|Screening Period||0
10133626|NCT02680639|11265715|FG002|COMPLETED|Screening Period||0
10133627|NCT02680639|11265713|FG000|NOT COMPLETED|Screening Period||7
10133628|NCT02680639|11265714|FG001|NOT COMPLETED|Screening Period||0
10133629|NCT02680639|11265715|FG002|NOT COMPLETED|Screening Period||0
10133630|NCT02680639|11265713|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0
10133631|NCT02680639|11265714|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2
10133632|NCT02680639|11265715|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1
10133633|NCT02680639|11265713|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10133634|NCT02680639|11265714|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
10133635|NCT02680639|11265715|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
10133636|NCT02680639|11265713|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10133637|NCT02680639|11265714|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10133638|NCT02680639|11265715|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10133639|NCT02680665|11265725|FG000|STARTED|Overall Study||120
10133640|NCT02680665|11265725|FG000|COMPLETED|Overall Study||115
10133641|NCT02680665|11265725|FG000|NOT COMPLETED|Overall Study||5
10133642|NCT02680756|11265731|FG000|STARTED|Overall Study||125
10133643|NCT02680756|11265732|FG001|STARTED|Overall Study||125
10133644|NCT02680756|11265731|FG000|Received Treatment|Overall Study||127
10133645|NCT02680756|11265732|FG001|Received Treatment|Overall Study||120
10133646|NCT02680756|11265731|FG000|COMPLETED|Overall Study||93
10133647|NCT02680756|11265732|FG001|COMPLETED|Overall Study||106
10133648|NCT02680756|11265731|FG000|NOT COMPLETED|Overall Study||32
10133649|NCT02680756|11265732|FG001|NOT COMPLETED|Overall Study||19
10133650|NCT02680834|11265740|FG000|STARTED|Overall Study||26
10133651|NCT02680834|11265741|FG001|STARTED|Overall Study||30
10133652|NCT02680834|11265740|FG000|COMPLETED|Overall Study||15
10133653|NCT02680834|11265741|FG001|COMPLETED|Overall Study||27
10133654|NCT02680834|11265740|FG000|NOT COMPLETED|Overall Study||11
10133655|NCT02680834|11265741|FG001|NOT COMPLETED|Overall Study||3
10133656|NCT02680847|11265750|FG000|STARTED|Overall Study||16
10133657|NCT02680847|11265751|FG001|STARTED|Overall Study||9
10133658|NCT02680847|11265752|FG002|STARTED|Overall Study||7
10133659|NCT02680847|11265750|FG000|COMPLETED|Overall Study||11
10133660|NCT02680847|11265751|FG001|COMPLETED|Overall Study||6
10133661|NCT02680847|11265752|FG002|COMPLETED|Overall Study||4
10133662|NCT02680847|11265750|FG000|NOT COMPLETED|Overall Study||5
10133663|NCT02680847|11265751|FG001|NOT COMPLETED|Overall Study||3
10133664|NCT02680847|11265752|FG002|NOT COMPLETED|Overall Study||3
10133665|NCT02681094|11265763|FG000|STARTED|1 -Modified Enrolled Participants Set||293
10133666|NCT02681094|11265764|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
10133667|NCT02681094|11265765|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
10133668|NCT02681094|11265763|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
10133669|NCT02681094|11265764|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
10133670|NCT02681094|11265765|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
10133671|NCT02681094|11265763|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256
10133672|NCT02681094|11265764|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255
10133673|NCT02681094|11265765|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243
10133674|NCT02681094|11265763|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
10133675|NCT02681094|11265764|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
10133676|NCT02681094|11265765|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
10133677|NCT02681094|11265763|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
10133678|NCT02681094|11265764|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
10133679|NCT02681094|11265765|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
10133680|NCT02681094|11265763|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
10133681|NCT02681094|11265764|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
10133682|NCT02681094|11265765|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
10133683|NCT02681094|11265763|FG000|COMPLETED|2 - Enrolled Participants Set||261
10133684|NCT02681094|11265764|FG001|COMPLETED|2 - Enrolled Participants Set||261
10133685|NCT02681094|11265765|FG002|COMPLETED|2 - Enrolled Participants Set||248
10133686|NCT02681094|11265763|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40
10133687|NCT02681094|11265764|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41
10133688|NCT02681094|11265765|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54
10133689|NCT02681172|11265774|FG000|STARTED|Overall Study||218
10133690|NCT02681172|11265774|FG000|Safety Analysis Set|Overall Study||205
10133691|NCT02681172|11265774|FG000|Full Analysis Set|Overall Study||205
10133692|NCT02681172|11265774|FG000|Per Protocol Set|Overall Study||205
10133693|NCT02681172|11265774|FG000|COMPLETED|Overall Study||205
10133694|NCT02681172|11265774|FG000|NOT COMPLETED|Overall Study||13
10133695|NCT02681458|11265780|FG000|STARTED|Overall Study||718
10133696|NCT02681458|11265781|FG001|STARTED|Overall Study||718
10133697|NCT02681458|11265780|FG000|COMPLETED|Overall Study||73
10133698|NCT02681458|11265781|FG001|COMPLETED|Overall Study||62
10133699|NCT02681458|11265780|FG000|NOT COMPLETED|Overall Study||645
10133700|NCT02681458|11265781|FG001|NOT COMPLETED|Overall Study||656
10133701|NCT02681510|11265787|FG000|STARTED|Overall Study||36
10133702|NCT02681510|11265787|FG000|COMPLETED|Overall Study||26
10133703|NCT02681510|11265787|FG000|NOT COMPLETED|Overall Study||10
10133704|NCT02681523|11265791|FG000|STARTED|Overall Study||8
10133705|NCT02681523|11265791|FG000|COMPLETED|Overall Study||6
10133706|NCT02681523|11265791|FG000|NOT COMPLETED|Overall Study||2
10133710|NCT02681757|11265802|FG000|STARTED|Overall Study||47
10133711|NCT02681757|11265803|FG001|STARTED|Overall Study||49
10133712|NCT02681757|11265802|FG000|COMPLETED|Overall Study||47
10133713|NCT02681757|11265803|FG001|COMPLETED|Overall Study||49
10133714|NCT02681757|11265802|FG000|NOT COMPLETED|Overall Study||0
10133715|NCT02681757|11265803|FG001|NOT COMPLETED|Overall Study||0
10133716|NCT02681809|11265812|FG000|STARTED|Overall Study||20
10133717|NCT02681809|11265813|FG001|STARTED|Overall Study||19
10133718|NCT02681809|11265814|FG002|STARTED|Overall Study||9
10133719|NCT02681809|11265812|FG000|COMPLETED|Overall Study||15
10133720|NCT02681809|11265813|FG001|COMPLETED|Overall Study||15
10133721|NCT02681809|11265814|FG002|COMPLETED|Overall Study||8
10133722|NCT02681809|11265812|FG000|NOT COMPLETED|Overall Study||5
10060422|NCT02097472|11185910|FG003|COMPLETED|Assessed for Immunogenicity||48
10060423|NCT02097472|11185911|FG004|COMPLETED|Assessed for Immunogenicity||50
10060424|NCT02097472|11185912|FG005|COMPLETED|Assessed for Immunogenicity||48
10060425|NCT02097472|11185913|FG006|COMPLETED|Assessed for Immunogenicity||47
10060426|NCT02097472|11185914|FG007|COMPLETED|Assessed for Immunogenicity||49
10060427|NCT02097472|11185907|FG000|NOT COMPLETED|Assessed for Immunogenicity||0
10060428|NCT02097472|11185908|FG001|NOT COMPLETED|Assessed for Immunogenicity||0
10060429|NCT02097472|11185909|FG002|NOT COMPLETED|Assessed for Immunogenicity||1
10060430|NCT02097472|11185910|FG003|NOT COMPLETED|Assessed for Immunogenicity||2
10060431|NCT02097472|11185911|FG004|NOT COMPLETED|Assessed for Immunogenicity||0
10060432|NCT02097472|11185912|FG005|NOT COMPLETED|Assessed for Immunogenicity||2
10060433|NCT02097472|11185913|FG006|NOT COMPLETED|Assessed for Immunogenicity||2
10060434|NCT02097472|11185914|FG007|NOT COMPLETED|Assessed for Immunogenicity||1
10060435|NCT02097485|11186000|FG000|STARTED|Overall Study||25
10060436|NCT02097485|11186001|FG001|STARTED|Overall Study||25
10060437|NCT02097485|11186000|FG000|COMPLETED|Overall Study||25
10060438|NCT02097485|11186001|FG001|COMPLETED|Overall Study||25
10060439|NCT02097485|11186000|FG000|NOT COMPLETED|Overall Study||0
10060440|NCT02097485|11186001|FG001|NOT COMPLETED|Overall Study||0
10060441|NCT02097537|11186007|FG000|STARTED|Overall Study||10
10060442|NCT02097537|11186007|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
10060443|NCT02097537|11186007|FG000|Follow-Up|Overall Study||10
10060444|NCT02097537|11186007|FG000|COMPLETED|Overall Study||10
10060445|NCT02097537|11186007|FG000|NOT COMPLETED|Overall Study||0
10060446|NCT02097641|11186013|FG000|STARTED|Overall Study||40
10060447|NCT02097641|11186014|FG001|STARTED|Overall Study||20
10060448|NCT02097641|11186013|FG000|COMPLETED|Overall Study||40
10060449|NCT02097641|11186014|FG001|COMPLETED|Overall Study||20
10060450|NCT02097641|11186013|FG000|NOT COMPLETED|Overall Study||0
10060451|NCT02097641|11186014|FG001|NOT COMPLETED|Overall Study||0
10060452|NCT02097719|11186024|FG000|STARTED|Overall Study||49
10060453|NCT02097719|11186025|FG001|STARTED|Overall Study||51
10060454|NCT02097719|11186024|FG000|COMPLETED|Overall Study||46
10060455|NCT02097719|11186025|FG001|COMPLETED|Overall Study||50
10060456|NCT02097719|11186024|FG000|NOT COMPLETED|Overall Study||3
10060457|NCT02097719|11186025|FG001|NOT COMPLETED|Overall Study||1
10060458|NCT02097732|11186033|FG000|STARTED|Overall Study||1
10060459|NCT02097732|11186034|FG001|STARTED|Overall Study||3
10060460|NCT02097732|11186033|FG000|COMPLETED|Overall Study||1
10060461|NCT02097732|11186034|FG001|COMPLETED|Overall Study||3
10060462|NCT02097732|11186033|FG000|NOT COMPLETED|Overall Study||0
10060463|NCT02097732|11186034|FG001|NOT COMPLETED|Overall Study||0
10060464|NCT02097745|11186041|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
10060465|NCT02097745|11186041|FG000|COMPLETED|Overall Study||157
10060466|NCT02097745|11186041|FG000|NOT COMPLETED|Overall Study||178
10060467|NCT02097823|11186050|FG000|STARTED|Overall Study||11
10060468|NCT02097823|11186051|FG001|STARTED|Overall Study||4
10060469|NCT02097823|11186050|FG000|COMPLETED|Overall Study||10
10060470|NCT02097823|11186051|FG001|COMPLETED|Overall Study||3
10060471|NCT02097823|11186050|FG000|NOT COMPLETED|Overall Study||1
10060472|NCT02097823|11186051|FG001|NOT COMPLETED|Overall Study||1
10060473|NCT02097849|11186060|FG000|STARTED|Overall Study||33
10060474|NCT02097849|11186061|FG001|STARTED|Overall Study||38
10060475|NCT02097849|11186060|FG000|COMPLETED|Overall Study||33
10060476|NCT02097849|11186061|FG001|COMPLETED|Overall Study||38
10060477|NCT02097849|11186060|FG000|NOT COMPLETED|Overall Study||0
10133723|NCT02681809|11265813|FG001|NOT COMPLETED|Overall Study||4
10133724|NCT02681809|11265814|FG002|NOT COMPLETED|Overall Study||1
10133725|NCT02682030|11265824|FG000|STARTED|Overall Study||1
10133726|NCT02682030|11265825|FG001|STARTED|Overall Study||4
10133727|NCT02682030|11265824|FG000|COMPLETED|Overall Study||0
10133728|NCT02682030|11265825|FG001|COMPLETED|Overall Study||2
10133729|NCT02682030|11265824|FG000|NOT COMPLETED|Overall Study||1
10133730|NCT02682030|11265825|FG001|NOT COMPLETED|Overall Study||2
10133731|NCT02682056|11265832|FG000|STARTED|Overall Study||15
10133732|NCT02682056|11265832|FG000|COMPLETED|Overall Study||15
10133733|NCT02682056|11265832|FG000|NOT COMPLETED|Overall Study||0
10133734|NCT02682069|11265840|FG000|STARTED|Overall Study||30
10133735|NCT02682069|11265840|FG000|COMPLETED|Overall Study||30
10133736|NCT02682069|11265840|FG000|NOT COMPLETED|Overall Study||0
10133737|NCT02682264|11265846|FG000|STARTED|Overall Study||317
10133738|NCT02682264|11265847|FG001|STARTED|Overall Study||290
10133739|NCT02682264|11265846|FG000|COMPLETED|Overall Study||179
10133740|NCT02682264|11265847|FG001|COMPLETED|Overall Study||168
10133741|NCT02682264|11265846|FG000|NOT COMPLETED|Overall Study||138
10133742|NCT02682264|11265847|FG001|NOT COMPLETED|Overall Study||122
10133743|NCT02682381|11265856|FG000|STARTED|Overall Study||24
10133744|NCT02682381|11265857|FG001|STARTED|Overall Study||26
10133745|NCT02682381|11265858|FG002|STARTED|Overall Study||9
10133746|NCT02682381|11265856|FG000|COMPLETED|Overall Study||24
10133747|NCT02682381|11265857|FG001|COMPLETED|Overall Study||26
10133748|NCT02682381|11265858|FG002|COMPLETED|Overall Study||9
10133749|NCT02682381|11265856|FG000|NOT COMPLETED|Overall Study||0
10133750|NCT02682381|11265857|FG001|NOT COMPLETED|Overall Study||0
10133751|NCT02682381|11265858|FG002|NOT COMPLETED|Overall Study||0
10133752|NCT02682420|11265866|FG000|STARTED|Overall Study||100
10133753|NCT02682420|11265866|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63
10133754|NCT02682420|11265866|FG000|NOT COMPLETED|Overall Study||37
10133755|NCT02682498|11265879|FG000|STARTED|Overall Study||18
10133756|NCT02682498|11265880|FG001|STARTED|Overall Study||20
10133757|NCT02682498|11265879|FG000|COMPLETED|Overall Study||18
10133758|NCT02682498|11265880|FG001|COMPLETED|Overall Study||20
10133759|NCT02682498|11265879|FG000|NOT COMPLETED|Overall Study||0
10133760|NCT02682498|11265880|FG001|NOT COMPLETED|Overall Study||0
10133761|NCT02682563|11265889|FG000|STARTED|Overall Study||24
10133762|NCT02682563|11265890|FG001|STARTED|Overall Study||20
10133763|NCT02682563|11265889|FG000|COMPLETED|Overall Study||24
10133764|NCT02682563|11265890|FG001|COMPLETED|Overall Study||20
10133765|NCT02682563|11265889|FG000|NOT COMPLETED|Overall Study||0
10133766|NCT02682563|11265890|FG001|NOT COMPLETED|Overall Study||0
10133767|NCT02682602|11265898|FG000|STARTED|Pre-operative Diseased & Normal Hips||11
10133768|NCT02682602|11265899|FG001|STARTED|Pre-operative Diseased & Normal Hips||10
10133769|NCT02682602|11265898|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10
10133770|NCT02682602|11265899|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10
10133771|NCT02682602|11265898|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
10133772|NCT02682602|11265899|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
10133773|NCT02682602|11265898|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10
10133774|NCT02682602|11265899|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0
10133775|NCT02682602|11265898|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7
10133776|NCT02682602|11265899|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
10133777|NCT02682602|11265898|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
10133778|NCT02682602|11265899|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
10133779|NCT02682784|11265913|FG000|STARTED|Overall Study||40
10133780|NCT02682784|11265914|FG001|STARTED|Overall Study||37
10133781|NCT02682784|11265915|FG002|STARTED|Overall Study||29
10133782|NCT02682784|11265916|FG003|STARTED|Overall Study||32
10133783|NCT02682784|11265913|FG000|COMPLETED|Overall Study||39
10133784|NCT02682784|11265914|FG001|COMPLETED|Overall Study||35
10133785|NCT02682784|11265915|FG002|COMPLETED|Overall Study||27
10133786|NCT02682784|11265916|FG003|COMPLETED|Overall Study||29
10133787|NCT02682784|11265913|FG000|NOT COMPLETED|Overall Study||1
10133788|NCT02682784|11265914|FG001|NOT COMPLETED|Overall Study||2
10133789|NCT02682784|11265915|FG002|NOT COMPLETED|Overall Study||2
10133790|NCT02682784|11265916|FG003|NOT COMPLETED|Overall Study||3
10133791|NCT02682823|11265931|FG000|STARTED|Overall Study||17
10133792|NCT02682823|11265932|FG001|STARTED|Overall Study||19
10133793|NCT02682823|11265933|FG002|STARTED|Overall Study||19
10133794|NCT02682823|11265934|FG003|STARTED|Overall Study||17
10133795|NCT02682823|11265935|FG004|STARTED|Overall Study||19
10133796|NCT02682823|11265931|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
10133797|NCT02682823|11265932|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
10133798|NCT02682823|11265933|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
10133799|NCT02682823|11265934|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
10133800|NCT02682823|11265935|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
10133801|NCT02682823|11265931|FG000|COMPLETED|Overall Study||17
10133802|NCT02682823|11265932|FG001|COMPLETED|Overall Study||18
10133803|NCT02682823|11265933|FG002|COMPLETED|Overall Study||18
10133804|NCT02682823|11265934|FG003|COMPLETED|Overall Study||16
10133805|NCT02682823|11265935|FG004|COMPLETED|Overall Study||18
10133806|NCT02682823|11265931|FG000|NOT COMPLETED|Overall Study||0
10133807|NCT02682823|11265932|FG001|NOT COMPLETED|Overall Study||1
10133808|NCT02682823|11265933|FG002|NOT COMPLETED|Overall Study||1
10133809|NCT02682823|11265934|FG003|NOT COMPLETED|Overall Study||1
10133810|NCT02682823|11265935|FG004|NOT COMPLETED|Overall Study||1
10133811|NCT02683083|11265947|FG000|STARTED|Overall Study||9
10133812|NCT02683083|11265947|FG000|COMPLETED|Overall Study||9
10133813|NCT02683083|11265947|FG000|NOT COMPLETED|Overall Study||0
10133814|NCT02683109|11265953|FG000|STARTED|Overall Study||110
10133815|NCT02683109|11265954|FG001|STARTED|Overall Study||111
10133816|NCT02683109|11265953|FG000|COMPLETED|Overall Study||109
10133817|NCT02683109|11265954|FG001|COMPLETED|Overall Study||111
10133818|NCT02683109|11265953|FG000|NOT COMPLETED|Overall Study||1
10133819|NCT02683109|11265954|FG001|NOT COMPLETED|Overall Study||0
10133820|NCT02683161|11265961|FG000|STARTED|Overall Study||5
10133821|NCT02683161|11265961|FG000|COMPLETED|Overall Study||5
10133822|NCT02683161|11265961|FG000|NOT COMPLETED|Overall Study||0
10133823|NCT02683174|11265965|FG000|STARTED|Overall Study||86
10133824|NCT02683174|11265965|FG000|COMPLETED|Overall Study||86
10133825|NCT02683174|11265965|FG000|NOT COMPLETED|Overall Study||0
10133826|NCT02683187|11265970|FG000|STARTED|Overall Study||40
10133827|NCT02683187|11265970|FG000|COMPLETED|Overall Study||32
10133828|NCT02683187|11265970|FG000|NOT COMPLETED|Overall Study||8
10133829|NCT02683421|11265982|FG000|STARTED|Overall Study||5
10133830|NCT02683421|11265983|FG001|STARTED|Overall Study||4
10133831|NCT02683421|11265984|FG002|STARTED|Overall Study||4
10133832|NCT02683421|11265985|FG003|STARTED|Overall Study||5
10133833|NCT02683421|11265982|FG000|COMPLETED|Overall Study||5
10133834|NCT02683421|11265983|FG001|COMPLETED|Overall Study||4
10133835|NCT02683421|11265984|FG002|COMPLETED|Overall Study||4
10133836|NCT02683421|11265985|FG003|COMPLETED|Overall Study||5
10133837|NCT02683421|11265982|FG000|NOT COMPLETED|Overall Study||0
10133838|NCT02683421|11265983|FG001|NOT COMPLETED|Overall Study||0
10133839|NCT02683421|11265984|FG002|NOT COMPLETED|Overall Study||0
10133840|NCT02683421|11265985|FG003|NOT COMPLETED|Overall Study||0
10133841|NCT02683525|11265995|FG000|STARTED|Overall Study||37
10133842|NCT02683525|11265995|FG000|COMPLETED|Overall Study||29
10133843|NCT02683525|11265995|FG000|NOT COMPLETED|Overall Study||8
10133844|NCT02683577|11266002|FG000|STARTED|Overall Study||8
10133845|NCT02683577|11266003|FG001|STARTED|Overall Study||8
10133846|NCT02683577|11266004|FG002|STARTED|Overall Study||8
10133847|NCT02683577|11266002|FG000|COMPLETED|Overall Study||8
10133848|NCT02683577|11266003|FG001|COMPLETED|Overall Study||8
10133849|NCT02683577|11266004|FG002|COMPLETED|Overall Study||8
10133850|NCT02683577|11266002|FG000|NOT COMPLETED|Overall Study||0
10133851|NCT02683577|11266003|FG001|NOT COMPLETED|Overall Study||0
10133852|NCT02683577|11266004|FG002|NOT COMPLETED|Overall Study||0
10133853|NCT02683668|11266014|FG000|STARTED|Period 1||44
10133854|NCT02683668|11266015|FG001|STARTED|Period 1||0
10133855|NCT02683668|11266016|FG002|STARTED|Period 1||0
10133856|NCT02683668|11266014|FG000|COMPLETED|Period 1||44
10133857|NCT02683668|11266015|FG001|COMPLETED|Period 1||0
10133858|NCT02683668|11266016|FG002|COMPLETED|Period 1||0
10133859|NCT02683668|11266014|FG000|NOT COMPLETED|Period 1||0
10133860|NCT02683668|11266015|FG001|NOT COMPLETED|Period 1||0
10133861|NCT02683668|11266016|FG002|NOT COMPLETED|Period 1||0
10133862|NCT02683668|11266014|FG000|STARTED|Period 2||0
10133863|NCT02683668|11266015|FG001|STARTED|Period 2||44
10133864|NCT02683668|11266016|FG002|STARTED|Period 2||0
10133865|NCT02683668|11266014|FG000|COMPLETED|Period 2||0
10133866|NCT02683668|11266015|FG001|COMPLETED|Period 2||43
10133867|NCT02683668|11266016|FG002|COMPLETED|Period 2||0
10133868|NCT02683668|11266014|FG000|NOT COMPLETED|Period 2||0
10133869|NCT02683668|11266015|FG001|NOT COMPLETED|Period 2||1
10133870|NCT02683668|11266016|FG002|NOT COMPLETED|Period 2||0
9706977|NCT04070326|10806104|FG001|COMPLETED|Treatment Period A (Weeks 1 to 26)||17
9706978|NCT04070326|10806103|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||1
9963849|NCT01488877|11083634|FG001|COMPLETED|Re-randomization||0
10133871|NCT02683668|11266014|FG000|STARTED|Period 3||0
10133872|NCT02683668|11266015|FG001|STARTED|Period 3||0
9706979|NCT04070326|10806104|FG001|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0
9706980|NCT04070326|10806103|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||3
9706981|NCT04070326|10806104|FG001|STARTED|Treatment Period B (Weeks 27 to 52)||17
9706982|NCT04070326|10806103|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||3
9706983|NCT04070326|10806104|FG001|COMPLETED|Treatment Period B (Weeks 27 to 52)||17
9706984|NCT04070326|10806103|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
9706985|NCT04070326|10806104|FG001|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
9729170|NCT00116831|10828743|FG000|COMPLETED|Overall Study||264
9729171|NCT00116831|10828744|FG001|COMPLETED|Overall Study||259
9729172|NCT00116831|10828743|FG000|NOT COMPLETED|Overall Study||73
9729173|NCT00116831|10828744|FG001|NOT COMPLETED|Overall Study||72
9729174|NCT00116844|10828752|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35
9729175|NCT00116844|10828753|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36
9729176|NCT00116844|10828752|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
9729177|NCT00116844|10828753|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
9729178|NCT00116844|10828752|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
9729179|NCT00116844|10828753|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
9729180|NCT00116844|10828752|FG000|STARTED|Period 2: Washout Period (7 Days)||28
9729181|NCT00116844|10828753|FG001|STARTED|Period 2: Washout Period (7 Days)||33
9729182|NCT00116844|10828752|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28
9729183|NCT00116844|10828753|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33
9729184|NCT00116844|10828752|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
9729185|NCT00116844|10828753|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
9729186|NCT00116844|10828752|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28
9729187|NCT00116844|10828753|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33
9729188|NCT00116844|10828752|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
9729189|NCT00116844|10828753|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
9729190|NCT00116844|10828752|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
9729191|NCT00116844|10828753|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
9729192|NCT00116857|10828761|FG000|STARTED|Overall Study||62
9729193|NCT00116857|10828762|FG001|STARTED|Overall Study||60
9729194|NCT00116857|10828761|FG000|COMPLETED|Overall Study||59
9729195|NCT00116857|10828762|FG001|COMPLETED|Overall Study||56
9729196|NCT00116857|10828761|FG000|NOT COMPLETED|Overall Study||3
9729197|NCT00116857|10828762|FG001|NOT COMPLETED|Overall Study||4
9729198|NCT00117143|10828772|FG000|STARTED|Overall Study||4
9729199|NCT00117143|10828773|FG001|STARTED|Overall Study||4
9729200|NCT00117143|10828774|FG002|STARTED|Overall Study||7
9729201|NCT00117143|10828775|FG003|STARTED|Overall Study||1
9729202|NCT00117143|10828772|FG000|Received First Dose|Overall Study||4
9729203|NCT00117143|10828773|FG001|Received First Dose|Overall Study||4
9729204|NCT00117143|10828774|FG002|Received First Dose|Overall Study||7
9729205|NCT00117143|10828775|FG003|Received First Dose|Overall Study||1
10133873|NCT02683668|11266016|FG002|STARTED|Period 3||43
10133874|NCT02683668|11266014|FG000|COMPLETED|Period 3||0
10133875|NCT02683668|11266015|FG001|COMPLETED|Period 3||0
10133876|NCT02683668|11266016|FG002|COMPLETED|Period 3||43
10133877|NCT02683668|11266014|FG000|NOT COMPLETED|Period 3||0
10133878|NCT02683668|11266015|FG001|NOT COMPLETED|Period 3||0
10133879|NCT02683668|11266016|FG002|NOT COMPLETED|Period 3||0
10133880|NCT02683707|11266024|FG000|STARTED|Overall Study||105
10133881|NCT02683707|11266025|FG001|STARTED|Overall Study||107
10133882|NCT02683707|11266024|FG000|COMPLETED|Overall Study||105
10133883|NCT02683707|11266025|FG001|COMPLETED|Overall Study||107
10133884|NCT02683707|11266024|FG000|NOT COMPLETED|Overall Study||0
10133885|NCT02683707|11266025|FG001|NOT COMPLETED|Overall Study||0
10133886|NCT02683746|11266033|FG000|STARTED|Overall Study||154
10133887|NCT02683746|11266034|FG001|STARTED|Overall Study||154
10133888|NCT02683746|11266033|FG000|COMPLETED|Overall Study||138
10133889|NCT02683746|11266034|FG001|COMPLETED|Overall Study||140
10133890|NCT02683746|11266033|FG000|NOT COMPLETED|Overall Study||16
10133891|NCT02683746|11266034|FG001|NOT COMPLETED|Overall Study||14
10133892|NCT02683772|11266040|FG000|STARTED|Overall Study||15
10133893|NCT02683772|11266041|FG001|STARTED|Overall Study||23
10133894|NCT02683772|11266040|FG000|COMPLETED|Overall Study||15
10133895|NCT02683772|11266041|FG001|COMPLETED|Overall Study||23
10133896|NCT02683772|11266040|FG000|NOT COMPLETED|Overall Study||0
10133897|NCT02683772|11266041|FG001|NOT COMPLETED|Overall Study||0
10133898|NCT02683785|11266053|FG000|STARTED|Overall Study||22
10133899|NCT02683785|11266054|FG001|STARTED|Overall Study||22
10133900|NCT02683785|11266053|FG000|COMPLETED|Overall Study||21
10133901|NCT02683785|11266054|FG001|COMPLETED|Overall Study||18
10133902|NCT02683785|11266053|FG000|NOT COMPLETED|Overall Study||1
10133903|NCT02683785|11266054|FG001|NOT COMPLETED|Overall Study||4
10133904|NCT02683876|11266064|FG000|STARTED|Overall Study||17
10133905|NCT02683876|11266065|FG001|STARTED|Overall Study||22
10133906|NCT02683876|11266064|FG000|COMPLETED|Overall Study||15
10133907|NCT02683876|11266065|FG001|COMPLETED|Overall Study||22
10133908|NCT02683876|11266064|FG000|NOT COMPLETED|Overall Study||2
10133909|NCT02683876|11266065|FG001|NOT COMPLETED|Overall Study||0
10133910|NCT02683928|11266075|FG000|STARTED|Overall Study||48
10133911|NCT02683928|11266076|FG001|STARTED|Overall Study||16
10133912|NCT02683928|11266075|FG000|COMPLETED|Overall Study||26
10133913|NCT02683928|11266076|FG001|COMPLETED|Overall Study||8
10133914|NCT02683928|11266075|FG000|NOT COMPLETED|Overall Study||22
10133915|NCT02683928|11266076|FG001|NOT COMPLETED|Overall Study||8
10133916|NCT02683941|11266084|FG000|STARTED|Double-blind Phase||51
10133917|NCT02683941|11266085|FG001|STARTED|Double-blind Phase||26
10133918|NCT02683941|11266084|FG000|COMPLETED|Double-blind Phase||41
10133919|NCT02683941|11266085|FG001|COMPLETED|Double-blind Phase||21
10133920|NCT02683941|11266084|FG000|NOT COMPLETED|Double-blind Phase||10
10133921|NCT02683941|11266085|FG001|NOT COMPLETED|Double-blind Phase||5
10133922|NCT02683941|11266084|FG000|STARTED|Open-label Treatment Phase||21
10133923|NCT02683941|11266085|FG001|STARTED|Open-label Treatment Phase||19
10133924|NCT02683941|11266084|FG000|COMPLETED|Open-label Treatment Phase||1
10133925|NCT02683941|11266085|FG001|COMPLETED|Open-label Treatment Phase||6
10133926|NCT02683941|11266084|FG000|NOT COMPLETED|Open-label Treatment Phase||20
10133927|NCT02683941|11266085|FG001|NOT COMPLETED|Open-label Treatment Phase||13
10133928|NCT02683941|11266084|FG000|STARTED|Open-label Follow-up Phase||18
10133929|NCT02683941|11266085|FG001|STARTED|Open-label Follow-up Phase||8
10133930|NCT02683941|11266084|FG000|COMPLETED|Open-label Follow-up Phase||0
10133931|NCT02683941|11266085|FG001|COMPLETED|Open-label Follow-up Phase||0
10133932|NCT02683941|11266084|FG000|NOT COMPLETED|Open-label Follow-up Phase||18
10133933|NCT02683941|11266085|FG001|NOT COMPLETED|Open-label Follow-up Phase||8
10133934|NCT02683954|11266097|FG000|STARTED|Overall Study||30
10133935|NCT02683954|11266098|FG001|STARTED|Overall Study||30
10133936|NCT02683954|11266097|FG000|COMPLETED|Overall Study||30
10133937|NCT02683954|11266098|FG001|COMPLETED|Overall Study||30
10133938|NCT02683954|11266097|FG000|NOT COMPLETED|Overall Study||0
10133939|NCT02683954|11266098|FG001|NOT COMPLETED|Overall Study||0
10133940|NCT02684097|11266106|FG000|STARTED|Overall Study||15
10133941|NCT02684097|11266107|FG001|STARTED|Overall Study||7
10133942|NCT02684097|11266106|FG000|COMPLETED|Overall Study||2
10133943|NCT02684097|11266107|FG001|COMPLETED|Overall Study||1
10133944|NCT02684097|11266106|FG000|NOT COMPLETED|Overall Study||13
10133945|NCT02684097|11266107|FG001|NOT COMPLETED|Overall Study||6
10133946|NCT02684136|11266113|FG000|STARTED|First Intervention (9 Nights)||5
10133947|NCT02684136|11266114|FG001|STARTED|First Intervention (9 Nights)||5
10133948|NCT02684136|11266113|FG000|COMPLETED|First Intervention (9 Nights)||5
10133949|NCT02684136|11266114|FG001|COMPLETED|First Intervention (9 Nights)||5
10133950|NCT02684136|11266113|FG000|NOT COMPLETED|First Intervention (9 Nights)||0
10133951|NCT02684136|11266114|FG001|NOT COMPLETED|First Intervention (9 Nights)||0
10133952|NCT02684136|11266113|FG000|STARTED|Washout (7 Days)||5
10133953|NCT02684136|11266114|FG001|STARTED|Washout (7 Days)||5
10133954|NCT02684136|11266113|FG000|COMPLETED|Washout (7 Days)||5
10133955|NCT02684136|11266114|FG001|COMPLETED|Washout (7 Days)||5
10133956|NCT02684136|11266113|FG000|NOT COMPLETED|Washout (7 Days)||0
10133957|NCT02684136|11266114|FG001|NOT COMPLETED|Washout (7 Days)||0
9706986|NCT04003610|10806115|FG000|STARTED|Overall Study||0
9706987|NCT04003610|10806116|FG001|STARTED|Overall Study||1
10133958|NCT02684136|11266113|FG000|STARTED|Second Intervention (9 Nights)||5
10133959|NCT02684136|11266114|FG001|STARTED|Second Intervention (9 Nights)||5
10133960|NCT02684136|11266113|FG000|COMPLETED|Second Intervention (9 Nights)||5
10133961|NCT02684136|11266114|FG001|COMPLETED|Second Intervention (9 Nights)||5
10133962|NCT02684136|11266113|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0
10133963|NCT02684136|11266114|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0
10133964|NCT02684188|11266122|FG000|STARTED|Overall Study||77
10133965|NCT02684188|11266123|FG001|STARTED|Overall Study||50
10133966|NCT02684188|11266122|FG000|COMPLETED|Overall Study||75
10133967|NCT02684188|11266123|FG001|COMPLETED|Overall Study||47
10133968|NCT02684188|11266122|FG000|NOT COMPLETED|Overall Study||2
10133969|NCT02684188|11266123|FG001|NOT COMPLETED|Overall Study||3
10133970|NCT02684279|11266132|FG000|STARTED|Overall Study||528
10133971|NCT02684279|11266132|FG000|COMPLETED|Overall Study||249
10133972|NCT02684279|11266132|FG000|NOT COMPLETED|Overall Study||279
10133973|NCT02684344|11266138|FG000|STARTED|Overall Study||1
10133974|NCT02684344|11266139|FG001|STARTED|Overall Study||4
10133975|NCT02684344|11266138|FG000|COMPLETED|Overall Study||1
10133976|NCT02684344|11266139|FG001|COMPLETED|Overall Study||3
10133977|NCT02684344|11266138|FG000|NOT COMPLETED|Overall Study||0
10133978|NCT02684344|11266139|FG001|NOT COMPLETED|Overall Study||1
10133979|NCT02684357|11266148|FG000|STARTED|Part A||98
10133980|NCT02684357|11266149|FG001|STARTED|Part A||99
10133981|NCT02684357|11266150|FG002|STARTED|Part A||294
10133982|NCT02684357|11266151|FG003|STARTED|Part A||0
10133983|NCT02684357|11266152|FG004|STARTED|Part A||0
10133984|NCT02684357|11266153|FG005|STARTED|Part A||0
10133985|NCT02684357|11266148|FG000|COMPLETED|Part A||94
10133986|NCT02684357|11266149|FG001|COMPLETED|Part A||96
10133987|NCT02684357|11266150|FG002|COMPLETED|Part A||292
10133988|NCT02684357|11266151|FG003|COMPLETED|Part A||0
10133989|NCT02684357|11266152|FG004|COMPLETED|Part A||0
10133990|NCT02684357|11266153|FG005|COMPLETED|Part A||0
10133991|NCT02684357|11266148|FG000|NOT COMPLETED|Part A||4
10133992|NCT02684357|11266149|FG001|NOT COMPLETED|Part A||3
10133993|NCT02684357|11266150|FG002|NOT COMPLETED|Part A||2
10133994|NCT02684357|11266151|FG003|NOT COMPLETED|Part A||0
10133995|NCT02684357|11266152|FG004|NOT COMPLETED|Part A||0
10133996|NCT02684357|11266153|FG005|NOT COMPLETED|Part A||0
10133997|NCT02684357|11266148|FG000|STARTED|Part B||0
10133998|NCT02684357|11266149|FG001|STARTED|Part B||0
10133999|NCT02684357|11266150|FG002|STARTED|Part B||0
10134000|NCT02684357|11266151|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
10134001|NCT02684357|11266152|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
10134002|NCT02684357|11266153|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
10134003|NCT02684357|11266148|FG000|COMPLETED|Part B||0
10134004|NCT02684357|11266149|FG001|COMPLETED|Part B||0
10134005|NCT02684357|11266150|FG002|COMPLETED|Part B||0
10134006|NCT02684357|11266151|FG003|COMPLETED|Part B||91
10134007|NCT02684357|11266152|FG004|COMPLETED|Part B||90
10134008|NCT02684357|11266153|FG005|COMPLETED|Part B||278
10134009|NCT02684357|11266148|FG000|NOT COMPLETED|Part B||0
10134010|NCT02684357|11266149|FG001|NOT COMPLETED|Part B||0
10134011|NCT02684357|11266150|FG002|NOT COMPLETED|Part B||0
10134012|NCT02684357|11266151|FG003|NOT COMPLETED|Part B||3
10134013|NCT02684357|11266152|FG004|NOT COMPLETED|Part B||4
10134014|NCT02684357|11266153|FG005|NOT COMPLETED|Part B||13
10134015|NCT02684370|11266169|FG000|STARTED|Part A||102
10134016|NCT02684370|11266170|FG001|STARTED|Part A||100
10134017|NCT02684370|11266171|FG002|STARTED|Part A||304
10134018|NCT02684370|11266172|FG003|STARTED|Part A||0
10134019|NCT02684370|11266173|FG004|STARTED|Part A||0
10134020|NCT02684370|11266174|FG005|STARTED|Part A||0
10134021|NCT02684370|11266169|FG000|COMPLETED|Part A||98
10134022|NCT02684370|11266170|FG001|COMPLETED|Part A||99
10134023|NCT02684370|11266171|FG002|COMPLETED|Part A||299
10134024|NCT02684370|11266172|FG003|COMPLETED|Part A||0
10134025|NCT02684370|11266173|FG004|COMPLETED|Part A||0
10134026|NCT02684370|11266174|FG005|COMPLETED|Part A||0
10134027|NCT02684370|11266169|FG000|NOT COMPLETED|Part A||4
10134028|NCT02684370|11266170|FG001|NOT COMPLETED|Part A||1
10134029|NCT02684370|11266171|FG002|NOT COMPLETED|Part A||5
10134030|NCT02684370|11266172|FG003|NOT COMPLETED|Part A||0
10134031|NCT02684370|11266173|FG004|NOT COMPLETED|Part A||0
10134032|NCT02684370|11266174|FG005|NOT COMPLETED|Part A||0
10134033|NCT02684370|11266169|FG000|STARTED|Part B||0
10134034|NCT02684370|11266170|FG001|STARTED|Part B||0
10134035|NCT02684370|11266171|FG002|STARTED|Part B||0
10134036|NCT02684370|11266172|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
10134037|NCT02684370|11266173|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
10134038|NCT02684370|11266174|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
10134039|NCT02684370|11266169|FG000|COMPLETED|Part B||0
10134040|NCT02684370|11266170|FG001|COMPLETED|Part B||0
10134041|NCT02684370|11266171|FG002|COMPLETED|Part B||0
10134042|NCT02684370|11266172|FG003|COMPLETED|Part B||95
10134043|NCT02684370|11266173|FG004|COMPLETED|Part B||94
10134044|NCT02684370|11266174|FG005|COMPLETED|Part B||289
10134045|NCT02684370|11266169|FG000|NOT COMPLETED|Part B||0
10134046|NCT02684370|11266170|FG001|NOT COMPLETED|Part B||0
10134047|NCT02684370|11266171|FG002|NOT COMPLETED|Part B||0
10134048|NCT02684370|11266172|FG003|NOT COMPLETED|Part B||2
10134049|NCT02684370|11266173|FG004|NOT COMPLETED|Part B||5
10134050|NCT02684370|11266174|FG005|NOT COMPLETED|Part B||8
10134051|NCT02684396|11266194|FG000|STARTED|Overall Study||6
10134052|NCT02684396|11266195|FG001|STARTED|Overall Study||6
10134053|NCT02684396|11266196|FG002|STARTED|Overall Study||6
10134054|NCT02684396|11266197|FG003|STARTED|Overall Study||6
10134055|NCT02684396|11266198|FG004|STARTED|Overall Study||5
10134056|NCT02684396|11266199|FG005|STARTED|Overall Study||10
10134057|NCT02684396|11266194|FG000|COMPLETED|Overall Study||6
10134058|NCT02684396|11266195|FG001|COMPLETED|Overall Study||6
10134059|NCT02684396|11266196|FG002|COMPLETED|Overall Study||6
10134060|NCT02684396|11266197|FG003|COMPLETED|Overall Study||6
10134061|NCT02684396|11266198|FG004|COMPLETED|Overall Study||5
10134062|NCT02684396|11266199|FG005|COMPLETED|Overall Study||10
10134063|NCT02684396|11266194|FG000|NOT COMPLETED|Overall Study||0
10134064|NCT02684396|11266195|FG001|NOT COMPLETED|Overall Study||0
10134065|NCT02684396|11266196|FG002|NOT COMPLETED|Overall Study||0
10134066|NCT02684396|11266197|FG003|NOT COMPLETED|Overall Study||0
10134067|NCT02684396|11266198|FG004|NOT COMPLETED|Overall Study||0
10134068|NCT02684396|11266199|FG005|NOT COMPLETED|Overall Study||0
10134069|NCT02684435|11266213|FG000|STARTED|Overall Study||63
10134070|NCT02684435|11266213|FG000|COMPLETED|Overall Study||63
10134071|NCT02684435|11266213|FG000|NOT COMPLETED|Overall Study||0
10134072|NCT02684591|11266219|FG000|STARTED|Overall Study||25
10134073|NCT02684591|11266220|FG001|STARTED|Overall Study||25
10134074|NCT02684591|11266219|FG000|COMPLETED|Overall Study||24
10134075|NCT02684591|11266220|FG001|COMPLETED|Overall Study||22
10134076|NCT02684591|11266219|FG000|NOT COMPLETED|Overall Study||1
10134077|NCT02684591|11266220|FG001|NOT COMPLETED|Overall Study||3
10134078|NCT02684604|11266228|FG000|STARTED|Overall Study||44
10134079|NCT02684604|11266229|FG001|STARTED|Overall Study||44
10134080|NCT02684604|11266228|FG000|COMPLETED|Overall Study||44
10134081|NCT02684604|11266229|FG001|COMPLETED|Overall Study||44
10134082|NCT02684604|11266228|FG000|NOT COMPLETED|Overall Study||0
10134083|NCT02684604|11266229|FG001|NOT COMPLETED|Overall Study||0
10134084|NCT02684617|11266238|FG000|STARTED|Overall Study||18
10134085|NCT02684617|11266239|FG001|STARTED|Overall Study||17
10134086|NCT02684617|11266240|FG002|STARTED|Overall Study||40
10134087|NCT02684617|11266238|FG000|Treated|Overall Study||17
10134088|NCT02684617|11266239|FG001|Treated|Overall Study||17
10134089|NCT02684617|11266240|FG002|Treated|Overall Study||38
10134090|NCT02684617|11266238|FG000|COMPLETED|Overall Study||0
10134091|NCT02684617|11266239|FG001|COMPLETED|Overall Study||0
10134092|NCT02684617|11266240|FG002|COMPLETED|Overall Study||0
10134093|NCT02684617|11266238|FG000|NOT COMPLETED|Overall Study||18
10134094|NCT02684617|11266239|FG001|NOT COMPLETED|Overall Study||17
10134095|NCT02684617|11266240|FG002|NOT COMPLETED|Overall Study||40
10134096|NCT02684630|11266250|FG000|STARTED|Overall Study||65
10134097|NCT02684630|11266251|FG001|STARTED|Overall Study||63
10134098|NCT02684630|11266250|FG000|COMPLETED|Overall Study||60
10134099|NCT02684630|11266251|FG001|COMPLETED|Overall Study||60
10134100|NCT02684630|11266250|FG000|NOT COMPLETED|Overall Study||5
10134101|NCT02684630|11266251|FG001|NOT COMPLETED|Overall Study||3
10134102|NCT02684942|11266259|FG000|STARTED|Overall Study||7
10134103|NCT02684942|11266260|FG001|STARTED|Overall Study||7
10134104|NCT02684942|11266261|FG002|STARTED|Overall Study||7
10134105|NCT02684942|11266262|FG003|STARTED|Overall Study||7
10134106|NCT02684942|11266263|FG004|STARTED|Overall Study||6
10134107|NCT02684942|11266264|FG005|STARTED|Overall Study||6
10134108|NCT02684942|11266259|FG000|COMPLETED|Overall Study||7
10134109|NCT02684942|11266260|FG001|COMPLETED|Overall Study||7
10134110|NCT02684942|11266261|FG002|COMPLETED|Overall Study||7
10134111|NCT02684942|11266262|FG003|COMPLETED|Overall Study||7
10134112|NCT02684942|11266263|FG004|COMPLETED|Overall Study||6
10134113|NCT02684942|11266264|FG005|COMPLETED|Overall Study||6
10134114|NCT02684942|11266259|FG000|NOT COMPLETED|Overall Study||0
10134115|NCT02684942|11266260|FG001|NOT COMPLETED|Overall Study||0
10134116|NCT02684942|11266261|FG002|NOT COMPLETED|Overall Study||0
10134117|NCT02684942|11266262|FG003|NOT COMPLETED|Overall Study||0
10134118|NCT02684942|11266263|FG004|NOT COMPLETED|Overall Study||0
10134119|NCT02684942|11266264|FG005|NOT COMPLETED|Overall Study||0
10134120|NCT02684981|11266278|FG000|STARTED|Overall Study||4100
10134121|NCT02684981|11266279|FG001|STARTED|Overall Study||3179
10134122|NCT02684981|11266280|FG002|STARTED|Overall Study||2186
10134123|NCT02684981|11266278|FG000|COMPLETED|Overall Study||3860
10134124|NCT02684981|11266279|FG001|COMPLETED|Overall Study||2969
10134125|NCT02684981|11266280|FG002|COMPLETED|Overall Study||2059
10134126|NCT02684981|11266278|FG000|NOT COMPLETED|Overall Study||240
10134127|NCT02684981|11266279|FG001|NOT COMPLETED|Overall Study||210
10134128|NCT02684981|11266280|FG002|NOT COMPLETED|Overall Study||127
10134129|NCT02685007|11266294|FG000|STARTED|Overall Study||131
10134130|NCT02685007|11266294|FG000|COMPLETED|Overall Study||131
10134131|NCT02685007|11266294|FG000|NOT COMPLETED|Overall Study||0
10134132|NCT02685033|11266300|FG000|STARTED|Overall Study||70
10134133|NCT02685033|11266301|FG001|STARTED|Overall Study||10
10134134|NCT02685033|11266300|FG000|COMPLETED|Overall Study||67
10134135|NCT02685033|11266301|FG001|COMPLETED|Overall Study||8
10134136|NCT02685033|11266300|FG000|NOT COMPLETED|Overall Study||3
10134137|NCT02685033|11266301|FG001|NOT COMPLETED|Overall Study||2
10134138|NCT02685072|11266309|FG000|STARTED|Treatment Period||33
10134139|NCT02685072|11266310|FG001|STARTED|Treatment Period||31
10134140|NCT02685072|11266309|FG000|Completed Week 2 Visit|Treatment Period||23
10134141|NCT02685072|11266310|FG001|Completed Week 2 Visit|Treatment Period||26
10134142|NCT02685072|11266309|FG000|Completed Week 3 Visit|Treatment Period||20
10134143|NCT02685072|11266310|FG001|Completed Week 3 Visit|Treatment Period||23
10134144|NCT02685072|11266309|FG000|Completed Week 4 Visit|Treatment Period||19
10134145|NCT02685072|11266310|FG001|Completed Week 4 Visit|Treatment Period||23
10134146|NCT02685072|11266309|FG000|Completed Week 5 Visit|Treatment Period||19
10134147|NCT02685072|11266310|FG001|Completed Week 5 Visit|Treatment Period||22
10134148|NCT02685072|11266309|FG000|Completed Week 6 Visit|Treatment Period||18
10134149|NCT02685072|11266310|FG001|Completed Week 6 Visit|Treatment Period||19
10134150|NCT02685072|11266309|FG000|Completed Week 7 Visit|Treatment Period||17
10134151|NCT02685072|11266310|FG001|Completed Week 7 Visit|Treatment Period||18
10134152|NCT02685072|11266309|FG000|Completed Week 8 Visit|Treatment Period||20
10134153|NCT02685072|11266310|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
10134154|NCT02685072|11266309|FG000|COMPLETED|Treatment Period||20
10134155|NCT02685072|11266310|FG001|COMPLETED|Treatment Period||22
10134156|NCT02685072|11266309|FG000|NOT COMPLETED|Treatment Period||13
10134157|NCT02685072|11266310|FG001|NOT COMPLETED|Treatment Period||9
10134158|NCT02685072|11266309|FG000|STARTED|1-Month Follow-Up||20
10134159|NCT02685072|11266310|FG001|STARTED|1-Month Follow-Up||22
10134160|NCT02685072|11266309|FG000|COMPLETED|1-Month Follow-Up||19
10134161|NCT02685072|11266310|FG001|COMPLETED|1-Month Follow-Up||22
10134162|NCT02685072|11266309|FG000|NOT COMPLETED|1-Month Follow-Up||1
10134163|NCT02685072|11266310|FG001|NOT COMPLETED|1-Month Follow-Up||0
10134164|NCT02685072|11266309|FG000|STARTED|3-Month Follow-Up||19
10134165|NCT02685072|11266310|FG001|STARTED|3-Month Follow-Up||22
10134166|NCT02685072|11266309|FG000|COMPLETED|3-Month Follow-Up||19
10134167|NCT02685072|11266310|FG001|COMPLETED|3-Month Follow-Up||22
10134168|NCT02685072|11266309|FG000|NOT COMPLETED|3-Month Follow-Up||0
10134169|NCT02685072|11266310|FG001|NOT COMPLETED|3-Month Follow-Up||0
10134170|NCT02685267|11266319|FG000|STARTED|Overall Study||5
10134171|NCT02685267|11266320|FG001|STARTED|Overall Study||4
10134172|NCT02685267|11266319|FG000|COMPLETED|Overall Study||5
10134173|NCT02685267|11266320|FG001|COMPLETED|Overall Study||4
10134174|NCT02685267|11266319|FG000|NOT COMPLETED|Overall Study||0
10134175|NCT02685267|11266320|FG001|NOT COMPLETED|Overall Study||0
10134176|NCT02685293|11266326|FG000|STARTED|Treatment Period 1||1
10134177|NCT02685293|11266327|FG001|STARTED|Treatment Period 1||3
10134178|NCT02685293|11266326|FG000|COMPLETED|Treatment Period 1||1
10134179|NCT02685293|11266327|FG001|COMPLETED|Treatment Period 1||3
10134180|NCT02685293|11266326|FG000|NOT COMPLETED|Treatment Period 1||0
10134181|NCT02685293|11266327|FG001|NOT COMPLETED|Treatment Period 1||0
10134182|NCT02685293|11266326|FG000|STARTED|Washout Period||1
10134183|NCT02685293|11266327|FG001|STARTED|Washout Period||3
10134184|NCT02685293|11266326|FG000|COMPLETED|Washout Period||1
10134185|NCT02685293|11266327|FG001|COMPLETED|Washout Period||3
10134186|NCT02685293|11266326|FG000|NOT COMPLETED|Washout Period||0
10134187|NCT02685293|11266327|FG001|NOT COMPLETED|Washout Period||0
10134188|NCT02685293|11266326|FG000|STARTED|Treatment Period 2||1
10134189|NCT02685293|11266327|FG001|STARTED|Treatment Period 2||3
10134190|NCT02685293|11266326|FG000|COMPLETED|Treatment Period 2||1
10134191|NCT02685293|11266327|FG001|COMPLETED|Treatment Period 2||3
10134192|NCT02685293|11266326|FG000|NOT COMPLETED|Treatment Period 2||0
10134193|NCT02685293|11266327|FG001|NOT COMPLETED|Treatment Period 2||0
10134194|NCT02685436|11266333|FG000|STARTED|Overall Study|the overall studied group|52
10134195|NCT02685436|11266333|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
10134196|NCT02685436|11266333|FG000|NOT COMPLETED|Overall Study||14
10134197|NCT02685488|11266339|FG000|STARTED|Overall Study||12
10134198|NCT02685488|11266340|FG001|STARTED|Overall Study||14
10134199|NCT02685488|11266339|FG000|COMPLETED|Overall Study||12
10134200|NCT02685488|11266340|FG001|COMPLETED|Overall Study||13
10134201|NCT02685488|11266339|FG000|NOT COMPLETED|Overall Study||0
10134202|NCT02685488|11266340|FG001|NOT COMPLETED|Overall Study||1
10134203|NCT02685566|11266346|FG000|STARTED|First Reading Session||50
10134204|NCT02685566|11266347|FG001|STARTED|First Reading Session||50
10134205|NCT02685566|11266346|FG000|COMPLETED|First Reading Session||50
10134206|NCT02685566|11266347|FG001|COMPLETED|First Reading Session||50
10134207|NCT02685566|11266346|FG000|NOT COMPLETED|First Reading Session||0
10134208|NCT02685566|11266347|FG001|NOT COMPLETED|First Reading Session||0
10134209|NCT02685566|11266346|FG000|STARTED|4 Week Memory Washout Period||50
10134210|NCT02685566|11266347|FG001|STARTED|4 Week Memory Washout Period||50
10134211|NCT02685566|11266346|FG000|COMPLETED|4 Week Memory Washout Period||50
10134212|NCT02685566|11266347|FG001|COMPLETED|4 Week Memory Washout Period||50
10134213|NCT02685566|11266346|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10134214|NCT02685566|11266347|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
10134215|NCT02685566|11266346|FG000|STARTED|Second Reading Session||50
10134216|NCT02685566|11266347|FG001|STARTED|Second Reading Session||50
10134217|NCT02685566|11266346|FG000|COMPLETED|Second Reading Session||50
10134218|NCT02685566|11266347|FG001|COMPLETED|Second Reading Session||50
10134219|NCT02685566|11266346|FG000|NOT COMPLETED|Second Reading Session||0
10134220|NCT02685566|11266347|FG001|NOT COMPLETED|Second Reading Session||0
10134221|NCT02685956|11266357|FG000|STARTED|Overall Study||317
10134222|NCT02685956|11266358|FG001|STARTED|Overall Study||1978
10134223|NCT02685956|11266357|FG000|COMPLETED|Overall Study||317
10134224|NCT02685956|11266358|FG001|COMPLETED|Overall Study||1978
10134225|NCT02685956|11266357|FG000|NOT COMPLETED|Overall Study||0
10134226|NCT02685956|11266358|FG001|NOT COMPLETED|Overall Study||0
10134227|NCT02685995|11266368|FG000|STARTED|Overall Study||50
10134228|NCT02685995|11266369|FG001|STARTED|Overall Study||50
10134229|NCT02685995|11266368|FG000|COMPLETED|Overall Study||49
10134230|NCT02685995|11266369|FG001|COMPLETED|Overall Study||49
10134231|NCT02685995|11266368|FG000|NOT COMPLETED|Overall Study||1
10134232|NCT02685995|11266369|FG001|NOT COMPLETED|Overall Study||1
10134233|NCT02686034|11266377|FG000|STARTED|Run-In Period 1||142
10134234|NCT02686034|11266378|FG001|STARTED|Run-In Period 1||143
10134235|NCT02686034|11266377|FG000|COMPLETED|Run-In Period 1||122
10134236|NCT02686034|11266378|FG001|COMPLETED|Run-In Period 1||126
10134237|NCT02686034|11266377|FG000|NOT COMPLETED|Run-In Period 1||20
10134238|NCT02686034|11266378|FG001|NOT COMPLETED|Run-In Period 1||17
10134239|NCT02686034|11266377|FG000|STARTED|Randomized Controlled Period 2||122
10134240|NCT02686034|11266378|FG001|STARTED|Randomized Controlled Period 2||126
10134241|NCT02686034|11266377|FG000|COMPLETED|Randomized Controlled Period 2||117
10134242|NCT02686034|11266378|FG001|COMPLETED|Randomized Controlled Period 2||122
10134243|NCT02686034|11266377|FG000|NOT COMPLETED|Randomized Controlled Period 2||5
10134244|NCT02686034|11266378|FG001|NOT COMPLETED|Randomized Controlled Period 2||4
10134245|NCT02686034|11266377|FG000|STARTED|Open Label Period 3||117
10134246|NCT02686034|11266378|FG001|STARTED|Open Label Period 3||122
10134247|NCT02686034|11266377|FG000|COMPLETED|Open Label Period 3||117
10134248|NCT02686034|11266378|FG001|COMPLETED|Open Label Period 3||121
10134249|NCT02686034|11266377|FG000|NOT COMPLETED|Open Label Period 3||0
10134250|NCT02686034|11266378|FG001|NOT COMPLETED|Open Label Period 3||1
10134251|NCT02686138|11266386|FG000|STARTED|Overall Study||293
10134252|NCT02686138|11266387|FG001|STARTED|Overall Study||300
10134253|NCT02686138|11266386|FG000|COMPLETED|Overall Study||219
10134254|NCT02686138|11266387|FG001|COMPLETED|Overall Study||235
10134255|NCT02686138|11266386|FG000|NOT COMPLETED|Overall Study||74
10134256|NCT02686138|11266387|FG001|NOT COMPLETED|Overall Study||65
10134257|NCT02686164|11266393|FG000|STARTED|Overall Study||30
10134258|NCT02686164|11266393|FG000|COMPLETED|Overall Study||27
10134259|NCT02686164|11266393|FG000|NOT COMPLETED|Overall Study||3
10134260|NCT02686437|11266402|FG000|STARTED|Overall Study||16
10134261|NCT02686437|11266403|FG001|STARTED|Overall Study||20
10134262|NCT02686437|11266402|FG000|COMPLETED|Overall Study||13
10134263|NCT02686437|11266403|FG001|COMPLETED|Overall Study||12
10134264|NCT02686437|11266402|FG000|NOT COMPLETED|Overall Study||3
10134265|NCT02686437|11266403|FG001|NOT COMPLETED|Overall Study||8
10134266|NCT02687035|11266409|FG000|STARTED|Overall Study||1822
10134267|NCT02687035|11266409|FG000|COMPLETED|Overall Study||1638
10134268|NCT02687035|11266409|FG000|NOT COMPLETED|Overall Study||184
10134269|NCT02687126|11266413|FG000|STARTED|Data Collection||106
10134270|NCT02687126|11266413|FG000|COMPLETED|Data Collection||106
10134271|NCT02687126|11266413|FG000|NOT COMPLETED|Data Collection||0
10134272|NCT02687126|11266413|FG000|STARTED|Data Analysis||106
10134273|NCT02687126|11266413|FG000|COMPLETED|Data Analysis||106
10134274|NCT02687126|11266413|FG000|NOT COMPLETED|Data Analysis||0
10134275|NCT02687139|11266420|FG000|STARTED|Overall Study||34
10134276|NCT02687139|11266420|FG000|COMPLETED|Overall Study||34
10134277|NCT02687139|11266420|FG000|NOT COMPLETED|Overall Study||0
10134278|NCT02687191|11266430|FG000|STARTED|Overall Study||3
10134279|NCT02687191|11266431|FG001|STARTED|Overall Study||3
10134280|NCT02687191|11266432|FG002|STARTED|Overall Study||3
10134281|NCT02687191|11266433|FG003|STARTED|Overall Study||6
10134282|NCT02687191|11266434|FG004|STARTED|Overall Study||3
10134283|NCT02687191|11266435|FG005|STARTED|Overall Study||3
10134284|NCT02687191|11266430|FG000|COMPLETED|Overall Study||3
10134285|NCT02687191|11266431|FG001|COMPLETED|Overall Study||2
10134286|NCT02687191|11266432|FG002|COMPLETED|Overall Study||2
10134287|NCT02687191|11266433|FG003|COMPLETED|Overall Study||5
10134288|NCT02687191|11266434|FG004|COMPLETED|Overall Study||2
10134289|NCT02687191|11266435|FG005|COMPLETED|Overall Study||2
10134290|NCT02687191|11266430|FG000|NOT COMPLETED|Overall Study||0
10134291|NCT02687191|11266431|FG001|NOT COMPLETED|Overall Study||1
10134292|NCT02687191|11266432|FG002|NOT COMPLETED|Overall Study||1
10134293|NCT02687191|11266433|FG003|NOT COMPLETED|Overall Study||1
10134294|NCT02687191|11266434|FG004|NOT COMPLETED|Overall Study||1
10134295|NCT02687191|11266435|FG005|NOT COMPLETED|Overall Study||1
10134296|NCT02687217|11266451|FG000|STARTED|Overall Study||30
10134297|NCT02687217|11266452|FG001|STARTED|Overall Study||30
10134298|NCT02687217|11266451|FG000|COMPLETED|Overall Study||30
10134299|NCT02687217|11266452|FG001|COMPLETED|Overall Study||30
10134300|NCT02687217|11266451|FG000|NOT COMPLETED|Overall Study||0
10134301|NCT02687217|11266452|FG001|NOT COMPLETED|Overall Study||0
10134302|NCT02687412|11266460|FG000|STARTED|Overall Study||50
10134303|NCT02687412|11266461|FG001|STARTED|Overall Study||57
10134304|NCT02687412|11266460|FG000|COMPLETED|Overall Study||50
10134305|NCT02687412|11266461|FG001|COMPLETED|Overall Study||57
10134306|NCT02687412|11266460|FG000|NOT COMPLETED|Overall Study||0
10134307|NCT02687412|11266461|FG001|NOT COMPLETED|Overall Study||0
10134308|NCT02687451|11266473|FG000|STARTED|Overall Study||6
10134309|NCT02687451|11266474|FG001|STARTED|Overall Study||5
10134310|NCT02687451|11266475|FG002|STARTED|Overall Study||5
9706988|NCT04003610|10806117|FG002|STARTED|Overall Study||6
10134311|NCT02687451|11266476|FG003|STARTED|Overall Study||5
10134312|NCT02687451|11266477|FG004|STARTED|Overall Study||4
10134313|NCT02687451|11266478|FG005|STARTED|Overall Study||3
10134314|NCT02687451|11266473|FG000|COMPLETED|Overall Study||5
10134315|NCT02687451|11266474|FG001|COMPLETED|Overall Study||5
10134316|NCT02687451|11266475|FG002|COMPLETED|Overall Study||5
10134317|NCT02687451|11266476|FG003|COMPLETED|Overall Study||5
10134318|NCT02687451|11266477|FG004|COMPLETED|Overall Study||4
10134319|NCT02687451|11266478|FG005|COMPLETED|Overall Study||2
10134320|NCT02687451|11266473|FG000|NOT COMPLETED|Overall Study||1
10134321|NCT02687451|11266474|FG001|NOT COMPLETED|Overall Study||0
10134322|NCT02687451|11266475|FG002|NOT COMPLETED|Overall Study||0
10134323|NCT02687451|11266476|FG003|NOT COMPLETED|Overall Study||0
10134324|NCT02687451|11266477|FG004|NOT COMPLETED|Overall Study||0
10134325|NCT02687451|11266478|FG005|NOT COMPLETED|Overall Study||1
10134326|NCT02687529|11266496|FG000|STARTED|Overall Study||34
10134327|NCT02687529|11266497|FG001|STARTED|Overall Study||32
10134328|NCT02687529|11266496|FG000|COMPLETED|Overall Study||34
10134329|NCT02687529|11266497|FG001|COMPLETED|Overall Study||32
10134330|NCT02687529|11266496|FG000|NOT COMPLETED|Overall Study||0
10134331|NCT02687529|11266497|FG001|NOT COMPLETED|Overall Study||0
10134332|NCT02687542|11266508|FG000|STARTED|Overall Study||23
10134333|NCT02687542|11266509|FG001|STARTED|Overall Study||13
10134334|NCT02687542|11266510|FG002|STARTED|Overall Study||15
10134335|NCT02687542|11266511|FG003|STARTED|Overall Study||13
10134336|NCT02687542|11266512|FG004|STARTED|Overall Study||44
10134337|NCT02687542|11266508|FG000|COMPLETED|Overall Study||15
10134338|NCT02687542|11266509|FG001|COMPLETED|Overall Study||1
10134339|NCT02687542|11266510|FG002|COMPLETED|Overall Study||1
10134340|NCT02687542|11266511|FG003|COMPLETED|Overall Study||3
10134341|NCT02687542|11266512|FG004|COMPLETED|Overall Study||24
10134342|NCT02687542|11266508|FG000|NOT COMPLETED|Overall Study||8
10134343|NCT02687542|11266509|FG001|NOT COMPLETED|Overall Study||12
10134344|NCT02687542|11266510|FG002|NOT COMPLETED|Overall Study||14
10134345|NCT02687542|11266511|FG003|NOT COMPLETED|Overall Study||10
10134346|NCT02687542|11266512|FG004|NOT COMPLETED|Overall Study||20
10134347|NCT02687711|11266524|FG000|STARTED|Overall Study||544
10134348|NCT02687711|11266524|FG000|COMPLETED|Overall Study||332
10134349|NCT02687711|11266524|FG000|NOT COMPLETED|Overall Study||212
10134350|NCT02687815|11266530|FG000|STARTED|Overall Study||96
10134351|NCT02687815|11266531|FG001|STARTED|Overall Study||96
10134352|NCT02687815|11266530|FG000|COMPLETED|Overall Study||92
10134353|NCT02687815|11266531|FG001|COMPLETED|Overall Study||88
10134354|NCT02687815|11266530|FG000|NOT COMPLETED|Overall Study||4
10134355|NCT02687815|11266531|FG001|NOT COMPLETED|Overall Study||8
10134356|NCT02687919|11266539|FG000|STARTED|Overall Study||16
10134357|NCT02687919|11266540|FG001|STARTED|Overall Study||15
10134358|NCT02687919|11266539|FG000|COMPLETED|Overall Study||8
10134359|NCT02687919|11266540|FG001|COMPLETED|Overall Study||9
10134360|NCT02687919|11266539|FG000|NOT COMPLETED|Overall Study||8
10134361|NCT02687919|11266540|FG001|NOT COMPLETED|Overall Study||6
10134362|NCT02688153|11266548|FG000|STARTED|Overall Study||62
10134363|NCT02688153|11266549|FG001|STARTED|Overall Study||58
10134364|NCT02688153|11266548|FG000|Final Randomized Arm/Group|Overall Study||59
10134365|NCT02688153|11266549|FG001|Final Randomized Arm/Group|Overall Study||61
10134366|NCT02688153|11266548|FG000|COMPLETED|Overall Study||47
10134367|NCT02688153|11266549|FG001|COMPLETED|Overall Study||51
10134368|NCT02688153|11266548|FG000|NOT COMPLETED|Overall Study||15
10134369|NCT02688153|11266549|FG001|NOT COMPLETED|Overall Study||7
10134370|NCT02688192|11266558|FG000|STARTED|Overall Study||25
10134371|NCT02688192|11266559|FG001|STARTED|Overall Study||24
10134372|NCT02688192|11266558|FG000|COMPLETED|Overall Study||13
10134373|NCT02688192|11266559|FG001|COMPLETED|Overall Study||19
10134374|NCT02688192|11266558|FG000|NOT COMPLETED|Overall Study||12
10134375|NCT02688192|11266559|FG001|NOT COMPLETED|Overall Study||5
10134376|NCT02688218|11266568|FG000|STARTED|First Exercise Intervention (2 Hours)||24
10134377|NCT02688218|11266569|FG001|STARTED|First Exercise Intervention (2 Hours)||6
10134378|NCT02688218|11266568|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24
10134379|NCT02688218|11266569|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6
10134380|NCT02688218|11266568|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
10134381|NCT02688218|11266569|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
10134382|NCT02688218|11266568|FG000|STARTED|Washout (30 Minutes)||24
10134383|NCT02688218|11266569|FG001|STARTED|Washout (30 Minutes)||6
10134384|NCT02688218|11266568|FG000|COMPLETED|Washout (30 Minutes)||24
10134385|NCT02688218|11266569|FG001|COMPLETED|Washout (30 Minutes)||6
10134386|NCT02688218|11266568|FG000|NOT COMPLETED|Washout (30 Minutes)||0
10134387|NCT02688218|11266569|FG001|NOT COMPLETED|Washout (30 Minutes)||0
10134388|NCT02688218|11266568|FG000|STARTED|Second Exercise Intervention (2 Hours)||24
10134389|NCT02688218|11266569|FG001|STARTED|Second Exercise Intervention (2 Hours)||6
10134390|NCT02688218|11266568|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24
10134391|NCT02688218|11266569|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6
10134392|NCT02688218|11266568|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
10134393|NCT02688218|11266569|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
10134394|NCT02688387|11266579|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3
10134395|NCT02688387|11266580|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3
10134396|NCT02688387|11266581|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4
10134397|NCT02688387|11266582|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3
10134398|NCT02688387|11266583|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3
10134399|NCT02688387|11266584|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2
10134400|NCT02688387|11266585|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2
10134401|NCT02688387|11266586|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2
10134402|NCT02688387|11266587|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2
10134403|NCT02688387|11266588|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2
10134404|NCT02688387|11266589|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134405|NCT02688387|11266590|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134406|NCT02688387|11266591|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134407|NCT02688387|11266592|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134408|NCT02688387|11266593|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134409|NCT02688387|11266594|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134410|NCT02688387|11266595|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134411|NCT02688387|11266596|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134412|NCT02688387|11266597|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134413|NCT02688387|11266598|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134414|NCT02688387|11266599|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134415|NCT02688387|11266600|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0
10134416|NCT02688387|11266579|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10134417|NCT02688387|11266580|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10134418|NCT02688387|11266581|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10134419|NCT02688387|11266582|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10134420|NCT02688387|11266583|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10134421|NCT02688387|11266584|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10134422|NCT02688387|11266585|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10134423|NCT02688387|11266586|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10134424|NCT02688387|11266587|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10134425|NCT02688387|11266588|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10134426|NCT02688387|11266589|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134427|NCT02688387|11266590|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134428|NCT02688387|11266591|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134429|NCT02688387|11266592|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134430|NCT02688387|11266593|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134431|NCT02688387|11266594|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134432|NCT02688387|11266595|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134433|NCT02688387|11266596|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134434|NCT02688387|11266597|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134435|NCT02688387|11266598|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134436|NCT02688387|11266599|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134437|NCT02688387|11266600|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134438|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134439|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134440|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
10134441|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
10134442|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134443|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134444|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134445|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134446|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134447|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134448|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134449|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134450|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134451|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134452|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134453|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134454|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134455|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134456|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134457|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134458|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134459|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10134460|NCT02688387|11266579|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3
10134461|NCT02688387|11266580|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3
10134462|NCT02688387|11266581|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3
10134463|NCT02688387|11266582|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2
10134464|NCT02688387|11266583|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3
10134465|NCT02688387|11266584|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2
10134466|NCT02688387|11266585|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2
10134467|NCT02688387|11266586|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2
10134468|NCT02688387|11266587|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2
10134469|NCT02688387|11266588|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2
10134470|NCT02688387|11266589|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134471|NCT02688387|11266590|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134472|NCT02688387|11266591|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134473|NCT02688387|11266592|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134474|NCT02688387|11266593|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134475|NCT02688387|11266594|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134476|NCT02688387|11266595|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134477|NCT02688387|11266596|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134478|NCT02688387|11266597|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134479|NCT02688387|11266598|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134480|NCT02688387|11266599|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134481|NCT02688387|11266600|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0
10134482|NCT02688387|11266579|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
10134483|NCT02688387|11266580|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10134484|NCT02688387|11266581|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
10134485|NCT02688387|11266582|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10134486|NCT02688387|11266583|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
10134487|NCT02688387|11266584|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10134488|NCT02688387|11266585|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10134489|NCT02688387|11266586|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10134490|NCT02688387|11266587|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10134491|NCT02688387|11266588|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10134492|NCT02688387|11266589|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134493|NCT02688387|11266590|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134494|NCT02688387|11266591|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134495|NCT02688387|11266592|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134496|NCT02688387|11266593|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134497|NCT02688387|11266594|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134498|NCT02688387|11266595|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134499|NCT02688387|11266596|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134500|NCT02688387|11266597|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134501|NCT02688387|11266598|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134502|NCT02688387|11266599|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134503|NCT02688387|11266600|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134504|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134505|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
10134506|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134507|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134508|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134509|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134510|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134511|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134512|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134513|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134514|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134515|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134516|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134517|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134518|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134519|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134520|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134521|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134522|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134523|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134524|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134525|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10134526|NCT02688387|11266579|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3
10134527|NCT02688387|11266580|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2
10134528|NCT02688387|11266581|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3
10134529|NCT02688387|11266582|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2
10134530|NCT02688387|11266583|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3
10134531|NCT02688387|11266584|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2
10134532|NCT02688387|11266585|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2
10134533|NCT02688387|11266586|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2
10134534|NCT02688387|11266587|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2
10134535|NCT02688387|11266588|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2
10134536|NCT02688387|11266589|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134537|NCT02688387|11266590|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134538|NCT02688387|11266591|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134539|NCT02688387|11266592|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134540|NCT02688387|11266593|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134541|NCT02688387|11266594|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134542|NCT02688387|11266595|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134543|NCT02688387|11266596|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134544|NCT02688387|11266597|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134545|NCT02688387|11266598|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134546|NCT02688387|11266599|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134547|NCT02688387|11266600|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0
10134548|NCT02688387|11266579|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
10134549|NCT02688387|11266580|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134550|NCT02688387|11266581|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134551|NCT02688387|11266582|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134552|NCT02688387|11266583|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134553|NCT02688387|11266584|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134554|NCT02688387|11266585|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134555|NCT02688387|11266586|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134556|NCT02688387|11266587|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134557|NCT02688387|11266588|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10134558|NCT02688387|11266589|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134559|NCT02688387|11266590|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134560|NCT02688387|11266591|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134561|NCT02688387|11266592|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134562|NCT02688387|11266593|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134563|NCT02688387|11266594|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134564|NCT02688387|11266595|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134565|NCT02688387|11266596|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134566|NCT02688387|11266597|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134567|NCT02688387|11266598|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134568|NCT02688387|11266599|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134569|NCT02688387|11266600|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134570|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134571|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134572|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
10134573|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134574|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
10134575|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134576|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134577|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134578|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134579|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134580|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134581|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134582|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134583|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134584|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134585|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134586|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134587|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134588|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134589|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134590|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134591|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10134592|NCT02688387|11266579|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3
10134593|NCT02688387|11266580|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134594|NCT02688387|11266581|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134595|NCT02688387|11266582|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134596|NCT02688387|11266583|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134597|NCT02688387|11266584|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134598|NCT02688387|11266585|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134599|NCT02688387|11266586|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134600|NCT02688387|11266587|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134601|NCT02688387|11266588|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2
10134602|NCT02688387|11266589|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134603|NCT02688387|11266590|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134604|NCT02688387|11266591|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134605|NCT02688387|11266592|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134606|NCT02688387|11266593|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134607|NCT02688387|11266594|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134608|NCT02688387|11266595|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134609|NCT02688387|11266596|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134610|NCT02688387|11266597|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134611|NCT02688387|11266598|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134612|NCT02688387|11266599|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134613|NCT02688387|11266600|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0
10134614|NCT02688387|11266579|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
10134615|NCT02688387|11266580|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134616|NCT02688387|11266581|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134617|NCT02688387|11266582|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134618|NCT02688387|11266583|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134619|NCT02688387|11266584|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134620|NCT02688387|11266585|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134621|NCT02688387|11266586|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134622|NCT02688387|11266587|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134623|NCT02688387|11266588|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10134624|NCT02688387|11266589|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134625|NCT02688387|11266590|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134626|NCT02688387|11266591|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134627|NCT02688387|11266592|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134628|NCT02688387|11266593|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134629|NCT02688387|11266594|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134630|NCT02688387|11266595|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134631|NCT02688387|11266596|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134632|NCT02688387|11266597|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134633|NCT02688387|11266598|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134634|NCT02688387|11266599|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134635|NCT02688387|11266600|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134636|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134637|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134638|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134639|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134640|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134641|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134642|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134643|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134644|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134645|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134646|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134647|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134648|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134649|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134650|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134651|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134652|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134653|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134654|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134655|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134656|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134657|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10134658|NCT02688387|11266579|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3
10134659|NCT02688387|11266580|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134660|NCT02688387|11266581|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134661|NCT02688387|11266582|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134662|NCT02688387|11266583|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134663|NCT02688387|11266584|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134664|NCT02688387|11266585|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134665|NCT02688387|11266586|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134666|NCT02688387|11266587|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134667|NCT02688387|11266588|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2
10134668|NCT02688387|11266589|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134669|NCT02688387|11266590|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134670|NCT02688387|11266591|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134671|NCT02688387|11266592|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134672|NCT02688387|11266593|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134673|NCT02688387|11266594|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134674|NCT02688387|11266595|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134675|NCT02688387|11266596|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134676|NCT02688387|11266597|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134677|NCT02688387|11266598|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134678|NCT02688387|11266599|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134679|NCT02688387|11266600|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0
10134680|NCT02688387|11266579|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
10134681|NCT02688387|11266580|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134682|NCT02688387|11266581|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134683|NCT02688387|11266582|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134684|NCT02688387|11266583|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134685|NCT02688387|11266584|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134686|NCT02688387|11266585|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134687|NCT02688387|11266586|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134688|NCT02688387|11266587|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134689|NCT02688387|11266588|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10134690|NCT02688387|11266589|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134691|NCT02688387|11266590|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134692|NCT02688387|11266591|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134693|NCT02688387|11266592|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134694|NCT02688387|11266593|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134695|NCT02688387|11266594|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134696|NCT02688387|11266595|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134697|NCT02688387|11266596|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134698|NCT02688387|11266597|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134699|NCT02688387|11266598|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134700|NCT02688387|11266599|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134701|NCT02688387|11266600|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134702|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134703|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134704|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134705|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134706|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134707|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134708|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134709|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134710|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134711|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134712|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134713|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134714|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134715|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134716|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134717|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134718|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134719|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134720|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134721|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134722|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134723|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10134724|NCT02688387|11266579|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3
10134725|NCT02688387|11266580|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134726|NCT02688387|11266581|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134727|NCT02688387|11266582|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134728|NCT02688387|11266583|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134729|NCT02688387|11266584|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134730|NCT02688387|11266585|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134731|NCT02688387|11266586|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134732|NCT02688387|11266587|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134733|NCT02688387|11266588|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2
10134734|NCT02688387|11266589|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134735|NCT02688387|11266590|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134736|NCT02688387|11266591|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134737|NCT02688387|11266592|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134738|NCT02688387|11266593|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134739|NCT02688387|11266594|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134740|NCT02688387|11266595|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134741|NCT02688387|11266596|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134742|NCT02688387|11266597|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134743|NCT02688387|11266598|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134744|NCT02688387|11266599|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134745|NCT02688387|11266600|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0
10134746|NCT02688387|11266579|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134747|NCT02688387|11266580|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134748|NCT02688387|11266581|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134749|NCT02688387|11266582|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134750|NCT02688387|11266583|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134751|NCT02688387|11266584|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134752|NCT02688387|11266585|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134753|NCT02688387|11266586|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134754|NCT02688387|11266587|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134755|NCT02688387|11266588|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10134756|NCT02688387|11266589|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134757|NCT02688387|11266590|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134758|NCT02688387|11266591|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134759|NCT02688387|11266592|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134760|NCT02688387|11266593|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134761|NCT02688387|11266594|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134762|NCT02688387|11266595|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134763|NCT02688387|11266596|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134764|NCT02688387|11266597|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134765|NCT02688387|11266598|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134766|NCT02688387|11266599|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134767|NCT02688387|11266600|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134768|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
10134769|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134770|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134771|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134772|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134773|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134774|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134775|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134776|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134777|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134778|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134779|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134780|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134781|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134782|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134783|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134784|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134785|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134786|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134787|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134788|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134789|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10134790|NCT02688387|11266579|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134791|NCT02688387|11266580|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134792|NCT02688387|11266581|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134793|NCT02688387|11266582|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134794|NCT02688387|11266583|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134795|NCT02688387|11266584|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134796|NCT02688387|11266585|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134797|NCT02688387|11266586|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134798|NCT02688387|11266587|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134799|NCT02688387|11266588|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2
10134800|NCT02688387|11266589|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134801|NCT02688387|11266590|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134802|NCT02688387|11266591|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134803|NCT02688387|11266592|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134804|NCT02688387|11266593|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134805|NCT02688387|11266594|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134806|NCT02688387|11266595|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134807|NCT02688387|11266596|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134808|NCT02688387|11266597|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134809|NCT02688387|11266598|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134810|NCT02688387|11266599|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134811|NCT02688387|11266600|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0
10134812|NCT02688387|11266579|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134813|NCT02688387|11266580|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134814|NCT02688387|11266581|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134815|NCT02688387|11266582|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134816|NCT02688387|11266583|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134817|NCT02688387|11266584|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134818|NCT02688387|11266585|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134819|NCT02688387|11266586|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134820|NCT02688387|11266587|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134821|NCT02688387|11266588|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10134822|NCT02688387|11266589|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134823|NCT02688387|11266590|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134824|NCT02688387|11266591|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134825|NCT02688387|11266592|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134826|NCT02688387|11266593|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134827|NCT02688387|11266594|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134828|NCT02688387|11266595|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134829|NCT02688387|11266596|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134830|NCT02688387|11266597|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134831|NCT02688387|11266598|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134832|NCT02688387|11266599|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134833|NCT02688387|11266600|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134834|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134835|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134836|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134837|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134838|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134839|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134840|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134841|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134842|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134843|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134844|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134845|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134846|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134847|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134848|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134849|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134850|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134851|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134852|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134853|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134854|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134855|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10134856|NCT02688387|11266579|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2
9706989|NCT04003610|10806115|FG000|COMPLETED|Overall Study||0
9706990|NCT04003610|10806116|FG001|COMPLETED|Overall Study||0
10134857|NCT02688387|11266580|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2
10134858|NCT02688387|11266581|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2
10134859|NCT02688387|11266582|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2
10134860|NCT02688387|11266583|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2
10134861|NCT02688387|11266584|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2
10134862|NCT02688387|11266585|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2
9706991|NCT04003610|10806117|FG002|COMPLETED|Overall Study||0
9706992|NCT04003610|10806115|FG000|NOT COMPLETED|Overall Study||0
9706993|NCT04003610|10806116|FG001|NOT COMPLETED|Overall Study||1
9706994|NCT04003610|10806117|FG002|NOT COMPLETED|Overall Study||6
9706995|NCT03920293|10806128|FG000|STARTED|Overall Study||86
10134863|NCT02688387|11266586|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2
9706996|NCT03920293|10806129|FG001|STARTED|Overall Study||89
10134864|NCT02688387|11266587|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2
10134865|NCT02688387|11266588|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2
10134866|NCT02688387|11266589|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134867|NCT02688387|11266590|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134868|NCT02688387|11266591|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134869|NCT02688387|11266592|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134870|NCT02688387|11266593|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134871|NCT02688387|11266594|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134872|NCT02688387|11266595|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134873|NCT02688387|11266596|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134874|NCT02688387|11266597|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134875|NCT02688387|11266598|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134876|NCT02688387|11266599|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134877|NCT02688387|11266600|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0
10134878|NCT02688387|11266579|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134879|NCT02688387|11266580|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134880|NCT02688387|11266581|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134881|NCT02688387|11266582|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134882|NCT02688387|11266583|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134883|NCT02688387|11266584|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134884|NCT02688387|11266585|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134885|NCT02688387|11266586|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134886|NCT02688387|11266587|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134887|NCT02688387|11266588|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10134888|NCT02688387|11266589|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134889|NCT02688387|11266590|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134890|NCT02688387|11266591|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134891|NCT02688387|11266592|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134892|NCT02688387|11266593|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134893|NCT02688387|11266594|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134894|NCT02688387|11266595|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134895|NCT02688387|11266596|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134896|NCT02688387|11266597|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134897|NCT02688387|11266598|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134898|NCT02688387|11266599|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134899|NCT02688387|11266600|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134900|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134901|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134902|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134903|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134904|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134905|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134906|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
9706997|NCT03920293|10806128|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
10134907|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134908|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134909|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134910|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134911|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134912|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134913|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134914|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134915|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134916|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134917|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134918|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134919|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134920|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134921|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10134922|NCT02688387|11266579|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134923|NCT02688387|11266580|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134924|NCT02688387|11266581|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134925|NCT02688387|11266582|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134926|NCT02688387|11266583|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134927|NCT02688387|11266584|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134928|NCT02688387|11266585|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134929|NCT02688387|11266586|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134930|NCT02688387|11266587|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134931|NCT02688387|11266588|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2
10134932|NCT02688387|11266589|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134933|NCT02688387|11266590|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134934|NCT02688387|11266591|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134935|NCT02688387|11266592|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134936|NCT02688387|11266593|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134937|NCT02688387|11266594|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134938|NCT02688387|11266595|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134939|NCT02688387|11266596|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134940|NCT02688387|11266597|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134941|NCT02688387|11266598|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134942|NCT02688387|11266599|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134943|NCT02688387|11266600|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0
10134944|NCT02688387|11266579|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134945|NCT02688387|11266580|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134946|NCT02688387|11266581|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134947|NCT02688387|11266582|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134948|NCT02688387|11266583|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134949|NCT02688387|11266584|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134950|NCT02688387|11266585|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134951|NCT02688387|11266586|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134952|NCT02688387|11266587|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134953|NCT02688387|11266588|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10134954|NCT02688387|11266589|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134955|NCT02688387|11266590|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134956|NCT02688387|11266591|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134957|NCT02688387|11266592|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134958|NCT02688387|11266593|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134959|NCT02688387|11266594|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134960|NCT02688387|11266595|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
9706998|NCT03920293|10806129|FG001|Received at Least 1 Dose of Study Drug|Overall Study||89
9706999|NCT03920293|10806128|FG000|COMPLETED|Overall Study||79
9707000|NCT03920293|10806129|FG001|COMPLETED|Overall Study||83
9707001|NCT03920293|10806128|FG000|NOT COMPLETED|Overall Study||7
9707002|NCT03920293|10806129|FG001|NOT COMPLETED|Overall Study||6
10134961|NCT02688387|11266596|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134962|NCT02688387|11266597|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134963|NCT02688387|11266598|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134964|NCT02688387|11266599|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134965|NCT02688387|11266600|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134966|NCT02688387|11266579|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134967|NCT02688387|11266580|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134968|NCT02688387|11266581|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134969|NCT02688387|11266582|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134970|NCT02688387|11266583|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134971|NCT02688387|11266584|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134972|NCT02688387|11266585|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134973|NCT02688387|11266586|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134974|NCT02688387|11266587|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134975|NCT02688387|11266588|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134976|NCT02688387|11266589|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134977|NCT02688387|11266590|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134978|NCT02688387|11266591|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134979|NCT02688387|11266592|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134980|NCT02688387|11266593|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134981|NCT02688387|11266594|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134982|NCT02688387|11266595|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134983|NCT02688387|11266596|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134984|NCT02688387|11266597|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134985|NCT02688387|11266598|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134986|NCT02688387|11266599|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134987|NCT02688387|11266600|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10134988|NCT02688387|11266579|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134989|NCT02688387|11266580|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134990|NCT02688387|11266581|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134991|NCT02688387|11266582|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134992|NCT02688387|11266583|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134993|NCT02688387|11266584|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134994|NCT02688387|11266585|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134995|NCT02688387|11266586|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134996|NCT02688387|11266587|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134997|NCT02688387|11266588|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0
10134998|NCT02688387|11266589|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6
10134999|NCT02688387|11266590|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5
10135000|NCT02688387|11266591|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5
10135001|NCT02688387|11266592|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5
10135002|NCT02688387|11266593|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135003|NCT02688387|11266594|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135004|NCT02688387|11266595|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135005|NCT02688387|11266596|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135006|NCT02688387|11266597|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135007|NCT02688387|11266598|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135008|NCT02688387|11266599|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135009|NCT02688387|11266600|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0
10135010|NCT02688387|11266579|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135011|NCT02688387|11266580|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135012|NCT02688387|11266581|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135013|NCT02688387|11266582|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135014|NCT02688387|11266583|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135015|NCT02688387|11266584|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135016|NCT02688387|11266585|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135017|NCT02688387|11266586|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135018|NCT02688387|11266587|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135019|NCT02688387|11266588|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135020|NCT02688387|11266589|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10135021|NCT02688387|11266590|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10135022|NCT02688387|11266591|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10135023|NCT02688387|11266592|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10135024|NCT02688387|11266593|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135025|NCT02688387|11266594|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135026|NCT02688387|11266595|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135027|NCT02688387|11266596|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135028|NCT02688387|11266597|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135029|NCT02688387|11266598|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135030|NCT02688387|11266599|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135031|NCT02688387|11266600|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135032|NCT02688387|11266579|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135033|NCT02688387|11266580|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135034|NCT02688387|11266581|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135035|NCT02688387|11266582|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135036|NCT02688387|11266583|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135037|NCT02688387|11266584|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135038|NCT02688387|11266585|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135039|NCT02688387|11266586|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135040|NCT02688387|11266587|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135041|NCT02688387|11266588|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135042|NCT02688387|11266589|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
10135043|NCT02688387|11266590|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135044|NCT02688387|11266591|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135045|NCT02688387|11266592|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135046|NCT02688387|11266593|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135047|NCT02688387|11266594|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135048|NCT02688387|11266595|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135049|NCT02688387|11266596|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135050|NCT02688387|11266597|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135051|NCT02688387|11266598|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135052|NCT02688387|11266599|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135053|NCT02688387|11266600|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10135054|NCT02688387|11266579|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135055|NCT02688387|11266580|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135056|NCT02688387|11266581|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135057|NCT02688387|11266582|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135058|NCT02688387|11266583|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135059|NCT02688387|11266584|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135060|NCT02688387|11266585|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135061|NCT02688387|11266586|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135062|NCT02688387|11266587|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135063|NCT02688387|11266588|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135064|NCT02688387|11266589|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5
10135065|NCT02688387|11266590|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5
10135066|NCT02688387|11266591|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5
10135067|NCT02688387|11266592|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5
10135068|NCT02688387|11266593|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135069|NCT02688387|11266594|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135070|NCT02688387|11266595|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135071|NCT02688387|11266596|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135072|NCT02688387|11266597|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135073|NCT02688387|11266598|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135074|NCT02688387|11266599|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135075|NCT02688387|11266600|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0
10135076|NCT02688387|11266579|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135077|NCT02688387|11266580|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135078|NCT02688387|11266581|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135079|NCT02688387|11266582|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135080|NCT02688387|11266583|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135081|NCT02688387|11266584|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135082|NCT02688387|11266585|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135083|NCT02688387|11266586|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135084|NCT02688387|11266587|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135085|NCT02688387|11266588|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135086|NCT02688387|11266589|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10135087|NCT02688387|11266590|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10135088|NCT02688387|11266591|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10135089|NCT02688387|11266592|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10135090|NCT02688387|11266593|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135091|NCT02688387|11266594|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135092|NCT02688387|11266595|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135093|NCT02688387|11266596|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135094|NCT02688387|11266597|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135095|NCT02688387|11266598|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135096|NCT02688387|11266599|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135097|NCT02688387|11266600|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135098|NCT02688387|11266579|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135099|NCT02688387|11266580|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135100|NCT02688387|11266581|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135101|NCT02688387|11266582|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135102|NCT02688387|11266583|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135103|NCT02688387|11266584|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135104|NCT02688387|11266585|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135105|NCT02688387|11266586|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135106|NCT02688387|11266587|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135107|NCT02688387|11266588|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135108|NCT02688387|11266589|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135109|NCT02688387|11266590|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135110|NCT02688387|11266591|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135111|NCT02688387|11266592|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135112|NCT02688387|11266593|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135113|NCT02688387|11266594|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135114|NCT02688387|11266595|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135115|NCT02688387|11266596|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135116|NCT02688387|11266597|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135117|NCT02688387|11266598|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135118|NCT02688387|11266599|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135119|NCT02688387|11266600|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10135120|NCT02688387|11266579|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135121|NCT02688387|11266580|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135122|NCT02688387|11266581|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135123|NCT02688387|11266582|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135124|NCT02688387|11266583|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135125|NCT02688387|11266584|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135126|NCT02688387|11266585|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135127|NCT02688387|11266586|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135128|NCT02688387|11266587|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135129|NCT02688387|11266588|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135130|NCT02688387|11266589|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5
10135131|NCT02688387|11266590|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5
10135132|NCT02688387|11266591|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5
10135133|NCT02688387|11266592|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5
10135134|NCT02688387|11266593|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135135|NCT02688387|11266594|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135136|NCT02688387|11266595|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135137|NCT02688387|11266596|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135138|NCT02688387|11266597|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135139|NCT02688387|11266598|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135140|NCT02688387|11266599|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135141|NCT02688387|11266600|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0
10135142|NCT02688387|11266579|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135143|NCT02688387|11266580|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135144|NCT02688387|11266581|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135145|NCT02688387|11266582|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135146|NCT02688387|11266583|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135147|NCT02688387|11266584|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135148|NCT02688387|11266585|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135149|NCT02688387|11266586|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135150|NCT02688387|11266587|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135151|NCT02688387|11266588|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135152|NCT02688387|11266589|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10135153|NCT02688387|11266590|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10135154|NCT02688387|11266591|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10135155|NCT02688387|11266592|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10135156|NCT02688387|11266593|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135157|NCT02688387|11266594|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135158|NCT02688387|11266595|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135159|NCT02688387|11266596|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135160|NCT02688387|11266597|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135161|NCT02688387|11266598|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135162|NCT02688387|11266599|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135163|NCT02688387|11266600|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135164|NCT02688387|11266579|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135165|NCT02688387|11266580|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135166|NCT02688387|11266581|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135167|NCT02688387|11266582|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135168|NCT02688387|11266583|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135169|NCT02688387|11266584|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135170|NCT02688387|11266585|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135171|NCT02688387|11266586|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135172|NCT02688387|11266587|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135173|NCT02688387|11266588|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135174|NCT02688387|11266589|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135175|NCT02688387|11266590|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135176|NCT02688387|11266591|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135177|NCT02688387|11266592|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135178|NCT02688387|11266593|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135179|NCT02688387|11266594|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135180|NCT02688387|11266595|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135181|NCT02688387|11266596|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135182|NCT02688387|11266597|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135183|NCT02688387|11266598|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135184|NCT02688387|11266599|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135185|NCT02688387|11266600|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10135186|NCT02688387|11266579|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135187|NCT02688387|11266580|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135188|NCT02688387|11266581|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135189|NCT02688387|11266582|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135190|NCT02688387|11266583|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135191|NCT02688387|11266584|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135192|NCT02688387|11266585|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135193|NCT02688387|11266586|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135194|NCT02688387|11266587|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135195|NCT02688387|11266588|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135196|NCT02688387|11266589|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5
10135197|NCT02688387|11266590|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5
10135198|NCT02688387|11266591|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5
10135199|NCT02688387|11266592|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5
10135200|NCT02688387|11266593|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135201|NCT02688387|11266594|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135202|NCT02688387|11266595|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135203|NCT02688387|11266596|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135204|NCT02688387|11266597|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135205|NCT02688387|11266598|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135206|NCT02688387|11266599|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135207|NCT02688387|11266600|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0
10135208|NCT02688387|11266579|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135209|NCT02688387|11266580|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135210|NCT02688387|11266581|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135211|NCT02688387|11266582|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135212|NCT02688387|11266583|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135213|NCT02688387|11266584|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135214|NCT02688387|11266585|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135215|NCT02688387|11266586|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135216|NCT02688387|11266587|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135217|NCT02688387|11266588|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135218|NCT02688387|11266589|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10135219|NCT02688387|11266590|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10135220|NCT02688387|11266591|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10135221|NCT02688387|11266592|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10135222|NCT02688387|11266593|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135223|NCT02688387|11266594|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135224|NCT02688387|11266595|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135225|NCT02688387|11266596|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135226|NCT02688387|11266597|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135227|NCT02688387|11266598|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135228|NCT02688387|11266599|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135229|NCT02688387|11266600|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135230|NCT02688387|11266579|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135231|NCT02688387|11266580|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135232|NCT02688387|11266581|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135233|NCT02688387|11266582|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135234|NCT02688387|11266583|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135235|NCT02688387|11266584|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135236|NCT02688387|11266585|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135237|NCT02688387|11266586|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135238|NCT02688387|11266587|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135239|NCT02688387|11266588|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135240|NCT02688387|11266589|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135241|NCT02688387|11266590|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135242|NCT02688387|11266591|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135243|NCT02688387|11266592|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135244|NCT02688387|11266593|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135245|NCT02688387|11266594|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135246|NCT02688387|11266595|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135247|NCT02688387|11266596|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135248|NCT02688387|11266597|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135249|NCT02688387|11266598|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10060478|NCT02097849|11186061|FG001|NOT COMPLETED|Overall Study||0
10060479|NCT02097992|11186071|FG000|STARTED|Treatment 1 (1 Day)||2
10060480|NCT02097992|11186072|FG001|STARTED|Treatment 1 (1 Day)||3
10060481|NCT02097992|11186073|FG002|STARTED|Treatment 1 (1 Day)||4
10060482|NCT02097992|11186074|FG003|STARTED|Treatment 1 (1 Day)||2
10060483|NCT02097992|11186071|FG000|COMPLETED|Treatment 1 (1 Day)||2
10060484|NCT02097992|11186072|FG001|COMPLETED|Treatment 1 (1 Day)||3
10060485|NCT02097992|11186073|FG002|COMPLETED|Treatment 1 (1 Day)||4
10060486|NCT02097992|11186074|FG003|COMPLETED|Treatment 1 (1 Day)||2
10060487|NCT02097992|11186071|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0
10135250|NCT02688387|11266599|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10060488|NCT02097992|11186072|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0
10060489|NCT02097992|11186073|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0
10135251|NCT02688387|11266600|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10135252|NCT02688387|11266579|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135253|NCT02688387|11266580|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135254|NCT02688387|11266581|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135255|NCT02688387|11266582|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135256|NCT02688387|11266583|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135257|NCT02688387|11266584|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135258|NCT02688387|11266585|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135259|NCT02688387|11266586|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135260|NCT02688387|11266587|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135261|NCT02688387|11266588|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135262|NCT02688387|11266589|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5
10135263|NCT02688387|11266590|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5
10135264|NCT02688387|11266591|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5
10135265|NCT02688387|11266592|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5
10135266|NCT02688387|11266593|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135267|NCT02688387|11266594|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135268|NCT02688387|11266595|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135269|NCT02688387|11266596|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135270|NCT02688387|11266597|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135271|NCT02688387|11266598|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135272|NCT02688387|11266599|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0
10060490|NCT02097992|11186074|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0
10060491|NCT02097992|11186071|FG000|STARTED|Treatment 2 (4 Weeks)||2
10060492|NCT02097992|11186072|FG001|STARTED|Treatment 2 (4 Weeks)||3
10060493|NCT02097992|11186073|FG002|STARTED|Treatment 2 (4 Weeks)||4
10060494|NCT02097992|11186074|FG003|STARTED|Treatment 2 (4 Weeks)||2
10060495|NCT02097992|11186071|FG000|COMPLETED|Treatment 2 (4 Weeks)||2
10135273|NCT02688387|11266600|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0
10135274|NCT02688387|11266579|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135275|NCT02688387|11266580|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135276|NCT02688387|11266581|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135277|NCT02688387|11266582|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
9707003|NCT03907540|10806135|FG000|STARTED|Overall Study||5
9707004|NCT03907540|10806135|FG000|Completed Part 1|Overall Study||5
9707005|NCT03907540|10806135|FG000|Completed Part 2|Overall Study||5
9707006|NCT03907540|10806135|FG000|COMPLETED|Overall Study||5
9707007|NCT03907540|10806135|FG000|NOT COMPLETED|Overall Study||0
9707008|NCT03904108|10806148|FG000|STARTED|Overall Study||3
9707009|NCT03904108|10806148|FG000|COMPLETED|Overall Study||3
9707010|NCT03904108|10806148|FG000|NOT COMPLETED|Overall Study||0
9707011|NCT03712345|10806155|FG000|STARTED|Overall Study||6
9707012|NCT03712345|10806156|FG001|STARTED|Overall Study||7
9707013|NCT03712345|10806157|FG002|STARTED|Overall Study|One participant was mistakenly randomized, but never treated because the participant was a screening failure.|7
9707014|NCT03712345|10806155|FG000|COMPLETED|Overall Study||6
9707015|NCT03712345|10806156|FG001|COMPLETED|Overall Study||7
9707016|NCT03712345|10806157|FG002|COMPLETED|Overall Study||6
10060496|NCT02097992|11186072|FG001|COMPLETED|Treatment 2 (4 Weeks)||3
10060497|NCT02097992|11186073|FG002|COMPLETED|Treatment 2 (4 Weeks)||4
10060498|NCT02097992|11186074|FG003|COMPLETED|Treatment 2 (4 Weeks)||2
10060499|NCT02097992|11186071|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10135278|NCT02688387|11266583|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135279|NCT02688387|11266584|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135280|NCT02688387|11266585|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135281|NCT02688387|11266586|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135282|NCT02688387|11266587|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135283|NCT02688387|11266588|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135284|NCT02688387|11266589|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10135285|NCT02688387|11266590|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10135286|NCT02688387|11266591|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10135287|NCT02688387|11266592|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10135288|NCT02688387|11266593|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135289|NCT02688387|11266594|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135290|NCT02688387|11266595|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135291|NCT02688387|11266596|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135292|NCT02688387|11266597|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135293|NCT02688387|11266598|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135294|NCT02688387|11266599|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135295|NCT02688387|11266600|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135296|NCT02688387|11266579|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135297|NCT02688387|11266580|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135298|NCT02688387|11266581|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135299|NCT02688387|11266582|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135300|NCT02688387|11266583|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135301|NCT02688387|11266584|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135302|NCT02688387|11266585|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135303|NCT02688387|11266586|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135304|NCT02688387|11266587|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135305|NCT02688387|11266588|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135306|NCT02688387|11266589|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135307|NCT02688387|11266590|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135308|NCT02688387|11266591|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135309|NCT02688387|11266592|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135310|NCT02688387|11266593|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135311|NCT02688387|11266594|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135312|NCT02688387|11266595|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135313|NCT02688387|11266596|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135314|NCT02688387|11266597|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135315|NCT02688387|11266598|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135316|NCT02688387|11266599|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135317|NCT02688387|11266600|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10135318|NCT02688387|11266579|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135319|NCT02688387|11266580|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135320|NCT02688387|11266581|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135321|NCT02688387|11266582|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135322|NCT02688387|11266583|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135323|NCT02688387|11266584|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135324|NCT02688387|11266585|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135325|NCT02688387|11266586|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135326|NCT02688387|11266587|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135327|NCT02688387|11266588|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135328|NCT02688387|11266589|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5
10135329|NCT02688387|11266590|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5
10135330|NCT02688387|11266591|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5
10135331|NCT02688387|11266592|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5
10135332|NCT02688387|11266593|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135333|NCT02688387|11266594|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135334|NCT02688387|11266595|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135335|NCT02688387|11266596|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135336|NCT02688387|11266597|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135337|NCT02688387|11266598|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135338|NCT02688387|11266599|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135339|NCT02688387|11266600|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0
10135340|NCT02688387|11266579|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135341|NCT02688387|11266580|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135342|NCT02688387|11266581|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135343|NCT02688387|11266582|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135344|NCT02688387|11266583|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135345|NCT02688387|11266584|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135346|NCT02688387|11266585|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135347|NCT02688387|11266586|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135348|NCT02688387|11266587|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135349|NCT02688387|11266588|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135350|NCT02688387|11266589|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10135351|NCT02688387|11266590|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10135352|NCT02688387|11266591|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10135353|NCT02688387|11266592|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10135354|NCT02688387|11266593|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135355|NCT02688387|11266594|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135356|NCT02688387|11266595|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135357|NCT02688387|11266596|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135358|NCT02688387|11266597|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135359|NCT02688387|11266598|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135360|NCT02688387|11266599|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135361|NCT02688387|11266600|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135362|NCT02688387|11266579|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135363|NCT02688387|11266580|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135364|NCT02688387|11266581|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135365|NCT02688387|11266582|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135366|NCT02688387|11266583|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135367|NCT02688387|11266584|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135368|NCT02688387|11266585|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135369|NCT02688387|11266586|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135370|NCT02688387|11266587|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135371|NCT02688387|11266588|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135372|NCT02688387|11266589|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135373|NCT02688387|11266590|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135374|NCT02688387|11266591|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135375|NCT02688387|11266592|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135376|NCT02688387|11266593|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135377|NCT02688387|11266594|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135378|NCT02688387|11266595|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135379|NCT02688387|11266596|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135380|NCT02688387|11266597|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135381|NCT02688387|11266598|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135382|NCT02688387|11266599|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135383|NCT02688387|11266600|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10135384|NCT02688387|11266579|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135385|NCT02688387|11266580|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135386|NCT02688387|11266581|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135387|NCT02688387|11266582|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135388|NCT02688387|11266583|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135389|NCT02688387|11266584|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135390|NCT02688387|11266585|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135391|NCT02688387|11266586|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135392|NCT02688387|11266587|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135393|NCT02688387|11266588|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135394|NCT02688387|11266589|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5
10135395|NCT02688387|11266590|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5
10135396|NCT02688387|11266591|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5
10135397|NCT02688387|11266592|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5
10135398|NCT02688387|11266593|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135399|NCT02688387|11266594|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135400|NCT02688387|11266595|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135401|NCT02688387|11266596|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135402|NCT02688387|11266597|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135403|NCT02688387|11266598|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135404|NCT02688387|11266599|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135405|NCT02688387|11266600|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0
10135406|NCT02688387|11266579|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135407|NCT02688387|11266580|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135408|NCT02688387|11266581|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135409|NCT02688387|11266582|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135410|NCT02688387|11266583|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135411|NCT02688387|11266584|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135412|NCT02688387|11266585|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135413|NCT02688387|11266586|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135414|NCT02688387|11266587|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135415|NCT02688387|11266588|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135416|NCT02688387|11266589|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10135417|NCT02688387|11266590|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10135418|NCT02688387|11266591|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10135419|NCT02688387|11266592|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10135420|NCT02688387|11266593|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135421|NCT02688387|11266594|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135422|NCT02688387|11266595|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135423|NCT02688387|11266596|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135424|NCT02688387|11266597|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135425|NCT02688387|11266598|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135426|NCT02688387|11266599|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135427|NCT02688387|11266600|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135428|NCT02688387|11266579|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135429|NCT02688387|11266580|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135430|NCT02688387|11266581|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135431|NCT02688387|11266582|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135432|NCT02688387|11266583|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135433|NCT02688387|11266584|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135434|NCT02688387|11266585|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135435|NCT02688387|11266586|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135436|NCT02688387|11266587|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135437|NCT02688387|11266588|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135438|NCT02688387|11266589|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135439|NCT02688387|11266590|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135440|NCT02688387|11266591|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135441|NCT02688387|11266592|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135442|NCT02688387|11266593|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135443|NCT02688387|11266594|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135444|NCT02688387|11266595|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135445|NCT02688387|11266596|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135446|NCT02688387|11266597|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135447|NCT02688387|11266598|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135448|NCT02688387|11266599|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135449|NCT02688387|11266600|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10135450|NCT02688387|11266579|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135451|NCT02688387|11266580|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135452|NCT02688387|11266581|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135453|NCT02688387|11266582|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135454|NCT02688387|11266583|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135455|NCT02688387|11266584|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135456|NCT02688387|11266585|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135457|NCT02688387|11266586|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135458|NCT02688387|11266587|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135459|NCT02688387|11266588|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135460|NCT02688387|11266589|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135461|NCT02688387|11266590|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135462|NCT02688387|11266591|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135463|NCT02688387|11266592|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135464|NCT02688387|11266593|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9
10135465|NCT02688387|11266594|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8
9707017|NCT03712345|10806155|FG000|NOT COMPLETED|Overall Study||0
9707018|NCT03712345|10806156|FG001|NOT COMPLETED|Overall Study||0
9707019|NCT03712345|10806157|FG002|NOT COMPLETED|Overall Study||1
9707020|NCT03694275|10806167|FG000|STARTED|Overall Study||8
9707021|NCT03694275|10806168|FG001|STARTED|Overall Study||12
9707022|NCT03694275|10806167|FG000|COMPLETED|Overall Study||8
9707023|NCT03694275|10806168|FG001|COMPLETED|Overall Study||10
9707024|NCT03694275|10806167|FG000|NOT COMPLETED|Overall Study||0
9707025|NCT03694275|10806168|FG001|NOT COMPLETED|Overall Study||2
10135466|NCT02688387|11266595|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8
10135467|NCT02688387|11266596|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8
10135468|NCT02688387|11266597|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135469|NCT02688387|11266598|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135470|NCT02688387|11266599|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135471|NCT02688387|11266600|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10135472|NCT02688387|11266579|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135473|NCT02688387|11266580|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135474|NCT02688387|11266581|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135475|NCT02688387|11266582|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135476|NCT02688387|11266583|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135477|NCT02688387|11266584|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135478|NCT02688387|11266585|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135479|NCT02688387|11266586|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135480|NCT02688387|11266587|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135481|NCT02688387|11266588|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135482|NCT02688387|11266589|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135483|NCT02688387|11266590|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135484|NCT02688387|11266591|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135485|NCT02688387|11266592|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135486|NCT02688387|11266593|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10135487|NCT02688387|11266594|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10135488|NCT02688387|11266595|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10135489|NCT02688387|11266596|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10135490|NCT02688387|11266597|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135491|NCT02688387|11266598|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135492|NCT02688387|11266599|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135493|NCT02688387|11266600|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135494|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135495|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135496|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135497|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135498|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135499|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135500|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135501|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135502|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135503|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135504|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135505|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135506|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135507|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135508|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
10135509|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135510|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135511|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135512|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135513|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135514|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
9729206|NCT00117143|10828772|FG000|Received Second Dose|Overall Study||4
9729207|NCT00117143|10828773|FG001|Received Second Dose|Overall Study||4
10135515|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10135516|NCT02688387|11266579|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135517|NCT02688387|11266580|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135518|NCT02688387|11266581|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135519|NCT02688387|11266582|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135520|NCT02688387|11266583|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135521|NCT02688387|11266584|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135522|NCT02688387|11266585|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135523|NCT02688387|11266586|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135524|NCT02688387|11266587|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135525|NCT02688387|11266588|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135526|NCT02688387|11266589|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135527|NCT02688387|11266590|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135528|NCT02688387|11266591|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135529|NCT02688387|11266592|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135530|NCT02688387|11266593|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10135531|NCT02688387|11266594|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10135532|NCT02688387|11266595|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10135533|NCT02688387|11266596|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10135534|NCT02688387|11266597|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135535|NCT02688387|11266598|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135536|NCT02688387|11266599|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135537|NCT02688387|11266600|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10135538|NCT02688387|11266579|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135539|NCT02688387|11266580|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135540|NCT02688387|11266581|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135541|NCT02688387|11266582|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135542|NCT02688387|11266583|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135543|NCT02688387|11266584|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135544|NCT02688387|11266585|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135545|NCT02688387|11266586|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135546|NCT02688387|11266587|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135547|NCT02688387|11266588|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135548|NCT02688387|11266589|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135549|NCT02688387|11266590|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135550|NCT02688387|11266591|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135551|NCT02688387|11266592|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135552|NCT02688387|11266593|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10135553|NCT02688387|11266594|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10135554|NCT02688387|11266595|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10135555|NCT02688387|11266596|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10135556|NCT02688387|11266597|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135557|NCT02688387|11266598|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135558|NCT02688387|11266599|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135559|NCT02688387|11266600|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135560|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135561|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135562|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135563|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135564|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135565|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135566|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135567|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135568|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135569|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135570|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135571|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135572|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135573|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135574|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135575|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135576|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135577|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135578|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135579|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135580|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135581|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10135582|NCT02688387|11266579|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135583|NCT02688387|11266580|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135584|NCT02688387|11266581|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135585|NCT02688387|11266582|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135586|NCT02688387|11266583|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135587|NCT02688387|11266584|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135588|NCT02688387|11266585|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135589|NCT02688387|11266586|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135590|NCT02688387|11266587|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135591|NCT02688387|11266588|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135592|NCT02688387|11266589|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135593|NCT02688387|11266590|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135594|NCT02688387|11266591|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135595|NCT02688387|11266592|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135596|NCT02688387|11266593|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10135597|NCT02688387|11266594|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10135598|NCT02688387|11266595|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10135599|NCT02688387|11266596|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10135600|NCT02688387|11266597|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135601|NCT02688387|11266598|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135602|NCT02688387|11266599|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135603|NCT02688387|11266600|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10135604|NCT02688387|11266579|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135605|NCT02688387|11266580|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135606|NCT02688387|11266581|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135607|NCT02688387|11266582|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135608|NCT02688387|11266583|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135609|NCT02688387|11266584|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135610|NCT02688387|11266585|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135611|NCT02688387|11266586|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135612|NCT02688387|11266587|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135613|NCT02688387|11266588|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135614|NCT02688387|11266589|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135615|NCT02688387|11266590|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135616|NCT02688387|11266591|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135617|NCT02688387|11266592|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135618|NCT02688387|11266593|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10135619|NCT02688387|11266594|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10135620|NCT02688387|11266595|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10135621|NCT02688387|11266596|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10135622|NCT02688387|11266597|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135623|NCT02688387|11266598|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135624|NCT02688387|11266599|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135625|NCT02688387|11266600|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135626|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135627|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135628|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135629|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135630|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135631|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135632|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135633|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135634|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135635|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135636|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135637|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135638|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135639|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135640|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135641|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135642|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135643|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135644|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135645|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135646|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135647|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10135648|NCT02688387|11266579|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135649|NCT02688387|11266580|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135650|NCT02688387|11266581|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135651|NCT02688387|11266582|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135652|NCT02688387|11266583|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135653|NCT02688387|11266584|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135654|NCT02688387|11266585|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135655|NCT02688387|11266586|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135656|NCT02688387|11266587|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135657|NCT02688387|11266588|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135658|NCT02688387|11266589|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135659|NCT02688387|11266590|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135660|NCT02688387|11266591|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135661|NCT02688387|11266592|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135662|NCT02688387|11266593|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10135663|NCT02688387|11266594|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10135664|NCT02688387|11266595|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10135665|NCT02688387|11266596|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10135666|NCT02688387|11266597|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135667|NCT02688387|11266598|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135668|NCT02688387|11266599|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135669|NCT02688387|11266600|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10135670|NCT02688387|11266579|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135671|NCT02688387|11266580|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135672|NCT02688387|11266581|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135673|NCT02688387|11266582|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135674|NCT02688387|11266583|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135675|NCT02688387|11266584|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135676|NCT02688387|11266585|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135677|NCT02688387|11266586|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135678|NCT02688387|11266587|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135679|NCT02688387|11266588|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135680|NCT02688387|11266589|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135681|NCT02688387|11266590|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135682|NCT02688387|11266591|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135683|NCT02688387|11266592|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135684|NCT02688387|11266593|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10135685|NCT02688387|11266594|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10135686|NCT02688387|11266595|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10135687|NCT02688387|11266596|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10135688|NCT02688387|11266597|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135689|NCT02688387|11266598|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135690|NCT02688387|11266599|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135691|NCT02688387|11266600|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135692|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135693|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135694|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135695|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135696|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135697|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135698|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135699|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135700|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135701|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135702|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135703|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135704|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135705|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135706|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135707|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135708|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135709|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135710|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135711|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135712|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135713|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10135714|NCT02688387|11266579|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135715|NCT02688387|11266580|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135716|NCT02688387|11266581|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135717|NCT02688387|11266582|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135718|NCT02688387|11266583|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135719|NCT02688387|11266584|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135720|NCT02688387|11266585|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135721|NCT02688387|11266586|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135722|NCT02688387|11266587|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135723|NCT02688387|11266588|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135724|NCT02688387|11266589|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135725|NCT02688387|11266590|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135726|NCT02688387|11266591|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135727|NCT02688387|11266592|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135728|NCT02688387|11266593|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10135729|NCT02688387|11266594|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10135730|NCT02688387|11266595|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10135731|NCT02688387|11266596|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10135732|NCT02688387|11266597|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135733|NCT02688387|11266598|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135734|NCT02688387|11266599|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135735|NCT02688387|11266600|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10135736|NCT02688387|11266579|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135737|NCT02688387|11266580|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135738|NCT02688387|11266581|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135739|NCT02688387|11266582|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135740|NCT02688387|11266583|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135741|NCT02688387|11266584|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135742|NCT02688387|11266585|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135743|NCT02688387|11266586|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135744|NCT02688387|11266587|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135745|NCT02688387|11266588|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135746|NCT02688387|11266589|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135747|NCT02688387|11266590|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135748|NCT02688387|11266591|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135749|NCT02688387|11266592|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135750|NCT02688387|11266593|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10135751|NCT02688387|11266594|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10135752|NCT02688387|11266595|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10135753|NCT02688387|11266596|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10135754|NCT02688387|11266597|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135755|NCT02688387|11266598|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135756|NCT02688387|11266599|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135757|NCT02688387|11266600|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135758|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135759|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135760|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135761|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135762|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135763|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135764|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135765|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135766|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135767|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135768|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135769|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135770|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135771|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135772|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135773|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135774|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135775|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135776|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135777|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135778|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135779|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10135780|NCT02688387|11266579|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135781|NCT02688387|11266580|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135782|NCT02688387|11266581|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135783|NCT02688387|11266582|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135784|NCT02688387|11266583|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135785|NCT02688387|11266584|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135786|NCT02688387|11266585|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135787|NCT02688387|11266586|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135788|NCT02688387|11266587|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135789|NCT02688387|11266588|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135790|NCT02688387|11266589|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135791|NCT02688387|11266590|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135792|NCT02688387|11266591|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135793|NCT02688387|11266592|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135794|NCT02688387|11266593|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10135795|NCT02688387|11266594|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10135796|NCT02688387|11266595|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10135797|NCT02688387|11266596|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10135798|NCT02688387|11266597|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135799|NCT02688387|11266598|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135800|NCT02688387|11266599|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135801|NCT02688387|11266600|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10135802|NCT02688387|11266579|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135803|NCT02688387|11266580|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135804|NCT02688387|11266581|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135805|NCT02688387|11266582|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135806|NCT02688387|11266583|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135807|NCT02688387|11266584|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135808|NCT02688387|11266585|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135809|NCT02688387|11266586|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135810|NCT02688387|11266587|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135811|NCT02688387|11266588|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135812|NCT02688387|11266589|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135813|NCT02688387|11266590|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135814|NCT02688387|11266591|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135815|NCT02688387|11266592|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135816|NCT02688387|11266593|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10135817|NCT02688387|11266594|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10135818|NCT02688387|11266595|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10135819|NCT02688387|11266596|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10135820|NCT02688387|11266597|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135821|NCT02688387|11266598|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135822|NCT02688387|11266599|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135823|NCT02688387|11266600|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135824|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135825|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135826|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135827|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135828|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135829|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135830|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135831|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135832|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135833|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135834|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135835|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135836|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135837|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135838|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135839|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135840|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135841|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135842|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135843|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135844|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135845|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10135846|NCT02688387|11266579|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135847|NCT02688387|11266580|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135848|NCT02688387|11266581|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135849|NCT02688387|11266582|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135850|NCT02688387|11266583|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135851|NCT02688387|11266584|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135852|NCT02688387|11266585|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135853|NCT02688387|11266586|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135854|NCT02688387|11266587|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135855|NCT02688387|11266588|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135856|NCT02688387|11266589|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135857|NCT02688387|11266590|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135858|NCT02688387|11266591|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135859|NCT02688387|11266592|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135860|NCT02688387|11266593|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10135861|NCT02688387|11266594|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10135862|NCT02688387|11266595|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10135863|NCT02688387|11266596|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10135864|NCT02688387|11266597|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135865|NCT02688387|11266598|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135866|NCT02688387|11266599|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135867|NCT02688387|11266600|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10135868|NCT02688387|11266579|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135869|NCT02688387|11266580|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135870|NCT02688387|11266581|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135871|NCT02688387|11266582|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135872|NCT02688387|11266583|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135873|NCT02688387|11266584|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135874|NCT02688387|11266585|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
9963850|NCT01488877|11083635|FG002|COMPLETED|Re-randomization||3
10135875|NCT02688387|11266586|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135876|NCT02688387|11266587|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135877|NCT02688387|11266588|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135878|NCT02688387|11266589|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135879|NCT02688387|11266590|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135880|NCT02688387|11266591|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135881|NCT02688387|11266592|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135882|NCT02688387|11266593|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10135883|NCT02688387|11266594|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10135884|NCT02688387|11266595|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10135885|NCT02688387|11266596|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10135886|NCT02688387|11266597|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135887|NCT02688387|11266598|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135888|NCT02688387|11266599|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135889|NCT02688387|11266600|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135890|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135891|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135892|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135893|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135894|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135895|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135896|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135897|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
9707026|NCT03391232|10806177|FG000|STARTED|Part A - First Dose (1-12weeks)||5
10135898|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135899|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135900|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135901|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135902|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135903|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135904|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
9707027|NCT03391232|10806178|FG001|STARTED|Part A - First Dose (1-12weeks)||6
10135905|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135906|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135907|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135908|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135909|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135910|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135911|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10135912|NCT02688387|11266579|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135913|NCT02688387|11266580|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135914|NCT02688387|11266581|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135915|NCT02688387|11266582|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135916|NCT02688387|11266583|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135917|NCT02688387|11266584|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135918|NCT02688387|11266585|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135919|NCT02688387|11266586|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135920|NCT02688387|11266587|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135921|NCT02688387|11266588|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135922|NCT02688387|11266589|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135923|NCT02688387|11266590|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135924|NCT02688387|11266591|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135925|NCT02688387|11266592|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135926|NCT02688387|11266593|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135927|NCT02688387|11266594|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135928|NCT02688387|11266595|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135929|NCT02688387|11266596|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10135930|NCT02688387|11266597|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10135931|NCT02688387|11266598|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10135932|NCT02688387|11266599|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10135933|NCT02688387|11266600|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10135934|NCT02688387|11266579|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135935|NCT02688387|11266580|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135936|NCT02688387|11266581|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135937|NCT02688387|11266582|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135938|NCT02688387|11266583|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135939|NCT02688387|11266584|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135940|NCT02688387|11266585|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135941|NCT02688387|11266586|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135942|NCT02688387|11266587|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135943|NCT02688387|11266588|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135944|NCT02688387|11266589|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135945|NCT02688387|11266590|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135946|NCT02688387|11266591|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135947|NCT02688387|11266592|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135948|NCT02688387|11266593|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135949|NCT02688387|11266594|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135950|NCT02688387|11266595|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135951|NCT02688387|11266596|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135952|NCT02688387|11266597|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10135953|NCT02688387|11266598|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10135954|NCT02688387|11266599|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10135955|NCT02688387|11266600|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10135956|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135957|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135958|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135959|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135960|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135961|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135962|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135963|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135964|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135965|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135966|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135967|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135968|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135969|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135970|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135971|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135972|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135973|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135974|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135975|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135976|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135977|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10135978|NCT02688387|11266579|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135979|NCT02688387|11266580|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0
9729208|NCT00117143|10828774|FG002|Received Second Dose|Overall Study||6
10135980|NCT02688387|11266581|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135981|NCT02688387|11266582|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135982|NCT02688387|11266583|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135983|NCT02688387|11266584|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135984|NCT02688387|11266585|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135985|NCT02688387|11266586|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135986|NCT02688387|11266587|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135987|NCT02688387|11266588|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135988|NCT02688387|11266589|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135989|NCT02688387|11266590|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135990|NCT02688387|11266591|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135991|NCT02688387|11266592|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135992|NCT02688387|11266593|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135993|NCT02688387|11266594|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135994|NCT02688387|11266595|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135995|NCT02688387|11266596|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10135996|NCT02688387|11266597|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10135997|NCT02688387|11266598|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10135998|NCT02688387|11266599|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10135999|NCT02688387|11266600|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10136000|NCT02688387|11266579|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136001|NCT02688387|11266580|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136002|NCT02688387|11266581|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136003|NCT02688387|11266582|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136004|NCT02688387|11266583|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136005|NCT02688387|11266584|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136006|NCT02688387|11266585|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136007|NCT02688387|11266586|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136008|NCT02688387|11266587|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136009|NCT02688387|11266588|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136010|NCT02688387|11266589|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136011|NCT02688387|11266590|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136012|NCT02688387|11266591|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136013|NCT02688387|11266592|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136014|NCT02688387|11266593|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136015|NCT02688387|11266594|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136016|NCT02688387|11266595|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136017|NCT02688387|11266596|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136018|NCT02688387|11266597|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10136019|NCT02688387|11266598|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10136020|NCT02688387|11266599|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10136021|NCT02688387|11266600|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10136022|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136023|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136024|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136025|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136026|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136027|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136028|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136029|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136030|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136031|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136032|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136033|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136034|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136035|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136036|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136037|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136038|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136039|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136040|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136041|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136042|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136043|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10136044|NCT02688387|11266579|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136045|NCT02688387|11266580|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136046|NCT02688387|11266581|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136047|NCT02688387|11266582|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136048|NCT02688387|11266583|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136049|NCT02688387|11266584|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136050|NCT02688387|11266585|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136051|NCT02688387|11266586|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136052|NCT02688387|11266587|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136053|NCT02688387|11266588|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136054|NCT02688387|11266589|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136055|NCT02688387|11266590|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136056|NCT02688387|11266591|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136057|NCT02688387|11266592|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136058|NCT02688387|11266593|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136059|NCT02688387|11266594|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136060|NCT02688387|11266595|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136061|NCT02688387|11266596|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10136062|NCT02688387|11266597|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10136063|NCT02688387|11266598|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10136064|NCT02688387|11266599|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10136065|NCT02688387|11266600|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10136066|NCT02688387|11266579|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136067|NCT02688387|11266580|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136068|NCT02688387|11266581|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136069|NCT02688387|11266582|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136070|NCT02688387|11266583|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136071|NCT02688387|11266584|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136072|NCT02688387|11266585|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136073|NCT02688387|11266586|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136074|NCT02688387|11266587|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136075|NCT02688387|11266588|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136076|NCT02688387|11266589|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136077|NCT02688387|11266590|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136078|NCT02688387|11266591|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136079|NCT02688387|11266592|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136080|NCT02688387|11266593|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136081|NCT02688387|11266594|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136082|NCT02688387|11266595|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136083|NCT02688387|11266596|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136084|NCT02688387|11266597|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10136085|NCT02688387|11266598|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10136086|NCT02688387|11266599|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10136087|NCT02688387|11266600|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10136088|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136089|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136090|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136091|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136092|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136093|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136094|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136095|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136096|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136097|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136098|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136099|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136100|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136101|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136102|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136103|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136104|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136105|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136106|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136107|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136108|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136109|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10136110|NCT02688387|11266579|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136111|NCT02688387|11266580|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136112|NCT02688387|11266581|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136113|NCT02688387|11266582|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136114|NCT02688387|11266583|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136115|NCT02688387|11266584|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136116|NCT02688387|11266585|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136117|NCT02688387|11266586|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136118|NCT02688387|11266587|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136119|NCT02688387|11266588|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136120|NCT02688387|11266589|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136121|NCT02688387|11266590|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136122|NCT02688387|11266591|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136123|NCT02688387|11266592|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136124|NCT02688387|11266593|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136125|NCT02688387|11266594|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136126|NCT02688387|11266595|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136127|NCT02688387|11266596|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10136128|NCT02688387|11266597|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10136129|NCT02688387|11266598|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10136130|NCT02688387|11266599|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10136131|NCT02688387|11266600|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10136132|NCT02688387|11266579|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136133|NCT02688387|11266580|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136134|NCT02688387|11266581|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136135|NCT02688387|11266582|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
9729209|NCT00117143|10828775|FG003|Received Second Dose|Overall Study||0
10136136|NCT02688387|11266583|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136137|NCT02688387|11266584|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136138|NCT02688387|11266585|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136139|NCT02688387|11266586|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136140|NCT02688387|11266587|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136141|NCT02688387|11266588|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136142|NCT02688387|11266589|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136143|NCT02688387|11266590|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136144|NCT02688387|11266591|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136145|NCT02688387|11266592|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136146|NCT02688387|11266593|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136147|NCT02688387|11266594|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136148|NCT02688387|11266595|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136149|NCT02688387|11266596|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136150|NCT02688387|11266597|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10136151|NCT02688387|11266598|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10136152|NCT02688387|11266599|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10136153|NCT02688387|11266600|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10136154|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136155|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136156|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136157|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136158|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136159|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136160|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136161|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136162|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136163|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136164|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136165|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136166|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136167|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136168|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136169|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136170|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136171|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136172|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136173|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136174|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136175|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10136176|NCT02688387|11266579|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136177|NCT02688387|11266580|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136178|NCT02688387|11266581|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136179|NCT02688387|11266582|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136180|NCT02688387|11266583|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136181|NCT02688387|11266584|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136182|NCT02688387|11266585|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136183|NCT02688387|11266586|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136184|NCT02688387|11266587|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136185|NCT02688387|11266588|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136186|NCT02688387|11266589|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136187|NCT02688387|11266590|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136188|NCT02688387|11266591|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136189|NCT02688387|11266592|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136190|NCT02688387|11266593|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136191|NCT02688387|11266594|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136192|NCT02688387|11266595|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136193|NCT02688387|11266596|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10136194|NCT02688387|11266597|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10136195|NCT02688387|11266598|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10136196|NCT02688387|11266599|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10136197|NCT02688387|11266600|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10136198|NCT02688387|11266579|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136199|NCT02688387|11266580|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136200|NCT02688387|11266581|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136201|NCT02688387|11266582|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136202|NCT02688387|11266583|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136203|NCT02688387|11266584|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136204|NCT02688387|11266585|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136205|NCT02688387|11266586|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136206|NCT02688387|11266587|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136207|NCT02688387|11266588|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136208|NCT02688387|11266589|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136209|NCT02688387|11266590|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136210|NCT02688387|11266591|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136211|NCT02688387|11266592|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136212|NCT02688387|11266593|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136213|NCT02688387|11266594|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136214|NCT02688387|11266595|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136215|NCT02688387|11266596|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136216|NCT02688387|11266597|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
10136217|NCT02688387|11266598|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
10136218|NCT02688387|11266599|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
10136219|NCT02688387|11266600|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
10136220|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136221|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136222|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136223|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136224|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136225|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136226|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136227|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136228|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136229|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136230|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136231|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136232|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136233|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136234|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136235|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136236|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136237|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136238|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136239|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10136240|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
10136241|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
9707028|NCT03391232|10806177|FG000|COMPLETED|Part A - First Dose (1-12weeks)|This cohort finished the trial here after 12 weeks.|5
9707029|NCT03391232|10806178|FG001|COMPLETED|Part A - First Dose (1-12weeks)|After interim analysis this cohort continued the trial.|6
9707030|NCT03391232|10806177|FG000|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
9707031|NCT03391232|10806178|FG001|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
9707032|NCT03391232|10806177|FG000|STARTED|Part B - Additional 2 Doses (13-38weeks)||0
9707033|NCT03391232|10806178|FG001|STARTED|Part B - Additional 2 Doses (13-38weeks)||6
9707034|NCT03391232|10806177|FG000|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
9707035|NCT03391232|10806178|FG001|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
9707036|NCT03391232|10806177|FG000|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
9707037|NCT03391232|10806178|FG001|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
9707038|NCT03323736|10806189|FG000|STARTED|Overall Study||241
9707039|NCT03323736|10806190|FG001|STARTED|Overall Study||59
9707040|NCT03323736|10806191|FG002|STARTED|Overall Study||70
9707041|NCT03323736|10806189|FG000|Treated|Overall Study||222
9707042|NCT03323736|10806190|FG001|Treated|Overall Study||47
9848776|NCT00862134|10961597|FG001|NOT COMPLETED|Overall Study||12
9848777|NCT00862186|10961603|FG000|STARTED|Overall Study||15
9848778|NCT00862186|10961603|FG000|COMPLETED|Overall Study||15
9848779|NCT00862186|10961603|FG000|NOT COMPLETED|Overall Study||0
9848780|NCT00862277|10961611|FG000|STARTED|Overall Study||561
9848781|NCT00862277|10961612|FG001|STARTED|Overall Study||96
9848782|NCT00862277|10961613|FG002|STARTED|Overall Study||105
9848783|NCT00862277|10961611|FG000|COMPLETED|Overall Study||560
9848784|NCT00862277|10961612|FG001|COMPLETED|Overall Study||94
9848785|NCT00862277|10961613|FG002|COMPLETED|Overall Study||100
9848786|NCT00862277|10961611|FG000|NOT COMPLETED|Overall Study||1
9848787|NCT00862277|10961612|FG001|NOT COMPLETED|Overall Study||2
9848788|NCT00862277|10961613|FG002|NOT COMPLETED|Overall Study||5
9848789|NCT00862446|10961621|FG000|STARTED|Overall Study||48
9848790|NCT00862446|10961621|FG000|COMPLETED|Overall Study||48
9848791|NCT00862446|10961621|FG000|NOT COMPLETED|Overall Study||0
9848792|NCT00862459|10961628|FG000|STARTED|Overall Study||72
9848793|NCT00862459|10961629|FG001|STARTED|Overall Study||93
9848794|NCT00862459|10961630|FG002|STARTED|Overall Study||72
9848795|NCT00862459|10961628|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
9848796|NCT00862459|10961629|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
9848797|NCT00862459|10961630|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
9848798|NCT00862459|10961628|FG000|COMPLETED|Overall Study||66
9848799|NCT00862459|10961629|FG001|COMPLETED|Overall Study||85
9848800|NCT00862459|10961630|FG002|COMPLETED|Overall Study||66
9848801|NCT00862459|10961628|FG000|NOT COMPLETED|Overall Study||6
9848802|NCT00862459|10961629|FG001|NOT COMPLETED|Overall Study||8
9848803|NCT00862459|10961630|FG002|NOT COMPLETED|Overall Study||6
9848804|NCT00862537|10961639|FG000|STARTED|Overall Study||18
9848805|NCT00862537|10961639|FG000|COMPLETED|Overall Study||11
9848806|NCT00862537|10961639|FG000|NOT COMPLETED|Overall Study||7
9848807|NCT00862563|10961647|FG000|STARTED|Overall Study||19
9848808|NCT00862563|10961648|FG001|STARTED|Overall Study||21
9848809|NCT00862563|10961649|FG002|STARTED|Overall Study||21
9848810|NCT00862563|10961650|FG003|STARTED|Overall Study||24
9848811|NCT00862563|10961647|FG000|COMPLETED|Overall Study||15
9848812|NCT00862563|10961648|FG001|COMPLETED|Overall Study||17
9848813|NCT00862563|10961649|FG002|COMPLETED|Overall Study||15
9848814|NCT00862563|10961650|FG003|COMPLETED|Overall Study||19
9848815|NCT00862563|10961647|FG000|NOT COMPLETED|Overall Study||4
9848816|NCT00862563|10961648|FG001|NOT COMPLETED|Overall Study||4
9848817|NCT00862563|10961649|FG002|NOT COMPLETED|Overall Study||6
9848818|NCT00862563|10961650|FG003|NOT COMPLETED|Overall Study||5
9848819|NCT00862641|10961673|FG000|STARTED|Overall Study||177
9848820|NCT00862641|10961674|FG001|STARTED|Overall Study||360
9848821|NCT00862641|10961675|FG002|STARTED|Overall Study||152
9848822|NCT00862641|10961676|FG003|STARTED|Overall Study||320
9848823|NCT00862641|10961673|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
9848824|NCT00862641|10961674|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
9848825|NCT00862641|10961675|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
9848826|NCT00862641|10961676|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
9848827|NCT00862641|10961673|FG000|NOT COMPLETED|Overall Study||1
9848828|NCT00862641|10961674|FG001|NOT COMPLETED|Overall Study||4
9848829|NCT00862641|10961675|FG002|NOT COMPLETED|Overall Study||1
9848830|NCT00862641|10961676|FG003|NOT COMPLETED|Overall Study||4
9848831|NCT00862654|10961690|FG000|STARTED|Overall Study||82
9848832|NCT00862654|10961691|FG001|STARTED|Overall Study||82
9848833|NCT00862654|10961692|FG002|STARTED|Overall Study||82
9848834|NCT00862654|10961693|FG003|STARTED|Overall Study||80
9848835|NCT00862654|10961690|FG000|COMPLETED|Overall Study||76
9848836|NCT00862654|10961691|FG001|COMPLETED|Overall Study||74
9848837|NCT00862654|10961692|FG002|COMPLETED|Overall Study||76
9848838|NCT00862654|10961693|FG003|COMPLETED|Overall Study||74
9848839|NCT00862654|10961690|FG000|NOT COMPLETED|Overall Study||6
9848840|NCT00862654|10961691|FG001|NOT COMPLETED|Overall Study||8
9848841|NCT00862654|10961692|FG002|NOT COMPLETED|Overall Study||6
9848842|NCT00862654|10961693|FG003|NOT COMPLETED|Overall Study||6
9848843|NCT00862719|10961707|FG000|STARTED|Overall Study||17
9848844|NCT00862719|10961708|FG001|STARTED|Overall Study||7
9848845|NCT00862719|10961709|FG002|STARTED|Overall Study||4
9848846|NCT00862719|10961710|FG003|STARTED|Overall Study||1
9848847|NCT00862719|10961707|FG000|COMPLETED|Overall Study||7
9848848|NCT00862719|10961708|FG001|COMPLETED|Overall Study||1
9848849|NCT00862719|10961709|FG002|COMPLETED|Overall Study||0
9848850|NCT00862719|10961710|FG003|COMPLETED|Overall Study||0
9848851|NCT00862719|10961707|FG000|NOT COMPLETED|Overall Study||10
9707043|NCT03323736|10806191|FG002|Treated|Overall Study||68
9707044|NCT03323736|10806189|FG000|COMPLETED|Overall Study||222
9707045|NCT03323736|10806190|FG001|COMPLETED|Overall Study||47
9707046|NCT03323736|10806191|FG002|COMPLETED|Overall Study||68
9707047|NCT03323736|10806189|FG000|NOT COMPLETED|Overall Study||19
9707048|NCT03323736|10806190|FG001|NOT COMPLETED|Overall Study||12
9707049|NCT03323736|10806191|FG002|NOT COMPLETED|Overall Study||2
9707050|NCT03179995|10806203|FG000|STARTED|Overall Study||20
9707051|NCT03179995|10806204|FG001|STARTED|Overall Study||4
9707052|NCT03179995|10806203|FG000|COMPLETED|Overall Study||4
9707053|NCT03179995|10806204|FG001|COMPLETED|Overall Study||1
9707054|NCT03179995|10806203|FG000|NOT COMPLETED|Overall Study||16
9707055|NCT03179995|10806204|FG001|NOT COMPLETED|Overall Study||3
9707056|NCT03073980|10806213|FG000|STARTED|Overall Study||53
9707057|NCT03073980|10806214|FG001|STARTED|Overall Study||54
9707058|NCT03073980|10806215|FG002|STARTED|Overall Study||54
9707059|NCT03073980|10806213|FG000|COMPLETED|Overall Study||43
9707060|NCT03073980|10806214|FG001|COMPLETED|Overall Study||52
9707061|NCT03073980|10806215|FG002|COMPLETED|Overall Study||43
9707062|NCT03073980|10806213|FG000|NOT COMPLETED|Overall Study||10
9707063|NCT03073980|10806214|FG001|NOT COMPLETED|Overall Study||2
9707064|NCT03073980|10806215|FG002|NOT COMPLETED|Overall Study||11
9707065|NCT02879318|10806229|FG000|STARTED|Overall Study||61
9707066|NCT02879318|10806230|FG001|STARTED|Overall Study||119
9707067|NCT02879318|10806229|FG000|COMPLETED|Overall Study||61
9707068|NCT02879318|10806230|FG001|COMPLETED|Overall Study||119
9707069|NCT02879318|10806229|FG000|NOT COMPLETED|Overall Study||0
9707070|NCT02879318|10806230|FG001|NOT COMPLETED|Overall Study||0
9707071|NCT02544074|10806257|FG000|STARTED|Overall Study||1
9707072|NCT02544074|10806258|FG001|STARTED|Overall Study||1
9707073|NCT02544074|10806259|FG002|STARTED|Overall Study||1
10136242|NCT02688387|11266579|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136243|NCT02688387|11266580|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136244|NCT02688387|11266581|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136245|NCT02688387|11266582|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136246|NCT02688387|11266583|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136247|NCT02688387|11266584|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136248|NCT02688387|11266585|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136249|NCT02688387|11266586|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136250|NCT02688387|11266587|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136251|NCT02688387|11266588|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136252|NCT02688387|11266589|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136253|NCT02688387|11266590|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136254|NCT02688387|11266591|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136255|NCT02688387|11266592|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136256|NCT02688387|11266593|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136257|NCT02688387|11266594|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0
9707074|NCT02544074|10806260|FG003|STARTED|Overall Study||1
9707075|NCT02544074|10806261|FG004|STARTED|Overall Study||4
9707076|NCT02544074|10806262|FG005|STARTED|Overall Study||1
9707077|NCT02544074|10806263|FG006|STARTED|Overall Study||2
9707078|NCT02544074|10806264|FG007|STARTED|Overall Study||4
9707079|NCT02544074|10806265|FG008|STARTED|Overall Study||6
9707080|NCT02544074|10806266|FG009|STARTED|Overall Study||2
10136258|NCT02688387|11266595|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136259|NCT02688387|11266596|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10136260|NCT02688387|11266597|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8
10136261|NCT02688387|11266598|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8
10136262|NCT02688387|11266599|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7
10136263|NCT02688387|11266600|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8
10136264|NCT02688387|11266579|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136265|NCT02688387|11266580|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136266|NCT02688387|11266581|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136267|NCT02688387|11266582|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136268|NCT02688387|11266583|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136269|NCT02688387|11266584|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136270|NCT02688387|11266585|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136271|NCT02688387|11266586|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136272|NCT02688387|11266587|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136273|NCT02688387|11266588|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136274|NCT02688387|11266589|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136275|NCT02688387|11266590|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136276|NCT02688387|11266591|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136277|NCT02688387|11266592|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136278|NCT02688387|11266593|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136279|NCT02688387|11266594|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136280|NCT02688387|11266595|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136281|NCT02688387|11266596|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136282|NCT02688387|11266597|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
10136283|NCT02688387|11266598|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
10136284|NCT02688387|11266599|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
10136285|NCT02688387|11266600|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
10136286|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136287|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136288|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136289|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136290|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136291|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136292|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136293|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136294|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136295|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136296|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136297|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136298|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136299|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136300|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136301|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136302|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136303|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136304|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
10136305|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
10136306|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
10136307|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10136308|NCT02688387|11266579|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136309|NCT02688387|11266580|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136310|NCT02688387|11266581|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136311|NCT02688387|11266582|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136312|NCT02688387|11266583|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136313|NCT02688387|11266584|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136314|NCT02688387|11266585|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136315|NCT02688387|11266586|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136316|NCT02688387|11266587|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136317|NCT02688387|11266588|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136318|NCT02688387|11266589|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136319|NCT02688387|11266590|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136320|NCT02688387|11266591|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136321|NCT02688387|11266592|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136322|NCT02688387|11266593|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136323|NCT02688387|11266594|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136324|NCT02688387|11266595|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136325|NCT02688387|11266596|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10136326|NCT02688387|11266597|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7
10136327|NCT02688387|11266598|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7
10136328|NCT02688387|11266599|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6
10136329|NCT02688387|11266600|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8
10136330|NCT02688387|11266579|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136331|NCT02688387|11266580|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136332|NCT02688387|11266581|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136333|NCT02688387|11266582|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136334|NCT02688387|11266583|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136335|NCT02688387|11266584|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136336|NCT02688387|11266585|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136337|NCT02688387|11266586|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136338|NCT02688387|11266587|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136339|NCT02688387|11266588|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136340|NCT02688387|11266589|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136341|NCT02688387|11266590|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136342|NCT02688387|11266591|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136343|NCT02688387|11266592|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
9707081|NCT02544074|10806267|FG010|STARTED|Overall Study||2
9707082|NCT02544074|10806268|FG011|STARTED|Overall Study||3
9707083|NCT02544074|10806269|FG012|STARTED|Overall Study||4
10136344|NCT02688387|11266593|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136345|NCT02688387|11266594|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
9707084|NCT02544074|10806270|FG013|STARTED|Overall Study||5
9707085|NCT02544074|10806271|FG014|STARTED|Overall Study||5
9707086|NCT02544074|10806272|FG015|STARTED|Overall Study||8
9707087|NCT02544074|10806273|FG016|STARTED|Overall Study||6
9707088|NCT02544074|10806274|FG017|STARTED|Overall Study||3
9707089|NCT02544074|10806275|FG018|STARTED|Overall Study||4
9707090|NCT02544074|10806276|FG019|STARTED|Overall Study||3
9707091|NCT02544074|10806277|FG020|STARTED|Overall Study||3
9707092|NCT02544074|10806257|FG000|COMPLETED|Overall Study||1
9707093|NCT02544074|10806258|FG001|COMPLETED|Overall Study||0
9707094|NCT02544074|10806259|FG002|COMPLETED|Overall Study||1
9707095|NCT02544074|10806260|FG003|COMPLETED|Overall Study||1
9707096|NCT02544074|10806261|FG004|COMPLETED|Overall Study||4
9707097|NCT02544074|10806262|FG005|COMPLETED|Overall Study||0
9707098|NCT02544074|10806263|FG006|COMPLETED|Overall Study||2
9707099|NCT02544074|10806264|FG007|COMPLETED|Overall Study||4
9707100|NCT02544074|10806265|FG008|COMPLETED|Overall Study||6
9707101|NCT02544074|10806266|FG009|COMPLETED|Overall Study||1
9707102|NCT02544074|10806267|FG010|COMPLETED|Overall Study||2
9707103|NCT02544074|10806268|FG011|COMPLETED|Overall Study||3
9707104|NCT02544074|10806269|FG012|COMPLETED|Overall Study||4
9707105|NCT02544074|10806270|FG013|COMPLETED|Overall Study||5
9707106|NCT02544074|10806271|FG014|COMPLETED|Overall Study||5
9707107|NCT02544074|10806272|FG015|COMPLETED|Overall Study||8
9707108|NCT02544074|10806273|FG016|COMPLETED|Overall Study||6
9707109|NCT02544074|10806274|FG017|COMPLETED|Overall Study||3
9707110|NCT02544074|10806275|FG018|COMPLETED|Overall Study||4
9707111|NCT02544074|10806276|FG019|COMPLETED|Overall Study||3
9707112|NCT02544074|10806277|FG020|COMPLETED|Overall Study||3
9707113|NCT02544074|10806257|FG000|NOT COMPLETED|Overall Study||0
9707114|NCT02544074|10806258|FG001|NOT COMPLETED|Overall Study||1
9707115|NCT02544074|10806259|FG002|NOT COMPLETED|Overall Study||0
9707116|NCT02544074|10806260|FG003|NOT COMPLETED|Overall Study||0
9707117|NCT02544074|10806261|FG004|NOT COMPLETED|Overall Study||0
9707118|NCT02544074|10806262|FG005|NOT COMPLETED|Overall Study||1
9707119|NCT02544074|10806263|FG006|NOT COMPLETED|Overall Study||0
9707120|NCT02544074|10806264|FG007|NOT COMPLETED|Overall Study||0
9707121|NCT02544074|10806265|FG008|NOT COMPLETED|Overall Study||0
9707122|NCT02544074|10806266|FG009|NOT COMPLETED|Overall Study||1
9707123|NCT02544074|10806267|FG010|NOT COMPLETED|Overall Study||0
9707124|NCT02544074|10806268|FG011|NOT COMPLETED|Overall Study||0
9707125|NCT02544074|10806269|FG012|NOT COMPLETED|Overall Study||0
9707126|NCT02544074|10806270|FG013|NOT COMPLETED|Overall Study||0
9707127|NCT02544074|10806271|FG014|NOT COMPLETED|Overall Study||0
9707128|NCT02544074|10806272|FG015|NOT COMPLETED|Overall Study||0
9707129|NCT02544074|10806273|FG016|NOT COMPLETED|Overall Study||0
9707130|NCT02544074|10806274|FG017|NOT COMPLETED|Overall Study||0
9707131|NCT02544074|10806275|FG018|NOT COMPLETED|Overall Study||0
10136346|NCT02688387|11266595|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136347|NCT02688387|11266596|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136348|NCT02688387|11266597|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
10136349|NCT02688387|11266598|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
10136350|NCT02688387|11266599|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
10136351|NCT02688387|11266600|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
10136352|NCT02688387|11266579|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136353|NCT02688387|11266580|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136354|NCT02688387|11266581|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136355|NCT02688387|11266582|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136356|NCT02688387|11266583|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136357|NCT02688387|11266584|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136358|NCT02688387|11266585|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136359|NCT02688387|11266586|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136360|NCT02688387|11266587|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136361|NCT02688387|11266588|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136362|NCT02688387|11266589|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136363|NCT02688387|11266590|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136364|NCT02688387|11266591|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136365|NCT02688387|11266592|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136366|NCT02688387|11266593|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136367|NCT02688387|11266594|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136368|NCT02688387|11266595|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136369|NCT02688387|11266596|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136370|NCT02688387|11266597|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136371|NCT02688387|11266598|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136372|NCT02688387|11266599|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136373|NCT02688387|11266600|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10136374|NCT02688556|11266648|FG000|STARTED|Overall Study||372
10136375|NCT02688556|11266649|FG001|STARTED|Overall Study||373
10136376|NCT02688556|11266648|FG000|COMPLETED|Overall Study||347
10136377|NCT02688556|11266649|FG001|COMPLETED|Overall Study||361
10136378|NCT02688556|11266648|FG000|NOT COMPLETED|Overall Study||25
10136379|NCT02688556|11266649|FG001|NOT COMPLETED|Overall Study||12
10136380|NCT02688621|11266657|FG000|STARTED|Overall Study||212
10136381|NCT02688621|11266658|FG001|STARTED|Overall Study||206
10136382|NCT02688621|11266657|FG000|COMPLETED|Overall Study||172
10136383|NCT02688621|11266658|FG001|COMPLETED|Overall Study||188
10136384|NCT02688621|11266657|FG000|NOT COMPLETED|Overall Study||40
10136385|NCT02688621|11266658|FG001|NOT COMPLETED|Overall Study||18
10136386|NCT02688764|11266669|FG000|STARTED|Overall Study||66
10136387|NCT02688764|11266670|FG001|STARTED|Overall Study||19
10136388|NCT02688764|11266669|FG000|Treated in Stage 1|Overall Study||66
10136389|NCT02688764|11266670|FG001|Treated in Stage 1|Overall Study||19
10136390|NCT02688764|11266669|FG000|Treated in Stage 2|Overall Study||43
10136391|NCT02688764|11266670|FG001|Treated in Stage 2|Overall Study||8
10136392|NCT02688764|11266669|FG000|COMPLETED|Overall Study||26
10136393|NCT02688764|11266670|FG001|COMPLETED|Overall Study||2
10136394|NCT02688764|11266669|FG000|NOT COMPLETED|Overall Study||40
10136395|NCT02688764|11266670|FG001|NOT COMPLETED|Overall Study||17
10136396|NCT02688829|11266679|FG000|STARTED|Overall Study||21
10136397|NCT02688829|11266679|FG000|COMPLETED|Overall Study||19
10136398|NCT02688829|11266679|FG000|NOT COMPLETED|Overall Study||2
10136399|NCT02688842|11266683|FG000|STARTED|Overall Study||38
10136400|NCT02688842|11266683|FG000|COMPLETED|Overall Study||38
10136401|NCT02688842|11266683|FG000|NOT COMPLETED|Overall Study||0
10136402|NCT02688868|11266687|FG000|STARTED|Overall Study||38
10136403|NCT02688868|11266687|FG000|COMPLETED|Overall Study||34
10136404|NCT02688868|11266687|FG000|NOT COMPLETED|Overall Study||4
10136405|NCT02689063|11266695|FG000|STARTED|Overall Study||75
10136406|NCT02689063|11266696|FG001|STARTED|Overall Study||75
10136407|NCT02689063|11266697|FG002|STARTED|Overall Study||76
10136408|NCT02689063|11266698|FG003|STARTED|Overall Study||50
10136409|NCT02689063|11266695|FG000|COMPLETED|Overall Study||75
10136410|NCT02689063|11266696|FG001|COMPLETED|Overall Study||73
10136411|NCT02689063|11266697|FG002|COMPLETED|Overall Study||73
10136412|NCT02689063|11266698|FG003|COMPLETED|Overall Study||50
10136413|NCT02689063|11266695|FG000|NOT COMPLETED|Overall Study||0
10136414|NCT02689063|11266696|FG001|NOT COMPLETED|Overall Study||2
10136415|NCT02689063|11266697|FG002|NOT COMPLETED|Overall Study||3
10136416|NCT02689063|11266698|FG003|NOT COMPLETED|Overall Study||0
10136417|NCT02689076|11266711|FG000|STARTED|Overall Study||268
10136418|NCT02689076|11266712|FG001|STARTED|Overall Study||337
10136419|NCT02689076|11266713|FG002|STARTED|Overall Study||191
10136420|NCT02689076|11266711|FG000|COMPLETED|Overall Study||87
10136421|NCT02689076|11266712|FG001|COMPLETED|Overall Study||115
10136422|NCT02689076|11266713|FG002|COMPLETED|Overall Study||191
10136423|NCT02689076|11266711|FG000|NOT COMPLETED|Overall Study||181
10136424|NCT02689076|11266712|FG001|NOT COMPLETED|Overall Study||222
10136425|NCT02689076|11266713|FG002|NOT COMPLETED|Overall Study||0
10196603|NCT03364309|11324819|FG002|STARTED|Induction Period||176
10196604|NCT03364309|11324820|FG003|STARTED|Induction Period||0
10196605|NCT03364309|11324821|FG004|STARTED|Induction Period||0
10196606|NCT03364309|11324822|FG005|STARTED|Induction Period||0
10196607|NCT03364309|11324823|FG006|STARTED|Induction Period||0
10196608|NCT03364309|11324824|FG007|STARTED|Induction Period||0
10136426|NCT02689154|11266721|FG000|STARTED|Overall Study||18
10136427|NCT02689154|11266721|FG000|COMPLETED|Overall Study||18
10136428|NCT02689154|11266721|FG000|NOT COMPLETED|Overall Study||0
10136429|NCT02689206|11266730|FG000|STARTED|Overall Study||20
10136430|NCT02689206|11266731|FG001|STARTED|Overall Study||20
10136431|NCT02689206|11266732|FG002|STARTED|Overall Study||20
10136432|NCT02689206|11266733|FG003|STARTED|Overall Study||21
10136433|NCT02689206|11266734|FG004|STARTED|Overall Study||22
10136434|NCT02689206|11266730|FG000|COMPLETED|Overall Study||17
10136435|NCT02689206|11266731|FG001|COMPLETED|Overall Study||19
10136436|NCT02689206|11266732|FG002|COMPLETED|Overall Study||16
10136437|NCT02689206|11266733|FG003|COMPLETED|Overall Study||17
10136438|NCT02689206|11266734|FG004|COMPLETED|Overall Study||14
10136439|NCT02689206|11266730|FG000|NOT COMPLETED|Overall Study||3
10136440|NCT02689206|11266731|FG001|NOT COMPLETED|Overall Study||1
10136441|NCT02689206|11266732|FG002|NOT COMPLETED|Overall Study||4
10136442|NCT02689206|11266733|FG003|NOT COMPLETED|Overall Study||4
10136443|NCT02689206|11266734|FG004|NOT COMPLETED|Overall Study||8
10136444|NCT02689219|11266752|FG000|STARTED|Overall Study||11
10136445|NCT02689219|11266753|FG001|STARTED|Overall Study||7
10136446|NCT02689219|11266752|FG000|COMPLETED|Overall Study||0
10136447|NCT02689219|11266753|FG001|COMPLETED|Overall Study||0
10136448|NCT02689219|11266752|FG000|NOT COMPLETED|Overall Study||11
10136449|NCT02689219|11266753|FG001|NOT COMPLETED|Overall Study||7
10136450|NCT02689492|11266759|FG000|STARTED|Overall Study||401
10136451|NCT02689492|11266759|FG000|COMPLETED|Overall Study||315
10136452|NCT02689492|11266759|FG000|NOT COMPLETED|Overall Study||86
10136453|NCT02689804|11266768|FG000|STARTED|Overall Study||18
10136454|NCT02689804|11266769|FG001|STARTED|Overall Study||16
10136455|NCT02689804|11266768|FG000|COMPLETED|Overall Study||16
10136456|NCT02689804|11266769|FG001|COMPLETED|Overall Study||16
10136457|NCT02689804|11266768|FG000|NOT COMPLETED|Overall Study||2
10136458|NCT02689804|11266769|FG001|NOT COMPLETED|Overall Study||0
10136459|NCT02689973|11266782|FG000|STARTED|Overall Study||311
10136460|NCT02689973|11266783|FG001|STARTED|Overall Study||270
10136461|NCT02689973|11266784|FG002|STARTED|Overall Study||351
10136462|NCT02689973|11266785|FG003|STARTED|Overall Study||285
10136463|NCT02689973|11266782|FG000|COMPLETED|Overall Study||257
10136464|NCT02689973|11266783|FG001|COMPLETED|Overall Study||221
10136465|NCT02689973|11266784|FG002|COMPLETED|Overall Study||279
10136466|NCT02689973|11266785|FG003|COMPLETED|Overall Study||232
10136467|NCT02689973|11266782|FG000|NOT COMPLETED|Overall Study||54
10136468|NCT02689973|11266783|FG001|NOT COMPLETED|Overall Study||49
10136469|NCT02689973|11266784|FG002|NOT COMPLETED|Overall Study||72
10136470|NCT02689973|11266785|FG003|NOT COMPLETED|Overall Study||53
10136471|NCT02690168|11266796|FG000|STARTED|Overall Study||6
10136472|NCT02690168|11266796|FG000|COMPLETED|Overall Study||6
10136473|NCT02690168|11266796|FG000|NOT COMPLETED|Overall Study||0
10136474|NCT02690181|11266807|FG000|STARTED|Overall Study||14
10136475|NCT02690181|11266808|FG001|STARTED|Overall Study||14
10136476|NCT02690181|11266809|FG002|STARTED|Overall Study||15
10136477|NCT02690181|11266810|FG003|STARTED|Overall Study||10
10136478|NCT02690181|11266811|FG004|STARTED|Overall Study||6
10136479|NCT02690181|11266812|FG005|STARTED|Overall Study||21
10136480|NCT02690181|11266807|FG000|COMPLETED|Overall Study||14
10136481|NCT02690181|11266808|FG001|COMPLETED|Overall Study||14
10136482|NCT02690181|11266809|FG002|COMPLETED|Overall Study||15
10136483|NCT02690181|11266810|FG003|COMPLETED|Overall Study||10
10136484|NCT02690181|11266811|FG004|COMPLETED|Overall Study||6
10136485|NCT02690181|11266812|FG005|COMPLETED|Overall Study||21
10136486|NCT02690181|11266807|FG000|NOT COMPLETED|Overall Study||0
10136487|NCT02690181|11266808|FG001|NOT COMPLETED|Overall Study||0
10136488|NCT02690181|11266809|FG002|NOT COMPLETED|Overall Study||0
10136489|NCT02690181|11266810|FG003|NOT COMPLETED|Overall Study||0
10136490|NCT02690181|11266811|FG004|NOT COMPLETED|Overall Study||0
10136491|NCT02690181|11266812|FG005|NOT COMPLETED|Overall Study||0
10136492|NCT02690194|11266829|FG000|STARTED|Overall Study||17
10136493|NCT02690194|11266830|FG001|STARTED|Overall Study||18
10136494|NCT02690194|11266831|FG002|STARTED|Overall Study||19
10136495|NCT02690194|11266829|FG000|COMPLETED|Overall Study||16
10136496|NCT02690194|11266830|FG001|COMPLETED|Overall Study||14
10136497|NCT02690194|11266831|FG002|COMPLETED|Overall Study||19
10136498|NCT02690194|11266829|FG000|NOT COMPLETED|Overall Study||1
10136499|NCT02690194|11266830|FG001|NOT COMPLETED|Overall Study||4
10136500|NCT02690194|11266831|FG002|NOT COMPLETED|Overall Study||0
10136501|NCT02690207|11266839|FG000|STARTED|Overall Study||8687
10136502|NCT02690207|11266839|FG000|COMPLETED|Overall Study||8434
10136503|NCT02690207|11266839|FG000|NOT COMPLETED|Overall Study||253
10136504|NCT02690558|11266843|FG000|STARTED|Overall Study||39
10136505|NCT02690558|11266843|FG000|COMPLETED|Overall Study||39
10136506|NCT02690558|11266843|FG000|NOT COMPLETED|Overall Study||0
10136507|NCT02690649|11266849|FG000|STARTED|Overall Study||80
10136508|NCT02690649|11266850|FG001|STARTED|Overall Study||80
10136509|NCT02690649|11266849|FG000|COMPLETED|Overall Study||79
10136510|NCT02690649|11266850|FG001|COMPLETED|Overall Study||76
10136511|NCT02690649|11266849|FG000|NOT COMPLETED|Overall Study||1
10136512|NCT02690649|11266850|FG001|NOT COMPLETED|Overall Study||4
10136513|NCT02690701|11266860|FG000|STARTED|Treatment Period 1||46
10136514|NCT02690701|11266861|FG001|STARTED|Treatment Period 1||45
10136515|NCT02690701|11266860|FG000|COMPLETED|Treatment Period 1||44
10136516|NCT02690701|11266861|FG001|COMPLETED|Treatment Period 1||42
10136517|NCT02690701|11266860|FG000|NOT COMPLETED|Treatment Period 1||2
10136518|NCT02690701|11266861|FG001|NOT COMPLETED|Treatment Period 1||3
10136519|NCT02690701|11266860|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
10136520|NCT02690701|11266861|FG001|STARTED|Treatment Period 2||42
10136521|NCT02690701|11266860|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
10136522|NCT02690701|11266861|FG001|COMPLETED|Treatment Period 2||37
10136523|NCT02690701|11266860|FG000|NOT COMPLETED|Treatment Period 2||3
10136524|NCT02690701|11266861|FG001|NOT COMPLETED|Treatment Period 2||5
10136525|NCT02690714|11266868|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
10136526|NCT02690714|11266868|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
10136527|NCT02690714|11266868|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
10136528|NCT02690714|11266868|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
10136529|NCT02690714|11266868|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
10136530|NCT02690714|11266868|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
10136531|NCT02690714|11266868|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15
10136532|NCT02690714|11266868|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
10136533|NCT02690714|11266868|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
10136534|NCT02690714|11266868|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
10136535|NCT02690714|11266868|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
10136536|NCT02690714|11266868|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
10136537|NCT02690727|11266876|FG000|STARTED|Overall Study||9
10136538|NCT02690727|11266877|FG001|STARTED|Overall Study||9
10136539|NCT02690727|11266876|FG000|COMPLETED|Overall Study||7
10136540|NCT02690727|11266877|FG001|COMPLETED|Overall Study||7
10136541|NCT02690727|11266876|FG000|NOT COMPLETED|Overall Study||2
10136542|NCT02690727|11266877|FG001|NOT COMPLETED|Overall Study||2
10136543|NCT02690935|11266887|FG000|STARTED|Overall Study|Count of participants|51
10136544|NCT02690935|11266888|FG001|STARTED|Overall Study|Count of participants|51
10136545|NCT02690935|11266887|FG000|COMPLETED|Overall Study|Count of participants|51
10136546|NCT02690935|11266888|FG001|COMPLETED|Overall Study|Count of participants|51
10136547|NCT02690935|11266887|FG000|NOT COMPLETED|Overall Study||0
10136548|NCT02690935|11266888|FG001|NOT COMPLETED|Overall Study||0
10136549|NCT02690948|11266896|FG000|STARTED|Overall Study||9
10136550|NCT02690948|11266897|FG001|STARTED|Overall Study||7
10136551|NCT02690948|11266896|FG000|COMPLETED|Overall Study||9
10136552|NCT02690948|11266897|FG001|COMPLETED|Overall Study||7
10136553|NCT02690948|11266896|FG000|NOT COMPLETED|Overall Study||0
10136554|NCT02690948|11266897|FG001|NOT COMPLETED|Overall Study||0
10136555|NCT02690974|11266903|FG000|STARTED|Overall Study||302
10136556|NCT02690974|11266903|FG000|COMPLETED|Overall Study||262
10136557|NCT02690974|11266903|FG000|NOT COMPLETED|Overall Study||40
10136558|NCT02691143|11266909|FG000|STARTED|Overall Study||27
10136559|NCT02691143|11266910|FG001|STARTED|Overall Study||23
10136560|NCT02691143|11266909|FG000|COMPLETED|Overall Study||27
10136561|NCT02691143|11266910|FG001|COMPLETED|Overall Study||23
10136562|NCT02691143|11266909|FG000|NOT COMPLETED|Overall Study||0
10136563|NCT02691143|11266910|FG001|NOT COMPLETED|Overall Study||0
10136564|NCT02691247|11266919|FG000|STARTED|Overall Study||40
10136565|NCT02691247|11266920|FG001|STARTED|Overall Study||24
10136566|NCT02691247|11266921|FG002|STARTED|Overall Study||46
10136567|NCT02691247|11266919|FG000|COMPLETED|Overall Study||37
10136568|NCT02691247|11266920|FG001|COMPLETED|Overall Study||22
10136569|NCT02691247|11266921|FG002|COMPLETED|Overall Study||43
10136570|NCT02691247|11266919|FG000|NOT COMPLETED|Overall Study||3
10136571|NCT02691247|11266920|FG001|NOT COMPLETED|Overall Study||2
10136572|NCT02691247|11266921|FG002|NOT COMPLETED|Overall Study||3
10136573|NCT02691260|11266933|FG000|STARTED|Overall Study||26
10136574|NCT02691260|11266934|FG001|STARTED|Overall Study||26
10136575|NCT02691260|11266935|FG002|STARTED|Overall Study||27
10136576|NCT02691260|11266936|FG003|STARTED|Overall Study||26
10136577|NCT02691260|11266933|FG000|COMPLETED|Overall Study||24
10136578|NCT02691260|11266934|FG001|COMPLETED|Overall Study||24
10136579|NCT02691260|11266935|FG002|COMPLETED|Overall Study||25
10136580|NCT02691260|11266936|FG003|COMPLETED|Overall Study||23
10136581|NCT02691260|11266933|FG000|NOT COMPLETED|Overall Study||2
10136582|NCT02691260|11266934|FG001|NOT COMPLETED|Overall Study||2
10136583|NCT02691260|11266935|FG002|NOT COMPLETED|Overall Study||2
10136584|NCT02691260|11266936|FG003|NOT COMPLETED|Overall Study||3
10136585|NCT02691416|11266948|FG000|STARTED|Overall Study||30
10136586|NCT02691416|11266949|FG001|STARTED|Overall Study||30
10136587|NCT02691416|11266948|FG000|COMPLETED|Overall Study||30
10136588|NCT02691416|11266949|FG001|COMPLETED|Overall Study||30
10136589|NCT02691416|11266948|FG000|NOT COMPLETED|Overall Study||0
10136590|NCT02691416|11266949|FG001|NOT COMPLETED|Overall Study||0
10136591|NCT02691455|11266961|FG000|STARTED|Overall Study||23
10136592|NCT02691455|11266962|FG001|STARTED|Overall Study||22
10136593|NCT02691455|11266961|FG000|Randomized|Overall Study||23
10136594|NCT02691455|11266962|FG001|Randomized|Overall Study||22
10136595|NCT02691455|11266961|FG000|Received Assigned Intervention|Overall Study||22
10136596|NCT02691455|11266962|FG001|Received Assigned Intervention|Overall Study||20
10136597|NCT02691455|11266961|FG000|Week 1 Follow up|Overall Study||22
10136598|NCT02691455|11266962|FG001|Week 1 Follow up|Overall Study||19
10136599|NCT02691455|11266961|FG000|Month 1 Follow up|Overall Study||22
10136600|NCT02691455|11266962|FG001|Month 1 Follow up|Overall Study||18
10136601|NCT02691455|11266961|FG000|Month 3 Follow up|Overall Study||21
10136602|NCT02691455|11266962|FG001|Month 3 Follow up|Overall Study||18
10136603|NCT02691455|11266961|FG000|Month 6 Follow up|Overall Study||19
10136604|NCT02691455|11266962|FG001|Month 6 Follow up|Overall Study||19
10136605|NCT02691455|11266961|FG000|Month 12 Follow up|Overall Study||16
10136606|NCT02691455|11266962|FG001|Month 12 Follow up|Overall Study||16
10136607|NCT02691455|11266961|FG000|Year 2 Follow up|Overall Study||6
10136608|NCT02691455|11266962|FG001|Year 2 Follow up|Overall Study||9
10136609|NCT02691455|11266961|FG000|Year 3 Follow up|Overall Study||7
10136610|NCT02691455|11266962|FG001|Year 3 Follow up|Overall Study||5
10136611|NCT02691455|11266961|FG000|COMPLETED|Overall Study||7
10136612|NCT02691455|11266962|FG001|COMPLETED|Overall Study||5
10136613|NCT02691455|11266961|FG000|NOT COMPLETED|Overall Study||16
10136614|NCT02691455|11266962|FG001|NOT COMPLETED|Overall Study||17
10136615|NCT02691468|11266970|FG000|STARTED|Overall Study||54
10136616|NCT02691468|11266971|FG001|STARTED|Overall Study||54
10136617|NCT02691468|11266970|FG000|COMPLETED|Overall Study||48
10136618|NCT02691468|11266971|FG001|COMPLETED|Overall Study||52
10136619|NCT02691468|11266970|FG000|NOT COMPLETED|Overall Study||6
10136620|NCT02691468|11266971|FG001|NOT COMPLETED|Overall Study||2
10136621|NCT02691494|11266980|FG000|STARTED|Treatment Period||94
10136622|NCT02691494|11266981|FG001|STARTED|Treatment Period||95
10136623|NCT02691494|11266982|FG002|STARTED|Treatment Period||189
10136624|NCT02691494|11266980|FG000|COMPLETED|Treatment Period|completed treatment period|72
10136625|NCT02691494|11266981|FG001|COMPLETED|Treatment Period|completed treatment period|69
10136626|NCT02691494|11266982|FG002|COMPLETED|Treatment Period|completed treatment period|148
10136627|NCT02691494|11266980|FG000|NOT COMPLETED|Treatment Period||22
10136628|NCT02691494|11266981|FG001|NOT COMPLETED|Treatment Period||26
10136629|NCT02691494|11266982|FG002|NOT COMPLETED|Treatment Period||41
10136630|NCT02691494|11266980|FG000|STARTED|Post-Treatment Follow-Up Period||14
10136631|NCT02691494|11266981|FG001|STARTED|Post-Treatment Follow-Up Period||25
10136632|NCT02691494|11266982|FG002|STARTED|Post-Treatment Follow-Up Period||59
10136633|NCT02691494|11266980|FG000|COMPLETED|Post-Treatment Follow-Up Period||9
10136634|NCT02691494|11266981|FG001|COMPLETED|Post-Treatment Follow-Up Period||18
10136635|NCT02691494|11266982|FG002|COMPLETED|Post-Treatment Follow-Up Period||42
10136636|NCT02691494|11266980|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5
10136637|NCT02691494|11266981|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7
10136638|NCT02691494|11266982|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17
10136639|NCT02691507|11266992|FG000|STARTED|Overall Study||40
10136640|NCT02691507|11266993|FG001|STARTED|Overall Study||13
10136641|NCT02691507|11266992|FG000|COMPLETED|Overall Study||40
10136642|NCT02691507|11266993|FG001|COMPLETED|Overall Study||12
10136643|NCT02691507|11266992|FG000|NOT COMPLETED|Overall Study||0
10136644|NCT02691507|11266993|FG001|NOT COMPLETED|Overall Study||1
10136645|NCT02691572|11267001|FG000|STARTED|Overall Study||40
10136646|NCT02691572|11267002|FG001|STARTED|Overall Study||40
10136647|NCT02691572|11267001|FG000|COMPLETED|Overall Study||39
10136648|NCT02691572|11267002|FG001|COMPLETED|Overall Study||39
10136649|NCT02691572|11267001|FG000|NOT COMPLETED|Overall Study||1
10136650|NCT02691572|11267002|FG001|NOT COMPLETED|Overall Study||1
10136651|NCT02691702|11267019|FG000|STARTED|Overall Study||10
10136652|NCT02691702|11267020|FG001|STARTED|Overall Study||11
10136653|NCT02691702|11267021|FG002|STARTED|Overall Study||8
10136654|NCT02691702|11267022|FG003|STARTED|Overall Study||8
10136655|NCT02691702|11267023|FG004|STARTED|Overall Study||8
10136656|NCT02691702|11267024|FG005|STARTED|Overall Study||8
10136657|NCT02691702|11267025|FG006|STARTED|Overall Study||8
10136658|NCT02691702|11267026|FG007|STARTED|Overall Study||12
10136659|NCT02691702|11267027|FG008|STARTED|Overall Study||8
10136660|NCT02691702|11267028|FG009|STARTED|Overall Study||8
10136661|NCT02691702|11267029|FG010|STARTED|Overall Study||8
10136662|NCT02691702|11267019|FG000|COMPLETED|Overall Study||8
10136663|NCT02691702|11267020|FG001|COMPLETED|Overall Study||10
10136664|NCT02691702|11267021|FG002|COMPLETED|Overall Study||7
10136665|NCT02691702|11267022|FG003|COMPLETED|Overall Study||8
10136666|NCT02691702|11267023|FG004|COMPLETED|Overall Study||8
10136667|NCT02691702|11267024|FG005|COMPLETED|Overall Study||5
10136668|NCT02691702|11267025|FG006|COMPLETED|Overall Study||5
10136669|NCT02691702|11267026|FG007|COMPLETED|Overall Study||12
10136670|NCT02691702|11267027|FG008|COMPLETED|Overall Study||6
10136671|NCT02691702|11267028|FG009|COMPLETED|Overall Study||6
10136672|NCT02691702|11267029|FG010|COMPLETED|Overall Study||6
10136673|NCT02691702|11267019|FG000|NOT COMPLETED|Overall Study||2
10136674|NCT02691702|11267020|FG001|NOT COMPLETED|Overall Study||1
10136675|NCT02691702|11267021|FG002|NOT COMPLETED|Overall Study||1
10136676|NCT02691702|11267022|FG003|NOT COMPLETED|Overall Study||0
10136677|NCT02691702|11267023|FG004|NOT COMPLETED|Overall Study||0
10136678|NCT02691702|11267024|FG005|NOT COMPLETED|Overall Study||3
10136679|NCT02691702|11267025|FG006|NOT COMPLETED|Overall Study||3
10136680|NCT02691702|11267026|FG007|NOT COMPLETED|Overall Study||0
10136681|NCT02691702|11267027|FG008|NOT COMPLETED|Overall Study||2
10136682|NCT02691702|11267028|FG009|NOT COMPLETED|Overall Study||2
10136683|NCT02691702|11267029|FG010|NOT COMPLETED|Overall Study||2
10136684|NCT02691741|11267063|FG000|STARTED|Overall Study||94
10136685|NCT02691741|11267064|FG001|STARTED|Overall Study||94
10136686|NCT02691741|11267063|FG000|All-Implanted Analysis Set|Overall Study||93
10136687|NCT02691741|11267064|FG001|All-Implanted Analysis Set|Overall Study||89
10136688|NCT02691741|11267063|FG000|Best-Case Analysis Set|Overall Study||86
10136689|NCT02691741|11267064|FG001|Best-Case Analysis Set|Overall Study||85
10136690|NCT02691741|11267063|FG000|Safety Analysis Set|Overall Study||93
10136691|NCT02691741|11267064|FG001|Safety Analysis Set|Overall Study||89
10136692|NCT02691741|11267063|FG000|COMPLETED|Overall Study||93
10136693|NCT02691741|11267064|FG001|COMPLETED|Overall Study||87
10136694|NCT02691741|11267063|FG000|NOT COMPLETED|Overall Study||1
10136695|NCT02691741|11267064|FG001|NOT COMPLETED|Overall Study||7
10136696|NCT02691936|11267077|FG000|STARTED|Overall Study||35
10136697|NCT02691936|11267078|FG001|STARTED|Overall Study||34
10136698|NCT02691936|11267077|FG000|COMPLETED|Overall Study||33
10136699|NCT02691936|11267078|FG001|COMPLETED|Overall Study||29
10136700|NCT02691936|11267077|FG000|NOT COMPLETED|Overall Study||2
10136701|NCT02691936|11267078|FG001|NOT COMPLETED|Overall Study||5
10136702|NCT02691962|11267084|FG000|STARTED|Overall Study||75
10136703|NCT02691962|11267084|FG000|COMPLETED|Overall Study||59
10136704|NCT02691962|11267084|FG000|NOT COMPLETED|Overall Study||16
10136705|NCT02692040|11267106|FG000|STARTED|Overall Study||10
10136706|NCT02692040|11267107|FG001|STARTED|Overall Study||4
10136707|NCT02692040|11267108|FG002|STARTED|Overall Study||5
10136708|NCT02692040|11267109|FG003|STARTED|Overall Study||5
10136709|NCT02692040|11267110|FG004|STARTED|Overall Study||4
10136710|NCT02692040|11267111|FG005|STARTED|Overall Study||5
10136711|NCT02692040|11267112|FG006|STARTED|Overall Study||5
10136712|NCT02692040|11267113|FG007|STARTED|Overall Study||5
10136713|NCT02692040|11267114|FG008|STARTED|Overall Study||5
10136714|NCT02692040|11267115|FG009|STARTED|Overall Study||4
10136715|NCT02692040|11267116|FG010|STARTED|Overall Study||5
10136716|NCT02692040|11267117|FG011|STARTED|Overall Study||5
10136717|NCT02692040|11267118|FG012|STARTED|Overall Study||6
10136718|NCT02692040|11267119|FG013|STARTED|Overall Study||6
10136719|NCT02692040|11267120|FG014|STARTED|Overall Study||6
10136720|NCT02692040|11267121|FG015|STARTED|Overall Study||6
10136721|NCT02692040|11267122|FG016|STARTED|Overall Study||4
10136722|NCT02692040|11267106|FG000|COMPLETED|Overall Study||10
10136723|NCT02692040|11267107|FG001|COMPLETED|Overall Study||4
10136724|NCT02692040|11267108|FG002|COMPLETED|Overall Study||5
10136725|NCT02692040|11267109|FG003|COMPLETED|Overall Study||5
10136726|NCT02692040|11267110|FG004|COMPLETED|Overall Study||4
10136727|NCT02692040|11267111|FG005|COMPLETED|Overall Study||5
10136728|NCT02692040|11267112|FG006|COMPLETED|Overall Study||5
10136729|NCT02692040|11267113|FG007|COMPLETED|Overall Study||5
10136730|NCT02692040|11267114|FG008|COMPLETED|Overall Study||5
10136731|NCT02692040|11267115|FG009|COMPLETED|Overall Study||4
10136732|NCT02692040|11267116|FG010|COMPLETED|Overall Study||5
10136733|NCT02692040|11267117|FG011|COMPLETED|Overall Study||5
10136734|NCT02692040|11267118|FG012|COMPLETED|Overall Study||5
10136735|NCT02692040|11267119|FG013|COMPLETED|Overall Study||3
10136736|NCT02692040|11267120|FG014|COMPLETED|Overall Study||5
10136737|NCT02692040|11267121|FG015|COMPLETED|Overall Study||5
10136738|NCT02692040|11267122|FG016|COMPLETED|Overall Study||4
10136739|NCT02692040|11267106|FG000|NOT COMPLETED|Overall Study||0
10136740|NCT02692040|11267107|FG001|NOT COMPLETED|Overall Study||0
10136741|NCT02692040|11267108|FG002|NOT COMPLETED|Overall Study||0
10136742|NCT02692040|11267109|FG003|NOT COMPLETED|Overall Study||0
10136743|NCT02692040|11267110|FG004|NOT COMPLETED|Overall Study||0
10136744|NCT02692040|11267111|FG005|NOT COMPLETED|Overall Study||0
10136745|NCT02692040|11267112|FG006|NOT COMPLETED|Overall Study||0
10136746|NCT02692040|11267113|FG007|NOT COMPLETED|Overall Study||0
10136747|NCT02692040|11267114|FG008|NOT COMPLETED|Overall Study||0
10136748|NCT02692040|11267115|FG009|NOT COMPLETED|Overall Study||0
10136749|NCT02692040|11267116|FG010|NOT COMPLETED|Overall Study||0
10136750|NCT02692040|11267117|FG011|NOT COMPLETED|Overall Study||0
10136751|NCT02692040|11267118|FG012|NOT COMPLETED|Overall Study||1
10136752|NCT02692040|11267119|FG013|NOT COMPLETED|Overall Study||3
10136753|NCT02692040|11267120|FG014|NOT COMPLETED|Overall Study||1
10136754|NCT02692040|11267121|FG015|NOT COMPLETED|Overall Study||1
10136755|NCT02692040|11267122|FG016|NOT COMPLETED|Overall Study||0
10136756|NCT02692209|11267199|FG000|STARTED|Overall Study||298
10136757|NCT02692209|11267199|FG000|COMPLETED|Overall Study||298
10136758|NCT02692209|11267199|FG000|NOT COMPLETED|Overall Study||0
10136759|NCT02692235|11267207|FG000|STARTED|Overall Study||14
10136760|NCT02692235|11267208|FG001|STARTED|Overall Study||14
10136761|NCT02692235|11267207|FG000|COMPLETED|Overall Study||11
10136762|NCT02692235|11267208|FG001|COMPLETED|Overall Study||11
10136763|NCT02692235|11267207|FG000|NOT COMPLETED|Overall Study||3
10136764|NCT02692235|11267208|FG001|NOT COMPLETED|Overall Study||3
10136765|NCT02692391|11267216|FG000|STARTED|Overall Study||24
10136766|NCT02692391|11267217|FG001|STARTED|Overall Study||18
10136767|NCT02692391|11267216|FG000|COMPLETED|Overall Study||24
10136768|NCT02692391|11267217|FG001|COMPLETED|Overall Study||18
10136769|NCT02692391|11267216|FG000|NOT COMPLETED|Overall Study||0
10136770|NCT02692391|11267217|FG001|NOT COMPLETED|Overall Study||0
10136771|NCT02692417|11267225|FG000|STARTED|Overall Study||9
10136772|NCT02692417|11267226|FG001|STARTED|Overall Study||7
10136773|NCT02692417|11267225|FG000|COMPLETED|Overall Study||3
10136774|NCT02692417|11267226|FG001|COMPLETED|Overall Study||6
10136775|NCT02692417|11267225|FG000|NOT COMPLETED|Overall Study||6
10136776|NCT02692417|11267226|FG001|NOT COMPLETED|Overall Study||1
10136777|NCT02692482|11267234|FG000|STARTED|Overall Study||177
10136778|NCT02692482|11267235|FG001|STARTED|Overall Study||182
10136779|NCT02692482|11267234|FG000|COMPLETED|Overall Study||174
10136780|NCT02692482|11267235|FG001|COMPLETED|Overall Study||178
10136781|NCT02692482|11267234|FG000|NOT COMPLETED|Overall Study||3
10136782|NCT02692482|11267235|FG001|NOT COMPLETED|Overall Study||4
10136783|NCT02692495|11267244|FG000|STARTED|Overall Study||12
10136784|NCT02692495|11267245|FG001|STARTED|Overall Study||4
10136785|NCT02692495|11267244|FG000|COMPLETED|Overall Study||12
10136786|NCT02692495|11267245|FG001|COMPLETED|Overall Study||4
10136787|NCT02692495|11267244|FG000|NOT COMPLETED|Overall Study||0
10136788|NCT02692495|11267245|FG001|NOT COMPLETED|Overall Study||0
10136789|NCT02692560|11267257|FG000|STARTED|Overall Study||29
10136790|NCT02692560|11267258|FG001|STARTED|Overall Study||31
10136791|NCT02692560|11267257|FG000|COMPLETED|Overall Study||29
10136792|NCT02692560|11267258|FG001|COMPLETED|Overall Study||25
10136793|NCT02692560|11267257|FG000|NOT COMPLETED|Overall Study||0
10136794|NCT02692560|11267258|FG001|NOT COMPLETED|Overall Study||6
10136795|NCT02692586|11267264|FG000|STARTED|Overall Study||106
10136796|NCT02692586|11267264|FG000|COMPLETED|Overall Study||103
10136797|NCT02692586|11267264|FG000|NOT COMPLETED|Overall Study||3
10136798|NCT02692703|11267268|FG000|STARTED|Overall Study||100
10136799|NCT02692703|11267268|FG000|COMPLETED|Overall Study||98
10136800|NCT02692703|11267268|FG000|NOT COMPLETED|Overall Study||2
10136801|NCT02692716|11267274|FG000|STARTED|Overall Study||1591
10136802|NCT02692716|11267275|FG001|STARTED|Overall Study||1592
10136803|NCT02692716|11267274|FG000|Full Analysis Set (FAS)|Overall Study||1591
10136804|NCT02692716|11267275|FG001|Full Analysis Set (FAS)|Overall Study||1592
10136805|NCT02692716|11267274|FG000|Exposed|Overall Study||1591
10136806|NCT02692716|11267275|FG001|Exposed|Overall Study||1591
10136807|NCT02692716|11267274|FG000|COMPLETED|Overall Study||1586
10136808|NCT02692716|11267275|FG001|COMPLETED|Overall Study||1586
10136809|NCT02692716|11267274|FG000|NOT COMPLETED|Overall Study||5
10136810|NCT02692716|11267275|FG001|NOT COMPLETED|Overall Study||6
10136811|NCT02692755|11267281|FG000|STARTED|Overall Study||35
10136812|NCT02692755|11267281|FG000|COMPLETED|Overall Study||35
10136813|NCT02692755|11267281|FG000|NOT COMPLETED|Overall Study||0
10136814|NCT02692859|11267288|FG000|STARTED|Overall Study||996
10136815|NCT02692859|11267289|FG001|STARTED|Overall Study||996
10136816|NCT02692859|11267288|FG000|COMPLETED|Overall Study||912
10136817|NCT02692859|11267289|FG001|COMPLETED|Overall Study||901
10136818|NCT02692859|11267288|FG000|NOT COMPLETED|Overall Study||84
10136819|NCT02692859|11267289|FG001|NOT COMPLETED|Overall Study||95
10136820|NCT02693106|11267295|FG000|STARTED|Overall Study||13
10136821|NCT02693106|11267295|FG000|COMPLETED|Overall Study||10
10136822|NCT02693106|11267295|FG000|NOT COMPLETED|Overall Study||3
10136823|NCT02693119|11267307|FG000|STARTED|Double-Blind Period||8
10136824|NCT02693119|11267308|FG001|STARTED|Double-Blind Period||4
10136825|NCT02693119|11267307|FG000|COMPLETED|Double-Blind Period||8
10136826|NCT02693119|11267308|FG001|COMPLETED|Double-Blind Period||4
10136827|NCT02693119|11267307|FG000|NOT COMPLETED|Double-Blind Period||0
10136828|NCT02693119|11267308|FG001|NOT COMPLETED|Double-Blind Period||0
10136829|NCT02693119|11267307|FG000|STARTED|Open-Label Period||8
10136830|NCT02693119|11267308|FG001|STARTED|Open-Label Period||4
10136831|NCT02693119|11267307|FG000|COMPLETED|Open-Label Period||8
10136832|NCT02693119|11267308|FG001|COMPLETED|Open-Label Period||3
10136833|NCT02693119|11267307|FG000|NOT COMPLETED|Open-Label Period||0
10136834|NCT02693119|11267308|FG001|NOT COMPLETED|Open-Label Period||1
10136835|NCT02693132|11267347|FG000|STARTED|Overall Study||17
10136836|NCT02693132|11267348|FG001|STARTED|Overall Study||17
10136837|NCT02693132|11267349|FG002|STARTED|Overall Study||18
10136838|NCT02693132|11267347|FG000|COMPLETED|Overall Study||16
10136839|NCT02693132|11267348|FG001|COMPLETED|Overall Study||16
10136840|NCT02693132|11267349|FG002|COMPLETED|Overall Study||17
10136841|NCT02693132|11267347|FG000|NOT COMPLETED|Overall Study||1
10136842|NCT02693132|11267348|FG001|NOT COMPLETED|Overall Study||1
10136843|NCT02693132|11267349|FG002|NOT COMPLETED|Overall Study||1
10136844|NCT02693262|11267357|FG000|STARTED|Overall Study||4
10136845|NCT02693262|11267358|FG001|STARTED|Overall Study||5
10136846|NCT02693262|11267357|FG000|COMPLETED|Overall Study||4
10136847|NCT02693262|11267358|FG001|COMPLETED|Overall Study||5
10136848|NCT02693262|11267357|FG000|NOT COMPLETED|Overall Study||0
10136849|NCT02693262|11267358|FG001|NOT COMPLETED|Overall Study||0
10136850|NCT02693418|11267369|FG000|STARTED|Overall Study||22
10136851|NCT02693418|11267370|FG001|STARTED|Overall Study||21
10136852|NCT02693418|11267371|FG002|STARTED|Overall Study||21
10136853|NCT02693418|11267372|FG003|STARTED|Overall Study||20
10136854|NCT02693418|11267373|FG004|STARTED|Overall Study||21
10136855|NCT02693418|11267369|FG000|COMPLETED|Overall Study||21
10136856|NCT02693418|11267370|FG001|COMPLETED|Overall Study||19
10136857|NCT02693418|11267371|FG002|COMPLETED|Overall Study||19
10136858|NCT02693418|11267372|FG003|COMPLETED|Overall Study||20
10136859|NCT02693418|11267373|FG004|COMPLETED|Overall Study||21
10060500|NCT02097992|11186072|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10060501|NCT02097992|11186073|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10060502|NCT02097992|11186074|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10060503|NCT02097992|11186071|FG000|STARTED|Washout (4 Weeks)||2
10060504|NCT02097992|11186072|FG001|STARTED|Washout (4 Weeks)||3
10060505|NCT02097992|11186073|FG002|STARTED|Washout (4 Weeks)||4
10136860|NCT02693418|11267369|FG000|NOT COMPLETED|Overall Study||1
10136861|NCT02693418|11267370|FG001|NOT COMPLETED|Overall Study||2
10136862|NCT02693418|11267371|FG002|NOT COMPLETED|Overall Study||2
10136863|NCT02693418|11267372|FG003|NOT COMPLETED|Overall Study||0
10136864|NCT02693418|11267373|FG004|NOT COMPLETED|Overall Study||0
10136865|NCT02693704|11267389|FG000|STARTED|Overall Study||10
10136866|NCT02693704|11267390|FG001|STARTED|Overall Study||10
10136867|NCT02693704|11267391|FG002|STARTED|Overall Study||10
10136868|NCT02693704|11267392|FG003|STARTED|Overall Study||10
10136869|NCT02693704|11267389|FG000|COMPLETED|Overall Study||10
10136870|NCT02693704|11267390|FG001|COMPLETED|Overall Study||10
10136871|NCT02693704|11267391|FG002|COMPLETED|Overall Study||10
10136872|NCT02693704|11267392|FG003|COMPLETED|Overall Study||10
10136873|NCT02693704|11267389|FG000|NOT COMPLETED|Overall Study||0
10136874|NCT02693704|11267390|FG001|NOT COMPLETED|Overall Study||0
10136875|NCT02693704|11267391|FG002|NOT COMPLETED|Overall Study||0
10136876|NCT02693704|11267392|FG003|NOT COMPLETED|Overall Study||0
10136877|NCT02693834|11267402|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
10136878|NCT02693834|11267403|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
10136879|NCT02693834|11267402|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
10136880|NCT02693834|11267403|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
10136881|NCT02693834|11267402|FG000|NOT COMPLETED|Baseline Measurement||2
10136882|NCT02693834|11267403|FG001|NOT COMPLETED|Baseline Measurement||0
10060506|NCT02097992|11186074|FG003|STARTED|Washout (4 Weeks)||2
10060507|NCT02097992|11186071|FG000|COMPLETED|Washout (4 Weeks)||2
10060508|NCT02097992|11186072|FG001|COMPLETED|Washout (4 Weeks)||3
10060509|NCT02097992|11186073|FG002|COMPLETED|Washout (4 Weeks)||4
10060510|NCT02097992|11186074|FG003|COMPLETED|Washout (4 Weeks)||2
10136883|NCT02693834|11267402|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
10060511|NCT02097992|11186071|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10060512|NCT02097992|11186072|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10136884|NCT02693834|11267403|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
10136885|NCT02693834|11267402|FG000|COMPLETED|Week 1 Practice||10
10136886|NCT02693834|11267403|FG001|COMPLETED|Week 1 Practice||11
10136887|NCT02693834|11267402|FG000|NOT COMPLETED|Week 1 Practice||0
10136888|NCT02693834|11267403|FG001|NOT COMPLETED|Week 1 Practice||0
10136889|NCT02693834|11267402|FG000|STARTED|Week 2 Practice||10
10136890|NCT02693834|11267403|FG001|STARTED|Week 2 Practice||11
10136891|NCT02693834|11267402|FG000|COMPLETED|Week 2 Practice||10
10136892|NCT02693834|11267403|FG001|COMPLETED|Week 2 Practice||10
10136893|NCT02693834|11267402|FG000|NOT COMPLETED|Week 2 Practice||0
10136894|NCT02693834|11267403|FG001|NOT COMPLETED|Week 2 Practice||1
10136895|NCT02694029|11267411|FG000|STARTED|Overall Study||5
10136896|NCT02694029|11267412|FG001|STARTED|Overall Study||5
10136897|NCT02694029|11267411|FG000|First Intervention|Overall Study||5
10136898|NCT02694029|11267412|FG001|First Intervention|Overall Study||5
10136899|NCT02694029|11267411|FG000|Second Intervention|Overall Study||5
10136900|NCT02694029|11267412|FG001|Second Intervention|Overall Study||5
10136901|NCT02694029|11267411|FG000|COMPLETED|Overall Study||5
10136902|NCT02694029|11267412|FG001|COMPLETED|Overall Study||5
10136903|NCT02694029|11267411|FG000|NOT COMPLETED|Overall Study||0
10136904|NCT02694029|11267412|FG001|NOT COMPLETED|Overall Study||0
10136905|NCT02694198|11267422|FG000|STARTED|Overall Study||135
10136906|NCT02694198|11267422|FG000|COMPLETED|Overall Study||135
10136907|NCT02694198|11267422|FG000|NOT COMPLETED|Overall Study||0
10136908|NCT02694315|11267426|FG000|STARTED|Overall Study||200
10136909|NCT02694315|11267426|FG000|COMPLETED|Overall Study||200
10136910|NCT02694315|11267426|FG000|NOT COMPLETED|Overall Study||0
10136911|NCT02694328|11267432|FG000|STARTED|Overall Study||276
10136912|NCT02694328|11267433|FG001|STARTED|Overall Study||274
10136913|NCT02694328|11267432|FG000|COMPLETED|Overall Study||176
10136914|NCT02694328|11267433|FG001|COMPLETED|Overall Study||176
10136915|NCT02694328|11267432|FG000|NOT COMPLETED|Overall Study||100
10136916|NCT02694328|11267433|FG001|NOT COMPLETED|Overall Study||98
10136917|NCT02694445|11267439|FG000|STARTED|Overall Study||3098
10136918|NCT02694445|11267439|FG000|COMPLETED|Overall Study||3046
10136919|NCT02694445|11267439|FG000|NOT COMPLETED|Overall Study||52
10136920|NCT02694523|11267445|FG000|STARTED|Part A||304
10136921|NCT02694523|11267446|FG001|STARTED|Part A||301
10136922|NCT02694523|11267447|FG002|STARTED|Part A||0
10136923|NCT02694523|11267448|FG003|STARTED|Part A||0
10136924|NCT02694523|11267449|FG004|STARTED|Part A||0
10136925|NCT02694523|11267450|FG005|STARTED|Part A||0
10136926|NCT02694523|11267451|FG006|STARTED|Part A||0
10136927|NCT02694523|11267445|FG000|COMPLETED|Part A||291
10136928|NCT02694523|11267446|FG001|COMPLETED|Part A||294
10136929|NCT02694523|11267447|FG002|COMPLETED|Part A||0
10136930|NCT02694523|11267448|FG003|COMPLETED|Part A||0
10136931|NCT02694523|11267449|FG004|COMPLETED|Part A||0
10136932|NCT02694523|11267450|FG005|COMPLETED|Part A||0
10136933|NCT02694523|11267451|FG006|COMPLETED|Part A||0
10136934|NCT02694523|11267445|FG000|NOT COMPLETED|Part A||13
10136935|NCT02694523|11267446|FG001|NOT COMPLETED|Part A||7
10136936|NCT02694523|11267447|FG002|NOT COMPLETED|Part A||0
10136937|NCT02694523|11267448|FG003|NOT COMPLETED|Part A||0
10136938|NCT02694523|11267449|FG004|NOT COMPLETED|Part A||0
10136939|NCT02694523|11267450|FG005|NOT COMPLETED|Part A||0
10136940|NCT02694523|11267451|FG006|NOT COMPLETED|Part A||0
10136941|NCT02694523|11267445|FG000|STARTED|Part B||0
10136942|NCT02694523|11267446|FG001|STARTED|Part B||0
10136943|NCT02694523|11267447|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
10136944|NCT02694523|11267448|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
10136945|NCT02694523|11267449|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
10136946|NCT02694523|11267450|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
10136947|NCT02694523|11267451|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
10136948|NCT02694523|11267445|FG000|COMPLETED|Part B||0
10136949|NCT02694523|11267446|FG001|COMPLETED|Part B||0
10136950|NCT02694523|11267447|FG002|COMPLETED|Part B||274
10136951|NCT02694523|11267448|FG003|COMPLETED|Part B||140
10136952|NCT02694523|11267449|FG004|COMPLETED|Part B||34
10136953|NCT02694523|11267450|FG005|COMPLETED|Part B||51
10136954|NCT02694523|11267451|FG006|COMPLETED|Part B||51
10136955|NCT02694523|11267445|FG000|NOT COMPLETED|Part B||0
10136956|NCT02694523|11267446|FG001|NOT COMPLETED|Part B||0
10136957|NCT02694523|11267447|FG002|NOT COMPLETED|Part B||20
10136958|NCT02694523|11267448|FG003|NOT COMPLETED|Part B||4
10136959|NCT02694523|11267449|FG004|NOT COMPLETED|Part B||4
10136960|NCT02694523|11267450|FG005|NOT COMPLETED|Part B||5
10136961|NCT02694523|11267451|FG006|NOT COMPLETED|Part B||2
10136962|NCT02694536|11267463|FG000|STARTED|Overall Study||80
10136963|NCT02694536|11267463|FG000|COMPLETED|Overall Study||0
10136964|NCT02694536|11267463|FG000|NOT COMPLETED|Overall Study||80
10136965|NCT02694549|11267467|FG000|STARTED|Overall Study||12
10136966|NCT02694549|11267467|FG000|COMPLETED|Overall Study||10
10136967|NCT02694549|11267467|FG000|NOT COMPLETED|Overall Study||2
10136968|NCT02694562|11267471|FG000|STARTED|Overall Study||20
10136969|NCT02694562|11267471|FG000|COMPLETED|Overall Study||2
10136970|NCT02694562|11267471|FG000|NOT COMPLETED|Overall Study||18
10136971|NCT02694601|11267475|FG000|STARTED|Overall Study||10
10136972|NCT02694601|11267475|FG000|COMPLETED|Overall Study||10
10136973|NCT02694601|11267475|FG000|NOT COMPLETED|Overall Study||0
10136974|NCT02694718|11267479|FG000|STARTED|Overall Study||60
10136975|NCT02694718|11267479|FG000|COMPLETED|Overall Study||58
10136976|NCT02694718|11267479|FG000|NOT COMPLETED|Overall Study||2
10136977|NCT02694744|11267485|FG000|STARTED|Overall Study||57
10136978|NCT02694744|11267486|FG001|STARTED|Overall Study||57
10136979|NCT02694744|11267485|FG000|Safety Population|Overall Study||57
10136980|NCT02694744|11267486|FG001|Safety Population|Overall Study||56
10136981|NCT02694744|11267485|FG000|ITT|Overall Study||57
10136982|NCT02694744|11267486|FG001|ITT|Overall Study||55
10136983|NCT02694744|11267485|FG000|COMPLETED|Overall Study||51
10136984|NCT02694744|11267486|FG001|COMPLETED|Overall Study||52
10136985|NCT02694744|11267485|FG000|NOT COMPLETED|Overall Study||6
10136986|NCT02694744|11267486|FG001|NOT COMPLETED|Overall Study||5
10136987|NCT02694835|11267496|FG000|STARTED|Overall Study||41
10136988|NCT02694835|11267497|FG001|STARTED|Overall Study||39
10136989|NCT02694835|11267496|FG000|COMPLETED|Overall Study||41
10136990|NCT02694835|11267497|FG001|COMPLETED|Overall Study||39
10136991|NCT02694835|11267496|FG000|NOT COMPLETED|Overall Study||0
10136992|NCT02694835|11267497|FG001|NOT COMPLETED|Overall Study||0
10136993|NCT02694978|11267505|FG000|STARTED|Overall Study||1006
10136994|NCT02694978|11267506|FG001|STARTED|Overall Study||1008
10136995|NCT02694978|11267505|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997
10136996|NCT02694978|11267506|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000
10136997|NCT02694978|11267505|FG000|COMPLETED|Overall Study||935
10136998|NCT02694978|11267506|FG001|COMPLETED|Overall Study||948
10136999|NCT02694978|11267505|FG000|NOT COMPLETED|Overall Study||71
10137000|NCT02694978|11267506|FG001|NOT COMPLETED|Overall Study||60
10137001|NCT02695290|11267512|FG000|STARTED|Overall Study||1
10137002|NCT02695290|11267512|FG000|COMPLETED|Overall Study||1
10137003|NCT02695290|11267512|FG000|NOT COMPLETED|Overall Study||0
10137004|NCT02695329|11267518|FG000|STARTED|Overall Study||50
10137005|NCT02695329|11267519|FG001|STARTED|Overall Study||50
10137006|NCT02695329|11267518|FG000|COMPLETED|Overall Study||45
10137007|NCT02695329|11267519|FG001|COMPLETED|Overall Study||45
10137008|NCT02695329|11267518|FG000|NOT COMPLETED|Overall Study||5
10137009|NCT02695329|11267519|FG001|NOT COMPLETED|Overall Study||5
10137010|NCT02695420|11267529|FG000|STARTED|Overall Study||21
10137011|NCT02695420|11267530|FG001|STARTED|Overall Study||21
10137012|NCT02695420|11267531|FG002|STARTED|Overall Study||19
10137013|NCT02695420|11267532|FG003|STARTED|Overall Study||20
10137014|NCT02695420|11267529|FG000|COMPLETED|Overall Study||21
10137015|NCT02695420|11267530|FG001|COMPLETED|Overall Study||20
10137016|NCT02695420|11267531|FG002|COMPLETED|Overall Study||19
10137017|NCT02695420|11267532|FG003|COMPLETED|Overall Study||20
10137018|NCT02695420|11267529|FG000|NOT COMPLETED|Overall Study||0
10137019|NCT02695420|11267530|FG001|NOT COMPLETED|Overall Study||1
10137020|NCT02695420|11267531|FG002|NOT COMPLETED|Overall Study||0
10137021|NCT02695420|11267532|FG003|NOT COMPLETED|Overall Study||0
10137022|NCT02695446|11267545|FG000|STARTED|Overall Study||12
10137023|NCT02695446|11267545|FG000|COMPLETED|Overall Study||12
10137024|NCT02695446|11267545|FG000|NOT COMPLETED|Overall Study||0
10137025|NCT02695524|11267551|FG000|STARTED|Overall Study||30
10137026|NCT02695524|11267552|FG001|STARTED|Overall Study||30
10137027|NCT02695524|11267551|FG000|COMPLETED|Overall Study||27
10137028|NCT02695524|11267552|FG001|COMPLETED|Overall Study||27
10137029|NCT02695524|11267551|FG000|NOT COMPLETED|Overall Study||3
10137030|NCT02695524|11267552|FG001|NOT COMPLETED|Overall Study||3
10137031|NCT02695537|11267558|FG000|STARTED|Overall Study||89
10137032|NCT02695537|11267558|FG000|COMPLETED|Overall Study||51
10137033|NCT02695537|11267558|FG000|NOT COMPLETED|Overall Study||38
10137034|NCT02695628|11267562|FG000|STARTED|Overall Study||5
10137035|NCT02695628|11267562|FG000|COMPLETED|Overall Study||4
10137036|NCT02695628|11267562|FG000|NOT COMPLETED|Overall Study||1
10137037|NCT02695719|11267568|FG000|STARTED|Overall Study||74
10137038|NCT02695719|11267569|FG001|STARTED|Overall Study||82
10137039|NCT02695719|11267568|FG000|COMPLETED|Overall Study||71
10137040|NCT02695719|11267569|FG001|COMPLETED|Overall Study||72
10137041|NCT02695719|11267568|FG000|NOT COMPLETED|Overall Study||3
10137042|NCT02695719|11267569|FG001|NOT COMPLETED|Overall Study||10
10137043|NCT02696070|11267577|FG000|STARTED|Overall Study||8
10137044|NCT02696070|11267578|FG001|STARTED|Overall Study||14
10137045|NCT02696070|11267577|FG000|COMPLETED|Overall Study||7
10137046|NCT02696070|11267578|FG001|COMPLETED|Overall Study||12
10137047|NCT02696070|11267577|FG000|NOT COMPLETED|Overall Study||1
10137048|NCT02696070|11267578|FG001|NOT COMPLETED|Overall Study||2
10137049|NCT02696083|11267584|FG000|STARTED|Overall Study||19
10137050|NCT02696083|11267584|FG000|COMPLETED|Overall Study||13
10137051|NCT02696083|11267584|FG000|NOT COMPLETED|Overall Study||6
10137052|NCT02696200|11267595|FG000|STARTED|Overall Study||32
10137053|NCT02696200|11267596|FG001|STARTED|Overall Study||30
10137054|NCT02696200|11267595|FG000|COMPLETED|Overall Study||32
10137055|NCT02696200|11267596|FG001|COMPLETED|Overall Study||30
10137056|NCT02696200|11267595|FG000|NOT COMPLETED|Overall Study||0
10137057|NCT02696200|11267596|FG001|NOT COMPLETED|Overall Study||0
10137058|NCT02696291|11267604|FG000|STARTED|Overall Study||5
10137059|NCT02696291|11267605|FG001|STARTED|Overall Study||2
10137060|NCT02696291|11267604|FG000|COMPLETED|Overall Study||5
10137061|NCT02696291|11267605|FG001|COMPLETED|Overall Study||2
10137062|NCT02696291|11267604|FG000|NOT COMPLETED|Overall Study||0
10137063|NCT02696291|11267605|FG001|NOT COMPLETED|Overall Study||0
10137064|NCT02696317|11267611|FG000|STARTED|Habitual, 10 Days of Wear||42
9707132|NCT02544074|10806276|FG019|NOT COMPLETED|Overall Study||0
9707133|NCT02544074|10806277|FG020|NOT COMPLETED|Overall Study||0
9707134|NCT02367040|10806313|FG000|STARTED|Overall Study||307
9707135|NCT02367040|10806314|FG001|STARTED|Overall Study||151
9707136|NCT02367040|10806313|FG000|Received Treatment|Overall Study||304
9707137|NCT02367040|10806314|FG001|Received Treatment|Overall Study||149
9707138|NCT02367040|10806313|FG000|COMPLETED|Overall Study||70
9707139|NCT02367040|10806314|FG001|COMPLETED|Overall Study||29
9707140|NCT02367040|10806313|FG000|NOT COMPLETED|Overall Study||237
9707141|NCT02367040|10806314|FG001|NOT COMPLETED|Overall Study||122
9707142|NCT02317627|10806323|FG000|STARTED|Overall Study||13
10137065|NCT02696317|11267612|FG001|STARTED|Habitual, 10 Days of Wear||40
10137066|NCT02696317|11267611|FG000|COMPLETED|Habitual, 10 Days of Wear||40
10137067|NCT02696317|11267612|FG001|COMPLETED|Habitual, 10 Days of Wear||36
10137068|NCT02696317|11267611|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2
10137069|NCT02696317|11267612|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4
10137070|NCT02696317|11267611|FG000|STARTED|Period 1, 10 Days of Wear||40
10137071|NCT02696317|11267612|FG001|STARTED|Period 1, 10 Days of Wear||36
10137072|NCT02696317|11267611|FG000|COMPLETED|Period 1, 10 Days of Wear||40
10137073|NCT02696317|11267612|FG001|COMPLETED|Period 1, 10 Days of Wear||36
10137074|NCT02696317|11267611|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0
10137075|NCT02696317|11267612|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0
10137076|NCT02696317|11267611|FG000|STARTED|Period 2, 10 Days of Wear||40
10137077|NCT02696317|11267612|FG001|STARTED|Period 2, 10 Days of Wear||36
10137078|NCT02696317|11267611|FG000|COMPLETED|Period 2, 10 Days of Wear||39
10137079|NCT02696317|11267612|FG001|COMPLETED|Period 2, 10 Days of Wear||36
10137080|NCT02696317|11267611|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1
10137081|NCT02696317|11267612|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
10137082|NCT02696434|11267622|FG000|STARTED|Overall Study||50
10137083|NCT02696434|11267623|FG001|STARTED|Overall Study||51
10137084|NCT02696434|11267622|FG000|COMPLETED|Overall Study||28
10137085|NCT02696434|11267623|FG001|COMPLETED|Overall Study||33
10137086|NCT02696434|11267622|FG000|NOT COMPLETED|Overall Study||22
10137087|NCT02696434|11267623|FG001|NOT COMPLETED|Overall Study||18
10137088|NCT02696785|11267633|FG000|STARTED|Blinded Treatment Period||87
10137089|NCT02696785|11267634|FG001|STARTED|Blinded Treatment Period||90
10137090|NCT02696785|11267635|FG002|STARTED|Blinded Treatment Period||83
10137091|NCT02696785|11267636|FG003|STARTED|Blinded Treatment Period||81
10137092|NCT02696785|11267633|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
10137093|NCT02696785|11267634|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
10137094|NCT02696785|11267635|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
10137095|NCT02696785|11267636|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
10137096|NCT02696785|11267633|FG000|COMPLETED|Blinded Treatment Period||86
10137097|NCT02696785|11267634|FG001|COMPLETED|Blinded Treatment Period||88
10137098|NCT02696785|11267635|FG002|COMPLETED|Blinded Treatment Period||79
10137099|NCT02696785|11267636|FG003|COMPLETED|Blinded Treatment Period||78
10137100|NCT02696785|11267633|FG000|NOT COMPLETED|Blinded Treatment Period||1
10137101|NCT02696785|11267634|FG001|NOT COMPLETED|Blinded Treatment Period||2
10137102|NCT02696785|11267635|FG002|NOT COMPLETED|Blinded Treatment Period||4
10137103|NCT02696785|11267636|FG003|NOT COMPLETED|Blinded Treatment Period||3
10137104|NCT02696785|11267633|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
10137105|NCT02696785|11267634|FG001|STARTED|Washout Period||88
10137106|NCT02696785|11267635|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
10137107|NCT02696785|11267636|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
10137108|NCT02696785|11267633|FG000|COMPLETED|Washout Period||0
10137109|NCT02696785|11267634|FG001|COMPLETED|Washout Period||86
10137110|NCT02696785|11267635|FG002|COMPLETED|Washout Period||0
10137111|NCT02696785|11267636|FG003|COMPLETED|Washout Period||0
10137112|NCT02696785|11267633|FG000|NOT COMPLETED|Washout Period||0
10137113|NCT02696785|11267634|FG001|NOT COMPLETED|Washout Period||2
10137114|NCT02696785|11267635|FG002|NOT COMPLETED|Washout Period||0
10137115|NCT02696785|11267636|FG003|NOT COMPLETED|Washout Period||0
10137116|NCT02696785|11267633|FG000|STARTED|Extended Treatment Period||86
10137117|NCT02696785|11267634|FG001|STARTED|Extended Treatment Period||86
10137118|NCT02696785|11267635|FG002|STARTED|Extended Treatment Period||79
10137119|NCT02696785|11267636|FG003|STARTED|Extended Treatment Period||78
10137120|NCT02696785|11267633|FG000|COMPLETED|Extended Treatment Period||83
10137121|NCT02696785|11267634|FG001|COMPLETED|Extended Treatment Period||80
10137122|NCT02696785|11267635|FG002|COMPLETED|Extended Treatment Period||74
10137123|NCT02696785|11267636|FG003|COMPLETED|Extended Treatment Period||72
10137124|NCT02696785|11267633|FG000|NOT COMPLETED|Extended Treatment Period||3
10137125|NCT02696785|11267634|FG001|NOT COMPLETED|Extended Treatment Period||6
10137126|NCT02696785|11267635|FG002|NOT COMPLETED|Extended Treatment Period||5
10137127|NCT02696785|11267636|FG003|NOT COMPLETED|Extended Treatment Period||6
10137128|NCT02696785|11267633|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
10137129|NCT02696785|11267634|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
10137130|NCT02696785|11267635|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
10137131|NCT02696785|11267636|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
10137132|NCT02696785|11267633|FG000|COMPLETED|Follow-up Period||0
10137133|NCT02696785|11267634|FG001|COMPLETED|Follow-up Period||0
10137134|NCT02696785|11267635|FG002|COMPLETED|Follow-up Period||11
10137135|NCT02696785|11267636|FG003|COMPLETED|Follow-up Period||8
10137136|NCT02696785|11267633|FG000|NOT COMPLETED|Follow-up Period||1
10137137|NCT02696785|11267634|FG001|NOT COMPLETED|Follow-up Period||0
10137138|NCT02696785|11267635|FG002|NOT COMPLETED|Follow-up Period||13
10137139|NCT02696785|11267636|FG003|NOT COMPLETED|Follow-up Period||8
10137140|NCT02696798|11267667|FG000|STARTED|Blinded Treatment Dosing Period||104
10137141|NCT02696798|11267668|FG001|STARTED|Blinded Treatment Dosing Period||114
10137142|NCT02696798|11267669|FG002|STARTED|Blinded Treatment Dosing Period||98
10137143|NCT02696798|11267667|FG000|COMPLETED|Blinded Treatment Dosing Period||93
10137144|NCT02696798|11267668|FG001|COMPLETED|Blinded Treatment Dosing Period||99
10137145|NCT02696798|11267669|FG002|COMPLETED|Blinded Treatment Dosing Period||90
10137146|NCT02696798|11267667|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11
10137147|NCT02696798|11267668|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15
10137148|NCT02696798|11267669|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8
10137149|NCT02696798|11267667|FG000|STARTED|Extended Treatment Period||93
10137150|NCT02696798|11267668|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
10137151|NCT02696798|11267669|FG002|STARTED|Extended Treatment Period||90
10137152|NCT02696798|11267667|FG000|COMPLETED|Extended Treatment Period||81
10137153|NCT02696798|11267668|FG001|COMPLETED|Extended Treatment Period||89
10137154|NCT02696798|11267669|FG002|COMPLETED|Extended Treatment Period||80
10137155|NCT02696798|11267667|FG000|NOT COMPLETED|Extended Treatment Period||12
10137156|NCT02696798|11267668|FG001|NOT COMPLETED|Extended Treatment Period||9
10137157|NCT02696798|11267669|FG002|NOT COMPLETED|Extended Treatment Period||10
10137158|NCT02696798|11267667|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
10137159|NCT02696798|11267668|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
10137160|NCT02696798|11267669|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
10137161|NCT02696798|11267667|FG000|COMPLETED|Post-treatment Follow-up Period||0
10137162|NCT02696798|11267668|FG001|COMPLETED|Post-treatment Follow-up Period||8
10137163|NCT02696798|11267669|FG002|COMPLETED|Post-treatment Follow-up Period||3
10137164|NCT02696798|11267667|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5
10137165|NCT02696798|11267668|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26
10137166|NCT02696798|11267669|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19
10137167|NCT02696850|11267693|FG000|STARTED|Overall Study||40
10137168|NCT02696850|11267694|FG001|STARTED|Overall Study||40
10137169|NCT02696850|11267693|FG000|COMPLETED|Overall Study||29
10137170|NCT02696850|11267694|FG001|COMPLETED|Overall Study||32
10137171|NCT02696850|11267693|FG000|NOT COMPLETED|Overall Study||11
10137172|NCT02696850|11267694|FG001|NOT COMPLETED|Overall Study||8
10137173|NCT02696902|11267703|FG000|STARTED|Overall Study||85
10137174|NCT02696902|11267704|FG001|STARTED|Overall Study||16
10137175|NCT02696902|11267705|FG002|STARTED|Overall Study||87
10137176|NCT02696902|11267703|FG000|Treated|Overall Study||83
10137177|NCT02696902|11267704|FG001|Treated|Overall Study||16
10137178|NCT02696902|11267705|FG002|Treated|Overall Study||85
10137179|NCT02696902|11267703|FG000|Intent-to-treat (ITT) Population|Overall Study||85
10137180|NCT02696902|11267704|FG001|Intent-to-treat (ITT) Population|Overall Study||16
10137181|NCT02696902|11267705|FG002|Intent-to-treat (ITT) Population|Overall Study||87
10137182|NCT02696902|11267703|FG000|As-treated Population|Overall Study||83
10137183|NCT02696902|11267704|FG001|As-treated Population|Overall Study||16
10137184|NCT02696902|11267705|FG002|As-treated Population|Overall Study||85
10137185|NCT02696902|11267703|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83
10137186|NCT02696902|11267704|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16
10137187|NCT02696902|11267705|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85
10137188|NCT02696902|11267703|FG000|COMPLETED|Overall Study||63
10137189|NCT02696902|11267704|FG001|COMPLETED|Overall Study||12
10137190|NCT02696902|11267705|FG002|COMPLETED|Overall Study||59
10137191|NCT02696902|11267703|FG000|NOT COMPLETED|Overall Study||22
10137192|NCT02696902|11267704|FG001|NOT COMPLETED|Overall Study||4
10137193|NCT02696902|11267705|FG002|NOT COMPLETED|Overall Study||28
10137194|NCT02696967|11267719|FG000|STARTED|Overall Study||4
10137195|NCT02696967|11267720|FG001|STARTED|Overall Study||6
10137196|NCT02696967|11267721|FG002|STARTED|Overall Study||6
10137197|NCT02696967|11267722|FG003|STARTED|Overall Study||10
10137198|NCT02696967|11267719|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10137199|NCT02696967|11267720|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6
10137200|NCT02696967|11267721|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10137201|NCT02696967|11267722|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10137202|NCT02696967|11267719|FG000|COMPLETED|Overall Study||4
10137203|NCT02696967|11267720|FG001|COMPLETED|Overall Study||6
10137204|NCT02696967|11267721|FG002|COMPLETED|Overall Study||6
10137205|NCT02696967|11267722|FG003|COMPLETED|Overall Study||10
10137206|NCT02696967|11267719|FG000|NOT COMPLETED|Overall Study||0
10137207|NCT02696967|11267720|FG001|NOT COMPLETED|Overall Study||0
10137208|NCT02696967|11267721|FG002|NOT COMPLETED|Overall Study||0
10137209|NCT02696967|11267722|FG003|NOT COMPLETED|Overall Study||0
10137210|NCT02697071|11267734|FG000|STARTED|Overall Study||18
10137211|NCT02697071|11267735|FG001|STARTED|Overall Study||16
10137212|NCT02697071|11267734|FG000|COMPLETED|Overall Study||18
10137213|NCT02697071|11267735|FG001|COMPLETED|Overall Study||16
10137214|NCT02697071|11267734|FG000|NOT COMPLETED|Overall Study||0
10137215|NCT02697071|11267735|FG001|NOT COMPLETED|Overall Study||0
10137216|NCT02697188|11267741|FG000|STARTED|TE Period 1 - 400 mg QD||12
10137217|NCT02697188|11267741|FG000|COMPLETED|TE Period 1 - 400 mg QD||12
10137218|NCT02697188|11267741|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0
10137219|NCT02697188|11267741|FG000|STARTED|TU Period 2 - 200 mg QD||12
10137220|NCT02697188|11267741|FG000|COMPLETED|TU Period 2 - 200 mg QD||12
10137221|NCT02697188|11267741|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0
10137222|NCT02697188|11267741|FG000|STARTED|TU Period 3 - 200 mg BID||12
10137223|NCT02697188|11267741|FG000|COMPLETED|TU Period 3 - 200 mg BID||12
10137224|NCT02697188|11267741|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0
10137225|NCT02697188|11267741|FG000|STARTED|TU Period 4 - 400 BID||12
10137226|NCT02697188|11267741|FG000|COMPLETED|TU Period 4 - 400 BID||12
10137227|NCT02697188|11267741|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0
10137228|NCT02697188|11267741|FG000|STARTED|TE Period 5 - 800 mg BID||12
9848852|NCT00862719|10961708|FG001|NOT COMPLETED|Overall Study||6
9848853|NCT00862719|10961709|FG002|NOT COMPLETED|Overall Study||4
9848854|NCT00862719|10961710|FG003|NOT COMPLETED|Overall Study||1
9848855|NCT00862745|10961722|FG000|STARTED|Randomized Control Trial||322
9848856|NCT00862745|10961723|FG001|STARTED|Randomized Control Trial||323
9848857|NCT00862745|10961722|FG000|COMPLETED|Randomized Control Trial||284
9848858|NCT00862745|10961723|FG001|COMPLETED|Randomized Control Trial||284
9848859|NCT00862745|10961722|FG000|NOT COMPLETED|Randomized Control Trial||38
9848860|NCT00862745|10961723|FG001|NOT COMPLETED|Randomized Control Trial||39
9848861|NCT00862745|10961722|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
9848862|NCT00862745|10961723|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
10137229|NCT02697188|11267741|FG000|COMPLETED|TE Period 5 - 800 mg BID||12
10137230|NCT02697188|11267741|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0
10137231|NCT02697214|11267753|FG000|STARTED|Overall Study||26
10137232|NCT02697214|11267754|FG001|STARTED|Overall Study||25
10137233|NCT02697214|11267755|FG002|STARTED|Overall Study||25
10137234|NCT02697214|11267756|FG003|STARTED|Overall Study||24
10137235|NCT02697214|11267757|FG004|STARTED|Overall Study||50
10137236|NCT02697214|11267758|FG005|STARTED|Overall Study||50
10137237|NCT02697214|11267753|FG000|Heart Rate at 2mph|Overall Study||26
10137238|NCT02697214|11267754|FG001|Heart Rate at 2mph|Overall Study||25
10137239|NCT02697214|11267755|FG002|Heart Rate at 2mph|Overall Study||25
10137240|NCT02697214|11267756|FG003|Heart Rate at 2mph|Overall Study||24
10137241|NCT02697214|11267757|FG004|Heart Rate at 2mph|Overall Study||50
10137242|NCT02697214|11267758|FG005|Heart Rate at 2mph|Overall Study||50
10137243|NCT02697214|11267753|FG000|Heart Rate at 3mph|Overall Study||26
10137244|NCT02697214|11267754|FG001|Heart Rate at 3mph|Overall Study||25
10137245|NCT02697214|11267755|FG002|Heart Rate at 3mph|Overall Study||25
10137246|NCT02697214|11267756|FG003|Heart Rate at 3mph|Overall Study||24
10137247|NCT02697214|11267757|FG004|Heart Rate at 3mph|Overall Study||50
10137248|NCT02697214|11267758|FG005|Heart Rate at 3mph|Overall Study||50
10137249|NCT02697214|11267753|FG000|Heart Rate at 4mph|Overall Study||26
10137250|NCT02697214|11267754|FG001|Heart Rate at 4mph|Overall Study||25
10137251|NCT02697214|11267755|FG002|Heart Rate at 4mph|Overall Study||25
10137252|NCT02697214|11267756|FG003|Heart Rate at 4mph|Overall Study||24
10137253|NCT02697214|11267757|FG004|Heart Rate at 4mph|Overall Study||50
10137254|NCT02697214|11267758|FG005|Heart Rate at 4mph|Overall Study||50
10137255|NCT02697214|11267753|FG000|Heart Rate at 6mph|Overall Study||26
10137256|NCT02697214|11267754|FG001|Heart Rate at 6mph|Overall Study||25
10137257|NCT02697214|11267755|FG002|Heart Rate at 6mph|Overall Study||25
10137258|NCT02697214|11267756|FG003|Heart Rate at 6mph|Overall Study||24
10137259|NCT02697214|11267757|FG004|Heart Rate at 6mph|Overall Study||50
10137260|NCT02697214|11267758|FG005|Heart Rate at 6mph|Overall Study||50
10137261|NCT02697214|11267753|FG000|COMPLETED|Overall Study||26
10137262|NCT02697214|11267754|FG001|COMPLETED|Overall Study||25
10137263|NCT02697214|11267755|FG002|COMPLETED|Overall Study||25
10137264|NCT02697214|11267756|FG003|COMPLETED|Overall Study||24
10137265|NCT02697214|11267757|FG004|COMPLETED|Overall Study||50
10137266|NCT02697214|11267758|FG005|COMPLETED|Overall Study||50
10137267|NCT02697214|11267753|FG000|NOT COMPLETED|Overall Study||0
10137268|NCT02697214|11267754|FG001|NOT COMPLETED|Overall Study||0
10137269|NCT02697214|11267755|FG002|NOT COMPLETED|Overall Study||0
10137270|NCT02697214|11267756|FG003|NOT COMPLETED|Overall Study||0
10137271|NCT02697214|11267757|FG004|NOT COMPLETED|Overall Study||0
10137272|NCT02697214|11267758|FG005|NOT COMPLETED|Overall Study||0
10137273|NCT02697240|11267768|FG000|STARTED|Overall Study||4
10137274|NCT02697240|11267768|FG000|COMPLETED|Overall Study||4
10137275|NCT02697240|11267768|FG000|NOT COMPLETED|Overall Study||0
10137276|NCT02697292|11267774|FG000|STARTED|Overall Study||9
10137277|NCT02697292|11267775|FG001|STARTED|Overall Study||8
10137278|NCT02697292|11267774|FG000|COMPLETED|Overall Study||9
10137279|NCT02697292|11267775|FG001|COMPLETED|Overall Study||8
10137280|NCT02697292|11267774|FG000|NOT COMPLETED|Overall Study||0
10137281|NCT02697292|11267775|FG001|NOT COMPLETED|Overall Study||0
10137282|NCT02697435|11267784|FG000|STARTED|Overall Study||25
10137283|NCT02697435|11267785|FG001|STARTED|Overall Study||30
10137284|NCT02697435|11267784|FG000|COMPLETED|Overall Study||24
10137285|NCT02697435|11267785|FG001|COMPLETED|Overall Study||26
10137286|NCT02697435|11267784|FG000|NOT COMPLETED|Overall Study||1
10137287|NCT02697435|11267785|FG001|NOT COMPLETED|Overall Study||4
10137288|NCT02697591|11267802|FG000|STARTED|Overall Study||4
10137289|NCT02697591|11267803|FG001|STARTED|Overall Study||4
10137290|NCT02697591|11267804|FG002|STARTED|Overall Study||4
10137291|NCT02697591|11267805|FG003|STARTED|Overall Study||3
10137292|NCT02697591|11267806|FG004|STARTED|Overall Study||15
10137293|NCT02697591|11267807|FG005|STARTED|Overall Study||18
10137294|NCT02697591|11267808|FG006|STARTED|Overall Study||16
10137295|NCT02697591|11267809|FG007|STARTED|Overall Study||4
10137296|NCT02697591|11267810|FG008|STARTED|Overall Study||10
10137297|NCT02697591|11267811|FG009|STARTED|Overall Study||22
10137298|NCT02697591|11267802|FG000|COMPLETED|Overall Study||0
10137299|NCT02697591|11267803|FG001|COMPLETED|Overall Study||0
10137300|NCT02697591|11267804|FG002|COMPLETED|Overall Study||1
10137301|NCT02697591|11267805|FG003|COMPLETED|Overall Study||0
10137302|NCT02697591|11267806|FG004|COMPLETED|Overall Study||2
10137303|NCT02697591|11267807|FG005|COMPLETED|Overall Study||2
10137304|NCT02697591|11267808|FG006|COMPLETED|Overall Study||0
10137305|NCT02697591|11267809|FG007|COMPLETED|Overall Study||1
10137306|NCT02697591|11267810|FG008|COMPLETED|Overall Study||1
10137307|NCT02697591|11267811|FG009|COMPLETED|Overall Study||2
10137308|NCT02697591|11267802|FG000|NOT COMPLETED|Overall Study||4
10137309|NCT02697591|11267803|FG001|NOT COMPLETED|Overall Study||4
10137310|NCT02697591|11267804|FG002|NOT COMPLETED|Overall Study||3
10137311|NCT02697591|11267805|FG003|NOT COMPLETED|Overall Study||3
10137312|NCT02697591|11267806|FG004|NOT COMPLETED|Overall Study||13
10137313|NCT02697591|11267807|FG005|NOT COMPLETED|Overall Study||16
10137314|NCT02697591|11267808|FG006|NOT COMPLETED|Overall Study||16
10137315|NCT02697591|11267809|FG007|NOT COMPLETED|Overall Study||3
10137316|NCT02697591|11267810|FG008|NOT COMPLETED|Overall Study||9
10137317|NCT02697591|11267811|FG009|NOT COMPLETED|Overall Study||20
10137318|NCT02697617|11267834|FG000|STARTED|Overall Study||9
10137319|NCT02697617|11267835|FG001|STARTED|Overall Study||9
10137320|NCT02697617|11267834|FG000|COMPLETED|Overall Study|15 completed both arms|8
10137321|NCT02697617|11267835|FG001|COMPLETED|Overall Study||7
10137322|NCT02697617|11267834|FG000|NOT COMPLETED|Overall Study||1
10137323|NCT02697617|11267835|FG001|NOT COMPLETED|Overall Study||2
10137324|NCT02697734|11267847|FG000|STARTED|Core Phase - up to Week 48||48
10137325|NCT02697734|11267848|FG001|STARTED|Core Phase - up to Week 48||25
10137326|NCT02697734|11267847|FG000|COMPLETED|Core Phase - up to Week 48||42
10137327|NCT02697734|11267848|FG001|COMPLETED|Core Phase - up to Week 48||23
10137328|NCT02697734|11267847|FG000|NOT COMPLETED|Core Phase - up to Week 48||6
10137329|NCT02697734|11267848|FG001|NOT COMPLETED|Core Phase - up to Week 48||2
10137330|NCT02697734|11267847|FG000|STARTED|Optional Extension Phase||38
10137331|NCT02697734|11267848|FG001|STARTED|Optional Extension Phase||22
10137332|NCT02697734|11267847|FG000|COMPLETED|Optional Extension Phase||33
10137333|NCT02697734|11267848|FG001|COMPLETED|Optional Extension Phase||20
10137334|NCT02697734|11267847|FG000|NOT COMPLETED|Optional Extension Phase||5
10137335|NCT02697734|11267848|FG001|NOT COMPLETED|Optional Extension Phase||2
10137336|NCT02697773|11267865|FG000|STARTED|Overall Study||233
10137337|NCT02697773|11267866|FG001|STARTED|Overall Study||232
10137338|NCT02697773|11267867|FG002|STARTED|Overall Study||233
10137339|NCT02697773|11267865|FG000|Treated|Overall Study||232
10137340|NCT02697773|11267866|FG001|Treated|Overall Study||231
10137341|NCT02697773|11267867|FG002|Treated|Overall Study||233
10137342|NCT02697773|11267865|FG000|COMPLETED|Overall Study||195
10137343|NCT02697773|11267866|FG001|COMPLETED|Overall Study||194
10137344|NCT02697773|11267867|FG002|COMPLETED|Overall Study||193
10137345|NCT02697773|11267865|FG000|NOT COMPLETED|Overall Study||38
10137346|NCT02697773|11267866|FG001|NOT COMPLETED|Overall Study||38
10137347|NCT02697773|11267867|FG002|NOT COMPLETED|Overall Study||40
10137348|NCT02697890|11267877|FG000|STARTED|Overall Study||14
10137349|NCT02697890|11267878|FG001|STARTED|Overall Study||14
10137350|NCT02697890|11267877|FG000|COMPLETED|Overall Study||14
10137351|NCT02697890|11267878|FG001|COMPLETED|Overall Study||14
10137352|NCT02697890|11267877|FG000|NOT COMPLETED|Overall Study||0
10137353|NCT02697890|11267878|FG001|NOT COMPLETED|Overall Study||0
10137354|NCT02697916|11267886|FG000|STARTED|Overall Study||7540
10137355|NCT02697916|11267887|FG001|STARTED|Overall Study||7536
10137356|NCT02697916|11267886|FG000|COMPLETED|Overall Study||6962
10137357|NCT02697916|11267887|FG001|COMPLETED|Overall Study||6828
10137358|NCT02697916|11267886|FG000|NOT COMPLETED|Overall Study||578
10137359|NCT02697916|11267887|FG001|NOT COMPLETED|Overall Study||708
10137360|NCT02698033|11267893|FG000|STARTED|Overall Study||7
10137361|NCT02698033|11267893|FG000|COMPLETED|Overall Study||6
10137362|NCT02698033|11267893|FG000|NOT COMPLETED|Overall Study||1
10137363|NCT02698176|11267900|FG000|STARTED|Overall Study||9
10137364|NCT02698176|11267901|FG001|STARTED|Overall Study||3
10137365|NCT02698176|11267902|FG002|STARTED|Overall Study||1
10137366|NCT02698176|11267903|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0
10137367|NCT02698176|11267900|FG000|COMPLETED|Overall Study||0
10137368|NCT02698176|11267901|FG001|COMPLETED|Overall Study||0
10137369|NCT02698176|11267902|FG002|COMPLETED|Overall Study||0
10137370|NCT02698176|11267903|FG003|COMPLETED|Overall Study||0
10137371|NCT02698176|11267900|FG000|NOT COMPLETED|Overall Study||9
10137372|NCT02698176|11267901|FG001|NOT COMPLETED|Overall Study||3
10137373|NCT02698176|11267902|FG002|NOT COMPLETED|Overall Study||1
10137374|NCT02698176|11267903|FG003|NOT COMPLETED|Overall Study||0
10137375|NCT02698189|11267916|FG000|STARTED|Overall Study||3
10137376|NCT02698189|11267917|FG001|STARTED|Overall Study||6
10137377|NCT02698189|11267916|FG000|COMPLETED|Overall Study||0
10137378|NCT02698189|11267917|FG001|COMPLETED|Overall Study||0
10137379|NCT02698189|11267916|FG000|NOT COMPLETED|Overall Study||3
10137380|NCT02698189|11267917|FG001|NOT COMPLETED|Overall Study||6
10137381|NCT02698215|11267927|FG000|STARTED|Overall Study||83
10137382|NCT02698215|11267928|FG001|STARTED|Overall Study||82
10137383|NCT02698215|11267927|FG000|COMPLETED|Overall Study||55
10137384|NCT02698215|11267928|FG001|COMPLETED|Overall Study||64
10137385|NCT02698215|11267927|FG000|NOT COMPLETED|Overall Study||28
10137386|NCT02698215|11267928|FG001|NOT COMPLETED|Overall Study||18
10196609|NCT03364309|11324825|FG008|STARTED|Induction Period||0
10196610|NCT03364309|11324826|FG009|STARTED|Induction Period||0
10196611|NCT03364309|11324827|FG010|STARTED|Induction Period||0
10196612|NCT03364309|11324828|FG011|STARTED|Induction Period||0
10196613|NCT03364309|11324829|FG012|STARTED|Induction Period||0
10196614|NCT03364309|11324830|FG013|STARTED|Induction Period||0
10196615|NCT03364309|11324831|FG014|STARTED|Induction Period||0
10196616|NCT03364309|11324832|FG015|STARTED|Induction Period||0
10196617|NCT03364309|11324833|FG016|STARTED|Induction Period||0
10196618|NCT03364309|11324834|FG017|STARTED|Induction Period||0
10196619|NCT03364309|11324835|FG018|STARTED|Induction Period||0
10196620|NCT03364309|11324817|FG000|Received at Least One Dose of Study Drug|Induction Period||88
10196621|NCT03364309|11324818|FG001|Received at Least One Dose of Study Drug|Induction Period||174
10196622|NCT03364309|11324819|FG002|Received at Least One Dose of Study Drug|Induction Period||176
10196623|NCT03364309|11324820|FG003|Received at Least One Dose of Study Drug|Induction Period||0
10196624|NCT03364309|11324821|FG004|Received at Least One Dose of Study Drug|Induction Period||0
10196625|NCT03364309|11324822|FG005|Received at Least One Dose of Study Drug|Induction Period||0
10196626|NCT03364309|11324823|FG006|Received at Least One Dose of Study Drug|Induction Period||0
10196627|NCT03364309|11324824|FG007|Received at Least One Dose of Study Drug|Induction Period||0
10196628|NCT03364309|11324825|FG008|Received at Least One Dose of Study Drug|Induction Period||0
10196629|NCT03364309|11324826|FG009|Received at Least One Dose of Study Drug|Induction Period||0
9707143|NCT02317627|10806324|FG001|STARTED|Overall Study||13
9707144|NCT02317627|10806325|FG002|STARTED|Overall Study||12
9707145|NCT02317627|10806323|FG000|COMPLETED|Overall Study||11
9707146|NCT02317627|10806324|FG001|COMPLETED|Overall Study||8
9707147|NCT02317627|10806325|FG002|COMPLETED|Overall Study||8
9707148|NCT02317627|10806323|FG000|NOT COMPLETED|Overall Study||2
9707149|NCT02317627|10806324|FG001|NOT COMPLETED|Overall Study||5
9707150|NCT02317627|10806325|FG002|NOT COMPLETED|Overall Study||4
9707151|NCT01935128|10806339|FG000|STARTED|Overall Study||50
9707152|NCT01935128|10806339|FG000|COMPLETED|Overall Study||43
9707153|NCT01935128|10806339|FG000|NOT COMPLETED|Overall Study||7
10196630|NCT03364309|11324827|FG010|Received at Least One Dose of Study Drug|Induction Period||0
10196631|NCT03364309|11324828|FG011|Received at Least One Dose of Study Drug|Induction Period||0
10196632|NCT03364309|11324829|FG012|Received at Least One Dose of Study Drug|Induction Period||0
10196633|NCT03364309|11324830|FG013|Received at Least One Dose of Study Drug|Induction Period||0
10196634|NCT03364309|11324831|FG014|Received at Least One Dose of Study Drug|Induction Period||0
10137387|NCT02698241|11267934|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79
10137388|NCT02698241|11267934|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
10137389|NCT02698241|11267934|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
10137390|NCT02698241|11267934|FG000|NOT COMPLETED|Overall Study||34
10137391|NCT02698371|11267938|FG000|STARTED|All Participants Flow||38
10137392|NCT02698371|11267938|FG000|COMPLETED|All Participants Flow||35
10137393|NCT02698371|11267938|FG000|NOT COMPLETED|All Participants Flow||3
10137394|NCT02698371|11267938|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
10137395|NCT02698371|11267938|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
10137396|NCT02698371|11267938|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
10137397|NCT02698371|11267938|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
10137398|NCT02698371|11267938|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
10137399|NCT02698371|11267938|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
10137400|NCT02698371|11267938|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
10137401|NCT02698371|11267938|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
10137402|NCT02698371|11267938|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
10137403|NCT02698371|11267938|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
10137404|NCT02698371|11267938|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
10137405|NCT02698371|11267938|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
10137406|NCT02698371|11267938|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
10137407|NCT02698371|11267938|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
10137408|NCT02698371|11267938|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
10137409|NCT02698371|11267938|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
10137410|NCT02698371|11267938|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
10137411|NCT02698371|11267938|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
10137412|NCT02698410|11267954|FG000|STARTED|Overall Study||40
10137413|NCT02698410|11267954|FG000|COMPLETED|Overall Study||36
10137414|NCT02698410|11267954|FG000|NOT COMPLETED|Overall Study||4
10137415|NCT02698423|11267960|FG000|STARTED|Overall Study||336
10137416|NCT02698423|11267961|FG001|STARTED|Overall Study||331
10137417|NCT02698423|11267960|FG000|COMPLETED|Overall Study||317
10137418|NCT02698423|11267961|FG001|COMPLETED|Overall Study||307
10137419|NCT02698423|11267960|FG000|NOT COMPLETED|Overall Study||19
10137420|NCT02698423|11267961|FG001|NOT COMPLETED|Overall Study||24
10137421|NCT02698436|11267971|FG000|STARTED|Overall Study||59
10137422|NCT02698436|11267972|FG001|STARTED|Overall Study||58
10137423|NCT02698436|11267971|FG000|COMPLETED|Overall Study||52
10137424|NCT02698436|11267972|FG001|COMPLETED|Overall Study||51
10137425|NCT02698436|11267971|FG000|NOT COMPLETED|Overall Study||7
10137426|NCT02698436|11267972|FG001|NOT COMPLETED|Overall Study||7
10137427|NCT02698475|11267978|FG000|STARTED|Main Study Period||44
10137428|NCT02698475|11267978|FG000|COMPLETED|Main Study Period||41
10137429|NCT02698475|11267978|FG000|NOT COMPLETED|Main Study Period||3
10137430|NCT02698475|11267978|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28
10137431|NCT02698475|11267978|FG000|COMPLETED|Long-Term Extension Period||0
10137432|NCT02698475|11267978|FG000|NOT COMPLETED|Long-Term Extension Period||28
10137433|NCT02698566|11267985|FG000|STARTED|Overall Study||35
10137434|NCT02698566|11267986|FG001|STARTED|Overall Study||3
10137435|NCT02698566|11267985|FG000|COMPLETED|Overall Study||35
10137436|NCT02698566|11267986|FG001|COMPLETED|Overall Study||3
10137437|NCT02698566|11267985|FG000|NOT COMPLETED|Overall Study||0
10137438|NCT02698566|11267986|FG001|NOT COMPLETED|Overall Study||0
10137439|NCT02698735|11267990|FG000|STARTED|Overall Study||5
10137440|NCT02698735|11267990|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
10137441|NCT02698735|11267990|FG000|NOT COMPLETED|Overall Study||0
10137442|NCT02698787|11268002|FG000|STARTED|First Intervention (3 Months)||6
10137443|NCT02698787|11268003|FG001|STARTED|First Intervention (3 Months)||5
10137444|NCT02698787|11268002|FG000|COMPLETED|First Intervention (3 Months)||6
10137445|NCT02698787|11268003|FG001|COMPLETED|First Intervention (3 Months)||5
10137446|NCT02698787|11268002|FG000|NOT COMPLETED|First Intervention (3 Months)||0
10137447|NCT02698787|11268003|FG001|NOT COMPLETED|First Intervention (3 Months)||0
10137448|NCT02698787|11268002|FG000|STARTED|Second Intervention (3 Months)||6
10137449|NCT02698787|11268003|FG001|STARTED|Second Intervention (3 Months)||5
10137450|NCT02698787|11268002|FG000|COMPLETED|Second Intervention (3 Months)||6
10137451|NCT02698787|11268003|FG001|COMPLETED|Second Intervention (3 Months)||4
10137452|NCT02698787|11268002|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
10137453|NCT02698787|11268003|FG001|NOT COMPLETED|Second Intervention (3 Months)||1
10137454|NCT02698800|11268010|FG000|STARTED|Overall Study||7
10137455|NCT02698800|11268011|FG001|STARTED|Overall Study||8
10137456|NCT02698800|11268010|FG000|COMPLETED|Overall Study||6
10137457|NCT02698800|11268011|FG001|COMPLETED|Overall Study||8
10137458|NCT02698800|11268010|FG000|NOT COMPLETED|Overall Study||1
10137459|NCT02698800|11268011|FG001|NOT COMPLETED|Overall Study||0
10137460|NCT02699099|11268020|FG000|STARTED|Overall Study||231
10137461|NCT02699099|11268021|FG001|STARTED|Overall Study||236
10137462|NCT02699099|11268022|FG002|STARTED|Overall Study||232
10137463|NCT02699099|11268020|FG000|COMPLETED|Overall Study||223
10137464|NCT02699099|11268021|FG001|COMPLETED|Overall Study||233
10137465|NCT02699099|11268022|FG002|COMPLETED|Overall Study||226
10137466|NCT02699099|11268020|FG000|NOT COMPLETED|Overall Study||8
10137467|NCT02699099|11268021|FG001|NOT COMPLETED|Overall Study||3
10137468|NCT02699099|11268022|FG002|NOT COMPLETED|Overall Study||6
10137469|NCT02699125|11268032|FG000|STARTED|Placebo||21
10137470|NCT02699125|11268033|FG001|STARTED|Placebo||20
10137471|NCT02699125|11268032|FG000|COMPLETED|Placebo||18
10137472|NCT02699125|11268033|FG001|COMPLETED|Placebo||16
10137473|NCT02699125|11268032|FG000|NOT COMPLETED|Placebo||3
10137474|NCT02699125|11268033|FG001|NOT COMPLETED|Placebo||4
10137475|NCT02699125|11268032|FG000|STARTED|First Intervention (6 Weeks).||18
10137476|NCT02699125|11268033|FG001|STARTED|First Intervention (6 Weeks).||16
10137477|NCT02699125|11268032|FG000|COMPLETED|First Intervention (6 Weeks).||18
10137478|NCT02699125|11268033|FG001|COMPLETED|First Intervention (6 Weeks).||16
10137479|NCT02699125|11268032|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0
10137480|NCT02699125|11268033|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0
10137481|NCT02699125|11268032|FG000|STARTED|Second Intervention (6 Weeks).||18
10137482|NCT02699125|11268033|FG001|STARTED|Second Intervention (6 Weeks).||16
10137483|NCT02699125|11268032|FG000|COMPLETED|Second Intervention (6 Weeks).||11
10137484|NCT02699125|11268033|FG001|COMPLETED|Second Intervention (6 Weeks).||14
10137485|NCT02699125|11268032|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7
10137486|NCT02699125|11268033|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
10137487|NCT02699450|11268046|FG000|STARTED|Overall Study||90
10137488|NCT02699450|11268047|FG001|STARTED|Overall Study||55
10137489|NCT02699450|11268048|FG002|STARTED|Overall Study||82
10137490|NCT02699450|11268046|FG000|Received at Least One Dose of Study Drug|Overall Study||89
10137491|NCT02699450|11268047|FG001|Received at Least One Dose of Study Drug|Overall Study||55
10137492|NCT02699450|11268048|FG002|Received at Least One Dose of Study Drug|Overall Study||80
10137493|NCT02699450|11268046|FG000|Completed up to Week 24|Overall Study||81
10137494|NCT02699450|11268047|FG001|Completed up to Week 24|Overall Study||53
10137495|NCT02699450|11268048|FG002|Completed up to Week 24|Overall Study||73
10137496|NCT02699450|11268046|FG000|COMPLETED|Overall Study||75
10137497|NCT02699450|11268047|FG001|COMPLETED|Overall Study||50
10137498|NCT02699450|11268048|FG002|COMPLETED|Overall Study||67
10137499|NCT02699450|11268046|FG000|NOT COMPLETED|Overall Study||15
10137500|NCT02699450|11268047|FG001|NOT COMPLETED|Overall Study||5
10137501|NCT02699450|11268048|FG002|NOT COMPLETED|Overall Study||15
10137502|NCT02699463|11268059|FG000|STARTED|Overall Study||115
10137503|NCT02699463|11268060|FG001|STARTED|Overall Study||118
10137504|NCT02699463|11268059|FG000|COMPLETED|Overall Study||100
10137505|NCT02699463|11268060|FG001|COMPLETED|Overall Study||109
10137506|NCT02699463|11268059|FG000|NOT COMPLETED|Overall Study||15
10137507|NCT02699463|11268060|FG001|NOT COMPLETED|Overall Study||9
10137508|NCT02699593|11268066|FG000|STARTED|Period 1||72
10137509|NCT02699593|11268067|FG001|STARTED|Period 1||69
10137510|NCT02699593|11268066|FG000|COMPLETED|Period 1||67
10137511|NCT02699593|11268067|FG001|COMPLETED|Period 1||62
10137512|NCT02699593|11268066|FG000|NOT COMPLETED|Period 1||5
10137513|NCT02699593|11268067|FG001|NOT COMPLETED|Period 1||7
10137514|NCT02699593|11268066|FG000|STARTED|Period 2||67
10137515|NCT02699593|11268067|FG001|STARTED|Period 2||62
10137516|NCT02699593|11268066|FG000|COMPLETED|Period 2||65
10137517|NCT02699593|11268067|FG001|COMPLETED|Period 2||60
10137518|NCT02699593|11268066|FG000|NOT COMPLETED|Period 2||2
10137519|NCT02699593|11268067|FG001|NOT COMPLETED|Period 2||2
10137520|NCT02699632|11268073|FG000|STARTED|Overall Study||360
10137521|NCT02699632|11268073|FG000|COMPLETED|Overall Study||358
10137522|NCT02699632|11268073|FG000|NOT COMPLETED|Overall Study||2
10137523|NCT02699684|11268080|FG000|STARTED|Period 1, First 30 Days of Wear||37
10137524|NCT02699684|11268081|FG001|STARTED|Period 1, First 30 Days of Wear||38
10137525|NCT02699684|11268080|FG000|COMPLETED|Period 1, First 30 Days of Wear||37
10137526|NCT02699684|11268081|FG001|COMPLETED|Period 1, First 30 Days of Wear||38
10137527|NCT02699684|11268080|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10137528|NCT02699684|11268081|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10137529|NCT02699684|11268080|FG000|STARTED|Period 2, Second 30 Days of Wear||37
10137530|NCT02699684|11268081|FG001|STARTED|Period 2, Second 30 Days of Wear||38
10137531|NCT02699684|11268080|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36
10137532|NCT02699684|11268081|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38
10137533|NCT02699684|11268080|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10137534|NCT02699684|11268081|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
10137535|NCT02699749|11268102|FG000|STARTED|Overall Study||3
10137536|NCT02699749|11268103|FG001|STARTED|Overall Study||3
10137537|NCT02699749|11268104|FG002|STARTED|Overall Study||16
10137538|NCT02699749|11268105|FG003|STARTED|Overall Study||3
10137539|NCT02699749|11268106|FG004|STARTED|Overall Study||3
10137540|NCT02699749|11268107|FG005|STARTED|Overall Study||9
10137541|NCT02699749|11268108|FG006|STARTED|Overall Study||6
10137542|NCT02699749|11268109|FG007|STARTED|Overall Study||6
10137543|NCT02699749|11268110|FG008|STARTED|Overall Study||6
10137544|NCT02699749|11268111|FG009|STARTED|Overall Study||6
10137545|NCT02699749|11268112|FG010|STARTED|Overall Study||6
10137546|NCT02699749|11268113|FG011|STARTED|Overall Study||4
10137547|NCT02699749|11268114|FG012|STARTED|Overall Study||3
10137548|NCT02699749|11268115|FG013|STARTED|Overall Study||6
10137549|NCT02699749|11268102|FG000|COMPLETED|Overall Study||0
10137550|NCT02699749|11268103|FG001|COMPLETED|Overall Study||0
10137551|NCT02699749|11268104|FG002|COMPLETED|Overall Study||0
10137552|NCT02699749|11268105|FG003|COMPLETED|Overall Study||0
10137553|NCT02699749|11268106|FG004|COMPLETED|Overall Study||0
10137554|NCT02699749|11268107|FG005|COMPLETED|Overall Study||0
10137555|NCT02699749|11268108|FG006|COMPLETED|Overall Study||0
10137556|NCT02699749|11268109|FG007|COMPLETED|Overall Study||0
10137557|NCT02699749|11268110|FG008|COMPLETED|Overall Study||0
10137558|NCT02699749|11268111|FG009|COMPLETED|Overall Study||0
10137559|NCT02699749|11268112|FG010|COMPLETED|Overall Study||0
10137560|NCT02699749|11268113|FG011|COMPLETED|Overall Study||0
10137561|NCT02699749|11268114|FG012|COMPLETED|Overall Study||0
10137562|NCT02699749|11268115|FG013|COMPLETED|Overall Study||0
10137563|NCT02699749|11268102|FG000|NOT COMPLETED|Overall Study||3
10137564|NCT02699749|11268103|FG001|NOT COMPLETED|Overall Study||3
10137565|NCT02699749|11268104|FG002|NOT COMPLETED|Overall Study||16
10137566|NCT02699749|11268105|FG003|NOT COMPLETED|Overall Study||3
10137567|NCT02699749|11268106|FG004|NOT COMPLETED|Overall Study||3
10137568|NCT02699749|11268107|FG005|NOT COMPLETED|Overall Study||9
10137569|NCT02699749|11268108|FG006|NOT COMPLETED|Overall Study||6
10137570|NCT02699749|11268109|FG007|NOT COMPLETED|Overall Study||6
10137571|NCT02699749|11268110|FG008|NOT COMPLETED|Overall Study||6
10137572|NCT02699749|11268111|FG009|NOT COMPLETED|Overall Study||6
10137573|NCT02699749|11268112|FG010|NOT COMPLETED|Overall Study||6
10137574|NCT02699749|11268113|FG011|NOT COMPLETED|Overall Study||4
10137575|NCT02699749|11268114|FG012|NOT COMPLETED|Overall Study||3
10137576|NCT02699749|11268115|FG013|NOT COMPLETED|Overall Study||6
10137577|NCT02699866|11268145|FG000|STARTED|Overall Study|First study centre initiation.|46
10137578|NCT02699866|11268145|FG000|Included|Overall Study||41
10137579|NCT02699866|11268145|FG000|COMPLETED|Overall Study|Last study centre close-out.|38
10137580|NCT02699866|11268145|FG000|NOT COMPLETED|Overall Study||8
10137581|NCT02699892|11268149|FG000|STARTED|Overall Study||130
10137582|NCT02699892|11268149|FG000|COMPLETED|Overall Study||94
10137583|NCT02699892|11268149|FG000|NOT COMPLETED|Overall Study||36
10137584|NCT02699970|11268153|FG000|STARTED|Overall Study||399
10137585|NCT02699970|11268153|FG000|Intra-system|Overall Study||399
10137586|NCT02699970|11268153|FG000|Inter-system|Overall Study||399
10137587|NCT02699970|11268153|FG000|COMPLETED|Overall Study||399
10137588|NCT02699970|11268153|FG000|NOT COMPLETED|Overall Study||0
10137589|NCT02699983|11268160|FG000|STARTED|Overall Study||18
10137590|NCT02699983|11268161|FG001|STARTED|Overall Study||17
10137591|NCT02699983|11268160|FG000|COMPLETED|Overall Study||17
10137592|NCT02699983|11268161|FG001|COMPLETED|Overall Study||17
10137593|NCT02699983|11268160|FG000|NOT COMPLETED|Overall Study||1
10137594|NCT02699983|11268161|FG001|NOT COMPLETED|Overall Study||0
10137595|NCT02699996|11268173|FG000|STARTED|Overall Study||20
10137596|NCT02699996|11268174|FG001|STARTED|Overall Study||11
10137597|NCT02699996|11268173|FG000|COMPLETED|Overall Study||15
10137598|NCT02699996|11268174|FG001|COMPLETED|Overall Study||9
10137599|NCT02699996|11268173|FG000|NOT COMPLETED|Overall Study||5
10137600|NCT02699996|11268174|FG001|NOT COMPLETED|Overall Study||2
10137601|NCT02700165|11268181|FG000|STARTED|Overall Study||14
10137602|NCT02700165|11268181|FG000|COMPLETED|Overall Study||14
10137603|NCT02700165|11268181|FG000|NOT COMPLETED|Overall Study||0
10137604|NCT02700334|11268188|FG000|STARTED|Overall Study||12
10137605|NCT02700334|11268189|FG001|STARTED|Overall Study||12
10137606|NCT02700334|11268188|FG000|COMPLETED|Overall Study||12
10137607|NCT02700334|11268189|FG001|COMPLETED|Overall Study||12
10137608|NCT02700334|11268188|FG000|NOT COMPLETED|Overall Study||0
10137609|NCT02700334|11268189|FG001|NOT COMPLETED|Overall Study||0
10137610|NCT02700412|11268195|FG000|STARTED|Overall Study||80
10137611|NCT02700412|11268195|FG000|COMPLETED|Overall Study||47
10137612|NCT02700412|11268195|FG000|NOT COMPLETED|Overall Study||33
10137613|NCT02700425|11268201|FG000|STARTED|Overall Study||21
10137614|NCT02700425|11268202|FG001|STARTED|Overall Study||20
10137615|NCT02700425|11268201|FG000|COMPLETED|Overall Study||21
10137616|NCT02700425|11268202|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19
10137617|NCT02700425|11268201|FG000|NOT COMPLETED|Overall Study||0
10137618|NCT02700425|11268202|FG001|NOT COMPLETED|Overall Study||1
10137619|NCT02700815|11268212|FG000|STARTED|Overall Study||75
10137620|NCT02700815|11268213|FG001|STARTED|Overall Study||223
10137621|NCT02700815|11268214|FG002|STARTED|Overall Study||223
10137622|NCT02700815|11268215|FG003|STARTED|Overall Study||225
10137623|NCT02700815|11268212|FG000|COMPLETED|Overall Study||74
10137624|NCT02700815|11268213|FG001|COMPLETED|Overall Study||216
10137625|NCT02700815|11268214|FG002|COMPLETED|Overall Study||219
10137626|NCT02700815|11268215|FG003|COMPLETED|Overall Study||218
10137627|NCT02700815|11268212|FG000|NOT COMPLETED|Overall Study||1
10137628|NCT02700815|11268213|FG001|NOT COMPLETED|Overall Study||7
10137629|NCT02700815|11268214|FG002|NOT COMPLETED|Overall Study||4
10137630|NCT02700815|11268215|FG003|NOT COMPLETED|Overall Study||7
10137631|NCT02700919|11268228|FG000|STARTED|Overall Study||94
10137632|NCT02700919|11268229|FG001|STARTED|Overall Study||97
10137633|NCT02700919|11268230|FG002|STARTED|Overall Study||91
10137634|NCT02700919|11268228|FG000|COMPLETED|Overall Study||82
10137635|NCT02700919|11268229|FG001|COMPLETED|Overall Study||85
10137636|NCT02700919|11268230|FG002|COMPLETED|Overall Study||87
10137637|NCT02700919|11268228|FG000|NOT COMPLETED|Overall Study||12
10137638|NCT02700919|11268229|FG001|NOT COMPLETED|Overall Study||12
10137639|NCT02700919|11268230|FG002|NOT COMPLETED|Overall Study||4
10137640|NCT02700984|11268240|FG000|STARTED|Overall Study||215
10137641|NCT02700984|11268241|FG001|STARTED|Overall Study||67
10137642|NCT02700984|11268240|FG000|COMPLETED|Overall Study||200
10137643|NCT02700984|11268241|FG001|COMPLETED|Overall Study||53
10137644|NCT02700984|11268240|FG000|NOT COMPLETED|Overall Study||15
10137645|NCT02700984|11268241|FG001|NOT COMPLETED|Overall Study||14
10137646|NCT02700997|11268257|FG000|STARTED|Overall Study||17
10137647|NCT02700997|11268257|FG000|COMPLETED|Overall Study||15
10137648|NCT02700997|11268257|FG000|NOT COMPLETED|Overall Study||2
10137649|NCT02701049|11268264|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209
10137650|NCT02701049|11268265|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342
10137651|NCT02701049|11268266|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198
10137652|NCT02701049|11268264|FG000|COMPLETED|Overall Study|Total patients included in analysis|209
10137653|NCT02701049|11268265|FG001|COMPLETED|Overall Study|Total patients included in analysis|342
10137654|NCT02701049|11268266|FG002|COMPLETED|Overall Study|Total patients included in analysis|198
10137655|NCT02701049|11268264|FG000|NOT COMPLETED|Overall Study||0
10137656|NCT02701049|11268265|FG001|NOT COMPLETED|Overall Study||0
10137657|NCT02701049|11268266|FG002|NOT COMPLETED|Overall Study||0
10137658|NCT02701062|11268280|FG000|STARTED|Baseline||376
10137659|NCT02701062|11268281|FG001|STARTED|Baseline||186
10137660|NCT02701062|11268280|FG000|COMPLETED|Baseline||376
10137661|NCT02701062|11268281|FG001|COMPLETED|Baseline||186
10137662|NCT02701062|11268280|FG000|NOT COMPLETED|Baseline||0
10137663|NCT02701062|11268281|FG001|NOT COMPLETED|Baseline||0
10137664|NCT02701062|11268280|FG000|STARTED|Index Procedure||376
10137665|NCT02701062|11268281|FG001|STARTED|Index Procedure||186
10137666|NCT02701062|11268280|FG000|COMPLETED|Index Procedure||376
10137667|NCT02701062|11268281|FG001|COMPLETED|Index Procedure||186
10137668|NCT02701062|11268280|FG000|NOT COMPLETED|Index Procedure||0
10137669|NCT02701062|11268281|FG001|NOT COMPLETED|Index Procedure||0
10137670|NCT02701062|11268280|FG000|STARTED|Discharge||376
10137671|NCT02701062|11268281|FG001|STARTED|Discharge||186
10137672|NCT02701062|11268280|FG000|COMPLETED|Discharge||376
10137673|NCT02701062|11268281|FG001|COMPLETED|Discharge||186
10137674|NCT02701062|11268280|FG000|NOT COMPLETED|Discharge||0
10137675|NCT02701062|11268281|FG001|NOT COMPLETED|Discharge||0
10137676|NCT02701062|11268280|FG000|STARTED|30 Day Follow-up||376
10137677|NCT02701062|11268281|FG001|STARTED|30 Day Follow-up||186
10137678|NCT02701062|11268280|FG000|COMPLETED|30 Day Follow-up||366
10137679|NCT02701062|11268281|FG001|COMPLETED|30 Day Follow-up||183
10137680|NCT02701062|11268280|FG000|NOT COMPLETED|30 Day Follow-up||10
10137681|NCT02701062|11268281|FG001|NOT COMPLETED|30 Day Follow-up||3
10137682|NCT02701062|11268280|FG000|STARTED|90 Day Follow-up||366
10137683|NCT02701062|11268281|FG001|STARTED|90 Day Follow-up||183
10137684|NCT02701062|11268280|FG000|COMPLETED|90 Day Follow-up||308
10137685|NCT02701062|11268281|FG001|COMPLETED|90 Day Follow-up||72
10137686|NCT02701062|11268280|FG000|NOT COMPLETED|90 Day Follow-up||58
10137687|NCT02701062|11268281|FG001|NOT COMPLETED|90 Day Follow-up||111
10137688|NCT02701062|11268280|FG000|STARTED|365 Day Follow-up||308
10137689|NCT02701062|11268281|FG001|STARTED|365 Day Follow-up||72
10137690|NCT02701062|11268280|FG000|COMPLETED|365 Day Follow-up||294
10137691|NCT02701062|11268281|FG001|COMPLETED|365 Day Follow-up||69
10137692|NCT02701062|11268280|FG000|NOT COMPLETED|365 Day Follow-up||14
10137693|NCT02701062|11268281|FG001|NOT COMPLETED|365 Day Follow-up||3
10137694|NCT02701101|11268295|FG000|STARTED|Overall Study||189
10137695|NCT02701101|11268295|FG000|COMPLETED|Overall Study||189
10137696|NCT02701101|11268295|FG000|NOT COMPLETED|Overall Study||0
10137697|NCT02701257|11268305|FG000|STARTED|Overall Study||6
10137698|NCT02701257|11268306|FG001|STARTED|Overall Study||6
10137699|NCT02701257|11268307|FG002|STARTED|Overall Study||0
10137700|NCT02701257|11268308|FG003|STARTED|Overall Study||4
10137701|NCT02701257|11268309|FG004|STARTED|Overall Study||4
10137702|NCT02701257|11268305|FG000|COMPLETED|Overall Study||6
10137703|NCT02701257|11268306|FG001|COMPLETED|Overall Study||3
10137704|NCT02701257|11268307|FG002|COMPLETED|Overall Study||0
10137705|NCT02701257|11268308|FG003|COMPLETED|Overall Study||3
10137706|NCT02701257|11268309|FG004|COMPLETED|Overall Study||1
10137707|NCT02701257|11268305|FG000|NOT COMPLETED|Overall Study||0
10137708|NCT02701257|11268306|FG001|NOT COMPLETED|Overall Study||3
10137709|NCT02701257|11268307|FG002|NOT COMPLETED|Overall Study||0
10137710|NCT02701257|11268308|FG003|NOT COMPLETED|Overall Study||1
10137711|NCT02701257|11268309|FG004|NOT COMPLETED|Overall Study||3
10137712|NCT02701270|11268325|FG000|STARTED|First Intervention at Visit 1||2
10137713|NCT02701270|11268326|FG001|STARTED|First Intervention at Visit 1||3
10137714|NCT02701270|11268327|FG002|STARTED|First Intervention at Visit 1||3
10137715|NCT02701270|11268328|FG003|STARTED|First Intervention at Visit 1||3
10137716|NCT02701270|11268325|FG000|COMPLETED|First Intervention at Visit 1||2
10137717|NCT02701270|11268326|FG001|COMPLETED|First Intervention at Visit 1||3
10137718|NCT02701270|11268327|FG002|COMPLETED|First Intervention at Visit 1||3
10137719|NCT02701270|11268328|FG003|COMPLETED|First Intervention at Visit 1||3
10137720|NCT02701270|11268325|FG000|NOT COMPLETED|First Intervention at Visit 1||0
10137721|NCT02701270|11268326|FG001|NOT COMPLETED|First Intervention at Visit 1||0
10137722|NCT02701270|11268327|FG002|NOT COMPLETED|First Intervention at Visit 1||0
10137723|NCT02701270|11268328|FG003|NOT COMPLETED|First Intervention at Visit 1||0
10137724|NCT02701270|11268325|FG000|STARTED|Second Intervention at Visit 2||2
10137725|NCT02701270|11268326|FG001|STARTED|Second Intervention at Visit 2||3
10137726|NCT02701270|11268327|FG002|STARTED|Second Intervention at Visit 2||3
10137727|NCT02701270|11268328|FG003|STARTED|Second Intervention at Visit 2||3
10137728|NCT02701270|11268325|FG000|COMPLETED|Second Intervention at Visit 2||2
10137729|NCT02701270|11268326|FG001|COMPLETED|Second Intervention at Visit 2||3
10137730|NCT02701270|11268327|FG002|COMPLETED|Second Intervention at Visit 2||3
10137731|NCT02701270|11268328|FG003|COMPLETED|Second Intervention at Visit 2||3
10137732|NCT02701270|11268325|FG000|NOT COMPLETED|Second Intervention at Visit 2||0
10137733|NCT02701270|11268326|FG001|NOT COMPLETED|Second Intervention at Visit 2||0
10137734|NCT02701270|11268327|FG002|NOT COMPLETED|Second Intervention at Visit 2||0
10137735|NCT02701270|11268328|FG003|NOT COMPLETED|Second Intervention at Visit 2||0
10137736|NCT02701270|11268325|FG000|STARTED|Third Intervention at Visit 3||2
10137737|NCT02701270|11268326|FG001|STARTED|Third Intervention at Visit 3||3
10137738|NCT02701270|11268327|FG002|STARTED|Third Intervention at Visit 3||3
10137739|NCT02701270|11268328|FG003|STARTED|Third Intervention at Visit 3||3
10137740|NCT02701270|11268325|FG000|COMPLETED|Third Intervention at Visit 3||2
10137741|NCT02701270|11268326|FG001|COMPLETED|Third Intervention at Visit 3||3
10137742|NCT02701270|11268327|FG002|COMPLETED|Third Intervention at Visit 3||3
10137743|NCT02701270|11268328|FG003|COMPLETED|Third Intervention at Visit 3||3
10137744|NCT02701270|11268325|FG000|NOT COMPLETED|Third Intervention at Visit 3||0
10137745|NCT02701270|11268326|FG001|NOT COMPLETED|Third Intervention at Visit 3||0
10137746|NCT02701270|11268327|FG002|NOT COMPLETED|Third Intervention at Visit 3||0
10137747|NCT02701270|11268328|FG003|NOT COMPLETED|Third Intervention at Visit 3||0
10137748|NCT02701270|11268325|FG000|STARTED|Fourth Intervention at Visit 4||2
10137749|NCT02701270|11268326|FG001|STARTED|Fourth Intervention at Visit 4||3
10137750|NCT02701270|11268327|FG002|STARTED|Fourth Intervention at Visit 4||3
10137751|NCT02701270|11268328|FG003|STARTED|Fourth Intervention at Visit 4||3
10137752|NCT02701270|11268325|FG000|COMPLETED|Fourth Intervention at Visit 4||2
10137753|NCT02701270|11268326|FG001|COMPLETED|Fourth Intervention at Visit 4||3
10137754|NCT02701270|11268327|FG002|COMPLETED|Fourth Intervention at Visit 4||3
10137755|NCT02701270|11268328|FG003|COMPLETED|Fourth Intervention at Visit 4||3
10137756|NCT02701270|11268325|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0
10137757|NCT02701270|11268326|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0
10137758|NCT02701270|11268327|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0
10137759|NCT02701270|11268328|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0
10137760|NCT02701296|11268341|FG000|STARTED|Overall Study||42
10137761|NCT02701296|11268342|FG001|STARTED|Overall Study||38
10137762|NCT02701296|11268341|FG000|COMPLETED|Overall Study||42
10137763|NCT02701296|11268342|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
10137764|NCT02701296|11268341|FG000|NOT COMPLETED|Overall Study||0
10137765|NCT02701296|11268342|FG001|NOT COMPLETED|Overall Study||2
10137766|NCT02701361|11268351|FG000|STARTED|Overall Study||31
10137767|NCT02701361|11268352|FG001|STARTED|Overall Study||31
10137768|NCT02701361|11268353|FG002|STARTED|Overall Study||18
10137769|NCT02701361|11268351|FG000|COMPLETED|Overall Study||22
10137770|NCT02701361|11268352|FG001|COMPLETED|Overall Study||28
10137771|NCT02701361|11268353|FG002|COMPLETED|Overall Study||16
10137772|NCT02701361|11268351|FG000|NOT COMPLETED|Overall Study||9
10137773|NCT02701361|11268352|FG001|NOT COMPLETED|Overall Study||3
10137774|NCT02701361|11268353|FG002|NOT COMPLETED|Overall Study||2
10137775|NCT02701387|11268363|FG000|STARTED|Overall Study||7
10137776|NCT02701387|11268363|FG000|COMPLETED|Overall Study||7
10137777|NCT02701387|11268363|FG000|NOT COMPLETED|Overall Study||0
10137778|NCT02701400|11268370|FG000|STARTED|Overall Study||9
10137779|NCT02701400|11268371|FG001|STARTED|Overall Study||9
10137780|NCT02701400|11268370|FG000|COMPLETED|Overall Study||9
10137781|NCT02701400|11268371|FG001|COMPLETED|Overall Study||9
10137782|NCT02701400|11268370|FG000|NOT COMPLETED|Overall Study||0
10137783|NCT02701400|11268371|FG001|NOT COMPLETED|Overall Study||0
10137784|NCT02701413|11268380|FG000|STARTED|Overall Study||33
10137785|NCT02701413|11268381|FG001|STARTED|Overall Study||33
10137786|NCT02701413|11268380|FG000|COMPLETED|Overall Study||26
10137787|NCT02701413|11268381|FG001|COMPLETED|Overall Study||22
10137788|NCT02701413|11268380|FG000|NOT COMPLETED|Overall Study||7
10137789|NCT02701413|11268381|FG001|NOT COMPLETED|Overall Study||11
10137790|NCT02701582|11268389|FG000|STARTED|Overall Study||35
10137791|NCT02701582|11268390|FG001|STARTED|Overall Study||33
10137792|NCT02701582|11268389|FG000|COMPLETED|Overall Study||33
10137793|NCT02701582|11268390|FG001|COMPLETED|Overall Study||33
10137794|NCT02701582|11268389|FG000|NOT COMPLETED|Overall Study||2
10137795|NCT02701582|11268390|FG001|NOT COMPLETED|Overall Study||0
10137796|NCT02701634|11268400|FG000|STARTED|Overall Study||33
10137797|NCT02701634|11268401|FG001|STARTED|Overall Study||33
10137798|NCT02701634|11268400|FG000|COMPLETED|Overall Study||1
10137799|NCT02701634|11268401|FG001|COMPLETED|Overall Study||2
10137800|NCT02701634|11268400|FG000|NOT COMPLETED|Overall Study||32
10137801|NCT02701634|11268401|FG001|NOT COMPLETED|Overall Study||31
10137802|NCT02701647|11268411|FG000|STARTED|Overall Study||17
10137803|NCT02701647|11268412|FG001|STARTED|Overall Study||17
10137804|NCT02701647|11268413|FG002|STARTED|Overall Study||17
10137805|NCT02701647|11268411|FG000|COMPLETED|Overall Study||17
10137806|NCT02701647|11268412|FG001|COMPLETED|Overall Study||17
10137807|NCT02701647|11268413|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
10137808|NCT02701647|11268411|FG000|NOT COMPLETED|Overall Study||0
10137809|NCT02701647|11268412|FG001|NOT COMPLETED|Overall Study||0
10137810|NCT02701647|11268413|FG002|NOT COMPLETED|Overall Study||1
10137811|NCT02701764|11268429|FG000|STARTED|Overall Study||21
10137812|NCT02701764|11268430|FG001|STARTED|Overall Study||22
10137813|NCT02701764|11268429|FG000|COMPLETED|Overall Study||21
10137814|NCT02701764|11268430|FG001|COMPLETED|Overall Study||21
10137815|NCT02701764|11268429|FG000|NOT COMPLETED|Overall Study||0
10137816|NCT02701764|11268430|FG001|NOT COMPLETED|Overall Study||1
10137817|NCT02701868|11268439|FG000|STARTED|Overall Study||21
10137818|NCT02701868|11268440|FG001|STARTED|Overall Study||75
10137819|NCT02701868|11268441|FG002|STARTED|Overall Study||75
10137820|NCT02701868|11268439|FG000|COMPLETED|Overall Study||21
10137821|NCT02701868|11268440|FG001|COMPLETED|Overall Study||75
10137822|NCT02701868|11268441|FG002|COMPLETED|Overall Study||75
10137823|NCT02701868|11268439|FG000|NOT COMPLETED|Overall Study||0
10137824|NCT02701868|11268440|FG001|NOT COMPLETED|Overall Study||0
10137825|NCT02701868|11268441|FG002|NOT COMPLETED|Overall Study||0
10137826|NCT02701985|11268452|FG000|STARTED|Overall Study||37
10137827|NCT02701985|11268453|FG001|STARTED|Overall Study||38
10137828|NCT02701985|11268452|FG000|COMPLETED|Overall Study||34
10137829|NCT02701985|11268453|FG001|COMPLETED|Overall Study||32
10137830|NCT02701985|11268452|FG000|NOT COMPLETED|Overall Study||3
10137831|NCT02701985|11268453|FG001|NOT COMPLETED|Overall Study||6
10137832|NCT02702011|11268464|FG000|STARTED|Overall Study|Started are the treated patients.|11
10137833|NCT02702011|11268465|FG001|STARTED|Overall Study|Started are the treated patients.|13
10137834|NCT02702011|11268466|FG002|STARTED|Overall Study|Started are the treated patients.|12
10137835|NCT02702011|11268467|FG003|STARTED|Overall Study|Started are the treated patients.|12
10137836|NCT02702011|11268464|FG000|COMPLETED|Overall Study||11
10137837|NCT02702011|11268465|FG001|COMPLETED|Overall Study||12
10137838|NCT02702011|11268466|FG002|COMPLETED|Overall Study||12
10137839|NCT02702011|11268467|FG003|COMPLETED|Overall Study||12
10137840|NCT02702011|11268464|FG000|NOT COMPLETED|Overall Study||0
10137841|NCT02702011|11268465|FG001|NOT COMPLETED|Overall Study||1
10137842|NCT02702011|11268466|FG002|NOT COMPLETED|Overall Study||0
10137843|NCT02702011|11268467|FG003|NOT COMPLETED|Overall Study||0
10137844|NCT02702193|11268479|FG000|STARTED|Baseline Assessment/Randomization||86
10137845|NCT02702193|11268480|FG001|STARTED|Baseline Assessment/Randomization||87
10137846|NCT02702193|11268479|FG000|COMPLETED|Baseline Assessment/Randomization||85
10137847|NCT02702193|11268480|FG001|COMPLETED|Baseline Assessment/Randomization||87
10137848|NCT02702193|11268479|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1
10137849|NCT02702193|11268480|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0
10137850|NCT02702193|11268479|FG000|STARTED|4 Month Follow up||86
10137851|NCT02702193|11268480|FG001|STARTED|4 Month Follow up||87
10137852|NCT02702193|11268479|FG000|COMPLETED|4 Month Follow up||68
10137853|NCT02702193|11268480|FG001|COMPLETED|4 Month Follow up||69
10137854|NCT02702193|11268479|FG000|NOT COMPLETED|4 Month Follow up||18
10137855|NCT02702193|11268480|FG001|NOT COMPLETED|4 Month Follow up||18
10137856|NCT02702193|11268479|FG000|STARTED|8 Month Follow up||86
10137857|NCT02702193|11268480|FG001|STARTED|8 Month Follow up||87
10137858|NCT02702193|11268479|FG000|COMPLETED|8 Month Follow up||71
10137859|NCT02702193|11268480|FG001|COMPLETED|8 Month Follow up||69
10137860|NCT02702193|11268479|FG000|NOT COMPLETED|8 Month Follow up||15
10137861|NCT02702193|11268480|FG001|NOT COMPLETED|8 Month Follow up||18
10137862|NCT02702193|11268479|FG000|STARTED|12 Month Follow up||86
10137863|NCT02702193|11268480|FG001|STARTED|12 Month Follow up||87
10137864|NCT02702193|11268479|FG000|COMPLETED|12 Month Follow up||69
10137865|NCT02702193|11268480|FG001|COMPLETED|12 Month Follow up||69
10137866|NCT02702193|11268479|FG000|NOT COMPLETED|12 Month Follow up||17
10137867|NCT02702193|11268480|FG001|NOT COMPLETED|12 Month Follow up||18
10137868|NCT02702388|11268488|FG000|STARTED|Overall Study||75
10137869|NCT02702388|11268489|FG001|STARTED|Overall Study||77
10137870|NCT02702388|11268488|FG000|COMPLETED|Overall Study||35
10137871|NCT02702388|11268489|FG001|COMPLETED|Overall Study||26
10137872|NCT02702388|11268488|FG000|NOT COMPLETED|Overall Study||40
10137873|NCT02702388|11268489|FG001|NOT COMPLETED|Overall Study||51
10137874|NCT02702401|11268506|FG000|STARTED|Overall Study||278
10137875|NCT02702401|11268507|FG001|STARTED|Overall Study||135
10137876|NCT02702401|11268506|FG000|Treated|Overall Study||278
10137877|NCT02702401|11268507|FG001|Treated|Overall Study||135
10137878|NCT02702401|11268506|FG000|COMPLETED|Overall Study||0
10137879|NCT02702401|11268507|FG001|COMPLETED|Overall Study||0
10137880|NCT02702401|11268506|FG000|NOT COMPLETED|Overall Study||278
10137881|NCT02702401|11268507|FG001|NOT COMPLETED|Overall Study||135
10137882|NCT02702518|11268515|FG000|STARTED|Overall Study||29
10137883|NCT02702518|11268516|FG001|STARTED|Overall Study||29
10137884|NCT02702518|11268515|FG000|COMPLETED|Overall Study||26
10137885|NCT02702518|11268516|FG001|COMPLETED|Overall Study||25
10137886|NCT02702518|11268515|FG000|NOT COMPLETED|Overall Study||3
10137887|NCT02702518|11268516|FG001|NOT COMPLETED|Overall Study||4
10137888|NCT02702609|11268524|FG000|STARTED|Overall Study||24
10137889|NCT02702609|11268525|FG001|STARTED|Overall Study||21
10137890|NCT02702609|11268524|FG000|Implant Placement|Overall Study||23
10137891|NCT02702609|11268525|FG001|Implant Placement|Overall Study||21
10137892|NCT02702609|11268524|FG000|Crown Delivery|Overall Study||16
10137893|NCT02702609|11268525|FG001|Crown Delivery|Overall Study||18
10137894|NCT02702609|11268524|FG000|COMPLETED|Overall Study||15
10137895|NCT02702609|11268525|FG001|COMPLETED|Overall Study||17
10137896|NCT02702609|11268524|FG000|NOT COMPLETED|Overall Study||9
10137897|NCT02702609|11268525|FG001|NOT COMPLETED|Overall Study||4
10137898|NCT02702921|11268533|FG000|STARTED|Overall Study||98
10137899|NCT02702921|11268534|FG001|STARTED|Overall Study||103
10137900|NCT02702921|11268533|FG000|COMPLETED|Overall Study||84
10137901|NCT02702921|11268534|FG001|COMPLETED|Overall Study||95
10137902|NCT02702921|11268533|FG000|NOT COMPLETED|Overall Study||14
10137903|NCT02702921|11268534|FG001|NOT COMPLETED|Overall Study||8
10137904|NCT02702999|11268542|FG000|STARTED|Overall Study||102
10137905|NCT02702999|11268543|FG001|STARTED|Overall Study||104
10137906|NCT02702999|11268542|FG000|COMPLETED|Overall Study||102
10137907|NCT02702999|11268543|FG001|COMPLETED|Overall Study||104
10137908|NCT02702999|11268542|FG000|NOT COMPLETED|Overall Study||0
10137909|NCT02702999|11268543|FG001|NOT COMPLETED|Overall Study||0
10137910|NCT02703259|11268551|FG000|STARTED|24 Hours Postoperative Assessment||70
10137911|NCT02703259|11268552|FG001|STARTED|24 Hours Postoperative Assessment||67
10137912|NCT02703259|11268551|FG000|COMPLETED|24 Hours Postoperative Assessment||68
10137913|NCT02703259|11268552|FG001|COMPLETED|24 Hours Postoperative Assessment||61
10137914|NCT02703259|11268551|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2
10137915|NCT02703259|11268552|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6
10137916|NCT02703259|11268551|FG000|STARTED|2 Weeks Postoperative Assessment||68
10137917|NCT02703259|11268552|FG001|STARTED|2 Weeks Postoperative Assessment||61
10137918|NCT02703259|11268551|FG000|COMPLETED|2 Weeks Postoperative Assessment||58
10137919|NCT02703259|11268552|FG001|COMPLETED|2 Weeks Postoperative Assessment||51
10137920|NCT02703259|11268551|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10
10137921|NCT02703259|11268552|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10
10137922|NCT02703311|11268558|FG000|STARTED|Overall Study||11
10137923|NCT02703311|11268558|FG000|Implanted|Overall Study||11
10137924|NCT02703311|11268558|FG000|30 Day Follow-Up Completed|Overall Study||9
10137925|NCT02703311|11268558|FG000|COMPLETED|Overall Study||3
10137926|NCT02703311|11268558|FG000|NOT COMPLETED|Overall Study||8
10137927|NCT02703324|11268562|FG000|STARTED|Period One||5
10137928|NCT02703324|11268563|FG001|STARTED|Period One||5
10137929|NCT02703324|11268564|FG002|STARTED|Period One||5
10137930|NCT02703324|11268565|FG003|STARTED|Period One||5
10137931|NCT02703324|11268566|FG004|STARTED|Period One||5
10137932|NCT02703324|11268567|FG005|STARTED|Period One||5
10137933|NCT02703324|11268562|FG000|Received Study Drug|Period One||5
10137934|NCT02703324|11268563|FG001|Received Study Drug|Period One||5
10137935|NCT02703324|11268564|FG002|Received Study Drug|Period One||5
10137936|NCT02703324|11268565|FG003|Received Study Drug|Period One||5
10137937|NCT02703324|11268566|FG004|Received Study Drug|Period One||5
10137938|NCT02703324|11268567|FG005|Received Study Drug|Period One||5
10137939|NCT02703324|11268562|FG000|COMPLETED|Period One||5
10137940|NCT02703324|11268563|FG001|COMPLETED|Period One||5
10137941|NCT02703324|11268564|FG002|COMPLETED|Period One||5
10137942|NCT02703324|11268565|FG003|COMPLETED|Period One||5
10137943|NCT02703324|11268566|FG004|COMPLETED|Period One||5
10137944|NCT02703324|11268567|FG005|COMPLETED|Period One||5
10137945|NCT02703324|11268562|FG000|NOT COMPLETED|Period One||0
10137946|NCT02703324|11268563|FG001|NOT COMPLETED|Period One||0
10137947|NCT02703324|11268564|FG002|NOT COMPLETED|Period One||0
10137948|NCT02703324|11268565|FG003|NOT COMPLETED|Period One||0
10137949|NCT02703324|11268566|FG004|NOT COMPLETED|Period One||0
10137950|NCT02703324|11268567|FG005|NOT COMPLETED|Period One||0
10137951|NCT02703324|11268562|FG000|STARTED|Period Two||5
10137952|NCT02703324|11268563|FG001|STARTED|Period Two||5
10137953|NCT02703324|11268564|FG002|STARTED|Period Two||5
10137954|NCT02703324|11268565|FG003|STARTED|Period Two||5
10137955|NCT02703324|11268566|FG004|STARTED|Period Two||5
10137956|NCT02703324|11268567|FG005|STARTED|Period Two||5
10137957|NCT02703324|11268562|FG000|Received Study Drug|Period Two||5
10137958|NCT02703324|11268563|FG001|Received Study Drug|Period Two||5
10137959|NCT02703324|11268564|FG002|Received Study Drug|Period Two||5
10137960|NCT02703324|11268565|FG003|Received Study Drug|Period Two||5
10137961|NCT02703324|11268566|FG004|Received Study Drug|Period Two||5
10137962|NCT02703324|11268567|FG005|Received Study Drug|Period Two||5
10137963|NCT02703324|11268562|FG000|COMPLETED|Period Two||5
10137964|NCT02703324|11268563|FG001|COMPLETED|Period Two||5
10137965|NCT02703324|11268564|FG002|COMPLETED|Period Two||4
10137966|NCT02703324|11268565|FG003|COMPLETED|Period Two||5
10137967|NCT02703324|11268566|FG004|COMPLETED|Period Two||5
10137968|NCT02703324|11268567|FG005|COMPLETED|Period Two||5
10137969|NCT02703324|11268562|FG000|NOT COMPLETED|Period Two||0
10137970|NCT02703324|11268563|FG001|NOT COMPLETED|Period Two||0
10137971|NCT02703324|11268564|FG002|NOT COMPLETED|Period Two||1
10137972|NCT02703324|11268565|FG003|NOT COMPLETED|Period Two||0
10137973|NCT02703324|11268566|FG004|NOT COMPLETED|Period Two||0
10137974|NCT02703324|11268567|FG005|NOT COMPLETED|Period Two||0
10137975|NCT02703324|11268562|FG000|STARTED|Period Three||5
10137976|NCT02703324|11268563|FG001|STARTED|Period Three||5
10137977|NCT02703324|11268564|FG002|STARTED|Period Three||4
10137978|NCT02703324|11268565|FG003|STARTED|Period Three||5
10137979|NCT02703324|11268566|FG004|STARTED|Period Three||5
10137980|NCT02703324|11268567|FG005|STARTED|Period Three||5
10137981|NCT02703324|11268562|FG000|Received Study Drug|Period Three||5
10137982|NCT02703324|11268563|FG001|Received Study Drug|Period Three||5
10137983|NCT02703324|11268564|FG002|Received Study Drug|Period Three||4
10137984|NCT02703324|11268565|FG003|Received Study Drug|Period Three||5
10137985|NCT02703324|11268566|FG004|Received Study Drug|Period Three||5
10137986|NCT02703324|11268567|FG005|Received Study Drug|Period Three||5
10137987|NCT02703324|11268562|FG000|COMPLETED|Period Three||5
10137988|NCT02703324|11268563|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
10137989|NCT02703324|11268564|FG002|COMPLETED|Period Three||4
10137990|NCT02703324|11268565|FG003|COMPLETED|Period Three||5
10137991|NCT02703324|11268566|FG004|COMPLETED|Period Three||5
10137992|NCT02703324|11268567|FG005|COMPLETED|Period Three||5
10137993|NCT02703324|11268562|FG000|NOT COMPLETED|Period Three||0
10137994|NCT02703324|11268563|FG001|NOT COMPLETED|Period Three||0
10137995|NCT02703324|11268564|FG002|NOT COMPLETED|Period Three||0
10137996|NCT02703324|11268565|FG003|NOT COMPLETED|Period Three||0
10137997|NCT02703324|11268566|FG004|NOT COMPLETED|Period Three||0
10137998|NCT02703324|11268567|FG005|NOT COMPLETED|Period Three||0
10137999|NCT02703324|11268562|FG000|STARTED|Period Four||5
10138000|NCT02703324|11268563|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
10138001|NCT02703324|11268564|FG002|STARTED|Period Four||4
10138002|NCT02703324|11268565|FG003|STARTED|Period Four||5
10138003|NCT02703324|11268566|FG004|STARTED|Period Four||5
10138004|NCT02703324|11268567|FG005|STARTED|Period Four||5
10138005|NCT02703324|11268562|FG000|Received Study Drug|Period Four||5
10138006|NCT02703324|11268563|FG001|Received Study Drug|Period Four||4
10138007|NCT02703324|11268564|FG002|Received Study Drug|Period Four||4
10138008|NCT02703324|11268565|FG003|Received Study Drug|Period Four||5
10138009|NCT02703324|11268566|FG004|Received Study Drug|Period Four||5
10138010|NCT02703324|11268567|FG005|Received Study Drug|Period Four||5
10138011|NCT02703324|11268562|FG000|COMPLETED|Period Four||5
10138012|NCT02703324|11268563|FG001|COMPLETED|Period Four||4
10138013|NCT02703324|11268564|FG002|COMPLETED|Period Four||4
10138014|NCT02703324|11268565|FG003|COMPLETED|Period Four||5
10138015|NCT02703324|11268566|FG004|COMPLETED|Period Four||5
10138016|NCT02703324|11268567|FG005|COMPLETED|Period Four||5
10138017|NCT02703324|11268562|FG000|NOT COMPLETED|Period Four||0
10138018|NCT02703324|11268563|FG001|NOT COMPLETED|Period Four||0
10138019|NCT02703324|11268564|FG002|NOT COMPLETED|Period Four||0
10138020|NCT02703324|11268565|FG003|NOT COMPLETED|Period Four||0
10138021|NCT02703324|11268566|FG004|NOT COMPLETED|Period Four||0
10138022|NCT02703324|11268567|FG005|NOT COMPLETED|Period Four||0
10138023|NCT02703337|11268576|FG000|STARTED|Period One (Part A)||5
10138024|NCT02703337|11268577|FG001|STARTED|Period One (Part A)||5
10138025|NCT02703337|11268578|FG002|STARTED|Period One (Part A)||5
10138026|NCT02703337|11268579|FG003|STARTED|Period One (Part A)||5
10138027|NCT02703337|11268580|FG004|STARTED|Period One (Part A)||5
10138028|NCT02703337|11268581|FG005|STARTED|Period One (Part A)||5
10138029|NCT02703337|11268582|FG006|STARTED|Period One (Part A)||0
10138030|NCT02703337|11268583|FG007|STARTED|Period One (Part A)||0
10138031|NCT02703337|11268576|FG000|Received Study Drug|Period One (Part A)||5
10138032|NCT02703337|11268577|FG001|Received Study Drug|Period One (Part A)||5
10138033|NCT02703337|11268578|FG002|Received Study Drug|Period One (Part A)||5
10138034|NCT02703337|11268579|FG003|Received Study Drug|Period One (Part A)||5
10138035|NCT02703337|11268580|FG004|Received Study Drug|Period One (Part A)||5
10138036|NCT02703337|11268581|FG005|Received Study Drug|Period One (Part A)||5
10138037|NCT02703337|11268582|FG006|Received Study Drug|Period One (Part A)||0
10138038|NCT02703337|11268583|FG007|Received Study Drug|Period One (Part A)||0
10138039|NCT02703337|11268576|FG000|COMPLETED|Period One (Part A)||5
10138040|NCT02703337|11268577|FG001|COMPLETED|Period One (Part A)||5
10138041|NCT02703337|11268578|FG002|COMPLETED|Period One (Part A)||5
10138042|NCT02703337|11268579|FG003|COMPLETED|Period One (Part A)||5
10138043|NCT02703337|11268580|FG004|COMPLETED|Period One (Part A)||4
10138044|NCT02703337|11268581|FG005|COMPLETED|Period One (Part A)||5
10138045|NCT02703337|11268582|FG006|COMPLETED|Period One (Part A)||0
10138046|NCT02703337|11268583|FG007|COMPLETED|Period One (Part A)||0
10138047|NCT02703337|11268576|FG000|NOT COMPLETED|Period One (Part A)||0
10138048|NCT02703337|11268577|FG001|NOT COMPLETED|Period One (Part A)||0
10138049|NCT02703337|11268578|FG002|NOT COMPLETED|Period One (Part A)||0
10138050|NCT02703337|11268579|FG003|NOT COMPLETED|Period One (Part A)||0
10138051|NCT02703337|11268580|FG004|NOT COMPLETED|Period One (Part A)||1
10138052|NCT02703337|11268581|FG005|NOT COMPLETED|Period One (Part A)||0
10138053|NCT02703337|11268582|FG006|NOT COMPLETED|Period One (Part A)||0
10138054|NCT02703337|11268583|FG007|NOT COMPLETED|Period One (Part A)||0
10138055|NCT02703337|11268576|FG000|STARTED|Period Two (Part A)||5
10138056|NCT02703337|11268577|FG001|STARTED|Period Two (Part A)||5
10138057|NCT02703337|11268578|FG002|STARTED|Period Two (Part A)||5
10138058|NCT02703337|11268579|FG003|STARTED|Period Two (Part A)||5
10138059|NCT02703337|11268580|FG004|STARTED|Period Two (Part A)||4
10138060|NCT02703337|11268581|FG005|STARTED|Period Two (Part A)||5
10138061|NCT02703337|11268582|FG006|STARTED|Period Two (Part A)||0
10138062|NCT02703337|11268583|FG007|STARTED|Period Two (Part A)||0
10138063|NCT02703337|11268576|FG000|Received Study Drug|Period Two (Part A)||5
10138064|NCT02703337|11268577|FG001|Received Study Drug|Period Two (Part A)||5
10138065|NCT02703337|11268578|FG002|Received Study Drug|Period Two (Part A)||5
10138066|NCT02703337|11268579|FG003|Received Study Drug|Period Two (Part A)||5
10138067|NCT02703337|11268580|FG004|Received Study Drug|Period Two (Part A)||4
10138068|NCT02703337|11268581|FG005|Received Study Drug|Period Two (Part A)||5
10138069|NCT02703337|11268582|FG006|Received Study Drug|Period Two (Part A)||0
10138070|NCT02703337|11268583|FG007|Received Study Drug|Period Two (Part A)||0
10138071|NCT02703337|11268576|FG000|COMPLETED|Period Two (Part A)||5
10138072|NCT02703337|11268577|FG001|COMPLETED|Period Two (Part A)||5
10138073|NCT02703337|11268578|FG002|COMPLETED|Period Two (Part A)||5
10138074|NCT02703337|11268579|FG003|COMPLETED|Period Two (Part A)||5
10138075|NCT02703337|11268580|FG004|COMPLETED|Period Two (Part A)||4
10138076|NCT02703337|11268581|FG005|COMPLETED|Period Two (Part A)||5
10138077|NCT02703337|11268582|FG006|COMPLETED|Period Two (Part A)||0
10138078|NCT02703337|11268583|FG007|COMPLETED|Period Two (Part A)||0
10138079|NCT02703337|11268576|FG000|NOT COMPLETED|Period Two (Part A)||0
10138080|NCT02703337|11268577|FG001|NOT COMPLETED|Period Two (Part A)||0
10138081|NCT02703337|11268578|FG002|NOT COMPLETED|Period Two (Part A)||0
10138082|NCT02703337|11268579|FG003|NOT COMPLETED|Period Two (Part A)||0
10138083|NCT02703337|11268580|FG004|NOT COMPLETED|Period Two (Part A)||0
10138084|NCT02703337|11268581|FG005|NOT COMPLETED|Period Two (Part A)||0
10138085|NCT02703337|11268582|FG006|NOT COMPLETED|Period Two (Part A)||0
10138086|NCT02703337|11268583|FG007|NOT COMPLETED|Period Two (Part A)||0
10138087|NCT02703337|11268576|FG000|STARTED|Period Three (Part A)||5
10138088|NCT02703337|11268577|FG001|STARTED|Period Three (Part A)||5
10138089|NCT02703337|11268578|FG002|STARTED|Period Three (Part A)||5
10138090|NCT02703337|11268579|FG003|STARTED|Period Three (Part A)||5
10138091|NCT02703337|11268580|FG004|STARTED|Period Three (Part A)||4
10138092|NCT02703337|11268581|FG005|STARTED|Period Three (Part A)||5
10138093|NCT02703337|11268582|FG006|STARTED|Period Three (Part A)||0
10138094|NCT02703337|11268583|FG007|STARTED|Period Three (Part A)||0
10138095|NCT02703337|11268576|FG000|Received Study Drug|Period Three (Part A)||5
10138096|NCT02703337|11268577|FG001|Received Study Drug|Period Three (Part A)||5
10138097|NCT02703337|11268578|FG002|Received Study Drug|Period Three (Part A)||5
10138098|NCT02703337|11268579|FG003|Received Study Drug|Period Three (Part A)||5
10138099|NCT02703337|11268580|FG004|Received Study Drug|Period Three (Part A)||4
10138100|NCT02703337|11268581|FG005|Received Study Drug|Period Three (Part A)||5
10138101|NCT02703337|11268582|FG006|Received Study Drug|Period Three (Part A)||0
10138102|NCT02703337|11268583|FG007|Received Study Drug|Period Three (Part A)||0
10138103|NCT02703337|11268576|FG000|COMPLETED|Period Three (Part A)||5
10138104|NCT02703337|11268577|FG001|COMPLETED|Period Three (Part A)||5
10138105|NCT02703337|11268578|FG002|COMPLETED|Period Three (Part A)||5
10138106|NCT02703337|11268579|FG003|COMPLETED|Period Three (Part A)||5
10138107|NCT02703337|11268580|FG004|COMPLETED|Period Three (Part A)||4
10138108|NCT02703337|11268581|FG005|COMPLETED|Period Three (Part A)||5
10138109|NCT02703337|11268582|FG006|COMPLETED|Period Three (Part A)||0
10138110|NCT02703337|11268583|FG007|COMPLETED|Period Three (Part A)||0
10138111|NCT02703337|11268576|FG000|NOT COMPLETED|Period Three (Part A)||0
10138112|NCT02703337|11268577|FG001|NOT COMPLETED|Period Three (Part A)||0
10138113|NCT02703337|11268578|FG002|NOT COMPLETED|Period Three (Part A)||0
10138114|NCT02703337|11268579|FG003|NOT COMPLETED|Period Three (Part A)||0
10138115|NCT02703337|11268580|FG004|NOT COMPLETED|Period Three (Part A)||0
10138116|NCT02703337|11268581|FG005|NOT COMPLETED|Period Three (Part A)||0
10138117|NCT02703337|11268582|FG006|NOT COMPLETED|Period Three (Part A)||0
10138118|NCT02703337|11268583|FG007|NOT COMPLETED|Period Three (Part A)||0
10138119|NCT02703337|11268576|FG000|STARTED|Period Four (Part A)||5
10138120|NCT02703337|11268577|FG001|STARTED|Period Four (Part A)||5
10138121|NCT02703337|11268578|FG002|STARTED|Period Four (Part A)||5
10138122|NCT02703337|11268579|FG003|STARTED|Period Four (Part A)||5
10138123|NCT02703337|11268580|FG004|STARTED|Period Four (Part A)||4
10138124|NCT02703337|11268581|FG005|STARTED|Period Four (Part A)||5
10138125|NCT02703337|11268582|FG006|STARTED|Period Four (Part A)||0
10138126|NCT02703337|11268583|FG007|STARTED|Period Four (Part A)||0
10138127|NCT02703337|11268576|FG000|Received Study Drug|Period Four (Part A)||5
10138128|NCT02703337|11268577|FG001|Received Study Drug|Period Four (Part A)||5
10138129|NCT02703337|11268578|FG002|Received Study Drug|Period Four (Part A)||5
10138130|NCT02703337|11268579|FG003|Received Study Drug|Period Four (Part A)||5
10138131|NCT02703337|11268580|FG004|Received Study Drug|Period Four (Part A)||4
10138132|NCT02703337|11268581|FG005|Received Study Drug|Period Four (Part A)||5
10138133|NCT02703337|11268582|FG006|Received Study Drug|Period Four (Part A)||0
10138134|NCT02703337|11268583|FG007|Received Study Drug|Period Four (Part A)||0
10138135|NCT02703337|11268576|FG000|COMPLETED|Period Four (Part A)||5
10138136|NCT02703337|11268577|FG001|COMPLETED|Period Four (Part A)||5
10138137|NCT02703337|11268578|FG002|COMPLETED|Period Four (Part A)||5
10138138|NCT02703337|11268579|FG003|COMPLETED|Period Four (Part A)||5
10138139|NCT02703337|11268580|FG004|COMPLETED|Period Four (Part A)||4
10138140|NCT02703337|11268581|FG005|COMPLETED|Period Four (Part A)||5
10138141|NCT02703337|11268582|FG006|COMPLETED|Period Four (Part A)||0
10138142|NCT02703337|11268583|FG007|COMPLETED|Period Four (Part A)||0
10138143|NCT02703337|11268576|FG000|NOT COMPLETED|Period Four (Part A)||0
10138144|NCT02703337|11268577|FG001|NOT COMPLETED|Period Four (Part A)||0
10138145|NCT02703337|11268578|FG002|NOT COMPLETED|Period Four (Part A)||0
10138146|NCT02703337|11268579|FG003|NOT COMPLETED|Period Four (Part A)||0
10138147|NCT02703337|11268580|FG004|NOT COMPLETED|Period Four (Part A)||0
10138148|NCT02703337|11268581|FG005|NOT COMPLETED|Period Four (Part A)||0
10138149|NCT02703337|11268582|FG006|NOT COMPLETED|Period Four (Part A)||0
10138150|NCT02703337|11268583|FG007|NOT COMPLETED|Period Four (Part A)||0
10138151|NCT02703337|11268576|FG000|STARTED|Period Five (Part A)||5
10138152|NCT02703337|11268577|FG001|STARTED|Period Five (Part A)||5
10138153|NCT02703337|11268578|FG002|STARTED|Period Five (Part A)||5
10138154|NCT02703337|11268579|FG003|STARTED|Period Five (Part A)||5
10138155|NCT02703337|11268580|FG004|STARTED|Period Five (Part A)||4
10138156|NCT02703337|11268581|FG005|STARTED|Period Five (Part A)||5
10138157|NCT02703337|11268582|FG006|STARTED|Period Five (Part A)||0
10138158|NCT02703337|11268583|FG007|STARTED|Period Five (Part A)||0
10138159|NCT02703337|11268576|FG000|Received Study Drug|Period Five (Part A)||5
10138160|NCT02703337|11268577|FG001|Received Study Drug|Period Five (Part A)||5
10138161|NCT02703337|11268578|FG002|Received Study Drug|Period Five (Part A)||5
10138162|NCT02703337|11268579|FG003|Received Study Drug|Period Five (Part A)||5
10138163|NCT02703337|11268580|FG004|Received Study Drug|Period Five (Part A)||4
10138164|NCT02703337|11268581|FG005|Received Study Drug|Period Five (Part A)||5
10138165|NCT02703337|11268582|FG006|Received Study Drug|Period Five (Part A)||0
10138166|NCT02703337|11268583|FG007|Received Study Drug|Period Five (Part A)||0
10138167|NCT02703337|11268576|FG000|COMPLETED|Period Five (Part A)||5
10138168|NCT02703337|11268577|FG001|COMPLETED|Period Five (Part A)||5
10138169|NCT02703337|11268578|FG002|COMPLETED|Period Five (Part A)||5
10138170|NCT02703337|11268579|FG003|COMPLETED|Period Five (Part A)||5
10138171|NCT02703337|11268580|FG004|COMPLETED|Period Five (Part A)||4
10138172|NCT02703337|11268581|FG005|COMPLETED|Period Five (Part A)||5
9729210|NCT00117143|10828772|FG000|COMPLETED|Overall Study||4
10060513|NCT02097992|11186073|FG002|NOT COMPLETED|Washout (4 Weeks)||0
10060514|NCT02097992|11186074|FG003|NOT COMPLETED|Washout (4 Weeks)||0
10060515|NCT02097992|11186071|FG000|STARTED|Treatment 3 (4 Weeks)||2
10060516|NCT02097992|11186072|FG001|STARTED|Treatment 3 (4 Weeks)||3
10138173|NCT02703337|11268582|FG006|COMPLETED|Period Five (Part A)||0
10138174|NCT02703337|11268583|FG007|COMPLETED|Period Five (Part A)||0
10138175|NCT02703337|11268576|FG000|NOT COMPLETED|Period Five (Part A)||0
10138176|NCT02703337|11268577|FG001|NOT COMPLETED|Period Five (Part A)||0
10138177|NCT02703337|11268578|FG002|NOT COMPLETED|Period Five (Part A)||0
10138178|NCT02703337|11268579|FG003|NOT COMPLETED|Period Five (Part A)||0
10138179|NCT02703337|11268580|FG004|NOT COMPLETED|Period Five (Part A)||0
10138180|NCT02703337|11268581|FG005|NOT COMPLETED|Period Five (Part A)||0
10138181|NCT02703337|11268582|FG006|NOT COMPLETED|Period Five (Part A)||0
10138182|NCT02703337|11268583|FG007|NOT COMPLETED|Period Five (Part A)||0
10138183|NCT02703337|11268576|FG000|STARTED|Period Six (Part A)||5
10138184|NCT02703337|11268577|FG001|STARTED|Period Six (Part A)||5
10138185|NCT02703337|11268578|FG002|STARTED|Period Six (Part A)||5
10138186|NCT02703337|11268579|FG003|STARTED|Period Six (Part A)||5
10138187|NCT02703337|11268580|FG004|STARTED|Period Six (Part A)||4
10138188|NCT02703337|11268581|FG005|STARTED|Period Six (Part A)||5
10138189|NCT02703337|11268582|FG006|STARTED|Period Six (Part A)||0
10138190|NCT02703337|11268583|FG007|STARTED|Period Six (Part A)||0
10138191|NCT02703337|11268576|FG000|Received Study Drug|Period Six (Part A)||5
10138192|NCT02703337|11268577|FG001|Received Study Drug|Period Six (Part A)||5
10138193|NCT02703337|11268578|FG002|Received Study Drug|Period Six (Part A)||5
10138194|NCT02703337|11268579|FG003|Received Study Drug|Period Six (Part A)||5
10138195|NCT02703337|11268580|FG004|Received Study Drug|Period Six (Part A)||4
10138196|NCT02703337|11268581|FG005|Received Study Drug|Period Six (Part A)||5
10138197|NCT02703337|11268582|FG006|Received Study Drug|Period Six (Part A)||0
10138198|NCT02703337|11268583|FG007|Received Study Drug|Period Six (Part A)||0
10138199|NCT02703337|11268576|FG000|COMPLETED|Period Six (Part A)||5
10138200|NCT02703337|11268577|FG001|COMPLETED|Period Six (Part A)||5
10138201|NCT02703337|11268578|FG002|COMPLETED|Period Six (Part A)||5
10138202|NCT02703337|11268579|FG003|COMPLETED|Period Six (Part A)||5
10138203|NCT02703337|11268580|FG004|COMPLETED|Period Six (Part A)||4
10138204|NCT02703337|11268581|FG005|COMPLETED|Period Six (Part A)||5
10138205|NCT02703337|11268582|FG006|COMPLETED|Period Six (Part A)||0
10138206|NCT02703337|11268583|FG007|COMPLETED|Period Six (Part A)||0
10138207|NCT02703337|11268576|FG000|NOT COMPLETED|Period Six (Part A)||0
10138208|NCT02703337|11268577|FG001|NOT COMPLETED|Period Six (Part A)||0
10138209|NCT02703337|11268578|FG002|NOT COMPLETED|Period Six (Part A)||0
10138210|NCT02703337|11268579|FG003|NOT COMPLETED|Period Six (Part A)||0
10138211|NCT02703337|11268580|FG004|NOT COMPLETED|Period Six (Part A)||0
10138212|NCT02703337|11268581|FG005|NOT COMPLETED|Period Six (Part A)||0
10138213|NCT02703337|11268582|FG006|NOT COMPLETED|Period Six (Part A)||0
10138214|NCT02703337|11268583|FG007|NOT COMPLETED|Period Six (Part A)||0
10138215|NCT02703337|11268576|FG000|STARTED|Part B||0
10138216|NCT02703337|11268577|FG001|STARTED|Part B||0
10138217|NCT02703337|11268578|FG002|STARTED|Part B||0
10138218|NCT02703337|11268579|FG003|STARTED|Part B||0
10060517|NCT02097992|11186073|FG002|STARTED|Treatment 3 (4 Weeks)||4
10060518|NCT02097992|11186074|FG003|STARTED|Treatment 3 (4 Weeks)||2
10060519|NCT02097992|11186071|FG000|COMPLETED|Treatment 3 (4 Weeks)||2
10060520|NCT02097992|11186072|FG001|COMPLETED|Treatment 3 (4 Weeks)||3
10060521|NCT02097992|11186073|FG002|COMPLETED|Treatment 3 (4 Weeks)||4
10138219|NCT02703337|11268580|FG004|STARTED|Part B||0
10138220|NCT02703337|11268581|FG005|STARTED|Part B||0
10138221|NCT02703337|11268582|FG006|STARTED|Part B||15
10138222|NCT02703337|11268583|FG007|STARTED|Part B||14
10138223|NCT02703337|11268576|FG000|Received Study Drug|Part B||0
10138224|NCT02703337|11268577|FG001|Received Study Drug|Part B||0
10138225|NCT02703337|11268578|FG002|Received Study Drug|Part B||0
10138226|NCT02703337|11268579|FG003|Received Study Drug|Part B||0
10138227|NCT02703337|11268580|FG004|Received Study Drug|Part B||0
10138228|NCT02703337|11268581|FG005|Received Study Drug|Part B||0
10060522|NCT02097992|11186074|FG003|COMPLETED|Treatment 3 (4 Weeks)||2
10138229|NCT02703337|11268582|FG006|Received Study Drug|Part B||15
10138230|NCT02703337|11268583|FG007|Received Study Drug|Part B||14
10138231|NCT02703337|11268576|FG000|COMPLETED|Part B||0
10138232|NCT02703337|11268577|FG001|COMPLETED|Part B||0
10138233|NCT02703337|11268578|FG002|COMPLETED|Part B||0
10138234|NCT02703337|11268579|FG003|COMPLETED|Part B||0
10138235|NCT02703337|11268580|FG004|COMPLETED|Part B||0
10138236|NCT02703337|11268581|FG005|COMPLETED|Part B||0
10138237|NCT02703337|11268582|FG006|COMPLETED|Part B||15
10138238|NCT02703337|11268583|FG007|COMPLETED|Part B||14
10138239|NCT02703337|11268576|FG000|NOT COMPLETED|Part B||0
10138240|NCT02703337|11268577|FG001|NOT COMPLETED|Part B||0
10138241|NCT02703337|11268578|FG002|NOT COMPLETED|Part B||0
10138242|NCT02703337|11268579|FG003|NOT COMPLETED|Part B||0
10138243|NCT02703337|11268580|FG004|NOT COMPLETED|Part B||0
10138244|NCT02703337|11268581|FG005|NOT COMPLETED|Part B||0
10138245|NCT02703337|11268582|FG006|NOT COMPLETED|Part B||0
10138246|NCT02703337|11268583|FG007|NOT COMPLETED|Part B||0
10138247|NCT02703350|11268601|FG000|STARTED|Period One (Part A)||5
10138248|NCT02703350|11268602|FG001|STARTED|Period One (Part A)||5
10138249|NCT02703350|11268603|FG002|STARTED|Period One (Part A)||5
10138250|NCT02703350|11268604|FG003|STARTED|Period One (Part A)||5
10138251|NCT02703350|11268605|FG004|STARTED|Period One (Part A)||5
10138252|NCT02703350|11268606|FG005|STARTED|Period One (Part A)||5
10138253|NCT02703350|11268607|FG006|STARTED|Period One (Part A)||0
10138254|NCT02703350|11268608|FG007|STARTED|Period One (Part A)||0
10138255|NCT02703350|11268601|FG000|Received Study Drug|Period One (Part A)||5
10138256|NCT02703350|11268602|FG001|Received Study Drug|Period One (Part A)||5
10138257|NCT02703350|11268603|FG002|Received Study Drug|Period One (Part A)||5
10138258|NCT02703350|11268604|FG003|Received Study Drug|Period One (Part A)||5
10138259|NCT02703350|11268605|FG004|Received Study Drug|Period One (Part A)||5
10138260|NCT02703350|11268606|FG005|Received Study Drug|Period One (Part A)||5
10138261|NCT02703350|11268607|FG006|Received Study Drug|Period One (Part A)||0
10138262|NCT02703350|11268608|FG007|Received Study Drug|Period One (Part A)||0
10138263|NCT02703350|11268601|FG000|COMPLETED|Period One (Part A)||5
10138264|NCT02703350|11268602|FG001|COMPLETED|Period One (Part A)||5
10138265|NCT02703350|11268603|FG002|COMPLETED|Period One (Part A)||5
10138266|NCT02703350|11268604|FG003|COMPLETED|Period One (Part A)||5
10138267|NCT02703350|11268605|FG004|COMPLETED|Period One (Part A)||5
10138268|NCT02703350|11268606|FG005|COMPLETED|Period One (Part A)||5
10138269|NCT02703350|11268607|FG006|COMPLETED|Period One (Part A)||0
10138270|NCT02703350|11268608|FG007|COMPLETED|Period One (Part A)||0
10138271|NCT02703350|11268601|FG000|NOT COMPLETED|Period One (Part A)||0
10138272|NCT02703350|11268602|FG001|NOT COMPLETED|Period One (Part A)||0
10138273|NCT02703350|11268603|FG002|NOT COMPLETED|Period One (Part A)||0
10138274|NCT02703350|11268604|FG003|NOT COMPLETED|Period One (Part A)||0
10138275|NCT02703350|11268605|FG004|NOT COMPLETED|Period One (Part A)||0
10138276|NCT02703350|11268606|FG005|NOT COMPLETED|Period One (Part A)||0
10138277|NCT02703350|11268607|FG006|NOT COMPLETED|Period One (Part A)||0
10138278|NCT02703350|11268608|FG007|NOT COMPLETED|Period One (Part A)||0
10138279|NCT02703350|11268601|FG000|STARTED|Period Two (Part A)||5
10138280|NCT02703350|11268602|FG001|STARTED|Period Two (Part A)||5
10138281|NCT02703350|11268603|FG002|STARTED|Period Two (Part A)||5
10138282|NCT02703350|11268604|FG003|STARTED|Period Two (Part A)||5
10138283|NCT02703350|11268605|FG004|STARTED|Period Two (Part A)||5
10138284|NCT02703350|11268606|FG005|STARTED|Period Two (Part A)||5
10138285|NCT02703350|11268607|FG006|STARTED|Period Two (Part A)||0
10138286|NCT02703350|11268608|FG007|STARTED|Period Two (Part A)||0
10138287|NCT02703350|11268601|FG000|Received Study Drug|Period Two (Part A)||5
10138288|NCT02703350|11268602|FG001|Received Study Drug|Period Two (Part A)||5
10138289|NCT02703350|11268603|FG002|Received Study Drug|Period Two (Part A)||5
10138290|NCT02703350|11268604|FG003|Received Study Drug|Period Two (Part A)||5
10138291|NCT02703350|11268605|FG004|Received Study Drug|Period Two (Part A)||5
10138292|NCT02703350|11268606|FG005|Received Study Drug|Period Two (Part A)||5
10138293|NCT02703350|11268607|FG006|Received Study Drug|Period Two (Part A)||0
10138294|NCT02703350|11268608|FG007|Received Study Drug|Period Two (Part A)||0
10138295|NCT02703350|11268601|FG000|COMPLETED|Period Two (Part A)||5
10138296|NCT02703350|11268602|FG001|COMPLETED|Period Two (Part A)||5
10138297|NCT02703350|11268603|FG002|COMPLETED|Period Two (Part A)||5
10138298|NCT02703350|11268604|FG003|COMPLETED|Period Two (Part A)||5
10138299|NCT02703350|11268605|FG004|COMPLETED|Period Two (Part A)||5
10138300|NCT02703350|11268606|FG005|COMPLETED|Period Two (Part A)||5
10138301|NCT02703350|11268607|FG006|COMPLETED|Period Two (Part A)||0
10138302|NCT02703350|11268608|FG007|COMPLETED|Period Two (Part A)||0
10138303|NCT02703350|11268601|FG000|NOT COMPLETED|Period Two (Part A)||0
10138304|NCT02703350|11268602|FG001|NOT COMPLETED|Period Two (Part A)||0
10138305|NCT02703350|11268603|FG002|NOT COMPLETED|Period Two (Part A)||0
10138306|NCT02703350|11268604|FG003|NOT COMPLETED|Period Two (Part A)||0
10138307|NCT02703350|11268605|FG004|NOT COMPLETED|Period Two (Part A)||0
10138308|NCT02703350|11268606|FG005|NOT COMPLETED|Period Two (Part A)||0
10138309|NCT02703350|11268607|FG006|NOT COMPLETED|Period Two (Part A)||0
10138310|NCT02703350|11268608|FG007|NOT COMPLETED|Period Two (Part A)||0
10138311|NCT02703350|11268601|FG000|STARTED|Period Three (Part A)||5
10138312|NCT02703350|11268602|FG001|STARTED|Period Three (Part A)||5
10138313|NCT02703350|11268603|FG002|STARTED|Period Three (Part A)||5
10138314|NCT02703350|11268604|FG003|STARTED|Period Three (Part A)||5
10138315|NCT02703350|11268605|FG004|STARTED|Period Three (Part A)||5
10138316|NCT02703350|11268606|FG005|STARTED|Period Three (Part A)||5
10138317|NCT02703350|11268607|FG006|STARTED|Period Three (Part A)||0
10138318|NCT02703350|11268608|FG007|STARTED|Period Three (Part A)||0
10138319|NCT02703350|11268601|FG000|Received Study Drug|Period Three (Part A)||5
10138320|NCT02703350|11268602|FG001|Received Study Drug|Period Three (Part A)||5
10138321|NCT02703350|11268603|FG002|Received Study Drug|Period Three (Part A)||5
10138322|NCT02703350|11268604|FG003|Received Study Drug|Period Three (Part A)||5
10138323|NCT02703350|11268605|FG004|Received Study Drug|Period Three (Part A)||5
10138324|NCT02703350|11268606|FG005|Received Study Drug|Period Three (Part A)||5
10138325|NCT02703350|11268607|FG006|Received Study Drug|Period Three (Part A)||0
10138326|NCT02703350|11268608|FG007|Received Study Drug|Period Three (Part A)||0
10138327|NCT02703350|11268601|FG000|COMPLETED|Period Three (Part A)||5
10138328|NCT02703350|11268602|FG001|COMPLETED|Period Three (Part A)||5
10138329|NCT02703350|11268603|FG002|COMPLETED|Period Three (Part A)||5
10138330|NCT02703350|11268604|FG003|COMPLETED|Period Three (Part A)||5
10138331|NCT02703350|11268605|FG004|COMPLETED|Period Three (Part A)||5
10138332|NCT02703350|11268606|FG005|COMPLETED|Period Three (Part A)||5
10138333|NCT02703350|11268607|FG006|COMPLETED|Period Three (Part A)||0
10138334|NCT02703350|11268608|FG007|COMPLETED|Period Three (Part A)||0
10138335|NCT02703350|11268601|FG000|NOT COMPLETED|Period Three (Part A)||0
10138336|NCT02703350|11268602|FG001|NOT COMPLETED|Period Three (Part A)||0
10138337|NCT02703350|11268603|FG002|NOT COMPLETED|Period Three (Part A)||0
10138338|NCT02703350|11268604|FG003|NOT COMPLETED|Period Three (Part A)||0
10138339|NCT02703350|11268605|FG004|NOT COMPLETED|Period Three (Part A)||0
10138340|NCT02703350|11268606|FG005|NOT COMPLETED|Period Three (Part A)||0
10138341|NCT02703350|11268607|FG006|NOT COMPLETED|Period Three (Part A)||0
10138342|NCT02703350|11268608|FG007|NOT COMPLETED|Period Three (Part A)||0
10138343|NCT02703350|11268601|FG000|STARTED|Period Four (Part A)||5
10138344|NCT02703350|11268602|FG001|STARTED|Period Four (Part A)||5
10138345|NCT02703350|11268603|FG002|STARTED|Period Four (Part A)||5
10138346|NCT02703350|11268604|FG003|STARTED|Period Four (Part A)||5
10138347|NCT02703350|11268605|FG004|STARTED|Period Four (Part A)||5
10138348|NCT02703350|11268606|FG005|STARTED|Period Four (Part A)||5
10138349|NCT02703350|11268607|FG006|STARTED|Period Four (Part A)||0
10138350|NCT02703350|11268608|FG007|STARTED|Period Four (Part A)||0
10138351|NCT02703350|11268601|FG000|Received Study Drug|Period Four (Part A)||5
10138352|NCT02703350|11268602|FG001|Received Study Drug|Period Four (Part A)||5
10138353|NCT02703350|11268603|FG002|Received Study Drug|Period Four (Part A)||5
10138354|NCT02703350|11268604|FG003|Received Study Drug|Period Four (Part A)||5
10138355|NCT02703350|11268605|FG004|Received Study Drug|Period Four (Part A)||5
10138356|NCT02703350|11268606|FG005|Received Study Drug|Period Four (Part A)||5
10138357|NCT02703350|11268607|FG006|Received Study Drug|Period Four (Part A)||0
10138358|NCT02703350|11268608|FG007|Received Study Drug|Period Four (Part A)||0
10138359|NCT02703350|11268601|FG000|COMPLETED|Period Four (Part A)||5
10138360|NCT02703350|11268602|FG001|COMPLETED|Period Four (Part A)||5
10138361|NCT02703350|11268603|FG002|COMPLETED|Period Four (Part A)||5
10138362|NCT02703350|11268604|FG003|COMPLETED|Period Four (Part A)||5
10138363|NCT02703350|11268605|FG004|COMPLETED|Period Four (Part A)||5
10138364|NCT02703350|11268606|FG005|COMPLETED|Period Four (Part A)||5
10138365|NCT02703350|11268607|FG006|COMPLETED|Period Four (Part A)||0
10138366|NCT02703350|11268608|FG007|COMPLETED|Period Four (Part A)||0
10138367|NCT02703350|11268601|FG000|NOT COMPLETED|Period Four (Part A)||0
10138368|NCT02703350|11268602|FG001|NOT COMPLETED|Period Four (Part A)||0
10138369|NCT02703350|11268603|FG002|NOT COMPLETED|Period Four (Part A)||0
10138370|NCT02703350|11268604|FG003|NOT COMPLETED|Period Four (Part A)||0
10138371|NCT02703350|11268605|FG004|NOT COMPLETED|Period Four (Part A)||0
10138372|NCT02703350|11268606|FG005|NOT COMPLETED|Period Four (Part A)||0
10138373|NCT02703350|11268607|FG006|NOT COMPLETED|Period Four (Part A)||0
10138374|NCT02703350|11268608|FG007|NOT COMPLETED|Period Four (Part A)||0
10138375|NCT02703350|11268601|FG000|STARTED|Period Five (Part A)||5
10138376|NCT02703350|11268602|FG001|STARTED|Period Five (Part A)||5
10138377|NCT02703350|11268603|FG002|STARTED|Period Five (Part A)||5
10138378|NCT02703350|11268604|FG003|STARTED|Period Five (Part A)||5
10138379|NCT02703350|11268605|FG004|STARTED|Period Five (Part A)||5
10138380|NCT02703350|11268606|FG005|STARTED|Period Five (Part A)||5
10138381|NCT02703350|11268607|FG006|STARTED|Period Five (Part A)||0
10138382|NCT02703350|11268608|FG007|STARTED|Period Five (Part A)||0
10138383|NCT02703350|11268601|FG000|Received Study Drug|Period Five (Part A)||5
10138384|NCT02703350|11268602|FG001|Received Study Drug|Period Five (Part A)||5
10138385|NCT02703350|11268603|FG002|Received Study Drug|Period Five (Part A)||5
10138386|NCT02703350|11268604|FG003|Received Study Drug|Period Five (Part A)||5
10138387|NCT02703350|11268605|FG004|Received Study Drug|Period Five (Part A)||5
10138388|NCT02703350|11268606|FG005|Received Study Drug|Period Five (Part A)||5
10138389|NCT02703350|11268607|FG006|Received Study Drug|Period Five (Part A)||0
10138390|NCT02703350|11268608|FG007|Received Study Drug|Period Five (Part A)||0
10138391|NCT02703350|11268601|FG000|COMPLETED|Period Five (Part A)||5
10138392|NCT02703350|11268602|FG001|COMPLETED|Period Five (Part A)||5
10138393|NCT02703350|11268603|FG002|COMPLETED|Period Five (Part A)||5
10138394|NCT02703350|11268604|FG003|COMPLETED|Period Five (Part A)||5
10138395|NCT02703350|11268605|FG004|COMPLETED|Period Five (Part A)||5
10138396|NCT02703350|11268606|FG005|COMPLETED|Period Five (Part A)||5
10138397|NCT02703350|11268607|FG006|COMPLETED|Period Five (Part A)||0
10138398|NCT02703350|11268608|FG007|COMPLETED|Period Five (Part A)||0
10138399|NCT02703350|11268601|FG000|NOT COMPLETED|Period Five (Part A)||0
10138400|NCT02703350|11268602|FG001|NOT COMPLETED|Period Five (Part A)||0
10138401|NCT02703350|11268603|FG002|NOT COMPLETED|Period Five (Part A)||0
10138402|NCT02703350|11268604|FG003|NOT COMPLETED|Period Five (Part A)||0
10138403|NCT02703350|11268605|FG004|NOT COMPLETED|Period Five (Part A)||0
10138404|NCT02703350|11268606|FG005|NOT COMPLETED|Period Five (Part A)||0
10138405|NCT02703350|11268607|FG006|NOT COMPLETED|Period Five (Part A)||0
10138406|NCT02703350|11268608|FG007|NOT COMPLETED|Period Five (Part A)||0
10138407|NCT02703350|11268601|FG000|STARTED|Period Six (Part A)||5
10138408|NCT02703350|11268602|FG001|STARTED|Period Six (Part A)||5
10138409|NCT02703350|11268603|FG002|STARTED|Period Six (Part A)||5
10138410|NCT02703350|11268604|FG003|STARTED|Period Six (Part A)||5
10138411|NCT02703350|11268605|FG004|STARTED|Period Six (Part A)||5
10138412|NCT02703350|11268606|FG005|STARTED|Period Six (Part A)||5
10138413|NCT02703350|11268607|FG006|STARTED|Period Six (Part A)||0
10138414|NCT02703350|11268608|FG007|STARTED|Period Six (Part A)||0
10138415|NCT02703350|11268601|FG000|Received Study Drug|Period Six (Part A)||5
10138416|NCT02703350|11268602|FG001|Received Study Drug|Period Six (Part A)||5
10138417|NCT02703350|11268603|FG002|Received Study Drug|Period Six (Part A)||5
10138418|NCT02703350|11268604|FG003|Received Study Drug|Period Six (Part A)||5
10138419|NCT02703350|11268605|FG004|Received Study Drug|Period Six (Part A)||5
10138420|NCT02703350|11268606|FG005|Received Study Drug|Period Six (Part A)||5
10138421|NCT02703350|11268607|FG006|Received Study Drug|Period Six (Part A)||0
10138422|NCT02703350|11268608|FG007|Received Study Drug|Period Six (Part A)||0
10138423|NCT02703350|11268601|FG000|COMPLETED|Period Six (Part A)||5
10138424|NCT02703350|11268602|FG001|COMPLETED|Period Six (Part A)||5
10138425|NCT02703350|11268603|FG002|COMPLETED|Period Six (Part A)||5
10138426|NCT02703350|11268604|FG003|COMPLETED|Period Six (Part A)||5
10138427|NCT02703350|11268605|FG004|COMPLETED|Period Six (Part A)||5
10138428|NCT02703350|11268606|FG005|COMPLETED|Period Six (Part A)||5
10138429|NCT02703350|11268607|FG006|COMPLETED|Period Six (Part A)||0
10138430|NCT02703350|11268608|FG007|COMPLETED|Period Six (Part A)||0
10138431|NCT02703350|11268601|FG000|NOT COMPLETED|Period Six (Part A)||0
10138432|NCT02703350|11268602|FG001|NOT COMPLETED|Period Six (Part A)||0
10138433|NCT02703350|11268603|FG002|NOT COMPLETED|Period Six (Part A)||0
10138434|NCT02703350|11268604|FG003|NOT COMPLETED|Period Six (Part A)||0
10138435|NCT02703350|11268605|FG004|NOT COMPLETED|Period Six (Part A)||0
10138436|NCT02703350|11268606|FG005|NOT COMPLETED|Period Six (Part A)||0
10138437|NCT02703350|11268607|FG006|NOT COMPLETED|Period Six (Part A)||0
10138438|NCT02703350|11268608|FG007|NOT COMPLETED|Period Six (Part A)||0
10138439|NCT02703350|11268601|FG000|STARTED|Part B||0
10138440|NCT02703350|11268602|FG001|STARTED|Part B||0
10138441|NCT02703350|11268603|FG002|STARTED|Part B||0
10138442|NCT02703350|11268604|FG003|STARTED|Part B||0
10138443|NCT02703350|11268605|FG004|STARTED|Part B||0
10138444|NCT02703350|11268606|FG005|STARTED|Part B||0
10138445|NCT02703350|11268607|FG006|STARTED|Part B||15
10138446|NCT02703350|11268608|FG007|STARTED|Part B||15
10138447|NCT02703350|11268601|FG000|Received Study Drug|Part B||0
10138448|NCT02703350|11268602|FG001|Received Study Drug|Part B||0
10138449|NCT02703350|11268603|FG002|Received Study Drug|Part B||0
10138450|NCT02703350|11268604|FG003|Received Study Drug|Part B||0
10138451|NCT02703350|11268605|FG004|Received Study Drug|Part B||0
10138452|NCT02703350|11268606|FG005|Received Study Drug|Part B||0
10138453|NCT02703350|11268607|FG006|Received Study Drug|Part B||15
10138454|NCT02703350|11268608|FG007|Received Study Drug|Part B||15
10138455|NCT02703350|11268601|FG000|COMPLETED|Part B||0
10138456|NCT02703350|11268602|FG001|COMPLETED|Part B||0
10138457|NCT02703350|11268603|FG002|COMPLETED|Part B||0
10138458|NCT02703350|11268604|FG003|COMPLETED|Part B||0
10138459|NCT02703350|11268605|FG004|COMPLETED|Part B||0
10138460|NCT02703350|11268606|FG005|COMPLETED|Part B||0
10138461|NCT02703350|11268607|FG006|COMPLETED|Part B||15
10138462|NCT02703350|11268608|FG007|COMPLETED|Part B||15
10138463|NCT02703350|11268601|FG000|NOT COMPLETED|Part B||0
10138464|NCT02703350|11268602|FG001|NOT COMPLETED|Part B||0
10138465|NCT02703350|11268603|FG002|NOT COMPLETED|Part B||0
10138466|NCT02703350|11268604|FG003|NOT COMPLETED|Part B||0
10138467|NCT02703350|11268605|FG004|NOT COMPLETED|Part B||0
10138468|NCT02703350|11268606|FG005|NOT COMPLETED|Part B||0
10138469|NCT02703350|11268607|FG006|NOT COMPLETED|Part B||0
10138470|NCT02703350|11268608|FG007|NOT COMPLETED|Part B||0
10138471|NCT02703454|11268628|FG000|STARTED|Overall Study||24
10138472|NCT02703454|11268629|FG001|STARTED|Overall Study||27
10138473|NCT02703454|11268628|FG000|Treated|Overall Study||23
10138474|NCT02703454|11268629|FG001|Treated|Overall Study||24
10138475|NCT02703454|11268628|FG000|COMPLETED|Overall Study||13
10138476|NCT02703454|11268629|FG001|COMPLETED|Overall Study||11
10138477|NCT02703454|11268628|FG000|NOT COMPLETED|Overall Study||11
10138478|NCT02703454|11268629|FG001|NOT COMPLETED|Overall Study||16
10138479|NCT02703467|11268638|FG000|STARTED|Overall Study||20
10138480|NCT02703467|11268639|FG001|STARTED|Overall Study||5
10138481|NCT02703467|11268640|FG002|STARTED|Overall Study||45
10138482|NCT02703467|11268638|FG000|COMPLETED|Overall Study||20
10138483|NCT02703467|11268639|FG001|COMPLETED|Overall Study||5
10138484|NCT02703467|11268640|FG002|COMPLETED|Overall Study||45
10138485|NCT02703467|11268638|FG000|NOT COMPLETED|Overall Study||0
10138486|NCT02703467|11268639|FG001|NOT COMPLETED|Overall Study||0
10138487|NCT02703467|11268640|FG002|NOT COMPLETED|Overall Study||0
10138488|NCT02703532|11268656|FG000|STARTED|Overall Study||21
10138489|NCT02703532|11268657|FG001|STARTED|Overall Study||11
10138490|NCT02703532|11268658|FG002|STARTED|Overall Study||21
10138491|NCT02703532|11268659|FG003|STARTED|Overall Study||11
10138492|NCT02703532|11268656|FG000|COMPLETED|Overall Study||19
10138493|NCT02703532|11268657|FG001|COMPLETED|Overall Study||10
10138494|NCT02703532|11268658|FG002|COMPLETED|Overall Study||19
10138495|NCT02703532|11268659|FG003|COMPLETED|Overall Study||10
10138496|NCT02703532|11268656|FG000|NOT COMPLETED|Overall Study||2
10138497|NCT02703532|11268657|FG001|NOT COMPLETED|Overall Study||1
10138498|NCT02703532|11268658|FG002|NOT COMPLETED|Overall Study||2
10138499|NCT02703532|11268659|FG003|NOT COMPLETED|Overall Study||1
10138500|NCT02703636|11268669|FG000|STARTED|Overall Study||118
10138501|NCT02703636|11268669|FG000|COMPLETED|Overall Study||102
10138502|NCT02703636|11268669|FG000|NOT COMPLETED|Overall Study||16
10138503|NCT02703779|11268675|FG000|STARTED|Overall Study||51
10138504|NCT02703779|11268676|FG001|STARTED|Overall Study||50
10138505|NCT02703779|11268675|FG000|COMPLETED|Overall Study||51
10138506|NCT02703779|11268676|FG001|COMPLETED|Overall Study||50
10138507|NCT02703779|11268675|FG000|NOT COMPLETED|Overall Study||0
10138508|NCT02703779|11268676|FG001|NOT COMPLETED|Overall Study||0
10138509|NCT02703909|11268686|FG000|STARTED|Overall Study||36
10138510|NCT02703909|11268687|FG001|STARTED|Overall Study||37
10138511|NCT02703909|11268688|FG002|STARTED|Overall Study||36
10138512|NCT02703909|11268689|FG003|STARTED|Overall Study||35
10138513|NCT02703909|11268686|FG000|COMPLETED|Overall Study||36
10138514|NCT02703909|11268687|FG001|COMPLETED|Overall Study||37
10138515|NCT02703909|11268688|FG002|COMPLETED|Overall Study||36
10138516|NCT02703909|11268689|FG003|COMPLETED|Overall Study||35
10138517|NCT02703909|11268686|FG000|NOT COMPLETED|Overall Study||0
10138518|NCT02703909|11268687|FG001|NOT COMPLETED|Overall Study||0
10138519|NCT02703909|11268688|FG002|NOT COMPLETED|Overall Study||0
10138520|NCT02703909|11268689|FG003|NOT COMPLETED|Overall Study||0
10138521|NCT02703948|11268701|FG000|STARTED|Overall Study||60
10138522|NCT02703948|11268701|FG000|COMPLETED|Overall Study||57
10138523|NCT02703948|11268701|FG000|NOT COMPLETED|Overall Study||3
10138524|NCT02703987|11268707|FG000|STARTED|Visit 3 Intervention (1 Day)||14
10138525|NCT02703987|11268708|FG001|STARTED|Visit 3 Intervention (1 Day)||14
10138526|NCT02703987|11268707|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13
10138527|NCT02703987|11268708|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11
10138528|NCT02703987|11268707|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
10138529|NCT02703987|11268708|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
10138530|NCT02703987|11268707|FG000|STARTED|Washout (Minimum 5 Days)||13
10138531|NCT02703987|11268708|FG001|STARTED|Washout (Minimum 5 Days)||11
10138532|NCT02703987|11268707|FG000|COMPLETED|Washout (Minimum 5 Days)||13
10138533|NCT02703987|11268708|FG001|COMPLETED|Washout (Minimum 5 Days)||11
10138534|NCT02703987|11268707|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0
10138535|NCT02703987|11268708|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0
10138536|NCT02703987|11268707|FG000|STARTED|Visit 4 Intervention (1 Day)||13
10138537|NCT02703987|11268708|FG001|STARTED|Visit 4 Intervention (1 Day)||11
10138538|NCT02703987|11268707|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12
10138539|NCT02703987|11268708|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10
10138540|NCT02703987|11268707|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
10138541|NCT02703987|11268708|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
10138542|NCT02704091|11268716|FG000|STARTED|Overall Study||430
10138543|NCT02704091|11268717|FG001|STARTED|Overall Study||423
10138544|NCT02704091|11268716|FG000|COMPLETED|Overall Study||402
10138545|NCT02704091|11268717|FG001|COMPLETED|Overall Study||400
10138546|NCT02704091|11268716|FG000|NOT COMPLETED|Overall Study||28
10138547|NCT02704091|11268717|FG001|NOT COMPLETED|Overall Study||23
10138548|NCT02704104|11268723|FG000|STARTED|Overall Study||46
10138549|NCT02704104|11268723|FG000|COMPLETED|Overall Study||46
10138550|NCT02704104|11268723|FG000|NOT COMPLETED|Overall Study||0
10138551|NCT02704143|11268731|FG000|STARTED|Overall Study||63
10138552|NCT02704143|11268731|FG000|COMPLETED|Overall Study||53
10138553|NCT02704143|11268731|FG000|NOT COMPLETED|Overall Study||10
10138554|NCT02704689|11268735|FG000|STARTED|Overall Study||9
10138555|NCT02704689|11268735|FG000|COMPLETED|Overall Study||6
10138556|NCT02704689|11268735|FG000|NOT COMPLETED|Overall Study||3
10138557|NCT02704702|11268745|FG000|STARTED|Overall Study||6
10138558|NCT02704702|11268746|FG001|STARTED|Overall Study||6
10138559|NCT02704702|11268747|FG002|STARTED|Overall Study||6
10138560|NCT02704702|11268748|FG003|STARTED|Overall Study||6
10138561|NCT02704702|11268749|FG004|STARTED|Overall Study||6
10138562|NCT02704702|11268750|FG005|STARTED|Overall Study||6
10138563|NCT02704702|11268745|FG000|COMPLETED|Overall Study||5
10138564|NCT02704702|11268746|FG001|COMPLETED|Overall Study||6
10138565|NCT02704702|11268747|FG002|COMPLETED|Overall Study||6
10138566|NCT02704702|11268748|FG003|COMPLETED|Overall Study||5
10138567|NCT02704702|11268749|FG004|COMPLETED|Overall Study||4
10138568|NCT02704702|11268750|FG005|COMPLETED|Overall Study||4
10138569|NCT02704702|11268745|FG000|NOT COMPLETED|Overall Study||1
10138570|NCT02704702|11268746|FG001|NOT COMPLETED|Overall Study||0
10138571|NCT02704702|11268747|FG002|NOT COMPLETED|Overall Study||0
10138572|NCT02704702|11268748|FG003|NOT COMPLETED|Overall Study||1
10138573|NCT02704702|11268749|FG004|NOT COMPLETED|Overall Study||2
10138574|NCT02704702|11268750|FG005|NOT COMPLETED|Overall Study||2
10138575|NCT02705105|11268776|FG000|STARTED|Treatment||4
10138576|NCT02705105|11268777|FG001|STARTED|Treatment||110
10138577|NCT02705105|11268776|FG000|Subjects Who Were Replaced|Treatment||1
10138578|NCT02705105|11268777|FG001|Subjects Who Were Replaced|Treatment||0
10138579|NCT02705105|11268776|FG000|D/C From Treatment Phase|Treatment||4
10138580|NCT02705105|11268777|FG001|D/C From Treatment Phase|Treatment||107
10138581|NCT02705105|11268776|FG000|D/C From Follow-Up|Treatment||4
10138582|NCT02705105|11268777|FG001|D/C From Follow-Up|Treatment||110
10138583|NCT02705105|11268776|FG000|COMPLETED|Treatment||0
10138584|NCT02705105|11268777|FG001|COMPLETED|Treatment||1
10138585|NCT02705105|11268776|FG000|NOT COMPLETED|Treatment||4
10138586|NCT02705105|11268777|FG001|NOT COMPLETED|Treatment||109
10138587|NCT02705105|11268776|FG000|STARTED|Follow-Up||4
10138588|NCT02705105|11268777|FG001|STARTED|Follow-Up||110
10138589|NCT02705105|11268776|FG000|COMPLETED|Follow-Up||0
10138590|NCT02705105|11268777|FG001|COMPLETED|Follow-Up||0
10138591|NCT02705105|11268776|FG000|NOT COMPLETED|Follow-Up||4
10138592|NCT02705105|11268777|FG001|NOT COMPLETED|Follow-Up||110
10138593|NCT02705352|11268797|FG000|STARTED|Overall Study||1
10138594|NCT02705352|11268798|FG001|STARTED|Overall Study||0
10138595|NCT02705352|11268797|FG000|COMPLETED|Overall Study||1
10138596|NCT02705352|11268798|FG001|COMPLETED|Overall Study||0
10138597|NCT02705352|11268797|FG000|NOT COMPLETED|Overall Study||0
10138598|NCT02705352|11268798|FG001|NOT COMPLETED|Overall Study||0
10138599|NCT02705365|11268806|FG000|STARTED|Overall Study||400
10138600|NCT02705365|11268807|FG001|STARTED|Overall Study||800
10138601|NCT02705365|11268806|FG000|COMPLETED|Overall Study||400
10138602|NCT02705365|11268807|FG001|COMPLETED|Overall Study||800
10138603|NCT02705365|11268806|FG000|NOT COMPLETED|Overall Study||0
10138604|NCT02705365|11268807|FG001|NOT COMPLETED|Overall Study||0
10138605|NCT02705586|11268813|FG000|STARTED|Overall Study||13
10138606|NCT02705586|11268813|FG000|COMPLETED|Overall Study||5
10138607|NCT02705586|11268813|FG000|NOT COMPLETED|Overall Study||8
10138608|NCT02705625|11268820|FG000|STARTED|Overall Study||82
10138609|NCT02705625|11268821|FG001|STARTED|Overall Study||82
10138610|NCT02705625|11268822|FG002|STARTED|Overall Study||80
10138611|NCT02705625|11268820|FG000|COMPLETED|Overall Study||74
10138612|NCT02705625|11268821|FG001|COMPLETED|Overall Study||72
10138613|NCT02705625|11268822|FG002|COMPLETED|Overall Study||69
10138614|NCT02705625|11268820|FG000|NOT COMPLETED|Overall Study||8
10138615|NCT02705625|11268821|FG001|NOT COMPLETED|Overall Study||10
10138616|NCT02705625|11268822|FG002|NOT COMPLETED|Overall Study||11
10138617|NCT02705716|11268832|FG000|STARTED|Overall Study||72
10138618|NCT02705716|11268833|FG001|STARTED|Overall Study||70
10138619|NCT02705716|11268832|FG000|COMPLETED|Overall Study||68
10138620|NCT02705716|11268833|FG001|COMPLETED|Overall Study||68
10138621|NCT02705716|11268832|FG000|NOT COMPLETED|Overall Study||4
10138622|NCT02705716|11268833|FG001|NOT COMPLETED|Overall Study||2
10138623|NCT02705807|11268839|FG000|STARTED|Overall Study||10
10138624|NCT02705807|11268839|FG000|COMPLETED|Overall Study||10
10138625|NCT02705807|11268839|FG000|NOT COMPLETED|Overall Study||0
10138626|NCT02706041|11268845|FG000|STARTED|Overall Study||18
10138627|NCT02706041|11268846|FG001|STARTED|Overall Study||21
10138628|NCT02706041|11268845|FG000|Received Allocated Intervention|Overall Study||18
10138629|NCT02706041|11268846|FG001|Received Allocated Intervention|Overall Study||18
10138630|NCT02706041|11268845|FG000|COMPLETED|Overall Study||18
10138631|NCT02706041|11268846|FG001|COMPLETED|Overall Study||18
10138632|NCT02706041|11268845|FG000|NOT COMPLETED|Overall Study||0
10138633|NCT02706041|11268846|FG001|NOT COMPLETED|Overall Study||3
10138634|NCT02706249|11268854|FG000|STARTED|Overall Study||25
10138635|NCT02706249|11268855|FG001|STARTED|Overall Study||25
10138636|NCT02706249|11268854|FG000|COMPLETED|Overall Study||23
10138637|NCT02706249|11268855|FG001|COMPLETED|Overall Study||24
10138638|NCT02706249|11268854|FG000|NOT COMPLETED|Overall Study||2
10138639|NCT02706249|11268855|FG001|NOT COMPLETED|Overall Study||1
10138640|NCT02706327|11268866|FG000|STARTED|Overall Study||22
10138641|NCT02706327|11268867|FG001|STARTED|Overall Study||22
10138642|NCT02706327|11268868|FG002|STARTED|Overall Study||23
10138643|NCT02706327|11268866|FG000|COMPLETED|Overall Study||21
10138644|NCT02706327|11268867|FG001|COMPLETED|Overall Study||21
10138645|NCT02706327|11268868|FG002|COMPLETED|Overall Study||21
10138646|NCT02706327|11268866|FG000|NOT COMPLETED|Overall Study||1
10138647|NCT02706327|11268867|FG001|NOT COMPLETED|Overall Study||1
10138648|NCT02706327|11268868|FG002|NOT COMPLETED|Overall Study||2
10138649|NCT02706483|11268876|FG000|STARTED|Overall Study||2272
10138650|NCT02706483|11268876|FG000|COMPLETED|Overall Study||1842
10138651|NCT02706483|11268876|FG000|NOT COMPLETED|Overall Study||430
10138652|NCT02706717|11268882|FG000|STARTED|Overall Study||47
10138653|NCT02706717|11268883|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
10138654|NCT02706717|11268882|FG000|COMPLETED|Overall Study||46
10138655|NCT02706717|11268883|FG001|COMPLETED|Overall Study||35
10138656|NCT02706717|11268882|FG000|NOT COMPLETED|Overall Study||1
10138657|NCT02706717|11268883|FG001|NOT COMPLETED|Overall Study||11
10138658|NCT02706834|11268900|FG000|STARTED|Overall Study||3
10138659|NCT02706834|11268901|FG001|STARTED|Overall Study||3
10138660|NCT02706834|11268902|FG002|STARTED|Overall Study||3
10138661|NCT02706834|11268903|FG003|STARTED|Overall Study||3
10138662|NCT02706834|11268904|FG004|STARTED|Overall Study||3
10138663|NCT02706834|11268905|FG005|STARTED|Overall Study||3
10138664|NCT02706834|11268906|FG006|STARTED|Overall Study||3
10138665|NCT02706834|11268907|FG007|STARTED|Overall Study||3
10138666|NCT02706834|11268908|FG008|STARTED|Overall Study||4
10138667|NCT02706834|11268909|FG009|STARTED|Overall Study||4
10138668|NCT02706834|11268910|FG010|STARTED|Overall Study||4
10138669|NCT02706834|11268900|FG000|COMPLETED|Overall Study|Completed = completed study drug|1
10138670|NCT02706834|11268901|FG001|COMPLETED|Overall Study||2
10138671|NCT02706834|11268902|FG002|COMPLETED|Overall Study||2
10138672|NCT02706834|11268903|FG003|COMPLETED|Overall Study||3
10138673|NCT02706834|11268904|FG004|COMPLETED|Overall Study||2
10138674|NCT02706834|11268905|FG005|COMPLETED|Overall Study||3
10138675|NCT02706834|11268906|FG006|COMPLETED|Overall Study||3
10138676|NCT02706834|11268907|FG007|COMPLETED|Overall Study||3
10138677|NCT02706834|11268908|FG008|COMPLETED|Overall Study||4
10138678|NCT02706834|11268909|FG009|COMPLETED|Overall Study||3
10138679|NCT02706834|11268910|FG010|COMPLETED|Overall Study||3
10138680|NCT02706834|11268900|FG000|NOT COMPLETED|Overall Study||2
10138681|NCT02706834|11268901|FG001|NOT COMPLETED|Overall Study||1
10138682|NCT02706834|11268902|FG002|NOT COMPLETED|Overall Study||1
10138683|NCT02706834|11268903|FG003|NOT COMPLETED|Overall Study||0
10138684|NCT02706834|11268904|FG004|NOT COMPLETED|Overall Study||1
10138685|NCT02706834|11268905|FG005|NOT COMPLETED|Overall Study||0
10138686|NCT02706834|11268906|FG006|NOT COMPLETED|Overall Study||0
10138687|NCT02706834|11268907|FG007|NOT COMPLETED|Overall Study||0
10138688|NCT02706834|11268908|FG008|NOT COMPLETED|Overall Study||0
10138689|NCT02706834|11268909|FG009|NOT COMPLETED|Overall Study||1
10138690|NCT02706834|11268910|FG010|NOT COMPLETED|Overall Study||1
10138691|NCT02706873|11268959|FG000|STARTED|Overall Study||315
10138692|NCT02706873|11268960|FG001|STARTED|Overall Study||55
10138693|NCT02706873|11268961|FG002|STARTED|Overall Study||317
10138694|NCT02706873|11268962|FG003|STARTED|Overall Study||315
10138695|NCT02706873|11268959|FG000|Received Study Drug|Overall Study||314
10138696|NCT02706873|11268960|FG001|Received Study Drug|Overall Study||55
10138697|NCT02706873|11268961|FG002|Received Study Drug|Overall Study||317
10138698|NCT02706873|11268962|FG003|Received Study Drug|Overall Study||314
10138699|NCT02706873|11268959|FG000|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
10138700|NCT02706873|11268960|FG001|Global Analysis Population|Overall Study||0
10138701|NCT02706873|11268961|FG002|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
10138702|NCT02706873|11268962|FG003|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
10138703|NCT02706873|11268959|FG000|Japan Sub-study|Overall Study||28
10138704|NCT02706873|11268960|FG001|Japan Sub-study|Overall Study||55
10138705|NCT02706873|11268961|FG002|Japan Sub-study|Overall Study||27
10138706|NCT02706873|11268962|FG003|Japan Sub-study|Overall Study||28
10138707|NCT02706873|11268959|FG000|COMPLETED|Overall Study||268
10138708|NCT02706873|11268960|FG001|COMPLETED|Overall Study||51
10138709|NCT02706873|11268961|FG002|COMPLETED|Overall Study||290
10138710|NCT02706873|11268962|FG003|COMPLETED|Overall Study||282
10138711|NCT02706873|11268959|FG000|NOT COMPLETED|Overall Study||47
10138712|NCT02706873|11268960|FG001|NOT COMPLETED|Overall Study||4
10138713|NCT02706873|11268961|FG002|NOT COMPLETED|Overall Study||27
10138714|NCT02706873|11268962|FG003|NOT COMPLETED|Overall Study||33
10138715|NCT02706886|11268983|FG000|STARTED|Part A: SAD Period||8
10138716|NCT02706886|11268984|FG001|STARTED|Part A: SAD Period||6
10138717|NCT02706886|11268985|FG002|STARTED|Part A: SAD Period||6
10138718|NCT02706886|11268986|FG003|STARTED|Part A: SAD Period||6
10138719|NCT02706886|11268987|FG004|STARTED|Part A: SAD Period||6
10138720|NCT02706886|11268988|FG005|STARTED|Part A: SAD Period||0
10138721|NCT02706886|11268989|FG006|STARTED|Part A: SAD Period||0
10138722|NCT02706886|11268990|FG007|STARTED|Part A: SAD Period||0
10138723|NCT02706886|11268991|FG008|STARTED|Part A: SAD Period||0
10138724|NCT02706886|11268983|FG000|COMPLETED|Part A: SAD Period||8
10138725|NCT02706886|11268984|FG001|COMPLETED|Part A: SAD Period||6
10138726|NCT02706886|11268985|FG002|COMPLETED|Part A: SAD Period||6
10138727|NCT02706886|11268986|FG003|COMPLETED|Part A: SAD Period||4
10138728|NCT02706886|11268987|FG004|COMPLETED|Part A: SAD Period||6
10138729|NCT02706886|11268988|FG005|COMPLETED|Part A: SAD Period||0
10138730|NCT02706886|11268989|FG006|COMPLETED|Part A: SAD Period||0
10138731|NCT02706886|11268990|FG007|COMPLETED|Part A: SAD Period||0
10138732|NCT02706886|11268991|FG008|COMPLETED|Part A: SAD Period||0
10138733|NCT02706886|11268983|FG000|NOT COMPLETED|Part A: SAD Period||0
10138734|NCT02706886|11268984|FG001|NOT COMPLETED|Part A: SAD Period||0
10138735|NCT02706886|11268985|FG002|NOT COMPLETED|Part A: SAD Period||0
10138736|NCT02706886|11268986|FG003|NOT COMPLETED|Part A: SAD Period||2
10138737|NCT02706886|11268987|FG004|NOT COMPLETED|Part A: SAD Period||0
10138738|NCT02706886|11268988|FG005|NOT COMPLETED|Part A: SAD Period||0
10138739|NCT02706886|11268989|FG006|NOT COMPLETED|Part A: SAD Period||0
10138740|NCT02706886|11268990|FG007|NOT COMPLETED|Part A: SAD Period||0
10138741|NCT02706886|11268991|FG008|NOT COMPLETED|Part A: SAD Period||0
10138742|NCT02706886|11268983|FG000|STARTED|Part B: MAD Study Days 1-85||0
10138743|NCT02706886|11268984|FG001|STARTED|Part B: MAD Study Days 1-85||0
10138744|NCT02706886|11268985|FG002|STARTED|Part B: MAD Study Days 1-85||0
10138745|NCT02706886|11268986|FG003|STARTED|Part B: MAD Study Days 1-85||0
10138746|NCT02706886|11268987|FG004|STARTED|Part B: MAD Study Days 1-85||0
10138747|NCT02706886|11268988|FG005|STARTED|Part B: MAD Study Days 1-85||3
10138748|NCT02706886|11268989|FG006|STARTED|Part B: MAD Study Days 1-85||7
10138749|NCT02706886|11268990|FG007|STARTED|Part B: MAD Study Days 1-85||7
10138750|NCT02706886|11268991|FG008|STARTED|Part B: MAD Study Days 1-85||3
10138751|NCT02706886|11268983|FG000|COMPLETED|Part B: MAD Study Days 1-85||0
10138752|NCT02706886|11268984|FG001|COMPLETED|Part B: MAD Study Days 1-85||0
10138753|NCT02706886|11268985|FG002|COMPLETED|Part B: MAD Study Days 1-85||0
10138754|NCT02706886|11268986|FG003|COMPLETED|Part B: MAD Study Days 1-85||0
10138755|NCT02706886|11268987|FG004|COMPLETED|Part B: MAD Study Days 1-85||0
10138756|NCT02706886|11268988|FG005|COMPLETED|Part B: MAD Study Days 1-85||3
10138757|NCT02706886|11268989|FG006|COMPLETED|Part B: MAD Study Days 1-85||7
10138758|NCT02706886|11268990|FG007|COMPLETED|Part B: MAD Study Days 1-85||7
10138759|NCT02706886|11268991|FG008|COMPLETED|Part B: MAD Study Days 1-85||3
10138760|NCT02706886|11268983|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138761|NCT02706886|11268984|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138762|NCT02706886|11268985|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138763|NCT02706886|11268986|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138764|NCT02706886|11268987|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138765|NCT02706886|11268988|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138766|NCT02706886|11268989|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138767|NCT02706886|11268990|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138768|NCT02706886|11268991|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10138769|NCT02706886|11268983|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0
10138770|NCT02706886|11268984|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0
10138771|NCT02706886|11268985|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0
10138772|NCT02706886|11268986|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0
10138773|NCT02706886|11268987|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0
10138774|NCT02706886|11268988|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0
10138775|NCT02706886|11268989|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
10138776|NCT02706886|11268990|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
10138777|NCT02706886|11268991|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
10138778|NCT02706886|11268983|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138779|NCT02706886|11268984|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138780|NCT02706886|11268985|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138781|NCT02706886|11268986|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138782|NCT02706886|11268987|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138783|NCT02706886|11268988|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138784|NCT02706886|11268989|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8
10138785|NCT02706886|11268990|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8
10138786|NCT02706886|11268991|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4
10138787|NCT02706886|11268983|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138788|NCT02706886|11268984|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138789|NCT02706886|11268985|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138790|NCT02706886|11268986|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138791|NCT02706886|11268987|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138792|NCT02706886|11268988|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138793|NCT02706886|11268989|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138794|NCT02706886|11268990|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138795|NCT02706886|11268991|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10138796|NCT02706899|11269036|FG000|STARTED|Overall Study||13
10138797|NCT02706899|11269037|FG001|STARTED|Overall Study||6
10138798|NCT02706899|11269036|FG000|COMPLETED|Overall Study||0
10138799|NCT02706899|11269037|FG001|COMPLETED|Overall Study||0
10138800|NCT02706899|11269036|FG000|NOT COMPLETED|Overall Study||13
10138801|NCT02706899|11269037|FG001|NOT COMPLETED|Overall Study||6
10138802|NCT02706925|11269052|FG000|STARTED|Overall Study||16
10138803|NCT02706925|11269053|FG001|STARTED|Overall Study||6
10138804|NCT02706925|11269054|FG002|STARTED|Overall Study||6
10138805|NCT02706925|11269055|FG003|STARTED|Overall Study||6
10138806|NCT02706925|11269056|FG004|STARTED|Overall Study||6
10138807|NCT02706925|11269057|FG005|STARTED|Overall Study||5
10138808|NCT02706925|11269058|FG006|STARTED|Overall Study||6
10138809|NCT02706925|11269059|FG007|STARTED|Overall Study||6
10138810|NCT02706925|11269060|FG008|STARTED|Overall Study||6
10138811|NCT02706925|11269052|FG000|COMPLETED|Overall Study||16
10138812|NCT02706925|11269053|FG001|COMPLETED|Overall Study||6
10138813|NCT02706925|11269054|FG002|COMPLETED|Overall Study||6
10138814|NCT02706925|11269055|FG003|COMPLETED|Overall Study||6
10138815|NCT02706925|11269056|FG004|COMPLETED|Overall Study||6
10138816|NCT02706925|11269057|FG005|COMPLETED|Overall Study||5
10138817|NCT02706925|11269058|FG006|COMPLETED|Overall Study||6
10138818|NCT02706925|11269059|FG007|COMPLETED|Overall Study||6
10138819|NCT02706925|11269060|FG008|COMPLETED|Overall Study||6
10138820|NCT02706925|11269052|FG000|NOT COMPLETED|Overall Study||0
10138821|NCT02706925|11269053|FG001|NOT COMPLETED|Overall Study||0
10138822|NCT02706925|11269054|FG002|NOT COMPLETED|Overall Study||0
10138823|NCT02706925|11269055|FG003|NOT COMPLETED|Overall Study||0
10138824|NCT02706925|11269056|FG004|NOT COMPLETED|Overall Study||0
10138825|NCT02706925|11269057|FG005|NOT COMPLETED|Overall Study||0
10138826|NCT02706925|11269058|FG006|NOT COMPLETED|Overall Study||0
10138827|NCT02706925|11269059|FG007|NOT COMPLETED|Overall Study||0
10138828|NCT02706925|11269060|FG008|NOT COMPLETED|Overall Study||0
10138829|NCT02706938|11269090|FG000|STARTED|First Period, 6 Weeks||32
10138830|NCT02706938|11269091|FG001|STARTED|First Period, 6 Weeks||33
10138831|NCT02706938|11269090|FG000|COMPLETED|First Period, 6 Weeks||21
10138832|NCT02706938|11269091|FG001|COMPLETED|First Period, 6 Weeks||31
10138833|NCT02706938|11269090|FG000|NOT COMPLETED|First Period, 6 Weeks||11
10138834|NCT02706938|11269091|FG001|NOT COMPLETED|First Period, 6 Weeks||2
10138835|NCT02706938|11269090|FG000|STARTED|Second Period, 6 Weeks||21
10138836|NCT02706938|11269091|FG001|STARTED|Second Period, 6 Weeks||31
10138837|NCT02706938|11269090|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
10138838|NCT02706938|11269091|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
10138839|NCT02706938|11269090|FG000|NOT COMPLETED|Second Period, 6 Weeks||0
10138840|NCT02706938|11269091|FG001|NOT COMPLETED|Second Period, 6 Weeks||10
10138841|NCT02706951|11269101|FG000|STARTED|Overall Study||216
10138842|NCT02706951|11269102|FG001|STARTED|Overall Study||217
10138843|NCT02706951|11269103|FG002|STARTED|Overall Study||215
10138844|NCT02706951|11269101|FG000|COMPLETED|Overall Study||202
10138845|NCT02706951|11269102|FG001|COMPLETED|Overall Study||201
10138846|NCT02706951|11269103|FG002|COMPLETED|Overall Study||205
10138847|NCT02706951|11269101|FG000|NOT COMPLETED|Overall Study||14
10138848|NCT02706951|11269102|FG001|NOT COMPLETED|Overall Study||16
10138849|NCT02706951|11269103|FG002|NOT COMPLETED|Overall Study||10
10138850|NCT02707146|11269113|FG000|STARTED|Overall Study||359
10138851|NCT02707146|11269114|FG001|STARTED|Overall Study||391
10138852|NCT02707146|11269113|FG000|COMPLETED|Overall Study||359
10138853|NCT02707146|11269114|FG001|COMPLETED|Overall Study||388
10138854|NCT02707146|11269113|FG000|NOT COMPLETED|Overall Study||0
10138855|NCT02707146|11269114|FG001|NOT COMPLETED|Overall Study||3
10138856|NCT02707172|11269120|FG000|STARTED|1st Set of Experiment||28
10138857|NCT02707172|11269120|FG000|COMPLETED|1st Set of Experiment||28
10138858|NCT02707172|11269120|FG000|NOT COMPLETED|1st Set of Experiment||0
10138859|NCT02707172|11269120|FG000|STARTED|Wash Out||28
10138860|NCT02707172|11269120|FG000|COMPLETED|Wash Out||28
10138861|NCT02707172|11269120|FG000|NOT COMPLETED|Wash Out||0
10138862|NCT02707172|11269120|FG000|STARTED|2nd Set of Experiment||28
10138863|NCT02707172|11269120|FG000|COMPLETED|2nd Set of Experiment||28
10138864|NCT02707172|11269120|FG000|NOT COMPLETED|2nd Set of Experiment||0
10138865|NCT02707432|11269127|FG000|STARTED|Overall Study||72
10138866|NCT02707432|11269128|FG001|STARTED|Overall Study||71
10138867|NCT02707432|11269127|FG000|COMPLETED|Overall Study||57
10138868|NCT02707432|11269128|FG001|COMPLETED|Overall Study||51
10138869|NCT02707432|11269127|FG000|NOT COMPLETED|Overall Study||15
10138870|NCT02707432|11269128|FG001|NOT COMPLETED|Overall Study||20
10138871|NCT02707523|11269137|FG000|STARTED|Overall Study||16
10138872|NCT02707523|11269138|FG001|STARTED|Overall Study||16
10138873|NCT02707523|11269139|FG002|STARTED|Overall Study||16
10138874|NCT02707523|11269137|FG000|COMPLETED|Overall Study||16
10138875|NCT02707523|11269138|FG001|COMPLETED|Overall Study||16
10138876|NCT02707523|11269139|FG002|COMPLETED|Overall Study||16
10138877|NCT02707523|11269137|FG000|NOT COMPLETED|Overall Study||0
10138878|NCT02707523|11269138|FG001|NOT COMPLETED|Overall Study||0
10138879|NCT02707523|11269139|FG002|NOT COMPLETED|Overall Study||0
10138880|NCT02707601|11269149|FG000|STARTED|Overall Study||76
10138881|NCT02707601|11269150|FG001|STARTED|Overall Study||74
10138882|NCT02707601|11269149|FG000|COMPLETED|Overall Study||72
10138883|NCT02707601|11269150|FG001|COMPLETED|Overall Study||70
10138884|NCT02707601|11269149|FG000|NOT COMPLETED|Overall Study||4
10138885|NCT02707601|11269150|FG001|NOT COMPLETED|Overall Study||4
10138886|NCT02707640|11269162|FG000|STARTED|Overall Study||61
10138887|NCT02707640|11269163|FG001|STARTED|Overall Study||62
10138888|NCT02707640|11269162|FG000|COMPLETED|Overall Study||52
10138889|NCT02707640|11269163|FG001|COMPLETED|Overall Study||55
10138890|NCT02707640|11269162|FG000|NOT COMPLETED|Overall Study||9
10138891|NCT02707640|11269163|FG001|NOT COMPLETED|Overall Study||7
10138892|NCT02707757|11269171|FG000|STARTED|Overall Study||88
10138893|NCT02707757|11269172|FG001|STARTED|Overall Study||96
10138894|NCT02707757|11269171|FG000|COMPLETED|Overall Study||76
10138895|NCT02707757|11269172|FG001|COMPLETED|Overall Study||84
10138896|NCT02707757|11269171|FG000|NOT COMPLETED|Overall Study||12
10138897|NCT02707757|11269172|FG001|NOT COMPLETED|Overall Study||12
10138898|NCT02707770|11269180|FG000|STARTED|Overall Study||10
10138899|NCT02707770|11269181|FG001|STARTED|Overall Study||10
10138900|NCT02707770|11269180|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
10138901|NCT02707770|11269181|FG001|COMPLETED|Overall Study||10
10138902|NCT02707770|11269180|FG000|NOT COMPLETED|Overall Study||1
10138903|NCT02707770|11269181|FG001|NOT COMPLETED|Overall Study||0
10196635|NCT03364309|11324832|FG015|Received at Least One Dose of Study Drug|Induction Period||0
10196636|NCT03364309|11324833|FG016|Received at Least One Dose of Study Drug|Induction Period||0
10196637|NCT03364309|11324834|FG017|Received at Least One Dose of Study Drug|Induction Period||0
10196638|NCT03364309|11324835|FG018|Received at Least One Dose of Study Drug|Induction Period||0
10196639|NCT03364309|11324817|FG000|COMPLETED|Induction Period||82
10196640|NCT03364309|11324818|FG001|COMPLETED|Induction Period||170
10196641|NCT03364309|11324819|FG002|COMPLETED|Induction Period||175
10196642|NCT03364309|11324820|FG003|COMPLETED|Induction Period||0
10196643|NCT03364309|11324821|FG004|COMPLETED|Induction Period||0
10196644|NCT03364309|11324822|FG005|COMPLETED|Induction Period||0
10196645|NCT03364309|11324823|FG006|COMPLETED|Induction Period||0
10196646|NCT03364309|11324824|FG007|COMPLETED|Induction Period||0
10196647|NCT03364309|11324825|FG008|COMPLETED|Induction Period||0
10196648|NCT03364309|11324826|FG009|COMPLETED|Induction Period||0
10196649|NCT03364309|11324827|FG010|COMPLETED|Induction Period||0
10196650|NCT03364309|11324828|FG011|COMPLETED|Induction Period||0
10196651|NCT03364309|11324829|FG012|COMPLETED|Induction Period||0
10196652|NCT03364309|11324830|FG013|COMPLETED|Induction Period||0
10196653|NCT03364309|11324831|FG014|COMPLETED|Induction Period||0
9729211|NCT00117143|10828773|FG001|COMPLETED|Overall Study||4
10196654|NCT03364309|11324832|FG015|COMPLETED|Induction Period||0
10138904|NCT02707861|11269191|FG000|STARTED|Overall Study||41
10138905|NCT02707861|11269192|FG001|STARTED|Overall Study||38
10138906|NCT02707861|11269191|FG000|COMPLETED|Overall Study||0
10138907|NCT02707861|11269192|FG001|COMPLETED|Overall Study||0
10138908|NCT02707861|11269191|FG000|NOT COMPLETED|Overall Study||41
10138909|NCT02707861|11269192|FG001|NOT COMPLETED|Overall Study||38
10138910|NCT02707952|11269202|FG000|STARTED|Overall Study||129
10138911|NCT02707952|11269203|FG001|STARTED|Overall Study||53
10138912|NCT02707952|11269204|FG002|STARTED|Overall Study||103
10138913|NCT02707952|11269205|FG003|STARTED|Overall Study||10
10138914|NCT02707952|11269202|FG000|Participants Who Received Study Drug|Overall Study||129
10138915|NCT02707952|11269203|FG001|Participants Who Received Study Drug|Overall Study||52
10138916|NCT02707952|11269204|FG002|Participants Who Received Study Drug|Overall Study||103
10138917|NCT02707952|11269205|FG003|Participants Who Received Study Drug|Overall Study||10
10138918|NCT02707952|11269202|FG000|COMPLETED|Overall Study||127
10138919|NCT02707952|11269203|FG001|COMPLETED|Overall Study||52
10138920|NCT02707952|11269204|FG002|COMPLETED|Overall Study||101
10138921|NCT02707952|11269205|FG003|COMPLETED|Overall Study||10
10138922|NCT02707952|11269202|FG000|NOT COMPLETED|Overall Study||2
10138923|NCT02707952|11269203|FG001|NOT COMPLETED|Overall Study||1
10138924|NCT02707952|11269204|FG002|NOT COMPLETED|Overall Study||2
10138925|NCT02707952|11269205|FG003|NOT COMPLETED|Overall Study||0
10138926|NCT02707965|11269226|FG000|STARTED|Overall Study||3
10138927|NCT02707965|11269227|FG001|STARTED|Overall Study||2
10138928|NCT02707965|11269228|FG002|STARTED|Overall Study||4
10138929|NCT02707965|11269229|FG003|STARTED|Overall Study||0
10138930|NCT02707965|11269230|FG004|STARTED|Overall Study||2
10138931|NCT02707965|11269231|FG005|STARTED|Overall Study||1
10138932|NCT02707965|11269232|FG006|STARTED|Overall Study||0
10138933|NCT02707965|11269233|FG007|STARTED|Overall Study||3
10138934|NCT02707965|11269234|FG008|STARTED|Overall Study||1
10138935|NCT02707965|11269235|FG009|STARTED|Overall Study||0
10138936|NCT02707965|11269236|FG010|STARTED|Overall Study||1
10138937|NCT02707965|11269237|FG011|STARTED|Overall Study||0
10138938|NCT02707965|11269238|FG012|STARTED|Overall Study||0
10138939|NCT02707965|11269239|FG013|STARTED|Overall Study||2
10138940|NCT02707965|11269240|FG014|STARTED|Overall Study||2
10138941|NCT02707965|11269241|FG015|STARTED|Overall Study||0
10138942|NCT02707965|11269226|FG000|COMPLETED|Overall Study||2
10138943|NCT02707965|11269227|FG001|COMPLETED|Overall Study||1
10138944|NCT02707965|11269228|FG002|COMPLETED|Overall Study||3
10138945|NCT02707965|11269229|FG003|COMPLETED|Overall Study||0
10138946|NCT02707965|11269230|FG004|COMPLETED|Overall Study||2
10138947|NCT02707965|11269231|FG005|COMPLETED|Overall Study||1
10138948|NCT02707965|11269232|FG006|COMPLETED|Overall Study||0
10138949|NCT02707965|11269233|FG007|COMPLETED|Overall Study||0
10138950|NCT02707965|11269234|FG008|COMPLETED|Overall Study||1
10138951|NCT02707965|11269235|FG009|COMPLETED|Overall Study||0
10138952|NCT02707965|11269236|FG010|COMPLETED|Overall Study||1
10138953|NCT02707965|11269237|FG011|COMPLETED|Overall Study||0
10138954|NCT02707965|11269238|FG012|COMPLETED|Overall Study||0
10138955|NCT02707965|11269239|FG013|COMPLETED|Overall Study||2
10138956|NCT02707965|11269240|FG014|COMPLETED|Overall Study||0
10138957|NCT02707965|11269241|FG015|COMPLETED|Overall Study||0
10138958|NCT02707965|11269226|FG000|NOT COMPLETED|Overall Study||1
10138959|NCT02707965|11269227|FG001|NOT COMPLETED|Overall Study||1
10138960|NCT02707965|11269228|FG002|NOT COMPLETED|Overall Study||1
10138961|NCT02707965|11269229|FG003|NOT COMPLETED|Overall Study||0
10138962|NCT02707965|11269230|FG004|NOT COMPLETED|Overall Study||0
10138963|NCT02707965|11269231|FG005|NOT COMPLETED|Overall Study||0
10138964|NCT02707965|11269232|FG006|NOT COMPLETED|Overall Study||0
10138965|NCT02707965|11269233|FG007|NOT COMPLETED|Overall Study||3
10138966|NCT02707965|11269234|FG008|NOT COMPLETED|Overall Study||0
10138967|NCT02707965|11269235|FG009|NOT COMPLETED|Overall Study||0
10138968|NCT02707965|11269236|FG010|NOT COMPLETED|Overall Study||0
10138969|NCT02707965|11269237|FG011|NOT COMPLETED|Overall Study||0
10138970|NCT02707965|11269238|FG012|NOT COMPLETED|Overall Study||0
10138971|NCT02707965|11269239|FG013|NOT COMPLETED|Overall Study||0
10138972|NCT02707965|11269240|FG014|NOT COMPLETED|Overall Study||2
10138973|NCT02707965|11269241|FG015|NOT COMPLETED|Overall Study||0
10138974|NCT02707991|11269276|FG000|STARTED|Overall Study||33
10138975|NCT02707991|11269277|FG001|STARTED|Overall Study||35
10138976|NCT02707991|11269276|FG000|Day 60 Data Collectio|Overall Study||32
10138977|NCT02707991|11269277|FG001|Day 60 Data Collectio|Overall Study||34
10138978|NCT02707991|11269276|FG000|Month 6 Data Collection|Overall Study||32
10138979|NCT02707991|11269277|FG001|Month 6 Data Collection|Overall Study||34
10138980|NCT02707991|11269276|FG000|COMPLETED|Overall Study||32
10138981|NCT02707991|11269277|FG001|COMPLETED|Overall Study||34
10138982|NCT02707991|11269276|FG000|NOT COMPLETED|Overall Study||1
10138983|NCT02707991|11269277|FG001|NOT COMPLETED|Overall Study||1
10138984|NCT02708095|11269286|FG000|STARTED|Overall Study||105
10138985|NCT02708095|11269287|FG001|STARTED|Overall Study||105
10138986|NCT02708095|11269288|FG002|STARTED|Overall Study||104
10138987|NCT02708095|11269286|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105
10138988|NCT02708095|11269287|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105
10138989|NCT02708095|11269288|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
10138990|NCT02708095|11269286|FG000|COMPLETED|Overall Study||83
10138991|NCT02708095|11269287|FG001|COMPLETED|Overall Study||86
10138992|NCT02708095|11269288|FG002|COMPLETED|Overall Study||86
10138993|NCT02708095|11269286|FG000|NOT COMPLETED|Overall Study||22
10138994|NCT02708095|11269287|FG001|NOT COMPLETED|Overall Study||19
10138995|NCT02708095|11269288|FG002|NOT COMPLETED|Overall Study||18
10138996|NCT02708121|11269300|FG000|STARTED|Overall Study||35
10138997|NCT02708121|11269301|FG001|STARTED|Overall Study||31
10138998|NCT02708121|11269300|FG000|Provided Acceptability Data|Overall Study||20
10138999|NCT02708121|11269301|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
10139000|NCT02708121|11269300|FG000|Treatment Program Use Data Available|Overall Study||34
10139001|NCT02708121|11269301|FG001|Treatment Program Use Data Available|Overall Study||24
10139002|NCT02708121|11269300|FG000|6 Month In-Person Follow Up Data|Overall Study||22
10139003|NCT02708121|11269301|FG001|6 Month In-Person Follow Up Data|Overall Study||19
10139004|NCT02708121|11269300|FG000|6 Month Weight Data Via EHR|Overall Study||14
10139005|NCT02708121|11269301|FG001|6 Month Weight Data Via EHR|Overall Study||13
10139006|NCT02708121|11269300|FG000|COMPLETED|Overall Study||34
10139007|NCT02708121|11269301|FG001|COMPLETED|Overall Study||26
10139008|NCT02708121|11269300|FG000|NOT COMPLETED|Overall Study||1
10139009|NCT02708121|11269301|FG001|NOT COMPLETED|Overall Study||5
10139010|NCT02708186|11269309|FG000|STARTED|Overall Study||16
10139011|NCT02708186|11269310|FG001|STARTED|Overall Study||18
10139012|NCT02708186|11269309|FG000|COMPLETED|Overall Study||14
10139013|NCT02708186|11269310|FG001|COMPLETED|Overall Study||16
10139014|NCT02708186|11269309|FG000|NOT COMPLETED|Overall Study||2
10139015|NCT02708186|11269310|FG001|NOT COMPLETED|Overall Study||2
10139016|NCT02708212|11269318|FG000|STARTED|Overall Study||60
10139017|NCT02708212|11269319|FG001|STARTED|Overall Study||60
10139018|NCT02708212|11269318|FG000|COMPLETED|Overall Study||60
10139019|NCT02708212|11269319|FG001|COMPLETED|Overall Study||60
10139020|NCT02708212|11269318|FG000|NOT COMPLETED|Overall Study||0
10139021|NCT02708212|11269319|FG001|NOT COMPLETED|Overall Study||0
10139022|NCT02708238|11269332|FG000|STARTED|Overall Study||60
10139023|NCT02708238|11269333|FG001|STARTED|Overall Study||60
10139024|NCT02708238|11269334|FG002|STARTED|Overall Study||60
10139025|NCT02708238|11269332|FG000|COMPLETED|Overall Study||60
10139026|NCT02708238|11269333|FG001|COMPLETED|Overall Study||59
10139027|NCT02708238|11269334|FG002|COMPLETED|Overall Study||57
10139028|NCT02708238|11269332|FG000|NOT COMPLETED|Overall Study||0
10139029|NCT02708238|11269333|FG001|NOT COMPLETED|Overall Study||1
10139030|NCT02708238|11269334|FG002|NOT COMPLETED|Overall Study||3
10139031|NCT02708277|11269344|FG000|STARTED|Overall Study||50
10139032|NCT02708277|11269345|FG001|STARTED|Overall Study||43
10139033|NCT02708277|11269344|FG000|COMPLETED|Overall Study||43
10139034|NCT02708277|11269345|FG001|COMPLETED|Overall Study||39
10139035|NCT02708277|11269344|FG000|NOT COMPLETED|Overall Study||7
10139036|NCT02708277|11269345|FG001|NOT COMPLETED|Overall Study||4
10139037|NCT02708290|11269353|FG000|STARTED|Overall Study||1009
10139038|NCT02708290|11269354|FG001|STARTED|Overall Study||1009
10139039|NCT02708290|11269353|FG000|COMPLETED|Overall Study||1009
10139040|NCT02708290|11269354|FG001|COMPLETED|Overall Study||1009
10139041|NCT02708290|11269353|FG000|NOT COMPLETED|Overall Study||0
10139042|NCT02708290|11269354|FG001|NOT COMPLETED|Overall Study||0
10139043|NCT02708355|11269363|FG000|STARTED|Overall Study||21
10139044|NCT02708355|11269364|FG001|STARTED|Overall Study||22
10139045|NCT02708355|11269365|FG002|STARTED|Overall Study||12
10139046|NCT02708355|11269363|FG000|COMPLETED|Overall Study||20
10139047|NCT02708355|11269364|FG001|COMPLETED|Overall Study||22
10139048|NCT02708355|11269365|FG002|COMPLETED|Overall Study||12
10139049|NCT02708355|11269363|FG000|NOT COMPLETED|Overall Study||1
10139050|NCT02708355|11269364|FG001|NOT COMPLETED|Overall Study||0
10139051|NCT02708355|11269365|FG002|NOT COMPLETED|Overall Study||0
10139052|NCT02708433|11269373|FG000|STARTED|First Intervention (Visit 1)||12
10139053|NCT02708433|11269374|FG001|STARTED|First Intervention (Visit 1)||11
10139054|NCT02708433|11269373|FG000|COMPLETED|First Intervention (Visit 1)||12
10139055|NCT02708433|11269374|FG001|COMPLETED|First Intervention (Visit 1)||11
10139056|NCT02708433|11269373|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
10139057|NCT02708433|11269374|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
10139058|NCT02708433|11269373|FG000|STARTED|Washout (at Least 1 Week)||12
10139059|NCT02708433|11269374|FG001|STARTED|Washout (at Least 1 Week)||11
10139060|NCT02708433|11269373|FG000|COMPLETED|Washout (at Least 1 Week)||12
10139061|NCT02708433|11269374|FG001|COMPLETED|Washout (at Least 1 Week)||11
10139062|NCT02708433|11269373|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
10139063|NCT02708433|11269374|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
10139064|NCT02708433|11269373|FG000|STARTED|Second Intervention (Visit 2)||12
10139065|NCT02708433|11269374|FG001|STARTED|Second Intervention (Visit 2)||11
10139066|NCT02708433|11269373|FG000|COMPLETED|Second Intervention (Visit 2)||12
10139067|NCT02708433|11269374|FG001|COMPLETED|Second Intervention (Visit 2)||11
10139068|NCT02708433|11269373|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
10139069|NCT02708433|11269374|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
10139070|NCT02708485|11269382|FG000|STARTED|Overall Study||3
10139071|NCT02708485|11269383|FG001|STARTED|Overall Study||12
10139072|NCT02708485|11269382|FG000|COMPLETED|Overall Study||0
10139073|NCT02708485|11269383|FG001|COMPLETED|Overall Study||10
10139074|NCT02708485|11269382|FG000|NOT COMPLETED|Overall Study||3
10139075|NCT02708485|11269383|FG001|NOT COMPLETED|Overall Study||2
10139076|NCT02708498|11269397|FG000|STARTED|Overall Study||42
10139077|NCT02708498|11269398|FG001|STARTED|Overall Study||40
10139078|NCT02708498|11269399|FG002|STARTED|Overall Study||152
10139079|NCT02708498|11269400|FG003|STARTED|Overall Study||156
10139080|NCT02708498|11269401|FG004|STARTED|Overall Study||363
10139081|NCT02708498|11269402|FG005|STARTED|Overall Study||330
10139082|NCT02708498|11269403|FG006|STARTED|Overall Study||20
10139083|NCT02708498|11269404|FG007|STARTED|Overall Study||48
10139084|NCT02708498|11269397|FG000|COMPLETED|Overall Study||22
10139085|NCT02708498|11269398|FG001|COMPLETED|Overall Study||21
10139086|NCT02708498|11269399|FG002|COMPLETED|Overall Study||90
10139087|NCT02708498|11269400|FG003|COMPLETED|Overall Study||105
10139088|NCT02708498|11269401|FG004|COMPLETED|Overall Study||167
10139089|NCT02708498|11269402|FG005|COMPLETED|Overall Study||198
10139090|NCT02708498|11269403|FG006|COMPLETED|Overall Study||20
10139091|NCT02708498|11269404|FG007|COMPLETED|Overall Study||48
10139092|NCT02708498|11269397|FG000|NOT COMPLETED|Overall Study||20
10139093|NCT02708498|11269398|FG001|NOT COMPLETED|Overall Study||19
10139094|NCT02708498|11269399|FG002|NOT COMPLETED|Overall Study||62
10139095|NCT02708498|11269400|FG003|NOT COMPLETED|Overall Study||51
10139096|NCT02708498|11269401|FG004|NOT COMPLETED|Overall Study||196
10139097|NCT02708498|11269402|FG005|NOT COMPLETED|Overall Study||132
10139098|NCT02708498|11269403|FG006|NOT COMPLETED|Overall Study||0
10139099|NCT02708498|11269404|FG007|NOT COMPLETED|Overall Study||0
10139100|NCT02708524|11269424|FG000|STARTED|Overall Study||139
10139101|NCT02708524|11269425|FG001|STARTED|Overall Study||136
10139102|NCT02708524|11269426|FG002|STARTED|Overall Study||137
10139103|NCT02708524|11269427|FG003|STARTED|Overall Study||136
10139104|NCT02708524|11269424|FG000|COMPLETED|Overall Study||135
10139105|NCT02708524|11269425|FG001|COMPLETED|Overall Study||130
10139106|NCT02708524|11269426|FG002|COMPLETED|Overall Study||134
10139107|NCT02708524|11269427|FG003|COMPLETED|Overall Study||136
10139108|NCT02708524|11269424|FG000|NOT COMPLETED|Overall Study||4
10139109|NCT02708524|11269425|FG001|NOT COMPLETED|Overall Study||6
10139110|NCT02708524|11269426|FG002|NOT COMPLETED|Overall Study||3
10139111|NCT02708524|11269427|FG003|NOT COMPLETED|Overall Study||0
10139112|NCT02708641|11269437|FG000|STARTED|Overall Study||12
10139113|NCT02708641|11269437|FG000|COMPLETED|Overall Study||12
10139114|NCT02708641|11269437|FG000|NOT COMPLETED|Overall Study||0
10139115|NCT02708745|11269445|FG000|STARTED|Overall Study||91
10139116|NCT02708745|11269446|FG001|STARTED|Overall Study||69
10139117|NCT02708745|11269447|FG002|STARTED|Overall Study||204
10139118|NCT02708745|11269448|FG003|STARTED|Overall Study||198
10139119|NCT02708745|11269445|FG000|COMPLETED|Overall Study||91
10139120|NCT02708745|11269446|FG001|COMPLETED|Overall Study||65
10139121|NCT02708745|11269447|FG002|COMPLETED|Overall Study||121
10139122|NCT02708745|11269448|FG003|COMPLETED|Overall Study||116
10139123|NCT02708745|11269445|FG000|NOT COMPLETED|Overall Study||0
10139124|NCT02708745|11269446|FG001|NOT COMPLETED|Overall Study||4
10139125|NCT02708745|11269447|FG002|NOT COMPLETED|Overall Study||83
10139126|NCT02708745|11269448|FG003|NOT COMPLETED|Overall Study||82
10139127|NCT02708862|11269460|FG000|STARTED|Overall Study||26
10139128|NCT02708862|11269460|FG000|COMPLETED|Overall Study||26
10139129|NCT02708862|11269460|FG000|NOT COMPLETED|Overall Study||0
10139130|NCT02708966|11269469|FG000|STARTED|Overall Study||15
10139131|NCT02708966|11269470|FG001|STARTED|Overall Study||15
10139132|NCT02708966|11269469|FG000|COMPLETED|Overall Study||13
10139133|NCT02708966|11269470|FG001|COMPLETED|Overall Study||13
10139134|NCT02708966|11269469|FG000|NOT COMPLETED|Overall Study||2
10139135|NCT02708966|11269470|FG001|NOT COMPLETED|Overall Study||2
10139136|NCT02709005|11269478|FG000|STARTED|Overall Study||73
10139137|NCT02709005|11269479|FG001|STARTED|Overall Study||36
10139138|NCT02709005|11269478|FG000|COMPLETED|Overall Study||69
10139139|NCT02709005|11269479|FG001|COMPLETED|Overall Study||35
10139140|NCT02709005|11269478|FG000|NOT COMPLETED|Overall Study||4
10139141|NCT02709005|11269479|FG001|NOT COMPLETED|Overall Study||1
10139142|NCT02709018|11269487|FG000|STARTED|Overall Study||75
10139143|NCT02709018|11269488|FG001|STARTED|Overall Study||74
10139144|NCT02709018|11269487|FG000|COMPLETED|Overall Study||59
10139145|NCT02709018|11269488|FG001|COMPLETED|Overall Study||58
10139146|NCT02709018|11269487|FG000|NOT COMPLETED|Overall Study||16
10139147|NCT02709018|11269488|FG001|NOT COMPLETED|Overall Study||16
10139148|NCT02709096|11269498|FG000|STARTED|Overall Study||22
10139149|NCT02709096|11269499|FG001|STARTED|Overall Study||11
10139150|NCT02709096|11269498|FG000|COMPLETED|Overall Study||21
10139151|NCT02709096|11269499|FG001|COMPLETED|Overall Study||10
10139152|NCT02709096|11269498|FG000|NOT COMPLETED|Overall Study||1
10139153|NCT02709096|11269499|FG001|NOT COMPLETED|Overall Study||1
10139154|NCT02709109|11269509|FG000|STARTED|Treatment Period 1 (28 Days)||49
10139155|NCT02709109|11269510|FG001|STARTED|Treatment Period 1 (28 Days)||47
10139156|NCT02709109|11269511|FG002|STARTED|Treatment Period 1 (28 Days)||22
10139157|NCT02709109|11269512|FG003|STARTED|Treatment Period 1 (28 Days)||24
10139158|NCT02709109|11269509|FG000|COMPLETED|Treatment Period 1 (28 Days)||45
10139159|NCT02709109|11269510|FG001|COMPLETED|Treatment Period 1 (28 Days)||42
10139160|NCT02709109|11269511|FG002|COMPLETED|Treatment Period 1 (28 Days)||21
10139161|NCT02709109|11269512|FG003|COMPLETED|Treatment Period 1 (28 Days)||24
10139162|NCT02709109|11269509|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4
10139163|NCT02709109|11269510|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5
10139164|NCT02709109|11269511|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10139165|NCT02709109|11269512|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10139166|NCT02709109|11269509|FG000|STARTED|Washout Period (28 Days)||45
10139167|NCT02709109|11269510|FG001|STARTED|Washout Period (28 Days)||42
10139168|NCT02709109|11269511|FG002|STARTED|Washout Period (28 Days)||21
10139169|NCT02709109|11269512|FG003|STARTED|Washout Period (28 Days)||24
10139170|NCT02709109|11269509|FG000|COMPLETED|Washout Period (28 Days)||43
10139171|NCT02709109|11269510|FG001|COMPLETED|Washout Period (28 Days)||40
10139172|NCT02709109|11269511|FG002|COMPLETED|Washout Period (28 Days)||18
10139173|NCT02709109|11269512|FG003|COMPLETED|Washout Period (28 Days)||24
10139174|NCT02709109|11269509|FG000|NOT COMPLETED|Washout Period (28 Days)||2
10139175|NCT02709109|11269510|FG001|NOT COMPLETED|Washout Period (28 Days)||2
10139176|NCT02709109|11269511|FG002|NOT COMPLETED|Washout Period (28 Days)||3
10139177|NCT02709109|11269512|FG003|NOT COMPLETED|Washout Period (28 Days)||0
10139178|NCT02709109|11269509|FG000|STARTED|Treatment Period 2 (28 Days)||43
10139179|NCT02709109|11269510|FG001|STARTED|Treatment Period 2 (28 Days)||40
10139180|NCT02709109|11269511|FG002|STARTED|Treatment Period 2 (28 Days)||18
10139181|NCT02709109|11269512|FG003|STARTED|Treatment Period 2 (28 Days)||24
10139182|NCT02709109|11269509|FG000|COMPLETED|Treatment Period 2 (28 Days)||41
10139183|NCT02709109|11269510|FG001|COMPLETED|Treatment Period 2 (28 Days)||36
10139184|NCT02709109|11269511|FG002|COMPLETED|Treatment Period 2 (28 Days)||15
10139185|NCT02709109|11269512|FG003|COMPLETED|Treatment Period 2 (28 Days)||24
10139186|NCT02709109|11269509|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2
10139187|NCT02709109|11269510|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4
10139188|NCT02709109|11269511|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3
10139189|NCT02709109|11269512|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10139190|NCT02709330|11269523|FG000|STARTED|Overall Study||50
10139191|NCT02709330|11269524|FG001|STARTED|Overall Study||10
10139192|NCT02709330|11269523|FG000|COMPLETED|Overall Study||37
10139193|NCT02709330|11269524|FG001|COMPLETED|Overall Study||10
10139194|NCT02709330|11269523|FG000|NOT COMPLETED|Overall Study||13
10139195|NCT02709330|11269524|FG001|NOT COMPLETED|Overall Study||0
10139196|NCT02709369|11269530|FG000|STARTED|Overall Study||300
10139197|NCT02709369|11269530|FG000|COMPLETED|Overall Study||273
10139198|NCT02709369|11269530|FG000|NOT COMPLETED|Overall Study||27
10139199|NCT02709486|11269537|FG000|STARTED|Overall Study||282
10139200|NCT02709486|11269538|FG001|STARTED|Overall Study||283
10139201|NCT02709486|11269539|FG002|STARTED|Overall Study||284
10139202|NCT02709486|11269537|FG000|COMPLETED|Overall Study||238
10139203|NCT02709486|11269538|FG001|COMPLETED|Overall Study||249
10139204|NCT02709486|11269539|FG002|COMPLETED|Overall Study||239
10139205|NCT02709486|11269537|FG000|NOT COMPLETED|Overall Study||44
10139206|NCT02709486|11269538|FG001|NOT COMPLETED|Overall Study||34
10139207|NCT02709486|11269539|FG002|NOT COMPLETED|Overall Study||45
10139208|NCT02709538|11269550|FG000|STARTED|Overall Study||400
10139209|NCT02709538|11269551|FG001|STARTED|Overall Study||100
10139210|NCT02709538|11269552|FG002|STARTED|Overall Study||101
10139211|NCT02709538|11269550|FG000|COMPLETED|Overall Study||287
10139212|NCT02709538|11269551|FG001|COMPLETED|Overall Study||72
10139213|NCT02709538|11269552|FG002|COMPLETED|Overall Study||81
10139214|NCT02709538|11269550|FG000|NOT COMPLETED|Overall Study||113
10139215|NCT02709538|11269551|FG001|NOT COMPLETED|Overall Study||28
10139216|NCT02709538|11269552|FG002|NOT COMPLETED|Overall Study||20
10139217|NCT02709577|11269562|FG000|STARTED|Overall Study||12
10139218|NCT02709577|11269563|FG001|STARTED|Overall Study||13
10139219|NCT02709577|11269564|FG002|STARTED|Overall Study||6
10139220|NCT02709577|11269565|FG003|STARTED|Overall Study||5
10139221|NCT02709577|11269562|FG000|COMPLETED|Overall Study||10
10139222|NCT02709577|11269563|FG001|COMPLETED|Overall Study||8
10139223|NCT02709577|11269564|FG002|COMPLETED|Overall Study||4
10139224|NCT02709577|11269565|FG003|COMPLETED|Overall Study||5
10139225|NCT02709577|11269562|FG000|NOT COMPLETED|Overall Study||2
10139226|NCT02709577|11269563|FG001|NOT COMPLETED|Overall Study||5
10139227|NCT02709577|11269564|FG002|NOT COMPLETED|Overall Study||2
10139228|NCT02709577|11269565|FG003|NOT COMPLETED|Overall Study||0
10139229|NCT02709694|11269576|FG000|STARTED|Overall Study||33
10139230|NCT02709694|11269576|FG000|Any Back Pain|Overall Study||19
10139231|NCT02709694|11269576|FG000|No Back Pain|Overall Study||14
10139232|NCT02709694|11269576|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4
10139233|NCT02709694|11269576|FG000|MRI Not Showing Sacroiliitis|Overall Study||29
10139234|NCT02709694|11269576|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6
10139235|NCT02709694|11269576|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25
10139236|NCT02709694|11269576|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33
10139237|NCT02709694|11269576|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33
10139238|NCT02709694|11269576|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33
10139239|NCT02709694|11269576|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33
10139240|NCT02709694|11269576|FG000|Having Ankylosis Seen in MRI|Overall Study||33
10139241|NCT02709694|11269576|FG000|COMPLETED|Overall Study||33
10139242|NCT02709694|11269576|FG000|NOT COMPLETED|Overall Study||0
10139243|NCT02709746|11269595|FG000|STARTED|Phase A (Single-blind Treatment Period)||784
10139244|NCT02709746|11269596|FG001|STARTED|Phase A (Single-blind Treatment Period)||0
10139245|NCT02709746|11269597|FG002|STARTED|Phase A (Single-blind Treatment Period)||0
10139246|NCT02709746|11269598|FG003|STARTED|Phase A (Single-blind Treatment Period)||0
10139247|NCT02709746|11269599|FG004|STARTED|Phase A (Single-blind Treatment Period)||0
10139248|NCT02709746|11269595|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616
10139249|NCT02709746|11269596|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0
10139250|NCT02709746|11269597|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0
10139251|NCT02709746|11269598|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0
10139252|NCT02709746|11269599|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0
10139253|NCT02709746|11269595|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
10139254|NCT02709746|11269596|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10139255|NCT02709746|11269597|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10139256|NCT02709746|11269598|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10139257|NCT02709746|11269599|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10139258|NCT02709746|11269595|FG000|STARTED|Phase B (Double-blind Treatment Period)||0
10139259|NCT02709746|11269596|FG001|STARTED|Phase B (Double-blind Treatment Period)||147
10139260|NCT02709746|11269597|FG002|STARTED|Phase B (Double-blind Treatment Period)||162
10139261|NCT02709746|11269598|FG003|STARTED|Phase B (Double-blind Treatment Period)||153
10139262|NCT02709746|11269599|FG004|STARTED|Phase B (Double-blind Treatment Period)||154
10139263|NCT02709746|11269595|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0
10139264|NCT02709746|11269596|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126
10139265|NCT02709746|11269597|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140
10139266|NCT02709746|11269598|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138
10139267|NCT02709746|11269599|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138
10139268|NCT02709746|11269595|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
10139269|NCT02709746|11269596|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
10139270|NCT02709746|11269597|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
10139271|NCT02709746|11269598|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
10139272|NCT02709746|11269599|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
10139273|NCT02709785|11269614|FG000|STARTED|Overall Study||24
10139274|NCT02709785|11269615|FG001|STARTED|Overall Study||28
10139275|NCT02709785|11269616|FG002|STARTED|Overall Study||28
10139276|NCT02709785|11269614|FG000|3 Weeks|Overall Study||23
10139277|NCT02709785|11269615|FG001|3 Weeks|Overall Study||27
10139278|NCT02709785|11269616|FG002|3 Weeks|Overall Study||27
10139279|NCT02709785|11269614|FG000|6 Weeks|Overall Study||23
10139280|NCT02709785|11269615|FG001|6 Weeks|Overall Study||26
10139281|NCT02709785|11269616|FG002|6 Weeks|Overall Study||27
10139282|NCT02709785|11269614|FG000|COMPLETED|Overall Study||23
10139283|NCT02709785|11269615|FG001|COMPLETED|Overall Study||26
10139284|NCT02709785|11269616|FG002|COMPLETED|Overall Study||27
10139285|NCT02709785|11269614|FG000|NOT COMPLETED|Overall Study||1
10139286|NCT02709785|11269615|FG001|NOT COMPLETED|Overall Study||2
10139287|NCT02709785|11269616|FG002|NOT COMPLETED|Overall Study||1
10139288|NCT02709889|11269632|FG000|STARTED|Overall Study||43
10139289|NCT02709889|11269633|FG001|STARTED|Overall Study||57
10139290|NCT02709889|11269634|FG002|STARTED|Overall Study||12
10139291|NCT02709889|11269635|FG003|STARTED|Overall Study||88
10139292|NCT02709889|11269632|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
10139293|NCT02709889|11269633|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
10139294|NCT02709889|11269634|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
10139295|NCT02709889|11269635|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
10139296|NCT02709889|11269632|FG000|Neuroendocrine Prostate Cancer|Overall Study||4
10139297|NCT02709889|11269633|FG001|Neuroendocrine Prostate Cancer|Overall Study||7
10139298|NCT02709889|11269634|FG002|Neuroendocrine Prostate Cancer|Overall Study||3
10139299|NCT02709889|11269635|FG003|Neuroendocrine Prostate Cancer|Overall Study||7
10139300|NCT02709889|11269632|FG000|Gastroenteropancreatic NEC|Overall Study||6
10139301|NCT02709889|11269633|FG001|Gastroenteropancreatic NEC|Overall Study||5
10139302|NCT02709889|11269634|FG002|Gastroenteropancreatic NEC|Overall Study||2
10139303|NCT02709889|11269635|FG003|Gastroenteropancreatic NEC|Overall Study||23
10139304|NCT02709889|11269632|FG000|Other NEC|Overall Study||11
10139305|NCT02709889|11269633|FG001|Other NEC|Overall Study||12
10139306|NCT02709889|11269634|FG002|Other NEC|Overall Study||1
10139307|NCT02709889|11269635|FG003|Other NEC|Overall Study||7
10139308|NCT02709889|11269632|FG000|Malignant Melanoma|Overall Study||3
10139309|NCT02709889|11269633|FG001|Malignant Melanoma|Overall Study||6
10139310|NCT02709889|11269634|FG002|Malignant Melanoma|Overall Study||0
10139311|NCT02709889|11269635|FG003|Malignant Melanoma|Overall Study||11
10139312|NCT02709889|11269632|FG000|Medullary Thyroid Cancer|Overall Study||3
10139313|NCT02709889|11269633|FG001|Medullary Thyroid Cancer|Overall Study||3
10139314|NCT02709889|11269634|FG002|Medullary Thyroid Cancer|Overall Study||0
10139315|NCT02709889|11269635|FG003|Medullary Thyroid Cancer|Overall Study||7
10139316|NCT02709889|11269632|FG000|Glioblastoma|Overall Study||4
10139317|NCT02709889|11269633|FG001|Glioblastoma|Overall Study||4
10139318|NCT02709889|11269634|FG002|Glioblastoma|Overall Study||1
10139319|NCT02709889|11269635|FG003|Glioblastoma|Overall Study||14
10139320|NCT02709889|11269632|FG000|Other Solid Tumors|Overall Study||9
10139321|NCT02709889|11269633|FG001|Other Solid Tumors|Overall Study||16
10139322|NCT02709889|11269634|FG002|Other Solid Tumors|Overall Study||3
10139323|NCT02709889|11269635|FG003|Other Solid Tumors|Overall Study||15
10139324|NCT02709889|11269632|FG000|COMPLETED|Overall Study||0
10139325|NCT02709889|11269633|FG001|COMPLETED|Overall Study||0
10139326|NCT02709889|11269634|FG002|COMPLETED|Overall Study||0
10139327|NCT02709889|11269635|FG003|COMPLETED|Overall Study||0
10139328|NCT02709889|11269632|FG000|NOT COMPLETED|Overall Study||43
10139329|NCT02709889|11269633|FG001|NOT COMPLETED|Overall Study||57
10139330|NCT02709889|11269634|FG002|NOT COMPLETED|Overall Study||12
10139331|NCT02709889|11269635|FG003|NOT COMPLETED|Overall Study||88
10139332|NCT02710045|11269683|FG000|STARTED|Overall Study||106
10139333|NCT02710045|11269684|FG001|STARTED|Overall Study||115
10139334|NCT02710045|11269685|FG002|STARTED|Overall Study||81
10139335|NCT02710045|11269683|FG000|COMPLETED|Overall Study||95
10139336|NCT02710045|11269684|FG001|COMPLETED|Overall Study||98
10139337|NCT02710045|11269685|FG002|COMPLETED|Overall Study||68
10139338|NCT02710045|11269683|FG000|NOT COMPLETED|Overall Study||11
10139339|NCT02710045|11269684|FG001|NOT COMPLETED|Overall Study||17
10139340|NCT02710045|11269685|FG002|NOT COMPLETED|Overall Study||13
10139341|NCT02710071|11269695|FG000|STARTED|Placebo (2 Weeks).||21
10139342|NCT02710071|11269696|FG001|STARTED|Placebo (2 Weeks).||20
10139343|NCT02710071|11269695|FG000|COMPLETED|Placebo (2 Weeks).||21
10139344|NCT02710071|11269696|FG001|COMPLETED|Placebo (2 Weeks).||20
10139345|NCT02710071|11269695|FG000|NOT COMPLETED|Placebo (2 Weeks).||0
10139346|NCT02710071|11269696|FG001|NOT COMPLETED|Placebo (2 Weeks).||0
10139347|NCT02710071|11269695|FG000|STARTED|First Intervention (6 Weeks).||21
10139348|NCT02710071|11269696|FG001|STARTED|First Intervention (6 Weeks).||20
10139349|NCT02710071|11269695|FG000|COMPLETED|First Intervention (6 Weeks).||18
10139350|NCT02710071|11269696|FG001|COMPLETED|First Intervention (6 Weeks).||16
10139351|NCT02710071|11269695|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3
10139352|NCT02710071|11269696|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4
10139353|NCT02710071|11269695|FG000|STARTED|Second Intervention (6 Weeks).||18
10139354|NCT02710071|11269696|FG001|STARTED|Second Intervention (6 Weeks).||16
10139355|NCT02710071|11269695|FG000|COMPLETED|Second Intervention (6 Weeks).||17
10139356|NCT02710071|11269696|FG001|COMPLETED|Second Intervention (6 Weeks).||14
10139357|NCT02710071|11269695|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1
10139358|NCT02710071|11269696|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
10139359|NCT02710136|11269705|FG000|STARTED|Study Enrollment||10
10139360|NCT02710136|11269706|FG001|STARTED|Study Enrollment||25
10139361|NCT02710136|11269705|FG000|COMPLETED|Study Enrollment||10
10139362|NCT02710136|11269706|FG001|COMPLETED|Study Enrollment||25
10139363|NCT02710136|11269705|FG000|NOT COMPLETED|Study Enrollment||0
10139364|NCT02710136|11269706|FG001|NOT COMPLETED|Study Enrollment||0
10139365|NCT02710136|11269705|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10
10139366|NCT02710136|11269706|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0
10139367|NCT02710136|11269705|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
10139368|NCT02710136|11269706|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
10139369|NCT02710136|11269705|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
10139370|NCT02710136|11269706|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
10139371|NCT02710136|11269705|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4
10139372|NCT02710136|11269706|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0
10139373|NCT02710136|11269705|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
10139374|NCT02710136|11269706|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
10139375|NCT02710136|11269705|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
10139376|NCT02710136|11269706|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
10139377|NCT02710136|11269705|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0
10139378|NCT02710136|11269706|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25
10139379|NCT02710136|11269705|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
10139380|NCT02710136|11269706|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
10139381|NCT02710136|11269705|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
10139382|NCT02710136|11269706|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
10139383|NCT02710214|11269715|FG000|STARTED|Overall Study||12
10139384|NCT02710214|11269716|FG001|STARTED|Overall Study||12
10139385|NCT02710214|11269715|FG000|COMPLETED|Overall Study||11
10139386|NCT02710214|11269716|FG001|COMPLETED|Overall Study||10
10139387|NCT02710214|11269715|FG000|NOT COMPLETED|Overall Study||1
10139388|NCT02710214|11269716|FG001|NOT COMPLETED|Overall Study||2
10139389|NCT02710240|11269722|FG000|STARTED|Overall Study||336
10139390|NCT02710240|11269722|FG000|COMPLETED|Overall Study||336
10139391|NCT02710240|11269722|FG000|NOT COMPLETED|Overall Study||0
10139392|NCT02710292|11269726|FG000|STARTED|Period 1, First 10 Days of Wear||47
10139393|NCT02710292|11269727|FG001|STARTED|Period 1, First 10 Days of Wear||52
10139394|NCT02710292|11269726|FG000|COMPLETED|Period 1, First 10 Days of Wear||46
10139395|NCT02710292|11269727|FG001|COMPLETED|Period 1, First 10 Days of Wear||49
10139396|NCT02710292|11269726|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1
10139397|NCT02710292|11269727|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3
10139398|NCT02710292|11269726|FG000|STARTED|Period 2, Second 10 Days of Wear||46
10139399|NCT02710292|11269727|FG001|STARTED|Period 2, Second 10 Days of Wear||49
10139400|NCT02710292|11269726|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46
10139401|NCT02710292|11269727|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49
10139402|NCT02710292|11269726|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
10139403|NCT02710292|11269727|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
10139404|NCT02710422|11269736|FG000|STARTED|Overall Study||12
10139405|NCT02710422|11269737|FG001|STARTED|Overall Study||12
10139406|NCT02710422|11269736|FG000|3 Month Visit|Overall Study||9
10139407|NCT02710422|11269737|FG001|3 Month Visit|Overall Study||11
10139408|NCT02710422|11269736|FG000|6 Month Visit|Overall Study||7
10139409|NCT02710422|11269737|FG001|6 Month Visit|Overall Study||8
10139410|NCT02710422|11269736|FG000|9 Month Visit|Overall Study||5
10139411|NCT02710422|11269737|FG001|9 Month Visit|Overall Study||5
10139412|NCT02710422|11269736|FG000|12 Month Visit|Overall Study||3
10139413|NCT02710422|11269737|FG001|12 Month Visit|Overall Study||3
10139414|NCT02710422|11269736|FG000|COMPLETED|Overall Study||3
10139415|NCT02710422|11269737|FG001|COMPLETED|Overall Study||3
10139416|NCT02710422|11269736|FG000|NOT COMPLETED|Overall Study||9
10139417|NCT02710422|11269737|FG001|NOT COMPLETED|Overall Study||9
10139418|NCT02710526|11269748|FG000|STARTED|Treatment Phase||28
10139419|NCT02710526|11269749|FG001|STARTED|Treatment Phase||20
10139420|NCT02710526|11269750|FG002|STARTED|Treatment Phase||18
10139421|NCT02710526|11269748|FG000|COMPLETED|Treatment Phase||22
10139422|NCT02710526|11269749|FG001|COMPLETED|Treatment Phase||16
10139423|NCT02710526|11269750|FG002|COMPLETED|Treatment Phase||12
10139424|NCT02710526|11269748|FG000|NOT COMPLETED|Treatment Phase||6
10139425|NCT02710526|11269749|FG001|NOT COMPLETED|Treatment Phase||4
10139426|NCT02710526|11269750|FG002|NOT COMPLETED|Treatment Phase||6
10139427|NCT02710526|11269748|FG000|STARTED|Safety Extension||15
10139428|NCT02710526|11269749|FG001|STARTED|Safety Extension||12
10139429|NCT02710526|11269750|FG002|STARTED|Safety Extension||0
10139430|NCT02710526|11269748|FG000|COMPLETED|Safety Extension||14
10139431|NCT02710526|11269749|FG001|COMPLETED|Safety Extension||12
10139432|NCT02710526|11269750|FG002|COMPLETED|Safety Extension||0
10139433|NCT02710526|11269748|FG000|NOT COMPLETED|Safety Extension||1
10139434|NCT02710526|11269749|FG001|NOT COMPLETED|Safety Extension||0
10139435|NCT02710526|11269750|FG002|NOT COMPLETED|Safety Extension||0
10139436|NCT02710591|11269772|FG000|STARTED|Overall Study||5
10139437|NCT02710591|11269773|FG001|STARTED|Overall Study||5
10139438|NCT02710591|11269774|FG002|STARTED|Overall Study||5
10139439|NCT02710591|11269775|FG003|STARTED|Overall Study||5
10139440|NCT02710591|11269772|FG000|COMPLETED|Overall Study||5
10139441|NCT02710591|11269773|FG001|COMPLETED|Overall Study||5
10139442|NCT02710591|11269774|FG002|COMPLETED|Overall Study||5
10139443|NCT02710591|11269775|FG003|COMPLETED|Overall Study||5
10139444|NCT02710591|11269772|FG000|NOT COMPLETED|Overall Study||0
10139445|NCT02710591|11269773|FG001|NOT COMPLETED|Overall Study||0
10139446|NCT02710591|11269774|FG002|NOT COMPLETED|Overall Study||0
10139447|NCT02710591|11269775|FG003|NOT COMPLETED|Overall Study||0
10139448|NCT02710630|11269790|FG000|STARTED|Period 1||7
10139449|NCT02710630|11269791|FG001|STARTED|Period 1||7
10139450|NCT02710630|11269792|FG002|STARTED|Period 1||7
10139451|NCT02710630|11269793|FG003|STARTED|Period 1||7
10139452|NCT02710630|11269794|FG004|STARTED|Period 1||7
10139453|NCT02710630|11269790|FG000|COMPLETED|Period 1||7
10139454|NCT02710630|11269791|FG001|COMPLETED|Period 1||7
10139455|NCT02710630|11269792|FG002|COMPLETED|Period 1||7
10139456|NCT02710630|11269793|FG003|COMPLETED|Period 1||7
10139457|NCT02710630|11269794|FG004|COMPLETED|Period 1||7
10139458|NCT02710630|11269790|FG000|NOT COMPLETED|Period 1||0
10139459|NCT02710630|11269791|FG001|NOT COMPLETED|Period 1||0
10139460|NCT02710630|11269792|FG002|NOT COMPLETED|Period 1||0
10139461|NCT02710630|11269793|FG003|NOT COMPLETED|Period 1||0
10139462|NCT02710630|11269794|FG004|NOT COMPLETED|Period 1||0
10139463|NCT02710630|11269790|FG000|STARTED|Period 2||7
10139464|NCT02710630|11269791|FG001|STARTED|Period 2||7
10139465|NCT02710630|11269792|FG002|STARTED|Period 2||7
10139466|NCT02710630|11269793|FG003|STARTED|Period 2||7
10139467|NCT02710630|11269794|FG004|STARTED|Period 2||7
10139468|NCT02710630|11269790|FG000|Not Treated|Period 2||1
10139469|NCT02710630|11269791|FG001|Not Treated|Period 2||0
10139470|NCT02710630|11269792|FG002|Not Treated|Period 2||0
10139471|NCT02710630|11269793|FG003|Not Treated|Period 2||0
10139472|NCT02710630|11269794|FG004|Not Treated|Period 2||0
10139473|NCT02710630|11269790|FG000|COMPLETED|Period 2||7
10139474|NCT02710630|11269791|FG001|COMPLETED|Period 2||7
10139475|NCT02710630|11269792|FG002|COMPLETED|Period 2||7
10139476|NCT02710630|11269793|FG003|COMPLETED|Period 2||7
10139477|NCT02710630|11269794|FG004|COMPLETED|Period 2||7
10139478|NCT02710630|11269790|FG000|NOT COMPLETED|Period 2||0
10139479|NCT02710630|11269791|FG001|NOT COMPLETED|Period 2||0
10139480|NCT02710630|11269792|FG002|NOT COMPLETED|Period 2||0
10139481|NCT02710630|11269793|FG003|NOT COMPLETED|Period 2||0
10139482|NCT02710630|11269794|FG004|NOT COMPLETED|Period 2||0
10139483|NCT02710630|11269790|FG000|STARTED|Period 3||7
10139484|NCT02710630|11269791|FG001|STARTED|Period 3||7
10139485|NCT02710630|11269792|FG002|STARTED|Period 3||7
10139486|NCT02710630|11269793|FG003|STARTED|Period 3||7
10139487|NCT02710630|11269794|FG004|STARTED|Period 3||7
10139488|NCT02710630|11269790|FG000|COMPLETED|Period 3||7
10139489|NCT02710630|11269791|FG001|COMPLETED|Period 3||7
10139490|NCT02710630|11269792|FG002|COMPLETED|Period 3||7
10139491|NCT02710630|11269793|FG003|COMPLETED|Period 3||7
10139492|NCT02710630|11269794|FG004|COMPLETED|Period 3||7
10139493|NCT02710630|11269790|FG000|NOT COMPLETED|Period 3||0
10139494|NCT02710630|11269791|FG001|NOT COMPLETED|Period 3||0
10139495|NCT02710630|11269792|FG002|NOT COMPLETED|Period 3||0
10139496|NCT02710630|11269793|FG003|NOT COMPLETED|Period 3||0
10139497|NCT02710630|11269794|FG004|NOT COMPLETED|Period 3||0
10139498|NCT02710630|11269790|FG000|STARTED|Period 4||7
10139499|NCT02710630|11269791|FG001|STARTED|Period 4||7
10139500|NCT02710630|11269792|FG002|STARTED|Period 4||7
10139501|NCT02710630|11269793|FG003|STARTED|Period 4||7
10139502|NCT02710630|11269794|FG004|STARTED|Period 4||7
10139503|NCT02710630|11269790|FG000|COMPLETED|Period 4||7
10139504|NCT02710630|11269791|FG001|COMPLETED|Period 4||7
10139505|NCT02710630|11269792|FG002|COMPLETED|Period 4||7
10139506|NCT02710630|11269793|FG003|COMPLETED|Period 4||7
10139507|NCT02710630|11269794|FG004|COMPLETED|Period 4||7
10139508|NCT02710630|11269790|FG000|NOT COMPLETED|Period 4||0
10139509|NCT02710630|11269791|FG001|NOT COMPLETED|Period 4||0
10139510|NCT02710630|11269792|FG002|NOT COMPLETED|Period 4||0
10139511|NCT02710630|11269793|FG003|NOT COMPLETED|Period 4||0
10139512|NCT02710630|11269794|FG004|NOT COMPLETED|Period 4||0
10139513|NCT02710630|11269790|FG000|STARTED|Period 5||7
10139514|NCT02710630|11269791|FG001|STARTED|Period 5||7
10139515|NCT02710630|11269792|FG002|STARTED|Period 5||7
10139516|NCT02710630|11269793|FG003|STARTED|Period 5||7
10139517|NCT02710630|11269794|FG004|STARTED|Period 5||7
10139518|NCT02710630|11269790|FG000|COMPLETED|Period 5||7
10139519|NCT02710630|11269791|FG001|COMPLETED|Period 5||7
10139520|NCT02710630|11269792|FG002|COMPLETED|Period 5||7
10139521|NCT02710630|11269793|FG003|COMPLETED|Period 5||7
10139522|NCT02710630|11269794|FG004|COMPLETED|Period 5||7
10139523|NCT02710630|11269790|FG000|NOT COMPLETED|Period 5||0
10139524|NCT02710630|11269791|FG001|NOT COMPLETED|Period 5||0
10139525|NCT02710630|11269792|FG002|NOT COMPLETED|Period 5||0
10139526|NCT02710630|11269793|FG003|NOT COMPLETED|Period 5||0
10139527|NCT02710630|11269794|FG004|NOT COMPLETED|Period 5||0
10139528|NCT02710630|11269790|FG000|STARTED|Period 6||7
10139529|NCT02710630|11269791|FG001|STARTED|Period 6||7
10139530|NCT02710630|11269792|FG002|STARTED|Period 6||7
10139531|NCT02710630|11269793|FG003|STARTED|Period 6||7
10139532|NCT02710630|11269794|FG004|STARTED|Period 6||7
10139533|NCT02710630|11269790|FG000|COMPLETED|Period 6||7
10139534|NCT02710630|11269791|FG001|COMPLETED|Period 6||7
10139535|NCT02710630|11269792|FG002|COMPLETED|Period 6||7
10139536|NCT02710630|11269793|FG003|COMPLETED|Period 6||7
10139537|NCT02710630|11269794|FG004|COMPLETED|Period 6||7
10139538|NCT02710630|11269790|FG000|NOT COMPLETED|Period 6||0
10139539|NCT02710630|11269791|FG001|NOT COMPLETED|Period 6||0
10139540|NCT02710630|11269792|FG002|NOT COMPLETED|Period 6||0
10139541|NCT02710630|11269793|FG003|NOT COMPLETED|Period 6||0
10139542|NCT02710630|11269794|FG004|NOT COMPLETED|Period 6||0
10139543|NCT02710890|11269810|FG000|STARTED|Overall Study||48
10139544|NCT02710890|11269811|FG001|STARTED|Overall Study||55
10139545|NCT02710890|11269810|FG000|COMPLETED|Overall Study||48
10139546|NCT02710890|11269811|FG001|COMPLETED|Overall Study||55
10139547|NCT02710890|11269810|FG000|NOT COMPLETED|Overall Study||0
10139548|NCT02710890|11269811|FG001|NOT COMPLETED|Overall Study||0
10139549|NCT02710981|11269817|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42
10139550|NCT02710981|11269818|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0
10139551|NCT02710981|11269817|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
10139552|NCT02710981|11269818|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
10139553|NCT02710981|11269817|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
10139554|NCT02710981|11269818|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
10139555|NCT02710981|11269817|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0
10139556|NCT02710981|11269818|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41
10139557|NCT02710981|11269817|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
10139558|NCT02710981|11269818|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
10139559|NCT02710981|11269817|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
10139560|NCT02710981|11269818|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
10139561|NCT02711306|11269828|FG000|STARTED|Overall Study||18
10139562|NCT02711306|11269829|FG001|STARTED|Overall Study||18
10139563|NCT02711306|11269828|FG000|COMPLETED|Overall Study||16
10139564|NCT02711306|11269829|FG001|COMPLETED|Overall Study||16
10139565|NCT02711306|11269828|FG000|NOT COMPLETED|Overall Study||2
10139566|NCT02711306|11269829|FG001|NOT COMPLETED|Overall Study||2
10139567|NCT02711345|11269845|FG000|STARTED|Overall Study||2
10139568|NCT02711345|11269846|FG001|STARTED|Overall Study||3
10139569|NCT02711345|11269847|FG002|STARTED|Overall Study||6
10139570|NCT02711345|11269848|FG003|STARTED|Overall Study||4
10139571|NCT02711345|11269849|FG004|STARTED|Overall Study||8
10139572|NCT02711345|11269850|FG005|STARTED|Overall Study||6
10139573|NCT02711345|11269851|FG006|STARTED|Overall Study||12
10139574|NCT02711345|11269852|FG007|STARTED|Overall Study||6
10139575|NCT02711345|11269853|FG008|STARTED|Overall Study||6
10139576|NCT02711345|11269854|FG009|STARTED|Overall Study||12
10139577|NCT02711345|11269845|FG000|COMPLETED|Overall Study||0
10139578|NCT02711345|11269846|FG001|COMPLETED|Overall Study||0
10139579|NCT02711345|11269847|FG002|COMPLETED|Overall Study||0
10139580|NCT02711345|11269848|FG003|COMPLETED|Overall Study||0
10139581|NCT02711345|11269849|FG004|COMPLETED|Overall Study||0
10139582|NCT02711345|11269850|FG005|COMPLETED|Overall Study||0
10139583|NCT02711345|11269851|FG006|COMPLETED|Overall Study||0
10139584|NCT02711345|11269852|FG007|COMPLETED|Overall Study||0
10139585|NCT02711345|11269853|FG008|COMPLETED|Overall Study||0
10139586|NCT02711345|11269854|FG009|COMPLETED|Overall Study||0
10139587|NCT02711345|11269845|FG000|NOT COMPLETED|Overall Study||2
10139588|NCT02711345|11269846|FG001|NOT COMPLETED|Overall Study||3
10139589|NCT02711345|11269847|FG002|NOT COMPLETED|Overall Study||6
10139590|NCT02711345|11269848|FG003|NOT COMPLETED|Overall Study||4
10139591|NCT02711345|11269849|FG004|NOT COMPLETED|Overall Study||8
10139592|NCT02711345|11269850|FG005|NOT COMPLETED|Overall Study||6
10139593|NCT02711345|11269851|FG006|NOT COMPLETED|Overall Study||12
10139594|NCT02711345|11269852|FG007|NOT COMPLETED|Overall Study||6
10139595|NCT02711345|11269853|FG008|NOT COMPLETED|Overall Study||6
10139596|NCT02711345|11269854|FG009|NOT COMPLETED|Overall Study||12
10139597|NCT02711553|11269885|FG000|STARTED|Overall Study||106
10139598|NCT02711553|11269886|FG001|STARTED|Overall Study||52
10139599|NCT02711553|11269887|FG002|STARTED|Overall Study||102
10139600|NCT02711553|11269888|FG003|STARTED|Overall Study||49
10139601|NCT02711553|11269885|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104
10139602|NCT02711553|11269886|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52
10139603|NCT02711553|11269887|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102
10139604|NCT02711553|11269888|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48
10139605|NCT02711553|11269885|FG000|COMPLETED|Overall Study||100
10139606|NCT02711553|11269886|FG001|COMPLETED|Overall Study||47
10139607|NCT02711553|11269887|FG002|COMPLETED|Overall Study||92
10139608|NCT02711553|11269888|FG003|COMPLETED|Overall Study||45
10139609|NCT02711553|11269885|FG000|NOT COMPLETED|Overall Study||6
10139610|NCT02711553|11269886|FG001|NOT COMPLETED|Overall Study||5
10139611|NCT02711553|11269887|FG002|NOT COMPLETED|Overall Study||10
10139612|NCT02711553|11269888|FG003|NOT COMPLETED|Overall Study||4
10139613|NCT02711800|11269900|FG000|STARTED|Overall Study||9
10139614|NCT02711800|11269900|FG000|COMPLETED|Overall Study||7
10139615|NCT02711800|11269900|FG000|NOT COMPLETED|Overall Study||2
10139616|NCT02711839|11269906|FG000|STARTED|Overall Study||20
10139617|NCT02711839|11269907|FG001|STARTED|Overall Study||34
10139618|NCT02711839|11269906|FG000|COMPLETED|Overall Study||16
10139619|NCT02711839|11269907|FG001|COMPLETED|Overall Study||24
10139620|NCT02711839|11269906|FG000|NOT COMPLETED|Overall Study||4
10139621|NCT02711839|11269907|FG001|NOT COMPLETED|Overall Study||10
10139622|NCT02711956|11269928|FG000|STARTED|Overall Study||2
10139623|NCT02711956|11269929|FG001|STARTED|Overall Study||2
10139624|NCT02711956|11269930|FG002|STARTED|Overall Study||3
10139625|NCT02711956|11269931|FG003|STARTED|Overall Study||5
10139626|NCT02711956|11269932|FG004|STARTED|Overall Study||4
10139627|NCT02711956|11269933|FG005|STARTED|Overall Study||3
10139628|NCT02711956|11269934|FG006|STARTED|Overall Study||4
10139629|NCT02711956|11269935|FG007|STARTED|Overall Study||4
10139630|NCT02711956|11269936|FG008|STARTED|Overall Study||4
10139631|NCT02711956|11269937|FG009|STARTED|Overall Study||3
10139632|NCT02711956|11269938|FG010|STARTED|Overall Study||1
10139633|NCT02711956|11269939|FG011|STARTED|Overall Study||9
10139634|NCT02711956|11269940|FG012|STARTED|Overall Study||17
10139635|NCT02711956|11269941|FG013|STARTED|Overall Study||6
10139636|NCT02711956|11269942|FG014|STARTED|Overall Study||8
10139637|NCT02711956|11269928|FG000|COMPLETED|Overall Study||0
10139638|NCT02711956|11269929|FG001|COMPLETED|Overall Study||0
10139639|NCT02711956|11269930|FG002|COMPLETED|Overall Study||1
10139640|NCT02711956|11269931|FG003|COMPLETED|Overall Study||2
10139641|NCT02711956|11269932|FG004|COMPLETED|Overall Study||0
10139642|NCT02711956|11269933|FG005|COMPLETED|Overall Study||1
10139643|NCT02711956|11269934|FG006|COMPLETED|Overall Study||0
10139644|NCT02711956|11269935|FG007|COMPLETED|Overall Study||2
10139645|NCT02711956|11269936|FG008|COMPLETED|Overall Study||0
10139646|NCT02711956|11269937|FG009|COMPLETED|Overall Study||0
10139647|NCT02711956|11269938|FG010|COMPLETED|Overall Study||0
10139648|NCT02711956|11269939|FG011|COMPLETED|Overall Study||0
10139649|NCT02711956|11269940|FG012|COMPLETED|Overall Study||1
10139650|NCT02711956|11269941|FG013|COMPLETED|Overall Study||1
10139651|NCT02711956|11269942|FG014|COMPLETED|Overall Study||0
10139652|NCT02711956|11269928|FG000|NOT COMPLETED|Overall Study||2
10139653|NCT02711956|11269929|FG001|NOT COMPLETED|Overall Study||2
10139654|NCT02711956|11269930|FG002|NOT COMPLETED|Overall Study||2
10139655|NCT02711956|11269931|FG003|NOT COMPLETED|Overall Study||3
10139656|NCT02711956|11269932|FG004|NOT COMPLETED|Overall Study||4
10139657|NCT02711956|11269933|FG005|NOT COMPLETED|Overall Study||2
10139658|NCT02711956|11269934|FG006|NOT COMPLETED|Overall Study||4
10139659|NCT02711956|11269935|FG007|NOT COMPLETED|Overall Study||2
10139660|NCT02711956|11269936|FG008|NOT COMPLETED|Overall Study||4
10139661|NCT02711956|11269937|FG009|NOT COMPLETED|Overall Study||3
10139662|NCT02711956|11269938|FG010|NOT COMPLETED|Overall Study||1
10139663|NCT02711956|11269939|FG011|NOT COMPLETED|Overall Study||9
10139664|NCT02711956|11269940|FG012|NOT COMPLETED|Overall Study||16
10139665|NCT02711956|11269941|FG013|NOT COMPLETED|Overall Study||5
10139666|NCT02711956|11269942|FG014|NOT COMPLETED|Overall Study||8
10139667|NCT02711995|11269983|FG000|STARTED|First Intervention (30 Days)||8
10139668|NCT02711995|11269983|FG000|COMPLETED|First Intervention (30 Days)||8
10139669|NCT02711995|11269983|FG000|NOT COMPLETED|First Intervention (30 Days)||0
10139670|NCT02711995|11269983|FG000|STARTED|Washout (90 Days)||8
10139671|NCT02711995|11269983|FG000|COMPLETED|Washout (90 Days)||7
10139672|NCT02711995|11269983|FG000|NOT COMPLETED|Washout (90 Days)||1
10139673|NCT02711995|11269983|FG000|STARTED|Second Intervention (30 Days)||7
10139674|NCT02711995|11269983|FG000|COMPLETED|Second Intervention (30 Days)||7
10139675|NCT02711995|11269983|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10139676|NCT02712008|11269992|FG000|STARTED|Baseline (Day 1) up to Week 12||50
10139677|NCT02712008|11269993|FG001|STARTED|Baseline (Day 1) up to Week 12||100
10139678|NCT02712008|11269994|FG002|STARTED|Baseline (Day 1) up to Week 12||152
10139679|NCT02712008|11269995|FG003|STARTED|Baseline (Day 1) up to Week 12||0
10139680|NCT02712008|11269996|FG004|STARTED|Baseline (Day 1) up to Week 12||0
10139681|NCT02712008|11269997|FG005|STARTED|Baseline (Day 1) up to Week 12||0
10139682|NCT02712008|11269998|FG006|STARTED|Baseline (Day 1) up to Week 12||0
10139683|NCT02712008|11269999|FG007|STARTED|Baseline (Day 1) up to Week 12||0
10139684|NCT02712008|11269992|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46
10139685|NCT02712008|11269993|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97
10139686|NCT02712008|11269994|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148
10139687|NCT02712008|11269995|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
10139688|NCT02712008|11269996|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
10139689|NCT02712008|11269997|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
10139690|NCT02712008|11269998|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
10139691|NCT02712008|11269999|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
10139692|NCT02712008|11269992|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
10139693|NCT02712008|11269993|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
10139694|NCT02712008|11269994|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
10139695|NCT02712008|11269995|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139696|NCT02712008|11269996|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139697|NCT02712008|11269997|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139698|NCT02712008|11269998|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139699|NCT02712008|11269999|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139700|NCT02712008|11269992|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
10139701|NCT02712008|11269993|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
10139702|NCT02712008|11269994|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
10139703|NCT02712008|11269995|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
10139704|NCT02712008|11269996|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
10139705|NCT02712008|11269997|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
10139706|NCT02712008|11269998|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
10139707|NCT02712008|11269999|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
10139708|NCT02712008|11269992|FG000|COMPLETED|From Week 12 up to Week 36||44
10139709|NCT02712008|11269993|FG001|COMPLETED|From Week 12 up to Week 36||0
10139710|NCT02712008|11269994|FG002|COMPLETED|From Week 12 up to Week 36||0
10139711|NCT02712008|11269995|FG003|COMPLETED|From Week 12 up to Week 36||42
10139712|NCT02712008|11269996|FG004|COMPLETED|From Week 12 up to Week 36||50
10139713|NCT02712008|11269997|FG005|COMPLETED|From Week 12 up to Week 36||46
10139714|NCT02712008|11269998|FG006|COMPLETED|From Week 12 up to Week 36||43
10139715|NCT02712008|11269999|FG007|COMPLETED|From Week 12 up to Week 36||45
10139716|NCT02712008|11269992|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
10139717|NCT02712008|11269993|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
10139718|NCT02712008|11269994|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
10139719|NCT02712008|11269995|FG003|NOT COMPLETED|From Week 12 up to Week 36||2
10139720|NCT02712008|11269996|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
10139721|NCT02712008|11269997|FG005|NOT COMPLETED|From Week 12 up to Week 36||0
10139722|NCT02712008|11269998|FG006|NOT COMPLETED|From Week 12 up to Week 36||5
10139723|NCT02712008|11269999|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
10139724|NCT02712047|11270013|FG000|STARTED|Treatment Period 1 (35 Days)||14
10139725|NCT02712047|11270014|FG001|STARTED|Treatment Period 1 (35 Days)||13
10139726|NCT02712047|11270013|FG000|COMPLETED|Treatment Period 1 (35 Days)||14
10139727|NCT02712047|11270014|FG001|COMPLETED|Treatment Period 1 (35 Days)||13
10139728|NCT02712047|11270013|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0
10139729|NCT02712047|11270014|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0
10139730|NCT02712047|11270013|FG000|STARTED|Washout Period (21 Days)||14
10139731|NCT02712047|11270014|FG001|STARTED|Washout Period (21 Days)||13
10139732|NCT02712047|11270013|FG000|COMPLETED|Washout Period (21 Days)||14
10139733|NCT02712047|11270014|FG001|COMPLETED|Washout Period (21 Days)||13
10139734|NCT02712047|11270013|FG000|NOT COMPLETED|Washout Period (21 Days)||0
10139735|NCT02712047|11270014|FG001|NOT COMPLETED|Washout Period (21 Days)||0
10139736|NCT02712047|11270013|FG000|STARTED|Treatment Period 2 (35 Days)||14
10139737|NCT02712047|11270014|FG001|STARTED|Treatment Period 2 (35 Days)||13
10139738|NCT02712047|11270013|FG000|COMPLETED|Treatment Period 2 (35 Days)||14
10139739|NCT02712047|11270014|FG001|COMPLETED|Treatment Period 2 (35 Days)||13
10139740|NCT02712047|11270013|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0
10139741|NCT02712047|11270014|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0
10139742|NCT02712099|11270022|FG000|STARTED|Overall Study||30
10139743|NCT02712099|11270023|FG001|STARTED|Overall Study||20
10139744|NCT02712099|11270022|FG000|COMPLETED|Overall Study||30
10139745|NCT02712099|11270023|FG001|COMPLETED|Overall Study||20
10139746|NCT02712099|11270022|FG000|NOT COMPLETED|Overall Study||0
10139747|NCT02712099|11270023|FG001|NOT COMPLETED|Overall Study||0
10139748|NCT02712320|11270029|FG000|STARTED|Overall Study||30
10060523|NCT02097992|11186071|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10060524|NCT02097992|11186072|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10060525|NCT02097992|11186073|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10060526|NCT02097992|11186074|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10060527|NCT02098109|11186084|FG000|STARTED|Overall Study||49
10060528|NCT02098109|11186085|FG001|STARTED|Overall Study||51
10060529|NCT02098109|11186084|FG000|COMPLETED|Overall Study||46
10060530|NCT02098109|11186085|FG001|COMPLETED|Overall Study||51
10060531|NCT02098109|11186084|FG000|NOT COMPLETED|Overall Study||3
10060532|NCT02098109|11186085|FG001|NOT COMPLETED|Overall Study||0
10060533|NCT02098304|11186091|FG000|STARTED|Overall Study||42
10060534|NCT02098304|11186091|FG000|COMPLETED|Overall Study||42
10060535|NCT02098304|11186091|FG000|NOT COMPLETED|Overall Study||0
10060536|NCT02098369|11186100|FG000|STARTED|Overall Study||142
10060537|NCT02098369|11186101|FG001|STARTED|Overall Study||154
10060538|NCT02098369|11186102|FG002|STARTED|Overall Study||148
10060539|NCT02098369|11186100|FG000|COMPLETED|Overall Study||135
10060540|NCT02098369|11186101|FG001|COMPLETED|Overall Study||145
10060541|NCT02098369|11186102|FG002|COMPLETED|Overall Study||143
10060542|NCT02098369|11186100|FG000|NOT COMPLETED|Overall Study||7
10060543|NCT02098369|11186101|FG001|NOT COMPLETED|Overall Study||9
10060544|NCT02098369|11186102|FG002|NOT COMPLETED|Overall Study||5
10060545|NCT02098395|11186114|FG000|STARTED|Overall Study||212
10060546|NCT02098395|11186115|FG001|STARTED|Overall Study||209
10060547|NCT02098395|11186116|FG002|STARTED|Overall Study||207
10060548|NCT02098395|11186117|FG003|STARTED|Overall Study||207
10060549|NCT02098395|11186114|FG000|Exposed|Overall Study||211
10060550|NCT02098395|11186115|FG001|Exposed|Overall Study||209
10060551|NCT02098395|11186116|FG002|Exposed|Overall Study||206
10060552|NCT02098395|11186117|FG003|Exposed|Overall Study||206
10060553|NCT02098395|11186114|FG000|COMPLETED|Overall Study||186
10139749|NCT02712320|11270029|FG000|COMPLETED|Overall Study||25
10139750|NCT02712320|11270029|FG000|NOT COMPLETED|Overall Study||5
9848863|NCT00862745|10961722|FG000|COMPLETED|Open-label Follow-up||229
10060554|NCT02098395|11186115|FG001|COMPLETED|Overall Study||177
10060555|NCT02098395|11186116|FG002|COMPLETED|Overall Study||165
10060556|NCT02098395|11186117|FG003|COMPLETED|Overall Study||180
10060557|NCT02098395|11186114|FG000|NOT COMPLETED|Overall Study||26
10060558|NCT02098395|11186115|FG001|NOT COMPLETED|Overall Study||32
10139751|NCT02712333|11270035|FG000|STARTED|First Period||34
10139752|NCT02712333|11270036|FG001|STARTED|First Period||26
10139753|NCT02712333|11270035|FG000|COMPLETED|First Period||31
10139754|NCT02712333|11270036|FG001|COMPLETED|First Period||24
10139755|NCT02712333|11270035|FG000|NOT COMPLETED|First Period||3
10139756|NCT02712333|11270036|FG001|NOT COMPLETED|First Period||2
10139757|NCT02712333|11270035|FG000|STARTED|Second Period||31
10139758|NCT02712333|11270036|FG001|STARTED|Second Period||24
10139759|NCT02712333|11270035|FG000|COMPLETED|Second Period||31
10139760|NCT02712333|11270036|FG001|COMPLETED|Second Period||24
10139761|NCT02712333|11270035|FG000|NOT COMPLETED|Second Period||0
10139762|NCT02712333|11270036|FG001|NOT COMPLETED|Second Period||0
10139763|NCT02712359|11270051|FG000|STARTED|Epoch 001: Persistence at Year 8||300
10139764|NCT02712359|11270052|FG001|STARTED|Epoch 001: Persistence at Year 8||300
10139765|NCT02712359|11270053|FG002|STARTED|Epoch 001: Persistence at Year 8||0
10139766|NCT02712359|11270054|FG003|STARTED|Epoch 001: Persistence at Year 8||0
10139767|NCT02712359|11270051|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300
10139768|NCT02712359|11270052|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300
10139769|NCT02712359|11270053|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0
10139770|NCT02712359|11270054|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0
10139771|NCT02712359|11270051|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10139772|NCT02712359|11270052|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10139773|NCT02712359|11270053|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10139774|NCT02712359|11270054|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10139775|NCT02712359|11270051|FG000|STARTED|Epoch 002: Persistence at Year 10||0
10139776|NCT02712359|11270052|FG001|STARTED|Epoch 002: Persistence at Year 10||0
10139777|NCT02712359|11270053|FG002|STARTED|Epoch 002: Persistence at Year 10||299
10139778|NCT02712359|11270054|FG003|STARTED|Epoch 002: Persistence at Year 10||300
10139779|NCT02712359|11270051|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0
10139780|NCT02712359|11270052|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0
10139781|NCT02712359|11270053|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299
10139782|NCT02712359|11270054|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300
10139783|NCT02712359|11270051|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10139784|NCT02712359|11270052|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10139785|NCT02712359|11270053|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10139786|NCT02712359|11270054|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10139787|NCT02712398|11270064|FG000|STARTED|Overall Study||120
10139788|NCT02712398|11270064|FG000|COMPLETED|Overall Study||83
10139789|NCT02712398|11270064|FG000|NOT COMPLETED|Overall Study||37
10139790|NCT02712424|11270070|FG000|STARTED|Overall Study||315
10139791|NCT02712424|11270071|FG001|STARTED|Overall Study||310
10139792|NCT02712424|11270070|FG000|COMPLETED|Overall Study||281
10139793|NCT02712424|11270071|FG001|COMPLETED|Overall Study||278
10139794|NCT02712424|11270070|FG000|NOT COMPLETED|Overall Study||34
10139795|NCT02712424|11270071|FG001|NOT COMPLETED|Overall Study||32
10139796|NCT02712554|11270079|FG000|STARTED|Part A: Dose Selection Phase||12
10139797|NCT02712554|11270080|FG001|STARTED|Part A: Dose Selection Phase||0
10139798|NCT02712554|11270079|FG000|COMPLETED|Part A: Dose Selection Phase||12
10139799|NCT02712554|11270080|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
10139800|NCT02712554|11270079|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0
10139801|NCT02712554|11270080|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0
10139802|NCT02712554|11270079|FG000|STARTED|Part B: Qualification Phase||0
10139803|NCT02712554|11270080|FG001|STARTED|Part B: Qualification Phase||61
10139804|NCT02712554|11270079|FG000|COMPLETED|Part B: Qualification Phase||0
10139805|NCT02712554|11270080|FG001|COMPLETED|Part B: Qualification Phase||40
10139806|NCT02712554|11270079|FG000|NOT COMPLETED|Part B: Qualification Phase||0
10139807|NCT02712554|11270080|FG001|NOT COMPLETED|Part B: Qualification Phase||21
10139808|NCT02712554|11270079|FG000|STARTED|Part B: Treatment Phase||0
10139809|NCT02712554|11270080|FG001|STARTED|Part B: Treatment Phase||40
10139810|NCT02712554|11270079|FG000|COMPLETED|Part B: Treatment Phase||0
10139811|NCT02712554|11270080|FG001|COMPLETED|Part B: Treatment Phase||37
10139812|NCT02712554|11270079|FG000|NOT COMPLETED|Part B: Treatment Phase||0
10139813|NCT02712554|11270080|FG001|NOT COMPLETED|Part B: Treatment Phase||3
10139814|NCT02712788|11270105|FG000|STARTED|Overall Study||2
10139815|NCT02712788|11270106|FG001|STARTED|Overall Study||2
10139816|NCT02712788|11270105|FG000|COMPLETED|Overall Study||0
10139817|NCT02712788|11270106|FG001|COMPLETED|Overall Study||2
10139818|NCT02712788|11270105|FG000|NOT COMPLETED|Overall Study||2
10139819|NCT02712788|11270106|FG001|NOT COMPLETED|Overall Study||0
10139820|NCT02712983|11270121|FG000|STARTED|Treatment Phase||14
10139821|NCT02712983|11270122|FG001|STARTED|Treatment Phase||13
10139822|NCT02712983|11270123|FG002|STARTED|Treatment Phase||7
10139823|NCT02712983|11270124|FG003|STARTED|Treatment Phase||15
10139824|NCT02712983|11270125|FG004|STARTED|Treatment Phase||14
10139825|NCT02712983|11270126|FG005|STARTED|Treatment Phase||7
10139826|NCT02712983|11270127|FG006|STARTED|Treatment Phase||15
10139827|NCT02712983|11270128|FG007|STARTED|Treatment Phase||15
10139828|NCT02712983|11270129|FG008|STARTED|Treatment Phase||7
10139829|NCT02712983|11270121|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14
10139830|NCT02712983|11270122|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13
10139831|NCT02712983|11270123|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0
10139832|NCT02712983|11270124|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15
10139833|NCT02712983|11270125|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14
10139834|NCT02712983|11270126|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0
10139835|NCT02712983|11270127|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15
10139836|NCT02712983|11270128|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14
10139837|NCT02712983|11270129|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0
10139838|NCT02712983|11270121|FG000|COMPLETED|Treatment Phase||9
10139839|NCT02712983|11270122|FG001|COMPLETED|Treatment Phase||12
10139840|NCT02712983|11270123|FG002|COMPLETED|Treatment Phase||6
10139841|NCT02712983|11270124|FG003|COMPLETED|Treatment Phase||7
10139842|NCT02712983|11270125|FG004|COMPLETED|Treatment Phase||10
10139843|NCT02712983|11270126|FG005|COMPLETED|Treatment Phase||7
10139844|NCT02712983|11270127|FG006|COMPLETED|Treatment Phase||6
10139845|NCT02712983|11270128|FG007|COMPLETED|Treatment Phase||6
10139846|NCT02712983|11270129|FG008|COMPLETED|Treatment Phase||5
10139847|NCT02712983|11270121|FG000|NOT COMPLETED|Treatment Phase||5
10139848|NCT02712983|11270122|FG001|NOT COMPLETED|Treatment Phase||1
10139849|NCT02712983|11270123|FG002|NOT COMPLETED|Treatment Phase||1
10139850|NCT02712983|11270124|FG003|NOT COMPLETED|Treatment Phase||8
10139851|NCT02712983|11270125|FG004|NOT COMPLETED|Treatment Phase||4
10139852|NCT02712983|11270126|FG005|NOT COMPLETED|Treatment Phase||0
10139853|NCT02712983|11270127|FG006|NOT COMPLETED|Treatment Phase||9
10139854|NCT02712983|11270128|FG007|NOT COMPLETED|Treatment Phase||9
10139855|NCT02712983|11270129|FG008|NOT COMPLETED|Treatment Phase||2
10139856|NCT02712983|11270121|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
10139857|NCT02712983|11270122|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
10139858|NCT02712983|11270123|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
10139859|NCT02712983|11270124|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
10139860|NCT02712983|11270125|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
10139861|NCT02712983|11270126|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
10139862|NCT02712983|11270127|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
10139863|NCT02712983|11270128|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
10139864|NCT02712983|11270129|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
10139865|NCT02712983|11270121|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139866|NCT02712983|11270122|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139867|NCT02712983|11270123|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139868|NCT02712983|11270124|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139869|NCT02712983|11270125|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139870|NCT02712983|11270126|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139871|NCT02712983|11270127|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139872|NCT02712983|11270128|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139873|NCT02712983|11270129|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139874|NCT02712983|11270121|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139875|NCT02712983|11270122|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
10139876|NCT02712983|11270123|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139877|NCT02712983|11270124|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
10139878|NCT02712983|11270125|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
10139879|NCT02712983|11270126|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
10139880|NCT02712983|11270127|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
10139881|NCT02712983|11270128|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
10139882|NCT02712983|11270129|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10139883|NCT02712996|11270151|FG000|STARTED|First Intervention (Study Days 1-42)||8
10139884|NCT02712996|11270152|FG001|STARTED|First Intervention (Study Days 1-42)||9
10139885|NCT02712996|11270151|FG000|COMPLETED|First Intervention (Study Days 1-42)||8
10139886|NCT02712996|11270152|FG001|COMPLETED|First Intervention (Study Days 1-42)||9
10139887|NCT02712996|11270151|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0
10139888|NCT02712996|11270152|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0
10139889|NCT02712996|11270151|FG000|STARTED|Second Intervention (Study Days 43-84)||8
10139890|NCT02712996|11270152|FG001|STARTED|Second Intervention (Study Days 43-84)||9
10139891|NCT02712996|11270151|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8
10139892|NCT02712996|11270152|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8
10139893|NCT02712996|11270151|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
10139894|NCT02712996|11270152|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
10139895|NCT02713178|11270163|FG000|STARTED|Overall Study||76
10139896|NCT02713178|11270164|FG001|STARTED|Overall Study||77
10139897|NCT02713178|11270165|FG002|STARTED|Overall Study||79
10139898|NCT02713178|11270163|FG000|COMPLETED|Overall Study||75
10139899|NCT02713178|11270164|FG001|COMPLETED|Overall Study||73
10139900|NCT02713178|11270165|FG002|COMPLETED|Overall Study||74
10139901|NCT02713178|11270163|FG000|NOT COMPLETED|Overall Study||1
10139902|NCT02713178|11270164|FG001|NOT COMPLETED|Overall Study||4
10139903|NCT02713178|11270165|FG002|NOT COMPLETED|Overall Study||5
10139904|NCT02713204|11270176|FG000|STARTED|Baseline (Day 1) up to Week 12||60
10139905|NCT02713204|11270177|FG001|STARTED|Baseline (Day 1) up to Week 12||122
10139906|NCT02713204|11270178|FG002|STARTED|Baseline (Day 1) up to Week 12||183
10139907|NCT02713204|11270179|FG003|STARTED|Baseline (Day 1) up to Week 12||0
10139908|NCT02713204|11270180|FG004|STARTED|Baseline (Day 1) up to Week 12||0
10139909|NCT02713204|11270181|FG005|STARTED|Baseline (Day 1) up to Week 12||0
10139910|NCT02713204|11270182|FG006|STARTED|Baseline (Day 1) up to Week 12||0
10139911|NCT02713204|11270183|FG007|STARTED|Baseline (Day 1) up to Week 12||0
10139912|NCT02713204|11270176|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59
10139913|NCT02713204|11270177|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121
10139914|NCT02713204|11270178|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181
10139915|NCT02713204|11270179|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
10139916|NCT02713204|11270180|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
10139917|NCT02713204|11270181|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
10139918|NCT02713204|11270182|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
10139919|NCT02713204|11270183|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
10139920|NCT02713204|11270176|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
10139921|NCT02713204|11270177|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
10139922|NCT02713204|11270178|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
10139923|NCT02713204|11270179|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139924|NCT02713204|11270180|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139925|NCT02713204|11270181|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139926|NCT02713204|11270182|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139927|NCT02713204|11270183|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10139928|NCT02713204|11270176|FG000|STARTED|From Week 12 up to Week 36||58
10139929|NCT02713204|11270177|FG001|STARTED|From Week 12 up to Week 36||0
10139930|NCT02713204|11270178|FG002|STARTED|From Week 12 up to Week 36||0
10139931|NCT02713204|11270179|FG003|STARTED|From Week 12 up to Week 36||57
10139932|NCT02713204|11270180|FG004|STARTED|From Week 12 up to Week 36||62
10139933|NCT02713204|11270181|FG005|STARTED|From Week 12 up to Week 36||60
10139934|NCT02713204|11270182|FG006|STARTED|From Week 12 up to Week 36||62
10139935|NCT02713204|11270183|FG007|STARTED|From Week 12 up to Week 36||58
10139936|NCT02713204|11270176|FG000|COMPLETED|From Week 12 up to Week 36||57
10139937|NCT02713204|11270177|FG001|COMPLETED|From Week 12 up to Week 36||0
10139938|NCT02713204|11270178|FG002|COMPLETED|From Week 12 up to Week 36||0
10139939|NCT02713204|11270179|FG003|COMPLETED|From Week 12 up to Week 36||53
10139940|NCT02713204|11270180|FG004|COMPLETED|From Week 12 up to Week 36||60
10139941|NCT02713204|11270181|FG005|COMPLETED|From Week 12 up to Week 36||59
10139942|NCT02713204|11270182|FG006|COMPLETED|From Week 12 up to Week 36||60
10139943|NCT02713204|11270183|FG007|COMPLETED|From Week 12 up to Week 36||54
10139944|NCT02713204|11270176|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
10139945|NCT02713204|11270177|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
10139946|NCT02713204|11270178|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
10139947|NCT02713204|11270179|FG003|NOT COMPLETED|From Week 12 up to Week 36||4
10139948|NCT02713204|11270180|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
10139949|NCT02713204|11270181|FG005|NOT COMPLETED|From Week 12 up to Week 36||1
10139950|NCT02713204|11270182|FG006|NOT COMPLETED|From Week 12 up to Week 36||2
10139951|NCT02713204|11270183|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
10139952|NCT02713230|11270203|FG000|STARTED|Overall Study||69
10139953|NCT02713230|11270204|FG001|STARTED|Overall Study||15
10139954|NCT02713230|11270205|FG002|STARTED|Overall Study||71
10139955|NCT02713230|11270203|FG000|COMPLETED|Overall Study||68
10139956|NCT02713230|11270204|FG001|COMPLETED|Overall Study||15
10139957|NCT02713230|11270205|FG002|COMPLETED|Overall Study||71
10139958|NCT02713230|11270203|FG000|NOT COMPLETED|Overall Study||1
10139959|NCT02713230|11270204|FG001|NOT COMPLETED|Overall Study||0
10139960|NCT02713230|11270205|FG002|NOT COMPLETED|Overall Study||0
10139961|NCT02713243|11270214|FG000|STARTED|Overall Study||10
10139962|NCT02713243|11270215|FG001|STARTED|Overall Study||10
10139963|NCT02713243|11270214|FG000|PD Analysis Set|Overall Study||9
10139964|NCT02713243|11270215|FG001|PD Analysis Set|Overall Study||10
10139965|NCT02713243|11270214|FG000|PK Analysis Set|Overall Study||8
10139966|NCT02713243|11270215|FG001|PK Analysis Set|Overall Study||9
10139967|NCT02713243|11270214|FG000|COMPLETED|Overall Study||9
10139968|NCT02713243|11270215|FG001|COMPLETED|Overall Study||8
10139969|NCT02713243|11270214|FG000|NOT COMPLETED|Overall Study||1
10139970|NCT02713243|11270215|FG001|NOT COMPLETED|Overall Study||2
10139971|NCT02713256|11270221|FG000|STARTED|Overall Study||15
10139972|NCT02713256|11270221|FG000|COMPLETED|Overall Study||15
10139973|NCT02713256|11270221|FG000|NOT COMPLETED|Overall Study||0
10139974|NCT02713425|11270225|FG000|STARTED|Overall Study||20
10139975|NCT02713425|11270225|FG000|COMPLETED|Overall Study||20
10139976|NCT02713425|11270225|FG000|NOT COMPLETED|Overall Study||0
10139977|NCT02713490|11270231|FG000|STARTED|Overall Study||71
10139978|NCT02713490|11270232|FG001|STARTED|Overall Study||69
10139979|NCT02713490|11270231|FG000|COMPLETED|Overall Study||68
10139980|NCT02713490|11270232|FG001|COMPLETED|Overall Study||67
10139981|NCT02713490|11270231|FG000|NOT COMPLETED|Overall Study||3
10139982|NCT02713490|11270232|FG001|NOT COMPLETED|Overall Study||2
10139983|NCT02713529|11270245|FG000|STARTED|Overall Study||8
10139984|NCT02713529|11270246|FG001|STARTED|Overall Study||7
10139985|NCT02713529|11270247|FG002|STARTED|Overall Study||42
10139986|NCT02713529|11270248|FG003|STARTED|Overall Study||31
10139987|NCT02713529|11270249|FG004|STARTED|Overall Study||4
10139988|NCT02713529|11270250|FG005|STARTED|Overall Study||19
10139989|NCT02713529|11270251|FG006|STARTED|Overall Study||6
10139990|NCT02713529|11270245|FG000|COMPLETED|Overall Study||1
10139991|NCT02713529|11270246|FG001|COMPLETED|Overall Study||3
10139992|NCT02713529|11270247|FG002|COMPLETED|Overall Study||11
10139993|NCT02713529|11270248|FG003|COMPLETED|Overall Study||2
10139994|NCT02713529|11270249|FG004|COMPLETED|Overall Study||1
10139995|NCT02713529|11270250|FG005|COMPLETED|Overall Study||5
10139996|NCT02713529|11270251|FG006|COMPLETED|Overall Study||2
10139997|NCT02713529|11270245|FG000|NOT COMPLETED|Overall Study||7
10139998|NCT02713529|11270246|FG001|NOT COMPLETED|Overall Study||4
10139999|NCT02713529|11270247|FG002|NOT COMPLETED|Overall Study||31
10140000|NCT02713529|11270248|FG003|NOT COMPLETED|Overall Study||29
10140001|NCT02713529|11270249|FG004|NOT COMPLETED|Overall Study||3
10140002|NCT02713529|11270250|FG005|NOT COMPLETED|Overall Study||14
10140003|NCT02713529|11270251|FG006|NOT COMPLETED|Overall Study||4
10140004|NCT02713542|11270273|FG000|STARTED|Overall Study||60
10140005|NCT02713542|11270274|FG001|STARTED|Overall Study||30
10140006|NCT02713542|11270273|FG000|COMPLETED|Overall Study||42
10140007|NCT02713542|11270274|FG001|COMPLETED|Overall Study||24
10140008|NCT02713542|11270273|FG000|NOT COMPLETED|Overall Study||18
10140009|NCT02713542|11270274|FG001|NOT COMPLETED|Overall Study||6
10140010|NCT02713594|11270282|FG000|STARTED|Overall Study||952
10140011|NCT02713594|11270283|FG001|STARTED|Overall Study||948
10140012|NCT02713594|11270282|FG000|COMPLETED|Overall Study||562
10140013|NCT02713594|11270283|FG001|COMPLETED|Overall Study||552
10140014|NCT02713594|11270282|FG000|NOT COMPLETED|Overall Study||390
10140015|NCT02713594|11270283|FG001|NOT COMPLETED|Overall Study||396
10140016|NCT02713659|11270293|FG000|STARTED|Baseline||60
10140017|NCT02713659|11270294|FG001|STARTED|Baseline||60
10140018|NCT02713659|11270293|FG000|COMPLETED|Baseline||60
10140019|NCT02713659|11270294|FG001|COMPLETED|Baseline||60
10140020|NCT02713659|11270293|FG000|NOT COMPLETED|Baseline||0
10140021|NCT02713659|11270294|FG001|NOT COMPLETED|Baseline||0
10140022|NCT02713659|11270293|FG000|STARTED|6 Month Study Visit||60
10140023|NCT02713659|11270294|FG001|STARTED|6 Month Study Visit||60
10140024|NCT02713659|11270293|FG000|COMPLETED|6 Month Study Visit||53
10140025|NCT02713659|11270294|FG001|COMPLETED|6 Month Study Visit||47
10140026|NCT02713659|11270293|FG000|NOT COMPLETED|6 Month Study Visit||7
10140027|NCT02713659|11270294|FG001|NOT COMPLETED|6 Month Study Visit||13
10140028|NCT02713659|11270293|FG000|STARTED|12 Month Study Visit||57
10140029|NCT02713659|11270294|FG001|STARTED|12 Month Study Visit||55
10140030|NCT02713659|11270293|FG000|COMPLETED|12 Month Study Visit||54
10140031|NCT02713659|11270294|FG001|COMPLETED|12 Month Study Visit||52
10140032|NCT02713659|11270293|FG000|NOT COMPLETED|12 Month Study Visit||3
10140033|NCT02713659|11270294|FG001|NOT COMPLETED|12 Month Study Visit||3
10140034|NCT02713659|11270293|FG000|STARTED|18 Month Study Visit||58
10140035|NCT02713659|11270294|FG001|STARTED|18 Month Study Visit||53
10140036|NCT02713659|11270293|FG000|COMPLETED|18 Month Study Visit||50
10140037|NCT02713659|11270294|FG001|COMPLETED|18 Month Study Visit||50
10140038|NCT02713659|11270293|FG000|NOT COMPLETED|18 Month Study Visit||8
10140039|NCT02713659|11270294|FG001|NOT COMPLETED|18 Month Study Visit||3
10140040|NCT02713659|11270293|FG000|STARTED|24 Month Study Visit||57
10140041|NCT02713659|11270294|FG001|STARTED|24 Month Study Visit||52
10140042|NCT02713659|11270293|FG000|COMPLETED|24 Month Study Visit||49
10140043|NCT02713659|11270294|FG001|COMPLETED|24 Month Study Visit||44
10140044|NCT02713659|11270293|FG000|NOT COMPLETED|24 Month Study Visit||8
10140045|NCT02713659|11270294|FG001|NOT COMPLETED|24 Month Study Visit||8
10140046|NCT02713698|11270303|FG000|STARTED|Overall Study||20
10140047|NCT02713698|11270304|FG001|STARTED|Overall Study||20
10140048|NCT02713698|11270305|FG002|STARTED|Overall Study||20
9848864|NCT00862745|10961723|FG001|COMPLETED|Open-label Follow-up||225
10140049|NCT02713698|11270303|FG000|COMPLETED|Overall Study||20
10140050|NCT02713698|11270304|FG001|COMPLETED|Overall Study||20
10140051|NCT02713698|11270305|FG002|COMPLETED|Overall Study||20
10140052|NCT02713698|11270303|FG000|NOT COMPLETED|Overall Study||0
10140053|NCT02713698|11270304|FG001|NOT COMPLETED|Overall Study||0
10140054|NCT02713698|11270305|FG002|NOT COMPLETED|Overall Study||0
10140055|NCT02713711|11270313|FG000|STARTED|Overall Study||9
10140056|NCT02713711|11270314|FG001|STARTED|Overall Study||6
10140057|NCT02713711|11270315|FG002|STARTED|Overall Study||6
10140058|NCT02713711|11270316|FG003|STARTED|Overall Study||10
10140059|NCT02713711|11270313|FG000|COMPLETED|Overall Study||9
10140060|NCT02713711|11270314|FG001|COMPLETED|Overall Study||6
10140061|NCT02713711|11270315|FG002|COMPLETED|Overall Study||6
10140062|NCT02713711|11270316|FG003|COMPLETED|Overall Study||10
10140063|NCT02713711|11270313|FG000|NOT COMPLETED|Overall Study||0
10140064|NCT02713711|11270314|FG001|NOT COMPLETED|Overall Study||0
10140065|NCT02713711|11270315|FG002|NOT COMPLETED|Overall Study||0
10140066|NCT02713711|11270316|FG003|NOT COMPLETED|Overall Study||0
10140067|NCT02713789|11270332|FG000|STARTED|Overall Study||8
10140068|NCT02713789|11270333|FG001|STARTED|Overall Study||10
10140069|NCT02713789|11270334|FG002|STARTED|Overall Study||8
10140070|NCT02713789|11270332|FG000|COMPLETED|Overall Study||8
10140071|NCT02713789|11270333|FG001|COMPLETED|Overall Study||9
10140072|NCT02713789|11270334|FG002|COMPLETED|Overall Study||7
10140073|NCT02713789|11270332|FG000|NOT COMPLETED|Overall Study||0
10140074|NCT02713789|11270333|FG001|NOT COMPLETED|Overall Study||1
10140075|NCT02713789|11270334|FG002|NOT COMPLETED|Overall Study||1
10140076|NCT02713828|11270344|FG000|STARTED|Overall Study||13
10140077|NCT02713828|11270345|FG001|STARTED|Overall Study||0
10140078|NCT02713828|11270344|FG000|COMPLETED|Overall Study||8
10140079|NCT02713828|11270345|FG001|COMPLETED|Overall Study||0
10140080|NCT02713828|11270344|FG000|NOT COMPLETED|Overall Study||5
10140081|NCT02713828|11270345|FG001|NOT COMPLETED|Overall Study||0
10140082|NCT02714153|11270350|FG000|STARTED|Overall Study||23
10140083|NCT02714153|11270350|FG000|COMPLETED|Overall Study||22
10140084|NCT02714153|11270350|FG000|NOT COMPLETED|Overall Study||1
10140085|NCT02714283|11270356|FG000|STARTED|Overall Study||83589
10140086|NCT02714283|11270357|FG001|STARTED|Overall Study||6500
10140087|NCT02714283|11270356|FG000|COMPLETED|Overall Study||83589
10140088|NCT02714283|11270357|FG001|COMPLETED|Overall Study||6500
10140089|NCT02714283|11270356|FG000|NOT COMPLETED|Overall Study||0
10140090|NCT02714283|11270357|FG001|NOT COMPLETED|Overall Study||0
10140091|NCT02714400|11270367|FG000|STARTED|First Intervention (1 Day)||12
10140092|NCT02714400|11270368|FG001|STARTED|First Intervention (1 Day)||8
10140093|NCT02714400|11270367|FG000|COMPLETED|First Intervention (1 Day)||12
10140094|NCT02714400|11270368|FG001|COMPLETED|First Intervention (1 Day)||8
10140095|NCT02714400|11270367|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10140096|NCT02714400|11270368|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10140097|NCT02714400|11270367|FG000|STARTED|Washout (>4 Days)||12
10140098|NCT02714400|11270368|FG001|STARTED|Washout (>4 Days)||8
10140099|NCT02714400|11270367|FG000|COMPLETED|Washout (>4 Days)||12
10140100|NCT02714400|11270368|FG001|COMPLETED|Washout (>4 Days)||8
10140101|NCT02714400|11270367|FG000|NOT COMPLETED|Washout (>4 Days)||0
10140102|NCT02714400|11270368|FG001|NOT COMPLETED|Washout (>4 Days)||0
10140103|NCT02714400|11270367|FG000|STARTED|Second Intervention (1 Day)||12
10140104|NCT02714400|11270368|FG001|STARTED|Second Intervention (1 Day)||8
10140105|NCT02714400|11270367|FG000|COMPLETED|Second Intervention (1 Day)||12
10140106|NCT02714400|11270368|FG001|COMPLETED|Second Intervention (1 Day)||8
10140107|NCT02714400|11270367|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10140108|NCT02714400|11270368|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10140109|NCT02714426|11270376|FG000|STARTED|Overall Study||21
10140110|NCT02714426|11270377|FG001|STARTED|Overall Study||21
10140111|NCT02714426|11270376|FG000|COMPLETED|Overall Study||19
10140112|NCT02714426|11270377|FG001|COMPLETED|Overall Study||19
10140113|NCT02714426|11270376|FG000|NOT COMPLETED|Overall Study||2
10140114|NCT02714426|11270377|FG001|NOT COMPLETED|Overall Study||2
10140115|NCT02714504|11270385|FG000|STARTED|Overall Study||61
10140116|NCT02714504|11270386|FG001|STARTED|Overall Study||178
10140117|NCT02714504|11270385|FG000|COMPLETED|Overall Study||61
10140118|NCT02714504|11270386|FG001|COMPLETED|Overall Study||178
10140119|NCT02714504|11270385|FG000|NOT COMPLETED|Overall Study||0
10140120|NCT02714504|11270386|FG001|NOT COMPLETED|Overall Study||0
10140121|NCT02714569|11270403|FG000|STARTED|Part A First Intervention||3
10140122|NCT02714569|11270404|FG001|STARTED|Part A First Intervention||3
10140123|NCT02714569|11270405|FG002|STARTED|Part A First Intervention||3
10140124|NCT02714569|11270406|FG003|STARTED|Part A First Intervention||3
10140125|NCT02714569|11270407|FG004|STARTED|Part A First Intervention||3
10140126|NCT02714569|11270408|FG005|STARTED|Part A First Intervention||3
10140127|NCT02714569|11270409|FG006|STARTED|Part A First Intervention||0
10140128|NCT02714569|11270410|FG007|STARTED|Part A First Intervention||0
10140129|NCT02714569|11270411|FG008|STARTED|Part A First Intervention||0
10140130|NCT02714569|11270412|FG009|STARTED|Part A First Intervention||0
10140131|NCT02714569|11270413|FG010|STARTED|Part A First Intervention||0
10140132|NCT02714569|11270403|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3
10140133|NCT02714569|11270404|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3
10140134|NCT02714569|11270405|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3
10140135|NCT02714569|11270406|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3
10140136|NCT02714569|11270407|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3
10140137|NCT02714569|11270408|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3
10140138|NCT02714569|11270409|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0
10140139|NCT02714569|11270410|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0
10140140|NCT02714569|11270411|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0
10140141|NCT02714569|11270412|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0
10140142|NCT02714569|11270413|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0
10140143|NCT02714569|11270403|FG000|COMPLETED|Part A First Intervention||3
10140144|NCT02714569|11270404|FG001|COMPLETED|Part A First Intervention||3
10140145|NCT02714569|11270405|FG002|COMPLETED|Part A First Intervention||3
10140146|NCT02714569|11270406|FG003|COMPLETED|Part A First Intervention||3
10140147|NCT02714569|11270407|FG004|COMPLETED|Part A First Intervention||3
10140148|NCT02714569|11270408|FG005|COMPLETED|Part A First Intervention||3
10140149|NCT02714569|11270409|FG006|COMPLETED|Part A First Intervention||0
10140150|NCT02714569|11270410|FG007|COMPLETED|Part A First Intervention||0
10140151|NCT02714569|11270411|FG008|COMPLETED|Part A First Intervention||0
10140152|NCT02714569|11270412|FG009|COMPLETED|Part A First Intervention||0
10140153|NCT02714569|11270413|FG010|COMPLETED|Part A First Intervention||0
10140154|NCT02714569|11270403|FG000|NOT COMPLETED|Part A First Intervention||0
10140155|NCT02714569|11270404|FG001|NOT COMPLETED|Part A First Intervention||0
10140156|NCT02714569|11270405|FG002|NOT COMPLETED|Part A First Intervention||0
10140157|NCT02714569|11270406|FG003|NOT COMPLETED|Part A First Intervention||0
10140158|NCT02714569|11270407|FG004|NOT COMPLETED|Part A First Intervention||0
10140159|NCT02714569|11270408|FG005|NOT COMPLETED|Part A First Intervention||0
10140160|NCT02714569|11270409|FG006|NOT COMPLETED|Part A First Intervention||0
10140161|NCT02714569|11270410|FG007|NOT COMPLETED|Part A First Intervention||0
10140162|NCT02714569|11270411|FG008|NOT COMPLETED|Part A First Intervention||0
10140163|NCT02714569|11270412|FG009|NOT COMPLETED|Part A First Intervention||0
10140164|NCT02714569|11270413|FG010|NOT COMPLETED|Part A First Intervention||0
10140165|NCT02714569|11270403|FG000|STARTED|Part A Second Intervention||3
10140166|NCT02714569|11270404|FG001|STARTED|Part A Second Intervention||3
10140167|NCT02714569|11270405|FG002|STARTED|Part A Second Intervention||3
10140168|NCT02714569|11270406|FG003|STARTED|Part A Second Intervention||3
10140169|NCT02714569|11270407|FG004|STARTED|Part A Second Intervention||3
10140170|NCT02714569|11270408|FG005|STARTED|Part A Second Intervention||3
10140171|NCT02714569|11270409|FG006|STARTED|Part A Second Intervention||0
10140172|NCT02714569|11270410|FG007|STARTED|Part A Second Intervention||0
10140173|NCT02714569|11270411|FG008|STARTED|Part A Second Intervention||0
10140174|NCT02714569|11270412|FG009|STARTED|Part A Second Intervention||0
10140175|NCT02714569|11270413|FG010|STARTED|Part A Second Intervention||0
10140176|NCT02714569|11270403|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10140177|NCT02714569|11270404|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2
10140178|NCT02714569|11270405|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10140179|NCT02714569|11270406|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10140180|NCT02714569|11270407|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10140181|NCT02714569|11270408|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10140182|NCT02714569|11270409|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10140183|NCT02714569|11270410|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10140184|NCT02714569|11270411|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10140185|NCT02714569|11270412|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0
9707268|NCT01909934|10806467|FG000|STARTED|Overall Study||50
9707269|NCT01909934|10806467|FG000|COMPLETED|Overall Study||0
9707270|NCT01909934|10806467|FG000|NOT COMPLETED|Overall Study||50
9707271|NCT01841359|10806471|FG000|STARTED|Overall Study||22
9707272|NCT01841359|10806471|FG000|COMPLETED|Overall Study||14
9707273|NCT01841359|10806471|FG000|NOT COMPLETED|Overall Study||8
9707274|NCT01459666|10806480|FG000|STARTED|Overall Study||5
9707275|NCT01459666|10806481|FG001|STARTED|Overall Study||4
9707276|NCT01459666|10806480|FG000|COMPLETED|Overall Study||0
9707277|NCT01459666|10806481|FG001|COMPLETED|Overall Study||0
9707278|NCT01459666|10806480|FG000|NOT COMPLETED|Overall Study||5
9707279|NCT01459666|10806481|FG001|NOT COMPLETED|Overall Study||4
9707280|NCT01369199|10806487|FG000|STARTED|Overall Study||28
9707281|NCT01369199|10806487|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
9707282|NCT01369199|10806487|FG000|COMPLETED|Overall Study||25
9707283|NCT01369199|10806487|FG000|NOT COMPLETED|Overall Study||3
9707284|NCT01368497|10806491|FG000|STARTED|Overall Study||60
9707285|NCT01368497|10806491|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
9707286|NCT01368497|10806491|FG000|COMPLETED|Overall Study||58
9707287|NCT01368497|10806491|FG000|NOT COMPLETED|Overall Study||2
9707316|NCT00977574|10806515|FG000|STARTED|Overall Study||116
9707317|NCT00977574|10806516|FG001|STARTED|Overall Study||115
9707318|NCT00977574|10806517|FG002|STARTED|Overall Study||118
9707319|NCT00977574|10806515|FG000|COMPLETED|Overall Study||112
9707320|NCT00977574|10806516|FG001|COMPLETED|Overall Study||113
9707321|NCT00977574|10806517|FG002|COMPLETED|Overall Study||114
9707322|NCT00977574|10806515|FG000|NOT COMPLETED|Overall Study||4
9707323|NCT00977574|10806516|FG001|NOT COMPLETED|Overall Study||2
9707324|NCT00977574|10806517|FG002|NOT COMPLETED|Overall Study||4
9729212|NCT00117143|10828774|FG002|COMPLETED|Overall Study||7
9729213|NCT00117143|10828775|FG003|COMPLETED|Overall Study||1
9729214|NCT00117143|10828772|FG000|NOT COMPLETED|Overall Study||0
9729215|NCT00117143|10828773|FG001|NOT COMPLETED|Overall Study||0
9729216|NCT00117143|10828774|FG002|NOT COMPLETED|Overall Study||0
9729217|NCT00117143|10828775|FG003|NOT COMPLETED|Overall Study||0
9729218|NCT00117156|10828785|FG000|STARTED|Overall Study||26
9729219|NCT00117156|10828785|FG000|COMPLETED|Overall Study||15
9729220|NCT00117156|10828785|FG000|NOT COMPLETED|Overall Study||11
10140186|NCT02714569|11270413|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10140187|NCT02714569|11270403|FG000|COMPLETED|Part A Second Intervention||3
10140188|NCT02714569|11270404|FG001|COMPLETED|Part A Second Intervention||2
10140189|NCT02714569|11270405|FG002|COMPLETED|Part A Second Intervention||3
10140190|NCT02714569|11270406|FG003|COMPLETED|Part A Second Intervention||3
10140191|NCT02714569|11270407|FG004|COMPLETED|Part A Second Intervention||3
10140192|NCT02714569|11270408|FG005|COMPLETED|Part A Second Intervention||3
10140193|NCT02714569|11270409|FG006|COMPLETED|Part A Second Intervention||0
10140194|NCT02714569|11270410|FG007|COMPLETED|Part A Second Intervention||0
10140195|NCT02714569|11270411|FG008|COMPLETED|Part A Second Intervention||0
10140196|NCT02714569|11270412|FG009|COMPLETED|Part A Second Intervention||0
10140197|NCT02714569|11270413|FG010|COMPLETED|Part A Second Intervention||0
10140198|NCT02714569|11270403|FG000|NOT COMPLETED|Part A Second Intervention||0
10140199|NCT02714569|11270404|FG001|NOT COMPLETED|Part A Second Intervention||1
10140200|NCT02714569|11270405|FG002|NOT COMPLETED|Part A Second Intervention||0
10140201|NCT02714569|11270406|FG003|NOT COMPLETED|Part A Second Intervention||0
10140202|NCT02714569|11270407|FG004|NOT COMPLETED|Part A Second Intervention||0
10140203|NCT02714569|11270408|FG005|NOT COMPLETED|Part A Second Intervention||0
10140204|NCT02714569|11270409|FG006|NOT COMPLETED|Part A Second Intervention||0
10140205|NCT02714569|11270410|FG007|NOT COMPLETED|Part A Second Intervention||0
10140206|NCT02714569|11270411|FG008|NOT COMPLETED|Part A Second Intervention||0
10140207|NCT02714569|11270412|FG009|NOT COMPLETED|Part A Second Intervention||0
10140208|NCT02714569|11270413|FG010|NOT COMPLETED|Part A Second Intervention||0
10140209|NCT02714569|11270403|FG000|STARTED|Part A Third Intervention||3
10140210|NCT02714569|11270404|FG001|STARTED|Part A Third Intervention||2
10140211|NCT02714569|11270405|FG002|STARTED|Part A Third Intervention||3
10140212|NCT02714569|11270406|FG003|STARTED|Part A Third Intervention||3
10140213|NCT02714569|11270407|FG004|STARTED|Part A Third Intervention||3
10140214|NCT02714569|11270408|FG005|STARTED|Part A Third Intervention||3
10140215|NCT02714569|11270409|FG006|STARTED|Part A Third Intervention||0
10140216|NCT02714569|11270410|FG007|STARTED|Part A Third Intervention||0
10140217|NCT02714569|11270411|FG008|STARTED|Part A Third Intervention||0
10140218|NCT02714569|11270412|FG009|STARTED|Part A Third Intervention||0
10140219|NCT02714569|11270413|FG010|STARTED|Part A Third Intervention||0
10140220|NCT02714569|11270403|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3
10140221|NCT02714569|11270404|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2
10140222|NCT02714569|11270405|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2
10140223|NCT02714569|11270406|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2
10140224|NCT02714569|11270407|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3
10140225|NCT02714569|11270408|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3
10140226|NCT02714569|11270409|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10140227|NCT02714569|11270410|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10140228|NCT02714569|11270411|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10140229|NCT02714569|11270412|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10140230|NCT02714569|11270413|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10140231|NCT02714569|11270403|FG000|COMPLETED|Part A Third Intervention||3
10140232|NCT02714569|11270404|FG001|COMPLETED|Part A Third Intervention||2
10140233|NCT02714569|11270405|FG002|COMPLETED|Part A Third Intervention||2
10140234|NCT02714569|11270406|FG003|COMPLETED|Part A Third Intervention||2
10140235|NCT02714569|11270407|FG004|COMPLETED|Part A Third Intervention||3
10140236|NCT02714569|11270408|FG005|COMPLETED|Part A Third Intervention||3
10140237|NCT02714569|11270409|FG006|COMPLETED|Part A Third Intervention||0
10140238|NCT02714569|11270410|FG007|COMPLETED|Part A Third Intervention||0
10140239|NCT02714569|11270411|FG008|COMPLETED|Part A Third Intervention||0
10140240|NCT02714569|11270412|FG009|COMPLETED|Part A Third Intervention||0
10140241|NCT02714569|11270413|FG010|COMPLETED|Part A Third Intervention||0
10140242|NCT02714569|11270403|FG000|NOT COMPLETED|Part A Third Intervention||0
10140243|NCT02714569|11270404|FG001|NOT COMPLETED|Part A Third Intervention||0
10140244|NCT02714569|11270405|FG002|NOT COMPLETED|Part A Third Intervention||1
10140245|NCT02714569|11270406|FG003|NOT COMPLETED|Part A Third Intervention||1
10140246|NCT02714569|11270407|FG004|NOT COMPLETED|Part A Third Intervention||0
10140247|NCT02714569|11270408|FG005|NOT COMPLETED|Part A Third Intervention||0
10140248|NCT02714569|11270409|FG006|NOT COMPLETED|Part A Third Intervention||0
10140249|NCT02714569|11270410|FG007|NOT COMPLETED|Part A Third Intervention||0
10140250|NCT02714569|11270411|FG008|NOT COMPLETED|Part A Third Intervention||0
10140251|NCT02714569|11270412|FG009|NOT COMPLETED|Part A Third Intervention||0
10140252|NCT02714569|11270413|FG010|NOT COMPLETED|Part A Third Intervention||0
10140253|NCT02714569|11270403|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
10140254|NCT02714569|11270404|FG001|STARTED|Part A Fourth Intervention||2
10140255|NCT02714569|11270405|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
10140256|NCT02714569|11270406|FG003|STARTED|Part A Fourth Intervention||2
10140257|NCT02714569|11270407|FG004|STARTED|Part A Fourth Intervention||3
10140258|NCT02714569|11270408|FG005|STARTED|Part A Fourth Intervention||3
10140259|NCT02714569|11270409|FG006|STARTED|Part A Fourth Intervention||0
10140260|NCT02714569|11270410|FG007|STARTED|Part A Fourth Intervention||0
10140261|NCT02714569|11270411|FG008|STARTED|Part A Fourth Intervention||0
10140262|NCT02714569|11270412|FG009|STARTED|Part A Fourth Intervention||0
10140263|NCT02714569|11270413|FG010|STARTED|Part A Fourth Intervention||0
10140264|NCT02714569|11270403|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
10140265|NCT02714569|11270404|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
10140266|NCT02714569|11270405|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
10140267|NCT02714569|11270406|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
10140268|NCT02714569|11270407|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
10140269|NCT02714569|11270408|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
10140270|NCT02714569|11270409|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10140271|NCT02714569|11270410|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10140272|NCT02714569|11270411|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10140273|NCT02714569|11270412|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10140274|NCT02714569|11270413|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10140275|NCT02714569|11270403|FG000|COMPLETED|Part A Fourth Intervention||3
10140276|NCT02714569|11270404|FG001|COMPLETED|Part A Fourth Intervention||2
10140277|NCT02714569|11270405|FG002|COMPLETED|Part A Fourth Intervention||3
10140278|NCT02714569|11270406|FG003|COMPLETED|Part A Fourth Intervention||2
10140279|NCT02714569|11270407|FG004|COMPLETED|Part A Fourth Intervention||3
10140280|NCT02714569|11270408|FG005|COMPLETED|Part A Fourth Intervention||2
10140281|NCT02714569|11270409|FG006|COMPLETED|Part A Fourth Intervention||0
10140282|NCT02714569|11270410|FG007|COMPLETED|Part A Fourth Intervention||0
10140283|NCT02714569|11270411|FG008|COMPLETED|Part A Fourth Intervention||0
10140284|NCT02714569|11270412|FG009|COMPLETED|Part A Fourth Intervention||0
10140285|NCT02714569|11270413|FG010|COMPLETED|Part A Fourth Intervention||0
10140286|NCT02714569|11270403|FG000|NOT COMPLETED|Part A Fourth Intervention||1
10140287|NCT02714569|11270404|FG001|NOT COMPLETED|Part A Fourth Intervention||0
10140288|NCT02714569|11270405|FG002|NOT COMPLETED|Part A Fourth Intervention||0
10140289|NCT02714569|11270406|FG003|NOT COMPLETED|Part A Fourth Intervention||0
10140290|NCT02714569|11270407|FG004|NOT COMPLETED|Part A Fourth Intervention||0
10140291|NCT02714569|11270408|FG005|NOT COMPLETED|Part A Fourth Intervention||1
10140292|NCT02714569|11270409|FG006|NOT COMPLETED|Part A Fourth Intervention||0
10140293|NCT02714569|11270410|FG007|NOT COMPLETED|Part A Fourth Intervention||0
10140294|NCT02714569|11270411|FG008|NOT COMPLETED|Part A Fourth Intervention||0
10140295|NCT02714569|11270412|FG009|NOT COMPLETED|Part A Fourth Intervention||0
10140296|NCT02714569|11270413|FG010|NOT COMPLETED|Part A Fourth Intervention||0
10140297|NCT02714569|11270403|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10140298|NCT02714569|11270404|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10140299|NCT02714569|11270405|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10140300|NCT02714569|11270406|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10140301|NCT02714569|11270407|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10140302|NCT02714569|11270408|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10140303|NCT02714569|11270409|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
10140304|NCT02714569|11270410|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
10140305|NCT02714569|11270411|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
10140306|NCT02714569|11270412|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
10140307|NCT02714569|11270413|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
10140308|NCT02714569|11270403|FG000|COMPLETED|Part B (Overall)||0
10140309|NCT02714569|11270404|FG001|COMPLETED|Part B (Overall)||0
10140310|NCT02714569|11270405|FG002|COMPLETED|Part B (Overall)||0
10140311|NCT02714569|11270406|FG003|COMPLETED|Part B (Overall)||0
10140312|NCT02714569|11270407|FG004|COMPLETED|Part B (Overall)||0
10140313|NCT02714569|11270408|FG005|COMPLETED|Part B (Overall)||0
10140314|NCT02714569|11270409|FG006|COMPLETED|Part B (Overall)||7
10140315|NCT02714569|11270410|FG007|COMPLETED|Part B (Overall)||7
10140316|NCT02714569|11270411|FG008|COMPLETED|Part B (Overall)||8
10140317|NCT02714569|11270412|FG009|COMPLETED|Part B (Overall)||6
10140318|NCT02714569|11270413|FG010|COMPLETED|Part B (Overall)||8
10140319|NCT02714569|11270403|FG000|NOT COMPLETED|Part B (Overall)||0
10140320|NCT02714569|11270404|FG001|NOT COMPLETED|Part B (Overall)||0
10140321|NCT02714569|11270405|FG002|NOT COMPLETED|Part B (Overall)||0
10140322|NCT02714569|11270406|FG003|NOT COMPLETED|Part B (Overall)||0
10140323|NCT02714569|11270407|FG004|NOT COMPLETED|Part B (Overall)||0
10140324|NCT02714569|11270408|FG005|NOT COMPLETED|Part B (Overall)||0
10140325|NCT02714569|11270409|FG006|NOT COMPLETED|Part B (Overall)||1
10140326|NCT02714569|11270410|FG007|NOT COMPLETED|Part B (Overall)||1
10140327|NCT02714569|11270411|FG008|NOT COMPLETED|Part B (Overall)||0
10140328|NCT02714569|11270412|FG009|NOT COMPLETED|Part B (Overall)||2
10140329|NCT02714569|11270413|FG010|NOT COMPLETED|Part B (Overall)||0
10140330|NCT02714595|11270475|FG000|STARTED|Overall Study||101
10140331|NCT02714595|11270476|FG001|STARTED|Overall Study||51
10140332|NCT02714595|11270475|FG000|Received Treatment|Overall Study||101
10140333|NCT02714595|11270476|FG001|Received Treatment|Overall Study||49
10140334|NCT02714595|11270475|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
10140335|NCT02714595|11270476|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
10140336|NCT02714595|11270475|FG000|COMPLETED|Overall Study||69
10140337|NCT02714595|11270476|FG001|COMPLETED|Overall Study||38
10140338|NCT02714595|11270475|FG000|NOT COMPLETED|Overall Study||32
10140339|NCT02714595|11270476|FG001|NOT COMPLETED|Overall Study||13
10140340|NCT02714868|11270502|FG000|STARTED|Overall Study||47
10140341|NCT02714868|11270503|FG001|STARTED|Overall Study||35
10140342|NCT02714868|11270502|FG000|COMPLETED|Overall Study||42
10140343|NCT02714868|11270503|FG001|COMPLETED|Overall Study||35
10140344|NCT02714868|11270502|FG000|NOT COMPLETED|Overall Study||5
10140345|NCT02714868|11270503|FG001|NOT COMPLETED|Overall Study||0
10140346|NCT02715076|11270516|FG000|STARTED|Overall Study||48
10140347|NCT02715076|11270517|FG001|STARTED|Overall Study||50
10140348|NCT02715076|11270518|FG002|STARTED|Overall Study||49
10140349|NCT02715076|11270519|FG003|STARTED|Overall Study||50
10140350|NCT02715076|11270520|FG004|STARTED|Overall Study||47
10140351|NCT02715076|11270521|FG005|STARTED|Overall Study||48
10140352|NCT02715076|11270516|FG000|COMPLETED|Overall Study||48
10140353|NCT02715076|11270517|FG001|COMPLETED|Overall Study||50
10140354|NCT02715076|11270518|FG002|COMPLETED|Overall Study||49
10140355|NCT02715076|11270519|FG003|COMPLETED|Overall Study||50
10140356|NCT02715076|11270520|FG004|COMPLETED|Overall Study||47
10140357|NCT02715076|11270521|FG005|COMPLETED|Overall Study||48
10140358|NCT02715076|11270516|FG000|NOT COMPLETED|Overall Study||0
10140359|NCT02715076|11270517|FG001|NOT COMPLETED|Overall Study||0
10140360|NCT02715076|11270518|FG002|NOT COMPLETED|Overall Study||0
10140361|NCT02715076|11270519|FG003|NOT COMPLETED|Overall Study||0
10140362|NCT02715076|11270520|FG004|NOT COMPLETED|Overall Study||0
10140363|NCT02715076|11270521|FG005|NOT COMPLETED|Overall Study||0
10140364|NCT02715258|11270537|FG000|STARTED|Overall Study||140
10140365|NCT02715258|11270538|FG001|STARTED|Overall Study||70
10140366|NCT02715258|11270537|FG000|Intent to Treat/Safety Analysis|Overall Study||138
10140367|NCT02715258|11270538|FG001|Intent to Treat/Safety Analysis|Overall Study||69
10140368|NCT02715258|11270537|FG000|COMPLETED|Overall Study||124
10140369|NCT02715258|11270538|FG001|COMPLETED|Overall Study||64
10140370|NCT02715258|11270537|FG000|NOT COMPLETED|Overall Study||16
10140371|NCT02715258|11270538|FG001|NOT COMPLETED|Overall Study||6
10140372|NCT02715700|11270544|FG000|STARTED|Overall Study||14
10140373|NCT02715700|11270544|FG000|COMPLETED|Overall Study||14
10140374|NCT02715700|11270544|FG000|NOT COMPLETED|Overall Study||0
10140375|NCT02715726|11270554|FG000|STARTED|Overall Study|Randomized|208
10140376|NCT02715726|11270555|FG001|STARTED|Overall Study|Randomized|407
10140377|NCT02715726|11270554|FG000|Treated|Overall Study||207
10140378|NCT02715726|11270555|FG001|Treated|Overall Study||405
10140379|NCT02715726|11270554|FG000|Safety Population|Overall Study||206
10140380|NCT02715726|11270555|FG001|Safety Population|Overall Study||406
10140381|NCT02715726|11270554|FG000|COMPLETED|Overall Study||190
10140382|NCT02715726|11270555|FG001|COMPLETED|Overall Study||380
10140383|NCT02715726|11270554|FG000|NOT COMPLETED|Overall Study||18
10140384|NCT02715726|11270555|FG001|NOT COMPLETED|Overall Study||27
10140385|NCT02715804|11270563|FG000|STARTED|Overall Study||327
10140386|NCT02715804|11270564|FG001|STARTED|Overall Study||165
10140387|NCT02715804|11270563|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323
10140388|NCT02715804|11270564|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158
10140389|NCT02715804|11270563|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
10140390|NCT02715804|11270564|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
10140391|NCT02715804|11270563|FG000|COMPLETED|Overall Study||98
10140392|NCT02715804|11270564|FG001|COMPLETED|Overall Study||52
10140393|NCT02715804|11270563|FG000|NOT COMPLETED|Overall Study||229
10140394|NCT02715804|11270564|FG001|NOT COMPLETED|Overall Study||113
10140395|NCT02716194|11270573|FG000|STARTED|Period 1 - ADVATE||11
10140396|NCT02716194|11270574|FG001|STARTED|Period 1 - ADVATE||16
10140397|NCT02716194|11270575|FG002|STARTED|Period 1 - ADVATE||13
10140398|NCT02716194|11270573|FG000|COMPLETED|Period 1 - ADVATE||10
10140399|NCT02716194|11270574|FG001|COMPLETED|Period 1 - ADVATE||15
10140400|NCT02716194|11270575|FG002|COMPLETED|Period 1 - ADVATE||13
10140401|NCT02716194|11270573|FG000|NOT COMPLETED|Period 1 - ADVATE||1
10140402|NCT02716194|11270574|FG001|NOT COMPLETED|Period 1 - ADVATE||1
10140403|NCT02716194|11270575|FG002|NOT COMPLETED|Period 1 - ADVATE||0
10140404|NCT02716194|11270573|FG000|STARTED|Period 2 - BAX 826||10
10140405|NCT02716194|11270574|FG001|STARTED|Period 2 - BAX 826||15
10140406|NCT02716194|11270575|FG002|STARTED|Period 2 - BAX 826||13
10140407|NCT02716194|11270573|FG000|COMPLETED|Period 2 - BAX 826||10
10140408|NCT02716194|11270574|FG001|COMPLETED|Period 2 - BAX 826||15
10140409|NCT02716194|11270575|FG002|COMPLETED|Period 2 - BAX 826||13
10140410|NCT02716194|11270573|FG000|NOT COMPLETED|Period 2 - BAX 826||0
10140411|NCT02716194|11270574|FG001|NOT COMPLETED|Period 2 - BAX 826||0
10140412|NCT02716194|11270575|FG002|NOT COMPLETED|Period 2 - BAX 826||0
10140413|NCT02716298|11270596|FG000|STARTED|First Intervention (1 Month)||25
10140414|NCT02716298|11270597|FG001|STARTED|First Intervention (1 Month)||24
10140415|NCT02716298|11270596|FG000|COMPLETED|First Intervention (1 Month)||24
10140416|NCT02716298|11270597|FG001|COMPLETED|First Intervention (1 Month)||23
10140417|NCT02716298|11270596|FG000|NOT COMPLETED|First Intervention (1 Month)||1
10140418|NCT02716298|11270597|FG001|NOT COMPLETED|First Intervention (1 Month)||1
10140419|NCT02716298|11270596|FG000|STARTED|Second Intervention (1 Month)||24
10140420|NCT02716298|11270597|FG001|STARTED|Second Intervention (1 Month)||23
10140421|NCT02716298|11270596|FG000|COMPLETED|Second Intervention (1 Month)||24
10140422|NCT02716298|11270597|FG001|COMPLETED|Second Intervention (1 Month)||23
10140423|NCT02716298|11270596|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
10140424|NCT02716298|11270597|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
10140425|NCT02716324|11270610|FG000|STARTED|Overall Study||149
10140426|NCT02716324|11270611|FG001|STARTED|Overall Study||154
10140427|NCT02716324|11270610|FG000|COMPLETED|Overall Study||130
10140428|NCT02716324|11270611|FG001|COMPLETED|Overall Study||143
10140429|NCT02716324|11270610|FG000|NOT COMPLETED|Overall Study||19
10140430|NCT02716324|11270611|FG001|NOT COMPLETED|Overall Study||11
10140431|NCT02716506|11270617|FG000|STARTED|Overall Study||3515
10140432|NCT02716506|11270617|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
10140433|NCT02716506|11270617|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
10140434|NCT02716506|11270617|FG000|COMPLETED|Overall Study||2351
10140435|NCT02716506|11270617|FG000|NOT COMPLETED|Overall Study||1164
10140436|NCT02716584|11270623|FG000|STARTED|Overall Study||35
10140437|NCT02716584|11270624|FG001|STARTED|Overall Study||18
10140438|NCT02716584|11270623|FG000|COMPLETED|Overall Study||27
10140439|NCT02716584|11270624|FG001|COMPLETED|Overall Study||13
10140440|NCT02716584|11270623|FG000|NOT COMPLETED|Overall Study||8
10140441|NCT02716584|11270624|FG001|NOT COMPLETED|Overall Study||5
10140442|NCT02716714|11270632|FG000|STARTED|Overall Study||67
10140443|NCT02716714|11270633|FG001|STARTED|Overall Study||10
10140444|NCT02716714|11270632|FG000|COMPLETED|Overall Study||55
10140445|NCT02716714|11270633|FG001|COMPLETED|Overall Study||8
10140446|NCT02716714|11270632|FG000|NOT COMPLETED|Overall Study||12
10140447|NCT02716714|11270633|FG001|NOT COMPLETED|Overall Study||2
10140448|NCT02716727|11270645|FG000|STARTED|Overall Study||7
10140449|NCT02716727|11270646|FG001|STARTED|Overall Study||9
10140450|NCT02716727|11270645|FG000|COMPLETED|Overall Study||7
10140451|NCT02716727|11270646|FG001|COMPLETED|Overall Study||9
10140452|NCT02716727|11270645|FG000|NOT COMPLETED|Overall Study||0
10140453|NCT02716727|11270646|FG001|NOT COMPLETED|Overall Study||0
10140454|NCT02716779|11270655|FG000|STARTED|Monotherapy||14
10140455|NCT02716779|11270656|FG001|STARTED|Monotherapy||26
10140456|NCT02716779|11270657|FG002|STARTED|Monotherapy||27
10140457|NCT02716779|11270655|FG000|COMPLETED|Monotherapy||14
10140458|NCT02716779|11270656|FG001|COMPLETED|Monotherapy||25
10140459|NCT02716779|11270657|FG002|COMPLETED|Monotherapy||26
10140460|NCT02716779|11270655|FG000|NOT COMPLETED|Monotherapy||0
10140461|NCT02716779|11270656|FG001|NOT COMPLETED|Monotherapy||1
10140462|NCT02716779|11270657|FG002|NOT COMPLETED|Monotherapy||1
10140463|NCT02716779|11270655|FG000|STARTED|Combination Therapy||14
10140464|NCT02716779|11270656|FG001|STARTED|Combination Therapy||25
10140465|NCT02716779|11270657|FG002|STARTED|Combination Therapy||26
10140466|NCT02716779|11270655|FG000|COMPLETED|Combination Therapy||14
10140467|NCT02716779|11270656|FG001|COMPLETED|Combination Therapy||23
10140468|NCT02716779|11270657|FG002|COMPLETED|Combination Therapy||25
10140469|NCT02716779|11270655|FG000|NOT COMPLETED|Combination Therapy||0
10140470|NCT02716779|11270656|FG001|NOT COMPLETED|Combination Therapy||2
10140471|NCT02716779|11270657|FG002|NOT COMPLETED|Combination Therapy||1
10196655|NCT03364309|11324833|FG016|COMPLETED|Induction Period||0
10196656|NCT03364309|11324834|FG017|COMPLETED|Induction Period||0
10196657|NCT03364309|11324835|FG018|COMPLETED|Induction Period||0
10196658|NCT03364309|11324817|FG000|NOT COMPLETED|Induction Period||6
10196659|NCT03364309|11324818|FG001|NOT COMPLETED|Induction Period||4
10196660|NCT03364309|11324819|FG002|NOT COMPLETED|Induction Period||1
10196661|NCT03364309|11324820|FG003|NOT COMPLETED|Induction Period||0
10196662|NCT03364309|11324821|FG004|NOT COMPLETED|Induction Period||0
10196663|NCT03364309|11324822|FG005|NOT COMPLETED|Induction Period||0
10196664|NCT03364309|11324823|FG006|NOT COMPLETED|Induction Period||0
10196665|NCT03364309|11324824|FG007|NOT COMPLETED|Induction Period||0
10196666|NCT03364309|11324825|FG008|NOT COMPLETED|Induction Period||0
10196667|NCT03364309|11324826|FG009|NOT COMPLETED|Induction Period||0
10196668|NCT03364309|11324827|FG010|NOT COMPLETED|Induction Period||0
10196669|NCT03364309|11324828|FG011|NOT COMPLETED|Induction Period||0
10196670|NCT03364309|11324829|FG012|NOT COMPLETED|Induction Period||0
10196671|NCT03364309|11324830|FG013|NOT COMPLETED|Induction Period||0
10196672|NCT03364309|11324831|FG014|NOT COMPLETED|Induction Period||0
10196673|NCT03364309|11324832|FG015|NOT COMPLETED|Induction Period||0
10196674|NCT03364309|11324833|FG016|NOT COMPLETED|Induction Period||0
10196675|NCT03364309|11324834|FG017|NOT COMPLETED|Induction Period||0
10196676|NCT03364309|11324835|FG018|NOT COMPLETED|Induction Period||0
10196677|NCT03364309|11324817|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
10196678|NCT03364309|11324818|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
10196679|NCT03364309|11324819|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
10140472|NCT02716805|11270671|FG000|STARTED|Overall Study||6
10140473|NCT02716805|11270672|FG001|STARTED|Overall Study||0
10140474|NCT02716805|11270673|FG002|STARTED|Overall Study||0
10140475|NCT02716805|11270674|FG003|STARTED|Overall Study||0
10140476|NCT02716805|11270671|FG000|COMPLETED|Overall Study||4
10140477|NCT02716805|11270672|FG001|COMPLETED|Overall Study||0
10140478|NCT02716805|11270673|FG002|COMPLETED|Overall Study||0
10140479|NCT02716805|11270674|FG003|COMPLETED|Overall Study||0
10140480|NCT02716805|11270671|FG000|NOT COMPLETED|Overall Study||2
10140481|NCT02716805|11270672|FG001|NOT COMPLETED|Overall Study||0
10140482|NCT02716805|11270673|FG002|NOT COMPLETED|Overall Study||0
10140483|NCT02716805|11270674|FG003|NOT COMPLETED|Overall Study||0
10140484|NCT02716818|11270680|FG000|STARTED|Overall Study||61
10140485|NCT02716818|11270681|FG001|STARTED|Overall Study||61
10140486|NCT02716818|11270680|FG000|COMPLETED|Overall Study||58
10140487|NCT02716818|11270681|FG001|COMPLETED|Overall Study||59
10140488|NCT02716818|11270680|FG000|NOT COMPLETED|Overall Study||3
10140489|NCT02716818|11270681|FG001|NOT COMPLETED|Overall Study||2
10140490|NCT02716896|11270711|FG000|STARTED|Overall Study||1
10140491|NCT02716896|11270712|FG001|STARTED|Overall Study||1
10140492|NCT02716896|11270711|FG000|COMPLETED|Overall Study||1
10140493|NCT02716896|11270712|FG001|COMPLETED|Overall Study||0
10140494|NCT02716896|11270711|FG000|NOT COMPLETED|Overall Study||0
10140495|NCT02716896|11270712|FG001|NOT COMPLETED|Overall Study||1
10140496|NCT02716987|11270724|FG000|STARTED|Overall Study||4
10140497|NCT02716987|11270725|FG001|STARTED|Overall Study||2
10140498|NCT02716987|11270726|FG002|STARTED|Overall Study||5
10140499|NCT02716987|11270727|FG003|STARTED|Overall Study||2
10140500|NCT02716987|11270728|FG004|STARTED|Overall Study||6
10140501|NCT02716987|11270729|FG005|STARTED|Overall Study||1
10140502|NCT02716987|11270724|FG000|COMPLETED|Overall Study||4
10140503|NCT02716987|11270725|FG001|COMPLETED|Overall Study||2
10140504|NCT02716987|11270726|FG002|COMPLETED|Overall Study||4
10140505|NCT02716987|11270727|FG003|COMPLETED|Overall Study||2
10140506|NCT02716987|11270728|FG004|COMPLETED|Overall Study||5
10140507|NCT02716987|11270729|FG005|COMPLETED|Overall Study||0
10140508|NCT02716987|11270724|FG000|NOT COMPLETED|Overall Study||0
10140509|NCT02716987|11270725|FG001|NOT COMPLETED|Overall Study||0
10140510|NCT02716987|11270726|FG002|NOT COMPLETED|Overall Study||1
10140511|NCT02716987|11270727|FG003|NOT COMPLETED|Overall Study||0
10140512|NCT02716987|11270728|FG004|NOT COMPLETED|Overall Study||1
10140513|NCT02716987|11270729|FG005|NOT COMPLETED|Overall Study||1
10140514|NCT02717195|11270758|FG000|STARTED|Prospective Confirmation (PC) Period||711
10140515|NCT02717195|11270759|FG001|STARTED|Prospective Confirmation (PC) Period||387
10140516|NCT02717195|11270760|FG002|STARTED|Prospective Confirmation (PC) Period||0
10140517|NCT02717195|11270761|FG003|STARTED|Prospective Confirmation (PC) Period||0
10140518|NCT02717195|11270762|FG004|STARTED|Prospective Confirmation (PC) Period||0
10140519|NCT02717195|11270758|FG000|COMPLETED|Prospective Confirmation (PC) Period||421
10140520|NCT02717195|11270759|FG001|COMPLETED|Prospective Confirmation (PC) Period||276
10140521|NCT02717195|11270760|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
10140522|NCT02717195|11270761|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
10140523|NCT02717195|11270762|FG004|COMPLETED|Prospective Confirmation (PC) Period||0
10140524|NCT02717195|11270758|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290
10140525|NCT02717195|11270759|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111
10140526|NCT02717195|11270760|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10140527|NCT02717195|11270761|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10140528|NCT02717195|11270762|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10140529|NCT02717195|11270758|FG000|STARTED|Double-blind Treatment (DBT) Period||0
10140530|NCT02717195|11270759|FG001|STARTED|Double-blind Treatment (DBT) Period||0
10140531|NCT02717195|11270760|FG002|STARTED|Double-blind Treatment (DBT) Period||235
10140532|NCT02717195|11270761|FG003|STARTED|Double-blind Treatment (DBT) Period||232
10140533|NCT02717195|11270762|FG004|STARTED|Double-blind Treatment (DBT) Period||230
10140534|NCT02717195|11270758|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0
10140535|NCT02717195|11270759|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0
10140536|NCT02717195|11270760|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198
10140537|NCT02717195|11270761|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188
10140538|NCT02717195|11270762|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200
10140539|NCT02717195|11270758|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
10140540|NCT02717195|11270759|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
10140541|NCT02717195|11270760|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
10140542|NCT02717195|11270761|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
10140543|NCT02717195|11270762|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
10140544|NCT02717273|11270777|FG000|STARTED|Overall Study||52
10140545|NCT02717273|11270778|FG001|STARTED|Overall Study||50
10140546|NCT02717273|11270777|FG000|COMPLETED|Overall Study||49
10140547|NCT02717273|11270778|FG001|COMPLETED|Overall Study||48
10140548|NCT02717273|11270777|FG000|NOT COMPLETED|Overall Study||3
10140549|NCT02717273|11270778|FG001|NOT COMPLETED|Overall Study||2
10140550|NCT02717494|11270787|FG000|STARTED|First Intervention (Step 1)||115
10140551|NCT02717494|11270788|FG001|STARTED|First Intervention (Step 1)||115
10140552|NCT02717494|11270789|FG002|STARTED|First Intervention (Step 1)||116
10140553|NCT02717494|11270787|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
10140554|NCT02717494|11270788|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
10140555|NCT02717494|11270789|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
10140556|NCT02717494|11270787|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
10140557|NCT02717494|11270788|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
10140558|NCT02717494|11270789|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
10140559|NCT02717494|11270787|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
10140560|NCT02717494|11270788|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
10140561|NCT02717494|11270789|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
10140562|NCT02717494|11270787|FG000|COMPLETED|First Intervention (Step 1)||109
10140563|NCT02717494|11270788|FG001|COMPLETED|First Intervention (Step 1)||108
10140564|NCT02717494|11270789|FG002|COMPLETED|First Intervention (Step 1)||111
10140565|NCT02717494|11270787|FG000|NOT COMPLETED|First Intervention (Step 1)||6
10140566|NCT02717494|11270788|FG001|NOT COMPLETED|First Intervention (Step 1)||7
10140567|NCT02717494|11270789|FG002|NOT COMPLETED|First Intervention (Step 1)||5
10140568|NCT02717494|11270787|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
10140569|NCT02717494|11270788|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
10140570|NCT02717494|11270789|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
10140571|NCT02717494|11270787|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
10140572|NCT02717494|11270788|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
10140573|NCT02717494|11270789|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
10140574|NCT02717494|11270787|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
10140575|NCT02717494|11270788|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
10140576|NCT02717494|11270789|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
10140577|NCT02717494|11270787|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
10140578|NCT02717494|11270788|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
10140579|NCT02717494|11270789|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
10140580|NCT02717494|11270787|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0
10140581|NCT02717494|11270788|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0
10140582|NCT02717494|11270789|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106
9707325|NCT05096312|10806527|FG000|STARTED|Overall Study||11
9707326|NCT05096312|10806528|FG001|STARTED|Overall Study||12
9707327|NCT05096312|10806527|FG000|COMPLETED|Overall Study||8
9707328|NCT05096312|10806528|FG001|COMPLETED|Overall Study||8
9707329|NCT05096312|10806527|FG000|NOT COMPLETED|Overall Study||3
9707330|NCT05096312|10806528|FG001|NOT COMPLETED|Overall Study||4
9707331|NCT02853344|10806536|FG000|STARTED|Overall Study||110
9707332|NCT02853344|10806537|FG001|STARTED|Overall Study||165
9707333|NCT02853344|10806536|FG000|COMPLETED|Overall Study||0
9707334|NCT02853344|10806537|FG001|COMPLETED|Overall Study||0
9707335|NCT02853344|10806536|FG000|NOT COMPLETED|Overall Study||110
9707336|NCT02853344|10806537|FG001|NOT COMPLETED|Overall Study||165
9707337|NCT03560258|10806548|FG000|STARTED|Overall Study||22
9707338|NCT03560258|10806549|FG001|STARTED|Overall Study||11
9707339|NCT03560258|10806550|FG002|STARTED|Overall Study||12
9707340|NCT03560258|10806548|FG000|Received at Least 1 Dose of Treatment|Overall Study||22
9707341|NCT03560258|10806549|FG001|Received at Least 1 Dose of Treatment|Overall Study||10
9707342|NCT03560258|10806550|FG002|Received at Least 1 Dose of Treatment|Overall Study||12
9707343|NCT03560258|10806548|FG000|COMPLETED|Overall Study||19
9707344|NCT03560258|10806549|FG001|COMPLETED|Overall Study||10
9707345|NCT03560258|10806550|FG002|COMPLETED|Overall Study||11
9707346|NCT03560258|10806548|FG000|NOT COMPLETED|Overall Study||3
9707347|NCT03560258|10806549|FG001|NOT COMPLETED|Overall Study||1
9707348|NCT03560258|10806550|FG002|NOT COMPLETED|Overall Study||1
9707349|NCT03684304|10806560|FG000|STARTED|Overall Study||19
9707350|NCT03684304|10806561|FG001|STARTED|Overall Study||17
9707351|NCT03684304|10806560|FG000|COMPLETED|Overall Study||0
9707352|NCT03684304|10806561|FG001|COMPLETED|Overall Study||0
9707353|NCT03684304|10806560|FG000|NOT COMPLETED|Overall Study||19
9707354|NCT03684304|10806561|FG001|NOT COMPLETED|Overall Study||17
9707355|NCT03275168|10806569|FG000|STARTED|Overall Study||34
9707356|NCT03275168|10806570|FG001|STARTED|Overall Study||34
9707357|NCT03275168|10806569|FG000|COMPLETED|Overall Study||27
9707358|NCT03275168|10806570|FG001|COMPLETED|Overall Study||25
9707359|NCT03275168|10806569|FG000|NOT COMPLETED|Overall Study||7
9707360|NCT03275168|10806570|FG001|NOT COMPLETED|Overall Study||9
9707361|NCT04528641|10806582|FG000|STARTED|Overall Study||15
9707362|NCT04528641|10806583|FG001|STARTED|Overall Study||15
10140583|NCT02717494|11270787|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
10140584|NCT02717494|11270788|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
10140585|NCT02717494|11270789|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
9707363|NCT04528641|10806584|FG002|STARTED|Overall Study||15
9707364|NCT04528641|10806585|FG003|STARTED|Overall Study||16
9707365|NCT04528641|10806586|FG004|STARTED|Overall Study||15
9707366|NCT04528641|10806587|FG005|STARTED|Overall Study||15
9707367|NCT04528641|10806582|FG000|COMPLETED|Overall Study||15
9707368|NCT04528641|10806583|FG001|COMPLETED|Overall Study||15
9707369|NCT04528641|10806584|FG002|COMPLETED|Overall Study||15
9707370|NCT04528641|10806585|FG003|COMPLETED|Overall Study||15
9707371|NCT04528641|10806586|FG004|COMPLETED|Overall Study||15
9707372|NCT04528641|10806587|FG005|COMPLETED|Overall Study||14
9707373|NCT04528641|10806582|FG000|NOT COMPLETED|Overall Study||0
9707374|NCT04528641|10806583|FG001|NOT COMPLETED|Overall Study||0
9707375|NCT04528641|10806584|FG002|NOT COMPLETED|Overall Study||0
9707376|NCT04528641|10806585|FG003|NOT COMPLETED|Overall Study||1
9707377|NCT04528641|10806586|FG004|NOT COMPLETED|Overall Study||0
9707378|NCT04528641|10806587|FG005|NOT COMPLETED|Overall Study||1
9707379|NCT04497883|10806606|FG000|STARTED|Treatment Period 1 (2 Days)||12
9707380|NCT04497883|10806607|FG001|STARTED|Treatment Period 1 (2 Days)||12
9707381|NCT04497883|10806608|FG002|STARTED|Treatment Period 1 (2 Days)||0
9707382|NCT04497883|10806609|FG003|STARTED|Treatment Period 1 (2 Days)||0
9707383|NCT04497883|10806606|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
9707384|NCT04497883|10806607|FG001|COMPLETED|Treatment Period 1 (2 Days)||12
9707385|NCT04497883|10806608|FG002|COMPLETED|Treatment Period 1 (2 Days)||0
9707386|NCT04497883|10806609|FG003|COMPLETED|Treatment Period 1 (2 Days)||0
9707387|NCT04497883|10806606|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9707388|NCT04497883|10806607|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9707389|NCT04497883|10806608|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9707390|NCT04497883|10806609|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9707391|NCT04497883|10806606|FG000|STARTED|Washout Period 1 (72 Hours)||12
9707392|NCT04497883|10806607|FG001|STARTED|Washout Period 1 (72 Hours)||12
9707393|NCT04497883|10806608|FG002|STARTED|Washout Period 1 (72 Hours)||0
9707394|NCT04497883|10806609|FG003|STARTED|Washout Period 1 (72 Hours)||0
9707395|NCT04497883|10806606|FG000|COMPLETED|Washout Period 1 (72 Hours)||12
9707396|NCT04497883|10806607|FG001|COMPLETED|Washout Period 1 (72 Hours)||12
9707397|NCT04497883|10806608|FG002|COMPLETED|Washout Period 1 (72 Hours)||0
9707398|NCT04497883|10806609|FG003|COMPLETED|Washout Period 1 (72 Hours)||0
9707399|NCT04497883|10806606|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0
9707400|NCT04497883|10806607|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0
9707401|NCT04497883|10806608|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0
9707402|NCT04497883|10806609|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0
9707403|NCT04497883|10806606|FG000|STARTED|Treatment Period 2 (2 Days)||0
9707404|NCT04497883|10806607|FG001|STARTED|Treatment Period 2 (2 Days)||0
9707405|NCT04497883|10806608|FG002|STARTED|Treatment Period 2 (2 Days)||6
9707406|NCT04497883|10806609|FG003|STARTED|Treatment Period 2 (2 Days)||6
9707407|NCT04497883|10806606|FG000|COMPLETED|Treatment Period 2 (2 Days)||0
9707408|NCT04497883|10806607|FG001|COMPLETED|Treatment Period 2 (2 Days)||0
9707409|NCT04497883|10806608|FG002|COMPLETED|Treatment Period 2 (2 Days)||6
9707410|NCT04497883|10806609|FG003|COMPLETED|Treatment Period 2 (2 Days)||6
9707411|NCT04497883|10806606|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9707412|NCT04497883|10806607|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9707413|NCT04497883|10806608|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9707414|NCT04497883|10806609|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9707415|NCT04497883|10806606|FG000|STARTED|Washout Period 2 (72 Hours)||0
9707416|NCT04497883|10806607|FG001|STARTED|Washout Period 2 (72 Hours)||0
9707417|NCT04497883|10806608|FG002|STARTED|Washout Period 2 (72 Hours)||6
9707418|NCT04497883|10806609|FG003|STARTED|Washout Period 2 (72 Hours)||6
9707419|NCT04497883|10806606|FG000|COMPLETED|Washout Period 2 (72 Hours)||0
9707420|NCT04497883|10806607|FG001|COMPLETED|Washout Period 2 (72 Hours)||0
9707421|NCT04497883|10806608|FG002|COMPLETED|Washout Period 2 (72 Hours)||6
9707422|NCT04497883|10806609|FG003|COMPLETED|Washout Period 2 (72 Hours)||6
9707423|NCT04497883|10806606|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0
9707424|NCT04497883|10806607|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0
9707425|NCT04497883|10806608|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0
9707426|NCT04497883|10806609|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0
9707427|NCT04497883|10806606|FG000|STARTED|Treatment Period 3 (2 Days)||0
9707428|NCT04497883|10806607|FG001|STARTED|Treatment Period 3 (2 Days)||0
9707429|NCT04497883|10806608|FG002|STARTED|Treatment Period 3 (2 Days)||6
9707430|NCT04497883|10806609|FG003|STARTED|Treatment Period 3 (2 Days)||6
9707431|NCT04497883|10806606|FG000|COMPLETED|Treatment Period 3 (2 Days)||0
9707432|NCT04497883|10806607|FG001|COMPLETED|Treatment Period 3 (2 Days)||0
9707433|NCT04497883|10806608|FG002|COMPLETED|Treatment Period 3 (2 Days)||6
9707434|NCT04497883|10806609|FG003|COMPLETED|Treatment Period 3 (2 Days)||6
9707435|NCT04497883|10806606|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9707436|NCT04497883|10806607|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9707437|NCT04497883|10806608|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9707438|NCT04497883|10806609|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9707439|NCT04034238|10806623|FG000|STARTED|Dose Escalation Phase||7
9707440|NCT04034238|10806624|FG001|STARTED|Dose Escalation Phase||3
10140586|NCT02717546|11270815|FG000|STARTED|Overall Study||32
10140587|NCT02717546|11270815|FG000|COMPLETED|Overall Study||20
10140588|NCT02717546|11270815|FG000|NOT COMPLETED|Overall Study||12
10140589|NCT02717754|11270825|FG000|STARTED|Overall Study||10
10140590|NCT02717754|11270826|FG001|STARTED|Overall Study||19
10140591|NCT02717754|11270827|FG002|STARTED|Overall Study||20
10140592|NCT02717754|11270828|FG003|STARTED|Overall Study||10
10140593|NCT02717754|11270829|FG004|STARTED|Overall Study||20
10140594|NCT02717754|11270830|FG005|STARTED|Overall Study||20
10140595|NCT02717754|11270825|FG000|COMPLETED|Overall Study||10
10140596|NCT02717754|11270826|FG001|COMPLETED|Overall Study||19
10140597|NCT02717754|11270827|FG002|COMPLETED|Overall Study||20
10140598|NCT02717754|11270828|FG003|COMPLETED|Overall Study||0
10140599|NCT02717754|11270829|FG004|COMPLETED|Overall Study||0
10140600|NCT02717754|11270830|FG005|COMPLETED|Overall Study||0
10140601|NCT02717754|11270825|FG000|NOT COMPLETED|Overall Study||0
10140602|NCT02717754|11270826|FG001|NOT COMPLETED|Overall Study||0
10140603|NCT02717754|11270827|FG002|NOT COMPLETED|Overall Study||0
10140604|NCT02717754|11270828|FG003|NOT COMPLETED|Overall Study||10
10140605|NCT02717754|11270829|FG004|NOT COMPLETED|Overall Study||20
10140606|NCT02717754|11270830|FG005|NOT COMPLETED|Overall Study||20
10140607|NCT02718040|11270840|FG000|STARTED|Overall Study||30
10140608|NCT02718040|11270840|FG000|COMPLETED|Overall Study||30
10140609|NCT02718040|11270840|FG000|NOT COMPLETED|Overall Study||0
10140610|NCT02718118|11270846|FG000|STARTED|Overall Study||30
10140611|NCT02718118|11270847|FG001|STARTED|Overall Study||30
10140612|NCT02718118|11270846|FG000|COMPLETED|Overall Study||28
10140613|NCT02718118|11270847|FG001|COMPLETED|Overall Study||29
10140614|NCT02718118|11270846|FG000|NOT COMPLETED|Overall Study||2
10140615|NCT02718118|11270847|FG001|NOT COMPLETED|Overall Study||1
10140616|NCT02718131|11270855|FG000|STARTED|Overall Study||5
10140617|NCT02718131|11270856|FG001|STARTED|Overall Study||0
10140618|NCT02718131|11270855|FG000|Completed 12 Months|Overall Study||2
10140619|NCT02718131|11270856|FG001|Completed 12 Months|Overall Study||0
10140620|NCT02718131|11270855|FG000|COMPLETED|Overall Study||2
10140621|NCT02718131|11270856|FG001|COMPLETED|Overall Study||0
10140622|NCT02718131|11270855|FG000|NOT COMPLETED|Overall Study||3
10140623|NCT02718131|11270856|FG001|NOT COMPLETED|Overall Study||0
10140624|NCT02718157|11270864|FG000|STARTED|Overall Study||771
10140625|NCT02718157|11270864|FG000|COMPLETED|Overall Study||609
10140626|NCT02718157|11270864|FG000|NOT COMPLETED|Overall Study||162
10140627|NCT02718248|11270868|FG000|STARTED|Overall Study||7
10140628|NCT02718248|11270868|FG000|COMPLETED|Overall Study||7
10140629|NCT02718248|11270868|FG000|NOT COMPLETED|Overall Study||0
10140630|NCT02718326|11270875|FG000|STARTED|Overall Study||133
10140631|NCT02718326|11270876|FG001|STARTED|Overall Study||135
10140632|NCT02718326|11270877|FG002|STARTED|Overall Study||134
10140633|NCT02718326|11270875|FG000|Completed Week 52|Overall Study||109
10140634|NCT02718326|11270876|FG001|Completed Week 52|Overall Study||122
10140635|NCT02718326|11270877|FG002|Completed Week 52|Overall Study||124
10140636|NCT02718326|11270875|FG000|COMPLETED|Overall Study||97
10140637|NCT02718326|11270876|FG001|COMPLETED|Overall Study||111
10140638|NCT02718326|11270877|FG002|COMPLETED|Overall Study||112
10140639|NCT02718326|11270875|FG000|NOT COMPLETED|Overall Study||36
10140640|NCT02718326|11270876|FG001|NOT COMPLETED|Overall Study||24
10140641|NCT02718326|11270877|FG002|NOT COMPLETED|Overall Study||22
10140642|NCT02718417|11270890|FG000|STARTED|Chemotherapy Phase (CP)||332
10140643|NCT02718417|11270891|FG001|STARTED|Chemotherapy Phase (CP)||331
10140644|NCT02718417|11270892|FG002|STARTED|Chemotherapy Phase (CP)||335
10140645|NCT02718417|11270890|FG000|Safety Population|Chemotherapy Phase (CP)||328
10140646|NCT02718417|11270891|FG001|Safety Population|Chemotherapy Phase (CP)||329
10140647|NCT02718417|11270892|FG002|Safety Population|Chemotherapy Phase (CP)||334
10140648|NCT02718417|11270890|FG000|COMPLETED|Chemotherapy Phase (CP)||280
10140649|NCT02718417|11270891|FG001|COMPLETED|Chemotherapy Phase (CP)||294
10140650|NCT02718417|11270892|FG002|COMPLETED|Chemotherapy Phase (CP)||289
10140651|NCT02718417|11270890|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52
10140652|NCT02718417|11270891|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37
10140653|NCT02718417|11270892|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46
10140654|NCT02718417|11270890|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
10140655|NCT02718417|11270891|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
10140656|NCT02718417|11270892|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
10140657|NCT02718417|11270890|FG000|COMPLETED|Maintenance Phase (MP)||1
10140658|NCT02718417|11270891|FG001|COMPLETED|Maintenance Phase (MP)||1
10140659|NCT02718417|11270892|FG002|COMPLETED|Maintenance Phase (MP)||0
10140660|NCT02718417|11270890|FG000|NOT COMPLETED|Maintenance Phase (MP)||266
10140661|NCT02718417|11270891|FG001|NOT COMPLETED|Maintenance Phase (MP)||287
10140662|NCT02718417|11270892|FG002|NOT COMPLETED|Maintenance Phase (MP)||0
10140663|NCT02718417|11270890|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
9848865|NCT00862745|10961722|FG000|NOT COMPLETED|Open-label Follow-up||39
9848866|NCT00862745|10961723|FG001|NOT COMPLETED|Open-label Follow-up||49
9848867|NCT00862784|10961729|FG000|STARTED|Overall Study||48
9848868|NCT00862784|10961729|FG000|Received Any Amount of Study Drug|Overall Study||48
10140664|NCT02718417|11270891|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
10140665|NCT02718417|11270892|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
10140666|NCT02718417|11270890|FG000|COMPLETED|Observation Phase (OP)||0
10140667|NCT02718417|11270891|FG001|COMPLETED|Observation Phase (OP)||0
10140668|NCT02718417|11270892|FG002|COMPLETED|Observation Phase (OP)||2
10140669|NCT02718417|11270890|FG000|NOT COMPLETED|Observation Phase (OP)||0
10140670|NCT02718417|11270891|FG001|NOT COMPLETED|Observation Phase (OP)||0
10140671|NCT02718417|11270892|FG002|NOT COMPLETED|Observation Phase (OP)||282
10140672|NCT02718417|11270890|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
10140673|NCT02718417|11270891|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
10140674|NCT02718417|11270892|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
10140675|NCT02718417|11270890|FG000|COMPLETED|Follow-up Phase||103
10140676|NCT02718417|11270891|FG001|COMPLETED|Follow-up Phase||91
10140677|NCT02718417|11270892|FG002|COMPLETED|Follow-up Phase||20
10140678|NCT02718417|11270890|FG000|NOT COMPLETED|Follow-up Phase||135
10140679|NCT02718417|11270891|FG001|NOT COMPLETED|Follow-up Phase||172
10140680|NCT02718417|11270892|FG002|NOT COMPLETED|Follow-up Phase||19
10140681|NCT02718417|11270890|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
10140682|NCT02718417|11270891|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
10140683|NCT02718417|11270892|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
10140684|NCT02718417|11270890|FG000|COMPLETED|Long-term Follow-up Phase||0
10140685|NCT02718417|11270891|FG001|COMPLETED|Long-term Follow-up Phase||0
10140686|NCT02718417|11270892|FG002|COMPLETED|Long-term Follow-up Phase||0
10140687|NCT02718417|11270890|FG000|NOT COMPLETED|Long-term Follow-up Phase||139
10140688|NCT02718417|11270891|FG001|NOT COMPLETED|Long-term Follow-up Phase||112
10140689|NCT02718417|11270892|FG002|NOT COMPLETED|Long-term Follow-up Phase||135
10140690|NCT02718625|11270909|FG000|STARTED|Overall Study||1
10140691|NCT02718625|11270910|FG001|STARTED|Overall Study||2
10140692|NCT02718625|11270909|FG000|COMPLETED|Overall Study||1
10140693|NCT02718625|11270910|FG001|COMPLETED|Overall Study||0
10140694|NCT02718625|11270909|FG000|NOT COMPLETED|Overall Study||0
10140695|NCT02718625|11270910|FG001|NOT COMPLETED|Overall Study||2
10140696|NCT02718898|11270918|FG000|STARTED|Blinded Treatment Period||74
10140697|NCT02718898|11270919|FG001|STARTED|Blinded Treatment Period||75
10140698|NCT02718898|11270920|FG002|STARTED|Blinded Treatment Period||0
10140699|NCT02718898|11270921|FG003|STARTED|Blinded Treatment Period||0
10140700|NCT02718898|11270922|FG004|STARTED|Blinded Treatment Period||0
10140701|NCT02718898|11270923|FG005|STARTED|Blinded Treatment Period||0
10140702|NCT02718898|11270924|FG006|STARTED|Blinded Treatment Period||0
10140703|NCT02718898|11270918|FG000|COMPLETED|Blinded Treatment Period||65
10140704|NCT02718898|11270919|FG001|COMPLETED|Blinded Treatment Period||74
10140705|NCT02718898|11270920|FG002|COMPLETED|Blinded Treatment Period||0
10140706|NCT02718898|11270921|FG003|COMPLETED|Blinded Treatment Period||0
10140707|NCT02718898|11270922|FG004|COMPLETED|Blinded Treatment Period||0
10140708|NCT02718898|11270923|FG005|COMPLETED|Blinded Treatment Period||0
10140709|NCT02718898|11270924|FG006|COMPLETED|Blinded Treatment Period||0
10140710|NCT02718898|11270918|FG000|NOT COMPLETED|Blinded Treatment Period||9
10140711|NCT02718898|11270919|FG001|NOT COMPLETED|Blinded Treatment Period||1
10140712|NCT02718898|11270920|FG002|NOT COMPLETED|Blinded Treatment Period||0
10140713|NCT02718898|11270921|FG003|NOT COMPLETED|Blinded Treatment Period||0
10140714|NCT02718898|11270922|FG004|NOT COMPLETED|Blinded Treatment Period||0
10140715|NCT02718898|11270923|FG005|NOT COMPLETED|Blinded Treatment Period||0
10140716|NCT02718898|11270924|FG006|NOT COMPLETED|Blinded Treatment Period||0
10140717|NCT02718898|11270918|FG000|STARTED|Open Label Treatment Period (OLTP)||0
10140718|NCT02718898|11270919|FG001|STARTED|Open Label Treatment Period (OLTP)||0
10140719|NCT02718898|11270920|FG002|STARTED|Open Label Treatment Period (OLTP)||65
10140720|NCT02718898|11270921|FG003|STARTED|Open Label Treatment Period (OLTP)||74
10140721|NCT02718898|11270922|FG004|STARTED|Open Label Treatment Period (OLTP)||0
10140722|NCT02718898|11270923|FG005|STARTED|Open Label Treatment Period (OLTP)||0
10140723|NCT02718898|11270924|FG006|STARTED|Open Label Treatment Period (OLTP)||0
10140724|NCT02718898|11270918|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0
10140725|NCT02718898|11270919|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0
10140726|NCT02718898|11270920|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62
10140727|NCT02718898|11270921|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64
10140728|NCT02718898|11270922|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0
10140729|NCT02718898|11270923|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0
10140730|NCT02718898|11270924|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0
10140731|NCT02718898|11270918|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10140732|NCT02718898|11270919|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10140733|NCT02718898|11270920|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
10140734|NCT02718898|11270921|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
10140735|NCT02718898|11270922|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10140736|NCT02718898|11270923|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10140737|NCT02718898|11270924|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10140738|NCT02718898|11270918|FG000|STARTED|Post Treatment Follow-up Period||0
10140739|NCT02718898|11270919|FG001|STARTED|Post Treatment Follow-up Period||0
10140740|NCT02718898|11270920|FG002|STARTED|Post Treatment Follow-up Period||0
10140741|NCT02718898|11270921|FG003|STARTED|Post Treatment Follow-up Period||0
10140742|NCT02718898|11270922|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
10140743|NCT02718898|11270923|FG005|STARTED|Post Treatment Follow-up Period||78
10140744|NCT02718898|11270924|FG006|STARTED|Post Treatment Follow-up Period||49
10140745|NCT02718898|11270918|FG000|COMPLETED|Post Treatment Follow-up Period||0
10140746|NCT02718898|11270919|FG001|COMPLETED|Post Treatment Follow-up Period||0
10140747|NCT02718898|11270920|FG002|COMPLETED|Post Treatment Follow-up Period||0
10140748|NCT02718898|11270921|FG003|COMPLETED|Post Treatment Follow-up Period||0
10140749|NCT02718898|11270922|FG004|COMPLETED|Post Treatment Follow-up Period||0
10140750|NCT02718898|11270923|FG005|COMPLETED|Post Treatment Follow-up Period||67
10140751|NCT02718898|11270924|FG006|COMPLETED|Post Treatment Follow-up Period||44
10060559|NCT02098395|11186116|FG002|NOT COMPLETED|Overall Study||42
10060560|NCT02098395|11186117|FG003|NOT COMPLETED|Overall Study||27
10060561|NCT02098733|11186127|FG000|STARTED|Overall Study||1168
10060562|NCT02098733|11186127|FG000|COMPLETED|Overall Study||1158
10060563|NCT02098733|11186127|FG000|NOT COMPLETED|Overall Study||10
10060564|NCT02098746|11186131|FG000|STARTED|Overall Study||294
10060565|NCT02098746|11186131|FG000|COMPLETED|Overall Study||289
10060566|NCT02098746|11186131|FG000|NOT COMPLETED|Overall Study||5
10060567|NCT02098993|11186137|FG000|STARTED|Overall Study||4
10060568|NCT02098993|11186138|FG001|STARTED|Overall Study||3
10060569|NCT02098993|11186137|FG000|COMPLETED|Overall Study||4
10060570|NCT02098993|11186138|FG001|COMPLETED|Overall Study||3
10060571|NCT02098993|11186137|FG000|NOT COMPLETED|Overall Study||0
10060572|NCT02098993|11186138|FG001|NOT COMPLETED|Overall Study||0
10060573|NCT02099006|11186144|FG000|STARTED|Overall Study||9
10060574|NCT02099006|11186144|FG000|Received Placebo|Overall Study||9
10060575|NCT02099006|11186144|FG000|Received Amitriptyline/ Baclofen|Overall Study||7
10060576|NCT02099006|11186144|FG000|Received Ketoprofen|Overall Study||3
10060577|NCT02099006|11186144|FG000|Received Loperamide|Overall Study||7
10060578|NCT02099006|11186144|FG000|Received Ketamine|Overall Study||6
10060579|NCT02099006|11186144|FG000|Received Gabapentin|Overall Study||8
10060580|NCT02099006|11186144|FG000|COMPLETED|Overall Study||8
10060581|NCT02099006|11186144|FG000|NOT COMPLETED|Overall Study||1
10060582|NCT02099084|11186150|FG000|STARTED|First Intervention||4
10060583|NCT02099084|11186151|FG001|STARTED|First Intervention||4
10060584|NCT02099084|11186150|FG000|COMPLETED|First Intervention||4
10060585|NCT02099084|11186151|FG001|COMPLETED|First Intervention||4
10060586|NCT02099084|11186150|FG000|NOT COMPLETED|First Intervention||0
10060587|NCT02099084|11186151|FG001|NOT COMPLETED|First Intervention||0
10060588|NCT02099084|11186150|FG000|STARTED|Washout Period of 14 Days||4
10060589|NCT02099084|11186151|FG001|STARTED|Washout Period of 14 Days||4
10060590|NCT02099084|11186150|FG000|COMPLETED|Washout Period of 14 Days||4
10060591|NCT02099084|11186151|FG001|COMPLETED|Washout Period of 14 Days||4
10060592|NCT02099084|11186150|FG000|NOT COMPLETED|Washout Period of 14 Days||0
10060593|NCT02099084|11186151|FG001|NOT COMPLETED|Washout Period of 14 Days||0
10060594|NCT02099084|11186150|FG000|STARTED|Second Intervention||4
10060595|NCT02099084|11186151|FG001|STARTED|Second Intervention||4
10060596|NCT02099084|11186150|FG000|COMPLETED|Second Intervention||4
10060597|NCT02099084|11186151|FG001|COMPLETED|Second Intervention||4
10060598|NCT02099084|11186150|FG000|NOT COMPLETED|Second Intervention||0
10060599|NCT02099084|11186151|FG001|NOT COMPLETED|Second Intervention||0
10060600|NCT02099110|11186162|FG000|STARTED|Overall Study||250
10060601|NCT02099110|11186163|FG001|STARTED|Overall Study||248
10060602|NCT02099110|11186164|FG002|STARTED|Overall Study||247
10060603|NCT02099110|11186165|FG003|STARTED|Overall Study||243
10060604|NCT02099110|11186166|FG004|STARTED|Overall Study||245
10060605|NCT02099110|11186162|FG000|Treated|Overall Study||250
10060606|NCT02099110|11186163|FG001|Treated|Overall Study||248
10060607|NCT02099110|11186164|FG002|Treated|Overall Study||247
10060608|NCT02099110|11186165|FG003|Treated|Overall Study||243
10060609|NCT02099110|11186166|FG004|Treated|Overall Study||244
10060610|NCT02099110|11186162|FG000|COMPLETED|Overall Study||226
10060611|NCT02099110|11186163|FG001|COMPLETED|Overall Study||217
10060612|NCT02099110|11186164|FG002|COMPLETED|Overall Study||219
10060613|NCT02099110|11186165|FG003|COMPLETED|Overall Study||221
10060614|NCT02099110|11186166|FG004|COMPLETED|Overall Study||218
10060615|NCT02099110|11186162|FG000|NOT COMPLETED|Overall Study||24
10060616|NCT02099110|11186163|FG001|NOT COMPLETED|Overall Study||31
10060617|NCT02099110|11186164|FG002|NOT COMPLETED|Overall Study||28
10060618|NCT02099110|11186165|FG003|NOT COMPLETED|Overall Study||22
10060619|NCT02099110|11186166|FG004|NOT COMPLETED|Overall Study||27
10060620|NCT02099266|11186178|FG000|STARTED|Overall Study||15
10060621|NCT02099266|11186178|FG000|COMPLETED|Overall Study||15
10060622|NCT02099266|11186178|FG000|NOT COMPLETED|Overall Study||0
10060623|NCT02099461|11186188|FG000|STARTED|Overall Study||27
10060624|NCT02099461|11186189|FG001|STARTED|Overall Study||27
10060625|NCT02099461|11186190|FG002|STARTED|Overall Study||28
10060626|NCT02099461|11186188|FG000|COMPLETED|Overall Study||27
10060627|NCT02099461|11186189|FG001|COMPLETED|Overall Study||27
10060628|NCT02099461|11186190|FG002|COMPLETED|Overall Study||28
10060629|NCT02099461|11186188|FG000|NOT COMPLETED|Overall Study||0
10060630|NCT02099461|11186189|FG001|NOT COMPLETED|Overall Study||0
10140752|NCT02718898|11270918|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
10140753|NCT02718898|11270919|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
10140754|NCT02718898|11270920|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
10140755|NCT02718898|11270921|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
10140756|NCT02718898|11270922|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1
10140757|NCT02718898|11270923|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11
10140758|NCT02718898|11270924|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5
10140759|NCT02718963|11270939|FG000|STARTED|Overall Study||10
10140760|NCT02718963|11270940|FG001|STARTED|Overall Study||10
10140761|NCT02718963|11270939|FG000|COMPLETED|Overall Study||9
10140762|NCT02718963|11270940|FG001|COMPLETED|Overall Study||9
10140763|NCT02718963|11270939|FG000|NOT COMPLETED|Overall Study||1
10140764|NCT02718963|11270940|FG001|NOT COMPLETED|Overall Study||1
10140765|NCT02719028|11270950|FG000|STARTED|Overall Study||30
10140766|NCT02719028|11270951|FG001|STARTED|Overall Study||30
10140767|NCT02719028|11270952|FG002|STARTED|Overall Study||30
10140768|NCT02719028|11270953|FG003|STARTED|Overall Study||30
10140769|NCT02719028|11270950|FG000|COMPLETED|Overall Study||28
10140770|NCT02719028|11270951|FG001|COMPLETED|Overall Study||28
10140771|NCT02719028|11270952|FG002|COMPLETED|Overall Study||24
10140772|NCT02719028|11270953|FG003|COMPLETED|Overall Study||20
10140773|NCT02719028|11270950|FG000|NOT COMPLETED|Overall Study||2
10140774|NCT02719028|11270951|FG001|NOT COMPLETED|Overall Study||2
10140775|NCT02719028|11270952|FG002|NOT COMPLETED|Overall Study||6
10140776|NCT02719028|11270953|FG003|NOT COMPLETED|Overall Study||10
10140777|NCT02719158|11270966|FG000|STARTED|Overall Study||38
10140778|NCT02719158|11270967|FG001|STARTED|Overall Study||38
10140779|NCT02719158|11270968|FG002|STARTED|Overall Study||19
10140780|NCT02719158|11270966|FG000|COMPLETED|Overall Study||38
10140781|NCT02719158|11270967|FG001|COMPLETED|Overall Study||38
10140782|NCT02719158|11270968|FG002|COMPLETED|Overall Study||18
10140783|NCT02719158|11270966|FG000|NOT COMPLETED|Overall Study||0
10140784|NCT02719158|11270967|FG001|NOT COMPLETED|Overall Study||0
10140785|NCT02719158|11270968|FG002|NOT COMPLETED|Overall Study||1
10140786|NCT02719171|11270981|FG000|STARTED|Overall Study||42
10140787|NCT02719171|11270982|FG001|STARTED|Overall Study||42
10140788|NCT02719171|11270983|FG002|STARTED|Overall Study||42
10140789|NCT02719171|11270984|FG003|STARTED|Overall Study||39
10140790|NCT02719171|11270985|FG004|STARTED|Overall Study||20
10140791|NCT02719171|11270981|FG000|COMPLETED|Overall Study||41
10140792|NCT02719171|11270982|FG001|COMPLETED|Overall Study||38
10140793|NCT02719171|11270983|FG002|COMPLETED|Overall Study||39
10140794|NCT02719171|11270984|FG003|COMPLETED|Overall Study||37
10140795|NCT02719171|11270985|FG004|COMPLETED|Overall Study||18
10140796|NCT02719171|11270981|FG000|NOT COMPLETED|Overall Study||1
10140797|NCT02719171|11270982|FG001|NOT COMPLETED|Overall Study||4
10140798|NCT02719171|11270983|FG002|NOT COMPLETED|Overall Study||3
10140799|NCT02719171|11270984|FG003|NOT COMPLETED|Overall Study||2
10140800|NCT02719171|11270985|FG004|NOT COMPLETED|Overall Study||2
10140801|NCT02719353|11271000|FG000|STARTED|First Intervention||7
10140802|NCT02719353|11271001|FG001|STARTED|First Intervention||7
10140803|NCT02719353|11271000|FG000|COMPLETED|First Intervention||7
10140804|NCT02719353|11271001|FG001|COMPLETED|First Intervention||6
10140805|NCT02719353|11271000|FG000|NOT COMPLETED|First Intervention||0
10140806|NCT02719353|11271001|FG001|NOT COMPLETED|First Intervention||1
10140807|NCT02719353|11271000|FG000|STARTED|Second Intervention||7
10140808|NCT02719353|11271001|FG001|STARTED|Second Intervention||6
10140809|NCT02719353|11271000|FG000|COMPLETED|Second Intervention||7
10140810|NCT02719353|11271001|FG001|COMPLETED|Second Intervention||6
10140811|NCT02719353|11271000|FG000|NOT COMPLETED|Second Intervention||0
10140812|NCT02719353|11271001|FG001|NOT COMPLETED|Second Intervention||0
10140813|NCT02719366|11271008|FG000|STARTED|First Intervention||6
10140814|NCT02719366|11271009|FG001|STARTED|First Intervention||6
10140815|NCT02719366|11271008|FG000|COMPLETED|First Intervention||6
10140816|NCT02719366|11271009|FG001|COMPLETED|First Intervention||6
10140817|NCT02719366|11271008|FG000|NOT COMPLETED|First Intervention||0
10140818|NCT02719366|11271009|FG001|NOT COMPLETED|First Intervention||0
10140819|NCT02719366|11271008|FG000|STARTED|Second Intervention||6
10140820|NCT02719366|11271009|FG001|STARTED|Second Intervention||6
10140821|NCT02719366|11271008|FG000|COMPLETED|Second Intervention||6
10060631|NCT02099461|11186190|FG002|NOT COMPLETED|Overall Study||0
10060632|NCT02099682|11186198|FG000|STARTED|Overall Study|Number of cases.|3366
10140822|NCT02719366|11271009|FG001|COMPLETED|Second Intervention||6
10140823|NCT02719366|11271008|FG000|NOT COMPLETED|Second Intervention||0
10140824|NCT02719366|11271009|FG001|NOT COMPLETED|Second Intervention||0
10140825|NCT02719535|11271016|FG000|STARTED|Overall Study||59
10140826|NCT02719535|11271016|FG000|COMPLETED|Overall Study||37
10140827|NCT02719535|11271016|FG000|NOT COMPLETED|Overall Study||22
10140828|NCT02719639|11271020|FG000|STARTED|Overall Study||7443
10140829|NCT02719639|11271020|FG000|COMPLETED|Overall Study||7443
10140830|NCT02719639|11271020|FG000|NOT COMPLETED|Overall Study||0
10140831|NCT02719743|11271029|FG000|STARTED|Overall Study||38
10140832|NCT02719743|11271030|FG001|STARTED|Overall Study||37
10140833|NCT02719743|11271031|FG002|STARTED|Overall Study||38
10140834|NCT02719743|11271032|FG003|STARTED|Overall Study||37
10140835|NCT02719743|11271033|FG004|STARTED|Overall Study||35
10140836|NCT02719743|11271029|FG000|COMPLETED|Overall Study||37
10140837|NCT02719743|11271030|FG001|COMPLETED|Overall Study||34
10140838|NCT02719743|11271031|FG002|COMPLETED|Overall Study||38
10140839|NCT02719743|11271032|FG003|COMPLETED|Overall Study||36
10140840|NCT02719743|11271033|FG004|COMPLETED|Overall Study||33
10140841|NCT02719743|11271029|FG000|NOT COMPLETED|Overall Study||1
10140842|NCT02719743|11271030|FG001|NOT COMPLETED|Overall Study||3
10140843|NCT02719743|11271031|FG002|NOT COMPLETED|Overall Study||0
10140844|NCT02719743|11271032|FG003|NOT COMPLETED|Overall Study||1
10140845|NCT02719743|11271033|FG004|NOT COMPLETED|Overall Study||2
10140846|NCT02719938|11271047|FG000|STARTED|Overall Study||30
10140847|NCT02719938|11271048|FG001|STARTED|Overall Study||32
10140848|NCT02719938|11271047|FG000|COMPLETED|Overall Study||26
10140849|NCT02719938|11271048|FG001|COMPLETED|Overall Study||31
10140850|NCT02719938|11271047|FG000|NOT COMPLETED|Overall Study||4
10140851|NCT02719938|11271048|FG001|NOT COMPLETED|Overall Study||1
10140852|NCT02720042|11271054|FG000|STARTED|Overall Study||84
10140853|NCT02720042|11271054|FG000|COMPLETED|Overall Study||69
10140854|NCT02720042|11271054|FG000|NOT COMPLETED|Overall Study||15
10140855|NCT02720081|11271060|FG000|STARTED|Overall Study||72
10140856|NCT02720081|11271061|FG001|STARTED|Overall Study||70
10140857|NCT02720081|11271060|FG000|Treated|Overall Study||70
10140858|NCT02720081|11271061|FG001|Treated|Overall Study||69
10140859|NCT02720081|11271060|FG000|COMPLETED|Overall Study||68
10140860|NCT02720081|11271061|FG001|COMPLETED|Overall Study||66
10140861|NCT02720081|11271060|FG000|NOT COMPLETED|Overall Study||4
10140862|NCT02720081|11271061|FG001|NOT COMPLETED|Overall Study||4
10140863|NCT02720107|11271067|FG000|STARTED|Overall Study||130
10140864|NCT02720107|11271067|FG000|COMPLETED|Overall Study||130
10140865|NCT02720107|11271067|FG000|NOT COMPLETED|Overall Study||0
10140866|NCT02720198|11271073|FG000|STARTED|Overall Study||29
10140867|NCT02720198|11271074|FG001|STARTED|Overall Study||31
10140868|NCT02720198|11271073|FG000|COMPLETED|Overall Study||29
10140869|NCT02720198|11271074|FG001|COMPLETED|Overall Study||30
10140870|NCT02720198|11271073|FG000|NOT COMPLETED|Overall Study||0
10140871|NCT02720198|11271074|FG001|NOT COMPLETED|Overall Study||1
10140872|NCT02720224|11271080|FG000|STARTED|Overall Study||6
10140873|NCT02720224|11271080|FG000|COMPLETED|Overall Study||6
10140874|NCT02720224|11271080|FG000|NOT COMPLETED|Overall Study||0
10140875|NCT02720484|11271084|FG000|STARTED|Treatment on Study||10
10140876|NCT02720484|11271084|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7
10140877|NCT02720484|11271084|FG000|Treated Cycle 3|Treatment on Study||4
10140878|NCT02720484|11271084|FG000|COMPLETED|Treatment on Study||4
10140879|NCT02720484|11271084|FG000|NOT COMPLETED|Treatment on Study||6
10140880|NCT02720484|11271084|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
10140881|NCT02720484|11271084|FG000|COMPLETED|Follow Up for 2 Years||1
10140882|NCT02720484|11271084|FG000|NOT COMPLETED|Follow Up for 2 Years||6
10140925|NCT02720536|11271111|FG000|STARTED|Overall Study||53
10140926|NCT02720536|11271111|FG000|COMPLETED|Overall Study||34
10140927|NCT02720536|11271111|FG000|NOT COMPLETED|Overall Study||19
10140928|NCT02720627|11271121|FG000|STARTED|Overall Study||27
10140929|NCT02720627|11271121|FG000|COMPLETED|Overall Study||27
10140930|NCT02720627|11271121|FG000|NOT COMPLETED|Overall Study||0
10140931|NCT02720757|11271125|FG000|STARTED|Overall Study||132
10140932|NCT02720757|11271125|FG000|COMPLETED|Overall Study||114
10140933|NCT02720757|11271125|FG000|NOT COMPLETED|Overall Study||18
10140934|NCT02721017|11271131|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
10140935|NCT02721017|11271132|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
10140936|NCT02721017|11271131|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
10140937|NCT02721017|11271132|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
10140938|NCT02721017|11271131|FG000|NOT COMPLETED|Hospital Stay||0
10140939|NCT02721017|11271132|FG001|NOT COMPLETED|Hospital Stay||0
10140940|NCT02721017|11271131|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
10140941|NCT02721017|11271132|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
10140942|NCT02721017|11271131|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
10140943|NCT02721017|11271132|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
10140944|NCT02721017|11271131|FG000|NOT COMPLETED|Participant Follow Up||0
10140945|NCT02721017|11271132|FG001|NOT COMPLETED|Participant Follow Up||0
10140946|NCT02721147|11271143|FG000|STARTED|Overall Study||40
10140947|NCT02721147|11271144|FG001|STARTED|Overall Study||18
10140948|NCT02721147|11271145|FG002|STARTED|Overall Study||31
10140949|NCT02721147|11271143|FG000|COMPLETED|Overall Study||38
10140950|NCT02721147|11271144|FG001|COMPLETED|Overall Study||18
10140951|NCT02721147|11271145|FG002|COMPLETED|Overall Study||31
10140952|NCT02721147|11271143|FG000|NOT COMPLETED|Overall Study||2
10140953|NCT02721147|11271144|FG001|NOT COMPLETED|Overall Study||0
10140954|NCT02721147|11271145|FG002|NOT COMPLETED|Overall Study||0
10140955|NCT02721251|11271156|FG000|STARTED|Overall Study||14
10140956|NCT02721251|11271157|FG001|STARTED|Overall Study||16
10140957|NCT02721251|11271158|FG002|STARTED|Overall Study||17
10140958|NCT02721251|11271156|FG000|COMPLETED|Overall Study||4
10140959|NCT02721251|11271157|FG001|COMPLETED|Overall Study||7
10140960|NCT02721251|11271158|FG002|COMPLETED|Overall Study||6
10140961|NCT02721251|11271156|FG000|NOT COMPLETED|Overall Study||10
10140962|NCT02721251|11271157|FG001|NOT COMPLETED|Overall Study||9
10140963|NCT02721251|11271158|FG002|NOT COMPLETED|Overall Study||11
10140964|NCT02721355|11271169|FG000|STARTED|Overall Study||42
10140965|NCT02721355|11271170|FG001|STARTED|Overall Study||42
10140966|NCT02721355|11271169|FG000|COMPLETED|Overall Study||36
10140967|NCT02721355|11271170|FG001|COMPLETED|Overall Study||41
10140968|NCT02721355|11271169|FG000|NOT COMPLETED|Overall Study||6
10140969|NCT02721355|11271170|FG001|NOT COMPLETED|Overall Study||1
10140970|NCT02721641|11271176|FG000|STARTED|Overall Study||69
10140971|NCT02721641|11271176|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
10140972|NCT02721641|11271176|FG000|NOT COMPLETED|Overall Study||0
10140973|NCT02721875|11271182|FG000|STARTED|Overall Study||1
10140974|NCT02721875|11271183|FG001|STARTED|Overall Study||0
10140975|NCT02721875|11271182|FG000|COMPLETED|Overall Study||0
10140976|NCT02721875|11271183|FG001|COMPLETED|Overall Study||0
10140977|NCT02721875|11271182|FG000|NOT COMPLETED|Overall Study||1
10140978|NCT02721875|11271183|FG001|NOT COMPLETED|Overall Study||0
10140979|NCT02721966|11271192|FG000|STARTED|Overall Study||167
10140980|NCT02721966|11271193|FG001|STARTED|Overall Study||165
10140981|NCT02721966|11271194|FG002|STARTED|Overall Study||81
10140982|NCT02721966|11271195|FG003|STARTED|Overall Study||80
10140983|NCT02721966|11271196|FG004|STARTED|Overall Study||5
10140984|NCT02721966|11271192|FG000|Completed Period 1 & Went to Period 2|Overall Study||162
10140985|NCT02721966|11271193|FG001|Completed Period 1 & Went to Period 2|Overall Study||153
10140986|NCT02721966|11271194|FG002|Completed Period 1 & Went to Period 2|Overall Study||81
10140987|NCT02721966|11271195|FG003|Completed Period 1 & Went to Period 2|Overall Study||80
10140988|NCT02721966|11271196|FG004|Completed Period 1 & Went to Period 2|Overall Study||0
10140989|NCT02721966|11271192|FG000|COMPLETED|Overall Study||138
10140990|NCT02721966|11271193|FG001|COMPLETED|Overall Study||142
10140991|NCT02721966|11271194|FG002|COMPLETED|Overall Study||72
10140992|NCT02721966|11271195|FG003|COMPLETED|Overall Study||73
10140993|NCT02721966|11271196|FG004|COMPLETED|Overall Study||0
10140994|NCT02721966|11271192|FG000|NOT COMPLETED|Overall Study||29
10140995|NCT02721966|11271193|FG001|NOT COMPLETED|Overall Study||23
10140996|NCT02721966|11271194|FG002|NOT COMPLETED|Overall Study||9
10140997|NCT02721966|11271195|FG003|NOT COMPLETED|Overall Study||7
9707441|NCT04034238|10806625|FG002|STARTED|Dose Escalation Phase||0
10140998|NCT02721966|11271196|FG004|NOT COMPLETED|Overall Study||5
9707442|NCT04034238|10806626|FG003|STARTED|Dose Escalation Phase||2
9707443|NCT04034238|10806623|FG000|COMPLETED|Dose Escalation Phase||6
10140999|NCT02722044|11271204|FG000|STARTED|Overall Study||33
10141000|NCT02722044|11271204|FG000|COMPLETED|Overall Study||28
10141001|NCT02722044|11271204|FG000|NOT COMPLETED|Overall Study||5
10141002|NCT02722148|11271209|FG000|STARTED|Overall Study||24
10141003|NCT02722148|11271209|FG000|COMPLETED|Overall Study||19
10141004|NCT02722148|11271209|FG000|NOT COMPLETED|Overall Study||5
10141005|NCT02722239|11271215|FG000|STARTED|Overall Study||20
10141006|NCT02722239|11271216|FG001|STARTED|Overall Study||20
10141007|NCT02722239|11271215|FG000|First Intervention (1 Day)|Overall Study||20
10141008|NCT02722239|11271216|FG001|First Intervention (1 Day)|Overall Study||20
10141009|NCT02722239|11271215|FG000|Washout (7 Days)|Overall Study||20
10141010|NCT02722239|11271216|FG001|Washout (7 Days)|Overall Study||20
10141011|NCT02722239|11271215|FG000|Second Intervention (1 Day)|Overall Study||20
10141012|NCT02722239|11271216|FG001|Second Intervention (1 Day)|Overall Study||20
10141013|NCT02722239|11271215|FG000|COMPLETED|Overall Study||20
10141014|NCT02722239|11271216|FG001|COMPLETED|Overall Study||20
10141015|NCT02722239|11271215|FG000|NOT COMPLETED|Overall Study||0
10141016|NCT02722239|11271216|FG001|NOT COMPLETED|Overall Study||0
10141017|NCT02722278|11271225|FG000|STARTED|Overall Study||166
10141018|NCT02722278|11271226|FG001|STARTED|Overall Study||56
10141019|NCT02722278|11271225|FG000|COMPLETED|Overall Study||154
10141020|NCT02722278|11271226|FG001|COMPLETED|Overall Study||49
10141021|NCT02722278|11271225|FG000|NOT COMPLETED|Overall Study||12
10141022|NCT02722278|11271226|FG001|NOT COMPLETED|Overall Study||7
10141023|NCT02722304|11271239|FG000|STARTED|Overall Study||1
10141024|NCT02722304|11271240|FG001|STARTED|Overall Study||0
10141025|NCT02722304|11271241|FG002|STARTED|Overall Study||2
10141026|NCT02722304|11271242|FG003|STARTED|Overall Study||2
10141027|NCT02722304|11271243|FG004|STARTED|Overall Study||2
10141028|NCT02722304|11271239|FG000|Treated|Overall Study||1
10141029|NCT02722304|11271240|FG001|Treated|Overall Study||0
10141030|NCT02722304|11271241|FG002|Treated|Overall Study||1
10141031|NCT02722304|11271242|FG003|Treated|Overall Study||1
10141032|NCT02722304|11271243|FG004|Treated|Overall Study||2
10141033|NCT02722304|11271239|FG000|COMPLETED|Overall Study||0
10141034|NCT02722304|11271240|FG001|COMPLETED|Overall Study||0
10141035|NCT02722304|11271241|FG002|COMPLETED|Overall Study||0
10141036|NCT02722304|11271242|FG003|COMPLETED|Overall Study||0
10141037|NCT02722304|11271243|FG004|COMPLETED|Overall Study||0
10141038|NCT02722304|11271239|FG000|NOT COMPLETED|Overall Study||1
10141039|NCT02722304|11271240|FG001|NOT COMPLETED|Overall Study||0
10141040|NCT02722304|11271241|FG002|NOT COMPLETED|Overall Study||2
10141041|NCT02722304|11271242|FG003|NOT COMPLETED|Overall Study||2
10141042|NCT02722304|11271243|FG004|NOT COMPLETED|Overall Study||2
10141043|NCT02722330|11271257|FG000|STARTED|Overall Study||23
10141044|NCT02722330|11271257|FG000|COMPLETED|Overall Study||23
10141045|NCT02722330|11271257|FG000|NOT COMPLETED|Overall Study||0
10141046|NCT02722408|11271261|FG000|STARTED|Overall Study||8
10141047|NCT02722408|11271261|FG000|COMPLETED|Overall Study||8
10141048|NCT02722408|11271261|FG000|NOT COMPLETED|Overall Study||0
10141049|NCT02722499|11271270|FG000|STARTED|Overall Study||20
10141050|NCT02722499|11271271|FG001|STARTED|Overall Study||20
10141051|NCT02722499|11271272|FG002|STARTED|Overall Study||20
10141052|NCT02722499|11271270|FG000|COMPLETED|Overall Study||18
10141053|NCT02722499|11271271|FG001|COMPLETED|Overall Study||20
10141054|NCT02722499|11271272|FG002|COMPLETED|Overall Study||19
10141055|NCT02722499|11271270|FG000|NOT COMPLETED|Overall Study||2
10141056|NCT02722499|11271271|FG001|NOT COMPLETED|Overall Study||0
10141057|NCT02722499|11271272|FG002|NOT COMPLETED|Overall Study||1
10141058|NCT02722564|11271280|FG000|STARTED|Overall Study||55
10141059|NCT02722564|11271280|FG000|COMPLETED|Overall Study||55
10141060|NCT02722564|11271280|FG000|NOT COMPLETED|Overall Study||0
10141061|NCT02722577|11271284|FG000|STARTED|Overall Study||20
10141062|NCT02722577|11271284|FG000|COMPLETED|Overall Study||20
10141063|NCT02722577|11271284|FG000|NOT COMPLETED|Overall Study||0
10141064|NCT02722837|11271288|FG000|STARTED|Overall Study||119
10141065|NCT02722837|11271288|FG000|COMPLETED|Overall Study||119
10141066|NCT02722837|11271288|FG000|NOT COMPLETED|Overall Study||0
10141067|NCT02722863|11271292|FG000|STARTED|Overall Study||908
10141068|NCT02722863|11271292|FG000|COMPLETED|Overall Study||908
10141069|NCT02722863|11271292|FG000|NOT COMPLETED|Overall Study||0
10141070|NCT02722928|11271299|FG000|STARTED|Overall Study||49
10141071|NCT02722928|11271300|FG001|STARTED|Overall Study||51
10141072|NCT02722928|11271299|FG000|COMPLETED|Overall Study||39
10141073|NCT02722928|11271300|FG001|COMPLETED|Overall Study||31
10141074|NCT02722928|11271299|FG000|NOT COMPLETED|Overall Study||10
10141075|NCT02722928|11271300|FG001|NOT COMPLETED|Overall Study||20
10141076|NCT02722967|11271313|FG000|STARTED|Overall Study||22
10141077|NCT02722967|11271314|FG001|STARTED|Overall Study||12
10141078|NCT02722967|11271315|FG002|STARTED|Overall Study||15
10141079|NCT02722967|11271313|FG000|COMPLETED|Overall Study||17
10141080|NCT02722967|11271314|FG001|COMPLETED|Overall Study||10
10141081|NCT02722967|11271315|FG002|COMPLETED|Overall Study||11
10141082|NCT02722967|11271313|FG000|NOT COMPLETED|Overall Study||5
10141083|NCT02722967|11271314|FG001|NOT COMPLETED|Overall Study||2
10141084|NCT02722967|11271315|FG002|NOT COMPLETED|Overall Study||4
10141085|NCT02723006|11271326|FG000|STARTED|Overall Study||1
10141086|NCT02723006|11271327|FG001|STARTED|Overall Study||9
10141087|NCT02723006|11271328|FG002|STARTED|Overall Study||12
10141088|NCT02723006|11271326|FG000|COMPLETED|Overall Study||0
10141089|NCT02723006|11271327|FG001|COMPLETED|Overall Study||2
10141090|NCT02723006|11271328|FG002|COMPLETED|Overall Study||5
10141091|NCT02723006|11271326|FG000|NOT COMPLETED|Overall Study||1
10141092|NCT02723006|11271327|FG001|NOT COMPLETED|Overall Study||7
10141093|NCT02723006|11271328|FG002|NOT COMPLETED|Overall Study||7
10141094|NCT02723084|11271338|FG000|STARTED|Overall Study||90
10141095|NCT02723084|11271339|FG001|STARTED|Overall Study||46
10141096|NCT02723084|11271338|FG000|COMPLETED|Overall Study||86
10141097|NCT02723084|11271339|FG001|COMPLETED|Overall Study||45
10141098|NCT02723084|11271338|FG000|NOT COMPLETED|Overall Study||4
10141099|NCT02723084|11271339|FG001|NOT COMPLETED|Overall Study||1
10141100|NCT02723175|11271347|FG000|STARTED|Overall Study||8
10141101|NCT02723175|11271348|FG001|STARTED|Overall Study||7
10141102|NCT02723175|11271347|FG000|COMPLETED|Overall Study||4
10141103|NCT02723175|11271348|FG001|COMPLETED|Overall Study||4
10141104|NCT02723175|11271347|FG000|NOT COMPLETED|Overall Study||4
10141105|NCT02723175|11271348|FG001|NOT COMPLETED|Overall Study||3
10141106|NCT02723188|11271357|FG000|STARTED|Overall Study||15
10141107|NCT02723188|11271358|FG001|STARTED|Overall Study||15
10141108|NCT02723188|11271359|FG002|STARTED|Overall Study||15
10141109|NCT02723188|11271357|FG000|COMPLETED|Overall Study||14
10141110|NCT02723188|11271358|FG001|COMPLETED|Overall Study||15
10141111|NCT02723188|11271359|FG002|COMPLETED|Overall Study||15
10141112|NCT02723188|11271357|FG000|NOT COMPLETED|Overall Study||1
10141113|NCT02723188|11271358|FG001|NOT COMPLETED|Overall Study||0
10141114|NCT02723188|11271359|FG002|NOT COMPLETED|Overall Study||0
10141115|NCT02723201|11271370|FG000|STARTED|First Intervention Period||11
10141116|NCT02723201|11271371|FG001|STARTED|First Intervention Period||7
10141117|NCT02723201|11271372|FG002|STARTED|First Intervention Period||7
10141118|NCT02723201|11271370|FG000|COMPLETED|First Intervention Period||11
10141119|NCT02723201|11271371|FG001|COMPLETED|First Intervention Period||7
10141120|NCT02723201|11271372|FG002|COMPLETED|First Intervention Period||7
10141121|NCT02723201|11271370|FG000|NOT COMPLETED|First Intervention Period||0
10141122|NCT02723201|11271371|FG001|NOT COMPLETED|First Intervention Period||0
10141123|NCT02723201|11271372|FG002|NOT COMPLETED|First Intervention Period||0
10141124|NCT02723201|11271370|FG000|STARTED|Washout Period 1||11
10141125|NCT02723201|11271371|FG001|STARTED|Washout Period 1||7
10141126|NCT02723201|11271372|FG002|STARTED|Washout Period 1||7
10141127|NCT02723201|11271370|FG000|COMPLETED|Washout Period 1||11
10141128|NCT02723201|11271371|FG001|COMPLETED|Washout Period 1||7
10141129|NCT02723201|11271372|FG002|COMPLETED|Washout Period 1||7
10141130|NCT02723201|11271370|FG000|NOT COMPLETED|Washout Period 1||0
10141131|NCT02723201|11271371|FG001|NOT COMPLETED|Washout Period 1||0
10141132|NCT02723201|11271372|FG002|NOT COMPLETED|Washout Period 1||0
10141133|NCT02723201|11271370|FG000|STARTED|Second Intervention Period||11
10141134|NCT02723201|11271371|FG001|STARTED|Second Intervention Period||7
10141135|NCT02723201|11271372|FG002|STARTED|Second Intervention Period||7
10141136|NCT02723201|11271370|FG000|COMPLETED|Second Intervention Period||9
10141137|NCT02723201|11271371|FG001|COMPLETED|Second Intervention Period||7
10141138|NCT02723201|11271372|FG002|COMPLETED|Second Intervention Period||7
10141139|NCT02723201|11271370|FG000|NOT COMPLETED|Second Intervention Period||2
10141140|NCT02723201|11271371|FG001|NOT COMPLETED|Second Intervention Period||0
10141141|NCT02723201|11271372|FG002|NOT COMPLETED|Second Intervention Period||0
10141142|NCT02723201|11271370|FG000|STARTED|Washout Period 2||9
10141143|NCT02723201|11271371|FG001|STARTED|Washout Period 2||0
10141144|NCT02723201|11271372|FG002|STARTED|Washout Period 2||0
10141145|NCT02723201|11271370|FG000|COMPLETED|Washout Period 2||9
10141146|NCT02723201|11271371|FG001|COMPLETED|Washout Period 2||0
10141147|NCT02723201|11271372|FG002|COMPLETED|Washout Period 2||0
10141148|NCT02723201|11271370|FG000|NOT COMPLETED|Washout Period 2||0
10141149|NCT02723201|11271371|FG001|NOT COMPLETED|Washout Period 2||0
10141150|NCT02723201|11271372|FG002|NOT COMPLETED|Washout Period 2||0
10141151|NCT02723201|11271370|FG000|STARTED|Third Intervention Period||9
10141152|NCT02723201|11271371|FG001|STARTED|Third Intervention Period||0
10141153|NCT02723201|11271372|FG002|STARTED|Third Intervention Period||0
10141154|NCT02723201|11271370|FG000|COMPLETED|Third Intervention Period||9
10141155|NCT02723201|11271371|FG001|COMPLETED|Third Intervention Period||0
10141156|NCT02723201|11271372|FG002|COMPLETED|Third Intervention Period||0
10141157|NCT02723201|11271370|FG000|NOT COMPLETED|Third Intervention Period||0
10141158|NCT02723201|11271371|FG001|NOT COMPLETED|Third Intervention Period||0
10141159|NCT02723201|11271372|FG002|NOT COMPLETED|Third Intervention Period||0
10141160|NCT02723201|11271370|FG000|STARTED|Washout Period 3||9
10141161|NCT02723201|11271371|FG001|STARTED|Washout Period 3||0
10141162|NCT02723201|11271372|FG002|STARTED|Washout Period 3||0
10141163|NCT02723201|11271370|FG000|COMPLETED|Washout Period 3||9
10141164|NCT02723201|11271371|FG001|COMPLETED|Washout Period 3||0
10141165|NCT02723201|11271372|FG002|COMPLETED|Washout Period 3||0
10141166|NCT02723201|11271370|FG000|NOT COMPLETED|Washout Period 3||0
10141167|NCT02723201|11271371|FG001|NOT COMPLETED|Washout Period 3||0
10141168|NCT02723201|11271372|FG002|NOT COMPLETED|Washout Period 3||0
10141169|NCT02723201|11271370|FG000|STARTED|Fourth Intervention Period||9
10141170|NCT02723201|11271371|FG001|STARTED|Fourth Intervention Period||0
10141171|NCT02723201|11271372|FG002|STARTED|Fourth Intervention Period||0
10141172|NCT02723201|11271370|FG000|COMPLETED|Fourth Intervention Period||9
10141173|NCT02723201|11271371|FG001|COMPLETED|Fourth Intervention Period||0
10141174|NCT02723201|11271372|FG002|COMPLETED|Fourth Intervention Period||0
10141175|NCT02723201|11271370|FG000|NOT COMPLETED|Fourth Intervention Period||0
10141176|NCT02723201|11271371|FG001|NOT COMPLETED|Fourth Intervention Period||0
10141177|NCT02723201|11271372|FG002|NOT COMPLETED|Fourth Intervention Period||0
10141178|NCT02723344|11271388|FG000|STARTED|Overall Study||15
10141179|NCT02723344|11271389|FG001|STARTED|Overall Study||16
10141180|NCT02723344|11271388|FG000|COMPLETED|Overall Study||15
10141181|NCT02723344|11271389|FG001|COMPLETED|Overall Study||12
10141182|NCT02723344|11271388|FG000|NOT COMPLETED|Overall Study||0
10141183|NCT02723344|11271389|FG001|NOT COMPLETED|Overall Study||4
10141184|NCT02723591|11271397|FG000|STARTED|Overall Study||300
10141185|NCT02723591|11271398|FG001|STARTED|Overall Study||299
10141186|NCT02723591|11271397|FG000|COMPLETED|Overall Study||204
10141187|NCT02723591|11271398|FG001|COMPLETED|Overall Study||198
10141188|NCT02723591|11271397|FG000|NOT COMPLETED|Overall Study||96
10141189|NCT02723591|11271398|FG001|NOT COMPLETED|Overall Study||101
10141190|NCT02723630|11271410|FG000|STARTED|Intervention Period 1||10
10141191|NCT02723630|11271411|FG001|STARTED|Intervention Period 1||10
10141192|NCT02723630|11271412|FG002|STARTED|Intervention Period 1||10
10141193|NCT02723630|11271413|FG003|STARTED|Intervention Period 1||10
10141194|NCT02723630|11271414|FG004|STARTED|Intervention Period 1||10
10141195|NCT02723630|11271415|FG005|STARTED|Intervention Period 1||10
9707444|NCT04034238|10806624|FG001|COMPLETED|Dose Escalation Phase||3
9707445|NCT04034238|10806625|FG002|COMPLETED|Dose Escalation Phase||0
9707446|NCT04034238|10806626|FG003|COMPLETED|Dose Escalation Phase||0
9707447|NCT04034238|10806623|FG000|NOT COMPLETED|Dose Escalation Phase||1
9707448|NCT04034238|10806624|FG001|NOT COMPLETED|Dose Escalation Phase||0
9707449|NCT04034238|10806625|FG002|NOT COMPLETED|Dose Escalation Phase||0
9707450|NCT04034238|10806626|FG003|NOT COMPLETED|Dose Escalation Phase||2
9707451|NCT04034238|10806623|FG000|STARTED|Dose Expansion Phase||0
9707452|NCT04034238|10806624|FG001|STARTED|Dose Expansion Phase||0
9707453|NCT04034238|10806625|FG002|STARTED|Dose Expansion Phase||6
9707454|NCT04034238|10806626|FG003|STARTED|Dose Expansion Phase||1
9707455|NCT04034238|10806623|FG000|COMPLETED|Dose Expansion Phase||0
9707456|NCT04034238|10806624|FG001|COMPLETED|Dose Expansion Phase||0
9707457|NCT04034238|10806625|FG002|COMPLETED|Dose Expansion Phase||5
9707458|NCT04034238|10806626|FG003|COMPLETED|Dose Expansion Phase||0
9707459|NCT04034238|10806623|FG000|NOT COMPLETED|Dose Expansion Phase||0
9707460|NCT04034238|10806624|FG001|NOT COMPLETED|Dose Expansion Phase||0
9707461|NCT04034238|10806625|FG002|NOT COMPLETED|Dose Expansion Phase||1
9707462|NCT04034238|10806626|FG003|NOT COMPLETED|Dose Expansion Phase||1
9729221|NCT00117286|10828791|FG000|STARTED|Overall Study|Safety analysis set|30
9729222|NCT00117286|10828792|FG001|STARTED|Overall Study||27
9729223|NCT00117286|10828791|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
9729224|NCT00117286|10828792|FG001|Switched to Higher Dose|Overall Study||17
9729225|NCT00117286|10828791|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
9729226|NCT00117286|10828792|FG001|COMPLETED|Overall Study||6
9729227|NCT00117286|10828791|FG000|NOT COMPLETED|Overall Study||28
9729228|NCT00117286|10828792|FG001|NOT COMPLETED|Overall Study||21
9729229|NCT00117312|10828802|FG000|STARTED|Overall Study||10
9729230|NCT00117312|10828803|FG001|STARTED|Overall Study||24
9729231|NCT00117312|10828804|FG002|STARTED|Overall Study||24
9729232|NCT00117312|10828805|FG003|STARTED|Overall Study||24
9729233|NCT00117312|10828802|FG000|Started FE200486 CS06A|Overall Study||1
9729234|NCT00117312|10828803|FG001|Started FE200486 CS06A|Overall Study||11
9729235|NCT00117312|10828804|FG002|Started FE200486 CS06A|Overall Study||16
9729236|NCT00117312|10828805|FG003|Started FE200486 CS06A|Overall Study||9
9729237|NCT00117312|10828802|FG000|COMPLETED|Overall Study||0
9729238|NCT00117312|10828803|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
9729239|NCT00117312|10828804|FG002|COMPLETED|Overall Study||0
9729240|NCT00117312|10828805|FG003|COMPLETED|Overall Study||3
9729241|NCT00117312|10828802|FG000|NOT COMPLETED|Overall Study||10
9729242|NCT00117312|10828803|FG001|NOT COMPLETED|Overall Study||20
9729243|NCT00117312|10828804|FG002|NOT COMPLETED|Overall Study||24
9729244|NCT00117312|10828805|FG003|NOT COMPLETED|Overall Study||21
9729245|NCT00117325|10828817|FG000|STARTED|Overall Study||173
9729246|NCT00117325|10828818|FG001|STARTED|Overall Study||179
9729247|NCT00117325|10828817|FG000|COMPLETED|Overall Study||160
9729248|NCT00117325|10828818|FG001|COMPLETED|Overall Study||167
9729249|NCT00117325|10828817|FG000|NOT COMPLETED|Overall Study||13
9729250|NCT00117325|10828818|FG001|NOT COMPLETED|Overall Study||12
9729251|NCT00117507|10828825|FG000|STARTED|Overall Study||24
9729252|NCT00117507|10828825|FG000|COMPLETED|Overall Study||9
9729253|NCT00117507|10828825|FG000|NOT COMPLETED|Overall Study||15
9729254|NCT00117559|10828832|FG000|STARTED|Overall Study||9
9729255|NCT00117559|10828833|FG001|STARTED|Overall Study||10
9729256|NCT00117559|10828832|FG000|COMPLETED|Overall Study||8
9729257|NCT00117559|10828833|FG001|COMPLETED|Overall Study||9
9729258|NCT00117559|10828832|FG000|NOT COMPLETED|Overall Study||1
9729259|NCT00117559|10828833|FG001|NOT COMPLETED|Overall Study||1
9729260|NCT00117572|10828841|FG000|STARTED|Overall Study||144
9729261|NCT00117572|10828842|FG001|STARTED|Overall Study||141
10141196|NCT02723630|11271410|FG000|COMPLETED|Intervention Period 1||9
10141197|NCT02723630|11271411|FG001|COMPLETED|Intervention Period 1||10
10141198|NCT02723630|11271412|FG002|COMPLETED|Intervention Period 1||10
10141199|NCT02723630|11271413|FG003|COMPLETED|Intervention Period 1||10
10141200|NCT02723630|11271414|FG004|COMPLETED|Intervention Period 1||10
10141201|NCT02723630|11271415|FG005|COMPLETED|Intervention Period 1||10
10141202|NCT02723630|11271410|FG000|NOT COMPLETED|Intervention Period 1||1
10141203|NCT02723630|11271411|FG001|NOT COMPLETED|Intervention Period 1||0
9729262|NCT00117572|10828841|FG000|COMPLETED|Overall Study||138
9729263|NCT00117572|10828842|FG001|COMPLETED|Overall Study||135
9729264|NCT00117572|10828841|FG000|NOT COMPLETED|Overall Study||6
10141204|NCT02723630|11271412|FG002|NOT COMPLETED|Intervention Period 1||0
10141205|NCT02723630|11271413|FG003|NOT COMPLETED|Intervention Period 1||0
10141206|NCT02723630|11271414|FG004|NOT COMPLETED|Intervention Period 1||0
10141207|NCT02723630|11271415|FG005|NOT COMPLETED|Intervention Period 1||0
10141208|NCT02723630|11271410|FG000|STARTED|Intervention Period 2||9
10141209|NCT02723630|11271411|FG001|STARTED|Intervention Period 2||10
10141210|NCT02723630|11271412|FG002|STARTED|Intervention Period 2||10
10141211|NCT02723630|11271413|FG003|STARTED|Intervention Period 2||10
10141212|NCT02723630|11271414|FG004|STARTED|Intervention Period 2||10
10141213|NCT02723630|11271415|FG005|STARTED|Intervention Period 2||10
10141214|NCT02723630|11271410|FG000|COMPLETED|Intervention Period 2||9
10141215|NCT02723630|11271411|FG001|COMPLETED|Intervention Period 2||10
10141216|NCT02723630|11271412|FG002|COMPLETED|Intervention Period 2||10
10141217|NCT02723630|11271413|FG003|COMPLETED|Intervention Period 2||10
10141218|NCT02723630|11271414|FG004|COMPLETED|Intervention Period 2||10
10141219|NCT02723630|11271415|FG005|COMPLETED|Intervention Period 2||10
10141220|NCT02723630|11271410|FG000|NOT COMPLETED|Intervention Period 2||0
10141221|NCT02723630|11271411|FG001|NOT COMPLETED|Intervention Period 2||0
10141222|NCT02723630|11271412|FG002|NOT COMPLETED|Intervention Period 2||0
10141223|NCT02723630|11271413|FG003|NOT COMPLETED|Intervention Period 2||0
10141224|NCT02723630|11271414|FG004|NOT COMPLETED|Intervention Period 2||0
10141225|NCT02723630|11271415|FG005|NOT COMPLETED|Intervention Period 2||0
10141226|NCT02723630|11271410|FG000|STARTED|Intervention Period 3||9
10141227|NCT02723630|11271411|FG001|STARTED|Intervention Period 3||10
10141228|NCT02723630|11271412|FG002|STARTED|Intervention Period 3||10
10141229|NCT02723630|11271413|FG003|STARTED|Intervention Period 3||10
10141230|NCT02723630|11271414|FG004|STARTED|Intervention Period 3||10
10141231|NCT02723630|11271415|FG005|STARTED|Intervention Period 3||10
10141232|NCT02723630|11271410|FG000|COMPLETED|Intervention Period 3||9
10141233|NCT02723630|11271411|FG001|COMPLETED|Intervention Period 3||9
10141234|NCT02723630|11271412|FG002|COMPLETED|Intervention Period 3||10
10141235|NCT02723630|11271413|FG003|COMPLETED|Intervention Period 3||10
10141236|NCT02723630|11271414|FG004|COMPLETED|Intervention Period 3||10
10141237|NCT02723630|11271415|FG005|COMPLETED|Intervention Period 3||10
10141238|NCT02723630|11271410|FG000|NOT COMPLETED|Intervention Period 3||0
10141239|NCT02723630|11271411|FG001|NOT COMPLETED|Intervention Period 3||1
10141240|NCT02723630|11271412|FG002|NOT COMPLETED|Intervention Period 3||0
10141241|NCT02723630|11271413|FG003|NOT COMPLETED|Intervention Period 3||0
10141242|NCT02723630|11271414|FG004|NOT COMPLETED|Intervention Period 3||0
10141243|NCT02723630|11271415|FG005|NOT COMPLETED|Intervention Period 3||0
10141244|NCT02723786|11271428|FG000|STARTED|Overall Study||7
10141245|NCT02723786|11271428|FG000|COMPLETED|Overall Study||6
10141246|NCT02723786|11271428|FG000|NOT COMPLETED|Overall Study||1
10141247|NCT02723916|11271434|FG000|STARTED|Overall Study||144
10141248|NCT02723916|11271435|FG001|STARTED|Overall Study||143
10141249|NCT02723916|11271434|FG000|COMPLETED|Overall Study||135
10141250|NCT02723916|11271435|FG001|COMPLETED|Overall Study||137
10141251|NCT02723916|11271434|FG000|NOT COMPLETED|Overall Study||9
10141252|NCT02723916|11271435|FG001|NOT COMPLETED|Overall Study||6
10141253|NCT02723929|11271443|FG000|STARTED|Overall Study||30
10141254|NCT02723929|11271444|FG001|STARTED|Overall Study||34
10141255|NCT02723929|11271443|FG000|COMPLETED|Overall Study||24
10141256|NCT02723929|11271444|FG001|COMPLETED|Overall Study||24
10141257|NCT02723929|11271443|FG000|NOT COMPLETED|Overall Study||6
10141258|NCT02723929|11271444|FG001|NOT COMPLETED|Overall Study||10
10141259|NCT02724020|11271455|FG000|STARTED|Overall Study||32
10141260|NCT02724020|11271456|FG001|STARTED|Overall Study||32
10141261|NCT02724020|11271457|FG002|STARTED|Overall Study||32
10141262|NCT02724020|11271455|FG000|Treated (Safety Analysis Set)|Overall Study||32
10141263|NCT02724020|11271456|FG001|Treated (Safety Analysis Set)|Overall Study||32
10141264|NCT02724020|11271457|FG002|Treated (Safety Analysis Set)|Overall Study||31
10141265|NCT02724020|11271455|FG000|COMPLETED|Overall Study||0
10141266|NCT02724020|11271456|FG001|COMPLETED|Overall Study||0
10141267|NCT02724020|11271457|FG002|COMPLETED|Overall Study||0
10141268|NCT02724020|11271455|FG000|NOT COMPLETED|Overall Study||32
10141269|NCT02724020|11271456|FG001|NOT COMPLETED|Overall Study||32
10141270|NCT02724020|11271457|FG002|NOT COMPLETED|Overall Study||32
10141271|NCT02724033|11271468|FG000|STARTED|Overall Study||11
10141272|NCT02724033|11271469|FG001|STARTED|Overall Study||14
10141273|NCT02724033|11271470|FG002|STARTED|Overall Study||12
10141274|NCT02724033|11271468|FG000|COMPLETED|Overall Study||11
10141275|NCT02724033|11271469|FG001|COMPLETED|Overall Study||14
10141276|NCT02724033|11271470|FG002|COMPLETED|Overall Study||12
10141277|NCT02724033|11271468|FG000|NOT COMPLETED|Overall Study||0
10141278|NCT02724033|11271469|FG001|NOT COMPLETED|Overall Study||0
10141279|NCT02724033|11271470|FG002|NOT COMPLETED|Overall Study||0
10141280|NCT02724111|11271480|FG000|STARTED|Overall Study||45
10141281|NCT02724111|11271481|FG001|STARTED|Overall Study||45
10141282|NCT02724111|11271480|FG000|COMPLETED|Overall Study||43
10141283|NCT02724111|11271481|FG001|COMPLETED|Overall Study||40
10141284|NCT02724111|11271480|FG000|NOT COMPLETED|Overall Study||2
10141285|NCT02724111|11271481|FG001|NOT COMPLETED|Overall Study||5
10141286|NCT02724423|11271487|FG000|STARTED|Overall Study||57
10141287|NCT02724423|11271487|FG000|COMPLETED|Overall Study||54
10141288|NCT02724423|11271487|FG000|NOT COMPLETED|Overall Study||3
10141289|NCT02724449|11271492|FG000|STARTED|Overall Study||16
10141290|NCT02724449|11271492|FG000|COMPLETED|Overall Study||16
10141291|NCT02724449|11271492|FG000|NOT COMPLETED|Overall Study||0
10141292|NCT02724462|11271498|FG000|STARTED|3 Month Follow-up Survey||1254
10141293|NCT02724462|11271499|FG001|STARTED|3 Month Follow-up Survey||1249
10141294|NCT02724462|11271498|FG000|COMPLETED|3 Month Follow-up Survey||1043
10141295|NCT02724462|11271499|FG001|COMPLETED|3 Month Follow-up Survey||1050
10141296|NCT02724462|11271498|FG000|NOT COMPLETED|3 Month Follow-up Survey||211
10141297|NCT02724462|11271499|FG001|NOT COMPLETED|3 Month Follow-up Survey||199
10141298|NCT02724462|11271498|FG000|STARTED|6 Month Follow-up Survey||1254
10141299|NCT02724462|11271499|FG001|STARTED|6 Month Follow-up Survey||1249
10141300|NCT02724462|11271498|FG000|COMPLETED|6 Month Follow-up Survey||1058
10141301|NCT02724462|11271499|FG001|COMPLETED|6 Month Follow-up Survey||1078
10141302|NCT02724462|11271498|FG000|NOT COMPLETED|6 Month Follow-up Survey||196
10141303|NCT02724462|11271499|FG001|NOT COMPLETED|6 Month Follow-up Survey||171
10141304|NCT02724462|11271498|FG000|STARTED|12 Month Follow-up Survey||1254
10141305|NCT02724462|11271499|FG001|STARTED|12 Month Follow-up Survey||1249
10141306|NCT02724462|11271498|FG000|COMPLETED|12 Month Follow-up Survey||1040
10141307|NCT02724462|11271499|FG001|COMPLETED|12 Month Follow-up Survey||1067
10141308|NCT02724462|11271498|FG000|NOT COMPLETED|12 Month Follow-up Survey||214
10141309|NCT02724462|11271499|FG001|NOT COMPLETED|12 Month Follow-up Survey||182
10141310|NCT02724592|11271507|FG000|STARTED|Overall Study||35
10141311|NCT02724592|11271508|FG001|STARTED|Overall Study||35
10141312|NCT02724592|11271507|FG000|COMPLETED|Overall Study||31
10141313|NCT02724592|11271508|FG001|COMPLETED|Overall Study||34
10141314|NCT02724592|11271507|FG000|NOT COMPLETED|Overall Study||4
10141315|NCT02724592|11271508|FG001|NOT COMPLETED|Overall Study||1
10141316|NCT02724644|11271516|FG000|STARTED|Overall Study||189
10141317|NCT02724644|11271517|FG001|STARTED|Overall Study||186
10141318|NCT02724644|11271516|FG000|COMPLETED|Overall Study||168
10141319|NCT02724644|11271517|FG001|COMPLETED|Overall Study||182
10141320|NCT02724644|11271516|FG000|NOT COMPLETED|Overall Study||21
10141321|NCT02724644|11271517|FG001|NOT COMPLETED|Overall Study||4
10141322|NCT02724787|11271523|FG000|STARTED|Overall Study||24
10141323|NCT02724787|11271523|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
10141324|NCT02724787|11271523|FG000|NOT COMPLETED|Overall Study||2
10141325|NCT02724800|11271529|FG000|STARTED|Overall Study||32
10141326|NCT02724800|11271530|FG001|STARTED|Overall Study||31
10141327|NCT02724800|11271529|FG000|COMPLETED|Overall Study||15
10141328|NCT02724800|11271530|FG001|COMPLETED|Overall Study||22
10141329|NCT02724800|11271529|FG000|NOT COMPLETED|Overall Study||17
10141330|NCT02724800|11271530|FG001|NOT COMPLETED|Overall Study||9
10141331|NCT02724839|11271539|FG000|STARTED|Overall Study||13
10141332|NCT02724839|11271540|FG001|STARTED|Overall Study||12
10141333|NCT02724839|11271541|FG002|STARTED|Overall Study||11
10141334|NCT02724839|11271539|FG000|COMPLETED|Overall Study||12
10141335|NCT02724839|11271540|FG001|COMPLETED|Overall Study||8
10141336|NCT02724839|11271541|FG002|COMPLETED|Overall Study||6
10141337|NCT02724839|11271539|FG000|NOT COMPLETED|Overall Study||1
10141338|NCT02724839|11271540|FG001|NOT COMPLETED|Overall Study||4
10141339|NCT02724839|11271541|FG002|NOT COMPLETED|Overall Study||5
10141340|NCT02724956|11271558|FG000|STARTED|Overall Study||27
10141341|NCT02724956|11271559|FG001|STARTED|Overall Study||26
10141342|NCT02724956|11271558|FG000|COMPLETED|Overall Study||26
10141343|NCT02724956|11271559|FG001|COMPLETED|Overall Study||24
10141344|NCT02724956|11271558|FG000|NOT COMPLETED|Overall Study||1
10141345|NCT02724956|11271559|FG001|NOT COMPLETED|Overall Study||2
10141346|NCT02725008|11271567|FG000|STARTED|Overall Study||46
10141347|NCT02725008|11271568|FG001|STARTED|Overall Study||51
10141348|NCT02725008|11271567|FG000|COMPLETED|Overall Study||37
10141349|NCT02725008|11271568|FG001|COMPLETED|Overall Study||39
10141350|NCT02725008|11271567|FG000|NOT COMPLETED|Overall Study||9
10141351|NCT02725008|11271568|FG001|NOT COMPLETED|Overall Study||12
10141352|NCT02725268|11271578|FG000|STARTED|Overall Study||90
10141353|NCT02725268|11271579|FG001|STARTED|Overall Study||90
10141354|NCT02725268|11271580|FG002|STARTED|Overall Study||41
10141355|NCT02725268|11271581|FG003|STARTED|Overall Study||20
10141356|NCT02725268|11271578|FG000|Started|Overall Study||90
10141357|NCT02725268|11271579|FG001|Started|Overall Study||90
10141358|NCT02725268|11271580|FG002|Started|Overall Study||41
10141359|NCT02725268|11271581|FG003|Started|Overall Study||20
10141360|NCT02725268|11271578|FG000|Completed|Overall Study||18
10141361|NCT02725268|11271579|FG001|Completed|Overall Study||20
10141362|NCT02725268|11271580|FG002|Completed|Overall Study||3
10141363|NCT02725268|11271581|FG003|Completed|Overall Study||2
10141364|NCT02725268|11271578|FG000|COMPLETED|Overall Study||18
10141365|NCT02725268|11271579|FG001|COMPLETED|Overall Study||20
10141366|NCT02725268|11271580|FG002|COMPLETED|Overall Study||3
10141367|NCT02725268|11271581|FG003|COMPLETED|Overall Study||2
10141368|NCT02725268|11271578|FG000|NOT COMPLETED|Overall Study||72
10141369|NCT02725268|11271579|FG001|NOT COMPLETED|Overall Study||70
10141370|NCT02725268|11271580|FG002|NOT COMPLETED|Overall Study||38
10141371|NCT02725268|11271581|FG003|NOT COMPLETED|Overall Study||18
10141372|NCT02725411|11271594|FG000|STARTED|Treatment Period (56 Weeks)||92
10141373|NCT02725411|11271595|FG001|STARTED|Treatment Period (56 Weeks)||93
10141374|NCT02725411|11271596|FG002|STARTED|Treatment Period (56 Weeks)||92
10141375|NCT02725411|11271594|FG000|Treated|Treatment Period (56 Weeks)||92
10141376|NCT02725411|11271595|FG001|Treated|Treatment Period (56 Weeks)||93
10141377|NCT02725411|11271596|FG002|Treated|Treatment Period (56 Weeks)||92
10141378|NCT02725411|11271594|FG000|COMPLETED|Treatment Period (56 Weeks)||62
10141379|NCT02725411|11271595|FG001|COMPLETED|Treatment Period (56 Weeks)||43
10141380|NCT02725411|11271596|FG002|COMPLETED|Treatment Period (56 Weeks)||43
10141381|NCT02725411|11271594|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30
10141382|NCT02725411|11271595|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50
10141383|NCT02725411|11271596|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49
10141384|NCT02725411|11271594|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
10141385|NCT02725411|11271595|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
10141386|NCT02725411|11271596|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
10141387|NCT02725411|11271594|FG000|COMPLETED|Follow-up Period (24 Weeks)||88
10141388|NCT02725411|11271595|FG001|COMPLETED|Follow-up Period (24 Weeks)||82
10141389|NCT02725411|11271596|FG002|COMPLETED|Follow-up Period (24 Weeks)||87
10141390|NCT02725411|11271594|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4
10141391|NCT02725411|11271595|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11
10141392|NCT02725411|11271596|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5
10141393|NCT02725476|11271606|FG000|STARTED|Overall Study||15
10141394|NCT02725476|11271607|FG001|STARTED|Overall Study||5
10141395|NCT02725476|11271606|FG000|COMPLETED|Overall Study||12
10141396|NCT02725476|11271607|FG001|COMPLETED|Overall Study||4
10141397|NCT02725476|11271606|FG000|NOT COMPLETED|Overall Study||3
10141398|NCT02725476|11271607|FG001|NOT COMPLETED|Overall Study||1
10141399|NCT02725515|11271615|FG000|STARTED|Overall Study||53
10141400|NCT02725515|11271616|FG001|STARTED|Overall Study||52
10141401|NCT02725515|11271615|FG000|COMPLETED|Overall Study||28
10141402|NCT02725515|11271616|FG001|COMPLETED|Overall Study||17
10141403|NCT02725515|11271615|FG000|NOT COMPLETED|Overall Study||25
10141404|NCT02725515|11271616|FG001|NOT COMPLETED|Overall Study||35
9707463|NCT03984305|10806639|FG000|STARTED|Overall Study||23
9707464|NCT03984305|10806640|FG001|STARTED|Overall Study||18
9707465|NCT03984305|10806639|FG000|COMPLETED|Overall Study||0
9707466|NCT03984305|10806640|FG001|COMPLETED|Overall Study||0
9707467|NCT03984305|10806639|FG000|NOT COMPLETED|Overall Study||23
9707468|NCT03984305|10806640|FG001|NOT COMPLETED|Overall Study||18
9707469|NCT03982368|10806649|FG000|STARTED|Overall Study||87
9707470|NCT03982368|10806650|FG001|STARTED|Overall Study||86
9707471|NCT03982368|10806651|FG002|STARTED|Overall Study||88
9707472|NCT03982368|10806649|FG000|FAS Popuation|Overall Study||81
9707473|NCT03982368|10806650|FG001|FAS Popuation|Overall Study||82
9707474|NCT03982368|10806651|FG002|FAS Popuation|Overall Study||84
9707475|NCT03982368|10806649|FG000|PP Population|Overall Study||72
9707476|NCT03982368|10806650|FG001|PP Population|Overall Study||71
9707477|NCT03982368|10806651|FG002|PP Population|Overall Study||80
10141405|NCT02725645|11271622|FG000|STARTED|Overall Study||14
9707478|NCT03982368|10806649|FG000|COMPLETED|Overall Study||74
9707479|NCT03982368|10806650|FG001|COMPLETED|Overall Study||79
10141406|NCT02725645|11271622|FG000|COMPLETED|Overall Study||14
10141407|NCT02725645|11271622|FG000|NOT COMPLETED|Overall Study||0
10141408|NCT02725710|11271628|FG000|STARTED|Overall Study||48
10141409|NCT02725710|11271629|FG001|STARTED|Overall Study||47
10141410|NCT02725710|11271628|FG000|COMPLETED|Overall Study||47
10141411|NCT02725710|11271629|FG001|COMPLETED|Overall Study||47
10141412|NCT02725710|11271628|FG000|NOT COMPLETED|Overall Study||1
10141413|NCT02725710|11271629|FG001|NOT COMPLETED|Overall Study||0
10141414|NCT02725788|11271637|FG000|STARTED|Overall Study||123
10141415|NCT02725788|11271638|FG001|STARTED|Overall Study||124
10141416|NCT02725788|11271637|FG000|COMPLETED|Overall Study||122
10141417|NCT02725788|11271638|FG001|COMPLETED|Overall Study||122
10141418|NCT02725788|11271637|FG000|NOT COMPLETED|Overall Study||1
10141419|NCT02725788|11271638|FG001|NOT COMPLETED|Overall Study||2
10141420|NCT02725801|11271646|FG000|STARTED|Overall Study||8
10141421|NCT02725801|11271647|FG001|STARTED|Overall Study||12
10141422|NCT02725801|11271646|FG000|COMPLETED|Overall Study||8
10141423|NCT02725801|11271647|FG001|COMPLETED|Overall Study||12
10141424|NCT02725801|11271646|FG000|NOT COMPLETED|Overall Study||0
10141425|NCT02725801|11271647|FG001|NOT COMPLETED|Overall Study||0
10141426|NCT02725866|11271653|FG000|STARTED|Overall Study||216
10141427|NCT02725866|11271653|FG000|COMPLETED|Overall Study||202
10141428|NCT02725866|11271653|FG000|NOT COMPLETED|Overall Study||14
10141429|NCT02726022|11271657|FG000|STARTED|Overall Study||114
10141430|NCT02726022|11271657|FG000|COMPLETED|Overall Study||78
10141431|NCT02726022|11271657|FG000|NOT COMPLETED|Overall Study||36
10141432|NCT02726074|11271661|FG000|STARTED|Overall Study||106
10141433|NCT02726074|11271661|FG000|Treated|Overall Study||102
10141434|NCT02726074|11271661|FG000|COMPLETED|Overall Study||80
10141435|NCT02726074|11271661|FG000|NOT COMPLETED|Overall Study||26
10141436|NCT02726113|11271667|FG000|STARTED|Total Enrollment||28
10141437|NCT02726113|11271668|FG001|STARTED|Total Enrollment||22
10141438|NCT02726113|11271667|FG000|COMPLETED|Total Enrollment||24
10141439|NCT02726113|11271668|FG001|COMPLETED|Total Enrollment||19
10141440|NCT02726113|11271667|FG000|NOT COMPLETED|Total Enrollment||4
10141441|NCT02726113|11271668|FG001|NOT COMPLETED|Total Enrollment||3
10141442|NCT02726113|11271667|FG000|STARTED|Genomic Analysis||19
10141443|NCT02726113|11271668|FG001|STARTED|Genomic Analysis||14
10141444|NCT02726113|11271667|FG000|COMPLETED|Genomic Analysis||15
10141445|NCT02726113|11271668|FG001|COMPLETED|Genomic Analysis||12
10141446|NCT02726113|11271667|FG000|NOT COMPLETED|Genomic Analysis||4
10141447|NCT02726113|11271668|FG001|NOT COMPLETED|Genomic Analysis||2
10141448|NCT02726178|11271677|FG000|STARTED|Overall Study||28
10141449|NCT02726178|11271678|FG001|STARTED|Overall Study||28
10141450|NCT02726178|11271677|FG000|COMPLETED|Overall Study||28
10141451|NCT02726178|11271678|FG001|COMPLETED|Overall Study||28
10141452|NCT02726178|11271677|FG000|NOT COMPLETED|Overall Study||0
10141453|NCT02726178|11271678|FG001|NOT COMPLETED|Overall Study||0
10141454|NCT02726451|11271688|FG000|STARTED|Overall Study||10
10141455|NCT02726451|11271689|FG001|STARTED|Overall Study||10
10141456|NCT02726451|11271688|FG000|COMPLETED|Overall Study||10
10141457|NCT02726451|11271689|FG001|COMPLETED|Overall Study||10
10141458|NCT02726451|11271688|FG000|NOT COMPLETED|Overall Study||0
10141459|NCT02726451|11271689|FG001|NOT COMPLETED|Overall Study||0
10141460|NCT02726542|11271697|FG000|STARTED|Overall Study||13
10141461|NCT02726542|11271698|FG001|STARTED|Overall Study||11
10141462|NCT02726542|11271697|FG000|COMPLETED|Overall Study||10
10141463|NCT02726542|11271698|FG001|COMPLETED|Overall Study||10
10141464|NCT02726542|11271697|FG000|NOT COMPLETED|Overall Study||3
10141465|NCT02726542|11271698|FG001|NOT COMPLETED|Overall Study||1
10141466|NCT02726620|11271706|FG000|STARTED|Historic Cohort - Three Years||17463
10141467|NCT02726620|11271707|FG001|STARTED|Historic Cohort - Three Years||0
10141468|NCT02726620|11271706|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
10141469|NCT02726620|11271707|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
10141470|NCT02726620|11271706|FG000|COMPLETED|Historic Cohort - Three Years||17463
10141471|NCT02726620|11271707|FG001|COMPLETED|Historic Cohort - Three Years||0
10141472|NCT02726620|11271706|FG000|NOT COMPLETED|Historic Cohort - Three Years||0
10141473|NCT02726620|11271707|FG001|NOT COMPLETED|Historic Cohort - Three Years||0
10141474|NCT02726620|11271706|FG000|STARTED|Month 1: Attending Randomization||0
10141475|NCT02726620|11271707|FG001|STARTED|Month 1: Attending Randomization||485
10141476|NCT02726620|11271706|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
10141477|NCT02726620|11271707|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
10141478|NCT02726620|11271706|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0
10141479|NCT02726620|11271707|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313
10141480|NCT02726620|11271706|FG000|COMPLETED|Month 1: Attending Randomization||0
10141481|NCT02726620|11271707|FG001|COMPLETED|Month 1: Attending Randomization||485
10141482|NCT02726620|11271706|FG000|NOT COMPLETED|Month 1: Attending Randomization||0
10141483|NCT02726620|11271707|FG001|NOT COMPLETED|Month 1: Attending Randomization||0
10141484|NCT02726620|11271706|FG000|STARTED|Months 2-3: In-room Providers Randomized||0
10141485|NCT02726620|11271707|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253
10141486|NCT02726620|11271706|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
10141487|NCT02726620|11271707|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
10141488|NCT02726620|11271706|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
10141489|NCT02726620|11271707|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
10141490|NCT02726620|11271706|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0
10141491|NCT02726620|11271707|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253
10141492|NCT02726620|11271706|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
10141493|NCT02726620|11271707|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
10141494|NCT02726620|11271706|FG000|STARTED|Through End of Study: All Interventions||0
10141495|NCT02726620|11271707|FG001|STARTED|Through End of Study: All Interventions||3234
10141496|NCT02726620|11271706|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
10141497|NCT02726620|11271707|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
10141498|NCT02726620|11271706|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0
10141499|NCT02726620|11271707|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072
10141500|NCT02726620|11271706|FG000|COMPLETED|Through End of Study: All Interventions||0
10141501|NCT02726620|11271707|FG001|COMPLETED|Through End of Study: All Interventions||3234
10141502|NCT02726620|11271706|FG000|NOT COMPLETED|Through End of Study: All Interventions||0
10141503|NCT02726620|11271707|FG001|NOT COMPLETED|Through End of Study: All Interventions||0
10141504|NCT02726789|11271713|FG000|STARTED|Overall Study||5
10141505|NCT02726789|11271713|FG000|COMPLETED|Overall Study||5
10141506|NCT02726789|11271713|FG000|NOT COMPLETED|Overall Study||0
10196680|NCT03364309|11324820|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
10196681|NCT03364309|11324821|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
10196682|NCT03364309|11324822|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
10196683|NCT03364309|11324823|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
10196684|NCT03364309|11324824|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
10196685|NCT03364309|11324825|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
10196686|NCT03364309|11324826|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
10196687|NCT03364309|11324827|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
10196688|NCT03364309|11324828|FG011|STARTED|Maintenance Period||0
10196689|NCT03364309|11324829|FG012|STARTED|Maintenance Period||0
10196690|NCT03364309|11324830|FG013|STARTED|Maintenance Period||0
10196691|NCT03364309|11324831|FG014|STARTED|Maintenance Period||0
10196692|NCT03364309|11324832|FG015|STARTED|Maintenance Period||0
10196693|NCT03364309|11324833|FG016|STARTED|Maintenance Period||0
10196694|NCT03364309|11324834|FG017|STARTED|Maintenance Period||0
10196695|NCT03364309|11324835|FG018|STARTED|Maintenance Period||0
10196696|NCT03364309|11324817|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0
10196697|NCT03364309|11324818|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0
10196698|NCT03364309|11324819|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0
10196699|NCT03364309|11324820|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47
10196700|NCT03364309|11324821|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92
10196701|NCT03364309|11324822|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50
10196702|NCT03364309|11324823|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100
10196703|NCT03364309|11324824|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3
10196704|NCT03364309|11324825|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79
10196705|NCT03364309|11324826|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31
10196706|NCT03364309|11324827|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23
10196707|NCT03364309|11324828|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0
10196708|NCT03364309|11324829|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0
10196709|NCT03364309|11324830|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0
10196710|NCT03364309|11324831|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0
10196711|NCT03364309|11324832|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0
10196712|NCT03364309|11324833|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0
10196713|NCT03364309|11324834|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0
10196714|NCT03364309|11324835|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0
10196715|NCT03364309|11324817|FG000|COMPLETED|Maintenance Period||0
10196716|NCT03364309|11324818|FG001|COMPLETED|Maintenance Period||0
10196717|NCT03364309|11324819|FG002|COMPLETED|Maintenance Period||0
10196718|NCT03364309|11324820|FG003|COMPLETED|Maintenance Period||3
10196719|NCT03364309|11324821|FG004|COMPLETED|Maintenance Period||80
10196720|NCT03364309|11324822|FG005|COMPLETED|Maintenance Period||4
10196721|NCT03364309|11324823|FG006|COMPLETED|Maintenance Period||84
10196722|NCT03364309|11324824|FG007|COMPLETED|Maintenance Period||1
10196723|NCT03364309|11324825|FG008|COMPLETED|Maintenance Period||73
10196724|NCT03364309|11324826|FG009|COMPLETED|Maintenance Period||27
10196725|NCT03364309|11324827|FG010|COMPLETED|Maintenance Period||17
10196726|NCT03364309|11324828|FG011|COMPLETED|Maintenance Period||0
10196727|NCT03364309|11324829|FG012|COMPLETED|Maintenance Period||0
10196728|NCT03364309|11324830|FG013|COMPLETED|Maintenance Period||0
10196729|NCT03364309|11324831|FG014|COMPLETED|Maintenance Period||0
10196730|NCT03364309|11324832|FG015|COMPLETED|Maintenance Period||0
10196731|NCT03364309|11324833|FG016|COMPLETED|Maintenance Period||0
10196732|NCT03364309|11324834|FG017|COMPLETED|Maintenance Period||0
10196733|NCT03364309|11324835|FG018|COMPLETED|Maintenance Period||0
10196734|NCT03364309|11324817|FG000|NOT COMPLETED|Maintenance Period||0
10196735|NCT03364309|11324818|FG001|NOT COMPLETED|Maintenance Period||0
10141507|NCT02726945|11271721|FG000|STARTED|Overall Study||13
10141508|NCT02726945|11271722|FG001|STARTED|Overall Study||13
10141509|NCT02726945|11271723|FG002|STARTED|Overall Study||13
10141510|NCT02726945|11271721|FG000|COMPLETED|Overall Study||13
10141511|NCT02726945|11271722|FG001|COMPLETED|Overall Study||12
10141512|NCT02726945|11271723|FG002|COMPLETED|Overall Study||12
10141513|NCT02726945|11271721|FG000|NOT COMPLETED|Overall Study||0
10141514|NCT02726945|11271722|FG001|NOT COMPLETED|Overall Study||1
10141515|NCT02726945|11271723|FG002|NOT COMPLETED|Overall Study||1
10141516|NCT02726971|11271733|FG000|STARTED|Overall Study||70
9707480|NCT03982368|10806651|FG002|COMPLETED|Overall Study||83
9707481|NCT03982368|10806649|FG000|NOT COMPLETED|Overall Study||13
9707482|NCT03982368|10806650|FG001|NOT COMPLETED|Overall Study||7
9707483|NCT03982368|10806651|FG002|NOT COMPLETED|Overall Study||5
9707484|NCT03952143|10806664|FG000|STARTED|Lead-In Period||628
9707485|NCT03952143|10806665|FG001|STARTED|Lead-In Period||0
9707486|NCT03952143|10806666|FG002|STARTED|Lead-In Period||0
9707487|NCT03952143|10806664|FG000|Participants Who Received at Least One Dose|Lead-In Period||628
9707488|NCT03952143|10806665|FG001|Participants Who Received at Least One Dose|Lead-In Period||0
9707489|NCT03952143|10806666|FG002|Participants Who Received at Least One Dose|Lead-In Period||0
9707490|NCT03952143|10806664|FG000|COMPLETED|Lead-In Period||595
9707491|NCT03952143|10806665|FG001|COMPLETED|Lead-In Period||0
9707492|NCT03952143|10806666|FG002|COMPLETED|Lead-In Period||0
9707493|NCT03952143|10806664|FG000|NOT COMPLETED|Lead-In Period||33
9707494|NCT03952143|10806665|FG001|NOT COMPLETED|Lead-In Period||0
9707495|NCT03952143|10806666|FG002|NOT COMPLETED|Lead-In Period||0
9707496|NCT03952143|10806664|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period|0
9707497|NCT03952143|10806665|FG001|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|200
9707498|NCT03952143|10806666|FG002|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|395
9707499|NCT03952143|10806664|FG000|Participants Who Received at Least One Dose|Treatment Period||0
9707500|NCT03952143|10806665|FG001|Participants Who Received at Least One Dose|Treatment Period||200
9707501|NCT03952143|10806666|FG002|Participants Who Received at Least One Dose|Treatment Period||395
9707502|NCT03952143|10806664|FG000|COMPLETED|Treatment Period||0
9707503|NCT03952143|10806665|FG001|COMPLETED|Treatment Period||191
9707504|NCT03952143|10806666|FG002|COMPLETED|Treatment Period||359
9707505|NCT03952143|10806664|FG000|NOT COMPLETED|Treatment Period||0
9707506|NCT03952143|10806665|FG001|NOT COMPLETED|Treatment Period||9
9707507|NCT03952143|10806666|FG002|NOT COMPLETED|Treatment Period||36
9707508|NCT03924752|10806673|FG000|STARTED|Overall Study||10
9707509|NCT03924752|10806673|FG000|COMPLETED|Overall Study||10
9707510|NCT03924752|10806673|FG000|NOT COMPLETED|Overall Study||0
9707511|NCT03829514|10806677|FG000|STARTED|Overall Study||10
9707512|NCT03829514|10806677|FG000|COMPLETED|Overall Study||10
9707513|NCT03829514|10806677|FG000|NOT COMPLETED|Overall Study||0
9707514|NCT03691428|10806683|FG000|STARTED|Overall Study||48
9707515|NCT03691428|10806684|FG001|STARTED|Overall Study||42
9707516|NCT03691428|10806683|FG000|COMPLETED|Overall Study||42
9707517|NCT03691428|10806684|FG001|COMPLETED|Overall Study||34
9707518|NCT03691428|10806683|FG000|NOT COMPLETED|Overall Study||6
9707519|NCT03691428|10806684|FG001|NOT COMPLETED|Overall Study||8
9707520|NCT03685708|10806693|FG000|STARTED|Overall Study||14
9707521|NCT03685708|10806694|FG001|STARTED|Overall Study||18
9707522|NCT03685708|10806695|FG002|STARTED|Overall Study||46
9707523|NCT03685708|10806693|FG000|COMPLETED|Overall Study||13
9707524|NCT03685708|10806694|FG001|COMPLETED|Overall Study||16
9707525|NCT03685708|10806695|FG002|COMPLETED|Overall Study||37
9707526|NCT03685708|10806693|FG000|NOT COMPLETED|Overall Study||1
9707527|NCT03685708|10806694|FG001|NOT COMPLETED|Overall Study||2
9707528|NCT03685708|10806695|FG002|NOT COMPLETED|Overall Study||9
9707529|NCT03669588|10806705|FG000|STARTED|Overall Study||84
9707530|NCT03669588|10806706|FG001|STARTED|Overall Study||83
9707531|NCT03669588|10806705|FG000|COMPLETED|Overall Study||80
9707532|NCT03669588|10806706|FG001|COMPLETED|Overall Study||76
9707533|NCT03669588|10806705|FG000|NOT COMPLETED|Overall Study||4
9707534|NCT03669588|10806706|FG001|NOT COMPLETED|Overall Study||7
9848869|NCT00862784|10961729|FG000|COMPLETED|Overall Study||48
9848870|NCT00862784|10961729|FG000|NOT COMPLETED|Overall Study||0
9848871|NCT00862810|10961735|FG000|STARTED|Overall Study||33
9848872|NCT00862810|10961736|FG001|STARTED|Overall Study||39
9848873|NCT00862810|10961735|FG000|COMPLETED|Overall Study||29
9848874|NCT00862810|10961736|FG001|COMPLETED|Overall Study||35
10141517|NCT02726971|11271734|FG001|STARTED|Overall Study||71
10141518|NCT02726971|11271733|FG000|COMPLETED|Overall Study||59
10141519|NCT02726971|11271734|FG001|COMPLETED|Overall Study||62
9707535|NCT03531632|10806715|FG000|STARTED|Overall Study||5
9707536|NCT03531632|10806716|FG001|STARTED|Overall Study||3
9707537|NCT03531632|10806717|FG002|STARTED|Overall Study||28
9848875|NCT00862810|10961735|FG000|NOT COMPLETED|Overall Study||4
10141520|NCT02726971|11271733|FG000|NOT COMPLETED|Overall Study||11
10141521|NCT02726971|11271734|FG001|NOT COMPLETED|Overall Study||9
10141522|NCT02727192|11271742|FG000|STARTED|Overall Study||54
10141523|NCT02727192|11271743|FG001|STARTED|Overall Study||54
10141524|NCT02727192|11271744|FG002|STARTED|Overall Study||1
10141525|NCT02727192|11271742|FG000|COMPLETED|Overall Study||53
10141526|NCT02727192|11271743|FG001|COMPLETED|Overall Study||54
10141527|NCT02727192|11271744|FG002|COMPLETED|Overall Study||1
10141528|NCT02727192|11271742|FG000|NOT COMPLETED|Overall Study||1
10141529|NCT02727192|11271743|FG001|NOT COMPLETED|Overall Study||0
10141530|NCT02727192|11271744|FG002|NOT COMPLETED|Overall Study||0
10141531|NCT02727322|11271753|FG000|STARTED|Overall Study||77
10141532|NCT02727322|11271754|FG001|STARTED|Overall Study||77
10141533|NCT02727322|11271753|FG000|COMPLETED|Overall Study||75
10141534|NCT02727322|11271754|FG001|COMPLETED|Overall Study||76
10141535|NCT02727322|11271753|FG000|NOT COMPLETED|Overall Study||2
10141536|NCT02727322|11271754|FG001|NOT COMPLETED|Overall Study||1
10141537|NCT02727660|11271767|FG000|STARTED|Overall Study||619
10141538|NCT02727660|11271768|FG001|STARTED|Overall Study||617
10141539|NCT02727660|11271769|FG002|STARTED|Overall Study||607
10141540|NCT02727660|11271767|FG000|COMPLETED|Overall Study||503
10141541|NCT02727660|11271768|FG001|COMPLETED|Overall Study||501
10141542|NCT02727660|11271769|FG002|COMPLETED|Overall Study||442
10141543|NCT02727660|11271767|FG000|NOT COMPLETED|Overall Study||116
10141544|NCT02727660|11271768|FG001|NOT COMPLETED|Overall Study||116
10141545|NCT02727660|11271769|FG002|NOT COMPLETED|Overall Study||165
10141546|NCT02727751|11271777|FG000|STARTED|Overall Study||312
10141547|NCT02727751|11271777|FG000|COMPLETED|Overall Study||262
10141548|NCT02727751|11271777|FG000|NOT COMPLETED|Overall Study||50
10141549|NCT02727777|11271784|FG000|STARTED|Overall Study||4
10141550|NCT02727777|11271785|FG001|STARTED|Overall Study||0
10141551|NCT02727777|11271786|FG002|STARTED|Overall Study||0
10141552|NCT02727777|11271784|FG000|COMPLETED|Overall Study||0
10141553|NCT02727777|11271785|FG001|COMPLETED|Overall Study||0
10141554|NCT02727777|11271786|FG002|COMPLETED|Overall Study||0
10141555|NCT02727777|11271784|FG000|NOT COMPLETED|Overall Study||4
10141556|NCT02727777|11271785|FG001|NOT COMPLETED|Overall Study||0
10141557|NCT02727777|11271786|FG002|NOT COMPLETED|Overall Study||0
10141558|NCT02727816|11271794|FG000|STARTED|Overall Study||35
10141559|NCT02727816|11271794|FG000|COMPLETED|Overall Study||35
10141560|NCT02727816|11271794|FG000|NOT COMPLETED|Overall Study||0
10141561|NCT02727842|11271814|FG000|STARTED|Overall Study||30
10141562|NCT02727842|11271814|FG000|COMPLETED|Overall Study||30
10141563|NCT02727842|11271814|FG000|NOT COMPLETED|Overall Study||0
10141564|NCT02727894|11271820|FG000|STARTED|Overall Study|March 2013|73
10141565|NCT02727894|11271821|FG001|STARTED|Overall Study|March 2013|192
10141566|NCT02727894|11271820|FG000|COMPLETED|Overall Study|September 2015|73
10141567|NCT02727894|11271821|FG001|COMPLETED|Overall Study|September 2015|192
10141568|NCT02727894|11271820|FG000|NOT COMPLETED|Overall Study||0
10141569|NCT02727894|11271821|FG001|NOT COMPLETED|Overall Study||0
10141570|NCT02728089|11271830|FG000|STARTED|Overall Study||115
10141571|NCT02728089|11271830|FG000|Treated|Overall Study||114
10141572|NCT02728089|11271830|FG000|COMPLETED|Overall Study||112
10141573|NCT02728089|11271830|FG000|NOT COMPLETED|Overall Study||3
10141574|NCT02728102|11271837|FG000|STARTED|Overall Study||68
10141575|NCT02728102|11271838|FG001|STARTED|Overall Study||37
10141576|NCT02728102|11271839|FG002|STARTED|Overall Study||35
10141577|NCT02728102|11271837|FG000|COMPLETED|Overall Study||67
10141578|NCT02728102|11271838|FG001|COMPLETED|Overall Study||35
10141579|NCT02728102|11271839|FG002|COMPLETED|Overall Study||33
10141580|NCT02728102|11271837|FG000|NOT COMPLETED|Overall Study||1
10141581|NCT02728102|11271838|FG001|NOT COMPLETED|Overall Study||2
10141582|NCT02728102|11271839|FG002|NOT COMPLETED|Overall Study||2
10141583|NCT02728206|11271846|FG000|STARTED|Overall Study||9
10141584|NCT02728206|11271846|FG000|COMPLETED|Overall Study||8
10141585|NCT02728206|11271846|FG000|NOT COMPLETED|Overall Study||1
10141586|NCT02728830|11271850|FG000|STARTED|Overall Study||39
10141587|NCT02728830|11271850|FG000|COMPLETED|Overall Study||15
10141588|NCT02728830|11271850|FG000|NOT COMPLETED|Overall Study||24
10141589|NCT02728895|11271856|FG000|STARTED|Overall Study||3
10141590|NCT02728895|11271857|FG001|STARTED|Overall Study||21
10141591|NCT02728895|11271856|FG000|COMPLETED|Overall Study||2
10141592|NCT02728895|11271857|FG001|COMPLETED|Overall Study||16
10141593|NCT02728895|11271856|FG000|NOT COMPLETED|Overall Study||1
10141594|NCT02728895|11271857|FG001|NOT COMPLETED|Overall Study||5
10141595|NCT02729025|11271865|FG000|STARTED|Overall Study||64
10141596|NCT02729025|11271866|FG001|STARTED|Overall Study||65
10141597|NCT02729025|11271865|FG000|COMPLETED|Overall Study||64
10141598|NCT02729025|11271866|FG001|COMPLETED|Overall Study||64
10141599|NCT02729025|11271865|FG000|NOT COMPLETED|Overall Study||0
10141600|NCT02729025|11271866|FG001|NOT COMPLETED|Overall Study||1
10141601|NCT02729038|11271876|FG000|STARTED|Part 1 (Up to 44 Days)||8
10141602|NCT02729038|11271877|FG001|STARTED|Part 1 (Up to 44 Days)||8
10141603|NCT02729038|11271878|FG002|STARTED|Part 1 (Up to 44 Days)||8
10141604|NCT02729038|11271879|FG003|STARTED|Part 1 (Up to 44 Days)||0
10141605|NCT02729038|11271876|FG000|COMPLETED|Part 1 (Up to 44 Days)||8
10141606|NCT02729038|11271877|FG001|COMPLETED|Part 1 (Up to 44 Days)||8
10141607|NCT02729038|11271878|FG002|COMPLETED|Part 1 (Up to 44 Days)||8
10141608|NCT02729038|11271879|FG003|COMPLETED|Part 1 (Up to 44 Days)||0
10141609|NCT02729038|11271876|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10141610|NCT02729038|11271877|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10141611|NCT02729038|11271878|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10141612|NCT02729038|11271879|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10141613|NCT02729038|11271876|FG000|STARTED|Part 2 (Up to 50 Days)||0
10141614|NCT02729038|11271877|FG001|STARTED|Part 2 (Up to 50 Days)||0
10141615|NCT02729038|11271878|FG002|STARTED|Part 2 (Up to 50 Days)||0
10141616|NCT02729038|11271879|FG003|STARTED|Part 2 (Up to 50 Days)||8
10141617|NCT02729038|11271876|FG000|COMPLETED|Part 2 (Up to 50 Days)||0
10141618|NCT02729038|11271877|FG001|COMPLETED|Part 2 (Up to 50 Days)||0
10141619|NCT02729038|11271878|FG002|COMPLETED|Part 2 (Up to 50 Days)||0
10141620|NCT02729038|11271879|FG003|COMPLETED|Part 2 (Up to 50 Days)||8
10141621|NCT02729038|11271876|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10141622|NCT02729038|11271877|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10141623|NCT02729038|11271878|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10141624|NCT02729038|11271879|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10141625|NCT02729051|11271898|FG000|STARTED|Overall Study||527
10141626|NCT02729051|11271899|FG001|STARTED|Overall Study||528
10141627|NCT02729051|11271898|FG000|COMPLETED|Overall Study||497
10141628|NCT02729051|11271899|FG001|COMPLETED|Overall Study||496
10141629|NCT02729051|11271898|FG000|NOT COMPLETED|Overall Study||30
10141630|NCT02729051|11271899|FG001|NOT COMPLETED|Overall Study||32
10141631|NCT02729194|11271905|FG000|STARTED|Overall Study||16
10141632|NCT02729194|11271905|FG000|COMPLETED|Overall Study||13
10141633|NCT02729194|11271905|FG000|NOT COMPLETED|Overall Study||3
10141634|NCT02729545|11271911|FG000|STARTED|Overall Study||30
10141635|NCT02729545|11271912|FG001|STARTED|Overall Study||30
10141636|NCT02729545|11271911|FG000|COMPLETED|Overall Study||27
10141637|NCT02729545|11271912|FG001|COMPLETED|Overall Study||25
10141638|NCT02729545|11271911|FG000|NOT COMPLETED|Overall Study||3
10141639|NCT02729545|11271912|FG001|NOT COMPLETED|Overall Study||5
10141640|NCT02729740|11271918|FG000|STARTED|Overall Study||995
10141641|NCT02729740|11271918|FG000|COMPLETED|Overall Study||864
10141642|NCT02729740|11271918|FG000|NOT COMPLETED|Overall Study||131
10141643|NCT02729831|11271926|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
10141644|NCT02729831|11271927|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
10141645|NCT02729831|11271928|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
10141646|NCT02729831|11271929|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
10141647|NCT02729831|11271926|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
10141648|NCT02729831|11271927|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
10141649|NCT02729831|11271928|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
10141650|NCT02729831|11271929|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
10141651|NCT02729831|11271926|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
10141652|NCT02729831|11271927|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
10141653|NCT02729831|11271928|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
10141654|NCT02729831|11271929|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
10141655|NCT02729831|11271926|FG000|STARTED|1 Week Post-visit||282
10141656|NCT02729831|11271927|FG001|STARTED|1 Week Post-visit||292
10141657|NCT02729831|11271928|FG002|STARTED|1 Week Post-visit||275
10141658|NCT02729831|11271929|FG003|STARTED|1 Week Post-visit||275
10141659|NCT02729831|11271926|FG000|COMPLETED|1 Week Post-visit||239
10141660|NCT02729831|11271927|FG001|COMPLETED|1 Week Post-visit||252
10141661|NCT02729831|11271928|FG002|COMPLETED|1 Week Post-visit||237
10141662|NCT02729831|11271929|FG003|COMPLETED|1 Week Post-visit||239
10141663|NCT02729831|11271926|FG000|NOT COMPLETED|1 Week Post-visit||43
10141664|NCT02729831|11271927|FG001|NOT COMPLETED|1 Week Post-visit||40
10141665|NCT02729831|11271928|FG002|NOT COMPLETED|1 Week Post-visit||38
10141666|NCT02729831|11271929|FG003|NOT COMPLETED|1 Week Post-visit||36
10141667|NCT02729831|11271926|FG000|STARTED|6 Month Follow-up||282
10141668|NCT02729831|11271927|FG001|STARTED|6 Month Follow-up||292
10141669|NCT02729831|11271928|FG002|STARTED|6 Month Follow-up||275
10141670|NCT02729831|11271929|FG003|STARTED|6 Month Follow-up||275
10141671|NCT02729831|11271926|FG000|COMPLETED|6 Month Follow-up||227
10141672|NCT02729831|11271927|FG001|COMPLETED|6 Month Follow-up||238
10141673|NCT02729831|11271928|FG002|COMPLETED|6 Month Follow-up||227
10141674|NCT02729831|11271929|FG003|COMPLETED|6 Month Follow-up||232
10141675|NCT02729831|11271926|FG000|NOT COMPLETED|6 Month Follow-up||55
10141676|NCT02729831|11271927|FG001|NOT COMPLETED|6 Month Follow-up||54
10141677|NCT02729831|11271928|FG002|NOT COMPLETED|6 Month Follow-up||48
10141678|NCT02729831|11271929|FG003|NOT COMPLETED|6 Month Follow-up||43
10141679|NCT02729896|11271942|FG000|STARTED|Overall Study||3
10141680|NCT02729896|11271943|FG001|STARTED|Overall Study||10
10141681|NCT02729896|11271944|FG002|STARTED|Overall Study||23
10141682|NCT02729896|11271942|FG000|COMPLETED|Overall Study||1
10141683|NCT02729896|11271943|FG001|COMPLETED|Overall Study||1
10141684|NCT02729896|11271944|FG002|COMPLETED|Overall Study||1
10141685|NCT02729896|11271942|FG000|NOT COMPLETED|Overall Study||2
10141686|NCT02729896|11271943|FG001|NOT COMPLETED|Overall Study||9
10141687|NCT02729896|11271944|FG002|NOT COMPLETED|Overall Study||22
10141688|NCT02729909|11271955|FG000|STARTED|Overall Study||105
10141689|NCT02729909|11271956|FG001|STARTED|Overall Study||106
10141690|NCT02729909|11271955|FG000|COMPLETED|Overall Study||104
10141691|NCT02729909|11271956|FG001|COMPLETED|Overall Study||101
10141692|NCT02729909|11271955|FG000|NOT COMPLETED|Overall Study||1
10141693|NCT02729909|11271956|FG001|NOT COMPLETED|Overall Study||5
10141694|NCT02730169|11271966|FG000|STARTED|Overall Study||67
10141695|NCT02730169|11271967|FG001|STARTED|Overall Study||66
10141696|NCT02730169|11271968|FG002|STARTED|Overall Study||67
10141697|NCT02730169|11271969|FG003|STARTED|Overall Study||71
10141698|NCT02730169|11271966|FG000|COMPLETED|Overall Study||53
10141699|NCT02730169|11271967|FG001|COMPLETED|Overall Study||45
10141700|NCT02730169|11271968|FG002|COMPLETED|Overall Study||50
10141701|NCT02730169|11271969|FG003|COMPLETED|Overall Study||55
10141702|NCT02730169|11271966|FG000|NOT COMPLETED|Overall Study||14
10141703|NCT02730169|11271967|FG001|NOT COMPLETED|Overall Study||21
10141704|NCT02730169|11271968|FG002|NOT COMPLETED|Overall Study||17
10141705|NCT02730169|11271969|FG003|NOT COMPLETED|Overall Study||16
10141706|NCT02730195|11271979|FG000|STARTED|Overall Study||9
10141707|NCT02730195|11271979|FG000|COMPLETED|Overall Study||8
10141708|NCT02730195|11271979|FG000|NOT COMPLETED|Overall Study||1
10141709|NCT02730208|11271985|FG000|STARTED|Overall Study||20
10141710|NCT02730208|11271986|FG001|STARTED|Overall Study||21
10141711|NCT02730208|11271985|FG000|COMPLETED|Overall Study||20
10141712|NCT02730208|11271986|FG001|COMPLETED|Overall Study||20
10141713|NCT02730208|11271985|FG000|NOT COMPLETED|Overall Study||0
10141714|NCT02730208|11271986|FG001|NOT COMPLETED|Overall Study||1
10141715|NCT02730234|11271992|FG000|STARTED|Overall Study||60
10141716|NCT02730234|11271992|FG000|COMPLETED|Overall Study|8 Deaths|52
10141717|NCT02730234|11271992|FG000|NOT COMPLETED|Overall Study||8
10141718|NCT02730247|11271996|FG000|STARTED|Overall Study||7
10141719|NCT02730247|11271996|FG000|COMPLETED|Overall Study||7
10141720|NCT02730247|11271996|FG000|NOT COMPLETED|Overall Study||0
10141721|NCT02730260|11272002|FG000|STARTED|Overall Study||258
10141722|NCT02730260|11272003|FG001|STARTED|Overall Study||260
10141723|NCT02730260|11272002|FG000|COMPLETED|Overall Study||176
10141724|NCT02730260|11272003|FG001|COMPLETED|Overall Study||185
10141725|NCT02730260|11272002|FG000|NOT COMPLETED|Overall Study||82
10141726|NCT02730260|11272003|FG001|NOT COMPLETED|Overall Study||75
10141727|NCT02730351|11272009|FG000|STARTED|Treatment Period 1 (2 Weeks)||37
10141728|NCT02730351|11272010|FG001|STARTED|Treatment Period 1 (2 Weeks)||37
10141729|NCT02730351|11272009|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36
10141730|NCT02730351|11272010|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37
10141731|NCT02730351|11272009|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
10141732|NCT02730351|11272010|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10141733|NCT02730351|11272009|FG000|STARTED|Wash-out Period (2 Weeks)||36
10141734|NCT02730351|11272010|FG001|STARTED|Wash-out Period (2 Weeks)||37
10141735|NCT02730351|11272009|FG000|COMPLETED|Wash-out Period (2 Weeks)||35
10141736|NCT02730351|11272010|FG001|COMPLETED|Wash-out Period (2 Weeks)||36
10141737|NCT02730351|11272009|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1
10141738|NCT02730351|11272010|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1
10141739|NCT02730351|11272009|FG000|STARTED|Treatment Period 2 (2 Weeks)||35
10141740|NCT02730351|11272010|FG001|STARTED|Treatment Period 2 (2 Weeks)||36
10141741|NCT02730351|11272009|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33
10141742|NCT02730351|11272010|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36
10141743|NCT02730351|11272009|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
10141744|NCT02730351|11272010|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10141745|NCT02730377|11272018|FG000|STARTED|Overall Study||996
10141746|NCT02730377|11272019|FG001|STARTED|Overall Study||995
10141747|NCT02730377|11272018|FG000|Treated|Overall Study||980
10141748|NCT02730377|11272019|FG001|Treated|Overall Study||984
10141749|NCT02730377|11272018|FG000|Full Analysis Set (FAS)|Overall Study||996
10141750|NCT02730377|11272019|FG001|Full Analysis Set (FAS)|Overall Study||995
10141751|NCT02730377|11272018|FG000|Safety Analysis Set (SAS)|Overall Study||980
10141752|NCT02730377|11272019|FG001|Safety Analysis Set (SAS)|Overall Study||984
10141753|NCT02730377|11272018|FG000|COMPLETED|Overall Study||446
10141754|NCT02730377|11272019|FG001|COMPLETED|Overall Study||362
10141755|NCT02730377|11272018|FG000|NOT COMPLETED|Overall Study||550
10141756|NCT02730377|11272019|FG001|NOT COMPLETED|Overall Study||633
10141757|NCT02730403|11272025|FG000|STARTED|Overall Study||211
10141758|NCT02730403|11272025|FG000|COMPLETED|Overall Study||157
10141759|NCT02730403|11272025|FG000|NOT COMPLETED|Overall Study||54
10141760|NCT02730455|11272033|FG000|STARTED|Overall Study||94
10141761|NCT02730455|11272034|FG001|STARTED|Overall Study||91
10141762|NCT02730455|11272035|FG002|STARTED|Overall Study||92
10141763|NCT02730455|11272033|FG000|Safety Population|Overall Study||91
10141764|NCT02730455|11272034|FG001|Safety Population|Overall Study||90
10141765|NCT02730455|11272035|FG002|Safety Population|Overall Study||89
10141766|NCT02730455|11272033|FG000|Participants Dosed|Overall Study||91
10141767|NCT02730455|11272034|FG001|Participants Dosed|Overall Study||88
10141768|NCT02730455|11272035|FG002|Participants Dosed|Overall Study||91
10141769|NCT02730455|11272033|FG000|Who Received Total Volume of Study Drug|Overall Study||90
10141770|NCT02730455|11272034|FG001|Who Received Total Volume of Study Drug|Overall Study||88
10141771|NCT02730455|11272035|FG002|Who Received Total Volume of Study Drug|Overall Study||89
10141772|NCT02730455|11272033|FG000|COMPLETED|Overall Study||81
10141773|NCT02730455|11272034|FG001|COMPLETED|Overall Study||77
10141774|NCT02730455|11272035|FG002|COMPLETED|Overall Study||81
10141775|NCT02730455|11272033|FG000|NOT COMPLETED|Overall Study||13
10141776|NCT02730455|11272034|FG001|NOT COMPLETED|Overall Study||14
10141777|NCT02730455|11272035|FG002|NOT COMPLETED|Overall Study||11
10141778|NCT02730598|11272045|FG000|STARTED|Overall Study||14
10141779|NCT02730598|11272046|FG001|STARTED|Overall Study||14
10141780|NCT02730598|11272045|FG000|COMPLETED|Overall Study||10
10141781|NCT02730598|11272046|FG001|COMPLETED|Overall Study||10
10141782|NCT02730598|11272045|FG000|NOT COMPLETED|Overall Study||4
10141783|NCT02730598|11272046|FG001|NOT COMPLETED|Overall Study||4
10141784|NCT02730663|11272052|FG000|STARTED|Overall Study||36
10141785|NCT02730663|11272052|FG000|COMPLETED|Overall Study||35
10141786|NCT02730663|11272052|FG000|NOT COMPLETED|Overall Study||1
10141787|NCT02730728|11272059|FG000|STARTED|Overall Study||53
10141788|NCT02730728|11272060|FG001|STARTED|Overall Study||53
10141789|NCT02730728|11272061|FG002|STARTED|Overall Study||53
10141790|NCT02730728|11272059|FG000|COMPLETED|Overall Study||53
10141791|NCT02730728|11272060|FG001|COMPLETED|Overall Study||51
10141792|NCT02730728|11272061|FG002|COMPLETED|Overall Study||52
10141793|NCT02730728|11272059|FG000|NOT COMPLETED|Overall Study||0
10141794|NCT02730728|11272060|FG001|NOT COMPLETED|Overall Study||2
10141795|NCT02730728|11272061|FG002|NOT COMPLETED|Overall Study||1
10141796|NCT02730819|11272069|FG000|STARTED|Overall Study||19
10141797|NCT02730819|11272069|FG000|Follow-up Week 2|Overall Study||15
10141798|NCT02730819|11272069|FG000|Follow-up Week 4|Overall Study||16
10141799|NCT02730819|11272069|FG000|Follow-up Week 8|Overall Study||14
10141800|NCT02730819|11272069|FG000|Follow-up Week 12|Overall Study||11
10141801|NCT02730819|11272069|FG000|Follow-up Week 16|Overall Study||11
10141802|NCT02730819|11272069|FG000|Follow-up Week 20|Overall Study||10
10141803|NCT02730819|11272069|FG000|COMPLETED|Overall Study||10
10141804|NCT02730819|11272069|FG000|NOT COMPLETED|Overall Study||9
10141805|NCT02730871|11272075|FG000|STARTED|Overall Study||67
10141806|NCT02730871|11272076|FG001|STARTED|Overall Study||67
10141807|NCT02730871|11272075|FG000|Full Analysis Set (FAS)|Overall Study||67
10141808|NCT02730871|11272076|FG001|Full Analysis Set (FAS)|Overall Study||67
10141809|NCT02730871|11272075|FG000|Safety Analysis Set|Overall Study||67
10141810|NCT02730871|11272076|FG001|Safety Analysis Set|Overall Study||67
10141811|NCT02730871|11272075|FG000|COMPLETED|Overall Study||61
10141812|NCT02730871|11272076|FG001|COMPLETED|Overall Study||67
10141813|NCT02730871|11272075|FG000|NOT COMPLETED|Overall Study||6
10141814|NCT02730871|11272076|FG001|NOT COMPLETED|Overall Study||0
10141815|NCT02730884|11272082|FG000|STARTED|Overall Study||3
10141816|NCT02730884|11272082|FG000|COMPLETED|Overall Study||3
10141817|NCT02730884|11272082|FG000|NOT COMPLETED|Overall Study||0
10141818|NCT02730962|11272088|FG000|STARTED|Overall Study||7
10141819|NCT02730962|11272089|FG001|STARTED|Overall Study||5
10141820|NCT02730962|11272088|FG000|COMPLETED|Overall Study||7
10141821|NCT02730962|11272089|FG001|COMPLETED|Overall Study||5
10141822|NCT02730962|11272088|FG000|NOT COMPLETED|Overall Study||0
10141823|NCT02730962|11272089|FG001|NOT COMPLETED|Overall Study||0
10141824|NCT02730988|11272097|FG000|STARTED|Overall Study||47
10141825|NCT02730988|11272098|FG001|STARTED|Overall Study||49
10141826|NCT02730988|11272097|FG000|COMPLETED|Overall Study||43
10141827|NCT02730988|11272098|FG001|COMPLETED|Overall Study||39
10141828|NCT02730988|11272097|FG000|NOT COMPLETED|Overall Study||4
10141829|NCT02730988|11272098|FG001|NOT COMPLETED|Overall Study||10
10141830|NCT02731131|11272106|FG000|STARTED|Overall Study||6
10141831|NCT02731131|11272107|FG001|STARTED|Overall Study||6
10141832|NCT02731131|11272106|FG000|COMPLETED|Overall Study||6
10141833|NCT02731131|11272107|FG001|COMPLETED|Overall Study||4
10141834|NCT02731131|11272106|FG000|NOT COMPLETED|Overall Study||0
10141835|NCT02731131|11272107|FG001|NOT COMPLETED|Overall Study||2
10141836|NCT02731157|11272113|FG000|STARTED|First Standard RCE||4
10141837|NCT02731157|11272113|FG000|COMPLETED|First Standard RCE||4
10141838|NCT02731157|11272113|FG000|NOT COMPLETED|First Standard RCE||0
10141839|NCT02731157|11272113|FG000|STARTED|First Rejuvenated RCE||4
10141840|NCT02731157|11272113|FG000|COMPLETED|First Rejuvenated RCE||3
10141841|NCT02731157|11272113|FG000|NOT COMPLETED|First Rejuvenated RCE||1
10141842|NCT02731157|11272113|FG000|STARTED|Second Rejuvenated RCE||3
10141843|NCT02731157|11272113|FG000|COMPLETED|Second Rejuvenated RCE||3
10141844|NCT02731157|11272113|FG000|NOT COMPLETED|Second Rejuvenated RCE||0
10141845|NCT02731157|11272113|FG000|STARTED|Third Rejuvenated RCE||3
10141846|NCT02731157|11272113|FG000|COMPLETED|Third Rejuvenated RCE||3
10141847|NCT02731157|11272113|FG000|NOT COMPLETED|Third Rejuvenated RCE||0
10141848|NCT02731157|11272113|FG000|STARTED|Second Standard RCE||3
10141849|NCT02731157|11272113|FG000|COMPLETED|Second Standard RCE||3
10141850|NCT02731157|11272113|FG000|NOT COMPLETED|Second Standard RCE||0
10141851|NCT02731157|11272113|FG000|STARTED|Third Standard RCE||3
10141852|NCT02731157|11272113|FG000|COMPLETED|Third Standard RCE||3
10141853|NCT02731157|11272113|FG000|NOT COMPLETED|Third Standard RCE||0
10141854|NCT02731300|11272121|FG000|STARTED|Overall Study||15
10141855|NCT02731300|11272122|FG001|STARTED|Overall Study||7
10141856|NCT02731300|11272121|FG000|COMPLETED|Overall Study||15
10141857|NCT02731300|11272122|FG001|COMPLETED|Overall Study||7
10141858|NCT02731300|11272121|FG000|NOT COMPLETED|Overall Study||0
10141859|NCT02731300|11272122|FG001|NOT COMPLETED|Overall Study||0
10141860|NCT02731313|11272128|FG000|STARTED|Overall Study||367
10141861|NCT02731313|11272128|FG000|COMPLETED|Overall Study||367
10141862|NCT02731313|11272128|FG000|NOT COMPLETED|Overall Study||0
10141863|NCT02731469|11272143|FG000|STARTED|Overall Study||3
10141864|NCT02731469|11272144|FG001|STARTED|Overall Study||3
10141865|NCT02731469|11272145|FG002|STARTED|Overall Study||3
10141866|NCT02731469|11272146|FG003|STARTED|Overall Study||3
10141867|NCT02731469|11272147|FG004|STARTED|Overall Study||3
10141868|NCT02731469|11272148|FG005|STARTED|Overall Study||3
10141869|NCT02731469|11272149|FG006|STARTED|Overall Study||3
10141870|NCT02731469|11272150|FG007|STARTED|Overall Study||6
10141871|NCT02731469|11272151|FG008|STARTED|Overall Study||6
10141872|NCT02731469|11272152|FG009|STARTED|Overall Study||6
10141873|NCT02731469|11272153|FG010|STARTED|Overall Study||6
10141874|NCT02731469|11272143|FG000|COMPLETED|Overall Study||3
10141875|NCT02731469|11272144|FG001|COMPLETED|Overall Study||3
10141876|NCT02731469|11272145|FG002|COMPLETED|Overall Study||3
10141877|NCT02731469|11272146|FG003|COMPLETED|Overall Study||3
10141878|NCT02731469|11272147|FG004|COMPLETED|Overall Study||3
10141879|NCT02731469|11272148|FG005|COMPLETED|Overall Study||3
10141880|NCT02731469|11272149|FG006|COMPLETED|Overall Study||3
10141881|NCT02731469|11272150|FG007|COMPLETED|Overall Study||6
10141882|NCT02731469|11272151|FG008|COMPLETED|Overall Study||6
10141883|NCT02731469|11272152|FG009|COMPLETED|Overall Study||6
10141884|NCT02731469|11272153|FG010|COMPLETED|Overall Study||6
10141885|NCT02731469|11272143|FG000|NOT COMPLETED|Overall Study||0
10141886|NCT02731469|11272144|FG001|NOT COMPLETED|Overall Study||0
10141887|NCT02731469|11272145|FG002|NOT COMPLETED|Overall Study||0
10141888|NCT02731469|11272146|FG003|NOT COMPLETED|Overall Study||0
10141889|NCT02731469|11272147|FG004|NOT COMPLETED|Overall Study||0
10141890|NCT02731469|11272148|FG005|NOT COMPLETED|Overall Study||0
10141891|NCT02731469|11272149|FG006|NOT COMPLETED|Overall Study||0
10141892|NCT02731469|11272150|FG007|NOT COMPLETED|Overall Study||0
10141893|NCT02731469|11272151|FG008|NOT COMPLETED|Overall Study||0
10141894|NCT02731469|11272152|FG009|NOT COMPLETED|Overall Study||0
10141895|NCT02731469|11272153|FG010|NOT COMPLETED|Overall Study||0
10141896|NCT02731638|11272179|FG000|STARTED|Overall Study||35
10141897|NCT02731638|11272180|FG001|STARTED|Overall Study||35
10141898|NCT02731638|11272179|FG000|COMPLETED|Overall Study||29
10141899|NCT02731638|11272180|FG001|COMPLETED|Overall Study||26
10141900|NCT02731638|11272179|FG000|NOT COMPLETED|Overall Study||6
10141901|NCT02731638|11272180|FG001|NOT COMPLETED|Overall Study||9
10141902|NCT02731690|11272186|FG000|STARTED|Overall Study||42
10141903|NCT02731690|11272186|FG000|COMPLETED|Overall Study||12
10141904|NCT02731690|11272186|FG000|NOT COMPLETED|Overall Study||30
10141905|NCT02731729|11272192|FG000|STARTED|Overall Study||10
10141906|NCT02731729|11272193|FG001|STARTED|Overall Study||10
10141907|NCT02731729|11272192|FG000|COMPLETED|Overall Study||1
10141908|NCT02731729|11272193|FG001|COMPLETED|Overall Study||2
10141909|NCT02731729|11272192|FG000|NOT COMPLETED|Overall Study||9
10141910|NCT02731729|11272193|FG001|NOT COMPLETED|Overall Study||8
10141911|NCT02731742|11272203|FG000|STARTED|Overall Study||3
10141912|NCT02731742|11272204|FG001|STARTED|Overall Study||3
10141913|NCT02731742|11272205|FG002|STARTED|Overall Study||6
10141914|NCT02731742|11272206|FG003|STARTED|Overall Study||2
10141915|NCT02731742|11272203|FG000|COMPLETED|Overall Study||0
10141916|NCT02731742|11272204|FG001|COMPLETED|Overall Study||0
10141917|NCT02731742|11272205|FG002|COMPLETED|Overall Study||0
10141918|NCT02731742|11272206|FG003|COMPLETED|Overall Study||0
10141919|NCT02731742|11272203|FG000|NOT COMPLETED|Overall Study||3
10141920|NCT02731742|11272204|FG001|NOT COMPLETED|Overall Study||3
10141921|NCT02731742|11272205|FG002|NOT COMPLETED|Overall Study||6
10141922|NCT02731742|11272206|FG003|NOT COMPLETED|Overall Study||2
10141923|NCT02731755|11272216|FG000|STARTED|First Intervention||8
10141924|NCT02731755|11272217|FG001|STARTED|First Intervention||10
10141925|NCT02731755|11272216|FG000|COMPLETED|First Intervention||8
10141926|NCT02731755|11272217|FG001|COMPLETED|First Intervention||8
10141927|NCT02731755|11272216|FG000|NOT COMPLETED|First Intervention||0
10141928|NCT02731755|11272217|FG001|NOT COMPLETED|First Intervention||2
10141929|NCT02731755|11272216|FG000|STARTED|Second Intervention||8
10141930|NCT02731755|11272217|FG001|STARTED|Second Intervention||8
10141931|NCT02731755|11272216|FG000|COMPLETED|Second Intervention||8
10141932|NCT02731755|11272217|FG001|COMPLETED|Second Intervention||8
10141933|NCT02731755|11272216|FG000|NOT COMPLETED|Second Intervention||0
10141934|NCT02731755|11272217|FG001|NOT COMPLETED|Second Intervention||0
10141935|NCT02731820|11272225|FG000|STARTED|Overall Study||20
10141936|NCT02731820|11272226|FG001|STARTED|Overall Study||20
10141937|NCT02731820|11272225|FG000|COMPLETED|Overall Study||17
10141938|NCT02731820|11272226|FG001|COMPLETED|Overall Study||18
10141939|NCT02731820|11272225|FG000|NOT COMPLETED|Overall Study||3
10141940|NCT02731820|11272226|FG001|NOT COMPLETED|Overall Study||2
10141941|NCT02731833|11272234|FG000|STARTED|Overall Study||111
10141942|NCT02731833|11272235|FG001|STARTED|Overall Study||111
10141943|NCT02731833|11272234|FG000|COMPLETED|Overall Study||111
10141944|NCT02731833|11272235|FG001|COMPLETED|Overall Study||111
10141945|NCT02731833|11272234|FG000|NOT COMPLETED|Overall Study||0
10141946|NCT02731833|11272235|FG001|NOT COMPLETED|Overall Study||0
10141947|NCT02732015|11272243|FG000|STARTED|Overall Study||9
10141948|NCT02732015|11272244|FG001|STARTED|Overall Study||27
10141949|NCT02732015|11272243|FG000|COMPLETED|Overall Study||9
10141950|NCT02732015|11272244|FG001|COMPLETED|Overall Study||26
10141951|NCT02732015|11272243|FG000|NOT COMPLETED|Overall Study||0
10141952|NCT02732015|11272244|FG001|NOT COMPLETED|Overall Study||1
10141953|NCT02732119|11272255|FG000|STARTED|Phase I||8
10141954|NCT02732119|11272256|FG001|STARTED|Phase I||10
10141955|NCT02732119|11272257|FG002|STARTED|Phase I||7
10141956|NCT02732119|11272258|FG003|STARTED|Phase I||0
10141957|NCT02732119|11272259|FG004|STARTED|Phase I||0
10141958|NCT02732119|11272255|FG000|COMPLETED|Phase I||0
10141959|NCT02732119|11272256|FG001|COMPLETED|Phase I||0
10141960|NCT02732119|11272257|FG002|COMPLETED|Phase I||0
10141961|NCT02732119|11272258|FG003|COMPLETED|Phase I||0
10141962|NCT02732119|11272259|FG004|COMPLETED|Phase I||0
10141963|NCT02732119|11272255|FG000|NOT COMPLETED|Phase I||8
10141964|NCT02732119|11272256|FG001|NOT COMPLETED|Phase I||10
10141965|NCT02732119|11272257|FG002|NOT COMPLETED|Phase I||7
10141966|NCT02732119|11272258|FG003|NOT COMPLETED|Phase I||0
10141967|NCT02732119|11272259|FG004|NOT COMPLETED|Phase I||0
10141968|NCT02732119|11272255|FG000|STARTED|Phase II||0
10141969|NCT02732119|11272256|FG001|STARTED|Phase II||0
10141970|NCT02732119|11272257|FG002|STARTED|Phase II||0
10141971|NCT02732119|11272258|FG003|STARTED|Phase II||46
10141972|NCT02732119|11272259|FG004|STARTED|Phase II||33
10141973|NCT02732119|11272255|FG000|Protocol Analysis Set|Phase II||0
10141974|NCT02732119|11272256|FG001|Protocol Analysis Set|Phase II||0
10141975|NCT02732119|11272257|FG002|Protocol Analysis Set|Phase II||0
10141976|NCT02732119|11272258|FG003|Protocol Analysis Set|Phase II||46
10141977|NCT02732119|11272259|FG004|Protocol Analysis Set|Phase II||32
10141978|NCT02732119|11272255|FG000|COMPLETED|Phase II||0
10141979|NCT02732119|11272256|FG001|COMPLETED|Phase II||0
10141980|NCT02732119|11272257|FG002|COMPLETED|Phase II||0
10141981|NCT02732119|11272258|FG003|COMPLETED|Phase II||0
10141982|NCT02732119|11272259|FG004|COMPLETED|Phase II||0
10141983|NCT02732119|11272255|FG000|NOT COMPLETED|Phase II||0
10141984|NCT02732119|11272256|FG001|NOT COMPLETED|Phase II||0
10141985|NCT02732119|11272257|FG002|NOT COMPLETED|Phase II||0
10141986|NCT02732119|11272258|FG003|NOT COMPLETED|Phase II||46
10141987|NCT02732119|11272259|FG004|NOT COMPLETED|Phase II||33
10141988|NCT02732145|11272275|FG000|STARTED|Overall Study||82
10141989|NCT02732145|11272276|FG001|STARTED|Overall Study||82
10141990|NCT02732145|11272277|FG002|STARTED|Overall Study||82
10141991|NCT02732145|11272278|FG003|STARTED|Overall Study||82
10141992|NCT02732145|11272275|FG000|COMPLETED|Overall Study||82
10141993|NCT02732145|11272276|FG001|COMPLETED|Overall Study||82
10141994|NCT02732145|11272277|FG002|COMPLETED|Overall Study||82
10141995|NCT02732145|11272278|FG003|COMPLETED|Overall Study||82
10141996|NCT02732145|11272275|FG000|NOT COMPLETED|Overall Study||0
10141997|NCT02732145|11272276|FG001|NOT COMPLETED|Overall Study||0
10141998|NCT02732145|11272277|FG002|NOT COMPLETED|Overall Study||0
10141999|NCT02732145|11272278|FG003|NOT COMPLETED|Overall Study||0
10142000|NCT02732210|11272310|FG000|STARTED|Overall Study||303
10142001|NCT02732210|11272311|FG001|STARTED|Overall Study||632
10142002|NCT02732210|11272310|FG000|COMPLETED|Overall Study||218
9707538|NCT03531632|10806715|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5
9707539|NCT03531632|10806716|FG001|Safety Population|Overall Study||3
10142003|NCT02732210|11272311|FG001|COMPLETED|Overall Study||338
10142004|NCT02732210|11272310|FG000|NOT COMPLETED|Overall Study||85
10142005|NCT02732210|11272311|FG001|NOT COMPLETED|Overall Study||294
10142006|NCT02732366|11272319|FG000|STARTED|Overall Study||23
10142007|NCT02732366|11272320|FG001|STARTED|Overall Study||23
10142008|NCT02732366|11272319|FG000|Withdrawal by Participant|Overall Study||5
10142009|NCT02732366|11272320|FG001|Withdrawal by Participant|Overall Study||2
10142010|NCT02732366|11272319|FG000|COMPLETED|Overall Study||18
10142011|NCT02732366|11272320|FG001|COMPLETED|Overall Study||21
10142012|NCT02732366|11272319|FG000|NOT COMPLETED|Overall Study||5
10142013|NCT02732366|11272320|FG001|NOT COMPLETED|Overall Study||2
10142014|NCT02732561|11272331|FG000|STARTED|Overall Study||5
10142015|NCT02732561|11272332|FG001|STARTED|Overall Study||5
10142016|NCT02732561|11272331|FG000|COMPLETED|Overall Study||3
10142017|NCT02732561|11272332|FG001|COMPLETED|Overall Study||4
10142018|NCT02732561|11272331|FG000|NOT COMPLETED|Overall Study||2
10142019|NCT02732561|11272332|FG001|NOT COMPLETED|Overall Study||1
10142020|NCT02732587|11272338|FG000|STARTED|Overall Study||5
10142021|NCT02732587|11272338|FG000|COMPLETED|Overall Study||5
10142022|NCT02732587|11272338|FG000|NOT COMPLETED|Overall Study||0
10142023|NCT02732600|11272344|FG000|STARTED|Overall Study||3525
10142024|NCT02732600|11272345|FG001|STARTED|Overall Study||2091
10142025|NCT02732600|11272344|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
10142026|NCT02732600|11272345|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
10142027|NCT02732600|11272344|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
10142028|NCT02732600|11272345|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
10142029|NCT02732600|11272344|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
10142030|NCT02732600|11272345|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
10142031|NCT02732600|11272344|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
10142032|NCT02732600|11272345|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
10142033|NCT02732600|11272344|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
10142034|NCT02732600|11272345|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
10142035|NCT02732600|11272344|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
10142036|NCT02732600|11272345|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
10142037|NCT02732600|11272344|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
10142038|NCT02732600|11272345|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
10142039|NCT02732600|11272344|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6
10142040|NCT02732600|11272345|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10
10142041|NCT02732600|11272344|FG000|COMPLETED|Overall Study||100
10142042|NCT02732600|11272345|FG001|COMPLETED|Overall Study||113
10142043|NCT02732600|11272344|FG000|NOT COMPLETED|Overall Study||3425
10142044|NCT02732600|11272345|FG001|NOT COMPLETED|Overall Study||1978
10142045|NCT02732639|11272352|FG000|STARTED|Overall Study||31
10142046|NCT02732639|11272352|FG000|COMPLETED|Overall Study||30
10142047|NCT02732639|11272352|FG000|NOT COMPLETED|Overall Study||1
10142048|NCT02732847|11272358|FG000|STARTED|Overall Study||75
10142049|NCT02732847|11272359|FG001|STARTED|Overall Study||74
10142050|NCT02732847|11272358|FG000|COMPLETED|Overall Study||33
10142051|NCT02732847|11272359|FG001|COMPLETED|Overall Study||32
10142052|NCT02732847|11272358|FG000|NOT COMPLETED|Overall Study||42
10142053|NCT02732847|11272359|FG001|NOT COMPLETED|Overall Study||42
10142054|NCT02732899|11272367|FG000|STARTED|Overall Study||10
10142055|NCT02732899|11272368|FG001|STARTED|Overall Study||10
10142056|NCT02732899|11272367|FG000|COMPLETED|Overall Study||10
10142057|NCT02732899|11272368|FG001|COMPLETED|Overall Study||10
9707540|NCT03531632|10806717|FG002|Safety Population|Overall Study||28
9707541|NCT03531632|10806715|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5
9707542|NCT03531632|10806716|FG001|Response Evaluable Population|Overall Study||3
9707543|NCT03531632|10806717|FG002|Response Evaluable Population|Overall Study||24
9707544|NCT03531632|10806715|FG000|COMPLETED|Overall Study||0
9707545|NCT03531632|10806716|FG001|COMPLETED|Overall Study||0
9707546|NCT03531632|10806717|FG002|COMPLETED|Overall Study||2
9707547|NCT03531632|10806715|FG000|NOT COMPLETED|Overall Study||5
9707548|NCT03531632|10806716|FG001|NOT COMPLETED|Overall Study||3
9707549|NCT03531632|10806717|FG002|NOT COMPLETED|Overall Study||26
9707550|NCT03488030|10806728|FG000|STARTED|Overall Study||101
9707551|NCT03488030|10806729|FG001|STARTED|Overall Study||145
9707552|NCT03488030|10806728|FG000|COMPLETED|Overall Study||101
9707553|NCT03488030|10806729|FG001|COMPLETED|Overall Study||145
9707554|NCT03488030|10806728|FG000|NOT COMPLETED|Overall Study||0
9707555|NCT03488030|10806729|FG001|NOT COMPLETED|Overall Study||0
9707556|NCT03412604|10806740|FG000|STARTED|Overall Study||5
9707557|NCT03412604|10806740|FG000|COMPLETED|Overall Study||4
9707558|NCT03412604|10806740|FG000|NOT COMPLETED|Overall Study||1
9729265|NCT00117572|10828842|FG001|NOT COMPLETED|Overall Study||6
9729266|NCT00117585|10828848|FG000|STARTED|Overall Study||341
9729267|NCT00117585|10828848|FG000|COMPLETED|Overall Study||341
9729268|NCT00117585|10828848|FG000|NOT COMPLETED|Overall Study||0
9729269|NCT00117598|10828855|FG000|STARTED|Prior to Treatment Cross Over||57
9729270|NCT00117598|10828856|FG001|STARTED|Prior to Treatment Cross Over||56
9729271|NCT00117598|10828857|FG002|STARTED|Prior to Treatment Cross Over||56
9729272|NCT00117598|10828858|FG003|STARTED|Prior to Treatment Cross Over||0
9729273|NCT00117598|10828859|FG004|STARTED|Prior to Treatment Cross Over||0
9729274|NCT00117598|10828855|FG000|COMPLETED|Prior to Treatment Cross Over||0
9963851|NCT01488877|11083633|FG000|NOT COMPLETED|Re-randomization||0
10142058|NCT02732899|11272367|FG000|NOT COMPLETED|Overall Study||0
10142059|NCT02732899|11272368|FG001|NOT COMPLETED|Overall Study||0
10142060|NCT02732912|11272376|FG000|STARTED|Overall Study||97
9729275|NCT00117598|10828856|FG001|COMPLETED|Prior to Treatment Cross Over||3
9729276|NCT00117598|10828857|FG002|COMPLETED|Prior to Treatment Cross Over||4
9729277|NCT00117598|10828858|FG003|COMPLETED|Prior to Treatment Cross Over||0
9729278|NCT00117598|10828859|FG004|COMPLETED|Prior to Treatment Cross Over||0
10142061|NCT02732912|11272377|FG001|STARTED|Overall Study||109
10142062|NCT02732912|11272376|FG000|COMPLETED|Overall Study||87
10142063|NCT02732912|11272377|FG001|COMPLETED|Overall Study||91
10142064|NCT02732912|11272376|FG000|NOT COMPLETED|Overall Study||10
10142065|NCT02732912|11272377|FG001|NOT COMPLETED|Overall Study||18
10142066|NCT02732938|11272385|FG000|STARTED|Overall Study||4
10142067|NCT02732938|11272386|FG001|STARTED|Overall Study||18
10142068|NCT02732938|11272387|FG002|STARTED|Overall Study||0
10142069|NCT02732938|11272385|FG000|Received Treatment|Overall Study||4
10142070|NCT02732938|11272386|FG001|Received Treatment|Overall Study||17
10142071|NCT02732938|11272387|FG002|Received Treatment|Overall Study||0
10142072|NCT02732938|11272385|FG000|COMPLETED|Overall Study||0
10142073|NCT02732938|11272386|FG001|COMPLETED|Overall Study||0
10142074|NCT02732938|11272387|FG002|COMPLETED|Overall Study||0
10142075|NCT02732938|11272385|FG000|NOT COMPLETED|Overall Study||4
10142076|NCT02732938|11272386|FG001|NOT COMPLETED|Overall Study||18
10142077|NCT02732938|11272387|FG002|NOT COMPLETED|Overall Study||0
10142078|NCT02732951|11272397|FG000|STARTED|Overall Study||53
10142079|NCT02732951|11272398|FG001|STARTED|Overall Study||52
10142080|NCT02732951|11272397|FG000|COMPLETED|Overall Study||48
10142081|NCT02732951|11272398|FG001|COMPLETED|Overall Study||46
10142082|NCT02732951|11272397|FG000|NOT COMPLETED|Overall Study||5
10142083|NCT02732951|11272398|FG001|NOT COMPLETED|Overall Study||6
9707559|NCT03206073|10806748|FG000|STARTED|Overall Study||4
9707560|NCT03206073|10806749|FG001|STARTED|Overall Study||12
9707561|NCT03206073|10806750|FG002|STARTED|Overall Study||4
9707562|NCT03206073|10806751|FG003|STARTED|Overall Study||14
9707563|NCT03206073|10806748|FG000|COMPLETED|Overall Study||3
9707564|NCT03206073|10806749|FG001|COMPLETED|Overall Study||11
9707565|NCT03206073|10806750|FG002|COMPLETED|Overall Study||0
9707566|NCT03206073|10806751|FG003|COMPLETED|Overall Study||14
9707567|NCT03206073|10806748|FG000|NOT COMPLETED|Overall Study||1
9707568|NCT03206073|10806749|FG001|NOT COMPLETED|Overall Study||1
9707569|NCT03206073|10806750|FG002|NOT COMPLETED|Overall Study||4
9707570|NCT03206073|10806751|FG003|NOT COMPLETED|Overall Study||0
9707571|NCT03195127|10806763|FG000|STARTED|Overall Study||15
9707572|NCT03195127|10806764|FG001|STARTED|Overall Study||18
9707573|NCT03195127|10806763|FG000|COMPLETED|Overall Study||15
9707574|NCT03195127|10806764|FG001|COMPLETED|Overall Study||17
9707575|NCT03195127|10806763|FG000|NOT COMPLETED|Overall Study||0
9707576|NCT03195127|10806764|FG001|NOT COMPLETED|Overall Study||1
9707577|NCT03102034|10806776|FG000|STARTED|Overall Study||21
9707578|NCT03102034|10806777|FG001|STARTED|Overall Study||11
9707579|NCT03102034|10806776|FG000|COMPLETED|Overall Study||20
9707580|NCT03102034|10806777|FG001|COMPLETED|Overall Study||11
9707581|NCT03102034|10806776|FG000|NOT COMPLETED|Overall Study||1
9707582|NCT03102034|10806777|FG001|NOT COMPLETED|Overall Study||0
9707583|NCT03076164|10806783|FG000|STARTED|Overall Study||24
9707584|NCT03076164|10806783|FG000|COMPLETED|Overall Study||24
9707585|NCT03076164|10806783|FG000|NOT COMPLETED|Overall Study||0
9707586|NCT02723864|10806794|FG000|STARTED|Overall Study||3
9707587|NCT02723864|10806795|FG001|STARTED|Overall Study||3
9707588|NCT02723864|10806796|FG002|STARTED|Overall Study||6
9707589|NCT02723864|10806797|FG003|STARTED|Overall Study||7
9707590|NCT02723864|10806798|FG004|STARTED|Overall Study||3
9707591|NCT02723864|10806799|FG005|STARTED|Overall Study||25
9707592|NCT02723864|10806800|FG006|STARTED|Overall Study||6
9707593|NCT02723864|10806794|FG000|COMPLETED|Overall Study||2
9707594|NCT02723864|10806795|FG001|COMPLETED|Overall Study||2
9707595|NCT02723864|10806796|FG002|COMPLETED|Overall Study||5
9707596|NCT02723864|10806797|FG003|COMPLETED|Overall Study||7
9707597|NCT02723864|10806798|FG004|COMPLETED|Overall Study||2
9707598|NCT02723864|10806799|FG005|COMPLETED|Overall Study||14
9707599|NCT02723864|10806800|FG006|COMPLETED|Overall Study||4
9707600|NCT02723864|10806794|FG000|NOT COMPLETED|Overall Study||1
9707601|NCT02723864|10806795|FG001|NOT COMPLETED|Overall Study||1
9707602|NCT02723864|10806796|FG002|NOT COMPLETED|Overall Study||1
9707603|NCT02723864|10806797|FG003|NOT COMPLETED|Overall Study||0
9707604|NCT02723864|10806798|FG004|NOT COMPLETED|Overall Study||1
9707605|NCT02723864|10806799|FG005|NOT COMPLETED|Overall Study||11
9707606|NCT02723864|10806800|FG006|NOT COMPLETED|Overall Study||2
9707607|NCT02701556|10806839|FG000|STARTED|Overall Study||198
9707608|NCT02701556|10806840|FG001|STARTED|Overall Study||198
9707609|NCT02701556|10806839|FG000|COMPLETED|Overall Study||175
9707610|NCT02701556|10806840|FG001|COMPLETED|Overall Study||178
9707611|NCT02701556|10806839|FG000|NOT COMPLETED|Overall Study||23
9707612|NCT02701556|10806840|FG001|NOT COMPLETED|Overall Study||20
9707613|NCT02691013|10806848|FG000|STARTED|Overall Study||61
9707614|NCT02691013|10806849|FG001|STARTED|Overall Study||59
10142084|NCT02733367|11272404|FG000|STARTED|Overall Study||18
10142085|NCT02733367|11272404|FG000|COMPLETED|Overall Study||12
10142086|NCT02733367|11272404|FG000|NOT COMPLETED|Overall Study||6
9707615|NCT02691013|10806848|FG000|COMPLETED|Overall Study||58
9707616|NCT02691013|10806849|FG001|COMPLETED|Overall Study||59
9707617|NCT02691013|10806848|FG000|NOT COMPLETED|Overall Study||3
9707618|NCT02691013|10806849|FG001|NOT COMPLETED|Overall Study||0
9707619|NCT02597062|10806857|FG000|STARTED|Overall Study||76
9707620|NCT02597062|10806857|FG000|COMPLETED|Overall Study||75
9707621|NCT02597062|10806857|FG000|NOT COMPLETED|Overall Study||1
9707622|NCT02130882|10806863|FG000|STARTED|Overall Study||10
9707623|NCT02130882|10806864|FG001|STARTED|Overall Study||10
9707624|NCT02130882|10806863|FG000|COMPLETED|Overall Study||10
9707625|NCT02130882|10806864|FG001|COMPLETED|Overall Study||9
9707626|NCT02130882|10806863|FG000|NOT COMPLETED|Overall Study||0
10142087|NCT02733588|11272409|FG000|STARTED|Overall Study||7
10142088|NCT02733588|11272409|FG000|COMPLETED|Overall Study||7
10142089|NCT02733588|11272409|FG000|NOT COMPLETED|Overall Study||0
10142090|NCT02733627|11272417|FG000|STARTED|Overall Study||9
10142091|NCT02733627|11272418|FG001|STARTED|Overall Study||9
10142092|NCT02733627|11272419|FG002|STARTED|Overall Study||9
10142093|NCT02733627|11272420|FG003|STARTED|Overall Study||9
10142094|NCT02733627|11272417|FG000|COMPLETED|Overall Study||9
10142095|NCT02733627|11272418|FG001|COMPLETED|Overall Study||8
10142096|NCT02733627|11272419|FG002|COMPLETED|Overall Study||7
10142097|NCT02733627|11272420|FG003|COMPLETED|Overall Study||9
10142098|NCT02733627|11272417|FG000|NOT COMPLETED|Overall Study||0
10142099|NCT02733627|11272418|FG001|NOT COMPLETED|Overall Study||1
10142100|NCT02733627|11272419|FG002|NOT COMPLETED|Overall Study||2
10142101|NCT02733627|11272420|FG003|NOT COMPLETED|Overall Study||0
10142102|NCT02733653|11272430|FG000|STARTED|Overall Study||50
10142103|NCT02733653|11272430|FG000|COMPLETED|Overall Study||49
10142104|NCT02733653|11272430|FG000|NOT COMPLETED|Overall Study||1
10142105|NCT02733757|11272438|FG000|STARTED|Overall Study||20
10142106|NCT02733757|11272439|FG001|STARTED|Overall Study||20
10142107|NCT02733757|11272440|FG002|STARTED|Overall Study||20
10142108|NCT02733757|11272441|FG003|STARTED|Overall Study||20
10142109|NCT02733757|11272438|FG000|COMPLETED|Overall Study||20
10142110|NCT02733757|11272439|FG001|COMPLETED|Overall Study||20
10142111|NCT02733757|11272440|FG002|COMPLETED|Overall Study||20
10142112|NCT02733757|11272441|FG003|COMPLETED|Overall Study||20
10142113|NCT02733757|11272438|FG000|NOT COMPLETED|Overall Study||0
10142114|NCT02733757|11272439|FG001|NOT COMPLETED|Overall Study||0
10142115|NCT02733757|11272440|FG002|NOT COMPLETED|Overall Study||0
10142116|NCT02733757|11272441|FG003|NOT COMPLETED|Overall Study||0
10142117|NCT02733991|11272453|FG000|STARTED|Overall Study||76
9707627|NCT02130882|10806864|FG001|NOT COMPLETED|Overall Study||1
9707628|NCT01850563|10806872|FG000|STARTED|Overall Study||22
9707629|NCT01850563|10806873|FG001|STARTED|Overall Study||19
9707630|NCT01850563|10806872|FG000|HBO Treatment Completed|Overall Study||19
9707631|NCT01850563|10806873|FG001|HBO Treatment Completed|Overall Study||0
9707632|NCT01850563|10806872|FG000|COMPLETED|Overall Study||19
9707633|NCT01850563|10806873|FG001|COMPLETED|Overall Study||19
9707634|NCT01850563|10806872|FG000|NOT COMPLETED|Overall Study||3
9707635|NCT01850563|10806873|FG001|NOT COMPLETED|Overall Study||0
9707636|NCT01827111|10806880|FG000|STARTED|Overall Study||19
9707637|NCT01827111|10806880|FG000|COMPLETED|Overall Study||18
9707638|NCT01827111|10806880|FG000|NOT COMPLETED|Overall Study||1
9707639|NCT01437111|10806884|FG000|STARTED|Overall Study||200
9707640|NCT01437111|10806884|FG000|Treated Participants|Overall Study||198
9707641|NCT01437111|10806884|FG000|COMPLETED|Overall Study||182
9707642|NCT01437111|10806884|FG000|NOT COMPLETED|Overall Study||18
9707643|NCT01057121|10806893|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3
9707644|NCT01057121|10806894|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0
9707645|NCT01057121|10806895|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0
9707646|NCT01057121|10806896|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0
9707647|NCT01057121|10806897|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0
9707648|NCT01057121|10806893|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
9707649|NCT01057121|10806894|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707650|NCT01057121|10806895|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707651|NCT01057121|10806896|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707652|NCT01057121|10806897|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707653|NCT01057121|10806893|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707654|NCT01057121|10806894|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707655|NCT01057121|10806895|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707656|NCT01057121|10806896|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707657|NCT01057121|10806897|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
9707658|NCT01057121|10806893|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0
9707659|NCT01057121|10806894|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3
9707660|NCT01057121|10806895|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0
9707661|NCT01057121|10806896|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0
9707662|NCT01057121|10806897|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0
9707663|NCT01057121|10806893|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707664|NCT01057121|10806894|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
9707665|NCT01057121|10806895|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707666|NCT01057121|10806896|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707667|NCT01057121|10806897|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707668|NCT01057121|10806893|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707669|NCT01057121|10806894|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707670|NCT01057121|10806895|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707671|NCT01057121|10806896|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707672|NCT01057121|10806897|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
9707673|NCT01057121|10806893|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0
9707674|NCT01057121|10806894|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0
9707675|NCT01057121|10806895|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3
10142118|NCT02733991|11272454|FG001|STARTED|Overall Study||77
10142119|NCT02733991|11272453|FG000|COMPLETED|Overall Study||75
10142120|NCT02733991|11272454|FG001|COMPLETED|Overall Study||72
10142121|NCT02733991|11272453|FG000|NOT COMPLETED|Overall Study||1
10142122|NCT02733991|11272454|FG001|NOT COMPLETED|Overall Study||5
10142123|NCT02734056|11272462|FG000|STARTED|Overall Study||50
10142124|NCT02734056|11272463|FG001|STARTED|Overall Study||50
10142125|NCT02734056|11272462|FG000|COMPLETED|Overall Study||50
10142126|NCT02734056|11272463|FG001|COMPLETED|Overall Study||49
10142127|NCT02734056|11272462|FG000|NOT COMPLETED|Overall Study||0
10142128|NCT02734056|11272463|FG001|NOT COMPLETED|Overall Study||1
10142129|NCT02734147|11272471|FG000|STARTED|Overall Study||12
10142130|NCT02734147|11272472|FG001|STARTED|Overall Study||12
10142131|NCT02734147|11272471|FG000|COMPLETED|Overall Study||9
10142132|NCT02734147|11272472|FG001|COMPLETED|Overall Study||11
10142133|NCT02734147|11272471|FG000|NOT COMPLETED|Overall Study||3
10142134|NCT02734147|11272472|FG001|NOT COMPLETED|Overall Study||1
10142135|NCT02734212|11272480|FG000|STARTED|Overall Study||29
10142136|NCT02734212|11272481|FG001|STARTED|Overall Study||28
10142137|NCT02734212|11272480|FG000|COMPLETED|Overall Study||24
10142138|NCT02734212|11272481|FG001|COMPLETED|Overall Study||18
10142139|NCT02734212|11272480|FG000|NOT COMPLETED|Overall Study||5
10142140|NCT02734212|11272481|FG001|NOT COMPLETED|Overall Study||10
10142141|NCT02734238|11272490|FG000|STARTED|Overall Study||26
10142142|NCT02734238|11272491|FG001|STARTED|Overall Study||24
10142143|NCT02734238|11272490|FG000|COMPLETED|Overall Study||26
10142144|NCT02734238|11272491|FG001|COMPLETED|Overall Study||24
10142145|NCT02734238|11272490|FG000|NOT COMPLETED|Overall Study||0
10142146|NCT02734238|11272491|FG001|NOT COMPLETED|Overall Study||0
10142147|NCT02734355|11272499|FG000|STARTED|Overall Study||34
10142148|NCT02734355|11272500|FG001|STARTED|Overall Study||30
10142149|NCT02734355|11272499|FG000|COMPLETED|Overall Study||34
10142150|NCT02734355|11272500|FG001|COMPLETED|Overall Study||30
9707676|NCT01057121|10806896|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0
9707677|NCT01057121|10806897|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0
9707678|NCT01057121|10806893|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707679|NCT01057121|10806894|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707680|NCT01057121|10806895|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
9707681|NCT01057121|10806896|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707682|NCT01057121|10806897|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707683|NCT01057121|10806893|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707684|NCT01057121|10806894|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707685|NCT01057121|10806895|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707686|NCT01057121|10806896|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707687|NCT01057121|10806897|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
9707688|NCT01057121|10806893|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0
9707689|NCT01057121|10806894|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0
9707690|NCT01057121|10806895|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0
9707691|NCT01057121|10806896|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6
9707692|NCT01057121|10806897|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0
9707693|NCT01057121|10806893|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707694|NCT01057121|10806894|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707695|NCT01057121|10806895|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707696|NCT01057121|10806896|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
9707697|NCT01057121|10806897|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707698|NCT01057121|10806893|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707699|NCT01057121|10806894|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707700|NCT01057121|10806895|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707701|NCT01057121|10806896|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707702|NCT01057121|10806897|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
9707703|NCT01057121|10806893|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0
9707704|NCT01057121|10806894|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0
9707705|NCT01057121|10806895|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0
9707706|NCT01057121|10806896|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0
9707707|NCT01057121|10806897|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23
9707708|NCT01057121|10806893|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707709|NCT01057121|10806894|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707710|NCT01057121|10806895|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707711|NCT01057121|10806896|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707712|NCT01057121|10806897|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
9707713|NCT01057121|10806893|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707714|NCT01057121|10806894|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707715|NCT01057121|10806895|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707716|NCT01057121|10806896|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707717|NCT01057121|10806897|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
9707718|NCT01004263|10806921|FG000|STARTED|Overall Study|Participants who took study drug|606
9707719|NCT01004263|10806921|FG000|COMPLETED|Overall Study||427
9707720|NCT01004263|10806921|FG000|NOT COMPLETED|Overall Study||179
9707721|NCT01001234|10806930|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492
9707722|NCT01001234|10806931|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31
9707723|NCT01001234|10806932|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409
9707724|NCT01001234|10806933|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410
9707725|NCT01001234|10806934|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40
10142151|NCT02734355|11272499|FG000|NOT COMPLETED|Overall Study||0
10142152|NCT02734355|11272500|FG001|NOT COMPLETED|Overall Study||0
10142153|NCT02734498|11272509|FG000|STARTED|Overall Study||2
10142154|NCT02734498|11272510|FG001|STARTED|Overall Study||0
10142155|NCT02734498|11272511|FG002|STARTED|Overall Study||0
10142156|NCT02734498|11272509|FG000|COMPLETED|Overall Study||2
10142157|NCT02734498|11272510|FG001|COMPLETED|Overall Study||0
10142158|NCT02734498|11272511|FG002|COMPLETED|Overall Study||0
10142159|NCT02734498|11272509|FG000|NOT COMPLETED|Overall Study||0
10142160|NCT02734498|11272510|FG001|NOT COMPLETED|Overall Study||0
10142161|NCT02734498|11272511|FG002|NOT COMPLETED|Overall Study||0
10142162|NCT02734576|11272519|FG000|STARTED|Overall Study||10
10142163|NCT02734576|11272519|FG000|COMPLETED|Overall Study||10
10142164|NCT02734576|11272519|FG000|NOT COMPLETED|Overall Study||0
10142165|NCT02734693|11272526|FG000|STARTED|Overall Study||56
10142166|NCT02734693|11272527|FG001|STARTED|Overall Study||56
10142167|NCT02734693|11272528|FG002|STARTED|Overall Study||20
10142168|NCT02734693|11272526|FG000|COMPLETED|Overall Study||50
10142169|NCT02734693|11272527|FG001|COMPLETED|Overall Study||53
10142170|NCT02734693|11272528|FG002|COMPLETED|Overall Study||17
10142171|NCT02734693|11272526|FG000|NOT COMPLETED|Overall Study||6
10142172|NCT02734693|11272527|FG001|NOT COMPLETED|Overall Study||3
10142173|NCT02734693|11272528|FG002|NOT COMPLETED|Overall Study||3
10142174|NCT02734810|11272538|FG000|STARTED|Overall Study||15
10142175|NCT02734810|11272539|FG001|STARTED|Overall Study||0
10142176|NCT02734810|11272538|FG000|COMPLETED|Overall Study||13
10142177|NCT02734810|11272539|FG001|COMPLETED|Overall Study||0
10142178|NCT02734810|11272538|FG000|NOT COMPLETED|Overall Study||2
10142179|NCT02734810|11272539|FG001|NOT COMPLETED|Overall Study||0
10142180|NCT02734849|11272548|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
10142181|NCT02734849|11272549|FG001|STARTED|Overall Study||14
10142182|NCT02734849|11272550|FG002|STARTED|Overall Study||10
10142183|NCT02734849|11272548|FG000|COMPLETED|Overall Study||12
10142184|NCT02734849|11272549|FG001|COMPLETED|Overall Study||14
10142185|NCT02734849|11272550|FG002|COMPLETED|Overall Study||9
10142186|NCT02734849|11272548|FG000|NOT COMPLETED|Overall Study||4
10142187|NCT02734849|11272549|FG001|NOT COMPLETED|Overall Study||0
10142188|NCT02734849|11272550|FG002|NOT COMPLETED|Overall Study||1
10142189|NCT02734862|11272561|FG000|STARTED|Part A||35
10142190|NCT02734862|11272562|FG001|STARTED|Part A||36
10142191|NCT02734862|11272563|FG002|STARTED|Part A||36
10142192|NCT02734862|11272561|FG000|COMPLETED|Part A||23
10142193|NCT02734862|11272562|FG001|COMPLETED|Part A||28
10142194|NCT02734862|11272563|FG002|COMPLETED|Part A||22
10142195|NCT02734862|11272561|FG000|NOT COMPLETED|Part A||12
10142196|NCT02734862|11272562|FG001|NOT COMPLETED|Part A||8
10142197|NCT02734862|11272563|FG002|NOT COMPLETED|Part A||14
10142198|NCT02734862|11272561|FG000|STARTED|Part B||46
10142199|NCT02734862|11272562|FG001|STARTED|Part B||21
10142200|NCT02734862|11272563|FG002|STARTED|Part B||33
10142201|NCT02734862|11272561|FG000|COMPLETED|Part B||33
10142202|NCT02734862|11272562|FG001|COMPLETED|Part B||14
10142203|NCT02734862|11272563|FG002|COMPLETED|Part B||28
10142204|NCT02734862|11272561|FG000|NOT COMPLETED|Part B||13
10142205|NCT02734862|11272562|FG001|NOT COMPLETED|Part B||7
10142206|NCT02734862|11272563|FG002|NOT COMPLETED|Part B||5
10142207|NCT02734953|11272572|FG000|STARTED|Overall Study||10
10142208|NCT02734953|11272572|FG000|COMPLETED|Overall Study||10
10142209|NCT02734953|11272572|FG000|NOT COMPLETED|Overall Study||0
10142210|NCT02734979|11272576|FG000|STARTED|Overall Study||1
10142211|NCT02734979|11272576|FG000|COMPLETED|Overall Study||1
10142212|NCT02734979|11272576|FG000|NOT COMPLETED|Overall Study||0
10142213|NCT02735096|11272588|FG000|STARTED|Overall Study||4
10142214|NCT02735096|11272588|FG000|COMPLETED|Overall Study||3
10142215|NCT02735096|11272588|FG000|NOT COMPLETED|Overall Study||1
10142216|NCT02735174|11272592|FG000|STARTED|Overall Study||21
10142217|NCT02735174|11272592|FG000|COMPLETED|Overall Study||21
10142218|NCT02735174|11272592|FG000|NOT COMPLETED|Overall Study||0
10142219|NCT02735187|11272598|FG000|STARTED|Overall Study||25
10142220|NCT02735187|11272599|FG001|STARTED|Overall Study||26
10142221|NCT02735187|11272598|FG000|COMPLETED|Overall Study||21
10142222|NCT02735187|11272599|FG001|COMPLETED|Overall Study||25
10142223|NCT02735187|11272598|FG000|NOT COMPLETED|Overall Study||4
10142224|NCT02735187|11272599|FG001|NOT COMPLETED|Overall Study||1
10142225|NCT02735200|11272613|FG000|STARTED|Overall Study||200
10142226|NCT02735200|11272614|FG001|STARTED|Overall Study||350
10142227|NCT02735200|11272613|FG000|COMPLETED|Overall Study||192
10142228|NCT02735200|11272614|FG001|COMPLETED|Overall Study||345
10142229|NCT02735200|11272613|FG000|NOT COMPLETED|Overall Study||8
10142230|NCT02735200|11272614|FG001|NOT COMPLETED|Overall Study||5
10142231|NCT02735382|11272624|FG000|STARTED|Overall Study||7481
10142232|NCT02735382|11272625|FG001|STARTED|Overall Study||7155
10142233|NCT02735382|11272626|FG002|STARTED|Overall Study||184
10142234|NCT02735382|11272627|FG003|STARTED|Overall Study||110
10142235|NCT02735382|11272624|FG000|COMPLETED|Overall Study||7481
10142236|NCT02735382|11272625|FG001|COMPLETED|Overall Study||7155
10142237|NCT02735382|11272626|FG002|COMPLETED|Overall Study||184
10142238|NCT02735382|11272627|FG003|COMPLETED|Overall Study||110
10142239|NCT02735382|11272624|FG000|NOT COMPLETED|Overall Study||0
10142240|NCT02735382|11272625|FG001|NOT COMPLETED|Overall Study||0
10142241|NCT02735382|11272626|FG002|NOT COMPLETED|Overall Study||0
10142242|NCT02735382|11272627|FG003|NOT COMPLETED|Overall Study||0
10142243|NCT02735421|11272637|FG000|STARTED|Overall Study||67
10142244|NCT02735421|11272637|FG000|COMPLETED|Overall Study||54
10142245|NCT02735421|11272637|FG000|NOT COMPLETED|Overall Study||13
10142246|NCT02735551|11272647|FG000|STARTED|Overall Study||3
10142247|NCT02735551|11272648|FG001|STARTED|Overall Study||0
10142248|NCT02735551|11272649|FG002|STARTED|Overall Study||0
10142249|NCT02735551|11272647|FG000|COMPLETED|Overall Study||3
10142250|NCT02735551|11272648|FG001|COMPLETED|Overall Study||0
10142251|NCT02735551|11272649|FG002|COMPLETED|Overall Study||0
10142252|NCT02735551|11272647|FG000|NOT COMPLETED|Overall Study||0
10142253|NCT02735551|11272648|FG001|NOT COMPLETED|Overall Study||0
10142254|NCT02735551|11272649|FG002|NOT COMPLETED|Overall Study||0
10142255|NCT02735577|11272657|FG000|STARTED|Disulfiram Treatment||7
10142256|NCT02735577|11272657|FG000|COMPLETED|Disulfiram Treatment||6
10142257|NCT02735577|11272657|FG000|NOT COMPLETED|Disulfiram Treatment||1
10142258|NCT02735577|11272657|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6
10142259|NCT02735577|11272657|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
10142260|NCT02735577|11272657|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
10142261|NCT02735642|11272663|FG000|STARTED|Overall Study||1046
10142262|NCT02735642|11272664|FG001|STARTED|Overall Study||152
10142263|NCT02735642|11272663|FG000|COMPLETED|Overall Study||1046
10142264|NCT02735642|11272664|FG001|COMPLETED|Overall Study||152
10142265|NCT02735642|11272663|FG000|NOT COMPLETED|Overall Study||0
10142266|NCT02735642|11272664|FG001|NOT COMPLETED|Overall Study||0
10142267|NCT02735915|11272674|FG000|STARTED|Overall Study||70
10142268|NCT02735915|11272674|FG000|Vaccinated|Overall Study||62
10142269|NCT02735915|11272674|FG000|COMPLETED|Overall Study||59
10142270|NCT02735915|11272674|FG000|NOT COMPLETED|Overall Study||11
10142271|NCT02735980|11272683|FG000|STARTED|Overall Study||58
10142272|NCT02735980|11272684|FG001|STARTED|Overall Study||60
10142273|NCT02735980|11272685|FG002|STARTED|Overall Study||15
10142274|NCT02735980|11272683|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56
10142275|NCT02735980|11272684|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
10142276|NCT02735980|11272685|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10142277|NCT02735980|11272683|FG000|COMPLETED|Overall Study||48
10142278|NCT02735980|11272684|FG001|COMPLETED|Overall Study||49
10142279|NCT02735980|11272685|FG002|COMPLETED|Overall Study||14
10142280|NCT02735980|11272683|FG000|NOT COMPLETED|Overall Study||10
10142281|NCT02735980|11272684|FG001|NOT COMPLETED|Overall Study||11
10142282|NCT02735980|11272685|FG002|NOT COMPLETED|Overall Study||1
10142283|NCT02736175|11272700|FG000|STARTED|Overall Study||216
10142284|NCT02736175|11272701|FG001|STARTED|Overall Study||222
10142285|NCT02736175|11272700|FG000|COMPLETED|Overall Study||214
10142286|NCT02736175|11272701|FG001|COMPLETED|Overall Study||221
10142287|NCT02736175|11272700|FG000|NOT COMPLETED|Overall Study||2
10142288|NCT02736175|11272701|FG001|NOT COMPLETED|Overall Study||1
10142289|NCT02736188|11272707|FG000|STARTED|Overall Study||142
10142290|NCT02736188|11272707|FG000|COMPLETED|Overall Study||0
10142291|NCT02736188|11272707|FG000|NOT COMPLETED|Overall Study||142
10196736|NCT03364309|11324819|FG002|NOT COMPLETED|Maintenance Period||0
10196737|NCT03364309|11324820|FG003|NOT COMPLETED|Maintenance Period||44
10196738|NCT03364309|11324821|FG004|NOT COMPLETED|Maintenance Period||12
10196739|NCT03364309|11324822|FG005|NOT COMPLETED|Maintenance Period||46
10196740|NCT03364309|11324823|FG006|NOT COMPLETED|Maintenance Period||16
10196741|NCT03364309|11324824|FG007|NOT COMPLETED|Maintenance Period||2
10196742|NCT03364309|11324825|FG008|NOT COMPLETED|Maintenance Period||6
10196743|NCT03364309|11324826|FG009|NOT COMPLETED|Maintenance Period||4
10196744|NCT03364309|11324827|FG010|NOT COMPLETED|Maintenance Period||6
10196745|NCT03364309|11324828|FG011|NOT COMPLETED|Maintenance Period||0
10196746|NCT03364309|11324829|FG012|NOT COMPLETED|Maintenance Period||0
10196747|NCT03364309|11324830|FG013|NOT COMPLETED|Maintenance Period||0
10196748|NCT03364309|11324831|FG014|NOT COMPLETED|Maintenance Period||0
10196749|NCT03364309|11324832|FG015|NOT COMPLETED|Maintenance Period||0
10196750|NCT03364309|11324833|FG016|NOT COMPLETED|Maintenance Period||0
10196751|NCT03364309|11324834|FG017|NOT COMPLETED|Maintenance Period||0
10196752|NCT03364309|11324835|FG018|NOT COMPLETED|Maintenance Period||0
10196753|NCT03364309|11324817|FG000|STARTED|Re-treatment (Maintenance) Period||0
10196754|NCT03364309|11324818|FG001|STARTED|Re-treatment (Maintenance) Period||0
10196755|NCT03364309|11324819|FG002|STARTED|Re-treatment (Maintenance) Period||0
10196756|NCT03364309|11324820|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196757|NCT03364309|11324821|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196758|NCT03364309|11324822|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196759|NCT03364309|11324823|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196760|NCT03364309|11324824|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196761|NCT03364309|11324825|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196762|NCT03364309|11324826|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196763|NCT03364309|11324827|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10196764|NCT03364309|11324828|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
10196765|NCT03364309|11324829|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
10196766|NCT03364309|11324830|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
10196767|NCT03364309|11324831|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
10196768|NCT03364309|11324832|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
10196769|NCT03364309|11324833|FG016|STARTED|Re-treatment (Maintenance) Period||0
10196770|NCT03364309|11324834|FG017|STARTED|Re-treatment (Maintenance) Period||0
10196771|NCT03364309|11324835|FG018|STARTED|Re-treatment (Maintenance) Period||0
10142292|NCT02736409|11272717|FG000|STARTED|Overall Study||23
10142293|NCT02736409|11272718|FG001|STARTED|Overall Study||25
10142294|NCT02736409|11272719|FG002|STARTED|Overall Study||106
10142295|NCT02736409|11272720|FG003|STARTED|Overall Study||65
10142296|NCT02736409|11272717|FG000|COMPLETED|Overall Study||19
10142297|NCT02736409|11272718|FG001|COMPLETED|Overall Study||22
10142298|NCT02736409|11272719|FG002|COMPLETED|Overall Study||80
10142299|NCT02736409|11272720|FG003|COMPLETED|Overall Study||53
10142300|NCT02736409|11272717|FG000|NOT COMPLETED|Overall Study||4
10142301|NCT02736409|11272718|FG001|NOT COMPLETED|Overall Study||3
10142302|NCT02736409|11272719|FG002|NOT COMPLETED|Overall Study||26
10142303|NCT02736409|11272720|FG003|NOT COMPLETED|Overall Study||12
10142304|NCT02736474|11272733|FG000|STARTED|Overall Study||11
10142305|NCT02736474|11272734|FG001|STARTED|Overall Study||11
10142306|NCT02736474|11272733|FG000|COMPLETED|Overall Study||11
10142307|NCT02736474|11272734|FG001|COMPLETED|Overall Study||10
10142308|NCT02736474|11272733|FG000|NOT COMPLETED|Overall Study||0
10142309|NCT02736474|11272734|FG001|NOT COMPLETED|Overall Study||1
10142310|NCT02736578|11272742|FG000|STARTED|Overall Study||6
10142311|NCT02736578|11272743|FG001|STARTED|Overall Study||2
10142312|NCT02736578|11272742|FG000|COMPLETED|Overall Study||5
10142313|NCT02736578|11272743|FG001|COMPLETED|Overall Study||2
10142314|NCT02736578|11272742|FG000|NOT COMPLETED|Overall Study||1
10142315|NCT02736578|11272743|FG001|NOT COMPLETED|Overall Study||0
10142316|NCT02736721|11272753|FG000|STARTED|Overall Study||41
10142317|NCT02736721|11272753|FG000|COMPLETED|Overall Study||25
10142318|NCT02736721|11272753|FG000|NOT COMPLETED|Overall Study||16
10142319|NCT02736825|11272759|FG000|STARTED|Overall Study||127
10142320|NCT02736825|11272760|FG001|STARTED|Overall Study||135
10142321|NCT02736825|11272759|FG000|COMPLETED|Overall Study||117
10142322|NCT02736825|11272760|FG001|COMPLETED|Overall Study||123
10142323|NCT02736825|11272759|FG000|NOT COMPLETED|Overall Study||10
10142324|NCT02736825|11272760|FG001|NOT COMPLETED|Overall Study||12
10142325|NCT02736890|11272769|FG000|STARTED|First 12 Weeks||5
10142326|NCT02736890|11272770|FG001|STARTED|First 12 Weeks||3
10142327|NCT02736890|11272769|FG000|COMPLETED|First 12 Weeks||5
10142328|NCT02736890|11272770|FG001|COMPLETED|First 12 Weeks||3
10142329|NCT02736890|11272769|FG000|NOT COMPLETED|First 12 Weeks||0
10142330|NCT02736890|11272770|FG001|NOT COMPLETED|First 12 Weeks||0
10142331|NCT02736890|11272769|FG000|STARTED|Crossover Next 12 Weeks||5
10142332|NCT02736890|11272770|FG001|STARTED|Crossover Next 12 Weeks||3
10142333|NCT02736890|11272769|FG000|COMPLETED|Crossover Next 12 Weeks||3
10142334|NCT02736890|11272770|FG001|COMPLETED|Crossover Next 12 Weeks||1
10142335|NCT02736890|11272769|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2
10142336|NCT02736890|11272770|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2
10142337|NCT02736955|11272779|FG000|STARTED|Overall Study||36
10142338|NCT02736955|11272780|FG001|STARTED|Overall Study||117
10142339|NCT02736955|11272781|FG002|STARTED|Overall Study||8
10142340|NCT02736955|11272779|FG000|COMPLETED|Overall Study||29
10142341|NCT02736955|11272780|FG001|COMPLETED|Overall Study||103
10142342|NCT02736955|11272781|FG002|COMPLETED|Overall Study||6
10142343|NCT02736955|11272779|FG000|NOT COMPLETED|Overall Study||7
10142344|NCT02736955|11272780|FG001|NOT COMPLETED|Overall Study||14
10142345|NCT02736955|11272781|FG002|NOT COMPLETED|Overall Study||2
10142346|NCT02737072|11272793|FG000|STARTED|Overall Study||3
10142347|NCT02737072|11272794|FG001|STARTED|Overall Study||3
10142348|NCT02737072|11272795|FG002|STARTED|Overall Study||3
10142349|NCT02737072|11272793|FG000|Received at Least One Dose of Drug|Overall Study||3
10142350|NCT02737072|11272794|FG001|Received at Least One Dose of Drug|Overall Study||3
10142351|NCT02737072|11272795|FG002|Received at Least One Dose of Drug|Overall Study||3
10142352|NCT02737072|11272793|FG000|COMPLETED|Overall Study||3
10142353|NCT02737072|11272794|FG001|COMPLETED|Overall Study||3
10142354|NCT02737072|11272795|FG002|COMPLETED|Overall Study||3
10142355|NCT02737072|11272793|FG000|NOT COMPLETED|Overall Study||0
10142356|NCT02737072|11272794|FG001|NOT COMPLETED|Overall Study||0
10142357|NCT02737072|11272795|FG002|NOT COMPLETED|Overall Study||0
10142358|NCT02737163|11272807|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
10142359|NCT02737163|11272807|FG000|COMPLETED|Overall Study||95
10142360|NCT02737163|11272807|FG000|NOT COMPLETED|Overall Study||0
10142361|NCT02737332|11272813|FG000|STARTED|Overall Study||29
10142362|NCT02737332|11272814|FG001|STARTED|Overall Study||24
10142363|NCT02737332|11272813|FG000|COMPLETED|Overall Study||28
10142364|NCT02737332|11272814|FG001|COMPLETED|Overall Study||23
10142365|NCT02737332|11272813|FG000|NOT COMPLETED|Overall Study||1
10142366|NCT02737332|11272814|FG001|NOT COMPLETED|Overall Study||1
10142367|NCT02737358|11272824|FG000|STARTED|Overall Study||55
10142368|NCT02737358|11272825|FG001|STARTED|Overall Study||59
10142369|NCT02737358|11272824|FG000|COMPLETED|Overall Study||46
10142370|NCT02737358|11272825|FG001|COMPLETED|Overall Study||44
10142371|NCT02737358|11272824|FG000|NOT COMPLETED|Overall Study||9
10142372|NCT02737358|11272825|FG001|NOT COMPLETED|Overall Study||15
10142373|NCT02737397|11272831|FG000|STARTED|Overall Study||13
10142374|NCT02737397|11272831|FG000|JMI-001|Overall Study||13
10142375|NCT02737397|11272831|FG000|SJP-304|Overall Study||12
10142376|NCT02737397|11272831|FG000|SJP-223|Overall Study||13
10142377|NCT02737397|11272831|FG000|Placebo|Overall Study||13
10142378|NCT02737397|11272831|FG000|COMPLETED|Overall Study||13
10142379|NCT02737397|11272831|FG000|NOT COMPLETED|Overall Study||0
10142380|NCT02737501|11272843|FG000|STARTED|Randomized Phase||137
10142381|NCT02737501|11272844|FG001|STARTED|Randomized Phase||138
10142382|NCT02737501|11272845|FG002|STARTED|Randomized Phase||0
10142383|NCT02737501|11272843|FG000|Safety Analysis Set|Randomized Phase||136
10142384|NCT02737501|11272844|FG001|Safety Analysis Set|Randomized Phase||137
10142385|NCT02737501|11272845|FG002|Safety Analysis Set|Randomized Phase||0
10142386|NCT02737501|11272843|FG000|COMPLETED|Randomized Phase||20
10142387|NCT02737501|11272844|FG001|COMPLETED|Randomized Phase||84
10142388|NCT02737501|11272845|FG002|COMPLETED|Randomized Phase||0
10142389|NCT02737501|11272843|FG000|NOT COMPLETED|Randomized Phase||117
10142390|NCT02737501|11272844|FG001|NOT COMPLETED|Randomized Phase||54
10142391|NCT02737501|11272845|FG002|NOT COMPLETED|Randomized Phase||0
10142392|NCT02737501|11272843|FG000|STARTED|Crossover Phase||0
10142393|NCT02737501|11272844|FG001|STARTED|Crossover Phase||0
10142394|NCT02737501|11272845|FG002|STARTED|Crossover Phase||65
10142395|NCT02737501|11272843|FG000|COMPLETED|Crossover Phase||0
10142396|NCT02737501|11272844|FG001|COMPLETED|Crossover Phase||0
10142397|NCT02737501|11272845|FG002|COMPLETED|Crossover Phase||10
10142398|NCT02737501|11272843|FG000|NOT COMPLETED|Crossover Phase||0
10142399|NCT02737501|11272844|FG001|NOT COMPLETED|Crossover Phase||0
10142400|NCT02737501|11272845|FG002|NOT COMPLETED|Crossover Phase||55
10142401|NCT02737592|11272853|FG000|STARTED|Overall Study||34
10142402|NCT02737592|11272853|FG000|COMPLETED|Overall Study||33
10142403|NCT02737592|11272853|FG000|NOT COMPLETED|Overall Study||1
10142404|NCT02737618|11272857|FG000|STARTED|Overall Study||43
10142405|NCT02737618|11272857|FG000|COMPLETED|Overall Study||34
10142406|NCT02737618|11272857|FG000|NOT COMPLETED|Overall Study||9
10142407|NCT02737631|11272861|FG000|STARTED|Overall Study||222
10142408|NCT02737631|11272861|FG000|COMPLETED|Overall Study||222
9707726|NCT01001234|10806930|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
9707727|NCT01001234|10806931|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
9707728|NCT01001234|10806932|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
9707729|NCT01001234|10806933|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
9707730|NCT01001234|10806934|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
9707731|NCT01001234|10806930|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368
9707732|NCT01001234|10806931|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23
9707733|NCT01001234|10806932|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9
9707734|NCT01001234|10806933|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5
9707735|NCT01001234|10806934|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0
9707736|NCT01001234|10806930|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
9707737|NCT01001234|10806931|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
9707738|NCT01001234|10806932|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
9707739|NCT01001234|10806933|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
9707740|NCT01001234|10806934|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
9707741|NCT01001234|10806930|FG000|NOT COMPLETED|Overall Study||405
9707742|NCT01001234|10806931|FG001|NOT COMPLETED|Overall Study||26
9707743|NCT01001234|10806932|FG002|NOT COMPLETED|Overall Study||32
9707744|NCT01001234|10806933|FG003|NOT COMPLETED|Overall Study||25
9707745|NCT01001234|10806934|FG004|NOT COMPLETED|Overall Study||0
9707746|NCT00924170|10806942|FG000|STARTED|Overall Study||10
9707747|NCT00924170|10806943|FG001|STARTED|Overall Study||8
9707748|NCT00924170|10806942|FG000|COMPLETED|Overall Study||3
9707749|NCT00924170|10806943|FG001|COMPLETED|Overall Study||0
10142409|NCT02737631|11272861|FG000|NOT COMPLETED|Overall Study||0
10142410|NCT02737722|11272869|FG000|STARTED|Overall Study||8
10142411|NCT02737722|11272870|FG001|STARTED|Overall Study||8
10142412|NCT02737722|11272871|FG002|STARTED|Overall Study||8
9707750|NCT00924170|10806942|FG000|NOT COMPLETED|Overall Study||7
9707751|NCT00924170|10806943|FG001|NOT COMPLETED|Overall Study||8
9707752|NCT00894556|10806958|FG000|STARTED|Baseline Phase||0
9707753|NCT00894556|10806959|FG001|STARTED|Baseline Phase||0
9707754|NCT00894556|10806960|FG002|STARTED|Baseline Phase||0
9707755|NCT00894556|10806961|FG003|STARTED|Baseline Phase||194
9707756|NCT00894556|10806958|FG000|COMPLETED|Baseline Phase||0
9707757|NCT00894556|10806959|FG001|COMPLETED|Baseline Phase||0
9707758|NCT00894556|10806960|FG002|COMPLETED|Baseline Phase||0
9707759|NCT00894556|10806961|FG003|COMPLETED|Baseline Phase||109
9707760|NCT00894556|10806958|FG000|NOT COMPLETED|Baseline Phase||0
9707761|NCT00894556|10806959|FG001|NOT COMPLETED|Baseline Phase||0
9707762|NCT00894556|10806960|FG002|NOT COMPLETED|Baseline Phase||0
9707763|NCT00894556|10806961|FG003|NOT COMPLETED|Baseline Phase||85
9707764|NCT00894556|10806958|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
9707765|NCT00894556|10806959|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
9707766|NCT00894556|10806960|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
9707767|NCT00894556|10806961|FG003|STARTED|Treatment Phase||0
9731906|NCT00137280|10831875|FG001|STARTED|Overall Study||412
10142413|NCT02737722|11272872|FG003|STARTED|Overall Study||6
10142414|NCT02737722|11272869|FG000|COMPLETED|Overall Study||8
10142415|NCT02737722|11272870|FG001|COMPLETED|Overall Study||8
10142416|NCT02737722|11272871|FG002|COMPLETED|Overall Study||7
10142417|NCT02737722|11272872|FG003|COMPLETED|Overall Study||6
10142418|NCT02737722|11272869|FG000|NOT COMPLETED|Overall Study||0
10142419|NCT02737722|11272870|FG001|NOT COMPLETED|Overall Study||0
10142420|NCT02737722|11272871|FG002|NOT COMPLETED|Overall Study||1
10142421|NCT02737722|11272872|FG003|NOT COMPLETED|Overall Study||0
10142422|NCT02737826|11272882|FG000|STARTED|Phase I - Buprenorphine Initiation||27
10142423|NCT02737826|11272883|FG001|STARTED|Phase I - Buprenorphine Initiation||0
10142424|NCT02737826|11272884|FG002|STARTED|Phase I - Buprenorphine Initiation||0
10142425|NCT02737826|11272882|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27
10142426|NCT02737826|11272883|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0
10142427|NCT02737826|11272884|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0
10142428|NCT02737826|11272882|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
10142429|NCT02737826|11272883|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
10142430|NCT02737826|11272884|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
10142431|NCT02737826|11272882|FG000|STARTED|Phase II - Randomization + Taper||0
10142432|NCT02737826|11272883|FG001|STARTED|Phase II - Randomization + Taper||13
10142433|NCT02737826|11272884|FG002|STARTED|Phase II - Randomization + Taper||14
10142434|NCT02737826|11272882|FG000|COMPLETED|Phase II - Randomization + Taper||0
10142435|NCT02737826|11272883|FG001|COMPLETED|Phase II - Randomization + Taper||1
10142436|NCT02737826|11272884|FG002|COMPLETED|Phase II - Randomization + Taper||0
10142437|NCT02737826|11272882|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0
10142438|NCT02737826|11272883|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12
10142439|NCT02737826|11272884|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14
10142440|NCT02737852|11272893|FG000|STARTED|Overall Study||32
10142441|NCT02737852|11272893|FG000|COMPLETED|Overall Study||30
10142442|NCT02737852|11272893|FG000|NOT COMPLETED|Overall Study||2
10142443|NCT02737891|11272899|FG000|STARTED|Overall Study||30
10142444|NCT02737891|11272900|FG001|STARTED|Overall Study||30
10142445|NCT02737891|11272899|FG000|COMPLETED|Overall Study||30
10142446|NCT02737891|11272900|FG001|COMPLETED|Overall Study||28
10142447|NCT02737891|11272899|FG000|NOT COMPLETED|Overall Study||0
10142448|NCT02737891|11272900|FG001|NOT COMPLETED|Overall Study||2
10142449|NCT02737917|11272908|FG000|STARTED|Overall Study||103
10142450|NCT02737917|11272909|FG001|STARTED|Overall Study||103
10142451|NCT02737917|11272908|FG000|COMPLETED|Overall Study||100
10142452|NCT02737917|11272909|FG001|COMPLETED|Overall Study||100
10142453|NCT02737917|11272908|FG000|NOT COMPLETED|Overall Study||3
10142454|NCT02737917|11272909|FG001|NOT COMPLETED|Overall Study||3
10142455|NCT02737930|11272917|FG000|STARTED|Overall Study||5
10142456|NCT02737930|11272918|FG001|STARTED|Overall Study||7
10142457|NCT02737930|11272917|FG000|COMPLETED|Overall Study||5
10142458|NCT02737930|11272918|FG001|COMPLETED|Overall Study||6
10142459|NCT02737930|11272917|FG000|NOT COMPLETED|Overall Study||0
10142460|NCT02737930|11272918|FG001|NOT COMPLETED|Overall Study||1
10142461|NCT02738008|11272927|FG000|STARTED|Overall Study||1
10142462|NCT02738008|11272928|FG001|STARTED|Overall Study||6
10142463|NCT02738008|11272929|FG002|STARTED|Overall Study||5
10142464|NCT02738008|11272927|FG000|COMPLETED|Overall Study||0
10142465|NCT02738008|11272928|FG001|COMPLETED|Overall Study||0
10142466|NCT02738008|11272929|FG002|COMPLETED|Overall Study||0
10142467|NCT02738008|11272927|FG000|NOT COMPLETED|Overall Study||1
10142468|NCT02738008|11272928|FG001|NOT COMPLETED|Overall Study||6
10142469|NCT02738008|11272929|FG002|NOT COMPLETED|Overall Study||5
10142470|NCT02738086|11272939|FG000|STARTED|Overall Study||16
10142471|NCT02738086|11272940|FG001|STARTED|Overall Study||15
10142472|NCT02738086|11272939|FG000|COMPLETED|Overall Study||14
10142473|NCT02738086|11272940|FG001|COMPLETED|Overall Study||13
10142474|NCT02738086|11272939|FG000|NOT COMPLETED|Overall Study||2
10142475|NCT02738086|11272940|FG001|NOT COMPLETED|Overall Study||2
10142476|NCT02738138|11272951|FG000|STARTED|Overall Study||137
10142477|NCT02738138|11272952|FG001|STARTED|Overall Study||16
10142478|NCT02738138|11272951|FG000|COMPLETED|Overall Study||134
10142479|NCT02738138|11272952|FG001|COMPLETED|Overall Study||15
10142480|NCT02738138|11272951|FG000|NOT COMPLETED|Overall Study||3
10142481|NCT02738138|11272952|FG001|NOT COMPLETED|Overall Study||1
10142482|NCT02738151|11272959|FG000|STARTED|Overall Study||466
10142483|NCT02738151|11272960|FG001|STARTED|Overall Study||463
10142484|NCT02738151|11272959|FG000|Treated|Overall Study||462
10142485|NCT02738151|11272960|FG001|Treated|Overall Study||462
10142486|NCT02738151|11272959|FG000|COMPLETED|Overall Study||443
10142487|NCT02738151|11272960|FG001|COMPLETED|Overall Study||432
10142488|NCT02738151|11272959|FG000|NOT COMPLETED|Overall Study||23
10142489|NCT02738151|11272960|FG001|NOT COMPLETED|Overall Study||31
10142490|NCT02738203|11272968|FG000|STARTED|Overall Study||110
10142491|NCT02738203|11272969|FG001|STARTED|Overall Study||110
10142492|NCT02738203|11272968|FG000|COMPLETED|Overall Study||108
10142493|NCT02738203|11272969|FG001|COMPLETED|Overall Study||107
10142494|NCT02738203|11272968|FG000|NOT COMPLETED|Overall Study||2
10142495|NCT02738203|11272969|FG001|NOT COMPLETED|Overall Study||3
10142496|NCT02738333|11272978|FG000|STARTED|Overall Study||106
10142497|NCT02738333|11272979|FG001|STARTED|Overall Study||108
10142498|NCT02738333|11272980|FG002|STARTED|Overall Study||25
10142499|NCT02738333|11272978|FG000|COMPLETED|Overall Study||104
10142500|NCT02738333|11272979|FG001|COMPLETED|Overall Study||108
10142501|NCT02738333|11272980|FG002|COMPLETED|Overall Study||25
10142502|NCT02738333|11272978|FG000|NOT COMPLETED|Overall Study||2
10142503|NCT02738333|11272979|FG001|NOT COMPLETED|Overall Study||0
10142504|NCT02738333|11272980|FG002|NOT COMPLETED|Overall Study||0
10142505|NCT02738450|11272992|FG000|STARTED|Overall Study||6
10142506|NCT02738450|11272993|FG001|STARTED|Overall Study||6
10142507|NCT02738450|11272994|FG002|STARTED|Overall Study||4
10142508|NCT02738450|11272992|FG000|COMPLETED|Overall Study||6
10142509|NCT02738450|11272993|FG001|COMPLETED|Overall Study||4
10142510|NCT02738450|11272994|FG002|COMPLETED|Overall Study||4
10142511|NCT02738450|11272992|FG000|NOT COMPLETED|Overall Study||0
10142512|NCT02738450|11272993|FG001|NOT COMPLETED|Overall Study||2
10142513|NCT02738450|11272994|FG002|NOT COMPLETED|Overall Study||0
10142514|NCT02738580|11273005|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56
10142515|NCT02738580|11273006|FG001|STARTED|Overall Study||56
10142516|NCT02738580|11273005|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
10142517|NCT02738580|11273006|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
10142518|NCT02738580|11273005|FG000|NOT COMPLETED|Overall Study||4
10142519|NCT02738580|11273006|FG001|NOT COMPLETED|Overall Study||4
10142520|NCT02738775|11273018|FG000|STARTED|Overall Study||8
10142521|NCT02738775|11273019|FG001|STARTED|Overall Study||8
9707768|NCT00894556|10806958|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
9707769|NCT00894556|10806959|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
9707770|NCT00894556|10806960|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
9707771|NCT00894556|10806961|FG003|COMPLETED|Treatment Phase||0
9707772|NCT00894556|10806958|FG000|NOT COMPLETED|Treatment Phase||4
9707773|NCT00894556|10806959|FG001|NOT COMPLETED|Treatment Phase||4
9707774|NCT00894556|10806960|FG002|NOT COMPLETED|Treatment Phase||1
9707775|NCT00894556|10806961|FG003|NOT COMPLETED|Treatment Phase||0
9707776|NCT00840177|10806971|FG000|STARTED|Overall Study||36
9707777|NCT00840177|10806972|FG001|STARTED|Overall Study||29
9707778|NCT00840177|10806973|FG002|STARTED|Overall Study||50
9707779|NCT00840177|10806971|FG000|Treated|Overall Study||36
9707780|NCT00840177|10806972|FG001|Treated|Overall Study||29
9707781|NCT00840177|10806973|FG002|Treated|Overall Study||46
9707782|NCT00840177|10806971|FG000|Assessed for AEs|Overall Study||35
9707783|NCT00840177|10806972|FG001|Assessed for AEs|Overall Study||29
9707784|NCT00840177|10806973|FG002|Assessed for AEs|Overall Study||46
9707785|NCT00840177|10806971|FG000|COMPLETED|Overall Study||18
9707786|NCT00840177|10806972|FG001|COMPLETED|Overall Study||20
9707787|NCT00840177|10806973|FG002|COMPLETED|Overall Study||39
9707788|NCT00840177|10806971|FG000|NOT COMPLETED|Overall Study||18
9707789|NCT00840177|10806972|FG001|NOT COMPLETED|Overall Study||9
9707790|NCT00840177|10806973|FG002|NOT COMPLETED|Overall Study||11
9707791|NCT00820950|10806986|FG000|STARTED|Overall Study||6
9707792|NCT00820950|10806987|FG001|STARTED|Overall Study||6
9707793|NCT00820950|10806988|FG002|STARTED|Overall Study||6
9707794|NCT00820950|10806989|FG003|STARTED|Overall Study||6
9707795|NCT00820950|10806990|FG004|STARTED|Overall Study||6
9707796|NCT00820950|10806991|FG005|STARTED|Overall Study||6
9707797|NCT00820950|10806992|FG006|STARTED|Overall Study||6
9707798|NCT00820950|10806993|FG007|STARTED|Overall Study||6
9707799|NCT00820950|10806994|FG008|STARTED|Overall Study||5
9707800|NCT00820950|10806995|FG009|STARTED|Overall Study||5
9707801|NCT00820950|10806986|FG000|COMPLETED|Overall Study||5
9707802|NCT00820950|10806987|FG001|COMPLETED|Overall Study||5
9707803|NCT00820950|10806988|FG002|COMPLETED|Overall Study||6
9707804|NCT00820950|10806989|FG003|COMPLETED|Overall Study||6
9707805|NCT00820950|10806990|FG004|COMPLETED|Overall Study||6
9707806|NCT00820950|10806991|FG005|COMPLETED|Overall Study||6
9707807|NCT00820950|10806992|FG006|COMPLETED|Overall Study||5
9707808|NCT00820950|10806993|FG007|COMPLETED|Overall Study||5
9707809|NCT00820950|10806994|FG008|COMPLETED|Overall Study||5
9707810|NCT00820950|10806995|FG009|COMPLETED|Overall Study||5
9707811|NCT00820950|10806986|FG000|NOT COMPLETED|Overall Study||1
9707812|NCT00820950|10806987|FG001|NOT COMPLETED|Overall Study||1
9707813|NCT00820950|10806988|FG002|NOT COMPLETED|Overall Study||0
9707814|NCT00820950|10806989|FG003|NOT COMPLETED|Overall Study||0
9707815|NCT00820950|10806990|FG004|NOT COMPLETED|Overall Study||0
9707816|NCT00820950|10806991|FG005|NOT COMPLETED|Overall Study||0
9707817|NCT00820950|10806992|FG006|NOT COMPLETED|Overall Study||1
9707818|NCT00820950|10806993|FG007|NOT COMPLETED|Overall Study||1
9707819|NCT00820950|10806994|FG008|NOT COMPLETED|Overall Study||0
9707820|NCT00820950|10806995|FG009|NOT COMPLETED|Overall Study||0
9707821|NCT00806416|10807037|FG000|STARTED|Period 1 - Part I||107
9707822|NCT00806416|10807038|FG001|STARTED|Period 1 - Part I||107
9707823|NCT00806416|10807039|FG002|STARTED|Period 1 - Part I||0
9707824|NCT00806416|10807040|FG003|STARTED|Period 1 - Part I||0
9707825|NCT00806416|10807037|FG000|COMPLETED|Period 1 - Part I||104
9707826|NCT00806416|10807038|FG001|COMPLETED|Period 1 - Part I||103
9707827|NCT00806416|10807039|FG002|COMPLETED|Period 1 - Part I||0
9707828|NCT00806416|10807040|FG003|COMPLETED|Period 1 - Part I||0
9707829|NCT00806416|10807037|FG000|NOT COMPLETED|Period 1 - Part I||3
9707830|NCT00806416|10807038|FG001|NOT COMPLETED|Period 1 - Part I||4
9707831|NCT00806416|10807039|FG002|NOT COMPLETED|Period 1 - Part I||0
9707832|NCT00806416|10807040|FG003|NOT COMPLETED|Period 1 - Part I||0
9707833|NCT00806416|10807037|FG000|STARTED|Period 2 - Part I||104
9707834|NCT00806416|10807038|FG001|STARTED|Period 2 - Part I||103
9707835|NCT00806416|10807039|FG002|STARTED|Period 2 - Part I||0
9707836|NCT00806416|10807040|FG003|STARTED|Period 2 - Part I||0
9707837|NCT00806416|10807037|FG000|COMPLETED|Period 2 - Part I||104
9707838|NCT00806416|10807038|FG001|COMPLETED|Period 2 - Part I||103
9707839|NCT00806416|10807039|FG002|COMPLETED|Period 2 - Part I||0
9707840|NCT00806416|10807040|FG003|COMPLETED|Period 2 - Part I||0
10142522|NCT02738775|11273020|FG002|STARTED|Overall Study||8
10142523|NCT02738775|11273021|FG003|STARTED|Overall Study||9
10142524|NCT02738775|11273022|FG004|STARTED|Overall Study||8
10142525|NCT02738775|11273023|FG005|STARTED|Overall Study||8
10142526|NCT02738775|11273018|FG000|Initially Treated With Placebo|Overall Study||0
10142527|NCT02738775|11273019|FG001|Initially Treated With Placebo|Overall Study||0
10142528|NCT02738775|11273020|FG002|Initially Treated With Placebo|Overall Study||0
10142529|NCT02738775|11273021|FG003|Initially Treated With Placebo|Overall Study||1
10142530|NCT02738775|11273022|FG004|Initially Treated With Placebo|Overall Study||0
10142531|NCT02738775|11273023|FG005|Initially Treated With Placebo|Overall Study||0
10142532|NCT02738775|11273018|FG000|COMPLETED|Overall Study||8
10142533|NCT02738775|11273019|FG001|COMPLETED|Overall Study||6
10142534|NCT02738775|11273020|FG002|COMPLETED|Overall Study||8
10142535|NCT02738775|11273021|FG003|COMPLETED|Overall Study||8
10142536|NCT02738775|11273022|FG004|COMPLETED|Overall Study||8
10142537|NCT02738775|11273023|FG005|COMPLETED|Overall Study||7
10142538|NCT02738775|11273018|FG000|NOT COMPLETED|Overall Study||0
10142539|NCT02738775|11273019|FG001|NOT COMPLETED|Overall Study||2
10142540|NCT02738775|11273020|FG002|NOT COMPLETED|Overall Study||0
10142541|NCT02738775|11273021|FG003|NOT COMPLETED|Overall Study||1
10142542|NCT02738775|11273022|FG004|NOT COMPLETED|Overall Study||0
10142543|NCT02738775|11273023|FG005|NOT COMPLETED|Overall Study||1
10142544|NCT02738801|11273043|FG000|STARTED|Overall Study||6
10142545|NCT02738801|11273044|FG001|STARTED|Overall Study||17
10142546|NCT02738801|11273043|FG000|COMPLETED|Overall Study||5
10142547|NCT02738801|11273044|FG001|COMPLETED|Overall Study||15
10142548|NCT02738801|11273043|FG000|NOT COMPLETED|Overall Study||1
10142549|NCT02738801|11273044|FG001|NOT COMPLETED|Overall Study||2
10142550|NCT02738840|11273051|FG000|STARTED|Overall Study||56
10142551|NCT02738840|11273051|FG000|COMPLETED|Overall Study||48
10142552|NCT02738840|11273051|FG000|NOT COMPLETED|Overall Study||8
10142553|NCT02738879|11273057|FG000|STARTED|Overall Study||374
10142554|NCT02738879|11273058|FG001|STARTED|Overall Study||372
10142555|NCT02738879|11273057|FG000|Treated|Overall Study||373
10142556|NCT02738879|11273058|FG001|Treated|Overall Study||370
10142557|NCT02738879|11273057|FG000|COMPLETED|Overall Study||361
10142558|NCT02738879|11273058|FG001|COMPLETED|Overall Study||347
10142559|NCT02738879|11273057|FG000|NOT COMPLETED|Overall Study||13
10142560|NCT02738879|11273058|FG001|NOT COMPLETED|Overall Study||25
10142561|NCT02739100|11273064|FG000|STARTED|Overall Study||13
10142562|NCT02739100|11273064|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
10142563|NCT02739100|11273064|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13
10142564|NCT02739100|11273064|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
10142565|NCT02739100|11273064|FG000|COMPLETED|Overall Study||13
10142566|NCT02739100|11273064|FG000|NOT COMPLETED|Overall Study||0
10142567|NCT02739269|11273074|FG000|STARTED|Overall Study||100
10142568|NCT02739269|11273075|FG001|STARTED|Overall Study||100
10142569|NCT02739269|11273074|FG000|COMPLETED|Overall Study||93
10142570|NCT02739269|11273075|FG001|COMPLETED|Overall Study||96
10142571|NCT02739269|11273074|FG000|NOT COMPLETED|Overall Study||7
10142572|NCT02739269|11273075|FG001|NOT COMPLETED|Overall Study||4
10142573|NCT02739321|11273083|FG000|STARTED|Overall Study||23
10142574|NCT02739321|11273084|FG001|STARTED|Overall Study||22
10142575|NCT02739321|11273083|FG000|COMPLETED|Overall Study||20
10142576|NCT02739321|11273084|FG001|COMPLETED|Overall Study||18
10142577|NCT02739321|11273083|FG000|NOT COMPLETED|Overall Study||3
10142578|NCT02739321|11273084|FG001|NOT COMPLETED|Overall Study||4
10142579|NCT02739360|11273099|FG000|STARTED|Overall Study||3
10142580|NCT02739360|11273099|FG000|COMPLETED|Overall Study||0
10142581|NCT02739360|11273099|FG000|NOT COMPLETED|Overall Study||3
10142582|NCT02739594|11273105|FG000|STARTED|Overall Study||46
10142583|NCT02739594|11273106|FG001|STARTED|Overall Study||43
10142584|NCT02739594|11273105|FG000|Completed at Week 44|Overall Study||11
10142585|NCT02739594|11273106|FG001|Completed at Week 44|Overall Study||5
10142586|NCT02739594|11273105|FG000|Completed at Week 96|Overall Study||10
10142587|NCT02739594|11273106|FG001|Completed at Week 96|Overall Study||10
10142588|NCT02739594|11273105|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
10142589|NCT02739594|11273106|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
10142590|NCT02739594|11273105|FG000|NOT COMPLETED|Overall Study||25
10142591|NCT02739594|11273106|FG001|NOT COMPLETED|Overall Study||28
10142592|NCT02739698|11273115|FG000|STARTED|Overall Study||22
10142593|NCT02739698|11273116|FG001|STARTED|Overall Study||21
10142594|NCT02739698|11273115|FG000|COMPLETED|Overall Study||16
10142595|NCT02739698|11273116|FG001|COMPLETED|Overall Study||16
10142596|NCT02739698|11273115|FG000|NOT COMPLETED|Overall Study||6
10142597|NCT02739698|11273116|FG001|NOT COMPLETED|Overall Study||5
10142598|NCT02739789|11273124|FG000|STARTED|First fMRI Scan||9
10142599|NCT02739789|11273125|FG001|STARTED|First fMRI Scan||10
10142600|NCT02739789|11273124|FG000|COMPLETED|First fMRI Scan||9
10142601|NCT02739789|11273125|FG001|COMPLETED|First fMRI Scan||10
10142602|NCT02739789|11273124|FG000|NOT COMPLETED|First fMRI Scan||0
10142603|NCT02739789|11273125|FG001|NOT COMPLETED|First fMRI Scan||0
10142604|NCT02739789|11273124|FG000|STARTED|~1 Week Waiting Period||9
10142605|NCT02739789|11273125|FG001|STARTED|~1 Week Waiting Period||10
10142606|NCT02739789|11273124|FG000|COMPLETED|~1 Week Waiting Period||9
10142607|NCT02739789|11273125|FG001|COMPLETED|~1 Week Waiting Period||7
10142608|NCT02739789|11273124|FG000|NOT COMPLETED|~1 Week Waiting Period||0
10142609|NCT02739789|11273125|FG001|NOT COMPLETED|~1 Week Waiting Period||3
10060633|NCT02099682|11186198|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
10060634|NCT02099682|11186198|FG000|COMPLETED|Overall Study||3255
10060635|NCT02099682|11186198|FG000|NOT COMPLETED|Overall Study||111
10060636|NCT02099708|11186202|FG000|STARTED|Overall Study|Number of cases.|3502
10060637|NCT02099708|11186202|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
10060638|NCT02099708|11186202|FG000|COMPLETED|Overall Study||3302
10060639|NCT02099708|11186202|FG000|NOT COMPLETED|Overall Study||200
10060640|NCT02099721|11186212|FG000|STARTED|Overall Study||1066
10060641|NCT02099721|11186213|FG001|STARTED|Overall Study||127
10060642|NCT02099721|11186214|FG002|STARTED|Overall Study||1068
10060643|NCT02099721|11186215|FG003|STARTED|Overall Study||845
10060644|NCT02099721|11186216|FG004|STARTED|Overall Study||331
10060645|NCT02099721|11186217|FG005|STARTED|Overall Study||452
10060646|NCT02099721|11186212|FG000|COMPLETED|Overall Study||990
10060647|NCT02099721|11186213|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
10060648|NCT02099721|11186214|FG002|COMPLETED|Overall Study||983
10060649|NCT02099721|11186215|FG003|COMPLETED|Overall Study||774
10060650|NCT02099721|11186216|FG004|COMPLETED|Overall Study||304
10060651|NCT02099721|11186217|FG005|COMPLETED|Overall Study||432
9707841|NCT00806416|10807037|FG000|NOT COMPLETED|Period 2 - Part I||0
9707842|NCT00806416|10807038|FG001|NOT COMPLETED|Period 2 - Part I||0
9707843|NCT00806416|10807039|FG002|NOT COMPLETED|Period 2 - Part I||0
9707844|NCT00806416|10807040|FG003|NOT COMPLETED|Period 2 - Part I||0
10060652|NCT02099721|11186212|FG000|NOT COMPLETED|Overall Study||76
10060653|NCT02099721|11186213|FG001|NOT COMPLETED|Overall Study||127
10142610|NCT02739789|11273124|FG000|STARTED|Second fMRI Scan||9
10142611|NCT02739789|11273125|FG001|STARTED|Second fMRI Scan||7
10142612|NCT02739789|11273124|FG000|COMPLETED|Second fMRI Scan||9
10142613|NCT02739789|11273125|FG001|COMPLETED|Second fMRI Scan||7
10142614|NCT02739789|11273124|FG000|NOT COMPLETED|Second fMRI Scan||0
10142615|NCT02739789|11273125|FG001|NOT COMPLETED|Second fMRI Scan||0
10142616|NCT02739828|11273131|FG000|STARTED|Overall Study||24
10142617|NCT02739828|11273131|FG000|COMPLETED|Overall Study||19
10142618|NCT02739828|11273131|FG000|NOT COMPLETED|Overall Study||5
10142619|NCT02739984|11273137|FG000|STARTED|Overall Study||143
10142620|NCT02739984|11273138|FG001|STARTED|Overall Study||281
10142621|NCT02739984|11273137|FG000|Received Study Drug|Overall Study||141
10142622|NCT02739984|11273138|FG001|Received Study Drug|Overall Study||280
10142623|NCT02739984|11273137|FG000|COMPLETED|Overall Study||138
10142624|NCT02739984|11273138|FG001|COMPLETED|Overall Study||279
10142625|NCT02739984|11273137|FG000|NOT COMPLETED|Overall Study||5
10142626|NCT02739984|11273138|FG001|NOT COMPLETED|Overall Study||2
10142627|NCT02739997|11273144|FG000|STARTED|Overall Study||100
10142628|NCT02739997|11273144|FG000|COMPLETED|Overall Study||98
10142629|NCT02739997|11273144|FG000|NOT COMPLETED|Overall Study||2
10142630|NCT02740049|11273148|FG000|STARTED|Overall Study||9
10142631|NCT02740049|11273148|FG000|COMPLETED|Overall Study||8
10142632|NCT02740049|11273148|FG000|NOT COMPLETED|Overall Study||1
10142633|NCT02740114|11273154|FG000|STARTED|Overall Study||54
10142634|NCT02740114|11273155|FG001|STARTED|Overall Study||48
10142635|NCT02740114|11273154|FG000|COMPLETED|Overall Study||54
10142636|NCT02740114|11273155|FG001|COMPLETED|Overall Study||48
10142637|NCT02740114|11273154|FG000|NOT COMPLETED|Overall Study||0
10142638|NCT02740114|11273155|FG001|NOT COMPLETED|Overall Study||0
10142639|NCT02740153|11273163|FG000|STARTED|Overall Study||101
10142640|NCT02740153|11273164|FG001|STARTED|Overall Study||86
10142641|NCT02740153|11273163|FG000|COMPLETED|Overall Study||101
10142642|NCT02740153|11273164|FG001|COMPLETED|Overall Study||86
10142643|NCT02740153|11273163|FG000|NOT COMPLETED|Overall Study||0
10142644|NCT02740153|11273164|FG001|NOT COMPLETED|Overall Study||0
10142645|NCT02740413|11273172|FG000|STARTED|Overall Study||86
10142646|NCT02740413|11273172|FG000|COMPLETED|Overall Study||86
10142647|NCT02740413|11273172|FG000|NOT COMPLETED|Overall Study||0
10142648|NCT02740478|11273180|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
10142649|NCT02740478|11273180|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
10142650|NCT02740478|11273180|FG000|NOT COMPLETED|Overall Study||1
10142651|NCT02740504|11273184|FG000|STARTED|Overall Study||20
10142652|NCT02740504|11273184|FG000|COMPLETED|Overall Study||20
10142653|NCT02740504|11273184|FG000|NOT COMPLETED|Overall Study||0
10142654|NCT02740517|11273191|FG000|STARTED|Overall Study||19
10142655|NCT02740517|11273192|FG001|STARTED|Overall Study||11
10142656|NCT02740517|11273193|FG002|STARTED|Overall Study||18
10142657|NCT02740517|11273191|FG000|COMPLETED|Overall Study||19
10142658|NCT02740517|11273192|FG001|COMPLETED|Overall Study||11
10142659|NCT02740517|11273193|FG002|COMPLETED|Overall Study||18
10142660|NCT02740517|11273191|FG000|NOT COMPLETED|Overall Study||0
10142661|NCT02740517|11273192|FG001|NOT COMPLETED|Overall Study||0
10142662|NCT02740517|11273193|FG002|NOT COMPLETED|Overall Study||0
10142663|NCT02740543|11273203|FG000|STARTED|Overall Study||9
10142664|NCT02740543|11273204|FG001|STARTED|Overall Study||9
10142665|NCT02740543|11273203|FG000|COMPLETED|Overall Study||9
10142666|NCT02740543|11273204|FG001|COMPLETED|Overall Study||9
10142667|NCT02740543|11273203|FG000|NOT COMPLETED|Overall Study||0
10142668|NCT02740543|11273204|FG001|NOT COMPLETED|Overall Study||0
10142669|NCT02740582|11273212|FG000|STARTED|First Intervention||29
10142670|NCT02740582|11273213|FG001|STARTED|First Intervention||33
10142671|NCT02740582|11273212|FG000|COMPLETED|First Intervention||24
10142672|NCT02740582|11273213|FG001|COMPLETED|First Intervention||31
10142673|NCT02740582|11273212|FG000|NOT COMPLETED|First Intervention||5
10142674|NCT02740582|11273213|FG001|NOT COMPLETED|First Intervention||2
10142675|NCT02740582|11273212|FG000|STARTED|Washout||24
10142676|NCT02740582|11273213|FG001|STARTED|Washout||31
10142677|NCT02740582|11273212|FG000|COMPLETED|Washout||24
10142678|NCT02740582|11273213|FG001|COMPLETED|Washout||31
10142679|NCT02740582|11273212|FG000|NOT COMPLETED|Washout||0
10142680|NCT02740582|11273213|FG001|NOT COMPLETED|Washout||0
10142681|NCT02740582|11273212|FG000|STARTED|Second Intervention||24
10142682|NCT02740582|11273213|FG001|STARTED|Second Intervention||31
10142683|NCT02740582|11273212|FG000|COMPLETED|Second Intervention||23
10142684|NCT02740582|11273213|FG001|COMPLETED|Second Intervention||28
10142685|NCT02740582|11273212|FG000|NOT COMPLETED|Second Intervention||1
10142686|NCT02740582|11273213|FG001|NOT COMPLETED|Second Intervention||3
10142687|NCT02740660|11273221|FG000|STARTED|Overall Study||6
10142688|NCT02740660|11273222|FG001|STARTED|Overall Study||6
10142689|NCT02740660|11273221|FG000|COMPLETED|Overall Study||6
10142690|NCT02740660|11273222|FG001|COMPLETED|Overall Study||6
10142691|NCT02740660|11273221|FG000|NOT COMPLETED|Overall Study||0
10142692|NCT02740660|11273222|FG001|NOT COMPLETED|Overall Study||0
10142693|NCT02740920|11273228|FG000|STARTED|Overall Study||9
10142694|NCT02740920|11273228|FG000|COMPLETED|Overall Study||9
10142695|NCT02740920|11273228|FG000|NOT COMPLETED|Overall Study||0
10142696|NCT02741076|11273236|FG000|STARTED|Overall Study||13
10142697|NCT02741076|11273237|FG001|STARTED|Overall Study||12
10142698|NCT02741076|11273238|FG002|STARTED|Overall Study||3
10142699|NCT02741076|11273239|FG003|STARTED|Overall Study||4
10142700|NCT02741076|11273236|FG000|COMPLETED|Overall Study||10
10142701|NCT02741076|11273237|FG001|COMPLETED|Overall Study||7
10142702|NCT02741076|11273238|FG002|COMPLETED|Overall Study||1
10142703|NCT02741076|11273239|FG003|COMPLETED|Overall Study||2
10142704|NCT02741076|11273236|FG000|NOT COMPLETED|Overall Study||3
10142705|NCT02741076|11273237|FG001|NOT COMPLETED|Overall Study||5
10142706|NCT02741076|11273238|FG002|NOT COMPLETED|Overall Study||2
10142707|NCT02741076|11273239|FG003|NOT COMPLETED|Overall Study||2
10142708|NCT02741284|11273252|FG000|STARTED|Overall Study||57
10142709|NCT02741284|11273253|FG001|STARTED|Overall Study||57
10142710|NCT02741284|11273252|FG000|COMPLETED|Overall Study||51
10142711|NCT02741284|11273253|FG001|COMPLETED|Overall Study||48
10142712|NCT02741284|11273252|FG000|NOT COMPLETED|Overall Study||6
10142713|NCT02741284|11273253|FG001|NOT COMPLETED|Overall Study||9
10142714|NCT02741297|11273261|FG000|STARTED|Overall Study||73
10142715|NCT02741297|11273261|FG000|COMPLETED|Overall Study||59
10142716|NCT02741297|11273261|FG000|NOT COMPLETED|Overall Study||14
10142717|NCT02741310|11273267|FG000|STARTED|Overall Study||12
10142718|NCT02741310|11273268|FG001|STARTED|Overall Study||22
10142719|NCT02741310|11273267|FG000|COMPLETED|Overall Study||10
10142720|NCT02741310|11273268|FG001|COMPLETED|Overall Study||20
10142721|NCT02741310|11273267|FG000|NOT COMPLETED|Overall Study||2
10142722|NCT02741310|11273268|FG001|NOT COMPLETED|Overall Study||2
10142723|NCT02741518|11273284|FG000|STARTED|Overall Study||11
10142724|NCT02741518|11273285|FG001|STARTED|Overall Study||11
10142725|NCT02741518|11273284|FG000|COMPLETED|Overall Study||10
10142726|NCT02741518|11273285|FG001|COMPLETED|Overall Study||10
10142727|NCT02741518|11273284|FG000|NOT COMPLETED|Overall Study||1
10142728|NCT02741518|11273285|FG001|NOT COMPLETED|Overall Study||1
10142729|NCT02741596|11273293|FG000|STARTED|Overall Study||109
10142730|NCT02741596|11273294|FG001|STARTED|Overall Study||103
10142731|NCT02741596|11273293|FG000|COMPLETED|Overall Study||31
10142732|NCT02741596|11273294|FG001|COMPLETED|Overall Study||25
10142733|NCT02741596|11273293|FG000|NOT COMPLETED|Overall Study||78
10142734|NCT02741596|11273294|FG001|NOT COMPLETED|Overall Study||78
10142735|NCT02741635|11273300|FG000|STARTED|Overall Study||15
10142736|NCT02741635|11273300|FG000|COMPLETED|Overall Study||14
10142737|NCT02741635|11273300|FG000|NOT COMPLETED|Overall Study||1
10142738|NCT02741687|11273307|FG000|STARTED|Overall Study||36
10142739|NCT02741687|11273308|FG001|STARTED|Overall Study||44
10142740|NCT02741687|11273307|FG000|COMPLETED|Overall Study||36
10142741|NCT02741687|11273308|FG001|COMPLETED|Overall Study||44
10142742|NCT02741687|11273307|FG000|NOT COMPLETED|Overall Study||0
10142743|NCT02741687|11273308|FG001|NOT COMPLETED|Overall Study||0
10142744|NCT02741713|11273316|FG000|STARTED|Overall Study||20
10142745|NCT02741713|11273317|FG001|STARTED|Overall Study||20
10142746|NCT02741713|11273316|FG000|COMPLETED|Overall Study||18
10142747|NCT02741713|11273317|FG001|COMPLETED|Overall Study||19
10142748|NCT02741713|11273316|FG000|NOT COMPLETED|Overall Study||2
10142749|NCT02741713|11273317|FG001|NOT COMPLETED|Overall Study||1
10142750|NCT02742077|11273324|FG000|STARTED|Overall Study||20
10142751|NCT02742077|11273324|FG000|COMPLETED|Overall Study||20
10142752|NCT02742077|11273324|FG000|NOT COMPLETED|Overall Study||0
10142753|NCT02742103|11273330|FG000|STARTED|Overall Study||55
10142754|NCT02742103|11273331|FG001|STARTED|Overall Study||28
10142755|NCT02742103|11273330|FG000|COMPLETED|Overall Study||46
10142756|NCT02742103|11273331|FG001|COMPLETED|Overall Study||23
10142757|NCT02742103|11273330|FG000|NOT COMPLETED|Overall Study||9
10142758|NCT02742103|11273331|FG001|NOT COMPLETED|Overall Study||5
10142759|NCT02742129|11273339|FG000|STARTED|Phase 1||53
10142760|NCT02742129|11273340|FG001|STARTED|Phase 1||52
10142761|NCT02742129|11273339|FG000|COMPLETED|Phase 1||51
10142762|NCT02742129|11273340|FG001|COMPLETED|Phase 1||50
10142763|NCT02742129|11273339|FG000|NOT COMPLETED|Phase 1||2
10142764|NCT02742129|11273340|FG001|NOT COMPLETED|Phase 1||2
10142765|NCT02742129|11273339|FG000|STARTED|Phase 2||51
10142766|NCT02742129|11273340|FG001|STARTED|Phase 2||50
10142767|NCT02742129|11273339|FG000|COMPLETED|Phase 2||50
10142768|NCT02742129|11273340|FG001|COMPLETED|Phase 2||48
10142769|NCT02742129|11273339|FG000|NOT COMPLETED|Phase 2||1
10142770|NCT02742129|11273340|FG001|NOT COMPLETED|Phase 2||2
10142771|NCT02742441|11273351|FG000|STARTED|Overall Study||205
10142772|NCT02742441|11273352|FG001|STARTED|Overall Study||204
10142773|NCT02742441|11273351|FG000|COMPLETED|Overall Study||199
10142774|NCT02742441|11273352|FG001|COMPLETED|Overall Study||196
10142775|NCT02742441|11273351|FG000|NOT COMPLETED|Overall Study||6
10142776|NCT02742441|11273352|FG001|NOT COMPLETED|Overall Study||8
10142777|NCT02742519|11273360|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
10142778|NCT02742519|11273361|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
10142779|NCT02742519|11273362|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
10142780|NCT02742519|11273360|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
10142781|NCT02742519|11273361|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
10142782|NCT02742519|11273362|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10142783|NCT02742519|11273360|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10142784|NCT02742519|11273361|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10142785|NCT02742519|11273362|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10142786|NCT02742519|11273360|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
10142787|NCT02742519|11273361|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
10142788|NCT02742519|11273362|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
10142789|NCT02742519|11273360|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
10142790|NCT02742519|11273361|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
10142791|NCT02742519|11273362|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
10142792|NCT02742519|11273360|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
10142793|NCT02742519|11273361|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
10142794|NCT02742519|11273362|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
10142795|NCT02742519|11273360|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0
10142796|NCT02742519|11273361|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0
10142797|NCT02742519|11273362|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
10142798|NCT02742519|11273360|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10142799|NCT02742519|11273361|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10142800|NCT02742519|11273362|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10142801|NCT02742519|11273360|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10142802|NCT02742519|11273361|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10142803|NCT02742519|11273362|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
10142804|NCT02742532|11273372|FG000|STARTED|Overall Study||31
10142805|NCT02742532|11273373|FG001|STARTED|Overall Study||32
10142806|NCT02742532|11273372|FG000|COMPLETED|Overall Study||28
10142807|NCT02742532|11273373|FG001|COMPLETED|Overall Study||31
10142808|NCT02742532|11273372|FG000|NOT COMPLETED|Overall Study||3
10142809|NCT02742532|11273373|FG001|NOT COMPLETED|Overall Study||1
10142810|NCT02742649|11273382|FG000|STARTED|Pre-Randomization Washout Period||55
10142811|NCT02742649|11273383|FG001|STARTED|Pre-Randomization Washout Period||0
10142812|NCT02742649|11273384|FG002|STARTED|Pre-Randomization Washout Period||0
10142813|NCT02742649|11273385|FG003|STARTED|Pre-Randomization Washout Period||0
10142814|NCT02742649|11273386|FG004|STARTED|Pre-Randomization Washout Period||0
10142815|NCT02742649|11273382|FG000|COMPLETED|Pre-Randomization Washout Period||50
10142816|NCT02742649|11273383|FG001|COMPLETED|Pre-Randomization Washout Period||0
10142817|NCT02742649|11273384|FG002|COMPLETED|Pre-Randomization Washout Period||0
10142818|NCT02742649|11273385|FG003|COMPLETED|Pre-Randomization Washout Period||0
10142819|NCT02742649|11273386|FG004|COMPLETED|Pre-Randomization Washout Period||0
10142820|NCT02742649|11273382|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5
10142821|NCT02742649|11273383|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
10142822|NCT02742649|11273384|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
10142823|NCT02742649|11273385|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
10142824|NCT02742649|11273386|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
10142825|NCT02742649|11273382|FG000|STARTED|Double-Blind Treatment Period||0
10142826|NCT02742649|11273383|FG001|STARTED|Double-Blind Treatment Period||17
10142827|NCT02742649|11273384|FG002|STARTED|Double-Blind Treatment Period||17
10142828|NCT02742649|11273385|FG003|STARTED|Double-Blind Treatment Period||16
10142829|NCT02742649|11273386|FG004|STARTED|Double-Blind Treatment Period||0
10142830|NCT02742649|11273382|FG000|COMPLETED|Double-Blind Treatment Period||0
10142831|NCT02742649|11273383|FG001|COMPLETED|Double-Blind Treatment Period||16
10142832|NCT02742649|11273384|FG002|COMPLETED|Double-Blind Treatment Period||17
10142833|NCT02742649|11273385|FG003|COMPLETED|Double-Blind Treatment Period||16
10142834|NCT02742649|11273386|FG004|COMPLETED|Double-Blind Treatment Period||0
10142835|NCT02742649|11273382|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10142836|NCT02742649|11273383|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
10142837|NCT02742649|11273384|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
10142838|NCT02742649|11273385|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
10142839|NCT02742649|11273386|FG004|NOT COMPLETED|Double-Blind Treatment Period||0
10142840|NCT02742649|11273382|FG000|STARTED|Open-Label Period||0
10142841|NCT02742649|11273383|FG001|STARTED|Open-Label Period||0
10142842|NCT02742649|11273384|FG002|STARTED|Open-Label Period||0
10142843|NCT02742649|11273385|FG003|STARTED|Open-Label Period||0
10142844|NCT02742649|11273386|FG004|STARTED|Open-Label Period||49
10142845|NCT02742649|11273382|FG000|COMPLETED|Open-Label Period||0
10142846|NCT02742649|11273383|FG001|COMPLETED|Open-Label Period||0
10142847|NCT02742649|11273384|FG002|COMPLETED|Open-Label Period||0
10142848|NCT02742649|11273385|FG003|COMPLETED|Open-Label Period||0
10142849|NCT02742649|11273386|FG004|COMPLETED|Open-Label Period||48
10142850|NCT02742649|11273382|FG000|NOT COMPLETED|Open-Label Period||0
10142851|NCT02742649|11273383|FG001|NOT COMPLETED|Open-Label Period||0
10142852|NCT02742649|11273384|FG002|NOT COMPLETED|Open-Label Period||0
10142853|NCT02742649|11273385|FG003|NOT COMPLETED|Open-Label Period||0
10142854|NCT02742649|11273386|FG004|NOT COMPLETED|Open-Label Period||1
10142855|NCT02742766|11273416|FG000|STARTED|Part 1 (Up to 8 Days)||20
10142856|NCT02742766|11273417|FG001|STARTED|Part 1 (Up to 8 Days)||6
10142857|NCT02742766|11273418|FG002|STARTED|Part 1 (Up to 8 Days)||6
10142858|NCT02742766|11273419|FG003|STARTED|Part 1 (Up to 8 Days)||6
10142859|NCT02742766|11273420|FG004|STARTED|Part 1 (Up to 8 Days)||6
10142860|NCT02742766|11273421|FG005|STARTED|Part 1 (Up to 8 Days)||6
10142861|NCT02742766|11273422|FG006|STARTED|Part 1 (Up to 8 Days)||6
10142862|NCT02742766|11273423|FG007|STARTED|Part 1 (Up to 8 Days)||6
10142863|NCT02742766|11273424|FG008|STARTED|Part 1 (Up to 8 Days)||6
10142864|NCT02742766|11273425|FG009|STARTED|Part 1 (Up to 8 Days)||0
10142865|NCT02742766|11273426|FG010|STARTED|Part 1 (Up to 8 Days)||6
10142866|NCT02742766|11273427|FG011|STARTED|Part 1 (Up to 8 Days)||6
10142867|NCT02742766|11273428|FG012|STARTED|Part 1 (Up to 8 Days)||0
10142868|NCT02742766|11273429|FG013|STARTED|Part 1 (Up to 8 Days)||0
10142869|NCT02742766|11273430|FG014|STARTED|Part 1 (Up to 8 Days)||0
10142870|NCT02742766|11273431|FG015|STARTED|Part 1 (Up to 8 Days)||0
10142871|NCT02742766|11273432|FG016|STARTED|Part 1 (Up to 8 Days)||0
10142872|NCT02742766|11273433|FG017|STARTED|Part 1 (Up to 8 Days)||0
10142873|NCT02742766|11273434|FG018|STARTED|Part 1 (Up to 8 Days)||0
10142874|NCT02742766|11273416|FG000|COMPLETED|Part 1 (Up to 8 Days)||20
10142875|NCT02742766|11273417|FG001|COMPLETED|Part 1 (Up to 8 Days)||6
9707845|NCT00806416|10807037|FG000|STARTED|Period 1 - Part II||0
9707846|NCT00806416|10807038|FG001|STARTED|Period 1 - Part II||0
9707847|NCT00806416|10807039|FG002|STARTED|Period 1 - Part II||14
9707848|NCT00806416|10807040|FG003|STARTED|Period 1 - Part II||16
9707849|NCT00806416|10807037|FG000|COMPLETED|Period 1 - Part II||0
9707850|NCT00806416|10807038|FG001|COMPLETED|Period 1 - Part II||0
9707851|NCT00806416|10807039|FG002|COMPLETED|Period 1 - Part II||14
9707852|NCT00806416|10807040|FG003|COMPLETED|Period 1 - Part II||14
9707853|NCT00806416|10807037|FG000|NOT COMPLETED|Period 1 - Part II||0
9707854|NCT00806416|10807038|FG001|NOT COMPLETED|Period 1 - Part II||0
9707855|NCT00806416|10807039|FG002|NOT COMPLETED|Period 1 - Part II||0
9707856|NCT00806416|10807040|FG003|NOT COMPLETED|Period 1 - Part II||2
9707857|NCT00806416|10807037|FG000|STARTED|Period 2 - Part II||0
9707858|NCT00806416|10807038|FG001|STARTED|Period 2 - Part II||0
9707859|NCT00806416|10807039|FG002|STARTED|Period 2 - Part II||14
9707860|NCT00806416|10807040|FG003|STARTED|Period 2 - Part II||14
9707861|NCT00806416|10807037|FG000|COMPLETED|Period 2 - Part II||0
9707862|NCT00806416|10807038|FG001|COMPLETED|Period 2 - Part II||0
9707863|NCT00806416|10807039|FG002|COMPLETED|Period 2 - Part II||14
9707864|NCT00806416|10807040|FG003|COMPLETED|Period 2 - Part II||14
9707865|NCT00806416|10807037|FG000|NOT COMPLETED|Period 2 - Part II||0
9707866|NCT00806416|10807038|FG001|NOT COMPLETED|Period 2 - Part II||0
9707867|NCT00806416|10807039|FG002|NOT COMPLETED|Period 2 - Part II||0
9707868|NCT00806416|10807040|FG003|NOT COMPLETED|Period 2 - Part II||0
9707869|NCT00729651|10807050|FG000|STARTED|Overall Study||173
9707870|NCT00729651|10807051|FG001|STARTED|Overall Study||170
10142876|NCT02742766|11273418|FG002|COMPLETED|Part 1 (Up to 8 Days)||6
10142877|NCT02742766|11273419|FG003|COMPLETED|Part 1 (Up to 8 Days)||6
10142878|NCT02742766|11273420|FG004|COMPLETED|Part 1 (Up to 8 Days)||6
10142879|NCT02742766|11273421|FG005|COMPLETED|Part 1 (Up to 8 Days)||6
10142880|NCT02742766|11273422|FG006|COMPLETED|Part 1 (Up to 8 Days)||6
10142881|NCT02742766|11273423|FG007|COMPLETED|Part 1 (Up to 8 Days)||6
10142882|NCT02742766|11273424|FG008|COMPLETED|Part 1 (Up to 8 Days)||6
10142883|NCT02742766|11273425|FG009|COMPLETED|Part 1 (Up to 8 Days)||0
10142884|NCT02742766|11273426|FG010|COMPLETED|Part 1 (Up to 8 Days)||6
10142885|NCT02742766|11273427|FG011|COMPLETED|Part 1 (Up to 8 Days)||6
10142886|NCT02742766|11273428|FG012|COMPLETED|Part 1 (Up to 8 Days)||0
10142887|NCT02742766|11273429|FG013|COMPLETED|Part 1 (Up to 8 Days)||0
10142888|NCT02742766|11273430|FG014|COMPLETED|Part 1 (Up to 8 Days)||0
10142889|NCT02742766|11273431|FG015|COMPLETED|Part 1 (Up to 8 Days)||0
10142890|NCT02742766|11273432|FG016|COMPLETED|Part 1 (Up to 8 Days)||0
10142891|NCT02742766|11273433|FG017|COMPLETED|Part 1 (Up to 8 Days)||0
10142892|NCT02742766|11273434|FG018|COMPLETED|Part 1 (Up to 8 Days)||0
10142893|NCT02742766|11273416|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142894|NCT02742766|11273417|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142895|NCT02742766|11273418|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142896|NCT02742766|11273419|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142897|NCT02742766|11273420|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142898|NCT02742766|11273421|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142899|NCT02742766|11273422|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142900|NCT02742766|11273423|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142901|NCT02742766|11273424|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142902|NCT02742766|11273425|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142903|NCT02742766|11273426|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142904|NCT02742766|11273427|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142905|NCT02742766|11273428|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142906|NCT02742766|11273429|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142907|NCT02742766|11273430|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142908|NCT02742766|11273431|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142909|NCT02742766|11273432|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142910|NCT02742766|11273433|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142911|NCT02742766|11273434|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10142912|NCT02742766|11273416|FG000|STARTED|Part 2 (Up to 22 Days)||0
10142913|NCT02742766|11273417|FG001|STARTED|Part 2 (Up to 22 Days)||0
10142914|NCT02742766|11273418|FG002|STARTED|Part 2 (Up to 22 Days)||0
10142915|NCT02742766|11273419|FG003|STARTED|Part 2 (Up to 22 Days)||0
10142916|NCT02742766|11273420|FG004|STARTED|Part 2 (Up to 22 Days)||0
10142917|NCT02742766|11273421|FG005|STARTED|Part 2 (Up to 22 Days)||0
10142918|NCT02742766|11273422|FG006|STARTED|Part 2 (Up to 22 Days)||0
9707871|NCT00729651|10807050|FG000|COMPLETED|Overall Study||154
9707872|NCT00729651|10807051|FG001|COMPLETED|Overall Study||152
9707873|NCT00729651|10807050|FG000|NOT COMPLETED|Overall Study||19
9707874|NCT00729651|10807051|FG001|NOT COMPLETED|Overall Study||18
9707875|NCT00698815|10807060|FG000|STARTED|Overall Study||42
9707876|NCT00698815|10807061|FG001|STARTED|Overall Study||47
9707877|NCT00698815|10807062|FG002|STARTED|Overall Study||41
9707878|NCT00698815|10807060|FG000|COMPLETED|Overall Study||32
9707879|NCT00698815|10807061|FG001|COMPLETED|Overall Study||33
9707880|NCT00698815|10807062|FG002|COMPLETED|Overall Study||31
9707881|NCT00698815|10807060|FG000|NOT COMPLETED|Overall Study||10
9707882|NCT00698815|10807061|FG001|NOT COMPLETED|Overall Study||14
9707883|NCT00698815|10807062|FG002|NOT COMPLETED|Overall Study||10
9707884|NCT00698022|10807073|FG000|STARTED|Overall Study||30
9707885|NCT00698022|10807074|FG001|STARTED|Overall Study||30
9707886|NCT00698022|10807075|FG002|STARTED|Overall Study||16
9707887|NCT00698022|10807073|FG000|COMPLETED|Overall Study||14
9707888|NCT00698022|10807074|FG001|COMPLETED|Overall Study||20
9707889|NCT00698022|10807075|FG002|COMPLETED|Overall Study||14
9707890|NCT00698022|10807073|FG000|NOT COMPLETED|Overall Study||16
9707891|NCT00698022|10807074|FG001|NOT COMPLETED|Overall Study||10
9707892|NCT00698022|10807075|FG002|NOT COMPLETED|Overall Study||2
9707893|NCT00692913|10807085|FG000|STARTED|Overall Study||257
9707894|NCT00692913|10807086|FG001|STARTED|Overall Study||258
9707895|NCT00692913|10807085|FG000|COMPLETED|Overall Study||228
9707896|NCT00692913|10807086|FG001|COMPLETED|Overall Study||228
9707897|NCT00692913|10807085|FG000|NOT COMPLETED|Overall Study||29
9707898|NCT00692913|10807086|FG001|NOT COMPLETED|Overall Study||30
9707899|NCT00617994|10807097|FG000|STARTED|Overall Study||5
9707900|NCT00617994|10807098|FG001|STARTED|Overall Study||5
9707901|NCT00617994|10807099|FG002|STARTED|Overall Study||5
9707902|NCT00617994|10807100|FG003|STARTED|Overall Study||5
9707903|NCT00617994|10807101|FG004|STARTED|Overall Study||5
9707904|NCT00617994|10807097|FG000|COMPLETED|Overall Study||5
9707905|NCT00617994|10807098|FG001|COMPLETED|Overall Study||5
9707906|NCT00617994|10807099|FG002|COMPLETED|Overall Study||5
9707907|NCT00617994|10807100|FG003|COMPLETED|Overall Study||5
9707908|NCT00617994|10807101|FG004|COMPLETED|Overall Study||5
9707909|NCT00617994|10807097|FG000|NOT COMPLETED|Overall Study||0
9707910|NCT00617994|10807098|FG001|NOT COMPLETED|Overall Study||0
9707911|NCT00617994|10807099|FG002|NOT COMPLETED|Overall Study||0
9707912|NCT00617994|10807100|FG003|NOT COMPLETED|Overall Study||0
9707913|NCT00617994|10807101|FG004|NOT COMPLETED|Overall Study||0
10142919|NCT02742766|11273423|FG007|STARTED|Part 2 (Up to 22 Days)||0
9707914|NCT00617708|10807132|FG000|STARTED|Overall Study||10
9707915|NCT00617708|10807133|FG001|STARTED|Overall Study||60
9707916|NCT00617708|10807134|FG002|STARTED|Overall Study||64
9707917|NCT00617708|10807132|FG000|Eligible and Began Protocol Therapy|Overall Study||9
9707918|NCT00617708|10807133|FG001|Eligible and Began Protocol Therapy|Overall Study||57
9707919|NCT00617708|10807134|FG002|Eligible and Began Protocol Therapy|Overall Study||59
10142920|NCT02742766|11273424|FG008|STARTED|Part 2 (Up to 22 Days)||0
10142921|NCT02742766|11273425|FG009|STARTED|Part 2 (Up to 22 Days)||0
10142922|NCT02742766|11273426|FG010|STARTED|Part 2 (Up to 22 Days)||0
10142923|NCT02742766|11273427|FG011|STARTED|Part 2 (Up to 22 Days)||0
10142924|NCT02742766|11273428|FG012|STARTED|Part 2 (Up to 22 Days)||6
10142925|NCT02742766|11273429|FG013|STARTED|Part 2 (Up to 22 Days)||6
10142926|NCT02742766|11273430|FG014|STARTED|Part 2 (Up to 22 Days)||6
10142927|NCT02742766|11273431|FG015|STARTED|Part 2 (Up to 22 Days)||6
10142928|NCT02742766|11273432|FG016|STARTED|Part 2 (Up to 22 Days)||0
10142929|NCT02742766|11273433|FG017|STARTED|Part 2 (Up to 22 Days)||0
10142930|NCT02742766|11273434|FG018|STARTED|Part 2 (Up to 22 Days)||0
10142931|NCT02742766|11273416|FG000|COMPLETED|Part 2 (Up to 22 Days)||0
10142932|NCT02742766|11273417|FG001|COMPLETED|Part 2 (Up to 22 Days)||0
10142933|NCT02742766|11273418|FG002|COMPLETED|Part 2 (Up to 22 Days)||0
10142934|NCT02742766|11273419|FG003|COMPLETED|Part 2 (Up to 22 Days)||0
10142935|NCT02742766|11273420|FG004|COMPLETED|Part 2 (Up to 22 Days)||0
10142936|NCT02742766|11273421|FG005|COMPLETED|Part 2 (Up to 22 Days)||0
10142937|NCT02742766|11273422|FG006|COMPLETED|Part 2 (Up to 22 Days)||0
10142938|NCT02742766|11273423|FG007|COMPLETED|Part 2 (Up to 22 Days)||0
10142939|NCT02742766|11273424|FG008|COMPLETED|Part 2 (Up to 22 Days)||0
10142940|NCT02742766|11273425|FG009|COMPLETED|Part 2 (Up to 22 Days)||0
10142941|NCT02742766|11273426|FG010|COMPLETED|Part 2 (Up to 22 Days)||0
10142942|NCT02742766|11273427|FG011|COMPLETED|Part 2 (Up to 22 Days)||0
10142943|NCT02742766|11273428|FG012|COMPLETED|Part 2 (Up to 22 Days)||4
10142944|NCT02742766|11273429|FG013|COMPLETED|Part 2 (Up to 22 Days)||0
10142945|NCT02742766|11273430|FG014|COMPLETED|Part 2 (Up to 22 Days)||6
10142946|NCT02742766|11273431|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
10142947|NCT02742766|11273432|FG016|COMPLETED|Part 2 (Up to 22 Days)||0
10142948|NCT02742766|11273433|FG017|COMPLETED|Part 2 (Up to 22 Days)||0
10142949|NCT02742766|11273434|FG018|COMPLETED|Part 2 (Up to 22 Days)||0
10142950|NCT02742766|11273416|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142951|NCT02742766|11273417|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142952|NCT02742766|11273418|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142953|NCT02742766|11273419|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142954|NCT02742766|11273420|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142955|NCT02742766|11273421|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142956|NCT02742766|11273422|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142957|NCT02742766|11273423|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142958|NCT02742766|11273424|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142959|NCT02742766|11273425|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142960|NCT02742766|11273426|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142961|NCT02742766|11273427|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142962|NCT02742766|11273428|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2
10142963|NCT02742766|11273429|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6
10142964|NCT02742766|11273430|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142965|NCT02742766|11273431|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1
10142966|NCT02742766|11273432|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142967|NCT02742766|11273433|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142968|NCT02742766|11273434|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10142969|NCT02742766|11273416|FG000|STARTED|Part 3 (Up to 36 Days)||0
10142970|NCT02742766|11273417|FG001|STARTED|Part 3 (Up to 36 Days)||0
10142971|NCT02742766|11273418|FG002|STARTED|Part 3 (Up to 36 Days)||0
10142972|NCT02742766|11273419|FG003|STARTED|Part 3 (Up to 36 Days)||0
10142973|NCT02742766|11273420|FG004|STARTED|Part 3 (Up to 36 Days)||0
10142974|NCT02742766|11273421|FG005|STARTED|Part 3 (Up to 36 Days)||0
10142975|NCT02742766|11273422|FG006|STARTED|Part 3 (Up to 36 Days)||0
10142976|NCT02742766|11273423|FG007|STARTED|Part 3 (Up to 36 Days)||0
10142977|NCT02742766|11273424|FG008|STARTED|Part 3 (Up to 36 Days)||0
10142978|NCT02742766|11273425|FG009|STARTED|Part 3 (Up to 36 Days)||0
10142979|NCT02742766|11273426|FG010|STARTED|Part 3 (Up to 36 Days)||0
10142980|NCT02742766|11273427|FG011|STARTED|Part 3 (Up to 36 Days)||0
10142981|NCT02742766|11273428|FG012|STARTED|Part 3 (Up to 36 Days)||0
10142982|NCT02742766|11273429|FG013|STARTED|Part 3 (Up to 36 Days)||0
10142983|NCT02742766|11273430|FG014|STARTED|Part 3 (Up to 36 Days)||0
10142984|NCT02742766|11273431|FG015|STARTED|Part 3 (Up to 36 Days)||0
10142985|NCT02742766|11273432|FG016|STARTED|Part 3 (Up to 36 Days)||0
10142986|NCT02742766|11273433|FG017|STARTED|Part 3 (Up to 36 Days)||0
10142987|NCT02742766|11273434|FG018|STARTED|Part 3 (Up to 36 Days)||0
10142988|NCT02742766|11273416|FG000|COMPLETED|Part 3 (Up to 36 Days)||0
10142989|NCT02742766|11273417|FG001|COMPLETED|Part 3 (Up to 36 Days)||0
10142990|NCT02742766|11273418|FG002|COMPLETED|Part 3 (Up to 36 Days)||0
10142991|NCT02742766|11273419|FG003|COMPLETED|Part 3 (Up to 36 Days)||0
10142992|NCT02742766|11273420|FG004|COMPLETED|Part 3 (Up to 36 Days)||0
10142993|NCT02742766|11273421|FG005|COMPLETED|Part 3 (Up to 36 Days)||0
10142994|NCT02742766|11273422|FG006|COMPLETED|Part 3 (Up to 36 Days)||0
10142995|NCT02742766|11273423|FG007|COMPLETED|Part 3 (Up to 36 Days)||0
10142996|NCT02742766|11273424|FG008|COMPLETED|Part 3 (Up to 36 Days)||0
10142997|NCT02742766|11273425|FG009|COMPLETED|Part 3 (Up to 36 Days)||0
10142998|NCT02742766|11273426|FG010|COMPLETED|Part 3 (Up to 36 Days)||0
10142999|NCT02742766|11273427|FG011|COMPLETED|Part 3 (Up to 36 Days)||0
10143000|NCT02742766|11273428|FG012|COMPLETED|Part 3 (Up to 36 Days)||0
10143001|NCT02742766|11273429|FG013|COMPLETED|Part 3 (Up to 36 Days)||0
10143002|NCT02742766|11273430|FG014|COMPLETED|Part 3 (Up to 36 Days)||0
10143003|NCT02742766|11273431|FG015|COMPLETED|Part 3 (Up to 36 Days)||0
10143004|NCT02742766|11273432|FG016|COMPLETED|Part 3 (Up to 36 Days)||0
10143005|NCT02742766|11273433|FG017|COMPLETED|Part 3 (Up to 36 Days)||0
10143006|NCT02742766|11273434|FG018|COMPLETED|Part 3 (Up to 36 Days)||0
10143007|NCT02742766|11273416|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143008|NCT02742766|11273417|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143009|NCT02742766|11273418|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143010|NCT02742766|11273419|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143011|NCT02742766|11273420|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143012|NCT02742766|11273421|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143013|NCT02742766|11273422|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143014|NCT02742766|11273423|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143015|NCT02742766|11273424|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143016|NCT02742766|11273425|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143017|NCT02742766|11273426|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143018|NCT02742766|11273427|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143019|NCT02742766|11273428|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143020|NCT02742766|11273429|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143021|NCT02742766|11273430|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143022|NCT02742766|11273431|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143023|NCT02742766|11273432|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143024|NCT02742766|11273433|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143025|NCT02742766|11273434|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10143026|NCT02742818|11273496|FG000|STARTED|Overall Study||25
10143027|NCT02742818|11273497|FG001|STARTED|Overall Study||25
10143028|NCT02742818|11273496|FG000|COMPLETED|Overall Study||25
10143029|NCT02742818|11273497|FG001|COMPLETED|Overall Study||23
10143030|NCT02742818|11273496|FG000|NOT COMPLETED|Overall Study||0
10143031|NCT02742818|11273497|FG001|NOT COMPLETED|Overall Study||2
10143032|NCT02742987|11273507|FG000|STARTED|Overall Study||21
9707920|NCT00617708|10807132|FG000|COMPLETED|Overall Study||0
9707921|NCT00617708|10807133|FG001|COMPLETED|Overall Study||0
9707922|NCT00617708|10807134|FG002|COMPLETED|Overall Study||0
9707923|NCT00617708|10807132|FG000|NOT COMPLETED|Overall Study||10
9707924|NCT00617708|10807133|FG001|NOT COMPLETED|Overall Study||60
9707925|NCT00617708|10807134|FG002|NOT COMPLETED|Overall Study||64
9707926|NCT00516737|10807146|FG000|STARTED|Overall Study||103
9707927|NCT00516737|10807147|FG001|STARTED|Overall Study||104
9707928|NCT00516737|10807146|FG000|COMPLETED|Overall Study||92
9707929|NCT00516737|10807147|FG001|COMPLETED|Overall Study||96
9707930|NCT00516737|10807146|FG000|NOT COMPLETED|Overall Study||11
9707931|NCT00516737|10807147|FG001|NOT COMPLETED|Overall Study||8
9707932|NCT00358527|10807155|FG000|STARTED|Overall Study||267
9707933|NCT00358527|10807156|FG001|STARTED|Overall Study||134
9707934|NCT00358527|10807155|FG000|COMPLETED|Overall Study||254
9707935|NCT00358527|10807156|FG001|COMPLETED|Overall Study||131
9707936|NCT00358527|10807155|FG000|NOT COMPLETED|Overall Study||13
9707937|NCT00358527|10807156|FG001|NOT COMPLETED|Overall Study||3
9707938|NCT00326898|10807165|FG000|STARTED|Overall Study||647
9707939|NCT00326898|10807166|FG001|STARTED|Overall Study||649
9707940|NCT00326898|10807167|FG002|STARTED|Overall Study||647
9707941|NCT00326898|10807165|FG000|Patients With Toxicity Data|Overall Study||625
9707942|NCT00326898|10807166|FG001|Patients With Toxicity Data|Overall Study||628
9707943|NCT00326898|10807167|FG002|Patients With Toxicity Data|Overall Study||626
9707944|NCT00326898|10807165|FG000|Patients With Clear Cell Histology|Overall Study||542
9707945|NCT00326898|10807166|FG001|Patients With Clear Cell Histology|Overall Study||540
9707946|NCT00326898|10807167|FG002|Patients With Clear Cell Histology|Overall Study||540
9707947|NCT00326898|10807165|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
9707948|NCT00326898|10807166|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
9707949|NCT00326898|10807167|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
9707950|NCT00326898|10807165|FG000|COMPLETED|Overall Study||296
9707951|NCT00326898|10807166|FG001|COMPLETED|Overall Study||306
9707952|NCT00326898|10807167|FG002|COMPLETED|Overall Study||444
9707953|NCT00326898|10807165|FG000|NOT COMPLETED|Overall Study||351
9707954|NCT00326898|10807166|FG001|NOT COMPLETED|Overall Study||343
9707955|NCT00326898|10807167|FG002|NOT COMPLETED|Overall Study||203
9707956|NCT00156065|10807178|FG000|STARTED|Overall Study||51
9707957|NCT00156065|10807179|FG001|STARTED|Overall Study||93
9707958|NCT00156065|10807180|FG002|STARTED|Overall Study||43
9707959|NCT00156065|10807178|FG000|COMPLETED|Overall Study||20
9707960|NCT00156065|10807179|FG001|COMPLETED|Overall Study||30
9707961|NCT00156065|10807180|FG002|COMPLETED|Overall Study||16
9707962|NCT00156065|10807178|FG000|NOT COMPLETED|Overall Study||31
9707963|NCT00156065|10807179|FG001|NOT COMPLETED|Overall Study||63
9707964|NCT00156065|10807180|FG002|NOT COMPLETED|Overall Study||27
9707965|NCT00150176|10807190|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
9707966|NCT00150176|10807191|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
9707967|NCT00150176|10807190|FG000|COMPLETED|Overall Study||135
9707968|NCT00150176|10807191|FG001|COMPLETED|Overall Study||72
9707969|NCT00150176|10807190|FG000|NOT COMPLETED|Overall Study||59
9707970|NCT00150176|10807191|FG001|NOT COMPLETED|Overall Study||120
10143033|NCT02742987|11273508|FG001|STARTED|Overall Study||21
10143034|NCT02742987|11273507|FG000|COMPLETED|Overall Study||21
10143035|NCT02742987|11273508|FG001|COMPLETED|Overall Study||21
9848876|NCT00862810|10961736|FG001|NOT COMPLETED|Overall Study||4
9848877|NCT00862823|10961742|FG000|STARTED|First Intervention||6
9848878|NCT00862823|10961743|FG001|STARTED|First Intervention||10
9848879|NCT00862823|10961742|FG000|COMPLETED|First Intervention||5
9848880|NCT00862823|10961743|FG001|COMPLETED|First Intervention||9
10143036|NCT02742987|11273507|FG000|NOT COMPLETED|Overall Study||0
10143037|NCT02742987|11273508|FG001|NOT COMPLETED|Overall Study||0
10143038|NCT02743078|11273514|FG000|STARTED|Overall Study||3
10143039|NCT02743078|11273514|FG000|Eligible Populaton|Overall Study||3
10143040|NCT02743078|11273514|FG000|Eligible With Six-month Follow-up Data|Overall Study||3
10143041|NCT02743078|11273514|FG000|COMPLETED|Overall Study||3
10143042|NCT02743078|11273514|FG000|NOT COMPLETED|Overall Study||0
10143043|NCT02743117|11273520|FG000|STARTED|Overall Study||60
10143044|NCT02743117|11273521|FG001|STARTED|Overall Study||241
10143045|NCT02743117|11273520|FG000|Treated|Overall Study||59
10143046|NCT02743117|11273521|FG001|Treated|Overall Study||241
10143047|NCT02743117|11273520|FG000|COMPLETED|Overall Study||59
10143048|NCT02743117|11273521|FG001|COMPLETED|Overall Study||240
10143049|NCT02743117|11273520|FG000|NOT COMPLETED|Overall Study||1
10143050|NCT02743117|11273521|FG001|NOT COMPLETED|Overall Study||1
10143051|NCT02743221|11273529|FG000|STARTED|Overall Study||77
10143052|NCT02743221|11273530|FG001|STARTED|Overall Study||77
10143053|NCT02743221|11273529|FG000|COMPLETED|Overall Study||21
10143054|NCT02743221|11273530|FG001|COMPLETED|Overall Study||17
10143055|NCT02743221|11273529|FG000|NOT COMPLETED|Overall Study||56
10143056|NCT02743221|11273530|FG001|NOT COMPLETED|Overall Study||60
10143057|NCT02743312|11273538|FG000|STARTED|Overall Study||3
10143058|NCT02743312|11273539|FG001|STARTED|Overall Study||2
10143059|NCT02743312|11273538|FG000|COMPLETED|Overall Study||3
10143060|NCT02743312|11273539|FG001|COMPLETED|Overall Study||2
10143061|NCT02743312|11273538|FG000|NOT COMPLETED|Overall Study||0
10143062|NCT02743312|11273539|FG001|NOT COMPLETED|Overall Study||0
10143063|NCT02743377|11273556|FG000|STARTED|Overall Study||9
10143064|NCT02743377|11273557|FG001|STARTED|Overall Study||6
10143065|NCT02743377|11273556|FG000|Brain PET With 11C Rolipram|Overall Study||8
10143066|NCT02743377|11273557|FG001|Brain PET With 11C Rolipram|Overall Study||3
10143067|NCT02743377|11273556|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
10143068|NCT02743377|11273557|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
10143069|NCT02743377|11273556|FG000|Whole Body PET Baseline & Blocked|Overall Study||0
10143070|NCT02743377|11273557|FG001|Whole Body PET Baseline & Blocked|Overall Study||2
10143071|NCT02743377|11273556|FG000|COMPLETED|Overall Study||7
10143072|NCT02743377|11273557|FG001|COMPLETED|Overall Study||6
10143073|NCT02743377|11273556|FG000|NOT COMPLETED|Overall Study||2
10143074|NCT02743377|11273557|FG001|NOT COMPLETED|Overall Study||0
10143075|NCT02743442|11273564|FG000|STARTED|Overall Study||8
10143076|NCT02743442|11273564|FG000|COMPLETED|Overall Study||8
10143077|NCT02743442|11273564|FG000|NOT COMPLETED|Overall Study||0
10143078|NCT02743520|11273568|FG000|STARTED|Overall Study||86
10143079|NCT02743520|11273568|FG000|COMPLETED|Overall Study||85
10143080|NCT02743520|11273568|FG000|NOT COMPLETED|Overall Study||1
10143081|NCT02743702|11273574|FG000|STARTED|Overall Study||11
10143082|NCT02743702|11273575|FG001|STARTED|Overall Study||10
10143083|NCT02743702|11273574|FG000|COMPLETED|Overall Study||11
10143084|NCT02743702|11273575|FG001|COMPLETED|Overall Study||10
10143085|NCT02743702|11273574|FG000|NOT COMPLETED|Overall Study||0
10143086|NCT02743702|11273575|FG001|NOT COMPLETED|Overall Study||0
10143087|NCT02743780|11273586|FG000|STARTED|Part 1 (3 Days)||6
10143088|NCT02743780|11273587|FG001|STARTED|Part 1 (3 Days)||6
10143089|NCT02743780|11273588|FG002|STARTED|Part 1 (3 Days)||6
10143090|NCT02743780|11273589|FG003|STARTED|Part 1 (3 Days)||6
10143091|NCT02743780|11273590|FG004|STARTED|Part 1 (3 Days)||8
10143092|NCT02743780|11273586|FG000|COMPLETED|Part 1 (3 Days)||6
10143093|NCT02743780|11273587|FG001|COMPLETED|Part 1 (3 Days)||6
10143094|NCT02743780|11273588|FG002|COMPLETED|Part 1 (3 Days)||6
10143095|NCT02743780|11273589|FG003|COMPLETED|Part 1 (3 Days)||6
10143096|NCT02743780|11273590|FG004|COMPLETED|Part 1 (3 Days)||8
9707971|NCT00145509|10807200|FG000|STARTED|Overall Study||41
9707972|NCT00145509|10807201|FG001|STARTED|Overall Study||36
9707973|NCT00145509|10807200|FG000|COMPLETED|Overall Study||19
9707974|NCT00145509|10807201|FG001|COMPLETED|Overall Study||15
9707975|NCT00145509|10807200|FG000|NOT COMPLETED|Overall Study||22
9707976|NCT00145509|10807201|FG001|NOT COMPLETED|Overall Study||21
9707977|NCT00145496|10807209|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
9707978|NCT00145496|10807210|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
9707979|NCT00145496|10807209|FG000|COMPLETED|Overall Study||121
9707980|NCT00145496|10807210|FG001|COMPLETED|Overall Study||143
9707981|NCT00145496|10807209|FG000|NOT COMPLETED|Overall Study||123
9707982|NCT00145496|10807210|FG001|NOT COMPLETED|Overall Study||81
9729279|NCT00117598|10828855|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57
9729280|NCT00117598|10828856|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53
9729281|NCT00117598|10828857|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52
9729282|NCT00117598|10828858|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0
9729283|NCT00117598|10828859|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0
9729284|NCT00117598|10828855|FG000|STARTED|After Treament Cross Over||0
9729285|NCT00117598|10828856|FG001|STARTED|After Treament Cross Over||0
10143097|NCT02743780|11273586|FG000|NOT COMPLETED|Part 1 (3 Days)||0
10143098|NCT02743780|11273587|FG001|NOT COMPLETED|Part 1 (3 Days)||0
10143099|NCT02743780|11273588|FG002|NOT COMPLETED|Part 1 (3 Days)||0
10143100|NCT02743780|11273589|FG003|NOT COMPLETED|Part 1 (3 Days)||0
10143101|NCT02743780|11273590|FG004|NOT COMPLETED|Part 1 (3 Days)||0
10143102|NCT02743780|11273586|FG000|STARTED|Part 2 (8 Days)||0
10143103|NCT02743780|11273587|FG001|STARTED|Part 2 (8 Days)||6
10143104|NCT02743780|11273588|FG002|STARTED|Part 2 (8 Days)||6
10143105|NCT02743780|11273589|FG003|STARTED|Part 2 (8 Days)||0
10143106|NCT02743780|11273590|FG004|STARTED|Part 2 (8 Days)||4
10143107|NCT02743780|11273586|FG000|COMPLETED|Part 2 (8 Days)||0
10143108|NCT02743780|11273587|FG001|COMPLETED|Part 2 (8 Days)||6
10143109|NCT02743780|11273588|FG002|COMPLETED|Part 2 (8 Days)||6
10143110|NCT02743780|11273589|FG003|COMPLETED|Part 2 (8 Days)||0
10143111|NCT02743780|11273590|FG004|COMPLETED|Part 2 (8 Days)||4
10143112|NCT02743780|11273586|FG000|NOT COMPLETED|Part 2 (8 Days)||0
10143113|NCT02743780|11273587|FG001|NOT COMPLETED|Part 2 (8 Days)||0
10143114|NCT02743780|11273588|FG002|NOT COMPLETED|Part 2 (8 Days)||0
10143115|NCT02743780|11273589|FG003|NOT COMPLETED|Part 2 (8 Days)||0
10143116|NCT02743780|11273590|FG004|NOT COMPLETED|Part 2 (8 Days)||0
10143117|NCT02743780|11273586|FG000|STARTED|Part 3 (7 Days)||0
10143118|NCT02743780|11273587|FG001|STARTED|Part 3 (7 Days)||0
10143119|NCT02743780|11273588|FG002|STARTED|Part 3 (7 Days)||25
10143120|NCT02743780|11273589|FG003|STARTED|Part 3 (7 Days)||0
10143121|NCT02743780|11273590|FG004|STARTED|Part 3 (7 Days)||25
10143122|NCT02743780|11273586|FG000|COMPLETED|Part 3 (7 Days)||0
10143123|NCT02743780|11273587|FG001|COMPLETED|Part 3 (7 Days)||0
10143124|NCT02743780|11273588|FG002|COMPLETED|Part 3 (7 Days)||24
10143125|NCT02743780|11273589|FG003|COMPLETED|Part 3 (7 Days)||0
10143126|NCT02743780|11273590|FG004|COMPLETED|Part 3 (7 Days)||25
10143127|NCT02743780|11273586|FG000|NOT COMPLETED|Part 3 (7 Days)||0
10143128|NCT02743780|11273587|FG001|NOT COMPLETED|Part 3 (7 Days)||0
10143129|NCT02743780|11273588|FG002|NOT COMPLETED|Part 3 (7 Days)||1
10143130|NCT02743780|11273589|FG003|NOT COMPLETED|Part 3 (7 Days)||0
10143131|NCT02743780|11273590|FG004|NOT COMPLETED|Part 3 (7 Days)||0
10143132|NCT02743793|11273612|FG000|STARTED|Overall Study||5
10143133|NCT02743793|11273613|FG001|STARTED|Overall Study||36
10143134|NCT02743793|11273612|FG000|COMPLETED|Overall Study||0
10143135|NCT02743793|11273613|FG001|COMPLETED|Overall Study||0
10143136|NCT02743793|11273612|FG000|NOT COMPLETED|Overall Study||5
10143137|NCT02743793|11273613|FG001|NOT COMPLETED|Overall Study||36
10143138|NCT02743936|11273620|FG000|STARTED|Overall Study||32
10143139|NCT02743936|11273621|FG001|STARTED|Overall Study||32
10143140|NCT02743936|11273620|FG000|COMPLETED|Overall Study||32
10143141|NCT02743936|11273621|FG001|COMPLETED|Overall Study||32
10143142|NCT02743936|11273620|FG000|NOT COMPLETED|Overall Study||0
10143143|NCT02743936|11273621|FG001|NOT COMPLETED|Overall Study||0
10143144|NCT02743949|11273630|FG000|STARTED|Overall Study||86
10143145|NCT02743949|11273631|FG001|STARTED|Overall Study||85
10143146|NCT02743949|11273632|FG002|STARTED|Overall Study||85
10143147|NCT02743949|11273630|FG000|COMPLETED|Overall Study||82
10143148|NCT02743949|11273631|FG001|COMPLETED|Overall Study||84
10143149|NCT02743949|11273632|FG002|COMPLETED|Overall Study||82
10143150|NCT02743949|11273630|FG000|NOT COMPLETED|Overall Study||4
10143151|NCT02743949|11273631|FG001|NOT COMPLETED|Overall Study||1
10143152|NCT02743949|11273632|FG002|NOT COMPLETED|Overall Study||3
10143153|NCT02743962|11273642|FG000|STARTED|Overall Study||5
10143154|NCT02743962|11273643|FG001|STARTED|Overall Study||5
10143155|NCT02743962|11273642|FG000|COMPLETED|Overall Study||4
10143156|NCT02743962|11273643|FG001|COMPLETED|Overall Study||5
10143157|NCT02743962|11273642|FG000|NOT COMPLETED|Overall Study||1
10143158|NCT02743962|11273643|FG001|NOT COMPLETED|Overall Study||0
10143159|NCT02744066|11273654|FG000|STARTED|Overall Study||25
10143160|NCT02744066|11273655|FG001|STARTED|Overall Study||30
10143161|NCT02744066|11273654|FG000|COMPLETED|Overall Study||25
10143162|NCT02744066|11273655|FG001|COMPLETED|Overall Study||25
10143163|NCT02744066|11273654|FG000|NOT COMPLETED|Overall Study||0
10143164|NCT02744066|11273655|FG001|NOT COMPLETED|Overall Study||5
10143165|NCT02744391|11273663|FG000|STARTED|Overall Study||47
10143166|NCT02744391|11273663|FG000|COMPLETED|Overall Study||33
10143167|NCT02744391|11273663|FG000|NOT COMPLETED|Overall Study||14
10143168|NCT02744534|11273667|FG000|STARTED|Overall Study||21
10143169|NCT02744534|11273667|FG000|COMPLETED|Overall Study||21
10143170|NCT02744534|11273667|FG000|NOT COMPLETED|Overall Study||0
10143171|NCT02744755|11273675|FG000|STARTED|Study Period 1||177
10143172|NCT02744755|11273676|FG001|STARTED|Study Period 1||176
10143173|NCT02744755|11273675|FG000|COMPLETED|Study Period 1||163
10143174|NCT02744755|11273676|FG001|COMPLETED|Study Period 1||168
10143175|NCT02744755|11273675|FG000|NOT COMPLETED|Study Period 1||14
10143176|NCT02744755|11273676|FG001|NOT COMPLETED|Study Period 1||8
10143177|NCT02744755|11273675|FG000|STARTED|Study Period 2||159
10143178|NCT02744755|11273676|FG001|STARTED|Study Period 2||166
10143179|NCT02744755|11273675|FG000|COMPLETED|Study Period 2||145
9707983|NCT00145470|10807218|FG000|STARTED|Overall Study||167
10143180|NCT02744755|11273676|FG001|COMPLETED|Study Period 2||158
10143181|NCT02744755|11273675|FG000|NOT COMPLETED|Study Period 2||14
10143182|NCT02744755|11273676|FG001|NOT COMPLETED|Study Period 2||8
10143183|NCT02744846|11273686|FG000|STARTED|5 Year Outcome Assessment||681739
10143184|NCT02744846|11273686|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
10143185|NCT02744846|11273686|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
10143186|NCT02744846|11273686|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189
10143187|NCT02744846|11273686|FG000|STARTED|10 Year Outcome Assessment||362550
10143188|NCT02744846|11273686|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
10143189|NCT02744846|11273686|FG000|COMPLETED|10 Year Outcome Assessment||56730
10143190|NCT02744846|11273686|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820
10143191|NCT02744898|11273694|FG000|STARTED|Overall Study||23
10143192|NCT02744898|11273694|FG000|COMPLETED|Overall Study||19
9707984|NCT00145470|10807219|FG001|STARTED|Overall Study||159
10143193|NCT02744898|11273694|FG000|NOT COMPLETED|Overall Study||4
10143194|NCT02745080|11273700|FG000|STARTED|Overall Study||426
10143195|NCT02745080|11273701|FG001|STARTED|Overall Study||427
10143196|NCT02745080|11273700|FG000|COMPLETED|Overall Study||371
10143197|NCT02745080|11273701|FG001|COMPLETED|Overall Study||338
10143198|NCT02745080|11273700|FG000|NOT COMPLETED|Overall Study||55
10143199|NCT02745080|11273701|FG001|NOT COMPLETED|Overall Study||89
10143200|NCT02745119|11273712|FG000|STARTED|Overall Study||145
10143201|NCT02745119|11273713|FG001|STARTED|Overall Study||274
10143202|NCT02745119|11273714|FG002|STARTED|Overall Study||146
10143203|NCT02745119|11273715|FG003|STARTED|Overall Study||277
10143204|NCT02745119|11273712|FG000|COMPLETED|Overall Study||0
10143205|NCT02745119|11273713|FG001|COMPLETED|Overall Study||0
10143206|NCT02745119|11273714|FG002|COMPLETED|Overall Study||0
10143207|NCT02745119|11273715|FG003|COMPLETED|Overall Study||0
10143208|NCT02745119|11273712|FG000|NOT COMPLETED|Overall Study||145
10143209|NCT02745119|11273713|FG001|NOT COMPLETED|Overall Study||274
10143210|NCT02745119|11273714|FG002|NOT COMPLETED|Overall Study||146
10143211|NCT02745119|11273715|FG003|NOT COMPLETED|Overall Study||277
10143212|NCT02745145|11273730|FG000|STARTED|Overall Study||10
10143213|NCT02745145|11273731|FG001|STARTED|Overall Study||5
10143214|NCT02745145|11273732|FG002|STARTED|Overall Study||9
10143215|NCT02745145|11273730|FG000|COMPLETED|Overall Study||0
10143216|NCT02745145|11273731|FG001|COMPLETED|Overall Study||0
10143217|NCT02745145|11273732|FG002|COMPLETED|Overall Study||0
10143218|NCT02745145|11273730|FG000|NOT COMPLETED|Overall Study||10
10143219|NCT02745145|11273731|FG001|NOT COMPLETED|Overall Study||5
10143220|NCT02745145|11273732|FG002|NOT COMPLETED|Overall Study||9
10143221|NCT02745353|11273742|FG000|STARTED|First Intervention (2 Weeks)||4
9707985|NCT00145470|10807218|FG000|Treated|Overall Study||166
9707986|NCT00145470|10807219|FG001|Treated|Overall Study||158
9707987|NCT00145470|10807218|FG000|COMPLETED|Overall Study||55
9707988|NCT00145470|10807219|FG001|COMPLETED|Overall Study||61
9707989|NCT00145470|10807218|FG000|NOT COMPLETED|Overall Study||112
9707990|NCT00145470|10807219|FG001|NOT COMPLETED|Overall Study||98
9707991|NCT00129402|10807227|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43
9707992|NCT00129402|10807228|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40
9707993|NCT00129402|10807229|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43
9707994|NCT00129402|10807230|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40
9707995|NCT00129402|10807231|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40
9707996|NCT00129402|10807232|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42
9707997|NCT00129402|10807233|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0
9707998|NCT00129402|10807227|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
9707999|NCT00129402|10807228|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
9708000|NCT00129402|10807229|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
9708001|NCT00129402|10807230|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
9708002|NCT00129402|10807231|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
9708003|NCT00129402|10807232|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
9708004|NCT00129402|10807233|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
9708005|NCT00129402|10807227|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
9708006|NCT00129402|10807228|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
9708007|NCT00129402|10807229|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
9708008|NCT00129402|10807230|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
9708009|NCT00129402|10807231|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
9708010|NCT00129402|10807232|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
9708011|NCT00129402|10807233|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
9708012|NCT00129402|10807227|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0
9708013|NCT00129402|10807228|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0
9708014|NCT00129402|10807229|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
9708015|NCT00129402|10807230|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0
9708016|NCT00129402|10807231|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0
9708017|NCT00129402|10807232|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
9708018|NCT00129402|10807233|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0
9708019|NCT00129402|10807227|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708020|NCT00129402|10807228|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708021|NCT00129402|10807229|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
9708022|NCT00129402|10807230|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10143222|NCT02745353|11273743|FG001|STARTED|First Intervention (2 Weeks)||3
10143223|NCT02745353|11273742|FG000|COMPLETED|First Intervention (2 Weeks)||1
10143224|NCT02745353|11273743|FG001|COMPLETED|First Intervention (2 Weeks)||1
10143225|NCT02745353|11273742|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3
10143226|NCT02745353|11273743|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
10143227|NCT02745353|11273742|FG000|STARTED|Washout (3 Days)||1
10143228|NCT02745353|11273743|FG001|STARTED|Washout (3 Days)||1
10143229|NCT02745353|11273742|FG000|COMPLETED|Washout (3 Days)||1
10143230|NCT02745353|11273743|FG001|COMPLETED|Washout (3 Days)||1
10143231|NCT02745353|11273742|FG000|NOT COMPLETED|Washout (3 Days)||0
10143232|NCT02745353|11273743|FG001|NOT COMPLETED|Washout (3 Days)||0
10143233|NCT02745353|11273742|FG000|STARTED|Second Intervention (2 Weeks)||1
10143234|NCT02745353|11273743|FG001|STARTED|Second Intervention (2 Weeks)||1
10143235|NCT02745353|11273742|FG000|COMPLETED|Second Intervention (2 Weeks)||1
10143236|NCT02745353|11273743|FG001|COMPLETED|Second Intervention (2 Weeks)||0
10143237|NCT02745353|11273742|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10143238|NCT02745353|11273743|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1
10143239|NCT02745392|11273753|FG000|STARTED|Overall Study||91
10143240|NCT02745392|11273754|FG001|STARTED|Overall Study||90
10143241|NCT02745392|11273755|FG002|STARTED|Overall Study||92
10143242|NCT02745392|11273756|FG003|STARTED|Overall Study||92
10143243|NCT02745392|11273753|FG000|COMPLETED|Overall Study||91
10143244|NCT02745392|11273754|FG001|COMPLETED|Overall Study||89
10143245|NCT02745392|11273755|FG002|COMPLETED|Overall Study||92
10143246|NCT02745392|11273756|FG003|COMPLETED|Overall Study||92
10143247|NCT02745392|11273753|FG000|NOT COMPLETED|Overall Study||0
10143248|NCT02745392|11273754|FG001|NOT COMPLETED|Overall Study||1
10143249|NCT02745392|11273755|FG002|NOT COMPLETED|Overall Study||0
10143250|NCT02745392|11273756|FG003|NOT COMPLETED|Overall Study||0
10143251|NCT02745626|11273769|FG000|STARTED|Overall Study||24
10143252|NCT02745626|11273770|FG001|STARTED|Overall Study||22
10143253|NCT02745626|11273771|FG002|STARTED|Overall Study||22
10143254|NCT02745626|11273769|FG000|COMPLETED|Overall Study||21
10143255|NCT02745626|11273770|FG001|COMPLETED|Overall Study||16
10143256|NCT02745626|11273771|FG002|COMPLETED|Overall Study||19
10143257|NCT02745626|11273769|FG000|NOT COMPLETED|Overall Study||3
10143258|NCT02745626|11273770|FG001|NOT COMPLETED|Overall Study||6
10143259|NCT02745626|11273771|FG002|NOT COMPLETED|Overall Study||3
10143260|NCT02746107|11273779|FG000|STARTED|Overall Study||968
10143261|NCT02746107|11273779|FG000|2 Diagrams DA|Overall Study||482
10143262|NCT02746107|11273779|FG000|1 Diagram DA|Overall Study||486
10143263|NCT02746107|11273779|FG000|1year Risk Estimate|Overall Study||483
10143264|NCT02746107|11273779|FG000|5year Risk Estimate|Overall Study||485
10143265|NCT02746107|11273779|FG000|Target=Patient|Overall Study||486
10143266|NCT02746107|11273779|FG000|Target=Physician|Overall Study||482
10143267|NCT02746107|11273779|FG000|CHA2DS2-VASC Score = 1|Overall Study||195
10143268|NCT02746107|11273779|FG000|CHA2DS2-VASC Score = 2|Overall Study||189
10143269|NCT02746107|11273779|FG000|CHA2DS2-VASC Score = 3|Overall Study||195
10143270|NCT02746107|11273779|FG000|CHA2DS2-VASC Score = 4|Overall Study||197
10143271|NCT02746107|11273779|FG000|CHA2DS2-VASC Score = 5|Overall Study||192
10143272|NCT02746107|11273779|FG000|COMPLETED|Overall Study||968
10143273|NCT02746107|11273779|FG000|NOT COMPLETED|Overall Study||0
10196772|NCT03364309|11324817|FG000|COMPLETED|Re-treatment (Maintenance) Period||0
10196773|NCT03364309|11324818|FG001|COMPLETED|Re-treatment (Maintenance) Period||0
10196774|NCT03364309|11324819|FG002|COMPLETED|Re-treatment (Maintenance) Period||0
10196775|NCT03364309|11324820|FG003|COMPLETED|Re-treatment (Maintenance) Period||0
10196776|NCT03364309|11324821|FG004|COMPLETED|Re-treatment (Maintenance) Period||0
10196777|NCT03364309|11324822|FG005|COMPLETED|Re-treatment (Maintenance) Period||0
10196778|NCT03364309|11324823|FG006|COMPLETED|Re-treatment (Maintenance) Period||0
10196779|NCT03364309|11324824|FG007|COMPLETED|Re-treatment (Maintenance) Period||0
10196780|NCT03364309|11324825|FG008|COMPLETED|Re-treatment (Maintenance) Period||0
10196781|NCT03364309|11324826|FG009|COMPLETED|Re-treatment (Maintenance) Period||0
10196782|NCT03364309|11324827|FG010|COMPLETED|Re-treatment (Maintenance) Period||0
10196783|NCT03364309|11324828|FG011|COMPLETED|Re-treatment (Maintenance) Period||2
10196784|NCT03364309|11324829|FG012|COMPLETED|Re-treatment (Maintenance) Period||42
10196785|NCT03364309|11324830|FG013|COMPLETED|Re-treatment (Maintenance) Period||6
10196786|NCT03364309|11324831|FG014|COMPLETED|Re-treatment (Maintenance) Period||43
10196787|NCT03364309|11324832|FG015|COMPLETED|Re-treatment (Maintenance) Period||8
10196788|NCT03364309|11324833|FG016|COMPLETED|Re-treatment (Maintenance) Period||0
9708023|NCT00129402|10807231|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708024|NCT00129402|10807232|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
9708025|NCT00129402|10807233|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708026|NCT00129402|10807227|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708027|NCT00129402|10807228|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708028|NCT00129402|10807229|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
9708029|NCT00129402|10807230|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708030|NCT00129402|10807231|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708031|NCT00129402|10807232|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
9708032|NCT00129402|10807233|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
9708033|NCT00129402|10807227|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0
9708034|NCT00129402|10807228|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0
9708035|NCT00129402|10807229|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0
9708036|NCT00129402|10807230|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0
9708037|NCT00129402|10807231|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0
9708038|NCT00129402|10807232|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0
9708039|NCT00129402|10807233|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
9729286|NCT00117598|10828857|FG002|STARTED|After Treament Cross Over||0
10196789|NCT03364309|11324834|FG017|COMPLETED|Re-treatment (Maintenance) Period||0
10196790|NCT03364309|11324835|FG018|COMPLETED|Re-treatment (Maintenance) Period||0
10196791|NCT03364309|11324817|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10143274|NCT02746406|11273794|FG000|STARTED|Overall Study||5
10143275|NCT02746406|11273794|FG000|COMPLETED|Overall Study||5
10143276|NCT02746406|11273794|FG000|NOT COMPLETED|Overall Study||0
10143277|NCT02746575|11273798|FG000|STARTED|Overall Study||70
10143278|NCT02746575|11273798|FG000|COMPLETED|Overall Study||20
10143279|NCT02746575|11273798|FG000|NOT COMPLETED|Overall Study||50
10143280|NCT02746627|11273805|FG000|STARTED|Overall Study||60
10143281|NCT02746627|11273806|FG001|STARTED|Overall Study||30
10143282|NCT02746627|11273807|FG002|STARTED|Overall Study||30
10143283|NCT02746627|11273805|FG000|COMPLETED|Overall Study||59
10143284|NCT02746627|11273806|FG001|COMPLETED|Overall Study||29
10143285|NCT02746627|11273807|FG002|COMPLETED|Overall Study||29
10143286|NCT02746627|11273805|FG000|NOT COMPLETED|Overall Study||1
10143287|NCT02746627|11273806|FG001|NOT COMPLETED|Overall Study||1
10143288|NCT02746627|11273807|FG002|NOT COMPLETED|Overall Study||1
10143289|NCT02746679|11273817|FG000|STARTED|Overall Study||80
10143290|NCT02746679|11273818|FG001|STARTED|Overall Study||81
10143291|NCT02746679|11273817|FG000|COMPLETED|Overall Study||76
10143292|NCT02746679|11273818|FG001|COMPLETED|Overall Study||75
10143293|NCT02746679|11273817|FG000|NOT COMPLETED|Overall Study||4
10143294|NCT02746679|11273818|FG001|NOT COMPLETED|Overall Study||6
10143295|NCT02746705|11273826|FG000|STARTED|Overall Study||17
10143296|NCT02746705|11273827|FG001|STARTED|Overall Study||14
10143297|NCT02746705|11273826|FG000|COMPLETED|Overall Study||15
10143298|NCT02746705|11273827|FG001|COMPLETED|Overall Study||12
10143299|NCT02746705|11273826|FG000|NOT COMPLETED|Overall Study||2
10143300|NCT02746705|11273827|FG001|NOT COMPLETED|Overall Study||2
10143301|NCT02746874|11273835|FG000|STARTED|Overall Study||35
10143302|NCT02746874|11273836|FG001|STARTED|Overall Study||35
10143303|NCT02746874|11273835|FG000|COMPLETED|Overall Study||35
10143304|NCT02746874|11273836|FG001|COMPLETED|Overall Study||32
10143305|NCT02746874|11273835|FG000|NOT COMPLETED|Overall Study||0
10143306|NCT02746874|11273836|FG001|NOT COMPLETED|Overall Study||3
10143307|NCT02746991|11273844|FG000|STARTED|Overall Study||52
10143308|NCT02746991|11273845|FG001|STARTED|Overall Study||101
10143309|NCT02746991|11273844|FG000|COMPLETED|Overall Study||24
10143310|NCT02746991|11273845|FG001|COMPLETED|Overall Study||67
10143311|NCT02746991|11273844|FG000|NOT COMPLETED|Overall Study||28
10143312|NCT02746991|11273845|FG001|NOT COMPLETED|Overall Study||34
10143313|NCT02747004|11273856|FG000|STARTED|Overall Study||78
10143314|NCT02747004|11273857|FG001|STARTED|Overall Study||79
10143315|NCT02747004|11273858|FG002|STARTED|Overall Study||77
10143316|NCT02747004|11273856|FG000|Received at Least One Dose of Study Drug|Overall Study||78
10143317|NCT02747004|11273857|FG001|Received at Least One Dose of Study Drug|Overall Study||79
10143318|NCT02747004|11273858|FG002|Received at Least One Dose of Study Drug|Overall Study||77
10143319|NCT02747004|11273856|FG000|COMPLETED|Overall Study||21
10143320|NCT02747004|11273857|FG001|COMPLETED|Overall Study||30
10143321|NCT02747004|11273858|FG002|COMPLETED|Overall Study||30
10143322|NCT02747004|11273856|FG000|NOT COMPLETED|Overall Study||57
10143323|NCT02747004|11273857|FG001|NOT COMPLETED|Overall Study||49
10143324|NCT02747004|11273858|FG002|NOT COMPLETED|Overall Study||47
10143325|NCT02747043|11273868|FG000|STARTED|Overall Study||128
10143326|NCT02747043|11273869|FG001|STARTED|Overall Study||128
10143327|NCT02747043|11273868|FG000|Treated|Overall Study||128
10143328|NCT02747043|11273869|FG001|Treated|Overall Study||126
10143329|NCT02747043|11273868|FG000|COMPLETED|Overall Study||118
10143330|NCT02747043|11273869|FG001|COMPLETED|Overall Study||123
10143331|NCT02747043|11273868|FG000|NOT COMPLETED|Overall Study||10
10143332|NCT02747043|11273869|FG001|NOT COMPLETED|Overall Study||5
10143333|NCT02747108|11273877|FG000|STARTED|Overall Study||253
10143334|NCT02747108|11273878|FG001|STARTED|Overall Study||62
10143335|NCT02747108|11273877|FG000|COMPLETED|Overall Study||248
10143336|NCT02747108|11273878|FG001|COMPLETED|Overall Study||60
10143337|NCT02747108|11273877|FG000|NOT COMPLETED|Overall Study||5
10143338|NCT02747108|11273878|FG001|NOT COMPLETED|Overall Study||2
10143339|NCT02747186|11273891|FG000|STARTED|First Intervention||12
10143340|NCT02747186|11273892|FG001|STARTED|First Intervention||12
10143341|NCT02747186|11273891|FG000|COMPLETED|First Intervention||12
10143342|NCT02747186|11273892|FG001|COMPLETED|First Intervention||12
10143343|NCT02747186|11273891|FG000|NOT COMPLETED|First Intervention||0
10143344|NCT02747186|11273892|FG001|NOT COMPLETED|First Intervention||0
10143345|NCT02747186|11273891|FG000|STARTED|Washout (1 Week)||12
10143346|NCT02747186|11273892|FG001|STARTED|Washout (1 Week)||12
10143347|NCT02747186|11273891|FG000|COMPLETED|Washout (1 Week)||12
10143348|NCT02747186|11273892|FG001|COMPLETED|Washout (1 Week)||12
10143349|NCT02747186|11273891|FG000|NOT COMPLETED|Washout (1 Week)||0
10143350|NCT02747186|11273892|FG001|NOT COMPLETED|Washout (1 Week)||0
10143351|NCT02747186|11273891|FG000|STARTED|Second Intervention||12
10143352|NCT02747186|11273892|FG001|STARTED|Second Intervention||12
10143353|NCT02747186|11273891|FG000|COMPLETED|Second Intervention||12
10143354|NCT02747186|11273892|FG001|COMPLETED|Second Intervention||12
10143355|NCT02747186|11273891|FG000|NOT COMPLETED|Second Intervention||0
10143356|NCT02747186|11273892|FG001|NOT COMPLETED|Second Intervention||0
10143357|NCT02747238|11273900|FG000|STARTED|Overall Study||12
10143358|NCT02747238|11273901|FG001|STARTED|Overall Study||20
10143359|NCT02747238|11273900|FG000|COMPLETED|Overall Study||9
10143360|NCT02747238|11273901|FG001|COMPLETED|Overall Study||14
10143361|NCT02747238|11273900|FG000|NOT COMPLETED|Overall Study||3
10143362|NCT02747238|11273901|FG001|NOT COMPLETED|Overall Study||6
10143363|NCT02747420|11273909|FG000|STARTED|Overall Study||18
10143364|NCT02747420|11273910|FG001|STARTED|Overall Study||22
10143365|NCT02747420|11273909|FG000|COMPLETED|Overall Study||11
10143366|NCT02747420|11273910|FG001|COMPLETED|Overall Study||18
10143367|NCT02747420|11273909|FG000|NOT COMPLETED|Overall Study||7
10143368|NCT02747420|11273910|FG001|NOT COMPLETED|Overall Study||4
10143369|NCT02747615|11273918|FG000|STARTED|Overall Study||30
10143370|NCT02747615|11273919|FG001|STARTED|Overall Study||30
10143371|NCT02747615|11273918|FG000|COMPLETED|Overall Study||30
10143372|NCT02747615|11273919|FG001|COMPLETED|Overall Study||30
10143373|NCT02747615|11273918|FG000|NOT COMPLETED|Overall Study||0
10143374|NCT02747615|11273919|FG001|NOT COMPLETED|Overall Study||0
10143375|NCT02747628|11273928|FG000|STARTED|Overall Study||20
10143376|NCT02747628|11273929|FG001|STARTED|Overall Study||20
10143377|NCT02747628|11273930|FG002|STARTED|Overall Study||20
10143378|NCT02747628|11273928|FG000|COMPLETED|Overall Study||20
10143379|NCT02747628|11273929|FG001|COMPLETED|Overall Study||20
10143380|NCT02747628|11273930|FG002|COMPLETED|Overall Study||20
10143381|NCT02747628|11273928|FG000|NOT COMPLETED|Overall Study||0
10143382|NCT02747628|11273929|FG001|NOT COMPLETED|Overall Study||0
10143383|NCT02747628|11273930|FG002|NOT COMPLETED|Overall Study||0
10143384|NCT02747875|11273940|FG000|STARTED|Overall Study||12
10143385|NCT02747875|11273941|FG001|STARTED|Overall Study||14
10143386|NCT02747875|11273940|FG000|COMPLETED|Overall Study||11
10143387|NCT02747875|11273941|FG001|COMPLETED|Overall Study||13
10143388|NCT02747875|11273940|FG000|NOT COMPLETED|Overall Study||1
10143389|NCT02747875|11273941|FG001|NOT COMPLETED|Overall Study||1
10143390|NCT02747927|11273949|FG000|STARTED|Overall Study||6698
10143391|NCT02747927|11273950|FG001|STARTED|Overall Study||13401
10143392|NCT02747927|11273949|FG000|Treated: Safety Set|Overall Study||6687
10143393|NCT02747927|11273950|FG001|Treated: Safety Set|Overall Study||13380
10143394|NCT02747927|11273949|FG000|COMPLETED|Overall Study||6477
10143395|NCT02747927|11273950|FG001|COMPLETED|Overall Study||12943
10143396|NCT02747927|11273949|FG000|NOT COMPLETED|Overall Study||221
10143397|NCT02747927|11273950|FG001|NOT COMPLETED|Overall Study||458
10143398|NCT02748070|11273958|FG000|STARTED|Overall Study||41
10143399|NCT02748070|11273959|FG001|STARTED|Overall Study||40
10143400|NCT02748070|11273958|FG000|Randomized and Treated|Overall Study||40
10143401|NCT02748070|11273959|FG001|Randomized and Treated|Overall Study||40
10143402|NCT02748070|11273958|FG000|COMPLETED|Overall Study||33
10143403|NCT02748070|11273959|FG001|COMPLETED|Overall Study||39
10143404|NCT02748070|11273958|FG000|NOT COMPLETED|Overall Study||8
10060654|NCT02099721|11186214|FG002|NOT COMPLETED|Overall Study||85
10060655|NCT02099721|11186215|FG003|NOT COMPLETED|Overall Study||71
10060656|NCT02099721|11186216|FG004|NOT COMPLETED|Overall Study||27
10060657|NCT02099721|11186217|FG005|NOT COMPLETED|Overall Study||20
10060658|NCT02099786|11186231|FG000|STARTED|Overall Study||24
10060659|NCT02099786|11186232|FG001|STARTED|Overall Study||23
10060660|NCT02099786|11186231|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
10060661|NCT02099786|11186232|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
10060662|NCT02099786|11186231|FG000|Program Eval 2|Overall Study|One month post randomization|23
10060663|NCT02099786|11186232|FG001|Program Eval 2|Overall Study|One month post randomization|19
10060664|NCT02099786|11186231|FG000|Program Eval 3|Overall Study|One year post randomization|21
10143405|NCT02748070|11273959|FG001|NOT COMPLETED|Overall Study||1
10143406|NCT02748096|11273967|FG000|STARTED|Overall Study||23
10143407|NCT02748096|11273968|FG001|STARTED|Overall Study||22
10143408|NCT02748096|11273967|FG000|COMPLETED|Overall Study||23
10143409|NCT02748096|11273968|FG001|COMPLETED|Overall Study||22
10143410|NCT02748096|11273967|FG000|NOT COMPLETED|Overall Study||0
10143411|NCT02748096|11273968|FG001|NOT COMPLETED|Overall Study||0
10143412|NCT02748213|11273976|FG000|STARTED|Overall Study||113
10143413|NCT02748213|11273977|FG001|STARTED|Overall Study||112
10143414|NCT02748213|11273976|FG000|Treated|Overall Study||112
10143415|NCT02748213|11273977|FG001|Treated|Overall Study||110
10143416|NCT02748213|11273976|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
10143417|NCT02748213|11273977|FG001|COMPLETED|Overall Study||0
10143418|NCT02748213|11273976|FG000|NOT COMPLETED|Overall Study||113
10143419|NCT02748213|11273977|FG001|NOT COMPLETED|Overall Study||112
10143420|NCT02748317|11273983|FG000|STARTED|Overall Study||96
10143421|NCT02748317|11273983|FG000|COMPLETED|Overall Study||73
10143422|NCT02748317|11273983|FG000|NOT COMPLETED|Overall Study||23
10143423|NCT02748356|11273987|FG000|STARTED|Overall Study||7
10143424|NCT02748356|11273987|FG000|COMPLETED|Overall Study||6
10143425|NCT02748356|11273987|FG000|NOT COMPLETED|Overall Study||1
10143426|NCT02748512|11273993|FG000|STARTED|Overall Study||14
10143427|NCT02748512|11273994|FG001|STARTED|Overall Study||12
10143428|NCT02748512|11273993|FG000|COMPLETED|Overall Study||13
9708040|NCT00129402|10807227|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708041|NCT00129402|10807228|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10143429|NCT02748512|11273994|FG001|COMPLETED|Overall Study||11
10143430|NCT02748512|11273993|FG000|NOT COMPLETED|Overall Study||1
10143431|NCT02748512|11273994|FG001|NOT COMPLETED|Overall Study||1
10143432|NCT02748525|11274000|FG000|STARTED|Overall Study||50
10143433|NCT02748525|11274000|FG000|Completed Study Intervention|Overall Study||50
10143434|NCT02748525|11274000|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39
10143435|NCT02748525|11274000|FG000|NOT COMPLETED|Overall Study||11
10143436|NCT02748694|11274019|FG000|STARTED|Overall Study||10
10143437|NCT02748694|11274020|FG001|STARTED|Overall Study||6
10143438|NCT02748694|11274021|FG002|STARTED|Overall Study||6
10143439|NCT02748694|11274022|FG003|STARTED|Overall Study||6
10143440|NCT02748694|11274023|FG004|STARTED|Overall Study||6
10143441|NCT02748694|11274024|FG005|STARTED|Overall Study||6
10143442|NCT02748694|11274025|FG006|STARTED|Overall Study||8
10143443|NCT02748694|11274026|FG007|STARTED|Overall Study||6
10143444|NCT02748694|11274027|FG008|STARTED|Overall Study||6
10143445|NCT02748694|11274028|FG009|STARTED|Overall Study||6
10143446|NCT02748694|11274029|FG010|STARTED|Overall Study||6
10143447|NCT02748694|11274030|FG011|STARTED|Overall Study||9
10143448|NCT02748694|11274031|FG012|STARTED|Overall Study||9
10143449|NCT02748694|11274032|FG013|STARTED|Overall Study||8
10143450|NCT02748694|11274033|FG014|STARTED|Overall Study||16
10143451|NCT02748694|11274019|FG000|COMPLETED|Overall Study||10
10143452|NCT02748694|11274020|FG001|COMPLETED|Overall Study||6
10143453|NCT02748694|11274021|FG002|COMPLETED|Overall Study||6
10143454|NCT02748694|11274022|FG003|COMPLETED|Overall Study||6
10143455|NCT02748694|11274023|FG004|COMPLETED|Overall Study||6
10143456|NCT02748694|11274024|FG005|COMPLETED|Overall Study||6
10143457|NCT02748694|11274025|FG006|COMPLETED|Overall Study||8
10143458|NCT02748694|11274026|FG007|COMPLETED|Overall Study||6
10143459|NCT02748694|11274027|FG008|COMPLETED|Overall Study||6
10143460|NCT02748694|11274028|FG009|COMPLETED|Overall Study||6
10143461|NCT02748694|11274029|FG010|COMPLETED|Overall Study||6
10143462|NCT02748694|11274030|FG011|COMPLETED|Overall Study||9
10143463|NCT02748694|11274031|FG012|COMPLETED|Overall Study||9
10143464|NCT02748694|11274032|FG013|COMPLETED|Overall Study||8
10143465|NCT02748694|11274033|FG014|COMPLETED|Overall Study||14
10143466|NCT02748694|11274019|FG000|NOT COMPLETED|Overall Study||0
10143467|NCT02748694|11274020|FG001|NOT COMPLETED|Overall Study||0
10143468|NCT02748694|11274021|FG002|NOT COMPLETED|Overall Study||0
10143469|NCT02748694|11274022|FG003|NOT COMPLETED|Overall Study||0
10143470|NCT02748694|11274023|FG004|NOT COMPLETED|Overall Study||0
10143471|NCT02748694|11274024|FG005|NOT COMPLETED|Overall Study||0
10143472|NCT02748694|11274025|FG006|NOT COMPLETED|Overall Study||0
10143473|NCT02748694|11274026|FG007|NOT COMPLETED|Overall Study||0
10143474|NCT02748694|11274027|FG008|NOT COMPLETED|Overall Study||0
10143475|NCT02748694|11274028|FG009|NOT COMPLETED|Overall Study||0
10143476|NCT02748694|11274029|FG010|NOT COMPLETED|Overall Study||0
10143477|NCT02748694|11274030|FG011|NOT COMPLETED|Overall Study||0
10143478|NCT02748694|11274031|FG012|NOT COMPLETED|Overall Study||0
10143479|NCT02748694|11274032|FG013|NOT COMPLETED|Overall Study||0
10143480|NCT02748694|11274033|FG014|NOT COMPLETED|Overall Study||2
10143481|NCT02748785|11274093|FG000|STARTED|Visit 1- Visit 2||69
10143482|NCT02748785|11274094|FG001|STARTED|Visit 1- Visit 2||68
10143483|NCT02748785|11274095|FG002|STARTED|Visit 1- Visit 2||71
10143484|NCT02748785|11274096|FG003|STARTED|Visit 1- Visit 2||69
10143485|NCT02748785|11274093|FG000|COMPLETED|Visit 1- Visit 2||59
10143486|NCT02748785|11274094|FG001|COMPLETED|Visit 1- Visit 2||49
10143487|NCT02748785|11274095|FG002|COMPLETED|Visit 1- Visit 2||57
10143488|NCT02748785|11274096|FG003|COMPLETED|Visit 1- Visit 2||63
10143489|NCT02748785|11274093|FG000|NOT COMPLETED|Visit 1- Visit 2||10
10143490|NCT02748785|11274094|FG001|NOT COMPLETED|Visit 1- Visit 2||19
10143491|NCT02748785|11274095|FG002|NOT COMPLETED|Visit 1- Visit 2||14
10143492|NCT02748785|11274096|FG003|NOT COMPLETED|Visit 1- Visit 2||6
10143493|NCT02748785|11274093|FG000|STARTED|Visit 2-Visit 3||59
10143494|NCT02748785|11274094|FG001|STARTED|Visit 2-Visit 3||49
10143495|NCT02748785|11274095|FG002|STARTED|Visit 2-Visit 3||57
10143496|NCT02748785|11274096|FG003|STARTED|Visit 2-Visit 3||63
10143497|NCT02748785|11274093|FG000|COMPLETED|Visit 2-Visit 3||54
10143498|NCT02748785|11274094|FG001|COMPLETED|Visit 2-Visit 3||44
10143499|NCT02748785|11274095|FG002|COMPLETED|Visit 2-Visit 3||49
10143500|NCT02748785|11274096|FG003|COMPLETED|Visit 2-Visit 3||52
10143501|NCT02748785|11274093|FG000|NOT COMPLETED|Visit 2-Visit 3||5
10143502|NCT02748785|11274094|FG001|NOT COMPLETED|Visit 2-Visit 3||5
10143503|NCT02748785|11274095|FG002|NOT COMPLETED|Visit 2-Visit 3||8
10143504|NCT02748785|11274096|FG003|NOT COMPLETED|Visit 2-Visit 3||11
10143505|NCT02748785|11274093|FG000|STARTED|Visit 3- Visit 4||54
10143506|NCT02748785|11274094|FG001|STARTED|Visit 3- Visit 4||44
10143507|NCT02748785|11274095|FG002|STARTED|Visit 3- Visit 4||49
10143508|NCT02748785|11274096|FG003|STARTED|Visit 3- Visit 4||52
9708042|NCT00129402|10807229|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708043|NCT00129402|10807230|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708044|NCT00129402|10807231|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708045|NCT00129402|10807232|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708046|NCT00129402|10807233|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
10143509|NCT02748785|11274093|FG000|COMPLETED|Visit 3- Visit 4||53
10143510|NCT02748785|11274094|FG001|COMPLETED|Visit 3- Visit 4||43
10143511|NCT02748785|11274095|FG002|COMPLETED|Visit 3- Visit 4||47
10143512|NCT02748785|11274096|FG003|COMPLETED|Visit 3- Visit 4||50
10143513|NCT02748785|11274093|FG000|NOT COMPLETED|Visit 3- Visit 4||1
10143514|NCT02748785|11274094|FG001|NOT COMPLETED|Visit 3- Visit 4||1
10143515|NCT02748785|11274095|FG002|NOT COMPLETED|Visit 3- Visit 4||2
10143516|NCT02748785|11274096|FG003|NOT COMPLETED|Visit 3- Visit 4||2
10143517|NCT02748863|11274109|FG000|STARTED|Treatment Period 1||72
10143518|NCT02748863|11274110|FG001|STARTED|Treatment Period 1||71
10143519|NCT02748863|11274111|FG002|STARTED|Treatment Period 1||71
10143520|NCT02748863|11274112|FG003|STARTED|Treatment Period 1|Not applicable for this period|0
10143521|NCT02748863|11274113|FG004|STARTED|Treatment Period 1|Not applicable for this period|0
10143522|NCT02748863|11274109|FG000|COMPLETED|Treatment Period 1||72
10143523|NCT02748863|11274110|FG001|COMPLETED|Treatment Period 1||69
10143524|NCT02748863|11274111|FG002|COMPLETED|Treatment Period 1||69
10143525|NCT02748863|11274112|FG003|COMPLETED|Treatment Period 1||0
10143526|NCT02748863|11274113|FG004|COMPLETED|Treatment Period 1||0
10143527|NCT02748863|11274109|FG000|NOT COMPLETED|Treatment Period 1||0
10143528|NCT02748863|11274110|FG001|NOT COMPLETED|Treatment Period 1||2
10143529|NCT02748863|11274111|FG002|NOT COMPLETED|Treatment Period 1||2
10143530|NCT02748863|11274112|FG003|NOT COMPLETED|Treatment Period 1||0
10143531|NCT02748863|11274113|FG004|NOT COMPLETED|Treatment Period 1||0
10143532|NCT02748863|11274109|FG000|STARTED|Treatment Period 2||72
10143533|NCT02748863|11274110|FG001|STARTED|Treatment Period 2||69
10143534|NCT02748863|11274111|FG002|STARTED|Treatment Period 2||0
10143535|NCT02748863|11274112|FG003|STARTED|Treatment Period 2||34
10143536|NCT02748863|11274113|FG004|STARTED|Treatment Period 2||34
10143537|NCT02748863|11274109|FG000|COMPLETED|Treatment Period 2||67
10143538|NCT02748863|11274110|FG001|COMPLETED|Treatment Period 2||66
10143539|NCT02748863|11274111|FG002|COMPLETED|Treatment Period 2||0
10143540|NCT02748863|11274112|FG003|COMPLETED|Treatment Period 2||32
10143541|NCT02748863|11274113|FG004|COMPLETED|Treatment Period 2||33
10143542|NCT02748863|11274109|FG000|NOT COMPLETED|Treatment Period 2||5
10143543|NCT02748863|11274110|FG001|NOT COMPLETED|Treatment Period 2||3
10143544|NCT02748863|11274111|FG002|NOT COMPLETED|Treatment Period 2||0
10143545|NCT02748863|11274112|FG003|NOT COMPLETED|Treatment Period 2||2
10143546|NCT02748863|11274113|FG004|NOT COMPLETED|Treatment Period 2||1
10143547|NCT02748889|11274130|FG000|STARTED|Overall Study||0
10143548|NCT02748889|11274131|FG001|STARTED|Overall Study||1
10143549|NCT02748889|11274130|FG000|COMPLETED|Overall Study||0
10143550|NCT02748889|11274131|FG001|COMPLETED|Overall Study||1
10143551|NCT02748889|11274130|FG000|NOT COMPLETED|Overall Study||0
10143552|NCT02748889|11274131|FG001|NOT COMPLETED|Overall Study||0
10143553|NCT02748928|11274135|FG000|STARTED|Overall Study||62
10143554|NCT02748928|11274135|FG000|COMPLETED|Overall Study||62
10143555|NCT02748928|11274135|FG000|NOT COMPLETED|Overall Study||0
10143556|NCT02749201|11274140|FG000|STARTED|Overall Study||10
10143557|NCT02749201|11274140|FG000|COMPLETED|Overall Study||10
10143558|NCT02749201|11274140|FG000|NOT COMPLETED|Overall Study||0
10143559|NCT02749370|11274144|FG000|STARTED|Overall Study||80
10143560|NCT02749370|11274144|FG000|COMPLETED|Overall Study||66
10143561|NCT02749370|11274144|FG000|NOT COMPLETED|Overall Study||14
10143562|NCT02749721|11274148|FG000|STARTED|Screening||31
10143563|NCT02749721|11274148|FG000|COMPLETED|Screening||25
10143564|NCT02749721|11274148|FG000|NOT COMPLETED|Screening||6
10143565|NCT02749721|11274148|FG000|STARTED|8-week Open-Label Treatment Phase||25
10143566|NCT02749721|11274148|FG000|COMPLETED|8-week Open-Label Treatment Phase||22
10143567|NCT02749721|11274148|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3
10143568|NCT02749799|11274154|FG000|STARTED|Overall Study||45
10143569|NCT02749799|11274154|FG000|COMPLETED|Overall Study||37
10143570|NCT02749799|11274154|FG000|NOT COMPLETED|Overall Study||8
10143571|NCT02749903|11274158|FG000|STARTED|Overall Study||46
10143572|NCT02749903|11274158|FG000|COMPLETED|Overall Study||46
10143573|NCT02749903|11274158|FG000|NOT COMPLETED|Overall Study||0
10143574|NCT02750267|11274164|FG000|STARTED|Overall Study||6
10143575|NCT02750267|11274165|FG001|STARTED|Overall Study||6
10143576|NCT02750267|11274164|FG000|COMPLETED|Overall Study||6
10143577|NCT02750267|11274165|FG001|COMPLETED|Overall Study||6
10143578|NCT02750267|11274164|FG000|NOT COMPLETED|Overall Study||0
10143579|NCT02750267|11274165|FG001|NOT COMPLETED|Overall Study||0
10143580|NCT02750306|11274175|FG000|STARTED|Overall Study||142
10143581|NCT02750306|11274176|FG001|STARTED|Overall Study||143
10143582|NCT02750306|11274175|FG000|COMPLETED|Overall Study||136
10143583|NCT02750306|11274176|FG001|COMPLETED|Overall Study||141
10143584|NCT02750306|11274175|FG000|NOT COMPLETED|Overall Study||6
10143585|NCT02750306|11274176|FG001|NOT COMPLETED|Overall Study||2
10143586|NCT02750332|11274182|FG000|STARTED|Treatment Period 1||10
10143587|NCT02750332|11274183|FG001|STARTED|Treatment Period 1||10
10143588|NCT02750332|11274182|FG000|COMPLETED|Treatment Period 1||10
10143589|NCT02750332|11274183|FG001|COMPLETED|Treatment Period 1||9
10143590|NCT02750332|11274182|FG000|NOT COMPLETED|Treatment Period 1||0
10143591|NCT02750332|11274183|FG001|NOT COMPLETED|Treatment Period 1||1
10143592|NCT02750332|11274182|FG000|STARTED|Treatment Period 2||10
10143593|NCT02750332|11274183|FG001|STARTED|Treatment Period 2||9
10143594|NCT02750332|11274182|FG000|COMPLETED|Treatment Period 2||10
9708047|NCT00129402|10807227|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708048|NCT00129402|10807228|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708049|NCT00129402|10807229|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708050|NCT00129402|10807230|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9729287|NCT00117598|10828858|FG003|STARTED|After Treament Cross Over||3
10143595|NCT02750332|11274183|FG001|COMPLETED|Treatment Period 2||9
10143596|NCT02750332|11274182|FG000|NOT COMPLETED|Treatment Period 2||0
10143597|NCT02750332|11274183|FG001|NOT COMPLETED|Treatment Period 2||0
10143598|NCT02750345|11274189|FG000|STARTED|Intervention 1||4
10143599|NCT02750345|11274190|FG001|STARTED|Intervention 1||4
10143600|NCT02750345|11274191|FG002|STARTED|Intervention 1||4
10143601|NCT02750345|11274192|FG003|STARTED|Intervention 1||4
10143602|NCT02750345|11274193|FG004|STARTED|Intervention 1||4
10143603|NCT02750345|11274194|FG005|STARTED|Intervention 1||4
10143604|NCT02750345|11274189|FG000|COMPLETED|Intervention 1||4
10143605|NCT02750345|11274190|FG001|COMPLETED|Intervention 1||4
10143606|NCT02750345|11274191|FG002|COMPLETED|Intervention 1||4
10143607|NCT02750345|11274192|FG003|COMPLETED|Intervention 1||4
10143608|NCT02750345|11274193|FG004|COMPLETED|Intervention 1||3
10143609|NCT02750345|11274194|FG005|COMPLETED|Intervention 1||4
10143610|NCT02750345|11274189|FG000|NOT COMPLETED|Intervention 1||0
10143611|NCT02750345|11274190|FG001|NOT COMPLETED|Intervention 1||0
10143612|NCT02750345|11274191|FG002|NOT COMPLETED|Intervention 1||0
10143613|NCT02750345|11274192|FG003|NOT COMPLETED|Intervention 1||0
10143614|NCT02750345|11274193|FG004|NOT COMPLETED|Intervention 1||1
10143615|NCT02750345|11274194|FG005|NOT COMPLETED|Intervention 1||0
10143616|NCT02750345|11274189|FG000|STARTED|Intervention 2||4
10143617|NCT02750345|11274190|FG001|STARTED|Intervention 2||4
10143618|NCT02750345|11274191|FG002|STARTED|Intervention 2||4
10143619|NCT02750345|11274192|FG003|STARTED|Intervention 2||4
10143620|NCT02750345|11274193|FG004|STARTED|Intervention 2||3
10143621|NCT02750345|11274194|FG005|STARTED|Intervention 2||4
10143622|NCT02750345|11274189|FG000|COMPLETED|Intervention 2||4
10143623|NCT02750345|11274190|FG001|COMPLETED|Intervention 2||4
10143624|NCT02750345|11274191|FG002|COMPLETED|Intervention 2||4
10143625|NCT02750345|11274192|FG003|COMPLETED|Intervention 2||4
10143626|NCT02750345|11274193|FG004|COMPLETED|Intervention 2||3
10143627|NCT02750345|11274194|FG005|COMPLETED|Intervention 2||4
10143628|NCT02750345|11274189|FG000|NOT COMPLETED|Intervention 2||0
10143629|NCT02750345|11274190|FG001|NOT COMPLETED|Intervention 2||0
10143630|NCT02750345|11274191|FG002|NOT COMPLETED|Intervention 2||0
10143631|NCT02750345|11274192|FG003|NOT COMPLETED|Intervention 2||0
10143632|NCT02750345|11274193|FG004|NOT COMPLETED|Intervention 2||0
10143633|NCT02750345|11274194|FG005|NOT COMPLETED|Intervention 2||0
10143634|NCT02750345|11274189|FG000|STARTED|Intervention 3||4
10143635|NCT02750345|11274190|FG001|STARTED|Intervention 3||4
10143636|NCT02750345|11274191|FG002|STARTED|Intervention 3||4
10143637|NCT02750345|11274192|FG003|STARTED|Intervention 3||4
10143638|NCT02750345|11274193|FG004|STARTED|Intervention 3||3
10143639|NCT02750345|11274194|FG005|STARTED|Intervention 3||4
10143640|NCT02750345|11274189|FG000|COMPLETED|Intervention 3||4
10143641|NCT02750345|11274190|FG001|COMPLETED|Intervention 3||4
10143642|NCT02750345|11274191|FG002|COMPLETED|Intervention 3||4
10143643|NCT02750345|11274192|FG003|COMPLETED|Intervention 3||4
10143644|NCT02750345|11274193|FG004|COMPLETED|Intervention 3||3
10143645|NCT02750345|11274194|FG005|COMPLETED|Intervention 3||4
10143646|NCT02750345|11274189|FG000|NOT COMPLETED|Intervention 3||0
10143647|NCT02750345|11274190|FG001|NOT COMPLETED|Intervention 3||0
10143648|NCT02750345|11274191|FG002|NOT COMPLETED|Intervention 3||0
10143649|NCT02750345|11274192|FG003|NOT COMPLETED|Intervention 3||0
10143650|NCT02750345|11274193|FG004|NOT COMPLETED|Intervention 3||0
10143651|NCT02750345|11274194|FG005|NOT COMPLETED|Intervention 3||0
9708051|NCT00129402|10807231|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708052|NCT00129402|10807232|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
9708053|NCT00129402|10807233|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
9708054|NCT00101439|10807243|FG000|STARTED|Period 1||28
9708055|NCT00101439|10807244|FG001|STARTED|Period 1||30
9708056|NCT00101439|10807243|FG000|COMPLETED|Period 1||28
9708057|NCT00101439|10807244|FG001|COMPLETED|Period 1||30
9708058|NCT00101439|10807243|FG000|NOT COMPLETED|Period 1||0
9708059|NCT00101439|10807244|FG001|NOT COMPLETED|Period 1||0
9708060|NCT00101439|10807243|FG000|STARTED|Period 2||28
9708061|NCT00101439|10807244|FG001|STARTED|Period 2||30
9708062|NCT00101439|10807243|FG000|COMPLETED|Period 2||28
9708063|NCT00101439|10807244|FG001|COMPLETED|Period 2||28
9708064|NCT00101439|10807243|FG000|NOT COMPLETED|Period 2||0
9708065|NCT00101439|10807244|FG001|NOT COMPLETED|Period 2||2
9708066|NCT00096200|10807253|FG000|STARTED|Overall Study||9
9708067|NCT00096200|10807254|FG001|STARTED|Overall Study||30
9708068|NCT00096200|10807255|FG002|STARTED|Overall Study||5
9708069|NCT00096200|10807253|FG000|COMPLETED|Overall Study||8
9708070|NCT00096200|10807254|FG001|COMPLETED|Overall Study||23
9708071|NCT00096200|10807255|FG002|COMPLETED|Overall Study||5
9708072|NCT00096200|10807253|FG000|NOT COMPLETED|Overall Study||1
9708073|NCT00096200|10807254|FG001|NOT COMPLETED|Overall Study||7
9708074|NCT00096200|10807255|FG002|NOT COMPLETED|Overall Study||0
10143652|NCT02750410|11274206|FG000|STARTED|Double-Blind Treatment Period||39
10143653|NCT02750410|11274207|FG001|STARTED|Double-Blind Treatment Period||120
10143654|NCT02750410|11274206|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
10143655|NCT02750410|11274207|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
10143656|NCT02750410|11274206|FG000|COMPLETED|Double-Blind Treatment Period||37
10143657|NCT02750410|11274207|FG001|COMPLETED|Double-Blind Treatment Period||117
10143658|NCT02750410|11274206|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
9729288|NCT00117598|10828859|FG004|STARTED|After Treament Cross Over||4
9729289|NCT00117598|10828855|FG000|COMPLETED|After Treament Cross Over||0
9729290|NCT00117598|10828856|FG001|COMPLETED|After Treament Cross Over||0
9729291|NCT00117598|10828857|FG002|COMPLETED|After Treament Cross Over||0
9729292|NCT00117598|10828858|FG003|COMPLETED|After Treament Cross Over||0
10143659|NCT02750410|11274207|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
10143660|NCT02750410|11274206|FG000|STARTED|Open-Label Extension Period||37
10143661|NCT02750410|11274207|FG001|STARTED|Open-Label Extension Period||117
10143662|NCT02750410|11274206|FG000|COMPLETED|Open-Label Extension Period||31
10143663|NCT02750410|11274207|FG001|COMPLETED|Open-Label Extension Period||111
10143664|NCT02750410|11274206|FG000|NOT COMPLETED|Open-Label Extension Period||6
10143665|NCT02750410|11274207|FG001|NOT COMPLETED|Open-Label Extension Period||6
10143666|NCT02750501|11274217|FG000|STARTED|Overall Study||44
10143667|NCT02750501|11274217|FG000|Enrolled|Overall Study||44
10143668|NCT02750501|11274217|FG000|Treated|Overall Study||39
9729293|NCT00117598|10828859|FG004|COMPLETED|After Treament Cross Over||0
10143669|NCT02750501|11274217|FG000|COMPLETED|Overall Study||36
10143670|NCT02750501|11274217|FG000|NOT COMPLETED|Overall Study||8
10143671|NCT02750514|11274230|FG000|STARTED|Track 1||40
10143672|NCT02750514|11274231|FG001|STARTED|Track 1||4
10143673|NCT02750514|11274232|FG002|STARTED|Track 1||0
10143674|NCT02750514|11274233|FG003|STARTED|Track 1||3
10143675|NCT02750514|11274234|FG004|STARTED|Track 1||0
10143676|NCT02750514|11274230|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
10143677|NCT02750514|11274231|FG001|COMPLETED|Track 1||2
10143678|NCT02750514|11274232|FG002|COMPLETED|Track 1||0
10143679|NCT02750514|11274233|FG003|COMPLETED|Track 1||1
10143680|NCT02750514|11274234|FG004|COMPLETED|Track 1||0
10143681|NCT02750514|11274230|FG000|NOT COMPLETED|Track 1||27
9708075|NCT03257267|10807265|FG000|STARTED|Overall Study||304
9708076|NCT03257267|10807266|FG001|STARTED|Overall Study||304
9708077|NCT03257267|10807265|FG000|Full Analysis Set (FAS)|Overall Study||304
9708078|NCT03257267|10807266|FG001|Full Analysis Set (FAS)|Overall Study||304
9708079|NCT03257267|10807265|FG000|Safety Analysis Set (SAF)|Overall Study||300
9708080|NCT03257267|10807266|FG001|Safety Analysis Set (SAF)|Overall Study||290
9708081|NCT03257267|10807265|FG000|Completed Treatment|Overall Study||13
9708082|NCT03257267|10807266|FG001|Completed Treatment|Overall Study||0
9708083|NCT03257267|10807265|FG000|COMPLETED|Overall Study||7
9708084|NCT03257267|10807266|FG001|COMPLETED|Overall Study||0
9708085|NCT03257267|10807265|FG000|NOT COMPLETED|Overall Study||297
9708086|NCT03257267|10807266|FG001|NOT COMPLETED|Overall Study||304
9708087|NCT04581811|10807274|FG000|STARTED|Overall Study||26
9708088|NCT04581811|10807275|FG001|STARTED|Overall Study||26
9708089|NCT04581811|10807274|FG000|COMPLETED|Overall Study||26
9708090|NCT04581811|10807275|FG001|COMPLETED|Overall Study||26
9708091|NCT04581811|10807274|FG000|NOT COMPLETED|Overall Study||0
9708092|NCT04581811|10807275|FG001|NOT COMPLETED|Overall Study||0
9708093|NCT04456959|10807281|FG000|STARTED|Overall Study||28
9708094|NCT04456959|10807281|FG000|COMPLETED|Overall Study||28
9708095|NCT04456959|10807281|FG000|NOT COMPLETED|Overall Study||0
9708096|NCT04263987|10807287|FG000|STARTED|Overall Study||30
9708097|NCT04263987|10807288|FG001|STARTED|Overall Study||30
9708098|NCT04263987|10807287|FG000|COMPLETED|Overall Study||30
9708099|NCT04263987|10807288|FG001|COMPLETED|Overall Study||30
9708100|NCT04263987|10807287|FG000|NOT COMPLETED|Overall Study||0
9708101|NCT04263987|10807288|FG001|NOT COMPLETED|Overall Study||0
9708102|NCT04223830|10807294|FG000|STARTED|Overall Study||200
9708103|NCT04223830|10807294|FG000|COMPLETED|Overall Study||190
9708104|NCT04223830|10807294|FG000|NOT COMPLETED|Overall Study||10
9708105|NCT04153435|10807301|FG000|STARTED|Overall Study||197
9708106|NCT04153435|10807302|FG001|STARTED|Overall Study||200
9708107|NCT04153435|10807301|FG000|COMPLETED|Overall Study||197
9708108|NCT04153435|10807302|FG001|COMPLETED|Overall Study||200
9708109|NCT04153435|10807301|FG000|NOT COMPLETED|Overall Study||0
9708110|NCT04153435|10807302|FG001|NOT COMPLETED|Overall Study||0
9708111|NCT04153188|10807310|FG000|STARTED|Overall Study||17
9708112|NCT04153188|10807311|FG001|STARTED|Overall Study||13
9708113|NCT04153188|10807310|FG000|COMPLETED|Overall Study||14
9708114|NCT04153188|10807311|FG001|COMPLETED|Overall Study||11
9708115|NCT04153188|10807310|FG000|NOT COMPLETED|Overall Study||3
9708116|NCT04153188|10807311|FG001|NOT COMPLETED|Overall Study||2
9708117|NCT04108429|10807317|FG000|STARTED|Overall Study||117
9708118|NCT04108429|10807317|FG000|COMPLETED|Overall Study||117
9708119|NCT04108429|10807317|FG000|NOT COMPLETED|Overall Study||0
9708120|NCT04531098|10807326|FG000|STARTED|Stage I||0
9708121|NCT04531098|10807327|FG001|STARTED|Stage I||67
9708122|NCT04531098|10807328|FG002|STARTED|Stage I||134
9708123|NCT04531098|10807326|FG000|COMPLETED|Stage I||0
9708124|NCT04531098|10807327|FG001|COMPLETED|Stage I||62
9708125|NCT04531098|10807328|FG002|COMPLETED|Stage I||116
9708126|NCT04531098|10807326|FG000|NOT COMPLETED|Stage I||0
9708127|NCT04531098|10807327|FG001|NOT COMPLETED|Stage I||5
9708128|NCT04531098|10807328|FG002|NOT COMPLETED|Stage I||18
9708129|NCT04531098|10807326|FG000|STARTED|Stage II||134
9708130|NCT04531098|10807327|FG001|STARTED|Stage II||67
9708131|NCT04531098|10807328|FG002|STARTED|Stage II||0
9708132|NCT04531098|10807326|FG000|COMPLETED|Stage II||121
9708133|NCT04531098|10807327|FG001|COMPLETED|Stage II||57
9708134|NCT04531098|10807328|FG002|COMPLETED|Stage II||0
9708135|NCT04531098|10807326|FG000|NOT COMPLETED|Stage II||13
9708136|NCT04531098|10807327|FG001|NOT COMPLETED|Stage II||10
9708137|NCT04531098|10807328|FG002|NOT COMPLETED|Stage II||0
9708138|NCT04233008|10807338|FG000|STARTED|Overall Study||89
9708139|NCT04233008|10807339|FG001|STARTED|Overall Study||89
9708140|NCT04233008|10807338|FG000|COMPLETED|Overall Study||89
9708141|NCT04233008|10807339|FG001|COMPLETED|Overall Study||89
9708142|NCT04233008|10807338|FG000|NOT COMPLETED|Overall Study||0
9708143|NCT04233008|10807339|FG001|NOT COMPLETED|Overall Study||0
9708144|NCT04179786|10807347|FG000|STARTED|Overall Study||91
9708145|NCT04179786|10807347|FG000|COMPLETED|Overall Study||83
9708146|NCT04179786|10807347|FG000|NOT COMPLETED|Overall Study||8
10143682|NCT02750514|11274231|FG001|NOT COMPLETED|Track 1||2
10143683|NCT02750514|11274232|FG002|NOT COMPLETED|Track 1||0
10143684|NCT02750514|11274233|FG003|NOT COMPLETED|Track 1||2
10143685|NCT02750514|11274234|FG004|NOT COMPLETED|Track 1||0
9708147|NCT04140292|10807353|FG000|STARTED|Overall Study||33
9708148|NCT04140292|10807354|FG001|STARTED|Overall Study||42
9708149|NCT04140292|10807353|FG000|COMPLETED|Overall Study||29
9708150|NCT04140292|10807354|FG001|COMPLETED|Overall Study||26
9708151|NCT04140292|10807353|FG000|NOT COMPLETED|Overall Study||4
10143686|NCT02750514|11274230|FG000|STARTED|Track 2||9
10143687|NCT02750514|11274231|FG001|STARTED|Track 2||8
10143688|NCT02750514|11274232|FG002|STARTED|Track 2||2
10143689|NCT02750514|11274233|FG003|STARTED|Track 2||12
10143690|NCT02750514|11274234|FG004|STARTED|Track 2||0
10143691|NCT02750514|11274230|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
10143692|NCT02750514|11274231|FG001|COMPLETED|Track 2||0
10143693|NCT02750514|11274232|FG002|COMPLETED|Track 2||0
10143694|NCT02750514|11274233|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
10143695|NCT02750514|11274234|FG004|COMPLETED|Track 2||0
10143696|NCT02750514|11274230|FG000|NOT COMPLETED|Track 2||6
10143697|NCT02750514|11274231|FG001|NOT COMPLETED|Track 2||8
10143698|NCT02750514|11274232|FG002|NOT COMPLETED|Track 2||2
10143699|NCT02750514|11274233|FG003|NOT COMPLETED|Track 2||7
10143700|NCT02750514|11274234|FG004|NOT COMPLETED|Track 2||0
10143701|NCT02750514|11274230|FG000|STARTED|Track 3||0
10143702|NCT02750514|11274231|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
10143703|NCT02750514|11274232|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16
10143704|NCT02750514|11274233|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
10143705|NCT02750514|11274234|FG004|STARTED|Track 3||0
10143706|NCT02750514|11274230|FG000|COMPLETED|Track 3||0
10143707|NCT02750514|11274231|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
10143708|NCT02750514|11274232|FG002|COMPLETED|Track 3||1
10143709|NCT02750514|11274233|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
9708152|NCT04140292|10807354|FG001|NOT COMPLETED|Overall Study||16
9708153|NCT04064229|10807361|FG000|STARTED|Overall Study||99
9708154|NCT04064229|10807361|FG000|COMPLETED|Overall Study||99
9708155|NCT04064229|10807361|FG000|NOT COMPLETED|Overall Study||0
9708156|NCT03993938|10807367|FG000|STARTED|Overall Study||30
9708157|NCT03993938|10807367|FG000|COMPLETED|Overall Study||30
9708158|NCT03993938|10807367|FG000|NOT COMPLETED|Overall Study||0
9708159|NCT03912805|10807373|FG000|STARTED|Overall Study||19
9708160|NCT03912805|10807374|FG001|STARTED|Overall Study||19
9708161|NCT03912805|10807373|FG000|COMPLETED|Overall Study||19
9708162|NCT03912805|10807374|FG001|COMPLETED|Overall Study||19
9708163|NCT03912805|10807373|FG000|NOT COMPLETED|Overall Study||0
9708164|NCT03912805|10807374|FG001|NOT COMPLETED|Overall Study||0
9708165|NCT03740724|10807380|FG000|STARTED|Overall Study||1
9708166|NCT03740724|10807380|FG000|COMPLETED|Overall Study||0
9708167|NCT03740724|10807380|FG000|NOT COMPLETED|Overall Study||1
9708168|NCT03730012|10807386|FG000|STARTED|Overall Study||3
9708169|NCT03730012|10807387|FG001|STARTED|Overall Study||8
9708170|NCT03730012|10807386|FG000|COMPLETED|Overall Study||0
9708171|NCT03730012|10807387|FG001|COMPLETED|Overall Study||0
9708172|NCT03730012|10807386|FG000|NOT COMPLETED|Overall Study||3
9708173|NCT03730012|10807387|FG001|NOT COMPLETED|Overall Study||8
9708174|NCT03553836|10807398|FG000|STARTED|Overall Study||487
9708175|NCT03553836|10807399|FG001|STARTED|Overall Study||489
9708176|NCT03553836|10807398|FG000|Treated|Overall Study||483
9708177|NCT03553836|10807399|FG001|Treated|Overall Study||486
9708178|NCT03553836|10807398|FG000|Re-challenged or Switched-over to Pembrolizumab|Overall Study||1
9708179|NCT03553836|10807399|FG001|Re-challenged or Switched-over to Pembrolizumab|Overall Study||45
10143710|NCT02750514|11274234|FG004|COMPLETED|Track 3||0
10143711|NCT02750514|11274230|FG000|NOT COMPLETED|Track 3||0
9708180|NCT03553836|10807398|FG000|COMPLETED|Overall Study||0
9708181|NCT03553836|10807399|FG001|COMPLETED|Overall Study||0
9708182|NCT03553836|10807398|FG000|NOT COMPLETED|Overall Study||487
9708183|NCT03553836|10807399|FG001|NOT COMPLETED|Overall Study||489
9708184|NCT03474107|10807408|FG000|STARTED|Overall Study||301
9708185|NCT03474107|10807409|FG001|STARTED|Overall Study||307
9708186|NCT03474107|10807408|FG000|Treated|Overall Study||296
9708187|NCT03474107|10807409|FG001|Treated|Overall Study||291
9708188|NCT03474107|10807408|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
9708189|NCT03474107|10807409|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
9708190|NCT03474107|10807408|FG000|NOT COMPLETED|Overall Study||245
9708191|NCT03474107|10807409|FG001|NOT COMPLETED|Overall Study||285
9708192|NCT02979522|10807417|FG000|STARTED|Overall Study||8
9708193|NCT02979522|10807418|FG001|STARTED|Overall Study||51
9708194|NCT02979522|10807417|FG000|COMPLETED|Overall Study||8
9708195|NCT02979522|10807418|FG001|COMPLETED|Overall Study||51
9708196|NCT02979522|10807417|FG000|NOT COMPLETED|Overall Study||0
9708197|NCT02979522|10807418|FG001|NOT COMPLETED|Overall Study||0
9708198|NCT02954237|10807430|FG000|STARTED|Overall Study||91
9708199|NCT02954237|10807430|FG000|COMPLETED|Overall Study||48
9708200|NCT02954237|10807430|FG000|NOT COMPLETED|Overall Study||43
9708201|NCT02856581|10807436|FG000|STARTED|Overall Study||12
9708202|NCT02856581|10807437|FG001|STARTED|Overall Study||11
9708203|NCT02856581|10807436|FG000|COMPLETED|Overall Study||12
9708204|NCT02856581|10807437|FG001|COMPLETED|Overall Study||11
9708205|NCT02856581|10807436|FG000|NOT COMPLETED|Overall Study||0
9708206|NCT02856581|10807437|FG001|NOT COMPLETED|Overall Study||0
9708207|NCT02714218|10807446|FG000|STARTED|Pre-Treatment Period||180
9708208|NCT02714218|10807447|FG001|STARTED|Pre-Treatment Period||180
9708209|NCT02714218|10807448|FG002|STARTED|Pre-Treatment Period||27
10143712|NCT02750514|11274231|FG001|NOT COMPLETED|Track 3||36
10143713|NCT02750514|11274232|FG002|NOT COMPLETED|Track 3||15
10143714|NCT02750514|11274233|FG003|NOT COMPLETED|Track 3||16
10143715|NCT02750514|11274234|FG004|NOT COMPLETED|Track 3||0
9708210|NCT02714218|10807446|FG000|COMPLETED|Pre-Treatment Period||180
10143716|NCT02750514|11274230|FG000|STARTED|Track 4||0
10143717|NCT02750514|11274231|FG001|STARTED|Track 4||53
10143718|NCT02750514|11274232|FG002|STARTED|Track 4||0
10143719|NCT02750514|11274233|FG003|STARTED|Track 4||60
10143720|NCT02750514|11274234|FG004|STARTED|Track 4||0
10143721|NCT02750514|11274230|FG000|COMPLETED|Track 4||0
10143722|NCT02750514|11274231|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
10143723|NCT02750514|11274232|FG002|COMPLETED|Track 4||0
10143724|NCT02750514|11274233|FG003|COMPLETED|Track 4||18
10143725|NCT02750514|11274234|FG004|COMPLETED|Track 4||0
10143726|NCT02750514|11274230|FG000|NOT COMPLETED|Track 4||0
10143727|NCT02750514|11274231|FG001|NOT COMPLETED|Track 4||51
10143728|NCT02750514|11274232|FG002|NOT COMPLETED|Track 4||0
10143729|NCT02750514|11274233|FG003|NOT COMPLETED|Track 4||42
10143730|NCT02750514|11274234|FG004|NOT COMPLETED|Track 4||0
10143731|NCT02750514|11274230|FG000|STARTED|Track 5||0
10143732|NCT02750514|11274231|FG001|STARTED|Track 5||0
10143733|NCT02750514|11274232|FG002|STARTED|Track 5||0
10143734|NCT02750514|11274233|FG003|STARTED|Track 5||0
10143735|NCT02750514|11274234|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
10143736|NCT02750514|11274230|FG000|COMPLETED|Track 5||0
10143737|NCT02750514|11274231|FG001|COMPLETED|Track 5||0
10143738|NCT02750514|11274232|FG002|COMPLETED|Track 5||0
10143739|NCT02750514|11274233|FG003|COMPLETED|Track 5||0
10143740|NCT02750514|11274234|FG004|COMPLETED|Track 5||0
10143741|NCT02750514|11274230|FG000|NOT COMPLETED|Track 5||0
10143742|NCT02750514|11274231|FG001|NOT COMPLETED|Track 5||0
10143743|NCT02750514|11274232|FG002|NOT COMPLETED|Track 5||0
10143744|NCT02750514|11274233|FG003|NOT COMPLETED|Track 5||0
10143745|NCT02750514|11274234|FG004|NOT COMPLETED|Track 5||43
10143746|NCT02750592|11274254|FG000|STARTED|Overall Study||30
10143747|NCT02750592|11274254|FG000|COMPLETED|Overall Study||25
10143748|NCT02750592|11274254|FG000|NOT COMPLETED|Overall Study||5
10143749|NCT02750618|11274258|FG000|STARTED|Overall Study||13
10143750|NCT02750618|11274258|FG000|Completed Week 40|Overall Study||13
10143751|NCT02750618|11274258|FG000|Completed Week 64|Overall Study||13
10143752|NCT02750618|11274258|FG000|COMPLETED|Overall Study||12
10143753|NCT02750618|11274258|FG000|NOT COMPLETED|Overall Study||1
10143754|NCT02750709|11274262|FG000|STARTED|Treatment Period 1||4
10143755|NCT02750709|11274263|FG001|STARTED|Treatment Period 1||4
10143756|NCT02750709|11274264|FG002|STARTED|Treatment Period 1||4
10143757|NCT02750709|11274265|FG003|STARTED|Treatment Period 1||4
10143758|NCT02750709|11274266|FG004|STARTED|Treatment Period 1||4
10143759|NCT02750709|11274267|FG005|STARTED|Treatment Period 1||4
10143760|NCT02750709|11274262|FG000|COMPLETED|Treatment Period 1||4
10143761|NCT02750709|11274263|FG001|COMPLETED|Treatment Period 1||4
10143762|NCT02750709|11274264|FG002|COMPLETED|Treatment Period 1||4
10143763|NCT02750709|11274265|FG003|COMPLETED|Treatment Period 1||4
10143764|NCT02750709|11274266|FG004|COMPLETED|Treatment Period 1||4
10143765|NCT02750709|11274267|FG005|COMPLETED|Treatment Period 1||3
10143766|NCT02750709|11274262|FG000|NOT COMPLETED|Treatment Period 1||0
9708211|NCT02714218|10807447|FG001|COMPLETED|Pre-Treatment Period||178
10143767|NCT02750709|11274263|FG001|NOT COMPLETED|Treatment Period 1||0
10143768|NCT02750709|11274264|FG002|NOT COMPLETED|Treatment Period 1||0
10143769|NCT02750709|11274265|FG003|NOT COMPLETED|Treatment Period 1||0
10143770|NCT02750709|11274266|FG004|NOT COMPLETED|Treatment Period 1||0
10143771|NCT02750709|11274267|FG005|NOT COMPLETED|Treatment Period 1||1
10143772|NCT02750709|11274262|FG000|STARTED|Treatment Period 2||4
10143773|NCT02750709|11274263|FG001|STARTED|Treatment Period 2||4
10143774|NCT02750709|11274264|FG002|STARTED|Treatment Period 2||4
10143775|NCT02750709|11274265|FG003|STARTED|Treatment Period 2||4
10143776|NCT02750709|11274266|FG004|STARTED|Treatment Period 2||4
10143777|NCT02750709|11274267|FG005|STARTED|Treatment Period 2||3
10143778|NCT02750709|11274262|FG000|COMPLETED|Treatment Period 2||4
10143779|NCT02750709|11274263|FG001|COMPLETED|Treatment Period 2||4
10143780|NCT02750709|11274264|FG002|COMPLETED|Treatment Period 2||4
10143781|NCT02750709|11274265|FG003|COMPLETED|Treatment Period 2||4
10143782|NCT02750709|11274266|FG004|COMPLETED|Treatment Period 2||4
10143783|NCT02750709|11274267|FG005|COMPLETED|Treatment Period 2||3
10143784|NCT02750709|11274262|FG000|NOT COMPLETED|Treatment Period 2||0
10143785|NCT02750709|11274263|FG001|NOT COMPLETED|Treatment Period 2||0
10143786|NCT02750709|11274264|FG002|NOT COMPLETED|Treatment Period 2||0
10143787|NCT02750709|11274265|FG003|NOT COMPLETED|Treatment Period 2||0
10143788|NCT02750709|11274266|FG004|NOT COMPLETED|Treatment Period 2||0
10143789|NCT02750709|11274267|FG005|NOT COMPLETED|Treatment Period 2||0
10143790|NCT02750709|11274262|FG000|STARTED|Treatment Period 3||4
10143791|NCT02750709|11274263|FG001|STARTED|Treatment Period 3||4
10143792|NCT02750709|11274264|FG002|STARTED|Treatment Period 3||4
10143793|NCT02750709|11274265|FG003|STARTED|Treatment Period 3||4
10143794|NCT02750709|11274266|FG004|STARTED|Treatment Period 3||4
10143795|NCT02750709|11274267|FG005|STARTED|Treatment Period 3||3
10143796|NCT02750709|11274262|FG000|COMPLETED|Treatment Period 3||4
10143797|NCT02750709|11274263|FG001|COMPLETED|Treatment Period 3||4
10143798|NCT02750709|11274264|FG002|COMPLETED|Treatment Period 3||4
10143799|NCT02750709|11274265|FG003|COMPLETED|Treatment Period 3||4
10143800|NCT02750709|11274266|FG004|COMPLETED|Treatment Period 3||4
10143801|NCT02750709|11274267|FG005|COMPLETED|Treatment Period 3||3
10143802|NCT02750709|11274262|FG000|NOT COMPLETED|Treatment Period 3||0
10143803|NCT02750709|11274263|FG001|NOT COMPLETED|Treatment Period 3||0
10143804|NCT02750709|11274264|FG002|NOT COMPLETED|Treatment Period 3||0
10143805|NCT02750709|11274265|FG003|NOT COMPLETED|Treatment Period 3||0
10143806|NCT02750709|11274266|FG004|NOT COMPLETED|Treatment Period 3||0
10143807|NCT02750709|11274267|FG005|NOT COMPLETED|Treatment Period 3||0
10143808|NCT02750761|11274281|FG000|STARTED|Overall Study||5
10143809|NCT02750761|11274282|FG001|STARTED|Overall Study||5
10143810|NCT02750761|11274283|FG002|STARTED|Overall Study||5
10143811|NCT02750761|11274284|FG003|STARTED|Overall Study||5
10143812|NCT02750761|11274285|FG004|STARTED|Overall Study||6
10143813|NCT02750761|11274286|FG005|STARTED|Overall Study||6
10143814|NCT02750761|11274281|FG000|COMPLETED|Overall Study||5
10143815|NCT02750761|11274282|FG001|COMPLETED|Overall Study||5
10143816|NCT02750761|11274283|FG002|COMPLETED|Overall Study||4
10143817|NCT02750761|11274284|FG003|COMPLETED|Overall Study||5
10143818|NCT02750761|11274285|FG004|COMPLETED|Overall Study||6
10143819|NCT02750761|11274286|FG005|COMPLETED|Overall Study||6
10143820|NCT02750761|11274281|FG000|NOT COMPLETED|Overall Study||0
10143821|NCT02750761|11274282|FG001|NOT COMPLETED|Overall Study||0
10143822|NCT02750761|11274283|FG002|NOT COMPLETED|Overall Study||1
10143823|NCT02750761|11274284|FG003|NOT COMPLETED|Overall Study||0
10143824|NCT02750761|11274285|FG004|NOT COMPLETED|Overall Study||0
10143825|NCT02750761|11274286|FG005|NOT COMPLETED|Overall Study||0
10143826|NCT02750800|11274310|FG000|STARTED|Overall Study||412
10143827|NCT02750800|11274310|FG000|COMPLETED|Overall Study||314
10143828|NCT02750800|11274310|FG000|NOT COMPLETED|Overall Study||98
10143829|NCT02750813|11274328|FG000|STARTED|Period 1, First 14 Days of Wear||125
10143830|NCT02750813|11274329|FG001|STARTED|Period 1, First 14 Days of Wear||121
10143831|NCT02750813|11274328|FG000|COMPLETED|Period 1, First 14 Days of Wear||124
10143832|NCT02750813|11274329|FG001|COMPLETED|Period 1, First 14 Days of Wear||120
10143833|NCT02750813|11274328|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1
10143834|NCT02750813|11274329|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
10143835|NCT02750813|11274328|FG000|STARTED|Period 2, Second 14 Days of Wear||124
10143836|NCT02750813|11274329|FG001|STARTED|Period 2, Second 14 Days of Wear||120
10143837|NCT02750813|11274328|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124
10143838|NCT02750813|11274329|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120
10143839|NCT02750813|11274328|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10143840|NCT02750813|11274329|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10143841|NCT02750930|11274336|FG000|STARTED|Overall Study||8
10143842|NCT02750930|11274336|FG000|COMPLETED|Overall Study||0
10143843|NCT02750930|11274336|FG000|NOT COMPLETED|Overall Study||8
10143844|NCT02750943|11274342|FG000|STARTED|Overall Study||125
10143845|NCT02750943|11274343|FG001|STARTED|Overall Study||128
10143846|NCT02750943|11274342|FG000|COMPLETED|Overall Study||119
10143847|NCT02750943|11274343|FG001|COMPLETED|Overall Study||119
10143848|NCT02750943|11274342|FG000|NOT COMPLETED|Overall Study||6
10143849|NCT02750943|11274343|FG001|NOT COMPLETED|Overall Study||9
10143850|NCT02751320|11274349|FG000|STARTED|Overall Study||45
10143851|NCT02751320|11274349|FG000|Received Test Product 1|Overall Study||29
10143852|NCT02751320|11274349|FG000|Received Test Prodcut 2|Overall Study||28
10143853|NCT02751320|11274349|FG000|Received Test Prodcut 3|Overall Study||28
10143854|NCT02751320|11274349|FG000|Received Reference Product 1|Overall Study||29
10143855|NCT02751320|11274349|FG000|Received Reference Product 2|Overall Study||28
10143856|NCT02751320|11274349|FG000|Received Reference Product 3|Overall Study||28
10143857|NCT02751320|11274349|FG000|COMPLETED|Overall Study||42
10143858|NCT02751320|11274349|FG000|NOT COMPLETED|Overall Study||3
10143859|NCT02751359|11274374|FG000|STARTED|Overall Study||18
10143860|NCT02751359|11274374|FG000|COMPLETED|Overall Study||17
10143861|NCT02751359|11274374|FG000|NOT COMPLETED|Overall Study||1
10143862|NCT02751385|11274384|FG000|STARTED|Period 1||2
10143863|NCT02751385|11274385|FG001|STARTED|Period 1||0
10143864|NCT02751385|11274384|FG000|COMPLETED|Period 1||2
10143865|NCT02751385|11274385|FG001|COMPLETED|Period 1||0
10143866|NCT02751385|11274384|FG000|NOT COMPLETED|Period 1||0
10143867|NCT02751385|11274385|FG001|NOT COMPLETED|Period 1||0
10143868|NCT02751385|11274384|FG000|STARTED|Period 2||0
10143869|NCT02751385|11274385|FG001|STARTED|Period 2||2
10143870|NCT02751385|11274384|FG000|COMPLETED|Period 2||0
10143871|NCT02751385|11274385|FG001|COMPLETED|Period 2||2
10143872|NCT02751385|11274384|FG000|NOT COMPLETED|Period 2||0
10143873|NCT02751385|11274385|FG001|NOT COMPLETED|Period 2||0
10143874|NCT02751424|11274402|FG000|STARTED|Part 1||6
10143875|NCT02751424|11274403|FG001|STARTED|Part 1||6
10143876|NCT02751424|11274404|FG002|STARTED|Part 1||6
10143877|NCT02751424|11274405|FG003|STARTED|Part 1||6
10143878|NCT02751424|11274406|FG004|STARTED|Part 1||6
10143879|NCT02751424|11274407|FG005|STARTED|Part 1||6
10143880|NCT02751424|11274408|FG006|STARTED|Part 1||12
10143881|NCT02751424|11274409|FG007|STARTED|Part 1||0
10143882|NCT02751424|11274410|FG008|STARTED|Part 1||0
10143883|NCT02751424|11274402|FG000|COMPLETED|Part 1||6
10143884|NCT02751424|11274403|FG001|COMPLETED|Part 1||6
10143885|NCT02751424|11274404|FG002|COMPLETED|Part 1||6
10143886|NCT02751424|11274405|FG003|COMPLETED|Part 1||6
10143887|NCT02751424|11274406|FG004|COMPLETED|Part 1||6
10143888|NCT02751424|11274407|FG005|COMPLETED|Part 1||6
10143889|NCT02751424|11274408|FG006|COMPLETED|Part 1||12
10143890|NCT02751424|11274409|FG007|COMPLETED|Part 1||0
10143891|NCT02751424|11274410|FG008|COMPLETED|Part 1||0
10143892|NCT02751424|11274402|FG000|NOT COMPLETED|Part 1||0
10143893|NCT02751424|11274403|FG001|NOT COMPLETED|Part 1||0
10143894|NCT02751424|11274404|FG002|NOT COMPLETED|Part 1||0
10143895|NCT02751424|11274405|FG003|NOT COMPLETED|Part 1||0
10143896|NCT02751424|11274406|FG004|NOT COMPLETED|Part 1||0
10143897|NCT02751424|11274407|FG005|NOT COMPLETED|Part 1||0
10143898|NCT02751424|11274408|FG006|NOT COMPLETED|Part 1||0
10143899|NCT02751424|11274409|FG007|NOT COMPLETED|Part 1||0
10143900|NCT02751424|11274410|FG008|NOT COMPLETED|Part 1||0
10143901|NCT02751424|11274402|FG000|STARTED|Part 2||0
10143902|NCT02751424|11274403|FG001|STARTED|Part 2||0
10143903|NCT02751424|11274404|FG002|STARTED|Part 2||0
10143904|NCT02751424|11274405|FG003|STARTED|Part 2||0
10143905|NCT02751424|11274406|FG004|STARTED|Part 2||0
10143906|NCT02751424|11274407|FG005|STARTED|Part 2||0
10143907|NCT02751424|11274408|FG006|STARTED|Part 2||0
10143908|NCT02751424|11274409|FG007|STARTED|Part 2||11
10143909|NCT02751424|11274410|FG008|STARTED|Part 2||3
10143910|NCT02751424|11274402|FG000|COMPLETED|Part 2||0
10143911|NCT02751424|11274403|FG001|COMPLETED|Part 2||0
10143912|NCT02751424|11274404|FG002|COMPLETED|Part 2||0
10143913|NCT02751424|11274405|FG003|COMPLETED|Part 2||0
10143914|NCT02751424|11274406|FG004|COMPLETED|Part 2||0
10143915|NCT02751424|11274407|FG005|COMPLETED|Part 2||0
10143916|NCT02751424|11274408|FG006|COMPLETED|Part 2||0
10143917|NCT02751424|11274409|FG007|COMPLETED|Part 2||6
10143918|NCT02751424|11274410|FG008|COMPLETED|Part 2||3
10143919|NCT02751424|11274402|FG000|NOT COMPLETED|Part 2||0
10143920|NCT02751424|11274403|FG001|NOT COMPLETED|Part 2||0
10143921|NCT02751424|11274404|FG002|NOT COMPLETED|Part 2||0
10143922|NCT02751424|11274405|FG003|NOT COMPLETED|Part 2||0
10143923|NCT02751424|11274406|FG004|NOT COMPLETED|Part 2||0
10143924|NCT02751424|11274407|FG005|NOT COMPLETED|Part 2||0
10143925|NCT02751424|11274408|FG006|NOT COMPLETED|Part 2||0
10143926|NCT02751424|11274409|FG007|NOT COMPLETED|Part 2||5
10143927|NCT02751424|11274410|FG008|NOT COMPLETED|Part 2||0
10143928|NCT02751450|11274435|FG000|STARTED|Overall Study||117
10143929|NCT02751450|11274436|FG001|STARTED|Overall Study||116
10143930|NCT02751450|11274435|FG000|COMPLETED|Overall Study||116
10143931|NCT02751450|11274436|FG001|COMPLETED|Overall Study||116
10143932|NCT02751450|11274435|FG000|NOT COMPLETED|Overall Study||1
10143933|NCT02751450|11274436|FG001|NOT COMPLETED|Overall Study||0
10143934|NCT02751580|11274444|FG000|STARTED|Overall Study||37
10143935|NCT02751580|11274444|FG000|COMPLETED|Overall Study||31
10143936|NCT02751580|11274444|FG000|NOT COMPLETED|Overall Study||6
10143937|NCT02751827|11274451|FG000|STARTED|Overall Study||41
9848881|NCT00862823|10961742|FG000|NOT COMPLETED|First Intervention||1
9848882|NCT00862823|10961743|FG001|NOT COMPLETED|First Intervention||1
9848883|NCT00862823|10961742|FG000|STARTED|Washout Period of 2 Weeks||5
9848884|NCT00862823|10961743|FG001|STARTED|Washout Period of 2 Weeks||9
9848885|NCT00862823|10961742|FG000|COMPLETED|Washout Period of 2 Weeks||5
10143938|NCT02751827|11274452|FG001|STARTED|Overall Study||171
10143939|NCT02751827|11274453|FG002|STARTED|Overall Study||100
10143940|NCT02751827|11274451|FG000|COMPLETED|Overall Study||41
10143941|NCT02751827|11274452|FG001|COMPLETED|Overall Study||171
10143942|NCT02751827|11274453|FG002|COMPLETED|Overall Study||99
10143943|NCT02751827|11274451|FG000|NOT COMPLETED|Overall Study||0
10143944|NCT02751827|11274452|FG001|NOT COMPLETED|Overall Study||0
10143945|NCT02751827|11274453|FG002|NOT COMPLETED|Overall Study||1
10143946|NCT02751879|11274463|FG000|STARTED|Overall Study||157
10143947|NCT02751879|11274464|FG001|STARTED|Overall Study||71
10143948|NCT02751879|11274463|FG000|On Treatment at Study Completion|Overall Study||81
10143949|NCT02751879|11274464|FG001|On Treatment at Study Completion|Overall Study||41
10143950|NCT02751879|11274463|FG000|COMPLETED|Overall Study||157
10143951|NCT02751879|11274464|FG001|COMPLETED|Overall Study||71
10143952|NCT02751879|11274463|FG000|NOT COMPLETED|Overall Study||0
10143953|NCT02751879|11274464|FG001|NOT COMPLETED|Overall Study||0
10143954|NCT02751931|11274475|FG000|STARTED|Overall Study||56
10143955|NCT02751931|11274476|FG001|STARTED|Overall Study||35
10143956|NCT02751931|11274475|FG000|Treated|Overall Study||55
10143957|NCT02751931|11274476|FG001|Treated|Overall Study||31
10143958|NCT02751931|11274475|FG000|COMPLETED|Overall Study||43
10143959|NCT02751931|11274476|FG001|COMPLETED|Overall Study||27
10143960|NCT02751931|11274475|FG000|NOT COMPLETED|Overall Study||13
10143961|NCT02751931|11274476|FG001|NOT COMPLETED|Overall Study||8
10143962|NCT02751983|11274490|FG000|STARTED|Baseline and Randomization||35
10143963|NCT02751983|11274491|FG001|STARTED|Baseline and Randomization||35
10143964|NCT02751983|11274490|FG000|COMPLETED|Baseline and Randomization||35
10143965|NCT02751983|11274491|FG001|COMPLETED|Baseline and Randomization||35
10143966|NCT02751983|11274490|FG000|NOT COMPLETED|Baseline and Randomization||0
10143967|NCT02751983|11274491|FG001|NOT COMPLETED|Baseline and Randomization||0
10143968|NCT02751983|11274490|FG000|STARTED|Treatment||35
10143969|NCT02751983|11274491|FG001|STARTED|Treatment||35
10143970|NCT02751983|11274490|FG000|COMPLETED|Treatment||31
10143971|NCT02751983|11274491|FG001|COMPLETED|Treatment||35
10143972|NCT02751983|11274490|FG000|NOT COMPLETED|Treatment||4
10143973|NCT02751983|11274491|FG001|NOT COMPLETED|Treatment||0
10143974|NCT02751983|11274490|FG000|STARTED|Post-Treatment Assessment||35
10143975|NCT02751983|11274491|FG001|STARTED|Post-Treatment Assessment||0
10143976|NCT02751983|11274490|FG000|COMPLETED|Post-Treatment Assessment||30
10143977|NCT02751983|11274491|FG001|COMPLETED|Post-Treatment Assessment||0
10143978|NCT02751983|11274490|FG000|NOT COMPLETED|Post-Treatment Assessment||5
10143979|NCT02751983|11274491|FG001|NOT COMPLETED|Post-Treatment Assessment||0
10143980|NCT02751983|11274490|FG000|STARTED|One-Month Follow-Up Assessments||35
10143981|NCT02751983|11274491|FG001|STARTED|One-Month Follow-Up Assessments||35
10143982|NCT02751983|11274490|FG000|COMPLETED|One-Month Follow-Up Assessments||21
10143983|NCT02751983|11274491|FG001|COMPLETED|One-Month Follow-Up Assessments||23
10143984|NCT02751983|11274490|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14
10143985|NCT02751983|11274491|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12
10143986|NCT02751983|11274490|FG000|STARTED|Three-Month Follow-Up Assessments||35
10143987|NCT02751983|11274491|FG001|STARTED|Three-Month Follow-Up Assessments||35
10143988|NCT02751983|11274490|FG000|COMPLETED|Three-Month Follow-Up Assessments||23
10143989|NCT02751983|11274491|FG001|COMPLETED|Three-Month Follow-Up Assessments||19
10143990|NCT02751983|11274490|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12
10143991|NCT02751983|11274491|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16
10143992|NCT02752048|11274500|FG000|STARTED|Overall Study||11
10143993|NCT02752048|11274501|FG001|STARTED|Overall Study||12
10143994|NCT02752048|11274502|FG002|STARTED|Overall Study||13
10143995|NCT02752048|11274500|FG000|COMPLETED|Overall Study||11
10143996|NCT02752048|11274501|FG001|COMPLETED|Overall Study||12
10143997|NCT02752048|11274502|FG002|COMPLETED|Overall Study||10
10143998|NCT02752048|11274500|FG000|NOT COMPLETED|Overall Study||0
10143999|NCT02752048|11274501|FG001|NOT COMPLETED|Overall Study||0
10144000|NCT02752048|11274502|FG002|NOT COMPLETED|Overall Study||3
10144001|NCT02752074|11274512|FG000|STARTED|Overall Study||354
10144002|NCT02752074|11274513|FG001|STARTED|Overall Study||352
10144003|NCT02752074|11274512|FG000|Treated|Overall Study||353
10144004|NCT02752074|11274513|FG001|Treated|Overall Study||352
10144005|NCT02752074|11274512|FG000|COMPLETED|Overall Study||198
10144006|NCT02752074|11274513|FG001|COMPLETED|Overall Study||209
10144007|NCT02752074|11274512|FG000|NOT COMPLETED|Overall Study||156
10144008|NCT02752074|11274513|FG001|NOT COMPLETED|Overall Study||143
10144009|NCT02752087|11274519|FG000|STARTED|Study Period 1||12
10144010|NCT02752087|11274520|FG001|STARTED|Study Period 1||12
10144011|NCT02752087|11274519|FG000|Received Study Drug|Study Period 1||12
10144012|NCT02752087|11274520|FG001|Received Study Drug|Study Period 1||12
10144013|NCT02752087|11274519|FG000|COMPLETED|Study Period 1||12
10144014|NCT02752087|11274520|FG001|COMPLETED|Study Period 1||12
10144015|NCT02752087|11274519|FG000|NOT COMPLETED|Study Period 1||0
10144016|NCT02752087|11274520|FG001|NOT COMPLETED|Study Period 1||0
10144017|NCT02752087|11274519|FG000|STARTED|Washout||12
10144018|NCT02752087|11274520|FG001|STARTED|Washout||12
10144019|NCT02752087|11274519|FG000|COMPLETED|Washout||11
10144020|NCT02752087|11274520|FG001|COMPLETED|Washout||12
10144021|NCT02752087|11274519|FG000|NOT COMPLETED|Washout||1
10144022|NCT02752087|11274520|FG001|NOT COMPLETED|Washout||0
10144023|NCT02752087|11274519|FG000|STARTED|Study Period 2||11
10144024|NCT02752087|11274520|FG001|STARTED|Study Period 2||12
10144025|NCT02752087|11274519|FG000|Received Study Drug|Study Period 2||11
10144026|NCT02752087|11274520|FG001|Received Study Drug|Study Period 2||12
10144027|NCT02752087|11274519|FG000|COMPLETED|Study Period 2||11
10144028|NCT02752087|11274520|FG001|COMPLETED|Study Period 2||12
10144029|NCT02752087|11274519|FG000|NOT COMPLETED|Study Period 2||0
10144030|NCT02752087|11274520|FG001|NOT COMPLETED|Study Period 2||0
10144031|NCT02752087|11274519|FG000|STARTED|Washout||11
10144032|NCT02752087|11274520|FG001|STARTED|Washout||12
10144033|NCT02752087|11274519|FG000|COMPLETED|Washout||11
9708212|NCT02714218|10807448|FG002|COMPLETED|Pre-Treatment Period||27
10144034|NCT02752087|11274520|FG001|COMPLETED|Washout||12
10144035|NCT02752087|11274519|FG000|NOT COMPLETED|Washout||0
10144036|NCT02752087|11274520|FG001|NOT COMPLETED|Washout||0
10144037|NCT02752087|11274519|FG000|STARTED|Study Period 3||11
10144038|NCT02752087|11274520|FG001|STARTED|Study Period 3||12
10144039|NCT02752087|11274519|FG000|Received Study Drug|Study Period 3||11
9708213|NCT02714218|10807446|FG000|NOT COMPLETED|Pre-Treatment Period||0
10144040|NCT02752087|11274520|FG001|Received Study Drug|Study Period 3||12
10144041|NCT02752087|11274519|FG000|COMPLETED|Study Period 3||11
10144042|NCT02752087|11274520|FG001|COMPLETED|Study Period 3||12
10144043|NCT02752087|11274519|FG000|NOT COMPLETED|Study Period 3||0
10144044|NCT02752087|11274520|FG001|NOT COMPLETED|Study Period 3||0
10144045|NCT02752087|11274519|FG000|STARTED|Washout||11
10144046|NCT02752087|11274520|FG001|STARTED|Washout||12
10144047|NCT02752087|11274519|FG000|COMPLETED|Washout||11
10144048|NCT02752087|11274520|FG001|COMPLETED|Washout||12
10144049|NCT02752087|11274519|FG000|NOT COMPLETED|Washout||0
10144050|NCT02752087|11274520|FG001|NOT COMPLETED|Washout||0
10144051|NCT02752087|11274519|FG000|STARTED|Study Period 4||11
10144052|NCT02752087|11274520|FG001|STARTED|Study Period 4||12
10144053|NCT02752087|11274519|FG000|Received Study Drug|Study Period 4||11
10144054|NCT02752087|11274520|FG001|Received Study Drug|Study Period 4||12
10144055|NCT02752087|11274519|FG000|COMPLETED|Study Period 4||11
10144056|NCT02752087|11274520|FG001|COMPLETED|Study Period 4||12
10144057|NCT02752087|11274519|FG000|NOT COMPLETED|Study Period 4||0
10144058|NCT02752087|11274520|FG001|NOT COMPLETED|Study Period 4||0
10144059|NCT02752087|11274519|FG000|STARTED|Follow-up||11
10144060|NCT02752087|11274520|FG001|STARTED|Follow-up||12
10144061|NCT02752087|11274519|FG000|COMPLETED|Follow-up||11
10144062|NCT02752087|11274520|FG001|COMPLETED|Follow-up||12
10144063|NCT02752087|11274519|FG000|NOT COMPLETED|Follow-up||0
10144064|NCT02752087|11274520|FG001|NOT COMPLETED|Follow-up||0
10144065|NCT02752256|11274528|FG000|STARTED|Overall Study||35
10144066|NCT02752256|11274529|FG001|STARTED|Overall Study||41
10144067|NCT02752256|11274528|FG000|COMPLETED|Overall Study||35
10144068|NCT02752256|11274529|FG001|COMPLETED|Overall Study||41
10144069|NCT02752256|11274528|FG000|NOT COMPLETED|Overall Study||0
10144070|NCT02752256|11274529|FG001|NOT COMPLETED|Overall Study||0
10144071|NCT02752490|11274537|FG000|STARTED|Overall Study||409
10144072|NCT02752490|11274538|FG001|STARTED|Overall Study||435
10144073|NCT02752490|11274537|FG000|COMPLETED|Overall Study||409
10144074|NCT02752490|11274538|FG001|COMPLETED|Overall Study||435
10144075|NCT02752490|11274537|FG000|NOT COMPLETED|Overall Study||0
10144076|NCT02752490|11274538|FG001|NOT COMPLETED|Overall Study||0
10144077|NCT02752633|11274544|FG000|STARTED|Overall Study||9
10144078|NCT02752633|11274544|FG000|COMPLETED|Overall Study||8
10144079|NCT02752633|11274544|FG000|NOT COMPLETED|Overall Study||1
10144080|NCT02752776|11274551|FG000|STARTED|Overall Study||663
10144081|NCT02752776|11274552|FG001|STARTED|Overall Study||673
10144082|NCT02752776|11274553|FG002|STARTED|Overall Study||324
10144083|NCT02752776|11274551|FG000|COMPLETED|Overall Study||611
10144084|NCT02752776|11274552|FG001|COMPLETED|Overall Study||597
10144085|NCT02752776|11274553|FG002|COMPLETED|Overall Study||276
10144086|NCT02752776|11274551|FG000|NOT COMPLETED|Overall Study||52
10144087|NCT02752776|11274552|FG001|NOT COMPLETED|Overall Study||76
10144088|NCT02752776|11274553|FG002|NOT COMPLETED|Overall Study||48
10144089|NCT02752802|11274565|FG000|STARTED|Overall Study||48
10144090|NCT02752802|11274566|FG001|STARTED|Overall Study||48
10144091|NCT02752802|11274565|FG000|COMPLETED|Overall Study||47
10144092|NCT02752802|11274566|FG001|COMPLETED|Overall Study||48
10144093|NCT02752802|11274565|FG000|NOT COMPLETED|Overall Study||1
10144094|NCT02752802|11274566|FG001|NOT COMPLETED|Overall Study||0
10144095|NCT02752880|11274576|FG000|STARTED|Overall Study||23
10144096|NCT02752880|11274577|FG001|STARTED|Overall Study||23
10144097|NCT02752880|11274576|FG000|COMPLETED|Overall Study||21
10144098|NCT02752880|11274577|FG001|COMPLETED|Overall Study||20
10144099|NCT02752880|11274576|FG000|NOT COMPLETED|Overall Study||2
10144100|NCT02752880|11274577|FG001|NOT COMPLETED|Overall Study||3
10144101|NCT02752958|11274584|FG000|STARTED|Overall Study||75
10144102|NCT02752958|11274584|FG000|COMPLETED|Overall Study||66
10144103|NCT02752958|11274584|FG000|NOT COMPLETED|Overall Study||9
10144104|NCT02753075|11274593|FG000|STARTED|Overall Study||79
10144105|NCT02753075|11274594|FG001|STARTED|Overall Study||80
10144106|NCT02753075|11274595|FG002|STARTED|Overall Study||81
10144107|NCT02753075|11274593|FG000|COMPLETED|Overall Study||71
10144108|NCT02753075|11274594|FG001|COMPLETED|Overall Study||77
10144109|NCT02753075|11274595|FG002|COMPLETED|Overall Study||78
10144110|NCT02753075|11274593|FG000|NOT COMPLETED|Overall Study||8
10144111|NCT02753075|11274594|FG001|NOT COMPLETED|Overall Study||3
10144112|NCT02753075|11274595|FG002|NOT COMPLETED|Overall Study||3
10144113|NCT02753400|11274606|FG000|STARTED|Overall Study||12
10144114|NCT02753400|11274607|FG001|STARTED|Overall Study||12
10144115|NCT02753400|11274606|FG000|COMPLETED|Overall Study||7
10144116|NCT02753400|11274607|FG001|COMPLETED|Overall Study||11
10144117|NCT02753400|11274606|FG000|NOT COMPLETED|Overall Study||5
10144118|NCT02753400|11274607|FG001|NOT COMPLETED|Overall Study||1
10144119|NCT02753413|11274615|FG000|STARTED|Overall Study||49
10144120|NCT02753413|11274616|FG001|STARTED|Overall Study||51
10144121|NCT02753413|11274615|FG000|COMPLETED|Overall Study||49
10144122|NCT02753413|11274616|FG001|COMPLETED|Overall Study||51
10144123|NCT02753413|11274615|FG000|NOT COMPLETED|Overall Study||0
10144124|NCT02753413|11274616|FG001|NOT COMPLETED|Overall Study||0
10144125|NCT02753595|11274624|FG000|STARTED|Overall Study||5
10144126|NCT02753595|11274625|FG001|STARTED|Overall Study||9
10144127|NCT02753595|11274624|FG000|COMPLETED|Overall Study||3
10144128|NCT02753595|11274625|FG001|COMPLETED|Overall Study||7
10144129|NCT02753595|11274624|FG000|NOT COMPLETED|Overall Study||2
10144130|NCT02753595|11274625|FG001|NOT COMPLETED|Overall Study||2
10144131|NCT02753699|11274633|FG000|STARTED|Overall Study||164
10144132|NCT02753699|11274634|FG001|STARTED|Overall Study||397
10144133|NCT02753699|11274635|FG002|STARTED|Overall Study||162
10144134|NCT02753699|11274633|FG000|COMPLETED|Overall Study||150
10144135|NCT02753699|11274634|FG001|COMPLETED|Overall Study||354
10144136|NCT02753699|11274635|FG002|COMPLETED|Overall Study||139
10144137|NCT02753699|11274633|FG000|NOT COMPLETED|Overall Study||14
10144138|NCT02753699|11274634|FG001|NOT COMPLETED|Overall Study||43
10144139|NCT02753699|11274635|FG002|NOT COMPLETED|Overall Study||23
10144140|NCT02753816|11274648|FG000|STARTED|Overall Study||7
10144141|NCT02753816|11274649|FG001|STARTED|Overall Study||11
10144142|NCT02753816|11274650|FG002|STARTED|Overall Study||7
10144143|NCT02753816|11274648|FG000|Tranexamic Acid|Overall Study||7
10144144|NCT02753816|11274649|FG001|Tranexamic Acid|Overall Study||0
10144145|NCT02753816|11274650|FG002|Tranexamic Acid|Overall Study||7
10144146|NCT02753816|11274648|FG000|Placebo|Overall Study||0
10144147|NCT02753816|11274649|FG001|Placebo|Overall Study||11
10144148|NCT02753816|11274650|FG002|Placebo|Overall Study||7
10144149|NCT02753816|11274648|FG000|COMPLETED|Overall Study||7
10144150|NCT02753816|11274649|FG001|COMPLETED|Overall Study||10
10144151|NCT02753816|11274650|FG002|COMPLETED|Overall Study||7
9708214|NCT02714218|10807447|FG001|NOT COMPLETED|Pre-Treatment Period||2
9708215|NCT02714218|10807448|FG002|NOT COMPLETED|Pre-Treatment Period||0
9708216|NCT02714218|10807446|FG000|STARTED|Treatment Period||180
9708217|NCT02714218|10807447|FG001|STARTED|Treatment Period||178
9708218|NCT02714218|10807448|FG002|STARTED|Treatment Period||27
9708219|NCT02714218|10807446|FG000|COMPLETED|Treatment Period||6
9708220|NCT02714218|10807447|FG001|COMPLETED|Treatment Period||2
9708221|NCT02714218|10807448|FG002|COMPLETED|Treatment Period||2
9708222|NCT02714218|10807446|FG000|NOT COMPLETED|Treatment Period||174
9708223|NCT02714218|10807447|FG001|NOT COMPLETED|Treatment Period||176
9708224|NCT02714218|10807448|FG002|NOT COMPLETED|Treatment Period||25
9708225|NCT02677896|10807457|FG000|STARTED|Double Blind Period (up to 35 Months)||574
9708226|NCT02677896|10807458|FG001|STARTED|Double Blind Period (up to 35 Months)||576
9708227|NCT02677896|10807457|FG000|Treated|Double Blind Period (up to 35 Months)||572
9708228|NCT02677896|10807458|FG001|Treated|Double Blind Period (up to 35 Months)||574
9708229|NCT02677896|10807457|FG000|COMPLETED|Double Blind Period (up to 35 Months)||0
9708230|NCT02677896|10807458|FG001|COMPLETED|Double Blind Period (up to 35 Months)||0
9708231|NCT02677896|10807457|FG000|NOT COMPLETED|Double Blind Period (up to 35 Months)||574
9708232|NCT02677896|10807458|FG001|NOT COMPLETED|Double Blind Period (up to 35 Months)||576
9708233|NCT02677896|10807457|FG000|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|365
9708234|NCT02677896|10807458|FG001|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|180
9708235|NCT02677896|10807457|FG000|COMPLETED|Open-Label Extension (up to 25 Months)||0
9708236|NCT02677896|10807458|FG001|COMPLETED|Open-Label Extension (up to 25 Months)||0
9708237|NCT02677896|10807457|FG000|NOT COMPLETED|Open-Label Extension (up to 25 Months)||365
9708238|NCT02677896|10807458|FG001|NOT COMPLETED|Open-Label Extension (up to 25 Months)||180
9708239|NCT02652949|10807465|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
9708240|NCT02652949|10807465|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
9708241|NCT02652949|10807465|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
9708242|NCT02652949|10807465|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
9708243|NCT02652949|10807465|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
9708244|NCT02652949|10807465|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
9708245|NCT02652949|10807465|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
9708246|NCT02652949|10807465|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91
9708247|NCT02652949|10807465|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
9708248|NCT02652949|10807465|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
9708249|NCT02652949|10807465|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
9708250|NCT02652949|10807465|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
9708251|NCT02652949|10807465|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
9708252|NCT02652949|10807465|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
9708253|NCT02652949|10807465|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
9708254|NCT02652949|10807465|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
9708255|NCT02652949|10807465|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
9708256|NCT02652949|10807465|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
9708257|NCT02649439|10807477|FG000|STARTED|Overall Study||40
9708258|NCT02649439|10807478|FG001|STARTED|Overall Study||40
9708259|NCT02649439|10807477|FG000|COMPLETED|Overall Study||13
9708260|NCT02649439|10807478|FG001|COMPLETED|Overall Study||12
9708261|NCT02649439|10807477|FG000|NOT COMPLETED|Overall Study||27
9708262|NCT02649439|10807478|FG001|NOT COMPLETED|Overall Study||28
9708263|NCT02634307|10807494|FG000|STARTED|Overall Study||593
9708264|NCT02634307|10807495|FG001|STARTED|Overall Study||239
9708265|NCT02634307|10807496|FG002|STARTED|Overall Study||225
9708266|NCT02634307|10807494|FG000|Safety Population|Overall Study||593
9708267|NCT02634307|10807495|FG001|Safety Population|Overall Study||239
9708268|NCT02634307|10807496|FG002|Safety Population|Overall Study||225
9708269|NCT02634307|10807494|FG000|Full Analysis Set (FAS) Population|Overall Study||582
9708270|NCT02634307|10807495|FG001|Full Analysis Set (FAS) Population|Overall Study||235
9708271|NCT02634307|10807496|FG002|Full Analysis Set (FAS) Population|Overall Study||224
9708272|NCT02634307|10807494|FG000|COMPLETED|Overall Study||468
9708273|NCT02634307|10807495|FG001|COMPLETED|Overall Study||168
9708274|NCT02634307|10807496|FG002|COMPLETED|Overall Study||164
9708275|NCT02634307|10807494|FG000|NOT COMPLETED|Overall Study||125
9708276|NCT02634307|10807495|FG001|NOT COMPLETED|Overall Study||71
9708277|NCT02634307|10807496|FG002|NOT COMPLETED|Overall Study||61
9708278|NCT02579811|10807504|FG000|STARTED|Overall Study||40
10144152|NCT02753816|11274648|FG000|NOT COMPLETED|Overall Study||0
10144153|NCT02753816|11274649|FG001|NOT COMPLETED|Overall Study||1
10144154|NCT02753816|11274650|FG002|NOT COMPLETED|Overall Study||0
10144155|NCT02753842|11274662|FG000|STARTED|First Follow-Up (Set of Condoms)||85
10144156|NCT02753842|11274663|FG001|STARTED|First Follow-Up (Set of Condoms)||84
10144157|NCT02753842|11274664|FG002|STARTED|First Follow-Up (Set of Condoms)||85
10144158|NCT02753842|11274665|FG003|STARTED|First Follow-Up (Set of Condoms)||83
10144159|NCT02753842|11274666|FG004|STARTED|First Follow-Up (Set of Condoms)||83
10144160|NCT02753842|11274667|FG005|STARTED|First Follow-Up (Set of Condoms)||84
10144161|NCT02753842|11274662|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75
10144162|NCT02753842|11274663|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76
10144163|NCT02753842|11274664|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76
10144164|NCT02753842|11274665|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81
10144165|NCT02753842|11274666|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76
10144166|NCT02753842|11274667|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79
10144167|NCT02753842|11274662|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
10144168|NCT02753842|11274663|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
10144169|NCT02753842|11274664|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
10144170|NCT02753842|11274665|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
10144171|NCT02753842|11274666|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
10144172|NCT02753842|11274667|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
10144173|NCT02753842|11274662|FG000|STARTED|Second Follow-Up (Set of Condoms)||75
10144174|NCT02753842|11274663|FG001|STARTED|Second Follow-Up (Set of Condoms)||76
10144175|NCT02753842|11274664|FG002|STARTED|Second Follow-Up (Set of Condoms)||76
10144176|NCT02753842|11274665|FG003|STARTED|Second Follow-Up (Set of Condoms)||81
10144177|NCT02753842|11274666|FG004|STARTED|Second Follow-Up (Set of Condoms)||76
10144178|NCT02753842|11274667|FG005|STARTED|Second Follow-Up (Set of Condoms)||79
10144179|NCT02753842|11274662|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71
10144180|NCT02753842|11274663|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71
10144181|NCT02753842|11274664|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71
10144182|NCT02753842|11274665|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76
10144183|NCT02753842|11274666|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75
10144184|NCT02753842|11274667|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72
10144185|NCT02753842|11274662|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
10144186|NCT02753842|11274663|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
10144187|NCT02753842|11274664|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
10144188|NCT02753842|11274665|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
10144189|NCT02753842|11274666|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
10144190|NCT02753842|11274667|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
10144191|NCT02753842|11274662|FG000|STARTED|Third Follow-Up (Set of Condoms)||71
10144192|NCT02753842|11274663|FG001|STARTED|Third Follow-Up (Set of Condoms)||71
10144193|NCT02753842|11274664|FG002|STARTED|Third Follow-Up (Set of Condoms)||71
10144194|NCT02753842|11274665|FG003|STARTED|Third Follow-Up (Set of Condoms)||76
10144195|NCT02753842|11274666|FG004|STARTED|Third Follow-Up (Set of Condoms)||75
10144196|NCT02753842|11274667|FG005|STARTED|Third Follow-Up (Set of Condoms)||72
10144197|NCT02753842|11274662|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65
10144198|NCT02753842|11274663|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66
10144199|NCT02753842|11274664|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68
10144200|NCT02753842|11274665|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70
10144201|NCT02753842|11274666|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71
10144202|NCT02753842|11274667|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69
10144203|NCT02753842|11274662|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
10144204|NCT02753842|11274663|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
10144205|NCT02753842|11274664|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
10144206|NCT02753842|11274665|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
10144207|NCT02753842|11274666|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
10144208|NCT02753842|11274667|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
10144209|NCT02753881|11274684|FG000|STARTED|Overall Study||10
10144210|NCT02753881|11274685|FG001|STARTED|Overall Study||10
10144211|NCT02753881|11274686|FG002|STARTED|Overall Study||10
10144212|NCT02753881|11274684|FG000|COMPLETED|Overall Study||10
10144213|NCT02753881|11274685|FG001|COMPLETED|Overall Study||10
10144214|NCT02753881|11274686|FG002|COMPLETED|Overall Study||10
10144215|NCT02753881|11274684|FG000|NOT COMPLETED|Overall Study||0
10144216|NCT02753881|11274685|FG001|NOT COMPLETED|Overall Study||0
10144217|NCT02753881|11274686|FG002|NOT COMPLETED|Overall Study||0
10144218|NCT02753920|11274696|FG000|STARTED|Overall Study||87
10144219|NCT02753920|11274697|FG001|STARTED|Overall Study||86
10144220|NCT02753920|11274696|FG000|COMPLETED|Overall Study||87
10144221|NCT02753920|11274697|FG001|COMPLETED|Overall Study||86
10144222|NCT02753920|11274696|FG000|NOT COMPLETED|Overall Study||0
10144223|NCT02753920|11274697|FG001|NOT COMPLETED|Overall Study||0
10144224|NCT02753946|11274709|FG000|STARTED|Overall Study||233
10144225|NCT02753946|11274710|FG001|STARTED|Overall Study||231
10144226|NCT02753946|11274709|FG000|COMPLETED|Overall Study||219
10144227|NCT02753946|11274710|FG001|COMPLETED|Overall Study||222
10144228|NCT02753946|11274709|FG000|NOT COMPLETED|Overall Study||14
10144229|NCT02753946|11274710|FG001|NOT COMPLETED|Overall Study||9
10144230|NCT02754310|11274718|FG000|STARTED|Overall Study||42
10144231|NCT02754310|11274719|FG001|STARTED|Overall Study||43
10144232|NCT02754310|11274718|FG000|COMPLETED|Overall Study||42
10144233|NCT02754310|11274719|FG001|COMPLETED|Overall Study||43
10144234|NCT02754310|11274718|FG000|NOT COMPLETED|Overall Study||0
10144235|NCT02754310|11274719|FG001|NOT COMPLETED|Overall Study||0
10144236|NCT02754427|11274727|FG000|STARTED|Overall Study||21
10144237|NCT02754427|11274728|FG001|STARTED|Overall Study||20
10144238|NCT02754427|11274727|FG000|COMPLETED|Overall Study||21
10144239|NCT02754427|11274728|FG001|COMPLETED|Overall Study||19
10144240|NCT02754427|11274727|FG000|NOT COMPLETED|Overall Study||0
10144241|NCT02754427|11274728|FG001|NOT COMPLETED|Overall Study||1
10144242|NCT02754440|11274738|FG000|STARTED|Overall Study||99
10144243|NCT02754440|11274739|FG001|STARTED|Overall Study||101
10144244|NCT02754440|11274740|FG002|STARTED|Overall Study||100
10144245|NCT02754440|11274741|FG003|STARTED|Overall Study||35
10144246|NCT02754440|11274738|FG000|COMPLETED|Overall Study||93
10144247|NCT02754440|11274739|FG001|COMPLETED|Overall Study||93
10144248|NCT02754440|11274740|FG002|COMPLETED|Overall Study||93
10144249|NCT02754440|11274741|FG003|COMPLETED|Overall Study||0
10144250|NCT02754440|11274738|FG000|NOT COMPLETED|Overall Study||6
10144251|NCT02754440|11274739|FG001|NOT COMPLETED|Overall Study||8
10144252|NCT02754440|11274740|FG002|NOT COMPLETED|Overall Study||7
10144253|NCT02754440|11274741|FG003|NOT COMPLETED|Overall Study||35
10144254|NCT02754492|11274754|FG000|STARTED|Overall Study||97
10144255|NCT02754492|11274755|FG001|STARTED|Overall Study||95
10144256|NCT02754492|11274756|FG002|STARTED|Overall Study||95
10144257|NCT02754492|11274757|FG003|STARTED|Overall Study||23
10144258|NCT02754492|11274754|FG000|COMPLETED|Overall Study||93
10144259|NCT02754492|11274755|FG001|COMPLETED|Overall Study||93
10144260|NCT02754492|11274756|FG002|COMPLETED|Overall Study||93
10144261|NCT02754492|11274757|FG003|COMPLETED|Overall Study||0
10144262|NCT02754492|11274754|FG000|NOT COMPLETED|Overall Study||4
10144263|NCT02754492|11274755|FG001|NOT COMPLETED|Overall Study||2
10144264|NCT02754492|11274756|FG002|NOT COMPLETED|Overall Study||2
10144265|NCT02754492|11274757|FG003|NOT COMPLETED|Overall Study||23
10144266|NCT02754518|11274766|FG000|STARTED|Overall Study||40
10144267|NCT02754518|11274766|FG000|COMPLETED|Overall Study||40
10144268|NCT02754518|11274766|FG000|NOT COMPLETED|Overall Study||0
10144269|NCT02754570|11274770|FG000|STARTED|Overall Study||27
10144270|NCT02754570|11274770|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27
10144271|NCT02754570|11274770|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27
10144272|NCT02754570|11274770|FG000|COMPLETED|Overall Study||27
10144273|NCT02754570|11274770|FG000|NOT COMPLETED|Overall Study||0
10144274|NCT02754661|11274778|FG000|STARTED|Overall Study||160
10144275|NCT02754661|11274779|FG001|STARTED|Overall Study||160
10144276|NCT02754661|11274778|FG000|COMPLETED|Overall Study||145
10144277|NCT02754661|11274779|FG001|COMPLETED|Overall Study||141
10144278|NCT02754661|11274778|FG000|NOT COMPLETED|Overall Study||15
10144279|NCT02754661|11274779|FG001|NOT COMPLETED|Overall Study||19
10144280|NCT02754674|11274789|FG000|STARTED|Overall Study||34
10144281|NCT02754674|11274790|FG001|STARTED|Overall Study||33
10144282|NCT02754674|11274789|FG000|COMPLETED|Overall Study||28
10144283|NCT02754674|11274790|FG001|COMPLETED|Overall Study||26
10144284|NCT02754674|11274789|FG000|NOT COMPLETED|Overall Study||6
10144285|NCT02754674|11274790|FG001|NOT COMPLETED|Overall Study||7
10144286|NCT02755090|11274798|FG000|STARTED|Overall Study||19
10144287|NCT02755090|11274799|FG001|STARTED|Overall Study||20
10144288|NCT02755090|11274798|FG000|COMPLETED|Overall Study||18
10144289|NCT02755090|11274799|FG001|COMPLETED|Overall Study||20
10144290|NCT02755090|11274798|FG000|NOT COMPLETED|Overall Study||1
10144291|NCT02755090|11274799|FG001|NOT COMPLETED|Overall Study||0
10144292|NCT02755116|11274807|FG000|STARTED|Overall Study||74
10144293|NCT02755116|11274808|FG001|STARTED|Overall Study||70
10144294|NCT02755116|11274807|FG000|COMPLETED|Overall Study||71
10144295|NCT02755116|11274808|FG001|COMPLETED|Overall Study||69
10144296|NCT02755116|11274807|FG000|NOT COMPLETED|Overall Study||3
10144297|NCT02755116|11274808|FG001|NOT COMPLETED|Overall Study||1
10144298|NCT02755129|11274814|FG000|STARTED|Overall Study||15
10144299|NCT02755129|11274814|FG000|COMPLETED|Overall Study||15
10144300|NCT02755129|11274814|FG000|NOT COMPLETED|Overall Study||0
10144301|NCT02755285|11274821|FG000|STARTED|Overall Study||20
10144302|NCT02755285|11274821|FG000|COMPLETED|Overall Study||20
10144303|NCT02755285|11274821|FG000|NOT COMPLETED|Overall Study||0
10144304|NCT02755649|11274828|FG000|STARTED|Overall Study||108
10144305|NCT02755649|11274829|FG001|STARTED|Overall Study||107
10144306|NCT02755649|11274830|FG002|STARTED|Overall Study||110
10144307|NCT02755649|11274828|FG000|Completed Treatment (Week 16)|Overall Study||107
10144308|NCT02755649|11274829|FG001|Completed Treatment (Week 16)|Overall Study||106
10144309|NCT02755649|11274830|FG002|Completed Treatment (Week 16)|Overall Study||109
10144310|NCT02755649|11274828|FG000|Completed Study (Week 28)|Overall Study||7
10144311|NCT02755649|11274829|FG001|Completed Study (Week 28)|Overall Study||8
10144312|NCT02755649|11274830|FG002|Completed Study (Week 28)|Overall Study||8
10144313|NCT02755649|11274828|FG000|COMPLETED|Overall Study||7
10144314|NCT02755649|11274829|FG001|COMPLETED|Overall Study||8
10144315|NCT02755649|11274830|FG002|COMPLETED|Overall Study||8
10144316|NCT02755649|11274828|FG000|NOT COMPLETED|Overall Study||101
10144317|NCT02755649|11274829|FG001|NOT COMPLETED|Overall Study||99
10144318|NCT02755649|11274830|FG002|NOT COMPLETED|Overall Study||102
10144319|NCT02755805|11274840|FG000|STARTED|Overall Study||15
10144320|NCT02755805|11274841|FG001|STARTED|Overall Study||15
10144321|NCT02755805|11274840|FG000|COMPLETED|Overall Study||13
10144322|NCT02755805|11274841|FG001|COMPLETED|Overall Study||11
10144323|NCT02755805|11274840|FG000|NOT COMPLETED|Overall Study||2
10144324|NCT02755805|11274841|FG001|NOT COMPLETED|Overall Study||4
10144325|NCT02755818|11274851|FG000|STARTED|Overall Study||30
10144326|NCT02755818|11274852|FG001|STARTED|Overall Study||2
10144327|NCT02755818|11274853|FG002|STARTED|Overall Study||2
10144328|NCT02755818|11274854|FG003|STARTED|Overall Study||17
10144329|NCT02755818|11274851|FG000|COMPLETED|Overall Study||30
10144330|NCT02755818|11274852|FG001|COMPLETED|Overall Study||2
10144331|NCT02755818|11274853|FG002|COMPLETED|Overall Study||1
10144332|NCT02755818|11274854|FG003|COMPLETED|Overall Study||14
10144333|NCT02755818|11274851|FG000|NOT COMPLETED|Overall Study||0
10144334|NCT02755818|11274852|FG001|NOT COMPLETED|Overall Study||0
10144335|NCT02755818|11274853|FG002|NOT COMPLETED|Overall Study||1
10144336|NCT02755818|11274854|FG003|NOT COMPLETED|Overall Study||3
10144337|NCT02755831|11274868|FG000|STARTED|Overall Study||100
10144338|NCT02755831|11274869|FG001|STARTED|Overall Study||93
10144339|NCT02755831|11274868|FG000|COMPLETED|Overall Study||97
10144340|NCT02755831|11274869|FG001|COMPLETED|Overall Study||90
10144341|NCT02755831|11274868|FG000|NOT COMPLETED|Overall Study||3
10144342|NCT02755831|11274869|FG001|NOT COMPLETED|Overall Study||3
10144343|NCT02755935|11274875|FG000|STARTED|Overall Study||24
10144344|NCT02755935|11274875|FG000|COMPLETED|Overall Study||22
10144345|NCT02755935|11274875|FG000|NOT COMPLETED|Overall Study||2
10144349|NCT02756078|11274883|FG000|STARTED|Period 1||85
10144350|NCT02756078|11274884|FG001|STARTED|Period 1||86
10144351|NCT02756078|11274883|FG000|COMPLETED|Period 1||76
10144352|NCT02756078|11274884|FG001|COMPLETED|Period 1||64
10144353|NCT02756078|11274883|FG000|NOT COMPLETED|Period 1||9
10144354|NCT02756078|11274884|FG001|NOT COMPLETED|Period 1||22
10144355|NCT02756078|11274883|FG000|STARTED|Period 2||76
10144356|NCT02756078|11274884|FG001|STARTED|Period 2||64
10144357|NCT02756078|11274883|FG000|COMPLETED|Period 2||70
10144358|NCT02756078|11274884|FG001|COMPLETED|Period 2||57
10144359|NCT02756078|11274883|FG000|NOT COMPLETED|Period 2||6
10144360|NCT02756078|11274884|FG001|NOT COMPLETED|Period 2||7
10144361|NCT02756182|11274890|FG000|STARTED|Overall Study||25
10144362|NCT02756182|11274890|FG000|COMPLETED|Overall Study||21
10144363|NCT02756182|11274890|FG000|NOT COMPLETED|Overall Study||4
10144364|NCT02756338|11274896|FG000|STARTED|Overall Study||77
10144365|NCT02756338|11274896|FG000|COMPLETED|Overall Study||72
10144366|NCT02756338|11274896|FG000|NOT COMPLETED|Overall Study||5
10196792|NCT03364309|11324818|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196793|NCT03364309|11324819|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196794|NCT03364309|11324820|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196795|NCT03364309|11324821|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196796|NCT03364309|11324822|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196797|NCT03364309|11324823|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196798|NCT03364309|11324824|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196799|NCT03364309|11324825|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196800|NCT03364309|11324826|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196801|NCT03364309|11324827|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196802|NCT03364309|11324828|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196803|NCT03364309|11324829|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1
10196804|NCT03364309|11324830|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1
10196805|NCT03364309|11324831|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2
10196806|NCT03364309|11324832|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2
10196807|NCT03364309|11324833|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196808|NCT03364309|11324834|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196809|NCT03364309|11324835|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10196810|NCT03364309|11324817|FG000|STARTED|Post-Treatment Followup Period||0
10196811|NCT03364309|11324818|FG001|STARTED|Post-Treatment Followup Period||0
10196812|NCT03364309|11324819|FG002|STARTED|Post-Treatment Followup Period||0
10196813|NCT03364309|11324820|FG003|STARTED|Post-Treatment Followup Period||0
10196814|NCT03364309|11324821|FG004|STARTED|Post-Treatment Followup Period||0
10196815|NCT03364309|11324822|FG005|STARTED|Post-Treatment Followup Period||0
10196816|NCT03364309|11324823|FG006|STARTED|Post-Treatment Followup Period||0
10196817|NCT03364309|11324824|FG007|STARTED|Post-Treatment Followup Period||0
10196818|NCT03364309|11324825|FG008|STARTED|Post-Treatment Followup Period||0
10196819|NCT03364309|11324826|FG009|STARTED|Post-Treatment Followup Period||0
10196820|NCT03364309|11324827|FG010|STARTED|Post-Treatment Followup Period||0
10196821|NCT03364309|11324828|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10196822|NCT03364309|11324829|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10196823|NCT03364309|11324830|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10196824|NCT03364309|11324831|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10196825|NCT03364309|11324832|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10196826|NCT03364309|11324833|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
10196827|NCT03364309|11324834|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
10196828|NCT03364309|11324835|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
10196829|NCT03364309|11324817|FG000|COMPLETED|Post-Treatment Followup Period||0
10196830|NCT03364309|11324818|FG001|COMPLETED|Post-Treatment Followup Period||0
10196831|NCT03364309|11324819|FG002|COMPLETED|Post-Treatment Followup Period||0
10196832|NCT03364309|11324820|FG003|COMPLETED|Post-Treatment Followup Period||0
10144367|NCT02756351|11274902|FG000|STARTED|Overall Study||24
10144368|NCT02756351|11274903|FG001|STARTED|Overall Study||24
10144369|NCT02756351|11274902|FG000|COMPLETED|Overall Study||24
10144370|NCT02756351|11274903|FG001|COMPLETED|Overall Study||24
10144371|NCT02756351|11274902|FG000|NOT COMPLETED|Overall Study||0
10144372|NCT02756351|11274903|FG001|NOT COMPLETED|Overall Study||0
10144373|NCT02756364|11274912|FG000|STARTED|Overall Study||46
10144374|NCT02756364|11274913|FG001|STARTED|Overall Study||47
10144375|NCT02756364|11274914|FG002|STARTED|Overall Study||48
10144376|NCT02756364|11274912|FG000|Treated Participants|Overall Study||46
10144377|NCT02756364|11274913|FG001|Treated Participants|Overall Study||47
10144378|NCT02756364|11274914|FG002|Treated Participants|Overall Study||47
10144379|NCT02756364|11274912|FG000|COMPLETED|Overall Study||0
10144380|NCT02756364|11274913|FG001|COMPLETED|Overall Study||0
10144381|NCT02756364|11274914|FG002|COMPLETED|Overall Study||0
10144382|NCT02756364|11274912|FG000|NOT COMPLETED|Overall Study||46
10144383|NCT02756364|11274913|FG001|NOT COMPLETED|Overall Study||47
10144384|NCT02756364|11274914|FG002|NOT COMPLETED|Overall Study||48
10144385|NCT02756572|11274922|FG000|STARTED|Overall Study||30
10144386|NCT02756572|11274922|FG000|COMPLETED|Overall Study||30
10144387|NCT02756572|11274922|FG000|NOT COMPLETED|Overall Study||0
10144388|NCT02756624|11274933|FG000|STARTED|Overall Study||343
10144389|NCT02756624|11274934|FG001|STARTED|Overall Study||173
10144390|NCT02756624|11274933|FG000|COMPLETED|Overall Study||327
10144391|NCT02756624|11274934|FG001|COMPLETED|Overall Study||166
10144392|NCT02756624|11274933|FG000|NOT COMPLETED|Overall Study||16
10144393|NCT02756624|11274934|FG001|NOT COMPLETED|Overall Study||7
10144394|NCT02756637|11274942|FG000|STARTED|Overall Study||317
10144395|NCT02756637|11274943|FG001|STARTED|Overall Study||317
10144396|NCT02756637|11274942|FG000|Eligible for SWOG 8710|Overall Study||307
10144397|NCT02756637|11274943|FG001|Eligible for SWOG 8710|Overall Study||307
10144398|NCT02756637|11274942|FG000|Had NLR Value|Overall Study||263
10144399|NCT02756637|11274943|FG001|Had NLR Value|Overall Study||263
10144400|NCT02756637|11274942|FG000|Completed Curative Treatment|Overall Study||230
10144401|NCT02756637|11274943|FG001|Completed Curative Treatment|Overall Study||0
10144402|NCT02756637|11274942|FG000|COMPLETED|Overall Study||230
10144403|NCT02756637|11274943|FG001|COMPLETED|Overall Study||263
10144404|NCT02756637|11274942|FG000|NOT COMPLETED|Overall Study||87
10144405|NCT02756637|11274943|FG001|NOT COMPLETED|Overall Study||54
10144406|NCT02756650|11274949|FG000|STARTED|Overall Study||8
10144407|NCT02756650|11274949|FG000|COMPLETED|Overall Study||6
10144408|NCT02756650|11274949|FG000|NOT COMPLETED|Overall Study||2
10144409|NCT02756689|11274955|FG000|STARTED|Overall Study||64
10144410|NCT02756689|11274956|FG001|STARTED|Overall Study||65
10144411|NCT02756689|11274955|FG000|COMPLETED|Overall Study||64
10144412|NCT02756689|11274956|FG001|COMPLETED|Overall Study||65
10144413|NCT02756689|11274955|FG000|NOT COMPLETED|Overall Study||0
10144414|NCT02756689|11274956|FG001|NOT COMPLETED|Overall Study||0
10144415|NCT02756819|11274996|FG000|STARTED|Overall Study||1945
10144416|NCT02756819|11274996|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
10144417|NCT02756819|11274996|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
10144418|NCT02756819|11274996|FG000|COMPLETED|Overall Study||1893
10144419|NCT02756819|11274996|FG000|NOT COMPLETED|Overall Study||52
10144420|NCT02756832|11275000|FG000|STARTED|Overall Study||1409
10144421|NCT02756832|11275000|FG000|Received Therapy|Overall Study||1393
10144422|NCT02756832|11275000|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399
10144423|NCT02756832|11275000|FG000|COMPLETED|Overall Study||1356
10144424|NCT02756832|11275000|FG000|NOT COMPLETED|Overall Study||53
10144425|NCT02756910|11275004|FG000|STARTED|Overall Study||80
10144426|NCT02756910|11275004|FG000|COMPLETED|Overall Study||80
10144427|NCT02756910|11275004|FG000|NOT COMPLETED|Overall Study||0
10144428|NCT02756949|11275010|FG000|STARTED|Overall Study||181
10144429|NCT02756949|11275011|FG001|STARTED|Overall Study||172
10144430|NCT02756949|11275010|FG000|COMPLETED|Overall Study||181
10144431|NCT02756949|11275011|FG001|COMPLETED|Overall Study||164
10144432|NCT02756949|11275010|FG000|NOT COMPLETED|Overall Study||0
10144433|NCT02756949|11275011|FG001|NOT COMPLETED|Overall Study||8
10144434|NCT02757092|11275019|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
10144435|NCT02757092|11275020|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
10144436|NCT02757092|11275019|FG000|COMPLETED|Overall Study|All subjects completed the study|18
10144437|NCT02757092|11275020|FG001|COMPLETED|Overall Study|All subjects completed the study|18
10144438|NCT02757092|11275019|FG000|NOT COMPLETED|Overall Study||0
10144439|NCT02757092|11275020|FG001|NOT COMPLETED|Overall Study||0
10144440|NCT02757105|11275086|FG000|STARTED|Overall Study||75
10144441|NCT02757105|11275087|FG001|STARTED|Overall Study||52
10144442|NCT02757105|11275086|FG000|Treated|Overall Study||75
10144443|NCT02757105|11275087|FG001|Treated|Overall Study||51
10144444|NCT02757105|11275086|FG000|COMPLETED|Overall Study||63
10144445|NCT02757105|11275087|FG001|COMPLETED|Overall Study||41
10144446|NCT02757105|11275086|FG000|NOT COMPLETED|Overall Study||12
10144447|NCT02757105|11275087|FG001|NOT COMPLETED|Overall Study||11
10144448|NCT02757326|11275097|FG000|STARTED|Overall Study||3
10144449|NCT02757326|11275098|FG001|STARTED|Overall Study||4
10144450|NCT02757326|11275099|FG002|STARTED|Overall Study||6
10144451|NCT02757326|11275097|FG000|COMPLETED|Overall Study||3
10144452|NCT02757326|11275098|FG001|COMPLETED|Overall Study||4
10144453|NCT02757326|11275099|FG002|COMPLETED|Overall Study||6
10144454|NCT02757326|11275097|FG000|NOT COMPLETED|Overall Study||0
10144455|NCT02757326|11275098|FG001|NOT COMPLETED|Overall Study||0
10144456|NCT02757326|11275099|FG002|NOT COMPLETED|Overall Study||0
10144457|NCT02757352|11275114|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105
10144458|NCT02757352|11275115|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96
10144459|NCT02757352|11275116|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102
10144460|NCT02757352|11275117|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10144461|NCT02757352|11275118|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10144462|NCT02757352|11275119|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10144463|NCT02757352|11275120|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10144464|NCT02757352|11275121|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10144465|NCT02757352|11275122|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10144466|NCT02757352|11275123|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10144467|NCT02757352|11275114|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
10144468|NCT02757352|11275115|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
10144469|NCT02757352|11275116|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
10144470|NCT02757352|11275117|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10144471|NCT02757352|11275118|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10144472|NCT02757352|11275119|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10144473|NCT02757352|11275120|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10144474|NCT02757352|11275121|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10144475|NCT02757352|11275122|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10144476|NCT02757352|11275123|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10144477|NCT02757352|11275114|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
10144478|NCT02757352|11275115|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
10144479|NCT02757352|11275116|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
10144480|NCT02757352|11275117|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144481|NCT02757352|11275118|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144482|NCT02757352|11275119|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144483|NCT02757352|11275120|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144484|NCT02757352|11275121|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144485|NCT02757352|11275122|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144486|NCT02757352|11275123|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144487|NCT02757352|11275114|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
10144488|NCT02757352|11275115|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
10144489|NCT02757352|11275116|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
10144490|NCT02757352|11275117|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144491|NCT02757352|11275118|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144492|NCT02757352|11275119|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144493|NCT02757352|11275120|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144494|NCT02757352|11275121|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144495|NCT02757352|11275122|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144496|NCT02757352|11275123|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10144497|NCT02757352|11275114|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97
10144498|NCT02757352|11275115|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95
10144499|NCT02757352|11275116|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98
10144500|NCT02757352|11275117|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10144501|NCT02757352|11275118|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10144502|NCT02757352|11275119|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10144503|NCT02757352|11275120|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10144504|NCT02757352|11275121|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10144505|NCT02757352|11275122|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10144506|NCT02757352|11275123|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10144507|NCT02757352|11275114|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
10144508|NCT02757352|11275115|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
10144509|NCT02757352|11275116|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
10144510|NCT02757352|11275117|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144511|NCT02757352|11275118|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144512|NCT02757352|11275119|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144513|NCT02757352|11275120|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144514|NCT02757352|11275121|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144515|NCT02757352|11275122|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144516|NCT02757352|11275123|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144517|NCT02757352|11275114|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
10144518|NCT02757352|11275115|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
10144519|NCT02757352|11275116|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
10144520|NCT02757352|11275117|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144521|NCT02757352|11275118|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144522|NCT02757352|11275119|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144523|NCT02757352|11275120|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144524|NCT02757352|11275121|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144525|NCT02757352|11275122|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144526|NCT02757352|11275123|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10144527|NCT02757352|11275114|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
10144528|NCT02757352|11275115|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
10144529|NCT02757352|11275116|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
10144530|NCT02757352|11275117|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
10144531|NCT02757352|11275118|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
10144532|NCT02757352|11275119|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
10144533|NCT02757352|11275120|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10144534|NCT02757352|11275121|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10144535|NCT02757352|11275122|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10144536|NCT02757352|11275123|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10144537|NCT02757352|11275114|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10144538|NCT02757352|11275115|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
9708279|NCT02579811|10807504|FG000|COMPLETED|Overall Study||40
9708280|NCT02579811|10807504|FG000|NOT COMPLETED|Overall Study||0
9708281|NCT02447718|10807510|FG000|STARTED|Overall Study||78
9708282|NCT02447718|10807511|FG001|STARTED|Overall Study||78
9708283|NCT02447718|10807510|FG000|Received Prevnar®13|Overall Study||74
9708284|NCT02447718|10807511|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0
9708285|NCT02447718|10807510|FG000|Received Pediacel®|Overall Study||73
9708286|NCT02447718|10807511|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0
9708287|NCT02447718|10807510|FG000|Received Pneumovax® 23|Overall Study||73
9708288|NCT02447718|10807511|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
9708289|NCT02447718|10807510|FG000|COMPLETED|Overall Study||66
9708290|NCT02447718|10807511|FG001|COMPLETED|Overall Study||78
9708291|NCT02447718|10807510|FG000|NOT COMPLETED|Overall Study||12
9708292|NCT02447718|10807511|FG001|NOT COMPLETED|Overall Study||0
9708293|NCT02157883|10807518|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
9708294|NCT02157883|10807518|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
9708295|NCT02157883|10807518|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
9708296|NCT02157883|10807518|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
9708297|NCT02157883|10807518|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
9708298|NCT02157883|10807518|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
9708299|NCT02157883|10807518|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
9708300|NCT02157883|10807518|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
9708301|NCT02157883|10807518|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
9708302|NCT01962948|10807529|FG000|STARTED|Overall Study||3
9708303|NCT01962948|10807530|FG001|STARTED|Overall Study||3
9708304|NCT01962948|10807531|FG002|STARTED|Overall Study||6
9708305|NCT01962948|10807532|FG003|STARTED|Overall Study||0
9708306|NCT01962948|10807529|FG000|COMPLETED|Overall Study||0
9708307|NCT01962948|10807530|FG001|COMPLETED|Overall Study||0
9708308|NCT01962948|10807531|FG002|COMPLETED|Overall Study||0
9708309|NCT01962948|10807532|FG003|COMPLETED|Overall Study||0
9708310|NCT01962948|10807529|FG000|NOT COMPLETED|Overall Study||3
9708311|NCT01962948|10807530|FG001|NOT COMPLETED|Overall Study||3
9708312|NCT01962948|10807531|FG002|NOT COMPLETED|Overall Study||6
9708313|NCT01962948|10807532|FG003|NOT COMPLETED|Overall Study||0
9708314|NCT01938001|10807541|FG000|STARTED|Overall Study||178
9708315|NCT01938001|10807542|FG001|STARTED|Overall Study||180
9708316|NCT01938001|10807541|FG000|Participants Received Treatment|Overall Study||176
9708317|NCT01938001|10807542|FG001|Participants Received Treatment|Overall Study||180
9708318|NCT01938001|10807541|FG000|Completed Treatment|Overall Study||124
9708319|NCT01938001|10807542|FG001|Completed Treatment|Overall Study||110
9708320|NCT01938001|10807541|FG000|COMPLETED|Overall Study||135
9708321|NCT01938001|10807542|FG001|COMPLETED|Overall Study||133
9708322|NCT01938001|10807541|FG000|NOT COMPLETED|Overall Study||43
9708323|NCT01938001|10807542|FG001|NOT COMPLETED|Overall Study||47
9708324|NCT01529008|10807550|FG000|STARTED|Screening||35
9708325|NCT01529008|10807551|FG001|STARTED|Screening||33
9708326|NCT01529008|10807550|FG000|COMPLETED|Screening||35
9708327|NCT01529008|10807551|FG001|COMPLETED|Screening||33
9708328|NCT01529008|10807550|FG000|NOT COMPLETED|Screening||0
9708329|NCT01529008|10807551|FG001|NOT COMPLETED|Screening||0
9848886|NCT00862823|10961743|FG001|COMPLETED|Washout Period of 2 Weeks||9
9848887|NCT00862823|10961742|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
9848888|NCT00862823|10961743|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
9848889|NCT00862823|10961742|FG000|STARTED|Second Intervention||5
9848890|NCT00862823|10961743|FG001|STARTED|Second Intervention||9
9848891|NCT00862823|10961742|FG000|COMPLETED|Second Intervention||5
9848892|NCT00862823|10961743|FG001|COMPLETED|Second Intervention||9
9848893|NCT00862823|10961742|FG000|NOT COMPLETED|Second Intervention||0
9848894|NCT00862823|10961743|FG001|NOT COMPLETED|Second Intervention||0
9848895|NCT00862836|10961748|FG000|STARTED|Overall Study||15
9963852|NCT01488877|11083634|FG001|NOT COMPLETED|Re-randomization||0
10144539|NCT02757352|11275116|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10144540|NCT02757352|11275117|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
10144541|NCT02757352|11275118|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10144542|NCT02757352|11275119|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
10144543|NCT02757352|11275120|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10144544|NCT02757352|11275121|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10144545|NCT02757352|11275122|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10144546|NCT02757352|11275123|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10144547|NCT02757352|11275114|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144548|NCT02757352|11275115|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144549|NCT02757352|11275116|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144550|NCT02757352|11275117|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
10144551|NCT02757352|11275118|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
10144552|NCT02757352|11275119|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
10144553|NCT02757352|11275120|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144554|NCT02757352|11275121|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144555|NCT02757352|11275122|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144556|NCT02757352|11275123|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144557|NCT02757352|11275114|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144558|NCT02757352|11275115|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144559|NCT02757352|11275116|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144560|NCT02757352|11275117|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
10144561|NCT02757352|11275118|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
10144562|NCT02757352|11275119|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
9708330|NCT01529008|10807550|FG000|STARTED|Bone Marrow Harvesting||35
9708331|NCT01529008|10807551|FG001|STARTED|Bone Marrow Harvesting||33
9708332|NCT01529008|10807550|FG000|COMPLETED|Bone Marrow Harvesting||34
9708333|NCT01529008|10807551|FG001|COMPLETED|Bone Marrow Harvesting||30
9708334|NCT01529008|10807550|FG000|NOT COMPLETED|Bone Marrow Harvesting||1
9708335|NCT01529008|10807551|FG001|NOT COMPLETED|Bone Marrow Harvesting||3
9708336|NCT01529008|10807550|FG000|STARTED|Treatment||34
9708337|NCT01529008|10807551|FG001|STARTED|Treatment||30
9708338|NCT01529008|10807550|FG000|COMPLETED|Treatment||25
9708339|NCT01529008|10807551|FG001|COMPLETED|Treatment||29
9708340|NCT01529008|10807550|FG000|NOT COMPLETED|Treatment||9
9708341|NCT01529008|10807551|FG001|NOT COMPLETED|Treatment||1
10060665|NCT02099786|11186232|FG001|Program Eval 3|Overall Study|One year post randomization|15
10060666|NCT02099786|11186231|FG000|COMPLETED|Overall Study||21
10060667|NCT02099786|11186232|FG001|COMPLETED|Overall Study||15
10060668|NCT02099786|11186231|FG000|NOT COMPLETED|Overall Study||3
10060669|NCT02099786|11186232|FG001|NOT COMPLETED|Overall Study||8
10060670|NCT02099799|11186241|FG000|STARTED|Overall Study||75
9708342|NCT01529008|10807550|FG000|STARTED|Efficacy Analysis||25
9708343|NCT01529008|10807551|FG001|STARTED|Efficacy Analysis||29
9708344|NCT01529008|10807550|FG000|COMPLETED|Efficacy Analysis||23
9708345|NCT01529008|10807551|FG001|COMPLETED|Efficacy Analysis||26
9708346|NCT01529008|10807550|FG000|NOT COMPLETED|Efficacy Analysis||2
9708347|NCT01529008|10807551|FG001|NOT COMPLETED|Efficacy Analysis||3
9708348|NCT01484691|10807560|FG000|STARTED|Overall Study||21
9708349|NCT01484691|10807561|FG001|STARTED|Overall Study||22
9708350|NCT01484691|10807562|FG002|STARTED|Overall Study||12
9708351|NCT01484691|10807560|FG000|COMPLETED|Overall Study||20
9708352|NCT01484691|10807561|FG001|COMPLETED|Overall Study||19
9708353|NCT01484691|10807562|FG002|COMPLETED|Overall Study||10
9708354|NCT01484691|10807560|FG000|NOT COMPLETED|Overall Study||1
9708355|NCT01484691|10807561|FG001|NOT COMPLETED|Overall Study||3
10060671|NCT02099799|11186242|FG001|STARTED|Overall Study||78
10060672|NCT02099799|11186241|FG000|COMPLETED|Overall Study||60
10060673|NCT02099799|11186242|FG001|COMPLETED|Overall Study||54
10060674|NCT02099799|11186241|FG000|NOT COMPLETED|Overall Study||15
10060675|NCT02099799|11186242|FG001|NOT COMPLETED|Overall Study||24
10060676|NCT02099838|11186252|FG000|STARTED|Overall Study||47
10060677|NCT02099838|11186253|FG001|STARTED|Overall Study||51
10060678|NCT02099838|11186252|FG000|COMPLETED|Overall Study||43
10060679|NCT02099838|11186253|FG001|COMPLETED|Overall Study||49
10060680|NCT02099838|11186252|FG000|NOT COMPLETED|Overall Study||4
10060681|NCT02099838|11186253|FG001|NOT COMPLETED|Overall Study||2
10060682|NCT02099864|11186259|FG000|STARTED|Overall Study||36
10060683|NCT02099864|11186259|FG000|COMPLETED|Overall Study||36
10060684|NCT02099864|11186259|FG000|NOT COMPLETED|Overall Study||0
10060685|NCT02100007|11186267|FG000|STARTED|Overall Study||46
10060686|NCT02100007|11186267|FG000|COMPLETED|Overall Study||46
10060687|NCT02100007|11186267|FG000|NOT COMPLETED|Overall Study||0
10060688|NCT02100072|11186272|FG000|STARTED|Overall Study||5
10060689|NCT02100072|11186272|FG000|COMPLETED|Overall Study||5
10060690|NCT02100072|11186272|FG000|NOT COMPLETED|Overall Study||0
10060691|NCT02100124|11186279|FG000|STARTED|Overall Study||329
10060692|NCT02100124|11186280|FG001|STARTED|Overall Study||329
10060693|NCT02100124|11186281|FG002|STARTED|Overall Study||326
10060694|NCT02100124|11186279|FG000|COMPLETED|Overall Study||323
10060695|NCT02100124|11186280|FG001|COMPLETED|Overall Study||318
10060696|NCT02100124|11186281|FG002|COMPLETED|Overall Study||323
10144563|NCT02757352|11275120|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144564|NCT02757352|11275121|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144565|NCT02757352|11275122|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144566|NCT02757352|11275123|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10144567|NCT02757352|11275114|FG000|STARTED|Follow-Up Period||0
10144568|NCT02757352|11275115|FG001|STARTED|Follow-Up Period||0
10144569|NCT02757352|11275116|FG002|STARTED|Follow-Up Period||0
10144570|NCT02757352|11275117|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
10196833|NCT03364309|11324821|FG004|COMPLETED|Post-Treatment Followup Period||0
10060697|NCT02100124|11186279|FG000|NOT COMPLETED|Overall Study||6
10060698|NCT02100124|11186280|FG001|NOT COMPLETED|Overall Study||11
10060699|NCT02100124|11186281|FG002|NOT COMPLETED|Overall Study||3
10060700|NCT02100189|11186289|FG000|STARTED|Overall Study||50
10060701|NCT02100189|11186289|FG000|COMPLETED|Overall Study||50
10060702|NCT02100189|11186289|FG000|NOT COMPLETED|Overall Study||0
10060703|NCT02100228|11186295|FG000|STARTED|Overall Study|735 treated with Apixaban|753
10060704|NCT02100228|11186296|FG001|STARTED|Overall Study|721 treated with Usual Care|747
10060705|NCT02100228|11186295|FG000|COMPLETED|Overall Study||678
10060706|NCT02100228|11186296|FG001|COMPLETED|Overall Study||657
10060707|NCT02100228|11186295|FG000|NOT COMPLETED|Overall Study||75
10060708|NCT02100228|11186296|FG001|NOT COMPLETED|Overall Study||90
10060709|NCT02100280|11186304|FG000|STARTED|Overall Study||48
10060710|NCT02100280|11186305|FG001|STARTED|Overall Study||48
10060711|NCT02100280|11186304|FG000|COMPLETED|Overall Study||44
10060712|NCT02100280|11186305|FG001|COMPLETED|Overall Study||44
10060713|NCT02100280|11186304|FG000|NOT COMPLETED|Overall Study||4
10060714|NCT02100280|11186305|FG001|NOT COMPLETED|Overall Study||4
10060715|NCT02100319|11186313|FG000|STARTED|Overall Study||387
10060716|NCT02100319|11186313|FG000|COMPLETED|Overall Study||371
10060717|NCT02100319|11186313|FG000|NOT COMPLETED|Overall Study||16
10060718|NCT02100410|11186317|FG000|STARTED|Exposure Pair 1, 30 Minutes||8
10060719|NCT02100410|11186318|FG001|STARTED|Exposure Pair 1, 30 Minutes||8
10060720|NCT02100410|11186319|FG002|STARTED|Exposure Pair 1, 30 Minutes||8
10060721|NCT02100410|11186320|FG003|STARTED|Exposure Pair 1, 30 Minutes||8
10060722|NCT02100410|11186321|FG004|STARTED|Exposure Pair 1, 30 Minutes||8
10060723|NCT02100410|11186322|FG005|STARTED|Exposure Pair 1, 30 Minutes||9
10060724|NCT02100410|11186317|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8
10060725|NCT02100410|11186318|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8
10060726|NCT02100410|11186319|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8
10060727|NCT02100410|11186320|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8
10060728|NCT02100410|11186321|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8
10060729|NCT02100410|11186322|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9
10060730|NCT02100410|11186317|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10060731|NCT02100410|11186318|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10060732|NCT02100410|11186319|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10060733|NCT02100410|11186320|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10060734|NCT02100410|11186321|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10060735|NCT02100410|11186322|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10060736|NCT02100410|11186317|FG000|STARTED|Exposure Pair 2, 30 Minutes||8
10060737|NCT02100410|11186318|FG001|STARTED|Exposure Pair 2, 30 Minutes||8
10060738|NCT02100410|11186319|FG002|STARTED|Exposure Pair 2, 30 Minutes||8
10060739|NCT02100410|11186320|FG003|STARTED|Exposure Pair 2, 30 Minutes||8
10060740|NCT02100410|11186321|FG004|STARTED|Exposure Pair 2, 30 Minutes||8
10060741|NCT02100410|11186322|FG005|STARTED|Exposure Pair 2, 30 Minutes||9
10060742|NCT02100410|11186317|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8
10060743|NCT02100410|11186318|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8
10060744|NCT02100410|11186319|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8
10060745|NCT02100410|11186320|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8
10060746|NCT02100410|11186321|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8
10060747|NCT02100410|11186322|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9
10060748|NCT02100410|11186317|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10060749|NCT02100410|11186318|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10060750|NCT02100410|11186319|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10060751|NCT02100410|11186320|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10060752|NCT02100410|11186321|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10060753|NCT02100410|11186322|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10060754|NCT02100410|11186317|FG000|STARTED|Exposure Pair 3, 30 Minutes||8
10060755|NCT02100410|11186318|FG001|STARTED|Exposure Pair 3, 30 Minutes||8
10060756|NCT02100410|11186319|FG002|STARTED|Exposure Pair 3, 30 Minutes||8
10060757|NCT02100410|11186320|FG003|STARTED|Exposure Pair 3, 30 Minutes||8
10060758|NCT02100410|11186321|FG004|STARTED|Exposure Pair 3, 30 Minutes||8
10060759|NCT02100410|11186322|FG005|STARTED|Exposure Pair 3, 30 Minutes||9
10060760|NCT02100410|11186317|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8
10060761|NCT02100410|11186318|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8
10060762|NCT02100410|11186319|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8
10060763|NCT02100410|11186320|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8
10060764|NCT02100410|11186321|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8
10060765|NCT02100410|11186322|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9
10060766|NCT02100410|11186317|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10060767|NCT02100410|11186318|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10144571|NCT02757352|11275118|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
10144572|NCT02757352|11275119|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
10144573|NCT02757352|11275120|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
10144574|NCT02757352|11275121|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
10144575|NCT02757352|11275122|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
10144576|NCT02757352|11275123|FG009|STARTED|Follow-Up Period||5
10144577|NCT02757352|11275114|FG000|COMPLETED|Follow-Up Period||0
10144578|NCT02757352|11275115|FG001|COMPLETED|Follow-Up Period||0
10144579|NCT02757352|11275116|FG002|COMPLETED|Follow-Up Period||0
10144580|NCT02757352|11275117|FG003|COMPLETED|Follow-Up Period||0
10144581|NCT02757352|11275118|FG004|COMPLETED|Follow-Up Period||0
10144582|NCT02757352|11275119|FG005|COMPLETED|Follow-Up Period||0
10144583|NCT02757352|11275120|FG006|COMPLETED|Follow-Up Period||2
10144584|NCT02757352|11275121|FG007|COMPLETED|Follow-Up Period||4
10144585|NCT02757352|11275122|FG008|COMPLETED|Follow-Up Period||18
10144586|NCT02757352|11275123|FG009|COMPLETED|Follow-Up Period||2
10144587|NCT02757352|11275114|FG000|NOT COMPLETED|Follow-Up Period||0
10144588|NCT02757352|11275115|FG001|NOT COMPLETED|Follow-Up Period||0
10144589|NCT02757352|11275116|FG002|NOT COMPLETED|Follow-Up Period||0
10144590|NCT02757352|11275117|FG003|NOT COMPLETED|Follow-Up Period||0
10144591|NCT02757352|11275118|FG004|NOT COMPLETED|Follow-Up Period||0
10144592|NCT02757352|11275119|FG005|NOT COMPLETED|Follow-Up Period||0
10144593|NCT02757352|11275120|FG006|NOT COMPLETED|Follow-Up Period||1
10144594|NCT02757352|11275121|FG007|NOT COMPLETED|Follow-Up Period||1
10144595|NCT02757352|11275122|FG008|NOT COMPLETED|Follow-Up Period||10
10144596|NCT02757352|11275123|FG009|NOT COMPLETED|Follow-Up Period||3
10144597|NCT02757430|11275154|FG000|STARTED|Overall Study||515
10144598|NCT02757430|11275154|FG000|Baseline Visits|Overall Study||503
10144599|NCT02757430|11275154|FG000|EP Mapping/Ablation Procedure|Overall Study||503
10144600|NCT02757430|11275154|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
10144601|NCT02757430|11275154|FG000|NOT COMPLETED|Overall Study||12
10144602|NCT02757625|11275171|FG000|STARTED|Overall Study||14
10144603|NCT02757625|11275172|FG001|STARTED|Overall Study||18
10144604|NCT02757625|11275173|FG002|STARTED|Overall Study||19
10144605|NCT02757625|11275174|FG003|STARTED|Overall Study||12
10144606|NCT02757625|11275171|FG000|COMPLETED|Overall Study||14
10144607|NCT02757625|11275172|FG001|COMPLETED|Overall Study||18
10144608|NCT02757625|11275173|FG002|COMPLETED|Overall Study||17
10144609|NCT02757625|11275174|FG003|COMPLETED|Overall Study||12
10144610|NCT02757625|11275171|FG000|NOT COMPLETED|Overall Study||0
10144611|NCT02757625|11275172|FG001|NOT COMPLETED|Overall Study||0
10144612|NCT02757625|11275173|FG002|NOT COMPLETED|Overall Study||2
10144613|NCT02757625|11275174|FG003|NOT COMPLETED|Overall Study||0
10144614|NCT02757768|11275188|FG000|STARTED|Overall Study||356
10144615|NCT02757768|11275189|FG001|STARTED|Overall Study||359
10144616|NCT02757768|11275188|FG000|Treated|Overall Study||352
10144617|NCT02757768|11275189|FG001|Treated|Overall Study||354
10144618|NCT02757768|11275188|FG000|COMPLETED|Overall Study||323
10144619|NCT02757768|11275189|FG001|COMPLETED|Overall Study||331
10144620|NCT02757768|11275188|FG000|NOT COMPLETED|Overall Study||33
10144621|NCT02757768|11275189|FG001|NOT COMPLETED|Overall Study||28
10144622|NCT02757950|11275199|FG000|STARTED|Overall Study||1203
10144623|NCT02757950|11275200|FG001|STARTED|Overall Study||1259
10144624|NCT02757950|11275199|FG000|COMPLETED|Overall Study||1199
10144625|NCT02757950|11275200|FG001|COMPLETED|Overall Study||1248
10144626|NCT02757950|11275199|FG000|NOT COMPLETED|Overall Study||4
10144627|NCT02757950|11275200|FG001|NOT COMPLETED|Overall Study||11
10144628|NCT02757963|11275207|FG000|STARTED|Overall Study||1658
10144629|NCT02757963|11275207|FG000|COMPLETED|Overall Study||561
10144630|NCT02757963|11275207|FG000|NOT COMPLETED|Overall Study||1097
10144631|NCT02758119|11275224|FG000|STARTED|Overall Study||41
10144632|NCT02758119|11275225|FG001|STARTED|Overall Study||41
10144633|NCT02758119|11275224|FG000|COMPLETED|Overall Study||39
10144634|NCT02758119|11275225|FG001|COMPLETED|Overall Study||40
10144635|NCT02758119|11275224|FG000|NOT COMPLETED|Overall Study||2
10144636|NCT02758119|11275225|FG001|NOT COMPLETED|Overall Study||1
10144637|NCT02758171|11275235|FG000|STARTED|Treatment Period 1||28
10144638|NCT02758171|11275236|FG001|STARTED|Treatment Period 1||28
10144639|NCT02758171|11275235|FG000|COMPLETED|Treatment Period 1||28
10144640|NCT02758171|11275236|FG001|COMPLETED|Treatment Period 1||28
10144641|NCT02758171|11275235|FG000|NOT COMPLETED|Treatment Period 1||0
10144642|NCT02758171|11275236|FG001|NOT COMPLETED|Treatment Period 1||0
10144643|NCT02758171|11275235|FG000|STARTED|Wash-out||28
10144644|NCT02758171|11275236|FG001|STARTED|Wash-out||28
10144645|NCT02758171|11275235|FG000|COMPLETED|Wash-out||26
10144646|NCT02758171|11275236|FG001|COMPLETED|Wash-out||28
10144647|NCT02758171|11275235|FG000|NOT COMPLETED|Wash-out||2
10144648|NCT02758171|11275236|FG001|NOT COMPLETED|Wash-out||0
10144649|NCT02758171|11275235|FG000|STARTED|Treatment Period 2||26
10144650|NCT02758171|11275236|FG001|STARTED|Treatment Period 2||28
10144651|NCT02758171|11275235|FG000|COMPLETED|Treatment Period 2||26
10144652|NCT02758171|11275236|FG001|COMPLETED|Treatment Period 2||28
10144653|NCT02758171|11275235|FG000|NOT COMPLETED|Treatment Period 2||0
10144654|NCT02758171|11275236|FG001|NOT COMPLETED|Treatment Period 2||0
10144655|NCT02758210|11275242|FG000|STARTED|Overall Study||20
10144656|NCT02758210|11275242|FG000|COMPLETED|Overall Study||20
10144657|NCT02758210|11275242|FG000|NOT COMPLETED|Overall Study||0
10144658|NCT02758301|11275248|FG000|STARTED|Overall Study||104
10144659|NCT02758301|11275249|FG001|STARTED|Overall Study||8
10144660|NCT02758301|11275248|FG000|COMPLETED|Overall Study||70
10144661|NCT02758301|11275249|FG001|COMPLETED|Overall Study||0
10144662|NCT02758301|11275248|FG000|NOT COMPLETED|Overall Study||34
10144663|NCT02758301|11275249|FG001|NOT COMPLETED|Overall Study||8
10144664|NCT02758613|11275259|FG000|STARTED|Treatment||8
10144665|NCT02758613|11275260|FG001|STARTED|Treatment||8
10144666|NCT02758613|11275261|FG002|STARTED|Treatment||9
10144667|NCT02758613|11275262|FG003|STARTED|Treatment||8
10144668|NCT02758613|11275259|FG000|Received at Least One Dose of Study Drug|Treatment||8
10144669|NCT02758613|11275260|FG001|Received at Least One Dose of Study Drug|Treatment||8
10144670|NCT02758613|11275261|FG002|Received at Least One Dose of Study Drug|Treatment||9
10144671|NCT02758613|11275262|FG003|Received at Least One Dose of Study Drug|Treatment||8
10144672|NCT02758613|11275259|FG000|COMPLETED|Treatment||6
10144673|NCT02758613|11275260|FG001|COMPLETED|Treatment||8
10144674|NCT02758613|11275261|FG002|COMPLETED|Treatment||8
10144675|NCT02758613|11275262|FG003|COMPLETED|Treatment||8
10144676|NCT02758613|11275259|FG000|NOT COMPLETED|Treatment||2
10144677|NCT02758613|11275260|FG001|NOT COMPLETED|Treatment||0
10144678|NCT02758613|11275261|FG002|NOT COMPLETED|Treatment||1
10144679|NCT02758613|11275262|FG003|NOT COMPLETED|Treatment||0
10144680|NCT02758613|11275259|FG000|STARTED|Follow-up||6
10144681|NCT02758613|11275260|FG001|STARTED|Follow-up||8
10144682|NCT02758613|11275261|FG002|STARTED|Follow-up||8
10144683|NCT02758613|11275262|FG003|STARTED|Follow-up||8
10144684|NCT02758613|11275259|FG000|COMPLETED|Follow-up||6
10144685|NCT02758613|11275260|FG001|COMPLETED|Follow-up||8
10144686|NCT02758613|11275261|FG002|COMPLETED|Follow-up||8
10144687|NCT02758613|11275262|FG003|COMPLETED|Follow-up||8
10144688|NCT02758613|11275259|FG000|NOT COMPLETED|Follow-up||0
10144689|NCT02758613|11275260|FG001|NOT COMPLETED|Follow-up||0
10144690|NCT02758613|11275261|FG002|NOT COMPLETED|Follow-up||0
10144691|NCT02758613|11275262|FG003|NOT COMPLETED|Follow-up||0
10144692|NCT02758899|11275277|FG000|STARTED|Overall Study||11
10144693|NCT02758899|11275278|FG001|STARTED|Overall Study||10
10144694|NCT02758899|11275277|FG000|COMPLETED|Overall Study||9
10144695|NCT02758899|11275278|FG001|COMPLETED|Overall Study||9
10144696|NCT02758899|11275277|FG000|NOT COMPLETED|Overall Study||2
10144697|NCT02758899|11275278|FG001|NOT COMPLETED|Overall Study||1
10144698|NCT02759016|11275286|FG000|STARTED|Overall Study||4
10144699|NCT02759016|11275287|FG001|STARTED|Overall Study||3
10144700|NCT02759016|11275286|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3
10144701|NCT02759016|11275287|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3
10144702|NCT02759016|11275286|FG000|COMPLETED|Overall Study||0
10144703|NCT02759016|11275287|FG001|COMPLETED|Overall Study||0
10144704|NCT02759016|11275286|FG000|NOT COMPLETED|Overall Study||4
10144705|NCT02759016|11275287|FG001|NOT COMPLETED|Overall Study||3
10144706|NCT02759055|11275296|FG000|STARTED|Overall Study||12702
10144707|NCT02759055|11275297|FG001|STARTED|Overall Study||8962
10144708|NCT02759055|11275296|FG000|COMPLETED|Overall Study||10775
10144709|NCT02759055|11275297|FG001|COMPLETED|Overall Study||7454
10144710|NCT02759055|11275296|FG000|NOT COMPLETED|Overall Study||1927
10144711|NCT02759055|11275297|FG001|NOT COMPLETED|Overall Study||1508
10144712|NCT02759120|11275305|FG000|STARTED|Overall Study||254
10144713|NCT02759120|11275306|FG001|STARTED|Overall Study||259
10144714|NCT02759120|11275305|FG000|COMPLETED|Overall Study||169
10144715|NCT02759120|11275306|FG001|COMPLETED|Overall Study||180
10144716|NCT02759120|11275305|FG000|NOT COMPLETED|Overall Study||85
10144717|NCT02759120|11275306|FG001|NOT COMPLETED|Overall Study||79
10144718|NCT02759146|11275318|FG000|STARTED|Week 1-4||57
10144719|NCT02759146|11275319|FG001|STARTED|Week 1-4||36
10144720|NCT02759146|11275320|FG002|STARTED|Week 1-4||33
10144721|NCT02759146|11275321|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
10144722|NCT02759146|11275322|FG004|STARTED|Week 1-4||49
10144723|NCT02759146|11275323|FG005|STARTED|Week 1-4||30
10144724|NCT02759146|11275324|FG006|STARTED|Week 1-4||27
10144725|NCT02759146|11275318|FG000|COMPLETED|Week 1-4||56
10144726|NCT02759146|11275319|FG001|COMPLETED|Week 1-4||34
10144727|NCT02759146|11275320|FG002|COMPLETED|Week 1-4||32
10144728|NCT02759146|11275321|FG003|COMPLETED|Week 1-4||44
10144729|NCT02759146|11275322|FG004|COMPLETED|Week 1-4||49
10144730|NCT02759146|11275323|FG005|COMPLETED|Week 1-4||29
10144731|NCT02759146|11275324|FG006|COMPLETED|Week 1-4||26
10144732|NCT02759146|11275318|FG000|NOT COMPLETED|Week 1-4||1
10144733|NCT02759146|11275319|FG001|NOT COMPLETED|Week 1-4||2
10144734|NCT02759146|11275320|FG002|NOT COMPLETED|Week 1-4||1
10144735|NCT02759146|11275321|FG003|NOT COMPLETED|Week 1-4||0
10144736|NCT02759146|11275322|FG004|NOT COMPLETED|Week 1-4||0
10144737|NCT02759146|11275323|FG005|NOT COMPLETED|Week 1-4||1
10144738|NCT02759146|11275324|FG006|NOT COMPLETED|Week 1-4||1
10144739|NCT02759146|11275318|FG000|STARTED|Week 5-8||56
10144740|NCT02759146|11275319|FG001|STARTED|Week 5-8||34
10144741|NCT02759146|11275320|FG002|STARTED|Week 5-8||32
10144742|NCT02759146|11275321|FG003|STARTED|Week 5-8||44
10144743|NCT02759146|11275322|FG004|STARTED|Week 5-8||49
10144744|NCT02759146|11275323|FG005|STARTED|Week 5-8||29
10144745|NCT02759146|11275324|FG006|STARTED|Week 5-8||26
10144746|NCT02759146|11275318|FG000|COMPLETED|Week 5-8||46
10144747|NCT02759146|11275319|FG001|COMPLETED|Week 5-8||29
10144748|NCT02759146|11275320|FG002|COMPLETED|Week 5-8||22
10144749|NCT02759146|11275321|FG003|COMPLETED|Week 5-8||37
10144750|NCT02759146|11275322|FG004|COMPLETED|Week 5-8||44
10144751|NCT02759146|11275323|FG005|COMPLETED|Week 5-8||23
10144752|NCT02759146|11275324|FG006|COMPLETED|Week 5-8||20
10144753|NCT02759146|11275318|FG000|NOT COMPLETED|Week 5-8||10
10144754|NCT02759146|11275319|FG001|NOT COMPLETED|Week 5-8||5
10144755|NCT02759146|11275320|FG002|NOT COMPLETED|Week 5-8||10
10144756|NCT02759146|11275321|FG003|NOT COMPLETED|Week 5-8||7
10144757|NCT02759146|11275322|FG004|NOT COMPLETED|Week 5-8||5
10144758|NCT02759146|11275323|FG005|NOT COMPLETED|Week 5-8||6
10144759|NCT02759146|11275324|FG006|NOT COMPLETED|Week 5-8||6
10144760|NCT02759315|11275345|FG000|STARTED|Overall Study||69
10144761|NCT02759315|11275346|FG001|STARTED|Overall Study||29
10144762|NCT02759315|11275347|FG002|STARTED|Overall Study||39
10144763|NCT02759315|11275348|FG003|STARTED|Overall Study||20
10144764|NCT02759315|11275349|FG004|STARTED|Overall Study||3
10144765|NCT02759315|11275345|FG000|COMPLETED|Overall Study||65
10144766|NCT02759315|11275346|FG001|COMPLETED|Overall Study||28
10144767|NCT02759315|11275347|FG002|COMPLETED|Overall Study||29
10144768|NCT02759315|11275348|FG003|COMPLETED|Overall Study||19
10144769|NCT02759315|11275349|FG004|COMPLETED|Overall Study||2
10144770|NCT02759315|11275345|FG000|NOT COMPLETED|Overall Study||4
10144771|NCT02759315|11275346|FG001|NOT COMPLETED|Overall Study||1
10144772|NCT02759315|11275347|FG002|NOT COMPLETED|Overall Study||10
10144773|NCT02759315|11275348|FG003|NOT COMPLETED|Overall Study||1
10144774|NCT02759315|11275349|FG004|NOT COMPLETED|Overall Study||1
10144775|NCT02759354|11275367|FG000|STARTED|Overall Study||192
10144776|NCT02759354|11275368|FG001|STARTED|Overall Study||190
10144777|NCT02759354|11275369|FG002|STARTED|Overall Study||181
10144778|NCT02759354|11275370|FG003|STARTED|Overall Study||191
10144779|NCT02759354|11275367|FG000|COMPLETED|Overall Study||192
10144780|NCT02759354|11275368|FG001|COMPLETED|Overall Study||190
10144781|NCT02759354|11275369|FG002|COMPLETED|Overall Study||181
10144782|NCT02759354|11275370|FG003|COMPLETED|Overall Study||191
10144783|NCT02759354|11275367|FG000|NOT COMPLETED|Overall Study||0
10144784|NCT02759354|11275368|FG001|NOT COMPLETED|Overall Study||0
10144785|NCT02759354|11275369|FG002|NOT COMPLETED|Overall Study||0
10144786|NCT02759354|11275370|FG003|NOT COMPLETED|Overall Study||0
10144787|NCT02759471|11275382|FG000|STARTED|Overall Study||54
10144788|NCT02759471|11275382|FG000|COMPLETED|Overall Study||52
10144789|NCT02759471|11275382|FG000|NOT COMPLETED|Overall Study||2
10144790|NCT02759562|11275390|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3
10144791|NCT02759562|11275391|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3
10144792|NCT02759562|11275390|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
10144793|NCT02759562|11275391|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
10144794|NCT02759562|11275390|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
10144795|NCT02759562|11275391|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
10144796|NCT02759562|11275390|FG000|STARTED|Open-Label Treatment Period||2
10144797|NCT02759562|11275391|FG001|STARTED|Open-Label Treatment Period||2
10144798|NCT02759562|11275390|FG000|COMPLETED|Open-Label Treatment Period||0
10144799|NCT02759562|11275391|FG001|COMPLETED|Open-Label Treatment Period||0
10144800|NCT02759562|11275390|FG000|NOT COMPLETED|Open-Label Treatment Period||2
10144801|NCT02759562|11275391|FG001|NOT COMPLETED|Open-Label Treatment Period||2
10144802|NCT02759575|11275398|FG000|STARTED|Overall Study||9
10144803|NCT02759575|11275398|FG000|COMPLETED|Overall Study||9
10144804|NCT02759575|11275398|FG000|NOT COMPLETED|Overall Study||0
10144805|NCT02759692|11275402|FG000|STARTED|Period 1||141
10144806|NCT02759692|11275403|FG001|STARTED|Period 1||142
10144807|NCT02759692|11275402|FG000|COMPLETED|Period 1||138
10144808|NCT02759692|11275403|FG001|COMPLETED|Period 1||140
10144809|NCT02759692|11275402|FG000|NOT COMPLETED|Period 1||3
10144810|NCT02759692|11275403|FG001|NOT COMPLETED|Period 1||2
10144811|NCT02759692|11275402|FG000|STARTED|Period 2||138
10144812|NCT02759692|11275403|FG001|STARTED|Period 2||140
10144813|NCT02759692|11275402|FG000|COMPLETED|Period 2||137
10144814|NCT02759692|11275403|FG001|COMPLETED|Period 2||139
10144815|NCT02759692|11275402|FG000|NOT COMPLETED|Period 2||1
10144816|NCT02759692|11275403|FG001|NOT COMPLETED|Period 2||1
10144817|NCT02759692|11275402|FG000|STARTED|Period 3||137
10144818|NCT02759692|11275403|FG001|STARTED|Period 3||139
10144819|NCT02759692|11275402|FG000|COMPLETED|Period 3||137
10144820|NCT02759692|11275403|FG001|COMPLETED|Period 3||139
10144821|NCT02759692|11275402|FG000|NOT COMPLETED|Period 3||0
10144822|NCT02759692|11275403|FG001|NOT COMPLETED|Period 3||0
10144823|NCT02759939|11275413|FG000|STARTED|Overall Study||1256
10144824|NCT02759939|11275414|FG001|STARTED|Overall Study||1143
10144825|NCT02759939|11275415|FG002|STARTED|Overall Study||1393
10144826|NCT02759939|11275416|FG003|STARTED|Overall Study||1246
10144827|NCT02759939|11275413|FG000|Analyzed at T1|Overall Study||1245
10144828|NCT02759939|11275414|FG001|Analyzed at T1|Overall Study||1141
10144829|NCT02759939|11275415|FG002|Analyzed at T1|Overall Study||1388
10144830|NCT02759939|11275416|FG003|Analyzed at T1|Overall Study||1244
10144831|NCT02759939|11275413|FG000|Eligible for T2 and T3|Overall Study||935
10144832|NCT02759939|11275414|FG001|Eligible for T2 and T3|Overall Study||962
10144833|NCT02759939|11275415|FG002|Eligible for T2 and T3|Overall Study||1022
10144834|NCT02759939|11275416|FG003|Eligible for T2 and T3|Overall Study||853
10144835|NCT02759939|11275413|FG000|Analyzed at T2 and/or T3|Overall Study||303
10144836|NCT02759939|11275414|FG001|Analyzed at T2 and/or T3|Overall Study||278
10144837|NCT02759939|11275415|FG002|Analyzed at T2 and/or T3|Overall Study||373
10144838|NCT02759939|11275416|FG003|Analyzed at T2 and/or T3|Overall Study||304
10144839|NCT02759939|11275413|FG000|Consented to T2 and T3|Overall Study||579
10144840|NCT02759939|11275414|FG001|Consented to T2 and T3|Overall Study||626
10144841|NCT02759939|11275415|FG002|Consented to T2 and T3|Overall Study||702
10144842|NCT02759939|11275416|FG003|Consented to T2 and T3|Overall Study||564
10144843|NCT02759939|11275413|FG000|COMPLETED|Overall Study||200
10144844|NCT02759939|11275414|FG001|COMPLETED|Overall Study||171
10144845|NCT02759939|11275415|FG002|COMPLETED|Overall Study||239
10144846|NCT02759939|11275416|FG003|COMPLETED|Overall Study||203
10144847|NCT02759939|11275413|FG000|NOT COMPLETED|Overall Study||1056
9708356|NCT01484691|10807562|FG002|NOT COMPLETED|Overall Study||2
9708357|NCT01125371|10807574|FG000|STARTED|Overall Study||146
9708358|NCT01125371|10807575|FG001|STARTED|Overall Study||145
9708359|NCT01125371|10807576|FG002|STARTED|Overall Study||148
9708360|NCT01125371|10807574|FG000|3 Months Follow up|Overall Study||127
9708361|NCT01125371|10807575|FG001|3 Months Follow up|Overall Study||131
9708362|NCT01125371|10807576|FG002|3 Months Follow up|Overall Study||135
9708363|NCT01125371|10807574|FG000|6 Months Follow up|Overall Study||125
9708364|NCT01125371|10807575|FG001|6 Months Follow up|Overall Study||133
9708365|NCT01125371|10807576|FG002|6 Months Follow up|Overall Study||131
9708366|NCT01125371|10807574|FG000|12 Months Follow up|Overall Study||120
9708367|NCT01125371|10807575|FG001|12 Months Follow up|Overall Study||130
9708368|NCT01125371|10807576|FG002|12 Months Follow up|Overall Study||129
9708369|NCT01125371|10807574|FG000|COMPLETED|Overall Study||120
9708370|NCT01125371|10807575|FG001|COMPLETED|Overall Study||130
9708371|NCT01125371|10807576|FG002|COMPLETED|Overall Study||129
9708372|NCT01125371|10807574|FG000|NOT COMPLETED|Overall Study||26
9708373|NCT01125371|10807575|FG001|NOT COMPLETED|Overall Study||15
9708374|NCT01125371|10807576|FG002|NOT COMPLETED|Overall Study||19
9708375|NCT00400946|10807589|FG000|STARTED|Overall Study||231
9708376|NCT00400946|10807590|FG001|STARTED|Overall Study||232
9708377|NCT00400946|10807591|FG002|STARTED|Overall Study||42
9708378|NCT00400946|10807592|FG003|STARTED|Overall Study||51
9708379|NCT00400946|10807593|FG004|STARTED|Overall Study||244
9708380|NCT00400946|10807589|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231
9708381|NCT00400946|10807590|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232
9708382|NCT00400946|10807591|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42
9708383|NCT00400946|10807592|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21
10144848|NCT02759939|11275414|FG001|NOT COMPLETED|Overall Study||972
10144849|NCT02759939|11275415|FG002|NOT COMPLETED|Overall Study||1154
10144850|NCT02759939|11275416|FG003|NOT COMPLETED|Overall Study||1043
10144851|NCT02760056|11275428|FG000|STARTED|Overall Study||10
10144852|NCT02760056|11275429|FG001|STARTED|Overall Study||5
10144853|NCT02760056|11275428|FG000|COMPLETED|Overall Study||10
10144854|NCT02760056|11275429|FG001|COMPLETED|Overall Study||5
10144855|NCT02760056|11275428|FG000|NOT COMPLETED|Overall Study||0
10144856|NCT02760056|11275429|FG001|NOT COMPLETED|Overall Study||0
10144857|NCT02760069|11275439|FG000|STARTED|Overall Study||40
10144858|NCT02760069|11275440|FG001|STARTED|Overall Study||41
10144859|NCT02760069|11275441|FG002|STARTED|Overall Study||41
10144860|NCT02760069|11275439|FG000|COMPLETED|Overall Study||40
10144861|NCT02760069|11275440|FG001|COMPLETED|Overall Study||40
10144862|NCT02760069|11275441|FG002|COMPLETED|Overall Study||40
10144863|NCT02760069|11275439|FG000|NOT COMPLETED|Overall Study||0
10144864|NCT02760069|11275440|FG001|NOT COMPLETED|Overall Study||1
10144865|NCT02760069|11275441|FG002|NOT COMPLETED|Overall Study||1
10144866|NCT02760264|11275453|FG000|STARTED|0.25 mg/kg/Day||12
10144867|NCT02760264|11275454|FG001|STARTED|0.25 mg/kg/Day||0
10144868|NCT02760264|11275455|FG002|STARTED|0.25 mg/kg/Day||0
10144869|NCT02760264|11275456|FG003|STARTED|0.25 mg/kg/Day||0
10144870|NCT02760264|11275453|FG000|COMPLETED|0.25 mg/kg/Day||12
10144871|NCT02760264|11275454|FG001|COMPLETED|0.25 mg/kg/Day||0
10144872|NCT02760264|11275455|FG002|COMPLETED|0.25 mg/kg/Day||0
10144873|NCT02760264|11275456|FG003|COMPLETED|0.25 mg/kg/Day||0
10144874|NCT02760264|11275453|FG000|NOT COMPLETED|0.25 mg/kg/Day||0
9708384|NCT00400946|10807593|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227
9708385|NCT00400946|10807589|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158
9708386|NCT00400946|10807590|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161
9708387|NCT00400946|10807591|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19
9708388|NCT00400946|10807592|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13
9708389|NCT00400946|10807593|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152
9708390|NCT00400946|10807589|FG000|Evaluable for Day 32 MRD|Overall Study||166
9708391|NCT00400946|10807590|FG001|Evaluable for Day 32 MRD|Overall Study||167
9708392|NCT00400946|10807591|FG002|Evaluable for Day 32 MRD|Overall Study||33
9708393|NCT00400946|10807592|FG003|Evaluable for Day 32 MRD|Overall Study||12
9708394|NCT00400946|10807593|FG004|Evaluable for Day 32 MRD|Overall Study||168
10144875|NCT02760264|11275454|FG001|NOT COMPLETED|0.25 mg/kg/Day||0
10144876|NCT02760264|11275455|FG002|NOT COMPLETED|0.25 mg/kg/Day||0
10144877|NCT02760264|11275456|FG003|NOT COMPLETED|0.25 mg/kg/Day||0
10144878|NCT02760264|11275453|FG000|STARTED|0.75 mg/kg/Day||0
10144879|NCT02760264|11275454|FG001|STARTED|0.75 mg/kg/Day||12
10144880|NCT02760264|11275455|FG002|STARTED|0.75 mg/kg/Day||0
10144881|NCT02760264|11275456|FG003|STARTED|0.75 mg/kg/Day||0
10144882|NCT02760264|11275453|FG000|COMPLETED|0.75 mg/kg/Day||0
10144883|NCT02760264|11275454|FG001|COMPLETED|0.75 mg/kg/Day||12
10144884|NCT02760264|11275455|FG002|COMPLETED|0.75 mg/kg/Day||0
10144885|NCT02760264|11275456|FG003|COMPLETED|0.75 mg/kg/Day||0
10144886|NCT02760264|11275453|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
10144887|NCT02760264|11275454|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
10144888|NCT02760264|11275455|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
10144889|NCT02760264|11275456|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
10144890|NCT02760264|11275453|FG000|STARTED|2.0 mg/kg/Day||0
10144891|NCT02760264|11275454|FG001|STARTED|2.0 mg/kg/Day||0
10144892|NCT02760264|11275455|FG002|STARTED|2.0 mg/kg/Day||12
10144893|NCT02760264|11275456|FG003|STARTED|2.0 mg/kg/Day||0
10144894|NCT02760264|11275453|FG000|COMPLETED|2.0 mg/kg/Day||0
10144895|NCT02760264|11275454|FG001|COMPLETED|2.0 mg/kg/Day||0
10144896|NCT02760264|11275455|FG002|COMPLETED|2.0 mg/kg/Day||12
10144897|NCT02760264|11275456|FG003|COMPLETED|2.0 mg/kg/Day||0
10144898|NCT02760264|11275453|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
10144899|NCT02760264|11275454|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
10144900|NCT02760264|11275455|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
10144901|NCT02760264|11275456|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
10144902|NCT02760264|11275453|FG000|STARTED|6.0 mg/kg/Day||0
10144903|NCT02760264|11275454|FG001|STARTED|6.0 mg/kg/Day||0
10144904|NCT02760264|11275455|FG002|STARTED|6.0 mg/kg/Day||0
10144905|NCT02760264|11275456|FG003|STARTED|6.0 mg/kg/Day||12
10144906|NCT02760264|11275453|FG000|COMPLETED|6.0 mg/kg/Day||0
10144907|NCT02760264|11275454|FG001|COMPLETED|6.0 mg/kg/Day||0
10144908|NCT02760264|11275455|FG002|COMPLETED|6.0 mg/kg/Day||0
10144909|NCT02760264|11275456|FG003|COMPLETED|6.0 mg/kg/Day||12
10144910|NCT02760264|11275453|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
10144911|NCT02760264|11275454|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
10144912|NCT02760264|11275455|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
10144913|NCT02760264|11275456|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
10144914|NCT02760277|11275471|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12
10144915|NCT02760277|11275472|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0
10144916|NCT02760277|11275473|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0
10144917|NCT02760277|11275474|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0
10144918|NCT02760277|11275471|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
10144919|NCT02760277|11275472|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
9708395|NCT00400946|10807589|FG000|Eligible and Treated|Overall Study||231
10144920|NCT02760277|11275473|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10144921|NCT02760277|11275474|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10144922|NCT02760277|11275471|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10144923|NCT02760277|11275472|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10144924|NCT02760277|11275473|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
9708396|NCT00400946|10807590|FG001|Eligible and Treated|Overall Study||232
10144925|NCT02760277|11275474|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10144926|NCT02760277|11275471|FG000|STARTED|0.75 mg/kg/Day||0
10144927|NCT02760277|11275472|FG001|STARTED|0.75 mg/kg/Day||12
10144928|NCT02760277|11275473|FG002|STARTED|0.75 mg/kg/Day||0
10144929|NCT02760277|11275474|FG003|STARTED|0.75 mg/kg/Day||0
10144930|NCT02760277|11275471|FG000|COMPLETED|0.75 mg/kg/Day||0
10144931|NCT02760277|11275472|FG001|COMPLETED|0.75 mg/kg/Day||12
10144932|NCT02760277|11275473|FG002|COMPLETED|0.75 mg/kg/Day||0
10144933|NCT02760277|11275474|FG003|COMPLETED|0.75 mg/kg/Day||0
10144934|NCT02760277|11275471|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
10144935|NCT02760277|11275472|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
10144936|NCT02760277|11275473|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
10144937|NCT02760277|11275474|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
10144938|NCT02760277|11275471|FG000|STARTED|2.0 mg/kg/Day||0
10144939|NCT02760277|11275472|FG001|STARTED|2.0 mg/kg/Day||0
10144940|NCT02760277|11275473|FG002|STARTED|2.0 mg/kg/Day||12
10144941|NCT02760277|11275474|FG003|STARTED|2.0 mg/kg/Day||0
10144942|NCT02760277|11275471|FG000|COMPLETED|2.0 mg/kg/Day||0
10144943|NCT02760277|11275472|FG001|COMPLETED|2.0 mg/kg/Day||0
10144944|NCT02760277|11275473|FG002|COMPLETED|2.0 mg/kg/Day||12
10144945|NCT02760277|11275474|FG003|COMPLETED|2.0 mg/kg/Day||0
10144946|NCT02760277|11275471|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
10144947|NCT02760277|11275472|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
10144948|NCT02760277|11275473|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
10144949|NCT02760277|11275474|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
10144950|NCT02760277|11275471|FG000|STARTED|6.0 mg/kg/Day||0
10144951|NCT02760277|11275472|FG001|STARTED|6.0 mg/kg/Day||0
10144952|NCT02760277|11275473|FG002|STARTED|6.0 mg/kg/Day||0
10144953|NCT02760277|11275474|FG003|STARTED|6.0 mg/kg/Day||12
10144954|NCT02760277|11275471|FG000|COMPLETED|6.0 mg/kg/Day||0
10144955|NCT02760277|11275472|FG001|COMPLETED|6.0 mg/kg/Day||0
10144956|NCT02760277|11275473|FG002|COMPLETED|6.0 mg/kg/Day||0
10144957|NCT02760277|11275474|FG003|COMPLETED|6.0 mg/kg/Day||12
10144958|NCT02760277|11275471|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
10144959|NCT02760277|11275472|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
10144960|NCT02760277|11275473|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
10144961|NCT02760277|11275474|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
10144962|NCT02760368|11275487|FG000|STARTED|Overall Study||143
10144963|NCT02760368|11275488|FG001|STARTED|Overall Study||142
10144964|NCT02760368|11275489|FG002|STARTED|Overall Study||143
10144965|NCT02760368|11275487|FG000|COMPLETED|Overall Study||130
10144966|NCT02760368|11275488|FG001|COMPLETED|Overall Study||134
10144967|NCT02760368|11275489|FG002|COMPLETED|Overall Study||132
10144968|NCT02760368|11275487|FG000|NOT COMPLETED|Overall Study||13
10144969|NCT02760368|11275488|FG001|NOT COMPLETED|Overall Study||8
10144970|NCT02760368|11275489|FG002|NOT COMPLETED|Overall Study||11
10144971|NCT02760407|11275501|FG000|STARTED|Overall Study||479
10144972|NCT02760407|11275502|FG001|STARTED|Overall Study||464
10144973|NCT02760407|11275503|FG002|STARTED|Overall Study||462
10144974|NCT02760407|11275504|FG003|STARTED|Overall Study||243
10144975|NCT02760407|11275501|FG000|COMPLETED|Overall Study||443
10144976|NCT02760407|11275502|FG001|COMPLETED|Overall Study||421
10144977|NCT02760407|11275503|FG002|COMPLETED|Overall Study||412
10144978|NCT02760407|11275504|FG003|COMPLETED|Overall Study||207
10144979|NCT02760407|11275501|FG000|NOT COMPLETED|Overall Study||36
10144980|NCT02760407|11275502|FG001|NOT COMPLETED|Overall Study||43
10144981|NCT02760407|11275503|FG002|NOT COMPLETED|Overall Study||50
10144982|NCT02760407|11275504|FG003|NOT COMPLETED|Overall Study||36
10144983|NCT02760433|11275520|FG000|STARTED|Overall Study||161
10144984|NCT02760433|11275521|FG001|STARTED|Overall Study||138
10144985|NCT02760433|11275522|FG002|STARTED|Overall Study||26
10144986|NCT02760433|11275523|FG003|STARTED|Overall Study||32
10144987|NCT02760433|11275524|FG004|STARTED|Overall Study||11
10144988|NCT02760433|11275520|FG000|COMPLETED|Overall Study||134
10144989|NCT02760433|11275521|FG001|COMPLETED|Overall Study||128
10144990|NCT02760433|11275522|FG002|COMPLETED|Overall Study||25
10144991|NCT02760433|11275523|FG003|COMPLETED|Overall Study||30
10144992|NCT02760433|11275524|FG004|COMPLETED|Overall Study||1
10144993|NCT02760433|11275520|FG000|NOT COMPLETED|Overall Study||27
10144994|NCT02760433|11275521|FG001|NOT COMPLETED|Overall Study||10
10144995|NCT02760433|11275522|FG002|NOT COMPLETED|Overall Study||1
10144996|NCT02760433|11275523|FG003|NOT COMPLETED|Overall Study||2
10144997|NCT02760433|11275524|FG004|NOT COMPLETED|Overall Study||10
10144998|NCT02760654|11275543|FG000|STARTED|Overall Study||30
10144999|NCT02760654|11275544|FG001|STARTED|Overall Study||30
10145000|NCT02760654|11275543|FG000|COMPLETED|Overall Study||23
10145001|NCT02760654|11275544|FG001|COMPLETED|Overall Study||24
10145002|NCT02760654|11275543|FG000|NOT COMPLETED|Overall Study||7
10145003|NCT02760654|11275544|FG001|NOT COMPLETED|Overall Study||6
10145004|NCT02760810|11275550|FG000|STARTED|Overall Study||30
10145005|NCT02760810|11275550|FG000|COMPLETED|Overall Study||29
10145006|NCT02760810|11275550|FG000|NOT COMPLETED|Overall Study||1
10145007|NCT02760862|11275556|FG000|STARTED|Overall Study||25
10145008|NCT02760862|11275557|FG001|STARTED|Overall Study||25
10145009|NCT02760862|11275556|FG000|COMPLETED|Overall Study||25
10145010|NCT02760862|11275557|FG001|COMPLETED|Overall Study||25
10145011|NCT02760862|11275556|FG000|NOT COMPLETED|Overall Study||0
10145012|NCT02760862|11275557|FG001|NOT COMPLETED|Overall Study||0
10145013|NCT02760927|11275563|FG000|STARTED|Overall Study||4
10145014|NCT02760927|11275563|FG000|COMPLETED|Overall Study||3
10145015|NCT02760927|11275563|FG000|NOT COMPLETED|Overall Study||1
10145016|NCT02761252|11275570|FG000|STARTED|Overall Study||143
10145017|NCT02761252|11275571|FG001|STARTED|Overall Study||140
10145018|NCT02761252|11275572|FG002|STARTED|Overall Study||137
10145019|NCT02761252|11275570|FG000|COMPLETED|Overall Study||133
10145020|NCT02761252|11275571|FG001|COMPLETED|Overall Study||132
10145021|NCT02761252|11275572|FG002|COMPLETED|Overall Study||123
10145022|NCT02761252|11275570|FG000|NOT COMPLETED|Overall Study||10
10145023|NCT02761252|11275571|FG001|NOT COMPLETED|Overall Study||8
10145024|NCT02761252|11275572|FG002|NOT COMPLETED|Overall Study||14
10145025|NCT02761330|11275582|FG000|STARTED|Treatment Week 1||2
10145026|NCT02761330|11275583|FG001|STARTED|Treatment Week 1||3
10145027|NCT02761330|11275584|FG002|STARTED|Treatment Week 1||2
10145028|NCT02761330|11275585|FG003|STARTED|Treatment Week 1||3
10145029|NCT02761330|11275586|FG004|STARTED|Treatment Week 1||1
10145030|NCT02761330|11275587|FG005|STARTED|Treatment Week 1||3
10145031|NCT02761330|11275582|FG000|COMPLETED|Treatment Week 1||2
10145032|NCT02761330|11275583|FG001|COMPLETED|Treatment Week 1||3
10145033|NCT02761330|11275584|FG002|COMPLETED|Treatment Week 1||2
10145034|NCT02761330|11275585|FG003|COMPLETED|Treatment Week 1||2
10145035|NCT02761330|11275586|FG004|COMPLETED|Treatment Week 1||1
10145036|NCT02761330|11275587|FG005|COMPLETED|Treatment Week 1||2
10145037|NCT02761330|11275582|FG000|NOT COMPLETED|Treatment Week 1||0
10145038|NCT02761330|11275583|FG001|NOT COMPLETED|Treatment Week 1||0
10145039|NCT02761330|11275584|FG002|NOT COMPLETED|Treatment Week 1||0
10145040|NCT02761330|11275585|FG003|NOT COMPLETED|Treatment Week 1||1
10145041|NCT02761330|11275586|FG004|NOT COMPLETED|Treatment Week 1||0
10145042|NCT02761330|11275587|FG005|NOT COMPLETED|Treatment Week 1||1
10145043|NCT02761330|11275582|FG000|STARTED|Treatment Week 2||2
10145044|NCT02761330|11275583|FG001|STARTED|Treatment Week 2||3
10145045|NCT02761330|11275584|FG002|STARTED|Treatment Week 2||2
10145046|NCT02761330|11275585|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
10145047|NCT02761330|11275586|FG004|STARTED|Treatment Week 2||1
10145048|NCT02761330|11275587|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
10145049|NCT02761330|11275582|FG000|COMPLETED|Treatment Week 2||2
10145050|NCT02761330|11275583|FG001|COMPLETED|Treatment Week 2||3
10145051|NCT02761330|11275584|FG002|COMPLETED|Treatment Week 2||2
10145052|NCT02761330|11275585|FG003|COMPLETED|Treatment Week 2||1
10145053|NCT02761330|11275586|FG004|COMPLETED|Treatment Week 2||1
10145054|NCT02761330|11275587|FG005|COMPLETED|Treatment Week 2||1
10145055|NCT02761330|11275582|FG000|NOT COMPLETED|Treatment Week 2||0
10145056|NCT02761330|11275583|FG001|NOT COMPLETED|Treatment Week 2||0
10145057|NCT02761330|11275584|FG002|NOT COMPLETED|Treatment Week 2||0
10145058|NCT02761330|11275585|FG003|NOT COMPLETED|Treatment Week 2||0
10145059|NCT02761330|11275586|FG004|NOT COMPLETED|Treatment Week 2||0
9708397|NCT00400946|10807591|FG002|Eligible and Treated|Overall Study||42
9708398|NCT00400946|10807592|FG003|Eligible and Treated|Overall Study||46
9708399|NCT00400946|10807593|FG004|Eligible and Treated|Overall Study||243
9708400|NCT00400946|10807589|FG000|COMPLETED|Overall Study||217
9708401|NCT00400946|10807590|FG001|COMPLETED|Overall Study||221
9708402|NCT00400946|10807591|FG002|COMPLETED|Overall Study||40
9708403|NCT00400946|10807592|FG003|COMPLETED|Overall Study||4
9708404|NCT00400946|10807593|FG004|COMPLETED|Overall Study||206
9708405|NCT00400946|10807589|FG000|NOT COMPLETED|Overall Study||14
9708406|NCT00400946|10807590|FG001|NOT COMPLETED|Overall Study||11
9708407|NCT00400946|10807591|FG002|NOT COMPLETED|Overall Study||2
9708408|NCT00400946|10807592|FG003|NOT COMPLETED|Overall Study||47
9708409|NCT00400946|10807593|FG004|NOT COMPLETED|Overall Study||38
9708410|NCT00180414|10807613|FG000|STARTED|Overall Study||4
9708411|NCT00180414|10807614|FG001|STARTED|Overall Study||4
9708412|NCT00180414|10807613|FG000|COMPLETED|Overall Study||0
9708413|NCT00180414|10807614|FG001|COMPLETED|Overall Study||0
9708414|NCT00180414|10807613|FG000|NOT COMPLETED|Overall Study||4
9708415|NCT00180414|10807614|FG001|NOT COMPLETED|Overall Study||4
9729294|NCT00117598|10828855|FG000|NOT COMPLETED|After Treament Cross Over||0
9729295|NCT00117598|10828856|FG001|NOT COMPLETED|After Treament Cross Over||0
9729296|NCT00117598|10828857|FG002|NOT COMPLETED|After Treament Cross Over||0
9729297|NCT00117598|10828858|FG003|NOT COMPLETED|After Treament Cross Over||3
9729298|NCT00117598|10828859|FG004|NOT COMPLETED|After Treament Cross Over||4
9729299|NCT00117637|10828871|FG000|STARTED|First Intervention (Period 1)||97
9729300|NCT00117637|10828872|FG001|STARTED|First Intervention (Period 1)||92
9729301|NCT00117637|10828871|FG000|Subjects Received Treatment|First Intervention (Period 1)||97
9729302|NCT00117637|10828872|FG001|Subjects Received Treatment|First Intervention (Period 1)||90
9729303|NCT00117637|10828871|FG000|COMPLETED|First Intervention (Period 1)||79
10145060|NCT02761330|11275587|FG005|NOT COMPLETED|Treatment Week 2||0
10145061|NCT02761629|11275603|FG000|STARTED|Overall Study||90
10145062|NCT02761629|11275604|FG001|STARTED|Overall Study||90
10145063|NCT02761629|11275603|FG000|Treated|Overall Study||82
10145064|NCT02761629|11275604|FG001|Treated|Overall Study||86
10145065|NCT02761629|11275603|FG000|COMPLETED|Overall Study||63
10145066|NCT02761629|11275604|FG001|COMPLETED|Overall Study||58
10145067|NCT02761629|11275603|FG000|NOT COMPLETED|Overall Study||27
10145068|NCT02761629|11275604|FG001|NOT COMPLETED|Overall Study||32
10145069|NCT02761642|11275610|FG000|STARTED|Overall Study||200
10145070|NCT02761642|11275610|FG000|Treated|Overall Study||197
10145071|NCT02761642|11275610|FG000|COMPLETED|Overall Study||130
10145072|NCT02761642|11275610|FG000|NOT COMPLETED|Overall Study||70
9729304|NCT00117637|10828872|FG001|COMPLETED|First Intervention (Period 1)||67
9729305|NCT00117637|10828871|FG000|NOT COMPLETED|First Intervention (Period 1)||18
10145073|NCT02761733|11275618|FG000|STARTED|Overall Study||60
10145074|NCT02761733|11275619|FG001|STARTED|Overall Study||60
10145075|NCT02761733|11275620|FG002|STARTED|Overall Study||60
10145076|NCT02761733|11275621|FG003|STARTED|Overall Study||60
10145077|NCT02761733|11275618|FG000|9/30/2014|Overall Study||53
10145078|NCT02761733|11275619|FG001|9/30/2014|Overall Study||56
10145079|NCT02761733|11275620|FG002|9/30/2014|Overall Study||48
10145080|NCT02761733|11275621|FG003|9/30/2014|Overall Study||55
10145081|NCT02761733|11275618|FG000|3/31/2015|Overall Study||48
10145082|NCT02761733|11275619|FG001|3/31/2015|Overall Study||47
10145083|NCT02761733|11275620|FG002|3/31/2015|Overall Study||43
10145084|NCT02761733|11275621|FG003|3/31/2015|Overall Study||50
10145085|NCT02761733|11275618|FG000|9/30/2015|Overall Study||40
10145086|NCT02761733|11275619|FG001|9/30/2015|Overall Study||44
10145087|NCT02761733|11275620|FG002|9/30/2015|Overall Study||33
10145088|NCT02761733|11275621|FG003|9/30/2015|Overall Study||50
10145089|NCT02761733|11275618|FG000|COMPLETED|Overall Study||30
10145090|NCT02761733|11275619|FG001|COMPLETED|Overall Study||39
10145091|NCT02761733|11275620|FG002|COMPLETED|Overall Study||33
10145092|NCT02761733|11275621|FG003|COMPLETED|Overall Study||45
10145093|NCT02761733|11275618|FG000|NOT COMPLETED|Overall Study||30
10145094|NCT02761733|11275619|FG001|NOT COMPLETED|Overall Study||21
10145095|NCT02761733|11275620|FG002|NOT COMPLETED|Overall Study||27
10145096|NCT02761733|11275621|FG003|NOT COMPLETED|Overall Study||15
10145097|NCT02761915|11275637|FG000|STARTED|Overall Study||4
10145098|NCT02761915|11275638|FG001|STARTED|Overall Study||1
10145099|NCT02761915|11275639|FG002|STARTED|Overall Study||1
10145100|NCT02761915|11275640|FG003|STARTED|Overall Study||3
10145101|NCT02761915|11275641|FG004|STARTED|Overall Study||3
10145102|NCT02761915|11275642|FG005|STARTED|Overall Study||5
10145103|NCT02761915|11275637|FG000|Underwent Leukapheresis|Overall Study||4
10145104|NCT02761915|11275638|FG001|Underwent Leukapheresis|Overall Study||1
10145105|NCT02761915|11275639|FG002|Underwent Leukapheresis|Overall Study||1
10145106|NCT02761915|11275640|FG003|Underwent Leukapheresis|Overall Study||3
10145107|NCT02761915|11275641|FG004|Underwent Leukapheresis|Overall Study||3
10145108|NCT02761915|11275642|FG005|Underwent Leukapheresis|Overall Study||5
10145109|NCT02761915|11275637|FG000|Received Investigational Medicinal Product|Overall Study||4
10145110|NCT02761915|11275638|FG001|Received Investigational Medicinal Product|Overall Study||1
10145111|NCT02761915|11275639|FG002|Received Investigational Medicinal Product|Overall Study||1
10145112|NCT02761915|11275640|FG003|Received Investigational Medicinal Product|Overall Study||3
10145113|NCT02761915|11275641|FG004|Received Investigational Medicinal Product|Overall Study||3
10145114|NCT02761915|11275642|FG005|Received Investigational Medicinal Product|Overall Study||0
10145115|NCT02761915|11275637|FG000|COMPLETED|Overall Study||0
10145116|NCT02761915|11275638|FG001|COMPLETED|Overall Study||0
10145117|NCT02761915|11275639|FG002|COMPLETED|Overall Study||0
10145118|NCT02761915|11275640|FG003|COMPLETED|Overall Study||0
10145119|NCT02761915|11275641|FG004|COMPLETED|Overall Study||0
10145120|NCT02761915|11275642|FG005|COMPLETED|Overall Study||0
10145121|NCT02761915|11275637|FG000|NOT COMPLETED|Overall Study||4
10145122|NCT02761915|11275638|FG001|NOT COMPLETED|Overall Study||1
10145123|NCT02761915|11275639|FG002|NOT COMPLETED|Overall Study||1
10145124|NCT02761915|11275640|FG003|NOT COMPLETED|Overall Study||3
10145125|NCT02761915|11275641|FG004|NOT COMPLETED|Overall Study||3
10145126|NCT02761915|11275642|FG005|NOT COMPLETED|Overall Study||5
10145127|NCT02761967|11275662|FG000|STARTED|Overall Study||70
10145128|NCT02761967|11275663|FG001|STARTED|Overall Study||70
10145129|NCT02761967|11275662|FG000|COMPLETED|Overall Study||65
10145130|NCT02761967|11275663|FG001|COMPLETED|Overall Study||64
10145131|NCT02761967|11275662|FG000|NOT COMPLETED|Overall Study||5
10145132|NCT02761967|11275663|FG001|NOT COMPLETED|Overall Study||6
10145133|NCT02761980|11275676|FG000|STARTED|Overall Study||29
10145134|NCT02761980|11275677|FG001|STARTED|Overall Study||87
10145135|NCT02761980|11275678|FG002|STARTED|Overall Study||87
10145136|NCT02761980|11275679|FG003|STARTED|Overall Study||87
10145137|NCT02761980|11275676|FG000|COMPLETED|Overall Study||25
10145138|NCT02761980|11275677|FG001|COMPLETED|Overall Study||80
10145139|NCT02761980|11275678|FG002|COMPLETED|Overall Study||81
10145140|NCT02761980|11275679|FG003|COMPLETED|Overall Study||81
10145141|NCT02761980|11275676|FG000|NOT COMPLETED|Overall Study||4
10145142|NCT02761980|11275677|FG001|NOT COMPLETED|Overall Study||7
10145143|NCT02761980|11275678|FG002|NOT COMPLETED|Overall Study||6
10145144|NCT02761980|11275679|FG003|NOT COMPLETED|Overall Study||6
10145145|NCT02761993|11275692|FG000|STARTED|Overall Study||52
10145146|NCT02761993|11275693|FG001|STARTED|Overall Study||49
10145147|NCT02761993|11275694|FG002|STARTED|Overall Study||50
10145148|NCT02761993|11275692|FG000|COMPLETED|Overall Study||50
10145149|NCT02761993|11275693|FG001|COMPLETED|Overall Study||43
10145150|NCT02761993|11275694|FG002|COMPLETED|Overall Study||46
10145151|NCT02761993|11275692|FG000|NOT COMPLETED|Overall Study||2
10145152|NCT02761993|11275693|FG001|NOT COMPLETED|Overall Study||6
10145153|NCT02761993|11275694|FG002|NOT COMPLETED|Overall Study||4
10145154|NCT02762071|11275704|FG000|STARTED|Overall Study||54
10145155|NCT02762071|11275705|FG001|STARTED|Overall Study||54
10145156|NCT02762071|11275704|FG000|COMPLETED|Overall Study||54
10145157|NCT02762071|11275705|FG001|COMPLETED|Overall Study||54
10145158|NCT02762071|11275704|FG000|NOT COMPLETED|Overall Study||0
10145159|NCT02762071|11275705|FG001|NOT COMPLETED|Overall Study||0
10145160|NCT02762084|11275715|FG000|STARTED|Overall Study||6
10145161|NCT02762084|11275716|FG001|STARTED|Overall Study||6
10145162|NCT02762084|11275717|FG002|STARTED|Overall Study||5
10145163|NCT02762084|11275715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10145164|NCT02762084|11275716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10145165|NCT02762084|11275717|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
10145166|NCT02762084|11275715|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6
10145167|NCT02762084|11275716|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6
10145168|NCT02762084|11275717|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4
10145169|NCT02762084|11275715|FG000|COMPLETED|Overall Study||5
10145170|NCT02762084|11275716|FG001|COMPLETED|Overall Study||6
10145171|NCT02762084|11275717|FG002|COMPLETED|Overall Study||4
10145172|NCT02762084|11275715|FG000|NOT COMPLETED|Overall Study||1
10145173|NCT02762084|11275716|FG001|NOT COMPLETED|Overall Study||0
10145174|NCT02762084|11275717|FG002|NOT COMPLETED|Overall Study||1
10145175|NCT02762331|11275729|FG000|STARTED|Overall Study||4
10145176|NCT02762331|11275730|FG001|STARTED|Overall Study||2
10145177|NCT02762331|11275729|FG000|COMPLETED|Overall Study||4
10145178|NCT02762331|11275730|FG001|COMPLETED|Overall Study||2
10145179|NCT02762331|11275729|FG000|NOT COMPLETED|Overall Study||0
10145180|NCT02762331|11275730|FG001|NOT COMPLETED|Overall Study||0
10145181|NCT02762370|11275738|FG000|STARTED|Overall Study||18
10145182|NCT02762370|11275739|FG001|STARTED|Overall Study||15
10145183|NCT02762370|11275738|FG000|COMPLETED|Overall Study||17
10145184|NCT02762370|11275739|FG001|COMPLETED|Overall Study||15
10145185|NCT02762370|11275738|FG000|NOT COMPLETED|Overall Study||1
10145186|NCT02762370|11275739|FG001|NOT COMPLETED|Overall Study||0
10145187|NCT02762500|11275749|FG000|STARTED|Overall Study||62
10145188|NCT02762500|11275750|FG001|STARTED|Overall Study||62
10145189|NCT02762500|11275749|FG000|COMPLETED|Overall Study||60
10145190|NCT02762500|11275750|FG001|COMPLETED|Overall Study||59
10145191|NCT02762500|11275749|FG000|NOT COMPLETED|Overall Study||2
10145192|NCT02762500|11275750|FG001|NOT COMPLETED|Overall Study||3
10145193|NCT02762513|11275756|FG000|STARTED|Overall Study||28
10145194|NCT02762513|11275756|FG000|COMPLETED|Overall Study||28
10145195|NCT02762513|11275756|FG000|NOT COMPLETED|Overall Study||0
10145196|NCT02762565|11275760|FG000|STARTED|Overall Study||89
10145197|NCT02762565|11275760|FG000|COMPLETED|Overall Study||78
10145198|NCT02762565|11275760|FG000|NOT COMPLETED|Overall Study||11
10145199|NCT02762578|11275766|FG000|STARTED|Overall Study||361
10145200|NCT02762578|11275767|FG001|STARTED|Overall Study||182
10145201|NCT02762578|11275766|FG000|Exposed|Overall Study||360
10145202|NCT02762578|11275767|FG001|Exposed|Overall Study||181
10145203|NCT02762578|11275766|FG000|COMPLETED|Overall Study||346
10145204|NCT02762578|11275767|FG001|COMPLETED|Overall Study||172
10145205|NCT02762578|11275766|FG000|NOT COMPLETED|Overall Study||15
10145206|NCT02762578|11275767|FG001|NOT COMPLETED|Overall Study||10
10145207|NCT02762799|11275777|FG000|STARTED|Overall Study||18
10145208|NCT02762799|11275778|FG001|STARTED|Overall Study||18
10145209|NCT02762799|11275779|FG002|STARTED|Overall Study||12
10145210|NCT02762799|11275780|FG003|STARTED|Overall Study||12
10145211|NCT02762799|11275777|FG000|COMPLETED|Overall Study||18
10145212|NCT02762799|11275778|FG001|COMPLETED|Overall Study||18
9708416|NCT04061915|10807622|FG000|STARTED|Overall Study||161
9708417|NCT04061915|10807623|FG001|STARTED|Overall Study||161
9708418|NCT04061915|10807622|FG000|COMPLETED|Overall Study||161
9708419|NCT04061915|10807623|FG001|COMPLETED|Overall Study||161
9708420|NCT04061915|10807622|FG000|NOT COMPLETED|Overall Study||0
9708421|NCT04061915|10807623|FG001|NOT COMPLETED|Overall Study||0
9708422|NCT03990766|10807632|FG000|STARTED|Overall Study||14
9708423|NCT03990766|10807633|FG001|STARTED|Overall Study||13
9708424|NCT03990766|10807632|FG000|COMPLETED|Overall Study||12
9708425|NCT03990766|10807633|FG001|COMPLETED|Overall Study||10
9708426|NCT03990766|10807632|FG000|NOT COMPLETED|Overall Study||2
9708427|NCT03990766|10807633|FG001|NOT COMPLETED|Overall Study||3
9708428|NCT03947333|10807641|FG000|STARTED|Overall Study||135
9708429|NCT03947333|10807642|FG001|STARTED|Overall Study||135
9708430|NCT03947333|10807641|FG000|COMPLETED|Overall Study||135
9708431|NCT03947333|10807642|FG001|COMPLETED|Overall Study||135
9708432|NCT03947333|10807641|FG000|NOT COMPLETED|Overall Study||0
9708433|NCT03947333|10807642|FG001|NOT COMPLETED|Overall Study||0
9708434|NCT03886220|10807651|FG000|STARTED|Treatment Period||28
9708435|NCT03886220|10807652|FG001|STARTED|Treatment Period||54
9708436|NCT03886220|10807651|FG000|COMPLETED|Treatment Period||23
9708437|NCT03886220|10807652|FG001|COMPLETED|Treatment Period||42
9708438|NCT03886220|10807651|FG000|NOT COMPLETED|Treatment Period||5
9708439|NCT03886220|10807652|FG001|NOT COMPLETED|Treatment Period||12
10145213|NCT02762799|11275779|FG002|COMPLETED|Overall Study||11
10145214|NCT02762799|11275780|FG003|COMPLETED|Overall Study||12
10145215|NCT02762799|11275777|FG000|NOT COMPLETED|Overall Study||0
10145216|NCT02762799|11275778|FG001|NOT COMPLETED|Overall Study||0
10145217|NCT02762799|11275779|FG002|NOT COMPLETED|Overall Study||1
9708440|NCT03886220|10807651|FG000|STARTED|Post-Treatment Follow-Up Period||25
9708441|NCT03886220|10807652|FG001|STARTED|Post-Treatment Follow-Up Period||41
9708442|NCT03886220|10807651|FG000|COMPLETED|Post-Treatment Follow-Up Period||23
9963853|NCT01488877|11083635|FG002|NOT COMPLETED|Re-randomization||0
10145218|NCT02762799|11275780|FG003|NOT COMPLETED|Overall Study||0
10145219|NCT02762877|11275794|FG000|STARTED|Overall Study||121
9708443|NCT03886220|10807652|FG001|COMPLETED|Post-Treatment Follow-Up Period||39
9708444|NCT03886220|10807651|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
9708445|NCT03886220|10807652|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||2
10145220|NCT02762877|11275795|FG001|STARTED|Overall Study||19
10145221|NCT02762877|11275794|FG000|COMPLETED|Overall Study||121
10145222|NCT02762877|11275795|FG001|COMPLETED|Overall Study||19
10145223|NCT02762877|11275794|FG000|NOT COMPLETED|Overall Study||0
10145224|NCT02762877|11275795|FG001|NOT COMPLETED|Overall Study||0
10145225|NCT02762994|11275806|FG000|STARTED|Overall Study||31
10145226|NCT02762994|11275807|FG001|STARTED|Overall Study||31
10145227|NCT02762994|11275808|FG002|STARTED|Overall Study||30
10145228|NCT02762994|11275809|FG003|STARTED|Overall Study||28
10145229|NCT02762994|11275806|FG000|COMPLETED|Overall Study||30
10145230|NCT02762994|11275807|FG001|COMPLETED|Overall Study||30
10145231|NCT02762994|11275808|FG002|COMPLETED|Overall Study||28
10145232|NCT02762994|11275809|FG003|COMPLETED|Overall Study||26
10145233|NCT02762994|11275806|FG000|NOT COMPLETED|Overall Study||1
10145234|NCT02762994|11275807|FG001|NOT COMPLETED|Overall Study||1
10145235|NCT02762994|11275808|FG002|NOT COMPLETED|Overall Study||2
10145236|NCT02762994|11275809|FG003|NOT COMPLETED|Overall Study||2
10145237|NCT02763046|11275826|FG000|STARTED|Overall Study||71
10145238|NCT02763046|11275827|FG001|STARTED|Overall Study||70
10145239|NCT02763046|11275828|FG002|STARTED|Overall Study||70
10145240|NCT02763046|11275826|FG000|COMPLETED|Overall Study||62
10145241|NCT02763046|11275827|FG001|COMPLETED|Overall Study||65
10145242|NCT02763046|11275828|FG002|COMPLETED|Overall Study||62
10145243|NCT02763046|11275826|FG000|NOT COMPLETED|Overall Study||9
10145244|NCT02763046|11275827|FG001|NOT COMPLETED|Overall Study||5
10145245|NCT02763046|11275828|FG002|NOT COMPLETED|Overall Study||8
10145246|NCT02763124|11275842|FG000|STARTED|Overall Study||18
10145247|NCT02763124|11275842|FG000|COMPLETED|Overall Study||18
10145248|NCT02763124|11275842|FG000|NOT COMPLETED|Overall Study||0
10145249|NCT02763215|11275846|FG000|STARTED|Overall Study||64
10145250|NCT02763215|11275846|FG000|COMPLETED|Overall Study||57
10145251|NCT02763215|11275846|FG000|NOT COMPLETED|Overall Study||7
10145252|NCT02763254|11275850|FG000|STARTED|Overall Study||1
10145253|NCT02763254|11275850|FG000|COMPLETED|Overall Study||0
10145254|NCT02763254|11275850|FG000|NOT COMPLETED|Overall Study||1
10145255|NCT02763566|11275858|FG000|STARTED|Overall Study||207
10145256|NCT02763566|11275859|FG001|STARTED|Overall Study||99
10145257|NCT02763566|11275860|FG002|STARTED|Overall Study||104
10145258|NCT02763566|11275861|FG003|STARTED|Overall Study||53
10145259|NCT02763566|11275858|FG000|COMPLETED|Overall Study||89
10145260|NCT02763566|11275859|FG001|COMPLETED|Overall Study||60
10145261|NCT02763566|11275860|FG002|COMPLETED|Overall Study||50
10145262|NCT02763566|11275861|FG003|COMPLETED|Overall Study||39
10145263|NCT02763566|11275858|FG000|NOT COMPLETED|Overall Study||118
10145264|NCT02763566|11275859|FG001|NOT COMPLETED|Overall Study||39
10145265|NCT02763566|11275860|FG002|NOT COMPLETED|Overall Study||54
10145266|NCT02763566|11275861|FG003|NOT COMPLETED|Overall Study||14
10145267|NCT02763644|11275877|FG000|STARTED|Overall Study||3
10145268|NCT02763644|11275878|FG001|STARTED|Overall Study||4
10145269|NCT02763644|11275877|FG000|COMPLETED|Overall Study||0
10145270|NCT02763644|11275878|FG001|COMPLETED|Overall Study||2
10145271|NCT02763644|11275877|FG000|NOT COMPLETED|Overall Study||3
10145272|NCT02763644|11275878|FG001|NOT COMPLETED|Overall Study||2
10145273|NCT02763826|11275893|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3
10145274|NCT02763826|11275894|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0
10145275|NCT02763826|11275895|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0
10145276|NCT02763826|11275896|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0
10145277|NCT02763826|11275897|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0
10145278|NCT02763826|11275898|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0
10145279|NCT02763826|11275899|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0
10145280|NCT02763826|11275900|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0
10145281|NCT02763826|11275893|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3
10145282|NCT02763826|11275894|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145283|NCT02763826|11275895|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145284|NCT02763826|11275896|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145285|NCT02763826|11275897|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145286|NCT02763826|11275898|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145287|NCT02763826|11275899|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145288|NCT02763826|11275900|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145289|NCT02763826|11275893|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145290|NCT02763826|11275894|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145291|NCT02763826|11275895|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145292|NCT02763826|11275896|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145293|NCT02763826|11275897|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145294|NCT02763826|11275898|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145295|NCT02763826|11275899|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145296|NCT02763826|11275900|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10145297|NCT02763826|11275893|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0
10145298|NCT02763826|11275894|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3
10145299|NCT02763826|11275895|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0
10145300|NCT02763826|11275896|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0
10145301|NCT02763826|11275897|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0
10145302|NCT02763826|11275898|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0
10145303|NCT02763826|11275899|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0
10145304|NCT02763826|11275900|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0
10145305|NCT02763826|11275893|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145306|NCT02763826|11275894|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3
10145307|NCT02763826|11275895|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145308|NCT02763826|11275896|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145309|NCT02763826|11275897|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145310|NCT02763826|11275898|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145311|NCT02763826|11275899|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145312|NCT02763826|11275900|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145313|NCT02763826|11275893|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145314|NCT02763826|11275894|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145315|NCT02763826|11275895|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145316|NCT02763826|11275896|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145317|NCT02763826|11275897|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145318|NCT02763826|11275898|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145319|NCT02763826|11275899|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145320|NCT02763826|11275900|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10145321|NCT02763826|11275893|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0
9848896|NCT00862836|10961748|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
9848897|NCT00862836|10961748|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10
9848898|NCT00862836|10961748|FG000|COMPLETED|Overall Study||14
10145322|NCT02763826|11275894|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10145323|NCT02763826|11275895|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3
10145324|NCT02763826|11275896|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10145325|NCT02763826|11275897|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10145326|NCT02763826|11275898|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10145327|NCT02763826|11275899|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10145328|NCT02763826|11275900|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10145329|NCT02763826|11275893|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145330|NCT02763826|11275894|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145331|NCT02763826|11275895|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3
10145332|NCT02763826|11275896|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145333|NCT02763826|11275897|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145334|NCT02763826|11275898|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145335|NCT02763826|11275899|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145336|NCT02763826|11275900|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145337|NCT02763826|11275893|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145338|NCT02763826|11275894|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145339|NCT02763826|11275895|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145340|NCT02763826|11275896|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145341|NCT02763826|11275897|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145342|NCT02763826|11275898|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145343|NCT02763826|11275899|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145344|NCT02763826|11275900|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10145345|NCT02763826|11275893|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0
10145346|NCT02763826|11275894|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0
10145347|NCT02763826|11275895|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0
10145348|NCT02763826|11275896|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3
10145349|NCT02763826|11275897|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0
10145350|NCT02763826|11275898|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0
10145351|NCT02763826|11275899|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0
10145352|NCT02763826|11275900|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0
10145353|NCT02763826|11275893|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145354|NCT02763826|11275894|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145355|NCT02763826|11275895|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145356|NCT02763826|11275896|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3
10145357|NCT02763826|11275897|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145358|NCT02763826|11275898|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145359|NCT02763826|11275899|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145360|NCT02763826|11275900|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145361|NCT02763826|11275893|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145362|NCT02763826|11275894|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145363|NCT02763826|11275895|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145364|NCT02763826|11275896|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145365|NCT02763826|11275897|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145366|NCT02763826|11275898|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145367|NCT02763826|11275899|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145368|NCT02763826|11275900|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10145369|NCT02763826|11275893|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10145370|NCT02763826|11275894|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10145371|NCT02763826|11275895|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10145372|NCT02763826|11275896|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10145373|NCT02763826|11275897|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3
10145374|NCT02763826|11275898|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10145375|NCT02763826|11275899|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10145376|NCT02763826|11275900|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10145377|NCT02763826|11275893|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145378|NCT02763826|11275894|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145379|NCT02763826|11275895|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145380|NCT02763826|11275896|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145381|NCT02763826|11275897|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3
10145382|NCT02763826|11275898|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145383|NCT02763826|11275899|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145384|NCT02763826|11275900|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
9848899|NCT00862836|10961748|FG000|NOT COMPLETED|Overall Study||1
10145385|NCT02763826|11275893|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145386|NCT02763826|11275894|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145387|NCT02763826|11275895|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145388|NCT02763826|11275896|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145389|NCT02763826|11275897|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145390|NCT02763826|11275898|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145391|NCT02763826|11275899|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145392|NCT02763826|11275900|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10145393|NCT02763826|11275893|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0
10145394|NCT02763826|11275894|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0
10145395|NCT02763826|11275895|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0
10145396|NCT02763826|11275896|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0
10145397|NCT02763826|11275897|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0
10145398|NCT02763826|11275898|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3
10145399|NCT02763826|11275899|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0
10145400|NCT02763826|11275900|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0
10145401|NCT02763826|11275893|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145402|NCT02763826|11275894|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145403|NCT02763826|11275895|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145404|NCT02763826|11275896|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145405|NCT02763826|11275897|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145406|NCT02763826|11275898|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3
10145407|NCT02763826|11275899|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145408|NCT02763826|11275900|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145409|NCT02763826|11275893|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145410|NCT02763826|11275894|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145411|NCT02763826|11275895|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145412|NCT02763826|11275896|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145413|NCT02763826|11275897|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145414|NCT02763826|11275898|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145415|NCT02763826|11275899|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145416|NCT02763826|11275900|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10145417|NCT02763826|11275893|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0
10145418|NCT02763826|11275894|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0
10145419|NCT02763826|11275895|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0
10145420|NCT02763826|11275896|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0
10145421|NCT02763826|11275897|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0
10145422|NCT02763826|11275898|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6
10145423|NCT02763826|11275899|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6
10145424|NCT02763826|11275900|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7
10145425|NCT02763826|11275893|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145426|NCT02763826|11275894|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145427|NCT02763826|11275895|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145428|NCT02763826|11275896|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145429|NCT02763826|11275897|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145430|NCT02763826|11275898|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
10145431|NCT02763826|11275899|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
10145432|NCT02763826|11275900|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7
10145433|NCT02763826|11275893|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145434|NCT02763826|11275894|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145435|NCT02763826|11275895|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145436|NCT02763826|11275896|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145437|NCT02763826|11275897|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145438|NCT02763826|11275898|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145439|NCT02763826|11275899|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145440|NCT02763826|11275900|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10145441|NCT02763826|11275893|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10145442|NCT02763826|11275894|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10145443|NCT02763826|11275895|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10145444|NCT02763826|11275896|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10145445|NCT02763826|11275897|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10145446|NCT02763826|11275898|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6
10145447|NCT02763826|11275899|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6
10145448|NCT02763826|11275900|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6
10145449|NCT02763826|11275893|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145450|NCT02763826|11275894|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145451|NCT02763826|11275895|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145452|NCT02763826|11275896|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145453|NCT02763826|11275897|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145454|NCT02763826|11275898|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
10145455|NCT02763826|11275899|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
10145456|NCT02763826|11275900|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
10145457|NCT02763826|11275893|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145458|NCT02763826|11275894|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145459|NCT02763826|11275895|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145460|NCT02763826|11275896|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145461|NCT02763826|11275897|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145462|NCT02763826|11275898|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145463|NCT02763826|11275899|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145464|NCT02763826|11275900|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10145465|NCT02763826|11275893|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10145466|NCT02763826|11275894|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10145467|NCT02763826|11275895|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10145468|NCT02763826|11275896|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10145469|NCT02763826|11275897|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10145470|NCT02763826|11275898|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6
10145471|NCT02763826|11275899|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6
10145472|NCT02763826|11275900|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6
10145473|NCT02763826|11275893|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145474|NCT02763826|11275894|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145475|NCT02763826|11275895|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
9708446|NCT03800979|10807658|FG000|STARTED|Overall Study||19
9708447|NCT03800979|10807658|FG000|COMPLETED|Overall Study||19
9708448|NCT03800979|10807658|FG000|NOT COMPLETED|Overall Study||0
9708449|NCT03794661|10807662|FG000|STARTED|Overall Study||8
9708450|NCT03794661|10807662|FG000|COMPLETED|Overall Study||8
9708451|NCT03794661|10807662|FG000|NOT COMPLETED|Overall Study||0
9708452|NCT03691909|10807666|FG000|STARTED|Overall Study||15
9708453|NCT03691909|10807666|FG000|Per Protocol Population Day 1|Overall Study||15
9708454|NCT03691909|10807666|FG000|Per Protocol Population Week 1|Overall Study||15
9708455|NCT03691909|10807666|FG000|Per Protocol Population Week 4|Overall Study||14
9708456|NCT03691909|10807666|FG000|Per Protocol Population Week 8|Overall Study||13
9708457|NCT03691909|10807666|FG000|Per Protocol Population Week 12|Overall Study||15
9708458|NCT03691909|10807666|FG000|Per Protocol Population Week 26|Overall Study||14
9708459|NCT03691909|10807666|FG000|Per Protocol Population Week 52|Overall Study||13
9708460|NCT03691909|10807666|FG000|COMPLETED|Overall Study||15
9708461|NCT03691909|10807666|FG000|NOT COMPLETED|Overall Study||0
9708462|NCT03627091|10807674|FG000|STARTED|Overall Study||19
9708463|NCT03627091|10807675|FG001|STARTED|Overall Study||10
9708464|NCT03627091|10807676|FG002|STARTED|Overall Study||11
9708465|NCT03627091|10807674|FG000|COMPLETED|Overall Study||7
9708466|NCT03627091|10807675|FG001|COMPLETED|Overall Study||4
9708467|NCT03627091|10807676|FG002|COMPLETED|Overall Study||6
9708468|NCT03627091|10807674|FG000|NOT COMPLETED|Overall Study||12
9708469|NCT03627091|10807675|FG001|NOT COMPLETED|Overall Study||6
9708470|NCT03627091|10807676|FG002|NOT COMPLETED|Overall Study||5
9729306|NCT00117637|10828872|FG001|NOT COMPLETED|First Intervention (Period 1)||25
9729307|NCT00117637|10828871|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
9729308|NCT00117637|10828872|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
9729309|NCT00117637|10828871|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49
9729310|NCT00117637|10828872|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61
9729311|NCT00117637|10828871|FG000|COMPLETED|Second Intervention (Period 2)||39
9729312|NCT00117637|10828872|FG001|COMPLETED|Second Intervention (Period 2)||39
9729313|NCT00117637|10828871|FG000|NOT COMPLETED|Second Intervention (Period 2)||10
9729314|NCT00117637|10828872|FG001|NOT COMPLETED|Second Intervention (Period 2)||22
9729315|NCT00117676|10828887|FG000|STARTED|Double-blind Period Through Week 48||254
9729316|NCT00117676|10828888|FG001|STARTED|Double-blind Period Through Week 48||128
9729317|NCT00117676|10828887|FG000|COMPLETED|Double-blind Period Through Week 48||244
9729318|NCT00117676|10828888|FG001|COMPLETED|Double-blind Period Through Week 48||121
9729319|NCT00117676|10828887|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10
9729320|NCT00117676|10828888|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7
9729321|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
9729322|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
9729323|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225
9729324|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110
9729325|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
9729326|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
9729327|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 97 - 144||225
9729328|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 97 - 144||110
9729329|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219
9729330|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109
9729331|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
9729332|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
9729333|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 145 - 192||219
9729334|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 145 - 192||109
9729335|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209
9729336|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106
10145476|NCT02763826|11275896|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145477|NCT02763826|11275897|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145478|NCT02763826|11275898|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
10145479|NCT02763826|11275899|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
10145480|NCT02763826|11275900|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
10145481|NCT02763826|11275893|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145482|NCT02763826|11275894|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145483|NCT02763826|11275895|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145484|NCT02763826|11275896|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145485|NCT02763826|11275897|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145486|NCT02763826|11275898|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145487|NCT02763826|11275899|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145488|NCT02763826|11275900|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10145489|NCT02763865|11275920|FG000|STARTED|Overall Study||5
10145490|NCT02763865|11275921|FG001|STARTED|Overall Study||5
10145491|NCT02763865|11275920|FG000|COMPLETED|Overall Study||5
10145492|NCT02763865|11275921|FG001|COMPLETED|Overall Study||5
10145493|NCT02763865|11275920|FG000|NOT COMPLETED|Overall Study||0
10145494|NCT02763865|11275921|FG001|NOT COMPLETED|Overall Study||0
10145495|NCT02764151|11275933|FG000|STARTED|Overall Study||2
10145496|NCT02764151|11275934|FG001|STARTED|Overall Study||4
10145497|NCT02764151|11275935|FG002|STARTED|Overall Study||3
10145498|NCT02764151|11275936|FG003|STARTED|Overall Study||8
10145499|NCT02764151|11275933|FG000|COMPLETED|Overall Study||2
10145500|NCT02764151|11275934|FG001|COMPLETED|Overall Study||4
10145501|NCT02764151|11275935|FG002|COMPLETED|Overall Study||3
9708471|NCT03568318|10807691|FG000|STARTED|Overall Study||264
9708472|NCT03568318|10807692|FG001|STARTED|Overall Study||261
9708473|NCT03568318|10807693|FG002|STARTED|Overall Study||260
9708474|NCT03568318|10807694|FG003|STARTED|Overall Study||63
9708475|NCT03568318|10807695|FG004|STARTED|Overall Study||60
9708476|NCT03568318|10807696|FG005|STARTED|Overall Study||60
9708477|NCT03568318|10807691|FG000|Received Study Drug|Overall Study||264
9708478|NCT03568318|10807692|FG001|Received Study Drug|Overall Study||261
9708479|NCT03568318|10807693|FG002|Received Study Drug|Overall Study||260
9708480|NCT03568318|10807694|FG003|Received Study Drug|Overall Study||62
10060768|NCT02100410|11186319|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10060769|NCT02100410|11186320|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10060770|NCT02100410|11186321|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10060771|NCT02100410|11186322|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10060772|NCT02100475|11186336|FG000|STARTED|Overall Study||16
10060773|NCT02100475|11186337|FG001|STARTED|Overall Study||15
10060774|NCT02100475|11186336|FG000|COMPLETED|Overall Study||14
10060775|NCT02100475|11186337|FG001|COMPLETED|Overall Study||13
10060776|NCT02100475|11186336|FG000|NOT COMPLETED|Overall Study||2
10060777|NCT02100475|11186337|FG001|NOT COMPLETED|Overall Study||2
10145502|NCT02764151|11275936|FG003|COMPLETED|Overall Study||5
10145503|NCT02764151|11275933|FG000|NOT COMPLETED|Overall Study||0
10145504|NCT02764151|11275934|FG001|NOT COMPLETED|Overall Study||0
10145505|NCT02764151|11275935|FG002|NOT COMPLETED|Overall Study||0
10145506|NCT02764151|11275936|FG003|NOT COMPLETED|Overall Study||3
10145507|NCT02764164|11275946|FG000|STARTED|Overall Study||1
10145508|NCT02764164|11275946|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
10145509|NCT02764164|11275946|FG000|NOT COMPLETED|Overall Study||0
10145510|NCT02764190|11275952|FG000|STARTED|Overall Study||167
10145511|NCT02764190|11275953|FG001|STARTED|Overall Study||135
10145512|NCT02764190|11275952|FG000|1 Day Follow-up|Overall Study||161
10145513|NCT02764190|11275953|FG001|1 Day Follow-up|Overall Study||131
10145514|NCT02764190|11275952|FG000|3 Month Follow-up|Overall Study||156
10145515|NCT02764190|11275953|FG001|3 Month Follow-up|Overall Study||128
10145516|NCT02764190|11275952|FG000|6 Month Follow-up|Overall Study||155
10145517|NCT02764190|11275953|FG001|6 Month Follow-up|Overall Study||128
10145518|NCT02764190|11275952|FG000|12 Month Follow-up|Overall Study||150
10145519|NCT02764190|11275953|FG001|12 Month Follow-up|Overall Study||122
10145520|NCT02764190|11275952|FG000|COMPLETED|Overall Study||150
10145521|NCT02764190|11275953|FG001|COMPLETED|Overall Study||122
10145522|NCT02764190|11275952|FG000|NOT COMPLETED|Overall Study||17
10145523|NCT02764190|11275953|FG001|NOT COMPLETED|Overall Study||13
10145524|NCT02764229|11275959|FG000|STARTED|Overall Study||112
10145525|NCT02764229|11275959|FG000|COMPLETED|Overall Study||10
10145526|NCT02764229|11275959|FG000|NOT COMPLETED|Overall Study||102
10145527|NCT02764320|11275965|FG000|STARTED|Overall Study||361
10145528|NCT02764320|11275966|FG001|STARTED|Overall Study||359
10145529|NCT02764320|11275965|FG000|COMPLETED|Overall Study||310
10145530|NCT02764320|11275966|FG001|COMPLETED|Overall Study||310
10145531|NCT02764320|11275965|FG000|NOT COMPLETED|Overall Study||51
10145532|NCT02764320|11275966|FG001|NOT COMPLETED|Overall Study||49
10145533|NCT02764333|11275972|FG000|STARTED|Overall Study||29
10145534|NCT02764333|11275972|FG000|COMPLETED|Overall Study||28
10145535|NCT02764333|11275972|FG000|NOT COMPLETED|Overall Study||1
10145536|NCT02764385|11275978|FG000|STARTED|Overall Study||9145
10145537|NCT02764385|11275979|FG001|STARTED|Overall Study||6641
10145538|NCT02764385|11275978|FG000|COMPLETED|Overall Study||9145
10145539|NCT02764385|11275979|FG001|COMPLETED|Overall Study||6641
10145540|NCT02764385|11275978|FG000|NOT COMPLETED|Overall Study||0
10145541|NCT02764385|11275979|FG001|NOT COMPLETED|Overall Study||0
10145542|NCT02764697|11275985|FG000|STARTED|Overall Study||5
9708481|NCT03568318|10807695|FG004|Received Study Drug|Overall Study||60
9708482|NCT03568318|10807696|FG005|Received Study Drug|Overall Study||60
9708483|NCT03568318|10807691|FG000|COMPLETED|Overall Study||244
10145543|NCT02764697|11275985|FG000|COMPLETED|Overall Study||2
10145544|NCT02764697|11275985|FG000|NOT COMPLETED|Overall Study||3
10145545|NCT02764762|11275989|FG000|STARTED|Overall Study||55
10145546|NCT02764762|11275989|FG000|COMPLETED|Overall Study||46
10145547|NCT02764762|11275989|FG000|NOT COMPLETED|Overall Study||9
10145548|NCT02764775|11275993|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
10145549|NCT02764775|11275993|FG000|COMPLETED|Overall Study||8
10145550|NCT02764775|11275993|FG000|NOT COMPLETED|Overall Study||6
10145551|NCT02764970|11275999|FG000|STARTED|Overall Study||65
10145552|NCT02764970|11276000|FG001|STARTED|Overall Study||47
10145553|NCT02764970|11275999|FG000|COMPLETED|Overall Study||65
10145554|NCT02764970|11276000|FG001|COMPLETED|Overall Study||47
10145555|NCT02764970|11275999|FG000|NOT COMPLETED|Overall Study||0
10145556|NCT02764970|11276000|FG001|NOT COMPLETED|Overall Study||0
10145557|NCT02765035|11276008|FG000|STARTED|First Intervention (90 Days)||5
10145558|NCT02765035|11276009|FG001|STARTED|First Intervention (90 Days)||8
10145559|NCT02765035|11276008|FG000|COMPLETED|First Intervention (90 Days)||4
10145560|NCT02765035|11276009|FG001|COMPLETED|First Intervention (90 Days)||7
10145561|NCT02765035|11276008|FG000|NOT COMPLETED|First Intervention (90 Days)||1
10145562|NCT02765035|11276009|FG001|NOT COMPLETED|First Intervention (90 Days)||1
10145563|NCT02765035|11276008|FG000|STARTED|Second Intervention (30 Days)||4
10145564|NCT02765035|11276009|FG001|STARTED|Second Intervention (30 Days)||7
10145565|NCT02765035|11276008|FG000|COMPLETED|Second Intervention (30 Days)||2
10145566|NCT02765035|11276009|FG001|COMPLETED|Second Intervention (30 Days)||5
10145567|NCT02765035|11276008|FG000|NOT COMPLETED|Second Intervention (30 Days)||2
10145568|NCT02765035|11276009|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
10145569|NCT02765100|11276018|FG000|STARTED|Overall Study||9
10145570|NCT02765100|11276019|FG001|STARTED|Overall Study||12
10145571|NCT02765100|11276018|FG000|COMPLETED|Overall Study||8
10145572|NCT02765100|11276019|FG001|COMPLETED|Overall Study||10
10145573|NCT02765100|11276018|FG000|NOT COMPLETED|Overall Study||1
10145574|NCT02765100|11276019|FG001|NOT COMPLETED|Overall Study||2
10145575|NCT02765165|11276032|FG000|STARTED|Treatment Period||3
10145576|NCT02765165|11276033|FG001|STARTED|Treatment Period||4
10145577|NCT02765165|11276034|FG002|STARTED|Treatment Period||3
10145578|NCT02765165|11276035|FG003|STARTED|Treatment Period||3
10145579|NCT02765165|11276036|FG004|STARTED|Treatment Period||6
10145580|NCT02765165|11276037|FG005|STARTED|Treatment Period||3
10145581|NCT02765165|11276038|FG006|STARTED|Treatment Period||4
10145582|NCT02765165|11276032|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10145583|NCT02765165|11276033|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10145584|NCT02765165|11276034|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10145585|NCT02765165|11276035|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10145586|NCT02765165|11276036|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10145587|NCT02765165|11276037|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10145588|NCT02765165|11276038|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10145589|NCT02765165|11276032|FG000|NOT COMPLETED|Treatment Period||3
10145590|NCT02765165|11276033|FG001|NOT COMPLETED|Treatment Period||4
10145591|NCT02765165|11276034|FG002|NOT COMPLETED|Treatment Period||3
10145592|NCT02765165|11276035|FG003|NOT COMPLETED|Treatment Period||3
10145593|NCT02765165|11276036|FG004|NOT COMPLETED|Treatment Period||6
10145594|NCT02765165|11276037|FG005|NOT COMPLETED|Treatment Period||3
10145595|NCT02765165|11276038|FG006|NOT COMPLETED|Treatment Period||4
10145596|NCT02765165|11276032|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
10145597|NCT02765165|11276033|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10145598|NCT02765165|11276034|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10145599|NCT02765165|11276035|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10145600|NCT02765165|11276036|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10145601|NCT02765165|11276037|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10145602|NCT02765165|11276038|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
10145603|NCT02765165|11276032|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
10145604|NCT02765165|11276033|FG001|COMPLETED|Post-treatment Follow-up||0
10145605|NCT02765165|11276034|FG002|COMPLETED|Post-treatment Follow-up||0
10145606|NCT02765165|11276035|FG003|COMPLETED|Post-treatment Follow-up||0
10145607|NCT02765165|11276036|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
10145608|NCT02765165|11276037|FG005|COMPLETED|Post-treatment Follow-up||0
10145609|NCT02765165|11276038|FG006|COMPLETED|Post-treatment Follow-up||0
10145610|NCT02765165|11276032|FG000|NOT COMPLETED|Post-treatment Follow-up||1
10145611|NCT02765165|11276033|FG001|NOT COMPLETED|Post-treatment Follow-up||3
10145612|NCT02765165|11276034|FG002|NOT COMPLETED|Post-treatment Follow-up||3
10145613|NCT02765165|11276035|FG003|NOT COMPLETED|Post-treatment Follow-up||3
10145614|NCT02765165|11276036|FG004|NOT COMPLETED|Post-treatment Follow-up||3
10145615|NCT02765165|11276037|FG005|NOT COMPLETED|Post-treatment Follow-up||3
10145616|NCT02765165|11276038|FG006|NOT COMPLETED|Post-treatment Follow-up||1
10145617|NCT02765256|11276060|FG000|STARTED|Overall Study||4
10145618|NCT02765256|11276061|FG001|STARTED|Overall Study||4
10145619|NCT02765256|11276060|FG000|COMPLETED|Overall Study||4
10145620|NCT02765256|11276061|FG001|COMPLETED|Overall Study||4
10145621|NCT02765256|11276060|FG000|NOT COMPLETED|Overall Study||0
10145622|NCT02765256|11276061|FG001|NOT COMPLETED|Overall Study||0
10145623|NCT02765269|11276069|FG000|STARTED|Overall Study||25
10145624|NCT02765269|11276070|FG001|STARTED|Overall Study||21
10145625|NCT02765269|11276069|FG000|COMPLETED|Overall Study||25
10145626|NCT02765269|11276070|FG001|COMPLETED|Overall Study||21
10145627|NCT02765269|11276069|FG000|NOT COMPLETED|Overall Study||0
10145628|NCT02765269|11276070|FG001|NOT COMPLETED|Overall Study||0
10145629|NCT02765490|11276078|FG000|STARTED|Overall Study||183
10145630|NCT02765490|11276079|FG001|STARTED|Overall Study||182
10145631|NCT02765490|11276078|FG000|COMPLETED|Overall Study||182
10145632|NCT02765490|11276079|FG001|COMPLETED|Overall Study||179
10145633|NCT02765490|11276078|FG000|NOT COMPLETED|Overall Study||1
10145634|NCT02765490|11276079|FG001|NOT COMPLETED|Overall Study||3
10145635|NCT02766023|11276087|FG000|STARTED|Overall Study||152
10145636|NCT02766023|11276088|FG001|STARTED|Overall Study||76
10145637|NCT02766023|11276087|FG000|COMPLETED|Overall Study||122
10145638|NCT02766023|11276088|FG001|COMPLETED|Overall Study||59
10145639|NCT02766023|11276087|FG000|NOT COMPLETED|Overall Study||30
10145640|NCT02766023|11276088|FG001|NOT COMPLETED|Overall Study||17
10145641|NCT02766088|11276094|FG000|STARTED|Overall Study||850
10145642|NCT02766088|11276094|FG000|COMPLETED|Overall Study||344
10145643|NCT02766088|11276094|FG000|NOT COMPLETED|Overall Study||506
10145644|NCT02766244|11276098|FG000|STARTED|Overall Study||3
10145645|NCT02766244|11276098|FG000|COMPLETED|Overall Study||3
10145646|NCT02766244|11276098|FG000|NOT COMPLETED|Overall Study||0
10145647|NCT02766283|11276107|FG000|STARTED|Overall Study||843
10145648|NCT02766283|11276107|FG000|COMPLETED|Overall Study||816
10145649|NCT02766283|11276107|FG000|NOT COMPLETED|Overall Study||27
10145650|NCT02766374|11276117|FG000|STARTED|Overall Study||35
10145651|NCT02766374|11276118|FG001|STARTED|Overall Study||33
10145652|NCT02766374|11276117|FG000|COMPLETED|Overall Study||25
10145653|NCT02766374|11276118|FG001|COMPLETED|Overall Study||30
10145654|NCT02766374|11276117|FG000|NOT COMPLETED|Overall Study||10
10145655|NCT02766374|11276118|FG001|NOT COMPLETED|Overall Study||3
10145656|NCT02766400|11276126|FG000|STARTED|Overall Study||21
10145657|NCT02766400|11276127|FG001|STARTED|Overall Study||22
10145658|NCT02766400|11276126|FG000|COMPLETED|Overall Study||19
10145659|NCT02766400|11276127|FG001|COMPLETED|Overall Study||20
10145660|NCT02766400|11276126|FG000|NOT COMPLETED|Overall Study||2
10145661|NCT02766400|11276127|FG001|NOT COMPLETED|Overall Study||2
10145662|NCT02766517|11276136|FG000|STARTED|Overall Study||19
10145663|NCT02766517|11276137|FG001|STARTED|Overall Study||9
10145664|NCT02766517|11276138|FG002|STARTED|Overall Study||9
10145665|NCT02766517|11276136|FG000|COMPLETED|Overall Study||19
10145666|NCT02766517|11276137|FG001|COMPLETED|Overall Study||9
10145667|NCT02766517|11276138|FG002|COMPLETED|Overall Study||9
10145668|NCT02766517|11276136|FG000|NOT COMPLETED|Overall Study||0
10145669|NCT02766517|11276137|FG001|NOT COMPLETED|Overall Study||0
10145670|NCT02766517|11276138|FG002|NOT COMPLETED|Overall Study||0
10196834|NCT03364309|11324822|FG005|COMPLETED|Post-Treatment Followup Period||0
10196835|NCT03364309|11324823|FG006|COMPLETED|Post-Treatment Followup Period||0
10196836|NCT03364309|11324824|FG007|COMPLETED|Post-Treatment Followup Period||0
10196837|NCT03364309|11324825|FG008|COMPLETED|Post-Treatment Followup Period||0
10196838|NCT03364309|11324826|FG009|COMPLETED|Post-Treatment Followup Period||0
10196839|NCT03364309|11324827|FG010|COMPLETED|Post-Treatment Followup Period||0
10196840|NCT03364309|11324828|FG011|COMPLETED|Post-Treatment Followup Period||0
10196841|NCT03364309|11324829|FG012|COMPLETED|Post-Treatment Followup Period||0
10196842|NCT03364309|11324830|FG013|COMPLETED|Post-Treatment Followup Period||0
10196843|NCT03364309|11324831|FG014|COMPLETED|Post-Treatment Followup Period||0
10196844|NCT03364309|11324832|FG015|COMPLETED|Post-Treatment Followup Period||0
10196845|NCT03364309|11324833|FG016|COMPLETED|Post-Treatment Followup Period||6
10196846|NCT03364309|11324834|FG017|COMPLETED|Post-Treatment Followup Period||344
10196847|NCT03364309|11324835|FG018|COMPLETED|Post-Treatment Followup Period||0
10196848|NCT03364309|11324817|FG000|NOT COMPLETED|Post-Treatment Followup Period||0
10196849|NCT03364309|11324818|FG001|NOT COMPLETED|Post-Treatment Followup Period||0
10196850|NCT03364309|11324819|FG002|NOT COMPLETED|Post-Treatment Followup Period||0
10196851|NCT03364309|11324820|FG003|NOT COMPLETED|Post-Treatment Followup Period||0
10196852|NCT03364309|11324821|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
10196853|NCT03364309|11324822|FG005|NOT COMPLETED|Post-Treatment Followup Period||0
10196854|NCT03364309|11324823|FG006|NOT COMPLETED|Post-Treatment Followup Period||0
10196855|NCT03364309|11324824|FG007|NOT COMPLETED|Post-Treatment Followup Period||0
10196856|NCT03364309|11324825|FG008|NOT COMPLETED|Post-Treatment Followup Period||0
10196857|NCT03364309|11324826|FG009|NOT COMPLETED|Post-Treatment Followup Period||0
10196858|NCT03364309|11324827|FG010|NOT COMPLETED|Post-Treatment Followup Period||0
10196859|NCT03364309|11324828|FG011|NOT COMPLETED|Post-Treatment Followup Period||0
10145671|NCT02766608|11276151|FG000|STARTED|Overall Study||655
10145672|NCT02766608|11276152|FG001|STARTED|Overall Study||637
10145673|NCT02766608|11276153|FG002|STARTED|Overall Study||644
10145674|NCT02766608|11276154|FG003|STARTED|Overall Study||206
10145675|NCT02766608|11276155|FG004|STARTED|Overall Study||219
10145676|NCT02766608|11276151|FG000|COMPLETED|Overall Study||576
10145677|NCT02766608|11276152|FG001|COMPLETED|Overall Study||567
10145678|NCT02766608|11276153|FG002|COMPLETED|Overall Study||554
10145679|NCT02766608|11276154|FG003|COMPLETED|Overall Study||169
10145680|NCT02766608|11276155|FG004|COMPLETED|Overall Study||190
10145681|NCT02766608|11276151|FG000|NOT COMPLETED|Overall Study||79
10145682|NCT02766608|11276152|FG001|NOT COMPLETED|Overall Study||70
10145683|NCT02766608|11276153|FG002|NOT COMPLETED|Overall Study||90
10145684|NCT02766608|11276154|FG003|NOT COMPLETED|Overall Study||37
10145685|NCT02766608|11276155|FG004|NOT COMPLETED|Overall Study||29
10145686|NCT02766673|11276170|FG000|STARTED|Overall Study||4
10145687|NCT02766673|11276171|FG001|STARTED|Overall Study||4
10145688|NCT02766673|11276172|FG002|STARTED|Overall Study||4
10145689|NCT02766673|11276173|FG003|STARTED|Overall Study||4
10145690|NCT02766673|11276174|FG004|STARTED|Overall Study||4
10145691|NCT02766673|11276175|FG005|STARTED|Overall Study||4
10145692|NCT02766673|11276170|FG000|COMPLETED|Overall Study||3
10145693|NCT02766673|11276171|FG001|COMPLETED|Overall Study||4
10145694|NCT02766673|11276172|FG002|COMPLETED|Overall Study||4
10145695|NCT02766673|11276173|FG003|COMPLETED|Overall Study||4
10145696|NCT02766673|11276174|FG004|COMPLETED|Overall Study||4
10145697|NCT02766673|11276175|FG005|COMPLETED|Overall Study||3
10145698|NCT02766673|11276170|FG000|NOT COMPLETED|Overall Study||1
10145699|NCT02766673|11276171|FG001|NOT COMPLETED|Overall Study||0
10145700|NCT02766673|11276172|FG002|NOT COMPLETED|Overall Study||0
10145701|NCT02766673|11276173|FG003|NOT COMPLETED|Overall Study||0
10145702|NCT02766673|11276174|FG004|NOT COMPLETED|Overall Study||0
10145703|NCT02766673|11276175|FG005|NOT COMPLETED|Overall Study||1
10145704|NCT02766777|11276183|FG000|STARTED|Overall Study||87
10145705|NCT02766777|11276183|FG000|Treated (Safety [SAF] Population)|Overall Study||87
10145706|NCT02766777|11276183|FG000|COMPLETED|Overall Study||53
10145707|NCT02766777|11276183|FG000|NOT COMPLETED|Overall Study||34
10145708|NCT02766907|11276189|FG000|STARTED|Overall Study||10
10145709|NCT02766907|11276190|FG001|STARTED|Overall Study||10
10145710|NCT02766907|11276189|FG000|COMPLETED|Overall Study||9
10145711|NCT02766907|11276190|FG001|COMPLETED|Overall Study||9
10145712|NCT02766907|11276189|FG000|NOT COMPLETED|Overall Study||1
10145713|NCT02766907|11276190|FG001|NOT COMPLETED|Overall Study||1
10145714|NCT02767011|11276198|FG000|STARTED|Overall Study||16
10145715|NCT02767011|11276199|FG001|STARTED|Overall Study||14
10145716|NCT02767011|11276198|FG000|COMPLETED|Overall Study||16
10145717|NCT02767011|11276199|FG001|COMPLETED|Overall Study||14
10145718|NCT02767011|11276198|FG000|NOT COMPLETED|Overall Study||0
10145719|NCT02767011|11276199|FG001|NOT COMPLETED|Overall Study||0
10145720|NCT02767128|11276205|FG000|STARTED|Overall Study||14
10145721|NCT02767128|11276205|FG000|Baseline|Overall Study||14
10145722|NCT02767128|11276205|FG000|Fer-In-Sol|Overall Study||14
10145723|NCT02767128|11276205|FG000|Shohl's + Fer-In-Sol|Overall Study||14
10145724|NCT02767128|11276205|FG000|Triferic|Overall Study||14
10145725|NCT02767128|11276205|FG000|Shohl's + Triferic After 10 Min|Overall Study||14
10145726|NCT02767128|11276205|FG000|Shohl's + Triferic Immediately|Overall Study||14
10145727|NCT02767128|11276205|FG000|COMPLETED|Overall Study||14
10145728|NCT02767128|11276205|FG000|NOT COMPLETED|Overall Study||0
10145729|NCT02767271|11276221|FG000|STARTED|Overall Study||15
10145730|NCT02767271|11276222|FG001|STARTED|Overall Study||15
10145731|NCT02767271|11276221|FG000|Safety Population|Overall Study||15
10145732|NCT02767271|11276222|FG001|Safety Population|Overall Study||15
10145733|NCT02767271|11276221|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
10145734|NCT02767271|11276222|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
10145735|NCT02767271|11276221|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
10145736|NCT02767271|11276222|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
10145737|NCT02767271|11276221|FG000|COMPLETED|Overall Study||15
10145738|NCT02767271|11276222|FG001|COMPLETED|Overall Study||15
10145739|NCT02767271|11276221|FG000|NOT COMPLETED|Overall Study||0
10145740|NCT02767271|11276222|FG001|NOT COMPLETED|Overall Study||0
10145741|NCT02767323|11276232|FG000|STARTED|Overall Study||83
10145742|NCT02767323|11276233|FG001|STARTED|Overall Study||42
10145743|NCT02767323|11276234|FG002|STARTED|Overall Study||58
10145744|NCT02767323|11276235|FG003|STARTED|Overall Study||1
10145745|NCT02767323|11276232|FG000|COMPLETED|Overall Study||49
10145746|NCT02767323|11276233|FG001|COMPLETED|Overall Study||17
10145747|NCT02767323|11276234|FG002|COMPLETED|Overall Study||28
10145748|NCT02767323|11276235|FG003|COMPLETED|Overall Study||1
10145749|NCT02767323|11276232|FG000|NOT COMPLETED|Overall Study||34
10145750|NCT02767323|11276233|FG001|NOT COMPLETED|Overall Study||25
10145751|NCT02767323|11276234|FG002|NOT COMPLETED|Overall Study||30
10145752|NCT02767323|11276235|FG003|NOT COMPLETED|Overall Study||0
10145753|NCT02767388|11276251|FG000|STARTED|Overall Study||15
10145754|NCT02767388|11276252|FG001|STARTED|Overall Study||15
10145755|NCT02767388|11276253|FG002|STARTED|Overall Study||15
10145756|NCT02767388|11276251|FG000|COMPLETED|Overall Study||8
10145757|NCT02767388|11276252|FG001|COMPLETED|Overall Study||10
10145758|NCT02767388|11276253|FG002|COMPLETED|Overall Study||12
10145759|NCT02767388|11276251|FG000|NOT COMPLETED|Overall Study||7
10145760|NCT02767388|11276252|FG001|NOT COMPLETED|Overall Study||5
10145761|NCT02767388|11276253|FG002|NOT COMPLETED|Overall Study||3
10145762|NCT02767427|11276263|FG000|STARTED|Overall Study||21
10145763|NCT02767427|11276264|FG001|STARTED|Overall Study||19
10145764|NCT02767427|11276263|FG000|COMPLETED|Overall Study||21
10145765|NCT02767427|11276264|FG001|COMPLETED|Overall Study||19
10145766|NCT02767427|11276263|FG000|NOT COMPLETED|Overall Study||0
10145767|NCT02767427|11276264|FG001|NOT COMPLETED|Overall Study||0
10145768|NCT02767492|11276272|FG000|STARTED|Overall Study||45
10145769|NCT02767492|11276273|FG001|STARTED|Overall Study||45
10145770|NCT02767492|11276272|FG000|COMPLETED|Overall Study||35
10145771|NCT02767492|11276273|FG001|COMPLETED|Overall Study||35
10145772|NCT02767492|11276272|FG000|NOT COMPLETED|Overall Study||10
10145773|NCT02767492|11276273|FG001|NOT COMPLETED|Overall Study||10
10145774|NCT02767609|11276279|FG000|STARTED|Overall Study||1
10145775|NCT02767609|11276279|FG000|COMPLETED|Overall Study||1
10145776|NCT02767609|11276279|FG000|NOT COMPLETED|Overall Study||0
10145777|NCT02767765|11276283|FG000|STARTED|Overall Study||61
10145778|NCT02767765|11276283|FG000|COMPLETED|Overall Study||50
10145779|NCT02767765|11276283|FG000|NOT COMPLETED|Overall Study||11
10145780|NCT02767843|11276287|FG000|STARTED|Overall Study||4
10145781|NCT02767843|11276287|FG000|COMPLETED|Overall Study||4
10145782|NCT02767843|11276287|FG000|NOT COMPLETED|Overall Study||0
10145783|NCT02767869|11276295|FG000|STARTED|Overall Study||12
10145784|NCT02767869|11276296|FG001|STARTED|Overall Study||12
10145785|NCT02767869|11276295|FG000|COMPLETED|Overall Study||12
10145786|NCT02767869|11276296|FG001|COMPLETED|Overall Study||12
10145787|NCT02767869|11276295|FG000|NOT COMPLETED|Overall Study||0
10145788|NCT02767869|11276296|FG001|NOT COMPLETED|Overall Study||0
10145789|NCT02767934|11276302|FG000|STARTED|Overall Study||12
10145790|NCT02767934|11276302|FG000|COMPLETED|Overall Study||12
10145791|NCT02767934|11276302|FG000|NOT COMPLETED|Overall Study||0
10145792|NCT02767947|11276309|FG000|STARTED|Overall Study||60
10145793|NCT02767947|11276310|FG001|STARTED|Overall Study||15
10145794|NCT02767947|11276309|FG000|Safety Population|Overall Study||60
10145795|NCT02767947|11276310|FG001|Safety Population|Overall Study||15
10145796|NCT02767947|11276309|FG000|Pharmacokinetic (PK) Population|Overall Study||12
10145797|NCT02767947|11276310|FG001|Pharmacokinetic (PK) Population|Overall Study||3
10145798|NCT02767947|11276309|FG000|COMPLETED|Overall Study||60
10145799|NCT02767947|11276310|FG001|COMPLETED|Overall Study||15
10145800|NCT02767947|11276309|FG000|NOT COMPLETED|Overall Study||0
10145801|NCT02767947|11276310|FG001|NOT COMPLETED|Overall Study||0
10145802|NCT02768103|11276316|FG000|STARTED|Overall Study||5
10145803|NCT02768103|11276316|FG000|COMPLETED|Overall Study||4
10145804|NCT02768103|11276316|FG000|NOT COMPLETED|Overall Study||1
10145805|NCT02768129|11276322|FG000|STARTED|Overall Study||11
10145806|NCT02768129|11276323|FG001|STARTED|Overall Study||10
10145807|NCT02768129|11276322|FG000|COMPLETED|Overall Study||11
10145808|NCT02768129|11276323|FG001|COMPLETED|Overall Study||10
10145809|NCT02768129|11276322|FG000|NOT COMPLETED|Overall Study||0
10145810|NCT02768129|11276323|FG001|NOT COMPLETED|Overall Study||0
10145811|NCT02768194|11276329|FG000|STARTED|Period 1||4
10145812|NCT02768194|11276330|FG001|STARTED|Period 1||4
10145813|NCT02768194|11276331|FG002|STARTED|Period 1||4
10145814|NCT02768194|11276332|FG003|STARTED|Period 1||4
10145815|NCT02768194|11276333|FG004|STARTED|Period 1||4
10145816|NCT02768194|11276334|FG005|STARTED|Period 1||4
10145817|NCT02768194|11276329|FG000|COMPLETED|Period 1||4
10145818|NCT02768194|11276330|FG001|COMPLETED|Period 1||4
10145819|NCT02768194|11276331|FG002|COMPLETED|Period 1||4
10145820|NCT02768194|11276332|FG003|COMPLETED|Period 1||3
10145821|NCT02768194|11276333|FG004|COMPLETED|Period 1||4
10145822|NCT02768194|11276334|FG005|COMPLETED|Period 1||4
10145823|NCT02768194|11276329|FG000|NOT COMPLETED|Period 1||0
10145824|NCT02768194|11276330|FG001|NOT COMPLETED|Period 1||0
10145825|NCT02768194|11276331|FG002|NOT COMPLETED|Period 1||0
10145826|NCT02768194|11276332|FG003|NOT COMPLETED|Period 1||1
10145827|NCT02768194|11276333|FG004|NOT COMPLETED|Period 1||0
10145828|NCT02768194|11276334|FG005|NOT COMPLETED|Period 1||0
10145829|NCT02768194|11276329|FG000|STARTED|Period 2||4
10145830|NCT02768194|11276330|FG001|STARTED|Period 2||4
10145831|NCT02768194|11276331|FG002|STARTED|Period 2||4
10145832|NCT02768194|11276332|FG003|STARTED|Period 2||3
10145833|NCT02768194|11276333|FG004|STARTED|Period 2||4
10145834|NCT02768194|11276334|FG005|STARTED|Period 2||4
10145835|NCT02768194|11276329|FG000|COMPLETED|Period 2||3
10145836|NCT02768194|11276330|FG001|COMPLETED|Period 2||4
10145837|NCT02768194|11276331|FG002|COMPLETED|Period 2||4
10145838|NCT02768194|11276332|FG003|COMPLETED|Period 2||3
10145839|NCT02768194|11276333|FG004|COMPLETED|Period 2||4
10145840|NCT02768194|11276334|FG005|COMPLETED|Period 2||4
10145841|NCT02768194|11276329|FG000|NOT COMPLETED|Period 2||1
10145842|NCT02768194|11276330|FG001|NOT COMPLETED|Period 2||0
10145843|NCT02768194|11276331|FG002|NOT COMPLETED|Period 2||0
10145844|NCT02768194|11276332|FG003|NOT COMPLETED|Period 2||0
10145845|NCT02768194|11276333|FG004|NOT COMPLETED|Period 2||0
10145846|NCT02768194|11276334|FG005|NOT COMPLETED|Period 2||0
10145847|NCT02768194|11276329|FG000|STARTED|Period 3||3
10145848|NCT02768194|11276330|FG001|STARTED|Period 3||4
10145849|NCT02768194|11276331|FG002|STARTED|Period 3||4
10145850|NCT02768194|11276332|FG003|STARTED|Period 3||3
10145851|NCT02768194|11276333|FG004|STARTED|Period 3||4
10145852|NCT02768194|11276334|FG005|STARTED|Period 3||4
10145853|NCT02768194|11276329|FG000|COMPLETED|Period 3||3
10145854|NCT02768194|11276330|FG001|COMPLETED|Period 3||3
10145855|NCT02768194|11276331|FG002|COMPLETED|Period 3||4
10145856|NCT02768194|11276332|FG003|COMPLETED|Period 3||3
10145857|NCT02768194|11276333|FG004|COMPLETED|Period 3||4
10145858|NCT02768194|11276334|FG005|COMPLETED|Period 3||4
10145859|NCT02768194|11276329|FG000|NOT COMPLETED|Period 3||0
10145860|NCT02768194|11276330|FG001|NOT COMPLETED|Period 3||1
10145861|NCT02768194|11276331|FG002|NOT COMPLETED|Period 3||0
10145862|NCT02768194|11276332|FG003|NOT COMPLETED|Period 3||0
10145863|NCT02768194|11276333|FG004|NOT COMPLETED|Period 3||0
10145864|NCT02768194|11276334|FG005|NOT COMPLETED|Period 3||0
10145865|NCT02768298|11276344|FG000|STARTED|Overall Study||103
10145866|NCT02768298|11276345|FG001|STARTED|Overall Study||98
10145867|NCT02768298|11276344|FG000|COMPLETED|Overall Study||99
10145868|NCT02768298|11276345|FG001|COMPLETED|Overall Study||91
10145869|NCT02768298|11276344|FG000|NOT COMPLETED|Overall Study||4
10145870|NCT02768298|11276345|FG001|NOT COMPLETED|Overall Study||7
10145871|NCT02768558|11276353|FG000|STARTED|Overall Study||3
10145872|NCT02768558|11276354|FG001|STARTED|Overall Study||5
10145873|NCT02768558|11276353|FG000|Eligible|Overall Study||3
10145874|NCT02768558|11276354|FG001|Eligible|Overall Study||5
10145875|NCT02768558|11276353|FG000|COMPLETED|Overall Study||3
10145876|NCT02768558|11276354|FG001|COMPLETED|Overall Study||5
10145877|NCT02768558|11276353|FG000|NOT COMPLETED|Overall Study||0
10145878|NCT02768558|11276354|FG001|NOT COMPLETED|Overall Study||0
10145879|NCT02768753|11276362|FG000|STARTED|Overall Study||30
10145880|NCT02768753|11276363|FG001|STARTED|Overall Study||30
10145881|NCT02768753|11276362|FG000|COMPLETED|Overall Study||30
10145882|NCT02768753|11276363|FG001|COMPLETED|Overall Study||30
10145883|NCT02768753|11276362|FG000|NOT COMPLETED|Overall Study||0
10145884|NCT02768753|11276363|FG001|NOT COMPLETED|Overall Study||0
10145885|NCT02768792|11276369|FG000|STARTED|Overall Study||38
10145886|NCT02768792|11276369|FG000|COMPLETED|Overall Study||37
10145887|NCT02768792|11276369|FG000|NOT COMPLETED|Overall Study||1
10145888|NCT02769065|11276403|FG000|STARTED|Overall Study||17
10145889|NCT02769065|11276404|FG001|STARTED|Overall Study||6
10145890|NCT02769065|11276405|FG002|STARTED|Overall Study||6
10145891|NCT02769065|11276406|FG003|STARTED|Overall Study||6
10145892|NCT02769065|11276407|FG004|STARTED|Overall Study||6
10145893|NCT02769065|11276408|FG005|STARTED|Overall Study||6
10145894|NCT02769065|11276409|FG006|STARTED|Overall Study||7
10145895|NCT02769065|11276410|FG007|STARTED|Overall Study||6
10145896|NCT02769065|11276411|FG008|STARTED|Overall Study||6
10145897|NCT02769065|11276412|FG009|STARTED|Overall Study||6
10145898|NCT02769065|11276413|FG010|STARTED|Overall Study||6
10145899|NCT02769065|11276414|FG011|STARTED|Overall Study||6
10145900|NCT02769065|11276415|FG012|STARTED|Overall Study||6
10145901|NCT02769065|11276416|FG013|STARTED|Overall Study||6
10145902|NCT02769065|11276417|FG014|STARTED|Overall Study||6
10145903|NCT02769065|11276418|FG015|STARTED|Overall Study||3
10145904|NCT02769065|11276419|FG016|STARTED|Overall Study||5
10145905|NCT02769065|11276420|FG017|STARTED|Overall Study||5
10145906|NCT02769065|11276421|FG018|STARTED|Overall Study||5
10145907|NCT02769065|11276422|FG019|STARTED|Overall Study||0
10145908|NCT02769065|11276423|FG020|STARTED|Overall Study||4
10145909|NCT02769065|11276424|FG021|STARTED|Overall Study||4
10145910|NCT02769065|11276425|FG022|STARTED|Overall Study||4
10145911|NCT02769065|11276426|FG023|STARTED|Overall Study||6
10145912|NCT02769065|11276427|FG024|STARTED|Overall Study||6
10145913|NCT02769065|11276428|FG025|STARTED|Overall Study||9
10145914|NCT02769065|11276429|FG026|STARTED|Overall Study||9
10145915|NCT02769065|11276430|FG027|STARTED|Overall Study||5
10145916|NCT02769065|11276431|FG028|STARTED|Overall Study||6
10145917|NCT02769065|11276432|FG029|STARTED|Overall Study||6
10145918|NCT02769065|11276403|FG000|COMPLETED|Overall Study||16
10145919|NCT02769065|11276404|FG001|COMPLETED|Overall Study||6
10145920|NCT02769065|11276405|FG002|COMPLETED|Overall Study||6
10145921|NCT02769065|11276406|FG003|COMPLETED|Overall Study||6
10145922|NCT02769065|11276407|FG004|COMPLETED|Overall Study||6
10145923|NCT02769065|11276408|FG005|COMPLETED|Overall Study||6
10145924|NCT02769065|11276409|FG006|COMPLETED|Overall Study||6
10145925|NCT02769065|11276410|FG007|COMPLETED|Overall Study||6
10145926|NCT02769065|11276411|FG008|COMPLETED|Overall Study||6
10145927|NCT02769065|11276412|FG009|COMPLETED|Overall Study||6
10145928|NCT02769065|11276413|FG010|COMPLETED|Overall Study||5
10145929|NCT02769065|11276414|FG011|COMPLETED|Overall Study||6
9708484|NCT03568318|10807692|FG001|COMPLETED|Overall Study||249
9708485|NCT03568318|10807693|FG002|COMPLETED|Overall Study||250
9708486|NCT03568318|10807694|FG003|COMPLETED|Overall Study||59
9708487|NCT03568318|10807695|FG004|COMPLETED|Overall Study||58
9708488|NCT03568318|10807696|FG005|COMPLETED|Overall Study||60
9708489|NCT03568318|10807691|FG000|NOT COMPLETED|Overall Study||20
9708490|NCT03568318|10807692|FG001|NOT COMPLETED|Overall Study||12
9708491|NCT03568318|10807693|FG002|NOT COMPLETED|Overall Study||10
9708492|NCT03568318|10807694|FG003|NOT COMPLETED|Overall Study||4
9708493|NCT03568318|10807695|FG004|NOT COMPLETED|Overall Study||2
9708494|NCT03568318|10807696|FG005|NOT COMPLETED|Overall Study||0
9708495|NCT03498560|10807710|FG000|STARTED|Overall Study||38
9708496|NCT03498560|10807710|FG000|Completed Baseline Assessment|Overall Study||32
9708497|NCT03498560|10807710|FG000|Completed PSG|Overall Study||25
9708498|NCT03498560|10807710|FG000|COMPLETED|Overall Study||17
9708499|NCT03498560|10807710|FG000|NOT COMPLETED|Overall Study||21
9708500|NCT03441360|10807718|FG000|STARTED|Overall Study||8
9708501|NCT03441360|10807719|FG001|STARTED|Overall Study||8
9708502|NCT03441360|10807720|FG002|STARTED|Overall Study||5
9708503|NCT03441360|10807718|FG000|COMPLETED|Overall Study||0
9708504|NCT03441360|10807719|FG001|COMPLETED|Overall Study||0
9708505|NCT03441360|10807720|FG002|COMPLETED|Overall Study||0
9708506|NCT03441360|10807718|FG000|NOT COMPLETED|Overall Study||8
9708507|NCT03441360|10807719|FG001|NOT COMPLETED|Overall Study||8
9708508|NCT03441360|10807720|FG002|NOT COMPLETED|Overall Study||5
9708509|NCT03434379|10807730|FG000|STARTED|Global Period||165
9708510|NCT03434379|10807731|FG001|STARTED|Global Period||336
9708511|NCT03434379|10807732|FG002|STARTED|Global Period||0
9708512|NCT03434379|10807733|FG003|STARTED|Global Period||0
9708513|NCT03434379|10807730|FG000|COMPLETED|Global Period||0
9708514|NCT03434379|10807731|FG001|COMPLETED|Global Period||0
9708515|NCT03434379|10807732|FG002|COMPLETED|Global Period||0
9708516|NCT03434379|10807733|FG003|COMPLETED|Global Period||0
9708517|NCT03434379|10807730|FG000|NOT COMPLETED|Global Period||165
10145930|NCT02769065|11276415|FG012|COMPLETED|Overall Study||6
9708518|NCT03434379|10807731|FG001|NOT COMPLETED|Global Period||336
9708519|NCT03434379|10807732|FG002|NOT COMPLETED|Global Period||0
9708520|NCT03434379|10807733|FG003|NOT COMPLETED|Global Period||0
9708521|NCT03434379|10807730|FG000|STARTED|China Extension Period||0
9708522|NCT03434379|10807731|FG001|STARTED|China Extension Period||0
9708523|NCT03434379|10807732|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61
9708524|NCT03434379|10807733|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133
10145931|NCT02769065|11276416|FG013|COMPLETED|Overall Study||6
10145932|NCT02769065|11276417|FG014|COMPLETED|Overall Study||6
10145933|NCT02769065|11276418|FG015|COMPLETED|Overall Study||3
10145934|NCT02769065|11276419|FG016|COMPLETED|Overall Study||5
10145935|NCT02769065|11276420|FG017|COMPLETED|Overall Study||5
10145936|NCT02769065|11276421|FG018|COMPLETED|Overall Study||5
10145937|NCT02769065|11276422|FG019|COMPLETED|Overall Study||0
10145938|NCT02769065|11276423|FG020|COMPLETED|Overall Study||4
10145939|NCT02769065|11276424|FG021|COMPLETED|Overall Study||4
10145940|NCT02769065|11276425|FG022|COMPLETED|Overall Study||4
10145941|NCT02769065|11276426|FG023|COMPLETED|Overall Study||6
10145942|NCT02769065|11276427|FG024|COMPLETED|Overall Study||6
10145943|NCT02769065|11276428|FG025|COMPLETED|Overall Study||9
10145944|NCT02769065|11276429|FG026|COMPLETED|Overall Study||9
10145945|NCT02769065|11276430|FG027|COMPLETED|Overall Study||5
10145946|NCT02769065|11276431|FG028|COMPLETED|Overall Study||6
10145947|NCT02769065|11276432|FG029|COMPLETED|Overall Study||6
10145948|NCT02769065|11276403|FG000|NOT COMPLETED|Overall Study||1
10145949|NCT02769065|11276404|FG001|NOT COMPLETED|Overall Study||0
10145950|NCT02769065|11276405|FG002|NOT COMPLETED|Overall Study||0
10145951|NCT02769065|11276406|FG003|NOT COMPLETED|Overall Study||0
10145952|NCT02769065|11276407|FG004|NOT COMPLETED|Overall Study||0
10145953|NCT02769065|11276408|FG005|NOT COMPLETED|Overall Study||0
10145954|NCT02769065|11276409|FG006|NOT COMPLETED|Overall Study||1
10145955|NCT02769065|11276410|FG007|NOT COMPLETED|Overall Study||0
10145956|NCT02769065|11276411|FG008|NOT COMPLETED|Overall Study||0
10145957|NCT02769065|11276412|FG009|NOT COMPLETED|Overall Study||0
10145958|NCT02769065|11276413|FG010|NOT COMPLETED|Overall Study||1
10145959|NCT02769065|11276414|FG011|NOT COMPLETED|Overall Study||0
10145960|NCT02769065|11276415|FG012|NOT COMPLETED|Overall Study||0
10145961|NCT02769065|11276416|FG013|NOT COMPLETED|Overall Study||0
10145962|NCT02769065|11276417|FG014|NOT COMPLETED|Overall Study||0
10145963|NCT02769065|11276418|FG015|NOT COMPLETED|Overall Study||0
10145964|NCT02769065|11276419|FG016|NOT COMPLETED|Overall Study||0
10145965|NCT02769065|11276420|FG017|NOT COMPLETED|Overall Study||0
10145966|NCT02769065|11276421|FG018|NOT COMPLETED|Overall Study||0
10145967|NCT02769065|11276422|FG019|NOT COMPLETED|Overall Study||0
10145968|NCT02769065|11276423|FG020|NOT COMPLETED|Overall Study||0
10145969|NCT02769065|11276424|FG021|NOT COMPLETED|Overall Study||0
10145970|NCT02769065|11276425|FG022|NOT COMPLETED|Overall Study||0
10145971|NCT02769065|11276426|FG023|NOT COMPLETED|Overall Study||0
10145972|NCT02769065|11276427|FG024|NOT COMPLETED|Overall Study||0
10145973|NCT02769065|11276428|FG025|NOT COMPLETED|Overall Study||0
10145974|NCT02769065|11276429|FG026|NOT COMPLETED|Overall Study||0
10145975|NCT02769065|11276430|FG027|NOT COMPLETED|Overall Study||0
10145976|NCT02769065|11276431|FG028|NOT COMPLETED|Overall Study||0
10145977|NCT02769065|11276432|FG029|NOT COMPLETED|Overall Study||0
10145978|NCT02769247|11276529|FG000|STARTED|Overall Study||40
10145979|NCT02769247|11276530|FG001|STARTED|Overall Study||40
10145980|NCT02769247|11276531|FG002|STARTED|Overall Study||40
10145981|NCT02769247|11276532|FG003|STARTED|Overall Study||40
10145982|NCT02769247|11276529|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
10145983|NCT02769247|11276530|FG001|COMPLETED|Overall Study||40
10145984|NCT02769247|11276531|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
10145985|NCT02769247|11276532|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
10145986|NCT02769247|11276529|FG000|NOT COMPLETED|Overall Study||2
10145987|NCT02769247|11276530|FG001|NOT COMPLETED|Overall Study||0
10145988|NCT02769247|11276531|FG002|NOT COMPLETED|Overall Study||1
10145989|NCT02769247|11276532|FG003|NOT COMPLETED|Overall Study||1
10145990|NCT02769312|11276548|FG000|STARTED|Double-Blind (0-2 Weeks)||25
10145991|NCT02769312|11276549|FG001|STARTED|Double-Blind (0-2 Weeks)||25
10145992|NCT02769312|11276548|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23
10145993|NCT02769312|11276549|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24
10145994|NCT02769312|11276548|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
10145995|NCT02769312|11276549|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
10145996|NCT02769312|11276548|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
10145997|NCT02769312|11276549|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24
10145998|NCT02769312|11276548|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
10145999|NCT02769312|11276549|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
10146000|NCT02769312|11276548|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
10146001|NCT02769312|11276549|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
10146002|NCT02769312|11276548|FG000|STARTED|Follow-up||23
10146003|NCT02769312|11276549|FG001|STARTED|Follow-up||24
10146004|NCT02769312|11276548|FG000|COMPLETED|Follow-up||22
10146005|NCT02769312|11276549|FG001|COMPLETED|Follow-up||23
10146006|NCT02769312|11276548|FG000|NOT COMPLETED|Follow-up||1
10146007|NCT02769312|11276549|FG001|NOT COMPLETED|Follow-up||1
10146008|NCT02769351|11276556|FG000|STARTED|Overall Study|SP|46
10146009|NCT02769351|11276556|FG000|COMPLETED|Overall Study|SP|4
10146010|NCT02769351|11276556|FG000|NOT COMPLETED|Overall Study||42
10146011|NCT02769442|11276563|FG000|STARTED|Overall Study||309
10146012|NCT02769442|11276564|FG001|STARTED|Overall Study||291
10146013|NCT02769442|11276563|FG000|COMPLETED|Overall Study||309
10146014|NCT02769442|11276564|FG001|COMPLETED|Overall Study||291
10146015|NCT02769442|11276563|FG000|NOT COMPLETED|Overall Study||0
10146016|NCT02769442|11276564|FG001|NOT COMPLETED|Overall Study||0
10146017|NCT02769481|11276572|FG000|STARTED|Overall Study||213
10146018|NCT02769481|11276573|FG001|STARTED|Overall Study||213
10146019|NCT02769481|11276572|FG000|Study Complete at Week 60|Overall Study||193
10146020|NCT02769481|11276573|FG001|Study Complete at Week 60|Overall Study||192
10146021|NCT02769481|11276572|FG000|COMPLETED|Overall Study||180
10146022|NCT02769481|11276573|FG001|COMPLETED|Overall Study||177
10146023|NCT02769481|11276572|FG000|NOT COMPLETED|Overall Study||33
10146024|NCT02769481|11276573|FG001|NOT COMPLETED|Overall Study||36
10146025|NCT02769624|11276579|FG000|STARTED|Overall Study||7
10146026|NCT02769624|11276580|FG001|STARTED|Overall Study||8
10146027|NCT02769624|11276579|FG000|COMPLETED|Overall Study||7
10146028|NCT02769624|11276580|FG001|COMPLETED|Overall Study||7
10146029|NCT02769624|11276579|FG000|NOT COMPLETED|Overall Study||0
10146030|NCT02769624|11276580|FG001|NOT COMPLETED|Overall Study||1
10146031|NCT02769702|11276586|FG000|STARTED|Overall Study||2
10146032|NCT02769702|11276586|FG000|COMPLETED|Overall Study||2
10146033|NCT02769702|11276586|FG000|NOT COMPLETED|Overall Study||0
10146034|NCT02769858|11276590|FG000|STARTED|Overall Study||10
10146035|NCT02769858|11276590|FG000|COMPLETED|Overall Study||8
10146036|NCT02769858|11276590|FG000|NOT COMPLETED|Overall Study||2
10146037|NCT02770014|11276594|FG000|STARTED|Plasma Genotyping||43
10146038|NCT02770014|11276594|FG000|COMPLETED|Plasma Genotyping||43
10146039|NCT02770014|11276594|FG000|NOT COMPLETED|Plasma Genotyping||0
10146040|NCT02770014|11276594|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
9708525|NCT03434379|10807730|FG000|COMPLETED|China Extension Period||0
9708526|NCT03434379|10807731|FG001|COMPLETED|China Extension Period||0
9708527|NCT03434379|10807732|FG002|COMPLETED|China Extension Period||0
9708528|NCT03434379|10807733|FG003|COMPLETED|China Extension Period||0
9708529|NCT03434379|10807730|FG000|NOT COMPLETED|China Extension Period||0
9708530|NCT03434379|10807731|FG001|NOT COMPLETED|China Extension Period||0
9708531|NCT03434379|10807732|FG002|NOT COMPLETED|China Extension Period||61
9708532|NCT03434379|10807733|FG003|NOT COMPLETED|China Extension Period||133
9708533|NCT03368170|10807747|FG000|STARTED|Overall Study||39
9708534|NCT03368170|10807748|FG001|STARTED|Overall Study||36
9708535|NCT03368170|10807747|FG000|COMPLETED|Overall Study||37
9708536|NCT03368170|10807748|FG001|COMPLETED|Overall Study||35
9708537|NCT03368170|10807747|FG000|NOT COMPLETED|Overall Study||2
9708538|NCT03368170|10807748|FG001|NOT COMPLETED|Overall Study||1
9708539|NCT03336528|10807756|FG000|STARTED|Overall Study||92
9708540|NCT03336528|10807757|FG001|STARTED|Overall Study||88
9708541|NCT03336528|10807756|FG000|Participated in Optional Outpatient Study|Overall Study||72
9708542|NCT03336528|10807757|FG001|Participated in Optional Outpatient Study|Overall Study||59
9708543|NCT03336528|10807756|FG000|COMPLETED|Overall Study||82
9708544|NCT03336528|10807757|FG001|COMPLETED|Overall Study||79
9708545|NCT03336528|10807756|FG000|NOT COMPLETED|Overall Study||10
9708546|NCT03336528|10807757|FG001|NOT COMPLETED|Overall Study||9
9708547|NCT03334409|10807767|FG000|STARTED|Overall Study||2
9708548|NCT03334409|10807768|FG001|STARTED|Overall Study||3
9708549|NCT03334409|10807767|FG000|COMPLETED|Overall Study||1
9708550|NCT03334409|10807768|FG001|COMPLETED|Overall Study||3
9708551|NCT03334409|10807767|FG000|NOT COMPLETED|Overall Study||1
9708552|NCT03334409|10807768|FG001|NOT COMPLETED|Overall Study||0
9708553|NCT03287843|10807776|FG000|STARTED|Overall Study||175
9708554|NCT03287843|10807777|FG001|STARTED|Overall Study||175
9708555|NCT03287843|10807776|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
9708556|NCT03287843|10807777|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
9708557|NCT03287843|10807776|FG000|Lost to Follow up|Overall Study||3
9708558|NCT03287843|10807777|FG001|Lost to Follow up|Overall Study||0
9708559|NCT03287843|10807776|FG000|COMPLETED|Overall Study||160
9708560|NCT03287843|10807777|FG001|COMPLETED|Overall Study||167
9708561|NCT03287843|10807776|FG000|NOT COMPLETED|Overall Study||15
9708562|NCT03287843|10807777|FG001|NOT COMPLETED|Overall Study||8
9708563|NCT03230292|10807783|FG000|STARTED|Overall Study||43
9708564|NCT03230292|10807783|FG000|COMPLETED|Overall Study||37
9708565|NCT03230292|10807783|FG000|NOT COMPLETED|Overall Study||6
9729337|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
9729338|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
9729339|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 193 - 240||209
9729340|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 193 - 240||106
9729341|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202
9729342|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103
9729343|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
9848900|NCT00862849|10961752|FG000|STARTED|Intervention 1||3
9963854|NCT01488994|11083644|FG000|STARTED|Overall Study||11
9729344|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
9729345|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 241 - 288||202
9729346|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 241 - 288||103
9729347|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192
9729348|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100
9729349|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
9729350|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
9729351|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 289 - 336||192
9729352|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 289 - 336||100
9729353|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183
9729354|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93
10146041|NCT02770014|11276594|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
10146042|NCT02770014|11276594|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
10146043|NCT02770170|11276603|FG000|STARTED|Overall Study||21
10146044|NCT02770170|11276604|FG001|STARTED|Overall Study||20
10146045|NCT02770170|11276605|FG002|STARTED|Overall Study||40
10146046|NCT02770170|11276606|FG003|STARTED|Overall Study||40
10146047|NCT02770170|11276603|FG000|COMPLETED|Overall Study||14
10146048|NCT02770170|11276604|FG001|COMPLETED|Overall Study||17
10146049|NCT02770170|11276605|FG002|COMPLETED|Overall Study||35
10146050|NCT02770170|11276606|FG003|COMPLETED|Overall Study||33
10146051|NCT02770170|11276603|FG000|NOT COMPLETED|Overall Study||7
10146052|NCT02770170|11276604|FG001|NOT COMPLETED|Overall Study||3
10146053|NCT02770170|11276605|FG002|NOT COMPLETED|Overall Study||5
10146054|NCT02770170|11276606|FG003|NOT COMPLETED|Overall Study||7
10146055|NCT02770248|11276618|FG000|STARTED|Overall Study||62
10146056|NCT02770248|11276619|FG001|STARTED|Overall Study||63
10146057|NCT02770248|11276618|FG000|COMPLETED|Overall Study||62
10146058|NCT02770248|11276619|FG001|COMPLETED|Overall Study||61
10146059|NCT02770248|11276618|FG000|NOT COMPLETED|Overall Study||0
10146060|NCT02770248|11276619|FG001|NOT COMPLETED|Overall Study||2
10146061|NCT02770287|11276625|FG000|STARTED|Overall Study||11
10146062|NCT02770287|11276625|FG000|COMPLETED|Overall Study||11
10146063|NCT02770287|11276625|FG000|NOT COMPLETED|Overall Study||0
10146064|NCT02770365|11276635|FG000|STARTED|Overall Study||277
10146065|NCT02770365|11276636|FG001|STARTED|Overall Study||279
10146066|NCT02770365|11276637|FG002|STARTED|Overall Study||139
10146067|NCT02770365|11276635|FG000|COMPLETED|Overall Study||272
10146068|NCT02770365|11276636|FG001|COMPLETED|Overall Study||275
10146069|NCT02770365|11276637|FG002|COMPLETED|Overall Study||139
10146070|NCT02770365|11276635|FG000|NOT COMPLETED|Overall Study||5
10146071|NCT02770365|11276636|FG001|NOT COMPLETED|Overall Study||4
10146072|NCT02770365|11276637|FG002|NOT COMPLETED|Overall Study||0
10146073|NCT02770521|11276647|FG000|STARTED|Period One||4
10146074|NCT02770521|11276648|FG001|STARTED|Period One||4
10146075|NCT02770521|11276649|FG002|STARTED|Period One||2
10146076|NCT02770521|11276650|FG003|STARTED|Period One||2
10146077|NCT02770521|11276651|FG004|STARTED|Period One||2
10146078|NCT02770521|11276652|FG005|STARTED|Period One||9
10146079|NCT02770521|11276647|FG000|Received Study Drug|Period One||4
10146080|NCT02770521|11276648|FG001|Received Study Drug|Period One||4
10146081|NCT02770521|11276649|FG002|Received Study Drug|Period One||2
10146082|NCT02770521|11276650|FG003|Received Study Drug|Period One||2
10146083|NCT02770521|11276651|FG004|Received Study Drug|Period One||2
10146084|NCT02770521|11276652|FG005|Received Study Drug|Period One||9
10146085|NCT02770521|11276647|FG000|COMPLETED|Period One||4
10146086|NCT02770521|11276648|FG001|COMPLETED|Period One||4
10146087|NCT02770521|11276649|FG002|COMPLETED|Period One||2
10146088|NCT02770521|11276650|FG003|COMPLETED|Period One||2
10146089|NCT02770521|11276651|FG004|COMPLETED|Period One||2
10146090|NCT02770521|11276652|FG005|COMPLETED|Period One||9
10146091|NCT02770521|11276647|FG000|NOT COMPLETED|Period One||0
10146092|NCT02770521|11276648|FG001|NOT COMPLETED|Period One||0
10146093|NCT02770521|11276649|FG002|NOT COMPLETED|Period One||0
10146094|NCT02770521|11276650|FG003|NOT COMPLETED|Period One||0
10146095|NCT02770521|11276651|FG004|NOT COMPLETED|Period One||0
10146096|NCT02770521|11276652|FG005|NOT COMPLETED|Period One||0
10146097|NCT02770521|11276647|FG000|STARTED|Period Two||4
10146098|NCT02770521|11276648|FG001|STARTED|Period Two||4
10146099|NCT02770521|11276649|FG002|STARTED|Period Two||2
10146100|NCT02770521|11276650|FG003|STARTED|Period Two||2
10146101|NCT02770521|11276651|FG004|STARTED|Period Two||2
10146102|NCT02770521|11276652|FG005|STARTED|Period Two||9
10146103|NCT02770521|11276647|FG000|Received Study Drug|Period Two||4
10146104|NCT02770521|11276648|FG001|Received Study Drug|Period Two||4
10146105|NCT02770521|11276649|FG002|Received Study Drug|Period Two||2
10146106|NCT02770521|11276650|FG003|Received Study Drug|Period Two||2
10146107|NCT02770521|11276651|FG004|Received Study Drug|Period Two||2
10146108|NCT02770521|11276652|FG005|Received Study Drug|Period Two||9
10146109|NCT02770521|11276647|FG000|COMPLETED|Period Two||4
10146110|NCT02770521|11276648|FG001|COMPLETED|Period Two||4
10146111|NCT02770521|11276649|FG002|COMPLETED|Period Two||2
10146112|NCT02770521|11276650|FG003|COMPLETED|Period Two||2
10146113|NCT02770521|11276651|FG004|COMPLETED|Period Two||2
10146114|NCT02770521|11276652|FG005|COMPLETED|Period Two||9
10146115|NCT02770521|11276647|FG000|NOT COMPLETED|Period Two||0
10146116|NCT02770521|11276648|FG001|NOT COMPLETED|Period Two||0
10146117|NCT02770521|11276649|FG002|NOT COMPLETED|Period Two||0
10146118|NCT02770521|11276650|FG003|NOT COMPLETED|Period Two||0
10146119|NCT02770521|11276651|FG004|NOT COMPLETED|Period Two||0
10146120|NCT02770521|11276652|FG005|NOT COMPLETED|Period Two||0
10146121|NCT02770521|11276647|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0
10146122|NCT02770521|11276648|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0
10146123|NCT02770521|11276649|FG002|STARTED|Period Three||2
10146124|NCT02770521|11276650|FG003|STARTED|Period Three||2
10146125|NCT02770521|11276651|FG004|STARTED|Period Three||2
10146126|NCT02770521|11276652|FG005|STARTED|Period Three||9
10146127|NCT02770521|11276647|FG000|Received Study Drug|Period Three||0
10146128|NCT02770521|11276648|FG001|Received Study Drug|Period Three||0
10146129|NCT02770521|11276649|FG002|Received Study Drug|Period Three||2
10146130|NCT02770521|11276650|FG003|Received Study Drug|Period Three||2
10146131|NCT02770521|11276651|FG004|Received Study Drug|Period Three||2
10146132|NCT02770521|11276652|FG005|Received Study Drug|Period Three||9
10146133|NCT02770521|11276647|FG000|COMPLETED|Period Three||0
10146134|NCT02770521|11276648|FG001|COMPLETED|Period Three||0
10146135|NCT02770521|11276649|FG002|COMPLETED|Period Three||2
10146136|NCT02770521|11276650|FG003|COMPLETED|Period Three||2
10146137|NCT02770521|11276651|FG004|COMPLETED|Period Three||2
10146138|NCT02770521|11276652|FG005|COMPLETED|Period Three||9
10146139|NCT02770521|11276647|FG000|NOT COMPLETED|Period Three||0
10146140|NCT02770521|11276648|FG001|NOT COMPLETED|Period Three||0
10146141|NCT02770521|11276649|FG002|NOT COMPLETED|Period Three||0
10146142|NCT02770521|11276650|FG003|NOT COMPLETED|Period Three||0
10146143|NCT02770521|11276651|FG004|NOT COMPLETED|Period Three||0
10146144|NCT02770521|11276652|FG005|NOT COMPLETED|Period Three||0
10146145|NCT02770547|11276672|FG000|STARTED|Overall Study||16
10146146|NCT02770547|11276673|FG001|STARTED|Overall Study||16
10146147|NCT02770547|11276672|FG000|COMPLETED|Overall Study||15
10146148|NCT02770547|11276673|FG001|COMPLETED|Overall Study||15
10146149|NCT02770547|11276672|FG000|NOT COMPLETED|Overall Study||1
10146150|NCT02770547|11276673|FG001|NOT COMPLETED|Overall Study||1
10146151|NCT02770612|11276679|FG000|STARTED|Overall Study||51
10146152|NCT02770612|11276679|FG000|COMPLETED|Overall Study||50
10146153|NCT02770612|11276679|FG000|NOT COMPLETED|Overall Study||1
10146154|NCT02770625|11276683|FG000|STARTED|Overall Study||8
10146155|NCT02770625|11276683|FG000|COMPLETED|Overall Study||8
10146156|NCT02770625|11276683|FG000|NOT COMPLETED|Overall Study||0
10146157|NCT02770820|11276687|FG000|STARTED|Overall Study||7
10146158|NCT02770820|11276687|FG000|COMPLETED|Overall Study||4
10146159|NCT02770820|11276687|FG000|NOT COMPLETED|Overall Study||3
10146160|NCT02770846|11276693|FG000|STARTED|Overall Study||25
10146161|NCT02770846|11276694|FG001|STARTED|Overall Study||25
10146162|NCT02770846|11276693|FG000|COMPLETED|Overall Study||25
10146163|NCT02770846|11276694|FG001|COMPLETED|Overall Study||25
10146164|NCT02770846|11276693|FG000|NOT COMPLETED|Overall Study||0
10146165|NCT02770846|11276694|FG001|NOT COMPLETED|Overall Study||0
10146166|NCT02771093|11276704|FG000|STARTED|Overall Study||13
10146167|NCT02771093|11276705|FG001|STARTED|Overall Study||14
10146168|NCT02771093|11276704|FG000|COMPLETED|Overall Study||13
10146169|NCT02771093|11276705|FG001|COMPLETED|Overall Study||14
10146170|NCT02771093|11276704|FG000|NOT COMPLETED|Overall Study||0
10146171|NCT02771093|11276705|FG001|NOT COMPLETED|Overall Study||0
10146172|NCT02771145|11276711|FG000|STARTED|Overall Study||90
10146173|NCT02771145|11276711|FG000|COMPLETED|Overall Study||86
10146174|NCT02771145|11276711|FG000|NOT COMPLETED|Overall Study||4
10146175|NCT02771210|11276733|FG000|STARTED|Period 1||102
10146176|NCT02771210|11276734|FG001|STARTED|Period 1||102
10146177|NCT02771210|11276733|FG000|COMPLETED|Period 1||91
10146178|NCT02771210|11276734|FG001|COMPLETED|Period 1||84
10146179|NCT02771210|11276733|FG000|NOT COMPLETED|Period 1||11
10146180|NCT02771210|11276734|FG001|NOT COMPLETED|Period 1||18
10146181|NCT02771210|11276733|FG000|STARTED|Period 2||91
10146182|NCT02771210|11276734|FG001|STARTED|Period 2||84
10146183|NCT02771210|11276733|FG000|COMPLETED|Period 2||89
10146184|NCT02771210|11276734|FG001|COMPLETED|Period 2||81
10146185|NCT02771210|11276733|FG000|NOT COMPLETED|Period 2||2
10146186|NCT02771210|11276734|FG001|NOT COMPLETED|Period 2||3
10146187|NCT02771340|11276743|FG000|STARTED|Overall Study||2
10146188|NCT02771340|11276744|FG001|STARTED|Overall Study||3
10146189|NCT02771340|11276745|FG002|STARTED|Overall Study||5
10146190|NCT02771340|11276743|FG000|COMPLETED|Overall Study||2
10146191|NCT02771340|11276744|FG001|COMPLETED|Overall Study||3
10146192|NCT02771340|11276745|FG002|COMPLETED|Overall Study||5
10146193|NCT02771340|11276743|FG000|NOT COMPLETED|Overall Study||0
10146194|NCT02771340|11276744|FG001|NOT COMPLETED|Overall Study||0
10146195|NCT02771340|11276745|FG002|NOT COMPLETED|Overall Study||0
10146196|NCT02771366|11276755|FG000|STARTED|Period 1||15
10146197|NCT02771366|11276756|FG001|STARTED|Period 1||15
10146198|NCT02771366|11276755|FG000|COMPLETED|Period 1||15
10146199|NCT02771366|11276756|FG001|COMPLETED|Period 1||13
10146200|NCT02771366|11276755|FG000|NOT COMPLETED|Period 1||0
10146201|NCT02771366|11276756|FG001|NOT COMPLETED|Period 1||2
10146202|NCT02771366|11276755|FG000|STARTED|Period 2 (Crossover)||15
10146203|NCT02771366|11276756|FG001|STARTED|Period 2 (Crossover)||13
10146204|NCT02771366|11276755|FG000|COMPLETED|Period 2 (Crossover)||13
10146205|NCT02771366|11276756|FG001|COMPLETED|Period 2 (Crossover)||13
10146206|NCT02771366|11276755|FG000|NOT COMPLETED|Period 2 (Crossover)||2
10146207|NCT02771366|11276756|FG001|NOT COMPLETED|Period 2 (Crossover)||0
10146208|NCT02771522|11276763|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
10146209|NCT02771522|11276763|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
10146210|NCT02771522|11276763|FG000|NOT COMPLETED|Overall Study||8
10146211|NCT02771574|11276777|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
10146212|NCT02771574|11276778|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146213|NCT02771574|11276779|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146214|NCT02771574|11276780|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146215|NCT02771574|11276781|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146216|NCT02771574|11276777|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
10146217|NCT02771574|11276778|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146218|NCT02771574|11276779|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146219|NCT02771574|11276780|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146220|NCT02771574|11276781|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146221|NCT02771574|11276777|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146222|NCT02771574|11276778|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146223|NCT02771574|11276779|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146224|NCT02771574|11276780|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146225|NCT02771574|11276781|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10146226|NCT02771574|11276777|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146227|NCT02771574|11276778|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
10146228|NCT02771574|11276779|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146229|NCT02771574|11276780|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146230|NCT02771574|11276781|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146231|NCT02771574|11276777|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
9708575|NCT03131960|10807804|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
9708576|NCT03131960|10807805|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
9708577|NCT03131960|10807804|FG000|COMPLETED|Overall Study||53
9708578|NCT03131960|10807805|FG001|COMPLETED|Overall Study||54
9708579|NCT03131960|10807804|FG000|NOT COMPLETED|Overall Study||0
9708580|NCT03131960|10807805|FG001|NOT COMPLETED|Overall Study||1
9708581|NCT03084536|10807814|FG000|STARTED|Overall Study||53
9708582|NCT03084536|10807815|FG001|STARTED|Overall Study||54
9708583|NCT03084536|10807816|FG002|STARTED|Overall Study||27
9708584|NCT03084536|10807814|FG000|COMPLETED|Overall Study||53
9708585|NCT03084536|10807815|FG001|COMPLETED|Overall Study||54
9708586|NCT03084536|10807816|FG002|COMPLETED|Overall Study||0
9708587|NCT03084536|10807814|FG000|NOT COMPLETED|Overall Study||0
9708588|NCT03084536|10807815|FG001|NOT COMPLETED|Overall Study||0
9708589|NCT03084536|10807816|FG002|NOT COMPLETED|Overall Study||27
9708590|NCT02996305|10807826|FG000|STARTED|Overall Study||29
9708591|NCT02996305|10807827|FG001|STARTED|Overall Study||29
9708592|NCT02996305|10807828|FG002|STARTED|Overall Study||30
9708593|NCT02996305|10807826|FG000|COMPLETED|Overall Study||26
9708594|NCT02996305|10807827|FG001|COMPLETED|Overall Study||27
9708595|NCT02996305|10807828|FG002|COMPLETED|Overall Study||25
9708596|NCT02996305|10807826|FG000|NOT COMPLETED|Overall Study||3
9708597|NCT02996305|10807827|FG001|NOT COMPLETED|Overall Study||2
9708598|NCT02996305|10807828|FG002|NOT COMPLETED|Overall Study||5
9708599|NCT02992119|10807843|FG000|STARTED|Overall Study||21
9708600|NCT02992119|10807844|FG001|STARTED|Overall Study||21
9708601|NCT02992119|10807845|FG002|STARTED|Overall Study||30
9708602|NCT02992119|10807846|FG003|STARTED|Overall Study||30
9708603|NCT02992119|10807847|FG004|STARTED|Overall Study||30
9708604|NCT02992119|10807848|FG005|STARTED|Overall Study||30
9708605|NCT02992119|10807849|FG006|STARTED|Overall Study||31
9708606|NCT02992119|10807843|FG000|COMPLETED|Overall Study||19
9708607|NCT02992119|10807844|FG001|COMPLETED|Overall Study||20
9708608|NCT02992119|10807845|FG002|COMPLETED|Overall Study||29
9708609|NCT02992119|10807846|FG003|COMPLETED|Overall Study||30
9708610|NCT02992119|10807847|FG004|COMPLETED|Overall Study||30
9708611|NCT02992119|10807848|FG005|COMPLETED|Overall Study||30
9708612|NCT02992119|10807849|FG006|COMPLETED|Overall Study||28
9708613|NCT02992119|10807843|FG000|NOT COMPLETED|Overall Study||2
9708614|NCT02992119|10807844|FG001|NOT COMPLETED|Overall Study||1
9708615|NCT02992119|10807845|FG002|NOT COMPLETED|Overall Study||1
9708616|NCT02992119|10807846|FG003|NOT COMPLETED|Overall Study||0
9708617|NCT02992119|10807847|FG004|NOT COMPLETED|Overall Study||0
9708618|NCT02992119|10807848|FG005|NOT COMPLETED|Overall Study||0
9708619|NCT02992119|10807849|FG006|NOT COMPLETED|Overall Study||3
9708620|NCT02988661|10807868|FG000|STARTED|Overall Study||168
9708621|NCT02988661|10807869|FG001|STARTED|Overall Study||531
9708622|NCT02988661|10807868|FG000|COMPLETED|Overall Study||165
9708623|NCT02988661|10807869|FG001|COMPLETED|Overall Study||447
9708624|NCT02988661|10807868|FG000|NOT COMPLETED|Overall Study||3
9708625|NCT02988661|10807869|FG001|NOT COMPLETED|Overall Study||84
9708629|NCT02921776|10807885|FG000|STARTED|Overall Study||13
9708630|NCT02921776|10807886|FG001|STARTED|Overall Study||23
9708631|NCT02921776|10807887|FG002|STARTED|Overall Study||7
9708632|NCT02921776|10807888|FG003|STARTED|Overall Study||31
9708633|NCT02921776|10807889|FG004|STARTED|Overall Study||32
9708634|NCT02921776|10807890|FG005|STARTED|Overall Study||7
9708635|NCT02921776|10807891|FG006|STARTED|Overall Study||18
9708636|NCT02921776|10807892|FG007|STARTED|Overall Study||16
9708637|NCT02921776|10807885|FG000|COMPLETED|Overall Study||11
9708638|NCT02921776|10807886|FG001|COMPLETED|Overall Study||15
9708639|NCT02921776|10807887|FG002|COMPLETED|Overall Study||7
9708640|NCT02921776|10807888|FG003|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 23|23
9708641|NCT02921776|10807889|FG004|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 26|26
9708642|NCT02921776|10807890|FG005|COMPLETED|Overall Study||5
9708643|NCT02921776|10807891|FG006|COMPLETED|Overall Study|"At discharge/ extubation =11~1-mos post-discharge = 8 3-mos post-discharge = 8"|7
9708644|NCT02921776|10807892|FG007|COMPLETED|Overall Study|"At discharge/ extubation =15~1-mos post-discharge = 12 3-mos post-discharge = 11"|9
9708645|NCT02921776|10807885|FG000|NOT COMPLETED|Overall Study||2
9708646|NCT02921776|10807886|FG001|NOT COMPLETED|Overall Study||8
10146232|NCT02771574|11276778|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
10146233|NCT02771574|11276779|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146234|NCT02771574|11276780|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146235|NCT02771574|11276781|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146236|NCT02771574|11276777|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146237|NCT02771574|11276778|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146238|NCT02771574|11276779|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146239|NCT02771574|11276780|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146240|NCT02771574|11276781|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10146241|NCT02771574|11276777|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146242|NCT02771574|11276778|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146243|NCT02771574|11276779|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
10146244|NCT02771574|11276780|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146245|NCT02771574|11276781|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146246|NCT02771574|11276777|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146247|NCT02771574|11276778|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146248|NCT02771574|11276779|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
10146249|NCT02771574|11276780|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146250|NCT02771574|11276781|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146251|NCT02771574|11276777|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146252|NCT02771574|11276778|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146253|NCT02771574|11276779|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146254|NCT02771574|11276780|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146255|NCT02771574|11276781|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10146256|NCT02771574|11276777|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146257|NCT02771574|11276778|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146258|NCT02771574|11276779|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146259|NCT02771574|11276780|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
10146260|NCT02771574|11276781|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146261|NCT02771574|11276777|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146262|NCT02771574|11276778|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146263|NCT02771574|11276779|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146264|NCT02771574|11276780|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
10146265|NCT02771574|11276781|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146266|NCT02771574|11276777|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146267|NCT02771574|11276778|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146268|NCT02771574|11276779|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146269|NCT02771574|11276780|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146270|NCT02771574|11276781|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10146271|NCT02771574|11276777|FG000|STARTED|Liq Avexitide (3 Days)||0
10146272|NCT02771574|11276778|FG001|STARTED|Liq Avexitide (3 Days)||0
10146273|NCT02771574|11276779|FG002|STARTED|Liq Avexitide (3 Days)||0
10146274|NCT02771574|11276780|FG003|STARTED|Liq Avexitide (3 Days)||0
10146275|NCT02771574|11276781|FG004|STARTED|Liq Avexitide (3 Days)||5
10146276|NCT02771574|11276777|FG000|COMPLETED|Liq Avexitide (3 Days)||0
10146277|NCT02771574|11276778|FG001|COMPLETED|Liq Avexitide (3 Days)||0
10146278|NCT02771574|11276779|FG002|COMPLETED|Liq Avexitide (3 Days)||0
10146279|NCT02771574|11276780|FG003|COMPLETED|Liq Avexitide (3 Days)||0
10146280|NCT02771574|11276781|FG004|COMPLETED|Liq Avexitide (3 Days)||5
10146281|NCT02771574|11276777|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0
10146282|NCT02771574|11276778|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0
10146283|NCT02771574|11276779|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0
10146284|NCT02771574|11276780|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0
10146285|NCT02771574|11276781|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0
10146286|NCT02772302|11276798|FG000|STARTED|Overall Study||10
10146287|NCT02772302|11276799|FG001|STARTED|Overall Study||10
10146288|NCT02772302|11276798|FG000|COMPLETED|Overall Study||10
10146289|NCT02772302|11276799|FG001|COMPLETED|Overall Study||10
10146290|NCT02772302|11276798|FG000|NOT COMPLETED|Overall Study||0
10146291|NCT02772302|11276799|FG001|NOT COMPLETED|Overall Study||0
10146292|NCT02772432|11276807|FG000|STARTED|Overall Study||31
10146293|NCT02772432|11276808|FG001|STARTED|Overall Study||22
10146294|NCT02772432|11276807|FG000|COMPLETED|Overall Study||19
10146295|NCT02772432|11276808|FG001|COMPLETED|Overall Study||21
10146296|NCT02772432|11276807|FG000|NOT COMPLETED|Overall Study||12
10146297|NCT02772432|11276808|FG001|NOT COMPLETED|Overall Study||1
10146298|NCT02772666|11276814|FG000|STARTED|O-Glas Then SFT||44
10146299|NCT02772666|11276814|FG000|COMPLETED|O-Glas Then SFT||44
10146300|NCT02772666|11276814|FG000|NOT COMPLETED|O-Glas Then SFT||0
10146301|NCT02772666|11276814|FG000|STARTED|SFT Then O-Glass||44
9708647|NCT02921776|10807887|FG002|NOT COMPLETED|Overall Study||0
9708648|NCT02921776|10807888|FG003|NOT COMPLETED|Overall Study||8
9708649|NCT02921776|10807889|FG004|NOT COMPLETED|Overall Study||6
9708650|NCT02921776|10807890|FG005|NOT COMPLETED|Overall Study||2
9708651|NCT02921776|10807891|FG006|NOT COMPLETED|Overall Study||11
9708652|NCT02921776|10807892|FG007|NOT COMPLETED|Overall Study||7
9963855|NCT01488994|11083645|FG001|STARTED|Overall Study||12
9963856|NCT01488994|11083644|FG000|COMPLETED|Overall Study||11
10146302|NCT02772666|11276814|FG000|COMPLETED|SFT Then O-Glass||44
10146303|NCT02772666|11276814|FG000|NOT COMPLETED|SFT Then O-Glass||0
10146304|NCT02772757|11276822|FG000|STARTED|Overall Study||22
10146305|NCT02772757|11276823|FG001|STARTED|Overall Study||24
10146306|NCT02772757|11276824|FG002|STARTED|Overall Study||26
10146307|NCT02772757|11276822|FG000|COMPLETED|Overall Study||21
10146308|NCT02772757|11276823|FG001|COMPLETED|Overall Study||21
10146309|NCT02772757|11276824|FG002|COMPLETED|Overall Study||21
10146310|NCT02772757|11276822|FG000|NOT COMPLETED|Overall Study||1
10146311|NCT02772757|11276823|FG001|NOT COMPLETED|Overall Study||3
10146312|NCT02772757|11276824|FG002|NOT COMPLETED|Overall Study||5
10146313|NCT02772783|11276833|FG000|STARTED|Experimental Condition 1, 1 Day||8
10146314|NCT02772783|11276834|FG001|STARTED|Experimental Condition 1, 1 Day||7
10146315|NCT02772783|11276833|FG000|COMPLETED|Experimental Condition 1, 1 Day||8
10146316|NCT02772783|11276834|FG001|COMPLETED|Experimental Condition 1, 1 Day||7
10146317|NCT02772783|11276833|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0
10146318|NCT02772783|11276834|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0
10146319|NCT02772783|11276833|FG000|STARTED|Wash-out, 1 Week||8
10146320|NCT02772783|11276834|FG001|STARTED|Wash-out, 1 Week||7
10146321|NCT02772783|11276833|FG000|COMPLETED|Wash-out, 1 Week||8
10146322|NCT02772783|11276834|FG001|COMPLETED|Wash-out, 1 Week||7
10146323|NCT02772783|11276833|FG000|NOT COMPLETED|Wash-out, 1 Week||0
10146324|NCT02772783|11276834|FG001|NOT COMPLETED|Wash-out, 1 Week||0
10146325|NCT02772783|11276833|FG000|STARTED|Comparison Condition, 1 Day||8
10146326|NCT02772783|11276834|FG001|STARTED|Comparison Condition, 1 Day||7
10146327|NCT02772783|11276833|FG000|COMPLETED|Comparison Condition, 1 Day||8
10146328|NCT02772783|11276834|FG001|COMPLETED|Comparison Condition, 1 Day||7
10146329|NCT02772783|11276833|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0
10146330|NCT02772783|11276834|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0
10146331|NCT02772783|11276833|FG000|STARTED|Wash-out, 1 Week||8
10146332|NCT02772783|11276834|FG001|STARTED|Wash-out, 1 Week||7
10146333|NCT02772783|11276833|FG000|COMPLETED|Wash-out, 1 Week||8
10146334|NCT02772783|11276834|FG001|COMPLETED|Wash-out, 1 Week||7
10146335|NCT02772783|11276833|FG000|NOT COMPLETED|Wash-out, 1 Week||0
10146336|NCT02772783|11276834|FG001|NOT COMPLETED|Wash-out, 1 Week||0
10146337|NCT02772783|11276833|FG000|STARTED|Experimental Condition 2, 1 Day||8
10146338|NCT02772783|11276834|FG001|STARTED|Experimental Condition 2, 1 Day||7
10146339|NCT02772783|11276833|FG000|COMPLETED|Experimental Condition 2, 1 Day||8
10146340|NCT02772783|11276834|FG001|COMPLETED|Experimental Condition 2, 1 Day||7
10146341|NCT02772783|11276833|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0
10146342|NCT02772783|11276834|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0
10146343|NCT02772809|11276842|FG000|STARTED|Overall Study||23
10146344|NCT02772809|11276842|FG000|COMPLETED|Overall Study||17
10146345|NCT02772809|11276842|FG000|NOT COMPLETED|Overall Study||6
10146346|NCT02772978|11276851|FG000|STARTED|Overall Study|First participant enrolled|10
10146347|NCT02772978|11276852|FG001|STARTED|Overall Study||9
10146348|NCT02772978|11276851|FG000|COMPLETED|Overall Study|Last participant enrolled|9
10146349|NCT02772978|11276852|FG001|COMPLETED|Overall Study||8
10146350|NCT02772978|11276851|FG000|NOT COMPLETED|Overall Study||1
10146351|NCT02772978|11276852|FG001|NOT COMPLETED|Overall Study||1
10146352|NCT02773368|11276859|FG000|STARTED|Overall Study||210
10146353|NCT02773368|11276860|FG001|STARTED|Overall Study||210
10146354|NCT02773368|11276859|FG000|Exposed|Overall Study||209
10146355|NCT02773368|11276860|FG001|Exposed|Overall Study||210
10146356|NCT02773368|11276859|FG000|COMPLETED|Overall Study||200
10146357|NCT02773368|11276860|FG001|COMPLETED|Overall Study||206
10146358|NCT02773368|11276859|FG000|NOT COMPLETED|Overall Study||10
10146359|NCT02773368|11276860|FG001|NOT COMPLETED|Overall Study||4
10146360|NCT02773446|11276872|FG000|STARTED|First Admission||7
10146361|NCT02773446|11276873|FG001|STARTED|First Admission||7
10146362|NCT02773446|11276874|FG002|STARTED|First Admission||7
10146363|NCT02773446|11276875|FG003|STARTED|First Admission||7
10146364|NCT02773446|11276876|FG004|STARTED|First Admission||0
10146365|NCT02773446|11276877|FG005|STARTED|First Admission||0
10146366|NCT02773446|11276872|FG000|COMPLETED|First Admission||6
10146367|NCT02773446|11276873|FG001|COMPLETED|First Admission||7
10146368|NCT02773446|11276874|FG002|COMPLETED|First Admission||7
10146369|NCT02773446|11276875|FG003|COMPLETED|First Admission||6
10146370|NCT02773446|11276876|FG004|COMPLETED|First Admission||0
10146371|NCT02773446|11276877|FG005|COMPLETED|First Admission||0
10146372|NCT02773446|11276872|FG000|NOT COMPLETED|First Admission||1
10146373|NCT02773446|11276873|FG001|NOT COMPLETED|First Admission||0
10146374|NCT02773446|11276874|FG002|NOT COMPLETED|First Admission||0
10146375|NCT02773446|11276875|FG003|NOT COMPLETED|First Admission||1
10146376|NCT02773446|11276876|FG004|NOT COMPLETED|First Admission||0
10146377|NCT02773446|11276877|FG005|NOT COMPLETED|First Admission||0
10146378|NCT02773446|11276872|FG000|STARTED|Second Admission||0
10146379|NCT02773446|11276873|FG001|STARTED|Second Admission||0
10146380|NCT02773446|11276874|FG002|STARTED|Second Admission||0
10146381|NCT02773446|11276875|FG003|STARTED|Second Admission||0
10146382|NCT02773446|11276876|FG004|STARTED|Second Admission||11
10146383|NCT02773446|11276877|FG005|STARTED|Second Admission||19
10146384|NCT02773446|11276872|FG000|COMPLETED|Second Admission||0
10146385|NCT02773446|11276873|FG001|COMPLETED|Second Admission||0
10146386|NCT02773446|11276874|FG002|COMPLETED|Second Admission||0
10146387|NCT02773446|11276875|FG003|COMPLETED|Second Admission||0
10146388|NCT02773446|11276876|FG004|COMPLETED|Second Admission||11
10146389|NCT02773446|11276877|FG005|COMPLETED|Second Admission||19
10146390|NCT02773446|11276872|FG000|NOT COMPLETED|Second Admission||0
10146391|NCT02773446|11276873|FG001|NOT COMPLETED|Second Admission||0
10146392|NCT02773446|11276874|FG002|NOT COMPLETED|Second Admission||0
10146393|NCT02773446|11276875|FG003|NOT COMPLETED|Second Admission||0
10146394|NCT02773446|11276876|FG004|NOT COMPLETED|Second Admission||0
10146395|NCT02773446|11276877|FG005|NOT COMPLETED|Second Admission||0
10146396|NCT02773537|11276897|FG000|STARTED|Overall Study||25
10146397|NCT02773537|11276898|FG001|STARTED|Overall Study||25
10146398|NCT02773537|11276899|FG002|STARTED|Overall Study||25
10146399|NCT02773537|11276897|FG000|COMPLETED|Overall Study||25
10146400|NCT02773537|11276898|FG001|COMPLETED|Overall Study||24
10146401|NCT02773537|11276899|FG002|COMPLETED|Overall Study||21
10146402|NCT02773537|11276897|FG000|NOT COMPLETED|Overall Study||0
10146403|NCT02773537|11276898|FG001|NOT COMPLETED|Overall Study||1
10146404|NCT02773537|11276899|FG002|NOT COMPLETED|Overall Study||4
10146405|NCT02773758|11276909|FG000|STARTED|Overall Study||71
10146406|NCT02773758|11276910|FG001|STARTED|Overall Study||70
10146407|NCT02773758|11276909|FG000|COMPLETED|Overall Study||71
10146408|NCT02773758|11276910|FG001|COMPLETED|Overall Study||70
10146409|NCT02773758|11276909|FG000|NOT COMPLETED|Overall Study||0
10146410|NCT02773758|11276910|FG001|NOT COMPLETED|Overall Study||0
10146411|NCT02773836|11276922|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000
10146412|NCT02773836|11276923|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003
10146413|NCT02773836|11276924|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001
10146414|NCT02773836|11276925|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001
10146415|NCT02773836|11276926|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000
10146416|NCT02773836|11276927|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006
10146417|NCT02773836|11276922|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000
10146418|NCT02773836|11276923|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003
10146419|NCT02773836|11276924|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001
10146420|NCT02773836|11276925|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001
10146421|NCT02773836|11276926|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000
10146422|NCT02773836|11276927|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006
10146423|NCT02773836|11276922|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10146424|NCT02773836|11276923|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10146425|NCT02773836|11276924|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10146426|NCT02773836|11276925|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10146427|NCT02773836|11276926|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10146428|NCT02773836|11276927|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10146429|NCT02773836|11276922|FG000|STARTED|Wave 2- Post-TPD Implementation||1010
10146430|NCT02773836|11276923|FG001|STARTED|Wave 2- Post-TPD Implementation||1013
10146431|NCT02773836|11276924|FG002|STARTED|Wave 2- Post-TPD Implementation||1003
10146432|NCT02773836|11276925|FG003|STARTED|Wave 2- Post-TPD Implementation||1010
10146433|NCT02773836|11276926|FG004|STARTED|Wave 2- Post-TPD Implementation||1002
10146434|NCT02773836|11276927|FG005|STARTED|Wave 2- Post-TPD Implementation||998
10146435|NCT02773836|11276922|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010
10146436|NCT02773836|11276923|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013
10146437|NCT02773836|11276924|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003
10146438|NCT02773836|11276925|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010
10146439|NCT02773836|11276926|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002
10146440|NCT02773836|11276927|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998
10146441|NCT02773836|11276922|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10146442|NCT02773836|11276923|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10146443|NCT02773836|11276924|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10146444|NCT02773836|11276925|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10146445|NCT02773836|11276926|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10146446|NCT02773836|11276927|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10146447|NCT02774213|11276947|FG000|STARTED|Overall Study||74
10146448|NCT02774213|11276947|FG000|COMPLETED|Overall Study||55
10146449|NCT02774213|11276947|FG000|NOT COMPLETED|Overall Study||19
10146450|NCT02774226|11276953|FG000|STARTED|Overall Study||8
10146451|NCT02774226|11276954|FG001|STARTED|Overall Study||7
10146452|NCT02774226|11276953|FG000|COMPLETED|Overall Study||8
10146453|NCT02774226|11276954|FG001|COMPLETED|Overall Study||7
10146454|NCT02774226|11276953|FG000|NOT COMPLETED|Overall Study||0
10146455|NCT02774226|11276954|FG001|NOT COMPLETED|Overall Study||0
10146456|NCT02774278|11276960|FG000|STARTED|Overall Study||264
10146457|NCT02774278|11276960|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
10146458|NCT02774278|11276960|FG000|COMPLETED|Overall Study||0
10146459|NCT02774278|11276960|FG000|NOT COMPLETED|Overall Study||264
10146460|NCT02774343|11276966|FG000|STARTED|Overall Study||15
10146461|NCT02774343|11276967|FG001|STARTED|Overall Study||15
10146462|NCT02774343|11276966|FG000|Received at Least One Capsule|Overall Study||12
10146463|NCT02774343|11276967|FG001|Received at Least One Capsule|Overall Study||14
10146464|NCT02774343|11276966|FG000|COMPLETED|Overall Study||9
10146465|NCT02774343|11276967|FG001|COMPLETED|Overall Study||12
10146466|NCT02774343|11276966|FG000|NOT COMPLETED|Overall Study||6
10146467|NCT02774343|11276967|FG001|NOT COMPLETED|Overall Study||3
10146468|NCT02774616|11276976|FG000|STARTED|Overall Study||95
10146469|NCT02774616|11276977|FG001|STARTED|Overall Study||167
10146470|NCT02774616|11276978|FG002|STARTED|Overall Study||16
10146471|NCT02774616|11276976|FG000|Died|Overall Study||6
10146472|NCT02774616|11276977|FG001|Died|Overall Study||3
10146473|NCT02774616|11276978|FG002|Died|Overall Study||1
10146474|NCT02774616|11276976|FG000|Withdrew Consent|Overall Study||3
10146475|NCT02774616|11276977|FG001|Withdrew Consent|Overall Study||3
10146476|NCT02774616|11276978|FG002|Withdrew Consent|Overall Study||0
10146477|NCT02774616|11276976|FG000|Lost to FU|Overall Study||2
10146478|NCT02774616|11276977|FG001|Lost to FU|Overall Study||0
10146479|NCT02774616|11276978|FG002|Lost to FU|Overall Study||0
10146480|NCT02774616|11276976|FG000|Device Explanted|Overall Study||2
10146481|NCT02774616|11276977|FG001|Device Explanted|Overall Study||1
10146482|NCT02774616|11276978|FG002|Device Explanted|Overall Study||1
10146483|NCT02774616|11276976|FG000|Other|Overall Study||2
10146484|NCT02774616|11276977|FG001|Other|Overall Study||4
10146485|NCT02774616|11276978|FG002|Other|Overall Study||1
10146486|NCT02774616|11276976|FG000|COMPLETED|Overall Study||80
10146487|NCT02774616|11276977|FG001|COMPLETED|Overall Study||156
10146488|NCT02774616|11276978|FG002|COMPLETED|Overall Study||13
10146489|NCT02774616|11276976|FG000|NOT COMPLETED|Overall Study||15
10146490|NCT02774616|11276977|FG001|NOT COMPLETED|Overall Study||11
10146491|NCT02774616|11276978|FG002|NOT COMPLETED|Overall Study||3
10146492|NCT02774681|11276988|FG000|STARTED|Treatment on Study||12
10146493|NCT02774681|11276988|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10
10146494|NCT02774681|11276988|FG000|Went on to Start Cycle 3|Treatment on Study||5
10146495|NCT02774681|11276988|FG000|COMPLETED|Treatment on Study||5
10146496|NCT02774681|11276988|FG000|NOT COMPLETED|Treatment on Study||7
10146497|NCT02774681|11276988|FG000|STARTED|Follow-Up for 3 Years||12
10146498|NCT02774681|11276988|FG000|COMPLETED|Follow-Up for 3 Years||0
10146499|NCT02774681|11276988|FG000|NOT COMPLETED|Follow-Up for 3 Years||12
10146500|NCT02774798|11276995|FG000|STARTED|Overall Study||7
10146501|NCT02774798|11276996|FG001|STARTED|Overall Study||17
10146502|NCT02774798|11276997|FG002|STARTED|Overall Study||7
10146503|NCT02774798|11276995|FG000|COMPLETED|Overall Study||7
10146504|NCT02774798|11276996|FG001|COMPLETED|Overall Study||17
10146505|NCT02774798|11276997|FG002|COMPLETED|Overall Study||7
10146506|NCT02774798|11276995|FG000|NOT COMPLETED|Overall Study||0
10146507|NCT02774798|11276996|FG001|NOT COMPLETED|Overall Study||0
10146508|NCT02774798|11276997|FG002|NOT COMPLETED|Overall Study||0
10146509|NCT02774850|11277007|FG000|STARTED|Overall Study||610
10146510|NCT02774850|11277007|FG000|Induction I|Overall Study||585
10146511|NCT02774850|11277007|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
10146512|NCT02774850|11277007|FG000|Induction II|Overall Study||564
10146513|NCT02774850|11277007|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
10146514|NCT02774850|11277007|FG000|Intensification I|Overall Study||476
10146515|NCT02774850|11277007|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
10146516|NCT02774850|11277007|FG000|Intensification II|Overall Study||342
10146517|NCT02774850|11277007|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
10146518|NCT02774850|11277007|FG000|Intensification III|Overall Study||48
10146519|NCT02774850|11277007|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
10146520|NCT02774850|11277007|FG000|COMPLETED|Overall Study||575
10146521|NCT02774850|11277007|FG000|NOT COMPLETED|Overall Study||35
10146522|NCT02774941|11277015|FG000|STARTED|Overall Study||110
10146523|NCT02774941|11277016|FG001|STARTED|Overall Study||110
10146524|NCT02774941|11277015|FG000|Subjects Excluded|Overall Study||1
10146525|NCT02774941|11277016|FG001|Subjects Excluded|Overall Study||2
10146526|NCT02774941|11277015|FG000|COMPLETED|Overall Study||109
10146527|NCT02774941|11277016|FG001|COMPLETED|Overall Study||108
10146528|NCT02774941|11277015|FG000|NOT COMPLETED|Overall Study||1
10146529|NCT02774941|11277016|FG001|NOT COMPLETED|Overall Study||2
10146530|NCT02775240|11277022|FG000|STARTED|Overall Study||18
10146531|NCT02775240|11277022|FG000|Started Treatment A|Overall Study||18
10146532|NCT02775240|11277022|FG000|Started Treatment B|Overall Study||17
10146533|NCT02775240|11277022|FG000|COMPLETED|Overall Study||17
10146534|NCT02775240|11277022|FG000|NOT COMPLETED|Overall Study||1
10146535|NCT02775344|11277031|FG000|STARTED|Overall Study||40
10146536|NCT02775344|11277032|FG001|STARTED|Overall Study||40
10146537|NCT02775344|11277031|FG000|COMPLETED|Overall Study||37
10146538|NCT02775344|11277032|FG001|COMPLETED|Overall Study||38
10146539|NCT02775344|11277031|FG000|NOT COMPLETED|Overall Study||3
10146540|NCT02775344|11277032|FG001|NOT COMPLETED|Overall Study||2
10146541|NCT02775617|11277040|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
10146542|NCT02775617|11277041|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
10196860|NCT03364309|11324829|FG012|NOT COMPLETED|Post-Treatment Followup Period||0
10146543|NCT02775617|11277040|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
10146544|NCT02775617|11277041|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
10146545|NCT02775617|11277040|FG000|NOT COMPLETED|Overall Study||48
10146546|NCT02775617|11277041|FG001|NOT COMPLETED|Overall Study||160
10146547|NCT02775864|11277051|FG000|STARTED|Overall Study||26014
10146548|NCT02775864|11277052|FG001|STARTED|Overall Study||31117
10146549|NCT02775864|11277053|FG002|STARTED|Overall Study||11941
10146550|NCT02775864|11277054|FG003|STARTED|Overall Study||12849
10146551|NCT02775864|11277051|FG000|COMPLETED|Overall Study||22772
10146552|NCT02775864|11277052|FG001|COMPLETED|Overall Study||26218
10146553|NCT02775864|11277053|FG002|COMPLETED|Overall Study||10081
10146554|NCT02775864|11277054|FG003|COMPLETED|Overall Study||10765
10146555|NCT02775864|11277051|FG000|NOT COMPLETED|Overall Study||3242
10146556|NCT02775864|11277052|FG001|NOT COMPLETED|Overall Study||4899
10146557|NCT02775864|11277053|FG002|NOT COMPLETED|Overall Study||1860
10146558|NCT02775864|11277054|FG003|NOT COMPLETED|Overall Study||2084
10146559|NCT02775916|11277067|FG000|STARTED|Overall Study||20
10146560|NCT02775916|11277068|FG001|STARTED|Overall Study||10
10146561|NCT02775916|11277067|FG000|COMPLETED|Overall Study||17
10146562|NCT02775916|11277068|FG001|COMPLETED|Overall Study||10
10146563|NCT02775916|11277067|FG000|NOT COMPLETED|Overall Study||3
10146564|NCT02775916|11277068|FG001|NOT COMPLETED|Overall Study||0
10146565|NCT02776033|11277077|FG000|STARTED|Overall Study||18
10146566|NCT02776033|11277078|FG001|STARTED|Overall Study||23
10146567|NCT02776033|11277079|FG002|STARTED|Overall Study||24
10146568|NCT02776033|11277077|FG000|COMPLETED|Overall Study||14
10146569|NCT02776033|11277078|FG001|COMPLETED|Overall Study||21
10146570|NCT02776033|11277079|FG002|COMPLETED|Overall Study||22
10146571|NCT02776033|11277077|FG000|NOT COMPLETED|Overall Study||4
10146572|NCT02776033|11277078|FG001|NOT COMPLETED|Overall Study||2
10146573|NCT02776033|11277079|FG002|NOT COMPLETED|Overall Study||2
10146574|NCT02776553|11277095|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
10146575|NCT02776553|11277096|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
10146576|NCT02776553|11277095|FG000|COMPLETED|Overall Study||6
10146577|NCT02776553|11277096|FG001|COMPLETED|Overall Study||5
10146578|NCT02776553|11277095|FG000|NOT COMPLETED|Overall Study||3
10146579|NCT02776553|11277096|FG001|NOT COMPLETED|Overall Study||3
10146580|NCT02776644|11277104|FG000|STARTED|Overall Study||1223
10146581|NCT02776644|11277105|FG001|STARTED|Overall Study||126
10146582|NCT02776644|11277104|FG000|COMPLETED|Overall Study||1223
10146583|NCT02776644|11277105|FG001|COMPLETED|Overall Study||126
10146584|NCT02776644|11277104|FG000|NOT COMPLETED|Overall Study||0
10146585|NCT02776644|11277105|FG001|NOT COMPLETED|Overall Study||0
10146586|NCT02776670|11277113|FG000|STARTED|Overall Study||117
10146587|NCT02776670|11277114|FG001|STARTED|Overall Study||114
10146588|NCT02776670|11277113|FG000|Full Analysis Set (FAS)|Overall Study||117
10146589|NCT02776670|11277114|FG001|Full Analysis Set (FAS)|Overall Study||114
10146590|NCT02776670|11277113|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115
10146591|NCT02776670|11277114|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113
10146592|NCT02776670|11277113|FG000|Safety Analysis Set|Overall Study||117
10146593|NCT02776670|11277114|FG001|Safety Analysis Set|Overall Study||114
10146594|NCT02776670|11277113|FG000|COMPLETED|Overall Study||117
10146595|NCT02776670|11277114|FG001|COMPLETED|Overall Study||108
10146596|NCT02776670|11277113|FG000|NOT COMPLETED|Overall Study||0
10146597|NCT02776670|11277114|FG001|NOT COMPLETED|Overall Study||6
10146598|NCT02776683|11277120|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
10146599|NCT02776683|11277121|FG001|STARTED|Pre-switch Period||0
10146600|NCT02776683|11277120|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43
10146601|NCT02776683|11277121|FG001|COMPLETED|Pre-switch Period||0
10146602|NCT02776683|11277120|FG000|NOT COMPLETED|Pre-switch Period||80
10146603|NCT02776683|11277121|FG001|NOT COMPLETED|Pre-switch Period||0
10146604|NCT02776683|11277120|FG000|STARTED|Post-switch Period||0
10146605|NCT02776683|11277121|FG001|STARTED|Post-switch Period|Entered into Switch Set|43
10146606|NCT02776683|11277120|FG000|COMPLETED|Post-switch Period||0
10146607|NCT02776683|11277121|FG001|COMPLETED|Post-switch Period||0
10146608|NCT02776683|11277120|FG000|NOT COMPLETED|Post-switch Period||0
10146609|NCT02776683|11277121|FG001|NOT COMPLETED|Post-switch Period||43
10146610|NCT02776774|11277125|FG000|STARTED|Overall Study||91
10146611|NCT02776774|11277125|FG000|COMPLETED|Overall Study|Total after data cleaning|91
10146612|NCT02776774|11277125|FG000|NOT COMPLETED|Overall Study||0
10146613|NCT02776904|11277131|FG000|STARTED|Overall Study||281
10146614|NCT02776904|11277132|FG001|STARTED|Overall Study||46
10146615|NCT02776904|11277131|FG000|Gait Assessment|Overall Study||178
10146616|NCT02776904|11277132|FG001|Gait Assessment|Overall Study||32
10146617|NCT02776904|11277131|FG000|ImPACT|Overall Study||21
10146618|NCT02776904|11277132|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
10146619|NCT02776904|11277131|FG000|COMPLETED|Overall Study||281
10146620|NCT02776904|11277132|FG001|COMPLETED|Overall Study||46
10146621|NCT02776904|11277131|FG000|NOT COMPLETED|Overall Study||0
10146622|NCT02776904|11277132|FG001|NOT COMPLETED|Overall Study||0
10146623|NCT02777021|11277147|FG000|STARTED|Overall Study||60
10146624|NCT02777021|11277148|FG001|STARTED|Overall Study||94
10146625|NCT02777021|11277147|FG000|COMPLETED|Overall Study||43
10146626|NCT02777021|11277148|FG001|COMPLETED|Overall Study||77
10146627|NCT02777021|11277147|FG000|NOT COMPLETED|Overall Study||17
10146628|NCT02777021|11277148|FG001|NOT COMPLETED|Overall Study||17
10146629|NCT02777086|11277156|FG000|STARTED|Overall Study||261
10146630|NCT02777086|11277157|FG001|STARTED|Overall Study||250
10146631|NCT02777086|11277156|FG000|COMPLETED|Overall Study||165
10146632|NCT02777086|11277157|FG001|COMPLETED|Overall Study||151
10146633|NCT02777086|11277156|FG000|NOT COMPLETED|Overall Study||96
10146634|NCT02777086|11277157|FG001|NOT COMPLETED|Overall Study||99
10146635|NCT02777125|11277165|FG000|STARTED|Overall Study||488
10146636|NCT02777125|11277166|FG001|STARTED|Overall Study||492
10146637|NCT02777125|11277165|FG000|COMPLETED|Overall Study||445
10146638|NCT02777125|11277166|FG001|COMPLETED|Overall Study||445
10146639|NCT02777125|11277165|FG000|NOT COMPLETED|Overall Study||43
10146640|NCT02777125|11277166|FG001|NOT COMPLETED|Overall Study||47
10146641|NCT02777242|11277173|FG000|STARTED|Overall Study||65
10146642|NCT02777242|11277173|FG000|COMPLETED|Overall Study||59
10146643|NCT02777242|11277173|FG000|NOT COMPLETED|Overall Study||6
10146644|NCT02777268|11277177|FG000|STARTED|Overall Study||16
10146645|NCT02777268|11277177|FG000|COMPLETED|Overall Study||16
10146646|NCT02777268|11277177|FG000|NOT COMPLETED|Overall Study||0
10146647|NCT02777333|11277201|FG000|STARTED|Overall Study||15
10146648|NCT02777333|11277202|FG001|STARTED|Overall Study||15
10146649|NCT02777333|11277201|FG000|COMPLETED|Overall Study||15
10146650|NCT02777333|11277202|FG001|COMPLETED|Overall Study||13
10146651|NCT02777333|11277201|FG000|NOT COMPLETED|Overall Study||0
10146652|NCT02777333|11277202|FG001|NOT COMPLETED|Overall Study||2
10196861|NCT03364309|11324830|FG013|NOT COMPLETED|Post-Treatment Followup Period||0
10196862|NCT03364309|11324831|FG014|NOT COMPLETED|Post-Treatment Followup Period||0
10196863|NCT03364309|11324832|FG015|NOT COMPLETED|Post-Treatment Followup Period||0
10196864|NCT03364309|11324833|FG016|NOT COMPLETED|Post-Treatment Followup Period||5
10196865|NCT03364309|11324834|FG017|NOT COMPLETED|Post-Treatment Followup Period||31
10196866|NCT03364309|11324835|FG018|NOT COMPLETED|Post-Treatment Followup Period||2
10196867|NCT03364335|11324864|FG000|STARTED|Overall Study||52
10196868|NCT03364335|11324865|FG001|STARTED|Overall Study||51
10196869|NCT03364335|11324866|FG002|STARTED|Overall Study||53
10196870|NCT03364335|11324867|FG003|STARTED|Overall Study||50
10196871|NCT03364335|11324868|FG004|STARTED|Overall Study||52
10196872|NCT03364335|11324864|FG000|COMPLETED|Overall Study||42
10196873|NCT03364335|11324865|FG001|COMPLETED|Overall Study||40
10196874|NCT03364335|11324866|FG002|COMPLETED|Overall Study||42
10196875|NCT03364335|11324867|FG003|COMPLETED|Overall Study||37
10196876|NCT03364335|11324868|FG004|COMPLETED|Overall Study||41
10196877|NCT03364335|11324864|FG000|NOT COMPLETED|Overall Study||10
10196878|NCT03364335|11324865|FG001|NOT COMPLETED|Overall Study||11
10196879|NCT03364335|11324866|FG002|NOT COMPLETED|Overall Study||11
10196880|NCT03364335|11324867|FG003|NOT COMPLETED|Overall Study||13
10196881|NCT03364335|11324868|FG004|NOT COMPLETED|Overall Study||11
10196882|NCT03364608|11324880|FG000|STARTED|Overall Study||86
10196883|NCT03364608|11324880|FG000|Placebo MDI|Overall Study||82
10196884|NCT03364608|11324880|FG000|AS MDI 90 µg|Overall Study||81
10196885|NCT03364608|11324880|FG000|AS MDI 180 µg|Overall Study||81
10196886|NCT03364608|11324880|FG000|Proventil 90 µg|Overall Study||82
10196887|NCT03364608|11324880|FG000|Proventil 180 µg|Overall Study||79
10196888|NCT03364608|11324880|FG000|COMPLETED|Overall Study||78
10146653|NCT04952701|11277208|FG000|STARTED|Control Lens||63
10146654|NCT04952701|11277208|FG000|COMPLETED|Control Lens||59
10146655|NCT04952701|11277208|FG000|NOT COMPLETED|Control Lens||4
10146656|NCT04952701|11277208|FG000|STARTED|Test Lens||59
10146657|NCT04952701|11277208|FG000|COMPLETED|Test Lens||58
10146658|NCT04952701|11277208|FG000|NOT COMPLETED|Test Lens||1
10146659|NCT04350606|11277214|FG000|STARTED|Overall Study||3
10146660|NCT04350606|11277214|FG000|Treated|Overall Study||3
10146661|NCT04350606|11277214|FG000|Follow-up|Overall Study||3
10146662|NCT04350606|11277214|FG000|COMPLETED|Overall Study||3
10146663|NCT04350606|11277214|FG000|NOT COMPLETED|Overall Study||0
10146664|NCT04074161|11277221|FG000|STARTED|Overall Study||126
10146665|NCT04074161|11277222|FG001|STARTED|Overall Study||127
10146666|NCT04074161|11277223|FG002|STARTED|Overall Study||85
10146667|NCT04074161|11277221|FG000|Full Analysis Set|Overall Study||126
10146668|NCT04074161|11277222|FG001|Full Analysis Set|Overall Study||127
10146669|NCT04074161|11277223|FG002|Full Analysis Set|Overall Study||85
10146670|NCT04074161|11277221|FG000|Safety Analysis Set|Overall Study||126
10146671|NCT04074161|11277222|FG001|Safety Analysis Set|Overall Study||127
10146672|NCT04074161|11277223|FG002|Safety Analysis Set|Overall Study||85
10146673|NCT04074161|11277221|FG000|COMPLETED|Overall Study||120
10146674|NCT04074161|11277222|FG001|COMPLETED|Overall Study||118
10146675|NCT04074161|11277223|FG002|COMPLETED|Overall Study||81
10146676|NCT04074161|11277221|FG000|NOT COMPLETED|Overall Study||6
10146677|NCT04074161|11277222|FG001|NOT COMPLETED|Overall Study||9
10146678|NCT04074161|11277223|FG002|NOT COMPLETED|Overall Study||4
10146679|NCT04033432|11277231|FG000|STARTED|Overall Study||14
10146680|NCT04033432|11277231|FG000|Registered for Study|Overall Study||14
10146681|NCT04033432|11277231|FG000|Started Cycle 1|Overall Study||14
10146682|NCT04033432|11277231|FG000|Started Cycle 2|Overall Study||13
10146683|NCT04033432|11277231|FG000|Started Cycle 3|Overall Study||10
10146684|NCT04033432|11277231|FG000|Started Cycle 4|Overall Study||7
10146685|NCT04033432|11277231|FG000|Started Cycle 5|Overall Study||1
10146686|NCT04033432|11277231|FG000|Started Cycle 6|Overall Study||1
10146687|NCT04033432|11277231|FG000|Started Cycle 7+|Overall Study||1
10146688|NCT04033432|11277231|FG000|COMPLETED|Overall Study||1
10146689|NCT04033432|11277231|FG000|NOT COMPLETED|Overall Study||13
10146690|NCT04030247|11277236|FG000|STARTED|Overall Study||50
10146691|NCT04030247|11277236|FG000|COMPLETED|Overall Study||33
10146692|NCT04030247|11277236|FG000|NOT COMPLETED|Overall Study||17
10146693|NCT03893565|11277245|FG000|STARTED|Double-blind Induction Phase (10 Weeks)||27
10146694|NCT03893565|11277246|FG001|STARTED|Double-blind Induction Phase (10 Weeks)||48
10146695|NCT03893565|11277247|FG002|STARTED|Double-blind Induction Phase (10 Weeks)||11
10146696|NCT03893565|11277248|FG003|STARTED|Double-blind Induction Phase (10 Weeks)||10
10146697|NCT03893565|11277249|FG004|STARTED|Double-blind Induction Phase (10 Weeks)||8
10146698|NCT03893565|11277250|FG005|STARTED|Double-blind Induction Phase (10 Weeks)||0
10146699|NCT03893565|11277251|FG006|STARTED|Double-blind Induction Phase (10 Weeks)||0
10146700|NCT03893565|11277252|FG007|STARTED|Double-blind Induction Phase (10 Weeks)||0
10146701|NCT03893565|11277253|FG008|STARTED|Double-blind Induction Phase (10 Weeks)||0
10146702|NCT03893565|11277245|FG000|COMPLETED|Double-blind Induction Phase (10 Weeks)||21
10146703|NCT03893565|11277246|FG001|COMPLETED|Double-blind Induction Phase (10 Weeks)||32
10146704|NCT03893565|11277247|FG002|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
10146705|NCT03893565|11277248|FG003|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
10146706|NCT03893565|11277249|FG004|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
10146707|NCT03893565|11277250|FG005|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146708|NCT03893565|11277251|FG006|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146709|NCT03893565|11277252|FG007|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146710|NCT03893565|11277253|FG008|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146711|NCT03893565|11277245|FG000|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||6
10146712|NCT03893565|11277246|FG001|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||16
10146713|NCT03893565|11277247|FG002|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||10
10146714|NCT03893565|11277248|FG003|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||9
10146715|NCT03893565|11277249|FG004|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||7
10146716|NCT03893565|11277250|FG005|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146717|NCT03893565|11277251|FG006|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146718|NCT03893565|11277252|FG007|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146719|NCT03893565|11277253|FG008|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10146720|NCT03893565|11277245|FG000|STARTED|Double-blind Extended Treatment(20weeks)||0
10146721|NCT03893565|11277246|FG001|STARTED|Double-blind Extended Treatment(20weeks)||0
10146722|NCT03893565|11277247|FG002|STARTED|Double-blind Extended Treatment(20weeks)||0
10146723|NCT03893565|11277248|FG003|STARTED|Double-blind Extended Treatment(20weeks)||0
10146724|NCT03893565|11277249|FG004|STARTED|Double-blind Extended Treatment(20weeks)||0
10146725|NCT03893565|11277250|FG005|STARTED|Double-blind Extended Treatment(20weeks)||5
10146726|NCT03893565|11277251|FG006|STARTED|Double-blind Extended Treatment(20weeks)||8
10146727|NCT03893565|11277252|FG007|STARTED|Double-blind Extended Treatment(20weeks)||0
10146728|NCT03893565|11277253|FG008|STARTED|Double-blind Extended Treatment(20weeks)||0
10146729|NCT03893565|11277245|FG000|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146730|NCT03893565|11277246|FG001|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146731|NCT03893565|11277247|FG002|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146732|NCT03893565|11277248|FG003|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146733|NCT03893565|11277249|FG004|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146734|NCT03893565|11277250|FG005|COMPLETED|Double-blind Extended Treatment(20weeks)||2
10146735|NCT03893565|11277251|FG006|COMPLETED|Double-blind Extended Treatment(20weeks)||4
10146736|NCT03893565|11277252|FG007|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146737|NCT03893565|11277253|FG008|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146738|NCT03893565|11277245|FG000|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146739|NCT03893565|11277246|FG001|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146740|NCT03893565|11277247|FG002|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146741|NCT03893565|11277248|FG003|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146742|NCT03893565|11277249|FG004|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146743|NCT03893565|11277250|FG005|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||3
10146744|NCT03893565|11277251|FG006|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||4
10146745|NCT03893565|11277252|FG007|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146746|NCT03893565|11277253|FG008|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10146747|NCT03893565|11277245|FG000|STARTED|Open-label Induction Phase (10 Weeks)||0
10146748|NCT03893565|11277246|FG001|STARTED|Open-label Induction Phase (10 Weeks)||0
10146749|NCT03893565|11277247|FG002|STARTED|Open-label Induction Phase (10 Weeks)||0
10146750|NCT03893565|11277248|FG003|STARTED|Open-label Induction Phase (10 Weeks)||0
10146751|NCT03893565|11277249|FG004|STARTED|Open-label Induction Phase (10 Weeks)||0
10146752|NCT03893565|11277250|FG005|STARTED|Open-label Induction Phase (10 Weeks)||0
10146753|NCT03893565|11277251|FG006|STARTED|Open-label Induction Phase (10 Weeks)||0
10146754|NCT03893565|11277252|FG007|STARTED|Open-label Induction Phase (10 Weeks)||42
10146755|NCT03893565|11277253|FG008|STARTED|Open-label Induction Phase (10 Weeks)||0
10146756|NCT03893565|11277245|FG000|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146757|NCT03893565|11277246|FG001|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146758|NCT03893565|11277247|FG002|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146759|NCT03893565|11277248|FG003|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146760|NCT03893565|11277249|FG004|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146761|NCT03893565|11277250|FG005|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146762|NCT03893565|11277251|FG006|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146763|NCT03893565|11277252|FG007|COMPLETED|Open-label Induction Phase (10 Weeks)||12
10146764|NCT03893565|11277253|FG008|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146765|NCT03893565|11277245|FG000|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146766|NCT03893565|11277246|FG001|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146767|NCT03893565|11277247|FG002|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146768|NCT03893565|11277248|FG003|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146769|NCT03893565|11277249|FG004|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146770|NCT03893565|11277250|FG005|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146771|NCT03893565|11277251|FG006|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146772|NCT03893565|11277252|FG007|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||30
10146773|NCT03893565|11277253|FG008|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10146774|NCT03893565|11277245|FG000|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146775|NCT03893565|11277246|FG001|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146776|NCT03893565|11277247|FG002|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146777|NCT03893565|11277248|FG003|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146778|NCT03893565|11277249|FG004|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146779|NCT03893565|11277250|FG005|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146780|NCT03893565|11277251|FG006|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146781|NCT03893565|11277252|FG007|STARTED|Open-label Extended Treatment (20 Weeks)||0
10146782|NCT03893565|11277253|FG008|STARTED|Open-label Extended Treatment (20 Weeks)||7
10146783|NCT03893565|11277245|FG000|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146784|NCT03893565|11277246|FG001|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146785|NCT03893565|11277247|FG002|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146786|NCT03893565|11277248|FG003|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146787|NCT03893565|11277249|FG004|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146788|NCT03893565|11277250|FG005|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146789|NCT03893565|11277251|FG006|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146790|NCT03893565|11277252|FG007|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146791|NCT03893565|11277253|FG008|COMPLETED|Open-label Extended Treatment (20 Weeks)||3
10146792|NCT03893565|11277245|FG000|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146793|NCT03893565|11277246|FG001|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146794|NCT03893565|11277247|FG002|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146795|NCT03893565|11277248|FG003|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146796|NCT03893565|11277249|FG004|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146797|NCT03893565|11277250|FG005|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146798|NCT03893565|11277251|FG006|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146799|NCT03893565|11277252|FG007|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10146800|NCT03893565|11277253|FG008|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||4
10146801|NCT03701516|11277272|FG000|STARTED|Period 1||131
10146802|NCT03701516|11277273|FG001|STARTED|Period 1||132
10146803|NCT03701516|11277272|FG000|COMPLETED|Period 1||127
10146804|NCT03701516|11277273|FG001|COMPLETED|Period 1||127
10146805|NCT03701516|11277272|FG000|NOT COMPLETED|Period 1||4
10146806|NCT03701516|11277273|FG001|NOT COMPLETED|Period 1||5
10146807|NCT03701516|11277272|FG000|STARTED|Period 2||127
10146808|NCT03701516|11277273|FG001|STARTED|Period 2||127
10146809|NCT03701516|11277272|FG000|COMPLETED|Period 2||126
10146810|NCT03701516|11277273|FG001|COMPLETED|Period 2||126
10146811|NCT03701516|11277272|FG000|NOT COMPLETED|Period 2||1
10146812|NCT03701516|11277273|FG001|NOT COMPLETED|Period 2||1
10146813|NCT03650556|11277279|FG000|STARTED|Overall Study||224
10146814|NCT03650556|11277279|FG000|Ablation Procedure|Overall Study||223
10146815|NCT03650556|11277279|FG000|Pre-Discharge|Overall Study||223
10146816|NCT03650556|11277279|FG000|7-day Follow-Up|Overall Study||223
10146817|NCT03650556|11277279|FG000|3-month Follow-Up|Overall Study||210
10146818|NCT03650556|11277279|FG000|6-month Follow-up|Overall Study||197
10146819|NCT03650556|11277279|FG000|12-month Follow-Up|Overall Study||189
10146820|NCT03650556|11277279|FG000|15-month Follow-Up|Overall Study||187
10146821|NCT03650556|11277279|FG000|COMPLETED|Overall Study||187
10146822|NCT03650556|11277279|FG000|NOT COMPLETED|Overall Study||37
10146823|NCT03639311|11277286|FG000|STARTED|Overall Study||90
10146824|NCT03639311|11277287|FG001|STARTED|Overall Study||7
10146825|NCT03639311|11277286|FG000|COMPLETED|Overall Study||0
10146826|NCT03639311|11277287|FG001|COMPLETED|Overall Study||7
10146827|NCT03639311|11277286|FG000|NOT COMPLETED|Overall Study||90
10146828|NCT03639311|11277287|FG001|NOT COMPLETED|Overall Study||0
10146829|NCT03628716|11277298|FG000|STARTED|Overall Study||19
10146830|NCT03628716|11277299|FG001|STARTED|Overall Study||24
10146831|NCT03628716|11277298|FG000|COMPLETED|Overall Study||0
10146832|NCT03628716|11277299|FG001|COMPLETED|Overall Study||1
10146833|NCT03628716|11277298|FG000|NOT COMPLETED|Overall Study||19
10146834|NCT03628716|11277299|FG001|NOT COMPLETED|Overall Study||23
10146835|NCT03377699|11277309|FG000|STARTED|Overall Study||111
10146836|NCT03377699|11277310|FG001|STARTED|Overall Study||114
10146837|NCT03377699|11277309|FG000|Treated|Overall Study||110
10146838|NCT03377699|11277310|FG001|Treated|Overall Study||112
10146839|NCT03377699|11277309|FG000|SASpregnant|Overall Study||91
10146840|NCT03377699|11277310|FG001|SASpregnant|Overall Study||94
10146841|NCT03377699|11277309|FG000|FASpregnant|Overall Study||92
10146842|NCT03377699|11277310|FG001|FASpregnant|Overall Study||96
10146843|NCT03377699|11277309|FG000|COMPLETED|Overall Study||89
10146844|NCT03377699|11277310|FG001|COMPLETED|Overall Study||89
10146845|NCT03377699|11277309|FG000|NOT COMPLETED|Overall Study||22
10146846|NCT03377699|11277310|FG001|NOT COMPLETED|Overall Study||25
10196889|NCT03364608|11324880|FG000|NOT COMPLETED|Overall Study||8
10196890|NCT03364738|11324892|FG000|STARTED|Overall Study||22
10196891|NCT03364738|11324892|FG000|COMPLETED|Overall Study||14
10196892|NCT03364738|11324892|FG000|NOT COMPLETED|Overall Study||8
10196893|NCT03364751|11324901|FG000|STARTED|Overall Study||70
10196894|NCT03364751|11324902|FG001|STARTED|Overall Study||84
10196895|NCT03364751|11324903|FG002|STARTED|Overall Study||17
10196896|NCT03364751|11324904|FG003|STARTED|Overall Study||1
10196897|NCT03364751|11324901|FG000|COMPLETED|Overall Study||69
10196898|NCT03364751|11324902|FG001|COMPLETED|Overall Study||83
10196899|NCT03364751|11324903|FG002|COMPLETED|Overall Study||17
10196900|NCT03364751|11324904|FG003|COMPLETED|Overall Study||1
10196901|NCT03364751|11324901|FG000|NOT COMPLETED|Overall Study||1
10196902|NCT03364751|11324902|FG001|NOT COMPLETED|Overall Study||1
10196903|NCT03364751|11324903|FG002|NOT COMPLETED|Overall Study||0
10196904|NCT03364751|11324904|FG003|NOT COMPLETED|Overall Study||0
10196905|NCT03365011|11324920|FG000|STARTED|Overall Study||20
10196906|NCT03365011|11324921|FG001|STARTED|Overall Study||20
10196907|NCT03365011|11324920|FG000|COMPLETED|Overall Study||19
10196908|NCT03365011|11324921|FG001|COMPLETED|Overall Study||18
10196909|NCT03365011|11324920|FG000|NOT COMPLETED|Overall Study||1
10196910|NCT03365011|11324921|FG001|NOT COMPLETED|Overall Study||2
10196911|NCT03365154|11324927|FG000|STARTED|Overall Study||10
10196912|NCT03365154|11324927|FG000|COMPLETED|Overall Study||10
10196913|NCT03365154|11324927|FG000|NOT COMPLETED|Overall Study||0
10196914|NCT03365778|11324934|FG000|STARTED|Overall Study||16
10196915|NCT03365778|11324935|FG001|STARTED|Overall Study||17
10196916|NCT03365778|11324936|FG002|STARTED|Overall Study||53
10196917|NCT03365778|11324934|FG000|COMPLETED|Overall Study||16
10196918|NCT03365778|11324935|FG001|COMPLETED|Overall Study||17
10196919|NCT03365778|11324936|FG002|COMPLETED|Overall Study||53
10196920|NCT03365778|11324934|FG000|NOT COMPLETED|Overall Study||0
10196921|NCT03365778|11324935|FG001|NOT COMPLETED|Overall Study||0
9708668|NCT02870348|10807938|FG000|STARTED|Overall Study||4
9708669|NCT02870348|10807938|FG000|COMPLETED|Overall Study||0
9708670|NCT02870348|10807938|FG000|NOT COMPLETED|Overall Study||4
9708671|NCT02841280|10807944|FG000|STARTED|Overall Study||81
9708672|NCT02841280|10807945|FG001|STARTED|Overall Study||79
9708673|NCT02841280|10807944|FG000|COMPLETED|Overall Study||67
9708674|NCT02841280|10807945|FG001|COMPLETED|Overall Study||73
9708675|NCT02841280|10807944|FG000|NOT COMPLETED|Overall Study||14
9708676|NCT02841280|10807945|FG001|NOT COMPLETED|Overall Study||6
9708677|NCT02786498|10807955|FG000|STARTED|Overall Study||27
9708678|NCT02786498|10807956|FG001|STARTED|Overall Study||24
9708679|NCT02786498|10807957|FG002|STARTED|Overall Study||24
10060778|NCT02100514|11186345|FG000|STARTED|Treatment Period||247
10060779|NCT02100514|11186346|FG001|STARTED|Treatment Period||499
9708680|NCT02786498|10807958|FG003|STARTED|Overall Study||27
9708681|NCT02786498|10807955|FG000|COMPLETED|Overall Study||25
9708682|NCT02786498|10807956|FG001|COMPLETED|Overall Study||24
9708683|NCT02786498|10807957|FG002|COMPLETED|Overall Study||24
9708684|NCT02786498|10807958|FG003|COMPLETED|Overall Study||26
9708685|NCT02786498|10807955|FG000|NOT COMPLETED|Overall Study||2
9708686|NCT02786498|10807956|FG001|NOT COMPLETED|Overall Study||0
9708687|NCT02786498|10807957|FG002|NOT COMPLETED|Overall Study||0
9708688|NCT02786498|10807958|FG003|NOT COMPLETED|Overall Study||1
9708689|NCT02771275|10807968|FG000|STARTED|Overall Study||13
9708690|NCT02771275|10807968|FG000|COMPLETED|Overall Study||0
9708691|NCT02771275|10807968|FG000|NOT COMPLETED|Overall Study||13
9729355|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
9729356|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
9729357|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 337 - 384||183
9729358|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 337 - 384||93
9729359|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176
9729360|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90
9729361|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
9729362|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
9729363|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
9729364|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
9729365|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82
9729366|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44
9729367|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
9729368|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
9729369|NCT00117676|10828887|FG000|STARTED|Open-label Period: Weeks 433 - 480||82
9729370|NCT00117676|10828888|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
9729371|NCT00117676|10828887|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80
9729372|NCT00117676|10828888|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41
9729373|NCT00117676|10828887|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
9729374|NCT00117676|10828888|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
9729375|NCT00117715|10828899|FG000|STARTED|Overall Study||121
9729376|NCT00117715|10828899|FG000|1 Year|Overall Study||88
9729377|NCT00117715|10828899|FG000|1.5 Year|Overall Study||85
9729378|NCT00117715|10828899|FG000|2 Year|Overall Study||76
9729379|NCT00117715|10828899|FG000|2.5 Year|Overall Study||70
9729380|NCT00117715|10828899|FG000|3 Year|Overall Study||61
9729381|NCT00117715|10828899|FG000|3.5 Year|Overall Study||60
9729382|NCT00117715|10828899|FG000|4 Year|Overall Study||58
9729383|NCT00117715|10828899|FG000|4.5 Year|Overall Study||55
9729384|NCT00117715|10828899|FG000|5 Year|Overall Study||49
9729385|NCT00117715|10828899|FG000|COMPLETED|Overall Study||49
9729386|NCT00117715|10828899|FG000|NOT COMPLETED|Overall Study||72
9729387|NCT00117793|10828903|FG000|STARTED|Overall Study||17
9729388|NCT00117793|10828903|FG000|COMPLETED|Overall Study||5
9729389|NCT00117793|10828903|FG000|NOT COMPLETED|Overall Study||12
10060780|NCT02100514|11186347|FG002|STARTED|Treatment Period||0
10060781|NCT02100514|11186348|FG003|STARTED|Treatment Period||0
10060782|NCT02100514|11186349|FG004|STARTED|Treatment Period||0
10060783|NCT02100514|11186345|FG000|COMPLETED|Treatment Period||218
10060784|NCT02100514|11186346|FG001|COMPLETED|Treatment Period||425
10060785|NCT02100514|11186347|FG002|COMPLETED|Treatment Period||0
10060786|NCT02100514|11186348|FG003|COMPLETED|Treatment Period||0
10060787|NCT02100514|11186349|FG004|COMPLETED|Treatment Period||0
10060788|NCT02100514|11186345|FG000|NOT COMPLETED|Treatment Period||29
10060789|NCT02100514|11186346|FG001|NOT COMPLETED|Treatment Period||74
10060790|NCT02100514|11186347|FG002|NOT COMPLETED|Treatment Period||0
10060791|NCT02100514|11186348|FG003|NOT COMPLETED|Treatment Period||0
9729390|NCT00117806|10828910|FG000|STARTED|Overall Study||81
9729391|NCT00117806|10828911|FG001|STARTED|Overall Study||76
9729392|NCT00117806|10828910|FG000|COMPLETED|Overall Study||43
9729393|NCT00117806|10828911|FG001|COMPLETED|Overall Study||60
9729394|NCT00117806|10828910|FG000|NOT COMPLETED|Overall Study||38
9729395|NCT00117806|10828911|FG001|NOT COMPLETED|Overall Study||16
9729396|NCT00117845|10828920|FG000|STARTED|Overall Study||17
9729397|NCT00117845|10828920|FG000|COMPLETED|Overall Study||16
9729398|NCT00117845|10828920|FG000|NOT COMPLETED|Overall Study||1
9729399|NCT00117949|10828928|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
9729400|NCT00117949|10828929|FG001|STARTED|Overall Study||24
10146847|NCT03275350|11277320|FG000|STARTED|Overall Study||55
10146848|NCT03275350|11277321|FG001|STARTED|Overall Study||59
10146849|NCT03275350|11277320|FG000|COMPLETED|Overall Study||47
10146850|NCT03275350|11277321|FG001|COMPLETED|Overall Study||51
10146851|NCT03275350|11277320|FG000|NOT COMPLETED|Overall Study||8
10146852|NCT03275350|11277321|FG001|NOT COMPLETED|Overall Study||8
10146853|NCT03272347|11277332|FG000|STARTED|Overall Study||31
10146854|NCT03272347|11277333|FG001|STARTED|Overall Study||30
10146855|NCT03272347|11277334|FG002|STARTED|Overall Study||31
10146856|NCT03272347|11277335|FG003|STARTED|Overall Study||31
10146857|NCT03272347|11277332|FG000|Treated|Overall Study||29
10146858|NCT03272347|11277333|FG001|Treated|Overall Study||30
10146859|NCT03272347|11277334|FG002|Treated|Overall Study||31
10146860|NCT03272347|11277335|FG003|Treated|Overall Study||31
10146861|NCT03272347|11277332|FG000|COMPLETED|Overall Study||0
10146862|NCT03272347|11277333|FG001|COMPLETED|Overall Study||1
10146863|NCT03272347|11277334|FG002|COMPLETED|Overall Study||0
10146864|NCT03272347|11277335|FG003|COMPLETED|Overall Study||2
10146865|NCT03272347|11277332|FG000|NOT COMPLETED|Overall Study||31
10146866|NCT03272347|11277333|FG001|NOT COMPLETED|Overall Study||29
10146867|NCT03272347|11277334|FG002|NOT COMPLETED|Overall Study||31
10146868|NCT03272347|11277335|FG003|NOT COMPLETED|Overall Study||29
10146869|NCT03138369|11277347|FG000|STARTED|Overall Study||11
10146870|NCT03138369|11277348|FG001|STARTED|Overall Study||11
10146871|NCT03138369|11277347|FG000|COMPLETED|Overall Study||8
10146872|NCT03138369|11277348|FG001|COMPLETED|Overall Study||3
10146873|NCT03138369|11277347|FG000|NOT COMPLETED|Overall Study||3
10146874|NCT03138369|11277348|FG001|NOT COMPLETED|Overall Study||8
10146887|NCT02758184|11277370|FG000|STARTED|Overall Study||11
10146888|NCT02758184|11277371|FG001|STARTED|Overall Study||10
10146889|NCT02758184|11277370|FG000|COMPLETED|Overall Study||11
10146890|NCT02758184|11277371|FG001|COMPLETED|Overall Study||10
10146891|NCT02758184|11277370|FG000|NOT COMPLETED|Overall Study||0
10146892|NCT02758184|11277371|FG001|NOT COMPLETED|Overall Study||0
10146893|NCT02677870|11277377|FG000|STARTED|Diet Treatment (4 Weeks)||4
10146894|NCT02677870|11277378|FG001|STARTED|Diet Treatment (4 Weeks)||3
10146895|NCT02677870|11277377|FG000|COMPLETED|Diet Treatment (4 Weeks)||4
10146896|NCT02677870|11277378|FG001|COMPLETED|Diet Treatment (4 Weeks)||3
9708692|NCT02675426|10807975|FG000|STARTED|Overall Study||221
9708693|NCT02675426|10807976|FG001|STARTED|Overall Study||221
9708694|NCT02675426|10807977|FG002|STARTED|Overall Study||219
9708695|NCT02675426|10807975|FG000|Treated|Overall Study||221
9708696|NCT02675426|10807976|FG001|Treated|Overall Study||221
10060792|NCT02100514|11186349|FG004|NOT COMPLETED|Treatment Period||0
10060793|NCT02100514|11186345|FG000|STARTED|Extension Period||0
10060794|NCT02100514|11186346|FG001|STARTED|Extension Period||0
9708697|NCT02675426|10807977|FG002|Treated|Overall Study||219
9708698|NCT02675426|10807975|FG000|COMPLETED|Overall Study||208
9708699|NCT02675426|10807976|FG001|COMPLETED|Overall Study||213
9708700|NCT02675426|10807977|FG002|COMPLETED|Overall Study||201
9708701|NCT02675426|10807975|FG000|NOT COMPLETED|Overall Study||13
9708702|NCT02675426|10807976|FG001|NOT COMPLETED|Overall Study||8
9708703|NCT02675426|10807977|FG002|NOT COMPLETED|Overall Study||18
9708704|NCT02639546|10807993|FG000|STARTED|Overall Study||6
9708705|NCT02639546|10807994|FG001|STARTED|Overall Study||6
9708706|NCT02639546|10807995|FG002|STARTED|Overall Study||6
9708707|NCT02639546|10807996|FG003|STARTED|Overall Study||6
9708708|NCT02639546|10807997|FG004|STARTED|Overall Study||7
10060795|NCT02100514|11186347|FG002|STARTED|Extension Period||44
10060796|NCT02100514|11186348|FG003|STARTED|Extension Period||33
10060797|NCT02100514|11186349|FG004|STARTED|Extension Period||56
10060798|NCT02100514|11186345|FG000|COMPLETED|Extension Period||0
10060799|NCT02100514|11186346|FG001|COMPLETED|Extension Period||0
10060800|NCT02100514|11186347|FG002|COMPLETED|Extension Period||42
10060801|NCT02100514|11186348|FG003|COMPLETED|Extension Period||33
10060802|NCT02100514|11186349|FG004|COMPLETED|Extension Period||56
10060803|NCT02100514|11186345|FG000|NOT COMPLETED|Extension Period||0
9708709|NCT02639546|10807998|FG005|STARTED|Overall Study||8
9708710|NCT02639546|10807999|FG006|STARTED|Overall Study||5
9708711|NCT02639546|10808000|FG007|STARTED|Overall Study||12
9708712|NCT02639546|10807993|FG000|Tumor Type - Neuroblastoma|Overall Study||0
9708713|NCT02639546|10807994|FG001|Tumor Type - Neuroblastoma|Overall Study||0
10146897|NCT02677870|11277377|FG000|NOT COMPLETED|Diet Treatment (4 Weeks)||0
9708714|NCT02639546|10807995|FG002|Tumor Type - Neuroblastoma|Overall Study||1
10146898|NCT02677870|11277378|FG001|NOT COMPLETED|Diet Treatment (4 Weeks)||0
10146899|NCT02677870|11277377|FG000|STARTED|First Saproterin Dihydrochloride tx||4
10146900|NCT02677870|11277378|FG001|STARTED|First Saproterin Dihydrochloride tx||3
10146901|NCT02677870|11277377|FG000|COMPLETED|First Saproterin Dihydrochloride tx||4
10146902|NCT02677870|11277378|FG001|COMPLETED|First Saproterin Dihydrochloride tx||3
10146903|NCT02677870|11277377|FG000|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
10146904|NCT02677870|11277378|FG001|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
10146905|NCT02677870|11277377|FG000|STARTED|Washout (2 Weeks)||4
10146906|NCT02677870|11277378|FG001|STARTED|Washout (2 Weeks)||3
10146907|NCT02677870|11277377|FG000|COMPLETED|Washout (2 Weeks)||4
10146908|NCT02677870|11277378|FG001|COMPLETED|Washout (2 Weeks)||3
10146909|NCT02677870|11277377|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10146910|NCT02677870|11277378|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10146911|NCT02677870|11277377|FG000|STARTED|Second Saproterin Dihydrochloride tx||4
10146912|NCT02677870|11277378|FG001|STARTED|Second Saproterin Dihydrochloride tx||3
10146913|NCT02677870|11277377|FG000|COMPLETED|Second Saproterin Dihydrochloride tx||4
10146914|NCT02677870|11277378|FG001|COMPLETED|Second Saproterin Dihydrochloride tx||3
10146915|NCT02677870|11277377|FG000|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
10146916|NCT02677870|11277378|FG001|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
10146917|NCT02674750|11277389|FG000|STARTED|Overall Study||5
10146918|NCT02674750|11277390|FG001|STARTED|Overall Study||49
10146919|NCT02674750|11277391|FG002|STARTED|Overall Study||16
10146920|NCT02674750|11277389|FG000|COMPLETED|Overall Study||0
10146921|NCT02674750|11277390|FG001|COMPLETED|Overall Study||4
10146922|NCT02674750|11277391|FG002|COMPLETED|Overall Study||4
10146923|NCT02674750|11277389|FG000|NOT COMPLETED|Overall Study||5
10146924|NCT02674750|11277390|FG001|NOT COMPLETED|Overall Study||45
10146925|NCT02674750|11277391|FG002|NOT COMPLETED|Overall Study||12
10146926|NCT02440854|11277398|FG000|STARTED|Overall Study||80
10146927|NCT02440854|11277398|FG000|Analyzed|Overall Study||77
10146928|NCT02440854|11277398|FG000|COMPLETED|Overall Study||0
10146929|NCT02440854|11277398|FG000|NOT COMPLETED|Overall Study||80
10146930|NCT02278185|11277404|FG000|STARTED|Overall Study||10
10146931|NCT02278185|11277405|FG001|STARTED|Overall Study||9
10146932|NCT02278185|11277404|FG000|COMPLETED|Overall Study||7
10146933|NCT02278185|11277405|FG001|COMPLETED|Overall Study||7
10146934|NCT02278185|11277404|FG000|NOT COMPLETED|Overall Study||3
10146935|NCT02278185|11277405|FG001|NOT COMPLETED|Overall Study||2
10196922|NCT03365778|11324936|FG002|NOT COMPLETED|Overall Study||0
10196923|NCT03365934|11324944|FG000|STARTED|Overall Study||35
10196924|NCT03365934|11324944|FG000|COMPLETED|Overall Study||33
10196925|NCT03365934|11324944|FG000|NOT COMPLETED|Overall Study||2
10196926|NCT03366207|11324953|FG000|STARTED|Overall Study||250
10196927|NCT03366207|11324953|FG000|COMPLETED|Overall Study||242
10196928|NCT03366207|11324953|FG000|NOT COMPLETED|Overall Study||8
10196929|NCT03366298|11324957|FG000|STARTED|Overall Study||3
10196930|NCT03366298|11324958|FG001|STARTED|Overall Study||3
10196931|NCT03366298|11324959|FG002|STARTED|Overall Study||3
10196932|NCT03366298|11324960|FG003|STARTED|Overall Study||3
10196933|NCT03366298|11324957|FG000|COMPLETED|Overall Study||3
10196934|NCT03366298|11324958|FG001|COMPLETED|Overall Study||3
10196935|NCT03366298|11324959|FG002|COMPLETED|Overall Study||3
10196936|NCT03366298|11324960|FG003|COMPLETED|Overall Study||3
10196937|NCT03366298|11324957|FG000|NOT COMPLETED|Overall Study||0
10196938|NCT03366298|11324958|FG001|NOT COMPLETED|Overall Study||0
10196939|NCT03366298|11324959|FG002|NOT COMPLETED|Overall Study||0
10196940|NCT03366298|11324960|FG003|NOT COMPLETED|Overall Study||0
10196941|NCT03367793|11324974|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5
10196942|NCT03367793|11324975|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5
10196943|NCT03367793|11324976|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5
10196944|NCT03367793|11324977|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5
10196945|NCT03367793|11324978|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5
10196946|NCT03367793|11324979|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5
10196947|NCT03367793|11324974|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10196948|NCT03367793|11324975|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10196949|NCT03367793|11324976|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10196950|NCT03367793|11324977|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10196951|NCT03367793|11324978|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10196952|NCT03367793|11324979|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10196953|NCT03367793|11324974|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10196954|NCT03367793|11324975|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10196955|NCT03367793|11324976|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10196956|NCT03367793|11324977|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10196957|NCT03367793|11324978|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10196958|NCT03367793|11324979|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10196959|NCT03367793|11324974|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10196960|NCT03367793|11324975|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10196961|NCT03367793|11324976|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10196962|NCT03367793|11324977|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10196963|NCT03367793|11324978|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10196964|NCT03367793|11324979|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10196965|NCT03367793|11324974|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10196966|NCT03367793|11324975|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10196967|NCT03367793|11324976|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10196968|NCT03367793|11324977|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10196969|NCT03367793|11324978|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10196970|NCT03367793|11324979|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10146936|NCT02154529|11277417|FG000|STARTED|Overall Study||4
10146937|NCT02154529|11277418|FG001|STARTED|Overall Study||3
10146938|NCT02154529|11277419|FG002|STARTED|Overall Study||8
10146939|NCT02154529|11277420|FG003|STARTED|Overall Study||2
10146940|NCT02154529|11277417|FG000|COMPLETED|Overall Study|Study terminated by sponsor|0
10146941|NCT02154529|11277418|FG001|COMPLETED|Overall Study|Study terminated by sponsor|0
10146942|NCT02154529|11277419|FG002|COMPLETED|Overall Study|Study terminated by sponsor|0
10146943|NCT02154529|11277420|FG003|COMPLETED|Overall Study|Study terminated by sponsor|0
10146944|NCT02154529|11277417|FG000|NOT COMPLETED|Overall Study||4
9708715|NCT02639546|10807996|FG003|Tumor Type - Neuroblastoma|Overall Study||0
9708716|NCT02639546|10807997|FG004|Tumor Type - Neuroblastoma|Overall Study||0
9708717|NCT02639546|10807998|FG005|Tumor Type - Neuroblastoma|Overall Study||0
9708718|NCT02639546|10807999|FG006|Tumor Type - Neuroblastoma|Overall Study||0
9708719|NCT02639546|10808000|FG007|Tumor Type - Neuroblastoma|Overall Study||0
9708720|NCT02639546|10807993|FG000|Tumor Type - High-Grade Glioma|Overall Study||3
9708721|NCT02639546|10807994|FG001|Tumor Type - High-Grade Glioma|Overall Study||1
9708722|NCT02639546|10807995|FG002|Tumor Type - High-Grade Glioma|Overall Study||0
9708723|NCT02639546|10807996|FG003|Tumor Type - High-Grade Glioma|Overall Study||0
9708724|NCT02639546|10807997|FG004|Tumor Type - High-Grade Glioma|Overall Study||1
9708725|NCT02639546|10807998|FG005|Tumor Type - High-Grade Glioma|Overall Study||0
9708726|NCT02639546|10807999|FG006|Tumor Type - High-Grade Glioma|Overall Study||0
9708727|NCT02639546|10808000|FG007|Tumor Type - High-Grade Glioma|Overall Study||0
9708728|NCT02639546|10807993|FG000|Tumor Type - Low-Grade Glioma|Overall Study||1
9708729|NCT02639546|10807994|FG001|Tumor Type - Low-Grade Glioma|Overall Study||2
9708730|NCT02639546|10807995|FG002|Tumor Type - Low-Grade Glioma|Overall Study||4
9708731|NCT02639546|10807996|FG003|Tumor Type - Low-Grade Glioma|Overall Study||5
9708732|NCT02639546|10807997|FG004|Tumor Type - Low-Grade Glioma|Overall Study||3
9708733|NCT02639546|10807998|FG005|Tumor Type - Low-Grade Glioma|Overall Study||2
9708734|NCT02639546|10807999|FG006|Tumor Type - Low-Grade Glioma|Overall Study||3
9708735|NCT02639546|10808000|FG007|Tumor Type - Low-Grade Glioma|Overall Study||12
9708736|NCT02639546|10807993|FG000|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708737|NCT02639546|10807994|FG001|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708738|NCT02639546|10807995|FG002|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708739|NCT02639546|10807996|FG003|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708740|NCT02639546|10807997|FG004|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708741|NCT02639546|10807998|FG005|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708742|NCT02639546|10807999|FG006|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
9708743|NCT02639546|10808000|FG007|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708744|NCT02639546|10807993|FG000|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
9708745|NCT02639546|10807994|FG001|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
9708746|NCT02639546|10807995|FG002|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
9708747|NCT02639546|10807996|FG003|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
9708748|NCT02639546|10807997|FG004|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
9708749|NCT02639546|10807998|FG005|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
9708750|NCT02639546|10807999|FG006|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
9708751|NCT02639546|10808000|FG007|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
9708752|NCT02639546|10807993|FG000|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
9708753|NCT02639546|10807994|FG001|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708754|NCT02639546|10807995|FG002|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708755|NCT02639546|10807996|FG003|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708756|NCT02639546|10807997|FG004|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708757|NCT02639546|10807998|FG005|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708758|NCT02639546|10807999|FG006|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708759|NCT02639546|10808000|FG007|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
9708760|NCT02639546|10807993|FG000|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
9708761|NCT02639546|10807994|FG001|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||1
9708762|NCT02639546|10807995|FG002|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
9708763|NCT02639546|10807996|FG003|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
9708764|NCT02639546|10807997|FG004|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
9708765|NCT02639546|10807998|FG005|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
9708766|NCT02639546|10807999|FG006|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10146945|NCT02154529|11277418|FG001|NOT COMPLETED|Overall Study||3
10146946|NCT02154529|11277419|FG002|NOT COMPLETED|Overall Study||8
10146947|NCT02154529|11277420|FG003|NOT COMPLETED|Overall Study||2
10146948|NCT00788125|11277432|FG000|STARTED|Overall Study||7
10146949|NCT00788125|11277432|FG000|COMPLETED|Overall Study||1
10146950|NCT00788125|11277432|FG000|NOT COMPLETED|Overall Study||6
10146951|NCT02777554|11277438|FG000|STARTED|Overall Study||62
10146952|NCT02777554|11277439|FG001|STARTED|Overall Study||62
10146953|NCT02777554|11277440|FG002|STARTED|Overall Study||5
10146954|NCT02777554|11277441|FG003|STARTED|Overall Study||5
10146955|NCT02777554|11277442|FG004|STARTED|Overall Study||5
10146956|NCT02777554|11277443|FG005|STARTED|Overall Study||5
10146957|NCT02777554|11277438|FG000|COMPLETED|Overall Study||32
10146958|NCT02777554|11277439|FG001|COMPLETED|Overall Study||37
10146959|NCT02777554|11277440|FG002|COMPLETED|Overall Study||4
10146960|NCT02777554|11277441|FG003|COMPLETED|Overall Study||4
10146961|NCT02777554|11277442|FG004|COMPLETED|Overall Study||5
10146962|NCT02777554|11277443|FG005|COMPLETED|Overall Study||5
10146963|NCT02777554|11277438|FG000|NOT COMPLETED|Overall Study||30
10146964|NCT02777554|11277439|FG001|NOT COMPLETED|Overall Study||25
10146965|NCT02777554|11277440|FG002|NOT COMPLETED|Overall Study||1
10146966|NCT02777554|11277441|FG003|NOT COMPLETED|Overall Study||1
10146967|NCT02777554|11277442|FG004|NOT COMPLETED|Overall Study||0
10146968|NCT02777554|11277443|FG005|NOT COMPLETED|Overall Study||0
10146969|NCT02777749|11277466|FG000|STARTED|Overall Study||53
10146970|NCT02777749|11277467|FG001|STARTED|Overall Study||51
10146971|NCT02777749|11277468|FG002|STARTED|Overall Study||51
10146972|NCT02777749|11277466|FG000|COMPLETED|Overall Study||53
10146973|NCT02777749|11277467|FG001|COMPLETED|Overall Study||51
10146974|NCT02777749|11277468|FG002|COMPLETED|Overall Study||51
10146975|NCT02777749|11277466|FG000|NOT COMPLETED|Overall Study||0
10146976|NCT02777749|11277467|FG001|NOT COMPLETED|Overall Study||0
10146977|NCT02777749|11277468|FG002|NOT COMPLETED|Overall Study||0
10146978|NCT02777827|11277480|FG000|STARTED|Treatment Period 1||5
10146979|NCT02777827|11277481|FG001|STARTED|Treatment Period 1||5
10146980|NCT02777827|11277482|FG002|STARTED|Treatment Period 1||5
10146981|NCT02777827|11277483|FG003|STARTED|Treatment Period 1||5
10146982|NCT02777827|11277484|FG004|STARTED|Treatment Period 1||4
10146983|NCT02777827|11277485|FG005|STARTED|Treatment Period 1||6
10146984|NCT02777827|11277480|FG000|COMPLETED|Treatment Period 1||5
10146985|NCT02777827|11277481|FG001|COMPLETED|Treatment Period 1||5
10146986|NCT02777827|11277482|FG002|COMPLETED|Treatment Period 1||5
10146987|NCT02777827|11277483|FG003|COMPLETED|Treatment Period 1||5
10146988|NCT02777827|11277484|FG004|COMPLETED|Treatment Period 1||4
10146989|NCT02777827|11277485|FG005|COMPLETED|Treatment Period 1||6
10146990|NCT02777827|11277480|FG000|NOT COMPLETED|Treatment Period 1||0
10146991|NCT02777827|11277481|FG001|NOT COMPLETED|Treatment Period 1||0
10146992|NCT02777827|11277482|FG002|NOT COMPLETED|Treatment Period 1||0
10146993|NCT02777827|11277483|FG003|NOT COMPLETED|Treatment Period 1||0
10146994|NCT02777827|11277484|FG004|NOT COMPLETED|Treatment Period 1||0
10146995|NCT02777827|11277485|FG005|NOT COMPLETED|Treatment Period 1||0
10146996|NCT02777827|11277480|FG000|STARTED|Washout Between Periods 1 and 2||5
10146997|NCT02777827|11277481|FG001|STARTED|Washout Between Periods 1 and 2||5
10146998|NCT02777827|11277482|FG002|STARTED|Washout Between Periods 1 and 2||5
10146999|NCT02777827|11277483|FG003|STARTED|Washout Between Periods 1 and 2||5
10147000|NCT02777827|11277484|FG004|STARTED|Washout Between Periods 1 and 2||4
10147001|NCT02777827|11277485|FG005|STARTED|Washout Between Periods 1 and 2||6
10147002|NCT02777827|11277480|FG000|COMPLETED|Washout Between Periods 1 and 2||5
9708767|NCT02639546|10808000|FG007|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
9708768|NCT02639546|10807993|FG000|Tumor Type - Plexiform Neurofibroma|Overall Study||1
9708769|NCT02639546|10807994|FG001|Tumor Type - Plexiform Neurofibroma|Overall Study||2
9708770|NCT02639546|10807995|FG002|Tumor Type - Plexiform Neurofibroma|Overall Study||1
9708771|NCT02639546|10807996|FG003|Tumor Type - Plexiform Neurofibroma|Overall Study||1
9708772|NCT02639546|10807997|FG004|Tumor Type - Plexiform Neurofibroma|Overall Study||2
9708773|NCT02639546|10807998|FG005|Tumor Type - Plexiform Neurofibroma|Overall Study||4
9708774|NCT02639546|10807999|FG006|Tumor Type - Plexiform Neurofibroma|Overall Study||1
9708775|NCT02639546|10808000|FG007|Tumor Type - Plexiform Neurofibroma|Overall Study||0
9708776|NCT02639546|10807993|FG000|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
9708777|NCT02639546|10807994|FG001|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
9708778|NCT02639546|10807995|FG002|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
9708779|NCT02639546|10807996|FG003|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
9708780|NCT02639546|10807997|FG004|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
9708781|NCT02639546|10807998|FG005|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||1
10147003|NCT02777827|11277481|FG001|COMPLETED|Washout Between Periods 1 and 2||5
10147004|NCT02777827|11277482|FG002|COMPLETED|Washout Between Periods 1 and 2||5
10147005|NCT02777827|11277483|FG003|COMPLETED|Washout Between Periods 1 and 2||5
9708782|NCT02639546|10807999|FG006|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
9708783|NCT02639546|10808000|FG007|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
9708784|NCT02639546|10807993|FG000|COMPLETED|Overall Study||0
10147006|NCT02777827|11277484|FG004|COMPLETED|Washout Between Periods 1 and 2||4
10147007|NCT02777827|11277485|FG005|COMPLETED|Washout Between Periods 1 and 2||6
10147008|NCT02777827|11277480|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
10147009|NCT02777827|11277481|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
10147010|NCT02777827|11277482|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
10147011|NCT02777827|11277483|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
10147012|NCT02777827|11277484|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
10147013|NCT02777827|11277485|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
10147014|NCT02777827|11277480|FG000|STARTED|Treatment Period 2||5
10147015|NCT02777827|11277481|FG001|STARTED|Treatment Period 2||5
10147016|NCT02777827|11277482|FG002|STARTED|Treatment Period 2||5
10147017|NCT02777827|11277483|FG003|STARTED|Treatment Period 2||5
10147018|NCT02777827|11277484|FG004|STARTED|Treatment Period 2||4
10147019|NCT02777827|11277485|FG005|STARTED|Treatment Period 2||6
10147020|NCT02777827|11277480|FG000|COMPLETED|Treatment Period 2||5
10147021|NCT02777827|11277481|FG001|COMPLETED|Treatment Period 2||5
10147022|NCT02777827|11277482|FG002|COMPLETED|Treatment Period 2||5
10147023|NCT02777827|11277483|FG003|COMPLETED|Treatment Period 2||5
10147024|NCT02777827|11277484|FG004|COMPLETED|Treatment Period 2||4
10147025|NCT02777827|11277485|FG005|COMPLETED|Treatment Period 2||6
10147026|NCT02777827|11277480|FG000|NOT COMPLETED|Treatment Period 2||0
10147027|NCT02777827|11277481|FG001|NOT COMPLETED|Treatment Period 2||0
10147028|NCT02777827|11277482|FG002|NOT COMPLETED|Treatment Period 2||0
10147029|NCT02777827|11277483|FG003|NOT COMPLETED|Treatment Period 2||0
10147030|NCT02777827|11277484|FG004|NOT COMPLETED|Treatment Period 2||0
10147031|NCT02777827|11277485|FG005|NOT COMPLETED|Treatment Period 2||0
10147032|NCT02777827|11277480|FG000|STARTED|Washout Between Periods 2 and 3||5
10147033|NCT02777827|11277481|FG001|STARTED|Washout Between Periods 2 and 3||5
10147034|NCT02777827|11277482|FG002|STARTED|Washout Between Periods 2 and 3||5
10147035|NCT02777827|11277483|FG003|STARTED|Washout Between Periods 2 and 3||5
10147036|NCT02777827|11277484|FG004|STARTED|Washout Between Periods 2 and 3||4
10147037|NCT02777827|11277485|FG005|STARTED|Washout Between Periods 2 and 3||6
10147038|NCT02777827|11277480|FG000|COMPLETED|Washout Between Periods 2 and 3||5
10147039|NCT02777827|11277481|FG001|COMPLETED|Washout Between Periods 2 and 3||5
10147040|NCT02777827|11277482|FG002|COMPLETED|Washout Between Periods 2 and 3||5
10147041|NCT02777827|11277483|FG003|COMPLETED|Washout Between Periods 2 and 3||5
10147042|NCT02777827|11277484|FG004|COMPLETED|Washout Between Periods 2 and 3||4
10147043|NCT02777827|11277485|FG005|COMPLETED|Washout Between Periods 2 and 3||6
10147044|NCT02777827|11277480|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
10147045|NCT02777827|11277481|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
10147046|NCT02777827|11277482|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
10147047|NCT02777827|11277483|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
10147048|NCT02777827|11277484|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
10147049|NCT02777827|11277485|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
10147050|NCT02777827|11277480|FG000|STARTED|Treatment Period 3||5
10147051|NCT02777827|11277481|FG001|STARTED|Treatment Period 3||5
10147052|NCT02777827|11277482|FG002|STARTED|Treatment Period 3||5
10147053|NCT02777827|11277483|FG003|STARTED|Treatment Period 3||5
10147054|NCT02777827|11277484|FG004|STARTED|Treatment Period 3||4
10147055|NCT02777827|11277485|FG005|STARTED|Treatment Period 3||6
10147056|NCT02777827|11277480|FG000|COMPLETED|Treatment Period 3||5
10147057|NCT02777827|11277481|FG001|COMPLETED|Treatment Period 3||5
10147058|NCT02777827|11277482|FG002|COMPLETED|Treatment Period 3||5
10147059|NCT02777827|11277483|FG003|COMPLETED|Treatment Period 3||5
10147060|NCT02777827|11277484|FG004|COMPLETED|Treatment Period 3||4
10147061|NCT02777827|11277485|FG005|COMPLETED|Treatment Period 3||6
10147062|NCT02777827|11277480|FG000|NOT COMPLETED|Treatment Period 3||0
10147063|NCT02777827|11277481|FG001|NOT COMPLETED|Treatment Period 3||0
10147064|NCT02777827|11277482|FG002|NOT COMPLETED|Treatment Period 3||0
10147065|NCT02777827|11277483|FG003|NOT COMPLETED|Treatment Period 3||0
10147066|NCT02777827|11277484|FG004|NOT COMPLETED|Treatment Period 3||0
10147067|NCT02777827|11277485|FG005|NOT COMPLETED|Treatment Period 3||0
10147068|NCT02777827|11277480|FG000|STARTED|Washout Between Periods 3 and 4||5
10147069|NCT02777827|11277481|FG001|STARTED|Washout Between Periods 3 and 4||5
10147070|NCT02777827|11277482|FG002|STARTED|Washout Between Periods 3 and 4||5
10147071|NCT02777827|11277483|FG003|STARTED|Washout Between Periods 3 and 4||5
10147072|NCT02777827|11277484|FG004|STARTED|Washout Between Periods 3 and 4||4
10147073|NCT02777827|11277485|FG005|STARTED|Washout Between Periods 3 and 4||6
10147074|NCT02777827|11277480|FG000|COMPLETED|Washout Between Periods 3 and 4||5
10147075|NCT02777827|11277481|FG001|COMPLETED|Washout Between Periods 3 and 4||5
10147076|NCT02777827|11277482|FG002|COMPLETED|Washout Between Periods 3 and 4||4
10147077|NCT02777827|11277483|FG003|COMPLETED|Washout Between Periods 3 and 4||5
10147078|NCT02777827|11277484|FG004|COMPLETED|Washout Between Periods 3 and 4||4
10147079|NCT02777827|11277485|FG005|COMPLETED|Washout Between Periods 3 and 4||6
10147080|NCT02777827|11277480|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0
10147081|NCT02777827|11277481|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0
10147082|NCT02777827|11277482|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1
10147083|NCT02777827|11277483|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0
10147084|NCT02777827|11277484|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0
10147085|NCT02777827|11277485|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0
10147086|NCT02777827|11277480|FG000|STARTED|Treatment Period 4||5
10147087|NCT02777827|11277481|FG001|STARTED|Treatment Period 4||5
10147088|NCT02777827|11277482|FG002|STARTED|Treatment Period 4||4
10147089|NCT02777827|11277483|FG003|STARTED|Treatment Period 4||5
10147090|NCT02777827|11277484|FG004|STARTED|Treatment Period 4||4
10147091|NCT02777827|11277485|FG005|STARTED|Treatment Period 4||6
10147092|NCT02777827|11277480|FG000|COMPLETED|Treatment Period 4||5
10147093|NCT02777827|11277481|FG001|COMPLETED|Treatment Period 4||5
10147094|NCT02777827|11277482|FG002|COMPLETED|Treatment Period 4||4
10147095|NCT02777827|11277483|FG003|COMPLETED|Treatment Period 4||5
10147096|NCT02777827|11277484|FG004|COMPLETED|Treatment Period 4||4
10147097|NCT02777827|11277485|FG005|COMPLETED|Treatment Period 4||6
10147098|NCT02777827|11277480|FG000|NOT COMPLETED|Treatment Period 4||0
10147099|NCT02777827|11277481|FG001|NOT COMPLETED|Treatment Period 4||0
10147100|NCT02777827|11277482|FG002|NOT COMPLETED|Treatment Period 4||0
10147101|NCT02777827|11277483|FG003|NOT COMPLETED|Treatment Period 4||0
10147102|NCT02777827|11277484|FG004|NOT COMPLETED|Treatment Period 4||0
10147103|NCT02777827|11277485|FG005|NOT COMPLETED|Treatment Period 4||0
10147104|NCT02777827|11277480|FG000|STARTED|Washout Between Periods 4 and 5||5
10147105|NCT02777827|11277481|FG001|STARTED|Washout Between Periods 4 and 5||5
10147106|NCT02777827|11277482|FG002|STARTED|Washout Between Periods 4 and 5||4
10147107|NCT02777827|11277483|FG003|STARTED|Washout Between Periods 4 and 5||5
10147108|NCT02777827|11277484|FG004|STARTED|Washout Between Periods 4 and 5||4
10147109|NCT02777827|11277485|FG005|STARTED|Washout Between Periods 4 and 5||6
10147110|NCT02777827|11277480|FG000|COMPLETED|Washout Between Periods 4 and 5||5
10147111|NCT02777827|11277481|FG001|COMPLETED|Washout Between Periods 4 and 5||5
10147112|NCT02777827|11277482|FG002|COMPLETED|Washout Between Periods 4 and 5||4
10147113|NCT02777827|11277483|FG003|COMPLETED|Washout Between Periods 4 and 5||5
10147114|NCT02777827|11277484|FG004|COMPLETED|Washout Between Periods 4 and 5||4
10147115|NCT02777827|11277485|FG005|COMPLETED|Washout Between Periods 4 and 5||6
10147116|NCT02777827|11277480|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
10147117|NCT02777827|11277481|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
10147118|NCT02777827|11277482|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
10147119|NCT02777827|11277483|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
10147120|NCT02777827|11277484|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
10147121|NCT02777827|11277485|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
10147122|NCT02777827|11277480|FG000|STARTED|Treatment Period 5||5
10147123|NCT02777827|11277481|FG001|STARTED|Treatment Period 5||5
10147124|NCT02777827|11277482|FG002|STARTED|Treatment Period 5||4
10147125|NCT02777827|11277483|FG003|STARTED|Treatment Period 5||5
10147126|NCT02777827|11277484|FG004|STARTED|Treatment Period 5||4
10147127|NCT02777827|11277485|FG005|STARTED|Treatment Period 5||6
10147128|NCT02777827|11277480|FG000|COMPLETED|Treatment Period 5||5
10147129|NCT02777827|11277481|FG001|COMPLETED|Treatment Period 5||5
10147130|NCT02777827|11277482|FG002|COMPLETED|Treatment Period 5||4
10147131|NCT02777827|11277483|FG003|COMPLETED|Treatment Period 5||5
10147132|NCT02777827|11277484|FG004|COMPLETED|Treatment Period 5||4
10147133|NCT02777827|11277485|FG005|COMPLETED|Treatment Period 5||6
10147134|NCT02777827|11277480|FG000|NOT COMPLETED|Treatment Period 5||0
10147135|NCT02777827|11277481|FG001|NOT COMPLETED|Treatment Period 5||0
10147136|NCT02777827|11277482|FG002|NOT COMPLETED|Treatment Period 5||0
10147137|NCT02777827|11277483|FG003|NOT COMPLETED|Treatment Period 5||0
10147138|NCT02777827|11277484|FG004|NOT COMPLETED|Treatment Period 5||0
10147139|NCT02777827|11277485|FG005|NOT COMPLETED|Treatment Period 5||0
10147140|NCT02777827|11277480|FG000|STARTED|Washout Between Periods 5 and 6||5
10147141|NCT02777827|11277481|FG001|STARTED|Washout Between Periods 5 and 6||5
10147142|NCT02777827|11277482|FG002|STARTED|Washout Between Periods 5 and 6||4
10147143|NCT02777827|11277483|FG003|STARTED|Washout Between Periods 5 and 6||5
10147144|NCT02777827|11277484|FG004|STARTED|Washout Between Periods 5 and 6||4
10147145|NCT02777827|11277485|FG005|STARTED|Washout Between Periods 5 and 6||6
10147146|NCT02777827|11277480|FG000|COMPLETED|Washout Between Periods 5 and 6||5
10147147|NCT02777827|11277481|FG001|COMPLETED|Washout Between Periods 5 and 6||5
10147148|NCT02777827|11277482|FG002|COMPLETED|Washout Between Periods 5 and 6||4
10147149|NCT02777827|11277483|FG003|COMPLETED|Washout Between Periods 5 and 6||5
10147150|NCT02777827|11277484|FG004|COMPLETED|Washout Between Periods 5 and 6||4
10147151|NCT02777827|11277485|FG005|COMPLETED|Washout Between Periods 5 and 6||6
10147152|NCT02777827|11277480|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
10147153|NCT02777827|11277481|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
10147154|NCT02777827|11277482|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
10147155|NCT02777827|11277483|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
10147156|NCT02777827|11277484|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
10147157|NCT02777827|11277485|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
10147158|NCT02777827|11277480|FG000|STARTED|Treatment Period 6||5
10147159|NCT02777827|11277481|FG001|STARTED|Treatment Period 6||5
10147160|NCT02777827|11277482|FG002|STARTED|Treatment Period 6||4
10147161|NCT02777827|11277483|FG003|STARTED|Treatment Period 6||5
10147162|NCT02777827|11277484|FG004|STARTED|Treatment Period 6||4
10147163|NCT02777827|11277485|FG005|STARTED|Treatment Period 6||6
10147164|NCT02777827|11277480|FG000|COMPLETED|Treatment Period 6||5
10147165|NCT02777827|11277481|FG001|COMPLETED|Treatment Period 6||5
10147166|NCT02777827|11277482|FG002|COMPLETED|Treatment Period 6||4
10147167|NCT02777827|11277483|FG003|COMPLETED|Treatment Period 6||5
10147168|NCT02777827|11277484|FG004|COMPLETED|Treatment Period 6||4
10147169|NCT02777827|11277485|FG005|COMPLETED|Treatment Period 6||6
10147170|NCT02777827|11277480|FG000|NOT COMPLETED|Treatment Period 6||0
10147171|NCT02777827|11277481|FG001|NOT COMPLETED|Treatment Period 6||0
10147172|NCT02777827|11277482|FG002|NOT COMPLETED|Treatment Period 6||0
10147173|NCT02777827|11277483|FG003|NOT COMPLETED|Treatment Period 6||0
10147174|NCT02777827|11277484|FG004|NOT COMPLETED|Treatment Period 6||0
10147175|NCT02777827|11277485|FG005|NOT COMPLETED|Treatment Period 6||0
10147176|NCT02777918|11277501|FG000|STARTED|Overall Study||53
10147177|NCT02777918|11277502|FG001|STARTED|Overall Study||47
10147178|NCT02777918|11277501|FG000|COMPLETED|Overall Study||50
10147179|NCT02777918|11277502|FG001|COMPLETED|Overall Study||43
10147180|NCT02777918|11277501|FG000|NOT COMPLETED|Overall Study||3
10147181|NCT02777918|11277502|FG001|NOT COMPLETED|Overall Study||4
10147182|NCT02777931|11277510|FG000|STARTED|Overall Study||49
10147183|NCT02777931|11277511|FG001|STARTED|Overall Study||52
10147184|NCT02777931|11277510|FG000|Safety Population|Overall Study||47
10147185|NCT02777931|11277511|FG001|Safety Population|Overall Study||50
10147186|NCT02777931|11277510|FG000|Modified Intent to Treat Population|Overall Study||46
10147187|NCT02777931|11277511|FG001|Modified Intent to Treat Population|Overall Study||50
10147188|NCT02777931|11277510|FG000|COMPLETED|Overall Study||37
10147189|NCT02777931|11277511|FG001|COMPLETED|Overall Study||39
10147190|NCT02777931|11277510|FG000|NOT COMPLETED|Overall Study||12
10147191|NCT02777931|11277511|FG001|NOT COMPLETED|Overall Study||13
10147192|NCT02777944|11277519|FG000|STARTED|Overall Study||157
10147193|NCT02777944|11277520|FG001|STARTED|Overall Study||156
10147194|NCT02777944|11277519|FG000|COMPLETED|Overall Study||157
10147195|NCT02777944|11277520|FG001|COMPLETED|Overall Study||156
10147196|NCT02777944|11277519|FG000|NOT COMPLETED|Overall Study||0
10147197|NCT02777944|11277520|FG001|NOT COMPLETED|Overall Study||0
10147198|NCT02777970|11277529|FG000|STARTED|Overall Study||261
10147199|NCT02777970|11277530|FG001|STARTED|Overall Study||262
10147200|NCT02777970|11277531|FG002|STARTED|Overall Study||131
10147201|NCT02777970|11277529|FG000|COMPLETED|Overall Study||260
10147202|NCT02777970|11277530|FG001|COMPLETED|Overall Study||261
10147203|NCT02777970|11277531|FG002|COMPLETED|Overall Study||131
10147204|NCT02777970|11277529|FG000|NOT COMPLETED|Overall Study||1
10147205|NCT02777970|11277530|FG001|NOT COMPLETED|Overall Study||1
10147206|NCT02777970|11277531|FG002|NOT COMPLETED|Overall Study||0
10147207|NCT02778074|11277543|FG000|STARTED|Overall Study||72
10147208|NCT02778074|11277544|FG001|STARTED|Overall Study||72
10147209|NCT02778074|11277543|FG000|COMPLETED|Overall Study||65
10147210|NCT02778074|11277544|FG001|COMPLETED|Overall Study||62
10147211|NCT02778074|11277543|FG000|NOT COMPLETED|Overall Study||7
10147212|NCT02778074|11277544|FG001|NOT COMPLETED|Overall Study||10
10147213|NCT02778100|11277552|FG000|STARTED|Period 1 (Common Cold)||18
10147214|NCT02778100|11277553|FG001|STARTED|Period 1 (Common Cold)||18
10147215|NCT02778100|11277552|FG000|COMPLETED|Period 1 (Common Cold)||17
10147216|NCT02778100|11277553|FG001|COMPLETED|Period 1 (Common Cold)||18
10147217|NCT02778100|11277552|FG000|NOT COMPLETED|Period 1 (Common Cold)||1
10147218|NCT02778100|11277553|FG001|NOT COMPLETED|Period 1 (Common Cold)||0
10147219|NCT02778100|11277552|FG000|STARTED|Period 2 (No Cold Symptoms)||17
10147220|NCT02778100|11277553|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
10147221|NCT02778100|11277552|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17
10147222|NCT02778100|11277553|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0
10147223|NCT02778100|11277552|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
10147224|NCT02778100|11277553|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
10147225|NCT02778113|11277561|FG000|STARTED|Study Period One||4
10147226|NCT02778113|11277562|FG001|STARTED|Study Period One||4
10147227|NCT02778113|11277563|FG002|STARTED|Study Period One||4
10147228|NCT02778113|11277564|FG003|STARTED|Study Period One||4
10147229|NCT02778113|11277561|FG000|Received Study Drug|Study Period One||4
10147230|NCT02778113|11277562|FG001|Received Study Drug|Study Period One||4
10147231|NCT02778113|11277563|FG002|Received Study Drug|Study Period One||4
10147232|NCT02778113|11277564|FG003|Received Study Drug|Study Period One||4
10147233|NCT02778113|11277561|FG000|COMPLETED|Study Period One||4
10147234|NCT02778113|11277562|FG001|COMPLETED|Study Period One||4
10147235|NCT02778113|11277563|FG002|COMPLETED|Study Period One||4
10147236|NCT02778113|11277564|FG003|COMPLETED|Study Period One||4
10147237|NCT02778113|11277561|FG000|NOT COMPLETED|Study Period One||0
10147238|NCT02778113|11277562|FG001|NOT COMPLETED|Study Period One||0
10147239|NCT02778113|11277563|FG002|NOT COMPLETED|Study Period One||0
10147240|NCT02778113|11277564|FG003|NOT COMPLETED|Study Period One||0
10147241|NCT02778113|11277561|FG000|STARTED|Study Period Two||4
10147242|NCT02778113|11277562|FG001|STARTED|Study Period Two||4
10147243|NCT02778113|11277563|FG002|STARTED|Study Period Two||4
10147244|NCT02778113|11277564|FG003|STARTED|Study Period Two||4
10147245|NCT02778113|11277561|FG000|Received Study Drug|Study Period Two||4
10147246|NCT02778113|11277562|FG001|Received Study Drug|Study Period Two||4
10147247|NCT02778113|11277563|FG002|Received Study Drug|Study Period Two||4
10147248|NCT02778113|11277564|FG003|Received Study Drug|Study Period Two||4
10147249|NCT02778113|11277561|FG000|COMPLETED|Study Period Two||4
10147250|NCT02778113|11277562|FG001|COMPLETED|Study Period Two||4
10147251|NCT02778113|11277563|FG002|COMPLETED|Study Period Two||4
10147252|NCT02778113|11277564|FG003|COMPLETED|Study Period Two||4
10147253|NCT02778113|11277561|FG000|NOT COMPLETED|Study Period Two||0
10147254|NCT02778113|11277562|FG001|NOT COMPLETED|Study Period Two||0
10147255|NCT02778113|11277563|FG002|NOT COMPLETED|Study Period Two||0
10147256|NCT02778113|11277564|FG003|NOT COMPLETED|Study Period Two||0
10147257|NCT02778113|11277561|FG000|STARTED|Study Period Three||4
10147258|NCT02778113|11277562|FG001|STARTED|Study Period Three||4
10147259|NCT02778113|11277563|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
10147260|NCT02778113|11277564|FG003|STARTED|Study Period Three||4
10147261|NCT02778113|11277561|FG000|Received Study Drug|Study Period Three||4
10147262|NCT02778113|11277562|FG001|Received Study Drug|Study Period Three||4
10147263|NCT02778113|11277563|FG002|Received Study Drug|Study Period Three||3
10147264|NCT02778113|11277564|FG003|Received Study Drug|Study Period Three||4
10147265|NCT02778113|11277561|FG000|COMPLETED|Study Period Three||4
10147266|NCT02778113|11277562|FG001|COMPLETED|Study Period Three||4
10147267|NCT02778113|11277563|FG002|COMPLETED|Study Period Three||3
10147268|NCT02778113|11277564|FG003|COMPLETED|Study Period Three||4
10147269|NCT02778113|11277561|FG000|NOT COMPLETED|Study Period Three||0
10147270|NCT02778113|11277562|FG001|NOT COMPLETED|Study Period Three||0
10147271|NCT02778113|11277563|FG002|NOT COMPLETED|Study Period Three||0
10147272|NCT02778113|11277564|FG003|NOT COMPLETED|Study Period Three||0
10147273|NCT02778113|11277561|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
10147274|NCT02778113|11277562|FG001|STARTED|Study Period Four||4
10147275|NCT02778113|11277563|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
10147276|NCT02778113|11277564|FG003|STARTED|Study Period Four||4
10147277|NCT02778113|11277561|FG000|Received Study Drug|Study Period Four||3
10147278|NCT02778113|11277562|FG001|Received Study Drug|Study Period Four||4
10147279|NCT02778113|11277563|FG002|Received Study Drug|Study Period Four||2
10147280|NCT02778113|11277564|FG003|Received Study Drug|Study Period Four||4
10147281|NCT02778113|11277561|FG000|COMPLETED|Study Period Four||3
10147282|NCT02778113|11277562|FG001|COMPLETED|Study Period Four||4
10147283|NCT02778113|11277563|FG002|COMPLETED|Study Period Four||2
10147284|NCT02778113|11277564|FG003|COMPLETED|Study Period Four||4
10147285|NCT02778113|11277561|FG000|NOT COMPLETED|Study Period Four||0
10147286|NCT02778113|11277562|FG001|NOT COMPLETED|Study Period Four||0
10147287|NCT02778113|11277563|FG002|NOT COMPLETED|Study Period Four||0
10147288|NCT02778113|11277564|FG003|NOT COMPLETED|Study Period Four||0
10147289|NCT02778152|11277576|FG000|STARTED|Overall Study||13
10147290|NCT02778152|11277576|FG000|COMPLETED|Overall Study||13
10147291|NCT02778152|11277576|FG000|NOT COMPLETED|Overall Study||0
10147292|NCT02778555|11277583|FG000|STARTED|Overall Study||186
10147293|NCT02778555|11277584|FG001|STARTED|Overall Study||209
10147294|NCT02778555|11277585|FG002|STARTED|Overall Study||318
10147295|NCT02778555|11277583|FG000|COMPLETED|Overall Study||131
10147296|NCT02778555|11277584|FG001|COMPLETED|Overall Study||177
10147297|NCT02778555|11277585|FG002|COMPLETED|Overall Study||211
10147298|NCT02778555|11277583|FG000|NOT COMPLETED|Overall Study||55
10147299|NCT02778555|11277584|FG001|NOT COMPLETED|Overall Study||32
10147300|NCT02778555|11277585|FG002|NOT COMPLETED|Overall Study||107
10147301|NCT02778867|11277595|FG000|STARTED|Phase 1||67
10147302|NCT02778867|11277596|FG001|STARTED|Phase 1||62
10147303|NCT02778867|11277597|FG002|STARTED|Phase 1||0
10147304|NCT02778867|11277598|FG003|STARTED|Phase 1||0
10147305|NCT02778867|11277595|FG000|COMPLETED|Phase 1||65
10147306|NCT02778867|11277596|FG001|COMPLETED|Phase 1||59
10147307|NCT02778867|11277597|FG002|COMPLETED|Phase 1||0
10147308|NCT02778867|11277598|FG003|COMPLETED|Phase 1||0
10147309|NCT02778867|11277595|FG000|NOT COMPLETED|Phase 1||2
10147310|NCT02778867|11277596|FG001|NOT COMPLETED|Phase 1||3
10147311|NCT02778867|11277597|FG002|NOT COMPLETED|Phase 1||0
10147312|NCT02778867|11277598|FG003|NOT COMPLETED|Phase 1||0
10147313|NCT02778867|11277595|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
10147314|NCT02778867|11277596|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
10147315|NCT02778867|11277597|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21
10147316|NCT02778867|11277598|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11
10147317|NCT02778867|11277595|FG000|COMPLETED|Phase 2||0
10147318|NCT02778867|11277596|FG001|COMPLETED|Phase 2||0
10147319|NCT02778867|11277597|FG002|COMPLETED|Phase 2||20
10147320|NCT02778867|11277598|FG003|COMPLETED|Phase 2||9
10147321|NCT02778867|11277595|FG000|NOT COMPLETED|Phase 2||0
10147322|NCT02778867|11277596|FG001|NOT COMPLETED|Phase 2||0
10147323|NCT02778867|11277597|FG002|NOT COMPLETED|Phase 2||1
10147324|NCT02778867|11277598|FG003|NOT COMPLETED|Phase 2||2
10147325|NCT02778880|11277610|FG000|STARTED|Overall Study||45
10147326|NCT02778880|11277611|FG001|STARTED|Overall Study||45
10147327|NCT02778880|11277610|FG000|COMPLETED|Overall Study||44
10147328|NCT02778880|11277611|FG001|COMPLETED|Overall Study||42
10147329|NCT02778880|11277610|FG000|NOT COMPLETED|Overall Study||1
10147330|NCT02778880|11277611|FG001|NOT COMPLETED|Overall Study||3
10147331|NCT02778932|11277619|FG000|STARTED|Overall Study||74
10147332|NCT02778932|11277620|FG001|STARTED|Overall Study||74
10147333|NCT02778932|11277619|FG000|COMPLETED|Overall Study||74
10147334|NCT02778932|11277620|FG001|COMPLETED|Overall Study||74
10147335|NCT02778932|11277619|FG000|NOT COMPLETED|Overall Study||0
10147336|NCT02778932|11277620|FG001|NOT COMPLETED|Overall Study||0
10147337|NCT02779075|11277628|FG000|STARTED|Overall Study||16
10147338|NCT02779075|11277629|FG001|STARTED|Overall Study||13
10147339|NCT02779075|11277628|FG000|COMPLETED|Overall Study||14
10147340|NCT02779075|11277629|FG001|COMPLETED|Overall Study||10
10147341|NCT02779075|11277628|FG000|NOT COMPLETED|Overall Study||2
10147342|NCT02779075|11277629|FG001|NOT COMPLETED|Overall Study||3
10147343|NCT02779166|11277637|FG000|STARTED|Overall Study||50
10147344|NCT02779166|11277638|FG001|STARTED|Overall Study||48
10147345|NCT02779166|11277637|FG000|COMPLETED|Overall Study||50
10147346|NCT02779166|11277638|FG001|COMPLETED|Overall Study||48
10147347|NCT02779166|11277637|FG000|NOT COMPLETED|Overall Study||0
10147348|NCT02779166|11277638|FG001|NOT COMPLETED|Overall Study||0
10147349|NCT02779491|11277648|FG000|STARTED|Overall Study||32
10147350|NCT02779491|11277649|FG001|STARTED|Overall Study||27
10147351|NCT02779491|11277650|FG002|STARTED|Overall Study||18
10147352|NCT02779491|11277651|FG003|STARTED|Overall Study||17
10147353|NCT02779491|11277648|FG000|COMPLETED|Overall Study||32
10147354|NCT02779491|11277649|FG001|COMPLETED|Overall Study||26
10147355|NCT02779491|11277650|FG002|COMPLETED|Overall Study||17
10147356|NCT02779491|11277651|FG003|COMPLETED|Overall Study||15
10147357|NCT02779491|11277648|FG000|NOT COMPLETED|Overall Study||0
10147358|NCT02779491|11277649|FG001|NOT COMPLETED|Overall Study||1
10147359|NCT02779491|11277650|FG002|NOT COMPLETED|Overall Study||1
10147360|NCT02779491|11277651|FG003|NOT COMPLETED|Overall Study||2
10147361|NCT02779543|11277663|FG000|STARTED|Overall Study||100
10147362|NCT02779543|11277664|FG001|STARTED|Overall Study||100
10147363|NCT02779543|11277663|FG000|COMPLETED|Overall Study||100
10147364|NCT02779543|11277664|FG001|COMPLETED|Overall Study||100
10147365|NCT02779543|11277663|FG000|NOT COMPLETED|Overall Study||0
10147366|NCT02779543|11277664|FG001|NOT COMPLETED|Overall Study||0
10147367|NCT02780115|11277676|FG000|STARTED|Overall Study||28
10147368|NCT02780115|11277677|FG001|STARTED|Overall Study||30
10147369|NCT02780115|11277678|FG002|STARTED|Overall Study||30
10147370|NCT02780115|11277679|FG003|STARTED|Overall Study||32
10147371|NCT02780115|11277680|FG004|STARTED|Overall Study||31
10147372|NCT02780115|11277676|FG000|COMPLETED|Overall Study||28
10147373|NCT02780115|11277677|FG001|COMPLETED|Overall Study||29
10147374|NCT02780115|11277678|FG002|COMPLETED|Overall Study||29
10147375|NCT02780115|11277679|FG003|COMPLETED|Overall Study||31
10147376|NCT02780115|11277680|FG004|COMPLETED|Overall Study||30
10147377|NCT02780115|11277676|FG000|NOT COMPLETED|Overall Study||0
10147378|NCT02780115|11277677|FG001|NOT COMPLETED|Overall Study||1
10147379|NCT02780115|11277678|FG002|NOT COMPLETED|Overall Study||1
10147380|NCT02780115|11277679|FG003|NOT COMPLETED|Overall Study||1
10147381|NCT02780115|11277680|FG004|NOT COMPLETED|Overall Study||1
10147382|NCT02780167|11277697|FG000|STARTED|Overall Study||56
10147383|NCT02780167|11277698|FG001|STARTED|Overall Study||49
10147384|NCT02780167|11277699|FG002|STARTED|Overall Study||51
10147385|NCT02780167|11277700|FG003|STARTED|Overall Study||56
10147386|NCT02780167|11277701|FG004|STARTED|Overall Study||55
10147387|NCT02780167|11277697|FG000|COMPLETED|Overall Study||28
10147388|NCT02780167|11277698|FG001|COMPLETED|Overall Study||27
10147389|NCT02780167|11277699|FG002|COMPLETED|Overall Study||27
10147390|NCT02780167|11277700|FG003|COMPLETED|Overall Study||37
10147391|NCT02780167|11277701|FG004|COMPLETED|Overall Study||38
10147392|NCT02780167|11277697|FG000|NOT COMPLETED|Overall Study||28
10147393|NCT02780167|11277698|FG001|NOT COMPLETED|Overall Study||22
10147394|NCT02780167|11277699|FG002|NOT COMPLETED|Overall Study||24
10147395|NCT02780167|11277700|FG003|NOT COMPLETED|Overall Study||19
10147396|NCT02780167|11277701|FG004|NOT COMPLETED|Overall Study||17
10147397|NCT02780349|11277713|FG000|STARTED|Overall Study||103
10147398|NCT02780349|11277713|FG000|COMPLETED|Overall Study||101
10147399|NCT02780349|11277713|FG000|NOT COMPLETED|Overall Study||2
10147400|NCT02780388|11277722|FG000|STARTED|Overall Study||15
10147401|NCT02780388|11277723|FG001|STARTED|Overall Study||8
10147402|NCT02780388|11277724|FG002|STARTED|Overall Study||10
10147403|NCT02780388|11277725|FG003|STARTED|Overall Study||12
10147404|NCT02780388|11277726|FG004|STARTED|Overall Study||12
10147405|NCT02780388|11277722|FG000|COMPLETED|Overall Study||14
10147406|NCT02780388|11277723|FG001|COMPLETED|Overall Study||6
10147407|NCT02780388|11277724|FG002|COMPLETED|Overall Study||10
10147408|NCT02780388|11277725|FG003|COMPLETED|Overall Study||12
10147409|NCT02780388|11277726|FG004|COMPLETED|Overall Study||12
10147410|NCT02780388|11277722|FG000|NOT COMPLETED|Overall Study||1
10147411|NCT02780388|11277723|FG001|NOT COMPLETED|Overall Study||2
10147412|NCT02780388|11277724|FG002|NOT COMPLETED|Overall Study||0
10147413|NCT02780388|11277725|FG003|NOT COMPLETED|Overall Study||0
10147414|NCT02780388|11277726|FG004|NOT COMPLETED|Overall Study||0
10147415|NCT02780622|11277742|FG000|STARTED|Treatment Period 1||10
10147416|NCT02780622|11277743|FG001|STARTED|Treatment Period 1||10
10147417|NCT02780622|11277742|FG000|COMPLETED|Treatment Period 1||10
10147418|NCT02780622|11277743|FG001|COMPLETED|Treatment Period 1||10
10147419|NCT02780622|11277742|FG000|NOT COMPLETED|Treatment Period 1||0
10147420|NCT02780622|11277743|FG001|NOT COMPLETED|Treatment Period 1||0
10147421|NCT02780622|11277742|FG000|STARTED|Treatment Period 2||10
10147422|NCT02780622|11277743|FG001|STARTED|Treatment Period 2||10
10147423|NCT02780622|11277742|FG000|COMPLETED|Treatment Period 2||10
10147424|NCT02780622|11277743|FG001|COMPLETED|Treatment Period 2||10
10147425|NCT02780622|11277742|FG000|NOT COMPLETED|Treatment Period 2||0
10147426|NCT02780622|11277743|FG001|NOT COMPLETED|Treatment Period 2||0
10147427|NCT02780661|11277750|FG000|STARTED|Period 1||10
10147428|NCT02780661|11277751|FG001|STARTED|Period 1||9
10147429|NCT02780661|11277750|FG000|COMPLETED|Period 1||10
10147430|NCT02780661|11277751|FG001|COMPLETED|Period 1||9
10147431|NCT02780661|11277750|FG000|NOT COMPLETED|Period 1||0
10147432|NCT02780661|11277751|FG001|NOT COMPLETED|Period 1||0
10147433|NCT02780661|11277750|FG000|STARTED|Wash Out Period||10
10147434|NCT02780661|11277751|FG001|STARTED|Wash Out Period||9
10147435|NCT02780661|11277750|FG000|COMPLETED|Wash Out Period||10
10147436|NCT02780661|11277751|FG001|COMPLETED|Wash Out Period||9
10147437|NCT02780661|11277750|FG000|NOT COMPLETED|Wash Out Period||0
10147438|NCT02780661|11277751|FG001|NOT COMPLETED|Wash Out Period||0
10147439|NCT02780661|11277750|FG000|STARTED|Period 2||10
10147440|NCT02780661|11277751|FG001|STARTED|Period 2||9
10147441|NCT02780661|11277750|FG000|COMPLETED|Period 2||10
10147442|NCT02780661|11277751|FG001|COMPLETED|Period 2||9
10147443|NCT02780661|11277750|FG000|NOT COMPLETED|Period 2||0
10147444|NCT02780661|11277751|FG001|NOT COMPLETED|Period 2||0
10147445|NCT02780687|11277760|FG000|STARTED|Overall Study||34
10147446|NCT02780687|11277761|FG001|STARTED|Overall Study||8
10147447|NCT02780687|11277760|FG000|COMPLETED|Overall Study||0
10147448|NCT02780687|11277761|FG001|COMPLETED|Overall Study||0
10147449|NCT02780687|11277760|FG000|NOT COMPLETED|Overall Study||34
10147450|NCT02780687|11277761|FG001|NOT COMPLETED|Overall Study||8
10147451|NCT02780700|11277766|FG000|STARTED|Overall Study||1
10147452|NCT02780700|11277766|FG000|COMPLETED|Overall Study||0
10147453|NCT02780700|11277766|FG000|NOT COMPLETED|Overall Study||1
10147454|NCT02780713|11277770|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
10147455|NCT02780713|11277771|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
10147456|NCT02780713|11277772|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
10147457|NCT02780713|11277773|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
10147458|NCT02780713|11277774|FG004|STARTED|Period 1: Variant A (100mg)||0
10147459|NCT02780713|11277770|FG000|COMPLETED|Period 1: Variant A (100mg)||14
10147460|NCT02780713|11277771|FG001|COMPLETED|Period 1: Variant A (100mg)||0
10147461|NCT02780713|11277772|FG002|COMPLETED|Period 1: Variant A (100mg)||0
10147462|NCT02780713|11277773|FG003|COMPLETED|Period 1: Variant A (100mg)||0
10147463|NCT02780713|11277774|FG004|COMPLETED|Period 1: Variant A (100mg)||0
10147464|NCT02780713|11277770|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0
10147465|NCT02780713|11277771|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0
10147466|NCT02780713|11277772|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0
10147467|NCT02780713|11277773|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0
10147468|NCT02780713|11277774|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0
10147469|NCT02780713|11277770|FG000|STARTED|Period 2: Reference (100mg)||0
10147470|NCT02780713|11277771|FG001|STARTED|Period 2: Reference (100mg)||14
10147471|NCT02780713|11277772|FG002|STARTED|Period 2: Reference (100mg)||0
10147472|NCT02780713|11277773|FG003|STARTED|Period 2: Reference (100mg)||0
10147473|NCT02780713|11277774|FG004|STARTED|Period 2: Reference (100mg)||0
10147474|NCT02780713|11277770|FG000|COMPLETED|Period 2: Reference (100mg)||0
10147475|NCT02780713|11277771|FG001|COMPLETED|Period 2: Reference (100mg)||14
10147476|NCT02780713|11277772|FG002|COMPLETED|Period 2: Reference (100mg)||0
10147477|NCT02780713|11277773|FG003|COMPLETED|Period 2: Reference (100mg)||0
10147478|NCT02780713|11277774|FG004|COMPLETED|Period 2: Reference (100mg)||0
10147479|NCT02780713|11277770|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0
10147480|NCT02780713|11277771|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0
10147481|NCT02780713|11277772|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0
10147482|NCT02780713|11277773|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0
10147483|NCT02780713|11277774|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0
10147484|NCT02780713|11277770|FG000|STARTED|Period 3: Variant B (100mg)||0
10147485|NCT02780713|11277771|FG001|STARTED|Period 3: Variant B (100mg)||0
10147486|NCT02780713|11277772|FG002|STARTED|Period 3: Variant B (100mg)||14
10147487|NCT02780713|11277773|FG003|STARTED|Period 3: Variant B (100mg)||0
10147488|NCT02780713|11277774|FG004|STARTED|Period 3: Variant B (100mg)||0
10147489|NCT02780713|11277770|FG000|COMPLETED|Period 3: Variant B (100mg)||0
10147490|NCT02780713|11277771|FG001|COMPLETED|Period 3: Variant B (100mg)||0
10147491|NCT02780713|11277772|FG002|COMPLETED|Period 3: Variant B (100mg)||12
10147492|NCT02780713|11277773|FG003|COMPLETED|Period 3: Variant B (100mg)||0
10147493|NCT02780713|11277774|FG004|COMPLETED|Period 3: Variant B (100mg)||0
10147494|NCT02780713|11277770|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0
10147495|NCT02780713|11277771|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0
10147496|NCT02780713|11277772|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2
10147497|NCT02780713|11277773|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0
10147498|NCT02780713|11277774|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0
10147499|NCT02780713|11277770|FG000|STARTED|Period 4: Variant C (100mg)||0
10147500|NCT02780713|11277771|FG001|STARTED|Period 4: Variant C (100mg)||0
10147501|NCT02780713|11277772|FG002|STARTED|Period 4: Variant C (100mg)||0
10147502|NCT02780713|11277773|FG003|STARTED|Period 4: Variant C (100mg)||12
10147503|NCT02780713|11277774|FG004|STARTED|Period 4: Variant C (100mg)||0
10147504|NCT02780713|11277770|FG000|COMPLETED|Period 4: Variant C (100mg)||0
9708785|NCT02639546|10807994|FG001|COMPLETED|Overall Study||0
9708786|NCT02639546|10807995|FG002|COMPLETED|Overall Study||0
9708787|NCT02639546|10807996|FG003|COMPLETED|Overall Study||0
9708788|NCT02639546|10807997|FG004|COMPLETED|Overall Study||0
9708789|NCT02639546|10807998|FG005|COMPLETED|Overall Study||0
9708790|NCT02639546|10807999|FG006|COMPLETED|Overall Study||0
9708791|NCT02639546|10808000|FG007|COMPLETED|Overall Study||0
9708792|NCT02639546|10807993|FG000|NOT COMPLETED|Overall Study||6
10147505|NCT02780713|11277771|FG001|COMPLETED|Period 4: Variant C (100mg)||0
10147506|NCT02780713|11277772|FG002|COMPLETED|Period 4: Variant C (100mg)||0
10147507|NCT02780713|11277773|FG003|COMPLETED|Period 4: Variant C (100mg)||12
10147508|NCT02780713|11277774|FG004|COMPLETED|Period 4: Variant C (100mg)||0
10147509|NCT02780713|11277770|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0
10147510|NCT02780713|11277771|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0
10147511|NCT02780713|11277772|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0
10147512|NCT02780713|11277773|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0
9708793|NCT02639546|10807994|FG001|NOT COMPLETED|Overall Study||6
9708794|NCT02639546|10807995|FG002|NOT COMPLETED|Overall Study||6
9708795|NCT02639546|10807996|FG003|NOT COMPLETED|Overall Study||6
9708796|NCT02639546|10807997|FG004|NOT COMPLETED|Overall Study||7
10147513|NCT02780713|11277774|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0
10147514|NCT02780713|11277770|FG000|STARTED|Period 5: Variant B (300mg)||0
10147515|NCT02780713|11277771|FG001|STARTED|Period 5: Variant B (300mg)||0
10147516|NCT02780713|11277772|FG002|STARTED|Period 5: Variant B (300mg)||0
10147517|NCT02780713|11277773|FG003|STARTED|Period 5: Variant B (300mg)||0
10147518|NCT02780713|11277774|FG004|STARTED|Period 5: Variant B (300mg)||12
10147519|NCT02780713|11277770|FG000|COMPLETED|Period 5: Variant B (300mg)||0
10147520|NCT02780713|11277771|FG001|COMPLETED|Period 5: Variant B (300mg)||0
10147521|NCT02780713|11277772|FG002|COMPLETED|Period 5: Variant B (300mg)||0
10147522|NCT02780713|11277773|FG003|COMPLETED|Period 5: Variant B (300mg)||0
10147523|NCT02780713|11277774|FG004|COMPLETED|Period 5: Variant B (300mg)||12
10147524|NCT02780713|11277770|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0
10147525|NCT02780713|11277771|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0
10147526|NCT02780713|11277772|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0
10147527|NCT02780713|11277773|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0
10147528|NCT02780713|11277774|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0
10147529|NCT02780765|11277795|FG000|STARTED|Overall Study||30
10147530|NCT02780765|11277796|FG001|STARTED|Overall Study||30
10147531|NCT02780765|11277795|FG000|COMPLETED|Overall Study||30
10147532|NCT02780765|11277796|FG001|COMPLETED|Overall Study||30
10147533|NCT02780765|11277795|FG000|NOT COMPLETED|Overall Study||0
9708797|NCT02639546|10807998|FG005|NOT COMPLETED|Overall Study||8
9708798|NCT02639546|10807999|FG006|NOT COMPLETED|Overall Study||5
9708799|NCT02639546|10808000|FG007|NOT COMPLETED|Overall Study||12
9708800|NCT02575339|10808035|FG000|STARTED|Study Treatment||7
9708801|NCT02575339|10808036|FG001|STARTED|Study Treatment|This study was terminated at Phase I.|4
9708802|NCT02575339|10808037|FG002|STARTED|Study Treatment|This study was terminated at Phase I.|0
9708803|NCT02575339|10808035|FG000|COMPLETED|Study Treatment||0
9708804|NCT02575339|10808036|FG001|COMPLETED|Study Treatment||0
9708805|NCT02575339|10808037|FG002|COMPLETED|Study Treatment||0
9708806|NCT02575339|10808035|FG000|NOT COMPLETED|Study Treatment||7
9708807|NCT02575339|10808036|FG001|NOT COMPLETED|Study Treatment||4
9708808|NCT02575339|10808037|FG002|NOT COMPLETED|Study Treatment||0
9708809|NCT02575339|10808035|FG000|STARTED|Follow up||7
9708810|NCT02575339|10808036|FG001|STARTED|Follow up||4
9708811|NCT02575339|10808037|FG002|STARTED|Follow up||0
9708812|NCT02575339|10808035|FG000|COMPLETED|Follow up||0
9708813|NCT02575339|10808036|FG001|COMPLETED|Follow up||0
9708814|NCT02575339|10808037|FG002|COMPLETED|Follow up||0
9708815|NCT02575339|10808035|FG000|NOT COMPLETED|Follow up||7
9708816|NCT02575339|10808036|FG001|NOT COMPLETED|Follow up||4
9708817|NCT02575339|10808037|FG002|NOT COMPLETED|Follow up||0
9708818|NCT02498444|10808049|FG000|STARTED|Overall Study||16
9708819|NCT02498444|10808050|FG001|STARTED|Overall Study||18
9708820|NCT02498444|10808049|FG000|COMPLETED|Overall Study||12
9708821|NCT02498444|10808050|FG001|COMPLETED|Overall Study||18
9708822|NCT02498444|10808049|FG000|NOT COMPLETED|Overall Study||4
9708823|NCT02498444|10808050|FG001|NOT COMPLETED|Overall Study||0
9708824|NCT02487108|10808060|FG000|STARTED|Overall Study||142
9708825|NCT02487108|10808061|FG001|STARTED|Overall Study||142
9708826|NCT02487108|10808062|FG002|STARTED|Overall Study||143
9708827|NCT02487108|10808063|FG003|STARTED|Overall Study||142
9708828|NCT02487108|10808060|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
9708829|NCT02487108|10808061|FG001|Received at Least 1 Dose of Study Drug|Overall Study||142
9708830|NCT02487108|10808062|FG002|Received at Least 1 Dose of Study Drug|Overall Study||141
9708831|NCT02487108|10808063|FG003|Received at Least 1 Dose of Study Drug|Overall Study||142
9708832|NCT02487108|10808060|FG000|COMPLETED|Overall Study||126
9708833|NCT02487108|10808061|FG001|COMPLETED|Overall Study||126
9708834|NCT02487108|10808062|FG002|COMPLETED|Overall Study||117
9708835|NCT02487108|10808063|FG003|COMPLETED|Overall Study||131
9708836|NCT02487108|10808060|FG000|NOT COMPLETED|Overall Study||16
9708837|NCT02487108|10808061|FG001|NOT COMPLETED|Overall Study||16
9708838|NCT02487108|10808062|FG002|NOT COMPLETED|Overall Study||26
9708839|NCT02487108|10808063|FG003|NOT COMPLETED|Overall Study||11
9708840|NCT02455557|10808073|FG000|STARTED|Overall Study||66
9708841|NCT02455557|10808073|FG000|COMPLETED|Overall Study||64
9708842|NCT02455557|10808073|FG000|NOT COMPLETED|Overall Study||2
9708849|NCT02393690|10808083|FG000|STARTED|Overall Study||29
9708850|NCT02393690|10808084|FG001|STARTED|Overall Study||31
9708851|NCT02393690|10808083|FG000|COMPLETED|Overall Study||29
9708852|NCT02393690|10808084|FG001|COMPLETED|Overall Study||31
9708853|NCT02393690|10808083|FG000|NOT COMPLETED|Overall Study||0
9708854|NCT02393690|10808084|FG001|NOT COMPLETED|Overall Study||0
9708855|NCT02387996|10808090|FG000|STARTED|Overall Study||270
9708856|NCT02387996|10808090|FG000|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
9708857|NCT02387996|10808090|FG000|NOT COMPLETED|Overall Study||204
9708858|NCT02363010|10808097|FG000|STARTED|Overall Study||110
9708859|NCT02363010|10808098|FG001|STARTED|Overall Study||105
10147534|NCT02780765|11277796|FG001|NOT COMPLETED|Overall Study||0
10147535|NCT02780856|11277802|FG000|STARTED|Overall Study||110
10147536|NCT02780856|11277802|FG000|COMPLETED|Overall Study||109
10147537|NCT02780856|11277802|FG000|NOT COMPLETED|Overall Study||1
10147538|NCT02780869|11277811|FG000|STARTED|Overall Study||175
10147539|NCT02780869|11277812|FG001|STARTED|Overall Study||83
10147540|NCT02780869|11277811|FG000|COMPLETED|Overall Study||162
10147541|NCT02780869|11277812|FG001|COMPLETED|Overall Study||74
10147542|NCT02780869|11277811|FG000|NOT COMPLETED|Overall Study||13
10147543|NCT02780869|11277812|FG001|NOT COMPLETED|Overall Study||9
10147544|NCT02781051|11277818|FG000|STARTED|Overall Study||16
10147545|NCT02781051|11277818|FG000|COMPLETED|Overall Study||14
10147546|NCT02781051|11277818|FG000|NOT COMPLETED|Overall Study||2
10147547|NCT02781311|11277826|FG000|STARTED|Overall Study||74
10147548|NCT02781311|11277827|FG001|STARTED|Overall Study||83
10147549|NCT02781311|11277828|FG002|STARTED|Overall Study||12
10147550|NCT02781311|11277826|FG000|Safety Population (Treated)|Overall Study||73
10147551|NCT02781311|11277827|FG001|Safety Population (Treated)|Overall Study||81
10147552|NCT02781311|11277828|FG002|Safety Population (Treated)|Overall Study||12
10147553|NCT02781311|11277826|FG000|mITT Population|Overall Study||70
10147554|NCT02781311|11277827|FG001|mITT Population|Overall Study||78
10147555|NCT02781311|11277828|FG002|mITT Population|Overall Study||11
10147556|NCT02781311|11277826|FG000|COMPLETED|Overall Study||48
10060804|NCT02100514|11186346|FG001|NOT COMPLETED|Extension Period||0
10060805|NCT02100514|11186347|FG002|NOT COMPLETED|Extension Period||2
10060806|NCT02100514|11186348|FG003|NOT COMPLETED|Extension Period||0
10060807|NCT02100514|11186349|FG004|NOT COMPLETED|Extension Period||0
10060808|NCT02100579|11186365|FG000|STARTED|Overall Study||20
10060809|NCT02100579|11186366|FG001|STARTED|Overall Study||20
10147557|NCT02781311|11277827|FG001|COMPLETED|Overall Study||57
10147558|NCT02781311|11277828|FG002|COMPLETED|Overall Study||8
10147559|NCT02781311|11277826|FG000|NOT COMPLETED|Overall Study||26
10147560|NCT02781311|11277827|FG001|NOT COMPLETED|Overall Study||26
10147561|NCT02781311|11277828|FG002|NOT COMPLETED|Overall Study||4
10147562|NCT02781324|11277837|FG000|STARTED|Overall Study||33
10147563|NCT02781324|11277838|FG001|STARTED|Overall Study||33
10147564|NCT02781324|11277837|FG000|COMPLETED|Overall Study||31
10147565|NCT02781324|11277838|FG001|COMPLETED|Overall Study||31
10147566|NCT02781324|11277837|FG000|NOT COMPLETED|Overall Study||2
10147567|NCT02781324|11277838|FG001|NOT COMPLETED|Overall Study||2
10147568|NCT02781454|11277849|FG000|STARTED|Overall Study||8
10147569|NCT02781454|11277850|FG001|STARTED|Overall Study||6
10147570|NCT02781454|11277851|FG002|STARTED|Overall Study||6
10147571|NCT02781454|11277849|FG000|COMPLETED|Overall Study||8
10147572|NCT02781454|11277850|FG001|COMPLETED|Overall Study||6
10147573|NCT02781454|11277851|FG002|COMPLETED|Overall Study||5
10147574|NCT02781454|11277849|FG000|NOT COMPLETED|Overall Study||0
10147575|NCT02781454|11277850|FG001|NOT COMPLETED|Overall Study||0
10147576|NCT02781454|11277851|FG002|NOT COMPLETED|Overall Study||1
10147577|NCT02781480|11277862|FG000|STARTED|Overall Study||9
10147578|NCT02781480|11277863|FG001|STARTED|Overall Study||3
10147579|NCT02781480|11277864|FG002|STARTED|Overall Study||3
10147580|NCT02781480|11277862|FG000|COMPLETED|Overall Study||9
10147581|NCT02781480|11277863|FG001|COMPLETED|Overall Study||3
10147582|NCT02781480|11277864|FG002|COMPLETED|Overall Study||3
10147583|NCT02781480|11277862|FG000|NOT COMPLETED|Overall Study||0
10147584|NCT02781480|11277863|FG001|NOT COMPLETED|Overall Study||0
10147585|NCT02781480|11277864|FG002|NOT COMPLETED|Overall Study||0
10147586|NCT02781558|11277874|FG000|STARTED|Overall Study||101
10147587|NCT02781558|11277875|FG001|STARTED|Overall Study||103
10147588|NCT02781558|11277874|FG000|COMPLETED|Overall Study||98
10147589|NCT02781558|11277875|FG001|COMPLETED|Overall Study||101
10147590|NCT02781558|11277874|FG000|NOT COMPLETED|Overall Study||3
10147591|NCT02781558|11277875|FG001|NOT COMPLETED|Overall Study||2
10147592|NCT02781571|11277882|FG000|STARTED|Overall Study||79
10147593|NCT02781571|11277882|FG000|COMPLETED|Overall Study||79
10147594|NCT02781571|11277882|FG000|NOT COMPLETED|Overall Study||0
10147595|NCT02781610|11277890|FG000|STARTED|Overall Study||140
10147596|NCT02781610|11277891|FG001|STARTED|Overall Study||137
10147597|NCT02781610|11277892|FG002|STARTED|Overall Study||353
10147598|NCT02781610|11277893|FG003|STARTED|Overall Study||352
10147599|NCT02781610|11277890|FG000|COMPLETED|Overall Study||134
10147600|NCT02781610|11277891|FG001|COMPLETED|Overall Study||130
10147601|NCT02781610|11277892|FG002|COMPLETED|Overall Study||336
10147602|NCT02781610|11277893|FG003|COMPLETED|Overall Study||323
10147603|NCT02781610|11277890|FG000|NOT COMPLETED|Overall Study||6
10147604|NCT02781610|11277891|FG001|NOT COMPLETED|Overall Study||7
10060810|NCT02100579|11186365|FG000|COMPLETED|Overall Study||20
10060811|NCT02100579|11186366|FG001|COMPLETED|Overall Study||20
10060812|NCT02100579|11186365|FG000|NOT COMPLETED|Overall Study||0
10060813|NCT02100579|11186366|FG001|NOT COMPLETED|Overall Study||0
10060814|NCT02100631|11186375|FG000|STARTED|Overall Study||299
10060815|NCT02100631|11186376|FG001|STARTED|Overall Study||99
10060816|NCT02100631|11186377|FG002|STARTED|Overall Study||2688
10060817|NCT02100631|11186375|FG000|COMPLETED|Overall Study||292
10060818|NCT02100631|11186376|FG001|COMPLETED|Overall Study||95
10147605|NCT02781610|11277892|FG002|NOT COMPLETED|Overall Study||17
10147606|NCT02781610|11277893|FG003|NOT COMPLETED|Overall Study||29
10147607|NCT02781649|11277906|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
10147608|NCT02781649|11277907|FG001|STARTED|Overall Study||0
10147609|NCT02781649|11277908|FG002|STARTED|Overall Study||3
10147610|NCT02781649|11277906|FG000|COMPLETED|Overall Study||7
10147611|NCT02781649|11277907|FG001|COMPLETED|Overall Study||0
10147612|NCT02781649|11277908|FG002|COMPLETED|Overall Study||3
10147613|NCT02781649|11277906|FG000|NOT COMPLETED|Overall Study||0
10147614|NCT02781649|11277907|FG001|NOT COMPLETED|Overall Study||0
9708860|NCT02363010|10808099|FG002|STARTED|Overall Study||105
9708861|NCT02363010|10808097|FG000|COMPLETED|Overall Study||88
9708862|NCT02363010|10808098|FG001|COMPLETED|Overall Study||94
9708863|NCT02363010|10808099|FG002|COMPLETED|Overall Study||89
9708864|NCT02363010|10808097|FG000|NOT COMPLETED|Overall Study||22
9708865|NCT02363010|10808098|FG001|NOT COMPLETED|Overall Study||11
9708866|NCT02363010|10808099|FG002|NOT COMPLETED|Overall Study||16
9708867|NCT02351856|10808107|FG000|STARTED|Overall Study||8
9708868|NCT02351856|10808107|FG000|COMPLETED|Overall Study||0
9708869|NCT02351856|10808107|FG000|NOT COMPLETED|Overall Study||8
9708870|NCT02349386|10808115|FG000|STARTED|24-Week Double-Blind Main Study||9
9708871|NCT02349386|10808116|FG001|STARTED|24-Week Double-Blind Main Study||8
9708872|NCT02349386|10808117|FG002|STARTED|24-Week Double-Blind Main Study||9
10060819|NCT02100631|11186377|FG002|COMPLETED|Overall Study||2688
10060820|NCT02100631|11186375|FG000|NOT COMPLETED|Overall Study||7
10060821|NCT02100631|11186376|FG001|NOT COMPLETED|Overall Study||4
10060822|NCT02100631|11186377|FG002|NOT COMPLETED|Overall Study||0
10060823|NCT02100644|11186385|FG000|STARTED|LTG Escalation Phase||33
10060824|NCT02100644|11186386|FG001|STARTED|LTG Escalation Phase||0
10060825|NCT02100644|11186387|FG002|STARTED|LTG Escalation Phase||0
10060826|NCT02100644|11186385|FG000|COMPLETED|LTG Escalation Phase||20
10060827|NCT02100644|11186386|FG001|COMPLETED|LTG Escalation Phase||0
10060828|NCT02100644|11186387|FG002|COMPLETED|LTG Escalation Phase||0
10060829|NCT02100644|11186385|FG000|NOT COMPLETED|LTG Escalation Phase||13
10060830|NCT02100644|11186386|FG001|NOT COMPLETED|LTG Escalation Phase||0
10060831|NCT02100644|11186387|FG002|NOT COMPLETED|LTG Escalation Phase||0
10060832|NCT02100644|11186385|FG000|STARTED|VPA Reduction Phase||0
10060833|NCT02100644|11186386|FG001|STARTED|VPA Reduction Phase||20
10060834|NCT02100644|11186387|FG002|STARTED|VPA Reduction Phase||0
10060835|NCT02100644|11186385|FG000|COMPLETED|VPA Reduction Phase||0
10060836|NCT02100644|11186386|FG001|COMPLETED|VPA Reduction Phase||20
10060837|NCT02100644|11186387|FG002|COMPLETED|VPA Reduction Phase||0
10147615|NCT02781649|11277908|FG002|NOT COMPLETED|Overall Study||0
10147616|NCT02781818|11277919|FG000|STARTED|Overall Study||20
10147617|NCT02781818|11277920|FG001|STARTED|Overall Study||18
10147618|NCT02781818|11277921|FG002|STARTED|Overall Study||17
10147619|NCT02781818|11277919|FG000|COMPLETED|Overall Study||16
10147620|NCT02781818|11277920|FG001|COMPLETED|Overall Study||16
10147621|NCT02781818|11277921|FG002|COMPLETED|Overall Study||16
10147622|NCT02781818|11277919|FG000|NOT COMPLETED|Overall Study||4
10147623|NCT02781818|11277920|FG001|NOT COMPLETED|Overall Study||2
10147624|NCT02781818|11277921|FG002|NOT COMPLETED|Overall Study||1
10147625|NCT02781844|11277933|FG000|STARTED|Treatment Period 1||5
10147626|NCT02781844|11277934|FG001|STARTED|Treatment Period 1||4
10147627|NCT02781844|11277935|FG002|STARTED|Treatment Period 1||4
10147628|NCT02781844|11277936|FG003|STARTED|Treatment Period 1||4
10147629|NCT02781844|11277937|FG004|STARTED|Treatment Period 1||4
10147630|NCT02781844|11277938|FG005|STARTED|Treatment Period 1||5
10147631|NCT02781844|11277939|FG006|STARTED|Treatment Period 1||4
10147632|NCT02781844|11277940|FG007|STARTED|Treatment Period 1||4
10147633|NCT02781844|11277933|FG000|COMPLETED|Treatment Period 1||5
10147634|NCT02781844|11277934|FG001|COMPLETED|Treatment Period 1||4
10147635|NCT02781844|11277935|FG002|COMPLETED|Treatment Period 1||4
10147636|NCT02781844|11277936|FG003|COMPLETED|Treatment Period 1||4
10147637|NCT02781844|11277937|FG004|COMPLETED|Treatment Period 1||4
10147638|NCT02781844|11277938|FG005|COMPLETED|Treatment Period 1||4
10147639|NCT02781844|11277939|FG006|COMPLETED|Treatment Period 1||4
10147640|NCT02781844|11277940|FG007|COMPLETED|Treatment Period 1||4
10147641|NCT02781844|11277933|FG000|NOT COMPLETED|Treatment Period 1||0
10147642|NCT02781844|11277934|FG001|NOT COMPLETED|Treatment Period 1||0
10147643|NCT02781844|11277935|FG002|NOT COMPLETED|Treatment Period 1||0
10147644|NCT02781844|11277936|FG003|NOT COMPLETED|Treatment Period 1||0
10147645|NCT02781844|11277937|FG004|NOT COMPLETED|Treatment Period 1||0
10147646|NCT02781844|11277938|FG005|NOT COMPLETED|Treatment Period 1||1
10147647|NCT02781844|11277939|FG006|NOT COMPLETED|Treatment Period 1||0
10147648|NCT02781844|11277940|FG007|NOT COMPLETED|Treatment Period 1||0
10147649|NCT02781844|11277933|FG000|STARTED|Treatment Period 2||5
10147650|NCT02781844|11277934|FG001|STARTED|Treatment Period 2||4
10147651|NCT02781844|11277935|FG002|STARTED|Treatment Period 2||4
10147652|NCT02781844|11277936|FG003|STARTED|Treatment Period 2||4
10147653|NCT02781844|11277937|FG004|STARTED|Treatment Period 2||4
10147654|NCT02781844|11277938|FG005|STARTED|Treatment Period 2||4
10147655|NCT02781844|11277939|FG006|STARTED|Treatment Period 2||4
10147656|NCT02781844|11277940|FG007|STARTED|Treatment Period 2||4
10147657|NCT02781844|11277933|FG000|COMPLETED|Treatment Period 2||5
10147658|NCT02781844|11277934|FG001|COMPLETED|Treatment Period 2||4
10147659|NCT02781844|11277935|FG002|COMPLETED|Treatment Period 2||4
10147660|NCT02781844|11277936|FG003|COMPLETED|Treatment Period 2||4
10147661|NCT02781844|11277937|FG004|COMPLETED|Treatment Period 2||4
10147662|NCT02781844|11277938|FG005|COMPLETED|Treatment Period 2||4
10147663|NCT02781844|11277939|FG006|COMPLETED|Treatment Period 2||4
10147664|NCT02781844|11277940|FG007|COMPLETED|Treatment Period 2||4
10147665|NCT02781844|11277933|FG000|NOT COMPLETED|Treatment Period 2||0
10147666|NCT02781844|11277934|FG001|NOT COMPLETED|Treatment Period 2||0
9708873|NCT02349386|10808118|FG003|STARTED|24-Week Double-Blind Main Study||8
9708874|NCT02349386|10808115|FG000|COMPLETED|24-Week Double-Blind Main Study||3
9708875|NCT02349386|10808116|FG001|COMPLETED|24-Week Double-Blind Main Study||2
9708876|NCT02349386|10808117|FG002|COMPLETED|24-Week Double-Blind Main Study||4
9708877|NCT02349386|10808118|FG003|COMPLETED|24-Week Double-Blind Main Study||0
9708878|NCT02349386|10808115|FG000|NOT COMPLETED|24-Week Double-Blind Main Study||6
9708879|NCT02349386|10808116|FG001|NOT COMPLETED|24-Week Double-Blind Main Study||6
9708880|NCT02349386|10808117|FG002|NOT COMPLETED|24-Week Double-Blind Main Study||5
9708881|NCT02349386|10808118|FG003|NOT COMPLETED|24-Week Double-Blind Main Study||8
9708882|NCT02349386|10808115|FG000|STARTED|28-Week Double-Blind Optional Extension||3
9848901|NCT00862849|10961753|FG001|STARTED|Intervention 1||5
9848902|NCT00862849|10961754|FG002|STARTED|Intervention 1||3
9848903|NCT00862849|10961755|FG003|STARTED|Intervention 1||4
9848904|NCT00862849|10961756|FG004|STARTED|Intervention 1||4
9848905|NCT00862849|10961757|FG005|STARTED|Intervention 1||3
9848906|NCT00862849|10961752|FG000|Received at Least One Dose of Study Drug|Intervention 1||3
9848907|NCT00862849|10961753|FG001|Received at Least One Dose of Study Drug|Intervention 1||5
9848908|NCT00862849|10961754|FG002|Received at Least One Dose of Study Drug|Intervention 1||3
9848909|NCT00862849|10961755|FG003|Received at Least One Dose of Study Drug|Intervention 1||4
9848910|NCT00862849|10961756|FG004|Received at Least One Dose of Study Drug|Intervention 1||4
9848911|NCT00862849|10961757|FG005|Received at Least One Dose of Study Drug|Intervention 1||3
9848912|NCT00862849|10961752|FG000|COMPLETED|Intervention 1||3
9848913|NCT00862849|10961753|FG001|COMPLETED|Intervention 1||5
9848914|NCT00862849|10961754|FG002|COMPLETED|Intervention 1||3
9848915|NCT00862849|10961755|FG003|COMPLETED|Intervention 1||4
9848916|NCT00862849|10961756|FG004|COMPLETED|Intervention 1||4
9848917|NCT00862849|10961757|FG005|COMPLETED|Intervention 1||3
9848918|NCT00862849|10961752|FG000|NOT COMPLETED|Intervention 1||0
9848919|NCT00862849|10961753|FG001|NOT COMPLETED|Intervention 1||0
9963857|NCT01488994|11083645|FG001|COMPLETED|Overall Study||11
9963858|NCT01488994|11083644|FG000|NOT COMPLETED|Overall Study||0
9963859|NCT01488994|11083645|FG001|NOT COMPLETED|Overall Study||1
9963860|NCT01489020|11083662|FG000|STARTED|Overall Study||12
9963861|NCT01489020|11083663|FG001|STARTED|Overall Study||4
9963862|NCT01489020|11083664|FG002|STARTED|Overall Study||12
9963863|NCT01489020|11083665|FG003|STARTED|Overall Study||4
9963864|NCT01489020|11083666|FG004|STARTED|Overall Study||12
9963865|NCT01489020|11083667|FG005|STARTED|Overall Study||4
9963866|NCT01489020|11083662|FG000|COMPLETED|Overall Study||11
9963867|NCT01489020|11083663|FG001|COMPLETED|Overall Study||4
9963868|NCT01489020|11083664|FG002|COMPLETED|Overall Study||9
9963869|NCT01489020|11083665|FG003|COMPLETED|Overall Study||4
9963870|NCT01489020|11083666|FG004|COMPLETED|Overall Study||6
9963871|NCT01489020|11083667|FG005|COMPLETED|Overall Study||4
9963872|NCT01489020|11083662|FG000|NOT COMPLETED|Overall Study||1
9963873|NCT01489020|11083663|FG001|NOT COMPLETED|Overall Study||0
9963874|NCT01489020|11083664|FG002|NOT COMPLETED|Overall Study||3
9963875|NCT01489020|11083665|FG003|NOT COMPLETED|Overall Study||0
9963876|NCT01489020|11083666|FG004|NOT COMPLETED|Overall Study||6
9963877|NCT01489020|11083667|FG005|NOT COMPLETED|Overall Study||0
9963878|NCT01489111|11083687|FG000|STARTED|Overall Study||36
9963879|NCT01489111|11083687|FG000|COMPLETED|Overall Study||35
9963880|NCT01489111|11083687|FG000|NOT COMPLETED|Overall Study||1
9963881|NCT01489189|11083693|FG000|STARTED|Overall Study|Number of Eyes|191
9963882|NCT01489189|11083694|FG001|STARTED|Overall Study|Number of Eyes|203
9963883|NCT01489189|11083693|FG000|COMPLETED|Overall Study|Number of Eyes|160
9963884|NCT01489189|11083694|FG001|COMPLETED|Overall Study|Number of Eyes|168
9963885|NCT01489189|11083693|FG000|NOT COMPLETED|Overall Study||31
9963886|NCT01489189|11083694|FG001|NOT COMPLETED|Overall Study||35
9963887|NCT01489254|11083704|FG000|STARTED|Double-blind Part||355
9963888|NCT01489254|11083705|FG001|STARTED|Double-blind Part||357
9963889|NCT01489254|11083706|FG002|STARTED|Double-blind Part||84
9963890|NCT01489254|11083707|FG003|STARTED|Double-blind Part||0
9963891|NCT01489254|11083704|FG000|COMPLETED|Double-blind Part||330
9963892|NCT01489254|11083705|FG001|COMPLETED|Double-blind Part||324
9963893|NCT01489254|11083706|FG002|COMPLETED|Double-blind Part||81
9963894|NCT01489254|11083707|FG003|COMPLETED|Double-blind Part||0
9963895|NCT01489254|11083704|FG000|NOT COMPLETED|Double-blind Part||25
9963896|NCT01489254|11083705|FG001|NOT COMPLETED|Double-blind Part||33
9963897|NCT01489254|11083706|FG002|NOT COMPLETED|Double-blind Part||3
9963898|NCT01489254|11083707|FG003|NOT COMPLETED|Double-blind Part||0
9963899|NCT01489254|11083704|FG000|STARTED|Open-label Extension Part||0
9963900|NCT01489254|11083705|FG001|STARTED|Open-label Extension Part||0
9963901|NCT01489254|11083706|FG002|STARTED|Open-label Extension Part||0
9963902|NCT01489254|11083707|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
9963903|NCT01489254|11083704|FG000|COMPLETED|Open-label Extension Part||0
9963904|NCT01489254|11083705|FG001|COMPLETED|Open-label Extension Part||0
9963905|NCT01489254|11083706|FG002|COMPLETED|Open-label Extension Part||0
9963906|NCT01489254|11083707|FG003|COMPLETED|Open-label Extension Part||670
9963907|NCT01489254|11083704|FG000|NOT COMPLETED|Open-label Extension Part||0
9963908|NCT01489254|11083705|FG001|NOT COMPLETED|Open-label Extension Part||0
9708883|NCT02349386|10808116|FG001|STARTED|28-Week Double-Blind Optional Extension||2
9708884|NCT02349386|10808117|FG002|STARTED|28-Week Double-Blind Optional Extension||4
9848920|NCT00862849|10961754|FG002|NOT COMPLETED|Intervention 1||0
9963909|NCT01489254|11083706|FG002|NOT COMPLETED|Open-label Extension Part||0
9963910|NCT01489254|11083707|FG003|NOT COMPLETED|Open-label Extension Part||58
9963911|NCT01489358|11083719|FG000|STARTED|Overall Study||5
9963912|NCT01489358|11083720|FG001|STARTED|Overall Study||10
9708885|NCT02349386|10808118|FG003|STARTED|28-Week Double-Blind Optional Extension||0
9708886|NCT02349386|10808115|FG000|COMPLETED|28-Week Double-Blind Optional Extension||1
9708887|NCT02349386|10808116|FG001|COMPLETED|28-Week Double-Blind Optional Extension||2
9708888|NCT02349386|10808117|FG002|COMPLETED|28-Week Double-Blind Optional Extension||1
9708889|NCT02349386|10808118|FG003|COMPLETED|28-Week Double-Blind Optional Extension||0
9708890|NCT02349386|10808115|FG000|NOT COMPLETED|28-Week Double-Blind Optional Extension||2
9708891|NCT02349386|10808116|FG001|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
9708892|NCT02349386|10808117|FG002|NOT COMPLETED|28-Week Double-Blind Optional Extension||3
9708893|NCT02349386|10808118|FG003|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
9708894|NCT02328014|10808132|FG000|STARTED|Overall Study||6
9708895|NCT02328014|10808133|FG001|STARTED|Overall Study||6
9708896|NCT02328014|10808134|FG002|STARTED|Overall Study||6
9708897|NCT02328014|10808135|FG003|STARTED|Overall Study||22
9708898|NCT02328014|10808132|FG000|COMPLETED|Overall Study||0
9708899|NCT02328014|10808133|FG001|COMPLETED|Overall Study||0
9708900|NCT02328014|10808134|FG002|COMPLETED|Overall Study||0
9708901|NCT02328014|10808135|FG003|COMPLETED|Overall Study||0
9708902|NCT02328014|10808132|FG000|NOT COMPLETED|Overall Study||6
9708903|NCT02328014|10808133|FG001|NOT COMPLETED|Overall Study||6
9708904|NCT02328014|10808134|FG002|NOT COMPLETED|Overall Study||6
9708905|NCT02328014|10808135|FG003|NOT COMPLETED|Overall Study||22
9708906|NCT02281500|10808145|FG000|STARTED|Overall Study||22
9708907|NCT02281500|10808145|FG000|COMPLETED|Overall Study||22
9708908|NCT02281500|10808145|FG000|NOT COMPLETED|Overall Study||0
9708909|NCT02243020|10808151|FG000|STARTED|Overall Study||8
9708910|NCT02243020|10808152|FG001|STARTED|Overall Study||9
9708911|NCT02243020|10808151|FG000|COMPLETED|Overall Study||8
9708912|NCT02243020|10808152|FG001|COMPLETED|Overall Study||9
9708913|NCT02243020|10808151|FG000|NOT COMPLETED|Overall Study||0
9708914|NCT02243020|10808152|FG001|NOT COMPLETED|Overall Study||0
9708918|NCT01905384|10808164|FG000|STARTED|Overall Study||3
9708919|NCT01905384|10808165|FG001|STARTED|Overall Study||3
9708920|NCT01905384|10808164|FG000|COMPLETED|Overall Study||3
9708921|NCT01905384|10808165|FG001|COMPLETED|Overall Study||3
9708922|NCT01905384|10808164|FG000|NOT COMPLETED|Overall Study||0
9708923|NCT01905384|10808165|FG001|NOT COMPLETED|Overall Study||0
9708924|NCT01904032|10808173|FG000|STARTED|Overall Study||64
9708925|NCT01904032|10808174|FG001|STARTED|Overall Study||65
9708926|NCT01904032|10808173|FG000|COMPLETED|Overall Study||57
9708927|NCT01904032|10808174|FG001|COMPLETED|Overall Study||62
9708928|NCT01904032|10808173|FG000|NOT COMPLETED|Overall Study||7
9708929|NCT01904032|10808174|FG001|NOT COMPLETED|Overall Study||3
9708930|NCT01876953|10808182|FG000|STARTED|Overall Study||17
10060838|NCT02100644|11186385|FG000|NOT COMPLETED|VPA Reduction Phase||0
10060839|NCT02100644|11186386|FG001|NOT COMPLETED|VPA Reduction Phase||0
10060840|NCT02100644|11186387|FG002|NOT COMPLETED|VPA Reduction Phase||0
10060841|NCT02100644|11186385|FG000|STARTED|LTG and VPA Maintenance Phase||0
10060842|NCT02100644|11186386|FG001|STARTED|LTG and VPA Maintenance Phase||0
10060843|NCT02100644|11186387|FG002|STARTED|LTG and VPA Maintenance Phase||20
10060844|NCT02100644|11186385|FG000|COMPLETED|LTG and VPA Maintenance Phase||0
10060845|NCT02100644|11186386|FG001|COMPLETED|LTG and VPA Maintenance Phase||0
10060846|NCT02100644|11186387|FG002|COMPLETED|LTG and VPA Maintenance Phase||20
10060847|NCT02100644|11186385|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0
10060848|NCT02100644|11186386|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0
10060849|NCT02100644|11186387|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0
10060850|NCT02100657|11186394|FG000|STARTED|Cohort 1: Dose Level 1||8
10060851|NCT02100657|11186395|FG001|STARTED|Cohort 1: Dose Level 1||0
10060852|NCT02100657|11186396|FG002|STARTED|Cohort 1: Dose Level 1||0
10060853|NCT02100657|11186394|FG000|COMPLETED|Cohort 1: Dose Level 1||0
10060854|NCT02100657|11186395|FG001|COMPLETED|Cohort 1: Dose Level 1||0
10060855|NCT02100657|11186396|FG002|COMPLETED|Cohort 1: Dose Level 1||0
10060856|NCT02100657|11186394|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8
10060857|NCT02100657|11186395|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
10060858|NCT02100657|11186396|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
10060859|NCT02100657|11186394|FG000|STARTED|Cohort 2: Dose Level 2||0
10060860|NCT02100657|11186395|FG001|STARTED|Cohort 2: Dose Level 2||4
10060861|NCT02100657|11186396|FG002|STARTED|Cohort 2: Dose Level 2||0
9708931|NCT01876953|10808183|FG001|STARTED|Overall Study||3
9708932|NCT01876953|10808182|FG000|COMPLETED|Overall Study||17
9708933|NCT01876953|10808183|FG001|COMPLETED|Overall Study||3
9708934|NCT01876953|10808182|FG000|NOT COMPLETED|Overall Study||0
10060862|NCT02100657|11186394|FG000|COMPLETED|Cohort 2: Dose Level 2||0
10060863|NCT02100657|11186395|FG001|COMPLETED|Cohort 2: Dose Level 2||0
9708935|NCT01876953|10808183|FG001|NOT COMPLETED|Overall Study||0
9708942|NCT01764711|10808200|FG000|STARTED|Overall Study||8
9708943|NCT01764711|10808201|FG001|STARTED|Overall Study||5
9708944|NCT01764711|10808200|FG000|COMPLETED|Overall Study||8
9708945|NCT01764711|10808201|FG001|COMPLETED|Overall Study||5
9708946|NCT01764711|10808200|FG000|NOT COMPLETED|Overall Study||0
9708947|NCT01764711|10808201|FG001|NOT COMPLETED|Overall Study||0
9729401|NCT00117949|10828930|FG002|STARTED|Overall Study||24
9729402|NCT00117949|10828931|FG003|STARTED|Overall Study||24
9729403|NCT00117949|10828928|FG000|COMPLETED|Overall Study||0
9729404|NCT00117949|10828929|FG001|COMPLETED|Overall Study||0
9729405|NCT00117949|10828930|FG002|COMPLETED|Overall Study||0
9729406|NCT00117949|10828931|FG003|COMPLETED|Overall Study||0
9729407|NCT00117949|10828928|FG000|NOT COMPLETED|Overall Study||10
9729408|NCT00117949|10828929|FG001|NOT COMPLETED|Overall Study||24
9729409|NCT00117949|10828930|FG002|NOT COMPLETED|Overall Study||24
9729410|NCT00117949|10828931|FG003|NOT COMPLETED|Overall Study||24
9729411|NCT00117962|10828943|FG000|STARTED|Overall Study||48
9729412|NCT00117962|10828944|FG001|STARTED|Overall Study||53
9729413|NCT00117962|10828943|FG000|COMPLETED|Overall Study||26
9729414|NCT00117962|10828944|FG001|COMPLETED|Overall Study||28
9729415|NCT00117962|10828943|FG000|NOT COMPLETED|Overall Study||22
9729416|NCT00117962|10828944|FG001|NOT COMPLETED|Overall Study||25
9729417|NCT00117988|10828950|FG000|STARTED|Overall Study||22
9729418|NCT00117988|10828950|FG000|COMPLETED|Overall Study||18
9729419|NCT00117988|10828950|FG000|NOT COMPLETED|Overall Study||4
9729420|NCT00118040|10828957|FG000|STARTED|Overall Study||20
9729421|NCT00118040|10828958|FG001|STARTED|Overall Study||20
9729422|NCT00118040|10828959|FG002|STARTED|Overall Study||20
9729423|NCT00118040|10828957|FG000|COMPLETED|Overall Study||19
9729424|NCT00118040|10828958|FG001|COMPLETED|Overall Study||18
9729425|NCT00118040|10828959|FG002|COMPLETED|Overall Study||14
9729426|NCT00118040|10828957|FG000|NOT COMPLETED|Overall Study||1
9729427|NCT00118040|10828958|FG001|NOT COMPLETED|Overall Study||2
9729428|NCT00118040|10828959|FG002|NOT COMPLETED|Overall Study||6
9729429|NCT00118092|10828972|FG000|STARTED|Overall Study||17
9729430|NCT00118092|10828972|FG000|COMPLETED|Overall Study||15
9729431|NCT00118092|10828972|FG000|NOT COMPLETED|Overall Study||2
9729432|NCT00118131|10828977|FG000|STARTED|Overall Study||49
9729433|NCT00118131|10828977|FG000|COMPLETED|Overall Study||49
9729434|NCT00118131|10828977|FG000|NOT COMPLETED|Overall Study||0
9729435|NCT00118144|10828981|FG000|STARTED|Overall Study||42
9729436|NCT00118144|10828981|FG000|COMPLETED|Overall Study||41
9729437|NCT00118144|10828981|FG000|NOT COMPLETED|Overall Study||1
9729438|NCT00118157|10828986|FG000|STARTED|Overall Study||19
9729439|NCT00118157|10828986|FG000|COMPLETED|Overall Study||7
9729440|NCT00118157|10828986|FG000|NOT COMPLETED|Overall Study||12
9729441|NCT00118209|10828993|FG000|STARTED|Overall Study||262
9729442|NCT00118209|10828994|FG001|STARTED|Overall Study||262
9729443|NCT00118209|10828993|FG000|Evaluable for Primary Endpoint|Overall Study||250
9729444|NCT00118209|10828994|FG001|Evaluable for Primary Endpoint|Overall Study||241
9729445|NCT00118209|10828993|FG000|Evaluable for Safety Analysis|Overall Study||243
9729446|NCT00118209|10828994|FG001|Evaluable for Safety Analysis|Overall Study||237
9729447|NCT00118209|10828993|FG000|COMPLETED|Overall Study||250
9729448|NCT00118209|10828994|FG001|COMPLETED|Overall Study||241
9729449|NCT00118209|10828993|FG000|NOT COMPLETED|Overall Study||12
9729450|NCT00118209|10828994|FG001|NOT COMPLETED|Overall Study||21
9729451|NCT00118248|10829002|FG000|STARTED|Overall Study||17
9729452|NCT00118248|10829003|FG001|STARTED|Overall Study||24
9729453|NCT00118248|10829002|FG000|COMPLETED|Overall Study||17
9729454|NCT00118248|10829003|FG001|COMPLETED|Overall Study||24
9729455|NCT00118248|10829002|FG000|NOT COMPLETED|Overall Study||0
9729456|NCT00118248|10829003|FG001|NOT COMPLETED|Overall Study||0
9729457|NCT00118274|10829012|FG000|STARTED|Overall Study||41
9729458|NCT00118274|10829013|FG001|STARTED|Overall Study||43
9729459|NCT00118274|10829014|FG002|STARTED|Overall Study||42
9729460|NCT00118274|10829015|FG003|STARTED|Overall Study||44
9729461|NCT00118274|10829012|FG000|COMPLETED|Overall Study||21
9729462|NCT00118274|10829013|FG001|COMPLETED|Overall Study||21
9729463|NCT00118274|10829014|FG002|COMPLETED|Overall Study||25
9729464|NCT00118274|10829015|FG003|COMPLETED|Overall Study||29
9729465|NCT00118274|10829012|FG000|NOT COMPLETED|Overall Study||20
9729466|NCT00118274|10829013|FG001|NOT COMPLETED|Overall Study||22
9729467|NCT00118274|10829014|FG002|NOT COMPLETED|Overall Study||17
9729468|NCT00118274|10829015|FG003|NOT COMPLETED|Overall Study||15
9729469|NCT00118287|10829025|FG000|STARTED|Overall Study||32
9729470|NCT00118287|10829025|FG000|COMPLETED|Overall Study||30
9729471|NCT00118287|10829025|FG000|NOT COMPLETED|Overall Study||2
9729472|NCT00118352|10829032|FG000|STARTED|Overall Study||12
9729473|NCT00118352|10829033|FG001|STARTED|Overall Study||0
9729474|NCT00118352|10829034|FG002|STARTED|Overall Study||0
9729475|NCT00118352|10829032|FG000|COMPLETED|Overall Study||12
9729476|NCT00118352|10829033|FG001|COMPLETED|Overall Study||0
9729477|NCT00118352|10829034|FG002|COMPLETED|Overall Study||0
9729478|NCT00118352|10829032|FG000|NOT COMPLETED|Overall Study||0
9729479|NCT00118352|10829033|FG001|NOT COMPLETED|Overall Study||0
9729480|NCT00118352|10829034|FG002|NOT COMPLETED|Overall Study||0
9729481|NCT00118365|10829044|FG000|STARTED|Overall Study||191
9729482|NCT00118365|10829045|FG001|STARTED|Overall Study||184
9729483|NCT00118365|10829044|FG000|COMPLETED|Overall Study||132
9729484|NCT00118365|10829045|FG001|COMPLETED|Overall Study||124
9729485|NCT00118365|10829044|FG000|NOT COMPLETED|Overall Study||59
9729486|NCT00118365|10829045|FG001|NOT COMPLETED|Overall Study||60
9729487|NCT00118378|10829083|FG000|STARTED|Overall Study||62
9729488|NCT00118378|10829084|FG001|STARTED|Overall Study||53
9729489|NCT00118378|10829083|FG000|COMPLETED|Overall Study||60
9729490|NCT00118378|10829084|FG001|COMPLETED|Overall Study||45
9729491|NCT00118378|10829083|FG000|NOT COMPLETED|Overall Study||2
9729492|NCT00118378|10829084|FG001|NOT COMPLETED|Overall Study||8
9708948|NCT01632878|10808209|FG000|STARTED|Screening||1531
9708949|NCT01632878|10808209|FG000|COMPLETED|Screening||1263
9708950|NCT01632878|10808209|FG000|NOT COMPLETED|Screening||268
9708951|NCT01632878|10808209|FG000|STARTED|Treatment||1263
9708952|NCT01632878|10808209|FG000|COMPLETED|Treatment||1105
9708953|NCT01632878|10808209|FG000|NOT COMPLETED|Treatment||158
9708954|NCT01275846|10808213|FG000|STARTED|Overall Study||26
9708955|NCT01275846|10808213|FG000|COMPLETED|Overall Study||25
9708956|NCT01275846|10808213|FG000|NOT COMPLETED|Overall Study||1
9708957|NCT01097005|10808217|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466
9708958|NCT01097005|10808217|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
9708959|NCT01097005|10808217|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
9708960|NCT01097005|10808217|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
9708961|NCT01097005|10808217|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
9708962|NCT01097005|10808217|FG000|COMPLETED|Overall Study||101
9708963|NCT01097005|10808217|FG000|NOT COMPLETED|Overall Study||365
9708964|NCT01072682|10808223|FG000|STARTED|Overall Study||35
9708965|NCT01072682|10808223|FG000|COMPLETED|Overall Study||35
9708966|NCT01072682|10808223|FG000|NOT COMPLETED|Overall Study||0
9708967|NCT00931255|10808229|FG000|STARTED|Overall Study||17
9708968|NCT00931255|10808230|FG001|STARTED|Overall Study||15
9708969|NCT00931255|10808229|FG000|COMPLETED|Overall Study||15
9708970|NCT00931255|10808230|FG001|COMPLETED|Overall Study||12
9708971|NCT00931255|10808229|FG000|NOT COMPLETED|Overall Study||2
9708972|NCT00931255|10808230|FG001|NOT COMPLETED|Overall Study||3
9708973|NCT00540995|10808238|FG000|STARTED|Overall Study||23
9708974|NCT00540995|10808239|FG001|STARTED|Overall Study||2
9708975|NCT00540995|10808238|FG000|COMPLETED|Overall Study||23
9708976|NCT00540995|10808239|FG001|COMPLETED|Overall Study||2
9708977|NCT00540995|10808238|FG000|NOT COMPLETED|Overall Study||0
9708978|NCT00540995|10808239|FG001|NOT COMPLETED|Overall Study||0
9708979|NCT00418301|10808244|FG000|STARTED|Overall Study||15
9708980|NCT00418301|10808244|FG000|COMPLETED|Overall Study||12
9708981|NCT00418301|10808244|FG000|NOT COMPLETED|Overall Study||3
9729493|NCT00118404|10829095|FG000|STARTED|Overall Study||86
9729494|NCT00118404|10829096|FG001|STARTED|Overall Study||86
9729495|NCT00118404|10829097|FG002|STARTED|Overall Study||69
9729496|NCT00118404|10829095|FG000|COMPLETED|Overall Study||62
9729497|NCT00118404|10829096|FG001|COMPLETED|Overall Study||70
9729498|NCT00118404|10829097|FG002|COMPLETED|Overall Study||49
9729499|NCT00118404|10829095|FG000|NOT COMPLETED|Overall Study||24
9729500|NCT00118404|10829096|FG001|NOT COMPLETED|Overall Study||16
9729501|NCT00118404|10829097|FG002|NOT COMPLETED|Overall Study||20
9729502|NCT00118417|10829105|FG000|STARTED|Phase I (Weeks 0 to 6)||39
9848921|NCT00862849|10961755|FG003|NOT COMPLETED|Intervention 1||0
10147667|NCT02781844|11277935|FG002|NOT COMPLETED|Treatment Period 2||0
10147668|NCT02781844|11277936|FG003|NOT COMPLETED|Treatment Period 2||0
10147669|NCT02781844|11277937|FG004|NOT COMPLETED|Treatment Period 2||0
10147670|NCT02781844|11277938|FG005|NOT COMPLETED|Treatment Period 2||0
10147671|NCT02781844|11277939|FG006|NOT COMPLETED|Treatment Period 2||0
10147672|NCT02781844|11277940|FG007|NOT COMPLETED|Treatment Period 2||0
10147673|NCT02782065|11277956|FG000|STARTED|Overall Study||58
10147674|NCT02782065|11277956|FG000|COMPLETED|Overall Study||58
10147675|NCT02782065|11277956|FG000|NOT COMPLETED|Overall Study||0
10147676|NCT02782169|11277963|FG000|STARTED|Overall Study||56
10147677|NCT02782169|11277964|FG001|STARTED|Overall Study||54
10147678|NCT02782169|11277963|FG000|COMPLETED|Overall Study||55
10147679|NCT02782169|11277964|FG001|COMPLETED|Overall Study||52
10147680|NCT02782169|11277963|FG000|NOT COMPLETED|Overall Study||1
9729503|NCT00118417|10829106|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
9729504|NCT00118417|10829105|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21
9729505|NCT00118417|10829106|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0
9729506|NCT00118417|10829105|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
9848922|NCT00862849|10961756|FG004|NOT COMPLETED|Intervention 1||0
9848923|NCT00862849|10961757|FG005|NOT COMPLETED|Intervention 1||0
9848924|NCT00862849|10961752|FG000|STARTED|Washout 1 (3 to 14 Days)||3
9848925|NCT00862849|10961753|FG001|STARTED|Washout 1 (3 to 14 Days)||5
9848926|NCT00862849|10961754|FG002|STARTED|Washout 1 (3 to 14 Days)||3
9848927|NCT00862849|10961755|FG003|STARTED|Washout 1 (3 to 14 Days)||4
9848928|NCT00862849|10961756|FG004|STARTED|Washout 1 (3 to 14 Days)||4
9848929|NCT00862849|10961757|FG005|STARTED|Washout 1 (3 to 14 Days)||3
9848930|NCT00862849|10961752|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3
9848931|NCT00862849|10961753|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4
9848932|NCT00862849|10961754|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
9848933|NCT00862849|10961755|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4
9848934|NCT00862849|10961756|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4
9848935|NCT00862849|10961757|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3
9848936|NCT00862849|10961752|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9848937|NCT00862849|10961753|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
9848938|NCT00862849|10961754|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9848939|NCT00862849|10961755|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9848940|NCT00862849|10961756|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9848941|NCT00862849|10961757|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
9848942|NCT00862849|10961752|FG000|STARTED|Intervention 2||3
9848943|NCT00862849|10961753|FG001|STARTED|Intervention 2||4
10147681|NCT02782169|11277964|FG001|NOT COMPLETED|Overall Study||2
10147682|NCT02782325|11277972|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
10147683|NCT02782325|11277973|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
10147684|NCT02782325|11277974|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
10147685|NCT02782325|11277972|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10147686|NCT02782325|11277973|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10147687|NCT02782325|11277974|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10147688|NCT02782325|11277972|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
10147689|NCT02782325|11277973|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
10147690|NCT02782325|11277974|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10147691|NCT02782325|11277972|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0
10147692|NCT02782325|11277973|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0
10147693|NCT02782325|11277974|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
10147694|NCT02782325|11277972|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10147695|NCT02782325|11277973|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10147696|NCT02782325|11277974|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
10147697|NCT02782325|11277972|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10147698|NCT02782325|11277973|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10147699|NCT02782325|11277974|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
10147700|NCT02782364|11277982|FG000|STARTED|Overall Study||18
10147701|NCT02782364|11277983|FG001|STARTED|Overall Study||18
10147702|NCT02782364|11277982|FG000|COMPLETED|Overall Study||18
10147703|NCT02782364|11277983|FG001|COMPLETED|Overall Study||18
10147704|NCT02782364|11277982|FG000|NOT COMPLETED|Overall Study||0
10147705|NCT02782364|11277983|FG001|NOT COMPLETED|Overall Study||0
10147706|NCT02782377|11277990|FG000|STARTED|Overall Study||40
10147707|NCT02782377|11277990|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
10147708|NCT02782377|11277990|FG000|NOT COMPLETED|Overall Study||5
10147709|NCT02782676|11277995|FG000|STARTED|Overall Study||211
10147710|NCT02782676|11277996|FG001|STARTED|Overall Study||210
10147711|NCT02782676|11277995|FG000|COMPLETED|Overall Study||211
10147712|NCT02782676|11277996|FG001|COMPLETED|Overall Study||209
10147713|NCT02782676|11277995|FG000|NOT COMPLETED|Overall Study||0
9708982|NCT04498273|10808252|FG000|STARTED|Overall Study||165
9708983|NCT04498273|10808253|FG001|STARTED|Overall Study||164
9708984|NCT04498273|10808254|FG002|STARTED|Overall Study||164
9708985|NCT04498273|10808255|FG003|STARTED|Overall Study||164
9708986|NCT04498273|10808252|FG000|COMPLETED|Overall Study||134
9708987|NCT04498273|10808253|FG001|COMPLETED|Overall Study||140
9708988|NCT04498273|10808254|FG002|COMPLETED|Overall Study||143
9708989|NCT04498273|10808255|FG003|COMPLETED|Overall Study||133
9708990|NCT04498273|10808252|FG000|NOT COMPLETED|Overall Study||31
9708991|NCT04498273|10808253|FG001|NOT COMPLETED|Overall Study||24
9708992|NCT04498273|10808254|FG002|NOT COMPLETED|Overall Study||21
9708993|NCT04498273|10808255|FG003|NOT COMPLETED|Overall Study||31
9708994|NCT05224453|10808267|FG000|STARTED|Overall Study||38
9708995|NCT05224453|10808268|FG001|STARTED|Overall Study||38
9708996|NCT05224453|10808267|FG000|COMPLETED|Overall Study||36
9708997|NCT05224453|10808268|FG001|COMPLETED|Overall Study||35
9708998|NCT05224453|10808267|FG000|NOT COMPLETED|Overall Study||2
9708999|NCT05224453|10808268|FG001|NOT COMPLETED|Overall Study||3
9709000|NCT04537078|10808276|FG000|STARTED|Overall Study||45
9709001|NCT04537078|10808277|FG001|STARTED|Overall Study||45
9709002|NCT04537078|10808276|FG000|COMPLETED|Overall Study||41
9709003|NCT04537078|10808277|FG001|COMPLETED|Overall Study||42
9709004|NCT04537078|10808276|FG000|NOT COMPLETED|Overall Study||4
9709005|NCT04537078|10808277|FG001|NOT COMPLETED|Overall Study||3
9709006|NCT04425252|10808292|FG000|STARTED|Overall Study||8
9709007|NCT04425252|10808293|FG001|STARTED|Overall Study||15
9709008|NCT04425252|10808292|FG000|COMPLETED|Overall Study||4
9709009|NCT04425252|10808293|FG001|COMPLETED|Overall Study||13
9709010|NCT04425252|10808292|FG000|NOT COMPLETED|Overall Study||4
9709011|NCT04425252|10808293|FG001|NOT COMPLETED|Overall Study||2
9709012|NCT04368260|10808302|FG000|STARTED|Overall Study||40
9709013|NCT04368260|10808302|FG000|COMPLETED|Overall Study||40
9709014|NCT04368260|10808302|FG000|NOT COMPLETED|Overall Study||0
9709015|NCT03940326|10808310|FG000|STARTED|Overall Study||45
9709016|NCT03940326|10808311|FG001|STARTED|Overall Study||58
9709017|NCT03940326|10808310|FG000|COMPLETED|Overall Study||45
9709018|NCT03940326|10808311|FG001|COMPLETED|Overall Study||58
9709019|NCT03940326|10808310|FG000|NOT COMPLETED|Overall Study||0
9709020|NCT03940326|10808311|FG001|NOT COMPLETED|Overall Study||0
9709021|NCT03875313|10808322|FG000|STARTED|Overall Study||3
9709022|NCT03875313|10808323|FG001|STARTED|Overall Study||16
9709023|NCT03875313|10808324|FG002|STARTED|Overall Study||6
9709024|NCT03875313|10808325|FG003|STARTED|Overall Study||4
9709025|NCT03875313|10808326|FG004|STARTED|Overall Study||4
9709026|NCT03875313|10808322|FG000|COMPLETED|Overall Study||0
9709027|NCT03875313|10808323|FG001|COMPLETED|Overall Study||0
9709028|NCT03875313|10808324|FG002|COMPLETED|Overall Study||0
9709029|NCT03875313|10808325|FG003|COMPLETED|Overall Study||0
9709030|NCT03875313|10808326|FG004|COMPLETED|Overall Study||0
9709031|NCT03875313|10808322|FG000|NOT COMPLETED|Overall Study||3
9709032|NCT03875313|10808323|FG001|NOT COMPLETED|Overall Study||16
9709033|NCT03875313|10808324|FG002|NOT COMPLETED|Overall Study||6
9709034|NCT03875313|10808325|FG003|NOT COMPLETED|Overall Study||4
9709035|NCT03875313|10808326|FG004|NOT COMPLETED|Overall Study||4
10147714|NCT02782676|11277996|FG001|NOT COMPLETED|Overall Study||1
10147715|NCT02782780|11278004|FG000|STARTED|Overall Study||46
10147716|NCT02782780|11278005|FG001|STARTED|Overall Study||39
10147717|NCT02782780|11278004|FG000|COMPLETED|Overall Study||39
10147718|NCT02782780|11278005|FG001|COMPLETED|Overall Study||32
10147719|NCT02782780|11278004|FG000|NOT COMPLETED|Overall Study||7
10147720|NCT02782780|11278005|FG001|NOT COMPLETED|Overall Study||7
10147721|NCT02782923|11278011|FG000|STARTED|Overall Study||19
10147722|NCT02782923|11278011|FG000|COMPLETED|Overall Study||4
10147723|NCT02782923|11278011|FG000|NOT COMPLETED|Overall Study||15
10147724|NCT02783027|11278017|FG000|STARTED|Overall Study||39
10147725|NCT02783027|11278018|FG001|STARTED|Overall Study||44
10147726|NCT02783027|11278017|FG000|COMPLETED|Overall Study||16
10147727|NCT02783027|11278018|FG001|COMPLETED|Overall Study||27
10147728|NCT02783027|11278017|FG000|NOT COMPLETED|Overall Study||23
10147729|NCT02783027|11278018|FG001|NOT COMPLETED|Overall Study||17
10147730|NCT02783066|11278024|FG000|STARTED|Overall Study||16
10147731|NCT02783066|11278024|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
10147732|NCT02783066|11278024|FG000|NOT COMPLETED|Overall Study||13
10147733|NCT02783170|11278031|FG000|STARTED|Overall Study||43
10147734|NCT02783170|11278032|FG001|STARTED|Overall Study||38
10147735|NCT02783170|11278031|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
10147736|NCT02783170|11278032|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
10147737|NCT02783170|11278031|FG000|COMPLETED|Overall Study||42
10147738|NCT02783170|11278032|FG001|COMPLETED|Overall Study||38
10147739|NCT02783170|11278031|FG000|NOT COMPLETED|Overall Study||1
10147740|NCT02783170|11278032|FG001|NOT COMPLETED|Overall Study||0
10147741|NCT02783443|11278041|FG000|STARTED|Overall Study||30
10147742|NCT02783443|11278042|FG001|STARTED|Overall Study||30
10147743|NCT02783443|11278041|FG000|COMPLETED|Overall Study||30
10147744|NCT02783443|11278042|FG001|COMPLETED|Overall Study||30
10147745|NCT02783443|11278041|FG000|NOT COMPLETED|Overall Study||0
10147746|NCT02783443|11278042|FG001|NOT COMPLETED|Overall Study||0
10147747|NCT02783469|11278048|FG000|STARTED|Overall Study||1915
10147748|NCT02783469|11278048|FG000|COMPLETED|Overall Study||1915
10147749|NCT02783469|11278048|FG000|NOT COMPLETED|Overall Study||0
10147750|NCT02783573|11278055|FG000|STARTED|Placebo-Controlled Treatment Period||562
10147751|NCT02783573|11278056|FG001|STARTED|Placebo-Controlled Treatment Period||590
10147752|NCT02783573|11278057|FG002|STARTED|Placebo-Controlled Treatment Period||570
10147753|NCT02783573|11278055|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
10147754|NCT02783573|11278056|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
10147755|NCT02783573|11278057|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
10147756|NCT02783573|11278055|FG000|COMPLETED|Placebo-Controlled Treatment Period||26
10147757|NCT02783573|11278056|FG001|COMPLETED|Placebo-Controlled Treatment Period||28
10147758|NCT02783573|11278057|FG002|COMPLETED|Placebo-Controlled Treatment Period||22
10147759|NCT02783573|11278055|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536
10147760|NCT02783573|11278056|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562
10147761|NCT02783573|11278057|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548
10147762|NCT02783573|11278055|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
10147763|NCT02783573|11278056|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
10147764|NCT02783573|11278057|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
10147765|NCT02783573|11278055|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
10147766|NCT02783573|11278056|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
10147767|NCT02783573|11278057|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
10147768|NCT02783573|11278055|FG000|COMPLETED|Delayed-Start Period||0
10147769|NCT02783573|11278056|FG001|COMPLETED|Delayed-Start Period||0
10147770|NCT02783573|11278057|FG002|COMPLETED|Delayed-Start Period||0
10147771|NCT02783573|11278055|FG000|NOT COMPLETED|Delayed-Start Period||0
10147772|NCT02783573|11278056|FG001|NOT COMPLETED|Delayed-Start Period||17
10147773|NCT02783573|11278057|FG002|NOT COMPLETED|Delayed-Start Period||12
10147774|NCT02783599|11278068|FG000|STARTED|Overall Study||51
10147775|NCT02783599|11278068|FG000|Received At Least One Dose of Study Drug|Overall Study||51
10147776|NCT02783599|11278068|FG000|COMPLETED|Overall Study||11
10147777|NCT02783599|11278068|FG000|NOT COMPLETED|Overall Study||40
10147778|NCT02783729|11278083|FG000|STARTED|Overall Study||208
10147779|NCT02783729|11278084|FG001|STARTED|Overall Study||263
10147780|NCT02783729|11278085|FG002|STARTED|Overall Study||266
10147781|NCT02783729|11278086|FG003|STARTED|Overall Study||269
10147782|NCT02783729|11278083|FG000|COMPLETED|Overall Study||198
10147783|NCT02783729|11278084|FG001|COMPLETED|Overall Study||246
10147784|NCT02783729|11278085|FG002|COMPLETED|Overall Study||258
10147785|NCT02783729|11278086|FG003|COMPLETED|Overall Study||260
10147786|NCT02783729|11278083|FG000|NOT COMPLETED|Overall Study||10
10147787|NCT02783729|11278084|FG001|NOT COMPLETED|Overall Study||17
10147788|NCT02783729|11278085|FG002|NOT COMPLETED|Overall Study||8
10147789|NCT02783729|11278086|FG003|NOT COMPLETED|Overall Study||9
10147790|NCT02783768|11278101|FG000|STARTED|Overall Study||6
10147791|NCT02783768|11278102|FG001|STARTED|Overall Study||5
10147792|NCT02783768|11278101|FG000|COMPLETED|Overall Study||5
10147793|NCT02783768|11278102|FG001|COMPLETED|Overall Study||5
10147794|NCT02783768|11278101|FG000|NOT COMPLETED|Overall Study||1
10147795|NCT02783768|11278102|FG001|NOT COMPLETED|Overall Study||0
10147796|NCT02783820|11278112|FG000|STARTED|Overall Study||6
10147797|NCT02783820|11278113|FG001|STARTED|Overall Study||6
10147798|NCT02783820|11278114|FG002|STARTED|Overall Study||6
10147799|NCT02783820|11278115|FG003|STARTED|Overall Study||6
10147800|NCT02783820|11278112|FG000|COMPLETED|Overall Study||6
10147801|NCT02783820|11278113|FG001|COMPLETED|Overall Study||6
10147802|NCT02783820|11278114|FG002|COMPLETED|Overall Study||6
10147803|NCT02783820|11278115|FG003|COMPLETED|Overall Study||6
10147804|NCT02783820|11278112|FG000|NOT COMPLETED|Overall Study||0
10147805|NCT02783820|11278113|FG001|NOT COMPLETED|Overall Study||0
10147806|NCT02783820|11278114|FG002|NOT COMPLETED|Overall Study||0
10147807|NCT02783820|11278115|FG003|NOT COMPLETED|Overall Study||0
10147808|NCT02783898|11278127|FG000|STARTED|Overall Study||125
10147809|NCT02783898|11278128|FG001|STARTED|Overall Study||117
10147810|NCT02783898|11278127|FG000|COMPLETED|Overall Study||124
10147811|NCT02783898|11278128|FG001|COMPLETED|Overall Study||116
10147812|NCT02783898|11278127|FG000|NOT COMPLETED|Overall Study||1
10147813|NCT02783898|11278128|FG001|NOT COMPLETED|Overall Study||1
10147814|NCT02783911|11278138|FG000|STARTED|Overall Study||11
10147815|NCT02783911|11278139|FG001|STARTED|Overall Study||46
10147816|NCT02783911|11278138|FG000|COMPLETED|Overall Study||8
10147817|NCT02783911|11278139|FG001|COMPLETED|Overall Study||14
10147818|NCT02783911|11278138|FG000|NOT COMPLETED|Overall Study||3
10147819|NCT02783911|11278139|FG001|NOT COMPLETED|Overall Study||32
10147820|NCT02783950|11278147|FG000|STARTED|Overall Study||182
10147821|NCT02783950|11278148|FG001|STARTED|Overall Study||174
10147822|NCT02783950|11278147|FG000|COMPLETED|Overall Study||175
10147823|NCT02783950|11278148|FG001|COMPLETED|Overall Study||165
10147824|NCT02783950|11278147|FG000|NOT COMPLETED|Overall Study||7
10147825|NCT02783950|11278148|FG001|NOT COMPLETED|Overall Study||9
10147826|NCT02784106|11278156|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32
10147827|NCT02784106|11278157|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33
10147828|NCT02784106|11278158|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0
10147829|NCT02784106|11278159|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0
10147830|NCT02784106|11278156|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
10147831|NCT02784106|11278157|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
10147832|NCT02784106|11278158|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10147833|NCT02784106|11278159|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10147834|NCT02784106|11278156|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
10147835|NCT02784106|11278157|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
10147836|NCT02784106|11278158|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10147837|NCT02784106|11278159|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10147838|NCT02784106|11278156|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0
10147839|NCT02784106|11278157|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0
10147840|NCT02784106|11278158|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18
10147841|NCT02784106|11278159|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21
10147842|NCT02784106|11278156|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0
10147843|NCT02784106|11278157|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0
10147844|NCT02784106|11278158|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15
10147845|NCT02784106|11278159|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19
10147846|NCT02784106|11278156|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
10147847|NCT02784106|11278157|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
10147848|NCT02784106|11278158|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
10147849|NCT02784106|11278159|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
10147850|NCT02784275|11278172|FG000|STARTED|Overall Study||16
10147851|NCT02784275|11278173|FG001|STARTED|Overall Study||16
10147852|NCT02784275|11278174|FG002|STARTED|Overall Study||17
10147853|NCT02784275|11278175|FG003|STARTED|Overall Study||15
10147854|NCT02784275|11278172|FG000|COMPLETED|Overall Study||15
10147855|NCT02784275|11278173|FG001|COMPLETED|Overall Study||16
10147856|NCT02784275|11278174|FG002|COMPLETED|Overall Study||16
10147857|NCT02784275|11278175|FG003|COMPLETED|Overall Study||14
10147858|NCT02784275|11278172|FG000|NOT COMPLETED|Overall Study||1
10147859|NCT02784275|11278173|FG001|NOT COMPLETED|Overall Study||0
10147860|NCT02784275|11278174|FG002|NOT COMPLETED|Overall Study||1
10147861|NCT02784275|11278175|FG003|NOT COMPLETED|Overall Study||1
10147862|NCT02784431|11278185|FG000|STARTED|Overall Study||20
10147863|NCT02784431|11278185|FG000|COMPLETED|Overall Study||0
10147864|NCT02784431|11278185|FG000|NOT COMPLETED|Overall Study||20
10147865|NCT02784444|11278193|FG000|STARTED|Overall Study||94
10147866|NCT02784444|11278194|FG001|STARTED|Overall Study||99
10147867|NCT02784444|11278195|FG002|STARTED|Overall Study||98
10147868|NCT02784444|11278196|FG003|STARTED|Overall Study||101
10147869|NCT02784444|11278193|FG000|COMPLETED|Overall Study||78
10147870|NCT02784444|11278194|FG001|COMPLETED|Overall Study||90
10147871|NCT02784444|11278195|FG002|COMPLETED|Overall Study||86
10147872|NCT02784444|11278196|FG003|COMPLETED|Overall Study||88
10147873|NCT02784444|11278193|FG000|NOT COMPLETED|Overall Study||16
10147874|NCT02784444|11278194|FG001|NOT COMPLETED|Overall Study||9
10147875|NCT02784444|11278195|FG002|NOT COMPLETED|Overall Study||12
10147876|NCT02784444|11278196|FG003|NOT COMPLETED|Overall Study||13
10147877|NCT02784548|11278206|FG000|STARTED|Overall Study||15
10147878|NCT02784548|11278206|FG000|COMPLETED|Overall Study||15
10147879|NCT02784548|11278206|FG000|NOT COMPLETED|Overall Study||0
10147880|NCT02784587|11278211|FG000|STARTED|Overall Study||25
10147881|NCT02784587|11278211|FG000|COMPLETED|Overall Study||25
9709036|NCT03694353|10808338|FG000|STARTED|Overall Study||37
9709037|NCT03694353|10808338|FG000|COMPLETED|Overall Study||35
9709038|NCT03694353|10808338|FG000|NOT COMPLETED|Overall Study||2
9709039|NCT03583554|10808342|FG000|STARTED|Period 1||4
9709040|NCT03583554|10808343|FG001|STARTED|Period 1||4
9709041|NCT03583554|10808344|FG002|STARTED|Period 1||4
9709042|NCT03583554|10808342|FG000|COMPLETED|Period 1||4
9709043|NCT03583554|10808343|FG001|COMPLETED|Period 1||4
9709044|NCT03583554|10808344|FG002|COMPLETED|Period 1||4
9709045|NCT03583554|10808342|FG000|NOT COMPLETED|Period 1||0
9709046|NCT03583554|10808343|FG001|NOT COMPLETED|Period 1||0
9709047|NCT03583554|10808344|FG002|NOT COMPLETED|Period 1||0
9709048|NCT03583554|10808342|FG000|STARTED|Period 2||4
9709049|NCT03583554|10808343|FG001|STARTED|Period 2||4
9709050|NCT03583554|10808344|FG002|STARTED|Period 2||4
9709051|NCT03583554|10808342|FG000|COMPLETED|Period 2||3
9709052|NCT03583554|10808343|FG001|COMPLETED|Period 2||4
9709053|NCT03583554|10808344|FG002|COMPLETED|Period 2||3
9709054|NCT03583554|10808342|FG000|NOT COMPLETED|Period 2||1
9709055|NCT03583554|10808343|FG001|NOT COMPLETED|Period 2||0
9709056|NCT03583554|10808344|FG002|NOT COMPLETED|Period 2||1
9709057|NCT03583554|10808342|FG000|STARTED|Period 3||3
9709058|NCT03583554|10808343|FG001|STARTED|Period 3||4
9709059|NCT03583554|10808344|FG002|STARTED|Period 3||3
9709060|NCT03583554|10808342|FG000|COMPLETED|Period 3||3
9709061|NCT03583554|10808343|FG001|COMPLETED|Period 3||4
9709062|NCT03583554|10808344|FG002|COMPLETED|Period 3||3
9709063|NCT03583554|10808342|FG000|NOT COMPLETED|Period 3||0
9709064|NCT03583554|10808343|FG001|NOT COMPLETED|Period 3||0
9709065|NCT03583554|10808344|FG002|NOT COMPLETED|Period 3||0
9709066|NCT03538717|10808355|FG000|STARTED|Overall Study||157
9709067|NCT03538717|10808355|FG000|COMPLETED|Overall Study||157
9709068|NCT03538717|10808355|FG000|NOT COMPLETED|Overall Study||0
9709069|NCT03408873|10808361|FG000|STARTED|Visit 1 Assessment (Baseline)||30
9709070|NCT03408873|10808361|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27
9709071|NCT03408873|10808361|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3
9709072|NCT03408873|10808361|FG000|STARTED|Visit 2 Assessment||27
9709073|NCT03408873|10808361|FG000|COMPLETED|Visit 2 Assessment||26
9709074|NCT03408873|10808361|FG000|NOT COMPLETED|Visit 2 Assessment||1
9709075|NCT03408873|10808361|FG000|STARTED|Visit 3 Assessment||26
9709076|NCT03408873|10808361|FG000|COMPLETED|Visit 3 Assessment||25
9709077|NCT03408873|10808361|FG000|NOT COMPLETED|Visit 3 Assessment||1
9709078|NCT03408873|10808361|FG000|STARTED|Visit 4 Assessment||25
9709079|NCT03408873|10808361|FG000|COMPLETED|Visit 4 Assessment||23
9709080|NCT03408873|10808361|FG000|NOT COMPLETED|Visit 4 Assessment||2
9709081|NCT03408873|10808361|FG000|STARTED|Visit 5 Assessment||23
9709082|NCT03408873|10808361|FG000|COMPLETED|Visit 5 Assessment||22
9709083|NCT03408873|10808361|FG000|NOT COMPLETED|Visit 5 Assessment||1
9709084|NCT03408873|10808361|FG000|STARTED|Visit 6 Assessment||22
9709085|NCT03408873|10808361|FG000|COMPLETED|Visit 6 Assessment||21
9709086|NCT03408873|10808361|FG000|NOT COMPLETED|Visit 6 Assessment||1
9709087|NCT03408873|10808361|FG000|STARTED|Visit 7 Assessment||21
9709088|NCT03408873|10808361|FG000|COMPLETED|Visit 7 Assessment||21
9709089|NCT03408873|10808361|FG000|NOT COMPLETED|Visit 7 Assessment||0
9709090|NCT03132467|10808365|FG000|STARTED|Overall Study||8
9709091|NCT03132467|10808365|FG000|COMPLETED|Overall Study||4
9709092|NCT03132467|10808365|FG000|NOT COMPLETED|Overall Study||4
9729507|NCT00118417|10829106|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
9729508|NCT00118417|10829105|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
9729509|NCT00118417|10829106|FG001|STARTED|Phase II (Weeks 6 to 12)||13
9729510|NCT00118417|10829105|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9
9729511|NCT00118417|10829106|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10
9729512|NCT00118417|10829105|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
9729513|NCT00118417|10829106|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
9729514|NCT00118417|10829105|FG000|STARTED|Phase III (Weeks 12 to 24)||9
9729515|NCT00118417|10829106|FG001|STARTED|Phase III (Weeks 12 to 24)||10
9729516|NCT00118417|10829105|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8
9729517|NCT00118417|10829106|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9
9729518|NCT00118417|10829105|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
9729519|NCT00118417|10829106|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
9729520|NCT00118430|10829119|FG000|STARTED|Overall Study||123
9729521|NCT00118430|10829120|FG001|STARTED|Overall Study||127
9729522|NCT00118430|10829121|FG002|STARTED|Overall Study||250
9729523|NCT00118430|10829119|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
9729524|NCT00118430|10829120|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
9729525|NCT00118430|10829121|FG002|COMPLETED|Overall Study||222
9729526|NCT00118430|10829119|FG000|NOT COMPLETED|Overall Study||21
9729527|NCT00118430|10829120|FG001|NOT COMPLETED|Overall Study||24
10147882|NCT02784587|11278211|FG000|NOT COMPLETED|Overall Study||0
10147883|NCT02784613|11278215|FG000|STARTED|Overall Study||10
9729528|NCT00118430|10829121|FG002|NOT COMPLETED|Overall Study||28
9729529|NCT00118482|10829130|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
9729530|NCT00118482|10829131|FG001|STARTED|Overall Study||105
9729531|NCT00118482|10829130|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
9729532|NCT00118482|10829131|FG001|COMPLETED|Overall Study||76
10147884|NCT02784613|11278215|FG000|COMPLETED|Overall Study||8
10147885|NCT02784613|11278215|FG000|NOT COMPLETED|Overall Study||2
10147886|NCT02784834|11278219|FG000|STARTED|Overall Study||2
10147887|NCT02784834|11278219|FG000|COMPLETED|Overall Study||1
10147888|NCT02784834|11278219|FG000|NOT COMPLETED|Overall Study||1
10147889|NCT02784925|11278223|FG000|STARTED|Overall Study||30
10147890|NCT02784925|11278223|FG000|COMPLETED|Overall Study||30
10147891|NCT02784925|11278223|FG000|NOT COMPLETED|Overall Study||0
10147892|NCT02785159|11278231|FG000|STARTED|Overall Study||62
10147893|NCT02785159|11278232|FG001|STARTED|Overall Study||58
10147894|NCT02785159|11278233|FG002|STARTED|Overall Study||15
10147895|NCT02785159|11278234|FG003|STARTED|Overall Study||17
10147896|NCT02785159|11278231|FG000|COMPLETED|Overall Study||51
10147897|NCT02785159|11278232|FG001|COMPLETED|Overall Study||45
10147898|NCT02785159|11278233|FG002|COMPLETED|Overall Study||12
10147899|NCT02785159|11278234|FG003|COMPLETED|Overall Study||14
10147900|NCT02785159|11278231|FG000|NOT COMPLETED|Overall Study||11
10147901|NCT02785159|11278232|FG001|NOT COMPLETED|Overall Study||13
10147902|NCT02785159|11278233|FG002|NOT COMPLETED|Overall Study||3
10147903|NCT02785159|11278234|FG003|NOT COMPLETED|Overall Study||3
10147904|NCT02785172|11278248|FG000|STARTED|Overall Study||61
10147905|NCT02785172|11278249|FG001|STARTED|Overall Study||63
10147906|NCT02785172|11278250|FG002|STARTED|Overall Study||16
10147907|NCT02785172|11278251|FG003|STARTED|Overall Study||14
10147908|NCT02785172|11278248|FG000|COMPLETED|Overall Study||61
10147909|NCT02785172|11278249|FG001|COMPLETED|Overall Study||62
10147910|NCT02785172|11278250|FG002|COMPLETED|Overall Study||15
10147911|NCT02785172|11278251|FG003|COMPLETED|Overall Study||14
10147912|NCT02785172|11278248|FG000|NOT COMPLETED|Overall Study||0
10147913|NCT02785172|11278249|FG001|NOT COMPLETED|Overall Study||1
10147914|NCT02785172|11278250|FG002|NOT COMPLETED|Overall Study||1
10147915|NCT02785172|11278251|FG003|NOT COMPLETED|Overall Study||0
10147916|NCT02785185|11278265|FG000|STARTED|Overall Study||60
10147917|NCT02785185|11278266|FG001|STARTED|Overall Study||57
10147918|NCT02785185|11278267|FG002|STARTED|Overall Study||17
10147919|NCT02785185|11278268|FG003|STARTED|Overall Study||16
10147920|NCT02785185|11278265|FG000|COMPLETED|Overall Study||59
10147921|NCT02785185|11278266|FG001|COMPLETED|Overall Study||56
10147922|NCT02785185|11278267|FG002|COMPLETED|Overall Study||15
10147923|NCT02785185|11278268|FG003|COMPLETED|Overall Study||16
10147924|NCT02785185|11278265|FG000|NOT COMPLETED|Overall Study||1
10147925|NCT02785185|11278266|FG001|NOT COMPLETED|Overall Study||1
10147926|NCT02785185|11278267|FG002|NOT COMPLETED|Overall Study||2
10147927|NCT02785185|11278268|FG003|NOT COMPLETED|Overall Study||0
10147928|NCT02785354|11278281|FG000|STARTED|Overall Study||27060
10147929|NCT02785354|11278282|FG001|STARTED|Overall Study||31388
10147930|NCT02785354|11278283|FG002|STARTED|Overall Study||44653
10147931|NCT02785354|11278281|FG000|COMPLETED|Overall Study||27060
10147932|NCT02785354|11278282|FG001|COMPLETED|Overall Study||31388
10147933|NCT02785354|11278283|FG002|COMPLETED|Overall Study||44653
10147934|NCT02785354|11278281|FG000|NOT COMPLETED|Overall Study||0
10147935|NCT02785354|11278282|FG001|NOT COMPLETED|Overall Study||0
10147936|NCT02785354|11278283|FG002|NOT COMPLETED|Overall Study||0
10147937|NCT02785406|11278294|FG000|STARTED|Overall Study||10
10147938|NCT02785406|11278295|FG001|STARTED|Overall Study||10
10147939|NCT02785406|11278294|FG000|Completed First Week|Overall Study||10
10147940|NCT02785406|11278295|FG001|Completed First Week|Overall Study||10
10147941|NCT02785406|11278294|FG000|Completed Second Week|Overall Study||10
10147942|NCT02785406|11278295|FG001|Completed Second Week|Overall Study||10
10147943|NCT02785406|11278294|FG000|COMPLETED|Overall Study||10
10147944|NCT02785406|11278295|FG001|COMPLETED|Overall Study||10
10147945|NCT02785406|11278294|FG000|NOT COMPLETED|Overall Study||0
10147946|NCT02785406|11278295|FG001|NOT COMPLETED|Overall Study||0
10147947|NCT02785432|11278303|FG000|STARTED|Overall Study||4
10147948|NCT02785432|11278304|FG001|STARTED|Overall Study||7
10147949|NCT02785432|11278303|FG000|COMPLETED|Overall Study||4
10147950|NCT02785432|11278304|FG001|COMPLETED|Overall Study||7
10147951|NCT02785432|11278303|FG000|NOT COMPLETED|Overall Study||0
10147952|NCT02785432|11278304|FG001|NOT COMPLETED|Overall Study||0
10147953|NCT02785458|11278312|FG000|STARTED|Baseline||526
10147954|NCT02785458|11278313|FG001|STARTED|Baseline||479
10147955|NCT02785458|11278312|FG000|COMPLETED|Baseline||526
10147956|NCT02785458|11278313|FG001|COMPLETED|Baseline||479
10147957|NCT02785458|11278312|FG000|NOT COMPLETED|Baseline||0
10147958|NCT02785458|11278313|FG001|NOT COMPLETED|Baseline||0
10147959|NCT02785458|11278312|FG000|STARTED|1 Month||526
10147960|NCT02785458|11278313|FG001|STARTED|1 Month||479
10147961|NCT02785458|11278312|FG000|COMPLETED|1 Month||443
10147962|NCT02785458|11278313|FG001|COMPLETED|1 Month||404
10147963|NCT02785458|11278312|FG000|NOT COMPLETED|1 Month||83
10147964|NCT02785458|11278313|FG001|NOT COMPLETED|1 Month||75
10147965|NCT02785458|11278312|FG000|STARTED|3 Months||443
10147966|NCT02785458|11278313|FG001|STARTED|3 Months||404
10147967|NCT02785458|11278312|FG000|COMPLETED|3 Months||315
10147968|NCT02785458|11278313|FG001|COMPLETED|3 Months||293
10147969|NCT02785458|11278312|FG000|NOT COMPLETED|3 Months||128
10147970|NCT02785458|11278313|FG001|NOT COMPLETED|3 Months||111
10147971|NCT02785588|11278319|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49
10147972|NCT02785588|11278319|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47
10147973|NCT02785588|11278319|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
10147974|NCT02785588|11278319|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
10147975|NCT02785588|11278319|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5
10147976|NCT02785588|11278319|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
10147977|NCT02785770|11278323|FG000|STARTED|Intervention Period 1 (1 Day)||11
10147978|NCT02785770|11278324|FG001|STARTED|Intervention Period 1 (1 Day)||11
10147979|NCT02785770|11278325|FG002|STARTED|Intervention Period 1 (1 Day)||11
10147980|NCT02785770|11278326|FG003|STARTED|Intervention Period 1 (1 Day)||11
10147981|NCT02785770|11278323|FG000|COMPLETED|Intervention Period 1 (1 Day)||11
10147982|NCT02785770|11278324|FG001|COMPLETED|Intervention Period 1 (1 Day)||11
10147983|NCT02785770|11278325|FG002|COMPLETED|Intervention Period 1 (1 Day)||11
10147984|NCT02785770|11278326|FG003|COMPLETED|Intervention Period 1 (1 Day)||11
10147985|NCT02785770|11278323|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10147986|NCT02785770|11278324|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10147987|NCT02785770|11278325|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10147988|NCT02785770|11278326|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10147989|NCT02785770|11278323|FG000|STARTED|Washout Period 1 (7 Days)||11
10147990|NCT02785770|11278324|FG001|STARTED|Washout Period 1 (7 Days)||11
10147991|NCT02785770|11278325|FG002|STARTED|Washout Period 1 (7 Days)||11
10147992|NCT02785770|11278326|FG003|STARTED|Washout Period 1 (7 Days)||11
10147993|NCT02785770|11278323|FG000|COMPLETED|Washout Period 1 (7 Days)||11
10147994|NCT02785770|11278324|FG001|COMPLETED|Washout Period 1 (7 Days)||11
10147995|NCT02785770|11278325|FG002|COMPLETED|Washout Period 1 (7 Days)||11
10147996|NCT02785770|11278326|FG003|COMPLETED|Washout Period 1 (7 Days)||11
10147997|NCT02785770|11278323|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10147998|NCT02785770|11278324|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10147999|NCT02785770|11278325|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10148000|NCT02785770|11278326|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10148001|NCT02785770|11278323|FG000|STARTED|Intervention Period 2 (1 Day)||11
10148002|NCT02785770|11278324|FG001|STARTED|Intervention Period 2 (1 Day)||11
10148003|NCT02785770|11278325|FG002|STARTED|Intervention Period 2 (1 Day)||11
10148004|NCT02785770|11278326|FG003|STARTED|Intervention Period 2 (1 Day)||11
10148005|NCT02785770|11278323|FG000|COMPLETED|Intervention Period 2 (1 Day)||11
10148006|NCT02785770|11278324|FG001|COMPLETED|Intervention Period 2 (1 Day)||10
10148007|NCT02785770|11278325|FG002|COMPLETED|Intervention Period 2 (1 Day)||10
10148008|NCT02785770|11278326|FG003|COMPLETED|Intervention Period 2 (1 Day)||11
10148009|NCT02785770|11278323|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
10148010|NCT02785770|11278324|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1
10148011|NCT02785770|11278325|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1
10148012|NCT02785770|11278326|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0
9709093|NCT03096288|10808374|FG000|STARTED|Overall Study||19
9709094|NCT03096288|10808375|FG001|STARTED|Overall Study||18
9709095|NCT03096288|10808376|FG002|STARTED|Overall Study||22
9709096|NCT03096288|10808377|FG003|STARTED|Overall Study||25
9709097|NCT03096288|10808374|FG000|COMPLETED|Overall Study||19
9709098|NCT03096288|10808375|FG001|COMPLETED|Overall Study||17
9709099|NCT03096288|10808376|FG002|COMPLETED|Overall Study||22
9709100|NCT03096288|10808377|FG003|COMPLETED|Overall Study||24
9709101|NCT03096288|10808374|FG000|NOT COMPLETED|Overall Study||0
9709102|NCT03096288|10808375|FG001|NOT COMPLETED|Overall Study||1
9709103|NCT03096288|10808376|FG002|NOT COMPLETED|Overall Study||0
9709104|NCT03096288|10808377|FG003|NOT COMPLETED|Overall Study||1
9709105|NCT02919436|10808389|FG000|STARTED|Overall Study||305
9709106|NCT02919436|10808390|FG001|STARTED|Overall Study||305
9709107|NCT02919436|10808389|FG000|COMPLETED|Overall Study||245
9709108|NCT02919436|10808390|FG001|COMPLETED|Overall Study||252
9709109|NCT02919436|10808389|FG000|NOT COMPLETED|Overall Study||60
9709110|NCT02919436|10808390|FG001|NOT COMPLETED|Overall Study||53
9709111|NCT02135484|10808398|FG000|STARTED|Overall Study||25
9709112|NCT02135484|10808398|FG000|COMPLETED|Overall Study||25
9709113|NCT02135484|10808398|FG000|NOT COMPLETED|Overall Study||0
9709114|NCT02028884|10808404|FG000|STARTED|Double-blind Period||42
9709115|NCT02028884|10808405|FG001|STARTED|Double-blind Period||41
9709116|NCT02028884|10808404|FG000|COMPLETED|Double-blind Period||24
9709117|NCT02028884|10808405|FG001|COMPLETED|Double-blind Period||18
9709118|NCT02028884|10808404|FG000|NOT COMPLETED|Double-blind Period||18
9709119|NCT02028884|10808405|FG001|NOT COMPLETED|Double-blind Period||23
9709120|NCT02028884|10808404|FG000|STARTED|Open-label Extension Period||24
9709121|NCT02028884|10808405|FG001|STARTED|Open-label Extension Period||18
9709122|NCT02028884|10808404|FG000|COMPLETED|Open-label Extension Period||0
9709123|NCT02028884|10808405|FG001|COMPLETED|Open-label Extension Period||0
9709124|NCT02028884|10808404|FG000|NOT COMPLETED|Open-label Extension Period||24
9709125|NCT02028884|10808405|FG001|NOT COMPLETED|Open-label Extension Period||18
9709126|NCT01983774|10808416|FG000|STARTED|Overall Study||9
9709127|NCT01983774|10808417|FG001|STARTED|Overall Study||8
10148013|NCT02785770|11278323|FG000|STARTED|Washout Period 2 (7 Days)||11
10148014|NCT02785770|11278324|FG001|STARTED|Washout Period 2 (7 Days)||10
10148015|NCT02785770|11278325|FG002|STARTED|Washout Period 2 (7 Days)||10
10148016|NCT02785770|11278326|FG003|STARTED|Washout Period 2 (7 Days)||11
10148017|NCT02785770|11278323|FG000|COMPLETED|Washout Period 2 (7 Days)||11
10148018|NCT02785770|11278324|FG001|COMPLETED|Washout Period 2 (7 Days)||10
10148019|NCT02785770|11278325|FG002|COMPLETED|Washout Period 2 (7 Days)||10
10148020|NCT02785770|11278326|FG003|COMPLETED|Washout Period 2 (7 Days)||11
9709128|NCT01983774|10808416|FG000|COMPLETED|Overall Study||8
9709129|NCT01983774|10808417|FG001|COMPLETED|Overall Study||7
9709130|NCT01983774|10808416|FG000|NOT COMPLETED|Overall Study||1
10148021|NCT02785770|11278323|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10148022|NCT02785770|11278324|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10148023|NCT02785770|11278325|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10148024|NCT02785770|11278326|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10148025|NCT02785770|11278323|FG000|STARTED|Intervention Period 3 (1 Day)||11
10148026|NCT02785770|11278324|FG001|STARTED|Intervention Period 3 (1 Day)||10
10148027|NCT02785770|11278325|FG002|STARTED|Intervention Period 3 (1 Day)||10
10148028|NCT02785770|11278326|FG003|STARTED|Intervention Period 3 (1 Day)||11
10148029|NCT02785770|11278323|FG000|COMPLETED|Intervention Period 3 (1 Day)||11
10148030|NCT02785770|11278324|FG001|COMPLETED|Intervention Period 3 (1 Day)||10
10148031|NCT02785770|11278325|FG002|COMPLETED|Intervention Period 3 (1 Day)||10
10148032|NCT02785770|11278326|FG003|COMPLETED|Intervention Period 3 (1 Day)||10
10148033|NCT02785770|11278323|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0
10148034|NCT02785770|11278324|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0
10148035|NCT02785770|11278325|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0
10148036|NCT02785770|11278326|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1
10148037|NCT02785770|11278323|FG000|STARTED|Washout Period 3 (7 Days)||11
10148038|NCT02785770|11278324|FG001|STARTED|Washout Period 3 (7 Days)||10
10148039|NCT02785770|11278325|FG002|STARTED|Washout Period 3 (7 Days)||10
10148040|NCT02785770|11278326|FG003|STARTED|Washout Period 3 (7 Days)||10
10148041|NCT02785770|11278323|FG000|COMPLETED|Washout Period 3 (7 Days)||11
10148042|NCT02785770|11278324|FG001|COMPLETED|Washout Period 3 (7 Days)||10
10148043|NCT02785770|11278325|FG002|COMPLETED|Washout Period 3 (7 Days)||10
10148044|NCT02785770|11278326|FG003|COMPLETED|Washout Period 3 (7 Days)||10
10148045|NCT02785770|11278323|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10148046|NCT02785770|11278324|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10148047|NCT02785770|11278325|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10148048|NCT02785770|11278326|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10148049|NCT02785770|11278323|FG000|STARTED|Intervention Period 4 (1 Day)||11
10148050|NCT02785770|11278324|FG001|STARTED|Intervention Period 4 (1 Day)||10
10148051|NCT02785770|11278325|FG002|STARTED|Intervention Period 4 (1 Day)||10
10148052|NCT02785770|11278326|FG003|STARTED|Intervention Period 4 (1 Day)||10
10148053|NCT02785770|11278323|FG000|COMPLETED|Intervention Period 4 (1 Day)||11
10148054|NCT02785770|11278324|FG001|COMPLETED|Intervention Period 4 (1 Day)||10
10148055|NCT02785770|11278325|FG002|COMPLETED|Intervention Period 4 (1 Day)||10
10148056|NCT02785770|11278326|FG003|COMPLETED|Intervention Period 4 (1 Day)||10
10148057|NCT02785770|11278323|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10148058|NCT02785770|11278324|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10148059|NCT02785770|11278325|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10148060|NCT02785770|11278326|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10148061|NCT02785900|11278341|FG000|STARTED|Overall Study||117
10148062|NCT02785900|11278342|FG001|STARTED|Overall Study||123
10148063|NCT02785900|11278341|FG000|COMPLETED|Overall Study||0
10148064|NCT02785900|11278342|FG001|COMPLETED|Overall Study||0
10148065|NCT02785900|11278341|FG000|NOT COMPLETED|Overall Study||117
10148066|NCT02785900|11278342|FG001|NOT COMPLETED|Overall Study||123
10148067|NCT02785913|11278348|FG000|STARTED|Overall Study||26
10148068|NCT02785913|11278348|FG000|COMPLETED|Overall Study||0
10148069|NCT02785913|11278348|FG000|NOT COMPLETED|Overall Study||26
10148070|NCT02785939|11278355|FG000|STARTED|Overall Study||31
10148071|NCT02785939|11278356|FG001|STARTED|Overall Study||10
10148072|NCT02785939|11278355|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
10148073|NCT02785939|11278356|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
10148074|NCT02785939|11278355|FG000|COMPLETED|Overall Study||0
10148075|NCT02785939|11278356|FG001|COMPLETED|Overall Study||0
10148076|NCT02785939|11278355|FG000|NOT COMPLETED|Overall Study||31
10148077|NCT02785939|11278356|FG001|NOT COMPLETED|Overall Study||10
10148078|NCT02786004|11278364|FG000|STARTED|Overall Study||14
10148079|NCT02786004|11278365|FG001|STARTED|Overall Study||10
10148080|NCT02786004|11278364|FG000|COMPLETED|Overall Study||14
10148081|NCT02786004|11278365|FG001|COMPLETED|Overall Study||9
10148082|NCT02786004|11278364|FG000|NOT COMPLETED|Overall Study||0
10148083|NCT02786004|11278365|FG001|NOT COMPLETED|Overall Study||1
10148084|NCT02786134|11278375|FG000|STARTED|Overall Study||25
10148085|NCT02786134|11278376|FG001|STARTED|Overall Study||25
10148086|NCT02786134|11278375|FG000|COMPLETED|Overall Study||25
10148087|NCT02786134|11278376|FG001|COMPLETED|Overall Study||25
10148088|NCT02786134|11278375|FG000|NOT COMPLETED|Overall Study||0
10148089|NCT02786134|11278376|FG001|NOT COMPLETED|Overall Study||0
10148090|NCT02786355|11278382|FG000|STARTED|Overall Study||35
10148091|NCT02786355|11278382|FG000|COMPLETED|Overall Study||35
10148092|NCT02786355|11278382|FG000|NOT COMPLETED|Overall Study||0
10148093|NCT02786719|11278389|FG000|STARTED|Overall Study||13
10148094|NCT02786719|11278389|FG000|COMPLETED|Overall Study||12
10148095|NCT02786719|11278389|FG000|NOT COMPLETED|Overall Study||1
10148096|NCT02786771|11278395|FG000|STARTED|Overall Study||63
10148097|NCT02786771|11278396|FG001|STARTED|Overall Study||62
10148098|NCT02786771|11278395|FG000|COMPLETED|Overall Study||53
10148099|NCT02786771|11278396|FG001|COMPLETED|Overall Study||56
10148100|NCT02786771|11278395|FG000|NOT COMPLETED|Overall Study||10
10148101|NCT02786771|11278396|FG001|NOT COMPLETED|Overall Study||6
10148102|NCT02786810|11278402|FG000|STARTED|Overall Study||10
10148103|NCT02786810|11278402|FG000|COMPLETED|Overall Study||10
10148104|NCT02786810|11278402|FG000|NOT COMPLETED|Overall Study||0
10148105|NCT02786836|11278406|FG000|STARTED|Overall Study||76
10148106|NCT02786836|11278406|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76
10148107|NCT02786836|11278406|FG000|COMPLETED|Overall Study||62
10148108|NCT02786836|11278406|FG000|NOT COMPLETED|Overall Study||14
10148109|NCT02786901|11278414|FG000|STARTED|Overall Study||199
10148110|NCT02786901|11278415|FG001|STARTED|Overall Study||201
10148111|NCT02786901|11278416|FG002|STARTED|Overall Study||200
10148112|NCT02786901|11278414|FG000|COMPLETED|Overall Study||122
10148113|NCT02786901|11278415|FG001|COMPLETED|Overall Study||145
10148114|NCT02786901|11278416|FG002|COMPLETED|Overall Study||159
10148115|NCT02786901|11278414|FG000|NOT COMPLETED|Overall Study||77
10148116|NCT02786901|11278415|FG001|NOT COMPLETED|Overall Study||56
10148117|NCT02786901|11278416|FG002|NOT COMPLETED|Overall Study||41
10148118|NCT02786927|11278424|FG000|STARTED|Overall Study||212
10148119|NCT02786927|11278424|FG000|COMPLETED|Overall Study||207
10148120|NCT02786927|11278424|FG000|NOT COMPLETED|Overall Study||5
10148121|NCT02786953|11278431|FG000|STARTED|Overall Study||20
10148122|NCT02786953|11278432|FG001|STARTED|Overall Study||19
10148123|NCT02786953|11278431|FG000|Baseline Teen Survey Data Completed|Overall Study||20
10148124|NCT02786953|11278432|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
10148125|NCT02786953|11278431|FG000|Baseline Parent Survey Completed|Overall Study||20
10148126|NCT02786953|11278432|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
10148127|NCT02786953|11278431|FG000|Actigraph Data Complete|Overall Study||14
10148128|NCT02786953|11278432|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
10148129|NCT02786953|11278431|FG000|A1C Data Baseline|Overall Study||20
10148130|NCT02786953|11278432|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
10148131|NCT02786953|11278431|FG000|Session 1 Completed|Overall Study||17
10148132|NCT02786953|11278432|FG001|Session 1 Completed|Overall Study||0
10148133|NCT02786953|11278431|FG000|Session 2 Completed|Overall Study||16
10148134|NCT02786953|11278432|FG001|Session 2 Completed|Overall Study||0
10148135|NCT02786953|11278431|FG000|Session 3 Completed|Overall Study||16
10148136|NCT02786953|11278432|FG001|Session 3 Completed|Overall Study||0
10148137|NCT02786953|11278431|FG000|3 Month Teen Survey Completed|Overall Study||17
10148138|NCT02786953|11278432|FG001|3 Month Teen Survey Completed|Overall Study||18
10148139|NCT02786953|11278431|FG000|3 Month Parent Survey Completed|Overall Study||17
10148140|NCT02786953|11278432|FG001|3 Month Parent Survey Completed|Overall Study||18
10148141|NCT02786953|11278431|FG000|A1C 3 Month|Overall Study||15
10148142|NCT02786953|11278432|FG001|A1C 3 Month|Overall Study||17
10148143|NCT02786953|11278431|FG000|COMPLETED|Overall Study||17
10148144|NCT02786953|11278432|FG001|COMPLETED|Overall Study||18
10148145|NCT02786953|11278431|FG000|NOT COMPLETED|Overall Study||3
10148146|NCT02786953|11278432|FG001|NOT COMPLETED|Overall Study||1
10148147|NCT02787057|11278440|FG000|STARTED|Overall Study||40
10148148|NCT02787057|11278441|FG001|STARTED|Overall Study||40
10148149|NCT02787057|11278440|FG000|COMPLETED|Overall Study||40
10148150|NCT02787057|11278441|FG001|COMPLETED|Overall Study||40
10148151|NCT02787057|11278440|FG000|NOT COMPLETED|Overall Study||0
10148152|NCT02787057|11278441|FG001|NOT COMPLETED|Overall Study||0
10148153|NCT02787083|11278449|FG000|STARTED|Overall Study||4
10148154|NCT02787083|11278450|FG001|STARTED|Overall Study||5
10148155|NCT02787083|11278449|FG000|COMPLETED|Overall Study||1
10148156|NCT02787083|11278450|FG001|COMPLETED|Overall Study||3
10148157|NCT02787083|11278449|FG000|NOT COMPLETED|Overall Study||3
10148158|NCT02787083|11278450|FG001|NOT COMPLETED|Overall Study||2
10148159|NCT02787291|11278456|FG000|STARTED|Overall Study||227
10148160|NCT02787291|11278456|FG000|COMPLETED|Overall Study||227
10148161|NCT02787291|11278456|FG000|NOT COMPLETED|Overall Study||0
10148162|NCT02787304|11278464|FG000|STARTED|Overall Study||49
10148163|NCT02787304|11278465|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
10148164|NCT02787304|11278466|FG002|STARTED|Overall Study||49
10148165|NCT02787304|11278467|FG003|STARTED|Overall Study||49
10148166|NCT02787304|11278464|FG000|COMPLETED|Overall Study||13
10148167|NCT02787304|11278465|FG001|COMPLETED|Overall Study||12
10148168|NCT02787304|11278466|FG002|COMPLETED|Overall Study||8
10148169|NCT02787304|11278467|FG003|COMPLETED|Overall Study||15
10148170|NCT02787304|11278464|FG000|NOT COMPLETED|Overall Study||36
10148171|NCT02787304|11278465|FG001|NOT COMPLETED|Overall Study||38
10148172|NCT02787304|11278466|FG002|NOT COMPLETED|Overall Study||41
10148173|NCT02787304|11278467|FG003|NOT COMPLETED|Overall Study||34
10148174|NCT02787564|11278479|FG000|STARTED|Overall Study||32
10148175|NCT02787564|11278480|FG001|STARTED|Overall Study||29
10148176|NCT02787564|11278479|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
10148177|NCT02787564|11278480|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
10148178|NCT02787564|11278479|FG000|NOT COMPLETED|Overall Study||7
10148179|NCT02787564|11278480|FG001|NOT COMPLETED|Overall Study||2
10148180|NCT02787655|11278488|FG000|STARTED|Overall Study||40
10148181|NCT02787655|11278489|FG001|STARTED|Overall Study||38
10148182|NCT02787655|11278488|FG000|COMPLETED|Overall Study||29
10148183|NCT02787655|11278489|FG001|COMPLETED|Overall Study||26
10148184|NCT02787655|11278488|FG000|NOT COMPLETED|Overall Study||11
10148185|NCT02787655|11278489|FG001|NOT COMPLETED|Overall Study||12
10148186|NCT02787681|11278495|FG000|STARTED|Overall Study||71
10148187|NCT02787681|11278495|FG000|COMPLETED|Overall Study||69
10148188|NCT02787681|11278495|FG000|NOT COMPLETED|Overall Study||2
10148189|NCT02787694|11278499|FG000|STARTED|Overall Study||22
10148190|NCT02787694|11278499|FG000|COMPLETED|Overall Study||17
10148191|NCT02787694|11278499|FG000|NOT COMPLETED|Overall Study||5
10148192|NCT02787863|11278511|FG000|STARTED|Overall Study||33
10148193|NCT02787863|11278512|FG001|STARTED|Overall Study||34
10148194|NCT02787863|11278513|FG002|STARTED|Overall Study||25
10148195|NCT02787863|11278514|FG003|STARTED|Overall Study||25
10148196|NCT02787863|11278515|FG004|STARTED|Overall Study||32
10148197|NCT02787863|11278516|FG005|STARTED|Overall Study||18
10148198|NCT02787863|11278517|FG006|STARTED|Overall Study||25
10148199|NCT02787863|11278518|FG007|STARTED|Overall Study||27
10148200|NCT02787863|11278511|FG000|1 Year After Vaccination|Overall Study||32
10148201|NCT02787863|11278512|FG001|1 Year After Vaccination|Overall Study||33
10148202|NCT02787863|11278513|FG002|1 Year After Vaccination|Overall Study||23
10148203|NCT02787863|11278514|FG003|1 Year After Vaccination|Overall Study||25
10148204|NCT02787863|11278515|FG004|1 Year After Vaccination|Overall Study||32
10148205|NCT02787863|11278516|FG005|1 Year After Vaccination|Overall Study||18
10148206|NCT02787863|11278517|FG006|1 Year After Vaccination|Overall Study||25
10148207|NCT02787863|11278518|FG007|1 Year After Vaccination|Overall Study||27
10148208|NCT02787863|11278511|FG000|4 Years After Vaccination|Overall Study||32
10148209|NCT02787863|11278512|FG001|4 Years After Vaccination|Overall Study||33
10148210|NCT02787863|11278513|FG002|4 Years After Vaccination|Overall Study||23
10148211|NCT02787863|11278514|FG003|4 Years After Vaccination|Overall Study||25
10148212|NCT02787863|11278515|FG004|4 Years After Vaccination|Overall Study||32
10148213|NCT02787863|11278516|FG005|4 Years After Vaccination|Overall Study||18
10148214|NCT02787863|11278517|FG006|4 Years After Vaccination|Overall Study||25
10148215|NCT02787863|11278518|FG007|4 Years After Vaccination|Overall Study||27
10148216|NCT02787863|11278511|FG000|COMPLETED|Overall Study||32
10148217|NCT02787863|11278512|FG001|COMPLETED|Overall Study||33
10148218|NCT02787863|11278513|FG002|COMPLETED|Overall Study||23
10148219|NCT02787863|11278514|FG003|COMPLETED|Overall Study||25
10148220|NCT02787863|11278515|FG004|COMPLETED|Overall Study||32
10148221|NCT02787863|11278516|FG005|COMPLETED|Overall Study||18
10148222|NCT02787863|11278517|FG006|COMPLETED|Overall Study||25
10148223|NCT02787863|11278518|FG007|COMPLETED|Overall Study||27
10148224|NCT02787863|11278511|FG000|NOT COMPLETED|Overall Study||1
10148225|NCT02787863|11278512|FG001|NOT COMPLETED|Overall Study||1
10148226|NCT02787863|11278513|FG002|NOT COMPLETED|Overall Study||2
10148227|NCT02787863|11278514|FG003|NOT COMPLETED|Overall Study||0
10148228|NCT02787863|11278515|FG004|NOT COMPLETED|Overall Study||0
10148229|NCT02787863|11278516|FG005|NOT COMPLETED|Overall Study||0
10148230|NCT02787863|11278517|FG006|NOT COMPLETED|Overall Study||0
10148231|NCT02787863|11278518|FG007|NOT COMPLETED|Overall Study||0
10148232|NCT02788019|11278561|FG000|STARTED|Overall Study||27
10148233|NCT02788019|11278562|FG001|STARTED|Overall Study||25
10148234|NCT02788019|11278561|FG000|COMPLETED|Overall Study||23
10148235|NCT02788019|11278562|FG001|COMPLETED|Overall Study||20
10148236|NCT02788019|11278561|FG000|NOT COMPLETED|Overall Study||4
10148237|NCT02788019|11278562|FG001|NOT COMPLETED|Overall Study||5
10148238|NCT02788097|11278570|FG000|STARTED|Overall Study||61
10148239|NCT02788097|11278571|FG001|STARTED|Overall Study||69
10148240|NCT02788097|11278570|FG000|COMPLETED|Overall Study||61
10148241|NCT02788097|11278571|FG001|COMPLETED|Overall Study||69
10148242|NCT02788097|11278570|FG000|NOT COMPLETED|Overall Study||0
10148243|NCT02788097|11278571|FG001|NOT COMPLETED|Overall Study||0
10148244|NCT02788175|11278577|FG000|STARTED|Overall Study||26
10148245|NCT02788175|11278577|FG000|Received Study Agent|Overall Study||20
10148246|NCT02788175|11278577|FG000|COMPLETED|Overall Study||13
10148247|NCT02788175|11278577|FG000|NOT COMPLETED|Overall Study||13
10148248|NCT02788188|11278588|FG000|STARTED|Overall Study||2
10148249|NCT02788188|11278589|FG001|STARTED|Overall Study||2
10148250|NCT02788188|11278590|FG002|STARTED|Overall Study||4
10148251|NCT02788188|11278591|FG003|STARTED|Overall Study||4
10148252|NCT02788188|11278592|FG004|STARTED|Overall Study||8
10148253|NCT02788188|11278593|FG005|STARTED|Overall Study||8
10148254|NCT02788188|11278594|FG006|STARTED|Overall Study||10
10148255|NCT02788188|11278588|FG000|COMPLETED|Overall Study||2
10148256|NCT02788188|11278589|FG001|COMPLETED|Overall Study||2
10148257|NCT02788188|11278590|FG002|COMPLETED|Overall Study||4
10148258|NCT02788188|11278591|FG003|COMPLETED|Overall Study||4
10148259|NCT02788188|11278592|FG004|COMPLETED|Overall Study||8
10148260|NCT02788188|11278593|FG005|COMPLETED|Overall Study||8
10148261|NCT02788188|11278594|FG006|COMPLETED|Overall Study||10
10148262|NCT02788188|11278588|FG000|NOT COMPLETED|Overall Study||0
10148263|NCT02788188|11278589|FG001|NOT COMPLETED|Overall Study||0
10148264|NCT02788188|11278590|FG002|NOT COMPLETED|Overall Study||0
10148265|NCT02788188|11278591|FG003|NOT COMPLETED|Overall Study||0
10148266|NCT02788188|11278592|FG004|NOT COMPLETED|Overall Study||0
10148267|NCT02788188|11278593|FG005|NOT COMPLETED|Overall Study||0
10148268|NCT02788188|11278594|FG006|NOT COMPLETED|Overall Study||0
10148269|NCT02788201|11278616|FG000|STARTED|Overall Study||1
10148270|NCT02788201|11278617|FG001|STARTED|Overall Study||1
10148271|NCT02788201|11278618|FG002|STARTED|Overall Study||1
10148272|NCT02788201|11278619|FG003|STARTED|Overall Study||1
10148273|NCT02788201|11278620|FG004|STARTED|Overall Study||1
10148274|NCT02788201|11278621|FG005|STARTED|Overall Study||3
10148275|NCT02788201|11278616|FG000|Did Not Start Treatment|Overall Study||0
10148276|NCT02788201|11278617|FG001|Did Not Start Treatment|Overall Study||0
10148277|NCT02788201|11278618|FG002|Did Not Start Treatment|Overall Study||0
10148278|NCT02788201|11278619|FG003|Did Not Start Treatment|Overall Study||0
10148279|NCT02788201|11278620|FG004|Did Not Start Treatment|Overall Study||0
10148280|NCT02788201|11278621|FG005|Did Not Start Treatment|Overall Study||3
10148281|NCT02788201|11278616|FG000|COMPLETED|Overall Study||0
10148282|NCT02788201|11278617|FG001|COMPLETED|Overall Study||0
10148283|NCT02788201|11278618|FG002|COMPLETED|Overall Study||0
10148284|NCT02788201|11278619|FG003|COMPLETED|Overall Study||0
10148285|NCT02788201|11278620|FG004|COMPLETED|Overall Study||1
10148286|NCT02788201|11278621|FG005|COMPLETED|Overall Study||0
10148287|NCT02788201|11278616|FG000|NOT COMPLETED|Overall Study||1
10148288|NCT02788201|11278617|FG001|NOT COMPLETED|Overall Study||1
10148289|NCT02788201|11278618|FG002|NOT COMPLETED|Overall Study||1
10148290|NCT02788201|11278619|FG003|NOT COMPLETED|Overall Study||1
10148291|NCT02788201|11278620|FG004|NOT COMPLETED|Overall Study||0
10148292|NCT02788201|11278621|FG005|NOT COMPLETED|Overall Study||3
10148293|NCT02788279|11278640|FG000|STARTED|Overall Study||90
10148294|NCT02788279|11278641|FG001|STARTED|Overall Study||183
10148295|NCT02788279|11278642|FG002|STARTED|Overall Study||90
10148296|NCT02788279|11278640|FG000|Received Treatment (Safety Population)|Overall Study||80
10148297|NCT02788279|11278641|FG001|Received Treatment (Safety Population)|Overall Study||179
10148298|NCT02788279|11278642|FG002|Received Treatment (Safety Population)|Overall Study||90
10148299|NCT02788279|11278640|FG000|Modified ITT Population|Overall Study||57
10148300|NCT02788279|11278641|FG001|Modified ITT Population|Overall Study||125
10148301|NCT02788279|11278642|FG002|Modified ITT Population|Overall Study||61
10148302|NCT02788279|11278640|FG000|COMPLETED|Overall Study||0
10148303|NCT02788279|11278641|FG001|COMPLETED|Overall Study||0
10148304|NCT02788279|11278642|FG002|COMPLETED|Overall Study||0
10148305|NCT02788279|11278640|FG000|NOT COMPLETED|Overall Study||90
10148306|NCT02788279|11278641|FG001|NOT COMPLETED|Overall Study||183
10148307|NCT02788279|11278642|FG002|NOT COMPLETED|Overall Study||90
10148308|NCT02788357|11278655|FG000|STARTED|Overall Study||6
10148309|NCT02788357|11278656|FG001|STARTED|Overall Study||6
10148310|NCT02788357|11278655|FG000|COMPLETED|Overall Study||3
10148311|NCT02788357|11278656|FG001|COMPLETED|Overall Study||6
10148312|NCT02788357|11278655|FG000|NOT COMPLETED|Overall Study||3
10148313|NCT02788357|11278656|FG001|NOT COMPLETED|Overall Study||0
10148314|NCT02788474|11278664|FG000|STARTED|Double Blind Treatment Period||231
10148315|NCT02788474|11278665|FG001|STARTED|Double Blind Treatment Period||116
10148316|NCT02788474|11278664|FG000|Treated|Double Blind Treatment Period||230
10148317|NCT02788474|11278665|FG001|Treated|Double Blind Treatment Period||116
10148318|NCT02788474|11278664|FG000|COMPLETED|Double Blind Treatment Period||221
10148319|NCT02788474|11278665|FG001|COMPLETED|Double Blind Treatment Period||112
10148320|NCT02788474|11278664|FG000|NOT COMPLETED|Double Blind Treatment Period||10
10148321|NCT02788474|11278665|FG001|NOT COMPLETED|Double Blind Treatment Period||4
10148322|NCT02788474|11278664|FG000|STARTED|Open Label Treatment Period||221
10148323|NCT02788474|11278665|FG001|STARTED|Open Label Treatment Period||112
10148324|NCT02788474|11278664|FG000|COMPLETED|Open Label Treatment Period||189
10148325|NCT02788474|11278665|FG001|COMPLETED|Open Label Treatment Period||100
10148326|NCT02788474|11278664|FG000|NOT COMPLETED|Open Label Treatment Period||32
10148327|NCT02788474|11278665|FG001|NOT COMPLETED|Open Label Treatment Period||12
10148328|NCT02788513|11278677|FG000|STARTED|Overall Study||123
10148329|NCT02788513|11278678|FG001|STARTED|Overall Study||122
10148330|NCT02788513|11278679|FG002|STARTED|Overall Study||122
10148331|NCT02788513|11278680|FG003|STARTED|Overall Study||123
10148332|NCT02788513|11278681|FG004|STARTED|Overall Study||120
10148333|NCT02788513|11278677|FG000|COMPLETED|Overall Study||114
10148334|NCT02788513|11278678|FG001|COMPLETED|Overall Study||114
10148335|NCT02788513|11278679|FG002|COMPLETED|Overall Study||114
10148336|NCT02788513|11278680|FG003|COMPLETED|Overall Study||117
10148337|NCT02788513|11278681|FG004|COMPLETED|Overall Study||115
10148338|NCT02788513|11278677|FG000|NOT COMPLETED|Overall Study||9
10148339|NCT02788513|11278678|FG001|NOT COMPLETED|Overall Study||8
10148340|NCT02788513|11278679|FG002|NOT COMPLETED|Overall Study||8
10148341|NCT02788513|11278680|FG003|NOT COMPLETED|Overall Study||6
10148342|NCT02788513|11278681|FG004|NOT COMPLETED|Overall Study||5
10148343|NCT02788656|11278695|FG000|STARTED|Overall Study||2
10148344|NCT02788656|11278696|FG001|STARTED|Overall Study||2
10148345|NCT02788656|11278695|FG000|COMPLETED|Overall Study||1
10148346|NCT02788656|11278696|FG001|COMPLETED|Overall Study||2
10148347|NCT02788656|11278695|FG000|NOT COMPLETED|Overall Study||1
10148348|NCT02788656|11278696|FG001|NOT COMPLETED|Overall Study||0
10148349|NCT02788747|11278705|FG000|STARTED|Overall Study||23
10148350|NCT02788747|11278706|FG001|STARTED|Overall Study||24
10148351|NCT02788747|11278707|FG002|STARTED|Overall Study||24
10148352|NCT02788747|11278705|FG000|COMPLETED|Overall Study||22
10148353|NCT02788747|11278706|FG001|COMPLETED|Overall Study||24
10148354|NCT02788747|11278707|FG002|COMPLETED|Overall Study||24
10148355|NCT02788747|11278705|FG000|NOT COMPLETED|Overall Study||1
10148356|NCT02788747|11278706|FG001|NOT COMPLETED|Overall Study||0
10148357|NCT02788747|11278707|FG002|NOT COMPLETED|Overall Study||0
10148358|NCT02788903|11278720|FG000|STARTED|Overall Study||567908
10148359|NCT02788903|11278721|FG001|STARTED|Overall Study||2054256
10148360|NCT02788903|11278720|FG000|COMPLETED|Overall Study||567908
10148361|NCT02788903|11278721|FG001|COMPLETED|Overall Study||2054256
10148362|NCT02788903|11278720|FG000|NOT COMPLETED|Overall Study||0
10148363|NCT02788903|11278721|FG001|NOT COMPLETED|Overall Study||0
10148364|NCT02789033|11278733|FG000|STARTED|Overall Study||17
10148365|NCT02789033|11278734|FG001|STARTED|Overall Study||17
10148366|NCT02789033|11278735|FG002|STARTED|Overall Study||17
10148367|NCT02789033|11278736|FG003|STARTED|Overall Study||17
10148368|NCT02789033|11278733|FG000|COMPLETED|Overall Study||15
10148369|NCT02789033|11278734|FG001|COMPLETED|Overall Study||15
10148370|NCT02789033|11278735|FG002|COMPLETED|Overall Study||16
10148371|NCT02789033|11278736|FG003|COMPLETED|Overall Study||15
10148372|NCT02789033|11278733|FG000|NOT COMPLETED|Overall Study||2
10148373|NCT02789033|11278734|FG001|NOT COMPLETED|Overall Study||2
10148374|NCT02789033|11278735|FG002|NOT COMPLETED|Overall Study||1
10148375|NCT02789033|11278736|FG003|NOT COMPLETED|Overall Study||2
10148376|NCT02789111|11278748|FG000|STARTED|Overall Study||24
10148377|NCT02789111|11278749|FG001|STARTED|Overall Study||25
10148378|NCT02789111|11278748|FG000|COMPLETED|Overall Study||23
10148379|NCT02789111|11278749|FG001|COMPLETED|Overall Study||21
10148380|NCT02789111|11278748|FG000|NOT COMPLETED|Overall Study||1
10148381|NCT02789111|11278749|FG001|NOT COMPLETED|Overall Study||4
10148382|NCT02789137|11278757|FG000|STARTED|Overall Study||111
10148383|NCT02789137|11278757|FG000|COMPLETED|Overall Study||53
10148384|NCT02789137|11278757|FG000|NOT COMPLETED|Overall Study||58
10148385|NCT02789176|11278766|FG000|STARTED|Overall Study||99
10148386|NCT02789176|11278767|FG001|STARTED|Overall Study||55
10148387|NCT02789176|11278768|FG002|STARTED|Overall Study||95
10148388|NCT02789176|11278769|FG003|STARTED|Overall Study||54
10148389|NCT02789176|11278766|FG000|COMPLETED|Overall Study||91
10148390|NCT02789176|11278767|FG001|COMPLETED|Overall Study||53
10148391|NCT02789176|11278768|FG002|COMPLETED|Overall Study||85
10148392|NCT02789176|11278769|FG003|COMPLETED|Overall Study||53
10148393|NCT02789176|11278766|FG000|NOT COMPLETED|Overall Study||8
10148394|NCT02789176|11278767|FG001|NOT COMPLETED|Overall Study||2
9709131|NCT01983774|10808417|FG001|NOT COMPLETED|Overall Study||1
9709132|NCT01974206|10808427|FG000|STARTED|Overall Study||74
9709133|NCT01974206|10808428|FG001|STARTED|Overall Study||76
9709134|NCT01974206|10808427|FG000|Received Treatment|Overall Study||74
9709135|NCT01974206|10808428|FG001|Received Treatment|Overall Study||75
9709136|NCT01974206|10808427|FG000|COMPLETED|Overall Study||68
10148395|NCT02789176|11278768|FG002|NOT COMPLETED|Overall Study||10
10148396|NCT02789176|11278769|FG003|NOT COMPLETED|Overall Study||1
10148397|NCT02789410|11278781|FG000|STARTED|Overall Study||66
10148398|NCT02789410|11278782|FG001|STARTED|Overall Study||68
10148399|NCT02789410|11278781|FG000|COMPLETED|Overall Study||66
10148400|NCT02789410|11278782|FG001|COMPLETED|Overall Study||68
10148401|NCT02789410|11278781|FG000|NOT COMPLETED|Overall Study||0
10148402|NCT02789410|11278782|FG001|NOT COMPLETED|Overall Study||0
10148403|NCT02790073|11278788|FG000|STARTED|Overall Study||14
10148404|NCT02790073|11278788|FG000|COMPLETED|Overall Study||11
10148405|NCT02790073|11278788|FG000|NOT COMPLETED|Overall Study||3
10148406|NCT02790281|11278792|FG000|STARTED|Overall Study||33
10148407|NCT02790281|11278792|FG000|COMPLETED|Overall Study||33
10148408|NCT02790281|11278792|FG000|NOT COMPLETED|Overall Study||0
10148409|NCT02790437|11278798|FG000|STARTED|Overall Study||16
10148410|NCT02790437|11278799|FG001|STARTED|Overall Study||3
10148411|NCT02790437|11278798|FG000|COMPLETED|Overall Study||13
10148412|NCT02790437|11278799|FG001|COMPLETED|Overall Study||3
9709137|NCT01974206|10808428|FG001|COMPLETED|Overall Study||75
9709138|NCT01974206|10808427|FG000|NOT COMPLETED|Overall Study||6
9709139|NCT01974206|10808428|FG001|NOT COMPLETED|Overall Study||1
9709140|NCT01970865|10808451|FG000|STARTED|Overall Study||3
9709141|NCT01970865|10808452|FG001|STARTED|Overall Study||3
9709142|NCT01970865|10808453|FG002|STARTED|Overall Study||3
9709143|NCT01970865|10808454|FG003|STARTED|Overall Study||13
9709144|NCT01970865|10808455|FG004|STARTED|Overall Study||17
9709145|NCT01970865|10808456|FG005|STARTED|Overall Study||3
9709146|NCT01970865|10808457|FG006|STARTED|Overall Study||3
9963913|NCT01489358|11083721|FG002|STARTED|Overall Study||10
9963914|NCT01489358|11083719|FG000|COMPLETED|Overall Study||5
9963915|NCT01489358|11083720|FG001|COMPLETED|Overall Study||10
9963916|NCT01489358|11083721|FG002|COMPLETED|Overall Study||8
9963917|NCT01489358|11083719|FG000|NOT COMPLETED|Overall Study||0
9963918|NCT01489358|11083720|FG001|NOT COMPLETED|Overall Study||0
9848944|NCT00862849|10961754|FG002|STARTED|Intervention 2||3
9848945|NCT00862849|10961755|FG003|STARTED|Intervention 2||4
9848946|NCT00862849|10961756|FG004|STARTED|Intervention 2||4
9848947|NCT00862849|10961757|FG005|STARTED|Intervention 2||3
9848948|NCT00862849|10961752|FG000|COMPLETED|Intervention 2||3
9848949|NCT00862849|10961753|FG001|COMPLETED|Intervention 2||4
9848950|NCT00862849|10961754|FG002|COMPLETED|Intervention 2||3
9848951|NCT00862849|10961755|FG003|COMPLETED|Intervention 2||4
9848952|NCT00862849|10961756|FG004|COMPLETED|Intervention 2||4
9848953|NCT00862849|10961757|FG005|COMPLETED|Intervention 2||3
9848954|NCT00862849|10961752|FG000|NOT COMPLETED|Intervention 2||0
9848955|NCT00862849|10961753|FG001|NOT COMPLETED|Intervention 2||0
9848956|NCT00862849|10961754|FG002|NOT COMPLETED|Intervention 2||0
9848957|NCT00862849|10961755|FG003|NOT COMPLETED|Intervention 2||0
9848958|NCT00862849|10961756|FG004|NOT COMPLETED|Intervention 2||0
9848959|NCT00862849|10961757|FG005|NOT COMPLETED|Intervention 2||0
9848960|NCT00862849|10961752|FG000|STARTED|Washout 2 (3 to 14 Days)||3
9848961|NCT00862849|10961753|FG001|STARTED|Washout 2 (3 to 14 Days)||4
10148413|NCT02790437|11278798|FG000|NOT COMPLETED|Overall Study||3
10148414|NCT02790437|11278799|FG001|NOT COMPLETED|Overall Study||0
10148415|NCT02790463|11278814|FG000|STARTED|Overall Study||782
10148416|NCT02790463|11278815|FG001|STARTED|Overall Study||681
10148417|NCT02790463|11278814|FG000|COMPLETED|Overall Study||782
10148418|NCT02790463|11278815|FG001|COMPLETED|Overall Study||372
10148419|NCT02790463|11278814|FG000|NOT COMPLETED|Overall Study||0
10148420|NCT02790463|11278815|FG001|NOT COMPLETED|Overall Study||309
9709147|NCT01970865|10808458|FG007|STARTED|Overall Study||3
9709148|NCT01970865|10808459|FG008|STARTED|Overall Study||3
9709149|NCT01970865|10808460|FG009|STARTED|Overall Study||4
9709150|NCT01970865|10808461|FG010|STARTED|Overall Study||30
10148421|NCT02790606|11278821|FG000|STARTED|Overall Study||110
10148422|NCT02790606|11278821|FG000|COMPLETED|Overall Study||75
10148423|NCT02790606|11278821|FG000|NOT COMPLETED|Overall Study||35
10148424|NCT02790736|11278827|FG000|STARTED|Overall Study||5
10148425|NCT02790736|11278828|FG001|STARTED|Overall Study||1
10148426|NCT02790736|11278827|FG000|COMPLETED|Overall Study||5
10148427|NCT02790736|11278828|FG001|COMPLETED|Overall Study||1
10148428|NCT02790736|11278827|FG000|NOT COMPLETED|Overall Study||0
10148429|NCT02790736|11278828|FG001|NOT COMPLETED|Overall Study||0
10148430|NCT02790788|11278836|FG000|STARTED|Overall Study||46
10148431|NCT02790788|11278837|FG001|STARTED|Overall Study||54
10148432|NCT02790788|11278836|FG000|COMPLETED|Overall Study||46
9709151|NCT01970865|10808462|FG011|STARTED|Overall Study||27
9709152|NCT01970865|10808463|FG012|STARTED|Overall Study||60
9709153|NCT01970865|10808464|FG013|STARTED|Overall Study||66
9709154|NCT01970865|10808465|FG014|STARTED|Overall Study||46
9709155|NCT01970865|10808466|FG015|STARTED|Overall Study||47
9709156|NCT01970865|10808467|FG016|STARTED|Overall Study||3
9709157|NCT01970865|10808451|FG000|Received Treatment|Overall Study||3
9709158|NCT01970865|10808452|FG001|Received Treatment|Overall Study||3
9709159|NCT01970865|10808453|FG002|Received Treatment|Overall Study||3
9709160|NCT01970865|10808454|FG003|Received Treatment|Overall Study||12
9709161|NCT01970865|10808455|FG004|Received Treatment|Overall Study||17
9709162|NCT01970865|10808456|FG005|Received Treatment|Overall Study||3
9709163|NCT01970865|10808457|FG006|Received Treatment|Overall Study||3
9709164|NCT01970865|10808458|FG007|Received Treatment|Overall Study||3
9709165|NCT01970865|10808459|FG008|Received Treatment|Overall Study||3
9709166|NCT01970865|10808460|FG009|Received Treatment|Overall Study||4
9709167|NCT01970865|10808461|FG010|Received Treatment|Overall Study||30
9709168|NCT01970865|10808462|FG011|Received Treatment|Overall Study||27
9709169|NCT01970865|10808463|FG012|Received Treatment|Overall Study||60
9709170|NCT01970865|10808464|FG013|Received Treatment|Overall Study||65
9709171|NCT01970865|10808465|FG014|Received Treatment|Overall Study||46
9709172|NCT01970865|10808466|FG015|Received Treatment|Overall Study||47
9709173|NCT01970865|10808467|FG016|Received Treatment|Overall Study||3
9709174|NCT01970865|10808451|FG000|COMPLETED|Overall Study||0
9709175|NCT01970865|10808452|FG001|COMPLETED|Overall Study||0
9709176|NCT01970865|10808453|FG002|COMPLETED|Overall Study||0
9709177|NCT01970865|10808454|FG003|COMPLETED|Overall Study||0
10148433|NCT02790788|11278837|FG001|COMPLETED|Overall Study||54
10148434|NCT02790788|11278836|FG000|NOT COMPLETED|Overall Study||0
9709178|NCT01970865|10808455|FG004|COMPLETED|Overall Study||0
9709179|NCT01970865|10808456|FG005|COMPLETED|Overall Study||0
9709180|NCT01970865|10808457|FG006|COMPLETED|Overall Study||0
9709181|NCT01970865|10808458|FG007|COMPLETED|Overall Study||0
10148435|NCT02790788|11278837|FG001|NOT COMPLETED|Overall Study||0
10148436|NCT02791191|11278848|FG000|STARTED|Overall Study||55
10148437|NCT02791191|11278849|FG001|STARTED|Overall Study||128
10148438|NCT02791191|11278850|FG002|STARTED|Overall Study||133
10148439|NCT02791191|11278848|FG000|Received One Dose of Study Drug|Overall Study||55
10148440|NCT02791191|11278849|FG001|Received One Dose of Study Drug|Overall Study||127
10148441|NCT02791191|11278850|FG002|Received One Dose of Study Drug|Overall Study||133
10148442|NCT02791191|11278848|FG000|COMPLETED|Overall Study||17
10148443|NCT02791191|11278849|FG001|COMPLETED|Overall Study||17
10148444|NCT02791191|11278850|FG002|COMPLETED|Overall Study||13
10148445|NCT02791191|11278848|FG000|NOT COMPLETED|Overall Study||38
10148446|NCT02791191|11278849|FG001|NOT COMPLETED|Overall Study||111
10148447|NCT02791191|11278850|FG002|NOT COMPLETED|Overall Study||120
10148448|NCT02791269|11278860|FG000|STARTED|Overall Study||4
10148449|NCT02791269|11278861|FG001|STARTED|Overall Study||20
10148450|NCT02791269|11278860|FG000|COMPLETED|Overall Study||4
10148451|NCT02791269|11278861|FG001|COMPLETED|Overall Study||19
10148452|NCT02791269|11278860|FG000|NOT COMPLETED|Overall Study||0
10148453|NCT02791269|11278861|FG001|NOT COMPLETED|Overall Study||1
10148454|NCT02791308|11278872|FG000|STARTED|Overall Study||195
10148455|NCT02791308|11278873|FG001|STARTED|Overall Study||196
10148456|NCT02791308|11278874|FG002|STARTED|Overall Study||196
10148457|NCT02791308|11278872|FG000|COMPLETED|Overall Study||185
10148458|NCT02791308|11278873|FG001|COMPLETED|Overall Study||187
10148459|NCT02791308|11278874|FG002|COMPLETED|Overall Study||179
10148460|NCT02791308|11278872|FG000|NOT COMPLETED|Overall Study||10
10148461|NCT02791308|11278873|FG001|NOT COMPLETED|Overall Study||9
10148462|NCT02791308|11278874|FG002|NOT COMPLETED|Overall Study||17
10196971|NCT03367793|11324974|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10196972|NCT03367793|11324975|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10196973|NCT03367793|11324976|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10196974|NCT03367793|11324977|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10196975|NCT03367793|11324978|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10196976|NCT03367793|11324979|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10196977|NCT03367793|11324974|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10196978|NCT03367793|11324975|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10196979|NCT03367793|11324976|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10196980|NCT03367793|11324977|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10196981|NCT03367793|11324978|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10196982|NCT03367793|11324979|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10196983|NCT03367793|11324974|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10196984|NCT03367793|11324975|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10196985|NCT03367793|11324976|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4
10196986|NCT03367793|11324977|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10196987|NCT03367793|11324978|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10196988|NCT03367793|11324979|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10196989|NCT03367793|11324974|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10196990|NCT03367793|11324975|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10196991|NCT03367793|11324976|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1
10196992|NCT03367793|11324977|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10196993|NCT03367793|11324978|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10196994|NCT03367793|11324979|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10196995|NCT03367793|11324974|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10196996|NCT03367793|11324975|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10196997|NCT03367793|11324976|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10196998|NCT03367793|11324977|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10196999|NCT03367793|11324978|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10197000|NCT03367793|11324979|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10197001|NCT03367793|11324974|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10197002|NCT03367793|11324975|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
9709182|NCT01970865|10808459|FG008|COMPLETED|Overall Study||0
9709183|NCT01970865|10808460|FG009|COMPLETED|Overall Study||0
9709184|NCT01970865|10808461|FG010|COMPLETED|Overall Study||0
10197003|NCT03367793|11324976|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10197004|NCT03367793|11324977|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10197005|NCT03367793|11324978|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10197006|NCT03367793|11324979|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10197007|NCT03367793|11324974|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10197008|NCT03367793|11324975|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10197009|NCT03367793|11324976|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10197010|NCT03367793|11324977|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10197011|NCT03367793|11324978|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10197012|NCT03367793|11324979|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10197013|NCT03368053|11324990|FG000|STARTED|Overall Study||36
10197014|NCT03368053|11324990|FG000|COMPLETED|Overall Study||36
10197015|NCT03368053|11324990|FG000|NOT COMPLETED|Overall Study||0
9709185|NCT01970865|10808462|FG011|COMPLETED|Overall Study||0
9709186|NCT01970865|10808463|FG012|COMPLETED|Overall Study||0
9709187|NCT01970865|10808464|FG013|COMPLETED|Overall Study||0
9709188|NCT01970865|10808465|FG014|COMPLETED|Overall Study||0
9709189|NCT01970865|10808466|FG015|COMPLETED|Overall Study||0
9709190|NCT01970865|10808467|FG016|COMPLETED|Overall Study||0
9709191|NCT01970865|10808451|FG000|NOT COMPLETED|Overall Study||3
10148463|NCT02791399|11278884|FG000|STARTED|Overall Study||136
10148464|NCT02791399|11278885|FG001|STARTED|Overall Study||150
10148465|NCT02791399|11278884|FG000|COMPLETED|Overall Study||123
10148466|NCT02791399|11278885|FG001|COMPLETED|Overall Study||135
10148467|NCT02791399|11278884|FG000|NOT COMPLETED|Overall Study||13
10148468|NCT02791399|11278885|FG001|NOT COMPLETED|Overall Study||15
10148469|NCT02791438|11278893|FG000|STARTED|Run-In Period||22
10148470|NCT02791438|11278894|FG001|STARTED|Run-In Period||5
10148471|NCT02791438|11278893|FG000|COMPLETED|Run-In Period||22
10148472|NCT02791438|11278894|FG001|COMPLETED|Run-In Period||5
10148473|NCT02791438|11278893|FG000|NOT COMPLETED|Run-In Period||0
10148474|NCT02791438|11278894|FG001|NOT COMPLETED|Run-In Period||0
10148475|NCT02791438|11278893|FG000|STARTED|Treatment Period||22
10148476|NCT02791438|11278894|FG001|STARTED|Treatment Period||5
10148477|NCT02791438|11278893|FG000|COMPLETED|Treatment Period||19
10148478|NCT02791438|11278894|FG001|COMPLETED|Treatment Period||4
10148479|NCT02791438|11278893|FG000|NOT COMPLETED|Treatment Period||3
10148480|NCT02791438|11278894|FG001|NOT COMPLETED|Treatment Period||1
10148481|NCT02791490|11278902|FG000|STARTED|Overall Study||229
10148482|NCT02791490|11278903|FG001|STARTED|Overall Study||229
10148483|NCT02791490|11278902|FG000|COMPLETED|Overall Study||226
10148484|NCT02791490|11278903|FG001|COMPLETED|Overall Study||221
10148485|NCT02791490|11278902|FG000|NOT COMPLETED|Overall Study||3
10148486|NCT02791490|11278903|FG001|NOT COMPLETED|Overall Study||8
10148487|NCT02791516|11278911|FG000|STARTED|Overall Study||33
10148488|NCT02791516|11278912|FG001|STARTED|Overall Study||34
10148489|NCT02791516|11278911|FG000|Completed 6-month Treatment Period|Overall Study||33
10148490|NCT02791516|11278912|FG001|Completed 6-month Treatment Period|Overall Study||33
10148491|NCT02791516|11278911|FG000|COMPLETED|Overall Study||32
10148492|NCT02791516|11278912|FG001|COMPLETED|Overall Study||33
10148493|NCT02791516|11278911|FG000|NOT COMPLETED|Overall Study||1
10148494|NCT02791516|11278912|FG001|NOT COMPLETED|Overall Study||1
10148495|NCT02791659|11278920|FG000|STARTED|Overall Study||27
10148496|NCT02791659|11278921|FG001|STARTED|Overall Study||28
10148497|NCT02791659|11278920|FG000|COMPLETED|Overall Study||27
10148498|NCT02791659|11278921|FG001|COMPLETED|Overall Study||27
10148499|NCT02791659|11278920|FG000|NOT COMPLETED|Overall Study||0
10148500|NCT02791659|11278921|FG001|NOT COMPLETED|Overall Study||1
10148501|NCT02791763|11278930|FG000|STARTED|Overall Study||149
10148502|NCT02791763|11278931|FG001|STARTED|Overall Study||150
10148503|NCT02791763|11278932|FG002|STARTED|Overall Study||56
10148504|NCT02791763|11278930|FG000|COMPLETED|Overall Study||111
10148505|NCT02791763|11278931|FG001|COMPLETED|Overall Study||113
10148506|NCT02791763|11278932|FG002|COMPLETED|Overall Study||43
10148507|NCT02791763|11278930|FG000|NOT COMPLETED|Overall Study||38
10148508|NCT02791763|11278931|FG001|NOT COMPLETED|Overall Study||37
10148509|NCT02791763|11278932|FG002|NOT COMPLETED|Overall Study||13
10148510|NCT02791893|11278951|FG000|STARTED|Blinded Phase||13
10148511|NCT02791893|11278952|FG001|STARTED|Blinded Phase||14
10148512|NCT02791893|11278951|FG000|COMPLETED|Blinded Phase||10
10148513|NCT02791893|11278952|FG001|COMPLETED|Blinded Phase||10
10148514|NCT02791893|11278951|FG000|NOT COMPLETED|Blinded Phase||3
10148515|NCT02791893|11278952|FG001|NOT COMPLETED|Blinded Phase||4
10148516|NCT02791893|11278951|FG000|STARTED|Open Label Phase||10
10148517|NCT02791893|11278952|FG001|STARTED|Open Label Phase||10
10148518|NCT02791893|11278951|FG000|COMPLETED|Open Label Phase||7
10148519|NCT02791893|11278952|FG001|COMPLETED|Open Label Phase||8
10148520|NCT02791893|11278951|FG000|NOT COMPLETED|Open Label Phase||3
10148521|NCT02791893|11278952|FG001|NOT COMPLETED|Open Label Phase||2
10148522|NCT02791906|11278960|FG000|STARTED|Overall Study||4
10148523|NCT02791906|11278961|FG001|STARTED|Overall Study||3
10148524|NCT02791906|11278960|FG000|COMPLETED|Overall Study||2
10148525|NCT02791906|11278961|FG001|COMPLETED|Overall Study||2
10148526|NCT02791906|11278960|FG000|NOT COMPLETED|Overall Study||2
10148527|NCT02791906|11278961|FG001|NOT COMPLETED|Overall Study||1
10148528|NCT02791945|11278971|FG000|STARTED|Overall Study||14
10148529|NCT02791945|11278972|FG001|STARTED|Overall Study||16
10148530|NCT02791945|11278971|FG000|COMPLETED|Overall Study||12
10148531|NCT02791945|11278972|FG001|COMPLETED|Overall Study||14
10148532|NCT02791945|11278971|FG000|NOT COMPLETED|Overall Study||2
10148533|NCT02791945|11278972|FG001|NOT COMPLETED|Overall Study||2
10148534|NCT02792049|11278980|FG000|STARTED|Overall Study||35
10148535|NCT02792049|11278981|FG001|STARTED|Overall Study||35
10148536|NCT02792049|11278980|FG000|COMPLETED|Overall Study||35
10148537|NCT02792049|11278981|FG001|COMPLETED|Overall Study||35
10148538|NCT02792049|11278980|FG000|NOT COMPLETED|Overall Study||0
10148539|NCT02792049|11278981|FG001|NOT COMPLETED|Overall Study||0
10148540|NCT02792062|11278995|FG000|STARTED|Intervention Period 1 (6 Days)||2
10148541|NCT02792062|11278996|FG001|STARTED|Intervention Period 1 (6 Days)||2
10148542|NCT02792062|11278997|FG002|STARTED|Intervention Period 1 (6 Days)||2
10148543|NCT02792062|11278998|FG003|STARTED|Intervention Period 1 (6 Days)||2
10148544|NCT02792062|11278999|FG004|STARTED|Intervention Period 1 (6 Days)||2
10148545|NCT02792062|11279000|FG005|STARTED|Intervention Period 1 (6 Days)||2
10148546|NCT02792062|11278995|FG000|COMPLETED|Intervention Period 1 (6 Days)||2
10148547|NCT02792062|11278996|FG001|COMPLETED|Intervention Period 1 (6 Days)||2
10148548|NCT02792062|11278997|FG002|COMPLETED|Intervention Period 1 (6 Days)||2
10148549|NCT02792062|11278998|FG003|COMPLETED|Intervention Period 1 (6 Days)||2
10148550|NCT02792062|11278999|FG004|COMPLETED|Intervention Period 1 (6 Days)||2
10148551|NCT02792062|11279000|FG005|COMPLETED|Intervention Period 1 (6 Days)||2
10148552|NCT02792062|11278995|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10148553|NCT02792062|11278996|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10148554|NCT02792062|11278997|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10148555|NCT02792062|11278998|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10148556|NCT02792062|11278999|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10148557|NCT02792062|11279000|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10148558|NCT02792062|11278995|FG000|STARTED|Washout Period (at Least 14 Days)||2
10148559|NCT02792062|11278996|FG001|STARTED|Washout Period (at Least 14 Days)||2
10148560|NCT02792062|11278997|FG002|STARTED|Washout Period (at Least 14 Days)||2
10148561|NCT02792062|11278998|FG003|STARTED|Washout Period (at Least 14 Days)||2
10148562|NCT02792062|11278999|FG004|STARTED|Washout Period (at Least 14 Days)||2
10148563|NCT02792062|11279000|FG005|STARTED|Washout Period (at Least 14 Days)||2
10148564|NCT02792062|11278995|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
10148565|NCT02792062|11278996|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
10148566|NCT02792062|11278997|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
10148567|NCT02792062|11278998|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
10148568|NCT02792062|11278999|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
10148569|NCT02792062|11279000|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
10148570|NCT02792062|11278995|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148571|NCT02792062|11278996|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148572|NCT02792062|11278997|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148573|NCT02792062|11278998|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148574|NCT02792062|11278999|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148575|NCT02792062|11279000|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148576|NCT02792062|11278995|FG000|STARTED|Intervention Period 2 (6 Days)||2
10148577|NCT02792062|11278996|FG001|STARTED|Intervention Period 2 (6 Days)||2
10148578|NCT02792062|11278997|FG002|STARTED|Intervention Period 2 (6 Days)||2
10148579|NCT02792062|11278998|FG003|STARTED|Intervention Period 2 (6 Days)||2
10148580|NCT02792062|11278999|FG004|STARTED|Intervention Period 2 (6 Days)||2
10148581|NCT02792062|11279000|FG005|STARTED|Intervention Period 2 (6 Days)||2
10148582|NCT02792062|11278995|FG000|COMPLETED|Intervention Period 2 (6 Days)||2
10148583|NCT02792062|11278996|FG001|COMPLETED|Intervention Period 2 (6 Days)||2
10148584|NCT02792062|11278997|FG002|COMPLETED|Intervention Period 2 (6 Days)||2
10148585|NCT02792062|11278998|FG003|COMPLETED|Intervention Period 2 (6 Days)||2
10148586|NCT02792062|11278999|FG004|COMPLETED|Intervention Period 2 (6 Days)||2
10148587|NCT02792062|11279000|FG005|COMPLETED|Intervention Period 2 (6 Days)||2
10148588|NCT02792062|11278995|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10148589|NCT02792062|11278996|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10148590|NCT02792062|11278997|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10148591|NCT02792062|11278998|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10148592|NCT02792062|11278999|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0
9709192|NCT01970865|10808452|FG001|NOT COMPLETED|Overall Study||3
10148593|NCT02792062|11279000|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10148594|NCT02792062|11278995|FG000|STARTED|Washout Period (at Least 14 Days)||2
10148595|NCT02792062|11278996|FG001|STARTED|Washout Period (at Least 14 Days)||2
10148596|NCT02792062|11278997|FG002|STARTED|Washout Period (at Least 14 Days)||2
10148597|NCT02792062|11278998|FG003|STARTED|Washout Period (at Least 14 Days)||2
10148598|NCT02792062|11278999|FG004|STARTED|Washout Period (at Least 14 Days)||2
10148599|NCT02792062|11279000|FG005|STARTED|Washout Period (at Least 14 Days)||2
10148600|NCT02792062|11278995|FG000|COMPLETED|Washout Period (at Least 14 Days)||1
10148601|NCT02792062|11278996|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
10148602|NCT02792062|11278997|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
10148603|NCT02792062|11278998|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
10148604|NCT02792062|11278999|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
10148605|NCT02792062|11279000|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
10148606|NCT02792062|11278995|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1
10148607|NCT02792062|11278996|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148608|NCT02792062|11278997|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148609|NCT02792062|11278998|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148610|NCT02792062|11278999|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148611|NCT02792062|11279000|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10148612|NCT02792062|11278995|FG000|STARTED|Intervention Period 3 (6 Days)||1
10148613|NCT02792062|11278996|FG001|STARTED|Intervention Period 3 (6 Days)||2
10148614|NCT02792062|11278997|FG002|STARTED|Intervention Period 3 (6 Days)||2
10148615|NCT02792062|11278998|FG003|STARTED|Intervention Period 3 (6 Days)||2
10148616|NCT02792062|11278999|FG004|STARTED|Intervention Period 3 (6 Days)||2
10148617|NCT02792062|11279000|FG005|STARTED|Intervention Period 3 (6 Days)||2
10148618|NCT02792062|11278995|FG000|COMPLETED|Intervention Period 3 (6 Days)||1
10148619|NCT02792062|11278996|FG001|COMPLETED|Intervention Period 3 (6 Days)||2
10148620|NCT02792062|11278997|FG002|COMPLETED|Intervention Period 3 (6 Days)||2
10148621|NCT02792062|11278998|FG003|COMPLETED|Intervention Period 3 (6 Days)||2
10148622|NCT02792062|11278999|FG004|COMPLETED|Intervention Period 3 (6 Days)||2
10148623|NCT02792062|11279000|FG005|COMPLETED|Intervention Period 3 (6 Days)||2
10148624|NCT02792062|11278995|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0
9709193|NCT01970865|10808453|FG002|NOT COMPLETED|Overall Study||3
10148625|NCT02792062|11278996|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10148626|NCT02792062|11278997|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10148627|NCT02792062|11278998|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10148628|NCT02792062|11278999|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10148629|NCT02792062|11279000|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10148630|NCT02792192|11279012|FG000|STARTED|Overall Study||12
10148631|NCT02792192|11279013|FG001|STARTED|Overall Study||12
10148632|NCT02792192|11279014|FG002|STARTED|Overall Study||0
10148633|NCT02792192|11279015|FG003|STARTED|Overall Study||0
10148634|NCT02792192|11279012|FG000|COMPLETED|Overall Study||0
10148635|NCT02792192|11279013|FG001|COMPLETED|Overall Study||1
10148636|NCT02792192|11279014|FG002|COMPLETED|Overall Study||0
10148637|NCT02792192|11279015|FG003|COMPLETED|Overall Study||0
10148638|NCT02792192|11279012|FG000|NOT COMPLETED|Overall Study||12
10148639|NCT02792192|11279013|FG001|NOT COMPLETED|Overall Study||11
10148640|NCT02792192|11279014|FG002|NOT COMPLETED|Overall Study||0
10148641|NCT02792192|11279015|FG003|NOT COMPLETED|Overall Study||0
10148642|NCT02792218|11279028|FG000|STARTED|Overall Study||465
10148643|NCT02792218|11279029|FG001|STARTED|Overall Study||462
10148644|NCT02792218|11279028|FG000|COMPLETED|Overall Study||416
10148645|NCT02792218|11279029|FG001|COMPLETED|Overall Study||381
10148646|NCT02792218|11279028|FG000|NOT COMPLETED|Overall Study||49
10148647|NCT02792218|11279029|FG001|NOT COMPLETED|Overall Study||81
10148648|NCT02792231|11279037|FG000|STARTED|Overall Study||481
10148649|NCT02792231|11279038|FG001|STARTED|Overall Study||474
10148650|NCT02792231|11279037|FG000|COMPLETED|Overall Study||399
10148651|NCT02792231|11279038|FG001|COMPLETED|Overall Study||390
10148652|NCT02792231|11279037|FG000|NOT COMPLETED|Overall Study||82
10148653|NCT02792231|11279038|FG001|NOT COMPLETED|Overall Study||84
10148654|NCT02792504|11279044|FG000|STARTED|Overall Study||669
10148655|NCT02792504|11279044|FG000|Safety Analysis Set|Overall Study||639
10148656|NCT02792504|11279044|FG000|Efficacy Analysis Set|Overall Study||390
10148657|NCT02792504|11279044|FG000|COMPLETED|Overall Study||639
10148658|NCT02792504|11279044|FG000|NOT COMPLETED|Overall Study||30
10148659|NCT02792517|11279048|FG000|STARTED|Overall Study||41
10148660|NCT02792517|11279048|FG000|Received Erenumab|Overall Study||24
10148661|NCT02792517|11279048|FG000|COMPLETED|Overall Study||21
10148662|NCT02792517|11279048|FG000|NOT COMPLETED|Overall Study||20
10148663|NCT02792699|11279055|FG000|STARTED|Overall Study||104
10148664|NCT02792699|11279056|FG001|STARTED|Overall Study||104
10148665|NCT02792699|11279057|FG002|STARTED|Overall Study||103
10148666|NCT02792699|11279055|FG000|Received First Infusion of First Dose|Overall Study||104
10148667|NCT02792699|11279056|FG001|Received First Infusion of First Dose|Overall Study||104
10148668|NCT02792699|11279057|FG002|Received First Infusion of First Dose|Overall Study||103
10148669|NCT02792699|11279055|FG000|Received Second Infusion of First Dose|Overall Study||102
10148670|NCT02792699|11279056|FG001|Received Second Infusion of First Dose|Overall Study||103
10148671|NCT02792699|11279057|FG002|Received Second Infusion of First Dose|Overall Study||99
10148672|NCT02792699|11279055|FG000|Received First Infusion of Second Dose|Overall Study||97
10148673|NCT02792699|11279056|FG001|Received First Infusion of Second Dose|Overall Study||99
10148674|NCT02792699|11279057|FG002|Received First Infusion of Second Dose|Overall Study||95
10148675|NCT02792699|11279055|FG000|Received Second Infusion of Second Dose|Overall Study||97
10148676|NCT02792699|11279056|FG001|Received Second Infusion of Second Dose|Overall Study||99
10148677|NCT02792699|11279057|FG002|Received Second Infusion of Second Dose|Overall Study||93
10148678|NCT02792699|11279055|FG000|COMPLETED|Overall Study||95
10148679|NCT02792699|11279056|FG001|COMPLETED|Overall Study||94
10148680|NCT02792699|11279057|FG002|COMPLETED|Overall Study||93
10148681|NCT02792699|11279055|FG000|NOT COMPLETED|Overall Study||9
10148682|NCT02792699|11279056|FG001|NOT COMPLETED|Overall Study||10
10148683|NCT02792699|11279057|FG002|NOT COMPLETED|Overall Study||10
10148684|NCT02792777|11279074|FG000|STARTED|Overall Study||96
10148685|NCT02792777|11279075|FG001|STARTED|Overall Study||52
10148686|NCT02792777|11279074|FG000|COMPLETED|Overall Study||89
10148687|NCT02792777|11279075|FG001|COMPLETED|Overall Study||52
10148688|NCT02792777|11279074|FG000|NOT COMPLETED|Overall Study||7
10148689|NCT02792777|11279075|FG001|NOT COMPLETED|Overall Study||0
10148690|NCT02792829|11279090|FG000|STARTED|Treatment Period 1||10
10148691|NCT02792829|11279091|FG001|STARTED|Treatment Period 1||10
10148692|NCT02792829|11279092|FG002|STARTED|Treatment Period 1||5
10148693|NCT02792829|11279093|FG003|STARTED|Treatment Period 1||5
10148694|NCT02792829|11279094|FG004|STARTED|Treatment Period 1||5
10148695|NCT02792829|11279095|FG005|STARTED|Treatment Period 1||5
10148696|NCT02792829|11279096|FG006|STARTED|Treatment Period 1||10
10148697|NCT02792829|11279097|FG007|STARTED|Treatment Period 1||10
10148698|NCT02792829|11279090|FG000|COMPLETED|Treatment Period 1||10
10148699|NCT02792829|11279091|FG001|COMPLETED|Treatment Period 1||10
10148700|NCT02792829|11279092|FG002|COMPLETED|Treatment Period 1||5
10148701|NCT02792829|11279093|FG003|COMPLETED|Treatment Period 1||5
10148702|NCT02792829|11279094|FG004|COMPLETED|Treatment Period 1||5
10148703|NCT02792829|11279095|FG005|COMPLETED|Treatment Period 1||5
10148704|NCT02792829|11279096|FG006|COMPLETED|Treatment Period 1||10
10148705|NCT02792829|11279097|FG007|COMPLETED|Treatment Period 1||10
10148706|NCT02792829|11279090|FG000|NOT COMPLETED|Treatment Period 1||0
10148707|NCT02792829|11279091|FG001|NOT COMPLETED|Treatment Period 1||0
10148708|NCT02792829|11279092|FG002|NOT COMPLETED|Treatment Period 1||0
10148709|NCT02792829|11279093|FG003|NOT COMPLETED|Treatment Period 1||0
10148710|NCT02792829|11279094|FG004|NOT COMPLETED|Treatment Period 1||0
10148711|NCT02792829|11279095|FG005|NOT COMPLETED|Treatment Period 1||0
10148712|NCT02792829|11279096|FG006|NOT COMPLETED|Treatment Period 1||0
10148713|NCT02792829|11279097|FG007|NOT COMPLETED|Treatment Period 1||0
10148714|NCT02792829|11279090|FG000|STARTED|Wash Out Period||10
10148715|NCT02792829|11279091|FG001|STARTED|Wash Out Period||10
10148716|NCT02792829|11279092|FG002|STARTED|Wash Out Period||5
10148717|NCT02792829|11279093|FG003|STARTED|Wash Out Period||5
10148718|NCT02792829|11279094|FG004|STARTED|Wash Out Period||5
10148719|NCT02792829|11279095|FG005|STARTED|Wash Out Period||5
10148720|NCT02792829|11279096|FG006|STARTED|Wash Out Period||10
10148721|NCT02792829|11279097|FG007|STARTED|Wash Out Period||10
10148722|NCT02792829|11279090|FG000|COMPLETED|Wash Out Period||10
10148723|NCT02792829|11279091|FG001|COMPLETED|Wash Out Period||10
10148724|NCT02792829|11279092|FG002|COMPLETED|Wash Out Period||5
10148725|NCT02792829|11279093|FG003|COMPLETED|Wash Out Period||5
10148726|NCT02792829|11279094|FG004|COMPLETED|Wash Out Period||5
10148727|NCT02792829|11279095|FG005|COMPLETED|Wash Out Period||5
10148728|NCT02792829|11279096|FG006|COMPLETED|Wash Out Period||10
10148729|NCT02792829|11279097|FG007|COMPLETED|Wash Out Period||10
10148730|NCT02792829|11279090|FG000|NOT COMPLETED|Wash Out Period||0
10148731|NCT02792829|11279091|FG001|NOT COMPLETED|Wash Out Period||0
10148732|NCT02792829|11279092|FG002|NOT COMPLETED|Wash Out Period||0
10148733|NCT02792829|11279093|FG003|NOT COMPLETED|Wash Out Period||0
10148734|NCT02792829|11279094|FG004|NOT COMPLETED|Wash Out Period||0
10148735|NCT02792829|11279095|FG005|NOT COMPLETED|Wash Out Period||0
10148736|NCT02792829|11279096|FG006|NOT COMPLETED|Wash Out Period||0
10148737|NCT02792829|11279097|FG007|NOT COMPLETED|Wash Out Period||0
10148738|NCT02792829|11279090|FG000|STARTED|Treatment Period 2||10
10148739|NCT02792829|11279091|FG001|STARTED|Treatment Period 2||10
10148740|NCT02792829|11279092|FG002|STARTED|Treatment Period 2||5
10148741|NCT02792829|11279093|FG003|STARTED|Treatment Period 2||5
10148742|NCT02792829|11279094|FG004|STARTED|Treatment Period 2||5
10148743|NCT02792829|11279095|FG005|STARTED|Treatment Period 2||5
10148744|NCT02792829|11279096|FG006|STARTED|Treatment Period 2||10
10148745|NCT02792829|11279097|FG007|STARTED|Treatment Period 2||10
10148746|NCT02792829|11279090|FG000|COMPLETED|Treatment Period 2||10
10148747|NCT02792829|11279091|FG001|COMPLETED|Treatment Period 2||9
10148748|NCT02792829|11279092|FG002|COMPLETED|Treatment Period 2||5
10148749|NCT02792829|11279093|FG003|COMPLETED|Treatment Period 2||5
10148750|NCT02792829|11279094|FG004|COMPLETED|Treatment Period 2||4
10148751|NCT02792829|11279095|FG005|COMPLETED|Treatment Period 2||5
10148752|NCT02792829|11279096|FG006|COMPLETED|Treatment Period 2||9
10148753|NCT02792829|11279097|FG007|COMPLETED|Treatment Period 2||8
10148754|NCT02792829|11279090|FG000|NOT COMPLETED|Treatment Period 2||0
10148755|NCT02792829|11279091|FG001|NOT COMPLETED|Treatment Period 2||1
10148756|NCT02792829|11279092|FG002|NOT COMPLETED|Treatment Period 2||0
10148757|NCT02792829|11279093|FG003|NOT COMPLETED|Treatment Period 2||0
10148758|NCT02792829|11279094|FG004|NOT COMPLETED|Treatment Period 2||1
10148759|NCT02792829|11279095|FG005|NOT COMPLETED|Treatment Period 2||0
10148760|NCT02792829|11279096|FG006|NOT COMPLETED|Treatment Period 2||1
10148761|NCT02792829|11279097|FG007|NOT COMPLETED|Treatment Period 2||2
10148762|NCT02792959|11279123|FG000|STARTED|Overall Study||11
10148763|NCT02792959|11279123|FG000|COMPLETED|Overall Study||10
10148764|NCT02792959|11279123|FG000|NOT COMPLETED|Overall Study||1
10148765|NCT02793128|11279127|FG000|STARTED|Overall Study||71
10148766|NCT02793128|11279127|FG000|COMPLETED|Overall Study||62
10148767|NCT02793128|11279127|FG000|NOT COMPLETED|Overall Study||9
10148768|NCT02793154|11279142|FG000|STARTED|Part A (Single Group-up to 12 Days)||4
10148769|NCT02793154|11279143|FG001|STARTED|Part A (Single Group-up to 12 Days)||0
10148770|NCT02793154|11279144|FG002|STARTED|Part A (Single Group-up to 12 Days)||0
10148771|NCT02793154|11279142|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4
10148772|NCT02793154|11279143|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0
10148773|NCT02793154|11279144|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0
10148774|NCT02793154|11279142|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
10148775|NCT02793154|11279143|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
10148776|NCT02793154|11279144|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
10148777|NCT02793154|11279142|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0
10148778|NCT02793154|11279143|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0
10148779|NCT02793154|11279144|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0
10148780|NCT02793154|11279142|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10148781|NCT02793154|11279143|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10148782|NCT02793154|11279144|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10148783|NCT02793154|11279142|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10148784|NCT02793154|11279143|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10148785|NCT02793154|11279144|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10148786|NCT02793232|11279161|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148787|NCT02793232|11279162|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148788|NCT02793232|11279163|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148789|NCT02793232|11279164|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148790|NCT02793232|11279165|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
9709194|NCT01970865|10808454|FG003|NOT COMPLETED|Overall Study||13
9709195|NCT01970865|10808455|FG004|NOT COMPLETED|Overall Study||17
9709196|NCT01970865|10808456|FG005|NOT COMPLETED|Overall Study||3
9709197|NCT01970865|10808457|FG006|NOT COMPLETED|Overall Study||3
9709198|NCT01970865|10808458|FG007|NOT COMPLETED|Overall Study||3
9709199|NCT01970865|10808459|FG008|NOT COMPLETED|Overall Study||3
9709200|NCT01970865|10808460|FG009|NOT COMPLETED|Overall Study||4
9709201|NCT01970865|10808461|FG010|NOT COMPLETED|Overall Study||30
9709202|NCT01970865|10808462|FG011|NOT COMPLETED|Overall Study||27
9709203|NCT01970865|10808463|FG012|NOT COMPLETED|Overall Study||60
9709204|NCT01970865|10808464|FG013|NOT COMPLETED|Overall Study||66
10148791|NCT02793232|11279166|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
10148792|NCT02793232|11279167|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
10148793|NCT02793232|11279168|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148794|NCT02793232|11279169|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
10148795|NCT02793232|11279161|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148796|NCT02793232|11279162|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148797|NCT02793232|11279163|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148798|NCT02793232|11279164|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148799|NCT02793232|11279165|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
10148800|NCT02793232|11279166|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
10148801|NCT02793232|11279167|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
10148802|NCT02793232|11279168|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10148803|NCT02793232|11279169|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
9709205|NCT01970865|10808465|FG014|NOT COMPLETED|Overall Study||46
9709206|NCT01970865|10808466|FG015|NOT COMPLETED|Overall Study||47
9709207|NCT01970865|10808467|FG016|NOT COMPLETED|Overall Study||3
9709208|NCT00589420|10808528|FG000|STARTED|Overall Study||18
9709209|NCT00589420|10808528|FG000|COMPLETED|Overall Study||17
10148804|NCT02793232|11279161|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10148805|NCT02793232|11279162|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10148806|NCT02793232|11279163|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10148807|NCT02793232|11279164|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10148808|NCT02793232|11279165|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
10148809|NCT02793232|11279166|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10148810|NCT02793232|11279167|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
10148811|NCT02793232|11279168|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10148812|NCT02793232|11279169|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10148813|NCT02793232|11279161|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2
10148814|NCT02793232|11279162|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2
10148815|NCT02793232|11279163|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2
10148816|NCT02793232|11279164|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2
10148817|NCT02793232|11279165|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0
10148818|NCT02793232|11279166|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0
10148819|NCT02793232|11279167|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0
10148820|NCT02793232|11279168|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0
10148821|NCT02793232|11279169|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0
10148822|NCT02793232|11279161|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10148823|NCT02793232|11279162|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10148824|NCT02793232|11279163|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10148825|NCT02793232|11279164|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10148826|NCT02793232|11279165|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148827|NCT02793232|11279166|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148828|NCT02793232|11279167|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148829|NCT02793232|11279168|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148830|NCT02793232|11279169|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148831|NCT02793232|11279161|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148832|NCT02793232|11279162|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148833|NCT02793232|11279163|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148834|NCT02793232|11279164|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148835|NCT02793232|11279165|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148836|NCT02793232|11279166|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148837|NCT02793232|11279167|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148838|NCT02793232|11279168|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148839|NCT02793232|11279169|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10148840|NCT02793232|11279161|FG000|STARTED|Period 2 (Part A: 5 Days)||2
10148841|NCT02793232|11279162|FG001|STARTED|Period 2 (Part A: 5 Days)||2
10148842|NCT02793232|11279163|FG002|STARTED|Period 2 (Part A: 5 Days)||2
10148843|NCT02793232|11279164|FG003|STARTED|Period 2 (Part A: 5 Days)||2
10148844|NCT02793232|11279165|FG004|STARTED|Period 2 (Part A: 5 Days)||0
10148845|NCT02793232|11279166|FG005|STARTED|Period 2 (Part A: 5 Days)||0
10148846|NCT02793232|11279167|FG006|STARTED|Period 2 (Part A: 5 Days)||0
10148847|NCT02793232|11279168|FG007|STARTED|Period 2 (Part A: 5 Days)||0
10148848|NCT02793232|11279169|FG008|STARTED|Period 2 (Part A: 5 Days)||0
10148849|NCT02793232|11279161|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2
10148850|NCT02793232|11279162|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2
10148851|NCT02793232|11279163|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2
10148852|NCT02793232|11279164|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2
10148853|NCT02793232|11279165|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0
10148854|NCT02793232|11279166|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0
10148855|NCT02793232|11279167|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0
10148856|NCT02793232|11279168|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0
10148857|NCT02793232|11279169|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0
10148858|NCT02793232|11279161|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148859|NCT02793232|11279162|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148860|NCT02793232|11279163|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148861|NCT02793232|11279164|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148862|NCT02793232|11279165|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148863|NCT02793232|11279166|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148864|NCT02793232|11279167|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148865|NCT02793232|11279168|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148866|NCT02793232|11279169|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10148867|NCT02793232|11279161|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2
10148868|NCT02793232|11279162|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2
10148869|NCT02793232|11279163|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2
10148870|NCT02793232|11279164|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2
10148871|NCT02793232|11279165|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0
10148872|NCT02793232|11279166|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0
10148873|NCT02793232|11279167|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0
10148874|NCT02793232|11279168|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0
10148875|NCT02793232|11279169|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0
10148876|NCT02793232|11279161|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10148877|NCT02793232|11279162|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10148878|NCT02793232|11279163|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10148879|NCT02793232|11279164|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10148880|NCT02793232|11279165|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148881|NCT02793232|11279166|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148882|NCT02793232|11279167|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148883|NCT02793232|11279168|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148884|NCT02793232|11279169|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148885|NCT02793232|11279161|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148886|NCT02793232|11279162|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148887|NCT02793232|11279163|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148888|NCT02793232|11279164|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148889|NCT02793232|11279165|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148890|NCT02793232|11279166|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148891|NCT02793232|11279167|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148892|NCT02793232|11279168|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148893|NCT02793232|11279169|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10148894|NCT02793232|11279161|FG000|STARTED|Period 3 (Part A: 5 Days)||2
10148895|NCT02793232|11279162|FG001|STARTED|Period 3 (Part A: 5 Days)||2
10148896|NCT02793232|11279163|FG002|STARTED|Period 3 (Part A: 5 Days)||2
10148897|NCT02793232|11279164|FG003|STARTED|Period 3 (Part A: 5 Days)||2
10148898|NCT02793232|11279165|FG004|STARTED|Period 3 (Part A: 5 Days)||0
10148899|NCT02793232|11279166|FG005|STARTED|Period 3 (Part A: 5 Days)||0
10148900|NCT02793232|11279167|FG006|STARTED|Period 3 (Part A: 5 Days)||0
10148901|NCT02793232|11279168|FG007|STARTED|Period 3 (Part A: 5 Days)||0
10148902|NCT02793232|11279169|FG008|STARTED|Period 3 (Part A: 5 Days)||0
10148903|NCT02793232|11279161|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2
10148904|NCT02793232|11279162|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2
10148905|NCT02793232|11279163|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2
10148906|NCT02793232|11279164|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2
10148907|NCT02793232|11279165|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0
10148908|NCT02793232|11279166|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0
10148909|NCT02793232|11279167|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0
10148910|NCT02793232|11279168|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0
10148911|NCT02793232|11279169|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0
10148912|NCT02793232|11279161|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148913|NCT02793232|11279162|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148914|NCT02793232|11279163|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148915|NCT02793232|11279164|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148916|NCT02793232|11279165|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148917|NCT02793232|11279166|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148918|NCT02793232|11279167|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148919|NCT02793232|11279168|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148920|NCT02793232|11279169|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10148921|NCT02793232|11279161|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2
10148922|NCT02793232|11279162|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2
10148923|NCT02793232|11279163|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2
10148924|NCT02793232|11279164|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2
10148925|NCT02793232|11279165|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0
10148926|NCT02793232|11279166|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0
10148927|NCT02793232|11279167|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0
10148928|NCT02793232|11279168|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0
10148929|NCT02793232|11279169|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0
10148930|NCT02793232|11279161|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10148931|NCT02793232|11279162|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10148932|NCT02793232|11279163|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10148933|NCT02793232|11279164|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10148934|NCT02793232|11279165|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148935|NCT02793232|11279166|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148936|NCT02793232|11279167|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148937|NCT02793232|11279168|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148938|NCT02793232|11279169|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148939|NCT02793232|11279161|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148940|NCT02793232|11279162|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148941|NCT02793232|11279163|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148942|NCT02793232|11279164|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148943|NCT02793232|11279165|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148944|NCT02793232|11279166|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148945|NCT02793232|11279167|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148946|NCT02793232|11279168|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148947|NCT02793232|11279169|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10148948|NCT02793232|11279161|FG000|STARTED|Period 4 (Part A: 5 Days)||2
10148949|NCT02793232|11279162|FG001|STARTED|Period 4 (Part A: 5 Days)||2
10148950|NCT02793232|11279163|FG002|STARTED|Period 4 (Part A: 5 Days)||2
10148951|NCT02793232|11279164|FG003|STARTED|Period 4 (Part A: 5 Days)||2
10148952|NCT02793232|11279165|FG004|STARTED|Period 4 (Part A: 5 Days)||0
10148953|NCT02793232|11279166|FG005|STARTED|Period 4 (Part A: 5 Days)||0
10148954|NCT02793232|11279167|FG006|STARTED|Period 4 (Part A: 5 Days)||0
10148955|NCT02793232|11279168|FG007|STARTED|Period 4 (Part A: 5 Days)||0
10148956|NCT02793232|11279169|FG008|STARTED|Period 4 (Part A: 5 Days)||0
10148957|NCT02793232|11279161|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2
10148958|NCT02793232|11279162|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2
10148959|NCT02793232|11279163|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2
10148960|NCT02793232|11279164|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2
10148961|NCT02793232|11279165|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0
10148962|NCT02793232|11279166|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0
10148963|NCT02793232|11279167|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0
10148964|NCT02793232|11279168|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0
10148965|NCT02793232|11279169|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0
10148966|NCT02793232|11279161|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148967|NCT02793232|11279162|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148968|NCT02793232|11279163|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148969|NCT02793232|11279164|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148970|NCT02793232|11279165|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148971|NCT02793232|11279166|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148972|NCT02793232|11279167|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148973|NCT02793232|11279168|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148974|NCT02793232|11279169|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10148975|NCT02793622|11279205|FG000|STARTED|Overall Study||391
10148976|NCT02793622|11279206|FG001|STARTED|Overall Study||391
10148977|NCT02793622|11279205|FG000|COMPLETED|Overall Study||338
10148978|NCT02793622|11279206|FG001|COMPLETED|Overall Study||349
10148979|NCT02793622|11279205|FG000|NOT COMPLETED|Overall Study||53
10148980|NCT02793622|11279206|FG001|NOT COMPLETED|Overall Study||42
10148981|NCT02793674|11279214|FG000|STARTED|Overall Study||9
10148982|NCT02793674|11279215|FG001|STARTED|Overall Study||12
10148983|NCT02793674|11279214|FG000|COMPLETED|Overall Study||9
10148984|NCT02793674|11279215|FG001|COMPLETED|Overall Study||12
10148985|NCT02793674|11279214|FG000|NOT COMPLETED|Overall Study||0
10148986|NCT02793674|11279215|FG001|NOT COMPLETED|Overall Study||0
10148987|NCT02793817|11279229|FG000|STARTED|Overall Study||261
10148988|NCT02793817|11279230|FG001|STARTED|Overall Study||259
10148989|NCT02793817|11279229|FG000|COMPLETED|Overall Study||258
10148990|NCT02793817|11279230|FG001|COMPLETED|Overall Study||254
10148991|NCT02793817|11279229|FG000|NOT COMPLETED|Overall Study||3
10148992|NCT02793817|11279230|FG001|NOT COMPLETED|Overall Study||5
10148993|NCT02793856|11279240|FG000|STARTED|Overall Study||2
10148994|NCT02793856|11279241|FG001|STARTED|Overall Study||4
10148995|NCT02793856|11279242|FG002|STARTED|Overall Study||3
10148996|NCT02793856|11279243|FG003|STARTED|Overall Study||3
10148997|NCT02793856|11279240|FG000|COMPLETED|Overall Study||2
10148998|NCT02793856|11279241|FG001|COMPLETED|Overall Study||4
10148999|NCT02793856|11279242|FG002|COMPLETED|Overall Study||3
10149000|NCT02793856|11279243|FG003|COMPLETED|Overall Study||3
10149001|NCT02793856|11279240|FG000|NOT COMPLETED|Overall Study||0
10149002|NCT02793856|11279241|FG001|NOT COMPLETED|Overall Study||0
10149003|NCT02793856|11279242|FG002|NOT COMPLETED|Overall Study||0
10149004|NCT02793856|11279243|FG003|NOT COMPLETED|Overall Study||0
10149005|NCT02793947|11279283|FG000|STARTED|Overall Study||47
10149006|NCT02793947|11279284|FG001|STARTED|Overall Study||55
10149007|NCT02793947|11279283|FG000|COMPLETED|Overall Study||45
10149008|NCT02793947|11279284|FG001|COMPLETED|Overall Study||50
10149009|NCT02793947|11279283|FG000|NOT COMPLETED|Overall Study||2
10149010|NCT02793947|11279284|FG001|NOT COMPLETED|Overall Study||5
10149011|NCT02794103|11279290|FG000|STARTED|Overall Study||18
10149012|NCT02794103|11279290|FG000|COMPLETED|Overall Study||15
10149013|NCT02794103|11279290|FG000|NOT COMPLETED|Overall Study||3
10149014|NCT02794207|11279296|FG000|STARTED|Overall Study||32
10149015|NCT02794207|11279297|FG001|STARTED|Overall Study||54
10149016|NCT02794207|11279296|FG000|COMPLETED|Overall Study||32
10149017|NCT02794207|11279297|FG001|COMPLETED|Overall Study||54
10149018|NCT02794207|11279296|FG000|NOT COMPLETED|Overall Study||0
10149019|NCT02794207|11279297|FG001|NOT COMPLETED|Overall Study||0
10149020|NCT02794246|11279302|FG000|STARTED|Overall Study||6
10149021|NCT02794246|11279302|FG000|Treated|Overall Study||3
10149022|NCT02794246|11279302|FG000|COMPLETED|Overall Study||0
10149023|NCT02794246|11279302|FG000|NOT COMPLETED|Overall Study||6
10149024|NCT02794441|11279308|FG000|STARTED|Overall Study||7
10149025|NCT02794441|11279309|FG001|STARTED|Overall Study||5
10149026|NCT02794441|11279308|FG000|COMPLETED|Overall Study||6
10149027|NCT02794441|11279309|FG001|COMPLETED|Overall Study||5
10149028|NCT02794441|11279308|FG000|NOT COMPLETED|Overall Study||1
10149029|NCT02794441|11279309|FG001|NOT COMPLETED|Overall Study||0
10149030|NCT02794480|11279317|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80
10149031|NCT02794480|11279318|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82
10149032|NCT02794480|11279319|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81
10149033|NCT02794480|11279320|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81
10149034|NCT02794480|11279317|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
10149035|NCT02794480|11279318|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
10149036|NCT02794480|11279319|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
10149037|NCT02794480|11279320|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
10149038|NCT02794480|11279317|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
10149039|NCT02794480|11279318|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
10149040|NCT02794480|11279319|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
10149041|NCT02794480|11279320|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
10149042|NCT02794480|11279317|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80
10149043|NCT02794480|11279318|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80
10149044|NCT02794480|11279319|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79
10149045|NCT02794480|11279320|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78
10149046|NCT02794480|11279317|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
10149047|NCT02794480|11279318|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
10149048|NCT02794480|11279319|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
10149049|NCT02794480|11279320|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
10149050|NCT02794480|11279317|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
10149051|NCT02794480|11279318|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
10149052|NCT02794480|11279319|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
10149053|NCT02794480|11279320|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
10149054|NCT02794597|11279330|FG000|STARTED|Overall Study||63
10149055|NCT02794597|11279331|FG001|STARTED|Overall Study||56
10149056|NCT02794597|11279330|FG000|COMPLETED|Overall Study||63
10149057|NCT02794597|11279331|FG001|COMPLETED|Overall Study||56
10149058|NCT02794597|11279330|FG000|NOT COMPLETED|Overall Study||0
10149059|NCT02794597|11279331|FG001|NOT COMPLETED|Overall Study||0
10149060|NCT02794727|11279340|FG000|STARTED|Overall Study||44
10149061|NCT02794727|11279341|FG001|STARTED|Overall Study||46
10149062|NCT02794727|11279342|FG002|STARTED|Overall Study||45
10149063|NCT02794727|11279340|FG000|COMPLETED|Overall Study||44
10149064|NCT02794727|11279341|FG001|COMPLETED|Overall Study||46
10149065|NCT02794727|11279342|FG002|COMPLETED|Overall Study||44
10149066|NCT02794727|11279340|FG000|NOT COMPLETED|Overall Study||0
10149067|NCT02794727|11279341|FG001|NOT COMPLETED|Overall Study||0
10149068|NCT02794727|11279342|FG002|NOT COMPLETED|Overall Study||1
10149069|NCT02794766|11279352|FG000|STARTED|Overall Study||15
10149070|NCT02794766|11279353|FG001|STARTED|Overall Study||15
10149071|NCT02794766|11279354|FG002|STARTED|Overall Study||15
10149072|NCT02794766|11279352|FG000|COMPLETED|Overall Study||15
10149073|NCT02794766|11279353|FG001|COMPLETED|Overall Study||15
10149074|NCT02794766|11279354|FG002|COMPLETED|Overall Study||14
10149075|NCT02794766|11279352|FG000|NOT COMPLETED|Overall Study||0
10149076|NCT02794766|11279353|FG001|NOT COMPLETED|Overall Study||0
10149077|NCT02794766|11279354|FG002|NOT COMPLETED|Overall Study||1
10149078|NCT02794844|11279362|FG000|STARTED|Overall Study||28
10149079|NCT02794844|11279362|FG000|COMPLETED|Overall Study||23
10149080|NCT02794844|11279362|FG000|NOT COMPLETED|Overall Study||5
9709210|NCT00589420|10808528|FG000|NOT COMPLETED|Overall Study||1
9729533|NCT00118482|10829130|FG000|NOT COMPLETED|Overall Study||30
9729534|NCT00118482|10829131|FG001|NOT COMPLETED|Overall Study||29
9729535|NCT00118534|10829139|FG000|STARTED|Overall Study||472
9729536|NCT00118534|10829140|FG001|STARTED|Overall Study||471
9729537|NCT00118534|10829139|FG000|COMPLETED|Overall Study||472
9729538|NCT00118534|10829140|FG001|COMPLETED|Overall Study||471
9729539|NCT00118534|10829139|FG000|NOT COMPLETED|Overall Study||0
9729540|NCT00118534|10829140|FG001|NOT COMPLETED|Overall Study||0
9729541|NCT00118703|10829149|FG000|STARTED|Overall Study||173
9729542|NCT00118703|10829150|FG001|STARTED|Overall Study||174
9729543|NCT00118703|10829149|FG000|COMPLETED|Overall Study||168
9729544|NCT00118703|10829150|FG001|COMPLETED|Overall Study||165
9729545|NCT00118703|10829149|FG000|NOT COMPLETED|Overall Study||5
9729546|NCT00118703|10829150|FG001|NOT COMPLETED|Overall Study||9
9729547|NCT00118716|10829158|FG000|STARTED|Overall Study||124
9729548|NCT00118716|10829159|FG001|STARTED|Overall Study||124
9729549|NCT00118716|10829158|FG000|COMPLETED|Overall Study||111
9729550|NCT00118716|10829159|FG001|COMPLETED|Overall Study||102
9729551|NCT00118716|10829158|FG000|NOT COMPLETED|Overall Study||13
9729552|NCT00118716|10829159|FG001|NOT COMPLETED|Overall Study||22
9729553|NCT00118742|10829167|FG000|STARTED|Overall Study||145
9729554|NCT00118742|10829168|FG001|STARTED|Overall Study||148
9729555|NCT00118742|10829167|FG000|COMPLETED|Overall Study||96
9729556|NCT00118742|10829168|FG001|COMPLETED|Overall Study||82
9729557|NCT00118742|10829167|FG000|NOT COMPLETED|Overall Study||49
9729558|NCT00118742|10829168|FG001|NOT COMPLETED|Overall Study||66
9729559|NCT00118755|10829176|FG000|STARTED|Overall Study||217
9729560|NCT00118755|10829177|FG001|STARTED|Overall Study||218
9729561|NCT00118755|10829176|FG000|Safety Population|Overall Study||208
9729562|NCT00118755|10829177|FG001|Safety Population|Overall Study||211
9729563|NCT00118755|10829176|FG000|COMPLETED|Overall Study||7
9729564|NCT00118755|10829177|FG001|COMPLETED|Overall Study||3
10149081|NCT02794870|11279368|FG000|STARTED|Overall Study||22
10149082|NCT02794870|11279369|FG001|STARTED|Overall Study||11
10149083|NCT02794870|11279368|FG000|Received Inoculation|Overall Study||21
10149084|NCT02794870|11279369|FG001|Received Inoculation|Overall Study||11
10149085|NCT02794870|11279368|FG000|COMPLETED|Overall Study||20
10149086|NCT02794870|11279369|FG001|COMPLETED|Overall Study||11
10149087|NCT02794870|11279368|FG000|NOT COMPLETED|Overall Study||2
10149088|NCT02794870|11279369|FG001|NOT COMPLETED|Overall Study||0
9729565|NCT00118755|10829176|FG000|NOT COMPLETED|Overall Study||210
9729566|NCT00118755|10829177|FG001|NOT COMPLETED|Overall Study||215
10149089|NCT02794974|11279377|FG000|STARTED|Overall Study||14
10149090|NCT02794974|11279378|FG001|STARTED|Overall Study||15
10149091|NCT02794974|11279377|FG000|COMPLETED|Overall Study||14
10149092|NCT02794974|11279378|FG001|COMPLETED|Overall Study||14
10149093|NCT02794974|11279377|FG000|NOT COMPLETED|Overall Study||0
10149094|NCT02794974|11279378|FG001|NOT COMPLETED|Overall Study||1
10149095|NCT02795117|11279387|FG000|STARTED|Overall Study||193
10149096|NCT02795117|11279388|FG001|STARTED|Overall Study||193
10149097|NCT02795117|11279389|FG002|STARTED|Overall Study||100
10149098|NCT02795117|11279387|FG000|COMPLETED|Overall Study||175
10149099|NCT02795117|11279388|FG001|COMPLETED|Overall Study||166
10149100|NCT02795117|11279389|FG002|COMPLETED|Overall Study||88
10149101|NCT02795117|11279387|FG000|NOT COMPLETED|Overall Study||18
10149102|NCT02795117|11279388|FG001|NOT COMPLETED|Overall Study||27
10149103|NCT02795117|11279389|FG002|NOT COMPLETED|Overall Study||12
10149104|NCT02795767|11279400|FG000|STARTED|Overall Study||68
10149105|NCT02795767|11279401|FG001|STARTED|Overall Study||10
10149106|NCT02795767|11279402|FG002|STARTED|Overall Study||10
10149107|NCT02795767|11279400|FG000|Received at Least One Dose of Emicizumab|Overall Study||68
10149108|NCT02795767|11279401|FG001|Received at Least One Dose of Emicizumab|Overall Study||10
10149109|NCT02795767|11279402|FG002|Received at Least One Dose of Emicizumab|Overall Study||10
10149110|NCT02795767|11279400|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
10149111|NCT02795767|11279401|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
10149112|NCT02795767|11279402|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
10149113|NCT02795767|11279400|FG000|Completed 52 Weeks in Study|Overall Study||67
10149114|NCT02795767|11279401|FG001|Completed 52 Weeks in Study|Overall Study||10
10149115|NCT02795767|11279402|FG002|Completed 52 Weeks in Study|Overall Study||9
10149116|NCT02795767|11279400|FG000|COMPLETED|Overall Study||67
10149117|NCT02795767|11279401|FG001|COMPLETED|Overall Study||10
10149118|NCT02795767|11279402|FG002|COMPLETED|Overall Study||10
10149119|NCT02795767|11279400|FG000|NOT COMPLETED|Overall Study||1
10149120|NCT02795767|11279401|FG001|NOT COMPLETED|Overall Study||0
10149121|NCT02795767|11279402|FG002|NOT COMPLETED|Overall Study||0
10149122|NCT02795780|11279416|FG000|STARTED|Overall Study||25
10149123|NCT02795780|11279417|FG001|STARTED|Overall Study||54
10149124|NCT02795780|11279416|FG000|COMPLETED|Overall Study||25
10149125|NCT02795780|11279417|FG001|COMPLETED|Overall Study||54
10149126|NCT02795780|11279416|FG000|NOT COMPLETED|Overall Study||0
10149127|NCT02795780|11279417|FG001|NOT COMPLETED|Overall Study||0
10149128|NCT02795819|11279425|FG000|STARTED|Overall Study||0
10149129|NCT02795819|11279426|FG001|STARTED|Overall Study||6
10149130|NCT02795819|11279427|FG002|STARTED|Overall Study||0
10149131|NCT02795819|11279428|FG003|STARTED|Overall Study||0
10149132|NCT02795819|11279429|FG004|STARTED|Overall Study||0
10149133|NCT02795819|11279430|FG005|STARTED|Overall Study||0
10149134|NCT02795819|11279431|FG006|STARTED|Overall Study||0
10149135|NCT02795819|11279425|FG000|COMPLETED|Overall Study||0
10149136|NCT02795819|11279426|FG001|COMPLETED|Overall Study||6
9709211|NCT05043142|10808532|FG000|STARTED|Overall Study||3632
9709212|NCT05043142|10808532|FG000|COMPLETED|Overall Study||3443
9709213|NCT05043142|10808532|FG000|NOT COMPLETED|Overall Study||189
9709214|NCT04993339|10808538|FG000|STARTED|Overall Study||14
9709215|NCT04993339|10808539|FG001|STARTED|Overall Study||12
9709216|NCT04993339|10808538|FG000|COMPLETED|Overall Study||11
9709217|NCT04993339|10808539|FG001|COMPLETED|Overall Study||10
9709218|NCT04993339|10808538|FG000|NOT COMPLETED|Overall Study||3
9709219|NCT04993339|10808539|FG001|NOT COMPLETED|Overall Study||2
9709229|NCT04929522|10808561|FG000|STARTED|Overall Study||40
9709230|NCT04929522|10808562|FG001|STARTED|Overall Study||40
9709231|NCT04929522|10808563|FG002|STARTED|Overall Study||40
9709232|NCT04929522|10808564|FG003|STARTED|Overall Study||40
9709233|NCT04929522|10808561|FG000|COMPLETED|Overall Study||40
9709234|NCT04929522|10808562|FG001|COMPLETED|Overall Study||40
9709235|NCT04929522|10808563|FG002|COMPLETED|Overall Study||40
9709236|NCT04929522|10808564|FG003|COMPLETED|Overall Study||40
10149137|NCT02795819|11279427|FG002|COMPLETED|Overall Study||0
10149138|NCT02795819|11279428|FG003|COMPLETED|Overall Study||0
10149139|NCT02795819|11279429|FG004|COMPLETED|Overall Study||0
10149140|NCT02795819|11279430|FG005|COMPLETED|Overall Study||0
10149141|NCT02795819|11279431|FG006|COMPLETED|Overall Study||0
10149142|NCT02795819|11279425|FG000|NOT COMPLETED|Overall Study||0
10149143|NCT02795819|11279426|FG001|NOT COMPLETED|Overall Study||0
10149144|NCT02795819|11279427|FG002|NOT COMPLETED|Overall Study||0
10149145|NCT02795819|11279428|FG003|NOT COMPLETED|Overall Study||0
9709237|NCT04929522|10808561|FG000|NOT COMPLETED|Overall Study||0
9709238|NCT04929522|10808562|FG001|NOT COMPLETED|Overall Study||0
9709239|NCT04929522|10808563|FG002|NOT COMPLETED|Overall Study||0
9709240|NCT04929522|10808564|FG003|NOT COMPLETED|Overall Study||0
9709241|NCT04927858|10808574|FG000|STARTED|Overall Study||460558
9709242|NCT04927858|10808574|FG000|Treated With Empagliflozin|Overall Study||16985
10149146|NCT02795819|11279429|FG004|NOT COMPLETED|Overall Study||0
10149147|NCT02795819|11279430|FG005|NOT COMPLETED|Overall Study||0
10149148|NCT02795819|11279431|FG006|NOT COMPLETED|Overall Study||0
10149149|NCT02795832|11279447|FG000|STARTED|Overall Study||8
10149150|NCT02795832|11279448|FG001|STARTED|Overall Study||4
10149151|NCT02795832|11279449|FG002|STARTED|Overall Study||8
9709243|NCT04927858|10808574|FG000|COMPLETED|Overall Study||460558
9709244|NCT04927858|10808574|FG000|NOT COMPLETED|Overall Study||0
9709245|NCT04919161|10808581|FG000|STARTED|Overall Study||16
10149152|NCT02795832|11279450|FG003|STARTED|Overall Study||3
10149153|NCT02795832|11279451|FG004|STARTED|Overall Study||20
10149154|NCT02795832|11279452|FG005|STARTED|Overall Study||10
10149155|NCT02795832|11279447|FG000|COMPLETED|Overall Study||8
10149156|NCT02795832|11279448|FG001|COMPLETED|Overall Study||4
10149157|NCT02795832|11279449|FG002|COMPLETED|Overall Study||8
10149158|NCT02795832|11279450|FG003|COMPLETED|Overall Study||3
10149159|NCT02795832|11279451|FG004|COMPLETED|Overall Study||20
10149160|NCT02795832|11279452|FG005|COMPLETED|Overall Study||7
10149161|NCT02795832|11279447|FG000|NOT COMPLETED|Overall Study||0
10149162|NCT02795832|11279448|FG001|NOT COMPLETED|Overall Study||0
10149163|NCT02795832|11279449|FG002|NOT COMPLETED|Overall Study||0
10149164|NCT02795832|11279450|FG003|NOT COMPLETED|Overall Study||0
10149165|NCT02795832|11279451|FG004|NOT COMPLETED|Overall Study||0
10149166|NCT02795832|11279452|FG005|NOT COMPLETED|Overall Study||3
10149167|NCT02796092|11279476|FG000|STARTED|Overall Study||50
10149168|NCT02796092|11279477|FG001|STARTED|Overall Study||50
10149169|NCT02796092|11279476|FG000|COMPLETED|Overall Study||50
10149170|NCT02796092|11279477|FG001|COMPLETED|Overall Study||50
10149171|NCT02796092|11279476|FG000|NOT COMPLETED|Overall Study||0
10149172|NCT02796092|11279477|FG001|NOT COMPLETED|Overall Study||0
10149173|NCT02796144|11279486|FG000|STARTED|Overall Study||23
10149174|NCT02796144|11279487|FG001|STARTED|Overall Study||24
10149175|NCT02796144|11279488|FG002|STARTED|Overall Study||24
10149176|NCT02796144|11279486|FG000|COMPLETED|Overall Study||18
10149177|NCT02796144|11279487|FG001|COMPLETED|Overall Study||21
10149178|NCT02796144|11279488|FG002|COMPLETED|Overall Study||18
10149179|NCT02796144|11279486|FG000|NOT COMPLETED|Overall Study||5
10149180|NCT02796144|11279487|FG001|NOT COMPLETED|Overall Study||3
10149181|NCT02796144|11279488|FG002|NOT COMPLETED|Overall Study||6
10149182|NCT02796274|11279498|FG000|STARTED|Overall Study||219
10149183|NCT02796274|11279498|FG000|COMPLETED|Overall Study||219
10149184|NCT02796274|11279498|FG000|NOT COMPLETED|Overall Study||0
10149185|NCT02796300|11279504|FG000|STARTED|Overall Study||10
10149186|NCT02796300|11279505|FG001|STARTED|Overall Study||22
10149187|NCT02796300|11279504|FG000|COMPLETED|Overall Study||10
10149188|NCT02796300|11279505|FG001|COMPLETED|Overall Study||22
10149189|NCT02796300|11279504|FG000|NOT COMPLETED|Overall Study||0
10149190|NCT02796300|11279505|FG001|NOT COMPLETED|Overall Study||0
10149191|NCT02796352|11279511|FG000|STARTED|Overall Study||1
10149192|NCT02796352|11279511|FG000|COMPLETED|Overall Study||1
10149193|NCT02796352|11279511|FG000|NOT COMPLETED|Overall Study||0
10149194|NCT02796560|11279517|FG000|STARTED|Overall Study||38
10149195|NCT02796560|11279518|FG001|STARTED|Overall Study||38
10149196|NCT02796560|11279517|FG000|COMPLETED|Overall Study||34
10149197|NCT02796560|11279518|FG001|COMPLETED|Overall Study||36
10149198|NCT02796560|11279517|FG000|NOT COMPLETED|Overall Study||4
10149199|NCT02796560|11279518|FG001|NOT COMPLETED|Overall Study||2
10149200|NCT02796625|11279524|FG000|STARTED|Overall Study||80
10149201|NCT02796625|11279524|FG000|COMPLETED|Overall Study||61
10149202|NCT02796625|11279524|FG000|NOT COMPLETED|Overall Study||19
10149203|NCT02796651|11279528|FG000|STARTED|Overall Study||132
10149204|NCT02796651|11279528|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107
10149205|NCT02796651|11279528|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121
10149206|NCT02796651|11279528|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105
10149207|NCT02796651|11279528|FG000|Perforomist 20 μg|Overall Study||118
10149208|NCT02796651|11279528|FG000|Perforomist 40 μg|Overall Study||108
10149209|NCT02796651|11279528|FG000|Placebo (Lactose Monohydrate)|Overall Study||38
10149210|NCT02796651|11279528|FG000|COMPLETED|Overall Study||106
10149211|NCT02796651|11279528|FG000|NOT COMPLETED|Overall Study||26
10149212|NCT02796664|11279545|FG000|STARTED|Overall Study||29
10149213|NCT02796664|11279546|FG001|STARTED|Overall Study||29
10149214|NCT02796664|11279545|FG000|COMPLETED|Overall Study||28
10149215|NCT02796664|11279546|FG001|COMPLETED|Overall Study||24
10149216|NCT02796664|11279545|FG000|NOT COMPLETED|Overall Study||1
10149217|NCT02796664|11279546|FG001|NOT COMPLETED|Overall Study||5
9709220|NCT04992442|10808545|FG000|STARTED|Treatment Period 1||6
9709221|NCT04992442|10808545|FG000|COMPLETED|Treatment Period 1||6
9709222|NCT04992442|10808545|FG000|NOT COMPLETED|Treatment Period 1||0
9709223|NCT04992442|10808545|FG000|STARTED|Washout Period||6
9709224|NCT04992442|10808545|FG000|COMPLETED|Washout Period||6
9709225|NCT04992442|10808545|FG000|NOT COMPLETED|Washout Period||0
9709226|NCT04992442|10808545|FG000|STARTED|Treatment Period 2||6
9709227|NCT04992442|10808545|FG000|COMPLETED|Treatment Period 2||6
9709228|NCT04992442|10808545|FG000|NOT COMPLETED|Treatment Period 2||0
9709246|NCT04919161|10808582|FG001|STARTED|Overall Study||16
9709247|NCT04919161|10808581|FG000|COMPLETED|Overall Study||15
9709248|NCT04919161|10808582|FG001|COMPLETED|Overall Study||14
9709249|NCT04919161|10808581|FG000|NOT COMPLETED|Overall Study||1
9709250|NCT04919161|10808582|FG001|NOT COMPLETED|Overall Study||2
10149218|NCT02796677|11279558|FG000|STARTED|Overall Study||317
10149219|NCT02796677|11279559|FG001|STARTED|Overall Study||478
10149220|NCT02796677|11279560|FG002|STARTED|Overall Study||320
10149221|NCT02796677|11279561|FG003|STARTED|Overall Study||479
10149222|NCT02796677|11279558|FG000|Completed Treatment and Follow-up|Overall Study||279
10149223|NCT02796677|11279559|FG001|Completed Treatment and Follow-up|Overall Study||405
10149224|NCT02796677|11279560|FG002|Completed Treatment and Follow-up|Overall Study||267
10149225|NCT02796677|11279561|FG003|Completed Treatment and Follow-up|Overall Study||403
10149226|NCT02796677|11279558|FG000|COMPLETED|Overall Study||279
10149227|NCT02796677|11279559|FG001|COMPLETED|Overall Study||405
10149228|NCT02796677|11279560|FG002|COMPLETED|Overall Study||267
9729567|NCT00118898|10829187|FG000|STARTED|Overall Study||464
9729568|NCT00118898|10829188|FG001|STARTED|Overall Study||465
10149229|NCT02796677|11279561|FG003|COMPLETED|Overall Study||405
10149230|NCT02796677|11279558|FG000|NOT COMPLETED|Overall Study||38
10149231|NCT02796677|11279559|FG001|NOT COMPLETED|Overall Study||73
10149232|NCT02796677|11279560|FG002|NOT COMPLETED|Overall Study||53
10149233|NCT02796677|11279561|FG003|NOT COMPLETED|Overall Study||74
10149234|NCT02796755|11279575|FG000|STARTED|Overall Study||15
10149235|NCT02796755|11279576|FG001|STARTED|Overall Study||15
10149236|NCT02796755|11279575|FG000|COMPLETED|Overall Study||13
10149237|NCT02796755|11279576|FG001|COMPLETED|Overall Study||15
10149238|NCT02796755|11279575|FG000|NOT COMPLETED|Overall Study||2
10149239|NCT02796755|11279576|FG001|NOT COMPLETED|Overall Study||0
10149240|NCT02796924|11279582|FG000|STARTED|Overall Study||10
10149241|NCT02796924|11279582|FG000|COMPLETED|Overall Study||10
10149242|NCT02796924|11279582|FG000|NOT COMPLETED|Overall Study||0
10149243|NCT02796963|11279590|FG000|STARTED|Overall Study||383
10149244|NCT02796963|11279591|FG001|STARTED|Overall Study||328
10149245|NCT02796963|11279592|FG002|STARTED|Overall Study||316
10149246|NCT02796963|11279593|FG003|STARTED|Overall Study||354
10149247|NCT02796963|11279590|FG000|First Follow up|Overall Study||293
10149248|NCT02796963|11279591|FG001|First Follow up|Overall Study||279
10149249|NCT02796963|11279592|FG002|First Follow up|Overall Study||257
9848962|NCT00862849|10961754|FG002|STARTED|Washout 2 (3 to 14 Days)||3
9848963|NCT00862849|10961755|FG003|STARTED|Washout 2 (3 to 14 Days)||4
9848964|NCT00862849|10961756|FG004|STARTED|Washout 2 (3 to 14 Days)||4
9848965|NCT00862849|10961757|FG005|STARTED|Washout 2 (3 to 14 Days)||3
9848966|NCT00862849|10961752|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3
9848967|NCT00862849|10961753|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3
9848968|NCT00862849|10961754|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
9848969|NCT00862849|10961755|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4
9848970|NCT00862849|10961756|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4
9848971|NCT00862849|10961757|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3
9848972|NCT00862849|10961752|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10149250|NCT02796963|11279593|FG003|First Follow up|Overall Study||291
10149251|NCT02796963|11279590|FG000|Second Follow up|Overall Study||280
10149252|NCT02796963|11279591|FG001|Second Follow up|Overall Study||260
10149253|NCT02796963|11279592|FG002|Second Follow up|Overall Study||255
10149254|NCT02796963|11279593|FG003|Second Follow up|Overall Study||293
10149255|NCT02796963|11279590|FG000|Third Follow up|Overall Study||276
10149256|NCT02796963|11279591|FG001|Third Follow up|Overall Study||237
10149257|NCT02796963|11279592|FG002|Third Follow up|Overall Study||245
10149258|NCT02796963|11279593|FG003|Third Follow up|Overall Study||286
10149259|NCT02796963|11279590|FG000|Fourth Follow up|Overall Study||275
10149260|NCT02796963|11279591|FG001|Fourth Follow up|Overall Study||233
10149261|NCT02796963|11279592|FG002|Fourth Follow up|Overall Study||236
10149262|NCT02796963|11279593|FG003|Fourth Follow up|Overall Study||263
10149263|NCT02796963|11279590|FG000|HIV Sero Converted|Overall Study||19
10149264|NCT02796963|11279591|FG001|HIV Sero Converted|Overall Study||19
10149265|NCT02796963|11279592|FG002|HIV Sero Converted|Overall Study||11
10149266|NCT02796963|11279593|FG003|HIV Sero Converted|Overall Study||19
10149267|NCT02796963|11279590|FG000|COMPLETED|Overall Study||294
10149268|NCT02796963|11279591|FG001|COMPLETED|Overall Study||252
10149269|NCT02796963|11279592|FG002|COMPLETED|Overall Study||247
10149270|NCT02796963|11279593|FG003|COMPLETED|Overall Study||282
10149271|NCT02796963|11279590|FG000|NOT COMPLETED|Overall Study||89
10149272|NCT02796963|11279591|FG001|NOT COMPLETED|Overall Study||76
10149273|NCT02796963|11279592|FG002|NOT COMPLETED|Overall Study||69
10149274|NCT02796963|11279593|FG003|NOT COMPLETED|Overall Study||72
10149275|NCT02797054|11279606|FG000|STARTED|Post-test||387
10149276|NCT02797054|11279607|FG001|STARTED|Post-test||383
10149277|NCT02797054|11279608|FG002|STARTED|Post-test||435
10149278|NCT02797054|11279606|FG000|COMPLETED|Post-test||380
10149279|NCT02797054|11279607|FG001|COMPLETED|Post-test||372
10149280|NCT02797054|11279608|FG002|COMPLETED|Post-test||87
10149281|NCT02797054|11279606|FG000|NOT COMPLETED|Post-test||7
10149282|NCT02797054|11279607|FG001|NOT COMPLETED|Post-test||11
10149283|NCT02797054|11279608|FG002|NOT COMPLETED|Post-test||348
10149284|NCT02797054|11279606|FG000|STARTED|Follow-up||387
10149285|NCT02797054|11279607|FG001|STARTED|Follow-up||383
10149286|NCT02797054|11279608|FG002|STARTED|Follow-up||435
10149287|NCT02797054|11279606|FG000|COMPLETED|Follow-up||178
10149288|NCT02797054|11279607|FG001|COMPLETED|Follow-up||155
10149289|NCT02797054|11279608|FG002|COMPLETED|Follow-up||150
10149290|NCT02797054|11279606|FG000|NOT COMPLETED|Follow-up||209
10149291|NCT02797054|11279607|FG001|NOT COMPLETED|Follow-up||228
10149292|NCT02797054|11279608|FG002|NOT COMPLETED|Follow-up||285
10149293|NCT02797080|11279616|FG000|STARTED|Overall Study||38
10149294|NCT02797080|11279616|FG000|COMPLETED|Overall Study||36
10149295|NCT02797080|11279616|FG000|NOT COMPLETED|Overall Study||2
10149296|NCT02797132|11279620|FG000|STARTED|Part A (15 Days)||12
10149297|NCT02797132|11279620|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4
10149298|NCT02797132|11279620|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8
10149299|NCT02797132|11279620|FG000|COMPLETED|Part A (15 Days)||11
10149300|NCT02797132|11279620|FG000|NOT COMPLETED|Part A (15 Days)||1
10149301|NCT02797132|11279620|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
10149302|NCT02797132|11279620|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19
10149303|NCT02797132|11279620|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
10149304|NCT02797132|11279620|FG000|COMPLETED|Part B (24 Weeks)||57
10149305|NCT02797132|11279620|FG000|NOT COMPLETED|Part B (24 Weeks)||3
10149306|NCT02797171|11279639|FG000|STARTED|Overall Study||23
10149307|NCT02797171|11279640|FG001|STARTED|Overall Study||23
10149308|NCT02797171|11279641|FG002|STARTED|Overall Study||7
10149309|NCT02797171|11279642|FG003|STARTED|Overall Study||16
10149310|NCT02797171|11279643|FG004|STARTED|Overall Study||10
10149311|NCT02797171|11279644|FG005|STARTED|Overall Study||1
10149312|NCT02797171|11279639|FG000|Safety Population|Overall Study||23
10149313|NCT02797171|11279640|FG001|Safety Population|Overall Study||23
10149314|NCT02797171|11279641|FG002|Safety Population|Overall Study||7
10149315|NCT02797171|11279642|FG003|Safety Population|Overall Study||16
10149316|NCT02797171|11279643|FG004|Safety Population|Overall Study||10
10149317|NCT02797171|11279644|FG005|Safety Population|Overall Study||1
10149318|NCT02797171|11279639|FG000|COMPLETED|Overall Study||19
10149319|NCT02797171|11279640|FG001|COMPLETED|Overall Study||21
10149320|NCT02797171|11279641|FG002|COMPLETED|Overall Study||5
10149321|NCT02797171|11279642|FG003|COMPLETED|Overall Study||15
10149322|NCT02797171|11279643|FG004|COMPLETED|Overall Study||8
10149323|NCT02797171|11279644|FG005|COMPLETED|Overall Study||0
10149324|NCT02797171|11279639|FG000|NOT COMPLETED|Overall Study||4
10149325|NCT02797171|11279640|FG001|NOT COMPLETED|Overall Study||2
10149326|NCT02797171|11279641|FG002|NOT COMPLETED|Overall Study||2
10149327|NCT02797171|11279642|FG003|NOT COMPLETED|Overall Study||1
10149328|NCT02797171|11279643|FG004|NOT COMPLETED|Overall Study||2
10149329|NCT02797171|11279644|FG005|NOT COMPLETED|Overall Study||1
10149330|NCT02797522|11279669|FG000|STARTED|Overall Study||4
10149331|NCT02797522|11279670|FG001|STARTED|Overall Study||4
10149332|NCT02797522|11279671|FG002|STARTED|Overall Study||4
10149333|NCT02797522|11279672|FG003|STARTED|Overall Study||4
10149334|NCT02797522|11279673|FG004|STARTED|Overall Study||4
10149335|NCT02797522|11279674|FG005|STARTED|Overall Study||4
10149336|NCT02797522|11279675|FG006|STARTED|Overall Study||12
10149337|NCT02797522|11279676|FG007|STARTED|Overall Study||4
10149338|NCT02797522|11279677|FG008|STARTED|Overall Study||2
10149339|NCT02797522|11279678|FG009|STARTED|Overall Study||4
10149340|NCT02797522|11279679|FG010|STARTED|Overall Study||1
10149341|NCT02797522|11279669|FG000|COMPLETED|Overall Study||4
10149342|NCT02797522|11279670|FG001|COMPLETED|Overall Study||4
10149343|NCT02797522|11279671|FG002|COMPLETED|Overall Study||4
10149344|NCT02797522|11279672|FG003|COMPLETED|Overall Study||4
10149345|NCT02797522|11279673|FG004|COMPLETED|Overall Study||4
10149346|NCT02797522|11279674|FG005|COMPLETED|Overall Study||4
10149347|NCT02797522|11279675|FG006|COMPLETED|Overall Study||12
10149348|NCT02797522|11279676|FG007|COMPLETED|Overall Study||0
10149349|NCT02797522|11279677|FG008|COMPLETED|Overall Study||0
10149350|NCT02797522|11279678|FG009|COMPLETED|Overall Study||0
10149351|NCT02797522|11279679|FG010|COMPLETED|Overall Study||0
10149352|NCT02797522|11279669|FG000|NOT COMPLETED|Overall Study||0
10149353|NCT02797522|11279670|FG001|NOT COMPLETED|Overall Study||0
10149354|NCT02797522|11279671|FG002|NOT COMPLETED|Overall Study||0
10149355|NCT02797522|11279672|FG003|NOT COMPLETED|Overall Study||0
10149356|NCT02797522|11279673|FG004|NOT COMPLETED|Overall Study||0
10149357|NCT02797522|11279674|FG005|NOT COMPLETED|Overall Study||0
10149358|NCT02797522|11279675|FG006|NOT COMPLETED|Overall Study||0
10149359|NCT02797522|11279676|FG007|NOT COMPLETED|Overall Study||4
10149360|NCT02797522|11279677|FG008|NOT COMPLETED|Overall Study||2
10149361|NCT02797522|11279678|FG009|NOT COMPLETED|Overall Study||4
10149362|NCT02797522|11279679|FG010|NOT COMPLETED|Overall Study||1
10149363|NCT02797613|11279709|FG000|STARTED|Overall Study||55
10149364|NCT02797613|11279710|FG001|STARTED|Overall Study||55
10149365|NCT02797613|11279709|FG000|COMPLETED|Overall Study||55
10149366|NCT02797613|11279710|FG001|COMPLETED|Overall Study||55
10149367|NCT02797613|11279709|FG000|NOT COMPLETED|Overall Study||0
10149368|NCT02797613|11279710|FG001|NOT COMPLETED|Overall Study||0
10149369|NCT02797678|11279716|FG000|STARTED|Screening Phase||62
10149370|NCT02797678|11279717|FG001|STARTED|Screening Phase||0
10149371|NCT02797678|11279718|FG002|STARTED|Screening Phase||0
10149372|NCT02797678|11279719|FG003|STARTED|Screening Phase||0
10149373|NCT02797678|11279716|FG000|COMPLETED|Screening Phase||37
10149374|NCT02797678|11279717|FG001|COMPLETED|Screening Phase||0
10149375|NCT02797678|11279718|FG002|COMPLETED|Screening Phase||0
10149376|NCT02797678|11279719|FG003|COMPLETED|Screening Phase||0
10149377|NCT02797678|11279716|FG000|NOT COMPLETED|Screening Phase||25
10149378|NCT02797678|11279717|FG001|NOT COMPLETED|Screening Phase||0
10149379|NCT02797678|11279718|FG002|NOT COMPLETED|Screening Phase||0
10149380|NCT02797678|11279719|FG003|NOT COMPLETED|Screening Phase||0
10149381|NCT02797678|11279716|FG000|STARTED|First Intervention (5 Nights)||0
10149382|NCT02797678|11279717|FG001|STARTED|First Intervention (5 Nights)||20
10149383|NCT02797678|11279718|FG002|STARTED|First Intervention (5 Nights)||17
10149384|NCT02797678|11279719|FG003|STARTED|First Intervention (5 Nights)||0
10149385|NCT02797678|11279716|FG000|COMPLETED|First Intervention (5 Nights)||0
10149386|NCT02797678|11279717|FG001|COMPLETED|First Intervention (5 Nights)||19
10149387|NCT02797678|11279718|FG002|COMPLETED|First Intervention (5 Nights)||17
10149388|NCT02797678|11279719|FG003|COMPLETED|First Intervention (5 Nights)||0
10149389|NCT02797678|11279716|FG000|NOT COMPLETED|First Intervention (5 Nights)||0
10149390|NCT02797678|11279717|FG001|NOT COMPLETED|First Intervention (5 Nights)||1
10149391|NCT02797678|11279718|FG002|NOT COMPLETED|First Intervention (5 Nights)||0
10149392|NCT02797678|11279719|FG003|NOT COMPLETED|First Intervention (5 Nights)||0
10149393|NCT02797678|11279716|FG000|STARTED|Washout||0
10149394|NCT02797678|11279717|FG001|STARTED|Washout||19
10149395|NCT02797678|11279718|FG002|STARTED|Washout||17
10149396|NCT02797678|11279719|FG003|STARTED|Washout||0
10149397|NCT02797678|11279716|FG000|COMPLETED|Washout||0
10149398|NCT02797678|11279717|FG001|COMPLETED|Washout||19
10149399|NCT02797678|11279718|FG002|COMPLETED|Washout||17
10149400|NCT02797678|11279719|FG003|COMPLETED|Washout||0
10149401|NCT02797678|11279716|FG000|NOT COMPLETED|Washout||0
10149402|NCT02797678|11279717|FG001|NOT COMPLETED|Washout||0
10149403|NCT02797678|11279718|FG002|NOT COMPLETED|Washout||0
10149404|NCT02797678|11279719|FG003|NOT COMPLETED|Washout||0
10149405|NCT02797678|11279716|FG000|STARTED|Second Intervention (5 Nights)||0
10149406|NCT02797678|11279717|FG001|STARTED|Second Intervention (5 Nights)||19
10149407|NCT02797678|11279718|FG002|STARTED|Second Intervention (5 Nights)||17
10149408|NCT02797678|11279719|FG003|STARTED|Second Intervention (5 Nights)||0
10149409|NCT02797678|11279716|FG000|COMPLETED|Second Intervention (5 Nights)||0
10149410|NCT02797678|11279717|FG001|COMPLETED|Second Intervention (5 Nights)||19
9709251|NCT04912700|10808613|FG000|STARTED|Overall Study||10880
9709252|NCT04912700|10808614|FG001|STARTED|Overall Study||825
9709253|NCT04912700|10808615|FG002|STARTED|Overall Study||129
9709254|NCT04912700|10808613|FG000|COMPLETED|Overall Study||10880
9709255|NCT04912700|10808614|FG001|COMPLETED|Overall Study||825
9709256|NCT04912700|10808615|FG002|COMPLETED|Overall Study||129
9709257|NCT04912700|10808613|FG000|NOT COMPLETED|Overall Study||0
9709258|NCT04912700|10808614|FG001|NOT COMPLETED|Overall Study||0
9709259|NCT04912700|10808615|FG002|NOT COMPLETED|Overall Study||0
9709260|NCT04912297|10808625|FG000|STARTED|Overall Study||99
9709261|NCT04912297|10808626|FG001|STARTED|Overall Study||87
9709262|NCT04912297|10808625|FG000|COMPLETED|Overall Study||68
9709263|NCT04912297|10808626|FG001|COMPLETED|Overall Study||54
9709264|NCT04912297|10808625|FG000|NOT COMPLETED|Overall Study||31
9709265|NCT04912297|10808626|FG001|NOT COMPLETED|Overall Study||33
9709272|NCT04904640|10808641|FG000|STARTED|Overall Study||150
9709273|NCT04904640|10808641|FG000|COMPLETED|Overall Study||150
9709274|NCT04904640|10808641|FG000|NOT COMPLETED|Overall Study||0
9709284|NCT04891874|10808664|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38
9709285|NCT04891874|10808665|FG001|STARTED|Overall Study||38
9709286|NCT04891874|10808664|FG000|COMPLETED|Overall Study||38
9709287|NCT04891874|10808665|FG001|COMPLETED|Overall Study||38
9709288|NCT04891874|10808664|FG000|NOT COMPLETED|Overall Study||0
9709289|NCT04891874|10808665|FG001|NOT COMPLETED|Overall Study||0
9709290|NCT04883541|10808673|FG000|STARTED|Overall Study||46
9709291|NCT04883541|10808674|FG001|STARTED|Overall Study||69
9709292|NCT04883541|10808673|FG000|COMPLETED|Overall Study||30
9709293|NCT04883541|10808674|FG001|COMPLETED|Overall Study||60
9709294|NCT04883541|10808673|FG000|NOT COMPLETED|Overall Study||16
9709295|NCT04883541|10808674|FG001|NOT COMPLETED|Overall Study||9
9709296|NCT04881968|10808680|FG000|STARTED|Overall Study||1261
9709297|NCT04881968|10808680|FG000|COMPLETED|Overall Study||1261
9709298|NCT04881968|10808680|FG000|NOT COMPLETED|Overall Study||0
9709299|NCT04486560|10808684|FG000|STARTED|Overall Study||51
9709300|NCT04486560|10808684|FG000|COMPLETED|Overall Study||50
9709301|NCT04486560|10808684|FG000|NOT COMPLETED|Overall Study||1
9709302|NCT04357782|10808690|FG000|STARTED|Overall Study||10
9709303|NCT04357782|10808691|FG001|STARTED|Overall Study||10
9709304|NCT04357782|10808690|FG000|COMPLETED|Overall Study||9
9709305|NCT04357782|10808691|FG001|COMPLETED|Overall Study||8
9709306|NCT04357782|10808690|FG000|NOT COMPLETED|Overall Study||1
9709307|NCT04357782|10808691|FG001|NOT COMPLETED|Overall Study||2
9709308|NCT04090658|10808699|FG000|STARTED|Overall Study||20
9709309|NCT04090658|10808700|FG001|STARTED|Overall Study||20
9709310|NCT04090658|10808699|FG000|COMPLETED|Overall Study||20
9709311|NCT04090658|10808700|FG001|COMPLETED|Overall Study||20
9709312|NCT04090658|10808699|FG000|NOT COMPLETED|Overall Study||0
9709313|NCT04090658|10808700|FG001|NOT COMPLETED|Overall Study||0
9709314|NCT03811028|10808708|FG000|STARTED|Overall Study||3
9709315|NCT03811028|10808709|FG001|STARTED|Overall Study||3
9709316|NCT03811028|10808708|FG000|COMPLETED|Overall Study||3
9709317|NCT03811028|10808709|FG001|COMPLETED|Overall Study||3
9709318|NCT03811028|10808708|FG000|NOT COMPLETED|Overall Study||0
9709319|NCT03811028|10808709|FG001|NOT COMPLETED|Overall Study||0
9709320|NCT03760068|10808718|FG000|STARTED|Overall Study||238
9709321|NCT03760068|10808719|FG001|STARTED|Overall Study||240
9709322|NCT03760068|10808718|FG000|COMPLETED|Overall Study||224
9709323|NCT03760068|10808719|FG001|COMPLETED|Overall Study||217
9709324|NCT03760068|10808718|FG000|NOT COMPLETED|Overall Study||14
9709325|NCT03760068|10808719|FG001|NOT COMPLETED|Overall Study||23
9709326|NCT03742986|10808728|FG000|STARTED|Overall Study||4
9709327|NCT03742986|10808729|FG001|STARTED|Overall Study||4
9709328|NCT03742986|10808728|FG000|COMPLETED|Overall Study||4
9709329|NCT03742986|10808729|FG001|COMPLETED|Overall Study||4
9709330|NCT03742986|10808728|FG000|NOT COMPLETED|Overall Study||0
9709331|NCT03742986|10808729|FG001|NOT COMPLETED|Overall Study||0
9709332|NCT03628781|10808737|FG000|STARTED|Overall Study||85
9709333|NCT03628781|10808738|FG001|STARTED|Overall Study||84
9709334|NCT03628781|10808737|FG000|6-month Timepoint|Overall Study||63
9709335|NCT03628781|10808738|FG001|6-month Timepoint|Overall Study||79
9709336|NCT03628781|10808737|FG000|12-month Timepoint|Overall Study||53
10149411|NCT02797678|11279718|FG002|COMPLETED|Second Intervention (5 Nights)||16
9709337|NCT03628781|10808738|FG001|12-month Timepoint|Overall Study||75
9709338|NCT03628781|10808737|FG000|COMPLETED|Overall Study||53
9709339|NCT03628781|10808738|FG001|COMPLETED|Overall Study||75
9709340|NCT03628781|10808737|FG000|NOT COMPLETED|Overall Study||32
9709341|NCT03628781|10808738|FG001|NOT COMPLETED|Overall Study||9
9709342|NCT03560206|10808746|FG000|STARTED|Overall Study||158
9709343|NCT03560206|10808747|FG001|STARTED|Overall Study||158
9709344|NCT03560206|10808746|FG000|COMPLETED|Overall Study||108
9709345|NCT03560206|10808747|FG001|COMPLETED|Overall Study||140
9709346|NCT03560206|10808746|FG000|NOT COMPLETED|Overall Study||50
9709347|NCT03560206|10808747|FG001|NOT COMPLETED|Overall Study||18
10149412|NCT02797678|11279719|FG003|COMPLETED|Second Intervention (5 Nights)||0
10149413|NCT02797678|11279716|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0
10149414|NCT02797678|11279717|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0
10149415|NCT02797678|11279718|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1
10149416|NCT02797678|11279719|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0
10149417|NCT02797678|11279716|FG000|STARTED|Sub-Study||0
10149418|NCT02797678|11279717|FG001|STARTED|Sub-Study||0
10149419|NCT02797678|11279718|FG002|STARTED|Sub-Study||0
10149420|NCT02797678|11279719|FG003|STARTED|Sub-Study||9
9848973|NCT00862849|10961753|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
9848974|NCT00862849|10961754|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9848975|NCT00862849|10961755|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9848976|NCT00862849|10961756|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9848977|NCT00862849|10961757|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
9848978|NCT00862849|10961752|FG000|STARTED|Intervention 3||3
9848979|NCT00862849|10961753|FG001|STARTED|Intervention 3||3
9848980|NCT00862849|10961754|FG002|STARTED|Intervention 3||3
9848981|NCT00862849|10961755|FG003|STARTED|Intervention 3||4
9848982|NCT00862849|10961756|FG004|STARTED|Intervention 3||4
10149421|NCT02797678|11279716|FG000|COMPLETED|Sub-Study||0
10149422|NCT02797678|11279717|FG001|COMPLETED|Sub-Study||0
10149423|NCT02797678|11279718|FG002|COMPLETED|Sub-Study||0
10149424|NCT02797678|11279719|FG003|COMPLETED|Sub-Study||9
10149425|NCT02797678|11279716|FG000|NOT COMPLETED|Sub-Study||0
10149426|NCT02797678|11279717|FG001|NOT COMPLETED|Sub-Study||0
10149427|NCT02797678|11279718|FG002|NOT COMPLETED|Sub-Study||0
10149428|NCT02797678|11279719|FG003|NOT COMPLETED|Sub-Study||0
10149429|NCT02797808|11279734|FG000|STARTED|Overall Study||23
10149430|NCT02797808|11279735|FG001|STARTED|Overall Study||18
10149431|NCT02797808|11279734|FG000|COMPLETED|Overall Study||16
10149432|NCT02797808|11279735|FG001|COMPLETED|Overall Study||15
10149433|NCT02797808|11279734|FG000|NOT COMPLETED|Overall Study||7
10149434|NCT02797808|11279735|FG001|NOT COMPLETED|Overall Study||3
10149435|NCT02797821|11279744|FG000|STARTED|Overall Study||8
10149436|NCT02797821|11279745|FG001|STARTED|Overall Study||10
10149437|NCT02797821|11279746|FG002|STARTED|Overall Study||9
10149438|NCT02797821|11279744|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10149439|NCT02797821|11279745|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10149440|NCT02797821|11279746|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
10149441|NCT02797821|11279744|FG000|COMPLETED|Overall Study||8
9709266|NCT04910165|10808634|FG000|STARTED|Overall Study||50
9709267|NCT04910165|10808635|FG001|STARTED|Overall Study||50
9709268|NCT04910165|10808634|FG000|COMPLETED|Overall Study||50
9709269|NCT04910165|10808635|FG001|COMPLETED|Overall Study||50
9709270|NCT04910165|10808634|FG000|NOT COMPLETED|Overall Study||0
9709271|NCT04910165|10808635|FG001|NOT COMPLETED|Overall Study||0
9709275|NCT04901897|10808652|FG000|STARTED|Overall Study||398
9709276|NCT04901897|10808653|FG001|STARTED|Overall Study||202
9709277|NCT04901897|10808654|FG002|STARTED|Overall Study||205
9709278|NCT04901897|10808652|FG000|COMPLETED|Overall Study||393
9709279|NCT04901897|10808653|FG001|COMPLETED|Overall Study||200
9709280|NCT04901897|10808654|FG002|COMPLETED|Overall Study||203
9709281|NCT04901897|10808652|FG000|NOT COMPLETED|Overall Study||5
9709282|NCT04901897|10808653|FG001|NOT COMPLETED|Overall Study||2
9709283|NCT04901897|10808654|FG002|NOT COMPLETED|Overall Study||2
9709348|NCT03340766|10808756|FG000|STARTED|Overall Study||12
9709349|NCT03340766|10808757|FG001|STARTED|Overall Study||10
9848983|NCT00862849|10961757|FG005|STARTED|Intervention 3||3
9848984|NCT00862849|10961752|FG000|COMPLETED|Intervention 3||3
9848985|NCT00862849|10961753|FG001|COMPLETED|Intervention 3||3
9848986|NCT00862849|10961754|FG002|COMPLETED|Intervention 3||3
10149442|NCT02797821|11279745|FG001|COMPLETED|Overall Study||10
10149443|NCT02797821|11279746|FG002|COMPLETED|Overall Study||9
10149444|NCT02797821|11279744|FG000|NOT COMPLETED|Overall Study||0
10149445|NCT02797821|11279745|FG001|NOT COMPLETED|Overall Study||0
10149446|NCT02797821|11279746|FG002|NOT COMPLETED|Overall Study||0
9709350|NCT03340766|10808758|FG002|STARTED|Overall Study||9
9709351|NCT03340766|10808756|FG000|Received Blinatumomab|Overall Study||12
10149447|NCT02798211|11279757|FG000|STARTED|Period 1||103
10149448|NCT02798211|11279758|FG001|STARTED|Period 1||103
10149449|NCT02798211|11279759|FG002|STARTED|Period 1||52
10149450|NCT02798211|11279760|FG003|STARTED|Period 1||0
10149451|NCT02798211|11279761|FG004|STARTED|Period 1||0
10149452|NCT02798211|11279762|FG005|STARTED|Period 1||0
10149453|NCT02798211|11279757|FG000|COMPLETED|Period 1||97
10149454|NCT02798211|11279758|FG001|COMPLETED|Period 1||93
10149455|NCT02798211|11279759|FG002|COMPLETED|Period 1||46
10149456|NCT02798211|11279760|FG003|COMPLETED|Period 1||0
10149457|NCT02798211|11279761|FG004|COMPLETED|Period 1||0
10149458|NCT02798211|11279762|FG005|COMPLETED|Period 1||0
10149459|NCT02798211|11279757|FG000|NOT COMPLETED|Period 1||6
10149460|NCT02798211|11279758|FG001|NOT COMPLETED|Period 1||10
10149461|NCT02798211|11279759|FG002|NOT COMPLETED|Period 1||6
10149462|NCT02798211|11279760|FG003|NOT COMPLETED|Period 1||0
10149463|NCT02798211|11279761|FG004|NOT COMPLETED|Period 1||0
10149464|NCT02798211|11279762|FG005|NOT COMPLETED|Period 1||0
10149465|NCT02798211|11279757|FG000|STARTED|Period 2||97
10149466|NCT02798211|11279758|FG001|STARTED|Period 2||0
10149467|NCT02798211|11279759|FG002|STARTED|Period 2||0
10149468|NCT02798211|11279760|FG003|STARTED|Period 2||50
10149469|NCT02798211|11279761|FG004|STARTED|Period 2||42
10149470|NCT02798211|11279762|FG005|STARTED|Period 2||46
10149471|NCT02798211|11279757|FG000|COMPLETED|Period 2||83
10149472|NCT02798211|11279758|FG001|COMPLETED|Period 2||0
10149473|NCT02798211|11279759|FG002|COMPLETED|Period 2||0
10149474|NCT02798211|11279760|FG003|COMPLETED|Period 2||43
10149475|NCT02798211|11279761|FG004|COMPLETED|Period 2||34
10149476|NCT02798211|11279762|FG005|COMPLETED|Period 2||40
10149477|NCT02798211|11279757|FG000|NOT COMPLETED|Period 2||14
10149478|NCT02798211|11279758|FG001|NOT COMPLETED|Period 2||0
10149479|NCT02798211|11279759|FG002|NOT COMPLETED|Period 2||0
10149480|NCT02798211|11279760|FG003|NOT COMPLETED|Period 2||7
10149481|NCT02798211|11279761|FG004|NOT COMPLETED|Period 2||8
10149482|NCT02798211|11279762|FG005|NOT COMPLETED|Period 2||6
10149483|NCT02798289|11279774|FG000|STARTED|Overall Study||55
10149484|NCT02798289|11279774|FG000|COMPLETED|Overall Study||55
10149485|NCT02798289|11279774|FG000|NOT COMPLETED|Overall Study||0
10149486|NCT02798315|11279778|FG000|STARTED|Overall Study||40
10149487|NCT02798315|11279778|FG000|COMPLETED|Overall Study||39
10149488|NCT02798315|11279778|FG000|NOT COMPLETED|Overall Study||1
10149489|NCT02798354|11279785|FG000|STARTED|First Intervention Period||1184
10149490|NCT02798354|11279786|FG001|STARTED|First Intervention Period||2176
10149491|NCT02798354|11279787|FG002|STARTED|First Intervention Period||990
10149492|NCT02798354|11279785|FG000|Control Data Error 1|First Intervention Period||440
10149493|NCT02798354|11279786|FG001|Control Data Error 1|First Intervention Period||549
10149494|NCT02798354|11279787|FG002|Control Data Error 1|First Intervention Period||345
10149495|NCT02798354|11279785|FG000|Intervention Data Error 1|First Intervention Period||744
10149496|NCT02798354|11279786|FG001|Intervention Data Error 1|First Intervention Period||1627
10149497|NCT02798354|11279787|FG002|Intervention Data Error 1|First Intervention Period||645
10149498|NCT02798354|11279785|FG000|COMPLETED|First Intervention Period||1184
10149499|NCT02798354|11279786|FG001|COMPLETED|First Intervention Period||2176
10149500|NCT02798354|11279787|FG002|COMPLETED|First Intervention Period||990
10149501|NCT02798354|11279785|FG000|NOT COMPLETED|First Intervention Period||0
10149502|NCT02798354|11279786|FG001|NOT COMPLETED|First Intervention Period||0
10149503|NCT02798354|11279787|FG002|NOT COMPLETED|First Intervention Period||0
10149504|NCT02798354|11279785|FG000|STARTED|Second Intervention Period||2617
10149505|NCT02798354|11279786|FG001|STARTED|Second Intervention Period||1047
10149506|NCT02798354|11279787|FG002|STARTED|Second Intervention Period||1368
10149507|NCT02798354|11279785|FG000|Control Data Error 2|Second Intervention Period||1378
10149508|NCT02798354|11279786|FG001|Control Data Error 2|Second Intervention Period||593
10149509|NCT02798354|11279787|FG002|Control Data Error 2|Second Intervention Period||668
10149510|NCT02798354|11279785|FG000|Intervention Data Error 2|Second Intervention Period||1239
10149511|NCT02798354|11279786|FG001|Intervention Data Error 2|Second Intervention Period||454
10149512|NCT02798354|11279787|FG002|Intervention Data Error 2|Second Intervention Period||700
10149513|NCT02798354|11279785|FG000|COMPLETED|Second Intervention Period||2617
9709352|NCT03340766|10808757|FG001|Received Blinatumomab|Overall Study||10
9709353|NCT03340766|10808758|FG002|Received Blinatumomab|Overall Study||9
9709354|NCT03340766|10808756|FG000|Received Pembrolizumab|Overall Study||10
9709355|NCT03340766|10808757|FG001|Received Pembrolizumab|Overall Study||7
9709356|NCT03340766|10808758|FG002|Received Pembrolizumab|Overall Study||7
9709357|NCT03340766|10808756|FG000|COMPLETED|Overall Study||1
9709358|NCT03340766|10808757|FG001|COMPLETED|Overall Study||0
9709359|NCT03340766|10808758|FG002|COMPLETED|Overall Study||0
9709360|NCT03340766|10808756|FG000|NOT COMPLETED|Overall Study||11
9709361|NCT03340766|10808757|FG001|NOT COMPLETED|Overall Study||10
9709362|NCT03340766|10808758|FG002|NOT COMPLETED|Overall Study||9
9709363|NCT03043599|10808772|FG000|STARTED|Overall Study||21
9709364|NCT03043599|10808772|FG000|COMPLETED|Overall Study||21
9709365|NCT03043599|10808772|FG000|NOT COMPLETED|Overall Study||0
10149514|NCT02798354|11279786|FG001|COMPLETED|Second Intervention Period||1047
10149515|NCT02798354|11279787|FG002|COMPLETED|Second Intervention Period||1368
9709366|NCT02706847|10808779|FG000|STARTED|Day 1 to Week 12||85
10149516|NCT02798354|11279785|FG000|NOT COMPLETED|Second Intervention Period||0
10149517|NCT02798354|11279786|FG001|NOT COMPLETED|Second Intervention Period||0
10149518|NCT02798354|11279787|FG002|NOT COMPLETED|Second Intervention Period||0
10149519|NCT02798354|11279785|FG000|STARTED|Third Intervention Period||746
10149520|NCT02798354|11279786|FG001|STARTED|Third Intervention Period||1010
10149521|NCT02798354|11279787|FG002|STARTED|Third Intervention Period||2715
10149522|NCT02798354|11279785|FG000|Control Data Error 3|Third Intervention Period||419
9709367|NCT02706847|10808780|FG001|STARTED|Day 1 to Week 12||84
9709368|NCT02706847|10808781|FG002|STARTED|Day 1 to Week 12||165
10149523|NCT02798354|11279786|FG001|Control Data Error 3|Third Intervention Period||620
10149524|NCT02798354|11279787|FG002|Control Data Error 3|Third Intervention Period||1467
10149525|NCT02798354|11279785|FG000|Intervention Data Error 3|Third Intervention Period||327
10149526|NCT02798354|11279786|FG001|Intervention Data Error 3|Third Intervention Period||390
10149527|NCT02798354|11279787|FG002|Intervention Data Error 3|Third Intervention Period||1248
10149528|NCT02798354|11279785|FG000|COMPLETED|Third Intervention Period||746
10149529|NCT02798354|11279786|FG001|COMPLETED|Third Intervention Period||1010
10149530|NCT02798354|11279787|FG002|COMPLETED|Third Intervention Period||2715
10149531|NCT02798354|11279785|FG000|NOT COMPLETED|Third Intervention Period||0
10149532|NCT02798354|11279786|FG001|NOT COMPLETED|Third Intervention Period||0
10149533|NCT02798354|11279787|FG002|NOT COMPLETED|Third Intervention Period||0
10149534|NCT02798380|11279801|FG000|STARTED|Overall Study||30
10149535|NCT02798380|11279801|FG000|COMPLETED|Overall Study||30
10149536|NCT02798380|11279801|FG000|NOT COMPLETED|Overall Study||0
10149537|NCT02798627|11279807|FG000|STARTED|Overall Study||27
10149538|NCT02798627|11279808|FG001|STARTED|Overall Study||28
10149539|NCT02798627|11279807|FG000|COMPLETED|Overall Study||27
10149540|NCT02798627|11279808|FG001|COMPLETED|Overall Study||28
10149541|NCT02798627|11279807|FG000|NOT COMPLETED|Overall Study||0
10149542|NCT02798627|11279808|FG001|NOT COMPLETED|Overall Study||0
10149543|NCT02798835|11279817|FG000|STARTED|Overall Study||60
10149544|NCT02798835|11279818|FG001|STARTED|Overall Study||60
10149545|NCT02798835|11279819|FG002|STARTED|Overall Study||60
10149546|NCT02798835|11279817|FG000|COMPLETED|Overall Study||60
10149547|NCT02798835|11279818|FG001|COMPLETED|Overall Study||60
10149548|NCT02798835|11279819|FG002|COMPLETED|Overall Study||57
10149549|NCT02798835|11279817|FG000|NOT COMPLETED|Overall Study||0
10149550|NCT02798835|11279818|FG001|NOT COMPLETED|Overall Study||0
10149551|NCT02798835|11279819|FG002|NOT COMPLETED|Overall Study||3
10149552|NCT02798861|11279827|FG000|STARTED|Overall Study||160
10149553|NCT02798861|11279827|FG000|COMPLETED|Overall Study||137
10149554|NCT02798861|11279827|FG000|NOT COMPLETED|Overall Study||23
10149555|NCT02798952|11279831|FG000|STARTED|Overall Study||302
10149556|NCT02798952|11279831|FG000|COMPLETED|Overall Study||302
10149557|NCT02798952|11279831|FG000|NOT COMPLETED|Overall Study||0
10149558|NCT02798978|11279842|FG000|STARTED|Part 1 (30 Days)||10
10149559|NCT02798978|11279843|FG001|STARTED|Part 1 (30 Days)||6
10149560|NCT02798978|11279844|FG002|STARTED|Part 1 (30 Days)||6
10149561|NCT02798978|11279845|FG003|STARTED|Part 1 (30 Days)||6
10149562|NCT02798978|11279846|FG004|STARTED|Part 1 (30 Days)||6
10149563|NCT02798978|11279847|FG005|STARTED|Part 1 (30 Days)||6
10149564|NCT02798978|11279848|FG006|STARTED|Part 1 (30 Days)||0
10149565|NCT02798978|11279842|FG000|COMPLETED|Part 1 (30 Days)||10
10149566|NCT02798978|11279843|FG001|COMPLETED|Part 1 (30 Days)||6
10149567|NCT02798978|11279844|FG002|COMPLETED|Part 1 (30 Days)||6
10149568|NCT02798978|11279845|FG003|COMPLETED|Part 1 (30 Days)||6
10149569|NCT02798978|11279846|FG004|COMPLETED|Part 1 (30 Days)||6
10149570|NCT02798978|11279847|FG005|COMPLETED|Part 1 (30 Days)||6
10149571|NCT02798978|11279848|FG006|COMPLETED|Part 1 (30 Days)||0
10149572|NCT02798978|11279842|FG000|NOT COMPLETED|Part 1 (30 Days)||0
10149573|NCT02798978|11279843|FG001|NOT COMPLETED|Part 1 (30 Days)||0
10149574|NCT02798978|11279844|FG002|NOT COMPLETED|Part 1 (30 Days)||0
10149575|NCT02798978|11279845|FG003|NOT COMPLETED|Part 1 (30 Days)||0
10149576|NCT02798978|11279846|FG004|NOT COMPLETED|Part 1 (30 Days)||0
10149577|NCT02798978|11279847|FG005|NOT COMPLETED|Part 1 (30 Days)||0
10149578|NCT02798978|11279848|FG006|NOT COMPLETED|Part 1 (30 Days)||0
10149579|NCT02798978|11279842|FG000|STARTED|Part 2 (45 Days)||0
10149580|NCT02798978|11279843|FG001|STARTED|Part 2 (45 Days)||0
10149581|NCT02798978|11279844|FG002|STARTED|Part 2 (45 Days)||0
10149582|NCT02798978|11279845|FG003|STARTED|Part 2 (45 Days)||0
10149583|NCT02798978|11279846|FG004|STARTED|Part 2 (45 Days)||0
10149584|NCT02798978|11279847|FG005|STARTED|Part 2 (45 Days)||0
10149585|NCT02798978|11279848|FG006|STARTED|Part 2 (45 Days)||0
10149586|NCT02798978|11279842|FG000|COMPLETED|Part 2 (45 Days)||0
10149587|NCT02798978|11279843|FG001|COMPLETED|Part 2 (45 Days)||0
10149588|NCT02798978|11279844|FG002|COMPLETED|Part 2 (45 Days)||0
10149589|NCT02798978|11279845|FG003|COMPLETED|Part 2 (45 Days)||0
10149590|NCT02798978|11279846|FG004|COMPLETED|Part 2 (45 Days)||0
10149591|NCT02798978|11279847|FG005|COMPLETED|Part 2 (45 Days)||0
10149592|NCT02798978|11279848|FG006|COMPLETED|Part 2 (45 Days)||0
10149593|NCT02798978|11279842|FG000|NOT COMPLETED|Part 2 (45 Days)||0
10149594|NCT02798978|11279843|FG001|NOT COMPLETED|Part 2 (45 Days)||0
10149595|NCT02798978|11279844|FG002|NOT COMPLETED|Part 2 (45 Days)||0
10149596|NCT02798978|11279845|FG003|NOT COMPLETED|Part 2 (45 Days)||0
10149597|NCT02798978|11279846|FG004|NOT COMPLETED|Part 2 (45 Days)||0
10149598|NCT02798978|11279847|FG005|NOT COMPLETED|Part 2 (45 Days)||0
10149599|NCT02798978|11279848|FG006|NOT COMPLETED|Part 2 (45 Days)||0
10149600|NCT02799069|11279873|FG000|STARTED|Overall Study||76
10149601|NCT02799069|11279874|FG001|STARTED|Overall Study||248
10149602|NCT02799069|11279875|FG002|STARTED|Overall Study||247
10149603|NCT02799069|11279873|FG000|ITT/Safety|Overall Study||76
10149604|NCT02799069|11279874|FG001|ITT/Safety|Overall Study||248
10149605|NCT02799069|11279875|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
10149606|NCT02799069|11279873|FG000|COMPLETED|Overall Study||68
10149607|NCT02799069|11279874|FG001|COMPLETED|Overall Study||241
10149608|NCT02799069|11279875|FG002|COMPLETED|Overall Study||240
10149609|NCT02799069|11279873|FG000|NOT COMPLETED|Overall Study||8
10149610|NCT02799069|11279874|FG001|NOT COMPLETED|Overall Study||7
10149611|NCT02799069|11279875|FG002|NOT COMPLETED|Overall Study||7
10149612|NCT02799082|11279885|FG000|STARTED|Overall Study||41
10149613|NCT02799082|11279886|FG001|STARTED|Overall Study||81
10149614|NCT02799082|11279885|FG000|COMPLETED|Overall Study||37
10149615|NCT02799082|11279886|FG001|COMPLETED|Overall Study||77
10149616|NCT02799082|11279885|FG000|NOT COMPLETED|Overall Study||4
10149617|NCT02799082|11279886|FG001|NOT COMPLETED|Overall Study||4
10149618|NCT02799290|11279895|FG000|STARTED|Overall Study||24
10149619|NCT02799290|11279896|FG001|STARTED|Overall Study||13
10149620|NCT02799290|11279897|FG002|STARTED|Overall Study||11
10149621|NCT02799290|11279895|FG000|COMPLETED|Overall Study||24
10149622|NCT02799290|11279896|FG001|COMPLETED|Overall Study||13
10149623|NCT02799290|11279897|FG002|COMPLETED|Overall Study||11
10149624|NCT02799290|11279895|FG000|NOT COMPLETED|Overall Study||0
10149625|NCT02799290|11279896|FG001|NOT COMPLETED|Overall Study||0
10149626|NCT02799290|11279897|FG002|NOT COMPLETED|Overall Study||0
10149627|NCT02799381|11279911|FG000|STARTED|Overall Study||33
10149628|NCT02799381|11279912|FG001|STARTED|Overall Study||28
10149629|NCT02799381|11279911|FG000|COMPLETED|Overall Study||29
10149630|NCT02799381|11279912|FG001|COMPLETED|Overall Study||25
10149631|NCT02799381|11279911|FG000|NOT COMPLETED|Overall Study||4
10149632|NCT02799381|11279912|FG001|NOT COMPLETED|Overall Study||3
10149633|NCT02799472|11279920|FG000|STARTED|Overall Study||11
10149634|NCT02799472|11279921|FG001|STARTED|Overall Study||28
10149635|NCT02799472|11279920|FG000|COMPLETED|Overall Study||7
10149636|NCT02799472|11279921|FG001|COMPLETED|Overall Study||23
10149637|NCT02799472|11279920|FG000|NOT COMPLETED|Overall Study||4
10149638|NCT02799472|11279921|FG001|NOT COMPLETED|Overall Study||5
10149639|NCT02799667|11279929|FG000|STARTED|Overall Study||55
10149640|NCT02799667|11279930|FG001|STARTED|Overall Study||55
10149641|NCT02799667|11279929|FG000|COMPLETED|Overall Study||54
10149642|NCT02799667|11279930|FG001|COMPLETED|Overall Study||54
10149643|NCT02799667|11279929|FG000|NOT COMPLETED|Overall Study||1
10149644|NCT02799667|11279930|FG001|NOT COMPLETED|Overall Study||1
10149645|NCT02799745|11279938|FG000|STARTED|Overall Study||114
10149646|NCT02799745|11279939|FG001|STARTED|Overall Study||113
10149647|NCT02799745|11279938|FG000|Treated|Overall Study||112
10149648|NCT02799745|11279939|FG001|Treated|Overall Study||113
10149649|NCT02799745|11279938|FG000|COMPLETED|Overall Study||58
10149650|NCT02799745|11279939|FG001|COMPLETED|Overall Study||42
10149651|NCT02799745|11279938|FG000|NOT COMPLETED|Overall Study||56
10149652|NCT02799745|11279939|FG001|NOT COMPLETED|Overall Study||71
10149653|NCT02799784|11279945|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
10149654|NCT02799784|11279946|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
10149655|NCT02799784|11279945|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
10149656|NCT02799784|11279946|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
10149657|NCT02799784|11279945|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
10149658|NCT02799784|11279946|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
10149659|NCT02799784|11279945|FG000|STARTED|Washout Period (3 Weeks)||111
10149660|NCT02799784|11279946|FG001|STARTED|Washout Period (3 Weeks)||118
10149661|NCT02799784|11279945|FG000|COMPLETED|Washout Period (3 Weeks)||111
10149662|NCT02799784|11279946|FG001|COMPLETED|Washout Period (3 Weeks)||118
10149663|NCT02799784|11279945|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
10149664|NCT02799784|11279946|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
10149665|NCT02799784|11279945|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
10149666|NCT02799784|11279946|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
10149667|NCT02799784|11279945|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
10149668|NCT02799784|11279946|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
10149669|NCT02799784|11279945|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
10149670|NCT02799784|11279946|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
10149671|NCT02800148|11279955|FG000|STARTED|Overall Study||224
10149672|NCT02800148|11279956|FG001|STARTED|Overall Study||224
10149673|NCT02800148|11279957|FG002|STARTED|Overall Study||219
10149674|NCT02800148|11279955|FG000|COMPLETED|Overall Study||199
10149675|NCT02800148|11279956|FG001|COMPLETED|Overall Study||204
10149676|NCT02800148|11279957|FG002|COMPLETED|Overall Study||194
10149677|NCT02800148|11279955|FG000|NOT COMPLETED|Overall Study||25
10149678|NCT02800148|11279956|FG001|NOT COMPLETED|Overall Study||20
10149679|NCT02800148|11279957|FG002|NOT COMPLETED|Overall Study||25
10149680|NCT02800213|11279967|FG000|STARTED|First Intervention||35
10149681|NCT02800213|11279968|FG001|STARTED|First Intervention||35
10149682|NCT02800213|11279967|FG000|COMPLETED|First Intervention||35
10149683|NCT02800213|11279968|FG001|COMPLETED|First Intervention||35
10149684|NCT02800213|11279967|FG000|NOT COMPLETED|First Intervention||0
10149685|NCT02800213|11279968|FG001|NOT COMPLETED|First Intervention||0
10149686|NCT02800213|11279967|FG000|STARTED|Second Intervention||35
10149687|NCT02800213|11279968|FG001|STARTED|Second Intervention||35
10149688|NCT02800213|11279967|FG000|COMPLETED|Second Intervention||35
10149689|NCT02800213|11279968|FG001|COMPLETED|Second Intervention||35
10149690|NCT02800213|11279967|FG000|NOT COMPLETED|Second Intervention||0
10149691|NCT02800213|11279968|FG001|NOT COMPLETED|Second Intervention||0
10149692|NCT02800356|11279974|FG000|STARTED|Overall Study||20
10149693|NCT02800356|11279974|FG000|COMPLETED|Overall Study||20
10149694|NCT02800356|11279974|FG000|NOT COMPLETED|Overall Study||0
10149695|NCT02800642|11279978|FG000|STARTED|Overall Study||162
10149696|NCT02800642|11279978|FG000|COMPLETED|Overall Study||137
10149697|NCT02800642|11279978|FG000|NOT COMPLETED|Overall Study||25
10149698|NCT02800928|11279982|FG000|STARTED|Overall Study||9
10149699|NCT02800928|11279983|FG001|STARTED|Overall Study||8
10149700|NCT02800928|11279982|FG000|COMPLETED|Overall Study||7
10149701|NCT02800928|11279983|FG001|COMPLETED|Overall Study||6
10149702|NCT02800928|11279982|FG000|NOT COMPLETED|Overall Study||2
10149703|NCT02800928|11279983|FG001|NOT COMPLETED|Overall Study||2
10149704|NCT02801006|11279989|FG000|STARTED|Lens 1||22
10149705|NCT02801006|11279990|FG001|STARTED|Lens 1||19
10149706|NCT02801006|11279989|FG000|COMPLETED|Lens 1||22
10149707|NCT02801006|11279990|FG001|COMPLETED|Lens 1||19
10149708|NCT02801006|11279989|FG000|NOT COMPLETED|Lens 1||0
10149709|NCT02801006|11279990|FG001|NOT COMPLETED|Lens 1||0
10149710|NCT02801006|11279989|FG000|STARTED|Lens 2||22
10149711|NCT02801006|11279990|FG001|STARTED|Lens 2||19
10149712|NCT02801006|11279989|FG000|COMPLETED|Lens 2||22
10149713|NCT02801006|11279990|FG001|COMPLETED|Lens 2||19
10149714|NCT02801006|11279989|FG000|NOT COMPLETED|Lens 2||0
10149715|NCT02801006|11279990|FG001|NOT COMPLETED|Lens 2||0
10149716|NCT02801370|11280000|FG000|STARTED|Overall Study||130
10149717|NCT02801370|11280001|FG001|STARTED|Overall Study||132
10149718|NCT02801370|11280000|FG000|COMPLETED|Overall Study||123
10149719|NCT02801370|11280001|FG001|COMPLETED|Overall Study||132
10149720|NCT02801370|11280000|FG000|NOT COMPLETED|Overall Study||7
10149721|NCT02801370|11280001|FG001|NOT COMPLETED|Overall Study||0
10149722|NCT02801396|11280008|FG000|STARTED|Period 1||17
10149723|NCT02801396|11280009|FG001|STARTED|Period 1||17
10149724|NCT02801396|11280010|FG002|STARTED|Period 1||17
10149725|NCT02801396|11280011|FG003|STARTED|Period 1||16
10149726|NCT02801396|11280012|FG004|STARTED|Period 1||17
10149727|NCT02801396|11280013|FG005|STARTED|Period 1||17
10149728|NCT02801396|11280008|FG000|COMPLETED|Period 1||17
10149729|NCT02801396|11280009|FG001|COMPLETED|Period 1||17
10149730|NCT02801396|11280010|FG002|COMPLETED|Period 1||17
10149731|NCT02801396|11280011|FG003|COMPLETED|Period 1||16
10149732|NCT02801396|11280012|FG004|COMPLETED|Period 1||16
10149733|NCT02801396|11280013|FG005|COMPLETED|Period 1||17
10149734|NCT02801396|11280008|FG000|NOT COMPLETED|Period 1||0
10149735|NCT02801396|11280009|FG001|NOT COMPLETED|Period 1||0
10149736|NCT02801396|11280010|FG002|NOT COMPLETED|Period 1||0
10149737|NCT02801396|11280011|FG003|NOT COMPLETED|Period 1||0
10149738|NCT02801396|11280012|FG004|NOT COMPLETED|Period 1||1
10149739|NCT02801396|11280013|FG005|NOT COMPLETED|Period 1||0
10149740|NCT02801396|11280008|FG000|STARTED|Period 2||17
10149741|NCT02801396|11280009|FG001|STARTED|Period 2||17
10149742|NCT02801396|11280010|FG002|STARTED|Period 2||17
10149743|NCT02801396|11280011|FG003|STARTED|Period 2||16
10149744|NCT02801396|11280012|FG004|STARTED|Period 2||16
10149745|NCT02801396|11280013|FG005|STARTED|Period 2||17
10149746|NCT02801396|11280008|FG000|COMPLETED|Period 2||17
10149747|NCT02801396|11280009|FG001|COMPLETED|Period 2||17
10149748|NCT02801396|11280010|FG002|COMPLETED|Period 2||17
10149749|NCT02801396|11280011|FG003|COMPLETED|Period 2||16
10149750|NCT02801396|11280012|FG004|COMPLETED|Period 2||16
10149751|NCT02801396|11280013|FG005|COMPLETED|Period 2||17
10149752|NCT02801396|11280008|FG000|NOT COMPLETED|Period 2||0
10149753|NCT02801396|11280009|FG001|NOT COMPLETED|Period 2||0
10149754|NCT02801396|11280010|FG002|NOT COMPLETED|Period 2||0
10149755|NCT02801396|11280011|FG003|NOT COMPLETED|Period 2||0
10149756|NCT02801396|11280012|FG004|NOT COMPLETED|Period 2||0
10149757|NCT02801396|11280013|FG005|NOT COMPLETED|Period 2||0
10149758|NCT02801396|11280008|FG000|STARTED|Period 3||17
10149759|NCT02801396|11280009|FG001|STARTED|Period 3||17
10149760|NCT02801396|11280010|FG002|STARTED|Period 3||17
10149761|NCT02801396|11280011|FG003|STARTED|Period 3||16
10149762|NCT02801396|11280012|FG004|STARTED|Period 3||16
10149763|NCT02801396|11280013|FG005|STARTED|Period 3||17
10149764|NCT02801396|11280008|FG000|COMPLETED|Period 3||17
10149765|NCT02801396|11280009|FG001|COMPLETED|Period 3||17
10149766|NCT02801396|11280010|FG002|COMPLETED|Period 3||17
10149767|NCT02801396|11280011|FG003|COMPLETED|Period 3||16
10149768|NCT02801396|11280012|FG004|COMPLETED|Period 3||16
10149769|NCT02801396|11280013|FG005|COMPLETED|Period 3||17
10149770|NCT02801396|11280008|FG000|NOT COMPLETED|Period 3||0
10149771|NCT02801396|11280009|FG001|NOT COMPLETED|Period 3||0
10149772|NCT02801396|11280010|FG002|NOT COMPLETED|Period 3||0
10149773|NCT02801396|11280011|FG003|NOT COMPLETED|Period 3||0
10149774|NCT02801396|11280012|FG004|NOT COMPLETED|Period 3||0
10149775|NCT02801396|11280013|FG005|NOT COMPLETED|Period 3||0
10149776|NCT02801578|11280021|FG000|STARTED|Overall Study||11
10149777|NCT02801578|11280021|FG000|COMPLETED|Overall Study||9
10149778|NCT02801578|11280021|FG000|NOT COMPLETED|Overall Study||2
10149779|NCT02801617|11280027|FG000|STARTED|Overall Study||51
10149780|NCT02801617|11280028|FG001|STARTED|Overall Study||56
10149781|NCT02801617|11280027|FG000|COMPLETED|Overall Study||49
10149782|NCT02801617|11280028|FG001|COMPLETED|Overall Study||50
10149783|NCT02801617|11280027|FG000|NOT COMPLETED|Overall Study||2
10149784|NCT02801617|11280028|FG001|NOT COMPLETED|Overall Study||6
10149785|NCT02801669|11280040|FG000|STARTED|Overall Study||492
10149786|NCT02801669|11280041|FG001|STARTED|Overall Study||492
10149787|NCT02801669|11280040|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492
10149788|NCT02801669|11280041|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490
10149789|NCT02801669|11280040|FG000|COMPLETED|Overall Study||341
10149790|NCT02801669|11280041|FG001|COMPLETED|Overall Study||340
10149791|NCT02801669|11280040|FG000|NOT COMPLETED|Overall Study||151
10149792|NCT02801669|11280041|FG001|NOT COMPLETED|Overall Study||152
10149793|NCT02801877|11280051|FG000|STARTED|Overall Study||74
10149794|NCT02801877|11280052|FG001|STARTED|Overall Study||75
10149795|NCT02801877|11280053|FG002|STARTED|Overall Study||76
10149796|NCT02801877|11280054|FG003|STARTED|Overall Study||76
10149797|NCT02801877|11280051|FG000|COMPLETED|Overall Study||71
10149798|NCT02801877|11280052|FG001|COMPLETED|Overall Study||74
10149799|NCT02801877|11280053|FG002|COMPLETED|Overall Study||70
10149800|NCT02801877|11280054|FG003|COMPLETED|Overall Study||76
10149801|NCT02801877|11280051|FG000|NOT COMPLETED|Overall Study||3
10149802|NCT02801877|11280052|FG001|NOT COMPLETED|Overall Study||1
10149803|NCT02801877|11280053|FG002|NOT COMPLETED|Overall Study||6
10149804|NCT02801877|11280054|FG003|NOT COMPLETED|Overall Study||0
10149805|NCT02801942|11280066|FG000|STARTED|Overall Study||12
10149806|NCT02801942|11280067|FG001|STARTED|Overall Study||10
10149807|NCT02801942|11280066|FG000|COMPLETED|Overall Study||12
10149808|NCT02801942|11280067|FG001|COMPLETED|Overall Study||10
10149809|NCT02801942|11280066|FG000|NOT COMPLETED|Overall Study||0
10149810|NCT02801942|11280067|FG001|NOT COMPLETED|Overall Study||0
10149811|NCT02802111|11280075|FG000|STARTED|First Intervention (5 Min of Drug)||12
10149812|NCT02802111|11280076|FG001|STARTED|First Intervention (5 Min of Drug)||12
10149813|NCT02802111|11280075|FG000|COMPLETED|First Intervention (5 Min of Drug)||12
10149814|NCT02802111|11280076|FG001|COMPLETED|First Intervention (5 Min of Drug)||12
10149815|NCT02802111|11280075|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0
10149816|NCT02802111|11280076|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0
10149817|NCT02802111|11280075|FG000|STARTED|Washout (4 Hours)||12
10149818|NCT02802111|11280076|FG001|STARTED|Washout (4 Hours)||12
10149819|NCT02802111|11280075|FG000|COMPLETED|Washout (4 Hours)||12
10149820|NCT02802111|11280076|FG001|COMPLETED|Washout (4 Hours)||12
10149821|NCT02802111|11280075|FG000|NOT COMPLETED|Washout (4 Hours)||0
10149822|NCT02802111|11280076|FG001|NOT COMPLETED|Washout (4 Hours)||0
10149823|NCT02802111|11280075|FG000|STARTED|Second Intervention (5 Min of Drug)||12
10149824|NCT02802111|11280076|FG001|STARTED|Second Intervention (5 Min of Drug)||12
10149825|NCT02802111|11280075|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12
10149826|NCT02802111|11280076|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12
10149827|NCT02802111|11280075|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
10149828|NCT02802111|11280076|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
10149829|NCT02802241|11280086|FG000|STARTED|Overall Study||97
10149830|NCT02802241|11280087|FG001|STARTED|Overall Study||97
10149831|NCT02802241|11280088|FG002|STARTED|Overall Study||48
10149832|NCT02802241|11280089|FG003|STARTED|Overall Study||98
10149833|NCT02802241|11280086|FG000|Planned Analysis|Overall Study||89
10149834|NCT02802241|11280087|FG001|Planned Analysis|Overall Study||86
10149835|NCT02802241|11280088|FG002|Planned Analysis|Overall Study|Not included in primary analysis|0
10149836|NCT02802241|11280089|FG003|Planned Analysis|Overall Study||87
10149837|NCT02802241|11280086|FG000|COMPLETED|Overall Study||68
10149838|NCT02802241|11280087|FG001|COMPLETED|Overall Study||71
10149839|NCT02802241|11280088|FG002|COMPLETED|Overall Study|Not included in primary analysis|0
10149840|NCT02802241|11280089|FG003|COMPLETED|Overall Study||72
10149841|NCT02802241|11280086|FG000|NOT COMPLETED|Overall Study||29
10149842|NCT02802241|11280087|FG001|NOT COMPLETED|Overall Study||26
10149843|NCT02802241|11280088|FG002|NOT COMPLETED|Overall Study||48
10149844|NCT02802241|11280089|FG003|NOT COMPLETED|Overall Study||26
10149845|NCT02802319|11280101|FG000|STARTED|Overall Study||22
10149846|NCT02802319|11280102|FG001|STARTED|Overall Study||22
10149847|NCT02802319|11280101|FG000|COMPLETED|Overall Study||20
10149848|NCT02802319|11280102|FG001|COMPLETED|Overall Study||17
10149849|NCT02802319|11280101|FG000|NOT COMPLETED|Overall Study||2
10149850|NCT02802319|11280102|FG001|NOT COMPLETED|Overall Study||5
10197016|NCT03368235|11324996|FG000|STARTED|Overall Study||11
10197017|NCT03368235|11324997|FG001|STARTED|Overall Study||10
10197018|NCT03368235|11324996|FG000|COMPLETED|Overall Study||11
10197019|NCT03368235|11324997|FG001|COMPLETED|Overall Study||10
10197020|NCT03368235|11324996|FG000|NOT COMPLETED|Overall Study||0
10197021|NCT03368235|11324997|FG001|NOT COMPLETED|Overall Study||0
10197022|NCT03368807|11325003|FG000|STARTED|Period 1 (Blinded CGM)||79
10197023|NCT03368807|11325003|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
10197024|NCT03368807|11325003|FG000|COMPLETED|Period 1 (Blinded CGM)||73
10197025|NCT03368807|11325003|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6
10197026|NCT03368807|11325003|FG000|STARTED|Period 2 (Unblinded CGM)||73
10197027|NCT03368807|11325003|FG000|COMPLETED|Period 2 (Unblinded CGM)||73
10197028|NCT03368807|11325003|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0
10197029|NCT03368859|11325011|FG000|STARTED|Overall Study||36
10197030|NCT03368859|11325012|FG001|STARTED|Overall Study||34
10197031|NCT03368859|11325011|FG000|COMPLETED|Overall Study||0
10197032|NCT03368859|11325012|FG001|COMPLETED|Overall Study||0
10197033|NCT03368859|11325011|FG000|NOT COMPLETED|Overall Study||36
10197034|NCT03368859|11325012|FG001|NOT COMPLETED|Overall Study||34
10197035|NCT03368898|11325021|FG000|STARTED|Overall Study||37
10197036|NCT03368898|11325022|FG001|STARTED|Overall Study||33
10197037|NCT03368898|11325023|FG002|STARTED|Overall Study||34
10197038|NCT03368898|11325021|FG000|COMPLETED|Overall Study||37
10197039|NCT03368898|11325022|FG001|COMPLETED|Overall Study||33
10197040|NCT03368898|11325023|FG002|COMPLETED|Overall Study||34
10197041|NCT03368898|11325021|FG000|NOT COMPLETED|Overall Study||0
10197042|NCT03368898|11325022|FG001|NOT COMPLETED|Overall Study||0
10197043|NCT03368898|11325023|FG002|NOT COMPLETED|Overall Study||0
10197044|NCT03369158|11325033|FG000|STARTED|Overall Study||14
10197045|NCT03369158|11325034|FG001|STARTED|Overall Study||15
10197046|NCT03369158|11325033|FG000|COMPLETED|Overall Study||14
10197047|NCT03369158|11325034|FG001|COMPLETED|Overall Study||15
10197048|NCT03369158|11325033|FG000|NOT COMPLETED|Overall Study||0
10197049|NCT03369158|11325034|FG001|NOT COMPLETED|Overall Study||0
10197050|NCT03369236|11325042|FG000|STARTED|Double-blind Treatment Period||6
10149851|NCT02802345|11280110|FG000|STARTED|Overall Study||136
10149852|NCT02802345|11280111|FG001|STARTED|Overall Study||138
10149853|NCT02802345|11280110|FG000|Treated|Overall Study||136
10149854|NCT02802345|11280111|FG001|Treated|Overall Study||137
10149855|NCT02802345|11280110|FG000|COMPLETED|Overall Study||104
10149856|NCT02802345|11280111|FG001|COMPLETED|Overall Study||108
10149857|NCT02802345|11280110|FG000|NOT COMPLETED|Overall Study||32
10149858|NCT02802345|11280111|FG001|NOT COMPLETED|Overall Study||30
10149859|NCT02802449|11280119|FG000|STARTED|Overall Study||111
10149860|NCT02802449|11280120|FG001|STARTED|Overall Study||219
10149861|NCT02802449|11280119|FG000|COMPLETED|Overall Study||102
10149862|NCT02802449|11280120|FG001|COMPLETED|Overall Study||202
10149863|NCT02802449|11280119|FG000|NOT COMPLETED|Overall Study||9
10149864|NCT02802449|11280120|FG001|NOT COMPLETED|Overall Study||17
10149865|NCT02802501|11280129|FG000|STARTED|Double-blind (Up to Day 180)||50
10149866|NCT02802501|11280130|FG001|STARTED|Double-blind (Up to Day 180)||50
10149867|NCT02802501|11280131|FG002|STARTED|Double-blind (Up to Day 180)||50
10149868|NCT02802501|11280129|FG000|COMPLETED|Double-blind (Up to Day 180)||50
10149869|NCT02802501|11280130|FG001|COMPLETED|Double-blind (Up to Day 180)||50
10149870|NCT02802501|11280131|FG002|COMPLETED|Double-blind (Up to Day 180)||50
10149871|NCT02802501|11280129|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0
10149872|NCT02802501|11280130|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0
10149873|NCT02802501|11280131|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0
10149874|NCT02802501|11280129|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
10149875|NCT02802501|11280130|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
10149876|NCT02802501|11280131|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
10149877|NCT02802501|11280129|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6
10149878|NCT02802501|11280130|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12
10149879|NCT02802501|11280131|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26
10149880|NCT02802501|11280129|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
10149881|NCT02802501|11280130|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
10149882|NCT02802501|11280131|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
10149883|NCT02802514|11280144|FG000|STARTED|Session 1 (up to Day 8)||1
10149884|NCT02802514|11280145|FG001|STARTED|Session 1 (up to Day 8)||1
10149885|NCT02802514|11280146|FG002|STARTED|Session 1 (up to Day 8)||1
10149886|NCT02802514|11280147|FG003|STARTED|Session 1 (up to Day 8)||1
10149887|NCT02802514|11280144|FG000|COMPLETED|Session 1 (up to Day 8)||1
10149888|NCT02802514|11280145|FG001|COMPLETED|Session 1 (up to Day 8)||1
10149889|NCT02802514|11280146|FG002|COMPLETED|Session 1 (up to Day 8)||1
10149890|NCT02802514|11280147|FG003|COMPLETED|Session 1 (up to Day 8)||1
10149891|NCT02802514|11280144|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0
10149892|NCT02802514|11280145|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0
10149893|NCT02802514|11280146|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0
10149894|NCT02802514|11280147|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0
10149895|NCT02802514|11280144|FG000|STARTED|Wash Out Period (up to Week 9)||1
10149896|NCT02802514|11280145|FG001|STARTED|Wash Out Period (up to Week 9)||1
10149897|NCT02802514|11280146|FG002|STARTED|Wash Out Period (up to Week 9)||1
10149898|NCT02802514|11280147|FG003|STARTED|Wash Out Period (up to Week 9)||1
10149899|NCT02802514|11280144|FG000|COMPLETED|Wash Out Period (up to Week 9)||1
10149900|NCT02802514|11280145|FG001|COMPLETED|Wash Out Period (up to Week 9)||1
10149901|NCT02802514|11280146|FG002|COMPLETED|Wash Out Period (up to Week 9)||1
10149902|NCT02802514|11280147|FG003|COMPLETED|Wash Out Period (up to Week 9)||1
10149903|NCT02802514|11280144|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10149904|NCT02802514|11280145|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10149905|NCT02802514|11280146|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10149906|NCT02802514|11280147|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10149907|NCT02802514|11280144|FG000|STARTED|Session 2 (Up to Day 8)||1
10149908|NCT02802514|11280145|FG001|STARTED|Session 2 (Up to Day 8)||1
10149909|NCT02802514|11280146|FG002|STARTED|Session 2 (Up to Day 8)||1
10149910|NCT02802514|11280147|FG003|STARTED|Session 2 (Up to Day 8)||1
10149911|NCT02802514|11280144|FG000|COMPLETED|Session 2 (Up to Day 8)||1
10149912|NCT02802514|11280145|FG001|COMPLETED|Session 2 (Up to Day 8)||1
10149913|NCT02802514|11280146|FG002|COMPLETED|Session 2 (Up to Day 8)||1
10149914|NCT02802514|11280147|FG003|COMPLETED|Session 2 (Up to Day 8)||1
10149915|NCT02802514|11280144|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0
10149916|NCT02802514|11280145|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0
10149917|NCT02802514|11280146|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0
10149918|NCT02802514|11280147|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0
10149919|NCT02802735|11280163|FG000|STARTED|Overall Study||4
10149920|NCT02802735|11280164|FG001|STARTED|Overall Study||4
10149921|NCT02802735|11280165|FG002|STARTED|Overall Study||4
10149922|NCT02802735|11280166|FG003|STARTED|Overall Study||12
10149923|NCT02802735|11280167|FG004|STARTED|Overall Study||4
10149924|NCT02802735|11280163|FG000|COMPLETED|Overall Study||4
10149925|NCT02802735|11280164|FG001|COMPLETED|Overall Study||3
10149926|NCT02802735|11280165|FG002|COMPLETED|Overall Study||4
10149927|NCT02802735|11280166|FG003|COMPLETED|Overall Study||12
10149928|NCT02802735|11280167|FG004|COMPLETED|Overall Study||4
10149929|NCT02802735|11280163|FG000|NOT COMPLETED|Overall Study||0
10149930|NCT02802735|11280164|FG001|NOT COMPLETED|Overall Study||1
10149931|NCT02802735|11280165|FG002|NOT COMPLETED|Overall Study||0
10149932|NCT02802735|11280166|FG003|NOT COMPLETED|Overall Study||0
10149933|NCT02802735|11280167|FG004|NOT COMPLETED|Overall Study||0
10149934|NCT02802865|11280184|FG000|STARTED|Overall Study||35
10149935|NCT02802865|11280185|FG001|STARTED|Overall Study||35
10149936|NCT02802865|11280184|FG000|COMPLETED|Overall Study||34
10149937|NCT02802865|11280185|FG001|COMPLETED|Overall Study||33
10149938|NCT02802865|11280184|FG000|NOT COMPLETED|Overall Study||1
10149939|NCT02802865|11280185|FG001|NOT COMPLETED|Overall Study||2
10149940|NCT02802878|11280193|FG000|STARTED|Overall Study||21
10149941|NCT02802878|11280194|FG001|STARTED|Overall Study||21
10149942|NCT02802878|11280193|FG000|COMPLETED|Overall Study||17
10149943|NCT02802878|11280194|FG001|COMPLETED|Overall Study||18
10149944|NCT02802878|11280193|FG000|NOT COMPLETED|Overall Study||4
10149945|NCT02802878|11280194|FG001|NOT COMPLETED|Overall Study||3
10149946|NCT02803138|11280200|FG000|STARTED|Overall Study||236
10149947|NCT02803138|11280200|FG000|COMPLETED|Overall Study||166
10149948|NCT02803138|11280200|FG000|NOT COMPLETED|Overall Study||70
10149949|NCT02803164|11280208|FG000|STARTED|Overall Study||10
10149950|NCT02803164|11280209|FG001|STARTED|Overall Study||11
10149951|NCT02803164|11280208|FG000|COMPLETED|Overall Study||10
10149952|NCT02803164|11280209|FG001|COMPLETED|Overall Study||11
10149953|NCT02803164|11280208|FG000|NOT COMPLETED|Overall Study||0
10149954|NCT02803164|11280209|FG001|NOT COMPLETED|Overall Study||0
10149955|NCT02803229|11280219|FG000|STARTED|Overall Study||15
10149956|NCT02803229|11280220|FG001|STARTED|Overall Study||13
10149957|NCT02803229|11280219|FG000|COMPLETED|Overall Study||11
10149958|NCT02803229|11280220|FG001|COMPLETED|Overall Study||7
10149959|NCT02803229|11280219|FG000|NOT COMPLETED|Overall Study||4
10149960|NCT02803229|11280220|FG001|NOT COMPLETED|Overall Study||6
10149961|NCT02803580|11280226|FG000|STARTED|Overall Study||209
10149962|NCT02803580|11280226|FG000|COMPLETED|Overall Study||173
10149963|NCT02803580|11280226|FG000|NOT COMPLETED|Overall Study||36
10149964|NCT02803749|11280232|FG000|STARTED|Overall Study||17
10149965|NCT02803749|11280233|FG001|STARTED|Overall Study||4
10149966|NCT02803749|11280232|FG000|COMPLETED|Overall Study||12
10149967|NCT02803749|11280233|FG001|COMPLETED|Overall Study||4
10149968|NCT02803749|11280232|FG000|NOT COMPLETED|Overall Study||5
10149969|NCT02803749|11280233|FG001|NOT COMPLETED|Overall Study||0
10149970|NCT02804178|11280239|FG000|STARTED|Overall Study||10
10149971|NCT02804178|11280239|FG000|COMPLETED|Overall Study||9
10149972|NCT02804178|11280239|FG000|NOT COMPLETED|Overall Study||1
10149973|NCT02804399|11280243|FG000|STARTED|Period 1||12
10149974|NCT02804399|11280244|FG001|STARTED|Period 1||0
10149975|NCT02804399|11280243|FG000|COMPLETED|Period 1||12
10149976|NCT02804399|11280244|FG001|COMPLETED|Period 1||0
10149977|NCT02804399|11280243|FG000|NOT COMPLETED|Period 1||0
10149978|NCT02804399|11280244|FG001|NOT COMPLETED|Period 1||0
10149979|NCT02804399|11280243|FG000|STARTED|Washout Period at Least 10 Days||12
10149980|NCT02804399|11280244|FG001|STARTED|Washout Period at Least 10 Days||0
10149981|NCT02804399|11280243|FG000|COMPLETED|Washout Period at Least 10 Days||12
10149982|NCT02804399|11280244|FG001|COMPLETED|Washout Period at Least 10 Days||0
10149983|NCT02804399|11280243|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0
10149984|NCT02804399|11280244|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0
10149985|NCT02804399|11280243|FG000|STARTED|Period 2||0
10149986|NCT02804399|11280244|FG001|STARTED|Period 2||12
9848987|NCT00862849|10961755|FG003|COMPLETED|Intervention 3||4
9848988|NCT00862849|10961756|FG004|COMPLETED|Intervention 3||4
9848989|NCT00862849|10961757|FG005|COMPLETED|Intervention 3||3
9848990|NCT00862849|10961752|FG000|NOT COMPLETED|Intervention 3||0
9848991|NCT00862849|10961753|FG001|NOT COMPLETED|Intervention 3||0
9848992|NCT00862849|10961754|FG002|NOT COMPLETED|Intervention 3||0
10149987|NCT02804399|11280243|FG000|COMPLETED|Period 2||0
10149988|NCT02804399|11280244|FG001|COMPLETED|Period 2||11
10149989|NCT02804399|11280243|FG000|NOT COMPLETED|Period 2||0
10149990|NCT02804399|11280244|FG001|NOT COMPLETED|Period 2||1
10149991|NCT02804594|11280255|FG000|STARTED|Overall Study||10
10149992|NCT02804594|11280256|FG001|STARTED|Overall Study||5
10149993|NCT02804594|11280255|FG000|COMPLETED|Overall Study||10
10149994|NCT02804594|11280256|FG001|COMPLETED|Overall Study||5
10149995|NCT02804594|11280255|FG000|NOT COMPLETED|Overall Study||0
10149996|NCT02804594|11280256|FG001|NOT COMPLETED|Overall Study||0
10149997|NCT02804750|11280264|FG000|STARTED|Period 1||17
10149998|NCT02804750|11280265|FG001|STARTED|Period 1||18
10149999|NCT02804750|11280264|FG000|COMPLETED|Period 1||17
10150000|NCT02804750|11280265|FG001|COMPLETED|Period 1||15
10150001|NCT02804750|11280264|FG000|NOT COMPLETED|Period 1||0
10150002|NCT02804750|11280265|FG001|NOT COMPLETED|Period 1||3
10150003|NCT02804750|11280264|FG000|STARTED|Period 2||17
10150004|NCT02804750|11280265|FG001|STARTED|Period 2||15
10150005|NCT02804750|11280264|FG000|COMPLETED|Period 2||16
10150006|NCT02804750|11280265|FG001|COMPLETED|Period 2||15
10150007|NCT02804750|11280264|FG000|NOT COMPLETED|Period 2||1
10150008|NCT02804750|11280265|FG001|NOT COMPLETED|Period 2||0
10150009|NCT02804750|11280264|FG000|STARTED|Period 3||16
10150010|NCT02804750|11280265|FG001|STARTED|Period 3||15
10150011|NCT02804750|11280264|FG000|COMPLETED|Period 3||16
10150012|NCT02804750|11280265|FG001|COMPLETED|Period 3||13
10150013|NCT02804750|11280264|FG000|NOT COMPLETED|Period 3||0
10150014|NCT02804750|11280265|FG001|NOT COMPLETED|Period 3||2
10150015|NCT02804750|11280264|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
10150016|NCT02804750|11280265|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
10150017|NCT02804750|11280264|FG000|COMPLETED|Period 4||0
10150018|NCT02804750|11280265|FG001|COMPLETED|Period 4||7
10150019|NCT02804750|11280264|FG000|NOT COMPLETED|Period 4||0
10150020|NCT02804750|11280265|FG001|NOT COMPLETED|Period 4||5
10150021|NCT02804763|11280277|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45
10150022|NCT02804763|11280278|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45
10150023|NCT02804763|11280279|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45
10150024|NCT02804763|11280280|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47
10150025|NCT02804763|11280277|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
10150026|NCT02804763|11280278|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
10150027|NCT02804763|11280279|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
10150028|NCT02804763|11280280|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
10150029|NCT02804763|11280277|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
10150030|NCT02804763|11280278|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
10150031|NCT02804763|11280279|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
10150032|NCT02804763|11280280|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
10150033|NCT02804763|11280277|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
10150034|NCT02804763|11280278|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
10150035|NCT02804763|11280279|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
10150036|NCT02804763|11280280|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
10150037|NCT02804763|11280277|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
10150038|NCT02804763|11280278|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
10150039|NCT02804763|11280279|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
10150040|NCT02804763|11280280|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
10150041|NCT02804763|11280277|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44
10150042|NCT02804763|11280278|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44
10150043|NCT02804763|11280279|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44
10150044|NCT02804763|11280280|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45
10150045|NCT02804763|11280277|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
10150046|NCT02804763|11280278|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
10150047|NCT02804763|11280279|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
10150048|NCT02804763|11280280|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
10150049|NCT02804763|11280277|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
10150050|NCT02804763|11280278|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
10150051|NCT02804763|11280279|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
10150052|NCT02804763|11280280|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
9709369|NCT02706847|10808782|FG003|STARTED|Day 1 to Week 12||165
9709370|NCT02706847|10808779|FG000|Received Study Treatment|Day 1 to Week 12||85
9709371|NCT02706847|10808780|FG001|Received Study Treatment|Day 1 to Week 12||84
9709372|NCT02706847|10808781|FG002|Received Study Treatment|Day 1 to Week 12||164
9709373|NCT02706847|10808782|FG003|Received Study Treatment|Day 1 to Week 12||165
9709374|NCT02706847|10808779|FG000|COMPLETED|Day 1 to Week 12||75
9709375|NCT02706847|10808780|FG001|COMPLETED|Day 1 to Week 12||76
9709376|NCT02706847|10808781|FG002|COMPLETED|Day 1 to Week 12||157
9709377|NCT02706847|10808782|FG003|COMPLETED|Day 1 to Week 12||149
9709378|NCT02706847|10808779|FG000|NOT COMPLETED|Day 1 to Week 12||10
9709379|NCT02706847|10808780|FG001|NOT COMPLETED|Day 1 to Week 12||8
9709380|NCT02706847|10808781|FG002|NOT COMPLETED|Day 1 to Week 12||8
9709381|NCT02706847|10808782|FG003|NOT COMPLETED|Day 1 to Week 12||16
9709382|NCT02706847|10808779|FG000|STARTED|Week 12 to Week 24||75
9709383|NCT02706847|10808780|FG001|STARTED|Week 12 to Week 24||76
9709384|NCT02706847|10808781|FG002|STARTED|Week 12 to Week 24||157
9709385|NCT02706847|10808782|FG003|STARTED|Week 12 to Week 24||149
9709386|NCT02706847|10808779|FG000|Received Study Treatment|Week 12 to Week 24||72
9709387|NCT02706847|10808780|FG001|Received Study Treatment|Week 12 to Week 24||75
9709388|NCT02706847|10808781|FG002|Received Study Treatment|Week 12 to Week 24||156
9709389|NCT02706847|10808782|FG003|Received Study Treatment|Week 12 to Week 24||148
9709390|NCT02706847|10808779|FG000|COMPLETED|Week 12 to Week 24||72
9709391|NCT02706847|10808780|FG001|COMPLETED|Week 12 to Week 24||74
9709392|NCT02706847|10808781|FG002|COMPLETED|Week 12 to Week 24||153
9709393|NCT02706847|10808782|FG003|COMPLETED|Week 12 to Week 24||135
9709394|NCT02706847|10808779|FG000|NOT COMPLETED|Week 12 to Week 24||3
9709395|NCT02706847|10808780|FG001|NOT COMPLETED|Week 12 to Week 24||2
9709396|NCT02706847|10808781|FG002|NOT COMPLETED|Week 12 to Week 24||4
9709397|NCT02706847|10808782|FG003|NOT COMPLETED|Week 12 to Week 24||14
9709398|NCT02701777|10808796|FG000|STARTED|Overall Study||17
9709399|NCT02701777|10808797|FG001|STARTED|Overall Study||16
9709400|NCT02701777|10808798|FG002|STARTED|Overall Study||16
9709401|NCT02701777|10808799|FG003|STARTED|Overall Study||13
9709402|NCT02701777|10808796|FG000|COMPLETED|Overall Study||13
9709403|NCT02701777|10808797|FG001|COMPLETED|Overall Study||13
9709404|NCT02701777|10808798|FG002|COMPLETED|Overall Study||12
9709405|NCT02701777|10808799|FG003|COMPLETED|Overall Study||11
9709406|NCT02701777|10808796|FG000|NOT COMPLETED|Overall Study||4
9709407|NCT02701777|10808797|FG001|NOT COMPLETED|Overall Study||3
9709408|NCT02701777|10808798|FG002|NOT COMPLETED|Overall Study||4
9709409|NCT02701777|10808799|FG003|NOT COMPLETED|Overall Study||2
9729569|NCT00118898|10829189|FG002|STARTED|Overall Study||465
9729570|NCT00118898|10829190|FG003|STARTED|Overall Study||463
9729571|NCT00118898|10829187|FG000|Initiated Treatment|Overall Study||461
9729572|NCT00118898|10829188|FG001|Initiated Treatment|Overall Study||461
9848993|NCT00862849|10961755|FG003|NOT COMPLETED|Intervention 3||0
9729573|NCT00118898|10829189|FG002|Initiated Treatment|Overall Study||464
10150053|NCT02805179|11280294|FG000|STARTED|Overall Study||26
10150054|NCT02805179|11280294|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
10150055|NCT02805179|11280294|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
10150056|NCT02805179|11280294|FG000|COMPLETED|Overall Study||23
10150057|NCT02805179|11280294|FG000|NOT COMPLETED|Overall Study||3
10150058|NCT02805309|11280301|FG000|STARTED|Overall Study||18
10150059|NCT02805309|11280302|FG001|STARTED|Overall Study||17
10150060|NCT02805309|11280303|FG002|STARTED|Overall Study||19
10150061|NCT02805309|11280301|FG000|COMPLETED|Overall Study||16
10150062|NCT02805309|11280302|FG001|COMPLETED|Overall Study||13
10150063|NCT02805309|11280303|FG002|COMPLETED|Overall Study||16
10150064|NCT02805309|11280301|FG000|NOT COMPLETED|Overall Study||2
10150065|NCT02805309|11280302|FG001|NOT COMPLETED|Overall Study||4
10150066|NCT02805309|11280303|FG002|NOT COMPLETED|Overall Study||3
10150067|NCT02805647|11280313|FG000|STARTED|Overall Study|at the moment of submision|100
10150068|NCT02805647|11280314|FG001|STARTED|Overall Study|at the moment of submision|122
10150069|NCT02805647|11280313|FG000|COMPLETED|Overall Study|after laboratory tests|100
10150070|NCT02805647|11280314|FG001|COMPLETED|Overall Study|after laboratory tests|122
10150071|NCT02805647|11280313|FG000|NOT COMPLETED|Overall Study||0
10150072|NCT02805647|11280314|FG001|NOT COMPLETED|Overall Study||0
10150073|NCT02805660|11280327|FG000|STARTED|Overall Study||5
10150074|NCT02805660|11280328|FG001|STARTED|Overall Study||4
10150075|NCT02805660|11280329|FG002|STARTED|Overall Study||11
10150076|NCT02805660|11280330|FG003|STARTED|Overall Study||18
10150077|NCT02805660|11280331|FG004|STARTED|Overall Study||3
10150078|NCT02805660|11280332|FG005|STARTED|Overall Study||23
10150079|NCT02805660|11280333|FG006|STARTED|Overall Study||19
10150080|NCT02805660|11280327|FG000|COMPLETED|Overall Study||0
10150081|NCT02805660|11280328|FG001|COMPLETED|Overall Study||0
10150082|NCT02805660|11280329|FG002|COMPLETED|Overall Study||0
10150083|NCT02805660|11280330|FG003|COMPLETED|Overall Study||0
10150084|NCT02805660|11280331|FG004|COMPLETED|Overall Study||0
10150085|NCT02805660|11280332|FG005|COMPLETED|Overall Study||0
10150086|NCT02805660|11280333|FG006|COMPLETED|Overall Study||0
10150087|NCT02805660|11280327|FG000|NOT COMPLETED|Overall Study||5
10150088|NCT02805660|11280328|FG001|NOT COMPLETED|Overall Study||4
10150089|NCT02805660|11280329|FG002|NOT COMPLETED|Overall Study||11
10150090|NCT02805660|11280330|FG003|NOT COMPLETED|Overall Study||18
10150091|NCT02805660|11280331|FG004|NOT COMPLETED|Overall Study||3
10150092|NCT02805660|11280332|FG005|NOT COMPLETED|Overall Study||23
10150093|NCT02805660|11280333|FG006|NOT COMPLETED|Overall Study||19
10150094|NCT02805790|11280364|FG000|STARTED|First Intervention (4 Weeks)||14
10150095|NCT02805790|11280365|FG001|STARTED|First Intervention (4 Weeks)||16
10150096|NCT02805790|11280364|FG000|COMPLETED|First Intervention (4 Weeks)||14
10150097|NCT02805790|11280365|FG001|COMPLETED|First Intervention (4 Weeks)||16
10150098|NCT02805790|11280364|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10150099|NCT02805790|11280365|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10150100|NCT02805790|11280364|FG000|STARTED|Washout (4 Weeks)||14
10150101|NCT02805790|11280365|FG001|STARTED|Washout (4 Weeks)||16
10150102|NCT02805790|11280364|FG000|COMPLETED|Washout (4 Weeks)||14
10150103|NCT02805790|11280365|FG001|COMPLETED|Washout (4 Weeks)||16
10150104|NCT02805790|11280364|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10150105|NCT02805790|11280365|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10150106|NCT02805790|11280364|FG000|STARTED|Second Intervention (4 Weeks)||14
10150107|NCT02805790|11280365|FG001|STARTED|Second Intervention (4 Weeks)||16
10150108|NCT02805790|11280364|FG000|COMPLETED|Second Intervention (4 Weeks)||14
10150109|NCT02805790|11280365|FG001|COMPLETED|Second Intervention (4 Weeks)||15
10150110|NCT02805790|11280364|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10150111|NCT02805790|11280365|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10150112|NCT02805907|11280373|FG000|STARTED|Overall Study||56
10150113|NCT02805907|11280374|FG001|STARTED|Overall Study||56
10150114|NCT02805907|11280373|FG000|COMPLETED|Overall Study||53
10150115|NCT02805907|11280374|FG001|COMPLETED|Overall Study||53
10150116|NCT02805907|11280373|FG000|NOT COMPLETED|Overall Study||3
10150117|NCT02805907|11280374|FG001|NOT COMPLETED|Overall Study||3
10150118|NCT02805972|11280382|FG000|STARTED|Intervention Visit 1||23
10150119|NCT02805972|11280383|FG001|STARTED|Intervention Visit 1||18
10150120|NCT02805972|11280382|FG000|COMPLETED|Intervention Visit 1||23
10150121|NCT02805972|11280383|FG001|COMPLETED|Intervention Visit 1||18
10150122|NCT02805972|11280382|FG000|NOT COMPLETED|Intervention Visit 1||0
10150123|NCT02805972|11280383|FG001|NOT COMPLETED|Intervention Visit 1||0
10150124|NCT02805972|11280382|FG000|STARTED|Washout Period||23
10150125|NCT02805972|11280383|FG001|STARTED|Washout Period||18
10150126|NCT02805972|11280382|FG000|COMPLETED|Washout Period||20
10150127|NCT02805972|11280383|FG001|COMPLETED|Washout Period||18
10150128|NCT02805972|11280382|FG000|NOT COMPLETED|Washout Period||3
10150129|NCT02805972|11280383|FG001|NOT COMPLETED|Washout Period||0
10150130|NCT02805972|11280382|FG000|STARTED|Intervention Visit 2||20
10150131|NCT02805972|11280383|FG001|STARTED|Intervention Visit 2||18
10150132|NCT02805972|11280382|FG000|COMPLETED|Intervention Visit 2||20
10150133|NCT02805972|11280383|FG001|COMPLETED|Intervention Visit 2||18
10150134|NCT02805972|11280382|FG000|NOT COMPLETED|Intervention Visit 2||0
10150135|NCT02805972|11280383|FG001|NOT COMPLETED|Intervention Visit 2||0
10150136|NCT02806024|11280401|FG000|STARTED|Overall Study||7
10150137|NCT02806024|11280402|FG001|STARTED|Overall Study||7
10150138|NCT02806024|11280401|FG000|COMPLETED|Overall Study||6
10150139|NCT02806024|11280402|FG001|COMPLETED|Overall Study||5
10150140|NCT02806024|11280401|FG000|NOT COMPLETED|Overall Study||1
10150141|NCT02806024|11280402|FG001|NOT COMPLETED|Overall Study||2
10150142|NCT02806232|11280417|FG000|STARTED|Overall Study||60
10150143|NCT02806232|11280418|FG001|STARTED|Overall Study||60
10150144|NCT02806232|11280419|FG002|STARTED|Overall Study||60
10150145|NCT02806232|11280420|FG003|STARTED|Overall Study||60
10150146|NCT02806232|11280421|FG004|STARTED|Overall Study||60
10150147|NCT02806232|11280422|FG005|STARTED|Overall Study||60
10150148|NCT02806232|11280423|FG006|STARTED|Overall Study||60
10150149|NCT02806232|11280424|FG007|STARTED|Overall Study||20
10150150|NCT02806232|11280425|FG008|STARTED|Overall Study||4
10150151|NCT02806232|11280417|FG000|COMPLETED|Overall Study||59
10150152|NCT02806232|11280418|FG001|COMPLETED|Overall Study||56
10150153|NCT02806232|11280419|FG002|COMPLETED|Overall Study||59
10150154|NCT02806232|11280420|FG003|COMPLETED|Overall Study||60
10150155|NCT02806232|11280421|FG004|COMPLETED|Overall Study||58
10150156|NCT02806232|11280422|FG005|COMPLETED|Overall Study||58
10150157|NCT02806232|11280423|FG006|COMPLETED|Overall Study||60
10150158|NCT02806232|11280424|FG007|COMPLETED|Overall Study||20
10150159|NCT02806232|11280425|FG008|COMPLETED|Overall Study||4
10150160|NCT02806232|11280417|FG000|NOT COMPLETED|Overall Study||1
10150161|NCT02806232|11280418|FG001|NOT COMPLETED|Overall Study||4
10150162|NCT02806232|11280419|FG002|NOT COMPLETED|Overall Study||1
10150163|NCT02806232|11280420|FG003|NOT COMPLETED|Overall Study||0
10150164|NCT02806232|11280421|FG004|NOT COMPLETED|Overall Study||2
10150165|NCT02806232|11280422|FG005|NOT COMPLETED|Overall Study||2
10150166|NCT02806232|11280423|FG006|NOT COMPLETED|Overall Study||0
10150167|NCT02806232|11280424|FG007|NOT COMPLETED|Overall Study||0
10150168|NCT02806232|11280425|FG008|NOT COMPLETED|Overall Study||0
10150169|NCT02806414|11280445|FG000|STARTED|Overall Study||25
10150170|NCT02806414|11280445|FG000|COMPLETED|Overall Study||23
10150171|NCT02806414|11280445|FG000|NOT COMPLETED|Overall Study||2
10150172|NCT02806505|11280451|FG000|STARTED|Overall Study||38
10150173|NCT02806505|11280452|FG001|STARTED|Overall Study||43
10150174|NCT02806505|11280451|FG000|COMPLETED|Overall Study||28
10150175|NCT02806505|11280452|FG001|COMPLETED|Overall Study||32
10150176|NCT02806505|11280451|FG000|NOT COMPLETED|Overall Study||10
10150177|NCT02806505|11280452|FG001|NOT COMPLETED|Overall Study||11
10150178|NCT02806544|11280458|FG000|STARTED|Overall Study||35
10150179|NCT02806544|11280458|FG000|COMPLETED|Overall Study||31
10150180|NCT02806544|11280458|FG000|NOT COMPLETED|Overall Study||4
10150181|NCT02806713|11280464|FG000|STARTED|Overall Study||46
10150182|NCT02806713|11280465|FG001|STARTED|Overall Study||46
10150183|NCT02806713|11280464|FG000|COMPLETED|Overall Study||44
10150184|NCT02806713|11280465|FG001|COMPLETED|Overall Study||44
10150185|NCT02806713|11280464|FG000|NOT COMPLETED|Overall Study||2
10150186|NCT02806713|11280465|FG001|NOT COMPLETED|Overall Study||2
10150187|NCT02806726|11280471|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7
10150188|NCT02806726|11280471|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6
10150189|NCT02806726|11280471|FG000|NOT COMPLETED|Overall Study||1
10150190|NCT02806869|11280478|FG000|STARTED|First Intervention (1 Day)||24
10150191|NCT02806869|11280479|FG001|STARTED|First Intervention (1 Day)||24
10150192|NCT02806869|11280478|FG000|COMPLETED|First Intervention (1 Day)||13
10150193|NCT02806869|11280479|FG001|COMPLETED|First Intervention (1 Day)||12
10150194|NCT02806869|11280478|FG000|NOT COMPLETED|First Intervention (1 Day)||11
10150195|NCT02806869|11280479|FG001|NOT COMPLETED|First Intervention (1 Day)||12
10150196|NCT02806869|11280478|FG000|STARTED|Washout (7 Days)||7
10150197|NCT02806869|11280479|FG001|STARTED|Washout (7 Days)||7
10150198|NCT02806869|11280478|FG000|COMPLETED|Washout (7 Days)||7
10150199|NCT02806869|11280479|FG001|COMPLETED|Washout (7 Days)||7
10150200|NCT02806869|11280478|FG000|NOT COMPLETED|Washout (7 Days)||0
10150201|NCT02806869|11280479|FG001|NOT COMPLETED|Washout (7 Days)||0
10150202|NCT02806869|11280478|FG000|STARTED|Second Intervention (1 Day)||7
10150203|NCT02806869|11280479|FG001|STARTED|Second Intervention (1 Day)||7
10150204|NCT02806869|11280478|FG000|COMPLETED|Second Intervention (1 Day)||7
10150205|NCT02806869|11280479|FG001|COMPLETED|Second Intervention (1 Day)||5
10150206|NCT02806869|11280478|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10150207|NCT02806869|11280479|FG001|NOT COMPLETED|Second Intervention (1 Day)||2
10150208|NCT02806895|11280487|FG000|STARTED|Overall Study||17
10150209|NCT02806895|11280488|FG001|STARTED|Overall Study||17
10150210|NCT02806895|11280487|FG000|COMPLETED|Overall Study||16
10150211|NCT02806895|11280488|FG001|COMPLETED|Overall Study||17
10150212|NCT02806895|11280487|FG000|NOT COMPLETED|Overall Study||1
10150213|NCT02806895|11280488|FG001|NOT COMPLETED|Overall Study||0
10150214|NCT02806908|11280497|FG000|STARTED|Overall Study||11
10150215|NCT02806908|11280498|FG001|STARTED|Overall Study||13
10150216|NCT02806908|11280497|FG000|COMPLETED|Overall Study||10
10150217|NCT02806908|11280498|FG001|COMPLETED|Overall Study||12
10150218|NCT02806908|11280497|FG000|NOT COMPLETED|Overall Study||1
10150219|NCT02806908|11280498|FG001|NOT COMPLETED|Overall Study||1
10150220|NCT02806947|11280507|FG000|STARTED|Overall Study||58
10150221|NCT02806947|11280508|FG001|STARTED|Overall Study||64
10150222|NCT02806947|11280507|FG000|COMPLETED|Overall Study||53
10150223|NCT02806947|11280508|FG001|COMPLETED|Overall Study||63
10150224|NCT02806947|11280507|FG000|NOT COMPLETED|Overall Study||5
10150225|NCT02806947|11280508|FG001|NOT COMPLETED|Overall Study||1
10150226|NCT02806973|11280514|FG000|STARTED|Period 1||8
10150227|NCT02806973|11280515|FG001|STARTED|Period 1||8
10150228|NCT02806973|11280516|FG002|STARTED|Period 1||8
10150229|NCT02806973|11280517|FG003|STARTED|Period 1||8
10150230|NCT02806973|11280514|FG000|COMPLETED|Period 1||8
10150231|NCT02806973|11280515|FG001|COMPLETED|Period 1||6
10150232|NCT02806973|11280516|FG002|COMPLETED|Period 1||7
10150233|NCT02806973|11280517|FG003|COMPLETED|Period 1||6
10150234|NCT02806973|11280514|FG000|NOT COMPLETED|Period 1||0
10150235|NCT02806973|11280515|FG001|NOT COMPLETED|Period 1||2
10150236|NCT02806973|11280516|FG002|NOT COMPLETED|Period 1||1
10150237|NCT02806973|11280517|FG003|NOT COMPLETED|Period 1||2
10150238|NCT02806973|11280514|FG000|STARTED|Period 2||8
10150239|NCT02806973|11280515|FG001|STARTED|Period 2||6
10150240|NCT02806973|11280516|FG002|STARTED|Period 2||7
10150241|NCT02806973|11280517|FG003|STARTED|Period 2||6
10150242|NCT02806973|11280514|FG000|COMPLETED|Period 2||8
10150243|NCT02806973|11280515|FG001|COMPLETED|Period 2||6
9709410|NCT02564900|10808828|FG000|STARTED|Dose Escalation||3
9709411|NCT02564900|10808829|FG001|STARTED|Dose Escalation||3
9709412|NCT02564900|10808830|FG002|STARTED|Dose Escalation||3
9709413|NCT02564900|10808831|FG003|STARTED|Dose Escalation||6
9709414|NCT02564900|10808832|FG004|STARTED|Dose Escalation||6
9709415|NCT02564900|10808833|FG005|STARTED|Dose Escalation||6
9709416|NCT02564900|10808834|FG006|STARTED|Dose Escalation||0
9709417|NCT02564900|10808835|FG007|STARTED|Dose Escalation||0
9709418|NCT02564900|10808836|FG008|STARTED|Dose Escalation||0
9709419|NCT02564900|10808837|FG009|STARTED|Dose Escalation||0
9709420|NCT02564900|10808838|FG010|STARTED|Dose Escalation||0
9709421|NCT02564900|10808839|FG011|STARTED|Dose Escalation||0
9709422|NCT02564900|10808840|FG012|STARTED|Dose Escalation||0
9709423|NCT02564900|10808841|FG013|STARTED|Dose Escalation||0
9709424|NCT02564900|10808842|FG014|STARTED|Dose Escalation||0
9709425|NCT02564900|10808828|FG000|COMPLETED|Dose Escalation||0
9709426|NCT02564900|10808829|FG001|COMPLETED|Dose Escalation||0
9709427|NCT02564900|10808830|FG002|COMPLETED|Dose Escalation||0
9709428|NCT02564900|10808831|FG003|COMPLETED|Dose Escalation||0
9709429|NCT02564900|10808832|FG004|COMPLETED|Dose Escalation||0
9709430|NCT02564900|10808833|FG005|COMPLETED|Dose Escalation||0
9709431|NCT02564900|10808834|FG006|COMPLETED|Dose Escalation||0
9709432|NCT02564900|10808835|FG007|COMPLETED|Dose Escalation||0
9709433|NCT02564900|10808836|FG008|COMPLETED|Dose Escalation||0
9709434|NCT02564900|10808837|FG009|COMPLETED|Dose Escalation||0
9709435|NCT02564900|10808838|FG010|COMPLETED|Dose Escalation||0
9709436|NCT02564900|10808839|FG011|COMPLETED|Dose Escalation||0
9709437|NCT02564900|10808840|FG012|COMPLETED|Dose Escalation||0
9709438|NCT02564900|10808841|FG013|COMPLETED|Dose Escalation||0
9709439|NCT02564900|10808842|FG014|COMPLETED|Dose Escalation||0
9709440|NCT02564900|10808828|FG000|NOT COMPLETED|Dose Escalation||3
9709441|NCT02564900|10808829|FG001|NOT COMPLETED|Dose Escalation||3
9709442|NCT02564900|10808830|FG002|NOT COMPLETED|Dose Escalation||3
9709443|NCT02564900|10808831|FG003|NOT COMPLETED|Dose Escalation||6
9709444|NCT02564900|10808832|FG004|NOT COMPLETED|Dose Escalation||6
9709445|NCT02564900|10808833|FG005|NOT COMPLETED|Dose Escalation||6
9709446|NCT02564900|10808834|FG006|NOT COMPLETED|Dose Escalation||0
9709447|NCT02564900|10808835|FG007|NOT COMPLETED|Dose Escalation||0
9709448|NCT02564900|10808836|FG008|NOT COMPLETED|Dose Escalation||0
9709449|NCT02564900|10808837|FG009|NOT COMPLETED|Dose Escalation||0
9709450|NCT02564900|10808838|FG010|NOT COMPLETED|Dose Escalation||0
9709451|NCT02564900|10808839|FG011|NOT COMPLETED|Dose Escalation||0
9709452|NCT02564900|10808840|FG012|NOT COMPLETED|Dose Escalation||0
9709453|NCT02564900|10808841|FG013|NOT COMPLETED|Dose Escalation||0
9709454|NCT02564900|10808842|FG014|NOT COMPLETED|Dose Escalation||0
9709455|NCT02564900|10808828|FG000|STARTED|Dose Expansion||0
9709456|NCT02564900|10808829|FG001|STARTED|Dose Expansion||0
9709457|NCT02564900|10808830|FG002|STARTED|Dose Expansion||0
9709458|NCT02564900|10808831|FG003|STARTED|Dose Expansion||0
9709459|NCT02564900|10808832|FG004|STARTED|Dose Expansion||0
9709460|NCT02564900|10808833|FG005|STARTED|Dose Expansion||0
9709461|NCT02564900|10808834|FG006|STARTED|Dose Expansion||49
9709462|NCT02564900|10808835|FG007|STARTED|Dose Expansion||62
9709463|NCT02564900|10808836|FG008|STARTED|Dose Expansion||20
9709464|NCT02564900|10808837|FG009|STARTED|Dose Expansion||33
9709465|NCT02564900|10808838|FG010|STARTED|Dose Expansion||17
9709466|NCT02564900|10808839|FG011|STARTED|Dose Expansion||24
9709467|NCT02564900|10808840|FG012|STARTED|Dose Expansion||18
9709468|NCT02564900|10808841|FG013|STARTED|Dose Expansion||20
9709469|NCT02564900|10808842|FG014|STARTED|Dose Expansion||22
9709470|NCT02564900|10808828|FG000|Enrolled, But Not Dosed|Dose Expansion||0
9709471|NCT02564900|10808829|FG001|Enrolled, But Not Dosed|Dose Expansion||0
9709472|NCT02564900|10808830|FG002|Enrolled, But Not Dosed|Dose Expansion||0
9709473|NCT02564900|10808831|FG003|Enrolled, But Not Dosed|Dose Expansion||0
9709474|NCT02564900|10808832|FG004|Enrolled, But Not Dosed|Dose Expansion||0
9709475|NCT02564900|10808833|FG005|Enrolled, But Not Dosed|Dose Expansion||0
9709476|NCT02564900|10808834|FG006|Enrolled, But Not Dosed|Dose Expansion||1
9709477|NCT02564900|10808835|FG007|Enrolled, But Not Dosed|Dose Expansion||1
9709478|NCT02564900|10808836|FG008|Enrolled, But Not Dosed|Dose Expansion||0
10150244|NCT02806973|11280516|FG002|COMPLETED|Period 2||7
10150245|NCT02806973|11280517|FG003|COMPLETED|Period 2||6
10150246|NCT02806973|11280514|FG000|NOT COMPLETED|Period 2||0
10150247|NCT02806973|11280515|FG001|NOT COMPLETED|Period 2||0
10150248|NCT02806973|11280516|FG002|NOT COMPLETED|Period 2||0
10150249|NCT02806973|11280517|FG003|NOT COMPLETED|Period 2||0
9709479|NCT02564900|10808837|FG009|Enrolled, But Not Dosed|Dose Expansion||0
9709480|NCT02564900|10808838|FG010|Enrolled, But Not Dosed|Dose Expansion||0
9709481|NCT02564900|10808839|FG011|Enrolled, But Not Dosed|Dose Expansion||0
9709482|NCT02564900|10808840|FG012|Enrolled, But Not Dosed|Dose Expansion||0
10150250|NCT02806973|11280514|FG000|STARTED|Period 3||8
10150251|NCT02806973|11280515|FG001|STARTED|Period 3||6
10150252|NCT02806973|11280516|FG002|STARTED|Period 3||7
10150253|NCT02806973|11280517|FG003|STARTED|Period 3||6
10150254|NCT02806973|11280514|FG000|COMPLETED|Period 3||8
10150255|NCT02806973|11280515|FG001|COMPLETED|Period 3||6
10150256|NCT02806973|11280516|FG002|COMPLETED|Period 3||6
10150257|NCT02806973|11280517|FG003|COMPLETED|Period 3||3
10150258|NCT02806973|11280514|FG000|NOT COMPLETED|Period 3||0
10150259|NCT02806973|11280515|FG001|NOT COMPLETED|Period 3||0
10150260|NCT02806973|11280516|FG002|NOT COMPLETED|Period 3||1
10150261|NCT02806973|11280517|FG003|NOT COMPLETED|Period 3||3
10150262|NCT02806973|11280514|FG000|STARTED|Period 4||8
10150263|NCT02806973|11280515|FG001|STARTED|Period 4||6
10150264|NCT02806973|11280516|FG002|STARTED|Period 4||6
10150265|NCT02806973|11280517|FG003|STARTED|Period 4||3
10150266|NCT02806973|11280514|FG000|COMPLETED|Period 4||8
10150267|NCT02806973|11280515|FG001|COMPLETED|Period 4||6
10150268|NCT02806973|11280516|FG002|COMPLETED|Period 4||6
10150269|NCT02806973|11280517|FG003|COMPLETED|Period 4||3
10150270|NCT02806973|11280514|FG000|NOT COMPLETED|Period 4||0
10150271|NCT02806973|11280515|FG001|NOT COMPLETED|Period 4||0
10150272|NCT02806973|11280516|FG002|NOT COMPLETED|Period 4||0
10150273|NCT02806973|11280517|FG003|NOT COMPLETED|Period 4||0
10150274|NCT02806986|11280527|FG000|STARTED|Treatment Stage 1||61
10150275|NCT02806986|11280527|FG000|COMPLETED|Treatment Stage 1||60
10150276|NCT02806986|11280527|FG000|NOT COMPLETED|Treatment Stage 1||1
10150277|NCT02806986|11280527|FG000|STARTED|Treatment Stage 2||60
10150278|NCT02806986|11280527|FG000|COMPLETED|Treatment Stage 2||55
10150279|NCT02806986|11280527|FG000|NOT COMPLETED|Treatment Stage 2||5
10150280|NCT02807259|11280537|FG000|STARTED|Baseline (3 Months)||405
10150281|NCT02807259|11280538|FG001|STARTED|Baseline (3 Months)||404
10150282|NCT02807259|11280537|FG000|COMPLETED|Baseline (3 Months)||328
10150283|NCT02807259|11280538|FG001|COMPLETED|Baseline (3 Months)||292
10150284|NCT02807259|11280537|FG000|NOT COMPLETED|Baseline (3 Months)||77
10150285|NCT02807259|11280538|FG001|NOT COMPLETED|Baseline (3 Months)||112
10150286|NCT02807259|11280537|FG000|STARTED|Midline (3 Months)||352
10150287|NCT02807259|11280538|FG001|STARTED|Midline (3 Months)||223
10150288|NCT02807259|11280537|FG000|COMPLETED|Midline (3 Months)||322
10150289|NCT02807259|11280538|FG001|COMPLETED|Midline (3 Months)||189
10150290|NCT02807259|11280537|FG000|NOT COMPLETED|Midline (3 Months)||30
10150291|NCT02807259|11280538|FG001|NOT COMPLETED|Midline (3 Months)||34
10150292|NCT02807259|11280537|FG000|STARTED|Endline (3 Months)||323
10150293|NCT02807259|11280538|FG001|STARTED|Endline (3 Months)||346
10150294|NCT02807259|11280537|FG000|COMPLETED|Endline (3 Months)||288
10150295|NCT02807259|11280538|FG001|COMPLETED|Endline (3 Months)||259
10150296|NCT02807259|11280537|FG000|NOT COMPLETED|Endline (3 Months)||35
10150297|NCT02807259|11280538|FG001|NOT COMPLETED|Endline (3 Months)||87
10150298|NCT02807376|11280548|FG000|STARTED|Overall Study||139
10150299|NCT02807376|11280549|FG001|STARTED|Overall Study||131
10150300|NCT02807376|11280548|FG000|COMPLETED|Overall Study||136
10150301|NCT02807376|11280549|FG001|COMPLETED|Overall Study||130
10150302|NCT02807376|11280548|FG000|NOT COMPLETED|Overall Study||3
10150303|NCT02807376|11280549|FG001|NOT COMPLETED|Overall Study||1
10150304|NCT02807402|11280555|FG000|STARTED|Overall Study||522
10150305|NCT02807402|11280555|FG000|COMPLETED|Overall Study||516
10150306|NCT02807402|11280555|FG000|NOT COMPLETED|Overall Study||6
10150307|NCT02807623|11280570|FG000|STARTED|Overall Study||98
10150308|NCT02807623|11280571|FG001|STARTED|Overall Study||100
10150309|NCT02807623|11280572|FG002|STARTED|Overall Study||102
10150310|NCT02807623|11280570|FG000|COMPLETED|Overall Study||75
10150311|NCT02807623|11280571|FG001|COMPLETED|Overall Study||79
10150312|NCT02807623|11280572|FG002|COMPLETED|Overall Study||79
10150313|NCT02807623|11280570|FG000|NOT COMPLETED|Overall Study||23
10150314|NCT02807623|11280571|FG001|NOT COMPLETED|Overall Study||21
10150315|NCT02807623|11280572|FG002|NOT COMPLETED|Overall Study||23
10150316|NCT02807844|11280599|FG000|STARTED|Overall Study||6
10150317|NCT02807844|11280600|FG001|STARTED|Overall Study||12
10150318|NCT02807844|11280601|FG002|STARTED|Overall Study||12
10150319|NCT02807844|11280602|FG003|STARTED|Overall Study||13
10150320|NCT02807844|11280603|FG004|STARTED|Overall Study||6
10150321|NCT02807844|11280604|FG005|STARTED|Overall Study||11
10150322|NCT02807844|11280605|FG006|STARTED|Overall Study||20
10150323|NCT02807844|11280606|FG007|STARTED|Overall Study||20
10150324|NCT02807844|11280607|FG008|STARTED|Overall Study||21
10150325|NCT02807844|11280608|FG009|STARTED|Overall Study||20
10150326|NCT02807844|11280599|FG000|COMPLETED|Overall Study||0
10150327|NCT02807844|11280600|FG001|COMPLETED|Overall Study||0
10150328|NCT02807844|11280601|FG002|COMPLETED|Overall Study||0
10150329|NCT02807844|11280602|FG003|COMPLETED|Overall Study||0
10150330|NCT02807844|11280603|FG004|COMPLETED|Overall Study||0
10150331|NCT02807844|11280604|FG005|COMPLETED|Overall Study||0
10150332|NCT02807844|11280605|FG006|COMPLETED|Overall Study||0
10150333|NCT02807844|11280606|FG007|COMPLETED|Overall Study||0
10150334|NCT02807844|11280607|FG008|COMPLETED|Overall Study||0
10150335|NCT02807844|11280608|FG009|COMPLETED|Overall Study||0
10150336|NCT02807844|11280599|FG000|NOT COMPLETED|Overall Study||6
10150337|NCT02807844|11280600|FG001|NOT COMPLETED|Overall Study||12
10150338|NCT02807844|11280601|FG002|NOT COMPLETED|Overall Study||12
10150339|NCT02807844|11280602|FG003|NOT COMPLETED|Overall Study||13
10150340|NCT02807844|11280603|FG004|NOT COMPLETED|Overall Study||6
10150341|NCT02807844|11280604|FG005|NOT COMPLETED|Overall Study||11
10150342|NCT02807844|11280605|FG006|NOT COMPLETED|Overall Study||20
10150343|NCT02807844|11280606|FG007|NOT COMPLETED|Overall Study||20
10150344|NCT02807844|11280607|FG008|NOT COMPLETED|Overall Study||21
10150345|NCT02807844|11280608|FG009|NOT COMPLETED|Overall Study||20
10150346|NCT02807857|11280634|FG000|STARTED|Enrolled Set||1415
10150347|NCT02807857|11280634|FG000|COMPLETED|Enrolled Set||864
10150348|NCT02807857|11280634|FG000|NOT COMPLETED|Enrolled Set||551
10150349|NCT02807857|11280634|FG000|STARTED|Follow-Up Set||864
10150350|NCT02807857|11280634|FG000|COMPLETED|Follow-Up Set||680
10150351|NCT02807857|11280634|FG000|NOT COMPLETED|Follow-Up Set||184
10150352|NCT02807948|11280644|FG000|STARTED|Overall Study||132
10150353|NCT02807948|11280645|FG001|STARTED|Overall Study||57
10150354|NCT02807948|11280644|FG000|COMPLETED|Overall Study||131
10150355|NCT02807948|11280645|FG001|COMPLETED|Overall Study||57
10150356|NCT02807948|11280644|FG000|NOT COMPLETED|Overall Study||1
10150357|NCT02807948|11280645|FG001|NOT COMPLETED|Overall Study||0
10150358|NCT02808052|11280653|FG000|STARTED|Overall Study||4
10150359|NCT02808052|11280654|FG001|STARTED|Overall Study||3
10150360|NCT02808052|11280655|FG002|STARTED|Overall Study||2
10150361|NCT02808052|11280653|FG000|COMPLETED|Overall Study||4
10150362|NCT02808052|11280654|FG001|COMPLETED|Overall Study||3
10150363|NCT02808052|11280655|FG002|COMPLETED|Overall Study||2
10150364|NCT02808052|11280653|FG000|NOT COMPLETED|Overall Study||0
10150365|NCT02808052|11280654|FG001|NOT COMPLETED|Overall Study||0
10150366|NCT02808052|11280655|FG002|NOT COMPLETED|Overall Study||0
10150367|NCT02808130|11280669|FG000|STARTED|Overall Study||15
9709483|NCT02564900|10808841|FG013|Enrolled, But Not Dosed|Dose Expansion||0
9709484|NCT02564900|10808842|FG014|Enrolled, But Not Dosed|Dose Expansion||1
9709485|NCT02564900|10808828|FG000|COMPLETED|Dose Expansion||0
9709486|NCT02564900|10808829|FG001|COMPLETED|Dose Expansion||0
9709487|NCT02564900|10808830|FG002|COMPLETED|Dose Expansion||0
9709488|NCT02564900|10808831|FG003|COMPLETED|Dose Expansion||0
9709489|NCT02564900|10808832|FG004|COMPLETED|Dose Expansion||0
9709490|NCT02564900|10808833|FG005|COMPLETED|Dose Expansion||0
9709491|NCT02564900|10808834|FG006|COMPLETED|Dose Expansion||0
9709492|NCT02564900|10808835|FG007|COMPLETED|Dose Expansion||0
9709493|NCT02564900|10808836|FG008|COMPLETED|Dose Expansion||0
9709494|NCT02564900|10808837|FG009|COMPLETED|Dose Expansion||0
9709495|NCT02564900|10808838|FG010|COMPLETED|Dose Expansion||0
9709496|NCT02564900|10808839|FG011|COMPLETED|Dose Expansion||0
9709497|NCT02564900|10808840|FG012|COMPLETED|Dose Expansion||0
9709498|NCT02564900|10808841|FG013|COMPLETED|Dose Expansion||0
9709499|NCT02564900|10808842|FG014|COMPLETED|Dose Expansion||0
9709500|NCT02564900|10808828|FG000|NOT COMPLETED|Dose Expansion||0
9709501|NCT02564900|10808829|FG001|NOT COMPLETED|Dose Expansion||0
9709502|NCT02564900|10808830|FG002|NOT COMPLETED|Dose Expansion||0
9709503|NCT02564900|10808831|FG003|NOT COMPLETED|Dose Expansion||0
9709504|NCT02564900|10808832|FG004|NOT COMPLETED|Dose Expansion||0
9709505|NCT02564900|10808833|FG005|NOT COMPLETED|Dose Expansion||0
9709506|NCT02564900|10808834|FG006|NOT COMPLETED|Dose Expansion||49
9709507|NCT02564900|10808835|FG007|NOT COMPLETED|Dose Expansion||62
9709508|NCT02564900|10808836|FG008|NOT COMPLETED|Dose Expansion||20
9709509|NCT02564900|10808837|FG009|NOT COMPLETED|Dose Expansion||33
9709510|NCT02564900|10808838|FG010|NOT COMPLETED|Dose Expansion||17
9709511|NCT02564900|10808839|FG011|NOT COMPLETED|Dose Expansion||24
9709512|NCT02564900|10808840|FG012|NOT COMPLETED|Dose Expansion||18
9709513|NCT02564900|10808841|FG013|NOT COMPLETED|Dose Expansion||20
9709514|NCT02564900|10808842|FG014|NOT COMPLETED|Dose Expansion||22
9709515|NCT02561299|10808885|FG000|STARTED|Overall Study||32
9709516|NCT02561299|10808886|FG001|STARTED|Overall Study||34
9709517|NCT02561299|10808885|FG000|COMPLETED|Overall Study||27
9709518|NCT02561299|10808886|FG001|COMPLETED|Overall Study||28
9709519|NCT02561299|10808885|FG000|NOT COMPLETED|Overall Study||5
9709520|NCT02561299|10808886|FG001|NOT COMPLETED|Overall Study||6
9709521|NCT02548143|10808894|FG000|STARTED|Overall Study||6
9709522|NCT02548143|10808895|FG001|STARTED|Overall Study||6
9709523|NCT02548143|10808894|FG000|COMPLETED|Overall Study||5
9709524|NCT02548143|10808895|FG001|COMPLETED|Overall Study||5
9709525|NCT02548143|10808894|FG000|NOT COMPLETED|Overall Study||1
9709526|NCT02548143|10808895|FG001|NOT COMPLETED|Overall Study||1
9709527|NCT02448680|10808903|FG000|STARTED|Overall Study||12
9709528|NCT02448680|10808904|FG001|STARTED|Overall Study||13
10150368|NCT02808130|11280670|FG001|STARTED|Overall Study||15
10150369|NCT02808130|11280671|FG002|STARTED|Overall Study||15
10150370|NCT02808130|11280672|FG003|STARTED|Overall Study||15
9709529|NCT02448680|10808903|FG000|COMPLETED|Overall Study||11
9709530|NCT02448680|10808904|FG001|COMPLETED|Overall Study||10
9709531|NCT02448680|10808903|FG000|NOT COMPLETED|Overall Study||1
9709532|NCT02448680|10808904|FG001|NOT COMPLETED|Overall Study||3
9709533|NCT02393859|10808914|FG000|STARTED|Overall Study||54
9709534|NCT02393859|10808915|FG001|STARTED|Overall Study||54
9709535|NCT02393859|10808914|FG000|COMPLETED|Overall Study||0
9709536|NCT02393859|10808915|FG001|COMPLETED|Overall Study||0
9709537|NCT02393859|10808914|FG000|NOT COMPLETED|Overall Study||54
9709538|NCT02393859|10808915|FG001|NOT COMPLETED|Overall Study||54
9709539|NCT02352103|10808924|FG000|STARTED|Overall Study||60
9848994|NCT00862849|10961756|FG004|NOT COMPLETED|Intervention 3||0
10150371|NCT02808130|11280673|FG004|STARTED|Overall Study||15
10150372|NCT02808130|11280674|FG005|STARTED|Overall Study||15
10150373|NCT02808130|11280669|FG000|COMPLETED|Overall Study||15
10150374|NCT02808130|11280670|FG001|COMPLETED|Overall Study||15
10150375|NCT02808130|11280671|FG002|COMPLETED|Overall Study||15
10150376|NCT02808130|11280672|FG003|COMPLETED|Overall Study||15
10150377|NCT02808130|11280673|FG004|COMPLETED|Overall Study||15
10150378|NCT02808130|11280674|FG005|COMPLETED|Overall Study||15
10150379|NCT02808130|11280669|FG000|NOT COMPLETED|Overall Study||0
10150380|NCT02808130|11280670|FG001|NOT COMPLETED|Overall Study||0
10150381|NCT02808130|11280671|FG002|NOT COMPLETED|Overall Study||0
10150382|NCT02808130|11280672|FG003|NOT COMPLETED|Overall Study||0
10150383|NCT02808130|11280673|FG004|NOT COMPLETED|Overall Study||0
10150384|NCT02808130|11280674|FG005|NOT COMPLETED|Overall Study||0
10150385|NCT02808312|11280696|FG000|STARTED|Overall Study||10
10150386|NCT02808312|11280697|FG001|STARTED|Overall Study||10
10150387|NCT02808312|11280698|FG002|STARTED|Overall Study||17
10150388|NCT02808312|11280699|FG003|STARTED|Overall Study||10
10150389|NCT02808312|11280700|FG004|STARTED|Overall Study||10
10150390|NCT02808312|11280696|FG000|COMPLETED|Overall Study||10
10150391|NCT02808312|11280697|FG001|COMPLETED|Overall Study||10
10150392|NCT02808312|11280698|FG002|COMPLETED|Overall Study||16
10150393|NCT02808312|11280699|FG003|COMPLETED|Overall Study||10
10150394|NCT02808312|11280700|FG004|COMPLETED|Overall Study||10
10150395|NCT02808312|11280696|FG000|NOT COMPLETED|Overall Study||0
10150396|NCT02808312|11280697|FG001|NOT COMPLETED|Overall Study||0
10150397|NCT02808312|11280698|FG002|NOT COMPLETED|Overall Study||1
10150398|NCT02808312|11280699|FG003|NOT COMPLETED|Overall Study||0
10150399|NCT02808312|11280700|FG004|NOT COMPLETED|Overall Study||0
10150400|NCT02808338|11280717|FG000|STARTED|Screening||25
10150401|NCT02808338|11280717|FG000|COMPLETED|Screening||15
10150402|NCT02808338|11280717|FG000|NOT COMPLETED|Screening||10
10150403|NCT02808338|11280717|FG000|STARTED|Overnight In-lab Polysomonography||15
10150404|NCT02808338|11280717|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
10150405|NCT02808338|11280717|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
10150406|NCT02808338|11280717|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
10150407|NCT02808338|11280717|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
10150408|NCT02808338|11280717|FG000|COMPLETED|Overnight In-lab Polysomonography||13
10150409|NCT02808338|11280717|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2
10150410|NCT02808338|11280717|FG000|STARTED|Take Home Period||13
10150411|NCT02808338|11280717|FG000|COMPLETED|Take Home Period||13
10150412|NCT02808338|11280717|FG000|NOT COMPLETED|Take Home Period||0
10150413|NCT02808429|11280731|FG000|STARTED|Overall Study||5
10150414|NCT02808429|11280732|FG001|STARTED|Overall Study||6
10150415|NCT02808429|11280733|FG002|STARTED|Overall Study||5
10150416|NCT02808429|11280731|FG000|COMPLETED|Overall Study||2
10150417|NCT02808429|11280732|FG001|COMPLETED|Overall Study||5
10150418|NCT02808429|11280733|FG002|COMPLETED|Overall Study||3
10150419|NCT02808429|11280731|FG000|NOT COMPLETED|Overall Study||3
10150420|NCT02808429|11280732|FG001|NOT COMPLETED|Overall Study||1
10150421|NCT02808429|11280733|FG002|NOT COMPLETED|Overall Study||2
10150422|NCT02808819|11280743|FG000|STARTED|Overall Study||220
10150423|NCT02808819|11280744|FG001|STARTED|Overall Study||226
10150424|NCT02808819|11280743|FG000|Treated|Overall Study||220
10150425|NCT02808819|11280744|FG001|Treated|Overall Study||226
10150426|NCT02808819|11280743|FG000|COMPLETED|Overall Study||189
10150427|NCT02808819|11280744|FG001|COMPLETED|Overall Study||195
10150428|NCT02808819|11280743|FG000|NOT COMPLETED|Overall Study||31
10150429|NCT02808819|11280744|FG001|NOT COMPLETED|Overall Study||31
10150430|NCT02808975|11280753|FG000|STARTED|Overall Study||103
10150431|NCT02808975|11280754|FG001|STARTED|Overall Study||103
10150432|NCT02808975|11280753|FG000|COMPLETED|Overall Study||81
10150433|NCT02808975|11280754|FG001|COMPLETED|Overall Study||84
10150434|NCT02808975|11280753|FG000|NOT COMPLETED|Overall Study||22
10150435|NCT02808975|11280754|FG001|NOT COMPLETED|Overall Study||19
10150436|NCT02809053|11280762|FG000|STARTED|Overall Study||157
10150437|NCT02809053|11280763|FG001|STARTED|Overall Study||158
10150438|NCT02809053|11280762|FG000|Completed Treatment|Overall Study||156
10150439|NCT02809053|11280763|FG001|Completed Treatment|Overall Study||156
10150440|NCT02809053|11280762|FG000|COMPLETED|Overall Study||150
10150441|NCT02809053|11280763|FG001|COMPLETED|Overall Study||152
10150442|NCT02809053|11280762|FG000|NOT COMPLETED|Overall Study||7
10150443|NCT02809053|11280763|FG001|NOT COMPLETED|Overall Study||6
10150444|NCT02809183|11280774|FG000|STARTED|Overall Study||25
10150445|NCT02809183|11280775|FG001|STARTED|Overall Study||25
10150446|NCT02809183|11280776|FG002|STARTED|Overall Study||25
10150447|NCT02809183|11280777|FG003|STARTED|Overall Study||26
10150448|NCT02809183|11280778|FG004|STARTED|Overall Study||6
10150449|NCT02809183|11280779|FG005|STARTED|Overall Study||28
10150450|NCT02809183|11280774|FG000|COMPLETED|Overall Study||25
10150451|NCT02809183|11280775|FG001|COMPLETED|Overall Study||25
10150452|NCT02809183|11280776|FG002|COMPLETED|Overall Study||25
10150453|NCT02809183|11280777|FG003|COMPLETED|Overall Study||26
10150454|NCT02809183|11280778|FG004|COMPLETED|Overall Study||6
10150455|NCT02809183|11280779|FG005|COMPLETED|Overall Study||28
10150456|NCT02809183|11280774|FG000|NOT COMPLETED|Overall Study||0
10150457|NCT02809183|11280775|FG001|NOT COMPLETED|Overall Study||0
10150458|NCT02809183|11280776|FG002|NOT COMPLETED|Overall Study||0
10150459|NCT02809183|11280777|FG003|NOT COMPLETED|Overall Study||0
10150460|NCT02809183|11280778|FG004|NOT COMPLETED|Overall Study||0
10150461|NCT02809183|11280779|FG005|NOT COMPLETED|Overall Study||0
10150462|NCT02809430|11280796|FG000|STARTED|Overall Study||90
10150463|NCT02809430|11280796|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
10150464|NCT02809430|11280796|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
10150465|NCT02809430|11280796|FG000|COMPLETED|Overall Study||52
10150466|NCT02809430|11280796|FG000|NOT COMPLETED|Overall Study||38
10150467|NCT02809833|11280803|FG000|STARTED|Overall Study||850
10150468|NCT02809833|11280803|FG000|COMPLETED|Overall Study||550
10150469|NCT02809833|11280803|FG000|NOT COMPLETED|Overall Study||300
10150470|NCT02809846|11280809|FG000|STARTED|Overall Study||17
10150471|NCT02809846|11280810|FG001|STARTED|Overall Study||16
10150472|NCT02809846|11280809|FG000|COMPLETED|Overall Study||8
10150473|NCT02809846|11280810|FG001|COMPLETED|Overall Study||9
10150474|NCT02809846|11280809|FG000|NOT COMPLETED|Overall Study||9
10150475|NCT02809846|11280810|FG001|NOT COMPLETED|Overall Study||7
10150476|NCT02809859|11280816|FG000|STARTED|Overall Study||139
10150477|NCT02809859|11280816|FG000|COMPLETED|Overall Study||125
10150478|NCT02809859|11280816|FG000|NOT COMPLETED|Overall Study||14
10150479|NCT02809911|11280822|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
10150480|NCT02809911|11280823|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
10150481|NCT02809911|11280822|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
10150482|NCT02809911|11280823|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
10150483|NCT02809911|11280822|FG000|NOT COMPLETED|Overall Study||0
10150484|NCT02809911|11280823|FG001|NOT COMPLETED|Overall Study||0
10150485|NCT02809976|11280829|FG000|STARTED|Overall Study||11
10150486|NCT02809976|11280829|FG000|COMPLETED|Overall Study||9
10150487|NCT02809976|11280829|FG000|NOT COMPLETED|Overall Study||2
10150488|NCT02810327|11280835|FG000|STARTED|Overall Study||76
9709540|NCT02352103|10808925|FG001|STARTED|Overall Study||60
9709541|NCT02352103|10808924|FG000|COMPLETED|Overall Study||60
9709542|NCT02352103|10808925|FG001|COMPLETED|Overall Study||59
9709543|NCT02352103|10808924|FG000|NOT COMPLETED|Overall Study||0
9709544|NCT02352103|10808925|FG001|NOT COMPLETED|Overall Study||1
9709545|NCT02273362|10808934|FG000|STARTED|Overall Study||5
9709546|NCT02273362|10808935|FG001|STARTED|Overall Study||6
9709547|NCT02273362|10808936|FG002|STARTED|Overall Study||14
9709548|NCT02273362|10808934|FG000|COMPLETED|Overall Study||5
9709549|NCT02273362|10808935|FG001|COMPLETED|Overall Study||6
9709550|NCT02273362|10808936|FG002|COMPLETED|Overall Study||14
9709551|NCT02273362|10808934|FG000|NOT COMPLETED|Overall Study||0
9709552|NCT02273362|10808935|FG001|NOT COMPLETED|Overall Study||0
9709553|NCT02273362|10808936|FG002|NOT COMPLETED|Overall Study||0
9709554|NCT02178358|10808947|FG000|STARTED|Overall Study||20
9709555|NCT02178358|10808948|FG001|STARTED|Overall Study||74
9709556|NCT02178358|10808949|FG002|STARTED|Overall Study||38
9709557|NCT02178358|10808947|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
9709558|NCT02178358|10808948|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
9709559|NCT02178358|10808949|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
9709560|NCT02178358|10808947|FG000|COMPLETED|Overall Study||19
9709561|NCT02178358|10808948|FG001|COMPLETED|Overall Study||72
9709562|NCT02178358|10808949|FG002|COMPLETED|Overall Study||36
9709563|NCT02178358|10808947|FG000|NOT COMPLETED|Overall Study||1
9709564|NCT02178358|10808948|FG001|NOT COMPLETED|Overall Study||2
9709565|NCT02178358|10808949|FG002|NOT COMPLETED|Overall Study||2
9709566|NCT02073279|10808960|FG000|STARTED|Double-blind Period||32
9709567|NCT02073279|10808961|FG001|STARTED|Double-blind Period||63
9709568|NCT02073279|10808960|FG000|COMPLETED|Double-blind Period||17
9709569|NCT02073279|10808961|FG001|COMPLETED|Double-blind Period||16
9709570|NCT02073279|10808960|FG000|NOT COMPLETED|Double-blind Period||15
9709571|NCT02073279|10808961|FG001|NOT COMPLETED|Double-blind Period||47
9709572|NCT02073279|10808960|FG000|STARTED|Open-label Extension Period||17
9709573|NCT02073279|10808961|FG001|STARTED|Open-label Extension Period||16
9709574|NCT02073279|10808960|FG000|COMPLETED|Open-label Extension Period||0
9709575|NCT02073279|10808961|FG001|COMPLETED|Open-label Extension Period||0
9709576|NCT02073279|10808960|FG000|NOT COMPLETED|Open-label Extension Period||17
9709577|NCT02073279|10808961|FG001|NOT COMPLETED|Open-label Extension Period||16
9709578|NCT01544127|10808973|FG000|STARTED|Overall Study||33
9709579|NCT01544127|10808974|FG001|STARTED|Overall Study||33
9709580|NCT01544127|10808975|FG002|STARTED|Overall Study||66
9709581|NCT01544127|10808973|FG000|COMPLETED|Overall Study||22
9709582|NCT01544127|10808974|FG001|COMPLETED|Overall Study||27
9709583|NCT01544127|10808975|FG002|COMPLETED|Overall Study||52
9709584|NCT01544127|10808973|FG000|NOT COMPLETED|Overall Study||11
9709585|NCT01544127|10808974|FG001|NOT COMPLETED|Overall Study||6
9709586|NCT01544127|10808975|FG002|NOT COMPLETED|Overall Study||14
9709587|NCT00806390|10808986|FG000|STARTED|Overall Study||7
9709588|NCT00806390|10808987|FG001|STARTED|Overall Study||8
9709589|NCT00806390|10808986|FG000|COMPLETED|Overall Study||7
9709590|NCT00806390|10808987|FG001|COMPLETED|Overall Study||8
9709591|NCT00806390|10808986|FG000|NOT COMPLETED|Overall Study||0
9709592|NCT00806390|10808987|FG001|NOT COMPLETED|Overall Study||0
9709593|NCT00566618|10808993|FG000|STARTED|Overall Study||1
9709594|NCT00566618|10808994|FG001|STARTED|Overall Study||6
9709595|NCT00566618|10808995|FG002|STARTED|Overall Study||18
9709596|NCT00566618|10808993|FG000|COMPLETED|Overall Study||0
9709597|NCT00566618|10808994|FG001|COMPLETED|Overall Study||0
9709598|NCT00566618|10808995|FG002|COMPLETED|Overall Study||0
9709599|NCT00566618|10808993|FG000|NOT COMPLETED|Overall Study||1
9709600|NCT00566618|10808994|FG001|NOT COMPLETED|Overall Study||6
10150489|NCT02810327|11280836|FG001|STARTED|Overall Study||41
10150490|NCT02810327|11280835|FG000|COMPLETED|Overall Study||69
10150491|NCT02810327|11280836|FG001|COMPLETED|Overall Study||34
10150492|NCT02810327|11280835|FG000|NOT COMPLETED|Overall Study||7
9709601|NCT00566618|10808995|FG002|NOT COMPLETED|Overall Study||18
10150493|NCT02810327|11280836|FG001|NOT COMPLETED|Overall Study||7
10150494|NCT02810340|11280845|FG000|STARTED|Overall Study||20
10150495|NCT02810340|11280846|FG001|STARTED|Overall Study||20
10150496|NCT02810340|11280847|FG002|STARTED|Overall Study||20
10150497|NCT02810340|11280845|FG000|COMPLETED|Overall Study||19
10150498|NCT02810340|11280846|FG001|COMPLETED|Overall Study||19
10150499|NCT02810340|11280847|FG002|COMPLETED|Overall Study||19
10150500|NCT02810340|11280845|FG000|NOT COMPLETED|Overall Study||1
10150501|NCT02810340|11280846|FG001|NOT COMPLETED|Overall Study||1
10150502|NCT02810340|11280847|FG002|NOT COMPLETED|Overall Study||1
10150503|NCT02810392|11280857|FG000|STARTED|Overall Study||9
10150504|NCT02810392|11280858|FG001|STARTED|Overall Study||10
10150505|NCT02810392|11280857|FG000|COMPLETED|Overall Study||8
10150506|NCT02810392|11280858|FG001|COMPLETED|Overall Study||9
10150507|NCT02810392|11280857|FG000|NOT COMPLETED|Overall Study||1
10150508|NCT02810392|11280858|FG001|NOT COMPLETED|Overall Study||1
10150509|NCT02810509|11280866|FG000|STARTED|Overall Study||584
10150510|NCT02810509|11280867|FG001|STARTED|Overall Study||1230
10150511|NCT02810509|11280866|FG000|COMPLETED|Overall Study||584
10150512|NCT02810509|11280867|FG001|COMPLETED|Overall Study||1230
10150513|NCT02810509|11280866|FG000|NOT COMPLETED|Overall Study||0
10150514|NCT02810509|11280867|FG001|NOT COMPLETED|Overall Study||0
10150515|NCT02810873|11280877|FG000|STARTED|Overall Study||6
10150516|NCT02810873|11280878|FG001|STARTED|Overall Study||13
10150517|NCT02810873|11280877|FG000|COMPLETED|Overall Study||6
10150518|NCT02810873|11280878|FG001|COMPLETED|Overall Study||13
10150519|NCT02810873|11280877|FG000|NOT COMPLETED|Overall Study||0
10150520|NCT02810873|11280878|FG001|NOT COMPLETED|Overall Study||0
10150521|NCT02810951|11280885|FG000|STARTED|Overall Study||6
10150522|NCT02810951|11280885|FG000|FCX-007 Injection|Overall Study||6
10150523|NCT02810951|11280885|FG000|No FCX-007 Injection|Overall Study||6
10150524|NCT02810951|11280885|FG000|COMPLETED|Overall Study||5
10150525|NCT02810951|11280885|FG000|NOT COMPLETED|Overall Study||1
10150526|NCT02810964|11280893|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32
10150527|NCT02810964|11280894|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32
10150528|NCT02810964|11280893|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
10150529|NCT02810964|11280894|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
10150530|NCT02810964|11280893|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
10150531|NCT02810964|11280894|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
10150532|NCT02810964|11280893|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
10150533|NCT02810964|11280894|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
10150534|NCT02810964|11280893|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
10150535|NCT02810964|11280894|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
10150536|NCT02810964|11280893|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
10150537|NCT02810964|11280894|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
10150538|NCT02811159|11280900|FG000|STARTED|Treatment Course 1||20
10150539|NCT02811159|11280900|FG000|COMPLETED|Treatment Course 1||19
10150540|NCT02811159|11280900|FG000|NOT COMPLETED|Treatment Course 1||1
10150541|NCT02811159|11280900|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
10150542|NCT02811159|11280900|FG000|COMPLETED|Treatment Course 2||4
10150543|NCT02811159|11280900|FG000|NOT COMPLETED|Treatment Course 2||0
10150544|NCT02811302|11280904|FG000|STARTED|Overall Study||1495
10150545|NCT02811302|11280904|FG000|COMPLETED|Overall Study||1282
10150546|NCT02811302|11280904|FG000|NOT COMPLETED|Overall Study||213
10150547|NCT02811419|11280911|FG000|STARTED|Overall Study||369
10150548|NCT02811419|11280912|FG001|STARTED|Overall Study||371
10150549|NCT02811419|11280911|FG000|COMPLETED|Overall Study||357
10150550|NCT02811419|11280912|FG001|COMPLETED|Overall Study||358
10150551|NCT02811419|11280911|FG000|NOT COMPLETED|Overall Study||12
10150552|NCT02811419|11280912|FG001|NOT COMPLETED|Overall Study||13
10150553|NCT02811445|11280920|FG000|STARTED|Overall Study||18
10150554|NCT02811445|11280921|FG001|STARTED|Overall Study||11
10150555|NCT02811445|11280920|FG000|COMPLETED|Overall Study||18
10150556|NCT02811445|11280921|FG001|COMPLETED|Overall Study||11
10150557|NCT02811445|11280920|FG000|NOT COMPLETED|Overall Study||0
10150558|NCT02811445|11280921|FG001|NOT COMPLETED|Overall Study||0
10150559|NCT02811640|11280927|FG000|STARTED|Overall Study||12
10150560|NCT02811640|11280927|FG000|COMPLETED|Overall Study||10
10150561|NCT02811640|11280927|FG000|NOT COMPLETED|Overall Study||2
10150562|NCT02811965|11280931|FG000|STARTED|Overall Study||21
10150563|NCT02811965|11280931|FG000|COMPLETED|Overall Study||21
10150564|NCT02811965|11280931|FG000|NOT COMPLETED|Overall Study||0
10150565|NCT02812160|11280949|FG000|STARTED|Overall Study||187
10150566|NCT02812160|11280950|FG001|STARTED|Overall Study||101
10150567|NCT02812160|11280949|FG000|COMPLETED|Overall Study||187
10150568|NCT02812160|11280950|FG001|COMPLETED|Overall Study||101
10150569|NCT02812160|11280949|FG000|NOT COMPLETED|Overall Study||0
10150570|NCT02812160|11280950|FG001|NOT COMPLETED|Overall Study||0
10150571|NCT02812186|11280958|FG000|STARTED|Period 1||40
10150572|NCT02812186|11280959|FG001|STARTED|Period 1||39
10150573|NCT02812186|11280958|FG000|COMPLETED|Period 1||29
10150574|NCT02812186|11280959|FG001|COMPLETED|Period 1||24
10150575|NCT02812186|11280958|FG000|NOT COMPLETED|Period 1||11
10150576|NCT02812186|11280959|FG001|NOT COMPLETED|Period 1||15
10150577|NCT02812186|11280958|FG000|STARTED|Period 2||29
10150578|NCT02812186|11280959|FG001|STARTED|Period 2||24
10150579|NCT02812186|11280958|FG000|COMPLETED|Period 2||29
10150580|NCT02812186|11280959|FG001|COMPLETED|Period 2||24
10150581|NCT02812186|11280958|FG000|NOT COMPLETED|Period 2||0
10150582|NCT02812186|11280959|FG001|NOT COMPLETED|Period 2||0
10150583|NCT02812238|11280968|FG000|STARTED|First Intervention||19
10150584|NCT02812238|11280969|FG001|STARTED|First Intervention||19
10150585|NCT02812238|11280968|FG000|COMPLETED|First Intervention||18
10150586|NCT02812238|11280969|FG001|COMPLETED|First Intervention||19
10150587|NCT02812238|11280968|FG000|NOT COMPLETED|First Intervention||1
10150588|NCT02812238|11280969|FG001|NOT COMPLETED|First Intervention||0
10150589|NCT02812238|11280968|FG000|STARTED|Second Intervention||18
10150590|NCT02812238|11280969|FG001|STARTED|Second Intervention||19
10150591|NCT02812238|11280968|FG000|COMPLETED|Second Intervention||18
10150592|NCT02812238|11280969|FG001|COMPLETED|Second Intervention||18
10150593|NCT02812238|11280968|FG000|NOT COMPLETED|Second Intervention||0
10150594|NCT02812238|11280969|FG001|NOT COMPLETED|Second Intervention||1
10150595|NCT02812342|11280975|FG000|STARTED|Overall Study||10
10150596|NCT02812342|11280975|FG000|COMPLETED|Overall Study||10
10150597|NCT02812342|11280975|FG000|NOT COMPLETED|Overall Study||0
10150598|NCT02812771|11280979|FG000|STARTED|Overall Study||62
10150599|NCT02812771|11280979|FG000|COMPLETED|Overall Study||50
10150600|NCT02812771|11280979|FG000|NOT COMPLETED|Overall Study||12
10150601|NCT02813070|11280986|FG000|STARTED|Overall Study||28
10150602|NCT02813070|11280987|FG001|STARTED|Overall Study||23
10150603|NCT02813070|11280988|FG002|STARTED|Overall Study||36
10150604|NCT02813070|11280986|FG000|Treated (Safety Population)|Overall Study||25
10150605|NCT02813070|11280987|FG001|Treated (Safety Population)|Overall Study||20
10150606|NCT02813070|11280988|FG002|Treated (Safety Population)|Overall Study||25
10150607|NCT02813070|11280986|FG000|COMPLETED|Overall Study||25
10150608|NCT02813070|11280987|FG001|COMPLETED|Overall Study||20
10150609|NCT02813070|11280988|FG002|COMPLETED|Overall Study||25
10150610|NCT02813070|11280986|FG000|NOT COMPLETED|Overall Study||3
10150611|NCT02813070|11280987|FG001|NOT COMPLETED|Overall Study||3
10150612|NCT02813070|11280988|FG002|NOT COMPLETED|Overall Study||11
10150613|NCT02813265|11280997|FG000|STARTED|Overall Study||459
10150614|NCT02813265|11280998|FG001|STARTED|Overall Study||456
10150615|NCT02813265|11280997|FG000|COMPLETED|Overall Study||455
10150616|NCT02813265|11280998|FG001|COMPLETED|Overall Study||453
10150617|NCT02813265|11280997|FG000|NOT COMPLETED|Overall Study||4
10150618|NCT02813265|11280998|FG001|NOT COMPLETED|Overall Study||3
10150619|NCT02813421|11281006|FG000|STARTED|Overall Study||5
10150620|NCT02813421|11281007|FG001|STARTED|Overall Study||6
10150621|NCT02813421|11281006|FG000|COMPLETED|Overall Study||3
10150622|NCT02813421|11281007|FG001|COMPLETED|Overall Study||3
10150623|NCT02813421|11281006|FG000|NOT COMPLETED|Overall Study||2
10150624|NCT02813421|11281007|FG001|NOT COMPLETED|Overall Study||3
10150625|NCT02813473|11281013|FG000|STARTED|Overall Study||223
10150626|NCT02813473|11281013|FG000|COMPLETED|Overall Study||223
10150627|NCT02813473|11281013|FG000|NOT COMPLETED|Overall Study||0
10150628|NCT02813551|11281019|FG000|STARTED|Overall Study||59
10150629|NCT02813551|11281020|FG001|STARTED|Overall Study||59
10150630|NCT02813551|11281019|FG000|COMPLETED|Overall Study||58
10150631|NCT02813551|11281020|FG001|COMPLETED|Overall Study||57
10150632|NCT02813551|11281019|FG000|NOT COMPLETED|Overall Study||1
10150633|NCT02813551|11281020|FG001|NOT COMPLETED|Overall Study||2
10150634|NCT02813577|11281026|FG000|STARTED|Overall Study||4
10150635|NCT02813577|11281026|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
10150636|NCT02813577|11281026|FG000|NOT COMPLETED|Overall Study||4
10150637|NCT02813681|11281033|FG000|STARTED|Overall Study||27
10150638|NCT02813681|11281034|FG001|STARTED|Overall Study||34
10150639|NCT02813681|11281035|FG002|STARTED|Overall Study||19
10150640|NCT02813681|11281033|FG000|COMPLETED|Overall Study||22
10150641|NCT02813681|11281034|FG001|COMPLETED|Overall Study||28
10150642|NCT02813681|11281035|FG002|COMPLETED|Overall Study||19
10150643|NCT02813681|11281033|FG000|NOT COMPLETED|Overall Study||5
10150644|NCT02813681|11281034|FG001|NOT COMPLETED|Overall Study||6
10150645|NCT02813681|11281035|FG002|NOT COMPLETED|Overall Study||0
10150646|NCT02813694|11281047|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370
10150647|NCT02813694|11281048|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368
10150648|NCT02813694|11281047|FG000|COMPLETED|Overall Study||353
10150649|NCT02813694|11281048|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
10150650|NCT02813694|11281047|FG000|NOT COMPLETED|Overall Study||17
10150651|NCT02813694|11281048|FG001|NOT COMPLETED|Overall Study||14
10150652|NCT02814175|11281056|FG000|STARTED|Part 1||122
10150653|NCT02814175|11281057|FG001|STARTED|Part 1||123
10150654|NCT02814175|11281058|FG002|STARTED|Part 1||0
10150655|NCT02814175|11281059|FG003|STARTED|Part 1||0
10150656|NCT02814175|11281060|FG004|STARTED|Part 1||0
10150657|NCT02814175|11281061|FG005|STARTED|Part 1||0
10150658|NCT02814175|11281056|FG000|COMPLETED|Part 1||110
10150659|NCT02814175|11281057|FG001|COMPLETED|Part 1||117
10150660|NCT02814175|11281058|FG002|COMPLETED|Part 1||0
10150661|NCT02814175|11281059|FG003|COMPLETED|Part 1||0
10150662|NCT02814175|11281060|FG004|COMPLETED|Part 1||0
10150663|NCT02814175|11281061|FG005|COMPLETED|Part 1||0
10150664|NCT02814175|11281056|FG000|NOT COMPLETED|Part 1||12
10150665|NCT02814175|11281057|FG001|NOT COMPLETED|Part 1||6
10150666|NCT02814175|11281058|FG002|NOT COMPLETED|Part 1||0
10150667|NCT02814175|11281059|FG003|NOT COMPLETED|Part 1||0
10150668|NCT02814175|11281060|FG004|NOT COMPLETED|Part 1||0
10150669|NCT02814175|11281061|FG005|NOT COMPLETED|Part 1||0
10150670|NCT02814175|11281056|FG000|STARTED|Part 2||0
10150671|NCT02814175|11281057|FG001|STARTED|Part 2||0
10150672|NCT02814175|11281058|FG002|STARTED|Part 2||15
10150673|NCT02814175|11281059|FG003|STARTED|Part 2||95
10150674|NCT02814175|11281060|FG004|STARTED|Part 2||54
10150675|NCT02814175|11281061|FG005|STARTED|Part 2||63
10150676|NCT02814175|11281056|FG000|COMPLETED|Part 2||0
10150677|NCT02814175|11281057|FG001|COMPLETED|Part 2||0
10150678|NCT02814175|11281058|FG002|COMPLETED|Part 2||15
10150679|NCT02814175|11281059|FG003|COMPLETED|Part 2||91
10150680|NCT02814175|11281060|FG004|COMPLETED|Part 2||52
10150681|NCT02814175|11281061|FG005|COMPLETED|Part 2||57
10150682|NCT02814175|11281056|FG000|NOT COMPLETED|Part 2||0
10150683|NCT02814175|11281057|FG001|NOT COMPLETED|Part 2||0
10150684|NCT02814175|11281058|FG002|NOT COMPLETED|Part 2||0
10150685|NCT02814175|11281059|FG003|NOT COMPLETED|Part 2||4
10150686|NCT02814175|11281060|FG004|NOT COMPLETED|Part 2||2
10150687|NCT02814175|11281061|FG005|NOT COMPLETED|Part 2||6
9709602|NCT00442559|10809002|FG000|STARTED|Overall Study||100
9709603|NCT00442559|10809003|FG001|STARTED|Overall Study||91
9709604|NCT00442559|10809002|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
9709605|NCT00442559|10809003|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
9709606|NCT00442559|10809002|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
9729574|NCT00118898|10829190|FG003|Initiated Treatment|Overall Study||462
10150688|NCT02814227|11281075|FG000|STARTED|Overall Study||52
10150689|NCT02814227|11281075|FG000|COMPLETED|Overall Study||52
10150690|NCT02814227|11281075|FG000|NOT COMPLETED|Overall Study||0
10150691|NCT02814279|11281081|FG000|STARTED|Overall Study||21
10150692|NCT02814279|11281082|FG001|STARTED|Overall Study||21
10150693|NCT02814279|11281081|FG000|COMPLETED|Overall Study||21
10150694|NCT02814279|11281082|FG001|COMPLETED|Overall Study||21
10150695|NCT02814279|11281081|FG000|NOT COMPLETED|Overall Study||0
10150696|NCT02814279|11281082|FG001|NOT COMPLETED|Overall Study||0
10150697|NCT02814448|11281093|FG000|STARTED|Overall Study||27
10150698|NCT02814448|11281094|FG001|STARTED|Overall Study||24
10150699|NCT02814448|11281095|FG002|STARTED|Overall Study||26
10150700|NCT02814448|11281096|FG003|STARTED|Overall Study||25
10150701|NCT02814448|11281097|FG004|STARTED|Overall Study||28
10150702|NCT02814448|11281093|FG000|COMPLETED|Overall Study||27
10150703|NCT02814448|11281094|FG001|COMPLETED|Overall Study||24
10150704|NCT02814448|11281095|FG002|COMPLETED|Overall Study||25
10150705|NCT02814448|11281096|FG003|COMPLETED|Overall Study||25
10150706|NCT02814448|11281097|FG004|COMPLETED|Overall Study||26
10150707|NCT02814448|11281093|FG000|NOT COMPLETED|Overall Study||0
10150708|NCT02814448|11281094|FG001|NOT COMPLETED|Overall Study||0
10150709|NCT02814448|11281095|FG002|NOT COMPLETED|Overall Study||1
10150710|NCT02814448|11281096|FG003|NOT COMPLETED|Overall Study||0
10150711|NCT02814448|11281097|FG004|NOT COMPLETED|Overall Study||2
10150712|NCT02814565|11281111|FG000|STARTED|Overall Study||90
10150713|NCT02814565|11281112|FG001|STARTED|Overall Study||90
10150714|NCT02814565|11281111|FG000|COMPLETED|Overall Study||89
10150715|NCT02814565|11281112|FG001|COMPLETED|Overall Study||88
10150716|NCT02814565|11281111|FG000|NOT COMPLETED|Overall Study||1
10150717|NCT02814565|11281112|FG001|NOT COMPLETED|Overall Study||2
10150718|NCT02814643|11281120|FG000|STARTED|Overall Study||51
10150719|NCT02814643|11281121|FG001|STARTED|Overall Study||52
10150720|NCT02814643|11281120|FG000|COMPLETED|Overall Study||50
10150721|NCT02814643|11281121|FG001|COMPLETED|Overall Study||49
10150722|NCT02814643|11281120|FG000|NOT COMPLETED|Overall Study||1
10150723|NCT02814643|11281121|FG001|NOT COMPLETED|Overall Study||3
10150724|NCT02814656|11281131|FG000|STARTED|Overall Study||6
10150725|NCT02814656|11281132|FG001|STARTED|Overall Study||6
10150726|NCT02814656|11281133|FG002|STARTED|Overall Study||6
10150727|NCT02814656|11281134|FG003|STARTED|Overall Study||6
10150728|NCT02814656|11281131|FG000|COMPLETED|Overall Study||6
10150729|NCT02814656|11281132|FG001|COMPLETED|Overall Study||6
10150730|NCT02814656|11281133|FG002|COMPLETED|Overall Study||6
10150731|NCT02814656|11281134|FG003|COMPLETED|Overall Study||6
10150732|NCT02814656|11281131|FG000|NOT COMPLETED|Overall Study||0
10150733|NCT02814656|11281132|FG001|NOT COMPLETED|Overall Study||0
10150734|NCT02814656|11281133|FG002|NOT COMPLETED|Overall Study||0
10150735|NCT02814656|11281134|FG003|NOT COMPLETED|Overall Study||0
10150736|NCT02814838|11281146|FG000|STARTED|Overall Study||50
10150737|NCT02814838|11281147|FG001|STARTED|Overall Study||26
10150738|NCT02814838|11281146|FG000|COMPLETED|Overall Study||48
10150739|NCT02814838|11281147|FG001|COMPLETED|Overall Study||25
10150740|NCT02814838|11281146|FG000|NOT COMPLETED|Overall Study||2
10150741|NCT02814838|11281147|FG001|NOT COMPLETED|Overall Study||1
10150742|NCT02814890|11281155|FG000|STARTED|Overall Study||33
10150743|NCT02814890|11281156|FG001|STARTED|Overall Study||32
10150744|NCT02814890|11281155|FG000|COMPLETED|Overall Study||30
10150745|NCT02814890|11281156|FG001|COMPLETED|Overall Study||30
10150746|NCT02814890|11281155|FG000|NOT COMPLETED|Overall Study||3
10150747|NCT02814890|11281156|FG001|NOT COMPLETED|Overall Study||2
10150748|NCT02815293|11281171|FG000|STARTED|Overall Study||10
10150749|NCT02815293|11281172|FG001|STARTED|Overall Study||8
10150750|NCT02815293|11281173|FG002|STARTED|Overall Study||18
10150751|NCT02815293|11281171|FG000|COMPLETED|Overall Study||0
10150752|NCT02815293|11281172|FG001|COMPLETED|Overall Study||0
10150753|NCT02815293|11281173|FG002|COMPLETED|Overall Study||0
10150754|NCT02815293|11281171|FG000|NOT COMPLETED|Overall Study||10
10150755|NCT02815293|11281172|FG001|NOT COMPLETED|Overall Study||8
10150756|NCT02815293|11281173|FG002|NOT COMPLETED|Overall Study||18
10150757|NCT02815644|11281181|FG000|STARTED|Treatment Period 1 + Washout||11
10150758|NCT02815644|11281182|FG001|STARTED|Treatment Period 1 + Washout||11
10150759|NCT02815644|11281181|FG000|COMPLETED|Treatment Period 1 + Washout||11
10150760|NCT02815644|11281182|FG001|COMPLETED|Treatment Period 1 + Washout||11
10150761|NCT02815644|11281181|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
10150762|NCT02815644|11281182|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
10150763|NCT02815644|11281181|FG000|STARTED|Treatment Period 2||11
10150764|NCT02815644|11281182|FG001|STARTED|Treatment Period 2||11
10150765|NCT02815644|11281181|FG000|COMPLETED|Treatment Period 2||11
10150766|NCT02815644|11281182|FG001|COMPLETED|Treatment Period 2||11
10150767|NCT02815644|11281181|FG000|NOT COMPLETED|Treatment Period 2||0
10150768|NCT02815644|11281182|FG001|NOT COMPLETED|Treatment Period 2||0
10150769|NCT02815670|11281188|FG000|STARTED|Overall Study||1
10150770|NCT02815670|11281188|FG000|COMPLETED|Overall Study||0
10150771|NCT02815670|11281188|FG000|NOT COMPLETED|Overall Study||1
10150772|NCT02815709|11281197|FG000|STARTED|Overall Study||82
10150773|NCT02815709|11281198|FG001|STARTED|Overall Study||86
10150774|NCT02815709|11281199|FG002|STARTED|Overall Study||82
10150775|NCT02815709|11281200|FG003|STARTED|Overall Study||84
10150776|NCT02815709|11281201|FG004|STARTED|Overall Study||84
10150777|NCT02815709|11281197|FG000|Treated With Study Medication|Overall Study||76
10150778|NCT02815709|11281198|FG001|Treated With Study Medication|Overall Study||79
10150779|NCT02815709|11281199|FG002|Treated With Study Medication|Overall Study||79
10150780|NCT02815709|11281200|FG003|Treated With Study Medication|Overall Study||79
10150781|NCT02815709|11281201|FG004|Treated With Study Medication|Overall Study||76
10150782|NCT02815709|11281197|FG000|COMPLETED|Overall Study|Completed Study|75
10150783|NCT02815709|11281198|FG001|COMPLETED|Overall Study|Completed Study|78
10150784|NCT02815709|11281199|FG002|COMPLETED|Overall Study|Completed Study|75
10150785|NCT02815709|11281200|FG003|COMPLETED|Overall Study|Completed Study|76
10150786|NCT02815709|11281201|FG004|COMPLETED|Overall Study|Completed Study|74
10150787|NCT02815709|11281197|FG000|NOT COMPLETED|Overall Study||7
10150788|NCT02815709|11281198|FG001|NOT COMPLETED|Overall Study||8
10150789|NCT02815709|11281199|FG002|NOT COMPLETED|Overall Study||7
10150790|NCT02815709|11281200|FG003|NOT COMPLETED|Overall Study||8
10150791|NCT02815709|11281201|FG004|NOT COMPLETED|Overall Study||10
10150792|NCT02815735|11281214|FG000|STARTED|First Intervention (4 Weeks)||36
10150793|NCT02815735|11281215|FG001|STARTED|First Intervention (4 Weeks)||38
10150794|NCT02815735|11281214|FG000|COMPLETED|First Intervention (4 Weeks)||34
10150795|NCT02815735|11281215|FG001|COMPLETED|First Intervention (4 Weeks)||37
9709607|NCT00442559|10809003|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
9709608|NCT00442559|10809002|FG000|NOT COMPLETED|Overall Study||34
9709609|NCT00442559|10809003|FG001|NOT COMPLETED|Overall Study||35
9709610|NCT00117338|10809017|FG000|STARTED|Overall Study||145
9709611|NCT00117338|10809018|FG001|STARTED|Overall Study||131
9709612|NCT00117338|10809017|FG000|COMPLETED|Overall Study||140
9709613|NCT00117338|10809018|FG001|COMPLETED|Overall Study||127
9709614|NCT00117338|10809017|FG000|NOT COMPLETED|Overall Study||5
9709615|NCT00117338|10809018|FG001|NOT COMPLETED|Overall Study||4
9729575|NCT00118898|10829187|FG000|COMPLETED|Overall Study||343
9729576|NCT00118898|10829188|FG001|COMPLETED|Overall Study||324
9729577|NCT00118898|10829189|FG002|COMPLETED|Overall Study||342
9729578|NCT00118898|10829190|FG003|COMPLETED|Overall Study||322
9729579|NCT00118898|10829187|FG000|NOT COMPLETED|Overall Study||121
9729580|NCT00118898|10829188|FG001|NOT COMPLETED|Overall Study||141
9729581|NCT00118898|10829189|FG002|NOT COMPLETED|Overall Study||123
9729582|NCT00118898|10829190|FG003|NOT COMPLETED|Overall Study||141
9729583|NCT00118911|10829202|FG000|STARTED|Overall Study||43
9729584|NCT00118911|10829203|FG001|STARTED|Overall Study||43
9729585|NCT00118911|10829202|FG000|Received Intervention as Assigned|Overall Study||41
9729586|NCT00118911|10829203|FG001|Received Intervention as Assigned|Overall Study||38
9729587|NCT00118911|10829202|FG000|Completed Post-Treatment Assessment|Overall Study||41
9729588|NCT00118911|10829203|FG001|Completed Post-Treatment Assessment|Overall Study||37
9729589|NCT00118911|10829202|FG000|6 Month Follow-up|Overall Study||37
9729590|NCT00118911|10829203|FG001|6 Month Follow-up|Overall Study||30
9729591|NCT00118911|10829202|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
9729592|NCT00118911|10829203|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
9729593|NCT00118911|10829202|FG000|COMPLETED|Overall Study||41
9729594|NCT00118911|10829203|FG001|COMPLETED|Overall Study||38
9729595|NCT00118911|10829202|FG000|NOT COMPLETED|Overall Study||2
9729596|NCT00118911|10829203|FG001|NOT COMPLETED|Overall Study||5
9729597|NCT00119015|10829211|FG000|STARTED|Open-Label Phase (2 Weeks)||102
9729598|NCT00119015|10829212|FG001|STARTED|Open-Label Phase (2 Weeks)||0
9729599|NCT00119015|10829213|FG002|STARTED|Open-Label Phase (2 Weeks)||0
9729600|NCT00119015|10829211|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54
9729601|NCT00119015|10829212|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0
9729602|NCT00119015|10829213|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0
9729603|NCT00119015|10829211|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
9729604|NCT00119015|10829212|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
9729605|NCT00119015|10829213|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
9729606|NCT00119015|10829211|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
9729607|NCT00119015|10829212|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
9729608|NCT00119015|10829213|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
9729609|NCT00119015|10829211|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
9729610|NCT00119015|10829212|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
9729611|NCT00119015|10829213|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
9729612|NCT00119015|10829211|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
9729613|NCT00119015|10829212|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
9729614|NCT00119015|10829213|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
9729615|NCT00119041|10829222|FG000|STARTED|Overall Study||199
9729616|NCT00119041|10829223|FG001|STARTED|Overall Study||83
9729617|NCT00119041|10829224|FG002|STARTED|Overall Study||22
9729618|NCT00119041|10829222|FG000|COMPLETED|Overall Study||199
9729619|NCT00119041|10829223|FG001|COMPLETED|Overall Study||83
9729620|NCT00119041|10829224|FG002|COMPLETED|Overall Study||22
9729621|NCT00119041|10829222|FG000|NOT COMPLETED|Overall Study||0
9729622|NCT00119041|10829223|FG001|NOT COMPLETED|Overall Study||0
9729623|NCT00119041|10829224|FG002|NOT COMPLETED|Overall Study||0
9729624|NCT00119106|10829235|FG000|STARTED|Overall Study||1204
9729625|NCT00119106|10829236|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
9729626|NCT00119106|10829235|FG000|COMPLETED|Overall Study||1025
10150796|NCT02815735|11281214|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10150797|NCT02815735|11281215|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
9729627|NCT00119106|10829236|FG001|COMPLETED|Overall Study||1031
9729628|NCT00119106|10829235|FG000|NOT COMPLETED|Overall Study||179
9729629|NCT00119106|10829236|FG001|NOT COMPLETED|Overall Study||178
9729630|NCT00119158|10829252|FG000|STARTED|Active Treatment|patients are self controls|45
9729631|NCT00119158|10829253|FG001|STARTED|Active Treatment||45
9729632|NCT00119158|10829252|FG000|COMPLETED|Active Treatment||45
9729633|NCT00119158|10829253|FG001|COMPLETED|Active Treatment||45
10150798|NCT02815735|11281214|FG000|STARTED|Second Intervention (4 Weeks)||34
10150799|NCT02815735|11281215|FG001|STARTED|Second Intervention (4 Weeks)||37
10150800|NCT02815735|11281214|FG000|COMPLETED|Second Intervention (4 Weeks)||33
10150801|NCT02815735|11281215|FG001|COMPLETED|Second Intervention (4 Weeks)||37
10150802|NCT02815735|11281214|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10150803|NCT02815735|11281215|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10150804|NCT02815982|11281234|FG000|STARTED|Overall Study||27
10150805|NCT02815982|11281235|FG001|STARTED|Overall Study||26
10150806|NCT02815982|11281236|FG002|STARTED|Overall Study||27
10150807|NCT02815982|11281237|FG003|STARTED|Overall Study||26
10150808|NCT02815982|11281234|FG000|COMPLETED|Overall Study||27
10150809|NCT02815982|11281235|FG001|COMPLETED|Overall Study||26
10150810|NCT02815982|11281236|FG002|COMPLETED|Overall Study||27
10150811|NCT02815982|11281237|FG003|COMPLETED|Overall Study||26
10150812|NCT02815982|11281234|FG000|NOT COMPLETED|Overall Study||0
10150813|NCT02815982|11281235|FG001|NOT COMPLETED|Overall Study||0
10150814|NCT02815982|11281236|FG002|NOT COMPLETED|Overall Study||0
10150815|NCT02815982|11281237|FG003|NOT COMPLETED|Overall Study||0
10197051|NCT03369236|11325043|FG001|STARTED|Double-blind Treatment Period||7
10197052|NCT03369236|11325042|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6
10197053|NCT03369236|11325043|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7
10197054|NCT03369236|11325042|FG000|COMPLETED|Double-blind Treatment Period||6
10197055|NCT03369236|11325043|FG001|COMPLETED|Double-blind Treatment Period||6
10197056|NCT03369236|11325042|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10197057|NCT03369236|11325043|FG001|NOT COMPLETED|Double-blind Treatment Period||1
10197058|NCT03369236|11325042|FG000|STARTED|Open-label Extension Period||6
10197059|NCT03369236|11325043|FG001|STARTED|Open-label Extension Period||6
10197060|NCT03369236|11325042|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
10197061|NCT03369236|11325043|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
10197062|NCT03369236|11325042|FG000|COMPLETED|Open-label Extension Period||1
10197063|NCT03369236|11325043|FG001|COMPLETED|Open-label Extension Period||0
10197064|NCT03369236|11325042|FG000|NOT COMPLETED|Open-label Extension Period||5
10197065|NCT03369236|11325043|FG001|NOT COMPLETED|Open-label Extension Period||6
10197066|NCT03369340|11325055|FG000|STARTED|Day 2||3
10197067|NCT03369340|11325056|FG001|STARTED|Day 2||3
10197068|NCT03369340|11325057|FG002|STARTED|Day 2||3
10197069|NCT03369340|11325058|FG003|STARTED|Day 2||3
10197070|NCT03369340|11325059|FG004|STARTED|Day 2||3
10197071|NCT03369340|11325060|FG005|STARTED|Day 2||3
10197072|NCT03369340|11325055|FG000|COMPLETED|Day 2||3
10197073|NCT03369340|11325056|FG001|COMPLETED|Day 2||3
10197074|NCT03369340|11325057|FG002|COMPLETED|Day 2||3
10197075|NCT03369340|11325058|FG003|COMPLETED|Day 2||3
10197076|NCT03369340|11325059|FG004|COMPLETED|Day 2||3
10197077|NCT03369340|11325060|FG005|COMPLETED|Day 2||3
10197078|NCT03369340|11325055|FG000|NOT COMPLETED|Day 2||0
10197079|NCT03369340|11325056|FG001|NOT COMPLETED|Day 2||0
10197080|NCT03369340|11325057|FG002|NOT COMPLETED|Day 2||0
10197081|NCT03369340|11325058|FG003|NOT COMPLETED|Day 2||0
10197082|NCT03369340|11325059|FG004|NOT COMPLETED|Day 2||0
10197083|NCT03369340|11325060|FG005|NOT COMPLETED|Day 2||0
10197084|NCT03369340|11325055|FG000|STARTED|Day 3||3
10197085|NCT03369340|11325056|FG001|STARTED|Day 3||3
10197086|NCT03369340|11325057|FG002|STARTED|Day 3||3
10197087|NCT03369340|11325058|FG003|STARTED|Day 3||3
10197088|NCT03369340|11325059|FG004|STARTED|Day 3||3
10197089|NCT03369340|11325060|FG005|STARTED|Day 3||3
9709616|NCT04851314|10809026|FG000|STARTED|Overall Study||55
9709617|NCT04851314|10809027|FG001|STARTED|Overall Study||55
9709618|NCT04851314|10809026|FG000|COMPLETED|Overall Study||52
9709619|NCT04851314|10809027|FG001|COMPLETED|Overall Study||51
9709620|NCT04851314|10809026|FG000|NOT COMPLETED|Overall Study||3
9709621|NCT04851314|10809027|FG001|NOT COMPLETED|Overall Study||4
9709622|NCT04845633|10809037|FG000|STARTED|Overall Study||12
9709623|NCT04845633|10809038|FG001|STARTED|Overall Study||12
9709624|NCT04845633|10809039|FG002|STARTED|Overall Study||12
9709625|NCT04845633|10809040|FG003|STARTED|Overall Study||12
9709626|NCT04845633|10809037|FG000|COMPLETED|Overall Study||12
9709627|NCT04845633|10809038|FG001|COMPLETED|Overall Study||12
9709628|NCT04845633|10809039|FG002|COMPLETED|Overall Study||12
9709629|NCT04845633|10809040|FG003|COMPLETED|Overall Study||12
9709630|NCT04845633|10809037|FG000|NOT COMPLETED|Overall Study||0
9709631|NCT04845633|10809038|FG001|NOT COMPLETED|Overall Study||0
10197090|NCT03369340|11325055|FG000|COMPLETED|Day 3||3
10197091|NCT03369340|11325056|FG001|COMPLETED|Day 3||3
10197092|NCT03369340|11325057|FG002|COMPLETED|Day 3||3
9709632|NCT04845633|10809039|FG002|NOT COMPLETED|Overall Study||0
9709633|NCT04845633|10809040|FG003|NOT COMPLETED|Overall Study||0
9709634|NCT04823494|10809054|FG000|STARTED|Overall Study||21
9709635|NCT04823494|10809055|FG001|STARTED|Overall Study||19
10197093|NCT03369340|11325058|FG003|COMPLETED|Day 3||3
10197094|NCT03369340|11325059|FG004|COMPLETED|Day 3||3
10197095|NCT03369340|11325060|FG005|COMPLETED|Day 3||3
10197096|NCT03369340|11325055|FG000|NOT COMPLETED|Day 3||0
10197097|NCT03369340|11325056|FG001|NOT COMPLETED|Day 3||0
9709636|NCT04823494|10809054|FG000|COMPLETED|Overall Study||19
9709637|NCT04823494|10809055|FG001|COMPLETED|Overall Study||18
9709638|NCT04823494|10809054|FG000|NOT COMPLETED|Overall Study||2
10197098|NCT03369340|11325057|FG002|NOT COMPLETED|Day 3||0
10197099|NCT03369340|11325058|FG003|NOT COMPLETED|Day 3||0
10150816|NCT02816138|11281249|FG000|STARTED|Overall Study||15
10150817|NCT02816138|11281249|FG000|COMPLETED|Overall Study||14
10150818|NCT02816138|11281249|FG000|NOT COMPLETED|Overall Study||1
10150819|NCT02816346|11281258|FG000|STARTED|Overall Study||10
10150820|NCT02816346|11281259|FG001|STARTED|Overall Study||10
10150821|NCT02816346|11281260|FG002|STARTED|Overall Study||10
10150822|NCT02816346|11281261|FG003|STARTED|Overall Study||10
10150823|NCT02816346|11281262|FG004|STARTED|Overall Study||16
10150824|NCT02816346|11281258|FG000|COMPLETED|Overall Study||10
10150825|NCT02816346|11281259|FG001|COMPLETED|Overall Study||10
10150826|NCT02816346|11281260|FG002|COMPLETED|Overall Study||10
10150827|NCT02816346|11281261|FG003|COMPLETED|Overall Study||10
10150828|NCT02816346|11281262|FG004|COMPLETED|Overall Study||16
10150829|NCT02816346|11281258|FG000|NOT COMPLETED|Overall Study||0
10150830|NCT02816346|11281259|FG001|NOT COMPLETED|Overall Study||0
10150831|NCT02816346|11281260|FG002|NOT COMPLETED|Overall Study||0
10150832|NCT02816346|11281261|FG003|NOT COMPLETED|Overall Study||0
10150833|NCT02816346|11281262|FG004|NOT COMPLETED|Overall Study||0
10150834|NCT02816398|11281274|FG000|STARTED|Overall Study||26
10150835|NCT02816398|11281274|FG000|COMPLETED|Overall Study||12
10150836|NCT02816398|11281274|FG000|NOT COMPLETED|Overall Study||14
10150837|NCT02816710|11281281|FG000|STARTED|Overall Study||38
10150838|NCT02816710|11281282|FG001|STARTED|Overall Study||38
10150839|NCT02816710|11281283|FG002|STARTED|Overall Study||36
10150840|NCT02816710|11281281|FG000|COMPLETED|Overall Study||34
10150841|NCT02816710|11281282|FG001|COMPLETED|Overall Study||35
10150842|NCT02816710|11281283|FG002|COMPLETED|Overall Study||29
10150843|NCT02816710|11281281|FG000|NOT COMPLETED|Overall Study||4
10150844|NCT02816710|11281282|FG001|NOT COMPLETED|Overall Study||3
10150845|NCT02816710|11281283|FG002|NOT COMPLETED|Overall Study||7
10150846|NCT02816723|11281296|FG000|STARTED|Overall Study||30
10150847|NCT02816723|11281297|FG001|STARTED|Overall Study||30
10150848|NCT02816723|11281296|FG000|COMPLETED|Overall Study||24
10150849|NCT02816723|11281297|FG001|COMPLETED|Overall Study||28
10150850|NCT02816723|11281296|FG000|NOT COMPLETED|Overall Study||6
10150851|NCT02816723|11281297|FG001|NOT COMPLETED|Overall Study||2
10150852|NCT02817087|11281305|FG000|STARTED|Overall Study||16
10150853|NCT02817087|11281306|FG001|STARTED|Overall Study||15
10150854|NCT02817087|11281305|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
10150855|NCT02817087|11281306|FG001|COMPLETED|Overall Study||15
10150856|NCT02817087|11281305|FG000|NOT COMPLETED|Overall Study||2
10150857|NCT02817087|11281306|FG001|NOT COMPLETED|Overall Study||0
10150858|NCT02817516|11281316|FG000|STARTED|Overall Study||6
10150859|NCT02817516|11281317|FG001|STARTED|Overall Study||6
10150860|NCT02817516|11281318|FG002|STARTED|Overall Study||6
10150861|NCT02817516|11281319|FG003|STARTED|Overall Study||6
10150862|NCT02817516|11281316|FG000|COMPLETED|Overall Study||6
10150863|NCT02817516|11281317|FG001|COMPLETED|Overall Study||6
10150864|NCT02817516|11281318|FG002|COMPLETED|Overall Study||5
10150865|NCT02817516|11281319|FG003|COMPLETED|Overall Study||6
10150866|NCT02817516|11281316|FG000|NOT COMPLETED|Overall Study||0
10150867|NCT02817516|11281317|FG001|NOT COMPLETED|Overall Study||0
10150868|NCT02817516|11281318|FG002|NOT COMPLETED|Overall Study||1
10150869|NCT02817516|11281319|FG003|NOT COMPLETED|Overall Study||0
10150870|NCT02817555|11281334|FG000|STARTED|Overall Study||24
10150871|NCT02817555|11281335|FG001|STARTED|Overall Study||26
10150872|NCT02817555|11281334|FG000|COMPLETED|Overall Study||21
10150873|NCT02817555|11281335|FG001|COMPLETED|Overall Study||21
10150874|NCT02817555|11281334|FG000|NOT COMPLETED|Overall Study||3
10150875|NCT02817555|11281335|FG001|NOT COMPLETED|Overall Study||5
10150876|NCT02817594|11281341|FG000|STARTED|Overall Study||51
10150877|NCT02817594|11281341|FG000|Received Treatment|Overall Study||50
10150878|NCT02817594|11281341|FG000|COMPLETED|Overall Study||48
10150879|NCT02817594|11281341|FG000|NOT COMPLETED|Overall Study||3
10150880|NCT02817763|11281351|FG000|STARTED|Overall Study||20
10150881|NCT02817763|11281352|FG001|STARTED|Overall Study||20
10150882|NCT02817763|11281351|FG000|COMPLETED|Overall Study||20
10150883|NCT02817763|11281352|FG001|COMPLETED|Overall Study||20
10150884|NCT02817763|11281351|FG000|NOT COMPLETED|Overall Study||0
10150885|NCT02817763|11281352|FG001|NOT COMPLETED|Overall Study||0
10150886|NCT02817776|11281358|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
10150887|NCT02817776|11281358|FG000|COMPLETED|Overall Study||293
10150888|NCT02817776|11281358|FG000|NOT COMPLETED|Overall Study||88
10150889|NCT02817828|11281362|FG000|STARTED|Overall Study||1553
10150890|NCT02817828|11281362|FG000|COMPLETED|Overall Study||1218
10150891|NCT02817828|11281362|FG000|NOT COMPLETED|Overall Study||335
10150892|NCT02817841|11281371|FG000|STARTED|Overall Study||1864
10150893|NCT02817841|11281371|FG000|COMPLETED|Overall Study||1016
10150894|NCT02817841|11281371|FG000|NOT COMPLETED|Overall Study||848
10150895|NCT02817906|11281381|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
10150896|NCT02817906|11281382|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
10150897|NCT02817906|11281381|FG000|COMPLETED|Overall Study||70
10150898|NCT02817906|11281382|FG001|COMPLETED|Overall Study||84
10150899|NCT02817906|11281381|FG000|NOT COMPLETED|Overall Study||16
10150900|NCT02817906|11281382|FG001|NOT COMPLETED|Overall Study||5
10150901|NCT02818036|11281390|FG000|STARTED|Overall Study||42
10150902|NCT02818036|11281391|FG001|STARTED|Overall Study||40
10150903|NCT02818036|11281390|FG000|COMPLETED|Overall Study||40
10150904|NCT02818036|11281391|FG001|COMPLETED|Overall Study||40
10150905|NCT02818036|11281390|FG000|NOT COMPLETED|Overall Study||2
10150906|NCT02818036|11281391|FG001|NOT COMPLETED|Overall Study||0
10150907|NCT02818114|11281397|FG000|STARTED|Overall Study||8
10150908|NCT02818114|11281397|FG000|COMPLETED|Overall Study||7
10150909|NCT02818114|11281397|FG000|NOT COMPLETED|Overall Study||1
10150910|NCT02818244|11281406|FG000|STARTED|Overall Study||25
10150911|NCT02818244|11281407|FG001|STARTED|Overall Study||25
10150912|NCT02818244|11281408|FG002|STARTED|Overall Study||25
10150913|NCT02818244|11281409|FG003|STARTED|Overall Study||25
10150914|NCT02818244|11281406|FG000|COMPLETED|Overall Study||25
10150915|NCT02818244|11281407|FG001|COMPLETED|Overall Study||25
10150916|NCT02818244|11281408|FG002|COMPLETED|Overall Study||25
10150917|NCT02818244|11281409|FG003|COMPLETED|Overall Study||25
10150918|NCT02818244|11281406|FG000|NOT COMPLETED|Overall Study||0
10150919|NCT02818244|11281407|FG001|NOT COMPLETED|Overall Study||0
10150920|NCT02818244|11281408|FG002|NOT COMPLETED|Overall Study||0
10150921|NCT02818244|11281409|FG003|NOT COMPLETED|Overall Study||0
10150922|NCT02818569|11281419|FG000|STARTED|Overall Study||8
10150923|NCT02818569|11281420|FG001|STARTED|Overall Study||7
10150924|NCT02818569|11281419|FG000|COMPLETED|Overall Study||8
10150925|NCT02818569|11281420|FG001|COMPLETED|Overall Study||7
10150926|NCT02818569|11281419|FG000|NOT COMPLETED|Overall Study||0
10150927|NCT02818569|11281420|FG001|NOT COMPLETED|Overall Study||0
10150928|NCT02818777|11281429|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13
10150929|NCT02818777|11281429|FG000|COMPLETED|Overall Study||10
10150930|NCT02818777|11281429|FG000|NOT COMPLETED|Overall Study||3
10150931|NCT02818998|11281442|FG000|STARTED|Overall Study||155
10150932|NCT02818998|11281443|FG001|STARTED|Overall Study||154
10150933|NCT02818998|11281444|FG002|STARTED|Overall Study||154
10150934|NCT02818998|11281442|FG000|Completed Week 52 Visit|Overall Study||144
10150935|NCT02818998|11281443|FG001|Completed Week 52 Visit|Overall Study||146
10150936|NCT02818998|11281444|FG002|Completed Week 52 Visit|Overall Study||140
10150937|NCT02818998|11281442|FG000|COMPLETED|Overall Study||137
10150938|NCT02818998|11281443|FG001|COMPLETED|Overall Study||138
10150939|NCT02818998|11281444|FG002|COMPLETED|Overall Study||136
10150940|NCT02818998|11281442|FG000|NOT COMPLETED|Overall Study||18
10150941|NCT02818998|11281443|FG001|NOT COMPLETED|Overall Study||16
10150942|NCT02818998|11281444|FG002|NOT COMPLETED|Overall Study||18
10150943|NCT02819011|11281454|FG000|STARTED|Overall Study||22
10150944|NCT02819011|11281455|FG001|STARTED|Overall Study||22
10150945|NCT02819011|11281454|FG000|COMPLETED|Overall Study||15
10150946|NCT02819011|11281455|FG001|COMPLETED|Overall Study||17
10150947|NCT02819011|11281454|FG000|NOT COMPLETED|Overall Study||7
10150948|NCT02819011|11281455|FG001|NOT COMPLETED|Overall Study||5
10150949|NCT02819284|11281464|FG000|STARTED|Overall Study||452
10150950|NCT02819284|11281465|FG001|STARTED|Overall Study||453
10150951|NCT02819284|11281464|FG000|COMPLETED|Overall Study||447
10150952|NCT02819284|11281465|FG001|COMPLETED|Overall Study||448
10150953|NCT02819284|11281464|FG000|NOT COMPLETED|Overall Study||5
10150954|NCT02819284|11281465|FG001|NOT COMPLETED|Overall Study||5
10150955|NCT02819297|11281473|FG000|STARTED|Overall Study||299
10150956|NCT02819297|11281474|FG001|STARTED|Overall Study||304
10150957|NCT02819297|11281473|FG000|COMPLETED|Overall Study||239
10150958|NCT02819297|11281474|FG001|COMPLETED|Overall Study||252
10150959|NCT02819297|11281473|FG000|NOT COMPLETED|Overall Study||60
10150960|NCT02819297|11281474|FG001|NOT COMPLETED|Overall Study||52
10150961|NCT02819310|11281480|FG000|STARTED|Overall Study||330
10150962|NCT02819310|11281480|FG000|COMPLETED|Overall Study||221
10150963|NCT02819310|11281480|FG000|NOT COMPLETED|Overall Study||109
10150964|NCT02819323|11281487|FG000|STARTED|Overall Study||31
10150965|NCT02819323|11281488|FG001|STARTED|Overall Study||28
10150966|NCT02819323|11281489|FG002|STARTED|Overall Study||32
10150967|NCT02819323|11281487|FG000|COMPLETED|Overall Study||26
10150968|NCT02819323|11281488|FG001|COMPLETED|Overall Study||26
10150969|NCT02819323|11281489|FG002|COMPLETED|Overall Study||31
10150970|NCT02819323|11281487|FG000|NOT COMPLETED|Overall Study||5
10150971|NCT02819323|11281488|FG001|NOT COMPLETED|Overall Study||2
10150972|NCT02819323|11281489|FG002|NOT COMPLETED|Overall Study||1
10150973|NCT02819557|11281497|FG000|STARTED|Overall Study||14
10150974|NCT02819557|11281497|FG000|Safety Population|Overall Study||14
10150975|NCT02819557|11281497|FG000|Pharmacokinetics (PK) Population|Overall Study||14
10150976|NCT02819557|11281497|FG000|Evaluable Population|Overall Study||14
10150977|NCT02819557|11281497|FG000|COMPLETED|Overall Study||14
10150978|NCT02819557|11281497|FG000|NOT COMPLETED|Overall Study||0
10150979|NCT02819726|11281504|FG000|STARTED|Part A (All Participants)||98
10150980|NCT02819726|11281505|FG001|STARTED|Part A (All Participants)||98
10150981|NCT02819726|11281506|FG002|STARTED|Part A (All Participants)||98
10150982|NCT02819726|11281507|FG003|STARTED|Part A (All Participants)||0
10150983|NCT02819726|11281504|FG000|COMPLETED|Part A (All Participants)||92
10150984|NCT02819726|11281505|FG001|COMPLETED|Part A (All Participants)||88
10150985|NCT02819726|11281506|FG002|COMPLETED|Part A (All Participants)||87
10150986|NCT02819726|11281507|FG003|COMPLETED|Part A (All Participants)||0
10150987|NCT02819726|11281504|FG000|NOT COMPLETED|Part A (All Participants)||6
10150988|NCT02819726|11281505|FG001|NOT COMPLETED|Part A (All Participants)||10
10150989|NCT02819726|11281506|FG002|NOT COMPLETED|Part A (All Participants)||11
10150990|NCT02819726|11281507|FG003|NOT COMPLETED|Part A (All Participants)||0
10150991|NCT02819726|11281504|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
10150992|NCT02819726|11281505|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
10150993|NCT02819726|11281506|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
10150994|NCT02819726|11281507|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
10150995|NCT02819726|11281504|FG000|COMPLETED|Part B (All Participants)||70
10150996|NCT02819726|11281505|FG001|COMPLETED|Part B (All Participants)||68
10150997|NCT02819726|11281506|FG002|COMPLETED|Part B (All Participants)||35
10150998|NCT02819726|11281507|FG003|COMPLETED|Part B (All Participants)||36
10150999|NCT02819726|11281504|FG000|NOT COMPLETED|Part B (All Participants)||3
10151000|NCT02819726|11281505|FG001|NOT COMPLETED|Part B (All Participants)||2
10151001|NCT02819726|11281506|FG002|NOT COMPLETED|Part B (All Participants)||4
10151002|NCT02819726|11281507|FG003|NOT COMPLETED|Part B (All Participants)||2
10151003|NCT02819973|11281518|FG000|STARTED|Overall Study||114
10151004|NCT02819973|11281519|FG001|STARTED|Overall Study||114
10151005|NCT02819973|11281520|FG002|STARTED|Overall Study||115
10151006|NCT02819973|11281518|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
10151007|NCT02819973|11281519|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
10151008|NCT02819973|11281520|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
10151009|NCT02819973|11281518|FG000|NOT COMPLETED|Overall Study||6
10151010|NCT02819973|11281519|FG001|NOT COMPLETED|Overall Study||3
10151011|NCT02819973|11281520|FG002|NOT COMPLETED|Overall Study||4
10151012|NCT02820038|11281538|FG000|STARTED|Overall Study||78
10151013|NCT02820038|11281539|FG001|STARTED|Overall Study||77
10151014|NCT02820038|11281540|FG002|STARTED|Overall Study||65
10151015|NCT02820038|11281541|FG003|STARTED|Overall Study||66
10151016|NCT02820038|11281538|FG000|COMPLETED|Overall Study||68
10151017|NCT02820038|11281539|FG001|COMPLETED|Overall Study||52
10151018|NCT02820038|11281540|FG002|COMPLETED|Overall Study||60
10151019|NCT02820038|11281541|FG003|COMPLETED|Overall Study||44
10151020|NCT02820038|11281538|FG000|NOT COMPLETED|Overall Study||10
10151021|NCT02820038|11281539|FG001|NOT COMPLETED|Overall Study||25
10151022|NCT02820038|11281540|FG002|NOT COMPLETED|Overall Study||5
10151023|NCT02820038|11281541|FG003|NOT COMPLETED|Overall Study||22
10151024|NCT02820181|11281554|FG000|STARTED|Overall Study||30
10151025|NCT02820181|11281555|FG001|STARTED|Overall Study||30
10151026|NCT02820181|11281554|FG000|COMPLETED|Overall Study||30
10151027|NCT02820181|11281555|FG001|COMPLETED|Overall Study||30
10151028|NCT02820181|11281554|FG000|NOT COMPLETED|Overall Study||0
10151029|NCT02820181|11281555|FG001|NOT COMPLETED|Overall Study||0
10151030|NCT02820298|11281563|FG000|STARTED|Overall Study||13
10151031|NCT02820298|11281564|FG001|STARTED|Overall Study||12
10151032|NCT02820298|11281563|FG000|COMPLETED|Overall Study||12
10151033|NCT02820298|11281564|FG001|COMPLETED|Overall Study||10
10151034|NCT02820298|11281563|FG000|NOT COMPLETED|Overall Study||1
10151035|NCT02820298|11281564|FG001|NOT COMPLETED|Overall Study||2
10151036|NCT02820324|11281581|FG000|STARTED|Overall Study||78
10151037|NCT02820324|11281582|FG001|STARTED|Overall Study||82
10151038|NCT02820324|11281583|FG002|STARTED|Overall Study||82
10151039|NCT02820324|11281584|FG003|STARTED|Overall Study||82
10151040|NCT02820324|11281585|FG004|STARTED|Overall Study||83
10151041|NCT02820324|11281581|FG000|Treated With Study Medication|Overall Study||77
10151042|NCT02820324|11281582|FG001|Treated With Study Medication|Overall Study||80
10151043|NCT02820324|11281583|FG002|Treated With Study Medication|Overall Study||80
10151044|NCT02820324|11281584|FG003|Treated With Study Medication|Overall Study||81
10151045|NCT02820324|11281585|FG004|Treated With Study Medication|Overall Study||83
10151046|NCT02820324|11281581|FG000|COMPLETED|Overall Study||76
10151047|NCT02820324|11281582|FG001|COMPLETED|Overall Study||79
10151048|NCT02820324|11281583|FG002|COMPLETED|Overall Study||79
10151049|NCT02820324|11281584|FG003|COMPLETED|Overall Study||79
10151050|NCT02820324|11281585|FG004|COMPLETED|Overall Study||80
10151051|NCT02820324|11281581|FG000|NOT COMPLETED|Overall Study||2
10151052|NCT02820324|11281582|FG001|NOT COMPLETED|Overall Study||3
10151053|NCT02820324|11281583|FG002|NOT COMPLETED|Overall Study||3
10151054|NCT02820324|11281584|FG003|NOT COMPLETED|Overall Study||3
10151055|NCT02820324|11281585|FG004|NOT COMPLETED|Overall Study||3
10151056|NCT02820597|11281597|FG000|STARTED|Overall Study||27
10151057|NCT02820597|11281597|FG000|1-day Post Treatment|Overall Study||27
10151058|NCT02820597|11281597|FG000|7-day Post Treatment|Overall Study||27
10151059|NCT02820597|11281597|FG000|30-day Post Treatment|Overall Study||27
10151060|NCT02820597|11281597|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
10151061|NCT02820597|11281597|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
10151062|NCT02820597|11281597|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
10151063|NCT02820597|11281597|FG000|NOT COMPLETED|Overall Study||12
10151064|NCT02820844|11281603|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124
10151065|NCT02820844|11281604|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124
10151066|NCT02820844|11281605|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
10151067|NCT02820844|11281606|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
10151068|NCT02820844|11281607|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
10151069|NCT02820844|11281608|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
10151070|NCT02820844|11281603|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119
10151071|NCT02820844|11281604|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115
10151072|NCT02820844|11281605|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151073|NCT02820844|11281606|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151074|NCT02820844|11281607|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151075|NCT02820844|11281608|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151076|NCT02820844|11281603|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
10151077|NCT02820844|11281604|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
10151078|NCT02820844|11281605|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151079|NCT02820844|11281606|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151080|NCT02820844|11281607|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151081|NCT02820844|11281608|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10151082|NCT02820844|11281603|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151083|NCT02820844|11281604|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151084|NCT02820844|11281605|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
10151085|NCT02820844|11281606|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
10151086|NCT02820844|11281607|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151087|NCT02820844|11281608|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151088|NCT02820844|11281603|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151089|NCT02820844|11281604|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151090|NCT02820844|11281605|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
10151091|NCT02820844|11281606|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
10151092|NCT02820844|11281607|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151093|NCT02820844|11281608|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151094|NCT02820844|11281603|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151095|NCT02820844|11281604|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151096|NCT02820844|11281605|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
10151097|NCT02820844|11281606|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
10151098|NCT02820844|11281607|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
9709639|NCT04823494|10809055|FG001|NOT COMPLETED|Overall Study||1
9729634|NCT00119158|10829252|FG000|NOT COMPLETED|Active Treatment||0
9729635|NCT00119158|10829253|FG001|NOT COMPLETED|Active Treatment||0
9729636|NCT00119158|10829252|FG000|STARTED|Placebo Treatment||45
9729637|NCT00119158|10829253|FG001|STARTED|Placebo Treatment||45
9729638|NCT00119158|10829252|FG000|COMPLETED|Placebo Treatment||45
9729639|NCT00119158|10829253|FG001|COMPLETED|Placebo Treatment||45
9729640|NCT00119158|10829252|FG000|NOT COMPLETED|Placebo Treatment||0
9729641|NCT00119158|10829253|FG001|NOT COMPLETED|Placebo Treatment||0
9729642|NCT00119262|10829261|FG000|STARTED|Overall Study||104
9729643|NCT00119262|10829262|FG001|STARTED|Overall Study||122
9729644|NCT00119262|10829261|FG000|Eligible|Overall Study||103
9729645|NCT00119262|10829262|FG001|Eligible|Overall Study||120
9729646|NCT00119262|10829261|FG000|Treated|Overall Study||103
9729647|NCT00119262|10829262|FG001|Treated|Overall Study||120
9729648|NCT00119262|10829261|FG000|Eligible and Treated|Overall Study||102
9729649|NCT00119262|10829262|FG001|Eligible and Treated|Overall Study||119
9729650|NCT00119262|10829261|FG000|COMPLETED|Overall Study||58
9729651|NCT00119262|10829262|FG001|COMPLETED|Overall Study||64
9729652|NCT00119262|10829261|FG000|NOT COMPLETED|Overall Study||46
9729653|NCT00119262|10829262|FG001|NOT COMPLETED|Overall Study||58
9729654|NCT00119379|10829270|FG000|STARTED|Overall Study||26
9729655|NCT00119379|10829271|FG001|STARTED|Overall Study||24
9729656|NCT00119379|10829270|FG000|COMPLETED|Overall Study||22
9729657|NCT00119379|10829271|FG001|COMPLETED|Overall Study||23
9729658|NCT00119379|10829270|FG000|NOT COMPLETED|Overall Study||4
9729659|NCT00119379|10829271|FG001|NOT COMPLETED|Overall Study||1
9729660|NCT00119392|10829277|FG000|STARTED|Overall Study||45
9729661|NCT00119392|10829277|FG000|COMPLETED|Overall Study||40
9729662|NCT00119392|10829277|FG000|NOT COMPLETED|Overall Study||5
9731907|NCT00137280|10831874|FG000|COMPLETED|Overall Study||305
9731908|NCT00137280|10831875|FG001|COMPLETED|Overall Study||357
9731909|NCT00137280|10831874|FG000|NOT COMPLETED|Overall Study||84
9731910|NCT00137280|10831875|FG001|NOT COMPLETED|Overall Study||55
9731911|NCT00137423|10831883|FG000|STARTED|Overall Study||54
9731912|NCT00137423|10831884|FG001|STARTED|Overall Study||53
9731913|NCT00137423|10831883|FG000|COMPLETED|Overall Study||15
9731914|NCT00137423|10831884|FG001|COMPLETED|Overall Study||9
9731915|NCT00137423|10831883|FG000|NOT COMPLETED|Overall Study||39
9731916|NCT00137423|10831884|FG001|NOT COMPLETED|Overall Study||44
9731917|NCT00137436|10831894|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
9731918|NCT00137436|10831894|FG000|COMPLETED|Overall Study||12
9731919|NCT00137436|10831894|FG000|NOT COMPLETED|Overall Study||43
9731920|NCT00137449|10831900|FG000|STARTED|Overall Study||30
9731921|NCT00137449|10831901|FG001|STARTED|Overall Study||30
9731922|NCT00137449|10831900|FG000|COMPLETED|Overall Study||14
9731923|NCT00137449|10831901|FG001|COMPLETED|Overall Study||12
9731924|NCT00137449|10831900|FG000|NOT COMPLETED|Overall Study||16
9731925|NCT00137449|10831901|FG001|NOT COMPLETED|Overall Study||18
9731926|NCT00137631|10831910|FG000|STARTED|Overall Study||164
9731927|NCT00137631|10831911|FG001|STARTED|Overall Study||174
9731928|NCT00137631|10831910|FG000|Complete 3-month Follow-up|Overall Study||120
9731929|NCT00137631|10831911|FG001|Complete 3-month Follow-up|Overall Study||125
9731930|NCT00137631|10831910|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
9731931|NCT00137631|10831911|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
9731932|NCT00137631|10831910|FG000|COMPLETED|Overall Study||127
9731933|NCT00137631|10831911|FG001|COMPLETED|Overall Study||133
9731934|NCT00137631|10831910|FG000|NOT COMPLETED|Overall Study||37
9731935|NCT00137631|10831911|FG001|NOT COMPLETED|Overall Study||41
10151099|NCT02820844|11281608|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10151100|NCT02820844|11281603|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151101|NCT02820844|11281604|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151102|NCT02820844|11281605|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151103|NCT02820844|11281606|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151104|NCT02820844|11281607|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
10151105|NCT02820844|11281608|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
10151106|NCT02820844|11281603|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151107|NCT02820844|11281604|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151108|NCT02820844|11281605|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151109|NCT02820844|11281606|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151110|NCT02820844|11281607|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
10151111|NCT02820844|11281608|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
10151112|NCT02820844|11281603|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151113|NCT02820844|11281604|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151114|NCT02820844|11281605|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151115|NCT02820844|11281606|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10151116|NCT02820844|11281607|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
10151117|NCT02820844|11281608|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
10151118|NCT02820870|11281627|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
10151119|NCT02820870|11281628|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
10151120|NCT02820870|11281627|FG000|COMPLETED|Before Intervention||15
10151121|NCT02820870|11281628|FG001|COMPLETED|Before Intervention||28
10151122|NCT02820870|11281627|FG000|NOT COMPLETED|Before Intervention||0
10151123|NCT02820870|11281628|FG001|NOT COMPLETED|Before Intervention||0
10151124|NCT02820870|11281627|FG000|STARTED|Intervention||15
10151125|NCT02820870|11281628|FG001|STARTED|Intervention||28
10151126|NCT02820870|11281627|FG000|COMPLETED|Intervention||15
10151127|NCT02820870|11281628|FG001|COMPLETED|Intervention||28
10151128|NCT02820870|11281627|FG000|NOT COMPLETED|Intervention||0
10151129|NCT02820870|11281628|FG001|NOT COMPLETED|Intervention||0
10151130|NCT02820870|11281627|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
10151131|NCT02820870|11281628|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
10151132|NCT02820870|11281627|FG000|COMPLETED|Post Intervention||15
10151133|NCT02820870|11281628|FG001|COMPLETED|Post Intervention||28
10151134|NCT02820870|11281627|FG000|NOT COMPLETED|Post Intervention||0
10151135|NCT02820870|11281628|FG001|NOT COMPLETED|Post Intervention||0
10151136|NCT02821104|11281636|FG000|STARTED|Overall Study||77
10151137|NCT02821104|11281636|FG000|COMPLETED|Overall Study||77
10151138|NCT02821104|11281636|FG000|NOT COMPLETED|Overall Study||0
10151139|NCT02821338|11281643|FG000|STARTED|Overall Study||15
10151140|NCT02821338|11281644|FG001|STARTED|Overall Study||15
10151141|NCT02821338|11281643|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
10151142|NCT02821338|11281644|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
10151143|NCT02821338|11281643|FG000|NOT COMPLETED|Overall Study||3
10151144|NCT02821338|11281644|FG001|NOT COMPLETED|Overall Study||2
10151145|NCT02821403|11281652|FG000|STARTED|"First Intervention (1 Month)"||40
10151146|NCT02821403|11281653|FG001|STARTED|"First Intervention (1 Month)"||40
10151147|NCT02821403|11281652|FG000|Used Clear Lens|"First Intervention (1 Month)"||13
10151148|NCT02821403|11281653|FG001|Used Clear Lens|"First Intervention (1 Month)"||13
10151149|NCT02821403|11281652|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
9709640|NCT04821245|10809063|FG000|STARTED|Overall Study||36
9709641|NCT04821245|10809063|FG000|COMPLETED|Overall Study||27
9709642|NCT04821245|10809063|FG000|NOT COMPLETED|Overall Study||9
9729663|NCT00119405|10829281|FG000|STARTED|Overall Study||18
9729664|NCT00119405|10829281|FG000|COMPLETED|Overall Study||17
9729665|NCT00119405|10829281|FG000|NOT COMPLETED|Overall Study||1
9729666|NCT00119678|10829287|FG000|STARTED|Double-blind Treatment Period||122
9729667|NCT00119678|10829288|FG001|STARTED|Double-blind Treatment Period||61
9729668|NCT00119678|10829287|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
9729669|NCT00119678|10829288|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
9729670|NCT00119678|10829287|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
9729671|NCT00119678|10829288|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
9729672|NCT00119678|10829287|FG000|COMPLETED|Double-blind Treatment Period||81
9729673|NCT00119678|10829288|FG001|COMPLETED|Double-blind Treatment Period||35
9729674|NCT00119678|10829287|FG000|NOT COMPLETED|Double-blind Treatment Period||41
9729675|NCT00119678|10829288|FG001|NOT COMPLETED|Double-blind Treatment Period||26
9729676|NCT00119678|10829287|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110
9729677|NCT00119678|10829288|FG001|STARTED|Open-label Treatment Period||0
9729678|NCT00119678|10829287|FG000|COMPLETED|Open-label Treatment Period||0
9729679|NCT00119678|10829288|FG001|COMPLETED|Open-label Treatment Period||0
9729680|NCT00119678|10829287|FG000|NOT COMPLETED|Open-label Treatment Period||110
9729681|NCT00119678|10829288|FG001|NOT COMPLETED|Open-label Treatment Period||0
9729682|NCT00120250|10829296|FG000|STARTED|Overall Study||13
9729683|NCT00120250|10829297|FG001|STARTED|Overall Study||14
10151150|NCT02821403|11281653|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
10151151|NCT02821403|11281652|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
10151152|NCT02821403|11281653|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
10151153|NCT02821403|11281652|FG000|COMPLETED|"First Intervention (1 Month)"||40
10151154|NCT02821403|11281653|FG001|COMPLETED|"First Intervention (1 Month)"||40
10151155|NCT02821403|11281652|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0
10151156|NCT02821403|11281653|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0
10151157|NCT02821403|11281652|FG000|STARTED|"Second Intervention (1 Month)"||40
10151158|NCT02821403|11281653|FG001|STARTED|"Second Intervention (1 Month)"||40
10151159|NCT02821403|11281652|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13
10151160|NCT02821403|11281653|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14
10151161|NCT02821403|11281652|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
10151162|NCT02821403|11281653|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
10151163|NCT02821403|11281652|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
10151164|NCT02821403|11281653|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
9709643|NCT04814459|10809071|FG000|STARTED|Overall Study||72
9709644|NCT04814459|10809072|FG001|STARTED|Overall Study||72
9709645|NCT04814459|10809071|FG000|COMPLETED|Overall Study||72
9709646|NCT04814459|10809072|FG001|COMPLETED|Overall Study||72
9709647|NCT04814459|10809071|FG000|NOT COMPLETED|Overall Study||0
9709648|NCT04814459|10809072|FG001|NOT COMPLETED|Overall Study||0
9709649|NCT04799782|10809078|FG000|STARTED|First Intervention||8
9709650|NCT04799782|10809079|FG001|STARTED|First Intervention||7
9709651|NCT04799782|10809078|FG000|COMPLETED|First Intervention||8
9709652|NCT04799782|10809079|FG001|COMPLETED|First Intervention||7
9709653|NCT04799782|10809078|FG000|NOT COMPLETED|First Intervention||0
9709654|NCT04799782|10809079|FG001|NOT COMPLETED|First Intervention||0
9709655|NCT04799782|10809078|FG000|STARTED|Washout||8
9709656|NCT04799782|10809079|FG001|STARTED|Washout||7
9709657|NCT04799782|10809078|FG000|COMPLETED|Washout||6
9709658|NCT04799782|10809079|FG001|COMPLETED|Washout||4
9709659|NCT04799782|10809078|FG000|NOT COMPLETED|Washout||2
9709660|NCT04799782|10809079|FG001|NOT COMPLETED|Washout||3
9709661|NCT04799782|10809078|FG000|STARTED|Second Intervention||6
9709662|NCT04799782|10809079|FG001|STARTED|Second Intervention||4
9709663|NCT04799782|10809078|FG000|COMPLETED|Second Intervention||6
9709664|NCT04799782|10809079|FG001|COMPLETED|Second Intervention||4
9709665|NCT04799782|10809078|FG000|NOT COMPLETED|Second Intervention||0
9709666|NCT04799782|10809079|FG001|NOT COMPLETED|Second Intervention||0
9709667|NCT04780919|10809087|FG000|STARTED|Overall Study||9
9709668|NCT04780919|10809088|FG001|STARTED|Overall Study||9
9709669|NCT04780919|10809087|FG000|COMPLETED|Overall Study||9
9709670|NCT04780919|10809088|FG001|COMPLETED|Overall Study||9
9709671|NCT04780919|10809087|FG000|NOT COMPLETED|Overall Study||0
9709672|NCT04780919|10809088|FG001|NOT COMPLETED|Overall Study||0
9729684|NCT00120250|10829296|FG000|COMPLETED|Overall Study||12
9729685|NCT00120250|10829297|FG001|COMPLETED|Overall Study||12
9729686|NCT00120250|10829296|FG000|NOT COMPLETED|Overall Study||1
9729687|NCT00120250|10829297|FG001|NOT COMPLETED|Overall Study||2
9729688|NCT00120289|10829306|FG000|STARTED|Overall Study||1718
9729689|NCT00120289|10829307|FG001|STARTED|Overall Study||1696
9729690|NCT00120289|10829306|FG000|COMPLETED|Overall Study||1597
9729691|NCT00120289|10829307|FG001|COMPLETED|Overall Study||1587
9729692|NCT00120289|10829306|FG000|NOT COMPLETED|Overall Study||121
9729693|NCT00120289|10829307|FG001|NOT COMPLETED|Overall Study||109
9729694|NCT00120406|10829315|FG000|STARTED|Overall Study||236
9729695|NCT00120406|10829316|FG001|STARTED|Overall Study||238
9729696|NCT00120406|10829315|FG000|COMPLETED|Overall Study||217
9729697|NCT00120406|10829316|FG001|COMPLETED|Overall Study||222
9729698|NCT00120406|10829315|FG000|NOT COMPLETED|Overall Study||19
9729699|NCT00120406|10829316|FG001|NOT COMPLETED|Overall Study||16
9729700|NCT00120523|10829324|FG000|STARTED|Treatment Period||1205
9729701|NCT00120523|10829325|FG001|STARTED|Treatment Period||1213
9729702|NCT00120523|10829324|FG000|COMPLETED|Treatment Period||836
9729703|NCT00120523|10829325|FG001|COMPLETED|Treatment Period||874
9729704|NCT00120523|10829324|FG000|NOT COMPLETED|Treatment Period||369
9729705|NCT00120523|10829325|FG001|NOT COMPLETED|Treatment Period||339
9729706|NCT00120523|10829324|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
9729707|NCT00120523|10829325|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
9729708|NCT00120523|10829324|FG000|COMPLETED|Follow-Up Period||90
9729709|NCT00120523|10829325|FG001|COMPLETED|Follow-Up Period||46
9729710|NCT00120523|10829324|FG000|NOT COMPLETED|Follow-Up Period||30
9729711|NCT00120523|10829325|FG001|NOT COMPLETED|Follow-Up Period||24
9729712|NCT00120627|10829334|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
9729713|NCT00120627|10829335|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
9729714|NCT00120627|10829334|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
9729715|NCT00120627|10829335|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
9729716|NCT00120627|10829334|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
9729717|NCT00120627|10829335|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
9729718|NCT00120627|10829334|FG000|COMPLETED|Overall Study||66
10151165|NCT02821403|11281652|FG000|COMPLETED|"Second Intervention (1 Month)"||40
10151166|NCT02821403|11281653|FG001|COMPLETED|"Second Intervention (1 Month)"||40
10151167|NCT02821403|11281652|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0
10151168|NCT02821403|11281653|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0
10151169|NCT02821403|11281652|FG000|STARTED|"Third Intervention (1 Month)"||40
10151170|NCT02821403|11281653|FG001|STARTED|"Third Intervention (1 Month)"||40
10151171|NCT02821403|11281652|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14
10151172|NCT02821403|11281653|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13
10151173|NCT02821403|11281652|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
10151174|NCT02821403|11281653|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
10151175|NCT02821403|11281652|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
10151176|NCT02821403|11281653|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
10151177|NCT02821403|11281652|FG000|COMPLETED|"Third Intervention (1 Month)"||40
10151178|NCT02821403|11281653|FG001|COMPLETED|"Third Intervention (1 Month)"||40
10151179|NCT02821403|11281652|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0
10151180|NCT02821403|11281653|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0
10151181|NCT02821416|11281667|FG000|STARTED|Overall Study||23
10151182|NCT02821416|11281668|FG001|STARTED|Overall Study||23
10151183|NCT02821416|11281667|FG000|COMPLETED|Overall Study||20
10151184|NCT02821416|11281668|FG001|COMPLETED|Overall Study||22
10151185|NCT02821416|11281667|FG000|NOT COMPLETED|Overall Study||3
10151186|NCT02821416|11281668|FG001|NOT COMPLETED|Overall Study||1
10151187|NCT02821455|11281675|FG000|STARTED|Overall Study||19
10151188|NCT02821455|11281675|FG000|COMPLETED|Overall Study||19
10151189|NCT02821455|11281675|FG000|NOT COMPLETED|Overall Study||0
10151190|NCT02821715|11281679|FG000|STARTED|Overall Study||8
10151191|NCT02821715|11281680|FG001|STARTED|Overall Study||8
10151192|NCT02821715|11281681|FG002|STARTED|Overall Study||8
10151193|NCT02821715|11281682|FG003|STARTED|Overall Study||9
10151194|NCT02821715|11281683|FG004|STARTED|Overall Study||6
10151195|NCT02821715|11281684|FG005|STARTED|Overall Study||9
10151196|NCT02821715|11281679|FG000|COMPLETED|Overall Study||7
10151197|NCT02821715|11281680|FG001|COMPLETED|Overall Study||8
10151198|NCT02821715|11281681|FG002|COMPLETED|Overall Study||8
10151199|NCT02821715|11281682|FG003|COMPLETED|Overall Study||9
10151200|NCT02821715|11281683|FG004|COMPLETED|Overall Study||6
10151201|NCT02821715|11281684|FG005|COMPLETED|Overall Study||9
10151202|NCT02821715|11281679|FG000|NOT COMPLETED|Overall Study||1
10151203|NCT02821715|11281680|FG001|NOT COMPLETED|Overall Study||0
10151204|NCT02821715|11281681|FG002|NOT COMPLETED|Overall Study||0
10151205|NCT02821715|11281682|FG003|NOT COMPLETED|Overall Study||0
10151206|NCT02821715|11281683|FG004|NOT COMPLETED|Overall Study||0
10151207|NCT02821715|11281684|FG005|NOT COMPLETED|Overall Study||0
10151208|NCT02821819|11281692|FG000|STARTED|Overall Study||15
10151209|NCT02821819|11281692|FG000|COMPLETED|Overall Study||14
10151210|NCT02821819|11281692|FG000|NOT COMPLETED|Overall Study||1
10151211|NCT02821910|11281702|FG000|STARTED|Overall Study||7
10151212|NCT02821910|11281703|FG001|STARTED|Overall Study||8
10151213|NCT02821910|11281704|FG002|STARTED|Overall Study||10
10151214|NCT02821910|11281705|FG003|STARTED|Overall Study||10
10151215|NCT02821910|11281706|FG004|STARTED|Overall Study||7
10151216|NCT02821910|11281707|FG005|STARTED|Overall Study||8
10151217|NCT02821910|11281702|FG000|COMPLETED|Overall Study||6
10151218|NCT02821910|11281703|FG001|COMPLETED|Overall Study||8
10151219|NCT02821910|11281704|FG002|COMPLETED|Overall Study||8
10151220|NCT02821910|11281705|FG003|COMPLETED|Overall Study||10
10151221|NCT02821910|11281706|FG004|COMPLETED|Overall Study||7
10151222|NCT02821910|11281707|FG005|COMPLETED|Overall Study||7
10151223|NCT02821910|11281702|FG000|NOT COMPLETED|Overall Study||1
10151224|NCT02821910|11281703|FG001|NOT COMPLETED|Overall Study||0
10151225|NCT02821910|11281704|FG002|NOT COMPLETED|Overall Study||2
10151226|NCT02821910|11281705|FG003|NOT COMPLETED|Overall Study||0
10151227|NCT02821910|11281706|FG004|NOT COMPLETED|Overall Study||0
10151228|NCT02821910|11281707|FG005|NOT COMPLETED|Overall Study||1
10151229|NCT02821962|11281723|FG000|STARTED|Overall Study||19
10151230|NCT02821962|11281724|FG001|STARTED|Overall Study||21
10151231|NCT02821962|11281723|FG000|COMPLETED|Overall Study||17
10151232|NCT02821962|11281724|FG001|COMPLETED|Overall Study||21
10151233|NCT02821962|11281723|FG000|NOT COMPLETED|Overall Study||2
10151234|NCT02821962|11281724|FG001|NOT COMPLETED|Overall Study||0
10151235|NCT02822222|11281732|FG000|STARTED|Overall Study||16
10151236|NCT02822222|11281733|FG001|STARTED|Overall Study||6
10151237|NCT02822222|11281732|FG000|COMPLETED|Overall Study||15
10151238|NCT02822222|11281733|FG001|COMPLETED|Overall Study||6
10151239|NCT02822222|11281732|FG000|NOT COMPLETED|Overall Study||1
10151240|NCT02822222|11281733|FG001|NOT COMPLETED|Overall Study||0
10151241|NCT02822235|11281741|FG000|STARTED|Cross-sectional Phase (Day 1)||264
10151242|NCT02822235|11281742|FG001|STARTED|Cross-sectional Phase (Day 1)||143
10151243|NCT02822235|11281741|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118
10151244|NCT02822235|11281742|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36
10151245|NCT02822235|11281741|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
10151246|NCT02822235|11281742|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
10151247|NCT02822235|11281741|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118
10151248|NCT02822235|11281742|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36
10151249|NCT02822235|11281741|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
10151250|NCT02822235|11281742|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
10151251|NCT02822235|11281741|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
10151252|NCT02822235|11281742|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
10151253|NCT02822287|11281755|FG000|STARTED|Overall Study||57
10151254|NCT02822287|11281755|FG000|COMPLETED|Overall Study||57
10151255|NCT02822287|11281755|FG000|NOT COMPLETED|Overall Study||0
10151256|NCT02822599|11281761|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
10151257|NCT02822599|11281762|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
10151258|NCT02822599|11281761|FG000|COMPLETED|Overall Study||15
10151259|NCT02822599|11281762|FG001|COMPLETED|Overall Study||15
10151260|NCT02822599|11281761|FG000|NOT COMPLETED|Overall Study||0
10151261|NCT02822599|11281762|FG001|NOT COMPLETED|Overall Study||0
10151262|NCT02822612|11281773|FG000|STARTED|Overall Study||14
10151263|NCT02822612|11281774|FG001|STARTED|Overall Study||13
10151264|NCT02822612|11281775|FG002|STARTED|Overall Study||14
10151265|NCT02822612|11281776|FG003|STARTED|Overall Study||4
10151266|NCT02822612|11281777|FG004|STARTED|Overall Study||15
10151267|NCT02822612|11281773|FG000|COMPLETED|Overall Study||14
10151268|NCT02822612|11281774|FG001|COMPLETED|Overall Study||13
10151269|NCT02822612|11281775|FG002|COMPLETED|Overall Study||14
10151270|NCT02822612|11281776|FG003|COMPLETED|Overall Study||4
10151271|NCT02822612|11281777|FG004|COMPLETED|Overall Study||15
10151272|NCT02822612|11281773|FG000|NOT COMPLETED|Overall Study||0
10151273|NCT02822612|11281774|FG001|NOT COMPLETED|Overall Study||0
10151274|NCT02822612|11281775|FG002|NOT COMPLETED|Overall Study||0
10151275|NCT02822612|11281776|FG003|NOT COMPLETED|Overall Study||0
10151276|NCT02822612|11281777|FG004|NOT COMPLETED|Overall Study||0
10151277|NCT02822794|11281793|FG000|STARTED|Overall Study||57
10151278|NCT02822794|11281794|FG001|STARTED|Overall Study||60
10151279|NCT02822794|11281793|FG000|COMPLETED|Overall Study||56
10151280|NCT02822794|11281794|FG001|COMPLETED|Overall Study||60
10151281|NCT02822794|11281793|FG000|NOT COMPLETED|Overall Study||1
10151282|NCT02822794|11281794|FG001|NOT COMPLETED|Overall Study||0
10151283|NCT02822885|11281807|FG000|STARTED|Overall Study||70
10151284|NCT02822885|11281807|FG000|COMPLETED|Overall Study||70
10151285|NCT02822885|11281807|FG000|NOT COMPLETED|Overall Study||0
10151286|NCT02822950|11281811|FG000|STARTED|Overall Study||10
10151287|NCT02822950|11281811|FG000|COMPLETED|Overall Study||10
10151288|NCT02822950|11281811|FG000|NOT COMPLETED|Overall Study||0
10151289|NCT02823080|11281817|FG000|STARTED|Overall Study||24
10151290|NCT02823080|11281818|FG001|STARTED|Overall Study||24
10151291|NCT02823080|11281817|FG000|COMPLETED|Overall Study||24
10151292|NCT02823080|11281818|FG001|COMPLETED|Overall Study||24
10151293|NCT02823080|11281817|FG000|NOT COMPLETED|Overall Study||0
10151294|NCT02823080|11281818|FG001|NOT COMPLETED|Overall Study||0
10151295|NCT02823431|11281827|FG000|STARTED|Overall Study||11
10151296|NCT02823431|11281828|FG001|STARTED|Overall Study||12
10151297|NCT02823431|11281827|FG000|COMPLETED|Overall Study||11
10151298|NCT02823431|11281828|FG001|COMPLETED|Overall Study||12
10151299|NCT02823431|11281827|FG000|NOT COMPLETED|Overall Study||0
10151300|NCT02823431|11281828|FG001|NOT COMPLETED|Overall Study||0
10151301|NCT02823470|11281836|FG000|STARTED|Overall Study||9
10151302|NCT02823470|11281837|FG001|STARTED|Overall Study||15
10151303|NCT02823470|11281836|FG000|COMPLETED|Overall Study||0
10151304|NCT02823470|11281837|FG001|COMPLETED|Overall Study||0
10151305|NCT02823470|11281836|FG000|NOT COMPLETED|Overall Study||9
10151306|NCT02823470|11281837|FG001|NOT COMPLETED|Overall Study||15
10151307|NCT02823600|11281846|FG000|STARTED|Overall Study||68
10151308|NCT02823600|11281846|FG000|COMPLETED|Overall Study||68
10151309|NCT02823600|11281846|FG000|NOT COMPLETED|Overall Study||0
10151310|NCT02823964|11281852|FG000|STARTED|Overall Study||25
10151311|NCT02823964|11281852|FG000|COMPLETED|Overall Study||20
10151312|NCT02823964|11281852|FG000|NOT COMPLETED|Overall Study||5
10151313|NCT02824224|11281858|FG000|STARTED|Overall Study||19
10151314|NCT02824224|11281859|FG001|STARTED|Overall Study||18
10151315|NCT02824224|11281858|FG000|COMPLETED|Overall Study||17
10151316|NCT02824224|11281859|FG001|COMPLETED|Overall Study||17
10151317|NCT02824224|11281858|FG000|NOT COMPLETED|Overall Study||2
10151318|NCT02824224|11281859|FG001|NOT COMPLETED|Overall Study||1
10151319|NCT02824432|11281867|FG000|STARTED|Overall Study||18
10151320|NCT02824432|11281868|FG001|STARTED|Overall Study||19
10151321|NCT02824432|11281867|FG000|COMPLETED|Overall Study||17
10151322|NCT02824432|11281868|FG001|COMPLETED|Overall Study||19
10151323|NCT02824432|11281867|FG000|NOT COMPLETED|Overall Study||1
10151324|NCT02824432|11281868|FG001|NOT COMPLETED|Overall Study||0
10151325|NCT02824562|11281876|FG000|STARTED|Overall Study||22
10151326|NCT02824562|11281877|FG001|STARTED|Overall Study||22
10151327|NCT02824562|11281876|FG000|COMPLETED|Overall Study||19
10151328|NCT02824562|11281877|FG001|COMPLETED|Overall Study||17
10151329|NCT02824562|11281876|FG000|NOT COMPLETED|Overall Study||3
10151330|NCT02824562|11281877|FG001|NOT COMPLETED|Overall Study||5
10151331|NCT02824913|11281885|FG000|STARTED|First Intervention (1 Day)||1
10151332|NCT02824913|11281886|FG001|STARTED|First Intervention (1 Day)||0
10151333|NCT02824913|11281885|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
10151334|NCT02824913|11281886|FG001|COMPLETED|First Intervention (1 Day)||0
10151335|NCT02824913|11281885|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10151336|NCT02824913|11281886|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10151337|NCT02824913|11281885|FG000|STARTED|Washout (7-14 Days)||1
10151338|NCT02824913|11281886|FG001|STARTED|Washout (7-14 Days)||0
10151339|NCT02824913|11281885|FG000|COMPLETED|Washout (7-14 Days)||1
10151340|NCT02824913|11281886|FG001|COMPLETED|Washout (7-14 Days)||0
10151341|NCT02824913|11281885|FG000|NOT COMPLETED|Washout (7-14 Days)||0
10151342|NCT02824913|11281886|FG001|NOT COMPLETED|Washout (7-14 Days)||0
10151343|NCT02824913|11281885|FG000|STARTED|Second Intervention (1 Day)||1
10151344|NCT02824913|11281886|FG001|STARTED|Second Intervention (1 Day)||0
10151345|NCT02824913|11281885|FG000|COMPLETED|Second Intervention (1 Day)||1
10151346|NCT02824913|11281886|FG001|COMPLETED|Second Intervention (1 Day)||0
10151347|NCT02824913|11281885|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10151348|NCT02824913|11281886|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10151349|NCT02825212|11281894|FG000|STARTED|Overall Study||10
10151350|NCT02825212|11281894|FG000|COMPLETED|Overall Study||10
10151351|NCT02825212|11281894|FG000|NOT COMPLETED|Overall Study||0
10151352|NCT02825251|11281900|FG000|STARTED|Overall Study||236
10151353|NCT02825251|11281901|FG001|STARTED|Overall Study||236
10151354|NCT02825251|11281900|FG000|COMPLETED|Overall Study||233
10151355|NCT02825251|11281901|FG001|COMPLETED|Overall Study||230
10151356|NCT02825251|11281900|FG000|NOT COMPLETED|Overall Study||3
10151357|NCT02825251|11281901|FG001|NOT COMPLETED|Overall Study||6
10151358|NCT02825420|11281909|FG000|STARTED|Overall Study||131
10151359|NCT02825420|11281910|FG001|STARTED|Overall Study||89
10151360|NCT02825420|11281909|FG000|COMPLETED|Overall Study||88
10151361|NCT02825420|11281910|FG001|COMPLETED|Overall Study||72
10151362|NCT02825420|11281909|FG000|NOT COMPLETED|Overall Study||43
10151363|NCT02825420|11281910|FG001|NOT COMPLETED|Overall Study||17
10151364|NCT02825550|11281921|FG000|STARTED|Overall Study||13
10151365|NCT02825550|11281921|FG000|COMPLETED|Overall Study||12
10151366|NCT02825550|11281921|FG000|NOT COMPLETED|Overall Study||1
10151367|NCT02825680|11281929|FG000|STARTED|Overall Study||82
9709673|NCT04779606|10809098|FG000|STARTED|First Phase: Tolerability and Safety||16
9709674|NCT04779606|10809099|FG001|STARTED|First Phase: Tolerability and Safety||4
9709675|NCT04779606|10809098|FG000|COMPLETED|First Phase: Tolerability and Safety||16
9709676|NCT04779606|10809099|FG001|COMPLETED|First Phase: Tolerability and Safety||4
9709677|NCT04779606|10809098|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0
9709678|NCT04779606|10809099|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0
9709679|NCT04779606|10809098|FG000|STARTED|Second Phase: Efficacy||68
10060864|NCT02100657|11186396|FG002|COMPLETED|Cohort 2: Dose Level 2||0
10060865|NCT02100657|11186394|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
10060866|NCT02100657|11186395|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4
10060867|NCT02100657|11186396|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
10060868|NCT02100657|11186394|FG000|STARTED|Cohort 3: Dose Level 3||0
10060869|NCT02100657|11186395|FG001|STARTED|Cohort 3: Dose Level 3||0
10060870|NCT02100657|11186396|FG002|STARTED|Cohort 3: Dose Level 3||27
10060871|NCT02100657|11186394|FG000|COMPLETED|Cohort 3: Dose Level 3||0
10060872|NCT02100657|11186395|FG001|COMPLETED|Cohort 3: Dose Level 3||0
10060873|NCT02100657|11186396|FG002|COMPLETED|Cohort 3: Dose Level 3||0
10060874|NCT02100657|11186394|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
10060875|NCT02100657|11186395|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
10060876|NCT02100657|11186396|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27
10060877|NCT02100670|11186409|FG000|STARTED|Overall Study||118
10060878|NCT02100670|11186410|FG001|STARTED|Overall Study||113
10060879|NCT02100670|11186411|FG002|STARTED|Overall Study||78
10060880|NCT02100670|11186412|FG003|STARTED|Overall Study||76
10060881|NCT02100670|11186409|FG000|COMPLETED|Overall Study||105
10060882|NCT02100670|11186410|FG001|COMPLETED|Overall Study||106
10060883|NCT02100670|11186411|FG002|COMPLETED|Overall Study||74
10060884|NCT02100670|11186412|FG003|COMPLETED|Overall Study||75
10060885|NCT02100670|11186409|FG000|NOT COMPLETED|Overall Study||13
10060886|NCT02100670|11186410|FG001|NOT COMPLETED|Overall Study||7
10060887|NCT02100670|11186411|FG002|NOT COMPLETED|Overall Study||4
10060888|NCT02100670|11186412|FG003|NOT COMPLETED|Overall Study||1
10060889|NCT02100696|11186435|FG000|STARTED|Induction Phase||130
10060890|NCT02100696|11186436|FG001|STARTED|Induction Phase||95
10060891|NCT02100696|11186437|FG002|STARTED|Induction Phase||384
10060892|NCT02100696|11186438|FG003|STARTED|Induction Phase||0
10060893|NCT02100696|11186439|FG004|STARTED|Induction Phase||0
10060894|NCT02100696|11186440|FG005|STARTED|Induction Phase||0
10060895|NCT02100696|11186435|FG000|COMPLETED|Induction Phase||115
10060896|NCT02100696|11186436|FG001|COMPLETED|Induction Phase||90
10060897|NCT02100696|11186437|FG002|COMPLETED|Induction Phase||358
10060898|NCT02100696|11186438|FG003|COMPLETED|Induction Phase||0
10060899|NCT02100696|11186439|FG004|COMPLETED|Induction Phase||0
10151368|NCT02825680|11281930|FG001|STARTED|Overall Study||55
10060900|NCT02100696|11186440|FG005|COMPLETED|Induction Phase||0
10060901|NCT02100696|11186435|FG000|NOT COMPLETED|Induction Phase||15
10060902|NCT02100696|11186436|FG001|NOT COMPLETED|Induction Phase||5
10151369|NCT02825680|11281929|FG000|COMPLETED|Overall Study||82
10151370|NCT02825680|11281930|FG001|COMPLETED|Overall Study||39
10151371|NCT02825680|11281929|FG000|NOT COMPLETED|Overall Study||0
10151372|NCT02825680|11281930|FG001|NOT COMPLETED|Overall Study||16
10151373|NCT02825849|11281938|FG000|STARTED|Overall Study||22
10151374|NCT02825849|11281939|FG001|STARTED|Overall Study||5
10151375|NCT02825849|11281938|FG000|COMPLETED|Overall Study||22
10151376|NCT02825849|11281939|FG001|COMPLETED|Overall Study||5
10151377|NCT02825849|11281938|FG000|NOT COMPLETED|Overall Study||0
10151378|NCT02825849|11281939|FG001|NOT COMPLETED|Overall Study||0
10151379|NCT02825966|11281945|FG000|STARTED|Overall Study||35
10151380|NCT02825966|11281945|FG000|COMPLETED|Overall Study||35
10151381|NCT02825966|11281945|FG000|NOT COMPLETED|Overall Study||0
10151382|NCT02825992|11281952|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
10151383|NCT02825992|11281952|FG000|COMPLETED|Overall Study||121
10151384|NCT02825992|11281952|FG000|NOT COMPLETED|Overall Study||8
10151385|NCT02826421|11281966|FG000|STARTED|Overall Study||22
10151386|NCT02826421|11281967|FG001|STARTED|Overall Study||29
10151387|NCT02826421|11281968|FG002|STARTED|Overall Study||28
10151388|NCT02826421|11281969|FG003|STARTED|Overall Study||30
10151389|NCT02826421|11281966|FG000|Treated|Overall Study||19
10151390|NCT02826421|11281967|FG001|Treated|Overall Study||26
10151391|NCT02826421|11281968|FG002|Treated|Overall Study||26
10151392|NCT02826421|11281969|FG003|Treated|Overall Study||28
10151393|NCT02826421|11281966|FG000|COMPLETED|Overall Study||19
10151394|NCT02826421|11281967|FG001|COMPLETED|Overall Study||26
10151395|NCT02826421|11281968|FG002|COMPLETED|Overall Study||26
10151396|NCT02826421|11281969|FG003|COMPLETED|Overall Study||28
10151397|NCT02826421|11281966|FG000|NOT COMPLETED|Overall Study||3
10151398|NCT02826421|11281967|FG001|NOT COMPLETED|Overall Study||3
10151399|NCT02826421|11281968|FG002|NOT COMPLETED|Overall Study||2
10151400|NCT02826421|11281969|FG003|NOT COMPLETED|Overall Study||2
10151401|NCT02826603|11281982|FG000|STARTED|Overall Study||550
10151402|NCT02826603|11281983|FG001|STARTED|Overall Study||552
10151403|NCT02826603|11281982|FG000|COMPLETED|Overall Study||489
10151404|NCT02826603|11281983|FG001|COMPLETED|Overall Study||488
10151405|NCT02826603|11281982|FG000|NOT COMPLETED|Overall Study||61
10151406|NCT02826603|11281983|FG001|NOT COMPLETED|Overall Study||64
10151407|NCT02826694|11281992|FG000|STARTED|Overall Study||61
10151408|NCT02826694|11281993|FG001|STARTED|Overall Study||45
10151409|NCT02826694|11281992|FG000|Decision Group|Overall Study||41
10151410|NCT02826694|11281993|FG001|Decision Group|Overall Study||30
10151411|NCT02826694|11281992|FG000|Control Group|Overall Study||20
10151412|NCT02826694|11281993|FG001|Control Group|Overall Study||15
10151413|NCT02826694|11281992|FG000|COMPLETED|Overall Study||61
10151414|NCT02826694|11281993|FG001|COMPLETED|Overall Study||45
10151415|NCT02826694|11281992|FG000|NOT COMPLETED|Overall Study||0
10151416|NCT02826694|11281993|FG001|NOT COMPLETED|Overall Study||0
10151417|NCT02826798|11282006|FG000|STARTED|Overall Study||25
10151418|NCT02826798|11282007|FG001|STARTED|Overall Study||26
10151419|NCT02826798|11282008|FG002|STARTED|Overall Study||26
10151420|NCT02826798|11282009|FG003|STARTED|Overall Study||25
10151421|NCT02826798|11282010|FG004|STARTED|Overall Study||26
10151422|NCT02826798|11282006|FG000|COMPLETED|Overall Study||25
10151423|NCT02826798|11282007|FG001|COMPLETED|Overall Study||25
10151424|NCT02826798|11282008|FG002|COMPLETED|Overall Study||26
10151425|NCT02826798|11282009|FG003|COMPLETED|Overall Study||24
10151426|NCT02826798|11282010|FG004|COMPLETED|Overall Study||26
10151427|NCT02826798|11282006|FG000|NOT COMPLETED|Overall Study||0
10151428|NCT02826798|11282007|FG001|NOT COMPLETED|Overall Study||1
10151429|NCT02826798|11282008|FG002|NOT COMPLETED|Overall Study||0
10151430|NCT02826798|11282009|FG003|NOT COMPLETED|Overall Study||1
10151431|NCT02826798|11282010|FG004|NOT COMPLETED|Overall Study||0
10151432|NCT02827500|11282024|FG000|STARTED|Overall Study||52
10151433|NCT02827500|11282025|FG001|STARTED|Overall Study||52
10151434|NCT02827500|11282024|FG000|COMPLETED|Overall Study||33
10151435|NCT02827500|11282025|FG001|COMPLETED|Overall Study||45
10151436|NCT02827500|11282024|FG000|NOT COMPLETED|Overall Study||19
10151437|NCT02827500|11282025|FG001|NOT COMPLETED|Overall Study||7
10151438|NCT02827708|11282033|FG000|STARTED|Overall Study||163
10151439|NCT02827708|11282034|FG001|STARTED|Overall Study||161
10151440|NCT02827708|11282033|FG000|Full Analysis Set (FAS)|Overall Study||163
10151441|NCT02827708|11282034|FG001|Full Analysis Set (FAS)|Overall Study||161
10151442|NCT02827708|11282033|FG000|Safety Analysis Set (SAS)|Overall Study||163
10151443|NCT02827708|11282034|FG001|Safety Analysis Set (SAS)|Overall Study||161
10151444|NCT02827708|11282033|FG000|COMPLETED|Overall Study||158
10151445|NCT02827708|11282034|FG001|COMPLETED|Overall Study||156
10151446|NCT02827708|11282033|FG000|NOT COMPLETED|Overall Study||5
10151447|NCT02827708|11282034|FG001|NOT COMPLETED|Overall Study||5
10151448|NCT02828020|11282043|FG000|STARTED|Treatment Period||559
10151449|NCT02828020|11282044|FG001|STARTED|Treatment Period||556
10151450|NCT02828020|11282045|FG002|STARTED|Treatment Period||557
10151451|NCT02828020|11282043|FG000|Safety Population: Received Study Drug|Treatment Period||485
10151452|NCT02828020|11282044|FG001|Safety Population: Received Study Drug|Treatment Period||466
10151453|NCT02828020|11282045|FG002|Safety Population: Received Study Drug|Treatment Period||485
10151454|NCT02828020|11282043|FG000|COMPLETED|Treatment Period||479
10151455|NCT02828020|11282044|FG001|COMPLETED|Treatment Period||457
10151456|NCT02828020|11282045|FG002|COMPLETED|Treatment Period||479
10151457|NCT02828020|11282043|FG000|NOT COMPLETED|Treatment Period||80
10151458|NCT02828020|11282044|FG001|NOT COMPLETED|Treatment Period||99
10151459|NCT02828020|11282045|FG002|NOT COMPLETED|Treatment Period||78
10151460|NCT02828020|11282043|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
10151461|NCT02828020|11282044|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
10151462|NCT02828020|11282045|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
10151463|NCT02828020|11282043|FG000|COMPLETED|Safety Follow-up Period||460
10151464|NCT02828020|11282044|FG001|COMPLETED|Safety Follow-up Period||440
10151465|NCT02828020|11282045|FG002|COMPLETED|Safety Follow-up Period||461
10151466|NCT02828020|11282043|FG000|NOT COMPLETED|Safety Follow-up Period||20
10151467|NCT02828020|11282044|FG001|NOT COMPLETED|Safety Follow-up Period||18
10151468|NCT02828020|11282045|FG002|NOT COMPLETED|Safety Follow-up Period||19
10151469|NCT02828111|11282058|FG000|STARTED|Overall Study||6
10151470|NCT02828111|11282059|FG001|STARTED|Overall Study||6
10151471|NCT02828111|11282060|FG002|STARTED|Overall Study||6
10151472|NCT02828111|11282061|FG003|STARTED|Overall Study||6
10151473|NCT02828111|11282062|FG004|STARTED|Overall Study||12
10151474|NCT02828111|11282058|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10151475|NCT02828111|11282059|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10151476|NCT02828111|11282060|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10151477|NCT02828111|11282061|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10151478|NCT02828111|11282062|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
10151479|NCT02828111|11282058|FG000|COMPLETED|Overall Study||6
10151480|NCT02828111|11282059|FG001|COMPLETED|Overall Study||6
10151481|NCT02828111|11282060|FG002|COMPLETED|Overall Study||4
10151482|NCT02828111|11282061|FG003|COMPLETED|Overall Study||5
10151483|NCT02828111|11282062|FG004|COMPLETED|Overall Study||11
10151484|NCT02828111|11282058|FG000|NOT COMPLETED|Overall Study||0
10151485|NCT02828111|11282059|FG001|NOT COMPLETED|Overall Study||0
10151486|NCT02828111|11282060|FG002|NOT COMPLETED|Overall Study||2
10151487|NCT02828111|11282061|FG003|NOT COMPLETED|Overall Study||1
10151488|NCT02828111|11282062|FG004|NOT COMPLETED|Overall Study||1
10151489|NCT02828137|11282086|FG000|STARTED|Overall Study||41
10151490|NCT02828137|11282087|FG001|STARTED|Overall Study||41
10151491|NCT02828137|11282088|FG002|STARTED|Overall Study||41
10151492|NCT02828137|11282086|FG000|COMPLETED|Overall Study||41
10151493|NCT02828137|11282087|FG001|COMPLETED|Overall Study||41
10151494|NCT02828137|11282088|FG002|COMPLETED|Overall Study||41
10151495|NCT02828137|11282086|FG000|NOT COMPLETED|Overall Study||0
10151496|NCT02828137|11282087|FG001|NOT COMPLETED|Overall Study||0
10151497|NCT02828137|11282088|FG002|NOT COMPLETED|Overall Study||0
10151498|NCT02828241|11282098|FG000|STARTED|Overall Study||38
10151499|NCT02828241|11282099|FG001|STARTED|Overall Study||23
10151500|NCT02828241|11282098|FG000|COMPLETED|Overall Study||30
10151501|NCT02828241|11282099|FG001|COMPLETED|Overall Study||21
10151502|NCT02828241|11282098|FG000|NOT COMPLETED|Overall Study||8
10151503|NCT02828241|11282099|FG001|NOT COMPLETED|Overall Study||2
10151504|NCT02828267|11282110|FG000|STARTED|Overall Study||10
10151505|NCT02828267|11282111|FG001|STARTED|Overall Study||21
10151506|NCT02828267|11282112|FG002|STARTED|Overall Study||24
10151507|NCT02828267|11282113|FG003|STARTED|Overall Study||20
10151508|NCT02828267|11282110|FG000|COMPLETED|Overall Study||10
10151509|NCT02828267|11282111|FG001|COMPLETED|Overall Study||21
10151510|NCT02828267|11282112|FG002|COMPLETED|Overall Study||24
10151511|NCT02828267|11282113|FG003|COMPLETED|Overall Study||20
10151512|NCT02828267|11282110|FG000|NOT COMPLETED|Overall Study||0
10151513|NCT02828267|11282111|FG001|NOT COMPLETED|Overall Study||0
10151514|NCT02828267|11282112|FG002|NOT COMPLETED|Overall Study||0
10151515|NCT02828267|11282113|FG003|NOT COMPLETED|Overall Study||0
10151516|NCT02828358|11282127|FG000|STARTED|Overall Study||56
10151517|NCT02828358|11282128|FG001|STARTED|Overall Study||22
10151518|NCT02828358|11282127|FG000|COMPLETED|Overall Study||11
10151519|NCT02828358|11282128|FG001|COMPLETED|Overall Study||0
10151520|NCT02828358|11282127|FG000|NOT COMPLETED|Overall Study||45
10151521|NCT02828358|11282128|FG001|NOT COMPLETED|Overall Study||22
10151522|NCT02828436|11282133|FG000|STARTED|Period 1||0
10151523|NCT02828436|11282134|FG001|STARTED|Period 1||9
10151524|NCT02828436|11282133|FG000|COMPLETED|Period 1||0
10151525|NCT02828436|11282134|FG001|COMPLETED|Period 1||5
10151526|NCT02828436|11282133|FG000|NOT COMPLETED|Period 1||0
10151527|NCT02828436|11282134|FG001|NOT COMPLETED|Period 1||4
10151528|NCT02828436|11282133|FG000|STARTED|Period 2||9
10151529|NCT02828436|11282134|FG001|STARTED|Period 2||0
10151530|NCT02828436|11282133|FG000|COMPLETED|Period 2||1
10151531|NCT02828436|11282134|FG001|COMPLETED|Period 2||0
10151532|NCT02828436|11282133|FG000|NOT COMPLETED|Period 2||8
10151533|NCT02828436|11282134|FG001|NOT COMPLETED|Period 2||0
10151534|NCT02828644|11282142|FG000|STARTED|Overall Study||88
10151535|NCT02828644|11282143|FG001|STARTED|Overall Study||87
10151536|NCT02828644|11282142|FG000|COMPLETED|Overall Study||65
10151537|NCT02828644|11282143|FG001|COMPLETED|Overall Study||65
10151538|NCT02828644|11282142|FG000|NOT COMPLETED|Overall Study||23
10151539|NCT02828644|11282143|FG001|NOT COMPLETED|Overall Study||22
10151540|NCT02829034|11282152|FG000|STARTED|Overall Study||14
10151541|NCT02829034|11282153|FG001|STARTED|Overall Study||8
10151542|NCT02829034|11282152|FG000|COMPLETED|Overall Study||9
10151543|NCT02829034|11282153|FG001|COMPLETED|Overall Study||6
10151544|NCT02829034|11282152|FG000|NOT COMPLETED|Overall Study||5
10151545|NCT02829034|11282153|FG001|NOT COMPLETED|Overall Study||2
10151546|NCT02829138|11282161|FG000|STARTED|Overall Study||29
10151547|NCT02829138|11282162|FG001|STARTED|Overall Study||28
10151548|NCT02829138|11282161|FG000|COMPLETED|Overall Study||28
10151549|NCT02829138|11282162|FG001|COMPLETED|Overall Study||28
10151550|NCT02829138|11282161|FG000|NOT COMPLETED|Overall Study||1
10151551|NCT02829138|11282162|FG001|NOT COMPLETED|Overall Study||0
10151552|NCT02829294|11282168|FG000|STARTED|Overall Study||19
10151553|NCT02829294|11282168|FG000|COMPLETED|Overall Study||19
10151554|NCT02829294|11282168|FG000|NOT COMPLETED|Overall Study||0
10151555|NCT02829307|11282174|FG000|STARTED|Overall Study||8
10151556|NCT02829307|11282174|FG000|COMPLETED|Overall Study||8
10151557|NCT02829307|11282174|FG000|NOT COMPLETED|Overall Study||0
10151558|NCT02829320|11282178|FG000|STARTED|Overall Study||28
10151559|NCT02829320|11282178|FG000|COMPLETED|Overall Study||28
10151560|NCT02829320|11282178|FG000|NOT COMPLETED|Overall Study||0
10151561|NCT02829463|11282191|FG000|STARTED|Overall Study||59
10151562|NCT02829463|11282192|FG001|STARTED|Overall Study||62
10151563|NCT02829463|11282191|FG000|COMPLETED|Overall Study||59
10151564|NCT02829463|11282192|FG001|COMPLETED|Overall Study||62
10151565|NCT02829463|11282191|FG000|NOT COMPLETED|Overall Study||0
10151566|NCT02829463|11282192|FG001|NOT COMPLETED|Overall Study||0
10151567|NCT02829775|11282198|FG000|STARTED|Overall Study||9
10151568|NCT02829775|11282198|FG000|COMPLETED|Overall Study||4
10151569|NCT02829775|11282198|FG000|NOT COMPLETED|Overall Study||5
10151570|NCT02829944|11282205|FG000|STARTED|Overall Study||44
10151571|NCT02829944|11282206|FG001|STARTED|Overall Study||40
10151572|NCT02829944|11282205|FG000|COMPLETED|Overall Study||38
10151573|NCT02829944|11282206|FG001|COMPLETED|Overall Study||33
10151574|NCT02829944|11282205|FG000|NOT COMPLETED|Overall Study||6
10151575|NCT02829944|11282206|FG001|NOT COMPLETED|Overall Study||7
10151576|NCT02829983|11282214|FG000|STARTED|Overall Study||20
10151577|NCT02829983|11282215|FG001|STARTED|Overall Study||20
10151578|NCT02829983|11282214|FG000|COMPLETED|Overall Study||20
10151579|NCT02829983|11282215|FG001|COMPLETED|Overall Study||20
10151580|NCT02829983|11282214|FG000|NOT COMPLETED|Overall Study||0
10151581|NCT02829983|11282215|FG001|NOT COMPLETED|Overall Study||0
10151582|NCT02829996|11282226|FG000|STARTED|Overall Study||39
10151583|NCT02829996|11282227|FG001|STARTED|Overall Study||39
10151584|NCT02829996|11282228|FG002|STARTED|Overall Study||40
10151585|NCT02829996|11282229|FG003|STARTED|Overall Study||41
10151586|NCT02829996|11282230|FG004|STARTED|Overall Study||42
10151587|NCT02829996|11282226|FG000|COMPLETED|Overall Study||38
10151588|NCT02829996|11282227|FG001|COMPLETED|Overall Study||39
10151589|NCT02829996|11282228|FG002|COMPLETED|Overall Study||40
10151590|NCT02829996|11282229|FG003|COMPLETED|Overall Study||41
10151591|NCT02829996|11282230|FG004|COMPLETED|Overall Study||42
10151592|NCT02829996|11282226|FG000|NOT COMPLETED|Overall Study||1
10151593|NCT02829996|11282227|FG001|NOT COMPLETED|Overall Study||0
10151594|NCT02829996|11282228|FG002|NOT COMPLETED|Overall Study||0
10151595|NCT02829996|11282229|FG003|NOT COMPLETED|Overall Study||0
10151596|NCT02829996|11282230|FG004|NOT COMPLETED|Overall Study||0
10151597|NCT02830074|11282244|FG000|STARTED|Overall Study||32
10151598|NCT02830074|11282245|FG001|STARTED|Overall Study||31
10151599|NCT02830074|11282244|FG000|COMPLETED|Overall Study||32
10151600|NCT02830074|11282245|FG001|COMPLETED|Overall Study||31
10151601|NCT02830074|11282244|FG000|NOT COMPLETED|Overall Study||0
10151602|NCT02830074|11282245|FG001|NOT COMPLETED|Overall Study||0
10151603|NCT02830087|11282258|FG000|STARTED|Overall Study||4
10151604|NCT02830087|11282259|FG001|STARTED|Overall Study||4
10151605|NCT02830087|11282260|FG002|STARTED|Overall Study||4
10151606|NCT02830087|11282261|FG003|STARTED|Overall Study||3
10151607|NCT02830087|11282262|FG004|STARTED|Overall Study||3
10151608|NCT02830087|11282263|FG005|STARTED|Overall Study||3
10151609|NCT02830087|11282258|FG000|COMPLETED|Overall Study||0
10151610|NCT02830087|11282259|FG001|COMPLETED|Overall Study||0
10151611|NCT02830087|11282260|FG002|COMPLETED|Overall Study||0
10151612|NCT02830087|11282261|FG003|COMPLETED|Overall Study||0
10151613|NCT02830087|11282262|FG004|COMPLETED|Overall Study||0
10151614|NCT02830087|11282263|FG005|COMPLETED|Overall Study||0
10151615|NCT02830087|11282258|FG000|NOT COMPLETED|Overall Study||4
10151616|NCT02830087|11282259|FG001|NOT COMPLETED|Overall Study||4
10151617|NCT02830087|11282260|FG002|NOT COMPLETED|Overall Study||4
10151618|NCT02830087|11282261|FG003|NOT COMPLETED|Overall Study||3
10151619|NCT02830087|11282262|FG004|NOT COMPLETED|Overall Study||3
10151620|NCT02830087|11282263|FG005|NOT COMPLETED|Overall Study||3
10151621|NCT02830438|11282277|FG000|STARTED|Overall Study||8
10151622|NCT02830438|11282277|FG000|COMPLETED|Overall Study||8
10151623|NCT02830438|11282277|FG000|NOT COMPLETED|Overall Study||0
10151624|NCT02830776|11282281|FG000|STARTED|Overall Study||15
10151625|NCT02830776|11282281|FG000|COMPLETED|Overall Study||14
10151626|NCT02830776|11282281|FG000|NOT COMPLETED|Overall Study||1
10151627|NCT02830880|11282286|FG000|STARTED|Overall Study||7
10151628|NCT02830880|11282286|FG000|Completed Visit After Cyle 1|Overall Study||7
10151629|NCT02830880|11282286|FG000|COMPLETED|Overall Study||4
10151630|NCT02830880|11282286|FG000|NOT COMPLETED|Overall Study||3
10151631|NCT02830893|11282292|FG000|STARTED|Overall Study||12
10151632|NCT02830893|11282293|FG001|STARTED|Overall Study||11
10151633|NCT02830893|11282292|FG000|COMPLETED|Overall Study||11
10151634|NCT02830893|11282293|FG001|COMPLETED|Overall Study||8
10151635|NCT02830893|11282292|FG000|NOT COMPLETED|Overall Study||1
10151636|NCT02830893|11282293|FG001|NOT COMPLETED|Overall Study||3
10151637|NCT02831387|11282301|FG000|STARTED|Overall Study||23
10151638|NCT02831387|11282302|FG001|STARTED|Overall Study||24
10151639|NCT02831387|11282301|FG000|COMPLETED|Overall Study||22
10151640|NCT02831387|11282302|FG001|COMPLETED|Overall Study||22
10151641|NCT02831387|11282301|FG000|NOT COMPLETED|Overall Study||1
10151642|NCT02831387|11282302|FG001|NOT COMPLETED|Overall Study||2
10197100|NCT03369340|11325059|FG004|NOT COMPLETED|Day 3||0
10197101|NCT03369340|11325060|FG005|NOT COMPLETED|Day 3||0
10197102|NCT03369340|11325055|FG000|STARTED|Day 4||3
10197103|NCT03369340|11325056|FG001|STARTED|Day 4||3
10197104|NCT03369340|11325057|FG002|STARTED|Day 4||3
10197105|NCT03369340|11325058|FG003|STARTED|Day 4||3
10197106|NCT03369340|11325059|FG004|STARTED|Day 4||3
10197107|NCT03369340|11325060|FG005|STARTED|Day 4||3
10197108|NCT03369340|11325055|FG000|COMPLETED|Day 4||3
10197109|NCT03369340|11325056|FG001|COMPLETED|Day 4||3
10197110|NCT03369340|11325057|FG002|COMPLETED|Day 4||3
10197111|NCT03369340|11325058|FG003|COMPLETED|Day 4||3
10197112|NCT03369340|11325059|FG004|COMPLETED|Day 4||3
10197113|NCT03369340|11325060|FG005|COMPLETED|Day 4||3
10197114|NCT03369340|11325055|FG000|NOT COMPLETED|Day 4||0
10197115|NCT03369340|11325056|FG001|NOT COMPLETED|Day 4||0
10197116|NCT03369340|11325057|FG002|NOT COMPLETED|Day 4||0
10197117|NCT03369340|11325058|FG003|NOT COMPLETED|Day 4||0
10197118|NCT03369340|11325059|FG004|NOT COMPLETED|Day 4||0
10197119|NCT03369340|11325060|FG005|NOT COMPLETED|Day 4||0
10197120|NCT03369418|11325072|FG000|STARTED|Overall Study||16
10197121|NCT03369418|11325073|FG001|STARTED|Overall Study||14
10197122|NCT03369418|11325072|FG000|COMPLETED|Overall Study||13
10197123|NCT03369418|11325073|FG001|COMPLETED|Overall Study||11
10197124|NCT03369418|11325072|FG000|NOT COMPLETED|Overall Study||3
10197125|NCT03369418|11325073|FG001|NOT COMPLETED|Overall Study||3
10197126|NCT03369704|11325081|FG000|STARTED|Treatment Epoch||162
10197127|NCT03369704|11325082|FG001|STARTED|Treatment Epoch||175
10197128|NCT03369704|11325081|FG000|COMPLETED|Treatment Epoch||158
10197129|NCT03369704|11325082|FG001|COMPLETED|Treatment Epoch||172
10197130|NCT03369704|11325081|FG000|NOT COMPLETED|Treatment Epoch||4
10197131|NCT03369704|11325082|FG001|NOT COMPLETED|Treatment Epoch||3
10197132|NCT03369704|11325081|FG000|STARTED|Follow-up Epoch||161
10197133|NCT03369704|11325082|FG001|STARTED|Follow-up Epoch||174
10197134|NCT03369704|11325081|FG000|COMPLETED|Follow-up Epoch||160
10197135|NCT03369704|11325082|FG001|COMPLETED|Follow-up Epoch||174
10197136|NCT03369704|11325081|FG000|NOT COMPLETED|Follow-up Epoch||1
10197137|NCT03369704|11325082|FG001|NOT COMPLETED|Follow-up Epoch||0
10197138|NCT03369756|11325088|FG000|STARTED|Overall Study||43
10197139|NCT03369756|11325088|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
10197140|NCT03369756|11325088|FG000|NOT COMPLETED|Overall Study||7
10197141|NCT03369951|11325092|FG000|STARTED|Overall Study||58
10197142|NCT03369951|11325092|FG000|Received Study Drug|Overall Study||57
10197143|NCT03369951|11325092|FG000|COMPLETED|Overall Study||52
10197144|NCT03369951|11325092|FG000|NOT COMPLETED|Overall Study||6
10197145|NCT03370042|11325098|FG000|STARTED|Overall Study||10
10197146|NCT03370042|11325099|FG001|STARTED|Overall Study||10
10197147|NCT03370042|11325098|FG000|COMPLETED|Overall Study||10
10197148|NCT03370042|11325099|FG001|COMPLETED|Overall Study||10
10197149|NCT03370042|11325098|FG000|NOT COMPLETED|Overall Study||0
10197150|NCT03370042|11325099|FG001|NOT COMPLETED|Overall Study||0
10197151|NCT03370289|11325109|FG000|STARTED|Overall Study||55
10197152|NCT03370289|11325109|FG000|COMPLETED|Overall Study||50
10197153|NCT03370289|11325109|FG000|NOT COMPLETED|Overall Study||5
10197154|NCT03370302|11325119|FG000|STARTED|Dose Escalation Phase||3
10197155|NCT03370302|11325120|FG001|STARTED|Dose Escalation Phase||6
10197156|NCT03370302|11325121|FG002|STARTED|Dose Escalation Phase||7
10197157|NCT03370302|11325122|FG003|STARTED|Dose Escalation Phase||0
10197158|NCT03370302|11325123|FG004|STARTED|Dose Escalation Phase||3
10197159|NCT03370302|11325124|FG005|STARTED|Dose Escalation Phase||3
10197160|NCT03370302|11325119|FG000|COMPLETED|Dose Escalation Phase||0
10197161|NCT03370302|11325120|FG001|COMPLETED|Dose Escalation Phase||0
10197162|NCT03370302|11325121|FG002|COMPLETED|Dose Escalation Phase||0
10197163|NCT03370302|11325122|FG003|COMPLETED|Dose Escalation Phase||0
10197164|NCT03370302|11325123|FG004|COMPLETED|Dose Escalation Phase||0
10197165|NCT03370302|11325124|FG005|COMPLETED|Dose Escalation Phase||0
10197166|NCT03370302|11325119|FG000|NOT COMPLETED|Dose Escalation Phase||3
10197167|NCT03370302|11325120|FG001|NOT COMPLETED|Dose Escalation Phase||6
10197168|NCT03370302|11325121|FG002|NOT COMPLETED|Dose Escalation Phase||7
10197169|NCT03370302|11325122|FG003|NOT COMPLETED|Dose Escalation Phase||0
10197170|NCT03370302|11325123|FG004|NOT COMPLETED|Dose Escalation Phase||3
10197171|NCT03370302|11325124|FG005|NOT COMPLETED|Dose Escalation Phase||3
10197172|NCT03370302|11325119|FG000|STARTED|Dose Expansion Phase||0
10197173|NCT03370302|11325120|FG001|STARTED|Dose Expansion Phase||0
10197174|NCT03370302|11325121|FG002|STARTED|Dose Expansion Phase||0
10151643|NCT02831569|11282308|FG000|STARTED|Overall Study||80
10151644|NCT02831569|11282308|FG000|COMPLETED|Overall Study||80
10151645|NCT02831569|11282308|FG000|NOT COMPLETED|Overall Study||0
10151646|NCT02831660|11282312|FG000|STARTED|Overall Study||1
10151647|NCT02831660|11282312|FG000|COMPLETED|Overall Study||1
10151648|NCT02831660|11282312|FG000|NOT COMPLETED|Overall Study||0
10151649|NCT02831816|11282316|FG000|STARTED|Overall Study||640
10151650|NCT02831816|11282316|FG000|ZP|Overall Study||589
10151651|NCT02831816|11282316|FG000|CP|Overall Study||590
10151652|NCT02831816|11282316|FG000|Vehicle|Overall Study||131
10151653|NCT02831816|11282316|FG000|COMPLETED|Overall Study||640
10151654|NCT02831816|11282316|FG000|NOT COMPLETED|Overall Study||0
10151655|NCT02831855|11282327|FG000|STARTED|Open Label Phase (24 Weeks)||694
10151656|NCT02831855|11282328|FG001|STARTED|Open Label Phase (24 Weeks)||0
10151657|NCT02831855|11282329|FG002|STARTED|Open Label Phase (24 Weeks)||0
10151658|NCT02831855|11282327|FG000|COMPLETED|Open Label Phase (24 Weeks)||623
10151659|NCT02831855|11282328|FG001|COMPLETED|Open Label Phase (24 Weeks)||0
10151660|NCT02831855|11282329|FG002|COMPLETED|Open Label Phase (24 Weeks)||0
10151661|NCT02831855|11282327|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71
10151662|NCT02831855|11282328|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0
10151663|NCT02831855|11282329|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0
10151664|NCT02831855|11282327|FG000|STARTED|Double Blind Phase (24 Weeks)||0
10151665|NCT02831855|11282328|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
10151666|NCT02831855|11282329|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
10151667|NCT02831855|11282327|FG000|Treated|Double Blind Phase (24 Weeks)||0
10151668|NCT02831855|11282328|FG001|Treated|Double Blind Phase (24 Weeks)||264
10151669|NCT02831855|11282329|FG002|Treated|Double Blind Phase (24 Weeks)||266
10151670|NCT02831855|11282327|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0
10151671|NCT02831855|11282328|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238
10151672|NCT02831855|11282329|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247
10151673|NCT02831855|11282327|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
10151674|NCT02831855|11282328|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
10151675|NCT02831855|11282329|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
10151676|NCT02831998|11282339|FG000|STARTED|Overall Study||440
10151677|NCT02831998|11282339|FG000|ZP|Overall Study||400
10151678|NCT02831998|11282339|FG000|CP|Overall Study||400
10151679|NCT02831998|11282339|FG000|Vehicle|Overall Study||80
10151680|NCT02831998|11282339|FG000|COMPLETED|Overall Study||440
10151681|NCT02831998|11282339|FG000|NOT COMPLETED|Overall Study||0
10151682|NCT02832037|11282355|FG000|STARTED|Overall Study||85
10151683|NCT02832037|11282356|FG001|STARTED|Overall Study||84
10151684|NCT02832037|11282357|FG002|STARTED|Overall Study||85
10151685|NCT02832037|11282358|FG003|STARTED|Overall Study||85
10151686|NCT02832037|11282359|FG004|STARTED|Overall Study||170
10151687|NCT02832037|11282355|FG000|COMPLETED|Overall Study||66
10151688|NCT02832037|11282356|FG001|COMPLETED|Overall Study||72
10151689|NCT02832037|11282357|FG002|COMPLETED|Overall Study||77
10151690|NCT02832037|11282358|FG003|COMPLETED|Overall Study||78
10151691|NCT02832037|11282359|FG004|COMPLETED|Overall Study||151
10151692|NCT02832037|11282355|FG000|NOT COMPLETED|Overall Study||19
10151693|NCT02832037|11282356|FG001|NOT COMPLETED|Overall Study||12
10151694|NCT02832037|11282357|FG002|NOT COMPLETED|Overall Study||8
10151695|NCT02832037|11282358|FG003|NOT COMPLETED|Overall Study||7
10151696|NCT02832037|11282359|FG004|NOT COMPLETED|Overall Study||19
10151697|NCT02832115|11282373|FG000|STARTED|Overall Study||48
10151698|NCT02832115|11282374|FG001|STARTED|Overall Study||52
10151699|NCT02832115|11282373|FG000|COMPLETED|Overall Study||48
10151700|NCT02832115|11282374|FG001|COMPLETED|Overall Study||52
10151701|NCT02832115|11282373|FG000|NOT COMPLETED|Overall Study||0
10151702|NCT02832115|11282374|FG001|NOT COMPLETED|Overall Study||0
10151703|NCT02832154|11282380|FG000|STARTED|Overall Study||43
10151704|NCT02832154|11282380|FG000|COMPLETED|Overall Study||43
10151705|NCT02832154|11282380|FG000|NOT COMPLETED|Overall Study||0
10151706|NCT02832284|11282384|FG000|STARTED|Overall Study||23
10151707|NCT02832284|11282384|FG000|COMPLETED|Overall Study||23
10151708|NCT02832284|11282384|FG000|NOT COMPLETED|Overall Study||0
10151709|NCT02832375|11282390|FG000|STARTED|Overall Study||121
10151710|NCT02832375|11282391|FG001|STARTED|Overall Study||121
10151711|NCT02832375|11282390|FG000|COMPLETED|Overall Study||119
10151712|NCT02832375|11282391|FG001|COMPLETED|Overall Study||121
10151713|NCT02832375|11282390|FG000|NOT COMPLETED|Overall Study||2
10151714|NCT02832375|11282391|FG001|NOT COMPLETED|Overall Study||0
10151715|NCT02832622|11282398|FG000|STARTED|Overall Study||2169
10151716|NCT02832622|11282398|FG000|COMPLETED|Overall Study||433
10151717|NCT02832622|11282398|FG000|NOT COMPLETED|Overall Study||1736
10151718|NCT02832674|11282403|FG000|STARTED|Overall Study||72
10151719|NCT02832674|11282403|FG000|COMPLETED|Overall Study||67
10151720|NCT02832674|11282403|FG000|NOT COMPLETED|Overall Study||5
10151721|NCT02833077|11282409|FG000|STARTED|Overall Study||144
10151722|NCT02833077|11282410|FG001|STARTED|Overall Study||48
10151723|NCT02833077|11282409|FG000|Participants Treated|Overall Study||144
10151724|NCT02833077|11282410|FG001|Participants Treated|Overall Study||38
10151725|NCT02833077|11282409|FG000|COMPLETED|Overall Study||127
10151726|NCT02833077|11282410|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
10151727|NCT02833077|11282409|FG000|NOT COMPLETED|Overall Study||17
10151728|NCT02833077|11282410|FG001|NOT COMPLETED|Overall Study||8
10151729|NCT02833337|11282417|FG000|STARTED|Overall Study||180
10151730|NCT02833337|11282417|FG000|COMPLETED|Overall Study||180
10151731|NCT02833337|11282417|FG000|NOT COMPLETED|Overall Study||0
10151732|NCT02833350|11282428|FG000|STARTED|Overall Study||40
10151733|NCT02833350|11282429|FG001|STARTED|Overall Study||109
10151734|NCT02833350|11282430|FG002|STARTED|Overall Study||110
10151735|NCT02833350|11282431|FG003|STARTED|Overall Study||110
10151736|NCT02833350|11282432|FG004|STARTED|Overall Study||111
10151737|NCT02833350|11282433|FG005|STARTED|Overall Study||49
10151738|NCT02833350|11282434|FG006|STARTED|Overall Study||49
10151739|NCT02833350|11282428|FG000|Randomized|Overall Study||40
10151740|NCT02833350|11282429|FG001|Randomized|Overall Study||109
10151741|NCT02833350|11282430|FG002|Randomized|Overall Study||110
10151742|NCT02833350|11282431|FG003|Randomized|Overall Study||110
10151743|NCT02833350|11282432|FG004|Randomized|Overall Study||111
10151744|NCT02833350|11282433|FG005|Randomized|Overall Study||48
10151745|NCT02833350|11282434|FG006|Randomized|Overall Study||50
10151746|NCT02833350|11282428|FG000|COMPLETED|Overall Study||37
10151747|NCT02833350|11282429|FG001|COMPLETED|Overall Study||100
10151748|NCT02833350|11282430|FG002|COMPLETED|Overall Study||102
10151749|NCT02833350|11282431|FG003|COMPLETED|Overall Study||102
10151750|NCT02833350|11282432|FG004|COMPLETED|Overall Study||108
10151751|NCT02833350|11282433|FG005|COMPLETED|Overall Study||48
10151752|NCT02833350|11282434|FG006|COMPLETED|Overall Study||44
10151753|NCT02833350|11282428|FG000|NOT COMPLETED|Overall Study||3
10151754|NCT02833350|11282429|FG001|NOT COMPLETED|Overall Study||9
10151755|NCT02833350|11282430|FG002|NOT COMPLETED|Overall Study||8
10151756|NCT02833350|11282431|FG003|NOT COMPLETED|Overall Study||8
10151757|NCT02833350|11282432|FG004|NOT COMPLETED|Overall Study||3
10151758|NCT02833350|11282433|FG005|NOT COMPLETED|Overall Study||1
10151759|NCT02833350|11282434|FG006|NOT COMPLETED|Overall Study||5
10151760|NCT02833415|11282455|FG000|STARTED|Overall Study||20
10151761|NCT02833415|11282456|FG001|STARTED|Overall Study||20
10151762|NCT02833415|11282455|FG000|COMPLETED|Overall Study||18
10151763|NCT02833415|11282456|FG001|COMPLETED|Overall Study||17
10151764|NCT02833415|11282455|FG000|NOT COMPLETED|Overall Study||2
10151765|NCT02833415|11282456|FG001|NOT COMPLETED|Overall Study||3
10151766|NCT02833857|11282462|FG000|STARTED|Overall Study||11
10151767|NCT02833857|11282462|FG000|COMPLETED|Overall Study||11
10151768|NCT02833857|11282462|FG000|NOT COMPLETED|Overall Study||0
10151769|NCT02833922|11282466|FG000|STARTED|Overall Study||718
9709680|NCT04779606|10809099|FG001|STARTED|Second Phase: Efficacy||17
9709681|NCT04779606|10809098|FG000|COMPLETED|Second Phase: Efficacy||68
9709682|NCT04779606|10809099|FG001|COMPLETED|Second Phase: Efficacy||17
9709683|NCT04779606|10809098|FG000|NOT COMPLETED|Second Phase: Efficacy||0
9709684|NCT04779606|10809099|FG001|NOT COMPLETED|Second Phase: Efficacy||0
9729719|NCT00120627|10829335|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
9729720|NCT00120627|10829334|FG000|NOT COMPLETED|Overall Study||5
9729721|NCT00120627|10829335|FG001|NOT COMPLETED|Overall Study||5
9729722|NCT00120874|10829352|FG000|STARTED|Overall Study||10
9729723|NCT00120874|10829353|FG001|STARTED|Overall Study||10
9729724|NCT00120874|10829352|FG000|Completed Study; Started Extension Study|Overall Study||10
9729725|NCT00120874|10829353|FG001|Completed Study; Started Extension Study|Overall Study||10
9729726|NCT00120874|10829352|FG000|COMPLETED|Overall Study||10
9729727|NCT00120874|10829353|FG001|COMPLETED|Overall Study||9
9729728|NCT00120874|10829352|FG000|NOT COMPLETED|Overall Study||0
9729729|NCT00120874|10829353|FG001|NOT COMPLETED|Overall Study||1
9729730|NCT00121134|10829363|FG000|STARTED|Overall Study||40
9729731|NCT00121134|10829364|FG001|STARTED|Overall Study||41
9729732|NCT00121134|10829365|FG002|STARTED|Overall Study||41
9729733|NCT00121134|10829366|FG003|STARTED|Overall Study||40
9729734|NCT00121134|10829363|FG000|COMPLETED|Overall Study||24
9729735|NCT00121134|10829364|FG001|COMPLETED|Overall Study||26
9729736|NCT00121134|10829365|FG002|COMPLETED|Overall Study||20
9729737|NCT00121134|10829366|FG003|COMPLETED|Overall Study||31
9729738|NCT00121134|10829363|FG000|NOT COMPLETED|Overall Study||16
9729739|NCT00121134|10829364|FG001|NOT COMPLETED|Overall Study||15
9729740|NCT00121134|10829365|FG002|NOT COMPLETED|Overall Study||21
9729741|NCT00121134|10829366|FG003|NOT COMPLETED|Overall Study||9
9729742|NCT00121173|10829379|FG000|STARTED|Overall Study||4
9729743|NCT00121173|10829380|FG001|STARTED|Overall Study||3
9729744|NCT00121173|10829381|FG002|STARTED|Overall Study||9
9729745|NCT00121173|10829379|FG000|COMPLETED|Overall Study||3
9729746|NCT00121173|10829380|FG001|COMPLETED|Overall Study||3
9729747|NCT00121173|10829381|FG002|COMPLETED|Overall Study||9
9729748|NCT00121173|10829379|FG000|NOT COMPLETED|Overall Study||1
9729749|NCT00121173|10829380|FG001|NOT COMPLETED|Overall Study||0
9729750|NCT00121173|10829381|FG002|NOT COMPLETED|Overall Study||0
9729751|NCT00121186|10829392|FG000|STARTED|Overall Study||1
10151770|NCT02833922|11282466|FG000|COMPLETED|Overall Study||336
9729752|NCT00121186|10829392|FG000|COMPLETED|Overall Study||1
9729753|NCT00121186|10829392|FG000|NOT COMPLETED|Overall Study||0
10151771|NCT02833922|11282466|FG000|NOT COMPLETED|Overall Study||382
9729754|NCT00121199|10829396|FG000|STARTED|Overall Study||73
10151772|NCT02833948|11282472|FG000|STARTED|Overall Study||116
10151773|NCT02833948|11282473|FG001|STARTED|Overall Study||115
10151774|NCT02833948|11282472|FG000|COMPLETED|Overall Study||101
10151775|NCT02833948|11282473|FG001|COMPLETED|Overall Study||97
10151776|NCT02833948|11282472|FG000|NOT COMPLETED|Overall Study||15
10151777|NCT02833948|11282473|FG001|NOT COMPLETED|Overall Study||18
10151778|NCT02833974|11282485|FG000|STARTED|Overall Study||14
10151779|NCT02833974|11282486|FG001|STARTED|Overall Study||22
10151780|NCT02833974|11282485|FG000|COMPLETED|Overall Study||13
10151781|NCT02833974|11282486|FG001|COMPLETED|Overall Study||19
10151782|NCT02833974|11282485|FG000|NOT COMPLETED|Overall Study||1
10151783|NCT02833974|11282486|FG001|NOT COMPLETED|Overall Study||3
10151784|NCT02834247|11282496|FG000|STARTED|Dose Escalation Phase||8
10151785|NCT02834247|11282497|FG001|STARTED|Dose Escalation Phase||11
10151786|NCT02834247|11282498|FG002|STARTED|Dose Escalation Phase||5
10151787|NCT02834247|11282499|FG003|STARTED|Dose Escalation Phase||0
10151788|NCT02834247|11282496|FG000|COMPLETED|Dose Escalation Phase||0
10151789|NCT02834247|11282497|FG001|COMPLETED|Dose Escalation Phase||0
10151790|NCT02834247|11282498|FG002|COMPLETED|Dose Escalation Phase||0
10151791|NCT02834247|11282499|FG003|COMPLETED|Dose Escalation Phase||0
10151792|NCT02834247|11282496|FG000|NOT COMPLETED|Dose Escalation Phase||8
10151793|NCT02834247|11282497|FG001|NOT COMPLETED|Dose Escalation Phase||11
10151794|NCT02834247|11282498|FG002|NOT COMPLETED|Dose Escalation Phase||5
10151795|NCT02834247|11282499|FG003|NOT COMPLETED|Dose Escalation Phase||0
10151796|NCT02834247|11282496|FG000|STARTED|Dose Expansion Phase||0
10151797|NCT02834247|11282497|FG001|STARTED|Dose Expansion Phase||0
10151798|NCT02834247|11282498|FG002|STARTED|Dose Expansion Phase||0
10151799|NCT02834247|11282499|FG003|STARTED|Dose Expansion Phase||17
10151800|NCT02834247|11282496|FG000|COMPLETED|Dose Expansion Phase||0
10151801|NCT02834247|11282497|FG001|COMPLETED|Dose Expansion Phase||0
10151802|NCT02834247|11282498|FG002|COMPLETED|Dose Expansion Phase||0
10151803|NCT02834247|11282499|FG003|COMPLETED|Dose Expansion Phase||0
10151804|NCT02834247|11282496|FG000|NOT COMPLETED|Dose Expansion Phase||0
10151805|NCT02834247|11282497|FG001|NOT COMPLETED|Dose Expansion Phase||0
10151806|NCT02834247|11282498|FG002|NOT COMPLETED|Dose Expansion Phase||0
10151807|NCT02834247|11282499|FG003|NOT COMPLETED|Dose Expansion Phase||17
10151808|NCT02834390|11282513|FG000|STARTED|Induction Phase||4
10151809|NCT02834390|11282514|FG001|STARTED|Induction Phase||3
10151810|NCT02834390|11282513|FG000|COMPLETED|Induction Phase||2
10151811|NCT02834390|11282514|FG001|COMPLETED|Induction Phase||1
10151812|NCT02834390|11282513|FG000|NOT COMPLETED|Induction Phase||2
10151813|NCT02834390|11282514|FG001|NOT COMPLETED|Induction Phase||2
10151814|NCT02834390|11282513|FG000|STARTED|Consolidation Phase||2
10151815|NCT02834390|11282514|FG001|STARTED|Consolidation Phase||1
10151816|NCT02834390|11282513|FG000|COMPLETED|Consolidation Phase||1
10151817|NCT02834390|11282514|FG001|COMPLETED|Consolidation Phase||0
10151818|NCT02834390|11282513|FG000|NOT COMPLETED|Consolidation Phase||1
10151819|NCT02834390|11282514|FG001|NOT COMPLETED|Consolidation Phase||1
10151820|NCT02834624|11282522|FG000|STARTED|Overall Study||15
10151821|NCT02834624|11282523|FG001|STARTED|Overall Study||15
10151822|NCT02834624|11282522|FG000|COMPLETED|Overall Study||15
10151823|NCT02834624|11282523|FG001|COMPLETED|Overall Study||15
10151824|NCT02834624|11282522|FG000|NOT COMPLETED|Overall Study||0
10151825|NCT02834624|11282523|FG001|NOT COMPLETED|Overall Study||0
10151826|NCT02834663|11282530|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
10151827|NCT02834663|11282530|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
10151828|NCT02834663|11282530|FG000|NOT COMPLETED|Overall Study||0
10151829|NCT02834806|11282548|FG000|STARTED|Overall Study||58
10151830|NCT02834806|11282548|FG000|COMPLETED|Overall Study||58
10151831|NCT02834806|11282548|FG000|NOT COMPLETED|Overall Study||0
10151832|NCT02834819|11282554|FG000|STARTED|Overall Study||9
10151833|NCT02834819|11282555|FG001|STARTED|Overall Study||9
10151834|NCT02834819|11282554|FG000|COMPLETED|Overall Study||4
10151835|NCT02834819|11282555|FG001|COMPLETED|Overall Study||9
10151836|NCT02834819|11282554|FG000|NOT COMPLETED|Overall Study||5
10151837|NCT02834819|11282555|FG001|NOT COMPLETED|Overall Study||0
10151838|NCT02835092|11282564|FG000|STARTED|Overall Study||66
10151839|NCT02835092|11282565|FG001|STARTED|Overall Study||65
10151840|NCT02835092|11282566|FG002|STARTED|Overall Study||67
10151841|NCT02835092|11282564|FG000|COMPLETED|Overall Study||63
10151842|NCT02835092|11282565|FG001|COMPLETED|Overall Study||57
10151843|NCT02835092|11282566|FG002|COMPLETED|Overall Study||64
10151844|NCT02835092|11282564|FG000|NOT COMPLETED|Overall Study||3
10151845|NCT02835092|11282565|FG001|NOT COMPLETED|Overall Study||8
10151846|NCT02835092|11282566|FG002|NOT COMPLETED|Overall Study||3
10151847|NCT02835274|11282576|FG000|STARTED|Overall Study||6
10151848|NCT02835274|11282577|FG001|STARTED|Overall Study||6
10151849|NCT02835274|11282576|FG000|COMPLETED|Overall Study||6
10151850|NCT02835274|11282577|FG001|COMPLETED|Overall Study||6
10151851|NCT02835274|11282576|FG000|NOT COMPLETED|Overall Study||0
10151852|NCT02835274|11282577|FG001|NOT COMPLETED|Overall Study||0
10151853|NCT02835339|11282585|FG000|STARTED|Overall Study||31
10151854|NCT02835339|11282586|FG001|STARTED|Overall Study||35
10151855|NCT02835339|11282585|FG000|COMPLETED|Overall Study||18
10151856|NCT02835339|11282586|FG001|COMPLETED|Overall Study||19
10151857|NCT02835339|11282585|FG000|NOT COMPLETED|Overall Study||13
10151858|NCT02835339|11282586|FG001|NOT COMPLETED|Overall Study||16
10151859|NCT02835495|11282594|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
10151860|NCT02835495|11282595|FG001|STARTED|Overall Study||25
10151861|NCT02835495|11282594|FG000|Intervention Start|Overall Study||25
10151862|NCT02835495|11282595|FG001|Intervention Start|Overall Study||25
10151863|NCT02835495|11282594|FG000|COMPLETED|Overall Study||21
10151864|NCT02835495|11282595|FG001|COMPLETED|Overall Study||23
10151865|NCT02835495|11282594|FG000|NOT COMPLETED|Overall Study||5
10151866|NCT02835495|11282595|FG001|NOT COMPLETED|Overall Study||2
10151867|NCT02835625|11282605|FG000|STARTED|Overall Study||14734
10151868|NCT02835625|11282606|FG001|STARTED|Overall Study||14719
10151869|NCT02835625|11282605|FG000|COMPLETED|Overall Study||14734
10151870|NCT02835625|11282606|FG001|COMPLETED|Overall Study||14719
10151871|NCT02835625|11282605|FG000|NOT COMPLETED|Overall Study||0
10151872|NCT02835625|11282606|FG001|NOT COMPLETED|Overall Study||0
10151873|NCT02835677|11282613|FG000|STARTED|Overall Study||25
10151874|NCT02835677|11282613|FG000|COMPLETED|Overall Study||25
10151875|NCT02835677|11282613|FG000|NOT COMPLETED|Overall Study||0
10151876|NCT02835820|11282619|FG000|STARTED|Overall Study||7
10151877|NCT02835820|11282620|FG001|STARTED|Overall Study||10
10151878|NCT02835820|11282619|FG000|Baseline Screen (OGTT)|Overall Study||7
10151879|NCT02835820|11282620|FG001|Baseline Screen (OGTT)|Overall Study||7
10151880|NCT02835820|11282619|FG000|COMPLETED|Overall Study||7
10151881|NCT02835820|11282620|FG001|COMPLETED|Overall Study||7
10151882|NCT02835820|11282619|FG000|NOT COMPLETED|Overall Study||0
10151883|NCT02835820|11282620|FG001|NOT COMPLETED|Overall Study||3
10151884|NCT02835846|11282626|FG000|STARTED|Overall Study||35
10151885|NCT02835846|11282626|FG000|COMPLETED|Overall Study||24
10151886|NCT02835846|11282626|FG000|NOT COMPLETED|Overall Study||11
10151887|NCT02836496|11282632|FG000|STARTED|Overall Study||54
10151888|NCT02836496|11282633|FG001|STARTED|Overall Study||54
10151889|NCT02836496|11282632|FG000|COMPLETED|Overall Study||52
10151890|NCT02836496|11282633|FG001|COMPLETED|Overall Study||52
10151891|NCT02836496|11282632|FG000|NOT COMPLETED|Overall Study||2
10151892|NCT02836496|11282633|FG001|NOT COMPLETED|Overall Study||2
10151893|NCT02836613|11282641|FG000|STARTED|Overall Study||80
10151894|NCT02836613|11282642|FG001|STARTED|Overall Study||80
10151895|NCT02836613|11282641|FG000|COMPLETED|Overall Study||79
10151896|NCT02836613|11282642|FG001|COMPLETED|Overall Study||77
10151897|NCT02836613|11282641|FG000|NOT COMPLETED|Overall Study||1
10151898|NCT02836613|11282642|FG001|NOT COMPLETED|Overall Study||3
10151899|NCT02836652|11282650|FG000|STARTED|Overall Study||35
10151900|NCT02836652|11282651|FG001|STARTED|Overall Study||37
9709685|NCT04773028|10809107|FG000|STARTED|Overall Study||24
9709686|NCT04773028|10809108|FG001|STARTED|Overall Study||24
9709687|NCT04773028|10809107|FG000|COMPLETED|Overall Study||24
9709688|NCT04773028|10809108|FG001|COMPLETED|Overall Study||24
9709689|NCT04773028|10809107|FG000|NOT COMPLETED|Overall Study||0
9709690|NCT04773028|10809108|FG001|NOT COMPLETED|Overall Study||0
9709691|NCT04755595|10809114|FG000|STARTED|Overall Study||20
9709692|NCT04755595|10809114|FG000|COMPLETED|Overall Study||19
9709693|NCT04755595|10809114|FG000|NOT COMPLETED|Overall Study||1
9709694|NCT04749745|10809119|FG000|STARTED|Overall Study||5
9709695|NCT04749745|10809120|FG001|STARTED|Overall Study||6
9709696|NCT04749745|10809119|FG000|First Intervention|Overall Study||4
9709697|NCT04749745|10809120|FG001|First Intervention|Overall Study||6
9709698|NCT04749745|10809119|FG000|Washout|Overall Study||4
9709699|NCT04749745|10809120|FG001|Washout|Overall Study||6
9709700|NCT04749745|10809119|FG000|Second Intervention|Overall Study||4
9709701|NCT04749745|10809120|FG001|Second Intervention|Overall Study||6
9709702|NCT04749745|10809119|FG000|COMPLETED|Overall Study||4
9709703|NCT04749745|10809120|FG001|COMPLETED|Overall Study||6
9709704|NCT04749745|10809119|FG000|NOT COMPLETED|Overall Study||1
9709705|NCT04749745|10809120|FG001|NOT COMPLETED|Overall Study||0
9709706|NCT04748341|10809128|FG000|STARTED|Overall Study||31
9709707|NCT04748341|10809129|FG001|STARTED|Overall Study||31
9709708|NCT04748341|10809128|FG000|COMPLETED|Overall Study||30
9709709|NCT04748341|10809129|FG001|COMPLETED|Overall Study||30
9709710|NCT04748341|10809128|FG000|NOT COMPLETED|Overall Study||1
9709711|NCT04748341|10809129|FG001|NOT COMPLETED|Overall Study||1
9709712|NCT04737278|10809137|FG000|STARTED|Overall Study||28
9709713|NCT04737278|10809138|FG001|STARTED|Overall Study||28
9709714|NCT04737278|10809137|FG000|COMPLETED|Overall Study||24
9709715|NCT04737278|10809138|FG001|COMPLETED|Overall Study||25
9709716|NCT04737278|10809137|FG000|NOT COMPLETED|Overall Study||4
9709717|NCT04737278|10809138|FG001|NOT COMPLETED|Overall Study||3
9709724|NCT04600375|10809161|FG000|STARTED|Overall Study||12
9709725|NCT04600375|10809162|FG001|STARTED|Overall Study||10
9709726|NCT04600375|10809161|FG000|COMPLETED|Overall Study||12
9709727|NCT04600375|10809162|FG001|COMPLETED|Overall Study||10
9709728|NCT04600375|10809161|FG000|NOT COMPLETED|Overall Study||0
9709729|NCT04600375|10809162|FG001|NOT COMPLETED|Overall Study||0
9709730|NCT04524598|10809172|FG000|STARTED|Phase I - Feasibility||35
9709731|NCT04524598|10809173|FG001|STARTED|Phase I - Feasibility||25
9709732|NCT04524598|10809174|FG002|STARTED|Phase I - Feasibility||0
9709733|NCT04524598|10809175|FG003|STARTED|Phase I - Feasibility||0
9709734|NCT04524598|10809176|FG004|STARTED|Phase I - Feasibility||0
9709735|NCT04524598|10809172|FG000|COMPLETED|Phase I - Feasibility||31
9709736|NCT04524598|10809173|FG001|COMPLETED|Phase I - Feasibility||20
9709737|NCT04524598|10809174|FG002|COMPLETED|Phase I - Feasibility||0
9709738|NCT04524598|10809175|FG003|COMPLETED|Phase I - Feasibility||0
9709739|NCT04524598|10809176|FG004|COMPLETED|Phase I - Feasibility||0
9709740|NCT04524598|10809172|FG000|NOT COMPLETED|Phase I - Feasibility||4
9709741|NCT04524598|10809173|FG001|NOT COMPLETED|Phase I - Feasibility||5
9709742|NCT04524598|10809174|FG002|NOT COMPLETED|Phase I - Feasibility||0
10151901|NCT02836652|11282650|FG000|As-treated Population|Overall Study||31
10151902|NCT02836652|11282651|FG001|As-treated Population|Overall Study||34
10151903|NCT02836652|11282650|FG000|COMPLETED|Overall Study||17
10151904|NCT02836652|11282651|FG001|COMPLETED|Overall Study||18
10151905|NCT02836652|11282650|FG000|NOT COMPLETED|Overall Study||18
10151906|NCT02836652|11282651|FG001|NOT COMPLETED|Overall Study||19
10151907|NCT02836769|11282657|FG000|STARTED|Overall Study||35
10151908|NCT02836769|11282657|FG000|Received Intervention|Overall Study||30
10151909|NCT02836769|11282657|FG000|Completed Post-test Assessment|Overall Study||21
10151910|NCT02836769|11282657|FG000|COMPLETED|Overall Study||20
10151911|NCT02836769|11282657|FG000|NOT COMPLETED|Overall Study||15
10151912|NCT02836873|11282663|FG000|STARTED|Overall Study||157
10151913|NCT02836873|11282664|FG001|STARTED|Overall Study||155
10151914|NCT02836873|11282663|FG000|COMPLETED|Overall Study||152
10151915|NCT02836873|11282664|FG001|COMPLETED|Overall Study||144
10151916|NCT02836873|11282663|FG000|NOT COMPLETED|Overall Study||5
10151917|NCT02836873|11282664|FG001|NOT COMPLETED|Overall Study||11
10151918|NCT02836990|11282672|FG000|STARTED|Overall Study||50
10151919|NCT02836990|11282673|FG001|STARTED|Overall Study||55
10151920|NCT02836990|11282672|FG000|COMPLETED|Overall Study||50
10151921|NCT02836990|11282673|FG001|COMPLETED|Overall Study||55
10151922|NCT02836990|11282672|FG000|NOT COMPLETED|Overall Study||0
10151923|NCT02836990|11282673|FG001|NOT COMPLETED|Overall Study||0
10151924|NCT02837237|11282681|FG000|STARTED|Overall Study||11
10151925|NCT02837237|11282681|FG000|COMPLETED|Overall Study||11
10151926|NCT02837237|11282681|FG000|NOT COMPLETED|Overall Study||0
10151927|NCT02837328|11282687|FG000|STARTED|Overall Study||29
10151928|NCT02837328|11282688|FG001|STARTED|Overall Study||30
10151929|NCT02837328|11282687|FG000|COMPLETED|Overall Study||29
10151930|NCT02837328|11282688|FG001|COMPLETED|Overall Study||30
10151931|NCT02837328|11282687|FG000|NOT COMPLETED|Overall Study||0
10151932|NCT02837328|11282688|FG001|NOT COMPLETED|Overall Study||0
10151933|NCT02837731|11282696|FG000|STARTED|Allocation||102
10151934|NCT02837731|11282697|FG001|STARTED|Allocation||48
10151935|NCT02837731|11282696|FG000|COMPLETED|Allocation||83
10151936|NCT02837731|11282697|FG001|COMPLETED|Allocation||41
10151937|NCT02837731|11282696|FG000|NOT COMPLETED|Allocation||19
10151938|NCT02837731|11282697|FG001|NOT COMPLETED|Allocation||7
10151939|NCT02837731|11282696|FG000|STARTED|Follow-up||83
10151940|NCT02837731|11282697|FG001|STARTED|Follow-up||41
10151941|NCT02837731|11282696|FG000|COMPLETED|Follow-up||83
10151942|NCT02837731|11282697|FG001|COMPLETED|Follow-up||41
10151943|NCT02837731|11282696|FG000|NOT COMPLETED|Follow-up||0
10151944|NCT02837731|11282697|FG001|NOT COMPLETED|Follow-up||0
10151945|NCT02837731|11282696|FG000|STARTED|Analysis||83
10151946|NCT02837731|11282697|FG001|STARTED|Analysis||41
10151947|NCT02837731|11282696|FG000|COMPLETED|Analysis||83
10151948|NCT02837731|11282697|FG001|COMPLETED|Analysis||41
10151949|NCT02837731|11282696|FG000|NOT COMPLETED|Analysis||0
10151950|NCT02837731|11282697|FG001|NOT COMPLETED|Analysis||0
10151951|NCT02837744|11282703|FG000|STARTED|Overall Study||70
10151952|NCT02837744|11282703|FG000|COMPLETED|Overall Study||70
10151953|NCT02837744|11282703|FG000|NOT COMPLETED|Overall Study||0
10151954|NCT02837913|11282709|FG000|STARTED|Overall Study||10
10151955|NCT02837913|11282710|FG001|STARTED|Overall Study||9
10151956|NCT02837913|11282709|FG000|COMPLETED|Overall Study||10
10151957|NCT02837913|11282710|FG001|COMPLETED|Overall Study||9
10151958|NCT02837913|11282709|FG000|NOT COMPLETED|Overall Study||0
10151959|NCT02837913|11282710|FG001|NOT COMPLETED|Overall Study||0
10151960|NCT02837952|11282718|FG000|STARTED|Overall Study||41
10151961|NCT02837952|11282719|FG001|STARTED|Overall Study||82
10151962|NCT02837952|11282718|FG000|COMPLETED|Overall Study||36
10151963|NCT02837952|11282719|FG001|COMPLETED|Overall Study||76
10151964|NCT02837952|11282718|FG000|NOT COMPLETED|Overall Study||5
10151965|NCT02837952|11282719|FG001|NOT COMPLETED|Overall Study||6
10151966|NCT02838017|11282727|FG000|STARTED|Overall Study||252
10151967|NCT02838017|11282728|FG001|STARTED|Overall Study||252
10151968|NCT02838017|11282727|FG000|COMPLETED|Overall Study||238
10151969|NCT02838017|11282728|FG001|COMPLETED|Overall Study||241
10151970|NCT02838017|11282727|FG000|NOT COMPLETED|Overall Study||14
10151971|NCT02838017|11282728|FG001|NOT COMPLETED|Overall Study||11
10151972|NCT02838134|11282736|FG000|STARTED|Overall Study||50
10151973|NCT02838134|11282737|FG001|STARTED|Overall Study||51
10151974|NCT02838134|11282736|FG000|COMPLETED|Overall Study||48
10151975|NCT02838134|11282737|FG001|COMPLETED|Overall Study||48
10151976|NCT02838134|11282736|FG000|NOT COMPLETED|Overall Study||2
10151977|NCT02838134|11282737|FG001|NOT COMPLETED|Overall Study||3
10151978|NCT02838407|11282743|FG000|STARTED|Overall Study||197
10151979|NCT02838407|11282743|FG000|COMPLETED|Overall Study||197
10151980|NCT02838407|11282743|FG000|NOT COMPLETED|Overall Study||0
10151981|NCT02838420|11282749|FG000|STARTED|Overall Study||125
10151982|NCT02838420|11282750|FG001|STARTED|Overall Study||62
10151983|NCT02838420|11282749|FG000|COMPLETED|Overall Study||0
10151984|NCT02838420|11282750|FG001|COMPLETED|Overall Study||0
10151985|NCT02838420|11282749|FG000|NOT COMPLETED|Overall Study||125
10151986|NCT02838420|11282750|FG001|NOT COMPLETED|Overall Study||62
10151987|NCT02838628|11282758|FG000|STARTED|Treatment and Follow-up Period||84
10151988|NCT02838628|11282759|FG001|STARTED|Treatment and Follow-up Period||84
10151989|NCT02838628|11282758|FG000|COMPLETED|Treatment and Follow-up Period||84
10151990|NCT02838628|11282759|FG001|COMPLETED|Treatment and Follow-up Period||84
10151991|NCT02838628|11282758|FG000|NOT COMPLETED|Treatment and Follow-up Period||0
10151992|NCT02838628|11282759|FG001|NOT COMPLETED|Treatment and Follow-up Period||0
10151993|NCT02838628|11282758|FG000|STARTED|Recurrence Follow-up Period||36
10151994|NCT02838628|11282759|FG001|STARTED|Recurrence Follow-up Period||27
10151995|NCT02838628|11282758|FG000|COMPLETED|Recurrence Follow-up Period||16
10151996|NCT02838628|11282759|FG001|COMPLETED|Recurrence Follow-up Period||10
10151997|NCT02838628|11282758|FG000|NOT COMPLETED|Recurrence Follow-up Period||20
10151998|NCT02838628|11282759|FG001|NOT COMPLETED|Recurrence Follow-up Period||17
10151999|NCT02838901|11282768|FG000|STARTED|Overall Study||9
10152000|NCT02838901|11282769|FG001|STARTED|Overall Study||9
10152001|NCT02838901|11282768|FG000|COMPLETED|Overall Study||7
10152002|NCT02838901|11282769|FG001|COMPLETED|Overall Study||7
10152003|NCT02838901|11282768|FG000|NOT COMPLETED|Overall Study||2
10152004|NCT02838901|11282769|FG001|NOT COMPLETED|Overall Study||2
10152005|NCT02839200|11282783|FG000|STARTED|Overall Study||60
9709718|NCT04736069|10809146|FG000|STARTED|Overall Study||30
9709719|NCT04736069|10809147|FG001|STARTED|Overall Study||30
9709720|NCT04736069|10809146|FG000|COMPLETED|Overall Study||30
9709721|NCT04736069|10809147|FG001|COMPLETED|Overall Study||22
9709722|NCT04736069|10809146|FG000|NOT COMPLETED|Overall Study||0
9709723|NCT04736069|10809147|FG001|NOT COMPLETED|Overall Study||8
9709743|NCT04524598|10809175|FG003|NOT COMPLETED|Phase I - Feasibility||0
9709744|NCT04524598|10809176|FG004|NOT COMPLETED|Phase I - Feasibility||0
9709745|NCT04524598|10809172|FG000|STARTED|Phase II - Outcomes||0
9709746|NCT04524598|10809173|FG001|STARTED|Phase II - Outcomes||0
9709747|NCT04524598|10809174|FG002|STARTED|Phase II - Outcomes||80
9709748|NCT04524598|10809175|FG003|STARTED|Phase II - Outcomes||80
9709749|NCT04524598|10809176|FG004|STARTED|Phase II - Outcomes||0
9709750|NCT04524598|10809172|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
9709751|NCT04524598|10809173|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
9709752|NCT04524598|10809174|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63
9709753|NCT04524598|10809175|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58
9709754|NCT04524598|10809176|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
9709755|NCT04524598|10809172|FG000|COMPLETED|Phase II - Outcomes||0
9709756|NCT04524598|10809173|FG001|COMPLETED|Phase II - Outcomes||0
9709757|NCT04524598|10809174|FG002|COMPLETED|Phase II - Outcomes||54
9848995|NCT00862849|10961757|FG005|NOT COMPLETED|Intervention 3||0
9848996|NCT00862849|10961752|FG000|STARTED|Washout 3 (3 to 14 Days)||3
9848997|NCT00862849|10961753|FG001|STARTED|Washout 3 (3 to 14 Days)||3
9848998|NCT00862849|10961754|FG002|STARTED|Washout 3 (3 to 14 Days)||3
9848999|NCT00862849|10961755|FG003|STARTED|Washout 3 (3 to 14 Days)||4
9849000|NCT00862849|10961756|FG004|STARTED|Washout 3 (3 to 14 Days)||4
9849001|NCT00862849|10961757|FG005|STARTED|Washout 3 (3 to 14 Days)||3
9849002|NCT00862849|10961752|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3
9849003|NCT00862849|10961753|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3
9849004|NCT00862849|10961754|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3
9849005|NCT00862849|10961755|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4
9849006|NCT00862849|10961756|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4
9849007|NCT00862849|10961757|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3
9849008|NCT00862849|10961752|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
9849009|NCT00862849|10961753|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
9849010|NCT00862849|10961754|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
9849011|NCT00862849|10961755|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
9849012|NCT00862849|10961756|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
9849013|NCT00862849|10961757|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
9849014|NCT00862849|10961752|FG000|STARTED|Intervention 4||3
9849015|NCT00862849|10961753|FG001|STARTED|Intervention 4||3
9849016|NCT00862849|10961754|FG002|STARTED|Intervention 4||3
9849017|NCT00862849|10961755|FG003|STARTED|Intervention 4||4
9849018|NCT00862849|10961756|FG004|STARTED|Intervention 4||4
9849019|NCT00862849|10961757|FG005|STARTED|Intervention 4||3
9849020|NCT00862849|10961752|FG000|COMPLETED|Intervention 4||3
9849021|NCT00862849|10961753|FG001|COMPLETED|Intervention 4||3
9849022|NCT00862849|10961754|FG002|COMPLETED|Intervention 4||3
9849023|NCT00862849|10961755|FG003|COMPLETED|Intervention 4||4
9849024|NCT00862849|10961756|FG004|COMPLETED|Intervention 4||4
9849025|NCT00862849|10961757|FG005|COMPLETED|Intervention 4||3
9849026|NCT00862849|10961752|FG000|NOT COMPLETED|Intervention 4||0
9849027|NCT00862849|10961753|FG001|NOT COMPLETED|Intervention 4||0
9849028|NCT00862849|10961754|FG002|NOT COMPLETED|Intervention 4||0
9849029|NCT00862849|10961755|FG003|NOT COMPLETED|Intervention 4||0
9849030|NCT00862849|10961756|FG004|NOT COMPLETED|Intervention 4||0
9849031|NCT00862849|10961757|FG005|NOT COMPLETED|Intervention 4||0
9849032|NCT00862849|10961752|FG000|STARTED|Washout 4 (3 to 14 Days)||3
9849033|NCT00862849|10961753|FG001|STARTED|Washout 4 (3 to 14 Days)||3
9849034|NCT00862849|10961754|FG002|STARTED|Washout 4 (3 to 14 Days)||3
9849035|NCT00862849|10961755|FG003|STARTED|Washout 4 (3 to 14 Days)||4
9849036|NCT00862849|10961756|FG004|STARTED|Washout 4 (3 to 14 Days)||4
9849037|NCT00862849|10961757|FG005|STARTED|Washout 4 (3 to 14 Days)||3
9849038|NCT00862849|10961752|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3
9849039|NCT00862849|10961753|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3
9849040|NCT00862849|10961754|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3
9849041|NCT00862849|10961755|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4
9849042|NCT00862849|10961756|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4
9849043|NCT00862849|10961757|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3
9849044|NCT00862849|10961752|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
9849045|NCT00862849|10961753|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
9849046|NCT00862849|10961754|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
9849047|NCT00862849|10961755|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
9849048|NCT00862849|10961756|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
9963919|NCT01489358|11083721|FG002|NOT COMPLETED|Overall Study||2
10152006|NCT02839200|11282784|FG001|STARTED|Overall Study||59
10152007|NCT02839200|11282785|FG002|STARTED|Overall Study||60
9963920|NCT01489527|11083731|FG000|STARTED|Overall Study||205
10152008|NCT02839200|11282786|FG003|STARTED|Overall Study||61
10152009|NCT02839200|11282787|FG004|STARTED|Overall Study||60
10152010|NCT02839200|11282788|FG005|STARTED|Overall Study||60
10152011|NCT02839200|11282783|FG000|COMPLETED|Overall Study||56
10152012|NCT02839200|11282784|FG001|COMPLETED|Overall Study||58
10152013|NCT02839200|11282785|FG002|COMPLETED|Overall Study||59
10152014|NCT02839200|11282786|FG003|COMPLETED|Overall Study||61
10152015|NCT02839200|11282787|FG004|COMPLETED|Overall Study||58
10152016|NCT02839200|11282788|FG005|COMPLETED|Overall Study||59
10152017|NCT02839200|11282783|FG000|NOT COMPLETED|Overall Study||4
10152018|NCT02839200|11282784|FG001|NOT COMPLETED|Overall Study||1
10152019|NCT02839200|11282785|FG002|NOT COMPLETED|Overall Study||1
10152020|NCT02839200|11282786|FG003|NOT COMPLETED|Overall Study||0
10152021|NCT02839200|11282787|FG004|NOT COMPLETED|Overall Study||2
10152022|NCT02839200|11282788|FG005|NOT COMPLETED|Overall Study||1
10152023|NCT02839330|11282806|FG000|STARTED|Overall Study||804
10152024|NCT02839330|11282807|FG001|STARTED|Overall Study||799
10152025|NCT02839330|11282808|FG002|STARTED|Overall Study||795
10152026|NCT02839330|11282809|FG003|STARTED|Overall Study||798
10152027|NCT02839330|11282806|FG000|Exposed|Overall Study||804
10152028|NCT02839330|11282807|FG001|Exposed|Overall Study||797
10152029|NCT02839330|11282808|FG002|Exposed|Overall Study||793
10152030|NCT02839330|11282809|FG003|Exposed|Overall Study||797
10152031|NCT02839330|11282806|FG000|COMPLETED|Overall Study||746
10152032|NCT02839330|11282807|FG001|COMPLETED|Overall Study||741
10152033|NCT02839330|11282808|FG002|COMPLETED|Overall Study||747
10152034|NCT02839330|11282809|FG003|COMPLETED|Overall Study||747
10152035|NCT02839330|11282806|FG000|NOT COMPLETED|Overall Study||58
10152036|NCT02839330|11282807|FG001|NOT COMPLETED|Overall Study||58
10152037|NCT02839330|11282808|FG002|NOT COMPLETED|Overall Study||48
10152038|NCT02839330|11282809|FG003|NOT COMPLETED|Overall Study||51
10152039|NCT02839681|11282820|FG000|STARTED|Overall Study||2
10152040|NCT02839681|11282820|FG000|COMPLETED|Overall Study||0
10152041|NCT02839681|11282820|FG000|NOT COMPLETED|Overall Study||2
10152042|NCT02839746|11282824|FG000|STARTED|Overall Study||671
10152043|NCT02839746|11282824|FG000|COMPLETED|Overall Study||659
10152044|NCT02839746|11282824|FG000|NOT COMPLETED|Overall Study||12
10152045|NCT02839772|11282830|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
9709758|NCT04524598|10809175|FG003|COMPLETED|Phase II - Outcomes||67
9709759|NCT04524598|10809176|FG004|COMPLETED|Phase II - Outcomes||0
9709760|NCT04524598|10809172|FG000|NOT COMPLETED|Phase II - Outcomes||0
9709761|NCT04524598|10809173|FG001|NOT COMPLETED|Phase II - Outcomes||0
9709762|NCT04524598|10809174|FG002|NOT COMPLETED|Phase II - Outcomes||26
9709763|NCT04524598|10809175|FG003|NOT COMPLETED|Phase II - Outcomes||13
9709764|NCT04524598|10809176|FG004|NOT COMPLETED|Phase II - Outcomes||0
9709765|NCT04524598|10809172|FG000|STARTED|Phase II - Control Extension||0
9709766|NCT04524598|10809173|FG001|STARTED|Phase II - Control Extension||0
9709767|NCT04524598|10809174|FG002|STARTED|Phase II - Control Extension||0
9709768|NCT04524598|10809175|FG003|STARTED|Phase II - Control Extension||0
9709769|NCT04524598|10809176|FG004|STARTED|Phase II - Control Extension||66
9709770|NCT04524598|10809172|FG000|COMPLETED|Phase II - Control Extension||0
9709771|NCT04524598|10809173|FG001|COMPLETED|Phase II - Control Extension||0
9709772|NCT04524598|10809174|FG002|COMPLETED|Phase II - Control Extension||0
9709773|NCT04524598|10809175|FG003|COMPLETED|Phase II - Control Extension||0
9709774|NCT04524598|10809176|FG004|COMPLETED|Phase II - Control Extension||54
9709775|NCT04524598|10809172|FG000|NOT COMPLETED|Phase II - Control Extension||0
9709776|NCT04524598|10809173|FG001|NOT COMPLETED|Phase II - Control Extension||0
9709777|NCT04524598|10809174|FG002|NOT COMPLETED|Phase II - Control Extension||0
9709778|NCT04524598|10809175|FG003|NOT COMPLETED|Phase II - Control Extension||0
9709779|NCT04524598|10809176|FG004|NOT COMPLETED|Phase II - Control Extension||12
9709780|NCT04334460|10809192|FG000|STARTED|Full Enrollment||81
9709781|NCT04334460|10809193|FG001|STARTED|Full Enrollment||39
9709782|NCT04334460|10809192|FG000|COMPLETED|Full Enrollment||81
9709783|NCT04334460|10809193|FG001|COMPLETED|Full Enrollment||39
9709784|NCT04334460|10809192|FG000|NOT COMPLETED|Full Enrollment||0
9709785|NCT04334460|10809193|FG001|NOT COMPLETED|Full Enrollment||0
9709786|NCT04334460|10809192|FG000|STARTED|Full Analysis Set (FAS)||81
9709787|NCT04334460|10809193|FG001|STARTED|Full Analysis Set (FAS)||39
9709788|NCT04334460|10809192|FG000|COMPLETED|Full Analysis Set (FAS)||77
9709789|NCT04334460|10809193|FG001|COMPLETED|Full Analysis Set (FAS)||38
9709790|NCT04334460|10809192|FG000|NOT COMPLETED|Full Analysis Set (FAS)||4
9709791|NCT04334460|10809193|FG001|NOT COMPLETED|Full Analysis Set (FAS)||1
9709792|NCT04334460|10809192|FG000|STARTED|Safety Analysis Population||81
9709793|NCT04334460|10809193|FG001|STARTED|Safety Analysis Population||39
9709794|NCT04334460|10809192|FG000|COMPLETED|Safety Analysis Population||77
9709795|NCT04334460|10809193|FG001|COMPLETED|Safety Analysis Population||38
9709796|NCT04334460|10809192|FG000|NOT COMPLETED|Safety Analysis Population||4
9709797|NCT04334460|10809193|FG001|NOT COMPLETED|Safety Analysis Population||1
9729755|NCT00121199|10829396|FG000|Eligible|Overall Study||64
9729756|NCT00121199|10829396|FG000|Eligible and Began Protocol Therapy|Overall Study||64
9729757|NCT00121199|10829396|FG000|COMPLETED|Overall Study||45
9729758|NCT00121199|10829396|FG000|NOT COMPLETED|Overall Study||28
9729759|NCT00121225|10829400|FG000|STARTED|Overall Study||32
9729760|NCT00121225|10829400|FG000|COMPLETED|Overall Study||32
9729761|NCT00121225|10829400|FG000|NOT COMPLETED|Overall Study||0
10152046|NCT02839772|11282831|FG001|STARTED|Overall Study||96
10152047|NCT02839772|11282830|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
10152048|NCT02839772|11282831|FG001|COMPLETED|Overall Study||96
10152049|NCT02839772|11282830|FG000|NOT COMPLETED|Overall Study||1
10152050|NCT02839772|11282831|FG001|NOT COMPLETED|Overall Study||0
10152051|NCT02839798|11282851|FG000|STARTED|Overall Study||6
10152052|NCT02839798|11282851|FG000|COMPLETED|Overall Study||4
10152053|NCT02839798|11282851|FG000|NOT COMPLETED|Overall Study||2
10152054|NCT02839876|11282857|FG000|STARTED|Overall Study||41
10152055|NCT02839876|11282858|FG001|STARTED|Overall Study||40
10152056|NCT02839876|11282857|FG000|COMPLETED|Overall Study||31
10152057|NCT02839876|11282858|FG001|COMPLETED|Overall Study||29
10152058|NCT02839876|11282857|FG000|NOT COMPLETED|Overall Study||10
10152059|NCT02839876|11282858|FG001|NOT COMPLETED|Overall Study||11
10152060|NCT02839889|11282866|FG000|STARTED|Randomization Period||2
10152061|NCT02839889|11282867|FG001|STARTED|Randomization Period||3
10152062|NCT02839889|11282866|FG000|COMPLETED|Randomization Period||2
10152063|NCT02839889|11282867|FG001|COMPLETED|Randomization Period||3
10152064|NCT02839889|11282866|FG000|NOT COMPLETED|Randomization Period||0
10152065|NCT02839889|11282867|FG001|NOT COMPLETED|Randomization Period||0
10152066|NCT02839889|11282866|FG000|STARTED|Open-Label Period||0
10152067|NCT02839889|11282867|FG001|STARTED|Open-Label Period||5
10152068|NCT02839889|11282866|FG000|COMPLETED|Open-Label Period||0
10152069|NCT02839889|11282867|FG001|COMPLETED|Open-Label Period||4
10152070|NCT02839889|11282866|FG000|NOT COMPLETED|Open-Label Period||0
10152071|NCT02839889|11282867|FG001|NOT COMPLETED|Open-Label Period||1
10152072|NCT02839902|11282875|FG000|STARTED|Overall Study||24
10152073|NCT02839902|11282876|FG001|STARTED|Overall Study||29
10152074|NCT02839902|11282875|FG000|COMPLETED|Overall Study||24
10152075|NCT02839902|11282876|FG001|COMPLETED|Overall Study||29
10152076|NCT02839902|11282875|FG000|NOT COMPLETED|Overall Study||0
10152077|NCT02839902|11282876|FG001|NOT COMPLETED|Overall Study||0
10152078|NCT02840097|11282885|FG000|STARTED|Overall Study||9
10152079|NCT02840097|11282886|FG001|STARTED|Overall Study||10
10152080|NCT02840097|11282887|FG002|STARTED|Overall Study||12
10152081|NCT02840097|11282885|FG000|COMPLETED|Overall Study||9
10152082|NCT02840097|11282886|FG001|COMPLETED|Overall Study||10
10152083|NCT02840097|11282887|FG002|COMPLETED|Overall Study||12
10152084|NCT02840097|11282885|FG000|NOT COMPLETED|Overall Study||0
9709798|NCT04247828|10809200|FG000|STARTED|Overall Study||30
9709799|NCT04247828|10809200|FG000|Started - Controls|Overall Study||19
9709800|NCT04247828|10809200|FG000|Started - Participants With SPI|Overall Study||11
9709801|NCT04247828|10809200|FG000|COMPLETED|Overall Study|16 controls and 5 participants with SPI completed the study|21
9709802|NCT04247828|10809200|FG000|NOT COMPLETED|Overall Study||9
9709803|NCT04084769|10809208|FG000|STARTED|Overall Study||191
9709804|NCT04084769|10809209|FG001|STARTED|Overall Study||190
9709805|NCT04084769|10809210|FG002|STARTED|Overall Study||95
9709806|NCT04084769|10809211|FG003|STARTED|Overall Study||94
9709807|NCT04084769|10809208|FG000|Safety Analysis Set (SAfAS)|Overall Study||186
9709808|NCT04084769|10809209|FG001|Safety Analysis Set (SAfAS)|Overall Study||184
9709809|NCT04084769|10809210|FG002|Safety Analysis Set (SAfAS)|Overall Study||93
9709810|NCT04084769|10809211|FG003|Safety Analysis Set (SAfAS)|Overall Study||92
9709811|NCT04084769|10809208|FG000|Full Analysis Set|Overall Study||191
9709812|NCT04084769|10809209|FG001|Full Analysis Set|Overall Study||190
9709813|NCT04084769|10809210|FG002|Full Analysis Set|Overall Study||95
9709814|NCT04084769|10809211|FG003|Full Analysis Set|Overall Study||94
9709815|NCT04084769|10809208|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
9709816|NCT04084769|10809209|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
9709817|NCT04084769|10809210|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
9709818|NCT04084769|10809211|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
9709819|NCT04084769|10809208|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
9709820|NCT04084769|10809209|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
9709821|NCT04084769|10809210|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
9709822|NCT04084769|10809211|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
9709823|NCT04084769|10809208|FG000|COMPLETED|Overall Study||187
9709824|NCT04084769|10809209|FG001|COMPLETED|Overall Study||186
9709825|NCT04084769|10809210|FG002|COMPLETED|Overall Study||95
9709826|NCT04084769|10809211|FG003|COMPLETED|Overall Study||92
9709827|NCT04084769|10809208|FG000|NOT COMPLETED|Overall Study||4
9709828|NCT04084769|10809209|FG001|NOT COMPLETED|Overall Study||4
9709829|NCT04084769|10809210|FG002|NOT COMPLETED|Overall Study||0
9709830|NCT04084769|10809211|FG003|NOT COMPLETED|Overall Study||2
9709831|NCT04024228|10809228|FG000|STARTED|Overall Study||774
9709832|NCT04024228|10809229|FG001|STARTED|Overall Study||765
9709833|NCT04024228|10809228|FG000|Vaccinated|Overall Study||772
9709834|NCT04024228|10809229|FG001|Vaccinated|Overall Study||761
10152085|NCT02840097|11282886|FG001|NOT COMPLETED|Overall Study||0
10152086|NCT02840097|11282887|FG002|NOT COMPLETED|Overall Study||0
10152087|NCT02840253|11282898|FG000|STARTED|Overall Study||23
10152088|NCT02840253|11282898|FG000|COMPLETED|Overall Study||19
10152089|NCT02840253|11282898|FG000|NOT COMPLETED|Overall Study||4
10152090|NCT02840461|11282905|FG000|STARTED|Overall Study||259
10152091|NCT02840461|11282906|FG001|STARTED|Overall Study||257
10152092|NCT02840461|11282907|FG002|STARTED|Overall Study||114
10152093|NCT02840461|11282905|FG000|COMPLETED|Overall Study||236
10152094|NCT02840461|11282906|FG001|COMPLETED|Overall Study||235
10152095|NCT02840461|11282907|FG002|COMPLETED|Overall Study||100
10152096|NCT02840461|11282905|FG000|NOT COMPLETED|Overall Study||23
9709835|NCT04024228|10809228|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
10152097|NCT02840461|11282906|FG001|NOT COMPLETED|Overall Study||22
10152098|NCT02840461|11282907|FG002|NOT COMPLETED|Overall Study||14
10152099|NCT02840474|11282918|FG000|STARTED|Overall Study||7
10152100|NCT02840474|11282919|FG001|STARTED|Overall Study||9
10152101|NCT02840474|11282918|FG000|Received Study Product|Overall Study||7
10152102|NCT02840474|11282919|FG001|Received Study Product|Overall Study||9
10152103|NCT02840474|11282918|FG000|COMPLETED|Overall Study||6
10152104|NCT02840474|11282919|FG001|COMPLETED|Overall Study||9
10152105|NCT02840474|11282918|FG000|NOT COMPLETED|Overall Study||1
10152106|NCT02840474|11282919|FG001|NOT COMPLETED|Overall Study||0
10152107|NCT02840721|11282925|FG000|STARTED|Treatment Period||50
10152108|NCT02840721|11282925|FG000|COMPLETED|Treatment Period||49
10152109|NCT02840721|11282925|FG000|NOT COMPLETED|Treatment Period||1
10152110|NCT02840721|11282925|FG000|STARTED|Follow-Up||49
10152111|NCT02840721|11282925|FG000|COMPLETED|Follow-Up||42
10152112|NCT02840721|11282925|FG000|NOT COMPLETED|Follow-Up||7
10152113|NCT02840916|11282931|FG000|STARTED|Overall Study||33
10152114|NCT02840916|11282932|FG001|STARTED|Overall Study||33
10152115|NCT02840916|11282931|FG000|COMPLETED|Overall Study||32
10152116|NCT02840916|11282932|FG001|COMPLETED|Overall Study||30
10152117|NCT02840916|11282931|FG000|NOT COMPLETED|Overall Study||1
10152118|NCT02840916|11282932|FG001|NOT COMPLETED|Overall Study||3
10152119|NCT02841033|11282938|FG000|STARTED|Overall Study||22
10152120|NCT02841033|11282938|FG000|COMPLETED|Overall Study||22
10152121|NCT02841033|11282938|FG000|NOT COMPLETED|Overall Study||0
10152122|NCT02841046|11282944|FG000|STARTED|Overall Study||25
10152123|NCT02841046|11282945|FG001|STARTED|Overall Study||25
10152124|NCT02841046|11282944|FG000|COMPLETED|Overall Study||25
10152125|NCT02841046|11282945|FG001|COMPLETED|Overall Study||25
10152126|NCT02841046|11282944|FG000|NOT COMPLETED|Overall Study||0
10152127|NCT02841046|11282945|FG001|NOT COMPLETED|Overall Study||0
10152128|NCT02841189|11282951|FG000|STARTED|Overall Study||100
10152129|NCT02841189|11282951|FG000|COMPLETED|Overall Study||65
10152130|NCT02841189|11282951|FG000|NOT COMPLETED|Overall Study||35
10152131|NCT02841241|11282955|FG000|STARTED|Overall Study||7
10152132|NCT02841241|11282955|FG000|COMPLETED|Overall Study||7
10152133|NCT02841241|11282955|FG000|NOT COMPLETED|Overall Study||0
10152134|NCT02841267|11282962|FG000|STARTED|Lead-in (Untreated)||4
10152135|NCT02841267|11282963|FG001|STARTED|Lead-in (Untreated)||7
10152136|NCT02841267|11282964|FG002|STARTED|Lead-in (Untreated)||8
10152137|NCT02841267|11282962|FG000|COMPLETED|Lead-in (Untreated)||4
10152138|NCT02841267|11282963|FG001|COMPLETED|Lead-in (Untreated)||7
10152139|NCT02841267|11282964|FG002|COMPLETED|Lead-in (Untreated)||8
10152140|NCT02841267|11282962|FG000|NOT COMPLETED|Lead-in (Untreated)||0
10152141|NCT02841267|11282963|FG001|NOT COMPLETED|Lead-in (Untreated)||0
10152142|NCT02841267|11282964|FG002|NOT COMPLETED|Lead-in (Untreated)||0
10152143|NCT02841267|11282962|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
10152144|NCT02841267|11282963|FG001|STARTED|Treatment Period||7
10152145|NCT02841267|11282964|FG002|STARTED|Treatment Period||8
10152146|NCT02841267|11282962|FG000|COMPLETED|Treatment Period||4
10152147|NCT02841267|11282963|FG001|COMPLETED|Treatment Period||7
10152148|NCT02841267|11282964|FG002|COMPLETED|Treatment Period||8
10152149|NCT02841267|11282962|FG000|NOT COMPLETED|Treatment Period||0
10152150|NCT02841267|11282963|FG001|NOT COMPLETED|Treatment Period||0
10152151|NCT02841267|11282964|FG002|NOT COMPLETED|Treatment Period||0
10152152|NCT02841267|11282962|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
10152153|NCT02841267|11282963|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
10152154|NCT02841267|11282964|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
10152155|NCT02841267|11282962|FG000|COMPLETED|Extension Study||4
10152156|NCT02841267|11282963|FG001|COMPLETED|Extension Study||6
10152157|NCT02841267|11282964|FG002|COMPLETED|Extension Study||6
9849049|NCT00862849|10961757|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
9849050|NCT00862849|10961752|FG000|STARTED|Intervention 5||3
9849051|NCT00862849|10961753|FG001|STARTED|Intervention 5||3
10152158|NCT02841267|11282962|FG000|NOT COMPLETED|Extension Study||0
10152159|NCT02841267|11282963|FG001|NOT COMPLETED|Extension Study||0
10152160|NCT02841267|11282964|FG002|NOT COMPLETED|Extension Study||0
10152161|NCT02841397|11282980|FG000|STARTED|Overall Study||50
10152162|NCT02841397|11282980|FG000|COMPLETED|Overall Study||48
10152163|NCT02841397|11282980|FG000|NOT COMPLETED|Overall Study||2
10152164|NCT02841449|11282986|FG000|STARTED|Overall Study||7
10152165|NCT02841449|11282987|FG001|STARTED|Overall Study||9
10152166|NCT02841449|11282986|FG000|COMPLETED|Overall Study||7
10152167|NCT02841449|11282987|FG001|COMPLETED|Overall Study||9
10152168|NCT02841449|11282986|FG000|NOT COMPLETED|Overall Study||0
10152169|NCT02841449|11282987|FG001|NOT COMPLETED|Overall Study||0
10152170|NCT02841709|11282993|FG000|STARTED|1st Intervention||12
10152171|NCT02841709|11282994|FG001|STARTED|1st Intervention||11
10152172|NCT02841709|11282995|FG002|STARTED|1st Intervention||12
10152173|NCT02841709|11282996|FG003|STARTED|1st Intervention||12
10152174|NCT02841709|11282997|FG004|STARTED|1st Intervention||11
10152175|NCT02841709|11282993|FG000|COMPLETED|1st Intervention||12
10152176|NCT02841709|11282994|FG001|COMPLETED|1st Intervention||11
10152177|NCT02841709|11282995|FG002|COMPLETED|1st Intervention||12
10152178|NCT02841709|11282996|FG003|COMPLETED|1st Intervention||12
10152179|NCT02841709|11282997|FG004|COMPLETED|1st Intervention||11
10152180|NCT02841709|11282993|FG000|NOT COMPLETED|1st Intervention||0
10152181|NCT02841709|11282994|FG001|NOT COMPLETED|1st Intervention||0
10152182|NCT02841709|11282995|FG002|NOT COMPLETED|1st Intervention||0
10152183|NCT02841709|11282996|FG003|NOT COMPLETED|1st Intervention||0
10152184|NCT02841709|11282997|FG004|NOT COMPLETED|1st Intervention||0
10152185|NCT02841709|11282993|FG000|STARTED|Washout Period 1||12
10152186|NCT02841709|11282994|FG001|STARTED|Washout Period 1||11
10152187|NCT02841709|11282995|FG002|STARTED|Washout Period 1||12
10152188|NCT02841709|11282996|FG003|STARTED|Washout Period 1||12
10152189|NCT02841709|11282997|FG004|STARTED|Washout Period 1||11
10152190|NCT02841709|11282993|FG000|COMPLETED|Washout Period 1||12
10152191|NCT02841709|11282994|FG001|COMPLETED|Washout Period 1||11
10152192|NCT02841709|11282995|FG002|COMPLETED|Washout Period 1||12
10152193|NCT02841709|11282996|FG003|COMPLETED|Washout Period 1||12
10152194|NCT02841709|11282997|FG004|COMPLETED|Washout Period 1||11
10152195|NCT02841709|11282993|FG000|NOT COMPLETED|Washout Period 1||0
10152196|NCT02841709|11282994|FG001|NOT COMPLETED|Washout Period 1||0
10152197|NCT02841709|11282995|FG002|NOT COMPLETED|Washout Period 1||0
10152198|NCT02841709|11282996|FG003|NOT COMPLETED|Washout Period 1||0
10152199|NCT02841709|11282997|FG004|NOT COMPLETED|Washout Period 1||0
10152200|NCT02841709|11282993|FG000|STARTED|2nd Intervention||12
10152201|NCT02841709|11282994|FG001|STARTED|2nd Intervention||11
10152202|NCT02841709|11282995|FG002|STARTED|2nd Intervention||12
10152203|NCT02841709|11282996|FG003|STARTED|2nd Intervention||12
10152204|NCT02841709|11282997|FG004|STARTED|2nd Intervention||11
10152205|NCT02841709|11282993|FG000|COMPLETED|2nd Intervention||12
10152206|NCT02841709|11282994|FG001|COMPLETED|2nd Intervention||11
10152207|NCT02841709|11282995|FG002|COMPLETED|2nd Intervention||12
10152208|NCT02841709|11282996|FG003|COMPLETED|2nd Intervention||12
10152209|NCT02841709|11282997|FG004|COMPLETED|2nd Intervention||11
10152210|NCT02841709|11282993|FG000|NOT COMPLETED|2nd Intervention||0
10152211|NCT02841709|11282994|FG001|NOT COMPLETED|2nd Intervention||0
10152212|NCT02841709|11282995|FG002|NOT COMPLETED|2nd Intervention||0
10152213|NCT02841709|11282996|FG003|NOT COMPLETED|2nd Intervention||0
10152214|NCT02841709|11282997|FG004|NOT COMPLETED|2nd Intervention||0
10152215|NCT02841709|11282993|FG000|STARTED|Washout Period 2||12
10152216|NCT02841709|11282994|FG001|STARTED|Washout Period 2||11
10152217|NCT02841709|11282995|FG002|STARTED|Washout Period 2||12
10152218|NCT02841709|11282996|FG003|STARTED|Washout Period 2||12
10152219|NCT02841709|11282997|FG004|STARTED|Washout Period 2||11
10152220|NCT02841709|11282993|FG000|COMPLETED|Washout Period 2||12
10152221|NCT02841709|11282994|FG001|COMPLETED|Washout Period 2||11
10152222|NCT02841709|11282995|FG002|COMPLETED|Washout Period 2||12
10152223|NCT02841709|11282996|FG003|COMPLETED|Washout Period 2||12
10152224|NCT02841709|11282997|FG004|COMPLETED|Washout Period 2||11
10152225|NCT02841709|11282993|FG000|NOT COMPLETED|Washout Period 2||0
10152226|NCT02841709|11282994|FG001|NOT COMPLETED|Washout Period 2||0
10152227|NCT02841709|11282995|FG002|NOT COMPLETED|Washout Period 2||0
10152228|NCT02841709|11282996|FG003|NOT COMPLETED|Washout Period 2||0
10152229|NCT02841709|11282997|FG004|NOT COMPLETED|Washout Period 2||0
10152230|NCT02841709|11282993|FG000|STARTED|3rd Intervention||12
10152231|NCT02841709|11282994|FG001|STARTED|3rd Intervention||11
10152232|NCT02841709|11282995|FG002|STARTED|3rd Intervention||12
10152233|NCT02841709|11282996|FG003|STARTED|3rd Intervention||12
10152234|NCT02841709|11282997|FG004|STARTED|3rd Intervention||11
10152235|NCT02841709|11282993|FG000|COMPLETED|3rd Intervention||12
10152236|NCT02841709|11282994|FG001|COMPLETED|3rd Intervention||11
10152237|NCT02841709|11282995|FG002|COMPLETED|3rd Intervention||12
10152238|NCT02841709|11282996|FG003|COMPLETED|3rd Intervention||12
10152239|NCT02841709|11282997|FG004|COMPLETED|3rd Intervention||11
10152240|NCT02841709|11282993|FG000|NOT COMPLETED|3rd Intervention||0
10152241|NCT02841709|11282994|FG001|NOT COMPLETED|3rd Intervention||0
10152242|NCT02841709|11282995|FG002|NOT COMPLETED|3rd Intervention||0
10152243|NCT02841709|11282996|FG003|NOT COMPLETED|3rd Intervention||0
10152244|NCT02841709|11282997|FG004|NOT COMPLETED|3rd Intervention||0
10152245|NCT02841709|11282993|FG000|STARTED|Washout Period 3||12
10152246|NCT02841709|11282994|FG001|STARTED|Washout Period 3||11
10152247|NCT02841709|11282995|FG002|STARTED|Washout Period 3||12
10152248|NCT02841709|11282996|FG003|STARTED|Washout Period 3||12
10152249|NCT02841709|11282997|FG004|STARTED|Washout Period 3||11
10152250|NCT02841709|11282993|FG000|COMPLETED|Washout Period 3||12
10152251|NCT02841709|11282994|FG001|COMPLETED|Washout Period 3||11
10152252|NCT02841709|11282995|FG002|COMPLETED|Washout Period 3||12
10152253|NCT02841709|11282996|FG003|COMPLETED|Washout Period 3||12
10152254|NCT02841709|11282997|FG004|COMPLETED|Washout Period 3||11
10152255|NCT02841709|11282993|FG000|NOT COMPLETED|Washout Period 3||0
10152256|NCT02841709|11282994|FG001|NOT COMPLETED|Washout Period 3||0
10152257|NCT02841709|11282995|FG002|NOT COMPLETED|Washout Period 3||0
10152258|NCT02841709|11282996|FG003|NOT COMPLETED|Washout Period 3||0
10152259|NCT02841709|11282997|FG004|NOT COMPLETED|Washout Period 3||0
10152260|NCT02841709|11282993|FG000|STARTED|4th Intervention||12
10152261|NCT02841709|11282994|FG001|STARTED|4th Intervention||11
10152262|NCT02841709|11282995|FG002|STARTED|4th Intervention||12
10152263|NCT02841709|11282996|FG003|STARTED|4th Intervention||12
10152264|NCT02841709|11282997|FG004|STARTED|4th Intervention||11
10152265|NCT02841709|11282993|FG000|COMPLETED|4th Intervention||12
10152266|NCT02841709|11282994|FG001|COMPLETED|4th Intervention||11
10152267|NCT02841709|11282995|FG002|COMPLETED|4th Intervention||12
10152268|NCT02841709|11282996|FG003|COMPLETED|4th Intervention||12
10152269|NCT02841709|11282997|FG004|COMPLETED|4th Intervention||11
10152270|NCT02841709|11282993|FG000|NOT COMPLETED|4th Intervention||0
10152271|NCT02841709|11282994|FG001|NOT COMPLETED|4th Intervention||0
10152272|NCT02841709|11282995|FG002|NOT COMPLETED|4th Intervention||0
10152273|NCT02841709|11282996|FG003|NOT COMPLETED|4th Intervention||0
10152274|NCT02841709|11282997|FG004|NOT COMPLETED|4th Intervention||0
10152275|NCT02841709|11282993|FG000|STARTED|Washout Period 4||12
10152276|NCT02841709|11282994|FG001|STARTED|Washout Period 4||11
10152277|NCT02841709|11282995|FG002|STARTED|Washout Period 4||12
10152278|NCT02841709|11282996|FG003|STARTED|Washout Period 4||12
10152279|NCT02841709|11282997|FG004|STARTED|Washout Period 4||11
10152280|NCT02841709|11282993|FG000|COMPLETED|Washout Period 4||12
10152281|NCT02841709|11282994|FG001|COMPLETED|Washout Period 4||11
10152282|NCT02841709|11282995|FG002|COMPLETED|Washout Period 4||12
10152283|NCT02841709|11282996|FG003|COMPLETED|Washout Period 4||12
10152284|NCT02841709|11282997|FG004|COMPLETED|Washout Period 4||11
10152285|NCT02841709|11282993|FG000|NOT COMPLETED|Washout Period 4||0
10152286|NCT02841709|11282994|FG001|NOT COMPLETED|Washout Period 4||0
10152287|NCT02841709|11282995|FG002|NOT COMPLETED|Washout Period 4||0
10152288|NCT02841709|11282996|FG003|NOT COMPLETED|Washout Period 4||0
10152289|NCT02841709|11282997|FG004|NOT COMPLETED|Washout Period 4||0
10152290|NCT02841709|11282993|FG000|STARTED|5th Intervention||12
10152291|NCT02841709|11282994|FG001|STARTED|5th Intervention||11
10152292|NCT02841709|11282995|FG002|STARTED|5th Intervention||12
10152293|NCT02841709|11282996|FG003|STARTED|5th Intervention||12
10152294|NCT02841709|11282997|FG004|STARTED|5th Intervention||11
10152295|NCT02841709|11282993|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
10152296|NCT02841709|11282994|FG001|COMPLETED|5th Intervention||11
10152297|NCT02841709|11282995|FG002|COMPLETED|5th Intervention||12
10152298|NCT02841709|11282996|FG003|COMPLETED|5th Intervention||12
10152299|NCT02841709|11282997|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
10152300|NCT02841709|11282993|FG000|NOT COMPLETED|5th Intervention||2
10152301|NCT02841709|11282994|FG001|NOT COMPLETED|5th Intervention||0
10152302|NCT02841709|11282995|FG002|NOT COMPLETED|5th Intervention||0
10152303|NCT02841709|11282996|FG003|NOT COMPLETED|5th Intervention||0
10152304|NCT02841709|11282997|FG004|NOT COMPLETED|5th Intervention||2
10152305|NCT02841787|11283013|FG000|STARTED|Overall Study||12
10152306|NCT02841787|11283014|FG001|STARTED|Overall Study||23
10152307|NCT02841787|11283015|FG002|STARTED|Overall Study||12
10152308|NCT02841787|11283013|FG000|COMPLETED|Overall Study||9
10152309|NCT02841787|11283014|FG001|COMPLETED|Overall Study||19
10152310|NCT02841787|11283015|FG002|COMPLETED|Overall Study||12
10152311|NCT02841787|11283013|FG000|NOT COMPLETED|Overall Study||3
10152312|NCT02841787|11283014|FG001|NOT COMPLETED|Overall Study||4
10152313|NCT02841787|11283015|FG002|NOT COMPLETED|Overall Study||0
10152314|NCT02842060|11283025|FG000|STARTED|Overall Study||120
10152315|NCT02842060|11283026|FG001|STARTED|Overall Study||60
10152316|NCT02842060|11283025|FG000|COMPLETED|Overall Study||120
10152317|NCT02842060|11283026|FG001|COMPLETED|Overall Study||60
10152318|NCT02842060|11283025|FG000|NOT COMPLETED|Overall Study||0
10152319|NCT02842060|11283026|FG001|NOT COMPLETED|Overall Study||0
10152320|NCT02842073|11283032|FG000|STARTED|Overall Study||12
10152321|NCT02842073|11283032|FG000|COMPLETED|Overall Study||11
10152322|NCT02842073|11283032|FG000|NOT COMPLETED|Overall Study||1
10152323|NCT02842086|11283038|FG000|STARTED|Overall Study||2700
10152324|NCT02842086|11283039|FG001|STARTED|Overall Study||2699
10152325|NCT02842086|11283038|FG000|COMPLETED|Overall Study||2156
10152326|NCT02842086|11283039|FG001|COMPLETED|Overall Study||2206
10152327|NCT02842086|11283038|FG000|NOT COMPLETED|Overall Study||544
10152328|NCT02842086|11283039|FG001|NOT COMPLETED|Overall Study||493
10152329|NCT02842151|11283045|FG000|STARTED|Overall Study||150
10152330|NCT02842151|11283045|FG000|COMPLETED|Overall Study||148
10152331|NCT02842151|11283045|FG000|NOT COMPLETED|Overall Study||2
10152332|NCT02842242|11283053|FG000|STARTED|Overall Study||11
10152333|NCT02842242|11283054|FG001|STARTED|Overall Study||10
10152334|NCT02842242|11283053|FG000|COMPLETED|Overall Study||10
10152335|NCT02842242|11283054|FG001|COMPLETED|Overall Study||10
10152336|NCT02842242|11283053|FG000|NOT COMPLETED|Overall Study||1
10152337|NCT02842242|11283054|FG001|NOT COMPLETED|Overall Study||0
10152338|NCT02842736|11283060|FG000|STARTED|Overall Study|Treated|242
10152339|NCT02842736|11283060|FG000|Known Month 12 Outcome|Overall Study||230
10152340|NCT02842736|11283060|FG000|24 Month Visit Performed|Overall Study||210
10152341|NCT02842736|11283060|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201
10152342|NCT02842736|11283060|FG000|NOT COMPLETED|Overall Study||41
10152343|NCT02843178|11283068|FG000|STARTED|Overall Study||86
10152344|NCT02843178|11283069|FG001|STARTED|Overall Study||90
10152345|NCT02843178|11283070|FG002|STARTED|Overall Study||92
9709836|NCT04024228|10809229|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
10152346|NCT02843178|11283071|FG003|STARTED|Overall Study||91
10152347|NCT02843178|11283068|FG000|COMPLETED|Overall Study||78
10152348|NCT02843178|11283069|FG001|COMPLETED|Overall Study||82
10152349|NCT02843178|11283070|FG002|COMPLETED|Overall Study||85
10152350|NCT02843178|11283071|FG003|COMPLETED|Overall Study||87
10152351|NCT02843178|11283068|FG000|NOT COMPLETED|Overall Study||8
10152352|NCT02843178|11283069|FG001|NOT COMPLETED|Overall Study||8
10152353|NCT02843178|11283070|FG002|NOT COMPLETED|Overall Study||7
10152354|NCT02843178|11283071|FG003|NOT COMPLETED|Overall Study||4
10152355|NCT02843529|11283083|FG000|STARTED|Overall Study||244
10152356|NCT02843529|11283084|FG001|STARTED|Overall Study||304
10152357|NCT02843529|11283083|FG000|COMPLETED|Overall Study||213
10152358|NCT02843529|11283084|FG001|COMPLETED|Overall Study||283
10152359|NCT02843529|11283083|FG000|NOT COMPLETED|Overall Study||31
10152360|NCT02843529|11283084|FG001|NOT COMPLETED|Overall Study||21
10152361|NCT02843659|11283093|FG000|STARTED|Overall Study||5
10152362|NCT02843659|11283094|FG001|STARTED|Overall Study||6
10152363|NCT02843659|11283095|FG002|STARTED|Overall Study||7
10152364|NCT02843659|11283093|FG000|COMPLETED|Overall Study||1
10152365|NCT02843659|11283094|FG001|COMPLETED|Overall Study||0
10152366|NCT02843659|11283095|FG002|COMPLETED|Overall Study||2
10152367|NCT02843659|11283093|FG000|NOT COMPLETED|Overall Study||4
10152368|NCT02843659|11283094|FG001|NOT COMPLETED|Overall Study||6
10152369|NCT02843659|11283095|FG002|NOT COMPLETED|Overall Study||5
10152370|NCT02844439|11283103|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40
10152371|NCT02844439|11283103|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24
10152372|NCT02844439|11283103|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11
10152373|NCT02844439|11283103|FG000|COMPLETED|Overall Study||0
10152374|NCT02844439|11283103|FG000|NOT COMPLETED|Overall Study||40
10152375|NCT02844543|11283114|FG000|STARTED|Overall Study||155
10152376|NCT02844543|11283114|FG000|COMPLETED|Overall Study||150
10152377|NCT02844543|11283114|FG000|NOT COMPLETED|Overall Study||5
10152378|NCT02844569|11283120|FG000|STARTED|Overall Study||12
10152379|NCT02844569|11283121|FG001|STARTED|Overall Study||12
10152380|NCT02844569|11283120|FG000|COMPLETED|Overall Study||12
10152381|NCT02844569|11283121|FG001|COMPLETED|Overall Study||12
10152382|NCT02844569|11283120|FG000|NOT COMPLETED|Overall Study||0
10152383|NCT02844569|11283121|FG001|NOT COMPLETED|Overall Study||0
10152384|NCT02844582|11283127|FG000|STARTED|Overall Study||2
10152385|NCT02844582|11283127|FG000|COMPLETED|Overall Study||2
10152386|NCT02844582|11283127|FG000|NOT COMPLETED|Overall Study||0
10152387|NCT02844920|11283131|FG000|STARTED|Overall Study||37
10152388|NCT02844920|11283131|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
10152389|NCT02844920|11283131|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
10152390|NCT02844920|11283131|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
10152391|NCT02844920|11283131|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35
10152392|NCT02844920|11283131|FG000|NOT COMPLETED|Overall Study||2
10152393|NCT02844998|11283138|FG000|STARTED|Overall Study||42
10152394|NCT02844998|11283139|FG001|STARTED|Overall Study||39
10152395|NCT02844998|11283140|FG002|STARTED|Overall Study||39
10152396|NCT02844998|11283138|FG000|COMPLETED|Overall Study||35
10152397|NCT02844998|11283139|FG001|COMPLETED|Overall Study||35
10152398|NCT02844998|11283140|FG002|COMPLETED|Overall Study||35
10152399|NCT02844998|11283138|FG000|NOT COMPLETED|Overall Study||7
10152400|NCT02844998|11283139|FG001|NOT COMPLETED|Overall Study||4
10152401|NCT02844998|11283140|FG002|NOT COMPLETED|Overall Study||4
10152402|NCT02845336|11283150|FG000|STARTED|Overall Study||6
10152403|NCT02845336|11283151|FG001|STARTED|Overall Study||1
10152404|NCT02845336|11283150|FG000|COMPLETED|Overall Study||1
10152405|NCT02845336|11283151|FG001|COMPLETED|Overall Study||0
10152406|NCT02845336|11283150|FG000|NOT COMPLETED|Overall Study||5
10152407|NCT02845336|11283151|FG001|NOT COMPLETED|Overall Study||1
10152408|NCT02845375|11283160|FG000|STARTED|Overall Study||13
10152409|NCT02845375|11283161|FG001|STARTED|Overall Study||14
10152410|NCT02845375|11283162|FG002|STARTED|Overall Study||13
10152411|NCT02845375|11283160|FG000|COMPLETED|Overall Study||12
10152412|NCT02845375|11283161|FG001|COMPLETED|Overall Study||12
10152413|NCT02845375|11283162|FG002|COMPLETED|Overall Study||12
10152414|NCT02845375|11283160|FG000|NOT COMPLETED|Overall Study||1
10152415|NCT02845375|11283161|FG001|NOT COMPLETED|Overall Study||2
10152416|NCT02845375|11283162|FG002|NOT COMPLETED|Overall Study||1
10152417|NCT02845674|11283172|FG000|STARTED|Overall Study||129
10152418|NCT02845674|11283173|FG001|STARTED|Overall Study||129
10152419|NCT02845674|11283172|FG000|COMPLETED|Overall Study||111
10152420|NCT02845674|11283173|FG001|COMPLETED|Overall Study||79
10152421|NCT02845674|11283172|FG000|NOT COMPLETED|Overall Study||18
10152422|NCT02845674|11283173|FG001|NOT COMPLETED|Overall Study||50
10152423|NCT02845700|11283181|FG000|STARTED|Baseline Appointment||6
10152424|NCT02845700|11283182|FG001|STARTED|Baseline Appointment||7
10152425|NCT02845700|11283181|FG000|COMPLETED|Baseline Appointment||6
10152426|NCT02845700|11283182|FG001|COMPLETED|Baseline Appointment||7
10152427|NCT02845700|11283181|FG000|NOT COMPLETED|Baseline Appointment||0
10152428|NCT02845700|11283182|FG001|NOT COMPLETED|Baseline Appointment||0
10152429|NCT02845700|11283181|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
10152430|NCT02845700|11283182|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
10152431|NCT02845700|11283181|FG000|COMPLETED|Intervention Session 1||5
10152432|NCT02845700|11283182|FG001|COMPLETED|Intervention Session 1||6
10152433|NCT02845700|11283181|FG000|NOT COMPLETED|Intervention Session 1||0
10152434|NCT02845700|11283182|FG001|NOT COMPLETED|Intervention Session 1||0
10152435|NCT02845700|11283181|FG000|STARTED|Intervention Session 2||5
10152436|NCT02845700|11283182|FG001|STARTED|Intervention Session 2||6
10152437|NCT02845700|11283181|FG000|COMPLETED|Intervention Session 2||5
10152438|NCT02845700|11283182|FG001|COMPLETED|Intervention Session 2||6
10152439|NCT02845700|11283181|FG000|NOT COMPLETED|Intervention Session 2||0
10152440|NCT02845700|11283182|FG001|NOT COMPLETED|Intervention Session 2||0
10152441|NCT02845700|11283181|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
10152442|NCT02845700|11283182|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
10152443|NCT02845700|11283181|FG000|COMPLETED|Month 1 Follow-Up||2
10152444|NCT02845700|11283182|FG001|COMPLETED|Month 1 Follow-Up||4
10152445|NCT02845700|11283181|FG000|NOT COMPLETED|Month 1 Follow-Up||0
10152446|NCT02845700|11283182|FG001|NOT COMPLETED|Month 1 Follow-Up||0
10152447|NCT02845752|11283190|FG000|STARTED|First Intervention (7 Days)||7
10152448|NCT02845752|11283191|FG001|STARTED|First Intervention (7 Days)||7
9709837|NCT04024228|10809228|FG000|COMPLETED|Overall Study||770
9709838|NCT04024228|10809229|FG001|COMPLETED|Overall Study||759
9709839|NCT04024228|10809228|FG000|NOT COMPLETED|Overall Study||4
9709840|NCT04024228|10809229|FG001|NOT COMPLETED|Overall Study||6
9709841|NCT03996148|10809240|FG000|STARTED|Overall Study||7
9709842|NCT03996148|10809241|FG001|STARTED|Overall Study||7
9709843|NCT03996148|10809242|FG002|STARTED|Overall Study||7
9709844|NCT03996148|10809240|FG000|COMPLETED|Overall Study||7
9709845|NCT03996148|10809241|FG001|COMPLETED|Overall Study||6
9709846|NCT03996148|10809242|FG002|COMPLETED|Overall Study||7
9709847|NCT03996148|10809240|FG000|NOT COMPLETED|Overall Study||0
9709848|NCT03996148|10809241|FG001|NOT COMPLETED|Overall Study||1
9709849|NCT03996148|10809242|FG002|NOT COMPLETED|Overall Study||0
9709850|NCT03980938|10809252|FG000|STARTED|Treatment Period 1||7
9709851|NCT03980938|10809253|FG001|STARTED|Treatment Period 1||8
9709852|NCT03980938|10809252|FG000|COMPLETED|Treatment Period 1||6
9709853|NCT03980938|10809253|FG001|COMPLETED|Treatment Period 1||7
9709854|NCT03980938|10809252|FG000|NOT COMPLETED|Treatment Period 1||1
9709855|NCT03980938|10809253|FG001|NOT COMPLETED|Treatment Period 1||1
9709856|NCT03980938|10809252|FG000|STARTED|Treatment Period 2||3
9709857|NCT03980938|10809253|FG001|STARTED|Treatment Period 2||2
9709858|NCT03980938|10809252|FG000|COMPLETED|Treatment Period 2|One participant completed the study remotely. On-site visits were no longer permitted due to COVID-19 pandemic. Visits were conducted remotely for Weeks 8 and 10 of Treatment Period 2, and the follow-up visit.|1
9709859|NCT03980938|10809253|FG001|COMPLETED|Treatment Period 2||0
9709860|NCT03980938|10809252|FG000|NOT COMPLETED|Treatment Period 2||2
9709861|NCT03980938|10809253|FG001|NOT COMPLETED|Treatment Period 2||2
9729762|NCT00121238|10829405|FG000|STARTED|Overall Study||16
9729763|NCT00121238|10829405|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
9729764|NCT00121238|10829405|FG000|NOT COMPLETED|Overall Study||3
9729765|NCT00121251|10829409|FG000|STARTED|Overall Study||17
9729766|NCT00121251|10829409|FG000|COMPLETED|Overall Study||17
9729767|NCT00121251|10829409|FG000|NOT COMPLETED|Overall Study||0
9729777|NCT00121641|10829435|FG000|STARTED|24-week Short-term Treatment Period||102
9729778|NCT00121641|10829436|FG001|STARTED|24-week Short-term Treatment Period||106
9729779|NCT00121641|10829437|FG002|STARTED|24-week Short-term Treatment Period||98
9729780|NCT00121641|10829438|FG003|STARTED|24-week Short-term Treatment Period||95
9729781|NCT00121641|10829439|FG004|STARTED|24-week Short-term Treatment Period||66
9729782|NCT00121641|10829435|FG000|COMPLETED|24-week Short-term Treatment Period||73
9729783|NCT00121641|10829436|FG001|COMPLETED|24-week Short-term Treatment Period||68
9729784|NCT00121641|10829437|FG002|COMPLETED|24-week Short-term Treatment Period||69
9729785|NCT00121641|10829438|FG003|COMPLETED|24-week Short-term Treatment Period||55
9729786|NCT00121641|10829439|FG004|COMPLETED|24-week Short-term Treatment Period||25
9729787|NCT00121641|10829435|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29
9729788|NCT00121641|10829436|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38
9729789|NCT00121641|10829437|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29
9729790|NCT00121641|10829438|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40
10060903|NCT02100696|11186437|FG002|NOT COMPLETED|Induction Phase||26
10060904|NCT02100696|11186438|FG003|NOT COMPLETED|Induction Phase||0
10060905|NCT02100696|11186439|FG004|NOT COMPLETED|Induction Phase||0
10060906|NCT02100696|11186440|FG005|NOT COMPLETED|Induction Phase||0
10060907|NCT02100696|11186435|FG000|STARTED|Maintenance Phase||0
10060908|NCT02100696|11186436|FG001|STARTED|Maintenance Phase||0
10060909|NCT02100696|11186437|FG002|STARTED|Maintenance Phase||0
10060910|NCT02100696|11186438|FG003|STARTED|Maintenance Phase||27
10060911|NCT02100696|11186439|FG004|STARTED|Maintenance Phase||115
10060912|NCT02100696|11186440|FG005|STARTED|Maintenance Phase||117
10060913|NCT02100696|11186435|FG000|COMPLETED|Maintenance Phase||0
10060914|NCT02100696|11186436|FG001|COMPLETED|Maintenance Phase||0
10060915|NCT02100696|11186437|FG002|COMPLETED|Maintenance Phase||0
10060916|NCT02100696|11186438|FG003|COMPLETED|Maintenance Phase||26
10060917|NCT02100696|11186439|FG004|COMPLETED|Maintenance Phase||106
10060918|NCT02100696|11186440|FG005|COMPLETED|Maintenance Phase||112
9729791|NCT00121641|10829439|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41
9729792|NCT00121641|10829435|FG000|STARTED|48-month Short Term + Long Term Period||102
9729793|NCT00121641|10829436|FG001|STARTED|48-month Short Term + Long Term Period||106
9729794|NCT00121641|10829437|FG002|STARTED|48-month Short Term + Long Term Period||98
10060919|NCT02100696|11186435|FG000|NOT COMPLETED|Maintenance Phase||0
10060920|NCT02100696|11186436|FG001|NOT COMPLETED|Maintenance Phase||0
10060921|NCT02100696|11186437|FG002|NOT COMPLETED|Maintenance Phase||0
10152449|NCT02845752|11283190|FG000|COMPLETED|First Intervention (7 Days)||7
10152450|NCT02845752|11283191|FG001|COMPLETED|First Intervention (7 Days)||7
10152451|NCT02845752|11283190|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10152452|NCT02845752|11283191|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10152453|NCT02845752|11283190|FG000|STARTED|Washout (14 Days)||7
10152454|NCT02845752|11283191|FG001|STARTED|Washout (14 Days)||7
10152455|NCT02845752|11283190|FG000|COMPLETED|Washout (14 Days)||7
10152456|NCT02845752|11283191|FG001|COMPLETED|Washout (14 Days)||7
10152457|NCT02845752|11283190|FG000|NOT COMPLETED|Washout (14 Days)||0
10152458|NCT02845752|11283191|FG001|NOT COMPLETED|Washout (14 Days)||0
10152459|NCT02845752|11283190|FG000|STARTED|Second Intervention (7 Days)||7
10152460|NCT02845752|11283191|FG001|STARTED|Second Intervention (7 Days)||7
10152461|NCT02845752|11283190|FG000|COMPLETED|Second Intervention (7 Days)||7
10152462|NCT02845752|11283191|FG001|COMPLETED|Second Intervention (7 Days)||7
10152463|NCT02845752|11283190|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10152464|NCT02845752|11283191|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10152465|NCT02846233|11283199|FG000|STARTED|Overall Study||12
10152466|NCT02846233|11283200|FG001|STARTED|Overall Study||10
10152467|NCT02846233|11283199|FG000|COMPLETED|Overall Study||10
10152468|NCT02846233|11283200|FG001|COMPLETED|Overall Study||8
10152469|NCT02846233|11283199|FG000|NOT COMPLETED|Overall Study||2
10152470|NCT02846233|11283200|FG001|NOT COMPLETED|Overall Study||2
10152471|NCT02846324|11283210|FG000|STARTED|Overall Study||9
10152472|NCT02846324|11283211|FG001|STARTED|Overall Study||6
10152473|NCT02846324|11283212|FG002|STARTED|Overall Study||14
10152474|NCT02846324|11283213|FG003|STARTED|Overall Study||10
10152475|NCT02846324|11283210|FG000|Completed Study Treatment|Overall Study||7
10152476|NCT02846324|11283211|FG001|Completed Study Treatment|Overall Study||5
10152477|NCT02846324|11283212|FG002|Completed Study Treatment|Overall Study||11
10152478|NCT02846324|11283213|FG003|Completed Study Treatment|Overall Study||10
10152479|NCT02846324|11283210|FG000|COMPLETED|Overall Study||7
10152480|NCT02846324|11283211|FG001|COMPLETED|Overall Study||6
10152481|NCT02846324|11283212|FG002|COMPLETED|Overall Study||10
10152482|NCT02846324|11283213|FG003|COMPLETED|Overall Study||10
10152483|NCT02846324|11283210|FG000|NOT COMPLETED|Overall Study||2
10152484|NCT02846324|11283211|FG001|NOT COMPLETED|Overall Study||0
10152485|NCT02846324|11283212|FG002|NOT COMPLETED|Overall Study||4
10152486|NCT02846324|11283213|FG003|NOT COMPLETED|Overall Study||0
10152487|NCT02846415|11283234|FG000|STARTED|Overall Study||18
10152488|NCT02846415|11283235|FG001|STARTED|Overall Study||12
10152489|NCT02846415|11283234|FG000|COMPLETED|Overall Study||15
10152490|NCT02846415|11283235|FG001|COMPLETED|Overall Study||11
10152491|NCT02846415|11283234|FG000|NOT COMPLETED|Overall Study||3
10152492|NCT02846415|11283235|FG001|NOT COMPLETED|Overall Study||1
10152493|NCT02846558|11283245|FG000|STARTED|Overall Study||15
10152494|NCT02846558|11283246|FG001|STARTED|Overall Study||12
10152495|NCT02846558|11283247|FG002|STARTED|Overall Study||14
10152496|NCT02846558|11283248|FG003|STARTED|Overall Study||13
10152497|NCT02846558|11283245|FG000|Baseline Study Visit|Overall Study||10
10152498|NCT02846558|11283246|FG001|Baseline Study Visit|Overall Study||9
10152499|NCT02846558|11283247|FG002|Baseline Study Visit|Overall Study||14
10152500|NCT02846558|11283248|FG003|Baseline Study Visit|Overall Study||12
10152501|NCT02846558|11283245|FG000|3 Month Study Visit|Overall Study||7
10152502|NCT02846558|11283246|FG001|3 Month Study Visit|Overall Study||8
10152503|NCT02846558|11283247|FG002|3 Month Study Visit|Overall Study||12
10152504|NCT02846558|11283248|FG003|3 Month Study Visit|Overall Study||11
10152505|NCT02846558|11283245|FG000|COMPLETED|Overall Study||7
10152506|NCT02846558|11283246|FG001|COMPLETED|Overall Study||8
10152507|NCT02846558|11283247|FG002|COMPLETED|Overall Study||12
10152508|NCT02846558|11283248|FG003|COMPLETED|Overall Study||11
10152509|NCT02846558|11283245|FG000|NOT COMPLETED|Overall Study||8
10152510|NCT02846558|11283246|FG001|NOT COMPLETED|Overall Study||4
10152511|NCT02846558|11283247|FG002|NOT COMPLETED|Overall Study||2
10152512|NCT02846558|11283248|FG003|NOT COMPLETED|Overall Study||2
10197175|NCT03370302|11325122|FG003|STARTED|Dose Expansion Phase||6
10197176|NCT03370302|11325123|FG004|STARTED|Dose Expansion Phase||0
10197177|NCT03370302|11325124|FG005|STARTED|Dose Expansion Phase||0
10197178|NCT03370302|11325119|FG000|COMPLETED|Dose Expansion Phase||0
10197179|NCT03370302|11325120|FG001|COMPLETED|Dose Expansion Phase||0
10197180|NCT03370302|11325121|FG002|COMPLETED|Dose Expansion Phase||0
10197181|NCT03370302|11325122|FG003|COMPLETED|Dose Expansion Phase||0
10197182|NCT03370302|11325123|FG004|COMPLETED|Dose Expansion Phase||0
10197183|NCT03370302|11325124|FG005|COMPLETED|Dose Expansion Phase||0
10197184|NCT03370302|11325119|FG000|NOT COMPLETED|Dose Expansion Phase||0
10197185|NCT03370302|11325120|FG001|NOT COMPLETED|Dose Expansion Phase||0
10197186|NCT03370302|11325121|FG002|NOT COMPLETED|Dose Expansion Phase||0
10197187|NCT03370302|11325122|FG003|NOT COMPLETED|Dose Expansion Phase||6
10197188|NCT03370302|11325123|FG004|NOT COMPLETED|Dose Expansion Phase||0
10197189|NCT03370302|11325124|FG005|NOT COMPLETED|Dose Expansion Phase||0
10197190|NCT03370419|11325142|FG000|STARTED|Overall Study||40
10197191|NCT03370419|11325142|FG000|COMPLETED|Overall Study||24
10197192|NCT03370419|11325142|FG000|NOT COMPLETED|Overall Study||16
10197193|NCT03370471|11325148|FG000|STARTED|Overall Study||23
10197194|NCT03370471|11325149|FG001|STARTED|Overall Study||5
10197195|NCT03370471|11325148|FG000|COMPLETED|Overall Study||16
10197196|NCT03370471|11325149|FG001|COMPLETED|Overall Study||3
10197197|NCT03370471|11325148|FG000|NOT COMPLETED|Overall Study||7
10197198|NCT03370471|11325149|FG001|NOT COMPLETED|Overall Study||2
10197199|NCT03370770|11325157|FG000|STARTED|Overall Study||204
10197200|NCT03370770|11325157|FG000|COMPLETED|Overall Study||98
10152513|NCT02846714|11283265|FG000|STARTED|Overall Study||42
10152514|NCT02846714|11283265|FG000|COMPLETED|Overall Study||36
10152515|NCT02846714|11283265|FG000|NOT COMPLETED|Overall Study||6
10152516|NCT02846740|11283271|FG000|STARTED|Overall Study||15
10152517|NCT02846740|11283272|FG001|STARTED|Overall Study||15
10152518|NCT02846740|11283271|FG000|COMPLETED|Overall Study||15
10152519|NCT02846740|11283272|FG001|COMPLETED|Overall Study||14
10152520|NCT02846740|11283271|FG000|NOT COMPLETED|Overall Study||0
10152521|NCT02846740|11283272|FG001|NOT COMPLETED|Overall Study||1
10152522|NCT02846779|11283281|FG000|STARTED|Overall Study||2000
10152523|NCT02846779|11283282|FG001|STARTED|Overall Study||2000
10152524|NCT02846779|11283283|FG002|STARTED|Overall Study||2000
10152525|NCT02846779|11283281|FG000|COMPLETED|Overall Study||1861
10152526|NCT02846779|11283282|FG001|COMPLETED|Overall Study||1873
10152527|NCT02846779|11283283|FG002|COMPLETED|Overall Study||1862
10152528|NCT02846779|11283281|FG000|NOT COMPLETED|Overall Study||139
10152529|NCT02846779|11283282|FG001|NOT COMPLETED|Overall Study||127
10152530|NCT02846779|11283283|FG002|NOT COMPLETED|Overall Study||138
10152531|NCT02846792|11283291|FG000|STARTED|Overall Study||5
10152532|NCT02846792|11283291|FG000|COMPLETED|Overall Study||5
10152533|NCT02846792|11283291|FG000|NOT COMPLETED|Overall Study||0
10152534|NCT02847169|11283295|FG000|STARTED|First Intervention (1 Week)||15
10152535|NCT02847169|11283296|FG001|STARTED|First Intervention (1 Week)||15
10152536|NCT02847169|11283295|FG000|COMPLETED|First Intervention (1 Week)||15
10152537|NCT02847169|11283296|FG001|COMPLETED|First Intervention (1 Week)||15
10152538|NCT02847169|11283295|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10152539|NCT02847169|11283296|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10152540|NCT02847169|11283295|FG000|STARTED|Second Intervention (1 Week)||15
10152541|NCT02847169|11283296|FG001|STARTED|Second Intervention (1 Week)||15
10152542|NCT02847169|11283295|FG000|COMPLETED|Second Intervention (1 Week)||15
10152543|NCT02847169|11283296|FG001|COMPLETED|Second Intervention (1 Week)||15
10152544|NCT02847169|11283295|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10152545|NCT02847169|11283296|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10152546|NCT02847182|11283319|FG000|STARTED|Overall Study||119
10152547|NCT02847182|11283320|FG001|STARTED|Overall Study||61
10152548|NCT02847182|11283319|FG000|First Intervention (6 Months)|Overall Study||119
10152549|NCT02847182|11283320|FG001|First Intervention (6 Months)|Overall Study||61
10152550|NCT02847182|11283319|FG000|Second Intervention (6 Months)|Overall Study||61
10152551|NCT02847182|11283320|FG001|Second Intervention (6 Months)|Overall Study||119
10152552|NCT02847182|11283319|FG000|COMPLETED|Overall Study||119
10152553|NCT02847182|11283320|FG001|COMPLETED|Overall Study||60
10152554|NCT02847182|11283319|FG000|NOT COMPLETED|Overall Study||0
10152555|NCT02847182|11283320|FG001|NOT COMPLETED|Overall Study||1
10152556|NCT02847260|11283332|FG000|STARTED|Overall Study||39
10152557|NCT02847260|11283332|FG000|COMPLETED|Overall Study||32
10152558|NCT02847260|11283332|FG000|NOT COMPLETED|Overall Study||7
10152559|NCT02847494|11283338|FG000|STARTED|Overall Study||109
10152560|NCT02847494|11283339|FG001|STARTED|Overall Study||111
10152561|NCT02847494|11283338|FG000|COMPLETED|Overall Study||101
10152562|NCT02847494|11283339|FG001|COMPLETED|Overall Study||106
10152563|NCT02847494|11283338|FG000|NOT COMPLETED|Overall Study||8
10152564|NCT02847494|11283339|FG001|NOT COMPLETED|Overall Study||5
10152565|NCT02847650|11283347|FG000|STARTED|Overall Study||29
10152566|NCT02847650|11283348|FG001|STARTED|Overall Study||28
10152567|NCT02847650|11283347|FG000|COMPLETED|Overall Study||25
10152568|NCT02847650|11283348|FG001|COMPLETED|Overall Study||22
10152569|NCT02847650|11283347|FG000|NOT COMPLETED|Overall Study||4
10152570|NCT02847650|11283348|FG001|NOT COMPLETED|Overall Study||6
10152571|NCT02847858|11283356|FG000|STARTED|Overall Study||693
10152572|NCT02847858|11283357|FG001|STARTED|Overall Study||667
10152573|NCT02847858|11283356|FG000|COMPLETED|Overall Study||292
10152574|NCT02847858|11283357|FG001|COMPLETED|Overall Study||398
10152575|NCT02847858|11283356|FG000|NOT COMPLETED|Overall Study||401
10152576|NCT02847858|11283357|FG001|NOT COMPLETED|Overall Study||269
10152577|NCT02848079|11283368|FG000|STARTED|Overall Study||41
10152578|NCT02848079|11283368|FG000|Receieved Study Treatment|Overall Study||41
10152579|NCT02848079|11283368|FG000|Discontinued|Overall Study||41
10152580|NCT02848079|11283368|FG000|COMPLETED|Overall Study||41
10152581|NCT02848079|11283368|FG000|NOT COMPLETED|Overall Study||0
10152582|NCT02848222|11283375|FG000|STARTED|Overall Study||25
10152583|NCT02848222|11283376|FG001|STARTED|Overall Study||18
10152584|NCT02848222|11283377|FG002|STARTED|Overall Study||17
10152585|NCT02848222|11283375|FG000|COMPLETED|Overall Study||18
10152586|NCT02848222|11283376|FG001|COMPLETED|Overall Study||17
10152587|NCT02848222|11283377|FG002|COMPLETED|Overall Study||17
10152588|NCT02848222|11283375|FG000|NOT COMPLETED|Overall Study||7
10152589|NCT02848222|11283376|FG001|NOT COMPLETED|Overall Study||1
10152590|NCT02848222|11283377|FG002|NOT COMPLETED|Overall Study||0
10152591|NCT02848313|11283387|FG000|STARTED|Overall Study||21
10152592|NCT02848313|11283388|FG001|STARTED|Overall Study||19
10152593|NCT02848313|11283387|FG000|COMPLETED|Overall Study||18
10152594|NCT02848313|11283388|FG001|COMPLETED|Overall Study||15
10152595|NCT02848313|11283387|FG000|NOT COMPLETED|Overall Study||3
10152596|NCT02848313|11283388|FG001|NOT COMPLETED|Overall Study||4
10152597|NCT02848326|11283400|FG000|STARTED|Treatment Period||186
10152598|NCT02848326|11283401|FG001|STARTED|Treatment Period||94
10152599|NCT02848326|11283402|FG002|STARTED|Treatment Period||185
10152600|NCT02848326|11283403|FG003|STARTED|Treatment Period||187
10152601|NCT02848326|11283404|FG004|STARTED|Treatment Period||89
10152602|NCT02848326|11283405|FG005|STARTED|Treatment Period||93
10152603|NCT02848326|11283400|FG000|Safety Population: Received Study Drug|Treatment Period||186
10152604|NCT02848326|11283401|FG001|Safety Population: Received Study Drug|Treatment Period||93
10152605|NCT02848326|11283402|FG002|Safety Population: Received Study Drug|Treatment Period||183
10152606|NCT02848326|11283403|FG003|Safety Population: Received Study Drug|Treatment Period||186
10152607|NCT02848326|11283404|FG004|Safety Population: Received Study Drug|Treatment Period||86
10152608|NCT02848326|11283405|FG005|Safety Population: Received Study Drug|Treatment Period||91
10152609|NCT02848326|11283400|FG000|COMPLETED|Treatment Period||148
10152610|NCT02848326|11283401|FG001|COMPLETED|Treatment Period||80
10152611|NCT02848326|11283402|FG002|COMPLETED|Treatment Period||149
10152612|NCT02848326|11283403|FG003|COMPLETED|Treatment Period||164
10152613|NCT02848326|11283404|FG004|COMPLETED|Treatment Period||70
10152614|NCT02848326|11283405|FG005|COMPLETED|Treatment Period||73
10152615|NCT02848326|11283400|FG000|NOT COMPLETED|Treatment Period||38
10152616|NCT02848326|11283401|FG001|NOT COMPLETED|Treatment Period||14
10152617|NCT02848326|11283402|FG002|NOT COMPLETED|Treatment Period||36
10152618|NCT02848326|11283403|FG003|NOT COMPLETED|Treatment Period||23
10152619|NCT02848326|11283404|FG004|NOT COMPLETED|Treatment Period||19
10152620|NCT02848326|11283405|FG005|NOT COMPLETED|Treatment Period||20
10152621|NCT02848326|11283400|FG000|STARTED|Safety Follow-up Period||161
10152622|NCT02848326|11283401|FG001|STARTED|Safety Follow-up Period||84
10152623|NCT02848326|11283402|FG002|STARTED|Safety Follow-up Period||156
10152624|NCT02848326|11283403|FG003|STARTED|Safety Follow-up Period||169
10152625|NCT02848326|11283404|FG004|STARTED|Safety Follow-up Period||77
10152626|NCT02848326|11283405|FG005|STARTED|Safety Follow-up Period||82
10152627|NCT02848326|11283400|FG000|COMPLETED|Safety Follow-up Period||157
10152628|NCT02848326|11283401|FG001|COMPLETED|Safety Follow-up Period||83
10152629|NCT02848326|11283402|FG002|COMPLETED|Safety Follow-up Period||153
10152630|NCT02848326|11283403|FG003|COMPLETED|Safety Follow-up Period||169
10152631|NCT02848326|11283404|FG004|COMPLETED|Safety Follow-up Period||76
10152632|NCT02848326|11283405|FG005|COMPLETED|Safety Follow-up Period||77
10152633|NCT02848326|11283400|FG000|NOT COMPLETED|Safety Follow-up Period||4
10152634|NCT02848326|11283401|FG001|NOT COMPLETED|Safety Follow-up Period||1
10152635|NCT02848326|11283402|FG002|NOT COMPLETED|Safety Follow-up Period||3
10152636|NCT02848326|11283403|FG003|NOT COMPLETED|Safety Follow-up Period||0
10152637|NCT02848326|11283404|FG004|NOT COMPLETED|Safety Follow-up Period||1
10152638|NCT02848326|11283405|FG005|NOT COMPLETED|Safety Follow-up Period||5
10152639|NCT02848599|11283421|FG000|STARTED|Overall Study||42
10152640|NCT02848599|11283422|FG001|STARTED|Overall Study||44
10152641|NCT02848599|11283421|FG000|COMPLETED|Overall Study||35
10152642|NCT02848599|11283422|FG001|COMPLETED|Overall Study||35
10152643|NCT02848599|11283421|FG000|NOT COMPLETED|Overall Study||7
10152644|NCT02848599|11283422|FG001|NOT COMPLETED|Overall Study||9
10152645|NCT02848651|11283430|FG000|STARTED|Overall Study||153
10152646|NCT02848651|11283430|FG000|Received Treatment|Overall Study||152
10152647|NCT02848651|11283430|FG000|COMPLETED|Overall Study||47
10152648|NCT02848651|11283430|FG000|NOT COMPLETED|Overall Study||106
10152649|NCT02848664|11283450|FG000|STARTED|Overall Study||11
10152650|NCT02848664|11283450|FG000|COMPLETED|Overall Study||7
10152651|NCT02848664|11283450|FG000|NOT COMPLETED|Overall Study||4
10152652|NCT02848729|11283460|FG000|STARTED|Overall Study||27
10152653|NCT02848729|11283461|FG001|STARTED|Overall Study||23
10152654|NCT02848729|11283460|FG000|Per Protocol Population|Overall Study||11
10152655|NCT02848729|11283461|FG001|Per Protocol Population|Overall Study||11
10152656|NCT02848729|11283460|FG000|Safety Population|Overall Study||27
10152657|NCT02848729|11283461|FG001|Safety Population|Overall Study||23
10152658|NCT02848729|11283460|FG000|COMPLETED|Overall Study||11
10152659|NCT02848729|11283461|FG001|COMPLETED|Overall Study||12
10152660|NCT02848729|11283460|FG000|NOT COMPLETED|Overall Study||16
10152661|NCT02848729|11283461|FG001|NOT COMPLETED|Overall Study||11
10152662|NCT02848833|11283474|FG000|STARTED|Overall Study||3368
10152663|NCT02848833|11283474|FG000|COMPLETED|Overall Study||3231
10152664|NCT02848833|11283474|FG000|NOT COMPLETED|Overall Study||137
10152665|NCT02849080|11283480|FG000|STARTED|Main Phase: 0 - 52 Weeks||253
10152666|NCT02849080|11283481|FG001|STARTED|Main Phase: 0 - 52 Weeks||251
10152667|NCT02849080|11283482|FG002|STARTED|Main Phase: 0 - 52 Weeks||0
10152668|NCT02849080|11283483|FG003|STARTED|Main Phase: 0 - 52 Weeks||0
10152669|NCT02849080|11283480|FG000|Exposed|Main Phase: 0 - 52 Weeks||253
10152670|NCT02849080|11283481|FG001|Exposed|Main Phase: 0 - 52 Weeks||250
10152671|NCT02849080|11283482|FG002|Exposed|Main Phase: 0 - 52 Weeks||0
10152672|NCT02849080|11283483|FG003|Exposed|Main Phase: 0 - 52 Weeks||0
10152673|NCT02849080|11283480|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
10152674|NCT02849080|11283481|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
10152675|NCT02849080|11283482|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
10152676|NCT02849080|11283483|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
10152677|NCT02849080|11283480|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
10152678|NCT02849080|11283481|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
10152679|NCT02849080|11283482|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
10152680|NCT02849080|11283483|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
10152681|NCT02849080|11283480|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241
10152682|NCT02849080|11283481|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244
10152683|NCT02849080|11283482|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0
10152684|NCT02849080|11283483|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0
10152685|NCT02849080|11283480|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
10152686|NCT02849080|11283481|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
10152687|NCT02849080|11283482|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
10152688|NCT02849080|11283483|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
10152689|NCT02849080|11283480|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
10152690|NCT02849080|11283481|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0
10152691|NCT02849080|11283482|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
10152692|NCT02849080|11283483|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
10152693|NCT02849080|11283480|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184
10152694|NCT02849080|11283481|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0
10152695|NCT02849080|11283482|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100
10152696|NCT02849080|11283483|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97
10152697|NCT02849080|11283480|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182
10152698|NCT02849080|11283481|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0
10152699|NCT02849080|11283482|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99
10152700|NCT02849080|11283483|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98
10152701|NCT02849080|11283480|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
10152702|NCT02849080|11283481|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
10152703|NCT02849080|11283482|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
10152704|NCT02849080|11283483|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
10152705|NCT02849184|11283497|FG000|STARTED|Overall Study||40
10152706|NCT02849184|11283498|FG001|STARTED|Overall Study||42
10152707|NCT02849184|11283497|FG000|COMPLETED|Overall Study||40
10152708|NCT02849184|11283498|FG001|COMPLETED|Overall Study||42
10152709|NCT02849184|11283497|FG000|NOT COMPLETED|Overall Study||0
10152710|NCT02849184|11283498|FG001|NOT COMPLETED|Overall Study||0
10152711|NCT02849418|11283506|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10
10152712|NCT02849418|11283507|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11
10152713|NCT02849418|11283508|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
10152714|NCT02849418|11283509|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
10152715|NCT02849418|11283510|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
10152716|NCT02849418|11283511|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
10152717|NCT02849418|11283506|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10
10152718|NCT02849418|11283507|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11
10152719|NCT02849418|11283508|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152720|NCT02849418|11283509|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152721|NCT02849418|11283510|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152722|NCT02849418|11283511|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152723|NCT02849418|11283506|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152724|NCT02849418|11283507|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152725|NCT02849418|11283508|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152726|NCT02849418|11283509|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152727|NCT02849418|11283510|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152728|NCT02849418|11283511|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10152729|NCT02849418|11283506|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
10152730|NCT02849418|11283507|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
9709862|NCT03863353|10809261|FG000|STARTED|Overall Study||282
9709863|NCT03863353|10809262|FG001|STARTED|Overall Study||221
9709864|NCT03863353|10809261|FG000|COMPLETED|Overall Study||258
9709865|NCT03863353|10809262|FG001|COMPLETED|Overall Study||201
9709866|NCT03863353|10809261|FG000|NOT COMPLETED|Overall Study||24
9709867|NCT03863353|10809262|FG001|NOT COMPLETED|Overall Study||20
9709868|NCT03622593|10809271|FG000|STARTED|Overall Study||317
9709869|NCT03622593|10809272|FG001|STARTED|Overall Study||319
9709870|NCT03622593|10809273|FG002|STARTED|Overall Study||315
9709871|NCT03622593|10809271|FG000|Received at Least One Dose of Study Drug|Overall Study||317
9709872|NCT03622593|10809272|FG001|Received at Least One Dose of Study Drug|Overall Study||319
9709873|NCT03622593|10809273|FG002|Received at Least One Dose of Study Drug|Overall Study||314
9709874|NCT03622593|10809271|FG000|Completed up to Week 56|Overall Study||298
9709875|NCT03622593|10809272|FG001|Completed up to Week 56|Overall Study||312
9709876|NCT03622593|10809273|FG002|Completed up to Week 56|Overall Study||299
9709877|NCT03622593|10809271|FG000|COMPLETED|Overall Study||0
9709878|NCT03622593|10809272|FG001|COMPLETED|Overall Study||0
9709879|NCT03622593|10809273|FG002|COMPLETED|Overall Study||0
9709880|NCT03622593|10809271|FG000|NOT COMPLETED|Overall Study||317
9709881|NCT03622593|10809272|FG001|NOT COMPLETED|Overall Study||319
9709882|NCT03622593|10809273|FG002|NOT COMPLETED|Overall Study||315
9709883|NCT03622580|10809285|FG000|STARTED|Overall Study||315
9709884|NCT03622580|10809286|FG001|STARTED|Overall Study||313
9709885|NCT03622580|10809287|FG002|STARTED|Overall Study||312
9709886|NCT03622580|10809285|FG000|Received at Least One Dose of Study Drug|Overall Study||313
10152731|NCT02849418|11283508|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
10152732|NCT02849418|11283509|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
10152733|NCT02849418|11283510|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
10152734|NCT02849418|11283511|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
10152735|NCT02849418|11283506|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152736|NCT02849418|11283507|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152737|NCT02849418|11283508|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
10152738|NCT02849418|11283509|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
10152739|NCT02849418|11283510|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152740|NCT02849418|11283511|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152741|NCT02849418|11283506|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152742|NCT02849418|11283507|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152743|NCT02849418|11283508|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152744|NCT02849418|11283509|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152745|NCT02849418|11283510|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152746|NCT02849418|11283511|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10152747|NCT02849418|11283506|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10152748|NCT02849418|11283507|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10152749|NCT02849418|11283508|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10152750|NCT02849418|11283509|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10152751|NCT02849418|11283510|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
10152752|NCT02849418|11283511|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
10152753|NCT02849418|11283506|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152754|NCT02849418|11283507|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152755|NCT02849418|11283508|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152756|NCT02849418|11283509|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152757|NCT02849418|11283510|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
10152758|NCT02849418|11283511|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
10152759|NCT02849418|11283506|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
9709887|NCT03622580|10809286|FG001|Received at Least One Dose of Study Drug|Overall Study||313
9709888|NCT03622580|10809287|FG002|Received at Least One Dose of Study Drug|Overall Study||311
10152760|NCT02849418|11283507|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152761|NCT02849418|11283508|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152762|NCT02849418|11283509|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152763|NCT02849418|11283510|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152764|NCT02849418|11283511|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10152765|NCT02849509|11283530|FG000|STARTED|Overall Study||379
10152766|NCT02849509|11283531|FG001|STARTED|Overall Study||591
10152767|NCT02849509|11283532|FG002|STARTED|Overall Study||343
10152768|NCT02849509|11283530|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
10152769|NCT02849509|11283531|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
10152770|NCT02849509|11283532|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
10152771|NCT02849509|11283530|FG000|NOT COMPLETED|Overall Study||90
10152772|NCT02849509|11283531|FG001|NOT COMPLETED|Overall Study||166
10152773|NCT02849509|11283532|FG002|NOT COMPLETED|Overall Study||85
10152774|NCT02849678|11283544|FG000|STARTED|Overall Study||20
10152775|NCT02849678|11283545|FG001|STARTED|Overall Study||24
10152776|NCT02849678|11283544|FG000|COMPLETED|Overall Study||17
10152777|NCT02849678|11283545|FG001|COMPLETED|Overall Study||18
10152778|NCT02849678|11283544|FG000|NOT COMPLETED|Overall Study||3
10152779|NCT02849678|11283545|FG001|NOT COMPLETED|Overall Study||6
10152780|NCT02849704|11283553|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11
10152781|NCT02849704|11283554|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0
10152782|NCT02849704|11283553|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
10152783|NCT02849704|11283554|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
10152784|NCT02849704|11283553|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
10152785|NCT02849704|11283554|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
10152786|NCT02849704|11283553|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24
10152787|NCT02849704|11283554|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24
10152788|NCT02849704|11283553|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
10152789|NCT02849704|11283554|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
10152790|NCT02849704|11283553|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
10152791|NCT02849704|11283554|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
10152792|NCT02849704|11283553|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24
10152793|NCT02849704|11283554|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0
10152794|NCT02849704|11283553|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
10152795|NCT02849704|11283554|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
10152796|NCT02849704|11283553|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
10152797|NCT02849704|11283554|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
10152798|NCT02849938|11283566|FG000|STARTED|Overall Study||9
10152799|NCT02849938|11283567|FG001|STARTED|Overall Study||15
10152800|NCT02849938|11283566|FG000|COMPLETED|Overall Study||9
10152801|NCT02849938|11283567|FG001|COMPLETED|Overall Study||15
10152802|NCT02849938|11283566|FG000|NOT COMPLETED|Overall Study||0
10152803|NCT02849938|11283567|FG001|NOT COMPLETED|Overall Study||0
10152804|NCT02850068|11283573|FG000|STARTED|Overall Study||20
10152805|NCT02850068|11283573|FG000|COMPLETED|Overall Study||0
10152806|NCT02850068|11283573|FG000|NOT COMPLETED|Overall Study||20
10152807|NCT02850159|11283579|FG000|STARTED|Overall Study||16
10152808|NCT02850159|11283580|FG001|STARTED|Overall Study||16
10152809|NCT02850159|11283579|FG000|COMPLETED|Overall Study||16
10152810|NCT02850159|11283580|FG001|COMPLETED|Overall Study||16
10152811|NCT02850159|11283579|FG000|NOT COMPLETED|Overall Study||0
10152812|NCT02850159|11283580|FG001|NOT COMPLETED|Overall Study||0
10152813|NCT02850276|11283586|FG000|STARTED|Overall Study||76
10152814|NCT02850276|11283586|FG000|COMPLETED|Overall Study||15
10152815|NCT02850276|11283586|FG000|NOT COMPLETED|Overall Study||61
10152816|NCT02850601|11283593|FG000|STARTED|Overall Study||12
9709889|NCT03622580|10809285|FG000|Completed up to Week 56|Overall Study||291
9709890|NCT03622580|10809286|FG001|Completed up to Week 56|Overall Study||289
9709891|NCT03622580|10809287|FG002|Completed up to Week 56|Overall Study||292
9709892|NCT03622580|10809285|FG000|COMPLETED|Overall Study||0
9709893|NCT03622580|10809286|FG001|COMPLETED|Overall Study||0
9709894|NCT03622580|10809287|FG002|COMPLETED|Overall Study||0
9709895|NCT03622580|10809285|FG000|NOT COMPLETED|Overall Study||315
9709896|NCT03622580|10809286|FG001|NOT COMPLETED|Overall Study||313
9709897|NCT03622580|10809287|FG002|NOT COMPLETED|Overall Study||312
9709898|NCT03572634|10809298|FG000|STARTED|Overall Study||1
9709899|NCT03572634|10809299|FG001|STARTED|Overall Study||2
9709900|NCT03572634|10809298|FG000|COMPLETED|Overall Study||1
9709901|NCT03572634|10809299|FG001|COMPLETED|Overall Study||2
9709902|NCT03572634|10809298|FG000|NOT COMPLETED|Overall Study||0
9709903|NCT03572634|10809299|FG001|NOT COMPLETED|Overall Study||0
9709904|NCT03562156|10809308|FG000|STARTED|Overall Study||217
9709905|NCT03562156|10809309|FG001|STARTED|Overall Study||109
9709906|NCT03562156|10809308|FG000|COMPLETED|Overall Study||182
9709907|NCT03562156|10809309|FG001|COMPLETED|Overall Study||91
9709908|NCT03562156|10809308|FG000|NOT COMPLETED|Overall Study||35
9709909|NCT03562156|10809309|FG001|NOT COMPLETED|Overall Study||18
9709910|NCT03476135|10809317|FG000|STARTED|Overall Study||42
9709911|NCT03476135|10809318|FG001|STARTED|Overall Study||49
9709912|NCT03476135|10809317|FG000|COMPLETED|Overall Study||42
9709913|NCT03476135|10809318|FG001|COMPLETED|Overall Study||49
9709914|NCT03476135|10809317|FG000|NOT COMPLETED|Overall Study||0
9709915|NCT03476135|10809318|FG001|NOT COMPLETED|Overall Study||0
9729795|NCT00121641|10829438|FG003|STARTED|48-month Short Term + Long Term Period||95
9729796|NCT00121641|10829439|FG004|STARTED|48-month Short Term + Long Term Period||66
9729797|NCT00121641|10829435|FG000|COMPLETED|48-month Short Term + Long Term Period||23
9729798|NCT00121641|10829436|FG001|COMPLETED|48-month Short Term + Long Term Period||24
9729799|NCT00121641|10829437|FG002|COMPLETED|48-month Short Term + Long Term Period||28
9729800|NCT00121641|10829438|FG003|COMPLETED|48-month Short Term + Long Term Period||24
9729801|NCT00121641|10829439|FG004|COMPLETED|48-month Short Term + Long Term Period||8
9729802|NCT00121641|10829435|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79
9729803|NCT00121641|10829436|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82
9729804|NCT00121641|10829437|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70
9729805|NCT00121641|10829438|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71
9729806|NCT00121641|10829439|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58
9729807|NCT00121667|10829457|FG000|STARTED|Short Term (ST) Period||192
9729808|NCT00121667|10829458|FG001|STARTED|Short Term (ST) Period||191
9729809|NCT00121667|10829459|FG002|STARTED|Short Term (ST) Period||181
9729810|NCT00121667|10829460|FG003|STARTED|Short Term (ST) Period||179
9729811|NCT00121667|10829457|FG000|COMPLETED|Short Term (ST) Period||148
9729812|NCT00121667|10829458|FG001|COMPLETED|Short Term (ST) Period||143
9729813|NCT00121667|10829459|FG002|COMPLETED|Short Term (ST) Period||140
9729814|NCT00121667|10829460|FG003|COMPLETED|Short Term (ST) Period||112
9729815|NCT00121667|10829457|FG000|NOT COMPLETED|Short Term (ST) Period||44
9729816|NCT00121667|10829458|FG001|NOT COMPLETED|Short Term (ST) Period||48
9729817|NCT00121667|10829459|FG002|NOT COMPLETED|Short Term (ST) Period||41
9729818|NCT00121667|10829460|FG003|NOT COMPLETED|Short Term (ST) Period||67
9729819|NCT00121667|10829457|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192
9729820|NCT00121667|10829458|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191
9729821|NCT00121667|10829459|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181
9729822|NCT00121667|10829460|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179
9729823|NCT00121667|10829457|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
9731936|NCT00137839|10831917|FG000|STARTED|Overall Study||84
9849052|NCT00862849|10961754|FG002|STARTED|Intervention 5||3
9849053|NCT00862849|10961755|FG003|STARTED|Intervention 5||4
9849054|NCT00862849|10961756|FG004|STARTED|Intervention 5||4
9849055|NCT00862849|10961757|FG005|STARTED|Intervention 5||3
9849056|NCT00862849|10961752|FG000|COMPLETED|Intervention 5||3
9849057|NCT00862849|10961753|FG001|COMPLETED|Intervention 5||3
9849058|NCT00862849|10961754|FG002|COMPLETED|Intervention 5||3
9849059|NCT00862849|10961755|FG003|COMPLETED|Intervention 5||4
9849060|NCT00862849|10961756|FG004|COMPLETED|Intervention 5||4
9849061|NCT00862849|10961757|FG005|COMPLETED|Intervention 5||3
9849062|NCT00862849|10961752|FG000|NOT COMPLETED|Intervention 5||0
9849063|NCT00862849|10961753|FG001|NOT COMPLETED|Intervention 5||0
9849064|NCT00862849|10961754|FG002|NOT COMPLETED|Intervention 5||0
9849065|NCT00862849|10961755|FG003|NOT COMPLETED|Intervention 5||0
9849066|NCT00862849|10961756|FG004|NOT COMPLETED|Intervention 5||0
9849067|NCT00862849|10961757|FG005|NOT COMPLETED|Intervention 5||0
9849068|NCT00862849|10961752|FG000|STARTED|Washout 5 (3 to 14 Days)||3
9849069|NCT00862849|10961753|FG001|STARTED|Washout 5 (3 to 14 Days)||3
9849070|NCT00862849|10961754|FG002|STARTED|Washout 5 (3 to 14 Days)||3
9849071|NCT00862849|10961755|FG003|STARTED|Washout 5 (3 to 14 Days)||4
9849072|NCT00862849|10961756|FG004|STARTED|Washout 5 (3 to 14 Days)||4
9849073|NCT00862849|10961757|FG005|STARTED|Washout 5 (3 to 14 Days)||3
9849074|NCT00862849|10961752|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3
9849075|NCT00862849|10961753|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3
9849076|NCT00862849|10961754|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3
9849077|NCT00862849|10961755|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4
9849078|NCT00862849|10961756|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4
9849079|NCT00862849|10961757|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3
10152817|NCT02850601|11283594|FG001|STARTED|Overall Study||12
10152818|NCT02850601|11283593|FG000|COMPLETED|Overall Study||12
10152819|NCT02850601|11283594|FG001|COMPLETED|Overall Study||12
10152820|NCT02850601|11283593|FG000|NOT COMPLETED|Overall Study||0
10152821|NCT02850601|11283594|FG001|NOT COMPLETED|Overall Study||0
10152822|NCT02850965|11283602|FG000|STARTED|Overall Study||159
10152823|NCT02850965|11283603|FG001|STARTED|Overall Study||159
10152824|NCT02850965|11283602|FG000|Treated|Overall Study||159
10152825|NCT02850965|11283603|FG001|Treated|Overall Study||158
10152826|NCT02850965|11283602|FG000|COMPLETED|Overall Study||141
10152827|NCT02850965|11283603|FG001|COMPLETED|Overall Study||134
10152828|NCT02850965|11283602|FG000|NOT COMPLETED|Overall Study||18
9709916|NCT03333928|10809327|FG000|STARTED|Initial Dosing Period (Period 1)||16
9709917|NCT03333928|10809328|FG001|STARTED|Initial Dosing Period (Period 1)||25
9709918|NCT03333928|10809329|FG002|STARTED|Initial Dosing Period (Period 1)||18
9709919|NCT03333928|10809327|FG000|COMPLETED|Initial Dosing Period (Period 1)||15
9709920|NCT03333928|10809328|FG001|COMPLETED|Initial Dosing Period (Period 1)||21
9709921|NCT03333928|10809329|FG002|COMPLETED|Initial Dosing Period (Period 1)||14
10152829|NCT02850965|11283603|FG001|NOT COMPLETED|Overall Study||25
10152830|NCT02850978|11283609|FG000|STARTED|Overall Study||1335
10152831|NCT02850978|11283609|FG000|Case Report Form (CRF) Collected|Overall Study||1308
10152832|NCT02850978|11283609|FG000|Treated|Overall Study||1308
10152833|NCT02850978|11283609|FG000|COMPLETED|Overall Study||909
10152834|NCT02850978|11283609|FG000|NOT COMPLETED|Overall Study||426
10152835|NCT02851069|11283613|FG000|STARTED|Overall Study||65
10152836|NCT02851069|11283613|FG000|COMPLETED|Overall Study||59
10152837|NCT02851069|11283613|FG000|NOT COMPLETED|Overall Study||6
10152838|NCT02851108|11283620|FG000|STARTED|Overall Study||50
10152839|NCT02851108|11283621|FG001|STARTED|Overall Study||50
10152840|NCT02851108|11283620|FG000|COMPLETED|Overall Study||42
10152841|NCT02851108|11283621|FG001|COMPLETED|Overall Study||49
10152842|NCT02851108|11283620|FG000|NOT COMPLETED|Overall Study||8
10152843|NCT02851108|11283621|FG001|NOT COMPLETED|Overall Study||1
10152844|NCT02851615|11283629|FG000|STARTED|Overall Study||27
10152845|NCT02851615|11283630|FG001|STARTED|Overall Study||31
10152846|NCT02851615|11283629|FG000|COMPLETED|Overall Study||26
10152847|NCT02851615|11283630|FG001|COMPLETED|Overall Study||27
10152848|NCT02851615|11283629|FG000|NOT COMPLETED|Overall Study||1
10152849|NCT02851615|11283630|FG001|NOT COMPLETED|Overall Study||4
10152850|NCT02851823|11283637|FG000|STARTED|Overall Study||25
10152851|NCT02851823|11283637|FG000|1 Month|Overall Study||25
10152852|NCT02851823|11283637|FG000|3 Months|Overall Study||25
10152853|NCT02851823|11283637|FG000|COMPLETED|Overall Study||25
10152854|NCT02851823|11283637|FG000|NOT COMPLETED|Overall Study||0
10152855|NCT02852005|11283648|FG000|STARTED|Overall Study||4
10152856|NCT02852005|11283649|FG001|STARTED|Overall Study||4
10152857|NCT02852005|11283650|FG002|STARTED|Overall Study||6
10152858|NCT02852005|11283651|FG003|STARTED|Overall Study||6
10152859|NCT02852005|11283652|FG004|STARTED|Overall Study||7
10152860|NCT02852005|11283648|FG000|Month 0.5|Overall Study||3
9709922|NCT03333928|10809327|FG000|NOT COMPLETED|Initial Dosing Period (Period 1)||1
9709923|NCT03333928|10809328|FG001|NOT COMPLETED|Initial Dosing Period (Period 1)||4
9709924|NCT03333928|10809329|FG002|NOT COMPLETED|Initial Dosing Period (Period 1)||4
9709925|NCT03333928|10809327|FG000|STARTED|Dose-controlled Extension (Period 2)||22
9709926|NCT03333928|10809328|FG001|STARTED|Dose-controlled Extension (Period 2)||29
9709927|NCT03333928|10809329|FG002|STARTED|Dose-controlled Extension (Period 2)||0
9709928|NCT03333928|10809327|FG000|COMPLETED|Dose-controlled Extension (Period 2)||19
9709929|NCT03333928|10809328|FG001|COMPLETED|Dose-controlled Extension (Period 2)||28
9709930|NCT03333928|10809329|FG002|COMPLETED|Dose-controlled Extension (Period 2)||0
9709931|NCT03333928|10809327|FG000|NOT COMPLETED|Dose-controlled Extension (Period 2)||3
9709932|NCT03333928|10809328|FG001|NOT COMPLETED|Dose-controlled Extension (Period 2)||1
9709933|NCT03333928|10809329|FG002|NOT COMPLETED|Dose-controlled Extension (Period 2)||0
9709934|NCT03333928|10809327|FG000|STARTED|Randomized Withdrawal (Period 3)||10
9709935|NCT03333928|10809328|FG001|STARTED|Randomized Withdrawal (Period 3)||14
9709936|NCT03333928|10809329|FG002|STARTED|Randomized Withdrawal (Period 3)||26
9709937|NCT03333928|10809327|FG000|COMPLETED|Randomized Withdrawal (Period 3)||8
9709938|NCT03333928|10809328|FG001|COMPLETED|Randomized Withdrawal (Period 3)||14
9709939|NCT03333928|10809329|FG002|COMPLETED|Randomized Withdrawal (Period 3)||25
9709940|NCT03333928|10809327|FG000|NOT COMPLETED|Randomized Withdrawal (Period 3)||2
9709941|NCT03333928|10809328|FG001|NOT COMPLETED|Randomized Withdrawal (Period 3)||0
9709942|NCT03333928|10809329|FG002|NOT COMPLETED|Randomized Withdrawal (Period 3)||1
9709943|NCT03298984|10809349|FG000|STARTED|Overall Study||3
9709944|NCT03298984|10809350|FG001|STARTED|Overall Study||3
9709945|NCT03298984|10809351|FG002|STARTED|Overall Study||3
10152861|NCT02852005|11283649|FG001|Month 0.5|Overall Study||4
10152862|NCT02852005|11283650|FG002|Month 0.5|Overall Study||6
10152863|NCT02852005|11283651|FG003|Month 0.5|Overall Study||6
10152864|NCT02852005|11283652|FG004|Month 0.5|Overall Study||7
10152865|NCT02852005|11283648|FG000|Month 4.5|Overall Study||3
10152866|NCT02852005|11283649|FG001|Month 4.5|Overall Study||4
10152867|NCT02852005|11283650|FG002|Month 4.5|Overall Study||6
10152868|NCT02852005|11283651|FG003|Month 4.5|Overall Study||6
10152869|NCT02852005|11283652|FG004|Month 4.5|Overall Study||7
10152870|NCT02852005|11283648|FG000|Month 10|Overall Study||3
10152871|NCT02852005|11283649|FG001|Month 10|Overall Study||3
9709946|NCT03298984|10809352|FG003|STARTED|Overall Study||23
9709947|NCT03298984|10809349|FG000|COMPLETED|Overall Study||2
10152872|NCT02852005|11283650|FG002|Month 10|Overall Study||6
10152873|NCT02852005|11283651|FG003|Month 10|Overall Study||5
10152874|NCT02852005|11283652|FG004|Month 10|Overall Study||7
10152875|NCT02852005|11283648|FG000|COMPLETED|Overall Study||3
10152876|NCT02852005|11283649|FG001|COMPLETED|Overall Study||4
10152877|NCT02852005|11283650|FG002|COMPLETED|Overall Study||6
10152878|NCT02852005|11283651|FG003|COMPLETED|Overall Study||6
10152879|NCT02852005|11283652|FG004|COMPLETED|Overall Study||6
10152880|NCT02852005|11283648|FG000|NOT COMPLETED|Overall Study||1
10152881|NCT02852005|11283649|FG001|NOT COMPLETED|Overall Study||0
10152882|NCT02852005|11283650|FG002|NOT COMPLETED|Overall Study||0
10152883|NCT02852005|11283651|FG003|NOT COMPLETED|Overall Study||0
10152884|NCT02852005|11283652|FG004|NOT COMPLETED|Overall Study||1
10152885|NCT02852265|11283668|FG000|STARTED|1-month Follow-up||10
10152886|NCT02852265|11283669|FG001|STARTED|1-month Follow-up||10
10152887|NCT02852265|11283668|FG000|COMPLETED|1-month Follow-up||10
10152888|NCT02852265|11283669|FG001|COMPLETED|1-month Follow-up||10
10152889|NCT02852265|11283668|FG000|NOT COMPLETED|1-month Follow-up||0
10152890|NCT02852265|11283669|FG001|NOT COMPLETED|1-month Follow-up||0
10152891|NCT02852265|11283668|FG000|STARTED|3-month Follow-up||10
10152892|NCT02852265|11283669|FG001|STARTED|3-month Follow-up||10
10152893|NCT02852265|11283668|FG000|COMPLETED|3-month Follow-up||9
10152894|NCT02852265|11283669|FG001|COMPLETED|3-month Follow-up||9
10152895|NCT02852265|11283668|FG000|NOT COMPLETED|3-month Follow-up||1
10152896|NCT02852265|11283669|FG001|NOT COMPLETED|3-month Follow-up||1
10152897|NCT02852265|11283668|FG000|STARTED|6-month Follow-up||9
10152898|NCT02852265|11283669|FG001|STARTED|6-month Follow-up||9
10152899|NCT02852265|11283668|FG000|COMPLETED|6-month Follow-up||9
10152900|NCT02852265|11283669|FG001|COMPLETED|6-month Follow-up||9
10152901|NCT02852265|11283668|FG000|NOT COMPLETED|6-month Follow-up||0
10152902|NCT02852265|11283669|FG001|NOT COMPLETED|6-month Follow-up||0
10152903|NCT02852330|11283679|FG000|STARTED|Overall Study||20
10152904|NCT02852330|11283679|FG000|COMPLETED|Overall Study||20
10152905|NCT02852330|11283679|FG000|NOT COMPLETED|Overall Study||0
10152906|NCT02852434|11283685|FG000|STARTED|Overall Study||36
10152907|NCT02852434|11283686|FG001|STARTED|Overall Study||36
10152908|NCT02852434|11283685|FG000|COMPLETED|Overall Study||34
10152909|NCT02852434|11283686|FG001|COMPLETED|Overall Study||35
10152910|NCT02852434|11283685|FG000|NOT COMPLETED|Overall Study||2
10152911|NCT02852434|11283686|FG001|NOT COMPLETED|Overall Study||1
10152912|NCT02853032|11283694|FG000|STARTED|Overall Study||60
10152913|NCT02853032|11283695|FG001|STARTED|Overall Study||59
10152914|NCT02853032|11283694|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
10152915|NCT02853032|11283695|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
10152916|NCT02853032|11283694|FG000|NOT COMPLETED|Overall Study||9
10152917|NCT02853032|11283695|FG001|NOT COMPLETED|Overall Study||3
10152918|NCT02853123|11283703|FG000|STARTED|Treatment Period 1||52
10152919|NCT02853123|11283704|FG001|STARTED|Treatment Period 1||54
10152920|NCT02853123|11283703|FG000|COMPLETED|Treatment Period 1||52
10152921|NCT02853123|11283704|FG001|COMPLETED|Treatment Period 1||51
10152922|NCT02853123|11283703|FG000|NOT COMPLETED|Treatment Period 1||0
10152923|NCT02853123|11283704|FG001|NOT COMPLETED|Treatment Period 1||3
10152924|NCT02853123|11283703|FG000|STARTED|Washout Period||52
10152925|NCT02853123|11283704|FG001|STARTED|Washout Period||51
10152926|NCT02853123|11283703|FG000|COMPLETED|Washout Period||51
10152927|NCT02853123|11283704|FG001|COMPLETED|Washout Period||48
10152928|NCT02853123|11283703|FG000|NOT COMPLETED|Washout Period||1
10152929|NCT02853123|11283704|FG001|NOT COMPLETED|Washout Period||3
10152930|NCT02853123|11283703|FG000|STARTED|Treatment Period 2||51
10152931|NCT02853123|11283704|FG001|STARTED|Treatment Period 2||48
10152932|NCT02853123|11283703|FG000|COMPLETED|Treatment Period 2||51
10152933|NCT02853123|11283704|FG001|COMPLETED|Treatment Period 2||48
10152934|NCT02853123|11283703|FG000|NOT COMPLETED|Treatment Period 2||0
10152935|NCT02853123|11283704|FG001|NOT COMPLETED|Treatment Period 2||0
10152936|NCT02853318|11283711|FG000|STARTED|Overall Study||40
10152937|NCT02853318|11283711|FG000|COMPLETED|Overall Study||39
10152938|NCT02853318|11283711|FG000|NOT COMPLETED|Overall Study||1
10152939|NCT02853435|11283718|FG000|STARTED|Part 1a, Period 1 (3 Days)||9
10152940|NCT02853435|11283719|FG001|STARTED|Part 1a, Period 1 (3 Days)||9
10152941|NCT02853435|11283720|FG002|STARTED|Part 1a, Period 1 (3 Days)||8
10152942|NCT02853435|11283721|FG003|STARTED|Part 1a, Period 1 (3 Days)||0
10152943|NCT02853435|11283722|FG004|STARTED|Part 1a, Period 1 (3 Days)||0
10152944|NCT02853435|11283723|FG005|STARTED|Part 1a, Period 1 (3 Days)||0
10152945|NCT02853435|11283718|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9
10152946|NCT02853435|11283719|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9
10152947|NCT02853435|11283720|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8
10152948|NCT02853435|11283721|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0
10152949|NCT02853435|11283722|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0
10152950|NCT02853435|11283723|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0
10152951|NCT02853435|11283718|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10152952|NCT02853435|11283719|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10152953|NCT02853435|11283720|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10152954|NCT02853435|11283721|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10152955|NCT02853435|11283722|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10152956|NCT02853435|11283723|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10152957|NCT02853435|11283718|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9
10152958|NCT02853435|11283719|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9
10152959|NCT02853435|11283720|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8
10152960|NCT02853435|11283721|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0
10152961|NCT02853435|11283722|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0
10152962|NCT02853435|11283723|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0
10152963|NCT02853435|11283718|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
10152964|NCT02853435|11283719|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
10152965|NCT02853435|11283720|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
10152966|NCT02853435|11283721|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152967|NCT02853435|11283722|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152968|NCT02853435|11283723|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152969|NCT02853435|11283718|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152970|NCT02853435|11283719|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152971|NCT02853435|11283720|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152972|NCT02853435|11283721|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152973|NCT02853435|11283722|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152974|NCT02853435|11283723|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10152975|NCT02853435|11283718|FG000|STARTED|Part 1a, Period 2 (3 Days)||9
10152976|NCT02853435|11283719|FG001|STARTED|Part 1a, Period 2 (3 Days)||9
10152977|NCT02853435|11283720|FG002|STARTED|Part 1a, Period 2 (3 Days)||8
10152978|NCT02853435|11283721|FG003|STARTED|Part 1a, Period 2 (3 Days)||0
10152979|NCT02853435|11283722|FG004|STARTED|Part 1a, Period 2 (3 Days)||0
10152980|NCT02853435|11283723|FG005|STARTED|Part 1a, Period 2 (3 Days)||0
10152981|NCT02853435|11283718|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9
10152982|NCT02853435|11283719|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9
10152983|NCT02853435|11283720|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8
10152984|NCT02853435|11283721|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0
10152985|NCT02853435|11283722|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0
10152986|NCT02853435|11283723|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0
10152987|NCT02853435|11283718|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10152988|NCT02853435|11283719|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10152989|NCT02853435|11283720|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10152990|NCT02853435|11283721|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10152991|NCT02853435|11283722|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10152992|NCT02853435|11283723|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10152993|NCT02853435|11283718|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9
10152994|NCT02853435|11283719|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9
10152995|NCT02853435|11283720|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8
10152996|NCT02853435|11283721|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0
10152997|NCT02853435|11283722|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0
10152998|NCT02853435|11283723|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0
10152999|NCT02853435|11283718|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
10153000|NCT02853435|11283719|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
10153001|NCT02853435|11283720|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
10153002|NCT02853435|11283721|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153003|NCT02853435|11283722|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153004|NCT02853435|11283723|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153005|NCT02853435|11283718|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153006|NCT02853435|11283719|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153007|NCT02853435|11283720|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153008|NCT02853435|11283721|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153009|NCT02853435|11283722|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153010|NCT02853435|11283723|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10153011|NCT02853435|11283718|FG000|STARTED|Part 1a, Period 3 (3 Days)||9
10153012|NCT02853435|11283719|FG001|STARTED|Part 1a, Period 3 (3 Days)||9
10153013|NCT02853435|11283720|FG002|STARTED|Part 1a, Period 3 (3 Days)||8
10153014|NCT02853435|11283721|FG003|STARTED|Part 1a, Period 3 (3 Days)||0
10153015|NCT02853435|11283722|FG004|STARTED|Part 1a, Period 3 (3 Days)||0
10153016|NCT02853435|11283723|FG005|STARTED|Part 1a, Period 3 (3 Days)||0
10153017|NCT02853435|11283718|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9
10153018|NCT02853435|11283719|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9
10153019|NCT02853435|11283720|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8
9709948|NCT03298984|10809350|FG001|COMPLETED|Overall Study||2
9709949|NCT03298984|10809351|FG002|COMPLETED|Overall Study||1
9709950|NCT03298984|10809352|FG003|COMPLETED|Overall Study||8
9709951|NCT03298984|10809349|FG000|NOT COMPLETED|Overall Study||1
9709952|NCT03298984|10809350|FG001|NOT COMPLETED|Overall Study||1
9709953|NCT03298984|10809351|FG002|NOT COMPLETED|Overall Study||2
9709954|NCT03298984|10809352|FG003|NOT COMPLETED|Overall Study||15
9709955|NCT03175198|10809363|FG000|STARTED|Overall Study||5565
9709956|NCT03175198|10809363|FG000|Safety Set 1|Overall Study||5436
9709957|NCT03175198|10809363|FG000|COMPLETED|Overall Study||3238
9709958|NCT03175198|10809363|FG000|NOT COMPLETED|Overall Study||2327
9709959|NCT03158727|10809369|FG000|STARTED|Overall Study||42
9709960|NCT03158727|10809370|FG001|STARTED|Overall Study||42
9709961|NCT03158727|10809369|FG000|Enrolled, Not Treated|Overall Study||1
9709962|NCT03158727|10809370|FG001|Enrolled, Not Treated|Overall Study||0
9709963|NCT03158727|10809369|FG000|COMPLETED|Overall Study||25
9709964|NCT03158727|10809370|FG001|COMPLETED|Overall Study||23
9709965|NCT03158727|10809369|FG000|NOT COMPLETED|Overall Study||17
9709966|NCT03158727|10809370|FG001|NOT COMPLETED|Overall Study||19
9709967|NCT03075826|10809376|FG000|STARTED|Overall Study||22
9709968|NCT03075826|10809376|FG000|COMPLETED|Overall Study||16
9709969|NCT03075826|10809376|FG000|NOT COMPLETED|Overall Study||6
9709970|NCT02993731|10809382|FG000|STARTED|Overall Study||565
10153020|NCT02853435|11283721|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0
10153021|NCT02853435|11283722|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0
10153022|NCT02853435|11283723|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0
10153023|NCT02853435|11283718|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10153024|NCT02853435|11283719|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10153025|NCT02853435|11283720|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10153026|NCT02853435|11283721|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10153027|NCT02853435|11283722|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10153028|NCT02853435|11283723|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10153029|NCT02853435|11283718|FG000|STARTED|Part 2, Period 1 (3 Days)||0
10153030|NCT02853435|11283719|FG001|STARTED|Part 2, Period 1 (3 Days)||0
10153031|NCT02853435|11283720|FG002|STARTED|Part 2, Period 1 (3 Days)||0
10153032|NCT02853435|11283721|FG003|STARTED|Part 2, Period 1 (3 Days)||10
10153033|NCT02853435|11283722|FG004|STARTED|Part 2, Period 1 (3 Days)||0
9709971|NCT02993731|10809383|FG001|STARTED|Overall Study||569
9709972|NCT02993731|10809382|FG000|COMPLETED|Overall Study||464
9709973|NCT02993731|10809383|FG001|COMPLETED|Overall Study||464
9709974|NCT02993731|10809382|FG000|NOT COMPLETED|Overall Study||101
9709975|NCT02993731|10809383|FG001|NOT COMPLETED|Overall Study||105
9709976|NCT02826161|10809401|FG000|STARTED|Overall Study||1
9709977|NCT02826161|10809402|FG001|STARTED|Overall Study||3
10153034|NCT02853435|11283723|FG005|STARTED|Part 2, Period 1 (3 Days)||0
10153035|NCT02853435|11283718|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
10153036|NCT02853435|11283719|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
10153037|NCT02853435|11283720|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
10153038|NCT02853435|11283721|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10
10153039|NCT02853435|11283722|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0
10153040|NCT02853435|11283723|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0
10153041|NCT02853435|11283718|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10153042|NCT02853435|11283719|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10153043|NCT02853435|11283720|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10153044|NCT02853435|11283721|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10153045|NCT02853435|11283722|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10153046|NCT02853435|11283723|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10153047|NCT02853435|11283718|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0
10153048|NCT02853435|11283719|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0
10153049|NCT02853435|11283720|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0
10153050|NCT02853435|11283721|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10
10153051|NCT02853435|11283722|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0
10153052|NCT02853435|11283723|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0
10153053|NCT02853435|11283718|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153054|NCT02853435|11283719|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153055|NCT02853435|11283720|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153056|NCT02853435|11283721|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
10153057|NCT02853435|11283722|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153058|NCT02853435|11283723|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153059|NCT02853435|11283718|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153060|NCT02853435|11283719|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153061|NCT02853435|11283720|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153062|NCT02853435|11283721|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153063|NCT02853435|11283722|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153064|NCT02853435|11283723|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10153065|NCT02853435|11283718|FG000|STARTED|Part 2, Period 2 (3 Days)||0
10153066|NCT02853435|11283719|FG001|STARTED|Part 2, Period 2 (3 Days)||0
10153067|NCT02853435|11283720|FG002|STARTED|Part 2, Period 2 (3 Days)||0
10153068|NCT02853435|11283721|FG003|STARTED|Part 2, Period 2 (3 Days)||10
10153069|NCT02853435|11283722|FG004|STARTED|Part 2, Period 2 (3 Days)||0
10153070|NCT02853435|11283723|FG005|STARTED|Part 2, Period 2 (3 Days)||0
10153071|NCT02853435|11283718|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
10153072|NCT02853435|11283719|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
10153073|NCT02853435|11283720|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
10153074|NCT02853435|11283721|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10
10153075|NCT02853435|11283722|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0
10153076|NCT02853435|11283723|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0
10153077|NCT02853435|11283718|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10153078|NCT02853435|11283719|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10153079|NCT02853435|11283720|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10153080|NCT02853435|11283721|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
9709978|NCT02826161|10809401|FG000|Discontinued Due to Treatment Related AE|Overall Study||1
9709979|NCT02826161|10809402|FG001|Discontinued Due to Treatment Related AE|Overall Study||0
9709980|NCT02826161|10809401|FG000|Discontinued Due to Death|Overall Study||0
9709981|NCT02826161|10809402|FG001|Discontinued Due to Death|Overall Study||1
9709982|NCT02826161|10809401|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0
9709983|NCT02826161|10809402|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1
9709984|NCT02826161|10809401|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
9709985|NCT02826161|10809402|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
9709986|NCT02826161|10809401|FG000|COMPLETED|Overall Study||1
9709987|NCT02826161|10809402|FG001|COMPLETED|Overall Study||3
9709988|NCT02826161|10809401|FG000|NOT COMPLETED|Overall Study||0
9709989|NCT02826161|10809402|FG001|NOT COMPLETED|Overall Study||0
9709990|NCT02586025|10809409|FG000|STARTED|Neoadjuvant Treatment||219
9709991|NCT02586025|10809410|FG001|STARTED|Neoadjuvant Treatment||110
9709992|NCT02586025|10809409|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
9709993|NCT02586025|10809410|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
9709994|NCT02586025|10809409|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
9709995|NCT02586025|10809410|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
9709996|NCT02586025|10809409|FG000|Underwent Surgery|Neoadjuvant Treatment||210
9709997|NCT02586025|10809410|FG001|Underwent Surgery|Neoadjuvant Treatment||105
9709998|NCT02586025|10809409|FG000|COMPLETED|Neoadjuvant Treatment||208
9709999|NCT02586025|10809410|FG001|COMPLETED|Neoadjuvant Treatment||103
9710000|NCT02586025|10809409|FG000|NOT COMPLETED|Neoadjuvant Treatment||11
9710001|NCT02586025|10809410|FG001|NOT COMPLETED|Neoadjuvant Treatment||7
9710002|NCT02586025|10809409|FG000|STARTED|Adjuvant Treatment||208
9710003|NCT02586025|10809410|FG001|STARTED|Adjuvant Treatment||103
9710004|NCT02586025|10809409|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
9710005|NCT02586025|10809410|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
9710006|NCT02586025|10809409|FG000|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
9710007|NCT02586025|10809410|FG001|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
9710008|NCT02586025|10809409|FG000|COMPLETED|Adjuvant Treatment||69
9710009|NCT02586025|10809410|FG001|COMPLETED|Adjuvant Treatment||34
10153081|NCT02853435|11283722|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10153082|NCT02853435|11283723|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10153083|NCT02853435|11283718|FG000|STARTED|Part 3, Period 1 (3 Days)||0
10153084|NCT02853435|11283719|FG001|STARTED|Part 3, Period 1 (3 Days)||0
10153085|NCT02853435|11283720|FG002|STARTED|Part 3, Period 1 (3 Days)||0
10153086|NCT02853435|11283721|FG003|STARTED|Part 3, Period 1 (3 Days)||0
10153087|NCT02853435|11283722|FG004|STARTED|Part 3, Period 1 (3 Days)||10
10153088|NCT02853435|11283723|FG005|STARTED|Part 3, Period 1 (3 Days)||2
10153089|NCT02853435|11283718|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0
10153090|NCT02853435|11283719|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0
10153091|NCT02853435|11283720|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0
10153092|NCT02853435|11283721|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0
10153093|NCT02853435|11283722|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10
10153094|NCT02853435|11283723|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2
10153095|NCT02853435|11283718|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10153096|NCT02853435|11283719|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10153097|NCT02853435|11283720|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10153098|NCT02853435|11283721|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10153099|NCT02853435|11283722|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10153100|NCT02853435|11283723|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10153101|NCT02853435|11283718|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0
10153102|NCT02853435|11283719|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0
10153103|NCT02853435|11283720|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0
10153104|NCT02853435|11283721|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0
10153105|NCT02853435|11283722|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10
10153106|NCT02853435|11283723|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2
10153107|NCT02853435|11283718|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153108|NCT02853435|11283719|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153109|NCT02853435|11283720|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153110|NCT02853435|11283721|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153111|NCT02853435|11283722|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
10153112|NCT02853435|11283723|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
10153113|NCT02853435|11283718|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153114|NCT02853435|11283719|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153115|NCT02853435|11283720|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153116|NCT02853435|11283721|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153117|NCT02853435|11283722|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153118|NCT02853435|11283723|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10153119|NCT02853435|11283718|FG000|STARTED|Part 3, Period 2 (3 Days)||0
10153120|NCT02853435|11283719|FG001|STARTED|Part 3, Period 2 (3 Days)||0
10153121|NCT02853435|11283720|FG002|STARTED|Part 3, Period 2 (3 Days)||0
10153122|NCT02853435|11283721|FG003|STARTED|Part 3, Period 2 (3 Days)||0
10153123|NCT02853435|11283722|FG004|STARTED|Part 3, Period 2 (3 Days)||10
10153124|NCT02853435|11283723|FG005|STARTED|Part 3, Period 2 (3 Days)||2
10153125|NCT02853435|11283718|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0
10153126|NCT02853435|11283719|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0
10153127|NCT02853435|11283720|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0
10153128|NCT02853435|11283721|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0
10153129|NCT02853435|11283722|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10
10153130|NCT02853435|11283723|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2
10153131|NCT02853435|11283718|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10153132|NCT02853435|11283719|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10153133|NCT02853435|11283720|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10153134|NCT02853435|11283721|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10153135|NCT02853435|11283722|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10153136|NCT02853435|11283723|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10153137|NCT02853435|11283718|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0
10153138|NCT02853435|11283719|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0
10153139|NCT02853435|11283720|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0
10153140|NCT02853435|11283721|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0
10153141|NCT02853435|11283722|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10
10153142|NCT02853435|11283723|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2
10153143|NCT02853435|11283718|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153144|NCT02853435|11283719|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153145|NCT02853435|11283720|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153146|NCT02853435|11283721|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153147|NCT02853435|11283722|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
10153148|NCT02853435|11283723|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
10153149|NCT02853435|11283718|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153150|NCT02853435|11283719|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153151|NCT02853435|11283720|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
9849080|NCT00862849|10961752|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
9849081|NCT00862849|10961753|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
9849082|NCT00862849|10961754|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
9849083|NCT00862849|10961755|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
9849084|NCT00862849|10961756|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
9849085|NCT00862849|10961757|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
9849086|NCT00862849|10961752|FG000|STARTED|Intervention 6||3
9849087|NCT00862849|10961753|FG001|STARTED|Intervention 6||3
9849088|NCT00862849|10961754|FG002|STARTED|Intervention 6||3
9849089|NCT00862849|10961755|FG003|STARTED|Intervention 6||4
10153152|NCT02853435|11283721|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153153|NCT02853435|11283722|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
10153154|NCT02853435|11283723|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10153155|NCT02853435|11283718|FG000|STARTED|Part 3, Period 3 (3 Days)||0
10153156|NCT02853435|11283719|FG001|STARTED|Part 3, Period 3 (3 Days)||0
10153157|NCT02853435|11283720|FG002|STARTED|Part 3, Period 3 (3 Days)||0
10153158|NCT02853435|11283721|FG003|STARTED|Part 3, Period 3 (3 Days)||0
10153159|NCT02853435|11283722|FG004|STARTED|Part 3, Period 3 (3 Days)||9
10153160|NCT02853435|11283723|FG005|STARTED|Part 3, Period 3 (3 Days)||2
10153161|NCT02853435|11283718|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0
10153162|NCT02853435|11283719|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0
10153163|NCT02853435|11283720|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0
10153164|NCT02853435|11283721|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0
10153165|NCT02853435|11283722|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9
10153166|NCT02853435|11283723|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2
10153167|NCT02853435|11283718|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10153168|NCT02853435|11283719|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10153169|NCT02853435|11283720|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10153170|NCT02853435|11283721|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10153171|NCT02853435|11283722|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10153172|NCT02853435|11283723|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10153173|NCT02853929|11283755|FG000|STARTED|Overall Study||270
10153174|NCT02853929|11283756|FG001|STARTED|Overall Study||281
10153175|NCT02853929|11283755|FG000|Vaccinated|Overall Study||263
10153176|NCT02853929|11283756|FG001|Vaccinated|Overall Study||277
10153177|NCT02853929|11283755|FG000|COMPLETED|Overall Study||259
10153178|NCT02853929|11283756|FG001|COMPLETED|Overall Study||277
10153179|NCT02853929|11283755|FG000|NOT COMPLETED|Overall Study||11
10153180|NCT02853929|11283756|FG001|NOT COMPLETED|Overall Study||4
10153181|NCT02854059|11283764|FG000|STARTED|Overall Study||2
10153182|NCT02854059|11283765|FG001|STARTED|Overall Study||0
10153183|NCT02854059|11283764|FG000|COMPLETED|Overall Study||2
10153184|NCT02854059|11283765|FG001|COMPLETED|Overall Study||0
10153185|NCT02854059|11283764|FG000|NOT COMPLETED|Overall Study||0
10153186|NCT02854059|11283765|FG001|NOT COMPLETED|Overall Study||0
10153187|NCT02854527|11283781|FG000|STARTED|Overall Study||3
10153188|NCT02854527|11283782|FG001|STARTED|Overall Study||3
10153189|NCT02854527|11283783|FG002|STARTED|Overall Study||3
10153190|NCT02854527|11283784|FG003|STARTED|Overall Study||3
10153191|NCT02854527|11283785|FG004|STARTED|Overall Study||3
10153192|NCT02854527|11283786|FG005|STARTED|Overall Study||3
10153193|NCT02854527|11283787|FG006|STARTED|Overall Study||3
10153194|NCT02854527|11283788|FG007|STARTED|Overall Study||3
10153195|NCT02854527|11283789|FG008|STARTED|Overall Study||3
10153196|NCT02854527|11283790|FG009|STARTED|Overall Study||3
10153197|NCT02854527|11283781|FG000|Received R1|Overall Study||3
10153198|NCT02854527|11283782|FG001|Received R1|Overall Study||3
10153199|NCT02854527|11283783|FG002|Received R1|Overall Study||3
10153200|NCT02854527|11283784|FG003|Received R1|Overall Study||2
10153201|NCT02854527|11283785|FG004|Received R1|Overall Study||2
10153202|NCT02854527|11283786|FG005|Received R1|Overall Study||3
10153203|NCT02854527|11283787|FG006|Received R1|Overall Study||3
10153204|NCT02854527|11283788|FG007|Received R1|Overall Study||3
10153205|NCT02854527|11283789|FG008|Received R1|Overall Study||3
10153206|NCT02854527|11283790|FG009|Received R1|Overall Study||3
10153207|NCT02854527|11283781|FG000|Received R2|Overall Study||3
10153208|NCT02854527|11283782|FG001|Received R2|Overall Study||3
10153209|NCT02854527|11283783|FG002|Received R2|Overall Study||3
10153210|NCT02854527|11283784|FG003|Received R2|Overall Study||3
10153211|NCT02854527|11283785|FG004|Received R2|Overall Study||3
10153212|NCT02854527|11283786|FG005|Received R2|Overall Study||3
10153213|NCT02854527|11283787|FG006|Received R2|Overall Study||3
10153214|NCT02854527|11283788|FG007|Received R2|Overall Study||3
10153215|NCT02854527|11283789|FG008|Received R2|Overall Study||3
10153216|NCT02854527|11283790|FG009|Received R2|Overall Study||3
10153217|NCT02854527|11283781|FG000|Received R3|Overall Study||3
10153218|NCT02854527|11283782|FG001|Received R3|Overall Study||3
10153219|NCT02854527|11283783|FG002|Received R3|Overall Study||3
10153220|NCT02854527|11283784|FG003|Received R3|Overall Study||2
10153221|NCT02854527|11283785|FG004|Received R3|Overall Study||3
10153222|NCT02854527|11283786|FG005|Received R3|Overall Study||3
10153223|NCT02854527|11283787|FG006|Received R3|Overall Study||3
10153224|NCT02854527|11283788|FG007|Received R3|Overall Study||3
10153225|NCT02854527|11283789|FG008|Received R3|Overall Study||3
10153226|NCT02854527|11283790|FG009|Received R3|Overall Study||3
10153227|NCT02854527|11283781|FG000|Received R4|Overall Study||3
10153228|NCT02854527|11283782|FG001|Received R4|Overall Study||3
10153229|NCT02854527|11283783|FG002|Received R4|Overall Study||3
10153230|NCT02854527|11283784|FG003|Received R4|Overall Study||2
10153231|NCT02854527|11283785|FG004|Received R4|Overall Study||3
10153232|NCT02854527|11283786|FG005|Received R4|Overall Study||3
10153233|NCT02854527|11283787|FG006|Received R4|Overall Study||3
10153234|NCT02854527|11283788|FG007|Received R4|Overall Study||3
10153235|NCT02854527|11283789|FG008|Received R4|Overall Study||3
10153236|NCT02854527|11283790|FG009|Received R4|Overall Study||3
10153237|NCT02854527|11283781|FG000|Received T|Overall Study||3
10153238|NCT02854527|11283782|FG001|Received T|Overall Study||3
10153239|NCT02854527|11283783|FG002|Received T|Overall Study||3
10153240|NCT02854527|11283784|FG003|Received T|Overall Study||2
10153241|NCT02854527|11283785|FG004|Received T|Overall Study||2
10153242|NCT02854527|11283786|FG005|Received T|Overall Study||3
10153243|NCT02854527|11283787|FG006|Received T|Overall Study||3
10153244|NCT02854527|11283788|FG007|Received T|Overall Study||3
10153245|NCT02854527|11283789|FG008|Received T|Overall Study||3
10153246|NCT02854527|11283790|FG009|Received T|Overall Study||3
10153247|NCT02854527|11283781|FG000|COMPLETED|Overall Study||3
10153248|NCT02854527|11283782|FG001|COMPLETED|Overall Study||3
10153249|NCT02854527|11283783|FG002|COMPLETED|Overall Study||3
10153250|NCT02854527|11283784|FG003|COMPLETED|Overall Study||2
10153251|NCT02854527|11283785|FG004|COMPLETED|Overall Study||2
10153252|NCT02854527|11283786|FG005|COMPLETED|Overall Study||3
10153253|NCT02854527|11283787|FG006|COMPLETED|Overall Study||3
10153254|NCT02854527|11283788|FG007|COMPLETED|Overall Study||3
10153255|NCT02854527|11283789|FG008|COMPLETED|Overall Study||3
9710010|NCT02586025|10809409|FG000|NOT COMPLETED|Adjuvant Treatment||139
9710011|NCT02586025|10809410|FG001|NOT COMPLETED|Adjuvant Treatment||69
9710012|NCT02586025|10809409|FG000|STARTED|Treatment-Free Follow-Up||59
9710013|NCT02586025|10809410|FG001|STARTED|Treatment-Free Follow-Up||38
9710014|NCT02586025|10809409|FG000|COMPLETED|Treatment-Free Follow-Up||3
9710015|NCT02586025|10809410|FG001|COMPLETED|Treatment-Free Follow-Up||3
9710016|NCT02586025|10809409|FG000|NOT COMPLETED|Treatment-Free Follow-Up||56
9710017|NCT02586025|10809410|FG001|NOT COMPLETED|Treatment-Free Follow-Up||35
9710018|NCT02520011|10809419|FG000|STARTED|Overall Study||11
9710019|NCT02520011|10809420|FG001|STARTED|Overall Study||79
9710020|NCT02520011|10809421|FG002|STARTED|Overall Study||14
9710021|NCT02520011|10809419|FG000|Stage 1|Overall Study||0
9710022|NCT02520011|10809420|FG001|Stage 1|Overall Study||32
9710023|NCT02520011|10809421|FG002|Stage 1|Overall Study||10
9710024|NCT02520011|10809419|FG000|Stage 2|Overall Study||11
9710025|NCT02520011|10809420|FG001|Stage 2|Overall Study||47
9710026|NCT02520011|10809421|FG002|Stage 2|Overall Study||4
9710027|NCT02520011|10809419|FG000|COMPLETED|Overall Study||6
9710028|NCT02520011|10809420|FG001|COMPLETED|Overall Study||33
9710029|NCT02520011|10809421|FG002|COMPLETED|Overall Study||5
9710030|NCT02520011|10809419|FG000|NOT COMPLETED|Overall Study||5
9710031|NCT02520011|10809420|FG001|NOT COMPLETED|Overall Study||46
9710032|NCT02520011|10809421|FG002|NOT COMPLETED|Overall Study||9
9710033|NCT02315534|10809436|FG000|STARTED|Overall Study||4
9710034|NCT02315534|10809437|FG001|STARTED|Overall Study||30
9710035|NCT02315534|10809436|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
9710036|NCT02315534|10809437|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
9710037|NCT02315534|10809436|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2
9710038|NCT02315534|10809437|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20
9710039|NCT02315534|10809436|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1
9710040|NCT02315534|10809437|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7
9710041|NCT02315534|10809436|FG000|Off Treatment Due to Patient Request|Overall Study||1
9710042|NCT02315534|10809437|FG001|Off Treatment Due to Patient Request|Overall Study||2
9710043|NCT02315534|10809436|FG000|Off Treatment Due to Clinical PD|Overall Study||0
9710044|NCT02315534|10809437|FG001|Off Treatment Due to Clinical PD|Overall Study||1
9710045|NCT02315534|10809436|FG000|COMPLETED|Overall Study||4
9710046|NCT02315534|10809437|FG001|COMPLETED|Overall Study||30
9710047|NCT02315534|10809436|FG000|NOT COMPLETED|Overall Study||0
9710048|NCT02315534|10809437|FG001|NOT COMPLETED|Overall Study||0
9710049|NCT02279719|10809458|FG000|STARTED|Overall Study||5
9710050|NCT02279719|10809459|FG001|STARTED|Overall Study||10
9710051|NCT02279719|10809460|FG002|STARTED|Overall Study||4
9710052|NCT02279719|10809461|FG003|STARTED|Overall Study||9
9710053|NCT02279719|10809462|FG004|STARTED|Overall Study||28
9710054|NCT02279719|10809463|FG005|STARTED|Overall Study||10
9710055|NCT02279719|10809464|FG006|STARTED|Overall Study||31
9710056|NCT02279719|10809458|FG000|COMPLETED|Overall Study||5
9710057|NCT02279719|10809459|FG001|COMPLETED|Overall Study||10
9710058|NCT02279719|10809460|FG002|COMPLETED|Overall Study||4
9710059|NCT02279719|10809461|FG003|COMPLETED|Overall Study||9
9710060|NCT02279719|10809462|FG004|COMPLETED|Overall Study||25
9710061|NCT02279719|10809463|FG005|COMPLETED|Overall Study||10
9710062|NCT02279719|10809464|FG006|COMPLETED|Overall Study||28
9710063|NCT02279719|10809458|FG000|NOT COMPLETED|Overall Study||0
9710064|NCT02279719|10809459|FG001|NOT COMPLETED|Overall Study||0
9710065|NCT02279719|10809460|FG002|NOT COMPLETED|Overall Study||0
9710066|NCT02279719|10809461|FG003|NOT COMPLETED|Overall Study||0
9710067|NCT02279719|10809462|FG004|NOT COMPLETED|Overall Study||3
9710068|NCT02279719|10809463|FG005|NOT COMPLETED|Overall Study||0
9710069|NCT02279719|10809464|FG006|NOT COMPLETED|Overall Study||3
9710070|NCT02178956|10809499|FG000|STARTED|Overall Study||357
9710071|NCT02178956|10809500|FG001|STARTED|Overall Study||357
10153256|NCT02854527|11283790|FG009|COMPLETED|Overall Study||3
9710072|NCT02178956|10809499|FG000|COMPLETED|Overall Study||286
9710073|NCT02178956|10809500|FG001|COMPLETED|Overall Study||279
10153257|NCT02854527|11283781|FG000|NOT COMPLETED|Overall Study||0
10153258|NCT02854527|11283782|FG001|NOT COMPLETED|Overall Study||0
10153259|NCT02854527|11283783|FG002|NOT COMPLETED|Overall Study||0
10153260|NCT02854527|11283784|FG003|NOT COMPLETED|Overall Study||1
10153261|NCT02854527|11283785|FG004|NOT COMPLETED|Overall Study||1
10153262|NCT02854527|11283786|FG005|NOT COMPLETED|Overall Study||0
10153263|NCT02854527|11283787|FG006|NOT COMPLETED|Overall Study||0
10153264|NCT02854527|11283788|FG007|NOT COMPLETED|Overall Study||0
10153265|NCT02854527|11283789|FG008|NOT COMPLETED|Overall Study||0
10153266|NCT02854527|11283790|FG009|NOT COMPLETED|Overall Study||0
10153267|NCT02854540|11283802|FG000|STARTED|Overall Study||13
10153268|NCT02854540|11283802|FG000|COMPLETED|Overall Study||11
10153269|NCT02854540|11283802|FG000|NOT COMPLETED|Overall Study||2
10153270|NCT02854605|11283811|FG000|STARTED|Overall Study||56
10153271|NCT02854605|11283812|FG001|STARTED|Overall Study||56
10153272|NCT02854605|11283813|FG002|STARTED|Overall Study||28
10153273|NCT02854605|11283811|FG000|COMPLETED|Overall Study||53
10153274|NCT02854605|11283812|FG001|COMPLETED|Overall Study||49
10153275|NCT02854605|11283813|FG002|COMPLETED|Overall Study||24
10153276|NCT02854605|11283811|FG000|NOT COMPLETED|Overall Study||3
10153277|NCT02854605|11283812|FG001|NOT COMPLETED|Overall Study||7
10153278|NCT02854605|11283813|FG002|NOT COMPLETED|Overall Study||4
10153279|NCT02854631|11283823|FG000|STARTED|Overall Study||52
10153280|NCT02854631|11283824|FG001|STARTED|Overall Study||52
10153281|NCT02854631|11283823|FG000|COMPLETED|Overall Study||26
10153282|NCT02854631|11283824|FG001|COMPLETED|Overall Study||37
10153283|NCT02854631|11283823|FG000|NOT COMPLETED|Overall Study||26
10153284|NCT02854631|11283824|FG001|NOT COMPLETED|Overall Study||15
10153285|NCT02854800|11283833|FG000|STARTED|Overall Study||32
10153286|NCT02854800|11283834|FG001|STARTED|Overall Study||28
10153287|NCT02854800|11283835|FG002|STARTED|Overall Study||14
10153288|NCT02854800|11283833|FG000|COMPLETED|Overall Study||12
10153289|NCT02854800|11283834|FG001|COMPLETED|Overall Study||15
10153290|NCT02854800|11283835|FG002|COMPLETED|Overall Study||8
10153291|NCT02854800|11283833|FG000|NOT COMPLETED|Overall Study||20
10153292|NCT02854800|11283834|FG001|NOT COMPLETED|Overall Study||13
10153293|NCT02854800|11283835|FG002|NOT COMPLETED|Overall Study||6
10153294|NCT02855086|11283848|FG000|STARTED|Overall Study||2
10153295|NCT02855086|11283849|FG001|STARTED|Overall Study||1
10153296|NCT02855086|11283848|FG000|COMPLETED|Overall Study||2
10153297|NCT02855086|11283849|FG001|COMPLETED|Overall Study||1
10153298|NCT02855086|11283848|FG000|NOT COMPLETED|Overall Study||0
10153299|NCT02855086|11283849|FG001|NOT COMPLETED|Overall Study||0
10153300|NCT02855164|11283863|FG000|STARTED|Parts A + B (Randomized Set)||14
10153301|NCT02855164|11283864|FG001|STARTED|Parts A + B (Randomized Set)||16
10153302|NCT02855164|11283865|FG002|STARTED|Parts A + B (Randomized Set)||37
10153303|NCT02855164|11283866|FG003|STARTED|Parts A + B (Randomized Set)||85
10153304|NCT02855164|11283867|FG004|STARTED|Parts A + B (Randomized Set)||46
10153305|NCT02855164|11283868|FG005|STARTED|Parts A + B (Randomized Set)||0
10153306|NCT02855164|11283869|FG006|STARTED|Parts A + B (Randomized Set)||0
10153307|NCT02855164|11283870|FG007|STARTED|Parts A + B (Randomized Set)||0
10153308|NCT02855164|11283863|FG000|COMPLETED|Parts A + B (Randomized Set)||14
10153309|NCT02855164|11283864|FG001|COMPLETED|Parts A + B (Randomized Set)||16
10153310|NCT02855164|11283865|FG002|COMPLETED|Parts A + B (Randomized Set)||36
10153311|NCT02855164|11283866|FG003|COMPLETED|Parts A + B (Randomized Set)||77
10153312|NCT02855164|11283867|FG004|COMPLETED|Parts A + B (Randomized Set)||45
10153313|NCT02855164|11283868|FG005|COMPLETED|Parts A + B (Randomized Set)||0
10153314|NCT02855164|11283869|FG006|COMPLETED|Parts A + B (Randomized Set)||0
10153315|NCT02855164|11283870|FG007|COMPLETED|Parts A + B (Randomized Set)||0
10153316|NCT02855164|11283863|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0
10153317|NCT02855164|11283864|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0
10153318|NCT02855164|11283865|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1
10153319|NCT02855164|11283866|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8
10153320|NCT02855164|11283867|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1
10153321|NCT02855164|11283868|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0
10153322|NCT02855164|11283869|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0
10153323|NCT02855164|11283870|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0
10153324|NCT02855164|11283863|FG000|STARTED|Part C (Randomized Set)||0
10153325|NCT02855164|11283864|FG001|STARTED|Part C (Randomized Set)||0
10153326|NCT02855164|11283865|FG002|STARTED|Part C (Randomized Set)||0
10153327|NCT02855164|11283866|FG003|STARTED|Part C (Randomized Set)||0
10153328|NCT02855164|11283867|FG004|STARTED|Part C (Randomized Set)||0
10153329|NCT02855164|11283868|FG005|STARTED|Part C (Randomized Set)||50
10153330|NCT02855164|11283869|FG006|STARTED|Part C (Randomized Set)||51
10153331|NCT02855164|11283870|FG007|STARTED|Part C (Randomized Set)||51
10153332|NCT02855164|11283863|FG000|COMPLETED|Part C (Randomized Set)||0
10153333|NCT02855164|11283864|FG001|COMPLETED|Part C (Randomized Set)||0
10153334|NCT02855164|11283865|FG002|COMPLETED|Part C (Randomized Set)||0
10153335|NCT02855164|11283866|FG003|COMPLETED|Part C (Randomized Set)||0
10153336|NCT02855164|11283867|FG004|COMPLETED|Part C (Randomized Set)||0
10153337|NCT02855164|11283868|FG005|COMPLETED|Part C (Randomized Set)||38
10153338|NCT02855164|11283869|FG006|COMPLETED|Part C (Randomized Set)||37
10153339|NCT02855164|11283870|FG007|COMPLETED|Part C (Randomized Set)||44
10153340|NCT02855164|11283863|FG000|NOT COMPLETED|Part C (Randomized Set)||0
10153341|NCT02855164|11283864|FG001|NOT COMPLETED|Part C (Randomized Set)||0
10153342|NCT02855164|11283865|FG002|NOT COMPLETED|Part C (Randomized Set)||0
10153343|NCT02855164|11283866|FG003|NOT COMPLETED|Part C (Randomized Set)||0
10153344|NCT02855164|11283867|FG004|NOT COMPLETED|Part C (Randomized Set)||0
10153345|NCT02855164|11283868|FG005|NOT COMPLETED|Part C (Randomized Set)||12
10153346|NCT02855164|11283869|FG006|NOT COMPLETED|Part C (Randomized Set)||14
10153347|NCT02855164|11283870|FG007|NOT COMPLETED|Part C (Randomized Set)||7
10153348|NCT02855281|11283908|FG000|STARTED|Overall Study||50
10153349|NCT02855281|11283908|FG000|COMPLETED|Overall Study||50
10153350|NCT02855281|11283908|FG000|NOT COMPLETED|Overall Study||0
10153351|NCT02855359|11283918|FG000|STARTED|Overall Study||11
10153352|NCT02855359|11283919|FG001|STARTED|Overall Study||13
10153353|NCT02855359|11283920|FG002|STARTED|Overall Study||0
10153354|NCT02855359|11283921|FG003|STARTED|Overall Study||0
10153355|NCT02855359|11283918|FG000|COMPLETED|Overall Study||0
10153356|NCT02855359|11283919|FG001|COMPLETED|Overall Study||0
10153357|NCT02855359|11283920|FG002|COMPLETED|Overall Study||0
10153358|NCT02855359|11283921|FG003|COMPLETED|Overall Study||0
10153359|NCT02855359|11283918|FG000|NOT COMPLETED|Overall Study||11
10153360|NCT02855359|11283919|FG001|NOT COMPLETED|Overall Study||13
10153361|NCT02855359|11283920|FG002|NOT COMPLETED|Overall Study||0
10153362|NCT02855359|11283921|FG003|NOT COMPLETED|Overall Study||0
10153363|NCT02855437|11283929|FG000|STARTED|Phase 1||23
10153364|NCT02855437|11283930|FG001|STARTED|Phase 1||21
10153365|NCT02855437|11283929|FG000|COMPLETED|Phase 1||21
10153366|NCT02855437|11283930|FG001|COMPLETED|Phase 1||19
10153367|NCT02855437|11283929|FG000|NOT COMPLETED|Phase 1||2
10153368|NCT02855437|11283930|FG001|NOT COMPLETED|Phase 1||2
10153369|NCT02855437|11283929|FG000|STARTED|Crossover Period (Same Day)||21
10153370|NCT02855437|11283930|FG001|STARTED|Crossover Period (Same Day)||19
10153371|NCT02855437|11283929|FG000|COMPLETED|Crossover Period (Same Day)||21
10153372|NCT02855437|11283930|FG001|COMPLETED|Crossover Period (Same Day)||19
10153373|NCT02855437|11283929|FG000|NOT COMPLETED|Crossover Period (Same Day)||0
10153374|NCT02855437|11283930|FG001|NOT COMPLETED|Crossover Period (Same Day)||0
10153375|NCT02855437|11283929|FG000|STARTED|Phase 2||21
10153376|NCT02855437|11283930|FG001|STARTED|Phase 2||19
10153377|NCT02855437|11283929|FG000|COMPLETED|Phase 2||20
10153378|NCT02855437|11283930|FG001|COMPLETED|Phase 2||18
10153379|NCT02855437|11283929|FG000|NOT COMPLETED|Phase 2||1
10153380|NCT02855437|11283930|FG001|NOT COMPLETED|Phase 2||1
10153381|NCT02855450|11283939|FG000|STARTED|Overall Study||40
10153382|NCT02855450|11283940|FG001|STARTED|Overall Study||20
10153383|NCT02855450|11283939|FG000|COMPLETED|Overall Study||35
10153384|NCT02855450|11283940|FG001|COMPLETED|Overall Study||20
10153385|NCT02855450|11283939|FG000|NOT COMPLETED|Overall Study||5
10153386|NCT02855450|11283940|FG001|NOT COMPLETED|Overall Study||0
10153387|NCT02855541|11283946|FG000|STARTED|Overall Study||25
10153388|NCT02855541|11283946|FG000|COMPLETED|Overall Study||21
10153389|NCT02855541|11283946|FG000|NOT COMPLETED|Overall Study||4
10153390|NCT02855567|11283952|FG000|STARTED|Overall Study||54
10153391|NCT02855567|11283953|FG001|STARTED|Overall Study||56
10153392|NCT02855567|11283952|FG000|COMPLETED|Overall Study||54
10153393|NCT02855567|11283953|FG001|COMPLETED|Overall Study||56
10153394|NCT02855567|11283952|FG000|NOT COMPLETED|Overall Study||0
10153395|NCT02855567|11283953|FG001|NOT COMPLETED|Overall Study||0
10153396|NCT02856035|11283959|FG000|STARTED|Overall Study||4
10153397|NCT02856035|11283959|FG000|COMPLETED|Overall Study||4
10153398|NCT02856035|11283959|FG000|NOT COMPLETED|Overall Study||0
10153399|NCT02856282|11283963|FG000|STARTED|Overall Study||46
10153400|NCT02856282|11283963|FG000|COMPLETED|Overall Study||45
10153401|NCT02856282|11283963|FG000|NOT COMPLETED|Overall Study||1
10153402|NCT02856490|11283970|FG000|STARTED|Overall Study||2
10153403|NCT02856490|11283971|FG001|STARTED|Overall Study||2
10153404|NCT02856490|11283972|FG002|STARTED|Overall Study||2
10153405|NCT02856490|11283970|FG000|COMPLETED|Overall Study||2
10153406|NCT02856490|11283971|FG001|COMPLETED|Overall Study||2
10153407|NCT02856490|11283972|FG002|COMPLETED|Overall Study||2
10153408|NCT02856490|11283970|FG000|NOT COMPLETED|Overall Study||0
10153409|NCT02856490|11283971|FG001|NOT COMPLETED|Overall Study||0
10153410|NCT02856490|11283972|FG002|NOT COMPLETED|Overall Study||0
10153411|NCT02856555|11283983|FG000|STARTED|Overall Study||51
10153412|NCT02856555|11283984|FG001|STARTED|Overall Study||50
10153413|NCT02856555|11283985|FG002|STARTED|Overall Study||26
10153414|NCT02856555|11283983|FG000|COMPLETED|Overall Study||46
10153415|NCT02856555|11283984|FG001|COMPLETED|Overall Study||46
10153416|NCT02856555|11283985|FG002|COMPLETED|Overall Study||26
10153417|NCT02856555|11283983|FG000|NOT COMPLETED|Overall Study||5
10153418|NCT02856555|11283984|FG001|NOT COMPLETED|Overall Study||4
10153419|NCT02856555|11283985|FG002|NOT COMPLETED|Overall Study||0
10153420|NCT02856802|11283995|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
10153421|NCT02856802|11283996|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
10153422|NCT02856802|11283995|FG000|COMPLETED|Double-Blind Treatment Period 1||48
10153423|NCT02856802|11283996|FG001|COMPLETED|Double-Blind Treatment Period 1||38
10153424|NCT02856802|11283995|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2
10153425|NCT02856802|11283996|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5
10153426|NCT02856802|11283995|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
10153427|NCT02856802|11283996|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
10153428|NCT02856802|11283995|FG000|COMPLETED|Double-Blind Treatment Period 2||36
10153429|NCT02856802|11283996|FG001|COMPLETED|Double-Blind Treatment Period 2||38
10153430|NCT02856802|11283995|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
10153431|NCT02856802|11283996|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0
10153432|NCT02856828|11284008|FG000|STARTED|Overall Study||2
10153433|NCT02856828|11284009|FG001|STARTED|Overall Study||3
10153434|NCT02856828|11284008|FG000|COMPLETED|Overall Study||2
10153435|NCT02856828|11284009|FG001|COMPLETED|Overall Study||3
10153436|NCT02856828|11284008|FG000|NOT COMPLETED|Overall Study||0
9710074|NCT02178956|10809499|FG000|NOT COMPLETED|Overall Study||71
9710075|NCT02178956|10809500|FG001|NOT COMPLETED|Overall Study||78
9710076|NCT02167945|10809510|FG000|STARTED|Overall Study||615
9710077|NCT02167945|10809510|FG000|COMPLETED|Overall Study||366
9710078|NCT02167945|10809510|FG000|NOT COMPLETED|Overall Study||249
9710079|NCT02097420|10809522|FG000|STARTED|Overall Study||20
9710080|NCT02097420|10809522|FG000|COMPLETED|Overall Study||6
9710081|NCT02097420|10809522|FG000|NOT COMPLETED|Overall Study||14
9710082|NCT02024607|10809533|FG000|STARTED|Overall Study||115
9710083|NCT02024607|10809534|FG001|STARTED|Overall Study||41
9710084|NCT02024607|10809535|FG002|STARTED|Overall Study||87
9710085|NCT02024607|10809536|FG003|STARTED|Overall Study||156
9710086|NCT02024607|10809537|FG004|STARTED|Overall Study||40
9710087|NCT02024607|10809538|FG005|STARTED|Overall Study||54
9710088|NCT02024607|10809539|FG006|STARTED|Overall Study||2
9710089|NCT02024607|10809533|FG000|COMPLETED|Overall Study||115
9710090|NCT02024607|10809534|FG001|COMPLETED|Overall Study||41
9710091|NCT02024607|10809535|FG002|COMPLETED|Overall Study||87
9710092|NCT02024607|10809536|FG003|COMPLETED|Overall Study||156
9710093|NCT02024607|10809537|FG004|COMPLETED|Overall Study||40
9710094|NCT02024607|10809538|FG005|COMPLETED|Overall Study||54
9710095|NCT02024607|10809539|FG006|COMPLETED|Overall Study||2
9710096|NCT02024607|10809533|FG000|NOT COMPLETED|Overall Study||0
9710097|NCT02024607|10809534|FG001|NOT COMPLETED|Overall Study||0
9710098|NCT02024607|10809535|FG002|NOT COMPLETED|Overall Study||0
9710099|NCT02024607|10809536|FG003|NOT COMPLETED|Overall Study||0
9710100|NCT02024607|10809537|FG004|NOT COMPLETED|Overall Study||0
9710101|NCT02024607|10809538|FG005|NOT COMPLETED|Overall Study||0
9710102|NCT02024607|10809539|FG006|NOT COMPLETED|Overall Study||0
9729824|NCT00121667|10829458|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
9729825|NCT00121667|10829459|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
9729826|NCT00121667|10829460|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
9729827|NCT00121667|10829457|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
9729828|NCT00121667|10829458|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
9729829|NCT00121667|10829459|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
9729830|NCT00121667|10829460|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
9729831|NCT00121667|10829457|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
9729832|NCT00121667|10829458|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
9729833|NCT00121667|10829459|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
9729834|NCT00121667|10829460|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
9729835|NCT00121719|10829482|FG000|STARTED|Dose Escalation (4 Weeks)||4
9729836|NCT00121719|10829483|FG001|STARTED|Dose Escalation (4 Weeks)||4
9729837|NCT00121719|10829484|FG002|STARTED|Dose Escalation (4 Weeks)||4
9729838|NCT00121719|10829485|FG003|STARTED|Dose Escalation (4 Weeks)||3
9729839|NCT00121719|10829486|FG004|STARTED|Dose Escalation (4 Weeks)||3
9729840|NCT00121719|10829487|FG005|STARTED|Dose Escalation (4 Weeks)||3
9729841|NCT00121719|10829488|FG006|STARTED|Dose Escalation (4 Weeks)||12
9729842|NCT00121719|10829489|FG007|STARTED|Dose Escalation (4 Weeks)||9
9729843|NCT00121719|10829490|FG008|STARTED|Dose Escalation (4 Weeks)||6
9729844|NCT00121719|10829491|FG009|STARTED|Dose Escalation (4 Weeks)||3
9729845|NCT00121719|10829492|FG010|STARTED|Dose Escalation (4 Weeks)||0
9729846|NCT00121719|10829493|FG011|STARTED|Dose Escalation (4 Weeks)||0
9729847|NCT00121719|10829494|FG012|STARTED|Dose Escalation (4 Weeks)||24
9729848|NCT00121719|10829495|FG013|STARTED|Dose Escalation (4 Weeks)||7
9729849|NCT00121719|10829482|FG000|COMPLETED|Dose Escalation (4 Weeks)||4
9729850|NCT00121719|10829483|FG001|COMPLETED|Dose Escalation (4 Weeks)||4
9729851|NCT00121719|10829484|FG002|COMPLETED|Dose Escalation (4 Weeks)||4
9729852|NCT00121719|10829485|FG003|COMPLETED|Dose Escalation (4 Weeks)||3
9729853|NCT00121719|10829486|FG004|COMPLETED|Dose Escalation (4 Weeks)||3
9729854|NCT00121719|10829487|FG005|COMPLETED|Dose Escalation (4 Weeks)||3
9729855|NCT00121719|10829488|FG006|COMPLETED|Dose Escalation (4 Weeks)||12
9729856|NCT00121719|10829489|FG007|COMPLETED|Dose Escalation (4 Weeks)||9
9729857|NCT00121719|10829490|FG008|COMPLETED|Dose Escalation (4 Weeks)||6
9729858|NCT00121719|10829491|FG009|COMPLETED|Dose Escalation (4 Weeks)||3
9729859|NCT00121719|10829492|FG010|COMPLETED|Dose Escalation (4 Weeks)||0
9729860|NCT00121719|10829493|FG011|COMPLETED|Dose Escalation (4 Weeks)||0
9729861|NCT00121719|10829494|FG012|COMPLETED|Dose Escalation (4 Weeks)||24
9729862|NCT00121719|10829495|FG013|COMPLETED|Dose Escalation (4 Weeks)||7
9729863|NCT00121719|10829482|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729864|NCT00121719|10829483|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9849090|NCT00862849|10961756|FG004|STARTED|Intervention 6||4
9849091|NCT00862849|10961757|FG005|STARTED|Intervention 6||3
9849092|NCT00862849|10961752|FG000|COMPLETED|Intervention 6||3
9849093|NCT00862849|10961753|FG001|COMPLETED|Intervention 6||3
9849094|NCT00862849|10961754|FG002|COMPLETED|Intervention 6||3
9849095|NCT00862849|10961755|FG003|COMPLETED|Intervention 6||4
9849096|NCT00862849|10961756|FG004|COMPLETED|Intervention 6||4
9849097|NCT00862849|10961757|FG005|COMPLETED|Intervention 6||3
9849098|NCT00862849|10961752|FG000|NOT COMPLETED|Intervention 6||0
9849099|NCT00862849|10961753|FG001|NOT COMPLETED|Intervention 6||0
9849100|NCT00862849|10961754|FG002|NOT COMPLETED|Intervention 6||0
10153437|NCT02856828|11284009|FG001|NOT COMPLETED|Overall Study||0
10153438|NCT02856880|11284023|FG000|STARTED|Overall Study||45
10153439|NCT02856880|11284023|FG000|Received Test Zinc-IPMP|Overall Study||44
10153440|NCT02856880|11284023|FG000|Received Test Zinc Non-IPMP|Overall Study||44
10153441|NCT02856880|11284023|FG000|Received Positive Control|Overall Study||45
10153442|NCT02856880|11284023|FG000|Received Non-SLS Negative Control|Overall Study||44
10153443|NCT02856880|11284023|FG000|Received SLS Negative Control|Overall Study||44
10153444|NCT02856880|11284023|FG000|COMPLETED|Overall Study||44
10153445|NCT02856880|11284023|FG000|NOT COMPLETED|Overall Study||1
10153446|NCT02857283|11284044|FG000|STARTED|First Exposure||8
10153447|NCT02857283|11284045|FG001|STARTED|First Exposure||7
10153448|NCT02857283|11284044|FG000|COMPLETED|First Exposure||7
10153449|NCT02857283|11284045|FG001|COMPLETED|First Exposure||7
10153450|NCT02857283|11284044|FG000|NOT COMPLETED|First Exposure||1
10153451|NCT02857283|11284045|FG001|NOT COMPLETED|First Exposure||0
10153452|NCT02857283|11284044|FG000|STARTED|Washout (2 Weeks)||7
10153453|NCT02857283|11284045|FG001|STARTED|Washout (2 Weeks)||7
10153454|NCT02857283|11284044|FG000|COMPLETED|Washout (2 Weeks)||7
10153455|NCT02857283|11284045|FG001|COMPLETED|Washout (2 Weeks)||7
10153456|NCT02857283|11284044|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10153457|NCT02857283|11284045|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10153458|NCT02857283|11284044|FG000|STARTED|Second Exposure||7
10153459|NCT02857283|11284045|FG001|STARTED|Second Exposure||7
10153460|NCT02857283|11284044|FG000|COMPLETED|Second Exposure||7
10153461|NCT02857283|11284045|FG001|COMPLETED|Second Exposure||7
10153462|NCT02857283|11284044|FG000|NOT COMPLETED|Second Exposure||0
10153463|NCT02857283|11284045|FG001|NOT COMPLETED|Second Exposure||0
10153464|NCT02857816|11284052|FG000|STARTED|Overall Study||154
10153465|NCT02857816|11284052|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120
10153466|NCT02857816|11284052|FG000|COMPLETED|Overall Study||116
10153467|NCT02857816|11284052|FG000|NOT COMPLETED|Overall Study||38
10153468|NCT02858050|11284059|FG000|STARTED|Overall Study||20
10153469|NCT02858050|11284060|FG001|STARTED|Overall Study||20
10153470|NCT02858050|11284059|FG000|COMPLETED|Overall Study||20
10153471|NCT02858050|11284060|FG001|COMPLETED|Overall Study||20
10153472|NCT02858050|11284059|FG000|NOT COMPLETED|Overall Study||0
10153473|NCT02858050|11284060|FG001|NOT COMPLETED|Overall Study||0
10153474|NCT02858076|11284068|FG000|STARTED|Overall Study||100
10153475|NCT02858076|11284069|FG001|STARTED|Overall Study||105
10153476|NCT02858076|11284068|FG000|COMPLETED|Overall Study||90
10153477|NCT02858076|11284069|FG001|COMPLETED|Overall Study||87
10153478|NCT02858076|11284068|FG000|NOT COMPLETED|Overall Study||10
10153479|NCT02858076|11284069|FG001|NOT COMPLETED|Overall Study||18
10153480|NCT02858180|11284079|FG000|STARTED|Overall Study||10
10153481|NCT02858180|11284080|FG001|STARTED|Overall Study||5
10153482|NCT02858180|11284079|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
10153483|NCT02858180|11284080|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
10153484|NCT02858180|11284079|FG000|NOT COMPLETED|Overall Study||0
10153485|NCT02858180|11284080|FG001|NOT COMPLETED|Overall Study||2
10153486|NCT02858349|11284086|FG000|STARTED|Overall Study||10
10153487|NCT02858349|11284086|FG000|COMPLETED|Overall Study||10
10153488|NCT02858349|11284086|FG000|NOT COMPLETED|Overall Study||0
10153489|NCT02858362|11284093|FG000|STARTED|Overall Study||30
10153490|NCT02858362|11284094|FG001|STARTED|Overall Study||10
10153491|NCT02858362|11284095|FG002|STARTED|Overall Study||3
10153492|NCT02858362|11284093|FG000|Did Not Enter Extension Phase|Overall Study||1
10153493|NCT02858362|11284094|FG001|Did Not Enter Extension Phase|Overall Study||2
10153494|NCT02858362|11284095|FG002|Did Not Enter Extension Phase|Overall Study||0
10153495|NCT02858362|11284093|FG000|COMPLETED|Overall Study||28
10153496|NCT02858362|11284094|FG001|COMPLETED|Overall Study||9
10153497|NCT02858362|11284095|FG002|COMPLETED|Overall Study||0
10153498|NCT02858362|11284093|FG000|NOT COMPLETED|Overall Study||2
10153499|NCT02858362|11284094|FG001|NOT COMPLETED|Overall Study||1
10153500|NCT02858362|11284095|FG002|NOT COMPLETED|Overall Study||3
10153501|NCT02858401|11284115|FG000|STARTED|Overall Study||6
10153502|NCT02858401|11284116|FG001|STARTED|Overall Study||6
10153503|NCT02858401|11284117|FG002|STARTED|Overall Study||6
10153504|NCT02858401|11284118|FG003|STARTED|Overall Study||6
10153505|NCT02858401|11284119|FG004|STARTED|Overall Study||6
10153506|NCT02858401|11284120|FG005|STARTED|Overall Study||6
10153507|NCT02858401|11284121|FG006|STARTED|Overall Study||12
10153508|NCT02858401|11284115|FG000|COMPLETED|Overall Study||6
10153509|NCT02858401|11284116|FG001|COMPLETED|Overall Study||5
10153510|NCT02858401|11284117|FG002|COMPLETED|Overall Study||6
10153511|NCT02858401|11284118|FG003|COMPLETED|Overall Study||6
10153512|NCT02858401|11284119|FG004|COMPLETED|Overall Study||6
10153513|NCT02858401|11284120|FG005|COMPLETED|Overall Study||5
10153514|NCT02858401|11284121|FG006|COMPLETED|Overall Study||12
10153515|NCT02858401|11284115|FG000|NOT COMPLETED|Overall Study||0
10153516|NCT02858401|11284116|FG001|NOT COMPLETED|Overall Study||1
10153517|NCT02858401|11284117|FG002|NOT COMPLETED|Overall Study||0
10153518|NCT02858401|11284118|FG003|NOT COMPLETED|Overall Study||0
10153519|NCT02858401|11284119|FG004|NOT COMPLETED|Overall Study||0
10153520|NCT02858401|11284120|FG005|NOT COMPLETED|Overall Study||1
10153521|NCT02858401|11284121|FG006|NOT COMPLETED|Overall Study||0
10153522|NCT02858440|11284146|FG000|STARTED|Overall Study||235
10153523|NCT02858440|11284146|FG000|COMPLETED|Overall Study||223
10153524|NCT02858440|11284146|FG000|NOT COMPLETED|Overall Study||12
10153525|NCT02858492|11284154|FG000|STARTED|Overall Study||3
10153526|NCT02858492|11284155|FG001|STARTED|Overall Study||15
10153527|NCT02858492|11284156|FG002|STARTED|Overall Study||5
10153528|NCT02858492|11284157|FG003|STARTED|Overall Study||28
10153529|NCT02858492|11284154|FG000|COMPLETED|Overall Study||3
10153530|NCT02858492|11284155|FG001|COMPLETED|Overall Study||14
10153531|NCT02858492|11284156|FG002|COMPLETED|Overall Study||5
10153532|NCT02858492|11284157|FG003|COMPLETED|Overall Study||22
10153533|NCT02858492|11284154|FG000|NOT COMPLETED|Overall Study||0
10153534|NCT02858492|11284155|FG001|NOT COMPLETED|Overall Study||1
10153535|NCT02858492|11284156|FG002|NOT COMPLETED|Overall Study||0
10153536|NCT02858492|11284157|FG003|NOT COMPLETED|Overall Study||6
10153537|NCT02858713|11284171|FG000|STARTED|Overall Study||68
10153538|NCT02858713|11284172|FG001|STARTED|Overall Study||66
10153539|NCT02858713|11284171|FG000|COMPLETED|Overall Study||61
10153540|NCT02858713|11284172|FG001|COMPLETED|Overall Study||61
10153541|NCT02858713|11284171|FG000|NOT COMPLETED|Overall Study||7
10153542|NCT02858713|11284172|FG001|NOT COMPLETED|Overall Study||5
10153543|NCT02858726|11284186|FG000|STARTED|Overall Study||44
10153544|NCT02858726|11284187|FG001|STARTED|Overall Study||42
10153545|NCT02858726|11284188|FG002|STARTED|Overall Study||44
10153546|NCT02858726|11284189|FG003|STARTED|Overall Study||45
10153547|NCT02858726|11284186|FG000|COMPLETED|Overall Study||39
10153548|NCT02858726|11284187|FG001|COMPLETED|Overall Study||35
10153549|NCT02858726|11284188|FG002|COMPLETED|Overall Study||33
10153550|NCT02858726|11284189|FG003|COMPLETED|Overall Study||42
10153551|NCT02858726|11284186|FG000|NOT COMPLETED|Overall Study||5
10153552|NCT02858726|11284187|FG001|NOT COMPLETED|Overall Study||7
10153553|NCT02858726|11284188|FG002|NOT COMPLETED|Overall Study||11
10153554|NCT02858726|11284189|FG003|NOT COMPLETED|Overall Study||3
10153555|NCT02859142|11284205|FG000|STARTED|Overall Study||61
10153556|NCT02859142|11284206|FG001|STARTED|Overall Study||61
10153557|NCT02859142|11284205|FG000|COMPLETED|Overall Study||57
10153558|NCT02859142|11284206|FG001|COMPLETED|Overall Study||52
10153559|NCT02859142|11284205|FG000|NOT COMPLETED|Overall Study||4
10153560|NCT02859142|11284206|FG001|NOT COMPLETED|Overall Study||9
10153561|NCT02859246|11284212|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15
10153562|NCT02859246|11284212|FG000|COMPLETED|Overall Study|10 subjects completed the study|10
10153563|NCT02859246|11284212|FG000|NOT COMPLETED|Overall Study||5
10153564|NCT02859324|11284220|FG000|STARTED|Overall Study||7
10153565|NCT02859324|11284221|FG001|STARTED|Overall Study||9
10153566|NCT02859324|11284222|FG002|STARTED|Overall Study||5
10153567|NCT02859324|11284220|FG000|COMPLETED|Overall Study||0
10153568|NCT02859324|11284221|FG001|COMPLETED|Overall Study||0
10153569|NCT02859324|11284222|FG002|COMPLETED|Overall Study||0
10153570|NCT02859324|11284220|FG000|NOT COMPLETED|Overall Study||7
10153571|NCT02859324|11284221|FG001|NOT COMPLETED|Overall Study||9
10153572|NCT02859324|11284222|FG002|NOT COMPLETED|Overall Study||5
10153573|NCT02859441|11284230|FG000|STARTED|Overall Study||3
10153574|NCT02859441|11284230|FG000|COMPLETED|Overall Study||3
10153575|NCT02859441|11284230|FG000|NOT COMPLETED|Overall Study||0
10153576|NCT02859454|11284251|FG000|STARTED|Overall Study||13
10153577|NCT02859454|11284251|FG000|COMPLETED|Overall Study||12
10153578|NCT02859454|11284251|FG000|NOT COMPLETED|Overall Study||1
10153579|NCT02859597|11284260|FG000|STARTED|Overall Study|started Dec 2016|22
10153580|NCT02859597|11284261|FG001|STARTED|Overall Study|Started Dec 2016|19
10153581|NCT02859597|11284260|FG000|COMPLETED|Overall Study|September 2018|22
10153582|NCT02859597|11284261|FG001|COMPLETED|Overall Study|September 2018|19
10153583|NCT02859597|11284260|FG000|NOT COMPLETED|Overall Study||0
10153584|NCT02859597|11284261|FG001|NOT COMPLETED|Overall Study||0
10153585|NCT02860130|11284271|FG000|STARTED|Overall Study||17
10153586|NCT02860130|11284272|FG001|STARTED|Overall Study||17
10153587|NCT02860130|11284271|FG000|COMPLETED|Overall Study||10
10153588|NCT02860130|11284272|FG001|COMPLETED|Overall Study||8
10153589|NCT02860130|11284271|FG000|NOT COMPLETED|Overall Study||7
10153590|NCT02860130|11284272|FG001|NOT COMPLETED|Overall Study||9
10153591|NCT02860286|11284280|FG000|STARTED|Overall Study||13
10153592|NCT02860286|11284281|FG001|STARTED|Overall Study||61
10153593|NCT02860286|11284280|FG000|COMPLETED|Overall Study||13
10153594|NCT02860286|11284281|FG001|COMPLETED|Overall Study||61
10153595|NCT02860286|11284280|FG000|NOT COMPLETED|Overall Study||0
10153596|NCT02860286|11284281|FG001|NOT COMPLETED|Overall Study||0
10153597|NCT02860507|11284298|FG000|STARTED|Overall Study||25
10153598|NCT02860507|11284299|FG001|STARTED|Overall Study||25
10153599|NCT02860507|11284298|FG000|COMPLETED|Overall Study||25
10153600|NCT02860507|11284299|FG001|COMPLETED|Overall Study||25
10153601|NCT02860507|11284298|FG000|NOT COMPLETED|Overall Study||0
10153602|NCT02860507|11284299|FG001|NOT COMPLETED|Overall Study||0
10153603|NCT02860546|11284305|FG000|STARTED|Overall Study||18
10153604|NCT02860546|11284305|FG000|COMPLETED|Overall Study||0
10153605|NCT02860546|11284305|FG000|NOT COMPLETED|Overall Study||18
10153606|NCT02860845|11284311|FG000|STARTED|Overall Study||24
10153607|NCT02860845|11284312|FG001|STARTED|Overall Study||24
10153608|NCT02860845|11284311|FG000|Analyzed Patients|Overall Study||22
10153609|NCT02860845|11284312|FG001|Analyzed Patients|Overall Study||23
10153610|NCT02860845|11284311|FG000|COMPLETED|Overall Study||22
10153611|NCT02860845|11284312|FG001|COMPLETED|Overall Study||23
10153612|NCT02860845|11284311|FG000|NOT COMPLETED|Overall Study||2
10153613|NCT02860845|11284312|FG001|NOT COMPLETED|Overall Study||1
10153614|NCT02860988|11284324|FG000|STARTED|Overall Study||201
10153615|NCT02860988|11284325|FG001|STARTED|Overall Study||200
10153616|NCT02860988|11284324|FG000|COMPLETED|Overall Study||117
10153617|NCT02860988|11284325|FG001|COMPLETED|Overall Study||94
10153618|NCT02860988|11284324|FG000|NOT COMPLETED|Overall Study||84
10153619|NCT02860988|11284325|FG001|NOT COMPLETED|Overall Study||106
10153620|NCT02861118|11284333|FG000|STARTED|Overall Study||194
10153621|NCT02861118|11284334|FG001|STARTED|Overall Study||116
10153622|NCT02861118|11284333|FG000|COMPLETED|Overall Study||194
10153623|NCT02861118|11284334|FG001|COMPLETED|Overall Study||116
10153624|NCT02861118|11284333|FG000|NOT COMPLETED|Overall Study||0
10153625|NCT02861118|11284334|FG001|NOT COMPLETED|Overall Study||0
10153626|NCT02861131|11284344|FG000|STARTED|Overall Study||100
10153627|NCT02861131|11284345|FG001|STARTED|Overall Study||100
10153628|NCT02861131|11284344|FG000|COMPLETED|Overall Study||100
10153629|NCT02861131|11284345|FG001|COMPLETED|Overall Study||100
10153630|NCT02861131|11284344|FG000|NOT COMPLETED|Overall Study||0
10153631|NCT02861131|11284345|FG001|NOT COMPLETED|Overall Study||0
10153632|NCT02861534|11284353|FG000|STARTED|Overall Study||2526
10153633|NCT02861534|11284354|FG001|STARTED|Overall Study||2524
10153634|NCT02861534|11284353|FG000|Treated|Overall Study||2519
10153635|NCT02861534|11284354|FG001|Treated|Overall Study||2515
10153636|NCT02861534|11284353|FG000|COMPLETED|Overall Study||1952
10153637|NCT02861534|11284354|FG001|COMPLETED|Overall Study||1937
10153638|NCT02861534|11284353|FG000|NOT COMPLETED|Overall Study||574
10153639|NCT02861534|11284354|FG001|NOT COMPLETED|Overall Study||587
10153640|NCT02861586|11284368|FG000|STARTED|Overall Study||51
10153641|NCT02861586|11284369|FG001|STARTED|Overall Study||18
10153642|NCT02861586|11284370|FG002|STARTED|Overall Study||47
10153643|NCT02861586|11284371|FG003|STARTED|Overall Study||16
10153644|NCT02861586|11284372|FG004|STARTED|Overall Study||47
10153645|NCT02861586|11284373|FG005|STARTED|Overall Study||50
10153646|NCT02861586|11284374|FG006|STARTED|Overall Study||18
10153647|NCT02861586|11284375|FG007|STARTED|Overall Study||16
10153648|NCT02861586|11284368|FG000|COMPLETED|Overall Study||47
10153649|NCT02861586|11284369|FG001|COMPLETED|Overall Study||15
10153650|NCT02861586|11284370|FG002|COMPLETED|Overall Study||46
10153651|NCT02861586|11284371|FG003|COMPLETED|Overall Study||16
10153652|NCT02861586|11284372|FG004|COMPLETED|Overall Study||47
10153653|NCT02861586|11284373|FG005|COMPLETED|Overall Study||45
10153654|NCT02861586|11284374|FG006|COMPLETED|Overall Study||17
10153655|NCT02861586|11284375|FG007|COMPLETED|Overall Study||16
10153656|NCT02861586|11284368|FG000|NOT COMPLETED|Overall Study||4
10153657|NCT02861586|11284369|FG001|NOT COMPLETED|Overall Study||3
10153658|NCT02861586|11284370|FG002|NOT COMPLETED|Overall Study||1
10153659|NCT02861586|11284371|FG003|NOT COMPLETED|Overall Study||0
10153660|NCT02861586|11284372|FG004|NOT COMPLETED|Overall Study||0
10153661|NCT02861586|11284373|FG005|NOT COMPLETED|Overall Study||5
10153662|NCT02861586|11284374|FG006|NOT COMPLETED|Overall Study||1
10153663|NCT02861586|11284375|FG007|NOT COMPLETED|Overall Study||0
10153664|NCT02861664|11284400|FG000|STARTED|Overall Study||67
10153665|NCT02861664|11284401|FG001|STARTED|Overall Study||68
10153666|NCT02861664|11284400|FG000|COMPLETED|Overall Study||67
9710103|NCT01925131|10809579|FG000|STARTED|Overall Study||5
9710104|NCT01925131|10809580|FG001|STARTED|Overall Study||4
9710105|NCT01925131|10809581|FG002|STARTED|Overall Study||10
9710106|NCT01925131|10809582|FG003|STARTED|Overall Study||5
9710107|NCT01925131|10809583|FG004|STARTED|Overall Study||11
9710108|NCT01925131|10809584|FG005|STARTED|Overall Study||13
9710109|NCT01925131|10809579|FG000|COMPLETED|Overall Study||0
9710110|NCT01925131|10809580|FG001|COMPLETED|Overall Study||2
9710111|NCT01925131|10809581|FG002|COMPLETED|Overall Study||1
9710112|NCT01925131|10809582|FG003|COMPLETED|Overall Study||0
9710113|NCT01925131|10809583|FG004|COMPLETED|Overall Study||0
9710114|NCT01925131|10809584|FG005|COMPLETED|Overall Study||3
9710115|NCT01925131|10809579|FG000|NOT COMPLETED|Overall Study||5
9710116|NCT01925131|10809580|FG001|NOT COMPLETED|Overall Study||2
9710117|NCT01925131|10809581|FG002|NOT COMPLETED|Overall Study||9
9710118|NCT01925131|10809582|FG003|NOT COMPLETED|Overall Study||5
9710119|NCT01925131|10809583|FG004|NOT COMPLETED|Overall Study||11
9710120|NCT01925131|10809584|FG005|NOT COMPLETED|Overall Study||10
9710121|NCT01776307|10809603|FG000|STARTED|Overall Study||49
9710122|NCT01776307|10809604|FG001|STARTED|Overall Study||75
9710123|NCT01776307|10809605|FG002|STARTED|Overall Study||76
9710124|NCT01776307|10809603|FG000|COMPLETED|Overall Study||49
9710125|NCT01776307|10809604|FG001|COMPLETED|Overall Study||75
9710126|NCT01776307|10809605|FG002|COMPLETED|Overall Study||75
9849101|NCT00862849|10961755|FG003|NOT COMPLETED|Intervention 6||0
9849102|NCT00862849|10961756|FG004|NOT COMPLETED|Intervention 6||0
9849103|NCT00862849|10961757|FG005|NOT COMPLETED|Intervention 6||0
9849104|NCT00862940|10961767|FG000|STARTED|Overall Study||133
9849105|NCT00862940|10961768|FG001|STARTED|Overall Study||144
10153667|NCT02861664|11284401|FG001|COMPLETED|Overall Study||67
10153668|NCT02861664|11284400|FG000|NOT COMPLETED|Overall Study||0
9849106|NCT00862940|10961767|FG000|COMPLETED|Overall Study||103
9849107|NCT00862940|10961768|FG001|COMPLETED|Overall Study||114
9849108|NCT00862940|10961767|FG000|NOT COMPLETED|Overall Study||30
9849109|NCT00862940|10961768|FG001|NOT COMPLETED|Overall Study||30
9849110|NCT00862979|10961776|FG000|STARTED|Overall Study||84
9849111|NCT00862979|10961777|FG001|STARTED|Overall Study||78
9849112|NCT00862979|10961776|FG000|Full Analysis Set (FAS)|Overall Study||74
9849113|NCT00862979|10961777|FG001|Full Analysis Set (FAS)|Overall Study||71
9849114|NCT00862979|10961776|FG000|COMPLETED|Overall Study||76
10153669|NCT02861664|11284401|FG001|NOT COMPLETED|Overall Study||1
10153670|NCT02861807|11284409|FG000|STARTED|Overall Study||47
10153671|NCT02861807|11284410|FG001|STARTED|Overall Study||37
10153672|NCT02861807|11284409|FG000|Attended Post-treatment Assessment|Overall Study||34
10153673|NCT02861807|11284410|FG001|Attended Post-treatment Assessment|Overall Study||18
10153674|NCT02861807|11284409|FG000|Attended 2-month Follow-up|Overall Study||32
10153675|NCT02861807|11284410|FG001|Attended 2-month Follow-up|Overall Study||20
10153676|NCT02861807|11284409|FG000|COMPLETED|Overall Study||35
10153677|NCT02861807|11284410|FG001|COMPLETED|Overall Study||23
10153678|NCT02861807|11284409|FG000|NOT COMPLETED|Overall Study||12
10153679|NCT02861807|11284410|FG001|NOT COMPLETED|Overall Study||14
10153680|NCT02861937|11284419|FG000|STARTED|Overall Study||10
10153681|NCT02861937|11284420|FG001|STARTED|Overall Study||12
10153682|NCT02861937|11284421|FG002|STARTED|Overall Study||12
10153683|NCT02861937|11284419|FG000|COMPLETED|Overall Study||10
10153684|NCT02861937|11284420|FG001|COMPLETED|Overall Study||12
10153685|NCT02861937|11284421|FG002|COMPLETED|Overall Study||12
10153686|NCT02861937|11284419|FG000|NOT COMPLETED|Overall Study||0
10153687|NCT02861937|11284420|FG001|NOT COMPLETED|Overall Study||0
10153688|NCT02861937|11284421|FG002|NOT COMPLETED|Overall Study||0
10153689|NCT02862080|11284432|FG000|STARTED|7 Days Before Any Intervention||1
10153690|NCT02862080|11284433|FG001|STARTED|7 Days Before Any Intervention||1
10153691|NCT02862080|11284434|FG002|STARTED|7 Days Before Any Intervention||1
10153692|NCT02862080|11284435|FG003|STARTED|7 Days Before Any Intervention||1
10153693|NCT02862080|11284432|FG000|COMPLETED|7 Days Before Any Intervention||1
10153694|NCT02862080|11284433|FG001|COMPLETED|7 Days Before Any Intervention||1
10153695|NCT02862080|11284434|FG002|COMPLETED|7 Days Before Any Intervention||1
10153696|NCT02862080|11284435|FG003|COMPLETED|7 Days Before Any Intervention||1
10153697|NCT02862080|11284432|FG000|NOT COMPLETED|7 Days Before Any Intervention||0
10153698|NCT02862080|11284433|FG001|NOT COMPLETED|7 Days Before Any Intervention||0
10153699|NCT02862080|11284434|FG002|NOT COMPLETED|7 Days Before Any Intervention||0
10153700|NCT02862080|11284435|FG003|NOT COMPLETED|7 Days Before Any Intervention||0
10153701|NCT02862080|11284432|FG000|STARTED|3 Days Before Any Intervention||1
10153702|NCT02862080|11284433|FG001|STARTED|3 Days Before Any Intervention||1
10153703|NCT02862080|11284434|FG002|STARTED|3 Days Before Any Intervention||1
10153704|NCT02862080|11284435|FG003|STARTED|3 Days Before Any Intervention||1
10153705|NCT02862080|11284432|FG000|COMPLETED|3 Days Before Any Intervention||1
10153706|NCT02862080|11284433|FG001|COMPLETED|3 Days Before Any Intervention||1
10153707|NCT02862080|11284434|FG002|COMPLETED|3 Days Before Any Intervention||1
10153708|NCT02862080|11284435|FG003|COMPLETED|3 Days Before Any Intervention||1
10153709|NCT02862080|11284432|FG000|NOT COMPLETED|3 Days Before Any Intervention||0
10153710|NCT02862080|11284433|FG001|NOT COMPLETED|3 Days Before Any Intervention||0
10153711|NCT02862080|11284434|FG002|NOT COMPLETED|3 Days Before Any Intervention||0
10153712|NCT02862080|11284435|FG003|NOT COMPLETED|3 Days Before Any Intervention||0
10153713|NCT02862080|11284432|FG000|STARTED|Intervention 1 (1 Week)||1
10153714|NCT02862080|11284433|FG001|STARTED|Intervention 1 (1 Week)||1
10153715|NCT02862080|11284434|FG002|STARTED|Intervention 1 (1 Week)||1
10153716|NCT02862080|11284435|FG003|STARTED|Intervention 1 (1 Week)||1
10153717|NCT02862080|11284432|FG000|COMPLETED|Intervention 1 (1 Week)||1
10153718|NCT02862080|11284433|FG001|COMPLETED|Intervention 1 (1 Week)||1
10153719|NCT02862080|11284434|FG002|COMPLETED|Intervention 1 (1 Week)||1
10153720|NCT02862080|11284435|FG003|COMPLETED|Intervention 1 (1 Week)||1
10153721|NCT02862080|11284432|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0
10153722|NCT02862080|11284433|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0
10153723|NCT02862080|11284434|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0
10153724|NCT02862080|11284435|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0
10153725|NCT02862080|11284432|FG000|STARTED|Washout (1 Week)||1
10153726|NCT02862080|11284433|FG001|STARTED|Washout (1 Week)||1
10153727|NCT02862080|11284434|FG002|STARTED|Washout (1 Week)||1
10153728|NCT02862080|11284435|FG003|STARTED|Washout (1 Week)||1
10153729|NCT02862080|11284432|FG000|COMPLETED|Washout (1 Week)||1
10153730|NCT02862080|11284433|FG001|COMPLETED|Washout (1 Week)||1
10153731|NCT02862080|11284434|FG002|COMPLETED|Washout (1 Week)||1
10153732|NCT02862080|11284435|FG003|COMPLETED|Washout (1 Week)||1
10153733|NCT02862080|11284432|FG000|NOT COMPLETED|Washout (1 Week)||0
10153734|NCT02862080|11284433|FG001|NOT COMPLETED|Washout (1 Week)||0
10153735|NCT02862080|11284434|FG002|NOT COMPLETED|Washout (1 Week)||0
10153736|NCT02862080|11284435|FG003|NOT COMPLETED|Washout (1 Week)||0
10153737|NCT02862080|11284432|FG000|STARTED|Intervention 2 (1 Week)||1
10153738|NCT02862080|11284433|FG001|STARTED|Intervention 2 (1 Week)||1
10153739|NCT02862080|11284434|FG002|STARTED|Intervention 2 (1 Week)||1
10153740|NCT02862080|11284435|FG003|STARTED|Intervention 2 (1 Week)||1
10153741|NCT02862080|11284432|FG000|COMPLETED|Intervention 2 (1 Week)||1
10153742|NCT02862080|11284433|FG001|COMPLETED|Intervention 2 (1 Week)||1
10153743|NCT02862080|11284434|FG002|COMPLETED|Intervention 2 (1 Week)||1
10153744|NCT02862080|11284435|FG003|COMPLETED|Intervention 2 (1 Week)||1
10153745|NCT02862080|11284432|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0
10153746|NCT02862080|11284433|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0
10153747|NCT02862080|11284434|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0
10153748|NCT02862080|11284435|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0
10153749|NCT02862080|11284432|FG000|STARTED|Washout (1 Week)||1
10153750|NCT02862080|11284433|FG001|STARTED|Washout (1 Week)||1
10153751|NCT02862080|11284434|FG002|STARTED|Washout (1 Week)||1
10153752|NCT02862080|11284435|FG003|STARTED|Washout (1 Week)||1
10153753|NCT02862080|11284432|FG000|COMPLETED|Washout (1 Week)||1
10153754|NCT02862080|11284433|FG001|COMPLETED|Washout (1 Week)||1
10153755|NCT02862080|11284434|FG002|COMPLETED|Washout (1 Week)||1
10153756|NCT02862080|11284435|FG003|COMPLETED|Washout (1 Week)||1
10153757|NCT02862080|11284432|FG000|NOT COMPLETED|Washout (1 Week)||0
10153758|NCT02862080|11284433|FG001|NOT COMPLETED|Washout (1 Week)||0
10153759|NCT02862080|11284434|FG002|NOT COMPLETED|Washout (1 Week)||0
10153760|NCT02862080|11284435|FG003|NOT COMPLETED|Washout (1 Week)||0
10153761|NCT02862080|11284432|FG000|STARTED|Intervention 1 Again (1 Week)||1
10153762|NCT02862080|11284433|FG001|STARTED|Intervention 1 Again (1 Week)||1
10153763|NCT02862080|11284434|FG002|STARTED|Intervention 1 Again (1 Week)||1
10153764|NCT02862080|11284435|FG003|STARTED|Intervention 1 Again (1 Week)||1
10153765|NCT02862080|11284432|FG000|COMPLETED|Intervention 1 Again (1 Week)||1
10153766|NCT02862080|11284433|FG001|COMPLETED|Intervention 1 Again (1 Week)||1
10153767|NCT02862080|11284434|FG002|COMPLETED|Intervention 1 Again (1 Week)||1
10153768|NCT02862080|11284435|FG003|COMPLETED|Intervention 1 Again (1 Week)||1
10153769|NCT02862080|11284432|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10153770|NCT02862080|11284433|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10153771|NCT02862080|11284434|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10153772|NCT02862080|11284435|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10153773|NCT02862106|11284451|FG000|STARTED|Overall Study||183
10153774|NCT02862106|11284452|FG001|STARTED|Overall Study||26
10153775|NCT02862106|11284451|FG000|COMPLETED|Overall Study||145
10153776|NCT02862106|11284452|FG001|COMPLETED|Overall Study||20
10153777|NCT02862106|11284451|FG000|NOT COMPLETED|Overall Study||38
10153778|NCT02862106|11284452|FG001|NOT COMPLETED|Overall Study||6
10153779|NCT02862535|11284468|FG000|STARTED|Overall Study||9
10153780|NCT02862535|11284469|FG001|STARTED|Overall Study||6
10153781|NCT02862535|11284470|FG002|STARTED|Overall Study||10
10153782|NCT02862535|11284471|FG003|STARTED|Overall Study||11
10153783|NCT02862535|11284468|FG000|COMPLETED|Overall Study||0
10153784|NCT02862535|11284469|FG001|COMPLETED|Overall Study||0
10153785|NCT02862535|11284470|FG002|COMPLETED|Overall Study||0
10153786|NCT02862535|11284471|FG003|COMPLETED|Overall Study||0
10153787|NCT02862535|11284468|FG000|NOT COMPLETED|Overall Study||9
10153788|NCT02862535|11284469|FG001|NOT COMPLETED|Overall Study||6
10153789|NCT02862535|11284470|FG002|NOT COMPLETED|Overall Study||10
10153790|NCT02862535|11284471|FG003|NOT COMPLETED|Overall Study||11
10197201|NCT03370770|11325157|FG000|NOT COMPLETED|Overall Study||106
10197202|NCT03371355|11325165|FG000|STARTED|Overall Study||27
9963921|NCT01489527|11083732|FG001|STARTED|Overall Study||201
9963922|NCT01489527|11083731|FG000|COMPLETED|Overall Study||183
9963923|NCT01489527|11083732|FG001|COMPLETED|Overall Study||175
9963924|NCT01489527|11083731|FG000|NOT COMPLETED|Overall Study||22
9963925|NCT01489527|11083732|FG001|NOT COMPLETED|Overall Study||26
9963926|NCT01489579|11083740|FG000|STARTED|Overall Study||56
9963927|NCT01489579|11083741|FG001|STARTED|Overall Study||64
9963928|NCT01489579|11083740|FG000|COMPLETED|Overall Study||47
9963929|NCT01489579|11083741|FG001|COMPLETED|Overall Study||57
9963930|NCT01489579|11083740|FG000|NOT COMPLETED|Overall Study||9
9963931|NCT01489579|11083741|FG001|NOT COMPLETED|Overall Study||7
9963932|NCT01489670|11083749|FG000|STARTED|Overall Study||387
10197203|NCT03371355|11325166|FG001|STARTED|Overall Study||26
10197204|NCT03371355|11325167|FG002|STARTED|Overall Study||26
10197205|NCT03371355|11325168|FG003|STARTED|Overall Study||26
10197206|NCT03371355|11325165|FG000|COMPLETED|Overall Study||26
9710127|NCT01776307|10809603|FG000|NOT COMPLETED|Overall Study||0
10197207|NCT03371355|11325166|FG001|COMPLETED|Overall Study||24
10197208|NCT03371355|11325167|FG002|COMPLETED|Overall Study||22
10197209|NCT03371355|11325168|FG003|COMPLETED|Overall Study||19
10197210|NCT03371355|11325165|FG000|NOT COMPLETED|Overall Study||1
10197211|NCT03371355|11325166|FG001|NOT COMPLETED|Overall Study||2
9963933|NCT01489670|11083749|FG000|COMPLETED|Overall Study||334
9963934|NCT01489670|11083749|FG000|NOT COMPLETED|Overall Study||53
10153791|NCT02862574|11284484|FG000|STARTED|Double-Blind Treatment Period||5
10153792|NCT02862574|11284485|FG001|STARTED|Double-Blind Treatment Period||5
10153793|NCT02862574|11284486|FG002|STARTED|Double-Blind Treatment Period||5
10153794|NCT02862574|11284484|FG000|COMPLETED|Double-Blind Treatment Period||2
10153795|NCT02862574|11284485|FG001|COMPLETED|Double-Blind Treatment Period||3
10153796|NCT02862574|11284486|FG002|COMPLETED|Double-Blind Treatment Period||1
10153797|NCT02862574|11284484|FG000|NOT COMPLETED|Double-Blind Treatment Period||3
10153798|NCT02862574|11284485|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
10153799|NCT02862574|11284486|FG002|NOT COMPLETED|Double-Blind Treatment Period||4
10153800|NCT02862574|11284484|FG000|STARTED|Open-Label Treatment Period||2
10153801|NCT02862574|11284485|FG001|STARTED|Open-Label Treatment Period||3
10153802|NCT02862574|11284486|FG002|STARTED|Open-Label Treatment Period||1
10153803|NCT02862574|11284484|FG000|COMPLETED|Open-Label Treatment Period||0
10153804|NCT02862574|11284485|FG001|COMPLETED|Open-Label Treatment Period||0
10153805|NCT02862574|11284486|FG002|COMPLETED|Open-Label Treatment Period||0
10153806|NCT02862574|11284484|FG000|NOT COMPLETED|Open-Label Treatment Period||2
10153807|NCT02862574|11284485|FG001|NOT COMPLETED|Open-Label Treatment Period||3
10153808|NCT02862574|11284486|FG002|NOT COMPLETED|Open-Label Treatment Period||1
10153809|NCT02862600|11284495|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
10153810|NCT02862600|11284495|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
10153811|NCT02862600|11284495|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
10153812|NCT02862600|11284495|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
10153813|NCT02862600|11284495|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
10153814|NCT02862600|11284495|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
10153815|NCT02862730|11284501|FG000|STARTED|Tslim Training Visit (2 Weeks)||4
10153816|NCT02862730|11284502|FG001|STARTED|Tslim Training Visit (2 Weeks)||1
10153817|NCT02862730|11284503|FG002|STARTED|Tslim Training Visit (2 Weeks)||8
10153818|NCT02862730|11284504|FG003|STARTED|Tslim Training Visit (2 Weeks)||5
10153819|NCT02862730|11284505|FG004|STARTED|Tslim Training Visit (2 Weeks)||5
10153820|NCT02862730|11284506|FG005|STARTED|Tslim Training Visit (2 Weeks)||1
10153821|NCT02862730|11284507|FG006|STARTED|Tslim Training Visit (2 Weeks)||1
10153822|NCT02862730|11284501|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4
10153823|NCT02862730|11284502|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1
10153824|NCT02862730|11284503|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7
10153825|NCT02862730|11284504|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5
10153826|NCT02862730|11284505|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5
10153827|NCT02862730|11284506|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1
10153828|NCT02862730|11284507|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1
10153829|NCT02862730|11284501|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10153830|NCT02862730|11284502|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10153831|NCT02862730|11284503|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
10153832|NCT02862730|11284504|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10153833|NCT02862730|11284505|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
9710128|NCT01776307|10809604|FG001|NOT COMPLETED|Overall Study||0
9710129|NCT01776307|10809605|FG002|NOT COMPLETED|Overall Study||1
9710130|NCT01623167|10809637|FG000|STARTED|Overall Study||30
9710131|NCT01623167|10809638|FG001|STARTED|Overall Study||31
9710132|NCT01623167|10809639|FG002|STARTED|Overall Study||31
9710133|NCT01623167|10809637|FG000|COMPLETED|Overall Study||13
9710134|NCT01623167|10809638|FG001|COMPLETED|Overall Study||17
9710135|NCT01623167|10809639|FG002|COMPLETED|Overall Study||18
9849115|NCT00862979|10961777|FG001|COMPLETED|Overall Study||71
9849116|NCT00862979|10961776|FG000|NOT COMPLETED|Overall Study||8
9849117|NCT00862979|10961777|FG001|NOT COMPLETED|Overall Study||7
9849118|NCT00862992|10961786|FG000|STARTED|Overall Study||12
9849119|NCT00862992|10961787|FG001|STARTED|Overall Study||10
9849120|NCT00862992|10961788|FG002|STARTED|Overall Study||12
9849121|NCT00862992|10961786|FG000|COMPLETED|Overall Study||9
9849122|NCT00862992|10961787|FG001|COMPLETED|Overall Study||9
9849123|NCT00862992|10961788|FG002|COMPLETED|Overall Study||9
9849124|NCT00862992|10961786|FG000|NOT COMPLETED|Overall Study||3
9849125|NCT00862992|10961787|FG001|NOT COMPLETED|Overall Study||1
9849126|NCT00862992|10961788|FG002|NOT COMPLETED|Overall Study||3
9849127|NCT00863057|10961800|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4
9849128|NCT00863057|10961801|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4
9849129|NCT00863057|10961802|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3
9849130|NCT00863057|10961803|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4
9849131|NCT00863057|10961800|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
10153834|NCT02862730|11284506|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10153835|NCT02862730|11284507|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10153836|NCT02862730|11284501|FG000|STARTED|First Rest Period (1-12 Weeks)||4
10153837|NCT02862730|11284502|FG001|STARTED|First Rest Period (1-12 Weeks)||1
10153838|NCT02862730|11284503|FG002|STARTED|First Rest Period (1-12 Weeks)||7
10153839|NCT02862730|11284504|FG003|STARTED|First Rest Period (1-12 Weeks)||5
9849132|NCT00863057|10961801|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
9849133|NCT00863057|10961802|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
9849134|NCT00863057|10961803|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
9849135|NCT00863057|10961800|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
10153840|NCT02862730|11284505|FG004|STARTED|First Rest Period (1-12 Weeks)||5
10153841|NCT02862730|11284506|FG005|STARTED|First Rest Period (1-12 Weeks)||1
10153842|NCT02862730|11284507|FG006|STARTED|First Rest Period (1-12 Weeks)||1
10153843|NCT02862730|11284501|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
10153844|NCT02862730|11284502|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1
10153845|NCT02862730|11284503|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7
10153846|NCT02862730|11284504|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5
10153847|NCT02862730|11284505|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5
10153848|NCT02862730|11284506|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1
10153849|NCT02862730|11284507|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
10153850|NCT02862730|11284501|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10153851|NCT02862730|11284502|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10153852|NCT02862730|11284503|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10153853|NCT02862730|11284504|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10153854|NCT02862730|11284505|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10153855|NCT02862730|11284506|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10153856|NCT02862730|11284507|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10153857|NCT02862730|11284501|FG000|STARTED|First Intervention (84 Hours)||4
10153858|NCT02862730|11284502|FG001|STARTED|First Intervention (84 Hours)||1
10153859|NCT02862730|11284503|FG002|STARTED|First Intervention (84 Hours)||7
10153860|NCT02862730|11284504|FG003|STARTED|First Intervention (84 Hours)||5
10153861|NCT02862730|11284505|FG004|STARTED|First Intervention (84 Hours)||5
10153862|NCT02862730|11284506|FG005|STARTED|First Intervention (84 Hours)||1
10153863|NCT02862730|11284507|FG006|STARTED|First Intervention (84 Hours)||1
10153864|NCT02862730|11284501|FG000|COMPLETED|First Intervention (84 Hours)||4
10153865|NCT02862730|11284502|FG001|COMPLETED|First Intervention (84 Hours)||1
10153866|NCT02862730|11284503|FG002|COMPLETED|First Intervention (84 Hours)||7
10153867|NCT02862730|11284504|FG003|COMPLETED|First Intervention (84 Hours)||5
10153868|NCT02862730|11284505|FG004|COMPLETED|First Intervention (84 Hours)||5
10153869|NCT02862730|11284506|FG005|COMPLETED|First Intervention (84 Hours)||1
10153870|NCT02862730|11284507|FG006|COMPLETED|First Intervention (84 Hours)||1
10153871|NCT02862730|11284501|FG000|NOT COMPLETED|First Intervention (84 Hours)||0
10153872|NCT02862730|11284502|FG001|NOT COMPLETED|First Intervention (84 Hours)||0
10153873|NCT02862730|11284503|FG002|NOT COMPLETED|First Intervention (84 Hours)||0
10153874|NCT02862730|11284504|FG003|NOT COMPLETED|First Intervention (84 Hours)||0
10153875|NCT02862730|11284505|FG004|NOT COMPLETED|First Intervention (84 Hours)||0
10153876|NCT02862730|11284506|FG005|NOT COMPLETED|First Intervention (84 Hours)||0
10153877|NCT02862730|11284507|FG006|NOT COMPLETED|First Intervention (84 Hours)||0
10153878|NCT02862730|11284501|FG000|STARTED|Second Rest Period (7-45 Days)||4
10153879|NCT02862730|11284502|FG001|STARTED|Second Rest Period (7-45 Days)||1
10153880|NCT02862730|11284503|FG002|STARTED|Second Rest Period (7-45 Days)||7
10153881|NCT02862730|11284504|FG003|STARTED|Second Rest Period (7-45 Days)||5
10153882|NCT02862730|11284505|FG004|STARTED|Second Rest Period (7-45 Days)||5
10153883|NCT02862730|11284506|FG005|STARTED|Second Rest Period (7-45 Days)||1
10153884|NCT02862730|11284507|FG006|STARTED|Second Rest Period (7-45 Days)||1
10153885|NCT02862730|11284501|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
10153886|NCT02862730|11284502|FG001|COMPLETED|Second Rest Period (7-45 Days)||1
10153887|NCT02862730|11284503|FG002|COMPLETED|Second Rest Period (7-45 Days)||7
10153888|NCT02862730|11284504|FG003|COMPLETED|Second Rest Period (7-45 Days)||5
10153889|NCT02862730|11284505|FG004|COMPLETED|Second Rest Period (7-45 Days)||5
10153890|NCT02862730|11284506|FG005|COMPLETED|Second Rest Period (7-45 Days)||1
10153891|NCT02862730|11284507|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
10153892|NCT02862730|11284501|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10153893|NCT02862730|11284502|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10153894|NCT02862730|11284503|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10153895|NCT02862730|11284504|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10153896|NCT02862730|11284505|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10153897|NCT02862730|11284506|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10153898|NCT02862730|11284507|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10153899|NCT02862730|11284501|FG000|STARTED|Second Intervention (84 Hours)||4
10153900|NCT02862730|11284502|FG001|STARTED|Second Intervention (84 Hours)||1
10153901|NCT02862730|11284503|FG002|STARTED|Second Intervention (84 Hours)||7
10153902|NCT02862730|11284504|FG003|STARTED|Second Intervention (84 Hours)||5
10153903|NCT02862730|11284505|FG004|STARTED|Second Intervention (84 Hours)||5
10153904|NCT02862730|11284506|FG005|STARTED|Second Intervention (84 Hours)||1
10153905|NCT02862730|11284507|FG006|STARTED|Second Intervention (84 Hours)||1
10153906|NCT02862730|11284501|FG000|COMPLETED|Second Intervention (84 Hours)||3
10153907|NCT02862730|11284502|FG001|COMPLETED|Second Intervention (84 Hours)||1
10153908|NCT02862730|11284503|FG002|COMPLETED|Second Intervention (84 Hours)||7
10153909|NCT02862730|11284504|FG003|COMPLETED|Second Intervention (84 Hours)||5
10153910|NCT02862730|11284505|FG004|COMPLETED|Second Intervention (84 Hours)||5
9710136|NCT01623167|10809637|FG000|NOT COMPLETED|Overall Study||17
9710137|NCT01623167|10809638|FG001|NOT COMPLETED|Overall Study||14
10153911|NCT02862730|11284506|FG005|COMPLETED|Second Intervention (84 Hours)||1
10153912|NCT02862730|11284507|FG006|COMPLETED|Second Intervention (84 Hours)||1
10153913|NCT02862730|11284501|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1
10153914|NCT02862730|11284502|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0
10153915|NCT02862730|11284503|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0
10153916|NCT02862730|11284504|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0
10153917|NCT02862730|11284505|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0
10153918|NCT02862730|11284506|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0
10153919|NCT02862730|11284507|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0
10153920|NCT02862730|11284501|FG000|STARTED|Third Rest Period (7-45 Days)||3
10153921|NCT02862730|11284502|FG001|STARTED|Third Rest Period (7-45 Days)||1
10153922|NCT02862730|11284503|FG002|STARTED|Third Rest Period (7-45 Days)||7
10153923|NCT02862730|11284504|FG003|STARTED|Third Rest Period (7-45 Days)||5
10153924|NCT02862730|11284505|FG004|STARTED|Third Rest Period (7-45 Days)||5
10153925|NCT02862730|11284506|FG005|STARTED|Third Rest Period (7-45 Days)||1
10153926|NCT02862730|11284507|FG006|STARTED|Third Rest Period (7-45 Days)||1
10153927|NCT02862730|11284501|FG000|COMPLETED|Third Rest Period (7-45 Days)||3
10153928|NCT02862730|11284502|FG001|COMPLETED|Third Rest Period (7-45 Days)||1
10153929|NCT02862730|11284503|FG002|COMPLETED|Third Rest Period (7-45 Days)||6
10153930|NCT02862730|11284504|FG003|COMPLETED|Third Rest Period (7-45 Days)||5
10153931|NCT02862730|11284505|FG004|COMPLETED|Third Rest Period (7-45 Days)||4
10153932|NCT02862730|11284506|FG005|COMPLETED|Third Rest Period (7-45 Days)||1
10153933|NCT02862730|11284507|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
10153934|NCT02862730|11284501|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10153935|NCT02862730|11284502|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10153936|NCT02862730|11284503|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1
10153937|NCT02862730|11284504|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10153938|NCT02862730|11284505|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1
10153939|NCT02862730|11284506|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10153940|NCT02862730|11284507|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10153941|NCT02862730|11284501|FG000|STARTED|Third Intervention (84 Hours)||3
10153942|NCT02862730|11284502|FG001|STARTED|Third Intervention (84 Hours)||1
10153943|NCT02862730|11284503|FG002|STARTED|Third Intervention (84 Hours)||6
10153944|NCT02862730|11284504|FG003|STARTED|Third Intervention (84 Hours)||5
10153945|NCT02862730|11284505|FG004|STARTED|Third Intervention (84 Hours)||4
10153946|NCT02862730|11284506|FG005|STARTED|Third Intervention (84 Hours)||1
10153947|NCT02862730|11284507|FG006|STARTED|Third Intervention (84 Hours)||1
10153948|NCT02862730|11284501|FG000|COMPLETED|Third Intervention (84 Hours)||3
10153949|NCT02862730|11284502|FG001|COMPLETED|Third Intervention (84 Hours)||1
10153950|NCT02862730|11284503|FG002|COMPLETED|Third Intervention (84 Hours)||6
10153951|NCT02862730|11284504|FG003|COMPLETED|Third Intervention (84 Hours)||4
10153952|NCT02862730|11284505|FG004|COMPLETED|Third Intervention (84 Hours)||4
10153953|NCT02862730|11284506|FG005|COMPLETED|Third Intervention (84 Hours)||1
10153954|NCT02862730|11284507|FG006|COMPLETED|Third Intervention (84 Hours)||1
10153955|NCT02862730|11284501|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0
10153956|NCT02862730|11284502|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0
10153957|NCT02862730|11284503|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0
10153958|NCT02862730|11284504|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1
10153959|NCT02862730|11284505|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0
10153960|NCT02862730|11284506|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0
10153961|NCT02862730|11284507|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0
10153962|NCT02862730|11284501|FG000|STARTED|Fourth Rest Period (7-45 Days)||3
10153963|NCT02862730|11284502|FG001|STARTED|Fourth Rest Period (7-45 Days)||1
10153964|NCT02862730|11284503|FG002|STARTED|Fourth Rest Period (7-45 Days)||6
10153965|NCT02862730|11284504|FG003|STARTED|Fourth Rest Period (7-45 Days)||4
10153966|NCT02862730|11284505|FG004|STARTED|Fourth Rest Period (7-45 Days)||4
10153967|NCT02862730|11284506|FG005|STARTED|Fourth Rest Period (7-45 Days)||1
10153968|NCT02862730|11284507|FG006|STARTED|Fourth Rest Period (7-45 Days)||1
10153969|NCT02862730|11284501|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3
10153970|NCT02862730|11284502|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1
10153971|NCT02862730|11284503|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6
10153972|NCT02862730|11284504|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4
10153973|NCT02862730|11284505|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4
10153974|NCT02862730|11284506|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1
10153975|NCT02862730|11284507|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1
10153976|NCT02862730|11284501|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10153977|NCT02862730|11284502|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
9710138|NCT01623167|10809639|FG002|NOT COMPLETED|Overall Study||13
9710139|NCT01535274|10809649|FG000|STARTED|Overall Study||28
9710140|NCT01535274|10809650|FG001|STARTED|Overall Study|"29 participants were initially randomized to receive desflurane treatment. One participant initially randomized to the desflurane arm was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below."|29
9710141|NCT01535274|10809649|FG000|Received Propofol|Overall Study||28
9710142|NCT01535274|10809650|FG001|Received Propofol|Overall Study|"Of the 29 participants initially randomized to receive desflurane treatment, one was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below. That participant is included in the baseline characteristics, outcome measures, and adverse events with the propofol arm."|1
9710143|NCT01535274|10809649|FG000|Received Desflurane|Overall Study||0
9710144|NCT01535274|10809650|FG001|Received Desflurane|Overall Study||28
9710145|NCT01535274|10809649|FG000|COMPLETED|Overall Study||28
9710146|NCT01535274|10809650|FG001|COMPLETED|Overall Study||27
9710147|NCT01535274|10809649|FG000|NOT COMPLETED|Overall Study||0
9710148|NCT01535274|10809650|FG001|NOT COMPLETED|Overall Study||2
9710149|NCT00544830|10809658|FG000|STARTED|Overall Study||29
10153978|NCT02862730|11284503|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10153979|NCT02862730|11284504|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10153980|NCT02862730|11284505|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10153981|NCT02862730|11284506|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10153982|NCT02862730|11284507|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10153983|NCT02862730|11284501|FG000|STARTED|Fourth Intervention (84 Hours)||3
10153984|NCT02862730|11284502|FG001|STARTED|Fourth Intervention (84 Hours)||1
10153985|NCT02862730|11284503|FG002|STARTED|Fourth Intervention (84 Hours)||6
10153986|NCT02862730|11284504|FG003|STARTED|Fourth Intervention (84 Hours)||4
10153987|NCT02862730|11284505|FG004|STARTED|Fourth Intervention (84 Hours)||4
10153988|NCT02862730|11284506|FG005|STARTED|Fourth Intervention (84 Hours)||1
10153989|NCT02862730|11284507|FG006|STARTED|Fourth Intervention (84 Hours)||1
10153990|NCT02862730|11284501|FG000|COMPLETED|Fourth Intervention (84 Hours)||3
10153991|NCT02862730|11284502|FG001|COMPLETED|Fourth Intervention (84 Hours)||1
10153992|NCT02862730|11284503|FG002|COMPLETED|Fourth Intervention (84 Hours)||6
10153993|NCT02862730|11284504|FG003|COMPLETED|Fourth Intervention (84 Hours)||4
10153994|NCT02862730|11284505|FG004|COMPLETED|Fourth Intervention (84 Hours)||4
10153995|NCT02862730|11284506|FG005|COMPLETED|Fourth Intervention (84 Hours)||1
10153996|NCT02862730|11284507|FG006|COMPLETED|Fourth Intervention (84 Hours)||1
10153997|NCT02862730|11284501|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10153998|NCT02862730|11284502|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10153999|NCT02862730|11284503|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10154000|NCT02862730|11284504|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10154001|NCT02862730|11284505|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10154002|NCT02862730|11284506|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10154003|NCT02862730|11284507|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10154004|NCT02862912|11284524|FG000|STARTED|Overall Study||23
10154005|NCT02862912|11284525|FG001|STARTED|Overall Study||20
10154006|NCT02862912|11284524|FG000|COMPLETED|Overall Study||22
10154007|NCT02862912|11284525|FG001|COMPLETED|Overall Study||20
10154008|NCT02862912|11284524|FG000|NOT COMPLETED|Overall Study||1
10154009|NCT02862912|11284525|FG001|NOT COMPLETED|Overall Study||0
10154010|NCT02863198|11284535|FG000|STARTED|Overall Study||60
10154011|NCT02863198|11284536|FG001|STARTED|Overall Study||60
10154012|NCT02863198|11284535|FG000|COMPLETED|Overall Study||60
10154013|NCT02863198|11284536|FG001|COMPLETED|Overall Study||60
10154014|NCT02863198|11284535|FG000|NOT COMPLETED|Overall Study||0
10154015|NCT02863198|11284536|FG001|NOT COMPLETED|Overall Study||0
10154016|NCT02863263|11284544|FG000|STARTED|Overall Study||3
10154017|NCT02863263|11284545|FG001|STARTED|Overall Study||2
10154018|NCT02863263|11284544|FG000|COMPLETED|Overall Study||2
10154019|NCT02863263|11284545|FG001|COMPLETED|Overall Study||1
10154020|NCT02863263|11284544|FG000|NOT COMPLETED|Overall Study||1
10154021|NCT02863263|11284545|FG001|NOT COMPLETED|Overall Study||1
10154022|NCT02863289|11284551|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
10154023|NCT02863289|11284551|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
10154024|NCT02863289|11284551|FG000|NOT COMPLETED|Overall Study||83
10154025|NCT02863328|11284558|FG000|STARTED|Overall Study||411
10154026|NCT02863328|11284559|FG001|STARTED|Overall Study||410
10154027|NCT02863328|11284558|FG000|Full Analysis Set (FAS)|Overall Study||411
10154028|NCT02863328|11284559|FG001|Full Analysis Set (FAS)|Overall Study||410
10154029|NCT02863328|11284558|FG000|Safety Analysis Set (SAS)|Overall Study||410
10154030|NCT02863328|11284559|FG001|Safety Analysis Set (SAS)|Overall Study||409
10154031|NCT02863328|11284558|FG000|COMPLETED|Overall Study||400
10154032|NCT02863328|11284559|FG001|COMPLETED|Overall Study||387
10154033|NCT02863328|11284558|FG000|NOT COMPLETED|Overall Study||11
10154034|NCT02863328|11284559|FG001|NOT COMPLETED|Overall Study||23
10154035|NCT02863354|11284567|FG000|STARTED|Year 1||23
10154036|NCT02863354|11284568|FG001|STARTED|Year 1||20
10154037|NCT02863354|11284567|FG000|COMPLETED|Year 1||19
10154038|NCT02863354|11284568|FG001|COMPLETED|Year 1||18
10154039|NCT02863354|11284567|FG000|NOT COMPLETED|Year 1||4
10154040|NCT02863354|11284568|FG001|NOT COMPLETED|Year 1||2
10154041|NCT02863354|11284567|FG000|STARTED|Year 2||19
10154042|NCT02863354|11284568|FG001|STARTED|Year 2||18
10154043|NCT02863354|11284567|FG000|COMPLETED|Year 2||17
10154044|NCT02863354|11284568|FG001|COMPLETED|Year 2||16
10154045|NCT02863354|11284567|FG000|NOT COMPLETED|Year 2||2
10154046|NCT02863354|11284568|FG001|NOT COMPLETED|Year 2||2
10154047|NCT02863419|11284577|FG000|STARTED|Overall Study||285
10154048|NCT02863419|11284578|FG001|STARTED|Overall Study||284
10154049|NCT02863419|11284579|FG002|STARTED|Overall Study||142
10154050|NCT02863419|11284577|FG000|Full Analysis Set (FAS)|Overall Study||285
10154051|NCT02863419|11284578|FG001|Full Analysis Set (FAS)|Overall Study||284
10154052|NCT02863419|11284579|FG002|Full Analysis Set (FAS)|Overall Study||142
10154053|NCT02863419|11284577|FG000|Safety Analysis Set (SAS)|Overall Study||285
10154054|NCT02863419|11284578|FG001|Safety Analysis Set (SAS)|Overall Study||284
10154055|NCT02863419|11284579|FG002|Safety Analysis Set (SAS)|Overall Study||142
10154056|NCT02863419|11284577|FG000|COMPLETED|Overall Study||277
10154057|NCT02863419|11284578|FG001|COMPLETED|Overall Study||274
10154058|NCT02863419|11284579|FG002|COMPLETED|Overall Study||134
10154059|NCT02863419|11284577|FG000|NOT COMPLETED|Overall Study||8
10154060|NCT02863419|11284578|FG001|NOT COMPLETED|Overall Study||10
10154061|NCT02863419|11284579|FG002|NOT COMPLETED|Overall Study||8
10154062|NCT02863575|11284590|FG000|STARTED|Overall Study||161
10154063|NCT02863575|11284591|FG001|STARTED|Overall Study||161
10154064|NCT02863575|11284592|FG002|STARTED|Overall Study||52
10154065|NCT02863575|11284590|FG000|COMPLETED|Overall Study||160
10154066|NCT02863575|11284591|FG001|COMPLETED|Overall Study||159
10154067|NCT02863575|11284592|FG002|COMPLETED|Overall Study||51
10154068|NCT02863575|11284590|FG000|NOT COMPLETED|Overall Study||1
10154069|NCT02863575|11284591|FG001|NOT COMPLETED|Overall Study||2
10154070|NCT02863575|11284592|FG002|NOT COMPLETED|Overall Study||1
10154071|NCT02864069|11284603|FG000|STARTED|Overall Study||18
10154072|NCT02864069|11284604|FG001|STARTED|Overall Study||13
10154073|NCT02864069|11284605|FG002|STARTED|Overall Study||21
10154074|NCT02864069|11284603|FG000|COMPLETED|Overall Study||12
10154075|NCT02864069|11284604|FG001|COMPLETED|Overall Study||5
10154076|NCT02864069|11284605|FG002|COMPLETED|Overall Study||13
10154077|NCT02864069|11284603|FG000|NOT COMPLETED|Overall Study||6
10154078|NCT02864069|11284604|FG001|NOT COMPLETED|Overall Study||8
10154079|NCT02864069|11284605|FG002|NOT COMPLETED|Overall Study||8
10154080|NCT02864082|11284615|FG000|STARTED|Overall Study||10
10154081|NCT02864082|11284616|FG001|STARTED|Overall Study||9
10154082|NCT02864082|11284615|FG000|COMPLETED|Overall Study||7
10154083|NCT02864082|11284616|FG001|COMPLETED|Overall Study||5
10154084|NCT02864082|11284615|FG000|NOT COMPLETED|Overall Study||3
10154085|NCT02864082|11284616|FG001|NOT COMPLETED|Overall Study||4
10154086|NCT02864316|11284638|FG000|STARTED|Overall Study||2
10154087|NCT02864316|11284639|FG001|STARTED|Overall Study||2
10154088|NCT02864316|11284638|FG000|COMPLETED|Overall Study||0
10154089|NCT02864316|11284639|FG001|COMPLETED|Overall Study||0
10154090|NCT02864316|11284638|FG000|NOT COMPLETED|Overall Study||2
10154091|NCT02864316|11284639|FG001|NOT COMPLETED|Overall Study||2
10154092|NCT02864342|11284647|FG000|STARTED|Overall Study||70
10154093|NCT02864342|11284648|FG001|STARTED|Overall Study||68
10154094|NCT02864342|11284647|FG000|Full Analysis Set (FAS)|Overall Study||70
10154095|NCT02864342|11284648|FG001|Full Analysis Set (FAS)|Overall Study||67
10154096|NCT02864342|11284647|FG000|COMPLETED|Overall Study||55
10154097|NCT02864342|11284648|FG001|COMPLETED|Overall Study||49
10154098|NCT02864342|11284647|FG000|NOT COMPLETED|Overall Study||15
10154099|NCT02864342|11284648|FG001|NOT COMPLETED|Overall Study||19
10154100|NCT02864355|11284657|FG000|STARTED|Overall Study||25
10154101|NCT02864355|11284658|FG001|STARTED|Overall Study||28
10154102|NCT02864355|11284657|FG000|COMPLETED|Overall Study||23
10154103|NCT02864355|11284658|FG001|COMPLETED|Overall Study||25
10154104|NCT02864355|11284657|FG000|NOT COMPLETED|Overall Study||2
10154105|NCT02864355|11284658|FG001|NOT COMPLETED|Overall Study||3
10154106|NCT02864381|11284666|FG000|STARTED|Overall Study||72
10154107|NCT02864381|11284667|FG001|STARTED|Overall Study||72
10154108|NCT02864381|11284666|FG000|COMPLETED|Overall Study||0
10154109|NCT02864381|11284667|FG001|COMPLETED|Overall Study||0
10154110|NCT02864381|11284666|FG000|NOT COMPLETED|Overall Study||72
10154111|NCT02864381|11284667|FG001|NOT COMPLETED|Overall Study||72
10154112|NCT02864394|11284675|FG000|STARTED|Overall Study||213
10154113|NCT02864394|11284676|FG001|STARTED|Overall Study||212
10154114|NCT02864394|11284675|FG000|Treated|Overall Study||213
10154115|NCT02864394|11284676|FG001|Treated|Overall Study||198
10154116|NCT02864394|11284675|FG000|COMPLETED|Overall Study||0
10154117|NCT02864394|11284676|FG001|COMPLETED|Overall Study||0
10154118|NCT02864394|11284675|FG000|NOT COMPLETED|Overall Study||213
10154119|NCT02864394|11284676|FG001|NOT COMPLETED|Overall Study||212
10154120|NCT02864706|11284684|FG000|STARTED|Overall Study||48
10154121|NCT02864706|11284685|FG001|STARTED|Overall Study||47
10154122|NCT02864706|11284684|FG000|Safety Set|Overall Study||48
10154123|NCT02864706|11284685|FG001|Safety Set|Overall Study||47
10154124|NCT02864706|11284684|FG000|Intent to Treat|Overall Study||46
10154125|NCT02864706|11284685|FG001|Intent to Treat|Overall Study||47
10154126|NCT02864706|11284684|FG000|COMPLETED|Overall Study||48
10154127|NCT02864706|11284685|FG001|COMPLETED|Overall Study||47
10154128|NCT02864706|11284684|FG000|NOT COMPLETED|Overall Study||0
10154129|NCT02864706|11284685|FG001|NOT COMPLETED|Overall Study||0
10154130|NCT02864732|11284693|FG000|STARTED|Overall Study||15
10154131|NCT02864732|11284694|FG001|STARTED|Overall Study||15
10154132|NCT02864732|11284693|FG000|COMPLETED|Overall Study||13
10154133|NCT02864732|11284694|FG001|COMPLETED|Overall Study||13
10154134|NCT02864732|11284693|FG000|NOT COMPLETED|Overall Study||2
10154135|NCT02864732|11284694|FG001|NOT COMPLETED|Overall Study||2
10154136|NCT02865343|11284703|FG000|STARTED|Overall Study||6
10154137|NCT02865343|11284704|FG001|STARTED|Overall Study||5
10154138|NCT02865343|11284703|FG000|COMPLETED|Overall Study||6
10154139|NCT02865343|11284704|FG001|COMPLETED|Overall Study||3
10154140|NCT02865343|11284703|FG000|NOT COMPLETED|Overall Study||0
10154141|NCT02865343|11284704|FG001|NOT COMPLETED|Overall Study||2
10154142|NCT02865434|11284723|FG000|STARTED|Overall Study||3
10154143|NCT02865434|11284724|FG001|STARTED|Overall Study||3
10154144|NCT02865434|11284725|FG002|STARTED|Overall Study||3
10154145|NCT02865434|11284726|FG003|STARTED|Overall Study||3
9710150|NCT00544830|10809658|FG000|COMPLETED|Overall Study||29
10154146|NCT02865434|11284727|FG004|STARTED|Overall Study||3
10154147|NCT02865434|11284728|FG005|STARTED|Overall Study||3
10154148|NCT02865434|11284729|FG006|STARTED|Overall Study||3
10154149|NCT02865434|11284730|FG007|STARTED|Overall Study||3
10154150|NCT02865434|11284731|FG008|STARTED|Overall Study||3
10154151|NCT02865434|11284732|FG009|STARTED|Overall Study||6
10154152|NCT02865434|11284733|FG010|STARTED|Overall Study||6
10154153|NCT02865434|11284723|FG000|COMPLETED|Overall Study||3
10154154|NCT02865434|11284724|FG001|COMPLETED|Overall Study||3
10154155|NCT02865434|11284725|FG002|COMPLETED|Overall Study||3
10154156|NCT02865434|11284726|FG003|COMPLETED|Overall Study||3
10154157|NCT02865434|11284727|FG004|COMPLETED|Overall Study||3
10154158|NCT02865434|11284728|FG005|COMPLETED|Overall Study||3
10154159|NCT02865434|11284729|FG006|COMPLETED|Overall Study||3
10154160|NCT02865434|11284730|FG007|COMPLETED|Overall Study||3
10154161|NCT02865434|11284731|FG008|COMPLETED|Overall Study||3
10154162|NCT02865434|11284732|FG009|COMPLETED|Overall Study||6
10154163|NCT02865434|11284733|FG010|COMPLETED|Overall Study||6
10154164|NCT02865434|11284723|FG000|NOT COMPLETED|Overall Study||0
10154165|NCT02865434|11284724|FG001|NOT COMPLETED|Overall Study||0
10154166|NCT02865434|11284725|FG002|NOT COMPLETED|Overall Study||0
10154167|NCT02865434|11284726|FG003|NOT COMPLETED|Overall Study||0
10154168|NCT02865434|11284727|FG004|NOT COMPLETED|Overall Study||0
10154169|NCT02865434|11284728|FG005|NOT COMPLETED|Overall Study||0
10154170|NCT02865434|11284729|FG006|NOT COMPLETED|Overall Study||0
10154171|NCT02865434|11284730|FG007|NOT COMPLETED|Overall Study||0
10154172|NCT02865434|11284731|FG008|NOT COMPLETED|Overall Study||0
10154173|NCT02865434|11284732|FG009|NOT COMPLETED|Overall Study||0
10154174|NCT02865434|11284733|FG010|NOT COMPLETED|Overall Study||0
10154175|NCT02865499|11284763|FG000|STARTED|Baseline||8
10154176|NCT02865499|11284763|FG000|COMPLETED|Baseline||6
10154177|NCT02865499|11284763|FG000|NOT COMPLETED|Baseline||2
10154178|NCT02865499|11284763|FG000|STARTED|8 Weeks||6
10154179|NCT02865499|11284763|FG000|COMPLETED|8 Weeks||6
10154180|NCT02865499|11284763|FG000|NOT COMPLETED|8 Weeks||0
10154181|NCT02865499|11284763|FG000|STARTED|12 Weeks||6
10154182|NCT02865499|11284763|FG000|COMPLETED|12 Weeks||6
10154183|NCT02865499|11284763|FG000|NOT COMPLETED|12 Weeks||0
10154184|NCT02865538|11284772|FG000|STARTED|Overall Study||18
10154185|NCT02865538|11284773|FG001|STARTED|Overall Study||15
10154186|NCT02865538|11284774|FG002|STARTED|Overall Study||15
10154187|NCT02865538|11284775|FG003|STARTED|Overall Study||15
10154188|NCT02865538|11284776|FG004|STARTED|Overall Study||13
10154189|NCT02865538|11284772|FG000|COMPLETED|Overall Study||17
10154190|NCT02865538|11284773|FG001|COMPLETED|Overall Study||15
10154191|NCT02865538|11284774|FG002|COMPLETED|Overall Study||14
10154192|NCT02865538|11284775|FG003|COMPLETED|Overall Study||15
10154193|NCT02865538|11284776|FG004|COMPLETED|Overall Study||13
10154194|NCT02865538|11284772|FG000|NOT COMPLETED|Overall Study||1
10154195|NCT02865538|11284773|FG001|NOT COMPLETED|Overall Study||0
10154196|NCT02865538|11284774|FG002|NOT COMPLETED|Overall Study||1
10154197|NCT02865538|11284775|FG003|NOT COMPLETED|Overall Study||0
10154198|NCT02865538|11284776|FG004|NOT COMPLETED|Overall Study||0
10154199|NCT02865590|11284790|FG000|STARTED|Overall Study||8
10154200|NCT02865590|11284791|FG001|STARTED|Overall Study||8
10154201|NCT02865590|11284790|FG000|COMPLETED|Overall Study||8
10154202|NCT02865590|11284791|FG001|COMPLETED|Overall Study||8
10154203|NCT02865590|11284790|FG000|NOT COMPLETED|Overall Study||0
10154204|NCT02865590|11284791|FG001|NOT COMPLETED|Overall Study||0
10154205|NCT02865720|11284799|FG000|STARTED|Overall Study||0
10154206|NCT02865720|11284800|FG001|STARTED|Overall Study||8
10154207|NCT02865720|11284799|FG000|COMPLETED|Overall Study||0
10154208|NCT02865720|11284800|FG001|COMPLETED|Overall Study||8
10154209|NCT02865720|11284799|FG000|NOT COMPLETED|Overall Study||0
10154210|NCT02865720|11284800|FG001|NOT COMPLETED|Overall Study||0
10154211|NCT02865811|11284805|FG000|STARTED|Overall Study||26
10154212|NCT02865811|11284805|FG000|COMPLETED|Overall Study||26
10154213|NCT02865811|11284805|FG000|NOT COMPLETED|Overall Study||0
10154214|NCT02866175|11284812|FG000|STARTED|Overall Study||751
10154215|NCT02866175|11284813|FG001|STARTED|Overall Study||755
10154216|NCT02866175|11284812|FG000|COMPLETED|Overall Study||616
10154217|NCT02866175|11284813|FG001|COMPLETED|Overall Study||580
10154218|NCT02866175|11284812|FG000|NOT COMPLETED|Overall Study||135
10154219|NCT02866175|11284813|FG001|NOT COMPLETED|Overall Study||175
10154220|NCT02866643|11284822|FG000|STARTED|Overall Study||48
10154221|NCT02866643|11284823|FG001|STARTED|Overall Study||47
10154222|NCT02866643|11284822|FG000|Intent-to-Treat (ITT) Population|Overall Study||38
10154223|NCT02866643|11284823|FG001|Intent-to-Treat (ITT) Population|Overall Study||39
10154224|NCT02866643|11284822|FG000|Per Protocol Population|Overall Study||35
10154225|NCT02866643|11284823|FG001|Per Protocol Population|Overall Study||35
10154226|NCT02866643|11284822|FG000|COMPLETED|Overall Study||35
10154227|NCT02866643|11284823|FG001|COMPLETED|Overall Study||35
10154228|NCT02866643|11284822|FG000|NOT COMPLETED|Overall Study||13
10154229|NCT02866643|11284823|FG001|NOT COMPLETED|Overall Study||12
10154230|NCT02866942|11284829|FG000|STARTED|Overall Study||479
10154231|NCT02866942|11284829|FG000|COMPLETED|Overall Study||478
10154232|NCT02866942|11284829|FG000|NOT COMPLETED|Overall Study||1
10154233|NCT02867059|11284835|FG000|STARTED|Overall Study||7
10154234|NCT02867059|11284836|FG001|STARTED|Overall Study||10
10154235|NCT02867059|11284835|FG000|COMPLETED|Overall Study||7
10154236|NCT02867059|11284836|FG001|COMPLETED|Overall Study||8
10154237|NCT02867059|11284835|FG000|NOT COMPLETED|Overall Study||0
10154238|NCT02867059|11284836|FG001|NOT COMPLETED|Overall Study||2
10154239|NCT02867150|11284842|FG000|STARTED|Overall Study||58
10154240|NCT02867150|11284842|FG000|COMPLETED|Overall Study||58
10154241|NCT02867150|11284842|FG000|NOT COMPLETED|Overall Study||0
10154242|NCT02867163|11284846|FG000|STARTED|Overall Study||25
10154243|NCT02867163|11284846|FG000|COMPLETED|Overall Study||25
10154244|NCT02867163|11284846|FG000|NOT COMPLETED|Overall Study||0
10154245|NCT02867202|11284852|FG000|STARTED|Overall Study||83
10154246|NCT02867202|11284853|FG001|STARTED|Overall Study||88
10154247|NCT02867202|11284852|FG000|COMPLETED|Overall Study||62
10154248|NCT02867202|11284853|FG001|COMPLETED|Overall Study||56
10154249|NCT02867202|11284852|FG000|NOT COMPLETED|Overall Study||21
10154250|NCT02867202|11284853|FG001|NOT COMPLETED|Overall Study||32
10154251|NCT02867605|11284859|FG000|STARTED|Overall Study||20
10154252|NCT02867605|11284859|FG000|COMPLETED|Overall Study||20
10154253|NCT02867605|11284859|FG000|NOT COMPLETED|Overall Study||0
10154254|NCT02867618|11284876|FG000|STARTED|Overall Study||11
10154255|NCT02867618|11284876|FG000|COMPLETED|Overall Study||11
10154256|NCT02867618|11284876|FG000|NOT COMPLETED|Overall Study||0
10154257|NCT02867709|11284883|FG000|STARTED|Treatment Period||563
10154258|NCT02867709|11284884|FG001|STARTED|Treatment Period||561
10154259|NCT02867709|11284885|FG002|STARTED|Treatment Period||562
10154260|NCT02867709|11284883|FG000|Safety Population: Received Study Drug|Treatment Period||499
10154261|NCT02867709|11284884|FG001|Safety Population: Received Study Drug|Treatment Period||478
10154262|NCT02867709|11284885|FG002|Safety Population: Received Study Drug|Treatment Period||488
10154263|NCT02867709|11284883|FG000|COMPLETED|Treatment Period||493
10154264|NCT02867709|11284884|FG001|COMPLETED|Treatment Period||474
10154265|NCT02867709|11284885|FG002|COMPLETED|Treatment Period||487
10154266|NCT02867709|11284883|FG000|NOT COMPLETED|Treatment Period||70
10154267|NCT02867709|11284884|FG001|NOT COMPLETED|Treatment Period||87
10154268|NCT02867709|11284885|FG002|NOT COMPLETED|Treatment Period||75
10154269|NCT02867709|11284883|FG000|STARTED|Safety Follow-up Period||493
10154270|NCT02867709|11284884|FG001|STARTED|Safety Follow-up Period||474
10154271|NCT02867709|11284885|FG002|STARTED|Safety Follow-up Period||487
10154272|NCT02867709|11284883|FG000|COMPLETED|Safety Follow-up Period||482
10154273|NCT02867709|11284884|FG001|COMPLETED|Safety Follow-up Period||459
10154274|NCT02867709|11284885|FG002|COMPLETED|Safety Follow-up Period||473
10154275|NCT02867709|11284883|FG000|NOT COMPLETED|Safety Follow-up Period||11
10154276|NCT02867709|11284884|FG001|NOT COMPLETED|Safety Follow-up Period||15
10154277|NCT02867709|11284885|FG002|NOT COMPLETED|Safety Follow-up Period||14
10154278|NCT02867995|11284895|FG000|STARTED|Overall Study|Total patients consented|9
10154279|NCT02867995|11284896|FG001|STARTED|Overall Study|Total patients consented|30
10154280|NCT02867995|11284895|FG000|COMPLETED|Overall Study|Total patients completed|9
9710151|NCT00544830|10809658|FG000|NOT COMPLETED|Overall Study||0
9710152|NCT00539981|10809664|FG000|STARTED|Overall Study||2344
9710153|NCT00539981|10809665|FG001|STARTED|Overall Study||2304
9710154|NCT00539981|10809664|FG000|COMPLETED|Overall Study||2049
9710155|NCT00539981|10809665|FG001|COMPLETED|Overall Study||2022
9710156|NCT00539981|10809664|FG000|NOT COMPLETED|Overall Study||295
9710157|NCT00539981|10809665|FG001|NOT COMPLETED|Overall Study||282
9729865|NCT00121719|10829484|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729866|NCT00121719|10829485|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729867|NCT00121719|10829486|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729868|NCT00121719|10829487|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729869|NCT00121719|10829488|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729870|NCT00121719|10829489|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729871|NCT00121719|10829490|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729872|NCT00121719|10829491|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729873|NCT00121719|10829492|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729874|NCT00121719|10829493|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729875|NCT00121719|10829494|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729876|NCT00121719|10829495|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0
9729877|NCT00121719|10829482|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729878|NCT00121719|10829483|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729879|NCT00121719|10829484|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729880|NCT00121719|10829485|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729881|NCT00121719|10829486|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729882|NCT00121719|10829487|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729883|NCT00121719|10829488|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729884|NCT00121719|10829489|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729885|NCT00121719|10829490|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729886|NCT00121719|10829491|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729887|NCT00121719|10829492|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6
9729888|NCT00121719|10829493|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5
9729889|NCT00121719|10829494|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729890|NCT00121719|10829495|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0
9729891|NCT00121719|10829482|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729892|NCT00121719|10829483|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729893|NCT00121719|10829484|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729894|NCT00121719|10829485|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729895|NCT00121719|10829486|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729896|NCT00121719|10829487|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729897|NCT00121719|10829488|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729898|NCT00121719|10829489|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10154281|NCT02867995|11284896|FG001|COMPLETED|Overall Study|Total patients completed|27
10154282|NCT02867995|11284895|FG000|NOT COMPLETED|Overall Study||0
10154283|NCT02867995|11284896|FG001|NOT COMPLETED|Overall Study||3
10154284|NCT02868216|11284908|FG000|STARTED|Overall Study||43
10154285|NCT02868216|11284909|FG001|STARTED|Overall Study||47
10154286|NCT02868216|11284908|FG000|COMPLETED|Overall Study||35
9729899|NCT00121719|10829490|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729900|NCT00121719|10829491|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729901|NCT00121719|10829492|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
9729902|NCT00121719|10829493|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
9731937|NCT00137839|10831917|FG000|Treated|Overall Study||83
10154287|NCT02868216|11284909|FG001|COMPLETED|Overall Study||41
10154288|NCT02868216|11284908|FG000|NOT COMPLETED|Overall Study||8
10154289|NCT02868216|11284909|FG001|NOT COMPLETED|Overall Study||6
10154290|NCT02868229|11284919|FG000|STARTED|Overall Study||12
9849136|NCT00863057|10961801|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
9849137|NCT00863057|10961802|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
9849138|NCT00863057|10961803|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
9849139|NCT00863057|10961800|FG000|STARTED|Period 2 (Weeks 6-10)||3
9849140|NCT00863057|10961801|FG001|STARTED|Period 2 (Weeks 6-10)||2
10154291|NCT02868229|11284920|FG001|STARTED|Overall Study||16
10154292|NCT02868229|11284921|FG002|STARTED|Overall Study||16
10154293|NCT02868229|11284922|FG003|STARTED|Overall Study||17
10154294|NCT02868229|11284919|FG000|Intent to Treat (ITT) Population|Overall Study||12
10154295|NCT02868229|11284920|FG001|Intent to Treat (ITT) Population|Overall Study||16
10154296|NCT02868229|11284921|FG002|Intent to Treat (ITT) Population|Overall Study||16
10154297|NCT02868229|11284922|FG003|Intent to Treat (ITT) Population|Overall Study||17
10154298|NCT02868229|11284919|FG000|Pharmacodynamic (PD) Population|Overall Study||12
10154299|NCT02868229|11284920|FG001|Pharmacodynamic (PD) Population|Overall Study||16
10154300|NCT02868229|11284921|FG002|Pharmacodynamic (PD) Population|Overall Study||13
10154301|NCT02868229|11284922|FG003|Pharmacodynamic (PD) Population|Overall Study||12
10154302|NCT02868229|11284919|FG000|Pharmacokinetic (PK) Population|Overall Study||12
10154303|NCT02868229|11284920|FG001|Pharmacokinetic (PK) Population|Overall Study||16
10154304|NCT02868229|11284921|FG002|Pharmacokinetic (PK) Population|Overall Study||16
10154305|NCT02868229|11284922|FG003|Pharmacokinetic (PK) Population|Overall Study||17
10154306|NCT02868229|11284919|FG000|Safety Analysis Population|Overall Study||12
10154307|NCT02868229|11284920|FG001|Safety Analysis Population|Overall Study||16
10154308|NCT02868229|11284921|FG002|Safety Analysis Population|Overall Study||16
10154309|NCT02868229|11284922|FG003|Safety Analysis Population|Overall Study||17
10154310|NCT02868229|11284919|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12
10154311|NCT02868229|11284920|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16
10154312|NCT02868229|11284921|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16
10154313|NCT02868229|11284922|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16
10154314|NCT02868229|11284919|FG000|COMPLETED|Overall Study||11
10154315|NCT02868229|11284920|FG001|COMPLETED|Overall Study||16
10154316|NCT02868229|11284921|FG002|COMPLETED|Overall Study||15
10154317|NCT02868229|11284922|FG003|COMPLETED|Overall Study||12
10154318|NCT02868229|11284919|FG000|NOT COMPLETED|Overall Study||1
10154319|NCT02868229|11284920|FG001|NOT COMPLETED|Overall Study||0
10154320|NCT02868229|11284921|FG002|NOT COMPLETED|Overall Study||1
10154321|NCT02868229|11284922|FG003|NOT COMPLETED|Overall Study||5
10154322|NCT02868242|11284937|FG000|STARTED|Overall Study||19
10154323|NCT02868242|11284937|FG000|COMPLETED|Overall Study||19
10154324|NCT02868242|11284937|FG000|NOT COMPLETED|Overall Study||0
10154325|NCT02868281|11284945|FG000|STARTED|Overall Study||252
10154326|NCT02868281|11284946|FG001|STARTED|Overall Study||278
10154327|NCT02868281|11284945|FG000|COMPLETED|Overall Study||209
10154328|NCT02868281|11284946|FG001|COMPLETED|Overall Study||234
10154329|NCT02868281|11284945|FG000|NOT COMPLETED|Overall Study||43
10154330|NCT02868281|11284946|FG001|NOT COMPLETED|Overall Study||44
10154331|NCT02868554|11284955|FG000|STARTED|Overall Study||10
10154332|NCT02868554|11284956|FG001|STARTED|Overall Study||12
10154333|NCT02868554|11284957|FG002|STARTED|Overall Study||12
10154334|NCT02868554|11284955|FG000|COMPLETED|Overall Study||7
10154335|NCT02868554|11284956|FG001|COMPLETED|Overall Study||12
9710158|NCT04732819|10809676|FG000|STARTED|Overall Study||12582
9710159|NCT04732819|10809677|FG001|STARTED|Overall Study||11186
9710160|NCT04732819|10809676|FG000|COMPLETED|Overall Study||12582
9710161|NCT04732819|10809677|FG001|COMPLETED|Overall Study||11186
9710162|NCT04732819|10809676|FG000|NOT COMPLETED|Overall Study||0
9710163|NCT04732819|10809677|FG001|NOT COMPLETED|Overall Study||0
9710164|NCT04732338|10809685|FG000|STARTED|Overall Study||13
9710165|NCT04732338|10809686|FG001|STARTED|Overall Study||13
9710166|NCT04732338|10809685|FG000|COMPLETED|Overall Study||10
9710167|NCT04732338|10809686|FG001|COMPLETED|Overall Study||10
9710168|NCT04732338|10809685|FG000|NOT COMPLETED|Overall Study||3
9710169|NCT04732338|10809686|FG001|NOT COMPLETED|Overall Study||3
9729903|NCT00121719|10829494|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729904|NCT00121719|10829495|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729905|NCT00121719|10829482|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729906|NCT00121719|10829483|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729907|NCT00121719|10829484|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729908|NCT00121719|10829485|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729909|NCT00121719|10829486|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10154336|NCT02868554|11284957|FG002|COMPLETED|Overall Study||11
10154337|NCT02868554|11284955|FG000|NOT COMPLETED|Overall Study||3
10154338|NCT02868554|11284956|FG001|NOT COMPLETED|Overall Study||0
10154339|NCT02868554|11284957|FG002|NOT COMPLETED|Overall Study||1
10154340|NCT02869295|11284970|FG000|STARTED|Overall Study||4
9729910|NCT00121719|10829487|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729911|NCT00121719|10829488|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729912|NCT00121719|10829489|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729913|NCT00121719|10829490|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729914|NCT00121719|10829491|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729915|NCT00121719|10829492|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10154341|NCT02869295|11284971|FG001|STARTED|Overall Study||11
10154342|NCT02869295|11284972|FG002|STARTED|Overall Study||6
10154343|NCT02869295|11284973|FG003|STARTED|Overall Study||6
10154344|NCT02869295|11284974|FG004|STARTED|Overall Study||1
10154345|NCT02869295|11284970|FG000|COMPLETED|Overall Study||0
10154346|NCT02869295|11284971|FG001|COMPLETED|Overall Study||0
10154347|NCT02869295|11284972|FG002|COMPLETED|Overall Study||0
10154348|NCT02869295|11284973|FG003|COMPLETED|Overall Study||0
10154349|NCT02869295|11284974|FG004|COMPLETED|Overall Study||0
10154350|NCT02869295|11284970|FG000|NOT COMPLETED|Overall Study||4
10154351|NCT02869295|11284971|FG001|NOT COMPLETED|Overall Study||11
10154352|NCT02869295|11284972|FG002|NOT COMPLETED|Overall Study||6
10154353|NCT02869295|11284973|FG003|NOT COMPLETED|Overall Study||6
10154354|NCT02869295|11284974|FG004|NOT COMPLETED|Overall Study||1
10154355|NCT02869334|11284988|FG000|STARTED|Overall Study||10
10154356|NCT02869334|11284989|FG001|STARTED|Overall Study||10
10154357|NCT02869334|11284988|FG000|COMPLETED|Overall Study||2
10154358|NCT02869334|11284989|FG001|COMPLETED|Overall Study||3
10154359|NCT02869334|11284988|FG000|NOT COMPLETED|Overall Study||8
10154360|NCT02869334|11284989|FG001|NOT COMPLETED|Overall Study||7
10154361|NCT02869438|11284997|FG000|STARTED|Overall Study||118
10154362|NCT02869438|11284998|FG001|STARTED|Overall Study||115
10154363|NCT02869438|11284997|FG000|COMPLETED|Overall Study||115
10154364|NCT02869438|11284998|FG001|COMPLETED|Overall Study||113
10154365|NCT02869438|11284997|FG000|NOT COMPLETED|Overall Study||3
10154366|NCT02869438|11284998|FG001|NOT COMPLETED|Overall Study||2
10154367|NCT02869451|11285004|FG000|STARTED|Overall Study||5
10154368|NCT02869451|11285004|FG000|COMPLETED|Overall Study||5
10154369|NCT02869451|11285004|FG000|NOT COMPLETED|Overall Study||0
10154370|NCT02869893|11285008|FG000|STARTED|Overall Study||57
10154371|NCT02869893|11285008|FG000|COMPLETED|Overall Study||50
10154372|NCT02869893|11285008|FG000|NOT COMPLETED|Overall Study||7
10154373|NCT02870101|11285013|FG000|STARTED|Overall Study||2767
10154374|NCT02870101|11285013|FG000|COMPLETED|Overall Study||2598
10154375|NCT02870101|11285013|FG000|NOT COMPLETED|Overall Study||169
10154376|NCT02870205|11285032|FG000|STARTED|Overall Study||294
10154377|NCT02870205|11285033|FG001|STARTED|Overall Study||294
10154378|NCT02870205|11285034|FG002|STARTED|Overall Study||294
10154379|NCT02870205|11285035|FG003|STARTED|Overall Study||294
10154380|NCT02870205|11285032|FG000|COMPLETED|Overall Study||284
10154381|NCT02870205|11285033|FG001|COMPLETED|Overall Study||289
10154382|NCT02870205|11285034|FG002|COMPLETED|Overall Study||287
10154383|NCT02870205|11285035|FG003|COMPLETED|Overall Study||287
10154384|NCT02870205|11285032|FG000|NOT COMPLETED|Overall Study||10
10154385|NCT02870205|11285033|FG001|NOT COMPLETED|Overall Study||5
10154386|NCT02870205|11285034|FG002|NOT COMPLETED|Overall Study||7
10154387|NCT02870205|11285035|FG003|NOT COMPLETED|Overall Study||7
10154388|NCT02870283|11285048|FG000|STARTED|Overall Study||38
10154389|NCT02870283|11285049|FG001|STARTED|Overall Study||35
10154390|NCT02870283|11285050|FG002|STARTED|Overall Study||34
10154391|NCT02870283|11285048|FG000|COMPLETED|Overall Study||35
10154392|NCT02870283|11285049|FG001|COMPLETED|Overall Study||26
10154393|NCT02870283|11285050|FG002|COMPLETED|Overall Study||15
10154394|NCT02870283|11285048|FG000|NOT COMPLETED|Overall Study||3
10154395|NCT02870283|11285049|FG001|NOT COMPLETED|Overall Study||9
10154396|NCT02870283|11285050|FG002|NOT COMPLETED|Overall Study||19
10154397|NCT02870309|11285058|FG000|STARTED|Overall Study||4
10154398|NCT02870309|11285058|FG000|COMPLETED|Overall Study||4
10154399|NCT02870309|11285058|FG000|NOT COMPLETED|Overall Study||0
10154400|NCT02870933|11285064|FG000|STARTED|Overall Study||15
10154401|NCT02870933|11285065|FG001|STARTED|Overall Study||15
10154402|NCT02870933|11285064|FG000|COMPLETED|Overall Study||13
10154403|NCT02870933|11285065|FG001|COMPLETED|Overall Study||13
10154404|NCT02870933|11285064|FG000|NOT COMPLETED|Overall Study||2
10154405|NCT02870933|11285065|FG001|NOT COMPLETED|Overall Study||2
10154406|NCT02870972|11285077|FG000|STARTED|Overall Study||18
9963935|NCT01489826|11083762|FG000|STARTED|Overall Study||3
9963936|NCT01489826|11083763|FG001|STARTED|Overall Study||3
9963937|NCT01489826|11083764|FG002|STARTED|Overall Study||3
9963938|NCT01489826|11083765|FG003|STARTED|Overall Study||7
9963939|NCT01489826|11083766|FG004|STARTED|Overall Study||3
9963940|NCT01489826|11083767|FG005|STARTED|Overall Study||3
9963941|NCT01489826|11083768|FG006|STARTED|Overall Study||9
9963942|NCT01489826|11083769|FG007|STARTED|Overall Study||3
9963943|NCT01489826|11083770|FG008|STARTED|Overall Study||6
9963944|NCT01489826|11083762|FG000|COMPLETED|Overall Study||3
9963945|NCT01489826|11083763|FG001|COMPLETED|Overall Study||3
9963946|NCT01489826|11083764|FG002|COMPLETED|Overall Study||3
10154407|NCT02870972|11285078|FG001|STARTED|Overall Study||14
10154408|NCT02870972|11285079|FG002|STARTED|Overall Study||14
10154409|NCT02870972|11285080|FG003|STARTED|Overall Study||7
10154410|NCT02870972|11285081|FG004|STARTED|Overall Study||22
10154411|NCT02870972|11285077|FG000|COMPLETED|Overall Study||17
10154412|NCT02870972|11285078|FG001|COMPLETED|Overall Study||14
10154413|NCT02870972|11285079|FG002|COMPLETED|Overall Study||14
9963947|NCT01489826|11083765|FG003|COMPLETED|Overall Study||7
9963948|NCT01489826|11083766|FG004|COMPLETED|Overall Study||3
9963949|NCT01489826|11083767|FG005|COMPLETED|Overall Study||3
9963950|NCT01489826|11083768|FG006|COMPLETED|Overall Study||9
10154414|NCT02870972|11285080|FG003|COMPLETED|Overall Study||7
10154415|NCT02870972|11285081|FG004|COMPLETED|Overall Study||22
10154416|NCT02870972|11285077|FG000|NOT COMPLETED|Overall Study||1
10154417|NCT02870972|11285078|FG001|NOT COMPLETED|Overall Study||0
10154418|NCT02870972|11285079|FG002|NOT COMPLETED|Overall Study||0
10154419|NCT02870972|11285080|FG003|NOT COMPLETED|Overall Study||0
10154420|NCT02870972|11285081|FG004|NOT COMPLETED|Overall Study||0
10154421|NCT02871011|11285097|FG000|STARTED|Overall Study||7
10154422|NCT02871011|11285098|FG001|STARTED|Overall Study||13
10154423|NCT02871011|11285097|FG000|COMPLETED|Overall Study||7
10154424|NCT02871011|11285098|FG001|COMPLETED|Overall Study||13
10154425|NCT02871011|11285097|FG000|NOT COMPLETED|Overall Study||0
10154426|NCT02871011|11285098|FG001|NOT COMPLETED|Overall Study||0
10154427|NCT02871128|11285107|FG000|STARTED|Overall Study||20
10154428|NCT02871128|11285108|FG001|STARTED|Overall Study||20
10154429|NCT02871128|11285109|FG002|STARTED|Overall Study||16
10154430|NCT02871128|11285107|FG000|COMPLETED|Overall Study||20
10154431|NCT02871128|11285108|FG001|COMPLETED|Overall Study||19
10154432|NCT02871128|11285109|FG002|COMPLETED|Overall Study||15
10154433|NCT02871128|11285107|FG000|NOT COMPLETED|Overall Study||0
10154434|NCT02871128|11285108|FG001|NOT COMPLETED|Overall Study||1
10154435|NCT02871128|11285109|FG002|NOT COMPLETED|Overall Study||1
10154436|NCT02871375|11285117|FG000|STARTED|Period 1, First 14 Days of Wear||89
10154437|NCT02871375|11285118|FG001|STARTED|Period 1, First 14 Days of Wear||77
10154438|NCT02871375|11285117|FG000|COMPLETED|Period 1, First 14 Days of Wear||89
10154439|NCT02871375|11285118|FG001|COMPLETED|Period 1, First 14 Days of Wear||76
10154440|NCT02871375|11285117|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
10154441|NCT02871375|11285118|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
10154442|NCT02871375|11285117|FG000|STARTED|Period 2, Second 14 Days of Wear||89
10154443|NCT02871375|11285118|FG001|STARTED|Period 2, Second 14 Days of Wear||76
10154444|NCT02871375|11285117|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89
10154445|NCT02871375|11285118|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76
10154446|NCT02871375|11285117|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10154447|NCT02871375|11285118|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10154448|NCT02871440|11285129|FG000|STARTED|Overall Study||12
10154449|NCT02871440|11285130|FG001|STARTED|Overall Study||13
10154450|NCT02871440|11285131|FG002|STARTED|Overall Study||15
10154451|NCT02871440|11285129|FG000|COMPLETED|Overall Study||12
10154452|NCT02871440|11285130|FG001|COMPLETED|Overall Study||13
10154453|NCT02871440|11285131|FG002|COMPLETED|Overall Study||15
10154454|NCT02871440|11285129|FG000|NOT COMPLETED|Overall Study||0
10154455|NCT02871440|11285130|FG001|NOT COMPLETED|Overall Study||0
10154456|NCT02871440|11285131|FG002|NOT COMPLETED|Overall Study||0
10154457|NCT02871479|11285145|FG000|STARTED|Overall Study||36
10154458|NCT02871479|11285146|FG001|STARTED|Overall Study||24
9710170|NCT04728802|10809694|FG000|STARTED|Overall Study||317
9710171|NCT04728802|10809695|FG001|STARTED|Overall Study||328
9710172|NCT04728802|10809694|FG000|COMPLETED|Overall Study||288
9710173|NCT04728802|10809695|FG001|COMPLETED|Overall Study||292
9710174|NCT04728802|10809694|FG000|NOT COMPLETED|Overall Study||29
9710175|NCT04728802|10809695|FG001|NOT COMPLETED|Overall Study||36
9710176|NCT04728594|10809704|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
9710177|NCT04728594|10809705|FG001|STARTED|Overall Study||3198
9710178|NCT04728594|10809706|FG002|STARTED|Overall Study||3190
9710179|NCT04728594|10809704|FG000|COMPLETED|Overall Study||3178
9710180|NCT04728594|10809705|FG001|COMPLETED|Overall Study||3198
9710181|NCT04728594|10809706|FG002|COMPLETED|Overall Study||3190
9710182|NCT04728594|10809704|FG000|NOT COMPLETED|Overall Study||0
9710183|NCT04728594|10809705|FG001|NOT COMPLETED|Overall Study||0
9710184|NCT04728594|10809706|FG002|NOT COMPLETED|Overall Study||0
9729916|NCT00121719|10829493|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729917|NCT00121719|10829494|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729918|NCT00121719|10829495|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
9729919|NCT00121810|10829539|FG000|STARTED|Overall Study||151
9729920|NCT00121810|10829540|FG001|STARTED|Overall Study||154
9729921|NCT00121810|10829539|FG000|Safety Population|Overall Study||148
9729922|NCT00121810|10829540|FG001|Safety Population|Overall Study||153
9849141|NCT00863057|10961802|FG002|STARTED|Period 2 (Weeks 6-10)||3
9849142|NCT00863057|10961803|FG003|STARTED|Period 2 (Weeks 6-10)||3
9849143|NCT00863057|10961800|FG000|COMPLETED|Period 2 (Weeks 6-10)||3
9849144|NCT00863057|10961801|FG001|COMPLETED|Period 2 (Weeks 6-10)||1
9849145|NCT00863057|10961802|FG002|COMPLETED|Period 2 (Weeks 6-10)||2
9849146|NCT00863057|10961803|FG003|COMPLETED|Period 2 (Weeks 6-10)||2
10154459|NCT02871479|11285147|FG002|STARTED|Overall Study||11
10154460|NCT02871479|11285145|FG000|COMPLETED|Overall Study||33
10154461|NCT02871479|11285146|FG001|COMPLETED|Overall Study||21
10154462|NCT02871479|11285147|FG002|COMPLETED|Overall Study||11
10154463|NCT02871479|11285145|FG000|NOT COMPLETED|Overall Study||3
10154464|NCT02871479|11285146|FG001|NOT COMPLETED|Overall Study||3
10154465|NCT02871479|11285147|FG002|NOT COMPLETED|Overall Study||0
10154466|NCT02871492|11285158|FG000|STARTED|Overall Study||73
10154467|NCT02871492|11285159|FG001|STARTED|Overall Study||73
10154468|NCT02871492|11285160|FG002|STARTED|Overall Study||77
10154469|NCT02871492|11285158|FG000|COMPLETED|Overall Study||67
10154470|NCT02871492|11285159|FG001|COMPLETED|Overall Study||70
10154471|NCT02871492|11285160|FG002|COMPLETED|Overall Study||71
10154472|NCT02871492|11285158|FG000|NOT COMPLETED|Overall Study||6
10154473|NCT02871492|11285159|FG001|NOT COMPLETED|Overall Study||3
10154474|NCT02871492|11285160|FG002|NOT COMPLETED|Overall Study||6
10154475|NCT02871570|11285170|FG000|STARTED|Overall Study||8
10154476|NCT02871570|11285171|FG001|STARTED|Overall Study||8
9849147|NCT00863057|10961800|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0
9849148|NCT00863057|10961801|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1
10154477|NCT02871570|11285170|FG000|COMPLETED|Overall Study||8
10154478|NCT02871570|11285171|FG001|COMPLETED|Overall Study||8
10154479|NCT02871570|11285170|FG000|NOT COMPLETED|Overall Study||0
10154480|NCT02871570|11285171|FG001|NOT COMPLETED|Overall Study||0
10154481|NCT02871635|11285179|FG000|STARTED|Overall Study||72
10154482|NCT02871635|11285180|FG001|STARTED|Overall Study||75
10154483|NCT02871635|11285179|FG000|COMPLETED|Overall Study||54
10154484|NCT02871635|11285180|FG001|COMPLETED|Overall Study||56
10154485|NCT02871635|11285179|FG000|NOT COMPLETED|Overall Study||18
10154486|NCT02871635|11285180|FG001|NOT COMPLETED|Overall Study||19
10154487|NCT02871739|11285192|FG000|STARTED|Overall Study||6
10154488|NCT02871739|11285193|FG001|STARTED|Overall Study||6
10154489|NCT02871739|11285194|FG002|STARTED|Overall Study||4
10154490|NCT02871739|11285195|FG003|STARTED|Overall Study||7
10154491|NCT02871739|11285192|FG000|Completed First SPI|Overall Study||3
10154492|NCT02871739|11285193|FG001|Completed First SPI|Overall Study||5
10154493|NCT02871739|11285194|FG002|Completed First SPI|Overall Study||4
10154494|NCT02871739|11285195|FG003|Completed First SPI|Overall Study||6
10154495|NCT02871739|11285192|FG000|Completed Second SPI|Overall Study||3
10154496|NCT02871739|11285193|FG001|Completed Second SPI|Overall Study||4
10154497|NCT02871739|11285194|FG002|Completed Second SPI|Overall Study||4
10154498|NCT02871739|11285195|FG003|Completed Second SPI|Overall Study||5
10154499|NCT02871739|11285192|FG000|Complete Final Survey|Overall Study||3
10154500|NCT02871739|11285193|FG001|Complete Final Survey|Overall Study||4
10154501|NCT02871739|11285194|FG002|Complete Final Survey|Overall Study||4
10154502|NCT02871739|11285195|FG003|Complete Final Survey|Overall Study||5
10154503|NCT02871739|11285192|FG000|COMPLETED|Overall Study||3
10154504|NCT02871739|11285193|FG001|COMPLETED|Overall Study||4
10154505|NCT02871739|11285194|FG002|COMPLETED|Overall Study||4
10154506|NCT02871739|11285195|FG003|COMPLETED|Overall Study||5
10154507|NCT02871739|11285192|FG000|NOT COMPLETED|Overall Study||3
10154508|NCT02871739|11285193|FG001|NOT COMPLETED|Overall Study||2
10154509|NCT02871739|11285194|FG002|NOT COMPLETED|Overall Study||0
10154510|NCT02871739|11285195|FG003|NOT COMPLETED|Overall Study||2
10154511|NCT02872012|11285210|FG000|STARTED|Overall Study||4
10154512|NCT02872012|11285211|FG001|STARTED|Overall Study||7
10154513|NCT02872012|11285212|FG002|STARTED|Overall Study||4
10154514|NCT02872012|11285213|FG003|STARTED|Overall Study||3
10154515|NCT02872012|11285214|FG004|STARTED|Overall Study||5
10154516|NCT02872012|11285210|FG000|COMPLETED|Overall Study||3
10154517|NCT02872012|11285211|FG001|COMPLETED|Overall Study||7
10154518|NCT02872012|11285212|FG002|COMPLETED|Overall Study||4
10154519|NCT02872012|11285213|FG003|COMPLETED|Overall Study||3
10154520|NCT02872012|11285214|FG004|COMPLETED|Overall Study||5
10154521|NCT02872012|11285210|FG000|NOT COMPLETED|Overall Study||1
10154522|NCT02872012|11285211|FG001|NOT COMPLETED|Overall Study||0
10154523|NCT02872012|11285212|FG002|NOT COMPLETED|Overall Study||0
10154524|NCT02872012|11285213|FG003|NOT COMPLETED|Overall Study||0
10154525|NCT02872012|11285214|FG004|NOT COMPLETED|Overall Study||0
10154526|NCT02872103|11285230|FG000|STARTED|Cycle 1||83
10154527|NCT02872103|11285231|FG001|STARTED|Cycle 1||39
10154528|NCT02872103|11285230|FG000|COMPLETED|Cycle 1||83
10154529|NCT02872103|11285231|FG001|COMPLETED|Cycle 1||38
10154530|NCT02872103|11285230|FG000|NOT COMPLETED|Cycle 1||0
10154531|NCT02872103|11285231|FG001|NOT COMPLETED|Cycle 1||1
10154532|NCT02872103|11285230|FG000|STARTED|Cycle 2-4||83
10154533|NCT02872103|11285231|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
10154534|NCT02872103|11285230|FG000|COMPLETED|Cycle 2-4||81
10154535|NCT02872103|11285231|FG001|COMPLETED|Cycle 2-4||37
10154536|NCT02872103|11285230|FG000|NOT COMPLETED|Cycle 2-4||2
10154537|NCT02872103|11285231|FG001|NOT COMPLETED|Cycle 2-4||1
10154538|NCT02872142|11285239|FG000|STARTED|Overall Study||12
10154539|NCT02872142|11285239|FG000|COMPLETED|Overall Study||6
10154540|NCT02872142|11285239|FG000|NOT COMPLETED|Overall Study||6
10154541|NCT02872285|11285245|FG000|STARTED|Overall Study||22
10154542|NCT02872285|11285246|FG001|STARTED|Overall Study||11
10154543|NCT02872285|11285245|FG000|COMPLETED|Overall Study||17
10154544|NCT02872285|11285246|FG001|COMPLETED|Overall Study||9
10154545|NCT02872285|11285245|FG000|NOT COMPLETED|Overall Study||5
10154546|NCT02872285|11285246|FG001|NOT COMPLETED|Overall Study||2
10154547|NCT02872311|11285257|FG000|STARTED|Overall Study||59
10154548|NCT02872311|11285258|FG001|STARTED|Overall Study||60
10154549|NCT02872311|11285259|FG002|STARTED|Overall Study||20
10154550|NCT02872311|11285260|FG003|STARTED|Overall Study||20
10154551|NCT02872311|11285261|FG004|STARTED|Overall Study||20
10154552|NCT02872311|11285257|FG000|COMPLETED|Overall Study||55
10154553|NCT02872311|11285258|FG001|COMPLETED|Overall Study||58
10154554|NCT02872311|11285259|FG002|COMPLETED|Overall Study||19
10154555|NCT02872311|11285260|FG003|COMPLETED|Overall Study||20
10154556|NCT02872311|11285261|FG004|COMPLETED|Overall Study||20
10154557|NCT02872311|11285257|FG000|NOT COMPLETED|Overall Study||4
10154558|NCT02872311|11285258|FG001|NOT COMPLETED|Overall Study||2
10154559|NCT02872311|11285259|FG002|NOT COMPLETED|Overall Study||1
10154560|NCT02872311|11285260|FG003|NOT COMPLETED|Overall Study||0
10154561|NCT02872311|11285261|FG004|NOT COMPLETED|Overall Study||0
10154562|NCT02872857|11285291|FG000|STARTED|Phase 1||15
10154563|NCT02872857|11285292|FG001|STARTED|Phase 1||15
10154564|NCT02872857|11285293|FG002|STARTED|Phase 1||0
10154565|NCT02872857|11285294|FG003|STARTED|Phase 1||0
10154566|NCT02872857|11285291|FG000|COMPLETED|Phase 1||15
10154567|NCT02872857|11285292|FG001|COMPLETED|Phase 1||15
10154568|NCT02872857|11285293|FG002|COMPLETED|Phase 1||0
10154569|NCT02872857|11285294|FG003|COMPLETED|Phase 1||0
10154570|NCT02872857|11285291|FG000|NOT COMPLETED|Phase 1||0
10154571|NCT02872857|11285292|FG001|NOT COMPLETED|Phase 1||0
10154572|NCT02872857|11285293|FG002|NOT COMPLETED|Phase 1||0
10154573|NCT02872857|11285294|FG003|NOT COMPLETED|Phase 1||0
10154574|NCT02872857|11285291|FG000|STARTED|Phase 2||0
10154575|NCT02872857|11285292|FG001|STARTED|Phase 2||0
10154576|NCT02872857|11285293|FG002|STARTED|Phase 2||15
10154577|NCT02872857|11285294|FG003|STARTED|Phase 2||15
10154578|NCT02872857|11285291|FG000|COMPLETED|Phase 2||0
10154579|NCT02872857|11285292|FG001|COMPLETED|Phase 2||0
10154580|NCT02872857|11285293|FG002|COMPLETED|Phase 2||15
10154581|NCT02872857|11285294|FG003|COMPLETED|Phase 2||15
10154582|NCT02872857|11285291|FG000|NOT COMPLETED|Phase 2||0
10154583|NCT02872857|11285292|FG001|NOT COMPLETED|Phase 2||0
10154584|NCT02872857|11285293|FG002|NOT COMPLETED|Phase 2||0
10154585|NCT02872857|11285294|FG003|NOT COMPLETED|Phase 2||0
10154586|NCT02872909|11285302|FG000|STARTED|Overall Study||32
10154587|NCT02872909|11285303|FG001|STARTED|Overall Study||18
10154588|NCT02872909|11285302|FG000|COMPLETED|Overall Study||32
10154589|NCT02872909|11285303|FG001|COMPLETED|Overall Study||18
10154590|NCT02872909|11285302|FG000|NOT COMPLETED|Overall Study||0
10154591|NCT02872909|11285303|FG001|NOT COMPLETED|Overall Study||0
10154592|NCT02872935|11285311|FG000|STARTED|Overall Study||11
10154593|NCT02872935|11285312|FG001|STARTED|Overall Study||11
10154594|NCT02872935|11285311|FG000|COMPLETED|Overall Study||11
10154595|NCT02872935|11285312|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
10154596|NCT02872935|11285311|FG000|NOT COMPLETED|Overall Study||0
10154597|NCT02872935|11285312|FG001|NOT COMPLETED|Overall Study||1
10154598|NCT02873104|11285320|FG000|STARTED|Overall Study||47
10154599|NCT02873104|11285321|FG001|STARTED|Overall Study||23
10154600|NCT02873104|11285320|FG000|COMPLETED|Overall Study||46
10154601|NCT02873104|11285321|FG001|COMPLETED|Overall Study||23
10154602|NCT02873104|11285320|FG000|NOT COMPLETED|Overall Study||1
10154603|NCT02873104|11285321|FG001|NOT COMPLETED|Overall Study||0
10154604|NCT02873208|11285327|FG000|STARTED|Overall Study||265
10154605|NCT02873208|11285327|FG000|COMPLETED|Overall Study||167
10154606|NCT02873208|11285327|FG000|NOT COMPLETED|Overall Study||98
10154607|NCT02873221|11285334|FG000|STARTED|Treatment Period||417
10154608|NCT02873221|11285335|FG001|STARTED|Treatment Period||417
10154609|NCT02873221|11285336|FG002|STARTED|Treatment Period||420
10154610|NCT02873221|11285334|FG000|Safety Population: Received Study Drug|Treatment Period||417
10154611|NCT02873221|11285335|FG001|Safety Population: Received Study Drug|Treatment Period||404
10154612|NCT02873221|11285336|FG002|Safety Population: Received Study Drug|Treatment Period||409
10154613|NCT02873221|11285334|FG000|COMPLETED|Treatment Period||329
10154614|NCT02873221|11285335|FG001|COMPLETED|Treatment Period||291
10154615|NCT02873221|11285336|FG002|COMPLETED|Treatment Period||315
10154616|NCT02873221|11285334|FG000|NOT COMPLETED|Treatment Period||88
10154617|NCT02873221|11285335|FG001|NOT COMPLETED|Treatment Period||126
10154618|NCT02873221|11285336|FG002|NOT COMPLETED|Treatment Period||105
10154619|NCT02873221|11285334|FG000|STARTED|Safety Follow-up Period||350
10154620|NCT02873221|11285335|FG001|STARTED|Safety Follow-up Period||356
10154621|NCT02873221|11285336|FG002|STARTED|Safety Follow-up Period||364
10154622|NCT02873221|11285334|FG000|COMPLETED|Safety Follow-up Period||343
10154623|NCT02873221|11285335|FG001|COMPLETED|Safety Follow-up Period||339
10154624|NCT02873221|11285336|FG002|COMPLETED|Safety Follow-up Period||350
10154625|NCT02873221|11285334|FG000|NOT COMPLETED|Safety Follow-up Period||7
10154626|NCT02873221|11285335|FG001|NOT COMPLETED|Safety Follow-up Period||17
10154627|NCT02873221|11285336|FG002|NOT COMPLETED|Safety Follow-up Period||14
10154628|NCT02873286|11285349|FG000|STARTED|Main Study||78
10154629|NCT02873286|11285350|FG001|STARTED|Main Study||89
10154630|NCT02873286|11285351|FG002|STARTED|Main Study||80
10154631|NCT02873286|11285352|FG003|STARTED|Main Study||90
10154632|NCT02873286|11285353|FG004|STARTED|Main Study||83
10154633|NCT02873286|11285349|FG000|COMPLETED|Main Study||76
10154634|NCT02873286|11285350|FG001|COMPLETED|Main Study||84
10154635|NCT02873286|11285351|FG002|COMPLETED|Main Study||78
10154636|NCT02873286|11285352|FG003|COMPLETED|Main Study||89
10154637|NCT02873286|11285353|FG004|COMPLETED|Main Study||81
10154638|NCT02873286|11285349|FG000|NOT COMPLETED|Main Study||2
10154639|NCT02873286|11285350|FG001|NOT COMPLETED|Main Study||5
10154640|NCT02873286|11285351|FG002|NOT COMPLETED|Main Study||2
10154641|NCT02873286|11285352|FG003|NOT COMPLETED|Main Study||1
10154642|NCT02873286|11285353|FG004|NOT COMPLETED|Main Study||2
10154643|NCT02873286|11285349|FG000|STARTED|Booster Substudy||43
10154644|NCT02873286|11285350|FG001|STARTED|Booster Substudy||0
10154645|NCT02873286|11285351|FG002|STARTED|Booster Substudy||45
10154646|NCT02873286|11285352|FG003|STARTED|Booster Substudy||0
10154647|NCT02873286|11285353|FG004|STARTED|Booster Substudy||0
10154648|NCT02873286|11285349|FG000|COMPLETED|Booster Substudy||43
10154649|NCT02873286|11285350|FG001|COMPLETED|Booster Substudy||0
10154650|NCT02873286|11285351|FG002|COMPLETED|Booster Substudy||45
10154651|NCT02873286|11285352|FG003|COMPLETED|Booster Substudy||0
10154652|NCT02873286|11285353|FG004|COMPLETED|Booster Substudy||0
10154653|NCT02873286|11285349|FG000|NOT COMPLETED|Booster Substudy||0
10154654|NCT02873286|11285350|FG001|NOT COMPLETED|Booster Substudy||0
10154655|NCT02873286|11285351|FG002|NOT COMPLETED|Booster Substudy||0
10154656|NCT02873286|11285352|FG003|NOT COMPLETED|Booster Substudy||0
10154657|NCT02873286|11285353|FG004|NOT COMPLETED|Booster Substudy||0
10154658|NCT02873338|11285368|FG000|STARTED|Overall Study||26
10154659|NCT02873338|11285369|FG001|STARTED|Overall Study||25
10154660|NCT02873338|11285370|FG002|STARTED|Overall Study||24
10154661|NCT02873338|11285368|FG000|COMPLETED|Overall Study||8
10154662|NCT02873338|11285369|FG001|COMPLETED|Overall Study||4
10154663|NCT02873338|11285370|FG002|COMPLETED|Overall Study||6
10154664|NCT02873338|11285368|FG000|NOT COMPLETED|Overall Study||18
10154665|NCT02873338|11285369|FG001|NOT COMPLETED|Overall Study||21
10154666|NCT02873338|11285370|FG002|NOT COMPLETED|Overall Study||18
10154667|NCT02873377|11285380|FG000|STARTED|Period 1: Enrollment||65
10154668|NCT02873377|11285381|FG001|STARTED|Period 1: Enrollment||69
10154669|NCT02873377|11285380|FG000|COMPLETED|Period 1: Enrollment||65
10154670|NCT02873377|11285381|FG001|COMPLETED|Period 1: Enrollment||69
10154671|NCT02873377|11285380|FG000|NOT COMPLETED|Period 1: Enrollment||0
10154672|NCT02873377|11285381|FG001|NOT COMPLETED|Period 1: Enrollment||0
10154673|NCT02873377|11285380|FG000|STARTED|Period Title 2: 3 Months Follow up||65
10154674|NCT02873377|11285381|FG001|STARTED|Period Title 2: 3 Months Follow up||69
10154675|NCT02873377|11285380|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43
10154676|NCT02873377|11285381|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47
10154677|NCT02873377|11285380|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
10154678|NCT02873377|11285381|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
10154679|NCT02873377|11285380|FG000|STARTED|Period Title 3: 6 Months Follow up||65
10154680|NCT02873377|11285381|FG001|STARTED|Period Title 3: 6 Months Follow up||69
10154681|NCT02873377|11285380|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50
10154682|NCT02873377|11285381|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46
10154683|NCT02873377|11285380|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
10154684|NCT02873377|11285381|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
10154685|NCT02873429|11285390|FG000|STARTED|Baseline||109
10154686|NCT02873429|11285391|FG001|STARTED|Baseline||100
10154687|NCT02873429|11285390|FG000|COMPLETED|Baseline||109
10154688|NCT02873429|11285391|FG001|COMPLETED|Baseline||100
10154689|NCT02873429|11285390|FG000|NOT COMPLETED|Baseline||0
10154690|NCT02873429|11285391|FG001|NOT COMPLETED|Baseline||0
10154691|NCT02873429|11285390|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
10154692|NCT02873429|11285391|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
10154693|NCT02873429|11285390|FG000|COMPLETED|6-8 Weeks||95
10154694|NCT02873429|11285391|FG001|COMPLETED|6-8 Weeks||97
10154695|NCT02873429|11285390|FG000|NOT COMPLETED|6-8 Weeks||10
10154696|NCT02873429|11285391|FG001|NOT COMPLETED|6-8 Weeks||1
10154697|NCT02873429|11285390|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
10154698|NCT02873429|11285391|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
10154699|NCT02873429|11285390|FG000|COMPLETED|16 Weeks||100
10154700|NCT02873429|11285391|FG001|COMPLETED|16 Weeks||96
10154701|NCT02873429|11285390|FG000|NOT COMPLETED|16 Weeks||5
10154702|NCT02873429|11285391|FG001|NOT COMPLETED|16 Weeks||2
10154703|NCT02873481|11285399|FG000|STARTED|Overall Study||15
10154704|NCT02873481|11285400|FG001|STARTED|Overall Study||17
10154705|NCT02873481|11285399|FG000|COMPLETED|Overall Study||15
10154706|NCT02873481|11285400|FG001|COMPLETED|Overall Study||17
10154707|NCT02873481|11285399|FG000|NOT COMPLETED|Overall Study||0
10154708|NCT02873481|11285400|FG001|NOT COMPLETED|Overall Study||0
10154709|NCT02873585|11285406|FG000|STARTED|Overall Study||32
10154710|NCT02873585|11285406|FG000|COMPLETED|Overall Study||32
10154711|NCT02873585|11285406|FG000|NOT COMPLETED|Overall Study||0
10154712|NCT02873689|11285416|FG000|STARTED|Overall Study||109
10154713|NCT02873689|11285417|FG001|STARTED|Overall Study||108
10154714|NCT02873689|11285416|FG000|Treated|Overall Study||108
10154715|NCT02873689|11285417|FG001|Treated|Overall Study||107
10154716|NCT02873689|11285416|FG000|COMPLETED|Overall Study||102
10154717|NCT02873689|11285417|FG001|COMPLETED|Overall Study||103
10154718|NCT02873689|11285416|FG000|NOT COMPLETED|Overall Study||7
10154719|NCT02873689|11285417|FG001|NOT COMPLETED|Overall Study||5
10154720|NCT02873702|11285425|FG000|STARTED|Healing Period (up to Week 8)||20
10154721|NCT02873702|11285426|FG001|STARTED|Healing Period (up to Week 8)||17
10154722|NCT02873702|11285427|FG002|STARTED|Healing Period (up to Week 8)||0
10154723|NCT02873702|11285428|FG003|STARTED|Healing Period (up to Week 8)||0
10154724|NCT02873702|11285425|FG000|COMPLETED|Healing Period (up to Week 8)||19
10154725|NCT02873702|11285426|FG001|COMPLETED|Healing Period (up to Week 8)||16
10154726|NCT02873702|11285427|FG002|COMPLETED|Healing Period (up to Week 8)||0
10154727|NCT02873702|11285428|FG003|COMPLETED|Healing Period (up to Week 8)||0
10154728|NCT02873702|11285425|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1
10154729|NCT02873702|11285426|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1
10154730|NCT02873702|11285427|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0
10154731|NCT02873702|11285428|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0
10154732|NCT02873702|11285425|FG000|STARTED|Maintenance Period (up to Month 6)||0
10154733|NCT02873702|11285426|FG001|STARTED|Maintenance Period (up to Month 6)||0
10154734|NCT02873702|11285427|FG002|STARTED|Maintenance Period (up to Month 6)||8
10154735|NCT02873702|11285428|FG003|STARTED|Maintenance Period (up to Month 6)||8
10154736|NCT02873702|11285425|FG000|COMPLETED|Maintenance Period (up to Month 6)||0
10154737|NCT02873702|11285426|FG001|COMPLETED|Maintenance Period (up to Month 6)||0
10154738|NCT02873702|11285427|FG002|COMPLETED|Maintenance Period (up to Month 6)||1
10154739|NCT02873702|11285428|FG003|COMPLETED|Maintenance Period (up to Month 6)||6
10154740|NCT02873702|11285425|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0
10154741|NCT02873702|11285426|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0
10154742|NCT02873702|11285427|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7
10154743|NCT02873702|11285428|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2
10154744|NCT02873754|11285438|FG000|STARTED|Overall Study||11
10154745|NCT02873754|11285438|FG000|COMPLETED|Overall Study||5
10154746|NCT02873754|11285438|FG000|NOT COMPLETED|Overall Study||6
10154747|NCT02873923|11285442|FG000|STARTED|Overall Study||2846
10154748|NCT02873923|11285442|FG000|COMPLETED|Overall Study||2846
10154749|NCT02873923|11285442|FG000|NOT COMPLETED|Overall Study||0
10154750|NCT02873936|11285449|FG000|STARTED|Overall Study||148
10154751|NCT02873936|11285450|FG001|STARTED|Overall Study||153
10154752|NCT02873936|11285451|FG002|STARTED|Overall Study||148
10154753|NCT02873936|11285449|FG000|COMPLETED|Overall Study||135
10154754|NCT02873936|11285450|FG001|COMPLETED|Overall Study||130
10154755|NCT02873936|11285451|FG002|COMPLETED|Overall Study||116
10154756|NCT02873936|11285449|FG000|NOT COMPLETED|Overall Study||13
10154757|NCT02873936|11285450|FG001|NOT COMPLETED|Overall Study||23
10154758|NCT02873936|11285451|FG002|NOT COMPLETED|Overall Study||32
10154759|NCT02874066|11285459|FG000|STARTED|Overall Study||46
10154760|NCT02874066|11285459|FG000|COMPLETED|Overall Study||46
10154761|NCT02874066|11285459|FG000|NOT COMPLETED|Overall Study||0
10154762|NCT02874092|11285465|FG000|STARTED|Overall Study||7
10154763|NCT02874092|11285466|FG001|STARTED|Overall Study||2
10154764|NCT02874092|11285465|FG000|COMPLETED|Overall Study||7
10154765|NCT02874092|11285466|FG001|COMPLETED|Overall Study||2
10154766|NCT02874092|11285465|FG000|NOT COMPLETED|Overall Study||0
10154767|NCT02874092|11285466|FG001|NOT COMPLETED|Overall Study||0
10154768|NCT02874404|11285471|FG000|STARTED|Overall Study||13
10154769|NCT02874404|11285471|FG000|COMPLETED|Overall Study||13
10154770|NCT02874404|11285471|FG000|NOT COMPLETED|Overall Study||0
10154771|NCT02874534|11285478|FG000|STARTED|Overall Study||31
10154772|NCT02874534|11285479|FG001|STARTED|Overall Study||26
10154773|NCT02874534|11285478|FG000|COMPLETED|Overall Study||23
10154774|NCT02874534|11285479|FG001|COMPLETED|Overall Study||15
10154775|NCT02874534|11285478|FG000|NOT COMPLETED|Overall Study||8
10154776|NCT02874534|11285479|FG001|NOT COMPLETED|Overall Study||11
10154777|NCT02874794|11285487|FG000|STARTED|Overall Study||233
10154778|NCT02874794|11285488|FG001|STARTED|Overall Study||232
10154779|NCT02874794|11285487|FG000|COMPLETED|Overall Study||226
10154780|NCT02874794|11285488|FG001|COMPLETED|Overall Study||221
10154781|NCT02874794|11285487|FG000|NOT COMPLETED|Overall Study||7
10154782|NCT02874794|11285488|FG001|NOT COMPLETED|Overall Study||11
10154783|NCT02874846|11285499|FG000|STARTED|Overall Study||8
10154784|NCT02874846|11285500|FG001|STARTED|Overall Study||4
10154785|NCT02874846|11285499|FG000|COMPLETED|Overall Study||8
10154786|NCT02874846|11285500|FG001|COMPLETED|Overall Study||4
10154787|NCT02874846|11285499|FG000|NOT COMPLETED|Overall Study||0
10154788|NCT02874846|11285500|FG001|NOT COMPLETED|Overall Study||0
10154789|NCT02874924|11285510|FG000|STARTED|Overall Study||14
10154790|NCT02874924|11285511|FG001|STARTED|Overall Study||14
10154791|NCT02874924|11285512|FG002|STARTED|Overall Study||6
10154792|NCT02874924|11285510|FG000|COMPLETED|Overall Study||11
10154793|NCT02874924|11285511|FG001|COMPLETED|Overall Study||14
10154794|NCT02874924|11285512|FG002|COMPLETED|Overall Study||6
10154795|NCT02874924|11285510|FG000|NOT COMPLETED|Overall Study||3
10154796|NCT02874924|11285511|FG001|NOT COMPLETED|Overall Study||0
10154797|NCT02874924|11285512|FG002|NOT COMPLETED|Overall Study||0
10154798|NCT02875028|11285522|FG000|STARTED|First Intervention (24 Hours)||8
10154799|NCT02875028|11285523|FG001|STARTED|First Intervention (24 Hours)||8
10154800|NCT02875028|11285522|FG000|COMPLETED|First Intervention (24 Hours)||8
10154801|NCT02875028|11285523|FG001|COMPLETED|First Intervention (24 Hours)||8
10154802|NCT02875028|11285522|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
10154803|NCT02875028|11285523|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
10154804|NCT02875028|11285522|FG000|STARTED|Washout Period||8
10154805|NCT02875028|11285523|FG001|STARTED|Washout Period||8
10154806|NCT02875028|11285522|FG000|COMPLETED|Washout Period||8
10154807|NCT02875028|11285523|FG001|COMPLETED|Washout Period||7
10154808|NCT02875028|11285522|FG000|NOT COMPLETED|Washout Period||0
10154809|NCT02875028|11285523|FG001|NOT COMPLETED|Washout Period||1
10154810|NCT02875028|11285522|FG000|STARTED|Second Intervention (24 Hours)||8
10154811|NCT02875028|11285523|FG001|STARTED|Second Intervention (24 Hours)||7
10154812|NCT02875028|11285522|FG000|COMPLETED|Second Intervention (24 Hours)||8
10154813|NCT02875028|11285523|FG001|COMPLETED|Second Intervention (24 Hours)||7
10154814|NCT02875028|11285522|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
10154815|NCT02875028|11285523|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
10154816|NCT02875080|11285534|FG000|STARTED|Overall Study||6
10154817|NCT02875080|11285535|FG001|STARTED|Overall Study||6
10154818|NCT02875080|11285536|FG002|STARTED|Overall Study||6
10154819|NCT02875080|11285534|FG000|COMPLETED|Overall Study||4
9710185|NCT04725500|10809716|FG000|STARTED|Screening||42
9710186|NCT04725500|10809716|FG000|COMPLETED|Screening||15
10154820|NCT02875080|11285535|FG001|COMPLETED|Overall Study||6
10154821|NCT02875080|11285536|FG002|COMPLETED|Overall Study||6
10154822|NCT02875080|11285534|FG000|NOT COMPLETED|Overall Study||2
10154823|NCT02875080|11285535|FG001|NOT COMPLETED|Overall Study||0
10154824|NCT02875080|11285536|FG002|NOT COMPLETED|Overall Study||0
10154825|NCT02875340|11285544|FG000|STARTED|Overall Study||8
10154826|NCT02875340|11285544|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
10154827|NCT02875340|11285544|FG000|NOT COMPLETED|Overall Study||8
10154828|NCT02875366|11285556|FG000|STARTED|Overall Study||36
10154829|NCT02875366|11285557|FG001|STARTED|Overall Study||34
10154830|NCT02875366|11285556|FG000|COMPLETED|Overall Study||36
10154831|NCT02875366|11285557|FG001|COMPLETED|Overall Study||31
10154832|NCT02875366|11285556|FG000|NOT COMPLETED|Overall Study||0
9710187|NCT04725500|10809716|FG000|NOT COMPLETED|Screening||27
10154833|NCT02875366|11285557|FG001|NOT COMPLETED|Overall Study||3
10154834|NCT02875392|11285565|FG000|STARTED|Overall Study||28
10154835|NCT02875392|11285566|FG001|STARTED|Overall Study||29
10154836|NCT02875392|11285565|FG000|COMPLETED|Overall Study||21
10154837|NCT02875392|11285566|FG001|COMPLETED|Overall Study||21
10154838|NCT02875392|11285565|FG000|NOT COMPLETED|Overall Study||7
10154839|NCT02875392|11285566|FG001|NOT COMPLETED|Overall Study||8
10154840|NCT02875613|11285572|FG000|STARTED|Overall Study||5
10154841|NCT02875613|11285572|FG000|COMPLETED|Overall Study||4
10154842|NCT02875613|11285572|FG000|NOT COMPLETED|Overall Study||1
10154843|NCT02875834|11285580|FG000|STARTED|Open-label Phase||267
10154844|NCT02875834|11285581|FG001|STARTED|Open-label Phase||0
10154845|NCT02875834|11285582|FG002|STARTED|Open-label Phase||0
10154846|NCT02875834|11285583|FG003|STARTED|Open-label Phase||0
10154847|NCT02875834|11285580|FG000|COMPLETED|Open-label Phase||260
10154848|NCT02875834|11285581|FG001|COMPLETED|Open-label Phase||0
10154849|NCT02875834|11285582|FG002|COMPLETED|Open-label Phase||0
10154850|NCT02875834|11285583|FG003|COMPLETED|Open-label Phase||0
10154851|NCT02875834|11285580|FG000|NOT COMPLETED|Open-label Phase||7
10154852|NCT02875834|11285581|FG001|NOT COMPLETED|Open-label Phase||0
10154853|NCT02875834|11285582|FG002|NOT COMPLETED|Open-label Phase||0
10154854|NCT02875834|11285583|FG003|NOT COMPLETED|Open-label Phase||0
10154855|NCT02875834|11285580|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
10154856|NCT02875834|11285581|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
10154857|NCT02875834|11285582|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
10154858|NCT02875834|11285583|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
10154859|NCT02875834|11285580|FG000|COMPLETED|Randomized Treatment Phase||0
10154860|NCT02875834|11285581|FG001|COMPLETED|Randomized Treatment Phase||85
10154861|NCT02875834|11285582|FG002|COMPLETED|Randomized Treatment Phase||88
10154862|NCT02875834|11285583|FG003|COMPLETED|Randomized Treatment Phase||41
10154863|NCT02875834|11285580|FG000|NOT COMPLETED|Randomized Treatment Phase||0
10154864|NCT02875834|11285581|FG001|NOT COMPLETED|Randomized Treatment Phase||14
10154865|NCT02875834|11285582|FG002|NOT COMPLETED|Randomized Treatment Phase||11
10154866|NCT02875834|11285583|FG003|NOT COMPLETED|Randomized Treatment Phase||9
10154867|NCT02875977|11285595|FG000|STARTED|Overall Study||100
10154868|NCT02875977|11285596|FG001|STARTED|Overall Study||100
10154869|NCT02875977|11285595|FG000|COMPLETED|Overall Study||58
10154870|NCT02875977|11285596|FG001|COMPLETED|Overall Study||71
10154871|NCT02875977|11285595|FG000|NOT COMPLETED|Overall Study||42
10154872|NCT02875977|11285596|FG001|NOT COMPLETED|Overall Study||29
10197212|NCT03371355|11325167|FG002|NOT COMPLETED|Overall Study||4
10197213|NCT03371355|11325168|FG003|NOT COMPLETED|Overall Study||7
10197214|NCT03371381|11325182|FG000|STARTED|Overall Study||12
10197215|NCT03371381|11325182|FG000|COMPLETED|Overall Study||0
10197216|NCT03371381|11325182|FG000|NOT COMPLETED|Overall Study||12
10197217|NCT03371459|11325186|FG000|STARTED|Period 1||23
10197218|NCT03371459|11325187|FG001|STARTED|Period 1||23
10197219|NCT03371459|11325186|FG000|COMPLETED|Period 1||23
10197220|NCT03371459|11325187|FG001|COMPLETED|Period 1||23
10197221|NCT03371459|11325186|FG000|NOT COMPLETED|Period 1||0
10197222|NCT03371459|11325187|FG001|NOT COMPLETED|Period 1||0
10197223|NCT03371459|11325186|FG000|STARTED|Washout||23
10197224|NCT03371459|11325187|FG001|STARTED|Washout||23
10197225|NCT03371459|11325186|FG000|COMPLETED|Washout||23
10197226|NCT03371459|11325187|FG001|COMPLETED|Washout||22
10197227|NCT03371459|11325186|FG000|NOT COMPLETED|Washout||0
10197228|NCT03371459|11325187|FG001|NOT COMPLETED|Washout||1
10197229|NCT03371459|11325186|FG000|STARTED|Period 2||23
10197230|NCT03371459|11325187|FG001|STARTED|Period 2||22
10197231|NCT03371459|11325186|FG000|COMPLETED|Period 2||23
10197232|NCT03371459|11325187|FG001|COMPLETED|Period 2||22
10197233|NCT03371459|11325186|FG000|NOT COMPLETED|Period 2||0
10197234|NCT03371459|11325187|FG001|NOT COMPLETED|Period 2||0
10197235|NCT03371732|11325195|FG000|STARTED|Overall Study||51
10197236|NCT03371732|11325196|FG001|STARTED|Overall Study||53
10197237|NCT03371732|11325195|FG000|COMPLETED|Overall Study||39
10197238|NCT03371732|11325196|FG001|COMPLETED|Overall Study||46
10197239|NCT03371732|11325195|FG000|NOT COMPLETED|Overall Study||12
10197240|NCT03371732|11325196|FG001|NOT COMPLETED|Overall Study||7
10197241|NCT03371836|11325204|FG000|STARTED|Overall Study||20
10197242|NCT03371836|11325204|FG000|COMPLETED|Overall Study||18
10197243|NCT03371836|11325204|FG000|NOT COMPLETED|Overall Study||2
10197244|NCT03372083|11325208|FG000|STARTED|Overall Study||44
10197245|NCT03372083|11325208|FG000|COMPLETED|Overall Study||39
10197246|NCT03372083|11325208|FG000|NOT COMPLETED|Overall Study||5
10197247|NCT03372096|11325212|FG000|STARTED|Overall Study||18
10197248|NCT03372096|11325212|FG000|Received Intervention|Overall Study||10
10197249|NCT03372096|11325212|FG000|COMPLETED|Overall Study||10
10197250|NCT03372096|11325212|FG000|NOT COMPLETED|Overall Study||8
10197251|NCT03372369|11325221|FG000|STARTED|Qualification Period||495
10197252|NCT03372369|11325222|FG001|STARTED|Qualification Period||495
9710188|NCT04725500|10809716|FG000|STARTED|Overnight Polysomnography (PSG)||15
9710189|NCT04725500|10809716|FG000|COMPLETED|Overnight Polysomnography (PSG)||15
9710190|NCT04725500|10809716|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0
9710191|NCT04725500|10809716|FG000|STARTED|2 Week Take Home||15
9710192|NCT04725500|10809716|FG000|COMPLETED|2 Week Take Home||10
9710193|NCT04725500|10809716|FG000|NOT COMPLETED|2 Week Take Home||5
9729923|NCT00121810|10829539|FG000|Intent-to-Treat (ITT) Population|Overall Study||148
9729924|NCT00121810|10829540|FG001|Intent-to-Treat (ITT) Population|Overall Study||151
9729925|NCT00121810|10829539|FG000|COMPLETED|Overall Study||121
9729926|NCT00121810|10829540|FG001|COMPLETED|Overall Study||115
9729927|NCT00121810|10829539|FG000|NOT COMPLETED|Overall Study||30
9729928|NCT00121810|10829540|FG001|NOT COMPLETED|Overall Study||39
9729929|NCT00121836|10829546|FG000|STARTED|Overall Study||109
9729930|NCT00121836|10829546|FG000|COMPLETED|Overall Study||54
9729931|NCT00121836|10829546|FG000|NOT COMPLETED|Overall Study||55
9729932|NCT00121992|10829553|FG000|STARTED|Overall Study||521
9729933|NCT00121992|10829554|FG001|STARTED|Overall Study||539
9729934|NCT00121992|10829553|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
9729935|NCT00121992|10829554|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
9729936|NCT00121992|10829553|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
9729937|NCT00121992|10829554|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
9729938|NCT00121992|10829553|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
9729939|NCT00121992|10829554|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
9729940|NCT00121992|10829553|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
9729941|NCT00121992|10829554|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
9729942|NCT00121992|10829553|FG000|COMPLETED|Overall Study||519
9729943|NCT00121992|10829554|FG001|COMPLETED|Overall Study||528
9729944|NCT00121992|10829553|FG000|NOT COMPLETED|Overall Study||2
9729945|NCT00121992|10829554|FG001|NOT COMPLETED|Overall Study||11
10197253|NCT03372369|11325221|FG000|COMPLETED|Qualification Period||469
10197254|NCT03372369|11325222|FG001|COMPLETED|Qualification Period||473
10197255|NCT03372369|11325221|FG000|NOT COMPLETED|Qualification Period||26
10197256|NCT03372369|11325222|FG001|NOT COMPLETED|Qualification Period||22
10197257|NCT03372369|11325221|FG000|STARTED|Intervention and Follow-Up Period||469
10197258|NCT03372369|11325222|FG001|STARTED|Intervention and Follow-Up Period||473
10197259|NCT03372369|11325221|FG000|COMPLETED|Intervention and Follow-Up Period||466
10197260|NCT03372369|11325222|FG001|COMPLETED|Intervention and Follow-Up Period||470
10197261|NCT03372369|11325221|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3
10197262|NCT03372369|11325222|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3
10197263|NCT03372382|11325230|FG000|STARTED|Overall Study||85
10197264|NCT03372382|11325231|FG001|STARTED|Overall Study||85
10154873|NCT02876055|11285605|FG000|STARTED|Overall Study||42
10154874|NCT02876055|11285606|FG001|STARTED|Overall Study||41
10154875|NCT02876055|11285607|FG002|STARTED|Overall Study||42
10154876|NCT02876055|11285605|FG000|COMPLETED|Overall Study||42
10154877|NCT02876055|11285606|FG001|COMPLETED|Overall Study||41
10154878|NCT02876055|11285607|FG002|COMPLETED|Overall Study||42
10154879|NCT02876055|11285605|FG000|NOT COMPLETED|Overall Study||0
10154880|NCT02876055|11285606|FG001|NOT COMPLETED|Overall Study||0
10154881|NCT02876055|11285607|FG002|NOT COMPLETED|Overall Study||0
10154882|NCT02876159|11285617|FG000|STARTED|Overall Study||10
10154883|NCT02876159|11285618|FG001|STARTED|Overall Study||10
10154884|NCT02876159|11285617|FG000|COMPLETED|Overall Study||10
10154885|NCT02876159|11285618|FG001|COMPLETED|Overall Study||10
10154886|NCT02876159|11285617|FG000|NOT COMPLETED|Overall Study||0
10154887|NCT02876159|11285618|FG001|NOT COMPLETED|Overall Study||0
10154888|NCT02876575|11285627|FG000|STARTED|Overall Study||48
10154889|NCT02876575|11285627|FG000|COMPLETED|Overall Study||48
10154890|NCT02876575|11285627|FG000|NOT COMPLETED|Overall Study||0
10154891|NCT02876601|11285636|FG000|STARTED|First Intervention (24 Hours)||8
10154892|NCT02876601|11285637|FG001|STARTED|First Intervention (24 Hours)||8
10154893|NCT02876601|11285638|FG002|STARTED|First Intervention (24 Hours)||2
10154894|NCT02876601|11285639|FG003|STARTED|First Intervention (24 Hours)||2
10154895|NCT02876601|11285636|FG000|COMPLETED|First Intervention (24 Hours)||8
10154896|NCT02876601|11285637|FG001|COMPLETED|First Intervention (24 Hours)||8
10154897|NCT02876601|11285638|FG002|COMPLETED|First Intervention (24 Hours)||2
10154898|NCT02876601|11285639|FG003|COMPLETED|First Intervention (24 Hours)||2
10154899|NCT02876601|11285636|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
10154900|NCT02876601|11285637|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
10154901|NCT02876601|11285638|FG002|NOT COMPLETED|First Intervention (24 Hours)||0
10154902|NCT02876601|11285639|FG003|NOT COMPLETED|First Intervention (24 Hours)||0
10154903|NCT02876601|11285636|FG000|STARTED|Washout (Minimum of 6 Weeks)||8
10154904|NCT02876601|11285637|FG001|STARTED|Washout (Minimum of 6 Weeks)||8
10154905|NCT02876601|11285638|FG002|STARTED|Washout (Minimum of 6 Weeks)||2
10154906|NCT02876601|11285639|FG003|STARTED|Washout (Minimum of 6 Weeks)||2
10154907|NCT02876601|11285636|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8
10154908|NCT02876601|11285637|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8
10154909|NCT02876601|11285638|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1
10154910|NCT02876601|11285639|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2
10154911|NCT02876601|11285636|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
10154912|NCT02876601|11285637|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
10154913|NCT02876601|11285638|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
10154914|NCT02876601|11285639|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
10154915|NCT02876601|11285636|FG000|STARTED|Second Intervention (24 Hours)||8
10154916|NCT02876601|11285637|FG001|STARTED|Second Intervention (24 Hours)||8
10154917|NCT02876601|11285638|FG002|STARTED|Second Intervention (24 Hours)||1
10154918|NCT02876601|11285639|FG003|STARTED|Second Intervention (24 Hours)||2
10154919|NCT02876601|11285636|FG000|COMPLETED|Second Intervention (24 Hours)||8
10154920|NCT02876601|11285637|FG001|COMPLETED|Second Intervention (24 Hours)||8
10154921|NCT02876601|11285638|FG002|COMPLETED|Second Intervention (24 Hours)||1
10154922|NCT02876601|11285639|FG003|COMPLETED|Second Intervention (24 Hours)||2
10154923|NCT02876601|11285636|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
10154924|NCT02876601|11285637|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
10154925|NCT02876601|11285638|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0
10154926|NCT02876601|11285639|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0
10154927|NCT02876757|11285686|FG000|STARTED|Overall Study||93197
10154928|NCT02876757|11285687|FG001|STARTED|Overall Study||93197
10154929|NCT02876757|11285686|FG000|COMPLETED|Overall Study||93197
10154930|NCT02876757|11285687|FG001|COMPLETED|Overall Study||93197
10154931|NCT02876757|11285686|FG000|NOT COMPLETED|Overall Study||0
10154932|NCT02876757|11285687|FG001|NOT COMPLETED|Overall Study||0
10154933|NCT02876887|11285695|FG000|STARTED|Overall Study||23
10154934|NCT02876887|11285696|FG001|STARTED|Overall Study||21
10154935|NCT02876887|11285695|FG000|COMPLETED|Overall Study||19
10154936|NCT02876887|11285696|FG001|COMPLETED|Overall Study||21
10154937|NCT02876887|11285695|FG000|NOT COMPLETED|Overall Study||4
10154938|NCT02876887|11285696|FG001|NOT COMPLETED|Overall Study||0
10154939|NCT02876900|11285705|FG000|STARTED|Overall Study||205
10154940|NCT02876900|11285706|FG001|STARTED|Overall Study||206
10154941|NCT02876900|11285707|FG002|STARTED|Overall Study||206
9849149|NCT00863057|10961802|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1
10154942|NCT02876900|11285705|FG000|COMPLETED|Overall Study||166
10154943|NCT02876900|11285706|FG001|COMPLETED|Overall Study||158
10154944|NCT02876900|11285707|FG002|COMPLETED|Overall Study||162
10154945|NCT02876900|11285705|FG000|NOT COMPLETED|Overall Study||39
10154946|NCT02876900|11285706|FG001|NOT COMPLETED|Overall Study||48
10154947|NCT02876900|11285707|FG002|NOT COMPLETED|Overall Study||44
10154948|NCT02876926|11285718|FG000|STARTED|Overall Study||21
10154949|NCT02876926|11285719|FG001|STARTED|Overall Study||22
10154950|NCT02876926|11285720|FG002|STARTED|Overall Study||22
10154951|NCT02876926|11285718|FG000|COMPLETED|Overall Study||3
10154952|NCT02876926|11285719|FG001|COMPLETED|Overall Study||3
10154953|NCT02876926|11285720|FG002|COMPLETED|Overall Study||2
10154954|NCT02876926|11285718|FG000|NOT COMPLETED|Overall Study||18
10154955|NCT02876926|11285719|FG001|NOT COMPLETED|Overall Study||19
10154956|NCT02876926|11285720|FG002|NOT COMPLETED|Overall Study||20
10154957|NCT02877004|11285731|FG000|STARTED|Overall Study||20
10154958|NCT02877004|11285732|FG001|STARTED|Overall Study||20
10154959|NCT02877004|11285733|FG002|STARTED|Overall Study||20
10154960|NCT02877004|11285731|FG000|COMPLETED|Overall Study||20
10154961|NCT02877004|11285732|FG001|COMPLETED|Overall Study||20
10154962|NCT02877004|11285733|FG002|COMPLETED|Overall Study||19
10154963|NCT02877004|11285731|FG000|NOT COMPLETED|Overall Study||0
10154964|NCT02877004|11285732|FG001|NOT COMPLETED|Overall Study||0
10154965|NCT02877004|11285733|FG002|NOT COMPLETED|Overall Study||1
10154966|NCT02877082|11285741|FG000|STARTED|Overall Study||5
10154967|NCT02877082|11285741|FG000|COMPLETED|Overall Study||0
10154968|NCT02877082|11285741|FG000|NOT COMPLETED|Overall Study||5
10154969|NCT02877095|11285747|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20
10154970|NCT02877095|11285748|FG001|STARTED|Overall Study||20
10154971|NCT02877095|11285747|FG000|COMPLETED|Overall Study||20
10154972|NCT02877095|11285748|FG001|COMPLETED|Overall Study||20
10060922|NCT02100696|11186438|FG003|NOT COMPLETED|Maintenance Phase||1
10060923|NCT02100696|11186439|FG004|NOT COMPLETED|Maintenance Phase||9
10060924|NCT02100696|11186440|FG005|NOT COMPLETED|Maintenance Phase||5
10060925|NCT02100748|11186473|FG000|STARTED|Overall Study||25
10060926|NCT02100748|11186474|FG001|STARTED|Overall Study||24
10060927|NCT02100748|11186475|FG002|STARTED|Overall Study||22
10060928|NCT02100748|11186476|FG003|STARTED|Overall Study||22
10060929|NCT02100748|11186477|FG004|STARTED|Overall Study||25
10060930|NCT02100748|11186478|FG005|STARTED|Overall Study||23
10060931|NCT02100748|11186479|FG006|STARTED|Overall Study||20
10060932|NCT02100748|11186480|FG007|STARTED|Overall Study||38
10060933|NCT02100748|11186481|FG008|STARTED|Overall Study||36
10060934|NCT02100748|11186482|FG009|STARTED|Overall Study||31
10060935|NCT02100748|11186483|FG010|STARTED|Overall Study||28
10060936|NCT02100748|11186484|FG011|STARTED|Overall Study||39
10060937|NCT02100748|11186473|FG000|COMPLETED|Overall Study||23
10154973|NCT02877095|11285747|FG000|NOT COMPLETED|Overall Study||0
10154974|NCT02877095|11285748|FG001|NOT COMPLETED|Overall Study||0
10154975|NCT02877485|11285756|FG000|STARTED|Overall Study||22
10154976|NCT02877485|11285757|FG001|STARTED|Overall Study||20
10154977|NCT02877485|11285756|FG000|COMPLETED|Overall Study||22
10154978|NCT02877485|11285757|FG001|COMPLETED|Overall Study||20
10154979|NCT02877485|11285756|FG000|NOT COMPLETED|Overall Study||0
10154980|NCT02877485|11285757|FG001|NOT COMPLETED|Overall Study||0
10154981|NCT02877680|11285766|FG000|STARTED|Overall Study||55
10154982|NCT02877680|11285767|FG001|STARTED|Overall Study||25
10154983|NCT02877680|11285766|FG000|COMPLETED|Overall Study||54
10154984|NCT02877680|11285767|FG001|COMPLETED|Overall Study||24
10154985|NCT02877680|11285766|FG000|NOT COMPLETED|Overall Study||1
10154986|NCT02877680|11285767|FG001|NOT COMPLETED|Overall Study||1
10154987|NCT02877927|11285779|FG000|STARTED|Overall Study||368
10154988|NCT02877927|11285780|FG001|STARTED|Overall Study||367
10154989|NCT02877927|11285779|FG000|COMPLETED|Overall Study||314
10154990|NCT02877927|11285780|FG001|COMPLETED|Overall Study||310
10154991|NCT02877927|11285779|FG000|NOT COMPLETED|Overall Study||54
10154992|NCT02877927|11285780|FG001|NOT COMPLETED|Overall Study||57
10154993|NCT02878057|11285786|FG000|STARTED|Overall Study||30
10154994|NCT02878057|11285786|FG000|COMPLETED|Overall Study||26
10154995|NCT02878057|11285786|FG000|NOT COMPLETED|Overall Study||4
10154996|NCT02878213|11285790|FG000|STARTED|Overall Study||39
10154997|NCT02878213|11285790|FG000|COMPLETED|Overall Study||36
10154998|NCT02878213|11285790|FG000|NOT COMPLETED|Overall Study||3
10154999|NCT02878330|11285797|FG000|STARTED|Overall Study||484
10155000|NCT02878330|11285798|FG001|STARTED|Overall Study||969
10155001|NCT02878330|11285797|FG000|COMPLETED|Overall Study||455
10155002|NCT02878330|11285798|FG001|COMPLETED|Overall Study||913
10155003|NCT02878330|11285797|FG000|NOT COMPLETED|Overall Study||29
10155004|NCT02878330|11285798|FG001|NOT COMPLETED|Overall Study||56
10155005|NCT02878382|11285805|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
10155006|NCT02878382|11285806|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
10155007|NCT02878382|11285805|FG000|COMPLETED|Overall Study||20
10155008|NCT02878382|11285806|FG001|COMPLETED|Overall Study||20
10155009|NCT02878382|11285805|FG000|NOT COMPLETED|Overall Study||0
10155010|NCT02878382|11285806|FG001|NOT COMPLETED|Overall Study||0
10155011|NCT02878486|11285816|FG000|STARTED|Overall Study||3
10155012|NCT02878486|11285817|FG001|STARTED|Overall Study||3
10155013|NCT02878486|11285816|FG000|COMPLETED|Overall Study||3
10155014|NCT02878486|11285817|FG001|COMPLETED|Overall Study||3
10155015|NCT02878486|11285816|FG000|NOT COMPLETED|Overall Study||0
9710194|NCT04724538|10809722|FG000|STARTED|Overall Study||11
9710195|NCT04724538|10809723|FG001|STARTED|Overall Study||14
9710196|NCT04724538|10809722|FG000|COMPLETED|Overall Study||11
10155016|NCT02878486|11285817|FG001|NOT COMPLETED|Overall Study||0
10155017|NCT02878590|11285823|FG000|STARTED|Overall Study||12
10155018|NCT02878590|11285823|FG000|COMPLETED|Overall Study||10
9710197|NCT04724538|10809723|FG001|COMPLETED|Overall Study||14
9710198|NCT04724538|10809722|FG000|NOT COMPLETED|Overall Study||0
10155019|NCT02878590|11285823|FG000|NOT COMPLETED|Overall Study||2
10155020|NCT02879032|11285827|FG000|STARTED|Overall Study||130
10155021|NCT02879032|11285827|FG000|COMPLETED|Overall Study||130
10155022|NCT02879032|11285827|FG000|NOT COMPLETED|Overall Study||0
10155023|NCT02879383|11285837|FG000|STARTED|First 24 Weeks||39
10155024|NCT02879383|11285838|FG001|STARTED|First 24 Weeks||37
10155025|NCT02879383|11285839|FG002|STARTED|First 24 Weeks||17
10060938|NCT02100748|11186474|FG001|COMPLETED|Overall Study||23
10060939|NCT02100748|11186475|FG002|COMPLETED|Overall Study||21
10060940|NCT02100748|11186476|FG003|COMPLETED|Overall Study||21
10155026|NCT02879383|11285840|FG003|STARTED|First 24 Weeks||16
10155027|NCT02879383|11285837|FG000|COMPLETED|First 24 Weeks||39
10155028|NCT02879383|11285838|FG001|COMPLETED|First 24 Weeks||36
10155029|NCT02879383|11285839|FG002|COMPLETED|First 24 Weeks||17
10155030|NCT02879383|11285840|FG003|COMPLETED|First 24 Weeks||16
10155031|NCT02879383|11285837|FG000|NOT COMPLETED|First 24 Weeks||0
10155032|NCT02879383|11285838|FG001|NOT COMPLETED|First 24 Weeks||1
10155033|NCT02879383|11285839|FG002|NOT COMPLETED|First 24 Weeks||0
9710199|NCT04724538|10809723|FG001|NOT COMPLETED|Overall Study||0
9729946|NCT00122109|10829562|FG000|STARTED|Overall Study|ITT|61
9729947|NCT00122109|10829563|FG001|STARTED|Overall Study|ITT|64
9729948|NCT00122109|10829562|FG000|COMPLETED|Overall Study||55
9729949|NCT00122109|10829563|FG001|COMPLETED|Overall Study||57
9729950|NCT00122109|10829562|FG000|NOT COMPLETED|Overall Study||6
9729951|NCT00122109|10829563|FG001|NOT COMPLETED|Overall Study||7
9729952|NCT00122135|10829574|FG000|STARTED|Overall Study||60
9729953|NCT00122135|10829575|FG001|STARTED|Overall Study||60
9729954|NCT00122135|10829574|FG000|COMPLETED|Overall Study||57
9729955|NCT00122135|10829575|FG001|COMPLETED|Overall Study||60
9729956|NCT00122135|10829574|FG000|NOT COMPLETED|Overall Study||3
9729957|NCT00122135|10829575|FG001|NOT COMPLETED|Overall Study||0
9729958|NCT00122187|10829583|FG000|STARTED|Overall Study||4
9729959|NCT00122187|10829584|FG001|STARTED|Overall Study||4
9729960|NCT00122187|10829583|FG000|Matched by Colonoscopy Volume|Overall Study||4
9729961|NCT00122187|10829584|FG001|Matched by Colonoscopy Volume|Overall Study||4
9729962|NCT00122187|10829583|FG000|Randomized to Intervention or Usual Care|Overall Study||4
9729963|NCT00122187|10829584|FG001|Randomized to Intervention or Usual Care|Overall Study||4
9729964|NCT00122187|10829583|FG000|Intervention Implemented|Overall Study||3
9729965|NCT00122187|10829584|FG001|Intervention Implemented|Overall Study||4
9729966|NCT00122187|10829583|FG000|Post-intervention Data Collection|Overall Study||2
9729967|NCT00122187|10829584|FG001|Post-intervention Data Collection|Overall Study||2
9729968|NCT00122187|10829583|FG000|COMPLETED|Overall Study||2
9729969|NCT00122187|10829584|FG001|COMPLETED|Overall Study||2
9729970|NCT00122187|10829583|FG000|NOT COMPLETED|Overall Study||2
9729971|NCT00122187|10829584|FG001|NOT COMPLETED|Overall Study||2
9729972|NCT00122278|10829594|FG000|STARTED|Overall Study||106
9729973|NCT00122278|10829595|FG001|STARTED|Overall Study||99
9729974|NCT00122278|10829594|FG000|COMPLETED|Overall Study||104
9729975|NCT00122278|10829595|FG001|COMPLETED|Overall Study||99
9729976|NCT00122278|10829594|FG000|NOT COMPLETED|Overall Study||2
9729977|NCT00122278|10829595|FG001|NOT COMPLETED|Overall Study||0
9729978|NCT00122317|10829601|FG000|STARTED|Overall Study||187
9729979|NCT00122317|10829601|FG000|COMPLETED|Overall Study||176
9729980|NCT00122317|10829601|FG000|NOT COMPLETED|Overall Study||11
9729981|NCT00122369|10829608|FG000|STARTED|Overall Study||76
9729982|NCT00122369|10829609|FG001|STARTED|Overall Study||82
9729983|NCT00122369|10829610|FG002|STARTED|Overall Study||78
9729984|NCT00122369|10829608|FG000|COMPLETED|Overall Study||76
9729985|NCT00122369|10829609|FG001|COMPLETED|Overall Study||82
9729986|NCT00122369|10829610|FG002|COMPLETED|Overall Study||78
9729987|NCT00122369|10829608|FG000|NOT COMPLETED|Overall Study||0
9729988|NCT00122369|10829609|FG001|NOT COMPLETED|Overall Study||0
9729989|NCT00122369|10829610|FG002|NOT COMPLETED|Overall Study||0
9729990|NCT00122382|10829623|FG000|STARTED|Double-Blind Study|participants randomized|256
9729991|NCT00122382|10829624|FG001|STARTED|Double-Blind Study|participants randomized|255
9729992|NCT00122382|10829625|FG002|STARTED|Double-Blind Study||0
9729993|NCT00122382|10829623|FG000|Treated|Double-Blind Study||256
9729994|NCT00122382|10829624|FG001|Treated|Double-Blind Study||253
9729995|NCT00122382|10829625|FG002|Treated|Double-Blind Study||0
9729996|NCT00122382|10829623|FG000|COMPLETED|Double-Blind Study||232
9729997|NCT00122382|10829624|FG001|COMPLETED|Double-Blind Study||227
9729998|NCT00122382|10829625|FG002|COMPLETED|Double-Blind Study||0
9729999|NCT00122382|10829623|FG000|NOT COMPLETED|Double-Blind Study||24
9730000|NCT00122382|10829624|FG001|NOT COMPLETED|Double-Blind Study||28
9730001|NCT00122382|10829625|FG002|NOT COMPLETED|Double-Blind Study||0
9730002|NCT00122382|10829623|FG000|STARTED|Open-Label Study||0
9730003|NCT00122382|10829624|FG001|STARTED|Open-Label Study||0
9730004|NCT00122382|10829625|FG002|STARTED|Open-Label Study||459
9730005|NCT00122382|10829623|FG000|COMPLETED|Open-Label Study||0
9730006|NCT00122382|10829624|FG001|COMPLETED|Open-Label Study||0
9730007|NCT00122382|10829625|FG002|COMPLETED|Open-Label Study||433
9730008|NCT00122382|10829623|FG000|NOT COMPLETED|Open-Label Study||0
9730009|NCT00122382|10829624|FG001|NOT COMPLETED|Open-Label Study||0
9730010|NCT00122382|10829625|FG002|NOT COMPLETED|Open-Label Study||26
9730011|NCT00122447|10829647|FG000|STARTED|Overall Study||18
9730012|NCT00122447|10829648|FG001|STARTED|Overall Study||18
9730013|NCT00122447|10829649|FG002|STARTED|Overall Study||17
9730014|NCT00122447|10829650|FG003|STARTED|Overall Study||17
9730015|NCT00122447|10829647|FG000|COMPLETED|Overall Study||17
9730016|NCT00122447|10829648|FG001|COMPLETED|Overall Study||13
9730017|NCT00122447|10829649|FG002|COMPLETED|Overall Study||16
9730018|NCT00122447|10829650|FG003|COMPLETED|Overall Study||14
9730019|NCT00122447|10829647|FG000|NOT COMPLETED|Overall Study||1
10155034|NCT02879383|11285840|FG003|NOT COMPLETED|First 24 Weeks||0
10155035|NCT02879383|11285837|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33
9730020|NCT00122447|10829648|FG001|NOT COMPLETED|Overall Study||5
9730021|NCT00122447|10829649|FG002|NOT COMPLETED|Overall Study||1
9730022|NCT00122447|10829650|FG003|NOT COMPLETED|Overall Study||3
9732177|NCT00141219|10832196|FG000|COMPLETED|Overall Study||138
10155036|NCT02879383|11285838|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0
10155037|NCT02879383|11285839|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4
10155038|NCT02879383|11285840|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0
10155039|NCT02879383|11285837|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
10155040|NCT02879383|11285838|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10155041|NCT02879383|11285839|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
10155042|NCT02879383|11285840|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10155043|NCT02879383|11285837|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10155044|NCT02879383|11285838|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10155045|NCT02879383|11285839|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10155046|NCT02879383|11285840|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10155047|NCT02879578|11285855|FG000|STARTED|Overall Study||33
10155048|NCT02879578|11285856|FG001|STARTED|Overall Study||41
10155049|NCT02879578|11285857|FG002|STARTED|Overall Study||81
10155050|NCT02879578|11285855|FG000|Safety Analysis Set|Overall Study||33
10155051|NCT02879578|11285856|FG001|Safety Analysis Set|Overall Study||40
10155052|NCT02879578|11285857|FG002|Safety Analysis Set|Overall Study||79
10155053|NCT02879578|11285855|FG000|COMPLETED|Overall Study||23
10155054|NCT02879578|11285856|FG001|COMPLETED|Overall Study||32
10155055|NCT02879578|11285857|FG002|COMPLETED|Overall Study||49
10155056|NCT02879578|11285855|FG000|NOT COMPLETED|Overall Study||10
10155057|NCT02879578|11285856|FG001|NOT COMPLETED|Overall Study||9
10155058|NCT02879578|11285857|FG002|NOT COMPLETED|Overall Study||32
10155059|NCT02879747|11285868|FG000|STARTED|Overall Study||27
10155060|NCT02879747|11285869|FG001|STARTED|Overall Study||38
10155061|NCT02879747|11285870|FG002|STARTED|Overall Study||33
10155062|NCT02879747|11285868|FG000|COMPLETED|Overall Study||23
10155063|NCT02879747|11285869|FG001|COMPLETED|Overall Study||32
10155064|NCT02879747|11285870|FG002|COMPLETED|Overall Study||31
10155065|NCT02879747|11285868|FG000|NOT COMPLETED|Overall Study||4
10155066|NCT02879747|11285869|FG001|NOT COMPLETED|Overall Study||6
10155067|NCT02879747|11285870|FG002|NOT COMPLETED|Overall Study||2
10155068|NCT02879812|11285889|FG000|STARTED|Overall Study||23370
10155069|NCT02879812|11285890|FG001|STARTED|Overall Study||22480
10155070|NCT02879812|11285889|FG000|COMPLETED|Overall Study||22153
10155071|NCT02879812|11285890|FG001|COMPLETED|Overall Study||21029
10155072|NCT02879812|11285889|FG000|NOT COMPLETED|Overall Study||1217
10155073|NCT02879812|11285890|FG001|NOT COMPLETED|Overall Study||1451
10155074|NCT02879994|11285896|FG000|STARTED|Overall Study||11
10155075|NCT02879994|11285896|FG000|COMPLETED|Overall Study||0
10155076|NCT02879994|11285896|FG000|NOT COMPLETED|Overall Study||11
10155077|NCT02880137|11285900|FG000|STARTED|Overall Study||36
10155078|NCT02880137|11285900|FG000|COMPLETED|Overall Study||36
10155079|NCT02880137|11285900|FG000|NOT COMPLETED|Overall Study||0
10155080|NCT02880176|11285906|FG000|STARTED|Overall Study||23
10155081|NCT02880176|11285907|FG001|STARTED|Overall Study||11
10155082|NCT02880176|11285906|FG000|Underwent Cystectomy|Overall Study||22
10155083|NCT02880176|11285907|FG001|Underwent Cystectomy|Overall Study||11
10155084|NCT02880176|11285906|FG000|Collected Postop Step Data|Overall Study||22
10155085|NCT02880176|11285907|FG001|Collected Postop Step Data|Overall Study||11
10155086|NCT02880176|11285906|FG000|Responded to 30 Day Survey|Overall Study||20
10155087|NCT02880176|11285907|FG001|Responded to 30 Day Survey|Overall Study||9
10155088|NCT02880176|11285906|FG000|COMPLETED|Overall Study||20
10155089|NCT02880176|11285907|FG001|COMPLETED|Overall Study||9
10155090|NCT02880176|11285906|FG000|NOT COMPLETED|Overall Study||3
10155091|NCT02880176|11285907|FG001|NOT COMPLETED|Overall Study||2
10155092|NCT02880228|11285913|FG000|STARTED|Overall Study||11
10155093|NCT02880228|11285913|FG000|COMPLETED|Overall Study||11
10155094|NCT02880228|11285913|FG000|NOT COMPLETED|Overall Study||0
10155095|NCT02880254|11285919|FG000|STARTED|Overall Study||13
10155096|NCT02880254|11285920|FG001|STARTED|Overall Study||14
10155097|NCT02880254|11285919|FG000|COMPLETED|Overall Study||4
10155098|NCT02880254|11285920|FG001|COMPLETED|Overall Study||4
10155099|NCT02880254|11285919|FG000|NOT COMPLETED|Overall Study||9
10155100|NCT02880254|11285920|FG001|NOT COMPLETED|Overall Study||10
10155101|NCT02880475|11285928|FG000|STARTED|Overall Study||13
10155102|NCT02880475|11285929|FG001|STARTED|Overall Study||17
10155103|NCT02880475|11285928|FG000|COMPLETED|Overall Study||13
10155104|NCT02880475|11285929|FG001|COMPLETED|Overall Study||17
10155105|NCT02880475|11285928|FG000|NOT COMPLETED|Overall Study||0
10155106|NCT02880475|11285929|FG001|NOT COMPLETED|Overall Study||0
10155107|NCT02880514|11285937|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
10155108|NCT02880514|11285938|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
10155109|NCT02880514|11285937|FG000|COMPLETED|Overall Study||50
10155110|NCT02880514|11285938|FG001|COMPLETED|Overall Study||50
10155111|NCT02880514|11285937|FG000|NOT COMPLETED|Overall Study||0
10155112|NCT02880514|11285938|FG001|NOT COMPLETED|Overall Study||0
10155113|NCT02880761|11285947|FG000|STARTED|Overall Study||103
10155114|NCT02880761|11285948|FG001|STARTED|Overall Study||106
10155115|NCT02880761|11285947|FG000|COMPLETED|Overall Study||87
10155116|NCT02880761|11285948|FG001|COMPLETED|Overall Study||85
10155117|NCT02880761|11285947|FG000|NOT COMPLETED|Overall Study||16
10155118|NCT02880761|11285948|FG001|NOT COMPLETED|Overall Study||21
10155119|NCT02880852|11285954|FG000|STARTED|Overall Study||20
10155120|NCT02880852|11285954|FG000|COMPLETED|Overall Study||20
10155121|NCT02880852|11285954|FG000|NOT COMPLETED|Overall Study||0
10155122|NCT02880865|11285960|FG000|STARTED|Overall Study||314
10155123|NCT02880865|11285961|FG001|STARTED|Overall Study||314
10155124|NCT02880865|11285960|FG000|Received MMR Dose 1|Overall Study||314
10155125|NCT02880865|11285961|FG001|Received MMR Dose 1|Overall Study||314
10155126|NCT02880865|11285960|FG000|Received CD-JEV|Overall Study||314
10155127|NCT02880865|11285961|FG001|Received CD-JEV|Overall Study||309
10155128|NCT02880865|11285960|FG000|Received MMR Dose 2|Overall Study||313
10155129|NCT02880865|11285961|FG001|Received MMR Dose 2|Overall Study||311
10155130|NCT02880865|11285960|FG000|COMPLETED|Overall Study||313
10155131|NCT02880865|11285961|FG001|COMPLETED|Overall Study||311
10155132|NCT02880865|11285960|FG000|NOT COMPLETED|Overall Study||1
10155133|NCT02880865|11285961|FG001|NOT COMPLETED|Overall Study||3
10155134|NCT02881008|11285994|FG000|STARTED|Overall Study||8
10155135|NCT02881008|11285995|FG001|STARTED|Overall Study||8
10155136|NCT02881008|11285996|FG002|STARTED|Overall Study||8
10155137|NCT02881008|11285997|FG003|STARTED|Overall Study||8
10155138|NCT02881008|11285998|FG004|STARTED|Overall Study||8
10155139|NCT02881008|11285999|FG005|STARTED|Overall Study||8
10155140|NCT02881008|11285994|FG000|COMPLETED|Overall Study||8
10155141|NCT02881008|11285995|FG001|COMPLETED|Overall Study||8
10155142|NCT02881008|11285996|FG002|COMPLETED|Overall Study||8
10155143|NCT02881008|11285997|FG003|COMPLETED|Overall Study||8
10155144|NCT02881008|11285998|FG004|COMPLETED|Overall Study||8
10155145|NCT02881008|11285999|FG005|COMPLETED|Overall Study||8
10155146|NCT02881008|11285994|FG000|NOT COMPLETED|Overall Study||0
10155147|NCT02881008|11285995|FG001|NOT COMPLETED|Overall Study||0
10155148|NCT02881008|11285996|FG002|NOT COMPLETED|Overall Study||0
10155149|NCT02881008|11285997|FG003|NOT COMPLETED|Overall Study||0
10155150|NCT02881008|11285998|FG004|NOT COMPLETED|Overall Study||0
10155151|NCT02881008|11285999|FG005|NOT COMPLETED|Overall Study||0
10155152|NCT02881047|11286016|FG000|STARTED|Overall Study||8
10155153|NCT02881047|11286016|FG000|COMPLETED|Overall Study||6
10155154|NCT02881047|11286016|FG000|NOT COMPLETED|Overall Study||2
10155155|NCT02881112|11286020|FG000|STARTED|Overall Study||180
10155156|NCT02881112|11286020|FG000|COMPLETED|Overall Study||152
10155157|NCT02881112|11286020|FG000|NOT COMPLETED|Overall Study||28
10155158|NCT02881567|11286024|FG000|STARTED|Overall Study||41
10155159|NCT02881567|11286024|FG000|COMPLETED|Overall Study||23
10155160|NCT02881567|11286024|FG000|NOT COMPLETED|Overall Study||18
10155161|NCT02881658|11286030|FG000|STARTED|Overall Study||100
10155162|NCT02881658|11286031|FG001|STARTED|Overall Study||101
10155163|NCT02881658|11286030|FG000|COMPLETED|Overall Study||98
10155164|NCT02881658|11286031|FG001|COMPLETED|Overall Study||96
10155165|NCT02881658|11286030|FG000|NOT COMPLETED|Overall Study||2
10155166|NCT02881658|11286031|FG001|NOT COMPLETED|Overall Study||5
10155167|NCT02881775|11286039|FG000|STARTED|Baseline||11
10155168|NCT02881775|11286040|FG001|STARTED|Baseline||9
10155169|NCT02881775|11286039|FG000|COMPLETED|Baseline||11
10155170|NCT02881775|11286040|FG001|COMPLETED|Baseline||9
10155171|NCT02881775|11286039|FG000|NOT COMPLETED|Baseline||0
10155172|NCT02881775|11286040|FG001|NOT COMPLETED|Baseline||0
10155173|NCT02881775|11286039|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
10155174|NCT02881775|11286040|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
10155175|NCT02881775|11286039|FG000|COMPLETED|First Intervention (1-hr Session)||9
10155176|NCT02881775|11286040|FG001|COMPLETED|First Intervention (1-hr Session)||7
10155177|NCT02881775|11286039|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0
10155178|NCT02881775|11286040|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0
10155179|NCT02881775|11286039|FG000|STARTED|Washout (1 Week)||9
10155180|NCT02881775|11286040|FG001|STARTED|Washout (1 Week)||7
10155181|NCT02881775|11286039|FG000|COMPLETED|Washout (1 Week)||9
10155182|NCT02881775|11286040|FG001|COMPLETED|Washout (1 Week)||7
10155183|NCT02881775|11286039|FG000|NOT COMPLETED|Washout (1 Week)||0
10155184|NCT02881775|11286040|FG001|NOT COMPLETED|Washout (1 Week)||0
10155185|NCT02881775|11286039|FG000|STARTED|Second Intervention (1-Hour Session)||9
10155186|NCT02881775|11286040|FG001|STARTED|Second Intervention (1-Hour Session)||7
10155187|NCT02881775|11286039|FG000|COMPLETED|Second Intervention (1-Hour Session)||9
10155188|NCT02881775|11286040|FG001|COMPLETED|Second Intervention (1-Hour Session)||7
10155189|NCT02881775|11286039|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0
10155190|NCT02881775|11286040|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0
10155191|NCT02881840|11286046|FG000|STARTED|Overall Study||6
10155192|NCT02881840|11286046|FG000|COMPLETED|Overall Study||6
10155193|NCT02881840|11286046|FG000|NOT COMPLETED|Overall Study||0
10155194|NCT02881996|11286052|FG000|STARTED|Overall Study||45
10155195|NCT02881996|11286053|FG001|STARTED|Overall Study||45
10155196|NCT02881996|11286052|FG000|COMPLETED|Overall Study||39
10155197|NCT02881996|11286053|FG001|COMPLETED|Overall Study||43
10155198|NCT02881996|11286052|FG000|NOT COMPLETED|Overall Study||6
10155199|NCT02881996|11286053|FG001|NOT COMPLETED|Overall Study||2
10155200|NCT02882152|11286061|FG000|STARTED|Overall Study||20
10155201|NCT02882152|11286062|FG001|STARTED|Overall Study||20
10155202|NCT02882152|11286061|FG000|COMPLETED|Overall Study||19
10155203|NCT02882152|11286062|FG001|COMPLETED|Overall Study||20
10155204|NCT02882152|11286061|FG000|NOT COMPLETED|Overall Study||1
10155205|NCT02882152|11286062|FG001|NOT COMPLETED|Overall Study||0
10155206|NCT02882178|11286068|FG000|STARTED|Overall Study||18
10155207|NCT02882178|11286068|FG000|COMPLETED|Overall Study||18
10155208|NCT02882178|11286068|FG000|NOT COMPLETED|Overall Study||0
10155209|NCT02882633|11286074|FG000|STARTED|Overall Study||25
10155210|NCT02882633|11286075|FG001|STARTED|Overall Study||25
10155211|NCT02882633|11286074|FG000|COMPLETED|Overall Study||23
10155212|NCT02882633|11286075|FG001|COMPLETED|Overall Study||25
10155213|NCT02882633|11286074|FG000|NOT COMPLETED|Overall Study||2
10155214|NCT02882633|11286075|FG001|NOT COMPLETED|Overall Study||0
10155215|NCT02882711|11286081|FG000|STARTED|Overall Study||6
10155216|NCT02882711|11286081|FG000|COMPLETED|Overall Study||2
10155217|NCT02882711|11286081|FG000|NOT COMPLETED|Overall Study||4
10155218|NCT02882854|11286087|FG000|STARTED|Overall Study||40
10155219|NCT02882854|11286088|FG001|STARTED|Overall Study||44
10155220|NCT02882854|11286087|FG000|COMPLETED|Overall Study||39
10155221|NCT02882854|11286088|FG001|COMPLETED|Overall Study||41
10155222|NCT02882854|11286087|FG000|NOT COMPLETED|Overall Study||1
10155223|NCT02882854|11286088|FG001|NOT COMPLETED|Overall Study||3
10155224|NCT02883244|11286096|FG000|STARTED|Overall Study||24
10155225|NCT02883244|11286097|FG001|STARTED|Overall Study||26
10155226|NCT02883244|11286096|FG000|COMPLETED|Overall Study||24
10155227|NCT02883244|11286097|FG001|COMPLETED|Overall Study||25
10155228|NCT02883244|11286096|FG000|NOT COMPLETED|Overall Study||0
10155229|NCT02883244|11286097|FG001|NOT COMPLETED|Overall Study||1
10155230|NCT02883452|11286109|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
10155231|NCT02883452|11286110|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
10155232|NCT02883452|11286111|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
10155233|NCT02883452|11286112|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8
10155234|NCT02883452|11286113|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
10155235|NCT02883452|11286114|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
10155236|NCT02883452|11286109|FG000|COMPLETED|Overall Study||8
10155237|NCT02883452|11286110|FG001|COMPLETED|Overall Study||9
10155238|NCT02883452|11286111|FG002|COMPLETED|Overall Study||7
10155239|NCT02883452|11286112|FG003|COMPLETED|Overall Study||6
10155240|NCT02883452|11286113|FG004|COMPLETED|Overall Study||55
10155241|NCT02883452|11286114|FG005|COMPLETED|Overall Study||50
10155242|NCT02883452|11286109|FG000|NOT COMPLETED|Overall Study||5
10155243|NCT02883452|11286110|FG001|NOT COMPLETED|Overall Study||2
10155244|NCT02883452|11286111|FG002|NOT COMPLETED|Overall Study||5
10155245|NCT02883452|11286112|FG003|NOT COMPLETED|Overall Study||2
10155246|NCT02883452|11286113|FG004|NOT COMPLETED|Overall Study||11
10155247|NCT02883452|11286114|FG005|NOT COMPLETED|Overall Study||15
10155248|NCT02884089|11286129|FG000|STARTED|Period 1||11
10155249|NCT02884089|11286130|FG001|STARTED|Period 1||11
10155250|NCT02884089|11286131|FG002|STARTED|Period 1||9
10155251|NCT02884089|11286132|FG003|STARTED|Period 1||9
10155252|NCT02884089|11286129|FG000|Received at Least One Dose of Study Drug|Period 1||11
10155253|NCT02884089|11286130|FG001|Received at Least One Dose of Study Drug|Period 1||11
10155254|NCT02884089|11286131|FG002|Received at Least One Dose of Study Drug|Period 1||9
10155255|NCT02884089|11286132|FG003|Received at Least One Dose of Study Drug|Period 1||9
10155256|NCT02884089|11286129|FG000|COMPLETED|Period 1||9
10155257|NCT02884089|11286130|FG001|COMPLETED|Period 1||9
10155258|NCT02884089|11286131|FG002|COMPLETED|Period 1||9
10155259|NCT02884089|11286132|FG003|COMPLETED|Period 1||9
10155260|NCT02884089|11286129|FG000|NOT COMPLETED|Period 1||2
10155261|NCT02884089|11286130|FG001|NOT COMPLETED|Period 1||2
10155262|NCT02884089|11286131|FG002|NOT COMPLETED|Period 1||0
10155263|NCT02884089|11286132|FG003|NOT COMPLETED|Period 1||0
10155264|NCT02884089|11286129|FG000|STARTED|Washout Period 1||9
10155265|NCT02884089|11286130|FG001|STARTED|Washout Period 1||9
10155266|NCT02884089|11286131|FG002|STARTED|Washout Period 1||9
10155267|NCT02884089|11286132|FG003|STARTED|Washout Period 1||9
10155268|NCT02884089|11286129|FG000|COMPLETED|Washout Period 1||9
10155269|NCT02884089|11286130|FG001|COMPLETED|Washout Period 1||7
10155270|NCT02884089|11286131|FG002|COMPLETED|Washout Period 1||9
10155271|NCT02884089|11286132|FG003|COMPLETED|Washout Period 1||8
10155272|NCT02884089|11286129|FG000|NOT COMPLETED|Washout Period 1||0
10155273|NCT02884089|11286130|FG001|NOT COMPLETED|Washout Period 1||2
10155274|NCT02884089|11286131|FG002|NOT COMPLETED|Washout Period 1||0
10155275|NCT02884089|11286132|FG003|NOT COMPLETED|Washout Period 1||1
10155276|NCT02884089|11286129|FG000|STARTED|Period 2||9
10155277|NCT02884089|11286130|FG001|STARTED|Period 2||7
10155278|NCT02884089|11286131|FG002|STARTED|Period 2||9
10155279|NCT02884089|11286132|FG003|STARTED|Period 2||8
10155280|NCT02884089|11286129|FG000|COMPLETED|Period 2||8
10155281|NCT02884089|11286130|FG001|COMPLETED|Period 2||7
10155282|NCT02884089|11286131|FG002|COMPLETED|Period 2||9
10155283|NCT02884089|11286132|FG003|COMPLETED|Period 2||8
10155284|NCT02884089|11286129|FG000|NOT COMPLETED|Period 2||1
10155285|NCT02884089|11286130|FG001|NOT COMPLETED|Period 2||0
10155286|NCT02884089|11286131|FG002|NOT COMPLETED|Period 2||0
10155287|NCT02884089|11286132|FG003|NOT COMPLETED|Period 2||0
10155288|NCT02884089|11286129|FG000|STARTED|Washout Period 2||8
10155289|NCT02884089|11286130|FG001|STARTED|Washout Period 2||7
10155290|NCT02884089|11286131|FG002|STARTED|Washout Period 2||9
10155291|NCT02884089|11286132|FG003|STARTED|Washout Period 2||8
10155292|NCT02884089|11286129|FG000|COMPLETED|Washout Period 2||8
10155293|NCT02884089|11286130|FG001|COMPLETED|Washout Period 2||7
10155294|NCT02884089|11286131|FG002|COMPLETED|Washout Period 2||9
10155295|NCT02884089|11286132|FG003|COMPLETED|Washout Period 2||8
10155296|NCT02884089|11286129|FG000|NOT COMPLETED|Washout Period 2||0
10155297|NCT02884089|11286130|FG001|NOT COMPLETED|Washout Period 2||0
10155298|NCT02884089|11286131|FG002|NOT COMPLETED|Washout Period 2||0
10155299|NCT02884089|11286132|FG003|NOT COMPLETED|Washout Period 2||0
10155300|NCT02884089|11286129|FG000|STARTED|Period 3||8
10155301|NCT02884089|11286130|FG001|STARTED|Period 3||7
10155302|NCT02884089|11286131|FG002|STARTED|Period 3||9
10155303|NCT02884089|11286132|FG003|STARTED|Period 3||8
10155304|NCT02884089|11286129|FG000|COMPLETED|Period 3||8
10155305|NCT02884089|11286130|FG001|COMPLETED|Period 3||7
10155306|NCT02884089|11286131|FG002|COMPLETED|Period 3||8
10155307|NCT02884089|11286132|FG003|COMPLETED|Period 3||8
10155308|NCT02884089|11286129|FG000|NOT COMPLETED|Period 3||0
10155309|NCT02884089|11286130|FG001|NOT COMPLETED|Period 3||0
10155310|NCT02884089|11286131|FG002|NOT COMPLETED|Period 3||1
10155311|NCT02884089|11286132|FG003|NOT COMPLETED|Period 3||0
10155312|NCT02884089|11286129|FG000|STARTED|Washout Period 3||8
10155313|NCT02884089|11286130|FG001|STARTED|Washout Period 3||7
10155314|NCT02884089|11286131|FG002|STARTED|Washout Period 3||8
10155315|NCT02884089|11286132|FG003|STARTED|Washout Period 3||8
10155316|NCT02884089|11286129|FG000|COMPLETED|Washout Period 3||8
10155317|NCT02884089|11286130|FG001|COMPLETED|Washout Period 3||7
10155318|NCT02884089|11286131|FG002|COMPLETED|Washout Period 3||7
10155319|NCT02884089|11286132|FG003|COMPLETED|Washout Period 3||7
10155320|NCT02884089|11286129|FG000|NOT COMPLETED|Washout Period 3||0
10155321|NCT02884089|11286130|FG001|NOT COMPLETED|Washout Period 3||0
10060941|NCT02100748|11186477|FG004|COMPLETED|Overall Study||23
10060942|NCT02100748|11186478|FG005|COMPLETED|Overall Study||23
10060943|NCT02100748|11186479|FG006|COMPLETED|Overall Study||18
10060944|NCT02100748|11186480|FG007|COMPLETED|Overall Study||34
10060945|NCT02100748|11186481|FG008|COMPLETED|Overall Study||33
10060946|NCT02100748|11186482|FG009|COMPLETED|Overall Study||29
10060947|NCT02100748|11186483|FG010|COMPLETED|Overall Study||26
10060948|NCT02100748|11186484|FG011|COMPLETED|Overall Study||39
10060949|NCT02100748|11186473|FG000|NOT COMPLETED|Overall Study||2
10155322|NCT02884089|11286131|FG002|NOT COMPLETED|Washout Period 3||1
10155323|NCT02884089|11286132|FG003|NOT COMPLETED|Washout Period 3||1
10155324|NCT02884089|11286129|FG000|STARTED|Period 4||8
10155325|NCT02884089|11286130|FG001|STARTED|Period 4||7
10155326|NCT02884089|11286131|FG002|STARTED|Period 4||7
10155327|NCT02884089|11286132|FG003|STARTED|Period 4||7
10155328|NCT02884089|11286129|FG000|COMPLETED|Period 4||7
10155329|NCT02884089|11286130|FG001|COMPLETED|Period 4||6
10155330|NCT02884089|11286131|FG002|COMPLETED|Period 4||7
10155331|NCT02884089|11286132|FG003|COMPLETED|Period 4||7
10155332|NCT02884089|11286129|FG000|NOT COMPLETED|Period 4||1
10155333|NCT02884089|11286130|FG001|NOT COMPLETED|Period 4||1
10155334|NCT02884089|11286131|FG002|NOT COMPLETED|Period 4||0
10155335|NCT02884089|11286132|FG003|NOT COMPLETED|Period 4||0
10155336|NCT02884089|11286129|FG000|STARTED|Follow-up Visit||7
10155337|NCT02884089|11286130|FG001|STARTED|Follow-up Visit||6
9710200|NCT04716426|10809731|FG000|STARTED|Overall Study||50
9710201|NCT04716426|10809732|FG001|STARTED|Overall Study||50
9710202|NCT04716426|10809731|FG000|COMPLETED|Overall Study||48
9710203|NCT04716426|10809732|FG001|COMPLETED|Overall Study||49
9710204|NCT04716426|10809731|FG000|NOT COMPLETED|Overall Study||2
9710205|NCT04716426|10809732|FG001|NOT COMPLETED|Overall Study||1
9710206|NCT04709068|10809738|FG000|STARTED|Overall Study||8
9710207|NCT04709068|10809738|FG000|COMPLETED|Overall Study||8
9710208|NCT04709068|10809738|FG000|NOT COMPLETED|Overall Study||0
10155338|NCT02884089|11286131|FG002|STARTED|Follow-up Visit||7
9710209|NCT04704713|10809744|FG000|STARTED|Overall Study||15
9710210|NCT04704713|10809745|FG001|STARTED|Overall Study||16
9710211|NCT04704713|10809744|FG000|COMPLETED|Overall Study||11
9710212|NCT04704713|10809745|FG001|COMPLETED|Overall Study||12
10060950|NCT02100748|11186474|FG001|NOT COMPLETED|Overall Study||1
9710213|NCT04704713|10809744|FG000|NOT COMPLETED|Overall Study||4
9710214|NCT04704713|10809745|FG001|NOT COMPLETED|Overall Study||4
9710215|NCT04698993|10809753|FG000|STARTED|Overall Study||275
9710216|NCT04698993|10809754|FG001|STARTED|Overall Study||113
9710217|NCT04698993|10809753|FG000|COMPLETED|Overall Study||272
10060951|NCT02100748|11186475|FG002|NOT COMPLETED|Overall Study||1
10060952|NCT02100748|11186476|FG003|NOT COMPLETED|Overall Study||1
10060953|NCT02100748|11186477|FG004|NOT COMPLETED|Overall Study||2
10060954|NCT02100748|11186478|FG005|NOT COMPLETED|Overall Study||0
10060955|NCT02100748|11186479|FG006|NOT COMPLETED|Overall Study||2
10155339|NCT02884089|11286132|FG003|STARTED|Follow-up Visit||7
9710218|NCT04698993|10809754|FG001|COMPLETED|Overall Study||106
10155340|NCT02884089|11286129|FG000|COMPLETED|Follow-up Visit||6
10155341|NCT02884089|11286130|FG001|COMPLETED|Follow-up Visit||6
10155342|NCT02884089|11286131|FG002|COMPLETED|Follow-up Visit||7
10155343|NCT02884089|11286132|FG003|COMPLETED|Follow-up Visit||6
10155344|NCT02884089|11286129|FG000|NOT COMPLETED|Follow-up Visit||1
10155345|NCT02884089|11286130|FG001|NOT COMPLETED|Follow-up Visit||0
10155346|NCT02884089|11286131|FG002|NOT COMPLETED|Follow-up Visit||0
10155347|NCT02884089|11286132|FG003|NOT COMPLETED|Follow-up Visit||1
10155348|NCT02884414|11286142|FG000|STARTED|Overall Study||56
10155349|NCT02884414|11286142|FG000|COMPLETED|Overall Study||56
10155350|NCT02884414|11286142|FG000|NOT COMPLETED|Overall Study||0
10155351|NCT02884427|11286149|FG000|STARTED|Overall Study||48
10155352|NCT02884427|11286150|FG001|STARTED|Overall Study||52
10155353|NCT02884427|11286151|FG002|STARTED|Overall Study||50
10155354|NCT02884427|11286149|FG000|COMPLETED|Overall Study||48
10155355|NCT02884427|11286150|FG001|COMPLETED|Overall Study||52
10155356|NCT02884427|11286151|FG002|COMPLETED|Overall Study||50
10155357|NCT02884427|11286149|FG000|NOT COMPLETED|Overall Study||0
10155358|NCT02884427|11286150|FG001|NOT COMPLETED|Overall Study||0
10155359|NCT02884427|11286151|FG002|NOT COMPLETED|Overall Study||0
10155360|NCT02884492|11286161|FG000|STARTED|Overall Study||7
10155361|NCT02884492|11286162|FG001|STARTED|Overall Study||10
10155362|NCT02884492|11286161|FG000|COMPLETED|Overall Study||7
10155363|NCT02884492|11286162|FG001|COMPLETED|Overall Study||10
10155364|NCT02884492|11286161|FG000|NOT COMPLETED|Overall Study||0
10155365|NCT02884492|11286162|FG001|NOT COMPLETED|Overall Study||0
10155366|NCT02885012|11286170|FG000|STARTED|Overall Study||1
10155367|NCT02885012|11286171|FG001|STARTED|Overall Study||2
10155368|NCT02885012|11286170|FG000|COMPLETED|Overall Study||1
10155369|NCT02885012|11286171|FG001|COMPLETED|Overall Study||2
10155370|NCT02885012|11286170|FG000|NOT COMPLETED|Overall Study||0
10155371|NCT02885012|11286171|FG001|NOT COMPLETED|Overall Study||0
10155372|NCT02885025|11286181|FG000|STARTED|Overall Study||16
10155373|NCT02885025|11286182|FG001|STARTED|Overall Study||14
10155374|NCT02885025|11286183|FG002|STARTED|Overall Study||9
10155375|NCT02885025|11286184|FG003|STARTED|Overall Study||8
10155376|NCT02885025|11286181|FG000|COMPLETED|Overall Study||16
10155377|NCT02885025|11286182|FG001|COMPLETED|Overall Study||12
10155378|NCT02885025|11286183|FG002|COMPLETED|Overall Study||9
10155379|NCT02885025|11286184|FG003|COMPLETED|Overall Study||8
10155380|NCT02885025|11286181|FG000|NOT COMPLETED|Overall Study||0
10155381|NCT02885025|11286182|FG001|NOT COMPLETED|Overall Study||2
10155382|NCT02885025|11286183|FG002|NOT COMPLETED|Overall Study||0
10155383|NCT02885025|11286184|FG003|NOT COMPLETED|Overall Study||0
10155384|NCT02885181|11286202|FG000|STARTED|Overall Study||20
10155385|NCT02885181|11286203|FG001|STARTED|Overall Study||20
10155386|NCT02885181|11286204|FG002|STARTED|Overall Study||21
10155387|NCT02885181|11286205|FG003|STARTED|Overall Study||22
10155388|NCT02885181|11286202|FG000|COMPLETED|Overall Study||20
10155389|NCT02885181|11286203|FG001|COMPLETED|Overall Study||19
10155390|NCT02885181|11286204|FG002|COMPLETED|Overall Study||21
10155391|NCT02885181|11286205|FG003|COMPLETED|Overall Study||19
10155392|NCT02885181|11286202|FG000|NOT COMPLETED|Overall Study||0
10155393|NCT02885181|11286203|FG001|NOT COMPLETED|Overall Study||1
10155394|NCT02885181|11286204|FG002|NOT COMPLETED|Overall Study||0
10155395|NCT02885181|11286205|FG003|NOT COMPLETED|Overall Study||3
10155396|NCT02885246|11286219|FG000|STARTED|Overall Study||1839
10155397|NCT02885246|11286219|FG000|COMPLETED|Overall Study||1839
10155398|NCT02885246|11286219|FG000|NOT COMPLETED|Overall Study||0
10155399|NCT02885350|11286227|FG000|STARTED|Overall Study||20
10155400|NCT02885350|11286228|FG001|STARTED|Overall Study||20
10155401|NCT02885350|11286229|FG002|STARTED|Overall Study||20
10155402|NCT02885350|11286230|FG003|STARTED|Overall Study||20
10155403|NCT02885350|11286227|FG000|COMPLETED|Overall Study||20
10155404|NCT02885350|11286228|FG001|COMPLETED|Overall Study||20
10155405|NCT02885350|11286229|FG002|COMPLETED|Overall Study||20
10155406|NCT02885350|11286230|FG003|COMPLETED|Overall Study||20
10155407|NCT02885350|11286227|FG000|NOT COMPLETED|Overall Study||0
10155408|NCT02885350|11286228|FG001|NOT COMPLETED|Overall Study||0
10155409|NCT02885350|11286229|FG002|NOT COMPLETED|Overall Study||0
10155410|NCT02885350|11286230|FG003|NOT COMPLETED|Overall Study||0
10155411|NCT02885506|11286250|FG000|STARTED|Part A||6
10155412|NCT02885506|11286251|FG001|STARTED|Part A||6
10155413|NCT02885506|11286252|FG002|STARTED|Part A||6
10155414|NCT02885506|11286253|FG003|STARTED|Part A||6
10155415|NCT02885506|11286254|FG004|STARTED|Part A||6
10155416|NCT02885506|11286255|FG005|STARTED|Part A||6
10155417|NCT02885506|11286256|FG006|STARTED|Part A||6
10155418|NCT02885506|11286257|FG007|STARTED|Part A||14
10155419|NCT02885506|11286258|FG008|STARTED|Part A||0
10155420|NCT02885506|11286259|FG009|STARTED|Part A||0
10155421|NCT02885506|11286250|FG000|COMPLETED|Part A||6
10155422|NCT02885506|11286251|FG001|COMPLETED|Part A||6
9849150|NCT00863057|10961803|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1
10155423|NCT02885506|11286252|FG002|COMPLETED|Part A||6
10155424|NCT02885506|11286253|FG003|COMPLETED|Part A||6
10155425|NCT02885506|11286254|FG004|COMPLETED|Part A||6
10155426|NCT02885506|11286255|FG005|COMPLETED|Part A||6
10155427|NCT02885506|11286256|FG006|COMPLETED|Part A||6
10155428|NCT02885506|11286257|FG007|COMPLETED|Part A||14
10155429|NCT02885506|11286258|FG008|COMPLETED|Part A||0
10155430|NCT02885506|11286259|FG009|COMPLETED|Part A||0
10155431|NCT02885506|11286250|FG000|NOT COMPLETED|Part A||0
10155432|NCT02885506|11286251|FG001|NOT COMPLETED|Part A||0
10155433|NCT02885506|11286252|FG002|NOT COMPLETED|Part A||0
10155434|NCT02885506|11286253|FG003|NOT COMPLETED|Part A||0
10155435|NCT02885506|11286254|FG004|NOT COMPLETED|Part A||0
10155436|NCT02885506|11286255|FG005|NOT COMPLETED|Part A||0
10155437|NCT02885506|11286256|FG006|NOT COMPLETED|Part A||0
10155438|NCT02885506|11286257|FG007|NOT COMPLETED|Part A||0
10155439|NCT02885506|11286258|FG008|NOT COMPLETED|Part A||0
10155440|NCT02885506|11286259|FG009|NOT COMPLETED|Part A||0
10155441|NCT02885506|11286250|FG000|STARTED|Part B||0
9849151|NCT00863057|10961800|FG000|STARTED|Period 3 (Weeks 11-15)||3
9849152|NCT00863057|10961801|FG001|STARTED|Period 3 (Weeks 11-15)||1
9849153|NCT00863057|10961802|FG002|STARTED|Period 3 (Weeks 11-15)||2
9849154|NCT00863057|10961803|FG003|STARTED|Period 3 (Weeks 11-15)||2
9849155|NCT00863057|10961800|FG000|COMPLETED|Period 3 (Weeks 11-15)||3
9849156|NCT00863057|10961801|FG001|COMPLETED|Period 3 (Weeks 11-15)||1
9849157|NCT00863057|10961802|FG002|COMPLETED|Period 3 (Weeks 11-15)||2
9849158|NCT00863057|10961803|FG003|COMPLETED|Period 3 (Weeks 11-15)||2
9849159|NCT00863057|10961800|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0
9849160|NCT00863057|10961801|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0
9849161|NCT00863057|10961802|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0
9849162|NCT00863057|10961803|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0
9849163|NCT00863057|10961800|FG000|STARTED|Period 4 (Weeks 16-20)||3
9849164|NCT00863057|10961801|FG001|STARTED|Period 4 (Weeks 16-20)||1
9849165|NCT00863057|10961802|FG002|STARTED|Period 4 (Weeks 16-20)||2
9849166|NCT00863057|10961803|FG003|STARTED|Period 4 (Weeks 16-20)||2
9849167|NCT00863057|10961800|FG000|COMPLETED|Period 4 (Weeks 16-20)||3
9849168|NCT00863057|10961801|FG001|COMPLETED|Period 4 (Weeks 16-20)||1
9849169|NCT00863057|10961802|FG002|COMPLETED|Period 4 (Weeks 16-20)||2
9849170|NCT00863057|10961803|FG003|COMPLETED|Period 4 (Weeks 16-20)||2
9849171|NCT00863057|10961800|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0
9849172|NCT00863057|10961801|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0
9849173|NCT00863057|10961802|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0
9849174|NCT00863057|10961803|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0
9849175|NCT00863109|10961819|FG000|STARTED|Treatment Period||130
9849176|NCT00863109|10961819|FG000|COMPLETED|Treatment Period||53
9849177|NCT00863109|10961819|FG000|NOT COMPLETED|Treatment Period||77
9849178|NCT00863109|10961819|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
9849179|NCT00863109|10961819|FG000|COMPLETED|Follow-up Period||48
10060956|NCT02100748|11186480|FG007|NOT COMPLETED|Overall Study||4
10060957|NCT02100748|11186481|FG008|NOT COMPLETED|Overall Study||3
10060958|NCT02100748|11186482|FG009|NOT COMPLETED|Overall Study||2
10060959|NCT02100748|11186483|FG010|NOT COMPLETED|Overall Study||2
10060960|NCT02100748|11186484|FG011|NOT COMPLETED|Overall Study||0
10060961|NCT02100813|11186518|FG000|STARTED|Overall Study||10
10060962|NCT02100813|11186519|FG001|STARTED|Overall Study||11
10060963|NCT02100813|11186520|FG002|STARTED|Overall Study||12
10060964|NCT02100813|11186521|FG003|STARTED|Overall Study||12
10060965|NCT02100813|11186522|FG004|STARTED|Overall Study||12
10060966|NCT02100813|11186523|FG005|STARTED|Overall Study||32
10060967|NCT02100813|11186524|FG006|STARTED|Overall Study||64
10060968|NCT02100813|11186525|FG007|STARTED|Overall Study||67
10060969|NCT02100813|11186518|FG000|COMPLETED|Overall Study||10
10060970|NCT02100813|11186519|FG001|COMPLETED|Overall Study||11
10060971|NCT02100813|11186520|FG002|COMPLETED|Overall Study||12
10060972|NCT02100813|11186521|FG003|COMPLETED|Overall Study||12
10060973|NCT02100813|11186522|FG004|COMPLETED|Overall Study||12
10060974|NCT02100813|11186523|FG005|COMPLETED|Overall Study||32
10060975|NCT02100813|11186524|FG006|COMPLETED|Overall Study||64
10060976|NCT02100813|11186525|FG007|COMPLETED|Overall Study||66
10060977|NCT02100813|11186518|FG000|NOT COMPLETED|Overall Study||0
10060978|NCT02100813|11186519|FG001|NOT COMPLETED|Overall Study||0
10060979|NCT02100813|11186520|FG002|NOT COMPLETED|Overall Study||0
10060980|NCT02100813|11186521|FG003|NOT COMPLETED|Overall Study||0
10060981|NCT02100813|11186522|FG004|NOT COMPLETED|Overall Study||0
10060982|NCT02100813|11186523|FG005|NOT COMPLETED|Overall Study||0
10060983|NCT02100813|11186524|FG006|NOT COMPLETED|Overall Study||0
10060984|NCT02100813|11186525|FG007|NOT COMPLETED|Overall Study||1
10060985|NCT02100826|11186543|FG000|STARTED|Period 1 (7 Days)||14
10060986|NCT02100826|11186544|FG001|STARTED|Period 1 (7 Days)||14
10060987|NCT02100826|11186543|FG000|COMPLETED|Period 1 (7 Days)||14
10060988|NCT02100826|11186544|FG001|COMPLETED|Period 1 (7 Days)||14
10060989|NCT02100826|11186543|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10060990|NCT02100826|11186544|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10060991|NCT02100826|11186543|FG000|STARTED|Washout Period (1 Day)||14
10060992|NCT02100826|11186544|FG001|STARTED|Washout Period (1 Day)||14
10060993|NCT02100826|11186543|FG000|COMPLETED|Washout Period (1 Day)||14
10060994|NCT02100826|11186544|FG001|COMPLETED|Washout Period (1 Day)||14
10060995|NCT02100826|11186543|FG000|NOT COMPLETED|Washout Period (1 Day)||0
10060996|NCT02100826|11186544|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10060997|NCT02100826|11186543|FG000|STARTED|Period 2 (7 Days)||14
9849180|NCT00863109|10961819|FG000|NOT COMPLETED|Follow-up Period||11
9849181|NCT00863122|10961827|FG000|STARTED|Overall Study||19
9849182|NCT00863122|10961828|FG001|STARTED|Overall Study||7
9849183|NCT00863122|10961827|FG000|COMPLETED|Overall Study||19
9963951|NCT01489826|11083769|FG007|COMPLETED|Overall Study||3
9963952|NCT01489826|11083770|FG008|COMPLETED|Overall Study||6
9963953|NCT01489826|11083762|FG000|NOT COMPLETED|Overall Study||0
9963954|NCT01489826|11083763|FG001|NOT COMPLETED|Overall Study||0
9963955|NCT01489826|11083764|FG002|NOT COMPLETED|Overall Study||0
9963956|NCT01489826|11083765|FG003|NOT COMPLETED|Overall Study||0
9963957|NCT01489826|11083766|FG004|NOT COMPLETED|Overall Study||0
9963958|NCT01489826|11083767|FG005|NOT COMPLETED|Overall Study||0
9963959|NCT01489826|11083768|FG006|NOT COMPLETED|Overall Study||0
9963960|NCT01489826|11083769|FG007|NOT COMPLETED|Overall Study||0
9963961|NCT01489826|11083770|FG008|NOT COMPLETED|Overall Study||0
9963962|NCT01489891|11083800|FG000|STARTED|Overall Study||60
9963963|NCT01489891|11083801|FG001|STARTED|Overall Study||60
9963964|NCT01489891|11083800|FG000|COMPLETED|Overall Study||59
9849184|NCT00863122|10961828|FG001|COMPLETED|Overall Study||7
9849185|NCT00863122|10961827|FG000|NOT COMPLETED|Overall Study||0
9849186|NCT00863122|10961828|FG001|NOT COMPLETED|Overall Study||0
9849187|NCT00863265|10961838|FG000|STARTED|Overall Study||4
9849188|NCT00863265|10961839|FG001|STARTED|Overall Study||3
9849189|NCT00863265|10961840|FG002|STARTED|Overall Study||4
9849190|NCT00863265|10961841|FG003|STARTED|Overall Study||4
9849191|NCT00863265|10961842|FG004|STARTED|Overall Study||4
9849192|NCT00863265|10961843|FG005|STARTED|Overall Study||3
9849193|NCT00863265|10961838|FG000|COMPLETED|Overall Study||4
9849194|NCT00863265|10961839|FG001|COMPLETED|Overall Study||3
9849195|NCT00863265|10961840|FG002|COMPLETED|Overall Study||4
9849196|NCT00863265|10961841|FG003|COMPLETED|Overall Study||4
9849197|NCT00863265|10961842|FG004|COMPLETED|Overall Study||3
9849198|NCT00863265|10961843|FG005|COMPLETED|Overall Study||3
9849199|NCT00863265|10961838|FG000|NOT COMPLETED|Overall Study||0
9849200|NCT00863265|10961839|FG001|NOT COMPLETED|Overall Study||0
9849201|NCT00863265|10961840|FG002|NOT COMPLETED|Overall Study||0
9849202|NCT00863265|10961841|FG003|NOT COMPLETED|Overall Study||0
9849203|NCT00863265|10961842|FG004|NOT COMPLETED|Overall Study||1
9849204|NCT00863265|10961843|FG005|NOT COMPLETED|Overall Study||0
9849205|NCT00863304|10961861|FG000|STARTED|Overall Study||212
9849206|NCT00863304|10961862|FG001|STARTED|Overall Study||212
9849207|NCT00863304|10961863|FG002|STARTED|Overall Study||213
9849208|NCT00863304|10961864|FG003|STARTED|Overall Study||212
9849209|NCT00863304|10961861|FG000|Treated|Overall Study||209
9849210|NCT00863304|10961862|FG001|Treated|Overall Study||211
9849211|NCT00863304|10961863|FG002|Treated|Overall Study||209
9849212|NCT00863304|10961864|FG003|Treated|Overall Study||211
9849213|NCT00863304|10961861|FG000|COMPLETED|Overall Study||18
9849214|NCT00863304|10961862|FG001|COMPLETED|Overall Study||27
9849215|NCT00863304|10961863|FG002|COMPLETED|Overall Study||26
9849216|NCT00863304|10961864|FG003|COMPLETED|Overall Study||21
9849217|NCT00863304|10961861|FG000|NOT COMPLETED|Overall Study||194
9849218|NCT00863304|10961862|FG001|NOT COMPLETED|Overall Study||185
9849219|NCT00863304|10961863|FG002|NOT COMPLETED|Overall Study||187
9849220|NCT00863304|10961864|FG003|NOT COMPLETED|Overall Study||191
9849221|NCT00863317|10961878|FG000|STARTED|Overall Study||68
9849222|NCT00863317|10961879|FG001|STARTED|Overall Study||73
9849223|NCT00863317|10961878|FG000|COMPLETED|Overall Study||60
9849224|NCT00863317|10961879|FG001|COMPLETED|Overall Study||64
9849225|NCT00863317|10961878|FG000|NOT COMPLETED|Overall Study||8
9849226|NCT00863317|10961879|FG001|NOT COMPLETED|Overall Study||9
9849227|NCT00863343|10961887|FG000|STARTED|Overall Study||17
9849228|NCT00863343|10961888|FG001|STARTED|Overall Study||374
9849229|NCT00863343|10961887|FG000|COMPLETED|Overall Study||17
9849230|NCT00863343|10961888|FG001|COMPLETED|Overall Study||374
9849231|NCT00863343|10961887|FG000|NOT COMPLETED|Overall Study||0
9849232|NCT00863343|10961888|FG001|NOT COMPLETED|Overall Study||0
9849233|NCT00863356|10961896|FG000|STARTED|Overall Study||20
9849234|NCT00863356|10961896|FG000|COMPLETED|Overall Study||20
9849235|NCT00863356|10961896|FG000|NOT COMPLETED|Overall Study||0
9849236|NCT00863434|10961900|FG000|STARTED|Overall Study||2
9849237|NCT00863434|10961900|FG000|COMPLETED|Overall Study||2
9849238|NCT00863434|10961900|FG000|NOT COMPLETED|Overall Study||0
9849239|NCT00863551|10961904|FG000|STARTED|Overall Study||12
9849240|NCT00863551|10961904|FG000|COMPLETED|Overall Study||12
9849241|NCT00863551|10961904|FG000|NOT COMPLETED|Overall Study||0
9849242|NCT00863655|10961910|FG000|STARTED|Overall Study||485
9849243|NCT00863655|10961911|FG001|STARTED|Overall Study||239
9849244|NCT00863655|10961910|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
9849245|NCT00863655|10961911|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
9849246|NCT00863655|10961910|FG000|NOT COMPLETED|Overall Study||485
9849247|NCT00863655|10961911|FG001|NOT COMPLETED|Overall Study||239
9849248|NCT00863681|10961920|FG000|STARTED|Overall Study||231
9849249|NCT00863681|10961921|FG001|STARTED|Overall Study||109
9849250|NCT00863681|10961922|FG002|STARTED|Overall Study||56
9849251|NCT00863681|10961920|FG000|COMPLETED|Overall Study|Completed treatment|140
9849252|NCT00863681|10961921|FG001|COMPLETED|Overall Study|Completed treatment|66
9849253|NCT00863681|10961922|FG002|COMPLETED|Overall Study|Completed treatment|38
9849254|NCT00863681|10961920|FG000|NOT COMPLETED|Overall Study||91
9849255|NCT00863681|10961921|FG001|NOT COMPLETED|Overall Study||43
9849256|NCT00863681|10961922|FG002|NOT COMPLETED|Overall Study||18
9849257|NCT00863707|10961932|FG000|STARTED|Overall Study||174
9849258|NCT00863707|10961933|FG001|STARTED|Overall Study||337
9849259|NCT00863707|10961932|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
9849260|NCT00863707|10961933|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
9849261|NCT00863707|10961932|FG000|NOT COMPLETED|Overall Study||4
9849262|NCT00863707|10961933|FG001|NOT COMPLETED|Overall Study||3
9849263|NCT00863746|10961941|FG000|STARTED|Treatment||350
9849264|NCT00863746|10961942|FG001|STARTED|Treatment||353
9849265|NCT00863746|10961941|FG000|Participants Received Treatment|Treatment|Safety population|346
9849266|NCT00863746|10961942|FG001|Participants Received Treatment|Treatment|Safety population|351
9849267|NCT00863746|10961941|FG000|COMPLETED|Treatment||279
9849268|NCT00863746|10961942|FG001|COMPLETED|Treatment||318
9849269|NCT00863746|10961941|FG000|NOT COMPLETED|Treatment||71
9849270|NCT00863746|10961942|FG001|NOT COMPLETED|Treatment||35
9849271|NCT00863746|10961941|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
9849272|NCT00863746|10961942|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
9963965|NCT01489891|11083801|FG001|COMPLETED|Overall Study||60
9963966|NCT01489891|11083800|FG000|NOT COMPLETED|Overall Study||1
10155442|NCT02885506|11286251|FG001|STARTED|Part B||0
10155443|NCT02885506|11286252|FG002|STARTED|Part B||0
10155444|NCT02885506|11286253|FG003|STARTED|Part B||0
10155445|NCT02885506|11286254|FG004|STARTED|Part B||0
10155446|NCT02885506|11286255|FG005|STARTED|Part B||0
10155447|NCT02885506|11286256|FG006|STARTED|Part B||0
10155448|NCT02885506|11286257|FG007|STARTED|Part B||0
10155449|NCT02885506|11286258|FG008|STARTED|Part B||4
10155450|NCT02885506|11286259|FG009|STARTED|Part B||4
10155451|NCT02885506|11286250|FG000|COMPLETED|Part B||0
10155452|NCT02885506|11286251|FG001|COMPLETED|Part B||0
10155453|NCT02885506|11286252|FG002|COMPLETED|Part B||0
10155454|NCT02885506|11286253|FG003|COMPLETED|Part B||0
10155455|NCT02885506|11286254|FG004|COMPLETED|Part B||0
10155456|NCT02885506|11286255|FG005|COMPLETED|Part B||0
10155457|NCT02885506|11286256|FG006|COMPLETED|Part B||0
10155458|NCT02885506|11286257|FG007|COMPLETED|Part B||0
10155459|NCT02885506|11286258|FG008|COMPLETED|Part B||4
10155460|NCT02885506|11286259|FG009|COMPLETED|Part B||4
10155461|NCT02885506|11286250|FG000|NOT COMPLETED|Part B||0
10155462|NCT02885506|11286251|FG001|NOT COMPLETED|Part B||0
10155463|NCT02885506|11286252|FG002|NOT COMPLETED|Part B||0
10155464|NCT02885506|11286253|FG003|NOT COMPLETED|Part B||0
10155465|NCT02885506|11286254|FG004|NOT COMPLETED|Part B||0
10155466|NCT02885506|11286255|FG005|NOT COMPLETED|Part B||0
10155467|NCT02885506|11286256|FG006|NOT COMPLETED|Part B||0
10155468|NCT02885506|11286257|FG007|NOT COMPLETED|Part B||0
10155469|NCT02885506|11286258|FG008|NOT COMPLETED|Part B||0
10155470|NCT02885506|11286259|FG009|NOT COMPLETED|Part B||0
10155471|NCT02885636|11286285|FG000|STARTED|Overall Study||15
10155472|NCT02885636|11286286|FG001|STARTED|Overall Study||15
10155473|NCT02885636|11286285|FG000|COMPLETED|Overall Study||15
10155474|NCT02885636|11286286|FG001|COMPLETED|Overall Study||15
10155475|NCT02885636|11286285|FG000|NOT COMPLETED|Overall Study||0
10155476|NCT02885636|11286286|FG001|NOT COMPLETED|Overall Study||0
10155477|NCT02886234|11286294|FG000|STARTED|Overall Study||20
10155478|NCT02886234|11286295|FG001|STARTED|Overall Study||24
10155479|NCT02886234|11286294|FG000|COMPLETED|Overall Study||20
10155480|NCT02886234|11286295|FG001|COMPLETED|Overall Study||22
10155481|NCT02886234|11286294|FG000|NOT COMPLETED|Overall Study||0
10155482|NCT02886234|11286295|FG001|NOT COMPLETED|Overall Study||2
10155483|NCT02886338|11286301|FG000|STARTED|Overall Study||10
10155484|NCT02886338|11286301|FG000|COMPLETED|Overall Study||9
10155485|NCT02886338|11286301|FG000|NOT COMPLETED|Overall Study||1
10155486|NCT02886494|11286307|FG000|STARTED|Overall Study||60
10155487|NCT02886494|11286308|FG001|STARTED|Overall Study||20
10155488|NCT02886494|11286307|FG000|COMPLETED|Overall Study||43
10155489|NCT02886494|11286308|FG001|COMPLETED|Overall Study||16
10155490|NCT02886494|11286307|FG000|NOT COMPLETED|Overall Study||17
10155491|NCT02886494|11286308|FG001|NOT COMPLETED|Overall Study||4
10155492|NCT02886624|11286317|FG000|STARTED|8-week Treatment||30
10155493|NCT02886624|11286317|FG000|COMPLETED|8-week Treatment||30
10155494|NCT02886624|11286317|FG000|NOT COMPLETED|8-week Treatment||0
10155495|NCT02886624|11286317|FG000|STARTED|12-week Post Treatment Follow-up||30
10155496|NCT02886624|11286317|FG000|COMPLETED|12-week Post Treatment Follow-up||29
10155497|NCT02886624|11286317|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1
10155498|NCT02886624|11286317|FG000|STARTED|48-week Post Treatment Follow-up||29
10155499|NCT02886624|11286317|FG000|COMPLETED|48-week Post Treatment Follow-up||28
10155500|NCT02886624|11286317|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1
10155501|NCT02886702|11286324|FG000|STARTED|Overall Study||284
10155502|NCT02886702|11286325|FG001|STARTED|Overall Study||286
10155503|NCT02886702|11286326|FG002|STARTED|Overall Study||285
10155504|NCT02886702|11286324|FG000|Modified Intent-to Treat (mITT)|Overall Study||263
10155505|NCT02886702|11286325|FG001|Modified Intent-to Treat (mITT)|Overall Study||266
10155506|NCT02886702|11286326|FG002|Modified Intent-to Treat (mITT)|Overall Study||275
10155507|NCT02886702|11286324|FG000|Per-Protocol Population (PP)|Overall Study||208
10155508|NCT02886702|11286325|FG001|Per-Protocol Population (PP)|Overall Study||209
10155509|NCT02886702|11286326|FG002|Per-Protocol Population (PP)|Overall Study||201
10155510|NCT02886702|11286324|FG000|COMPLETED|Overall Study||236
10155511|NCT02886702|11286325|FG001|COMPLETED|Overall Study||235
10155512|NCT02886702|11286326|FG002|COMPLETED|Overall Study||232
10155513|NCT02886702|11286324|FG000|NOT COMPLETED|Overall Study||48
10155514|NCT02886702|11286325|FG001|NOT COMPLETED|Overall Study||51
10155515|NCT02886702|11286326|FG002|NOT COMPLETED|Overall Study||53
10155516|NCT02886715|11286337|FG000|STARTED|Overall Study||442
10155517|NCT02886715|11286338|FG001|STARTED|Overall Study||445
10155518|NCT02886715|11286339|FG002|STARTED|Overall Study||223
10155519|NCT02886715|11286337|FG000|Modified ITT (mITT)|Overall Study||421
10155520|NCT02886715|11286338|FG001|Modified ITT (mITT)|Overall Study||418
10155521|NCT02886715|11286339|FG002|Modified ITT (mITT)|Overall Study||217
10155522|NCT02886715|11286337|FG000|Per Protocol (PP) Population|Overall Study||346
10155523|NCT02886715|11286338|FG001|Per Protocol (PP) Population|Overall Study||351
10155524|NCT02886715|11286339|FG002|Per Protocol (PP) Population|Overall Study||176
10155525|NCT02886715|11286337|FG000|COMPLETED|Overall Study||378
10155526|NCT02886715|11286338|FG001|COMPLETED|Overall Study||390
10155527|NCT02886715|11286339|FG002|COMPLETED|Overall Study||203
10155528|NCT02886715|11286337|FG000|NOT COMPLETED|Overall Study||64
10155529|NCT02886715|11286338|FG001|NOT COMPLETED|Overall Study||55
10155530|NCT02886715|11286339|FG002|NOT COMPLETED|Overall Study||20
10155531|NCT02886728|11286351|FG000|STARTED|Overall Study||417
10155532|NCT02886728|11286352|FG001|STARTED|Overall Study||207
10155533|NCT02886728|11286353|FG002|STARTED|Overall Study||210
10155534|NCT02886728|11286354|FG003|STARTED|Overall Study||418
10155535|NCT02886728|11286351|FG000|COMPLETED|Overall Study||345
10155536|NCT02886728|11286352|FG001|COMPLETED|Overall Study||175
10155537|NCT02886728|11286353|FG002|COMPLETED|Overall Study||174
10155538|NCT02886728|11286354|FG003|COMPLETED|Overall Study||331
10155539|NCT02886728|11286351|FG000|NOT COMPLETED|Overall Study||72
10155540|NCT02886728|11286352|FG001|NOT COMPLETED|Overall Study||32
10155541|NCT02886728|11286353|FG002|NOT COMPLETED|Overall Study||36
10155542|NCT02886728|11286354|FG003|NOT COMPLETED|Overall Study||87
10155543|NCT02886923|11286364|FG000|STARTED|Period 1||12
10155544|NCT02886923|11286365|FG001|STARTED|Period 1||11
10155545|NCT02886923|11286364|FG000|COMPLETED|Period 1||12
10155546|NCT02886923|11286365|FG001|COMPLETED|Period 1||11
10155547|NCT02886923|11286364|FG000|NOT COMPLETED|Period 1||0
10155548|NCT02886923|11286365|FG001|NOT COMPLETED|Period 1||0
10155549|NCT02886923|11286364|FG000|STARTED|Period 2||12
10155550|NCT02886923|11286365|FG001|STARTED|Period 2||11
10155551|NCT02886923|11286364|FG000|COMPLETED|Period 2||12
10155552|NCT02886923|11286365|FG001|COMPLETED|Period 2||11
10155553|NCT02886923|11286364|FG000|NOT COMPLETED|Period 2||0
10155554|NCT02886923|11286365|FG001|NOT COMPLETED|Period 2||0
10155555|NCT02887183|11286371|FG000|STARTED|Overall Study||795
10155556|NCT02887183|11286371|FG000|Full Analysis Set|Overall Study||794
10155557|NCT02887183|11286371|FG000|COMPLETED|Overall Study||654
10155558|NCT02887183|11286371|FG000|NOT COMPLETED|Overall Study||141
10155559|NCT02887404|11286377|FG000|STARTED|Overall Study||150
10155560|NCT02887404|11286378|FG001|STARTED|Overall Study||149
10155561|NCT02887404|11286377|FG000|COMPLETED|Overall Study||150
10155562|NCT02887404|11286378|FG001|COMPLETED|Overall Study||149
10155563|NCT02887404|11286377|FG000|NOT COMPLETED|Overall Study||0
10155564|NCT02887404|11286378|FG001|NOT COMPLETED|Overall Study||0
9710219|NCT04698993|10809753|FG000|NOT COMPLETED|Overall Study||3
9710220|NCT04698993|10809754|FG001|NOT COMPLETED|Overall Study||7
9730023|NCT00122460|10829666|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
9730024|NCT00122460|10829667|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
9730025|NCT00122460|10829666|FG000|COMPLETED|Overall Study||215
9730026|NCT00122460|10829667|FG001|COMPLETED|Overall Study||219
9730027|NCT00122460|10829666|FG000|NOT COMPLETED|Overall Study||7
9730028|NCT00122460|10829667|FG001|NOT COMPLETED|Overall Study||1
9730029|NCT00122681|10829675|FG000|STARTED|Overall Study||9325
9730030|NCT00122681|10829676|FG001|STARTED|Overall Study||9319
9730031|NCT00122681|10829675|FG000|COMPLETED|Overall Study||7811
9730032|NCT00122681|10829676|FG001|COMPLETED|Overall Study||7798
9730033|NCT00122681|10829675|FG000|NOT COMPLETED|Overall Study||1514
9730034|NCT00122681|10829676|FG001|NOT COMPLETED|Overall Study||1521
9730035|NCT00122954|10829692|FG000|STARTED|Overall Study||18
9730036|NCT00122954|10829693|FG001|STARTED|Overall Study||21
9730037|NCT00122954|10829692|FG000|COMPLETED|Overall Study||16
9730038|NCT00122954|10829693|FG001|COMPLETED|Overall Study||18
9730039|NCT00122954|10829692|FG000|NOT COMPLETED|Overall Study||2
9730040|NCT00122954|10829693|FG001|NOT COMPLETED|Overall Study||3
9730041|NCT00122980|10829701|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
9730042|NCT00122980|10829702|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
9730043|NCT00122980|10829701|FG000|COMPLETED|Overall Study|Study terminated early|24
9730044|NCT00122980|10829702|FG001|COMPLETED|Overall Study|Study terminated early|26
9730045|NCT00122980|10829701|FG000|NOT COMPLETED|Overall Study||43
9730046|NCT00122980|10829702|FG001|NOT COMPLETED|Overall Study||40
9730047|NCT00123110|10829711|FG000|STARTED|Overall Study||12
9849273|NCT00863746|10961941|FG000|COMPLETED|Survival Follow up||45
9849274|NCT00863746|10961942|FG001|COMPLETED|Survival Follow up||51
9849275|NCT00863746|10961941|FG000|NOT COMPLETED|Survival Follow up||253
9849276|NCT00863746|10961942|FG001|NOT COMPLETED|Survival Follow up||280
9849277|NCT00863772|10961951|FG000|STARTED|Overall Study||74
9849278|NCT00863772|10961952|FG001|STARTED|Overall Study||74
10155565|NCT02887521|11286387|FG000|STARTED|Overall Study||4
10155566|NCT02887521|11286388|FG001|STARTED|Overall Study||5
10155567|NCT02887521|11286387|FG000|COMPLETED|Overall Study||4
10155568|NCT02887521|11286388|FG001|COMPLETED|Overall Study||2
9849279|NCT00863772|10961953|FG002|STARTED|Overall Study||72
9849280|NCT00863772|10961951|FG000|Treated|Overall Study||73
9849281|NCT00863772|10961952|FG001|Treated|Overall Study||74
9849282|NCT00863772|10961953|FG002|Treated|Overall Study||72
10155569|NCT02887521|11286387|FG000|NOT COMPLETED|Overall Study||0
10155570|NCT02887521|11286388|FG001|NOT COMPLETED|Overall Study||3
10155571|NCT02887989|11286396|FG000|STARTED|Overall Study||70
10155572|NCT02887989|11286397|FG001|STARTED|Overall Study||70
10155573|NCT02887989|11286396|FG000|COMPLETED|Overall Study||61
10155574|NCT02887989|11286397|FG001|COMPLETED|Overall Study||59
10155575|NCT02887989|11286396|FG000|NOT COMPLETED|Overall Study||9
9730048|NCT00123110|10829712|FG001|STARTED|Overall Study||12
9730049|NCT00123110|10829713|FG002|STARTED|Overall Study||11
9849283|NCT00863772|10961951|FG000|COMPLETED|Overall Study||6
9849284|NCT00863772|10961952|FG001|COMPLETED|Overall Study||9
9849285|NCT00863772|10961953|FG002|COMPLETED|Overall Study||11
10155576|NCT02887989|11286397|FG001|NOT COMPLETED|Overall Study||11
10155577|NCT02888080|11286405|FG000|STARTED|Overall Study||20
10155578|NCT02888080|11286406|FG001|STARTED|Overall Study||20
10155579|NCT02888080|11286405|FG000|COMPLETED|Overall Study||18
10155580|NCT02888080|11286406|FG001|COMPLETED|Overall Study||15
10155581|NCT02888080|11286405|FG000|NOT COMPLETED|Overall Study||2
10155582|NCT02888080|11286406|FG001|NOT COMPLETED|Overall Study||5
10155583|NCT02888093|11286414|FG000|STARTED|Overall Study||22
10155584|NCT02888093|11286415|FG001|STARTED|Overall Study||22
10155585|NCT02888093|11286414|FG000|COMPLETED|Overall Study||20
10155586|NCT02888093|11286415|FG001|COMPLETED|Overall Study||20
10155587|NCT02888093|11286414|FG000|NOT COMPLETED|Overall Study||2
10155588|NCT02888093|11286415|FG001|NOT COMPLETED|Overall Study||2
10155589|NCT02888106|11286429|FG000|STARTED|Overall Study||15
10155590|NCT02888106|11286430|FG001|STARTED|Overall Study||15
10155591|NCT02888106|11286431|FG002|STARTED|Overall Study||15
10155592|NCT02888106|11286432|FG003|STARTED|Overall Study||15
10155593|NCT02888106|11286433|FG004|STARTED|Overall Study||15
10155594|NCT02888106|11286434|FG005|STARTED|Overall Study||15
10155595|NCT02888106|11286429|FG000|COMPLETED|Overall Study||10
10155596|NCT02888106|11286430|FG001|COMPLETED|Overall Study||13
10155597|NCT02888106|11286431|FG002|COMPLETED|Overall Study||15
10155598|NCT02888106|11286432|FG003|COMPLETED|Overall Study||13
10155599|NCT02888106|11286433|FG004|COMPLETED|Overall Study||14
10155600|NCT02888106|11286434|FG005|COMPLETED|Overall Study||14
10155601|NCT02888106|11286429|FG000|NOT COMPLETED|Overall Study||5
10155602|NCT02888106|11286430|FG001|NOT COMPLETED|Overall Study||2
10155603|NCT02888106|11286431|FG002|NOT COMPLETED|Overall Study||0
9710221|NCT04697888|10809760|FG000|STARTED|Overall Study||2
9710222|NCT04697888|10809760|FG000|COMPLETED|Overall Study||2
9710223|NCT04697888|10809760|FG000|NOT COMPLETED|Overall Study||0
9730050|NCT00123110|10829711|FG000|COMPLETED|Overall Study||12
9730051|NCT00123110|10829712|FG001|COMPLETED|Overall Study||12
9730052|NCT00123110|10829713|FG002|COMPLETED|Overall Study||11
9730053|NCT00123110|10829711|FG000|NOT COMPLETED|Overall Study||0
9730054|NCT00123110|10829712|FG001|NOT COMPLETED|Overall Study||0
9730055|NCT00123110|10829713|FG002|NOT COMPLETED|Overall Study||0
9730056|NCT00123123|10829724|FG000|STARTED|Overall Study||59
9730057|NCT00123123|10829725|FG001|STARTED|Overall Study||58
9730058|NCT00123123|10829726|FG002|STARTED|Overall Study||58
9730059|NCT00123123|10829724|FG000|COMPLETED|Overall Study||59
9730060|NCT00123123|10829725|FG001|COMPLETED|Overall Study||58
9730061|NCT00123123|10829726|FG002|COMPLETED|Overall Study||58
9730062|NCT00123123|10829724|FG000|NOT COMPLETED|Overall Study||0
9730063|NCT00123123|10829725|FG001|NOT COMPLETED|Overall Study||0
9730064|NCT00123123|10829726|FG002|NOT COMPLETED|Overall Study||0
9730065|NCT00123162|10829736|FG000|STARTED|Overall Study||13
9730066|NCT00123162|10829737|FG001|STARTED|Overall Study||12
9730067|NCT00123162|10829736|FG000|COMPLETED|Overall Study||13
9730068|NCT00123162|10829737|FG001|COMPLETED|Overall Study||12
9730069|NCT00123162|10829736|FG000|NOT COMPLETED|Overall Study||0
9730070|NCT00123162|10829737|FG001|NOT COMPLETED|Overall Study||0
9730071|NCT00123409|10829745|FG000|STARTED|Overall Study||72
9730072|NCT00123409|10829746|FG001|STARTED|Overall Study||74
9730073|NCT00123409|10829745|FG000|COMPLETED|Overall Study||68
9730074|NCT00123409|10829746|FG001|COMPLETED|Overall Study||71
9730075|NCT00123409|10829745|FG000|NOT COMPLETED|Overall Study||4
9730076|NCT00123409|10829746|FG001|NOT COMPLETED|Overall Study||3
9730077|NCT00123422|10829757|FG000|STARTED|Overall Study||35
9730078|NCT00123422|10829758|FG001|STARTED|Overall Study||33
9730079|NCT00123422|10829759|FG002|STARTED|Overall Study||35
9730080|NCT00123422|10829757|FG000|8-week Testing|Overall Study||32
9730081|NCT00123422|10829758|FG001|8-week Testing|Overall Study||30
9730082|NCT00123422|10829759|FG002|8-week Testing|Overall Study||27
9730083|NCT00123422|10829757|FG000|COMPLETED|Overall Study||31
9730084|NCT00123422|10829758|FG001|COMPLETED|Overall Study||27
9730085|NCT00123422|10829759|FG002|COMPLETED|Overall Study||25
9730086|NCT00123422|10829757|FG000|NOT COMPLETED|Overall Study||4
9730087|NCT00123422|10829758|FG001|NOT COMPLETED|Overall Study||6
9730088|NCT00123422|10829759|FG002|NOT COMPLETED|Overall Study||10
9730089|NCT00123474|10829771|FG000|STARTED|Randomized to Treatment||167
9730090|NCT00123474|10829772|FG001|STARTED|Randomized to Treatment||167
9730091|NCT00123474|10829773|FG002|STARTED|Randomized to Treatment||168
9730092|NCT00123474|10829774|FG003|STARTED|Randomized to Treatment||168
9730093|NCT00123474|10829771|FG000|COMPLETED|Randomized to Treatment||166
9730094|NCT00123474|10829772|FG001|COMPLETED|Randomized to Treatment||163
9730095|NCT00123474|10829773|FG002|COMPLETED|Randomized to Treatment||166
9730096|NCT00123474|10829774|FG003|COMPLETED|Randomized to Treatment||167
9730097|NCT00123474|10829771|FG000|NOT COMPLETED|Randomized to Treatment||1
9730098|NCT00123474|10829772|FG001|NOT COMPLETED|Randomized to Treatment||4
9730099|NCT00123474|10829773|FG002|NOT COMPLETED|Randomized to Treatment||2
9730100|NCT00123474|10829774|FG003|NOT COMPLETED|Randomized to Treatment||1
9730101|NCT00123474|10829771|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
9730102|NCT00123474|10829772|FG001|STARTED|As Treated at Study Closure||163
9730103|NCT00123474|10829773|FG002|STARTED|As Treated at Study Closure||167
9849286|NCT00863772|10961951|FG000|NOT COMPLETED|Overall Study||68
9730104|NCT00123474|10829774|FG003|STARTED|As Treated at Study Closure||167
9730105|NCT00123474|10829771|FG000|COMPLETED|As Treated at Study Closure||0
10155604|NCT02888106|11286432|FG003|NOT COMPLETED|Overall Study||2
10155605|NCT02888106|11286433|FG004|NOT COMPLETED|Overall Study||1
10155606|NCT02888106|11286434|FG005|NOT COMPLETED|Overall Study||1
10155607|NCT02888171|11286456|FG000|STARTED|Overall Study||30
10155608|NCT02888171|11286457|FG001|STARTED|Overall Study||30
10155609|NCT02888171|11286456|FG000|COMPLETED|Overall Study||25
10155610|NCT02888171|11286457|FG001|COMPLETED|Overall Study||26
10155611|NCT02888171|11286456|FG000|NOT COMPLETED|Overall Study||5
10155612|NCT02888171|11286457|FG001|NOT COMPLETED|Overall Study||4
10155613|NCT02888665|11286466|FG000|STARTED|Overall Study||3
10155614|NCT02888665|11286467|FG001|STARTED|Overall Study||3
10155615|NCT02888665|11286468|FG002|STARTED|Overall Study||31
10155616|NCT02888665|11286466|FG000|COMPLETED|Overall Study||3
10155617|NCT02888665|11286467|FG001|COMPLETED|Overall Study||3
10155618|NCT02888665|11286468|FG002|COMPLETED|Overall Study||31
10155619|NCT02888665|11286466|FG000|NOT COMPLETED|Overall Study||0
10155620|NCT02888665|11286467|FG001|NOT COMPLETED|Overall Study||0
10155621|NCT02888665|11286468|FG002|NOT COMPLETED|Overall Study||0
10155622|NCT02888691|11286477|FG000|STARTED|First Intervention Period||7
10155623|NCT02888691|11286478|FG001|STARTED|First Intervention Period||7
10155624|NCT02888691|11286477|FG000|COMPLETED|First Intervention Period||6
10155625|NCT02888691|11286478|FG001|COMPLETED|First Intervention Period||7
10155626|NCT02888691|11286477|FG000|NOT COMPLETED|First Intervention Period||1
10155627|NCT02888691|11286478|FG001|NOT COMPLETED|First Intervention Period||0
10155628|NCT02888691|11286477|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
10155629|NCT02888691|11286478|FG001|STARTED|Second Intervention Period||5
10155630|NCT02888691|11286477|FG000|COMPLETED|Second Intervention Period||7
10155631|NCT02888691|11286478|FG001|COMPLETED|Second Intervention Period||3
10155632|NCT02888691|11286477|FG000|NOT COMPLETED|Second Intervention Period||0
10155633|NCT02888691|11286478|FG001|NOT COMPLETED|Second Intervention Period||2
10155634|NCT02888756|11286487|FG000|STARTED|Vaccination Period||16
10155635|NCT02888756|11286488|FG001|STARTED|Vaccination Period||9
10155636|NCT02888756|11286489|FG002|STARTED|Vaccination Period||8
10155637|NCT02888756|11286487|FG000|COMPLETED|Vaccination Period||16
10155638|NCT02888756|11286488|FG001|COMPLETED|Vaccination Period||9
10155639|NCT02888756|11286489|FG002|COMPLETED|Vaccination Period||8
10155640|NCT02888756|11286487|FG000|NOT COMPLETED|Vaccination Period||0
10155641|NCT02888756|11286488|FG001|NOT COMPLETED|Vaccination Period||0
10155642|NCT02888756|11286489|FG002|NOT COMPLETED|Vaccination Period||0
10155643|NCT02888756|11286487|FG000|STARTED|Analytical Treatment Interruption||15
10155644|NCT02888756|11286488|FG001|STARTED|Analytical Treatment Interruption||9
10155645|NCT02888756|11286489|FG002|STARTED|Analytical Treatment Interruption||8
10155646|NCT02888756|11286487|FG000|COMPLETED|Analytical Treatment Interruption||5
10155647|NCT02888756|11286488|FG001|COMPLETED|Analytical Treatment Interruption||3
10155648|NCT02888756|11286489|FG002|COMPLETED|Analytical Treatment Interruption||3
10155649|NCT02888756|11286487|FG000|NOT COMPLETED|Analytical Treatment Interruption||10
10155650|NCT02888756|11286488|FG001|NOT COMPLETED|Analytical Treatment Interruption||6
10155651|NCT02888756|11286489|FG002|NOT COMPLETED|Analytical Treatment Interruption||5
10155652|NCT02889289|11286497|FG000|STARTED|Overall Study||1
10155653|NCT02889289|11286497|FG000|COMPLETED|Overall Study||1
10155654|NCT02889289|11286497|FG000|NOT COMPLETED|Overall Study||0
10155655|NCT02889393|11286503|FG000|STARTED|Overall Study||3
10155656|NCT02889393|11286504|FG001|STARTED|Overall Study||3
10155657|NCT02889393|11286503|FG000|COMPLETED|Overall Study||3
10155658|NCT02889393|11286504|FG001|COMPLETED|Overall Study||3
10155659|NCT02889393|11286503|FG000|NOT COMPLETED|Overall Study||0
10155660|NCT02889393|11286504|FG001|NOT COMPLETED|Overall Study||0
10155661|NCT02889510|11286511|FG000|STARTED|Overall Study||35
10155662|NCT02889510|11286512|FG001|STARTED|Overall Study||37
10155663|NCT02889510|11286511|FG000|COMPLETED|Overall Study||27
10155664|NCT02889510|11286512|FG001|COMPLETED|Overall Study||32
10155665|NCT02889510|11286511|FG000|NOT COMPLETED|Overall Study||8
10155666|NCT02889510|11286512|FG001|NOT COMPLETED|Overall Study||5
10155667|NCT02889562|11286520|FG000|STARTED|Overall Study||28
10155668|NCT02889562|11286521|FG001|STARTED|Overall Study||28
10155669|NCT02889562|11286520|FG000|COMPLETED|Overall Study||28
10155670|NCT02889562|11286521|FG001|COMPLETED|Overall Study||26
10155671|NCT02889562|11286520|FG000|NOT COMPLETED|Overall Study||0
10155672|NCT02889562|11286521|FG001|NOT COMPLETED|Overall Study||2
10155673|NCT02889796|11286531|FG000|STARTED|Overall Study||477
10155674|NCT02889796|11286532|FG001|STARTED|Overall Study||480
10155675|NCT02889796|11286533|FG002|STARTED|Overall Study||325
10155676|NCT02889796|11286534|FG003|STARTED|Overall Study||190
10155677|NCT02889796|11286535|FG004|STARTED|Overall Study||191
10155678|NCT02889796|11286536|FG005|STARTED|Overall Study||96
10155679|NCT02889796|11286531|FG000|COMPLETED|Overall Study||424
10155680|NCT02889796|11286532|FG001|COMPLETED|Overall Study||422
10155681|NCT02889796|11286533|FG002|COMPLETED|Overall Study||281
10155682|NCT02889796|11286534|FG003|COMPLETED|Overall Study||181
10155683|NCT02889796|11286535|FG004|COMPLETED|Overall Study||185
10155684|NCT02889796|11286536|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
10155685|NCT02889796|11286531|FG000|NOT COMPLETED|Overall Study||53
10155686|NCT02889796|11286532|FG001|NOT COMPLETED|Overall Study||58
10155687|NCT02889796|11286533|FG002|NOT COMPLETED|Overall Study||44
10155688|NCT02889796|11286534|FG003|NOT COMPLETED|Overall Study||9
10155689|NCT02889796|11286535|FG004|NOT COMPLETED|Overall Study||6
10155690|NCT02889796|11286536|FG005|NOT COMPLETED|Overall Study||72
10155691|NCT02889861|11286559|FG000|STARTED|Overall Study||3
10155692|NCT02889861|11286559|FG000|COMPLETED|Overall Study||1
10155693|NCT02889861|11286559|FG000|NOT COMPLETED|Overall Study||2
10155694|NCT02890303|11286568|FG000|STARTED|Overall Study||100
10155695|NCT02890303|11286568|FG000|COMPLETED|Overall Study||100
10155696|NCT02890303|11286568|FG000|NOT COMPLETED|Overall Study||0
10155697|NCT02890381|11286574|FG000|STARTED|Overall Study||11
10155698|NCT02890381|11286575|FG001|STARTED|Overall Study||6
10155699|NCT02890381|11286574|FG000|COMPLETED|Overall Study||11
10155700|NCT02890381|11286575|FG001|COMPLETED|Overall Study||6
10155701|NCT02890381|11286574|FG000|NOT COMPLETED|Overall Study||0
10155702|NCT02890381|11286575|FG001|NOT COMPLETED|Overall Study||0
10155703|NCT02890992|11286589|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4
10155704|NCT02890992|11286590|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6
10155705|NCT02890992|11286591|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4
10155706|NCT02890992|11286592|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6
10155707|NCT02890992|11286593|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6
10155708|NCT02890992|11286594|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5
10155709|NCT02890992|11286595|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6
10155710|NCT02890992|11286596|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5
10155711|NCT02890992|11286589|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4
10155712|NCT02890992|11286590|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6
10155713|NCT02890992|11286591|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4
10155714|NCT02890992|11286592|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6
10155715|NCT02890992|11286593|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6
10155716|NCT02890992|11286594|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5
10155717|NCT02890992|11286595|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6
10155718|NCT02890992|11286596|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5
10155719|NCT02890992|11286589|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
10155720|NCT02890992|11286590|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10155721|NCT02890992|11286591|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
10155722|NCT02890992|11286592|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10155723|NCT02890992|11286593|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10155724|NCT02890992|11286594|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
10155725|NCT02890992|11286595|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10155726|NCT02890992|11286596|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
10155727|NCT02890992|11286589|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155728|NCT02890992|11286590|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155729|NCT02890992|11286591|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155730|NCT02890992|11286592|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155731|NCT02890992|11286593|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155732|NCT02890992|11286594|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155733|NCT02890992|11286595|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155734|NCT02890992|11286596|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10155735|NCT02890992|11286589|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
10155736|NCT02890992|11286590|FG001|STARTED|130 Weeks Open-Label Extension Period||6
10155737|NCT02890992|11286591|FG002|STARTED|130 Weeks Open-Label Extension Period||4
10155738|NCT02890992|11286592|FG003|STARTED|130 Weeks Open-Label Extension Period||6
10155739|NCT02890992|11286593|FG004|STARTED|130 Weeks Open-Label Extension Period||6
10155740|NCT02890992|11286594|FG005|STARTED|130 Weeks Open-Label Extension Period||5
9710224|NCT04693078|10809764|FG000|STARTED|Overall Study||100
9710225|NCT04693078|10809764|FG000|COMPLETED|Overall Study||100
9710226|NCT04693078|10809764|FG000|NOT COMPLETED|Overall Study||0
9710227|NCT04688346|10809770|FG000|STARTED|Overall Study||6
9710228|NCT04688346|10809771|FG001|STARTED|Overall Study||7
9710229|NCT04688346|10809770|FG000|First Intervention|Overall Study||6
9710230|NCT04688346|10809771|FG001|First Intervention|Overall Study||7
9710231|NCT04688346|10809770|FG000|Second Intervention|Overall Study||6
9710232|NCT04688346|10809771|FG001|Second Intervention|Overall Study||7
9710233|NCT04688346|10809770|FG000|COMPLETED|Overall Study||6
9710234|NCT04688346|10809771|FG001|COMPLETED|Overall Study||7
9710235|NCT04688346|10809770|FG000|NOT COMPLETED|Overall Study||0
9710236|NCT04688346|10809771|FG001|NOT COMPLETED|Overall Study||0
9710237|NCT04684992|10809777|FG000|STARTED|Overall Study||36
9710238|NCT04684992|10809777|FG000|COMPLETED|Overall Study||34
9710239|NCT04684992|10809777|FG000|NOT COMPLETED|Overall Study||2
9710240|NCT04674644|10809781|FG000|STARTED|Overall Study||850
9710241|NCT04674644|10809781|FG000|COMPLETED|Overall Study||813
9710242|NCT04674644|10809781|FG000|NOT COMPLETED|Overall Study||37
9710251|NCT04668989|10809799|FG000|STARTED|First Intervention||36
9710252|NCT04668989|10809800|FG001|STARTED|First Intervention||30
9710253|NCT04668989|10809799|FG000|COMPLETED|First Intervention||36
9710254|NCT04668989|10809800|FG001|COMPLETED|First Intervention||29
9710255|NCT04668989|10809799|FG000|NOT COMPLETED|First Intervention||0
9710256|NCT04668989|10809800|FG001|NOT COMPLETED|First Intervention||1
9710257|NCT04668989|10809799|FG000|STARTED|Second Intervention||36
9710258|NCT04668989|10809800|FG001|STARTED|Second Intervention||29
9710259|NCT04668989|10809799|FG000|COMPLETED|Second Intervention||36
9710260|NCT04668989|10809800|FG001|COMPLETED|Second Intervention||28
9710261|NCT04668989|10809799|FG000|NOT COMPLETED|Second Intervention||0
9710262|NCT04668989|10809800|FG001|NOT COMPLETED|Second Intervention||1
9710263|NCT04668352|10809808|FG000|STARTED|Overall Study||511
9710264|NCT04668352|10809809|FG001|STARTED|Overall Study||513
9710265|NCT04668352|10809808|FG000|COMPLETED|Overall Study||510
9710266|NCT04668352|10809809|FG001|COMPLETED|Overall Study||511
9710267|NCT04668352|10809808|FG000|NOT COMPLETED|Overall Study||1
10155741|NCT02890992|11286595|FG006|STARTED|130 Weeks Open-Label Extension Period||6
10155742|NCT02890992|11286596|FG007|STARTED|130 Weeks Open-Label Extension Period||5
10155743|NCT02890992|11286589|FG000|Treated|130 Weeks Open-Label Extension Period||3
10155744|NCT02890992|11286590|FG001|Treated|130 Weeks Open-Label Extension Period||6
10155745|NCT02890992|11286591|FG002|Treated|130 Weeks Open-Label Extension Period||4
10155746|NCT02890992|11286592|FG003|Treated|130 Weeks Open-Label Extension Period||6
10155747|NCT02890992|11286593|FG004|Treated|130 Weeks Open-Label Extension Period||6
10155748|NCT02890992|11286594|FG005|Treated|130 Weeks Open-Label Extension Period||5
10155749|NCT02890992|11286595|FG006|Treated|130 Weeks Open-Label Extension Period||5
10155750|NCT02890992|11286596|FG007|Treated|130 Weeks Open-Label Extension Period||4
10155751|NCT02890992|11286589|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3
10155752|NCT02890992|11286590|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3
10155753|NCT02890992|11286591|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4
10155754|NCT02890992|11286592|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6
10155755|NCT02890992|11286593|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6
10155756|NCT02890992|11286594|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5
10155757|NCT02890992|11286595|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5
10155758|NCT02890992|11286596|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4
10155759|NCT02890992|11286589|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10155760|NCT02890992|11286590|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
10155761|NCT02890992|11286591|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10155762|NCT02890992|11286592|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10155763|NCT02890992|11286593|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10155764|NCT02890992|11286594|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10155765|NCT02890992|11286595|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
10155766|NCT02890992|11286596|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
10155767|NCT02891070|11286623|FG000|STARTED|Overall Study||110
10155768|NCT02891070|11286624|FG001|STARTED|Overall Study||114
10155769|NCT02891070|11286623|FG000|COMPLETED|Overall Study||100
10155770|NCT02891070|11286624|FG001|COMPLETED|Overall Study||106
10155771|NCT02891070|11286623|FG000|NOT COMPLETED|Overall Study||10
10155772|NCT02891070|11286624|FG001|NOT COMPLETED|Overall Study||8
9710243|NCT04673214|10809788|FG000|STARTED|Overall Study||67
9710244|NCT04673214|10809789|FG001|STARTED|Overall Study||47
9710245|NCT04673214|10809788|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
9710246|NCT04673214|10809789|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
9710247|NCT04673214|10809788|FG000|COMPLETED|Overall Study||65
9710248|NCT04673214|10809789|FG001|COMPLETED|Overall Study||46
9710249|NCT04673214|10809788|FG000|NOT COMPLETED|Overall Study||2
9710250|NCT04673214|10809789|FG001|NOT COMPLETED|Overall Study||1
9710268|NCT04668352|10809809|FG001|NOT COMPLETED|Overall Study||2
9730106|NCT00123474|10829772|FG001|COMPLETED|As Treated at Study Closure||0
9730107|NCT00123474|10829773|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
9730108|NCT00123474|10829774|FG003|COMPLETED|As Treated at Study Closure||0
9730109|NCT00123474|10829771|FG000|NOT COMPLETED|As Treated at Study Closure||165
9730110|NCT00123474|10829772|FG001|NOT COMPLETED|As Treated at Study Closure||163
9730111|NCT00123474|10829773|FG002|NOT COMPLETED|As Treated at Study Closure||167
9730112|NCT00123474|10829774|FG003|NOT COMPLETED|As Treated at Study Closure||167
9730113|NCT00123487|10829807|FG000|STARTED|Randomized||306
9730114|NCT00123487|10829808|FG001|STARTED|Randomized||305
9730115|NCT00123487|10829807|FG000|COMPLETED|Randomized||305
9730116|NCT00123487|10829808|FG001|COMPLETED|Randomized||304
9730117|NCT00123487|10829807|FG000|NOT COMPLETED|Randomized||1
9730118|NCT00123487|10829808|FG001|NOT COMPLETED|Randomized||1
9730119|NCT00123487|10829807|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
9730120|NCT00123487|10829808|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
9730121|NCT00123487|10829807|FG000|COMPLETED|Treated With Study Drug||0
9730122|NCT00123487|10829808|FG001|COMPLETED|Treated With Study Drug||0
9730123|NCT00123487|10829807|FG000|NOT COMPLETED|Treated With Study Drug||304
9730124|NCT00123487|10829808|FG001|NOT COMPLETED|Treated With Study Drug||305
9730125|NCT00123604|10829817|FG000|STARTED|Overall Study||19
9730126|NCT00123604|10829818|FG001|STARTED|Overall Study||17
9730127|NCT00123604|10829817|FG000|COMPLETED|Overall Study||18
9730128|NCT00123604|10829818|FG001|COMPLETED|Overall Study||16
9730129|NCT00123604|10829817|FG000|NOT COMPLETED|Overall Study||1
9730130|NCT00123604|10829818|FG001|NOT COMPLETED|Overall Study||1
9730131|NCT00123630|10829826|FG000|STARTED|Overall Study||15
9730132|NCT00123630|10829827|FG001|STARTED|Overall Study||15
10155773|NCT02891174|11286632|FG000|STARTED|First Intervention (24 Hours)||20
10155774|NCT02891174|11286633|FG001|STARTED|First Intervention (24 Hours)||23
10155775|NCT02891174|11286632|FG000|Received First Intervention|First Intervention (24 Hours)||19
10155776|NCT02891174|11286633|FG001|Received First Intervention|First Intervention (24 Hours)||18
10155777|NCT02891174|11286632|FG000|COMPLETED|First Intervention (24 Hours)||17
10155778|NCT02891174|11286633|FG001|COMPLETED|First Intervention (24 Hours)||10
10155779|NCT02891174|11286632|FG000|NOT COMPLETED|First Intervention (24 Hours)||3
10155780|NCT02891174|11286633|FG001|NOT COMPLETED|First Intervention (24 Hours)||13
10155781|NCT02891174|11286632|FG000|STARTED|Second Intervention (24 Hours)||17
10155782|NCT02891174|11286633|FG001|STARTED|Second Intervention (24 Hours)||10
10155783|NCT02891174|11286632|FG000|COMPLETED|Second Intervention (24 Hours)||11
10155784|NCT02891174|11286633|FG001|COMPLETED|Second Intervention (24 Hours)||3
10155785|NCT02891174|11286632|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6
10155786|NCT02891174|11286633|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7
10155787|NCT02891200|11286645|FG000|STARTED|Overall Study||145
10155788|NCT02891200|11286646|FG001|STARTED|Overall Study||147
10155789|NCT02891200|11286645|FG000|COMPLETED|Overall Study||103
10155790|NCT02891200|11286646|FG001|COMPLETED|Overall Study||98
10155791|NCT02891200|11286645|FG000|NOT COMPLETED|Overall Study||42
10155792|NCT02891200|11286646|FG001|NOT COMPLETED|Overall Study||49
10155793|NCT02891408|11286659|FG000|STARTED|Overall Study||10
10155794|NCT02891408|11286660|FG001|STARTED|Overall Study||10
10155795|NCT02891408|11286661|FG002|STARTED|Overall Study||14
10155796|NCT02891408|11286662|FG003|STARTED|Overall Study||10
10155797|NCT02891408|11286663|FG004|STARTED|Overall Study||10
10155798|NCT02891408|11286664|FG005|STARTED|Overall Study||10
10155799|NCT02891408|11286665|FG006|STARTED|Overall Study||10
10155800|NCT02891408|11286659|FG000|COMPLETED|Overall Study||10
10155801|NCT02891408|11286660|FG001|COMPLETED|Overall Study||10
10155802|NCT02891408|11286661|FG002|COMPLETED|Overall Study||13
10155803|NCT02891408|11286662|FG003|COMPLETED|Overall Study||10
10155804|NCT02891408|11286663|FG004|COMPLETED|Overall Study||10
10155805|NCT02891408|11286664|FG005|COMPLETED|Overall Study||10
10155806|NCT02891408|11286665|FG006|COMPLETED|Overall Study||10
10155807|NCT02891408|11286659|FG000|NOT COMPLETED|Overall Study||0
10155808|NCT02891408|11286660|FG001|NOT COMPLETED|Overall Study||0
10155809|NCT02891408|11286661|FG002|NOT COMPLETED|Overall Study||1
10155810|NCT02891408|11286662|FG003|NOT COMPLETED|Overall Study||0
10155811|NCT02891408|11286663|FG004|NOT COMPLETED|Overall Study||0
10155812|NCT02891408|11286664|FG005|NOT COMPLETED|Overall Study||0
10155813|NCT02891408|11286665|FG006|NOT COMPLETED|Overall Study||0
10155814|NCT02891629|11286693|FG000|STARTED|Overall Study||10
10155815|NCT02891629|11286694|FG001|STARTED|Overall Study||5
10155816|NCT02891629|11286693|FG000|COMPLETED|Overall Study||10
10155817|NCT02891629|11286694|FG001|COMPLETED|Overall Study||4
10155818|NCT02891629|11286693|FG000|NOT COMPLETED|Overall Study||0
10155819|NCT02891629|11286694|FG001|NOT COMPLETED|Overall Study||1
10155820|NCT02891681|11286703|FG000|STARTED|Overall Study||39
10155821|NCT02891681|11286704|FG001|STARTED|Overall Study||1
10155822|NCT02891681|11286705|FG002|STARTED|Overall Study||1
10155823|NCT02891681|11286703|FG000|COMPLETED|Overall Study||36
10155824|NCT02891681|11286704|FG001|COMPLETED|Overall Study||1
10155825|NCT02891681|11286705|FG002|COMPLETED|Overall Study||0
10155826|NCT02891681|11286703|FG000|NOT COMPLETED|Overall Study||3
10155827|NCT02891681|11286704|FG001|NOT COMPLETED|Overall Study||0
10155828|NCT02891681|11286705|FG002|NOT COMPLETED|Overall Study||1
10155829|NCT02891850|11286715|FG000|STARTED|Overall Study||111
10155830|NCT02891850|11286716|FG001|STARTED|Overall Study||114
10155831|NCT02891850|11286715|FG000|COMPLETED|Overall Study||104
10155832|NCT02891850|11286716|FG001|COMPLETED|Overall Study||107
10155833|NCT02891850|11286715|FG000|NOT COMPLETED|Overall Study||7
10155834|NCT02891850|11286716|FG001|NOT COMPLETED|Overall Study||7
10155835|NCT02891863|11286722|FG000|STARTED|Overall Study||9
10155836|NCT02891863|11286722|FG000|COMPLETED|Overall Study||9
10155837|NCT02891863|11286722|FG000|NOT COMPLETED|Overall Study||0
10155838|NCT02891915|11286728|FG000|STARTED|Overall Study||192
10155839|NCT02891915|11286729|FG001|STARTED|Overall Study||193
10155840|NCT02891915|11286728|FG000|COMPLETED|Overall Study||179
10155841|NCT02891915|11286729|FG001|COMPLETED|Overall Study||181
10155842|NCT02891915|11286728|FG000|NOT COMPLETED|Overall Study||13
10155843|NCT02891915|11286729|FG001|NOT COMPLETED|Overall Study||12
10155844|NCT02892019|11286737|FG000|STARTED|Overall Study||41
10155845|NCT02892019|11286738|FG001|STARTED|Overall Study||39
10155846|NCT02892019|11286737|FG000|COMPLETED|Overall Study||40
10155847|NCT02892019|11286738|FG001|COMPLETED|Overall Study||36
10155848|NCT02892019|11286737|FG000|NOT COMPLETED|Overall Study||1
10155849|NCT02892019|11286738|FG001|NOT COMPLETED|Overall Study||3
10155850|NCT02892110|11286746|FG000|STARTED|Overall Study||35
10155851|NCT02892110|11286747|FG001|STARTED|Overall Study||37
10155852|NCT02892110|11286746|FG000|COMPLETED|Overall Study||22
10155853|NCT02892110|11286747|FG001|COMPLETED|Overall Study||25
10155854|NCT02892110|11286746|FG000|NOT COMPLETED|Overall Study||13
10155855|NCT02892110|11286747|FG001|NOT COMPLETED|Overall Study||12
10197265|NCT03372382|11325230|FG000|COMPLETED|Overall Study||76
10197266|NCT03372382|11325231|FG001|COMPLETED|Overall Study||81
10197267|NCT03372382|11325230|FG000|NOT COMPLETED|Overall Study||9
10197268|NCT03372382|11325231|FG001|NOT COMPLETED|Overall Study||4
10197269|NCT03372434|11325242|FG000|STARTED|Overall Study||78
10197270|NCT03372434|11325243|FG001|STARTED|Overall Study||73
10197271|NCT03372434|11325244|FG002|STARTED|Overall Study||74
10197272|NCT03372434|11325242|FG000|1 Month Follow-up|Overall Study||76
10197273|NCT03372434|11325243|FG001|1 Month Follow-up|Overall Study||72
10197274|NCT03372434|11325244|FG002|1 Month Follow-up|Overall Study||73
10155856|NCT02892344|11286755|FG000|STARTED|Overall Study||398
10155857|NCT02892344|11286756|FG001|STARTED|Overall Study||404
10155858|NCT02892344|11286755|FG000|Full Analysis Set|Overall Study||395
10155859|NCT02892344|11286756|FG001|Full Analysis Set|Overall Study||399
10155860|NCT02892344|11286755|FG000|COMPLETED|Overall Study||394
10155861|NCT02892344|11286756|FG001|COMPLETED|Overall Study||383
10155862|NCT02892344|11286755|FG000|NOT COMPLETED|Overall Study||4
10155863|NCT02892344|11286756|FG001|NOT COMPLETED|Overall Study||21
10155864|NCT02892409|11286764|FG000|STARTED|Overall Study||15
10155865|NCT02892409|11286765|FG001|STARTED|Overall Study||15
10155866|NCT02892409|11286764|FG000|COMPLETED|Overall Study||12
10155867|NCT02892409|11286765|FG001|COMPLETED|Overall Study||14
10155868|NCT02892409|11286764|FG000|NOT COMPLETED|Overall Study||3
10155869|NCT02892409|11286765|FG001|NOT COMPLETED|Overall Study||1
10155870|NCT02892422|11286771|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
10155871|NCT02892422|11286771|FG000|COMPLETED|Overall Study||318
10155872|NCT02892422|11286771|FG000|NOT COMPLETED|Overall Study||210
10155873|NCT02892448|11286778|FG000|STARTED|Overall Study||12
10155874|NCT02892448|11286779|FG001|STARTED|Overall Study||12
10155875|NCT02892448|11286780|FG002|STARTED|Overall Study||11
10155876|NCT02892448|11286778|FG000|COMPLETED|Overall Study||10
10155877|NCT02892448|11286779|FG001|COMPLETED|Overall Study||10
10155878|NCT02892448|11286780|FG002|COMPLETED|Overall Study||10
10155879|NCT02892448|11286778|FG000|NOT COMPLETED|Overall Study||2
10155880|NCT02892448|11286779|FG001|NOT COMPLETED|Overall Study||2
10155881|NCT02892448|11286780|FG002|NOT COMPLETED|Overall Study||1
10155882|NCT02892513|11286790|FG000|STARTED|Overall Study||28
10155883|NCT02892513|11286791|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
10155884|NCT02892513|11286790|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
10155885|NCT02892513|11286791|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
10155886|NCT02892513|11286790|FG000|NOT COMPLETED|Overall Study||0
10155887|NCT02892513|11286791|FG001|NOT COMPLETED|Overall Study||1
10155888|NCT02892734|11286797|FG000|STARTED|Treatment on Study||3
10155889|NCT02892734|11286797|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
10155890|NCT02892734|11286797|FG000|Went on to Start Cycle 2|Treatment on Study||1
10155891|NCT02892734|11286797|FG000|COMPLETED|Treatment on Study||1
10155892|NCT02892734|11286797|FG000|NOT COMPLETED|Treatment on Study||2
10155893|NCT02892734|11286797|FG000|STARTED|Follow up for 2 Years||3
10155894|NCT02892734|11286797|FG000|COMPLETED|Follow up for 2 Years||0
10155895|NCT02892734|11286797|FG000|NOT COMPLETED|Follow up for 2 Years||3
10155896|NCT02892760|11286801|FG000|STARTED|Overall Study||17
10155897|NCT02892760|11286801|FG000|Received Intervention|Overall Study||15
10155898|NCT02892760|11286801|FG000|COMPLETED|Overall Study||14
10155899|NCT02892760|11286801|FG000|NOT COMPLETED|Overall Study||3
10155900|NCT02893878|11286808|FG000|STARTED|Overall Study||13861
10155901|NCT02893878|11286809|FG001|STARTED|Overall Study||2295
10155902|NCT02893878|11286810|FG002|STARTED|Overall Study||3178
10155903|NCT02893878|11286808|FG000|COMPLETED|Overall Study||13861
10155904|NCT02893878|11286809|FG001|COMPLETED|Overall Study||2295
10155905|NCT02893878|11286810|FG002|COMPLETED|Overall Study||3178
10155906|NCT02893878|11286808|FG000|NOT COMPLETED|Overall Study||0
10155907|NCT02893878|11286809|FG001|NOT COMPLETED|Overall Study||0
10155908|NCT02893878|11286810|FG002|NOT COMPLETED|Overall Study||0
10155909|NCT02894502|11286824|FG000|STARTED|Baseline||155
10155910|NCT02894502|11286825|FG001|STARTED|Baseline||177
10155911|NCT02894502|11286826|FG002|STARTED|Baseline||178
10155912|NCT02894502|11286824|FG000|COMPLETED|Baseline||128
10155913|NCT02894502|11286825|FG001|COMPLETED|Baseline||145
10155914|NCT02894502|11286826|FG002|COMPLETED|Baseline||133
10155915|NCT02894502|11286824|FG000|NOT COMPLETED|Baseline||27
10155916|NCT02894502|11286825|FG001|NOT COMPLETED|Baseline||32
10155917|NCT02894502|11286826|FG002|NOT COMPLETED|Baseline||45
10155918|NCT02894502|11286824|FG000|STARTED|First Follow up||128
10155919|NCT02894502|11286825|FG001|STARTED|First Follow up||145
10155920|NCT02894502|11286826|FG002|STARTED|First Follow up||133
10155921|NCT02894502|11286824|FG000|COMPLETED|First Follow up||94
10155922|NCT02894502|11286825|FG001|COMPLETED|First Follow up||114
10155923|NCT02894502|11286826|FG002|COMPLETED|First Follow up||93
10155924|NCT02894502|11286824|FG000|NOT COMPLETED|First Follow up||34
10155925|NCT02894502|11286825|FG001|NOT COMPLETED|First Follow up||31
10155926|NCT02894502|11286826|FG002|NOT COMPLETED|First Follow up||40
10155927|NCT02894502|11286824|FG000|STARTED|Second Follow up||94
10155928|NCT02894502|11286825|FG001|STARTED|Second Follow up||114
10155929|NCT02894502|11286826|FG002|STARTED|Second Follow up||93
10155930|NCT02894502|11286824|FG000|COMPLETED|Second Follow up||79
10155931|NCT02894502|11286825|FG001|COMPLETED|Second Follow up||96
10155932|NCT02894502|11286826|FG002|COMPLETED|Second Follow up||79
10155933|NCT02894502|11286824|FG000|NOT COMPLETED|Second Follow up||15
10155934|NCT02894502|11286825|FG001|NOT COMPLETED|Second Follow up||18
10155935|NCT02894502|11286826|FG002|NOT COMPLETED|Second Follow up||14
10155936|NCT02894502|11286824|FG000|STARTED|Third Follow up||79
10155937|NCT02894502|11286825|FG001|STARTED|Third Follow up||96
10155938|NCT02894502|11286826|FG002|STARTED|Third Follow up||79
10155939|NCT02894502|11286824|FG000|COMPLETED|Third Follow up||73
10155940|NCT02894502|11286825|FG001|COMPLETED|Third Follow up||89
10155941|NCT02894502|11286826|FG002|COMPLETED|Third Follow up||76
10155942|NCT02894502|11286824|FG000|NOT COMPLETED|Third Follow up||6
10155943|NCT02894502|11286825|FG001|NOT COMPLETED|Third Follow up||7
10155944|NCT02894502|11286826|FG002|NOT COMPLETED|Third Follow up||3
10155945|NCT02894840|11286841|FG000|STARTED|Overall Study||20
10155946|NCT02894840|11286842|FG001|STARTED|Overall Study||20
10155947|NCT02894840|11286843|FG002|STARTED|Overall Study||200
10155948|NCT02894840|11286844|FG003|STARTED|Overall Study||100
10155949|NCT02894840|11286841|FG000|COMPLETED|Overall Study||19
10155950|NCT02894840|11286842|FG001|COMPLETED|Overall Study||20
10155951|NCT02894840|11286843|FG002|COMPLETED|Overall Study||197
10155952|NCT02894840|11286844|FG003|COMPLETED|Overall Study||100
10155953|NCT02894840|11286841|FG000|NOT COMPLETED|Overall Study||1
10155954|NCT02894840|11286842|FG001|NOT COMPLETED|Overall Study||0
10155955|NCT02894840|11286843|FG002|NOT COMPLETED|Overall Study||3
10155956|NCT02894840|11286844|FG003|NOT COMPLETED|Overall Study||0
10155957|NCT02895035|11286859|FG000|STARTED|Overall Study||23
10155958|NCT02895035|11286860|FG001|STARTED|Overall Study||36
10155959|NCT02895035|11286859|FG000|COMPLETED|Overall Study||18
10155960|NCT02895035|11286860|FG001|COMPLETED|Overall Study||24
10155961|NCT02895035|11286859|FG000|NOT COMPLETED|Overall Study||5
10155962|NCT02895035|11286860|FG001|NOT COMPLETED|Overall Study||12
10155963|NCT02895100|11286870|FG000|STARTED|Overall Study||25
10155964|NCT02895100|11286871|FG001|STARTED|Overall Study||25
10155965|NCT02895100|11286872|FG002|STARTED|Overall Study||23
10155966|NCT02895100|11286873|FG003|STARTED|Overall Study||25
10155967|NCT02895100|11286870|FG000|COMPLETED|Overall Study||14
10155968|NCT02895100|11286871|FG001|COMPLETED|Overall Study||14
10155969|NCT02895100|11286872|FG002|COMPLETED|Overall Study||15
10155970|NCT02895100|11286873|FG003|COMPLETED|Overall Study||15
10155971|NCT02895100|11286870|FG000|NOT COMPLETED|Overall Study||11
10155972|NCT02895100|11286871|FG001|NOT COMPLETED|Overall Study||11
10155973|NCT02895100|11286872|FG002|NOT COMPLETED|Overall Study||8
10155974|NCT02895100|11286873|FG003|NOT COMPLETED|Overall Study||10
10155975|NCT02895295|11286886|FG000|STARTED|Overall Study||384
10155976|NCT02895295|11286887|FG001|STARTED|Overall Study||410
10155977|NCT02895295|11286888|FG002|STARTED|Overall Study||391
10155978|NCT02895295|11286886|FG000|COMPLETED|Overall Study||313
10155979|NCT02895295|11286887|FG001|COMPLETED|Overall Study||316
10155980|NCT02895295|11286888|FG002|COMPLETED|Overall Study||299
10155981|NCT02895295|11286886|FG000|NOT COMPLETED|Overall Study||71
10155982|NCT02895295|11286887|FG001|NOT COMPLETED|Overall Study||94
10155983|NCT02895295|11286888|FG002|NOT COMPLETED|Overall Study||92
10155984|NCT02895347|11286898|FG000|STARTED|Overall Study||20
10155985|NCT02895347|11286899|FG001|STARTED|Overall Study||20
10155986|NCT02895347|11286898|FG000|COMPLETED|Overall Study||17
10155987|NCT02895347|11286899|FG001|COMPLETED|Overall Study||19
10155988|NCT02895347|11286898|FG000|NOT COMPLETED|Overall Study||3
10155989|NCT02895347|11286899|FG001|NOT COMPLETED|Overall Study||1
9710269|NCT04653766|10809820|FG000|STARTED|Overall Study||6
9710270|NCT04653766|10809821|FG001|STARTED|Overall Study||6
9710271|NCT04653766|10809822|FG002|STARTED|Overall Study||6
9710272|NCT04653766|10809823|FG003|STARTED|Overall Study||6
9710273|NCT04653766|10809824|FG004|STARTED|Overall Study||8
9710274|NCT04653766|10809820|FG000|COMPLETED|Overall Study||6
9710275|NCT04653766|10809821|FG001|COMPLETED|Overall Study||6
9710276|NCT04653766|10809822|FG002|COMPLETED|Overall Study||6
9710277|NCT04653766|10809823|FG003|COMPLETED|Overall Study||6
9710278|NCT04653766|10809824|FG004|COMPLETED|Overall Study||8
9710279|NCT04653766|10809820|FG000|NOT COMPLETED|Overall Study||0
9710280|NCT04653766|10809821|FG001|NOT COMPLETED|Overall Study||0
9710281|NCT04653766|10809822|FG002|NOT COMPLETED|Overall Study||0
9710282|NCT04653766|10809823|FG003|NOT COMPLETED|Overall Study||0
9710283|NCT04653766|10809824|FG004|NOT COMPLETED|Overall Study||0
9710284|NCT04646291|10809848|FG000|STARTED|Overall Study||272
9710285|NCT04646291|10809849|FG001|STARTED|Overall Study||70
9710286|NCT04646291|10809850|FG002|STARTED|Overall Study||8
9710287|NCT04646291|10809848|FG000|COMPLETED|Overall Study||272
9710288|NCT04646291|10809849|FG001|COMPLETED|Overall Study||70
9710289|NCT04646291|10809850|FG002|COMPLETED|Overall Study||8
9710290|NCT04646291|10809848|FG000|NOT COMPLETED|Overall Study||0
9710291|NCT04646291|10809849|FG001|NOT COMPLETED|Overall Study||0
9710292|NCT04646291|10809850|FG002|NOT COMPLETED|Overall Study||0
9730133|NCT00123630|10829826|FG000|COMPLETED|Overall Study||15
9730134|NCT00123630|10829827|FG001|COMPLETED|Overall Study||15
9730135|NCT00123630|10829826|FG000|NOT COMPLETED|Overall Study||0
9730136|NCT00123630|10829827|FG001|NOT COMPLETED|Overall Study||0
9730137|NCT00123643|10829835|FG000|STARTED|Overall Study||20
9730138|NCT00123643|10829836|FG001|STARTED|Overall Study||16
9730139|NCT00123643|10829835|FG000|COMPLETED|Overall Study||20
9730140|NCT00123643|10829836|FG001|COMPLETED|Overall Study||16
9730141|NCT00123643|10829835|FG000|NOT COMPLETED|Overall Study||0
9730142|NCT00123643|10829836|FG001|NOT COMPLETED|Overall Study||0
10155990|NCT02895360|11286912|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4
9730143|NCT00123682|10829846|FG000|STARTED|Overall Study||1069
9730144|NCT00123682|10829847|FG001|STARTED|Overall Study||934
9730145|NCT00123682|10829848|FG002|STARTED|Overall Study||592
9730146|NCT00123682|10829849|FG003|STARTED|Overall Study||525
10155991|NCT02895360|11286913|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0
10155992|NCT02895360|11286914|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0
10155993|NCT02895360|11286915|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0
10155994|NCT02895360|11286916|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0
10155995|NCT02895360|11286917|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0
10155996|NCT02895360|11286912|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10155997|NCT02895360|11286913|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10155998|NCT02895360|11286914|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10155999|NCT02895360|11286915|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156000|NCT02895360|11286916|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156001|NCT02895360|11286917|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156002|NCT02895360|11286912|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4
10156003|NCT02895360|11286913|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156004|NCT02895360|11286914|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156005|NCT02895360|11286915|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156006|NCT02895360|11286916|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156007|NCT02895360|11286917|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10156008|NCT02895360|11286912|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0
10156009|NCT02895360|11286913|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3
10156010|NCT02895360|11286914|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0
10156011|NCT02895360|11286915|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0
10156012|NCT02895360|11286916|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0
10156013|NCT02895360|11286917|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0
10156014|NCT02895360|11286912|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156015|NCT02895360|11286913|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156016|NCT02895360|11286914|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156017|NCT02895360|11286915|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156018|NCT02895360|11286916|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156019|NCT02895360|11286917|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156020|NCT02895360|11286912|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156021|NCT02895360|11286913|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3
10156022|NCT02895360|11286914|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156023|NCT02895360|11286915|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156024|NCT02895360|11286916|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156025|NCT02895360|11286917|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10156026|NCT02895360|11286912|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0
10156027|NCT02895360|11286913|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0
10156028|NCT02895360|11286914|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9
10156029|NCT02895360|11286915|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0
10156030|NCT02895360|11286916|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0
10156031|NCT02895360|11286917|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0
10156032|NCT02895360|11286912|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156033|NCT02895360|11286913|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156034|NCT02895360|11286914|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156035|NCT02895360|11286915|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156036|NCT02895360|11286916|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156037|NCT02895360|11286917|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156038|NCT02895360|11286912|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156039|NCT02895360|11286913|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156040|NCT02895360|11286914|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9
10156041|NCT02895360|11286915|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156042|NCT02895360|11286916|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156043|NCT02895360|11286917|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10156044|NCT02895360|11286912|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0
10156045|NCT02895360|11286913|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0
10156046|NCT02895360|11286914|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0
10156047|NCT02895360|11286915|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4
10156048|NCT02895360|11286916|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0
10156049|NCT02895360|11286917|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0
10156050|NCT02895360|11286912|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156051|NCT02895360|11286913|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156052|NCT02895360|11286914|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156053|NCT02895360|11286915|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156054|NCT02895360|11286916|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156055|NCT02895360|11286917|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156056|NCT02895360|11286912|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156057|NCT02895360|11286913|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156058|NCT02895360|11286914|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156059|NCT02895360|11286915|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4
10156060|NCT02895360|11286916|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156061|NCT02895360|11286917|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10156062|NCT02895360|11286912|FG000|STARTED|Phase 2a||0
10156063|NCT02895360|11286913|FG001|STARTED|Phase 2a||0
10156064|NCT02895360|11286914|FG002|STARTED|Phase 2a||0
10156065|NCT02895360|11286915|FG003|STARTED|Phase 2a||0
10156066|NCT02895360|11286916|FG004|STARTED|Phase 2a||11
10156067|NCT02895360|11286917|FG005|STARTED|Phase 2a||12
10156068|NCT02895360|11286912|FG000|COMPLETED|Phase 2a||0
10156069|NCT02895360|11286913|FG001|COMPLETED|Phase 2a||0
10156070|NCT02895360|11286914|FG002|COMPLETED|Phase 2a||0
10156071|NCT02895360|11286915|FG003|COMPLETED|Phase 2a||0
10156072|NCT02895360|11286916|FG004|COMPLETED|Phase 2a||0
10156073|NCT02895360|11286917|FG005|COMPLETED|Phase 2a||0
10156074|NCT02895360|11286912|FG000|NOT COMPLETED|Phase 2a||0
10156075|NCT02895360|11286913|FG001|NOT COMPLETED|Phase 2a||0
10156076|NCT02895360|11286914|FG002|NOT COMPLETED|Phase 2a||0
10156077|NCT02895360|11286915|FG003|NOT COMPLETED|Phase 2a||0
10156078|NCT02895360|11286916|FG004|NOT COMPLETED|Phase 2a||11
10156079|NCT02895360|11286917|FG005|NOT COMPLETED|Phase 2a||12
10156080|NCT02895945|11286951|FG000|STARTED|Overall Study||7
10156081|NCT02895945|11286952|FG001|STARTED|Overall Study||1
10156082|NCT02895945|11286951|FG000|SAS|Overall Study||7
10156083|NCT02895945|11286952|FG001|SAS|Overall Study||1
10156084|NCT02895945|11286951|FG000|FAS|Overall Study||7
10156085|NCT02895945|11286952|FG001|FAS|Overall Study||0
10156086|NCT02895945|11286951|FG000|COMPLETED|Overall Study||5
10156087|NCT02895945|11286952|FG001|COMPLETED|Overall Study||0
10156088|NCT02895945|11286951|FG000|NOT COMPLETED|Overall Study||2
10156089|NCT02895945|11286952|FG001|NOT COMPLETED|Overall Study||1
10156090|NCT02896075|11286958|FG000|STARTED|Overall Study||40
10156091|NCT02896075|11286958|FG000|Leg Soreness|Overall Study||40
10156092|NCT02896075|11286958|FG000|COMPLETED|Overall Study||40
10156093|NCT02896075|11286958|FG000|NOT COMPLETED|Overall Study||0
10156094|NCT02896127|11286967|FG000|STARTED|COMPLETED WEEK 52||305
10156095|NCT02896127|11286968|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
10156096|NCT02896127|11286967|FG000|COMPLETED|COMPLETED WEEK 52||278
10156097|NCT02896127|11286968|FG001|COMPLETED|COMPLETED WEEK 52||142
10156098|NCT02896127|11286967|FG000|NOT COMPLETED|COMPLETED WEEK 52||27
10156099|NCT02896127|11286968|FG001|NOT COMPLETED|COMPLETED WEEK 52||11
10156100|NCT02896127|11286967|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
10156101|NCT02896127|11286968|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
10156102|NCT02896127|11286967|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
10156103|NCT02896127|11286968|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
10156104|NCT02896127|11286967|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
10156105|NCT02896127|11286968|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
10156106|NCT02896296|11286974|FG000|STARTED|Overall Study||208
10156107|NCT02896296|11286974|FG000|COMPLETED|Overall Study||166
10156108|NCT02896296|11286974|FG000|NOT COMPLETED|Overall Study||42
10156109|NCT02896361|11286978|FG000|STARTED|First Intervention (2 Weeks)||9
10156110|NCT02896361|11286979|FG001|STARTED|First Intervention (2 Weeks)||10
10156111|NCT02896361|11286980|FG002|STARTED|First Intervention (2 Weeks)||8
10156112|NCT02896361|11286978|FG000|COMPLETED|First Intervention (2 Weeks)||9
10156113|NCT02896361|11286979|FG001|COMPLETED|First Intervention (2 Weeks)||10
10156114|NCT02896361|11286980|FG002|COMPLETED|First Intervention (2 Weeks)||8
10156115|NCT02896361|11286978|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10156116|NCT02896361|11286979|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10156117|NCT02896361|11286980|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
10156118|NCT02896361|11286978|FG000|STARTED|Second Intervention (2 Weeks)||9
10156119|NCT02896361|11286979|FG001|STARTED|Second Intervention (2 Weeks)||10
10156120|NCT02896361|11286980|FG002|STARTED|Second Intervention (2 Weeks)||8
10156121|NCT02896361|11286978|FG000|COMPLETED|Second Intervention (2 Weeks)||9
10156122|NCT02896361|11286979|FG001|COMPLETED|Second Intervention (2 Weeks)||10
10156123|NCT02896361|11286980|FG002|COMPLETED|Second Intervention (2 Weeks)||8
10156124|NCT02896361|11286978|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10156125|NCT02896361|11286979|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10156126|NCT02896361|11286980|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
10156127|NCT02896361|11286978|FG000|STARTED|Third Intervention (2 Weeks)||9
10156128|NCT02896361|11286979|FG001|STARTED|Third Intervention (2 Weeks)||10
10156129|NCT02896361|11286980|FG002|STARTED|Third Intervention (2 Weeks)||8
10156130|NCT02896361|11286978|FG000|COMPLETED|Third Intervention (2 Weeks)||8
10156131|NCT02896361|11286979|FG001|COMPLETED|Third Intervention (2 Weeks)||9
10156132|NCT02896361|11286980|FG002|COMPLETED|Third Intervention (2 Weeks)||8
10156133|NCT02896361|11286978|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1
10156134|NCT02896361|11286979|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1
10156135|NCT02896361|11286980|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
10156136|NCT02896400|11287008|FG000|STARTED|Baseline||66
10156137|NCT02896400|11287009|FG001|STARTED|Baseline||66
10156138|NCT02896400|11287010|FG002|STARTED|Baseline||66
10156139|NCT02896400|11287011|FG003|STARTED|Baseline||66
10156140|NCT02896400|11287012|FG004|STARTED|Baseline||66
10156141|NCT02896400|11287013|FG005|STARTED|Baseline||66
10156142|NCT02896400|11287014|FG006|STARTED|Baseline||66
10156143|NCT02896400|11287015|FG007|STARTED|Baseline||66
10156144|NCT02896400|11287016|FG008|STARTED|Baseline||66
10156145|NCT02896400|11287017|FG009|STARTED|Baseline||66
10156146|NCT02896400|11287018|FG010|STARTED|Baseline||66
10156147|NCT02896400|11287019|FG011|STARTED|Baseline||66
10156148|NCT02896400|11287020|FG012|STARTED|Baseline||66
10156149|NCT02896400|11287021|FG013|STARTED|Baseline||66
10156150|NCT02896400|11287022|FG014|STARTED|Baseline||66
10156151|NCT02896400|11287023|FG015|STARTED|Baseline||66
10156152|NCT02896400|11287008|FG000|COMPLETED|Baseline||66
10156153|NCT02896400|11287009|FG001|COMPLETED|Baseline||66
9710293|NCT04646109|10809866|FG000|STARTED|Overall Study||30
10156154|NCT02896400|11287010|FG002|COMPLETED|Baseline||66
10156155|NCT02896400|11287011|FG003|COMPLETED|Baseline||66
10156156|NCT02896400|11287012|FG004|COMPLETED|Baseline||66
10156157|NCT02896400|11287013|FG005|COMPLETED|Baseline||66
10156158|NCT02896400|11287014|FG006|COMPLETED|Baseline||66
10156159|NCT02896400|11287015|FG007|COMPLETED|Baseline||66
10156160|NCT02896400|11287016|FG008|COMPLETED|Baseline||66
10156161|NCT02896400|11287017|FG009|COMPLETED|Baseline||66
10156162|NCT02896400|11287018|FG010|COMPLETED|Baseline||66
10156163|NCT02896400|11287019|FG011|COMPLETED|Baseline||66
10156164|NCT02896400|11287020|FG012|COMPLETED|Baseline||66
10156165|NCT02896400|11287021|FG013|COMPLETED|Baseline||66
10156166|NCT02896400|11287022|FG014|COMPLETED|Baseline||66
10156167|NCT02896400|11287023|FG015|COMPLETED|Baseline||66
10156168|NCT02896400|11287008|FG000|NOT COMPLETED|Baseline||0
10156169|NCT02896400|11287009|FG001|NOT COMPLETED|Baseline||0
10156170|NCT02896400|11287010|FG002|NOT COMPLETED|Baseline||0
10156171|NCT02896400|11287011|FG003|NOT COMPLETED|Baseline||0
10156172|NCT02896400|11287012|FG004|NOT COMPLETED|Baseline||0
10156173|NCT02896400|11287013|FG005|NOT COMPLETED|Baseline||0
10156174|NCT02896400|11287014|FG006|NOT COMPLETED|Baseline||0
10156175|NCT02896400|11287015|FG007|NOT COMPLETED|Baseline||0
10156176|NCT02896400|11287016|FG008|NOT COMPLETED|Baseline||0
10156177|NCT02896400|11287017|FG009|NOT COMPLETED|Baseline||0
10156178|NCT02896400|11287018|FG010|NOT COMPLETED|Baseline||0
10156179|NCT02896400|11287019|FG011|NOT COMPLETED|Baseline||0
10156180|NCT02896400|11287020|FG012|NOT COMPLETED|Baseline||0
10156181|NCT02896400|11287021|FG013|NOT COMPLETED|Baseline||0
10156182|NCT02896400|11287022|FG014|NOT COMPLETED|Baseline||0
10156183|NCT02896400|11287023|FG015|NOT COMPLETED|Baseline||0
10156184|NCT02896400|11287008|FG000|STARTED|1 Month Follow-up||66
10156185|NCT02896400|11287009|FG001|STARTED|1 Month Follow-up||66
10156186|NCT02896400|11287010|FG002|STARTED|1 Month Follow-up||66
10156187|NCT02896400|11287011|FG003|STARTED|1 Month Follow-up||66
10156188|NCT02896400|11287012|FG004|STARTED|1 Month Follow-up||66
10156189|NCT02896400|11287013|FG005|STARTED|1 Month Follow-up||66
10156190|NCT02896400|11287014|FG006|STARTED|1 Month Follow-up||66
10156191|NCT02896400|11287015|FG007|STARTED|1 Month Follow-up||66
10156192|NCT02896400|11287016|FG008|STARTED|1 Month Follow-up||66
10156193|NCT02896400|11287017|FG009|STARTED|1 Month Follow-up||66
10156194|NCT02896400|11287018|FG010|STARTED|1 Month Follow-up||66
10156195|NCT02896400|11287019|FG011|STARTED|1 Month Follow-up||66
10156196|NCT02896400|11287020|FG012|STARTED|1 Month Follow-up||66
10156197|NCT02896400|11287021|FG013|STARTED|1 Month Follow-up||66
10156198|NCT02896400|11287022|FG014|STARTED|1 Month Follow-up||66
10156199|NCT02896400|11287023|FG015|STARTED|1 Month Follow-up||66
10156200|NCT02896400|11287008|FG000|COMPLETED|1 Month Follow-up||59
10156201|NCT02896400|11287009|FG001|COMPLETED|1 Month Follow-up||59
10156202|NCT02896400|11287010|FG002|COMPLETED|1 Month Follow-up||61
10156203|NCT02896400|11287011|FG003|COMPLETED|1 Month Follow-up||58
10156204|NCT02896400|11287012|FG004|COMPLETED|1 Month Follow-up||57
10156205|NCT02896400|11287013|FG005|COMPLETED|1 Month Follow-up||60
10156206|NCT02896400|11287014|FG006|COMPLETED|1 Month Follow-up||61
10156207|NCT02896400|11287015|FG007|COMPLETED|1 Month Follow-up||60
10156208|NCT02896400|11287016|FG008|COMPLETED|1 Month Follow-up||62
10156209|NCT02896400|11287017|FG009|COMPLETED|1 Month Follow-up||59
10156210|NCT02896400|11287018|FG010|COMPLETED|1 Month Follow-up||61
10156211|NCT02896400|11287019|FG011|COMPLETED|1 Month Follow-up||61
10156212|NCT02896400|11287020|FG012|COMPLETED|1 Month Follow-up||63
10156213|NCT02896400|11287021|FG013|COMPLETED|1 Month Follow-up||62
10156214|NCT02896400|11287022|FG014|COMPLETED|1 Month Follow-up||65
10156215|NCT02896400|11287023|FG015|COMPLETED|1 Month Follow-up||63
10156216|NCT02896400|11287008|FG000|NOT COMPLETED|1 Month Follow-up||7
10156217|NCT02896400|11287009|FG001|NOT COMPLETED|1 Month Follow-up||7
10156218|NCT02896400|11287010|FG002|NOT COMPLETED|1 Month Follow-up||5
10156219|NCT02896400|11287011|FG003|NOT COMPLETED|1 Month Follow-up||8
10156220|NCT02896400|11287012|FG004|NOT COMPLETED|1 Month Follow-up||9
10156221|NCT02896400|11287013|FG005|NOT COMPLETED|1 Month Follow-up||6
10156222|NCT02896400|11287014|FG006|NOT COMPLETED|1 Month Follow-up||5
10156223|NCT02896400|11287015|FG007|NOT COMPLETED|1 Month Follow-up||6
10156224|NCT02896400|11287016|FG008|NOT COMPLETED|1 Month Follow-up||4
10156225|NCT02896400|11287017|FG009|NOT COMPLETED|1 Month Follow-up||7
10156226|NCT02896400|11287018|FG010|NOT COMPLETED|1 Month Follow-up||5
10156227|NCT02896400|11287019|FG011|NOT COMPLETED|1 Month Follow-up||5
10156228|NCT02896400|11287020|FG012|NOT COMPLETED|1 Month Follow-up||3
10156229|NCT02896400|11287021|FG013|NOT COMPLETED|1 Month Follow-up||4
10156230|NCT02896400|11287022|FG014|NOT COMPLETED|1 Month Follow-up||1
10156231|NCT02896400|11287023|FG015|NOT COMPLETED|1 Month Follow-up||3
10156232|NCT02896400|11287008|FG000|STARTED|3 Month Follow-up||66
10156233|NCT02896400|11287009|FG001|STARTED|3 Month Follow-up||66
10156234|NCT02896400|11287010|FG002|STARTED|3 Month Follow-up||66
10156235|NCT02896400|11287011|FG003|STARTED|3 Month Follow-up||66
10156236|NCT02896400|11287012|FG004|STARTED|3 Month Follow-up||66
10156237|NCT02896400|11287013|FG005|STARTED|3 Month Follow-up||66
10156238|NCT02896400|11287014|FG006|STARTED|3 Month Follow-up||66
10156239|NCT02896400|11287015|FG007|STARTED|3 Month Follow-up||66
10156240|NCT02896400|11287016|FG008|STARTED|3 Month Follow-up||66
10156241|NCT02896400|11287017|FG009|STARTED|3 Month Follow-up||66
10156242|NCT02896400|11287018|FG010|STARTED|3 Month Follow-up||66
10156243|NCT02896400|11287019|FG011|STARTED|3 Month Follow-up||66
10156244|NCT02896400|11287020|FG012|STARTED|3 Month Follow-up||66
10156245|NCT02896400|11287021|FG013|STARTED|3 Month Follow-up||66
10156246|NCT02896400|11287022|FG014|STARTED|3 Month Follow-up||66
10156247|NCT02896400|11287023|FG015|STARTED|3 Month Follow-up||65
10156248|NCT02896400|11287008|FG000|COMPLETED|3 Month Follow-up||60
10156249|NCT02896400|11287009|FG001|COMPLETED|3 Month Follow-up||63
10156250|NCT02896400|11287010|FG002|COMPLETED|3 Month Follow-up||60
10156251|NCT02896400|11287011|FG003|COMPLETED|3 Month Follow-up||55
10156252|NCT02896400|11287012|FG004|COMPLETED|3 Month Follow-up||54
10156253|NCT02896400|11287013|FG005|COMPLETED|3 Month Follow-up||60
10156254|NCT02896400|11287014|FG006|COMPLETED|3 Month Follow-up||62
10156255|NCT02896400|11287015|FG007|COMPLETED|3 Month Follow-up||63
10156256|NCT02896400|11287016|FG008|COMPLETED|3 Month Follow-up||60
10156257|NCT02896400|11287017|FG009|COMPLETED|3 Month Follow-up||61
10156258|NCT02896400|11287018|FG010|COMPLETED|3 Month Follow-up||60
10156259|NCT02896400|11287019|FG011|COMPLETED|3 Month Follow-up||60
10156260|NCT02896400|11287020|FG012|COMPLETED|3 Month Follow-up||63
10156261|NCT02896400|11287021|FG013|COMPLETED|3 Month Follow-up||60
10156262|NCT02896400|11287022|FG014|COMPLETED|3 Month Follow-up||62
10156263|NCT02896400|11287023|FG015|COMPLETED|3 Month Follow-up||63
10156264|NCT02896400|11287008|FG000|NOT COMPLETED|3 Month Follow-up||6
10156265|NCT02896400|11287009|FG001|NOT COMPLETED|3 Month Follow-up||3
10156266|NCT02896400|11287010|FG002|NOT COMPLETED|3 Month Follow-up||6
10156267|NCT02896400|11287011|FG003|NOT COMPLETED|3 Month Follow-up||11
10156268|NCT02896400|11287012|FG004|NOT COMPLETED|3 Month Follow-up||12
10156269|NCT02896400|11287013|FG005|NOT COMPLETED|3 Month Follow-up||6
10156270|NCT02896400|11287014|FG006|NOT COMPLETED|3 Month Follow-up||4
10156271|NCT02896400|11287015|FG007|NOT COMPLETED|3 Month Follow-up||3
10156272|NCT02896400|11287016|FG008|NOT COMPLETED|3 Month Follow-up||6
10156273|NCT02896400|11287017|FG009|NOT COMPLETED|3 Month Follow-up||5
10156274|NCT02896400|11287018|FG010|NOT COMPLETED|3 Month Follow-up||6
10156275|NCT02896400|11287019|FG011|NOT COMPLETED|3 Month Follow-up||6
10156276|NCT02896400|11287020|FG012|NOT COMPLETED|3 Month Follow-up||3
10156277|NCT02896400|11287021|FG013|NOT COMPLETED|3 Month Follow-up||6
10156278|NCT02896400|11287022|FG014|NOT COMPLETED|3 Month Follow-up||4
10156279|NCT02896400|11287023|FG015|NOT COMPLETED|3 Month Follow-up||2
9710294|NCT04646109|10809867|FG001|STARTED|Overall Study||36
9849287|NCT00863772|10961952|FG001|NOT COMPLETED|Overall Study||65
9849288|NCT00863772|10961953|FG002|NOT COMPLETED|Overall Study||61
9849289|NCT00863798|10961964|FG000|STARTED|Overall Study||227
9849290|NCT00863798|10961965|FG001|STARTED|Overall Study||228
9849291|NCT00863798|10961966|FG002|STARTED|Overall Study||227
9849292|NCT00863798|10961964|FG000|Treated|Overall Study||223
9849293|NCT00863798|10961965|FG001|Treated|Overall Study||226
9849294|NCT00863798|10961966|FG002|Treated|Overall Study||224
9849295|NCT00863798|10961964|FG000|COMPLETED|Overall Study||195
9849296|NCT00863798|10961965|FG001|COMPLETED|Overall Study||198
9849297|NCT00863798|10961966|FG002|COMPLETED|Overall Study||202
9849298|NCT00863798|10961964|FG000|NOT COMPLETED|Overall Study||32
9849299|NCT00863798|10961965|FG001|NOT COMPLETED|Overall Study||30
9849300|NCT00863798|10961966|FG002|NOT COMPLETED|Overall Study||25
9849301|NCT00863928|10961976|FG000|STARTED|Overall Study||94
9849302|NCT00863928|10961977|FG001|STARTED|Overall Study||41
9849303|NCT00863928|10961976|FG000|COMPLETED|Overall Study||58
9849304|NCT00863928|10961977|FG001|COMPLETED|Overall Study||41
9849305|NCT00863928|10961976|FG000|NOT COMPLETED|Overall Study||36
9849306|NCT00863928|10961977|FG001|NOT COMPLETED|Overall Study||0
9849307|NCT00864032|10961983|FG000|STARTED|Overall Study||3
9849308|NCT00864032|10961984|FG001|STARTED|Overall Study||5
9849309|NCT00864032|10961985|FG002|STARTED|Overall Study||0
9849310|NCT00864032|10961983|FG000|COMPLETED|Overall Study||3
9849311|NCT00864032|10961984|FG001|COMPLETED|Overall Study||5
9849312|NCT00864032|10961985|FG002|COMPLETED|Overall Study||0
9849313|NCT00864032|10961983|FG000|NOT COMPLETED|Overall Study||0
9849314|NCT00864032|10961984|FG001|NOT COMPLETED|Overall Study||0
9849315|NCT00864032|10961985|FG002|NOT COMPLETED|Overall Study||0
9849316|NCT00864084|10961991|FG000|STARTED|Overall Study||14
9849317|NCT00864084|10961991|FG000|COMPLETED|Overall Study||11
9849318|NCT00864084|10961991|FG000|NOT COMPLETED|Overall Study||3
9849319|NCT00864097|10962004|FG000|STARTED|Overall Study||154
9849320|NCT00864097|10962005|FG001|STARTED|Overall Study||157
9849321|NCT00864097|10962006|FG002|STARTED|Overall Study||151
9849322|NCT00864097|10962007|FG003|STARTED|Overall Study||145
9849323|NCT00864097|10962004|FG000|Treated|Overall Study||152
9849324|NCT00864097|10962005|FG001|Treated|Overall Study||157
9849325|NCT00864097|10962006|FG002|Treated|Overall Study||150
9849326|NCT00864097|10962007|FG003|Treated|Overall Study||145
9849327|NCT00864097|10962004|FG000|COMPLETED|Overall Study||15
9849328|NCT00864097|10962005|FG001|COMPLETED|Overall Study||20
9849329|NCT00864097|10962006|FG002|COMPLETED|Overall Study||19
9849330|NCT00864097|10962007|FG003|COMPLETED|Overall Study||20
9849331|NCT00864097|10962004|FG000|NOT COMPLETED|Overall Study||139
9849332|NCT00864097|10962005|FG001|NOT COMPLETED|Overall Study||137
9849333|NCT00864097|10962006|FG002|NOT COMPLETED|Overall Study||132
10156280|NCT02896400|11287008|FG000|STARTED|Biochemical Verification at 3 Months||60
10156281|NCT02896400|11287009|FG001|STARTED|Biochemical Verification at 3 Months||63
10156282|NCT02896400|11287010|FG002|STARTED|Biochemical Verification at 3 Months||60
10156283|NCT02896400|11287011|FG003|STARTED|Biochemical Verification at 3 Months||55
10156284|NCT02896400|11287012|FG004|STARTED|Biochemical Verification at 3 Months||54
9849334|NCT00864097|10962007|FG003|NOT COMPLETED|Overall Study||125
9849335|NCT00864123|10962019|FG000|STARTED|Overall Study||15
9849336|NCT00864123|10962020|FG001|STARTED|Overall Study||15
9849337|NCT00864123|10962019|FG000|COMPLETED|Overall Study||15
9849338|NCT00864123|10962020|FG001|COMPLETED|Overall Study||15
9849339|NCT00864123|10962019|FG000|NOT COMPLETED|Overall Study||0
9849340|NCT00864123|10962020|FG001|NOT COMPLETED|Overall Study||0
9849341|NCT00864253|10962028|FG000|STARTED|Overall Study||264
9849342|NCT00864253|10962029|FG001|STARTED|Overall Study||265
9849343|NCT00864253|10962028|FG000|Treated|Overall Study||257
10156285|NCT02896400|11287013|FG005|STARTED|Biochemical Verification at 3 Months||60
10156286|NCT02896400|11287014|FG006|STARTED|Biochemical Verification at 3 Months||62
10156287|NCT02896400|11287015|FG007|STARTED|Biochemical Verification at 3 Months||63
10156288|NCT02896400|11287016|FG008|STARTED|Biochemical Verification at 3 Months||60
10156289|NCT02896400|11287017|FG009|STARTED|Biochemical Verification at 3 Months||61
10156290|NCT02896400|11287018|FG010|STARTED|Biochemical Verification at 3 Months||60
10156291|NCT02896400|11287019|FG011|STARTED|Biochemical Verification at 3 Months||60
10156292|NCT02896400|11287020|FG012|STARTED|Biochemical Verification at 3 Months||63
10156293|NCT02896400|11287021|FG013|STARTED|Biochemical Verification at 3 Months||60
10156294|NCT02896400|11287022|FG014|STARTED|Biochemical Verification at 3 Months||62
10156295|NCT02896400|11287023|FG015|STARTED|Biochemical Verification at 3 Months||63
10156296|NCT02896400|11287008|FG000|COMPLETED|Biochemical Verification at 3 Months||14
10156297|NCT02896400|11287009|FG001|COMPLETED|Biochemical Verification at 3 Months||15
10156298|NCT02896400|11287010|FG002|COMPLETED|Biochemical Verification at 3 Months||13
10156299|NCT02896400|11287011|FG003|COMPLETED|Biochemical Verification at 3 Months||14
10156300|NCT02896400|11287012|FG004|COMPLETED|Biochemical Verification at 3 Months||9
10156301|NCT02896400|11287013|FG005|COMPLETED|Biochemical Verification at 3 Months||11
10156302|NCT02896400|11287014|FG006|COMPLETED|Biochemical Verification at 3 Months||11
10156303|NCT02896400|11287015|FG007|COMPLETED|Biochemical Verification at 3 Months||14
10156304|NCT02896400|11287016|FG008|COMPLETED|Biochemical Verification at 3 Months||15
10156305|NCT02896400|11287017|FG009|COMPLETED|Biochemical Verification at 3 Months||8
10156306|NCT02896400|11287018|FG010|COMPLETED|Biochemical Verification at 3 Months||5
10156307|NCT02896400|11287019|FG011|COMPLETED|Biochemical Verification at 3 Months||19
10156308|NCT02896400|11287020|FG012|COMPLETED|Biochemical Verification at 3 Months||10
10156309|NCT02896400|11287021|FG013|COMPLETED|Biochemical Verification at 3 Months||12
10156310|NCT02896400|11287022|FG014|COMPLETED|Biochemical Verification at 3 Months||7
10156311|NCT02896400|11287023|FG015|COMPLETED|Biochemical Verification at 3 Months||6
10156312|NCT02896400|11287008|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46
10156313|NCT02896400|11287009|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48
10156314|NCT02896400|11287010|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47
10156315|NCT02896400|11287011|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41
10156316|NCT02896400|11287012|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45
10156317|NCT02896400|11287013|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49
10156318|NCT02896400|11287014|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51
10156319|NCT02896400|11287015|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49
10156320|NCT02896400|11287016|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45
10156321|NCT02896400|11287017|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53
10156322|NCT02896400|11287018|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55
10156323|NCT02896400|11287019|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41
10156324|NCT02896400|11287020|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53
10156325|NCT02896400|11287021|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48
10156326|NCT02896400|11287022|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55
10156327|NCT02896400|11287023|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57
10156328|NCT02896569|11287051|FG000|STARTED|Overall Study||25
10156329|NCT02896569|11287052|FG001|STARTED|Overall Study||24
10156330|NCT02896569|11287051|FG000|COMPLETED|Overall Study||21
10156331|NCT02896569|11287052|FG001|COMPLETED|Overall Study||19
10156332|NCT02896569|11287051|FG000|NOT COMPLETED|Overall Study||4
10156333|NCT02896569|11287052|FG001|NOT COMPLETED|Overall Study||5
10156334|NCT02896595|11287060|FG000|STARTED|Overall Study||50
10156335|NCT02896595|11287061|FG001|STARTED|Overall Study||50
10156336|NCT02896595|11287060|FG000|COMPLETED|Overall Study||50
10156337|NCT02896595|11287061|FG001|COMPLETED|Overall Study||50
10156338|NCT02896595|11287060|FG000|NOT COMPLETED|Overall Study||0
10156339|NCT02896595|11287061|FG001|NOT COMPLETED|Overall Study||0
10156340|NCT02896907|11287067|FG000|STARTED|Overall Study||8
10156341|NCT02896907|11287067|FG000|COMPLETED|Overall Study||8
10156342|NCT02896907|11287067|FG000|NOT COMPLETED|Overall Study||0
10156343|NCT02897115|11287073|FG000|STARTED|Overall Study||14
10156344|NCT02897115|11287074|FG001|STARTED|Overall Study||8
10156345|NCT02897115|11287073|FG000|COMPLETED|Overall Study||3
10156346|NCT02897115|11287074|FG001|COMPLETED|Overall Study||0
10156347|NCT02897115|11287073|FG000|NOT COMPLETED|Overall Study||11
10156348|NCT02897115|11287074|FG001|NOT COMPLETED|Overall Study||8
10156349|NCT02897141|11287082|FG000|STARTED|Overall Study||40
10156350|NCT02897141|11287083|FG001|STARTED|Overall Study||40
10156351|NCT02897141|11287082|FG000|COMPLETED|Overall Study||38
10156352|NCT02897141|11287083|FG001|COMPLETED|Overall Study||39
10156353|NCT02897141|11287082|FG000|NOT COMPLETED|Overall Study||2
10156354|NCT02897141|11287083|FG001|NOT COMPLETED|Overall Study||1
10156355|NCT02897349|11287102|FG000|STARTED|Overall Study||102
10156356|NCT02897349|11287103|FG001|STARTED|Overall Study||104
10156357|NCT02897349|11287102|FG000|COMPLETED|Overall Study||97
10156358|NCT02897349|11287103|FG001|COMPLETED|Overall Study||98
10156359|NCT02897349|11287102|FG000|NOT COMPLETED|Overall Study||5
10156360|NCT02897349|11287103|FG001|NOT COMPLETED|Overall Study||6
10156361|NCT02898103|11287111|FG000|STARTED|Overall Study||4
10156362|NCT02898103|11287112|FG001|STARTED|Overall Study||3
10156363|NCT02898103|11287111|FG000|COMPLETED|Overall Study||4
10156364|NCT02898103|11287112|FG001|COMPLETED|Overall Study||3
10156365|NCT02898103|11287111|FG000|NOT COMPLETED|Overall Study||0
10156366|NCT02898103|11287112|FG001|NOT COMPLETED|Overall Study||0
10156367|NCT02898116|11287122|FG000|STARTED|Overall Study||2
10156368|NCT02898116|11287122|FG000|COMPLETED|Overall Study||0
10156369|NCT02898116|11287122|FG000|NOT COMPLETED|Overall Study||2
10156370|NCT02898454|11287129|FG000|STARTED|Overall Study||153
10156371|NCT02898454|11287130|FG001|STARTED|Overall Study||145
10156372|NCT02898454|11287131|FG002|STARTED|Overall Study||150
10156373|NCT02898454|11287129|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
10156374|NCT02898454|11287130|FG001|Intent-to-Treat (ITT) Population|Overall Study||145
10156375|NCT02898454|11287131|FG002|Intent-to-Treat (ITT) Population|Overall Study||150
10156376|NCT02898454|11287129|FG000|Treated|Overall Study||152
10156377|NCT02898454|11287130|FG001|Treated|Overall Study||145
10156378|NCT02898454|11287131|FG002|Treated|Overall Study||150
10156379|NCT02898454|11287129|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
10156380|NCT02898454|11287130|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
10156381|NCT02898454|11287131|FG002|Safety Population|Overall Study||149
10156382|NCT02898454|11287129|FG000|COMPLETED|Overall Study||136
10156383|NCT02898454|11287130|FG001|COMPLETED|Overall Study||140
10156384|NCT02898454|11287131|FG002|COMPLETED|Overall Study||144
10156385|NCT02898454|11287129|FG000|NOT COMPLETED|Overall Study||17
10156386|NCT02898454|11287130|FG001|NOT COMPLETED|Overall Study||5
10156387|NCT02898454|11287131|FG002|NOT COMPLETED|Overall Study||6
10156388|NCT02898597|11287146|FG000|STARTED|Overall Study||25
10156389|NCT02898597|11287147|FG001|STARTED|Overall Study||24
10156390|NCT02898597|11287146|FG000|COMPLETED|Overall Study||21
10156391|NCT02898597|11287147|FG001|COMPLETED|Overall Study||12
10156392|NCT02898597|11287146|FG000|NOT COMPLETED|Overall Study||4
10156393|NCT02898597|11287147|FG001|NOT COMPLETED|Overall Study||12
10156394|NCT02898662|11287155|FG000|STARTED|Overall Study||40
10156395|NCT02898662|11287156|FG001|STARTED|Overall Study||41
10156396|NCT02898662|11287155|FG000|Completed Treatment|Overall Study||25
10156397|NCT02898662|11287156|FG001|Completed Treatment|Overall Study||29
10156398|NCT02898662|11287155|FG000|COMPLETED|Overall Study||11
10156399|NCT02898662|11287156|FG001|COMPLETED|Overall Study||13
10156400|NCT02898662|11287155|FG000|NOT COMPLETED|Overall Study||29
10156401|NCT02898662|11287156|FG001|NOT COMPLETED|Overall Study||28
10156402|NCT02898740|11287164|FG000|STARTED|Overall Study||21
10156403|NCT02898740|11287165|FG001|STARTED|Overall Study||19
10156404|NCT02898740|11287164|FG000|COMPLETED|Overall Study||21
10156405|NCT02898740|11287165|FG001|COMPLETED|Overall Study||19
10156406|NCT02898740|11287164|FG000|NOT COMPLETED|Overall Study||0
10156407|NCT02898740|11287165|FG001|NOT COMPLETED|Overall Study||0
10156408|NCT02898974|11287173|FG000|STARTED|Overall Study||13
10156409|NCT02898974|11287174|FG001|STARTED|Overall Study||9
10156410|NCT02898974|11287173|FG000|COMPLETED|Overall Study||13
10156411|NCT02898974|11287174|FG001|COMPLETED|Overall Study||9
10156412|NCT02898974|11287173|FG000|NOT COMPLETED|Overall Study||0
10156413|NCT02898974|11287174|FG001|NOT COMPLETED|Overall Study||0
10156414|NCT02899156|11287182|FG000|STARTED|Overall Study||11
10156415|NCT02899156|11287183|FG001|STARTED|Overall Study||11
10156416|NCT02899156|11287182|FG000|COMPLETED|Overall Study||10
10156417|NCT02899156|11287183|FG001|COMPLETED|Overall Study||10
10156418|NCT02899156|11287182|FG000|NOT COMPLETED|Overall Study||1
10156419|NCT02899156|11287183|FG001|NOT COMPLETED|Overall Study||1
10156420|NCT02899195|11287189|FG000|STARTED|Concurrent Durvalumab||55
10156421|NCT02899195|11287189|FG000|COMPLETED|Concurrent Durvalumab||44
10156422|NCT02899195|11287189|FG000|NOT COMPLETED|Concurrent Durvalumab||11
10156423|NCT02899195|11287189|FG000|STARTED|Maintenance Durvalumab||44
10156424|NCT02899195|11287189|FG000|COMPLETED|Maintenance Durvalumab||10
10156425|NCT02899195|11287189|FG000|NOT COMPLETED|Maintenance Durvalumab||34
10156426|NCT02899338|11287195|FG000|STARTED|Overall Study||81
10156427|NCT02899338|11287196|FG001|STARTED|Overall Study||81
10156428|NCT02899338|11287195|FG000|COMPLETED|Overall Study||78
10156429|NCT02899338|11287196|FG001|COMPLETED|Overall Study||79
10156430|NCT02899338|11287195|FG000|NOT COMPLETED|Overall Study||3
10156431|NCT02899338|11287196|FG001|NOT COMPLETED|Overall Study||2
10156432|NCT02899377|11287204|FG000|STARTED|Overall Study||13
10156433|NCT02899377|11287205|FG001|STARTED|Overall Study||12
10156434|NCT02899377|11287204|FG000|COMPLETED|Overall Study||12
10156435|NCT02899377|11287205|FG001|COMPLETED|Overall Study||12
10156436|NCT02899377|11287204|FG000|NOT COMPLETED|Overall Study||1
10156437|NCT02899377|11287205|FG001|NOT COMPLETED|Overall Study||0
10156438|NCT02899650|11287216|FG000|STARTED|Overall Study||15
10156439|NCT02899650|11287217|FG001|STARTED|Overall Study||10
10156440|NCT02899650|11287218|FG002|STARTED|Overall Study||14
10156441|NCT02899650|11287219|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
10156442|NCT02899650|11287216|FG000|COMPLETED|Overall Study||15
10156443|NCT02899650|11287217|FG001|COMPLETED|Overall Study||10
10156444|NCT02899650|11287218|FG002|COMPLETED|Overall Study||14
10156445|NCT02899650|11287219|FG003|COMPLETED|Overall Study||0
10156446|NCT02899650|11287216|FG000|NOT COMPLETED|Overall Study||0
10156447|NCT02899650|11287217|FG001|NOT COMPLETED|Overall Study||0
10156448|NCT02899650|11287218|FG002|NOT COMPLETED|Overall Study||0
10156449|NCT02899650|11287219|FG003|NOT COMPLETED|Overall Study||0
10156450|NCT02899689|11287230|FG000|STARTED|Overall Study||209
10156451|NCT02899689|11287231|FG001|STARTED|Overall Study||210
10156452|NCT02899689|11287230|FG000|COMPLETED|Overall Study||209
10156453|NCT02899689|11287231|FG001|COMPLETED|Overall Study||208
10156454|NCT02899689|11287230|FG000|NOT COMPLETED|Overall Study||0
10156455|NCT02899689|11287231|FG001|NOT COMPLETED|Overall Study||2
10156456|NCT02899884|11287237|FG000|STARTED|Overall Study||3765
10156457|NCT02899884|11287237|FG000|COMPLETED|Overall Study||3765
10156458|NCT02899884|11287237|FG000|NOT COMPLETED|Overall Study||0
10156459|NCT02899962|11287241|FG000|STARTED|Open-label Phase||650
10156460|NCT02899962|11287242|FG001|STARTED|Open-label Phase||0
10156461|NCT02899962|11287243|FG002|STARTED|Open-label Phase||0
10156462|NCT02899962|11287241|FG000|COMPLETED|Open-label Phase||623
10156463|NCT02899962|11287242|FG001|COMPLETED|Open-label Phase||0
10156464|NCT02899962|11287243|FG002|COMPLETED|Open-label Phase||0
10156465|NCT02899962|11287241|FG000|NOT COMPLETED|Open-label Phase||27
10156466|NCT02899962|11287242|FG001|NOT COMPLETED|Open-label Phase||0
10156467|NCT02899962|11287243|FG002|NOT COMPLETED|Open-label Phase||0
10156468|NCT02899962|11287241|FG000|STARTED|Maintenance Phase||0
10156469|NCT02899962|11287242|FG001|STARTED|Maintenance Phase||272
10156470|NCT02899962|11287243|FG002|STARTED|Maintenance Phase||273
10156471|NCT02899962|11287241|FG000|COMPLETED|Maintenance Phase||0
10156472|NCT02899962|11287242|FG001|COMPLETED|Maintenance Phase||131
10156473|NCT02899962|11287243|FG002|COMPLETED|Maintenance Phase||120
10156474|NCT02899962|11287241|FG000|NOT COMPLETED|Maintenance Phase||0
10156475|NCT02899962|11287242|FG001|NOT COMPLETED|Maintenance Phase||141
10156476|NCT02899962|11287243|FG002|NOT COMPLETED|Maintenance Phase||153
10156477|NCT02899988|11287254|FG000|STARTED|Induction Period (16 Weeks)||52
10156478|NCT02899988|11287255|FG001|STARTED|Induction Period (16 Weeks)||51
10156479|NCT02899988|11287256|FG002|STARTED|Induction Period (16 Weeks)||51
10156480|NCT02899988|11287257|FG003|STARTED|Induction Period (16 Weeks)||51
10156481|NCT02899988|11287258|FG004|STARTED|Induction Period (16 Weeks)||0
10156482|NCT02899988|11287259|FG005|STARTED|Induction Period (16 Weeks)||0
10156483|NCT02899988|11287260|FG006|STARTED|Induction Period (16 Weeks)||0
10156484|NCT02899988|11287261|FG007|STARTED|Induction Period (16 Weeks)||0
10156485|NCT02899988|11287262|FG008|STARTED|Induction Period (16 Weeks)||0
10156486|NCT02899988|11287263|FG009|STARTED|Induction Period (16 Weeks)||0
10156487|NCT02899988|11287264|FG010|STARTED|Induction Period (16 Weeks)||0
10156488|NCT02899988|11287254|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
10156489|NCT02899988|11287255|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
10156490|NCT02899988|11287256|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
10156491|NCT02899988|11287257|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
10156492|NCT02899988|11287258|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10156493|NCT02899988|11287259|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10156494|NCT02899988|11287260|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10156495|NCT02899988|11287261|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10156496|NCT02899988|11287262|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10156497|NCT02899988|11287263|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10156498|NCT02899988|11287264|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10156499|NCT02899988|11287254|FG000|COMPLETED|Induction Period (16 Weeks)||50
10156500|NCT02899988|11287255|FG001|COMPLETED|Induction Period (16 Weeks)||49
10156501|NCT02899988|11287256|FG002|COMPLETED|Induction Period (16 Weeks)||51
10156502|NCT02899988|11287257|FG003|COMPLETED|Induction Period (16 Weeks)||49
10156503|NCT02899988|11287258|FG004|COMPLETED|Induction Period (16 Weeks)||0
10156504|NCT02899988|11287259|FG005|COMPLETED|Induction Period (16 Weeks)||0
10156505|NCT02899988|11287260|FG006|COMPLETED|Induction Period (16 Weeks)||0
10156506|NCT02899988|11287261|FG007|COMPLETED|Induction Period (16 Weeks)||0
10156507|NCT02899988|11287262|FG008|COMPLETED|Induction Period (16 Weeks)||0
10156508|NCT02899988|11287263|FG009|COMPLETED|Induction Period (16 Weeks)||0
10156509|NCT02899988|11287264|FG010|COMPLETED|Induction Period (16 Weeks)||0
10156510|NCT02899988|11287254|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2
10156511|NCT02899988|11287255|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2
10156512|NCT02899988|11287256|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
10156513|NCT02899988|11287257|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2
10156514|NCT02899988|11287258|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
10156515|NCT02899988|11287259|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
10156516|NCT02899988|11287260|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
10156517|NCT02899988|11287261|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
10156518|NCT02899988|11287262|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
10156519|NCT02899988|11287263|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
10156520|NCT02899988|11287264|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
10156521|NCT02899988|11287254|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
10156522|NCT02899988|11287255|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
10156523|NCT02899988|11287256|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
10156524|NCT02899988|11287257|FG003|STARTED|Maintenance Period (88 Weeks)||0
10156525|NCT02899988|11287258|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
10156526|NCT02899988|11287259|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
10156527|NCT02899988|11287260|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
10156528|NCT02899988|11287261|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
10156529|NCT02899988|11287262|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
10156530|NCT02899988|11287263|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
10156531|NCT02899988|11287264|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
10156532|NCT02899988|11287254|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0
10156533|NCT02899988|11287255|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0
10156534|NCT02899988|11287256|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0
10156535|NCT02899988|11287257|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
10156536|NCT02899988|11287258|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0
10156537|NCT02899988|11287259|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0
10156538|NCT02899988|11287260|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0
10156539|NCT02899988|11287261|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0
10156540|NCT02899988|11287262|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0
10156541|NCT02899988|11287263|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0
10156542|NCT02899988|11287264|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0
10156543|NCT02899988|11287254|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10156544|NCT02899988|11287255|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10156545|NCT02899988|11287256|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10156546|NCT02899988|11287257|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
10156547|NCT02899988|11287258|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
10156548|NCT02899988|11287259|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
10156549|NCT02899988|11287260|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
10156550|NCT02899988|11287261|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
10156551|NCT02899988|11287262|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
10156552|NCT02899988|11287263|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
10156553|NCT02899988|11287264|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10156554|NCT02899988|11287254|FG000|COMPLETED|Maintenance Period (88 Weeks)||0
10156555|NCT02899988|11287255|FG001|COMPLETED|Maintenance Period (88 Weeks)||0
10156556|NCT02899988|11287256|FG002|COMPLETED|Maintenance Period (88 Weeks)||0
10156557|NCT02899988|11287257|FG003|COMPLETED|Maintenance Period (88 Weeks)||0
10156558|NCT02899988|11287258|FG004|COMPLETED|Maintenance Period (88 Weeks)||13
10156559|NCT02899988|11287259|FG005|COMPLETED|Maintenance Period (88 Weeks)||27
10156560|NCT02899988|11287260|FG006|COMPLETED|Maintenance Period (88 Weeks)||30
10156561|NCT02899988|11287261|FG007|COMPLETED|Maintenance Period (88 Weeks)||45
10156562|NCT02899988|11287262|FG008|COMPLETED|Maintenance Period (88 Weeks)||30
10156563|NCT02899988|11287263|FG009|COMPLETED|Maintenance Period (88 Weeks)||19
10156564|NCT02899988|11287264|FG010|COMPLETED|Maintenance Period (88 Weeks)||13
10156565|NCT02899988|11287254|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10156566|NCT02899988|11287255|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10156567|NCT02899988|11287256|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10156568|NCT02899988|11287257|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10156569|NCT02899988|11287258|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2
10156570|NCT02899988|11287259|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3
10156571|NCT02899988|11287260|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4
10156572|NCT02899988|11287261|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5
10156573|NCT02899988|11287262|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4
10156574|NCT02899988|11287263|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2
10156575|NCT02899988|11287264|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2
10156576|NCT02899988|11287254|FG000|STARTED|Follow-Up (16 Weeks)||0
10156577|NCT02899988|11287255|FG001|STARTED|Follow-Up (16 Weeks)||0
10156578|NCT02899988|11287256|FG002|STARTED|Follow-Up (16 Weeks)||0
10156579|NCT02899988|11287257|FG003|STARTED|Follow-Up (16 Weeks)||0
10156580|NCT02899988|11287258|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
10156581|NCT02899988|11287259|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
10156582|NCT02899988|11287260|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
10156583|NCT02899988|11287261|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
10156584|NCT02899988|11287262|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
10156585|NCT02899988|11287263|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
10156586|NCT02899988|11287264|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
10156587|NCT02899988|11287254|FG000|COMPLETED|Follow-Up (16 Weeks)||0
10156588|NCT02899988|11287255|FG001|COMPLETED|Follow-Up (16 Weeks)||0
10156589|NCT02899988|11287256|FG002|COMPLETED|Follow-Up (16 Weeks)||0
10156590|NCT02899988|11287257|FG003|COMPLETED|Follow-Up (16 Weeks)||0
10156591|NCT02899988|11287258|FG004|COMPLETED|Follow-Up (16 Weeks)||2
10156592|NCT02899988|11287259|FG005|COMPLETED|Follow-Up (16 Weeks)||4
10156593|NCT02899988|11287260|FG006|COMPLETED|Follow-Up (16 Weeks)||3
10156594|NCT02899988|11287261|FG007|COMPLETED|Follow-Up (16 Weeks)||3
10156595|NCT02899988|11287262|FG008|COMPLETED|Follow-Up (16 Weeks)||6
10156596|NCT02899988|11287263|FG009|COMPLETED|Follow-Up (16 Weeks)||2
10156597|NCT02899988|11287264|FG010|COMPLETED|Follow-Up (16 Weeks)||0
10156598|NCT02899988|11287254|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156599|NCT02899988|11287255|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156600|NCT02899988|11287256|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156601|NCT02899988|11287257|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156602|NCT02899988|11287258|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156603|NCT02899988|11287259|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156604|NCT02899988|11287260|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156605|NCT02899988|11287261|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156606|NCT02899988|11287262|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156607|NCT02899988|11287263|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156608|NCT02899988|11287264|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0
10156609|NCT02900092|11287296|FG000|STARTED|Overall Study||10
10156610|NCT02900092|11287296|FG000|COMPLETED|Overall Study||9
9710295|NCT04646109|10809866|FG000|COMPLETED|Overall Study||30
9710296|NCT04646109|10809867|FG001|COMPLETED|Overall Study||30
9710297|NCT04646109|10809866|FG000|NOT COMPLETED|Overall Study||0
9710298|NCT04646109|10809867|FG001|NOT COMPLETED|Overall Study||6
9730147|NCT00123682|10829846|FG000|COMPLETED|Overall Study||749
9730148|NCT00123682|10829847|FG001|COMPLETED|Overall Study||731
9730149|NCT00123682|10829848|FG002|COMPLETED|Overall Study||438
9730150|NCT00123682|10829849|FG003|COMPLETED|Overall Study||430
9730151|NCT00123682|10829846|FG000|NOT COMPLETED|Overall Study||320
9730152|NCT00123682|10829847|FG001|NOT COMPLETED|Overall Study||203
9730153|NCT00123682|10829848|FG002|NOT COMPLETED|Overall Study||154
9730154|NCT00123682|10829849|FG003|NOT COMPLETED|Overall Study||95
9730155|NCT00123734|10829863|FG000|STARTED|Overall Study||82
9730156|NCT00123734|10829863|FG000|COMPLETED|Overall Study||74
9730157|NCT00123734|10829863|FG000|NOT COMPLETED|Overall Study||8
9730158|NCT00123955|10829872|FG000|STARTED|Overall Study||42
9730159|NCT00123955|10829873|FG001|STARTED|Overall Study||38
9730160|NCT00123955|10829872|FG000|COMPLETED|Overall Study||37
9730161|NCT00123955|10829873|FG001|COMPLETED|Overall Study||34
9730162|NCT00123955|10829872|FG000|NOT COMPLETED|Overall Study||5
9730163|NCT00123955|10829873|FG001|NOT COMPLETED|Overall Study||4
9730164|NCT00124020|10829881|FG000|STARTED|Overall Study||377
9730165|NCT00124020|10829882|FG001|STARTED|Overall Study||380
9730166|NCT00124020|10829881|FG000|COMPLETED|Overall Study||289
9730167|NCT00124020|10829882|FG001|COMPLETED|Overall Study||289
9730168|NCT00124020|10829881|FG000|NOT COMPLETED|Overall Study||88
9730169|NCT00124020|10829882|FG001|NOT COMPLETED|Overall Study||91
9730170|NCT00124072|10829892|FG000|STARTED|Overall Study||3017
9730171|NCT00124072|10829893|FG001|STARTED|Overall Study||3016
9730172|NCT00124072|10829894|FG002|STARTED|Overall Study||3016
9730173|NCT00124072|10829895|FG003|STARTED|Overall Study||3015
9730174|NCT00124072|10829892|FG000|COMPLETED|Overall Study||2503
9730175|NCT00124072|10829893|FG001|COMPLETED|Overall Study||2504
9730176|NCT00124072|10829894|FG002|COMPLETED|Overall Study||2524
9730177|NCT00124072|10829895|FG003|COMPLETED|Overall Study||2515
9730178|NCT00124072|10829892|FG000|NOT COMPLETED|Overall Study||514
9730179|NCT00124072|10829893|FG001|NOT COMPLETED|Overall Study||512
9730180|NCT00124072|10829894|FG002|NOT COMPLETED|Overall Study||492
9730181|NCT00124072|10829895|FG003|NOT COMPLETED|Overall Study||500
9730182|NCT00124176|10829907|FG000|STARTED|Overall Study||40
9730183|NCT00124176|10829908|FG001|STARTED|Overall Study||41
9730184|NCT00124176|10829907|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
9730185|NCT00124176|10829908|FG001|Received Study Drug|Overall Study||41
9730186|NCT00124176|10829907|FG000|COMPLETED|Overall Study||40
9730187|NCT00124176|10829908|FG001|COMPLETED|Overall Study||41
9730188|NCT00124176|10829907|FG000|NOT COMPLETED|Overall Study||0
9730189|NCT00124176|10829908|FG001|NOT COMPLETED|Overall Study||0
9730190|NCT00124449|10829916|FG000|STARTED|6-month Double-Blind Treatment Period||28
9730191|NCT00124449|10829917|FG001|STARTED|6-month Double-Blind Treatment Period||28
9730192|NCT00124449|10829916|FG000|COMPLETED|6-month Double-Blind Treatment Period||22
9730193|NCT00124449|10829917|FG001|COMPLETED|6-month Double-Blind Treatment Period||17
9730194|NCT00124449|10829916|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6
9730195|NCT00124449|10829917|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11
9730196|NCT00124449|10829916|FG000|STARTED|18-Month Untreated Observation Period||22
9730197|NCT00124449|10829917|FG001|STARTED|18-Month Untreated Observation Period||17
9730198|NCT00124449|10829916|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14
9730199|NCT00124449|10829917|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9
9730200|NCT00124449|10829916|FG000|COMPLETED|18-Month Untreated Observation Period||7
9730201|NCT00124449|10829917|FG001|COMPLETED|18-Month Untreated Observation Period||4
9730202|NCT00124449|10829916|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15
9730203|NCT00124449|10829917|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13
9730204|NCT00124462|10829926|FG000|STARTED|Overall Study||40
9730205|NCT00124462|10829927|FG001|STARTED|Overall Study||40
9730206|NCT00124462|10829926|FG000|COMPLETED|Overall Study||29
9730207|NCT00124462|10829927|FG001|COMPLETED|Overall Study||27
9730208|NCT00124462|10829926|FG000|NOT COMPLETED|Overall Study||11
9730209|NCT00124462|10829927|FG001|NOT COMPLETED|Overall Study||13
9730210|NCT00124514|10829938|FG000|STARTED|Overall Study||6
9730211|NCT00124514|10829939|FG001|STARTED|Overall Study||9
9730212|NCT00124514|10829940|FG002|STARTED|Overall Study||8
9730213|NCT00124514|10829941|FG003|STARTED|Overall Study||6
10156611|NCT02900092|11287296|FG000|NOT COMPLETED|Overall Study||1
10156612|NCT02900170|11287300|FG000|STARTED|Overall Study||8
10156613|NCT02900170|11287300|FG000|COMPLETED|Overall Study||0
10156614|NCT02900170|11287300|FG000|NOT COMPLETED|Overall Study||8
10156615|NCT02900378|11287306|FG000|STARTED|Randomization (Visit 2)||310
10156616|NCT02900378|11287307|FG001|STARTED|Randomization (Visit 2)||311
10156617|NCT02900378|11287306|FG000|COMPLETED|Randomization (Visit 2)||287
10156618|NCT02900378|11287307|FG001|COMPLETED|Randomization (Visit 2)||283
10156619|NCT02900378|11287306|FG000|NOT COMPLETED|Randomization (Visit 2)||23
10156620|NCT02900378|11287307|FG001|NOT COMPLETED|Randomization (Visit 2)||28
10156621|NCT02900378|11287306|FG000|STARTED|Treatment Phase||309
10156622|NCT02900378|11287307|FG001|STARTED|Treatment Phase||310
10156623|NCT02900378|11287306|FG000|Full Analysis Set|Treatment Phase||302
10156624|NCT02900378|11287307|FG001|Full Analysis Set|Treatment Phase||302
10156625|NCT02900378|11287306|FG000|COMPLETED|Treatment Phase||309
10156626|NCT02900378|11287307|FG001|COMPLETED|Treatment Phase||310
10156627|NCT02900378|11287306|FG000|NOT COMPLETED|Treatment Phase||0
10156628|NCT02900378|11287307|FG001|NOT COMPLETED|Treatment Phase||0
10156629|NCT02901054|11287313|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
10156630|NCT02901054|11287313|FG000|COMPLETED|Overall Study||15
10156631|NCT02901054|11287313|FG000|NOT COMPLETED|Overall Study||4
10156632|NCT02901080|11287317|FG000|STARTED|Overall Study||161
10156633|NCT02901080|11287317|FG000|COMPLETED|Overall Study||112
10156634|NCT02901080|11287317|FG000|NOT COMPLETED|Overall Study||49
10156635|NCT02901249|11287323|FG000|STARTED|Overall Study||68
10156636|NCT02901249|11287323|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
10156637|NCT02901249|11287323|FG000|NOT COMPLETED|Overall Study||25
10156638|NCT02901275|11287327|FG000|STARTED|Overall Study||29
10156639|NCT02901275|11287327|FG000|Placebo + Placebo|Overall Study||29
10156640|NCT02901275|11287327|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
10156641|NCT02901275|11287327|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
10156642|NCT02901275|11287327|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
10156643|NCT02901275|11287327|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
10156644|NCT02901275|11287327|FG000|COMPLETED|Overall Study||29
10156645|NCT02901275|11287327|FG000|NOT COMPLETED|Overall Study||0
10156646|NCT02901431|11287347|FG000|STARTED|PK Part||12
10156647|NCT02901431|11287348|FG001|STARTED|PK Part||11
10156648|NCT02901431|11287349|FG002|STARTED|PK Part||15
10156649|NCT02901431|11287350|FG003|STARTED|PK Part||0
10156650|NCT02901431|11287351|FG004|STARTED|PK Part||0
10156651|NCT02901431|11287352|FG005|STARTED|PK Part||0
10156652|NCT02901431|11287353|FG006|STARTED|PK Part||0
10156653|NCT02901431|11287354|FG007|STARTED|PK Part||0
10156654|NCT02901431|11287355|FG008|STARTED|PK Part||0
10156655|NCT02901431|11287356|FG009|STARTED|PK Part||0
10156656|NCT02901431|11287357|FG010|STARTED|PK Part||0
10156657|NCT02901431|11287358|FG011|STARTED|PK Part||0
10156658|NCT02901431|11287359|FG012|STARTED|PK Part||0
10156659|NCT02901431|11287347|FG000|COMPLETED|PK Part||5
10156660|NCT02901431|11287348|FG001|COMPLETED|PK Part||5
10156661|NCT02901431|11287349|FG002|COMPLETED|PK Part||6
10156662|NCT02901431|11287350|FG003|COMPLETED|PK Part||0
10156663|NCT02901431|11287351|FG004|COMPLETED|PK Part||0
10156664|NCT02901431|11287352|FG005|COMPLETED|PK Part||0
10156665|NCT02901431|11287353|FG006|COMPLETED|PK Part||0
10156666|NCT02901431|11287354|FG007|COMPLETED|PK Part||0
10156667|NCT02901431|11287355|FG008|COMPLETED|PK Part||0
10156668|NCT02901431|11287356|FG009|COMPLETED|PK Part||0
10156669|NCT02901431|11287357|FG010|COMPLETED|PK Part||0
10156670|NCT02901431|11287358|FG011|COMPLETED|PK Part||0
10156671|NCT02901431|11287359|FG012|COMPLETED|PK Part||0
10156672|NCT02901431|11287347|FG000|NOT COMPLETED|PK Part||7
10156673|NCT02901431|11287348|FG001|NOT COMPLETED|PK Part||6
10156674|NCT02901431|11287349|FG002|NOT COMPLETED|PK Part||9
10156675|NCT02901431|11287350|FG003|NOT COMPLETED|PK Part||0
10156676|NCT02901431|11287351|FG004|NOT COMPLETED|PK Part||0
10156677|NCT02901431|11287352|FG005|NOT COMPLETED|PK Part||0
10156678|NCT02901431|11287353|FG006|NOT COMPLETED|PK Part||0
10156679|NCT02901431|11287354|FG007|NOT COMPLETED|PK Part||0
10156680|NCT02901431|11287355|FG008|NOT COMPLETED|PK Part||0
10156681|NCT02901431|11287356|FG009|NOT COMPLETED|PK Part||0
10156682|NCT02901431|11287357|FG010|NOT COMPLETED|PK Part||0
10156683|NCT02901431|11287358|FG011|NOT COMPLETED|PK Part||0
10156684|NCT02901431|11287359|FG012|NOT COMPLETED|PK Part||0
10156685|NCT02901431|11287347|FG000|STARTED|Main Treatment Part||0
10156686|NCT02901431|11287348|FG001|STARTED|Main Treatment Part||0
10156687|NCT02901431|11287349|FG002|STARTED|Main Treatment Part||0
10156688|NCT02901431|11287350|FG003|STARTED|Main Treatment Part||112
10156689|NCT02901431|11287351|FG004|STARTED|Main Treatment Part||57
10156690|NCT02901431|11287352|FG005|STARTED|Main Treatment Part||66
10156691|NCT02901431|11287353|FG006|STARTED|Main Treatment Part||66
10156692|NCT02901431|11287354|FG007|STARTED|Main Treatment Part||7
10156693|NCT02901431|11287355|FG008|STARTED|Main Treatment Part||0
10156694|NCT02901431|11287356|FG009|STARTED|Main Treatment Part||0
10156695|NCT02901431|11287357|FG010|STARTED|Main Treatment Part||0
10156696|NCT02901431|11287358|FG011|STARTED|Main Treatment Part||0
10156697|NCT02901431|11287359|FG012|STARTED|Main Treatment Part||0
10156698|NCT02901431|11287347|FG000|COMPLETED|Main Treatment Part||0
10156699|NCT02901431|11287348|FG001|COMPLETED|Main Treatment Part||0
10156700|NCT02901431|11287349|FG002|COMPLETED|Main Treatment Part||0
10156701|NCT02901431|11287350|FG003|COMPLETED|Main Treatment Part||86
10156702|NCT02901431|11287351|FG004|COMPLETED|Main Treatment Part||50
10156703|NCT02901431|11287352|FG005|COMPLETED|Main Treatment Part||54
10156704|NCT02901431|11287353|FG006|COMPLETED|Main Treatment Part||55
10156705|NCT02901431|11287354|FG007|COMPLETED|Main Treatment Part||7
10156706|NCT02901431|11287355|FG008|COMPLETED|Main Treatment Part||0
10156707|NCT02901431|11287356|FG009|COMPLETED|Main Treatment Part||0
10156708|NCT02901431|11287357|FG010|COMPLETED|Main Treatment Part||0
10156709|NCT02901431|11287358|FG011|COMPLETED|Main Treatment Part||0
10156710|NCT02901431|11287359|FG012|COMPLETED|Main Treatment Part||0
10156711|NCT02901431|11287347|FG000|NOT COMPLETED|Main Treatment Part||0
10156712|NCT02901431|11287348|FG001|NOT COMPLETED|Main Treatment Part||0
10156713|NCT02901431|11287349|FG002|NOT COMPLETED|Main Treatment Part||0
10156714|NCT02901431|11287350|FG003|NOT COMPLETED|Main Treatment Part||26
10156715|NCT02901431|11287351|FG004|NOT COMPLETED|Main Treatment Part||7
10156716|NCT02901431|11287352|FG005|NOT COMPLETED|Main Treatment Part||12
10156717|NCT02901431|11287353|FG006|NOT COMPLETED|Main Treatment Part||11
10156718|NCT02901431|11287354|FG007|NOT COMPLETED|Main Treatment Part||0
10156719|NCT02901431|11287355|FG008|NOT COMPLETED|Main Treatment Part||0
10156720|NCT02901431|11287356|FG009|NOT COMPLETED|Main Treatment Part||0
10156721|NCT02901431|11287357|FG010|NOT COMPLETED|Main Treatment Part||0
10156722|NCT02901431|11287358|FG011|NOT COMPLETED|Main Treatment Part||0
10156723|NCT02901431|11287359|FG012|NOT COMPLETED|Main Treatment Part||0
10156724|NCT02901431|11287347|FG000|STARTED|Open Label Part||0
10156725|NCT02901431|11287348|FG001|STARTED|Open Label Part||0
10156726|NCT02901431|11287349|FG002|STARTED|Open Label Part||0
10156727|NCT02901431|11287350|FG003|STARTED|Open Label Part||0
10156728|NCT02901431|11287351|FG004|STARTED|Open Label Part||0
10156729|NCT02901431|11287352|FG005|STARTED|Open Label Part||0
10156730|NCT02901431|11287353|FG006|STARTED|Open Label Part||0
9710299|NCT04637997|10809876|FG000|STARTED|Overall Study||9
9710300|NCT04637997|10809877|FG001|STARTED|Overall Study||9
9710301|NCT04637997|10809876|FG000|COMPLETED|Overall Study||9
9710302|NCT04637997|10809877|FG001|COMPLETED|Overall Study||9
9710303|NCT04637997|10809876|FG000|NOT COMPLETED|Overall Study||0
9710304|NCT04637997|10809877|FG001|NOT COMPLETED|Overall Study||0
9710305|NCT04634903|10809890|FG000|STARTED|Overall Study||818
9710306|NCT04634903|10809891|FG001|STARTED|Overall Study||821
9710307|NCT04634903|10809892|FG002|STARTED|Overall Study||813
9710308|NCT04634903|10809890|FG000|COMPLETED|Overall Study||669
9710309|NCT04634903|10809891|FG001|COMPLETED|Overall Study||732
9710310|NCT04634903|10809892|FG002|COMPLETED|Overall Study||653
9710311|NCT04634903|10809890|FG000|NOT COMPLETED|Overall Study||149
9710312|NCT04634903|10809891|FG001|NOT COMPLETED|Overall Study||89
9710313|NCT04634903|10809892|FG002|NOT COMPLETED|Overall Study||160
9710314|NCT04633642|10809902|FG000|STARTED|Overall Study|27 participants|27
9710315|NCT04633642|10809903|FG001|STARTED|Overall Study|24 participants|24
9710316|NCT04633642|10809902|FG000|COMPLETED|Overall Study|26 participants|26
9710317|NCT04633642|10809903|FG001|COMPLETED|Overall Study|22 participants|22
9710318|NCT04633642|10809902|FG000|NOT COMPLETED|Overall Study||1
9710319|NCT04633642|10809903|FG001|NOT COMPLETED|Overall Study||2
9710320|NCT04633174|10809909|FG000|STARTED|Overall Study||1
9710321|NCT04633174|10809909|FG000|COMPLETED|Overall Study||1
9710322|NCT04633174|10809909|FG000|NOT COMPLETED|Overall Study||0
9710323|NCT04628221|10809914|FG000|STARTED|Overall Study||40
9710324|NCT04628221|10809914|FG000|COMPLETED|Overall Study||40
9710325|NCT04628221|10809914|FG000|NOT COMPLETED|Overall Study||0
9710326|NCT04625426|10809921|FG000|STARTED|Overall Study||23
9710327|NCT04625426|10809922|FG001|STARTED|Overall Study||37
9710328|NCT04625426|10809923|FG002|STARTED|Overall Study||24
9710329|NCT04625426|10809921|FG000|COMPLETED|Overall Study||9
9710330|NCT04625426|10809922|FG001|COMPLETED|Overall Study||12
9710331|NCT04625426|10809923|FG002|COMPLETED|Overall Study||12
9710332|NCT04625426|10809921|FG000|NOT COMPLETED|Overall Study||14
9710333|NCT04625426|10809922|FG001|NOT COMPLETED|Overall Study||25
9710334|NCT04625426|10809923|FG002|NOT COMPLETED|Overall Study||12
9710335|NCT04617509|10809931|FG000|STARTED|Period 1: Part 1 Formulation A||14
9710336|NCT04617509|10809932|FG001|STARTED|Period 1: Part 1 Formulation A||0
9710337|NCT04617509|10809933|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
9710338|NCT04617509|10809931|FG000|COMPLETED|Period 1: Part 1 Formulation A||14
9710339|NCT04617509|10809932|FG001|COMPLETED|Period 1: Part 1 Formulation A||0
9710340|NCT04617509|10809933|FG002|COMPLETED|Period 1: Part 1 Formulation A||0
9710341|NCT04617509|10809931|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0
9710342|NCT04617509|10809932|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0
9710343|NCT04617509|10809933|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0
9710344|NCT04617509|10809931|FG000|STARTED|Period 2: Part 1 Formulation B||0
9710345|NCT04617509|10809932|FG001|STARTED|Period 2: Part 1 Formulation B||14
9710346|NCT04617509|10809933|FG002|STARTED|Period 2: Part 1 Formulation B||0
10156731|NCT02901431|11287354|FG007|STARTED|Open Label Part||0
10156732|NCT02901431|11287355|FG008|STARTED|Open Label Part||68
10156733|NCT02901431|11287356|FG009|STARTED|Open Label Part||35
10156734|NCT02901431|11287357|FG010|STARTED|Open Label Part||40
10156735|NCT02901431|11287358|FG011|STARTED|Open Label Part||46
10156736|NCT02901431|11287359|FG012|STARTED|Open Label Part||5
10156737|NCT02901431|11287347|FG000|COMPLETED|Open Label Part||0
10156738|NCT02901431|11287348|FG001|COMPLETED|Open Label Part||0
10156739|NCT02901431|11287349|FG002|COMPLETED|Open Label Part||0
10156740|NCT02901431|11287350|FG003|COMPLETED|Open Label Part||0
10156741|NCT02901431|11287351|FG004|COMPLETED|Open Label Part||0
10156742|NCT02901431|11287352|FG005|COMPLETED|Open Label Part||0
10156743|NCT02901431|11287353|FG006|COMPLETED|Open Label Part||0
10156744|NCT02901431|11287354|FG007|COMPLETED|Open Label Part||0
10156745|NCT02901431|11287355|FG008|COMPLETED|Open Label Part||20
10156746|NCT02901431|11287356|FG009|COMPLETED|Open Label Part||11
10156747|NCT02901431|11287357|FG010|COMPLETED|Open Label Part||11
10156748|NCT02901431|11287358|FG011|COMPLETED|Open Label Part||7
10156749|NCT02901431|11287359|FG012|COMPLETED|Open Label Part||2
10156750|NCT02901431|11287347|FG000|NOT COMPLETED|Open Label Part||0
10156751|NCT02901431|11287348|FG001|NOT COMPLETED|Open Label Part||0
10156752|NCT02901431|11287349|FG002|NOT COMPLETED|Open Label Part||0
10156753|NCT02901431|11287350|FG003|NOT COMPLETED|Open Label Part||0
10156754|NCT02901431|11287351|FG004|NOT COMPLETED|Open Label Part||0
10156755|NCT02901431|11287352|FG005|NOT COMPLETED|Open Label Part||0
10156756|NCT02901431|11287353|FG006|NOT COMPLETED|Open Label Part||0
10156757|NCT02901431|11287354|FG007|NOT COMPLETED|Open Label Part||0
10156758|NCT02901431|11287355|FG008|NOT COMPLETED|Open Label Part||48
10156759|NCT02901431|11287356|FG009|NOT COMPLETED|Open Label Part||24
10156760|NCT02901431|11287357|FG010|NOT COMPLETED|Open Label Part||29
10156761|NCT02901431|11287358|FG011|NOT COMPLETED|Open Label Part||39
10156762|NCT02901431|11287359|FG012|NOT COMPLETED|Open Label Part||3
9710347|NCT04617509|10809931|FG000|COMPLETED|Period 2: Part 1 Formulation B||0
9710348|NCT04617509|10809932|FG001|COMPLETED|Period 2: Part 1 Formulation B||14
9710349|NCT04617509|10809933|FG002|COMPLETED|Period 2: Part 1 Formulation B||0
9710350|NCT04617509|10809931|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0
9710351|NCT04617509|10809932|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0
9710352|NCT04617509|10809933|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0
9710353|NCT04617509|10809931|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
9710354|NCT04617509|10809932|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
9710355|NCT04617509|10809933|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
9710356|NCT04617509|10809931|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
9710357|NCT04617509|10809932|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
9710358|NCT04617509|10809933|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
9710359|NCT04617509|10809931|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
9710360|NCT04617509|10809932|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
9710361|NCT04617509|10809933|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
9710362|NCT04616430|10809946|FG000|STARTED|Overall Study||30
9710363|NCT04616430|10809947|FG001|STARTED|Overall Study||30
9710364|NCT04616430|10809948|FG002|STARTED|Overall Study||30
9710365|NCT04616430|10809946|FG000|COMPLETED|Overall Study||23
9710366|NCT04616430|10809947|FG001|COMPLETED|Overall Study||2
9710367|NCT04616430|10809948|FG002|COMPLETED|Overall Study||0
9710368|NCT04616430|10809946|FG000|NOT COMPLETED|Overall Study||7
9710369|NCT04616430|10809947|FG001|NOT COMPLETED|Overall Study||28
9710370|NCT04616430|10809948|FG002|NOT COMPLETED|Overall Study||30
9730214|NCT00124514|10829942|FG004|STARTED|Overall Study||2
9730215|NCT00124514|10829938|FG000|COMPLETED|Overall Study||2
9730216|NCT00124514|10829939|FG001|COMPLETED|Overall Study||7
9730217|NCT00124514|10829940|FG002|COMPLETED|Overall Study||7
9730218|NCT00124514|10829941|FG003|COMPLETED|Overall Study||5
9730219|NCT00124514|10829942|FG004|COMPLETED|Overall Study||1
9730220|NCT00124514|10829938|FG000|NOT COMPLETED|Overall Study||4
9730221|NCT00124514|10829939|FG001|NOT COMPLETED|Overall Study||2
9730222|NCT00124514|10829940|FG002|NOT COMPLETED|Overall Study||1
9730223|NCT00124514|10829941|FG003|NOT COMPLETED|Overall Study||1
9730224|NCT00124514|10829942|FG004|NOT COMPLETED|Overall Study||1
9730225|NCT00124579|10829949|FG000|STARTED|Induction||7
9730226|NCT00124579|10829949|FG000|COMPLETED|Induction||2
9730227|NCT00124579|10829949|FG000|NOT COMPLETED|Induction||5
9730228|NCT00124579|10829949|FG000|STARTED|Maintenance||2
9730229|NCT00124579|10829949|FG000|COMPLETED|Maintenance||0
9730230|NCT00124579|10829949|FG000|NOT COMPLETED|Maintenance||2
9730231|NCT00124618|10829954|FG000|STARTED|Overall Study||58
9730232|NCT00124618|10829954|FG000|COMPLETED|Overall Study||57
10156763|NCT02901899|11287384|FG000|STARTED|Reached 1st Response Assessment||45
10156764|NCT02901899|11287384|FG000|Registered|Reached 1st Response Assessment||45
10156765|NCT02901899|11287384|FG000|Started Treatment|Reached 1st Response Assessment||43
10156766|NCT02901899|11287384|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
10156767|NCT02901899|11287384|FG000|COMPLETED|Reached 1st Response Assessment||37
10156768|NCT02901899|11287384|FG000|NOT COMPLETED|Reached 1st Response Assessment||8
10156769|NCT02901899|11287384|FG000|STARTED|Continued Treatment After 1st Response||37
10156770|NCT02901899|11287384|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
10156771|NCT02901899|11287384|FG000|COMPLETED|Continued Treatment After 1st Response||21
10156772|NCT02901899|11287384|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16
9730233|NCT00124618|10829954|FG000|NOT COMPLETED|Overall Study||1
9730234|NCT00124657|10829961|FG000|STARTED|Overall Study||18
9730235|NCT00124657|10829962|FG001|STARTED|Overall Study||5
9730236|NCT00124657|10829963|FG002|STARTED|Overall Study||39
9730237|NCT00124657|10829961|FG000|COMPLETED|Overall Study||2
9730238|NCT00124657|10829962|FG001|COMPLETED|Overall Study||0
9730239|NCT00124657|10829963|FG002|COMPLETED|Overall Study||7
9730240|NCT00124657|10829961|FG000|NOT COMPLETED|Overall Study||16
10197275|NCT03372434|11325242|FG000|COMPLETED|Overall Study||76
10156773|NCT02901899|11287384|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
10156774|NCT02901899|11287384|FG000|COMPLETED|Follow up||27
10156775|NCT02901899|11287384|FG000|NOT COMPLETED|Follow up||16
10156776|NCT02901951|11287388|FG000|STARTED|Overall Study||103
10156777|NCT02901951|11287388|FG000|COMPLETED|Overall Study||103
10156778|NCT02901951|11287388|FG000|NOT COMPLETED|Overall Study||0
10156779|NCT02902081|11287392|FG000|STARTED|Overall Study||38
10156780|NCT02902081|11287392|FG000|COMPLETED|Overall Study||38
10156781|NCT02902081|11287392|FG000|NOT COMPLETED|Overall Study||0
10156782|NCT02902146|11287402|FG000|STARTED|Overall Study||381
10156783|NCT02902146|11287403|FG001|STARTED|Overall Study||376
10156784|NCT02902146|11287402|FG000|COMPLETED|Overall Study||381
10156785|NCT02902146|11287403|FG001|COMPLETED|Overall Study||376
10156786|NCT02902146|11287402|FG000|NOT COMPLETED|Overall Study||0
10156787|NCT02902146|11287403|FG001|NOT COMPLETED|Overall Study||0
10156788|NCT02902172|11287411|FG000|STARTED|Overall Study||16
10156789|NCT02902172|11287412|FG001|STARTED|Overall Study||20
10156790|NCT02902172|11287411|FG000|COMPLETED|Overall Study||16
10156791|NCT02902172|11287412|FG001|COMPLETED|Overall Study||20
10156792|NCT02902172|11287411|FG000|NOT COMPLETED|Overall Study||0
10156793|NCT02902172|11287412|FG001|NOT COMPLETED|Overall Study||0
10156794|NCT02902237|11287419|FG000|STARTED|Overall Study||17
10156795|NCT02902237|11287419|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
10156796|NCT02902237|11287419|FG000|NOT COMPLETED|Overall Study||0
10156797|NCT02902770|11287433|FG000|STARTED|Overall Study||50
10156798|NCT02902770|11287434|FG001|STARTED|Overall Study||50
10156799|NCT02902770|11287435|FG002|STARTED|Overall Study||50
10156800|NCT02902770|11287433|FG000|COMPLETED|Overall Study||50
10156801|NCT02902770|11287434|FG001|COMPLETED|Overall Study||50
10156802|NCT02902770|11287435|FG002|COMPLETED|Overall Study||50
10156803|NCT02902770|11287433|FG000|NOT COMPLETED|Overall Study||0
10156804|NCT02902770|11287434|FG001|NOT COMPLETED|Overall Study||0
10156805|NCT02902770|11287435|FG002|NOT COMPLETED|Overall Study||0
10156806|NCT02902809|11287443|FG000|STARTED|Overall Study||28
10156807|NCT02902809|11287443|FG000|Treatment Received|Overall Study||28
10156808|NCT02902809|11287443|FG000|Treatment Completed|Overall Study||2
10156809|NCT02902809|11287443|FG000|COMPLETED|Overall Study||0
10156810|NCT02902809|11287443|FG000|NOT COMPLETED|Overall Study||28
10156811|NCT02902913|11287447|FG000|STARTED|Overall Study||9
10156812|NCT02902913|11287447|FG000|First Intervention (1 Day)|Overall Study||9
10156813|NCT02902913|11287447|FG000|Washout (7 Days)|Overall Study||9
10156814|NCT02902913|11287447|FG000|Second Intervention (1 Day)|Overall Study||9
10156815|NCT02902913|11287447|FG000|Washout (7 Days)|Overall Study||9
10156816|NCT02902913|11287447|FG000|Third Intervention (1 Day)|Overall Study||9
10156817|NCT02902913|11287447|FG000|Washout (7 Days)|Overall Study||9
10156818|NCT02902913|11287447|FG000|Ibuprofen (400mg)|Overall Study||9
10156819|NCT02902913|11287447|FG000|COMPLETED|Overall Study||9
10156820|NCT02902913|11287447|FG000|NOT COMPLETED|Overall Study||0
10156821|NCT02902965|11287455|FG000|STARTED|Overall Study||74
10156822|NCT02902965|11287455|FG000|COMPLETED|Overall Study||64
10156823|NCT02902965|11287455|FG000|NOT COMPLETED|Overall Study||10
10156824|NCT02903030|11287462|FG000|STARTED|First Intervention (8 Weeks)||8
10156825|NCT02903030|11287463|FG001|STARTED|First Intervention (8 Weeks)||5
10156826|NCT02903030|11287462|FG000|Received Intervention|First Intervention (8 Weeks)||6
10156827|NCT02903030|11287463|FG001|Received Intervention|First Intervention (8 Weeks)||4
10156828|NCT02903030|11287462|FG000|COMPLETED|First Intervention (8 Weeks)||6
10156829|NCT02903030|11287463|FG001|COMPLETED|First Intervention (8 Weeks)||4
10156830|NCT02903030|11287462|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2
10156831|NCT02903030|11287463|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
10156832|NCT02903030|11287462|FG000|STARTED|Washout (3 Weeks)||6
10156833|NCT02903030|11287463|FG001|STARTED|Washout (3 Weeks)||4
10156834|NCT02903030|11287462|FG000|COMPLETED|Washout (3 Weeks)||6
10156835|NCT02903030|11287463|FG001|COMPLETED|Washout (3 Weeks)||4
10156836|NCT02903030|11287462|FG000|NOT COMPLETED|Washout (3 Weeks)||0
10156837|NCT02903030|11287463|FG001|NOT COMPLETED|Washout (3 Weeks)||0
10156838|NCT02903030|11287462|FG000|STARTED|Second Intervention (8 Weeks)||6
10156839|NCT02903030|11287463|FG001|STARTED|Second Intervention (8 Weeks)||4
10156840|NCT02903030|11287462|FG000|COMPLETED|Second Intervention (8 Weeks)||6
10156841|NCT02903030|11287463|FG001|COMPLETED|Second Intervention (8 Weeks)||4
10156842|NCT02903030|11287462|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
10156843|NCT02903030|11287463|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10156844|NCT02903121|11287474|FG000|STARTED|Overall Study||57
10156845|NCT02903121|11287475|FG001|STARTED|Overall Study||52
10156846|NCT02903121|11287474|FG000|COMPLETED|Overall Study||34
10156847|NCT02903121|11287475|FG001|COMPLETED|Overall Study||38
10156848|NCT02903121|11287474|FG000|NOT COMPLETED|Overall Study||23
10156849|NCT02903121|11287475|FG001|NOT COMPLETED|Overall Study||14
10156850|NCT02903238|11287481|FG000|STARTED|Overall Study||21
10156851|NCT02903238|11287481|FG000|COMPLETED|Overall Study||17
10156852|NCT02903238|11287481|FG000|NOT COMPLETED|Overall Study||4
10156853|NCT02903368|11287488|FG000|STARTED|Overall Study||59
10156854|NCT02903368|11287489|FG001|STARTED|Overall Study||59
10156855|NCT02903368|11287488|FG000|COMPLETED|Overall Study||55
10156856|NCT02903368|11287489|FG001|COMPLETED|Overall Study||59
10156857|NCT02903368|11287488|FG000|NOT COMPLETED|Overall Study||4
10156858|NCT02903368|11287489|FG001|NOT COMPLETED|Overall Study||0
10156859|NCT02903394|11287500|FG000|STARTED|Overall Study||5
10156860|NCT02903394|11287501|FG001|STARTED|Overall Study||50
10156861|NCT02903394|11287500|FG000|COMPLETED|Overall Study||5
10156862|NCT02903394|11287501|FG001|COMPLETED|Overall Study||50
10156863|NCT02903394|11287500|FG000|NOT COMPLETED|Overall Study||0
10156864|NCT02903394|11287501|FG001|NOT COMPLETED|Overall Study||0
10156865|NCT02903407|11287510|FG000|STARTED|Overall Study||4
10156866|NCT02903407|11287511|FG001|STARTED|Overall Study||3
10156867|NCT02903407|11287510|FG000|COMPLETED|Overall Study||4
10156868|NCT02903407|11287511|FG001|COMPLETED|Overall Study||3
10156869|NCT02903407|11287510|FG000|NOT COMPLETED|Overall Study||0
10156870|NCT02903407|11287511|FG001|NOT COMPLETED|Overall Study||0
10156871|NCT02903420|11287517|FG000|STARTED|Overall Study||28
10156872|NCT02903420|11287517|FG000|COMPLETED|Overall Study||25
10156873|NCT02903420|11287517|FG000|NOT COMPLETED|Overall Study||3
10156874|NCT02903446|11287523|FG000|STARTED|Overall Study||10
10156875|NCT02903446|11287524|FG001|STARTED|Overall Study||10
10156876|NCT02903446|11287523|FG000|COMPLETED|Overall Study||10
10156877|NCT02903446|11287524|FG001|COMPLETED|Overall Study||10
10156878|NCT02903446|11287523|FG000|NOT COMPLETED|Overall Study||0
10156879|NCT02903446|11287524|FG001|NOT COMPLETED|Overall Study||0
10156880|NCT02903511|11287532|FG000|STARTED|Overall Study||26
10156881|NCT02903511|11287533|FG001|STARTED|Overall Study||25
10156882|NCT02903511|11287532|FG000|Received Intervention|Overall Study||25
10156883|NCT02903511|11287533|FG001|Received Intervention|Overall Study||25
10156884|NCT02903511|11287532|FG000|COMPLETED|Overall Study||22
10156885|NCT02903511|11287533|FG001|COMPLETED|Overall Study||23
10156886|NCT02903511|11287532|FG000|NOT COMPLETED|Overall Study||4
10156887|NCT02903511|11287533|FG001|NOT COMPLETED|Overall Study||2
10156888|NCT02903836|11287542|FG000|STARTED|Overall Study||74
10156889|NCT02903836|11287543|FG001|STARTED|Overall Study||73
10156890|NCT02903836|11287544|FG002|STARTED|Overall Study||77
10156891|NCT02903836|11287542|FG000|COMPLETED|Overall Study||71
10156892|NCT02903836|11287543|FG001|COMPLETED|Overall Study||69
10156893|NCT02903836|11287544|FG002|COMPLETED|Overall Study||73
10156894|NCT02903836|11287542|FG000|NOT COMPLETED|Overall Study||3
10156895|NCT02903836|11287543|FG001|NOT COMPLETED|Overall Study||4
10156896|NCT02903836|11287544|FG002|NOT COMPLETED|Overall Study||4
10156897|NCT02903966|11287554|FG000|STARTED|Part A (Day 1 to 43)||12
10156898|NCT02903966|11287555|FG001|STARTED|Part A (Day 1 to 43)||24
10156899|NCT02903966|11287554|FG000|COMPLETED|Part A (Day 1 to 43)||11
10156900|NCT02903966|11287555|FG001|COMPLETED|Part A (Day 1 to 43)||24
10156901|NCT02903966|11287554|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1
10156902|NCT02903966|11287555|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0
10156903|NCT02903966|11287554|FG000|STARTED|Part B (Day 44 to 112)||11
9710371|NCT04615507|10809958|FG000|STARTED|Period 1||34
9710372|NCT04615507|10809959|FG001|STARTED|Period 1||34
9710373|NCT04615507|10809958|FG000|COMPLETED|Period 1||32
9710374|NCT04615507|10809959|FG001|COMPLETED|Period 1||33
9710375|NCT04615507|10809958|FG000|NOT COMPLETED|Period 1||2
9710376|NCT04615507|10809959|FG001|NOT COMPLETED|Period 1||1
9710377|NCT04615507|10809958|FG000|STARTED|Period 2||32
9710378|NCT04615507|10809959|FG001|STARTED|Period 2||33
9710379|NCT04615507|10809958|FG000|COMPLETED|Period 2||30
9710380|NCT04615507|10809959|FG001|COMPLETED|Period 2||31
9710381|NCT04615507|10809958|FG000|NOT COMPLETED|Period 2||2
9710382|NCT04615507|10809959|FG001|NOT COMPLETED|Period 2||2
9710383|NCT04615507|10809958|FG000|STARTED|Period 3||30
9710384|NCT04615507|10809959|FG001|STARTED|Period 3||31
9710385|NCT04615507|10809958|FG000|COMPLETED|Period 3||30
9710386|NCT04615507|10809959|FG001|COMPLETED|Period 3||30
9710387|NCT04615507|10809958|FG000|NOT COMPLETED|Period 3||0
9710388|NCT04615507|10809959|FG001|NOT COMPLETED|Period 3||1
9730241|NCT00124657|10829962|FG001|NOT COMPLETED|Overall Study||5
9730242|NCT00124657|10829963|FG002|NOT COMPLETED|Overall Study||32
9730243|NCT00124709|10829986|FG000|STARTED|Overall Study||546
9730244|NCT00124709|10829987|FG001|STARTED|Overall Study||545
9730245|NCT00124709|10829986|FG000|Patients Who Received Study Medication|Overall Study||543
9730246|NCT00124709|10829987|FG001|Patients Who Received Study Medication|Overall Study||544
9730247|NCT00124709|10829986|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
9730248|NCT00124709|10829987|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
9730249|NCT00124709|10829986|FG000|NOT COMPLETED|Overall Study||255
9730250|NCT00124709|10829987|FG001|NOT COMPLETED|Overall Study||272
9730251|NCT00124735|10830003|FG000|STARTED|Overall Study||5
9730252|NCT00124735|10830004|FG001|STARTED|Overall Study||8
10156904|NCT02903966|11287555|FG001|STARTED|Part B (Day 44 to 112)||24
10156905|NCT02903966|11287554|FG000|COMPLETED|Part B (Day 44 to 112)||11
10156906|NCT02903966|11287555|FG001|COMPLETED|Part B (Day 44 to 112)||22
10156907|NCT02903966|11287554|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0
10156908|NCT02903966|11287555|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2
9730253|NCT00124735|10830005|FG002|STARTED|Overall Study||18
9730254|NCT00124735|10830006|FG003|STARTED|Overall Study||21
9730255|NCT00124735|10830007|FG004|STARTED|Overall Study||19
10156909|NCT02904057|11287569|FG000|STARTED|Overall Study||19
10156910|NCT02904057|11287570|FG001|STARTED|Overall Study||10
10156911|NCT02904057|11287569|FG000|COMPLETED|Overall Study||19
10156912|NCT02904057|11287570|FG001|COMPLETED|Overall Study||10
10156913|NCT02904057|11287569|FG000|NOT COMPLETED|Overall Study||0
9730256|NCT00124735|10830008|FG005|STARTED|Overall Study||7
9730257|NCT00124735|10830009|FG006|STARTED|Overall Study||6
9730258|NCT00124735|10830010|FG007|STARTED|Overall Study||20
9730259|NCT00124735|10830011|FG008|STARTED|Overall Study||25
9730260|NCT00124735|10830012|FG009|STARTED|Overall Study||20
10156914|NCT02904057|11287570|FG001|NOT COMPLETED|Overall Study||0
10156915|NCT02904096|11287578|FG000|STARTED|Overall Study||130
10156916|NCT02904096|11287579|FG001|STARTED|Overall Study||126
10156917|NCT02904096|11287578|FG000|COMPLETED|Overall Study||111
10156918|NCT02904096|11287579|FG001|COMPLETED|Overall Study||105
10156919|NCT02904096|11287578|FG000|NOT COMPLETED|Overall Study||19
10156920|NCT02904096|11287579|FG001|NOT COMPLETED|Overall Study||21
10156921|NCT02904200|11287585|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
10156922|NCT02904200|11287586|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
10156923|NCT02904200|11287585|FG000|COMPLETED|Overall Study||1
10156924|NCT02904200|11287586|FG001|COMPLETED|Overall Study||0
10156925|NCT02904200|11287585|FG000|NOT COMPLETED|Overall Study||1
10156926|NCT02904200|11287586|FG001|NOT COMPLETED|Overall Study||0
10156927|NCT02904226|11287598|FG000|STARTED|Overall Study||40
10156928|NCT02904226|11287599|FG001|STARTED|Overall Study||31
10156929|NCT02904226|11287600|FG002|STARTED|Overall Study||30
10156930|NCT02904226|11287601|FG003|STARTED|Overall Study||100
10156931|NCT02904226|11287602|FG004|STARTED|Overall Study||11
10156932|NCT02904226|11287603|FG005|STARTED|Overall Study||0
10156933|NCT02904226|11287604|FG006|STARTED|Overall Study||6
10156934|NCT02904226|11287605|FG007|STARTED|Overall Study||0
10156935|NCT02904226|11287598|FG000|COMPLETED|Overall Study||0
10156936|NCT02904226|11287599|FG001|COMPLETED|Overall Study||2
10156937|NCT02904226|11287600|FG002|COMPLETED|Overall Study||0
10156938|NCT02904226|11287601|FG003|COMPLETED|Overall Study||4
10156939|NCT02904226|11287602|FG004|COMPLETED|Overall Study||0
10156940|NCT02904226|11287603|FG005|COMPLETED|Overall Study||0
10156941|NCT02904226|11287604|FG006|COMPLETED|Overall Study||0
10156942|NCT02904226|11287605|FG007|COMPLETED|Overall Study||0
10156943|NCT02904226|11287598|FG000|NOT COMPLETED|Overall Study||40
10156944|NCT02904226|11287599|FG001|NOT COMPLETED|Overall Study||29
10156945|NCT02904226|11287600|FG002|NOT COMPLETED|Overall Study||30
10156946|NCT02904226|11287601|FG003|NOT COMPLETED|Overall Study||96
10156947|NCT02904226|11287602|FG004|NOT COMPLETED|Overall Study||11
10156948|NCT02904226|11287603|FG005|NOT COMPLETED|Overall Study||0
10156949|NCT02904226|11287604|FG006|NOT COMPLETED|Overall Study||6
10156950|NCT02904226|11287605|FG007|NOT COMPLETED|Overall Study||0
10156951|NCT02904265|11287623|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
10156952|NCT02904265|11287624|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
10156953|NCT02904265|11287623|FG000|COMPLETED|Overall Study||0
10156954|NCT02904265|11287624|FG001|COMPLETED|Overall Study||0
10156955|NCT02904265|11287623|FG000|NOT COMPLETED|Overall Study||1
10156956|NCT02904265|11287624|FG001|NOT COMPLETED|Overall Study||2
10156957|NCT02904512|11287632|FG000|STARTED|Overall Study||9
10156958|NCT02904512|11287633|FG001|STARTED|Overall Study||7
10156959|NCT02904512|11287632|FG000|COMPLETED|Overall Study||6
10156960|NCT02904512|11287633|FG001|COMPLETED|Overall Study||7
10156961|NCT02904512|11287632|FG000|NOT COMPLETED|Overall Study||3
10156962|NCT02904512|11287633|FG001|NOT COMPLETED|Overall Study||0
10156963|NCT02904902|11287639|FG000|STARTED|Overall Study||15
10156964|NCT02904902|11287639|FG000|COMPLETED|Overall Study||14
10156965|NCT02904902|11287639|FG000|NOT COMPLETED|Overall Study||1
10156966|NCT02904915|11287645|FG000|STARTED|Overall Study||25
10156967|NCT02904915|11287646|FG001|STARTED|Overall Study||25
10156968|NCT02904915|11287645|FG000|COMPLETED|Overall Study||25
10156969|NCT02904915|11287646|FG001|COMPLETED|Overall Study||25
10156970|NCT02904915|11287645|FG000|NOT COMPLETED|Overall Study||0
10156971|NCT02904915|11287646|FG001|NOT COMPLETED|Overall Study||0
10156972|NCT02904954|11287654|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30
10156973|NCT02904954|11287655|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30
10156974|NCT02904954|11287654|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
10156975|NCT02904954|11287655|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
10156976|NCT02904954|11287654|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
10156977|NCT02904954|11287655|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
10156978|NCT02904954|11287654|FG000|STARTED|Adjuvant Durvalumab||26
10156979|NCT02904954|11287655|FG001|STARTED|Adjuvant Durvalumab||26
10156980|NCT02904954|11287654|FG000|COMPLETED|Adjuvant Durvalumab||5
10156981|NCT02904954|11287655|FG001|COMPLETED|Adjuvant Durvalumab||10
10156982|NCT02904954|11287654|FG000|NOT COMPLETED|Adjuvant Durvalumab||21
10156983|NCT02904954|11287655|FG001|NOT COMPLETED|Adjuvant Durvalumab||16
10156984|NCT02905006|11287669|FG000|STARTED|Overall Study||42
10156985|NCT02905006|11287670|FG001|STARTED|Overall Study||39
10156986|NCT02905006|11287671|FG002|STARTED|Overall Study||43
10156987|NCT02905006|11287672|FG003|STARTED|Overall Study||40
10156988|NCT02905006|11287673|FG004|STARTED|Overall Study||43
10156989|NCT02905006|11287674|FG005|STARTED|Overall Study||43
10156990|NCT02905006|11287669|FG000|Completed Treatment Period|Overall Study||37
10156991|NCT02905006|11287670|FG001|Completed Treatment Period|Overall Study||36
10156992|NCT02905006|11287671|FG002|Completed Treatment Period|Overall Study||38
10156993|NCT02905006|11287672|FG003|Completed Treatment Period|Overall Study||34
10156994|NCT02905006|11287673|FG004|Completed Treatment Period|Overall Study||40
10156995|NCT02905006|11287674|FG005|Completed Treatment Period|Overall Study||39
10156996|NCT02905006|11287669|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38
10156997|NCT02905006|11287670|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35
10156998|NCT02905006|11287671|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39
10156999|NCT02905006|11287672|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38
10157000|NCT02905006|11287673|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42
10157001|NCT02905006|11287674|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40
10157002|NCT02905006|11287669|FG000|Entered Safety Follow-up Period|Overall Study||4
10157003|NCT02905006|11287670|FG001|Entered Safety Follow-up Period|Overall Study||4
10157004|NCT02905006|11287671|FG002|Entered Safety Follow-up Period|Overall Study||4
10157005|NCT02905006|11287672|FG003|Entered Safety Follow-up Period|Overall Study||2
10157006|NCT02905006|11287673|FG004|Entered Safety Follow-up Period|Overall Study||1
10157007|NCT02905006|11287674|FG005|Entered Safety Follow-up Period|Overall Study||3
10157008|NCT02905006|11287669|FG000|COMPLETED|Overall Study||37
10157009|NCT02905006|11287670|FG001|COMPLETED|Overall Study||36
10157010|NCT02905006|11287671|FG002|COMPLETED|Overall Study||38
10157011|NCT02905006|11287672|FG003|COMPLETED|Overall Study||34
10157012|NCT02905006|11287673|FG004|COMPLETED|Overall Study||40
10157013|NCT02905006|11287674|FG005|COMPLETED|Overall Study||39
10157014|NCT02905006|11287669|FG000|NOT COMPLETED|Overall Study||5
10157015|NCT02905006|11287670|FG001|NOT COMPLETED|Overall Study||3
10157016|NCT02905006|11287671|FG002|NOT COMPLETED|Overall Study||5
10157017|NCT02905006|11287672|FG003|NOT COMPLETED|Overall Study||6
10157018|NCT02905006|11287673|FG004|NOT COMPLETED|Overall Study||3
10157019|NCT02905006|11287674|FG005|NOT COMPLETED|Overall Study||4
10157020|NCT02905149|11287714|FG000|STARTED|Overall Study||30
10157021|NCT02905149|11287715|FG001|STARTED|Overall Study||30
10157022|NCT02905149|11287714|FG000|COMPLETED|Overall Study||28
10157023|NCT02905149|11287715|FG001|COMPLETED|Overall Study||30
10157024|NCT02905149|11287714|FG000|NOT COMPLETED|Overall Study||2
10157025|NCT02905149|11287715|FG001|NOT COMPLETED|Overall Study||0
10157026|NCT02905266|11287723|FG000|STARTED|Treatment Phase Part 1||53
10157027|NCT02905266|11287724|FG001|STARTED|Treatment Phase Part 1||53
10157028|NCT02905266|11287723|FG000|COMPLETED|Treatment Phase Part 1||24
10157029|NCT02905266|11287724|FG001|COMPLETED|Treatment Phase Part 1||30
10157030|NCT02905266|11287723|FG000|NOT COMPLETED|Treatment Phase Part 1||29
10157031|NCT02905266|11287724|FG001|NOT COMPLETED|Treatment Phase Part 1||23
10157032|NCT02905266|11287723|FG000|STARTED|Transition From Part 1 to Part 2||24
10157033|NCT02905266|11287724|FG001|STARTED|Transition From Part 1 to Part 2||30
10157034|NCT02905266|11287723|FG000|COMPLETED|Transition From Part 1 to Part 2||20
10157035|NCT02905266|11287724|FG001|COMPLETED|Transition From Part 1 to Part 2||22
10157036|NCT02905266|11287723|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4
10157037|NCT02905266|11287724|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8
10157038|NCT02905266|11287723|FG000|STARTED|Maintenance Phase Part 2||20
10157039|NCT02905266|11287724|FG001|STARTED|Maintenance Phase Part 2||22
10157040|NCT02905266|11287723|FG000|COMPLETED|Maintenance Phase Part 2||8
10157041|NCT02905266|11287724|FG001|COMPLETED|Maintenance Phase Part 2||14
10157042|NCT02905266|11287723|FG000|NOT COMPLETED|Maintenance Phase Part 2||12
10157043|NCT02905266|11287724|FG001|NOT COMPLETED|Maintenance Phase Part 2||8
10157044|NCT02905331|11287732|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
10157045|NCT02905331|11287733|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
10157046|NCT02905331|11287734|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
10157047|NCT02905331|11287732|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
10157048|NCT02905331|11287733|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
10157049|NCT02905331|11287734|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
10157050|NCT02905331|11287732|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
10157051|NCT02905331|11287733|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
10157052|NCT02905331|11287734|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
10157053|NCT02905331|11287732|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0
10157054|NCT02905331|11287733|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61
10157055|NCT02905331|11287734|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13
10157056|NCT02905331|11287732|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0
10157057|NCT02905331|11287733|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53
10157058|NCT02905331|11287734|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13
10157059|NCT02905331|11287732|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
10157060|NCT02905331|11287733|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
10157061|NCT02905331|11287734|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
10157062|NCT02905435|11287742|FG000|STARTED|Overall Study||14
10157063|NCT02905435|11287742|FG000|COMPLETED|Overall Study||7
10157064|NCT02905435|11287742|FG000|NOT COMPLETED|Overall Study||7
10157065|NCT02905825|11287747|FG000|STARTED|Overall Study||53
10157066|NCT02905825|11287747|FG000|COMPLETED|Overall Study||41
10157067|NCT02905825|11287747|FG000|NOT COMPLETED|Overall Study||12
10157068|NCT02905981|11287751|FG000|STARTED|Overall Study||1
10157069|NCT02905981|11287751|FG000|COMPLETED|Overall Study||0
10157070|NCT02905981|11287751|FG000|NOT COMPLETED|Overall Study||1
10157071|NCT02906358|11287757|FG000|STARTED|Overall Study||58
10157072|NCT02906358|11287758|FG001|STARTED|Overall Study||53
10157073|NCT02906358|11287757|FG000|Completed 3 Month Measures|Overall Study||36
10157074|NCT02906358|11287758|FG001|Completed 3 Month Measures|Overall Study||33
10157075|NCT02906358|11287757|FG000|COMPLETED|Overall Study||36
10157076|NCT02906358|11287758|FG001|COMPLETED|Overall Study||31
10157077|NCT02906358|11287757|FG000|NOT COMPLETED|Overall Study||22
10157078|NCT02906358|11287758|FG001|NOT COMPLETED|Overall Study||22
10157079|NCT02906566|11287766|FG000|STARTED|Overall Study||24
10157080|NCT02906566|11287767|FG001|STARTED|Overall Study||10
10157081|NCT02906566|11287766|FG000|COMPLETED|Overall Study||21
10157082|NCT02906566|11287767|FG001|COMPLETED|Overall Study||10
10157083|NCT02906566|11287766|FG000|NOT COMPLETED|Overall Study||3
10157084|NCT02906566|11287767|FG001|NOT COMPLETED|Overall Study||0
10157085|NCT02906579|11287775|FG000|STARTED|Overall Study||11
10157086|NCT02906579|11287775|FG000|Completed Cycle 1 (Placebo)|Overall Study||11
10157087|NCT02906579|11287775|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
10157088|NCT02906579|11287775|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
10157089|NCT02906579|11287775|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
10157090|NCT02906579|11287775|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
10157091|NCT02906579|11287775|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
10157092|NCT02906579|11287775|FG000|COMPLETED|Overall Study||9
10157093|NCT02906579|11287775|FG000|NOT COMPLETED|Overall Study||2
10157094|NCT02906644|11287797|FG000|STARTED|First 2 Weeks||31
10157095|NCT02906644|11287798|FG001|STARTED|First 2 Weeks||30
10157096|NCT02906644|11287797|FG000|COMPLETED|First 2 Weeks||30
10157097|NCT02906644|11287798|FG001|COMPLETED|First 2 Weeks||27
10157098|NCT02906644|11287797|FG000|NOT COMPLETED|First 2 Weeks||1
10157099|NCT02906644|11287798|FG001|NOT COMPLETED|First 2 Weeks||3
10157100|NCT02906644|11287797|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
10157101|NCT02906644|11287798|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
10157102|NCT02906644|11287797|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
10157103|NCT02906644|11287798|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
10157104|NCT02906644|11287797|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
10157105|NCT02906644|11287798|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
10157106|NCT02906644|11287797|FG000|COMPLETED|Weeks 3 to 14||14
10157107|NCT02906644|11287798|FG001|COMPLETED|Weeks 3 to 14||16
10157108|NCT02906644|11287797|FG000|NOT COMPLETED|Weeks 3 to 14||16
10157109|NCT02906644|11287798|FG001|NOT COMPLETED|Weeks 3 to 14||11
10157110|NCT02906670|11287815|FG000|STARTED|Cohort 1, QW||1
10157111|NCT02906670|11287816|FG001|STARTED|Cohort 1, QW||0
10157112|NCT02906670|11287817|FG002|STARTED|Cohort 1, QW||0
10157113|NCT02906670|11287818|FG003|STARTED|Cohort 1, QW||0
10157114|NCT02906670|11287819|FG004|STARTED|Cohort 1, QW||0
10157115|NCT02906670|11287820|FG005|STARTED|Cohort 1, QW||0
10157116|NCT02906670|11287821|FG006|STARTED|Cohort 1, QW||0
10157117|NCT02906670|11287822|FG007|STARTED|Cohort 1, QW||0
10157118|NCT02906670|11287823|FG008|STARTED|Cohort 1, QW||0
10157119|NCT02906670|11287824|FG009|STARTED|Cohort 1, QW||0
10157120|NCT02906670|11287815|FG000|COMPLETED|Cohort 1, QW||0
10157121|NCT02906670|11287816|FG001|COMPLETED|Cohort 1, QW||0
10157122|NCT02906670|11287817|FG002|COMPLETED|Cohort 1, QW||0
10157123|NCT02906670|11287818|FG003|COMPLETED|Cohort 1, QW||0
10157124|NCT02906670|11287819|FG004|COMPLETED|Cohort 1, QW||0
10157125|NCT02906670|11287820|FG005|COMPLETED|Cohort 1, QW||0
10157126|NCT02906670|11287821|FG006|COMPLETED|Cohort 1, QW||0
10157127|NCT02906670|11287822|FG007|COMPLETED|Cohort 1, QW||0
10157128|NCT02906670|11287823|FG008|COMPLETED|Cohort 1, QW||0
10157129|NCT02906670|11287824|FG009|COMPLETED|Cohort 1, QW||0
10157130|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 1, QW||1
10157131|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 1, QW||0
10157132|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 1, QW||0
10157133|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 1, QW||0
10157134|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 1, QW||0
10157135|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 1, QW||0
10157136|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 1, QW||0
10157137|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 1, QW||0
10157138|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 1, QW||0
10157139|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 1, QW||0
10157140|NCT02906670|11287815|FG000|STARTED|Cohort 2, QW||0
10157141|NCT02906670|11287816|FG001|STARTED|Cohort 2, QW||1
10157142|NCT02906670|11287817|FG002|STARTED|Cohort 2, QW||0
10157143|NCT02906670|11287818|FG003|STARTED|Cohort 2, QW||0
10157144|NCT02906670|11287819|FG004|STARTED|Cohort 2, QW||0
10157145|NCT02906670|11287820|FG005|STARTED|Cohort 2, QW||0
10157146|NCT02906670|11287821|FG006|STARTED|Cohort 2, QW||0
10157147|NCT02906670|11287822|FG007|STARTED|Cohort 2, QW||0
10157148|NCT02906670|11287823|FG008|STARTED|Cohort 2, QW||0
10157149|NCT02906670|11287824|FG009|STARTED|Cohort 2, QW||0
10157150|NCT02906670|11287815|FG000|COMPLETED|Cohort 2, QW||0
10157151|NCT02906670|11287816|FG001|COMPLETED|Cohort 2, QW||0
10157152|NCT02906670|11287817|FG002|COMPLETED|Cohort 2, QW||0
10157153|NCT02906670|11287818|FG003|COMPLETED|Cohort 2, QW||0
10157154|NCT02906670|11287819|FG004|COMPLETED|Cohort 2, QW||0
10157155|NCT02906670|11287820|FG005|COMPLETED|Cohort 2, QW||0
10157156|NCT02906670|11287821|FG006|COMPLETED|Cohort 2, QW||0
10157157|NCT02906670|11287822|FG007|COMPLETED|Cohort 2, QW||0
10157158|NCT02906670|11287823|FG008|COMPLETED|Cohort 2, QW||0
10157159|NCT02906670|11287824|FG009|COMPLETED|Cohort 2, QW||0
10157160|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 2, QW||0
10157161|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 2, QW||1
10157162|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 2, QW||0
10157163|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 2, QW||0
10157164|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 2, QW||0
10157165|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 2, QW||0
10157166|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 2, QW||0
10157167|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 2, QW||0
10157168|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 2, QW||0
10157169|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 2, QW||0
10157170|NCT02906670|11287815|FG000|STARTED|Cohort 3, QW||0
10157171|NCT02906670|11287816|FG001|STARTED|Cohort 3, QW||0
10157172|NCT02906670|11287817|FG002|STARTED|Cohort 3, QW||4
10157173|NCT02906670|11287818|FG003|STARTED|Cohort 3, QW||0
10157174|NCT02906670|11287819|FG004|STARTED|Cohort 3, QW||0
10157175|NCT02906670|11287820|FG005|STARTED|Cohort 3, QW||0
10157176|NCT02906670|11287821|FG006|STARTED|Cohort 3, QW||0
10157177|NCT02906670|11287822|FG007|STARTED|Cohort 3, QW||0
10157178|NCT02906670|11287823|FG008|STARTED|Cohort 3, QW||0
10157179|NCT02906670|11287824|FG009|STARTED|Cohort 3, QW||0
10157180|NCT02906670|11287815|FG000|COMPLETED|Cohort 3, QW||0
10157181|NCT02906670|11287816|FG001|COMPLETED|Cohort 3, QW||0
10157182|NCT02906670|11287817|FG002|COMPLETED|Cohort 3, QW||0
10157183|NCT02906670|11287818|FG003|COMPLETED|Cohort 3, QW||0
10157184|NCT02906670|11287819|FG004|COMPLETED|Cohort 3, QW||0
10157185|NCT02906670|11287820|FG005|COMPLETED|Cohort 3, QW||0
10157186|NCT02906670|11287821|FG006|COMPLETED|Cohort 3, QW||0
10157187|NCT02906670|11287822|FG007|COMPLETED|Cohort 3, QW||0
10157188|NCT02906670|11287823|FG008|COMPLETED|Cohort 3, QW||0
10157189|NCT02906670|11287824|FG009|COMPLETED|Cohort 3, QW||0
10157190|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 3, QW||0
10157191|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 3, QW||0
10157192|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 3, QW||4
10157193|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 3, QW||0
10157194|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 3, QW||0
10157195|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 3, QW||0
10157196|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 3, QW||0
10157197|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 3, QW||0
10157198|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 3, QW||0
10157199|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 3, QW||0
10157200|NCT02906670|11287815|FG000|STARTED|Cohort 4, Q2W||0
10157201|NCT02906670|11287816|FG001|STARTED|Cohort 4, Q2W||0
10157202|NCT02906670|11287817|FG002|STARTED|Cohort 4, Q2W||0
10157203|NCT02906670|11287818|FG003|STARTED|Cohort 4, Q2W||0
10157204|NCT02906670|11287819|FG004|STARTED|Cohort 4, Q2W||0
10157205|NCT02906670|11287820|FG005|STARTED|Cohort 4, Q2W||3
10157206|NCT02906670|11287821|FG006|STARTED|Cohort 4, Q2W||0
10157207|NCT02906670|11287822|FG007|STARTED|Cohort 4, Q2W||0
9710389|NCT04610489|10809965|FG000|STARTED|Overall Study||117
10157208|NCT02906670|11287823|FG008|STARTED|Cohort 4, Q2W||0
10157209|NCT02906670|11287824|FG009|STARTED|Cohort 4, Q2W||0
10157210|NCT02906670|11287815|FG000|COMPLETED|Cohort 4, Q2W||0
10157211|NCT02906670|11287816|FG001|COMPLETED|Cohort 4, Q2W||0
10157212|NCT02906670|11287817|FG002|COMPLETED|Cohort 4, Q2W||0
10157213|NCT02906670|11287818|FG003|COMPLETED|Cohort 4, Q2W||0
10157214|NCT02906670|11287819|FG004|COMPLETED|Cohort 4, Q2W||0
10157215|NCT02906670|11287820|FG005|COMPLETED|Cohort 4, Q2W||0
10157216|NCT02906670|11287821|FG006|COMPLETED|Cohort 4, Q2W||0
10157217|NCT02906670|11287822|FG007|COMPLETED|Cohort 4, Q2W||0
10157218|NCT02906670|11287823|FG008|COMPLETED|Cohort 4, Q2W||0
10157219|NCT02906670|11287824|FG009|COMPLETED|Cohort 4, Q2W||0
10157220|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 4, Q2W||0
10157221|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 4, Q2W||0
10157222|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 4, Q2W||0
10157223|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 4, Q2W||0
10157224|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 4, Q2W||0
10157225|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 4, Q2W||3
10157226|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 4, Q2W||0
10157227|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 4, Q2W||0
10157228|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 4, Q2W||0
10157229|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 4, Q2W||0
10157230|NCT02906670|11287815|FG000|STARTED|Cohort 5, Q2W||0
10157231|NCT02906670|11287816|FG001|STARTED|Cohort 5, Q2W||0
10157232|NCT02906670|11287817|FG002|STARTED|Cohort 5, Q2W||0
10157233|NCT02906670|11287818|FG003|STARTED|Cohort 5, Q2W||0
10157234|NCT02906670|11287819|FG004|STARTED|Cohort 5, Q2W||0
10157235|NCT02906670|11287820|FG005|STARTED|Cohort 5, Q2W||0
10157236|NCT02906670|11287821|FG006|STARTED|Cohort 5, Q2W||7
10157237|NCT02906670|11287822|FG007|STARTED|Cohort 5, Q2W||0
10157238|NCT02906670|11287823|FG008|STARTED|Cohort 5, Q2W||0
10157239|NCT02906670|11287824|FG009|STARTED|Cohort 5, Q2W||0
10157240|NCT02906670|11287815|FG000|COMPLETED|Cohort 5, Q2W||0
10157241|NCT02906670|11287816|FG001|COMPLETED|Cohort 5, Q2W||0
10157242|NCT02906670|11287817|FG002|COMPLETED|Cohort 5, Q2W||0
10157243|NCT02906670|11287818|FG003|COMPLETED|Cohort 5, Q2W||0
10157244|NCT02906670|11287819|FG004|COMPLETED|Cohort 5, Q2W||0
10157245|NCT02906670|11287820|FG005|COMPLETED|Cohort 5, Q2W||0
10157246|NCT02906670|11287821|FG006|COMPLETED|Cohort 5, Q2W||0
10157247|NCT02906670|11287822|FG007|COMPLETED|Cohort 5, Q2W||0
10157248|NCT02906670|11287823|FG008|COMPLETED|Cohort 5, Q2W||0
10157249|NCT02906670|11287824|FG009|COMPLETED|Cohort 5, Q2W||0
10157250|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 5, Q2W||0
10157251|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 5, Q2W||0
10157252|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 5, Q2W||0
10157253|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 5, Q2W||0
10157254|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 5, Q2W||0
10157255|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 5, Q2W||0
10157256|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 5, Q2W||7
10157257|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 5, Q2W||0
10157258|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 5, Q2W||0
10157259|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 5, Q2W||0
10157260|NCT02906670|11287815|FG000|STARTED|Cohort 5P, Q2W||0
10157261|NCT02906670|11287816|FG001|STARTED|Cohort 5P, Q2W||0
10157262|NCT02906670|11287817|FG002|STARTED|Cohort 5P, Q2W||0
10157263|NCT02906670|11287818|FG003|STARTED|Cohort 5P, Q2W||0
10157264|NCT02906670|11287819|FG004|STARTED|Cohort 5P, Q2W||0
10157265|NCT02906670|11287820|FG005|STARTED|Cohort 5P, Q2W||0
10157266|NCT02906670|11287821|FG006|STARTED|Cohort 5P, Q2W||0
10157267|NCT02906670|11287822|FG007|STARTED|Cohort 5P, Q2W||3
10157268|NCT02906670|11287823|FG008|STARTED|Cohort 5P, Q2W||0
10157269|NCT02906670|11287824|FG009|STARTED|Cohort 5P, Q2W||0
10157270|NCT02906670|11287815|FG000|COMPLETED|Cohort 5P, Q2W||0
10157271|NCT02906670|11287816|FG001|COMPLETED|Cohort 5P, Q2W||0
10157272|NCT02906670|11287817|FG002|COMPLETED|Cohort 5P, Q2W||0
10157273|NCT02906670|11287818|FG003|COMPLETED|Cohort 5P, Q2W||0
10157274|NCT02906670|11287819|FG004|COMPLETED|Cohort 5P, Q2W||0
10157275|NCT02906670|11287820|FG005|COMPLETED|Cohort 5P, Q2W||0
10157276|NCT02906670|11287821|FG006|COMPLETED|Cohort 5P, Q2W||0
10157277|NCT02906670|11287822|FG007|COMPLETED|Cohort 5P, Q2W||0
10157278|NCT02906670|11287823|FG008|COMPLETED|Cohort 5P, Q2W||0
10157279|NCT02906670|11287824|FG009|COMPLETED|Cohort 5P, Q2W||0
10157280|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 5P, Q2W||0
10157281|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 5P, Q2W||0
10157282|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 5P, Q2W||0
10157283|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 5P, Q2W||0
10157284|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 5P, Q2W||0
10157285|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 5P, Q2W||0
10157286|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 5P, Q2W||0
10157287|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 5P, Q2W||3
10157288|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 5P, Q2W||0
10157289|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 5P, Q2W||0
10157290|NCT02906670|11287815|FG000|STARTED|Cohort 6P, Q2W||0
10157291|NCT02906670|11287816|FG001|STARTED|Cohort 6P, Q2W||0
10157292|NCT02906670|11287817|FG002|STARTED|Cohort 6P, Q2W||0
10157293|NCT02906670|11287818|FG003|STARTED|Cohort 6P, Q2W||0
10157294|NCT02906670|11287819|FG004|STARTED|Cohort 6P, Q2W||0
10157295|NCT02906670|11287820|FG005|STARTED|Cohort 6P, Q2W||0
10157296|NCT02906670|11287821|FG006|STARTED|Cohort 6P, Q2W||0
10157297|NCT02906670|11287822|FG007|STARTED|Cohort 6P, Q2W||0
10157298|NCT02906670|11287823|FG008|STARTED|Cohort 6P, Q2W||4
10157299|NCT02906670|11287824|FG009|STARTED|Cohort 6P, Q2W||0
10157300|NCT02906670|11287815|FG000|COMPLETED|Cohort 6P, Q2W||0
10157301|NCT02906670|11287816|FG001|COMPLETED|Cohort 6P, Q2W||0
10157302|NCT02906670|11287817|FG002|COMPLETED|Cohort 6P, Q2W||0
10157303|NCT02906670|11287818|FG003|COMPLETED|Cohort 6P, Q2W||0
10157304|NCT02906670|11287819|FG004|COMPLETED|Cohort 6P, Q2W||0
10157305|NCT02906670|11287820|FG005|COMPLETED|Cohort 6P, Q2W||0
10157306|NCT02906670|11287821|FG006|COMPLETED|Cohort 6P, Q2W||0
10157307|NCT02906670|11287822|FG007|COMPLETED|Cohort 6P, Q2W||0
10157308|NCT02906670|11287823|FG008|COMPLETED|Cohort 6P, Q2W||0
10157309|NCT02906670|11287824|FG009|COMPLETED|Cohort 6P, Q2W||0
10157310|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 6P, Q2W||0
10157311|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 6P, Q2W||0
10157312|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 6P, Q2W||0
10157313|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 6P, Q2W||0
10157314|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 6P, Q2W||0
10157315|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 6P, Q2W||0
10157316|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 6P, Q2W||0
10157317|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 6P, Q2W||0
10157318|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 6P, Q2W||4
10157319|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 6P, Q2W||0
10157320|NCT02906670|11287815|FG000|STARTED|Cohort 4P, QW||0
10157321|NCT02906670|11287816|FG001|STARTED|Cohort 4P, QW||0
10157322|NCT02906670|11287817|FG002|STARTED|Cohort 4P, QW||0
10157323|NCT02906670|11287818|FG003|STARTED|Cohort 4P, QW||3
10157324|NCT02906670|11287819|FG004|STARTED|Cohort 4P, QW||0
10157325|NCT02906670|11287820|FG005|STARTED|Cohort 4P, QW||0
10157326|NCT02906670|11287821|FG006|STARTED|Cohort 4P, QW||0
10157327|NCT02906670|11287822|FG007|STARTED|Cohort 4P, QW||0
10157328|NCT02906670|11287823|FG008|STARTED|Cohort 4P, QW||0
10157329|NCT02906670|11287824|FG009|STARTED|Cohort 4P, QW||0
10157330|NCT02906670|11287815|FG000|COMPLETED|Cohort 4P, QW||0
10157331|NCT02906670|11287816|FG001|COMPLETED|Cohort 4P, QW||0
10157332|NCT02906670|11287817|FG002|COMPLETED|Cohort 4P, QW||0
10157333|NCT02906670|11287818|FG003|COMPLETED|Cohort 4P, QW||0
10157334|NCT02906670|11287819|FG004|COMPLETED|Cohort 4P, QW||0
10157335|NCT02906670|11287820|FG005|COMPLETED|Cohort 4P, QW||0
10157336|NCT02906670|11287821|FG006|COMPLETED|Cohort 4P, QW||0
10157337|NCT02906670|11287822|FG007|COMPLETED|Cohort 4P, QW||0
10157338|NCT02906670|11287823|FG008|COMPLETED|Cohort 4P, QW||0
10157339|NCT02906670|11287824|FG009|COMPLETED|Cohort 4P, QW||0
10157340|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 4P, QW||0
10157341|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 4P, QW||0
10157342|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 4P, QW||0
10157343|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 4P, QW||3
10157344|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 4P, QW||0
10157345|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 4P, QW||0
10157346|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 4P, QW||0
10157347|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 4P, QW||0
10157348|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 4P, QW||0
9710390|NCT04610489|10809965|FG000|COMPLETED|Overall Study||117
9710391|NCT04610489|10809965|FG000|NOT COMPLETED|Overall Study||0
10157349|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 4P, QW||0
10157350|NCT02906670|11287815|FG000|STARTED|Cohort 7P, Q2W||0
10157351|NCT02906670|11287816|FG001|STARTED|Cohort 7P, Q2W||0
10157352|NCT02906670|11287817|FG002|STARTED|Cohort 7P, Q2W||0
10157353|NCT02906670|11287818|FG003|STARTED|Cohort 7P, Q2W||0
10157354|NCT02906670|11287819|FG004|STARTED|Cohort 7P, Q2W||0
10157355|NCT02906670|11287820|FG005|STARTED|Cohort 7P, Q2W||0
10157356|NCT02906670|11287821|FG006|STARTED|Cohort 7P, Q2W||0
10157357|NCT02906670|11287822|FG007|STARTED|Cohort 7P, Q2W||0
10157358|NCT02906670|11287823|FG008|STARTED|Cohort 7P, Q2W||0
10157359|NCT02906670|11287824|FG009|STARTED|Cohort 7P, Q2W||3
10157360|NCT02906670|11287815|FG000|COMPLETED|Cohort 7P, Q2W||0
10157361|NCT02906670|11287816|FG001|COMPLETED|Cohort 7P, Q2W||0
10157362|NCT02906670|11287817|FG002|COMPLETED|Cohort 7P, Q2W||0
10157363|NCT02906670|11287818|FG003|COMPLETED|Cohort 7P, Q2W||0
10157364|NCT02906670|11287819|FG004|COMPLETED|Cohort 7P, Q2W||0
10157365|NCT02906670|11287820|FG005|COMPLETED|Cohort 7P, Q2W||0
10157366|NCT02906670|11287821|FG006|COMPLETED|Cohort 7P, Q2W||0
10157367|NCT02906670|11287822|FG007|COMPLETED|Cohort 7P, Q2W||0
10157368|NCT02906670|11287823|FG008|COMPLETED|Cohort 7P, Q2W||0
10157369|NCT02906670|11287824|FG009|COMPLETED|Cohort 7P, Q2W||0
10157370|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 7P, Q2W||0
10157371|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 7P, Q2W||0
10157372|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 7P, Q2W||0
10157373|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 7P, Q2W||0
10157374|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 7P, Q2W||0
10157375|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 7P, Q2W||0
10157376|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 7P, Q2W||0
10157377|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 7P, Q2W||0
10157378|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 7P, Q2W||0
10157379|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 7P, Q2W||3
10157380|NCT02906670|11287815|FG000|STARTED|Cohort 5P, QW||0
10157381|NCT02906670|11287816|FG001|STARTED|Cohort 5P, QW||0
10157382|NCT02906670|11287817|FG002|STARTED|Cohort 5P, QW||0
10157383|NCT02906670|11287818|FG003|STARTED|Cohort 5P, QW||0
10157384|NCT02906670|11287819|FG004|STARTED|Cohort 5P, QW||3
10157385|NCT02906670|11287820|FG005|STARTED|Cohort 5P, QW||0
10157386|NCT02906670|11287821|FG006|STARTED|Cohort 5P, QW||0
10157387|NCT02906670|11287822|FG007|STARTED|Cohort 5P, QW||0
10157388|NCT02906670|11287823|FG008|STARTED|Cohort 5P, QW||0
10157389|NCT02906670|11287824|FG009|STARTED|Cohort 5P, QW||0
10157390|NCT02906670|11287815|FG000|COMPLETED|Cohort 5P, QW||0
10157391|NCT02906670|11287816|FG001|COMPLETED|Cohort 5P, QW||0
10157392|NCT02906670|11287817|FG002|COMPLETED|Cohort 5P, QW||0
10157393|NCT02906670|11287818|FG003|COMPLETED|Cohort 5P, QW||0
10157394|NCT02906670|11287819|FG004|COMPLETED|Cohort 5P, QW||0
10157395|NCT02906670|11287820|FG005|COMPLETED|Cohort 5P, QW||0
10157396|NCT02906670|11287821|FG006|COMPLETED|Cohort 5P, QW||0
10157397|NCT02906670|11287822|FG007|COMPLETED|Cohort 5P, QW||0
10157398|NCT02906670|11287823|FG008|COMPLETED|Cohort 5P, QW||0
10157399|NCT02906670|11287824|FG009|COMPLETED|Cohort 5P, QW||0
10157400|NCT02906670|11287815|FG000|NOT COMPLETED|Cohort 5P, QW||0
10157401|NCT02906670|11287816|FG001|NOT COMPLETED|Cohort 5P, QW||0
10157402|NCT02906670|11287817|FG002|NOT COMPLETED|Cohort 5P, QW||0
10157403|NCT02906670|11287818|FG003|NOT COMPLETED|Cohort 5P, QW||0
10157404|NCT02906670|11287819|FG004|NOT COMPLETED|Cohort 5P, QW||3
10157405|NCT02906670|11287820|FG005|NOT COMPLETED|Cohort 5P, QW||0
10157406|NCT02906670|11287821|FG006|NOT COMPLETED|Cohort 5P, QW||0
10157407|NCT02906670|11287822|FG007|NOT COMPLETED|Cohort 5P, QW||0
10157408|NCT02906670|11287823|FG008|NOT COMPLETED|Cohort 5P, QW||0
10157409|NCT02906670|11287824|FG009|NOT COMPLETED|Cohort 5P, QW||0
10157410|NCT02906696|11287874|FG000|STARTED|Overall Study||8
10157411|NCT02906696|11287874|FG000|COMPLETED|Overall Study||8
10157412|NCT02906696|11287874|FG000|NOT COMPLETED|Overall Study||0
10157413|NCT02906709|11287880|FG000|STARTED|Phase A (Week 0 to Week 16)||123
10157414|NCT02906709|11287881|FG001|STARTED|Phase A (Week 0 to Week 16)||61
10157415|NCT02906709|11287880|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122
10157416|NCT02906709|11287881|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58
10157417|NCT02906709|11287880|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
10157418|NCT02906709|11287881|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
10157419|NCT02906709|11287880|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122
10157420|NCT02906709|11287881|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58
10157421|NCT02906709|11287880|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
10157422|NCT02906709|11287881|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
10157423|NCT02906709|11287880|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
10157424|NCT02906709|11287881|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
10157425|NCT02906813|11287896|FG000|STARTED|Intervention Period 1 (3 Days)||3
10157426|NCT02906813|11287897|FG001|STARTED|Intervention Period 1 (3 Days)||3
10157427|NCT02906813|11287898|FG002|STARTED|Intervention Period 1 (3 Days)||3
10157428|NCT02906813|11287896|FG000|COMPLETED|Intervention Period 1 (3 Days)||3
10157429|NCT02906813|11287897|FG001|COMPLETED|Intervention Period 1 (3 Days)||3
10157430|NCT02906813|11287898|FG002|COMPLETED|Intervention Period 1 (3 Days)||3
10157431|NCT02906813|11287896|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10157432|NCT02906813|11287897|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10157433|NCT02906813|11287898|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10157434|NCT02906813|11287896|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3
10060998|NCT02100826|11186544|FG001|STARTED|Period 2 (7 Days)||14
10060999|NCT02100826|11186543|FG000|COMPLETED|Period 2 (7 Days)||14
10061000|NCT02100826|11186544|FG001|COMPLETED|Period 2 (7 Days)||14
10061001|NCT02100826|11186543|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10061002|NCT02100826|11186544|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10061003|NCT02100839|11186552|FG000|STARTED|Single Ascending Dose||24
10061004|NCT02100839|11186553|FG001|STARTED|Single Ascending Dose||12
10061005|NCT02100839|11186552|FG000|COMPLETED|Single Ascending Dose||24
10061006|NCT02100839|11186553|FG001|COMPLETED|Single Ascending Dose||12
10061007|NCT02100839|11186552|FG000|NOT COMPLETED|Single Ascending Dose||0
10061008|NCT02100839|11186553|FG001|NOT COMPLETED|Single Ascending Dose||0
10157435|NCT02906813|11287897|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3
10157436|NCT02906813|11287898|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3
10157437|NCT02906813|11287896|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3
10157438|NCT02906813|11287897|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3
10157439|NCT02906813|11287898|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3
10157440|NCT02906813|11287896|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
10157441|NCT02906813|11287897|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
10157442|NCT02906813|11287898|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
10157443|NCT02906813|11287896|FG000|STARTED|Intervention Period 2 (3 Days)||3
10157444|NCT02906813|11287897|FG001|STARTED|Intervention Period 2 (3 Days)||3
10157445|NCT02906813|11287898|FG002|STARTED|Intervention Period 2 (3 Days)||3
10157446|NCT02906813|11287896|FG000|COMPLETED|Intervention Period 2 (3 Days)||3
10157447|NCT02906813|11287897|FG001|COMPLETED|Intervention Period 2 (3 Days)||3
10157448|NCT02906813|11287898|FG002|COMPLETED|Intervention Period 2 (3 Days)||3
10157449|NCT02906813|11287896|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10157450|NCT02906813|11287897|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10157451|NCT02906813|11287898|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10157452|NCT02906813|11287896|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3
10157453|NCT02906813|11287897|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3
10157454|NCT02906813|11287898|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3
10157455|NCT02906813|11287896|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3
10157456|NCT02906813|11287897|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3
10157457|NCT02906813|11287898|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3
10157458|NCT02906813|11287896|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
10157459|NCT02906813|11287897|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
10157460|NCT02906813|11287898|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
10157461|NCT02906813|11287896|FG000|STARTED|Intervention Period 3 (3 Days)||3
10157462|NCT02906813|11287897|FG001|STARTED|Intervention Period 3 (3 Days)||3
10157463|NCT02906813|11287898|FG002|STARTED|Intervention Period 3 (3 Days)||3
10157464|NCT02906813|11287896|FG000|COMPLETED|Intervention Period 3 (3 Days)||3
10157465|NCT02906813|11287897|FG001|COMPLETED|Intervention Period 3 (3 Days)||3
10157466|NCT02906813|11287898|FG002|COMPLETED|Intervention Period 3 (3 Days)||3
10157467|NCT02906813|11287896|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10157468|NCT02906813|11287897|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10157469|NCT02906813|11287898|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10157470|NCT02906917|11287908|FG000|STARTED|Initiation Period (Week 0-26)||267
10157471|NCT02906917|11287909|FG001|STARTED|Initiation Period (Week 0-26)||265
10157472|NCT02906917|11287908|FG000|Exposed|Initiation Period (Week 0-26)||265
10157473|NCT02906917|11287909|FG001|Exposed|Initiation Period (Week 0-26)||263
10157474|NCT02906917|11287908|FG000|COMPLETED|Initiation Period (Week 0-26)||261
10157475|NCT02906917|11287909|FG001|COMPLETED|Initiation Period (Week 0-26)||254
10157476|NCT02906917|11287908|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6
10157477|NCT02906917|11287909|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11
10157478|NCT02906917|11287908|FG000|STARTED|Intensification Period (Week 26-38)||261
10157479|NCT02906917|11287909|FG001|STARTED|Intensification Period (Week 26-38)||254
10157480|NCT02906917|11287908|FG000|COMPLETED|Intensification Period (Week 26-38)||252
10157481|NCT02906917|11287909|FG001|COMPLETED|Intensification Period (Week 26-38)||247
10157482|NCT02906917|11287908|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9
10157483|NCT02906917|11287909|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7
10157484|NCT02906930|11287919|FG000|STARTED|Overall Study||175
10157485|NCT02906930|11287920|FG001|STARTED|Overall Study||175
10157486|NCT02906930|11287921|FG002|STARTED|Overall Study||175
10157487|NCT02906930|11287922|FG003|STARTED|Overall Study||178
10157488|NCT02906930|11287919|FG000|Full Analysis Set (FAS)|Overall Study||175
10157489|NCT02906930|11287920|FG001|Full Analysis Set (FAS)|Overall Study||175
10157490|NCT02906930|11287921|FG002|Full Analysis Set (FAS)|Overall Study||175
10157491|NCT02906930|11287922|FG003|Full Analysis Set (FAS)|Overall Study||178
10157492|NCT02906930|11287919|FG000|Safety Analysis Set (SAS)|Overall Study||175
10157493|NCT02906930|11287920|FG001|Safety Analysis Set (SAS)|Overall Study||175
10157494|NCT02906930|11287921|FG002|Safety Analysis Set (SAS)|Overall Study||175
10157495|NCT02906930|11287922|FG003|Safety Analysis Set (SAS)|Overall Study||178
10157496|NCT02906930|11287919|FG000|COMPLETED|Overall Study||169
10157497|NCT02906930|11287920|FG001|COMPLETED|Overall Study||161
10157498|NCT02906930|11287921|FG002|COMPLETED|Overall Study||163
10157499|NCT02906930|11287922|FG003|COMPLETED|Overall Study||170
10157500|NCT02906930|11287919|FG000|NOT COMPLETED|Overall Study||6
10157501|NCT02906930|11287920|FG001|NOT COMPLETED|Overall Study||14
10157502|NCT02906930|11287921|FG002|NOT COMPLETED|Overall Study||12
10157503|NCT02906930|11287922|FG003|NOT COMPLETED|Overall Study||8
10157504|NCT02907073|11287935|FG000|STARTED|Overall Study||8
10157505|NCT02907073|11287936|FG001|STARTED|Overall Study||0
10157506|NCT02907073|11287937|FG002|STARTED|Overall Study||0
10157507|NCT02907073|11287935|FG000|COMPLETED|Overall Study||8
10157508|NCT02907073|11287936|FG001|COMPLETED|Overall Study||0
10157509|NCT02907073|11287937|FG002|COMPLETED|Overall Study||0
10157510|NCT02907073|11287935|FG000|NOT COMPLETED|Overall Study||0
10157511|NCT02907073|11287936|FG001|NOT COMPLETED|Overall Study||0
10157512|NCT02907073|11287937|FG002|NOT COMPLETED|Overall Study||0
10157513|NCT02907177|11287947|FG000|STARTED|Overall Study||68
10157514|NCT02907177|11287948|FG001|STARTED|Overall Study||68
10157515|NCT02907177|11287947|FG000|Treated|Overall Study||67
10157516|NCT02907177|11287948|FG001|Treated|Overall Study||68
10157517|NCT02907177|11287947|FG000|Randomized Analysis Set|Overall Study||68
10157518|NCT02907177|11287948|FG001|Randomized Analysis Set|Overall Study||68
10157519|NCT02907177|11287947|FG000|COMPLETED|Overall Study||0
10157520|NCT02907177|11287948|FG001|COMPLETED|Overall Study||0
10157521|NCT02907177|11287947|FG000|NOT COMPLETED|Overall Study||68
10157522|NCT02907177|11287948|FG001|NOT COMPLETED|Overall Study||68
10197276|NCT03372434|11325243|FG001|COMPLETED|Overall Study||70
10197277|NCT03372434|11325244|FG002|COMPLETED|Overall Study||72
10197278|NCT03372434|11325242|FG000|NOT COMPLETED|Overall Study||2
10197279|NCT03372434|11325243|FG001|NOT COMPLETED|Overall Study||3
10197280|NCT03372434|11325244|FG002|NOT COMPLETED|Overall Study||2
10197281|NCT03372551|11325252|FG000|STARTED|First Intervention (1 Week)||17
10197282|NCT03372551|11325253|FG001|STARTED|First Intervention (1 Week)||16
10197283|NCT03372551|11325252|FG000|COMPLETED|First Intervention (1 Week)||16
10197284|NCT03372551|11325253|FG001|COMPLETED|First Intervention (1 Week)||16
10197285|NCT03372551|11325252|FG000|NOT COMPLETED|First Intervention (1 Week)||1
10197286|NCT03372551|11325253|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10197287|NCT03372551|11325252|FG000|STARTED|Second Intervention (1 Week)||16
10197288|NCT03372551|11325253|FG001|STARTED|Second Intervention (1 Week)||16
10197289|NCT03372551|11325252|FG000|COMPLETED|Second Intervention (1 Week)||16
10197290|NCT03372551|11325253|FG001|COMPLETED|Second Intervention (1 Week)||16
10197291|NCT03372551|11325252|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10197292|NCT03372551|11325253|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10197293|NCT03372603|11325266|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9
10197294|NCT03372603|11325267|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8
10197295|NCT03372603|11325266|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
10197296|NCT03372603|11325267|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
10197297|NCT03372603|11325266|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
10197298|NCT03372603|11325267|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
10197299|NCT03372603|11325266|FG000|STARTED|Wash-out Period (14-21 Days)||9
10197300|NCT03372603|11325267|FG001|STARTED|Wash-out Period (14-21 Days)||8
10197301|NCT03372603|11325266|FG000|COMPLETED|Wash-out Period (14-21 Days)||8
10197302|NCT03372603|11325267|FG001|COMPLETED|Wash-out Period (14-21 Days)||8
10197303|NCT03372603|11325266|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1
10197304|NCT03372603|11325267|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0
9710392|NCT04608500|10809972|FG000|STARTED|Overall Study||514
9710393|NCT04608500|10809973|FG001|STARTED|Overall Study||257
9710394|NCT04608500|10809972|FG000|COMPLETED|Overall Study||479
9710395|NCT04608500|10809973|FG001|COMPLETED|Overall Study||239
9710396|NCT04608500|10809972|FG000|NOT COMPLETED|Overall Study||35
9710397|NCT04608500|10809973|FG001|NOT COMPLETED|Overall Study||18
9710398|NCT04607291|10809979|FG000|STARTED|Overall Study||183
9710399|NCT04607291|10809979|FG000|COMPLETED|Overall Study||183
9710400|NCT04607291|10809979|FG000|NOT COMPLETED|Overall Study||0
9730261|NCT00124735|10830003|FG000|COMPLETED|Overall Study||4
9730262|NCT00124735|10830004|FG001|COMPLETED|Overall Study||6
9730263|NCT00124735|10830005|FG002|COMPLETED|Overall Study||18
9730264|NCT00124735|10830006|FG003|COMPLETED|Overall Study||18
9730265|NCT00124735|10830007|FG004|COMPLETED|Overall Study||17
9730266|NCT00124735|10830008|FG005|COMPLETED|Overall Study||5
9730267|NCT00124735|10830009|FG006|COMPLETED|Overall Study||6
9730268|NCT00124735|10830010|FG007|COMPLETED|Overall Study||19
9730269|NCT00124735|10830011|FG008|COMPLETED|Overall Study||22
9730270|NCT00124735|10830012|FG009|COMPLETED|Overall Study||18
9730271|NCT00124735|10830003|FG000|NOT COMPLETED|Overall Study||1
9730272|NCT00124735|10830004|FG001|NOT COMPLETED|Overall Study||2
9730273|NCT00124735|10830005|FG002|NOT COMPLETED|Overall Study||0
9730274|NCT00124735|10830006|FG003|NOT COMPLETED|Overall Study||3
9730275|NCT00124735|10830007|FG004|NOT COMPLETED|Overall Study||2
9730276|NCT00124735|10830008|FG005|NOT COMPLETED|Overall Study||2
9730277|NCT00124735|10830009|FG006|NOT COMPLETED|Overall Study||0
9730278|NCT00124735|10830010|FG007|NOT COMPLETED|Overall Study||1
9730279|NCT00124735|10830011|FG008|NOT COMPLETED|Overall Study||3
9730280|NCT00124735|10830012|FG009|NOT COMPLETED|Overall Study||2
9730281|NCT00124748|10830028|FG000|STARTED|Overall Study||157
9730282|NCT00124748|10830029|FG001|STARTED|Overall Study||319
9730283|NCT00124748|10830028|FG000|Safety Population|Overall Study||157
9730284|NCT00124748|10830029|FG001|Safety Population|Overall Study||316
9730285|NCT00124748|10830028|FG000|COMPLETED|Overall Study||14
9730286|NCT00124748|10830029|FG001|COMPLETED|Overall Study||35
9730287|NCT00124748|10830028|FG000|NOT COMPLETED|Overall Study||143
9730288|NCT00124748|10830029|FG001|NOT COMPLETED|Overall Study||284
9730289|NCT00124917|10830035|FG000|STARTED|Overall Study||6
9730290|NCT00124917|10830035|FG000|COMPLETED|Overall Study||3
9730291|NCT00124917|10830035|FG000|NOT COMPLETED|Overall Study||3
9730292|NCT00124943|10830044|FG000|STARTED|Phase I||3
9730293|NCT00124943|10830045|FG001|STARTED|Phase I||3
9730294|NCT00124943|10830046|FG002|STARTED|Phase I||3
9730295|NCT00124943|10830047|FG003|STARTED|Phase I||3
9730296|NCT00124943|10830044|FG000|COMPLETED|Phase I||3
9730297|NCT00124943|10830045|FG001|COMPLETED|Phase I||3
9730298|NCT00124943|10830046|FG002|COMPLETED|Phase I||3
10197305|NCT03372603|11325266|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8
10197306|NCT03372603|11325267|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8
10197307|NCT03372603|11325266|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
10197308|NCT03372603|11325267|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
9730299|NCT00124943|10830047|FG003|COMPLETED|Phase I||3
9730300|NCT00124943|10830044|FG000|NOT COMPLETED|Phase I||0
9730301|NCT00124943|10830045|FG001|NOT COMPLETED|Phase I||0
9730302|NCT00124943|10830046|FG002|NOT COMPLETED|Phase I||0
9730303|NCT00124943|10830047|FG003|NOT COMPLETED|Phase I||0
10157523|NCT02907216|11287956|FG000|STARTED|Overall Study||147
10157524|NCT02907216|11287957|FG001|STARTED|Overall Study||145
10157525|NCT02907216|11287956|FG000|COMPLETED|Overall Study||146
10157526|NCT02907216|11287957|FG001|COMPLETED|Overall Study||144
10157527|NCT02907216|11287956|FG000|NOT COMPLETED|Overall Study||1
10157528|NCT02907216|11287957|FG001|NOT COMPLETED|Overall Study||1
10157529|NCT02907268|11287965|FG000|STARTED|Overall Study||5
10157530|NCT02907268|11287966|FG001|STARTED|Overall Study||5
10157531|NCT02907268|11287965|FG000|COMPLETED|Overall Study||5
10157532|NCT02907268|11287966|FG001|COMPLETED|Overall Study||5
10157533|NCT02907268|11287965|FG000|NOT COMPLETED|Overall Study||0
10157534|NCT02907268|11287966|FG001|NOT COMPLETED|Overall Study||0
10157535|NCT02907463|11287971|FG000|STARTED|Overall Study||280
10157536|NCT02907463|11287971|FG000|Enrolled Cohort|Overall Study||280
10157537|NCT02907463|11287971|FG000|Per Protocol Cohort|Overall Study||276
10157538|NCT02907463|11287971|FG000|COMPLETED|Overall Study||243
10157539|NCT02907463|11287971|FG000|NOT COMPLETED|Overall Study||37
10157540|NCT02907489|11287985|FG000|STARTED|Overall Study||42
10157541|NCT02907489|11287986|FG001|STARTED|Overall Study||42
10157542|NCT02907489|11287985|FG000|COMPLETED|Overall Study||40
10157543|NCT02907489|11287986|FG001|COMPLETED|Overall Study||41
10157544|NCT02907489|11287985|FG000|NOT COMPLETED|Overall Study||2
10157545|NCT02907489|11287986|FG001|NOT COMPLETED|Overall Study||1
10157546|NCT02907619|11287995|FG000|STARTED|Overall Study||19
10157547|NCT02907619|11287996|FG001|STARTED|Overall Study||20
10157548|NCT02907619|11287997|FG002|STARTED|Overall Study||20
10157549|NCT02907619|11287995|FG000|Received Treatment|Overall Study||19
10157550|NCT02907619|11287996|FG001|Received Treatment|Overall Study||20
10157551|NCT02907619|11287997|FG002|Received Treatment|Overall Study||20
10157552|NCT02907619|11287995|FG000|COMPLETED|Overall Study||0
10157553|NCT02907619|11287996|FG001|COMPLETED|Overall Study||0
10157554|NCT02907619|11287997|FG002|COMPLETED|Overall Study||0
10157555|NCT02907619|11287995|FG000|NOT COMPLETED|Overall Study||19
10157556|NCT02907619|11287996|FG001|NOT COMPLETED|Overall Study||20
10157557|NCT02907619|11287997|FG002|NOT COMPLETED|Overall Study||20
10157558|NCT02907814|11288009|FG000|STARTED|Overall Study||6
10157559|NCT02907814|11288010|FG001|STARTED|Overall Study||0
10157560|NCT02907814|11288009|FG000|COMPLETED|Overall Study||0
10157561|NCT02907814|11288010|FG001|COMPLETED|Overall Study||0
10157562|NCT02907814|11288009|FG000|NOT COMPLETED|Overall Study||6
10157563|NCT02907814|11288010|FG001|NOT COMPLETED|Overall Study||0
10157564|NCT02907892|11288018|FG000|STARTED|Overall Study||277
10157565|NCT02907892|11288019|FG001|STARTED|Overall Study||276
10157566|NCT02907892|11288018|FG000|COMPLETED|Overall Study||250
10157567|NCT02907892|11288019|FG001|COMPLETED|Overall Study||236
10157568|NCT02907892|11288018|FG000|NOT COMPLETED|Overall Study||27
10157569|NCT02907892|11288019|FG001|NOT COMPLETED|Overall Study||40
10157570|NCT02907918|11288025|FG000|STARTED|Overall Study||26
10157571|NCT02907918|11288025|FG000|COMPLETED|Overall Study||26
10157572|NCT02907918|11288025|FG000|NOT COMPLETED|Overall Study||0
10157573|NCT02908100|11288035|FG000|STARTED|Overall Study||86
10157574|NCT02908100|11288036|FG001|STARTED|Overall Study||87
10157575|NCT02908100|11288037|FG002|STARTED|Overall Study||87
10157576|NCT02908100|11288035|FG000|COMPLETED|Overall Study||63
10157577|NCT02908100|11288036|FG001|COMPLETED|Overall Study||66
10157578|NCT02908100|11288037|FG002|COMPLETED|Overall Study||66
10157579|NCT02908100|11288035|FG000|NOT COMPLETED|Overall Study||23
10157580|NCT02908100|11288036|FG001|NOT COMPLETED|Overall Study||21
10157581|NCT02908100|11288037|FG002|NOT COMPLETED|Overall Study||21
10157582|NCT02908178|11288051|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
10157583|NCT02908178|11288052|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
10157584|NCT02908178|11288053|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
10157585|NCT02908178|11288054|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
10157586|NCT02908178|11288051|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
10157587|NCT02908178|11288052|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
10157588|NCT02908178|11288053|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
10157589|NCT02908178|11288054|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
10157590|NCT02908178|11288051|FG000|NOT COMPLETED|Overall Study||0
10157591|NCT02908178|11288052|FG001|NOT COMPLETED|Overall Study||8388
10157592|NCT02908178|11288053|FG002|NOT COMPLETED|Overall Study||0
10157593|NCT02908178|11288054|FG003|NOT COMPLETED|Overall Study||6819
10157594|NCT02908347|11288065|FG000|STARTED|Overall Study||23
10157595|NCT02908347|11288066|FG001|STARTED|Overall Study||23
10157596|NCT02908347|11288065|FG000|COMPLETED|Overall Study||22
10157597|NCT02908347|11288066|FG001|COMPLETED|Overall Study||22
10157598|NCT02908347|11288065|FG000|NOT COMPLETED|Overall Study||1
10157599|NCT02908347|11288066|FG001|NOT COMPLETED|Overall Study||1
10157600|NCT02908464|11288088|FG000|STARTED|Overall Study||22
10157601|NCT02908464|11288089|FG001|STARTED|Overall Study||23
10157602|NCT02908464|11288088|FG000|COMPLETED|Overall Study||20
10157603|NCT02908464|11288089|FG001|COMPLETED|Overall Study||20
10157604|NCT02908464|11288088|FG000|NOT COMPLETED|Overall Study||2
10157605|NCT02908464|11288089|FG001|NOT COMPLETED|Overall Study||3
10157606|NCT02908490|11288098|FG000|STARTED|Overall Study||12
10157607|NCT02908490|11288099|FG001|STARTED|Overall Study||13
10157608|NCT02908490|11288098|FG000|COMPLETED|Overall Study||10
10157609|NCT02908490|11288099|FG001|COMPLETED|Overall Study||11
10157610|NCT02908490|11288098|FG000|NOT COMPLETED|Overall Study||2
10157611|NCT02908490|11288099|FG001|NOT COMPLETED|Overall Study||2
10157612|NCT02908529|11288105|FG000|STARTED|Overall Study||10
10157613|NCT02908529|11288106|FG001|STARTED|Overall Study||12
10157614|NCT02908529|11288105|FG000|COMPLETED|Overall Study||10
10157615|NCT02908529|11288106|FG001|COMPLETED|Overall Study||10
10157616|NCT02908529|11288105|FG000|NOT COMPLETED|Overall Study||0
10157617|NCT02908529|11288106|FG001|NOT COMPLETED|Overall Study||2
10157618|NCT02908620|11288118|FG000|STARTED|Overall Study||10
10157619|NCT02908620|11288119|FG001|STARTED|Overall Study||10
10157620|NCT02908620|11288120|FG002|STARTED|Overall Study||10
10157621|NCT02908620|11288121|FG003|STARTED|Overall Study||10
10157622|NCT02908620|11288118|FG000|COMPLETED|Overall Study||10
10157623|NCT02908620|11288119|FG001|COMPLETED|Overall Study||10
10157624|NCT02908620|11288120|FG002|COMPLETED|Overall Study||10
10157625|NCT02908620|11288121|FG003|COMPLETED|Overall Study||10
10157626|NCT02908620|11288118|FG000|NOT COMPLETED|Overall Study||0
10157627|NCT02908620|11288119|FG001|NOT COMPLETED|Overall Study||0
10157628|NCT02908620|11288120|FG002|NOT COMPLETED|Overall Study||0
10157629|NCT02908620|11288121|FG003|NOT COMPLETED|Overall Study||0
10157630|NCT02908841|11288137|FG000|STARTED|Overall Study||10
10157631|NCT02908841|11288138|FG001|STARTED|Overall Study||12
10157632|NCT02908841|11288137|FG000|COMPLETED|Overall Study||6
10157633|NCT02908841|11288138|FG001|COMPLETED|Overall Study||12
10157634|NCT02908841|11288137|FG000|NOT COMPLETED|Overall Study||4
10157635|NCT02908841|11288138|FG001|NOT COMPLETED|Overall Study||0
10157636|NCT02908880|11288144|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
10157637|NCT02908880|11288144|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
10157638|NCT02908880|11288144|FG000|NOT COMPLETED|Overall Study||27
10157639|NCT02909101|11288150|FG000|STARTED|Overall Study||29
10157640|NCT02909101|11288151|FG001|STARTED|Overall Study||29
10157641|NCT02909101|11288150|FG000|COMPLETED|Overall Study||28
10157642|NCT02909101|11288151|FG001|COMPLETED|Overall Study||28
10157643|NCT02909101|11288150|FG000|NOT COMPLETED|Overall Study||1
10157644|NCT02909101|11288151|FG001|NOT COMPLETED|Overall Study||1
10157645|NCT02909140|11288160|FG000|STARTED|Overall Study||0
10157646|NCT02909140|11288161|FG001|STARTED|Overall Study||2
10157647|NCT02909140|11288162|FG002|STARTED|Overall Study||0
10157648|NCT02909140|11288160|FG000|COMPLETED|Overall Study||0
10157649|NCT02909140|11288161|FG001|COMPLETED|Overall Study||2
10157650|NCT02909140|11288162|FG002|COMPLETED|Overall Study||0
10157651|NCT02909140|11288160|FG000|NOT COMPLETED|Overall Study||0
10157652|NCT02909140|11288161|FG001|NOT COMPLETED|Overall Study||0
10157653|NCT02909140|11288162|FG002|NOT COMPLETED|Overall Study||0
10157654|NCT02909153|11288175|FG000|STARTED|Overall Study||6
10157655|NCT02909153|11288176|FG001|STARTED|Overall Study||6
10157656|NCT02909153|11288177|FG002|STARTED|Overall Study||6
10157657|NCT02909153|11288178|FG003|STARTED|Overall Study||6
10157658|NCT02909153|11288179|FG004|STARTED|Overall Study||6
10157659|NCT02909153|11288175|FG000|Triferic in Dianeal PD Solution|Overall Study||6
10157660|NCT02909153|11288176|FG001|Triferic in Dianeal PD Solution|Overall Study||6
10157661|NCT02909153|11288177|FG002|Triferic in Dianeal PD Solution|Overall Study||6
10157662|NCT02909153|11288178|FG003|Triferic in Dianeal PD Solution|Overall Study||0
10157663|NCT02909153|11288179|FG004|Triferic in Dianeal PD Solution|Overall Study||0
10157664|NCT02909153|11288175|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10157665|NCT02909153|11288176|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
10157666|NCT02909153|11288177|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10157667|NCT02909153|11288178|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10157668|NCT02909153|11288179|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10157669|NCT02909153|11288175|FG000|Triferic in Extraneal PD Solution|Overall Study||0
10157670|NCT02909153|11288176|FG001|Triferic in Extraneal PD Solution|Overall Study||0
10157671|NCT02909153|11288177|FG002|Triferic in Extraneal PD Solution|Overall Study||0
10157672|NCT02909153|11288178|FG003|Triferic in Extraneal PD Solution|Overall Study||6
10157673|NCT02909153|11288179|FG004|Triferic in Extraneal PD Solution|Overall Study||6
10157674|NCT02909153|11288175|FG000|COMPLETED|Overall Study||6
10157675|NCT02909153|11288176|FG001|COMPLETED|Overall Study||5
10157676|NCT02909153|11288177|FG002|COMPLETED|Overall Study||6
10157677|NCT02909153|11288178|FG003|COMPLETED|Overall Study||6
10157678|NCT02909153|11288179|FG004|COMPLETED|Overall Study||6
10157679|NCT02909153|11288175|FG000|NOT COMPLETED|Overall Study||0
10157680|NCT02909153|11288176|FG001|NOT COMPLETED|Overall Study||1
10157681|NCT02909153|11288177|FG002|NOT COMPLETED|Overall Study||0
10157682|NCT02909153|11288178|FG003|NOT COMPLETED|Overall Study||0
10157683|NCT02909153|11288179|FG004|NOT COMPLETED|Overall Study||0
10157684|NCT02909439|11288193|FG000|STARTED|Overall Study||31
10157685|NCT02909439|11288194|FG001|STARTED|Overall Study||31
10157686|NCT02909439|11288193|FG000|COMPLETED|Overall Study||31
10157687|NCT02909439|11288194|FG001|COMPLETED|Overall Study||31
10157688|NCT02909439|11288193|FG000|NOT COMPLETED|Overall Study||0
10157689|NCT02909439|11288194|FG001|NOT COMPLETED|Overall Study||0
10157690|NCT02909504|11288200|FG000|STARTED|Overall Study||24
10157691|NCT02909504|11288200|FG000|COMPLETED|Overall Study||12
10157692|NCT02909504|11288200|FG000|NOT COMPLETED|Overall Study||12
10157693|NCT02909764|11288207|FG000|STARTED|Overall Study||19
10157694|NCT02909764|11288208|FG001|STARTED|Overall Study||20
10157695|NCT02909764|11288207|FG000|COMPLETED|Overall Study||19
10157696|NCT02909764|11288208|FG001|COMPLETED|Overall Study||20
10157697|NCT02909764|11288207|FG000|NOT COMPLETED|Overall Study||0
10157698|NCT02909764|11288208|FG001|NOT COMPLETED|Overall Study||0
10157699|NCT02909907|11288219|FG000|STARTED|Overall Study||10
10157700|NCT02909907|11288220|FG001|STARTED|Overall Study||10
10157701|NCT02909907|11288219|FG000|COMPLETED|Overall Study||10
10157702|NCT02909907|11288220|FG001|COMPLETED|Overall Study||9
10157703|NCT02909907|11288219|FG000|NOT COMPLETED|Overall Study||0
10157704|NCT02909907|11288220|FG001|NOT COMPLETED|Overall Study||1
10157705|NCT02909959|11288228|FG000|STARTED|Overall Study||24
10157706|NCT02909959|11288229|FG001|STARTED|Overall Study||24
10157707|NCT02909959|11288228|FG000|COMPLETED|Overall Study||24
10157708|NCT02909959|11288229|FG001|COMPLETED|Overall Study||24
10157709|NCT02909959|11288228|FG000|NOT COMPLETED|Overall Study||0
10157710|NCT02909959|11288229|FG001|NOT COMPLETED|Overall Study||0
10157711|NCT02910011|11288235|FG000|STARTED|Overall Study||15
10157712|NCT02910011|11288235|FG000|COMPLETED|Overall Study||13
10157713|NCT02910011|11288235|FG000|NOT COMPLETED|Overall Study||2
10157714|NCT02910037|11288241|FG000|STARTED|Overall Study||214
10157715|NCT02910037|11288241|FG000|COMPLETED|Overall Study||204
10157716|NCT02910037|11288241|FG000|NOT COMPLETED|Overall Study||10
10157717|NCT02910063|11288261|FG000|STARTED|Phase 2||41
10157718|NCT02910063|11288262|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
10157719|NCT02910063|11288263|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
10157720|NCT02910063|11288261|FG000|Started Cycle 1|Phase 2||41
10157721|NCT02910063|11288262|FG001|Started Cycle 1|Phase 2||0
10157722|NCT02910063|11288263|FG002|Started Cycle 1|Phase 2||0
10157723|NCT02910063|11288261|FG000|Started Optional Cycle 2|Phase 2||4
10157724|NCT02910063|11288262|FG001|Started Optional Cycle 2|Phase 2||0
10157725|NCT02910063|11288263|FG002|Started Optional Cycle 2|Phase 2||0
9710401|NCT04605588|10809985|FG000|STARTED|Overall Study||2
9710402|NCT04605588|10809986|FG001|STARTED|Overall Study||5
9710403|NCT04605588|10809985|FG000|COMPLETED|Overall Study||1
9710404|NCT04605588|10809986|FG001|COMPLETED|Overall Study||5
9710405|NCT04605588|10809985|FG000|NOT COMPLETED|Overall Study||1
9710406|NCT04605588|10809986|FG001|NOT COMPLETED|Overall Study||0
9730304|NCT00124943|10830044|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
9730305|NCT00124943|10830045|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
9730306|NCT00124943|10830046|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
9730307|NCT00124943|10830047|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
9730308|NCT00124943|10830044|FG000|COMPLETED|Phase II||3
9730309|NCT00124943|10830045|FG001|COMPLETED|Phase II||49
9730310|NCT00124943|10830046|FG002|COMPLETED|Phase II||3
9730311|NCT00124943|10830047|FG003|COMPLETED|Phase II||50
9730312|NCT00124943|10830044|FG000|NOT COMPLETED|Phase II||0
9730313|NCT00124943|10830045|FG001|NOT COMPLETED|Phase II||2
9730314|NCT00124943|10830046|FG002|NOT COMPLETED|Phase II||0
9730315|NCT00124943|10830047|FG003|NOT COMPLETED|Phase II||5
9730316|NCT00124982|10830059|FG000|STARTED|Short-term Period||449
9730317|NCT00124982|10830060|FG001|STARTED|Short-term Period||597
9730318|NCT00124982|10830061|FG002|STARTED|Short-term Period||0
9730319|NCT00124982|10830059|FG000|COMPLETED|Short-term Period||377
9730320|NCT00124982|10830060|FG001|COMPLETED|Short-term Period||483
9730321|NCT00124982|10830061|FG002|COMPLETED|Short-term Period||0
9730322|NCT00124982|10830059|FG000|NOT COMPLETED|Short-term Period||72
9730323|NCT00124982|10830060|FG001|NOT COMPLETED|Short-term Period||114
9730324|NCT00124982|10830061|FG002|NOT COMPLETED|Short-term Period||0
9730325|NCT00124982|10830059|FG000|STARTED|Long-term Period||0
9730326|NCT00124982|10830060|FG001|STARTED|Long-term Period||0
9730327|NCT00124982|10830061|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
9730328|NCT00124982|10830059|FG000|COMPLETED|Long-term Period||0
9730329|NCT00124982|10830060|FG001|COMPLETED|Long-term Period||0
9730330|NCT00124982|10830061|FG002|COMPLETED|Long-term Period||441
9730331|NCT00124982|10830059|FG000|NOT COMPLETED|Long-term Period||0
9730332|NCT00124982|10830060|FG001|NOT COMPLETED|Long-term Period||0
9730333|NCT00124982|10830061|FG002|NOT COMPLETED|Long-term Period||89
9730334|NCT00125034|10830072|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
9730335|NCT00125034|10830073|FG001|STARTED|Overall Study|Randomized & treated|168
9730336|NCT00125034|10830072|FG000|COMPLETED|Overall Study||170
9730337|NCT00125034|10830073|FG001|COMPLETED|Overall Study||168
9730338|NCT00125034|10830072|FG000|NOT COMPLETED|Overall Study||0
9730339|NCT00125034|10830073|FG001|NOT COMPLETED|Overall Study||0
9730340|NCT00125138|10830083|FG000|STARTED|Overall Study||15
9730341|NCT00125138|10830084|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
9730342|NCT00125138|10830085|FG002|STARTED|Overall Study||25
9730343|NCT00125138|10830086|FG003|STARTED|Overall Study||30
9730344|NCT00125138|10830083|FG000|COMPLETED|Overall Study||12
9730345|NCT00125138|10830084|FG001|COMPLETED|Overall Study||17
9730346|NCT00125138|10830085|FG002|COMPLETED|Overall Study||21
9730347|NCT00125138|10830086|FG003|COMPLETED|Overall Study||25
9730348|NCT00125138|10830083|FG000|NOT COMPLETED|Overall Study||3
9730349|NCT00125138|10830084|FG001|NOT COMPLETED|Overall Study||3
9730350|NCT00125138|10830085|FG002|NOT COMPLETED|Overall Study||4
10157726|NCT02910063|11288261|FG000|COMPLETED|Phase 2||13
10157727|NCT02910063|11288262|FG001|COMPLETED|Phase 2||0
10157728|NCT02910063|11288263|FG002|COMPLETED|Phase 2||0
10157729|NCT02910063|11288261|FG000|NOT COMPLETED|Phase 2||28
10157730|NCT02910063|11288262|FG001|NOT COMPLETED|Phase 2||0
10157731|NCT02910063|11288263|FG002|NOT COMPLETED|Phase 2||0
10157732|NCT02910063|11288261|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
10157733|NCT02910063|11288262|FG001|STARTED|Phase 3||0
10157734|NCT02910063|11288263|FG002|STARTED|Phase 3||0
10157735|NCT02910063|11288261|FG000|COMPLETED|Phase 3||0
10157736|NCT02910063|11288262|FG001|COMPLETED|Phase 3||0
10157737|NCT02910063|11288263|FG002|COMPLETED|Phase 3||0
10157738|NCT02910063|11288261|FG000|NOT COMPLETED|Phase 3||0
10157739|NCT02910063|11288262|FG001|NOT COMPLETED|Phase 3||0
10157740|NCT02910063|11288263|FG002|NOT COMPLETED|Phase 3||0
10157741|NCT02910089|11288274|FG000|STARTED|Overall Study|Patients allocated to intervention|700
10157742|NCT02910089|11288275|FG001|STARTED|Overall Study|Patients allocated to control|700
10157743|NCT02910089|11288274|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
10157744|NCT02910089|11288275|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
10157745|NCT02910089|11288274|FG000|NOT COMPLETED|Overall Study||22
10157746|NCT02910089|11288275|FG001|NOT COMPLETED|Overall Study||16
10157747|NCT02910102|11288283|FG000|STARTED|Overall Study||21
10157748|NCT02910102|11288284|FG001|STARTED|Overall Study||17
10157749|NCT02910102|11288283|FG000|Safety Population|Overall Study||21
10157750|NCT02910102|11288284|FG001|Safety Population|Overall Study||17
10157751|NCT02910102|11288283|FG000|Intent to Treat (ITT) Population|Overall Study||21
10157752|NCT02910102|11288284|FG001|Intent to Treat (ITT) Population|Overall Study||17
10157753|NCT02910102|11288283|FG000|Per-Protocol Population|Overall Study||20
10157754|NCT02910102|11288284|FG001|Per-Protocol Population|Overall Study||17
10157755|NCT02910102|11288283|FG000|COMPLETED|Overall Study||21
10157756|NCT02910102|11288284|FG001|COMPLETED|Overall Study||17
10157757|NCT02910102|11288283|FG000|NOT COMPLETED|Overall Study||0
10157758|NCT02910102|11288284|FG001|NOT COMPLETED|Overall Study||0
10157759|NCT02910167|11288295|FG000|STARTED|Overall Study||360
10157760|NCT02910167|11288295|FG000|COMPLETED|Overall Study||341
10157761|NCT02910167|11288295|FG000|NOT COMPLETED|Overall Study||19
10157762|NCT02910362|11288301|FG000|STARTED|Overall Study||8
10157763|NCT02910362|11288302|FG001|STARTED|Overall Study||7
10157764|NCT02910362|11288301|FG000|COMPLETED|Overall Study||8
9710407|NCT04599959|10809992|FG000|STARTED|Overall Study||151
9710408|NCT04599959|10809992|FG000|COMPLETED|Overall Study||151
9710409|NCT04599959|10809992|FG000|NOT COMPLETED|Overall Study||0
9710410|NCT04596085|10810000|FG000|STARTED|Overall Study||59
9710411|NCT04596085|10810001|FG001|STARTED|Overall Study||59
9710412|NCT04596085|10810000|FG000|COMPLETED|Overall Study||59
9710413|NCT04596085|10810001|FG001|COMPLETED|Overall Study||59
9710414|NCT04596085|10810000|FG000|NOT COMPLETED|Overall Study||0
9710415|NCT04596085|10810001|FG001|NOT COMPLETED|Overall Study||0
9710416|NCT04590027|10810011|FG000|STARTED|Overall Study||47
9710417|NCT04590027|10810012|FG001|STARTED|Overall Study||39
9710418|NCT04590027|10810011|FG000|COMPLETED|Overall Study||30
9710419|NCT04590027|10810012|FG001|COMPLETED|Overall Study||22
9710420|NCT04590027|10810011|FG000|NOT COMPLETED|Overall Study||17
9710421|NCT04590027|10810012|FG001|NOT COMPLETED|Overall Study||17
9710422|NCT04578457|10810022|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19
9710423|NCT04578457|10810022|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17
9710424|NCT04578457|10810022|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2
9710425|NCT04578457|10810022|FG000|STARTED|Hearing Aid With NR (1)||19
9710426|NCT04578457|10810022|FG000|COMPLETED|Hearing Aid With NR (1)||17
9710427|NCT04578457|10810022|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2
9710428|NCT04578457|10810022|FG000|STARTED|Hearing Aid With NR (2)||19
9710429|NCT04578457|10810022|FG000|COMPLETED|Hearing Aid With NR (2)||17
9710430|NCT04578457|10810022|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2
9710431|NCT04578457|10810022|FG000|STARTED|Hearing Aid With NR (4)||19
9710432|NCT04578457|10810022|FG000|COMPLETED|Hearing Aid With NR (4)||17
9710433|NCT04578457|10810022|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2
9710434|NCT04578496|10810030|FG000|STARTED|Overall Study||16
9710435|NCT04578496|10810030|FG000|COMPLETED|Overall Study||12
9710436|NCT04578496|10810030|FG000|NOT COMPLETED|Overall Study||4
9730351|NCT00125138|10830086|FG003|NOT COMPLETED|Overall Study||5
9730352|NCT00125164|10830100|FG000|STARTED|Overall Study||25
9730353|NCT00125164|10830101|FG001|STARTED|Overall Study||16
9730354|NCT00125164|10830102|FG002|STARTED|Overall Study||44
9730355|NCT00125164|10830103|FG003|STARTED|Overall Study||51
9730356|NCT00125164|10830100|FG000|COMPLETED|Overall Study||23
9730357|NCT00125164|10830101|FG001|COMPLETED|Overall Study||16
10157765|NCT02910362|11288302|FG001|COMPLETED|Overall Study||7
10157766|NCT02910362|11288301|FG000|NOT COMPLETED|Overall Study||0
10157767|NCT02910362|11288302|FG001|NOT COMPLETED|Overall Study||0
10157768|NCT02910466|11288308|FG000|STARTED|Overall Study||39
10157769|NCT02910466|11288308|FG000|Safety Set|Overall Study||39
10157770|NCT02910466|11288308|FG000|Treated|Overall Study||36
9730358|NCT00125164|10830102|FG002|COMPLETED|Overall Study||40
9730359|NCT00125164|10830103|FG003|COMPLETED|Overall Study||45
9730360|NCT00125164|10830100|FG000|NOT COMPLETED|Overall Study||2
9730361|NCT00125164|10830101|FG001|NOT COMPLETED|Overall Study||0
9730362|NCT00125164|10830102|FG002|NOT COMPLETED|Overall Study||4
9730363|NCT00125164|10830103|FG003|NOT COMPLETED|Overall Study||6
9730364|NCT00125190|10830113|FG000|STARTED|Overall Study||45
9730365|NCT00125190|10830113|FG000|Completed 34 Weeks of Study|Overall Study||43
9730366|NCT00125190|10830113|FG000|COMPLETED|Overall Study||30
9730367|NCT00125190|10830113|FG000|NOT COMPLETED|Overall Study||15
9730368|NCT00125242|10830120|FG000|STARTED|Overall Study||94
9730369|NCT00125242|10830121|FG001|STARTED|Overall Study||16
10157771|NCT02910466|11288308|FG000|COMPLETED|Overall Study||0
10157772|NCT02910466|11288308|FG000|NOT COMPLETED|Overall Study||39
10157773|NCT02910674|11288312|FG000|STARTED|Overall Study||102
10157774|NCT02910674|11288312|FG000|COMPLETED|Overall Study||102
10157775|NCT02910674|11288312|FG000|NOT COMPLETED|Overall Study||0
10157776|NCT02910713|11288317|FG000|STARTED|Overall Study||185
10157777|NCT02910713|11288317|FG000|Safety Population: Entered CAE|Overall Study||171
10157778|NCT02910713|11288317|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
10157779|NCT02910713|11288317|FG000|NOT COMPLETED|Overall Study||42
10157780|NCT02910739|11288324|FG000|STARTED|Overall Study||8
10157781|NCT02910739|11288325|FG001|STARTED|Overall Study||8
10157782|NCT02910739|11288326|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10157783|NCT02910739|11288327|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10157784|NCT02910739|11288324|FG000|COMPLETED|Overall Study||7
10157785|NCT02910739|11288325|FG001|COMPLETED|Overall Study||8
10157786|NCT02910739|11288326|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10157787|NCT02910739|11288327|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10157788|NCT02910739|11288324|FG000|NOT COMPLETED|Overall Study||1
10157789|NCT02910739|11288325|FG001|NOT COMPLETED|Overall Study||0
10157790|NCT02910739|11288326|FG002|NOT COMPLETED|Overall Study||0
10157791|NCT02910739|11288327|FG003|NOT COMPLETED|Overall Study||0
10157792|NCT02911025|11288333|FG000|STARTED|Overall Study||13
10157793|NCT02911025|11288333|FG000|COMPLETED|Overall Study||10
10157794|NCT02911025|11288333|FG000|NOT COMPLETED|Overall Study||3
10157795|NCT02911116|11288339|FG000|STARTED|Overall Study||5
10157796|NCT02911116|11288340|FG001|STARTED|Overall Study||3
10157797|NCT02911116|11288339|FG000|COMPLETED|Overall Study||4
10157798|NCT02911116|11288340|FG001|COMPLETED|Overall Study||2
10157799|NCT02911116|11288339|FG000|NOT COMPLETED|Overall Study||1
10157800|NCT02911116|11288340|FG001|NOT COMPLETED|Overall Study||1
10157801|NCT02911285|11288348|FG000|STARTED|Overall Study||49
10157802|NCT02911285|11288349|FG001|STARTED|Overall Study||41
10157803|NCT02911285|11288348|FG000|COMPLETED|Overall Study||40
10157804|NCT02911285|11288349|FG001|COMPLETED|Overall Study||36
10157805|NCT02911285|11288348|FG000|NOT COMPLETED|Overall Study||9
10157806|NCT02911285|11288349|FG001|NOT COMPLETED|Overall Study||5
10157807|NCT02911324|11288361|FG000|STARTED|Overall Study||9
10157808|NCT02911324|11288362|FG001|STARTED|Overall Study||7
10157809|NCT02911324|11288361|FG000|COMPLETED|Overall Study||6
10157810|NCT02911324|11288362|FG001|COMPLETED|Overall Study||6
10157811|NCT02911324|11288361|FG000|NOT COMPLETED|Overall Study||3
10157812|NCT02911324|11288362|FG001|NOT COMPLETED|Overall Study||1
10157813|NCT02911519|11288371|FG000|STARTED|Overall Study||90
10157814|NCT02911519|11288372|FG001|STARTED|Overall Study||86
10157815|NCT02911519|11288371|FG000|COMPLETED|Overall Study||88
10157816|NCT02911519|11288372|FG001|COMPLETED|Overall Study||82
10157817|NCT02911519|11288371|FG000|NOT COMPLETED|Overall Study||2
10157818|NCT02911519|11288372|FG001|NOT COMPLETED|Overall Study||4
10157819|NCT02911688|11288380|FG000|STARTED|First Intervention||9
10157820|NCT02911688|11288381|FG001|STARTED|First Intervention||9
10157821|NCT02911688|11288380|FG000|Received Intervention|First Intervention||9
10157822|NCT02911688|11288381|FG001|Received Intervention|First Intervention||9
10157823|NCT02911688|11288380|FG000|COMPLETED|First Intervention||9
10157824|NCT02911688|11288381|FG001|COMPLETED|First Intervention||9
10157825|NCT02911688|11288380|FG000|NOT COMPLETED|First Intervention||0
10157826|NCT02911688|11288381|FG001|NOT COMPLETED|First Intervention||0
10157827|NCT02911688|11288380|FG000|STARTED|Washout||9
10157828|NCT02911688|11288381|FG001|STARTED|Washout||9
10157829|NCT02911688|11288380|FG000|COMPLETED|Washout||8
10157830|NCT02911688|11288381|FG001|COMPLETED|Washout||7
10157831|NCT02911688|11288380|FG000|NOT COMPLETED|Washout||1
10157832|NCT02911688|11288381|FG001|NOT COMPLETED|Washout||2
10157833|NCT02911688|11288380|FG000|STARTED|Second Intervention||8
10157834|NCT02911688|11288381|FG001|STARTED|Second Intervention||7
10157835|NCT02911688|11288380|FG000|COMPLETED|Second Intervention||8
10157836|NCT02911688|11288381|FG001|COMPLETED|Second Intervention||7
10157837|NCT02911688|11288380|FG000|NOT COMPLETED|Second Intervention||0
10157838|NCT02911688|11288381|FG001|NOT COMPLETED|Second Intervention||0
10157839|NCT02911753|11288392|FG000|STARTED|Overall Study||21
10157840|NCT02911753|11288393|FG001|STARTED|Overall Study||19
10157841|NCT02911753|11288394|FG002|STARTED|Overall Study||10
10157842|NCT02911753|11288392|FG000|COMPLETED|Overall Study||18
10157843|NCT02911753|11288393|FG001|COMPLETED|Overall Study||16
10157844|NCT02911753|11288394|FG002|COMPLETED|Overall Study||10
10157845|NCT02911753|11288392|FG000|NOT COMPLETED|Overall Study||3
10157846|NCT02911753|11288393|FG001|NOT COMPLETED|Overall Study||3
10157847|NCT02911753|11288394|FG002|NOT COMPLETED|Overall Study||0
10157848|NCT02911818|11288423|FG000|STARTED|52 Week Study||50
10157849|NCT02911818|11288424|FG001|STARTED|52 Week Study||50
10157850|NCT02911818|11288425|FG002|STARTED|52 Week Study||50
10157851|NCT02911818|11288426|FG003|STARTED|52 Week Study||0
10157852|NCT02911818|11288427|FG004|STARTED|52 Week Study||0
10157853|NCT02911818|11288423|FG000|COMPLETED|52 Week Study||46
10157854|NCT02911818|11288424|FG001|COMPLETED|52 Week Study||45
10157855|NCT02911818|11288425|FG002|COMPLETED|52 Week Study||46
10157856|NCT02911818|11288426|FG003|COMPLETED|52 Week Study||0
10157857|NCT02911818|11288427|FG004|COMPLETED|52 Week Study||0
10157858|NCT02911818|11288423|FG000|NOT COMPLETED|52 Week Study||4
10157859|NCT02911818|11288424|FG001|NOT COMPLETED|52 Week Study||5
10157860|NCT02911818|11288425|FG002|NOT COMPLETED|52 Week Study||4
10157861|NCT02911818|11288426|FG003|NOT COMPLETED|52 Week Study||0
10157862|NCT02911818|11288427|FG004|NOT COMPLETED|52 Week Study||0
10157863|NCT02911818|11288423|FG000|STARTED|12 Week Extension Study||0
10157864|NCT02911818|11288424|FG001|STARTED|12 Week Extension Study||0
10157865|NCT02911818|11288425|FG002|STARTED|12 Week Extension Study||0
10157866|NCT02911818|11288426|FG003|STARTED|12 Week Extension Study||22
10157867|NCT02911818|11288427|FG004|STARTED|12 Week Extension Study||23
10157868|NCT02911818|11288423|FG000|COMPLETED|12 Week Extension Study||0
10157869|NCT02911818|11288424|FG001|COMPLETED|12 Week Extension Study||0
10157870|NCT02911818|11288425|FG002|COMPLETED|12 Week Extension Study||0
10157871|NCT02911818|11288426|FG003|COMPLETED|12 Week Extension Study||22
10157872|NCT02911818|11288427|FG004|COMPLETED|12 Week Extension Study||22
10157873|NCT02911818|11288423|FG000|NOT COMPLETED|12 Week Extension Study||0
10157874|NCT02911818|11288424|FG001|NOT COMPLETED|12 Week Extension Study||0
10157875|NCT02911818|11288425|FG002|NOT COMPLETED|12 Week Extension Study||0
10157876|NCT02911818|11288426|FG003|NOT COMPLETED|12 Week Extension Study||0
10157877|NCT02911818|11288427|FG004|NOT COMPLETED|12 Week Extension Study||1
10157878|NCT02911844|11288441|FG000|STARTED|Overall Study||5
10157879|NCT02911844|11288441|FG000|COMPLETED|Overall Study||5
10157880|NCT02911844|11288441|FG000|NOT COMPLETED|Overall Study||0
10157881|NCT02911857|11288448|FG000|STARTED|Overall Study||2
10157882|NCT02911857|11288449|FG001|STARTED|Overall Study||1
10157883|NCT02911857|11288450|FG002|STARTED|Overall Study||1
10157884|NCT02911857|11288448|FG000|COMPLETED|Overall Study||2
10157885|NCT02911857|11288449|FG001|COMPLETED|Overall Study||1
10157886|NCT02911857|11288450|FG002|COMPLETED|Overall Study||1
10157887|NCT02911857|11288448|FG000|NOT COMPLETED|Overall Study||0
10157888|NCT02911857|11288449|FG001|NOT COMPLETED|Overall Study||0
10157889|NCT02911857|11288450|FG002|NOT COMPLETED|Overall Study||0
10157890|NCT02911909|11288460|FG000|STARTED|Overall Study||4
10157891|NCT02911909|11288461|FG001|STARTED|Overall Study||3
10157892|NCT02911909|11288460|FG000|COMPLETED|Overall Study||2
10157893|NCT02911909|11288461|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0
10157894|NCT02911909|11288460|FG000|NOT COMPLETED|Overall Study||2
10157895|NCT02911909|11288461|FG001|NOT COMPLETED|Overall Study||3
10157896|NCT02911922|11288469|FG000|STARTED|Overall Study||1
10157897|NCT02911922|11288470|FG001|STARTED|Overall Study||0
10157898|NCT02911922|11288469|FG000|COMPLETED|Overall Study||1
10157899|NCT02911922|11288470|FG001|COMPLETED|Overall Study||0
10157900|NCT02911922|11288469|FG000|NOT COMPLETED|Overall Study||0
10157901|NCT02911922|11288470|FG001|NOT COMPLETED|Overall Study||0
10157902|NCT02911948|11288480|FG000|STARTED|Overall Study||105
10157903|NCT02911948|11288481|FG001|STARTED|Overall Study||105
10157904|NCT02911948|11288480|FG000|COMPLETED|Overall Study||105
10157905|NCT02911948|11288481|FG001|COMPLETED|Overall Study||98
10157906|NCT02911948|11288480|FG000|NOT COMPLETED|Overall Study||0
10157907|NCT02911948|11288481|FG001|NOT COMPLETED|Overall Study||7
10157908|NCT02912195|11288489|FG000|STARTED|Overall Study||16
10157909|NCT02912195|11288490|FG001|STARTED|Overall Study||16
10157910|NCT02912195|11288489|FG000|COMPLETED|Overall Study||16
10157911|NCT02912195|11288490|FG001|COMPLETED|Overall Study||16
10157912|NCT02912195|11288489|FG000|NOT COMPLETED|Overall Study||0
10157913|NCT02912195|11288490|FG001|NOT COMPLETED|Overall Study||0
10157914|NCT02912364|11288496|FG000|STARTED|Treatment 1||23
10157915|NCT02912364|11288497|FG001|STARTED|Treatment 1||23
10157916|NCT02912364|11288496|FG000|Received Intervention|Treatment 1||18
10157917|NCT02912364|11288497|FG001|Received Intervention|Treatment 1||18
10157918|NCT02912364|11288496|FG000|COMPLETED|Treatment 1||13
10157919|NCT02912364|11288497|FG001|COMPLETED|Treatment 1||11
10157920|NCT02912364|11288496|FG000|NOT COMPLETED|Treatment 1||10
10157921|NCT02912364|11288497|FG001|NOT COMPLETED|Treatment 1||12
10157922|NCT02912364|11288496|FG000|STARTED|Washout Period||13
10157923|NCT02912364|11288497|FG001|STARTED|Washout Period||11
10157924|NCT02912364|11288496|FG000|COMPLETED|Washout Period||13
10157925|NCT02912364|11288497|FG001|COMPLETED|Washout Period||11
10157926|NCT02912364|11288496|FG000|NOT COMPLETED|Washout Period||0
10157927|NCT02912364|11288497|FG001|NOT COMPLETED|Washout Period||0
10157928|NCT02912364|11288496|FG000|STARTED|Treatment 2||13
10157929|NCT02912364|11288497|FG001|STARTED|Treatment 2||11
10157930|NCT02912364|11288496|FG000|Received Intervention|Treatment 2||12
10157931|NCT02912364|11288497|FG001|Received Intervention|Treatment 2||11
10157932|NCT02912364|11288496|FG000|COMPLETED|Treatment 2||12
10157933|NCT02912364|11288497|FG001|COMPLETED|Treatment 2||11
10157934|NCT02912364|11288496|FG000|NOT COMPLETED|Treatment 2||1
10157935|NCT02912364|11288497|FG001|NOT COMPLETED|Treatment 2||0
10157936|NCT02912455|11288508|FG000|STARTED|Overall Study||11
10157937|NCT02912455|11288509|FG001|STARTED|Overall Study||5
10157938|NCT02912455|11288508|FG000|COMPLETED|Overall Study||9
10157939|NCT02912455|11288509|FG001|COMPLETED|Overall Study||2
10157940|NCT02912455|11288508|FG000|NOT COMPLETED|Overall Study||2
10157941|NCT02912455|11288509|FG001|NOT COMPLETED|Overall Study||3
10157942|NCT02912468|11288517|FG000|STARTED|Overall Study||133
10157943|NCT02912468|11288518|FG001|STARTED|Overall Study||143
10157944|NCT02912468|11288517|FG000|Treated|Overall Study||133
10157945|NCT02912468|11288518|FG001|Treated|Overall Study||142
10157946|NCT02912468|11288517|FG000|Safety Population|Overall Study||132
10157947|NCT02912468|11288518|FG001|Safety Population|Overall Study||143
10157948|NCT02912468|11288517|FG000|COMPLETED|Overall Study||124
10157949|NCT02912468|11288518|FG001|COMPLETED|Overall Study||138
10157950|NCT02912468|11288517|FG000|NOT COMPLETED|Overall Study||9
10157951|NCT02912468|11288518|FG001|NOT COMPLETED|Overall Study||5
10157952|NCT02912650|11288529|FG000|STARTED|Overall Study||56
10157953|NCT02912650|11288530|FG001|STARTED|Overall Study||172
10157954|NCT02912650|11288531|FG002|STARTED|Overall Study||175
10157955|NCT02912650|11288532|FG003|STARTED|Overall Study||165
10157956|NCT02912650|11288529|FG000|COMPLETED|Overall Study||55
10157957|NCT02912650|11288530|FG001|COMPLETED|Overall Study||172
10157958|NCT02912650|11288531|FG002|COMPLETED|Overall Study||173
10157959|NCT02912650|11288532|FG003|COMPLETED|Overall Study||160
10157960|NCT02912650|11288529|FG000|NOT COMPLETED|Overall Study||1
10157961|NCT02912650|11288530|FG001|NOT COMPLETED|Overall Study||0
10157962|NCT02912650|11288531|FG002|NOT COMPLETED|Overall Study||2
10157963|NCT02912650|11288532|FG003|NOT COMPLETED|Overall Study||5
10157964|NCT02913105|11288545|FG000|STARTED|Overall Study||37
10157965|NCT02913105|11288546|FG001|STARTED|Overall Study||44
10157966|NCT02913105|11288547|FG002|STARTED|Overall Study||40
10157967|NCT02913105|11288545|FG000|COMPLETED|Overall Study||22
10157968|NCT02913105|11288546|FG001|COMPLETED|Overall Study||39
10157969|NCT02913105|11288547|FG002|COMPLETED|Overall Study||33
10157970|NCT02913105|11288545|FG000|NOT COMPLETED|Overall Study||15
10157971|NCT02913105|11288546|FG001|NOT COMPLETED|Overall Study||5
10157972|NCT02913105|11288547|FG002|NOT COMPLETED|Overall Study||7
10157973|NCT02913326|11288558|FG000|STARTED|Overall Study||60
10157974|NCT02913326|11288559|FG001|STARTED|Overall Study||60
10157975|NCT02913326|11288558|FG000|COMPLETED|Overall Study||59
10157976|NCT02913326|11288559|FG001|COMPLETED|Overall Study||58
10157977|NCT02913326|11288558|FG000|NOT COMPLETED|Overall Study||1
10157978|NCT02913326|11288559|FG001|NOT COMPLETED|Overall Study||2
10157979|NCT02913521|11288568|FG000|STARTED|Overall Study||316
10157980|NCT02913521|11288569|FG001|STARTED|Overall Study||312
10157981|NCT02913521|11288570|FG002|STARTED|Overall Study||306
10157982|NCT02913521|11288568|FG000|COMPLETED|Overall Study||263
10157983|NCT02913521|11288569|FG001|COMPLETED|Overall Study||262
10157984|NCT02913521|11288570|FG002|COMPLETED|Overall Study||261
10157985|NCT02913521|11288568|FG000|NOT COMPLETED|Overall Study||53
10157986|NCT02913521|11288569|FG001|NOT COMPLETED|Overall Study||50
10157987|NCT02913521|11288570|FG002|NOT COMPLETED|Overall Study||45
10157988|NCT02913924|11288580|FG000|STARTED|Overall Study||34
10157989|NCT02913924|11288581|FG001|STARTED|Overall Study||34
10157990|NCT02913924|11288580|FG000|COMPLETED|Overall Study||21
10157991|NCT02913924|11288581|FG001|COMPLETED|Overall Study||21
10157992|NCT02913924|11288580|FG000|NOT COMPLETED|Overall Study||13
10157993|NCT02913924|11288581|FG001|NOT COMPLETED|Overall Study||13
10157994|NCT02914119|11288587|FG000|STARTED|Overall Study||30430
10157995|NCT02914119|11288587|FG000|COMPLETED|Overall Study||30430
10157996|NCT02914119|11288587|FG000|NOT COMPLETED|Overall Study||0
10157997|NCT02914132|11288591|FG000|STARTED|Overall Study||15
10157998|NCT02914132|11288591|FG000|COMPLETED|Overall Study||15
10157999|NCT02914132|11288591|FG000|NOT COMPLETED|Overall Study||0
10158000|NCT02914184|11288599|FG000|STARTED|Overall Study||400
10158001|NCT02914184|11288600|FG001|STARTED|Overall Study||396
10158002|NCT02914184|11288601|FG002|STARTED|Overall Study||402
10158003|NCT02914184|11288602|FG003|STARTED|Overall Study||402
10158004|NCT02914184|11288599|FG000|COMPLETED|Overall Study||386
10158005|NCT02914184|11288600|FG001|COMPLETED|Overall Study||383
10158006|NCT02914184|11288601|FG002|COMPLETED|Overall Study||385
10158007|NCT02914184|11288602|FG003|COMPLETED|Overall Study||391
10158008|NCT02914184|11288599|FG000|NOT COMPLETED|Overall Study||14
10158009|NCT02914184|11288600|FG001|NOT COMPLETED|Overall Study||13
10158010|NCT02914184|11288601|FG002|NOT COMPLETED|Overall Study||17
10158011|NCT02914184|11288602|FG003|NOT COMPLETED|Overall Study||11
10158012|NCT02914210|11288616|FG000|STARTED|Overall Study||153
10158013|NCT02914210|11288617|FG001|STARTED|Overall Study||153
10158014|NCT02914210|11288616|FG000|COMPLETED|Overall Study||143
10158015|NCT02914210|11288617|FG001|COMPLETED|Overall Study||144
10158016|NCT02914210|11288616|FG000|NOT COMPLETED|Overall Study||10
10158017|NCT02914210|11288617|FG001|NOT COMPLETED|Overall Study||9
10158018|NCT02914236|11288623|FG000|STARTED|Overall Study||50
10158019|NCT02914236|11288623|FG000|4-week Follow-up Visit|Overall Study||50
10158020|NCT02914236|11288623|FG000|12-week Follow-up Visit|Overall Study||50
10158021|NCT02914236|11288623|FG000|26-week Follow-up Visit|Overall Study||49
10158022|NCT02914236|11288623|FG000|COMPLETED|Overall Study||49
10158023|NCT02914236|11288623|FG000|NOT COMPLETED|Overall Study||1
10158024|NCT02914275|11288629|FG000|STARTED|Overall Study||1687
10158025|NCT02914275|11288630|FG001|STARTED|Overall Study||563
10158026|NCT02914275|11288629|FG000|Included in Clinical Database / FAS|Overall Study||1684
10158027|NCT02914275|11288630|FG001|Included in Clinical Database / FAS|Overall Study||563
10158028|NCT02914275|11288629|FG000|COMPLETED|Overall Study||1566
10158029|NCT02914275|11288630|FG001|COMPLETED|Overall Study||521
10158030|NCT02914275|11288629|FG000|NOT COMPLETED|Overall Study||121
10158031|NCT02914275|11288630|FG001|NOT COMPLETED|Overall Study||42
10158032|NCT02914457|11288640|FG000|STARTED|Overall Study||31
10158033|NCT02914457|11288640|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
10158034|NCT02914457|11288640|FG000|NOT COMPLETED|Overall Study||6
10158035|NCT02914509|11288646|FG000|STARTED|Overall Study||348
10158036|NCT02914509|11288647|FG001|STARTED|Overall Study||217
10158037|NCT02914509|11288646|FG000|COMPLETED|Overall Study||343
10158038|NCT02914509|11288647|FG001|COMPLETED|Overall Study||211
10158039|NCT02914509|11288646|FG000|NOT COMPLETED|Overall Study||5
10158040|NCT02914509|11288647|FG001|NOT COMPLETED|Overall Study||6
10158041|NCT02914522|11288661|FG000|STARTED|Induction Study: Up to Week 11||245
10158042|NCT02914522|11288662|FG001|STARTED|Induction Study: Up to Week 11||278
10158043|NCT02914522|11288663|FG002|STARTED|Induction Study: Up to Week 11||137
10158044|NCT02914522|11288664|FG003|STARTED|Induction Study: Up to Week 11||262
10158045|NCT02914522|11288665|FG004|STARTED|Induction Study: Up to Week 11||286
10158046|NCT02914522|11288666|FG005|STARTED|Induction Study: Up to Week 11||143
10158047|NCT02914522|11288667|FG006|STARTED|Induction Study: Up to Week 11||0
10158048|NCT02914522|11288668|FG007|STARTED|Induction Study: Up to Week 11||0
10158049|NCT02914522|11288669|FG008|STARTED|Induction Study: Up to Week 11||0
10158050|NCT02914522|11288670|FG009|STARTED|Induction Study: Up to Week 11||0
10158051|NCT02914522|11288671|FG010|STARTED|Induction Study: Up to Week 11||0
10158052|NCT02914522|11288661|FG000|COMPLETED|Induction Study: Up to Week 11||235
10158053|NCT02914522|11288662|FG001|COMPLETED|Induction Study: Up to Week 11||256
10158054|NCT02914522|11288663|FG002|COMPLETED|Induction Study: Up to Week 11||127
10158055|NCT02914522|11288664|FG003|COMPLETED|Induction Study: Up to Week 11||234
10158056|NCT02914522|11288665|FG004|COMPLETED|Induction Study: Up to Week 11||262
10158057|NCT02914522|11288666|FG005|COMPLETED|Induction Study: Up to Week 11||127
9710437|NCT04577183|10810034|FG000|STARTED|Overall Study||13
9710438|NCT04577183|10810034|FG000|COMPLETED|Overall Study||7
9710439|NCT04577183|10810034|FG000|NOT COMPLETED|Overall Study||6
9730370|NCT00125242|10830120|FG000|COMPLETED|Overall Study||87
9730371|NCT00125242|10830121|FG001|COMPLETED|Overall Study||14
9730372|NCT00125242|10830120|FG000|NOT COMPLETED|Overall Study||7
9730373|NCT00125242|10830121|FG001|NOT COMPLETED|Overall Study||2
9730374|NCT00125359|10830126|FG000|STARTED|Overall Study||42
9730375|NCT00125359|10830126|FG000|COMPLETED|Overall Study||19
9730376|NCT00125359|10830126|FG000|NOT COMPLETED|Overall Study||23
9730377|NCT00125372|10830130|FG000|STARTED|Overall Study||12
9730378|NCT00125372|10830130|FG000|COMPLETED|Overall Study||10
9730379|NCT00125372|10830130|FG000|NOT COMPLETED|Overall Study||2
9730380|NCT00125515|10830137|FG000|STARTED|Overall Study||27
9730381|NCT00125515|10830138|FG001|STARTED|Overall Study||27
9730382|NCT00125515|10830139|FG002|STARTED|Overall Study||27
9730383|NCT00125515|10830137|FG000|COMPLETED|Overall Study||7
9730384|NCT00125515|10830138|FG001|COMPLETED|Overall Study||7
9730385|NCT00125515|10830139|FG002|COMPLETED|Overall Study||6
9730386|NCT00125515|10830137|FG000|NOT COMPLETED|Overall Study||20
9730387|NCT00125515|10830138|FG001|NOT COMPLETED|Overall Study||20
9730388|NCT00125515|10830139|FG002|NOT COMPLETED|Overall Study||21
9730389|NCT00125528|10830149|FG000|STARTED|Overall Study||20
9730390|NCT00125528|10830150|FG001|STARTED|Overall Study||21
9730391|NCT00125528|10830149|FG000|COMPLETED|Overall Study||18
9730392|NCT00125528|10830150|FG001|COMPLETED|Overall Study||20
9730393|NCT00125528|10830149|FG000|NOT COMPLETED|Overall Study||2
9730394|NCT00125528|10830150|FG001|NOT COMPLETED|Overall Study||1
9730395|NCT00125593|10830158|FG000|STARTED|Overall Study||4650
9730396|NCT00125593|10830159|FG001|STARTED|Overall Study||4620
9730397|NCT00125593|10830158|FG000|COMPLETED|Overall Study||4549
9730398|NCT00125593|10830159|FG001|COMPLETED|Overall Study||4517
9730399|NCT00125593|10830158|FG000|NOT COMPLETED|Overall Study||101
9730400|NCT00125593|10830159|FG001|NOT COMPLETED|Overall Study||103
9730401|NCT00125619|10830167|FG000|STARTED|Overall Study||8
9730402|NCT00125619|10830168|FG001|STARTED|Overall Study||8
9730403|NCT00125619|10830167|FG000|COMPLETED|Overall Study||8
10061009|NCT02100839|11186552|FG000|STARTED|Multiple Ascending Dose||13
10061010|NCT02100839|11186553|FG001|STARTED|Multiple Ascending Dose||3
10061011|NCT02100839|11186552|FG000|COMPLETED|Multiple Ascending Dose||9
10061012|NCT02100839|11186553|FG001|COMPLETED|Multiple Ascending Dose||3
10061013|NCT02100839|11186552|FG000|NOT COMPLETED|Multiple Ascending Dose||4
10061014|NCT02100839|11186553|FG001|NOT COMPLETED|Multiple Ascending Dose||0
10061015|NCT02100930|11186559|FG000|STARTED|Overall Study||69
10061016|NCT02100930|11186559|FG000|COMPLETED|Overall Study||69
10061017|NCT02100930|11186559|FG000|NOT COMPLETED|Overall Study||0
10061018|NCT02100969|11186563|FG000|STARTED|Overall Study||23
10061019|NCT02100969|11186563|FG000|COMPLETED|Overall Study||22
10061020|NCT02100969|11186563|FG000|NOT COMPLETED|Overall Study||1
10061021|NCT02101008|11186568|FG000|STARTED|Overall Study||12
10061022|NCT02101008|11186568|FG000|COMPLETED|Overall Study||12
10061023|NCT02101008|11186568|FG000|NOT COMPLETED|Overall Study||0
10061024|NCT02101021|11186577|FG000|STARTED|Overall Study||7
10061025|NCT02101021|11186578|FG001|STARTED|Overall Study||4
10061026|NCT02101021|11186579|FG002|STARTED|Overall Study||7
10061027|NCT02101021|11186580|FG003|STARTED|Overall Study||3
10061028|NCT02101021|11186581|FG004|STARTED|Overall Study||4
10061029|NCT02101021|11186577|FG000|COMPLETED|Overall Study||0
10061030|NCT02101021|11186578|FG001|COMPLETED|Overall Study||0
10061031|NCT02101021|11186579|FG002|COMPLETED|Overall Study||0
10061032|NCT02101021|11186580|FG003|COMPLETED|Overall Study||0
10061033|NCT02101021|11186581|FG004|COMPLETED|Overall Study||0
10061034|NCT02101021|11186577|FG000|NOT COMPLETED|Overall Study||7
10061035|NCT02101021|11186578|FG001|NOT COMPLETED|Overall Study||4
9730404|NCT00125619|10830168|FG001|COMPLETED|Overall Study||8
9730405|NCT00125619|10830167|FG000|NOT COMPLETED|Overall Study||0
9730406|NCT00125619|10830168|FG001|NOT COMPLETED|Overall Study||0
10061036|NCT02101021|11186579|FG002|NOT COMPLETED|Overall Study||7
10158058|NCT02914522|11288667|FG006|COMPLETED|Induction Study: Up to Week 11||0
9730407|NCT00125658|10830177|FG000|STARTED|Overall Study||8
9730408|NCT00125658|10830178|FG001|STARTED|Overall Study||6
10061037|NCT02101021|11186580|FG003|NOT COMPLETED|Overall Study||3
10061038|NCT02101021|11186581|FG004|NOT COMPLETED|Overall Study||4
10061039|NCT02101060|11186595|FG000|STARTED|Overall Study||17
10158059|NCT02914522|11288668|FG007|COMPLETED|Induction Study: Up to Week 11||0
10158060|NCT02914522|11288669|FG008|COMPLETED|Induction Study: Up to Week 11||0
10158061|NCT02914522|11288670|FG009|COMPLETED|Induction Study: Up to Week 11||0
10158062|NCT02914522|11288671|FG010|COMPLETED|Induction Study: Up to Week 11||0
10158063|NCT02914522|11288661|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10
10158064|NCT02914522|11288662|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22
10158065|NCT02914522|11288663|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10
10158066|NCT02914522|11288664|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28
10158067|NCT02914522|11288665|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24
10158068|NCT02914522|11288666|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16
10158069|NCT02914522|11288667|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0
10158070|NCT02914522|11288668|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0
10158071|NCT02914522|11288669|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0
10158072|NCT02914522|11288670|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0
10158073|NCT02914522|11288671|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0
10158074|NCT02914522|11288661|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10158075|NCT02914522|11288662|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10158076|NCT02914522|11288663|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10158077|NCT02914522|11288664|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0
10158078|NCT02914522|11288665|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0
10158079|NCT02914522|11288666|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10158080|NCT02914522|11288667|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
10158081|NCT02914522|11288668|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
10158082|NCT02914522|11288669|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
10158083|NCT02914522|11288670|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
10158084|NCT02914522|11288671|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93
10158085|NCT02914522|11288661|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158086|NCT02914522|11288662|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158087|NCT02914522|11288663|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158088|NCT02914522|11288664|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158089|NCT02914522|11288665|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158090|NCT02914522|11288666|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158091|NCT02914522|11288667|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150
10158092|NCT02914522|11288668|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41
10158093|NCT02914522|11288669|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104
10158094|NCT02914522|11288670|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42
10158095|NCT02914522|11288671|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64
10158096|NCT02914522|11288661|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158097|NCT02914522|11288662|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158098|NCT02914522|11288663|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158099|NCT02914522|11288664|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158100|NCT02914522|11288665|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158101|NCT02914522|11288666|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10158102|NCT02914522|11288667|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
10158103|NCT02914522|11288668|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
10158104|NCT02914522|11288669|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
10158105|NCT02914522|11288670|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
10158106|NCT02914522|11288671|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
10158107|NCT02914548|11288701|FG000|STARTED|Overall Study||67
10158108|NCT02914548|11288702|FG001|STARTED|Overall Study||67
10158109|NCT02914548|11288703|FG002|STARTED|Overall Study||66
10158110|NCT02914548|11288701|FG000|COMPLETED|Overall Study||46
10158111|NCT02914548|11288702|FG001|COMPLETED|Overall Study||53
10158112|NCT02914548|11288703|FG002|COMPLETED|Overall Study||46
10158113|NCT02914548|11288701|FG000|NOT COMPLETED|Overall Study||21
10158114|NCT02914548|11288702|FG001|NOT COMPLETED|Overall Study||14
10158115|NCT02914548|11288703|FG002|NOT COMPLETED|Overall Study||20
10158116|NCT02914795|11288713|FG000|STARTED|Overall Study||77
10158117|NCT02914795|11288714|FG001|STARTED|Overall Study||22
10158118|NCT02914795|11288713|FG000|COMPLETED|Overall Study||77
10158119|NCT02914795|11288714|FG001|COMPLETED|Overall Study||22
10158120|NCT02914795|11288713|FG000|NOT COMPLETED|Overall Study||0
10158121|NCT02914795|11288714|FG001|NOT COMPLETED|Overall Study||0
10158122|NCT02914834|11288724|FG000|STARTED|Overall Study||12
10158123|NCT02914834|11288725|FG001|STARTED|Overall Study||15
10158124|NCT02914834|11288724|FG000|COMPLETED|Overall Study||11
10158125|NCT02914834|11288725|FG001|COMPLETED|Overall Study||13
10158126|NCT02914834|11288724|FG000|NOT COMPLETED|Overall Study||1
10158127|NCT02914834|11288725|FG001|NOT COMPLETED|Overall Study||2
10158128|NCT02915029|11288733|FG000|STARTED|Overall Study||63
10158129|NCT02915029|11288734|FG001|STARTED|Overall Study||62
10158130|NCT02915029|11288733|FG000|COMPLETED|Overall Study||50
10158131|NCT02915029|11288734|FG001|COMPLETED|Overall Study||48
10158132|NCT02915029|11288733|FG000|NOT COMPLETED|Overall Study||13
10158133|NCT02915029|11288734|FG001|NOT COMPLETED|Overall Study||14
10158134|NCT02915159|11288742|FG000|STARTED|Overall Study||92
10158135|NCT02915159|11288743|FG001|STARTED|Overall Study||95
10158136|NCT02915159|11288742|FG000|COMPLETED|Overall Study||81
10158137|NCT02915159|11288743|FG001|COMPLETED|Overall Study||87
10158138|NCT02915159|11288742|FG000|NOT COMPLETED|Overall Study||11
10158139|NCT02915159|11288743|FG001|NOT COMPLETED|Overall Study||8
10158140|NCT02915705|11288755|FG000|STARTED|Treatment Period||32
10158141|NCT02915705|11288756|FG001|STARTED|Treatment Period||29
10158142|NCT02915705|11288755|FG000|Completed Week 40|Treatment Period||32
10158143|NCT02915705|11288756|FG001|Completed Week 40|Treatment Period||29
10158144|NCT02915705|11288755|FG000|Completed Week 64|Treatment Period||32
10158145|NCT02915705|11288756|FG001|Completed Week 64|Treatment Period||29
10158146|NCT02915705|11288755|FG000|COMPLETED|Treatment Period||32
10158147|NCT02915705|11288756|FG001|COMPLETED|Treatment Period||29
10158148|NCT02915705|11288755|FG000|NOT COMPLETED|Treatment Period||0
10158149|NCT02915705|11288756|FG001|NOT COMPLETED|Treatment Period||0
9710440|NCT04574999|10810040|FG000|STARTED|Overall Study||114
10158150|NCT02915705|11288755|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
10158151|NCT02915705|11288756|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
10158152|NCT02915705|11288755|FG000|COMPLETED|Long Term Extension Period||26
10158153|NCT02915705|11288756|FG001|COMPLETED|Long Term Extension Period||25
10158154|NCT02915705|11288755|FG000|NOT COMPLETED|Long Term Extension Period||0
10158155|NCT02915705|11288756|FG001|NOT COMPLETED|Long Term Extension Period||0
10158156|NCT02915744|11288767|FG000|STARTED|Overall Study||92
10158157|NCT02915744|11288768|FG001|STARTED|Overall Study||86
10158158|NCT02915744|11288767|FG000|COMPLETED|Overall Study||13
10158159|NCT02915744|11288768|FG001|COMPLETED|Overall Study||9
10158160|NCT02915744|11288767|FG000|NOT COMPLETED|Overall Study||79
10158161|NCT02915744|11288768|FG001|NOT COMPLETED|Overall Study||77
10158162|NCT02915835|11288778|FG000|STARTED|Overall Study||9
10158163|NCT02915835|11288779|FG001|STARTED|Overall Study||8
10158164|NCT02915835|11288778|FG000|COMPLETED|Overall Study||8
10158165|NCT02915835|11288779|FG001|COMPLETED|Overall Study||7
10158166|NCT02915835|11288778|FG000|NOT COMPLETED|Overall Study||1
10158167|NCT02915835|11288779|FG001|NOT COMPLETED|Overall Study||1
10158168|NCT02915874|11288787|FG000|STARTED|Overall Study||44
10158169|NCT02915874|11288788|FG001|STARTED|Overall Study||28
10158170|NCT02915874|11288787|FG000|Week 6 Follow Up|Overall Study||41
10158171|NCT02915874|11288788|FG001|Week 6 Follow Up|Overall Study||26
10158172|NCT02915874|11288787|FG000|COMPLETED|Overall Study||38
10158173|NCT02915874|11288788|FG001|COMPLETED|Overall Study||22
10158174|NCT02915874|11288787|FG000|NOT COMPLETED|Overall Study||6
10158175|NCT02915874|11288788|FG001|NOT COMPLETED|Overall Study||6
10158176|NCT02915978|11288797|FG000|STARTED|Overall Study||15
10158177|NCT02915978|11288798|FG001|STARTED|Overall Study||15
10158178|NCT02915978|11288799|FG002|STARTED|Overall Study||15
10158179|NCT02915978|11288797|FG000|COMPLETED|Overall Study||13
10158180|NCT02915978|11288798|FG001|COMPLETED|Overall Study||14
10158181|NCT02915978|11288799|FG002|COMPLETED|Overall Study||15
10158182|NCT02915978|11288797|FG000|NOT COMPLETED|Overall Study||2
10158183|NCT02915978|11288798|FG001|NOT COMPLETED|Overall Study||1
10158184|NCT02915978|11288799|FG002|NOT COMPLETED|Overall Study||0
10158185|NCT02916056|11288807|FG000|STARTED|Overall Study||297
10158186|NCT02916056|11288807|FG000|COMPLETED|Overall Study||0
10158187|NCT02916056|11288807|FG000|NOT COMPLETED|Overall Study||297
10158188|NCT02916407|11288813|FG000|STARTED|Overall Study||28
10158189|NCT02916407|11288814|FG001|STARTED|Overall Study||28
10158190|NCT02916407|11288813|FG000|COMPLETED|Overall Study||28
10158191|NCT02916407|11288814|FG001|COMPLETED|Overall Study||28
10158192|NCT02916407|11288813|FG000|NOT COMPLETED|Overall Study||0
10158193|NCT02916407|11288814|FG001|NOT COMPLETED|Overall Study||0
10158194|NCT02916433|11288822|FG000|STARTED|Overall Study||3
10158195|NCT02916433|11288823|FG001|STARTED|Overall Study||2
10158196|NCT02916433|11288822|FG000|COMPLETED|Overall Study||1
10158197|NCT02916433|11288823|FG001|COMPLETED|Overall Study||2
10158198|NCT02916433|11288822|FG000|NOT COMPLETED|Overall Study||2
10158199|NCT02916433|11288823|FG001|NOT COMPLETED|Overall Study||0
10158200|NCT02916498|11288834|FG000|STARTED|First Intervention, 21 Days||2
10158201|NCT02916498|11288835|FG001|STARTED|First Intervention, 21 Days||4
10158202|NCT02916498|11288834|FG000|COMPLETED|First Intervention, 21 Days||2
10158203|NCT02916498|11288835|FG001|COMPLETED|First Intervention, 21 Days||4
10158204|NCT02916498|11288834|FG000|NOT COMPLETED|First Intervention, 21 Days||0
10158205|NCT02916498|11288835|FG001|NOT COMPLETED|First Intervention, 21 Days||0
10158206|NCT02916498|11288834|FG000|STARTED|Second Intervention, 21 Days||2
10158207|NCT02916498|11288835|FG001|STARTED|Second Intervention, 21 Days||4
10158208|NCT02916498|11288834|FG000|COMPLETED|Second Intervention, 21 Days||2
10158209|NCT02916498|11288835|FG001|COMPLETED|Second Intervention, 21 Days||4
10158210|NCT02916498|11288834|FG000|NOT COMPLETED|Second Intervention, 21 Days||0
10158211|NCT02916498|11288835|FG001|NOT COMPLETED|Second Intervention, 21 Days||0
10158212|NCT02916563|11288841|FG000|STARTED|Overall Study||50
10158213|NCT02916563|11288841|FG000|COMPLETED|Overall Study||50
10158214|NCT02916563|11288841|FG000|NOT COMPLETED|Overall Study||0
10158215|NCT02916693|11288845|FG000|STARTED|Overall Study||20
10158216|NCT02916693|11288845|FG000|COMPLETED|Overall Study||13
10158217|NCT02916693|11288845|FG000|NOT COMPLETED|Overall Study||7
10158218|NCT02916745|11288853|FG000|STARTED|Overall Study||5
10158219|NCT02916745|11288853|FG000|COMPLETED|Overall Study||5
10158220|NCT02916745|11288853|FG000|NOT COMPLETED|Overall Study||0
10158221|NCT02916927|11288859|FG000|STARTED|Overall Study||31
10158222|NCT02916927|11288860|FG001|STARTED|Overall Study||31
10158223|NCT02916927|11288859|FG000|Received Study Drug|Overall Study||31
10158224|NCT02916927|11288860|FG001|Received Study Drug|Overall Study||29
10158225|NCT02916927|11288859|FG000|COMPLETED|Overall Study||30
10158226|NCT02916927|11288860|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
9710441|NCT04574999|10810041|FG001|STARTED|Overall Study||53
10158227|NCT02916927|11288859|FG000|NOT COMPLETED|Overall Study||1
10158228|NCT02916927|11288860|FG001|NOT COMPLETED|Overall Study||3
10158229|NCT02917031|11288869|FG000|STARTED|Overall Study||112
10158230|NCT02917031|11288870|FG001|STARTED|Overall Study||115
10158231|NCT02917031|11288871|FG002|STARTED|Overall Study||120
10158232|NCT02917031|11288869|FG000|COMPLETED|Overall Study||94
10158233|NCT02917031|11288870|FG001|COMPLETED|Overall Study||102
10158234|NCT02917031|11288871|FG002|COMPLETED|Overall Study||105
10158235|NCT02917031|11288869|FG000|NOT COMPLETED|Overall Study||18
10158236|NCT02917031|11288870|FG001|NOT COMPLETED|Overall Study||13
10158237|NCT02917031|11288871|FG002|NOT COMPLETED|Overall Study||15
10158238|NCT02917122|11288882|FG000|STARTED|Overall Study||8
10158239|NCT02917122|11288883|FG001|STARTED|Overall Study||7
10158240|NCT02917122|11288882|FG000|COMPLETED|Overall Study||8
10158241|NCT02917122|11288883|FG001|COMPLETED|Overall Study||7
10158242|NCT02917122|11288882|FG000|NOT COMPLETED|Overall Study||0
10158243|NCT02917122|11288883|FG001|NOT COMPLETED|Overall Study||0
10158244|NCT02917265|11288891|FG000|STARTED|Overall Study||5
10158245|NCT02917265|11288892|FG001|STARTED|Overall Study||2
10158246|NCT02917265|11288891|FG000|COMPLETED|Overall Study||3
10158247|NCT02917265|11288892|FG001|COMPLETED|Overall Study||2
10158248|NCT02917265|11288891|FG000|NOT COMPLETED|Overall Study||2
10158249|NCT02917265|11288892|FG001|NOT COMPLETED|Overall Study||0
10158250|NCT02917278|11288902|FG000|STARTED|Overall Study||10
10158251|NCT02917278|11288903|FG001|STARTED|Overall Study||9
10158252|NCT02917278|11288902|FG000|COMPLETED|Overall Study||9
10158253|NCT02917278|11288903|FG001|COMPLETED|Overall Study||9
10158254|NCT02917278|11288902|FG000|NOT COMPLETED|Overall Study||1
10158255|NCT02917278|11288903|FG001|NOT COMPLETED|Overall Study||0
10158256|NCT02917447|11288911|FG000|STARTED|Overall Study||51
10158257|NCT02917447|11288912|FG001|STARTED|Overall Study||51
10158258|NCT02917447|11288911|FG000|COMPLETED|Overall Study||44
10158259|NCT02917447|11288912|FG001|COMPLETED|Overall Study||48
10158260|NCT02917447|11288911|FG000|NOT COMPLETED|Overall Study||7
10158261|NCT02917447|11288912|FG001|NOT COMPLETED|Overall Study||3
10158262|NCT02917603|11288920|FG000|STARTED|Overall Study||20
10158263|NCT02917603|11288921|FG001|STARTED|Overall Study||20
10158264|NCT02917603|11288920|FG000|COMPLETED|Overall Study||19
10158265|NCT02917603|11288921|FG001|COMPLETED|Overall Study||16
10158266|NCT02917603|11288920|FG000|NOT COMPLETED|Overall Study||1
10158267|NCT02917603|11288921|FG001|NOT COMPLETED|Overall Study||4
10158268|NCT02917642|11288930|FG000|STARTED|Overall Study||25
10158269|NCT02917642|11288931|FG001|STARTED|Overall Study||25
10158270|NCT02917642|11288930|FG000|COMPLETED|Overall Study||25
10158271|NCT02917642|11288931|FG001|COMPLETED|Overall Study||25
10158272|NCT02917642|11288930|FG000|NOT COMPLETED|Overall Study||0
10158273|NCT02917642|11288931|FG001|NOT COMPLETED|Overall Study||0
10158274|NCT02917941|11288937|FG000|STARTED|Treatment Period||34
10158275|NCT02917941|11288937|FG000|COMPLETED|Treatment Period||10
10158276|NCT02917941|11288937|FG000|NOT COMPLETED|Treatment Period||24
10158277|NCT02917941|11288937|FG000|STARTED|Survival Follow-up Period||31
10158278|NCT02917941|11288937|FG000|COMPLETED|Survival Follow-up Period||26
10158279|NCT02917941|11288937|FG000|NOT COMPLETED|Survival Follow-up Period||5
10158280|NCT02918071|11288941|FG000|STARTED|Overall Study||121
10158281|NCT02918071|11288941|FG000|COMPLETED|Overall Study||118
10158282|NCT02918071|11288941|FG000|NOT COMPLETED|Overall Study||3
10158283|NCT02918097|11288945|FG000|STARTED|Overall Study||78
10158284|NCT02918097|11288945|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
10158285|NCT02918097|11288945|FG000|NOT COMPLETED|Overall Study||20
10158286|NCT02918266|11288960|FG000|STARTED|Part 1||6
10158287|NCT02918266|11288961|FG001|STARTED|Part 1||0
10158288|NCT02918266|11288962|FG002|STARTED|Part 1||0
9849344|NCT00864253|10962029|FG001|Treated|Overall Study||258
9849345|NCT00864253|10962028|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
9849346|NCT00864253|10962029|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
9849347|NCT00864253|10962028|FG000|NOT COMPLETED|Overall Study||99
9849348|NCT00864253|10962029|FG001|NOT COMPLETED|Overall Study||58
10158289|NCT02918266|11288963|FG003|STARTED|Part 1||0
10158290|NCT02918266|11288964|FG004|STARTED|Part 1||0
10158291|NCT02918266|11288965|FG005|STARTED|Part 1||0
10158292|NCT02918266|11288966|FG006|STARTED|Part 1||0
10158293|NCT02918266|11288967|FG007|STARTED|Part 1||0
10158294|NCT02918266|11288968|FG008|STARTED|Part 1||0
10158295|NCT02918266|11288969|FG009|STARTED|Part 1||0
10158296|NCT02918266|11288970|FG010|STARTED|Part 1||0
10158297|NCT02918266|11288960|FG000|COMPLETED|Part 1||6
10158298|NCT02918266|11288961|FG001|COMPLETED|Part 1||0
10158299|NCT02918266|11288962|FG002|COMPLETED|Part 1||0
10158300|NCT02918266|11288963|FG003|COMPLETED|Part 1||0
10158301|NCT02918266|11288964|FG004|COMPLETED|Part 1||0
10158302|NCT02918266|11288965|FG005|COMPLETED|Part 1||0
10158303|NCT02918266|11288966|FG006|COMPLETED|Part 1||0
10158304|NCT02918266|11288967|FG007|COMPLETED|Part 1||0
10158305|NCT02918266|11288968|FG008|COMPLETED|Part 1||0
10158306|NCT02918266|11288969|FG009|COMPLETED|Part 1||0
10158307|NCT02918266|11288970|FG010|COMPLETED|Part 1||0
10158308|NCT02918266|11288960|FG000|NOT COMPLETED|Part 1||0
10158309|NCT02918266|11288961|FG001|NOT COMPLETED|Part 1||0
10158310|NCT02918266|11288962|FG002|NOT COMPLETED|Part 1||0
10158311|NCT02918266|11288963|FG003|NOT COMPLETED|Part 1||0
10158312|NCT02918266|11288964|FG004|NOT COMPLETED|Part 1||0
10158313|NCT02918266|11288965|FG005|NOT COMPLETED|Part 1||0
10158314|NCT02918266|11288966|FG006|NOT COMPLETED|Part 1||0
10158315|NCT02918266|11288967|FG007|NOT COMPLETED|Part 1||0
10158316|NCT02918266|11288968|FG008|NOT COMPLETED|Part 1||0
10158317|NCT02918266|11288969|FG009|NOT COMPLETED|Part 1||0
10158318|NCT02918266|11288970|FG010|NOT COMPLETED|Part 1||0
10158319|NCT02918266|11288960|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0
10158320|NCT02918266|11288961|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158321|NCT02918266|11288962|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158322|NCT02918266|11288963|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158323|NCT02918266|11288964|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158324|NCT02918266|11288965|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158325|NCT02918266|11288966|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2
10158326|NCT02918266|11288967|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158327|NCT02918266|11288968|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2
10158328|NCT02918266|11288969|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158329|NCT02918266|11288970|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10158330|NCT02918266|11288960|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158331|NCT02918266|11288961|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158332|NCT02918266|11288962|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158333|NCT02918266|11288963|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158334|NCT02918266|11288964|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158335|NCT02918266|11288965|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158336|NCT02918266|11288966|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158337|NCT02918266|11288967|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158338|NCT02918266|11288968|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158339|NCT02918266|11288969|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158340|NCT02918266|11288970|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158341|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10158342|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158343|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158344|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158345|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158346|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158347|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
10158348|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158349|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
10158350|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158351|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10158352|NCT02918266|11288960|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158353|NCT02918266|11288961|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158354|NCT02918266|11288962|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158355|NCT02918266|11288963|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158356|NCT02918266|11288964|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158357|NCT02918266|11288965|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158358|NCT02918266|11288966|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158359|NCT02918266|11288967|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158360|NCT02918266|11288968|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158361|NCT02918266|11288969|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158362|NCT02918266|11288970|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10158363|NCT02918266|11288960|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158364|NCT02918266|11288961|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158365|NCT02918266|11288962|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158366|NCT02918266|11288963|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158367|NCT02918266|11288964|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158368|NCT02918266|11288965|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158369|NCT02918266|11288966|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158370|NCT02918266|11288967|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158371|NCT02918266|11288968|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158372|NCT02918266|11288969|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158373|NCT02918266|11288970|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158374|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158375|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158376|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158377|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158378|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158379|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158380|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158381|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158382|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158383|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158384|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10158385|NCT02918266|11288960|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158386|NCT02918266|11288961|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158387|NCT02918266|11288962|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158388|NCT02918266|11288963|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158389|NCT02918266|11288964|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158390|NCT02918266|11288965|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158391|NCT02918266|11288966|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158392|NCT02918266|11288967|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158393|NCT02918266|11288968|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158394|NCT02918266|11288969|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158395|NCT02918266|11288970|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10158396|NCT02918266|11288960|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158397|NCT02918266|11288961|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158398|NCT02918266|11288962|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158399|NCT02918266|11288963|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158400|NCT02918266|11288964|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158401|NCT02918266|11288965|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158402|NCT02918266|11288966|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158403|NCT02918266|11288967|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158404|NCT02918266|11288968|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158405|NCT02918266|11288969|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158406|NCT02918266|11288970|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158407|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158408|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158409|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158410|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158411|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158412|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158413|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158414|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158415|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158416|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158417|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10158418|NCT02918266|11288960|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158419|NCT02918266|11288961|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158420|NCT02918266|11288962|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158421|NCT02918266|11288963|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158422|NCT02918266|11288964|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158423|NCT02918266|11288965|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158424|NCT02918266|11288966|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158425|NCT02918266|11288967|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158426|NCT02918266|11288968|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158427|NCT02918266|11288969|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158428|NCT02918266|11288970|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10158429|NCT02918266|11288960|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158430|NCT02918266|11288961|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158431|NCT02918266|11288962|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158432|NCT02918266|11288963|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158433|NCT02918266|11288964|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158434|NCT02918266|11288965|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158435|NCT02918266|11288966|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158436|NCT02918266|11288967|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158437|NCT02918266|11288968|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158438|NCT02918266|11288969|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158439|NCT02918266|11288970|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158440|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158441|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158442|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158443|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158444|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158445|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158446|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158447|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158448|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158449|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158450|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10158451|NCT02918266|11288960|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158452|NCT02918266|11288961|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158453|NCT02918266|11288962|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158454|NCT02918266|11288963|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158455|NCT02918266|11288964|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158456|NCT02918266|11288965|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158457|NCT02918266|11288966|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158458|NCT02918266|11288967|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158459|NCT02918266|11288968|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158460|NCT02918266|11288969|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158461|NCT02918266|11288970|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10158462|NCT02918266|11288960|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158463|NCT02918266|11288961|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158464|NCT02918266|11288962|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158465|NCT02918266|11288963|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158466|NCT02918266|11288964|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158467|NCT02918266|11288965|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158468|NCT02918266|11288966|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158469|NCT02918266|11288967|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158470|NCT02918266|11288968|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158471|NCT02918266|11288969|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158472|NCT02918266|11288970|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158473|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158474|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158475|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158476|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158477|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158478|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158479|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158480|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158481|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158482|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158483|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10158484|NCT02918266|11288960|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158485|NCT02918266|11288961|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158486|NCT02918266|11288962|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158487|NCT02918266|11288963|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158488|NCT02918266|11288964|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158489|NCT02918266|11288965|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158490|NCT02918266|11288966|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158491|NCT02918266|11288967|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158492|NCT02918266|11288968|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158493|NCT02918266|11288969|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158494|NCT02918266|11288970|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10158495|NCT02918266|11288960|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158496|NCT02918266|11288961|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158497|NCT02918266|11288962|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158498|NCT02918266|11288963|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158499|NCT02918266|11288964|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158500|NCT02918266|11288965|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158501|NCT02918266|11288966|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158502|NCT02918266|11288967|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158503|NCT02918266|11288968|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158504|NCT02918266|11288969|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158505|NCT02918266|11288970|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158506|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158507|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158508|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158509|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158510|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158511|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158512|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158513|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158514|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158515|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158516|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10158517|NCT02918266|11288960|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158518|NCT02918266|11288961|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158519|NCT02918266|11288962|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158520|NCT02918266|11288963|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158521|NCT02918266|11288964|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158522|NCT02918266|11288965|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158523|NCT02918266|11288966|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158524|NCT02918266|11288967|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158525|NCT02918266|11288968|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158526|NCT02918266|11288969|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158527|NCT02918266|11288970|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10158528|NCT02918266|11288960|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158529|NCT02918266|11288961|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158530|NCT02918266|11288962|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158531|NCT02918266|11288963|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158532|NCT02918266|11288964|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158533|NCT02918266|11288965|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158534|NCT02918266|11288966|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158535|NCT02918266|11288967|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158536|NCT02918266|11288968|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158537|NCT02918266|11288969|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158538|NCT02918266|11288970|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158539|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158540|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158541|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158542|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158543|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158544|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158545|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158546|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158547|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158548|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158549|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10158550|NCT02918266|11288960|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158551|NCT02918266|11288961|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158552|NCT02918266|11288962|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158553|NCT02918266|11288963|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158554|NCT02918266|11288964|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158555|NCT02918266|11288965|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158556|NCT02918266|11288966|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158557|NCT02918266|11288967|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158558|NCT02918266|11288968|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158559|NCT02918266|11288969|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158560|NCT02918266|11288970|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10158561|NCT02918266|11288960|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158562|NCT02918266|11288961|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158563|NCT02918266|11288962|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158564|NCT02918266|11288963|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158565|NCT02918266|11288964|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158566|NCT02918266|11288965|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158567|NCT02918266|11288966|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9710442|NCT04574999|10810040|FG000|COMPLETED|Overall Study||105
9710443|NCT04574999|10810041|FG001|COMPLETED|Overall Study||48
9710444|NCT04574999|10810040|FG000|NOT COMPLETED|Overall Study||9
9710445|NCT04574999|10810041|FG001|NOT COMPLETED|Overall Study||5
9730409|NCT00125658|10830177|FG000|COMPLETED|Overall Study||8
9730410|NCT00125658|10830178|FG001|COMPLETED|Overall Study||6
9730411|NCT00125658|10830177|FG000|NOT COMPLETED|Overall Study||0
9730412|NCT00125658|10830178|FG001|NOT COMPLETED|Overall Study||0
9730413|NCT00125762|10830186|FG000|STARTED|Overall Study||907
9730414|NCT00125762|10830186|FG000|COMPLETED|Overall Study||748
9730415|NCT00125762|10830186|FG000|NOT COMPLETED|Overall Study||159
9730416|NCT00125788|10830192|FG000|STARTED|Overall Study||37
9730417|NCT00125788|10830193|FG001|STARTED|Overall Study||33
9730418|NCT00125788|10830192|FG000|COMPLETED|Overall Study||33
9730419|NCT00125788|10830193|FG001|COMPLETED|Overall Study||29
9730420|NCT00125788|10830192|FG000|NOT COMPLETED|Overall Study||4
9730421|NCT00125788|10830193|FG001|NOT COMPLETED|Overall Study||4
9730422|NCT00125853|10830199|FG000|STARTED|Wash-out (4 Weeks)||27
9730423|NCT00125853|10830200|FG001|STARTED|Wash-out (4 Weeks)||27
9730424|NCT00125853|10830199|FG000|COMPLETED|Wash-out (4 Weeks)||27
9730425|NCT00125853|10830200|FG001|COMPLETED|Wash-out (4 Weeks)||27
9730426|NCT00125853|10830199|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
9730427|NCT00125853|10830200|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
9730428|NCT00125853|10830199|FG000|STARTED|First Intervention (8 Weeks)||27
9730429|NCT00125853|10830200|FG001|STARTED|First Intervention (8 Weeks)||27
9730430|NCT00125853|10830199|FG000|COMPLETED|First Intervention (8 Weeks)||27
9730431|NCT00125853|10830200|FG001|COMPLETED|First Intervention (8 Weeks)||27
9730432|NCT00125853|10830199|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
9730433|NCT00125853|10830200|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
9730434|NCT00125853|10830199|FG000|STARTED|Wash-out (4 Weeks)||27
9730435|NCT00125853|10830200|FG001|STARTED|Wash-out (4 Weeks)||27
9730436|NCT00125853|10830199|FG000|COMPLETED|Wash-out (4 Weeks)||24
9730437|NCT00125853|10830200|FG001|COMPLETED|Wash-out (4 Weeks)||20
10158568|NCT02918266|11288967|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158569|NCT02918266|11288968|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158570|NCT02918266|11288969|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158571|NCT02918266|11288970|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158572|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9730438|NCT00125853|10830199|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3
9730439|NCT00125853|10830200|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7
9730440|NCT00125853|10830199|FG000|STARTED|Second Intervention (8 Weeks)||24
9730441|NCT00125853|10830200|FG001|STARTED|Second Intervention (8 Weeks)||20
9730442|NCT00125853|10830199|FG000|COMPLETED|Second Intervention (8 Weeks)||24
9730443|NCT00125853|10830200|FG001|COMPLETED|Second Intervention (8 Weeks)||20
9730444|NCT00125853|10830199|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
9730445|NCT00125853|10830200|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
9730446|NCT00125931|10830206|FG000|STARTED|Overall Study||10
9730447|NCT00125931|10830206|FG000|COMPLETED|Overall Study||10
9730448|NCT00125931|10830206|FG000|NOT COMPLETED|Overall Study||0
10158573|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158574|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158575|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158576|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158577|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158578|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158579|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158580|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158581|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158582|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10158583|NCT02918266|11288960|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158584|NCT02918266|11288961|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158585|NCT02918266|11288962|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158586|NCT02918266|11288963|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158587|NCT02918266|11288964|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158588|NCT02918266|11288965|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158589|NCT02918266|11288966|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158590|NCT02918266|11288967|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158591|NCT02918266|11288968|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158592|NCT02918266|11288969|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158593|NCT02918266|11288970|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10158594|NCT02918266|11288960|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158595|NCT02918266|11288961|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158596|NCT02918266|11288962|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158597|NCT02918266|11288963|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158598|NCT02918266|11288964|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158599|NCT02918266|11288965|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158600|NCT02918266|11288966|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158601|NCT02918266|11288967|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158602|NCT02918266|11288968|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158603|NCT02918266|11288969|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158604|NCT02918266|11288970|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158605|NCT02918266|11288960|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158606|NCT02918266|11288961|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158607|NCT02918266|11288962|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158608|NCT02918266|11288963|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158609|NCT02918266|11288964|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158610|NCT02918266|11288965|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158611|NCT02918266|11288966|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158612|NCT02918266|11288967|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158613|NCT02918266|11288968|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158614|NCT02918266|11288969|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158615|NCT02918266|11288970|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10158616|NCT02918279|11288992|FG000|STARTED|Overall Study||125
10158617|NCT02918279|11288993|FG001|STARTED|Overall Study||126
10158618|NCT02918279|11288992|FG000|Full Analysis Set|Overall Study||125
10158619|NCT02918279|11288993|FG001|Full Analysis Set|Overall Study||126
10158620|NCT02918279|11288992|FG000|Safety Analysis Set|Overall Study||125
10158621|NCT02918279|11288993|FG001|Safety Analysis Set|Overall Study||126
10158622|NCT02918279|11288992|FG000|COMPLETED|Overall Study||112
10158623|NCT02918279|11288993|FG001|COMPLETED|Overall Study||103
10158624|NCT02918279|11288992|FG000|NOT COMPLETED|Overall Study||13
10158625|NCT02918279|11288993|FG001|NOT COMPLETED|Overall Study||23
10158626|NCT02918318|11289003|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41
10158627|NCT02918318|11289004|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40
10158628|NCT02918318|11289005|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41
10158629|NCT02918318|11289006|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80
10158630|NCT02918318|11289007|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0
10158631|NCT02918318|11289003|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13
10158632|NCT02918318|11289004|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11
10158633|NCT02918318|11289005|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17
10158634|NCT02918318|11289006|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27
10158635|NCT02918318|11289007|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0
10158636|NCT02918318|11289003|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
10158637|NCT02918318|11289004|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
10158638|NCT02918318|11289005|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
10158639|NCT02918318|11289006|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
10158640|NCT02918318|11289007|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
10158641|NCT02918318|11289003|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
10158642|NCT02918318|11289004|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
10158643|NCT02918318|11289005|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
10158644|NCT02918318|11289006|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
10158645|NCT02918318|11289007|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
10158646|NCT02918318|11289003|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
10158647|NCT02918318|11289004|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
10158648|NCT02918318|11289005|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
10158649|NCT02918318|11289006|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
10158650|NCT02918318|11289007|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
10158651|NCT02918318|11289003|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
10158652|NCT02918318|11289004|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
10158653|NCT02918318|11289005|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
10158654|NCT02918318|11289006|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
10158655|NCT02918318|11289007|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
10158656|NCT02918318|11289003|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
10158657|NCT02918318|11289004|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
10158658|NCT02918318|11289005|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
10158659|NCT02918318|11289006|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
10158660|NCT02918318|11289007|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
10158661|NCT02918318|11289003|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13
10158662|NCT02918318|11289004|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11
10158663|NCT02918318|11289005|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17
10158664|NCT02918318|11289006|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27
10158665|NCT02918318|11289007|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0
10158666|NCT02918318|11289003|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
10158667|NCT02918318|11289004|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
10158668|NCT02918318|11289005|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
10158669|NCT02918318|11289006|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
10158670|NCT02918318|11289007|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
10158671|NCT02918318|11289003|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
10158672|NCT02918318|11289004|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
10158673|NCT02918318|11289005|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
10158674|NCT02918318|11289006|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
10158675|NCT02918318|11289007|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
10158676|NCT02918318|11289003|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0
10158677|NCT02918318|11289004|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0
10158678|NCT02918318|11289005|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0
10158679|NCT02918318|11289006|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0
10158680|NCT02918318|11289007|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48
10158681|NCT02918318|11289003|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158682|NCT02918318|11289004|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158683|NCT02918318|11289005|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158684|NCT02918318|11289006|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158685|NCT02918318|11289007|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
10158686|NCT02918318|11289003|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158687|NCT02918318|11289004|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158688|NCT02918318|11289005|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158689|NCT02918318|11289006|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10158690|NCT02918318|11289007|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
10158691|NCT02918318|11289003|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10158692|NCT02918318|11289004|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10158693|NCT02918318|11289005|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10158694|NCT02918318|11289006|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10158695|NCT02918318|11289007|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48
10158696|NCT02918318|11289003|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158697|NCT02918318|11289004|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158698|NCT02918318|11289005|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158699|NCT02918318|11289006|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158700|NCT02918318|11289007|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
10158701|NCT02918318|11289003|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158702|NCT02918318|11289004|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158703|NCT02918318|11289005|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158704|NCT02918318|11289006|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10158705|NCT02918318|11289007|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
10158706|NCT02918357|11289028|FG000|STARTED|Overall Study||385
10158707|NCT02918357|11289028|FG000|Investigational Drug Administration|Overall Study||385
10158708|NCT02918357|11289028|FG000|PET/CT Scan|Overall Study||385
10158709|NCT02918357|11289028|FG000|COMPLETED|Overall Study||385
10158710|NCT02918357|11289028|FG000|NOT COMPLETED|Overall Study||0
10158711|NCT02918396|11289053|FG000|STARTED|Overall Study||2
10158712|NCT02918396|11289054|FG001|STARTED|Overall Study||1
10158713|NCT02918396|11289055|FG002|STARTED|Overall Study||2
10158714|NCT02918396|11289053|FG000|COMPLETED|Overall Study||2
10158715|NCT02918396|11289054|FG001|COMPLETED|Overall Study||1
10158716|NCT02918396|11289055|FG002|COMPLETED|Overall Study||2
10158717|NCT02918396|11289053|FG000|NOT COMPLETED|Overall Study||0
10158718|NCT02918396|11289054|FG001|NOT COMPLETED|Overall Study||0
10158719|NCT02918396|11289055|FG002|NOT COMPLETED|Overall Study||0
10197309|NCT03372603|11325266|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
10197310|NCT03372603|11325267|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
10197311|NCT03372928|11325273|FG000|STARTED|First Intervention (5 d Energy Deficit)||10
10197312|NCT03372928|11325274|FG001|STARTED|First Intervention (5 d Energy Deficit)||10
10197313|NCT03372928|11325273|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10
10158720|NCT02918552|11289065|FG000|STARTED|Overall Study||7
10158721|NCT02918552|11289066|FG001|STARTED|Overall Study||8
10158722|NCT02918552|11289065|FG000|COMPLETED|Overall Study||6
10158723|NCT02918552|11289066|FG001|COMPLETED|Overall Study||6
10158724|NCT02918552|11289065|FG000|NOT COMPLETED|Overall Study||1
10158725|NCT02918552|11289066|FG001|NOT COMPLETED|Overall Study||2
10158726|NCT02918617|11289081|FG000|STARTED|Overall Study||21
10158727|NCT02918617|11289082|FG001|STARTED|Overall Study||20
10158728|NCT02918617|11289083|FG002|STARTED|Overall Study||22
10158729|NCT02918617|11289084|FG003|STARTED|Overall Study||22
10158730|NCT02918617|11289085|FG004|STARTED|Overall Study||24
10158731|NCT02918617|11289086|FG005|STARTED|Overall Study||20
10158732|NCT02918617|11289087|FG006|STARTED|Overall Study||22
10158733|NCT02918617|11289088|FG007|STARTED|Overall Study||26
10158734|NCT02918617|11289089|FG008|STARTED|Overall Study||26
10158735|NCT02918617|11289081|FG000|COMPLETED|Overall Study||20
10158736|NCT02918617|11289082|FG001|COMPLETED|Overall Study||20
10158737|NCT02918617|11289083|FG002|COMPLETED|Overall Study||19
10158738|NCT02918617|11289084|FG003|COMPLETED|Overall Study||22
10158739|NCT02918617|11289085|FG004|COMPLETED|Overall Study||24
10158740|NCT02918617|11289086|FG005|COMPLETED|Overall Study||20
10158741|NCT02918617|11289087|FG006|COMPLETED|Overall Study||22
10158742|NCT02918617|11289088|FG007|COMPLETED|Overall Study||25
10158743|NCT02918617|11289089|FG008|COMPLETED|Overall Study||26
10158744|NCT02918617|11289081|FG000|NOT COMPLETED|Overall Study||1
10158745|NCT02918617|11289082|FG001|NOT COMPLETED|Overall Study||0
10158746|NCT02918617|11289083|FG002|NOT COMPLETED|Overall Study||3
10158747|NCT02918617|11289084|FG003|NOT COMPLETED|Overall Study||0
10158748|NCT02918617|11289085|FG004|NOT COMPLETED|Overall Study||0
10158749|NCT02918617|11289086|FG005|NOT COMPLETED|Overall Study||0
10158750|NCT02918617|11289087|FG006|NOT COMPLETED|Overall Study||0
10158751|NCT02918617|11289088|FG007|NOT COMPLETED|Overall Study||1
10158752|NCT02918617|11289089|FG008|NOT COMPLETED|Overall Study||0
10158753|NCT02918630|11289111|FG000|STARTED|Overall Study||4
10158754|NCT02918630|11289112|FG001|STARTED|Overall Study||3
10158755|NCT02918630|11289111|FG000|COMPLETED|Overall Study||4
10158756|NCT02918630|11289112|FG001|COMPLETED|Overall Study||3
10158757|NCT02918630|11289111|FG000|NOT COMPLETED|Overall Study||0
10158758|NCT02918630|11289112|FG001|NOT COMPLETED|Overall Study||0
10158759|NCT02918656|11289121|FG000|STARTED|Overall Study||54
10158760|NCT02918656|11289122|FG001|STARTED|Overall Study||60
10158761|NCT02918656|11289123|FG002|STARTED|Overall Study||57
10158762|NCT02918656|11289121|FG000|COMPLETED|Overall Study||54
10158763|NCT02918656|11289122|FG001|COMPLETED|Overall Study||60
10158764|NCT02918656|11289123|FG002|COMPLETED|Overall Study||57
10158765|NCT02918656|11289121|FG000|NOT COMPLETED|Overall Study||0
10158766|NCT02918656|11289122|FG001|NOT COMPLETED|Overall Study||0
10158767|NCT02918656|11289123|FG002|NOT COMPLETED|Overall Study||0
10158768|NCT02918669|11289131|FG000|STARTED|Overall Study||12
10158769|NCT02918669|11289131|FG000|COMPLETED|Overall Study||8
10158770|NCT02918669|11289131|FG000|NOT COMPLETED|Overall Study||4
10158771|NCT02918721|11289135|FG000|STARTED|Overall Study||70
10158772|NCT02918721|11289135|FG000|COMPLETED|Overall Study||70
10158773|NCT02918721|11289135|FG000|NOT COMPLETED|Overall Study||0
10158774|NCT02918773|11289142|FG000|STARTED|Overall Study||11
10158775|NCT02918773|11289143|FG001|STARTED|Overall Study||11
10158776|NCT02918773|11289142|FG000|COMPLETED|Overall Study||11
10158777|NCT02918773|11289143|FG001|COMPLETED|Overall Study||11
10158778|NCT02918773|11289142|FG000|NOT COMPLETED|Overall Study||0
10158779|NCT02918773|11289143|FG001|NOT COMPLETED|Overall Study||0
10158780|NCT02918851|11289153|FG000|STARTED|Overall Study||14
10158781|NCT02918851|11289154|FG001|STARTED|Overall Study||14
10158782|NCT02918851|11289155|FG002|STARTED|Overall Study||14
10158783|NCT02918851|11289153|FG000|COMPLETED|Overall Study||10
10158784|NCT02918851|11289154|FG001|COMPLETED|Overall Study||10
10158785|NCT02918851|11289155|FG002|COMPLETED|Overall Study||10
10158786|NCT02918851|11289153|FG000|NOT COMPLETED|Overall Study||4
10158787|NCT02918851|11289154|FG001|NOT COMPLETED|Overall Study||4
10158788|NCT02918851|11289155|FG002|NOT COMPLETED|Overall Study||4
10158789|NCT02918877|11289165|FG000|STARTED|Overall Study||24
10158790|NCT02918877|11289166|FG001|STARTED|Overall Study||25
10158791|NCT02918877|11289165|FG000|COMPLETED|Overall Study||18
10158792|NCT02918877|11289166|FG001|COMPLETED|Overall Study||22
10158793|NCT02918877|11289165|FG000|NOT COMPLETED|Overall Study||6
10158794|NCT02918877|11289166|FG001|NOT COMPLETED|Overall Study||3
10158795|NCT02918968|11289174|FG000|STARTED|1st Line AAT||102
10158796|NCT02918968|11289175|FG001|STARTED|1st Line AAT||104
10158797|NCT02918968|11289174|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25
10158798|NCT02918968|11289175|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8
10158799|NCT02918968|11289174|FG000|COMPLETED|1st Line AAT||73
10158800|NCT02918968|11289175|FG001|COMPLETED|1st Line AAT||93
10158801|NCT02918968|11289174|FG000|NOT COMPLETED|1st Line AAT||29
10158802|NCT02918968|11289175|FG001|NOT COMPLETED|1st Line AAT||11
10158803|NCT02918968|11289174|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
10158804|NCT02918968|11289175|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
10158805|NCT02918968|11289174|FG000|COMPLETED|2nd Line AAT||23
10158806|NCT02918968|11289175|FG001|COMPLETED|2nd Line AAT||73
10158807|NCT02918968|11289174|FG000|NOT COMPLETED|2nd Line AAT||25
10158808|NCT02918968|11289175|FG001|NOT COMPLETED|2nd Line AAT||12
10158809|NCT02919007|11289183|FG000|STARTED|Overall Study||25
10158810|NCT02919007|11289183|FG000|COMPLETED|Overall Study||25
10158811|NCT02919007|11289183|FG000|NOT COMPLETED|Overall Study||0
10158812|NCT02919111|11289187|FG000|STARTED|Overall Study||299
10158813|NCT02919111|11289187|FG000|COMPLETED|Overall Study||299
10158814|NCT02919111|11289187|FG000|NOT COMPLETED|Overall Study||0
10158815|NCT02919267|11289195|FG000|STARTED|Overall Study||10
10158816|NCT02919267|11289196|FG001|STARTED|Overall Study||12
10158817|NCT02919267|11289197|FG002|STARTED|Overall Study||13
10158818|NCT02919267|11289198|FG003|STARTED|Overall Study||14
10158819|NCT02919267|11289195|FG000|COMPLETED|Overall Study||10
10158820|NCT02919267|11289196|FG001|COMPLETED|Overall Study||9
10158821|NCT02919267|11289197|FG002|COMPLETED|Overall Study||10
10158822|NCT02919267|11289198|FG003|COMPLETED|Overall Study||10
10158823|NCT02919267|11289195|FG000|NOT COMPLETED|Overall Study||0
10158824|NCT02919267|11289196|FG001|NOT COMPLETED|Overall Study||3
10158825|NCT02919267|11289197|FG002|NOT COMPLETED|Overall Study||3
10158826|NCT02919267|11289198|FG003|NOT COMPLETED|Overall Study||4
10158827|NCT02919423|11289210|FG000|STARTED|Overall Study||6
10158828|NCT02919423|11289211|FG001|STARTED|Overall Study||25
10158829|NCT02919423|11289210|FG000|COMPLETED|Overall Study||4
10158830|NCT02919423|11289211|FG001|COMPLETED|Overall Study||16
10158831|NCT02919423|11289210|FG000|NOT COMPLETED|Overall Study||2
10158832|NCT02919423|11289211|FG001|NOT COMPLETED|Overall Study||9
9710446|NCT04572997|10810047|FG000|STARTED|Overall Study||21
9710447|NCT04572997|10810047|FG000|COMPLETED|Overall Study||20
9710448|NCT04572997|10810047|FG000|NOT COMPLETED|Overall Study||1
9730449|NCT00125957|10830212|FG000|STARTED|First Intervention (3 Weeks)||15
9730450|NCT00125957|10830213|FG001|STARTED|First Intervention (3 Weeks)||17
9730451|NCT00125957|10830212|FG000|COMPLETED|First Intervention (3 Weeks)||15
9730452|NCT00125957|10830213|FG001|COMPLETED|First Intervention (3 Weeks)||17
9730453|NCT00125957|10830212|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
9730454|NCT00125957|10830213|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
9730455|NCT00125957|10830212|FG000|STARTED|Second Intervention (3 Weeks)||15
9730456|NCT00125957|10830213|FG001|STARTED|Second Intervention (3 Weeks)||17
9730457|NCT00125957|10830212|FG000|COMPLETED|Second Intervention (3 Weeks)||15
9730458|NCT00125957|10830213|FG001|COMPLETED|Second Intervention (3 Weeks)||17
9730459|NCT00125957|10830212|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
9730460|NCT00125957|10830213|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9730461|NCT00126113|10830221|FG000|STARTED|Overall Study||37
9730462|NCT00126113|10830222|FG001|STARTED|Overall Study||37
9730463|NCT00126113|10830221|FG000|COMPLETED|Overall Study||34
9730464|NCT00126113|10830222|FG001|COMPLETED|Overall Study||35
9730465|NCT00126113|10830221|FG000|NOT COMPLETED|Overall Study||3
9730466|NCT00126113|10830222|FG001|NOT COMPLETED|Overall Study||2
9730467|NCT00126126|10830230|FG000|STARTED|Overall Study||9
9730468|NCT00126126|10830231|FG001|STARTED|Overall Study||9
9730469|NCT00126126|10830230|FG000|COMPLETED|Overall Study||9
9730470|NCT00126126|10830231|FG001|COMPLETED|Overall Study||7
9730471|NCT00126126|10830230|FG000|NOT COMPLETED|Overall Study||0
9730472|NCT00126126|10830231|FG001|NOT COMPLETED|Overall Study||2
9730473|NCT00126191|10830239|FG000|STARTED|Overall Study||2
9730474|NCT00126191|10830240|FG001|STARTED|Overall Study||8
9730475|NCT00126191|10830239|FG000|COMPLETED|Overall Study||2
9730476|NCT00126191|10830240|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
9730477|NCT00126191|10830239|FG000|NOT COMPLETED|Overall Study||0
9730478|NCT00126191|10830240|FG001|NOT COMPLETED|Overall Study||2
9730479|NCT00126425|10830248|FG000|STARTED|Overall Study||539
9730480|NCT00126425|10830249|FG001|STARTED|Overall Study||48
9730481|NCT00126425|10830248|FG000|COMPLETED|Overall Study||498
9730482|NCT00126425|10830249|FG001|COMPLETED|Overall Study||37
9730483|NCT00126425|10830248|FG000|NOT COMPLETED|Overall Study||41
9730484|NCT00126425|10830249|FG001|NOT COMPLETED|Overall Study||11
9730485|NCT00126438|10830257|FG000|STARTED|Overall Study||453
9730486|NCT00126438|10830258|FG001|STARTED|Overall Study||62
9730487|NCT00126438|10830257|FG000|COMPLETED|Overall Study||419
9730488|NCT00126438|10830258|FG001|COMPLETED|Overall Study||52
9730489|NCT00126438|10830257|FG000|NOT COMPLETED|Overall Study||34
9730490|NCT00126438|10830258|FG001|NOT COMPLETED|Overall Study||10
10158833|NCT02919475|11289222|FG000|STARTED|Overall Study||52
10158834|NCT02919475|11289223|FG001|STARTED|Overall Study||52
10158835|NCT02919475|11289224|FG002|STARTED|Overall Study||52
10158836|NCT02919475|11289225|FG003|STARTED|Overall Study||51
10158837|NCT02919475|11289226|FG004|STARTED|Overall Study||52
10158838|NCT02919475|11289222|FG000|Started Dosing|Overall Study||51
9730491|NCT00126490|10830264|FG000|STARTED|Overall Study||19
9730492|NCT00126490|10830264|FG000|COMPLETED|Overall Study||18
9730493|NCT00126490|10830264|FG000|NOT COMPLETED|Overall Study||1
9730494|NCT00126503|10830270|FG000|STARTED|Overall Study||48
9730495|NCT00126503|10830271|FG001|STARTED|Overall Study||21
9730496|NCT00126503|10830270|FG000|COMPLETED|Overall Study||1
9730497|NCT00126503|10830271|FG001|COMPLETED|Overall Study||0
9730498|NCT00126503|10830270|FG000|NOT COMPLETED|Overall Study||47
9730499|NCT00126503|10830271|FG001|NOT COMPLETED|Overall Study||21
9730500|NCT00126555|10830281|FG000|STARTED|Overall Study||23
9730501|NCT00126555|10830281|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
9730502|NCT00126555|10830281|FG000|Stratum 2- Unresectable|Overall Study||4
9730503|NCT00126555|10830281|FG000|COMPLETED|Overall Study||17
10158839|NCT02919475|11289223|FG001|Started Dosing|Overall Study||52
10158840|NCT02919475|11289224|FG002|Started Dosing|Overall Study||52
10158841|NCT02919475|11289225|FG003|Started Dosing|Overall Study||51
10158842|NCT02919475|11289226|FG004|Started Dosing|Overall Study||52
10158843|NCT02919475|11289222|FG000|COMPLETED|Overall Study||46
10158844|NCT02919475|11289223|FG001|COMPLETED|Overall Study||44
10158845|NCT02919475|11289224|FG002|COMPLETED|Overall Study||47
10158846|NCT02919475|11289225|FG003|COMPLETED|Overall Study||38
10158847|NCT02919475|11289226|FG004|COMPLETED|Overall Study||48
10158848|NCT02919475|11289222|FG000|NOT COMPLETED|Overall Study||6
10158849|NCT02919475|11289223|FG001|NOT COMPLETED|Overall Study||8
10158850|NCT02919475|11289224|FG002|NOT COMPLETED|Overall Study||5
10158851|NCT02919475|11289225|FG003|NOT COMPLETED|Overall Study||13
10158852|NCT02919475|11289226|FG004|NOT COMPLETED|Overall Study||4
10158853|NCT02919657|11289238|FG000|STARTED|Overall Study|10 Participants|10
10158854|NCT02919657|11289239|FG001|STARTED|Overall Study|10 Participants|10
10158855|NCT02919657|11289238|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10
10158856|NCT02919657|11289239|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10
10158857|NCT02919657|11289238|FG000|NOT COMPLETED|Overall Study||0
10158858|NCT02919657|11289239|FG001|NOT COMPLETED|Overall Study||0
10158859|NCT02919696|11289247|FG000|STARTED|Overall Study||12
10158860|NCT02919696|11289248|FG001|STARTED|Overall Study||14
10158861|NCT02919696|11289247|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10158862|NCT02919696|11289248|FG001|Received at Least One Dose of Study Drug|Overall Study||13
10158863|NCT02919696|11289247|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5
10158864|NCT02919696|11289248|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0
10158865|NCT02919696|11289247|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0
10158866|NCT02919696|11289248|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2
10158867|NCT02919696|11289247|FG000|Death On Treatment|Overall Study||1
10158868|NCT02919696|11289248|FG001|Death On Treatment|Overall Study||0
10158869|NCT02919696|11289247|FG000|Progressive Disease|Overall Study||7
10158870|NCT02919696|11289248|FG001|Progressive Disease|Overall Study||9
10158871|NCT02919696|11289247|FG000|COMPLETED|Overall Study||8
10158872|NCT02919696|11289248|FG001|COMPLETED|Overall Study||9
10158873|NCT02919696|11289247|FG000|NOT COMPLETED|Overall Study||4
10158874|NCT02919696|11289248|FG001|NOT COMPLETED|Overall Study||5
10158875|NCT02919761|11289260|FG000|STARTED|Part 1: Open Label||259
10158876|NCT02919761|11289261|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
10158877|NCT02919761|11289262|FG002|STARTED|Part 1: Open Label||0
10158878|NCT02919761|11289260|FG000|mITT Population|Part 1: Open Label||259
10158879|NCT02919761|11289261|FG001|mITT Population|Part 1: Open Label||0
10158880|NCT02919761|11289262|FG002|mITT Population|Part 1: Open Label||0
10158881|NCT02919761|11289260|FG000|Safety Population|Part 1: Open Label||259
10158882|NCT02919761|11289261|FG001|Safety Population|Part 1: Open Label||0
10158883|NCT02919761|11289262|FG002|Safety Population|Part 1: Open Label||0
10158884|NCT02919761|11289260|FG000|Per Protocol Population|Part 1: Open Label||236
10158885|NCT02919761|11289261|FG001|Per Protocol Population|Part 1: Open Label||0
10158886|NCT02919761|11289262|FG002|Per Protocol Population|Part 1: Open Label||0
10158887|NCT02919761|11289260|FG000|COMPLETED|Part 1: Open Label||235
10158888|NCT02919761|11289261|FG001|COMPLETED|Part 1: Open Label||0
10158889|NCT02919761|11289262|FG002|COMPLETED|Part 1: Open Label||0
10158890|NCT02919761|11289260|FG000|NOT COMPLETED|Part 1: Open Label||24
10158891|NCT02919761|11289261|FG001|NOT COMPLETED|Part 1: Open Label||0
10158892|NCT02919761|11289262|FG002|NOT COMPLETED|Part 1: Open Label||0
10158893|NCT02919761|11289260|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
9710449|NCT04563767|10810055|FG000|STARTED|Overall Study||4
9710450|NCT04563767|10810055|FG000|COMPLETED|Overall Study||4
9710451|NCT04563767|10810055|FG000|NOT COMPLETED|Overall Study||0
9710458|NCT04555525|10810072|FG000|STARTED|Overall Study||75
9710459|NCT04555525|10810073|FG001|STARTED|Overall Study||25
9710460|NCT04555525|10810072|FG000|COMPLETED|Overall Study||72
9710461|NCT04555525|10810073|FG001|COMPLETED|Overall Study||25
9710462|NCT04555525|10810072|FG000|NOT COMPLETED|Overall Study||3
9710463|NCT04555525|10810073|FG001|NOT COMPLETED|Overall Study||0
9710470|NCT04548622|10810091|FG000|STARTED|Overall Study||15
9710471|NCT04548622|10810091|FG000|COMPLETED|Overall Study||15
9710472|NCT04548622|10810091|FG000|NOT COMPLETED|Overall Study||0
9710473|NCT04547036|10810095|FG000|STARTED|Overall Study||129
9710474|NCT04547036|10810095|FG000|COMPLETED|Overall Study||129
9710475|NCT04547036|10810095|FG000|NOT COMPLETED|Overall Study||0
9710476|NCT04544566|10810105|FG000|STARTED|Overall Study||2
9710477|NCT04544566|10810106|FG001|STARTED|Overall Study||2
9710478|NCT04544566|10810107|FG002|STARTED|Overall Study||2
9710479|NCT04544566|10810108|FG003|STARTED|Overall Study||2
9710480|NCT04544566|10810109|FG004|STARTED|Overall Study||2
9710481|NCT04544566|10810110|FG005|STARTED|Overall Study||2
9710482|NCT04544566|10810105|FG000|COMPLETED|Overall Study||2
9710483|NCT04544566|10810106|FG001|COMPLETED|Overall Study||2
9710484|NCT04544566|10810107|FG002|COMPLETED|Overall Study||2
9710485|NCT04544566|10810108|FG003|COMPLETED|Overall Study||2
9710486|NCT04544566|10810109|FG004|COMPLETED|Overall Study||2
9710487|NCT04544566|10810110|FG005|COMPLETED|Overall Study||2
9710488|NCT04544566|10810105|FG000|NOT COMPLETED|Overall Study||0
9710489|NCT04544566|10810106|FG001|NOT COMPLETED|Overall Study||0
9710490|NCT04544566|10810107|FG002|NOT COMPLETED|Overall Study||0
9710491|NCT04544566|10810108|FG003|NOT COMPLETED|Overall Study||0
9710492|NCT04544566|10810109|FG004|NOT COMPLETED|Overall Study||0
9710493|NCT04544566|10810110|FG005|NOT COMPLETED|Overall Study||0
9730504|NCT00126555|10830281|FG000|NOT COMPLETED|Overall Study||6
9730505|NCT00126568|10830297|FG000|STARTED|Overall Study||20
10158894|NCT02919761|11289261|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
10158895|NCT02919761|11289262|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
10158896|NCT02919761|11289260|FG000|Safety Population|Part 2: Double-blind||0
10158897|NCT02919761|11289261|FG001|Safety Population|Part 2: Double-blind||77
10158898|NCT02919761|11289262|FG002|Safety Population|Part 2: Double-blind||77
9710452|NCT04560374|10810061|FG000|STARTED|Overall Study||50
9710453|NCT04560374|10810062|FG001|STARTED|Overall Study||50
9710454|NCT04560374|10810061|FG000|COMPLETED|Overall Study||50
9710455|NCT04560374|10810062|FG001|COMPLETED|Overall Study||50
9710456|NCT04560374|10810061|FG000|NOT COMPLETED|Overall Study||0
9710457|NCT04560374|10810062|FG001|NOT COMPLETED|Overall Study||0
9710464|NCT04553497|10810081|FG000|STARTED|Overall Study||17
9710465|NCT04553497|10810082|FG001|STARTED|Overall Study||18
9710466|NCT04553497|10810081|FG000|COMPLETED|Overall Study||15
9710467|NCT04553497|10810082|FG001|COMPLETED|Overall Study||17
9710468|NCT04553497|10810081|FG000|NOT COMPLETED|Overall Study||2
9710469|NCT04553497|10810082|FG001|NOT COMPLETED|Overall Study||1
9710494|NCT04542694|10810126|FG000|STARTED|Overall Study||100
9710495|NCT04542694|10810127|FG001|STARTED|Overall Study||100
9710496|NCT04542694|10810126|FG000|COMPLETED|Overall Study||96
9710497|NCT04542694|10810127|FG001|COMPLETED|Overall Study||100
9710498|NCT04542694|10810126|FG000|NOT COMPLETED|Overall Study||4
9710499|NCT04542694|10810127|FG001|NOT COMPLETED|Overall Study||0
9730506|NCT00126568|10830297|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
9730507|NCT00126568|10830297|FG000|NOT COMPLETED|Overall Study||2
9730508|NCT00126581|10830304|FG000|STARTED|Overall Study||81
9730509|NCT00126581|10830305|FG001|STARTED|Overall Study||100
9730510|NCT00126581|10830304|FG000|COMPLETED|Overall Study||68
9730511|NCT00126581|10830305|FG001|COMPLETED|Overall Study||80
9730512|NCT00126581|10830304|FG000|NOT COMPLETED|Overall Study||13
9730513|NCT00126581|10830305|FG001|NOT COMPLETED|Overall Study||20
9730514|NCT00126594|10830315|FG000|STARTED|Overall Study||40
9730515|NCT00126594|10830316|FG001|STARTED|Overall Study||40
9730516|NCT00126594|10830315|FG000|COMPLETED|Overall Study||1
9730517|NCT00126594|10830316|FG001|COMPLETED|Overall Study||3
9730518|NCT00126594|10830315|FG000|NOT COMPLETED|Overall Study||39
9730519|NCT00126594|10830316|FG001|NOT COMPLETED|Overall Study||37
9730520|NCT00126737|10830327|FG000|STARTED|Overall Study||28
9730521|NCT00126737|10830328|FG001|STARTED|Overall Study||27
9730522|NCT00126737|10830329|FG002|STARTED|Overall Study||30
9730523|NCT00126737|10830330|FG003|STARTED|Overall Study||25
9730524|NCT00126737|10830327|FG000|COMPLETED|Overall Study||22
9730525|NCT00126737|10830328|FG001|COMPLETED|Overall Study||24
9730526|NCT00126737|10830329|FG002|COMPLETED|Overall Study||24
9730527|NCT00126737|10830330|FG003|COMPLETED|Overall Study||18
9730528|NCT00126737|10830327|FG000|NOT COMPLETED|Overall Study||6
9730529|NCT00126737|10830328|FG001|NOT COMPLETED|Overall Study||3
9730530|NCT00126737|10830329|FG002|NOT COMPLETED|Overall Study||6
9730531|NCT00126737|10830330|FG003|NOT COMPLETED|Overall Study||7
9730532|NCT00126750|10830345|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385
9730533|NCT00126750|10830346|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462
9730534|NCT00126750|10830345|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
9730535|NCT00126750|10830346|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
9730536|NCT00126750|10830345|FG000|NOT COMPLETED|Overall Study||180
9730537|NCT00126750|10830346|FG001|NOT COMPLETED|Overall Study||266
9730538|NCT00127036|10830354|FG000|STARTED|Overall Study||34
9730539|NCT00127036|10830355|FG001|STARTED|Overall Study||31
9730540|NCT00127036|10830354|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26
9730541|NCT00127036|10830355|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20
9730542|NCT00127036|10830354|FG000|NOT COMPLETED|Overall Study||8
10158899|NCT02919761|11289260|FG000|mITT Population|Part 2: Double-blind||0
10158900|NCT02919761|11289261|FG001|mITT Population|Part 2: Double-blind||77
10158901|NCT02919761|11289262|FG002|mITT Population|Part 2: Double-blind||76
10158902|NCT02919761|11289260|FG000|Per Protocol Population|Part 2: Double-blind||0
10158903|NCT02919761|11289261|FG001|Per Protocol Population|Part 2: Double-blind||76
10158904|NCT02919761|11289262|FG002|Per Protocol Population|Part 2: Double-blind||73
10158905|NCT02919761|11289260|FG000|COMPLETED|Part 2: Double-blind||0
10158906|NCT02919761|11289261|FG001|COMPLETED|Part 2: Double-blind||71
10158907|NCT02919761|11289262|FG002|COMPLETED|Part 2: Double-blind||56
10158908|NCT02919761|11289260|FG000|NOT COMPLETED|Part 2: Double-blind||0
10158909|NCT02919761|11289261|FG001|NOT COMPLETED|Part 2: Double-blind||6
10158910|NCT02919761|11289262|FG002|NOT COMPLETED|Part 2: Double-blind||21
10158911|NCT02919813|11289275|FG000|STARTED|Overall Study||14
10158912|NCT02919813|11289276|FG001|STARTED|Overall Study||17
10158913|NCT02919813|11289275|FG000|COMPLETED|Overall Study||14
10158914|NCT02919813|11289276|FG001|COMPLETED|Overall Study||17
10158915|NCT02919813|11289275|FG000|NOT COMPLETED|Overall Study||0
10158916|NCT02919813|11289276|FG001|NOT COMPLETED|Overall Study||0
10158917|NCT02919826|11289284|FG000|STARTED|Overall Study||10
10158918|NCT02919826|11289285|FG001|STARTED|Overall Study||10
10158919|NCT02919826|11289284|FG000|COMPLETED|Overall Study||10
10158920|NCT02919826|11289285|FG001|COMPLETED|Overall Study||8
10158921|NCT02919826|11289284|FG000|NOT COMPLETED|Overall Study||0
10158922|NCT02919826|11289285|FG001|NOT COMPLETED|Overall Study||2
10158923|NCT02919995|11289299|FG000|STARTED|Overall Study||1
10158924|NCT02919995|11289300|FG001|STARTED|Overall Study||2
10158925|NCT02919995|11289301|FG002|STARTED|Overall Study||2
10158926|NCT02919995|11289302|FG003|STARTED|Overall Study||2
10158927|NCT02919995|11289303|FG004|STARTED|Overall Study||1
10158928|NCT02919995|11289304|FG005|STARTED|Overall Study||2
10158929|NCT02919995|11289299|FG000|COMPLETED|Overall Study||1
10158930|NCT02919995|11289300|FG001|COMPLETED|Overall Study||2
10158931|NCT02919995|11289301|FG002|COMPLETED|Overall Study||2
10158932|NCT02919995|11289302|FG003|COMPLETED|Overall Study||2
10158933|NCT02919995|11289303|FG004|COMPLETED|Overall Study||1
10158934|NCT02919995|11289304|FG005|COMPLETED|Overall Study||1
10158935|NCT02919995|11289299|FG000|NOT COMPLETED|Overall Study||0
10158936|NCT02919995|11289300|FG001|NOT COMPLETED|Overall Study||0
10158937|NCT02919995|11289301|FG002|NOT COMPLETED|Overall Study||0
10158938|NCT02919995|11289302|FG003|NOT COMPLETED|Overall Study||0
10158939|NCT02919995|11289303|FG004|NOT COMPLETED|Overall Study||0
10158940|NCT02919995|11289304|FG005|NOT COMPLETED|Overall Study||1
10158941|NCT02920528|11289315|FG000|STARTED|Overall Study||35
10158942|NCT02920528|11289316|FG001|STARTED|Overall Study||36
10158943|NCT02920528|11289317|FG002|STARTED|Overall Study||35
10158944|NCT02920528|11289315|FG000|COMPLETED|Overall Study||32
10158945|NCT02920528|11289316|FG001|COMPLETED|Overall Study||35
10158946|NCT02920528|11289317|FG002|COMPLETED|Overall Study||30
10158947|NCT02920528|11289315|FG000|NOT COMPLETED|Overall Study||3
10158948|NCT02920528|11289316|FG001|NOT COMPLETED|Overall Study||1
10158949|NCT02920528|11289317|FG002|NOT COMPLETED|Overall Study||5
10158950|NCT02920749|11289329|FG000|STARTED|Overall Study||30
10158951|NCT02920749|11289330|FG001|STARTED|Overall Study||30
10158952|NCT02920749|11289331|FG002|STARTED|Overall Study||30
10158953|NCT02920749|11289332|FG003|STARTED|Overall Study||30
10158954|NCT02920749|11289329|FG000|COMPLETED|Overall Study||30
10158955|NCT02920749|11289330|FG001|COMPLETED|Overall Study||30
10158956|NCT02920749|11289331|FG002|COMPLETED|Overall Study||30
10158957|NCT02920749|11289332|FG003|COMPLETED|Overall Study||30
10158958|NCT02920749|11289329|FG000|NOT COMPLETED|Overall Study||0
10158959|NCT02920749|11289330|FG001|NOT COMPLETED|Overall Study||0
10158960|NCT02920749|11289331|FG002|NOT COMPLETED|Overall Study||0
10158961|NCT02920749|11289332|FG003|NOT COMPLETED|Overall Study||0
10158962|NCT02920918|11289348|FG000|STARTED|Overall Study||17
10158963|NCT02920918|11289349|FG001|STARTED|Overall Study||19
10158964|NCT02920918|11289348|FG000|COMPLETED|Overall Study||17
10158965|NCT02920918|11289349|FG001|COMPLETED|Overall Study||19
10158966|NCT02920918|11289348|FG000|NOT COMPLETED|Overall Study||0
10158967|NCT02920918|11289349|FG001|NOT COMPLETED|Overall Study||0
10158968|NCT02920957|11289355|FG000|STARTED|First Intervention : 1 Month||46
10158969|NCT02920957|11289356|FG001|STARTED|First Intervention : 1 Month||41
10158970|NCT02920957|11289355|FG000|COMPLETED|First Intervention : 1 Month||42
10158971|NCT02920957|11289356|FG001|COMPLETED|First Intervention : 1 Month||41
10158972|NCT02920957|11289355|FG000|NOT COMPLETED|First Intervention : 1 Month||4
10158973|NCT02920957|11289356|FG001|NOT COMPLETED|First Intervention : 1 Month||0
10158974|NCT02920957|11289355|FG000|STARTED|Second Intervention: 1 Month||42
10158975|NCT02920957|11289356|FG001|STARTED|Second Intervention: 1 Month||41
10158976|NCT02920957|11289355|FG000|COMPLETED|Second Intervention: 1 Month||42
10158977|NCT02920957|11289356|FG001|COMPLETED|Second Intervention: 1 Month||40
10158978|NCT02920957|11289355|FG000|NOT COMPLETED|Second Intervention: 1 Month||0
10158979|NCT02920957|11289356|FG001|NOT COMPLETED|Second Intervention: 1 Month||1
10158980|NCT02920970|11289373|FG000|STARTED|First Intervention||38
10158981|NCT02920970|11289374|FG001|STARTED|First Intervention||32
10158982|NCT02920970|11289373|FG000|COMPLETED|First Intervention||38
10158983|NCT02920970|11289374|FG001|COMPLETED|First Intervention||30
10158984|NCT02920970|11289373|FG000|NOT COMPLETED|First Intervention||0
10158985|NCT02920970|11289374|FG001|NOT COMPLETED|First Intervention||2
10158986|NCT02920970|11289373|FG000|STARTED|Second Intervention||38
10158987|NCT02920970|11289374|FG001|STARTED|Second Intervention||30
10158988|NCT02920970|11289373|FG000|COMPLETED|Second Intervention||37
10158989|NCT02920970|11289374|FG001|COMPLETED|Second Intervention||30
10158990|NCT02920970|11289373|FG000|NOT COMPLETED|Second Intervention||1
10158991|NCT02920970|11289374|FG001|NOT COMPLETED|Second Intervention||0
10158992|NCT02920983|11289382|FG000|STARTED|Dispense 1||8
10158993|NCT02920983|11289383|FG001|STARTED|Dispense 1||10
10158994|NCT02920983|11289384|FG002|STARTED|Dispense 1||7
10158995|NCT02920983|11289385|FG003|STARTED|Dispense 1||6
10158996|NCT02920983|11289386|FG004|STARTED|Dispense 1||13
10158997|NCT02920983|11289387|FG005|STARTED|Dispense 1||7
10158998|NCT02920983|11289382|FG000|COMPLETED|Dispense 1||8
10158999|NCT02920983|11289383|FG001|COMPLETED|Dispense 1||10
10159000|NCT02920983|11289384|FG002|COMPLETED|Dispense 1||7
10159001|NCT02920983|11289385|FG003|COMPLETED|Dispense 1||6
10159002|NCT02920983|11289386|FG004|COMPLETED|Dispense 1||12
10159003|NCT02920983|11289387|FG005|COMPLETED|Dispense 1||7
10159004|NCT02920983|11289382|FG000|NOT COMPLETED|Dispense 1||0
10159005|NCT02920983|11289383|FG001|NOT COMPLETED|Dispense 1||0
10159006|NCT02920983|11289384|FG002|NOT COMPLETED|Dispense 1||0
10159007|NCT02920983|11289385|FG003|NOT COMPLETED|Dispense 1||0
10159008|NCT02920983|11289386|FG004|NOT COMPLETED|Dispense 1||1
10159009|NCT02920983|11289387|FG005|NOT COMPLETED|Dispense 1||0
10159010|NCT02920983|11289382|FG000|STARTED|Dispense 2||8
10159011|NCT02920983|11289383|FG001|STARTED|Dispense 2||10
10159012|NCT02920983|11289384|FG002|STARTED|Dispense 2||7
10159013|NCT02920983|11289385|FG003|STARTED|Dispense 2||6
10159014|NCT02920983|11289386|FG004|STARTED|Dispense 2||13
10159015|NCT02920983|11289387|FG005|STARTED|Dispense 2||7
10159016|NCT02920983|11289382|FG000|COMPLETED|Dispense 2||7
10159017|NCT02920983|11289383|FG001|COMPLETED|Dispense 2||10
10159018|NCT02920983|11289384|FG002|COMPLETED|Dispense 2||7
10159019|NCT02920983|11289385|FG003|COMPLETED|Dispense 2||6
10159020|NCT02920983|11289386|FG004|COMPLETED|Dispense 2||12
10159021|NCT02920983|11289387|FG005|COMPLETED|Dispense 2||7
10159022|NCT02920983|11289382|FG000|NOT COMPLETED|Dispense 2||1
10159023|NCT02920983|11289383|FG001|NOT COMPLETED|Dispense 2||0
10159024|NCT02920983|11289384|FG002|NOT COMPLETED|Dispense 2||0
10159025|NCT02920983|11289385|FG003|NOT COMPLETED|Dispense 2||0
10159026|NCT02920983|11289386|FG004|NOT COMPLETED|Dispense 2||1
10159027|NCT02920983|11289387|FG005|NOT COMPLETED|Dispense 2||0
10159028|NCT02920983|11289382|FG000|STARTED|Dispense 3||8
10159029|NCT02920983|11289383|FG001|STARTED|Dispense 3||10
10159030|NCT02920983|11289384|FG002|STARTED|Dispense 3||7
10159031|NCT02920983|11289385|FG003|STARTED|Dispense 3||6
10159032|NCT02920983|11289386|FG004|STARTED|Dispense 3||13
10159033|NCT02920983|11289387|FG005|STARTED|Dispense 3||7
10159034|NCT02920983|11289382|FG000|COMPLETED|Dispense 3||7
10159035|NCT02920983|11289383|FG001|COMPLETED|Dispense 3||9
10159036|NCT02920983|11289384|FG002|COMPLETED|Dispense 3||7
10159037|NCT02920983|11289385|FG003|COMPLETED|Dispense 3||6
10159038|NCT02920983|11289386|FG004|COMPLETED|Dispense 3||12
10159039|NCT02920983|11289387|FG005|COMPLETED|Dispense 3||7
10159040|NCT02920983|11289382|FG000|NOT COMPLETED|Dispense 3||1
10159041|NCT02920983|11289383|FG001|NOT COMPLETED|Dispense 3||1
10159042|NCT02920983|11289384|FG002|NOT COMPLETED|Dispense 3||0
10159043|NCT02920983|11289385|FG003|NOT COMPLETED|Dispense 3||0
10159044|NCT02920983|11289386|FG004|NOT COMPLETED|Dispense 3||1
10159045|NCT02920983|11289387|FG005|NOT COMPLETED|Dispense 3||0
10159046|NCT02921061|11289395|FG000|STARTED|Overall Study||28
10159047|NCT02921061|11289395|FG000|COMPLETED|Overall Study||28
10159048|NCT02921061|11289395|FG000|NOT COMPLETED|Overall Study||0
10159049|NCT02921087|11289401|FG000|STARTED|Overall Study||12
10159050|NCT02921087|11289402|FG001|STARTED|Overall Study||11
10159051|NCT02921087|11289401|FG000|COMPLETED|Overall Study||12
10159052|NCT02921087|11289402|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
10159053|NCT02921087|11289401|FG000|NOT COMPLETED|Overall Study||0
10159054|NCT02921087|11289402|FG001|NOT COMPLETED|Overall Study||1
10159055|NCT02921295|11289418|FG000|STARTED|Sidekicks||1
10159056|NCT02921295|11289418|FG000|COMPLETED|Sidekicks||1
10159057|NCT02921295|11289418|FG000|NOT COMPLETED|Sidekicks||0
10159058|NCT02921295|11289418|FG000|STARTED|Conventional Prostheses||1
10159059|NCT02921295|11289418|FG000|COMPLETED|Conventional Prostheses||1
10159060|NCT02921295|11289418|FG000|NOT COMPLETED|Conventional Prostheses||0
10159061|NCT02921386|11289427|FG000|STARTED|Sequence A: Fasting||18
10159062|NCT02921386|11289427|FG000|COMPLETED|Sequence A: Fasting||18
10159063|NCT02921386|11289427|FG000|NOT COMPLETED|Sequence A: Fasting||0
10159064|NCT02921386|11289427|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18
10159065|NCT02921386|11289427|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18
10159066|NCT02921386|11289427|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
10159067|NCT02921386|11289427|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18
10159068|NCT02921386|11289427|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18
10159069|NCT02921386|11289427|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
10159070|NCT02921386|11289427|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18
10159071|NCT02921386|11289427|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18
10159072|NCT02921386|11289427|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
10159073|NCT02921386|11289427|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18
10159074|NCT02921386|11289427|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18
10159075|NCT02921386|11289427|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
10159076|NCT02921412|11289435|FG000|STARTED|Overall Study||36
10159077|NCT02921412|11289435|FG000|COMPLETED|Overall Study||36
10159078|NCT02921412|11289435|FG000|NOT COMPLETED|Overall Study||0
10159079|NCT02921425|11289446|FG000|STARTED|Overall Study||47
10159080|NCT02921425|11289446|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
10159081|NCT02921425|11289446|FG000|COMPLETED|Overall Study||38
10159082|NCT02921425|11289446|FG000|NOT COMPLETED|Overall Study||9
10159083|NCT02921490|11289450|FG000|STARTED|Overall Study||10
10159084|NCT02921490|11289450|FG000|COMPLETED|Overall Study||10
10159085|NCT02921490|11289450|FG000|NOT COMPLETED|Overall Study||0
10159086|NCT02921737|11289454|FG000|STARTED|Overall Study||7
10159087|NCT02921737|11289454|FG000|COMPLETED|Overall Study||7
10159088|NCT02921737|11289454|FG000|NOT COMPLETED|Overall Study||0
10159089|NCT02921750|11289460|FG000|STARTED|Overall Study||124
10159090|NCT02921750|11289461|FG001|STARTED|Overall Study||124
10159091|NCT02921750|11289460|FG000|Intention to Treat (ITT)|Overall Study||122
10159092|NCT02921750|11289461|FG001|Intention to Treat (ITT)|Overall Study||123
10159093|NCT02921750|11289460|FG000|Per Protocol (PP)|Overall Study||100
10159094|NCT02921750|11289461|FG001|Per Protocol (PP)|Overall Study||107
10159095|NCT02921750|11289460|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97
10159096|NCT02921750|11289461|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104
10159097|NCT02921750|11289460|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
10159098|NCT02921750|11289461|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
10159099|NCT02921750|11289460|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
10159100|NCT02921750|11289461|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
10159101|NCT02921750|11289460|FG000|COMPLETED|Overall Study||115
10159102|NCT02921750|11289461|FG001|COMPLETED|Overall Study||113
10159103|NCT02921750|11289460|FG000|NOT COMPLETED|Overall Study||9
10159104|NCT02921750|11289461|FG001|NOT COMPLETED|Overall Study||11
10159105|NCT02921841|11289472|FG000|STARTED|Overall Study||68
10159106|NCT02921841|11289473|FG001|STARTED|Overall Study||57
10159107|NCT02921841|11289472|FG000|COMPLETED|Overall Study||52
10159108|NCT02921841|11289473|FG001|COMPLETED|Overall Study||44
10159109|NCT02921841|11289472|FG000|NOT COMPLETED|Overall Study||16
10159110|NCT02921841|11289473|FG001|NOT COMPLETED|Overall Study||13
10159111|NCT02922153|11289481|FG000|STARTED|Overall Study||65
10159112|NCT02922153|11289482|FG001|STARTED|Overall Study||19
10159113|NCT02922153|11289481|FG000|COMPLETED|Overall Study||55
10159114|NCT02922153|11289482|FG001|COMPLETED|Overall Study||17
10159115|NCT02922153|11289481|FG000|NOT COMPLETED|Overall Study||10
10159116|NCT02922153|11289482|FG001|NOT COMPLETED|Overall Study||2
10159117|NCT02922582|11289492|FG000|STARTED|Overall Study||4
10159118|NCT02922582|11289493|FG001|STARTED|Overall Study||4
10159119|NCT02922582|11289494|FG002|STARTED|Overall Study||4
10159120|NCT02922582|11289495|FG003|STARTED|Overall Study||4
10159121|NCT02922582|11289492|FG000|COMPLETED|Overall Study||4
10159122|NCT02922582|11289493|FG001|COMPLETED|Overall Study||3
10159123|NCT02922582|11289494|FG002|COMPLETED|Overall Study||4
10159124|NCT02922582|11289495|FG003|COMPLETED|Overall Study||4
10159125|NCT02922582|11289492|FG000|NOT COMPLETED|Overall Study||0
10159126|NCT02922582|11289493|FG001|NOT COMPLETED|Overall Study||1
10159127|NCT02922582|11289494|FG002|NOT COMPLETED|Overall Study||0
10159128|NCT02922582|11289495|FG003|NOT COMPLETED|Overall Study||0
10159129|NCT02922634|11289505|FG000|STARTED|Overall Study||229
10159130|NCT02922634|11289505|FG000|COMPLETED|Overall Study||219
10159131|NCT02922634|11289505|FG000|NOT COMPLETED|Overall Study||10
10159132|NCT02922738|11289518|FG000|STARTED|Overall Study|158 patients and 17 providers|175
10159133|NCT02922738|11289519|FG001|STARTED|Overall Study|275 patients and 15 providers|290
10159134|NCT02922738|11289518|FG000|COMPLETED|Overall Study||175
10159135|NCT02922738|11289519|FG001|COMPLETED|Overall Study||290
10159136|NCT02922738|11289518|FG000|NOT COMPLETED|Overall Study||0
10159137|NCT02922738|11289519|FG001|NOT COMPLETED|Overall Study||0
10159138|NCT02922868|11289529|FG000|STARTED|Overall Study||30
10159139|NCT02922868|11289530|FG001|STARTED|Overall Study||30
10159140|NCT02922868|11289529|FG000|COMPLETED|Overall Study||30
10159141|NCT02922868|11289530|FG001|COMPLETED|Overall Study||30
10159142|NCT02922868|11289529|FG000|NOT COMPLETED|Overall Study||0
10159143|NCT02922868|11289530|FG001|NOT COMPLETED|Overall Study||0
10159144|NCT02922959|11289538|FG000|STARTED|Overall Study||40
10159145|NCT02922959|11289539|FG001|STARTED|Overall Study||40
10159146|NCT02922959|11289538|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38
10159147|NCT02922959|11289539|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36
10159148|NCT02922959|11289538|FG000|3 Months|Overall Study|n=35 (87.5%)|35
10159149|NCT02922959|11289539|FG001|3 Months|Overall Study|n=31 (77.5%)|31
10159150|NCT02922959|11289538|FG000|6 Months|Overall Study|n=28 (70.0%)|28
10159151|NCT02922959|11289539|FG001|6 Months|Overall Study|n=30 (75.0%)|30
10159152|NCT02922959|11289538|FG000|12 Months|Overall Study|n=21 (52.5%)|21
10159153|NCT02922959|11289539|FG001|12 Months|Overall Study|n=23 (57.5%)|23
10159154|NCT02922959|11289538|FG000|COMPLETED|Overall Study||21
10159155|NCT02922959|11289539|FG001|COMPLETED|Overall Study||23
10159156|NCT02922959|11289538|FG000|NOT COMPLETED|Overall Study||19
10159157|NCT02922959|11289539|FG001|NOT COMPLETED|Overall Study||17
10159158|NCT02923115|11289551|FG000|STARTED|Overall Study||12
10159159|NCT02923115|11289552|FG001|STARTED|Overall Study||16
10159160|NCT02923115|11289553|FG002|STARTED|Overall Study||23
10159161|NCT02923115|11289554|FG003|STARTED|Overall Study||23
10159162|NCT02923115|11289555|FG004|STARTED|Overall Study||22
10159163|NCT02923115|11289556|FG005|STARTED|Overall Study||38
10159164|NCT02923115|11289551|FG000|Treated|Overall Study||12
10159165|NCT02923115|11289552|FG001|Treated|Overall Study||16
10159166|NCT02923115|11289553|FG002|Treated|Overall Study||20
10159167|NCT02923115|11289554|FG003|Treated|Overall Study||22
10159168|NCT02923115|11289555|FG004|Treated|Overall Study||17
10159169|NCT02923115|11289556|FG005|Treated|Overall Study||38
10159170|NCT02923115|11289551|FG000|COMPLETED|Overall Study||12
10159171|NCT02923115|11289552|FG001|COMPLETED|Overall Study||15
10159172|NCT02923115|11289553|FG002|COMPLETED|Overall Study||20
10159173|NCT02923115|11289554|FG003|COMPLETED|Overall Study||21
10159174|NCT02923115|11289555|FG004|COMPLETED|Overall Study||17
10159175|NCT02923115|11289556|FG005|COMPLETED|Overall Study||38
10159176|NCT02923115|11289551|FG000|NOT COMPLETED|Overall Study||0
10159177|NCT02923115|11289552|FG001|NOT COMPLETED|Overall Study||1
10159178|NCT02923115|11289553|FG002|NOT COMPLETED|Overall Study||3
10159179|NCT02923115|11289554|FG003|NOT COMPLETED|Overall Study||2
10159180|NCT02923115|11289555|FG004|NOT COMPLETED|Overall Study||5
10159181|NCT02923115|11289556|FG005|NOT COMPLETED|Overall Study||0
10159182|NCT02923167|11289570|FG000|STARTED|Overall Study||6
10159183|NCT02923167|11289570|FG000|COMPLETED|Overall Study||4
10159184|NCT02923167|11289570|FG000|NOT COMPLETED|Overall Study||2
10159185|NCT02923180|11289575|FG000|STARTED|Overall Study||32
10159186|NCT02923180|11289575|FG000|COMPLETED|Overall Study||6
10159187|NCT02923180|11289575|FG000|NOT COMPLETED|Overall Study||26
10159188|NCT02923245|11289581|FG000|STARTED|Overall Study||60
10159189|NCT02923245|11289582|FG001|STARTED|Overall Study||60
10159190|NCT02923245|11289581|FG000|COMPLETED|Overall Study||58
10159191|NCT02923245|11289582|FG001|COMPLETED|Overall Study||59
10159192|NCT02923245|11289581|FG000|NOT COMPLETED|Overall Study||2
10159193|NCT02923245|11289582|FG001|NOT COMPLETED|Overall Study||1
10159194|NCT02923271|11289591|FG000|STARTED|Overall Study||18
10159195|NCT02923271|11289592|FG001|STARTED|Overall Study||16
10159196|NCT02923271|11289591|FG000|COMPLETED|Overall Study||10
10159197|NCT02923271|11289592|FG001|COMPLETED|Overall Study||14
10159198|NCT02923271|11289591|FG000|NOT COMPLETED|Overall Study||8
10159199|NCT02923271|11289592|FG001|NOT COMPLETED|Overall Study||2
10159200|NCT02923349|11289605|FG000|STARTED|Overall Study||4
10159201|NCT02923349|11289606|FG001|STARTED|Overall Study||4
10159202|NCT02923349|11289607|FG002|STARTED|Overall Study||22
10159203|NCT02923349|11289608|FG003|STARTED|Overall Study||18
10159204|NCT02923349|11289609|FG004|STARTED|Overall Study||23
10159205|NCT02923349|11289610|FG005|STARTED|Overall Study||12
10159206|NCT02923349|11289611|FG006|STARTED|Overall Study||4
10159207|NCT02923349|11289605|FG000|COMPLETED|Overall Study||0
10159208|NCT02923349|11289606|FG001|COMPLETED|Overall Study||0
10159209|NCT02923349|11289607|FG002|COMPLETED|Overall Study||5
10159210|NCT02923349|11289608|FG003|COMPLETED|Overall Study||2
10159211|NCT02923349|11289609|FG004|COMPLETED|Overall Study||4
10159212|NCT02923349|11289610|FG005|COMPLETED|Overall Study||5
10159213|NCT02923349|11289611|FG006|COMPLETED|Overall Study||1
10159214|NCT02923349|11289605|FG000|NOT COMPLETED|Overall Study||4
10159215|NCT02923349|11289606|FG001|NOT COMPLETED|Overall Study||4
10159216|NCT02923349|11289607|FG002|NOT COMPLETED|Overall Study||17
10159217|NCT02923349|11289608|FG003|NOT COMPLETED|Overall Study||16
10159218|NCT02923349|11289609|FG004|NOT COMPLETED|Overall Study||19
10159219|NCT02923349|11289610|FG005|NOT COMPLETED|Overall Study||7
10159220|NCT02923349|11289611|FG006|NOT COMPLETED|Overall Study||3
10159221|NCT02923427|11289629|FG000|STARTED|Overall Study||55
10159222|NCT02923427|11289630|FG001|STARTED|Overall Study||57
10159223|NCT02923427|11289629|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
10159224|NCT02923427|11289630|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55
10159225|NCT02923427|11289629|FG000|NOT COMPLETED|Overall Study||4
10159226|NCT02923427|11289630|FG001|NOT COMPLETED|Overall Study||2
10159227|NCT02923895|11289638|FG000|STARTED|Overall Study||97
10159228|NCT02923895|11289639|FG001|STARTED|Overall Study||95
10159229|NCT02923895|11289638|FG000|COMPLETED|Overall Study||97
10159230|NCT02923895|11289639|FG001|COMPLETED|Overall Study||95
10159231|NCT02923895|11289638|FG000|NOT COMPLETED|Overall Study||0
10159232|NCT02923895|11289639|FG001|NOT COMPLETED|Overall Study||0
10159233|NCT02923921|11289647|FG000|STARTED|Overall Study||283
10159234|NCT02923921|11289648|FG001|STARTED|Overall Study||284
10159235|NCT02923921|11289647|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278
10159236|NCT02923921|11289648|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251
10159237|NCT02923921|11289647|FG000|Safety Population|Overall Study||278
10159238|NCT02923921|11289648|FG001|Safety Population|Overall Study||251
10159239|NCT02923921|11289647|FG000|COMPLETED|Overall Study||230
10159240|NCT02923921|11289648|FG001|COMPLETED|Overall Study||227
10159241|NCT02923921|11289647|FG000|NOT COMPLETED|Overall Study||53
10159242|NCT02923921|11289648|FG001|NOT COMPLETED|Overall Study||57
10159243|NCT02924051|11289656|FG000|STARTED|Overall Study||82
10159244|NCT02924051|11289657|FG001|STARTED|Overall Study||106
10159245|NCT02924051|11289656|FG000|COMPLETED|Overall Study||81
10159246|NCT02924051|11289657|FG001|COMPLETED|Overall Study||97
10159247|NCT02924051|11289656|FG000|NOT COMPLETED|Overall Study||1
10159248|NCT02924051|11289657|FG001|NOT COMPLETED|Overall Study||9
10159249|NCT02924350|11289667|FG000|STARTED|Overall Study||102
10159250|NCT02924350|11289668|FG001|STARTED|Overall Study||102
10159251|NCT02924350|11289667|FG000|COMPLETED|Overall Study||102
10159252|NCT02924350|11289668|FG001|COMPLETED|Overall Study||100
10159253|NCT02924350|11289667|FG000|NOT COMPLETED|Overall Study||0
10159254|NCT02924350|11289668|FG001|NOT COMPLETED|Overall Study||2
10159255|NCT02924428|11289676|FG000|STARTED|Overall Study||20
10159256|NCT02924428|11289677|FG001|STARTED|Overall Study||19
10159257|NCT02924428|11289676|FG000|COMPLETED|Overall Study||16
10159258|NCT02924428|11289677|FG001|COMPLETED|Overall Study||14
10159259|NCT02924428|11289676|FG000|NOT COMPLETED|Overall Study||4
10159260|NCT02924428|11289677|FG001|NOT COMPLETED|Overall Study||5
10159261|NCT02924688|11289689|FG000|STARTED|Overall Study||407
10159262|NCT02924688|11289690|FG001|STARTED|Overall Study||405
10159263|NCT02924688|11289691|FG002|STARTED|Overall Study||406
10159264|NCT02924688|11289692|FG003|STARTED|Overall Study||406
10159265|NCT02924688|11289693|FG004|STARTED|Overall Study||404
10159266|NCT02924688|11289694|FG005|STARTED|Overall Study||408
10159267|NCT02924688|11289689|FG000|COMPLETED|Overall Study||374
10159268|NCT02924688|11289690|FG001|COMPLETED|Overall Study||374
10159269|NCT02924688|11289691|FG002|COMPLETED|Overall Study||383
10159270|NCT02924688|11289692|FG003|COMPLETED|Overall Study||378
10159271|NCT02924688|11289693|FG004|COMPLETED|Overall Study||381
10159272|NCT02924688|11289694|FG005|COMPLETED|Overall Study||384
10159273|NCT02924688|11289689|FG000|NOT COMPLETED|Overall Study||33
10159274|NCT02924688|11289690|FG001|NOT COMPLETED|Overall Study||31
10159275|NCT02924688|11289691|FG002|NOT COMPLETED|Overall Study||23
10159276|NCT02924688|11289692|FG003|NOT COMPLETED|Overall Study||28
10159277|NCT02924688|11289693|FG004|NOT COMPLETED|Overall Study||23
10159278|NCT02924688|11289694|FG005|NOT COMPLETED|Overall Study||24
10159279|NCT02924883|11289713|FG000|STARTED|Overall Study||133
10159280|NCT02924883|11289714|FG001|STARTED|Overall Study||69
10159281|NCT02924883|11289713|FG000|COMPLETED|Overall Study||0
10159282|NCT02924883|11289714|FG001|COMPLETED|Overall Study||0
10159283|NCT02924883|11289713|FG000|NOT COMPLETED|Overall Study||133
10159284|NCT02924883|11289714|FG001|NOT COMPLETED|Overall Study||69
10159285|NCT02925078|11289724|FG000|STARTED|Overall Study||14
10159286|NCT02925078|11289725|FG001|STARTED|Overall Study||16
10159287|NCT02925078|11289724|FG000|COMPLETED|Overall Study||13
10159288|NCT02925078|11289725|FG001|COMPLETED|Overall Study||13
10159289|NCT02925078|11289724|FG000|NOT COMPLETED|Overall Study||1
10159290|NCT02925078|11289725|FG001|NOT COMPLETED|Overall Study||3
10159291|NCT02925117|11289735|FG000|STARTED|Period 1 (Weeks 0 - 16)||41
10159292|NCT02925117|11289736|FG001|STARTED|Period 1 (Weeks 0 - 16)||42
10159293|NCT02925117|11289737|FG002|STARTED|Period 1 (Weeks 0 - 16)||42
10159294|NCT02925117|11289738|FG003|STARTED|Period 1 (Weeks 0 - 16)||42
10159295|NCT02925117|11289739|FG004|STARTED|Period 1 (Weeks 0 - 16)||0
10159296|NCT02925117|11289740|FG005|STARTED|Period 1 (Weeks 0 - 16)||0
10159297|NCT02925117|11289741|FG006|STARTED|Period 1 (Weeks 0 - 16)||0
10159298|NCT02925117|11289742|FG007|STARTED|Period 1 (Weeks 0 - 16)||0
10159299|NCT02925117|11289743|FG008|STARTED|Period 1 (Weeks 0 - 16)||0
10159300|NCT02925117|11289744|FG009|STARTED|Period 1 (Weeks 0 - 16)||0
10159301|NCT02925117|11289745|FG010|STARTED|Period 1 (Weeks 0 - 16)||0
10159302|NCT02925117|11289746|FG011|STARTED|Period 1 (Weeks 0 - 16)||0
10159303|NCT02925117|11289735|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40
10159304|NCT02925117|11289736|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42
10159305|NCT02925117|11289737|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42
10159306|NCT02925117|11289738|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42
10159307|NCT02925117|11289739|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159308|NCT02925117|11289740|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159309|NCT02925117|11289741|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159310|NCT02925117|11289742|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159311|NCT02925117|11289743|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159312|NCT02925117|11289744|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159313|NCT02925117|11289745|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159314|NCT02925117|11289746|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0
10159315|NCT02925117|11289735|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23
10159316|NCT02925117|11289736|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31
10159317|NCT02925117|11289737|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37
10159318|NCT02925117|11289738|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39
10159319|NCT02925117|11289739|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159320|NCT02925117|11289740|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159321|NCT02925117|11289741|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159322|NCT02925117|11289742|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159323|NCT02925117|11289743|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159324|NCT02925117|11289744|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159325|NCT02925117|11289745|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159326|NCT02925117|11289746|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0
10159327|NCT02925117|11289735|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
10159328|NCT02925117|11289736|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
10159329|NCT02925117|11289737|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
10159330|NCT02925117|11289738|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
10159331|NCT02925117|11289739|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159332|NCT02925117|11289740|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159333|NCT02925117|11289741|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159334|NCT02925117|11289742|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159335|NCT02925117|11289743|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159336|NCT02925117|11289744|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159337|NCT02925117|11289745|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159338|NCT02925117|11289746|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10159339|NCT02925117|11289735|FG000|STARTED|Period 2 (Weeks 16 - 88)||0
10159340|NCT02925117|11289736|FG001|STARTED|Period 2 (Weeks 16 - 88)||0
10159341|NCT02925117|11289737|FG002|STARTED|Period 2 (Weeks 16 - 88)||0
10159342|NCT02925117|11289738|FG003|STARTED|Period 2 (Weeks 16 - 88)||0
10159343|NCT02925117|11289739|FG004|STARTED|Period 2 (Weeks 16 - 88)||10
10159344|NCT02925117|11289740|FG005|STARTED|Period 2 (Weeks 16 - 88)||10
10159345|NCT02925117|11289741|FG006|STARTED|Period 2 (Weeks 16 - 88)||15
10159346|NCT02925117|11289742|FG007|STARTED|Period 2 (Weeks 16 - 88)||16
10159347|NCT02925117|11289743|FG008|STARTED|Period 2 (Weeks 16 - 88)||19
10159348|NCT02925117|11289744|FG009|STARTED|Period 2 (Weeks 16 - 88)||18
10159349|NCT02925117|11289745|FG010|STARTED|Period 2 (Weeks 16 - 88)||19
10159350|NCT02925117|11289746|FG011|STARTED|Period 2 (Weeks 16 - 88)||19
10159351|NCT02925117|11289735|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10159352|NCT02925117|11289736|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10159353|NCT02925117|11289737|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10159354|NCT02925117|11289738|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10159355|NCT02925117|11289739|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
10159356|NCT02925117|11289740|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
10159357|NCT02925117|11289741|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
10159358|NCT02925117|11289742|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
10159359|NCT02925117|11289743|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
10159360|NCT02925117|11289744|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
10159361|NCT02925117|11289745|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
10159362|NCT02925117|11289746|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
10159363|NCT02925117|11289735|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0
10159364|NCT02925117|11289736|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0
10159365|NCT02925117|11289737|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0
10159366|NCT02925117|11289738|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0
10159367|NCT02925117|11289739|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8
10159368|NCT02925117|11289740|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5
10159369|NCT02925117|11289741|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9
10159370|NCT02925117|11289742|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11
10159371|NCT02925117|11289743|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13
10159372|NCT02925117|11289744|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12
10159373|NCT02925117|11289745|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11
10159374|NCT02925117|11289746|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14
10159375|NCT02925117|11289735|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10159376|NCT02925117|11289736|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10159377|NCT02925117|11289737|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10159378|NCT02925117|11289738|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10159379|NCT02925117|11289739|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
10159380|NCT02925117|11289740|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
10159381|NCT02925117|11289741|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
10159382|NCT02925117|11289742|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
10159383|NCT02925117|11289743|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
10159384|NCT02925117|11289744|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
10159385|NCT02925117|11289745|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
10159386|NCT02925117|11289746|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
10159387|NCT02925143|11289768|FG000|STARTED|Overall Study||6525
10159388|NCT02925143|11289768|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
10159389|NCT02925143|11289768|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
10159390|NCT02925143|11289768|FG000|COMPLETED|Overall Study||6525
10159391|NCT02925143|11289768|FG000|NOT COMPLETED|Overall Study||0
10159392|NCT02925312|11289774|FG000|STARTED|Overall Study||125
10159393|NCT02925312|11289775|FG001|STARTED|Overall Study||294
10159394|NCT02925312|11289774|FG000|COMPLETED|Overall Study||98
10159395|NCT02925312|11289775|FG001|COMPLETED|Overall Study||294
10159396|NCT02925312|11289774|FG000|NOT COMPLETED|Overall Study||27
10159397|NCT02925312|11289775|FG001|NOT COMPLETED|Overall Study||0
9710500|NCT04542226|10810133|FG000|STARTED|Overall Study||81
9710501|NCT04542226|10810133|FG000|COMPLETED|Overall Study||81
9710502|NCT04542226|10810133|FG000|NOT COMPLETED|Overall Study||0
9710503|NCT04540627|10810140|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6
9710504|NCT04540627|10810141|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
9710505|NCT04540627|10810142|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
9710506|NCT04540627|10810140|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6
9710507|NCT04540627|10810141|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0
9710508|NCT04540627|10810142|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0
9710509|NCT04540627|10810140|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
9710510|NCT04540627|10810141|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
9710511|NCT04540627|10810142|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
9710512|NCT04540627|10810140|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0
9710513|NCT04540627|10810141|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
9710514|NCT04540627|10810142|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
9710515|NCT04540627|10810140|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0
9710516|NCT04540627|10810141|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25
9710517|NCT04540627|10810142|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25
9710518|NCT04540627|10810140|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
10159398|NCT02925403|11289783|FG000|STARTED|Overall Study||8
10159399|NCT02925403|11289784|FG001|STARTED|Overall Study||5
10159400|NCT02925403|11289783|FG000|COMPLETED|Overall Study||8
10159401|NCT02925403|11289784|FG001|COMPLETED|Overall Study||4
10159402|NCT02925403|11289783|FG000|NOT COMPLETED|Overall Study||0
10159403|NCT02925403|11289784|FG001|NOT COMPLETED|Overall Study||1
10159404|NCT02925455|11289792|FG000|STARTED|Overall Study||9
10159405|NCT02925455|11289793|FG001|STARTED|Overall Study||6
10159406|NCT02925455|11289792|FG000|COMPLETED|Overall Study||7
10159407|NCT02925455|11289793|FG001|COMPLETED|Overall Study||6
10159408|NCT02925455|11289792|FG000|NOT COMPLETED|Overall Study||2
10159409|NCT02925455|11289793|FG001|NOT COMPLETED|Overall Study||0
10159410|NCT02925494|11289803|FG000|STARTED|Treatment Period||59
10159411|NCT02925494|11289804|FG001|STARTED|Treatment Period||58
10159412|NCT02925494|11289805|FG002|STARTED|Treatment Period||98
10159413|NCT02925494|11289806|FG003|STARTED|Treatment Period||218
10159414|NCT02925494|11289803|FG000|COMPLETED|Treatment Period||50
10159415|NCT02925494|11289804|FG001|COMPLETED|Treatment Period||43
10159416|NCT02925494|11289805|FG002|COMPLETED|Treatment Period||79
10159417|NCT02925494|11289806|FG003|COMPLETED|Treatment Period||182
10159418|NCT02925494|11289803|FG000|NOT COMPLETED|Treatment Period||9
10159419|NCT02925494|11289804|FG001|NOT COMPLETED|Treatment Period||15
10159420|NCT02925494|11289805|FG002|NOT COMPLETED|Treatment Period||19
10159421|NCT02925494|11289806|FG003|NOT COMPLETED|Treatment Period||36
10159422|NCT02925494|11289803|FG000|STARTED|Post-Treatment Follow-Up Period||54
10159423|NCT02925494|11289804|FG001|STARTED|Post-Treatment Follow-Up Period||47
10159424|NCT02925494|11289805|FG002|STARTED|Post-Treatment Follow-Up Period||88
10159425|NCT02925494|11289806|FG003|STARTED|Post-Treatment Follow-Up Period||184
10159426|NCT02925494|11289803|FG000|COMPLETED|Post-Treatment Follow-Up Period||40
10159427|NCT02925494|11289804|FG001|COMPLETED|Post-Treatment Follow-Up Period||37
10159428|NCT02925494|11289805|FG002|COMPLETED|Post-Treatment Follow-Up Period||64
10159429|NCT02925494|11289806|FG003|COMPLETED|Post-Treatment Follow-Up Period||134
10159430|NCT02925494|11289803|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14
10159431|NCT02925494|11289804|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10
10159432|NCT02925494|11289805|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24
10159433|NCT02925494|11289806|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50
10159434|NCT02925611|11289819|FG000|STARTED|Overall Study||30
10159435|NCT02925611|11289820|FG001|STARTED|Overall Study||30
10159436|NCT02925611|11289819|FG000|COMPLETED|Overall Study||30
10159437|NCT02925611|11289820|FG001|COMPLETED|Overall Study||30
10159438|NCT02925611|11289819|FG000|NOT COMPLETED|Overall Study||0
10159439|NCT02925611|11289820|FG001|NOT COMPLETED|Overall Study||0
10159440|NCT02925741|11289828|FG000|STARTED|Overall Study||1637
10159441|NCT02925741|11289829|FG001|STARTED|Overall Study||1706
10159442|NCT02925741|11289828|FG000|COMPLETED|Overall Study||1626
10159443|NCT02925741|11289829|FG001|COMPLETED|Overall Study||1706
10159444|NCT02925741|11289828|FG000|NOT COMPLETED|Overall Study||11
10159445|NCT02925741|11289829|FG001|NOT COMPLETED|Overall Study||0
10159446|NCT02925858|11289840|FG000|STARTED|Overall Study||42
10159447|NCT02925858|11289841|FG001|STARTED|Overall Study||38
10159448|NCT02925858|11289840|FG000|COMPLETED|Overall Study||42
10159449|NCT02925858|11289841|FG001|COMPLETED|Overall Study||38
10159450|NCT02925858|11289840|FG000|NOT COMPLETED|Overall Study||0
10159451|NCT02925858|11289841|FG001|NOT COMPLETED|Overall Study||0
10159452|NCT02925923|11289849|FG000|STARTED|Overall Study||50
10159453|NCT02925923|11289850|FG001|STARTED|Overall Study||50
10159454|NCT02925923|11289849|FG000|COMPLETED|Overall Study||50
10159455|NCT02925923|11289850|FG001|COMPLETED|Overall Study||48
10159456|NCT02925923|11289849|FG000|NOT COMPLETED|Overall Study||0
10159457|NCT02925923|11289850|FG001|NOT COMPLETED|Overall Study||2
10159458|NCT02926027|11289858|FG000|STARTED|Overall Study||40
10159459|NCT02926027|11289859|FG001|STARTED|Overall Study||40
10159460|NCT02926027|11289858|FG000|COMPLETED|Overall Study||31
10159461|NCT02926027|11289859|FG001|COMPLETED|Overall Study||37
10159462|NCT02926027|11289858|FG000|NOT COMPLETED|Overall Study||9
10159463|NCT02926027|11289859|FG001|NOT COMPLETED|Overall Study||3
10159464|NCT02926209|11289865|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
10159465|NCT02926209|11289866|FG001|STARTED|Study Cohort||37
10159466|NCT02926209|11289865|FG000|COMPLETED|Study Cohort||41
10159467|NCT02926209|11289866|FG001|COMPLETED|Study Cohort||37
10159468|NCT02926209|11289865|FG000|NOT COMPLETED|Study Cohort||1
10159469|NCT02926209|11289866|FG001|NOT COMPLETED|Study Cohort||0
10159470|NCT02926209|11289865|FG000|STARTED|Training Cohort - First Patients||20
10159471|NCT02926209|11289866|FG001|STARTED|Training Cohort - First Patients||0
10159472|NCT02926209|11289865|FG000|COMPLETED|Training Cohort - First Patients||20
10159473|NCT02926209|11289866|FG001|COMPLETED|Training Cohort - First Patients||0
10159474|NCT02926209|11289865|FG000|NOT COMPLETED|Training Cohort - First Patients||0
10159475|NCT02926209|11289866|FG001|NOT COMPLETED|Training Cohort - First Patients||0
10159476|NCT02926573|11289875|FG000|STARTED|Overall Study||55
10159477|NCT02926573|11289876|FG001|STARTED|Overall Study||55
10159478|NCT02926573|11289875|FG000|COMPLETED|Overall Study||44
10159479|NCT02926573|11289876|FG001|COMPLETED|Overall Study||46
10159480|NCT02926573|11289875|FG000|NOT COMPLETED|Overall Study||11
10159481|NCT02926573|11289876|FG001|NOT COMPLETED|Overall Study||9
10159482|NCT02926677|11289885|FG000|STARTED|Overall Study||25
10159483|NCT02926677|11289886|FG001|STARTED|Overall Study||22
10159484|NCT02926677|11289887|FG002|STARTED|Overall Study||26
10159485|NCT02926677|11289885|FG000|COMPLETED|Overall Study||8
10159486|NCT02926677|11289886|FG001|COMPLETED|Overall Study||8
10159487|NCT02926677|11289887|FG002|COMPLETED|Overall Study||6
10159488|NCT02926677|11289885|FG000|NOT COMPLETED|Overall Study||17
10159489|NCT02926677|11289886|FG001|NOT COMPLETED|Overall Study||14
10159490|NCT02926677|11289887|FG002|NOT COMPLETED|Overall Study||20
10159491|NCT02926937|11289899|FG000|STARTED|Overall Study||150
10159492|NCT02926937|11289900|FG001|STARTED|Overall Study||142
10159493|NCT02926937|11289901|FG002|STARTED|Overall Study||107
10159494|NCT02926937|11289899|FG000|COMPLETED|Overall Study||131
10159495|NCT02926937|11289900|FG001|COMPLETED|Overall Study||127
10159496|NCT02926937|11289901|FG002|COMPLETED|Overall Study||96
10159497|NCT02926937|11289899|FG000|NOT COMPLETED|Overall Study||19
10159498|NCT02926937|11289900|FG001|NOT COMPLETED|Overall Study||15
10159499|NCT02926937|11289901|FG002|NOT COMPLETED|Overall Study||11
10159500|NCT02926950|11289912|FG000|STARTED|Overall Study||259
10159501|NCT02926950|11289913|FG001|STARTED|Overall Study||259
10159502|NCT02926950|11289912|FG000|COMPLETED|Overall Study||210
10159503|NCT02926950|11289913|FG001|COMPLETED|Overall Study||211
10159504|NCT02926950|11289912|FG000|NOT COMPLETED|Overall Study||49
10159505|NCT02926950|11289913|FG001|NOT COMPLETED|Overall Study||48
10159506|NCT02927080|11289930|FG000|STARTED|Overall Study||6
10159507|NCT02927080|11289931|FG001|STARTED|Overall Study||6
10159508|NCT02927080|11289932|FG002|STARTED|Overall Study||6
10159509|NCT02927080|11289933|FG003|STARTED|Overall Study||6
10159510|NCT02927080|11289934|FG004|STARTED|Overall Study||7
10159511|NCT02927080|11289935|FG005|STARTED|Overall Study||6
10159512|NCT02927080|11289936|FG006|STARTED|Overall Study||15
10159513|NCT02927080|11289937|FG007|STARTED|Overall Study||14
10159514|NCT02927080|11289938|FG008|STARTED|Overall Study||15
10159515|NCT02927080|11289939|FG009|STARTED|Overall Study||14
10159516|NCT02927080|11289930|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10159517|NCT02927080|11289931|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10159518|NCT02927080|11289932|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10159519|NCT02927080|11289933|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10159520|NCT02927080|11289934|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10159521|NCT02927080|11289935|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10159522|NCT02927080|11289936|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
10159523|NCT02927080|11289937|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
9710519|NCT04540627|10810141|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
9710520|NCT04540627|10810142|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
9710521|NCT04540510|10810155|FG000|STARTED|Overall Study||5
9710522|NCT04540510|10810156|FG001|STARTED|Overall Study||6
9710523|NCT04540510|10810155|FG000|COMPLETED|Overall Study||5
10159524|NCT02927080|11289938|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
10159525|NCT02927080|11289939|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
10159526|NCT02927080|11289930|FG000|COMPLETED|Overall Study||6
10159527|NCT02927080|11289931|FG001|COMPLETED|Overall Study||5
10159528|NCT02927080|11289932|FG002|COMPLETED|Overall Study||6
10159529|NCT02927080|11289933|FG003|COMPLETED|Overall Study||6
10159530|NCT02927080|11289934|FG004|COMPLETED|Overall Study||6
10159531|NCT02927080|11289935|FG005|COMPLETED|Overall Study||6
10159532|NCT02927080|11289936|FG006|COMPLETED|Overall Study||7
10159533|NCT02927080|11289937|FG007|COMPLETED|Overall Study||5
10159534|NCT02927080|11289938|FG008|COMPLETED|Overall Study||12
10159535|NCT02927080|11289939|FG009|COMPLETED|Overall Study||7
10159536|NCT02927080|11289930|FG000|NOT COMPLETED|Overall Study||0
10159537|NCT02927080|11289931|FG001|NOT COMPLETED|Overall Study||1
10159538|NCT02927080|11289932|FG002|NOT COMPLETED|Overall Study||0
10159539|NCT02927080|11289933|FG003|NOT COMPLETED|Overall Study||0
10159540|NCT02927080|11289934|FG004|NOT COMPLETED|Overall Study||1
10159541|NCT02927080|11289935|FG005|NOT COMPLETED|Overall Study||0
10159542|NCT02927080|11289936|FG006|NOT COMPLETED|Overall Study||8
10159543|NCT02927080|11289937|FG007|NOT COMPLETED|Overall Study||9
10159544|NCT02927080|11289938|FG008|NOT COMPLETED|Overall Study||3
10159545|NCT02927080|11289939|FG009|NOT COMPLETED|Overall Study||7
10159546|NCT02927171|11289986|FG000|STARTED|Overall Study||53
10159547|NCT02927171|11289987|FG001|STARTED|Overall Study||51
10159548|NCT02927171|11289986|FG000|COMPLETED|Overall Study||53
10159549|NCT02927171|11289987|FG001|COMPLETED|Overall Study||50
10159550|NCT02927171|11289986|FG000|NOT COMPLETED|Overall Study||0
10159551|NCT02927171|11289987|FG001|NOT COMPLETED|Overall Study||1
10159552|NCT02927223|11289993|FG000|STARTED|Overall Study||6
10159553|NCT02927223|11289993|FG000|COMPLETED|Overall Study||6
10159554|NCT02927223|11289993|FG000|NOT COMPLETED|Overall Study||0
10159555|NCT02927301|11289999|FG000|STARTED|Overall Study||181
10159556|NCT02927301|11289999|FG000|COMPLETED|Overall Study||171
10159557|NCT02927301|11289999|FG000|NOT COMPLETED|Overall Study||10
10159558|NCT02927327|11290005|FG000|STARTED|Overall Study||30
10159559|NCT02927327|11290006|FG001|STARTED|Overall Study||31
10159560|NCT02927327|11290005|FG000|COMPLETED|Overall Study||30
10159561|NCT02927327|11290006|FG001|COMPLETED|Overall Study||31
10159562|NCT02927327|11290005|FG000|NOT COMPLETED|Overall Study||0
10159563|NCT02927327|11290006|FG001|NOT COMPLETED|Overall Study||0
10159564|NCT02927366|11290014|FG000|STARTED|Overall Study||6
10159565|NCT02927366|11290015|FG001|STARTED|Overall Study||2
10159566|NCT02927366|11290014|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
10159567|NCT02927366|11290015|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10159568|NCT02927366|11290014|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10159569|NCT02927366|11290015|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10159570|NCT02927366|11290014|FG000|COMPLETED|Overall Study||4
10159571|NCT02927366|11290015|FG001|COMPLETED|Overall Study||2
10159572|NCT02927366|11290014|FG000|NOT COMPLETED|Overall Study||2
10159573|NCT02927366|11290015|FG001|NOT COMPLETED|Overall Study||0
10159574|NCT02927431|11290024|FG000|STARTED|Overall Study||2
10159575|NCT02927431|11290025|FG001|STARTED|Overall Study||4
10159576|NCT02927431|11290026|FG002|STARTED|Overall Study||4
10159577|NCT02927431|11290024|FG000|COMPLETED|Overall Study||2
10159578|NCT02927431|11290025|FG001|COMPLETED|Overall Study||4
10159579|NCT02927431|11290026|FG002|COMPLETED|Overall Study||3
10159580|NCT02927431|11290024|FG000|NOT COMPLETED|Overall Study||0
10159581|NCT02927431|11290025|FG001|NOT COMPLETED|Overall Study||0
10159582|NCT02927431|11290026|FG002|NOT COMPLETED|Overall Study||1
10159583|NCT02927457|11290038|FG000|STARTED|Overall Study||0
10159584|NCT02927457|11290039|FG001|STARTED|Overall Study||11
10159585|NCT02927457|11290038|FG000|COMPLETED|Overall Study||0
10159586|NCT02927457|11290039|FG001|COMPLETED|Overall Study||11
10159587|NCT02927457|11290038|FG000|NOT COMPLETED|Overall Study||0
10159588|NCT02927457|11290039|FG001|NOT COMPLETED|Overall Study||0
10159589|NCT02927639|11290051|FG000|STARTED|Overall Study||83
10159590|NCT02927639|11290052|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
10159591|NCT02927639|11290051|FG000|COMPLETED|Overall Study||10
10159592|NCT02927639|11290052|FG001|COMPLETED|Overall Study||13
10159593|NCT02927639|11290051|FG000|NOT COMPLETED|Overall Study||73
10159594|NCT02927639|11290052|FG001|NOT COMPLETED|Overall Study||69
10159595|NCT02927795|11290058|FG000|STARTED|Overall Study||257
10159596|NCT02927795|11290058|FG000|Treated|Overall Study||253
10159597|NCT02927795|11290058|FG000|COMPLETED|Overall Study||234
10159598|NCT02927795|11290058|FG000|NOT COMPLETED|Overall Study||23
10159599|NCT02927834|11290065|FG000|STARTED|Overall Study||8
10159600|NCT02927834|11290066|FG001|STARTED|Overall Study||8
10159601|NCT02927834|11290067|FG002|STARTED|Overall Study||8
10159602|NCT02927834|11290065|FG000|COMPLETED|Overall Study||7
10159603|NCT02927834|11290066|FG001|COMPLETED|Overall Study||6
10159604|NCT02927834|11290067|FG002|COMPLETED|Overall Study||6
10159605|NCT02927834|11290065|FG000|NOT COMPLETED|Overall Study||1
10159606|NCT02927834|11290066|FG001|NOT COMPLETED|Overall Study||2
9710524|NCT04540510|10810156|FG001|COMPLETED|Overall Study||6
9710525|NCT04540510|10810155|FG000|NOT COMPLETED|Overall Study||0
9710526|NCT04540510|10810156|FG001|NOT COMPLETED|Overall Study||0
9730543|NCT00127036|10830355|FG001|NOT COMPLETED|Overall Study||11
9730544|NCT00127062|10830363|FG000|STARTED|First intervention_Oxford Street||31
9730545|NCT00127062|10830364|FG001|STARTED|First intervention_Oxford Street||29
9730546|NCT00127062|10830363|FG000|COMPLETED|First intervention_Oxford Street||31
9730547|NCT00127062|10830364|FG001|COMPLETED|First intervention_Oxford Street||29
9730548|NCT00127062|10830363|FG000|NOT COMPLETED|First intervention_Oxford Street||0
9730549|NCT00127062|10830364|FG001|NOT COMPLETED|First intervention_Oxford Street||0
9730550|NCT00127062|10830363|FG000|STARTED|Second intervention_Hyde Park||31
9730551|NCT00127062|10830364|FG001|STARTED|Second intervention_Hyde Park||29
9730552|NCT00127062|10830363|FG000|COMPLETED|Second intervention_Hyde Park||31
9730553|NCT00127062|10830364|FG001|COMPLETED|Second intervention_Hyde Park||29
9730554|NCT00127062|10830363|FG000|NOT COMPLETED|Second intervention_Hyde Park||0
10159607|NCT02927834|11290067|FG002|NOT COMPLETED|Overall Study||2
10159608|NCT02927873|11290081|FG000|STARTED|Overall Study||11
10159609|NCT02927873|11290082|FG001|STARTED|Overall Study||14
10159610|NCT02927873|11290083|FG002|STARTED|Overall Study||18
10159611|NCT02927873|11290084|FG003|STARTED|Overall Study||11
10159612|NCT02927873|11290085|FG004|STARTED|Overall Study||11
10159613|NCT02927873|11290086|FG005|STARTED|Overall Study||17
10159614|NCT02927873|11290081|FG000|COMPLETED|Overall Study||9
10159615|NCT02927873|11290082|FG001|COMPLETED|Overall Study||11
10159616|NCT02927873|11290083|FG002|COMPLETED|Overall Study||18
10159617|NCT02927873|11290084|FG003|COMPLETED|Overall Study||11
10159618|NCT02927873|11290085|FG004|COMPLETED|Overall Study||11
10159619|NCT02927873|11290086|FG005|COMPLETED|Overall Study||16
10159620|NCT02927873|11290081|FG000|NOT COMPLETED|Overall Study||2
10159621|NCT02927873|11290082|FG001|NOT COMPLETED|Overall Study||3
10159622|NCT02927873|11290083|FG002|NOT COMPLETED|Overall Study||0
10159623|NCT02927873|11290084|FG003|NOT COMPLETED|Overall Study||0
10159624|NCT02927873|11290085|FG004|NOT COMPLETED|Overall Study||0
10159625|NCT02927873|11290086|FG005|NOT COMPLETED|Overall Study||1
10159626|NCT02927925|11290100|FG000|STARTED|Overall Study||32
10159627|NCT02927925|11290100|FG000|COMPLETED|Overall Study||0
10159628|NCT02927925|11290100|FG000|NOT COMPLETED|Overall Study||32
10159629|NCT02928029|11290106|FG000|STARTED|Overall Study||3
10159630|NCT02928029|11290107|FG001|STARTED|Overall Study||4
10159631|NCT02928029|11290106|FG000|COMPLETED|Overall Study||0
10159632|NCT02928029|11290107|FG001|COMPLETED|Overall Study||0
10159633|NCT02928029|11290106|FG000|NOT COMPLETED|Overall Study||3
10159634|NCT02928029|11290107|FG001|NOT COMPLETED|Overall Study||4
10159635|NCT02928055|11290116|FG000|STARTED|Overall Study||8
10159636|NCT02928055|11290117|FG001|STARTED|Overall Study||8
10159637|NCT02928055|11290118|FG002|STARTED|Overall Study||7
10159638|NCT02928055|11290116|FG000|End of Treatment|Overall Study||8
10159639|NCT02928055|11290117|FG001|End of Treatment|Overall Study||8
10159640|NCT02928055|11290118|FG002|End of Treatment|Overall Study||6
10159641|NCT02928055|11290116|FG000|1 Month Follow up|Overall Study||7
10159642|NCT02928055|11290117|FG001|1 Month Follow up|Overall Study||7
10159643|NCT02928055|11290118|FG002|1 Month Follow up|Overall Study||6
10159644|NCT02928055|11290116|FG000|2 Month Follow up|Overall Study||6
10159645|NCT02928055|11290117|FG001|2 Month Follow up|Overall Study||7
10159646|NCT02928055|11290118|FG002|2 Month Follow up|Overall Study||5
10159647|NCT02928055|11290116|FG000|3 Month Follow up|Overall Study||5
10159648|NCT02928055|11290117|FG001|3 Month Follow up|Overall Study||6
10159649|NCT02928055|11290118|FG002|3 Month Follow up|Overall Study||5
10159650|NCT02928055|11290116|FG000|COMPLETED|Overall Study||5
10159651|NCT02928055|11290117|FG001|COMPLETED|Overall Study||6
10159652|NCT02928055|11290118|FG002|COMPLETED|Overall Study||5
10159653|NCT02928055|11290116|FG000|NOT COMPLETED|Overall Study||3
10159654|NCT02928055|11290117|FG001|NOT COMPLETED|Overall Study||2
10159655|NCT02928055|11290118|FG002|NOT COMPLETED|Overall Study||2
10159656|NCT02928380|11290126|FG000|STARTED|Period 1||13
10159657|NCT02928380|11290127|FG001|STARTED|Period 1||14
10159658|NCT02928380|11290128|FG002|STARTED|Period 1||14
10159659|NCT02928380|11290129|FG003|STARTED|Period 1||14
10159660|NCT02928380|11290130|FG004|STARTED|Period 1||14
10159661|NCT02928380|11290131|FG005|STARTED|Period 1||14
10159662|NCT02928380|11290126|FG000|COMPLETED|Period 1||13
10159663|NCT02928380|11290127|FG001|COMPLETED|Period 1||14
10159664|NCT02928380|11290128|FG002|COMPLETED|Period 1||14
10159665|NCT02928380|11290129|FG003|COMPLETED|Period 1||14
10159666|NCT02928380|11290130|FG004|COMPLETED|Period 1||14
10159667|NCT02928380|11290131|FG005|COMPLETED|Period 1||14
10159668|NCT02928380|11290126|FG000|NOT COMPLETED|Period 1||0
10159669|NCT02928380|11290127|FG001|NOT COMPLETED|Period 1||0
10159670|NCT02928380|11290128|FG002|NOT COMPLETED|Period 1||0
10159671|NCT02928380|11290129|FG003|NOT COMPLETED|Period 1||0
10159672|NCT02928380|11290130|FG004|NOT COMPLETED|Period 1||0
10159673|NCT02928380|11290131|FG005|NOT COMPLETED|Period 1||0
10159674|NCT02928380|11290126|FG000|STARTED|Wash Out Period 1||13
10159675|NCT02928380|11290127|FG001|STARTED|Wash Out Period 1||14
10159676|NCT02928380|11290128|FG002|STARTED|Wash Out Period 1||14
10159677|NCT02928380|11290129|FG003|STARTED|Wash Out Period 1||14
10159678|NCT02928380|11290130|FG004|STARTED|Wash Out Period 1||14
10159679|NCT02928380|11290131|FG005|STARTED|Wash Out Period 1||14
10159680|NCT02928380|11290126|FG000|COMPLETED|Wash Out Period 1||13
10159681|NCT02928380|11290127|FG001|COMPLETED|Wash Out Period 1||14
10159682|NCT02928380|11290128|FG002|COMPLETED|Wash Out Period 1||14
10159683|NCT02928380|11290129|FG003|COMPLETED|Wash Out Period 1||14
10159684|NCT02928380|11290130|FG004|COMPLETED|Wash Out Period 1||14
10159685|NCT02928380|11290131|FG005|COMPLETED|Wash Out Period 1||14
10159686|NCT02928380|11290126|FG000|NOT COMPLETED|Wash Out Period 1||0
10159687|NCT02928380|11290127|FG001|NOT COMPLETED|Wash Out Period 1||0
10159688|NCT02928380|11290128|FG002|NOT COMPLETED|Wash Out Period 1||0
10159689|NCT02928380|11290129|FG003|NOT COMPLETED|Wash Out Period 1||0
10159690|NCT02928380|11290130|FG004|NOT COMPLETED|Wash Out Period 1||0
10159691|NCT02928380|11290131|FG005|NOT COMPLETED|Wash Out Period 1||0
10159692|NCT02928380|11290126|FG000|STARTED|Period 2||13
10159693|NCT02928380|11290127|FG001|STARTED|Period 2||14
10159694|NCT02928380|11290128|FG002|STARTED|Period 2||14
10159695|NCT02928380|11290129|FG003|STARTED|Period 2||14
10159696|NCT02928380|11290130|FG004|STARTED|Period 2||14
10159697|NCT02928380|11290131|FG005|STARTED|Period 2||14
10159698|NCT02928380|11290126|FG000|COMPLETED|Period 2||13
10159699|NCT02928380|11290127|FG001|COMPLETED|Period 2||14
10159700|NCT02928380|11290128|FG002|COMPLETED|Period 2||14
10159701|NCT02928380|11290129|FG003|COMPLETED|Period 2||14
10159702|NCT02928380|11290130|FG004|COMPLETED|Period 2||14
10159703|NCT02928380|11290131|FG005|COMPLETED|Period 2||14
10159704|NCT02928380|11290126|FG000|NOT COMPLETED|Period 2||0
10159705|NCT02928380|11290127|FG001|NOT COMPLETED|Period 2||0
10159706|NCT02928380|11290128|FG002|NOT COMPLETED|Period 2||0
10159707|NCT02928380|11290129|FG003|NOT COMPLETED|Period 2||0
10159708|NCT02928380|11290130|FG004|NOT COMPLETED|Period 2||0
10159709|NCT02928380|11290131|FG005|NOT COMPLETED|Period 2||0
10159710|NCT02928380|11290126|FG000|STARTED|Wash Out Period 2||13
10159711|NCT02928380|11290127|FG001|STARTED|Wash Out Period 2||14
10159712|NCT02928380|11290128|FG002|STARTED|Wash Out Period 2||14
10159713|NCT02928380|11290129|FG003|STARTED|Wash Out Period 2||14
10159714|NCT02928380|11290130|FG004|STARTED|Wash Out Period 2||14
10159715|NCT02928380|11290131|FG005|STARTED|Wash Out Period 2||14
10159716|NCT02928380|11290126|FG000|COMPLETED|Wash Out Period 2||13
10159717|NCT02928380|11290127|FG001|COMPLETED|Wash Out Period 2||14
10159718|NCT02928380|11290128|FG002|COMPLETED|Wash Out Period 2||14
10159719|NCT02928380|11290129|FG003|COMPLETED|Wash Out Period 2||14
10159720|NCT02928380|11290130|FG004|COMPLETED|Wash Out Period 2||14
10159721|NCT02928380|11290131|FG005|COMPLETED|Wash Out Period 2||14
10159722|NCT02928380|11290126|FG000|NOT COMPLETED|Wash Out Period 2||0
10159723|NCT02928380|11290127|FG001|NOT COMPLETED|Wash Out Period 2||0
10159724|NCT02928380|11290128|FG002|NOT COMPLETED|Wash Out Period 2||0
10159725|NCT02928380|11290129|FG003|NOT COMPLETED|Wash Out Period 2||0
10159726|NCT02928380|11290130|FG004|NOT COMPLETED|Wash Out Period 2||0
9710527|NCT04534764|10810162|FG000|STARTED|Period 1||18
9710528|NCT04534764|10810163|FG001|STARTED|Period 1||17
9710529|NCT04534764|10810162|FG000|COMPLETED|Period 1||18
9710530|NCT04534764|10810163|FG001|COMPLETED|Period 1||17
9710531|NCT04534764|10810162|FG000|NOT COMPLETED|Period 1||0
9710532|NCT04534764|10810163|FG001|NOT COMPLETED|Period 1||0
9710533|NCT04534764|10810162|FG000|STARTED|Period 2||18
9710534|NCT04534764|10810163|FG001|STARTED|Period 2||17
9710535|NCT04534764|10810162|FG000|COMPLETED|Period 2||18
10159727|NCT02928380|11290131|FG005|NOT COMPLETED|Wash Out Period 2||0
10159728|NCT02928380|11290126|FG000|STARTED|Period 3||13
10159729|NCT02928380|11290127|FG001|STARTED|Period 3||14
10159730|NCT02928380|11290128|FG002|STARTED|Period 3||14
10159731|NCT02928380|11290129|FG003|STARTED|Period 3||14
10159732|NCT02928380|11290130|FG004|STARTED|Period 3||14
10159733|NCT02928380|11290131|FG005|STARTED|Period 3||14
10159734|NCT02928380|11290126|FG000|COMPLETED|Period 3||13
10159735|NCT02928380|11290127|FG001|COMPLETED|Period 3||14
10159736|NCT02928380|11290128|FG002|COMPLETED|Period 3||14
10159737|NCT02928380|11290129|FG003|COMPLETED|Period 3||14
10159738|NCT02928380|11290130|FG004|COMPLETED|Period 3||14
10159739|NCT02928380|11290131|FG005|COMPLETED|Period 3||14
10159740|NCT02928380|11290126|FG000|NOT COMPLETED|Period 3||0
10159741|NCT02928380|11290127|FG001|NOT COMPLETED|Period 3||0
10159742|NCT02928380|11290128|FG002|NOT COMPLETED|Period 3||0
10159743|NCT02928380|11290129|FG003|NOT COMPLETED|Period 3||0
10159744|NCT02928380|11290130|FG004|NOT COMPLETED|Period 3||0
10159745|NCT02928380|11290131|FG005|NOT COMPLETED|Period 3||0
10159746|NCT02928536|11290142|FG000|STARTED|Overall Study||11902
10159747|NCT02928536|11290142|FG000|COMPLETED|Overall Study||11902
10159748|NCT02928536|11290142|FG000|NOT COMPLETED|Overall Study||0
10159749|NCT02928770|11290146|FG000|STARTED|Overall Study||32
10159750|NCT02928770|11290146|FG000|COMPLETED|Overall Study||30
10159751|NCT02928770|11290146|FG000|NOT COMPLETED|Overall Study||2
10159752|NCT02928848|11290152|FG000|STARTED|Arm 1||9
10159753|NCT02928848|11290153|FG001|STARTED|Arm 1||7
10159754|NCT02928848|11290152|FG000|COMPLETED|Arm 1||9
10159755|NCT02928848|11290153|FG001|COMPLETED|Arm 1||6
10159756|NCT02928848|11290152|FG000|NOT COMPLETED|Arm 1||0
10159757|NCT02928848|11290153|FG001|NOT COMPLETED|Arm 1||1
10159758|NCT02928848|11290152|FG000|STARTED|Arm 2||9
10159759|NCT02928848|11290153|FG001|STARTED|Arm 2||6
10159760|NCT02928848|11290152|FG000|COMPLETED|Arm 2||8
10159761|NCT02928848|11290153|FG001|COMPLETED|Arm 2||6
10159762|NCT02928848|11290152|FG000|NOT COMPLETED|Arm 2||1
10159763|NCT02928848|11290153|FG001|NOT COMPLETED|Arm 2||0
10159764|NCT02928952|11290163|FG000|STARTED|Overall Study||65
10159765|NCT02928952|11290164|FG001|STARTED|Overall Study||67
10159766|NCT02928952|11290163|FG000|COMPLETED|Overall Study||55
10159767|NCT02928952|11290164|FG001|COMPLETED|Overall Study||60
10159768|NCT02928952|11290163|FG000|NOT COMPLETED|Overall Study||10
10159769|NCT02928952|11290164|FG001|NOT COMPLETED|Overall Study||7
10159770|NCT02929329|11290172|FG000|STARTED|Overall Study||4112
10159771|NCT02929329|11290173|FG001|STARTED|Overall Study||4120
10159772|NCT02929329|11290172|FG000|Received Treatment|Overall Study||4101
10159773|NCT02929329|11290173|FG001|Received Treatment|Overall Study||4110
10159774|NCT02929329|11290172|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
10159775|NCT02929329|11290173|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
10159776|NCT02929329|11290172|FG000|NOT COMPLETED|Overall Study||1104
10159777|NCT02929329|11290173|FG001|NOT COMPLETED|Overall Study||1092
10159778|NCT02929407|11290183|FG000|STARTED|Overall Study||4
10159779|NCT02929407|11290183|FG000|COMPLETED|Overall Study||3
10159780|NCT02929407|11290183|FG000|NOT COMPLETED|Overall Study||1
9710536|NCT04534764|10810163|FG001|COMPLETED|Period 2||17
9710537|NCT04534764|10810162|FG000|NOT COMPLETED|Period 2||0
9710538|NCT04534764|10810163|FG001|NOT COMPLETED|Period 2||0
9710539|NCT04534491|10810169|FG000|STARTED|Overall Study||855
9710540|NCT04534491|10810169|FG000|Treated|Overall Study||727
10159781|NCT02929498|11290190|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
10159782|NCT02929498|11290191|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
10159783|NCT02929498|11290192|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
10159784|NCT02929498|11290190|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10159785|NCT02929498|11290191|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10159786|NCT02929498|11290192|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10159787|NCT02929498|11290190|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
10159788|NCT02929498|11290191|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10159789|NCT02929498|11290192|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10159790|NCT02929498|11290190|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159791|NCT02929498|11290191|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159792|NCT02929498|11290192|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159793|NCT02929498|11290190|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159794|NCT02929498|11290191|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159795|NCT02929498|11290192|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159796|NCT02929498|11290190|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159797|NCT02929498|11290191|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159798|NCT02929498|11290192|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10159799|NCT02929667|11290200|FG000|STARTED|Overall Study||11
10159800|NCT02929667|11290201|FG001|STARTED|Overall Study||11
10159801|NCT02929667|11290200|FG000|COMPLETED|Overall Study||11
10159802|NCT02929667|11290201|FG001|COMPLETED|Overall Study||11
10159803|NCT02929667|11290200|FG000|NOT COMPLETED|Overall Study||0
10159804|NCT02929667|11290201|FG001|NOT COMPLETED|Overall Study||0
10159805|NCT02929823|11290212|FG000|STARTED|Overall Study||42
10159806|NCT02929823|11290213|FG001|STARTED|Overall Study||46
10159807|NCT02929823|11290214|FG002|STARTED|Overall Study||42
10159808|NCT02929823|11290212|FG000|COMPLETED|Overall Study||39
10159809|NCT02929823|11290213|FG001|COMPLETED|Overall Study||40
10159810|NCT02929823|11290214|FG002|COMPLETED|Overall Study||38
10159811|NCT02929823|11290212|FG000|NOT COMPLETED|Overall Study||3
10159812|NCT02929823|11290213|FG001|NOT COMPLETED|Overall Study||6
10159813|NCT02929823|11290214|FG002|NOT COMPLETED|Overall Study||4
10159814|NCT02929979|11290224|FG000|STARTED|Overall Study||52
10159815|NCT02929979|11290225|FG001|STARTED|Overall Study||38
10159816|NCT02929979|11290224|FG000|COMPLETED|Overall Study||25
10159817|NCT02929979|11290225|FG001|COMPLETED|Overall Study||28
10159818|NCT02929979|11290224|FG000|NOT COMPLETED|Overall Study||27
10159819|NCT02929979|11290225|FG001|NOT COMPLETED|Overall Study||10
10197314|NCT03372928|11325274|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10
10197315|NCT03372928|11325273|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
10197316|NCT03372928|11325274|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
10197317|NCT03372928|11325273|FG000|STARTED|Washout (14 d)||10
10197318|NCT03372928|11325274|FG001|STARTED|Washout (14 d)||10
10197319|NCT03372928|11325273|FG000|COMPLETED|Washout (14 d)||10
10197320|NCT03372928|11325274|FG001|COMPLETED|Washout (14 d)||9
10197321|NCT03372928|11325273|FG000|NOT COMPLETED|Washout (14 d)||0
10197322|NCT03372928|11325274|FG001|NOT COMPLETED|Washout (14 d)||1
10197323|NCT03372928|11325273|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10
10197324|NCT03372928|11325274|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9
10197325|NCT03372928|11325273|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10
10197326|NCT03372928|11325274|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9
10197327|NCT03372928|11325273|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
10197328|NCT03372928|11325274|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
10197329|NCT03373162|11325285|FG000|STARTED|Overall Study||10
10197330|NCT03373162|11325285|FG000|COMPLETED|Overall Study||10
10197331|NCT03373162|11325285|FG000|NOT COMPLETED|Overall Study||0
9710541|NCT04534491|10810169|FG000|COMPLETED|Overall Study||703
9710542|NCT04534491|10810169|FG000|NOT COMPLETED|Overall Study||152
9710543|NCT04534465|10810173|FG000|STARTED|Overall Study||10
9710544|NCT04534465|10810174|FG001|STARTED|Overall Study||10
9710545|NCT04534465|10810175|FG002|STARTED|Overall Study||10
9710546|NCT04534465|10810176|FG003|STARTED|Overall Study||10
9710547|NCT04534465|10810177|FG004|STARTED|Overall Study||10
9710548|NCT04534465|10810173|FG000|COMPLETED|Overall Study||10
9710549|NCT04534465|10810174|FG001|COMPLETED|Overall Study||10
9710550|NCT04534465|10810175|FG002|COMPLETED|Overall Study||10
9710551|NCT04534465|10810176|FG003|COMPLETED|Overall Study||10
9710552|NCT04534465|10810177|FG004|COMPLETED|Overall Study||10
9710553|NCT04534465|10810173|FG000|NOT COMPLETED|Overall Study||0
9710554|NCT04534465|10810174|FG001|NOT COMPLETED|Overall Study||0
9710555|NCT04534465|10810175|FG002|NOT COMPLETED|Overall Study||0
9710556|NCT04534465|10810176|FG003|NOT COMPLETED|Overall Study||0
9710557|NCT04534465|10810177|FG004|NOT COMPLETED|Overall Study||0
9730555|NCT00127062|10830364|FG001|NOT COMPLETED|Second intervention_Hyde Park||0
9730556|NCT00127101|10830380|FG000|STARTED|Base Protocol||3
10197332|NCT03373240|11325292|FG000|STARTED|Overall Study||22
10197333|NCT03373240|11325293|FG001|STARTED|Overall Study||24
10197334|NCT03373240|11325292|FG000|4-week Post Treatment|Overall Study||14
9730557|NCT00127101|10830381|FG001|STARTED|Base Protocol||5
9730558|NCT00127101|10830382|FG002|STARTED|Base Protocol||3
9730559|NCT00127101|10830383|FG003|STARTED|Base Protocol||3
9730560|NCT00127101|10830384|FG004|STARTED|Base Protocol||5
9730561|NCT00127101|10830385|FG005|STARTED|Base Protocol||4
9730562|NCT00127101|10830380|FG000|COMPLETED|Base Protocol||1
9730563|NCT00127101|10830381|FG001|COMPLETED|Base Protocol||1
9730564|NCT00127101|10830382|FG002|COMPLETED|Base Protocol||1
9730565|NCT00127101|10830383|FG003|COMPLETED|Base Protocol||3
9730566|NCT00127101|10830384|FG004|COMPLETED|Base Protocol||3
9730567|NCT00127101|10830385|FG005|COMPLETED|Base Protocol||3
9730568|NCT00127101|10830380|FG000|NOT COMPLETED|Base Protocol||2
10159820|NCT02930005|11290234|FG000|STARTED|Overall Study||2
10159821|NCT02930005|11290235|FG001|STARTED|Overall Study||6
10159822|NCT02930005|11290234|FG000|Completed 2 Weeks|Overall Study||2
10159823|NCT02930005|11290235|FG001|Completed 2 Weeks|Overall Study||2
10159824|NCT02930005|11290234|FG000|COMPLETED|Overall Study||1
10159825|NCT02930005|11290235|FG001|COMPLETED|Overall Study||1
10159826|NCT02930005|11290234|FG000|NOT COMPLETED|Overall Study||1
10159827|NCT02930005|11290235|FG001|NOT COMPLETED|Overall Study||5
10159828|NCT02930018|11290243|FG000|STARTED|Overall Study||556
10159829|NCT02930018|11290244|FG001|STARTED|Overall Study||549
10159830|NCT02930018|11290243|FG000|COMPLETED|Overall Study||550
10159831|NCT02930018|11290244|FG001|COMPLETED|Overall Study||546
10159832|NCT02930018|11290243|FG000|NOT COMPLETED|Overall Study||6
10159833|NCT02930018|11290244|FG001|NOT COMPLETED|Overall Study||3
10159834|NCT02930174|11290252|FG000|STARTED|Overall Study||12
10159835|NCT02930174|11290253|FG001|STARTED|Overall Study||8
10159836|NCT02930174|11290252|FG000|COMPLETED|Overall Study||12
10159837|NCT02930174|11290253|FG001|COMPLETED|Overall Study||8
10159838|NCT02930174|11290252|FG000|NOT COMPLETED|Overall Study||0
10159839|NCT02930174|11290253|FG001|NOT COMPLETED|Overall Study||0
10159840|NCT02930226|11290267|FG000|STARTED|Overall Study||4
10159841|NCT02930226|11290268|FG001|STARTED|Overall Study||4
10159842|NCT02930226|11290269|FG002|STARTED|Overall Study||4
10159843|NCT02930226|11290270|FG003|STARTED|Overall Study||4
10159844|NCT02930226|11290271|FG004|STARTED|Overall Study||4
10159845|NCT02930226|11290272|FG005|STARTED|Overall Study||4
10159846|NCT02930226|11290267|FG000|COMPLETED|Overall Study||4
9710558|NCT04533204|10810191|FG000|STARTED|Overall Study||29
9710559|NCT04533204|10810192|FG001|STARTED|Overall Study||30
9710560|NCT04533204|10810191|FG000|COMPLETED|Overall Study||28
9710561|NCT04533204|10810192|FG001|COMPLETED|Overall Study||29
9710562|NCT04533204|10810191|FG000|NOT COMPLETED|Overall Study||1
9710563|NCT04533204|10810192|FG001|NOT COMPLETED|Overall Study||1
9710564|NCT04532164|10810198|FG000|STARTED|Overall Study||137
9710565|NCT04532164|10810198|FG000|Treated|Overall Study||132
9710566|NCT04532164|10810198|FG000|COMPLETED|Overall Study||113
9710567|NCT04532164|10810198|FG000|NOT COMPLETED|Overall Study||24
9710568|NCT04531813|10810203|FG000|STARTED|Overall Study||32
9710569|NCT04531813|10810203|FG000|Treated|Overall Study||31
9710570|NCT04531813|10810203|FG000|COMPLETED|Overall Study||30
10159847|NCT02930226|11290268|FG001|COMPLETED|Overall Study||4
10159848|NCT02930226|11290269|FG002|COMPLETED|Overall Study||4
10159849|NCT02930226|11290270|FG003|COMPLETED|Overall Study||4
10159850|NCT02930226|11290271|FG004|COMPLETED|Overall Study||3
10159851|NCT02930226|11290272|FG005|COMPLETED|Overall Study||4
10159852|NCT02930226|11290267|FG000|NOT COMPLETED|Overall Study||0
9710571|NCT04531813|10810203|FG000|NOT COMPLETED|Overall Study||2
10159853|NCT02930226|11290268|FG001|NOT COMPLETED|Overall Study||0
10159854|NCT02930226|11290269|FG002|NOT COMPLETED|Overall Study||0
10159855|NCT02930226|11290270|FG003|NOT COMPLETED|Overall Study||0
10159856|NCT02930226|11290271|FG004|NOT COMPLETED|Overall Study||1
10159857|NCT02930226|11290272|FG005|NOT COMPLETED|Overall Study||0
10159858|NCT02930343|11290290|FG000|STARTED|Overall Study||68
10159859|NCT02930343|11290291|FG001|STARTED|Overall Study||68
10159860|NCT02930343|11290290|FG000|COMPLETED|Overall Study||59
10159861|NCT02930343|11290291|FG001|COMPLETED|Overall Study||61
10159862|NCT02930343|11290290|FG000|NOT COMPLETED|Overall Study||9
10159863|NCT02930343|11290291|FG001|NOT COMPLETED|Overall Study||7
10159864|NCT02930824|11290301|FG000|STARTED|Overall Study||62
10159865|NCT02930824|11290302|FG001|STARTED|Overall Study||63
10159866|NCT02930824|11290303|FG002|STARTED|Overall Study||30
9730569|NCT00127101|10830381|FG001|NOT COMPLETED|Base Protocol||4
10159867|NCT02930824|11290304|FG003|STARTED|Overall Study||30
10159868|NCT02930824|11290301|FG000|COMPLETED|Overall Study||56
10159869|NCT02930824|11290302|FG001|COMPLETED|Overall Study||57
10159870|NCT02930824|11290303|FG002|COMPLETED|Overall Study||20
10159871|NCT02930824|11290304|FG003|COMPLETED|Overall Study||23
10159872|NCT02930824|11290301|FG000|NOT COMPLETED|Overall Study||6
10159873|NCT02930824|11290302|FG001|NOT COMPLETED|Overall Study||6
10159874|NCT02930824|11290303|FG002|NOT COMPLETED|Overall Study||10
10159875|NCT02930824|11290304|FG003|NOT COMPLETED|Overall Study||7
10159876|NCT02930837|11290320|FG000|STARTED|Overall Study|Started are treated patients|120
10159877|NCT02930837|11290320|FG000|COMPLETED|Overall Study|Completed the trial|108
10159878|NCT02930837|11290320|FG000|NOT COMPLETED|Overall Study||12
10159879|NCT02930941|11290326|FG000|STARTED|Overall Study||17
10159880|NCT02930941|11290327|FG001|STARTED|Overall Study||18
10159881|NCT02930941|11290326|FG000|COMPLETED|Overall Study||16
10159882|NCT02930941|11290327|FG001|COMPLETED|Overall Study||16
10159883|NCT02930941|11290326|FG000|NOT COMPLETED|Overall Study||1
10159884|NCT02930941|11290327|FG001|NOT COMPLETED|Overall Study||2
10159885|NCT02930980|11290337|FG000|STARTED|Overall Study||43
10159886|NCT02930980|11290337|FG000|COMPLETED|Overall Study||43
10159887|NCT02930980|11290337|FG000|NOT COMPLETED|Overall Study||0
10159888|NCT02931045|11290343|FG000|STARTED|Overall Study||30
10159889|NCT02931045|11290344|FG001|STARTED|Overall Study||30
10159890|NCT02931045|11290343|FG000|COMPLETED|Overall Study||27
10159891|NCT02931045|11290344|FG001|COMPLETED|Overall Study||28
10159892|NCT02931045|11290343|FG000|NOT COMPLETED|Overall Study||3
10159893|NCT02931045|11290344|FG001|NOT COMPLETED|Overall Study||2
10159894|NCT02931253|11290352|FG000|STARTED|Overall Study||2
10159895|NCT02931253|11290353|FG001|STARTED|Overall Study||4
10159896|NCT02931253|11290352|FG000|COMPLETED|Overall Study||2
10159897|NCT02931253|11290353|FG001|COMPLETED|Overall Study||4
10159898|NCT02931253|11290352|FG000|NOT COMPLETED|Overall Study||0
10159899|NCT02931253|11290353|FG001|NOT COMPLETED|Overall Study||0
10159900|NCT02931396|11290361|FG000|STARTED|Overall Study||10
10159901|NCT02931396|11290362|FG001|STARTED|Overall Study||10
10159902|NCT02931396|11290361|FG000|COMPLETED|Overall Study||5
10159903|NCT02931396|11290362|FG001|COMPLETED|Overall Study||10
10159904|NCT02931396|11290361|FG000|NOT COMPLETED|Overall Study||5
10159905|NCT02931396|11290362|FG001|NOT COMPLETED|Overall Study||0
10159906|NCT02931539|11290370|FG000|STARTED|Period 1: Treatment Phase||117
10159907|NCT02931539|11290371|FG001|STARTED|Period 1: Treatment Phase||235
10159908|NCT02931539|11290372|FG002|STARTED|Period 1: Treatment Phase||0
10159909|NCT02931539|11290370|FG000|Treated Participants|Period 1: Treatment Phase||116
10159910|NCT02931539|11290371|FG001|Treated Participants|Period 1: Treatment Phase||234
10159911|NCT02931539|11290372|FG002|Treated Participants|Period 1: Treatment Phase||0
10159912|NCT02931539|11290370|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56
10159913|NCT02931539|11290371|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
10159914|NCT02931539|11290372|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
10159915|NCT02931539|11290370|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47
10159916|NCT02931539|11290371|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0
10159917|NCT02931539|11290372|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0
10159918|NCT02931539|11290370|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6
10159919|NCT02931539|11290371|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0
10159920|NCT02931539|11290372|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0
10159921|NCT02931539|11290370|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7
10159922|NCT02931539|11290371|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
10159923|NCT02931539|11290372|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
10159924|NCT02931539|11290370|FG000|COMPLETED|Period 1: Treatment Phase||58
10159925|NCT02931539|11290371|FG001|COMPLETED|Period 1: Treatment Phase||199
10159926|NCT02931539|11290372|FG002|COMPLETED|Period 1: Treatment Phase||0
10159927|NCT02931539|11290370|FG000|NOT COMPLETED|Period 1: Treatment Phase||59
10159928|NCT02931539|11290371|FG001|NOT COMPLETED|Period 1: Treatment Phase||36
10159929|NCT02931539|11290372|FG002|NOT COMPLETED|Period 1: Treatment Phase||0
10159930|NCT02931539|11290370|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0
10159931|NCT02931539|11290371|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0
10159932|NCT02931539|11290372|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22
10159933|NCT02931539|11290370|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0
10159934|NCT02931539|11290371|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0
10159935|NCT02931539|11290372|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20
10159936|NCT02931539|11290370|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
10159937|NCT02931539|11290371|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
10159938|NCT02931539|11290372|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2
10159939|NCT02931565|11290387|FG000|STARTED|Overall Study||2
10159940|NCT02931565|11290388|FG001|STARTED|Overall Study||7
10159941|NCT02931565|11290387|FG000|COMPLETED|Overall Study||2
10159942|NCT02931565|11290388|FG001|COMPLETED|Overall Study||7
10159943|NCT02931565|11290387|FG000|NOT COMPLETED|Overall Study||0
10159944|NCT02931565|11290388|FG001|NOT COMPLETED|Overall Study||0
10159945|NCT02931838|11290401|FG000|STARTED|Overall Study||45
10159946|NCT02931838|11290402|FG001|STARTED|Overall Study||44
10159947|NCT02931838|11290403|FG002|STARTED|Overall Study||44
10159948|NCT02931838|11290404|FG003|STARTED|Overall Study||45
10159949|NCT02931838|11290405|FG004|STARTED|Overall Study||45
10159950|NCT02931838|11290406|FG005|STARTED|Overall Study||44
10159951|NCT02931838|11290401|FG000|COMPLETED|Overall Study||31
10159952|NCT02931838|11290402|FG001|COMPLETED|Overall Study||34
10159953|NCT02931838|11290403|FG002|COMPLETED|Overall Study||36
10159954|NCT02931838|11290404|FG003|COMPLETED|Overall Study||42
10159955|NCT02931838|11290405|FG004|COMPLETED|Overall Study||39
10159956|NCT02931838|11290406|FG005|COMPLETED|Overall Study||42
10159957|NCT02931838|11290401|FG000|NOT COMPLETED|Overall Study||14
10159958|NCT02931838|11290402|FG001|NOT COMPLETED|Overall Study||10
10159959|NCT02931838|11290403|FG002|NOT COMPLETED|Overall Study||8
10159960|NCT02931838|11290404|FG003|NOT COMPLETED|Overall Study||3
10159961|NCT02931838|11290405|FG004|NOT COMPLETED|Overall Study||6
10159962|NCT02931838|11290406|FG005|NOT COMPLETED|Overall Study||2
10159963|NCT02932228|11290427|FG000|STARTED|Overall Study||150
10159964|NCT02932228|11290428|FG001|STARTED|Overall Study||433
10159965|NCT02932228|11290427|FG000|COMPLETED|Overall Study||140
10159966|NCT02932228|11290428|FG001|COMPLETED|Overall Study||405
10159967|NCT02932228|11290427|FG000|NOT COMPLETED|Overall Study||10
10159968|NCT02932228|11290428|FG001|NOT COMPLETED|Overall Study||28
10159969|NCT02932267|11290436|FG000|STARTED|Overall Study||50
10159970|NCT02932267|11290436|FG000|COMPLETED|Overall Study||42
10159971|NCT02932267|11290436|FG000|NOT COMPLETED|Overall Study||8
10159972|NCT02932306|11290442|FG000|STARTED|Overall Study||406
10159973|NCT02932306|11290443|FG001|STARTED|Overall Study||414
10159974|NCT02932306|11290442|FG000|Intent-to-treat (ITT) Population|Overall Study||406
10159975|NCT02932306|11290443|FG001|Intent-to-treat (ITT) Population|Overall Study||414
10159976|NCT02932306|11290442|FG000|Safety Population|Overall Study||378
10159977|NCT02932306|11290443|FG001|Safety Population|Overall Study||385
10159978|NCT02932306|11290442|FG000|COMPLETED|Overall Study||338
10159979|NCT02932306|11290443|FG001|COMPLETED|Overall Study||337
10159980|NCT02932306|11290442|FG000|NOT COMPLETED|Overall Study||68
10159981|NCT02932306|11290443|FG001|NOT COMPLETED|Overall Study||77
10159982|NCT02932462|11290451|FG000|STARTED|Overall Study||184
10159983|NCT02932462|11290452|FG001|STARTED|Overall Study||189
10159984|NCT02932462|11290451|FG000|COMPLETED|Overall Study||177
10159985|NCT02932462|11290452|FG001|COMPLETED|Overall Study||176
10159986|NCT02932462|11290451|FG000|NOT COMPLETED|Overall Study||7
10159987|NCT02932462|11290452|FG001|NOT COMPLETED|Overall Study||13
10159988|NCT02932787|11290460|FG000|STARTED|Overall Study||22
10159989|NCT02932787|11290461|FG001|STARTED|Overall Study||9
10159990|NCT02932787|11290460|FG000|COMPLETED|Overall Study||22
10159991|NCT02932787|11290461|FG001|COMPLETED|Overall Study||9
10159992|NCT02932787|11290460|FG000|NOT COMPLETED|Overall Study||0
10159993|NCT02932787|11290461|FG001|NOT COMPLETED|Overall Study||0
10159994|NCT02932878|11290472|FG000|STARTED|Overall Study||15
10159995|NCT02932878|11290473|FG001|STARTED|Overall Study||1
10159996|NCT02932878|11290472|FG000|COMPLETED|Overall Study||13
10159997|NCT02932878|11290473|FG001|COMPLETED|Overall Study||0
10159998|NCT02932878|11290472|FG000|NOT COMPLETED|Overall Study||2
10159999|NCT02932878|11290473|FG001|NOT COMPLETED|Overall Study||1
10160000|NCT02932891|11290479|FG000|STARTED|Overall Study||28
10160001|NCT02932891|11290479|FG000|COMPLETED|Overall Study||24
10160002|NCT02932891|11290479|FG000|NOT COMPLETED|Overall Study||4
10160003|NCT02932904|11290487|FG000|STARTED|Overall Study||92
10160004|NCT02932904|11290488|FG001|STARTED|Overall Study||85
10160005|NCT02932904|11290489|FG002|STARTED|Overall Study||91
10160006|NCT02932904|11290490|FG003|STARTED|Overall Study||93
10160007|NCT02932904|11290487|FG000|Treated|Overall Study||91
10160008|NCT02932904|11290488|FG001|Treated|Overall Study||84
10160009|NCT02932904|11290489|FG002|Treated|Overall Study||91
10160010|NCT02932904|11290490|FG003|Treated|Overall Study||91
10160011|NCT02932904|11290487|FG000|COMPLETED|Overall Study||76
10160012|NCT02932904|11290488|FG001|COMPLETED|Overall Study||67
10160013|NCT02932904|11290489|FG002|COMPLETED|Overall Study||68
10160014|NCT02932904|11290490|FG003|COMPLETED|Overall Study||79
10160015|NCT02932904|11290487|FG000|NOT COMPLETED|Overall Study||16
10160016|NCT02932904|11290488|FG001|NOT COMPLETED|Overall Study||18
10160017|NCT02932904|11290489|FG002|NOT COMPLETED|Overall Study||23
10160018|NCT02932904|11290490|FG003|NOT COMPLETED|Overall Study||14
10160019|NCT02932943|11290505|FG000|STARTED|Overall Study||227
10160020|NCT02932943|11290506|FG001|STARTED|Overall Study||231
10160021|NCT02932943|11290505|FG000|COMPLETED|Overall Study||222
10160022|NCT02932943|11290506|FG001|COMPLETED|Overall Study||224
10160023|NCT02932943|11290505|FG000|NOT COMPLETED|Overall Study||5
10160024|NCT02932943|11290506|FG001|NOT COMPLETED|Overall Study||7
10160025|NCT02933034|11290512|FG000|STARTED|Overall Study||33
10160026|NCT02933034|11290512|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24
10160027|NCT02933034|11290512|FG000|COMPLETED|Overall Study||24
10160028|NCT02933034|11290512|FG000|NOT COMPLETED|Overall Study||9
10160029|NCT02933060|11290518|FG000|STARTED|Overall Study||25
10160030|NCT02933060|11290519|FG001|STARTED|Overall Study||25
10160031|NCT02933060|11290518|FG000|COMPLETED|Overall Study||25
10160032|NCT02933060|11290519|FG001|COMPLETED|Overall Study||24
10160033|NCT02933060|11290518|FG000|NOT COMPLETED|Overall Study||0
10160034|NCT02933060|11290519|FG001|NOT COMPLETED|Overall Study||1
10160035|NCT02933320|11290529|FG000|STARTED|Overall Study||13
10160036|NCT02933320|11290530|FG001|STARTED|Overall Study||1
10160037|NCT02933320|11290531|FG002|STARTED|Overall Study|Trial terminated early|0
10160038|NCT02933320|11290532|FG003|STARTED|Overall Study|Trial terminated early|0
10160039|NCT02933320|11290529|FG000|COMPLETED|Overall Study||13
10160040|NCT02933320|11290530|FG001|COMPLETED|Overall Study||1
10160041|NCT02933320|11290531|FG002|COMPLETED|Overall Study||0
10160042|NCT02933320|11290532|FG003|COMPLETED|Overall Study||0
10160043|NCT02933320|11290529|FG000|NOT COMPLETED|Overall Study||0
10160044|NCT02933320|11290530|FG001|NOT COMPLETED|Overall Study||0
10160045|NCT02933320|11290531|FG002|NOT COMPLETED|Overall Study||0
10160046|NCT02933320|11290532|FG003|NOT COMPLETED|Overall Study||0
10160047|NCT02933372|11290544|FG000|STARTED|Overall Study||15
10160048|NCT02933372|11290545|FG001|STARTED|Overall Study||10
10160049|NCT02933372|11290544|FG000|COMPLETED|Overall Study||15
10160050|NCT02933372|11290545|FG001|COMPLETED|Overall Study||10
10160051|NCT02933372|11290544|FG000|NOT COMPLETED|Overall Study||0
10160052|NCT02933372|11290545|FG001|NOT COMPLETED|Overall Study||0
10160053|NCT02933450|11290553|FG000|STARTED|Overall Study||20
10160054|NCT02933450|11290554|FG001|STARTED|Overall Study||23
10160055|NCT02933450|11290553|FG000|COMPLETED|Overall Study||15
10160056|NCT02933450|11290554|FG001|COMPLETED|Overall Study||15
10160057|NCT02933450|11290553|FG000|NOT COMPLETED|Overall Study||5
9710572|NCT04531527|10810207|FG000|STARTED|Overall Study||32
9710573|NCT04531527|10810207|FG000|Treated|Overall Study||29
9710574|NCT04531527|10810207|FG000|COMPLETED|Overall Study||29
9710575|NCT04531527|10810207|FG000|NOT COMPLETED|Overall Study||3
9710576|NCT04531540|10810211|FG000|STARTED|Overall Study||225
9710577|NCT04531540|10810211|FG000|Treated|Overall Study||222
9710578|NCT04531540|10810211|FG000|COMPLETED|Overall Study||216
9710579|NCT04531540|10810211|FG000|NOT COMPLETED|Overall Study||9
9710580|NCT04530591|10810215|FG000|STARTED|Overall Study||97
9710581|NCT04530591|10810215|FG000|COMPLETED|Overall Study||97
9710582|NCT04530591|10810215|FG000|NOT COMPLETED|Overall Study||0
9730570|NCT00127101|10830382|FG002|NOT COMPLETED|Base Protocol||2
9730571|NCT00127101|10830383|FG003|NOT COMPLETED|Base Protocol||0
9730572|NCT00127101|10830384|FG004|NOT COMPLETED|Base Protocol||2
9730573|NCT00127101|10830385|FG005|NOT COMPLETED|Base Protocol||1
9730574|NCT00127101|10830380|FG000|STARTED|Continuation Phase||0
9730575|NCT00127101|10830381|FG001|STARTED|Continuation Phase||0
9730576|NCT00127101|10830382|FG002|STARTED|Continuation Phase||1
9730577|NCT00127101|10830383|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
9730578|NCT00127101|10830384|FG004|STARTED|Continuation Phase||3
9730579|NCT00127101|10830385|FG005|STARTED|Continuation Phase||3
9730580|NCT00127101|10830380|FG000|COMPLETED|Continuation Phase||0
9730581|NCT00127101|10830381|FG001|COMPLETED|Continuation Phase||0
9730582|NCT00127101|10830382|FG002|COMPLETED|Continuation Phase||0
9730583|NCT00127101|10830383|FG003|COMPLETED|Continuation Phase||0
9730584|NCT00127101|10830384|FG004|COMPLETED|Continuation Phase||0
9730585|NCT00127101|10830385|FG005|COMPLETED|Continuation Phase||0
9730586|NCT00127101|10830380|FG000|NOT COMPLETED|Continuation Phase||0
9730587|NCT00127101|10830381|FG001|NOT COMPLETED|Continuation Phase||0
9730588|NCT00127101|10830382|FG002|NOT COMPLETED|Continuation Phase||1
9730589|NCT00127101|10830383|FG003|NOT COMPLETED|Continuation Phase||0
9730590|NCT00127101|10830384|FG004|NOT COMPLETED|Continuation Phase||3
9730591|NCT00127101|10830385|FG005|NOT COMPLETED|Continuation Phase||3
9730592|NCT00127166|10830401|FG000|STARTED|Period I||78
9730593|NCT00127166|10830402|FG001|STARTED|Period I||76
9730594|NCT00127166|10830401|FG000|COMPLETED|Period I||75
9730595|NCT00127166|10830402|FG001|COMPLETED|Period I||74
9730596|NCT00127166|10830401|FG000|NOT COMPLETED|Period I||3
9730597|NCT00127166|10830402|FG001|NOT COMPLETED|Period I||2
9730598|NCT00127166|10830401|FG000|STARTED|Washout Period||75
9730599|NCT00127166|10830402|FG001|STARTED|Washout Period||74
9730600|NCT00127166|10830401|FG000|COMPLETED|Washout Period||75
9730601|NCT00127166|10830402|FG001|COMPLETED|Washout Period||73
9730602|NCT00127166|10830401|FG000|NOT COMPLETED|Washout Period||0
9730603|NCT00127166|10830402|FG001|NOT COMPLETED|Washout Period||1
9730604|NCT00127166|10830401|FG000|STARTED|Period II||75
9730605|NCT00127166|10830402|FG001|STARTED|Period II||73
9730606|NCT00127166|10830401|FG000|COMPLETED|Period II||72
9730607|NCT00127166|10830402|FG001|COMPLETED|Period II||73
9730608|NCT00127166|10830401|FG000|NOT COMPLETED|Period II||3
9730609|NCT00127166|10830402|FG001|NOT COMPLETED|Period II||0
9730610|NCT00127192|10830413|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
9730611|NCT00127192|10830414|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
9730612|NCT00127192|10830415|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70
9730613|NCT00127192|10830416|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
9730614|NCT00127192|10830417|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
10160058|NCT02933450|11290554|FG001|NOT COMPLETED|Overall Study||8
9730615|NCT00127192|10830413|FG000|COMPLETED|Overall Study||77
9730616|NCT00127192|10830414|FG001|COMPLETED|Overall Study||71
9730617|NCT00127192|10830415|FG002|COMPLETED|Overall Study||68
9730618|NCT00127192|10830416|FG003|COMPLETED|Overall Study||67
9730619|NCT00127192|10830417|FG004|COMPLETED|Overall Study||68
9730620|NCT00127192|10830413|FG000|NOT COMPLETED|Overall Study||3
9730621|NCT00127192|10830414|FG001|NOT COMPLETED|Overall Study||1
9730622|NCT00127192|10830415|FG002|NOT COMPLETED|Overall Study||2
9730623|NCT00127192|10830416|FG003|NOT COMPLETED|Overall Study||1
9730624|NCT00127192|10830417|FG004|NOT COMPLETED|Overall Study||5
9730625|NCT00127205|10830432|FG000|STARTED|Overall Study||2262
10160059|NCT02933476|11290560|FG000|STARTED|Overall Study||5
10160060|NCT02933476|11290560|FG000|COMPLETED|Overall Study||5
10160061|NCT02933476|11290560|FG000|NOT COMPLETED|Overall Study||0
10160062|NCT02933489|11290566|FG000|STARTED|Overall Study||757
10160063|NCT02933489|11290567|FG001|STARTED|Overall Study||759
9730626|NCT00127205|10830433|FG001|STARTED|Overall Study||2268
9730627|NCT00127205|10830434|FG002|STARTED|Overall Study||1567
10160064|NCT02933489|11290566|FG000|DBTperformed|Overall Study||726
10160065|NCT02933489|11290567|FG001|DBTperformed|Overall Study||737
10160066|NCT02933489|11290566|FG000|AB MR Performed|Overall Study||713
10160067|NCT02933489|11290567|FG001|AB MR Performed|Overall Study||733
10160068|NCT02933489|11290566|FG000|COMPLETED|Overall Study||713
10160069|NCT02933489|11290567|FG001|COMPLETED|Overall Study||731
10160070|NCT02933489|11290566|FG000|NOT COMPLETED|Overall Study||44
10160071|NCT02933489|11290567|FG001|NOT COMPLETED|Overall Study||28
10160072|NCT02933502|11290578|FG000|STARTED|Overall Study||3
10160073|NCT02933502|11290578|FG000|COMPLETED|Overall Study||3
10160074|NCT02933502|11290578|FG000|NOT COMPLETED|Overall Study||0
10160075|NCT02933528|11290582|FG000|STARTED|Overall Study||24
10160076|NCT02933528|11290582|FG000|COMPLETED|Overall Study||22
10160077|NCT02933528|11290582|FG000|NOT COMPLETED|Overall Study||2
10160078|NCT02933866|11290588|FG000|STARTED|Overall Study||186
10160079|NCT02933866|11290589|FG001|STARTED|Overall Study||185
10160080|NCT02933866|11290588|FG000|COMPLETED|Overall Study||174
10160081|NCT02933866|11290589|FG001|COMPLETED|Overall Study||176
10160082|NCT02933866|11290588|FG000|NOT COMPLETED|Overall Study||12
10160083|NCT02933866|11290589|FG001|NOT COMPLETED|Overall Study||9
10160084|NCT02933879|11290598|FG000|STARTED|Overall Study||64
10160085|NCT02933879|11290599|FG001|STARTED|Overall Study||62
10160086|NCT02933879|11290600|FG002|STARTED|Overall Study||58
10160087|NCT02933879|11290598|FG000|COMPLETED|Overall Study||48
10160088|NCT02933879|11290599|FG001|COMPLETED|Overall Study||48
10160089|NCT02933879|11290600|FG002|COMPLETED|Overall Study||41
10160090|NCT02933879|11290598|FG000|NOT COMPLETED|Overall Study||16
10160091|NCT02933879|11290599|FG001|NOT COMPLETED|Overall Study||14
10160092|NCT02933879|11290600|FG002|NOT COMPLETED|Overall Study||17
10160093|NCT02934178|11290612|FG000|STARTED|Received Vaccination 1||12
10160094|NCT02934178|11290613|FG001|STARTED|Received Vaccination 1||4
10160095|NCT02934178|11290612|FG000|COMPLETED|Received Vaccination 1||12
10160096|NCT02934178|11290613|FG001|COMPLETED|Received Vaccination 1||4
10160097|NCT02934178|11290612|FG000|NOT COMPLETED|Received Vaccination 1||0
10160098|NCT02934178|11290613|FG001|NOT COMPLETED|Received Vaccination 1||0
10160099|NCT02934178|11290612|FG000|STARTED|Received Vaccination 2||12
10160100|NCT02934178|11290613|FG001|STARTED|Received Vaccination 2||4
10160101|NCT02934178|11290612|FG000|COMPLETED|Received Vaccination 2||12
10160102|NCT02934178|11290613|FG001|COMPLETED|Received Vaccination 2||3
10160103|NCT02934178|11290612|FG000|NOT COMPLETED|Received Vaccination 2||0
10160104|NCT02934178|11290613|FG001|NOT COMPLETED|Received Vaccination 2||1
10160105|NCT02934178|11290612|FG000|STARTED|Received Vaccination 3||12
10160106|NCT02934178|11290613|FG001|STARTED|Received Vaccination 3||3
10160107|NCT02934178|11290612|FG000|COMPLETED|Received Vaccination 3||11
10160108|NCT02934178|11290613|FG001|COMPLETED|Received Vaccination 3||3
10160109|NCT02934178|11290612|FG000|NOT COMPLETED|Received Vaccination 3||1
10160110|NCT02934178|11290613|FG001|NOT COMPLETED|Received Vaccination 3||0
10160111|NCT02934191|11290622|FG000|STARTED|Overall Study||87
10160112|NCT02934191|11290623|FG001|STARTED|Overall Study||85
10160113|NCT02934191|11290622|FG000|COMPLETED|Overall Study||87
10160114|NCT02934191|11290623|FG001|COMPLETED|Overall Study||85
10160115|NCT02934191|11290622|FG000|NOT COMPLETED|Overall Study||0
10160116|NCT02934191|11290623|FG001|NOT COMPLETED|Overall Study||0
10160117|NCT02934347|11290631|FG000|STARTED|Overall Study||374
10160118|NCT02934347|11290632|FG001|STARTED|Overall Study||407
10160119|NCT02934347|11290631|FG000|COMPLETED|Overall Study||374
10160120|NCT02934347|11290632|FG001|COMPLETED|Overall Study||407
10160121|NCT02934347|11290631|FG000|NOT COMPLETED|Overall Study||0
10160122|NCT02934347|11290632|FG001|NOT COMPLETED|Overall Study||0
10160123|NCT02934555|11290640|FG000|STARTED|Overall Study||23
10160124|NCT02934555|11290641|FG001|STARTED|Overall Study||25
10160125|NCT02934555|11290640|FG000|COMPLETED|Overall Study||21
10160126|NCT02934555|11290641|FG001|COMPLETED|Overall Study||22
10160127|NCT02934555|11290640|FG000|NOT COMPLETED|Overall Study||2
10160128|NCT02934555|11290641|FG001|NOT COMPLETED|Overall Study||3
10160129|NCT02934698|11290647|FG000|STARTED|Overall Study||2
10160130|NCT02934698|11290647|FG000|COMPLETED|Overall Study||2
10160131|NCT02934698|11290647|FG000|NOT COMPLETED|Overall Study||0
10160132|NCT02935036|11290653|FG000|STARTED|Overall Study||147
10160133|NCT02935036|11290654|FG001|STARTED|Overall Study||147
10160134|NCT02935036|11290653|FG000|COMPLETED|Overall Study||137
10160135|NCT02935036|11290654|FG001|COMPLETED|Overall Study||136
10160136|NCT02935036|11290653|FG000|NOT COMPLETED|Overall Study||10
10160137|NCT02935036|11290654|FG001|NOT COMPLETED|Overall Study||11
10160138|NCT02935062|11290663|FG000|STARTED|Overall Study||8
10160139|NCT02935062|11290664|FG001|STARTED|Overall Study||8
10160140|NCT02935062|11290665|FG002|STARTED|Overall Study||8
10160141|NCT02935062|11290663|FG000|COMPLETED|Overall Study||8
10160142|NCT02935062|11290664|FG001|COMPLETED|Overall Study||8
10160143|NCT02935062|11290665|FG002|COMPLETED|Overall Study||8
10160144|NCT02935062|11290663|FG000|NOT COMPLETED|Overall Study||0
10160145|NCT02935062|11290664|FG001|NOT COMPLETED|Overall Study||0
10160146|NCT02935062|11290665|FG002|NOT COMPLETED|Overall Study||0
10160147|NCT02935088|11290673|FG000|STARTED|Overall Study||2217
10160148|NCT02935088|11290673|FG000|COMPLETED|Overall Study||2115
10160149|NCT02935088|11290673|FG000|NOT COMPLETED|Overall Study||102
10160150|NCT02935179|11290686|FG000|STARTED|Overall Study||30
10160151|NCT02935179|11290687|FG001|STARTED|Overall Study||30
10160152|NCT02935179|11290686|FG000|COMPLETED|Overall Study||29
10160153|NCT02935179|11290687|FG001|COMPLETED|Overall Study||29
10160154|NCT02935179|11290686|FG000|NOT COMPLETED|Overall Study||1
10160155|NCT02935179|11290687|FG001|NOT COMPLETED|Overall Study||1
10160156|NCT02935192|11290695|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
10160157|NCT02935192|11290696|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
10160158|NCT02935192|11290695|FG000|Received Vaccine/Placebo|Overall Study||312
10160159|NCT02935192|11290696|FG001|Received Vaccine/Placebo|Overall Study||156
10160160|NCT02935192|11290695|FG000|COMPLETED|Overall Study||312
10160161|NCT02935192|11290696|FG001|COMPLETED|Overall Study||156
10160162|NCT02935192|11290695|FG000|NOT COMPLETED|Overall Study||8
10160163|NCT02935192|11290696|FG001|NOT COMPLETED|Overall Study||4
10160164|NCT02935452|11290704|FG000|STARTED|Overall Study||30
10160165|NCT02935452|11290705|FG001|STARTED|Overall Study||30
10160166|NCT02935452|11290704|FG000|COMPLETED|Overall Study||27
10160167|NCT02935452|11290705|FG001|COMPLETED|Overall Study||29
10160168|NCT02935452|11290704|FG000|NOT COMPLETED|Overall Study||3
10160169|NCT02935452|11290705|FG001|NOT COMPLETED|Overall Study||1
10160170|NCT02935543|11290711|FG000|STARTED|Overall Study||1
10160171|NCT02935543|11290711|FG000|COMPLETED|Overall Study||1
10160172|NCT02935543|11290711|FG000|NOT COMPLETED|Overall Study||0
10160173|NCT02935673|11290718|FG000|STARTED|Overall Study||16
10160174|NCT02935673|11290719|FG001|STARTED|Overall Study||27
10160175|NCT02935673|11290720|FG002|STARTED|Overall Study||6
10160176|NCT02935673|11290718|FG000|COMPLETED|Overall Study||15
10160177|NCT02935673|11290719|FG001|COMPLETED|Overall Study||24
10160178|NCT02935673|11290720|FG002|COMPLETED|Overall Study||6
10160179|NCT02935673|11290718|FG000|NOT COMPLETED|Overall Study||1
10160180|NCT02935673|11290719|FG001|NOT COMPLETED|Overall Study||3
10160181|NCT02935673|11290720|FG002|NOT COMPLETED|Overall Study||0
10160182|NCT02935699|11290732|FG000|STARTED|Overall Study||127
10160183|NCT02935699|11290733|FG001|STARTED|Overall Study||135
10160184|NCT02935699|11290732|FG000|COMPLETED|Overall Study||127
10160185|NCT02935699|11290733|FG001|COMPLETED|Overall Study||135
10160186|NCT02935699|11290732|FG000|NOT COMPLETED|Overall Study||0
10160187|NCT02935699|11290733|FG001|NOT COMPLETED|Overall Study||0
10160188|NCT02935738|11290743|FG000|STARTED|Overall Study||67
10160189|NCT02935738|11290744|FG001|STARTED|Overall Study||74
10160190|NCT02935738|11290745|FG002|STARTED|Overall Study||47
10160191|NCT02935738|11290746|FG003|STARTED|Overall Study||53
10160192|NCT02935738|11290743|FG000|COMPLETED|Overall Study||50
10160193|NCT02935738|11290744|FG001|COMPLETED|Overall Study||53
10160194|NCT02935738|11290745|FG002|COMPLETED|Overall Study||46
10160195|NCT02935738|11290746|FG003|COMPLETED|Overall Study||48
10160196|NCT02935738|11290743|FG000|NOT COMPLETED|Overall Study||17
10160197|NCT02935738|11290744|FG001|NOT COMPLETED|Overall Study||21
10160198|NCT02935738|11290745|FG002|NOT COMPLETED|Overall Study||1
10160199|NCT02935738|11290746|FG003|NOT COMPLETED|Overall Study||5
10160200|NCT02935842|11290760|FG000|STARTED|Testing and Therapy Period 1||8
10160201|NCT02935842|11290761|FG001|STARTED|Testing and Therapy Period 1||6
10160202|NCT02935842|11290762|FG002|STARTED|Testing and Therapy Period 1||6
10160203|NCT02935842|11290763|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
10160204|NCT02935842|11290760|FG000|COMPLETED|Testing and Therapy Period 1||8
10160205|NCT02935842|11290761|FG001|COMPLETED|Testing and Therapy Period 1||6
10160206|NCT02935842|11290762|FG002|COMPLETED|Testing and Therapy Period 1||6
10160207|NCT02935842|11290763|FG003|COMPLETED|Testing and Therapy Period 1||0
10160208|NCT02935842|11290760|FG000|NOT COMPLETED|Testing and Therapy Period 1||0
10160209|NCT02935842|11290761|FG001|NOT COMPLETED|Testing and Therapy Period 1||0
10160210|NCT02935842|11290762|FG002|NOT COMPLETED|Testing and Therapy Period 1||0
10160211|NCT02935842|11290763|FG003|NOT COMPLETED|Testing and Therapy Period 1||0
10160212|NCT02935842|11290760|FG000|STARTED|Testing and Therapy Period 2||8
10160213|NCT02935842|11290761|FG001|STARTED|Testing and Therapy Period 2||6
10160214|NCT02935842|11290762|FG002|STARTED|Testing and Therapy Period 2||6
10160215|NCT02935842|11290763|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
10160216|NCT02935842|11290760|FG000|COMPLETED|Testing and Therapy Period 2||6
10160217|NCT02935842|11290761|FG001|COMPLETED|Testing and Therapy Period 2||6
10160218|NCT02935842|11290762|FG002|COMPLETED|Testing and Therapy Period 2||6
10160219|NCT02935842|11290763|FG003|COMPLETED|Testing and Therapy Period 2||0
10160220|NCT02935842|11290760|FG000|NOT COMPLETED|Testing and Therapy Period 2||2
10160221|NCT02935842|11290761|FG001|NOT COMPLETED|Testing and Therapy Period 2||0
10160222|NCT02935842|11290762|FG002|NOT COMPLETED|Testing and Therapy Period 2||0
10160223|NCT02935842|11290763|FG003|NOT COMPLETED|Testing and Therapy Period 2||0
10160224|NCT02935842|11290760|FG000|STARTED|Testing and Therapy Period 3||6
10160225|NCT02935842|11290761|FG001|STARTED|Testing and Therapy Period 3||6
10160226|NCT02935842|11290762|FG002|STARTED|Testing and Therapy Period 3||6
10160227|NCT02935842|11290763|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
10160228|NCT02935842|11290760|FG000|COMPLETED|Testing and Therapy Period 3||3
10160229|NCT02935842|11290761|FG001|COMPLETED|Testing and Therapy Period 3||2
10160230|NCT02935842|11290762|FG002|COMPLETED|Testing and Therapy Period 3||1
10160231|NCT02935842|11290763|FG003|COMPLETED|Testing and Therapy Period 3||17
10160232|NCT02935842|11290760|FG000|NOT COMPLETED|Testing and Therapy Period 3||3
10160233|NCT02935842|11290761|FG001|NOT COMPLETED|Testing and Therapy Period 3||4
10160234|NCT02935842|11290762|FG002|NOT COMPLETED|Testing and Therapy Period 3||5
10160235|NCT02935842|11290763|FG003|NOT COMPLETED|Testing and Therapy Period 3||1
10160236|NCT02935894|11290780|FG000|STARTED|Overall Study||14
10160237|NCT02935894|11290780|FG000|COMPLETED|Overall Study||13
10160238|NCT02935894|11290780|FG000|NOT COMPLETED|Overall Study||1
10160239|NCT02936037|11290786|FG000|STARTED|Double-Blind Treatment Period||316
10160240|NCT02936037|11290787|FG001|STARTED|Double-Blind Treatment Period||326
10160241|NCT02936037|11290786|FG000|COMPLETED|Double-Blind Treatment Period||267
10160242|NCT02936037|11290787|FG001|COMPLETED|Double-Blind Treatment Period||261
10160243|NCT02936037|11290786|FG000|NOT COMPLETED|Double-Blind Treatment Period||49
10160244|NCT02936037|11290787|FG001|NOT COMPLETED|Double-Blind Treatment Period||65
10160245|NCT02936037|11290786|FG000|STARTED|Open Label Extension||0
10160246|NCT02936037|11290787|FG001|STARTED|Open Label Extension||528
10160247|NCT02936037|11290786|FG000|COMPLETED|Open Label Extension||0
10160248|NCT02936037|11290787|FG001|COMPLETED|Open Label Extension||518
10160249|NCT02936037|11290786|FG000|NOT COMPLETED|Open Label Extension||0
10160250|NCT02936037|11290787|FG001|NOT COMPLETED|Open Label Extension||10
10160251|NCT02936076|11290795|FG000|STARTED|Overall Study||25
10160252|NCT02936076|11290796|FG001|STARTED|Overall Study||24
10160253|NCT02936076|11290795|FG000|COMPLETED|Overall Study||19
10160254|NCT02936076|11290796|FG001|COMPLETED|Overall Study||20
10160255|NCT02936076|11290795|FG000|NOT COMPLETED|Overall Study||6
10160256|NCT02936076|11290796|FG001|NOT COMPLETED|Overall Study||4
10160257|NCT02936479|11290802|FG000|STARTED|Overall Study||1
10160258|NCT02936479|11290802|FG000|COMPLETED|Overall Study||1
10160259|NCT02936479|11290802|FG000|NOT COMPLETED|Overall Study||0
10160260|NCT02936635|11290808|FG000|STARTED|Overall Study||115
10160261|NCT02936635|11290809|FG001|STARTED|Overall Study||165
10160262|NCT02936635|11290808|FG000|COMPLETED|Overall Study||0
10160263|NCT02936635|11290809|FG001|COMPLETED|Overall Study||0
10160264|NCT02936635|11290808|FG000|NOT COMPLETED|Overall Study||115
10160265|NCT02936635|11290809|FG001|NOT COMPLETED|Overall Study||165
10160266|NCT02936648|11290815|FG000|STARTED|Overall Study||2209
10160267|NCT02936648|11290815|FG000|COMPLETED|Overall Study||2209
10160268|NCT02936648|11290815|FG000|NOT COMPLETED|Overall Study||0
10160269|NCT02936869|11290821|FG000|STARTED|Overall Study||104
10160270|NCT02936869|11290822|FG001|STARTED|Overall Study||103
10160271|NCT02936869|11290821|FG000|COMPLETED|Overall Study||102
10160272|NCT02936869|11290822|FG001|COMPLETED|Overall Study||98
10160273|NCT02936869|11290821|FG000|NOT COMPLETED|Overall Study||2
10160274|NCT02936869|11290822|FG001|NOT COMPLETED|Overall Study||5
10160275|NCT02937116|11290841|FG000|STARTED|Overall Study||3
10160276|NCT02937116|11290842|FG001|STARTED|Overall Study||3
10160277|NCT02937116|11290843|FG002|STARTED|Overall Study||3
10160278|NCT02937116|11290844|FG003|STARTED|Overall Study||3
10160279|NCT02937116|11290845|FG004|STARTED|Overall Study||22
10160280|NCT02937116|11290846|FG005|STARTED|Overall Study||87
10160281|NCT02937116|11290847|FG006|STARTED|Overall Study||37
10160282|NCT02937116|11290848|FG007|STARTED|Overall Study||21
10160283|NCT02937116|11290849|FG008|STARTED|Overall Study||20
10160284|NCT02937116|11290850|FG009|STARTED|Overall Study||20
10160285|NCT02937116|11290851|FG010|STARTED|Overall Study||7
10160286|NCT02937116|11290852|FG011|STARTED|Overall Study||7
10160287|NCT02937116|11290841|FG000|COMPLETED|Overall Study||0
10160288|NCT02937116|11290842|FG001|COMPLETED|Overall Study||0
10160289|NCT02937116|11290843|FG002|COMPLETED|Overall Study||0
10160290|NCT02937116|11290844|FG003|COMPLETED|Overall Study||0
10160291|NCT02937116|11290845|FG004|COMPLETED|Overall Study||0
10160292|NCT02937116|11290846|FG005|COMPLETED|Overall Study||0
10160293|NCT02937116|11290847|FG006|COMPLETED|Overall Study||0
10160294|NCT02937116|11290848|FG007|COMPLETED|Overall Study||0
10160295|NCT02937116|11290849|FG008|COMPLETED|Overall Study||0
10160296|NCT02937116|11290850|FG009|COMPLETED|Overall Study||0
10160297|NCT02937116|11290851|FG010|COMPLETED|Overall Study||0
10160298|NCT02937116|11290852|FG011|COMPLETED|Overall Study||0
10160299|NCT02937116|11290841|FG000|NOT COMPLETED|Overall Study||3
10160300|NCT02937116|11290842|FG001|NOT COMPLETED|Overall Study||3
10160301|NCT02937116|11290843|FG002|NOT COMPLETED|Overall Study||3
10160302|NCT02937116|11290844|FG003|NOT COMPLETED|Overall Study||3
10160303|NCT02937116|11290845|FG004|NOT COMPLETED|Overall Study||22
10160304|NCT02937116|11290846|FG005|NOT COMPLETED|Overall Study||87
10160305|NCT02937116|11290847|FG006|NOT COMPLETED|Overall Study||37
10160306|NCT02937116|11290848|FG007|NOT COMPLETED|Overall Study||21
10160307|NCT02937116|11290849|FG008|NOT COMPLETED|Overall Study||20
10160308|NCT02937116|11290850|FG009|NOT COMPLETED|Overall Study||20
10160309|NCT02937116|11290851|FG010|NOT COMPLETED|Overall Study||7
10160310|NCT02937116|11290852|FG011|NOT COMPLETED|Overall Study||7
10160311|NCT02937168|11290878|FG000|STARTED|PET/CT Screening Period (21 Days)||5
10160312|NCT02937168|11290879|FG001|STARTED|PET/CT Screening Period (21 Days)||0
10160313|NCT02937168|11290880|FG002|STARTED|PET/CT Screening Period (21 Days)||0
10160314|NCT02937168|11290878|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5
10160315|NCT02937168|11290879|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0
10160316|NCT02937168|11290880|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0
10160317|NCT02937168|11290878|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
10160318|NCT02937168|11290879|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
10160319|NCT02937168|11290880|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
10160320|NCT02937168|11290878|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0
10160321|NCT02937168|11290879|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0
10160322|NCT02937168|11290880|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0
10160323|NCT02937168|11290878|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10160324|NCT02937168|11290879|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10160325|NCT02937168|11290880|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10160326|NCT02937168|11290878|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10160327|NCT02937168|11290879|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10160328|NCT02937168|11290880|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10160329|NCT02937194|11290888|FG000|STARTED|1-year Followup||294
10160330|NCT02937194|11290889|FG001|STARTED|1-year Followup||286
10160331|NCT02937194|11290888|FG000|COMPLETED|1-year Followup||223
10160332|NCT02937194|11290889|FG001|COMPLETED|1-year Followup||218
10160333|NCT02937194|11290888|FG000|NOT COMPLETED|1-year Followup||71
10160334|NCT02937194|11290889|FG001|NOT COMPLETED|1-year Followup||68
10160335|NCT02937194|11290888|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
10197335|NCT03373240|11325293|FG001|4-week Post Treatment|Overall Study||23
10197336|NCT03373240|11325292|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11
10160336|NCT02937194|11290889|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
10160337|NCT02937194|11290888|FG000|COMPLETED|2-years Followup||216
10160338|NCT02937194|11290889|FG001|COMPLETED|2-years Followup||208
10160339|NCT02937194|11290888|FG000|NOT COMPLETED|2-years Followup||78
10160340|NCT02937194|11290889|FG001|NOT COMPLETED|2-years Followup||78
10160341|NCT02937194|11290888|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
10160342|NCT02937194|11290889|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
10160343|NCT02937194|11290888|FG000|COMPLETED|3-years Followup||228
10160344|NCT02937194|11290889|FG001|COMPLETED|3-years Followup||208
10160345|NCT02937194|11290888|FG000|NOT COMPLETED|3-years Followup||66
10160346|NCT02937194|11290889|FG001|NOT COMPLETED|3-years Followup||78
10160347|NCT02937350|11290898|FG000|STARTED|Overall Study||43
10160348|NCT02937350|11290899|FG001|STARTED|Overall Study||25
10160349|NCT02937350|11290900|FG002|STARTED|Overall Study||20
10160350|NCT02937350|11290898|FG000|COMPLETED|Overall Study||43
10160351|NCT02937350|11290899|FG001|COMPLETED|Overall Study||24
9849349|NCT00864383|10962040|FG000|STARTED|Per- Protocol||640
9849350|NCT00864383|10962041|FG001|STARTED|Per- Protocol||655
9849351|NCT00864383|10962042|FG002|STARTED|Per- Protocol||636
9849352|NCT00864383|10962040|FG000|COMPLETED|Per- Protocol||510
9849353|NCT00864383|10962041|FG001|COMPLETED|Per- Protocol||514
10160352|NCT02937350|11290900|FG002|COMPLETED|Overall Study||20
10160353|NCT02937350|11290898|FG000|NOT COMPLETED|Overall Study||0
10160354|NCT02937350|11290899|FG001|NOT COMPLETED|Overall Study||1
10160355|NCT02937350|11290900|FG002|NOT COMPLETED|Overall Study||0
10160356|NCT02937454|11290908|FG000|STARTED|Overall Study||567
10160357|NCT02937454|11290909|FG001|STARTED|Overall Study||565
10160358|NCT02937454|11290908|FG000|Started Treatment|Overall Study||559
10160359|NCT02937454|11290909|FG001|Started Treatment|Overall Study||551
10160360|NCT02937454|11290908|FG000|COMPLETED|Overall Study||427
10160361|NCT02937454|11290909|FG001|COMPLETED|Overall Study||437
10160362|NCT02937454|11290908|FG000|NOT COMPLETED|Overall Study||140
10160363|NCT02937454|11290909|FG001|NOT COMPLETED|Overall Study||128
10160364|NCT02937506|11290918|FG000|STARTED|Overall Study||300
10160365|NCT02937506|11290919|FG001|STARTED|Overall Study||300
10160366|NCT02937506|11290918|FG000|COMPLETED|Overall Study||300
10160367|NCT02937506|11290919|FG001|COMPLETED|Overall Study||300
10160368|NCT02937506|11290918|FG000|NOT COMPLETED|Overall Study||0
10160369|NCT02937506|11290919|FG001|NOT COMPLETED|Overall Study||0
10160370|NCT02937545|11290927|FG000|STARTED|Overall Study||69
10160371|NCT02937545|11290928|FG001|STARTED|Overall Study||85
10160372|NCT02937545|11290929|FG002|STARTED|Overall Study||15
10160373|NCT02937545|11290930|FG003|STARTED|Overall Study||21
10160374|NCT02937545|11290927|FG000|COMPLETED|Overall Study||67
10160375|NCT02937545|11290928|FG001|COMPLETED|Overall Study||83
10160376|NCT02937545|11290929|FG002|COMPLETED|Overall Study||9
10160377|NCT02937545|11290930|FG003|COMPLETED|Overall Study||14
10160378|NCT02937545|11290927|FG000|NOT COMPLETED|Overall Study||2
10160379|NCT02937545|11290928|FG001|NOT COMPLETED|Overall Study||2
10160380|NCT02937545|11290929|FG002|NOT COMPLETED|Overall Study||6
10160381|NCT02937545|11290930|FG003|NOT COMPLETED|Overall Study||7
10160382|NCT02937558|11290943|FG000|STARTED|Double-blind Phase||3
10160383|NCT02937558|11290944|FG001|STARTED|Double-blind Phase||2
10160384|NCT02937558|11290943|FG000|COMPLETED|Double-blind Phase||3
10160385|NCT02937558|11290944|FG001|COMPLETED|Double-blind Phase||2
10160386|NCT02937558|11290943|FG000|NOT COMPLETED|Double-blind Phase||0
10160387|NCT02937558|11290944|FG001|NOT COMPLETED|Double-blind Phase||0
10160388|NCT02937558|11290943|FG000|STARTED|Open-label Phase||5
10160389|NCT02937558|11290944|FG001|STARTED|Open-label Phase||0
10160390|NCT02937558|11290943|FG000|COMPLETED|Open-label Phase||5
10160391|NCT02937558|11290944|FG001|COMPLETED|Open-label Phase||0
10160392|NCT02937558|11290943|FG000|NOT COMPLETED|Open-label Phase||0
10160393|NCT02937558|11290944|FG001|NOT COMPLETED|Open-label Phase||0
10160394|NCT02937584|11290951|FG000|STARTED|Period 1||11
10160395|NCT02937584|11290952|FG001|STARTED|Period 1||12
10160396|NCT02937584|11290951|FG000|COMPLETED|Period 1||10
10160397|NCT02937584|11290952|FG001|COMPLETED|Period 1||10
10160398|NCT02937584|11290951|FG000|NOT COMPLETED|Period 1||1
10160399|NCT02937584|11290952|FG001|NOT COMPLETED|Period 1||2
10160400|NCT02937584|11290951|FG000|STARTED|Washout||10
10160401|NCT02937584|11290952|FG001|STARTED|Washout||10
10160402|NCT02937584|11290951|FG000|COMPLETED|Washout||10
10160403|NCT02937584|11290952|FG001|COMPLETED|Washout||9
10160404|NCT02937584|11290951|FG000|NOT COMPLETED|Washout||0
10160405|NCT02937584|11290952|FG001|NOT COMPLETED|Washout||1
10160406|NCT02937584|11290951|FG000|STARTED|Period 2||10
10160407|NCT02937584|11290952|FG001|STARTED|Period 2||9
10160408|NCT02937584|11290951|FG000|COMPLETED|Period 2||10
10160409|NCT02937584|11290952|FG001|COMPLETED|Period 2||9
10160410|NCT02937584|11290951|FG000|NOT COMPLETED|Period 2||0
10160411|NCT02937584|11290952|FG001|NOT COMPLETED|Period 2||0
10160412|NCT02937623|11290960|FG000|STARTED|Overall Study||60
10160413|NCT02937623|11290961|FG001|STARTED|Overall Study||60
10160414|NCT02937623|11290960|FG000|COMPLETED|Overall Study||60
10160415|NCT02937623|11290961|FG001|COMPLETED|Overall Study||60
10160416|NCT02937623|11290960|FG000|NOT COMPLETED|Overall Study||0
10160417|NCT02937623|11290961|FG001|NOT COMPLETED|Overall Study||0
10160418|NCT02937636|11290969|FG000|STARTED|Overall Study||63
10160419|NCT02937636|11290970|FG001|STARTED|Overall Study||65
10160420|NCT02937636|11290969|FG000|COMPLETED|Overall Study||60
10160421|NCT02937636|11290970|FG001|COMPLETED|Overall Study||63
10160422|NCT02937636|11290969|FG000|NOT COMPLETED|Overall Study||3
10160423|NCT02937636|11290970|FG001|NOT COMPLETED|Overall Study||2
10160424|NCT02937701|11290979|FG000|STARTED|Day 1 to Week 22||279
10160425|NCT02937701|11290980|FG001|STARTED|Day 1 to Week 22||279
10160426|NCT02937701|11290981|FG002|STARTED|Day 1 to Week 22||0
10160427|NCT02937701|11290982|FG003|STARTED|Day 1 to Week 22||0
10160428|NCT02937701|11290983|FG004|STARTED|Day 1 to Week 22||0
10160429|NCT02937701|11290979|FG000|Received Treatment|Day 1 to Week 22||278
10160430|NCT02937701|11290980|FG001|Received Treatment|Day 1 to Week 22||278
10160431|NCT02937701|11290981|FG002|Received Treatment|Day 1 to Week 22||0
10160432|NCT02937701|11290982|FG003|Received Treatment|Day 1 to Week 22||0
10160433|NCT02937701|11290983|FG004|Received Treatment|Day 1 to Week 22||0
10160434|NCT02937701|11290979|FG000|COMPLETED|Day 1 to Week 22||244
10160435|NCT02937701|11290980|FG001|COMPLETED|Day 1 to Week 22||240
10160436|NCT02937701|11290981|FG002|COMPLETED|Day 1 to Week 22||0
10160437|NCT02937701|11290982|FG003|COMPLETED|Day 1 to Week 22||0
10160438|NCT02937701|11290983|FG004|COMPLETED|Day 1 to Week 22||0
10160439|NCT02937701|11290979|FG000|NOT COMPLETED|Day 1 to Week 22||35
10160440|NCT02937701|11290980|FG001|NOT COMPLETED|Day 1 to Week 22||39
10160441|NCT02937701|11290981|FG002|NOT COMPLETED|Day 1 to Week 22||0
10160442|NCT02937701|11290982|FG003|NOT COMPLETED|Day 1 to Week 22||0
10160443|NCT02937701|11290983|FG004|NOT COMPLETED|Day 1 to Week 22||0
10160444|NCT02937701|11290979|FG000|STARTED|Week 22 to Week 50||0
10160445|NCT02937701|11290980|FG001|STARTED|Week 22 to Week 50||0
10160446|NCT02937701|11290981|FG002|STARTED|Week 22 to Week 50||244
10160447|NCT02937701|11290982|FG003|STARTED|Week 22 to Week 50||121
10160448|NCT02937701|11290983|FG004|STARTED|Week 22 to Week 50||119
10160449|NCT02937701|11290979|FG000|COMPLETED|Week 22 to Week 50||0
10160450|NCT02937701|11290980|FG001|COMPLETED|Week 22 to Week 50||0
10160451|NCT02937701|11290981|FG002|COMPLETED|Week 22 to Week 50||212
10160452|NCT02937701|11290982|FG003|COMPLETED|Week 22 to Week 50||113
10160453|NCT02937701|11290983|FG004|COMPLETED|Week 22 to Week 50||110
10160454|NCT02937701|11290979|FG000|NOT COMPLETED|Week 22 to Week 50||0
10160455|NCT02937701|11290980|FG001|NOT COMPLETED|Week 22 to Week 50||0
10160456|NCT02937701|11290981|FG002|NOT COMPLETED|Week 22 to Week 50||32
10160457|NCT02937701|11290982|FG003|NOT COMPLETED|Week 22 to Week 50||8
10160458|NCT02937701|11290983|FG004|NOT COMPLETED|Week 22 to Week 50||9
10160459|NCT02937740|11290997|FG000|STARTED|BID for 90 Days, 22 mg/Day||24
10160460|NCT02937740|11290998|FG001|STARTED|BID for 90 Days, 22 mg/Day||93
10160461|NCT02937740|11290997|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19
10160462|NCT02937740|11290998|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62
10160463|NCT02937740|11290997|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
10160464|NCT02937740|11290998|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
10160465|NCT02937740|11290997|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
10160466|NCT02937740|11290998|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
10160467|NCT02937740|11290997|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
10160468|NCT02937740|11290998|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
10160469|NCT02937740|11290997|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
10160470|NCT02937740|11290998|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
10160471|NCT02937870|11291010|FG000|STARTED|Overall Study||23
10160472|NCT02937870|11291010|FG000|Received Test Adhesive 1|Overall Study||21
10160473|NCT02937870|11291010|FG000|Received Test Adhesive 2|Overall Study||22
10160474|NCT02937870|11291010|FG000|Received Positive Control Adhesive|Overall Study||21
10160475|NCT02937870|11291010|FG000|Received no Adhesive|Overall Study||20
10160476|NCT02937870|11291010|FG000|COMPLETED|Overall Study||20
10160477|NCT02937870|11291010|FG000|NOT COMPLETED|Overall Study||3
10160478|NCT02938052|11291024|FG000|STARTED|Overall Study||10
10160479|NCT02938052|11291024|FG000|COMPLETED|Overall Study||10
10160480|NCT02938052|11291024|FG000|NOT COMPLETED|Overall Study||0
10160481|NCT02938169|11291033|FG000|STARTED|Overall Study||15
10160482|NCT02938169|11291034|FG001|STARTED|Overall Study||15
10160483|NCT02938169|11291035|FG002|STARTED|Overall Study||15
10160484|NCT02938169|11291036|FG003|STARTED|Overall Study||15
10160485|NCT02938169|11291033|FG000|COMPLETED|Overall Study||13
10160486|NCT02938169|11291034|FG001|COMPLETED|Overall Study||13
10160487|NCT02938169|11291035|FG002|COMPLETED|Overall Study||10
10160488|NCT02938169|11291036|FG003|COMPLETED|Overall Study||12
10160489|NCT02938169|11291033|FG000|NOT COMPLETED|Overall Study||2
10160490|NCT02938169|11291034|FG001|NOT COMPLETED|Overall Study||2
10160491|NCT02938169|11291035|FG002|NOT COMPLETED|Overall Study||5
10160492|NCT02938169|11291036|FG003|NOT COMPLETED|Overall Study||3
10160493|NCT02938494|11291057|FG000|STARTED|Overall Study||69
10160494|NCT02938494|11291058|FG001|STARTED|Overall Study||72
10160495|NCT02938494|11291059|FG002|STARTED|Overall Study||34
10160496|NCT02938494|11291060|FG003|STARTED|Overall Study||35
10160497|NCT02938494|11291057|FG000|COMPLETED|Overall Study||65
10160498|NCT02938494|11291058|FG001|COMPLETED|Overall Study||63
10160499|NCT02938494|11291059|FG002|COMPLETED|Overall Study||30
10160500|NCT02938494|11291060|FG003|COMPLETED|Overall Study||31
10160501|NCT02938494|11291057|FG000|NOT COMPLETED|Overall Study||4
10160502|NCT02938494|11291058|FG001|NOT COMPLETED|Overall Study||9
9710583|NCT04615832|10810219|FG000|STARTED|Overall Study||44
9710584|NCT04615832|10810219|FG000|COMPLETED|Overall Study||44
9710585|NCT04615832|10810219|FG000|NOT COMPLETED|Overall Study||0
9710586|NCT04093258|10810223|FG000|STARTED|Period 1||21
9710587|NCT04093258|10810224|FG001|STARTED|Period 1||20
9710588|NCT04093258|10810223|FG000|COMPLETED|Period 1||21
9710589|NCT04093258|10810224|FG001|COMPLETED|Period 1||20
9710590|NCT04093258|10810223|FG000|NOT COMPLETED|Period 1||0
9710591|NCT04093258|10810224|FG001|NOT COMPLETED|Period 1||0
9710592|NCT04093258|10810223|FG000|STARTED|Period 2||21
9710593|NCT04093258|10810224|FG001|STARTED|Period 2||20
9710594|NCT04093258|10810223|FG000|COMPLETED|Period 2||20
10160503|NCT02938494|11291059|FG002|NOT COMPLETED|Overall Study||4
10160504|NCT02938494|11291060|FG003|NOT COMPLETED|Overall Study||4
10160505|NCT02938585|11291073|FG000|STARTED|Overall Study||9
10160506|NCT02938585|11291074|FG001|STARTED|Overall Study||33
10160507|NCT02938585|11291075|FG002|STARTED|Overall Study||11
10160508|NCT02938585|11291076|FG003|STARTED|Overall Study||15
10160509|NCT02938585|11291073|FG000|Exposed to Prophylaxis Regimen|Overall Study||9
10160510|NCT02938585|11291074|FG001|Exposed to Prophylaxis Regimen|Overall Study||31
10160511|NCT02938585|11291075|FG002|Exposed to Prophylaxis Regimen|Overall Study||11
10160512|NCT02938585|11291076|FG003|Exposed to Prophylaxis Regimen|Overall Study||12
10160513|NCT02938585|11291073|FG000|Exposed to On-demand Regimen|Overall Study||1
9710595|NCT04093258|10810224|FG001|COMPLETED|Period 2||20
9710596|NCT04093258|10810223|FG000|NOT COMPLETED|Period 2||1
9710597|NCT04093258|10810224|FG001|NOT COMPLETED|Period 2||0
10160514|NCT02938585|11291074|FG001|Exposed to On-demand Regimen|Overall Study||7
10160515|NCT02938585|11291075|FG002|Exposed to On-demand Regimen|Overall Study||1
10160516|NCT02938585|11291076|FG003|Exposed to On-demand Regimen|Overall Study||8
9710598|NCT04011826|10810230|FG000|STARTED|Overall Study||45
10160517|NCT02938585|11291073|FG000|COMPLETED|Overall Study||9
10160518|NCT02938585|11291074|FG001|COMPLETED|Overall Study||32
10160519|NCT02938585|11291075|FG002|COMPLETED|Overall Study||11
10160520|NCT02938585|11291076|FG003|COMPLETED|Overall Study||10
10160521|NCT02938585|11291073|FG000|NOT COMPLETED|Overall Study||0
10160522|NCT02938585|11291074|FG001|NOT COMPLETED|Overall Study||1
10160523|NCT02938585|11291075|FG002|NOT COMPLETED|Overall Study||0
10160524|NCT02938585|11291076|FG003|NOT COMPLETED|Overall Study||5
10160525|NCT02938949|11291102|FG000|STARTED|Overall Study||10
10160526|NCT02938949|11291103|FG001|STARTED|Overall Study||10
10160527|NCT02938949|11291102|FG000|COMPLETED|Overall Study||10
10160528|NCT02938949|11291103|FG001|COMPLETED|Overall Study||10
10160529|NCT02938949|11291102|FG000|NOT COMPLETED|Overall Study||0
10160530|NCT02938949|11291103|FG001|NOT COMPLETED|Overall Study||0
10160531|NCT02939014|11291111|FG000|STARTED|Overall Study||30
10160532|NCT02939014|11291112|FG001|STARTED|Overall Study||9
10160533|NCT02939014|11291111|FG000|COMPLETED|Overall Study||25
10160534|NCT02939014|11291112|FG001|COMPLETED|Overall Study||6
10160535|NCT02939014|11291111|FG000|NOT COMPLETED|Overall Study||5
10160536|NCT02939014|11291112|FG001|NOT COMPLETED|Overall Study||3
10160537|NCT02939079|11291121|FG000|STARTED|Overall Study||25
10160538|NCT02939079|11291122|FG001|STARTED|Overall Study||25
10160539|NCT02939079|11291121|FG000|COMPLETED|Overall Study||21
10160540|NCT02939079|11291122|FG001|COMPLETED|Overall Study||20
10160541|NCT02939079|11291121|FG000|NOT COMPLETED|Overall Study||4
10160542|NCT02939079|11291122|FG001|NOT COMPLETED|Overall Study||5
10160543|NCT02939105|11291128|FG000|STARTED|Overall Study||15
10160544|NCT02939105|11291128|FG000|COMPLETED|Overall Study||15
10160545|NCT02939105|11291128|FG000|NOT COMPLETED|Overall Study||0
10160546|NCT02939131|11291135|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
10160547|NCT02939131|11291136|FG001|STARTED|Overall Study||75
10160548|NCT02939131|11291135|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
10160549|NCT02939131|11291136|FG001|Week 24 Visit|Overall Study||72
10160550|NCT02939131|11291135|FG000|COMPLETED|Overall Study||70
10160551|NCT02939131|11291136|FG001|COMPLETED|Overall Study||66
10160552|NCT02939131|11291135|FG000|NOT COMPLETED|Overall Study||11
10160553|NCT02939131|11291136|FG001|NOT COMPLETED|Overall Study||9
9849354|NCT00864383|10962042|FG002|COMPLETED|Per- Protocol||524
9849355|NCT00864383|10962040|FG000|NOT COMPLETED|Per- Protocol||130
10160554|NCT02939170|11291145|FG000|STARTED|Overall Study||40
10160555|NCT02939170|11291146|FG001|STARTED|Overall Study||40
10160556|NCT02939170|11291145|FG000|COMPLETED|Overall Study||40
10160557|NCT02939170|11291146|FG001|COMPLETED|Overall Study||40
10160558|NCT02939170|11291145|FG000|NOT COMPLETED|Overall Study||0
10160559|NCT02939170|11291146|FG001|NOT COMPLETED|Overall Study||0
10160560|NCT02939326|11291161|FG000|STARTED|Overall Study||7
10160561|NCT02939326|11291162|FG001|STARTED|Overall Study||5
10160562|NCT02939326|11291163|FG002|STARTED|Overall Study||5
10160563|NCT02939326|11291164|FG003|STARTED|Overall Study||5
10160564|NCT02939326|11291165|FG004|STARTED|Overall Study||5
10160565|NCT02939326|11291166|FG005|STARTED|Overall Study||5
10160566|NCT02939326|11291167|FG006|STARTED|Overall Study||5
10160567|NCT02939326|11291168|FG007|STARTED|Overall Study||5
10160568|NCT02939326|11291161|FG000|COMPLETED|Overall Study||7
10160569|NCT02939326|11291162|FG001|COMPLETED|Overall Study||5
10160570|NCT02939326|11291163|FG002|COMPLETED|Overall Study||5
10160571|NCT02939326|11291164|FG003|COMPLETED|Overall Study||5
10160572|NCT02939326|11291165|FG004|COMPLETED|Overall Study||5
10160573|NCT02939326|11291166|FG005|COMPLETED|Overall Study||5
10160574|NCT02939326|11291167|FG006|COMPLETED|Overall Study||5
10160575|NCT02939326|11291168|FG007|COMPLETED|Overall Study||5
10160576|NCT02939326|11291161|FG000|NOT COMPLETED|Overall Study||0
10160577|NCT02939326|11291162|FG001|NOT COMPLETED|Overall Study||0
10160578|NCT02939326|11291163|FG002|NOT COMPLETED|Overall Study||0
10160579|NCT02939326|11291164|FG003|NOT COMPLETED|Overall Study||0
10160580|NCT02939326|11291165|FG004|NOT COMPLETED|Overall Study||0
10160581|NCT02939326|11291166|FG005|NOT COMPLETED|Overall Study||0
10160582|NCT02939326|11291167|FG006|NOT COMPLETED|Overall Study||0
10160583|NCT02939326|11291168|FG007|NOT COMPLETED|Overall Study||0
10160584|NCT02939560|11291186|FG000|STARTED|Overall Study||13
10160585|NCT02939560|11291186|FG000|COMPLETED|Overall Study||10
10160586|NCT02939560|11291186|FG000|NOT COMPLETED|Overall Study||3
10160587|NCT02939599|11291192|FG000|STARTED|Overall Study||3
10160588|NCT02939599|11291193|FG001|STARTED|Overall Study||2
10160589|NCT02939599|11291192|FG000|COMPLETED|Overall Study||0
10160590|NCT02939599|11291193|FG001|COMPLETED|Overall Study||0
10160591|NCT02939599|11291192|FG000|NOT COMPLETED|Overall Study||3
10160592|NCT02939599|11291193|FG001|NOT COMPLETED|Overall Study||2
10160593|NCT02939651|11291200|FG000|STARTED|Overall Study||21
9849356|NCT00864383|10962041|FG001|NOT COMPLETED|Per- Protocol||141
10160594|NCT02939651|11291200|FG000|COMPLETED|Overall Study||21
10160595|NCT02939651|11291200|FG000|NOT COMPLETED|Overall Study||0
10160596|NCT02939716|11291204|FG000|STARTED|Overall Study||3
10160597|NCT02939716|11291205|FG001|STARTED|Overall Study||3
10160598|NCT02939716|11291206|FG002|STARTED|Overall Study||3
10160599|NCT02939716|11291207|FG003|STARTED|Overall Study||3
10160600|NCT02939716|11291208|FG004|STARTED|Overall Study||3
10160601|NCT02939716|11291209|FG005|STARTED|Overall Study||3
10160602|NCT02939716|11291204|FG000|COMPLETED|Overall Study||3
10160603|NCT02939716|11291205|FG001|COMPLETED|Overall Study||3
10160604|NCT02939716|11291206|FG002|COMPLETED|Overall Study||3
10160605|NCT02939716|11291207|FG003|COMPLETED|Overall Study||2
10160606|NCT02939716|11291208|FG004|COMPLETED|Overall Study||2
10160607|NCT02939716|11291209|FG005|COMPLETED|Overall Study||2
10160608|NCT02939716|11291204|FG000|NOT COMPLETED|Overall Study||0
10160609|NCT02939716|11291205|FG001|NOT COMPLETED|Overall Study||0
10160610|NCT02939716|11291206|FG002|NOT COMPLETED|Overall Study||0
10160611|NCT02939716|11291207|FG003|NOT COMPLETED|Overall Study||1
10160612|NCT02939716|11291208|FG004|NOT COMPLETED|Overall Study||1
10160613|NCT02939716|11291209|FG005|NOT COMPLETED|Overall Study||1
10160614|NCT02939781|11291226|FG000|STARTED|Overall Study||12
10160615|NCT02939781|11291226|FG000|COMPLETED|Overall Study||3
10160616|NCT02939781|11291226|FG000|NOT COMPLETED|Overall Study||9
10160617|NCT02939937|11291233|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
10160618|NCT02939937|11291234|FG001|STARTED|Overall Study|3 patients excluded from study|50
10160619|NCT02939937|11291233|FG000|COMPLETED|Overall Study||15
10160620|NCT02939937|11291234|FG001|COMPLETED|Overall Study||47
10160621|NCT02939937|11291233|FG000|NOT COMPLETED|Overall Study||6
10160622|NCT02939937|11291234|FG001|NOT COMPLETED|Overall Study||3
10160623|NCT02939950|11291242|FG000|STARTED|Overall Study||406
10160624|NCT02939950|11291243|FG001|STARTED|Overall Study||410
10160625|NCT02939950|11291242|FG000|Dispensed the Assigned Lenses|Overall Study||405
10160626|NCT02939950|11291243|FG001|Dispensed the Assigned Lenses|Overall Study||410
10160627|NCT02939950|11291242|FG000|Eligible at Baseline|Overall Study||403
10160628|NCT02939950|11291243|FG001|Eligible at Baseline|Overall Study||402
10160629|NCT02939950|11291242|FG000|COMPLETED|Overall Study||340
10160630|NCT02939950|11291243|FG001|COMPLETED|Overall Study||329
9710599|NCT04011826|10810230|FG000|COMPLETED|Overall Study||45
9710600|NCT04011826|10810230|FG000|NOT COMPLETED|Overall Study||0
9710601|NCT03993379|10810238|FG000|STARTED|Overall Study||0
9710602|NCT03993379|10810239|FG001|STARTED|Overall Study||3
9710603|NCT03993379|10810240|FG002|STARTED|Overall Study||0
9710604|NCT03993379|10810241|FG003|STARTED|Overall Study||0
9710605|NCT03993379|10810238|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
9710606|NCT03993379|10810239|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0
9710607|NCT03993379|10810240|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
9710608|NCT03993379|10810241|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
9710609|NCT03993379|10810238|FG000|NOT COMPLETED|Overall Study||0
9710610|NCT03993379|10810239|FG001|NOT COMPLETED|Overall Study||3
9710611|NCT03993379|10810240|FG002|NOT COMPLETED|Overall Study||0
9710612|NCT03993379|10810241|FG003|NOT COMPLETED|Overall Study||0
9710613|NCT03956615|10810251|FG000|STARTED|Overall Study||10
9710614|NCT03956615|10810251|FG000|COMPLETED|Overall Study||3
9710615|NCT03956615|10810251|FG000|NOT COMPLETED|Overall Study||7
9710616|NCT03803059|10810255|FG000|STARTED|Overall Study||35
9710617|NCT03803059|10810255|FG000|COMPLETED|Overall Study||32
9710618|NCT03803059|10810255|FG000|NOT COMPLETED|Overall Study||3
9710619|NCT03723590|10810260|FG000|STARTED|Overall Study||5
9710620|NCT03723590|10810260|FG000|COMPLETED|Overall Study||2
9710621|NCT03723590|10810260|FG000|NOT COMPLETED|Overall Study||3
9710622|NCT03720392|10810266|FG000|STARTED|Overall Study||3
9710623|NCT03720392|10810267|FG001|STARTED|Overall Study||3
9710624|NCT03720392|10810266|FG000|COMPLETED|Overall Study||3
10061040|NCT02101060|11186596|FG001|STARTED|Overall Study||16
10061041|NCT02101060|11186595|FG000|COMPLETED|Overall Study||12
10061042|NCT02101060|11186596|FG001|COMPLETED|Overall Study||12
10061043|NCT02101060|11186595|FG000|NOT COMPLETED|Overall Study||5
10061044|NCT02101060|11186596|FG001|NOT COMPLETED|Overall Study||4
10061045|NCT02101112|11186602|FG000|STARTED|Overall Study||6
10061046|NCT02101112|11186603|FG001|STARTED|Overall Study||5
10061047|NCT02101112|11186604|FG002|STARTED|Overall Study||6
10061048|NCT02101112|11186605|FG003|STARTED|Overall Study||5
10061049|NCT02101112|11186606|FG004|STARTED|Overall Study||6
10061050|NCT02101112|11186607|FG005|STARTED|Overall Study||5
10061051|NCT02101112|11186602|FG000|COMPLETED|Overall Study||6
10061052|NCT02101112|11186603|FG001|COMPLETED|Overall Study||5
10061053|NCT02101112|11186604|FG002|COMPLETED|Overall Study||5
10061054|NCT02101112|11186605|FG003|COMPLETED|Overall Study||5
10061055|NCT02101112|11186606|FG004|COMPLETED|Overall Study||5
10061056|NCT02101112|11186607|FG005|COMPLETED|Overall Study||5
10061057|NCT02101112|11186602|FG000|NOT COMPLETED|Overall Study||0
10061058|NCT02101112|11186603|FG001|NOT COMPLETED|Overall Study||0
10061059|NCT02101112|11186604|FG002|NOT COMPLETED|Overall Study||1
10061060|NCT02101112|11186605|FG003|NOT COMPLETED|Overall Study||0
10061061|NCT02101112|11186606|FG004|NOT COMPLETED|Overall Study||1
10061062|NCT02101112|11186607|FG005|NOT COMPLETED|Overall Study||0
10160631|NCT02939950|11291242|FG000|NOT COMPLETED|Overall Study||66
10160632|NCT02939950|11291243|FG001|NOT COMPLETED|Overall Study||81
10160633|NCT02940249|11291249|FG000|STARTED|Overall Study||34
10160634|NCT02940249|11291249|FG000|COMPLETED|Overall Study||30
10160635|NCT02940249|11291249|FG000|NOT COMPLETED|Overall Study||4
10160636|NCT02940327|11291259|FG000|STARTED|Overall Study||24
10160637|NCT02940327|11291259|FG000|COMPLETED|Overall Study||24
10160638|NCT02940327|11291259|FG000|NOT COMPLETED|Overall Study||0
10160639|NCT02940392|11291264|FG000|STARTED|Overall Study||15
10160640|NCT02940392|11291264|FG000|COMPLETED|Overall Study||7
10160641|NCT02940392|11291264|FG000|NOT COMPLETED|Overall Study||8
10160642|NCT02940574|11291270|FG000|STARTED|From Study Start to 1-month Follow-up||22
10160643|NCT02940574|11291271|FG001|STARTED|From Study Start to 1-month Follow-up||18
10061063|NCT02101190|11186619|FG000|STARTED|Overall Study||8
10160644|NCT02940574|11291270|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
10160645|NCT02940574|11291271|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
10160646|NCT02940574|11291270|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1
10160647|NCT02940574|11291271|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0
10160648|NCT02940574|11291270|FG000|STARTED|1-year Follow-up||21
10160649|NCT02940574|11291271|FG001|STARTED|1-year Follow-up||18
10160650|NCT02940574|11291270|FG000|COMPLETED|1-year Follow-up||18
10160651|NCT02940574|11291271|FG001|COMPLETED|1-year Follow-up||14
10160652|NCT02940574|11291270|FG000|NOT COMPLETED|1-year Follow-up||3
10160653|NCT02940574|11291271|FG001|NOT COMPLETED|1-year Follow-up||4
10160654|NCT02940626|11291283|FG000|STARTED|Overall Study||77
10160655|NCT02940626|11291284|FG001|STARTED|Overall Study||78
10160656|NCT02940626|11291283|FG000|Randomized Into Primary Prevention Study|Overall Study||77
10160657|NCT02940626|11291284|FG001|Randomized Into Primary Prevention Study|Overall Study||77
10160658|NCT02940626|11291283|FG000|Randomized Into Treatment Sub-study|Overall Study||0
10160659|NCT02940626|11291284|FG001|Randomized Into Treatment Sub-study|Overall Study||1
10160660|NCT02940626|11291283|FG000|Received Study Treatment|Overall Study||77
10160661|NCT02940626|11291284|FG001|Received Study Treatment|Overall Study||77
10160662|NCT02940626|11291283|FG000|Completed Through Study Day 22|Overall Study||42
10160663|NCT02940626|11291284|FG001|Completed Through Study Day 22|Overall Study||49
10160664|NCT02940626|11291283|FG000|COMPLETED|Overall Study||30
10160665|NCT02940626|11291284|FG001|COMPLETED|Overall Study||43
10160666|NCT02940626|11291283|FG000|NOT COMPLETED|Overall Study||47
10160667|NCT02940626|11291284|FG001|NOT COMPLETED|Overall Study||35
10160668|NCT02940691|11291292|FG000|STARTED|Overall Study||32
10160669|NCT02940691|11291292|FG000|COMPLETED|Overall Study||26
10160670|NCT02940691|11291292|FG000|NOT COMPLETED|Overall Study||6
10160671|NCT02940730|11291299|FG000|STARTED|Intervention 1||10
10160672|NCT02940730|11291300|FG001|STARTED|Intervention 1||0
10160673|NCT02940730|11291299|FG000|Received Intervention|Intervention 1||10
10160674|NCT02940730|11291300|FG001|Received Intervention|Intervention 1||0
10160675|NCT02940730|11291299|FG000|COMPLETED|Intervention 1||10
10160676|NCT02940730|11291300|FG001|COMPLETED|Intervention 1||0
10160677|NCT02940730|11291299|FG000|NOT COMPLETED|Intervention 1||0
10160678|NCT02940730|11291300|FG001|NOT COMPLETED|Intervention 1||0
10160679|NCT02940730|11291299|FG000|STARTED|Intervention 2||10
10160680|NCT02940730|11291300|FG001|STARTED|Intervention 2||0
10160681|NCT02940730|11291299|FG000|Received Intervention|Intervention 2||3
10160682|NCT02940730|11291300|FG001|Received Intervention|Intervention 2||0
10160683|NCT02940730|11291299|FG000|COMPLETED|Intervention 2||3
10160684|NCT02940730|11291300|FG001|COMPLETED|Intervention 2||0
10160685|NCT02940730|11291299|FG000|NOT COMPLETED|Intervention 2||7
10160686|NCT02940730|11291300|FG001|NOT COMPLETED|Intervention 2||0
10160687|NCT02940860|11291308|FG000|STARTED|Overall Study||1027
10160688|NCT02940860|11291309|FG001|STARTED|Overall Study||511
10160689|NCT02940860|11291308|FG000|COMPLETED|Overall Study||971
10160690|NCT02940860|11291309|FG001|COMPLETED|Overall Study||476
10160691|NCT02940860|11291308|FG000|NOT COMPLETED|Overall Study||56
10160692|NCT02940860|11291309|FG001|NOT COMPLETED|Overall Study||35
10160693|NCT02940886|11291319|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
10160694|NCT02940886|11291320|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
10160695|NCT02940886|11291319|FG000|Safety Analysis Set|Overall Study||989
10160696|NCT02940886|11291320|FG001|Safety Analysis Set|Overall Study||494
10160697|NCT02940886|11291319|FG000|COMPLETED|Overall Study||907
10160698|NCT02940886|11291320|FG001|COMPLETED|Overall Study||449
10160699|NCT02940886|11291319|FG000|NOT COMPLETED|Overall Study||102
10160700|NCT02940886|11291320|FG001|NOT COMPLETED|Overall Study||54
10160701|NCT02941523|11291330|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
10160702|NCT02941523|11291331|FG001|STARTED|Monotherapy||8
10160703|NCT02941523|11291330|FG000|COMPLETED|Monotherapy||8
10160704|NCT02941523|11291331|FG001|COMPLETED|Monotherapy||7
10160705|NCT02941523|11291330|FG000|NOT COMPLETED|Monotherapy||0
10160706|NCT02941523|11291331|FG001|NOT COMPLETED|Monotherapy||1
10160707|NCT02941523|11291330|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
10160708|NCT02941523|11291331|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
10160709|NCT02941523|11291330|FG000|COMPLETED|Carboplatin Combination Therapy||3
10160710|NCT02941523|11291331|FG001|COMPLETED|Carboplatin Combination Therapy||6
10160711|NCT02941523|11291330|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5
10160712|NCT02941523|11291331|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4
10197337|NCT03373240|11325293|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20
10197338|NCT03373240|11325292|FG000|NOT COMPLETED|Overall Study||11
10197339|NCT03373240|11325293|FG001|NOT COMPLETED|Overall Study||4
10197340|NCT03373383|11325304|FG000|STARTED|Treatment Period: Wk0-16||83
10197341|NCT03373383|11325305|FG001|STARTED|Treatment Period: Wk0-16||81
10197342|NCT03373383|11325306|FG002|STARTED|Treatment Period: Wk0-16||83
10197343|NCT03373383|11325307|FG003|STARTED|Treatment Period: Wk0-16||82
10197344|NCT03373383|11325308|FG004|STARTED|Treatment Period: Wk0-16||82
10197345|NCT03373383|11325304|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
10197346|NCT03373383|11325305|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
10197347|NCT03373383|11325306|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
10160713|NCT02941614|11291347|FG000|STARTED|Overall Study||744
10160714|NCT02941614|11291348|FG001|STARTED|Overall Study||692
10160715|NCT02941614|11291347|FG000|COMPLETED|Overall Study||603
10160716|NCT02941614|11291348|FG001|COMPLETED|Overall Study||446
10160717|NCT02941614|11291347|FG000|NOT COMPLETED|Overall Study||141
10160718|NCT02941614|11291348|FG001|NOT COMPLETED|Overall Study||246
10160719|NCT02941627|11291356|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53
10160720|NCT02941627|11291356|FG000|Clinical Safety on Overall Participants|Overall Study||51
10160721|NCT02941627|11291356|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33
10160722|NCT02941627|11291356|FG000|COMPLETED|Overall Study||50
10160723|NCT02941627|11291356|FG000|NOT COMPLETED|Overall Study||3
10160724|NCT02941640|11291370|FG000|STARTED|Overall Study||30
10160725|NCT02941640|11291371|FG001|STARTED|Overall Study||30
10160726|NCT02941640|11291372|FG002|STARTED|Overall Study||30
10160727|NCT02941640|11291373|FG003|STARTED|Overall Study||30
10160728|NCT02941640|11291370|FG000|COMPLETED|Overall Study||30
10160729|NCT02941640|11291371|FG001|COMPLETED|Overall Study||30
10160730|NCT02941640|11291372|FG002|COMPLETED|Overall Study||30
10160731|NCT02941640|11291373|FG003|COMPLETED|Overall Study||30
10160732|NCT02941640|11291370|FG000|NOT COMPLETED|Overall Study||0
10160733|NCT02941640|11291371|FG001|NOT COMPLETED|Overall Study||0
10160734|NCT02941640|11291372|FG002|NOT COMPLETED|Overall Study||0
10160735|NCT02941640|11291373|FG003|NOT COMPLETED|Overall Study||0
10160736|NCT02941692|11291385|FG000|STARTED|Overall Study||32
10160737|NCT02941692|11291386|FG001|STARTED|Overall Study||34
10160738|NCT02941692|11291385|FG000|COMPLETED|Overall Study||32
10160739|NCT02941692|11291386|FG001|COMPLETED|Overall Study||34
10160740|NCT02941692|11291385|FG000|NOT COMPLETED|Overall Study||0
10160741|NCT02941692|11291386|FG001|NOT COMPLETED|Overall Study||0
10160742|NCT02942160|11291392|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
10160743|NCT02942160|11291392|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
10160744|NCT02942160|11291392|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
10160745|NCT02942160|11291392|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
10160746|NCT02942160|11291392|FG000|NOT COMPLETED|Overall Study||103
10160747|NCT02942264|11291409|FG000|STARTED|Phase 1 MTD Finding Stage||6
10160748|NCT02942264|11291410|FG001|STARTED|Phase 1 MTD Finding Stage||13
10160749|NCT02942264|11291411|FG002|STARTED|Phase 1 MTD Finding Stage||3
10160750|NCT02942264|11291412|FG003|STARTED|Phase 1 MTD Finding Stage||6
10160751|NCT02942264|11291413|FG004|STARTED|Phase 1 MTD Finding Stage||3
10160752|NCT02942264|11291414|FG005|STARTED|Phase 1 MTD Finding Stage||2
10160753|NCT02942264|11291415|FG006|STARTED|Phase 1 MTD Finding Stage||7
10160754|NCT02942264|11291416|FG007|STARTED|Phase 1 MTD Finding Stage||0
10160755|NCT02942264|11291417|FG008|STARTED|Phase 1 MTD Finding Stage||0
10160756|NCT02942264|11291409|FG000|COMPLETED|Phase 1 MTD Finding Stage||6
10160757|NCT02942264|11291410|FG001|COMPLETED|Phase 1 MTD Finding Stage||12
10160758|NCT02942264|11291411|FG002|COMPLETED|Phase 1 MTD Finding Stage||3
10160759|NCT02942264|11291412|FG003|COMPLETED|Phase 1 MTD Finding Stage||6
10160760|NCT02942264|11291413|FG004|COMPLETED|Phase 1 MTD Finding Stage||3
10160761|NCT02942264|11291414|FG005|COMPLETED|Phase 1 MTD Finding Stage||2
10160762|NCT02942264|11291415|FG006|COMPLETED|Phase 1 MTD Finding Stage||6
10160763|NCT02942264|11291416|FG007|COMPLETED|Phase 1 MTD Finding Stage||0
10160764|NCT02942264|11291417|FG008|COMPLETED|Phase 1 MTD Finding Stage||0
10160765|NCT02942264|11291409|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10160766|NCT02942264|11291410|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1
10160767|NCT02942264|11291411|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10160768|NCT02942264|11291412|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10160769|NCT02942264|11291413|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10160770|NCT02942264|11291414|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10160771|NCT02942264|11291415|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1
10160772|NCT02942264|11291416|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10160773|NCT02942264|11291417|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10160774|NCT02942264|11291409|FG000|STARTED|Phase 1 Cohort Expansion Stage||0
10160775|NCT02942264|11291410|FG001|STARTED|Phase 1 Cohort Expansion Stage||0
10160776|NCT02942264|11291411|FG002|STARTED|Phase 1 Cohort Expansion Stage||0
10160777|NCT02942264|11291412|FG003|STARTED|Phase 1 Cohort Expansion Stage||0
10160778|NCT02942264|11291413|FG004|STARTED|Phase 1 Cohort Expansion Stage||0
10160779|NCT02942264|11291414|FG005|STARTED|Phase 1 Cohort Expansion Stage||0
10160780|NCT02942264|11291415|FG006|STARTED|Phase 1 Cohort Expansion Stage||0
10160781|NCT02942264|11291416|FG007|STARTED|Phase 1 Cohort Expansion Stage||6
10160782|NCT02942264|11291417|FG008|STARTED|Phase 1 Cohort Expansion Stage||7
10160783|NCT02942264|11291409|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0
10160784|NCT02942264|11291410|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0
10160785|NCT02942264|11291411|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0
10160786|NCT02942264|11291412|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0
10160787|NCT02942264|11291413|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0
10160788|NCT02942264|11291414|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0
10160789|NCT02942264|11291415|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0
10160790|NCT02942264|11291416|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6
10160791|NCT02942264|11291417|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6
10160792|NCT02942264|11291409|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160793|NCT02942264|11291410|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160794|NCT02942264|11291411|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160795|NCT02942264|11291412|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160796|NCT02942264|11291413|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160797|NCT02942264|11291414|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160798|NCT02942264|11291415|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160799|NCT02942264|11291416|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10160800|NCT02942264|11291417|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1
10160801|NCT02942407|11291444|FG000|STARTED|Overall Study||82
10160802|NCT02942407|11291445|FG001|STARTED|Overall Study||72
10160803|NCT02942407|11291444|FG000|COMPLETED|Overall Study||56
10160804|NCT02942407|11291445|FG001|COMPLETED|Overall Study||48
10160805|NCT02942407|11291444|FG000|NOT COMPLETED|Overall Study||26
10160806|NCT02942407|11291445|FG001|NOT COMPLETED|Overall Study||24
10160807|NCT02942485|11291461|FG000|STARTED|Overall Study||7
10160808|NCT02942485|11291462|FG001|STARTED|Overall Study||1
10160809|NCT02942485|11291461|FG000|COMPLETED|Overall Study||6
10160810|NCT02942485|11291462|FG001|COMPLETED|Overall Study||1
10160811|NCT02942485|11291461|FG000|NOT COMPLETED|Overall Study||1
10160812|NCT02942485|11291462|FG001|NOT COMPLETED|Overall Study||0
10160813|NCT02942576|11291470|FG000|STARTED|Overall Study||405
10160814|NCT02942576|11291471|FG001|STARTED|Overall Study||197
10160815|NCT02942576|11291470|FG000|COMPLETED|Overall Study||359
10160816|NCT02942576|11291471|FG001|COMPLETED|Overall Study||174
10160817|NCT02942576|11291470|FG000|NOT COMPLETED|Overall Study||46
10160818|NCT02942576|11291471|FG001|NOT COMPLETED|Overall Study||23
10160819|NCT02942654|11291477|FG000|STARTED|Period 1||16
10160820|NCT02942654|11291478|FG001|STARTED|Period 1||16
10160821|NCT02942654|11291477|FG000|Received at Least 1 Dose of Study Drug|Period 1||16
10160822|NCT02942654|11291478|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
10160823|NCT02942654|11291477|FG000|COMPLETED|Period 1||16
10160824|NCT02942654|11291478|FG001|COMPLETED|Period 1||16
10160825|NCT02942654|11291477|FG000|NOT COMPLETED|Period 1||0
10160826|NCT02942654|11291478|FG001|NOT COMPLETED|Period 1||0
10160827|NCT02942654|11291477|FG000|STARTED|Washout||16
10160828|NCT02942654|11291478|FG001|STARTED|Washout||16
10160829|NCT02942654|11291477|FG000|COMPLETED|Washout||16
10160830|NCT02942654|11291478|FG001|COMPLETED|Washout||16
10160831|NCT02942654|11291477|FG000|NOT COMPLETED|Washout||0
10160832|NCT02942654|11291478|FG001|NOT COMPLETED|Washout||0
10160833|NCT02942654|11291477|FG000|STARTED|Period 2||16
10160834|NCT02942654|11291478|FG001|STARTED|Period 2||16
10160835|NCT02942654|11291477|FG000|COMPLETED|Period 2||16
10160836|NCT02942654|11291478|FG001|COMPLETED|Period 2||16
10160837|NCT02942654|11291477|FG000|NOT COMPLETED|Period 2||0
10160838|NCT02942654|11291478|FG001|NOT COMPLETED|Period 2||0
10160839|NCT02942771|11291489|FG000|STARTED|Overall Study||9
10160840|NCT02942771|11291490|FG001|STARTED|Overall Study||6
10160841|NCT02942771|11291491|FG002|STARTED|Overall Study||6
10160842|NCT02942771|11291492|FG003|STARTED|Overall Study||6
10160843|NCT02942771|11291493|FG004|STARTED|Overall Study||8
10160844|NCT02942771|11291489|FG000|COMPLETED|Overall Study||6
10160845|NCT02942771|11291490|FG001|COMPLETED|Overall Study||6
10160846|NCT02942771|11291491|FG002|COMPLETED|Overall Study||6
10160847|NCT02942771|11291492|FG003|COMPLETED|Overall Study||6
10160848|NCT02942771|11291493|FG004|COMPLETED|Overall Study||4
10160849|NCT02942771|11291489|FG000|NOT COMPLETED|Overall Study||3
10160850|NCT02942771|11291490|FG001|NOT COMPLETED|Overall Study||0
10160851|NCT02942771|11291491|FG002|NOT COMPLETED|Overall Study||0
10160852|NCT02942771|11291492|FG003|NOT COMPLETED|Overall Study||0
10160853|NCT02942771|11291493|FG004|NOT COMPLETED|Overall Study||4
10160854|NCT02942979|11291507|FG000|STARTED|Step 0||108
10160855|NCT02942979|11291508|FG001|STARTED|Step 0||0
10160856|NCT02942979|11291507|FG000|COMPLETED|Step 0||108
10160857|NCT02942979|11291508|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0
10160858|NCT02942979|11291507|FG000|NOT COMPLETED|Step 0||0
10160859|NCT02942979|11291508|FG001|NOT COMPLETED|Step 0||0
10160860|NCT02942979|11291507|FG000|STARTED|Step 1||15
10160861|NCT02942979|11291508|FG001|STARTED|Step 1||93
10160862|NCT02942979|11291507|FG000|COMPLETED|Step 1||15
10160863|NCT02942979|11291508|FG001|COMPLETED|Step 1||93
10160864|NCT02942979|11291507|FG000|NOT COMPLETED|Step 1||0
10160865|NCT02942979|11291508|FG001|NOT COMPLETED|Step 1||0
10160866|NCT02942979|11291507|FG000|STARTED|Step 2||0
10160867|NCT02942979|11291508|FG001|STARTED|Step 2||108
10160868|NCT02942979|11291507|FG000|COMPLETED|Step 2||0
10160869|NCT02942979|11291508|FG001|COMPLETED|Step 2||108
10160870|NCT02942979|11291507|FG000|NOT COMPLETED|Step 2||0
10160871|NCT02942979|11291508|FG001|NOT COMPLETED|Step 2||0
10160872|NCT02943070|11291514|FG000|STARTED|Overall Study||50
10160873|NCT02943070|11291514|FG000|COMPLETED|Overall Study||7
10160874|NCT02943070|11291514|FG000|NOT COMPLETED|Overall Study||43
10160875|NCT02943096|11291527|FG000|STARTED|Overall Study||3
10160876|NCT02943096|11291528|FG001|STARTED|Overall Study||3
10160877|NCT02943096|11291527|FG000|COMPLETED|Overall Study||3
10160878|NCT02943096|11291528|FG001|COMPLETED|Overall Study||2
10160879|NCT02943096|11291527|FG000|NOT COMPLETED|Overall Study||0
10160880|NCT02943096|11291528|FG001|NOT COMPLETED|Overall Study||1
10160881|NCT02943213|11291534|FG000|STARTED|Treatment Period 1||20
10160882|NCT02943213|11291534|FG000|COMPLETED|Treatment Period 1||20
10160883|NCT02943213|11291534|FG000|NOT COMPLETED|Treatment Period 1||0
10160884|NCT02943213|11291534|FG000|STARTED|Treatment Period 2||20
10160885|NCT02943213|11291534|FG000|COMPLETED|Treatment Period 2||20
10160886|NCT02943213|11291534|FG000|NOT COMPLETED|Treatment Period 2||0
10160887|NCT02943226|11291542|FG000|STARTED|Overall Study||31
10160888|NCT02943226|11291543|FG001|STARTED|Overall Study||30
10160889|NCT02943226|11291542|FG000|COMPLETED|Overall Study||31
10160890|NCT02943226|11291543|FG001|COMPLETED|Overall Study||30
10160891|NCT02943226|11291542|FG000|NOT COMPLETED|Overall Study||0
10160892|NCT02943226|11291543|FG001|NOT COMPLETED|Overall Study||0
10160893|NCT02943447|11291552|FG000|STARTED|Blinded Study Phase||28
10160894|NCT02943447|11291553|FG001|STARTED|Blinded Study Phase||30
10160895|NCT02943447|11291554|FG002|STARTED|Blinded Study Phase||13
10160896|NCT02943447|11291552|FG000|COMPLETED|Blinded Study Phase||23
10160897|NCT02943447|11291553|FG001|COMPLETED|Blinded Study Phase||28
10160898|NCT02943447|11291554|FG002|COMPLETED|Blinded Study Phase||12
10160899|NCT02943447|11291552|FG000|NOT COMPLETED|Blinded Study Phase||5
10160900|NCT02943447|11291553|FG001|NOT COMPLETED|Blinded Study Phase||2
10160901|NCT02943447|11291554|FG002|NOT COMPLETED|Blinded Study Phase||1
10160902|NCT02943447|11291552|FG000|STARTED|Open-Label Extension Phase||23
10160903|NCT02943447|11291553|FG001|STARTED|Open-Label Extension Phase||28
10160904|NCT02943447|11291554|FG002|STARTED|Open-Label Extension Phase||12
10160905|NCT02943447|11291552|FG000|COMPLETED|Open-Label Extension Phase||5
10160906|NCT02943447|11291553|FG001|COMPLETED|Open-Label Extension Phase||3
10160907|NCT02943447|11291554|FG002|COMPLETED|Open-Label Extension Phase||2
10160908|NCT02943447|11291552|FG000|NOT COMPLETED|Open-Label Extension Phase||18
10160909|NCT02943447|11291553|FG001|NOT COMPLETED|Open-Label Extension Phase||25
10160910|NCT02943447|11291554|FG002|NOT COMPLETED|Open-Label Extension Phase||10
10160911|NCT02943460|11291574|FG000|STARTED|Blinded Study Phase||22
10160912|NCT02943460|11291575|FG001|STARTED|Blinded Study Phase||20
10160913|NCT02943460|11291576|FG002|STARTED|Blinded Study Phase||10
10160914|NCT02943460|11291574|FG000|COMPLETED|Blinded Study Phase||19
10160915|NCT02943460|11291575|FG001|COMPLETED|Blinded Study Phase||19
10160916|NCT02943460|11291576|FG002|COMPLETED|Blinded Study Phase||10
10160917|NCT02943460|11291574|FG000|NOT COMPLETED|Blinded Study Phase||3
10160918|NCT02943460|11291575|FG001|NOT COMPLETED|Blinded Study Phase||1
10160919|NCT02943460|11291576|FG002|NOT COMPLETED|Blinded Study Phase||0
10160920|NCT02943460|11291574|FG000|STARTED|Open Label Extension (OLE) Phase||19
10160921|NCT02943460|11291575|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
10160922|NCT02943460|11291576|FG002|STARTED|Open Label Extension (OLE) Phase||10
10160923|NCT02943460|11291574|FG000|COMPLETED|Open Label Extension (OLE) Phase||14
10160924|NCT02943460|11291575|FG001|COMPLETED|Open Label Extension (OLE) Phase||11
10160925|NCT02943460|11291576|FG002|COMPLETED|Open Label Extension (OLE) Phase||8
10160926|NCT02943460|11291574|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5
10160927|NCT02943460|11291575|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7
10160928|NCT02943460|11291576|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2
10160929|NCT02943473|11291585|FG000|STARTED|Overall Study||9
10160930|NCT02943473|11291585|FG000|COMPLETED|Overall Study||3
10160931|NCT02943473|11291585|FG000|NOT COMPLETED|Overall Study||6
10160932|NCT02943499|11291591|FG000|STARTED|Overall Study||41
10160933|NCT02943499|11291592|FG001|STARTED|Overall Study||39
10160934|NCT02943499|11291591|FG000|COMPLETED|Overall Study||34
10160935|NCT02943499|11291592|FG001|COMPLETED|Overall Study||34
10160936|NCT02943499|11291591|FG000|NOT COMPLETED|Overall Study||7
10160937|NCT02943499|11291592|FG001|NOT COMPLETED|Overall Study||5
10160938|NCT02943564|11291601|FG000|STARTED|Overall Study||217
10160939|NCT02943564|11291602|FG001|STARTED|Overall Study||211
10160940|NCT02943564|11291603|FG002|STARTED|Overall Study||210
10160941|NCT02943564|11291601|FG000|Responder|Overall Study||83
10160942|NCT02943564|11291602|FG001|Responder|Overall Study||77
10160943|NCT02943564|11291603|FG002|Responder|Overall Study||77
10160944|NCT02943564|11291601|FG000|Non-Responder|Overall Study||134
10160945|NCT02943564|11291602|FG001|Non-Responder|Overall Study||134
10160946|NCT02943564|11291603|FG002|Non-Responder|Overall Study||133
10160947|NCT02943564|11291601|FG000|COMPLETED|Overall Study||207
10160948|NCT02943564|11291602|FG001|COMPLETED|Overall Study||198
10160949|NCT02943564|11291603|FG002|COMPLETED|Overall Study||201
10160950|NCT02943564|11291601|FG000|NOT COMPLETED|Overall Study||10
10160951|NCT02943564|11291602|FG001|NOT COMPLETED|Overall Study||13
10160952|NCT02943564|11291603|FG002|NOT COMPLETED|Overall Study||9
10160953|NCT02943577|11291613|FG000|STARTED|Overall Study||209
10160954|NCT02943577|11291614|FG001|STARTED|Overall Study||206
10160955|NCT02943577|11291613|FG000|COMPLETED|Overall Study||204
10160956|NCT02943577|11291614|FG001|COMPLETED|Overall Study||201
10160957|NCT02943577|11291613|FG000|NOT COMPLETED|Overall Study||5
10160958|NCT02943577|11291614|FG001|NOT COMPLETED|Overall Study||5
10160959|NCT02943668|11291620|FG000|STARTED|Overall Study||2
10160960|NCT02943668|11291620|FG000|COMPLETED|Overall Study||1
10160961|NCT02943668|11291620|FG000|NOT COMPLETED|Overall Study||1
10160962|NCT02943941|11291627|FG000|STARTED|Overall Study||16
10160963|NCT02943941|11291627|FG000|COMPLETED|Overall Study||16
10160964|NCT02943941|11291627|FG000|NOT COMPLETED|Overall Study||0
10160965|NCT02944383|11291635|FG000|STARTED|Overall Study||30
10160966|NCT02944383|11291636|FG001|STARTED|Overall Study||30
10160967|NCT02944383|11291637|FG002|STARTED|Overall Study||31
10160968|NCT02944383|11291635|FG000|COMPLETED|Overall Study||29
10160969|NCT02944383|11291636|FG001|COMPLETED|Overall Study||30
10160970|NCT02944383|11291637|FG002|COMPLETED|Overall Study||30
10160971|NCT02944383|11291635|FG000|NOT COMPLETED|Overall Study||1
10160972|NCT02944383|11291636|FG001|NOT COMPLETED|Overall Study||0
10160973|NCT02944383|11291637|FG002|NOT COMPLETED|Overall Study||1
10160974|NCT02944448|11291649|FG000|STARTED|Overall Study||316
10160975|NCT02944448|11291650|FG001|STARTED|Overall Study||160
10160976|NCT02944448|11291649|FG000|COMPLETED|Overall Study||227
10160977|NCT02944448|11291650|FG001|COMPLETED|Overall Study||136
10160978|NCT02944448|11291649|FG000|NOT COMPLETED|Overall Study||89
10160979|NCT02944448|11291650|FG001|NOT COMPLETED|Overall Study||24
10160980|NCT02944461|11291657|FG000|STARTED|Overall Study||20
10160981|NCT02944461|11291657|FG000|COMPLETED|Overall Study||15
10160982|NCT02944461|11291657|FG000|NOT COMPLETED|Overall Study||5
10160983|NCT02944565|11291661|FG000|STARTED|Overall Study||28
10160984|NCT02944565|11291661|FG000|COMPLETED|Overall Study||28
10160985|NCT02944565|11291661|FG000|NOT COMPLETED|Overall Study||0
10160986|NCT02944656|11291668|FG000|STARTED|Overall Study||57
10160987|NCT02944656|11291669|FG001|STARTED|Overall Study||57
10160988|NCT02944656|11291668|FG000|Completed Procedure Day|Overall Study||54
10160989|NCT02944656|11291669|FG001|Completed Procedure Day|Overall Study||57
10160990|NCT02944656|11291668|FG000|Completed Day 1 Follow up|Overall Study||47
10160991|NCT02944656|11291669|FG001|Completed Day 1 Follow up|Overall Study||47
10160992|NCT02944656|11291668|FG000|COMPLETED|Overall Study||47
10160993|NCT02944656|11291669|FG001|COMPLETED|Overall Study||47
10160994|NCT02944656|11291668|FG000|NOT COMPLETED|Overall Study||10
10160995|NCT02944656|11291669|FG001|NOT COMPLETED|Overall Study||10
10160996|NCT02944968|11291675|FG000|STARTED|Overall Study||51
10160997|NCT02944968|11291675|FG000|COMPLETED|Overall Study||48
10160998|NCT02944968|11291675|FG000|NOT COMPLETED|Overall Study||3
10160999|NCT02945046|11291682|FG000|STARTED|Overall Study||59
10161000|NCT02945046|11291683|FG001|STARTED|Overall Study||55
10161001|NCT02945046|11291684|FG002|STARTED|Overall Study||55
10161002|NCT02945046|11291682|FG000|Safety Analysis Set|Overall Study||59
10161003|NCT02945046|11291683|FG001|Safety Analysis Set|Overall Study||55
10161004|NCT02945046|11291684|FG002|Safety Analysis Set|Overall Study||55
10161005|NCT02945046|11291682|FG000|Full Analysis Set|Overall Study||57
10161006|NCT02945046|11291683|FG001|Full Analysis Set|Overall Study||53
10161007|NCT02945046|11291684|FG002|Full Analysis Set|Overall Study||55
10161008|NCT02945046|11291682|FG000|COMPLETED|Overall Study||46
10161009|NCT02945046|11291683|FG001|COMPLETED|Overall Study||42
9710625|NCT03720392|10810267|FG001|COMPLETED|Overall Study||3
9710626|NCT03720392|10810266|FG000|NOT COMPLETED|Overall Study||0
9710627|NCT03720392|10810267|FG001|NOT COMPLETED|Overall Study||0
9710628|NCT03515226|10810275|FG000|STARTED|Overall Study||10
9710629|NCT03515226|10810276|FG001|STARTED|Overall Study||15
9710630|NCT03515226|10810275|FG000|COMPLETED|Overall Study||8
9710631|NCT03515226|10810276|FG001|COMPLETED|Overall Study||11
9710632|NCT03515226|10810275|FG000|NOT COMPLETED|Overall Study||2
9710633|NCT03515226|10810276|FG001|NOT COMPLETED|Overall Study||4
9710634|NCT03430895|10810283|FG000|STARTED|Overall Study||15
9710635|NCT03430895|10810283|FG000|COMPLETED|Overall Study||13
9710636|NCT03430895|10810283|FG000|NOT COMPLETED|Overall Study||2
9710637|NCT03321617|10810291|FG000|STARTED|Overall Study||3
9710638|NCT03321617|10810292|FG001|STARTED|Overall Study||3
9710639|NCT03321617|10810293|FG002|STARTED|Overall Study||2
9710640|NCT03321617|10810294|FG003|STARTED|Overall Study||3
9710641|NCT03321617|10810291|FG000|COMPLETED|Overall Study||2
9710642|NCT03321617|10810292|FG001|COMPLETED|Overall Study||3
9710643|NCT03321617|10810293|FG002|COMPLETED|Overall Study||2
9710644|NCT03321617|10810294|FG003|COMPLETED|Overall Study||2
9710645|NCT03321617|10810291|FG000|NOT COMPLETED|Overall Study||1
9710646|NCT03321617|10810292|FG001|NOT COMPLETED|Overall Study||0
9710647|NCT03321617|10810293|FG002|NOT COMPLETED|Overall Study||0
9710648|NCT03321617|10810294|FG003|NOT COMPLETED|Overall Study||1
9710649|NCT03230838|10810306|FG000|STARTED|Overall Study||101
9710650|NCT03230838|10810307|FG001|STARTED|Overall Study||33
9710651|NCT03230838|10810306|FG000|Treated|Overall Study||100
9710652|NCT03230838|10810307|FG001|Treated|Overall Study||33
9710653|NCT03230838|10810306|FG000|COMPLETED|Overall Study||97
9710654|NCT03230838|10810307|FG001|COMPLETED|Overall Study||33
9710655|NCT03230838|10810306|FG000|NOT COMPLETED|Overall Study||4
9710656|NCT03230838|10810307|FG001|NOT COMPLETED|Overall Study||0
9730628|NCT00127205|10830432|FG000|COMPLETED|Overall Study||1433
9730629|NCT00127205|10830433|FG001|COMPLETED|Overall Study||1295
9730630|NCT00127205|10830434|FG002|COMPLETED|Overall Study||955
9730631|NCT00127205|10830432|FG000|NOT COMPLETED|Overall Study||829
10161010|NCT02945046|11291684|FG002|COMPLETED|Overall Study||40
10161011|NCT02945046|11291682|FG000|NOT COMPLETED|Overall Study||13
10161012|NCT02945046|11291683|FG001|NOT COMPLETED|Overall Study||13
10161013|NCT02945046|11291684|FG002|NOT COMPLETED|Overall Study||15
10161014|NCT02945150|11291692|FG000|STARTED|Overall Study||8
10161015|NCT02945150|11291692|FG000|SVR12|Overall Study||8
10161016|NCT02945150|11291692|FG000|COMPLETED|Overall Study||8
10161017|NCT02945150|11291692|FG000|NOT COMPLETED|Overall Study||0
10161018|NCT02945254|11291698|FG000|STARTED|Overall Study||10
9730632|NCT00127205|10830433|FG001|NOT COMPLETED|Overall Study||973
9730633|NCT00127205|10830434|FG002|NOT COMPLETED|Overall Study||612
9730634|NCT00127218|10830446|FG000|STARTED|Overall Study||72
9730635|NCT00127218|10830447|FG001|STARTED|Overall Study||73
9730636|NCT00127218|10830446|FG000|COMPLETED|Overall Study||59
9730637|NCT00127218|10830447|FG001|COMPLETED|Overall Study||58
9730638|NCT00127218|10830446|FG000|NOT COMPLETED|Overall Study||13
10161019|NCT02945254|11291699|FG001|STARTED|Overall Study||10
10161020|NCT02945254|11291698|FG000|COMPLETED|Overall Study||8
10161021|NCT02945254|11291699|FG001|COMPLETED|Overall Study||10
10161022|NCT02945254|11291698|FG000|NOT COMPLETED|Overall Study||2
10161023|NCT02945254|11291699|FG001|NOT COMPLETED|Overall Study||0
10161024|NCT02945410|11291711|FG000|STARTED|Intervention 1 (5 Days)||3
10161025|NCT02945410|11291712|FG001|STARTED|Intervention 1 (5 Days)||4
10161026|NCT02945410|11291713|FG002|STARTED|Intervention 1 (5 Days)||2
10161027|NCT02945410|11291714|FG003|STARTED|Intervention 1 (5 Days)||3
10161028|NCT02945410|11291715|FG004|STARTED|Intervention 1 (5 Days)||2
10161029|NCT02945410|11291716|FG005|STARTED|Intervention 1 (5 Days)||1
10161030|NCT02945410|11291711|FG000|COMPLETED|Intervention 1 (5 Days)||2
10161031|NCT02945410|11291712|FG001|COMPLETED|Intervention 1 (5 Days)||1
10161032|NCT02945410|11291713|FG002|COMPLETED|Intervention 1 (5 Days)||2
10161033|NCT02945410|11291714|FG003|COMPLETED|Intervention 1 (5 Days)||3
10161034|NCT02945410|11291715|FG004|COMPLETED|Intervention 1 (5 Days)||2
10161035|NCT02945410|11291716|FG005|COMPLETED|Intervention 1 (5 Days)||0
10161036|NCT02945410|11291711|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1
10161037|NCT02945410|11291712|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3
10161038|NCT02945410|11291713|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0
10161039|NCT02945410|11291714|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0
10161040|NCT02945410|11291715|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0
10161041|NCT02945410|11291716|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1
10161042|NCT02945410|11291711|FG000|STARTED|Washout 1 (14 Days)||2
10161043|NCT02945410|11291712|FG001|STARTED|Washout 1 (14 Days)||1
10161044|NCT02945410|11291713|FG002|STARTED|Washout 1 (14 Days)||2
10161045|NCT02945410|11291714|FG003|STARTED|Washout 1 (14 Days)||3
10161046|NCT02945410|11291715|FG004|STARTED|Washout 1 (14 Days)||2
10161047|NCT02945410|11291716|FG005|STARTED|Washout 1 (14 Days)||0
10161048|NCT02945410|11291711|FG000|COMPLETED|Washout 1 (14 Days)||2
10161049|NCT02945410|11291712|FG001|COMPLETED|Washout 1 (14 Days)||1
10161050|NCT02945410|11291713|FG002|COMPLETED|Washout 1 (14 Days)||0
10161051|NCT02945410|11291714|FG003|COMPLETED|Washout 1 (14 Days)||3
10161052|NCT02945410|11291715|FG004|COMPLETED|Washout 1 (14 Days)||1
10161053|NCT02945410|11291716|FG005|COMPLETED|Washout 1 (14 Days)||0
10161054|NCT02945410|11291711|FG000|NOT COMPLETED|Washout 1 (14 Days)||0
10161055|NCT02945410|11291712|FG001|NOT COMPLETED|Washout 1 (14 Days)||0
10161056|NCT02945410|11291713|FG002|NOT COMPLETED|Washout 1 (14 Days)||2
10161057|NCT02945410|11291714|FG003|NOT COMPLETED|Washout 1 (14 Days)||0
10161058|NCT02945410|11291715|FG004|NOT COMPLETED|Washout 1 (14 Days)||1
10161059|NCT02945410|11291716|FG005|NOT COMPLETED|Washout 1 (14 Days)||0
10161060|NCT02945410|11291711|FG000|STARTED|Intervention 2 (5 Days)||2
10161061|NCT02945410|11291712|FG001|STARTED|Intervention 2 (5 Days)||1
10161062|NCT02945410|11291713|FG002|STARTED|Intervention 2 (5 Days)||0
10161063|NCT02945410|11291714|FG003|STARTED|Intervention 2 (5 Days)||3
10161064|NCT02945410|11291715|FG004|STARTED|Intervention 2 (5 Days)||1
10161065|NCT02945410|11291716|FG005|STARTED|Intervention 2 (5 Days)||0
10161066|NCT02945410|11291711|FG000|COMPLETED|Intervention 2 (5 Days)||2
10161067|NCT02945410|11291712|FG001|COMPLETED|Intervention 2 (5 Days)||1
10161068|NCT02945410|11291713|FG002|COMPLETED|Intervention 2 (5 Days)||0
10161069|NCT02945410|11291714|FG003|COMPLETED|Intervention 2 (5 Days)||3
10161070|NCT02945410|11291715|FG004|COMPLETED|Intervention 2 (5 Days)||1
10161071|NCT02945410|11291716|FG005|COMPLETED|Intervention 2 (5 Days)||0
10161072|NCT02945410|11291711|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
10161073|NCT02945410|11291712|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
10161074|NCT02945410|11291713|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0
10161075|NCT02945410|11291714|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0
10161076|NCT02945410|11291715|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0
10161077|NCT02945410|11291716|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0
10161078|NCT02945410|11291711|FG000|STARTED|Washout 2 (14 Days)||2
10161079|NCT02945410|11291712|FG001|STARTED|Washout 2 (14 Days)||1
10161080|NCT02945410|11291713|FG002|STARTED|Washout 2 (14 Days)||0
10161081|NCT02945410|11291714|FG003|STARTED|Washout 2 (14 Days)||3
10161082|NCT02945410|11291715|FG004|STARTED|Washout 2 (14 Days)||1
10161083|NCT02945410|11291716|FG005|STARTED|Washout 2 (14 Days)||0
10161084|NCT02945410|11291711|FG000|COMPLETED|Washout 2 (14 Days)||2
10161085|NCT02945410|11291712|FG001|COMPLETED|Washout 2 (14 Days)||1
10161086|NCT02945410|11291713|FG002|COMPLETED|Washout 2 (14 Days)||0
10161087|NCT02945410|11291714|FG003|COMPLETED|Washout 2 (14 Days)||3
10161088|NCT02945410|11291715|FG004|COMPLETED|Washout 2 (14 Days)||1
10161089|NCT02945410|11291716|FG005|COMPLETED|Washout 2 (14 Days)||0
10161090|NCT02945410|11291711|FG000|NOT COMPLETED|Washout 2 (14 Days)||0
10161091|NCT02945410|11291712|FG001|NOT COMPLETED|Washout 2 (14 Days)||0
10161092|NCT02945410|11291713|FG002|NOT COMPLETED|Washout 2 (14 Days)||0
10161093|NCT02945410|11291714|FG003|NOT COMPLETED|Washout 2 (14 Days)||0
10161094|NCT02945410|11291715|FG004|NOT COMPLETED|Washout 2 (14 Days)||0
10161095|NCT02945410|11291716|FG005|NOT COMPLETED|Washout 2 (14 Days)||0
10161096|NCT02945410|11291711|FG000|STARTED|Intervention 3 (5 Days)||2
10161097|NCT02945410|11291712|FG001|STARTED|Intervention 3 (5 Days)||1
10161098|NCT02945410|11291713|FG002|STARTED|Intervention 3 (5 Days)||0
10161099|NCT02945410|11291714|FG003|STARTED|Intervention 3 (5 Days)||3
10161100|NCT02945410|11291715|FG004|STARTED|Intervention 3 (5 Days)||1
10161101|NCT02945410|11291716|FG005|STARTED|Intervention 3 (5 Days)||0
10161102|NCT02945410|11291711|FG000|COMPLETED|Intervention 3 (5 Days)||2
10161103|NCT02945410|11291712|FG001|COMPLETED|Intervention 3 (5 Days)||1
10161104|NCT02945410|11291713|FG002|COMPLETED|Intervention 3 (5 Days)||0
10161105|NCT02945410|11291714|FG003|COMPLETED|Intervention 3 (5 Days)||3
10161106|NCT02945410|11291715|FG004|COMPLETED|Intervention 3 (5 Days)||1
9710657|NCT03183778|10810313|FG000|STARTED|Overall Study||3
9710658|NCT03183778|10810313|FG000|COMPLETED|Overall Study||2
9710659|NCT03183778|10810313|FG000|NOT COMPLETED|Overall Study||1
9710660|NCT03113955|10810317|FG000|STARTED|Overall Study||109
9710661|NCT03113955|10810317|FG000|COMPLETED|Overall Study||92
9710662|NCT03113955|10810317|FG000|NOT COMPLETED|Overall Study||17
9710663|NCT02995694|10810324|FG000|STARTED|Overall Study||215
9710664|NCT02995694|10810325|FG001|STARTED|Overall Study||211
9710665|NCT02995694|10810326|FG002|STARTED|Overall Study||109
9710666|NCT02995694|10810324|FG000|COMPLETED|Overall Study||181
9710667|NCT02995694|10810325|FG001|COMPLETED|Overall Study||183
9710668|NCT02995694|10810326|FG002|COMPLETED|Overall Study||94
9710669|NCT02995694|10810324|FG000|NOT COMPLETED|Overall Study||34
9710670|NCT02995694|10810325|FG001|NOT COMPLETED|Overall Study||28
9710671|NCT02995694|10810326|FG002|NOT COMPLETED|Overall Study||15
9710672|NCT02700698|10810339|FG000|STARTED|Overall Study||17
9710673|NCT02700698|10810340|FG001|STARTED|Overall Study||18
9710674|NCT02700698|10810339|FG000|COMPLETED|Overall Study||16
9710675|NCT02700698|10810340|FG001|COMPLETED|Overall Study||18
9710676|NCT02700698|10810339|FG000|NOT COMPLETED|Overall Study||1
9710677|NCT02700698|10810340|FG001|NOT COMPLETED|Overall Study||0
9710678|NCT02699086|10810346|FG000|STARTED|Overall Study||0
9710679|NCT02699086|10810347|FG001|STARTED|Overall Study||6
9710680|NCT02699086|10810346|FG000|COMPLETED|Overall Study||0
9710681|NCT02699086|10810347|FG001|COMPLETED|Overall Study||6
9710682|NCT02699086|10810346|FG000|NOT COMPLETED|Overall Study||0
9710683|NCT02699086|10810347|FG001|NOT COMPLETED|Overall Study||0
9710684|NCT02698865|10810357|FG000|STARTED|Overall Study||140
9710685|NCT02698865|10810358|FG001|STARTED|Overall Study||80
9710686|NCT02698865|10810357|FG000|Treated|Overall Study||140
9710687|NCT02698865|10810358|FG001|Treated|Overall Study||80
9710688|NCT02698865|10810357|FG000|COMPLETED|Overall Study||105
9710689|NCT02698865|10810358|FG001|COMPLETED|Overall Study||47
9710690|NCT02698865|10810357|FG000|NOT COMPLETED|Overall Study||35
9710691|NCT02698865|10810358|FG001|NOT COMPLETED|Overall Study||33
9710692|NCT02660086|10810366|FG000|STARTED|Overall Study- 12-month||299
9710693|NCT02660086|10810367|FG001|STARTED|Overall Study- 12-month||303
9710694|NCT02660086|10810366|FG000|COMPLETED|Overall Study- 12-month||273
9710695|NCT02660086|10810367|FG001|COMPLETED|Overall Study- 12-month||274
9710696|NCT02660086|10810366|FG000|NOT COMPLETED|Overall Study- 12-month||26
9710697|NCT02660086|10810367|FG001|NOT COMPLETED|Overall Study- 12-month||29
9710698|NCT02660086|10810366|FG000|STARTED|Overall Study: 24-month Follow-up||281
9710699|NCT02660086|10810367|FG001|STARTED|Overall Study: 24-month Follow-up||278
9710700|NCT02660086|10810366|FG000|COMPLETED|Overall Study: 24-month Follow-up||255
9710701|NCT02660086|10810367|FG001|COMPLETED|Overall Study: 24-month Follow-up||254
9710702|NCT02660086|10810366|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26
9710703|NCT02660086|10810367|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24
9710704|NCT02335749|10810373|FG000|STARTED|Overall Study||40
9710705|NCT02335749|10810373|FG000|COMPLETED|Overall Study||40
9710706|NCT02335749|10810373|FG000|NOT COMPLETED|Overall Study||0
9710707|NCT02129647|10810377|FG000|STARTED|Overall Study||13
9710708|NCT02129647|10810377|FG000|COMPLETED|Overall Study||10
9710709|NCT02129647|10810377|FG000|NOT COMPLETED|Overall Study||3
9710710|NCT02071901|10810381|FG000|STARTED|Overall Study||31
9710711|NCT02071901|10810381|FG000|COMPLETED|Overall Study||31
9710712|NCT02071901|10810381|FG000|NOT COMPLETED|Overall Study||0
9710713|NCT01959139|10810389|FG000|STARTED|Phase I: Cohort 1||5
9710714|NCT01959139|10810390|FG001|STARTED|Phase I: Cohort 1||0
9710715|NCT01959139|10810391|FG002|STARTED|Phase I: Cohort 1||0
9710716|NCT01959139|10810392|FG003|STARTED|Phase I: Cohort 1||0
9710717|NCT01959139|10810389|FG000|COMPLETED|Phase I: Cohort 1||5
9710718|NCT01959139|10810390|FG001|COMPLETED|Phase I: Cohort 1||0
9710719|NCT01959139|10810391|FG002|COMPLETED|Phase I: Cohort 1||0
9710720|NCT01959139|10810392|FG003|COMPLETED|Phase I: Cohort 1||0
9710721|NCT01959139|10810389|FG000|NOT COMPLETED|Phase I: Cohort 1||0
9710722|NCT01959139|10810390|FG001|NOT COMPLETED|Phase I: Cohort 1||0
9710723|NCT01959139|10810391|FG002|NOT COMPLETED|Phase I: Cohort 1||0
9710724|NCT01959139|10810392|FG003|NOT COMPLETED|Phase I: Cohort 1||0
9710725|NCT01959139|10810389|FG000|STARTED|Phase I: Cohort 2||0
9710726|NCT01959139|10810390|FG001|STARTED|Phase I: Cohort 2||6
9710727|NCT01959139|10810391|FG002|STARTED|Phase I: Cohort 2||0
9710728|NCT01959139|10810392|FG003|STARTED|Phase I: Cohort 2||0
9710729|NCT01959139|10810389|FG000|COMPLETED|Phase I: Cohort 2||0
9710730|NCT01959139|10810390|FG001|COMPLETED|Phase I: Cohort 2||6
9710731|NCT01959139|10810391|FG002|COMPLETED|Phase I: Cohort 2||0
9710732|NCT01959139|10810392|FG003|COMPLETED|Phase I: Cohort 2||0
9710733|NCT01959139|10810389|FG000|NOT COMPLETED|Phase I: Cohort 2||0
9710734|NCT01959139|10810390|FG001|NOT COMPLETED|Phase I: Cohort 2||0
9710735|NCT01959139|10810391|FG002|NOT COMPLETED|Phase I: Cohort 2||0
9710736|NCT01959139|10810392|FG003|NOT COMPLETED|Phase I: Cohort 2||0
9710737|NCT01959139|10810389|FG000|STARTED|Phase II||0
9710738|NCT01959139|10810390|FG001|STARTED|Phase II||0
9710739|NCT01959139|10810391|FG002|STARTED|Phase II||56
9710740|NCT01959139|10810392|FG003|STARTED|Phase II||55
9849357|NCT00864383|10962042|FG002|NOT COMPLETED|Per- Protocol||112
10161107|NCT02945410|11291716|FG005|COMPLETED|Intervention 3 (5 Days)||0
10161108|NCT02945410|11291711|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0
10161109|NCT02945410|11291712|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0
10161110|NCT02945410|11291713|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0
10161111|NCT02945410|11291714|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0
10161112|NCT02945410|11291715|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0
10161113|NCT02945410|11291716|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0
10161114|NCT02945553|11291726|FG000|STARTED|Overall Study||14
10161115|NCT02945553|11291727|FG001|STARTED|Overall Study||11
10161116|NCT02945553|11291726|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11
10161117|NCT02945553|11291727|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9
10161118|NCT02945553|11291726|FG000|NOT COMPLETED|Overall Study||3
10161119|NCT02945553|11291727|FG001|NOT COMPLETED|Overall Study||2
10161120|NCT02945657|11291737|FG000|STARTED|Overall Study||32
10161121|NCT02945657|11291737|FG000|COMPLETED|Overall Study||28
10161122|NCT02945657|11291737|FG000|NOT COMPLETED|Overall Study||4
10161123|NCT02946021|11291744|FG000|STARTED|Overall Study||6
10161124|NCT02946021|11291745|FG001|STARTED|Overall Study||5
10161125|NCT02946021|11291744|FG000|COMPLETED|Overall Study||6
10161126|NCT02946021|11291745|FG001|COMPLETED|Overall Study||5
10161127|NCT02946021|11291744|FG000|NOT COMPLETED|Overall Study||0
10161128|NCT02946021|11291745|FG001|NOT COMPLETED|Overall Study||0
10161129|NCT02946034|11291751|FG000|STARTED|Overall Study||10
10161130|NCT02946034|11291751|FG000|COMPLETED|Overall Study||10
10161131|NCT02946034|11291751|FG000|NOT COMPLETED|Overall Study||0
10161132|NCT02946073|11291761|FG000|STARTED|Titration Phase||811
10161133|NCT02946073|11291762|FG001|STARTED|Titration Phase||0
10161134|NCT02946073|11291763|FG002|STARTED|Titration Phase||98
10161135|NCT02946073|11291764|FG003|STARTED|Titration Phase||0
10161136|NCT02946073|11291761|FG000|COMPLETED|Titration Phase||222
10161137|NCT02946073|11291762|FG001|COMPLETED|Titration Phase||0
10161138|NCT02946073|11291763|FG002|COMPLETED|Titration Phase||75
10161139|NCT02946073|11291764|FG003|COMPLETED|Titration Phase||0
10161140|NCT02946073|11291761|FG000|NOT COMPLETED|Titration Phase||589
10161141|NCT02946073|11291762|FG001|NOT COMPLETED|Titration Phase||0
10161142|NCT02946073|11291763|FG002|NOT COMPLETED|Titration Phase||23
10161143|NCT02946073|11291764|FG003|NOT COMPLETED|Titration Phase||0
10161144|NCT02946073|11291761|FG000|STARTED|Double Blind Phase||112
10161145|NCT02946073|11291762|FG001|STARTED|Double Blind Phase||110
10161146|NCT02946073|11291763|FG002|STARTED|Double Blind Phase||0
10161147|NCT02946073|11291764|FG003|STARTED|Double Blind Phase||0
10161148|NCT02946073|11291761|FG000|COMPLETED|Double Blind Phase||88
10161149|NCT02946073|11291762|FG001|COMPLETED|Double Blind Phase||70
10161150|NCT02946073|11291763|FG002|COMPLETED|Double Blind Phase||0
10161151|NCT02946073|11291764|FG003|COMPLETED|Double Blind Phase||0
10161152|NCT02946073|11291761|FG000|NOT COMPLETED|Double Blind Phase||24
10161153|NCT02946073|11291762|FG001|NOT COMPLETED|Double Blind Phase||40
10161154|NCT02946073|11291763|FG002|NOT COMPLETED|Double Blind Phase||0
10161155|NCT02946073|11291764|FG003|NOT COMPLETED|Double Blind Phase||0
10161156|NCT02946073|11291761|FG000|STARTED|Open Label Phase||0
10161157|NCT02946073|11291762|FG001|STARTED|Open Label Phase||0
10161158|NCT02946073|11291763|FG002|STARTED|Open Label Phase||75
10161159|NCT02946073|11291764|FG003|STARTED|Open Label Phase||57
10161160|NCT02946073|11291761|FG000|COMPLETED|Open Label Phase||0
10161161|NCT02946073|11291762|FG001|COMPLETED|Open Label Phase||0
10161162|NCT02946073|11291763|FG002|COMPLETED|Open Label Phase||54
10161163|NCT02946073|11291764|FG003|COMPLETED|Open Label Phase||44
10161164|NCT02946073|11291761|FG000|NOT COMPLETED|Open Label Phase||0
10161165|NCT02946073|11291762|FG001|NOT COMPLETED|Open Label Phase||0
10161166|NCT02946073|11291763|FG002|NOT COMPLETED|Open Label Phase||21
10161167|NCT02946073|11291764|FG003|NOT COMPLETED|Open Label Phase||13
10161168|NCT02946229|11291783|FG000|STARTED|Overall Study||142
10161169|NCT02946229|11291783|FG000|COMPLETED|Overall Study||142
10161170|NCT02946229|11291783|FG000|NOT COMPLETED|Overall Study||0
10161171|NCT02946385|11291793|FG000|STARTED|Overall Study||126
10161172|NCT02946385|11291794|FG001|STARTED|Overall Study||127
10161173|NCT02946385|11291795|FG002|STARTED|Overall Study||99
10161174|NCT02946385|11291796|FG003|STARTED|Overall Study||74
10161175|NCT02946385|11291797|FG004|STARTED|Overall Study||101
10161176|NCT02946385|11291798|FG005|STARTED|Overall Study||77
10161177|NCT02946385|11291793|FG000|COMPLETED|Overall Study||126
10161178|NCT02946385|11291794|FG001|COMPLETED|Overall Study||127
10161179|NCT02946385|11291795|FG002|COMPLETED|Overall Study||96
10161180|NCT02946385|11291796|FG003|COMPLETED|Overall Study||74
10161181|NCT02946385|11291797|FG004|COMPLETED|Overall Study||99
10161182|NCT02946385|11291798|FG005|COMPLETED|Overall Study||76
10161183|NCT02946385|11291793|FG000|NOT COMPLETED|Overall Study||0
10161184|NCT02946385|11291794|FG001|NOT COMPLETED|Overall Study||0
10161185|NCT02946385|11291795|FG002|NOT COMPLETED|Overall Study||3
10161186|NCT02946385|11291796|FG003|NOT COMPLETED|Overall Study||0
10161187|NCT02946385|11291797|FG004|NOT COMPLETED|Overall Study||2
10161188|NCT02946385|11291798|FG005|NOT COMPLETED|Overall Study||1
10161189|NCT02946463|11291820|FG000|STARTED|Primary Evaluation Period||125
10161190|NCT02946463|11291821|FG001|STARTED|Primary Evaluation Period||121
10161191|NCT02946463|11291820|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
10161192|NCT02946463|11291821|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
10161193|NCT02946463|11291820|FG000|COMPLETED|Primary Evaluation Period||125
10161194|NCT02946463|11291821|FG001|COMPLETED|Primary Evaluation Period||119
10161195|NCT02946463|11291820|FG000|NOT COMPLETED|Primary Evaluation Period||0
10161196|NCT02946463|11291821|FG001|NOT COMPLETED|Primary Evaluation Period||2
10161197|NCT02946463|11291820|FG000|STARTED|Extension Period||124
10161198|NCT02946463|11291821|FG001|STARTED|Extension Period||119
10161199|NCT02946463|11291820|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124
10161200|NCT02946463|11291821|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119
10161201|NCT02946463|11291820|FG000|COMPLETED|Extension Period||0
10161202|NCT02946463|11291821|FG001|COMPLETED|Extension Period||0
10161203|NCT02946463|11291820|FG000|NOT COMPLETED|Extension Period||124
10161204|NCT02946463|11291821|FG001|NOT COMPLETED|Extension Period||119
10161205|NCT02946489|11291827|FG000|STARTED|Overall Study||8
10161206|NCT02946489|11291827|FG000|COMPLETED|Overall Study||8
10161207|NCT02946489|11291827|FG000|NOT COMPLETED|Overall Study||0
10161208|NCT02946515|11291833|FG000|STARTED|Overall Study||22
10161209|NCT02946515|11291834|FG001|STARTED|Overall Study||22
10161210|NCT02946515|11291833|FG000|COMPLETED|Overall Study||20
10161211|NCT02946515|11291834|FG001|COMPLETED|Overall Study||21
10161212|NCT02946515|11291833|FG000|NOT COMPLETED|Overall Study||2
10161213|NCT02946515|11291834|FG001|NOT COMPLETED|Overall Study||1
10161214|NCT02946580|11291842|FG000|STARTED|Overall Study||28
10161215|NCT02946580|11291843|FG001|STARTED|Overall Study||25
10161216|NCT02946580|11291842|FG000|COMPLETED|Overall Study||27
10161217|NCT02946580|11291843|FG001|COMPLETED|Overall Study||20
10161218|NCT02946580|11291842|FG000|NOT COMPLETED|Overall Study||1
10161219|NCT02946580|11291843|FG001|NOT COMPLETED|Overall Study||5
10161220|NCT02946892|11291849|FG000|STARTED|First Intervention (12 Weeks)||11
10161221|NCT02946892|11291850|FG001|STARTED|First Intervention (12 Weeks)||15
10161222|NCT02946892|11291849|FG000|COMPLETED|First Intervention (12 Weeks)||11
10161223|NCT02946892|11291850|FG001|COMPLETED|First Intervention (12 Weeks)||14
10161224|NCT02946892|11291849|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10161225|NCT02946892|11291850|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10161226|NCT02946892|11291849|FG000|STARTED|Washout (6 Weeks)||11
10161227|NCT02946892|11291850|FG001|STARTED|Washout (6 Weeks)||14
10161228|NCT02946892|11291849|FG000|COMPLETED|Washout (6 Weeks)||9
10161229|NCT02946892|11291850|FG001|COMPLETED|Washout (6 Weeks)||14
10161230|NCT02946892|11291849|FG000|NOT COMPLETED|Washout (6 Weeks)||2
10161231|NCT02946892|11291850|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10161232|NCT02946892|11291849|FG000|STARTED|Second Intervention||9
10161233|NCT02946892|11291850|FG001|STARTED|Second Intervention||14
10161234|NCT02946892|11291849|FG000|COMPLETED|Second Intervention||9
10161235|NCT02946892|11291850|FG001|COMPLETED|Second Intervention||14
10161236|NCT02946892|11291849|FG000|NOT COMPLETED|Second Intervention||0
10161237|NCT02946892|11291850|FG001|NOT COMPLETED|Second Intervention||0
10161238|NCT02946918|11291858|FG000|STARTED|Overall Study||6
10161239|NCT02946918|11291859|FG001|STARTED|Overall Study||8
10161240|NCT02946918|11291858|FG000|COMPLETED|Overall Study||5
10161241|NCT02946918|11291859|FG001|COMPLETED|Overall Study||5
10161242|NCT02946918|11291858|FG000|NOT COMPLETED|Overall Study||1
10161243|NCT02946918|11291859|FG001|NOT COMPLETED|Overall Study||3
10161244|NCT02947984|11291867|FG000|STARTED|Overall Study||22
10161245|NCT02947984|11291868|FG001|STARTED|Overall Study||22
10161246|NCT02947984|11291867|FG000|COMPLETED|Overall Study||22
10161247|NCT02947984|11291868|FG001|COMPLETED|Overall Study||22
10161248|NCT02947984|11291867|FG000|NOT COMPLETED|Overall Study||0
10161249|NCT02947984|11291868|FG001|NOT COMPLETED|Overall Study||0
10161250|NCT02947997|11291874|FG000|STARTED|Overall Study||4
10161251|NCT02947997|11291874|FG000|COMPLETED|Overall Study||4
10161252|NCT02947997|11291874|FG000|NOT COMPLETED|Overall Study||0
10161253|NCT02948257|11291878|FG000|STARTED|Overall Study||52
10161254|NCT02948257|11291878|FG000|COMPLETED|Overall Study||52
10161255|NCT02948257|11291878|FG000|NOT COMPLETED|Overall Study||0
10161256|NCT02948426|11291886|FG000|STARTED|Overall Study||3
10161257|NCT02948426|11291887|FG001|STARTED|Overall Study||6
10161258|NCT02948426|11291888|FG002|STARTED|Overall Study||3
10161259|NCT02948426|11291889|FG003|STARTED|Overall Study||6
10161260|NCT02948426|11291886|FG000|COMPLETED|Overall Study||3
10161261|NCT02948426|11291887|FG001|COMPLETED|Overall Study||6
10161262|NCT02948426|11291888|FG002|COMPLETED|Overall Study||3
10161263|NCT02948426|11291889|FG003|COMPLETED|Overall Study||6
10161264|NCT02948426|11291886|FG000|NOT COMPLETED|Overall Study||0
10161265|NCT02948426|11291887|FG001|NOT COMPLETED|Overall Study||0
10161266|NCT02948426|11291888|FG002|NOT COMPLETED|Overall Study||0
10161267|NCT02948426|11291889|FG003|NOT COMPLETED|Overall Study||0
10161268|NCT02948582|11291901|FG000|STARTED|Treatment Period 1||7
10161269|NCT02948582|11291902|FG001|STARTED|Treatment Period 1||7
10161270|NCT02948582|11291903|FG002|STARTED|Treatment Period 1||7
10161271|NCT02948582|11291904|FG003|STARTED|Treatment Period 1||7
10161272|NCT02948582|11291905|FG004|STARTED|Treatment Period 1||7
10161273|NCT02948582|11291906|FG005|STARTED|Treatment Period 1||7
10161274|NCT02948582|11291901|FG000|COMPLETED|Treatment Period 1||7
10161275|NCT02948582|11291902|FG001|COMPLETED|Treatment Period 1||7
10161276|NCT02948582|11291903|FG002|COMPLETED|Treatment Period 1||7
10161277|NCT02948582|11291904|FG003|COMPLETED|Treatment Period 1||7
10161278|NCT02948582|11291905|FG004|COMPLETED|Treatment Period 1||7
10161279|NCT02948582|11291906|FG005|COMPLETED|Treatment Period 1||7
10161280|NCT02948582|11291901|FG000|NOT COMPLETED|Treatment Period 1||0
10161281|NCT02948582|11291902|FG001|NOT COMPLETED|Treatment Period 1||0
10161282|NCT02948582|11291903|FG002|NOT COMPLETED|Treatment Period 1||0
10161283|NCT02948582|11291904|FG003|NOT COMPLETED|Treatment Period 1||0
10161284|NCT02948582|11291905|FG004|NOT COMPLETED|Treatment Period 1||0
10161285|NCT02948582|11291906|FG005|NOT COMPLETED|Treatment Period 1||0
10161286|NCT02948582|11291901|FG000|STARTED|Washout Period 1||7
10161287|NCT02948582|11291902|FG001|STARTED|Washout Period 1||7
10161288|NCT02948582|11291903|FG002|STARTED|Washout Period 1||7
10161289|NCT02948582|11291904|FG003|STARTED|Washout Period 1||7
10161290|NCT02948582|11291905|FG004|STARTED|Washout Period 1||7
10161291|NCT02948582|11291906|FG005|STARTED|Washout Period 1||7
10161292|NCT02948582|11291901|FG000|COMPLETED|Washout Period 1||7
10161293|NCT02948582|11291902|FG001|COMPLETED|Washout Period 1||5
10161294|NCT02948582|11291903|FG002|COMPLETED|Washout Period 1||7
10161295|NCT02948582|11291904|FG003|COMPLETED|Washout Period 1||7
10161296|NCT02948582|11291905|FG004|COMPLETED|Washout Period 1||7
10161297|NCT02948582|11291906|FG005|COMPLETED|Washout Period 1||6
10161298|NCT02948582|11291901|FG000|NOT COMPLETED|Washout Period 1||0
9710741|NCT01959139|10810389|FG000|Assessed for AEs|Phase II||0
9710742|NCT01959139|10810390|FG001|Assessed for AEs|Phase II||0
9710743|NCT01959139|10810391|FG002|Assessed for AEs|Phase II||54
9710744|NCT01959139|10810392|FG003|Assessed for AEs|Phase II||51
9710745|NCT01959139|10810389|FG000|COMPLETED|Phase II||0
9710746|NCT01959139|10810390|FG001|COMPLETED|Phase II||0
9710747|NCT01959139|10810391|FG002|COMPLETED|Phase II||0
9710748|NCT01959139|10810392|FG003|COMPLETED|Phase II||0
9710749|NCT01959139|10810389|FG000|NOT COMPLETED|Phase II||0
9710750|NCT01959139|10810390|FG001|NOT COMPLETED|Phase II||0
9710751|NCT01959139|10810391|FG002|NOT COMPLETED|Phase II||56
9710752|NCT01959139|10810392|FG003|NOT COMPLETED|Phase II||55
9710753|NCT01597778|10810409|FG000|STARTED|Overall Study||186
9710754|NCT01597778|10810410|FG001|STARTED|Overall Study||182
9710755|NCT01597778|10810409|FG000|COMPLETED|Overall Study||172
9710756|NCT01597778|10810410|FG001|COMPLETED|Overall Study||153
9710757|NCT01597778|10810409|FG000|NOT COMPLETED|Overall Study||14
9710758|NCT01597778|10810410|FG001|NOT COMPLETED|Overall Study||29
9849358|NCT00864383|10962040|FG000|STARTED|Modified Intent to Treat||640
9849359|NCT00864383|10962041|FG001|STARTED|Modified Intent to Treat||655
9849360|NCT00864383|10962042|FG002|STARTED|Modified Intent to Treat||636
9849361|NCT00864383|10962040|FG000|COMPLETED|Modified Intent to Treat||555
9849362|NCT00864383|10962041|FG001|COMPLETED|Modified Intent to Treat||568
9849363|NCT00864383|10962042|FG002|COMPLETED|Modified Intent to Treat||551
9849364|NCT00864383|10962040|FG000|NOT COMPLETED|Modified Intent to Treat||85
9849365|NCT00864383|10962041|FG001|NOT COMPLETED|Modified Intent to Treat||87
9849366|NCT00864383|10962042|FG002|NOT COMPLETED|Modified Intent to Treat||85
9849367|NCT00864513|10962050|FG000|STARTED|Overall Study||15
9849368|NCT00864513|10962050|FG000|COMPLETED|Overall Study||12
9849369|NCT00864513|10962050|FG000|NOT COMPLETED|Overall Study||3
9849370|NCT00864539|10962060|FG000|STARTED|Overall Study||104
9849371|NCT00864539|10962061|FG001|STARTED|Overall Study||95
9849372|NCT00864539|10962062|FG002|STARTED|Overall Study||102
9849373|NCT00864539|10962063|FG003|STARTED|Overall Study||96
9849374|NCT00864539|10962064|FG004|STARTED|Overall Study||103
9849375|NCT00864539|10962065|FG005|STARTED|Overall Study||85
9849376|NCT00864539|10962060|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
9849377|NCT00864539|10962061|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
9849378|NCT00864539|10962062|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
9849379|NCT00864539|10962063|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
9849380|NCT00864539|10962064|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
9849381|NCT00864539|10962065|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
9849382|NCT00864539|10962060|FG000|NOT COMPLETED|Overall Study||9
9849383|NCT00864539|10962061|FG001|NOT COMPLETED|Overall Study||23
9849384|NCT00864539|10962062|FG002|NOT COMPLETED|Overall Study||10
9849385|NCT00864539|10962063|FG003|NOT COMPLETED|Overall Study||7
9849386|NCT00864539|10962064|FG004|NOT COMPLETED|Overall Study||22
9849387|NCT00864539|10962065|FG005|NOT COMPLETED|Overall Study||14
9849388|NCT00864682|10962082|FG000|STARTED|Overall Study||52
9849389|NCT00864682|10962083|FG001|STARTED|Overall Study||51
9849390|NCT00864682|10962084|FG002|STARTED|Overall Study||53
9849391|NCT00864682|10962082|FG000|COMPLETED|Overall Study||50
9849392|NCT00864682|10962083|FG001|COMPLETED|Overall Study||50
9849393|NCT00864682|10962084|FG002|COMPLETED|Overall Study||51
9849394|NCT00864682|10962082|FG000|NOT COMPLETED|Overall Study||2
9849395|NCT00864682|10962083|FG001|NOT COMPLETED|Overall Study||1
9849396|NCT00864682|10962084|FG002|NOT COMPLETED|Overall Study||2
9849397|NCT00864708|10962092|FG000|STARTED|Overall Study||1
9849398|NCT00864708|10962092|FG000|COMPLETED|Overall Study||1
9849399|NCT00864708|10962092|FG000|NOT COMPLETED|Overall Study||0
9849400|NCT00864721|10962098|FG000|STARTED|Overall Study||63
9849401|NCT00864721|10962098|FG000|COMPLETED|Overall Study||29
9849402|NCT00864721|10962098|FG000|NOT COMPLETED|Overall Study||34
9849403|NCT00864851|10962105|FG000|STARTED|Overall Study||20
9849404|NCT00864851|10962106|FG001|STARTED|Overall Study||19
9849405|NCT00864851|10962107|FG002|STARTED|Overall Study||5
9849406|NCT00864851|10962105|FG000|COMPLETED|Overall Study||17
9849407|NCT00864851|10962106|FG001|COMPLETED|Overall Study||18
10161299|NCT02948582|11291902|FG001|NOT COMPLETED|Washout Period 1||2
10161300|NCT02948582|11291903|FG002|NOT COMPLETED|Washout Period 1||0
10161301|NCT02948582|11291904|FG003|NOT COMPLETED|Washout Period 1||0
10161302|NCT02948582|11291905|FG004|NOT COMPLETED|Washout Period 1||0
10161303|NCT02948582|11291906|FG005|NOT COMPLETED|Washout Period 1||1
10161304|NCT02948582|11291901|FG000|STARTED|Treatment Period 2||7
10161305|NCT02948582|11291902|FG001|STARTED|Treatment Period 2||5
10161306|NCT02948582|11291903|FG002|STARTED|Treatment Period 2||7
10161307|NCT02948582|11291904|FG003|STARTED|Treatment Period 2||7
10161308|NCT02948582|11291905|FG004|STARTED|Treatment Period 2||7
10161309|NCT02948582|11291906|FG005|STARTED|Treatment Period 2||6
10161310|NCT02948582|11291901|FG000|COMPLETED|Treatment Period 2||7
10161311|NCT02948582|11291902|FG001|COMPLETED|Treatment Period 2||5
10161312|NCT02948582|11291903|FG002|COMPLETED|Treatment Period 2||7
10161313|NCT02948582|11291904|FG003|COMPLETED|Treatment Period 2||7
10161314|NCT02948582|11291905|FG004|COMPLETED|Treatment Period 2||7
10161315|NCT02948582|11291906|FG005|COMPLETED|Treatment Period 2||6
10161316|NCT02948582|11291901|FG000|NOT COMPLETED|Treatment Period 2||0
10161317|NCT02948582|11291902|FG001|NOT COMPLETED|Treatment Period 2||0
10161318|NCT02948582|11291903|FG002|NOT COMPLETED|Treatment Period 2||0
10161319|NCT02948582|11291904|FG003|NOT COMPLETED|Treatment Period 2||0
10161320|NCT02948582|11291905|FG004|NOT COMPLETED|Treatment Period 2||0
10161321|NCT02948582|11291906|FG005|NOT COMPLETED|Treatment Period 2||0
10161322|NCT02948582|11291901|FG000|STARTED|Washout Period 2||7
10161323|NCT02948582|11291902|FG001|STARTED|Washout Period 2||5
10161324|NCT02948582|11291903|FG002|STARTED|Washout Period 2||7
10161325|NCT02948582|11291904|FG003|STARTED|Washout Period 2||7
10161326|NCT02948582|11291905|FG004|STARTED|Washout Period 2||7
10161327|NCT02948582|11291906|FG005|STARTED|Washout Period 2||6
10161328|NCT02948582|11291901|FG000|COMPLETED|Washout Period 2||7
10161329|NCT02948582|11291902|FG001|COMPLETED|Washout Period 2||4
10161330|NCT02948582|11291903|FG002|COMPLETED|Washout Period 2||7
10161331|NCT02948582|11291904|FG003|COMPLETED|Washout Period 2||6
10161332|NCT02948582|11291905|FG004|COMPLETED|Washout Period 2||7
10161333|NCT02948582|11291906|FG005|COMPLETED|Washout Period 2||6
10161334|NCT02948582|11291901|FG000|NOT COMPLETED|Washout Period 2||0
10161335|NCT02948582|11291902|FG001|NOT COMPLETED|Washout Period 2||1
10161336|NCT02948582|11291903|FG002|NOT COMPLETED|Washout Period 2||0
10161337|NCT02948582|11291904|FG003|NOT COMPLETED|Washout Period 2||1
10161338|NCT02948582|11291905|FG004|NOT COMPLETED|Washout Period 2||0
10161339|NCT02948582|11291906|FG005|NOT COMPLETED|Washout Period 2||0
10161340|NCT02948582|11291901|FG000|STARTED|Treatment Period 3||7
10161341|NCT02948582|11291902|FG001|STARTED|Treatment Period 3||4
10161342|NCT02948582|11291903|FG002|STARTED|Treatment Period 3||7
10161343|NCT02948582|11291904|FG003|STARTED|Treatment Period 3||6
10161344|NCT02948582|11291905|FG004|STARTED|Treatment Period 3||7
10161345|NCT02948582|11291906|FG005|STARTED|Treatment Period 3||6
10161346|NCT02948582|11291901|FG000|COMPLETED|Treatment Period 3||7
10161347|NCT02948582|11291902|FG001|COMPLETED|Treatment Period 3||4
10161348|NCT02948582|11291903|FG002|COMPLETED|Treatment Period 3||7
10161349|NCT02948582|11291904|FG003|COMPLETED|Treatment Period 3||6
10161350|NCT02948582|11291905|FG004|COMPLETED|Treatment Period 3||7
10161351|NCT02948582|11291906|FG005|COMPLETED|Treatment Period 3||6
10161352|NCT02948582|11291901|FG000|NOT COMPLETED|Treatment Period 3||0
10161353|NCT02948582|11291902|FG001|NOT COMPLETED|Treatment Period 3||0
10161354|NCT02948582|11291903|FG002|NOT COMPLETED|Treatment Period 3||0
10161355|NCT02948582|11291904|FG003|NOT COMPLETED|Treatment Period 3||0
10161356|NCT02948582|11291905|FG004|NOT COMPLETED|Treatment Period 3||0
10161357|NCT02948582|11291906|FG005|NOT COMPLETED|Treatment Period 3||0
10161358|NCT02948582|11291901|FG000|STARTED|Washout Period 3||7
10161359|NCT02948582|11291902|FG001|STARTED|Washout Period 3||4
10161360|NCT02948582|11291903|FG002|STARTED|Washout Period 3||7
10161361|NCT02948582|11291904|FG003|STARTED|Washout Period 3||6
10161362|NCT02948582|11291905|FG004|STARTED|Washout Period 3||7
10161363|NCT02948582|11291906|FG005|STARTED|Washout Period 3||6
10161364|NCT02948582|11291901|FG000|COMPLETED|Washout Period 3||7
10161365|NCT02948582|11291902|FG001|COMPLETED|Washout Period 3||4
10161366|NCT02948582|11291903|FG002|COMPLETED|Washout Period 3||7
10161367|NCT02948582|11291904|FG003|COMPLETED|Washout Period 3||6
10161368|NCT02948582|11291905|FG004|COMPLETED|Washout Period 3||7
10161369|NCT02948582|11291906|FG005|COMPLETED|Washout Period 3||6
10161370|NCT02948582|11291901|FG000|NOT COMPLETED|Washout Period 3||0
10161371|NCT02948582|11291902|FG001|NOT COMPLETED|Washout Period 3||0
10161372|NCT02948582|11291903|FG002|NOT COMPLETED|Washout Period 3||0
10161373|NCT02948582|11291904|FG003|NOT COMPLETED|Washout Period 3||0
10161374|NCT02948582|11291905|FG004|NOT COMPLETED|Washout Period 3||0
10161375|NCT02948582|11291906|FG005|NOT COMPLETED|Washout Period 3||0
10161376|NCT02948582|11291901|FG000|STARTED|Treatment Period 4||7
10161377|NCT02948582|11291902|FG001|STARTED|Treatment Period 4||4
10161378|NCT02948582|11291903|FG002|STARTED|Treatment Period 4||7
10161379|NCT02948582|11291904|FG003|STARTED|Treatment Period 4||6
10161380|NCT02948582|11291905|FG004|STARTED|Treatment Period 4||7
10161381|NCT02948582|11291906|FG005|STARTED|Treatment Period 4||6
10161382|NCT02948582|11291901|FG000|COMPLETED|Treatment Period 4||7
10161383|NCT02948582|11291902|FG001|COMPLETED|Treatment Period 4||4
10161384|NCT02948582|11291903|FG002|COMPLETED|Treatment Period 4||7
10161385|NCT02948582|11291904|FG003|COMPLETED|Treatment Period 4||6
10161386|NCT02948582|11291905|FG004|COMPLETED|Treatment Period 4||7
10161387|NCT02948582|11291906|FG005|COMPLETED|Treatment Period 4||6
10161388|NCT02948582|11291901|FG000|NOT COMPLETED|Treatment Period 4||0
10161389|NCT02948582|11291902|FG001|NOT COMPLETED|Treatment Period 4||0
10161390|NCT02948582|11291903|FG002|NOT COMPLETED|Treatment Period 4||0
10161391|NCT02948582|11291904|FG003|NOT COMPLETED|Treatment Period 4||0
10161392|NCT02948582|11291905|FG004|NOT COMPLETED|Treatment Period 4||0
10161393|NCT02948582|11291906|FG005|NOT COMPLETED|Treatment Period 4||0
10161394|NCT02948582|11291901|FG000|STARTED|Washout Period 4||7
10161395|NCT02948582|11291902|FG001|STARTED|Washout Period 4||4
10161396|NCT02948582|11291903|FG002|STARTED|Washout Period 4||7
10161397|NCT02948582|11291904|FG003|STARTED|Washout Period 4||6
10161398|NCT02948582|11291905|FG004|STARTED|Washout Period 4||7
10161399|NCT02948582|11291906|FG005|STARTED|Washout Period 4||6
10161400|NCT02948582|11291901|FG000|COMPLETED|Washout Period 4||6
10161401|NCT02948582|11291902|FG001|COMPLETED|Washout Period 4||4
10161402|NCT02948582|11291903|FG002|COMPLETED|Washout Period 4||6
10161403|NCT02948582|11291904|FG003|COMPLETED|Washout Period 4||6
10161404|NCT02948582|11291905|FG004|COMPLETED|Washout Period 4||7
10161405|NCT02948582|11291906|FG005|COMPLETED|Washout Period 4||6
10161406|NCT02948582|11291901|FG000|NOT COMPLETED|Washout Period 4||1
10161407|NCT02948582|11291902|FG001|NOT COMPLETED|Washout Period 4||0
10161408|NCT02948582|11291903|FG002|NOT COMPLETED|Washout Period 4||1
10161409|NCT02948582|11291904|FG003|NOT COMPLETED|Washout Period 4||0
10161410|NCT02948582|11291905|FG004|NOT COMPLETED|Washout Period 4||0
10161411|NCT02948582|11291906|FG005|NOT COMPLETED|Washout Period 4||0
10161412|NCT02948582|11291901|FG000|STARTED|Treatment Period 5||6
10161413|NCT02948582|11291902|FG001|STARTED|Treatment Period 5||4
10161414|NCT02948582|11291903|FG002|STARTED|Treatment Period 5||6
10161415|NCT02948582|11291904|FG003|STARTED|Treatment Period 5||6
10161416|NCT02948582|11291905|FG004|STARTED|Treatment Period 5||7
10161417|NCT02948582|11291906|FG005|STARTED|Treatment Period 5||6
10161418|NCT02948582|11291901|FG000|COMPLETED|Treatment Period 5||6
10161419|NCT02948582|11291902|FG001|COMPLETED|Treatment Period 5||4
10161420|NCT02948582|11291903|FG002|COMPLETED|Treatment Period 5||6
10161421|NCT02948582|11291904|FG003|COMPLETED|Treatment Period 5||6
10161422|NCT02948582|11291905|FG004|COMPLETED|Treatment Period 5||7
10161423|NCT02948582|11291906|FG005|COMPLETED|Treatment Period 5||6
10161424|NCT02948582|11291901|FG000|NOT COMPLETED|Treatment Period 5||0
10161425|NCT02948582|11291902|FG001|NOT COMPLETED|Treatment Period 5||0
10161426|NCT02948582|11291903|FG002|NOT COMPLETED|Treatment Period 5||0
10161427|NCT02948582|11291904|FG003|NOT COMPLETED|Treatment Period 5||0
10161428|NCT02948582|11291905|FG004|NOT COMPLETED|Treatment Period 5||0
10161429|NCT02948582|11291906|FG005|NOT COMPLETED|Treatment Period 5||0
10161430|NCT02948582|11291901|FG000|STARTED|Washout Period 5||6
10161431|NCT02948582|11291902|FG001|STARTED|Washout Period 5||4
10161432|NCT02948582|11291903|FG002|STARTED|Washout Period 5||6
10161433|NCT02948582|11291904|FG003|STARTED|Washout Period 5||6
10161434|NCT02948582|11291905|FG004|STARTED|Washout Period 5||7
10161435|NCT02948582|11291906|FG005|STARTED|Washout Period 5||6
10161436|NCT02948582|11291901|FG000|COMPLETED|Washout Period 5||6
10161437|NCT02948582|11291902|FG001|COMPLETED|Washout Period 5||4
10161438|NCT02948582|11291903|FG002|COMPLETED|Washout Period 5||6
10161439|NCT02948582|11291904|FG003|COMPLETED|Washout Period 5||6
10161440|NCT02948582|11291905|FG004|COMPLETED|Washout Period 5||7
10161441|NCT02948582|11291906|FG005|COMPLETED|Washout Period 5||6
10161442|NCT02948582|11291901|FG000|NOT COMPLETED|Washout Period 5||0
10161443|NCT02948582|11291902|FG001|NOT COMPLETED|Washout Period 5||0
10161444|NCT02948582|11291903|FG002|NOT COMPLETED|Washout Period 5||0
10161445|NCT02948582|11291904|FG003|NOT COMPLETED|Washout Period 5||0
10161446|NCT02948582|11291905|FG004|NOT COMPLETED|Washout Period 5||0
10161447|NCT02948582|11291906|FG005|NOT COMPLETED|Washout Period 5||0
10161448|NCT02948582|11291901|FG000|STARTED|Treatment Period 6||6
10161449|NCT02948582|11291902|FG001|STARTED|Treatment Period 6||4
10161450|NCT02948582|11291903|FG002|STARTED|Treatment Period 6||6
10161451|NCT02948582|11291904|FG003|STARTED|Treatment Period 6||6
10161452|NCT02948582|11291905|FG004|STARTED|Treatment Period 6||7
10161453|NCT02948582|11291906|FG005|STARTED|Treatment Period 6||6
10161454|NCT02948582|11291901|FG000|COMPLETED|Treatment Period 6||6
10161455|NCT02948582|11291902|FG001|COMPLETED|Treatment Period 6||4
10161456|NCT02948582|11291903|FG002|COMPLETED|Treatment Period 6||6
10161457|NCT02948582|11291904|FG003|COMPLETED|Treatment Period 6||6
10161458|NCT02948582|11291905|FG004|COMPLETED|Treatment Period 6||7
10161459|NCT02948582|11291906|FG005|COMPLETED|Treatment Period 6||6
10161460|NCT02948582|11291901|FG000|NOT COMPLETED|Treatment Period 6||0
10161461|NCT02948582|11291902|FG001|NOT COMPLETED|Treatment Period 6||0
10161462|NCT02948582|11291903|FG002|NOT COMPLETED|Treatment Period 6||0
10161463|NCT02948582|11291904|FG003|NOT COMPLETED|Treatment Period 6||0
10161464|NCT02948582|11291905|FG004|NOT COMPLETED|Treatment Period 6||0
10161465|NCT02948582|11291906|FG005|NOT COMPLETED|Treatment Period 6||0
10161466|NCT02948582|11291901|FG000|STARTED|Wshout Period 6||6
10161467|NCT02948582|11291902|FG001|STARTED|Wshout Period 6||4
10161468|NCT02948582|11291903|FG002|STARTED|Wshout Period 6||6
10161469|NCT02948582|11291904|FG003|STARTED|Wshout Period 6||6
10161470|NCT02948582|11291905|FG004|STARTED|Wshout Period 6||7
10161471|NCT02948582|11291906|FG005|STARTED|Wshout Period 6||6
10161472|NCT02948582|11291901|FG000|COMPLETED|Wshout Period 6||6
10161473|NCT02948582|11291902|FG001|COMPLETED|Wshout Period 6||4
10161474|NCT02948582|11291903|FG002|COMPLETED|Wshout Period 6||6
10161475|NCT02948582|11291904|FG003|COMPLETED|Wshout Period 6||6
10161476|NCT02948582|11291905|FG004|COMPLETED|Wshout Period 6||7
10161477|NCT02948582|11291906|FG005|COMPLETED|Wshout Period 6||6
10161478|NCT02948582|11291901|FG000|NOT COMPLETED|Wshout Period 6||0
10161479|NCT02948582|11291902|FG001|NOT COMPLETED|Wshout Period 6||0
10161480|NCT02948582|11291903|FG002|NOT COMPLETED|Wshout Period 6||0
10161481|NCT02948582|11291904|FG003|NOT COMPLETED|Wshout Period 6||0
10161482|NCT02948582|11291905|FG004|NOT COMPLETED|Wshout Period 6||0
10161483|NCT02948582|11291906|FG005|NOT COMPLETED|Wshout Period 6||0
10161484|NCT02948634|11291922|FG000|STARTED|Overall Study||17
10161485|NCT02948634|11291923|FG001|STARTED|Overall Study||11
10161486|NCT02948634|11291922|FG000|COMPLETED|Overall Study||7
10161487|NCT02948634|11291923|FG001|COMPLETED|Overall Study||9
10161488|NCT02948634|11291922|FG000|NOT COMPLETED|Overall Study||10
10161489|NCT02948634|11291923|FG001|NOT COMPLETED|Overall Study||2
10161490|NCT02948777|11291929|FG000|STARTED|Overall Study||14
10161491|NCT02948777|11291929|FG000|COMPLETED|Overall Study||13
10161492|NCT02948777|11291929|FG000|NOT COMPLETED|Overall Study||1
9849408|NCT00864851|10962107|FG002|COMPLETED|Overall Study||5
9849409|NCT00864851|10962105|FG000|NOT COMPLETED|Overall Study||3
9849410|NCT00864851|10962106|FG001|NOT COMPLETED|Overall Study||1
9849411|NCT00864851|10962107|FG002|NOT COMPLETED|Overall Study||0
9849412|NCT00864916|10962119|FG000|STARTED|Overall Study||10
9849413|NCT00864916|10962120|FG001|STARTED|Overall Study||9
9849414|NCT00864916|10962119|FG000|COMPLETED|Overall Study||4
9849415|NCT00864916|10962120|FG001|COMPLETED|Overall Study||5
9849416|NCT00864916|10962119|FG000|NOT COMPLETED|Overall Study||6
9849417|NCT00864916|10962120|FG001|NOT COMPLETED|Overall Study||4
9849418|NCT00865020|10962128|FG000|STARTED|Overall Study||414
9849419|NCT00865020|10962129|FG001|STARTED|Overall Study||408
9849420|NCT00865020|10962128|FG000|COMPLETED|Overall Study||365
9849421|NCT00865020|10962129|FG001|COMPLETED|Overall Study||357
9849422|NCT00865020|10962128|FG000|NOT COMPLETED|Overall Study||49
9849423|NCT00865020|10962129|FG001|NOT COMPLETED|Overall Study||51
9849424|NCT00865046|10962138|FG000|STARTED|Overall Study||63
9849425|NCT00865046|10962139|FG001|STARTED|Overall Study||64
9849426|NCT00865046|10962140|FG002|STARTED|Overall Study||63
9849427|NCT00865046|10962138|FG000|COMPLETED|Overall Study||57
9849428|NCT00865046|10962139|FG001|COMPLETED|Overall Study||59
9849429|NCT00865046|10962140|FG002|COMPLETED|Overall Study||62
9849430|NCT00865046|10962138|FG000|NOT COMPLETED|Overall Study||6
9849431|NCT00865046|10962139|FG001|NOT COMPLETED|Overall Study||5
9849432|NCT00865046|10962140|FG002|NOT COMPLETED|Overall Study||1
9849433|NCT00865098|10962148|FG000|STARTED|Overall Study||22
9849434|NCT00865098|10962148|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
9849435|NCT00865098|10962148|FG000|NOT COMPLETED|Overall Study||1
9849436|NCT00865124|10962155|FG000|STARTED|Overall Study||27
9849437|NCT00865124|10962156|FG001|STARTED|Overall Study||25
9849438|NCT00865124|10962157|FG002|STARTED|Overall Study||17
9849439|NCT00865124|10962155|FG000|COMPLETED|Overall Study||23
9849440|NCT00865124|10962156|FG001|COMPLETED|Overall Study||24
9849441|NCT00865124|10962157|FG002|COMPLETED|Overall Study||17
9849442|NCT00865124|10962155|FG000|NOT COMPLETED|Overall Study||4
10161493|NCT02948829|11291934|FG000|STARTED|Overall Study||200
10161494|NCT02948829|11291934|FG000|COMPLETED|Overall Study||0
10161495|NCT02948829|11291934|FG000|NOT COMPLETED|Overall Study||200
10161496|NCT02949011|11291956|FG000|STARTED|Overall Study||730
10161497|NCT02949011|11291957|FG001|STARTED|Overall Study||729
10161498|NCT02949011|11291958|FG002|STARTED|Overall Study||725
10161499|NCT02949011|11291956|FG000|Received Study Drug|Overall Study||728
10161500|NCT02949011|11291957|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
10161501|NCT02949011|11291958|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
9849443|NCT00865124|10962156|FG001|NOT COMPLETED|Overall Study||1
9849444|NCT00865124|10962157|FG002|NOT COMPLETED|Overall Study||0
9849445|NCT00865189|10962167|FG000|STARTED|Overall Study||46
9849446|NCT00865189|10962168|FG001|STARTED|Overall Study||45
9849447|NCT00865189|10962167|FG000|COMPLETED|Overall Study||34
9849448|NCT00865189|10962168|FG001|COMPLETED|Overall Study||26
10161502|NCT02949011|11291956|FG000|Intention to Treat Infected Population|Overall Study||388
10161503|NCT02949011|11291957|FG001|Intention to Treat Infected Population|Overall Study||386
10161504|NCT02949011|11291958|FG002|Intention to Treat Infected Population|Overall Study||389
10161505|NCT02949011|11291956|FG000|COMPLETED|Overall Study||697
10161506|NCT02949011|11291957|FG001|COMPLETED|Overall Study||695
10161507|NCT02949011|11291958|FG002|COMPLETED|Overall Study||683
10161508|NCT02949011|11291956|FG000|NOT COMPLETED|Overall Study||33
9710774|NCT01134601|10810441|FG000|STARTED|Overall Study||1
9710775|NCT01134601|10810441|FG000|COMPLETED|Overall Study||1
9710776|NCT01134601|10810441|FG000|NOT COMPLETED|Overall Study||0
9710777|NCT01118026|10810445|FG000|STARTED|Overall Study||101
9710778|NCT01118026|10810445|FG000|COMPLETED|Overall Study||101
9710779|NCT01118026|10810445|FG000|NOT COMPLETED|Overall Study||0
9710780|NCT00879086|10810452|FG000|STARTED|Overall Study||52
9710781|NCT00879086|10810453|FG001|STARTED|Overall Study||52
9710782|NCT00879086|10810452|FG000|Safety Analysis Set (SAS)|Overall Study||51
9710783|NCT00879086|10810453|FG001|Safety Analysis Set (SAS)|Overall Study||50
9710784|NCT00879086|10810452|FG000|COMPLETED|Overall Study||0
9710785|NCT00879086|10810453|FG001|COMPLETED|Overall Study||0
9710786|NCT00879086|10810452|FG000|NOT COMPLETED|Overall Study||52
9710787|NCT00879086|10810453|FG001|NOT COMPLETED|Overall Study||52
9710788|NCT00864227|10810459|FG000|STARTED|Overall Study||54
9710789|NCT00864227|10810459|FG000|COMPLETED|Overall Study||50
9710790|NCT00864227|10810459|FG000|NOT COMPLETED|Overall Study||4
9710800|NCT00685360|10810484|FG000|STARTED|Overall Study||161
9710801|NCT00685360|10810485|FG001|STARTED|Overall Study||160
9710802|NCT00685360|10810486|FG002|STARTED|Overall Study||160
9710803|NCT00685360|10810484|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141
9710804|NCT00685360|10810485|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136
9710805|NCT00685360|10810486|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125
9710806|NCT00685360|10810484|FG000|MITT (Solid Culture)|Overall Study||119
9710807|NCT00685360|10810485|FG001|MITT (Solid Culture)|Overall Study||115
9710808|NCT00685360|10810486|FG002|MITT (Solid Culture)|Overall Study||113
9710809|NCT00685360|10810484|FG000|COMPLETED|Overall Study||143
9710810|NCT00685360|10810485|FG001|COMPLETED|Overall Study||146
9710811|NCT00685360|10810486|FG002|COMPLETED|Overall Study||145
9710812|NCT00685360|10810484|FG000|NOT COMPLETED|Overall Study||18
9710813|NCT00685360|10810485|FG001|NOT COMPLETED|Overall Study||14
9710814|NCT00685360|10810486|FG002|NOT COMPLETED|Overall Study||15
9710815|NCT00299728|10810496|FG000|STARTED|Overall Study||11
9710816|NCT00299728|10810497|FG001|STARTED|Overall Study||11
9710817|NCT00299728|10810496|FG000|COMPLETED|Overall Study||11
9710818|NCT00299728|10810497|FG001|COMPLETED|Overall Study||8
9710819|NCT00299728|10810496|FG000|NOT COMPLETED|Overall Study||0
9710820|NCT00299728|10810497|FG001|NOT COMPLETED|Overall Study||3
9730639|NCT00127218|10830447|FG001|NOT COMPLETED|Overall Study||15
9731938|NCT00137839|10831917|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
9731939|NCT00137839|10831917|FG000|NOT COMPLETED|Overall Study||84
9731940|NCT00137969|10831926|FG000|STARTED|Overall Study||174
9731941|NCT00137969|10831927|FG001|STARTED|Overall Study||88
9731942|NCT00137969|10831926|FG000|Received Study Drug|Overall Study||169
9731943|NCT00137969|10831927|FG001|Received Study Drug|Overall Study||88
9731944|NCT00137969|10831926|FG000|COMPLETED|Overall Study||107
9731945|NCT00137969|10831927|FG001|COMPLETED|Overall Study||67
10161509|NCT02949011|11291957|FG001|NOT COMPLETED|Overall Study||34
10161510|NCT02949011|11291958|FG002|NOT COMPLETED|Overall Study||42
9731946|NCT00137969|10831926|FG000|NOT COMPLETED|Overall Study||67
9731947|NCT00137969|10831927|FG001|NOT COMPLETED|Overall Study||21
9731948|NCT00138034|10831935|FG000|STARTED|Overall Study||26
10161511|NCT02949024|11291968|FG000|STARTED|Overall Study||10
10161512|NCT02949024|11291969|FG001|STARTED|Overall Study||10
10161513|NCT02949024|11291968|FG000|COMPLETED|Overall Study||10
10161514|NCT02949024|11291969|FG001|COMPLETED|Overall Study||9
10161515|NCT02949024|11291968|FG000|NOT COMPLETED|Overall Study||0
10161516|NCT02949024|11291969|FG001|NOT COMPLETED|Overall Study||1
10161517|NCT02949141|11291977|FG000|STARTED|Overall Study||62
10161518|NCT02949141|11291977|FG000|COMPLETED|Overall Study||62
10161519|NCT02949141|11291977|FG000|NOT COMPLETED|Overall Study||0
10161520|NCT02949271|11291986|FG000|STARTED|Overall Study||90
10161521|NCT02949271|11291987|FG001|STARTED|Overall Study||89
10161522|NCT02949271|11291986|FG000|COMPLETED|Overall Study||61
10161523|NCT02949271|11291987|FG001|COMPLETED|Overall Study||59
10161524|NCT02949271|11291986|FG000|NOT COMPLETED|Overall Study||29
10161525|NCT02949271|11291987|FG001|NOT COMPLETED|Overall Study||30
10161526|NCT02949362|11291995|FG000|STARTED|Retrospective Period||24
10161527|NCT02949362|11291996|FG001|STARTED|Retrospective Period||5
10161528|NCT02949362|11291997|FG002|STARTED|Retrospective Period||0
10161529|NCT02949362|11291998|FG003|STARTED|Retrospective Period||0
10161530|NCT02949362|11291995|FG000|COMPLETED|Retrospective Period||20
10161531|NCT02949362|11291996|FG001|COMPLETED|Retrospective Period||4
10161532|NCT02949362|11291997|FG002|COMPLETED|Retrospective Period||0
10161533|NCT02949362|11291998|FG003|COMPLETED|Retrospective Period||0
10161534|NCT02949362|11291995|FG000|NOT COMPLETED|Retrospective Period||4
10161535|NCT02949362|11291996|FG001|NOT COMPLETED|Retrospective Period||1
10161536|NCT02949362|11291997|FG002|NOT COMPLETED|Retrospective Period||0
10161537|NCT02949362|11291998|FG003|NOT COMPLETED|Retrospective Period||0
10161538|NCT02949362|11291995|FG000|STARTED|Prospective Period||0
10161539|NCT02949362|11291996|FG001|STARTED|Prospective Period||0
10161540|NCT02949362|11291997|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
10161541|NCT02949362|11291998|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
10161542|NCT02949362|11291995|FG000|COMPLETED|Prospective Period||0
10161543|NCT02949362|11291996|FG001|COMPLETED|Prospective Period||0
10161544|NCT02949362|11291997|FG002|COMPLETED|Prospective Period||4
10161545|NCT02949362|11291998|FG003|COMPLETED|Prospective Period||15
10161546|NCT02949362|11291995|FG000|NOT COMPLETED|Prospective Period||0
10161547|NCT02949362|11291996|FG001|NOT COMPLETED|Prospective Period||0
10161548|NCT02949362|11291997|FG002|NOT COMPLETED|Prospective Period||1
10161549|NCT02949362|11291998|FG003|NOT COMPLETED|Prospective Period||4
10161550|NCT02949518|11292012|FG000|STARTED|Overall Study||28
10161551|NCT02949518|11292013|FG001|STARTED|Overall Study||28
10161552|NCT02949518|11292012|FG000|COMPLETED|Overall Study||25
10161553|NCT02949518|11292013|FG001|COMPLETED|Overall Study||26
10161554|NCT02949518|11292012|FG000|NOT COMPLETED|Overall Study||3
10161555|NCT02949518|11292013|FG001|NOT COMPLETED|Overall Study||2
10161556|NCT02949674|11292024|FG000|STARTED|Overall Study||31
10161557|NCT02949674|11292025|FG001|STARTED|Overall Study||31
10161558|NCT02949674|11292026|FG002|STARTED|Overall Study||31
10161559|NCT02949674|11292024|FG000|COMPLETED|Overall Study||31
10161560|NCT02949674|11292025|FG001|COMPLETED|Overall Study||31
10161561|NCT02949674|11292026|FG002|COMPLETED|Overall Study||31
10161562|NCT02949674|11292024|FG000|NOT COMPLETED|Overall Study||0
10161563|NCT02949674|11292025|FG001|NOT COMPLETED|Overall Study||0
10161564|NCT02949674|11292026|FG002|NOT COMPLETED|Overall Study||0
10161565|NCT02949908|11292034|FG000|STARTED|Overall Study||2
10161566|NCT02949908|11292034|FG000|COMPLETED|Overall Study||0
10161567|NCT02949908|11292034|FG000|NOT COMPLETED|Overall Study||2
10161568|NCT02949921|11292040|FG000|STARTED|Overall Study||10
10161569|NCT02949921|11292041|FG001|STARTED|Overall Study||10
10161570|NCT02949921|11292040|FG000|COMPLETED|Overall Study||10
10161571|NCT02949921|11292041|FG001|COMPLETED|Overall Study||10
10161572|NCT02949921|11292040|FG000|NOT COMPLETED|Overall Study||0
10161573|NCT02949921|11292041|FG001|NOT COMPLETED|Overall Study||0
10161574|NCT02949973|11292047|FG000|STARTED|Overall Study||10
10161575|NCT02949973|11292047|FG000|COMPLETED|Overall Study||9
10161576|NCT02949973|11292047|FG000|NOT COMPLETED|Overall Study||1
10161577|NCT02950025|11292053|FG000|STARTED|Overall Study||2
10161578|NCT02950025|11292054|FG001|STARTED|Overall Study||3
10161579|NCT02950025|11292053|FG000|COMPLETED|Overall Study||2
10161580|NCT02950025|11292054|FG001|COMPLETED|Overall Study||3
10161581|NCT02950025|11292053|FG000|NOT COMPLETED|Overall Study||0
10161582|NCT02950025|11292054|FG001|NOT COMPLETED|Overall Study||0
10161583|NCT02950467|11292060|FG000|STARTED|Open-label Treatment||18
10161584|NCT02950467|11292060|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
10161585|NCT02950467|11292060|FG000|NOT COMPLETED|Open-label Treatment||0
10161586|NCT02950467|11292060|FG000|STARTED|3-month Follow-up||18
10161587|NCT02950467|11292060|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
10161588|NCT02950467|11292060|FG000|NOT COMPLETED|3-month Follow-up||0
10161589|NCT02950545|11292070|FG000|STARTED|Session 1 (70 Minutes)||9
9849449|NCT00865189|10962167|FG000|NOT COMPLETED|Overall Study||12
10161590|NCT02950545|11292071|FG001|STARTED|Session 1 (70 Minutes)||9
10161591|NCT02950545|11292072|FG002|STARTED|Session 1 (70 Minutes)||7
10161592|NCT02950545|11292073|FG003|STARTED|Session 1 (70 Minutes)||8
10161593|NCT02950545|11292074|FG004|STARTED|Session 1 (70 Minutes)||8
10161594|NCT02950545|11292075|FG005|STARTED|Session 1 (70 Minutes)||10
10161595|NCT02950545|11292070|FG000|COMPLETED|Session 1 (70 Minutes)||9
10161596|NCT02950545|11292071|FG001|COMPLETED|Session 1 (70 Minutes)||9
10161597|NCT02950545|11292072|FG002|COMPLETED|Session 1 (70 Minutes)||7
10161598|NCT02950545|11292073|FG003|COMPLETED|Session 1 (70 Minutes)||8
10161599|NCT02950545|11292074|FG004|COMPLETED|Session 1 (70 Minutes)||8
10161600|NCT02950545|11292075|FG005|COMPLETED|Session 1 (70 Minutes)||9
10161601|NCT02950545|11292070|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0
10161602|NCT02950545|11292071|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0
10161603|NCT02950545|11292072|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0
10161604|NCT02950545|11292073|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0
10161605|NCT02950545|11292074|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0
10161606|NCT02950545|11292075|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1
10161607|NCT02950545|11292070|FG000|STARTED|Washout 1 (5 Minutes)||9
10161608|NCT02950545|11292071|FG001|STARTED|Washout 1 (5 Minutes)||9
10161609|NCT02950545|11292072|FG002|STARTED|Washout 1 (5 Minutes)||7
10161610|NCT02950545|11292073|FG003|STARTED|Washout 1 (5 Minutes)||8
10161611|NCT02950545|11292074|FG004|STARTED|Washout 1 (5 Minutes)||8
10161612|NCT02950545|11292075|FG005|STARTED|Washout 1 (5 Minutes)||9
10161613|NCT02950545|11292070|FG000|COMPLETED|Washout 1 (5 Minutes)||8
10161614|NCT02950545|11292071|FG001|COMPLETED|Washout 1 (5 Minutes)||9
10161615|NCT02950545|11292072|FG002|COMPLETED|Washout 1 (5 Minutes)||7
10161616|NCT02950545|11292073|FG003|COMPLETED|Washout 1 (5 Minutes)||7
10161617|NCT02950545|11292074|FG004|COMPLETED|Washout 1 (5 Minutes)||8
10161618|NCT02950545|11292075|FG005|COMPLETED|Washout 1 (5 Minutes)||8
10161619|NCT02950545|11292070|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1
10161620|NCT02950545|11292071|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0
10161621|NCT02950545|11292072|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0
10161622|NCT02950545|11292073|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1
10161623|NCT02950545|11292074|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0
10161624|NCT02950545|11292075|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1
10161625|NCT02950545|11292070|FG000|STARTED|Session 2 (70 Minutes)||8
10161626|NCT02950545|11292071|FG001|STARTED|Session 2 (70 Minutes)||9
10161627|NCT02950545|11292072|FG002|STARTED|Session 2 (70 Minutes)||7
10161628|NCT02950545|11292073|FG003|STARTED|Session 2 (70 Minutes)||7
10161629|NCT02950545|11292074|FG004|STARTED|Session 2 (70 Minutes)||8
10161630|NCT02950545|11292075|FG005|STARTED|Session 2 (70 Minutes)||8
10161631|NCT02950545|11292070|FG000|COMPLETED|Session 2 (70 Minutes)||8
10161632|NCT02950545|11292071|FG001|COMPLETED|Session 2 (70 Minutes)||9
10161633|NCT02950545|11292072|FG002|COMPLETED|Session 2 (70 Minutes)||7
10161634|NCT02950545|11292073|FG003|COMPLETED|Session 2 (70 Minutes)||7
10161635|NCT02950545|11292074|FG004|COMPLETED|Session 2 (70 Minutes)||7
10161636|NCT02950545|11292075|FG005|COMPLETED|Session 2 (70 Minutes)||8
10161637|NCT02950545|11292070|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0
10161638|NCT02950545|11292071|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0
10161639|NCT02950545|11292072|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0
10161640|NCT02950545|11292073|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0
10161641|NCT02950545|11292074|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1
10161642|NCT02950545|11292075|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0
10161643|NCT02950545|11292070|FG000|STARTED|Washout 2 (5 Minutes)||8
10161644|NCT02950545|11292071|FG001|STARTED|Washout 2 (5 Minutes)||9
10161645|NCT02950545|11292072|FG002|STARTED|Washout 2 (5 Minutes)||7
10161646|NCT02950545|11292073|FG003|STARTED|Washout 2 (5 Minutes)||7
10161647|NCT02950545|11292074|FG004|STARTED|Washout 2 (5 Minutes)||7
10161648|NCT02950545|11292075|FG005|STARTED|Washout 2 (5 Minutes)||8
10161649|NCT02950545|11292070|FG000|COMPLETED|Washout 2 (5 Minutes)||7
10161650|NCT02950545|11292071|FG001|COMPLETED|Washout 2 (5 Minutes)||9
10161651|NCT02950545|11292072|FG002|COMPLETED|Washout 2 (5 Minutes)||7
10161652|NCT02950545|11292073|FG003|COMPLETED|Washout 2 (5 Minutes)||7
10161653|NCT02950545|11292074|FG004|COMPLETED|Washout 2 (5 Minutes)||7
10161654|NCT02950545|11292075|FG005|COMPLETED|Washout 2 (5 Minutes)||8
10161655|NCT02950545|11292070|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1
10161656|NCT02950545|11292071|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0
10161657|NCT02950545|11292072|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0
10161658|NCT02950545|11292073|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0
10161659|NCT02950545|11292074|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0
10161660|NCT02950545|11292075|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0
10161661|NCT02950545|11292070|FG000|STARTED|Session 3 (70 Minutes)||7
10161662|NCT02950545|11292071|FG001|STARTED|Session 3 (70 Minutes)||9
10161663|NCT02950545|11292072|FG002|STARTED|Session 3 (70 Minutes)||7
10161664|NCT02950545|11292073|FG003|STARTED|Session 3 (70 Minutes)||7
10161665|NCT02950545|11292074|FG004|STARTED|Session 3 (70 Minutes)||7
10161666|NCT02950545|11292075|FG005|STARTED|Session 3 (70 Minutes)||8
10161667|NCT02950545|11292070|FG000|COMPLETED|Session 3 (70 Minutes)||7
10161668|NCT02950545|11292071|FG001|COMPLETED|Session 3 (70 Minutes)||9
10161669|NCT02950545|11292072|FG002|COMPLETED|Session 3 (70 Minutes)||7
10161670|NCT02950545|11292073|FG003|COMPLETED|Session 3 (70 Minutes)||7
10161671|NCT02950545|11292074|FG004|COMPLETED|Session 3 (70 Minutes)||7
10161672|NCT02950545|11292075|FG005|COMPLETED|Session 3 (70 Minutes)||7
10161673|NCT02950545|11292070|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0
10161674|NCT02950545|11292071|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0
10161675|NCT02950545|11292072|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0
10161676|NCT02950545|11292073|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0
10161677|NCT02950545|11292074|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0
10161678|NCT02950545|11292075|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1
10161679|NCT02950558|11292083|FG000|STARTED|Overall Study||8
10161680|NCT02950558|11292084|FG001|STARTED|Overall Study||6
10161681|NCT02950558|11292083|FG000|12 Month Pain Questionnaire|Overall Study||6
10161682|NCT02950558|11292084|FG001|12 Month Pain Questionnaire|Overall Study||6
10161683|NCT02950558|11292083|FG000|COMPLETED|Overall Study||6
10161684|NCT02950558|11292084|FG001|COMPLETED|Overall Study||6
10161685|NCT02950558|11292083|FG000|NOT COMPLETED|Overall Study||2
10161686|NCT02950558|11292084|FG001|NOT COMPLETED|Overall Study||0
10161687|NCT02950753|11292093|FG000|STARTED|Overall Study||15
10161688|NCT02950753|11292094|FG001|STARTED|Overall Study||15
10161689|NCT02950753|11292093|FG000|COMPLETED|Overall Study||15
10161690|NCT02950753|11292094|FG001|COMPLETED|Overall Study||15
10161691|NCT02950753|11292093|FG000|NOT COMPLETED|Overall Study||0
10161692|NCT02950753|11292094|FG001|NOT COMPLETED|Overall Study||0
10161693|NCT02950831|11292100|FG000|STARTED|Overall Study||27
10161694|NCT02950831|11292100|FG000|Complete Trial|Overall Study||26
10161695|NCT02950831|11292100|FG000|Permanent Implant|Overall Study||20
10161696|NCT02950831|11292100|FG000|4 Week Follow up|Overall Study||20
10161697|NCT02950831|11292100|FG000|8 Weeks Follow up|Overall Study||19
10161698|NCT02950831|11292100|FG000|COMPLETED|Overall Study||18
9710844|NCT04450823|10810533|FG000|STARTED|Overall Study||61
9710845|NCT04450823|10810533|FG000|COMPLETED|Overall Study||58
9710846|NCT04450823|10810533|FG000|NOT COMPLETED|Overall Study||3
9710847|NCT04446247|10810537|FG000|STARTED|Overall Study||14
9710848|NCT04446247|10810537|FG000|COMPLETED|Overall Study||14
9710849|NCT04446247|10810537|FG000|NOT COMPLETED|Overall Study||0
9710850|NCT04386785|10810543|FG000|STARTED|Overall Study||27
9710851|NCT04386785|10810543|FG000|COMPLETED|Overall Study||27
9710852|NCT04386785|10810543|FG000|NOT COMPLETED|Overall Study||0
9710853|NCT04347564|10810547|FG000|STARTED|Overall Study||45
9710854|NCT04347564|10810547|FG000|COMPLETED|Overall Study||45
9710855|NCT04347564|10810547|FG000|NOT COMPLETED|Overall Study||0
9710874|NCT04274556|10810584|FG000|STARTED|Overall Study||86
9710875|NCT04274556|10810584|FG000|COMPLETED|Overall Study||86
9710876|NCT04274556|10810584|FG000|NOT COMPLETED|Overall Study||0
9710877|NCT04270292|10810588|FG000|STARTED|Overall Study||164
9710878|NCT04270292|10810588|FG000|COMPLETED|Overall Study||164
9710879|NCT04270292|10810588|FG000|NOT COMPLETED|Overall Study||0
9710880|NCT04182217|10810592|FG000|STARTED|Overall Study||91
9710881|NCT04182217|10810592|FG000|COMPLETED|Overall Study||91
9710882|NCT04182217|10810592|FG000|NOT COMPLETED|Overall Study||0
9710883|NCT04160988|10810596|FG000|STARTED|Overall Study||703
9710884|NCT04160988|10810596|FG000|COMPLETED|Overall Study||675
9710885|NCT04160988|10810596|FG000|NOT COMPLETED|Overall Study||28
9710886|NCT04083404|10810601|FG000|STARTED|Overall Study||202
9710887|NCT04083404|10810601|FG000|COMPLETED|Overall Study||202
9710888|NCT04083404|10810601|FG000|NOT COMPLETED|Overall Study||0
9710889|NCT04079114|10810605|FG000|STARTED|Overall Study||166
9710890|NCT04079114|10810605|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0
9710891|NCT04079114|10810605|FG000|NOT COMPLETED|Overall Study||166
9710892|NCT04075279|10810609|FG000|STARTED|Overall Study||19
9710893|NCT04075279|10810609|FG000|COMPLETED|Overall Study||19
9710894|NCT04075279|10810609|FG000|NOT COMPLETED|Overall Study||0
9710917|NCT03977818|10810638|FG000|STARTED|Overall Study||2165
9710918|NCT03977818|10810638|FG000|COMPLETED|Overall Study||2165
9710919|NCT03977818|10810638|FG000|NOT COMPLETED|Overall Study||0
9710920|NCT03976531|10810642|FG000|STARTED|Overall Study||42
9710921|NCT03976531|10810642|FG000|COMPLETED|Overall Study||42
9710922|NCT03976531|10810642|FG000|NOT COMPLETED|Overall Study||0
9730640|NCT00127231|10830457|FG000|STARTED|Overall Study||74
9730641|NCT00127231|10830458|FG001|STARTED|Overall Study||74
9730642|NCT00127231|10830457|FG000|COMPLETED|Overall Study||68
9730643|NCT00127231|10830458|FG001|COMPLETED|Overall Study||68
9730644|NCT00127231|10830457|FG000|NOT COMPLETED|Overall Study||6
9730645|NCT00127231|10830458|FG001|NOT COMPLETED|Overall Study||6
9730646|NCT00127413|10830468|FG000|STARTED|Overall Study||12
9730647|NCT00127413|10830469|FG001|STARTED|Overall Study||10
9730648|NCT00127413|10830470|FG002|STARTED|Overall Study||13
9730649|NCT00127413|10830471|FG003|STARTED|Overall Study||7
9730650|NCT00127413|10830468|FG000|COMPLETED|Overall Study||6
9730651|NCT00127413|10830469|FG001|COMPLETED|Overall Study||6
9730652|NCT00127413|10830470|FG002|COMPLETED|Overall Study||5
9730653|NCT00127413|10830471|FG003|COMPLETED|Overall Study||5
9730654|NCT00127413|10830468|FG000|NOT COMPLETED|Overall Study||6
9730655|NCT00127413|10830469|FG001|NOT COMPLETED|Overall Study||4
9730656|NCT00127413|10830470|FG002|NOT COMPLETED|Overall Study||8
9730657|NCT00127413|10830471|FG003|NOT COMPLETED|Overall Study||2
9730658|NCT00127439|10830483|FG000|STARTED|Overall Study||9
9730659|NCT00127439|10830484|FG001|STARTED|Overall Study||10
9730660|NCT00127439|10830483|FG000|COMPLETED|Overall Study||9
9730661|NCT00127439|10830484|FG001|COMPLETED|Overall Study||10
9730662|NCT00127439|10830483|FG000|NOT COMPLETED|Overall Study||0
9730663|NCT00127439|10830484|FG001|NOT COMPLETED|Overall Study||0
9730664|NCT00127530|10830495|FG000|STARTED|Overall Study||72
9730665|NCT00127530|10830496|FG001|STARTED|Overall Study||228
9730666|NCT00127530|10830495|FG000|COMPLETED|Overall Study||71
9730667|NCT00127530|10830496|FG001|COMPLETED|Overall Study||207
9730668|NCT00127530|10830495|FG000|NOT COMPLETED|Overall Study||1
9730669|NCT00127530|10830496|FG001|NOT COMPLETED|Overall Study||21
9730670|NCT00127608|10830502|FG000|STARTED|Overall Study||36
9730671|NCT00127608|10830502|FG000|COMPLETED|Overall Study||35
9730672|NCT00127608|10830502|FG000|NOT COMPLETED|Overall Study||1
10161699|NCT02950831|11292100|FG000|NOT COMPLETED|Overall Study||9
10161700|NCT02951143|11292110|FG000|STARTED|Overall Study||97
9730673|NCT00127660|10830510|FG000|STARTED|Overall Study||153
9730674|NCT00127660|10830511|FG001|STARTED|Overall Study||154
9730675|NCT00127660|10830512|FG002|STARTED|Overall Study||148
10161701|NCT02951143|11292111|FG001|STARTED|Overall Study||41
10161702|NCT02951143|11292112|FG002|STARTED|Overall Study||47
10161703|NCT02951143|11292113|FG003|STARTED|Overall Study||39
10161704|NCT02951143|11292114|FG004|STARTED|Overall Study||37
10161705|NCT02951143|11292115|FG005|STARTED|Overall Study||44
10161706|NCT02951143|11292110|FG000|COMPLETED|Overall Study||36
10161707|NCT02951143|11292111|FG001|COMPLETED|Overall Study||32
10161708|NCT02951143|11292112|FG002|COMPLETED|Overall Study||29
10161709|NCT02951143|11292113|FG003|COMPLETED|Overall Study||30
10161710|NCT02951143|11292114|FG004|COMPLETED|Overall Study||31
10161711|NCT02951143|11292115|FG005|COMPLETED|Overall Study||29
10161712|NCT02951143|11292110|FG000|NOT COMPLETED|Overall Study||61
10161713|NCT02951143|11292111|FG001|NOT COMPLETED|Overall Study||9
10161714|NCT02951143|11292112|FG002|NOT COMPLETED|Overall Study||18
10161715|NCT02951143|11292113|FG003|NOT COMPLETED|Overall Study||9
10161716|NCT02951143|11292114|FG004|NOT COMPLETED|Overall Study||6
10161717|NCT02951143|11292115|FG005|NOT COMPLETED|Overall Study||15
10161718|NCT02951156|11292132|FG000|STARTED|Overall Study||9
10161719|NCT02951156|11292133|FG001|STARTED|Overall Study||9
10161720|NCT02951156|11292134|FG002|STARTED|Overall Study||11
10161721|NCT02951156|11292132|FG000|COMPLETED|Overall Study||0
10161722|NCT02951156|11292133|FG001|COMPLETED|Overall Study||0
10161723|NCT02951156|11292134|FG002|COMPLETED|Overall Study||1
10161724|NCT02951156|11292132|FG000|NOT COMPLETED|Overall Study||9
10161725|NCT02951156|11292133|FG001|NOT COMPLETED|Overall Study||9
10161726|NCT02951156|11292134|FG002|NOT COMPLETED|Overall Study||10
10161727|NCT02951182|11292149|FG000|STARTED|Overall Study||11
10161728|NCT02951182|11292150|FG001|STARTED|Overall Study||9
10161729|NCT02951182|11292151|FG002|STARTED|Overall Study||9
10161730|NCT02951182|11292152|FG003|STARTED|Overall Study||18
10161731|NCT02951182|11292153|FG004|STARTED|Overall Study||6
10161732|NCT02951182|11292154|FG005|STARTED|Overall Study||20
10161733|NCT02951182|11292149|FG000|COMPLETED|Overall Study||11
10161734|NCT02951182|11292150|FG001|COMPLETED|Overall Study||9
10161735|NCT02951182|11292151|FG002|COMPLETED|Overall Study||9
10161736|NCT02951182|11292152|FG003|COMPLETED|Overall Study||18
10161737|NCT02951182|11292153|FG004|COMPLETED|Overall Study||6
10161738|NCT02951182|11292154|FG005|COMPLETED|Overall Study||20
10161739|NCT02951182|11292149|FG000|NOT COMPLETED|Overall Study||0
10161740|NCT02951182|11292150|FG001|NOT COMPLETED|Overall Study||0
10161741|NCT02951182|11292151|FG002|NOT COMPLETED|Overall Study||0
10161742|NCT02951182|11292152|FG003|NOT COMPLETED|Overall Study||0
10161743|NCT02951182|11292153|FG004|NOT COMPLETED|Overall Study||0
10161744|NCT02951182|11292154|FG005|NOT COMPLETED|Overall Study||0
10161745|NCT02951195|11292182|FG000|STARTED|Overall Study||8
10161746|NCT02951195|11292183|FG001|STARTED|Overall Study||6
10161747|NCT02951195|11292184|FG002|STARTED|Overall Study||10
10161748|NCT02951195|11292185|FG003|STARTED|Overall Study||10
10161749|NCT02951195|11292186|FG004|STARTED|Overall Study||4
10161750|NCT02951195|11292187|FG005|STARTED|Overall Study||10
10161751|NCT02951195|11292188|FG006|STARTED|Overall Study||7
10161752|NCT02951195|11292189|FG007|STARTED|Overall Study||21
10161753|NCT02951195|11292182|FG000|COMPLETED|Overall Study||8
10161754|NCT02951195|11292183|FG001|COMPLETED|Overall Study||6
10161755|NCT02951195|11292184|FG002|COMPLETED|Overall Study||10
10161756|NCT02951195|11292185|FG003|COMPLETED|Overall Study||10
10161757|NCT02951195|11292186|FG004|COMPLETED|Overall Study||4
10161758|NCT02951195|11292187|FG005|COMPLETED|Overall Study||10
10161759|NCT02951195|11292188|FG006|COMPLETED|Overall Study||7
10161760|NCT02951195|11292189|FG007|COMPLETED|Overall Study||21
10161761|NCT02951195|11292182|FG000|NOT COMPLETED|Overall Study||0
10161762|NCT02951195|11292183|FG001|NOT COMPLETED|Overall Study||0
10161763|NCT02951195|11292184|FG002|NOT COMPLETED|Overall Study||0
10161764|NCT02951195|11292185|FG003|NOT COMPLETED|Overall Study||0
10161765|NCT02951195|11292186|FG004|NOT COMPLETED|Overall Study||0
10161766|NCT02951195|11292187|FG005|NOT COMPLETED|Overall Study||0
10161767|NCT02951195|11292188|FG006|NOT COMPLETED|Overall Study||0
10161768|NCT02951195|11292189|FG007|NOT COMPLETED|Overall Study||0
10161769|NCT02951273|11292217|FG000|STARTED|Overall Study||30
10161770|NCT02951273|11292217|FG000|COMPLETED|Overall Study||27
10161771|NCT02951273|11292217|FG000|NOT COMPLETED|Overall Study||3
10161772|NCT02951312|11292225|FG000|STARTED|Study Part 1||6
10161773|NCT02951312|11292226|FG001|STARTED|Study Part 1||6
10161774|NCT02951312|11292227|FG002|STARTED|Study Part 1||0
10161775|NCT02951312|11292228|FG003|STARTED|Study Part 1||0
10161776|NCT02951312|11292225|FG000|COMPLETED|Study Part 1||6
10161777|NCT02951312|11292226|FG001|COMPLETED|Study Part 1||6
10161778|NCT02951312|11292227|FG002|COMPLETED|Study Part 1||0
10161779|NCT02951312|11292228|FG003|COMPLETED|Study Part 1||0
10161780|NCT02951312|11292225|FG000|NOT COMPLETED|Study Part 1||0
10161781|NCT02951312|11292226|FG001|NOT COMPLETED|Study Part 1||0
10161782|NCT02951312|11292227|FG002|NOT COMPLETED|Study Part 1||0
10161783|NCT02951312|11292228|FG003|NOT COMPLETED|Study Part 1||0
10161784|NCT02951312|11292225|FG000|STARTED|Study Part 2||0
10161785|NCT02951312|11292226|FG001|STARTED|Study Part 2||0
10161786|NCT02951312|11292227|FG002|STARTED|Study Part 2||6
10161787|NCT02951312|11292228|FG003|STARTED|Study Part 2||6
10161788|NCT02951312|11292225|FG000|COMPLETED|Study Part 2||0
10161789|NCT02951312|11292226|FG001|COMPLETED|Study Part 2||0
10161790|NCT02951312|11292227|FG002|COMPLETED|Study Part 2||6
10161791|NCT02951312|11292228|FG003|COMPLETED|Study Part 2||6
10161792|NCT02951312|11292225|FG000|NOT COMPLETED|Study Part 2||0
10161793|NCT02951312|11292226|FG001|NOT COMPLETED|Study Part 2||0
10161794|NCT02951312|11292227|FG002|NOT COMPLETED|Study Part 2||0
10161795|NCT02951312|11292228|FG003|NOT COMPLETED|Study Part 2||0
10161796|NCT02951351|11292250|FG000|STARTED|Overall Study||19
10161797|NCT02951351|11292251|FG001|STARTED|Overall Study||17
10161798|NCT02951351|11292250|FG000|COMPLETED|Overall Study||19
10161799|NCT02951351|11292251|FG001|COMPLETED|Overall Study||17
10161800|NCT02951351|11292250|FG000|NOT COMPLETED|Overall Study||0
10161801|NCT02951351|11292251|FG001|NOT COMPLETED|Overall Study||0
10161802|NCT02951429|11292259|FG000|STARTED|Overall Study||88
10161803|NCT02951429|11292260|FG001|STARTED|Overall Study||89
10161804|NCT02951429|11292259|FG000|COMPLETED|Overall Study||16
10161805|NCT02951429|11292260|FG001|COMPLETED|Overall Study||6
10161806|NCT02951429|11292259|FG000|NOT COMPLETED|Overall Study||72
10161807|NCT02951429|11292260|FG001|NOT COMPLETED|Overall Study||83
10161808|NCT02951533|11292268|FG000|STARTED|Part I (Week 0 Through Week 24)||60
10161809|NCT02951533|11292269|FG001|STARTED|Part I (Week 0 Through Week 24)||59
10161810|NCT02951533|11292270|FG002|STARTED|Part I (Week 0 Through Week 24)||0
10161811|NCT02951533|11292268|FG000|Treated|Part I (Week 0 Through Week 24)||60
10161812|NCT02951533|11292269|FG001|Treated|Part I (Week 0 Through Week 24)||58
10161813|NCT02951533|11292270|FG002|Treated|Part I (Week 0 Through Week 24)||0
10161814|NCT02951533|11292268|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56
10161815|NCT02951533|11292269|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36
10161816|NCT02951533|11292270|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0
10161817|NCT02951533|11292268|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
10161818|NCT02951533|11292269|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
10161819|NCT02951533|11292270|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
10161820|NCT02951533|11292268|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56
10161821|NCT02951533|11292269|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
10161822|NCT02951533|11292270|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0
10161823|NCT02951533|11292268|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
10161824|NCT02951533|11292269|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
10161825|NCT02951533|11292270|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
10161826|NCT02951533|11292268|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
10161827|NCT02951533|11292269|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
10161828|NCT02951533|11292270|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
10161829|NCT02951533|11292268|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55
10161830|NCT02951533|11292269|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34
10161831|NCT02951533|11292270|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0
10161832|NCT02951533|11292268|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
10161833|NCT02951533|11292269|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
10161834|NCT02951533|11292270|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
10161835|NCT02951533|11292268|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55
10161836|NCT02951533|11292269|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
10161837|NCT02951533|11292270|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
10161838|NCT02951533|11292268|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54
10161839|NCT02951533|11292269|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10
10161840|NCT02951533|11292270|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20
10161841|NCT02951533|11292268|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
10161842|NCT02951533|11292269|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
10161843|NCT02951533|11292270|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
10197348|NCT03373383|11325307|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
10197349|NCT03373383|11325308|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
10197350|NCT03373383|11325304|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70
10197351|NCT03373383|11325305|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66
10197352|NCT03373383|11325306|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68
10197353|NCT03373383|11325307|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61
10197354|NCT03373383|11325308|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58
10161844|NCT02951533|11292268|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
10161845|NCT02951533|11292269|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
10161846|NCT02951533|11292270|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
10161847|NCT02951533|11292268|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32
10161848|NCT02951533|11292269|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0
10161849|NCT02951533|11292270|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10
10161850|NCT02951533|11292268|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
10161851|NCT02951533|11292269|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
10161852|NCT02951533|11292270|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
10161853|NCT02951702|11292289|FG000|STARTED|Overall Study||34
10161854|NCT02951702|11292290|FG001|STARTED|Overall Study||17
10161855|NCT02951702|11292289|FG000|COMPLETED|Overall Study||34
10161856|NCT02951702|11292290|FG001|COMPLETED|Overall Study||17
10161857|NCT02951702|11292289|FG000|NOT COMPLETED|Overall Study||0
10161858|NCT02951702|11292290|FG001|NOT COMPLETED|Overall Study||0
10161859|NCT02951780|11292305|FG000|STARTED|Period 1||3
10161860|NCT02951780|11292306|FG001|STARTED|Period 1||2
10161861|NCT02951780|11292307|FG002|STARTED|Period 1||3
10161862|NCT02951780|11292308|FG003|STARTED|Period 1||3
10161863|NCT02951780|11292309|FG004|STARTED|Period 1||2
10161864|NCT02951780|11292310|FG005|STARTED|Period 1||3
10161865|NCT02951780|11292311|FG006|STARTED|Period 1||2
10161866|NCT02951780|11292312|FG007|STARTED|Period 1||3
10161867|NCT02951780|11292313|FG008|STARTED|Period 1||2
10161868|NCT02951780|11292305|FG000|COMPLETED|Period 1||3
10161869|NCT02951780|11292306|FG001|COMPLETED|Period 1||2
10161870|NCT02951780|11292307|FG002|COMPLETED|Period 1||3
10161871|NCT02951780|11292308|FG003|COMPLETED|Period 1||2
10161872|NCT02951780|11292309|FG004|COMPLETED|Period 1||2
10161873|NCT02951780|11292310|FG005|COMPLETED|Period 1||3
10161874|NCT02951780|11292311|FG006|COMPLETED|Period 1||2
10161875|NCT02951780|11292312|FG007|COMPLETED|Period 1||2
10161876|NCT02951780|11292313|FG008|COMPLETED|Period 1||2
10161877|NCT02951780|11292305|FG000|NOT COMPLETED|Period 1||0
10161878|NCT02951780|11292306|FG001|NOT COMPLETED|Period 1||0
10161879|NCT02951780|11292307|FG002|NOT COMPLETED|Period 1||0
10161880|NCT02951780|11292308|FG003|NOT COMPLETED|Period 1||1
10161881|NCT02951780|11292309|FG004|NOT COMPLETED|Period 1||0
10161882|NCT02951780|11292310|FG005|NOT COMPLETED|Period 1||0
10161883|NCT02951780|11292311|FG006|NOT COMPLETED|Period 1||0
10161884|NCT02951780|11292312|FG007|NOT COMPLETED|Period 1||1
10161885|NCT02951780|11292313|FG008|NOT COMPLETED|Period 1||0
10161886|NCT02951780|11292305|FG000|STARTED|Period 2||3
10161887|NCT02951780|11292306|FG001|STARTED|Period 2||2
10161888|NCT02951780|11292307|FG002|STARTED|Period 2||3
10161889|NCT02951780|11292308|FG003|STARTED|Period 2||2
10161890|NCT02951780|11292309|FG004|STARTED|Period 2||2
10161891|NCT02951780|11292310|FG005|STARTED|Period 2||3
10161892|NCT02951780|11292311|FG006|STARTED|Period 2||2
10161893|NCT02951780|11292312|FG007|STARTED|Period 2||2
10161894|NCT02951780|11292313|FG008|STARTED|Period 2||2
10161895|NCT02951780|11292305|FG000|COMPLETED|Period 2||3
10161896|NCT02951780|11292306|FG001|COMPLETED|Period 2||2
10161897|NCT02951780|11292307|FG002|COMPLETED|Period 2||3
10161898|NCT02951780|11292308|FG003|COMPLETED|Period 2||2
10161899|NCT02951780|11292309|FG004|COMPLETED|Period 2||2
10161900|NCT02951780|11292310|FG005|COMPLETED|Period 2||3
10161901|NCT02951780|11292311|FG006|COMPLETED|Period 2||2
10161902|NCT02951780|11292312|FG007|COMPLETED|Period 2||1
10161903|NCT02951780|11292313|FG008|COMPLETED|Period 2||2
10161904|NCT02951780|11292305|FG000|NOT COMPLETED|Period 2||0
10161905|NCT02951780|11292306|FG001|NOT COMPLETED|Period 2||0
10161906|NCT02951780|11292307|FG002|NOT COMPLETED|Period 2||0
10161907|NCT02951780|11292308|FG003|NOT COMPLETED|Period 2||0
10161908|NCT02951780|11292309|FG004|NOT COMPLETED|Period 2||0
10161909|NCT02951780|11292310|FG005|NOT COMPLETED|Period 2||0
10161910|NCT02951780|11292311|FG006|NOT COMPLETED|Period 2||0
10161911|NCT02951780|11292312|FG007|NOT COMPLETED|Period 2||1
10161912|NCT02951780|11292313|FG008|NOT COMPLETED|Period 2||0
10161913|NCT02951780|11292305|FG000|STARTED|Period 3||3
10161914|NCT02951780|11292306|FG001|STARTED|Period 3||2
10161915|NCT02951780|11292307|FG002|STARTED|Period 3||3
10161916|NCT02951780|11292308|FG003|STARTED|Period 3||2
10161917|NCT02951780|11292309|FG004|STARTED|Period 3||2
10161918|NCT02951780|11292310|FG005|STARTED|Period 3||3
10161919|NCT02951780|11292311|FG006|STARTED|Period 3||2
10161920|NCT02951780|11292312|FG007|STARTED|Period 3||1
10161921|NCT02951780|11292313|FG008|STARTED|Period 3||2
10161922|NCT02951780|11292305|FG000|COMPLETED|Period 3||3
10161923|NCT02951780|11292306|FG001|COMPLETED|Period 3||2
10161924|NCT02951780|11292307|FG002|COMPLETED|Period 3||3
10161925|NCT02951780|11292308|FG003|COMPLETED|Period 3||2
10161926|NCT02951780|11292309|FG004|COMPLETED|Period 3||2
10161927|NCT02951780|11292310|FG005|COMPLETED|Period 3||3
10161928|NCT02951780|11292311|FG006|COMPLETED|Period 3||2
10161929|NCT02951780|11292312|FG007|COMPLETED|Period 3||1
10161930|NCT02951780|11292313|FG008|COMPLETED|Period 3||2
10161931|NCT02951780|11292305|FG000|NOT COMPLETED|Period 3||0
10161932|NCT02951780|11292306|FG001|NOT COMPLETED|Period 3||0
10161933|NCT02951780|11292307|FG002|NOT COMPLETED|Period 3||0
10161934|NCT02951780|11292308|FG003|NOT COMPLETED|Period 3||0
10161935|NCT02951780|11292309|FG004|NOT COMPLETED|Period 3||0
10161936|NCT02951780|11292310|FG005|NOT COMPLETED|Period 3||0
10161937|NCT02951780|11292311|FG006|NOT COMPLETED|Period 3||0
10161938|NCT02951780|11292312|FG007|NOT COMPLETED|Period 3||0
10161939|NCT02951780|11292313|FG008|NOT COMPLETED|Period 3||0
10161940|NCT02951819|11292335|FG000|STARTED|Overall Study||87
10161941|NCT02951819|11292336|FG001|STARTED|Overall Study||14
10161942|NCT02951819|11292335|FG000|Treated|Overall Study||86
10161943|NCT02951819|11292336|FG001|Treated|Overall Study||14
10161944|NCT02951819|11292335|FG000|COMPLETED|Overall Study||59
10161945|NCT02951819|11292336|FG001|COMPLETED|Overall Study||7
10161946|NCT02951819|11292335|FG000|NOT COMPLETED|Overall Study||28
10161947|NCT02951819|11292336|FG001|NOT COMPLETED|Overall Study||7
10161948|NCT02951884|11292345|FG000|STARTED|Overall Study||0
10161949|NCT02951884|11292346|FG001|STARTED|Overall Study||1
10161950|NCT02951884|11292347|FG002|STARTED|Overall Study||1
10161951|NCT02951884|11292345|FG000|COMPLETED|Overall Study||0
10161952|NCT02951884|11292346|FG001|COMPLETED|Overall Study||1
10161953|NCT02951884|11292347|FG002|COMPLETED|Overall Study||1
10161954|NCT02951884|11292345|FG000|NOT COMPLETED|Overall Study||0
10161955|NCT02951884|11292346|FG001|NOT COMPLETED|Overall Study||0
10161956|NCT02951884|11292347|FG002|NOT COMPLETED|Overall Study||0
10161957|NCT02951988|11292358|FG000|STARTED|Open-Label Treatment Period||1304
10161958|NCT02951988|11292359|FG001|STARTED|Open-Label Treatment Period||0
10161959|NCT02951988|11292360|FG002|STARTED|Open-Label Treatment Period||0
10161960|NCT02951988|11292361|FG003|STARTED|Open-Label Treatment Period||0
10161961|NCT02951988|11292358|FG000|COMPLETED|Open-Label Treatment Period||1056
10161962|NCT02951988|11292359|FG001|COMPLETED|Open-Label Treatment Period||0
10161963|NCT02951988|11292360|FG002|COMPLETED|Open-Label Treatment Period||0
10161964|NCT02951988|11292361|FG003|COMPLETED|Open-Label Treatment Period||0
10161965|NCT02951988|11292358|FG000|NOT COMPLETED|Open-Label Treatment Period||248
10161966|NCT02951988|11292359|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10161967|NCT02951988|11292360|FG002|NOT COMPLETED|Open-Label Treatment Period||0
10161968|NCT02951988|11292361|FG003|NOT COMPLETED|Open-Label Treatment Period||0
10161969|NCT02951988|11292358|FG000|STARTED|Double-Blind Treatment Period||0
10161970|NCT02951988|11292359|FG001|STARTED|Double-Blind Treatment Period||202
10161971|NCT02951988|11292360|FG002|STARTED|Double-Blind Treatment Period||202
10161972|NCT02951988|11292361|FG003|STARTED|Double-Blind Treatment Period||200
10161973|NCT02951988|11292358|FG000|COMPLETED|Double-Blind Treatment Period||0
10161974|NCT02951988|11292359|FG001|COMPLETED|Double-Blind Treatment Period||101
10161975|NCT02951988|11292360|FG002|COMPLETED|Double-Blind Treatment Period||101
10161976|NCT02951988|11292361|FG003|COMPLETED|Double-Blind Treatment Period||85
10161977|NCT02951988|11292358|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10161978|NCT02951988|11292359|FG001|NOT COMPLETED|Double-Blind Treatment Period||101
10161979|NCT02951988|11292360|FG002|NOT COMPLETED|Double-Blind Treatment Period||101
10161980|NCT02951988|11292361|FG003|NOT COMPLETED|Double-Blind Treatment Period||115
10161981|NCT02952001|11292373|FG000|STARTED|Overall Study||28
10161982|NCT02952001|11292374|FG001|STARTED|Overall Study||5
10161983|NCT02952001|11292373|FG000|COMPLETED|Overall Study||14
10161984|NCT02952001|11292374|FG001|COMPLETED|Overall Study||2
10161985|NCT02952001|11292373|FG000|NOT COMPLETED|Overall Study||14
10161986|NCT02952001|11292374|FG001|NOT COMPLETED|Overall Study||3
10161987|NCT02952261|11292383|FG000|STARTED|Overall Study||100
10161988|NCT02952261|11292384|FG001|STARTED|Overall Study||100
10161989|NCT02952261|11292383|FG000|COMPLETED|Overall Study||95
10161990|NCT02952261|11292384|FG001|COMPLETED|Overall Study||95
10161991|NCT02952261|11292383|FG000|NOT COMPLETED|Overall Study||5
10161992|NCT02952261|11292384|FG001|NOT COMPLETED|Overall Study||5
10161993|NCT02952313|11292390|FG000|STARTED|Primary Endpoint||113
10161994|NCT02952313|11292390|FG000|6 Months|Primary Endpoint||106
10161995|NCT02952313|11292390|FG000|COMPLETED|Primary Endpoint||106
10161996|NCT02952313|11292390|FG000|NOT COMPLETED|Primary Endpoint||7
10161997|NCT02952313|11292390|FG000|STARTED|Long-term Follow-up||107
10161998|NCT02952313|11292390|FG000|12-Month|Long-term Follow-up||93
10161999|NCT02952313|11292390|FG000|18-Month|Long-term Follow-up||79
10162000|NCT02952313|11292390|FG000|COMPLETED|Long-term Follow-up||75
10162001|NCT02952313|11292390|FG000|NOT COMPLETED|Long-term Follow-up||32
10162002|NCT02952586|11292397|FG000|STARTED|Lead-In Phase (7 Days)||350
10162003|NCT02952586|11292398|FG001|STARTED|Lead-In Phase (7 Days)||347
10162004|NCT02952586|11292397|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348
10162005|NCT02952586|11292398|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344
10162006|NCT02952586|11292397|FG000|COMPLETED|Lead-In Phase (7 Days)||345
10162007|NCT02952586|11292398|FG001|COMPLETED|Lead-In Phase (7 Days)||343
10162008|NCT02952586|11292397|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5
10162009|NCT02952586|11292398|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4
10162010|NCT02952586|11292397|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345
10162011|NCT02952586|11292398|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340
10162012|NCT02952586|11292397|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
10162013|NCT02952586|11292398|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
10162014|NCT02952586|11292397|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
10162015|NCT02952586|11292398|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
10162016|NCT02952586|11292397|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
10162017|NCT02952586|11292398|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
10162018|NCT02952586|11292397|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234
10162019|NCT02952586|11292398|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236
10162020|NCT02952586|11292397|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
10162021|NCT02952586|11292398|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
10162022|NCT02952586|11292397|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
10162023|NCT02952586|11292398|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
10162024|NCT02952586|11292397|FG000|COMPLETED|CRT for IMRT (63 Days)||322
10162025|NCT02952586|11292398|FG001|COMPLETED|CRT for IMRT (63 Days)||320
10162026|NCT02952586|11292397|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23
10162027|NCT02952586|11292398|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20
10162028|NCT02952586|11292397|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291
10162029|NCT02952586|11292398|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304
10162030|NCT02952586|11292397|FG000|COMPLETED|Maintenance Phase (12 Months)||139
10162031|NCT02952586|11292398|FG001|COMPLETED|Maintenance Phase (12 Months)||177
10162032|NCT02952586|11292397|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152
10162033|NCT02952586|11292398|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127
10162034|NCT02952586|11292397|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266
10162035|NCT02952586|11292398|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284
10162036|NCT02952586|11292397|FG000|COMPLETED|Follow-Up Phase (90 Days)||208
10162037|NCT02952586|11292398|FG001|COMPLETED|Follow-Up Phase (90 Days)||216
10162038|NCT02952586|11292397|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58
10162039|NCT02952586|11292398|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68
10162040|NCT02952586|11292397|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247
10162041|NCT02952586|11292398|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237
10162042|NCT02952586|11292397|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0
10162043|NCT02952586|11292398|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0
10162044|NCT02952586|11292397|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247
10162045|NCT02952586|11292398|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237
10162046|NCT02952820|11292408|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325
10162047|NCT02952820|11292409|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323
10162048|NCT02952820|11292410|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323
10162049|NCT02952820|11292408|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321
10162050|NCT02952820|11292409|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319
10162051|NCT02952820|11292410|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319
10162052|NCT02952820|11292408|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
10162053|NCT02952820|11292409|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
10162054|NCT02952820|11292410|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
10162055|NCT02952820|11292408|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
10162056|NCT02952820|11292409|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
10162057|NCT02952820|11292410|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
10162058|NCT02952820|11292408|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
10162059|NCT02952820|11292409|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
10162060|NCT02952820|11292410|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
10162061|NCT02952820|11292408|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
10162062|NCT02952820|11292409|FG001|STARTED|Active Treatment Period (6 Months)||384
10162063|NCT02952820|11292410|FG002|STARTED|Active Treatment Period (6 Months)||352
10162064|NCT02952820|11292408|FG000|COMPLETED|Active Treatment Period (6 Months)||0
10162065|NCT02952820|11292409|FG001|COMPLETED|Active Treatment Period (6 Months)||346
10162066|NCT02952820|11292410|FG002|COMPLETED|Active Treatment Period (6 Months)||321
10162067|NCT02952820|11292408|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0
10162068|NCT02952820|11292409|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38
10162069|NCT02952820|11292410|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31
10162070|NCT02952872|11292437|FG000|STARTED|Overall Study||22
10162071|NCT02952872|11292438|FG001|STARTED|Overall Study||22
10162072|NCT02952872|11292439|FG002|STARTED|Overall Study||22
10162073|NCT02952872|11292440|FG003|STARTED|Overall Study||22
10162074|NCT02952872|11292441|FG004|STARTED|Overall Study||22
10162075|NCT02952872|11292442|FG005|STARTED|Overall Study||21
10162076|NCT02952872|11292443|FG006|STARTED|Overall Study||22
10162077|NCT02952872|11292444|FG007|STARTED|Overall Study||21
10162078|NCT02952872|11292445|FG008|STARTED|Overall Study||22
10162079|NCT02952872|11292446|FG009|STARTED|Overall Study||22
10162080|NCT02952872|11292447|FG010|STARTED|Overall Study||23
10162081|NCT02952872|11292448|FG011|STARTED|Overall Study||22
10162082|NCT02952872|11292449|FG012|STARTED|Overall Study||22
10162083|NCT02952872|11292450|FG013|STARTED|Overall Study||22
10162084|NCT02952872|11292451|FG014|STARTED|Overall Study||22
10162085|NCT02952872|11292452|FG015|STARTED|Overall Study||23
10162086|NCT02952872|11292437|FG000|COMPLETED|Overall Study||22
10162087|NCT02952872|11292438|FG001|COMPLETED|Overall Study||22
10162088|NCT02952872|11292439|FG002|COMPLETED|Overall Study||22
10162089|NCT02952872|11292440|FG003|COMPLETED|Overall Study||22
10162090|NCT02952872|11292441|FG004|COMPLETED|Overall Study||22
10162091|NCT02952872|11292442|FG005|COMPLETED|Overall Study||21
10162092|NCT02952872|11292443|FG006|COMPLETED|Overall Study||22
10162093|NCT02952872|11292444|FG007|COMPLETED|Overall Study||21
10162094|NCT02952872|11292445|FG008|COMPLETED|Overall Study||22
10162095|NCT02952872|11292446|FG009|COMPLETED|Overall Study||22
10162096|NCT02952872|11292447|FG010|COMPLETED|Overall Study||23
10162097|NCT02952872|11292448|FG011|COMPLETED|Overall Study||22
10162098|NCT02952872|11292449|FG012|COMPLETED|Overall Study||22
10162099|NCT02952872|11292450|FG013|COMPLETED|Overall Study||22
10162100|NCT02952872|11292451|FG014|COMPLETED|Overall Study||22
10162101|NCT02952872|11292452|FG015|COMPLETED|Overall Study||23
10162102|NCT02952872|11292437|FG000|NOT COMPLETED|Overall Study||0
10162103|NCT02952872|11292438|FG001|NOT COMPLETED|Overall Study||0
10162104|NCT02952872|11292439|FG002|NOT COMPLETED|Overall Study||0
10162105|NCT02952872|11292440|FG003|NOT COMPLETED|Overall Study||0
10162106|NCT02952872|11292441|FG004|NOT COMPLETED|Overall Study||0
10162107|NCT02952872|11292442|FG005|NOT COMPLETED|Overall Study||0
10162108|NCT02952872|11292443|FG006|NOT COMPLETED|Overall Study||0
10162109|NCT02952872|11292444|FG007|NOT COMPLETED|Overall Study||0
10162110|NCT02952872|11292445|FG008|NOT COMPLETED|Overall Study||0
10162111|NCT02952872|11292446|FG009|NOT COMPLETED|Overall Study||0
10162112|NCT02952872|11292447|FG010|NOT COMPLETED|Overall Study||0
10162113|NCT02952872|11292448|FG011|NOT COMPLETED|Overall Study||0
10162114|NCT02952872|11292449|FG012|NOT COMPLETED|Overall Study||0
10162115|NCT02952872|11292450|FG013|NOT COMPLETED|Overall Study||0
10162116|NCT02952872|11292451|FG014|NOT COMPLETED|Overall Study||0
10162117|NCT02952872|11292452|FG015|NOT COMPLETED|Overall Study||0
10162118|NCT02952898|11292489|FG000|STARTED|Overall Study||220
10162119|NCT02952898|11292490|FG001|STARTED|Overall Study||221
10162120|NCT02952898|11292491|FG002|STARTED|Overall Study||224
10162121|NCT02952898|11292489|FG000|COMPLETED|Overall Study||198
10162122|NCT02952898|11292490|FG001|COMPLETED|Overall Study||202
10162123|NCT02952898|11292491|FG002|COMPLETED|Overall Study||209
10162124|NCT02952898|11292489|FG000|NOT COMPLETED|Overall Study||22
10162125|NCT02952898|11292490|FG001|NOT COMPLETED|Overall Study||19
10162126|NCT02952898|11292491|FG002|NOT COMPLETED|Overall Study||15
10162127|NCT02953262|11292503|FG000|STARTED|Overall Study||68
10162128|NCT02953262|11292504|FG001|STARTED|Overall Study||69
10162129|NCT02953262|11292505|FG002|STARTED|Overall Study||68
10162130|NCT02953262|11292506|FG003|STARTED|Overall Study||70
10162131|NCT02953262|11292503|FG000|COMPLETED|Overall Study||65
10162132|NCT02953262|11292504|FG001|COMPLETED|Overall Study||63
10162133|NCT02953262|11292505|FG002|COMPLETED|Overall Study||65
10162134|NCT02953262|11292506|FG003|COMPLETED|Overall Study||67
10162135|NCT02953262|11292503|FG000|NOT COMPLETED|Overall Study||3
10162136|NCT02953262|11292504|FG001|NOT COMPLETED|Overall Study||6
10162137|NCT02953262|11292505|FG002|NOT COMPLETED|Overall Study||3
10162138|NCT02953262|11292506|FG003|NOT COMPLETED|Overall Study||3
10162139|NCT02953314|11292522|FG000|STARTED|Overall Study||13
10162140|NCT02953314|11292523|FG001|STARTED|Overall Study||70
10162141|NCT02953314|11292522|FG000|COMPLETED|Overall Study||13
10162142|NCT02953314|11292523|FG001|COMPLETED|Overall Study||67
10162143|NCT02953314|11292522|FG000|NOT COMPLETED|Overall Study||0
10162144|NCT02953314|11292523|FG001|NOT COMPLETED|Overall Study||3
10162145|NCT02953418|11292529|FG000|STARTED|Overall Study||34
10162146|NCT02953418|11292529|FG000|COMPLETED|Overall Study||34
10162147|NCT02953418|11292529|FG000|NOT COMPLETED|Overall Study||0
10162148|NCT02953548|11292533|FG000|STARTED|Overall Study||5
10162149|NCT02953548|11292534|FG001|STARTED|Overall Study||4
10162150|NCT02953548|11292533|FG000|COMPLETED|Overall Study||5
10162151|NCT02953548|11292534|FG001|COMPLETED|Overall Study||4
10162152|NCT02953548|11292533|FG000|NOT COMPLETED|Overall Study||0
10162153|NCT02953548|11292534|FG001|NOT COMPLETED|Overall Study||0
10162154|NCT02953561|11292541|FG000|STARTED|Overall Study||19
10162155|NCT02953561|11292541|FG000|COMPLETED|Overall Study||19
10162156|NCT02953561|11292541|FG000|NOT COMPLETED|Overall Study||0
10162157|NCT02953639|11292548|FG000|STARTED|Overall Study||81
10162158|NCT02953639|11292549|FG001|STARTED|Overall Study||54
10162159|NCT02953639|11292550|FG002|STARTED|Overall Study||78
10162160|NCT02953639|11292548|FG000|COMPLETED|Overall Study||61
10162161|NCT02953639|11292549|FG001|COMPLETED|Overall Study||40
10162162|NCT02953639|11292550|FG002|COMPLETED|Overall Study||62
10162163|NCT02953639|11292548|FG000|NOT COMPLETED|Overall Study||20
10162164|NCT02953639|11292549|FG001|NOT COMPLETED|Overall Study||14
10162165|NCT02953639|11292550|FG002|NOT COMPLETED|Overall Study||16
10162166|NCT02953678|11292560|FG000|STARTED|Overall Study||71
10162167|NCT02953678|11292560|FG000|COMPLETED|Overall Study||0
10162168|NCT02953678|11292560|FG000|NOT COMPLETED|Overall Study||71
10162169|NCT02953782|11292573|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
10162170|NCT02953782|11292574|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
10162171|NCT02953782|11292575|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
10162172|NCT02953782|11292576|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
10162173|NCT02953782|11292577|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
10162174|NCT02953782|11292578|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162175|NCT02953782|11292579|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162176|NCT02953782|11292580|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162177|NCT02953782|11292573|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162178|NCT02953782|11292574|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162179|NCT02953782|11292575|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162180|NCT02953782|11292576|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162181|NCT02953782|11292577|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162182|NCT02953782|11292578|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162183|NCT02953782|11292579|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162184|NCT02953782|11292580|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162185|NCT02953782|11292573|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
10162186|NCT02953782|11292574|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
10162187|NCT02953782|11292575|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
10162188|NCT02953782|11292576|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
10162189|NCT02953782|11292577|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
10162190|NCT02953782|11292578|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162191|NCT02953782|11292579|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162192|NCT02953782|11292580|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10162193|NCT02953782|11292573|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162194|NCT02953782|11292574|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162195|NCT02953782|11292575|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162196|NCT02953782|11292576|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162197|NCT02953782|11292577|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
9710856|NCT04330157|10810554|FG000|STARTED|Overall Study||50
9710857|NCT04330157|10810554|FG000|COMPLETED|Overall Study||43
9710858|NCT04330157|10810554|FG000|NOT COMPLETED|Overall Study||7
9710895|NCT04066686|10810615|FG000|STARTED|Overall Study||14
9710896|NCT04066686|10810616|FG001|STARTED|Overall Study||13
9710897|NCT04066686|10810615|FG000|COMPLETED|Overall Study||12
9710898|NCT04066686|10810616|FG001|COMPLETED|Overall Study||13
9710899|NCT04066686|10810615|FG000|NOT COMPLETED|Overall Study||2
9710900|NCT04066686|10810616|FG001|NOT COMPLETED|Overall Study||0
9710901|NCT04058626|10810622|FG000|STARTED|Overall Study||305
9710902|NCT04058626|10810622|FG000|COMPLETED|Overall Study||305
9710903|NCT04058626|10810622|FG000|NOT COMPLETED|Overall Study||0
9710904|NCT04057235|10810626|FG000|STARTED|Overall Study||129
9710905|NCT04057235|10810626|FG000|Had Radiographic Data|Overall Study||58
9710906|NCT04057235|10810626|FG000|Had ODI Data|Overall Study||43
9710907|NCT04057235|10810626|FG000|Had VAS Back Data|Overall Study||45
9710908|NCT04057235|10810626|FG000|Had VAS Leg Data|Overall Study||45
9710909|NCT04057235|10810626|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
9710910|NCT04057235|10810626|FG000|NOT COMPLETED|Overall Study||0
9710923|NCT03964649|10810656|FG000|STARTED|Overall Study||349
9710924|NCT03964649|10810657|FG001|STARTED|Overall Study||304
9710925|NCT03964649|10810658|FG002|STARTED|Overall Study||2728
9710926|NCT03964649|10810659|FG003|STARTED|Overall Study||192
9710927|NCT03964649|10810660|FG004|STARTED|Overall Study||1948
9710928|NCT03964649|10810661|FG005|STARTED|Overall Study||349
9710929|NCT03964649|10810662|FG006|STARTED|Overall Study||376
9710930|NCT03964649|10810663|FG007|STARTED|Overall Study||325
9710931|NCT03964649|10810664|FG008|STARTED|Overall Study||204
9710932|NCT03964649|10810665|FG009|STARTED|Overall Study||533
9710933|NCT03964649|10810656|FG000|COMPLETED|Overall Study||349
9849450|NCT00865189|10962168|FG001|NOT COMPLETED|Overall Study||19
9849451|NCT00865202|10962176|FG000|STARTED|Overall Study||152
9849452|NCT00865202|10962177|FG001|STARTED|Overall Study||149
9849453|NCT00865202|10962176|FG000|COMPLETED|Overall Study||152
10162198|NCT02953782|11292578|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
10162199|NCT02953782|11292579|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
10162200|NCT02953782|11292580|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
10162201|NCT02953782|11292573|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162202|NCT02953782|11292574|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162203|NCT02953782|11292575|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162204|NCT02953782|11292576|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162205|NCT02953782|11292577|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162206|NCT02953782|11292578|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162207|NCT02953782|11292579|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162208|NCT02953782|11292580|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162209|NCT02953782|11292573|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162210|NCT02953782|11292574|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162211|NCT02953782|11292575|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162212|NCT02953782|11292576|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162213|NCT02953782|11292577|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10162214|NCT02953782|11292578|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
10162215|NCT02953782|11292579|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
10162216|NCT02953782|11292580|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
10197355|NCT03373383|11325304|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
10197356|NCT03373383|11325305|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
10197357|NCT03373383|11325306|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
10197358|NCT03373383|11325307|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
10197359|NCT03373383|11325308|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
10197360|NCT03373383|11325304|FG000|COMPLETED|Treatment Period: Wk0-16||70
10197361|NCT03373383|11325305|FG001|COMPLETED|Treatment Period: Wk0-16||66
10197362|NCT03373383|11325306|FG002|COMPLETED|Treatment Period: Wk0-16||68
10197363|NCT03373383|11325307|FG003|COMPLETED|Treatment Period: Wk0-16||61
10197364|NCT03373383|11325308|FG004|COMPLETED|Treatment Period: Wk0-16||58
10197365|NCT03373383|11325304|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13
10197366|NCT03373383|11325305|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15
10197367|NCT03373383|11325306|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15
10197368|NCT03373383|11325307|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21
10197369|NCT03373383|11325308|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24
10197370|NCT03373383|11325304|FG000|STARTED|Post-Treatment Period: Wk16-23||70
10197371|NCT03373383|11325305|FG001|STARTED|Post-Treatment Period: Wk16-23||66
10197372|NCT03373383|11325306|FG002|STARTED|Post-Treatment Period: Wk16-23||68
10197373|NCT03373383|11325307|FG003|STARTED|Post-Treatment Period: Wk16-23||61
10197374|NCT03373383|11325308|FG004|STARTED|Post-Treatment Period: Wk16-23||58
10197375|NCT03373383|11325304|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69
10197376|NCT03373383|11325305|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64
10197377|NCT03373383|11325306|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66
10197378|NCT03373383|11325307|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55
10197379|NCT03373383|11325308|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57
10197380|NCT03373383|11325304|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
10197381|NCT03373383|11325305|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
10197382|NCT03373383|11325306|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
10197383|NCT03373383|11325307|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
10197384|NCT03373383|11325308|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
10197385|NCT03373383|11325304|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
10197386|NCT03373383|11325305|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
10197387|NCT03373383|11325306|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
10197388|NCT03373383|11325307|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
10197389|NCT03373383|11325308|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
10197390|NCT03373383|11325304|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
10197391|NCT03373383|11325305|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
10197392|NCT03373383|11325306|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
10197393|NCT03373383|11325307|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
10197394|NCT03373383|11325308|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
10197395|NCT03373383|11325304|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69
10197396|NCT03373383|11325305|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66
10197397|NCT03373383|11325306|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68
10197398|NCT03373383|11325307|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61
10197399|NCT03373383|11325308|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58
10197400|NCT03373383|11325304|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
10197401|NCT03373383|11325305|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
10197402|NCT03373383|11325306|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
10197403|NCT03373383|11325307|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
9849454|NCT00865202|10962177|FG001|COMPLETED|Overall Study||149
10162217|NCT02953821|11292603|FG000|STARTED|Overall Study||86
10162218|NCT02953821|11292604|FG001|STARTED|Overall Study||86
10162219|NCT02953821|11292603|FG000|Safety Population|Overall Study||86
10162220|NCT02953821|11292604|FG001|Safety Population|Overall Study||86
10162221|NCT02953821|11292603|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85
10162222|NCT02953821|11292604|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84
10162223|NCT02953821|11292603|FG000|Per Protocol (PP) Population|Overall Study||72
10162224|NCT02953821|11292604|FG001|Per Protocol (PP) Population|Overall Study||75
10162225|NCT02953821|11292603|FG000|Completed Week 16 Visit|Overall Study||76
10162226|NCT02953821|11292604|FG001|Completed Week 16 Visit|Overall Study||77
10162227|NCT02953821|11292603|FG000|Completed Study Treatment (Week 24)|Overall Study||73
10162228|NCT02953821|11292604|FG001|Completed Study Treatment (Week 24)|Overall Study||76
10162229|NCT02953821|11292603|FG000|COMPLETED|Overall Study||71
10162230|NCT02953821|11292604|FG001|COMPLETED|Overall Study||73
10162231|NCT02953821|11292603|FG000|NOT COMPLETED|Overall Study||15
10162232|NCT02953821|11292604|FG001|NOT COMPLETED|Overall Study||13
10162233|NCT02953860|11292612|FG000|STARTED|Overall Study||32
10162234|NCT02953860|11292612|FG000|COMPLETED|Overall Study||32
10162235|NCT02953860|11292612|FG000|NOT COMPLETED|Overall Study||0
10162236|NCT02953873|11292616|FG000|STARTED|Overall Study||25
10162237|NCT02953873|11292616|FG000|COMPLETED|Overall Study||25
10162238|NCT02953873|11292616|FG000|NOT COMPLETED|Overall Study||0
10162239|NCT02953886|11292620|FG000|STARTED|Overall Study||20
10162240|NCT02953886|11292620|FG000|COMPLETED|Overall Study||20
10162241|NCT02953886|11292620|FG000|NOT COMPLETED|Overall Study||0
10162242|NCT02953938|11292626|FG000|STARTED|Overall Study||29
10162243|NCT02953938|11292627|FG001|STARTED|Overall Study||30
10162244|NCT02953938|11292626|FG000|COMPLETED|Overall Study||28
10162245|NCT02953938|11292627|FG001|COMPLETED|Overall Study||28
10162246|NCT02953938|11292626|FG000|NOT COMPLETED|Overall Study||1
10162247|NCT02953938|11292627|FG001|NOT COMPLETED|Overall Study||2
10162248|NCT02954172|11292636|FG000|STARTED|Overall Study||226
10162249|NCT02954172|11292637|FG001|STARTED|Overall Study||224
10162250|NCT02954172|11292636|FG000|COMPLETED|Overall Study||220
10162251|NCT02954172|11292637|FG001|COMPLETED|Overall Study||221
10162252|NCT02954172|11292636|FG000|NOT COMPLETED|Overall Study||6
10162253|NCT02954172|11292637|FG001|NOT COMPLETED|Overall Study||3
10162254|NCT02954198|11292646|FG000|STARTED|Overall Study||20
10162255|NCT02954198|11292647|FG001|STARTED|Overall Study||20
10162256|NCT02954198|11292646|FG000|COMPLETED|Overall Study||20
10162257|NCT02954198|11292647|FG001|COMPLETED|Overall Study||20
10162258|NCT02954198|11292646|FG000|NOT COMPLETED|Overall Study||0
10162259|NCT02954198|11292647|FG001|NOT COMPLETED|Overall Study||0
10162260|NCT02954354|11292656|FG000|STARTED|Overall Study||612
10162261|NCT02954354|11292657|FG001|STARTED|Overall Study||310
10162262|NCT02954354|11292658|FG002|STARTED|Overall Study||514
10162263|NCT02954354|11292656|FG000|Received Study Drug|Overall Study||610
10162264|NCT02954354|11292657|FG001|Received Study Drug|Overall Study||309
10162265|NCT02954354|11292658|FG002|Received Study Drug|Overall Study||513
10162266|NCT02954354|11292656|FG000|Intention to Treat Infected Population|Overall Study||456
10162267|NCT02954354|11292657|FG001|Intention to Treat Infected Population|Overall Study||231
10162268|NCT02954354|11292658|FG002|Intention to Treat Infected Population|Overall Study||377
10162269|NCT02954354|11292656|FG000|COMPLETED|Overall Study||578
10162270|NCT02954354|11292657|FG001|COMPLETED|Overall Study||290
10162271|NCT02954354|11292658|FG002|COMPLETED|Overall Study||498
10162272|NCT02954354|11292656|FG000|NOT COMPLETED|Overall Study||34
10162273|NCT02954354|11292657|FG001|NOT COMPLETED|Overall Study||20
10162274|NCT02954354|11292658|FG002|NOT COMPLETED|Overall Study||16
10162275|NCT02954458|11292672|FG000|STARTED|Overall Study||7
10162276|NCT02954458|11292673|FG001|STARTED|Overall Study||3
10162277|NCT02954458|11292674|FG002|STARTED|Overall Study||1
10162278|NCT02954458|11292675|FG003|STARTED|Overall Study||50
10162279|NCT02954458|11292672|FG000|COMPLETED|Overall Study||6
10162280|NCT02954458|11292673|FG001|COMPLETED|Overall Study||3
10162281|NCT02954458|11292674|FG002|COMPLETED|Overall Study||0
10162282|NCT02954458|11292675|FG003|COMPLETED|Overall Study||38
10162283|NCT02954458|11292672|FG000|NOT COMPLETED|Overall Study||1
10162284|NCT02954458|11292673|FG001|NOT COMPLETED|Overall Study||0
10162285|NCT02954458|11292674|FG002|NOT COMPLETED|Overall Study||1
10162286|NCT02954458|11292675|FG003|NOT COMPLETED|Overall Study||12
10162287|NCT02954575|11292689|FG000|STARTED|Overall Study||57
10162288|NCT02954575|11292689|FG000|Received Treatment|Overall Study||55
10162289|NCT02954575|11292689|FG000|SAF Population|Overall Study||55
10162290|NCT02954575|11292689|FG000|FAS Population|Overall Study||55
10162291|NCT02954575|11292689|FG000|PP Population|Overall Study||52
10162292|NCT02954575|11292689|FG000|PK Population|Overall Study||21
10162293|NCT02954575|11292689|FG000|SURG Population|Overall Study||1
10162294|NCT02954575|11292689|FG000|COMPLETED|Overall Study||54
10162295|NCT02954575|11292689|FG000|NOT COMPLETED|Overall Study||3
10162296|NCT02954601|11292701|FG000|STARTED|First Intervention (Five Days)||11
10162297|NCT02954601|11292702|FG001|STARTED|First Intervention (Five Days)||6
10162298|NCT02954601|11292703|FG002|STARTED|First Intervention (Five Days)||8
10162299|NCT02954601|11292704|FG003|STARTED|First Intervention (Five Days)||7
10162300|NCT02954601|11292701|FG000|COMPLETED|First Intervention (Five Days)||11
10162301|NCT02954601|11292702|FG001|COMPLETED|First Intervention (Five Days)||6
10162302|NCT02954601|11292703|FG002|COMPLETED|First Intervention (Five Days)||7
10162303|NCT02954601|11292704|FG003|COMPLETED|First Intervention (Five Days)||7
10162304|NCT02954601|11292701|FG000|NOT COMPLETED|First Intervention (Five Days)||0
10162305|NCT02954601|11292702|FG001|NOT COMPLETED|First Intervention (Five Days)||0
10162306|NCT02954601|11292703|FG002|NOT COMPLETED|First Intervention (Five Days)||1
10162307|NCT02954601|11292704|FG003|NOT COMPLETED|First Intervention (Five Days)||0
10162308|NCT02954601|11292701|FG000|STARTED|Second Intervention (Five Days)||11
10162309|NCT02954601|11292702|FG001|STARTED|Second Intervention (Five Days)||6
10162310|NCT02954601|11292703|FG002|STARTED|Second Intervention (Five Days)||8
10162311|NCT02954601|11292704|FG003|STARTED|Second Intervention (Five Days)||6
10162312|NCT02954601|11292701|FG000|COMPLETED|Second Intervention (Five Days)||11
10162313|NCT02954601|11292702|FG001|COMPLETED|Second Intervention (Five Days)||6
10162314|NCT02954601|11292703|FG002|COMPLETED|Second Intervention (Five Days)||8
10162315|NCT02954601|11292704|FG003|COMPLETED|Second Intervention (Five Days)||6
10162316|NCT02954601|11292701|FG000|NOT COMPLETED|Second Intervention (Five Days)||0
10162317|NCT02954601|11292702|FG001|NOT COMPLETED|Second Intervention (Five Days)||0
10162318|NCT02954601|11292703|FG002|NOT COMPLETED|Second Intervention (Five Days)||0
10162319|NCT02954601|11292704|FG003|NOT COMPLETED|Second Intervention (Five Days)||0
10162320|NCT02954601|11292701|FG000|STARTED|Third Intervention (Five Days)||9
10162321|NCT02954601|11292702|FG001|STARTED|Third Intervention (Five Days)||8
10162322|NCT02954601|11292703|FG002|STARTED|Third Intervention (Five Days)||6
10162323|NCT02954601|11292704|FG003|STARTED|Third Intervention (Five Days)||8
10162324|NCT02954601|11292701|FG000|COMPLETED|Third Intervention (Five Days)||9
10162325|NCT02954601|11292702|FG001|COMPLETED|Third Intervention (Five Days)||8
10162326|NCT02954601|11292703|FG002|COMPLETED|Third Intervention (Five Days)||6
10162327|NCT02954601|11292704|FG003|COMPLETED|Third Intervention (Five Days)||8
10162328|NCT02954601|11292701|FG000|NOT COMPLETED|Third Intervention (Five Days)||0
10162329|NCT02954601|11292702|FG001|NOT COMPLETED|Third Intervention (Five Days)||0
10162330|NCT02954601|11292703|FG002|NOT COMPLETED|Third Intervention (Five Days)||0
10162331|NCT02954601|11292704|FG003|NOT COMPLETED|Third Intervention (Five Days)||0
10162332|NCT02954653|11292716|FG000|STARTED|Overall Study||4
10162333|NCT02954653|11292717|FG001|STARTED|Overall Study||4
10162334|NCT02954653|11292718|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0
10162335|NCT02954653|11292719|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0
10162336|NCT02954653|11292720|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0
10162337|NCT02954653|11292721|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0
10162338|NCT02954653|11292722|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0
10162339|NCT02954653|11292723|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0
10162340|NCT02954653|11292724|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0
9710859|NCT04317690|10810568|FG000|STARTED|Overall Study||100
9710860|NCT04317690|10810569|FG001|STARTED|Overall Study||100
9710861|NCT04317690|10810570|FG002|STARTED|Overall Study||140
9710862|NCT04317690|10810571|FG003|STARTED|Overall Study||100
9710863|NCT04317690|10810572|FG004|STARTED|Overall Study||99
9710864|NCT04317690|10810568|FG000|COMPLETED|Overall Study||100
9710865|NCT04317690|10810569|FG001|COMPLETED|Overall Study||96
9710866|NCT04317690|10810570|FG002|COMPLETED|Overall Study||140
9710867|NCT04317690|10810571|FG003|COMPLETED|Overall Study||98
9710868|NCT04317690|10810572|FG004|COMPLETED|Overall Study||99
9710869|NCT04317690|10810568|FG000|NOT COMPLETED|Overall Study||0
9710870|NCT04317690|10810569|FG001|NOT COMPLETED|Overall Study||4
9710871|NCT04317690|10810570|FG002|NOT COMPLETED|Overall Study||0
9710872|NCT04317690|10810571|FG003|NOT COMPLETED|Overall Study||2
9710873|NCT04317690|10810572|FG004|NOT COMPLETED|Overall Study||0
9710911|NCT04041037|10810630|FG000|STARTED|Overall Study||2
9710912|NCT04041037|10810630|FG000|COMPLETED|Overall Study||2
9710913|NCT04041037|10810630|FG000|NOT COMPLETED|Overall Study||0
9710914|NCT04034043|10810634|FG000|STARTED|Overall Study||68
9710915|NCT04034043|10810634|FG000|COMPLETED|Overall Study||68
9710916|NCT04034043|10810634|FG000|NOT COMPLETED|Overall Study||0
9710934|NCT03964649|10810657|FG001|COMPLETED|Overall Study||304
9710935|NCT03964649|10810658|FG002|COMPLETED|Overall Study||2728
9710936|NCT03964649|10810659|FG003|COMPLETED|Overall Study||192
9710937|NCT03964649|10810660|FG004|COMPLETED|Overall Study||1948
9710938|NCT03964649|10810661|FG005|COMPLETED|Overall Study||349
10061064|NCT02101190|11186620|FG001|STARTED|Overall Study||8
10061065|NCT02101190|11186619|FG000|COMPLETED|Overall Study||8
10061066|NCT02101190|11186620|FG001|COMPLETED|Overall Study||8
10061067|NCT02101190|11186619|FG000|NOT COMPLETED|Overall Study||0
10061068|NCT02101190|11186620|FG001|NOT COMPLETED|Overall Study||0
10061069|NCT02101281|11186628|FG000|STARTED|Overall Study||20
10061070|NCT02101281|11186629|FG001|STARTED|Overall Study||20
10061071|NCT02101281|11186628|FG000|COMPLETED|Overall Study||20
10061072|NCT02101281|11186629|FG001|COMPLETED|Overall Study||19
9710939|NCT03964649|10810662|FG006|COMPLETED|Overall Study||376
9710940|NCT03964649|10810663|FG007|COMPLETED|Overall Study||325
9710941|NCT03964649|10810664|FG008|COMPLETED|Overall Study||204
9710942|NCT03964649|10810665|FG009|COMPLETED|Overall Study||533
9710943|NCT03964649|10810656|FG000|NOT COMPLETED|Overall Study||0
9710944|NCT03964649|10810657|FG001|NOT COMPLETED|Overall Study||0
10061073|NCT02101281|11186628|FG000|NOT COMPLETED|Overall Study||0
10061074|NCT02101281|11186629|FG001|NOT COMPLETED|Overall Study||1
10162341|NCT02954653|11292716|FG000|Received Treatment|Overall Study||3
10162342|NCT02954653|11292717|FG001|Received Treatment|Overall Study||4
10162343|NCT02954653|11292718|FG002|Received Treatment|Overall Study||0
10162344|NCT02954653|11292719|FG003|Received Treatment|Overall Study||0
10162345|NCT02954653|11292720|FG004|Received Treatment|Overall Study||0
10162346|NCT02954653|11292721|FG005|Received Treatment|Overall Study||0
10162347|NCT02954653|11292722|FG006|Received Treatment|Overall Study||0
10162348|NCT02954653|11292723|FG007|Received Treatment|Overall Study||0
10162349|NCT02954653|11292724|FG008|Received Treatment|Overall Study||0
10162350|NCT02954653|11292716|FG000|COMPLETED|Overall Study||0
10162351|NCT02954653|11292717|FG001|COMPLETED|Overall Study||1
10162352|NCT02954653|11292718|FG002|COMPLETED|Overall Study||0
10162353|NCT02954653|11292719|FG003|COMPLETED|Overall Study||0
10162354|NCT02954653|11292720|FG004|COMPLETED|Overall Study||0
10162355|NCT02954653|11292721|FG005|COMPLETED|Overall Study||0
10162356|NCT02954653|11292722|FG006|COMPLETED|Overall Study||0
10162357|NCT02954653|11292723|FG007|COMPLETED|Overall Study||0
10162358|NCT02954653|11292724|FG008|COMPLETED|Overall Study||0
10162359|NCT02954653|11292716|FG000|NOT COMPLETED|Overall Study||4
10162360|NCT02954653|11292717|FG001|NOT COMPLETED|Overall Study||3
10162361|NCT02954653|11292718|FG002|NOT COMPLETED|Overall Study||0
10162362|NCT02954653|11292719|FG003|NOT COMPLETED|Overall Study||0
10162363|NCT02954653|11292720|FG004|NOT COMPLETED|Overall Study||0
10162364|NCT02954653|11292721|FG005|NOT COMPLETED|Overall Study||0
10162365|NCT02954653|11292722|FG006|NOT COMPLETED|Overall Study||0
10162366|NCT02954653|11292723|FG007|NOT COMPLETED|Overall Study||0
10162367|NCT02954653|11292724|FG008|NOT COMPLETED|Overall Study||0
10162368|NCT02954848|11292738|FG000|STARTED|Overall Study||245
10162369|NCT02954848|11292739|FG001|STARTED|Overall Study||239
10162370|NCT02954848|11292738|FG000|Treated|Overall Study||245
10162371|NCT02954848|11292739|FG001|Treated|Overall Study||238
10162372|NCT02954848|11292738|FG000|COMPLETED|Overall Study||243
10162373|NCT02954848|11292739|FG001|COMPLETED|Overall Study||234
10162374|NCT02954848|11292738|FG000|NOT COMPLETED|Overall Study||2
10162375|NCT02954848|11292739|FG001|NOT COMPLETED|Overall Study||5
10162376|NCT02954887|11292745|FG000|STARTED|Overall Study||9
10162377|NCT02954887|11292745|FG000|COMPLETED|Overall Study||2
10162378|NCT02954887|11292745|FG000|NOT COMPLETED|Overall Study||7
10162379|NCT02955069|11292751|FG000|STARTED|Overall Study||95
10162380|NCT02955069|11292752|FG001|STARTED|Overall Study||21
10162381|NCT02955069|11292751|FG000|Full Analysis Set (FAS)|Overall Study||95
10162382|NCT02955069|11292752|FG001|Full Analysis Set (FAS)|Overall Study||21
10162383|NCT02955069|11292751|FG000|Safety Set|Overall Study||95
10162384|NCT02955069|11292752|FG001|Safety Set|Overall Study||21
10162385|NCT02955069|11292751|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
10162386|NCT02955069|11292752|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
10162387|NCT02955069|11292751|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94
10162388|NCT02955069|11292752|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21
10162389|NCT02955069|11292751|FG000|IG Incidence Set|Overall Study||84
10162390|NCT02955069|11292752|FG001|IG Incidence Set|Overall Study||17
10162391|NCT02955069|11292751|FG000|COMPLETED|Overall Study||0
10162392|NCT02955069|11292752|FG001|COMPLETED|Overall Study||0
10162393|NCT02955069|11292751|FG000|NOT COMPLETED|Overall Study||95
10162394|NCT02955069|11292752|FG001|NOT COMPLETED|Overall Study||21
10162395|NCT02955147|11292760|FG000|STARTED|Overall Study||13
10162396|NCT02955147|11292760|FG000|COMPLETED|Overall Study||13
10162397|NCT02955147|11292760|FG000|NOT COMPLETED|Overall Study||0
10162398|NCT02955186|11292766|FG000|STARTED|Overall Study||33
10162399|NCT02955186|11292767|FG001|STARTED|Overall Study||17
10162400|NCT02955186|11292766|FG000|COMPLETED|Overall Study||26
10162401|NCT02955186|11292767|FG001|COMPLETED|Overall Study||15
9710945|NCT03964649|10810658|FG002|NOT COMPLETED|Overall Study||0
9710946|NCT03964649|10810659|FG003|NOT COMPLETED|Overall Study||0
9710947|NCT03964649|10810660|FG004|NOT COMPLETED|Overall Study||0
9710948|NCT03964649|10810661|FG005|NOT COMPLETED|Overall Study||0
9710949|NCT03964649|10810662|FG006|NOT COMPLETED|Overall Study||0
9710950|NCT03964649|10810663|FG007|NOT COMPLETED|Overall Study||0
9710951|NCT03964649|10810664|FG008|NOT COMPLETED|Overall Study||0
9710952|NCT03964649|10810665|FG009|NOT COMPLETED|Overall Study||0
9730676|NCT00127660|10830513|FG003|STARTED|Overall Study||150
9730677|NCT00127660|10830510|FG000|COMPLETED|Overall Study||150
9730678|NCT00127660|10830511|FG001|COMPLETED|Overall Study||151
9730679|NCT00127660|10830512|FG002|COMPLETED|Overall Study||143
9730680|NCT00127660|10830513|FG003|COMPLETED|Overall Study||150
9730681|NCT00127660|10830510|FG000|NOT COMPLETED|Overall Study||3
9730682|NCT00127660|10830511|FG001|NOT COMPLETED|Overall Study||3
9730683|NCT00127660|10830512|FG002|NOT COMPLETED|Overall Study||5
9730684|NCT00127660|10830513|FG003|NOT COMPLETED|Overall Study||0
9730685|NCT00127712|10830525|FG000|STARTED|Overall Study||65
9730686|NCT00127712|10830526|FG001|STARTED|Overall Study||65
9730687|NCT00127712|10830525|FG000|COMPLETED|Overall Study||60
9730688|NCT00127712|10830526|FG001|COMPLETED|Overall Study||65
9730689|NCT00127712|10830525|FG000|NOT COMPLETED|Overall Study||5
9730690|NCT00127712|10830526|FG001|NOT COMPLETED|Overall Study||0
9730691|NCT00127790|10830536|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
10162402|NCT02955186|11292766|FG000|NOT COMPLETED|Overall Study||7
10162403|NCT02955186|11292767|FG001|NOT COMPLETED|Overall Study||2
10162404|NCT02955212|11292775|FG000|STARTED|Period 1: Double-blind Treatment Period||169
10162405|NCT02955212|11292776|FG001|STARTED|Period 1: Double-blind Treatment Period||169
10162406|NCT02955212|11292775|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153
10162407|NCT02955212|11292776|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157
10162408|NCT02955212|11292775|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16
10162409|NCT02955212|11292776|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12
10162410|NCT02955212|11292775|FG000|STARTED|Period 2: Open-label Extension||153
10162411|NCT02955212|11292776|FG001|STARTED|Period 2: Open-label Extension||157
10162412|NCT02955212|11292775|FG000|COMPLETED|Period 2: Open-label Extension||136
10162413|NCT02955212|11292776|FG001|COMPLETED|Period 2: Open-label Extension||139
10162414|NCT02955212|11292775|FG000|NOT COMPLETED|Period 2: Open-label Extension||17
10162415|NCT02955212|11292776|FG001|NOT COMPLETED|Period 2: Open-label Extension||18
10162416|NCT02955329|11292783|FG000|STARTED|Tobacco Arm||8
10162417|NCT02955329|11292783|FG000|COMPLETED|Tobacco Arm||8
10162418|NCT02955329|11292783|FG000|NOT COMPLETED|Tobacco Arm||0
10162419|NCT02955329|11292783|FG000|STARTED|Cannabis Arm||8
10162420|NCT02955329|11292783|FG000|COMPLETED|Cannabis Arm||8
10162421|NCT02955329|11292783|FG000|NOT COMPLETED|Cannabis Arm||0
10162422|NCT02955329|11292783|FG000|STARTED|Combined Cannabis and Tobacco Arm||8
10162423|NCT02955329|11292783|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8
10162424|NCT02955329|11292783|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
10162425|NCT02956044|11292794|FG000|STARTED|Overall Study||18
10162426|NCT02956044|11292795|FG001|STARTED|Overall Study||18
10162427|NCT02956044|11292796|FG002|STARTED|Overall Study||18
10162428|NCT02956044|11292794|FG000|COMPLETED|Overall Study||18
10162429|NCT02956044|11292795|FG001|COMPLETED|Overall Study||18
10162430|NCT02956044|11292796|FG002|COMPLETED|Overall Study||18
10162431|NCT02956044|11292794|FG000|NOT COMPLETED|Overall Study||0
10162432|NCT02956044|11292795|FG001|NOT COMPLETED|Overall Study||0
10162433|NCT02956044|11292796|FG002|NOT COMPLETED|Overall Study||0
10162434|NCT02956057|11292824|FG000|STARTED|Overall Study||174
10162435|NCT02956057|11292825|FG001|STARTED|Overall Study||174
10162436|NCT02956057|11292826|FG002|STARTED|Overall Study||174
9710953|NCT03941015|10810689|FG000|STARTED|Overall Study||38
9710954|NCT03941015|10810690|FG001|STARTED|Overall Study||207
9710955|NCT03941015|10810689|FG000|COMPLETED|Overall Study||38
9710956|NCT03941015|10810690|FG001|COMPLETED|Overall Study||204
9710957|NCT03941015|10810689|FG000|NOT COMPLETED|Overall Study||0
9710958|NCT03941015|10810690|FG001|NOT COMPLETED|Overall Study||3
9730692|NCT00127790|10830537|FG001|STARTED|Pre-Treatment||5
9730693|NCT00127790|10830538|FG002|STARTED|Pre-Treatment||6
9730694|NCT00127790|10830539|FG003|STARTED|Pre-Treatment||4
9730695|NCT00127790|10830536|FG000|COMPLETED|Pre-Treatment||6
9730696|NCT00127790|10830537|FG001|COMPLETED|Pre-Treatment||5
9730697|NCT00127790|10830538|FG002|COMPLETED|Pre-Treatment||6
9730698|NCT00127790|10830539|FG003|COMPLETED|Pre-Treatment||4
9730699|NCT00127790|10830536|FG000|NOT COMPLETED|Pre-Treatment||0
9730700|NCT00127790|10830537|FG001|NOT COMPLETED|Pre-Treatment||0
9730701|NCT00127790|10830538|FG002|NOT COMPLETED|Pre-Treatment||0
9730702|NCT00127790|10830539|FG003|NOT COMPLETED|Pre-Treatment||0
9730703|NCT00127790|10830536|FG000|STARTED|Post-Treatment||6
9730704|NCT00127790|10830537|FG001|STARTED|Post-Treatment||5
9730705|NCT00127790|10830538|FG002|STARTED|Post-Treatment||6
9730706|NCT00127790|10830539|FG003|STARTED|Post-Treatment||4
9730707|NCT00127790|10830536|FG000|COMPLETED|Post-Treatment||6
9730708|NCT00127790|10830537|FG001|COMPLETED|Post-Treatment||5
9730709|NCT00127790|10830538|FG002|COMPLETED|Post-Treatment||6
9730710|NCT00127790|10830539|FG003|COMPLETED|Post-Treatment||4
9730711|NCT00127790|10830536|FG000|NOT COMPLETED|Post-Treatment||0
9730712|NCT00127790|10830537|FG001|NOT COMPLETED|Post-Treatment||0
9730713|NCT00127790|10830538|FG002|NOT COMPLETED|Post-Treatment||0
9730714|NCT00127790|10830539|FG003|NOT COMPLETED|Post-Treatment||0
9730715|NCT00127803|10830553|FG000|STARTED|Overall Study||13
9730716|NCT00127803|10830554|FG001|STARTED|Overall Study||13
9730717|NCT00127803|10830555|FG002|STARTED|Overall Study||12
10061075|NCT02101294|11186641|FG000|STARTED|Overall Study||31
9730718|NCT00127803|10830556|FG003|STARTED|Overall Study||12
9730719|NCT00127803|10830553|FG000|COMPLETED|Overall Study||10
9730720|NCT00127803|10830554|FG001|COMPLETED|Overall Study||13
9730721|NCT00127803|10830555|FG002|COMPLETED|Overall Study||12
9730722|NCT00127803|10830556|FG003|COMPLETED|Overall Study||11
9730723|NCT00127803|10830553|FG000|NOT COMPLETED|Overall Study||3
9730724|NCT00127803|10830554|FG001|NOT COMPLETED|Overall Study||0
10061076|NCT02101294|11186641|FG000|COMPLETED|Overall Study||20
10061077|NCT02101294|11186641|FG000|NOT COMPLETED|Overall Study||11
10061078|NCT02101359|11186650|FG000|STARTED|Overall Study||295
10061079|NCT02101359|11186651|FG001|STARTED|Overall Study||296
10061080|NCT02101359|11186650|FG000|COMPLETED|Overall Study||266
10061081|NCT02101359|11186651|FG001|COMPLETED|Overall Study||277
10061082|NCT02101359|11186650|FG000|NOT COMPLETED|Overall Study||29
10061083|NCT02101359|11186651|FG001|NOT COMPLETED|Overall Study||19
10061084|NCT02101411|11186660|FG000|STARTED|Overall Study||111
10061085|NCT02101411|11186661|FG001|STARTED|Overall Study||109
10061086|NCT02101411|11186662|FG002|STARTED|Overall Study||114
10061087|NCT02101411|11186660|FG000|COMPLETED|Overall Study||107
10061088|NCT02101411|11186661|FG001|COMPLETED|Overall Study||102
10061089|NCT02101411|11186662|FG002|COMPLETED|Overall Study||104
10061090|NCT02101411|11186660|FG000|NOT COMPLETED|Overall Study||4
10061091|NCT02101411|11186661|FG001|NOT COMPLETED|Overall Study||7
10061092|NCT02101411|11186662|FG002|NOT COMPLETED|Overall Study||10
10061093|NCT02101437|11186674|FG000|STARTED|Overall Study||20
10061094|NCT02101437|11186675|FG001|STARTED|Overall Study||54
10162437|NCT02956057|11292827|FG003|STARTED|Overall Study||174
10162438|NCT02956057|11292828|FG004|STARTED|Overall Study||174
10162439|NCT02956057|11292829|FG005|STARTED|Overall Study||174
10162440|NCT02956057|11292824|FG000|COMPLETED|Overall Study||160
10162441|NCT02956057|11292825|FG001|COMPLETED|Overall Study||162
10162442|NCT02956057|11292826|FG002|COMPLETED|Overall Study||166
10162443|NCT02956057|11292827|FG003|COMPLETED|Overall Study||159
10162444|NCT02956057|11292828|FG004|COMPLETED|Overall Study||169
10162445|NCT02956057|11292829|FG005|COMPLETED|Overall Study||157
10162446|NCT02956057|11292824|FG000|NOT COMPLETED|Overall Study||14
10162447|NCT02956057|11292825|FG001|NOT COMPLETED|Overall Study||12
10162448|NCT02956057|11292826|FG002|NOT COMPLETED|Overall Study||8
10162449|NCT02956057|11292827|FG003|NOT COMPLETED|Overall Study||15
10162450|NCT02956057|11292828|FG004|NOT COMPLETED|Overall Study||5
10162451|NCT02956057|11292829|FG005|NOT COMPLETED|Overall Study||17
10162452|NCT02956070|11292845|FG000|STARTED|Overall Study||35
10162453|NCT02956070|11292846|FG001|STARTED|Overall Study||35
10162454|NCT02956070|11292845|FG000|COMPLETED|Overall Study||35
10162455|NCT02956070|11292846|FG001|COMPLETED|Overall Study||35
10162456|NCT02956070|11292845|FG000|NOT COMPLETED|Overall Study||0
10162457|NCT02956070|11292846|FG001|NOT COMPLETED|Overall Study||0
10162458|NCT02956122|11292852|FG000|STARTED|Overall Study||1
10162459|NCT02956122|11292852|FG000|COMPLETED|Overall Study||1
10162460|NCT02956122|11292852|FG000|NOT COMPLETED|Overall Study||0
10162461|NCT02956278|11292866|FG000|STARTED|Overall Study||15
10162462|NCT02956278|11292867|FG001|STARTED|Overall Study||9
10162463|NCT02956278|11292868|FG002|STARTED|Overall Study||3
10162464|NCT02956278|11292866|FG000|COMPLETED|Overall Study||9
10162465|NCT02956278|11292867|FG001|COMPLETED|Overall Study||7
10162466|NCT02956278|11292868|FG002|COMPLETED|Overall Study||3
10162467|NCT02956278|11292866|FG000|NOT COMPLETED|Overall Study||6
10162468|NCT02956278|11292867|FG001|NOT COMPLETED|Overall Study||2
10162469|NCT02956278|11292868|FG002|NOT COMPLETED|Overall Study||0
10162470|NCT02956460|11292878|FG000|STARTED|Lens 1||30
10162471|NCT02956460|11292879|FG001|STARTED|Lens 1||34
10162472|NCT02956460|11292878|FG000|COMPLETED|Lens 1||29
10162473|NCT02956460|11292879|FG001|COMPLETED|Lens 1||34
10162474|NCT02956460|11292878|FG000|NOT COMPLETED|Lens 1||1
10162475|NCT02956460|11292879|FG001|NOT COMPLETED|Lens 1||0
10162476|NCT02956460|11292878|FG000|STARTED|Lens 2||29
10162477|NCT02956460|11292879|FG001|STARTED|Lens 2||34
10162478|NCT02956460|11292878|FG000|COMPLETED|Lens 2||29
10162479|NCT02956460|11292879|FG001|COMPLETED|Lens 2||34
10162480|NCT02956460|11292878|FG000|NOT COMPLETED|Lens 2||0
10162481|NCT02956460|11292879|FG001|NOT COMPLETED|Lens 2||0
10162482|NCT02956486|11292887|FG000|STARTED|Core Phase||1108
10162483|NCT02956486|11292888|FG001|STARTED|Core Phase||1104
10162484|NCT02956486|11292889|FG002|STARTED|Core Phase||0
10162485|NCT02956486|11292887|FG000|Treated|Core Phase||1108
10162486|NCT02956486|11292888|FG001|Treated|Core Phase||1101
10162487|NCT02956486|11292889|FG002|Treated|Core Phase||0
10162488|NCT02956486|11292887|FG000|Safety Analysis Set (SAS)|Core Phase||1105
10162489|NCT02956486|11292888|FG001|Safety Analysis Set (SAS)|Core Phase||1099
10162490|NCT02956486|11292889|FG002|Safety Analysis Set (SAS)|Core Phase||0
10162491|NCT02956486|11292887|FG000|Full Analysis Set (FAS)|Core Phase||1084
10162492|NCT02956486|11292888|FG001|Full Analysis Set (FAS)|Core Phase||1062
10162493|NCT02956486|11292889|FG002|Full Analysis Set (FAS)|Core Phase||0
10162494|NCT02956486|11292887|FG000|COMPLETED|Core Phase||29
10162495|NCT02956486|11292888|FG001|COMPLETED|Core Phase||32
10162496|NCT02956486|11292889|FG002|COMPLETED|Core Phase||0
10162497|NCT02956486|11292887|FG000|NOT COMPLETED|Core Phase||1079
10162498|NCT02956486|11292888|FG001|NOT COMPLETED|Core Phase||1072
10162499|NCT02956486|11292889|FG002|NOT COMPLETED|Core Phase||0
10162500|NCT02956486|11292887|FG000|STARTED|Extension Phase||0
10162501|NCT02956486|11292888|FG001|STARTED|Extension Phase||0
10162502|NCT02956486|11292889|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
10162503|NCT02956486|11292887|FG000|Treated|Extension Phase||0
10162504|NCT02956486|11292888|FG001|Treated|Extension Phase||0
10162505|NCT02956486|11292889|FG002|Treated|Extension Phase||18
10162506|NCT02956486|11292887|FG000|Safety Analysis Set (SAS)|Extension Phase||0
10162507|NCT02956486|11292888|FG001|Safety Analysis Set (SAS)|Extension Phase||0
10162508|NCT02956486|11292889|FG002|Safety Analysis Set (SAS)|Extension Phase||18
10162509|NCT02956486|11292887|FG000|COMPLETED|Extension Phase||0
10162510|NCT02956486|11292888|FG001|COMPLETED|Extension Phase||0
10162511|NCT02956486|11292889|FG002|COMPLETED|Extension Phase||0
10162512|NCT02956486|11292887|FG000|NOT COMPLETED|Extension Phase||0
10162513|NCT02956486|11292888|FG001|NOT COMPLETED|Extension Phase||0
10162514|NCT02956486|11292889|FG002|NOT COMPLETED|Extension Phase||19
10162515|NCT02956616|11292900|FG000|STARTED|Overall Study||58
10162516|NCT02956616|11292901|FG001|STARTED|Overall Study||60
10162517|NCT02956616|11292900|FG000|COMPLETED|Overall Study||58
10162518|NCT02956616|11292901|FG001|COMPLETED|Overall Study||60
10162519|NCT02956616|11292900|FG000|NOT COMPLETED|Overall Study||0
10162520|NCT02956616|11292901|FG001|NOT COMPLETED|Overall Study||0
10162521|NCT02956629|11292913|FG000|STARTED|Overall Study||78
10162522|NCT02956629|11292914|FG001|STARTED|Overall Study||47
10162523|NCT02956629|11292915|FG002|STARTED|Overall Study||61
10162524|NCT02956629|11292916|FG003|STARTED|Overall Study||56
10162525|NCT02956629|11292917|FG004|STARTED|Overall Study||18
10162526|NCT02956629|11292918|FG005|STARTED|Overall Study||22
10162527|NCT02956629|11292913|FG000|COMPLETED|Overall Study||73
10162528|NCT02956629|11292914|FG001|COMPLETED|Overall Study||41
10162529|NCT02956629|11292915|FG002|COMPLETED|Overall Study||57
10162530|NCT02956629|11292916|FG003|COMPLETED|Overall Study||55
10162531|NCT02956629|11292917|FG004|COMPLETED|Overall Study||18
10162532|NCT02956629|11292918|FG005|COMPLETED|Overall Study||21
10162533|NCT02956629|11292913|FG000|NOT COMPLETED|Overall Study||5
10162534|NCT02956629|11292914|FG001|NOT COMPLETED|Overall Study||6
10162535|NCT02956629|11292915|FG002|NOT COMPLETED|Overall Study||4
10162536|NCT02956629|11292916|FG003|NOT COMPLETED|Overall Study||1
10162537|NCT02956629|11292917|FG004|NOT COMPLETED|Overall Study||0
10162538|NCT02956629|11292918|FG005|NOT COMPLETED|Overall Study||1
10162539|NCT02956746|11292936|FG000|STARTED|Overall Study||40
10162540|NCT02956746|11292937|FG001|STARTED|Overall Study||40
10162541|NCT02956746|11292938|FG002|STARTED|Overall Study||42
10162542|NCT02956746|11292939|FG003|STARTED|Overall Study||42
10162543|NCT02956746|11292936|FG000|COMPLETED|Overall Study||38
10162544|NCT02956746|11292937|FG001|COMPLETED|Overall Study||37
10162545|NCT02956746|11292938|FG002|COMPLETED|Overall Study||36
10162546|NCT02956746|11292939|FG003|COMPLETED|Overall Study||38
10162547|NCT02956746|11292936|FG000|NOT COMPLETED|Overall Study||2
10162548|NCT02956746|11292937|FG001|NOT COMPLETED|Overall Study||3
10162549|NCT02956746|11292938|FG002|NOT COMPLETED|Overall Study||6
10162550|NCT02956746|11292939|FG003|NOT COMPLETED|Overall Study||4
10162551|NCT02956837|11292954|FG000|STARTED|Overall Study||100
10162552|NCT02956837|11292955|FG001|STARTED|Overall Study||99
10162553|NCT02956837|11292956|FG002|STARTED|Overall Study||99
10162554|NCT02956837|11292957|FG003|STARTED|Overall Study||102
10162555|NCT02956837|11292954|FG000|COMPLETED|Overall Study||100
10162556|NCT02956837|11292955|FG001|COMPLETED|Overall Study||96
10162557|NCT02956837|11292956|FG002|COMPLETED|Overall Study||97
10162558|NCT02956837|11292957|FG003|COMPLETED|Overall Study||99
10162559|NCT02956837|11292954|FG000|NOT COMPLETED|Overall Study||0
10162560|NCT02956837|11292955|FG001|NOT COMPLETED|Overall Study||3
10162561|NCT02956837|11292956|FG002|NOT COMPLETED|Overall Study||2
10162562|NCT02956837|11292957|FG003|NOT COMPLETED|Overall Study||3
10162563|NCT02956967|11292970|FG000|STARTED|Overall Study||171
10162564|NCT02956967|11292970|FG000|COMPLETED|Overall Study||123
10162565|NCT02956967|11292970|FG000|NOT COMPLETED|Overall Study||48
10162566|NCT02957123|11292974|FG000|STARTED|Overall Study||30
10162567|NCT02957123|11292974|FG000|COMPLETED|Overall Study||30
10162568|NCT02957123|11292974|FG000|NOT COMPLETED|Overall Study||0
10162569|NCT02957136|11292980|FG000|STARTED|Overall Study||95
10162570|NCT02957136|11292981|FG001|STARTED|Overall Study||99
10162571|NCT02957136|11292980|FG000|COMPLETED|Overall Study||93
10162572|NCT02957136|11292981|FG001|COMPLETED|Overall Study||98
10162573|NCT02957136|11292980|FG000|NOT COMPLETED|Overall Study||2
10162574|NCT02957136|11292981|FG001|NOT COMPLETED|Overall Study||1
10162575|NCT02957305|11292989|FG000|STARTED|Overall Study||106
10162576|NCT02957305|11292990|FG001|STARTED|Overall Study||105
10162577|NCT02957305|11292989|FG000|COMPLETED|Overall Study||106
10162578|NCT02957305|11292990|FG001|COMPLETED|Overall Study||105
10162579|NCT02957305|11292989|FG000|NOT COMPLETED|Overall Study||0
10162580|NCT02957305|11292990|FG001|NOT COMPLETED|Overall Study||0
10162581|NCT02957331|11292998|FG000|STARTED|Overall Study||14
10162582|NCT02957331|11292999|FG001|STARTED|Overall Study||12
10162583|NCT02957331|11292998|FG000|COMPLETED|Overall Study||13
10162584|NCT02957331|11292999|FG001|COMPLETED|Overall Study||12
10162585|NCT02957331|11292998|FG000|NOT COMPLETED|Overall Study||1
10162586|NCT02957331|11292999|FG001|NOT COMPLETED|Overall Study||0
10162587|NCT02957357|11293007|FG000|STARTED|Overall Study||10479
10162588|NCT02957357|11293008|FG001|STARTED|Overall Study||835
10162589|NCT02957357|11293007|FG000|COMPLETED|Overall Study||10479
10162590|NCT02957357|11293008|FG001|COMPLETED|Overall Study||835
10162591|NCT02957357|11293007|FG000|NOT COMPLETED|Overall Study||0
10162592|NCT02957357|11293008|FG001|NOT COMPLETED|Overall Study||0
10162593|NCT02957682|11293023|FG000|STARTED|Overall Study||1088
10162594|NCT02957682|11293024|FG001|STARTED|Overall Study||1088
10162595|NCT02957682|11293023|FG000|Randomized and Treated|Overall Study||1085
10162596|NCT02957682|11293024|FG001|Randomized and Treated|Overall Study||1086
10162597|NCT02957682|11293023|FG000|COMPLETED|Overall Study||890
10162598|NCT02957682|11293024|FG001|COMPLETED|Overall Study||919
10162599|NCT02957682|11293023|FG000|NOT COMPLETED|Overall Study||198
10162600|NCT02957682|11293024|FG001|NOT COMPLETED|Overall Study||169
10162601|NCT02957747|11293032|FG000|STARTED|Overall Study||76
10162602|NCT02957747|11293033|FG001|STARTED|Overall Study||77
10162603|NCT02957747|11293032|FG000|COMPLETED|Overall Study||66
10162604|NCT02957747|11293033|FG001|COMPLETED|Overall Study||69
10162605|NCT02957747|11293032|FG000|NOT COMPLETED|Overall Study||10
10162606|NCT02957747|11293033|FG001|NOT COMPLETED|Overall Study||8
10162607|NCT02957942|11293042|FG000|STARTED|Overall Study||7
10162608|NCT02957942|11293043|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
10162609|NCT02957942|11293042|FG000|COMPLETED|Overall Study||7
10162610|NCT02957942|11293043|FG001|COMPLETED|Overall Study||6
10162611|NCT02957942|11293042|FG000|NOT COMPLETED|Overall Study||0
10162612|NCT02957942|11293043|FG001|NOT COMPLETED|Overall Study||7
10162613|NCT02958267|11293051|FG000|STARTED|Enrollment||17
10162614|NCT02958267|11293052|FG001|STARTED|Enrollment||15
10162615|NCT02958267|11293051|FG000|COMPLETED|Enrollment||17
10162616|NCT02958267|11293052|FG001|COMPLETED|Enrollment||15
10162617|NCT02958267|11293051|FG000|NOT COMPLETED|Enrollment||0
10162618|NCT02958267|11293052|FG001|NOT COMPLETED|Enrollment||0
10162619|NCT02958267|11293051|FG000|STARTED|Enrollment to Actual Treatment Complete||17
10162620|NCT02958267|11293052|FG001|STARTED|Enrollment to Actual Treatment Complete||15
10162621|NCT02958267|11293051|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15
10162622|NCT02958267|11293052|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15
10162623|NCT02958267|11293051|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
10162624|NCT02958267|11293052|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
10162625|NCT02958267|11293051|FG000|STARTED|Follow-up Visits||15
10162626|NCT02958267|11293052|FG001|STARTED|Follow-up Visits||15
10162627|NCT02958267|11293051|FG000|3 Month Follow-up|Follow-up Visits||15
10162628|NCT02958267|11293052|FG001|3 Month Follow-up|Follow-up Visits||15
10162629|NCT02958267|11293051|FG000|6 Month Follow-up|Follow-up Visits||14
10162630|NCT02958267|11293052|FG001|6 Month Follow-up|Follow-up Visits||14
10162631|NCT02958267|11293051|FG000|12 Month Follow-up|Follow-up Visits||13
10162632|NCT02958267|11293052|FG001|12 Month Follow-up|Follow-up Visits||14
10162633|NCT02958267|11293051|FG000|COMPLETED|Follow-up Visits||13
10162634|NCT02958267|11293052|FG001|COMPLETED|Follow-up Visits||14
10162635|NCT02958267|11293051|FG000|NOT COMPLETED|Follow-up Visits||2
10162636|NCT02958267|11293052|FG001|NOT COMPLETED|Follow-up Visits||1
10162637|NCT02958345|11293060|FG000|STARTED|Overall Study||14
10162638|NCT02958345|11293061|FG001|STARTED|Overall Study||14
9710959|NCT03889028|10810699|FG000|STARTED|Overall Study||144
9710960|NCT03889028|10810700|FG001|STARTED|Overall Study||422
9710961|NCT03889028|10810701|FG002|STARTED|Overall Study||312
9710962|NCT03889028|10810699|FG000|COMPLETED|Overall Study||144
9710963|NCT03889028|10810700|FG001|COMPLETED|Overall Study||422
9710964|NCT03889028|10810701|FG002|COMPLETED|Overall Study||312
9710965|NCT03889028|10810699|FG000|NOT COMPLETED|Overall Study||0
9710966|NCT03889028|10810700|FG001|NOT COMPLETED|Overall Study||0
9710967|NCT03889028|10810701|FG002|NOT COMPLETED|Overall Study||0
9710968|NCT03842683|10810708|FG000|STARTED|Overall Study||472
9710969|NCT03842683|10810708|FG000|COMPLETED|Overall Study||472
9710970|NCT03842683|10810708|FG000|NOT COMPLETED|Overall Study||0
9710971|NCT03839511|10810713|FG000|STARTED|Overall Study||4
9710972|NCT03839511|10810713|FG000|COMPLETED|Overall Study||4
9710973|NCT03839511|10810713|FG000|NOT COMPLETED|Overall Study||0
9710974|NCT03835546|10810720|FG000|STARTED|Overall Study||15
9710975|NCT03835546|10810721|FG001|STARTED|Overall Study||15
9710976|NCT03835546|10810722|FG002|STARTED|Overall Study||15
9710977|NCT03835546|10810720|FG000|COMPLETED|Overall Study||12
9710978|NCT03835546|10810721|FG001|COMPLETED|Overall Study||15
10162639|NCT02958345|11293060|FG000|COMPLETED|Overall Study||13
10162640|NCT02958345|11293061|FG001|COMPLETED|Overall Study||13
10162641|NCT02958345|11293060|FG000|NOT COMPLETED|Overall Study||1
10162642|NCT02958345|11293061|FG001|NOT COMPLETED|Overall Study||1
10162643|NCT02958527|11293067|FG000|STARTED|Overall Study||1408
10162644|NCT02958527|11293067|FG000|COMPLETED|Overall Study||1396
10162645|NCT02958527|11293067|FG000|NOT COMPLETED|Overall Study||12
10162646|NCT02958553|11293080|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
10162647|NCT02958553|11293080|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
10162648|NCT02958553|11293080|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
10162649|NCT02958553|11293080|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
10162650|NCT02958553|11293080|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
10162651|NCT02958553|11293080|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
10162652|NCT02958553|11293080|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
10162653|NCT02958553|11293080|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
10162654|NCT02958553|11293080|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
10162655|NCT02958553|11293080|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
10162656|NCT02958553|11293080|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
10162657|NCT02958553|11293080|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
10162658|NCT02958553|11293080|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4
10162659|NCT02958553|11293080|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
10162660|NCT02958553|11293080|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
10162661|NCT02958553|11293080|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
10162662|NCT02958553|11293080|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
10162663|NCT02958553|11293080|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
10162664|NCT02958553|11293080|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
10162665|NCT02958553|11293080|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
10162666|NCT02958553|11293080|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
10162667|NCT02958787|11293085|FG000|STARTED|Overall Study||135
10162668|NCT02958787|11293085|FG000|COMPLETED|Overall Study||135
10162669|NCT02958787|11293085|FG000|NOT COMPLETED|Overall Study||0
10162670|NCT02958826|11293091|FG000|STARTED|Overall Study||80
10162671|NCT02958826|11293092|FG001|STARTED|Overall Study||80
10162672|NCT02958826|11293091|FG000|COMPLETED|Overall Study||80
9710979|NCT03835546|10810722|FG002|COMPLETED|Overall Study||15
9710980|NCT03835546|10810720|FG000|NOT COMPLETED|Overall Study||3
9710981|NCT03835546|10810721|FG001|NOT COMPLETED|Overall Study||0
9710982|NCT03835546|10810722|FG002|NOT COMPLETED|Overall Study||0
10162673|NCT02958826|11293092|FG001|COMPLETED|Overall Study||80
10162674|NCT02958826|11293091|FG000|NOT COMPLETED|Overall Study||0
10162675|NCT02958826|11293092|FG001|NOT COMPLETED|Overall Study||0
10162676|NCT02958956|11293102|FG000|STARTED|Overall Study||38190
10162677|NCT02958956|11293103|FG001|STARTED|Overall Study||198317
10162678|NCT02958956|11293102|FG000|COMPLETED|Overall Study||38190
10162679|NCT02958956|11293103|FG001|COMPLETED|Overall Study||198317
10162680|NCT02958956|11293102|FG000|NOT COMPLETED|Overall Study||0
10162681|NCT02958956|11293103|FG001|NOT COMPLETED|Overall Study||0
10162682|NCT02958969|11293110|FG000|STARTED|Overall Study||50
10162683|NCT02958969|11293110|FG000|COMPLETED|Overall Study||50
10162684|NCT02958969|11293110|FG000|NOT COMPLETED|Overall Study||0
10162685|NCT02958982|11293125|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1
10162686|NCT02958982|11293126|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3
10162687|NCT02958982|11293127|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0
10162688|NCT02958982|11293128|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0
10162689|NCT02958982|11293129|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0
10162690|NCT02958982|11293130|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0
10162691|NCT02958982|11293131|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0
10162692|NCT02958982|11293132|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0
10162693|NCT02958982|11293133|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0
10162694|NCT02958982|11293134|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0
10162695|NCT02958982|11293135|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0
10162696|NCT02958982|11293125|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1
10162697|NCT02958982|11293126|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3
9710983|NCT04461795|10810730|FG000|STARTED|Overall Study||40
9710984|NCT04461795|10810730|FG000|COMPLETED|Overall Study||35
9710985|NCT04461795|10810730|FG000|NOT COMPLETED|Overall Study||5
9710986|NCT04405999|10810737|FG000|STARTED|Overall Study||25
9710987|NCT04405999|10810738|FG001|STARTED|Overall Study||25
9710988|NCT04405999|10810737|FG000|COMPLETED|Overall Study||25
9710989|NCT04405999|10810738|FG001|COMPLETED|Overall Study||25
9710990|NCT04405999|10810737|FG000|NOT COMPLETED|Overall Study||0
9710991|NCT04405999|10810738|FG001|NOT COMPLETED|Overall Study||0
9710992|NCT04383587|10810744|FG000|STARTED|Overall Study||300
9710993|NCT04383587|10810744|FG000|COMPLETED|Overall Study||292
9710994|NCT04383587|10810744|FG000|NOT COMPLETED|Overall Study||8
9710995|NCT04035473|10810751|FG000|STARTED|Screening/Baseline||20
9710996|NCT04035473|10810752|FG001|STARTED|Screening/Baseline||22
9710997|NCT04035473|10810751|FG000|COMPLETED|Screening/Baseline||20
9710998|NCT04035473|10810752|FG001|COMPLETED|Screening/Baseline||20
10162698|NCT02958982|11293127|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162699|NCT02958982|11293128|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162700|NCT02958982|11293129|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162701|NCT02958982|11293130|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162702|NCT02958982|11293131|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162703|NCT02958982|11293132|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162704|NCT02958982|11293133|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162705|NCT02958982|11293134|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162706|NCT02958982|11293135|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162707|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162708|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162709|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162710|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162711|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162712|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162713|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162714|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162715|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162716|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162717|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10162718|NCT02958982|11293125|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2
10162719|NCT02958982|11293126|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0
10162720|NCT02958982|11293127|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4
10162721|NCT02958982|11293128|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0
10162722|NCT02958982|11293129|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0
10162723|NCT02958982|11293130|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0
10162724|NCT02958982|11293131|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0
10162725|NCT02958982|11293132|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0
10162726|NCT02958982|11293133|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0
10162727|NCT02958982|11293134|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0
10162728|NCT02958982|11293135|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0
10162729|NCT02958982|11293125|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2
10162730|NCT02958982|11293126|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162731|NCT02958982|11293127|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4
10162732|NCT02958982|11293128|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162733|NCT02958982|11293129|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162734|NCT02958982|11293130|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162735|NCT02958982|11293131|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162736|NCT02958982|11293132|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162737|NCT02958982|11293133|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162738|NCT02958982|11293134|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162739|NCT02958982|11293135|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162740|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9710999|NCT04035473|10810751|FG000|NOT COMPLETED|Screening/Baseline||0
9711000|NCT04035473|10810752|FG001|NOT COMPLETED|Screening/Baseline||2
9711001|NCT04035473|10810751|FG000|STARTED|Treatment Period 1||20
9711002|NCT04035473|10810752|FG001|STARTED|Treatment Period 1||20
10162741|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162742|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162743|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162744|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162745|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162746|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162747|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162748|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162749|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162750|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10162751|NCT02958982|11293125|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2
10162752|NCT02958982|11293126|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0
10162753|NCT02958982|11293127|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0
10162754|NCT02958982|11293128|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4
10162755|NCT02958982|11293129|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0
10162756|NCT02958982|11293130|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0
10162757|NCT02958982|11293131|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0
10162758|NCT02958982|11293132|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0
10162759|NCT02958982|11293133|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0
10162760|NCT02958982|11293134|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0
10162761|NCT02958982|11293135|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0
10162762|NCT02958982|11293125|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2
10162763|NCT02958982|11293126|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162764|NCT02958982|11293127|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162765|NCT02958982|11293128|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4
10162766|NCT02958982|11293129|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162767|NCT02958982|11293130|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162768|NCT02958982|11293131|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162769|NCT02958982|11293132|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162770|NCT02958982|11293133|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162771|NCT02958982|11293134|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162772|NCT02958982|11293135|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162773|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162774|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162775|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162776|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162777|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162778|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162779|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162780|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162781|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162782|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162783|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10162784|NCT02958982|11293125|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2
10162785|NCT02958982|11293126|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0
10162786|NCT02958982|11293127|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0
10162787|NCT02958982|11293128|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0
10162788|NCT02958982|11293129|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6
10162789|NCT02958982|11293130|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0
10162790|NCT02958982|11293131|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0
10162791|NCT02958982|11293132|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0
10162792|NCT02958982|11293133|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0
10162793|NCT02958982|11293134|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0
9711003|NCT04035473|10810751|FG000|COMPLETED|Treatment Period 1||20
9711004|NCT04035473|10810752|FG001|COMPLETED|Treatment Period 1||20
9711005|NCT04035473|10810751|FG000|NOT COMPLETED|Treatment Period 1||0
9711006|NCT04035473|10810752|FG001|NOT COMPLETED|Treatment Period 1||0
9711007|NCT04035473|10810751|FG000|STARTED|Treatment Period 2|2 subjects withdrew before starting treatment period 2 due to diease progression and withdrawal from study treatment and procedure.|18
9711008|NCT04035473|10810752|FG001|STARTED|Treatment Period 2|1 subject withdrew before starting treatment period 2 due to SAE and investigator's decision.|19
9711009|NCT04035473|10810751|FG000|COMPLETED|Treatment Period 2||18
9711010|NCT04035473|10810752|FG001|COMPLETED|Treatment Period 2||19
10162794|NCT02958982|11293135|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0
10162795|NCT02958982|11293125|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2
10162796|NCT02958982|11293126|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162797|NCT02958982|11293127|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162798|NCT02958982|11293128|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162799|NCT02958982|11293129|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6
10162800|NCT02958982|11293130|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162801|NCT02958982|11293131|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162802|NCT02958982|11293132|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162803|NCT02958982|11293133|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162804|NCT02958982|11293134|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162805|NCT02958982|11293135|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162806|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162807|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162808|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162809|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162810|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162811|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162812|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162813|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162814|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162815|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162816|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10162817|NCT02958982|11293125|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2
10162818|NCT02958982|11293126|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0
10162819|NCT02958982|11293127|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0
10162820|NCT02958982|11293128|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0
10162821|NCT02958982|11293129|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0
10162822|NCT02958982|11293130|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6
10162823|NCT02958982|11293131|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0
10162824|NCT02958982|11293132|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0
10162825|NCT02958982|11293133|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0
10162826|NCT02958982|11293134|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0
10162827|NCT02958982|11293135|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0
10162828|NCT02958982|11293125|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2
10162829|NCT02958982|11293126|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162830|NCT02958982|11293127|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162831|NCT02958982|11293128|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162832|NCT02958982|11293129|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162833|NCT02958982|11293130|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6
10162834|NCT02958982|11293131|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162835|NCT02958982|11293132|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162836|NCT02958982|11293133|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162837|NCT02958982|11293134|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162838|NCT02958982|11293135|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162839|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162840|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162841|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162842|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162843|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162844|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162845|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162846|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162847|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162848|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162849|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10162850|NCT02958982|11293125|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162851|NCT02958982|11293126|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162852|NCT02958982|11293127|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162853|NCT02958982|11293128|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162854|NCT02958982|11293129|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162855|NCT02958982|11293130|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162856|NCT02958982|11293131|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2
10162857|NCT02958982|11293132|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6
10162858|NCT02958982|11293133|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162859|NCT02958982|11293134|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162860|NCT02958982|11293135|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0
10162861|NCT02958982|11293125|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162862|NCT02958982|11293126|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162863|NCT02958982|11293127|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162864|NCT02958982|11293128|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162865|NCT02958982|11293129|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162866|NCT02958982|11293130|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162867|NCT02958982|11293131|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
10162868|NCT02958982|11293132|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
10162869|NCT02958982|11293133|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162870|NCT02958982|11293134|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162871|NCT02958982|11293135|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162872|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162873|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162874|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162875|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162876|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162877|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162878|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162879|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162880|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162881|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162882|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10162883|NCT02958982|11293125|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0
10162884|NCT02958982|11293126|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0
10162885|NCT02958982|11293127|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0
10162886|NCT02958982|11293128|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0
10162887|NCT02958982|11293129|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0
10162888|NCT02958982|11293130|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0
10162889|NCT02958982|11293131|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2
10162890|NCT02958982|11293132|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0
10162891|NCT02958982|11293133|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6
10162892|NCT02958982|11293134|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0
10162893|NCT02958982|11293135|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0
10162894|NCT02958982|11293125|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162895|NCT02958982|11293126|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162896|NCT02958982|11293127|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162897|NCT02958982|11293128|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162898|NCT02958982|11293129|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162899|NCT02958982|11293130|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162900|NCT02958982|11293131|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2
10162901|NCT02958982|11293132|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162902|NCT02958982|11293133|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6
10162903|NCT02958982|11293134|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162904|NCT02958982|11293135|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162905|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162906|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162907|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162908|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162909|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162910|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162911|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162912|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162913|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162914|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162915|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10162916|NCT02958982|11293125|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0
10162917|NCT02958982|11293126|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0
10162918|NCT02958982|11293127|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0
10162919|NCT02958982|11293128|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0
10162920|NCT02958982|11293129|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0
10162921|NCT02958982|11293130|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0
10162922|NCT02958982|11293131|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2
10162923|NCT02958982|11293132|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0
10162924|NCT02958982|11293133|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0
10162925|NCT02958982|11293134|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6
10162926|NCT02958982|11293135|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0
10162927|NCT02958982|11293125|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162928|NCT02958982|11293126|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162929|NCT02958982|11293127|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162930|NCT02958982|11293128|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162931|NCT02958982|11293129|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162932|NCT02958982|11293130|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162933|NCT02958982|11293131|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2
10162934|NCT02958982|11293132|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162935|NCT02958982|11293133|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162936|NCT02958982|11293134|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6
10162937|NCT02958982|11293135|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162938|NCT02958982|11293125|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162939|NCT02958982|11293126|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162940|NCT02958982|11293127|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162941|NCT02958982|11293128|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162942|NCT02958982|11293129|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162943|NCT02958982|11293130|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162944|NCT02958982|11293131|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162945|NCT02958982|11293132|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162946|NCT02958982|11293133|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162947|NCT02958982|11293134|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162948|NCT02958982|11293135|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10162949|NCT02958982|11293125|FG000|STARTED|Proof of Concept Study||0
10162950|NCT02958982|11293126|FG001|STARTED|Proof of Concept Study||0
10162951|NCT02958982|11293127|FG002|STARTED|Proof of Concept Study||0
10162952|NCT02958982|11293128|FG003|STARTED|Proof of Concept Study||0
10162953|NCT02958982|11293129|FG004|STARTED|Proof of Concept Study||0
10162954|NCT02958982|11293130|FG005|STARTED|Proof of Concept Study||0
10162955|NCT02958982|11293131|FG006|STARTED|Proof of Concept Study||0
10162956|NCT02958982|11293132|FG007|STARTED|Proof of Concept Study||0
10162957|NCT02958982|11293133|FG008|STARTED|Proof of Concept Study||0
10162958|NCT02958982|11293134|FG009|STARTED|Proof of Concept Study||0
10162959|NCT02958982|11293135|FG010|STARTED|Proof of Concept Study||1
10162960|NCT02958982|11293125|FG000|COMPLETED|Proof of Concept Study||0
10162961|NCT02958982|11293126|FG001|COMPLETED|Proof of Concept Study||0
10162962|NCT02958982|11293127|FG002|COMPLETED|Proof of Concept Study||0
10162963|NCT02958982|11293128|FG003|COMPLETED|Proof of Concept Study||0
10162964|NCT02958982|11293129|FG004|COMPLETED|Proof of Concept Study||0
10162965|NCT02958982|11293130|FG005|COMPLETED|Proof of Concept Study||0
10162966|NCT02958982|11293131|FG006|COMPLETED|Proof of Concept Study||0
10162967|NCT02958982|11293132|FG007|COMPLETED|Proof of Concept Study||0
10162968|NCT02958982|11293133|FG008|COMPLETED|Proof of Concept Study||0
10162969|NCT02958982|11293134|FG009|COMPLETED|Proof of Concept Study||0
10162970|NCT02958982|11293135|FG010|COMPLETED|Proof of Concept Study||1
10162971|NCT02958982|11293125|FG000|NOT COMPLETED|Proof of Concept Study||0
10162972|NCT02958982|11293126|FG001|NOT COMPLETED|Proof of Concept Study||0
10162973|NCT02958982|11293127|FG002|NOT COMPLETED|Proof of Concept Study||0
10162974|NCT02958982|11293128|FG003|NOT COMPLETED|Proof of Concept Study||0
10162975|NCT02958982|11293129|FG004|NOT COMPLETED|Proof of Concept Study||0
10162976|NCT02958982|11293130|FG005|NOT COMPLETED|Proof of Concept Study||0
10162977|NCT02958982|11293131|FG006|NOT COMPLETED|Proof of Concept Study||0
10162978|NCT02958982|11293132|FG007|NOT COMPLETED|Proof of Concept Study||0
10162979|NCT02958982|11293133|FG008|NOT COMPLETED|Proof of Concept Study||0
10162980|NCT02958982|11293134|FG009|NOT COMPLETED|Proof of Concept Study||0
10162981|NCT02958982|11293135|FG010|NOT COMPLETED|Proof of Concept Study||0
10162982|NCT02958995|11293170|FG000|STARTED|Overall Study||2630666
10162983|NCT02958995|11293171|FG001|STARTED|Overall Study||107495
10162984|NCT02958995|11293170|FG000|COMPLETED|Overall Study||2630666
10162985|NCT02958995|11293171|FG001|COMPLETED|Overall Study||107495
10162986|NCT02958995|11293170|FG000|NOT COMPLETED|Overall Study||0
10162987|NCT02958995|11293171|FG001|NOT COMPLETED|Overall Study||0
10162988|NCT02959138|11293180|FG000|STARTED|Overall Study||10
10162989|NCT02959138|11293181|FG001|STARTED|Overall Study||10
10162990|NCT02959138|11293182|FG002|STARTED|Overall Study||16
10162991|NCT02959138|11293180|FG000|COMPLETED|Overall Study||10
10162992|NCT02959138|11293181|FG001|COMPLETED|Overall Study||9
10162993|NCT02959138|11293182|FG002|COMPLETED|Overall Study||16
10162994|NCT02959138|11293180|FG000|NOT COMPLETED|Overall Study||0
10162995|NCT02959138|11293181|FG001|NOT COMPLETED|Overall Study||1
10162996|NCT02959138|11293182|FG002|NOT COMPLETED|Overall Study||0
10162997|NCT02959177|11293197|FG000|STARTED|Double-Blind Treatment Phase||115
10162998|NCT02959177|11293198|FG001|STARTED|Double-Blind Treatment Phase||114
10162999|NCT02959177|11293199|FG002|STARTED|Double-Blind Treatment Phase||230
10163000|NCT02959177|11293197|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
10163001|NCT02959177|11293198|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
10163002|NCT02959177|11293199|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
10163003|NCT02959177|11293197|FG000|COMPLETED|Double-Blind Treatment Phase||104
10163004|NCT02959177|11293198|FG001|COMPLETED|Double-Blind Treatment Phase||111
10163005|NCT02959177|11293199|FG002|COMPLETED|Double-Blind Treatment Phase||225
10163006|NCT02959177|11293197|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11
10163007|NCT02959177|11293198|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
10163008|NCT02959177|11293199|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5
10163009|NCT02959177|11293197|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
10163010|NCT02959177|11293198|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
10163011|NCT02959177|11293199|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
10163012|NCT02959177|11293197|FG000|COMPLETED|Follow-up Post Treatment Phase||51
10163013|NCT02959177|11293198|FG001|COMPLETED|Follow-up Post Treatment Phase||51
10163014|NCT02959177|11293199|FG002|COMPLETED|Follow-up Post Treatment Phase||98
10163015|NCT02959177|11293197|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1
10163016|NCT02959177|11293198|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1
10163017|NCT02959177|11293199|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2
10163018|NCT02959190|11293217|FG000|STARTED|Open Label||120
10163019|NCT02959190|11293218|FG001|STARTED|Open Label||126
10163020|NCT02959190|11293219|FG002|STARTED|Open Label||32
10163021|NCT02959190|11293220|FG003|STARTED|Open Label||33
10163022|NCT02959190|11293217|FG000|Received at Least 1 Dose of Study Drug|Open Label||120
10163023|NCT02959190|11293218|FG001|Received at Least 1 Dose of Study Drug|Open Label||126
10163024|NCT02959190|11293219|FG002|Received at Least 1 Dose of Study Drug|Open Label||32
10163025|NCT02959190|11293220|FG003|Received at Least 1 Dose of Study Drug|Open Label||33
10163026|NCT02959190|11293217|FG000|120mg/120mg Galcanezumab - EM|Open Label||58
10163027|NCT02959190|11293218|FG001|120mg/120mg Galcanezumab - EM|Open Label||0
10163028|NCT02959190|11293219|FG002|120mg/120mg Galcanezumab - EM|Open Label||0
10163029|NCT02959190|11293220|FG003|120mg/120mg Galcanezumab - EM|Open Label||0
10163030|NCT02959190|11293217|FG000|240mg/240mg Galcanezumab - EM|Open Label||0
10163031|NCT02959190|11293218|FG001|240mg/240mg Galcanezumab - EM|Open Label||62
10163032|NCT02959190|11293219|FG002|240mg/240mg Galcanezumab - EM|Open Label||0
10163033|NCT02959190|11293220|FG003|240mg/240mg Galcanezumab - EM|Open Label||0
10163034|NCT02959190|11293217|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62
10163035|NCT02959190|11293218|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0
10163036|NCT02959190|11293219|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0
10163037|NCT02959190|11293220|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0
10163038|NCT02959190|11293217|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0
10163039|NCT02959190|11293218|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64
10163040|NCT02959190|11293219|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0
10163041|NCT02959190|11293220|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0
10163042|NCT02959190|11293217|FG000|COMPLETED|Open Label||113
10163043|NCT02959190|11293218|FG001|COMPLETED|Open Label||110
10163044|NCT02959190|11293219|FG002|COMPLETED|Open Label||28
10163045|NCT02959190|11293220|FG003|COMPLETED|Open Label||27
10163046|NCT02959190|11293217|FG000|NOT COMPLETED|Open Label||7
10163047|NCT02959190|11293218|FG001|NOT COMPLETED|Open Label||16
10163048|NCT02959190|11293219|FG002|NOT COMPLETED|Open Label||4
10163049|NCT02959190|11293220|FG003|NOT COMPLETED|Open Label||6
10163050|NCT02959190|11293217|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
10163051|NCT02959190|11293218|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
10163052|NCT02959190|11293219|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
10163053|NCT02959190|11293220|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
10163054|NCT02959190|11293217|FG000|COMPLETED|Post Treatment Follow Up||114
10163055|NCT02959190|11293218|FG001|COMPLETED|Post Treatment Follow Up||119
10163056|NCT02959190|11293219|FG002|COMPLETED|Post Treatment Follow Up||31
10163057|NCT02959190|11293220|FG003|COMPLETED|Post Treatment Follow Up||32
10163058|NCT02959190|11293217|FG000|NOT COMPLETED|Post Treatment Follow Up||3
10163059|NCT02959190|11293218|FG001|NOT COMPLETED|Post Treatment Follow Up||1
10163060|NCT02959190|11293219|FG002|NOT COMPLETED|Post Treatment Follow Up||1
10163061|NCT02959190|11293220|FG003|NOT COMPLETED|Post Treatment Follow Up||0
10163062|NCT02959307|11293241|FG000|STARTED|Phase 1||18
10163063|NCT02959307|11293242|FG001|STARTED|Phase 1||31
10163064|NCT02959307|11293241|FG000|COMPLETED|Phase 1||15
9711011|NCT04035473|10810751|FG000|NOT COMPLETED|Treatment Period 2||0
9711012|NCT04035473|10810752|FG001|NOT COMPLETED|Treatment Period 2||0
9711013|NCT04035473|10810751|FG000|STARTED|Follow-up Period||18
9711014|NCT04035473|10810752|FG001|STARTED|Follow-up Period||19
9711015|NCT04035473|10810751|FG000|COMPLETED|Follow-up Period||16
9711016|NCT04035473|10810752|FG001|COMPLETED|Follow-up Period||19
9711017|NCT04035473|10810751|FG000|NOT COMPLETED|Follow-up Period||2
9711018|NCT04035473|10810752|FG001|NOT COMPLETED|Follow-up Period||0
9730725|NCT00127803|10830555|FG002|NOT COMPLETED|Overall Study||0
9730726|NCT00127803|10830556|FG003|NOT COMPLETED|Overall Study||1
9730727|NCT00127842|10830566|FG000|STARTED|Overall Study||110
9730728|NCT00127842|10830566|FG000|COMPLETED|Overall Study||71
9730729|NCT00127842|10830566|FG000|NOT COMPLETED|Overall Study||39
9730730|NCT00127855|10830575|FG000|STARTED|Primary Vaccination Course||82
9730731|NCT00127855|10830576|FG001|STARTED|Primary Vaccination Course||82
9730732|NCT00127855|10830577|FG002|STARTED|Primary Vaccination Course||80
9730733|NCT00127855|10830578|FG003|STARTED|Primary Vaccination Course||81
9730734|NCT00127855|10830579|FG004|STARTED|Primary Vaccination Course||82
9730735|NCT00127855|10830575|FG000|COMPLETED|Primary Vaccination Course||80
9730736|NCT00127855|10830576|FG001|COMPLETED|Primary Vaccination Course||81
9730737|NCT00127855|10830577|FG002|COMPLETED|Primary Vaccination Course||78
9730738|NCT00127855|10830578|FG003|COMPLETED|Primary Vaccination Course||81
9730739|NCT00127855|10830579|FG004|COMPLETED|Primary Vaccination Course||78
9730740|NCT00127855|10830575|FG000|NOT COMPLETED|Primary Vaccination Course||2
9730741|NCT00127855|10830576|FG001|NOT COMPLETED|Primary Vaccination Course||1
9730742|NCT00127855|10830577|FG002|NOT COMPLETED|Primary Vaccination Course||2
9730743|NCT00127855|10830578|FG003|NOT COMPLETED|Primary Vaccination Course||0
9730744|NCT00127855|10830579|FG004|NOT COMPLETED|Primary Vaccination Course||4
9730745|NCT00127855|10830575|FG000|STARTED|Polysaccharide Challenge Dose||80
9730746|NCT00127855|10830576|FG001|STARTED|Polysaccharide Challenge Dose||79
9730747|NCT00127855|10830577|FG002|STARTED|Polysaccharide Challenge Dose||77
9730748|NCT00127855|10830578|FG003|STARTED|Polysaccharide Challenge Dose||81
9730749|NCT00127855|10830579|FG004|STARTED|Polysaccharide Challenge Dose||77
10163065|NCT02959307|11293242|FG001|COMPLETED|Phase 1||23
10163066|NCT02959307|11293241|FG000|NOT COMPLETED|Phase 1||3
10163067|NCT02959307|11293242|FG001|NOT COMPLETED|Phase 1||8
10163068|NCT02959307|11293241|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
10163069|NCT02959307|11293242|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
10163070|NCT02959307|11293241|FG000|COMPLETED|Phase 2||26
10163071|NCT02959307|11293242|FG001|COMPLETED|Phase 2||10
10163072|NCT02959307|11293241|FG000|NOT COMPLETED|Phase 2||2
10163073|NCT02959307|11293242|FG001|NOT COMPLETED|Phase 2||0
10163074|NCT02959437|11293252|FG000|STARTED|Overall Study||62
10163075|NCT02959437|11293253|FG001|STARTED|Overall Study||8
10163076|NCT02959437|11293254|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
10163077|NCT02959437|11293255|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
10163078|NCT02959437|11293252|FG000|COMPLETED|Overall Study||0
10163079|NCT02959437|11293253|FG001|COMPLETED|Overall Study||0
10163080|NCT02959437|11293254|FG002|COMPLETED|Overall Study||0
10163081|NCT02959437|11293255|FG003|COMPLETED|Overall Study||0
10163082|NCT02959437|11293252|FG000|NOT COMPLETED|Overall Study||62
10163083|NCT02959437|11293253|FG001|NOT COMPLETED|Overall Study||8
10163084|NCT02959437|11293254|FG002|NOT COMPLETED|Overall Study||0
10163085|NCT02959437|11293255|FG003|NOT COMPLETED|Overall Study||0
10163086|NCT02959671|11293266|FG000|STARTED|Overall Study||34
10163087|NCT02959671|11293266|FG000|COMPLETED|Overall Study||29
10163088|NCT02959671|11293266|FG000|NOT COMPLETED|Overall Study||5
10163089|NCT02959814|11293270|FG000|STARTED|Overall Study|22-02-2017|329
10163090|NCT02959814|11293270|FG000|COMPLETED|Overall Study|17-10-2017|272
10163091|NCT02959814|11293270|FG000|NOT COMPLETED|Overall Study||57
10163092|NCT02959827|11293275|FG000|STARTED|Overall Study||2320
10163093|NCT02959827|11293275|FG000|COMPLETED|Overall Study||2320
10163094|NCT02959827|11293275|FG000|NOT COMPLETED|Overall Study||0
10163095|NCT02959840|11293286|FG000|STARTED|Overall Study||60
10163096|NCT02959840|11293287|FG001|STARTED|Overall Study||60
10163097|NCT02959840|11293288|FG002|STARTED|Overall Study||60
10163098|NCT02959840|11293286|FG000|COMPLETED|Overall Study||60
10163099|NCT02959840|11293287|FG001|COMPLETED|Overall Study||60
10163100|NCT02959840|11293288|FG002|COMPLETED|Overall Study||60
10163101|NCT02959840|11293286|FG000|NOT COMPLETED|Overall Study||0
10163102|NCT02959840|11293287|FG001|NOT COMPLETED|Overall Study||0
10163103|NCT02959840|11293288|FG002|NOT COMPLETED|Overall Study||0
10163104|NCT02959853|11293298|FG000|STARTED|Overall Study||11
10163105|NCT02959853|11293299|FG001|STARTED|Overall Study||12
10163106|NCT02959853|11293298|FG000|COMPLETED|Overall Study||7
10163107|NCT02959853|11293299|FG001|COMPLETED|Overall Study||10
10163108|NCT02959853|11293298|FG000|NOT COMPLETED|Overall Study||4
10163109|NCT02959853|11293299|FG001|NOT COMPLETED|Overall Study||2
10163110|NCT02959866|11293306|FG000|STARTED|Overall Study||59
10163111|NCT02959866|11293306|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59
10163112|NCT02959866|11293306|FG000|COMPLETED|Overall Study||58
10163113|NCT02959866|11293306|FG000|NOT COMPLETED|Overall Study||1
10163114|NCT02959892|11293313|FG000|STARTED|Overall Study||6
10163115|NCT02959892|11293314|FG001|STARTED|Overall Study||6
10163116|NCT02959892|11293313|FG000|COMPLETED|Overall Study||5
10163117|NCT02959892|11293314|FG001|COMPLETED|Overall Study||5
10163118|NCT02959892|11293313|FG000|NOT COMPLETED|Overall Study||1
10163119|NCT02959892|11293314|FG001|NOT COMPLETED|Overall Study||1
10163120|NCT02959970|11293322|FG000|STARTED|Overall Study||17
10163121|NCT02959970|11293323|FG001|STARTED|Overall Study||83
10163122|NCT02959970|11293322|FG000|COMPLETED|Overall Study||15
10163123|NCT02959970|11293323|FG001|COMPLETED|Overall Study||76
10163124|NCT02959970|11293322|FG000|NOT COMPLETED|Overall Study||2
10163125|NCT02959970|11293323|FG001|NOT COMPLETED|Overall Study||7
10163126|NCT02959983|11293333|FG000|STARTED|Overall Study||172
10163127|NCT02959983|11293334|FG001|STARTED|Overall Study||174
10163128|NCT02959983|11293333|FG000|COMPLETED|Overall Study||146
10163129|NCT02959983|11293334|FG001|COMPLETED|Overall Study||149
10163130|NCT02959983|11293333|FG000|NOT COMPLETED|Overall Study||26
10163131|NCT02959983|11293334|FG001|NOT COMPLETED|Overall Study||25
10163132|NCT02959996|11293342|FG000|STARTED|Overall Study||40
10163133|NCT02959996|11293343|FG001|STARTED|Overall Study||39
10163134|NCT02959996|11293342|FG000|COMPLETED|Overall Study||40
10163135|NCT02959996|11293343|FG001|COMPLETED|Overall Study||39
10163136|NCT02959996|11293342|FG000|NOT COMPLETED|Overall Study||0
10163137|NCT02959996|11293343|FG001|NOT COMPLETED|Overall Study||0
10163138|NCT02960217|11293351|FG000|STARTED|Maintenance Phase: Treatment Period 1||22
10163139|NCT02960217|11293352|FG001|STARTED|Maintenance Phase: Treatment Period 1||21
10163140|NCT02960217|11293351|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21
10163141|NCT02960217|11293352|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21
10163142|NCT02960217|11293351|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
10163143|NCT02960217|11293352|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
10163144|NCT02960217|11293351|FG000|STARTED|Maintenance Phase: Crossover Washout||21
10163145|NCT02960217|11293352|FG001|STARTED|Maintenance Phase: Crossover Washout||21
10163146|NCT02960217|11293351|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21
10163147|NCT02960217|11293352|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21
10163148|NCT02960217|11293351|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
10163149|NCT02960217|11293352|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
10163150|NCT02960217|11293351|FG000|STARTED|Maintenance Phase: Treatment Period 2||21
10163151|NCT02960217|11293352|FG001|STARTED|Maintenance Phase: Treatment Period 2||21
10163152|NCT02960217|11293351|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20
10163153|NCT02960217|11293352|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18
10163154|NCT02960217|11293351|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
10163155|NCT02960217|11293352|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
10163156|NCT02960217|11293351|FG000|STARTED|Open-Label Extension Phase||20
10163157|NCT02960217|11293352|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
10163158|NCT02960217|11293351|FG000|COMPLETED|Open-Label Extension Phase||0
10163159|NCT02960217|11293352|FG001|COMPLETED|Open-Label Extension Phase||0
10163160|NCT02960217|11293351|FG000|NOT COMPLETED|Open-Label Extension Phase||20
10163161|NCT02960217|11293352|FG001|NOT COMPLETED|Open-Label Extension Phase||13
10163162|NCT02960295|11293362|FG000|STARTED|Overall Study||10
10163163|NCT02960295|11293362|FG000|COMPLETED|Overall Study||10
10163164|NCT02960295|11293362|FG000|NOT COMPLETED|Overall Study||0
10163165|NCT02960438|11293371|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
10163166|NCT02960438|11293372|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
10163167|NCT02960438|11293373|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
10163168|NCT02960438|11293374|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
10163169|NCT02960438|11293371|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
10163170|NCT02960438|11293372|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
10163171|NCT02960438|11293373|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
10163172|NCT02960438|11293374|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
10163173|NCT02960438|11293371|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
10163174|NCT02960438|11293372|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
10163175|NCT02960438|11293373|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
10163176|NCT02960438|11293374|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
10163177|NCT02960438|11293371|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
10163178|NCT02960438|11293372|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
10163179|NCT02960438|11293373|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
10163180|NCT02960438|11293374|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
10163181|NCT02960438|11293371|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47
10163182|NCT02960438|11293372|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26
10163183|NCT02960438|11293373|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50
10163184|NCT02960438|11293374|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46
10163185|NCT02960438|11293371|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
10163186|NCT02960438|11293372|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
10163187|NCT02960438|11293373|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
10163188|NCT02960438|11293374|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
10163189|NCT02960438|11293371|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
10163190|NCT02960438|11293372|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
10163191|NCT02960438|11293373|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
10163192|NCT02960438|11293374|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
10163193|NCT02960490|11293394|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
10163194|NCT02960490|11293395|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
10163195|NCT02960490|11293396|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163196|NCT02960490|11293397|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163197|NCT02960490|11293398|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163198|NCT02960490|11293399|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163199|NCT02960490|11293400|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163200|NCT02960490|11293401|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163201|NCT02960490|11293402|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163202|NCT02960490|11293403|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10163203|NCT02960490|11293394|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33
10163204|NCT02960490|11293395|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31
10163205|NCT02960490|11293396|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10163206|NCT02960490|11293397|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10163207|NCT02960490|11293398|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9711019|NCT03796676|10810761|FG000|STARTED|Overall Study||96
9711020|NCT03796676|10810762|FG001|STARTED|Overall Study||95
9711021|NCT03796676|10810763|FG002|STARTED|Overall Study||94
9711022|NCT03796676|10810761|FG000|COMPLETED|Overall Study||90
9711023|NCT03796676|10810762|FG001|COMPLETED|Overall Study||92
9711024|NCT03796676|10810763|FG002|COMPLETED|Overall Study||91
9711025|NCT03796676|10810761|FG000|NOT COMPLETED|Overall Study||6
9711026|NCT03796676|10810762|FG001|NOT COMPLETED|Overall Study||3
9711027|NCT03796676|10810763|FG002|NOT COMPLETED|Overall Study||3
9711028|NCT03366220|10810776|FG000|STARTED|Overall Study||4
9711029|NCT03366220|10810777|FG001|STARTED|Overall Study||4
9711030|NCT03366220|10810776|FG000|COMPLETED|Overall Study||4
9711031|NCT03366220|10810777|FG001|COMPLETED|Overall Study||4
9711032|NCT03366220|10810776|FG000|NOT COMPLETED|Overall Study||0
9711033|NCT03366220|10810777|FG001|NOT COMPLETED|Overall Study||0
9711034|NCT02989857|10810785|FG000|STARTED|Randomization Phase||126
9711035|NCT02989857|10810786|FG001|STARTED|Randomization Phase||61
9711036|NCT02989857|10810787|FG002|STARTED|Randomization Phase||0
9711037|NCT02989857|10810785|FG000|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
10163208|NCT02960490|11293399|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10163209|NCT02960490|11293400|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10163210|NCT02960490|11293401|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10163211|NCT02960490|11293402|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10163212|NCT02960490|11293403|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10163213|NCT02960490|11293394|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
10163214|NCT02960490|11293395|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
10163215|NCT02960490|11293396|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163216|NCT02960490|11293397|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163217|NCT02960490|11293398|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163218|NCT02960490|11293399|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163219|NCT02960490|11293400|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9711038|NCT02989857|10810786|FG001|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
9711039|NCT02989857|10810787|FG002|COMPLETED|Randomization Phase||0
9711040|NCT02989857|10810785|FG000|NOT COMPLETED|Randomization Phase||126
9711041|NCT02989857|10810786|FG001|NOT COMPLETED|Randomization Phase||61
9711042|NCT02989857|10810787|FG002|NOT COMPLETED|Randomization Phase||0
9711043|NCT02989857|10810785|FG000|STARTED|Cross Over Phase||0
9711044|NCT02989857|10810786|FG001|STARTED|Cross Over Phase||0
9711045|NCT02989857|10810787|FG002|STARTED|Cross Over Phase|Participants who had experienced disease progression and received placebo were allowed to cross over to receive AG-120.|43
9711046|NCT02989857|10810785|FG000|COMPLETED|Cross Over Phase||0
9711047|NCT02989857|10810786|FG001|COMPLETED|Cross Over Phase||0
9711048|NCT02989857|10810787|FG002|COMPLETED|Cross Over Phase|Completed implies the participants who completed the study treatment.|0
9711049|NCT02989857|10810785|FG000|NOT COMPLETED|Cross Over Phase||0
9711050|NCT02989857|10810786|FG001|NOT COMPLETED|Cross Over Phase||0
9711051|NCT02989857|10810787|FG002|NOT COMPLETED|Cross Over Phase||43
9711052|NCT02983799|10810799|FG000|STARTED|Overall Study||75
9711053|NCT02983799|10810800|FG001|STARTED|Overall Study||26
9711054|NCT02983799|10810801|FG002|STARTED|Overall Study||68
9711055|NCT02983799|10810802|FG003|STARTED|Overall Study||90
9711056|NCT02983799|10810803|FG004|STARTED|Overall Study||13
9711057|NCT02983799|10810799|FG000|COMPLETED|Overall Study||25
9711058|NCT02983799|10810800|FG001|COMPLETED|Overall Study||8
9711059|NCT02983799|10810801|FG002|COMPLETED|Overall Study||18
9711060|NCT02983799|10810802|FG003|COMPLETED|Overall Study||14
9711061|NCT02983799|10810803|FG004|COMPLETED|Overall Study||3
9711062|NCT02983799|10810799|FG000|NOT COMPLETED|Overall Study||50
9711063|NCT02983799|10810800|FG001|NOT COMPLETED|Overall Study||18
9711064|NCT02983799|10810801|FG002|NOT COMPLETED|Overall Study||50
9711065|NCT02983799|10810802|FG003|NOT COMPLETED|Overall Study||76
9711066|NCT02983799|10810803|FG004|NOT COMPLETED|Overall Study||10
9711067|NCT02971683|10810821|FG000|STARTED|Overall Study||75
9711068|NCT02971683|10810822|FG001|STARTED|Overall Study||73
9711069|NCT02971683|10810821|FG000|COMPLETED|Overall Study||69
9711070|NCT02971683|10810822|FG001|COMPLETED|Overall Study||65
9711071|NCT02971683|10810821|FG000|NOT COMPLETED|Overall Study||6
9711072|NCT02971683|10810822|FG001|NOT COMPLETED|Overall Study||8
9711073|NCT02682992|10810828|FG000|STARTED|Overall Study||47
9711074|NCT02682992|10810828|FG000|COMPLETED|Overall Study||47
9711075|NCT02682992|10810828|FG000|NOT COMPLETED|Overall Study||0
9711076|NCT02631577|10810834|FG000|STARTED|Overall Study||4
9711077|NCT02631577|10810835|FG001|STARTED|Overall Study||34
9711078|NCT02631577|10810834|FG000|COMPLETED|Overall Study||3
9711079|NCT02631577|10810835|FG001|COMPLETED|Overall Study||24
9711080|NCT02631577|10810834|FG000|NOT COMPLETED|Overall Study||1
9711081|NCT02631577|10810835|FG001|NOT COMPLETED|Overall Study||10
9711082|NCT02573779|10810843|FG000|STARTED|Overall Study||74
9711083|NCT02573779|10810844|FG001|STARTED|Overall Study||43
9711084|NCT02573779|10810843|FG000|COMPLETED|Overall Study||74
9711085|NCT02573779|10810844|FG001|COMPLETED|Overall Study||43
9711086|NCT02573779|10810843|FG000|NOT COMPLETED|Overall Study||0
9711087|NCT02573779|10810844|FG001|NOT COMPLETED|Overall Study||0
9711088|NCT02408315|10810852|FG000|STARTED|Overall Study||148
9711089|NCT02408315|10810853|FG001|STARTED|Overall Study||152
9711090|NCT02408315|10810852|FG000|COMPLETED|Overall Study||148
9711091|NCT02408315|10810853|FG001|COMPLETED|Overall Study||152
9711092|NCT02408315|10810852|FG000|NOT COMPLETED|Overall Study||0
9711093|NCT02408315|10810853|FG001|NOT COMPLETED|Overall Study||0
9711094|NCT02300233|10810862|FG000|STARTED|Overall Study||38
9711095|NCT02300233|10810863|FG001|STARTED|Overall Study||25
9711096|NCT02300233|10810864|FG002|STARTED|Overall Study||50
9711097|NCT02300233|10810862|FG000|COMPLETED|Overall Study||34
9711098|NCT02300233|10810863|FG001|COMPLETED|Overall Study||24
9711099|NCT02300233|10810864|FG002|COMPLETED|Overall Study||27
9711100|NCT02300233|10810862|FG000|NOT COMPLETED|Overall Study||4
9711101|NCT02300233|10810863|FG001|NOT COMPLETED|Overall Study||1
9711102|NCT02300233|10810864|FG002|NOT COMPLETED|Overall Study||23
9711103|NCT02211209|10810875|FG000|STARTED|Overall Study||34
9711104|NCT02211209|10810876|FG001|STARTED|Overall Study||33
9711105|NCT02211209|10810875|FG000|Dosed|Overall Study||33
9711106|NCT02211209|10810876|FG001|Dosed|Overall Study||33
9711107|NCT02211209|10810875|FG000|COMPLETED|Overall Study||32
9711108|NCT02211209|10810876|FG001|COMPLETED|Overall Study||19
9711109|NCT02211209|10810875|FG000|NOT COMPLETED|Overall Study||2
9711110|NCT02211209|10810876|FG001|NOT COMPLETED|Overall Study||14
9711111|NCT02125461|10810884|FG000|STARTED|Overall Study||476
10163220|NCT02960490|11293401|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163221|NCT02960490|11293402|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163222|NCT02960490|11293403|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163223|NCT02960490|11293394|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
10163224|NCT02960490|11293395|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
10163225|NCT02960490|11293396|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163226|NCT02960490|11293397|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163227|NCT02960490|11293398|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163228|NCT02960490|11293399|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163229|NCT02960490|11293400|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163230|NCT02960490|11293401|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163231|NCT02960490|11293402|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163232|NCT02960490|11293403|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10163233|NCT02960490|11293394|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
10163234|NCT02960490|11293395|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
10163235|NCT02960490|11293396|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163236|NCT02960490|11293397|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163237|NCT02960490|11293398|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163238|NCT02960490|11293399|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163239|NCT02960490|11293400|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163240|NCT02960490|11293401|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163241|NCT02960490|11293402|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9711112|NCT02125461|10810885|FG001|STARTED|Overall Study||237
9711113|NCT02125461|10810884|FG000|Full Analysis Set (FAS)|Overall Study||476
9711114|NCT02125461|10810885|FG001|Full Analysis Set (FAS)|Overall Study||237
9711115|NCT02125461|10810884|FG000|Received Treatment|Overall Study||473
9711116|NCT02125461|10810885|FG001|Received Treatment|Overall Study||236
9711117|NCT02125461|10810884|FG000|Safety Analysis Set|Overall Study||475
9711118|NCT02125461|10810885|FG001|Safety Analysis Set|Overall Study||234
9711119|NCT02125461|10810884|FG000|Completed 12 Months of Treatment|Overall Study||232
9711120|NCT02125461|10810885|FG001|Completed 12 Months of Treatment|Overall Study||82
9711121|NCT02125461|10810884|FG000|COMPLETED|Overall Study||178
9711122|NCT02125461|10810885|FG001|COMPLETED|Overall Study||68
9711123|NCT02125461|10810884|FG000|NOT COMPLETED|Overall Study||298
9711124|NCT02125461|10810885|FG001|NOT COMPLETED|Overall Study||169
9730750|NCT00127855|10830575|FG000|COMPLETED|Polysaccharide Challenge Dose||80
9730751|NCT00127855|10830576|FG001|COMPLETED|Polysaccharide Challenge Dose||79
9730752|NCT00127855|10830577|FG002|COMPLETED|Polysaccharide Challenge Dose||77
9730753|NCT00127855|10830578|FG003|COMPLETED|Polysaccharide Challenge Dose||81
9730754|NCT00127855|10830579|FG004|COMPLETED|Polysaccharide Challenge Dose||77
9730755|NCT00127855|10830575|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0
9730756|NCT00127855|10830576|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0
9730757|NCT00127855|10830577|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0
9730758|NCT00127855|10830578|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0
9730759|NCT00127855|10830579|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0
9730760|NCT00127933|10830593|FG000|STARTED|Overall Study||123
9730761|NCT00127933|10830594|FG001|STARTED|Overall Study||34
9730762|NCT00127933|10830593|FG000|Pathological Response|Overall Study||101
9730763|NCT00127933|10830594|FG001|Pathological Response|Overall Study||28
9730764|NCT00127933|10830593|FG000|Clinical Response|Overall Study||122
9730765|NCT00127933|10830594|FG001|Clinical Response|Overall Study||34
9730766|NCT00127933|10830593|FG000|Safety Population|Overall Study||122
9730767|NCT00127933|10830594|FG001|Safety Population|Overall Study||34
9730768|NCT00127933|10830593|FG000|Quality of Life Population|Overall Study||118
9730769|NCT00127933|10830594|FG001|Quality of Life Population|Overall Study||33
9730770|NCT00127933|10830593|FG000|Postoperative|Overall Study||98
9730771|NCT00127933|10830594|FG001|Postoperative|Overall Study||27
9730772|NCT00127933|10830593|FG000|COMPLETED|Overall Study||122
9730773|NCT00127933|10830594|FG001|COMPLETED|Overall Study||34
9730774|NCT00127933|10830593|FG000|NOT COMPLETED|Overall Study||1
9730775|NCT00127933|10830594|FG001|NOT COMPLETED|Overall Study||0
9730776|NCT00128102|10830602|FG000|STARTED|Overall Study||329
9730777|NCT00128102|10830603|FG001|STARTED|Overall Study||332
9730778|NCT00128102|10830602|FG000|Treated|Overall Study||329
9730779|NCT00128102|10830603|FG001|Treated|Overall Study||329
9730780|NCT00128102|10830602|FG000|COMPLETED|Overall Study||1
9730781|NCT00128102|10830603|FG001|COMPLETED|Overall Study||0
9730782|NCT00128102|10830602|FG000|NOT COMPLETED|Overall Study||328
9730783|NCT00128102|10830603|FG001|NOT COMPLETED|Overall Study||332
9730784|NCT00128180|10830611|FG000|STARTED|Overall Study||32
9730785|NCT00128180|10830612|FG001|STARTED|Overall Study||34
9730786|NCT00128180|10830611|FG000|COMPLETED|Overall Study||32
9730787|NCT00128180|10830612|FG001|COMPLETED|Overall Study||34
9730788|NCT00128180|10830611|FG000|NOT COMPLETED|Overall Study||0
9730789|NCT00128180|10830612|FG001|NOT COMPLETED|Overall Study||0
9730790|NCT00128193|10830630|FG000|STARTED|Overall Study||5
9730791|NCT00128193|10830631|FG001|STARTED|Overall Study||5
9730792|NCT00128193|10830632|FG002|STARTED|Overall Study||45
9730793|NCT00128193|10830633|FG003|STARTED|Overall Study||45
9730794|NCT00128193|10830634|FG004|STARTED|Overall Study||20
9730795|NCT00128193|10830635|FG005|STARTED|Overall Study||20
10163242|NCT02960490|11293403|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163243|NCT02960490|11293394|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
10163244|NCT02960490|11293395|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
10163245|NCT02960490|11293396|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163246|NCT02960490|11293397|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163247|NCT02960490|11293398|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163248|NCT02960490|11293399|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163249|NCT02960490|11293400|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163250|NCT02960490|11293401|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163251|NCT02960490|11293402|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163252|NCT02960490|11293403|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10163253|NCT02960490|11293394|FG000|STARTED|Re-randomized Participants: 12 Weeks||0
10163254|NCT02960490|11293395|FG001|STARTED|Re-randomized Participants: 12 Weeks||0
10163255|NCT02960490|11293396|FG002|STARTED|Re-randomized Participants: 12 Weeks||15
10163256|NCT02960490|11293397|FG003|STARTED|Re-randomized Participants: 12 Weeks||14
10163257|NCT02960490|11293398|FG004|STARTED|Re-randomized Participants: 12 Weeks||14
10163258|NCT02960490|11293399|FG005|STARTED|Re-randomized Participants: 12 Weeks||12
10163259|NCT02960490|11293400|FG006|STARTED|Re-randomized Participants: 12 Weeks||0
10163260|NCT02960490|11293401|FG007|STARTED|Re-randomized Participants: 12 Weeks||0
10163261|NCT02960490|11293402|FG008|STARTED|Re-randomized Participants: 12 Weeks||0
10163262|NCT02960490|11293403|FG009|STARTED|Re-randomized Participants: 12 Weeks||0
10163263|NCT02960490|11293394|FG000|Treated|Re-randomized Participants: 12 Weeks||0
10163264|NCT02960490|11293395|FG001|Treated|Re-randomized Participants: 12 Weeks||0
10163265|NCT02960490|11293396|FG002|Treated|Re-randomized Participants: 12 Weeks||15
10163266|NCT02960490|11293397|FG003|Treated|Re-randomized Participants: 12 Weeks||14
10163267|NCT02960490|11293398|FG004|Treated|Re-randomized Participants: 12 Weeks||14
10163268|NCT02960490|11293399|FG005|Treated|Re-randomized Participants: 12 Weeks||12
10163269|NCT02960490|11293400|FG006|Treated|Re-randomized Participants: 12 Weeks||0
10163270|NCT02960490|11293401|FG007|Treated|Re-randomized Participants: 12 Weeks||0
10163271|NCT02960490|11293402|FG008|Treated|Re-randomized Participants: 12 Weeks||0
10163272|NCT02960490|11293403|FG009|Treated|Re-randomized Participants: 12 Weeks||0
10163273|NCT02960490|11293394|FG000|FAS|Re-randomized Participants: 12 Weeks||0
10163274|NCT02960490|11293395|FG001|FAS|Re-randomized Participants: 12 Weeks||0
10163275|NCT02960490|11293396|FG002|FAS|Re-randomized Participants: 12 Weeks||15
10163276|NCT02960490|11293397|FG003|FAS|Re-randomized Participants: 12 Weeks||14
10163277|NCT02960490|11293398|FG004|FAS|Re-randomized Participants: 12 Weeks||14
10163278|NCT02960490|11293399|FG005|FAS|Re-randomized Participants: 12 Weeks||12
10163279|NCT02960490|11293400|FG006|FAS|Re-randomized Participants: 12 Weeks||0
10163280|NCT02960490|11293401|FG007|FAS|Re-randomized Participants: 12 Weeks||0
10163281|NCT02960490|11293402|FG008|FAS|Re-randomized Participants: 12 Weeks||0
10163282|NCT02960490|11293403|FG009|FAS|Re-randomized Participants: 12 Weeks||0
10163283|NCT02960490|11293394|FG000|SAS|Re-randomized Participants: 12 Weeks||0
10163284|NCT02960490|11293395|FG001|SAS|Re-randomized Participants: 12 Weeks||0
10163285|NCT02960490|11293396|FG002|SAS|Re-randomized Participants: 12 Weeks||15
10163286|NCT02960490|11293397|FG003|SAS|Re-randomized Participants: 12 Weeks||14
10163287|NCT02960490|11293398|FG004|SAS|Re-randomized Participants: 12 Weeks||14
10163288|NCT02960490|11293399|FG005|SAS|Re-randomized Participants: 12 Weeks||12
10163289|NCT02960490|11293400|FG006|SAS|Re-randomized Participants: 12 Weeks||0
10163290|NCT02960490|11293401|FG007|SAS|Re-randomized Participants: 12 Weeks||0
10163291|NCT02960490|11293402|FG008|SAS|Re-randomized Participants: 12 Weeks||0
10163292|NCT02960490|11293403|FG009|SAS|Re-randomized Participants: 12 Weeks||0
10163293|NCT02960490|11293394|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0
10163294|NCT02960490|11293395|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0
10163295|NCT02960490|11293396|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13
10163296|NCT02960490|11293397|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12
10163297|NCT02960490|11293398|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13
10163298|NCT02960490|11293399|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10
10163299|NCT02960490|11293400|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0
10163300|NCT02960490|11293401|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0
10163301|NCT02960490|11293402|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0
10163302|NCT02960490|11293403|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0
10163303|NCT02960490|11293394|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10163304|NCT02960490|11293395|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10163305|NCT02960490|11293396|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
10163306|NCT02960490|11293397|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
10163307|NCT02960490|11293398|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
10163308|NCT02960490|11293399|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
10163309|NCT02960490|11293400|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10163310|NCT02960490|11293401|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10163311|NCT02960490|11293402|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10163312|NCT02960490|11293403|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10163313|NCT02960490|11293394|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0
10163314|NCT02960490|11293395|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0
10163315|NCT02960490|11293396|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0
10163316|NCT02960490|11293397|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0
10163317|NCT02960490|11293398|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0
10163318|NCT02960490|11293399|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0
10163319|NCT02960490|11293400|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13
10163320|NCT02960490|11293401|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
10163321|NCT02960490|11293402|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13
10163322|NCT02960490|11293403|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10
10163323|NCT02960490|11293394|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0
10163324|NCT02960490|11293395|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0
10163325|NCT02960490|11293396|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0
10163326|NCT02960490|11293397|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0
10163327|NCT02960490|11293398|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0
10163328|NCT02960490|11293399|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0
10163329|NCT02960490|11293400|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13
10163330|NCT02960490|11293401|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11
10163331|NCT02960490|11293402|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13
10163332|NCT02960490|11293403|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10
10163333|NCT02960490|11293394|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0
10163334|NCT02960490|11293395|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0
10163335|NCT02960490|11293396|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0
10163336|NCT02960490|11293397|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0
10163337|NCT02960490|11293398|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0
10163338|NCT02960490|11293399|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0
10163339|NCT02960490|11293400|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13
10163340|NCT02960490|11293401|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11
10163341|NCT02960490|11293402|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13
10163342|NCT02960490|11293403|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10
10163343|NCT02960490|11293394|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0
10163344|NCT02960490|11293395|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0
10163345|NCT02960490|11293396|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0
10163346|NCT02960490|11293397|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0
10163347|NCT02960490|11293398|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0
10163348|NCT02960490|11293399|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0
10163349|NCT02960490|11293400|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13
10163350|NCT02960490|11293401|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11
10163351|NCT02960490|11293402|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13
10163352|NCT02960490|11293403|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10
10163353|NCT02960490|11293394|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163354|NCT02960490|11293395|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163355|NCT02960490|11293396|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163356|NCT02960490|11293397|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163357|NCT02960490|11293398|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163358|NCT02960490|11293399|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163359|NCT02960490|11293400|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
10163360|NCT02960490|11293401|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
10163361|NCT02960490|11293402|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
10163362|NCT02960490|11293403|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
10163363|NCT02960490|11293394|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163364|NCT02960490|11293395|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163365|NCT02960490|11293396|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163366|NCT02960490|11293397|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163367|NCT02960490|11293398|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163368|NCT02960490|11293399|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10163369|NCT02960490|11293400|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
10163370|NCT02960490|11293401|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
10163371|NCT02960490|11293402|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
10163372|NCT02960490|11293403|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
10163373|NCT02960854|11293427|FG000|STARTED|Overall Study||15
10163374|NCT02960854|11293428|FG001|STARTED|Overall Study||16
10163375|NCT02960854|11293427|FG000|COMPLETED|Overall Study||8
10163376|NCT02960854|11293428|FG001|COMPLETED|Overall Study||7
10163377|NCT02960854|11293427|FG000|NOT COMPLETED|Overall Study||7
10163378|NCT02960854|11293428|FG001|NOT COMPLETED|Overall Study||9
10163379|NCT02961062|11293436|FG000|STARTED|Overall Study||20
10163380|NCT02961062|11293437|FG001|STARTED|Overall Study||20
9711125|NCT02000115|10810894|FG000|STARTED|Overall Study||381
9711126|NCT02000115|10810895|FG001|STARTED|Overall Study||369
9711127|NCT02000115|10810896|FG002|STARTED|Overall Study||100
9711128|NCT02000115|10810897|FG003|STARTED|Overall Study||53
9711129|NCT02000115|10810894|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
9711130|NCT02000115|10810895|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
9711131|NCT02000115|10810896|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
9711132|NCT02000115|10810897|FG003|COMPLETED|Overall Study||0
9711133|NCT02000115|10810894|FG000|NOT COMPLETED|Overall Study||79
9711134|NCT02000115|10810895|FG001|NOT COMPLETED|Overall Study||68
9711135|NCT02000115|10810896|FG002|NOT COMPLETED|Overall Study||1
10163381|NCT02961062|11293436|FG000|COMPLETED|Overall Study||20
10163382|NCT02961062|11293437|FG001|COMPLETED|Overall Study||20
10163383|NCT02961062|11293436|FG000|NOT COMPLETED|Overall Study||0
10163384|NCT02961062|11293437|FG001|NOT COMPLETED|Overall Study||0
10163385|NCT02961218|11293445|FG000|STARTED|Overall Study||25
10163386|NCT02961218|11293446|FG001|STARTED|Overall Study||24
10163387|NCT02961218|11293445|FG000|Safety Analysis Set|Overall Study||25
10163388|NCT02961218|11293446|FG001|Safety Analysis Set|Overall Study||24
10163389|NCT02961218|11293445|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25
10163390|NCT02961218|11293446|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
10163391|NCT02961218|11293445|FG000|Primary PD Analysis Set|Overall Study||25
10163392|NCT02961218|11293446|FG001|Primary PD Analysis Set|Overall Study||24
10163393|NCT02961218|11293445|FG000|COMPLETED|Overall Study||22
10163394|NCT02961218|11293446|FG001|COMPLETED|Overall Study||19
10163395|NCT02961218|11293445|FG000|NOT COMPLETED|Overall Study||3
10163396|NCT02961218|11293446|FG001|NOT COMPLETED|Overall Study||5
10163397|NCT02961244|11293456|FG000|STARTED|Overall Study||64
10163398|NCT02961244|11293457|FG001|STARTED|Overall Study||64
10163399|NCT02961244|11293456|FG000|Patients Excluded During Randomization|Overall Study||0
10163400|NCT02961244|11293457|FG001|Patients Excluded During Randomization|Overall Study||1
10163401|NCT02961244|11293456|FG000|COMPLETED|Overall Study||63
10163402|NCT02961244|11293457|FG001|COMPLETED|Overall Study||55
10163403|NCT02961244|11293456|FG000|NOT COMPLETED|Overall Study||1
10163404|NCT02961244|11293457|FG001|NOT COMPLETED|Overall Study||9
10163405|NCT02961751|11293463|FG000|STARTED|Overall Study||211
10163406|NCT02961751|11293463|FG000|COMPLETED|Overall Study||196
10163407|NCT02961751|11293463|FG000|NOT COMPLETED|Overall Study||15
10163408|NCT02961764|11293469|FG000|STARTED|Overall Study||160
10163409|NCT02961764|11293470|FG001|STARTED|Overall Study||153
10163410|NCT02961764|11293469|FG000|COMPLETED|Overall Study||121
10163411|NCT02961764|11293470|FG001|COMPLETED|Overall Study||128
10163412|NCT02961764|11293469|FG000|NOT COMPLETED|Overall Study||39
10163413|NCT02961764|11293470|FG001|NOT COMPLETED|Overall Study||25
10163414|NCT02961790|11293480|FG000|STARTED|Overall Study||50
10163415|NCT02961790|11293481|FG001|STARTED|Overall Study||51
10163416|NCT02961790|11293482|FG002|STARTED|Overall Study||24
10163417|NCT02961790|11293483|FG003|STARTED|Overall Study||25
10163418|NCT02961790|11293480|FG000|COMPLETED|Overall Study||35
10163419|NCT02961790|11293481|FG001|COMPLETED|Overall Study||40
10163420|NCT02961790|11293482|FG002|COMPLETED|Overall Study||18
10163421|NCT02961790|11293483|FG003|COMPLETED|Overall Study||20
10163422|NCT02961790|11293480|FG000|NOT COMPLETED|Overall Study||15
10163423|NCT02961790|11293481|FG001|NOT COMPLETED|Overall Study||11
10163424|NCT02961790|11293482|FG002|NOT COMPLETED|Overall Study||6
10163425|NCT02961790|11293483|FG003|NOT COMPLETED|Overall Study||5
10163426|NCT02961894|11293494|FG000|STARTED|Overall Study||121
10163427|NCT02961894|11293494|FG000|COMPLETED|Overall Study||121
10163428|NCT02961894|11293494|FG000|NOT COMPLETED|Overall Study||0
10163429|NCT02961920|11293500|FG000|STARTED|Overall Study||25
10163430|NCT02961920|11293501|FG001|STARTED|Overall Study||25
10163431|NCT02961920|11293500|FG000|COMPLETED|Overall Study||24
10163432|NCT02961920|11293501|FG001|COMPLETED|Overall Study||24
10163433|NCT02961920|11293500|FG000|NOT COMPLETED|Overall Study||1
10163434|NCT02961920|11293501|FG001|NOT COMPLETED|Overall Study||1
10163435|NCT02961946|11293510|FG000|STARTED|Overall Study||66
10163436|NCT02961946|11293511|FG001|STARTED|Overall Study||66
10163437|NCT02961946|11293512|FG002|STARTED|Overall Study||66
10163438|NCT02961946|11293510|FG000|COMPLETED|Overall Study||66
10163439|NCT02961946|11293511|FG001|COMPLETED|Overall Study||66
10163440|NCT02961946|11293512|FG002|COMPLETED|Overall Study||66
10163441|NCT02961946|11293510|FG000|NOT COMPLETED|Overall Study||0
10163442|NCT02961946|11293511|FG001|NOT COMPLETED|Overall Study||0
10163443|NCT02961946|11293512|FG002|NOT COMPLETED|Overall Study||0
10163444|NCT02962284|11293522|FG000|STARTED|Overall Study||9
10163445|NCT02962284|11293523|FG001|STARTED|Overall Study||11
10163446|NCT02962284|11293522|FG000|COMPLETED|Overall Study||4
10163447|NCT02962284|11293523|FG001|COMPLETED|Overall Study||8
10163448|NCT02962284|11293522|FG000|NOT COMPLETED|Overall Study||5
10163449|NCT02962284|11293523|FG001|NOT COMPLETED|Overall Study||3
10163450|NCT02962427|11293533|FG000|STARTED|Overall Study||3
10163451|NCT02962427|11293534|FG001|STARTED|Overall Study||1
10163452|NCT02962427|11293533|FG000|COMPLETED|Overall Study||3
10163453|NCT02962427|11293534|FG001|COMPLETED|Overall Study||1
10163454|NCT02962427|11293533|FG000|NOT COMPLETED|Overall Study||0
10163455|NCT02962427|11293534|FG001|NOT COMPLETED|Overall Study||0
10163456|NCT02962609|11293544|FG000|STARTED|Overall Study||38
10163457|NCT02962609|11293545|FG001|STARTED|Overall Study||42
10163458|NCT02962609|11293544|FG000|COMPLETED|Overall Study||38
10163459|NCT02962609|11293545|FG001|COMPLETED|Overall Study||42
10163460|NCT02962609|11293544|FG000|NOT COMPLETED|Overall Study||0
10163461|NCT02962609|11293545|FG001|NOT COMPLETED|Overall Study||0
10163462|NCT02962648|11293551|FG000|STARTED|Overall Study||103
10163463|NCT02962648|11293551|FG000|COMPLETED|Overall Study||94
10163464|NCT02962648|11293551|FG000|NOT COMPLETED|Overall Study||9
10163465|NCT02962674|11293555|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49
10163466|NCT02962674|11293555|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46
10163467|NCT02962674|11293555|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46
10163468|NCT02962674|11293555|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32
10163469|NCT02962674|11293555|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18
10163470|NCT02962674|11293555|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4
10163471|NCT02962674|11293555|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0
10163472|NCT02962674|11293555|FG000|NOT COMPLETED|Overall Study||49
10163473|NCT02962687|11293563|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
10163474|NCT02962687|11293564|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
10163475|NCT02962687|11293563|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
10163476|NCT02962687|11293564|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
10163477|NCT02962687|11293563|FG000|NOT COMPLETED|Overall Study||10
10163478|NCT02962687|11293564|FG001|NOT COMPLETED|Overall Study||8
10163479|NCT02962739|11293572|FG000|STARTED|Overall Study||6
10163480|NCT02962739|11293573|FG001|STARTED|Overall Study||7
10163481|NCT02962739|11293574|FG002|STARTED|Overall Study||7
10163482|NCT02962739|11293575|FG003|STARTED|Overall Study||6
10163483|NCT02962739|11293576|FG004|STARTED|Overall Study||6
10163484|NCT02962739|11293577|FG005|STARTED|Overall Study||6
10163485|NCT02962739|11293572|FG000|COMPLETED|Overall Study||6
10163486|NCT02962739|11293573|FG001|COMPLETED|Overall Study||6
10163487|NCT02962739|11293574|FG002|COMPLETED|Overall Study||6
10163488|NCT02962739|11293575|FG003|COMPLETED|Overall Study||6
10163489|NCT02962739|11293576|FG004|COMPLETED|Overall Study||5
10163490|NCT02962739|11293577|FG005|COMPLETED|Overall Study||6
10163491|NCT02962739|11293572|FG000|NOT COMPLETED|Overall Study||0
10163492|NCT02962739|11293573|FG001|NOT COMPLETED|Overall Study||1
10163493|NCT02962739|11293574|FG002|NOT COMPLETED|Overall Study||1
10163494|NCT02962739|11293575|FG003|NOT COMPLETED|Overall Study||0
10163495|NCT02962739|11293576|FG004|NOT COMPLETED|Overall Study||1
10163496|NCT02962739|11293577|FG005|NOT COMPLETED|Overall Study||0
10163497|NCT02962765|11293583|FG000|STARTED|Overall Study||78
10163498|NCT02962765|11293583|FG000|FAS Population|Overall Study||78
10163499|NCT02962765|11293583|FG000|SAF Population|Overall Study||78
10163500|NCT02962765|11293583|FG000|Prophylactic Treatment Group|Overall Study||77
10163501|NCT02962765|11293583|FG000|On Demand Treatment Group|Overall Study||2
10163502|NCT02962765|11293583|FG000|SURG Population|Overall Study||4
10163503|NCT02962765|11293583|FG000|COMPLETED|Overall Study||61
10163504|NCT02962765|11293583|FG000|NOT COMPLETED|Overall Study||17
10163505|NCT02962882|11293594|FG000|STARTED|Overall Study||50
10163506|NCT02962882|11293594|FG000|COMPLETED|Overall Study||14
10163507|NCT02962882|11293594|FG000|NOT COMPLETED|Overall Study||36
10163508|NCT02962908|11293603|FG000|STARTED|Overall Study||58
10163509|NCT02962908|11293604|FG001|STARTED|Overall Study||58
10163510|NCT02962908|11293605|FG002|STARTED|Overall Study||32
10163511|NCT02962908|11293606|FG003|STARTED|Overall Study||27
10163512|NCT02962908|11293603|FG000|COMPLETED|Overall Study||58
10163513|NCT02962908|11293604|FG001|COMPLETED|Overall Study||50
10163514|NCT02962908|11293605|FG002|COMPLETED|Overall Study||32
10163515|NCT02962908|11293606|FG003|COMPLETED|Overall Study||24
10163516|NCT02962908|11293603|FG000|NOT COMPLETED|Overall Study||0
10163517|NCT02962908|11293604|FG001|NOT COMPLETED|Overall Study||8
10163518|NCT02962908|11293605|FG002|NOT COMPLETED|Overall Study||0
9711136|NCT02000115|10810897|FG003|NOT COMPLETED|Overall Study||53
9711137|NCT01888653|10810908|FG000|STARTED|Overall Study||24
9711138|NCT01888653|10810909|FG001|STARTED|Overall Study||26
9711139|NCT01888653|10810908|FG000|COMPLETED|Overall Study||24
9711140|NCT01888653|10810909|FG001|COMPLETED|Overall Study||26
9711141|NCT01888653|10810908|FG000|NOT COMPLETED|Overall Study||0
9711142|NCT01888653|10810909|FG001|NOT COMPLETED|Overall Study||0
9711143|NCT01813227|10810915|FG000|STARTED|Overall Study||7
9711144|NCT01813227|10810915|FG000|COMPLETED|Overall Study||7
9711145|NCT01813227|10810915|FG000|NOT COMPLETED|Overall Study||0
9711146|NCT01695317|10810921|FG000|STARTED|Period 1 in the Cross-over Design||36
9711147|NCT01695317|10810922|FG001|STARTED|Period 1 in the Cross-over Design||36
9711148|NCT01695317|10810921|FG000|COMPLETED|Period 1 in the Cross-over Design||34
9711149|NCT01695317|10810922|FG001|COMPLETED|Period 1 in the Cross-over Design||35
9711150|NCT01695317|10810921|FG000|NOT COMPLETED|Period 1 in the Cross-over Design||2
9711151|NCT01695317|10810922|FG001|NOT COMPLETED|Period 1 in the Cross-over Design||1
9711152|NCT01695317|10810921|FG000|STARTED|Cross-over to Period 2||34
9711153|NCT01695317|10810922|FG001|STARTED|Cross-over to Period 2||35
9711154|NCT01695317|10810921|FG000|COMPLETED|Cross-over to Period 2||30
9711155|NCT01695317|10810922|FG001|COMPLETED|Cross-over to Period 2||1
9711156|NCT01695317|10810921|FG000|NOT COMPLETED|Cross-over to Period 2||4
9711157|NCT01695317|10810922|FG001|NOT COMPLETED|Cross-over to Period 2||34
9711158|NCT01683825|10810931|FG000|STARTED|Overall Study||10
9711159|NCT01683825|10810932|FG001|STARTED|Overall Study||6
9711160|NCT01683825|10810933|FG002|STARTED|Overall Study||7
9711161|NCT01683825|10810931|FG000|COMPLETED|Overall Study||10
10163519|NCT02962908|11293606|FG003|NOT COMPLETED|Overall Study||3
10163520|NCT02962934|11293624|FG000|STARTED|Overall Study||12
10163521|NCT02962934|11293625|FG001|STARTED|Overall Study||6
10163522|NCT02962934|11293624|FG000|COMPLETED|Overall Study||12
10163523|NCT02962934|11293625|FG001|COMPLETED|Overall Study||6
10163524|NCT02962934|11293624|FG000|NOT COMPLETED|Overall Study||0
10163525|NCT02962934|11293625|FG001|NOT COMPLETED|Overall Study||0
10163526|NCT02962960|11293634|FG000|STARTED|Overall Study||14
10163527|NCT02962960|11293635|FG001|STARTED|Overall Study||13
10163528|NCT02962960|11293636|FG002|STARTED|Overall Study||9
10163529|NCT02962960|11293634|FG000|COMPLETED|Overall Study||11
10163530|NCT02962960|11293635|FG001|COMPLETED|Overall Study||11
10163531|NCT02962960|11293636|FG002|COMPLETED|Overall Study||9
10163532|NCT02962960|11293634|FG000|NOT COMPLETED|Overall Study||3
10163533|NCT02962960|11293635|FG001|NOT COMPLETED|Overall Study||2
10163534|NCT02962960|11293636|FG002|NOT COMPLETED|Overall Study||0
10163535|NCT02963311|11293646|FG000|STARTED|Overall Study||9
10163536|NCT02963311|11293646|FG000|COMPLETED|Overall Study||4
10163537|NCT02963311|11293646|FG000|NOT COMPLETED|Overall Study||5
10163538|NCT02963376|11293654|FG000|STARTED|Overall Study||6
10163539|NCT02963376|11293655|FG001|STARTED|Overall Study||2
10163540|NCT02963376|11293656|FG002|STARTED|Overall Study||6
10163541|NCT02963376|11293657|FG003|STARTED|Overall Study||2
10163542|NCT02963376|11293658|FG004|STARTED|Overall Study||6
10163543|NCT02963376|11293659|FG005|STARTED|Overall Study||2
10163544|NCT02963376|11293654|FG000|COMPLETED|Overall Study||6
10163545|NCT02963376|11293655|FG001|COMPLETED|Overall Study||2
10163546|NCT02963376|11293656|FG002|COMPLETED|Overall Study||6
10163547|NCT02963376|11293657|FG003|COMPLETED|Overall Study||2
10163548|NCT02963376|11293658|FG004|COMPLETED|Overall Study||6
10163549|NCT02963376|11293659|FG005|COMPLETED|Overall Study||2
10163550|NCT02963376|11293654|FG000|NOT COMPLETED|Overall Study||0
10163551|NCT02963376|11293655|FG001|NOT COMPLETED|Overall Study||0
10163552|NCT02963376|11293656|FG002|NOT COMPLETED|Overall Study||0
10163553|NCT02963376|11293657|FG003|NOT COMPLETED|Overall Study||0
10163554|NCT02963376|11293658|FG004|NOT COMPLETED|Overall Study||0
10163555|NCT02963376|11293659|FG005|NOT COMPLETED|Overall Study||0
10163556|NCT02963441|11293681|FG000|STARTED|Overall Study||900
10163557|NCT02963441|11293681|FG000|COMPLETED|Overall Study||819
10163558|NCT02963441|11293681|FG000|NOT COMPLETED|Overall Study||81
10163559|NCT02963506|11293691|FG000|STARTED|Double-Blind Period||60
10163560|NCT02963506|11293692|FG001|STARTED|Double-Blind Period||61
10163561|NCT02963506|11293693|FG002|STARTED|Double-Blind Period||61
10163562|NCT02963506|11293694|FG003|STARTED|Double-Blind Period||60
10163563|NCT02963506|11293695|FG004|STARTED|Double-Blind Period||61
10163564|NCT02963506|11293696|FG005|STARTED|Double-Blind Period||0
10163565|NCT02963506|11293697|FG006|STARTED|Double-Blind Period||0
10163566|NCT02963506|11293698|FG007|STARTED|Double-Blind Period||0
10163567|NCT02963506|11293699|FG008|STARTED|Double-Blind Period||0
10163568|NCT02963506|11293700|FG009|STARTED|Double-Blind Period||0
10163569|NCT02963506|11293701|FG010|STARTED|Double-Blind Period||0
10163570|NCT02963506|11293702|FG011|STARTED|Double-Blind Period||0
10163571|NCT02963506|11293703|FG012|STARTED|Double-Blind Period||0
10163572|NCT02963506|11293691|FG000|Completed Double-Blind Period|Double-Blind Period||60
10163573|NCT02963506|11293692|FG001|Completed Double-Blind Period|Double-Blind Period||59
10163574|NCT02963506|11293693|FG002|Completed Double-Blind Period|Double-Blind Period||59
10163575|NCT02963506|11293694|FG003|Completed Double-Blind Period|Double-Blind Period||58
10163576|NCT02963506|11293695|FG004|Completed Double-Blind Period|Double-Blind Period||61
10163577|NCT02963506|11293696|FG005|Completed Double-Blind Period|Double-Blind Period||0
10163578|NCT02963506|11293697|FG006|Completed Double-Blind Period|Double-Blind Period||0
10163579|NCT02963506|11293698|FG007|Completed Double-Blind Period|Double-Blind Period||0
10163580|NCT02963506|11293699|FG008|Completed Double-Blind Period|Double-Blind Period||0
10163581|NCT02963506|11293700|FG009|Completed Double-Blind Period|Double-Blind Period||0
10163582|NCT02963506|11293701|FG010|Completed Double-Blind Period|Double-Blind Period||0
10163583|NCT02963506|11293702|FG011|Completed Double-Blind Period|Double-Blind Period||0
10163584|NCT02963506|11293703|FG012|Completed Double-Blind Period|Double-Blind Period||0
10163585|NCT02963506|11293691|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
10163586|NCT02963506|11293692|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
10163587|NCT02963506|11293693|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
10163588|NCT02963506|11293694|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
10163589|NCT02963506|11293695|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
10163590|NCT02963506|11293696|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163591|NCT02963506|11293697|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163592|NCT02963506|11293698|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163593|NCT02963506|11293699|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163594|NCT02963506|11293700|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163595|NCT02963506|11293701|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163596|NCT02963506|11293702|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163597|NCT02963506|11293703|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10163598|NCT02963506|11293691|FG000|COMPLETED|Double-Blind Period||60
10163599|NCT02963506|11293692|FG001|COMPLETED|Double-Blind Period||58
10163600|NCT02963506|11293693|FG002|COMPLETED|Double-Blind Period||59
10163601|NCT02963506|11293694|FG003|COMPLETED|Double-Blind Period||58
10163602|NCT02963506|11293695|FG004|COMPLETED|Double-Blind Period||61
10163603|NCT02963506|11293696|FG005|COMPLETED|Double-Blind Period||0
10163604|NCT02963506|11293697|FG006|COMPLETED|Double-Blind Period||0
10163605|NCT02963506|11293698|FG007|COMPLETED|Double-Blind Period||0
10163606|NCT02963506|11293699|FG008|COMPLETED|Double-Blind Period||0
10163607|NCT02963506|11293700|FG009|COMPLETED|Double-Blind Period||0
10163608|NCT02963506|11293701|FG010|COMPLETED|Double-Blind Period||0
10163609|NCT02963506|11293702|FG011|COMPLETED|Double-Blind Period||0
10163610|NCT02963506|11293703|FG012|COMPLETED|Double-Blind Period||0
10163611|NCT02963506|11293691|FG000|NOT COMPLETED|Double-Blind Period||0
10163612|NCT02963506|11293692|FG001|NOT COMPLETED|Double-Blind Period||3
10163613|NCT02963506|11293693|FG002|NOT COMPLETED|Double-Blind Period||2
10163614|NCT02963506|11293694|FG003|NOT COMPLETED|Double-Blind Period||2
10163615|NCT02963506|11293695|FG004|NOT COMPLETED|Double-Blind Period||0
10163616|NCT02963506|11293696|FG005|NOT COMPLETED|Double-Blind Period||0
10163617|NCT02963506|11293697|FG006|NOT COMPLETED|Double-Blind Period||0
10163618|NCT02963506|11293698|FG007|NOT COMPLETED|Double-Blind Period||0
10163619|NCT02963506|11293699|FG008|NOT COMPLETED|Double-Blind Period||0
10163620|NCT02963506|11293700|FG009|NOT COMPLETED|Double-Blind Period||0
10163621|NCT02963506|11293701|FG010|NOT COMPLETED|Double-Blind Period||0
10163622|NCT02963506|11293702|FG011|NOT COMPLETED|Double-Blind Period||0
10163623|NCT02963506|11293703|FG012|NOT COMPLETED|Double-Blind Period||0
10163624|NCT02963506|11293691|FG000|STARTED|Dose-Blind Period||0
10163625|NCT02963506|11293692|FG001|STARTED|Dose-Blind Period||0
10163626|NCT02963506|11293693|FG002|STARTED|Dose-Blind Period||0
10163627|NCT02963506|11293694|FG003|STARTED|Dose-Blind Period||0
10163628|NCT02963506|11293695|FG004|STARTED|Dose-Blind Period||0
10163629|NCT02963506|11293696|FG005|STARTED|Dose-Blind Period||24
10163630|NCT02963506|11293697|FG006|STARTED|Dose-Blind Period||36
10163631|NCT02963506|11293698|FG007|STARTED|Dose-Blind Period||31
10163632|NCT02963506|11293699|FG008|STARTED|Dose-Blind Period||27
10163633|NCT02963506|11293700|FG009|STARTED|Dose-Blind Period||34
10163634|NCT02963506|11293701|FG010|STARTED|Dose-Blind Period||25
10163635|NCT02963506|11293702|FG011|STARTED|Dose-Blind Period||58
10163636|NCT02963506|11293703|FG012|STARTED|Dose-Blind Period||61
10163637|NCT02963506|11293691|FG000|COMPLETED|Dose-Blind Period||0
10163638|NCT02963506|11293692|FG001|COMPLETED|Dose-Blind Period||0
10163639|NCT02963506|11293693|FG002|COMPLETED|Dose-Blind Period||0
10163640|NCT02963506|11293694|FG003|COMPLETED|Dose-Blind Period||0
10163641|NCT02963506|11293695|FG004|COMPLETED|Dose-Blind Period||0
10163642|NCT02963506|11293696|FG005|COMPLETED|Dose-Blind Period||20
10163643|NCT02963506|11293697|FG006|COMPLETED|Dose-Blind Period||31
10163644|NCT02963506|11293698|FG007|COMPLETED|Dose-Blind Period||26
10163645|NCT02963506|11293699|FG008|COMPLETED|Dose-Blind Period||24
10163646|NCT02963506|11293700|FG009|COMPLETED|Dose-Blind Period||30
10163647|NCT02963506|11293701|FG010|COMPLETED|Dose-Blind Period||24
10163648|NCT02963506|11293702|FG011|COMPLETED|Dose-Blind Period||56
10163649|NCT02963506|11293703|FG012|COMPLETED|Dose-Blind Period||54
10163650|NCT02963506|11293691|FG000|NOT COMPLETED|Dose-Blind Period||0
10163651|NCT02963506|11293692|FG001|NOT COMPLETED|Dose-Blind Period||0
10163652|NCT02963506|11293693|FG002|NOT COMPLETED|Dose-Blind Period||0
10163653|NCT02963506|11293694|FG003|NOT COMPLETED|Dose-Blind Period||0
10163654|NCT02963506|11293695|FG004|NOT COMPLETED|Dose-Blind Period||0
10163655|NCT02963506|11293696|FG005|NOT COMPLETED|Dose-Blind Period||4
10163656|NCT02963506|11293697|FG006|NOT COMPLETED|Dose-Blind Period||5
10163657|NCT02963506|11293698|FG007|NOT COMPLETED|Dose-Blind Period||5
10163658|NCT02963506|11293699|FG008|NOT COMPLETED|Dose-Blind Period||3
10163659|NCT02963506|11293700|FG009|NOT COMPLETED|Dose-Blind Period||4
10163660|NCT02963506|11293701|FG010|NOT COMPLETED|Dose-Blind Period||1
10163661|NCT02963506|11293702|FG011|NOT COMPLETED|Dose-Blind Period||2
10163662|NCT02963506|11293703|FG012|NOT COMPLETED|Dose-Blind Period||7
10163663|NCT02963597|11293722|FG000|STARTED|Overall Study||10
10163664|NCT02963597|11293723|FG001|STARTED|Overall Study||11
10163665|NCT02963597|11293722|FG000|COMPLETED|Overall Study||10
10163666|NCT02963597|11293723|FG001|COMPLETED|Overall Study||11
10163667|NCT02963597|11293722|FG000|NOT COMPLETED|Overall Study||0
10163668|NCT02963597|11293723|FG001|NOT COMPLETED|Overall Study||0
10163669|NCT02963701|11293731|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28
10163670|NCT02963701|11293732|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28
10163671|NCT02963701|11293731|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
10163672|NCT02963701|11293732|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28
10163673|NCT02963701|11293731|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
10163674|NCT02963701|11293732|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
10163675|NCT02963701|11293731|FG000|STARTED|Period 2 (2 Days)||27
10163676|NCT02963701|11293732|FG001|STARTED|Period 2 (2 Days)||28
10163677|NCT02963701|11293731|FG000|COMPLETED|Period 2 (2 Days)||27
10163678|NCT02963701|11293732|FG001|COMPLETED|Period 2 (2 Days)||28
10163679|NCT02963701|11293731|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10163680|NCT02963701|11293732|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10163681|NCT02963922|11293740|FG000|STARTED|Overall Study||198
10163682|NCT02963922|11293741|FG001|STARTED|Overall Study||198
10163683|NCT02963922|11293740|FG000|COMPLETED|Overall Study||166
10163684|NCT02963922|11293741|FG001|COMPLETED|Overall Study||168
10163685|NCT02963922|11293740|FG000|NOT COMPLETED|Overall Study||32
10163686|NCT02963922|11293741|FG001|NOT COMPLETED|Overall Study||30
10163687|NCT02963935|11293749|FG000|STARTED|Overall Study||142
10163688|NCT02963935|11293750|FG001|STARTED|Overall Study||140
10163689|NCT02963935|11293749|FG000|COMPLETED|Overall Study||114
10163690|NCT02963935|11293750|FG001|COMPLETED|Overall Study||103
10163691|NCT02963935|11293749|FG000|NOT COMPLETED|Overall Study||28
10163692|NCT02963935|11293750|FG001|NOT COMPLETED|Overall Study||37
10163693|NCT02963974|11293756|FG000|STARTED|Overall Study||20
10163694|NCT02963974|11293756|FG000|COMPLETED|Overall Study||19
10163695|NCT02963974|11293756|FG000|NOT COMPLETED|Overall Study||1
10163696|NCT02963987|11293760|FG000|STARTED|First Intervention Period||31
10163697|NCT02963987|11293761|FG001|STARTED|First Intervention Period||19
10163698|NCT02963987|11293760|FG000|COMPLETED|First Intervention Period||31
10163699|NCT02963987|11293761|FG001|COMPLETED|First Intervention Period||19
10163700|NCT02963987|11293760|FG000|NOT COMPLETED|First Intervention Period||0
10163701|NCT02963987|11293761|FG001|NOT COMPLETED|First Intervention Period||0
10163702|NCT02963987|11293760|FG000|STARTED|Second Intervention Period||31
10163703|NCT02963987|11293761|FG001|STARTED|Second Intervention Period||19
9711162|NCT01683825|10810932|FG001|COMPLETED|Overall Study||6
10163704|NCT02963987|11293760|FG000|COMPLETED|Second Intervention Period||31
10163705|NCT02963987|11293761|FG001|COMPLETED|Second Intervention Period||19
10163706|NCT02963987|11293760|FG000|NOT COMPLETED|Second Intervention Period||0
10163707|NCT02963987|11293761|FG001|NOT COMPLETED|Second Intervention Period||0
10197404|NCT03373383|11325308|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
10197405|NCT03373591|11325338|FG000|STARTED|Overall Study||75
10197406|NCT03373591|11325339|FG001|STARTED|Overall Study||71
10197407|NCT03373591|11325340|FG002|STARTED|Overall Study||73
10197408|NCT03373591|11325338|FG000|COMPLETED|Overall Study||75
10197409|NCT03373591|11325339|FG001|COMPLETED|Overall Study||71
10197410|NCT03373591|11325340|FG002|COMPLETED|Overall Study||73
10197411|NCT03373591|11325338|FG000|NOT COMPLETED|Overall Study||0
10197412|NCT03373591|11325339|FG001|NOT COMPLETED|Overall Study||0
10197413|NCT03373591|11325340|FG002|NOT COMPLETED|Overall Study||0
10197414|NCT03373890|11325350|FG000|STARTED|Overall Study||6
10197415|NCT03373890|11325351|FG001|STARTED|Overall Study||6
10197416|NCT03373890|11325350|FG000|COMPLETED|Overall Study||6
10197417|NCT03373890|11325351|FG001|COMPLETED|Overall Study||6
10197418|NCT03373890|11325350|FG000|NOT COMPLETED|Overall Study||0
10197419|NCT03373890|11325351|FG001|NOT COMPLETED|Overall Study||0
10197420|NCT03374176|11325361|FG000|STARTED|Overall Study||21
10197421|NCT03374176|11325362|FG001|STARTED|Overall Study||21
10197422|NCT03374176|11325361|FG000|COMPLETED|Overall Study||21
10197423|NCT03374176|11325362|FG001|COMPLETED|Overall Study||21
10197424|NCT03374176|11325361|FG000|NOT COMPLETED|Overall Study||0
10197425|NCT03374176|11325362|FG001|NOT COMPLETED|Overall Study||0
10197426|NCT03374189|11325370|FG000|STARTED|Overall Study||40
10197427|NCT03374189|11325371|FG001|STARTED|Overall Study||39
10197428|NCT03374189|11325370|FG000|COMPLETED|Overall Study||39
10197429|NCT03374189|11325371|FG001|COMPLETED|Overall Study||39
10197430|NCT03374189|11325370|FG000|NOT COMPLETED|Overall Study||1
10197431|NCT03374189|11325371|FG001|NOT COMPLETED|Overall Study||0
10197432|NCT03374358|11325379|FG000|STARTED|Overall Study||24
10197433|NCT03374358|11325380|FG001|STARTED|Overall Study||21
10197434|NCT03374358|11325379|FG000|COMPLETED|Overall Study||24
10197435|NCT03374358|11325380|FG001|COMPLETED|Overall Study||19
10197436|NCT03374358|11325379|FG000|NOT COMPLETED|Overall Study||0
10197437|NCT03374358|11325380|FG001|NOT COMPLETED|Overall Study||2
10197438|NCT03374488|11325388|FG000|STARTED|Overall Study||42
10197439|NCT03374488|11325389|FG001|STARTED|Overall Study||42
10197440|NCT03374488|11325388|FG000|Intention-to-Treat (ITT)|Overall Study||42
10197441|NCT03374488|11325389|FG001|Intention-to-Treat (ITT)|Overall Study||42
10197442|NCT03374488|11325388|FG000|All Participants as Treated (APaT)|Overall Study||42
10197443|NCT03374488|11325389|FG001|All Participants as Treated (APaT)|Overall Study||41
10197444|NCT03374488|11325388|FG000|COMPLETED|Overall Study||23
10197445|NCT03374488|11325389|FG001|COMPLETED|Overall Study||28
10197446|NCT03374488|11325388|FG000|NOT COMPLETED|Overall Study||19
10197447|NCT03374488|11325389|FG001|NOT COMPLETED|Overall Study||14
10197448|NCT03374683|11325399|FG000|STARTED|Overall Study||148
10197449|NCT03374683|11325400|FG001|STARTED|Overall Study||150
10197450|NCT03374683|11325401|FG002|STARTED|Overall Study||153
10197451|NCT03374683|11325399|FG000|1-week Post-intervention|Overall Study||135
10197452|NCT03374683|11325400|FG001|1-week Post-intervention|Overall Study||113
10197453|NCT03374683|11325401|FG002|1-week Post-intervention|Overall Study||85
10197454|NCT03374683|11325399|FG000|COMPLETED|Overall Study||123
10197455|NCT03374683|11325400|FG001|COMPLETED|Overall Study||105
10197456|NCT03374683|11325401|FG002|COMPLETED|Overall Study||84
10197457|NCT03374683|11325399|FG000|NOT COMPLETED|Overall Study||25
10197458|NCT03374683|11325400|FG001|NOT COMPLETED|Overall Study||45
10197459|NCT03374683|11325401|FG002|NOT COMPLETED|Overall Study||69
10197460|NCT03374995|11325411|FG000|STARTED|Overall Study||13
10197461|NCT03374995|11325412|FG001|STARTED|Overall Study||12
10197462|NCT03374995|11325411|FG000|COMPLETED|Overall Study||13
10197463|NCT03374995|11325412|FG001|COMPLETED|Overall Study||11
10197464|NCT03374995|11325411|FG000|NOT COMPLETED|Overall Study||0
10197465|NCT03374995|11325412|FG001|NOT COMPLETED|Overall Study||1
10197466|NCT03375294|11325418|FG000|STARTED|Overall Study||3
10197467|NCT03375294|11325418|FG000|COMPLETED|Overall Study||3
10197468|NCT03375294|11325418|FG000|NOT COMPLETED|Overall Study||0
10197469|NCT03376061|11325424|FG000|STARTED|Overall Study||49
10197470|NCT03376061|11325425|FG001|STARTED|Overall Study||48
10197471|NCT03376061|11325424|FG000|COMPLETED|Overall Study||49
10197472|NCT03376061|11325425|FG001|COMPLETED|Overall Study||48
10197473|NCT03376061|11325424|FG000|NOT COMPLETED|Overall Study||0
10197474|NCT03376061|11325425|FG001|NOT COMPLETED|Overall Study||0
10197475|NCT03376256|11325434|FG000|STARTED|Overall Study||2
10197476|NCT03376256|11325435|FG001|STARTED|Overall Study||0
10197477|NCT03376256|11325434|FG000|COMPLETED|Overall Study||2
10197478|NCT03376256|11325435|FG001|COMPLETED|Overall Study||0
10197479|NCT03376256|11325434|FG000|NOT COMPLETED|Overall Study||0
10197480|NCT03376256|11325435|FG001|NOT COMPLETED|Overall Study||0
10197481|NCT03376295|11325443|FG000|STARTED|Overall Study||1977
10197482|NCT03376295|11325444|FG001|STARTED|Overall Study||1977
10197483|NCT03376295|11325443|FG000|COMPLETED|Overall Study||1977
10197484|NCT03376295|11325444|FG001|COMPLETED|Overall Study||1977
10197485|NCT03376295|11325443|FG000|NOT COMPLETED|Overall Study||0
10197486|NCT03376295|11325444|FG001|NOT COMPLETED|Overall Study||0
10197487|NCT03376321|11325452|FG000|STARTED|Overall Study||168
10197488|NCT03376321|11325453|FG001|STARTED|Overall Study||166
10197489|NCT03376321|11325452|FG000|Treated|Overall Study||163
10197490|NCT03376321|11325453|FG001|Treated|Overall Study||163
10197491|NCT03376321|11325452|FG000|COMPLETED|Overall Study||145
10197492|NCT03376321|11325453|FG001|COMPLETED|Overall Study||141
10197493|NCT03376321|11325452|FG000|NOT COMPLETED|Overall Study||23
10163708|NCT02964234|11293771|FG000|STARTED|Overall Study||76
10163709|NCT02964234|11293772|FG001|STARTED|Overall Study||69
10163710|NCT02964234|11293771|FG000|COMPLETED|Overall Study||54
10163711|NCT02964234|11293772|FG001|COMPLETED|Overall Study||56
10163712|NCT02964234|11293771|FG000|NOT COMPLETED|Overall Study||22
10163713|NCT02964234|11293772|FG001|NOT COMPLETED|Overall Study||13
10163714|NCT02964247|11293780|FG000|STARTED|Overall Study||203
10163715|NCT02964247|11293781|FG001|STARTED|Overall Study||100
10163716|NCT02964247|11293780|FG000|Exposed to Trial Product|Overall Study||202
10163717|NCT02964247|11293781|FG001|Exposed to Trial Product|Overall Study||100
10163718|NCT02964247|11293780|FG000|COMPLETED|Overall Study||200
10163719|NCT02964247|11293781|FG001|COMPLETED|Overall Study||98
10163720|NCT02964247|11293780|FG000|NOT COMPLETED|Overall Study||3
10163721|NCT02964247|11293781|FG001|NOT COMPLETED|Overall Study||2
10163722|NCT02964312|11293787|FG000|STARTED|Overall Study||166
10163723|NCT02964312|11293787|FG000|1-Month Follow-up|Overall Study||164
10163724|NCT02964312|11293787|FG000|3-Month Follow-up|Overall Study||159
10163725|NCT02964312|11293787|FG000|6-Month Follow-up|Overall Study||152
10163726|NCT02964312|11293787|FG000|12-Month Follow-up|Overall Study||139
10163727|NCT02964312|11293787|FG000|18-Month Follow-up|Overall Study||112
9711163|NCT01683825|10810933|FG002|COMPLETED|Overall Study||7
9711164|NCT01683825|10810931|FG000|NOT COMPLETED|Overall Study||0
9711165|NCT01683825|10810932|FG001|NOT COMPLETED|Overall Study||0
9711166|NCT01683825|10810933|FG002|NOT COMPLETED|Overall Study||0
9711167|NCT01196936|10810944|FG000|STARTED|Overall Study||34
9711168|NCT01196936|10810945|FG001|STARTED|Overall Study||38
9711169|NCT01196936|10810944|FG000|Year One Post Treatment|Overall Study||27
9711170|NCT01196936|10810945|FG001|Year One Post Treatment|Overall Study||28
9711171|NCT01196936|10810944|FG000|COMPLETED|Overall Study||23
9711172|NCT01196936|10810945|FG001|COMPLETED|Overall Study||21
9711173|NCT01196936|10810944|FG000|NOT COMPLETED|Overall Study||11
9711174|NCT01196936|10810945|FG001|NOT COMPLETED|Overall Study||17
9711175|NCT01127451|10810953|FG000|STARTED|Overall Study||43
9711176|NCT01127451|10810954|FG001|STARTED|Overall Study||32
9711177|NCT01127451|10810953|FG000|Safety Analysis Set|Overall Study||43
9711178|NCT01127451|10810954|FG001|Safety Analysis Set|Overall Study||32
9711179|NCT01127451|10810953|FG000|Modified Intent-to-Treat (MITT)|Overall Study||42
9711180|NCT01127451|10810954|FG001|Modified Intent-to-Treat (MITT)|Overall Study||32
9711181|NCT01127451|10810953|FG000|COMPLETED|Overall Study||0
9711182|NCT01127451|10810954|FG001|COMPLETED|Overall Study||0
9711183|NCT01127451|10810953|FG000|NOT COMPLETED|Overall Study||43
9711184|NCT01127451|10810954|FG001|NOT COMPLETED|Overall Study||32
9711185|NCT01004874|10810960|FG000|STARTED|Overall Study||80
9711186|NCT01004874|10810960|FG000|COMPLETED|Overall Study||80
9711187|NCT01004874|10810960|FG000|NOT COMPLETED|Overall Study||0
9730796|NCT00128193|10830636|FG006|STARTED|Overall Study||20
9730797|NCT00128193|10830637|FG007|STARTED|Overall Study||20
9730798|NCT00128193|10830638|FG008|STARTED|Overall Study||20
9730799|NCT00128193|10830639|FG009|STARTED|Overall Study||20
9730800|NCT00128193|10830640|FG010|STARTED|Overall Study||20
9730801|NCT00128193|10830641|FG011|STARTED|Overall Study||20
9730802|NCT00128193|10830630|FG000|COMPLETED|Overall Study||5
9730803|NCT00128193|10830631|FG001|COMPLETED|Overall Study||5
9730804|NCT00128193|10830632|FG002|COMPLETED|Overall Study||42
9730805|NCT00128193|10830633|FG003|COMPLETED|Overall Study||44
9730806|NCT00128193|10830634|FG004|COMPLETED|Overall Study||18
9730807|NCT00128193|10830635|FG005|COMPLETED|Overall Study||17
9730808|NCT00128193|10830636|FG006|COMPLETED|Overall Study||16
9730809|NCT00128193|10830637|FG007|COMPLETED|Overall Study||20
9730810|NCT00128193|10830638|FG008|COMPLETED|Overall Study||18
9730811|NCT00128193|10830639|FG009|COMPLETED|Overall Study||18
9730812|NCT00128193|10830640|FG010|COMPLETED|Overall Study||17
9730813|NCT00128193|10830641|FG011|COMPLETED|Overall Study||18
9730814|NCT00128193|10830630|FG000|NOT COMPLETED|Overall Study||0
9730815|NCT00128193|10830631|FG001|NOT COMPLETED|Overall Study||0
9730816|NCT00128193|10830632|FG002|NOT COMPLETED|Overall Study||3
9730817|NCT00128193|10830633|FG003|NOT COMPLETED|Overall Study||1
9730818|NCT00128193|10830634|FG004|NOT COMPLETED|Overall Study||2
9730819|NCT00128193|10830635|FG005|NOT COMPLETED|Overall Study||3
9730820|NCT00128193|10830636|FG006|NOT COMPLETED|Overall Study||4
9730821|NCT00128193|10830637|FG007|NOT COMPLETED|Overall Study||0
9730822|NCT00128193|10830638|FG008|NOT COMPLETED|Overall Study||2
9730823|NCT00128193|10830639|FG009|NOT COMPLETED|Overall Study||2
9730824|NCT00128193|10830640|FG010|NOT COMPLETED|Overall Study||3
9730825|NCT00128193|10830641|FG011|NOT COMPLETED|Overall Study||2
9730826|NCT00128206|10830723|FG000|STARTED|Overall Study||184
9730827|NCT00128206|10830724|FG001|STARTED|Overall Study||180
9730828|NCT00128206|10830723|FG000|COMPLETED|Overall Study||47
9730829|NCT00128206|10830724|FG001|COMPLETED|Overall Study||60
9730830|NCT00128206|10830723|FG000|NOT COMPLETED|Overall Study||137
9730831|NCT00128206|10830724|FG001|NOT COMPLETED|Overall Study||120
9730832|NCT00128219|10830732|FG000|STARTED|Overall Study||333
9730833|NCT00128219|10830733|FG001|STARTED|Overall Study||334
9730834|NCT00128219|10830732|FG000|COMPLETED|Overall Study||264
9730835|NCT00128219|10830733|FG001|COMPLETED|Overall Study||263
9730836|NCT00128219|10830732|FG000|NOT COMPLETED|Overall Study||69
10163728|NCT02964312|11293787|FG000|24-Month Follow-up|Overall Study||102
10163729|NCT02964312|11293787|FG000|COMPLETED|Overall Study||102
10163730|NCT02964312|11293787|FG000|NOT COMPLETED|Overall Study||64
10163731|NCT02964325|11293796|FG000|STARTED|Overall Study||164
10163732|NCT02964325|11293797|FG001|STARTED|Overall Study||166
10163733|NCT02964325|11293796|FG000|Full Analysis Set|Overall Study||164
10163734|NCT02964325|11293797|FG001|Full Analysis Set|Overall Study||166
10163735|NCT02964325|11293796|FG000|Modified Intent-to-Treat|Overall Study||145
10163736|NCT02964325|11293797|FG001|Modified Intent-to-Treat|Overall Study||152
10163737|NCT02964325|11293796|FG000|Safety Set|Overall Study||141
10163738|NCT02964325|11293797|FG001|Safety Set|Overall Study||161
10163739|NCT02964325|11293796|FG000|COMPLETED|Overall Study||143
10163740|NCT02964325|11293797|FG001|COMPLETED|Overall Study||143
10163741|NCT02964325|11293796|FG000|NOT COMPLETED|Overall Study||21
10163742|NCT02964325|11293797|FG001|NOT COMPLETED|Overall Study||23
10163743|NCT02964338|11293806|FG000|STARTED|Overall Study||84
10163744|NCT02964338|11293807|FG001|STARTED|Overall Study||88
10163745|NCT02964338|11293808|FG002|STARTED|Overall Study||87
10163746|NCT02964338|11293806|FG000|Safety Analysis Set|Overall Study||83
10163747|NCT02964338|11293807|FG001|Safety Analysis Set|Overall Study||88
10163748|NCT02964338|11293808|FG002|Safety Analysis Set|Overall Study||87
10163749|NCT02964338|11293806|FG000|Full Analysis Set|Overall Study||81
10163750|NCT02964338|11293807|FG001|Full Analysis Set|Overall Study||86
10163751|NCT02964338|11293808|FG002|Full Analysis Set|Overall Study||87
10163752|NCT02964338|11293806|FG000|COMPLETED|Overall Study||67
10163753|NCT02964338|11293807|FG001|COMPLETED|Overall Study||64
10163754|NCT02964338|11293808|FG002|COMPLETED|Overall Study||68
10163755|NCT02964338|11293806|FG000|NOT COMPLETED|Overall Study||17
10163756|NCT02964338|11293807|FG001|NOT COMPLETED|Overall Study||24
10163757|NCT02964338|11293808|FG002|NOT COMPLETED|Overall Study||19
10163758|NCT02964416|11293818|FG000|STARTED|Overall Study||39
10163759|NCT02964416|11293819|FG001|STARTED|Overall Study||41
10163760|NCT02964416|11293818|FG000|COMPLETED|Overall Study||38
10163761|NCT02964416|11293819|FG001|COMPLETED|Overall Study||41
10163762|NCT02964416|11293818|FG000|NOT COMPLETED|Overall Study||1
10163763|NCT02964416|11293819|FG001|NOT COMPLETED|Overall Study||0
10163764|NCT02964767|11293828|FG000|STARTED|Overall Study||171
10163765|NCT02964767|11293829|FG001|STARTED|Overall Study||48
10163766|NCT02964767|11293828|FG000|COMPLETED|Overall Study||171
10163767|NCT02964767|11293829|FG001|COMPLETED|Overall Study||48
10163768|NCT02964767|11293828|FG000|NOT COMPLETED|Overall Study||0
10163769|NCT02964767|11293829|FG001|NOT COMPLETED|Overall Study||0
10163770|NCT02964910|11293838|FG000|STARTED|Overall Study||235
10163771|NCT02964910|11293839|FG001|STARTED|Overall Study||240
10163772|NCT02964910|11293838|FG000|COMPLETED|Overall Study||192
10163773|NCT02964910|11293839|FG001|COMPLETED|Overall Study||196
10163774|NCT02964910|11293838|FG000|NOT COMPLETED|Overall Study||43
10163775|NCT02964910|11293839|FG001|NOT COMPLETED|Overall Study||44
10163776|NCT02965144|11293847|FG000|STARTED|Overall Study||13
10163777|NCT02965144|11293847|FG000|COMPLETED|Overall Study||13
10163778|NCT02965144|11293847|FG000|NOT COMPLETED|Overall Study||0
10163779|NCT02965378|11293856|FG000|STARTED|Overall Study||25
10163780|NCT02965378|11293857|FG001|STARTED|Overall Study||9
10163781|NCT02965378|11293856|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
10163782|NCT02965378|11293857|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
10163783|NCT02965378|11293856|FG000|COMPLETED|Overall Study||0
10163784|NCT02965378|11293857|FG001|COMPLETED|Overall Study||0
10163785|NCT02965378|11293856|FG000|NOT COMPLETED|Overall Study||25
10163786|NCT02965378|11293857|FG001|NOT COMPLETED|Overall Study||9
10163787|NCT02965456|11293865|FG000|STARTED|Overall Study||413
10163788|NCT02965456|11293866|FG001|STARTED|Overall Study||407
10163789|NCT02965456|11293865|FG000|Intent-to-treat (ITT) Population|Overall Study||413
10163790|NCT02965456|11293866|FG001|Intent-to-treat (ITT) Population|Overall Study||407
10163791|NCT02965456|11293865|FG000|Safety Population|Overall Study||389
10163792|NCT02965456|11293866|FG001|Safety Population|Overall Study||398
10163793|NCT02965456|11293865|FG000|COMPLETED|Overall Study||342
10163794|NCT02965456|11293866|FG001|COMPLETED|Overall Study||364
10163795|NCT02965456|11293865|FG000|NOT COMPLETED|Overall Study||71
10163796|NCT02965456|11293866|FG001|NOT COMPLETED|Overall Study||43
10163797|NCT02965534|11293872|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45
10163798|NCT02965534|11293873|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55
10163799|NCT02965534|11293872|FG000|COMPLETED|Overall Study||45
10163800|NCT02965534|11293873|FG001|COMPLETED|Overall Study||55
10163801|NCT02965534|11293872|FG000|NOT COMPLETED|Overall Study||0
10163802|NCT02965534|11293873|FG001|NOT COMPLETED|Overall Study||0
10163803|NCT02965573|11293882|FG000|STARTED|Overall Study||12
10163804|NCT02965573|11293883|FG001|STARTED|Overall Study||12
10163805|NCT02965573|11293882|FG000|COMPLETED|Overall Study||11
10163806|NCT02965573|11293883|FG001|COMPLETED|Overall Study||12
10163807|NCT02965573|11293882|FG000|NOT COMPLETED|Overall Study||1
10163808|NCT02965573|11293883|FG001|NOT COMPLETED|Overall Study||0
10163809|NCT02965599|11293891|FG000|STARTED|Overall Study||2
10163810|NCT02965599|11293892|FG001|STARTED|Overall Study||1
10163811|NCT02965599|11293891|FG000|COMPLETED|Overall Study||1
10163812|NCT02965599|11293892|FG001|COMPLETED|Overall Study||1
10163813|NCT02965599|11293891|FG000|NOT COMPLETED|Overall Study||1
10163814|NCT02965599|11293892|FG001|NOT COMPLETED|Overall Study||0
10163815|NCT02965781|11293902|FG000|STARTED|Overall Study||46
10163816|NCT02965781|11293903|FG001|STARTED|Overall Study||46
10163817|NCT02965781|11293904|FG002|STARTED|Overall Study||47
10163818|NCT02965781|11293902|FG000|COMPLETED|Overall Study||46
10163819|NCT02965781|11293903|FG001|COMPLETED|Overall Study||46
10163820|NCT02965781|11293904|FG002|COMPLETED|Overall Study||47
10163821|NCT02965781|11293902|FG000|NOT COMPLETED|Overall Study||0
10163822|NCT02965781|11293903|FG001|NOT COMPLETED|Overall Study||0
10163823|NCT02965781|11293904|FG002|NOT COMPLETED|Overall Study||0
10163824|NCT02965820|11293912|FG000|STARTED|Period 1, First 30 Days||59
10163825|NCT02965820|11293913|FG001|STARTED|Period 1, First 30 Days||62
10163826|NCT02965820|11293912|FG000|COMPLETED|Period 1, First 30 Days||59
10163827|NCT02965820|11293913|FG001|COMPLETED|Period 1, First 30 Days||62
10163828|NCT02965820|11293912|FG000|NOT COMPLETED|Period 1, First 30 Days||0
10163829|NCT02965820|11293913|FG001|NOT COMPLETED|Period 1, First 30 Days||0
10163830|NCT02965820|11293912|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
10163831|NCT02965820|11293913|FG001|STARTED|Period 2, Second 30 Days||62
10163832|NCT02965820|11293912|FG000|COMPLETED|Period 2, Second 30 Days||57
10163833|NCT02965820|11293913|FG001|COMPLETED|Period 2, Second 30 Days||61
10163834|NCT02965820|11293912|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
10163835|NCT02965820|11293913|FG001|NOT COMPLETED|Period 2, Second 30 Days||1
10163836|NCT02965833|11293919|FG000|STARTED|Period 1, First 30 Days of Wear||67
10163837|NCT02965833|11293920|FG001|STARTED|Period 1, First 30 Days of Wear||54
10163838|NCT02965833|11293919|FG000|COMPLETED|Period 1, First 30 Days of Wear||64
10163839|NCT02965833|11293920|FG001|COMPLETED|Period 1, First 30 Days of Wear||52
10163840|NCT02965833|11293919|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
10163841|NCT02965833|11293920|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2
10163842|NCT02965833|11293919|FG000|STARTED|Period 2, Second 30 Days of Wear||64
10163843|NCT02965833|11293920|FG001|STARTED|Period 2, Second 30 Days of Wear||52
10163844|NCT02965833|11293919|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62
10163845|NCT02965833|11293920|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52
9711188|NCT04762771|10810966|FG000|STARTED|Overall Study||1
9711189|NCT04762771|10810967|FG001|STARTED|Overall Study||1
9711190|NCT04762771|10810966|FG000|COMPLETED|Overall Study||1
9711191|NCT04762771|10810967|FG001|COMPLETED|Overall Study||1
9711192|NCT04762771|10810966|FG000|NOT COMPLETED|Overall Study||0
9711193|NCT04762771|10810967|FG001|NOT COMPLETED|Overall Study||0
9711194|NCT04748120|10810975|FG000|STARTED|Overall Study||1
9711195|NCT04748120|10810976|FG001|STARTED|Overall Study||1
9711196|NCT04748120|10810975|FG000|COMPLETED|Overall Study||1
9711197|NCT04748120|10810976|FG001|COMPLETED|Overall Study||1
9711198|NCT04748120|10810975|FG000|NOT COMPLETED|Overall Study||0
9711199|NCT04748120|10810976|FG001|NOT COMPLETED|Overall Study||0
9711200|NCT04559698|10810986|FG000|STARTED|Overall Study||61
10163846|NCT02965833|11293919|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10163847|NCT02965833|11293920|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
10163848|NCT02965924|11293926|FG000|STARTED|Overall Study||20
10163849|NCT02965924|11293926|FG000|COMPLETED|Overall Study||20
10163850|NCT02965924|11293926|FG000|NOT COMPLETED|Overall Study||0
10163851|NCT02965989|11293932|FG000|STARTED|Overall Study||26
10163852|NCT02965989|11293933|FG001|STARTED|Overall Study||22
10163853|NCT02965989|11293932|FG000|COMPLETED|Overall Study||26
10163854|NCT02965989|11293933|FG001|COMPLETED|Overall Study||22
10163855|NCT02965989|11293932|FG000|NOT COMPLETED|Overall Study||0
10163856|NCT02965989|11293933|FG001|NOT COMPLETED|Overall Study||0
10163857|NCT02966002|11293945|FG000|STARTED|Overall Study||9
10163858|NCT02966002|11293945|FG000|COMPLETED|Overall Study||5
10163859|NCT02966002|11293945|FG000|NOT COMPLETED|Overall Study||4
10163860|NCT02966015|11293951|FG000|STARTED|Inclusion Visit||95
10163861|NCT02966015|11293952|FG001|STARTED|Inclusion Visit||58
10163862|NCT02966015|11293951|FG000|COMPLETED|Inclusion Visit||87
10163863|NCT02966015|11293952|FG001|COMPLETED|Inclusion Visit||55
10163864|NCT02966015|11293951|FG000|NOT COMPLETED|Inclusion Visit||8
10163865|NCT02966015|11293952|FG001|NOT COMPLETED|Inclusion Visit||3
10163866|NCT02966015|11293951|FG000|STARTED|Test Period||87
10163867|NCT02966015|11293952|FG001|STARTED|Test Period||55
10163868|NCT02966015|11293951|FG000|COMPLETED|Test Period||87
10163869|NCT02966015|11293952|FG001|COMPLETED|Test Period||55
10163870|NCT02966015|11293951|FG000|NOT COMPLETED|Test Period||0
10163871|NCT02966015|11293952|FG001|NOT COMPLETED|Test Period||0
10163872|NCT02966028|11293961|FG000|STARTED|Overall Study||92
10163873|NCT02966028|11293962|FG001|STARTED|Overall Study||91
10163874|NCT02966028|11293963|FG002|STARTED|Overall Study||91
10163875|NCT02966028|11293961|FG000|COMPLETED|Overall Study||68
10163876|NCT02966028|11293962|FG001|COMPLETED|Overall Study||57
10163877|NCT02966028|11293963|FG002|COMPLETED|Overall Study||60
10163878|NCT02966028|11293961|FG000|NOT COMPLETED|Overall Study||24
10163879|NCT02966028|11293962|FG001|NOT COMPLETED|Overall Study||34
10163880|NCT02966028|11293963|FG002|NOT COMPLETED|Overall Study||31
10163881|NCT02966275|11293975|FG000|STARTED|Overall Study||10
10163882|NCT02966275|11293975|FG000|COMPLETED|Overall Study||10
10163883|NCT02966275|11293975|FG000|NOT COMPLETED|Overall Study||0
10163884|NCT02966314|11293984|FG000|STARTED|Overall Study||5
10163885|NCT02966314|11293985|FG001|STARTED|Overall Study||5
10163886|NCT02966314|11293984|FG000|COMPLETED|Overall Study||4
10163887|NCT02966314|11293985|FG001|COMPLETED|Overall Study||5
10163888|NCT02966314|11293984|FG000|NOT COMPLETED|Overall Study||1
10163889|NCT02966314|11293985|FG001|NOT COMPLETED|Overall Study||0
10163890|NCT02966340|11293991|FG000|STARTED|Overall Study||37
10163891|NCT02966340|11293992|FG001|STARTED|Overall Study||33
10163892|NCT02966340|11293991|FG000|COMPLETED|Overall Study||34
10061095|NCT02101437|11186676|FG002|STARTED|Overall Study||52
10061096|NCT02101437|11186677|FG003|STARTED|Overall Study||49
10061097|NCT02101437|11186674|FG000|COMPLETED|Overall Study||20
10163893|NCT02966340|11293992|FG001|COMPLETED|Overall Study||30
10163894|NCT02966340|11293991|FG000|NOT COMPLETED|Overall Study||3
10163895|NCT02966340|11293992|FG001|NOT COMPLETED|Overall Study||3
10163896|NCT02966353|11293998|FG000|STARTED|Overall Study||51
10163897|NCT02966353|11293998|FG000|Completed After Data Cutoff|Overall Study||1
10163898|NCT02966353|11293998|FG000|COMPLETED|Overall Study||29
10163899|NCT02966353|11293998|FG000|NOT COMPLETED|Overall Study||22
10163900|NCT02966509|11294004|FG000|STARTED|Baseline Satisfaction Survey||105
10163901|NCT02966509|11294005|FG001|STARTED|Baseline Satisfaction Survey||108
10163902|NCT02966509|11294004|FG000|COMPLETED|Baseline Satisfaction Survey||101
10163903|NCT02966509|11294005|FG001|COMPLETED|Baseline Satisfaction Survey||101
10163904|NCT02966509|11294004|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4
10163905|NCT02966509|11294005|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7
10163906|NCT02966509|11294004|FG000|STARTED|6 Month Satisfaction Decision Survey||105
10163907|NCT02966509|11294005|FG001|STARTED|6 Month Satisfaction Decision Survey||108
10163908|NCT02966509|11294004|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80
10163909|NCT02966509|11294005|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77
10163910|NCT02966509|11294004|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
10163911|NCT02966509|11294005|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
10163912|NCT02966509|11294004|FG000|STARTED|6 Month Satisfaction Survey||105
10163913|NCT02966509|11294005|FG001|STARTED|6 Month Satisfaction Survey||108
10163914|NCT02966509|11294004|FG000|COMPLETED|6 Month Satisfaction Survey||58
10163915|NCT02966509|11294005|FG001|COMPLETED|6 Month Satisfaction Survey||60
10163916|NCT02966509|11294004|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47
10061098|NCT02101437|11186675|FG001|COMPLETED|Overall Study||54
10061099|NCT02101437|11186676|FG002|COMPLETED|Overall Study||52
10061100|NCT02101437|11186677|FG003|COMPLETED|Overall Study||49
10061101|NCT02101437|11186674|FG000|NOT COMPLETED|Overall Study||0
10061102|NCT02101437|11186675|FG001|NOT COMPLETED|Overall Study||0
10061103|NCT02101437|11186676|FG002|NOT COMPLETED|Overall Study||0
10061104|NCT02101437|11186677|FG003|NOT COMPLETED|Overall Study||0
10061105|NCT02101515|11186689|FG000|STARTED|Overall Study||37
10061106|NCT02101515|11186690|FG001|STARTED|Overall Study||41
10061107|NCT02101515|11186689|FG000|COMPLETED|Overall Study||37
10061108|NCT02101515|11186690|FG001|COMPLETED|Overall Study||41
10061109|NCT02101515|11186689|FG000|NOT COMPLETED|Overall Study||0
10061110|NCT02101515|11186690|FG001|NOT COMPLETED|Overall Study||0
10061111|NCT02101554|11186699|FG000|STARTED|Overall Study||6
10061112|NCT02101554|11186700|FG001|STARTED|Overall Study||10
10163917|NCT02966509|11294005|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48
10163918|NCT02966509|11294004|FG000|STARTED|6-Month Utilization and Cost||105
10163919|NCT02966509|11294005|FG001|STARTED|6-Month Utilization and Cost||108
10163920|NCT02966509|11294004|FG000|COMPLETED|6-Month Utilization and Cost||105
10163921|NCT02966509|11294005|FG001|COMPLETED|6-Month Utilization and Cost||108
10163922|NCT02966509|11294004|FG000|NOT COMPLETED|6-Month Utilization and Cost||0
10163923|NCT02966509|11294005|FG001|NOT COMPLETED|6-Month Utilization and Cost||0
10163924|NCT02966509|11294004|FG000|STARTED|15-Month Utilization and Cost||105
10163925|NCT02966509|11294005|FG001|STARTED|15-Month Utilization and Cost||108
10163926|NCT02966509|11294004|FG000|COMPLETED|15-Month Utilization and Cost||105
10163927|NCT02966509|11294005|FG001|COMPLETED|15-Month Utilization and Cost||108
10163928|NCT02966509|11294004|FG000|NOT COMPLETED|15-Month Utilization and Cost||0
10163929|NCT02966509|11294005|FG001|NOT COMPLETED|15-Month Utilization and Cost||0
10163930|NCT02966509|11294004|FG000|STARTED|End of Life Utilization and Cost 6 Month||105
10163931|NCT02966509|11294005|FG001|STARTED|End of Life Utilization and Cost 6 Month||108
10163932|NCT02966509|11294004|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36
10163933|NCT02966509|11294005|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33
10163934|NCT02966509|11294004|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
10163935|NCT02966509|11294005|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
10163936|NCT02966509|11294004|FG000|STARTED|End of Life Utilization and Cost 15month||105
10163937|NCT02966509|11294005|FG001|STARTED|End of Life Utilization and Cost 15month||108
10163938|NCT02966509|11294004|FG000|COMPLETED|End of Life Utilization and Cost 15month||60
10163939|NCT02966509|11294005|FG001|COMPLETED|End of Life Utilization and Cost 15month||60
10163940|NCT02966509|11294004|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45
10163941|NCT02966509|11294005|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48
10163942|NCT02966795|11294013|FG000|STARTED|Overall Study||23
10163943|NCT02966795|11294014|FG001|STARTED|Overall Study||61
10163944|NCT02966795|11294013|FG000|COMPLETED|Overall Study||23
10163945|NCT02966795|11294014|FG001|COMPLETED|Overall Study||60
10163946|NCT02966795|11294013|FG000|NOT COMPLETED|Overall Study||0
10163947|NCT02966795|11294014|FG001|NOT COMPLETED|Overall Study||1
10163948|NCT02966834|11294025|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36
10163949|NCT02966834|11294026|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16
10163950|NCT02966834|11294027|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23
10163951|NCT02966834|11294028|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27
10163952|NCT02966834|11294029|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23
10163953|NCT02966834|11294030|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22
10163954|NCT02966834|11294025|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35
10163955|NCT02966834|11294026|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16
10163956|NCT02966834|11294027|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19
10163957|NCT02966834|11294028|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19
10163958|NCT02966834|11294029|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22
10163959|NCT02966834|11294030|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17
10163960|NCT02966834|11294025|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
10163961|NCT02966834|11294026|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
10163962|NCT02966834|11294027|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
10163963|NCT02966834|11294028|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
10163964|NCT02966834|11294029|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
10163965|NCT02966834|11294030|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
10163966|NCT02966834|11294025|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35
10163967|NCT02966834|11294026|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16
10163968|NCT02966834|11294027|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19
10163969|NCT02966834|11294028|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19
10163970|NCT02966834|11294029|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
10163971|NCT02966834|11294030|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17
10163972|NCT02966834|11294025|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35
10163973|NCT02966834|11294026|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16
10163974|NCT02966834|11294027|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19
10163975|NCT02966834|11294028|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19
10163976|NCT02966834|11294029|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21
10163977|NCT02966834|11294030|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17
10163978|NCT02966834|11294025|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10163979|NCT02966834|11294026|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10163980|NCT02966834|11294027|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10163981|NCT02966834|11294028|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10163982|NCT02966834|11294029|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10163983|NCT02966834|11294030|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10163984|NCT02966834|11294025|FG000|STARTED|Follow-up (Up to 4 Weeks)||35
10163985|NCT02966834|11294026|FG001|STARTED|Follow-up (Up to 4 Weeks)||16
10163986|NCT02966834|11294027|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
10163987|NCT02966834|11294028|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
10163988|NCT02966834|11294029|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
10163989|NCT02966834|11294030|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
10163990|NCT02966834|11294025|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35
10163991|NCT02966834|11294026|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16
10163992|NCT02966834|11294027|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22
10163993|NCT02966834|11294028|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22
10163994|NCT02966834|11294029|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22
10163995|NCT02966834|11294030|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21
10163996|NCT02966834|11294025|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
10163997|NCT02966834|11294026|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
10163998|NCT02966834|11294027|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
10163999|NCT02966834|11294028|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
10164000|NCT02966834|11294029|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
10164001|NCT02966834|11294030|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
10164002|NCT02967016|11294081|FG000|STARTED|Overall Study||25
10164003|NCT02967016|11294082|FG001|STARTED|Overall Study||25
10164004|NCT02967016|11294081|FG000|COMPLETED|Overall Study||25
10164005|NCT02967016|11294082|FG001|COMPLETED|Overall Study||25
10164006|NCT02967016|11294081|FG000|NOT COMPLETED|Overall Study||0
10164007|NCT02967016|11294082|FG001|NOT COMPLETED|Overall Study||0
10164008|NCT02967055|11294088|FG000|STARTED|Overall Study|Assessed for eligibility|54
10164009|NCT02967055|11294088|FG000|In-person Screening|Overall Study||14
10164010|NCT02967055|11294088|FG000|Enrolled|Overall Study|Enrolled|9
10164011|NCT02967055|11294088|FG000|Completed 4 Week Follow-up Visit|Overall Study||8
10164012|NCT02967055|11294088|FG000|COMPLETED|Overall Study||5
10164013|NCT02967055|11294088|FG000|NOT COMPLETED|Overall Study||49
10164014|NCT02967354|11294097|FG000|STARTED|Overall Study||8
10164015|NCT02967354|11294098|FG001|STARTED|Overall Study||7
10164016|NCT02967354|11294099|FG002|STARTED|Overall Study||9
10164017|NCT02967354|11294100|FG003|STARTED|Overall Study||7
10164018|NCT02967354|11294101|FG004|STARTED|Overall Study||8
10164019|NCT02967354|11294097|FG000|COMPLETED|Overall Study||8
10164020|NCT02967354|11294098|FG001|COMPLETED|Overall Study||7
10164021|NCT02967354|11294099|FG002|COMPLETED|Overall Study||9
10164022|NCT02967354|11294100|FG003|COMPLETED|Overall Study||7
10164023|NCT02967354|11294101|FG004|COMPLETED|Overall Study||8
10164024|NCT02967354|11294097|FG000|NOT COMPLETED|Overall Study||0
10164025|NCT02967354|11294098|FG001|NOT COMPLETED|Overall Study||0
10164026|NCT02967354|11294099|FG002|NOT COMPLETED|Overall Study||0
10164027|NCT02967354|11294100|FG003|NOT COMPLETED|Overall Study||0
10164028|NCT02967354|11294101|FG004|NOT COMPLETED|Overall Study||0
10164029|NCT02967367|11294118|FG000|STARTED|Overall Study||36
10164030|NCT02967367|11294118|FG000|COMPLETED|Overall Study||22
10164031|NCT02967367|11294118|FG000|NOT COMPLETED|Overall Study||14
10164032|NCT02967393|11294124|FG000|STARTED|Overall Study||20
10164033|NCT02967393|11294125|FG001|STARTED|Overall Study||20
10164034|NCT02967393|11294124|FG000|COMPLETED|Overall Study||20
10164035|NCT02967393|11294125|FG001|COMPLETED|Overall Study||20
10164036|NCT02967393|11294124|FG000|NOT COMPLETED|Overall Study||0
10164037|NCT02967393|11294125|FG001|NOT COMPLETED|Overall Study||0
10164038|NCT02967458|11294133|FG000|STARTED|Overall Study||55
10164039|NCT02967458|11294133|FG000|COMPLETED|Overall Study||55
10164040|NCT02967458|11294133|FG000|NOT COMPLETED|Overall Study||0
10164041|NCT02967510|11294142|FG000|STARTED|Overall Study||70
10164042|NCT02967510|11294143|FG001|STARTED|Overall Study||70
10164043|NCT02967510|11294144|FG002|STARTED|Overall Study||72
10164044|NCT02967510|11294145|FG003|STARTED|Overall Study||71
10164045|NCT02967510|11294142|FG000|COMPLETED|Overall Study||66
10164046|NCT02967510|11294143|FG001|COMPLETED|Overall Study||67
10164047|NCT02967510|11294144|FG002|COMPLETED|Overall Study||65
10164048|NCT02967510|11294145|FG003|COMPLETED|Overall Study||63
10164049|NCT02967510|11294142|FG000|NOT COMPLETED|Overall Study||4
10164050|NCT02967510|11294143|FG001|NOT COMPLETED|Overall Study||3
10164051|NCT02967510|11294144|FG002|NOT COMPLETED|Overall Study||7
9711201|NCT04559698|10810987|FG001|STARTED|Overall Study||60
9711202|NCT04559698|10810986|FG000|Four-month Pre-intervention|Overall Study|Participants in this arm started training immediately after randomization, and therefore, did not have a four-month waiting period prior to receiving the training.|0
9711203|NCT04559698|10810987|FG001|Four-month Pre-intervention|Overall Study||60
9711204|NCT04559698|10810986|FG000|Immediate Pre-intervention|Overall Study||61
9711205|NCT04559698|10810987|FG001|Immediate Pre-intervention|Overall Study||55
9711206|NCT04559698|10810986|FG000|Immediate Post-intervention|Overall Study||52
9711207|NCT04559698|10810987|FG001|Immediate Post-intervention|Overall Study||44
9711208|NCT04559698|10810986|FG000|Four-month Post-intervention|Overall Study||47
9711209|NCT04559698|10810987|FG001|Four-month Post-intervention|Overall Study|Participants in this arm started training four months after randomization (waitlist) and therefore, were not assessed at the four-month follow-up time point due to completion of the study.|0
9711210|NCT04559698|10810986|FG000|COMPLETED|Overall Study||47
9711211|NCT04559698|10810987|FG001|COMPLETED|Overall Study||44
9711212|NCT04559698|10810986|FG000|NOT COMPLETED|Overall Study||14
9711213|NCT04559698|10810987|FG001|NOT COMPLETED|Overall Study||16
9711214|NCT04492475|10810995|FG000|STARTED|Overall Study||487
9711215|NCT04492475|10810996|FG001|STARTED|Overall Study||482
9711216|NCT04492475|10810995|FG000|ITT and Modified ITT Population|Overall Study||487
10164052|NCT02967510|11294145|FG003|NOT COMPLETED|Overall Study||8
10164053|NCT02967562|11294157|FG000|STARTED|Overall Study||32
10164054|NCT02967562|11294158|FG001|STARTED|Overall Study||31
10164055|NCT02967562|11294157|FG000|COMPLETED|Overall Study||30
10164056|NCT02967562|11294158|FG001|COMPLETED|Overall Study||30
10164057|NCT02967562|11294157|FG000|NOT COMPLETED|Overall Study||2
10164058|NCT02967562|11294158|FG001|NOT COMPLETED|Overall Study||1
10164059|NCT02967679|11294164|FG000|STARTED|Overall Study||15
10164060|NCT02967679|11294164|FG000|COMPLETED|Overall Study||14
10164061|NCT02967679|11294164|FG000|NOT COMPLETED|Overall Study||1
10164062|NCT02967991|11294168|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
10164063|NCT02967991|11294169|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
10164064|NCT02967991|11294168|FG000|COMPLETED|Overall Study||10
10164065|NCT02967991|11294169|FG001|COMPLETED|Overall Study||10
10164066|NCT02967991|11294168|FG000|NOT COMPLETED|Overall Study||0
10164067|NCT02967991|11294169|FG001|NOT COMPLETED|Overall Study||0
10164068|NCT02968004|11294181|FG000|STARTED|Overall Study||109
10164069|NCT02968004|11294182|FG001|STARTED|Overall Study||115
10164070|NCT02968004|11294181|FG000|COMPLETED|Overall Study||108
10164071|NCT02968004|11294182|FG001|COMPLETED|Overall Study||114
10164072|NCT02968004|11294181|FG000|NOT COMPLETED|Overall Study||1
10164073|NCT02968004|11294182|FG001|NOT COMPLETED|Overall Study||1
10164074|NCT02968134|11294188|FG000|STARTED|Overall Study||8
10164075|NCT02968134|11294188|FG000|COMPLETED|Overall Study||8
10164076|NCT02968134|11294188|FG000|NOT COMPLETED|Overall Study||0
10164077|NCT02968173|11294192|FG000|STARTED|Overall Study||50
10164078|NCT02968173|11294192|FG000|COMPLETED|Overall Study||49
10164079|NCT02968173|11294192|FG000|NOT COMPLETED|Overall Study||1
10164080|NCT02968277|11294200|FG000|STARTED|Overall Study||10
10164081|NCT02968277|11294201|FG001|STARTED|Overall Study||7
10164082|NCT02968277|11294202|FG002|STARTED|Overall Study||13
10164083|NCT02968277|11294200|FG000|COMPLETED|Overall Study||10
10164084|NCT02968277|11294201|FG001|COMPLETED|Overall Study||7
10164085|NCT02968277|11294202|FG002|COMPLETED|Overall Study||13
10164086|NCT02968277|11294200|FG000|NOT COMPLETED|Overall Study||0
10164087|NCT02968277|11294201|FG001|NOT COMPLETED|Overall Study||0
10164088|NCT02968277|11294202|FG002|NOT COMPLETED|Overall Study||0
10164089|NCT02968368|11294216|FG000|STARTED|Double Blind Phase||111
10164090|NCT02968368|11294217|FG001|STARTED|Double Blind Phase||56
10164091|NCT02968368|11294216|FG000|COMPLETED|Double Blind Phase||90
10164092|NCT02968368|11294217|FG001|COMPLETED|Double Blind Phase||39
10164093|NCT02968368|11294216|FG000|NOT COMPLETED|Double Blind Phase||21
10164094|NCT02968368|11294217|FG001|NOT COMPLETED|Double Blind Phase||17
10164095|NCT02968368|11294216|FG000|STARTED|Open Label Phase||86
10164096|NCT02968368|11294217|FG001|STARTED|Open Label Phase||39
10164097|NCT02968368|11294216|FG000|COMPLETED|Open Label Phase||67
10164098|NCT02968368|11294217|FG001|COMPLETED|Open Label Phase||25
10164099|NCT02968368|11294216|FG000|NOT COMPLETED|Open Label Phase||19
10164100|NCT02968368|11294217|FG001|NOT COMPLETED|Open Label Phase||14
10164101|NCT02968420|11294228|FG000|STARTED|Overall Study||6
10164102|NCT02968420|11294229|FG001|STARTED|Overall Study||6
10164103|NCT02968420|11294230|FG002|STARTED|Overall Study||6
10164104|NCT02968420|11294228|FG000|COMPLETED|Overall Study||6
10164105|NCT02968420|11294229|FG001|COMPLETED|Overall Study||6
10164106|NCT02968420|11294230|FG002|COMPLETED|Overall Study||6
10164107|NCT02968420|11294228|FG000|NOT COMPLETED|Overall Study||0
10164108|NCT02968420|11294229|FG001|NOT COMPLETED|Overall Study||0
10164109|NCT02968420|11294230|FG002|NOT COMPLETED|Overall Study||0
10164110|NCT02968433|11294238|FG000|STARTED|Overall Study||16
10164111|NCT02968433|11294238|FG000|COMPLETED|Overall Study||15
10164112|NCT02968433|11294238|FG000|NOT COMPLETED|Overall Study||1
10164113|NCT02968576|11294248|FG000|STARTED|Overall Study||11
10164114|NCT02968576|11294249|FG001|STARTED|Overall Study||14
10164115|NCT02968576|11294248|FG000|COMPLETED|Overall Study||11
10164116|NCT02968576|11294249|FG001|COMPLETED|Overall Study||13
10164117|NCT02968576|11294248|FG000|NOT COMPLETED|Overall Study||0
10164118|NCT02968576|11294249|FG001|NOT COMPLETED|Overall Study||1
10164119|NCT02968758|11294255|FG000|STARTED|Overall Study||797
10164120|NCT02968758|11294256|FG001|STARTED|Overall Study||1664
10164121|NCT02968758|11294255|FG000|COMPLETED|Overall Study||797
10164122|NCT02968758|11294256|FG001|COMPLETED|Overall Study||1664
10164123|NCT02968758|11294255|FG000|NOT COMPLETED|Overall Study||0
10164124|NCT02968758|11294256|FG001|NOT COMPLETED|Overall Study||0
10164125|NCT02968914|11294263|FG000|STARTED|Overall Study||90
10164126|NCT02968914|11294264|FG001|STARTED|Overall Study||90
10164127|NCT02968914|11294263|FG000|COMPLETED|Overall Study||90
10164128|NCT02968914|11294264|FG001|COMPLETED|Overall Study||90
10164129|NCT02968914|11294263|FG000|NOT COMPLETED|Overall Study||0
10164130|NCT02968914|11294264|FG001|NOT COMPLETED|Overall Study||0
10164131|NCT02968979|11294270|FG000|STARTED|Overall Study||539
10164132|NCT02968979|11294270|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
10164133|NCT02968979|11294270|FG000|NOT COMPLETED|Overall Study||8
10164134|NCT02968992|11294322|FG000|STARTED|Overall Study||18
10164135|NCT02968992|11294323|FG001|STARTED|Overall Study||18
10164136|NCT02968992|11294322|FG000|COMPLETED|Overall Study||18
10164137|NCT02968992|11294323|FG001|COMPLETED|Overall Study||17
10164138|NCT02968992|11294322|FG000|NOT COMPLETED|Overall Study||0
10164139|NCT02968992|11294323|FG001|NOT COMPLETED|Overall Study||1
10164140|NCT02969018|11294337|FG000|STARTED|Overall Study||25
10164141|NCT02969018|11294338|FG001|STARTED|Overall Study||29
10164142|NCT02969018|11294339|FG002|STARTED|Overall Study||26
10164143|NCT02969018|11294340|FG003|STARTED|Overall Study||25
10164144|NCT02969018|11294341|FG004|STARTED|Overall Study||29
10164145|NCT02969018|11294342|FG005|STARTED|Overall Study||25
10164146|NCT02969018|11294343|FG006|STARTED|Overall Study||30
10164147|NCT02969018|11294344|FG007|STARTED|Overall Study||23
10164148|NCT02969018|11294337|FG000|COMPLETED|Overall Study||21
10164149|NCT02969018|11294338|FG001|COMPLETED|Overall Study||21
10164150|NCT02969018|11294339|FG002|COMPLETED|Overall Study||20
10164151|NCT02969018|11294340|FG003|COMPLETED|Overall Study||20
10164152|NCT02969018|11294341|FG004|COMPLETED|Overall Study||27
10164153|NCT02969018|11294342|FG005|COMPLETED|Overall Study||17
10164154|NCT02969018|11294343|FG006|COMPLETED|Overall Study||22
10164155|NCT02969018|11294344|FG007|COMPLETED|Overall Study||16
10164156|NCT02969018|11294337|FG000|NOT COMPLETED|Overall Study||4
10164157|NCT02969018|11294338|FG001|NOT COMPLETED|Overall Study||8
10164158|NCT02969018|11294339|FG002|NOT COMPLETED|Overall Study||6
10164159|NCT02969018|11294340|FG003|NOT COMPLETED|Overall Study||5
10164160|NCT02969018|11294341|FG004|NOT COMPLETED|Overall Study||2
10164161|NCT02969018|11294342|FG005|NOT COMPLETED|Overall Study||8
10164162|NCT02969018|11294343|FG006|NOT COMPLETED|Overall Study||8
10164163|NCT02969018|11294344|FG007|NOT COMPLETED|Overall Study||7
10164164|NCT02969031|11294367|FG000|STARTED|Enrolled and Randomized||73
10164165|NCT02969031|11294368|FG001|STARTED|Enrolled and Randomized||75
10164166|NCT02969031|11294367|FG000|COMPLETED|Enrolled and Randomized||73
10164167|NCT02969031|11294368|FG001|COMPLETED|Enrolled and Randomized||75
10164168|NCT02969031|11294367|FG000|NOT COMPLETED|Enrolled and Randomized||0
10164169|NCT02969031|11294368|FG001|NOT COMPLETED|Enrolled and Randomized||0
10164170|NCT02969031|11294367|FG000|STARTED|Collection of Baseline Surveys||73
10164171|NCT02969031|11294368|FG001|STARTED|Collection of Baseline Surveys||75
10164172|NCT02969031|11294367|FG000|COMPLETED|Collection of Baseline Surveys||34
10164173|NCT02969031|11294368|FG001|COMPLETED|Collection of Baseline Surveys||23
10164174|NCT02969031|11294367|FG000|NOT COMPLETED|Collection of Baseline Surveys||39
10164175|NCT02969031|11294368|FG001|NOT COMPLETED|Collection of Baseline Surveys||52
10164176|NCT02969031|11294367|FG000|STARTED|Collection of Baseline Recordings||34
10164177|NCT02969031|11294368|FG001|STARTED|Collection of Baseline Recordings||23
10164178|NCT02969031|11294367|FG000|COMPLETED|Collection of Baseline Recordings||22
10164179|NCT02969031|11294368|FG001|COMPLETED|Collection of Baseline Recordings||18
10164180|NCT02969031|11294367|FG000|NOT COMPLETED|Collection of Baseline Recordings||12
10164181|NCT02969031|11294368|FG001|NOT COMPLETED|Collection of Baseline Recordings||5
10164182|NCT02969031|11294367|FG000|STARTED|Completed Intervention||22
10164183|NCT02969031|11294368|FG001|STARTED|Completed Intervention||18
10164184|NCT02969031|11294367|FG000|COMPLETED|Completed Intervention||15
10164185|NCT02969031|11294368|FG001|COMPLETED|Completed Intervention||14
10164186|NCT02969031|11294367|FG000|NOT COMPLETED|Completed Intervention||7
10164187|NCT02969031|11294368|FG001|NOT COMPLETED|Completed Intervention||4
10164188|NCT02969031|11294367|FG000|STARTED|Collection of Follow-Up Surveys||15
10164189|NCT02969031|11294368|FG001|STARTED|Collection of Follow-Up Surveys||14
10164190|NCT02969031|11294367|FG000|COMPLETED|Collection of Follow-Up Surveys||15
10164191|NCT02969031|11294368|FG001|COMPLETED|Collection of Follow-Up Surveys||12
10164192|NCT02969031|11294367|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0
10164193|NCT02969031|11294368|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2
10164194|NCT02969031|11294367|FG000|STARTED|Collection of Follow-Up Recordings||15
10164195|NCT02969031|11294368|FG001|STARTED|Collection of Follow-Up Recordings||12
10164196|NCT02969031|11294367|FG000|COMPLETED|Collection of Follow-Up Recordings||15
10164197|NCT02969031|11294368|FG001|COMPLETED|Collection of Follow-Up Recordings||12
10164198|NCT02969031|11294367|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0
10164199|NCT02969031|11294368|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0
10164200|NCT02969031|11294367|FG000|STARTED|Completed and Analyzed||15
10164201|NCT02969031|11294368|FG001|STARTED|Completed and Analyzed||12
10164202|NCT02969031|11294367|FG000|COMPLETED|Completed and Analyzed||15
10164203|NCT02969031|11294368|FG001|COMPLETED|Completed and Analyzed||12
10164204|NCT02969031|11294367|FG000|NOT COMPLETED|Completed and Analyzed||0
10164205|NCT02969031|11294368|FG001|NOT COMPLETED|Completed and Analyzed||0
10164206|NCT02969044|11294376|FG000|STARTED|Overall Study||42
10164207|NCT02969044|11294377|FG001|STARTED|Overall Study||28
10164208|NCT02969044|11294376|FG000|COMPLETED|Overall Study||37
10164209|NCT02969044|11294377|FG001|COMPLETED|Overall Study||22
10164210|NCT02969044|11294376|FG000|NOT COMPLETED|Overall Study||5
10164211|NCT02969044|11294377|FG001|NOT COMPLETED|Overall Study||6
10164212|NCT02969187|11294385|FG000|STARTED|Overall Study||63
10164213|NCT02969187|11294386|FG001|STARTED|Overall Study||63
10164214|NCT02969187|11294385|FG000|COMPLETED|Overall Study||51
10164215|NCT02969187|11294386|FG001|COMPLETED|Overall Study||50
10164216|NCT02969187|11294385|FG000|NOT COMPLETED|Overall Study||12
10164217|NCT02969187|11294386|FG001|NOT COMPLETED|Overall Study||13
10164218|NCT02969317|11294394|FG000|STARTED|Overall Study||12
10164219|NCT02969317|11294394|FG000|COMPLETED|Overall Study||12
10164220|NCT02969317|11294394|FG000|NOT COMPLETED|Overall Study||0
10164221|NCT02969356|11294399|FG000|STARTED|Overall Study||157
10164222|NCT02969356|11294399|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
10164223|NCT02969356|11294399|FG000|COMPLETED|Overall Study||134
10164224|NCT02969356|11294399|FG000|NOT COMPLETED|Overall Study||23
10164225|NCT02969382|11294405|FG000|STARTED|Overall Study||125
10164226|NCT02969382|11294406|FG001|STARTED|Overall Study||120
10164227|NCT02969382|11294405|FG000|Subjects Continued Into Extension Study|Overall Study||79
10164228|NCT02969382|11294406|FG001|Subjects Continued Into Extension Study|Overall Study||78
10164229|NCT02969382|11294405|FG000|COMPLETED|Overall Study||99
10164230|NCT02969382|11294406|FG001|COMPLETED|Overall Study||94
10164231|NCT02969382|11294405|FG000|NOT COMPLETED|Overall Study||26
10164232|NCT02969382|11294406|FG001|NOT COMPLETED|Overall Study||26
10164233|NCT02969408|11294412|FG000|STARTED|Overall Study||397
10164234|NCT02969408|11294412|FG000|Used ABS eMDPI at Least Once|Overall Study||370
10164235|NCT02969408|11294412|FG000|COMPLETED|Overall Study||381
10164236|NCT02969408|11294412|FG000|NOT COMPLETED|Overall Study||16
10164237|NCT02969421|11294418|FG000|STARTED|Overall Study||33
10164238|NCT02969421|11294419|FG001|STARTED|Overall Study||33
10164239|NCT02969421|11294418|FG000|COMPLETED|Overall Study||33
10164240|NCT02969421|11294419|FG001|COMPLETED|Overall Study||33
10164241|NCT02969421|11294418|FG000|NOT COMPLETED|Overall Study||0
10164242|NCT02969421|11294419|FG001|NOT COMPLETED|Overall Study||0
10164243|NCT02969499|11294425|FG000|STARTED|Overall Study||33
10164244|NCT02969499|11294425|FG000|COMPLETED|Overall Study||33
10164245|NCT02969499|11294425|FG000|NOT COMPLETED|Overall Study||0
10164246|NCT02969525|11294434|FG000|STARTED|Double-Blind Period||42
10164247|NCT02969525|11294435|FG001|STARTED|Double-Blind Period||41
10164248|NCT02969525|11294436|FG002|STARTED|Double-Blind Period||41
10164249|NCT02969525|11294437|FG003|STARTED|Double-Blind Period||41
10164250|NCT02969525|11294438|FG004|STARTED|Double-Blind Period||41
10164251|NCT02969525|11294439|FG005|STARTED|Double-Blind Period||0
10164252|NCT02969525|11294440|FG006|STARTED|Double-Blind Period||0
10164253|NCT02969525|11294441|FG007|STARTED|Double-Blind Period||0
10164254|NCT02969525|11294442|FG008|STARTED|Double-Blind Period||0
10164255|NCT02969525|11294443|FG009|STARTED|Double-Blind Period||0
10164256|NCT02969525|11294444|FG010|STARTED|Double-Blind Period||0
10164257|NCT02969525|11294445|FG011|STARTED|Double-Blind Period||0
10164258|NCT02969525|11294434|FG000|Completed Double-Blind Period|Double-Blind Period||42
10164259|NCT02969525|11294435|FG001|Completed Double-Blind Period|Double-Blind Period||41
9711217|NCT04492475|10810996|FG001|ITT and Modified ITT Population|Overall Study||482
9711218|NCT04492475|10810995|FG000|As Treated Population|Overall Study||477
10164260|NCT02969525|11294436|FG002|Completed Double-Blind Period|Double-Blind Period||40
10164261|NCT02969525|11294437|FG003|Completed Double-Blind Period|Double-Blind Period||39
10164262|NCT02969525|11294438|FG004|Completed Double-Blind Period|Double-Blind Period||41
10164263|NCT02969525|11294439|FG005|Completed Double-Blind Period|Double-Blind Period||0
10164264|NCT02969525|11294440|FG006|Completed Double-Blind Period|Double-Blind Period||0
10164265|NCT02969525|11294441|FG007|Completed Double-Blind Period|Double-Blind Period||0
10164266|NCT02969525|11294442|FG008|Completed Double-Blind Period|Double-Blind Period||0
10164267|NCT02969525|11294443|FG009|Completed Double-Blind Period|Double-Blind Period||0
10164268|NCT02969525|11294444|FG010|Completed Double-Blind Period|Double-Blind Period||0
10164269|NCT02969525|11294445|FG011|Completed Double-Blind Period|Double-Blind Period||0
10164270|NCT02969525|11294434|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
10164271|NCT02969525|11294435|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
10164272|NCT02969525|11294436|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
10164273|NCT02969525|11294437|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
10164274|NCT02969525|11294438|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
10164275|NCT02969525|11294439|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10164276|NCT02969525|11294440|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10164277|NCT02969525|11294441|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10164278|NCT02969525|11294442|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10164279|NCT02969525|11294443|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10164280|NCT02969525|11294444|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10164281|NCT02969525|11294445|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10164282|NCT02969525|11294434|FG000|COMPLETED|Double-Blind Period||40
10164283|NCT02969525|11294435|FG001|COMPLETED|Double-Blind Period||41
10164284|NCT02969525|11294436|FG002|COMPLETED|Double-Blind Period||40
10164285|NCT02969525|11294437|FG003|COMPLETED|Double-Blind Period||37
10164286|NCT02969525|11294438|FG004|COMPLETED|Double-Blind Period||41
10164287|NCT02969525|11294439|FG005|COMPLETED|Double-Blind Period||0
10164288|NCT02969525|11294440|FG006|COMPLETED|Double-Blind Period||0
10164289|NCT02969525|11294441|FG007|COMPLETED|Double-Blind Period||0
10164290|NCT02969525|11294442|FG008|COMPLETED|Double-Blind Period||0
10164291|NCT02969525|11294443|FG009|COMPLETED|Double-Blind Period||0
10164292|NCT02969525|11294444|FG010|COMPLETED|Double-Blind Period||0
10164293|NCT02969525|11294445|FG011|COMPLETED|Double-Blind Period||0
10164294|NCT02969525|11294434|FG000|NOT COMPLETED|Double-Blind Period||2
10164295|NCT02969525|11294435|FG001|NOT COMPLETED|Double-Blind Period||0
10164296|NCT02969525|11294436|FG002|NOT COMPLETED|Double-Blind Period||1
10164297|NCT02969525|11294437|FG003|NOT COMPLETED|Double-Blind Period||4
10164298|NCT02969525|11294438|FG004|NOT COMPLETED|Double-Blind Period||0
10164299|NCT02969525|11294439|FG005|NOT COMPLETED|Double-Blind Period||0
10164300|NCT02969525|11294440|FG006|NOT COMPLETED|Double-Blind Period||0
10164301|NCT02969525|11294441|FG007|NOT COMPLETED|Double-Blind Period||0
10164302|NCT02969525|11294442|FG008|NOT COMPLETED|Double-Blind Period||0
10164303|NCT02969525|11294443|FG009|NOT COMPLETED|Double-Blind Period||0
10164304|NCT02969525|11294444|FG010|NOT COMPLETED|Double-Blind Period||0
10164305|NCT02969525|11294445|FG011|NOT COMPLETED|Double-Blind Period||0
10164306|NCT02969525|11294434|FG000|STARTED|Dose-Blind Period||0
10164307|NCT02969525|11294435|FG001|STARTED|Dose-Blind Period||0
10164308|NCT02969525|11294436|FG002|STARTED|Dose-Blind Period||0
10164309|NCT02969525|11294437|FG003|STARTED|Dose-Blind Period||0
10164310|NCT02969525|11294438|FG004|STARTED|Dose-Blind Period||0
10164311|NCT02969525|11294439|FG005|STARTED|Dose-Blind Period||20
10164312|NCT02969525|11294440|FG006|STARTED|Dose-Blind Period||20
10164313|NCT02969525|11294441|FG007|STARTED|Dose-Blind Period||22
10164314|NCT02969525|11294442|FG008|STARTED|Dose-Blind Period||19
10164315|NCT02969525|11294443|FG009|STARTED|Dose-Blind Period||37
10164316|NCT02969525|11294444|FG010|STARTED|Dose-Blind Period||40
10164317|NCT02969525|11294445|FG011|STARTED|Dose-Blind Period||41
10164318|NCT02969525|11294434|FG000|COMPLETED|Dose-Blind Period||0
10164319|NCT02969525|11294435|FG001|COMPLETED|Dose-Blind Period||0
10164320|NCT02969525|11294436|FG002|COMPLETED|Dose-Blind Period||0
10164321|NCT02969525|11294437|FG003|COMPLETED|Dose-Blind Period||0
10164322|NCT02969525|11294438|FG004|COMPLETED|Dose-Blind Period||0
10164323|NCT02969525|11294439|FG005|COMPLETED|Dose-Blind Period||20
10164324|NCT02969525|11294440|FG006|COMPLETED|Dose-Blind Period||18
10164325|NCT02969525|11294441|FG007|COMPLETED|Dose-Blind Period||22
10164326|NCT02969525|11294442|FG008|COMPLETED|Dose-Blind Period||18
10164327|NCT02969525|11294443|FG009|COMPLETED|Dose-Blind Period||34
10164328|NCT02969525|11294444|FG010|COMPLETED|Dose-Blind Period||38
10164329|NCT02969525|11294445|FG011|COMPLETED|Dose-Blind Period||39
10164330|NCT02969525|11294434|FG000|NOT COMPLETED|Dose-Blind Period||0
10164331|NCT02969525|11294435|FG001|NOT COMPLETED|Dose-Blind Period||0
10164332|NCT02969525|11294436|FG002|NOT COMPLETED|Dose-Blind Period||0
10164333|NCT02969525|11294437|FG003|NOT COMPLETED|Dose-Blind Period||0
10164334|NCT02969525|11294438|FG004|NOT COMPLETED|Dose-Blind Period||0
10164335|NCT02969525|11294439|FG005|NOT COMPLETED|Dose-Blind Period||0
10164336|NCT02969525|11294440|FG006|NOT COMPLETED|Dose-Blind Period||2
10164337|NCT02969525|11294441|FG007|NOT COMPLETED|Dose-Blind Period||0
10164338|NCT02969525|11294442|FG008|NOT COMPLETED|Dose-Blind Period||1
10164339|NCT02969525|11294443|FG009|NOT COMPLETED|Dose-Blind Period||3
10164340|NCT02969525|11294444|FG010|NOT COMPLETED|Dose-Blind Period||2
10164341|NCT02969525|11294445|FG011|NOT COMPLETED|Dose-Blind Period||2
10164342|NCT02969590|11294467|FG000|STARTED|Screening Period||5
10164343|NCT02969590|11294468|FG001|STARTED|Screening Period||0
10164344|NCT02969590|11294469|FG002|STARTED|Screening Period||0
10164345|NCT02969590|11294467|FG000|COMPLETED|Screening Period||4
10164346|NCT02969590|11294468|FG001|COMPLETED|Screening Period||0
10164347|NCT02969590|11294469|FG002|COMPLETED|Screening Period||0
10164348|NCT02969590|11294467|FG000|NOT COMPLETED|Screening Period||1
10164349|NCT02969590|11294468|FG001|NOT COMPLETED|Screening Period||0
10164350|NCT02969590|11294469|FG002|NOT COMPLETED|Screening Period||0
10164351|NCT02969590|11294467|FG000|STARTED|Treatment Period 1||0
10164352|NCT02969590|11294468|FG001|STARTED|Treatment Period 1||2
10164353|NCT02969590|11294469|FG002|STARTED|Treatment Period 1||2
10164354|NCT02969590|11294467|FG000|COMPLETED|Treatment Period 1||0
10164355|NCT02969590|11294468|FG001|COMPLETED|Treatment Period 1||2
10164356|NCT02969590|11294469|FG002|COMPLETED|Treatment Period 1||2
10164357|NCT02969590|11294467|FG000|NOT COMPLETED|Treatment Period 1||0
10164358|NCT02969590|11294468|FG001|NOT COMPLETED|Treatment Period 1||0
10164359|NCT02969590|11294469|FG002|NOT COMPLETED|Treatment Period 1||0
10164360|NCT02969590|11294467|FG000|STARTED|Treatment Period 2||0
10164361|NCT02969590|11294468|FG001|STARTED|Treatment Period 2||2
10164362|NCT02969590|11294469|FG002|STARTED|Treatment Period 2||2
10164363|NCT02969590|11294467|FG000|COMPLETED|Treatment Period 2||0
10164364|NCT02969590|11294468|FG001|COMPLETED|Treatment Period 2||2
10164365|NCT02969590|11294469|FG002|COMPLETED|Treatment Period 2||2
10164366|NCT02969590|11294467|FG000|NOT COMPLETED|Treatment Period 2||0
10164367|NCT02969590|11294468|FG001|NOT COMPLETED|Treatment Period 2||0
10164368|NCT02969590|11294469|FG002|NOT COMPLETED|Treatment Period 2||0
10164369|NCT02969655|11294481|FG000|STARTED|Overall Study||136
10164370|NCT02969655|11294482|FG001|STARTED|Overall Study||135
10164371|NCT02969655|11294481|FG000|COMPLETED|Overall Study||115
10164372|NCT02969655|11294482|FG001|COMPLETED|Overall Study||120
10164373|NCT02969655|11294481|FG000|NOT COMPLETED|Overall Study||21
10164374|NCT02969655|11294482|FG001|NOT COMPLETED|Overall Study||15
10164375|NCT02969707|11294491|FG000|STARTED|Overall Study||49
10164376|NCT02969707|11294492|FG001|STARTED|Overall Study||52
10164377|NCT02969707|11294491|FG000|COMPLETED|Overall Study||41
10164378|NCT02969707|11294492|FG001|COMPLETED|Overall Study||44
10164379|NCT02969707|11294491|FG000|NOT COMPLETED|Overall Study||8
10164380|NCT02969707|11294492|FG001|NOT COMPLETED|Overall Study||8
10164381|NCT02969863|11294503|FG000|STARTED|Overall Study||4
10164382|NCT02969863|11294504|FG001|STARTED|Overall Study||4
10164383|NCT02969863|11294505|FG002|STARTED|Overall Study||4
10164384|NCT02969863|11294506|FG003|STARTED|Overall Study||4
10164385|NCT02969863|11294507|FG004|STARTED|Overall Study||4
10164386|NCT02969863|11294508|FG005|STARTED|Overall Study||4
10164387|NCT02969863|11294503|FG000|COMPLETED|Overall Study||3
10164388|NCT02969863|11294504|FG001|COMPLETED|Overall Study||4
10164389|NCT02969863|11294505|FG002|COMPLETED|Overall Study||4
10164390|NCT02969863|11294506|FG003|COMPLETED|Overall Study||4
10164391|NCT02969863|11294507|FG004|COMPLETED|Overall Study||4
10164392|NCT02969863|11294508|FG005|COMPLETED|Overall Study||4
10164393|NCT02969863|11294503|FG000|NOT COMPLETED|Overall Study||1
10164394|NCT02969863|11294504|FG001|NOT COMPLETED|Overall Study||0
10164395|NCT02969863|11294505|FG002|NOT COMPLETED|Overall Study||0
10164396|NCT02969863|11294506|FG003|NOT COMPLETED|Overall Study||0
10164397|NCT02969863|11294507|FG004|NOT COMPLETED|Overall Study||0
10164398|NCT02969863|11294508|FG005|NOT COMPLETED|Overall Study||0
10164399|NCT02969876|11294522|FG000|STARTED|Overall Study||2
10164400|NCT02969876|11294522|FG000|COMPLETED|Overall Study||2
10164401|NCT02969876|11294522|FG000|NOT COMPLETED|Overall Study||0
10164402|NCT02970006|11294527|FG000|STARTED|Overall Study||15
10164403|NCT02970006|11294527|FG000|COMPLETED|Overall Study||14
10164404|NCT02970006|11294527|FG000|NOT COMPLETED|Overall Study||1
10164405|NCT02970032|11294531|FG000|STARTED|Standard Heparin Dose||20
10164406|NCT02970032|11294531|FG000|COMPLETED|Standard Heparin Dose||20
10164407|NCT02970032|11294531|FG000|NOT COMPLETED|Standard Heparin Dose||0
10164408|NCT02970032|11294531|FG000|STARTED|Real Time Heparin Dose Adjustment||20
10164409|NCT02970032|11294531|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20
10164410|NCT02970032|11294531|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
10164411|NCT02970162|11294538|FG000|STARTED|Overall Study||13
10164412|NCT02970162|11294539|FG001|STARTED|Overall Study||13
10164413|NCT02970162|11294538|FG000|COMPLETED|Overall Study||13
10164414|NCT02970162|11294539|FG001|COMPLETED|Overall Study||13
10164415|NCT02970162|11294538|FG000|NOT COMPLETED|Overall Study||0
10164416|NCT02970162|11294539|FG001|NOT COMPLETED|Overall Study||0
10164417|NCT02970292|11294547|FG000|STARTED|Overall Study||198
10164418|NCT02970292|11294548|FG001|STARTED|Overall Study||198
10164419|NCT02970292|11294547|FG000|COMPLETED|Overall Study||174
10164420|NCT02970292|11294548|FG001|COMPLETED|Overall Study||190
10164421|NCT02970292|11294547|FG000|NOT COMPLETED|Overall Study||24
10164422|NCT02970292|11294548|FG001|NOT COMPLETED|Overall Study||8
10164423|NCT02970305|11294556|FG000|STARTED|Overall Study||201
10164424|NCT02970305|11294557|FG001|STARTED|Overall Study||202
10164425|NCT02970305|11294556|FG000|COMPLETED|Overall Study||172
10164426|NCT02970305|11294557|FG001|COMPLETED|Overall Study||174
10164427|NCT02970305|11294556|FG000|NOT COMPLETED|Overall Study||29
10164428|NCT02970305|11294557|FG001|NOT COMPLETED|Overall Study||28
10164429|NCT02970422|11294563|FG000|STARTED|Overall Study||200
10164430|NCT02970422|11294563|FG000|COMPLETED|Overall Study||200
10164431|NCT02970422|11294563|FG000|NOT COMPLETED|Overall Study||0
10164432|NCT02970552|11294588|FG000|STARTED|Overall Study||70
10164433|NCT02970552|11294589|FG001|STARTED|Overall Study||70
10164434|NCT02970552|11294588|FG000|COMPLETED|Overall Study||67
10164435|NCT02970552|11294589|FG001|COMPLETED|Overall Study||67
10164436|NCT02970552|11294588|FG000|NOT COMPLETED|Overall Study||3
10164437|NCT02970552|11294589|FG001|NOT COMPLETED|Overall Study||3
10164438|NCT02970669|11294601|FG000|STARTED|Double-blind Period||70
10164439|NCT02970669|11294602|FG001|STARTED|Double-blind Period||70
10164440|NCT02970669|11294601|FG000|COMPLETED|Double-blind Period||62
10164441|NCT02970669|11294602|FG001|COMPLETED|Double-blind Period||64
10164442|NCT02970669|11294601|FG000|NOT COMPLETED|Double-blind Period||8
10164443|NCT02970669|11294602|FG001|NOT COMPLETED|Double-blind Period||6
10164444|NCT02970669|11294601|FG000|STARTED|Open-label Period||62
10164445|NCT02970669|11294602|FG001|STARTED|Open-label Period||64
10164446|NCT02970669|11294601|FG000|COMPLETED|Open-label Period||58
10164447|NCT02970669|11294602|FG001|COMPLETED|Open-label Period||62
10164448|NCT02970669|11294601|FG000|NOT COMPLETED|Open-label Period||4
10164449|NCT02970669|11294602|FG001|NOT COMPLETED|Open-label Period||2
10164450|NCT02970812|11294612|FG000|STARTED|Overall Study||30
10164451|NCT02970812|11294613|FG001|STARTED|Overall Study||30
10164452|NCT02970812|11294612|FG000|COMPLETED|Overall Study||22
10164453|NCT02970812|11294613|FG001|COMPLETED|Overall Study||28
10164454|NCT02970812|11294612|FG000|NOT COMPLETED|Overall Study||8
10164455|NCT02970812|11294613|FG001|NOT COMPLETED|Overall Study||2
10164456|NCT02970942|11294623|FG000|STARTED|Overall Study||80
10164457|NCT02970942|11294624|FG001|STARTED|Overall Study||78
10164458|NCT02970942|11294625|FG002|STARTED|Overall Study||82
10164459|NCT02970942|11294626|FG003|STARTED|Overall Study||80
10164460|NCT02970942|11294623|FG000|Full Analysis Set|Overall Study||80
10164461|NCT02970942|11294624|FG001|Full Analysis Set|Overall Study||78
10164462|NCT02970942|11294625|FG002|Full Analysis Set|Overall Study||82
10164463|NCT02970942|11294626|FG003|Full Analysis Set|Overall Study||80
10164464|NCT02970942|11294623|FG000|Safety Analysis Set|Overall Study||80
10164465|NCT02970942|11294624|FG001|Safety Analysis Set|Overall Study||78
10164466|NCT02970942|11294625|FG002|Safety Analysis Set|Overall Study||81
10164467|NCT02970942|11294626|FG003|Safety Analysis Set|Overall Study||80
10164468|NCT02970942|11294623|FG000|Exposed|Overall Study||80
10164469|NCT02970942|11294624|FG001|Exposed|Overall Study||78
10164470|NCT02970942|11294625|FG002|Exposed|Overall Study||81
10164471|NCT02970942|11294626|FG003|Exposed|Overall Study||80
10164472|NCT02970942|11294623|FG000|COMPLETED|Overall Study||76
10164473|NCT02970942|11294624|FG001|COMPLETED|Overall Study||72
10164474|NCT02970942|11294625|FG002|COMPLETED|Overall Study||77
10164475|NCT02970942|11294626|FG003|COMPLETED|Overall Study||77
10164476|NCT02970942|11294623|FG000|NOT COMPLETED|Overall Study||4
10164477|NCT02970942|11294624|FG001|NOT COMPLETED|Overall Study||6
10164478|NCT02970942|11294625|FG002|NOT COMPLETED|Overall Study||5
10164479|NCT02970942|11294626|FG003|NOT COMPLETED|Overall Study||3
10164480|NCT02971007|11294639|FG000|STARTED|Overall Study||46
10164481|NCT02971007|11294640|FG001|STARTED|Overall Study||45
10164482|NCT02971007|11294641|FG002|STARTED|Overall Study||46
10164483|NCT02971007|11294639|FG000|COMPLETED|Overall Study||44
10164484|NCT02971007|11294640|FG001|COMPLETED|Overall Study||42
10164485|NCT02971007|11294641|FG002|COMPLETED|Overall Study||45
10164486|NCT02971007|11294639|FG000|NOT COMPLETED|Overall Study||2
10164487|NCT02971007|11294640|FG001|NOT COMPLETED|Overall Study||3
10164488|NCT02971007|11294641|FG002|NOT COMPLETED|Overall Study||1
10164489|NCT02971163|11294651|FG000|STARTED|Overall Study||24
10164490|NCT02971163|11294652|FG001|STARTED|Overall Study||26
10164491|NCT02971163|11294651|FG000|COMPLETED|Overall Study||20
10164492|NCT02971163|11294652|FG001|COMPLETED|Overall Study||24
10164493|NCT02971163|11294651|FG000|NOT COMPLETED|Overall Study||4
10164494|NCT02971163|11294652|FG001|NOT COMPLETED|Overall Study||2
10164495|NCT02971202|11294661|FG000|STARTED|Overall Study||12
9849455|NCT00865202|10962176|FG000|NOT COMPLETED|Overall Study||0
10061113|NCT02101554|11186701|FG002|STARTED|Overall Study||3
10061114|NCT02101554|11186699|FG000|COMPLETED|Overall Study||3
10061115|NCT02101554|11186700|FG001|COMPLETED|Overall Study||5
10061116|NCT02101554|11186701|FG002|COMPLETED|Overall Study||2
10061117|NCT02101554|11186699|FG000|NOT COMPLETED|Overall Study||3
10061118|NCT02101554|11186700|FG001|NOT COMPLETED|Overall Study||5
10061119|NCT02101554|11186701|FG002|NOT COMPLETED|Overall Study||1
10061120|NCT02101918|11186709|FG000|STARTED|Overall Study||22
10061121|NCT02101918|11186709|FG000|COMPLETED|Overall Study||22
10061122|NCT02101918|11186709|FG000|NOT COMPLETED|Overall Study||0
10061123|NCT02101983|11186715|FG000|STARTED|Overall Study||5
10061124|NCT02101983|11186716|FG001|STARTED|Overall Study||6
10061125|NCT02101983|11186715|FG000|COMPLETED|Overall Study||4
10061126|NCT02101983|11186716|FG001|COMPLETED|Overall Study||6
10061127|NCT02101983|11186715|FG000|NOT COMPLETED|Overall Study||1
10061128|NCT02101983|11186716|FG001|NOT COMPLETED|Overall Study||0
10061129|NCT02102100|11186724|FG000|STARTED|Overall Study||32
10061130|NCT02102100|11186725|FG001|STARTED|Overall Study||25
10061131|NCT02102100|11186724|FG000|COMPLETED|Overall Study||23
10061132|NCT02102100|11186725|FG001|COMPLETED|Overall Study||18
10061133|NCT02102100|11186724|FG000|NOT COMPLETED|Overall Study||9
10061134|NCT02102100|11186725|FG001|NOT COMPLETED|Overall Study||7
10061135|NCT02102204|11186731|FG000|STARTED|Overall Study||902
10061136|NCT02102204|11186731|FG000|Received Etelcalcetide|Overall Study||884
10061137|NCT02102204|11186731|FG000|COMPLETED|Overall Study||598
10061138|NCT02102204|11186731|FG000|NOT COMPLETED|Overall Study||304
10061139|NCT02102230|11186738|FG000|STARTED|Overall Study||42
10061140|NCT02102230|11186739|FG001|STARTED|Overall Study||28
10061141|NCT02102230|11186740|FG002|STARTED|Overall Study||41
10061142|NCT02102230|11186738|FG000|COMPLETED|Overall Study||25
10061143|NCT02102230|11186739|FG001|COMPLETED|Overall Study||11
10061144|NCT02102230|11186740|FG002|COMPLETED|Overall Study||24
10061145|NCT02102230|11186738|FG000|NOT COMPLETED|Overall Study||17
10061146|NCT02102230|11186739|FG001|NOT COMPLETED|Overall Study||17
10061147|NCT02102230|11186740|FG002|NOT COMPLETED|Overall Study||17
10061148|NCT02102399|11186751|FG000|STARTED|Overall Study||20
10061149|NCT02102399|11186752|FG001|STARTED|Overall Study||21
10061150|NCT02102399|11186751|FG000|COMPLETED|Overall Study||14
10061151|NCT02102399|11186752|FG001|COMPLETED|Overall Study||17
10061152|NCT02102399|11186751|FG000|NOT COMPLETED|Overall Study||6
10061153|NCT02102399|11186752|FG001|NOT COMPLETED|Overall Study||4
10061154|NCT02102464|11186765|FG000|STARTED|Randomized Study||29
10061155|NCT02102464|11186766|FG001|STARTED|Randomized Study||26
10061156|NCT02102464|11186767|FG002|STARTED|Randomized Study||0
10061157|NCT02102464|11186765|FG000|COMPLETED|Randomized Study||29
10061158|NCT02102464|11186766|FG001|COMPLETED|Randomized Study||25
10061159|NCT02102464|11186767|FG002|COMPLETED|Randomized Study||0
10061160|NCT02102464|11186765|FG000|NOT COMPLETED|Randomized Study||0
10061161|NCT02102464|11186766|FG001|NOT COMPLETED|Randomized Study||1
10061162|NCT02102464|11186767|FG002|NOT COMPLETED|Randomized Study||0
10061163|NCT02102464|11186765|FG000|STARTED|Crossover LipiFlow Treatment of Control||0
10061164|NCT02102464|11186766|FG001|STARTED|Crossover LipiFlow Treatment of Control||0
10061165|NCT02102464|11186767|FG002|STARTED|Crossover LipiFlow Treatment of Control||25
10061166|NCT02102464|11186765|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0
10061167|NCT02102464|11186766|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0
10061168|NCT02102464|11186767|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25
10061169|NCT02102464|11186765|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
10061170|NCT02102464|11186766|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
10061171|NCT02102464|11186767|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
10061172|NCT02102490|11186776|FG000|STARTED|Overall Study||132
10061173|NCT02102490|11186776|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132
10061174|NCT02102490|11186776|FG000|COMPLETED|Overall Study||125
10061175|NCT02102490|11186776|FG000|NOT COMPLETED|Overall Study||7
10061176|NCT02102724|11186782|FG000|STARTED|Overall Study||18
10061177|NCT02102724|11186783|FG001|STARTED|Overall Study||19
10061178|NCT02102724|11186782|FG000|COMPLETED|Overall Study||16
10061179|NCT02102724|11186783|FG001|COMPLETED|Overall Study||18
10061180|NCT02102724|11186782|FG000|NOT COMPLETED|Overall Study||2
10061181|NCT02102724|11186783|FG001|NOT COMPLETED|Overall Study||1
10061182|NCT02102932|11186797|FG000|STARTED|Overall Study||12
10061183|NCT02102932|11186798|FG001|STARTED|Overall Study||12
10061184|NCT02102932|11186799|FG002|STARTED|Overall Study||12
10061185|NCT02102932|11186800|FG003|STARTED|Overall Study||12
10061186|NCT02102932|11186801|FG004|STARTED|Overall Study||12
10061187|NCT02102932|11186802|FG005|STARTED|Overall Study||12
10061188|NCT02102932|11186803|FG006|STARTED|Overall Study||12
10061189|NCT02102932|11186804|FG007|STARTED|Overall Study||12
10061190|NCT02102932|11186797|FG000|COMPLETED|Overall Study||12
10061191|NCT02102932|11186798|FG001|COMPLETED|Overall Study||12
10061192|NCT02102932|11186799|FG002|COMPLETED|Overall Study||12
10061193|NCT02102932|11186800|FG003|COMPLETED|Overall Study||12
9849456|NCT00865202|10962177|FG001|NOT COMPLETED|Overall Study||0
10061194|NCT02102932|11186801|FG004|COMPLETED|Overall Study||12
10061195|NCT02102932|11186802|FG005|COMPLETED|Overall Study||12
10061196|NCT02102932|11186803|FG006|COMPLETED|Overall Study||12
10061197|NCT02102932|11186804|FG007|COMPLETED|Overall Study||12
10061198|NCT02102932|11186797|FG000|NOT COMPLETED|Overall Study||0
10061199|NCT02102932|11186798|FG001|NOT COMPLETED|Overall Study||0
10164496|NCT02971202|11294662|FG001|STARTED|Overall Study||10
10164497|NCT02971202|11294663|FG002|STARTED|Overall Study||11
10164498|NCT02971202|11294661|FG000|Started Study|Overall Study||11
10164499|NCT02971202|11294662|FG001|Started Study|Overall Study||10
10164500|NCT02971202|11294663|FG002|Started Study|Overall Study||10
10164501|NCT02971202|11294661|FG000|COMPLETED|Overall Study||10
10164502|NCT02971202|11294662|FG001|COMPLETED|Overall Study||10
10164503|NCT02971202|11294663|FG002|COMPLETED|Overall Study||10
10164504|NCT02971202|11294661|FG000|NOT COMPLETED|Overall Study||2
10164505|NCT02971202|11294662|FG001|NOT COMPLETED|Overall Study||0
10164506|NCT02971202|11294663|FG002|NOT COMPLETED|Overall Study||1
10164507|NCT02971228|11294671|FG000|STARTED|Overall Study||1
10164508|NCT02971228|11294672|FG001|STARTED|Overall Study||7
10164509|NCT02971228|11294673|FG002|STARTED|Overall Study||5
10164510|NCT02971228|11294674|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10164511|NCT02971228|11294675|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10164512|NCT02971228|11294671|FG000|Randomized and Treated|Overall Study||0
10164513|NCT02971228|11294672|FG001|Randomized and Treated|Overall Study||7
10164514|NCT02971228|11294673|FG002|Randomized and Treated|Overall Study||5
10164515|NCT02971228|11294674|FG003|Randomized and Treated|Overall Study||0
10164516|NCT02971228|11294675|FG004|Randomized and Treated|Overall Study||0
10164517|NCT02971228|11294671|FG000|COMPLETED|Overall Study||0
10164518|NCT02971228|11294672|FG001|COMPLETED|Overall Study||5
10164519|NCT02971228|11294673|FG002|COMPLETED|Overall Study||5
10164520|NCT02971228|11294674|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10164521|NCT02971228|11294675|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10164522|NCT02971228|11294671|FG000|NOT COMPLETED|Overall Study||1
10164523|NCT02971228|11294672|FG001|NOT COMPLETED|Overall Study||2
10164524|NCT02971228|11294673|FG002|NOT COMPLETED|Overall Study||0
10164525|NCT02971228|11294674|FG003|NOT COMPLETED|Overall Study||0
10164526|NCT02971228|11294675|FG004|NOT COMPLETED|Overall Study||0
10164527|NCT02971293|11294686|FG000|STARTED|Overall Study||42
10164528|NCT02971293|11294686|FG000|COMPLETED|Overall Study||31
10164529|NCT02971293|11294686|FG000|NOT COMPLETED|Overall Study||11
10164530|NCT02971488|11294694|FG000|STARTED|Overall Study||529
10164531|NCT02971488|11294694|FG000|COMPLETED|Overall Study||529
10164532|NCT02971488|11294694|FG000|NOT COMPLETED|Overall Study||0
10164533|NCT02971605|11294701|FG000|STARTED|Overall Study||13
10164534|NCT02971605|11294701|FG000|COMPLETED|Overall Study||12
10164535|NCT02971605|11294701|FG000|NOT COMPLETED|Overall Study||1
10164536|NCT02971631|11294707|FG000|STARTED|First Intervention - One Day||3
10164537|NCT02971631|11294708|FG001|STARTED|First Intervention - One Day||2
10164538|NCT02971631|11294707|FG000|COMPLETED|First Intervention - One Day||3
10164539|NCT02971631|11294708|FG001|COMPLETED|First Intervention - One Day||2
10164540|NCT02971631|11294707|FG000|NOT COMPLETED|First Intervention - One Day||0
10164541|NCT02971631|11294708|FG001|NOT COMPLETED|First Intervention - One Day||0
10164542|NCT02971631|11294707|FG000|STARTED|Second Intervention - One Day||3
10164543|NCT02971631|11294708|FG001|STARTED|Second Intervention - One Day||2
10164544|NCT02971631|11294707|FG000|COMPLETED|Second Intervention - One Day||3
10164545|NCT02971631|11294708|FG001|COMPLETED|Second Intervention - One Day||2
10164546|NCT02971631|11294707|FG000|NOT COMPLETED|Second Intervention - One Day||0
10164547|NCT02971631|11294708|FG001|NOT COMPLETED|Second Intervention - One Day||0
10164548|NCT02971670|11294719|FG000|STARTED|Overall Study||13
10164549|NCT02971670|11294720|FG001|STARTED|Overall Study||2
10164550|NCT02971670|11294721|FG002|STARTED|Overall Study||5
10164551|NCT02971670|11294722|FG003|STARTED|Overall Study||3
10164552|NCT02971670|11294719|FG000|COMPLETED|Overall Study||9
10164553|NCT02971670|11294720|FG001|COMPLETED|Overall Study||1
10164554|NCT02971670|11294721|FG002|COMPLETED|Overall Study||4
10164555|NCT02971670|11294722|FG003|COMPLETED|Overall Study||1
10164556|NCT02971670|11294719|FG000|NOT COMPLETED|Overall Study||4
10164557|NCT02971670|11294720|FG001|NOT COMPLETED|Overall Study||1
10164558|NCT02971670|11294721|FG002|NOT COMPLETED|Overall Study||1
10164559|NCT02971670|11294722|FG003|NOT COMPLETED|Overall Study||2
10164560|NCT02971735|11294734|FG000|STARTED|Overall Study||30
10164561|NCT02971735|11294735|FG001|STARTED|Overall Study||30
10164562|NCT02971735|11294734|FG000|COMPLETED|Overall Study||30
10164563|NCT02971735|11294735|FG001|COMPLETED|Overall Study||30
10164564|NCT02971735|11294734|FG000|NOT COMPLETED|Overall Study||0
10164565|NCT02971735|11294735|FG001|NOT COMPLETED|Overall Study||0
10164566|NCT02971800|11294741|FG000|STARTED|Overall Study||37
10164567|NCT02971800|11294741|FG000|COMPLETED|Overall Study||30
10164568|NCT02971800|11294741|FG000|NOT COMPLETED|Overall Study||7
10164569|NCT02972242|11294747|FG000|STARTED|Overall Study||82
10164570|NCT02972242|11294748|FG001|STARTED|Overall Study||93
10164571|NCT02972242|11294747|FG000|COMPLETED|Overall Study||81
10164572|NCT02972242|11294748|FG001|COMPLETED|Overall Study||93
10164573|NCT02972242|11294747|FG000|NOT COMPLETED|Overall Study||1
10164574|NCT02972242|11294748|FG001|NOT COMPLETED|Overall Study||0
10164575|NCT02972359|11294754|FG000|STARTED|Overall Study||318
10164576|NCT02972359|11294754|FG000|COMPLETED|Overall Study||247
10164577|NCT02972359|11294754|FG000|NOT COMPLETED|Overall Study||71
10164578|NCT02972502|11294760|FG000|STARTED|Overall Study||35
10164579|NCT02972502|11294761|FG001|STARTED|Overall Study||31
10164580|NCT02972502|11294760|FG000|COMPLETED|Overall Study||31
10164581|NCT02972502|11294761|FG001|COMPLETED|Overall Study||29
10164582|NCT02972502|11294760|FG000|NOT COMPLETED|Overall Study||4
10164583|NCT02972502|11294761|FG001|NOT COMPLETED|Overall Study||2
10164584|NCT02972515|11294767|FG000|STARTED|Overall Study||166
10164585|NCT02972515|11294767|FG000|COMPLETED|Overall Study||88
10164586|NCT02972515|11294767|FG000|NOT COMPLETED|Overall Study||78
10164587|NCT02972554|11294773|FG000|STARTED|Overall Study||44
10164588|NCT02972554|11294774|FG001|STARTED|Overall Study||48
10164589|NCT02972554|11294773|FG000|COMPLETED|Overall Study||44
10164590|NCT02972554|11294774|FG001|COMPLETED|Overall Study||48
10164591|NCT02972554|11294773|FG000|NOT COMPLETED|Overall Study||0
10164592|NCT02972554|11294774|FG001|NOT COMPLETED|Overall Study||0
10164593|NCT02972632|11294780|FG000|STARTED|Overall Study||123
10164594|NCT02972632|11294780|FG000|Safety Analysis Set|Overall Study||122
10164595|NCT02972632|11294780|FG000|COMPLETED|Overall Study||106
10164596|NCT02972632|11294780|FG000|NOT COMPLETED|Overall Study||17
10164597|NCT02972658|11294788|FG000|STARTED|Overall Study||76
10164598|NCT02972658|11294789|FG001|STARTED|Overall Study||139
10164599|NCT02972658|11294790|FG002|STARTED|Overall Study||75
10164600|NCT02972658|11294791|FG003|STARTED|Overall Study||131
10164601|NCT02972658|11294788|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
10164602|NCT02972658|11294789|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
10164603|NCT02972658|11294790|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74
10164604|NCT02972658|11294791|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131
10164605|NCT02972658|11294788|FG000|COMPLETED|Overall Study||0
10164606|NCT02972658|11294789|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
10164607|NCT02972658|11294790|FG002|COMPLETED|Overall Study||0
10164608|NCT02972658|11294791|FG003|COMPLETED|Overall Study||0
10164609|NCT02972658|11294788|FG000|NOT COMPLETED|Overall Study||76
10164610|NCT02972658|11294789|FG001|NOT COMPLETED|Overall Study||138
10164611|NCT02972658|11294790|FG002|NOT COMPLETED|Overall Study||75
10164612|NCT02972658|11294791|FG003|NOT COMPLETED|Overall Study||131
10164613|NCT02973048|11294803|FG000|STARTED|Overall Study||20
10164614|NCT02973048|11294804|FG001|STARTED|Overall Study||20
10164615|NCT02973048|11294803|FG000|COMPLETED|Overall Study||19
10164616|NCT02973048|11294804|FG001|COMPLETED|Overall Study||17
10164617|NCT02973048|11294803|FG000|NOT COMPLETED|Overall Study||1
10164618|NCT02973048|11294804|FG001|NOT COMPLETED|Overall Study||3
10164619|NCT02973087|11294812|FG000|STARTED|Overall Study||13
10164620|NCT02973087|11294813|FG001|STARTED|Overall Study||10
10164621|NCT02973087|11294812|FG000|COMPLETED|Overall Study||9
10164622|NCT02973087|11294813|FG001|COMPLETED|Overall Study||8
10164623|NCT02973087|11294812|FG000|NOT COMPLETED|Overall Study||4
10164624|NCT02973087|11294813|FG001|NOT COMPLETED|Overall Study||2
10164625|NCT02973100|11294824|FG000|STARTED|Overall Study||82
10164626|NCT02973100|11294825|FG001|STARTED|Overall Study||81
10164627|NCT02973100|11294826|FG002|STARTED|Overall Study||79
10164628|NCT02973100|11294827|FG003|STARTED|Overall Study||76
10164629|NCT02973100|11294824|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
10164630|NCT02973100|11294825|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
10164631|NCT02973100|11294826|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79
10164632|NCT02973100|11294827|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76
10164633|NCT02973100|11294824|FG000|COMPLETED|Overall Study||75
10164634|NCT02973100|11294825|FG001|COMPLETED|Overall Study||73
10164635|NCT02973100|11294826|FG002|COMPLETED|Overall Study||75
10164636|NCT02973100|11294827|FG003|COMPLETED|Overall Study||69
10164637|NCT02973100|11294824|FG000|NOT COMPLETED|Overall Study||7
10164638|NCT02973100|11294825|FG001|NOT COMPLETED|Overall Study||8
10164639|NCT02973100|11294826|FG002|NOT COMPLETED|Overall Study||4
10164640|NCT02973100|11294827|FG003|NOT COMPLETED|Overall Study||7
10164641|NCT02973438|11294844|FG000|STARTED|First Treatment Session (4 Days)||2
10164642|NCT02973438|11294845|FG001|STARTED|First Treatment Session (4 Days)||1
10164643|NCT02973438|11294846|FG002|STARTED|First Treatment Session (4 Days)||2
10164644|NCT02973438|11294847|FG003|STARTED|First Treatment Session (4 Days)||1
10164645|NCT02973438|11294844|FG000|COMPLETED|First Treatment Session (4 Days)||2
10164646|NCT02973438|11294845|FG001|COMPLETED|First Treatment Session (4 Days)||1
10164647|NCT02973438|11294846|FG002|COMPLETED|First Treatment Session (4 Days)||2
10164648|NCT02973438|11294847|FG003|COMPLETED|First Treatment Session (4 Days)||1
10164649|NCT02973438|11294844|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0
10164650|NCT02973438|11294845|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0
10164651|NCT02973438|11294846|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0
10164652|NCT02973438|11294847|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0
10164653|NCT02973438|11294844|FG000|STARTED|Washout (Three Weeks)||2
10164654|NCT02973438|11294845|FG001|STARTED|Washout (Three Weeks)||1
10164655|NCT02973438|11294846|FG002|STARTED|Washout (Three Weeks)||2
10164656|NCT02973438|11294847|FG003|STARTED|Washout (Three Weeks)||1
10164657|NCT02973438|11294844|FG000|COMPLETED|Washout (Three Weeks)||2
10164658|NCT02973438|11294845|FG001|COMPLETED|Washout (Three Weeks)||1
9711219|NCT04492475|10810996|FG001|As Treated Population|Overall Study||468
9711220|NCT04492475|10810995|FG000|COMPLETED|Overall Study||473
9711221|NCT04492475|10810996|FG001|COMPLETED|Overall Study||474
9711222|NCT04492475|10810995|FG000|NOT COMPLETED|Overall Study||14
9711223|NCT04492475|10810996|FG001|NOT COMPLETED|Overall Study||8
9711224|NCT04401579|10811011|FG000|STARTED|Overall Study||515
9711225|NCT04401579|10811012|FG001|STARTED|Overall Study||518
9711226|NCT04401579|10811011|FG000|Treated|Overall Study||507
9711227|NCT04401579|10811012|FG001|Treated|Overall Study||509
9711228|NCT04401579|10811011|FG000|COMPLETED|Overall Study||431
9711229|NCT04401579|10811012|FG001|COMPLETED|Overall Study||408
9711230|NCT04401579|10811011|FG000|NOT COMPLETED|Overall Study||84
9711231|NCT04401579|10811012|FG001|NOT COMPLETED|Overall Study||110
9711232|NCT04321460|10811020|FG000|STARTED|Overall Study||260
9711233|NCT04321460|10811021|FG001|STARTED|Overall Study||260
9711234|NCT04321460|10811020|FG000|Intention to Treat (ITT) Population|Overall Study||260
9711235|NCT04321460|10811021|FG001|Intention to Treat (ITT) Population|Overall Study||260
9711236|NCT04321460|10811020|FG000|Per-protocol (PP) Population|Overall Study||252
9711237|NCT04321460|10811021|FG001|Per-protocol (PP) Population|Overall Study||248
9711238|NCT04321460|10811020|FG000|COMPLETED|Overall Study||259
9711239|NCT04321460|10811021|FG001|COMPLETED|Overall Study||259
9711240|NCT04321460|10811020|FG000|NOT COMPLETED|Overall Study||1
9711241|NCT04321460|10811021|FG001|NOT COMPLETED|Overall Study||1
9711242|NCT04280705|10811029|FG000|STARTED|Overall Study||521
9711243|NCT04280705|10811030|FG001|STARTED|Overall Study||541
9711244|NCT04280705|10811029|FG000|Received Treatment|Overall Study||517
10164659|NCT02973438|11294846|FG002|COMPLETED|Washout (Three Weeks)||2
10164660|NCT02973438|11294847|FG003|COMPLETED|Washout (Three Weeks)||1
10164661|NCT02973438|11294844|FG000|NOT COMPLETED|Washout (Three Weeks)||0
10164662|NCT02973438|11294845|FG001|NOT COMPLETED|Washout (Three Weeks)||0
10164663|NCT02973438|11294846|FG002|NOT COMPLETED|Washout (Three Weeks)||0
10164664|NCT02973438|11294847|FG003|NOT COMPLETED|Washout (Three Weeks)||0
10164665|NCT02973438|11294844|FG000|STARTED|Second Treatment Session (4 Days)||2
10164666|NCT02973438|11294845|FG001|STARTED|Second Treatment Session (4 Days)||1
10164667|NCT02973438|11294846|FG002|STARTED|Second Treatment Session (4 Days)||2
10164668|NCT02973438|11294847|FG003|STARTED|Second Treatment Session (4 Days)||1
10164669|NCT02973438|11294844|FG000|COMPLETED|Second Treatment Session (4 Days)||2
10164670|NCT02973438|11294845|FG001|COMPLETED|Second Treatment Session (4 Days)||1
10164671|NCT02973438|11294846|FG002|COMPLETED|Second Treatment Session (4 Days)||2
10164672|NCT02973438|11294847|FG003|COMPLETED|Second Treatment Session (4 Days)||1
10164673|NCT02973438|11294844|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0
10164674|NCT02973438|11294845|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0
10164675|NCT02973438|11294846|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0
10164676|NCT02973438|11294847|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0
10164677|NCT02973477|11294860|FG000|STARTED|First Intervention||19
10164678|NCT02973477|11294861|FG001|STARTED|First Intervention||26
10164679|NCT02973477|11294860|FG000|COMPLETED|First Intervention||19
10164680|NCT02973477|11294861|FG001|COMPLETED|First Intervention||24
10164681|NCT02973477|11294860|FG000|NOT COMPLETED|First Intervention||0
10164682|NCT02973477|11294861|FG001|NOT COMPLETED|First Intervention||2
10164683|NCT02973477|11294860|FG000|STARTED|Washout||19
10164684|NCT02973477|11294861|FG001|STARTED|Washout||24
10164685|NCT02973477|11294860|FG000|COMPLETED|Washout||18
10164686|NCT02973477|11294861|FG001|COMPLETED|Washout||24
10164687|NCT02973477|11294860|FG000|NOT COMPLETED|Washout||1
10164688|NCT02973477|11294861|FG001|NOT COMPLETED|Washout||0
10164689|NCT02973477|11294860|FG000|STARTED|Second Intervention||18
10164690|NCT02973477|11294861|FG001|STARTED|Second Intervention||24
10164691|NCT02973477|11294860|FG000|COMPLETED|Second Intervention||17
10164692|NCT02973477|11294861|FG001|COMPLETED|Second Intervention||24
10164693|NCT02973477|11294860|FG000|NOT COMPLETED|Second Intervention||1
10164694|NCT02973477|11294861|FG001|NOT COMPLETED|Second Intervention||0
10197494|NCT03376321|11325453|FG001|NOT COMPLETED|Overall Study||25
10197495|NCT03376516|11325459|FG000|STARTED|Overall Study||11
10197496|NCT03376516|11325459|FG000|Received Treatment|Overall Study||10
10197497|NCT03376516|11325459|FG000|SAF Population|Overall Study||10
10197498|NCT03376516|11325459|FG000|FAS Population|Overall Study||10
10197499|NCT03376516|11325459|FG000|PK Population|Overall Study||10
10197500|NCT03376516|11325459|FG000|PP Population|Overall Study||9
10197501|NCT03376516|11325459|FG000|SURG Population|Overall Study||2
10197502|NCT03376516|11325459|FG000|COMPLETED|Overall Study||9
10197503|NCT03376516|11325459|FG000|NOT COMPLETED|Overall Study||2
10197504|NCT03377127|11325476|FG000|STARTED|Overall Study||42
10197505|NCT03377127|11325477|FG001|STARTED|Overall Study||44
10197506|NCT03377127|11325476|FG000|COMPLETED|Overall Study||42
10197507|NCT03377127|11325477|FG001|COMPLETED|Overall Study||44
10197508|NCT03377127|11325476|FG000|NOT COMPLETED|Overall Study||0
10197509|NCT03377127|11325477|FG001|NOT COMPLETED|Overall Study||0
10197510|NCT03377244|11325486|FG000|STARTED|Baseline||19
10197511|NCT03377244|11325487|FG001|STARTED|Baseline||14
10197512|NCT03377244|11325488|FG002|STARTED|Baseline||69
10197513|NCT03377244|11325486|FG000|COMPLETED|Baseline||19
10197514|NCT03377244|11325487|FG001|COMPLETED|Baseline||14
10197515|NCT03377244|11325488|FG002|COMPLETED|Baseline||69
10197516|NCT03377244|11325486|FG000|NOT COMPLETED|Baseline||0
10197517|NCT03377244|11325487|FG001|NOT COMPLETED|Baseline||0
10197518|NCT03377244|11325488|FG002|NOT COMPLETED|Baseline||0
10197519|NCT03377244|11325486|FG000|STARTED|6 Months Post-intervention||19
10197520|NCT03377244|11325487|FG001|STARTED|6 Months Post-intervention||14
10197521|NCT03377244|11325488|FG002|STARTED|6 Months Post-intervention||69
10197522|NCT03377244|11325486|FG000|COMPLETED|6 Months Post-intervention||13
10197523|NCT03377244|11325487|FG001|COMPLETED|6 Months Post-intervention||7
10197524|NCT03377244|11325488|FG002|COMPLETED|6 Months Post-intervention||55
10197525|NCT03377244|11325486|FG000|NOT COMPLETED|6 Months Post-intervention||6
10197526|NCT03377244|11325487|FG001|NOT COMPLETED|6 Months Post-intervention||7
10197527|NCT03377244|11325488|FG002|NOT COMPLETED|6 Months Post-intervention||14
10197528|NCT03377556|11325496|FG000|STARTED|Overall Study||47
10197529|NCT03377556|11325496|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
10197530|NCT03377556|11325496|FG000|COMPLETED|Overall Study||0
10197531|NCT03377556|11325496|FG000|NOT COMPLETED|Overall Study||47
10197532|NCT03377634|11325502|FG000|STARTED|Intervention Usability Testing Period||5
10197533|NCT03377634|11325503|FG001|STARTED|Intervention Usability Testing Period||0
10197534|NCT03377634|11325502|FG000|COMPLETED|Intervention Usability Testing Period||5
10197535|NCT03377634|11325503|FG001|COMPLETED|Intervention Usability Testing Period||0
10197536|NCT03377634|11325502|FG000|NOT COMPLETED|Intervention Usability Testing Period||0
10197537|NCT03377634|11325503|FG001|NOT COMPLETED|Intervention Usability Testing Period||0
10197538|NCT03377634|11325502|FG000|STARTED|Study Period||15
10197539|NCT03377634|11325503|FG001|STARTED|Study Period||13
10197540|NCT03377634|11325502|FG000|COMPLETED|Study Period||13
10197541|NCT03377634|11325503|FG001|COMPLETED|Study Period||13
10197542|NCT03377634|11325502|FG000|NOT COMPLETED|Study Period||2
10197543|NCT03377634|11325503|FG001|NOT COMPLETED|Study Period||0
10164695|NCT02973503|11294873|FG000|STARTED|Overall Study||117
10164696|NCT02973503|11294873|FG000|COMPLETED|Overall Study||117
10164697|NCT02973503|11294873|FG000|NOT COMPLETED|Overall Study||0
10164698|NCT02973516|11294884|FG000|STARTED|Overall Study||30
10164699|NCT02973516|11294885|FG001|STARTED|Overall Study||10
10164700|NCT02973516|11294884|FG000|COMPLETED|Overall Study||30
10164701|NCT02973516|11294885|FG001|COMPLETED|Overall Study||10
10164702|NCT02973516|11294884|FG000|NOT COMPLETED|Overall Study||0
10164703|NCT02973516|11294885|FG001|NOT COMPLETED|Overall Study||0
10164704|NCT02973802|11294891|FG000|STARTED|Overall Study||12
10164705|NCT02973802|11294891|FG000|COMPLETED|Overall Study||10
10164706|NCT02973802|11294891|FG000|NOT COMPLETED|Overall Study||2
10164707|NCT02974010|11294900|FG000|STARTED|Overall Study||12
10164708|NCT02974010|11294901|FG001|STARTED|Overall Study||5
10164709|NCT02974010|11294902|FG002|STARTED|Overall Study||4
10164710|NCT02974010|11294903|FG003|STARTED|Overall Study||1
10164711|NCT02974010|11294900|FG000|COMPLETED|Overall Study||6
10164712|NCT02974010|11294901|FG001|COMPLETED|Overall Study||2
10164713|NCT02974010|11294902|FG002|COMPLETED|Overall Study||2
10164714|NCT02974010|11294903|FG003|COMPLETED|Overall Study||1
10164715|NCT02974010|11294900|FG000|NOT COMPLETED|Overall Study||6
10164716|NCT02974010|11294901|FG001|NOT COMPLETED|Overall Study||3
10164717|NCT02974010|11294902|FG002|NOT COMPLETED|Overall Study||2
10164718|NCT02974010|11294903|FG003|NOT COMPLETED|Overall Study||0
10164719|NCT02974088|11294915|FG000|STARTED|Overall Study||23
10164720|NCT02974088|11294916|FG001|STARTED|Overall Study||24
10164721|NCT02974088|11294915|FG000|COMPLETED|Overall Study||23
10164722|NCT02974088|11294916|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
10164723|NCT02974088|11294915|FG000|NOT COMPLETED|Overall Study||0
10164724|NCT02974088|11294916|FG001|NOT COMPLETED|Overall Study||3
10164725|NCT02974114|11294925|FG000|STARTED|Overall Study||6
10164726|NCT02974114|11294926|FG001|STARTED|Overall Study||7
10164727|NCT02974114|11294927|FG002|STARTED|Overall Study||8
10164728|NCT02974114|11294925|FG000|COMPLETED|Overall Study||6
10164729|NCT02974114|11294926|FG001|COMPLETED|Overall Study||6
10164730|NCT02974114|11294927|FG002|COMPLETED|Overall Study||6
10164731|NCT02974114|11294925|FG000|NOT COMPLETED|Overall Study||0
10164732|NCT02974114|11294926|FG001|NOT COMPLETED|Overall Study||1
10164733|NCT02974114|11294927|FG002|NOT COMPLETED|Overall Study||2
10164734|NCT02974140|11294937|FG000|STARTED|Overall Study||39
10164735|NCT02974140|11294937|FG000|CRS (Left or Right Eye)|Overall Study||38
10164736|NCT02974140|11294937|FG000|Manual (Fellow Eye)|Overall Study||38
10164737|NCT02974140|11294937|FG000|COMPLETED|Overall Study||0
10164738|NCT02974140|11294937|FG000|NOT COMPLETED|Overall Study||39
10164739|NCT02974153|11294947|FG000|STARTED|Overall Study||374
10164740|NCT02974153|11294948|FG001|STARTED|Overall Study||372
10164741|NCT02974153|11294949|FG002|STARTED|Overall Study||375
10164742|NCT02974153|11294947|FG000|Participants Treated|Overall Study||350
10164743|NCT02974153|11294948|FG001|Participants Treated|Overall Study||356
10164744|NCT02974153|11294949|FG002|Participants Treated|Overall Study||366
10164745|NCT02974153|11294947|FG000|COMPLETED|Overall Study||322
10164746|NCT02974153|11294948|FG001|COMPLETED|Overall Study||324
10164747|NCT02974153|11294949|FG002|COMPLETED|Overall Study||325
10164748|NCT02974153|11294947|FG000|NOT COMPLETED|Overall Study||52
10164749|NCT02974153|11294948|FG001|NOT COMPLETED|Overall Study||48
10164750|NCT02974153|11294949|FG002|NOT COMPLETED|Overall Study||50
10164751|NCT02974296|11294959|FG000|STARTED|Overall Study||10
10164752|NCT02974296|11294960|FG001|STARTED|Overall Study||23
10164753|NCT02974296|11294959|FG000|COMPLETED|Overall Study||10
10164754|NCT02974296|11294960|FG001|COMPLETED|Overall Study||22
10164755|NCT02974296|11294959|FG000|NOT COMPLETED|Overall Study||0
10164756|NCT02974296|11294960|FG001|NOT COMPLETED|Overall Study||1
10164757|NCT02974543|11294968|FG000|STARTED|Overall Study||11
10164758|NCT02974543|11294969|FG001|STARTED|Overall Study||10
10164759|NCT02974543|11294968|FG000|Began Washout Period|Overall Study||10
9711245|NCT04280705|10811030|FG001|Received Treatment|Overall Study||531
9711246|NCT04280705|10811029|FG000|COMPLETED|Overall Study||508
9711247|NCT04280705|10811030|FG001|COMPLETED|Overall Study||517
9711248|NCT04280705|10811029|FG000|NOT COMPLETED|Overall Study||13
9711249|NCT04280705|10811030|FG001|NOT COMPLETED|Overall Study||24
9730837|NCT00128219|10830733|FG001|NOT COMPLETED|Overall Study||71
9730838|NCT00128401|10830741|FG000|STARTED|Overall Study||20
9730839|NCT00128401|10830742|FG001|STARTED|Overall Study||19
9730840|NCT00128401|10830741|FG000|COMPLETED|Overall Study||14
9730841|NCT00128401|10830742|FG001|COMPLETED|Overall Study||15
10164760|NCT02974543|11294969|FG001|Began Washout Period|Overall Study||10
10164761|NCT02974543|11294968|FG000|Began Crossover Assignment|Overall Study||10
10164762|NCT02974543|11294969|FG001|Began Crossover Assignment|Overall Study||10
10164763|NCT02974543|11294968|FG000|COMPLETED|Overall Study||10
10164764|NCT02974543|11294969|FG001|COMPLETED|Overall Study||10
10164765|NCT02974543|11294968|FG000|NOT COMPLETED|Overall Study||1
10164766|NCT02974543|11294969|FG001|NOT COMPLETED|Overall Study||0
10164767|NCT02974634|11294985|FG000|STARTED|Overall Study||106
10164768|NCT02974634|11294986|FG001|STARTED|Overall Study||110
10164769|NCT02974634|11294985|FG000|COMPLETED|Overall Study||78
10164770|NCT02974634|11294986|FG001|COMPLETED|Overall Study||89
10164771|NCT02974634|11294985|FG000|NOT COMPLETED|Overall Study||28
10164772|NCT02974634|11294986|FG001|NOT COMPLETED|Overall Study||21
10164773|NCT02974842|11294993|FG000|STARTED|Overall Study|Participants|50
10164774|NCT02974842|11294993|FG000|COMPLETED|Overall Study||42
10164775|NCT02974842|11294993|FG000|NOT COMPLETED|Overall Study||8
9711250|NCT04208750|10811038|FG000|STARTED|Overall Study||58
9711251|NCT04208750|10811039|FG001|STARTED|Overall Study||61
9711252|NCT04208750|10811038|FG000|Visit 2|Overall Study||58
9711253|NCT04208750|10811039|FG001|Visit 2|Overall Study||61
9711254|NCT04208750|10811038|FG000|Visit 3|Overall Study||58
9711255|NCT04208750|10811039|FG001|Visit 3|Overall Study||53
9711256|NCT04208750|10811038|FG000|Visit 4|Overall Study||43
9711257|NCT04208750|10811039|FG001|Visit 4|Overall Study||47
9711258|NCT04208750|10811038|FG000|COMPLETED|Overall Study||42
9711259|NCT04208750|10811039|FG001|COMPLETED|Overall Study||46
9711260|NCT04208750|10811038|FG000|NOT COMPLETED|Overall Study||16
9711261|NCT04208750|10811039|FG001|NOT COMPLETED|Overall Study||15
9711262|NCT03713281|10811045|FG000|STARTED|Overall Study||28
9711263|NCT03713281|10811045|FG000|COMPLETED|Overall Study||25
9711264|NCT03713281|10811045|FG000|NOT COMPLETED|Overall Study||3
9711265|NCT03608254|10811049|FG000|STARTED|Overall Study||11
9711266|NCT03608254|10811049|FG000|COMPLETED|Overall Study||8
9711267|NCT03608254|10811049|FG000|NOT COMPLETED|Overall Study||3
9730842|NCT00128401|10830741|FG000|NOT COMPLETED|Overall Study||6
9730843|NCT00128401|10830742|FG001|NOT COMPLETED|Overall Study||4
10164776|NCT02974855|11295001|FG000|STARTED|Overall Study||7
10164777|NCT02974855|11295002|FG001|STARTED|Overall Study||6
10164778|NCT02974855|11295003|FG002|STARTED|Overall Study||6
10164779|NCT02974855|11295004|FG003|STARTED|Overall Study||7
10164780|NCT02974855|11295001|FG000|COMPLETED|Overall Study||7
10164781|NCT02974855|11295002|FG001|COMPLETED|Overall Study||5
10164782|NCT02974855|11295003|FG002|COMPLETED|Overall Study||6
10164783|NCT02974855|11295004|FG003|COMPLETED|Overall Study||6
10164784|NCT02974855|11295001|FG000|NOT COMPLETED|Overall Study||0
10164785|NCT02974855|11295002|FG001|NOT COMPLETED|Overall Study||1
10164786|NCT02974855|11295003|FG002|NOT COMPLETED|Overall Study||0
10164787|NCT02974855|11295004|FG003|NOT COMPLETED|Overall Study||1
10164788|NCT02974868|11295021|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24
10164789|NCT02974868|11295022|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23
10164790|NCT02974868|11295023|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48
10164791|NCT02974868|11295024|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47
10164792|NCT02974868|11295021|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20
10164793|NCT02974868|11295022|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14
10164794|NCT02974868|11295023|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45
10164795|NCT02974868|11295024|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35
10164796|NCT02974868|11295021|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
10164797|NCT02974868|11295022|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
10164798|NCT02974868|11295023|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
10164799|NCT02974868|11295024|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
10164800|NCT02974868|11295021|FG000|STARTED|Single-Blind Extension (SBE) Period||17
10164801|NCT02974868|11295022|FG001|STARTED|Single-Blind Extension (SBE) Period||12
10164802|NCT02974868|11295023|FG002|STARTED|Single-Blind Extension (SBE) Period||38
10164803|NCT02974868|11295024|FG003|STARTED|Single-Blind Extension (SBE) Period||29
10164804|NCT02974868|11295021|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15
10164805|NCT02974868|11295022|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11
10164806|NCT02974868|11295023|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27
10164807|NCT02974868|11295024|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23
9730844|NCT00128492|10830751|FG000|STARTED|Overall Study||85
9730845|NCT00128492|10830752|FG001|STARTED|Overall Study||189
9730846|NCT00128492|10830751|FG000|COMPLETED|Overall Study||65
9730847|NCT00128492|10830752|FG001|COMPLETED|Overall Study||130
9730848|NCT00128492|10830751|FG000|NOT COMPLETED|Overall Study||20
9730849|NCT00128492|10830752|FG001|NOT COMPLETED|Overall Study||59
9730850|NCT00128661|10830760|FG000|STARTED|Overall Study||3727
9730851|NCT00128661|10830761|FG001|STARTED|Overall Study||3739
9730852|NCT00128661|10830760|FG000|COMPLETED|Overall Study||3453
9730853|NCT00128661|10830761|FG001|COMPLETED|Overall Study||3481
9730854|NCT00128661|10830760|FG000|NOT COMPLETED|Overall Study||274
9730855|NCT00128661|10830761|FG001|NOT COMPLETED|Overall Study||258
9730856|NCT00128713|10830770|FG000|STARTED|Overall Study||453
9730857|NCT00128713|10830771|FG001|STARTED|Overall Study||449
9730858|NCT00128713|10830772|FG002|STARTED|Overall Study||449
9730859|NCT00128713|10830770|FG000|COMPLETED|Overall Study||453
9730860|NCT00128713|10830771|FG001|COMPLETED|Overall Study||449
9730861|NCT00128713|10830772|FG002|COMPLETED|Overall Study||449
9730862|NCT00128713|10830770|FG000|NOT COMPLETED|Overall Study||0
9730863|NCT00128713|10830771|FG001|NOT COMPLETED|Overall Study||0
9730864|NCT00128713|10830772|FG002|NOT COMPLETED|Overall Study||0
9730865|NCT00128830|10830780|FG000|STARTED|Overall Study||211
9730866|NCT00128830|10830780|FG000|COMPLETED|Overall Study||139
9730867|NCT00128830|10830780|FG000|NOT COMPLETED|Overall Study||72
9730868|NCT00128921|10830789|FG000|STARTED|Overall Study||10
9730869|NCT00128921|10830790|FG001|STARTED|Overall Study||8
9730870|NCT00128921|10830791|FG002|STARTED|Overall Study||0
9730871|NCT00128921|10830789|FG000|Received Bortezomib|Overall Study||10
9730872|NCT00128921|10830790|FG001|Received Bortezomib|Overall Study||6
9730873|NCT00128921|10830791|FG002|Received Bortezomib|Overall Study||0
9730874|NCT00128921|10830789|FG000|COMPLETED|Overall Study||5
9730875|NCT00128921|10830790|FG001|COMPLETED|Overall Study||3
9730876|NCT00128921|10830791|FG002|COMPLETED|Overall Study||0
10164808|NCT02974868|11295021|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
10164809|NCT02974868|11295022|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
10164810|NCT02974868|11295023|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
10164811|NCT02974868|11295024|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
10164812|NCT02974868|11295021|FG000|STARTED|Cross-Over Extension (COE) Period||7
10164813|NCT02974868|11295022|FG001|STARTED|Cross-Over Extension (COE) Period||2
10164814|NCT02974868|11295023|FG002|STARTED|Cross-Over Extension (COE) Period||11
10164815|NCT02974868|11295024|FG003|STARTED|Cross-Over Extension (COE) Period||3
10164816|NCT02974868|11295021|FG000|COMPLETED|Cross-Over Extension (COE) Period||5
10164817|NCT02974868|11295022|FG001|COMPLETED|Cross-Over Extension (COE) Period||1
10164818|NCT02974868|11295023|FG002|COMPLETED|Cross-Over Extension (COE) Period||8
10164819|NCT02974868|11295024|FG003|COMPLETED|Cross-Over Extension (COE) Period||3
10164820|NCT02974868|11295021|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2
10164821|NCT02974868|11295022|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1
10164822|NCT02974868|11295023|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3
10164823|NCT02974868|11295024|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0
10164824|NCT02975206|11295068|FG000|STARTED|Overall Study||161
10164825|NCT02975206|11295069|FG001|STARTED|Overall Study||161
10164826|NCT02975206|11295070|FG002|STARTED|Overall Study||162
10164827|NCT02975206|11295068|FG000|COMPLETED|Overall Study||134
10164828|NCT02975206|11295069|FG001|COMPLETED|Overall Study||144
10164829|NCT02975206|11295070|FG002|COMPLETED|Overall Study||145
10164830|NCT02975206|11295068|FG000|NOT COMPLETED|Overall Study||27
10164831|NCT02975206|11295069|FG001|NOT COMPLETED|Overall Study||17
10164832|NCT02975206|11295070|FG002|NOT COMPLETED|Overall Study||17
10164833|NCT02975297|11295080|FG000|STARTED|Overall Study||41
10164834|NCT02975297|11295081|FG001|STARTED|Overall Study||41
10164835|NCT02975297|11295080|FG000|COMPLETED|Overall Study||34
10164836|NCT02975297|11295081|FG001|COMPLETED|Overall Study||35
10164837|NCT02975297|11295080|FG000|NOT COMPLETED|Overall Study||7
10164838|NCT02975297|11295081|FG001|NOT COMPLETED|Overall Study||6
10164839|NCT02975336|11295091|FG000|STARTED|DBPC (52 Weeks)||117
10164840|NCT02975336|11295092|FG001|STARTED|DBPC (52 Weeks)||118
10164841|NCT02975336|11295093|FG002|STARTED|DBPC (52 Weeks)||117
10164842|NCT02975336|11295094|FG003|STARTED|DBPC (52 Weeks)||117
10164843|NCT02975336|11295095|FG004|STARTED|DBPC (52 Weeks)||0
10164844|NCT02975336|11295096|FG005|STARTED|DBPC (52 Weeks)||0
10164845|NCT02975336|11295097|FG006|STARTED|DBPC (52 Weeks)||0
10164846|NCT02975336|11295098|FG007|STARTED|DBPC (52 Weeks)||0
10164847|NCT02975336|11295091|FG000|COMPLETED|DBPC (52 Weeks)||85
10164848|NCT02975336|11295092|FG001|COMPLETED|DBPC (52 Weeks)||89
10164849|NCT02975336|11295093|FG002|COMPLETED|DBPC (52 Weeks)||90
10164850|NCT02975336|11295094|FG003|COMPLETED|DBPC (52 Weeks)||84
10164851|NCT02975336|11295095|FG004|COMPLETED|DBPC (52 Weeks)||0
10164852|NCT02975336|11295096|FG005|COMPLETED|DBPC (52 Weeks)||0
10164853|NCT02975336|11295097|FG006|COMPLETED|DBPC (52 Weeks)||0
10164854|NCT02975336|11295098|FG007|COMPLETED|DBPC (52 Weeks)||0
10164855|NCT02975336|11295091|FG000|NOT COMPLETED|DBPC (52 Weeks)||32
10164856|NCT02975336|11295092|FG001|NOT COMPLETED|DBPC (52 Weeks)||29
10164857|NCT02975336|11295093|FG002|NOT COMPLETED|DBPC (52 Weeks)||27
10164858|NCT02975336|11295094|FG003|NOT COMPLETED|DBPC (52 Weeks)||33
10164859|NCT02975336|11295095|FG004|NOT COMPLETED|DBPC (52 Weeks)||0
10164860|NCT02975336|11295096|FG005|NOT COMPLETED|DBPC (52 Weeks)||0
10164861|NCT02975336|11295097|FG006|NOT COMPLETED|DBPC (52 Weeks)||0
10164862|NCT02975336|11295098|FG007|NOT COMPLETED|DBPC (52 Weeks)||0
10164863|NCT02975336|11295091|FG000|STARTED|LTE (104 Weeks)||0
10164864|NCT02975336|11295092|FG001|STARTED|LTE (104 Weeks)||0
10164865|NCT02975336|11295093|FG002|STARTED|LTE (104 Weeks)||0
10164866|NCT02975336|11295094|FG003|STARTED|LTE (104 Weeks)||0
10164867|NCT02975336|11295095|FG004|STARTED|LTE (104 Weeks)||62
10164868|NCT02975336|11295096|FG005|STARTED|LTE (104 Weeks)||69
10164869|NCT02975336|11295097|FG006|STARTED|LTE (104 Weeks)||80
10164870|NCT02975336|11295098|FG007|STARTED|LTE (104 Weeks)||72
10164871|NCT02975336|11295091|FG000|COMPLETED|LTE (104 Weeks)||0
10164872|NCT02975336|11295092|FG001|COMPLETED|LTE (104 Weeks)||0
10164873|NCT02975336|11295093|FG002|COMPLETED|LTE (104 Weeks)||0
10164874|NCT02975336|11295094|FG003|COMPLETED|LTE (104 Weeks)||0
10164875|NCT02975336|11295095|FG004|COMPLETED|LTE (104 Weeks)||0
10164876|NCT02975336|11295096|FG005|COMPLETED|LTE (104 Weeks)||0
10164877|NCT02975336|11295097|FG006|COMPLETED|LTE (104 Weeks)||0
10164878|NCT02975336|11295098|FG007|COMPLETED|LTE (104 Weeks)||0
10164879|NCT02975336|11295091|FG000|NOT COMPLETED|LTE (104 Weeks)||0
10164880|NCT02975336|11295092|FG001|NOT COMPLETED|LTE (104 Weeks)||0
10164881|NCT02975336|11295093|FG002|NOT COMPLETED|LTE (104 Weeks)||0
10164882|NCT02975336|11295094|FG003|NOT COMPLETED|LTE (104 Weeks)||0
10164883|NCT02975336|11295095|FG004|NOT COMPLETED|LTE (104 Weeks)||62
10164884|NCT02975336|11295096|FG005|NOT COMPLETED|LTE (104 Weeks)||69
10164885|NCT02975336|11295097|FG006|NOT COMPLETED|LTE (104 Weeks)||80
10164886|NCT02975336|11295098|FG007|NOT COMPLETED|LTE (104 Weeks)||72
10164887|NCT02975349|11295117|FG000|STARTED|Active Treatment Period (24 Weeks)||54
10164888|NCT02975349|11295118|FG001|STARTED|Active Treatment Period (24 Weeks)||0
10164889|NCT02975349|11295119|FG002|STARTED|Active Treatment Period (24 Weeks)||52
10164890|NCT02975349|11295120|FG003|STARTED|Active Treatment Period (24 Weeks)||53
10164891|NCT02975349|11295121|FG004|STARTED|Active Treatment Period (24 Weeks)||54
10164892|NCT02975349|11295122|FG005|STARTED|Active Treatment Period (24 Weeks)||54
10164893|NCT02975349|11295117|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49
10164894|NCT02975349|11295118|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0
10164895|NCT02975349|11295119|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47
10164896|NCT02975349|11295120|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48
10164897|NCT02975349|11295121|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48
10164898|NCT02975349|11295122|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52
10164899|NCT02975349|11295117|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
10164900|NCT02975349|11295118|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
10164901|NCT02975349|11295119|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
10164902|NCT02975349|11295120|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
10164903|NCT02975349|11295121|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
10164904|NCT02975349|11295122|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
10164905|NCT02975349|11295117|FG000|STARTED|Blinded Extension Period (24 Weeks)||0
10164906|NCT02975349|11295118|FG001|STARTED|Blinded Extension Period (24 Weeks)||49
10164907|NCT02975349|11295119|FG002|STARTED|Blinded Extension Period (24 Weeks)||47
10164908|NCT02975349|11295120|FG003|STARTED|Blinded Extension Period (24 Weeks)||48
10164909|NCT02975349|11295121|FG004|STARTED|Blinded Extension Period (24 Weeks)||48
10164910|NCT02975349|11295122|FG005|STARTED|Blinded Extension Period (24 Weeks)||52
10164911|NCT02975349|11295117|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0
10164912|NCT02975349|11295118|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42
9711268|NCT03512275|10811055|FG000|STARTED|Overall Study||24
9711269|NCT03512275|10811056|FG001|STARTED|Overall Study||18
9711270|NCT03512275|10811055|FG000|COMPLETED|Overall Study||22
9711271|NCT03512275|10811056|FG001|COMPLETED|Overall Study||11
9711272|NCT03512275|10811055|FG000|NOT COMPLETED|Overall Study||2
9711273|NCT03512275|10811056|FG001|NOT COMPLETED|Overall Study||7
9711274|NCT03414983|10811064|FG000|STARTED|Pre-Treatment||127
9711275|NCT03414983|10811065|FG001|STARTED|Pre-Treatment||68
9711276|NCT03414983|10811064|FG000|COMPLETED|Pre-Treatment||123
9711277|NCT03414983|10811065|FG001|COMPLETED|Pre-Treatment||62
9711278|NCT03414983|10811064|FG000|NOT COMPLETED|Pre-Treatment||4
9711279|NCT03414983|10811065|FG001|NOT COMPLETED|Pre-Treatment||6
9711280|NCT03414983|10811064|FG000|STARTED|Treatment||123
10061200|NCT02102932|11186799|FG002|NOT COMPLETED|Overall Study||0
10061201|NCT02102932|11186800|FG003|NOT COMPLETED|Overall Study||0
10061202|NCT02102932|11186801|FG004|NOT COMPLETED|Overall Study||0
10061203|NCT02102932|11186802|FG005|NOT COMPLETED|Overall Study||0
10061204|NCT02102932|11186803|FG006|NOT COMPLETED|Overall Study||0
10061205|NCT02102932|11186804|FG007|NOT COMPLETED|Overall Study||0
10061206|NCT02103062|11186824|FG000|STARTED|Overall Study||18
10061207|NCT02103062|11186825|FG001|STARTED|Overall Study||23
10061208|NCT02103062|11186824|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
10061209|NCT02103062|11186825|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
10061210|NCT02103062|11186824|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
10061211|NCT02103062|11186825|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
10061212|NCT02103062|11186824|FG000|COMPLETED|Overall Study||0
10061213|NCT02103062|11186825|FG001|COMPLETED|Overall Study||0
10061214|NCT02103062|11186824|FG000|NOT COMPLETED|Overall Study||18
10061215|NCT02103062|11186825|FG001|NOT COMPLETED|Overall Study||23
10061216|NCT02103114|11186835|FG000|STARTED|Overall Study||20
10061217|NCT02103114|11186836|FG001|STARTED|Overall Study||20
10061218|NCT02103114|11186835|FG000|COMPLETED|Overall Study||20
10061219|NCT02103114|11186836|FG001|COMPLETED|Overall Study||19
10061220|NCT02103114|11186835|FG000|NOT COMPLETED|Overall Study||0
10061221|NCT02103114|11186836|FG001|NOT COMPLETED|Overall Study||1
10061222|NCT02103127|11186843|FG000|STARTED|Overall Study||20
10061223|NCT02103127|11186843|FG000|COMPLETED|Overall Study||17
10061224|NCT02103127|11186843|FG000|NOT COMPLETED|Overall Study||3
10061225|NCT02103153|11186847|FG000|STARTED|Overall Study||44
10061226|NCT02103153|11186847|FG000|COMPLETED|Overall Study||27
10061227|NCT02103153|11186847|FG000|NOT COMPLETED|Overall Study||17
10061228|NCT02103218|11186858|FG000|STARTED|Overall Study||51
10061229|NCT02103218|11186859|FG001|STARTED|Overall Study||59
10061230|NCT02103218|11186860|FG002|STARTED|Overall Study||48
10061231|NCT02103218|11186861|FG003|STARTED|Overall Study||54
10061232|NCT02103218|11186858|FG000|COMPLETED|Overall Study||46
10061233|NCT02103218|11186859|FG001|COMPLETED|Overall Study||51
10061234|NCT02103218|11186860|FG002|COMPLETED|Overall Study||44
10061235|NCT02103218|11186861|FG003|COMPLETED|Overall Study||47
10061236|NCT02103218|11186858|FG000|NOT COMPLETED|Overall Study||5
10061237|NCT02103218|11186859|FG001|NOT COMPLETED|Overall Study||8
10061238|NCT02103218|11186860|FG002|NOT COMPLETED|Overall Study||4
10061239|NCT02103218|11186861|FG003|NOT COMPLETED|Overall Study||7
10061240|NCT02103270|11186872|FG000|STARTED|Overall Study||60
10061241|NCT02103270|11186873|FG001|STARTED|Overall Study||35
10164913|NCT02975349|11295119|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43
10164914|NCT02975349|11295120|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44
10164915|NCT02975349|11295121|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46
10164916|NCT02975349|11295122|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52
10164917|NCT02975349|11295117|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
10164918|NCT02975349|11295118|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
10164919|NCT02975349|11295119|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
10164920|NCT02975349|11295120|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
10164921|NCT02975349|11295121|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
10164922|NCT02975349|11295122|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
10164923|NCT02975557|11295144|FG000|STARTED|Overall Study||4
10164924|NCT02975557|11295145|FG001|STARTED|Overall Study||5
10164925|NCT02975557|11295146|FG002|STARTED|Overall Study||6
10164926|NCT02975557|11295144|FG000|COMPLETED|Overall Study||3
10164927|NCT02975557|11295145|FG001|COMPLETED|Overall Study||2
10164928|NCT02975557|11295146|FG002|COMPLETED|Overall Study||5
10164929|NCT02975557|11295144|FG000|NOT COMPLETED|Overall Study||1
10164930|NCT02975557|11295145|FG001|NOT COMPLETED|Overall Study||3
10164931|NCT02975557|11295146|FG002|NOT COMPLETED|Overall Study||1
10164932|NCT02975804|11295156|FG000|STARTED|Overall Study||9
10164933|NCT02975804|11295157|FG001|STARTED|Overall Study||9
10164934|NCT02975804|11295156|FG000|COMPLETED|Overall Study||9
10164935|NCT02975804|11295157|FG001|COMPLETED|Overall Study||9
10164936|NCT02975804|11295156|FG000|NOT COMPLETED|Overall Study||0
10164937|NCT02975804|11295157|FG001|NOT COMPLETED|Overall Study||0
10164938|NCT02975973|11295167|FG000|STARTED|Overall Study||1
10164939|NCT02975973|11295168|FG001|STARTED|Overall Study||2
10164940|NCT02975973|11295169|FG002|STARTED|Overall Study||1
10164941|NCT02975973|11295170|FG003|STARTED|Overall Study||4
10164942|NCT02975973|11295167|FG000|COMPLETED|Overall Study||0
10164943|NCT02975973|11295168|FG001|COMPLETED|Overall Study||1
10164944|NCT02975973|11295169|FG002|COMPLETED|Overall Study||0
10164945|NCT02975973|11295170|FG003|COMPLETED|Overall Study||4
10164946|NCT02975973|11295167|FG000|NOT COMPLETED|Overall Study||1
10164947|NCT02975973|11295168|FG001|NOT COMPLETED|Overall Study||1
10164948|NCT02975973|11295169|FG002|NOT COMPLETED|Overall Study||1
10164949|NCT02975973|11295170|FG003|NOT COMPLETED|Overall Study||0
10164950|NCT02976103|11295182|FG000|STARTED|Overall Study||67
10164951|NCT02976103|11295183|FG001|STARTED|Overall Study||72
10164952|NCT02976103|11295182|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
10164953|NCT02976103|11295183|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
10164954|NCT02976103|11295182|FG000|NOT COMPLETED|Overall Study||13
10164955|NCT02976103|11295183|FG001|NOT COMPLETED|Overall Study||8
10164956|NCT02976181|11295190|FG000|STARTED|Overall Study||113
10164957|NCT02976181|11295190|FG000|COMPLETED|Overall Study||112
10164958|NCT02976181|11295190|FG000|NOT COMPLETED|Overall Study||1
10164959|NCT02976519|11295202|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10164960|NCT02976519|11295203|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10164961|NCT02976519|11295204|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10164962|NCT02976519|11295205|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10164963|NCT02976519|11295206|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10164964|NCT02976519|11295207|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
10164965|NCT02976519|11295208|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
10164966|NCT02976519|11295202|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
10164967|NCT02976519|11295203|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
10164968|NCT02976519|11295204|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
10164969|NCT02976519|11295205|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
10164970|NCT02976519|11295206|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
10164971|NCT02976519|11295207|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
10164972|NCT02976519|11295208|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
10164973|NCT02976519|11295202|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10164974|NCT02976519|11295203|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
10164975|NCT02976519|11295204|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10164976|NCT02976519|11295205|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
10164977|NCT02976519|11295206|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10164978|NCT02976519|11295207|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10164979|NCT02976519|11295208|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
9711281|NCT03414983|10811065|FG001|STARTED|Treatment||62
9711282|NCT03414983|10811064|FG000|COMPLETED|Treatment||4
9711283|NCT03414983|10811065|FG001|COMPLETED|Treatment||2
9711284|NCT03414983|10811064|FG000|NOT COMPLETED|Treatment||119
9711285|NCT03414983|10811065|FG001|NOT COMPLETED|Treatment||60
9711286|NCT03383692|10811073|FG000|STARTED|Overall Study||17
9711287|NCT03383692|10811074|FG001|STARTED|Overall Study||23
10164980|NCT02976519|11295202|FG000|STARTED|Wash-out Period (Part 2 Only)||0
10164981|NCT02976519|11295203|FG001|STARTED|Wash-out Period (Part 2 Only)||0
10164982|NCT02976519|11295204|FG002|STARTED|Wash-out Period (Part 2 Only)||0
10164983|NCT02976519|11295205|FG003|STARTED|Wash-out Period (Part 2 Only)||0
10164984|NCT02976519|11295206|FG004|STARTED|Wash-out Period (Part 2 Only)||0
10164985|NCT02976519|11295207|FG005|STARTED|Wash-out Period (Part 2 Only)||12
10164986|NCT02976519|11295208|FG006|STARTED|Wash-out Period (Part 2 Only)||12
10164987|NCT02976519|11295202|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0
10164988|NCT02976519|11295203|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0
10164989|NCT02976519|11295204|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0
10164990|NCT02976519|11295205|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0
10164991|NCT02976519|11295206|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0
10164992|NCT02976519|11295207|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12
10164993|NCT02976519|11295208|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10
10164994|NCT02976519|11295202|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10164995|NCT02976519|11295203|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10164996|NCT02976519|11295204|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10164997|NCT02976519|11295205|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10164998|NCT02976519|11295206|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10164999|NCT02976519|11295207|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10165000|NCT02976519|11295208|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
10165001|NCT02976519|11295202|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0
10165002|NCT02976519|11295203|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0
10165003|NCT02976519|11295204|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0
10165004|NCT02976519|11295205|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0
10165005|NCT02976519|11295206|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0
10165006|NCT02976519|11295207|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12
10165007|NCT02976519|11295208|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10
10165008|NCT02976519|11295202|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165009|NCT02976519|11295203|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165010|NCT02976519|11295204|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165011|NCT02976519|11295205|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165012|NCT02976519|11295206|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165013|NCT02976519|11295207|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12
10165014|NCT02976519|11295208|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9
10165015|NCT02976519|11295202|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165016|NCT02976519|11295203|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165017|NCT02976519|11295204|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165018|NCT02976519|11295205|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165019|NCT02976519|11295206|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165020|NCT02976519|11295207|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10165021|NCT02976519|11295208|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
10165022|NCT02977507|11295228|FG000|STARTED|Overall Study||8
10165023|NCT02977507|11295229|FG001|STARTED|Overall Study||10
10165024|NCT02977507|11295228|FG000|COMPLETED|Overall Study||6
10165025|NCT02977507|11295229|FG001|COMPLETED|Overall Study||10
10165026|NCT02977507|11295228|FG000|NOT COMPLETED|Overall Study||2
10165027|NCT02977507|11295229|FG001|NOT COMPLETED|Overall Study||0
10165028|NCT02977572|11295238|FG000|STARTED|Overall Study||58
10165029|NCT02977572|11295239|FG001|STARTED|Overall Study||56
10165030|NCT02977572|11295238|FG000|COMPLETED|Overall Study||56
10165031|NCT02977572|11295239|FG001|COMPLETED|Overall Study||54
10165032|NCT02977572|11295238|FG000|NOT COMPLETED|Overall Study||2
10165033|NCT02977572|11295239|FG001|NOT COMPLETED|Overall Study||2
10165034|NCT02978157|11295251|FG000|STARTED|Overall Study||52
10165035|NCT02978157|11295252|FG001|STARTED|Overall Study||50
10165036|NCT02978157|11295251|FG000|COMPLETED|Overall Study||52
10165037|NCT02978157|11295252|FG001|COMPLETED|Overall Study||50
10165038|NCT02978157|11295251|FG000|NOT COMPLETED|Overall Study||0
10165039|NCT02978157|11295252|FG001|NOT COMPLETED|Overall Study||0
10165040|NCT02978183|11295260|FG000|STARTED|Overall Study||34
10165041|NCT02978183|11295261|FG001|STARTED|Overall Study||36
10165042|NCT02978183|11295260|FG000|COMPLETED|Overall Study||34
10165043|NCT02978183|11295261|FG001|COMPLETED|Overall Study||36
10165044|NCT02978183|11295260|FG000|NOT COMPLETED|Overall Study||0
10165045|NCT02978183|11295261|FG001|NOT COMPLETED|Overall Study||0
10165046|NCT02978339|11295267|FG000|STARTED|Overall Study||15
10165047|NCT02978339|11295267|FG000|COMPLETED|Overall Study||15
10165048|NCT02978339|11295267|FG000|NOT COMPLETED|Overall Study||0
10165049|NCT02978417|11295273|FG000|STARTED|Overall Study||5
10165050|NCT02978417|11295274|FG001|STARTED|Overall Study||5
10165051|NCT02978417|11295273|FG000|COMPLETED|Overall Study||3
10165052|NCT02978417|11295274|FG001|COMPLETED|Overall Study||3
10165053|NCT02978417|11295273|FG000|NOT COMPLETED|Overall Study||2
10165054|NCT02978417|11295274|FG001|NOT COMPLETED|Overall Study||2
10165055|NCT02978508|11295282|FG000|STARTED|Overall Study||70
10165056|NCT02978508|11295283|FG001|STARTED|Overall Study||70
10165057|NCT02978508|11295282|FG000|COMPLETED|Overall Study||70
10165058|NCT02978508|11295283|FG001|COMPLETED|Overall Study||70
10165059|NCT02978508|11295282|FG000|NOT COMPLETED|Overall Study||0
10165060|NCT02978508|11295283|FG001|NOT COMPLETED|Overall Study||0
10165061|NCT02979054|11295291|FG000|STARTED|Overall Study||71
10165062|NCT02979054|11295292|FG001|STARTED|Overall Study||64
10165063|NCT02979054|11295291|FG000|COMPLETED|Overall Study||71
10165064|NCT02979054|11295292|FG001|COMPLETED|Overall Study||64
9711288|NCT03383692|10811073|FG000|COMPLETED|Overall Study||11
9711289|NCT03383692|10811074|FG001|COMPLETED|Overall Study||19
9711290|NCT03383692|10811073|FG000|NOT COMPLETED|Overall Study||6
9711291|NCT03383692|10811074|FG001|NOT COMPLETED|Overall Study||4
9711292|NCT03371251|10811088|FG000|STARTED|Overall Study||7
9711293|NCT03371251|10811089|FG001|STARTED|Overall Study||5
9711294|NCT03371251|10811090|FG002|STARTED|Overall Study||9
9711295|NCT03371251|10811091|FG003|STARTED|Overall Study||9
9711296|NCT03371251|10811092|FG004|STARTED|Overall Study||37
9711297|NCT03371251|10811093|FG005|STARTED|Overall Study||76
9711298|NCT03371251|10811088|FG000|COMPLETED|Overall Study||5
9711299|NCT03371251|10811089|FG001|COMPLETED|Overall Study||5
9711300|NCT03371251|10811090|FG002|COMPLETED|Overall Study||8
9711301|NCT03371251|10811091|FG003|COMPLETED|Overall Study||9
9711302|NCT03371251|10811092|FG004|COMPLETED|Overall Study||30
9711303|NCT03371251|10811093|FG005|COMPLETED|Overall Study||71
9711304|NCT03371251|10811088|FG000|NOT COMPLETED|Overall Study||2
9711305|NCT03371251|10811089|FG001|NOT COMPLETED|Overall Study||0
9711306|NCT03371251|10811090|FG002|NOT COMPLETED|Overall Study||1
9711307|NCT03371251|10811091|FG003|NOT COMPLETED|Overall Study||0
9711308|NCT03371251|10811092|FG004|NOT COMPLETED|Overall Study||7
9711309|NCT03371251|10811093|FG005|NOT COMPLETED|Overall Study||5
9711310|NCT03349268|10811113|FG000|STARTED|Overall Study||9117
9711311|NCT03349268|10811114|FG001|STARTED|Overall Study||10296
9711312|NCT03349268|10811115|FG002|STARTED|Overall Study||6319
9711313|NCT03349268|10811113|FG000|COMPLETED|Overall Study||9117
9711314|NCT03349268|10811114|FG001|COMPLETED|Overall Study||10296
9711315|NCT03349268|10811115|FG002|COMPLETED|Overall Study||6319
9711316|NCT03349268|10811113|FG000|NOT COMPLETED|Overall Study||0
9711317|NCT03349268|10811114|FG001|NOT COMPLETED|Overall Study||0
10061242|NCT02103270|11186874|FG002|STARTED|Overall Study||25
10061243|NCT02103270|11186872|FG000|COMPLETED|Overall Study||51
10061244|NCT02103270|11186873|FG001|COMPLETED|Overall Study||29
10061245|NCT02103270|11186874|FG002|COMPLETED|Overall Study||1
10061246|NCT02103270|11186872|FG000|NOT COMPLETED|Overall Study||9
10061247|NCT02103270|11186873|FG001|NOT COMPLETED|Overall Study||6
10061248|NCT02103270|11186874|FG002|NOT COMPLETED|Overall Study||24
10061249|NCT02103309|11186885|FG000|STARTED|Overall Study||20
10061250|NCT02103309|11186886|FG001|STARTED|Overall Study||22
10061251|NCT02103309|11186885|FG000|COMPLETED|Overall Study||20
10061252|NCT02103309|11186886|FG001|COMPLETED|Overall Study||22
10061253|NCT02103309|11186885|FG000|NOT COMPLETED|Overall Study||0
10061254|NCT02103309|11186886|FG001|NOT COMPLETED|Overall Study||0
10061255|NCT02103439|11186894|FG000|STARTED|Overall Study||70
10061256|NCT02103439|11186895|FG001|STARTED|Overall Study||70
10061257|NCT02103439|11186894|FG000|COMPLETED|Overall Study||67
10061258|NCT02103439|11186895|FG001|COMPLETED|Overall Study||67
10061259|NCT02103439|11186894|FG000|NOT COMPLETED|Overall Study||3
10061260|NCT02103439|11186895|FG001|NOT COMPLETED|Overall Study||3
10061261|NCT02103478|11186912|FG000|STARTED|Overall Study||7
10061262|NCT02103478|11186913|FG001|STARTED|Overall Study||6
10061263|NCT02103478|11186914|FG002|STARTED|Overall Study||6
10061264|NCT02103478|11186915|FG003|STARTED|Overall Study||6
10061265|NCT02103478|11186916|FG004|STARTED|Overall Study||19
10061266|NCT02103478|11186917|FG005|STARTED|Overall Study||25
10061267|NCT02103478|11186918|FG006|STARTED|Overall Study||25
10061268|NCT02103478|11186919|FG007|STARTED|Overall Study||16
10061269|NCT02103478|11186920|FG008|STARTED|Overall Study||14
10061270|NCT02103478|11186912|FG000|COMPLETED|Overall Study||0
10061271|NCT02103478|11186913|FG001|COMPLETED|Overall Study||0
10061272|NCT02103478|11186914|FG002|COMPLETED|Overall Study||0
10061273|NCT02103478|11186915|FG003|COMPLETED|Overall Study||0
10061274|NCT02103478|11186916|FG004|COMPLETED|Overall Study||0
10061275|NCT02103478|11186917|FG005|COMPLETED|Overall Study||0
10061276|NCT02103478|11186918|FG006|COMPLETED|Overall Study||0
10061277|NCT02103478|11186919|FG007|COMPLETED|Overall Study||0
10061278|NCT02103478|11186920|FG008|COMPLETED|Overall Study||0
9711318|NCT03349268|10811115|FG002|NOT COMPLETED|Overall Study||0
9711319|NCT03307785|10811133|FG000|STARTED|Part A: Up to 28.5 Months||16
9711320|NCT03307785|10811134|FG001|STARTED|Part A: Up to 28.5 Months||6
9711321|NCT03307785|10811135|FG002|STARTED|Part A: Up to 28.5 Months||0
9711322|NCT03307785|10811136|FG003|STARTED|Part A: Up to 28.5 Months||0
9711323|NCT03307785|10811137|FG004|STARTED|Part A: Up to 28.5 Months||0
9711324|NCT03307785|10811138|FG005|STARTED|Part A: Up to 28.5 Months||0
9711325|NCT03307785|10811139|FG006|STARTED|Part A: Up to 28.5 Months||0
9711326|NCT03307785|10811140|FG007|STARTED|Part A: Up to 28.5 Months||0
9711327|NCT03307785|10811141|FG008|STARTED|Part A: Up to 28.5 Months||0
9711328|NCT03307785|10811142|FG009|STARTED|Part A: Up to 28.5 Months||0
9711329|NCT03307785|10811143|FG010|STARTED|Part A: Up to 28.5 Months||0
10061279|NCT02103478|11186912|FG000|NOT COMPLETED|Overall Study||7
9711330|NCT03307785|10811133|FG000|COMPLETED|Part A: Up to 28.5 Months||0
9711331|NCT03307785|10811134|FG001|COMPLETED|Part A: Up to 28.5 Months||0
9711332|NCT03307785|10811135|FG002|COMPLETED|Part A: Up to 28.5 Months||0
10061280|NCT02103478|11186913|FG001|NOT COMPLETED|Overall Study||6
10061281|NCT02103478|11186914|FG002|NOT COMPLETED|Overall Study||6
10061282|NCT02103478|11186915|FG003|NOT COMPLETED|Overall Study||6
10061283|NCT02103478|11186916|FG004|NOT COMPLETED|Overall Study||19
10061284|NCT02103478|11186917|FG005|NOT COMPLETED|Overall Study||25
10061285|NCT02103478|11186918|FG006|NOT COMPLETED|Overall Study||25
10061286|NCT02103478|11186919|FG007|NOT COMPLETED|Overall Study||16
10165065|NCT02979054|11295291|FG000|NOT COMPLETED|Overall Study||0
10165066|NCT02979054|11295292|FG001|NOT COMPLETED|Overall Study||0
10165067|NCT02979197|11295301|FG000|STARTED|Overall Study||48
10165068|NCT02979197|11295302|FG001|STARTED|Overall Study||49
10165069|NCT02979197|11295303|FG002|STARTED|Overall Study||8
10165070|NCT02979197|11295301|FG000|COMPLETED|Overall Study||44
10165071|NCT02979197|11295302|FG001|COMPLETED|Overall Study||45
10165072|NCT02979197|11295303|FG002|COMPLETED|Overall Study||8
10165073|NCT02979197|11295301|FG000|NOT COMPLETED|Overall Study||4
10165074|NCT02979197|11295302|FG001|NOT COMPLETED|Overall Study||4
10165075|NCT02979197|11295303|FG002|NOT COMPLETED|Overall Study||0
10165076|NCT02979249|11295311|FG000|STARTED|Overall Study||16
10165077|NCT02979249|11295311|FG000|COMPLETED|Overall Study||10
10165078|NCT02979249|11295311|FG000|NOT COMPLETED|Overall Study||6
10165079|NCT02979262|11295317|FG000|STARTED|Overall Study||33
10165080|NCT02979262|11295318|FG001|STARTED|Overall Study||29
10165081|NCT02979262|11295317|FG000|Received Allocated Intervention|Overall Study||30
10165082|NCT02979262|11295318|FG001|Received Allocated Intervention|Overall Study||27
10165083|NCT02979262|11295317|FG000|COMPLETED|Overall Study||21
10165084|NCT02979262|11295318|FG001|COMPLETED|Overall Study||20
10165085|NCT02979262|11295317|FG000|NOT COMPLETED|Overall Study||12
10165086|NCT02979262|11295318|FG001|NOT COMPLETED|Overall Study||9
10165087|NCT02979301|11295326|FG000|STARTED|Overall Study||11
10165088|NCT02979301|11295327|FG001|STARTED|Overall Study||11
10165089|NCT02979301|11295326|FG000|COMPLETED|Overall Study||10
10165090|NCT02979301|11295327|FG001|COMPLETED|Overall Study||11
10165091|NCT02979301|11295326|FG000|NOT COMPLETED|Overall Study||1
10165092|NCT02979301|11295327|FG001|NOT COMPLETED|Overall Study||0
10165093|NCT02979431|11295337|FG000|STARTED|Overall Study||44
10165094|NCT02979431|11295338|FG001|STARTED|Overall Study||46
10165095|NCT02979431|11295339|FG002|STARTED|Overall Study||45
10165096|NCT02979431|11295340|FG003|STARTED|Overall Study||45
10165097|NCT02979431|11295337|FG000|Included in the mITT Population|Overall Study||42
10165098|NCT02979431|11295338|FG001|Included in the mITT Population|Overall Study||45
10165099|NCT02979431|11295339|FG002|Included in the mITT Population|Overall Study||43
10165100|NCT02979431|11295340|FG003|Included in the mITT Population|Overall Study||45
10165101|NCT02979431|11295337|FG000|Included in the Safety Population|Overall Study||40
10165102|NCT02979431|11295338|FG001|Included in the Safety Population|Overall Study||45
10165103|NCT02979431|11295339|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
10165104|NCT02979431|11295340|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
10165105|NCT02979431|11295337|FG000|COMPLETED|Overall Study||40
10165106|NCT02979431|11295338|FG001|COMPLETED|Overall Study||44
10165107|NCT02979431|11295339|FG002|COMPLETED|Overall Study||43
10165108|NCT02979431|11295340|FG003|COMPLETED|Overall Study||44
10165109|NCT02979431|11295337|FG000|NOT COMPLETED|Overall Study||4
10165110|NCT02979431|11295338|FG001|NOT COMPLETED|Overall Study||2
10165111|NCT02979431|11295339|FG002|NOT COMPLETED|Overall Study||2
10165112|NCT02979431|11295340|FG003|NOT COMPLETED|Overall Study||1
10165113|NCT02979444|11295353|FG000|STARTED|Overall Study||405
10165114|NCT02979444|11295354|FG001|STARTED|Overall Study||310
10165115|NCT02979444|11295355|FG002|STARTED|Overall Study||159
10165116|NCT02979444|11295353|FG000|COMPLETED|Overall Study||382
10165117|NCT02979444|11295354|FG001|COMPLETED|Overall Study||293
10165118|NCT02979444|11295355|FG002|COMPLETED|Overall Study||149
10165119|NCT02979444|11295353|FG000|NOT COMPLETED|Overall Study||23
10165120|NCT02979444|11295354|FG001|NOT COMPLETED|Overall Study||17
10165121|NCT02979444|11295355|FG002|NOT COMPLETED|Overall Study||10
10165122|NCT02979613|11295365|FG000|STARTED|Double-Blind Phase||245
10165123|NCT02979613|11295366|FG001|STARTED|Double-Blind Phase||245
10165124|NCT02979613|11295365|FG000|COMPLETED|Double-Blind Phase||235
10165125|NCT02979613|11295366|FG001|COMPLETED|Double-Blind Phase||237
10165126|NCT02979613|11295365|FG000|NOT COMPLETED|Double-Blind Phase||10
10165127|NCT02979613|11295366|FG001|NOT COMPLETED|Double-Blind Phase||8
10165128|NCT02979613|11295365|FG000|STARTED|Open-Label Extension (OLE) Phase||235
10165129|NCT02979613|11295366|FG001|STARTED|Open-Label Extension (OLE) Phase||237
10165130|NCT02979613|11295365|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232
10165131|NCT02979613|11295366|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231
10165132|NCT02979613|11295365|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
10165133|NCT02979613|11295366|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
10165134|NCT02979626|11295376|FG000|STARTED|Overall Study||313
10165135|NCT02979626|11295377|FG001|STARTED|Overall Study||98
10165136|NCT02979626|11295376|FG000|COMPLETED|Overall Study||313
10165137|NCT02979626|11295377|FG001|COMPLETED|Overall Study||98
10165138|NCT02979626|11295376|FG000|NOT COMPLETED|Overall Study||0
10165139|NCT02979626|11295377|FG001|NOT COMPLETED|Overall Study||0
10165140|NCT02979639|11295383|FG000|STARTED|Overall Study||401
10165141|NCT02979639|11295383|FG000|COMPLETED|Overall Study||387
10165142|NCT02979639|11295383|FG000|NOT COMPLETED|Overall Study||14
10165143|NCT02979899|11295389|FG000|STARTED|Overall Study||64
10165144|NCT02979899|11295390|FG001|STARTED|Overall Study||64
10165145|NCT02979899|11295389|FG000|COMPLETED|Overall Study||64
10165146|NCT02979899|11295390|FG001|COMPLETED|Overall Study||64
10165147|NCT02979899|11295389|FG000|NOT COMPLETED|Overall Study||0
10165148|NCT02979899|11295390|FG001|NOT COMPLETED|Overall Study||0
10165149|NCT02979925|11295398|FG000|STARTED|Overall Study||28
10165150|NCT02979925|11295399|FG001|STARTED|Overall Study||29
10165151|NCT02979925|11295398|FG000|COMPLETED|Overall Study||28
10165152|NCT02979925|11295399|FG001|COMPLETED|Overall Study||23
10165153|NCT02979925|11295398|FG000|NOT COMPLETED|Overall Study||0
10165154|NCT02979925|11295399|FG001|NOT COMPLETED|Overall Study||6
10165155|NCT02980042|11295407|FG000|STARTED|Overall Study||100
10165156|NCT02980042|11295408|FG001|STARTED|Overall Study||100
10165157|NCT02980042|11295407|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
10165158|NCT02980042|11295408|FG001|COMPLETED|Overall Study||100
10165159|NCT02980042|11295407|FG000|NOT COMPLETED|Overall Study||7
10165160|NCT02980042|11295408|FG001|NOT COMPLETED|Overall Study||0
10165161|NCT02980107|11295428|FG000|STARTED|Overall Study||105
10165162|NCT02980107|11295429|FG001|STARTED|Overall Study||107
10165163|NCT02980107|11295428|FG000|COMPLETED|Overall Study||54
10165164|NCT02980107|11295429|FG001|COMPLETED|Overall Study||45
10165165|NCT02980107|11295428|FG000|NOT COMPLETED|Overall Study||51
10165166|NCT02980107|11295429|FG001|NOT COMPLETED|Overall Study||62
10165167|NCT02980133|11295439|FG000|STARTED|Overall Study||209
10165168|NCT02980133|11295440|FG001|STARTED|Overall Study||211
10165169|NCT02980133|11295441|FG002|STARTED|Overall Study||210
10165170|NCT02980133|11295442|FG003|STARTED|Overall Study||211
10165171|NCT02980133|11295439|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209
10165172|NCT02980133|11295440|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211
10165173|NCT02980133|11295441|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208
10165174|NCT02980133|11295442|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211
10165175|NCT02980133|11295439|FG000|COMPLETED|Overall Study||202
10165176|NCT02980133|11295440|FG001|COMPLETED|Overall Study||206
10165177|NCT02980133|11295441|FG002|COMPLETED|Overall Study||203
10165178|NCT02980133|11295442|FG003|COMPLETED|Overall Study||205
10165179|NCT02980133|11295439|FG000|NOT COMPLETED|Overall Study||7
10165180|NCT02980133|11295440|FG001|NOT COMPLETED|Overall Study||5
10165181|NCT02980133|11295441|FG002|NOT COMPLETED|Overall Study||7
10165182|NCT02980133|11295442|FG003|NOT COMPLETED|Overall Study||6
10165183|NCT02980211|11295455|FG000|STARTED|Overall Study||17
10165184|NCT02980211|11295455|FG000|COMPLETED|Overall Study||17
10165185|NCT02980211|11295455|FG000|NOT COMPLETED|Overall Study||0
10165186|NCT02980224|11295461|FG000|STARTED|Overall Study||89
10165187|NCT02980224|11295462|FG001|STARTED|Overall Study||91
10165188|NCT02980224|11295461|FG000|COMPLETED|Overall Study||85
10165189|NCT02980224|11295462|FG001|COMPLETED|Overall Study||88
10165190|NCT02980224|11295461|FG000|NOT COMPLETED|Overall Study||4
10165191|NCT02980224|11295462|FG001|NOT COMPLETED|Overall Study||3
10165192|NCT02980523|11295473|FG000|STARTED|Overall Study||30
10165193|NCT02980523|11295474|FG001|STARTED|Overall Study||30
10165194|NCT02980523|11295475|FG002|STARTED|Overall Study||30
10165195|NCT02980523|11295476|FG003|STARTED|Overall Study||30
10165196|NCT02980523|11295477|FG004|STARTED|Overall Study||30
10165197|NCT02980523|11295473|FG000|COMPLETED|Overall Study||27
10165198|NCT02980523|11295474|FG001|COMPLETED|Overall Study||19
10165199|NCT02980523|11295475|FG002|COMPLETED|Overall Study||24
10165200|NCT02980523|11295476|FG003|COMPLETED|Overall Study||21
10165201|NCT02980523|11295477|FG004|COMPLETED|Overall Study||20
10165202|NCT02980523|11295473|FG000|NOT COMPLETED|Overall Study||3
10165203|NCT02980523|11295474|FG001|NOT COMPLETED|Overall Study||11
10165204|NCT02980523|11295475|FG002|NOT COMPLETED|Overall Study||6
10165205|NCT02980523|11295476|FG003|NOT COMPLETED|Overall Study||9
10165206|NCT02980523|11295477|FG004|NOT COMPLETED|Overall Study||10
10165207|NCT02980601|11295494|FG000|STARTED|Overall Study||6
10165208|NCT02980601|11295495|FG001|STARTED|Overall Study||4
10165209|NCT02980601|11295494|FG000|COMPLETED|Overall Study||1
10165210|NCT02980601|11295495|FG001|COMPLETED|Overall Study||1
10165211|NCT02980601|11295494|FG000|NOT COMPLETED|Overall Study||5
10165212|NCT02980601|11295495|FG001|NOT COMPLETED|Overall Study||3
10165213|NCT02980692|11295506|FG000|STARTED|Overall Study||78
10165214|NCT02980692|11295507|FG001|STARTED|Overall Study||79
10165215|NCT02980692|11295508|FG002|STARTED|Overall Study||77
10165216|NCT02980692|11295509|FG003|STARTED|Overall Study||78
10165217|NCT02980692|11295510|FG004|STARTED|Overall Study||79
10165218|NCT02980692|11295506|FG000|COMPLETED|Overall Study||69
10165219|NCT02980692|11295507|FG001|COMPLETED|Overall Study||73
10165220|NCT02980692|11295508|FG002|COMPLETED|Overall Study||65
10165221|NCT02980692|11295509|FG003|COMPLETED|Overall Study||69
10165222|NCT02980692|11295510|FG004|COMPLETED|Overall Study||68
10165223|NCT02980692|11295506|FG000|NOT COMPLETED|Overall Study||9
10165224|NCT02980692|11295507|FG001|NOT COMPLETED|Overall Study||6
10165225|NCT02980692|11295508|FG002|NOT COMPLETED|Overall Study||12
10165226|NCT02980692|11295509|FG003|NOT COMPLETED|Overall Study||9
10165227|NCT02980692|11295510|FG004|NOT COMPLETED|Overall Study||11
10165228|NCT02980705|11295525|FG000|STARTED|Overall Study||50
10165229|NCT02980705|11295526|FG001|STARTED|Overall Study||51
10165230|NCT02980705|11295525|FG000|COMPLETED|Overall Study||42
10165231|NCT02980705|11295526|FG001|COMPLETED|Overall Study||40
10165232|NCT02980705|11295525|FG000|NOT COMPLETED|Overall Study||8
10165233|NCT02980705|11295526|FG001|NOT COMPLETED|Overall Study||11
10165234|NCT02980783|11295533|FG000|STARTED|Overall Study||53
10165235|NCT02980783|11295533|FG000|COMPLETED|Overall Study||52
10165236|NCT02980783|11295533|FG000|NOT COMPLETED|Overall Study||1
10165237|NCT02980874|11295539|FG000|STARTED|Overall Study||231
10165238|NCT02980874|11295540|FG001|STARTED|Overall Study||229
10165239|NCT02980874|11295539|FG000|COMPLETED|Overall Study||128
10165240|NCT02980874|11295540|FG001|COMPLETED|Overall Study||127
10165241|NCT02980874|11295539|FG000|NOT COMPLETED|Overall Study||103
10165242|NCT02980874|11295540|FG001|NOT COMPLETED|Overall Study||102
10165243|NCT02980978|11295548|FG000|STARTED|Overall Study||60
10165244|NCT02980978|11295549|FG001|STARTED|Overall Study||58
10165245|NCT02980978|11295548|FG000|COMPLETED|Overall Study||54
10165246|NCT02980978|11295549|FG001|COMPLETED|Overall Study||50
10165247|NCT02980978|11295548|FG000|NOT COMPLETED|Overall Study||6
10165248|NCT02980978|11295549|FG001|NOT COMPLETED|Overall Study||8
10165249|NCT02981342|11295559|FG000|STARTED|Overall Study||7
10165250|NCT02981342|11295560|FG001|STARTED|Overall Study||33
10165251|NCT02981342|11295561|FG002|STARTED|Overall Study||33
10165252|NCT02981342|11295562|FG003|STARTED|Overall Study||33
10165253|NCT02981342|11295559|FG000|Received at Least One Dose of Study Drug|Overall Study||7
10165254|NCT02981342|11295560|FG001|Received at Least One Dose of Study Drug|Overall Study||32
10165255|NCT02981342|11295561|FG002|Received at Least One Dose of Study Drug|Overall Study||33
10165256|NCT02981342|11295562|FG003|Received at Least One Dose of Study Drug|Overall Study||26
10165257|NCT02981342|11295559|FG000|COMPLETED|Overall Study||7
10165258|NCT02981342|11295560|FG001|COMPLETED|Overall Study||22
10165259|NCT02981342|11295561|FG002|COMPLETED|Overall Study||20
10165260|NCT02981342|11295562|FG003|COMPLETED|Overall Study||19
10165261|NCT02981342|11295559|FG000|NOT COMPLETED|Overall Study||0
10165262|NCT02981342|11295560|FG001|NOT COMPLETED|Overall Study||11
10165263|NCT02981342|11295561|FG002|NOT COMPLETED|Overall Study||13
10165264|NCT02981342|11295562|FG003|NOT COMPLETED|Overall Study||14
10165265|NCT02981368|11295576|FG000|STARTED|Overall Study||268
10165266|NCT02981368|11295577|FG001|STARTED|Overall Study||117
10165267|NCT02981368|11295576|FG000|COMPLETED|Overall Study||248
10165268|NCT02981368|11295577|FG001|COMPLETED|Overall Study||102
10165269|NCT02981368|11295576|FG000|NOT COMPLETED|Overall Study||20
10165270|NCT02981368|11295577|FG001|NOT COMPLETED|Overall Study||15
10165271|NCT02981524|11295610|FG000|STARTED|Overall Study||17
10165272|NCT02981524|11295610|FG000|COMPLETED|Overall Study||0
10165273|NCT02981524|11295610|FG000|NOT COMPLETED|Overall Study||17
10165274|NCT02981602|11295619|FG000|STARTED|Overall Study||6
10165275|NCT02981602|11295620|FG001|STARTED|Overall Study||12
10165276|NCT02981602|11295621|FG002|STARTED|Overall Study||6
10165277|NCT02981602|11295622|FG003|STARTED|Overall Study||5
10165278|NCT02981602|11295623|FG004|STARTED|Overall Study||2
10165279|NCT02981602|11295619|FG000|COMPLETED|Overall Study||6
10165280|NCT02981602|11295620|FG001|COMPLETED|Overall Study||12
10165281|NCT02981602|11295621|FG002|COMPLETED|Overall Study||6
10165282|NCT02981602|11295622|FG003|COMPLETED|Overall Study||4
10165283|NCT02981602|11295623|FG004|COMPLETED|Overall Study||2
10165284|NCT02981602|11295619|FG000|NOT COMPLETED|Overall Study||0
10165285|NCT02981602|11295620|FG001|NOT COMPLETED|Overall Study||0
10165286|NCT02981602|11295621|FG002|NOT COMPLETED|Overall Study||0
10165287|NCT02981602|11295622|FG003|NOT COMPLETED|Overall Study||1
10165288|NCT02981602|11295623|FG004|NOT COMPLETED|Overall Study||0
10165289|NCT02981953|11295636|FG000|STARTED|Overall Study||40
10165290|NCT02981953|11295636|FG000|COMPLETED|Overall Study||29
10165291|NCT02981953|11295636|FG000|NOT COMPLETED|Overall Study||11
10165292|NCT02982018|11295642|FG000|STARTED|Overall Study||67
10165293|NCT02982018|11295643|FG001|STARTED|Overall Study||64
10165294|NCT02982018|11295642|FG000|COMPLETED|Overall Study||62
10165295|NCT02982018|11295643|FG001|COMPLETED|Overall Study||61
10165296|NCT02982018|11295642|FG000|NOT COMPLETED|Overall Study||5
10165297|NCT02982018|11295643|FG001|NOT COMPLETED|Overall Study||3
10165298|NCT02982187|11295651|FG000|STARTED|Overall Study||20
10165299|NCT02982187|11295652|FG001|STARTED|Overall Study||20
10165300|NCT02982187|11295653|FG002|STARTED|Overall Study||20
10165301|NCT02982187|11295654|FG003|STARTED|Overall Study||20
10165302|NCT02982187|11295655|FG004|STARTED|Overall Study||20
10165303|NCT02982187|11295656|FG005|STARTED|Overall Study||20
10165304|NCT02982187|11295657|FG006|STARTED|Overall Study||20
10165305|NCT02982187|11295658|FG007|STARTED|Overall Study||20
10165306|NCT02982187|11295651|FG000|COMPLETED|Overall Study||20
10165307|NCT02982187|11295652|FG001|COMPLETED|Overall Study||20
10165308|NCT02982187|11295653|FG002|COMPLETED|Overall Study||20
10165309|NCT02982187|11295654|FG003|COMPLETED|Overall Study||20
10165310|NCT02982187|11295655|FG004|COMPLETED|Overall Study||20
10165311|NCT02982187|11295656|FG005|COMPLETED|Overall Study||20
10165312|NCT02982187|11295657|FG006|COMPLETED|Overall Study||19
10061287|NCT02103478|11186920|FG008|NOT COMPLETED|Overall Study||14
10061288|NCT02103608|11186950|FG000|STARTED|Overall Study||17
10061289|NCT02103608|11186950|FG000|COMPLETED|Overall Study||15
10061290|NCT02103608|11186950|FG000|NOT COMPLETED|Overall Study||2
10061291|NCT02103816|11186954|FG000|STARTED|Overall Study||21
10061292|NCT02103816|11186954|FG000|COMPLETED|Overall Study||13
10061293|NCT02103816|11186954|FG000|NOT COMPLETED|Overall Study||8
10061294|NCT02103855|11186958|FG000|STARTED|Overall Study||6
10061295|NCT02103855|11186958|FG000|COMPLETED|Overall Study||4
10061296|NCT02103855|11186958|FG000|NOT COMPLETED|Overall Study||2
10061297|NCT02104141|11186962|FG000|STARTED|Overall Study||51
10061298|NCT02104141|11186962|FG000|COMPLETED|Overall Study||51
10061299|NCT02104141|11186962|FG000|NOT COMPLETED|Overall Study||0
10061300|NCT02104167|11186966|FG000|STARTED|Overall Study||110
10165313|NCT02982187|11295658|FG007|COMPLETED|Overall Study||20
10165314|NCT02982187|11295651|FG000|NOT COMPLETED|Overall Study||0
10165315|NCT02982187|11295652|FG001|NOT COMPLETED|Overall Study||0
10165316|NCT02982187|11295653|FG002|NOT COMPLETED|Overall Study||0
10165317|NCT02982187|11295654|FG003|NOT COMPLETED|Overall Study||0
10061301|NCT02104167|11186966|FG000|COMPLETED|Overall Study||110
10061302|NCT02104167|11186966|FG000|NOT COMPLETED|Overall Study||0
10165318|NCT02982187|11295655|FG004|NOT COMPLETED|Overall Study||0
10165319|NCT02982187|11295656|FG005|NOT COMPLETED|Overall Study||0
10165320|NCT02982187|11295657|FG006|NOT COMPLETED|Overall Study||1
10165321|NCT02982187|11295658|FG007|NOT COMPLETED|Overall Study||0
10165322|NCT02982213|11295670|FG000|STARTED|Overall Study||75
10165323|NCT02982213|11295671|FG001|STARTED|Overall Study||75
10165324|NCT02982213|11295670|FG000|COMPLETED|Overall Study||70
10165325|NCT02982213|11295671|FG001|COMPLETED|Overall Study||74
10165326|NCT02982213|11295670|FG000|NOT COMPLETED|Overall Study||5
10165327|NCT02982213|11295671|FG001|NOT COMPLETED|Overall Study||1
10165328|NCT02982239|11295679|FG000|STARTED|Overall Study||20
10165329|NCT02982239|11295680|FG001|STARTED|Overall Study||20
10165330|NCT02982239|11295679|FG000|COMPLETED|Overall Study||17
10165331|NCT02982239|11295680|FG001|COMPLETED|Overall Study||18
10165332|NCT02982239|11295679|FG000|NOT COMPLETED|Overall Study||3
10165333|NCT02982239|11295680|FG001|NOT COMPLETED|Overall Study||2
10165334|NCT02982590|11295689|FG000|STARTED|Overall Study||13
10165335|NCT02982590|11295690|FG001|STARTED|Overall Study||14
10165336|NCT02982590|11295689|FG000|COMPLETED|Overall Study||9
10165337|NCT02982590|11295690|FG001|COMPLETED|Overall Study||13
10165338|NCT02982590|11295689|FG000|NOT COMPLETED|Overall Study||4
10165339|NCT02982590|11295690|FG001|NOT COMPLETED|Overall Study||1
10165340|NCT02982772|11295698|FG000|STARTED|Enrollment||245
10165341|NCT02982772|11295699|FG001|STARTED|Enrollment||243
10165342|NCT02982772|11295698|FG000|COMPLETED|Enrollment||245
10165343|NCT02982772|11295699|FG001|COMPLETED|Enrollment||243
10165344|NCT02982772|11295698|FG000|NOT COMPLETED|Enrollment||0
10165345|NCT02982772|11295699|FG001|NOT COMPLETED|Enrollment||0
10165346|NCT02982772|11295698|FG000|STARTED|Intervention||245
10165347|NCT02982772|11295699|FG001|STARTED|Intervention||243
10165348|NCT02982772|11295698|FG000|COMPLETED|Intervention||226
10165349|NCT02982772|11295699|FG001|COMPLETED|Intervention||230
10165350|NCT02982772|11295698|FG000|NOT COMPLETED|Intervention||19
10165351|NCT02982772|11295699|FG001|NOT COMPLETED|Intervention||13
10165352|NCT02982772|11295698|FG000|STARTED|1M Follow-Up||226
10165353|NCT02982772|11295699|FG001|STARTED|1M Follow-Up||230
10165354|NCT02982772|11295698|FG000|COMPLETED|1M Follow-Up||205
10165355|NCT02982772|11295699|FG001|COMPLETED|1M Follow-Up||212
10165356|NCT02982772|11295698|FG000|NOT COMPLETED|1M Follow-Up||21
10165357|NCT02982772|11295699|FG001|NOT COMPLETED|1M Follow-Up||18
10165358|NCT02982772|11295698|FG000|STARTED|3M Follow-Up||205
10165359|NCT02982772|11295699|FG001|STARTED|3M Follow-Up||212
10165360|NCT02982772|11295698|FG000|COMPLETED|3M Follow-Up||188
10165361|NCT02982772|11295699|FG001|COMPLETED|3M Follow-Up||201
10165362|NCT02982772|11295698|FG000|NOT COMPLETED|3M Follow-Up||17
10165363|NCT02982772|11295699|FG001|NOT COMPLETED|3M Follow-Up||11
10165364|NCT02982772|11295698|FG000|STARTED|6M Follow-Up||188
10165365|NCT02982772|11295699|FG001|STARTED|6M Follow-Up||201
10165366|NCT02982772|11295698|FG000|COMPLETED|6M Follow-Up||177
10165367|NCT02982772|11295699|FG001|COMPLETED|6M Follow-Up||192
10165368|NCT02982772|11295698|FG000|NOT COMPLETED|6M Follow-Up||11
10165369|NCT02982772|11295699|FG001|NOT COMPLETED|6M Follow-Up||9
10165370|NCT02982772|11295698|FG000|STARTED|12M Follow-Up||177
10165371|NCT02982772|11295699|FG001|STARTED|12M Follow-Up||192
10165372|NCT02982772|11295698|FG000|COMPLETED|12M Follow-Up||166
10165373|NCT02982772|11295699|FG001|COMPLETED|12M Follow-Up||187
10165374|NCT02982772|11295698|FG000|NOT COMPLETED|12M Follow-Up||11
10165375|NCT02982772|11295699|FG001|NOT COMPLETED|12M Follow-Up||5
10165376|NCT02982863|11295712|FG000|STARTED|Overall Study||5745
10165377|NCT02982863|11295713|FG001|STARTED|Overall Study||16745
10165378|NCT02982863|11295714|FG002|STARTED|Overall Study||13238
10165379|NCT02982863|11295715|FG003|STARTED|Overall Study||10158
10165380|NCT02982863|11295716|FG004|STARTED|Overall Study||2760
10165381|NCT02982863|11295712|FG000|COMPLETED|Overall Study||4936
9711333|NCT03307785|10811136|FG003|COMPLETED|Part A: Up to 28.5 Months||0
9711334|NCT03307785|10811137|FG004|COMPLETED|Part A: Up to 28.5 Months||0
9711335|NCT03307785|10811138|FG005|COMPLETED|Part A: Up to 28.5 Months||0
9711336|NCT03307785|10811139|FG006|COMPLETED|Part A: Up to 28.5 Months||0
9711337|NCT03307785|10811140|FG007|COMPLETED|Part A: Up to 28.5 Months||0
9711338|NCT03307785|10811141|FG008|COMPLETED|Part A: Up to 28.5 Months||0
10165382|NCT02982863|11295713|FG001|COMPLETED|Overall Study||12484
10165383|NCT02982863|11295714|FG002|COMPLETED|Overall Study||11386
10165384|NCT02982863|11295715|FG003|COMPLETED|Overall Study||8758
10165385|NCT02982863|11295716|FG004|COMPLETED|Overall Study||2268
10165386|NCT02982863|11295712|FG000|NOT COMPLETED|Overall Study||809
10165387|NCT02982863|11295713|FG001|NOT COMPLETED|Overall Study||4261
10165388|NCT02982863|11295714|FG002|NOT COMPLETED|Overall Study||1852
10165389|NCT02982863|11295715|FG003|NOT COMPLETED|Overall Study||1400
10165390|NCT02982863|11295716|FG004|NOT COMPLETED|Overall Study||492
10165391|NCT02982928|11295732|FG000|STARTED|Overall Study||11
10165392|NCT02982928|11295732|FG000|COMPLETED|Overall Study||11
10165393|NCT02982928|11295732|FG000|NOT COMPLETED|Overall Study||0
10165394|NCT02983058|11295738|FG000|STARTED|Overall Study||7
10165395|NCT02983058|11295739|FG001|STARTED|Overall Study||5
10165396|NCT02983058|11295738|FG000|COMPLETED|Overall Study||2
9711339|NCT03307785|10811142|FG009|COMPLETED|Part A: Up to 28.5 Months||0
9711340|NCT03307785|10811143|FG010|COMPLETED|Part A: Up to 28.5 Months||0
9711341|NCT03307785|10811133|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16
10165397|NCT02983058|11295739|FG001|COMPLETED|Overall Study||2
10165398|NCT02983058|11295738|FG000|NOT COMPLETED|Overall Study||5
10165399|NCT02983058|11295739|FG001|NOT COMPLETED|Overall Study||3
10165400|NCT02983227|11295747|FG000|STARTED|Overall Study||410
10165401|NCT02983227|11295748|FG001|STARTED|Overall Study||86
9711342|NCT03307785|10811134|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6
9711343|NCT03307785|10811135|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711344|NCT03307785|10811136|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711345|NCT03307785|10811137|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711346|NCT03307785|10811138|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711347|NCT03307785|10811139|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711348|NCT03307785|10811140|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711349|NCT03307785|10811141|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711350|NCT03307785|10811142|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711351|NCT03307785|10811143|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0
9711352|NCT03307785|10811133|FG000|STARTED|Part B: Up to 28.5 Months||0
9711353|NCT03307785|10811134|FG001|STARTED|Part B: Up to 28.5 Months||0
9711354|NCT03307785|10811135|FG002|STARTED|Part B: Up to 28.5 Months||14
9711355|NCT03307785|10811136|FG003|STARTED|Part B: Up to 28.5 Months||0
9711356|NCT03307785|10811137|FG004|STARTED|Part B: Up to 28.5 Months||0
9711357|NCT03307785|10811138|FG005|STARTED|Part B: Up to 28.5 Months||0
9711358|NCT03307785|10811139|FG006|STARTED|Part B: Up to 28.5 Months||0
9711359|NCT03307785|10811140|FG007|STARTED|Part B: Up to 28.5 Months||0
9711360|NCT03307785|10811141|FG008|STARTED|Part B: Up to 28.5 Months||0
9711361|NCT03307785|10811142|FG009|STARTED|Part B: Up to 28.5 Months||0
9711362|NCT03307785|10811143|FG010|STARTED|Part B: Up to 28.5 Months||0
10165402|NCT02983227|11295747|FG000|COMPLETED|Overall Study||351
10165403|NCT02983227|11295748|FG001|COMPLETED|Overall Study||72
10165404|NCT02983227|11295747|FG000|NOT COMPLETED|Overall Study||59
10165405|NCT02983227|11295748|FG001|NOT COMPLETED|Overall Study||14
10165406|NCT02983305|11295756|FG000|STARTED|Overall Study||12
10165407|NCT02983305|11295757|FG001|STARTED|Overall Study||10
10165408|NCT02983305|11295756|FG000|COMPLETED|Overall Study||10
10165409|NCT02983305|11295757|FG001|COMPLETED|Overall Study||10
10165410|NCT02983305|11295756|FG000|NOT COMPLETED|Overall Study||2
10165411|NCT02983305|11295757|FG001|NOT COMPLETED|Overall Study||0
10165412|NCT02983448|11295763|FG000|STARTED|Overall Study||12
10165413|NCT02983448|11295764|FG001|STARTED|Overall Study||12
10165414|NCT02983448|11295763|FG000|COMPLETED|Overall Study||12
10165415|NCT02983448|11295764|FG001|COMPLETED|Overall Study||12
10165416|NCT02983448|11295763|FG000|NOT COMPLETED|Overall Study||0
10165417|NCT02983448|11295764|FG001|NOT COMPLETED|Overall Study||0
10165418|NCT02983552|11295776|FG000|STARTED|Overall Study||69
10165419|NCT02983552|11295777|FG001|STARTED|Overall Study||69
10165420|NCT02983552|11295778|FG002|STARTED|Overall Study||92
10165421|NCT02983552|11295779|FG003|STARTED|Overall Study||90
10165422|NCT02983552|11295776|FG000|4 Week Visit|Overall Study||69
10165423|NCT02983552|11295777|FG001|4 Week Visit|Overall Study||67
10165424|NCT02983552|11295778|FG002|4 Week Visit|Overall Study||85
10165425|NCT02983552|11295779|FG003|4 Week Visit|Overall Study||84
10165426|NCT02983552|11295776|FG000|8 Week Visit|Overall Study||67
10165427|NCT02983552|11295777|FG001|8 Week Visit|Overall Study||68
10165428|NCT02983552|11295778|FG002|8 Week Visit|Overall Study||85
10165429|NCT02983552|11295779|FG003|8 Week Visit|Overall Study||84
10165430|NCT02983552|11295776|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
10165431|NCT02983552|11295777|FG001|16 Week Visit|Overall Study||66
10165432|NCT02983552|11295778|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
10165433|NCT02983552|11295779|FG003|16 Week Visit|Overall Study||72
10165434|NCT02983552|11295776|FG000|COMPLETED|Overall Study||69
10165435|NCT02983552|11295777|FG001|COMPLETED|Overall Study||67
10165436|NCT02983552|11295778|FG002|COMPLETED|Overall Study||92
10165437|NCT02983552|11295779|FG003|COMPLETED|Overall Study||90
10165438|NCT02983552|11295776|FG000|NOT COMPLETED|Overall Study||0
10165439|NCT02983552|11295777|FG001|NOT COMPLETED|Overall Study||2
10165440|NCT02983552|11295778|FG002|NOT COMPLETED|Overall Study||0
10165441|NCT02983552|11295779|FG003|NOT COMPLETED|Overall Study||0
10165442|NCT02983604|11295797|FG000|STARTED|Overall Study||4
10165443|NCT02983604|11295798|FG001|STARTED|Overall Study||3
10165444|NCT02983604|11295799|FG002|STARTED|Overall Study||4
10165445|NCT02983604|11295800|FG003|STARTED|Overall Study||3
10165446|NCT02983604|11295797|FG000|COMPLETED|Overall Study||4
10165447|NCT02983604|11295798|FG001|COMPLETED|Overall Study||3
10165448|NCT02983604|11295799|FG002|COMPLETED|Overall Study||3
10165449|NCT02983604|11295800|FG003|COMPLETED|Overall Study||3
10165450|NCT02983604|11295797|FG000|NOT COMPLETED|Overall Study||0
10165451|NCT02983604|11295798|FG001|NOT COMPLETED|Overall Study||0
10165452|NCT02983604|11295799|FG002|NOT COMPLETED|Overall Study||1
10165453|NCT02983604|11295800|FG003|NOT COMPLETED|Overall Study||0
10165454|NCT02983825|11295810|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
10165455|NCT02983825|11295810|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
10165456|NCT02983825|11295810|FG000|NOT COMPLETED|Overall Study||3
10165457|NCT02983877|11295814|FG000|STARTED|Overall Study||38
10165458|NCT02983877|11295814|FG000|COMPLETED|Overall Study||38
10165459|NCT02983877|11295814|FG000|NOT COMPLETED|Overall Study||0
10165460|NCT02983981|11295819|FG000|STARTED|Overall Study||20
10165461|NCT02983981|11295819|FG000|COMPLETED|Overall Study||20
10165462|NCT02983981|11295819|FG000|NOT COMPLETED|Overall Study||0
10165463|NCT02984267|11295825|FG000|STARTED|Overall Study||8
10165464|NCT02984267|11295826|FG001|STARTED|Overall Study||10
10165465|NCT02984267|11295825|FG000|COMPLETED|Overall Study||7
10165466|NCT02984267|11295826|FG001|COMPLETED|Overall Study||9
10165467|NCT02984267|11295825|FG000|NOT COMPLETED|Overall Study||1
10165468|NCT02984267|11295826|FG001|NOT COMPLETED|Overall Study||1
10165469|NCT02984644|11295834|FG000|STARTED|Overall Study||20
10165470|NCT02984644|11295835|FG001|STARTED|Overall Study||10
10165471|NCT02984644|11295834|FG000|COMPLETED|Overall Study||20
10165472|NCT02984644|11295835|FG001|COMPLETED|Overall Study||10
10165473|NCT02984644|11295834|FG000|NOT COMPLETED|Overall Study||0
10165474|NCT02984644|11295835|FG001|NOT COMPLETED|Overall Study||0
10165475|NCT02984683|11295864|FG000|STARTED|Overall Study||11
10165476|NCT02984683|11295865|FG001|STARTED|Overall Study||12
10165477|NCT02984683|11295864|FG000|COMPLETED|Overall Study||0
10165478|NCT02984683|11295865|FG001|COMPLETED|Overall Study||0
10165479|NCT02984683|11295864|FG000|NOT COMPLETED|Overall Study||11
10165480|NCT02984683|11295865|FG001|NOT COMPLETED|Overall Study||12
10165481|NCT02984709|11295873|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
10165482|NCT02984709|11295874|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
10165483|NCT02984709|11295873|FG000|COMPLETED|Overall Study||24
10165484|NCT02984709|11295874|FG001|COMPLETED|Overall Study||24
10165485|NCT02984709|11295873|FG000|NOT COMPLETED|Overall Study||0
10165486|NCT02984709|11295874|FG001|NOT COMPLETED|Overall Study||0
10165487|NCT02984878|11295884|FG000|STARTED|Overall Study||30
10165488|NCT02984878|11295885|FG001|STARTED|Overall Study||41
10165489|NCT02984878|11295884|FG000|COMPLETED|Overall Study||30
10165490|NCT02984878|11295885|FG001|COMPLETED|Overall Study||41
10165491|NCT02984878|11295884|FG000|NOT COMPLETED|Overall Study||0
10165492|NCT02984878|11295885|FG001|NOT COMPLETED|Overall Study||0
10165493|NCT02984943|11295894|FG000|STARTED|Overall Study||14
10165494|NCT02984943|11295894|FG000|COMPLETED|Overall Study||10
10165495|NCT02984943|11295894|FG000|NOT COMPLETED|Overall Study||4
10165496|NCT02984982|11295900|FG000|STARTED|Overall Study||102
10165497|NCT02984982|11295901|FG001|STARTED|Overall Study||104
10165498|NCT02984982|11295900|FG000|Treated|Overall Study||102
10165499|NCT02984982|11295901|FG001|Treated|Overall Study||103
10165500|NCT02984982|11295900|FG000|COMPLETED|Overall Study||94
10165501|NCT02984982|11295901|FG001|COMPLETED|Overall Study||94
10165502|NCT02984982|11295900|FG000|NOT COMPLETED|Overall Study||8
9711363|NCT03307785|10811133|FG000|COMPLETED|Part B: Up to 28.5 Months||0
10165503|NCT02984982|11295901|FG001|NOT COMPLETED|Overall Study||10
10165504|NCT02984995|11295910|FG000|STARTED|Overall Study||34
10165505|NCT02984995|11295911|FG001|STARTED|Overall Study||3
10165506|NCT02984995|11295910|FG000|COMPLETED|Overall Study||9
10165507|NCT02984995|11295911|FG001|COMPLETED|Overall Study||0
10165508|NCT02984995|11295910|FG000|NOT COMPLETED|Overall Study||25
10165509|NCT02984995|11295911|FG001|NOT COMPLETED|Overall Study||3
10165510|NCT02985021|11295923|FG000|STARTED|Overall Study||2
10165511|NCT02985021|11295923|FG000|COMPLETED|Overall Study||1
10165512|NCT02985021|11295923|FG000|NOT COMPLETED|Overall Study||1
10165513|NCT02985398|11295927|FG000|STARTED|Overall Study||128
10165514|NCT02985398|11295927|FG000|Participants Treated|Overall Study||128
10165515|NCT02985398|11295927|FG000|COMPLETED|Overall Study||106
10165516|NCT02985398|11295927|FG000|NOT COMPLETED|Overall Study||22
10165517|NCT02985450|11295931|FG000|STARTED|Overall Study||82
10165518|NCT02985450|11295931|FG000|COMPLETED|Overall Study||75
10165519|NCT02985450|11295931|FG000|NOT COMPLETED|Overall Study||7
10165520|NCT02985710|11295940|FG000|STARTED|Overall Study||69
10165521|NCT02985710|11295941|FG001|STARTED|Overall Study||33
10165522|NCT02985710|11295940|FG000|COMPLETED|Overall Study||65
10165523|NCT02985710|11295941|FG001|COMPLETED|Overall Study||33
10165524|NCT02985710|11295940|FG000|NOT COMPLETED|Overall Study||4
10165525|NCT02985710|11295941|FG001|NOT COMPLETED|Overall Study||0
10165526|NCT02985827|11295949|FG000|STARTED|Overall Study||33
10165527|NCT02985827|11295950|FG001|STARTED|Overall Study||15
10165528|NCT02985827|11295949|FG000|COMPLETED|Overall Study||33
10165529|NCT02985827|11295950|FG001|COMPLETED|Overall Study||15
10165530|NCT02985827|11295949|FG000|NOT COMPLETED|Overall Study||0
10165531|NCT02985827|11295950|FG001|NOT COMPLETED|Overall Study||0
10165532|NCT02985879|11295959|FG000|STARTED|Overall Study||126
10165533|NCT02985879|11295960|FG001|STARTED|Overall Study||127
10165534|NCT02985879|11295961|FG002|STARTED|Overall Study||125
10165535|NCT02985879|11295959|FG000|COMPLETED|Overall Study||50
10165536|NCT02985879|11295960|FG001|COMPLETED|Overall Study||52
10165537|NCT02985879|11295961|FG002|COMPLETED|Overall Study||48
10165538|NCT02985879|11295959|FG000|NOT COMPLETED|Overall Study||76
10165539|NCT02985879|11295960|FG001|NOT COMPLETED|Overall Study||75
10165540|NCT02985879|11295961|FG002|NOT COMPLETED|Overall Study||77
10165541|NCT02985996|11295980|FG000|STARTED|Overall Study||5
10165542|NCT02985996|11295981|FG001|STARTED|Overall Study||8
10165543|NCT02985996|11295982|FG002|STARTED|Overall Study||10
10165544|NCT02985996|11295983|FG003|STARTED|Overall Study||7
10165545|NCT02985996|11295984|FG004|STARTED|Overall Study||9
10165546|NCT02985996|11295980|FG000|COMPLETED|Overall Study||5
10165547|NCT02985996|11295981|FG001|COMPLETED|Overall Study||7
10165548|NCT02985996|11295982|FG002|COMPLETED|Overall Study||9
10165549|NCT02985996|11295983|FG003|COMPLETED|Overall Study||7
10165550|NCT02985996|11295984|FG004|COMPLETED|Overall Study||9
10165551|NCT02985996|11295980|FG000|NOT COMPLETED|Overall Study||0
10165552|NCT02985996|11295981|FG001|NOT COMPLETED|Overall Study||1
10165553|NCT02985996|11295982|FG002|NOT COMPLETED|Overall Study||1
10165554|NCT02985996|11295983|FG003|NOT COMPLETED|Overall Study||0
10165555|NCT02985996|11295984|FG004|NOT COMPLETED|Overall Study||0
10165556|NCT02986074|11296000|FG000|STARTED|First Trial Period||26
10165557|NCT02986074|11296001|FG001|STARTED|First Trial Period||29
10165558|NCT02986074|11296002|FG002|STARTED|First Trial Period||0
10165559|NCT02986074|11296003|FG003|STARTED|First Trial Period||0
10165560|NCT02986074|11296000|FG000|COMPLETED|First Trial Period||25
10165561|NCT02986074|11296001|FG001|COMPLETED|First Trial Period||29
10165562|NCT02986074|11296002|FG002|COMPLETED|First Trial Period||0
10165563|NCT02986074|11296003|FG003|COMPLETED|First Trial Period||0
10165564|NCT02986074|11296000|FG000|NOT COMPLETED|First Trial Period||1
10165565|NCT02986074|11296001|FG001|NOT COMPLETED|First Trial Period||0
10165566|NCT02986074|11296002|FG002|NOT COMPLETED|First Trial Period||0
10165567|NCT02986074|11296003|FG003|NOT COMPLETED|First Trial Period||0
10165568|NCT02986074|11296000|FG000|STARTED|Second Trial Period||25
10165569|NCT02986074|11296001|FG001|STARTED|Second Trial Period||29
10165570|NCT02986074|11296002|FG002|STARTED|Second Trial Period||0
10165571|NCT02986074|11296003|FG003|STARTED|Second Trial Period||0
10165572|NCT02986074|11296000|FG000|COMPLETED|Second Trial Period||25
10165573|NCT02986074|11296001|FG001|COMPLETED|Second Trial Period||29
10165574|NCT02986074|11296002|FG002|COMPLETED|Second Trial Period||0
10165575|NCT02986074|11296003|FG003|COMPLETED|Second Trial Period||0
10165576|NCT02986074|11296000|FG000|NOT COMPLETED|Second Trial Period||0
10165577|NCT02986074|11296001|FG001|NOT COMPLETED|Second Trial Period||0
9711364|NCT03307785|10811134|FG001|COMPLETED|Part B: Up to 28.5 Months||0
9711365|NCT03307785|10811135|FG002|COMPLETED|Part B: Up to 28.5 Months||0
9711366|NCT03307785|10811136|FG003|COMPLETED|Part B: Up to 28.5 Months||0
9711367|NCT03307785|10811137|FG004|COMPLETED|Part B: Up to 28.5 Months||0
9711368|NCT03307785|10811138|FG005|COMPLETED|Part B: Up to 28.5 Months||0
9711369|NCT03307785|10811139|FG006|COMPLETED|Part B: Up to 28.5 Months||0
9711370|NCT03307785|10811140|FG007|COMPLETED|Part B: Up to 28.5 Months||0
10165578|NCT02986074|11296002|FG002|NOT COMPLETED|Second Trial Period||0
10165579|NCT02986074|11296003|FG003|NOT COMPLETED|Second Trial Period||0
10165580|NCT02986074|11296000|FG000|STARTED|Follow up Period||0
10165581|NCT02986074|11296001|FG001|STARTED|Follow up Period||0
10165582|NCT02986074|11296002|FG002|STARTED|Follow up Period||21
10165583|NCT02986074|11296003|FG003|STARTED|Follow up Period||22
10165584|NCT02986074|11296000|FG000|3 Month Follow up|Follow up Period||0
10165585|NCT02986074|11296001|FG001|3 Month Follow up|Follow up Period||0
10165586|NCT02986074|11296002|FG002|3 Month Follow up|Follow up Period||21
10165587|NCT02986074|11296003|FG003|3 Month Follow up|Follow up Period||21
10165588|NCT02986074|11296000|FG000|6 Month Follow up|Follow up Period||0
10165589|NCT02986074|11296001|FG001|6 Month Follow up|Follow up Period||0
9711371|NCT03307785|10811141|FG008|COMPLETED|Part B: Up to 28.5 Months||0
9711372|NCT03307785|10811142|FG009|COMPLETED|Part B: Up to 28.5 Months||0
9711373|NCT03307785|10811143|FG010|COMPLETED|Part B: Up to 28.5 Months||0
9711374|NCT03307785|10811133|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711375|NCT03307785|10811134|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711376|NCT03307785|10811135|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14
10165590|NCT02986074|11296002|FG002|6 Month Follow up|Follow up Period||21
10165591|NCT02986074|11296003|FG003|6 Month Follow up|Follow up Period||20
10165592|NCT02986074|11296000|FG000|COMPLETED|Follow up Period||0
10165593|NCT02986074|11296001|FG001|COMPLETED|Follow up Period||0
10165594|NCT02986074|11296002|FG002|COMPLETED|Follow up Period||20
10165595|NCT02986074|11296003|FG003|COMPLETED|Follow up Period||19
10165596|NCT02986074|11296000|FG000|NOT COMPLETED|Follow up Period||0
10165597|NCT02986074|11296001|FG001|NOT COMPLETED|Follow up Period||0
10165598|NCT02986074|11296002|FG002|NOT COMPLETED|Follow up Period||1
10165599|NCT02986074|11296003|FG003|NOT COMPLETED|Follow up Period||3
10165600|NCT02986139|11296010|FG000|STARTED|Overall Study||56
10165601|NCT02986139|11296011|FG001|STARTED|Overall Study||55
10165602|NCT02986139|11296010|FG000|Received Etanercept|Overall Study||56
10165603|NCT02986139|11296011|FG001|Received Etanercept|Overall Study||53
10165604|NCT02986139|11296010|FG000|COMPLETED|Overall Study||55
10165605|NCT02986139|11296011|FG001|COMPLETED|Overall Study||51
10165606|NCT02986139|11296010|FG000|NOT COMPLETED|Overall Study||1
10165607|NCT02986139|11296011|FG001|NOT COMPLETED|Overall Study||4
10165608|NCT02986282|11296021|FG000|STARTED|Overall Study||115
10165609|NCT02986282|11296021|FG000|COMPLETED|Overall Study||99
10165610|NCT02986282|11296021|FG000|NOT COMPLETED|Overall Study||16
10165611|NCT02986373|11296025|FG000|STARTED|Overall Study||145
10165612|NCT02986373|11296025|FG000|COMPLETED|Overall Study||106
10165613|NCT02986373|11296025|FG000|NOT COMPLETED|Overall Study||39
10165614|NCT02986711|11296031|FG000|STARTED|Overall Study||78
10165615|NCT02986711|11296032|FG001|STARTED|Overall Study||80
10165616|NCT02986711|11296031|FG000|COMPLETED|Overall Study||70
10165617|NCT02986711|11296032|FG001|COMPLETED|Overall Study||70
10165618|NCT02986711|11296031|FG000|NOT COMPLETED|Overall Study||8
10165619|NCT02986711|11296032|FG001|NOT COMPLETED|Overall Study||10
10165620|NCT02986802|11296042|FG000|STARTED|Overall Study||1360
10165621|NCT02986802|11296043|FG001|STARTED|Overall Study||2839
10165622|NCT02986802|11296044|FG002|STARTED|Overall Study||1873
10165623|NCT02986802|11296045|FG003|STARTED|Overall Study||83060
10165624|NCT02986802|11296042|FG000|COMPLETED|Overall Study||1360
10165625|NCT02986802|11296043|FG001|COMPLETED|Overall Study||2839
10165626|NCT02986802|11296044|FG002|COMPLETED|Overall Study||1873
10165627|NCT02986802|11296045|FG003|COMPLETED|Overall Study||83060
10165628|NCT02986802|11296042|FG000|NOT COMPLETED|Overall Study||0
10165629|NCT02986802|11296043|FG001|NOT COMPLETED|Overall Study||0
10165630|NCT02986802|11296044|FG002|NOT COMPLETED|Overall Study||0
10165631|NCT02986802|11296045|FG003|NOT COMPLETED|Overall Study||0
10165632|NCT02986854|11296058|FG000|STARTED|Overall Study||301
10165633|NCT02986854|11296059|FG001|STARTED|Overall Study||300
10165634|NCT02986854|11296060|FG002|STARTED|Overall Study||100
10165635|NCT02986854|11296058|FG000|COMPLETED|Overall Study||298
10165636|NCT02986854|11296059|FG001|COMPLETED|Overall Study||288
10165637|NCT02986854|11296060|FG002|COMPLETED|Overall Study||97
10165638|NCT02986854|11296058|FG000|NOT COMPLETED|Overall Study||3
10165639|NCT02986854|11296059|FG001|NOT COMPLETED|Overall Study||12
10165640|NCT02986854|11296060|FG002|NOT COMPLETED|Overall Study||3
10165641|NCT02986958|11296072|FG000|STARTED|Overall Study||49
10165642|NCT02986958|11296073|FG001|STARTED|Overall Study||44
10165643|NCT02986958|11296072|FG000|COMPLETED|Overall Study||49
10165644|NCT02986958|11296073|FG001|COMPLETED|Overall Study||44
10165645|NCT02986958|11296072|FG000|NOT COMPLETED|Overall Study||0
10165646|NCT02986958|11296073|FG001|NOT COMPLETED|Overall Study||0
10197544|NCT03378076|11325511|FG000|STARTED|Overall Study||12
10197545|NCT03378076|11325512|FG001|STARTED|Overall Study||12
10197546|NCT03378076|11325511|FG000|COMPLETED|Overall Study||12
10197547|NCT03378076|11325512|FG001|COMPLETED|Overall Study||12
10197548|NCT03378076|11325511|FG000|NOT COMPLETED|Overall Study||0
10197549|NCT03378076|11325512|FG001|NOT COMPLETED|Overall Study||0
10197550|NCT03378635|11325521|FG000|STARTED|Overall Study||84
10197551|NCT03378635|11325522|FG001|STARTED|Overall Study||43
10197552|NCT03378635|11325523|FG002|STARTED|Overall Study||43
10197553|NCT03378635|11325521|FG000|Randomized and Exposed to Treatment|Overall Study||82
10197554|NCT03378635|11325522|FG001|Randomized and Exposed to Treatment|Overall Study||43
10197555|NCT03378635|11325523|FG002|Randomized and Exposed to Treatment|Overall Study||43
10197556|NCT03378635|11325521|FG000|COMPLETED|Overall Study||82
10197557|NCT03378635|11325522|FG001|COMPLETED|Overall Study||43
10197558|NCT03378635|11325523|FG002|COMPLETED|Overall Study||43
10197559|NCT03378635|11325521|FG000|NOT COMPLETED|Overall Study||2
10197560|NCT03378635|11325522|FG001|NOT COMPLETED|Overall Study||0
10197561|NCT03378635|11325523|FG002|NOT COMPLETED|Overall Study||0
10197562|NCT03378921|11325534|FG000|STARTED|Overall Study||13
10197563|NCT03378921|11325535|FG001|STARTED|Overall Study||13
10197564|NCT03378921|11325534|FG000|COMPLETED|Overall Study||13
10197565|NCT03378921|11325535|FG001|COMPLETED|Overall Study||13
10197566|NCT03378921|11325534|FG000|NOT COMPLETED|Overall Study||0
10197567|NCT03378921|11325535|FG001|NOT COMPLETED|Overall Study||0
10197568|NCT03378973|11325543|FG000|STARTED|Overall Study||4
10197569|NCT03378973|11325544|FG001|STARTED|Overall Study||3
10197570|NCT03378973|11325543|FG000|COMPLETED|Overall Study||4
10197571|NCT03378973|11325544|FG001|COMPLETED|Overall Study||3
10197572|NCT03378973|11325543|FG000|NOT COMPLETED|Overall Study||0
10197573|NCT03378973|11325544|FG001|NOT COMPLETED|Overall Study||0
10197574|NCT03379259|11325556|FG000|STARTED|Overall Study||3
10197575|NCT03379259|11325557|FG001|STARTED|Overall Study||3
10197576|NCT03379259|11325558|FG002|STARTED|Overall Study||6
10197577|NCT03379259|11325559|FG003|STARTED|Overall Study||3
10197578|NCT03379259|11325560|FG004|STARTED|Overall Study||12
10197579|NCT03379259|11325561|FG005|STARTED|Overall Study||12
10197580|NCT03379259|11325556|FG000|COMPLETED|Overall Study||2
10197581|NCT03379259|11325557|FG001|COMPLETED|Overall Study||2
10197582|NCT03379259|11325558|FG002|COMPLETED|Overall Study||3
10197583|NCT03379259|11325559|FG003|COMPLETED|Overall Study||0
10165647|NCT02987205|11296079|FG000|STARTED|Overall Study||163
10165648|NCT02987205|11296079|FG000|Treated - Bilateral NLF Injection|Overall Study||163
10165649|NCT02987205|11296079|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
10165650|NCT02987205|11296079|FG000|NOT COMPLETED|Overall Study||4
10165651|NCT02987231|11296087|FG000|STARTED|Overall Study||30
10165652|NCT02987231|11296088|FG001|STARTED|Overall Study||30
10165653|NCT02987231|11296087|FG000|COMPLETED|Overall Study||30
10165654|NCT02987231|11296088|FG001|COMPLETED|Overall Study||30
10165655|NCT02987231|11296087|FG000|NOT COMPLETED|Overall Study||0
10165656|NCT02987231|11296088|FG001|NOT COMPLETED|Overall Study||0
10165657|NCT02987374|11296094|FG000|STARTED|Overall Study||10
10165658|NCT02987374|11296094|FG000|COMPLETED|Overall Study||10
10165659|NCT02987374|11296094|FG000|NOT COMPLETED|Overall Study||0
10165660|NCT02987621|11296098|FG000|STARTED|Overall Study||7
10165661|NCT02987621|11296099|FG001|STARTED|Overall Study||7
10165662|NCT02987621|11296098|FG000|COMPLETED|Overall Study||7
10165663|NCT02987621|11296099|FG001|COMPLETED|Overall Study||7
10165664|NCT02987621|11296098|FG000|NOT COMPLETED|Overall Study||0
10165665|NCT02987621|11296099|FG001|NOT COMPLETED|Overall Study||0
10165666|NCT02987660|11296109|FG000|STARTED|Overall Study||10
10165667|NCT02987660|11296110|FG001|STARTED|Overall Study||10
10165668|NCT02987660|11296109|FG000|COMPLETED|Overall Study||0
10165669|NCT02987660|11296110|FG001|COMPLETED|Overall Study||0
10165670|NCT02987660|11296109|FG000|NOT COMPLETED|Overall Study||10
10165671|NCT02987660|11296110|FG001|NOT COMPLETED|Overall Study||10
10165672|NCT02987829|11296122|FG000|STARTED|Overall Study||1
10165673|NCT02987829|11296123|FG001|STARTED|Overall Study||1
10165674|NCT02987829|11296124|FG002|STARTED|Overall Study||2
10165675|NCT02987829|11296125|FG003|STARTED|Overall Study||7
10165676|NCT02987829|11296126|FG004|STARTED|Overall Study||51
10165677|NCT02987829|11296127|FG005|STARTED|Overall Study||10
10165678|NCT02987829|11296122|FG000|COMPLETED|Overall Study||1
10165679|NCT02987829|11296123|FG001|COMPLETED|Overall Study||1
10165680|NCT02987829|11296124|FG002|COMPLETED|Overall Study||2
10165681|NCT02987829|11296125|FG003|COMPLETED|Overall Study||7
10165682|NCT02987829|11296126|FG004|COMPLETED|Overall Study||51
10165683|NCT02987829|11296127|FG005|COMPLETED|Overall Study||10
10165684|NCT02987829|11296122|FG000|NOT COMPLETED|Overall Study||0
10165685|NCT02987829|11296123|FG001|NOT COMPLETED|Overall Study||0
10165686|NCT02987829|11296124|FG002|NOT COMPLETED|Overall Study||0
10165687|NCT02987829|11296125|FG003|NOT COMPLETED|Overall Study||0
10165688|NCT02987829|11296126|FG004|NOT COMPLETED|Overall Study||0
10165689|NCT02987829|11296127|FG005|NOT COMPLETED|Overall Study||0
10165690|NCT02987868|11296144|FG000|STARTED|First Intervention||8
10165691|NCT02987868|11296145|FG001|STARTED|First Intervention||8
10165692|NCT02987868|11296144|FG000|COMPLETED|First Intervention||8
10165693|NCT02987868|11296145|FG001|COMPLETED|First Intervention||8
10165694|NCT02987868|11296144|FG000|NOT COMPLETED|First Intervention||0
10165695|NCT02987868|11296145|FG001|NOT COMPLETED|First Intervention||0
10165696|NCT02987868|11296144|FG000|STARTED|Wash Out Period 1 Week||8
10165697|NCT02987868|11296145|FG001|STARTED|Wash Out Period 1 Week||8
10165698|NCT02987868|11296144|FG000|COMPLETED|Wash Out Period 1 Week||8
10165699|NCT02987868|11296145|FG001|COMPLETED|Wash Out Period 1 Week||8
10165700|NCT02987868|11296144|FG000|NOT COMPLETED|Wash Out Period 1 Week||0
10165701|NCT02987868|11296145|FG001|NOT COMPLETED|Wash Out Period 1 Week||0
10165702|NCT02987868|11296144|FG000|STARTED|Second Intervention||8
10165703|NCT02987868|11296145|FG001|STARTED|Second Intervention||8
10165704|NCT02987868|11296144|FG000|COMPLETED|Second Intervention||8
10165705|NCT02987868|11296145|FG001|COMPLETED|Second Intervention||8
10165706|NCT02987868|11296144|FG000|NOT COMPLETED|Second Intervention||0
10165707|NCT02987868|11296145|FG001|NOT COMPLETED|Second Intervention||0
10165708|NCT02987972|11296154|FG000|STARTED|Overall Study||351
10165709|NCT02987972|11296155|FG001|STARTED|Overall Study||350
10165710|NCT02987972|11296156|FG002|STARTED|Overall Study||350
10165711|NCT02987972|11296154|FG000|Vaccination 1|Overall Study||350
10165712|NCT02987972|11296155|FG001|Vaccination 1|Overall Study||347
10165713|NCT02987972|11296156|FG002|Vaccination 1|Overall Study||347
10165714|NCT02987972|11296154|FG000|Vaccination 2|Overall Study||333
10165715|NCT02987972|11296155|FG001|Vaccination 2|Overall Study||335
10165716|NCT02987972|11296156|FG002|Vaccination 2|Overall Study||335
10165717|NCT02987972|11296154|FG000|Vaccination 3|Overall Study||330
10165718|NCT02987972|11296155|FG001|Vaccination 3|Overall Study||331
10165719|NCT02987972|11296156|FG002|Vaccination 3|Overall Study||332
10165720|NCT02987972|11296154|FG000|Vaccination 4|Overall Study||310
10165721|NCT02987972|11296155|FG001|Vaccination 4|Overall Study||306
10165722|NCT02987972|11296156|FG002|Vaccination 4|Overall Study||311
10165723|NCT02987972|11296154|FG000|COMPLETED|Overall Study||308
10165724|NCT02987972|11296155|FG001|COMPLETED|Overall Study||305
10165725|NCT02987972|11296156|FG002|COMPLETED|Overall Study||308
10165726|NCT02987972|11296154|FG000|NOT COMPLETED|Overall Study||43
10165727|NCT02987972|11296155|FG001|NOT COMPLETED|Overall Study||45
10165728|NCT02987972|11296156|FG002|NOT COMPLETED|Overall Study||42
10165729|NCT02988050|11296166|FG000|STARTED|Overall Study||30
10165730|NCT02988050|11296167|FG001|STARTED|Overall Study||30
10165731|NCT02988050|11296166|FG000|COMPLETED|Overall Study||30
10165732|NCT02988050|11296167|FG001|COMPLETED|Overall Study||30
10165733|NCT02988050|11296166|FG000|NOT COMPLETED|Overall Study||0
10165734|NCT02988050|11296167|FG001|NOT COMPLETED|Overall Study||0
10165735|NCT02988115|11296175|FG000|STARTED|Overall Study||234
10165736|NCT02988115|11296176|FG001|STARTED|Overall Study||111
10165737|NCT02988115|11296175|FG000|COMPLETED|Overall Study||220
10165738|NCT02988115|11296176|FG001|COMPLETED|Overall Study||107
10165739|NCT02988115|11296175|FG000|NOT COMPLETED|Overall Study||14
10165740|NCT02988115|11296176|FG001|NOT COMPLETED|Overall Study||4
10165741|NCT02988193|11296184|FG000|STARTED|Overall Study||12
10165742|NCT02988193|11296185|FG001|STARTED|Overall Study||16
10165743|NCT02988193|11296184|FG000|COMPLETED|Overall Study||12
10165744|NCT02988193|11296185|FG001|COMPLETED|Overall Study||16
10165745|NCT02988193|11296184|FG000|NOT COMPLETED|Overall Study||0
10165746|NCT02988193|11296185|FG001|NOT COMPLETED|Overall Study||0
10165747|NCT02988219|11296193|FG000|STARTED|Overall Study||25
10165748|NCT02988219|11296194|FG001|STARTED|Overall Study||25
10165749|NCT02988219|11296193|FG000|COMPLETED|Overall Study||24
10165750|NCT02988219|11296194|FG001|COMPLETED|Overall Study||22
10165751|NCT02988219|11296193|FG000|NOT COMPLETED|Overall Study||1
10165752|NCT02988219|11296194|FG001|NOT COMPLETED|Overall Study||3
10165753|NCT02988349|11296202|FG000|STARTED|Overall Study||21
10165754|NCT02988349|11296203|FG001|STARTED|Overall Study||21
10165755|NCT02988349|11296202|FG000|COMPLETED|Overall Study||21
10165756|NCT02988349|11296203|FG001|COMPLETED|Overall Study||21
10165757|NCT02988349|11296202|FG000|NOT COMPLETED|Overall Study||0
10165758|NCT02988349|11296203|FG001|NOT COMPLETED|Overall Study||0
10165759|NCT02988622|11296209|FG000|STARTED|Overall Study||100
10165760|NCT02988622|11296209|FG000|COMPLETED|Overall Study||83
10165761|NCT02988622|11296209|FG000|NOT COMPLETED|Overall Study||17
10165762|NCT02988843|11296215|FG000|STARTED|Overall Study||1
10165763|NCT02988843|11296215|FG000|COMPLETED|Overall Study||1
10165764|NCT02988843|11296215|FG000|NOT COMPLETED|Overall Study||0
10165765|NCT02988856|11296219|FG000|STARTED|Overall Study||11
10165766|NCT02988856|11296219|FG000|COMPLETED|Overall Study||8
10165767|NCT02988856|11296219|FG000|NOT COMPLETED|Overall Study||3
10165768|NCT02988882|11296225|FG000|STARTED|Overall Study||44
10165769|NCT02988882|11296226|FG001|STARTED|Overall Study||42
10165770|NCT02988882|11296225|FG000|COMPLETED|Overall Study||41
10165771|NCT02988882|11296226|FG001|COMPLETED|Overall Study||40
10165772|NCT02988882|11296225|FG000|NOT COMPLETED|Overall Study||3
10165773|NCT02988882|11296226|FG001|NOT COMPLETED|Overall Study||2
10165774|NCT02988986|11296232|FG000|STARTED|Overall Study||28
10165775|NCT02988986|11296232|FG000|COMPLETED|Overall Study||25
10165776|NCT02988986|11296232|FG000|NOT COMPLETED|Overall Study||3
10165777|NCT02989168|11296239|FG000|STARTED|Overall Study||11
10165778|NCT02989168|11296240|FG001|STARTED|Overall Study||3
10165779|NCT02989168|11296239|FG000|COMPLETED|Overall Study||7
10165780|NCT02989168|11296240|FG001|COMPLETED|Overall Study||0
10165781|NCT02989168|11296239|FG000|NOT COMPLETED|Overall Study||4
10165782|NCT02989168|11296240|FG001|NOT COMPLETED|Overall Study||3
10165783|NCT02989246|11296248|FG000|STARTED|Overall Study||32
10165784|NCT02989246|11296248|FG000|COMPLETED|Overall Study||32
10165785|NCT02989246|11296248|FG000|NOT COMPLETED|Overall Study||0
10165786|NCT02989389|11296262|FG000|STARTED|Period 1||3
10165787|NCT02989389|11296263|FG001|STARTED|Period 1||4
10165788|NCT02989389|11296264|FG002|STARTED|Period 1||3
10165789|NCT02989389|11296265|FG003|STARTED|Period 1||3
10165790|NCT02989389|11296266|FG004|STARTED|Period 1||3
10165791|NCT02989389|11296267|FG005|STARTED|Period 1||3
10165792|NCT02989389|11296268|FG006|STARTED|Period 1||6
10165793|NCT02989389|11296269|FG007|STARTED|Period 1||5
10165794|NCT02989389|11296270|FG008|STARTED|Period 1||6
10165795|NCT02989389|11296271|FG009|STARTED|Period 1||6
10165796|NCT02989389|11296262|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10165797|NCT02989389|11296263|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
10165798|NCT02989389|11296264|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
10165799|NCT02989389|11296265|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
10165800|NCT02989389|11296266|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
10165801|NCT02989389|11296267|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
10165802|NCT02989389|11296268|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
10165803|NCT02989389|11296269|FG007|Received at Least 1 Dose of Study Drug|Period 1||5
10165804|NCT02989389|11296270|FG008|Received at Least 1 Dose of Study Drug|Period 1||6
10165805|NCT02989389|11296271|FG009|Received at Least 1 Dose of Study Drug|Period 1||6
10165806|NCT02989389|11296262|FG000|COMPLETED|Period 1||3
10165807|NCT02989389|11296263|FG001|COMPLETED|Period 1||3
10165808|NCT02989389|11296264|FG002|COMPLETED|Period 1||3
10165809|NCT02989389|11296265|FG003|COMPLETED|Period 1||3
10165810|NCT02989389|11296266|FG004|COMPLETED|Period 1||3
10165811|NCT02989389|11296267|FG005|COMPLETED|Period 1||3
10165812|NCT02989389|11296268|FG006|COMPLETED|Period 1||6
10165813|NCT02989389|11296269|FG007|COMPLETED|Period 1||5
10165814|NCT02989389|11296270|FG008|COMPLETED|Period 1||5
10165815|NCT02989389|11296271|FG009|COMPLETED|Period 1||6
10165816|NCT02989389|11296262|FG000|NOT COMPLETED|Period 1||0
10165817|NCT02989389|11296263|FG001|NOT COMPLETED|Period 1||1
10165818|NCT02989389|11296264|FG002|NOT COMPLETED|Period 1||0
10165819|NCT02989389|11296265|FG003|NOT COMPLETED|Period 1||0
10165820|NCT02989389|11296266|FG004|NOT COMPLETED|Period 1||0
10165821|NCT02989389|11296267|FG005|NOT COMPLETED|Period 1||0
10165822|NCT02989389|11296268|FG006|NOT COMPLETED|Period 1||0
10165823|NCT02989389|11296269|FG007|NOT COMPLETED|Period 1||0
10165824|NCT02989389|11296270|FG008|NOT COMPLETED|Period 1||1
10165825|NCT02989389|11296271|FG009|NOT COMPLETED|Period 1||0
10165826|NCT02989389|11296262|FG000|STARTED|Period 2||3
10165827|NCT02989389|11296263|FG001|STARTED|Period 2||3
10165828|NCT02989389|11296264|FG002|STARTED|Period 2||3
10165829|NCT02989389|11296265|FG003|STARTED|Period 2||3
10165830|NCT02989389|11296266|FG004|STARTED|Period 2||3
9711377|NCT03307785|10811136|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711378|NCT03307785|10811137|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711379|NCT03307785|10811138|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711380|NCT03307785|10811139|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711381|NCT03307785|10811140|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711382|NCT03307785|10811141|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711383|NCT03307785|10811142|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711384|NCT03307785|10811143|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0
9711385|NCT03307785|10811133|FG000|STARTED|Part C: Up to 22.5 Months||0
9711386|NCT03307785|10811134|FG001|STARTED|Part C: Up to 22.5 Months||0
9711387|NCT03307785|10811135|FG002|STARTED|Part C: Up to 22.5 Months||0
9711388|NCT03307785|10811136|FG003|STARTED|Part C: Up to 22.5 Months||6
9711389|NCT03307785|10811137|FG004|STARTED|Part C: Up to 22.5 Months||7
9711390|NCT03307785|10811138|FG005|STARTED|Part C: Up to 22.5 Months||0
9711391|NCT03307785|10811139|FG006|STARTED|Part C: Up to 22.5 Months||0
9711392|NCT03307785|10811140|FG007|STARTED|Part C: Up to 22.5 Months||0
9711393|NCT03307785|10811141|FG008|STARTED|Part C: Up to 22.5 Months||0
9711394|NCT03307785|10811142|FG009|STARTED|Part C: Up to 22.5 Months||0
9711395|NCT03307785|10811143|FG010|STARTED|Part C: Up to 22.5 Months||0
9711396|NCT03307785|10811133|FG000|COMPLETED|Part C: Up to 22.5 Months||0
9711397|NCT03307785|10811134|FG001|COMPLETED|Part C: Up to 22.5 Months||0
9711398|NCT03307785|10811135|FG002|COMPLETED|Part C: Up to 22.5 Months||0
9711399|NCT03307785|10811136|FG003|COMPLETED|Part C: Up to 22.5 Months||0
9711400|NCT03307785|10811137|FG004|COMPLETED|Part C: Up to 22.5 Months||0
10061303|NCT02104219|11186970|FG000|STARTED|Overall Study||32
10061304|NCT02104219|11186970|FG000|COMPLETED|Overall Study||32
10061305|NCT02104219|11186970|FG000|NOT COMPLETED|Overall Study||0
10061306|NCT02104414|11186977|FG000|STARTED|Overall Study||5
10061307|NCT02104414|11186978|FG001|STARTED|Overall Study||4
10061308|NCT02104414|11186979|FG002|STARTED|Overall Study||2
10061309|NCT02104414|11186977|FG000|COMPLETED|Overall Study||5
10061310|NCT02104414|11186978|FG001|COMPLETED|Overall Study||4
10061311|NCT02104414|11186979|FG002|COMPLETED|Overall Study||2
10061312|NCT02104414|11186977|FG000|NOT COMPLETED|Overall Study||0
10061313|NCT02104414|11186978|FG001|NOT COMPLETED|Overall Study||0
10061314|NCT02104414|11186979|FG002|NOT COMPLETED|Overall Study||0
10061315|NCT02104427|11186987|FG000|STARTED|Overall Study||12
10061316|NCT02104427|11186987|FG000|COMPLETED|Overall Study||12
10061317|NCT02104427|11186987|FG000|NOT COMPLETED|Overall Study||0
10061318|NCT02104505|11187011|FG000|STARTED|First Intervention (14 Days)||12
10061319|NCT02104505|11187012|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
10061320|NCT02104505|11187011|FG000|COMPLETED|First Intervention (14 Days)||10
10061321|NCT02104505|11187012|FG001|COMPLETED|First Intervention (14 Days)||8
10061322|NCT02104505|11187011|FG000|NOT COMPLETED|First Intervention (14 Days)||2
10061323|NCT02104505|11187012|FG001|NOT COMPLETED|First Intervention (14 Days)||3
10061324|NCT02104505|11187011|FG000|STARTED|Washout (Minimum 3 Weeks)||10
10061325|NCT02104505|11187012|FG001|STARTED|Washout (Minimum 3 Weeks)||8
10061326|NCT02104505|11187011|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10
10061327|NCT02104505|11187012|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8
10061328|NCT02104505|11187011|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
10061329|NCT02104505|11187012|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
10061330|NCT02104505|11187011|FG000|STARTED|Second Intervention (14 Days)||10
10061331|NCT02104505|11187012|FG001|STARTED|Second Intervention (14 Days)||8
10061332|NCT02104505|11187011|FG000|COMPLETED|Second Intervention (14 Days)||8
10061333|NCT02104505|11187012|FG001|COMPLETED|Second Intervention (14 Days)||7
10061334|NCT02104505|11187011|FG000|NOT COMPLETED|Second Intervention (14 Days)||2
10061335|NCT02104505|11187012|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
10061336|NCT02104557|11187019|FG000|STARTED|Overall Study||362
10061337|NCT02104557|11187019|FG000|Safety Population|Overall Study||337
10061338|NCT02104557|11187019|FG000|COMPLETED|Overall Study||185
10061339|NCT02104557|11187019|FG000|NOT COMPLETED|Overall Study||177
10061340|NCT02104583|11187028|FG000|STARTED|Overall Study||48
10165831|NCT02989389|11296267|FG005|STARTED|Period 2||3
10165832|NCT02989389|11296268|FG006|STARTED|Period 2|Part B was planned as a single period study.|0
10165833|NCT02989389|11296269|FG007|STARTED|Period 2|Part B was planned as a single period study.|0
10165834|NCT02989389|11296270|FG008|STARTED|Period 2|Part B was planned as a single period study.|0
10165835|NCT02989389|11296271|FG009|STARTED|Period 2|Part B was planned as a single period study.|0
9711401|NCT03307785|10811138|FG005|COMPLETED|Part C: Up to 22.5 Months||0
9711402|NCT03307785|10811139|FG006|COMPLETED|Part C: Up to 22.5 Months||0
9711403|NCT03307785|10811140|FG007|COMPLETED|Part C: Up to 22.5 Months||0
9711404|NCT03307785|10811141|FG008|COMPLETED|Part C: Up to 22.5 Months||0
9711405|NCT03307785|10811142|FG009|COMPLETED|Part C: Up to 22.5 Months||0
9711406|NCT03307785|10811143|FG010|COMPLETED|Part C: Up to 22.5 Months||0
10061341|NCT02104583|11187029|FG001|STARTED|Overall Study||46
10061342|NCT02104583|11187030|FG002|STARTED|Overall Study||70
10061343|NCT02104583|11187031|FG003|STARTED|Overall Study||74
10061344|NCT02104583|11187032|FG004|STARTED|Overall Study||75
9711407|NCT03307785|10811133|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711408|NCT03307785|10811134|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711409|NCT03307785|10811135|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0
10165836|NCT02989389|11296262|FG000|COMPLETED|Period 2||3
10165837|NCT02989389|11296263|FG001|COMPLETED|Period 2||3
10165838|NCT02989389|11296264|FG002|COMPLETED|Period 2||3
10165839|NCT02989389|11296265|FG003|COMPLETED|Period 2||3
10165840|NCT02989389|11296266|FG004|COMPLETED|Period 2||3
10165841|NCT02989389|11296267|FG005|COMPLETED|Period 2||3
10165842|NCT02989389|11296268|FG006|COMPLETED|Period 2||0
10165843|NCT02989389|11296269|FG007|COMPLETED|Period 2||0
10165844|NCT02989389|11296270|FG008|COMPLETED|Period 2||0
10165845|NCT02989389|11296271|FG009|COMPLETED|Period 2||0
10165846|NCT02989389|11296262|FG000|NOT COMPLETED|Period 2||0
10165847|NCT02989389|11296263|FG001|NOT COMPLETED|Period 2||0
10165848|NCT02989389|11296264|FG002|NOT COMPLETED|Period 2||0
10165849|NCT02989389|11296265|FG003|NOT COMPLETED|Period 2||0
10165850|NCT02989389|11296266|FG004|NOT COMPLETED|Period 2||0
10165851|NCT02989389|11296267|FG005|NOT COMPLETED|Period 2||0
10165852|NCT02989389|11296268|FG006|NOT COMPLETED|Period 2||0
10165853|NCT02989389|11296269|FG007|NOT COMPLETED|Period 2||0
10165854|NCT02989389|11296270|FG008|NOT COMPLETED|Period 2||0
10165855|NCT02989389|11296271|FG009|NOT COMPLETED|Period 2||0
10165856|NCT02989389|11296262|FG000|STARTED|Period 3||3
10165857|NCT02989389|11296263|FG001|STARTED|Period 3||3
10165858|NCT02989389|11296264|FG002|STARTED|Period 3||3
10165859|NCT02989389|11296265|FG003|STARTED|Period 3||3
10165860|NCT02989389|11296266|FG004|STARTED|Period 3||3
10165861|NCT02989389|11296267|FG005|STARTED|Period 3||3
10165862|NCT02989389|11296268|FG006|STARTED|Period 3||0
10165863|NCT02989389|11296269|FG007|STARTED|Period 3||0
10165864|NCT02989389|11296270|FG008|STARTED|Period 3||0
10165865|NCT02989389|11296271|FG009|STARTED|Period 3||0
10165866|NCT02989389|11296262|FG000|COMPLETED|Period 3||3
10165867|NCT02989389|11296263|FG001|COMPLETED|Period 3||3
10165868|NCT02989389|11296264|FG002|COMPLETED|Period 3||3
10165869|NCT02989389|11296265|FG003|COMPLETED|Period 3||3
9711410|NCT03307785|10811136|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6
9711411|NCT03307785|10811137|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7
9711412|NCT03307785|10811138|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711413|NCT03307785|10811139|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711414|NCT03307785|10811140|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711415|NCT03307785|10811141|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711416|NCT03307785|10811142|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711417|NCT03307785|10811143|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0
9711418|NCT03307785|10811133|FG000|STARTED|Part D: Up to 9.5 Months||0
9711419|NCT03307785|10811134|FG001|STARTED|Part D: Up to 9.5 Months||0
9711420|NCT03307785|10811135|FG002|STARTED|Part D: Up to 9.5 Months||0
9711421|NCT03307785|10811136|FG003|STARTED|Part D: Up to 9.5 Months||0
9711422|NCT03307785|10811137|FG004|STARTED|Part D: Up to 9.5 Months||0
9711423|NCT03307785|10811138|FG005|STARTED|Part D: Up to 9.5 Months||6
9711424|NCT03307785|10811139|FG006|STARTED|Part D: Up to 9.5 Months||0
9711425|NCT03307785|10811140|FG007|STARTED|Part D: Up to 9.5 Months||0
9711426|NCT03307785|10811141|FG008|STARTED|Part D: Up to 9.5 Months||0
9711427|NCT03307785|10811142|FG009|STARTED|Part D: Up to 9.5 Months||0
9711428|NCT03307785|10811143|FG010|STARTED|Part D: Up to 9.5 Months||0
9711429|NCT03307785|10811133|FG000|COMPLETED|Part D: Up to 9.5 Months||0
9711430|NCT03307785|10811134|FG001|COMPLETED|Part D: Up to 9.5 Months||0
9711431|NCT03307785|10811135|FG002|COMPLETED|Part D: Up to 9.5 Months||0
9711432|NCT03307785|10811136|FG003|COMPLETED|Part D: Up to 9.5 Months||0
9711433|NCT03307785|10811137|FG004|COMPLETED|Part D: Up to 9.5 Months||0
9711434|NCT03307785|10811138|FG005|COMPLETED|Part D: Up to 9.5 Months||3
9711435|NCT03307785|10811139|FG006|COMPLETED|Part D: Up to 9.5 Months||0
9711436|NCT03307785|10811140|FG007|COMPLETED|Part D: Up to 9.5 Months||0
9711437|NCT03307785|10811141|FG008|COMPLETED|Part D: Up to 9.5 Months||0
9711438|NCT03307785|10811142|FG009|COMPLETED|Part D: Up to 9.5 Months||0
9711439|NCT03307785|10811143|FG010|COMPLETED|Part D: Up to 9.5 Months||0
9711440|NCT03307785|10811133|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711441|NCT03307785|10811134|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711442|NCT03307785|10811135|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711443|NCT03307785|10811136|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711444|NCT03307785|10811137|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711445|NCT03307785|10811138|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3
9711446|NCT03307785|10811139|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711447|NCT03307785|10811140|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711448|NCT03307785|10811141|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711449|NCT03307785|10811142|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0
9711450|NCT03307785|10811143|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0
10165870|NCT02989389|11296266|FG004|COMPLETED|Period 3||3
10165871|NCT02989389|11296267|FG005|COMPLETED|Period 3||3
10165872|NCT02989389|11296268|FG006|COMPLETED|Period 3||0
10165873|NCT02989389|11296269|FG007|COMPLETED|Period 3||0
10165874|NCT02989389|11296270|FG008|COMPLETED|Period 3||0
10165875|NCT02989389|11296271|FG009|COMPLETED|Period 3||0
10165876|NCT02989389|11296262|FG000|NOT COMPLETED|Period 3||0
10165877|NCT02989389|11296263|FG001|NOT COMPLETED|Period 3||0
10165878|NCT02989389|11296264|FG002|NOT COMPLETED|Period 3||0
10165879|NCT02989389|11296265|FG003|NOT COMPLETED|Period 3||0
10165880|NCT02989389|11296266|FG004|NOT COMPLETED|Period 3||0
10165881|NCT02989389|11296267|FG005|NOT COMPLETED|Period 3||0
10165882|NCT02989389|11296268|FG006|NOT COMPLETED|Period 3||0
10165883|NCT02989389|11296269|FG007|NOT COMPLETED|Period 3||0
10165884|NCT02989389|11296270|FG008|NOT COMPLETED|Period 3||0
10165885|NCT02989389|11296271|FG009|NOT COMPLETED|Period 3||0
10165886|NCT02989493|11296313|FG000|STARTED|Overall Study||29
10165887|NCT02989493|11296314|FG001|STARTED|Overall Study||32
10165888|NCT02989493|11296313|FG000|COMPLETED|Overall Study||29
10165889|NCT02989493|11296314|FG001|COMPLETED|Overall Study||32
10165890|NCT02989493|11296313|FG000|NOT COMPLETED|Overall Study||0
10165891|NCT02989493|11296314|FG001|NOT COMPLETED|Overall Study||0
10165892|NCT02989545|11296320|FG000|STARTED|Control Period - no Intervention||20
10165893|NCT02989545|11296320|FG000|COMPLETED|Control Period - no Intervention||20
10165894|NCT02989545|11296320|FG000|NOT COMPLETED|Control Period - no Intervention||0
10165895|NCT02989545|11296320|FG000|STARTED|Treatment Period - Anal Tape Provided||20
10165896|NCT02989545|11296320|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20
10165897|NCT02989545|11296320|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
10165898|NCT02989610|11296328|FG000|STARTED|Overall Study||234
10165899|NCT02989610|11296328|FG000|COMPLETED|Overall Study||195
10165900|NCT02989610|11296328|FG000|NOT COMPLETED|Overall Study||39
10165901|NCT02989649|11296332|FG000|STARTED|Overall Study||593
10165902|NCT02989649|11296332|FG000|Started But Not Treated|Overall Study||84
10165903|NCT02989649|11296332|FG000|Eligible to Enter Into Treatment Period|Overall Study||509
10165904|NCT02989649|11296332|FG000|COMPLETED|Overall Study||173
10165905|NCT02989649|11296332|FG000|NOT COMPLETED|Overall Study||420
10165906|NCT02989714|11296336|FG000|STARTED|Overall Study||13
10165907|NCT02989714|11296336|FG000|Started Nivolumab|Overall Study||12
9711451|NCT03307785|10811133|FG000|STARTED|Part E: Up to 4.4 Months||0
9711452|NCT03307785|10811134|FG001|STARTED|Part E: Up to 4.4 Months||0
9711453|NCT03307785|10811135|FG002|STARTED|Part E: Up to 4.4 Months||0
9711454|NCT03307785|10811136|FG003|STARTED|Part E: Up to 4.4 Months||0
9711455|NCT03307785|10811137|FG004|STARTED|Part E: Up to 4.4 Months||0
9711456|NCT03307785|10811138|FG005|STARTED|Part E: Up to 4.4 Months||0
9711457|NCT03307785|10811139|FG006|STARTED|Part E: Up to 4.4 Months||2
9711458|NCT03307785|10811140|FG007|STARTED|Part E: Up to 4.4 Months||0
9711459|NCT03307785|10811141|FG008|STARTED|Part E: Up to 4.4 Months||0
9711460|NCT03307785|10811142|FG009|STARTED|Part E: Up to 4.4 Months||0
9711461|NCT03307785|10811143|FG010|STARTED|Part E: Up to 4.4 Months||0
9711462|NCT03307785|10811133|FG000|COMPLETED|Part E: Up to 4.4 Months||0
9711463|NCT03307785|10811134|FG001|COMPLETED|Part E: Up to 4.4 Months||0
9711464|NCT03307785|10811135|FG002|COMPLETED|Part E: Up to 4.4 Months||0
9711465|NCT03307785|10811136|FG003|COMPLETED|Part E: Up to 4.4 Months||0
9711466|NCT03307785|10811137|FG004|COMPLETED|Part E: Up to 4.4 Months||0
9711467|NCT03307785|10811138|FG005|COMPLETED|Part E: Up to 4.4 Months||0
9711468|NCT03307785|10811139|FG006|COMPLETED|Part E: Up to 4.4 Months||0
9711469|NCT03307785|10811140|FG007|COMPLETED|Part E: Up to 4.4 Months||0
9711470|NCT03307785|10811141|FG008|COMPLETED|Part E: Up to 4.4 Months||0
9711471|NCT03307785|10811142|FG009|COMPLETED|Part E: Up to 4.4 Months||0
9711472|NCT03307785|10811143|FG010|COMPLETED|Part E: Up to 4.4 Months||0
9711473|NCT03307785|10811133|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711474|NCT03307785|10811134|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711475|NCT03307785|10811135|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711476|NCT03307785|10811136|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711477|NCT03307785|10811137|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711478|NCT03307785|10811138|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711479|NCT03307785|10811139|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2
9711480|NCT03307785|10811140|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711481|NCT03307785|10811141|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711482|NCT03307785|10811142|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711483|NCT03307785|10811143|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0
9711484|NCT03307785|10811133|FG000|STARTED|Part F: Up to 3.5 Months||0
9711485|NCT03307785|10811134|FG001|STARTED|Part F: Up to 3.5 Months||0
9711486|NCT03307785|10811135|FG002|STARTED|Part F: Up to 3.5 Months||0
9711487|NCT03307785|10811136|FG003|STARTED|Part F: Up to 3.5 Months||0
9711488|NCT03307785|10811137|FG004|STARTED|Part F: Up to 3.5 Months||0
9711489|NCT03307785|10811138|FG005|STARTED|Part F: Up to 3.5 Months||0
9711490|NCT03307785|10811139|FG006|STARTED|Part F: Up to 3.5 Months||0
9711491|NCT03307785|10811140|FG007|STARTED|Part F: Up to 3.5 Months||1
9711492|NCT03307785|10811141|FG008|STARTED|Part F: Up to 3.5 Months||0
9711493|NCT03307785|10811142|FG009|STARTED|Part F: Up to 3.5 Months||0
9711494|NCT03307785|10811143|FG010|STARTED|Part F: Up to 3.5 Months||0
9711495|NCT03307785|10811133|FG000|COMPLETED|Part F: Up to 3.5 Months||0
9711496|NCT03307785|10811134|FG001|COMPLETED|Part F: Up to 3.5 Months||0
9711497|NCT03307785|10811135|FG002|COMPLETED|Part F: Up to 3.5 Months||0
9711498|NCT03307785|10811136|FG003|COMPLETED|Part F: Up to 3.5 Months||0
9711499|NCT03307785|10811137|FG004|COMPLETED|Part F: Up to 3.5 Months||0
9711500|NCT03307785|10811138|FG005|COMPLETED|Part F: Up to 3.5 Months||0
9711501|NCT03307785|10811139|FG006|COMPLETED|Part F: Up to 3.5 Months||0
9711502|NCT03307785|10811140|FG007|COMPLETED|Part F: Up to 3.5 Months||0
9711503|NCT03307785|10811141|FG008|COMPLETED|Part F: Up to 3.5 Months||0
9711504|NCT03307785|10811142|FG009|COMPLETED|Part F: Up to 3.5 Months||0
9711505|NCT03307785|10811143|FG010|COMPLETED|Part F: Up to 3.5 Months||0
9711506|NCT03307785|10811133|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711507|NCT03307785|10811134|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711508|NCT03307785|10811135|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711509|NCT03307785|10811136|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0
10165908|NCT02989714|11296336|FG000|COMPLETED|Overall Study||12
10165909|NCT02989714|11296336|FG000|NOT COMPLETED|Overall Study||1
10165910|NCT02989727|11296345|FG000|STARTED|Overall Study||46
10165911|NCT02989727|11296346|FG001|STARTED|Overall Study||44
10165912|NCT02989727|11296347|FG002|STARTED|Overall Study||30
10165913|NCT02989727|11296348|FG003|STARTED|Overall Study||30
10165914|NCT02989727|11296345|FG000|COMPLETED|Overall Study||46
10165915|NCT02989727|11296346|FG001|COMPLETED|Overall Study||44
10165916|NCT02989727|11296347|FG002|COMPLETED|Overall Study||30
10165917|NCT02989727|11296348|FG003|COMPLETED|Overall Study||30
10165918|NCT02989727|11296345|FG000|NOT COMPLETED|Overall Study||0
10165919|NCT02989727|11296346|FG001|NOT COMPLETED|Overall Study||0
10165920|NCT02989727|11296347|FG002|NOT COMPLETED|Overall Study||0
10165921|NCT02989727|11296348|FG003|NOT COMPLETED|Overall Study||0
10165922|NCT02989805|11296358|FG000|STARTED|Overall Study||160
10165923|NCT02989805|11296359|FG001|STARTED|Overall Study||166
10165924|NCT02989805|11296358|FG000|COMPLETED|Overall Study||154
10165925|NCT02989805|11296359|FG001|COMPLETED|Overall Study||162
10165926|NCT02989805|11296358|FG000|NOT COMPLETED|Overall Study||6
10165927|NCT02989805|11296359|FG001|NOT COMPLETED|Overall Study||4
10165928|NCT02990000|11296367|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
10165929|NCT02990000|11296368|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
10165930|NCT02990000|11296367|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
10165931|NCT02990000|11296368|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
10165932|NCT02990000|11296367|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
10165933|NCT02990000|11296368|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
10165934|NCT02990000|11296367|FG000|NOT COMPLETED|Overall Study||36
10165935|NCT02990000|11296368|FG001|NOT COMPLETED|Overall Study||34
10165936|NCT02990910|11296376|FG000|STARTED|Overall Study||140
10165937|NCT02990910|11296377|FG001|STARTED|Overall Study||140
10165938|NCT02990910|11296376|FG000|COMPLETED|Overall Study||134
10165939|NCT02990910|11296377|FG001|COMPLETED|Overall Study||130
10165940|NCT02990910|11296376|FG000|NOT COMPLETED|Overall Study||6
10165941|NCT02990910|11296377|FG001|NOT COMPLETED|Overall Study||10
10165942|NCT02991040|11296383|FG000|STARTED|Overall Study||100
10165943|NCT02991040|11296383|FG000|COMPLETED|Overall Study||96
10165944|NCT02991040|11296383|FG000|NOT COMPLETED|Overall Study||4
10165945|NCT02991118|11296391|FG000|STARTED|Overall Study||257
10165946|NCT02991118|11296392|FG001|STARTED|Overall Study||522
10165947|NCT02991118|11296391|FG000|COMPLETED|Overall Study||250
10165948|NCT02991118|11296392|FG001|COMPLETED|Overall Study||490
10165949|NCT02991118|11296391|FG000|NOT COMPLETED|Overall Study||7
10165950|NCT02991118|11296392|FG001|NOT COMPLETED|Overall Study||32
10165951|NCT02991729|11296400|FG000|STARTED|Overall Study||105
10165952|NCT02991729|11296401|FG001|STARTED|Overall Study||92
10165953|NCT02991729|11296400|FG000|COMPLETED|Overall Study||105
10165954|NCT02991729|11296401|FG001|COMPLETED|Overall Study||92
10165955|NCT02991729|11296400|FG000|NOT COMPLETED|Overall Study||0
10165956|NCT02991729|11296401|FG001|NOT COMPLETED|Overall Study||0
10165957|NCT02991820|11296411|FG000|STARTED|Overall Study||12
10165958|NCT02991820|11296412|FG001|STARTED|Overall Study||31
10165959|NCT02991820|11296411|FG000|COMPLETED|Overall Study||12
10165960|NCT02991820|11296412|FG001|COMPLETED|Overall Study||31
10165961|NCT02991820|11296411|FG000|NOT COMPLETED|Overall Study||0
10165962|NCT02991820|11296412|FG001|NOT COMPLETED|Overall Study||0
10165963|NCT02991859|11296437|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165964|NCT02991859|11296438|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10165965|NCT02991859|11296439|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165966|NCT02991859|11296440|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165967|NCT02991859|11296441|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10165968|NCT02991859|11296442|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10165969|NCT02991859|11296443|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165970|NCT02991859|11296444|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165971|NCT02991859|11296445|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165972|NCT02991859|11296446|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165973|NCT02991859|11296447|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165974|NCT02991859|11296448|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10165975|NCT02991859|11296449|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
10165976|NCT02991859|11296450|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
10165977|NCT02991859|11296451|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
10165978|NCT02991859|11296452|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10165979|NCT02991859|11296453|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10165980|NCT02991859|11296437|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165981|NCT02991859|11296438|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165982|NCT02991859|11296439|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165983|NCT02991859|11296440|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165984|NCT02991859|11296441|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165985|NCT02991859|11296442|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
10165986|NCT02991859|11296443|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165987|NCT02991859|11296444|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165988|NCT02991859|11296445|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165989|NCT02991859|11296446|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165990|NCT02991859|11296447|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165991|NCT02991859|11296448|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10165992|NCT02991859|11296449|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
10165993|NCT02991859|11296450|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
10165994|NCT02991859|11296451|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
10165995|NCT02991859|11296452|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
10165996|NCT02991859|11296453|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
10165997|NCT02991859|11296437|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10165998|NCT02991859|11296438|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
10165999|NCT02991859|11296439|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166000|NCT02991859|11296440|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166001|NCT02991859|11296441|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
10166002|NCT02991859|11296442|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166003|NCT02991859|11296443|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166004|NCT02991859|11296444|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166005|NCT02991859|11296445|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166006|NCT02991859|11296446|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166007|NCT02991859|11296447|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9711510|NCT03307785|10811137|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711511|NCT03307785|10811138|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711512|NCT03307785|10811139|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711513|NCT03307785|10811140|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1
9711514|NCT03307785|10811141|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711515|NCT03307785|10811142|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711516|NCT03307785|10811143|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0
9711517|NCT03307785|10811133|FG000|STARTED|Part G: Up to 24 Months||0
9711518|NCT03307785|10811134|FG001|STARTED|Part G: Up to 24 Months||0
9711519|NCT03307785|10811135|FG002|STARTED|Part G: Up to 24 Months||0
9711520|NCT03307785|10811136|FG003|STARTED|Part G: Up to 24 Months||0
9711521|NCT03307785|10811137|FG004|STARTED|Part G: Up to 24 Months||0
9711522|NCT03307785|10811138|FG005|STARTED|Part G: Up to 24 Months||0
9711523|NCT03307785|10811139|FG006|STARTED|Part G: Up to 24 Months||0
9711524|NCT03307785|10811140|FG007|STARTED|Part G: Up to 24 Months||0
9711525|NCT03307785|10811141|FG008|STARTED|Part G: Up to 24 Months||0
9711526|NCT03307785|10811142|FG009|STARTED|Part G: Up to 24 Months||0
9711527|NCT03307785|10811143|FG010|STARTED|Part G: Up to 24 Months||0
9711528|NCT03307785|10811133|FG000|COMPLETED|Part G: Up to 24 Months||0
9711529|NCT03307785|10811134|FG001|COMPLETED|Part G: Up to 24 Months||0
9711530|NCT03307785|10811135|FG002|COMPLETED|Part G: Up to 24 Months||0
9711531|NCT03307785|10811136|FG003|COMPLETED|Part G: Up to 24 Months||0
9711532|NCT03307785|10811137|FG004|COMPLETED|Part G: Up to 24 Months||0
9711533|NCT03307785|10811138|FG005|COMPLETED|Part G: Up to 24 Months||0
9711534|NCT03307785|10811139|FG006|COMPLETED|Part G: Up to 24 Months||0
9711535|NCT03307785|10811140|FG007|COMPLETED|Part G: Up to 24 Months||0
9711536|NCT03307785|10811141|FG008|COMPLETED|Part G: Up to 24 Months||0
9711537|NCT03307785|10811142|FG009|COMPLETED|Part G: Up to 24 Months||0
10166008|NCT02991859|11296448|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166009|NCT02991859|11296449|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166010|NCT02991859|11296450|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166011|NCT02991859|11296451|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166012|NCT02991859|11296452|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166013|NCT02991859|11296453|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10166014|NCT02991859|11296437|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166015|NCT02991859|11296438|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166016|NCT02991859|11296439|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166017|NCT02991859|11296440|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166018|NCT02991859|11296441|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166019|NCT02991859|11296442|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
10166020|NCT02991859|11296443|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166021|NCT02991859|11296444|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166022|NCT02991859|11296445|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166023|NCT02991859|11296446|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166024|NCT02991859|11296447|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166025|NCT02991859|11296448|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10166026|NCT02991859|11296449|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
10166027|NCT02991859|11296450|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
10166028|NCT02991859|11296451|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
10166029|NCT02991859|11296452|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
10166030|NCT02991859|11296453|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
10166031|NCT02991859|11296437|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166032|NCT02991859|11296438|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166033|NCT02991859|11296439|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166034|NCT02991859|11296440|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166035|NCT02991859|11296441|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166036|NCT02991859|11296442|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
10166037|NCT02991859|11296443|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166038|NCT02991859|11296444|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166039|NCT02991859|11296445|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166040|NCT02991859|11296446|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166041|NCT02991859|11296447|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166042|NCT02991859|11296448|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10166043|NCT02991859|11296449|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
10166044|NCT02991859|11296450|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
10166045|NCT02991859|11296451|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
10166046|NCT02991859|11296452|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
10166047|NCT02991859|11296453|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
10166048|NCT02991859|11296437|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166049|NCT02991859|11296438|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166050|NCT02991859|11296439|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166051|NCT02991859|11296440|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166052|NCT02991859|11296441|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166053|NCT02991859|11296442|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166054|NCT02991859|11296443|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166055|NCT02991859|11296444|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166056|NCT02991859|11296445|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166057|NCT02991859|11296446|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166058|NCT02991859|11296447|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166059|NCT02991859|11296448|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166060|NCT02991859|11296449|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166061|NCT02991859|11296450|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166062|NCT02991859|11296451|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166063|NCT02991859|11296452|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166064|NCT02991859|11296453|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10166065|NCT02991859|11296437|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166066|NCT02991859|11296438|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166067|NCT02991859|11296439|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166068|NCT02991859|11296440|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166069|NCT02991859|11296441|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166070|NCT02991859|11296442|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3
10166071|NCT02991859|11296443|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166072|NCT02991859|11296444|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166073|NCT02991859|11296445|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166074|NCT02991859|11296446|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166075|NCT02991859|11296447|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166076|NCT02991859|11296448|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2
10166077|NCT02991859|11296449|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7
10166078|NCT02991859|11296450|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7
10166079|NCT02991859|11296451|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6
10166080|NCT02991859|11296452|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3
10166081|NCT02991859|11296453|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3
10166082|NCT02991859|11296437|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166083|NCT02991859|11296438|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166084|NCT02991859|11296439|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166085|NCT02991859|11296440|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166086|NCT02991859|11296441|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166087|NCT02991859|11296442|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
10166088|NCT02991859|11296443|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166089|NCT02991859|11296444|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166090|NCT02991859|11296445|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166091|NCT02991859|11296446|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166092|NCT02991859|11296447|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166093|NCT02991859|11296448|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10166094|NCT02991859|11296449|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
10166095|NCT02991859|11296450|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
10166096|NCT02991859|11296451|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
10166097|NCT02991859|11296452|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
10166098|NCT02991859|11296453|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
10166099|NCT02991859|11296437|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166100|NCT02991859|11296438|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166101|NCT02991859|11296439|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166102|NCT02991859|11296440|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166103|NCT02991859|11296441|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166104|NCT02991859|11296442|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166105|NCT02991859|11296443|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166106|NCT02991859|11296444|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166107|NCT02991859|11296445|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166108|NCT02991859|11296446|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166109|NCT02991859|11296447|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166110|NCT02991859|11296448|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166111|NCT02991859|11296449|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
10166112|NCT02991859|11296450|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
10166113|NCT02991859|11296451|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166114|NCT02991859|11296452|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166115|NCT02991859|11296453|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10166116|NCT02991859|11296437|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166117|NCT02991859|11296438|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166118|NCT02991859|11296439|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166119|NCT02991859|11296440|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166120|NCT02991859|11296441|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166121|NCT02991859|11296442|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
10166122|NCT02991859|11296443|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166123|NCT02991859|11296444|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166124|NCT02991859|11296445|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166125|NCT02991859|11296446|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166126|NCT02991859|11296447|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166127|NCT02991859|11296448|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2
10166128|NCT02991859|11296449|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6
10166129|NCT02991859|11296450|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6
10166130|NCT02991859|11296451|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6
10166131|NCT02991859|11296452|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3
10166132|NCT02991859|11296453|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3
10166133|NCT02991859|11296437|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166134|NCT02991859|11296438|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166135|NCT02991859|11296439|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166136|NCT02991859|11296440|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166137|NCT02991859|11296441|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166138|NCT02991859|11296442|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166139|NCT02991859|11296443|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166140|NCT02991859|11296444|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166141|NCT02991859|11296445|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166142|NCT02991859|11296446|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166143|NCT02991859|11296447|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166144|NCT02991859|11296448|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10166145|NCT02991859|11296449|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
10166146|NCT02991859|11296450|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
10166147|NCT02991859|11296451|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
10166148|NCT02991859|11296452|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
10166149|NCT02991859|11296453|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
10166150|NCT02991859|11296437|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166151|NCT02991859|11296438|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166152|NCT02991859|11296439|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166153|NCT02991859|11296440|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166154|NCT02991859|11296441|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166155|NCT02991859|11296442|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166156|NCT02991859|11296443|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166157|NCT02991859|11296444|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166158|NCT02991859|11296445|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166159|NCT02991859|11296446|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166160|NCT02991859|11296447|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166161|NCT02991859|11296448|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166162|NCT02991859|11296449|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166163|NCT02991859|11296450|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166164|NCT02991859|11296451|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166165|NCT02991859|11296452|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166166|NCT02991859|11296453|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10166167|NCT02991859|11296437|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166168|NCT02991859|11296438|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166169|NCT02991859|11296439|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166170|NCT02991859|11296440|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166171|NCT02991859|11296441|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166172|NCT02991859|11296442|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166173|NCT02991859|11296443|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166174|NCT02991859|11296444|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166175|NCT02991859|11296445|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166176|NCT02991859|11296446|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166177|NCT02991859|11296447|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
10166178|NCT02991859|11296448|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2
10166179|NCT02991859|11296449|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6
10166180|NCT02991859|11296450|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6
10166181|NCT02991859|11296451|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6
10166182|NCT02991859|11296452|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3
10166183|NCT02991859|11296453|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3
10166184|NCT02991859|11296437|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166185|NCT02991859|11296438|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166186|NCT02991859|11296439|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166187|NCT02991859|11296440|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166188|NCT02991859|11296441|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166189|NCT02991859|11296442|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166190|NCT02991859|11296443|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166191|NCT02991859|11296444|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166192|NCT02991859|11296445|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166193|NCT02991859|11296446|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166194|NCT02991859|11296447|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
10166195|NCT02991859|11296448|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10166196|NCT02991859|11296449|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
10166197|NCT02991859|11296450|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
10166198|NCT02991859|11296451|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
10166199|NCT02991859|11296452|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
10166200|NCT02991859|11296453|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
10166201|NCT02991859|11296437|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166202|NCT02991859|11296438|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166203|NCT02991859|11296439|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166204|NCT02991859|11296440|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166205|NCT02991859|11296441|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166206|NCT02991859|11296442|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166207|NCT02991859|11296443|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166208|NCT02991859|11296444|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166209|NCT02991859|11296445|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166210|NCT02991859|11296446|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10061345|NCT02104583|11187028|FG000|COMPLETED|Overall Study||30
10061346|NCT02104583|11187029|FG001|COMPLETED|Overall Study||35
10061347|NCT02104583|11187030|FG002|COMPLETED|Overall Study||54
10061348|NCT02104583|11187031|FG003|COMPLETED|Overall Study||57
10061349|NCT02104583|11187032|FG004|COMPLETED|Overall Study||63
10061350|NCT02104583|11187028|FG000|NOT COMPLETED|Overall Study||18
10061351|NCT02104583|11187029|FG001|NOT COMPLETED|Overall Study||11
10061352|NCT02104583|11187030|FG002|NOT COMPLETED|Overall Study||16
10061353|NCT02104583|11187031|FG003|NOT COMPLETED|Overall Study||17
10061354|NCT02104583|11187032|FG004|NOT COMPLETED|Overall Study||12
10166211|NCT02991859|11296447|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166212|NCT02991859|11296448|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166213|NCT02991859|11296449|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166214|NCT02991859|11296450|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10061355|NCT02104739|11187053|FG000|STARTED|First Intervention (1 Day)||2
10061356|NCT02104739|11187054|FG001|STARTED|First Intervention (1 Day)||5
10166215|NCT02991859|11296451|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166216|NCT02991859|11296452|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166217|NCT02991859|11296453|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10166218|NCT02991859|11296437|FG000|STARTED|Wash Out, Up to Day 77||2
10166219|NCT02991859|11296438|FG001|STARTED|Wash Out, Up to Day 77||2
10166220|NCT02991859|11296439|FG002|STARTED|Wash Out, Up to Day 77||2
10166221|NCT02991859|11296440|FG003|STARTED|Wash Out, Up to Day 77||2
10166222|NCT02991859|11296441|FG004|STARTED|Wash Out, Up to Day 77||2
10166223|NCT02991859|11296442|FG005|STARTED|Wash Out, Up to Day 77||2
10166224|NCT02991859|11296443|FG006|STARTED|Wash Out, Up to Day 77||2
10166225|NCT02991859|11296444|FG007|STARTED|Wash Out, Up to Day 77||2
10166226|NCT02991859|11296445|FG008|STARTED|Wash Out, Up to Day 77||2
10166227|NCT02991859|11296446|FG009|STARTED|Wash Out, Up to Day 77||2
10166228|NCT02991859|11296447|FG010|STARTED|Wash Out, Up to Day 77||1
10166229|NCT02991859|11296448|FG011|STARTED|Wash Out, Up to Day 77||2
10166230|NCT02991859|11296449|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10166231|NCT02991859|11296450|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10166232|NCT02991859|11296451|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10166233|NCT02991859|11296452|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10166234|NCT02991859|11296453|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10166235|NCT02991859|11296437|FG000|COMPLETED|Wash Out, Up to Day 77||2
10166236|NCT02991859|11296438|FG001|COMPLETED|Wash Out, Up to Day 77||2
10166237|NCT02991859|11296439|FG002|COMPLETED|Wash Out, Up to Day 77||2
10166238|NCT02991859|11296440|FG003|COMPLETED|Wash Out, Up to Day 77||2
10166239|NCT02991859|11296441|FG004|COMPLETED|Wash Out, Up to Day 77||2
10166240|NCT02991859|11296442|FG005|COMPLETED|Wash Out, Up to Day 77||1
10166241|NCT02991859|11296443|FG006|COMPLETED|Wash Out, Up to Day 77||2
10166242|NCT02991859|11296444|FG007|COMPLETED|Wash Out, Up to Day 77||2
10166243|NCT02991859|11296445|FG008|COMPLETED|Wash Out, Up to Day 77||2
10166244|NCT02991859|11296446|FG009|COMPLETED|Wash Out, Up to Day 77||1
10166245|NCT02991859|11296447|FG010|COMPLETED|Wash Out, Up to Day 77||1
10166246|NCT02991859|11296448|FG011|COMPLETED|Wash Out, Up to Day 77||2
10166247|NCT02991859|11296449|FG012|COMPLETED|Wash Out, Up to Day 77||0
10166248|NCT02991859|11296450|FG013|COMPLETED|Wash Out, Up to Day 77||0
10166249|NCT02991859|11296451|FG014|COMPLETED|Wash Out, Up to Day 77||0
10166250|NCT02991859|11296452|FG015|COMPLETED|Wash Out, Up to Day 77||0
10166251|NCT02991859|11296453|FG016|COMPLETED|Wash Out, Up to Day 77||0
10166252|NCT02991859|11296437|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0
10166253|NCT02991859|11296438|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0
10166254|NCT02991859|11296439|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0
10166255|NCT02991859|11296440|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0
10166256|NCT02991859|11296441|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0
10166257|NCT02991859|11296442|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1
10166258|NCT02991859|11296443|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0
10166259|NCT02991859|11296444|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0
10166260|NCT02991859|11296445|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0
10166261|NCT02991859|11296446|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1
10166262|NCT02991859|11296447|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0
10166263|NCT02991859|11296448|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0
10166264|NCT02991859|11296449|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0
10166265|NCT02991859|11296450|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0
10166266|NCT02991859|11296451|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0
10166267|NCT02991859|11296452|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0
10166268|NCT02991859|11296453|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0
10166269|NCT02991859|11296437|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166270|NCT02991859|11296438|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166271|NCT02991859|11296439|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166272|NCT02991859|11296440|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166273|NCT02991859|11296441|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166274|NCT02991859|11296442|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1
10166275|NCT02991859|11296443|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166276|NCT02991859|11296444|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166277|NCT02991859|11296445|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166278|NCT02991859|11296446|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
10166279|NCT02991859|11296447|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
10166280|NCT02991859|11296448|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10166281|NCT02991859|11296449|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10166282|NCT02991859|11296450|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10166283|NCT02991859|11296451|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10166284|NCT02991859|11296452|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10166285|NCT02991859|11296453|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10166286|NCT02991859|11296437|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166287|NCT02991859|11296438|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166288|NCT02991859|11296439|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166289|NCT02991859|11296440|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166290|NCT02991859|11296441|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166291|NCT02991859|11296442|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
10166292|NCT02991859|11296443|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166293|NCT02991859|11296444|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166294|NCT02991859|11296445|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166295|NCT02991859|11296446|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166296|NCT02991859|11296447|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166297|NCT02991859|11296448|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10166298|NCT02991859|11296449|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166299|NCT02991859|11296450|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166300|NCT02991859|11296451|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166301|NCT02991859|11296452|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166302|NCT02991859|11296453|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166303|NCT02991859|11296437|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166304|NCT02991859|11296438|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166305|NCT02991859|11296439|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166306|NCT02991859|11296440|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166307|NCT02991859|11296441|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166308|NCT02991859|11296442|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166309|NCT02991859|11296443|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166310|NCT02991859|11296444|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166311|NCT02991859|11296445|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166312|NCT02991859|11296446|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166313|NCT02991859|11296447|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166314|NCT02991859|11296448|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166315|NCT02991859|11296449|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166316|NCT02991859|11296450|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166317|NCT02991859|11296451|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166318|NCT02991859|11296452|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166319|NCT02991859|11296453|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10166320|NCT02991859|11296437|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166321|NCT02991859|11296438|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166322|NCT02991859|11296439|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166323|NCT02991859|11296440|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166324|NCT02991859|11296441|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166325|NCT02991859|11296442|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1
10166326|NCT02991859|11296443|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166327|NCT02991859|11296444|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166328|NCT02991859|11296445|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166329|NCT02991859|11296446|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166330|NCT02991859|11296447|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166331|NCT02991859|11296448|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10166332|NCT02991859|11296449|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10166333|NCT02991859|11296450|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10166334|NCT02991859|11296451|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10166335|NCT02991859|11296452|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10166336|NCT02991859|11296453|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10166337|NCT02991859|11296437|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166338|NCT02991859|11296438|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166339|NCT02991859|11296439|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166340|NCT02991859|11296440|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166341|NCT02991859|11296441|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166342|NCT02991859|11296442|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
10166343|NCT02991859|11296443|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166344|NCT02991859|11296444|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166345|NCT02991859|11296445|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166346|NCT02991859|11296446|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166347|NCT02991859|11296447|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166348|NCT02991859|11296448|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10166349|NCT02991859|11296449|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166350|NCT02991859|11296450|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166351|NCT02991859|11296451|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166352|NCT02991859|11296452|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166353|NCT02991859|11296453|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166354|NCT02991859|11296437|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166355|NCT02991859|11296438|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166356|NCT02991859|11296439|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166357|NCT02991859|11296440|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166358|NCT02991859|11296441|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166359|NCT02991859|11296442|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166360|NCT02991859|11296443|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10197584|NCT03379259|11325560|FG004|COMPLETED|Overall Study||3
9849457|NCT00865280|10962186|FG000|STARTED|Overall Study||70
9849458|NCT00865280|10962187|FG001|STARTED|Overall Study||73
9849459|NCT00865280|10962186|FG000|COMPLETED|Overall Study||64
9849460|NCT00865280|10962187|FG001|COMPLETED|Overall Study||70
9849461|NCT00865280|10962186|FG000|NOT COMPLETED|Overall Study||6
9711538|NCT03307785|10811143|FG010|COMPLETED|Part G: Up to 24 Months||0
9711539|NCT03307785|10811133|FG000|NOT COMPLETED|Part G: Up to 24 Months||0
9849462|NCT00865280|10962187|FG001|NOT COMPLETED|Overall Study||3
9849463|NCT00865306|10962195|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
9849464|NCT00865306|10962196|FG001|STARTED|Controlled Trial||30
9849465|NCT00865306|10962195|FG000|COMPLETED|Controlled Trial||29
9849466|NCT00865306|10962196|FG001|COMPLETED|Controlled Trial||28
9849467|NCT00865306|10962195|FG000|NOT COMPLETED|Controlled Trial||5
9849468|NCT00865306|10962196|FG001|NOT COMPLETED|Controlled Trial||2
9849469|NCT00865306|10962195|FG000|STARTED|One-Year Follow-Up||29
9849470|NCT00865306|10962196|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
9849471|NCT00865306|10962195|FG000|COMPLETED|One-Year Follow-Up||29
9849472|NCT00865306|10962196|FG001|COMPLETED|One-Year Follow-Up||15
9849473|NCT00865306|10962195|FG000|NOT COMPLETED|One-Year Follow-Up||0
9849474|NCT00865306|10962196|FG001|NOT COMPLETED|One-Year Follow-Up||0
9849475|NCT00865345|10962202|FG000|STARTED|Overall Study||63
9849476|NCT00865345|10962202|FG000|COMPLETED|Overall Study||61
9849477|NCT00865345|10962202|FG000|NOT COMPLETED|Overall Study||2
9849478|NCT00865566|10962208|FG000|STARTED|Overall Study||1253
9849479|NCT00865566|10962209|FG001|STARTED|Overall Study||1251
9849480|NCT00865566|10962208|FG000|Modified Intent-to-Treat Population|Overall Study||1251
9849481|NCT00865566|10962209|FG001|Modified Intent-to-Treat Population|Overall Study||1245
9849482|NCT00865566|10962208|FG000|COMPLETED|Overall Study||629
9849483|NCT00865566|10962209|FG001|COMPLETED|Overall Study||564
9849484|NCT00865566|10962208|FG000|NOT COMPLETED|Overall Study||624
9849485|NCT00865566|10962209|FG001|NOT COMPLETED|Overall Study||687
9963967|NCT01489891|11083801|FG001|NOT COMPLETED|Overall Study||0
9963968|NCT01489956|11083809|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
9963969|NCT01489956|11083810|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
9963970|NCT01489956|11083811|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
9963971|NCT01489956|11083809|FG000|COMPLETED|Overall Study||12
9963972|NCT01489956|11083810|FG001|COMPLETED|Overall Study||0
9963973|NCT01489956|11083811|FG002|COMPLETED|Overall Study||5
9963974|NCT01489956|11083809|FG000|NOT COMPLETED|Overall Study||1
9963975|NCT01489956|11083810|FG001|NOT COMPLETED|Overall Study||0
9963976|NCT01489956|11083811|FG002|NOT COMPLETED|Overall Study||1
9963977|NCT01489969|11083822|FG000|STARTED|Overall Study||45
9963978|NCT01489969|11083823|FG001|STARTED|Overall Study||47
9963979|NCT01489969|11083824|FG002|STARTED|Overall Study||45
9963980|NCT01489969|11083822|FG000|COMPLETED|Overall Study||40
9963981|NCT01489969|11083823|FG001|COMPLETED|Overall Study||43
9963982|NCT01489969|11083824|FG002|COMPLETED|Overall Study||44
9963983|NCT01489969|11083822|FG000|NOT COMPLETED|Overall Study||5
9963984|NCT01489969|11083823|FG001|NOT COMPLETED|Overall Study||4
9963985|NCT01489969|11083824|FG002|NOT COMPLETED|Overall Study||1
9967853|NCT01517178|11088213|FG000|NOT COMPLETED|Period 1||4
9967854|NCT01517178|11088214|FG001|NOT COMPLETED|Period 1||5
9967855|NCT01517178|11088213|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
9967856|NCT01517178|11088214|FG001|STARTED|Period 2||6
9967857|NCT01517178|11088213|FG000|COMPLETED|Period 2||5
9967858|NCT01517178|11088214|FG001|COMPLETED|Period 2||4
9967859|NCT01517178|11088213|FG000|NOT COMPLETED|Period 2||6
9967860|NCT01517178|11088214|FG001|NOT COMPLETED|Period 2||2
9967861|NCT01517282|11088224|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
9967862|NCT01517282|11088225|FG001|STARTED|Overall Study||8
9967863|NCT01517282|11088226|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
9967864|NCT01517282|11088227|FG003|STARTED|Overall Study||6
9967865|NCT01517282|11088224|FG000|COMPLETED|Overall Study||8
9967866|NCT01517282|11088225|FG001|COMPLETED|Overall Study||7
9967867|NCT01517282|11088226|FG002|COMPLETED|Overall Study||8
9967868|NCT01517282|11088227|FG003|COMPLETED|Overall Study||5
9967869|NCT01517282|11088224|FG000|NOT COMPLETED|Overall Study||1
9967870|NCT01517282|11088225|FG001|NOT COMPLETED|Overall Study||1
9967871|NCT01517282|11088226|FG002|NOT COMPLETED|Overall Study||1
9967872|NCT01517282|11088227|FG003|NOT COMPLETED|Overall Study||1
9967873|NCT01517295|11088239|FG000|STARTED|Overall Study||16
9967874|NCT01517295|11088240|FG001|STARTED|Overall Study||14
9967875|NCT01517295|11088239|FG000|COMPLETED|Overall Study||15
9967876|NCT01517295|11088240|FG001|COMPLETED|Overall Study||14
9967877|NCT01517295|11088239|FG000|NOT COMPLETED|Overall Study||1
9967878|NCT01517295|11088240|FG001|NOT COMPLETED|Overall Study||0
9967879|NCT01517373|11088251|FG000|STARTED|Run-in Period||361
9967880|NCT01517373|11088252|FG001|STARTED|Run-in Period||0
9967881|NCT01517373|11088253|FG002|STARTED|Run-in Period||0
9967882|NCT01517373|11088254|FG003|STARTED|Run-in Period||0
9967883|NCT01517373|11088255|FG004|STARTED|Run-in Period||0
9967884|NCT01517373|11088256|FG005|STARTED|Run-in Period||0
9967885|NCT01517373|11088251|FG000|COMPLETED|Run-in Period||304
9967886|NCT01517373|11088252|FG001|COMPLETED|Run-in Period||0
9967887|NCT01517373|11088253|FG002|COMPLETED|Run-in Period||0
9967888|NCT01517373|11088254|FG003|COMPLETED|Run-in Period||0
9967889|NCT01517373|11088255|FG004|COMPLETED|Run-in Period||0
9967890|NCT01517373|11088256|FG005|COMPLETED|Run-in Period||0
10166361|NCT02991859|11296444|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166362|NCT02991859|11296445|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166363|NCT02991859|11296446|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166364|NCT02991859|11296447|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166365|NCT02991859|11296448|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166366|NCT02991859|11296449|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166367|NCT02991859|11296450|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166368|NCT02991859|11296451|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166369|NCT02991859|11296452|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166370|NCT02991859|11296453|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10166371|NCT02991859|11296437|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166372|NCT02991859|11296438|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166373|NCT02991859|11296439|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166374|NCT02991859|11296440|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166375|NCT02991859|11296441|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166376|NCT02991859|11296442|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1
9711540|NCT03307785|10811134|FG001|NOT COMPLETED|Part G: Up to 24 Months||0
9711541|NCT03307785|10811135|FG002|NOT COMPLETED|Part G: Up to 24 Months||0
9711542|NCT03307785|10811136|FG003|NOT COMPLETED|Part G: Up to 24 Months||0
9711543|NCT03307785|10811137|FG004|NOT COMPLETED|Part G: Up to 24 Months||0
9711544|NCT03307785|10811138|FG005|NOT COMPLETED|Part G: Up to 24 Months||0
9711545|NCT03307785|10811139|FG006|NOT COMPLETED|Part G: Up to 24 Months||0
9711546|NCT03307785|10811140|FG007|NOT COMPLETED|Part G: Up to 24 Months||0
9711547|NCT03307785|10811141|FG008|NOT COMPLETED|Part G: Up to 24 Months||0
9849486|NCT00865709|10962217|FG000|STARTED|Treatment||97
9849487|NCT00865709|10962218|FG001|STARTED|Treatment||101
9849488|NCT00865709|10962217|FG000|Received Treatment|Treatment|Safety population|97
9849489|NCT00865709|10962218|FG001|Received Treatment|Treatment|Safety population|101
9849490|NCT00865709|10962217|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
9849491|NCT00865709|10962218|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
9849492|NCT00865709|10962217|FG000|NOT COMPLETED|Treatment||30
9849493|NCT00865709|10962218|FG001|NOT COMPLETED|Treatment||18
9849494|NCT00865709|10962217|FG000|STARTED|Active Follow-up||25
9849495|NCT00865709|10962218|FG001|STARTED|Active Follow-up||16
9849496|NCT00865709|10962217|FG000|COMPLETED|Active Follow-up||17
9849497|NCT00865709|10962218|FG001|COMPLETED|Active Follow-up||15
9849498|NCT00865709|10962217|FG000|NOT COMPLETED|Active Follow-up||8
9849499|NCT00865709|10962218|FG001|NOT COMPLETED|Active Follow-up||1
9849500|NCT00865709|10962217|FG000|STARTED|Long Term Follow-up||70
9849501|NCT00865709|10962218|FG001|STARTED|Long Term Follow-up||82
9849502|NCT00865709|10962217|FG000|COMPLETED|Long Term Follow-up||24
9849503|NCT00865709|10962218|FG001|COMPLETED|Long Term Follow-up||33
9849504|NCT00865709|10962217|FG000|NOT COMPLETED|Long Term Follow-up||46
9849505|NCT00865709|10962218|FG001|NOT COMPLETED|Long Term Follow-up||49
9849506|NCT00865904|10962231|FG000|STARTED|Overall Study|Randomized.|19
9849507|NCT00865904|10962232|FG001|STARTED|Overall Study|Randomized.|18
9849508|NCT00865904|10962233|FG002|STARTED|Overall Study|Randomized.|18
9849509|NCT00865904|10962234|FG003|STARTED|Overall Study|Randomized.|18
9849510|NCT00865904|10962235|FG004|STARTED|Overall Study|Randomized.|20
9849511|NCT00865904|10962231|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17
9849512|NCT00865904|10962232|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18
9849513|NCT00865904|10962233|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18
9849514|NCT00865904|10962234|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17
9849515|NCT00865904|10962235|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19
9849516|NCT00865904|10962231|FG000|NOT COMPLETED|Overall Study||2
9849517|NCT00865904|10962232|FG001|NOT COMPLETED|Overall Study||0
9849518|NCT00865904|10962233|FG002|NOT COMPLETED|Overall Study||0
9849519|NCT00865904|10962234|FG003|NOT COMPLETED|Overall Study||1
9849520|NCT00865904|10962235|FG004|NOT COMPLETED|Overall Study||1
9849521|NCT00865969|10962251|FG000|STARTED|Overall Study||129
9849522|NCT00865969|10962251|FG000|COMPLETED|Overall Study||129
9849523|NCT00865969|10962251|FG000|NOT COMPLETED|Overall Study||0
9849524|NCT00866034|10962257|FG000|STARTED|Overall Study||308
9849525|NCT00866034|10962258|FG001|STARTED|Overall Study||309
10166377|NCT02991859|11296443|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166378|NCT02991859|11296444|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166379|NCT02991859|11296445|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9849526|NCT00866034|10962257|FG000|COMPLETED|Overall Study||292
9849527|NCT00866034|10962258|FG001|COMPLETED|Overall Study||301
9849528|NCT00866034|10962257|FG000|NOT COMPLETED|Overall Study||16
9849529|NCT00866034|10962258|FG001|NOT COMPLETED|Overall Study||8
9849530|NCT00866047|10962264|FG000|STARTED|Treatment Period||58
9849531|NCT00866047|10962264|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
9849532|NCT00866047|10962264|FG000|NOT COMPLETED|Treatment Period||48
9849533|NCT00866047|10962264|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58
10166380|NCT02991859|11296446|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166381|NCT02991859|11296447|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166382|NCT02991859|11296448|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10166383|NCT02991859|11296449|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10166384|NCT02991859|11296450|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10166385|NCT02991859|11296451|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10166386|NCT02991859|11296452|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10166387|NCT02991859|11296453|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10166388|NCT02991859|11296437|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166389|NCT02991859|11296438|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166390|NCT02991859|11296439|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166391|NCT02991859|11296440|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166392|NCT02991859|11296441|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166393|NCT02991859|11296442|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
10166394|NCT02991859|11296443|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166395|NCT02991859|11296444|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166396|NCT02991859|11296445|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166397|NCT02991859|11296446|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166398|NCT02991859|11296447|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166399|NCT02991859|11296448|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10166400|NCT02991859|11296449|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166401|NCT02991859|11296450|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166402|NCT02991859|11296451|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166403|NCT02991859|11296452|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166404|NCT02991859|11296453|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166405|NCT02991859|11296437|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166406|NCT02991859|11296438|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166407|NCT02991859|11296439|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166408|NCT02991859|11296440|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166409|NCT02991859|11296441|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166410|NCT02991859|11296442|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166411|NCT02991859|11296443|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166412|NCT02991859|11296444|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166413|NCT02991859|11296445|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166414|NCT02991859|11296446|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166415|NCT02991859|11296447|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166416|NCT02991859|11296448|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166417|NCT02991859|11296449|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166418|NCT02991859|11296450|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166419|NCT02991859|11296451|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166420|NCT02991859|11296452|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166421|NCT02991859|11296453|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10166422|NCT02991859|11296437|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166423|NCT02991859|11296438|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166424|NCT02991859|11296439|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166425|NCT02991859|11296440|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166426|NCT02991859|11296441|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166427|NCT02991859|11296442|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1
10166428|NCT02991859|11296443|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166429|NCT02991859|11296444|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166430|NCT02991859|11296445|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166431|NCT02991859|11296446|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166432|NCT02991859|11296447|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166433|NCT02991859|11296448|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10166434|NCT02991859|11296449|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10166435|NCT02991859|11296450|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10166436|NCT02991859|11296451|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10166437|NCT02991859|11296452|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10166438|NCT02991859|11296453|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10166439|NCT02991859|11296437|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166440|NCT02991859|11296438|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166441|NCT02991859|11296439|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166442|NCT02991859|11296440|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166443|NCT02991859|11296441|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166444|NCT02991859|11296442|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
10166445|NCT02991859|11296443|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166446|NCT02991859|11296444|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166447|NCT02991859|11296445|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
10166448|NCT02991859|11296446|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166449|NCT02991859|11296447|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166450|NCT02991859|11296448|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10166451|NCT02991859|11296449|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166452|NCT02991859|11296450|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166453|NCT02991859|11296451|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166454|NCT02991859|11296452|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166455|NCT02991859|11296453|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166456|NCT02991859|11296437|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166457|NCT02991859|11296438|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166458|NCT02991859|11296439|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166459|NCT02991859|11296440|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166460|NCT02991859|11296441|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166461|NCT02991859|11296442|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166462|NCT02991859|11296443|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166463|NCT02991859|11296444|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166464|NCT02991859|11296445|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
10166465|NCT02991859|11296446|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166466|NCT02991859|11296447|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166467|NCT02991859|11296448|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166468|NCT02991859|11296449|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166469|NCT02991859|11296450|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166470|NCT02991859|11296451|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166471|NCT02991859|11296452|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166472|NCT02991859|11296453|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10166473|NCT02991859|11296437|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166474|NCT02991859|11296438|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166475|NCT02991859|11296439|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166476|NCT02991859|11296440|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166477|NCT02991859|11296441|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166478|NCT02991859|11296442|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1
10166479|NCT02991859|11296443|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166480|NCT02991859|11296444|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166481|NCT02991859|11296445|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1
10166482|NCT02991859|11296446|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166483|NCT02991859|11296447|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166484|NCT02991859|11296448|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10166485|NCT02991859|11296449|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10166486|NCT02991859|11296450|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10166487|NCT02991859|11296451|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10166488|NCT02991859|11296452|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10166489|NCT02991859|11296453|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10166490|NCT02991859|11296437|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166491|NCT02991859|11296438|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166492|NCT02991859|11296439|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166493|NCT02991859|11296440|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166494|NCT02991859|11296441|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166495|NCT02991859|11296442|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
10166496|NCT02991859|11296443|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166497|NCT02991859|11296444|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166498|NCT02991859|11296445|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
10166499|NCT02991859|11296446|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166500|NCT02991859|11296447|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166501|NCT02991859|11296448|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10166502|NCT02991859|11296449|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166503|NCT02991859|11296450|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166504|NCT02991859|11296451|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166505|NCT02991859|11296452|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166506|NCT02991859|11296453|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166507|NCT02991859|11296437|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166508|NCT02991859|11296438|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166509|NCT02991859|11296439|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166510|NCT02991859|11296440|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166511|NCT02991859|11296441|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166512|NCT02991859|11296442|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166513|NCT02991859|11296443|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166514|NCT02991859|11296444|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166515|NCT02991859|11296445|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166516|NCT02991859|11296446|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166517|NCT02991859|11296447|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166518|NCT02991859|11296448|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166519|NCT02991859|11296449|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166520|NCT02991859|11296450|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166521|NCT02991859|11296451|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166522|NCT02991859|11296452|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166523|NCT02991859|11296453|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10166524|NCT02991898|11296528|FG000|STARTED|Overall Study||3
10166525|NCT02991898|11296528|FG000|COMPLETED|Overall Study||3
10166526|NCT02991898|11296528|FG000|NOT COMPLETED|Overall Study||0
10166527|NCT02992067|11296532|FG000|STARTED|Overall Study||359
10166528|NCT02992067|11296532|FG000|COMPLETED|Overall Study||359
10166529|NCT02992067|11296532|FG000|NOT COMPLETED|Overall Study||0
10166530|NCT02992132|11296539|FG000|STARTED|Overall Study||40
10166531|NCT02992132|11296540|FG001|STARTED|Overall Study||35
10166532|NCT02992132|11296541|FG002|STARTED|Overall Study||36
10166533|NCT02992132|11296539|FG000|COMPLETED|Overall Study||27
10166534|NCT02992132|11296540|FG001|COMPLETED|Overall Study||27
10166535|NCT02992132|11296541|FG002|COMPLETED|Overall Study||29
10166536|NCT02992132|11296539|FG000|NOT COMPLETED|Overall Study||13
10166537|NCT02992132|11296540|FG001|NOT COMPLETED|Overall Study||8
10166538|NCT02992132|11296541|FG002|NOT COMPLETED|Overall Study||7
10166539|NCT02992197|11296551|FG000|STARTED|Overall Study||110
10166540|NCT02992197|11296552|FG001|STARTED|Overall Study||110
10166541|NCT02992197|11296551|FG000|COMPLETED|Overall Study||99
10166542|NCT02992197|11296552|FG001|COMPLETED|Overall Study||103
10166543|NCT02992197|11296551|FG000|NOT COMPLETED|Overall Study||11
10166544|NCT02992197|11296552|FG001|NOT COMPLETED|Overall Study||7
9711548|NCT03307785|10811142|FG009|NOT COMPLETED|Part G: Up to 24 Months||0
9711549|NCT03307785|10811143|FG010|NOT COMPLETED|Part G: Up to 24 Months||0
9711550|NCT03307785|10811133|FG000|STARTED|Part H: Up to 24 Months||0
9711551|NCT03307785|10811134|FG001|STARTED|Part H: Up to 24 Months||0
9711552|NCT03307785|10811135|FG002|STARTED|Part H: Up to 24 Months||0
9711553|NCT03307785|10811136|FG003|STARTED|Part H: Up to 24 Months||0
9711554|NCT03307785|10811137|FG004|STARTED|Part H: Up to 24 Months||0
9711555|NCT03307785|10811138|FG005|STARTED|Part H: Up to 24 Months||0
9711556|NCT03307785|10811139|FG006|STARTED|Part H: Up to 24 Months||0
9711557|NCT03307785|10811140|FG007|STARTED|Part H: Up to 24 Months||0
9711558|NCT03307785|10811141|FG008|STARTED|Part H: Up to 24 Months||0
9711559|NCT03307785|10811142|FG009|STARTED|Part H: Up to 24 Months||0
9711560|NCT03307785|10811143|FG010|STARTED|Part H: Up to 24 Months||0
9711561|NCT03307785|10811133|FG000|COMPLETED|Part H: Up to 24 Months||0
9711562|NCT03307785|10811134|FG001|COMPLETED|Part H: Up to 24 Months||0
9711563|NCT03307785|10811135|FG002|COMPLETED|Part H: Up to 24 Months||0
9711564|NCT03307785|10811136|FG003|COMPLETED|Part H: Up to 24 Months||0
9711565|NCT03307785|10811137|FG004|COMPLETED|Part H: Up to 24 Months||0
9711566|NCT03307785|10811138|FG005|COMPLETED|Part H: Up to 24 Months||0
9711567|NCT03307785|10811139|FG006|COMPLETED|Part H: Up to 24 Months||0
9711568|NCT03307785|10811140|FG007|COMPLETED|Part H: Up to 24 Months||0
9711569|NCT03307785|10811141|FG008|COMPLETED|Part H: Up to 24 Months||0
9711570|NCT03307785|10811142|FG009|COMPLETED|Part H: Up to 24 Months||0
9711571|NCT03307785|10811143|FG010|COMPLETED|Part H: Up to 24 Months||0
9711572|NCT03307785|10811133|FG000|NOT COMPLETED|Part H: Up to 24 Months||0
9711573|NCT03307785|10811134|FG001|NOT COMPLETED|Part H: Up to 24 Months||0
9711574|NCT03307785|10811135|FG002|NOT COMPLETED|Part H: Up to 24 Months||0
9711575|NCT03307785|10811136|FG003|NOT COMPLETED|Part H: Up to 24 Months||0
9711576|NCT03307785|10811137|FG004|NOT COMPLETED|Part H: Up to 24 Months||0
9711577|NCT03307785|10811138|FG005|NOT COMPLETED|Part H: Up to 24 Months||0
9711578|NCT03307785|10811139|FG006|NOT COMPLETED|Part H: Up to 24 Months||0
9849534|NCT00866047|10962264|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
9849535|NCT00866047|10962264|FG000|NOT COMPLETED|Follow-up Period||5
9849536|NCT00866177|10962268|FG000|STARTED|Overall Study||167
9849537|NCT00866177|10962268|FG000|COMPLETED|Overall Study||15
9849538|NCT00866177|10962268|FG000|NOT COMPLETED|Overall Study||152
9849539|NCT00866281|10962274|FG000|STARTED|Overall Study||7
9849540|NCT00866281|10962275|FG001|STARTED|Overall Study||15
9849541|NCT00866281|10962274|FG000|COMPLETED|Overall Study||0
9849542|NCT00866281|10962275|FG001|COMPLETED|Overall Study||0
9849543|NCT00866281|10962274|FG000|NOT COMPLETED|Overall Study||7
9849544|NCT00866281|10962275|FG001|NOT COMPLETED|Overall Study||15
9849545|NCT00866294|10962287|FG000|STARTED|Overall Study||172
9849546|NCT00866294|10962288|FG001|STARTED|Overall Study||161
9849547|NCT00866294|10962289|FG002|STARTED|Overall Study||83
9849548|NCT00866294|10962287|FG000|COMPLETED|Overall Study||139
9849549|NCT00866294|10962288|FG001|COMPLETED|Overall Study||141
9849550|NCT00866294|10962289|FG002|COMPLETED|Overall Study||72
9849551|NCT00866294|10962287|FG000|NOT COMPLETED|Overall Study||33
9849552|NCT00866294|10962288|FG001|NOT COMPLETED|Overall Study||20
9849553|NCT00866294|10962289|FG002|NOT COMPLETED|Overall Study||11
9849554|NCT00866307|10962305|FG000|STARTED|Induction||104
9849555|NCT00866307|10962306|FG001|STARTED|Induction||0
9849556|NCT00866307|10962307|FG002|STARTED|Induction||0
9849557|NCT00866307|10962305|FG000|COMPLETED|Induction||84
9849558|NCT00866307|10962306|FG001|COMPLETED|Induction||0
9849559|NCT00866307|10962307|FG002|COMPLETED|Induction||0
9849560|NCT00866307|10962305|FG000|NOT COMPLETED|Induction||20
9849561|NCT00866307|10962306|FG001|NOT COMPLETED|Induction||0
9849562|NCT00866307|10962307|FG002|NOT COMPLETED|Induction||0
9849563|NCT00866307|10962305|FG000|STARTED|Consolidation/Maintenance||0
9849564|NCT00866307|10962306|FG001|STARTED|Consolidation/Maintenance||54
10166545|NCT02992236|11296560|FG000|STARTED|Overall Study||8
10166546|NCT02992236|11296561|FG001|STARTED|Overall Study||8
10166547|NCT02992236|11296560|FG000|COMPLETED|Overall Study||8
10166548|NCT02992236|11296561|FG001|COMPLETED|Overall Study||8
10166549|NCT02992236|11296560|FG000|NOT COMPLETED|Overall Study||0
10166550|NCT02992236|11296561|FG001|NOT COMPLETED|Overall Study||0
9849565|NCT00866307|10962307|FG002|STARTED|Consolidation/Maintenance||30
9849566|NCT00866307|10962305|FG000|COMPLETED|Consolidation/Maintenance||0
9849567|NCT00866307|10962306|FG001|COMPLETED|Consolidation/Maintenance||45
10166551|NCT02992288|11296575|FG000|STARTED|Overall Study||106
10166552|NCT02992288|11296576|FG001|STARTED|Overall Study||37
10166553|NCT02992288|11296577|FG002|STARTED|Overall Study||70
10166554|NCT02992288|11296578|FG003|STARTED|Overall Study||73
10166555|NCT02992288|11296579|FG004|STARTED|Overall Study||69
10166556|NCT02992288|11296580|FG005|STARTED|Overall Study||72
10166557|NCT02992288|11296575|FG000|Treated|Overall Study||106
10166558|NCT02992288|11296576|FG001|Treated|Overall Study||37
10166559|NCT02992288|11296577|FG002|Treated|Overall Study||70
10166560|NCT02992288|11296578|FG003|Treated|Overall Study||72
10166561|NCT02992288|11296579|FG004|Treated|Overall Study||69
10166562|NCT02992288|11296580|FG005|Treated|Overall Study||72
10166563|NCT02992288|11296575|FG000|COMPLETED|Overall Study||89
10166564|NCT02992288|11296576|FG001|COMPLETED|Overall Study||32
9711579|NCT03307785|10811140|FG007|NOT COMPLETED|Part H: Up to 24 Months||0
9711580|NCT03307785|10811141|FG008|NOT COMPLETED|Part H: Up to 24 Months||0
9711581|NCT03307785|10811142|FG009|NOT COMPLETED|Part H: Up to 24 Months||0
9711582|NCT03307785|10811143|FG010|NOT COMPLETED|Part H: Up to 24 Months||0
9711583|NCT03307785|10811133|FG000|STARTED|Part I: Up to 24 Months||0
9711584|NCT03307785|10811134|FG001|STARTED|Part I: Up to 24 Months||0
9711585|NCT03307785|10811135|FG002|STARTED|Part I: Up to 24 Months||0
9711586|NCT03307785|10811136|FG003|STARTED|Part I: Up to 24 Months||0
9711587|NCT03307785|10811137|FG004|STARTED|Part I: Up to 24 Months||0
9711588|NCT03307785|10811138|FG005|STARTED|Part I: Up to 24 Months||0
9711589|NCT03307785|10811139|FG006|STARTED|Part I: Up to 24 Months||0
9711590|NCT03307785|10811140|FG007|STARTED|Part I: Up to 24 Months||0
9711591|NCT03307785|10811141|FG008|STARTED|Part I: Up to 24 Months||0
9711592|NCT03307785|10811142|FG009|STARTED|Part I: Up to 24 Months||0
9711593|NCT03307785|10811143|FG010|STARTED|Part I: Up to 24 Months||0
9711594|NCT03307785|10811133|FG000|COMPLETED|Part I: Up to 24 Months||0
9711595|NCT03307785|10811134|FG001|COMPLETED|Part I: Up to 24 Months||0
9711596|NCT03307785|10811135|FG002|COMPLETED|Part I: Up to 24 Months||0
9711597|NCT03307785|10811136|FG003|COMPLETED|Part I: Up to 24 Months||0
9711598|NCT03307785|10811137|FG004|COMPLETED|Part I: Up to 24 Months||0
9711599|NCT03307785|10811138|FG005|COMPLETED|Part I: Up to 24 Months||0
9711600|NCT03307785|10811139|FG006|COMPLETED|Part I: Up to 24 Months||0
9711601|NCT03307785|10811140|FG007|COMPLETED|Part I: Up to 24 Months||0
9711602|NCT03307785|10811141|FG008|COMPLETED|Part I: Up to 24 Months||0
9711603|NCT03307785|10811142|FG009|COMPLETED|Part I: Up to 24 Months||0
9711604|NCT03307785|10811143|FG010|COMPLETED|Part I: Up to 24 Months||0
9711605|NCT03307785|10811133|FG000|NOT COMPLETED|Part I: Up to 24 Months||0
9711606|NCT03307785|10811134|FG001|NOT COMPLETED|Part I: Up to 24 Months||0
9711607|NCT03307785|10811135|FG002|NOT COMPLETED|Part I: Up to 24 Months||0
9711608|NCT03307785|10811136|FG003|NOT COMPLETED|Part I: Up to 24 Months||0
9711609|NCT03307785|10811137|FG004|NOT COMPLETED|Part I: Up to 24 Months||0
9711610|NCT03307785|10811138|FG005|NOT COMPLETED|Part I: Up to 24 Months||0
9711611|NCT03307785|10811139|FG006|NOT COMPLETED|Part I: Up to 24 Months||0
9711612|NCT03307785|10811140|FG007|NOT COMPLETED|Part I: Up to 24 Months||0
9711613|NCT03307785|10811141|FG008|NOT COMPLETED|Part I: Up to 24 Months||0
9711614|NCT03307785|10811142|FG009|NOT COMPLETED|Part I: Up to 24 Months||0
9711615|NCT03307785|10811143|FG010|NOT COMPLETED|Part I: Up to 24 Months||0
9711616|NCT03088826|10811166|FG000|STARTED|Overall Study||40
9711617|NCT03088826|10811167|FG001|STARTED|Overall Study||40
9711618|NCT03088826|10811166|FG000|COMPLETED|Overall Study||40
9711619|NCT03088826|10811167|FG001|COMPLETED|Overall Study||40
9711620|NCT03088826|10811166|FG000|NOT COMPLETED|Overall Study||0
9711621|NCT03088826|10811167|FG001|NOT COMPLETED|Overall Study||0
9711622|NCT03043872|10811176|FG000|STARTED|Overall Study||329
9711623|NCT03043872|10811177|FG001|STARTED|Overall Study||328
9711624|NCT03043872|10811178|FG002|STARTED|Overall Study||330
9711625|NCT03043872|10811176|FG000|Randomized and Included in Global Cohort Analysis|Overall Study||268
9711626|NCT03043872|10811177|FG001|Randomized and Included in Global Cohort Analysis|Overall Study||268
9711627|NCT03043872|10811178|FG002|Randomized and Included in Global Cohort Analysis|Overall Study||269
9711628|NCT03043872|10811176|FG000|Received Treatment in Global Cohort|Overall Study||266
9711629|NCT03043872|10811177|FG001|Received Treatment in Global Cohort|Overall Study||265
9711630|NCT03043872|10811178|FG002|Received Treatment in Global Cohort|Overall Study||266
10061357|NCT02104739|11187055|FG002|STARTED|First Intervention (1 Day)||2
10061358|NCT02104739|11187056|FG003|STARTED|First Intervention (1 Day)||8
10061359|NCT02104739|11187057|FG004|STARTED|First Intervention (1 Day)||0
10061360|NCT02104739|11187058|FG005|STARTED|First Intervention (1 Day)||3
10061361|NCT02104739|11187059|FG006|STARTED|First Intervention (1 Day)||0
10061362|NCT02104739|11187053|FG000|COMPLETED|First Intervention (1 Day)||2
10061363|NCT02104739|11187054|FG001|COMPLETED|First Intervention (1 Day)||4
10061364|NCT02104739|11187055|FG002|COMPLETED|First Intervention (1 Day)||2
10061365|NCT02104739|11187056|FG003|COMPLETED|First Intervention (1 Day)||7
10061366|NCT02104739|11187057|FG004|COMPLETED|First Intervention (1 Day)||0
10061367|NCT02104739|11187058|FG005|COMPLETED|First Intervention (1 Day)||3
10166565|NCT02992288|11296577|FG002|COMPLETED|Overall Study||63
10166566|NCT02992288|11296578|FG003|COMPLETED|Overall Study||64
9711631|NCT03043872|10811176|FG000|Randomized and Included in China Cohort Analysis|Overall Study||65
9711632|NCT03043872|10811177|FG001|Randomized and Included in China Cohort Analysis|Overall Study||61
10061368|NCT02104739|11187059|FG006|COMPLETED|First Intervention (1 Day)||0
10061369|NCT02104739|11187053|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10061370|NCT02104739|11187054|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10061371|NCT02104739|11187055|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10166567|NCT02992288|11296579|FG004|COMPLETED|Overall Study||61
10166568|NCT02992288|11296580|FG005|COMPLETED|Overall Study||59
10166569|NCT02992288|11296575|FG000|NOT COMPLETED|Overall Study||17
10166570|NCT02992288|11296576|FG001|NOT COMPLETED|Overall Study||5
10166571|NCT02992288|11296577|FG002|NOT COMPLETED|Overall Study||7
10166572|NCT02992288|11296578|FG003|NOT COMPLETED|Overall Study||9
10166573|NCT02992288|11296579|FG004|NOT COMPLETED|Overall Study||8
10166574|NCT02992288|11296580|FG005|NOT COMPLETED|Overall Study||13
10166575|NCT02992691|11296594|FG000|STARTED|Overall Study||56
10166576|NCT02992691|11296594|FG000|Received Test Product 1|Overall Study||55
10166577|NCT02992691|11296594|FG000|Received Test Product 2|Overall Study||55
10166578|NCT02992691|11296594|FG000|Received Test Product 3|Overall Study||52
10166579|NCT02992691|11296594|FG000|Received Positive Control|Overall Study||55
10166580|NCT02992691|11296594|FG000|Received Negative Control|Overall Study||55
10166581|NCT02992691|11296594|FG000|COMPLETED|Overall Study||53
10166582|NCT02992691|11296594|FG000|NOT COMPLETED|Overall Study||3
10166583|NCT02992899|11296611|FG000|STARTED|Overall Study||27
10166584|NCT02992899|11296612|FG001|STARTED|Overall Study||29
10166585|NCT02992899|11296611|FG000|COMPLETED|Overall Study||25
10166586|NCT02992899|11296612|FG001|COMPLETED|Overall Study||26
10166587|NCT02992899|11296611|FG000|NOT COMPLETED|Overall Study||2
10166588|NCT02992899|11296612|FG001|NOT COMPLETED|Overall Study||3
10166589|NCT02993224|11296618|FG000|STARTED|Core Phase - Period 1||148
10166590|NCT02993224|11296618|FG000|COMPLETED|Core Phase - Period 1||140
10166591|NCT02993224|11296618|FG000|NOT COMPLETED|Core Phase - Period 1||8
10166592|NCT02993224|11296618|FG000|STARTED|Core Phase- Period 2||140
10166593|NCT02993224|11296618|FG000|COMPLETED|Core Phase- Period 2||136
10166594|NCT02993224|11296618|FG000|NOT COMPLETED|Core Phase- Period 2||4
10166595|NCT02993224|11296618|FG000|STARTED|Extension Phase||116
10166596|NCT02993224|11296618|FG000|COMPLETED|Extension Phase||80
10166597|NCT02993224|11296618|FG000|NOT COMPLETED|Extension Phase||36
10166598|NCT02993250|11296626|FG000|STARTED|Overall Study||22
10166599|NCT02993250|11296627|FG001|STARTED|Overall Study||11
10166600|NCT02993250|11296626|FG000|COMPLETED|Overall Study||22
10166601|NCT02993250|11296627|FG001|COMPLETED|Overall Study||10
10166602|NCT02993250|11296626|FG000|NOT COMPLETED|Overall Study||0
10166603|NCT02993250|11296627|FG001|NOT COMPLETED|Overall Study||1
10166604|NCT02993302|11296635|FG000|STARTED|Overall Study||13
10166605|NCT02993302|11296636|FG001|STARTED|Overall Study||12
10166606|NCT02993302|11296635|FG000|COMPLETED|Overall Study||13
10166607|NCT02993302|11296636|FG001|COMPLETED|Overall Study||12
10166608|NCT02993302|11296635|FG000|NOT COMPLETED|Overall Study||0
10166609|NCT02993302|11296636|FG001|NOT COMPLETED|Overall Study||0
10166610|NCT02993445|11296644|FG000|STARTED|First Intervention (5 Minutes)||6
10166611|NCT02993445|11296645|FG001|STARTED|First Intervention (5 Minutes)||5
10166612|NCT02993445|11296644|FG000|COMPLETED|First Intervention (5 Minutes)||6
10166613|NCT02993445|11296645|FG001|COMPLETED|First Intervention (5 Minutes)||5
10166614|NCT02993445|11296644|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0
10166615|NCT02993445|11296645|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0
10166616|NCT02993445|11296644|FG000|STARTED|Washout (2 Weeks)||6
10166617|NCT02993445|11296645|FG001|STARTED|Washout (2 Weeks)||5
10166618|NCT02993445|11296644|FG000|COMPLETED|Washout (2 Weeks)||6
10166619|NCT02993445|11296645|FG001|COMPLETED|Washout (2 Weeks)||5
10166620|NCT02993445|11296644|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10166621|NCT02993445|11296645|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10166622|NCT02993445|11296644|FG000|STARTED|Second Intervention (5 Mins)||6
10166623|NCT02993445|11296645|FG001|STARTED|Second Intervention (5 Mins)||5
10166624|NCT02993445|11296644|FG000|COMPLETED|Second Intervention (5 Mins)||6
9711633|NCT03043872|10811178|FG002|Randomized and Included in China Cohort Analysis|Overall Study||62
9711634|NCT03043872|10811176|FG000|Received Treatment in China Cohort|Overall Study||65
9711635|NCT03043872|10811177|FG001|Received Treatment in China Cohort|Overall Study||61
9711636|NCT03043872|10811178|FG002|Received Treatment in China Cohort|Overall Study||62
9711637|NCT03043872|10811176|FG000|Included in Both Cohorts (Global + China)|Overall Study||4
9711638|NCT03043872|10811177|FG001|Included in Both Cohorts (Global + China)|Overall Study||1
9711639|NCT03043872|10811178|FG002|Included in Both Cohorts (Global + China)|Overall Study||1
9711640|NCT03043872|10811176|FG000|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
9711641|NCT03043872|10811177|FG001|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
9711642|NCT03043872|10811178|FG002|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||31
9711643|NCT03043872|10811176|FG000|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||16
9849568|NCT00866307|10962307|FG002|COMPLETED|Consolidation/Maintenance||14
10166625|NCT02993445|11296645|FG001|COMPLETED|Second Intervention (5 Mins)||5
10166626|NCT02993445|11296644|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0
10166627|NCT02993445|11296645|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0
10166628|NCT02993471|11296651|FG000|STARTED|Period 1 (Drug Cocktail)||28
10166629|NCT02993471|11296651|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
10166630|NCT02993471|11296651|FG000|COMPLETED|Period 1 (Drug Cocktail)||28
10166631|NCT02993471|11296651|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0
10166632|NCT02993471|11296651|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
10166633|NCT02993471|11296651|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
10166634|NCT02993471|11296651|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
10166635|NCT02993471|11296651|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
10166636|NCT02993783|11296675|FG000|STARTED|Overall Study||8
10166637|NCT02993783|11296676|FG001|STARTED|Overall Study||9
10166638|NCT02993783|11296675|FG000|COMPLETED|Overall Study||2
10166639|NCT02993783|11296676|FG001|COMPLETED|Overall Study||0
10166640|NCT02993783|11296675|FG000|NOT COMPLETED|Overall Study||6
10166641|NCT02993783|11296676|FG001|NOT COMPLETED|Overall Study||9
10166642|NCT02994056|11296682|FG000|STARTED|Overall Study||32
10166643|NCT02994056|11296682|FG000|COMPLETED|Overall Study||23
10166644|NCT02994056|11296682|FG000|NOT COMPLETED|Overall Study||9
10166645|NCT02994108|11296697|FG000|STARTED|Intervention Messages||74
10166646|NCT02994108|11296698|FG001|STARTED|Intervention Messages||76
10166647|NCT02994108|11296697|FG000|COMPLETED|Intervention Messages||72
10166648|NCT02994108|11296698|FG001|COMPLETED|Intervention Messages||76
10166649|NCT02994108|11296697|FG000|NOT COMPLETED|Intervention Messages||2
10166650|NCT02994108|11296698|FG001|NOT COMPLETED|Intervention Messages||0
10166651|NCT02994108|11296697|FG000|STARTED|Phase 1 Assessment||72
10166652|NCT02994108|11296698|FG001|STARTED|Phase 1 Assessment||76
10166653|NCT02994108|11296697|FG000|COMPLETED|Phase 1 Assessment||67
10166654|NCT02994108|11296698|FG001|COMPLETED|Phase 1 Assessment||73
10166655|NCT02994108|11296697|FG000|NOT COMPLETED|Phase 1 Assessment||5
10166656|NCT02994108|11296698|FG001|NOT COMPLETED|Phase 1 Assessment||3
10166657|NCT02994108|11296697|FG000|STARTED|Phase 2 Assessment||72
10166658|NCT02994108|11296698|FG001|STARTED|Phase 2 Assessment||76
10166659|NCT02994108|11296697|FG000|COMPLETED|Phase 2 Assessment||63
10166660|NCT02994108|11296698|FG001|COMPLETED|Phase 2 Assessment||69
10166661|NCT02994108|11296697|FG000|NOT COMPLETED|Phase 2 Assessment||9
10166662|NCT02994108|11296698|FG001|NOT COMPLETED|Phase 2 Assessment||7
10166663|NCT02994238|11296707|FG000|STARTED|Overall Study||125
9711644|NCT03043872|10811177|FG001|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||11
9711645|NCT03043872|10811178|FG002|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||7
9711646|NCT03043872|10811176|FG000|COMPLETED|Overall Study||51
9711647|NCT03043872|10811177|FG001|COMPLETED|Overall Study||52
9711648|NCT03043872|10811178|FG002|COMPLETED|Overall Study||18
9711649|NCT03043872|10811176|FG000|NOT COMPLETED|Overall Study||278
9711650|NCT03043872|10811177|FG001|NOT COMPLETED|Overall Study||276
9711651|NCT03043872|10811178|FG002|NOT COMPLETED|Overall Study||312
9711652|NCT03034018|10811198|FG000|STARTED|Overall Study||30
9711653|NCT03034018|10811199|FG001|STARTED|Overall Study||30
9711654|NCT03034018|10811198|FG000|Initiated Assigned Treatment|Overall Study||27
9711655|NCT03034018|10811199|FG001|Initiated Assigned Treatment|Overall Study||29
9711656|NCT03034018|10811198|FG000|COMPLETED|Overall Study||25
9711657|NCT03034018|10811199|FG001|COMPLETED|Overall Study||28
9711658|NCT03034018|10811198|FG000|NOT COMPLETED|Overall Study||5
9711659|NCT03034018|10811199|FG001|NOT COMPLETED|Overall Study||2
9711660|NCT02750215|10811205|FG000|STARTED|Overall Study||20
9711661|NCT02750215|10811205|FG000|COMPLETED|Overall Study||20
9711662|NCT02750215|10811205|FG000|NOT COMPLETED|Overall Study||0
9711663|NCT02673333|10811209|FG000|STARTED|Overall Study||39
9711664|NCT02673333|10811209|FG000|COMPLETED|Overall Study||39
9711665|NCT02673333|10811209|FG000|NOT COMPLETED|Overall Study||0
9711666|NCT01984346|10811215|FG000|STARTED|Overall Study|Date of full approval was 8/22/13. Date of first treated patient was 01/08/14|115
9711667|NCT01984346|10811216|FG001|STARTED|Overall Study||55
9711668|NCT01984346|10811215|FG000|Treated|Overall Study||102
9711669|NCT01984346|10811216|FG001|Treated|Overall Study||51
9711670|NCT01984346|10811215|FG000|COMPLETED|Overall Study||98
9711671|NCT01984346|10811216|FG001|COMPLETED|Overall Study||50
9711672|NCT01984346|10811215|FG000|NOT COMPLETED|Overall Study||17
9711673|NCT01984346|10811216|FG001|NOT COMPLETED|Overall Study||5
9711674|NCT01750281|10811225|FG000|STARTED|Overall Study||43
9711675|NCT01750281|10811226|FG001|STARTED|Overall Study||85
9711676|NCT01750281|10811227|FG002|STARTED|Overall Study||84
9711677|NCT01750281|10811225|FG000|Received Treatment|Overall Study||43
9711678|NCT01750281|10811226|FG001|Received Treatment|Overall Study||84
9711679|NCT01750281|10811227|FG002|Received Treatment|Overall Study||84
9711680|NCT01750281|10811225|FG000|Did Not Receive Treatment|Overall Study||0
9711681|NCT01750281|10811226|FG001|Did Not Receive Treatment|Overall Study||1
9711682|NCT01750281|10811227|FG002|Did Not Receive Treatment|Overall Study||0
9711683|NCT01750281|10811225|FG000|COMPLETED|Overall Study||0
9711684|NCT01750281|10811226|FG001|COMPLETED|Overall Study||0
9711685|NCT01750281|10811227|FG002|COMPLETED|Overall Study||0
9711686|NCT01750281|10811225|FG000|NOT COMPLETED|Overall Study||43
9711687|NCT01750281|10811226|FG001|NOT COMPLETED|Overall Study||85
9711688|NCT01750281|10811227|FG002|NOT COMPLETED|Overall Study||84
9711689|NCT01353118|10811237|FG000|STARTED|Overall Study||21
9711690|NCT01353118|10811238|FG001|STARTED|Overall Study||20
9711691|NCT01353118|10811237|FG000|COMPLETED|Overall Study||21
9711692|NCT01353118|10811238|FG001|COMPLETED|Overall Study||20
9711693|NCT01353118|10811237|FG000|NOT COMPLETED|Overall Study||0
9711694|NCT01353118|10811238|FG001|NOT COMPLETED|Overall Study||0
9711695|NCT01252953|10811246|FG000|STARTED|Overall Study||15225
9711696|NCT01252953|10811247|FG001|STARTED|Overall Study||15224
9711697|NCT01252953|10811246|FG000|COMPLETED|Overall Study||15187
10166664|NCT02994238|11296708|FG001|STARTED|Overall Study||127
10166665|NCT02994238|11296707|FG000|COMPLETED|Overall Study||125
9711698|NCT01252953|10811247|FG001|COMPLETED|Overall Study||15186
9711699|NCT01252953|10811246|FG000|NOT COMPLETED|Overall Study||38
9711700|NCT01252953|10811247|FG001|NOT COMPLETED|Overall Study||38
9711701|NCT01012609|10811256|FG000|STARTED|Overall Study||21
9711702|NCT01012609|10811257|FG001|STARTED|Overall Study||26
9711703|NCT01012609|10811256|FG000|COMPLETED|Overall Study||20
10166666|NCT02994238|11296708|FG001|COMPLETED|Overall Study||127
10166667|NCT02994238|11296707|FG000|NOT COMPLETED|Overall Study||0
10166668|NCT02994238|11296708|FG001|NOT COMPLETED|Overall Study||0
10166669|NCT02994394|11296716|FG000|STARTED|Period 1 (Days 1 to 3)||14
10166670|NCT02994394|11296717|FG001|STARTED|Period 1 (Days 1 to 3)||14
10166671|NCT02994394|11296718|FG002|STARTED|Period 1 (Days 1 to 3)||14
10166672|NCT02994394|11296719|FG003|STARTED|Period 1 (Days 1 to 3)||14
10166673|NCT02994394|11296720|FG004|STARTED|Period 1 (Days 1 to 3)||14
10166674|NCT02994394|11296721|FG005|STARTED|Period 1 (Days 1 to 3)||14
10166675|NCT02994394|11296716|FG000|COMPLETED|Period 1 (Days 1 to 3)||14
10166676|NCT02994394|11296717|FG001|COMPLETED|Period 1 (Days 1 to 3)||14
10166677|NCT02994394|11296718|FG002|COMPLETED|Period 1 (Days 1 to 3)||13
10166678|NCT02994394|11296719|FG003|COMPLETED|Period 1 (Days 1 to 3)||14
10166679|NCT02994394|11296720|FG004|COMPLETED|Period 1 (Days 1 to 3)||14
10166680|NCT02994394|11296721|FG005|COMPLETED|Period 1 (Days 1 to 3)||14
10166681|NCT02994394|11296716|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10166682|NCT02994394|11296717|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10166683|NCT02994394|11296718|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1
10166684|NCT02994394|11296719|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10166685|NCT02994394|11296720|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10166686|NCT02994394|11296721|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10166687|NCT02994394|11296716|FG000|STARTED|Period 2 (Days 4 to 6)||14
10166688|NCT02994394|11296717|FG001|STARTED|Period 2 (Days 4 to 6)||14
10166689|NCT02994394|11296718|FG002|STARTED|Period 2 (Days 4 to 6)||13
10166690|NCT02994394|11296719|FG003|STARTED|Period 2 (Days 4 to 6)||14
10166691|NCT02994394|11296720|FG004|STARTED|Period 2 (Days 4 to 6)||14
10166692|NCT02994394|11296721|FG005|STARTED|Period 2 (Days 4 to 6)||14
10166693|NCT02994394|11296716|FG000|COMPLETED|Period 2 (Days 4 to 6)||14
10166694|NCT02994394|11296717|FG001|COMPLETED|Period 2 (Days 4 to 6)||13
10166695|NCT02994394|11296718|FG002|COMPLETED|Period 2 (Days 4 to 6)||13
10166696|NCT02994394|11296719|FG003|COMPLETED|Period 2 (Days 4 to 6)||14
10166697|NCT02994394|11296720|FG004|COMPLETED|Period 2 (Days 4 to 6)||13
10166698|NCT02994394|11296721|FG005|COMPLETED|Period 2 (Days 4 to 6)||14
10166699|NCT02994394|11296716|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10166700|NCT02994394|11296717|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1
10166701|NCT02994394|11296718|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10166702|NCT02994394|11296719|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10166703|NCT02994394|11296720|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1
10166704|NCT02994394|11296721|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10166705|NCT02994394|11296716|FG000|STARTED|Period 3 (Days 7 and 8)||14
10166706|NCT02994394|11296717|FG001|STARTED|Period 3 (Days 7 and 8)||13
10166707|NCT02994394|11296718|FG002|STARTED|Period 3 (Days 7 and 8)||13
10166708|NCT02994394|11296719|FG003|STARTED|Period 3 (Days 7 and 8)||14
10166709|NCT02994394|11296720|FG004|STARTED|Period 3 (Days 7 and 8)||13
10166710|NCT02994394|11296721|FG005|STARTED|Period 3 (Days 7 and 8)||14
10166711|NCT02994394|11296716|FG000|COMPLETED|Period 3 (Days 7 and 8)||14
10166712|NCT02994394|11296717|FG001|COMPLETED|Period 3 (Days 7 and 8)||13
10166713|NCT02994394|11296718|FG002|COMPLETED|Period 3 (Days 7 and 8)||13
10166714|NCT02994394|11296719|FG003|COMPLETED|Period 3 (Days 7 and 8)||14
10166715|NCT02994394|11296720|FG004|COMPLETED|Period 3 (Days 7 and 8)||13
10166716|NCT02994394|11296721|FG005|COMPLETED|Period 3 (Days 7 and 8)||14
10166717|NCT02994394|11296716|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10166718|NCT02994394|11296717|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10166719|NCT02994394|11296718|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10166720|NCT02994394|11296719|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10166721|NCT02994394|11296720|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10166722|NCT02994394|11296721|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10166723|NCT02994654|11296735|FG000|STARTED|Overall Study||12
10166724|NCT02994654|11296735|FG000|COMPLETED|Overall Study||11
10166725|NCT02994654|11296735|FG000|NOT COMPLETED|Overall Study||1
10166726|NCT02994732|11296740|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
10166727|NCT02994732|11296740|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
10166728|NCT02994732|11296740|FG000|NOT COMPLETED|Overall Study||0
10166729|NCT02994940|11296747|FG000|STARTED|Overall Study||37
10166730|NCT02994940|11296748|FG001|STARTED|Overall Study||37
10166731|NCT02994940|11296747|FG000|COMPLETED|Overall Study||30
10166732|NCT02994940|11296748|FG001|COMPLETED|Overall Study||36
10166733|NCT02994940|11296747|FG000|NOT COMPLETED|Overall Study||7
10166734|NCT02994940|11296748|FG001|NOT COMPLETED|Overall Study||1
10166735|NCT02994979|11296756|FG000|STARTED|Overall Study||114
10166736|NCT02994979|11296757|FG001|STARTED|Overall Study||105
10166737|NCT02994979|11296756|FG000|COMPLETED|Overall Study||114
10166738|NCT02994979|11296757|FG001|COMPLETED|Overall Study||105
10166739|NCT02994979|11296756|FG000|NOT COMPLETED|Overall Study||0
10166740|NCT02994979|11296757|FG001|NOT COMPLETED|Overall Study||0
10166741|NCT02995915|11296765|FG000|STARTED|Overall Study||30
10166742|NCT02995915|11296766|FG001|STARTED|Overall Study||15
10166743|NCT02995915|11296765|FG000|COMPLETED|Overall Study||30
10166744|NCT02995915|11296766|FG001|COMPLETED|Overall Study||15
10166745|NCT02995915|11296765|FG000|NOT COMPLETED|Overall Study||0
10166746|NCT02995915|11296766|FG001|NOT COMPLETED|Overall Study||0
10166747|NCT02995980|11296772|FG000|STARTED|Overall Study||128
10166748|NCT02995980|11296772|FG000|COMPLETED|Overall Study||114
10166749|NCT02995980|11296772|FG000|NOT COMPLETED|Overall Study||14
10166750|NCT02996097|11296777|FG000|STARTED|Overall Study||30
10166751|NCT02996097|11296778|FG001|STARTED|Overall Study||30
10166752|NCT02996097|11296777|FG000|Per Protocol Population|Overall Study||22
10166753|NCT02996097|11296778|FG001|Per Protocol Population|Overall Study||22
10166754|NCT02996097|11296777|FG000|COMPLETED|Overall Study||19
10166755|NCT02996097|11296778|FG001|COMPLETED|Overall Study||19
10166756|NCT02996097|11296777|FG000|NOT COMPLETED|Overall Study||11
10166757|NCT02996097|11296778|FG001|NOT COMPLETED|Overall Study||11
10166758|NCT02996448|11296783|FG000|STARTED|Overall Study||3
10166759|NCT02996448|11296783|FG000|COMPLETED|Overall Study||0
10166760|NCT02996448|11296783|FG000|NOT COMPLETED|Overall Study||3
10166761|NCT02996474|11296788|FG000|STARTED|Overall Study||10
10166762|NCT02996474|11296788|FG000|COMPLETED|Overall Study||5
10166763|NCT02996474|11296788|FG000|NOT COMPLETED|Overall Study||5
10166764|NCT02996500|11296798|FG000|STARTED|Overall Study||39
10166765|NCT02996500|11296799|FG001|STARTED|Overall Study||43
10166766|NCT02996500|11296800|FG002|STARTED|Overall Study||39
10166767|NCT02996500|11296801|FG003|STARTED|Overall Study||50
10166768|NCT02996500|11296802|FG004|STARTED|Overall Study||50
10166769|NCT02996500|11296803|FG005|STARTED|Overall Study||48
10166770|NCT02996500|11296798|FG000|COMPLETED|Overall Study||31
10166771|NCT02996500|11296799|FG001|COMPLETED|Overall Study||42
10166772|NCT02996500|11296800|FG002|COMPLETED|Overall Study||29
10166773|NCT02996500|11296801|FG003|COMPLETED|Overall Study||46
10166774|NCT02996500|11296802|FG004|COMPLETED|Overall Study||45
10166775|NCT02996500|11296803|FG005|COMPLETED|Overall Study||44
10166776|NCT02996500|11296798|FG000|NOT COMPLETED|Overall Study||8
10166777|NCT02996500|11296799|FG001|NOT COMPLETED|Overall Study||1
10166778|NCT02996500|11296800|FG002|NOT COMPLETED|Overall Study||10
10166779|NCT02996500|11296801|FG003|NOT COMPLETED|Overall Study||4
10166780|NCT02996500|11296802|FG004|NOT COMPLETED|Overall Study||5
10166781|NCT02996500|11296803|FG005|NOT COMPLETED|Overall Study||4
10166782|NCT02996591|11296823|FG000|STARTED|Overall Study||18
10166783|NCT02996591|11296824|FG001|STARTED|Overall Study||18
10166784|NCT02996591|11296823|FG000|COMPLETED|Overall Study||18
10166785|NCT02996591|11296824|FG001|COMPLETED|Overall Study||18
10166786|NCT02996591|11296823|FG000|NOT COMPLETED|Overall Study||0
10166787|NCT02996591|11296824|FG001|NOT COMPLETED|Overall Study||0
10166788|NCT02996682|11296832|FG000|STARTED|Overall Study||51
10166789|NCT02996682|11296833|FG001|STARTED|Overall Study||51
10166790|NCT02996682|11296832|FG000|COMPLETED|Overall Study||51
10166791|NCT02996682|11296833|FG001|COMPLETED|Overall Study||48
10166792|NCT02996682|11296832|FG000|NOT COMPLETED|Overall Study||0
10166793|NCT02996682|11296833|FG001|NOT COMPLETED|Overall Study||3
10166794|NCT02996864|11296841|FG000|STARTED|Overall Study||150
10166795|NCT02996864|11296842|FG001|STARTED|Overall Study||150
10166796|NCT02996864|11296841|FG000|COMPLETED|Overall Study||142
10166797|NCT02996864|11296842|FG001|COMPLETED|Overall Study||136
10166798|NCT02996864|11296841|FG000|NOT COMPLETED|Overall Study||8
10166799|NCT02996864|11296842|FG001|NOT COMPLETED|Overall Study||14
10166800|NCT02996968|11296850|FG000|STARTED|Overall Study||79
10166801|NCT02996968|11296851|FG001|STARTED|Overall Study||79
10166802|NCT02996968|11296850|FG000|COMPLETED|Overall Study||78
10166803|NCT02996968|11296851|FG001|COMPLETED|Overall Study||79
10166804|NCT02996968|11296850|FG000|NOT COMPLETED|Overall Study||1
10166805|NCT02996968|11296851|FG001|NOT COMPLETED|Overall Study||0
10166806|NCT02997085|11296860|FG000|STARTED|Overall Study||34
10166807|NCT02997085|11296861|FG001|STARTED|Overall Study||35
10166808|NCT02997085|11296862|FG002|STARTED|Overall Study||34
10166809|NCT02997085|11296860|FG000|COMPLETED|Overall Study||34
10166810|NCT02997085|11296861|FG001|COMPLETED|Overall Study||35
10166811|NCT02997085|11296862|FG002|COMPLETED|Overall Study||34
10166812|NCT02997085|11296860|FG000|NOT COMPLETED|Overall Study||0
10166813|NCT02997085|11296861|FG001|NOT COMPLETED|Overall Study||0
10166814|NCT02997085|11296862|FG002|NOT COMPLETED|Overall Study||0
10166815|NCT02997163|11296873|FG000|STARTED|Overall Study||9
10166816|NCT02997163|11296874|FG001|STARTED|Overall Study||9
10166817|NCT02997163|11296875|FG002|STARTED|Overall Study||8
10166818|NCT02997163|11296876|FG003|STARTED|Overall Study||8
10166819|NCT02997163|11296873|FG000|COMPLETED|Overall Study||8
10166820|NCT02997163|11296874|FG001|COMPLETED|Overall Study||9
10166821|NCT02997163|11296875|FG002|COMPLETED|Overall Study||8
10166822|NCT02997163|11296876|FG003|COMPLETED|Overall Study||7
10166823|NCT02997163|11296873|FG000|NOT COMPLETED|Overall Study||1
10166824|NCT02997163|11296874|FG001|NOT COMPLETED|Overall Study||0
10166825|NCT02997163|11296875|FG002|NOT COMPLETED|Overall Study||0
10166826|NCT02997163|11296876|FG003|NOT COMPLETED|Overall Study||1
10166827|NCT02997176|11296890|FG000|STARTED|Overall Study||7
10166828|NCT02997176|11296891|FG001|STARTED|Overall Study||10
10166829|NCT02997176|11296892|FG002|STARTED|Overall Study||5
10166830|NCT02997176|11296893|FG003|STARTED|Overall Study||16
10166831|NCT02997176|11296890|FG000|COMPLETED|Overall Study||6
10166832|NCT02997176|11296891|FG001|COMPLETED|Overall Study||8
10166833|NCT02997176|11296892|FG002|COMPLETED|Overall Study||3
10166834|NCT02997176|11296893|FG003|COMPLETED|Overall Study||5
10166835|NCT02997176|11296890|FG000|NOT COMPLETED|Overall Study||1
10166836|NCT02997176|11296891|FG001|NOT COMPLETED|Overall Study||2
10166837|NCT02997176|11296892|FG002|NOT COMPLETED|Overall Study||2
10166838|NCT02997176|11296893|FG003|NOT COMPLETED|Overall Study||11
10166839|NCT02997722|11296905|FG000|STARTED|Overall Study||3
10166840|NCT02997722|11296906|FG001|STARTED|Overall Study||1
10166841|NCT02997722|11296905|FG000|COMPLETED|Overall Study||3
10166842|NCT02997722|11296906|FG001|COMPLETED|Overall Study||1
10166843|NCT02997722|11296905|FG000|NOT COMPLETED|Overall Study||0
10166844|NCT02997722|11296906|FG001|NOT COMPLETED|Overall Study||0
10166845|NCT02997735|11296914|FG000|STARTED|Overall Study||233
10166846|NCT02997735|11296915|FG001|STARTED|Overall Study||251
10166847|NCT02997735|11296914|FG000|COMPLETED|Overall Study||233
10166848|NCT02997735|11296915|FG001|COMPLETED|Overall Study||251
10166849|NCT02997735|11296914|FG000|NOT COMPLETED|Overall Study||0
10166850|NCT02997735|11296915|FG001|NOT COMPLETED|Overall Study||0
10166851|NCT02997904|11296923|FG000|STARTED|Overall Study||51
10166852|NCT02997904|11296924|FG001|STARTED|Overall Study||49
10166853|NCT02997904|11296923|FG000|COMPLETED|Overall Study||51
10166854|NCT02997904|11296924|FG001|COMPLETED|Overall Study||49
10166855|NCT02997904|11296923|FG000|NOT COMPLETED|Overall Study||0
10166856|NCT02997904|11296924|FG001|NOT COMPLETED|Overall Study||0
10166857|NCT02998021|11296936|FG000|STARTED|Overall Study||8
10166858|NCT02998021|11296937|FG001|STARTED|Overall Study||2
10166859|NCT02998021|11296936|FG000|COMPLETED|Overall Study||5
10166860|NCT02998021|11296937|FG001|COMPLETED|Overall Study||0
10166861|NCT02998021|11296936|FG000|NOT COMPLETED|Overall Study||3
10166862|NCT02998021|11296937|FG001|NOT COMPLETED|Overall Study||2
10166863|NCT02998151|11296943|FG000|STARTED|Overall Study||29
10166864|NCT02998151|11296943|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27
10166865|NCT02998151|11296943|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16
10166866|NCT02998151|11296943|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29
10166867|NCT02998151|11296943|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27
10166868|NCT02998151|11296943|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18
10166869|NCT02998151|11296943|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5
10166870|NCT02998151|11296943|FG000|NOT COMPLETED|Overall Study||24
10166871|NCT02998541|11296958|FG000|STARTED|Overall Study||86
10166872|NCT02998541|11296959|FG001|STARTED|Overall Study||90
10166873|NCT02998541|11296960|FG002|STARTED|Overall Study||43
10166874|NCT02998541|11296958|FG000|COMPLETED|Overall Study||78
10166875|NCT02998541|11296959|FG001|COMPLETED|Overall Study||81
10166876|NCT02998541|11296960|FG002|COMPLETED|Overall Study||37
10166877|NCT02998541|11296958|FG000|NOT COMPLETED|Overall Study||8
10166878|NCT02998541|11296959|FG001|NOT COMPLETED|Overall Study||9
10166879|NCT02998541|11296960|FG002|NOT COMPLETED|Overall Study||6
10166880|NCT02998554|11296970|FG000|STARTED|Overall Study||79
10166881|NCT02998554|11296971|FG001|STARTED|Overall Study||77
10166882|NCT02998554|11296970|FG000|COMPLETED|Overall Study||68
10166883|NCT02998554|11296971|FG001|COMPLETED|Overall Study||66
10166884|NCT02998554|11296970|FG000|NOT COMPLETED|Overall Study||11
10166885|NCT02998554|11296971|FG001|NOT COMPLETED|Overall Study||11
10166886|NCT02998671|11296984|FG000|STARTED|Period 1||21
10166887|NCT02998671|11296985|FG001|STARTED|Period 1||13
10166888|NCT02998671|11296986|FG002|STARTED|Period 1||6
10166889|NCT02998671|11296987|FG003|STARTED|Period 1||8
10166890|NCT02998671|11296988|FG004|STARTED|Period 1||4
10166891|NCT02998671|11296984|FG000|COMPLETED|Period 1||17
10166892|NCT02998671|11296985|FG001|COMPLETED|Period 1||10
10166893|NCT02998671|11296986|FG002|COMPLETED|Period 1||6
10166894|NCT02998671|11296987|FG003|COMPLETED|Period 1||8
10166895|NCT02998671|11296988|FG004|COMPLETED|Period 1||0
10166896|NCT02998671|11296984|FG000|NOT COMPLETED|Period 1||4
10166897|NCT02998671|11296985|FG001|NOT COMPLETED|Period 1||3
10166898|NCT02998671|11296986|FG002|NOT COMPLETED|Period 1||0
10166899|NCT02998671|11296987|FG003|NOT COMPLETED|Period 1||0
10166900|NCT02998671|11296988|FG004|NOT COMPLETED|Period 1||4
10166901|NCT02998671|11296984|FG000|STARTED|Period 2||17
10166902|NCT02998671|11296985|FG001|STARTED|Period 2||10
10166903|NCT02998671|11296986|FG002|STARTED|Period 2||6
10166904|NCT02998671|11296987|FG003|STARTED|Period 2||8
10166905|NCT02998671|11296988|FG004|STARTED|Period 2||0
10166906|NCT02998671|11296984|FG000|COMPLETED|Period 2||14
10166907|NCT02998671|11296985|FG001|COMPLETED|Period 2||3
10166908|NCT02998671|11296986|FG002|COMPLETED|Period 2||5
10166909|NCT02998671|11296987|FG003|COMPLETED|Period 2||4
10166910|NCT02998671|11296988|FG004|COMPLETED|Period 2||0
10166911|NCT02998671|11296984|FG000|NOT COMPLETED|Period 2||3
10166912|NCT02998671|11296985|FG001|NOT COMPLETED|Period 2||7
10166913|NCT02998671|11296986|FG002|NOT COMPLETED|Period 2||1
10166914|NCT02998671|11296987|FG003|NOT COMPLETED|Period 2||4
10166915|NCT02998671|11296988|FG004|NOT COMPLETED|Period 2||0
10166916|NCT02998684|11297010|FG000|STARTED|Overall Study||7
10166917|NCT02998684|11297011|FG001|STARTED|Overall Study||7
10166918|NCT02998684|11297010|FG000|COMPLETED|Overall Study||4
10166919|NCT02998684|11297011|FG001|COMPLETED|Overall Study||6
10166920|NCT02998684|11297010|FG000|NOT COMPLETED|Overall Study||3
10166921|NCT02998684|11297011|FG001|NOT COMPLETED|Overall Study||1
10166922|NCT02998996|11297023|FG000|STARTED|Overall Study||36
10166923|NCT02998996|11297024|FG001|STARTED|Overall Study||35
10166924|NCT02998996|11297025|FG002|STARTED|Overall Study||36
10166925|NCT02998996|11297026|FG003|STARTED|Overall Study||18
10166926|NCT02998996|11297027|FG004|STARTED|Overall Study||18
10166927|NCT02998996|11297028|FG005|STARTED|Overall Study||19
10166928|NCT02998996|11297023|FG000|COMPLETED|Overall Study||36
10166929|NCT02998996|11297024|FG001|COMPLETED|Overall Study||34
10166930|NCT02998996|11297025|FG002|COMPLETED|Overall Study||35
10166931|NCT02998996|11297026|FG003|COMPLETED|Overall Study||18
10166932|NCT02998996|11297027|FG004|COMPLETED|Overall Study||17
10166933|NCT02998996|11297028|FG005|COMPLETED|Overall Study||19
10166934|NCT02998996|11297023|FG000|NOT COMPLETED|Overall Study||0
10166935|NCT02998996|11297024|FG001|NOT COMPLETED|Overall Study||1
10166936|NCT02998996|11297025|FG002|NOT COMPLETED|Overall Study||1
10166937|NCT02998996|11297026|FG003|NOT COMPLETED|Overall Study||0
10166938|NCT02998996|11297027|FG004|NOT COMPLETED|Overall Study||1
10166939|NCT02998996|11297028|FG005|NOT COMPLETED|Overall Study||0
10166940|NCT02999100|11297048|FG000|STARTED|Part 1 (up to 15 Days)||9
10166941|NCT02999100|11297049|FG001|STARTED|Part 1 (up to 15 Days)||8
10166942|NCT02999100|11297050|FG002|STARTED|Part 1 (up to 15 Days)||0
10166943|NCT02999100|11297051|FG003|STARTED|Part 1 (up to 15 Days)||0
10166944|NCT02999100|11297052|FG004|STARTED|Part 1 (up to 15 Days)||0
10166945|NCT02999100|11297053|FG005|STARTED|Part 1 (up to 15 Days)||0
10166946|NCT02999100|11297048|FG000|COMPLETED|Part 1 (up to 15 Days)||9
10166947|NCT02999100|11297049|FG001|COMPLETED|Part 1 (up to 15 Days)||7
10166948|NCT02999100|11297050|FG002|COMPLETED|Part 1 (up to 15 Days)||0
10166949|NCT02999100|11297051|FG003|COMPLETED|Part 1 (up to 15 Days)||0
10166950|NCT02999100|11297052|FG004|COMPLETED|Part 1 (up to 15 Days)||0
10166951|NCT02999100|11297053|FG005|COMPLETED|Part 1 (up to 15 Days)||0
10166952|NCT02999100|11297048|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0
10166953|NCT02999100|11297049|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1
10166954|NCT02999100|11297050|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0
10166955|NCT02999100|11297051|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0
10166956|NCT02999100|11297052|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0
10166957|NCT02999100|11297053|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0
10166958|NCT02999100|11297048|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
10166959|NCT02999100|11297049|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
10166960|NCT02999100|11297050|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
10166961|NCT02999100|11297051|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
10166962|NCT02999100|11297052|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
10166963|NCT02999100|11297053|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
10166964|NCT02999100|11297048|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10166965|NCT02999100|11297049|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10166966|NCT02999100|11297050|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
10166967|NCT02999100|11297051|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
10166968|NCT02999100|11297052|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
10166969|NCT02999100|11297053|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
10166970|NCT02999100|11297048|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10166971|NCT02999100|11297049|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10166972|NCT02999100|11297050|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
10166973|NCT02999100|11297051|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10166974|NCT02999100|11297052|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10166975|NCT02999100|11297053|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
10166976|NCT02999100|11297048|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0
10166977|NCT02999100|11297049|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0
10166978|NCT02999100|11297050|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4
10166979|NCT02999100|11297051|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3
10166980|NCT02999100|11297052|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3
10166981|NCT02999100|11297053|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2
10166982|NCT02999100|11297048|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166983|NCT02999100|11297049|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166984|NCT02999100|11297050|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
10166985|NCT02999100|11297051|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
10166986|NCT02999100|11297052|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
10166987|NCT02999100|11297053|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
10166988|NCT02999100|11297048|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166989|NCT02999100|11297049|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166990|NCT02999100|11297050|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166991|NCT02999100|11297051|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166992|NCT02999100|11297052|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166993|NCT02999100|11297053|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10166994|NCT02999178|11297077|FG000|STARTED|Overall Study||332
10166995|NCT02999178|11297078|FG001|STARTED|Overall Study||331
10166996|NCT02999178|11297077|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
10197585|NCT03379259|11325561|FG005|COMPLETED|Overall Study||5
10166997|NCT02999178|11297078|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
10166998|NCT02999178|11297077|FG000|NOT COMPLETED|Overall Study||114
10166999|NCT02999178|11297078|FG001|NOT COMPLETED|Overall Study||100
10167000|NCT02999191|11297087|FG000|STARTED|Treatment Period 1 [1 Day]||6
10167001|NCT02999191|11297088|FG001|STARTED|Treatment Period 1 [1 Day]||6
10167002|NCT02999191|11297089|FG002|STARTED|Treatment Period 1 [1 Day]||6
10167003|NCT02999191|11297087|FG000|COMPLETED|Treatment Period 1 [1 Day]||6
10167004|NCT02999191|11297088|FG001|COMPLETED|Treatment Period 1 [1 Day]||6
10167005|NCT02999191|11297089|FG002|COMPLETED|Treatment Period 1 [1 Day]||6
10167006|NCT02999191|11297087|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0
10167007|NCT02999191|11297088|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0
10167008|NCT02999191|11297089|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0
10167009|NCT02999191|11297087|FG000|STARTED|Wash-out Period 1 [21 Days]||6
10167010|NCT02999191|11297088|FG001|STARTED|Wash-out Period 1 [21 Days]||6
10167011|NCT02999191|11297089|FG002|STARTED|Wash-out Period 1 [21 Days]||6
10167012|NCT02999191|11297087|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6
10167013|NCT02999191|11297088|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5
10167014|NCT02999191|11297089|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6
10167015|NCT02999191|11297087|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
10167016|NCT02999191|11297088|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
10167017|NCT02999191|11297089|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
10167018|NCT02999191|11297087|FG000|STARTED|Treatment Period 2 [1 Day]||6
10167019|NCT02999191|11297088|FG001|STARTED|Treatment Period 2 [1 Day]||5
10167020|NCT02999191|11297089|FG002|STARTED|Treatment Period 2 [1 Day]||6
10167021|NCT02999191|11297087|FG000|COMPLETED|Treatment Period 2 [1 Day]||6
10167022|NCT02999191|11297088|FG001|COMPLETED|Treatment Period 2 [1 Day]||5
10167023|NCT02999191|11297089|FG002|COMPLETED|Treatment Period 2 [1 Day]||6
10167024|NCT02999191|11297087|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0
10167025|NCT02999191|11297088|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0
10167026|NCT02999191|11297089|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0
10167027|NCT02999191|11297087|FG000|STARTED|Wash-out Period 2 [21 Days]||6
10167028|NCT02999191|11297088|FG001|STARTED|Wash-out Period 2 [21 Days]||5
10167029|NCT02999191|11297089|FG002|STARTED|Wash-out Period 2 [21 Days]||6
10167030|NCT02999191|11297087|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6
10167031|NCT02999191|11297088|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5
10167032|NCT02999191|11297089|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6
10167033|NCT02999191|11297087|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
10167034|NCT02999191|11297088|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
10167035|NCT02999191|11297089|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
10167036|NCT02999191|11297087|FG000|STARTED|Treatment Period 3 [1 Day]||6
10167037|NCT02999191|11297088|FG001|STARTED|Treatment Period 3 [1 Day]||6
10167038|NCT02999191|11297089|FG002|STARTED|Treatment Period 3 [1 Day]||6
10167039|NCT02999191|11297087|FG000|COMPLETED|Treatment Period 3 [1 Day]||6
10167040|NCT02999191|11297088|FG001|COMPLETED|Treatment Period 3 [1 Day]||6
10167041|NCT02999191|11297089|FG002|COMPLETED|Treatment Period 3 [1 Day]||6
10167042|NCT02999191|11297087|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0
10167043|NCT02999191|11297088|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0
10167044|NCT02999191|11297089|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0
10167045|NCT02999672|11297099|FG000|STARTED|Overall Study||13
10167046|NCT02999672|11297100|FG001|STARTED|Overall Study||7
10167047|NCT02999672|11297099|FG000|COMPLETED|Overall Study||0
10167048|NCT02999672|11297100|FG001|COMPLETED|Overall Study||0
10167049|NCT02999672|11297099|FG000|NOT COMPLETED|Overall Study||13
10167050|NCT02999672|11297100|FG001|NOT COMPLETED|Overall Study||7
10167051|NCT02999763|11297106|FG000|STARTED|Overall Study||70
10167052|NCT02999763|11297106|FG000|COMPLETED|Overall Study||58
10167053|NCT02999763|11297106|FG000|NOT COMPLETED|Overall Study||12
10167054|NCT03000010|11297112|FG000|STARTED|Overall Study||21
10167055|NCT03000010|11297113|FG001|STARTED|Overall Study||20
10167056|NCT03000010|11297112|FG000|COMPLETED|Overall Study||21
10167057|NCT03000010|11297113|FG001|COMPLETED|Overall Study||20
10167058|NCT03000010|11297112|FG000|NOT COMPLETED|Overall Study||0
10167059|NCT03000010|11297113|FG001|NOT COMPLETED|Overall Study||0
10167060|NCT03000075|11297122|FG000|STARTED|Part A||58
10167061|NCT03000075|11297123|FG001|STARTED|Part A||58
10167062|NCT03000075|11297124|FG002|STARTED|Part A||55
10167063|NCT03000075|11297125|FG003|STARTED|Part A||0
10061372|NCT02104739|11187056|FG003|NOT COMPLETED|First Intervention (1 Day)||1
10061373|NCT02104739|11187057|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10061374|NCT02104739|11187058|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10061375|NCT02104739|11187059|FG006|NOT COMPLETED|First Intervention (1 Day)||0
10061376|NCT02104739|11187053|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
10061377|NCT02104739|11187054|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
10061378|NCT02104739|11187055|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10061379|NCT02104739|11187056|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
10061380|NCT02104739|11187057|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10061381|NCT02104739|11187058|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10061382|NCT02104739|11187059|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10061383|NCT02104739|11187053|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
10061384|NCT02104739|11187054|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
10167064|NCT03000075|11297126|FG004|STARTED|Part A||0
10167065|NCT03000075|11297127|FG005|STARTED|Part A||0
10167066|NCT03000075|11297128|FG006|STARTED|Part A||0
10167067|NCT03000075|11297122|FG000|COMPLETED|Part A||54
10167068|NCT03000075|11297123|FG001|COMPLETED|Part A||58
10167069|NCT03000075|11297124|FG002|COMPLETED|Part A||55
10167070|NCT03000075|11297125|FG003|COMPLETED|Part A||0
10167071|NCT03000075|11297126|FG004|COMPLETED|Part A||0
10167072|NCT03000075|11297127|FG005|COMPLETED|Part A||0
10167073|NCT03000075|11297128|FG006|COMPLETED|Part A||0
10167074|NCT03000075|11297122|FG000|NOT COMPLETED|Part A||4
10167075|NCT03000075|11297123|FG001|NOT COMPLETED|Part A||0
10167076|NCT03000075|11297124|FG002|NOT COMPLETED|Part A||0
10167077|NCT03000075|11297125|FG003|NOT COMPLETED|Part A||0
10167078|NCT03000075|11297126|FG004|NOT COMPLETED|Part A||0
10167079|NCT03000075|11297127|FG005|NOT COMPLETED|Part A||0
10167080|NCT03000075|11297128|FG006|NOT COMPLETED|Part A||0
10167081|NCT03000075|11297122|FG000|STARTED|Part B||0
10167082|NCT03000075|11297123|FG001|STARTED|Part B||0
10167083|NCT03000075|11297124|FG002|STARTED|Part B||0
10167084|NCT03000075|11297125|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
10167085|NCT03000075|11297126|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
9711704|NCT01012609|10811257|FG001|COMPLETED|Overall Study||25
9711705|NCT01012609|10811256|FG000|NOT COMPLETED|Overall Study||1
9711706|NCT01012609|10811257|FG001|NOT COMPLETED|Overall Study||1
9711707|NCT00920387|10811266|FG000|STARTED|Stage 1||8
9711708|NCT00920387|10811267|FG001|STARTED|Stage 1||4
9711709|NCT00920387|10811268|FG002|STARTED|Stage 1||0
9711710|NCT00920387|10811266|FG000|COMPLETED|Stage 1||7
9711711|NCT00920387|10811267|FG001|COMPLETED|Stage 1||4
9711712|NCT00920387|10811268|FG002|COMPLETED|Stage 1||0
9711713|NCT00920387|10811266|FG000|NOT COMPLETED|Stage 1||1
9711714|NCT00920387|10811267|FG001|NOT COMPLETED|Stage 1||0
9711715|NCT00920387|10811268|FG002|NOT COMPLETED|Stage 1||0
9711716|NCT00920387|10811266|FG000|STARTED|Stage 2||0
9711717|NCT00920387|10811267|FG001|STARTED|Stage 2||0
9711718|NCT00920387|10811268|FG002|STARTED|Stage 2||3
9711719|NCT00920387|10811266|FG000|COMPLETED|Stage 2||0
9711720|NCT00920387|10811267|FG001|COMPLETED|Stage 2||0
9711721|NCT00920387|10811268|FG002|COMPLETED|Stage 2||3
9711722|NCT00920387|10811266|FG000|NOT COMPLETED|Stage 2||0
9711723|NCT00920387|10811267|FG001|NOT COMPLETED|Stage 2||0
9711724|NCT00920387|10811268|FG002|NOT COMPLETED|Stage 2||0
9711731|NCT00458835|10811294|FG000|STARTED|Overall Study||5
9711732|NCT00458835|10811295|FG001|STARTED|Overall Study||5
9711733|NCT00458835|10811296|FG002|STARTED|Overall Study||5
9711734|NCT00458835|10811297|FG003|STARTED|Overall Study||5
9711735|NCT00458835|10811298|FG004|STARTED|Overall Study||5
9711736|NCT00458835|10811299|FG005|STARTED|Overall Study||5
9711737|NCT00458835|10811294|FG000|COMPLETED|Overall Study||5
9711738|NCT00458835|10811295|FG001|COMPLETED|Overall Study||5
9711739|NCT00458835|10811296|FG002|COMPLETED|Overall Study||5
9711740|NCT00458835|10811297|FG003|COMPLETED|Overall Study||5
9711741|NCT00458835|10811298|FG004|COMPLETED|Overall Study||5
9711742|NCT00458835|10811299|FG005|COMPLETED|Overall Study||4
9711743|NCT00458835|10811294|FG000|NOT COMPLETED|Overall Study||0
9711744|NCT00458835|10811295|FG001|NOT COMPLETED|Overall Study||0
9711745|NCT00458835|10811296|FG002|NOT COMPLETED|Overall Study||0
9711746|NCT00458835|10811297|FG003|NOT COMPLETED|Overall Study||0
9711747|NCT00458835|10811298|FG004|NOT COMPLETED|Overall Study||0
9711748|NCT00458835|10811299|FG005|NOT COMPLETED|Overall Study||1
9711749|NCT00403559|10811309|FG000|STARTED|Overall Study||56
9711750|NCT00403559|10811310|FG001|STARTED|Overall Study||56
9711751|NCT00403559|10811309|FG000|COMPLETED|Overall Study||52
9711752|NCT00403559|10811310|FG001|COMPLETED|Overall Study||52
9711753|NCT00403559|10811309|FG000|NOT COMPLETED|Overall Study||4
9711754|NCT00403559|10811310|FG001|NOT COMPLETED|Overall Study||4
9711755|NCT00353938|10811320|FG000|STARTED|Stage 1||9
9711756|NCT00353938|10811321|FG001|STARTED|Stage 1||5
9711757|NCT00353938|10811322|FG002|STARTED|Stage 1||0
9711758|NCT00353938|10811323|FG003|STARTED|Stage 1||0
9711759|NCT00353938|10811320|FG000|COMPLETED|Stage 1||8
9711760|NCT00353938|10811321|FG001|COMPLETED|Stage 1||5
9711761|NCT00353938|10811322|FG002|COMPLETED|Stage 1||0
9711762|NCT00353938|10811323|FG003|COMPLETED|Stage 1||0
9711763|NCT00353938|10811320|FG000|NOT COMPLETED|Stage 1||1
9711764|NCT00353938|10811321|FG001|NOT COMPLETED|Stage 1||0
9711765|NCT00353938|10811322|FG002|NOT COMPLETED|Stage 1||0
9711766|NCT00353938|10811323|FG003|NOT COMPLETED|Stage 1||0
9711767|NCT00353938|10811320|FG000|STARTED|Stage 2||0
9711768|NCT00353938|10811321|FG001|STARTED|Stage 2||0
9711769|NCT00353938|10811322|FG002|STARTED|Stage 2||4
9711770|NCT00353938|10811323|FG003|STARTED|Stage 2||0
9711771|NCT00353938|10811320|FG000|COMPLETED|Stage 2||0
9711772|NCT00353938|10811321|FG001|COMPLETED|Stage 2||0
9711773|NCT00353938|10811322|FG002|COMPLETED|Stage 2||4
9711774|NCT00353938|10811323|FG003|COMPLETED|Stage 2||0
9711775|NCT00353938|10811320|FG000|NOT COMPLETED|Stage 2||0
9711776|NCT00353938|10811321|FG001|NOT COMPLETED|Stage 2||0
9711777|NCT00353938|10811322|FG002|NOT COMPLETED|Stage 2||0
9711778|NCT00353938|10811323|FG003|NOT COMPLETED|Stage 2||0
9711779|NCT00353938|10811320|FG000|STARTED|Stage 3||0
9711780|NCT00353938|10811321|FG001|STARTED|Stage 3||0
9711781|NCT00353938|10811322|FG002|STARTED|Stage 3||0
9711782|NCT00353938|10811323|FG003|STARTED|Stage 3||3
10167086|NCT03000075|11297127|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
10167087|NCT03000075|11297128|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
10167088|NCT03000075|11297122|FG000|COMPLETED|Part B||0
10167089|NCT03000075|11297123|FG001|COMPLETED|Part B||0
10167090|NCT03000075|11297124|FG002|COMPLETED|Part B||0
10167091|NCT03000075|11297125|FG003|COMPLETED|Part B||27
10167092|NCT03000075|11297126|FG004|COMPLETED|Part B||26
10167093|NCT03000075|11297127|FG005|COMPLETED|Part B||56
10167094|NCT03000075|11297128|FG006|COMPLETED|Part B||54
10167095|NCT03000075|11297122|FG000|NOT COMPLETED|Part B||0
10167096|NCT03000075|11297123|FG001|NOT COMPLETED|Part B||0
10167097|NCT03000075|11297124|FG002|NOT COMPLETED|Part B||0
10167098|NCT03000075|11297125|FG003|NOT COMPLETED|Part B||0
10167099|NCT03000075|11297126|FG004|NOT COMPLETED|Part B||1
10167100|NCT03000075|11297127|FG005|NOT COMPLETED|Part B||2
10167101|NCT03000075|11297128|FG006|NOT COMPLETED|Part B||1
10167102|NCT03000088|11297146|FG000|STARTED|Overall Study||70
10167103|NCT03000088|11297147|FG001|STARTED|Overall Study||70
10167104|NCT03000088|11297146|FG000|COMPLETED|Overall Study||70
10167105|NCT03000088|11297147|FG001|COMPLETED|Overall Study||70
10167106|NCT03000088|11297146|FG000|NOT COMPLETED|Overall Study||0
10167107|NCT03000088|11297147|FG001|NOT COMPLETED|Overall Study||0
10167108|NCT03000166|11297155|FG000|STARTED|Overall Study||25
10167109|NCT03000166|11297156|FG001|STARTED|Overall Study||22
10167110|NCT03000166|11297155|FG000|COMPLETED|Overall Study||25
10167111|NCT03000166|11297156|FG001|COMPLETED|Overall Study||19
10167112|NCT03000166|11297155|FG000|NOT COMPLETED|Overall Study||0
10167113|NCT03000166|11297156|FG001|NOT COMPLETED|Overall Study||3
10167114|NCT03000283|11297163|FG000|STARTED|Overall Study||7
10167115|NCT03000283|11297163|FG000|COMPLETED|Overall Study||7
10167116|NCT03000283|11297163|FG000|NOT COMPLETED|Overall Study||0
10167117|NCT03000309|11297167|FG000|STARTED|Overall Study||20
10167118|NCT03000309|11297167|FG000|COMPLETED|Overall Study||19
10167119|NCT03000309|11297167|FG000|NOT COMPLETED|Overall Study||1
10167120|NCT03000348|11297177|FG000|STARTED|Overall Study||17
10167121|NCT03000348|11297178|FG001|STARTED|Overall Study||11
10167122|NCT03000348|11297179|FG002|STARTED|Overall Study||15
10167123|NCT03000348|11297180|FG003|STARTED|Overall Study||15
10167124|NCT03000348|11297181|FG004|STARTED|Overall Study||16
10167125|NCT03000348|11297182|FG005|STARTED|Overall Study||15
10167126|NCT03000348|11297177|FG000|Day 14 Treatment Period|Overall Study||17
10167127|NCT03000348|11297178|FG001|Day 14 Treatment Period|Overall Study||10
10167128|NCT03000348|11297179|FG002|Day 14 Treatment Period|Overall Study||13
10167129|NCT03000348|11297180|FG003|Day 14 Treatment Period|Overall Study||14
10167130|NCT03000348|11297181|FG004|Day 14 Treatment Period|Overall Study||13
10167131|NCT03000348|11297182|FG005|Day 14 Treatment Period|Overall Study||14
10167132|NCT03000348|11297177|FG000|COMPLETED|Overall Study||14
10167133|NCT03000348|11297178|FG001|COMPLETED|Overall Study||7
10167134|NCT03000348|11297179|FG002|COMPLETED|Overall Study||11
10167135|NCT03000348|11297180|FG003|COMPLETED|Overall Study||12
10167136|NCT03000348|11297181|FG004|COMPLETED|Overall Study||11
10167137|NCT03000348|11297182|FG005|COMPLETED|Overall Study||13
10167138|NCT03000348|11297177|FG000|NOT COMPLETED|Overall Study||3
10167139|NCT03000348|11297178|FG001|NOT COMPLETED|Overall Study||4
10167140|NCT03000348|11297179|FG002|NOT COMPLETED|Overall Study||4
10167141|NCT03000348|11297180|FG003|NOT COMPLETED|Overall Study||3
10167142|NCT03000348|11297181|FG004|NOT COMPLETED|Overall Study||5
10167143|NCT03000348|11297182|FG005|NOT COMPLETED|Overall Study||2
10167144|NCT03000452|11297199|FG000|STARTED|Treatment Period||18
10167145|NCT03000452|11297199|FG000|COMPLETED|Treatment Period||0
10167146|NCT03000452|11297199|FG000|NOT COMPLETED|Treatment Period||18
10167147|NCT03000452|11297199|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
10167148|NCT03000452|11297199|FG000|COMPLETED|Follow-Up Period||10
10167149|NCT03000452|11297199|FG000|NOT COMPLETED|Follow-Up Period||7
10167150|NCT03000608|11297205|FG000|STARTED|Overall Study||46
10167151|NCT03000608|11297206|FG001|STARTED|Overall Study||23
10167152|NCT03000608|11297205|FG000|COMPLETED|Overall Study||40
10167153|NCT03000608|11297206|FG001|COMPLETED|Overall Study||19
10167154|NCT03000608|11297205|FG000|NOT COMPLETED|Overall Study||6
10167155|NCT03000608|11297206|FG001|NOT COMPLETED|Overall Study||4
10167156|NCT03000673|11297216|FG000|STARTED|Overall Study||7
10167157|NCT03000673|11297217|FG001|STARTED|Overall Study||9
10167158|NCT03000673|11297218|FG002|STARTED|Overall Study||7
10167159|NCT03000673|11297219|FG003|STARTED|Overall Study||9
10167160|NCT03000673|11297216|FG000|COMPLETED|Overall Study||6
10167161|NCT03000673|11297217|FG001|COMPLETED|Overall Study||9
10167162|NCT03000673|11297218|FG002|COMPLETED|Overall Study||7
10167163|NCT03000673|11297219|FG003|COMPLETED|Overall Study||9
10167164|NCT03000673|11297216|FG000|NOT COMPLETED|Overall Study||1
10167165|NCT03000673|11297217|FG001|NOT COMPLETED|Overall Study||0
10167166|NCT03000673|11297218|FG002|NOT COMPLETED|Overall Study||0
10167167|NCT03000673|11297219|FG003|NOT COMPLETED|Overall Study||0
10167168|NCT03000686|11297232|FG000|STARTED|Part 1, Period 1 (1 Day)||5
10167169|NCT03000686|11297233|FG001|STARTED|Part 1, Period 1 (1 Day)||6
10167170|NCT03000686|11297234|FG002|STARTED|Part 1, Period 1 (1 Day)||0
10167171|NCT03000686|11297235|FG003|STARTED|Part 1, Period 1 (1 Day)||0
10167172|NCT03000686|11297232|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5
10167173|NCT03000686|11297233|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5
10167174|NCT03000686|11297234|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
10167175|NCT03000686|11297235|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
10167176|NCT03000686|11297232|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10167177|NCT03000686|11297233|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
10167178|NCT03000686|11297234|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10167179|NCT03000686|11297235|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10167180|NCT03000686|11297232|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5
10167181|NCT03000686|11297233|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5
10167182|NCT03000686|11297234|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0
10167183|NCT03000686|11297235|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0
10167184|NCT03000686|11297232|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
10167185|NCT03000686|11297233|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
10167186|NCT03000686|11297234|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10167187|NCT03000686|11297235|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10167188|NCT03000686|11297232|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10167189|NCT03000686|11297233|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10167190|NCT03000686|11297234|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10167191|NCT03000686|11297235|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10167192|NCT03000686|11297232|FG000|STARTED|Part 1, Period 2 (1 Day)||5
10167193|NCT03000686|11297233|FG001|STARTED|Part 1, Period 2 (1 Day)||5
10167194|NCT03000686|11297234|FG002|STARTED|Part 1, Period 2 (1 Day)||0
10167195|NCT03000686|11297235|FG003|STARTED|Part 1, Period 2 (1 Day)||0
10167196|NCT03000686|11297232|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5
10167197|NCT03000686|11297233|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5
10167198|NCT03000686|11297234|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
10167199|NCT03000686|11297235|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
10167200|NCT03000686|11297232|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10167201|NCT03000686|11297233|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10167202|NCT03000686|11297234|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10167203|NCT03000686|11297235|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10167204|NCT03000686|11297232|FG000|STARTED|Part 2, Period 1 (1 Day)||0
10167205|NCT03000686|11297233|FG001|STARTED|Part 2, Period 1 (1 Day)||0
10167206|NCT03000686|11297234|FG002|STARTED|Part 2, Period 1 (1 Day)||3
10167207|NCT03000686|11297235|FG003|STARTED|Part 2, Period 1 (1 Day)||3
10167208|NCT03000686|11297232|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
10167209|NCT03000686|11297233|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
10167210|NCT03000686|11297234|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3
10167211|NCT03000686|11297235|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3
10167212|NCT03000686|11297232|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10167213|NCT03000686|11297233|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10167214|NCT03000686|11297234|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10167215|NCT03000686|11297235|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10167216|NCT03000686|11297232|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0
10167217|NCT03000686|11297233|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0
10167218|NCT03000686|11297234|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3
10167219|NCT03000686|11297235|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3
10167220|NCT03000686|11297232|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10167221|NCT03000686|11297233|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10167222|NCT03000686|11297234|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
10167223|NCT03000686|11297235|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
10167224|NCT03000686|11297232|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10167225|NCT03000686|11297233|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10167226|NCT03000686|11297234|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10167227|NCT03000686|11297235|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10167228|NCT03000686|11297232|FG000|STARTED|Part 2, Period 2 (1 Day)||0
10167229|NCT03000686|11297233|FG001|STARTED|Part 2, Period 2 (1 Day)||0
10167230|NCT03000686|11297234|FG002|STARTED|Part 2, Period 2 (1 Day)||3
10167231|NCT03000686|11297235|FG003|STARTED|Part 2, Period 2 (1 Day)||3
10167232|NCT03000686|11297232|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
10167233|NCT03000686|11297233|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
10167234|NCT03000686|11297234|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3
10167235|NCT03000686|11297235|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3
10167236|NCT03000686|11297232|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10167237|NCT03000686|11297233|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10167238|NCT03000686|11297234|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10167239|NCT03000686|11297235|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10167240|NCT03001076|11297249|FG000|STARTED|Overall Study||88
10167241|NCT03001076|11297250|FG001|STARTED|Overall Study||181
10167242|NCT03001076|11297249|FG000|COMPLETED|Overall Study||81
10167243|NCT03001076|11297250|FG001|COMPLETED|Overall Study||176
10167244|NCT03001076|11297249|FG000|NOT COMPLETED|Overall Study||7
10167245|NCT03001076|11297250|FG001|NOT COMPLETED|Overall Study||5
10167246|NCT03001219|11297258|FG000|STARTED|Proof of Concept||37
10167247|NCT03001219|11297259|FG001|STARTED|Proof of Concept||72
10167248|NCT03001219|11297258|FG000|COMPLETED|Proof of Concept||35
10167249|NCT03001219|11297259|FG001|COMPLETED|Proof of Concept||65
10167250|NCT03001219|11297258|FG000|NOT COMPLETED|Proof of Concept||2
10167251|NCT03001219|11297259|FG001|NOT COMPLETED|Proof of Concept||7
10167252|NCT03001219|11297258|FG000|STARTED|Extension Period Analysis||9
10167253|NCT03001219|11297259|FG001|STARTED|Extension Period Analysis||97
10167254|NCT03001219|11297258|FG000|COMPLETED|Extension Period Analysis||4
10167255|NCT03001219|11297259|FG001|COMPLETED|Extension Period Analysis||52
10167256|NCT03001219|11297258|FG000|NOT COMPLETED|Extension Period Analysis||5
10167257|NCT03001219|11297259|FG001|NOT COMPLETED|Extension Period Analysis||45
10167258|NCT03001258|11297273|FG000|STARTED|Overall Study||765
10167259|NCT03001258|11297274|FG001|STARTED|Overall Study||751
10167260|NCT03001258|11297275|FG002|STARTED|Overall Study||485
10167261|NCT03001258|11297273|FG000|COMPLETED|Overall Study||765
10167262|NCT03001258|11297274|FG001|COMPLETED|Overall Study||751
10167263|NCT03001258|11297275|FG002|COMPLETED|Overall Study||485
10167264|NCT03001258|11297273|FG000|NOT COMPLETED|Overall Study||0
10167265|NCT03001258|11297274|FG001|NOT COMPLETED|Overall Study||0
10167266|NCT03001258|11297275|FG002|NOT COMPLETED|Overall Study||0
10167267|NCT03001453|11297285|FG000|STARTED|Overall Study||50
10167268|NCT03001453|11297286|FG001|STARTED|Overall Study||57
10167269|NCT03001453|11297285|FG000|COMPLETED|Overall Study||50
10167270|NCT03001453|11297286|FG001|COMPLETED|Overall Study||57
10167271|NCT03001453|11297285|FG000|NOT COMPLETED|Overall Study||0
10167272|NCT03001453|11297286|FG001|NOT COMPLETED|Overall Study||0
10197586|NCT03379259|11325556|FG000|NOT COMPLETED|Overall Study||1
10197587|NCT03379259|11325557|FG001|NOT COMPLETED|Overall Study||1
10197588|NCT03379259|11325558|FG002|NOT COMPLETED|Overall Study||3
10197589|NCT03379259|11325559|FG003|NOT COMPLETED|Overall Study||3
10197590|NCT03379259|11325560|FG004|NOT COMPLETED|Overall Study||9
10197591|NCT03379259|11325561|FG005|NOT COMPLETED|Overall Study||7
10197592|NCT03379376|11325578|FG000|STARTED|Overall Study||10
10197593|NCT03379376|11325578|FG000|COMPLETED|Overall Study||5
10197594|NCT03379376|11325578|FG000|NOT COMPLETED|Overall Study||5
10197595|NCT03379506|11325586|FG000|STARTED|Overall Study||22
10197596|NCT03379506|11325587|FG001|STARTED|Overall Study||17
10197597|NCT03379506|11325588|FG002|STARTED|Overall Study||7
10197598|NCT03379506|11325589|FG003|STARTED|Overall Study||11
10197599|NCT03379506|11325586|FG000|COMPLETED|Overall Study||22
10197600|NCT03379506|11325587|FG001|COMPLETED|Overall Study||17
10197601|NCT03379506|11325588|FG002|COMPLETED|Overall Study||7
10197602|NCT03379506|11325589|FG003|COMPLETED|Overall Study||11
10197603|NCT03379506|11325586|FG000|NOT COMPLETED|Overall Study||0
10197604|NCT03379506|11325587|FG001|NOT COMPLETED|Overall Study||0
10197605|NCT03379506|11325588|FG002|NOT COMPLETED|Overall Study||0
10197606|NCT03379506|11325589|FG003|NOT COMPLETED|Overall Study||0
10197607|NCT03379545|11325599|FG000|STARTED|Overall Study||29
10197608|NCT03379545|11325599|FG000|COMPLETED|Overall Study||29
10197609|NCT03379545|11325599|FG000|NOT COMPLETED|Overall Study||0
10197610|NCT03379662|11325606|FG000|STARTED|Overall Study||21
10197611|NCT03379662|11325607|FG001|STARTED|Overall Study||19
10197612|NCT03379662|11325606|FG000|COMPLETED|Overall Study||21
10197613|NCT03379662|11325607|FG001|COMPLETED|Overall Study||19
10197614|NCT03379662|11325606|FG000|NOT COMPLETED|Overall Study||0
10197615|NCT03379662|11325607|FG001|NOT COMPLETED|Overall Study||0
10197616|NCT03379740|11325615|FG000|STARTED|Overall Study||8
10197617|NCT03379740|11325616|FG001|STARTED|Overall Study||7
10197618|NCT03379740|11325615|FG000|COMPLETED|Overall Study||8
10197619|NCT03379740|11325616|FG001|COMPLETED|Overall Study||7
10197620|NCT03379740|11325615|FG000|NOT COMPLETED|Overall Study||0
10197621|NCT03379740|11325616|FG001|NOT COMPLETED|Overall Study||0
10197622|NCT03379753|11325631|FG000|STARTED|Overall Study||61
10197623|NCT03379753|11325632|FG001|STARTED|Overall Study||71
10197624|NCT03379753|11325631|FG000|COMPLETED|Overall Study||46
10197625|NCT03379753|11325632|FG001|COMPLETED|Overall Study||46
10197626|NCT03379753|11325631|FG000|NOT COMPLETED|Overall Study||15
10197627|NCT03379753|11325632|FG001|NOT COMPLETED|Overall Study||25
10197628|NCT03380000|11325638|FG000|STARTED|First Intervention (1day)||8
10197629|NCT03380000|11325639|FG001|STARTED|First Intervention (1day)||8
10197630|NCT03380000|11325638|FG000|COMPLETED|First Intervention (1day)||8
10197631|NCT03380000|11325639|FG001|COMPLETED|First Intervention (1day)||8
10197632|NCT03380000|11325638|FG000|NOT COMPLETED|First Intervention (1day)||0
10197633|NCT03380000|11325639|FG001|NOT COMPLETED|First Intervention (1day)||0
10197634|NCT03380000|11325638|FG000|STARTED|Washout (>7days)||8
10197635|NCT03380000|11325639|FG001|STARTED|Washout (>7days)||8
10197636|NCT03380000|11325638|FG000|COMPLETED|Washout (>7days)||8
10197637|NCT03380000|11325639|FG001|COMPLETED|Washout (>7days)||8
10197638|NCT03380000|11325638|FG000|NOT COMPLETED|Washout (>7days)||0
10197639|NCT03380000|11325639|FG001|NOT COMPLETED|Washout (>7days)||0
10197640|NCT03380000|11325638|FG000|STARTED|Second Intervention (1day)||8
10197641|NCT03380000|11325639|FG001|STARTED|Second Intervention (1day)||8
10197642|NCT03380000|11325638|FG000|COMPLETED|Second Intervention (1day)||8
10197643|NCT03380000|11325639|FG001|COMPLETED|Second Intervention (1day)||8
10197644|NCT03380000|11325638|FG000|NOT COMPLETED|Second Intervention (1day)||0
10197645|NCT03380000|11325639|FG001|NOT COMPLETED|Second Intervention (1day)||0
10197646|NCT03380026|11325645|FG000|STARTED|Overall Study||28
10197647|NCT03380026|11325645|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28
10197648|NCT03380026|11325645|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28
10197649|NCT03380026|11325645|FG000|COMPLETED|Overall Study||25
10197650|NCT03380026|11325645|FG000|NOT COMPLETED|Overall Study||3
10197651|NCT03380091|11325654|FG000|STARTED|Overall Study||3
10197652|NCT03380091|11325655|FG001|STARTED|Overall Study||2
10197653|NCT03380091|11325654|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
10197654|NCT03380091|11325655|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
10197655|NCT03380091|11325654|FG000|COMPLETED|Overall Study||1
10197656|NCT03380091|11325655|FG001|COMPLETED|Overall Study||1
10197657|NCT03380091|11325654|FG000|NOT COMPLETED|Overall Study||2
10197658|NCT03380091|11325655|FG001|NOT COMPLETED|Overall Study||1
10167273|NCT03001557|11297297|FG000|STARTED|Core Phase||12
10167274|NCT03001557|11297298|FG001|STARTED|Core Phase||12
10167275|NCT03001557|11297299|FG002|STARTED|Core Phase||14
10167276|NCT03001557|11297300|FG003|STARTED|Core Phase||13
10167277|NCT03001557|11297301|FG004|STARTED|Core Phase||12
10167278|NCT03001557|11297302|FG005|STARTED|Core Phase||0
10167279|NCT03001557|11297303|FG006|STARTED|Core Phase||0
10167280|NCT03001557|11297304|FG007|STARTED|Core Phase||0
10167281|NCT03001557|11297297|FG000|Treated|Core Phase||12
10167282|NCT03001557|11297298|FG001|Treated|Core Phase||12
10167283|NCT03001557|11297299|FG002|Treated|Core Phase||13
10167284|NCT03001557|11297300|FG003|Treated|Core Phase||13
10167285|NCT03001557|11297301|FG004|Treated|Core Phase||12
10167286|NCT03001557|11297302|FG005|Treated|Core Phase||0
10167287|NCT03001557|11297303|FG006|Treated|Core Phase||0
10167288|NCT03001557|11297304|FG007|Treated|Core Phase||0
10167289|NCT03001557|11297297|FG000|COMPLETED|Core Phase||12
10167290|NCT03001557|11297298|FG001|COMPLETED|Core Phase||12
10167291|NCT03001557|11297299|FG002|COMPLETED|Core Phase||13
10167292|NCT03001557|11297300|FG003|COMPLETED|Core Phase||13
10167293|NCT03001557|11297301|FG004|COMPLETED|Core Phase||12
10167294|NCT03001557|11297302|FG005|COMPLETED|Core Phase||0
10167295|NCT03001557|11297303|FG006|COMPLETED|Core Phase||0
10167296|NCT03001557|11297304|FG007|COMPLETED|Core Phase||0
10167297|NCT03001557|11297297|FG000|NOT COMPLETED|Core Phase||0
10167298|NCT03001557|11297298|FG001|NOT COMPLETED|Core Phase||0
10167299|NCT03001557|11297299|FG002|NOT COMPLETED|Core Phase||1
10167300|NCT03001557|11297300|FG003|NOT COMPLETED|Core Phase||0
10167301|NCT03001557|11297301|FG004|NOT COMPLETED|Core Phase||0
10167302|NCT03001557|11297302|FG005|NOT COMPLETED|Core Phase||0
10167303|NCT03001557|11297303|FG006|NOT COMPLETED|Core Phase||0
10167304|NCT03001557|11297304|FG007|NOT COMPLETED|Core Phase||0
10167305|NCT03001557|11297297|FG000|STARTED|Extension Phase||0
10167306|NCT03001557|11297298|FG001|STARTED|Extension Phase||0
10167307|NCT03001557|11297299|FG002|STARTED|Extension Phase||0
10167308|NCT03001557|11297300|FG003|STARTED|Extension Phase||0
10167309|NCT03001557|11297301|FG004|STARTED|Extension Phase||0
10167310|NCT03001557|11297302|FG005|STARTED|Extension Phase||5
10167311|NCT03001557|11297303|FG006|STARTED|Extension Phase||14
10167312|NCT03001557|11297304|FG007|STARTED|Extension Phase||6
10167313|NCT03001557|11297297|FG000|COMPLETED|Extension Phase||0
10167314|NCT03001557|11297298|FG001|COMPLETED|Extension Phase||0
10167315|NCT03001557|11297299|FG002|COMPLETED|Extension Phase||0
10167316|NCT03001557|11297300|FG003|COMPLETED|Extension Phase||0
10167317|NCT03001557|11297301|FG004|COMPLETED|Extension Phase||0
10167318|NCT03001557|11297302|FG005|COMPLETED|Extension Phase||0
10167319|NCT03001557|11297303|FG006|COMPLETED|Extension Phase||0
10167320|NCT03001557|11297304|FG007|COMPLETED|Extension Phase||0
10167321|NCT03001557|11297297|FG000|NOT COMPLETED|Extension Phase||0
10167322|NCT03001557|11297298|FG001|NOT COMPLETED|Extension Phase||0
10167323|NCT03001557|11297299|FG002|NOT COMPLETED|Extension Phase||0
10167324|NCT03001557|11297300|FG003|NOT COMPLETED|Extension Phase||0
10167325|NCT03001557|11297301|FG004|NOT COMPLETED|Extension Phase||0
10167326|NCT03001557|11297302|FG005|NOT COMPLETED|Extension Phase||5
10167327|NCT03001557|11297303|FG006|NOT COMPLETED|Extension Phase||14
10167328|NCT03001557|11297304|FG007|NOT COMPLETED|Extension Phase||6
10167329|NCT03001674|11297328|FG000|STARTED|Overall Study||10
10167330|NCT03001674|11297329|FG001|STARTED|Overall Study||5
10167331|NCT03001674|11297328|FG000|COMPLETED|Overall Study||10
10167332|NCT03001674|11297329|FG001|COMPLETED|Overall Study||5
10167333|NCT03001674|11297328|FG000|NOT COMPLETED|Overall Study||0
10167334|NCT03001674|11297329|FG001|NOT COMPLETED|Overall Study||0
10167335|NCT03001778|11297337|FG000|STARTED|Overall Study||21
10167336|NCT03001778|11297338|FG001|STARTED|Overall Study||46
9711783|NCT00353938|10811320|FG000|COMPLETED|Stage 3||0
9711784|NCT00353938|10811321|FG001|COMPLETED|Stage 3||0
9711785|NCT00353938|10811322|FG002|COMPLETED|Stage 3||0
9711786|NCT00353938|10811323|FG003|COMPLETED|Stage 3||3
9711787|NCT00353938|10811320|FG000|NOT COMPLETED|Stage 3||0
9711788|NCT00353938|10811321|FG001|NOT COMPLETED|Stage 3||0
9711789|NCT00353938|10811322|FG002|NOT COMPLETED|Stage 3||0
9711790|NCT00353938|10811323|FG003|NOT COMPLETED|Stage 3||0
9711791|NCT00176436|10811333|FG000|STARTED|Overall Study||20
10167337|NCT03001778|11297337|FG000|COMPLETED|Overall Study||21
10167338|NCT03001778|11297338|FG001|COMPLETED|Overall Study||46
10167339|NCT03001778|11297337|FG000|NOT COMPLETED|Overall Study||0
9711792|NCT00176436|10811334|FG001|STARTED|Overall Study||17
9711793|NCT00176436|10811333|FG000|COMPLETED|Overall Study||14
9711794|NCT00176436|10811334|FG001|COMPLETED|Overall Study||12
9711795|NCT00176436|10811333|FG000|NOT COMPLETED|Overall Study||6
10167340|NCT03001778|11297338|FG001|NOT COMPLETED|Overall Study||0
10167341|NCT03001843|11297346|FG000|STARTED|Overall Study||27
10167342|NCT03001843|11297347|FG001|STARTED|Overall Study||27
10167343|NCT03001843|11297346|FG000|COMPLETED|Overall Study||27
10167344|NCT03001843|11297347|FG001|COMPLETED|Overall Study||27
10167345|NCT03001843|11297346|FG000|NOT COMPLETED|Overall Study||0
10167346|NCT03001843|11297347|FG001|NOT COMPLETED|Overall Study||0
10167347|NCT03002012|11297355|FG000|STARTED|Overall Study||11
10167348|NCT03002012|11297356|FG001|STARTED|Overall Study||11
10167349|NCT03002012|11297355|FG000|COMPLETED|Overall Study||11
10167350|NCT03002012|11297356|FG001|COMPLETED|Overall Study||11
10167351|NCT03002012|11297355|FG000|NOT COMPLETED|Overall Study||0
10167352|NCT03002012|11297356|FG001|NOT COMPLETED|Overall Study||0
10167353|NCT03002038|11297364|FG000|STARTED|Overall Study||46
10167354|NCT03002038|11297365|FG001|STARTED|Overall Study||40
10167355|NCT03002038|11297364|FG000|COMPLETED|Overall Study||35
10167356|NCT03002038|11297365|FG001|COMPLETED|Overall Study||33
10167357|NCT03002038|11297364|FG000|NOT COMPLETED|Overall Study||11
10167358|NCT03002038|11297365|FG001|NOT COMPLETED|Overall Study||7
9711796|NCT00176436|10811334|FG001|NOT COMPLETED|Overall Study||5
9730877|NCT00128921|10830789|FG000|NOT COMPLETED|Overall Study||5
9730878|NCT00128921|10830790|FG001|NOT COMPLETED|Overall Study||5
9730879|NCT00128921|10830791|FG002|NOT COMPLETED|Overall Study||0
9730880|NCT00129116|10830806|FG000|STARTED|Primary Phase||78
9730881|NCT00129116|10830807|FG001|STARTED|Primary Phase||77
9730882|NCT00129116|10830808|FG002|STARTED|Primary Phase||78
9730883|NCT00129116|10830809|FG003|STARTED|Primary Phase||78
9730884|NCT00129116|10830810|FG004|STARTED|Primary Phase||77
9730885|NCT00129116|10830806|FG000|COMPLETED|Primary Phase||76
9730886|NCT00129116|10830807|FG001|COMPLETED|Primary Phase||73
9730887|NCT00129116|10830808|FG002|COMPLETED|Primary Phase||77
9730888|NCT00129116|10830809|FG003|COMPLETED|Primary Phase||77
9730889|NCT00129116|10830810|FG004|COMPLETED|Primary Phase||76
9730890|NCT00129116|10830806|FG000|NOT COMPLETED|Primary Phase||2
9730891|NCT00129116|10830807|FG001|NOT COMPLETED|Primary Phase||4
9730892|NCT00129116|10830808|FG002|NOT COMPLETED|Primary Phase||1
9730893|NCT00129116|10830809|FG003|NOT COMPLETED|Primary Phase||1
9730894|NCT00129116|10830810|FG004|NOT COMPLETED|Primary Phase||1
9730895|NCT00129116|10830806|FG000|STARTED|Booster Phase||47
9730896|NCT00129116|10830807|FG001|STARTED|Booster Phase||42
9730897|NCT00129116|10830808|FG002|STARTED|Booster Phase||44
9730898|NCT00129116|10830809|FG003|STARTED|Booster Phase||44
9730899|NCT00129116|10830810|FG004|STARTED|Booster Phase||44
9730900|NCT00129116|10830806|FG000|COMPLETED|Booster Phase||45
9730901|NCT00129116|10830807|FG001|COMPLETED|Booster Phase||42
9730902|NCT00129116|10830808|FG002|COMPLETED|Booster Phase||44
9730903|NCT00129116|10830809|FG003|COMPLETED|Booster Phase||44
9730904|NCT00129116|10830810|FG004|COMPLETED|Booster Phase||43
9730905|NCT00129116|10830806|FG000|NOT COMPLETED|Booster Phase||2
9730906|NCT00129116|10830807|FG001|NOT COMPLETED|Booster Phase||0
9730907|NCT00129116|10830808|FG002|NOT COMPLETED|Booster Phase||0
9730908|NCT00129116|10830809|FG003|NOT COMPLETED|Booster Phase||0
9730909|NCT00129116|10830810|FG004|NOT COMPLETED|Booster Phase||1
9730910|NCT00129129|10830825|FG000|STARTED|Primary Phase||287
9730911|NCT00129129|10830826|FG001|STARTED|Primary Phase||319
9730912|NCT00129129|10830827|FG002|STARTED|Primary Phase||150
9730913|NCT00129129|10830828|FG003|STARTED|Primary Phase||0
9730914|NCT00129129|10830829|FG004|STARTED|Primary Phase||0
9730915|NCT00129129|10830825|FG000|COMPLETED|Primary Phase||262
9730916|NCT00129129|10830826|FG001|COMPLETED|Primary Phase||294
9730917|NCT00129129|10830827|FG002|COMPLETED|Primary Phase||150
9730918|NCT00129129|10830828|FG003|COMPLETED|Primary Phase||0
9730919|NCT00129129|10830829|FG004|COMPLETED|Primary Phase||0
9730920|NCT00129129|10830825|FG000|NOT COMPLETED|Primary Phase||25
9730921|NCT00129129|10830826|FG001|NOT COMPLETED|Primary Phase||25
9730922|NCT00129129|10830827|FG002|NOT COMPLETED|Primary Phase||0
9730923|NCT00129129|10830828|FG003|NOT COMPLETED|Primary Phase||0
9730924|NCT00129129|10830829|FG004|NOT COMPLETED|Primary Phase||0
9730925|NCT00129129|10830825|FG000|STARTED|Fourth Dose Phase||236
9730926|NCT00129129|10830826|FG001|STARTED|Fourth Dose Phase||0
9730927|NCT00129129|10830827|FG002|STARTED|Fourth Dose Phase||0
9730928|NCT00129129|10830828|FG003|STARTED|Fourth Dose Phase||132
9730929|NCT00129129|10830829|FG004|STARTED|Fourth Dose Phase||130
9730930|NCT00129129|10830825|FG000|COMPLETED|Fourth Dose Phase||232
9730931|NCT00129129|10830826|FG001|COMPLETED|Fourth Dose Phase||0
9730932|NCT00129129|10830827|FG002|COMPLETED|Fourth Dose Phase||0
9730933|NCT00129129|10830828|FG003|COMPLETED|Fourth Dose Phase||128
9730934|NCT00129129|10830829|FG004|COMPLETED|Fourth Dose Phase||124
9730935|NCT00129129|10830825|FG000|NOT COMPLETED|Fourth Dose Phase||4
9730936|NCT00129129|10830826|FG001|NOT COMPLETED|Fourth Dose Phase||0
9730937|NCT00129129|10830827|FG002|NOT COMPLETED|Fourth Dose Phase||0
9730938|NCT00129129|10830828|FG003|NOT COMPLETED|Fourth Dose Phase||4
9730939|NCT00129129|10830829|FG004|NOT COMPLETED|Fourth Dose Phase||6
9730940|NCT00129220|10830852|FG000|STARTED|Study Period II||105
9730941|NCT00129220|10830853|FG001|STARTED|Study Period II||20
9730942|NCT00129220|10830854|FG002|STARTED|Study Period II||99
9730943|NCT00129220|10830852|FG000|Received at Least One Dose of Study Drug|Study Period II||104
9730944|NCT00129220|10830853|FG001|Received at Least One Dose of Study Drug|Study Period II||20
9730945|NCT00129220|10830854|FG002|Received at Least One Dose of Study Drug|Study Period II||97
9730946|NCT00129220|10830852|FG000|COMPLETED|Study Period II||72
9730947|NCT00129220|10830853|FG001|COMPLETED|Study Period II||8
9730948|NCT00129220|10830854|FG002|COMPLETED|Study Period II||52
9730949|NCT00129220|10830852|FG000|NOT COMPLETED|Study Period II||33
9730950|NCT00129220|10830853|FG001|NOT COMPLETED|Study Period II||12
9730951|NCT00129220|10830854|FG002|NOT COMPLETED|Study Period II||47
9730952|NCT00129220|10830852|FG000|STARTED|Study Period III||72
9730953|NCT00129220|10830853|FG001|STARTED|Study Period III||8
9730954|NCT00129220|10830854|FG002|STARTED|Study Period III||52
9730955|NCT00129220|10830852|FG000|COMPLETED|Study Period III||59
9730956|NCT00129220|10830853|FG001|COMPLETED|Study Period III||7
9730957|NCT00129220|10830854|FG002|COMPLETED|Study Period III||42
9730958|NCT00129220|10830852|FG000|NOT COMPLETED|Study Period III||13
9730959|NCT00129220|10830853|FG001|NOT COMPLETED|Study Period III||1
9730960|NCT00129220|10830854|FG002|NOT COMPLETED|Study Period III||10
9730961|NCT00129246|10830866|FG000|STARTED|Overall Study||20
10167359|NCT03002077|11297371|FG000|STARTED|Overall Study||617
10167360|NCT03002077|11297371|FG000|COMPLETED|Overall Study||179
10167361|NCT03002077|11297371|FG000|NOT COMPLETED|Overall Study||438
10167362|NCT03002194|11297375|FG000|STARTED|Overall Study||48
10167363|NCT03002194|11297375|FG000|COMPLETED|Overall Study||38
10167364|NCT03002194|11297375|FG000|NOT COMPLETED|Overall Study||10
10167365|NCT03002311|11297381|FG000|STARTED|Overall Study||147
10167366|NCT03002311|11297382|FG001|STARTED|Overall Study||180
10167367|NCT03002311|11297381|FG000|COMPLETED|Overall Study||128
10167368|NCT03002311|11297382|FG001|COMPLETED|Overall Study||150
10167369|NCT03002311|11297381|FG000|NOT COMPLETED|Overall Study||19
10167370|NCT03002311|11297382|FG001|NOT COMPLETED|Overall Study||30
10167371|NCT03002454|11297388|FG000|STARTED|Overall Study||4
10167372|NCT03002454|11297388|FG000|COMPLETED|Overall Study||4
10167373|NCT03002454|11297388|FG000|NOT COMPLETED|Overall Study||0
10167374|NCT03002506|11297393|FG000|STARTED|Overall Study||6
10167375|NCT03002506|11297393|FG000|COMPLETED|Overall Study||6
10167376|NCT03002506|11297393|FG000|NOT COMPLETED|Overall Study||0
10167377|NCT03002610|11297400|FG000|STARTED|Overall Study||24
10167378|NCT03002610|11297401|FG001|STARTED|Overall Study||50
10167379|NCT03002610|11297402|FG002|STARTED|Overall Study||34
10167380|NCT03002610|11297400|FG000|COMPLETED|Overall Study||18
10167381|NCT03002610|11297401|FG001|COMPLETED|Overall Study||25
10167382|NCT03002610|11297402|FG002|COMPLETED|Overall Study||21
10167383|NCT03002610|11297400|FG000|NOT COMPLETED|Overall Study||6
10167384|NCT03002610|11297401|FG001|NOT COMPLETED|Overall Study||25
10167385|NCT03002610|11297402|FG002|NOT COMPLETED|Overall Study||13
10167386|NCT03002623|11297412|FG000|STARTED|Overall Study||4
10167387|NCT03002623|11297413|FG001|STARTED|Overall Study||3
10167388|NCT03002623|11297412|FG000|COMPLETED|Overall Study||2
10167389|NCT03002623|11297413|FG001|COMPLETED|Overall Study||2
10167390|NCT03002623|11297412|FG000|NOT COMPLETED|Overall Study||2
10167391|NCT03002623|11297413|FG001|NOT COMPLETED|Overall Study||1
10167392|NCT03002753|11297423|FG000|STARTED|First Randomization||10
10167393|NCT03002753|11297424|FG001|STARTED|First Randomization||12
10167394|NCT03002753|11297425|FG002|STARTED|First Randomization||21
10167395|NCT03002753|11297423|FG000|COMPLETED|First Randomization||9
10167396|NCT03002753|11297424|FG001|COMPLETED|First Randomization||11
10167397|NCT03002753|11297425|FG002|COMPLETED|First Randomization||21
10167398|NCT03002753|11297423|FG000|NOT COMPLETED|First Randomization||1
10167399|NCT03002753|11297424|FG001|NOT COMPLETED|First Randomization||1
10167400|NCT03002753|11297425|FG002|NOT COMPLETED|First Randomization||0
10167401|NCT03002753|11297423|FG000|STARTED|Second Randomization (Re-randomization)||11
10167402|NCT03002753|11297424|FG001|STARTED|Second Randomization (Re-randomization)||10
10167403|NCT03002753|11297425|FG002|STARTED|Second Randomization (Re-randomization)||0
10167404|NCT03002753|11297423|FG000|COMPLETED|Second Randomization (Re-randomization)||11
10167405|NCT03002753|11297424|FG001|COMPLETED|Second Randomization (Re-randomization)||9
10167406|NCT03002753|11297425|FG002|COMPLETED|Second Randomization (Re-randomization)||0
10167407|NCT03002753|11297423|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0
10167408|NCT03002753|11297424|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1
10167409|NCT03002753|11297425|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0
10167410|NCT03002818|11297433|FG000|STARTED|Overall Study||41
10167411|NCT03002818|11297433|FG000|COMPLETED|Overall Study||40
10167412|NCT03002818|11297433|FG000|NOT COMPLETED|Overall Study||1
10167413|NCT03002974|11297440|FG000|STARTED|Overall Study||55
10167414|NCT03002974|11297441|FG001|STARTED|Overall Study||56
10167415|NCT03002974|11297442|FG002|STARTED|Overall Study||54
10167416|NCT03002974|11297440|FG000|Intention To Treat Populatio|Overall Study||55
10167417|NCT03002974|11297441|FG001|Intention To Treat Populatio|Overall Study||56
10167418|NCT03002974|11297442|FG002|Intention To Treat Populatio|Overall Study||54
10167419|NCT03002974|11297440|FG000|Safety Population|Overall Study||54
10167420|NCT03002974|11297441|FG001|Safety Population|Overall Study||55
10167421|NCT03002974|11297442|FG002|Safety Population|Overall Study||52
10167422|NCT03002974|11297440|FG000|COMPLETED|Overall Study||35
10167423|NCT03002974|11297441|FG001|COMPLETED|Overall Study||40
10167424|NCT03002974|11297442|FG002|COMPLETED|Overall Study||36
10167425|NCT03002974|11297440|FG000|NOT COMPLETED|Overall Study||20
10167426|NCT03002974|11297441|FG001|NOT COMPLETED|Overall Study||16
10167427|NCT03002974|11297442|FG002|NOT COMPLETED|Overall Study||18
10167428|NCT03003000|11297453|FG000|STARTED|Overall Study||126
10167429|NCT03003000|11297454|FG001|STARTED|Overall Study||253
10167430|NCT03003000|11297455|FG002|STARTED|Overall Study||256
10167431|NCT03003000|11297453|FG000|COMPLETED|Overall Study||121
10167432|NCT03003000|11297454|FG001|COMPLETED|Overall Study||249
10167433|NCT03003000|11297455|FG002|COMPLETED|Overall Study||251
10167434|NCT03003000|11297453|FG000|NOT COMPLETED|Overall Study||5
10167435|NCT03003000|11297454|FG001|NOT COMPLETED|Overall Study||4
10167436|NCT03003000|11297455|FG002|NOT COMPLETED|Overall Study||5
10167437|NCT03003130|11297465|FG000|STARTED|Overall Study||88
10167438|NCT03003130|11297466|FG001|STARTED|Overall Study||87
10167439|NCT03003130|11297465|FG000|COMPLETED|Overall Study||80
10167440|NCT03003130|11297466|FG001|COMPLETED|Overall Study||80
10167441|NCT03003130|11297465|FG000|NOT COMPLETED|Overall Study||8
10167442|NCT03003130|11297466|FG001|NOT COMPLETED|Overall Study||7
10167443|NCT03003390|11297474|FG000|STARTED|Overall Study||27
10167444|NCT03003390|11297475|FG001|STARTED|Overall Study||24
10167445|NCT03003390|11297474|FG000|COMPLETED|Overall Study||23
10167446|NCT03003390|11297475|FG001|COMPLETED|Overall Study||24
10167447|NCT03003390|11297474|FG000|NOT COMPLETED|Overall Study||4
10167448|NCT03003390|11297475|FG001|NOT COMPLETED|Overall Study||0
10167449|NCT03003494|11297486|FG000|STARTED|Overall Study||306
10167450|NCT03003494|11297486|FG000|COMPLETED|Overall Study||278
10167451|NCT03003494|11297486|FG000|NOT COMPLETED|Overall Study||28
10167452|NCT03003676|11297492|FG000|STARTED|Overall Study||9
10167453|NCT03003676|11297493|FG001|STARTED|Overall Study||12
10167454|NCT03003676|11297492|FG000|COMPLETED|Overall Study||3
10167455|NCT03003676|11297493|FG001|COMPLETED|Overall Study||4
10167456|NCT03003676|11297492|FG000|NOT COMPLETED|Overall Study||6
10167457|NCT03003676|11297493|FG001|NOT COMPLETED|Overall Study||8
10167458|NCT03003793|11297503|FG000|STARTED|Overall Study||16
10167459|NCT03003793|11297504|FG001|STARTED|Overall Study||16
10167460|NCT03003793|11297503|FG000|COMPLETED|Overall Study||16
10167461|NCT03003793|11297504|FG001|COMPLETED|Overall Study||16
10167462|NCT03003793|11297503|FG000|NOT COMPLETED|Overall Study||0
10167463|NCT03003793|11297504|FG001|NOT COMPLETED|Overall Study||0
10167464|NCT03003949|11297512|FG000|STARTED|Overall Study||40
10167465|NCT03003949|11297513|FG001|STARTED|Overall Study||42
10167466|NCT03003949|11297512|FG000|Week 8|Overall Study||40
10167467|NCT03003949|11297513|FG001|Week 8|Overall Study||42
10167468|NCT03003949|11297512|FG000|Week 16|Overall Study||38
10167469|NCT03003949|11297513|FG001|Week 16|Overall Study||35
10167470|NCT03003949|11297512|FG000|Week 20|Overall Study||35
10167471|NCT03003949|11297513|FG001|Week 20|Overall Study||33
10167472|NCT03003949|11297512|FG000|Week 24|Overall Study||35
10167473|NCT03003949|11297513|FG001|Week 24|Overall Study||32
10167474|NCT03003949|11297512|FG000|COMPLETED|Overall Study||35
10167475|NCT03003949|11297513|FG001|COMPLETED|Overall Study||32
10167476|NCT03003949|11297512|FG000|NOT COMPLETED|Overall Study||5
10167477|NCT03003949|11297513|FG001|NOT COMPLETED|Overall Study||10
10167478|NCT03004469|11297522|FG000|STARTED|Overall Study||189
10167479|NCT03004469|11297523|FG001|STARTED|Overall Study||184
10167480|NCT03004469|11297524|FG002|STARTED|Overall Study||85
10167481|NCT03004469|11297522|FG000|COMPLETED|Overall Study||128
10167482|NCT03004469|11297523|FG001|COMPLETED|Overall Study||135
10167483|NCT03004469|11297524|FG002|COMPLETED|Overall Study||60
10167484|NCT03004469|11297522|FG000|NOT COMPLETED|Overall Study||61
10167485|NCT03004469|11297523|FG001|NOT COMPLETED|Overall Study||49
10167486|NCT03004469|11297524|FG002|NOT COMPLETED|Overall Study||25
10167487|NCT03004534|11297533|FG000|STARTED|Overall Study||36
10167488|NCT03004534|11297533|FG000|COMPLETED|Overall Study||36
10167489|NCT03004534|11297533|FG000|NOT COMPLETED|Overall Study||0
10167490|NCT03004638|11297543|FG000|STARTED|Overall Study||6
10167491|NCT03004638|11297544|FG001|STARTED|Overall Study||6
10167492|NCT03004638|11297545|FG002|STARTED|Overall Study||6
10167493|NCT03004638|11297546|FG003|STARTED|Overall Study||6
10167494|NCT03004638|11297547|FG004|STARTED|Overall Study||1
10167495|NCT03004638|11297548|FG005|STARTED|Overall Study||7
10167496|NCT03004638|11297543|FG000|COMPLETED|Overall Study||6
10167497|NCT03004638|11297544|FG001|COMPLETED|Overall Study||6
10167498|NCT03004638|11297545|FG002|COMPLETED|Overall Study||6
10167499|NCT03004638|11297546|FG003|COMPLETED|Overall Study||6
10167500|NCT03004638|11297547|FG004|COMPLETED|Overall Study||1
10167501|NCT03004638|11297548|FG005|COMPLETED|Overall Study||7
10167502|NCT03004638|11297543|FG000|NOT COMPLETED|Overall Study||0
10167503|NCT03004638|11297544|FG001|NOT COMPLETED|Overall Study||0
9711797|NCT04749459|10811340|FG000|STARTED|Overall Study||14
9711798|NCT04749459|10811340|FG000|CSM Classic|Overall Study||12
9711799|NCT04749459|10811340|FG000|CSM Strawberry Flavor|Overall Study||10
9711800|NCT04749459|10811340|FG000|P2 Control Standard|Overall Study||14
9711801|NCT04749459|10811340|FG000|COMPLETED|Overall Study||14
9711802|NCT04749459|10811340|FG000|NOT COMPLETED|Overall Study||0
9711803|NCT04702984|10811351|FG000|STARTED|Overall Study||39
9711804|NCT04702984|10811351|FG000|COMPLETED|Overall Study||38
9711805|NCT04702984|10811351|FG000|NOT COMPLETED|Overall Study||1
9711806|NCT04633564|10811359|FG000|STARTED|Period 1||335
9711807|NCT04633564|10811360|FG001|STARTED|Period 1||329
9711808|NCT04633564|10811359|FG000|COMPLETED|Period 1||227
9711809|NCT04633564|10811360|FG001|COMPLETED|Period 1||220
9711810|NCT04633564|10811359|FG000|NOT COMPLETED|Period 1||108
9711811|NCT04633564|10811360|FG001|NOT COMPLETED|Period 1||109
9711812|NCT04633564|10811359|FG000|STARTED|Period 2||200
9711813|NCT04633564|10811360|FG001|STARTED|Period 2||199
9711814|NCT04633564|10811359|FG000|COMPLETED|Period 2||107
9711815|NCT04633564|10811360|FG001|COMPLETED|Period 2||102
9711816|NCT04633564|10811359|FG000|NOT COMPLETED|Period 2||93
10167504|NCT03004638|11297545|FG002|NOT COMPLETED|Overall Study||0
10167505|NCT03004638|11297546|FG003|NOT COMPLETED|Overall Study||0
10167506|NCT03004638|11297547|FG004|NOT COMPLETED|Overall Study||0
10167507|NCT03004638|11297548|FG005|NOT COMPLETED|Overall Study||0
10167508|NCT03004846|11297569|FG000|STARTED|Part A (Up to 14 Weeks)||8
10167509|NCT03004846|11297570|FG001|STARTED|Part A (Up to 14 Weeks)||0
10167510|NCT03004846|11297571|FG002|STARTED|Part A (Up to 14 Weeks)||0
10167511|NCT03004846|11297569|FG000|COMPLETED|Part A (Up to 14 Weeks)||8
10167512|NCT03004846|11297570|FG001|COMPLETED|Part A (Up to 14 Weeks)||0
9711817|NCT04633564|10811360|FG001|NOT COMPLETED|Period 2||97
9711818|NCT04481035|10811368|FG000|STARTED|Period 1||3
9711819|NCT04481035|10811369|FG001|STARTED|Period 1||2
9711820|NCT04481035|10811368|FG000|COMPLETED|Period 1||3
10167513|NCT03004846|11297571|FG002|COMPLETED|Part A (Up to 14 Weeks)||0
10167514|NCT03004846|11297569|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0
10167515|NCT03004846|11297570|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0
10167516|NCT03004846|11297571|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0
9711821|NCT04481035|10811369|FG001|COMPLETED|Period 1||2
10167517|NCT03004846|11297569|FG000|STARTED|Part B (Up to 14 Weeks)||0
10167518|NCT03004846|11297570|FG001|STARTED|Part B (Up to 14 Weeks)||0
10167519|NCT03004846|11297571|FG002|STARTED|Part B (Up to 14 Weeks)||0
10167520|NCT03004846|11297569|FG000|COMPLETED|Part B (Up to 14 Weeks)||0
10167521|NCT03004846|11297570|FG001|COMPLETED|Part B (Up to 14 Weeks)||0
10167522|NCT03004846|11297571|FG002|COMPLETED|Part B (Up to 14 Weeks)||0
10167523|NCT03004846|11297569|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0
10167524|NCT03004846|11297570|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0
10167525|NCT03004846|11297571|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0
10167526|NCT03004911|11297582|FG000|STARTED|Overall Study||20
10167527|NCT03004911|11297583|FG001|STARTED|Overall Study||20
10167528|NCT03004911|11297582|FG000|COMPLETED|Overall Study||19
10167529|NCT03004911|11297583|FG001|COMPLETED|Overall Study||17
10167530|NCT03004911|11297582|FG000|NOT COMPLETED|Overall Study||1
10167531|NCT03004911|11297583|FG001|NOT COMPLETED|Overall Study||3
10167532|NCT03004924|11297592|FG000|STARTED|Overall Study||324
10167533|NCT03004924|11297593|FG001|STARTED|Overall Study||108
10167534|NCT03004924|11297594|FG002|STARTED|Overall Study||321
10167535|NCT03004924|11297592|FG000|COMPLETED|Overall Study||297
10167536|NCT03004924|11297593|FG001|COMPLETED|Overall Study||94
10167537|NCT03004924|11297594|FG002|COMPLETED|Overall Study||293
10167538|NCT03004924|11297592|FG000|NOT COMPLETED|Overall Study||27
10167539|NCT03004924|11297593|FG001|NOT COMPLETED|Overall Study||14
10167540|NCT03004924|11297594|FG002|NOT COMPLETED|Overall Study||28
10167541|NCT03005041|11297603|FG000|STARTED|Period 1||28
10167542|NCT03005041|11297604|FG001|STARTED|Period 1||27
10167543|NCT03005041|11297603|FG000|COMPLETED|Period 1||28
10167544|NCT03005041|11297604|FG001|COMPLETED|Period 1||27
10167545|NCT03005041|11297603|FG000|NOT COMPLETED|Period 1||0
10167546|NCT03005041|11297604|FG001|NOT COMPLETED|Period 1||0
10167547|NCT03005041|11297603|FG000|STARTED|Washout Period 1||28
10167548|NCT03005041|11297604|FG001|STARTED|Washout Period 1||27
10167549|NCT03005041|11297603|FG000|COMPLETED|Washout Period 1||28
10167550|NCT03005041|11297604|FG001|COMPLETED|Washout Period 1||27
10167551|NCT03005041|11297603|FG000|NOT COMPLETED|Washout Period 1||0
10167552|NCT03005041|11297604|FG001|NOT COMPLETED|Washout Period 1||0
10167553|NCT03005041|11297603|FG000|STARTED|Period 2||28
10167554|NCT03005041|11297604|FG001|STARTED|Period 2||27
10167555|NCT03005041|11297603|FG000|COMPLETED|Period 2||28
10167556|NCT03005041|11297604|FG001|COMPLETED|Period 2||27
10167557|NCT03005041|11297603|FG000|NOT COMPLETED|Period 2||0
10167558|NCT03005041|11297604|FG001|NOT COMPLETED|Period 2||0
10167559|NCT03005054|11297610|FG000|STARTED|Overall Study||3
10167560|NCT03005054|11297610|FG000|COMPLETED|Overall Study||3
10167561|NCT03005054|11297610|FG000|NOT COMPLETED|Overall Study||0
10167562|NCT03005067|11297616|FG000|STARTED|Overall Study||90
10167563|NCT03005067|11297617|FG001|STARTED|Overall Study||81
10167564|NCT03005067|11297616|FG000|COMPLETED|Overall Study||80
10167565|NCT03005067|11297617|FG001|COMPLETED|Overall Study||74
10167566|NCT03005067|11297616|FG000|NOT COMPLETED|Overall Study||10
10167567|NCT03005067|11297617|FG001|NOT COMPLETED|Overall Study||7
10167568|NCT03005106|11297623|FG000|STARTED|Overall Study||71
10167569|NCT03005106|11297623|FG000|Completed Month 3 Visit|Overall Study||64
10167570|NCT03005106|11297623|FG000|Completed Month 12 Visit|Overall Study||51
9711822|NCT04481035|10811368|FG000|NOT COMPLETED|Period 1||0
9711823|NCT04481035|10811369|FG001|NOT COMPLETED|Period 1||0
9711824|NCT04481035|10811368|FG000|STARTED|Period 2||3
9711825|NCT04481035|10811369|FG001|STARTED|Period 2||2
9711826|NCT04481035|10811368|FG000|COMPLETED|Period 2||3
9711827|NCT04481035|10811369|FG001|COMPLETED|Period 2||2
9711828|NCT04481035|10811368|FG000|NOT COMPLETED|Period 2||0
9711829|NCT04481035|10811369|FG001|NOT COMPLETED|Period 2||0
9730962|NCT00129246|10830867|FG001|STARTED|Overall Study||20
9730963|NCT00129246|10830866|FG000|COMPLETED|Overall Study||20
9730964|NCT00129246|10830867|FG001|COMPLETED|Overall Study||20
9730965|NCT00129246|10830866|FG000|NOT COMPLETED|Overall Study||0
9730966|NCT00129246|10830867|FG001|NOT COMPLETED|Overall Study||0
9730967|NCT00129259|10830875|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
9730968|NCT00129259|10830876|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
9730969|NCT00129259|10830875|FG000|Received All or Part of Cycle 1|Overall Study||52
9730970|NCT00129259|10830876|FG001|Received All or Part of Cycle 1|Overall Study||0
9730971|NCT00129259|10830875|FG000|Received All or Part of Cycle 2|Overall Study||40
9730972|NCT00129259|10830876|FG001|Received All or Part of Cycle 2|Overall Study||0
9730973|NCT00129259|10830875|FG000|COMPLETED|Overall Study||49
9730974|NCT00129259|10830876|FG001|COMPLETED|Overall Study||22
10167571|NCT03005106|11297623|FG000|COMPLETED|Overall Study||51
10167572|NCT03005106|11297623|FG000|NOT COMPLETED|Overall Study||20
10167573|NCT03005288|11297629|FG000|STARTED|Overall Study||39
10167574|NCT03005288|11297630|FG001|STARTED|Overall Study||39
9730975|NCT00129259|10830875|FG000|NOT COMPLETED|Overall Study||3
10167575|NCT03005288|11297629|FG000|Safety Analysis Set|Overall Study||37
10167576|NCT03005288|11297630|FG001|Safety Analysis Set|Overall Study||38
10167577|NCT03005288|11297629|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
10167578|NCT03005288|11297630|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
10167579|NCT03005288|11297629|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
10167580|NCT03005288|11297630|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
10167581|NCT03005288|11297629|FG000|COMPLETED|Overall Study||27
10167582|NCT03005288|11297630|FG001|COMPLETED|Overall Study||31
10167583|NCT03005288|11297629|FG000|NOT COMPLETED|Overall Study||12
10167584|NCT03005288|11297630|FG001|NOT COMPLETED|Overall Study||8
10167585|NCT03006341|11297640|FG000|STARTED|Overall Study||26199
10167586|NCT03006341|11297641|FG001|STARTED|Overall Study||70071
10167587|NCT03006341|11297642|FG002|STARTED|Overall Study||32595
10167588|NCT03006341|11297643|FG003|STARTED|Overall Study||11322
10167589|NCT03006341|11297640|FG000|COMPLETED|Overall Study||1130
10167590|NCT03006341|11297641|FG001|COMPLETED|Overall Study||2566
10167591|NCT03006341|11297642|FG002|COMPLETED|Overall Study||1602
10167592|NCT03006341|11297643|FG003|COMPLETED|Overall Study||637
10167593|NCT03006341|11297640|FG000|NOT COMPLETED|Overall Study||25069
10167594|NCT03006341|11297641|FG001|NOT COMPLETED|Overall Study||67505
10167595|NCT03006341|11297642|FG002|NOT COMPLETED|Overall Study||30993
10167596|NCT03006341|11297643|FG003|NOT COMPLETED|Overall Study||10685
10167597|NCT03006393|11297653|FG000|STARTED|Overall Study||21
10167598|NCT03006393|11297654|FG001|STARTED|Overall Study||21
10167599|NCT03006393|11297653|FG000|COMPLETED|Overall Study||20
10167600|NCT03006393|11297654|FG001|COMPLETED|Overall Study||18
10167601|NCT03006393|11297653|FG000|NOT COMPLETED|Overall Study||1
10167602|NCT03006393|11297654|FG001|NOT COMPLETED|Overall Study||3
10167603|NCT03006458|11297660|FG000|STARTED|First Intervention||14
10167604|NCT03006458|11297661|FG001|STARTED|First Intervention||10
10167605|NCT03006458|11297660|FG000|COMPLETED|First Intervention||14
10167606|NCT03006458|11297661|FG001|COMPLETED|First Intervention||7
10167607|NCT03006458|11297660|FG000|NOT COMPLETED|First Intervention||0
10167608|NCT03006458|11297661|FG001|NOT COMPLETED|First Intervention||3
10167609|NCT03006458|11297660|FG000|STARTED|Second Intervention||14
10167610|NCT03006458|11297661|FG001|STARTED|Second Intervention||10
10167611|NCT03006458|11297660|FG000|COMPLETED|Second Intervention||14
10167612|NCT03006458|11297661|FG001|COMPLETED|Second Intervention||10
10167613|NCT03006458|11297660|FG000|NOT COMPLETED|Second Intervention||0
10167614|NCT03006458|11297661|FG001|NOT COMPLETED|Second Intervention||0
10167615|NCT03006471|11297669|FG000|STARTED|Overall Study||15
10167616|NCT03006471|11297670|FG001|STARTED|Overall Study||15
10167617|NCT03006471|11297669|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
10167618|NCT03006471|11297670|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
10167619|NCT03006471|11297669|FG000|NOT COMPLETED|Overall Study||2
10167620|NCT03006471|11297670|FG001|NOT COMPLETED|Overall Study||2
10167621|NCT03006562|11297678|FG000|STARTED|Overall Study||251
10167622|NCT03006562|11297679|FG001|STARTED|Overall Study||250
10167623|NCT03006562|11297678|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141
10167624|NCT03006562|11297679|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137
10167625|NCT03006562|11297678|FG000|COMPLETED|Overall Study||251
10167626|NCT03006562|11297679|FG001|COMPLETED|Overall Study||249
10167627|NCT03006562|11297678|FG000|NOT COMPLETED|Overall Study||0
10167628|NCT03006562|11297679|FG001|NOT COMPLETED|Overall Study||1
10167629|NCT03006848|11297685|FG000|STARTED|Overall Study||18
10167630|NCT03006848|11297685|FG000|COMPLETED|Overall Study||0
10167631|NCT03006848|11297685|FG000|NOT COMPLETED|Overall Study||18
10167632|NCT03006887|11297696|FG000|STARTED|Overall Study||6
10167633|NCT03006887|11297696|FG000|COMPLETED|Overall Study||5
10167634|NCT03006887|11297696|FG000|NOT COMPLETED|Overall Study||1
10167635|NCT03007225|11297702|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
10167636|NCT03007225|11297703|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25
10167637|NCT03007225|11297702|FG000|COMPLETED|Overall Study||25
10167638|NCT03007225|11297703|FG001|COMPLETED|Overall Study||25
10167639|NCT03007225|11297702|FG000|NOT COMPLETED|Overall Study||0
10167640|NCT03007225|11297703|FG001|NOT COMPLETED|Overall Study||0
10167641|NCT03007394|11297711|FG000|STARTED|Overall Study||118
10167642|NCT03007394|11297712|FG001|STARTED|Overall Study||154
10167643|NCT03007394|11297711|FG000|COMPLETED|Overall Study||91
10167644|NCT03007394|11297712|FG001|COMPLETED|Overall Study||91
10167645|NCT03007394|11297711|FG000|NOT COMPLETED|Overall Study||27
10167646|NCT03007394|11297712|FG001|NOT COMPLETED|Overall Study||63
10167647|NCT03007472|11297718|FG000|STARTED|Overall Study||96
10167648|NCT03007472|11297718|FG000|COMPLETED|Overall Study||91
10167649|NCT03007472|11297718|FG000|NOT COMPLETED|Overall Study||5
10167650|NCT03007953|11297724|FG000|STARTED|Overall Study||73
10167651|NCT03007953|11297725|FG001|STARTED|Overall Study||78
10167652|NCT03007953|11297724|FG000|COMPLETED|Overall Study||57
10167653|NCT03007953|11297725|FG001|COMPLETED|Overall Study||65
10167654|NCT03007953|11297724|FG000|NOT COMPLETED|Overall Study||16
10167655|NCT03007953|11297725|FG001|NOT COMPLETED|Overall Study||13
10167656|NCT03007966|11297733|FG000|STARTED|Overall Study||30
10167657|NCT03007966|11297734|FG001|STARTED|Overall Study||30
10167658|NCT03007966|11297733|FG000|COMPLETED|Overall Study||29
10167659|NCT03007966|11297734|FG001|COMPLETED|Overall Study||30
10167660|NCT03007966|11297733|FG000|NOT COMPLETED|Overall Study||1
10167661|NCT03007966|11297734|FG001|NOT COMPLETED|Overall Study||0
10167662|NCT03008070|11297744|FG000|STARTED|Overall Study||83
10167663|NCT03008070|11297745|FG001|STARTED|Overall Study||83
10167664|NCT03008070|11297746|FG002|STARTED|Overall Study||81
10167665|NCT03008070|11297744|FG000|COMPLETED|Overall Study||77
10167666|NCT03008070|11297745|FG001|COMPLETED|Overall Study||77
10167667|NCT03008070|11297746|FG002|COMPLETED|Overall Study||74
10167668|NCT03008070|11297744|FG000|NOT COMPLETED|Overall Study||6
10167669|NCT03008070|11297745|FG001|NOT COMPLETED|Overall Study||6
10167670|NCT03008070|11297746|FG002|NOT COMPLETED|Overall Study||7
10167671|NCT03008174|11297758|FG000|STARTED|Overall Study||10
9711830|NCT04195958|10811375|FG000|STARTED|Overall Study||3
9711831|NCT04195958|10811375|FG000|COMPLETED|Overall Study||1
9711832|NCT04195958|10811375|FG000|NOT COMPLETED|Overall Study||2
9711833|NCT04191148|10811381|FG000|STARTED|Overall Study||24
9711834|NCT04191148|10811382|FG001|STARTED|Overall Study||12
9711835|NCT04191148|10811381|FG000|COMPLETED|Overall Study||22
9711836|NCT04191148|10811382|FG001|COMPLETED|Overall Study||12
9711837|NCT04191148|10811381|FG000|NOT COMPLETED|Overall Study||2
9711838|NCT04191148|10811382|FG001|NOT COMPLETED|Overall Study||0
9711839|NCT04130802|10811393|FG000|STARTED|Overall Study||51
9711840|NCT04130802|10811394|FG001|STARTED|Overall Study||51
9711841|NCT04130802|10811395|FG002|STARTED|Overall Study||51
9711842|NCT04130802|10811393|FG000|COMPLETED|Overall Study||50
9711843|NCT04130802|10811394|FG001|COMPLETED|Overall Study||50
9711844|NCT04130802|10811395|FG002|COMPLETED|Overall Study||48
9711845|NCT04130802|10811393|FG000|NOT COMPLETED|Overall Study||1
9711846|NCT04130802|10811394|FG001|NOT COMPLETED|Overall Study||1
9711847|NCT04130802|10811395|FG002|NOT COMPLETED|Overall Study||3
9711848|NCT04105738|10811406|FG000|STARTED|Overall Study||13
9711849|NCT04105738|10811407|FG001|STARTED|Overall Study||0
9711850|NCT04105738|10811406|FG000|COMPLETED|Overall Study||13
9711851|NCT04105738|10811407|FG001|COMPLETED|Overall Study||0
9711852|NCT04105738|10811406|FG000|NOT COMPLETED|Overall Study||0
9711853|NCT04105738|10811407|FG001|NOT COMPLETED|Overall Study||0
9711854|NCT04022733|10811415|FG000|STARTED|Overall Study||67
9711855|NCT04022733|10811416|FG001|STARTED|Overall Study||67
9711856|NCT04022733|10811415|FG000|COMPLETED|Overall Study||64
9711857|NCT04022733|10811416|FG001|COMPLETED|Overall Study||64
9711858|NCT04022733|10811415|FG000|NOT COMPLETED|Overall Study||3
9711859|NCT04022733|10811416|FG001|NOT COMPLETED|Overall Study||3
9711860|NCT04021524|10811424|FG000|STARTED|Overall Study||25
9711861|NCT04021524|10811425|FG001|STARTED|Overall Study||25
9711862|NCT04021524|10811424|FG000|COMPLETED|Overall Study||25
9711863|NCT04021524|10811425|FG001|COMPLETED|Overall Study||24
9711864|NCT04021524|10811424|FG000|NOT COMPLETED|Overall Study||0
9711865|NCT04021524|10811425|FG001|NOT COMPLETED|Overall Study||1
9711866|NCT03830359|10811431|FG000|STARTED|Overall Study||62
9711867|NCT03830359|10811431|FG000|COMPLETED|Overall Study||62
9711868|NCT03830359|10811431|FG000|NOT COMPLETED|Overall Study||0
9730976|NCT00129259|10830876|FG001|NOT COMPLETED|Overall Study||3
9730977|NCT00129272|10830884|FG000|STARTED|Overall Study||71
9730978|NCT00129272|10830885|FG001|STARTED|Overall Study||73
9730979|NCT00129272|10830884|FG000|COMPLETED|Overall Study||54
9730980|NCT00129272|10830885|FG001|COMPLETED|Overall Study||51
9730981|NCT00129272|10830884|FG000|NOT COMPLETED|Overall Study||17
9730982|NCT00129272|10830885|FG001|NOT COMPLETED|Overall Study||22
9730983|NCT00129285|10830894|FG000|STARTED|Overall Study||65
9730984|NCT00129285|10830895|FG001|STARTED|Overall Study||70
9730985|NCT00129285|10830896|FG002|STARTED|Overall Study||75
9730986|NCT00129285|10830894|FG000|COMPLETED|Overall Study||40
9730987|NCT00129285|10830895|FG001|COMPLETED|Overall Study||43
9730988|NCT00129285|10830896|FG002|COMPLETED|Overall Study||37
9730989|NCT00129285|10830894|FG000|NOT COMPLETED|Overall Study||25
9730990|NCT00129285|10830895|FG001|NOT COMPLETED|Overall Study||27
9730991|NCT00129285|10830896|FG002|NOT COMPLETED|Overall Study||38
9730992|NCT00129311|10830910|FG000|STARTED|Overall Study||51
9730993|NCT00129311|10830911|FG001|STARTED|Overall Study||50
9730994|NCT00129311|10830910|FG000|COMPLETED|Overall Study||39
9730995|NCT00129311|10830911|FG001|COMPLETED|Overall Study||31
9730996|NCT00129311|10830910|FG000|NOT COMPLETED|Overall Study||12
9730997|NCT00129311|10830911|FG001|NOT COMPLETED|Overall Study||19
9730998|NCT00129376|10830917|FG000|STARTED|Overall Study||63
9730999|NCT00129376|10830917|FG000|COMPLETED|Overall Study||61
9731000|NCT00129376|10830917|FG000|NOT COMPLETED|Overall Study||2
9731001|NCT00129389|10830923|FG000|STARTED|Overall Study||974
9731002|NCT00129389|10830924|FG001|STARTED|Overall Study||951
9731003|NCT00129389|10830923|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
9731004|NCT00129389|10830924|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
9731005|NCT00129389|10830923|FG000|NOT COMPLETED|Overall Study||33
9731006|NCT00129389|10830924|FG001|NOT COMPLETED|Overall Study||140
9731007|NCT00129441|10830932|FG000|STARTED|Overall Study||9
9731008|NCT00129441|10830933|FG001|STARTED|Overall Study||6
10061385|NCT02104739|11187055|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10061386|NCT02104739|11187056|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
10061387|NCT02104739|11187057|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061388|NCT02104739|11187058|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10061389|NCT02104739|11187059|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061390|NCT02104739|11187053|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061391|NCT02104739|11187054|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
9731009|NCT00129441|10830932|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
9731010|NCT00129441|10830933|FG001|Baseline, Visit 1|Overall Study||6
9731011|NCT00129441|10830932|FG000|Week 1, Visit 2|Overall Study||9
9731012|NCT00129441|10830933|FG001|Week 1, Visit 2|Overall Study||6
10061392|NCT02104739|11187055|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061393|NCT02104739|11187056|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
9731013|NCT00129441|10830932|FG000|Week 2, Visit 3|Overall Study||9
9731014|NCT00129441|10830933|FG001|Week 2, Visit 3|Overall Study||6
10167672|NCT03008174|11297759|FG001|STARTED|Overall Study||10
10167673|NCT03008174|11297758|FG000|COMPLETED|Overall Study||7
10167674|NCT03008174|11297759|FG001|COMPLETED|Overall Study||6
10167675|NCT03008174|11297758|FG000|NOT COMPLETED|Overall Study||3
9849569|NCT00866307|10962305|FG000|NOT COMPLETED|Consolidation/Maintenance||0
9849570|NCT00866307|10962306|FG001|NOT COMPLETED|Consolidation/Maintenance||9
9849571|NCT00866307|10962307|FG002|NOT COMPLETED|Consolidation/Maintenance||16
10167676|NCT03008174|11297759|FG001|NOT COMPLETED|Overall Study||4
10167677|NCT03008213|11297765|FG000|STARTED|Overall Study||1
10167678|NCT03008213|11297765|FG000|COMPLETED|Overall Study||1
10167679|NCT03008213|11297765|FG000|NOT COMPLETED|Overall Study||0
10167680|NCT03008460|11297771|FG000|STARTED|Overall Study||126
10167681|NCT03008460|11297772|FG001|STARTED|Overall Study||124
10167682|NCT03008460|11297771|FG000|COMPLETED|Overall Study||119
10167683|NCT03008460|11297772|FG001|COMPLETED|Overall Study||110
10167684|NCT03008460|11297771|FG000|NOT COMPLETED|Overall Study||7
10167685|NCT03008460|11297772|FG001|NOT COMPLETED|Overall Study||14
10167686|NCT03008590|11297780|FG000|STARTED|Overall Study||14
10167687|NCT03008590|11297781|FG001|STARTED|Overall Study||15
10167688|NCT03008590|11297780|FG000|COMPLETED|Overall Study||11
10167689|NCT03008590|11297781|FG001|COMPLETED|Overall Study||12
10167690|NCT03008590|11297780|FG000|NOT COMPLETED|Overall Study||3
10167691|NCT03008590|11297781|FG001|NOT COMPLETED|Overall Study||3
10167692|NCT03008707|11297789|FG000|STARTED|Overall Study||28
10167693|NCT03008707|11297790|FG001|STARTED|Overall Study||38
10167694|NCT03008707|11297789|FG000|COMPLETED|Overall Study||28
10167695|NCT03008707|11297790|FG001|COMPLETED|Overall Study||38
10167696|NCT03008707|11297789|FG000|NOT COMPLETED|Overall Study||0
10167697|NCT03008707|11297790|FG001|NOT COMPLETED|Overall Study||0
10167698|NCT03008837|11297798|FG000|STARTED|Overall Study||12
10167699|NCT03008837|11297799|FG001|STARTED|Overall Study||9
10167700|NCT03008837|11297798|FG000|COMPLETED|Overall Study||9
10167701|NCT03008837|11297799|FG001|COMPLETED|Overall Study||5
10167702|NCT03008837|11297798|FG000|NOT COMPLETED|Overall Study||3
10167703|NCT03008837|11297799|FG001|NOT COMPLETED|Overall Study||4
10167704|NCT03008889|11297810|FG000|STARTED|Overall Study||1
10167705|NCT03008889|11297811|FG001|STARTED|Overall Study||1
10167706|NCT03008889|11297810|FG000|COMPLETED|Overall Study||1
10167707|NCT03008889|11297811|FG001|COMPLETED|Overall Study||1
10167708|NCT03008889|11297810|FG000|NOT COMPLETED|Overall Study||0
10167709|NCT03008889|11297811|FG001|NOT COMPLETED|Overall Study||0
10167710|NCT03008915|11297818|FG000|STARTED|Treatment 1||8
10167711|NCT03008915|11297819|FG001|STARTED|Treatment 1||7
10167712|NCT03008915|11297818|FG000|COMPLETED|Treatment 1||8
10167713|NCT03008915|11297819|FG001|COMPLETED|Treatment 1||6
10167714|NCT03008915|11297818|FG000|NOT COMPLETED|Treatment 1||0
10167715|NCT03008915|11297819|FG001|NOT COMPLETED|Treatment 1||1
10167716|NCT03008915|11297818|FG000|STARTED|Treatment 2||8
10167717|NCT03008915|11297819|FG001|STARTED|Treatment 2||6
10167718|NCT03008915|11297818|FG000|COMPLETED|Treatment 2||8
10167719|NCT03008915|11297819|FG001|COMPLETED|Treatment 2||6
10167720|NCT03008915|11297818|FG000|NOT COMPLETED|Treatment 2||0
10167721|NCT03008915|11297819|FG001|NOT COMPLETED|Treatment 2||0
10167722|NCT03009162|11297828|FG000|STARTED|Overall Study||8
10167723|NCT03009162|11297829|FG001|STARTED|Overall Study||8
10167724|NCT03009162|11297828|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10167725|NCT03009162|11297829|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10167726|NCT03009162|11297828|FG000|COMPLETED|Overall Study||8
10167727|NCT03009162|11297829|FG001|COMPLETED|Overall Study||8
10167728|NCT03009162|11297828|FG000|NOT COMPLETED|Overall Study||0
10167729|NCT03009162|11297829|FG001|NOT COMPLETED|Overall Study||0
10167730|NCT03009396|11297835|FG000|STARTED|Overall Study||16
10167731|NCT03009396|11297836|FG001|STARTED|Overall Study||38
10167732|NCT03009396|11297835|FG000|COMPLETED|Overall Study||9
10167733|NCT03009396|11297836|FG001|COMPLETED|Overall Study||21
10167734|NCT03009396|11297835|FG000|NOT COMPLETED|Overall Study||7
10167735|NCT03009396|11297836|FG001|NOT COMPLETED|Overall Study||17
10167736|NCT03010137|11297845|FG000|STARTED|Overall Study||15
10167737|NCT03010137|11297846|FG001|STARTED|Overall Study||15
10167738|NCT03010137|11297845|FG000|COMPLETED|Overall Study||15
10167739|NCT03010137|11297846|FG001|COMPLETED|Overall Study||15
10167740|NCT03010137|11297845|FG000|NOT COMPLETED|Overall Study||0
10167741|NCT03010137|11297846|FG001|NOT COMPLETED|Overall Study||0
10167742|NCT03010254|11297854|FG000|STARTED|Overall Study||159
10167743|NCT03010254|11297855|FG001|STARTED|Overall Study||123
10167744|NCT03010254|11297854|FG000|Attempted Implantation|Overall Study||156
10167745|NCT03010254|11297855|FG001|Attempted Implantation|Overall Study||120
10167746|NCT03010254|11297854|FG000|Successful Implantation|Overall Study||156
10167747|NCT03010254|11297855|FG001|Successful Implantation|Overall Study||120
10167748|NCT03010254|11297854|FG000|COMPLETED|Overall Study||152
10167749|NCT03010254|11297855|FG001|COMPLETED|Overall Study||118
10167750|NCT03010254|11297854|FG000|NOT COMPLETED|Overall Study||7
10167751|NCT03010254|11297855|FG001|NOT COMPLETED|Overall Study||5
10167752|NCT03010462|11297870|FG000|STARTED|Overall Study||31
10167753|NCT03010462|11297871|FG001|STARTED|Overall Study||29
10167754|NCT03010462|11297870|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
10167755|NCT03010462|11297871|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
10167756|NCT03010462|11297870|FG000|NOT COMPLETED|Overall Study||3
10167757|NCT03010462|11297871|FG001|NOT COMPLETED|Overall Study||1
10167758|NCT03010488|11297879|FG000|STARTED|Overall Study||22
10167759|NCT03010488|11297880|FG001|STARTED|Overall Study||22
10167760|NCT03010488|11297879|FG000|COMPLETED|Overall Study||17
10167761|NCT03010488|11297880|FG001|COMPLETED|Overall Study||15
10167762|NCT03010488|11297879|FG000|NOT COMPLETED|Overall Study||5
10167763|NCT03010488|11297880|FG001|NOT COMPLETED|Overall Study||7
10167764|NCT03010501|11297886|FG000|STARTED|Study Week 1||9
10167765|NCT03010501|11297887|FG001|STARTED|Study Week 1||15
10167766|NCT03010501|11297888|FG002|STARTED|Study Week 1||7
10167767|NCT03010501|11297889|FG003|STARTED|Study Week 1||7
10167768|NCT03010501|11297890|FG004|STARTED|Study Week 1||7
10167769|NCT03010501|11297891|FG005|STARTED|Study Week 1||11
10167770|NCT03010501|11297886|FG000|COMPLETED|Study Week 1||7
10167771|NCT03010501|11297887|FG001|COMPLETED|Study Week 1||14
10167772|NCT03010501|11297888|FG002|COMPLETED|Study Week 1||7
10167773|NCT03010501|11297889|FG003|COMPLETED|Study Week 1||5
10167774|NCT03010501|11297890|FG004|COMPLETED|Study Week 1||7
10167775|NCT03010501|11297891|FG005|COMPLETED|Study Week 1||11
10167776|NCT03010501|11297886|FG000|NOT COMPLETED|Study Week 1||2
10167777|NCT03010501|11297887|FG001|NOT COMPLETED|Study Week 1||1
10167778|NCT03010501|11297888|FG002|NOT COMPLETED|Study Week 1||0
10167779|NCT03010501|11297889|FG003|NOT COMPLETED|Study Week 1||2
10167780|NCT03010501|11297890|FG004|NOT COMPLETED|Study Week 1||0
10167781|NCT03010501|11297891|FG005|NOT COMPLETED|Study Week 1||0
10167782|NCT03010501|11297886|FG000|STARTED|Study Week 2||7
10167783|NCT03010501|11297887|FG001|STARTED|Study Week 2||14
10167784|NCT03010501|11297888|FG002|STARTED|Study Week 2||7
10167785|NCT03010501|11297889|FG003|STARTED|Study Week 2||5
10167786|NCT03010501|11297890|FG004|STARTED|Study Week 2||7
10167787|NCT03010501|11297891|FG005|STARTED|Study Week 2||11
10167788|NCT03010501|11297886|FG000|COMPLETED|Study Week 2||7
10167789|NCT03010501|11297887|FG001|COMPLETED|Study Week 2||14
10167790|NCT03010501|11297888|FG002|COMPLETED|Study Week 2||7
10167791|NCT03010501|11297889|FG003|COMPLETED|Study Week 2||5
10167792|NCT03010501|11297890|FG004|COMPLETED|Study Week 2||7
10167793|NCT03010501|11297891|FG005|COMPLETED|Study Week 2||11
10167794|NCT03010501|11297886|FG000|NOT COMPLETED|Study Week 2||0
10167795|NCT03010501|11297887|FG001|NOT COMPLETED|Study Week 2||0
10167796|NCT03010501|11297888|FG002|NOT COMPLETED|Study Week 2||0
10167797|NCT03010501|11297889|FG003|NOT COMPLETED|Study Week 2||0
9711869|NCT03675516|10811437|FG000|STARTED|Overall Study||6591
9711870|NCT03675516|10811438|FG001|STARTED|Overall Study||6591
9711871|NCT03675516|10811437|FG000|COMPLETED|Overall Study||6591
9711872|NCT03675516|10811438|FG001|COMPLETED|Overall Study||6591
9711873|NCT03675516|10811437|FG000|NOT COMPLETED|Overall Study||0
9711874|NCT03675516|10811438|FG001|NOT COMPLETED|Overall Study||0
9711875|NCT03605680|10811449|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604
10167798|NCT03010501|11297890|FG004|NOT COMPLETED|Study Week 2||0
10167799|NCT03010501|11297891|FG005|NOT COMPLETED|Study Week 2||0
10167800|NCT03010501|11297886|FG000|STARTED|Study Week 3||7
10167801|NCT03010501|11297887|FG001|STARTED|Study Week 3||14
10167802|NCT03010501|11297888|FG002|STARTED|Study Week 3||7
10167803|NCT03010501|11297889|FG003|STARTED|Study Week 3||5
10167804|NCT03010501|11297890|FG004|STARTED|Study Week 3||7
10167805|NCT03010501|11297891|FG005|STARTED|Study Week 3||11
10167806|NCT03010501|11297886|FG000|COMPLETED|Study Week 3||7
10167807|NCT03010501|11297887|FG001|COMPLETED|Study Week 3||14
10167808|NCT03010501|11297888|FG002|COMPLETED|Study Week 3||7
10167809|NCT03010501|11297889|FG003|COMPLETED|Study Week 3||4
10167810|NCT03010501|11297890|FG004|COMPLETED|Study Week 3||7
10167811|NCT03010501|11297891|FG005|COMPLETED|Study Week 3||11
10167812|NCT03010501|11297886|FG000|NOT COMPLETED|Study Week 3||0
10167813|NCT03010501|11297887|FG001|NOT COMPLETED|Study Week 3||0
10167814|NCT03010501|11297888|FG002|NOT COMPLETED|Study Week 3||0
10167815|NCT03010501|11297889|FG003|NOT COMPLETED|Study Week 3||1
10167816|NCT03010501|11297890|FG004|NOT COMPLETED|Study Week 3||0
10167817|NCT03010501|11297891|FG005|NOT COMPLETED|Study Week 3||0
10167818|NCT03010527|11297902|FG000|STARTED|Overall Study||15
10167819|NCT03010527|11297903|FG001|STARTED|Overall Study||111
10167820|NCT03010527|11297904|FG002|STARTED|Overall Study||91
10167821|NCT03010527|11297902|FG000|COMPLETED|Overall Study||15
10167822|NCT03010527|11297903|FG001|COMPLETED|Overall Study||92
10167823|NCT03010527|11297904|FG002|COMPLETED|Overall Study||75
10167824|NCT03010527|11297902|FG000|NOT COMPLETED|Overall Study||0
10167825|NCT03010527|11297903|FG001|NOT COMPLETED|Overall Study||19
10167826|NCT03010527|11297904|FG002|NOT COMPLETED|Overall Study||16
10167827|NCT03010631|11297925|FG000|STARTED|Cohort 1||18
10167828|NCT03010631|11297926|FG001|STARTED|Cohort 1||17
10167829|NCT03010631|11297927|FG002|STARTED|Cohort 1||0
10167830|NCT03010631|11297928|FG003|STARTED|Cohort 1||0
10167831|NCT03010631|11297925|FG000|COMPLETED|Cohort 1||14
10167832|NCT03010631|11297926|FG001|COMPLETED|Cohort 1||17
10167833|NCT03010631|11297927|FG002|COMPLETED|Cohort 1||0
10167834|NCT03010631|11297928|FG003|COMPLETED|Cohort 1||0
10167835|NCT03010631|11297925|FG000|NOT COMPLETED|Cohort 1||4
10167836|NCT03010631|11297926|FG001|NOT COMPLETED|Cohort 1||0
10167837|NCT03010631|11297927|FG002|NOT COMPLETED|Cohort 1||0
10167838|NCT03010631|11297928|FG003|NOT COMPLETED|Cohort 1||0
10167839|NCT03010631|11297925|FG000|STARTED|Cohort 2||0
10167840|NCT03010631|11297926|FG001|STARTED|Cohort 2||0
10167841|NCT03010631|11297927|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
10167842|NCT03010631|11297928|FG003|STARTED|Cohort 2||7
10167843|NCT03010631|11297925|FG000|COMPLETED|Cohort 2||0
10167844|NCT03010631|11297926|FG001|COMPLETED|Cohort 2||0
10167845|NCT03010631|11297927|FG002|COMPLETED|Cohort 2||7
10167846|NCT03010631|11297928|FG003|COMPLETED|Cohort 2||7
10167847|NCT03010631|11297925|FG000|NOT COMPLETED|Cohort 2||0
10167848|NCT03010631|11297926|FG001|NOT COMPLETED|Cohort 2||0
10167849|NCT03010631|11297927|FG002|NOT COMPLETED|Cohort 2||0
10167850|NCT03010631|11297928|FG003|NOT COMPLETED|Cohort 2||0
10167851|NCT03010683|11297944|FG000|STARTED|Overall Study||30
10167852|NCT03010683|11297945|FG001|STARTED|Overall Study||30
10167853|NCT03010683|11297944|FG000|COMPLETED|Overall Study||30
10167854|NCT03010683|11297945|FG001|COMPLETED|Overall Study||30
10167855|NCT03010683|11297944|FG000|NOT COMPLETED|Overall Study||0
10167856|NCT03010683|11297945|FG001|NOT COMPLETED|Overall Study||0
10167857|NCT03010800|11297953|FG000|STARTED|Initial Assignment||4
10167858|NCT03010800|11297954|FG001|STARTED|Initial Assignment||4
10167859|NCT03010800|11297953|FG000|COMPLETED|Initial Assignment||4
10167860|NCT03010800|11297954|FG001|COMPLETED|Initial Assignment||4
10167861|NCT03010800|11297953|FG000|NOT COMPLETED|Initial Assignment||0
10167862|NCT03010800|11297954|FG001|NOT COMPLETED|Initial Assignment||0
10167863|NCT03010800|11297953|FG000|STARTED|Cross Over||4
10167864|NCT03010800|11297954|FG001|STARTED|Cross Over||4
10167865|NCT03010800|11297953|FG000|COMPLETED|Cross Over||4
10167866|NCT03010800|11297954|FG001|COMPLETED|Cross Over||4
10167867|NCT03010800|11297953|FG000|NOT COMPLETED|Cross Over||0
10167868|NCT03010800|11297954|FG001|NOT COMPLETED|Cross Over||0
10167869|NCT03011099|11297962|FG000|STARTED|Overall Study||6
10167870|NCT03011099|11297963|FG001|STARTED|Overall Study||5
10167871|NCT03011099|11297962|FG000|COMPLETED|Overall Study||6
10167872|NCT03011099|11297963|FG001|COMPLETED|Overall Study||3
10167873|NCT03011099|11297962|FG000|NOT COMPLETED|Overall Study||0
10167874|NCT03011099|11297963|FG001|NOT COMPLETED|Overall Study||2
10167875|NCT03011333|11297978|FG000|STARTED|Overall Study||12
10167876|NCT03011333|11297979|FG001|STARTED|Overall Study||27
10167877|NCT03011333|11297980|FG002|STARTED|Overall Study||25
10167878|NCT03011333|11297981|FG003|STARTED|Overall Study||47
10167879|NCT03011333|11297982|FG004|STARTED|Overall Study||50
10167880|NCT03011333|11297983|FG005|STARTED|Overall Study||41
10167881|NCT03011333|11297984|FG006|STARTED|Overall Study||41
10167882|NCT03011333|11297978|FG000|COMPLETED|Overall Study||12
10167883|NCT03011333|11297979|FG001|COMPLETED|Overall Study||26
10167884|NCT03011333|11297980|FG002|COMPLETED|Overall Study||25
10167885|NCT03011333|11297981|FG003|COMPLETED|Overall Study||46
10167886|NCT03011333|11297982|FG004|COMPLETED|Overall Study||46
10167887|NCT03011333|11297983|FG005|COMPLETED|Overall Study||37
10167888|NCT03011333|11297984|FG006|COMPLETED|Overall Study||36
10167889|NCT03011333|11297978|FG000|NOT COMPLETED|Overall Study||0
10167890|NCT03011333|11297979|FG001|NOT COMPLETED|Overall Study||1
10167891|NCT03011333|11297980|FG002|NOT COMPLETED|Overall Study||0
10167892|NCT03011333|11297981|FG003|NOT COMPLETED|Overall Study||1
10167893|NCT03011333|11297982|FG004|NOT COMPLETED|Overall Study||4
10167894|NCT03011333|11297983|FG005|NOT COMPLETED|Overall Study||4
10167895|NCT03011333|11297984|FG006|NOT COMPLETED|Overall Study||5
10167896|NCT03011840|11298002|FG000|STARTED|Overall Study||232
10167897|NCT03011840|11298003|FG001|STARTED|Overall Study||217
10167898|NCT03011840|11298002|FG000|COMPLETED|Overall Study||232
10167899|NCT03011840|11298003|FG001|COMPLETED|Overall Study||196
10167900|NCT03011840|11298002|FG000|NOT COMPLETED|Overall Study||0
10167901|NCT03011840|11298003|FG001|NOT COMPLETED|Overall Study||21
10167902|NCT03011892|11298015|FG000|STARTED|Double Blind (DB) Period||52
10167903|NCT03011892|11298016|FG001|STARTED|Double Blind (DB) Period||51
10167904|NCT03011892|11298017|FG002|STARTED|Double Blind (DB) Period||51
10167905|NCT03011892|11298018|FG003|STARTED|Double Blind (DB) Period||51
10167906|NCT03011892|11298019|FG004|STARTED|Double Blind (DB) Period||52
10167907|NCT03011892|11298020|FG005|STARTED|Double Blind (DB) Period||50
10167908|NCT03011892|11298021|FG006|STARTED|Double Blind (DB) Period||0
10167909|NCT03011892|11298022|FG007|STARTED|Double Blind (DB) Period||0
10167910|NCT03011892|11298023|FG008|STARTED|Double Blind (DB) Period||0
10167911|NCT03011892|11298024|FG009|STARTED|Double Blind (DB) Period||0
10167912|NCT03011892|11298025|FG010|STARTED|Double Blind (DB) Period||0
10167913|NCT03011892|11298026|FG011|STARTED|Double Blind (DB) Period||0
10167914|NCT03011892|11298015|FG000|Treated in DB Period|Double Blind (DB) Period||52
10167915|NCT03011892|11298016|FG001|Treated in DB Period|Double Blind (DB) Period||51
10167916|NCT03011892|11298017|FG002|Treated in DB Period|Double Blind (DB) Period||51
10167917|NCT03011892|11298018|FG003|Treated in DB Period|Double Blind (DB) Period||51
10167918|NCT03011892|11298019|FG004|Treated in DB Period|Double Blind (DB) Period||51
10167919|NCT03011892|11298020|FG005|Treated in DB Period|Double Blind (DB) Period||50
10167920|NCT03011892|11298021|FG006|Treated in DB Period|Double Blind (DB) Period||0
10167921|NCT03011892|11298022|FG007|Treated in DB Period|Double Blind (DB) Period||0
10167922|NCT03011892|11298023|FG008|Treated in DB Period|Double Blind (DB) Period||0
10167923|NCT03011892|11298024|FG009|Treated in DB Period|Double Blind (DB) Period||0
10167924|NCT03011892|11298025|FG010|Treated in DB Period|Double Blind (DB) Period||0
10167925|NCT03011892|11298026|FG011|Treated in DB Period|Double Blind (DB) Period||0
10167926|NCT03011892|11298015|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44
10167927|NCT03011892|11298016|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46
10167928|NCT03011892|11298017|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48
10167929|NCT03011892|11298018|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47
10167930|NCT03011892|11298019|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49
10167931|NCT03011892|11298020|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49
10167932|NCT03011892|11298021|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10167933|NCT03011892|11298022|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10167934|NCT03011892|11298023|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10167935|NCT03011892|11298024|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10167936|NCT03011892|11298025|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10167937|NCT03011892|11298026|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10167938|NCT03011892|11298015|FG000|COMPLETED|Double Blind (DB) Period||41
10167939|NCT03011892|11298016|FG001|COMPLETED|Double Blind (DB) Period||41
9711876|NCT03605680|10811450|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0
9711877|NCT03605680|10811451|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0
9711878|NCT03605680|10811452|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0
9711879|NCT03605680|10811449|FG000|Treated|SB Placebo Run-in Period (1 Week)||584
9711880|NCT03605680|10811450|FG001|Treated|SB Placebo Run-in Period (1 Week)||0
9711881|NCT03605680|10811451|FG002|Treated|SB Placebo Run-in Period (1 Week)||0
9711882|NCT03605680|10811452|FG003|Treated|SB Placebo Run-in Period (1 Week)||0
9711883|NCT03605680|10811449|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466
9711884|NCT03605680|10811450|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0
9711885|NCT03605680|10811451|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0
9711886|NCT03605680|10811452|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0
9711887|NCT03605680|10811449|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
9711888|NCT03605680|10811450|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
9711889|NCT03605680|10811451|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
9711890|NCT03605680|10811452|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
9711891|NCT03605680|10811449|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0
9711892|NCT03605680|10811450|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154
9711893|NCT03605680|10811451|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156
9711894|NCT03605680|10811452|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156
9711895|NCT03605680|10811449|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
9711896|NCT03605680|10811450|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
9711897|NCT03605680|10811451|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
9711898|NCT03605680|10811452|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
9711899|NCT03605680|10811449|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
9711900|NCT03605680|10811450|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
9711901|NCT03605680|10811451|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
9711902|NCT03605680|10811452|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
9711903|NCT03485950|10811463|FG000|STARTED|Overall Study||50
9711904|NCT03485950|10811464|FG001|STARTED|Overall Study||50
9711905|NCT03485950|10811463|FG000|COMPLETED|Overall Study||43
9711906|NCT03485950|10811464|FG001|COMPLETED|Overall Study||48
9711907|NCT03485950|10811463|FG000|NOT COMPLETED|Overall Study||7
9711908|NCT03485950|10811464|FG001|NOT COMPLETED|Overall Study||2
9731015|NCT00129441|10830932|FG000|Week 3, Visit 4|Overall Study||9
9731016|NCT00129441|10830933|FG001|Week 3, Visit 4|Overall Study||6
9731017|NCT00129441|10830932|FG000|Week 4, Visit 5|Overall Study||9
9731018|NCT00129441|10830933|FG001|Week 4, Visit 5|Overall Study||6
9731019|NCT00129441|10830932|FG000|Week 5, Visit 6|Overall Study||9
9731020|NCT00129441|10830933|FG001|Week 5, Visit 6|Overall Study||6
9731021|NCT00129441|10830932|FG000|Week 26, Visit 7|Overall Study||9
9731022|NCT00129441|10830933|FG001|Week 26, Visit 7|Overall Study||6
9731023|NCT00129441|10830932|FG000|Year 1, Visit 8|Overall Study||9
9731024|NCT00129441|10830933|FG001|Year 1, Visit 8|Overall Study||6
9731025|NCT00129441|10830932|FG000|COMPLETED|Overall Study||9
9731026|NCT00129441|10830933|FG001|COMPLETED|Overall Study||6
9731027|NCT00129441|10830932|FG000|NOT COMPLETED|Overall Study||0
9731028|NCT00129441|10830933|FG001|NOT COMPLETED|Overall Study||0
9731029|NCT00129467|10830941|FG000|STARTED|Received Intervention||15
9731030|NCT00129467|10830942|FG001|STARTED|Received Intervention||17
9731031|NCT00129467|10830941|FG000|COMPLETED|Received Intervention||9
9731032|NCT00129467|10830942|FG001|COMPLETED|Received Intervention||13
9731033|NCT00129467|10830941|FG000|NOT COMPLETED|Received Intervention||6
9731034|NCT00129467|10830942|FG001|NOT COMPLETED|Received Intervention||4
9731035|NCT00129467|10830941|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
9731036|NCT00129467|10830942|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0
9731037|NCT00129467|10830941|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
9731038|NCT00129467|10830942|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
9731039|NCT00129467|10830941|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
9731040|NCT00129467|10830942|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
10167940|NCT03011892|11298017|FG002|COMPLETED|Double Blind (DB) Period||45
10167941|NCT03011892|11298018|FG003|COMPLETED|Double Blind (DB) Period||44
10167942|NCT03011892|11298019|FG004|COMPLETED|Double Blind (DB) Period||45
10167943|NCT03011892|11298020|FG005|COMPLETED|Double Blind (DB) Period||45
10167944|NCT03011892|11298021|FG006|COMPLETED|Double Blind (DB) Period||0
10167945|NCT03011892|11298022|FG007|COMPLETED|Double Blind (DB) Period||0
10167946|NCT03011892|11298023|FG008|COMPLETED|Double Blind (DB) Period||0
10167947|NCT03011892|11298024|FG009|COMPLETED|Double Blind (DB) Period||0
10167948|NCT03011892|11298025|FG010|COMPLETED|Double Blind (DB) Period||0
10167949|NCT03011892|11298026|FG011|COMPLETED|Double Blind (DB) Period||0
10167950|NCT03011892|11298015|FG000|NOT COMPLETED|Double Blind (DB) Period||11
10167951|NCT03011892|11298016|FG001|NOT COMPLETED|Double Blind (DB) Period||10
10167952|NCT03011892|11298017|FG002|NOT COMPLETED|Double Blind (DB) Period||6
10167953|NCT03011892|11298018|FG003|NOT COMPLETED|Double Blind (DB) Period||7
10167954|NCT03011892|11298019|FG004|NOT COMPLETED|Double Blind (DB) Period||7
10167955|NCT03011892|11298020|FG005|NOT COMPLETED|Double Blind (DB) Period||5
10167956|NCT03011892|11298021|FG006|NOT COMPLETED|Double Blind (DB) Period||0
10167957|NCT03011892|11298022|FG007|NOT COMPLETED|Double Blind (DB) Period||0
10167958|NCT03011892|11298023|FG008|NOT COMPLETED|Double Blind (DB) Period||0
10167959|NCT03011892|11298024|FG009|NOT COMPLETED|Double Blind (DB) Period||0
10167960|NCT03011892|11298025|FG010|NOT COMPLETED|Double Blind (DB) Period||0
10167961|NCT03011892|11298026|FG011|NOT COMPLETED|Double Blind (DB) Period||0
10167962|NCT03011892|11298015|FG000|STARTED|Open Label (OL) Period||0
10167963|NCT03011892|11298016|FG001|STARTED|Open Label (OL) Period||0
10167964|NCT03011892|11298017|FG002|STARTED|Open Label (OL) Period||0
10167965|NCT03011892|11298018|FG003|STARTED|Open Label (OL) Period||0
10167966|NCT03011892|11298019|FG004|STARTED|Open Label (OL) Period||0
10167967|NCT03011892|11298020|FG005|STARTED|Open Label (OL) Period||0
10167968|NCT03011892|11298021|FG006|STARTED|Open Label (OL) Period||41
10167969|NCT03011892|11298022|FG007|STARTED|Open Label (OL) Period||40
10167970|NCT03011892|11298023|FG008|STARTED|Open Label (OL) Period||45
10167971|NCT03011892|11298024|FG009|STARTED|Open Label (OL) Period||41
10167972|NCT03011892|11298025|FG010|STARTED|Open Label (OL) Period||42
10167973|NCT03011892|11298026|FG011|STARTED|Open Label (OL) Period||43
10167974|NCT03011892|11298015|FG000|COMPLETED|Open Label (OL) Period||0
10167975|NCT03011892|11298016|FG001|COMPLETED|Open Label (OL) Period||0
10167976|NCT03011892|11298017|FG002|COMPLETED|Open Label (OL) Period||0
10167977|NCT03011892|11298018|FG003|COMPLETED|Open Label (OL) Period||0
10167978|NCT03011892|11298019|FG004|COMPLETED|Open Label (OL) Period||0
10167979|NCT03011892|11298020|FG005|COMPLETED|Open Label (OL) Period||0
10167980|NCT03011892|11298021|FG006|COMPLETED|Open Label (OL) Period||34
10167981|NCT03011892|11298022|FG007|COMPLETED|Open Label (OL) Period||37
10167982|NCT03011892|11298023|FG008|COMPLETED|Open Label (OL) Period||43
10167983|NCT03011892|11298024|FG009|COMPLETED|Open Label (OL) Period||41
10167984|NCT03011892|11298025|FG010|COMPLETED|Open Label (OL) Period||40
10167985|NCT03011892|11298026|FG011|COMPLETED|Open Label (OL) Period||40
10167986|NCT03011892|11298015|FG000|NOT COMPLETED|Open Label (OL) Period||0
10167987|NCT03011892|11298016|FG001|NOT COMPLETED|Open Label (OL) Period||0
10167988|NCT03011892|11298017|FG002|NOT COMPLETED|Open Label (OL) Period||0
10167989|NCT03011892|11298018|FG003|NOT COMPLETED|Open Label (OL) Period||0
10167990|NCT03011892|11298019|FG004|NOT COMPLETED|Open Label (OL) Period||0
10167991|NCT03011892|11298020|FG005|NOT COMPLETED|Open Label (OL) Period||0
10167992|NCT03011892|11298021|FG006|NOT COMPLETED|Open Label (OL) Period||7
10167993|NCT03011892|11298022|FG007|NOT COMPLETED|Open Label (OL) Period||3
9711909|NCT03404518|10811472|FG000|STARTED|Overall Study||97
9711910|NCT03404518|10811473|FG001|STARTED|Overall Study||88
9711911|NCT03404518|10811472|FG000|COMPLETED|Overall Study||56
9711912|NCT03404518|10811473|FG001|COMPLETED|Overall Study||52
9711913|NCT03404518|10811472|FG000|NOT COMPLETED|Overall Study||41
9711914|NCT03404518|10811473|FG001|NOT COMPLETED|Overall Study||36
9711915|NCT03370757|10811481|FG000|STARTED|Overall Study||20
9711916|NCT03370757|10811482|FG001|STARTED|Overall Study||28
9711917|NCT03370757|10811481|FG000|COMPLETED|Overall Study||20
9711918|NCT03370757|10811482|FG001|COMPLETED|Overall Study||26
9711919|NCT03370757|10811481|FG000|NOT COMPLETED|Overall Study||0
9711920|NCT03370757|10811482|FG001|NOT COMPLETED|Overall Study||2
9711921|NCT03303989|10811492|FG000|STARTED|Overall Study||24
9711922|NCT03303989|10811493|FG001|STARTED|Overall Study||11
9711923|NCT03303989|10811492|FG000|COMPLETED|Overall Study||22
9711924|NCT03303989|10811493|FG001|COMPLETED|Overall Study||10
9711925|NCT03303989|10811492|FG000|NOT COMPLETED|Overall Study||2
9711926|NCT03303989|10811493|FG001|NOT COMPLETED|Overall Study||1
9711927|NCT03289143|10811503|FG000|STARTED|Overall Study||135
9711928|NCT03289143|10811504|FG001|STARTED|Overall Study||94
9711929|NCT03289143|10811505|FG002|STARTED|Overall Study||136
10167994|NCT03011892|11298023|FG008|NOT COMPLETED|Open Label (OL) Period||2
10167995|NCT03011892|11298024|FG009|NOT COMPLETED|Open Label (OL) Period||0
9711930|NCT03289143|10811506|FG003|STARTED|Overall Study||92
9711931|NCT03289143|10811503|FG000|COMPLETED|Overall Study||1
9711932|NCT03289143|10811504|FG001|COMPLETED|Overall Study||0
9711933|NCT03289143|10811505|FG002|COMPLETED|Overall Study||2
9711934|NCT03289143|10811506|FG003|COMPLETED|Overall Study||0
9711935|NCT03289143|10811503|FG000|NOT COMPLETED|Overall Study||134
9711936|NCT03289143|10811504|FG001|NOT COMPLETED|Overall Study||94
9711937|NCT03289143|10811505|FG002|NOT COMPLETED|Overall Study||134
9711938|NCT03289143|10811506|FG003|NOT COMPLETED|Overall Study||92
10167996|NCT03011892|11298025|FG010|NOT COMPLETED|Open Label (OL) Period||2
10167997|NCT03011892|11298026|FG011|NOT COMPLETED|Open Label (OL) Period||3
10167998|NCT03012061|11298056|FG000|STARTED|Overall Study||143
10167999|NCT03012061|11298057|FG001|STARTED|Overall Study||139
10168000|NCT03012061|11298058|FG002|STARTED|Overall Study||139
10168001|NCT03012061|11298056|FG000|COMPLETED|Overall Study||137
10168002|NCT03012061|11298057|FG001|COMPLETED|Overall Study||130
10168003|NCT03012061|11298058|FG002|COMPLETED|Overall Study||131
10168004|NCT03012061|11298056|FG000|NOT COMPLETED|Overall Study||6
10168005|NCT03012061|11298057|FG001|NOT COMPLETED|Overall Study||9
10168006|NCT03012061|11298058|FG002|NOT COMPLETED|Overall Study||8
10168007|NCT03012191|11298069|FG000|STARTED|Overall Study||2
10168008|NCT03012191|11298070|FG001|STARTED|Overall Study||2
10168009|NCT03012191|11298071|FG002|STARTED|Overall Study||2
10168010|NCT03012191|11298069|FG000|COMPLETED|Overall Study||2
10168011|NCT03012191|11298070|FG001|COMPLETED|Overall Study||2
10168012|NCT03012191|11298071|FG002|COMPLETED|Overall Study||2
10168013|NCT03012191|11298069|FG000|NOT COMPLETED|Overall Study||0
10168014|NCT03012191|11298070|FG001|NOT COMPLETED|Overall Study||0
10168015|NCT03012191|11298071|FG002|NOT COMPLETED|Overall Study||0
10168016|NCT03012334|11298090|FG000|STARTED|Period 1||9
10168017|NCT03012334|11298091|FG001|STARTED|Period 1||9
10168018|NCT03012334|11298092|FG002|STARTED|Period 1||9
10168019|NCT03012334|11298093|FG003|STARTED|Period 1||9
10168020|NCT03012334|11298094|FG004|STARTED|Period 1||9
10168021|NCT03012334|11298095|FG005|STARTED|Period 1||9
10168022|NCT03012334|11298096|FG006|STARTED|Period 1||9
10168023|NCT03012334|11298097|FG007|STARTED|Period 1||9
10168024|NCT03012334|11298098|FG008|STARTED|Period 1||9
10168025|NCT03012334|11298099|FG009|STARTED|Period 1||9
10168026|NCT03012334|11298090|FG000|COMPLETED|Period 1||9
10168027|NCT03012334|11298091|FG001|COMPLETED|Period 1||9
10168028|NCT03012334|11298092|FG002|COMPLETED|Period 1||9
10168029|NCT03012334|11298093|FG003|COMPLETED|Period 1||9
10168030|NCT03012334|11298094|FG004|COMPLETED|Period 1||9
10168031|NCT03012334|11298095|FG005|COMPLETED|Period 1||9
10168032|NCT03012334|11298096|FG006|COMPLETED|Period 1||9
10168033|NCT03012334|11298097|FG007|COMPLETED|Period 1||9
10168034|NCT03012334|11298098|FG008|COMPLETED|Period 1||9
10168035|NCT03012334|11298099|FG009|COMPLETED|Period 1||8
10168036|NCT03012334|11298090|FG000|NOT COMPLETED|Period 1||0
10168037|NCT03012334|11298091|FG001|NOT COMPLETED|Period 1||0
10168038|NCT03012334|11298092|FG002|NOT COMPLETED|Period 1||0
10168039|NCT03012334|11298093|FG003|NOT COMPLETED|Period 1||0
10168040|NCT03012334|11298094|FG004|NOT COMPLETED|Period 1||0
10168041|NCT03012334|11298095|FG005|NOT COMPLETED|Period 1||0
10168042|NCT03012334|11298096|FG006|NOT COMPLETED|Period 1||0
10168043|NCT03012334|11298097|FG007|NOT COMPLETED|Period 1||0
10168044|NCT03012334|11298098|FG008|NOT COMPLETED|Period 1||0
10168045|NCT03012334|11298099|FG009|NOT COMPLETED|Period 1||1
10168046|NCT03012334|11298090|FG000|STARTED|Period 2||9
10168047|NCT03012334|11298091|FG001|STARTED|Period 2||9
10168048|NCT03012334|11298092|FG002|STARTED|Period 2||9
10168049|NCT03012334|11298093|FG003|STARTED|Period 2||9
10168050|NCT03012334|11298094|FG004|STARTED|Period 2||9
10168051|NCT03012334|11298095|FG005|STARTED|Period 2||9
10168052|NCT03012334|11298096|FG006|STARTED|Period 2||9
10168053|NCT03012334|11298097|FG007|STARTED|Period 2||9
10168054|NCT03012334|11298098|FG008|STARTED|Period 2||9
10168055|NCT03012334|11298099|FG009|STARTED|Period 2||8
10168056|NCT03012334|11298090|FG000|COMPLETED|Period 2||9
10168057|NCT03012334|11298091|FG001|COMPLETED|Period 2||8
10168058|NCT03012334|11298092|FG002|COMPLETED|Period 2||8
10168059|NCT03012334|11298093|FG003|COMPLETED|Period 2||9
10168060|NCT03012334|11298094|FG004|COMPLETED|Period 2||9
10168061|NCT03012334|11298095|FG005|COMPLETED|Period 2||9
10168062|NCT03012334|11298096|FG006|COMPLETED|Period 2||9
10168063|NCT03012334|11298097|FG007|COMPLETED|Period 2||8
10168064|NCT03012334|11298098|FG008|COMPLETED|Period 2||9
10168065|NCT03012334|11298099|FG009|COMPLETED|Period 2||8
10168066|NCT03012334|11298090|FG000|NOT COMPLETED|Period 2||0
10168067|NCT03012334|11298091|FG001|NOT COMPLETED|Period 2||1
10168068|NCT03012334|11298092|FG002|NOT COMPLETED|Period 2||1
10168069|NCT03012334|11298093|FG003|NOT COMPLETED|Period 2||0
10168070|NCT03012334|11298094|FG004|NOT COMPLETED|Period 2||0
10168071|NCT03012334|11298095|FG005|NOT COMPLETED|Period 2||0
10168072|NCT03012334|11298096|FG006|NOT COMPLETED|Period 2||0
10168073|NCT03012334|11298097|FG007|NOT COMPLETED|Period 2||1
10168074|NCT03012334|11298098|FG008|NOT COMPLETED|Period 2||0
10168075|NCT03012334|11298099|FG009|NOT COMPLETED|Period 2||0
10168076|NCT03012334|11298090|FG000|STARTED|Period 3||9
10168077|NCT03012334|11298091|FG001|STARTED|Period 3||8
10168078|NCT03012334|11298092|FG002|STARTED|Period 3||8
10168079|NCT03012334|11298093|FG003|STARTED|Period 3||9
10168080|NCT03012334|11298094|FG004|STARTED|Period 3||9
10168081|NCT03012334|11298095|FG005|STARTED|Period 3||9
10168082|NCT03012334|11298096|FG006|STARTED|Period 3||9
10168083|NCT03012334|11298097|FG007|STARTED|Period 3||8
10168084|NCT03012334|11298098|FG008|STARTED|Period 3||9
10168085|NCT03012334|11298099|FG009|STARTED|Period 3||8
10168086|NCT03012334|11298090|FG000|COMPLETED|Period 3||9
10168087|NCT03012334|11298091|FG001|COMPLETED|Period 3||8
10168088|NCT03012334|11298092|FG002|COMPLETED|Period 3||8
10168089|NCT03012334|11298093|FG003|COMPLETED|Period 3||9
10168090|NCT03012334|11298094|FG004|COMPLETED|Period 3||9
10168091|NCT03012334|11298095|FG005|COMPLETED|Period 3||9
10168092|NCT03012334|11298096|FG006|COMPLETED|Period 3||9
10168093|NCT03012334|11298097|FG007|COMPLETED|Period 3||8
10168094|NCT03012334|11298098|FG008|COMPLETED|Period 3||9
10168095|NCT03012334|11298099|FG009|COMPLETED|Period 3||8
10168096|NCT03012334|11298090|FG000|NOT COMPLETED|Period 3||0
10168097|NCT03012334|11298091|FG001|NOT COMPLETED|Period 3||0
10168098|NCT03012334|11298092|FG002|NOT COMPLETED|Period 3||0
10168099|NCT03012334|11298093|FG003|NOT COMPLETED|Period 3||0
10168100|NCT03012334|11298094|FG004|NOT COMPLETED|Period 3||0
10168101|NCT03012334|11298095|FG005|NOT COMPLETED|Period 3||0
10168102|NCT03012334|11298096|FG006|NOT COMPLETED|Period 3||0
10168103|NCT03012334|11298097|FG007|NOT COMPLETED|Period 3||0
10168104|NCT03012334|11298098|FG008|NOT COMPLETED|Period 3||0
10168105|NCT03012334|11298099|FG009|NOT COMPLETED|Period 3||0
10168106|NCT03012334|11298090|FG000|STARTED|Period 4||9
10168107|NCT03012334|11298091|FG001|STARTED|Period 4||8
10168108|NCT03012334|11298092|FG002|STARTED|Period 4||8
10168109|NCT03012334|11298093|FG003|STARTED|Period 4||9
10168110|NCT03012334|11298094|FG004|STARTED|Period 4||9
10168111|NCT03012334|11298095|FG005|STARTED|Period 4||9
10168112|NCT03012334|11298096|FG006|STARTED|Period 4||9
10168113|NCT03012334|11298097|FG007|STARTED|Period 4||8
10168114|NCT03012334|11298098|FG008|STARTED|Period 4||9
10168115|NCT03012334|11298099|FG009|STARTED|Period 4||8
10168116|NCT03012334|11298090|FG000|COMPLETED|Period 4||9
10168117|NCT03012334|11298091|FG001|COMPLETED|Period 4||8
10168118|NCT03012334|11298092|FG002|COMPLETED|Period 4||8
10168119|NCT03012334|11298093|FG003|COMPLETED|Period 4||9
10168120|NCT03012334|11298094|FG004|COMPLETED|Period 4||9
10168121|NCT03012334|11298095|FG005|COMPLETED|Period 4||9
10168122|NCT03012334|11298096|FG006|COMPLETED|Period 4||8
10168123|NCT03012334|11298097|FG007|COMPLETED|Period 4||8
10168124|NCT03012334|11298098|FG008|COMPLETED|Period 4||8
10168125|NCT03012334|11298099|FG009|COMPLETED|Period 4||8
10168126|NCT03012334|11298090|FG000|NOT COMPLETED|Period 4||0
10168127|NCT03012334|11298091|FG001|NOT COMPLETED|Period 4||0
10168128|NCT03012334|11298092|FG002|NOT COMPLETED|Period 4||0
10168129|NCT03012334|11298093|FG003|NOT COMPLETED|Period 4||0
10168130|NCT03012334|11298094|FG004|NOT COMPLETED|Period 4||0
10168131|NCT03012334|11298095|FG005|NOT COMPLETED|Period 4||0
10168132|NCT03012334|11298096|FG006|NOT COMPLETED|Period 4||1
10168133|NCT03012334|11298097|FG007|NOT COMPLETED|Period 4||0
10168134|NCT03012334|11298098|FG008|NOT COMPLETED|Period 4||1
10168135|NCT03012334|11298099|FG009|NOT COMPLETED|Period 4||0
10168136|NCT03012334|11298090|FG000|STARTED|Period 5||9
10168137|NCT03012334|11298091|FG001|STARTED|Period 5||8
10168138|NCT03012334|11298092|FG002|STARTED|Period 5||8
10168139|NCT03012334|11298093|FG003|STARTED|Period 5||9
10168140|NCT03012334|11298094|FG004|STARTED|Period 5||9
10168141|NCT03012334|11298095|FG005|STARTED|Period 5||9
10168142|NCT03012334|11298096|FG006|STARTED|Period 5||8
10168143|NCT03012334|11298097|FG007|STARTED|Period 5||8
10168144|NCT03012334|11298098|FG008|STARTED|Period 5||8
10168145|NCT03012334|11298099|FG009|STARTED|Period 5||8
10168146|NCT03012334|11298090|FG000|COMPLETED|Period 5||9
10168147|NCT03012334|11298091|FG001|COMPLETED|Period 5||8
10168148|NCT03012334|11298092|FG002|COMPLETED|Period 5||8
10168149|NCT03012334|11298093|FG003|COMPLETED|Period 5||9
10168150|NCT03012334|11298094|FG004|COMPLETED|Period 5||9
10168151|NCT03012334|11298095|FG005|COMPLETED|Period 5||9
10168152|NCT03012334|11298096|FG006|COMPLETED|Period 5||8
10168153|NCT03012334|11298097|FG007|COMPLETED|Period 5||8
10168154|NCT03012334|11298098|FG008|COMPLETED|Period 5||8
10168155|NCT03012334|11298099|FG009|COMPLETED|Period 5||8
10168156|NCT03012334|11298090|FG000|NOT COMPLETED|Period 5||0
10168157|NCT03012334|11298091|FG001|NOT COMPLETED|Period 5||0
10168158|NCT03012334|11298092|FG002|NOT COMPLETED|Period 5||0
10168159|NCT03012334|11298093|FG003|NOT COMPLETED|Period 5||0
10168160|NCT03012334|11298094|FG004|NOT COMPLETED|Period 5||0
10168161|NCT03012334|11298095|FG005|NOT COMPLETED|Period 5||0
10168162|NCT03012334|11298096|FG006|NOT COMPLETED|Period 5||0
10168163|NCT03012334|11298097|FG007|NOT COMPLETED|Period 5||0
10168164|NCT03012334|11298098|FG008|NOT COMPLETED|Period 5||0
10168165|NCT03012334|11298099|FG009|NOT COMPLETED|Period 5||0
10168166|NCT03012477|11298112|FG000|STARTED|Overall Study||34
10168167|NCT03012477|11298112|FG000|COMPLETED|Overall Study||34
10168168|NCT03012477|11298112|FG000|NOT COMPLETED|Overall Study||0
10168169|NCT03012594|11298116|FG000|STARTED|Overall Study||12
10168170|NCT03012594|11298116|FG000|COMPLETED|Overall Study||9
10168171|NCT03012594|11298116|FG000|NOT COMPLETED|Overall Study||3
10168172|NCT03012828|11298126|FG000|STARTED|Overall Study||10
10168173|NCT03012828|11298127|FG001|STARTED|Overall Study||10
10168174|NCT03012828|11298128|FG002|STARTED|Overall Study||10
10168175|NCT03012828|11298129|FG003|STARTED|Overall Study||10
10168176|NCT03012828|11298130|FG004|STARTED|Overall Study||10
10168177|NCT03012828|11298131|FG005|STARTED|Overall Study||10
10168178|NCT03012828|11298126|FG000|COMPLETED|Overall Study||9
10168179|NCT03012828|11298127|FG001|COMPLETED|Overall Study||10
10168180|NCT03012828|11298128|FG002|COMPLETED|Overall Study||8
10168181|NCT03012828|11298129|FG003|COMPLETED|Overall Study||10
10168182|NCT03012828|11298130|FG004|COMPLETED|Overall Study||8
10168183|NCT03012828|11298131|FG005|COMPLETED|Overall Study||8
10168184|NCT03012828|11298126|FG000|NOT COMPLETED|Overall Study||1
10168185|NCT03012828|11298127|FG001|NOT COMPLETED|Overall Study||0
10168186|NCT03012828|11298128|FG002|NOT COMPLETED|Overall Study||2
10168187|NCT03012828|11298129|FG003|NOT COMPLETED|Overall Study||0
10168188|NCT03012828|11298130|FG004|NOT COMPLETED|Overall Study||2
10168189|NCT03012828|11298131|FG005|NOT COMPLETED|Overall Study||2
10168190|NCT03012841|11298147|FG000|STARTED|Overall Study||165
10168191|NCT03012841|11298148|FG001|STARTED|Overall Study||21
10168192|NCT03012841|11298147|FG000|COMPLETED|Overall Study||145
10168193|NCT03012841|11298148|FG001|COMPLETED|Overall Study||0
10168194|NCT03012841|11298147|FG000|NOT COMPLETED|Overall Study||20
10168195|NCT03012841|11298148|FG001|NOT COMPLETED|Overall Study||21
10168196|NCT03013985|11298155|FG000|STARTED|Overall Study||108
10168197|NCT03013985|11298156|FG001|STARTED|Overall Study||103
10168198|NCT03013985|11298155|FG000|COMPLETED|Overall Study||92
10168199|NCT03013985|11298156|FG001|COMPLETED|Overall Study||84
10168200|NCT03013985|11298155|FG000|NOT COMPLETED|Overall Study||16
10168201|NCT03013985|11298156|FG001|NOT COMPLETED|Overall Study||19
10168202|NCT03014011|11298162|FG000|STARTED|First Intervention||14
10168203|NCT03014011|11298163|FG001|STARTED|First Intervention||13
10168204|NCT03014011|11298162|FG000|COMPLETED|First Intervention||13
10168205|NCT03014011|11298163|FG001|COMPLETED|First Intervention||13
10168206|NCT03014011|11298162|FG000|NOT COMPLETED|First Intervention||1
10168207|NCT03014011|11298163|FG001|NOT COMPLETED|First Intervention||0
10168208|NCT03014011|11298162|FG000|STARTED|Washout||13
10168209|NCT03014011|11298163|FG001|STARTED|Washout||13
10168210|NCT03014011|11298162|FG000|COMPLETED|Washout||12
10168211|NCT03014011|11298163|FG001|COMPLETED|Washout||13
10168212|NCT03014011|11298162|FG000|NOT COMPLETED|Washout||1
10168213|NCT03014011|11298163|FG001|NOT COMPLETED|Washout||0
10168214|NCT03014011|11298162|FG000|STARTED|Second Intervention||12
10168215|NCT03014011|11298163|FG001|STARTED|Second Intervention||13
10168216|NCT03014011|11298162|FG000|COMPLETED|Second Intervention||12
10168217|NCT03014011|11298163|FG001|COMPLETED|Second Intervention||13
10168218|NCT03014011|11298162|FG000|NOT COMPLETED|Second Intervention||0
10168219|NCT03014011|11298163|FG001|NOT COMPLETED|Second Intervention||0
10168220|NCT03014180|11298169|FG000|STARTED|Overall Study||60
10168221|NCT03014180|11298169|FG000|COMPLETED|Overall Study||58
10168222|NCT03014180|11298169|FG000|NOT COMPLETED|Overall Study||2
10168223|NCT03014206|11298177|FG000|STARTED|Overall Study||696
10168224|NCT03014206|11298177|FG000|COMPLETED|Overall Study||684
10168225|NCT03014206|11298177|FG000|NOT COMPLETED|Overall Study||12
10168226|NCT03014453|11298181|FG000|STARTED|Overall Study||187
10168227|NCT03014453|11298181|FG000|COMPLETED|Overall Study||116
10168228|NCT03014453|11298181|FG000|NOT COMPLETED|Overall Study||71
10168229|NCT03014479|11298187|FG000|STARTED|Overall Study||110
10168230|NCT03014479|11298188|FG001|STARTED|Overall Study||109
10168231|NCT03014479|11298187|FG000|COMPLETED|Overall Study||110
10168232|NCT03014479|11298188|FG001|COMPLETED|Overall Study||105
10168233|NCT03014479|11298187|FG000|NOT COMPLETED|Overall Study||0
10168234|NCT03014479|11298188|FG001|NOT COMPLETED|Overall Study||4
10168235|NCT03014492|11298196|FG000|STARTED|Overall Study||44
10168236|NCT03014492|11298197|FG001|STARTED|Overall Study||28
10168237|NCT03014492|11298196|FG000|COMPLETED|Overall Study||44
10168238|NCT03014492|11298197|FG001|COMPLETED|Overall Study||28
10168239|NCT03014492|11298196|FG000|NOT COMPLETED|Overall Study||0
10168240|NCT03014492|11298197|FG001|NOT COMPLETED|Overall Study||0
10168241|NCT03014674|11298206|FG000|STARTED|Overall Study||85
10168242|NCT03014674|11298207|FG001|STARTED|Overall Study||79
10168243|NCT03014674|11298208|FG002|STARTED|Overall Study||80
10168244|NCT03014674|11298206|FG000|COMPLETED|Overall Study||84
10168245|NCT03014674|11298207|FG001|COMPLETED|Overall Study||79
10168246|NCT03014674|11298208|FG002|COMPLETED|Overall Study||80
10168247|NCT03014674|11298206|FG000|NOT COMPLETED|Overall Study||1
10168248|NCT03014674|11298207|FG001|NOT COMPLETED|Overall Study||0
10168249|NCT03014674|11298208|FG002|NOT COMPLETED|Overall Study||0
10168250|NCT03014700|11298218|FG000|STARTED|Overall Study||30
10168251|NCT03014700|11298219|FG001|STARTED|Overall Study||30
9711939|NCT03156504|10811521|FG000|STARTED|Overall Study||75
9711940|NCT03156504|10811521|FG000|COMPLETED|Overall Study||74
9711941|NCT03156504|10811521|FG000|NOT COMPLETED|Overall Study||1
9711942|NCT03006926|10811527|FG000|STARTED|Overall Study||6
9711943|NCT03006926|10811528|FG001|STARTED|Overall Study||98
9711944|NCT03006926|10811527|FG000|COMPLETED|Overall Study||6
9711945|NCT03006926|10811528|FG001|COMPLETED|Overall Study||0
9711946|NCT03006926|10811527|FG000|NOT COMPLETED|Overall Study||0
9711947|NCT03006926|10811528|FG001|NOT COMPLETED|Overall Study||98
9711948|NCT02993926|10811536|FG000|STARTED|Enantone Treatment Phase||108
9711949|NCT02993926|10811537|FG001|STARTED|Enantone Treatment Phase||0
9711950|NCT02993926|10811538|FG002|STARTED|Enantone Treatment Phase||0
9711951|NCT02993926|10811536|FG000|COMPLETED|Enantone Treatment Phase||76
9711952|NCT02993926|10811537|FG001|COMPLETED|Enantone Treatment Phase||0
9711953|NCT02993926|10811538|FG002|COMPLETED|Enantone Treatment Phase||0
9711954|NCT02993926|10811536|FG000|NOT COMPLETED|Enantone Treatment Phase||32
9711955|NCT02993926|10811537|FG001|NOT COMPLETED|Enantone Treatment Phase||0
9711956|NCT02993926|10811538|FG002|NOT COMPLETED|Enantone Treatment Phase||0
9711957|NCT02993926|10811536|FG000|STARTED|Follow-Up Phase||0
9711958|NCT02993926|10811537|FG001|STARTED|Follow-Up Phase||44
9711959|NCT02993926|10811538|FG002|STARTED|Follow-Up Phase||26
9711960|NCT02993926|10811536|FG000|COMPLETED|Follow-Up Phase||0
9711961|NCT02993926|10811537|FG001|COMPLETED|Follow-Up Phase||44
9711962|NCT02993926|10811538|FG002|COMPLETED|Follow-Up Phase||26
9711963|NCT02993926|10811536|FG000|NOT COMPLETED|Follow-Up Phase||0
9711964|NCT02993926|10811537|FG001|NOT COMPLETED|Follow-Up Phase||0
10168252|NCT03014700|11298218|FG000|COMPLETED|Overall Study||25
10168253|NCT03014700|11298219|FG001|COMPLETED|Overall Study||29
10168254|NCT03014700|11298218|FG000|NOT COMPLETED|Overall Study||5
10168255|NCT03014700|11298219|FG001|NOT COMPLETED|Overall Study||1
10168256|NCT03015116|11298228|FG000|STARTED|Overall Study||38
10168257|NCT03015116|11298229|FG001|STARTED|Overall Study||38
10168258|NCT03015116|11298230|FG002|STARTED|Overall Study||38
10168259|NCT03015116|11298228|FG000|COMPLETED|Overall Study||31
10168260|NCT03015116|11298229|FG001|COMPLETED|Overall Study||36
10168261|NCT03015116|11298230|FG002|COMPLETED|Overall Study||36
10168262|NCT03015116|11298228|FG000|NOT COMPLETED|Overall Study||7
10168263|NCT03015116|11298229|FG001|NOT COMPLETED|Overall Study||2
10168264|NCT03015116|11298230|FG002|NOT COMPLETED|Overall Study||2
10168265|NCT03015181|11298247|FG000|STARTED|Overall Study||4
10168266|NCT03015181|11298248|FG001|STARTED|Overall Study||3
10168267|NCT03015181|11298249|FG002|STARTED|Overall Study||3
10168268|NCT03015181|11298250|FG003|STARTED|Overall Study||3
10168269|NCT03015181|11298251|FG004|STARTED|Overall Study||3
10168270|NCT03015181|11298252|FG005|STARTED|Overall Study||5
10168271|NCT03015181|11298253|FG006|STARTED|Overall Study||5
10168272|NCT03015181|11298247|FG000|Received VRC07-523LS Per Protocol|Overall Study||3
10168273|NCT03015181|11298248|FG001|Received VRC07-523LS Per Protocol|Overall Study||3
10168274|NCT03015181|11298249|FG002|Received VRC07-523LS Per Protocol|Overall Study||3
10168275|NCT03015181|11298250|FG003|Received VRC07-523LS Per Protocol|Overall Study||3
10168276|NCT03015181|11298251|FG004|Received VRC07-523LS Per Protocol|Overall Study||3
10168277|NCT03015181|11298252|FG005|Received VRC07-523LS Per Protocol|Overall Study||4
10168278|NCT03015181|11298253|FG006|Received VRC07-523LS Per Protocol|Overall Study||4
10168279|NCT03015181|11298247|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
10168280|NCT03015181|11298248|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0
10168281|NCT03015181|11298249|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0
10168282|NCT03015181|11298250|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0
10168283|NCT03015181|11298251|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0
10168284|NCT03015181|11298252|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
10168285|NCT03015181|11298253|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
10168286|NCT03015181|11298247|FG000|COMPLETED|Overall Study||3
10168287|NCT03015181|11298248|FG001|COMPLETED|Overall Study||3
10168288|NCT03015181|11298249|FG002|COMPLETED|Overall Study||3
10168289|NCT03015181|11298250|FG003|COMPLETED|Overall Study||3
10168290|NCT03015181|11298251|FG004|COMPLETED|Overall Study||3
10168291|NCT03015181|11298252|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
10168292|NCT03015181|11298253|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
10168293|NCT03015181|11298247|FG000|NOT COMPLETED|Overall Study||1
10168294|NCT03015181|11298248|FG001|NOT COMPLETED|Overall Study||0
10168295|NCT03015181|11298249|FG002|NOT COMPLETED|Overall Study||0
10168296|NCT03015181|11298250|FG003|NOT COMPLETED|Overall Study||0
10168297|NCT03015181|11298251|FG004|NOT COMPLETED|Overall Study||0
10168298|NCT03015181|11298252|FG005|NOT COMPLETED|Overall Study||1
10168299|NCT03015181|11298253|FG006|NOT COMPLETED|Overall Study||1
10168300|NCT03015220|11298293|FG000|STARTED|Overall Study||131
10168301|NCT03015220|11298294|FG001|STARTED|Overall Study||132
10168302|NCT03015220|11298295|FG002|STARTED|Overall Study||130
10168303|NCT03015220|11298296|FG003|STARTED|Overall Study||65
10168304|NCT03015220|11298293|FG000|Full Analysis Set (FAS)|Overall Study||131
10168305|NCT03015220|11298294|FG001|Full Analysis Set (FAS)|Overall Study||132
10168306|NCT03015220|11298295|FG002|Full Analysis Set (FAS)|Overall Study||130
10168307|NCT03015220|11298296|FG003|Full Analysis Set (FAS)|Overall Study||65
10168308|NCT03015220|11298293|FG000|Safety Analysis Set (SAS)|Overall Study||131
10168309|NCT03015220|11298294|FG001|Safety Analysis Set (SAS)|Overall Study||132
10168310|NCT03015220|11298295|FG002|Safety Analysis Set (SAS)|Overall Study||130
10168311|NCT03015220|11298296|FG003|Safety Analysis Set (SAS)|Overall Study||65
10168312|NCT03015220|11298293|FG000|COMPLETED|Overall Study||128
10168313|NCT03015220|11298294|FG001|COMPLETED|Overall Study||130
10168314|NCT03015220|11298295|FG002|COMPLETED|Overall Study||127
10168315|NCT03015220|11298296|FG003|COMPLETED|Overall Study||63
10168316|NCT03015220|11298293|FG000|NOT COMPLETED|Overall Study||3
10168317|NCT03015220|11298294|FG001|NOT COMPLETED|Overall Study||2
10168318|NCT03015220|11298295|FG002|NOT COMPLETED|Overall Study||3
10168319|NCT03015220|11298296|FG003|NOT COMPLETED|Overall Study||2
10168320|NCT03015363|11298306|FG000|STARTED|Overall Study||37
10168321|NCT03015363|11298306|FG000|COMPLETED|Overall Study||20
9711965|NCT02993926|10811538|FG002|NOT COMPLETED|Follow-Up Phase||0
9711966|NCT02932579|10811550|FG000|STARTED|Overall Study||33
9711967|NCT02932579|10811551|FG001|STARTED|Overall Study||26
10168322|NCT03015363|11298306|FG000|NOT COMPLETED|Overall Study||17
10168323|NCT03015532|11298318|FG000|STARTED|Overall Study||20
10168324|NCT03015532|11298319|FG001|STARTED|Overall Study||22
10168325|NCT03015532|11298320|FG002|STARTED|Overall Study||11
10168326|NCT03015532|11298321|FG003|STARTED|Overall Study||10
10168327|NCT03015532|11298322|FG004|STARTED|Overall Study||58
10168328|NCT03015532|11298323|FG005|STARTED|Overall Study||56
10168329|NCT03015532|11298324|FG006|STARTED|Overall Study||53
10168330|NCT03015532|11298325|FG007|STARTED|Overall Study||55
10168331|NCT03015532|11298318|FG000|COMPLETED|Overall Study||20
10168332|NCT03015532|11298319|FG001|COMPLETED|Overall Study||22
10168333|NCT03015532|11298320|FG002|COMPLETED|Overall Study||11
10168334|NCT03015532|11298321|FG003|COMPLETED|Overall Study||10
10168335|NCT03015532|11298322|FG004|COMPLETED|Overall Study||58
10168336|NCT03015532|11298323|FG005|COMPLETED|Overall Study||54
10168337|NCT03015532|11298324|FG006|COMPLETED|Overall Study||51
10168338|NCT03015532|11298325|FG007|COMPLETED|Overall Study||55
10168339|NCT03015532|11298318|FG000|NOT COMPLETED|Overall Study||0
10168340|NCT03015532|11298319|FG001|NOT COMPLETED|Overall Study||0
10168341|NCT03015532|11298320|FG002|NOT COMPLETED|Overall Study||0
10168342|NCT03015532|11298321|FG003|NOT COMPLETED|Overall Study||0
10168343|NCT03015532|11298322|FG004|NOT COMPLETED|Overall Study||0
10168344|NCT03015532|11298323|FG005|NOT COMPLETED|Overall Study||2
10168345|NCT03015532|11298324|FG006|NOT COMPLETED|Overall Study||2
10168346|NCT03015532|11298325|FG007|NOT COMPLETED|Overall Study||0
10168347|NCT03015649|11298345|FG000|STARTED|Overall Study||34
10168348|NCT03015649|11298345|FG000|COMPLETED|Overall Study||34
10168349|NCT03015649|11298345|FG000|NOT COMPLETED|Overall Study||0
10168350|NCT03015961|11298351|FG000|STARTED|Overall Study||18
10168351|NCT03015961|11298352|FG001|STARTED|Overall Study||20
9711968|NCT02932579|10811550|FG000|COMPLETED|Overall Study||29
9711969|NCT02932579|10811551|FG001|COMPLETED|Overall Study||25
9711970|NCT02932579|10811550|FG000|NOT COMPLETED|Overall Study||4
9711971|NCT02932579|10811551|FG001|NOT COMPLETED|Overall Study||1
9711972|NCT02928224|10811561|FG000|STARTED|Overall Study||37
9711973|NCT02928224|10811562|FG001|STARTED|Overall Study||224
9711974|NCT02928224|10811563|FG002|STARTED|Overall Study||220
9711975|NCT02928224|10811564|FG003|STARTED|Overall Study||221
9711976|NCT02928224|10811561|FG000|COMPLETED|Overall Study||0
9711977|NCT02928224|10811562|FG001|COMPLETED|Overall Study||0
9711978|NCT02928224|10811563|FG002|COMPLETED|Overall Study||0
9711979|NCT02928224|10811564|FG003|COMPLETED|Overall Study||0
9711980|NCT02928224|10811561|FG000|NOT COMPLETED|Overall Study||37
9711981|NCT02928224|10811562|FG001|NOT COMPLETED|Overall Study||224
9711982|NCT02928224|10811563|FG002|NOT COMPLETED|Overall Study||220
9711983|NCT02928224|10811564|FG003|NOT COMPLETED|Overall Study||221
9711984|NCT02858154|10811579|FG000|STARTED|HFNC 3-4 Hours||9
9711985|NCT02858154|10811579|FG000|COMPLETED|HFNC 3-4 Hours||9
9711986|NCT02858154|10811579|FG000|NOT COMPLETED|HFNC 3-4 Hours||0
9711987|NCT02858154|10811579|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
9711988|NCT02858154|10811579|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
9711989|NCT02858154|10811579|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
9711990|NCT02852967|10811589|FG000|STARTED|Overall Study||23
9711991|NCT02852967|10811590|FG001|STARTED|Overall Study||22
9711992|NCT02852967|10811591|FG002|STARTED|Overall Study||21
9711993|NCT02852967|10811592|FG003|STARTED|Overall Study||26
9711994|NCT02852967|10811593|FG004|STARTED|Overall Study||18
9711995|NCT02852967|10811589|FG000|Completed Period 1: Double-blind|Overall Study||14
9711996|NCT02852967|10811590|FG001|Completed Period 1: Double-blind|Overall Study||15
9711997|NCT02852967|10811591|FG002|Completed Period 1: Double-blind|Overall Study||17
9711998|NCT02852967|10811592|FG003|Completed Period 1: Double-blind|Overall Study||16
9711999|NCT02852967|10811593|FG004|Completed Period 1: Double-blind|Overall Study||10
9712000|NCT02852967|10811589|FG000|Completed Period 2: Open-label|Overall Study||11
9712001|NCT02852967|10811590|FG001|Completed Period 2: Open-label|Overall Study||8
9712002|NCT02852967|10811591|FG002|Completed Period 2: Open-label|Overall Study||13
9712003|NCT02852967|10811592|FG003|Completed Period 2: Open-label|Overall Study||11
9712004|NCT02852967|10811593|FG004|Completed Period 2: Open-label|Overall Study||14
9712005|NCT02852967|10811589|FG000|COMPLETED|Overall Study||9
9712006|NCT02852967|10811590|FG001|COMPLETED|Overall Study||6
9712007|NCT02852967|10811591|FG002|COMPLETED|Overall Study||9
9712008|NCT02852967|10811592|FG003|COMPLETED|Overall Study||4
9712009|NCT02852967|10811593|FG004|COMPLETED|Overall Study||2
9712010|NCT02852967|10811589|FG000|NOT COMPLETED|Overall Study||14
9712011|NCT02852967|10811590|FG001|NOT COMPLETED|Overall Study||16
9712012|NCT02852967|10811591|FG002|NOT COMPLETED|Overall Study||12
9712013|NCT02852967|10811592|FG003|NOT COMPLETED|Overall Study||22
9712014|NCT02852967|10811593|FG004|NOT COMPLETED|Overall Study||16
9712015|NCT02810418|10811620|FG000|STARTED|Arm A Dose Escalation||6
9712016|NCT02810418|10811621|FG001|STARTED|Arm A Dose Escalation||8
9712017|NCT02810418|10811622|FG002|STARTED|Arm A Dose Escalation||0
9712018|NCT02810418|10811623|FG003|STARTED|Arm A Dose Escalation||0
9712019|NCT02810418|10811624|FG004|STARTED|Arm A Dose Escalation||0
9712020|NCT02810418|10811625|FG005|STARTED|Arm A Dose Escalation||0
9712021|NCT02810418|10811626|FG006|STARTED|Arm A Dose Escalation||0
9712022|NCT02810418|10811620|FG000|COMPLETED|Arm A Dose Escalation||4
9712023|NCT02810418|10811621|FG001|COMPLETED|Arm A Dose Escalation||7
9712024|NCT02810418|10811622|FG002|COMPLETED|Arm A Dose Escalation||0
9712025|NCT02810418|10811623|FG003|COMPLETED|Arm A Dose Escalation||0
9712026|NCT02810418|10811624|FG004|COMPLETED|Arm A Dose Escalation||0
9712027|NCT02810418|10811625|FG005|COMPLETED|Arm A Dose Escalation||0
9712028|NCT02810418|10811626|FG006|COMPLETED|Arm A Dose Escalation||0
9712029|NCT02810418|10811620|FG000|NOT COMPLETED|Arm A Dose Escalation||2
10168352|NCT03015961|11298351|FG000|COMPLETED|Overall Study||18
9712030|NCT02810418|10811621|FG001|NOT COMPLETED|Arm A Dose Escalation||1
9712031|NCT02810418|10811622|FG002|NOT COMPLETED|Arm A Dose Escalation||0
9712032|NCT02810418|10811623|FG003|NOT COMPLETED|Arm A Dose Escalation||0
10168353|NCT03015961|11298352|FG001|COMPLETED|Overall Study||18
10168354|NCT03015961|11298351|FG000|NOT COMPLETED|Overall Study||0
10168355|NCT03015961|11298352|FG001|NOT COMPLETED|Overall Study||2
10168356|NCT03016078|11298358|FG000|STARTED|Overall Study||21
10168357|NCT03016078|11298358|FG000|COMPLETED|Overall Study||19
10168358|NCT03016078|11298358|FG000|NOT COMPLETED|Overall Study||2
10168359|NCT03016325|11298370|FG000|STARTED|Treatment Period||48
10168360|NCT03016325|11298371|FG001|STARTED|Treatment Period||49
10168361|NCT03016325|11298372|FG002|STARTED|Treatment Period||71
10168362|NCT03016325|11298373|FG003|STARTED|Treatment Period||71
10168363|NCT03016325|11298374|FG004|STARTED|Treatment Period||72
10168364|NCT03016325|11298375|FG005|STARTED|Treatment Period||6
10168365|NCT03016325|11298376|FG006|STARTED|Treatment Period||6
10168366|NCT03016325|11298377|FG007|STARTED|Treatment Period||6
10168367|NCT03016325|11298370|FG000|COMPLETED|Treatment Period||48
10168368|NCT03016325|11298371|FG001|COMPLETED|Treatment Period||48
10168369|NCT03016325|11298372|FG002|COMPLETED|Treatment Period||70
10168370|NCT03016325|11298373|FG003|COMPLETED|Treatment Period||71
10168371|NCT03016325|11298374|FG004|COMPLETED|Treatment Period||70
10168372|NCT03016325|11298375|FG005|COMPLETED|Treatment Period||6
10168373|NCT03016325|11298376|FG006|COMPLETED|Treatment Period||6
10168374|NCT03016325|11298377|FG007|COMPLETED|Treatment Period||6
10168375|NCT03016325|11298370|FG000|NOT COMPLETED|Treatment Period||0
10168376|NCT03016325|11298371|FG001|NOT COMPLETED|Treatment Period||1
10168377|NCT03016325|11298372|FG002|NOT COMPLETED|Treatment Period||1
10168378|NCT03016325|11298373|FG003|NOT COMPLETED|Treatment Period||0
10168379|NCT03016325|11298374|FG004|NOT COMPLETED|Treatment Period||2
10168380|NCT03016325|11298375|FG005|NOT COMPLETED|Treatment Period||0
10168381|NCT03016325|11298376|FG006|NOT COMPLETED|Treatment Period||0
10168382|NCT03016325|11298377|FG007|NOT COMPLETED|Treatment Period||0
10168383|NCT03016325|11298370|FG000|STARTED|32-Day Follow-Up Period||48
10168384|NCT03016325|11298371|FG001|STARTED|32-Day Follow-Up Period||49
10168385|NCT03016325|11298372|FG002|STARTED|32-Day Follow-Up Period||71
10168386|NCT03016325|11298373|FG003|STARTED|32-Day Follow-Up Period||71
10168387|NCT03016325|11298374|FG004|STARTED|32-Day Follow-Up Period||72
10168388|NCT03016325|11298375|FG005|STARTED|32-Day Follow-Up Period||6
10168389|NCT03016325|11298376|FG006|STARTED|32-Day Follow-Up Period||6
10168390|NCT03016325|11298377|FG007|STARTED|32-Day Follow-Up Period||6
10168391|NCT03016325|11298370|FG000|COMPLETED|32-Day Follow-Up Period||44
10168392|NCT03016325|11298371|FG001|COMPLETED|32-Day Follow-Up Period||47
10168393|NCT03016325|11298372|FG002|COMPLETED|32-Day Follow-Up Period||62
10168394|NCT03016325|11298373|FG003|COMPLETED|32-Day Follow-Up Period||63
10168395|NCT03016325|11298374|FG004|COMPLETED|32-Day Follow-Up Period||64
10168396|NCT03016325|11298375|FG005|COMPLETED|32-Day Follow-Up Period||6
10168397|NCT03016325|11298376|FG006|COMPLETED|32-Day Follow-Up Period||5
10168398|NCT03016325|11298377|FG007|COMPLETED|32-Day Follow-Up Period||6
10168399|NCT03016325|11298370|FG000|NOT COMPLETED|32-Day Follow-Up Period||4
10168400|NCT03016325|11298371|FG001|NOT COMPLETED|32-Day Follow-Up Period||2
10168401|NCT03016325|11298372|FG002|NOT COMPLETED|32-Day Follow-Up Period||9
10168402|NCT03016325|11298373|FG003|NOT COMPLETED|32-Day Follow-Up Period||8
10168403|NCT03016325|11298374|FG004|NOT COMPLETED|32-Day Follow-Up Period||8
10168404|NCT03016325|11298375|FG005|NOT COMPLETED|32-Day Follow-Up Period||0
10168405|NCT03016325|11298376|FG006|NOT COMPLETED|32-Day Follow-Up Period||1
10168406|NCT03016325|11298377|FG007|NOT COMPLETED|32-Day Follow-Up Period||0
10168407|NCT03016325|11298370|FG000|STARTED|182-Day Follow-Up Period||48
10168408|NCT03016325|11298371|FG001|STARTED|182-Day Follow-Up Period||49
10168409|NCT03016325|11298372|FG002|STARTED|182-Day Follow-Up Period||71
10168410|NCT03016325|11298373|FG003|STARTED|182-Day Follow-Up Period||71
10168411|NCT03016325|11298374|FG004|STARTED|182-Day Follow-Up Period||72
10168412|NCT03016325|11298375|FG005|STARTED|182-Day Follow-Up Period||6
10168413|NCT03016325|11298376|FG006|STARTED|182-Day Follow-Up Period||6
10168414|NCT03016325|11298377|FG007|STARTED|182-Day Follow-Up Period||6
10168415|NCT03016325|11298370|FG000|COMPLETED|182-Day Follow-Up Period||44
10168416|NCT03016325|11298371|FG001|COMPLETED|182-Day Follow-Up Period||45
10168417|NCT03016325|11298372|FG002|COMPLETED|182-Day Follow-Up Period||60
10168418|NCT03016325|11298373|FG003|COMPLETED|182-Day Follow-Up Period||58
10168419|NCT03016325|11298374|FG004|COMPLETED|182-Day Follow-Up Period||60
10168420|NCT03016325|11298375|FG005|COMPLETED|182-Day Follow-Up Period||1
10168421|NCT03016325|11298376|FG006|COMPLETED|182-Day Follow-Up Period||2
10168422|NCT03016325|11298377|FG007|COMPLETED|182-Day Follow-Up Period||1
10168423|NCT03016325|11298370|FG000|NOT COMPLETED|182-Day Follow-Up Period||4
10168424|NCT03016325|11298371|FG001|NOT COMPLETED|182-Day Follow-Up Period||4
10168425|NCT03016325|11298372|FG002|NOT COMPLETED|182-Day Follow-Up Period||11
10168426|NCT03016325|11298373|FG003|NOT COMPLETED|182-Day Follow-Up Period||13
10168427|NCT03016325|11298374|FG004|NOT COMPLETED|182-Day Follow-Up Period||12
10168428|NCT03016325|11298375|FG005|NOT COMPLETED|182-Day Follow-Up Period||5
10168429|NCT03016325|11298376|FG006|NOT COMPLETED|182-Day Follow-Up Period||4
10168430|NCT03016325|11298377|FG007|NOT COMPLETED|182-Day Follow-Up Period||5
10168431|NCT03016403|11298402|FG000|STARTED|Baseline||139
10168432|NCT03016403|11298403|FG001|STARTED|Baseline||147
10168433|NCT03016403|11298404|FG002|STARTED|Baseline||118
10168434|NCT03016403|11298405|FG003|STARTED|Baseline||131
10168435|NCT03016403|11298402|FG000|COMPLETED|Baseline||123
10168436|NCT03016403|11298403|FG001|COMPLETED|Baseline||120
10168437|NCT03016403|11298404|FG002|COMPLETED|Baseline||107
10168438|NCT03016403|11298405|FG003|COMPLETED|Baseline||97
10168439|NCT03016403|11298402|FG000|NOT COMPLETED|Baseline||16
10168440|NCT03016403|11298403|FG001|NOT COMPLETED|Baseline||27
10168441|NCT03016403|11298404|FG002|NOT COMPLETED|Baseline||11
10168442|NCT03016403|11298405|FG003|NOT COMPLETED|Baseline||34
10168443|NCT03016403|11298402|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
10168444|NCT03016403|11298403|FG001|STARTED|6-week Follow-up||120
10168445|NCT03016403|11298404|FG002|STARTED|6-week Follow-up||107
10168446|NCT03016403|11298405|FG003|STARTED|6-week Follow-up||97
10168447|NCT03016403|11298402|FG000|COMPLETED|6-week Follow-up||120
10168448|NCT03016403|11298403|FG001|COMPLETED|6-week Follow-up||107
10168449|NCT03016403|11298404|FG002|COMPLETED|6-week Follow-up||103
10168450|NCT03016403|11298405|FG003|COMPLETED|6-week Follow-up||88
10168451|NCT03016403|11298402|FG000|NOT COMPLETED|6-week Follow-up||3
10168452|NCT03016403|11298403|FG001|NOT COMPLETED|6-week Follow-up||13
10168453|NCT03016403|11298404|FG002|NOT COMPLETED|6-week Follow-up||4
10168454|NCT03016403|11298405|FG003|NOT COMPLETED|6-week Follow-up||9
10168455|NCT03016403|11298402|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120
10168456|NCT03016403|11298403|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107
10168457|NCT03016403|11298404|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103
10168458|NCT03016403|11298405|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88
10168459|NCT03016403|11298402|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108
10168460|NCT03016403|11298403|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96
10168461|NCT03016403|11298404|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95
10168462|NCT03016403|11298405|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81
10168463|NCT03016403|11298402|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
10168464|NCT03016403|11298403|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
10168465|NCT03016403|11298404|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
10168466|NCT03016403|11298405|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
10168467|NCT03016598|11298419|FG000|STARTED|Overall Study||18
10168468|NCT03016598|11298420|FG001|STARTED|Overall Study||22
10168469|NCT03016598|11298419|FG000|COMPLETED|Overall Study||18
10168470|NCT03016598|11298420|FG001|COMPLETED|Overall Study||20
10168471|NCT03016598|11298419|FG000|NOT COMPLETED|Overall Study||0
10168472|NCT03016598|11298420|FG001|NOT COMPLETED|Overall Study||2
10168473|NCT03017079|11298428|FG000|STARTED|Overall Study||20
10168474|NCT03017079|11298429|FG001|STARTED|Overall Study||20
10168475|NCT03017079|11298428|FG000|COMPLETED|Overall Study||14
10168476|NCT03017079|11298429|FG001|COMPLETED|Overall Study||14
10168477|NCT03017079|11298428|FG000|NOT COMPLETED|Overall Study||6
10168478|NCT03017079|11298429|FG001|NOT COMPLETED|Overall Study||6
10168479|NCT03017235|11298444|FG000|STARTED|Overall Study||456
10168480|NCT03017235|11298445|FG001|STARTED|Overall Study||461
10168481|NCT03017235|11298444|FG000|COMPLETED|Overall Study||444
10168482|NCT03017235|11298445|FG001|COMPLETED|Overall Study||447
10168483|NCT03017235|11298444|FG000|NOT COMPLETED|Overall Study||12
10168484|NCT03017235|11298445|FG001|NOT COMPLETED|Overall Study||14
10168485|NCT03017261|11298451|FG000|STARTED|6 Week Follow up||115
10168486|NCT03017261|11298451|FG000|COMPLETED|6 Week Follow up||115
10168487|NCT03017261|11298451|FG000|NOT COMPLETED|6 Week Follow up||0
10168488|NCT03017261|11298451|FG000|STARTED|3 Month Follow up||115
10168489|NCT03017261|11298451|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
10168490|NCT03017261|11298451|FG000|NOT COMPLETED|3 Month Follow up||0
10168491|NCT03017261|11298451|FG000|STARTED|6 Month Follow up||115
10168492|NCT03017261|11298451|FG000|COMPLETED|6 Month Follow up||106
10168493|NCT03017261|11298451|FG000|NOT COMPLETED|6 Month Follow up||9
10168494|NCT03017261|11298451|FG000|STARTED|12 Month Follow up||106
10168495|NCT03017261|11298451|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
10168496|NCT03017261|11298451|FG000|NOT COMPLETED|12 Month Follow up||47
10197659|NCT03380390|11325663|FG000|STARTED|Overall Study||46
10197660|NCT03380390|11325663|FG000|COMPLETED|Overall Study||43
10197661|NCT03380390|11325663|FG000|NOT COMPLETED|Overall Study||3
10197662|NCT03380429|11325672|FG000|STARTED|Overall Study||87
10197663|NCT03380429|11325673|FG001|STARTED|Overall Study||88
10197664|NCT03380429|11325674|FG002|STARTED|Overall Study||88
10197665|NCT03380429|11325675|FG003|STARTED|Overall Study||88
10197666|NCT03380429|11325676|FG004|STARTED|Overall Study||86
10197667|NCT03380429|11325672|FG000|COMPLETED|Overall Study||82
10197668|NCT03380429|11325673|FG001|COMPLETED|Overall Study||81
10197669|NCT03380429|11325674|FG002|COMPLETED|Overall Study||77
10197670|NCT03380429|11325675|FG003|COMPLETED|Overall Study||78
10197671|NCT03380429|11325676|FG004|COMPLETED|Overall Study||81
10197672|NCT03380429|11325672|FG000|NOT COMPLETED|Overall Study||5
10197673|NCT03380429|11325673|FG001|NOT COMPLETED|Overall Study||7
10197674|NCT03380429|11325674|FG002|NOT COMPLETED|Overall Study||11
10197675|NCT03380429|11325675|FG003|NOT COMPLETED|Overall Study||10
10197676|NCT03380429|11325676|FG004|NOT COMPLETED|Overall Study||5
10197677|NCT03380572|11325695|FG000|STARTED|Overall Study||20
10197678|NCT03380572|11325696|FG001|STARTED|Overall Study||20
10197679|NCT03380572|11325695|FG000|COMPLETED|Overall Study||20
10197680|NCT03380572|11325696|FG001|COMPLETED|Overall Study||20
10197681|NCT03380572|11325695|FG000|NOT COMPLETED|Overall Study||0
10197682|NCT03380572|11325696|FG001|NOT COMPLETED|Overall Study||0
10197683|NCT03380624|11325702|FG000|STARTED|Overall Study||10
10197684|NCT03380624|11325703|FG001|STARTED|Overall Study||9
10197685|NCT03380624|11325702|FG000|COMPLETED|Overall Study||10
10197686|NCT03380624|11325703|FG001|COMPLETED|Overall Study||9
10197687|NCT03380624|11325702|FG000|NOT COMPLETED|Overall Study||0
10197688|NCT03380624|11325703|FG001|NOT COMPLETED|Overall Study||0
10197689|NCT03380780|11325709|FG000|STARTED|Overall Study||16
10197690|NCT03380780|11325709|FG000|COMPLETED|Overall Study||16
10197691|NCT03380780|11325709|FG000|NOT COMPLETED|Overall Study||0
10168497|NCT03017508|11298457|FG000|STARTED|Overall Study||12
10168498|NCT03017508|11298458|FG001|STARTED|Overall Study||10
10168499|NCT03017508|11298457|FG000|First Intervention (1 Day)|Overall Study||12
10168500|NCT03017508|11298458|FG001|First Intervention (1 Day)|Overall Study||10
10168501|NCT03017508|11298457|FG000|Washout (2-10 Days)|Overall Study||12
10168502|NCT03017508|11298458|FG001|Washout (2-10 Days)|Overall Study||10
10168503|NCT03017508|11298457|FG000|Second Intervention (1 Day)|Overall Study||12
10168504|NCT03017508|11298458|FG001|Second Intervention (1 Day)|Overall Study||10
10168505|NCT03017508|11298457|FG000|COMPLETED|Overall Study||12
10168506|NCT03017508|11298458|FG001|COMPLETED|Overall Study||10
10168507|NCT03017508|11298457|FG000|NOT COMPLETED|Overall Study||0
10168508|NCT03017508|11298458|FG001|NOT COMPLETED|Overall Study||0
10168509|NCT03017612|11298464|FG000|STARTED|Overall Study||13
10168510|NCT03017612|11298464|FG000|COMPLETED|Overall Study||11
10168511|NCT03017612|11298464|FG000|NOT COMPLETED|Overall Study||2
10168512|NCT03017846|11298468|FG000|STARTED|Overall Study||30
10168513|NCT03017846|11298468|FG000|COMPLETED|Overall Study||25
10168514|NCT03017846|11298468|FG000|NOT COMPLETED|Overall Study||5
10168515|NCT03017924|11298476|FG000|STARTED|Overall Study||12
10168516|NCT03017924|11298477|FG001|STARTED|Overall Study||11
10168517|NCT03017924|11298476|FG000|COMPLETED|Overall Study||10
10168518|NCT03017924|11298477|FG001|COMPLETED|Overall Study||8
10168519|NCT03017924|11298476|FG000|NOT COMPLETED|Overall Study||2
10168520|NCT03017924|11298477|FG001|NOT COMPLETED|Overall Study||3
10168521|NCT03017937|11298485|FG000|STARTED|Overall Study||155
10168522|NCT03017937|11298485|FG000|COMPLETED|Overall Study||155
10168523|NCT03017937|11298485|FG000|NOT COMPLETED|Overall Study||0
10168524|NCT03018028|11298495|FG000|STARTED|Overall Study||49
10168525|NCT03018028|11298496|FG001|STARTED|Overall Study||49
10168526|NCT03018028|11298497|FG002|STARTED|Overall Study||48
10168527|NCT03018028|11298498|FG003|STARTED|Overall Study||48
10168528|NCT03018028|11298499|FG004|STARTED|Overall Study||49
10168529|NCT03018028|11298495|FG000|Full Analysis Set (FAS)|Overall Study||49
10168530|NCT03018028|11298496|FG001|Full Analysis Set (FAS)|Overall Study||49
10168531|NCT03018028|11298497|FG002|Full Analysis Set (FAS)|Overall Study||48
10168532|NCT03018028|11298498|FG003|Full Analysis Set (FAS)|Overall Study||48
10168533|NCT03018028|11298499|FG004|Full Analysis Set (FAS)|Overall Study||49
10168534|NCT03018028|11298495|FG000|Safety Analysis Set (SAS)|Overall Study||49
10168535|NCT03018028|11298496|FG001|Safety Analysis Set (SAS)|Overall Study||49
10168536|NCT03018028|11298497|FG002|Safety Analysis Set (SAS)|Overall Study||48
10168537|NCT03018028|11298498|FG003|Safety Analysis Set (SAS)|Overall Study||48
10168538|NCT03018028|11298499|FG004|Safety Analysis Set (SAS)|Overall Study||49
10168539|NCT03018028|11298495|FG000|COMPLETED|Overall Study||46
10168540|NCT03018028|11298496|FG001|COMPLETED|Overall Study||49
10168541|NCT03018028|11298497|FG002|COMPLETED|Overall Study||47
10168542|NCT03018028|11298498|FG003|COMPLETED|Overall Study||46
10168543|NCT03018028|11298499|FG004|COMPLETED|Overall Study||49
10168544|NCT03018028|11298495|FG000|NOT COMPLETED|Overall Study||3
10168545|NCT03018028|11298496|FG001|NOT COMPLETED|Overall Study||0
10168546|NCT03018028|11298497|FG002|NOT COMPLETED|Overall Study||1
10168547|NCT03018028|11298498|FG003|NOT COMPLETED|Overall Study||2
10168548|NCT03018028|11298499|FG004|NOT COMPLETED|Overall Study||0
10168549|NCT03018106|11298513|FG000|STARTED|Overall Study||0
10168550|NCT03018106|11298514|FG001|STARTED|Overall Study||1
10168551|NCT03018106|11298513|FG000|COMPLETED|Overall Study||0
10168552|NCT03018106|11298514|FG001|COMPLETED|Overall Study||0
10168553|NCT03018106|11298513|FG000|NOT COMPLETED|Overall Study||0
10168554|NCT03018106|11298514|FG001|NOT COMPLETED|Overall Study||1
10168555|NCT03018223|11298518|FG000|STARTED|Overall Study||32
10168556|NCT03018223|11298518|FG000|COMPLETED|Overall Study||32
10168557|NCT03018223|11298518|FG000|NOT COMPLETED|Overall Study||0
10168558|NCT03018249|11298524|FG000|STARTED|Overall Study||25
10168559|NCT03018249|11298525|FG001|STARTED|Overall Study||25
10168560|NCT03018249|11298524|FG000|COMPLETED|Overall Study||23
10168561|NCT03018249|11298525|FG001|COMPLETED|Overall Study||23
10168562|NCT03018249|11298524|FG000|NOT COMPLETED|Overall Study||2
10168563|NCT03018249|11298525|FG001|NOT COMPLETED|Overall Study||2
10168564|NCT03018340|11298533|FG000|STARTED|Overall Study||52
10168565|NCT03018340|11298534|FG001|STARTED|Overall Study||155
10168566|NCT03018340|11298533|FG000|COMPLETED|Overall Study||44
10168567|NCT03018340|11298534|FG001|COMPLETED|Overall Study||125
10168568|NCT03018340|11298533|FG000|NOT COMPLETED|Overall Study||8
10168569|NCT03018340|11298534|FG001|NOT COMPLETED|Overall Study||30
10168570|NCT03018691|11298547|FG000|STARTED|Overall Study||24
10168571|NCT03018691|11298548|FG001|STARTED|Overall Study||25
10168572|NCT03018691|11298549|FG002|STARTED|Overall Study||24
10168573|NCT03018691|11298547|FG000|COMPLETED|Overall Study||22
10168574|NCT03018691|11298548|FG001|COMPLETED|Overall Study||24
10168575|NCT03018691|11298549|FG002|COMPLETED|Overall Study||17
10168576|NCT03018691|11298547|FG000|NOT COMPLETED|Overall Study||2
10168577|NCT03018691|11298548|FG001|NOT COMPLETED|Overall Study||1
10168578|NCT03018691|11298549|FG002|NOT COMPLETED|Overall Study||7
10168579|NCT03018925|11298559|FG000|STARTED|Overall Study||15
10168580|NCT03018925|11298559|FG000|COMPLETED|Overall Study||15
10168581|NCT03018925|11298559|FG000|NOT COMPLETED|Overall Study||0
10168582|NCT03018938|11298586|FG000|STARTED|Overall Study||404
10168583|NCT03018938|11298587|FG001|STARTED|Overall Study||410
10168584|NCT03018938|11298586|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404
10168585|NCT03018938|11298587|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410
10168586|NCT03018938|11298586|FG000|COMPLETED|Overall Study||338
10168587|NCT03018938|11298587|FG001|COMPLETED|Overall Study||325
10168588|NCT03018938|11298586|FG000|NOT COMPLETED|Overall Study||66
10168589|NCT03018938|11298587|FG001|NOT COMPLETED|Overall Study||85
10168590|NCT03019055|11298597|FG000|STARTED|Overall Study||0
10168591|NCT03019055|11298598|FG001|STARTED|Overall Study||3
10168592|NCT03019055|11298599|FG002|STARTED|Overall Study||3
10168593|NCT03019055|11298600|FG003|STARTED|Overall Study||20
10168594|NCT03019055|11298597|FG000|COMPLETED|Overall Study||0
10168595|NCT03019055|11298598|FG001|COMPLETED|Overall Study||3
10168596|NCT03019055|11298599|FG002|COMPLETED|Overall Study||3
10168597|NCT03019055|11298600|FG003|COMPLETED|Overall Study||20
10168598|NCT03019055|11298597|FG000|NOT COMPLETED|Overall Study||0
10168599|NCT03019055|11298598|FG001|NOT COMPLETED|Overall Study||0
10168600|NCT03019055|11298599|FG002|NOT COMPLETED|Overall Study||0
10168601|NCT03019055|11298600|FG003|NOT COMPLETED|Overall Study||0
10168602|NCT03019107|11298612|FG000|STARTED|Overall Study||1
10168603|NCT03019107|11298613|FG001|STARTED|Overall Study||0
10168604|NCT03019107|11298612|FG000|COMPLETED|Overall Study||1
10168605|NCT03019107|11298613|FG001|COMPLETED|Overall Study||0
10168606|NCT03019107|11298612|FG000|NOT COMPLETED|Overall Study||0
10168607|NCT03019107|11298613|FG001|NOT COMPLETED|Overall Study||0
10168608|NCT03019289|11298628|FG000|STARTED|Overall Study||5
10168609|NCT03019289|11298629|FG001|STARTED|Overall Study||1
10168610|NCT03019289|11298630|FG002|STARTED|Overall Study||3
10168611|NCT03019289|11298631|FG003|STARTED|Overall Study||2
10168612|NCT03019289|11298632|FG004|STARTED|Overall Study||1
10168613|NCT03019289|11298633|FG005|STARTED|Overall Study||1
10168614|NCT03019289|11298634|FG006|STARTED|Overall Study||3
10168615|NCT03019289|11298635|FG007|STARTED|Overall Study||4
10168616|NCT03019289|11298636|FG008|STARTED|Overall Study||3
10168617|NCT03019289|11298628|FG000|COMPLETED|Overall Study||3
10168618|NCT03019289|11298629|FG001|COMPLETED|Overall Study||1
10168619|NCT03019289|11298630|FG002|COMPLETED|Overall Study||3
10168620|NCT03019289|11298631|FG003|COMPLETED|Overall Study||2
10168621|NCT03019289|11298632|FG004|COMPLETED|Overall Study||1
10168622|NCT03019289|11298633|FG005|COMPLETED|Overall Study||1
10168623|NCT03019289|11298634|FG006|COMPLETED|Overall Study||3
10168624|NCT03019289|11298635|FG007|COMPLETED|Overall Study||4
10168625|NCT03019289|11298636|FG008|COMPLETED|Overall Study||2
10168626|NCT03019289|11298628|FG000|NOT COMPLETED|Overall Study||2
10168627|NCT03019289|11298629|FG001|NOT COMPLETED|Overall Study||0
10168628|NCT03019289|11298630|FG002|NOT COMPLETED|Overall Study||0
10168629|NCT03019289|11298631|FG003|NOT COMPLETED|Overall Study||0
10168630|NCT03019289|11298632|FG004|NOT COMPLETED|Overall Study||0
10168631|NCT03019289|11298633|FG005|NOT COMPLETED|Overall Study||0
10168632|NCT03019289|11298634|FG006|NOT COMPLETED|Overall Study||0
10168633|NCT03019289|11298635|FG007|NOT COMPLETED|Overall Study||0
10168634|NCT03019289|11298636|FG008|NOT COMPLETED|Overall Study||1
10168635|NCT03019458|11298659|FG000|STARTED|Overall Study||24
10168636|NCT03019458|11298660|FG001|STARTED|Overall Study||26
10168637|NCT03019458|11298659|FG000|COMPLETED|Overall Study||24
10168638|NCT03019458|11298660|FG001|COMPLETED|Overall Study||25
10168639|NCT03019458|11298659|FG000|NOT COMPLETED|Overall Study||0
10168640|NCT03019458|11298660|FG001|NOT COMPLETED|Overall Study||1
10168641|NCT03019549|11298668|FG000|STARTED|Period 1||42
10168642|NCT03019549|11298668|FG000|Received 1 Dose of Study Drug|Period 1||42
10168643|NCT03019549|11298668|FG000|COMPLETED|Period 1||42
10168644|NCT03019549|11298668|FG000|NOT COMPLETED|Period 1||0
10168645|NCT03019549|11298668|FG000|STARTED|Washout||42
10168646|NCT03019549|11298668|FG000|COMPLETED|Washout||31
10168647|NCT03019549|11298668|FG000|NOT COMPLETED|Washout||11
10168648|NCT03019549|11298668|FG000|STARTED|Period 2||31
10168649|NCT03019549|11298668|FG000|Received at Least 1 Dose of Study Drug|Period 2||29
10168650|NCT03019549|11298668|FG000|COMPLETED|Period 2||26
10168651|NCT03019549|11298668|FG000|NOT COMPLETED|Period 2||5
10168652|NCT03019627|11298679|FG000|STARTED|Overall Study||100
10168653|NCT03019627|11298680|FG001|STARTED|Overall Study||50
10168654|NCT03019627|11298679|FG000|COMPLETED|Overall Study||85
10168655|NCT03019627|11298680|FG001|COMPLETED|Overall Study||42
10168656|NCT03019627|11298679|FG000|NOT COMPLETED|Overall Study||15
10168657|NCT03019627|11298680|FG001|NOT COMPLETED|Overall Study||8
10168658|NCT03019744|11298688|FG000|STARTED|Overall Study||38
10168659|NCT03019744|11298689|FG001|STARTED|Overall Study||44
10168660|NCT03019744|11298688|FG000|COMPLETED|Overall Study||32
10168661|NCT03019744|11298689|FG001|COMPLETED|Overall Study||36
10168662|NCT03019744|11298688|FG000|NOT COMPLETED|Overall Study||6
10168663|NCT03019744|11298689|FG001|NOT COMPLETED|Overall Study||8
10168664|NCT03019783|11298697|FG000|STARTED|Overall Study||29
10168665|NCT03019783|11298698|FG001|STARTED|Overall Study||31
10168666|NCT03019783|11298697|FG000|COMPLETED|Overall Study||29
10168667|NCT03019783|11298698|FG001|COMPLETED|Overall Study||31
10168668|NCT03019783|11298697|FG000|NOT COMPLETED|Overall Study||0
10168669|NCT03019783|11298698|FG001|NOT COMPLETED|Overall Study||0
10168670|NCT03019796|11298704|FG000|STARTED|First Intervention Drug Tests||20
10168671|NCT03019796|11298705|FG001|STARTED|First Intervention Drug Tests||20
10168672|NCT03019796|11298704|FG000|COMPLETED|First Intervention Drug Tests||20
10168673|NCT03019796|11298705|FG001|COMPLETED|First Intervention Drug Tests||20
10168674|NCT03019796|11298704|FG000|NOT COMPLETED|First Intervention Drug Tests||0
10168675|NCT03019796|11298705|FG001|NOT COMPLETED|First Intervention Drug Tests||0
10168676|NCT03019796|11298704|FG000|STARTED|Second Intervention Training (4 Months)||20
10168677|NCT03019796|11298705|FG001|STARTED|Second Intervention Training (4 Months)||20
10168678|NCT03019796|11298704|FG000|COMPLETED|Second Intervention Training (4 Months)||19
10168679|NCT03019796|11298705|FG001|COMPLETED|Second Intervention Training (4 Months)||19
10168680|NCT03019796|11298704|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1
10168681|NCT03019796|11298705|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1
10168682|NCT03019796|11298704|FG000|STARTED|Third Intervention Drug Test||19
10168683|NCT03019796|11298705|FG001|STARTED|Third Intervention Drug Test||19
10168684|NCT03019796|11298704|FG000|COMPLETED|Third Intervention Drug Test||19
10168685|NCT03019796|11298705|FG001|COMPLETED|Third Intervention Drug Test||19
10168686|NCT03019796|11298704|FG000|NOT COMPLETED|Third Intervention Drug Test||0
10168687|NCT03019796|11298705|FG001|NOT COMPLETED|Third Intervention Drug Test||0
10168688|NCT03019887|11298712|FG000|STARTED|Overall Study||139
10168689|NCT03019887|11298712|FG000|COMPLETED|Overall Study||130
10168690|NCT03019887|11298712|FG000|NOT COMPLETED|Overall Study||9
10168691|NCT03019939|11298716|FG000|STARTED|Overall Study||65
10168692|NCT03019939|11298716|FG000|COMPLETED|Overall Study||65
10168693|NCT03019939|11298716|FG000|NOT COMPLETED|Overall Study||0
10168694|NCT03019965|11298722|FG000|STARTED|Overall Study||211
10168695|NCT03019965|11298723|FG001|STARTED|Overall Study||215
10168696|NCT03019965|11298722|FG000|COMPLETED|Overall Study||201
10168697|NCT03019965|11298723|FG001|COMPLETED|Overall Study||202
10168698|NCT03019965|11298722|FG000|NOT COMPLETED|Overall Study||10
10168699|NCT03019965|11298723|FG001|NOT COMPLETED|Overall Study||13
10168700|NCT03020004|11298729|FG000|STARTED|Overall Study||70
10168701|NCT03020004|11298729|FG000|COMPLETED|Overall Study||69
10168702|NCT03020004|11298729|FG000|NOT COMPLETED|Overall Study||1
10168703|NCT03020069|11298735|FG000|STARTED|Overall Study||9
10168704|NCT03020069|11298736|FG001|STARTED|Overall Study||4
10168705|NCT03020069|11298735|FG000|COMPLETED|Overall Study||9
10168706|NCT03020069|11298736|FG001|COMPLETED|Overall Study||3
10168707|NCT03020069|11298735|FG000|NOT COMPLETED|Overall Study||0
10168708|NCT03020069|11298736|FG001|NOT COMPLETED|Overall Study||1
10168709|NCT03020082|11298742|FG000|STARTED|Overall Study||141
10168710|NCT03020082|11298742|FG000|COMPLETED|Overall Study||138
10168711|NCT03020082|11298742|FG000|NOT COMPLETED|Overall Study||3
10168712|NCT03020095|11298746|FG000|STARTED|Overall Study||38
10168713|NCT03020095|11298746|FG000|COMPLETED|Overall Study||37
10168714|NCT03020095|11298746|FG000|NOT COMPLETED|Overall Study||1
10168715|NCT03020407|11298752|FG000|STARTED|Overall Study||105
10168716|NCT03020407|11298753|FG001|STARTED|Overall Study||106
10168717|NCT03020407|11298752|FG000|COMPLETED|Overall Study||101
10168718|NCT03020407|11298753|FG001|COMPLETED|Overall Study||101
10168719|NCT03020407|11298752|FG000|NOT COMPLETED|Overall Study||4
10168720|NCT03020407|11298753|FG001|NOT COMPLETED|Overall Study||5
10168721|NCT03020472|11298759|FG000|STARTED|Overall Study||6
10168722|NCT03020472|11298759|FG000|COMPLETED|Overall Study||6
10168723|NCT03020472|11298759|FG000|NOT COMPLETED|Overall Study||0
10168724|NCT03020498|11298766|FG000|STARTED|Overall Study||14
10168725|NCT03020498|11298767|FG001|STARTED|Overall Study||41
10168726|NCT03020498|11298768|FG002|STARTED|Overall Study||36
10168727|NCT03020498|11298766|FG000|COMPLETED|Overall Study||14
10168728|NCT03020498|11298767|FG001|COMPLETED|Overall Study||38
10168729|NCT03020498|11298768|FG002|COMPLETED|Overall Study||36
10168730|NCT03020498|11298766|FG000|NOT COMPLETED|Overall Study||0
10168731|NCT03020498|11298767|FG001|NOT COMPLETED|Overall Study||3
10168732|NCT03020498|11298768|FG002|NOT COMPLETED|Overall Study||0
10168733|NCT03020524|11298779|FG000|STARTED|Overall Study||3
10168734|NCT03020524|11298780|FG001|STARTED|Overall Study||3
10168735|NCT03020524|11298781|FG002|STARTED|Overall Study||3
10168736|NCT03020524|11298779|FG000|COMPLETED|Overall Study||3
10168737|NCT03020524|11298780|FG001|COMPLETED|Overall Study||3
10168738|NCT03020524|11298781|FG002|COMPLETED|Overall Study||3
10168739|NCT03020524|11298779|FG000|NOT COMPLETED|Overall Study||0
10168740|NCT03020524|11298780|FG001|NOT COMPLETED|Overall Study||0
10168741|NCT03020524|11298781|FG002|NOT COMPLETED|Overall Study||0
10168742|NCT03020537|11298791|FG000|STARTED|Overall Study||1
10168743|NCT03020537|11298792|FG001|STARTED|Overall Study||7
10168744|NCT03020537|11298791|FG000|COMPLETED|Overall Study||1
10168745|NCT03020537|11298792|FG001|COMPLETED|Overall Study||7
10168746|NCT03020537|11298791|FG000|NOT COMPLETED|Overall Study||0
10168747|NCT03020537|11298792|FG001|NOT COMPLETED|Overall Study||0
10168748|NCT03020550|11298800|FG000|STARTED|Overall Study||8
10168749|NCT03020550|11298801|FG001|STARTED|Overall Study||16
10168750|NCT03020550|11298800|FG000|COMPLETED|Overall Study||8
10168751|NCT03020550|11298801|FG001|COMPLETED|Overall Study||16
10168752|NCT03020550|11298800|FG000|NOT COMPLETED|Overall Study||0
10168753|NCT03020550|11298801|FG001|NOT COMPLETED|Overall Study||0
10168754|NCT03020576|11298809|FG000|STARTED|Overall Study||15
10168755|NCT03020576|11298810|FG001|STARTED|Overall Study||16
10168756|NCT03020576|11298809|FG000|COMPLETED|Overall Study||14
10168757|NCT03020576|11298810|FG001|COMPLETED|Overall Study||14
10168758|NCT03020576|11298809|FG000|NOT COMPLETED|Overall Study||1
10168759|NCT03020576|11298810|FG001|NOT COMPLETED|Overall Study||2
10168760|NCT03020615|11298819|FG000|STARTED|Overall Study||26
10168761|NCT03020615|11298820|FG001|STARTED|Overall Study||25
10168762|NCT03020615|11298821|FG002|STARTED|Overall Study||7
10168763|NCT03020615|11298819|FG000|COMPLETED|Overall Study||19
10168764|NCT03020615|11298820|FG001|COMPLETED|Overall Study||23
10168765|NCT03020615|11298821|FG002|COMPLETED|Overall Study||0
10168766|NCT03020615|11298819|FG000|NOT COMPLETED|Overall Study||7
10168767|NCT03020615|11298820|FG001|NOT COMPLETED|Overall Study||2
10168768|NCT03020615|11298821|FG002|NOT COMPLETED|Overall Study||7
10168769|NCT03020641|11298834|FG000|STARTED|Overall Study||50
10168770|NCT03020641|11298835|FG001|STARTED|Overall Study||50
10168771|NCT03020641|11298834|FG000|COMPLETED|Overall Study||48
10168772|NCT03020641|11298835|FG001|COMPLETED|Overall Study||47
10168773|NCT03020641|11298834|FG000|NOT COMPLETED|Overall Study||2
10168774|NCT03020641|11298835|FG001|NOT COMPLETED|Overall Study||3
10168775|NCT03020719|11298846|FG000|STARTED|Overall Study||30
10168776|NCT03020719|11298847|FG001|STARTED|Overall Study||30
10168777|NCT03020719|11298846|FG000|COMPLETED|Overall Study||30
10168778|NCT03020719|11298847|FG001|COMPLETED|Overall Study||28
10168779|NCT03020719|11298846|FG000|NOT COMPLETED|Overall Study||0
10168780|NCT03020719|11298847|FG001|NOT COMPLETED|Overall Study||2
10168781|NCT03020745|11298861|FG000|STARTED|Part 1 (Up to 60 Days)||3
10168782|NCT03020745|11298862|FG001|STARTED|Part 1 (Up to 60 Days)||3
10168783|NCT03020745|11298863|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
10168784|NCT03020745|11298864|FG003|STARTED|Part 1 (Up to 60 Days)||6
10168785|NCT03020745|11298865|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
10168786|NCT03020745|11298866|FG005|STARTED|Part 1 (Up to 60 Days)||0
10168787|NCT03020745|11298867|FG006|STARTED|Part 1 (Up to 60 Days)||0
10168788|NCT03020745|11298868|FG007|STARTED|Part 1 (Up to 60 Days)||0
10168789|NCT03020745|11298869|FG008|STARTED|Part 1 (Up to 60 Days)||0
10168790|NCT03020745|11298870|FG009|STARTED|Part 1 (Up to 60 Days)||0
10168791|NCT03020745|11298861|FG000|COMPLETED|Part 1 (Up to 60 Days)||3
10168792|NCT03020745|11298862|FG001|COMPLETED|Part 1 (Up to 60 Days)||3
10168793|NCT03020745|11298863|FG002|COMPLETED|Part 1 (Up to 60 Days)||0
10168794|NCT03020745|11298864|FG003|COMPLETED|Part 1 (Up to 60 Days)||6
10168795|NCT03020745|11298865|FG004|COMPLETED|Part 1 (Up to 60 Days)||0
10168796|NCT03020745|11298866|FG005|COMPLETED|Part 1 (Up to 60 Days)||0
10168797|NCT03020745|11298867|FG006|COMPLETED|Part 1 (Up to 60 Days)||0
10168798|NCT03020745|11298868|FG007|COMPLETED|Part 1 (Up to 60 Days)||0
10168799|NCT03020745|11298869|FG008|COMPLETED|Part 1 (Up to 60 Days)||0
10168800|NCT03020745|11298870|FG009|COMPLETED|Part 1 (Up to 60 Days)||0
10168801|NCT03020745|11298861|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168802|NCT03020745|11298862|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168803|NCT03020745|11298863|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168804|NCT03020745|11298864|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168805|NCT03020745|11298865|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168806|NCT03020745|11298866|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168807|NCT03020745|11298867|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168808|NCT03020745|11298868|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168809|NCT03020745|11298869|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168810|NCT03020745|11298870|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10168811|NCT03020745|11298861|FG000|STARTED|Part 2 (Up to 169 Days)||0
10168812|NCT03020745|11298862|FG001|STARTED|Part 2 (Up to 169 Days)||0
10168813|NCT03020745|11298863|FG002|STARTED|Part 2 (Up to 169 Days)||0
10168814|NCT03020745|11298864|FG003|STARTED|Part 2 (Up to 169 Days)||0
10168815|NCT03020745|11298865|FG004|STARTED|Part 2 (Up to 169 Days)||0
10168816|NCT03020745|11298866|FG005|STARTED|Part 2 (Up to 169 Days)||10
10168817|NCT03020745|11298867|FG006|STARTED|Part 2 (Up to 169 Days)||6
10168818|NCT03020745|11298868|FG007|STARTED|Part 2 (Up to 169 Days)||20
10168819|NCT03020745|11298869|FG008|STARTED|Part 2 (Up to 169 Days)||15
10168820|NCT03020745|11298870|FG009|STARTED|Part 2 (Up to 169 Days)||15
10168821|NCT03020745|11298861|FG000|COMPLETED|Part 2 (Up to 169 Days)||0
10168822|NCT03020745|11298862|FG001|COMPLETED|Part 2 (Up to 169 Days)||0
10168823|NCT03020745|11298863|FG002|COMPLETED|Part 2 (Up to 169 Days)||0
10168824|NCT03020745|11298864|FG003|COMPLETED|Part 2 (Up to 169 Days)||0
10168825|NCT03020745|11298865|FG004|COMPLETED|Part 2 (Up to 169 Days)||0
10168826|NCT03020745|11298866|FG005|COMPLETED|Part 2 (Up to 169 Days)||10
10168827|NCT03020745|11298867|FG006|COMPLETED|Part 2 (Up to 169 Days)||6
10168828|NCT03020745|11298868|FG007|COMPLETED|Part 2 (Up to 169 Days)||19
10168829|NCT03020745|11298869|FG008|COMPLETED|Part 2 (Up to 169 Days)||14
10168830|NCT03020745|11298870|FG009|COMPLETED|Part 2 (Up to 169 Days)||15
10168831|NCT03020745|11298861|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168832|NCT03020745|11298862|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168833|NCT03020745|11298863|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168834|NCT03020745|11298864|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168835|NCT03020745|11298865|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168836|NCT03020745|11298866|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168837|NCT03020745|11298867|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168838|NCT03020745|11298868|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1
10168839|NCT03020745|11298869|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1
10168840|NCT03020745|11298870|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10168841|NCT03020745|11298861|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10168842|NCT03020745|11298862|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10168843|NCT03020745|11298863|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10168844|NCT03020745|11298864|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10168845|NCT03020745|11298865|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10168846|NCT03020745|11298866|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10
10168847|NCT03020745|11298867|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
10168848|NCT03020745|11298868|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
10168849|NCT03020745|11298869|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
10168850|NCT03020745|11298870|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15
10168851|NCT03020745|11298861|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168852|NCT03020745|11298862|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168853|NCT03020745|11298863|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168854|NCT03020745|11298864|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168855|NCT03020745|11298865|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168856|NCT03020745|11298866|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
10168857|NCT03020745|11298867|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
10168858|NCT03020745|11298868|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
10168859|NCT03020745|11298869|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
10168860|NCT03020745|11298870|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
10168861|NCT03020745|11298861|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168862|NCT03020745|11298862|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168863|NCT03020745|11298863|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168864|NCT03020745|11298864|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168865|NCT03020745|11298865|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168866|NCT03020745|11298866|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
10168867|NCT03020745|11298867|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168868|NCT03020745|11298868|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168869|NCT03020745|11298869|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
10168870|NCT03020745|11298870|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10168871|NCT03020888|11298894|FG000|STARTED|Overall Study||120
10168872|NCT03020888|11298894|FG000|COMPLETED|Overall Study||107
10168873|NCT03020888|11298894|FG000|NOT COMPLETED|Overall Study||13
10168874|NCT03020966|11298900|FG000|STARTED|Overall Study||77
10168875|NCT03020966|11298901|FG001|STARTED|Overall Study||77
10168876|NCT03020966|11298900|FG000|COMPLETED|Overall Study||75
10168877|NCT03020966|11298901|FG001|COMPLETED|Overall Study||77
10168878|NCT03020966|11298900|FG000|NOT COMPLETED|Overall Study||2
10168879|NCT03020966|11298901|FG001|NOT COMPLETED|Overall Study||0
10168880|NCT03020992|11298907|FG000|STARTED|Overall Study||89
10168881|NCT03020992|11298907|FG000|COMPLETED|Overall Study||83
10168882|NCT03020992|11298907|FG000|NOT COMPLETED|Overall Study||6
10168883|NCT03021005|11298914|FG000|STARTED|Overall Study||102
10168884|NCT03021005|11298915|FG001|STARTED|Overall Study||98
10168885|NCT03021005|11298914|FG000|COMPLETED|Overall Study||63
10168886|NCT03021005|11298915|FG001|COMPLETED|Overall Study||72
10168887|NCT03021005|11298914|FG000|NOT COMPLETED|Overall Study||39
10168888|NCT03021005|11298915|FG001|NOT COMPLETED|Overall Study||26
10168889|NCT03021018|11298924|FG000|STARTED|Overall Study||16
10168890|NCT03021018|11298925|FG001|STARTED|Overall Study||15
10168891|NCT03021018|11298926|FG002|STARTED|Overall Study||15
10168892|NCT03021018|11298924|FG000|COMPLETED|Overall Study||14
10168893|NCT03021018|11298925|FG001|COMPLETED|Overall Study||15
10168894|NCT03021018|11298926|FG002|COMPLETED|Overall Study||15
10168895|NCT03021018|11298924|FG000|NOT COMPLETED|Overall Study||2
10168896|NCT03021018|11298925|FG001|NOT COMPLETED|Overall Study||0
10168897|NCT03021018|11298926|FG002|NOT COMPLETED|Overall Study||0
10168898|NCT03021187|11298938|FG000|STARTED|Overall Study||184
10168899|NCT03021187|11298939|FG001|STARTED|Overall Study||182
10168900|NCT03021187|11298940|FG002|STARTED|Overall Study||181
10168901|NCT03021187|11298941|FG003|STARTED|Overall Study||184
10168902|NCT03021187|11298938|FG000|Exposed|Overall Study||184
10168903|NCT03021187|11298939|FG001|Exposed|Overall Study||181
10168904|NCT03021187|11298940|FG002|Exposed|Overall Study||181
10168905|NCT03021187|11298941|FG003|Exposed|Overall Study||184
10168906|NCT03021187|11298938|FG000|Full Analysis Set (FAS)|Overall Study||184
10168907|NCT03021187|11298939|FG001|Full Analysis Set (FAS)|Overall Study||182
10168908|NCT03021187|11298940|FG002|Full Analysis Set (FAS)|Overall Study||181
10168909|NCT03021187|11298941|FG003|Full Analysis Set (FAS)|Overall Study||184
10168910|NCT03021187|11298938|FG000|Safety Analysis Set (SAS)|Overall Study||184
10168911|NCT03021187|11298939|FG001|Safety Analysis Set (SAS)|Overall Study||181
10168912|NCT03021187|11298940|FG002|Safety Analysis Set (SAS)|Overall Study||181
10168913|NCT03021187|11298941|FG003|Safety Analysis Set (SAS)|Overall Study||184
10168914|NCT03021187|11298938|FG000|COMPLETED|Overall Study||174
10168915|NCT03021187|11298939|FG001|COMPLETED|Overall Study||173
10168916|NCT03021187|11298940|FG002|COMPLETED|Overall Study||175
10168917|NCT03021187|11298941|FG003|COMPLETED|Overall Study||175
10168918|NCT03021187|11298938|FG000|NOT COMPLETED|Overall Study||10
10168919|NCT03021187|11298939|FG001|NOT COMPLETED|Overall Study||9
10168920|NCT03021187|11298940|FG002|NOT COMPLETED|Overall Study||6
10168921|NCT03021187|11298941|FG003|NOT COMPLETED|Overall Study||9
10168922|NCT03021265|11298951|FG000|STARTED|Overall Study||676
10168923|NCT03021265|11298951|FG000|COMPLETED|Overall Study||554
10168924|NCT03021265|11298951|FG000|NOT COMPLETED|Overall Study||122
10168925|NCT03021304|11298955|FG000|STARTED|Overall Study||56
10168926|NCT03021304|11298955|FG000|COMPLETED|Overall Study||55
10168927|NCT03021304|11298955|FG000|NOT COMPLETED|Overall Study||1
10168928|NCT03021343|11298961|FG000|STARTED|Overall Study||179
10168929|NCT03021343|11298962|FG001|STARTED|Overall Study||181
10168930|NCT03021343|11298961|FG000|COMPLETED|Overall Study||174
10168931|NCT03021343|11298962|FG001|COMPLETED|Overall Study||174
10168932|NCT03021343|11298961|FG000|NOT COMPLETED|Overall Study||5
10168933|NCT03021343|11298962|FG001|NOT COMPLETED|Overall Study||7
10168934|NCT03021499|11298970|FG000|STARTED|Overall Study||179
10168935|NCT03021499|11298971|FG001|STARTED|Overall Study||178
10168936|NCT03021499|11298970|FG000|Week 24|Overall Study||167
10168937|NCT03021499|11298971|FG001|Week 24|Overall Study||162
10168938|NCT03021499|11298970|FG000|Week 52|Overall Study||162
10168939|NCT03021499|11298971|FG001|Week 52|Overall Study||147
10168940|NCT03021499|11298970|FG000|COMPLETED|Overall Study||163
10168941|NCT03021499|11298971|FG001|COMPLETED|Overall Study||147
10168942|NCT03021499|11298970|FG000|NOT COMPLETED|Overall Study||16
10168943|NCT03021499|11298971|FG001|NOT COMPLETED|Overall Study||31
10168944|NCT03021538|11298981|FG000|STARTED|Overall Study||6
10168945|NCT03021538|11298982|FG001|STARTED|Overall Study||7
10168946|NCT03021538|11298981|FG000|COMPLETED|Overall Study||6
10168947|NCT03021538|11298982|FG001|COMPLETED|Overall Study||7
10168948|NCT03021538|11298981|FG000|NOT COMPLETED|Overall Study||0
10168949|NCT03021538|11298982|FG001|NOT COMPLETED|Overall Study||0
10168950|NCT03021564|11298990|FG000|STARTED|Overall Study||120
10168951|NCT03021564|11298991|FG001|STARTED|Overall Study||557
10168952|NCT03021564|11298990|FG000|COMPLETED|Overall Study||36
10168953|NCT03021564|11298991|FG001|COMPLETED|Overall Study||89
10168954|NCT03021564|11298990|FG000|NOT COMPLETED|Overall Study||84
10168955|NCT03021564|11298991|FG001|NOT COMPLETED|Overall Study||468
10168956|NCT03021642|11299001|FG000|STARTED|Treatment Period 1 (Day 1)||12
10168957|NCT03021642|11299002|FG001|STARTED|Treatment Period 1 (Day 1)||12
10168958|NCT03021642|11299001|FG000|COMPLETED|Treatment Period 1 (Day 1)||12
10168959|NCT03021642|11299002|FG001|COMPLETED|Treatment Period 1 (Day 1)||12
10168960|NCT03021642|11299001|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10168961|NCT03021642|11299002|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10168962|NCT03021642|11299001|FG000|STARTED|Washout Period (21 Days)||12
10168963|NCT03021642|11299002|FG001|STARTED|Washout Period (21 Days)||12
10168964|NCT03021642|11299001|FG000|COMPLETED|Washout Period (21 Days)||11
10168965|NCT03021642|11299002|FG001|COMPLETED|Washout Period (21 Days)||11
10168966|NCT03021642|11299001|FG000|NOT COMPLETED|Washout Period (21 Days)||1
10168967|NCT03021642|11299002|FG001|NOT COMPLETED|Washout Period (21 Days)||1
10168968|NCT03021642|11299001|FG000|STARTED|Treatment Period 2 (Day 22)||11
10168969|NCT03021642|11299002|FG001|STARTED|Treatment Period 2 (Day 22)||11
10168970|NCT03021642|11299001|FG000|COMPLETED|Treatment Period 2 (Day 22)||11
10168971|NCT03021642|11299002|FG001|COMPLETED|Treatment Period 2 (Day 22)||11
10168972|NCT03021642|11299001|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0
10168973|NCT03021642|11299002|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0
10168974|NCT03021668|11299010|FG000|STARTED|Overall Study||62
10168975|NCT03021668|11299011|FG001|STARTED|Overall Study||62
10168976|NCT03021668|11299010|FG000|COMPLETED|Overall Study||62
10168977|NCT03021668|11299011|FG001|COMPLETED|Overall Study||61
10168978|NCT03021668|11299010|FG000|NOT COMPLETED|Overall Study||0
10168979|NCT03021668|11299011|FG001|NOT COMPLETED|Overall Study||1
10168980|NCT03021759|11299020|FG000|STARTED|Overall Study||1566
10168981|NCT03021759|11299021|FG001|STARTED|Overall Study||1743
10168982|NCT03021759|11299022|FG002|STARTED|Overall Study||1465
10168983|NCT03021759|11299020|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
10168984|NCT03021759|11299021|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
10168985|NCT03021759|11299022|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
10168986|NCT03021759|11299020|FG000|NOT COMPLETED|Overall Study||0
10168987|NCT03021759|11299021|FG001|NOT COMPLETED|Overall Study||0
10168988|NCT03021759|11299022|FG002|NOT COMPLETED|Overall Study||0
10168989|NCT03022045|11299032|FG000|STARTED|Overall Study||9
10168990|NCT03022045|11299033|FG001|STARTED|Overall Study||8
10168991|NCT03022045|11299032|FG000|COMPLETED|Overall Study||8
10168992|NCT03022045|11299033|FG001|COMPLETED|Overall Study||6
10168993|NCT03022045|11299032|FG000|NOT COMPLETED|Overall Study||1
10168994|NCT03022045|11299033|FG001|NOT COMPLETED|Overall Study||2
10168995|NCT03022084|11299045|FG000|STARTED|Overall Study||29
10168996|NCT03022084|11299046|FG001|STARTED|Overall Study||32
10168997|NCT03022084|11299045|FG000|COMPLETED|Overall Study||27
10168998|NCT03022084|11299046|FG001|COMPLETED|Overall Study||29
10168999|NCT03022084|11299045|FG000|NOT COMPLETED|Overall Study||2
10169000|NCT03022084|11299046|FG001|NOT COMPLETED|Overall Study||3
10169001|NCT03022370|11299056|FG000|STARTED|Overall Study||677
10169002|NCT03022370|11299057|FG001|STARTED|Overall Study||674
10169003|NCT03022370|11299056|FG000|COMPLETED|Overall Study||497
10169004|NCT03022370|11299057|FG001|COMPLETED|Overall Study||553
10169005|NCT03022370|11299056|FG000|NOT COMPLETED|Overall Study||180
10169006|NCT03022370|11299057|FG001|NOT COMPLETED|Overall Study||121
10169007|NCT03022396|11299073|FG000|STARTED|Overall Study||16
10169008|NCT03022396|11299074|FG001|STARTED|Overall Study||14
10169009|NCT03022396|11299075|FG002|STARTED|Overall Study||10
10169010|NCT03022396|11299076|FG003|STARTED|Overall Study||20
10169011|NCT03022396|11299077|FG004|STARTED|Overall Study||14
10169012|NCT03022396|11299078|FG005|STARTED|Overall Study||8
10169013|NCT03022396|11299073|FG000|COMPLETED|Overall Study||16
10169014|NCT03022396|11299074|FG001|COMPLETED|Overall Study||14
10169015|NCT03022396|11299075|FG002|COMPLETED|Overall Study||10
10169016|NCT03022396|11299076|FG003|COMPLETED|Overall Study||20
10169017|NCT03022396|11299077|FG004|COMPLETED|Overall Study||14
10169018|NCT03022396|11299078|FG005|COMPLETED|Overall Study||8
10169019|NCT03022396|11299073|FG000|NOT COMPLETED|Overall Study||0
10169020|NCT03022396|11299074|FG001|NOT COMPLETED|Overall Study||0
10169021|NCT03022396|11299075|FG002|NOT COMPLETED|Overall Study||0
10169022|NCT03022396|11299076|FG003|NOT COMPLETED|Overall Study||0
10169023|NCT03022396|11299077|FG004|NOT COMPLETED|Overall Study||0
10169024|NCT03022396|11299078|FG005|NOT COMPLETED|Overall Study||0
10169025|NCT03022422|11299098|FG000|STARTED|Overall Study||8
10169026|NCT03022422|11299099|FG001|STARTED|Overall Study||10
10169027|NCT03022422|11299100|FG002|STARTED|Overall Study||23
10169028|NCT03022422|11299101|FG003|STARTED|Overall Study||12
10169029|NCT03022422|11299102|FG004|STARTED|Overall Study||5
10169030|NCT03022422|11299103|FG005|STARTED|Overall Study||5
10169031|NCT03022422|11299098|FG000|COMPLETED|Overall Study||8
10169032|NCT03022422|11299099|FG001|COMPLETED|Overall Study||10
10169033|NCT03022422|11299100|FG002|COMPLETED|Overall Study||20
10169034|NCT03022422|11299101|FG003|COMPLETED|Overall Study||12
10169035|NCT03022422|11299102|FG004|COMPLETED|Overall Study||5
10169036|NCT03022422|11299103|FG005|COMPLETED|Overall Study||5
10169037|NCT03022422|11299098|FG000|NOT COMPLETED|Overall Study||0
10169038|NCT03022422|11299099|FG001|NOT COMPLETED|Overall Study||0
10169039|NCT03022422|11299100|FG002|NOT COMPLETED|Overall Study||3
10169040|NCT03022422|11299101|FG003|NOT COMPLETED|Overall Study||0
10169041|NCT03022422|11299102|FG004|NOT COMPLETED|Overall Study||0
10169042|NCT03022422|11299103|FG005|NOT COMPLETED|Overall Study||0
10169043|NCT03022435|11299124|FG000|STARTED|Overall Study||5
10169044|NCT03022435|11299125|FG001|STARTED|Overall Study||5
10169045|NCT03022435|11299126|FG002|STARTED|Overall Study||6
10169046|NCT03022435|11299127|FG003|STARTED|Overall Study||3
10169047|NCT03022435|11299128|FG004|STARTED|Overall Study||3
10169048|NCT03022435|11299124|FG000|COMPLETED|Overall Study||5
10169049|NCT03022435|11299125|FG001|COMPLETED|Overall Study||5
10169050|NCT03022435|11299126|FG002|COMPLETED|Overall Study||6
10169051|NCT03022435|11299127|FG003|COMPLETED|Overall Study||3
10169052|NCT03022435|11299128|FG004|COMPLETED|Overall Study||3
10169053|NCT03022435|11299124|FG000|NOT COMPLETED|Overall Study||0
10169054|NCT03022435|11299125|FG001|NOT COMPLETED|Overall Study||0
10169055|NCT03022435|11299126|FG002|NOT COMPLETED|Overall Study||0
10169056|NCT03022435|11299127|FG003|NOT COMPLETED|Overall Study||0
10169057|NCT03022435|11299128|FG004|NOT COMPLETED|Overall Study||0
10169058|NCT03022526|11299145|FG000|STARTED|Overall Study||31
10169059|NCT03022526|11299146|FG001|STARTED|Overall Study||30
9712033|NCT02810418|10811624|FG004|NOT COMPLETED|Arm A Dose Escalation||0
9712034|NCT02810418|10811625|FG005|NOT COMPLETED|Arm A Dose Escalation||0
9712035|NCT02810418|10811626|FG006|NOT COMPLETED|Arm A Dose Escalation||0
9712036|NCT02810418|10811620|FG000|STARTED|Dose Expansion||0
9712037|NCT02810418|10811621|FG001|STARTED|Dose Expansion||8
9712038|NCT02810418|10811622|FG002|STARTED|Dose Expansion||6
9712039|NCT02810418|10811623|FG003|STARTED|Dose Expansion||0
9712040|NCT02810418|10811624|FG004|STARTED|Dose Expansion||0
9712041|NCT02810418|10811625|FG005|STARTED|Dose Expansion||0
9712042|NCT02810418|10811626|FG006|STARTED|Dose Expansion||0
9712043|NCT02810418|10811620|FG000|COMPLETED|Dose Expansion||0
9712044|NCT02810418|10811621|FG001|COMPLETED|Dose Expansion||7
9712045|NCT02810418|10811622|FG002|COMPLETED|Dose Expansion||3
9712046|NCT02810418|10811623|FG003|COMPLETED|Dose Expansion||0
9712047|NCT02810418|10811624|FG004|COMPLETED|Dose Expansion||0
9712048|NCT02810418|10811625|FG005|COMPLETED|Dose Expansion||0
9712049|NCT02810418|10811626|FG006|COMPLETED|Dose Expansion||0
9712050|NCT02810418|10811620|FG000|NOT COMPLETED|Dose Expansion||0
9712051|NCT02810418|10811621|FG001|NOT COMPLETED|Dose Expansion||1
9712052|NCT02810418|10811622|FG002|NOT COMPLETED|Dose Expansion||3
9712053|NCT02810418|10811623|FG003|NOT COMPLETED|Dose Expansion||0
9712054|NCT02810418|10811624|FG004|NOT COMPLETED|Dose Expansion||0
9712055|NCT02810418|10811625|FG005|NOT COMPLETED|Dose Expansion||0
9712056|NCT02810418|10811626|FG006|NOT COMPLETED|Dose Expansion||0
9712057|NCT02810418|10811620|FG000|STARTED|Arm B Dose Escalation||0
9712058|NCT02810418|10811621|FG001|STARTED|Arm B Dose Escalation||0
9712059|NCT02810418|10811622|FG002|STARTED|Arm B Dose Escalation||0
9712060|NCT02810418|10811623|FG003|STARTED|Arm B Dose Escalation||6
9712061|NCT02810418|10811624|FG004|STARTED|Arm B Dose Escalation||3
9712062|NCT02810418|10811625|FG005|STARTED|Arm B Dose Escalation||6
9712063|NCT02810418|10811626|FG006|STARTED|Arm B Dose Escalation||0
9712064|NCT02810418|10811620|FG000|COMPLETED|Arm B Dose Escalation||0
9712065|NCT02810418|10811621|FG001|COMPLETED|Arm B Dose Escalation||0
9712066|NCT02810418|10811622|FG002|COMPLETED|Arm B Dose Escalation||0
9712067|NCT02810418|10811623|FG003|COMPLETED|Arm B Dose Escalation||6
9712068|NCT02810418|10811624|FG004|COMPLETED|Arm B Dose Escalation||2
9712069|NCT02810418|10811625|FG005|COMPLETED|Arm B Dose Escalation||4
9712070|NCT02810418|10811626|FG006|COMPLETED|Arm B Dose Escalation||0
9712071|NCT02810418|10811620|FG000|NOT COMPLETED|Arm B Dose Escalation||0
9712072|NCT02810418|10811621|FG001|NOT COMPLETED|Arm B Dose Escalation||0
9712073|NCT02810418|10811622|FG002|NOT COMPLETED|Arm B Dose Escalation||0
9712074|NCT02810418|10811623|FG003|NOT COMPLETED|Arm B Dose Escalation||0
9712075|NCT02810418|10811624|FG004|NOT COMPLETED|Arm B Dose Escalation||1
10169060|NCT03022526|11299145|FG000|COMPLETED|Overall Study||21
10169061|NCT03022526|11299146|FG001|COMPLETED|Overall Study||25
10169062|NCT03022526|11299145|FG000|NOT COMPLETED|Overall Study||10
10169063|NCT03022526|11299146|FG001|NOT COMPLETED|Overall Study||5
10169064|NCT03022617|11299152|FG000|STARTED|Overall Study||12
10169065|NCT03022617|11299152|FG000|COMPLETED|Overall Study||6
10169066|NCT03022617|11299152|FG000|NOT COMPLETED|Overall Study||6
10169067|NCT03022630|11299158|FG000|STARTED|Overall Study||31
10169068|NCT03022630|11299159|FG001|STARTED|Overall Study||32
10169069|NCT03022630|11299158|FG000|COMPLETED|Overall Study||22
10169070|NCT03022630|11299159|FG001|COMPLETED|Overall Study||20
10169071|NCT03022630|11299158|FG000|NOT COMPLETED|Overall Study||9
10169072|NCT03022630|11299159|FG001|NOT COMPLETED|Overall Study||12
10169073|NCT03022799|11299183|FG000|STARTED|Overall Study||6
10169074|NCT03022799|11299184|FG001|STARTED|Overall Study||6
10169075|NCT03022799|11299185|FG002|STARTED|Overall Study||6
10169076|NCT03022799|11299186|FG003|STARTED|Overall Study||6
10169077|NCT03022799|11299187|FG004|STARTED|Overall Study||6
10169078|NCT03022799|11299188|FG005|STARTED|Overall Study||6
10169079|NCT03022799|11299189|FG006|STARTED|Overall Study||12
10169080|NCT03022799|11299190|FG007|STARTED|Overall Study||6
10169081|NCT03022799|11299191|FG008|STARTED|Overall Study||6
10169082|NCT03022799|11299192|FG009|STARTED|Overall Study||6
10169083|NCT03022799|11299193|FG010|STARTED|Overall Study||6
10169084|NCT03022799|11299194|FG011|STARTED|Overall Study||6
10169085|NCT03022799|11299195|FG012|STARTED|Overall Study||10
10169086|NCT03022799|11299183|FG000|COMPLETED|Overall Study||6
10169087|NCT03022799|11299184|FG001|COMPLETED|Overall Study||6
10169088|NCT03022799|11299185|FG002|COMPLETED|Overall Study||6
10169089|NCT03022799|11299186|FG003|COMPLETED|Overall Study||6
10169090|NCT03022799|11299187|FG004|COMPLETED|Overall Study||6
10169091|NCT03022799|11299188|FG005|COMPLETED|Overall Study||6
10169092|NCT03022799|11299189|FG006|COMPLETED|Overall Study||12
10169093|NCT03022799|11299190|FG007|COMPLETED|Overall Study||6
10169094|NCT03022799|11299191|FG008|COMPLETED|Overall Study||6
10169095|NCT03022799|11299192|FG009|COMPLETED|Overall Study||5
10169096|NCT03022799|11299193|FG010|COMPLETED|Overall Study||5
10169097|NCT03022799|11299194|FG011|COMPLETED|Overall Study||6
10169098|NCT03022799|11299195|FG012|COMPLETED|Overall Study||10
10169099|NCT03022799|11299183|FG000|NOT COMPLETED|Overall Study||0
10169100|NCT03022799|11299184|FG001|NOT COMPLETED|Overall Study||0
10169101|NCT03022799|11299185|FG002|NOT COMPLETED|Overall Study||0
10169102|NCT03022799|11299186|FG003|NOT COMPLETED|Overall Study||0
10169103|NCT03022799|11299187|FG004|NOT COMPLETED|Overall Study||0
10169104|NCT03022799|11299188|FG005|NOT COMPLETED|Overall Study||0
10169105|NCT03022799|11299189|FG006|NOT COMPLETED|Overall Study||0
10169106|NCT03022799|11299190|FG007|NOT COMPLETED|Overall Study||0
10169107|NCT03022799|11299191|FG008|NOT COMPLETED|Overall Study||0
10169108|NCT03022799|11299192|FG009|NOT COMPLETED|Overall Study||1
10169109|NCT03022799|11299193|FG010|NOT COMPLETED|Overall Study||1
10169110|NCT03022799|11299194|FG011|NOT COMPLETED|Overall Study||0
10169111|NCT03022799|11299195|FG012|NOT COMPLETED|Overall Study||0
10169112|NCT03022916|11299240|FG000|STARTED|Overall Study||5
10169113|NCT03022916|11299241|FG001|STARTED|Overall Study||5
10169114|NCT03022916|11299242|FG002|STARTED|Overall Study||5
10169115|NCT03022916|11299243|FG003|STARTED|Overall Study||5
10169116|NCT03022916|11299240|FG000|Nail Polish|Overall Study||5
10169117|NCT03022916|11299241|FG001|Nail Polish|Overall Study||5
10169118|NCT03022916|11299242|FG002|Nail Polish|Overall Study||5
10169119|NCT03022916|11299243|FG003|Nail Polish|Overall Study||5
10169120|NCT03022916|11299240|FG000|Nail Polish, Base Coat|Overall Study||5
10169121|NCT03022916|11299241|FG001|Nail Polish, Base Coat|Overall Study||5
10169122|NCT03022916|11299242|FG002|Nail Polish, Base Coat|Overall Study||5
10169123|NCT03022916|11299243|FG003|Nail Polish, Base Coat|Overall Study||5
10169124|NCT03022916|11299240|FG000|Nail Polish, Top Coat|Overall Study||5
10169125|NCT03022916|11299241|FG001|Nail Polish, Top Coat|Overall Study||5
9712076|NCT02810418|10811625|FG005|NOT COMPLETED|Arm B Dose Escalation||2
9712077|NCT02810418|10811626|FG006|NOT COMPLETED|Arm B Dose Escalation||0
9712078|NCT02810418|10811620|FG000|STARTED|Arm B Combination Therapy||0
9712079|NCT02810418|10811621|FG001|STARTED|Arm B Combination Therapy||0
9712080|NCT02810418|10811622|FG002|STARTED|Arm B Combination Therapy||0
9712081|NCT02810418|10811623|FG003|STARTED|Arm B Combination Therapy||0
9712082|NCT02810418|10811624|FG004|STARTED|Arm B Combination Therapy||0
9712083|NCT02810418|10811625|FG005|STARTED|Arm B Combination Therapy||0
9712084|NCT02810418|10811626|FG006|STARTED|Arm B Combination Therapy||5
9712085|NCT02810418|10811620|FG000|COMPLETED|Arm B Combination Therapy||0
9712086|NCT02810418|10811621|FG001|COMPLETED|Arm B Combination Therapy||0
9712087|NCT02810418|10811622|FG002|COMPLETED|Arm B Combination Therapy||0
9712088|NCT02810418|10811623|FG003|COMPLETED|Arm B Combination Therapy||0
9712089|NCT02810418|10811624|FG004|COMPLETED|Arm B Combination Therapy||0
9712090|NCT02810418|10811625|FG005|COMPLETED|Arm B Combination Therapy||0
9712091|NCT02810418|10811626|FG006|COMPLETED|Arm B Combination Therapy||5
9712092|NCT02810418|10811620|FG000|NOT COMPLETED|Arm B Combination Therapy||0
9712093|NCT02810418|10811621|FG001|NOT COMPLETED|Arm B Combination Therapy||0
9712094|NCT02810418|10811622|FG002|NOT COMPLETED|Arm B Combination Therapy||0
9712095|NCT02810418|10811623|FG003|NOT COMPLETED|Arm B Combination Therapy||0
9712096|NCT02810418|10811624|FG004|NOT COMPLETED|Arm B Combination Therapy||0
9712097|NCT02810418|10811625|FG005|NOT COMPLETED|Arm B Combination Therapy||0
9712098|NCT02810418|10811626|FG006|NOT COMPLETED|Arm B Combination Therapy||0
9731041|NCT00129480|10830950|FG000|STARTED|Overall Study||187
9731042|NCT00129480|10830951|FG001|STARTED|Overall Study||214
10169126|NCT03022916|11299242|FG002|Nail Polish, Top Coat|Overall Study||5
10169127|NCT03022916|11299243|FG003|Nail Polish, Top Coat|Overall Study||5
10169128|NCT03022916|11299240|FG000|COMPLETED|Overall Study||5
10169129|NCT03022916|11299241|FG001|COMPLETED|Overall Study||5
10169130|NCT03022916|11299242|FG002|COMPLETED|Overall Study||5
10169131|NCT03022916|11299243|FG003|COMPLETED|Overall Study||5
10169132|NCT03022916|11299240|FG000|NOT COMPLETED|Overall Study||0
10169133|NCT03022916|11299241|FG001|NOT COMPLETED|Overall Study||0
10169134|NCT03022916|11299242|FG002|NOT COMPLETED|Overall Study||0
10169135|NCT03022916|11299243|FG003|NOT COMPLETED|Overall Study||0
10169136|NCT03022981|11299253|FG000|STARTED|Overall Study||102
10169137|NCT03022981|11299254|FG001|STARTED|Overall Study||73
10169138|NCT03022981|11299255|FG002|STARTED|Overall Study||41
10169139|NCT03022981|11299253|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
10169140|NCT03022981|11299254|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
10169141|NCT03022981|11299255|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
10169142|NCT03022981|11299253|FG000|COMPLETED|Overall Study||96
10169143|NCT03022981|11299254|FG001|COMPLETED|Overall Study||69
10169144|NCT03022981|11299255|FG002|COMPLETED|Overall Study||35
10169145|NCT03022981|11299253|FG000|NOT COMPLETED|Overall Study||6
10169146|NCT03022981|11299254|FG001|NOT COMPLETED|Overall Study||4
10169147|NCT03022981|11299255|FG002|NOT COMPLETED|Overall Study||6
10169148|NCT03023137|11299275|FG000|STARTED|Overall Study||178
10169149|NCT03023137|11299276|FG001|STARTED|Overall Study||171
10169150|NCT03023137|11299275|FG000|COMPLETED|Overall Study||174
10169151|NCT03023137|11299276|FG001|COMPLETED|Overall Study||162
10169152|NCT03023137|11299275|FG000|NOT COMPLETED|Overall Study||4
10169153|NCT03023137|11299276|FG001|NOT COMPLETED|Overall Study||9
10169154|NCT03023176|11299283|FG000|STARTED|Overall Study||20
10169155|NCT03023176|11299283|FG000|COMPLETED|Overall Study||20
10169156|NCT03023176|11299283|FG000|NOT COMPLETED|Overall Study||0
10169157|NCT03023397|11299290|FG000|STARTED|Run-In||8
10169158|NCT03023397|11299291|FG001|STARTED|Run-In||3
10169159|NCT03023397|11299292|FG002|STARTED|Run-In||1
10169160|NCT03023397|11299290|FG000|COMPLETED|Run-In||6
10169161|NCT03023397|11299291|FG001|COMPLETED|Run-In||3
10169162|NCT03023397|11299292|FG002|COMPLETED|Run-In||1
10169163|NCT03023397|11299290|FG000|NOT COMPLETED|Run-In||2
10169164|NCT03023397|11299291|FG001|NOT COMPLETED|Run-In||0
10169165|NCT03023397|11299292|FG002|NOT COMPLETED|Run-In||0
10169166|NCT03023397|11299290|FG000|STARTED|Main Study||6
10169167|NCT03023397|11299291|FG001|STARTED|Main Study||3
10169168|NCT03023397|11299292|FG002|STARTED|Main Study||1
10169169|NCT03023397|11299290|FG000|COMPLETED|Main Study||6
10169170|NCT03023397|11299291|FG001|COMPLETED|Main Study||3
10169171|NCT03023397|11299292|FG002|COMPLETED|Main Study||1
10169172|NCT03023397|11299290|FG000|NOT COMPLETED|Main Study||0
10169173|NCT03023397|11299291|FG001|NOT COMPLETED|Main Study||0
10169174|NCT03023397|11299292|FG002|NOT COMPLETED|Main Study||0
10169175|NCT03023423|11299304|FG000|STARTED|Overall Study||7
10169176|NCT03023423|11299305|FG001|STARTED|Overall Study||46
10169177|NCT03023423|11299306|FG002|STARTED|Overall Study||46
10169178|NCT03023423|11299304|FG000|Treated|Overall Study||7
10169179|NCT03023423|11299305|FG001|Treated|Overall Study||44
10169180|NCT03023423|11299306|FG002|Treated|Overall Study||44
10169181|NCT03023423|11299304|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0
10169182|NCT03023423|11299305|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
10169183|NCT03023423|11299306|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0
10169184|NCT03023423|11299304|FG000|COMPLETED|Overall Study||0
10169185|NCT03023423|11299305|FG001|COMPLETED|Overall Study||0
10169186|NCT03023423|11299306|FG002|COMPLETED|Overall Study||0
10169187|NCT03023423|11299304|FG000|NOT COMPLETED|Overall Study||7
10169188|NCT03023423|11299305|FG001|NOT COMPLETED|Overall Study||46
10169189|NCT03023423|11299306|FG002|NOT COMPLETED|Overall Study||46
10169190|NCT03023488|11299318|FG000|STARTED|Overall Study||46
10169191|NCT03023488|11299318|FG000|COMPLETED|Overall Study||46
10169192|NCT03023488|11299318|FG000|NOT COMPLETED|Overall Study||0
10169193|NCT03023553|11299330|FG000|STARTED|Overall Study||4
10169194|NCT03023553|11299331|FG001|STARTED|Overall Study||9
10169195|NCT03023553|11299330|FG000|COMPLETED|Overall Study||4
10169196|NCT03023553|11299331|FG001|COMPLETED|Overall Study||8
10169197|NCT03023553|11299330|FG000|NOT COMPLETED|Overall Study||0
10169198|NCT03023553|11299331|FG001|NOT COMPLETED|Overall Study||1
10169199|NCT03023683|11299339|FG000|STARTED|Overall Study||0
10169200|NCT03023683|11299340|FG001|STARTED|Overall Study||18
10169201|NCT03023683|11299339|FG000|COMPLETED|Overall Study||0
10169202|NCT03023683|11299340|FG001|COMPLETED|Overall Study||17
10169203|NCT03023683|11299339|FG000|NOT COMPLETED|Overall Study||0
10169204|NCT03023683|11299340|FG001|NOT COMPLETED|Overall Study||1
10169205|NCT03023709|11299348|FG000|STARTED|Overall Study||3
10169206|NCT03023709|11299349|FG001|STARTED|Overall Study||0
10169207|NCT03023709|11299348|FG000|COMPLETED|Overall Study||3
10169208|NCT03023709|11299349|FG001|COMPLETED|Overall Study||0
10169209|NCT03023709|11299348|FG000|NOT COMPLETED|Overall Study||0
10169210|NCT03023709|11299349|FG001|NOT COMPLETED|Overall Study||0
10169211|NCT03023722|11299357|FG000|STARTED|Overall Study||18
10169212|NCT03023722|11299357|FG000|COMPLETED|Overall Study||14
10169213|NCT03023722|11299357|FG000|NOT COMPLETED|Overall Study||4
10169214|NCT03023826|11299361|FG000|STARTED|Period 1||4
10169215|NCT03023826|11299362|FG001|STARTED|Period 1||4
10169216|NCT03023826|11299363|FG002|STARTED|Period 1||5
10169217|NCT03023826|11299364|FG003|STARTED|Period 1||4
10169218|NCT03023826|11299365|FG004|STARTED|Period 1||4
10169219|NCT03023826|11299366|FG005|STARTED|Period 1||5
10169220|NCT03023826|11299361|FG000|Received at Least One Dose of Study Drug|Period 1||4
10169221|NCT03023826|11299362|FG001|Received at Least One Dose of Study Drug|Period 1||4
10169222|NCT03023826|11299363|FG002|Received at Least One Dose of Study Drug|Period 1||5
10169223|NCT03023826|11299364|FG003|Received at Least One Dose of Study Drug|Period 1||4
10169224|NCT03023826|11299365|FG004|Received at Least One Dose of Study Drug|Period 1||4
10169225|NCT03023826|11299366|FG005|Received at Least One Dose of Study Drug|Period 1||5
10169226|NCT03023826|11299361|FG000|COMPLETED|Period 1||4
10169227|NCT03023826|11299362|FG001|COMPLETED|Period 1||4
10169228|NCT03023826|11299363|FG002|COMPLETED|Period 1||5
10169229|NCT03023826|11299364|FG003|COMPLETED|Period 1||4
10169230|NCT03023826|11299365|FG004|COMPLETED|Period 1||3
10169231|NCT03023826|11299366|FG005|COMPLETED|Period 1||5
10169232|NCT03023826|11299361|FG000|NOT COMPLETED|Period 1||0
10169233|NCT03023826|11299362|FG001|NOT COMPLETED|Period 1||0
10169234|NCT03023826|11299363|FG002|NOT COMPLETED|Period 1||0
10169235|NCT03023826|11299364|FG003|NOT COMPLETED|Period 1||0
10169236|NCT03023826|11299365|FG004|NOT COMPLETED|Period 1||1
10169237|NCT03023826|11299366|FG005|NOT COMPLETED|Period 1||0
10169238|NCT03023826|11299361|FG000|STARTED|Period 2||4
10169239|NCT03023826|11299362|FG001|STARTED|Period 2||4
10169240|NCT03023826|11299363|FG002|STARTED|Period 2||5
10169241|NCT03023826|11299364|FG003|STARTED|Period 2||4
10169242|NCT03023826|11299365|FG004|STARTED|Period 2||3
10169243|NCT03023826|11299366|FG005|STARTED|Period 2||5
10169244|NCT03023826|11299361|FG000|COMPLETED|Period 2||4
10169245|NCT03023826|11299362|FG001|COMPLETED|Period 2||4
10169246|NCT03023826|11299363|FG002|COMPLETED|Period 2||5
10169247|NCT03023826|11299364|FG003|COMPLETED|Period 2||4
10169248|NCT03023826|11299365|FG004|COMPLETED|Period 2||3
10169249|NCT03023826|11299366|FG005|COMPLETED|Period 2||5
10169250|NCT03023826|11299361|FG000|NOT COMPLETED|Period 2||0
10169251|NCT03023826|11299362|FG001|NOT COMPLETED|Period 2||0
10169252|NCT03023826|11299363|FG002|NOT COMPLETED|Period 2||0
10169253|NCT03023826|11299364|FG003|NOT COMPLETED|Period 2||0
10169254|NCT03023826|11299365|FG004|NOT COMPLETED|Period 2||0
10169255|NCT03023826|11299366|FG005|NOT COMPLETED|Period 2||0
10169256|NCT03023826|11299361|FG000|STARTED|Period 3||4
10169257|NCT03023826|11299362|FG001|STARTED|Period 3||4
10169258|NCT03023826|11299363|FG002|STARTED|Period 3||5
10169259|NCT03023826|11299364|FG003|STARTED|Period 3||4
10169260|NCT03023826|11299365|FG004|STARTED|Period 3||3
10169261|NCT03023826|11299366|FG005|STARTED|Period 3||5
10169262|NCT03023826|11299361|FG000|COMPLETED|Period 3||4
10169263|NCT03023826|11299362|FG001|COMPLETED|Period 3||4
10169264|NCT03023826|11299363|FG002|COMPLETED|Period 3||5
10169265|NCT03023826|11299364|FG003|COMPLETED|Period 3||4
10169266|NCT03023826|11299365|FG004|COMPLETED|Period 3||3
10169267|NCT03023826|11299366|FG005|COMPLETED|Period 3||5
10169268|NCT03023826|11299361|FG000|NOT COMPLETED|Period 3||0
10169269|NCT03023826|11299362|FG001|NOT COMPLETED|Period 3||0
10169270|NCT03023826|11299363|FG002|NOT COMPLETED|Period 3||0
10169271|NCT03023826|11299364|FG003|NOT COMPLETED|Period 3||0
10169272|NCT03023826|11299365|FG004|NOT COMPLETED|Period 3||0
10169273|NCT03023826|11299366|FG005|NOT COMPLETED|Period 3||0
10169274|NCT03023878|11299374|FG000|STARTED|Pre-Study Run-In Period||47
10169275|NCT03023878|11299374|FG000|COMPLETED|Pre-Study Run-In Period||30
10169276|NCT03023878|11299374|FG000|NOT COMPLETED|Pre-Study Run-In Period||17
10169277|NCT03023878|11299374|FG000|STARTED|Between Run-In and Treatment Periods||30
10169278|NCT03023878|11299374|FG000|COMPLETED|Between Run-In and Treatment Periods||28
10169279|NCT03023878|11299374|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2
10169280|NCT03023878|11299374|FG000|STARTED|Treatment Period||28
10169281|NCT03023878|11299374|FG000|Started Cycle 1|Treatment Period||28
10169282|NCT03023878|11299374|FG000|Started Cycle 2|Treatment Period||11
10169283|NCT03023878|11299374|FG000|COMPLETED|Treatment Period||25
10169284|NCT03023878|11299374|FG000|NOT COMPLETED|Treatment Period||3
10169285|NCT03023878|11299374|FG000|STARTED|Long Term Follow-Up Period||28
10169286|NCT03023878|11299374|FG000|COMPLETED|Long Term Follow-Up Period||26
10169287|NCT03023878|11299374|FG000|NOT COMPLETED|Long Term Follow-Up Period||2
10169288|NCT03023891|11299378|FG000|STARTED|Overall Study||18
10169289|NCT03023891|11299378|FG000|COMPLETED|Overall Study||18
10169290|NCT03023891|11299378|FG000|NOT COMPLETED|Overall Study||0
10169291|NCT03024112|11299384|FG000|STARTED|Overall Study||25
10169292|NCT03024112|11299385|FG001|STARTED|Overall Study||26
10169293|NCT03024112|11299384|FG000|COMPLETED|Overall Study||18
10169294|NCT03024112|11299385|FG001|COMPLETED|Overall Study||26
10169295|NCT03024112|11299384|FG000|NOT COMPLETED|Overall Study||7
10169296|NCT03024112|11299385|FG001|NOT COMPLETED|Overall Study||0
10169297|NCT03024606|11299393|FG000|STARTED|Overall Study||23
10169298|NCT03024606|11299394|FG001|STARTED|Overall Study||26
10169299|NCT03024606|11299393|FG000|COMPLETED|Overall Study||14
10169300|NCT03024606|11299394|FG001|COMPLETED|Overall Study||16
10169301|NCT03024606|11299393|FG000|NOT COMPLETED|Overall Study||9
10169302|NCT03024606|11299394|FG001|NOT COMPLETED|Overall Study||10
10169303|NCT03024970|11299400|FG000|STARTED|First Intervention||34
10169304|NCT03024970|11299401|FG001|STARTED|First Intervention||38
10169305|NCT03024970|11299400|FG000|COMPLETED|First Intervention||33
10169306|NCT03024970|11299401|FG001|COMPLETED|First Intervention||38
10169307|NCT03024970|11299400|FG000|NOT COMPLETED|First Intervention||1
10169308|NCT03024970|11299401|FG001|NOT COMPLETED|First Intervention||0
10169309|NCT03024970|11299400|FG000|STARTED|Second Intervention||33
10169310|NCT03024970|11299401|FG001|STARTED|Second Intervention||38
10169311|NCT03024970|11299400|FG000|COMPLETED|Second Intervention||32
10169312|NCT03024970|11299401|FG001|COMPLETED|Second Intervention||38
10169313|NCT03024970|11299400|FG000|NOT COMPLETED|Second Intervention||1
10169314|NCT03024970|11299401|FG001|NOT COMPLETED|Second Intervention||0
10169315|NCT03025217|11299407|FG000|STARTED|Overall Study||31
10169316|NCT03025217|11299407|FG000|COMPLETED|Overall Study||27
10169317|NCT03025217|11299407|FG000|NOT COMPLETED|Overall Study||4
10169318|NCT03025945|11299413|FG000|STARTED|Overall Study||331
10169319|NCT03025945|11299414|FG001|STARTED|Overall Study||331
10169320|NCT03025945|11299413|FG000|COMPLETED|Overall Study||331
10169321|NCT03025945|11299414|FG001|COMPLETED|Overall Study||331
10169322|NCT03025945|11299413|FG000|NOT COMPLETED|Overall Study||0
10169323|NCT03025945|11299414|FG001|NOT COMPLETED|Overall Study||0
10169324|NCT03026075|11299420|FG000|STARTED|Overall Study||47
10169325|NCT03026075|11299420|FG000|COMPLETED|Overall Study||46
10169326|NCT03026075|11299420|FG000|NOT COMPLETED|Overall Study||1
10169327|NCT03026088|11299424|FG000|STARTED|Overall Study||20
10169328|NCT03026088|11299424|FG000|COMPLETED|Overall Study||0
10169329|NCT03026088|11299424|FG000|NOT COMPLETED|Overall Study||20
10169330|NCT03026166|11299430|FG000|STARTED|Overall Study||30
10169331|NCT03026166|11299431|FG001|STARTED|Overall Study||12
10169332|NCT03026166|11299430|FG000|COMPLETED|Overall Study||0
10169333|NCT03026166|11299431|FG001|COMPLETED|Overall Study||0
10169334|NCT03026166|11299430|FG000|NOT COMPLETED|Overall Study||30
10169335|NCT03026166|11299431|FG001|NOT COMPLETED|Overall Study||12
10169336|NCT03026257|11299443|FG000|STARTED|Overall Study||60
10169337|NCT03026257|11299444|FG001|STARTED|Overall Study||64
10169338|NCT03026257|11299445|FG002|STARTED|Overall Study||34
10169339|NCT03026257|11299446|FG003|STARTED|Overall Study||25
10169340|NCT03026257|11299447|FG004|STARTED|Overall Study||23
10169341|NCT03026257|11299448|FG005|STARTED|Overall Study||46
10169342|NCT03026257|11299443|FG000|Treated|Overall Study||58
10169343|NCT03026257|11299444|FG001|Treated|Overall Study||65
10169344|NCT03026257|11299445|FG002|Treated|Overall Study||35
10169345|NCT03026257|11299446|FG003|Treated|Overall Study||24
10169346|NCT03026257|11299447|FG004|Treated|Overall Study||23
10169347|NCT03026257|11299448|FG005|Treated|Overall Study||47
10169348|NCT03026257|11299443|FG000|COMPLETED|Overall Study||54
10169349|NCT03026257|11299444|FG001|COMPLETED|Overall Study||63
10169350|NCT03026257|11299445|FG002|COMPLETED|Overall Study||34
10169351|NCT03026257|11299446|FG003|COMPLETED|Overall Study||24
10169352|NCT03026257|11299447|FG004|COMPLETED|Overall Study||22
10169353|NCT03026257|11299448|FG005|COMPLETED|Overall Study||46
10169354|NCT03026257|11299443|FG000|NOT COMPLETED|Overall Study||6
10169355|NCT03026257|11299444|FG001|NOT COMPLETED|Overall Study||1
10169356|NCT03026257|11299445|FG002|NOT COMPLETED|Overall Study||0
10169357|NCT03026257|11299446|FG003|NOT COMPLETED|Overall Study||1
10169358|NCT03026257|11299447|FG004|NOT COMPLETED|Overall Study||1
10169359|NCT03026257|11299448|FG005|NOT COMPLETED|Overall Study||0
10169360|NCT03026283|11299462|FG000|STARTED|CCTA Diagnosis||586
10169361|NCT03026283|11299463|FG001|STARTED|CCTA Diagnosis||0
10169362|NCT03026283|11299464|FG002|STARTED|CCTA Diagnosis||0
10169363|NCT03026283|11299465|FG003|STARTED|CCTA Diagnosis||0
10169364|NCT03026283|11299466|FG004|STARTED|CCTA Diagnosis||0
10169365|NCT03026283|11299467|FG005|STARTED|CCTA Diagnosis||0
10169366|NCT03026283|11299468|FG006|STARTED|CCTA Diagnosis||0
10169367|NCT03026283|11299469|FG007|STARTED|CCTA Diagnosis||0
10169368|NCT03026283|11299462|FG000|COMPLETED|CCTA Diagnosis||572
10169369|NCT03026283|11299463|FG001|COMPLETED|CCTA Diagnosis||0
10169370|NCT03026283|11299464|FG002|COMPLETED|CCTA Diagnosis||0
10169371|NCT03026283|11299465|FG003|COMPLETED|CCTA Diagnosis||0
9712099|NCT02785991|10811689|FG000|STARTED|Overall Study||1742
9712100|NCT02785991|10811689|FG000|COMPLETED|Overall Study||1741
9712101|NCT02785991|10811689|FG000|NOT COMPLETED|Overall Study||1
9712102|NCT02781584|10811707|FG000|STARTED|Pre-treatment Phase||0
9712103|NCT02781584|10811708|FG001|STARTED|Pre-treatment Phase||0
9712104|NCT02781584|10811709|FG002|STARTED|Pre-treatment Phase||0
9712105|NCT02781584|10811710|FG003|STARTED|Pre-treatment Phase||0
9712106|NCT02781584|10811711|FG004|STARTED|Pre-treatment Phase||0
9712107|NCT02781584|10811712|FG005|STARTED|Pre-treatment Phase||0
9712108|NCT02781584|10811713|FG006|STARTED|Pre-treatment Phase||0
9712109|NCT02781584|10811714|FG007|STARTED|Pre-treatment Phase||0
9712110|NCT02781584|10811715|FG008|STARTED|Pre-treatment Phase||0
9712111|NCT02781584|10811716|FG009|STARTED|Pre-treatment Phase||15
9712112|NCT02781584|10811717|FG010|STARTED|Pre-treatment Phase||16
9712113|NCT02781584|10811718|FG011|STARTED|Pre-treatment Phase||33
9712114|NCT02781584|10811719|FG012|STARTED|Pre-treatment Phase||33
9712115|NCT02781584|10811707|FG000|COMPLETED|Pre-treatment Phase||0
9712116|NCT02781584|10811708|FG001|COMPLETED|Pre-treatment Phase||0
9712117|NCT02781584|10811709|FG002|COMPLETED|Pre-treatment Phase||0
9712118|NCT02781584|10811710|FG003|COMPLETED|Pre-treatment Phase||0
9712119|NCT02781584|10811711|FG004|COMPLETED|Pre-treatment Phase||0
9712120|NCT02781584|10811712|FG005|COMPLETED|Pre-treatment Phase||0
9712121|NCT02781584|10811713|FG006|COMPLETED|Pre-treatment Phase||0
9712122|NCT02781584|10811714|FG007|COMPLETED|Pre-treatment Phase||0
9712123|NCT02781584|10811715|FG008|COMPLETED|Pre-treatment Phase||0
9712124|NCT02781584|10811716|FG009|COMPLETED|Pre-treatment Phase||15
10169372|NCT03026283|11299466|FG004|COMPLETED|CCTA Diagnosis||0
10169373|NCT03026283|11299467|FG005|COMPLETED|CCTA Diagnosis||0
10169374|NCT03026283|11299468|FG006|COMPLETED|CCTA Diagnosis||0
10169375|NCT03026283|11299469|FG007|COMPLETED|CCTA Diagnosis||0
10169376|NCT03026283|11299462|FG000|NOT COMPLETED|CCTA Diagnosis||14
10169377|NCT03026283|11299463|FG001|NOT COMPLETED|CCTA Diagnosis||0
10169378|NCT03026283|11299464|FG002|NOT COMPLETED|CCTA Diagnosis||0
10169379|NCT03026283|11299465|FG003|NOT COMPLETED|CCTA Diagnosis||0
10169380|NCT03026283|11299466|FG004|NOT COMPLETED|CCTA Diagnosis||0
10169381|NCT03026283|11299467|FG005|NOT COMPLETED|CCTA Diagnosis||0
10169382|NCT03026283|11299468|FG006|NOT COMPLETED|CCTA Diagnosis||0
10169383|NCT03026283|11299469|FG007|NOT COMPLETED|CCTA Diagnosis||0
10169384|NCT03026283|11299462|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10169385|NCT03026283|11299463|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
10169386|NCT03026283|11299464|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
10169387|NCT03026283|11299465|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10169388|NCT03026283|11299466|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10169389|NCT03026283|11299467|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10169390|NCT03026283|11299468|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10169391|NCT03026283|11299469|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10169392|NCT03026283|11299462|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169393|NCT03026283|11299463|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
10169394|NCT03026283|11299464|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
10169395|NCT03026283|11299465|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169396|NCT03026283|11299466|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169397|NCT03026283|11299467|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169398|NCT03026283|11299468|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169399|NCT03026283|11299469|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169400|NCT03026283|11299462|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169401|NCT03026283|11299463|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
10169402|NCT03026283|11299464|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
10169403|NCT03026283|11299465|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169404|NCT03026283|11299466|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169405|NCT03026283|11299467|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169406|NCT03026283|11299468|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169407|NCT03026283|11299469|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10169408|NCT03026283|11299462|FG000|STARTED|Optimal Care/Stress Test/ICA||0
10169409|NCT03026283|11299463|FG001|STARTED|Optimal Care/Stress Test/ICA||0
9712125|NCT02781584|10811717|FG010|COMPLETED|Pre-treatment Phase||16
9712126|NCT02781584|10811718|FG011|COMPLETED|Pre-treatment Phase||30
9712127|NCT02781584|10811719|FG012|COMPLETED|Pre-treatment Phase||32
9712128|NCT02781584|10811707|FG000|NOT COMPLETED|Pre-treatment Phase||0
9712129|NCT02781584|10811708|FG001|NOT COMPLETED|Pre-treatment Phase||0
9712130|NCT02781584|10811709|FG002|NOT COMPLETED|Pre-treatment Phase||0
9712131|NCT02781584|10811710|FG003|NOT COMPLETED|Pre-treatment Phase||0
9712132|NCT02781584|10811711|FG004|NOT COMPLETED|Pre-treatment Phase||0
9712133|NCT02781584|10811712|FG005|NOT COMPLETED|Pre-treatment Phase||0
9712134|NCT02781584|10811713|FG006|NOT COMPLETED|Pre-treatment Phase||0
9712135|NCT02781584|10811714|FG007|NOT COMPLETED|Pre-treatment Phase||0
9712136|NCT02781584|10811715|FG008|NOT COMPLETED|Pre-treatment Phase||0
9712137|NCT02781584|10811716|FG009|NOT COMPLETED|Pre-treatment Phase||0
9712138|NCT02781584|10811717|FG010|NOT COMPLETED|Pre-treatment Phase||0
9712139|NCT02781584|10811718|FG011|NOT COMPLETED|Pre-treatment Phase||3
9712140|NCT02781584|10811719|FG012|NOT COMPLETED|Pre-treatment Phase||1
9712141|NCT02781584|10811707|FG000|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
9712142|NCT02781584|10811708|FG001|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
9712143|NCT02781584|10811709|FG002|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
9712144|NCT02781584|10811710|FG003|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
9712145|NCT02781584|10811711|FG004|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
9712146|NCT02781584|10811712|FG005|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
9712147|NCT02781584|10811713|FG006|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
9712148|NCT02781584|10811714|FG007|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
9712149|NCT02781584|10811715|FG008|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|13
9712150|NCT02781584|10811716|FG009|STARTED|Treatment Phase||15
9712151|NCT02781584|10811717|FG010|STARTED|Treatment Phase||16
9712152|NCT02781584|10811718|FG011|STARTED|Treatment Phase||30
9712153|NCT02781584|10811719|FG012|STARTED|Treatment Phase||32
9712154|NCT02781584|10811707|FG000|COMPLETED|Treatment Phase||10
9712155|NCT02781584|10811708|FG001|COMPLETED|Treatment Phase||10
9712156|NCT02781584|10811709|FG002|COMPLETED|Treatment Phase||10
9712157|NCT02781584|10811710|FG003|COMPLETED|Treatment Phase||20
9712158|NCT02781584|10811711|FG004|COMPLETED|Treatment Phase||20
9712159|NCT02781584|10811712|FG005|COMPLETED|Treatment Phase||19
9712160|NCT02781584|10811713|FG006|COMPLETED|Treatment Phase||10
9712161|NCT02781584|10811714|FG007|COMPLETED|Treatment Phase||9
9712162|NCT02781584|10811715|FG008|COMPLETED|Treatment Phase||13
9712163|NCT02781584|10811716|FG009|COMPLETED|Treatment Phase||15
9712164|NCT02781584|10811717|FG010|COMPLETED|Treatment Phase||15
9712165|NCT02781584|10811718|FG011|COMPLETED|Treatment Phase||28
9712166|NCT02781584|10811719|FG012|COMPLETED|Treatment Phase||32
9712167|NCT02781584|10811707|FG000|NOT COMPLETED|Treatment Phase||0
9712168|NCT02781584|10811708|FG001|NOT COMPLETED|Treatment Phase||0
9712169|NCT02781584|10811709|FG002|NOT COMPLETED|Treatment Phase||0
9712170|NCT02781584|10811710|FG003|NOT COMPLETED|Treatment Phase||0
9712171|NCT02781584|10811711|FG004|NOT COMPLETED|Treatment Phase||0
9849572|NCT00866320|10962313|FG000|STARTED|Overall Study||49
9849573|NCT00866320|10962313|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
9849574|NCT00866320|10962313|FG000|NOT COMPLETED|Overall Study||6
9849575|NCT00866333|10962322|FG000|STARTED|Overall Study||16
9849576|NCT00866333|10962323|FG001|STARTED|Overall Study||17
9849577|NCT00866333|10962324|FG002|STARTED|Overall Study||16
9849578|NCT00866333|10962322|FG000|COMPLETED|Overall Study||11
9849579|NCT00866333|10962323|FG001|COMPLETED|Overall Study||10
10169410|NCT03026283|11299464|FG002|STARTED|Optimal Care/Stress Test/ICA||0
10169411|NCT03026283|11299465|FG003|STARTED|Optimal Care/Stress Test/ICA||128
10169412|NCT03026283|11299466|FG004|STARTED|Optimal Care/Stress Test/ICA||52
10169413|NCT03026283|11299467|FG005|STARTED|Optimal Care/Stress Test/ICA||101
10169414|NCT03026283|11299468|FG006|STARTED|Optimal Care/Stress Test/ICA||0
10169415|NCT03026283|11299469|FG007|STARTED|Optimal Care/Stress Test/ICA||0
10169416|NCT03026283|11299462|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0
10169417|NCT03026283|11299463|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0
10169418|NCT03026283|11299464|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0
10169419|NCT03026283|11299465|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108
10169420|NCT03026283|11299466|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14
10169421|NCT03026283|11299467|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73
10169422|NCT03026283|11299468|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0
10169423|NCT03026283|11299469|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0
10169424|NCT03026283|11299462|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10169425|NCT03026283|11299463|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10169426|NCT03026283|11299464|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10169427|NCT03026283|11299465|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
10169428|NCT03026283|11299466|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
10169429|NCT03026283|11299467|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
10169430|NCT03026283|11299468|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10169431|NCT03026283|11299469|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10169432|NCT03026283|11299462|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0
10169433|NCT03026283|11299463|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0
10169434|NCT03026283|11299464|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0
10169435|NCT03026283|11299465|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0
10169436|NCT03026283|11299466|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0
10169437|NCT03026283|11299467|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0
10169438|NCT03026283|11299468|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21
10169439|NCT03026283|11299469|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0
10169440|NCT03026283|11299462|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169441|NCT03026283|11299463|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9712172|NCT02781584|10811712|FG005|NOT COMPLETED|Treatment Phase||1
9712173|NCT02781584|10811713|FG006|NOT COMPLETED|Treatment Phase||0
9712174|NCT02781584|10811714|FG007|NOT COMPLETED|Treatment Phase||1
9712175|NCT02781584|10811715|FG008|NOT COMPLETED|Treatment Phase||0
9712176|NCT02781584|10811716|FG009|NOT COMPLETED|Treatment Phase||0
9712177|NCT02781584|10811717|FG010|NOT COMPLETED|Treatment Phase||1
9712178|NCT02781584|10811718|FG011|NOT COMPLETED|Treatment Phase||2
9712179|NCT02781584|10811719|FG012|NOT COMPLETED|Treatment Phase||0
9712180|NCT02730130|10811747|FG000|STARTED|Overall Study||17
9712181|NCT02730130|10811747|FG000|COMPLETED|Overall Study||17
9712182|NCT02730130|10811747|FG000|NOT COMPLETED|Overall Study||0
9712183|NCT02714062|10811754|FG000|STARTED|Overall Study||14
9712184|NCT02714062|10811755|FG001|STARTED|Overall Study||15
9712185|NCT02714062|10811756|FG002|STARTED|Overall Study||13
9712186|NCT02714062|10811754|FG000|COMPLETED|Overall Study||13
9712187|NCT02714062|10811755|FG001|COMPLETED|Overall Study||14
9712188|NCT02714062|10811756|FG002|COMPLETED|Overall Study||10
9712189|NCT02714062|10811754|FG000|NOT COMPLETED|Overall Study||1
9712190|NCT02714062|10811755|FG001|NOT COMPLETED|Overall Study||1
9712191|NCT02714062|10811756|FG002|NOT COMPLETED|Overall Study||3
9712192|NCT02707055|10811768|FG000|STARTED|Phase 1||18
9712193|NCT02707055|10811769|FG001|STARTED|Phase 1||19
9712194|NCT02707055|10811768|FG000|COMPLETED|Phase 1||17
9712195|NCT02707055|10811769|FG001|COMPLETED|Phase 1||16
9712196|NCT02707055|10811768|FG000|NOT COMPLETED|Phase 1||1
9712197|NCT02707055|10811769|FG001|NOT COMPLETED|Phase 1||3
9712198|NCT02707055|10811768|FG000|STARTED|Washout Period||17
9712199|NCT02707055|10811769|FG001|STARTED|Washout Period||16
9712200|NCT02707055|10811768|FG000|COMPLETED|Washout Period||17
9712201|NCT02707055|10811769|FG001|COMPLETED|Washout Period||16
9712202|NCT02707055|10811768|FG000|NOT COMPLETED|Washout Period||0
9712203|NCT02707055|10811769|FG001|NOT COMPLETED|Washout Period||0
9712204|NCT02707055|10811768|FG000|STARTED|Phase 2||17
9712205|NCT02707055|10811769|FG001|STARTED|Phase 2||16
9712206|NCT02707055|10811768|FG000|COMPLETED|Phase 2||16
9712207|NCT02707055|10811769|FG001|COMPLETED|Phase 2||14
9712208|NCT02707055|10811768|FG000|NOT COMPLETED|Phase 2||1
9712209|NCT02707055|10811769|FG001|NOT COMPLETED|Phase 2||2
9712210|NCT02696759|10811775|FG000|STARTED|Overall Study||15
9712211|NCT02696759|10811775|FG000|COMPLETED|Overall Study||15
9712212|NCT02696759|10811775|FG000|NOT COMPLETED|Overall Study||0
9712213|NCT02656290|10811779|FG000|STARTED|Overall Study||26
9712214|NCT02656290|10811779|FG000|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
9712215|NCT02656290|10811779|FG000|2 Year|Overall Study||17
9712216|NCT02656290|10811779|FG000|3 Year|Overall Study||6
9712217|NCT02656290|10811779|FG000|COMPLETED|Overall Study||0
9712218|NCT02656290|10811779|FG000|NOT COMPLETED|Overall Study||26
9712219|NCT02652130|10811783|FG000|STARTED|Overall Study||32
9712220|NCT02652130|10811783|FG000|COMPLETED|Overall Study||31
9712221|NCT02652130|10811783|FG000|NOT COMPLETED|Overall Study||1
9712222|NCT02616393|10811790|FG000|STARTED|Overall Study||13
9712223|NCT02616393|10811791|FG001|STARTED|Overall Study||20
9712224|NCT02616393|10811792|FG002|STARTED|Overall Study||3
9712225|NCT02616393|10811790|FG000|COMPLETED|Overall Study||0
9712226|NCT02616393|10811791|FG001|COMPLETED|Overall Study||0
9712227|NCT02616393|10811792|FG002|COMPLETED|Overall Study||0
10169442|NCT03026283|11299464|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169443|NCT03026283|11299465|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169444|NCT03026283|11299466|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169445|NCT03026283|11299467|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169446|NCT03026283|11299468|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
10169447|NCT03026283|11299469|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169448|NCT03026283|11299462|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169449|NCT03026283|11299463|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169450|NCT03026283|11299464|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169451|NCT03026283|11299465|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169452|NCT03026283|11299466|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169453|NCT03026283|11299467|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169454|NCT03026283|11299468|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169455|NCT03026283|11299469|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10169456|NCT03026530|11299484|FG000|STARTED|Overall Study||100
10169457|NCT03026530|11299485|FG001|STARTED|Overall Study||100
10169458|NCT03026530|11299484|FG000|COMPLETED|Overall Study||79
10169459|NCT03026530|11299485|FG001|COMPLETED|Overall Study||71
10169460|NCT03026530|11299484|FG000|NOT COMPLETED|Overall Study||21
10169461|NCT03026530|11299485|FG001|NOT COMPLETED|Overall Study||29
10169462|NCT03026556|11299494|FG000|STARTED|Overall Study||12763
10169463|NCT03026556|11299495|FG001|STARTED|Overall Study||17177
10169464|NCT03026556|11299496|FG002|STARTED|Overall Study||12594
10169465|NCT03026556|11299494|FG000|COMPLETED|Overall Study||12763
10169466|NCT03026556|11299495|FG001|COMPLETED|Overall Study||17177
10169467|NCT03026556|11299496|FG002|COMPLETED|Overall Study||12594
10169468|NCT03026556|11299494|FG000|NOT COMPLETED|Overall Study||0
10169469|NCT03026556|11299495|FG001|NOT COMPLETED|Overall Study||0
10169470|NCT03026556|11299496|FG002|NOT COMPLETED|Overall Study||0
10169471|NCT03026777|11299507|FG000|STARTED|Overall Study||168
10169472|NCT03026777|11299508|FG001|STARTED|Overall Study||169
10169473|NCT03026777|11299507|FG000|COMPLETED|Overall Study||168
10169474|NCT03026777|11299508|FG001|COMPLETED|Overall Study||169
10169475|NCT03026777|11299507|FG000|NOT COMPLETED|Overall Study||0
10169476|NCT03026777|11299508|FG001|NOT COMPLETED|Overall Study||0
10169477|NCT03026803|11299514|FG000|STARTED|Overall Study||4
10169478|NCT03026803|11299514|FG000|COMPLETED|Overall Study||4
10169479|NCT03026803|11299514|FG000|NOT COMPLETED|Overall Study||0
10169480|NCT03027466|11299522|FG000|STARTED|Overall Study||2027
10169481|NCT03027466|11299523|FG001|STARTED|Overall Study||1984
10169482|NCT03027466|11299524|FG002|STARTED|Overall Study||1903
10169483|NCT03027466|11299525|FG003|STARTED|Overall Study||1985
10169484|NCT03027466|11299522|FG000|COMPLETED|Overall Study||158
10169485|NCT03027466|11299523|FG001|COMPLETED|Overall Study||165
10169486|NCT03027466|11299524|FG002|COMPLETED|Overall Study||160
10169487|NCT03027466|11299525|FG003|COMPLETED|Overall Study||164
10169488|NCT03027466|11299522|FG000|NOT COMPLETED|Overall Study||1869
10169489|NCT03027466|11299523|FG001|NOT COMPLETED|Overall Study||1819
10169490|NCT03027466|11299524|FG002|NOT COMPLETED|Overall Study||1743
10169491|NCT03027466|11299525|FG003|NOT COMPLETED|Overall Study||1821
10169492|NCT03027557|11299538|FG000|STARTED|Overall Study||15
10169493|NCT03027557|11299539|FG001|STARTED|Overall Study||16
10169494|NCT03027557|11299540|FG002|STARTED|Overall Study||15
10169495|NCT03027557|11299538|FG000|COMPLETED|Overall Study||14
10169496|NCT03027557|11299539|FG001|COMPLETED|Overall Study||16
10169497|NCT03027557|11299540|FG002|COMPLETED|Overall Study||15
10169498|NCT03027557|11299538|FG000|NOT COMPLETED|Overall Study||1
10169499|NCT03027557|11299539|FG001|NOT COMPLETED|Overall Study||0
10169500|NCT03027557|11299540|FG002|NOT COMPLETED|Overall Study||0
10169501|NCT03027661|11299550|FG000|STARTED|Overall Study||20
10169502|NCT03027661|11299551|FG001|STARTED|Overall Study||21
10169503|NCT03027661|11299550|FG000|COMPLETED|Overall Study||20
10169504|NCT03027661|11299551|FG001|COMPLETED|Overall Study||21
10169505|NCT03027661|11299550|FG000|NOT COMPLETED|Overall Study||0
10169506|NCT03027661|11299551|FG001|NOT COMPLETED|Overall Study||0
10169507|NCT03028012|11299560|FG000|STARTED|Overall Study||4
10169508|NCT03028012|11299561|FG001|STARTED|Overall Study||3
10169509|NCT03028012|11299562|FG002|STARTED|Overall Study||3
10169510|NCT03028012|11299560|FG000|COMPLETED|Overall Study||2
10169511|NCT03028012|11299561|FG001|COMPLETED|Overall Study||0
10169512|NCT03028012|11299562|FG002|COMPLETED|Overall Study||0
10169513|NCT03028012|11299560|FG000|NOT COMPLETED|Overall Study||2
10169514|NCT03028012|11299561|FG001|NOT COMPLETED|Overall Study||3
10169515|NCT03028012|11299562|FG002|NOT COMPLETED|Overall Study||3
10169516|NCT03028025|11299573|FG000|STARTED|Overall Study||90
10169517|NCT03028025|11299574|FG001|STARTED|Overall Study||94
9712228|NCT02616393|10811790|FG000|NOT COMPLETED|Overall Study||13
10169518|NCT03028025|11299573|FG000|COMPLETED|Overall Study||87
10169519|NCT03028025|11299574|FG001|COMPLETED|Overall Study||93
10169520|NCT03028025|11299573|FG000|NOT COMPLETED|Overall Study||3
10169521|NCT03028025|11299574|FG001|NOT COMPLETED|Overall Study||1
10169522|NCT03028103|11299582|FG000|STARTED|Overall Study||16
10169523|NCT03028103|11299583|FG001|STARTED|Overall Study||16
10169524|NCT03028103|11299582|FG000|COMPLETED|Overall Study||16
10169525|NCT03028103|11299583|FG001|COMPLETED|Overall Study||16
10169526|NCT03028103|11299582|FG000|NOT COMPLETED|Overall Study||0
10169527|NCT03028103|11299583|FG001|NOT COMPLETED|Overall Study||0
10169528|NCT03028129|11299595|FG000|STARTED|Overall Study||258
10169529|NCT03028129|11299596|FG001|STARTED|Overall Study||209
10169530|NCT03028129|11299595|FG000|COMPLETED|Overall Study||132
10169531|NCT03028129|11299596|FG001|COMPLETED|Overall Study||122
10169532|NCT03028129|11299595|FG000|NOT COMPLETED|Overall Study||126
10169533|NCT03028129|11299596|FG001|NOT COMPLETED|Overall Study||87
10197692|NCT03380845|11325713|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
10197693|NCT03380845|11325713|FG000|COMPLETED|Overall Study||4
10197694|NCT03380845|11325713|FG000|NOT COMPLETED|Overall Study||0
10197695|NCT03381196|11325721|FG000|STARTED|Overall Study||276
10197696|NCT03381196|11325722|FG001|STARTED|Overall Study||277
10197697|NCT03381196|11325721|FG000|Treated|Overall Study||273
10197698|NCT03381196|11325722|FG001|Treated|Overall Study||271
10197699|NCT03381196|11325721|FG000|COMPLETED|Overall Study||260
10197700|NCT03381196|11325722|FG001|COMPLETED|Overall Study||258
10197701|NCT03381196|11325721|FG000|NOT COMPLETED|Overall Study||16
10197702|NCT03381196|11325722|FG001|NOT COMPLETED|Overall Study||19
10197703|NCT03381248|11325730|FG000|STARTED|Overall Study||89
10197704|NCT03381248|11325731|FG001|STARTED|Overall Study||88
10197705|NCT03381248|11325730|FG000|COMPLETED|Overall Study||76
10197706|NCT03381248|11325731|FG001|COMPLETED|Overall Study||82
10197707|NCT03381248|11325730|FG000|NOT COMPLETED|Overall Study||13
10197708|NCT03381248|11325731|FG001|NOT COMPLETED|Overall Study||6
10197709|NCT03381339|11325739|FG000|STARTED|Overall Study||27
10197710|NCT03381339|11325740|FG001|STARTED|Overall Study||28
10197711|NCT03381339|11325739|FG000|COMPLETED|Overall Study||23
10197712|NCT03381339|11325740|FG001|COMPLETED|Overall Study||24
10197713|NCT03381339|11325739|FG000|NOT COMPLETED|Overall Study||4
10197714|NCT03381339|11325740|FG001|NOT COMPLETED|Overall Study||4
10197715|NCT03381742|11325750|FG000|STARTED|Overall Study||525
10197716|NCT03381742|11325751|FG001|STARTED|Overall Study||501
10197717|NCT03381742|11325752|FG002|STARTED|Overall Study||1511
10197718|NCT03381742|11325753|FG003|STARTED|Overall Study||506
10197719|NCT03381742|11325750|FG000|COMPLETED|Overall Study||525
10197720|NCT03381742|11325751|FG001|COMPLETED|Overall Study||501
10197721|NCT03381742|11325752|FG002|COMPLETED|Overall Study||1511
10197722|NCT03381742|11325753|FG003|COMPLETED|Overall Study||506
10197723|NCT03381742|11325750|FG000|NOT COMPLETED|Overall Study||0
10197724|NCT03381742|11325751|FG001|NOT COMPLETED|Overall Study||0
10197725|NCT03381742|11325752|FG002|NOT COMPLETED|Overall Study||0
10197726|NCT03381742|11325753|FG003|NOT COMPLETED|Overall Study||0
10197727|NCT03381989|11325763|FG000|STARTED|Overall Study||30
10197728|NCT03381989|11325763|FG000|COMPLETED|Overall Study||22
10197729|NCT03381989|11325763|FG000|NOT COMPLETED|Overall Study||8
10197730|NCT03382262|11325772|FG000|STARTED|Overall Study||12
10197731|NCT03382262|11325773|FG001|STARTED|Overall Study||13
10197732|NCT03382262|11325774|FG002|STARTED|Overall Study||15
10197733|NCT03382262|11325775|FG003|STARTED|Overall Study||15
10197734|NCT03382262|11325772|FG000|COMPLETED|Overall Study||12
10197735|NCT03382262|11325773|FG001|COMPLETED|Overall Study||13
10197736|NCT03382262|11325774|FG002|COMPLETED|Overall Study||14
10197737|NCT03382262|11325775|FG003|COMPLETED|Overall Study||14
10197738|NCT03382262|11325772|FG000|NOT COMPLETED|Overall Study||0
10197739|NCT03382262|11325773|FG001|NOT COMPLETED|Overall Study||0
10197740|NCT03382262|11325774|FG002|NOT COMPLETED|Overall Study||1
10197741|NCT03382262|11325775|FG003|NOT COMPLETED|Overall Study||1
10197742|NCT03382418|11325788|FG000|STARTED|Overall Study||25
10197743|NCT03382418|11325789|FG001|STARTED|Overall Study||15
10197744|NCT03382418|11325790|FG002|STARTED|Overall Study||5
10197745|NCT03382418|11325788|FG000|Month .5 Immunogenicity Cohort|Overall Study||25
10197746|NCT03382418|11325789|FG001|Month .5 Immunogenicity Cohort|Overall Study||14
10197747|NCT03382418|11325790|FG002|Month .5 Immunogenicity Cohort|Overall Study||5
10197748|NCT03382418|11325788|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21
10197749|NCT03382418|11325789|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13
10197750|NCT03382418|11325790|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5
10197751|NCT03382418|11325788|FG000|COMPLETED|Overall Study||22
9712229|NCT02616393|10811791|FG001|NOT COMPLETED|Overall Study||20
9712230|NCT02616393|10811792|FG002|NOT COMPLETED|Overall Study||3
9712231|NCT02602288|10811818|FG000|STARTED|End of Treatment/3 Month Follow-up||199
10061394|NCT02104739|11187057|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061395|NCT02104739|11187058|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10197752|NCT03382418|11325789|FG001|COMPLETED|Overall Study||12
10061396|NCT02104739|11187059|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061397|NCT02104739|11187053|FG000|STARTED|Second Intervention (1 Day)||1
10061398|NCT02104739|11187054|FG001|STARTED|Second Intervention (1 Day)||4
10061399|NCT02104739|11187055|FG002|STARTED|Second Intervention (1 Day)||2
10061400|NCT02104739|11187056|FG003|STARTED|Second Intervention (1 Day)||7
10061401|NCT02104739|11187057|FG004|STARTED|Second Intervention (1 Day)||0
10061402|NCT02104739|11187058|FG005|STARTED|Second Intervention (1 Day)||2
10061403|NCT02104739|11187059|FG006|STARTED|Second Intervention (1 Day)||0
10061404|NCT02104739|11187053|FG000|COMPLETED|Second Intervention (1 Day)||1
10061405|NCT02104739|11187054|FG001|COMPLETED|Second Intervention (1 Day)||4
10061406|NCT02104739|11187055|FG002|COMPLETED|Second Intervention (1 Day)||2
10197753|NCT03382418|11325790|FG002|COMPLETED|Overall Study||5
10197754|NCT03382418|11325788|FG000|NOT COMPLETED|Overall Study||3
10197755|NCT03382418|11325789|FG001|NOT COMPLETED|Overall Study||3
10197756|NCT03382418|11325790|FG002|NOT COMPLETED|Overall Study||0
10169534|NCT03028142|11299602|FG000|STARTED|Overall Study||5
10169535|NCT03028142|11299603|FG001|STARTED|Overall Study||5
10169536|NCT03028142|11299604|FG002|STARTED|Overall Study||6
10169537|NCT03028142|11299605|FG003|STARTED|Overall Study||4
10169538|NCT03028142|11299606|FG004|STARTED|Overall Study||6
10169539|NCT03028142|11299607|FG005|STARTED|Overall Study||4
10169540|NCT03028142|11299602|FG000|COMPLETED|Overall Study||4
10169541|NCT03028142|11299603|FG001|COMPLETED|Overall Study||4
10169542|NCT03028142|11299604|FG002|COMPLETED|Overall Study||6
10169543|NCT03028142|11299605|FG003|COMPLETED|Overall Study||4
10169544|NCT03028142|11299606|FG004|COMPLETED|Overall Study||5
10169545|NCT03028142|11299607|FG005|COMPLETED|Overall Study||3
10169546|NCT03028142|11299602|FG000|NOT COMPLETED|Overall Study||1
10169547|NCT03028142|11299603|FG001|NOT COMPLETED|Overall Study||1
10169548|NCT03028142|11299604|FG002|NOT COMPLETED|Overall Study||0
10169549|NCT03028142|11299605|FG003|NOT COMPLETED|Overall Study||0
10169550|NCT03028142|11299606|FG004|NOT COMPLETED|Overall Study||1
10169551|NCT03028142|11299607|FG005|NOT COMPLETED|Overall Study||1
10169552|NCT03028220|11299618|FG000|STARTED|Overall Study||20
10169553|NCT03028220|11299619|FG001|STARTED|Overall Study||20
10169554|NCT03028220|11299618|FG000|COMPLETED|Overall Study||20
10169555|NCT03028220|11299619|FG001|COMPLETED|Overall Study||20
10169556|NCT03028220|11299618|FG000|NOT COMPLETED|Overall Study||0
10169557|NCT03028220|11299619|FG001|NOT COMPLETED|Overall Study||0
10169558|NCT03028324|11299625|FG000|STARTED|Overall Study||4
10169559|NCT03028324|11299625|FG000|COMPLETED|Overall Study||4
10169560|NCT03028324|11299625|FG000|NOT COMPLETED|Overall Study||0
10169561|NCT03028363|11299631|FG000|STARTED|Overall Study||498
10169562|NCT03028363|11299632|FG001|STARTED|Overall Study||261
10169563|NCT03028363|11299631|FG000|COMPLETED|Overall Study||420
10169564|NCT03028363|11299632|FG001|COMPLETED|Overall Study||228
10169565|NCT03028363|11299631|FG000|NOT COMPLETED|Overall Study||78
10169566|NCT03028363|11299632|FG001|NOT COMPLETED|Overall Study||33
10169567|NCT03028415|11299640|FG000|STARTED|Overall Study||39
10169568|NCT03028415|11299641|FG001|STARTED|Overall Study||17
10169569|NCT03028415|11299640|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39
10169570|NCT03028415|11299641|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17
10169571|NCT03028415|11299640|FG000|COMPLETED|Overall Study||31
10169572|NCT03028415|11299641|FG001|COMPLETED|Overall Study||14
10169573|NCT03028415|11299640|FG000|NOT COMPLETED|Overall Study||8
10169574|NCT03028415|11299641|FG001|NOT COMPLETED|Overall Study||3
10169575|NCT03028467|11299652|FG000|STARTED|Overall Study||4
10169576|NCT03028467|11299653|FG001|STARTED|Overall Study||3
10169577|NCT03028467|11299654|FG002|STARTED|Overall Study||4
10169578|NCT03028467|11299655|FG003|STARTED|Overall Study||4
10169579|NCT03028467|11299652|FG000|COMPLETED|Overall Study||4
10169580|NCT03028467|11299653|FG001|COMPLETED|Overall Study||3
10169581|NCT03028467|11299654|FG002|COMPLETED|Overall Study||4
10169582|NCT03028467|11299655|FG003|COMPLETED|Overall Study||4
10169583|NCT03028467|11299652|FG000|NOT COMPLETED|Overall Study||0
10169584|NCT03028467|11299653|FG001|NOT COMPLETED|Overall Study||0
10169585|NCT03028467|11299654|FG002|NOT COMPLETED|Overall Study||0
10169586|NCT03028467|11299655|FG003|NOT COMPLETED|Overall Study||0
10169587|NCT03028636|11299668|FG000|STARTED|Overall Study||17
10169588|NCT03028636|11299668|FG000|COMPLETED|Overall Study||11
10169589|NCT03028636|11299668|FG000|NOT COMPLETED|Overall Study||6
10169590|NCT03028870|11299681|FG000|STARTED|Overall Study||74
10169591|NCT03028870|11299682|FG001|STARTED|Overall Study||67
10169592|NCT03028870|11299683|FG002|STARTED|Overall Study||76
10169593|NCT03028870|11299684|FG003|STARTED|Overall Study||74
10169594|NCT03028870|11299681|FG000|COMPLETED|Overall Study||57
10169595|NCT03028870|11299682|FG001|COMPLETED|Overall Study||57
10169596|NCT03028870|11299683|FG002|COMPLETED|Overall Study||60
10169597|NCT03028870|11299684|FG003|COMPLETED|Overall Study||65
10169598|NCT03028870|11299681|FG000|NOT COMPLETED|Overall Study||17
10169599|NCT03028870|11299682|FG001|NOT COMPLETED|Overall Study||10
10169600|NCT03028870|11299683|FG002|NOT COMPLETED|Overall Study||16
10169601|NCT03028870|11299684|FG003|NOT COMPLETED|Overall Study||9
10169602|NCT03028974|11299699|FG000|STARTED|2014-2015||1
10169603|NCT03028974|11299700|FG001|STARTED|2014-2015||0
10169604|NCT03028974|11299701|FG002|STARTED|2014-2015||0
10169605|NCT03028974|11299702|FG003|STARTED|2014-2015||3
10169606|NCT03028974|11299703|FG004|STARTED|2014-2015||0
10169607|NCT03028974|11299704|FG005|STARTED|2014-2015||11
10169608|NCT03028974|11299705|FG006|STARTED|2014-2015||13
10169609|NCT03028974|11299699|FG000|COMPLETED|2014-2015||1
10169610|NCT03028974|11299700|FG001|COMPLETED|2014-2015||0
10169611|NCT03028974|11299701|FG002|COMPLETED|2014-2015||0
10169612|NCT03028974|11299702|FG003|COMPLETED|2014-2015||3
10169613|NCT03028974|11299703|FG004|COMPLETED|2014-2015||0
10169614|NCT03028974|11299704|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
10169615|NCT03028974|11299705|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
10169616|NCT03028974|11299699|FG000|NOT COMPLETED|2014-2015||0
10169617|NCT03028974|11299700|FG001|NOT COMPLETED|2014-2015||0
10169618|NCT03028974|11299701|FG002|NOT COMPLETED|2014-2015||0
10169619|NCT03028974|11299702|FG003|NOT COMPLETED|2014-2015||0
10169620|NCT03028974|11299703|FG004|NOT COMPLETED|2014-2015||0
10169621|NCT03028974|11299704|FG005|NOT COMPLETED|2014-2015||0
10169622|NCT03028974|11299705|FG006|NOT COMPLETED|2014-2015||0
10169623|NCT03028974|11299699|FG000|STARTED|2015-2016||0
10169624|NCT03028974|11299700|FG001|STARTED|2015-2016||0
10169625|NCT03028974|11299701|FG002|STARTED|2015-2016||0
10169626|NCT03028974|11299702|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
10169627|NCT03028974|11299703|FG004|STARTED|2015-2016||0
10169628|NCT03028974|11299704|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
10169629|NCT03028974|11299705|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
10169630|NCT03028974|11299699|FG000|COMPLETED|2015-2016||0
10169631|NCT03028974|11299700|FG001|COMPLETED|2015-2016||0
10169632|NCT03028974|11299701|FG002|COMPLETED|2015-2016||0
10169633|NCT03028974|11299702|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
10169634|NCT03028974|11299703|FG004|COMPLETED|2015-2016||0
10169635|NCT03028974|11299704|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
10169636|NCT03028974|11299705|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
10169637|NCT03028974|11299699|FG000|NOT COMPLETED|2015-2016||0
10169638|NCT03028974|11299700|FG001|NOT COMPLETED|2015-2016||0
10169639|NCT03028974|11299701|FG002|NOT COMPLETED|2015-2016||0
10169640|NCT03028974|11299702|FG003|NOT COMPLETED|2015-2016||0
10169641|NCT03028974|11299703|FG004|NOT COMPLETED|2015-2016||0
10169642|NCT03028974|11299704|FG005|NOT COMPLETED|2015-2016||0
10169643|NCT03028974|11299705|FG006|NOT COMPLETED|2015-2016||0
10169644|NCT03028974|11299699|FG000|STARTED|2016-2017||0
10169645|NCT03028974|11299700|FG001|STARTED|2016-2017||0
10169646|NCT03028974|11299701|FG002|STARTED|2016-2017||0
10169647|NCT03028974|11299702|FG003|STARTED|2016-2017|1 new participant was enrolled.|4
10169648|NCT03028974|11299703|FG004|STARTED|2016-2017|2 new participants were enrolled.|2
10169649|NCT03028974|11299704|FG005|STARTED|2016-2017||0
10169650|NCT03028974|11299705|FG006|STARTED|2016-2017|18 new participants were enrolled.|18
10169651|NCT03028974|11299699|FG000|COMPLETED|2016-2017||0
10169652|NCT03028974|11299700|FG001|COMPLETED|2016-2017||0
10169653|NCT03028974|11299701|FG002|COMPLETED|2016-2017||0
10169654|NCT03028974|11299702|FG003|COMPLETED|2016-2017||4
10169655|NCT03028974|11299703|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2
10169656|NCT03028974|11299704|FG005|COMPLETED|2016-2017||0
10169657|NCT03028974|11299705|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
10169658|NCT03028974|11299699|FG000|NOT COMPLETED|2016-2017||0
10169659|NCT03028974|11299700|FG001|NOT COMPLETED|2016-2017||0
10169660|NCT03028974|11299701|FG002|NOT COMPLETED|2016-2017||0
10169661|NCT03028974|11299702|FG003|NOT COMPLETED|2016-2017||0
10169662|NCT03028974|11299703|FG004|NOT COMPLETED|2016-2017||0
10169663|NCT03028974|11299704|FG005|NOT COMPLETED|2016-2017||0
10169664|NCT03028974|11299705|FG006|NOT COMPLETED|2016-2017||0
10169665|NCT03028974|11299699|FG000|STARTED|2017-2018||0
10169666|NCT03028974|11299700|FG001|STARTED|2017-2018||0
10169667|NCT03028974|11299701|FG002|STARTED|2017-2018||0
10169668|NCT03028974|11299702|FG003|STARTED|2017-2018||5
10169669|NCT03028974|11299703|FG004|STARTED|2017-2018||0
10169670|NCT03028974|11299704|FG005|STARTED|2017-2018||0
10169671|NCT03028974|11299705|FG006|STARTED|2017-2018|5 new participants were enrolled.|5
10169672|NCT03028974|11299699|FG000|COMPLETED|2017-2018||0
10169673|NCT03028974|11299700|FG001|COMPLETED|2017-2018||0
10169674|NCT03028974|11299701|FG002|COMPLETED|2017-2018||0
10169675|NCT03028974|11299702|FG003|COMPLETED|2017-2018||5
10169676|NCT03028974|11299703|FG004|COMPLETED|2017-2018||0
10169677|NCT03028974|11299704|FG005|COMPLETED|2017-2018||0
10169678|NCT03028974|11299705|FG006|COMPLETED|2017-2018||5
10169679|NCT03028974|11299699|FG000|NOT COMPLETED|2017-2018||0
10169680|NCT03028974|11299700|FG001|NOT COMPLETED|2017-2018||0
10169681|NCT03028974|11299701|FG002|NOT COMPLETED|2017-2018||0
10169682|NCT03028974|11299702|FG003|NOT COMPLETED|2017-2018||0
10169683|NCT03028974|11299703|FG004|NOT COMPLETED|2017-2018||0
10169684|NCT03028974|11299704|FG005|NOT COMPLETED|2017-2018||0
10169685|NCT03028974|11299705|FG006|NOT COMPLETED|2017-2018||0
10169686|NCT03028987|11299720|FG000|STARTED|Overall Study||5
10169687|NCT03028987|11299721|FG001|STARTED|Overall Study||5
10169688|NCT03028987|11299720|FG000|COMPLETED|Overall Study||5
10169689|NCT03028987|11299721|FG001|COMPLETED|Overall Study||5
10169690|NCT03028987|11299720|FG000|NOT COMPLETED|Overall Study||0
10169691|NCT03028987|11299721|FG001|NOT COMPLETED|Overall Study||0
10169692|NCT03029091|11299729|FG000|STARTED|Overall Study||8
10169693|NCT03029091|11299730|FG001|STARTED|Overall Study||7
10169694|NCT03029091|11299729|FG000|COMPLETED|Overall Study||8
10169695|NCT03029091|11299730|FG001|COMPLETED|Overall Study||7
10169696|NCT03029091|11299729|FG000|NOT COMPLETED|Overall Study||0
10169697|NCT03029091|11299730|FG001|NOT COMPLETED|Overall Study||0
10169698|NCT03029143|11299738|FG000|STARTED|Lead-in Period (6 Weeks)||278
10169699|NCT03029143|11299739|FG001|STARTED|Lead-in Period (6 Weeks)||0
10169700|NCT03029143|11299740|FG002|STARTED|Lead-in Period (6 Weeks)||0
10169701|NCT03029143|11299738|FG000|COMPLETED|Lead-in Period (6 Weeks)||109
10169702|NCT03029143|11299739|FG001|COMPLETED|Lead-in Period (6 Weeks)||0
10169703|NCT03029143|11299740|FG002|COMPLETED|Lead-in Period (6 Weeks)||0
10169704|NCT03029143|11299738|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169
10169705|NCT03029143|11299739|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0
10169706|NCT03029143|11299740|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0
10169707|NCT03029143|11299738|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0
10169708|NCT03029143|11299739|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54
10169709|NCT03029143|11299740|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55
10169710|NCT03029143|11299738|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
9731043|NCT00129480|10830950|FG000|COMPLETED|Overall Study||187
10169711|NCT03029143|11299739|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1
10169712|NCT03029143|11299740|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
10169713|NCT03029143|11299738|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0
10169714|NCT03029143|11299739|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53
10169715|NCT03029143|11299740|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55
10169716|NCT03029143|11299738|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0
10169717|NCT03029143|11299739|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31
10169718|NCT03029143|11299740|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31
10169719|NCT03029143|11299738|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0
10169720|NCT03029143|11299739|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23
10169721|NCT03029143|11299740|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24
10169722|NCT03029208|11299751|FG000|STARTED|Overall Study||157
10169723|NCT03029208|11299752|FG001|STARTED|Overall Study||155
10169724|NCT03029208|11299751|FG000|COMPLETED|Overall Study||155
10169725|NCT03029208|11299752|FG001|COMPLETED|Overall Study||151
10169726|NCT03029208|11299751|FG000|NOT COMPLETED|Overall Study||2
10169727|NCT03029208|11299752|FG001|NOT COMPLETED|Overall Study||4
10169728|NCT03029247|11299769|FG000|STARTED|Acute Challenge 1 (Day 1)||45
10169729|NCT03029247|11299770|FG001|STARTED|Acute Challenge 1 (Day 1)||43
10169730|NCT03029247|11299769|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45
10169731|NCT03029247|11299770|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43
10169732|NCT03029247|11299769|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
10169733|NCT03029247|11299770|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
10169734|NCT03029247|11299769|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45
10169735|NCT03029247|11299770|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43
10169736|NCT03029247|11299769|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
10169737|NCT03029247|11299770|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
10169738|NCT03029247|11299769|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
10169739|NCT03029247|11299770|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
10169740|NCT03029247|11299769|FG000|STARTED|Acute Challenge 2 (Day 57)||32
10169741|NCT03029247|11299770|FG001|STARTED|Acute Challenge 2 (Day 57)||36
10169742|NCT03029247|11299769|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32
10169743|NCT03029247|11299770|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36
10169744|NCT03029247|11299769|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
10169745|NCT03029247|11299770|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
10169746|NCT03029247|11299769|FG000|STARTED|Follow-up Period (14 Days)||32
10169747|NCT03029247|11299770|FG001|STARTED|Follow-up Period (14 Days)||36
10169748|NCT03029247|11299769|FG000|COMPLETED|Follow-up Period (14 Days)||32
10169749|NCT03029247|11299770|FG001|COMPLETED|Follow-up Period (14 Days)||36
10169750|NCT03029247|11299769|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
10169751|NCT03029247|11299770|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0
10169752|NCT03029585|11299778|FG000|STARTED|Overall Study||7
10169753|NCT03029585|11299779|FG001|STARTED|Overall Study||3
10169754|NCT03029585|11299778|FG000|COMPLETED|Overall Study||5
10169755|NCT03029585|11299779|FG001|COMPLETED|Overall Study||2
10169756|NCT03029585|11299778|FG000|NOT COMPLETED|Overall Study||2
10169757|NCT03029585|11299779|FG001|NOT COMPLETED|Overall Study||1
10169758|NCT03029624|11299785|FG000|STARTED|Overall Study||46
10169759|NCT03029624|11299785|FG000|Primary Endpoint (3 Months)|Overall Study||44
10169760|NCT03029624|11299785|FG000|COMPLETED|Overall Study||41
10169761|NCT03029624|11299785|FG000|NOT COMPLETED|Overall Study||5
10169762|NCT03029650|11299791|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
10169763|NCT03029650|11299792|FG001|STARTED|First Intervention (3 - 6 Days)||12
10169764|NCT03029650|11299791|FG000|COMPLETED|First Intervention (3 - 6 Days)||14
10169765|NCT03029650|11299792|FG001|COMPLETED|First Intervention (3 - 6 Days)||12
10169766|NCT03029650|11299791|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0
10169767|NCT03029650|11299792|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0
10169768|NCT03029650|11299791|FG000|STARTED|Washout (1 Week)||14
10169769|NCT03029650|11299792|FG001|STARTED|Washout (1 Week)||12
10169770|NCT03029650|11299791|FG000|COMPLETED|Washout (1 Week)||13
10169771|NCT03029650|11299792|FG001|COMPLETED|Washout (1 Week)||10
10169772|NCT03029650|11299791|FG000|NOT COMPLETED|Washout (1 Week)||1
10169773|NCT03029650|11299792|FG001|NOT COMPLETED|Washout (1 Week)||2
10169774|NCT03029650|11299791|FG000|STARTED|2nd Intervention (3 - 6 Days)||13
10169775|NCT03029650|11299792|FG001|STARTED|2nd Intervention (3 - 6 Days)||10
10169776|NCT03029650|11299791|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13
10169777|NCT03029650|11299792|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10
10169778|NCT03029650|11299791|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
10169779|NCT03029650|11299792|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
10169780|NCT03029715|11299804|FG000|STARTED|Overall Study||50
10169781|NCT03029715|11299805|FG001|STARTED|Overall Study||50
10169782|NCT03029715|11299804|FG000|COMPLETED|Overall Study||50
10169783|NCT03029715|11299805|FG001|COMPLETED|Overall Study||50
10169784|NCT03029715|11299804|FG000|NOT COMPLETED|Overall Study||0
10169785|NCT03029715|11299805|FG001|NOT COMPLETED|Overall Study||0
10169792|NCT03029819|11299822|FG000|STARTED|Overall Study||33
10169793|NCT03029819|11299823|FG001|STARTED|Overall Study||39
10169794|NCT03029819|11299822|FG000|COMPLETED|Overall Study||30
10169795|NCT03029819|11299823|FG001|COMPLETED|Overall Study||33
10169796|NCT03029819|11299822|FG000|NOT COMPLETED|Overall Study||3
10169797|NCT03029819|11299823|FG001|NOT COMPLETED|Overall Study||6
10169798|NCT03029988|11299832|FG000|STARTED|Overall Study||3
10169799|NCT03029988|11299832|FG000|COMPLETED|Overall Study||3
10169800|NCT03029988|11299832|FG000|NOT COMPLETED|Overall Study||0
10169801|NCT03030183|11299837|FG000|STARTED|Overall Study||3
10169802|NCT03030183|11299837|FG000|COMPLETED|Overall Study||3
10169803|NCT03030183|11299837|FG000|NOT COMPLETED|Overall Study||0
10169804|NCT03030599|11299841|FG000|STARTED|Open Label Treatment and Titration||201
10169805|NCT03030599|11299842|FG001|STARTED|Open Label Treatment and Titration||0
10169806|NCT03030599|11299843|FG002|STARTED|Open Label Treatment and Titration||0
10169807|NCT03030599|11299841|FG000|COMPLETED|Open Label Treatment and Titration||155
10169808|NCT03030599|11299842|FG001|COMPLETED|Open Label Treatment and Titration||0
10169809|NCT03030599|11299843|FG002|COMPLETED|Open Label Treatment and Titration||0
10169810|NCT03030599|11299841|FG000|NOT COMPLETED|Open Label Treatment and Titration||46
10169811|NCT03030599|11299842|FG001|NOT COMPLETED|Open Label Treatment and Titration||0
10169812|NCT03030599|11299843|FG002|NOT COMPLETED|Open Label Treatment and Titration||0
10169813|NCT03030599|11299841|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
10169814|NCT03030599|11299842|FG001|STARTED|Stable Dose||0
10169815|NCT03030599|11299843|FG002|STARTED|Stable Dose||0
10169816|NCT03030599|11299841|FG000|COMPLETED|Stable Dose||144
10169817|NCT03030599|11299842|FG001|COMPLETED|Stable Dose||0
10169818|NCT03030599|11299843|FG002|COMPLETED|Stable Dose||0
10169819|NCT03030599|11299841|FG000|NOT COMPLETED|Stable Dose||5
10169820|NCT03030599|11299842|FG001|NOT COMPLETED|Stable Dose||0
10169821|NCT03030599|11299843|FG002|NOT COMPLETED|Stable Dose||0
10169822|NCT03030599|11299841|FG000|STARTED|Double Blind Randomized Withdrawal||0
10169823|NCT03030599|11299842|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
10169824|NCT03030599|11299843|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
10169825|NCT03030599|11299841|FG000|COMPLETED|Double Blind Randomized Withdrawal||0
10169826|NCT03030599|11299842|FG001|COMPLETED|Double Blind Randomized Withdrawal||69
10169827|NCT03030599|11299843|FG002|COMPLETED|Double Blind Randomized Withdrawal||59
10169828|NCT03030599|11299841|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0
10169829|NCT03030599|11299842|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0
10169830|NCT03030599|11299843|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8
10169831|NCT03030599|11299841|FG000|STARTED|Open-label Extension||74
10169832|NCT03030599|11299842|FG001|STARTED|Open-label Extension||0
10169833|NCT03030599|11299843|FG002|STARTED|Open-label Extension||0
10169834|NCT03030599|11299841|FG000|COMPLETED|Open-label Extension||67
10169835|NCT03030599|11299842|FG001|COMPLETED|Open-label Extension||0
10169836|NCT03030599|11299843|FG002|COMPLETED|Open-label Extension||0
10169837|NCT03030599|11299841|FG000|NOT COMPLETED|Open-label Extension||7
10169838|NCT03030599|11299842|FG001|NOT COMPLETED|Open-label Extension||0
10169839|NCT03030599|11299843|FG002|NOT COMPLETED|Open-label Extension||0
10169840|NCT03030638|11299857|FG000|STARTED|Overall Study||1386
10169841|NCT03030638|11299858|FG001|STARTED|Overall Study||1841
10169842|NCT03030638|11299859|FG002|STARTED|Overall Study||1712
10169843|NCT03030638|11299860|FG003|STARTED|Overall Study||6406
10169844|NCT03030638|11299861|FG004|STARTED|Overall Study||696
10169845|NCT03030638|11299862|FG005|STARTED|Overall Study||1592
10169846|NCT03030638|11299863|FG006|STARTED|Overall Study||364
10169847|NCT03030638|11299864|FG007|STARTED|Overall Study||127
10169848|NCT03030638|11299857|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
10169849|NCT03030638|11299858|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
10169850|NCT03030638|11299859|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10169851|NCT03030638|11299860|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10169852|NCT03030638|11299861|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10169853|NCT03030638|11299862|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10169854|NCT03030638|11299863|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10169855|NCT03030638|11299864|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10169856|NCT03030638|11299857|FG000|COMPLETED|Overall Study||1386
10169857|NCT03030638|11299858|FG001|COMPLETED|Overall Study||1841
10169858|NCT03030638|11299859|FG002|COMPLETED|Overall Study||1712
10169859|NCT03030638|11299860|FG003|COMPLETED|Overall Study||6406
10169860|NCT03030638|11299861|FG004|COMPLETED|Overall Study||696
10169861|NCT03030638|11299862|FG005|COMPLETED|Overall Study||1592
10169862|NCT03030638|11299863|FG006|COMPLETED|Overall Study||364
10169863|NCT03030638|11299864|FG007|COMPLETED|Overall Study||127
10169864|NCT03030638|11299857|FG000|NOT COMPLETED|Overall Study||0
10169865|NCT03030638|11299858|FG001|NOT COMPLETED|Overall Study||0
10169866|NCT03030638|11299859|FG002|NOT COMPLETED|Overall Study||0
10169867|NCT03030638|11299860|FG003|NOT COMPLETED|Overall Study||0
10169868|NCT03030638|11299861|FG004|NOT COMPLETED|Overall Study||0
10169869|NCT03030638|11299862|FG005|NOT COMPLETED|Overall Study||0
10169870|NCT03030638|11299863|FG006|NOT COMPLETED|Overall Study||0
10169871|NCT03030638|11299864|FG007|NOT COMPLETED|Overall Study||0
10169872|NCT03030989|11299886|FG000|STARTED|Overall Study||21
10169873|NCT03030989|11299887|FG001|STARTED|Overall Study||29
10169874|NCT03030989|11299886|FG000|COMPLETED|Overall Study||9
10169875|NCT03030989|11299887|FG001|COMPLETED|Overall Study||15
10169876|NCT03030989|11299886|FG000|NOT COMPLETED|Overall Study||12
10169877|NCT03030989|11299887|FG001|NOT COMPLETED|Overall Study||14
10169878|NCT03031431|11299893|FG000|STARTED|Overall Study||130
10169879|NCT03031431|11299893|FG000|COMPLETED|Overall Study||129
10169880|NCT03031431|11299893|FG000|NOT COMPLETED|Overall Study||1
10169881|NCT03031496|11299897|FG000|STARTED|Period 1||21
10169882|NCT03031496|11299898|FG001|STARTED|Period 1||21
10169883|NCT03031496|11299897|FG000|COMPLETED|Period 1||19
10169884|NCT03031496|11299898|FG001|COMPLETED|Period 1||19
10169885|NCT03031496|11299897|FG000|NOT COMPLETED|Period 1||2
10169886|NCT03031496|11299898|FG001|NOT COMPLETED|Period 1||2
10169887|NCT03031496|11299897|FG000|STARTED|Period 2||19
10169888|NCT03031496|11299898|FG001|STARTED|Period 2||19
10169889|NCT03031496|11299897|FG000|COMPLETED|Period 2||19
10169890|NCT03031496|11299898|FG001|COMPLETED|Period 2||19
10169891|NCT03031496|11299897|FG000|NOT COMPLETED|Period 2||0
10169892|NCT03031496|11299898|FG001|NOT COMPLETED|Period 2||0
10169893|NCT03031678|11299904|FG000|STARTED|Overall Study||50
10169894|NCT03031678|11299904|FG000|EAS Test Condition Complete|Overall Study||39
10169895|NCT03031678|11299904|FG000|CI Alone Test Condition Complete|Overall Study||10
10169896|NCT03031678|11299904|FG000|COMPLETED|Overall Study||49
10169897|NCT03031678|11299904|FG000|NOT COMPLETED|Overall Study||1
10169898|NCT03031795|11299914|FG000|STARTED|Overall Study||35
10169899|NCT03031795|11299915|FG001|STARTED|Overall Study||36
10169900|NCT03031795|11299914|FG000|COMPLETED|Overall Study||35
10169901|NCT03031795|11299915|FG001|COMPLETED|Overall Study||35
10169902|NCT03031795|11299914|FG000|NOT COMPLETED|Overall Study||0
10169903|NCT03031795|11299915|FG001|NOT COMPLETED|Overall Study||1
9712232|NCT02602288|10811819|FG001|STARTED|End of Treatment/3 Month Follow-up||197
9712233|NCT02602288|10811818|FG000|COMPLETED|End of Treatment/3 Month Follow-up||174
9712234|NCT02602288|10811819|FG001|COMPLETED|End of Treatment/3 Month Follow-up||179
9712235|NCT02602288|10811818|FG000|NOT COMPLETED|End of Treatment/3 Month Follow-up||25
9712236|NCT02602288|10811819|FG001|NOT COMPLETED|End of Treatment/3 Month Follow-up||18
9712237|NCT02602288|10811818|FG000|STARTED|12 Month Follow-up||174
9712238|NCT02602288|10811819|FG001|STARTED|12 Month Follow-up||179
9712239|NCT02602288|10811818|FG000|COMPLETED|12 Month Follow-up||172
9712240|NCT02602288|10811819|FG001|COMPLETED|12 Month Follow-up||175
9712241|NCT02602288|10811818|FG000|NOT COMPLETED|12 Month Follow-up||2
9712242|NCT02602288|10811819|FG001|NOT COMPLETED|12 Month Follow-up||4
9712243|NCT02577523|10811827|FG000|STARTED|Overall Study||19
9712244|NCT02577523|10811828|FG001|STARTED|Overall Study||19
9712245|NCT02577523|10811827|FG000|COMPLETED|Overall Study||16
9712246|NCT02577523|10811828|FG001|COMPLETED|Overall Study||17
9712247|NCT02577523|10811827|FG000|NOT COMPLETED|Overall Study||3
9712248|NCT02577523|10811828|FG001|NOT COMPLETED|Overall Study||2
10169904|NCT03031899|11299921|FG000|STARTED|Overall Study||27
10169905|NCT03031899|11299921|FG000|COMPLETED|Overall Study||25
10169906|NCT03031899|11299921|FG000|NOT COMPLETED|Overall Study||2
10169907|NCT03031938|11299931|FG000|STARTED|Overall Study||2
10169908|NCT03031938|11299932|FG001|STARTED|Overall Study||2
10169909|NCT03031938|11299931|FG000|COMPLETED|Overall Study||1
10169910|NCT03031938|11299932|FG001|COMPLETED|Overall Study||2
10169911|NCT03031938|11299931|FG000|NOT COMPLETED|Overall Study||1
10169912|NCT03031938|11299932|FG001|NOT COMPLETED|Overall Study||0
10169913|NCT03032263|11299940|FG000|STARTED|Overall Study||6
10169914|NCT03032263|11299941|FG001|STARTED|Overall Study||6
10169915|NCT03032263|11299940|FG000|COMPLETED|Overall Study||6
9712249|NCT02563002|10811836|FG000|STARTED|Overall Study||153
9712250|NCT02563002|10811837|FG001|STARTED|Overall Study||154
9712251|NCT02563002|10811836|FG000|Treated|Overall Study||153
9712252|NCT02563002|10811837|FG001|Treated|Overall Study||143
9712253|NCT02563002|10811836|FG000|Received Second Course of Pembrolizumab|Overall Study||8
9712254|NCT02563002|10811837|FG001|Received Second Course of Pembrolizumab|Overall Study||4
9712255|NCT02563002|10811836|FG000|Switched Over to Pembrolizumab|Overall Study||0
9712256|NCT02563002|10811837|FG001|Switched Over to Pembrolizumab|Overall Study||56
9712257|NCT02563002|10811836|FG000|COMPLETED|Overall Study||0
9712258|NCT02563002|10811837|FG001|COMPLETED|Overall Study||0
9712259|NCT02563002|10811836|FG000|NOT COMPLETED|Overall Study||153
9712260|NCT02563002|10811837|FG001|NOT COMPLETED|Overall Study||154
9712261|NCT02461225|10811848|FG000|STARTED|Overall Study||19
9712262|NCT02461225|10811849|FG001|STARTED|Overall Study||11
9712263|NCT02461225|10811848|FG000|COMPLETED|Overall Study||19
9712264|NCT02461225|10811849|FG001|COMPLETED|Overall Study||11
9712265|NCT02461225|10811848|FG000|NOT COMPLETED|Overall Study||0
9712266|NCT02461225|10811849|FG001|NOT COMPLETED|Overall Study||0
9712267|NCT02427958|10811855|FG000|STARTED|Overall Study||307
9712268|NCT02427958|10811855|FG000|COMPLETED|Overall Study||283
9712269|NCT02427958|10811855|FG000|NOT COMPLETED|Overall Study||24
9712270|NCT02425826|10811861|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
9712271|NCT02425826|10811862|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
9712272|NCT02425826|10811863|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
9712273|NCT02425826|10811861|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
9712274|NCT02425826|10811862|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
9712275|NCT02425826|10811863|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
9712276|NCT02425826|10811861|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
9712277|NCT02425826|10811862|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
9712278|NCT02425826|10811863|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
9712279|NCT02425826|10811861|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
9712280|NCT02425826|10811862|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
9712281|NCT02425826|10811863|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
9712282|NCT02425826|10811861|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
9712283|NCT02425826|10811862|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
9712284|NCT02425826|10811863|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
9712285|NCT02425826|10811861|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
9712286|NCT02425826|10811862|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
9712287|NCT02425826|10811863|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
9712288|NCT02425826|10811861|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
9712289|NCT02425826|10811862|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
9712290|NCT02425826|10811863|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
10061407|NCT02104739|11187056|FG003|COMPLETED|Second Intervention (1 Day)||7
10061408|NCT02104739|11187057|FG004|COMPLETED|Second Intervention (1 Day)||0
10061409|NCT02104739|11187058|FG005|COMPLETED|Second Intervention (1 Day)||2
10061410|NCT02104739|11187059|FG006|COMPLETED|Second Intervention (1 Day)||0
10061411|NCT02104739|11187053|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10061412|NCT02104739|11187054|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10061413|NCT02104739|11187055|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10061414|NCT02104739|11187056|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10061415|NCT02104739|11187057|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10061416|NCT02104739|11187058|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10061417|NCT02104739|11187059|FG006|NOT COMPLETED|Second Intervention (1 Day)||0
10061418|NCT02104739|11187053|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
10061419|NCT02104739|11187054|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
10061420|NCT02104739|11187055|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10061421|NCT02104739|11187056|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
10061422|NCT02104739|11187057|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10061423|NCT02104739|11187058|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10061424|NCT02104739|11187059|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10061425|NCT02104739|11187053|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
10061426|NCT02104739|11187054|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
10061427|NCT02104739|11187055|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10061428|NCT02104739|11187056|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
10061429|NCT02104739|11187057|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061430|NCT02104739|11187058|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10061431|NCT02104739|11187059|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061432|NCT02104739|11187053|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061433|NCT02104739|11187054|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061434|NCT02104739|11187055|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061435|NCT02104739|11187056|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061436|NCT02104739|11187057|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061437|NCT02104739|11187058|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061438|NCT02104739|11187059|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10061439|NCT02104739|11187053|FG000|STARTED|Third Intervention (1 Day)||1
10169916|NCT03032263|11299941|FG001|COMPLETED|Overall Study||6
10169917|NCT03032263|11299940|FG000|NOT COMPLETED|Overall Study||0
10169918|NCT03032263|11299941|FG001|NOT COMPLETED|Overall Study||0
10169919|NCT03032380|11299949|FG000|STARTED|Overall Study||148
10169920|NCT03032380|11299950|FG001|STARTED|Overall Study||152
10169921|NCT03032380|11299949|FG000|Received Treatment|Overall Study||148
10169922|NCT03032380|11299950|FG001|Received Treatment|Overall Study||150
10169923|NCT03032380|11299949|FG000|COMPLETED|Overall Study||106
10169924|NCT03032380|11299950|FG001|COMPLETED|Overall Study||112
10169925|NCT03032380|11299949|FG000|NOT COMPLETED|Overall Study||42
10169926|NCT03032380|11299950|FG001|NOT COMPLETED|Overall Study||40
10169927|NCT03032393|11299958|FG000|STARTED|Overall Study||15
10169928|NCT03032393|11299959|FG001|STARTED|Overall Study||15
10169929|NCT03032393|11299958|FG000|COMPLETED|Overall Study||15
10169930|NCT03032393|11299959|FG001|COMPLETED|Overall Study||15
10169931|NCT03032393|11299958|FG000|NOT COMPLETED|Overall Study||0
10169932|NCT03032393|11299959|FG001|NOT COMPLETED|Overall Study||0
10169933|NCT03032523|11299967|FG000|STARTED|Overall Study||15
10169934|NCT03032523|11299968|FG001|STARTED|Overall Study||6
10169935|NCT03032523|11299967|FG000|COMPLETED|Overall Study||12
10169936|NCT03032523|11299968|FG001|COMPLETED|Overall Study||4
10169937|NCT03032523|11299967|FG000|NOT COMPLETED|Overall Study||3
10169938|NCT03032523|11299968|FG001|NOT COMPLETED|Overall Study||2
10169939|NCT03032965|11299977|FG000|STARTED|Overall Study||61
10169940|NCT03032965|11299978|FG001|STARTED|Overall Study||68
10169941|NCT03032965|11299977|FG000|COMPLETED|Overall Study||61
10169942|NCT03032965|11299978|FG001|COMPLETED|Overall Study||68
10169943|NCT03032965|11299977|FG000|NOT COMPLETED|Overall Study||0
10169944|NCT03032965|11299978|FG001|NOT COMPLETED|Overall Study||0
10169945|NCT03033108|11299987|FG000|STARTED|Overall Study||7
10169946|NCT03033108|11299988|FG001|STARTED|Overall Study||9
10169947|NCT03033108|11299989|FG002|STARTED|Overall Study||7
10169948|NCT03033108|11299987|FG000|COMPLETED|Overall Study||7
10169949|NCT03033108|11299988|FG001|COMPLETED|Overall Study||8
10169950|NCT03033108|11299989|FG002|COMPLETED|Overall Study||7
10169951|NCT03033108|11299987|FG000|NOT COMPLETED|Overall Study||0
10169952|NCT03033108|11299988|FG001|NOT COMPLETED|Overall Study||1
10169953|NCT03033108|11299989|FG002|NOT COMPLETED|Overall Study||0
10169954|NCT03033134|11299999|FG000|STARTED|Overall Study||42
10169955|NCT03033134|11300000|FG001|STARTED|Overall Study||12
10169956|NCT03033134|11299999|FG000|6-month Primary Endpoints|Overall Study||42
10169957|NCT03033134|11300000|FG001|6-month Primary Endpoints|Overall Study||12
10169958|NCT03033134|11299999|FG000|COMPLETED|Overall Study||0
10169959|NCT03033134|11300000|FG001|COMPLETED|Overall Study||0
10169960|NCT03033134|11299999|FG000|NOT COMPLETED|Overall Study||42
10169961|NCT03033134|11300000|FG001|NOT COMPLETED|Overall Study||12
10169962|NCT03033394|11300008|FG000|STARTED|Completed Sampling||65
10169963|NCT03033394|11300008|FG000|COMPLETED|Completed Sampling||65
10169964|NCT03033394|11300008|FG000|NOT COMPLETED|Completed Sampling||0
10169965|NCT03033394|11300008|FG000|STARTED|Completed Pharmacokinetic Analysis||65
10169966|NCT03033394|11300008|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59
10169967|NCT03033394|11300008|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
10169968|NCT03033394|11300008|FG000|STARTED|Completed Final Analysis||59
10169969|NCT03033394|11300008|FG000|COMPLETED|Completed Final Analysis||58
10169970|NCT03033394|11300008|FG000|NOT COMPLETED|Completed Final Analysis||1
10169971|NCT03033511|11300019|FG000|STARTED|Overall Study||376
10169972|NCT03033511|11300020|FG001|STARTED|Overall Study||372
10169973|NCT03033511|11300019|FG000|COMPLETED|Overall Study||376
10169974|NCT03033511|11300020|FG001|COMPLETED|Overall Study||372
10169975|NCT03033511|11300019|FG000|NOT COMPLETED|Overall Study||0
10169976|NCT03033511|11300020|FG001|NOT COMPLETED|Overall Study||0
10169977|NCT03033745|11300029|FG000|STARTED|Overall Study||15
10169978|NCT03033745|11300030|FG001|STARTED|Overall Study||18
10169979|NCT03033745|11300031|FG002|STARTED|Overall Study||16
10169980|NCT03033745|11300029|FG000|COMPLETED|Overall Study||14
10169981|NCT03033745|11300030|FG001|COMPLETED|Overall Study||17
10169982|NCT03033745|11300031|FG002|COMPLETED|Overall Study||14
10169983|NCT03033745|11300029|FG000|NOT COMPLETED|Overall Study||1
10169984|NCT03033745|11300030|FG001|NOT COMPLETED|Overall Study||1
10169985|NCT03033745|11300031|FG002|NOT COMPLETED|Overall Study||2
10169986|NCT03033784|11300048|FG000|STARTED|Overall Study||9
10169987|NCT03033784|11300049|FG001|STARTED|Overall Study||2
10169988|NCT03033784|11300050|FG002|STARTED|Overall Study||4
10169989|NCT03033784|11300051|FG003|STARTED|Overall Study||4
10169990|NCT03033784|11300052|FG004|STARTED|Overall Study||3
10169991|NCT03033784|11300053|FG005|STARTED|Overall Study||2
10169992|NCT03033784|11300054|FG006|STARTED|Overall Study||2
10169993|NCT03033784|11300055|FG007|STARTED|Overall Study||2
10169994|NCT03033784|11300056|FG008|STARTED|Overall Study||1
10169995|NCT03033784|11300057|FG009|STARTED|Overall Study||1
10169996|NCT03033784|11300058|FG010|STARTED|Overall Study||1
10169997|NCT03033784|11300059|FG011|STARTED|Overall Study||1
10169998|NCT03033784|11300060|FG012|STARTED|Overall Study||19
10169999|NCT03033784|11300048|FG000|Clinical Visit 2|Overall Study||9
10170000|NCT03033784|11300049|FG001|Clinical Visit 2|Overall Study||2
10170001|NCT03033784|11300050|FG002|Clinical Visit 2|Overall Study||4
10170002|NCT03033784|11300051|FG003|Clinical Visit 2|Overall Study||4
10170003|NCT03033784|11300052|FG004|Clinical Visit 2|Overall Study||3
10170004|NCT03033784|11300053|FG005|Clinical Visit 2|Overall Study||2
10170005|NCT03033784|11300054|FG006|Clinical Visit 2|Overall Study||2
10170006|NCT03033784|11300055|FG007|Clinical Visit 2|Overall Study||2
10170007|NCT03033784|11300056|FG008|Clinical Visit 2|Overall Study||1
10170008|NCT03033784|11300057|FG009|Clinical Visit 2|Overall Study||1
10170009|NCT03033784|11300058|FG010|Clinical Visit 2|Overall Study||1
10170010|NCT03033784|11300059|FG011|Clinical Visit 2|Overall Study||1
10170011|NCT03033784|11300060|FG012|Clinical Visit 2|Overall Study||17
10170012|NCT03033784|11300048|FG000|Clinical Visit 3|Overall Study||9
10170013|NCT03033784|11300049|FG001|Clinical Visit 3|Overall Study||1
10170014|NCT03033784|11300050|FG002|Clinical Visit 3|Overall Study||4
10170015|NCT03033784|11300051|FG003|Clinical Visit 3|Overall Study||4
10170016|NCT03033784|11300052|FG004|Clinical Visit 3|Overall Study||3
10170017|NCT03033784|11300053|FG005|Clinical Visit 3|Overall Study||2
10170018|NCT03033784|11300054|FG006|Clinical Visit 3|Overall Study||2
10170019|NCT03033784|11300055|FG007|Clinical Visit 3|Overall Study||2
10170020|NCT03033784|11300056|FG008|Clinical Visit 3|Overall Study||1
10170021|NCT03033784|11300057|FG009|Clinical Visit 3|Overall Study||1
10170022|NCT03033784|11300058|FG010|Clinical Visit 3|Overall Study||1
10170023|NCT03033784|11300059|FG011|Clinical Visit 3|Overall Study||1
10170024|NCT03033784|11300060|FG012|Clinical Visit 3|Overall Study||0
10170025|NCT03033784|11300048|FG000|Clinical Visit 4|Overall Study||9
10170026|NCT03033784|11300049|FG001|Clinical Visit 4|Overall Study||1
10170027|NCT03033784|11300050|FG002|Clinical Visit 4|Overall Study||4
10170028|NCT03033784|11300051|FG003|Clinical Visit 4|Overall Study||4
10170029|NCT03033784|11300052|FG004|Clinical Visit 4|Overall Study||3
10170030|NCT03033784|11300053|FG005|Clinical Visit 4|Overall Study||2
10170031|NCT03033784|11300054|FG006|Clinical Visit 4|Overall Study||2
10170032|NCT03033784|11300055|FG007|Clinical Visit 4|Overall Study||2
10170033|NCT03033784|11300056|FG008|Clinical Visit 4|Overall Study||1
10170034|NCT03033784|11300057|FG009|Clinical Visit 4|Overall Study||1
10170035|NCT03033784|11300058|FG010|Clinical Visit 4|Overall Study||1
10170036|NCT03033784|11300059|FG011|Clinical Visit 4|Overall Study||1
10170037|NCT03033784|11300060|FG012|Clinical Visit 4|Overall Study||0
10170038|NCT03033784|11300048|FG000|COMPLETED|Overall Study||9
10170039|NCT03033784|11300049|FG001|COMPLETED|Overall Study||1
10170040|NCT03033784|11300050|FG002|COMPLETED|Overall Study||4
10170041|NCT03033784|11300051|FG003|COMPLETED|Overall Study||4
10170042|NCT03033784|11300052|FG004|COMPLETED|Overall Study||3
10170043|NCT03033784|11300053|FG005|COMPLETED|Overall Study||2
10170044|NCT03033784|11300054|FG006|COMPLETED|Overall Study||2
10170045|NCT03033784|11300055|FG007|COMPLETED|Overall Study||2
10170046|NCT03033784|11300056|FG008|COMPLETED|Overall Study||1
10170047|NCT03033784|11300057|FG009|COMPLETED|Overall Study||1
10170048|NCT03033784|11300058|FG010|COMPLETED|Overall Study||1
10170049|NCT03033784|11300059|FG011|COMPLETED|Overall Study||1
9712291|NCT02425826|10811861|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
9712292|NCT02425826|10811862|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
9712293|NCT02425826|10811863|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
9712294|NCT02425826|10811861|FG000|STARTED|Post-Treatment Observational Follow-Up||81
9712295|NCT02425826|10811862|FG001|STARTED|Post-Treatment Observational Follow-Up||0
9712296|NCT02425826|10811863|FG002|STARTED|Post-Treatment Observational Follow-Up||49
9712297|NCT02425826|10811861|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80
9712298|NCT02425826|10811862|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0
9712299|NCT02425826|10811863|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49
9712300|NCT02425826|10811861|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
9712301|NCT02425826|10811862|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
9712302|NCT02425826|10811863|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
9712303|NCT02384239|10811875|FG000|STARTED|Overall Study||36
9712304|NCT02384239|10811876|FG001|STARTED|Overall Study||34
9712305|NCT02384239|10811875|FG000|COMPLETED|Overall Study||36
9712306|NCT02384239|10811876|FG001|COMPLETED|Overall Study||34
9712307|NCT02384239|10811875|FG000|NOT COMPLETED|Overall Study||0
9712308|NCT02384239|10811876|FG001|NOT COMPLETED|Overall Study||0
9712309|NCT02356705|10811886|FG000|STARTED|Overall Study||14
9712310|NCT02356705|10811887|FG001|STARTED|Overall Study||14
9712311|NCT02356705|10811888|FG002|STARTED|Overall Study||14
9712312|NCT02356705|10811886|FG000|COMPLETED|Overall Study||14
9712313|NCT02356705|10811887|FG001|COMPLETED|Overall Study||14
9712314|NCT02356705|10811888|FG002|COMPLETED|Overall Study||14
9712315|NCT02356705|10811886|FG000|NOT COMPLETED|Overall Study||0
9712316|NCT02356705|10811887|FG001|NOT COMPLETED|Overall Study||0
9712317|NCT02356705|10811888|FG002|NOT COMPLETED|Overall Study||0
9712318|NCT02353247|10811901|FG000|STARTED|Overall Study||30
9712319|NCT02353247|10811902|FG001|STARTED|Overall Study||23
9712320|NCT02353247|10811903|FG002|STARTED|Overall Study||35
9712321|NCT02353247|10811901|FG000|COMPLETED|Overall Study||21
9712322|NCT02353247|10811902|FG001|COMPLETED|Overall Study||18
9712323|NCT02353247|10811903|FG002|COMPLETED|Overall Study||0
9712324|NCT02353247|10811901|FG000|NOT COMPLETED|Overall Study||9
9712325|NCT02353247|10811902|FG001|NOT COMPLETED|Overall Study||5
9712326|NCT02353247|10811903|FG002|NOT COMPLETED|Overall Study||35
9712327|NCT02316002|10811917|FG000|STARTED|Overall Study||51
9712328|NCT02316002|10811917|FG000|COMPLETED|Overall Study||45
9712329|NCT02316002|10811917|FG000|NOT COMPLETED|Overall Study||6
9712330|NCT02021071|10811923|FG000|STARTED|Overall Study||12
9712331|NCT02021071|10811924|FG001|STARTED|Overall Study||12
9712332|NCT02021071|10811923|FG000|COMPLETED|Overall Study||12
9712333|NCT02021071|10811924|FG001|COMPLETED|Overall Study||12
10170050|NCT03033784|11300060|FG012|COMPLETED|Overall Study||17
10170051|NCT03033784|11300048|FG000|NOT COMPLETED|Overall Study||0
10170052|NCT03033784|11300049|FG001|NOT COMPLETED|Overall Study||1
10170053|NCT03033784|11300050|FG002|NOT COMPLETED|Overall Study||0
10170054|NCT03033784|11300051|FG003|NOT COMPLETED|Overall Study||0
10170055|NCT03033784|11300052|FG004|NOT COMPLETED|Overall Study||0
10170056|NCT03033784|11300053|FG005|NOT COMPLETED|Overall Study||0
10170057|NCT03033784|11300054|FG006|NOT COMPLETED|Overall Study||0
10170058|NCT03033784|11300055|FG007|NOT COMPLETED|Overall Study||0
10170059|NCT03033784|11300056|FG008|NOT COMPLETED|Overall Study||0
10170060|NCT03033784|11300057|FG009|NOT COMPLETED|Overall Study||0
10170061|NCT03033784|11300058|FG010|NOT COMPLETED|Overall Study||0
10170062|NCT03033784|11300059|FG011|NOT COMPLETED|Overall Study||0
10170063|NCT03033784|11300060|FG012|NOT COMPLETED|Overall Study||2
10170064|NCT03034044|11300071|FG000|STARTED|Overall Study||106
10170065|NCT03034044|11300071|FG000|Received Xyntha|Overall Study||105
10170066|NCT03034044|11300071|FG000|COMPLETED|Overall Study||105
10170067|NCT03034044|11300071|FG000|NOT COMPLETED|Overall Study||1
10170068|NCT03034057|11300075|FG000|STARTED|Overall Study||169
10170069|NCT03034057|11300075|FG000|COMPLETED|Overall Study||114
10170070|NCT03034057|11300075|FG000|NOT COMPLETED|Overall Study||55
10170071|NCT03034135|11300079|FG000|STARTED|Overall Study||23
10170072|NCT03034135|11300079|FG000|COMPLETED|Overall Study||21
10170073|NCT03034135|11300079|FG000|NOT COMPLETED|Overall Study||2
10170074|NCT03034460|11300085|FG000|STARTED|Overall Study||48
10170075|NCT03034460|11300086|FG001|STARTED|Overall Study||22
10170076|NCT03034460|11300085|FG000|COMPLETED|Overall Study||45
10170077|NCT03034460|11300086|FG001|COMPLETED|Overall Study||19
10170078|NCT03034460|11300085|FG000|NOT COMPLETED|Overall Study||3
10170079|NCT03034460|11300086|FG001|NOT COMPLETED|Overall Study||3
10170080|NCT03034577|11300098|FG000|STARTED|Overall Study||175
10170081|NCT03034577|11300099|FG001|STARTED|Overall Study||175
10170082|NCT03034577|11300098|FG000|COMPLETED|Overall Study||144
10170083|NCT03034577|11300099|FG001|COMPLETED|Overall Study||140
10170084|NCT03034577|11300098|FG000|NOT COMPLETED|Overall Study||31
10170085|NCT03034577|11300099|FG001|NOT COMPLETED|Overall Study||35
10170086|NCT03034772|11300109|FG000|STARTED|Overall Study||27
10170087|NCT03034772|11300110|FG001|STARTED|Overall Study||25
10170088|NCT03034772|11300109|FG000|COMPLETED|Overall Study||27
10170089|NCT03034772|11300110|FG001|COMPLETED|Overall Study||23
10170090|NCT03034772|11300109|FG000|NOT COMPLETED|Overall Study||0
10170091|NCT03034772|11300110|FG001|NOT COMPLETED|Overall Study||2
10170092|NCT03034915|11300119|FG000|STARTED|Overall Study||812
10170093|NCT03034915|11300120|FG001|STARTED|Overall Study||804
10170094|NCT03034915|11300121|FG002|STARTED|Overall Study||809
10170095|NCT03034915|11300119|FG000|COMPLETED|Overall Study||717
10170096|NCT03034915|11300120|FG001|COMPLETED|Overall Study||650
9712334|NCT02021071|10811923|FG000|NOT COMPLETED|Overall Study||0
9712335|NCT02021071|10811924|FG001|NOT COMPLETED|Overall Study||0
9712336|NCT02000622|10811933|FG000|STARTED|Overall Study||205
9712337|NCT02000622|10811934|FG001|STARTED|Overall Study||97
9712338|NCT02000622|10811933|FG000|COMPLETED|Overall Study||36
9712339|NCT02000622|10811934|FG001|COMPLETED|Overall Study||17
9712340|NCT02000622|10811933|FG000|NOT COMPLETED|Overall Study||169
9712341|NCT02000622|10811934|FG001|NOT COMPLETED|Overall Study||80
9712342|NCT01933932|10811942|FG000|STARTED|Overall Study||254
9712343|NCT01933932|10811943|FG001|STARTED|Overall Study||256
9849580|NCT00866333|10962324|FG002|COMPLETED|Overall Study||4
10170097|NCT03034915|11300121|FG002|COMPLETED|Overall Study||683
10170098|NCT03034915|11300119|FG000|NOT COMPLETED|Overall Study||95
10170099|NCT03034915|11300120|FG001|NOT COMPLETED|Overall Study||154
10170100|NCT03034915|11300121|FG002|NOT COMPLETED|Overall Study||126
10170101|NCT03034928|11300129|FG000|STARTED|Period 1, First 2 Hours of Wear||8
10170102|NCT03034928|11300130|FG001|STARTED|Period 1, First 2 Hours of Wear||8
10170103|NCT03034928|11300131|FG002|STARTED|Period 1, First 2 Hours of Wear||9
10170104|NCT03034928|11300132|FG003|STARTED|Period 1, First 2 Hours of Wear||8
10170105|NCT03034928|11300129|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8
10170106|NCT03034928|11300130|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8
10170107|NCT03034928|11300131|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9
10170108|NCT03034928|11300132|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8
10170109|NCT03034928|11300129|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10170110|NCT03034928|11300130|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10170111|NCT03034928|11300131|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10170112|NCT03034928|11300132|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10170113|NCT03034928|11300129|FG000|STARTED|Washout Period Between Lens Wear||8
10170114|NCT03034928|11300130|FG001|STARTED|Washout Period Between Lens Wear||8
10170115|NCT03034928|11300131|FG002|STARTED|Washout Period Between Lens Wear||9
10170116|NCT03034928|11300132|FG003|STARTED|Washout Period Between Lens Wear||8
10170117|NCT03034928|11300129|FG000|COMPLETED|Washout Period Between Lens Wear||8
10170118|NCT03034928|11300130|FG001|COMPLETED|Washout Period Between Lens Wear||8
10170119|NCT03034928|11300131|FG002|COMPLETED|Washout Period Between Lens Wear||9
10170120|NCT03034928|11300132|FG003|COMPLETED|Washout Period Between Lens Wear||8
10170121|NCT03034928|11300129|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0
10170122|NCT03034928|11300130|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0
10170123|NCT03034928|11300131|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0
10170124|NCT03034928|11300132|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0
10170125|NCT03034928|11300129|FG000|STARTED|Period 2, Second 2 Hours of Wear||8
10170126|NCT03034928|11300130|FG001|STARTED|Period 2, Second 2 Hours of Wear||8
10170127|NCT03034928|11300131|FG002|STARTED|Period 2, Second 2 Hours of Wear||9
10170128|NCT03034928|11300132|FG003|STARTED|Period 2, Second 2 Hours of Wear||8
10170129|NCT03034928|11300129|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8
10170130|NCT03034928|11300130|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8
10170131|NCT03034928|11300131|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9
10170132|NCT03034928|11300132|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8
10170133|NCT03034928|11300129|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10170134|NCT03034928|11300130|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10170135|NCT03034928|11300131|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10170136|NCT03034928|11300132|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10170137|NCT03034954|11300143|FG000|STARTED|Overall Study||21
10170138|NCT03034954|11300144|FG001|STARTED|Overall Study||21
10170139|NCT03034954|11300143|FG000|COMPLETED|Overall Study||20
10170140|NCT03034954|11300144|FG001|COMPLETED|Overall Study||21
10170141|NCT03034954|11300143|FG000|NOT COMPLETED|Overall Study||1
10170142|NCT03034954|11300144|FG001|NOT COMPLETED|Overall Study||0
10170143|NCT03034967|11300156|FG000|STARTED|Overall Study||102
10170144|NCT03034967|11300157|FG001|STARTED|Overall Study||102
10170145|NCT03034967|11300158|FG002|STARTED|Overall Study||103
10170146|NCT03034967|11300159|FG003|STARTED|Overall Study||103
10170147|NCT03034967|11300160|FG004|STARTED|Overall Study||102
10170148|NCT03034967|11300161|FG005|STARTED|Overall Study||102
10170149|NCT03034967|11300156|FG000|COMPLETED|Overall Study||88
10170150|NCT03034967|11300157|FG001|COMPLETED|Overall Study||97
10170151|NCT03034967|11300158|FG002|COMPLETED|Overall Study||90
10170152|NCT03034967|11300159|FG003|COMPLETED|Overall Study||92
10170153|NCT03034967|11300160|FG004|COMPLETED|Overall Study||88
10170154|NCT03034967|11300161|FG005|COMPLETED|Overall Study||87
10170155|NCT03034967|11300156|FG000|NOT COMPLETED|Overall Study||14
10170156|NCT03034967|11300157|FG001|NOT COMPLETED|Overall Study||5
10170157|NCT03034967|11300158|FG002|NOT COMPLETED|Overall Study||13
10170158|NCT03034967|11300159|FG003|NOT COMPLETED|Overall Study||11
10170159|NCT03034967|11300160|FG004|NOT COMPLETED|Overall Study||14
10170160|NCT03034967|11300161|FG005|NOT COMPLETED|Overall Study||15
10170161|NCT03035032|11300180|FG000|STARTED|Overall Study||107
10170162|NCT03035032|11300180|FG000|COMPLETED|Overall Study||64
10170163|NCT03035032|11300180|FG000|NOT COMPLETED|Overall Study||43
10170164|NCT03035318|11300189|FG000|STARTED|Overall Study||24
10170165|NCT03035318|11300190|FG001|STARTED|Overall Study||25
10170166|NCT03035318|11300191|FG002|STARTED|Overall Study||25
10170167|NCT03035318|11300192|FG003|STARTED|Overall Study||25
10170168|NCT03035318|11300193|FG004|STARTED|Overall Study||27
10170169|NCT03035318|11300189|FG000|COMPLETED|Overall Study||22
10170170|NCT03035318|11300190|FG001|COMPLETED|Overall Study||21
10170171|NCT03035318|11300191|FG002|COMPLETED|Overall Study||21
10170172|NCT03035318|11300192|FG003|COMPLETED|Overall Study||23
10170173|NCT03035318|11300193|FG004|COMPLETED|Overall Study||20
10170174|NCT03035318|11300189|FG000|NOT COMPLETED|Overall Study||2
10170175|NCT03035318|11300190|FG001|NOT COMPLETED|Overall Study||4
10170176|NCT03035318|11300191|FG002|NOT COMPLETED|Overall Study||4
10170177|NCT03035318|11300192|FG003|NOT COMPLETED|Overall Study||2
10170178|NCT03035318|11300193|FG004|NOT COMPLETED|Overall Study||7
10170179|NCT03035487|11300205|FG000|STARTED|Overall Study||9
10170180|NCT03035487|11300205|FG000|COMPLETED|Overall Study||9
10170181|NCT03035487|11300205|FG000|NOT COMPLETED|Overall Study||0
10170182|NCT03035708|11300211|FG000|STARTED|Overall Study||23
10170183|NCT03035708|11300212|FG001|STARTED|Overall Study||24
10170184|NCT03035708|11300211|FG000|COMPLETED|Overall Study||19
10170185|NCT03035708|11300212|FG001|COMPLETED|Overall Study||13
10170186|NCT03035708|11300211|FG000|NOT COMPLETED|Overall Study||4
10170187|NCT03035708|11300212|FG001|NOT COMPLETED|Overall Study||11
10170188|NCT03035760|11300225|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8
10170189|NCT03035760|11300226|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8
10170190|NCT03035760|11300227|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8
10170191|NCT03035760|11300228|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6
10170192|NCT03035760|11300229|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6
10170193|NCT03035760|11300225|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8
10170194|NCT03035760|11300226|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8
10170195|NCT03035760|11300227|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8
10170196|NCT03035760|11300228|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6
10170197|NCT03035760|11300229|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6
10170198|NCT03035760|11300225|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10170199|NCT03035760|11300226|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10170200|NCT03035760|11300227|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10170201|NCT03035760|11300228|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10170202|NCT03035760|11300229|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10170203|NCT03035760|11300225|FG000|STARTED|Second Intervention - 7 Days Follow-up||0
10170204|NCT03035760|11300226|FG001|STARTED|Second Intervention - 7 Days Follow-up||0
10170205|NCT03035760|11300227|FG002|STARTED|Second Intervention - 7 Days Follow-up||0
10170206|NCT03035760|11300228|FG003|STARTED|Second Intervention - 7 Days Follow-up||6
10170207|NCT03035760|11300229|FG004|STARTED|Second Intervention - 7 Days Follow-up||6
10170208|NCT03035760|11300225|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0
10170209|NCT03035760|11300226|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0
10170210|NCT03035760|11300227|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0
10170211|NCT03035760|11300228|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6
10170212|NCT03035760|11300229|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6
10170213|NCT03035760|11300225|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10170214|NCT03035760|11300226|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10170215|NCT03035760|11300227|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10170216|NCT03035760|11300228|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10170217|NCT03035760|11300229|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10170218|NCT03035864|11300244|FG000|STARTED|Treatment Period||120
10170219|NCT03035864|11300245|FG001|STARTED|Treatment Period||60
10170220|NCT03035864|11300244|FG000|COMPLETED|Treatment Period||116
10170221|NCT03035864|11300245|FG001|COMPLETED|Treatment Period||59
10170222|NCT03035864|11300244|FG000|NOT COMPLETED|Treatment Period||4
10170223|NCT03035864|11300245|FG001|NOT COMPLETED|Treatment Period||1
10170224|NCT03035864|11300244|FG000|STARTED|Follow-up Period||116
10170225|NCT03035864|11300245|FG001|STARTED|Follow-up Period||59
10170226|NCT03035864|11300244|FG000|COMPLETED|Follow-up Period||105
10170227|NCT03035864|11300245|FG001|COMPLETED|Follow-up Period||55
10170228|NCT03035864|11300244|FG000|NOT COMPLETED|Follow-up Period||11
10170229|NCT03035864|11300245|FG001|NOT COMPLETED|Follow-up Period||4
10170230|NCT03035916|11300254|FG000|STARTED|Overall Study||30
10170231|NCT03035916|11300255|FG001|STARTED|Overall Study||30
10170232|NCT03035916|11300256|FG002|STARTED|Overall Study||31
10170233|NCT03035916|11300254|FG000|COMPLETED|Overall Study||30
10170234|NCT03035916|11300255|FG001|COMPLETED|Overall Study||28
10170235|NCT03035916|11300256|FG002|COMPLETED|Overall Study||31
10170236|NCT03035916|11300254|FG000|NOT COMPLETED|Overall Study||0
10170237|NCT03035916|11300255|FG001|NOT COMPLETED|Overall Study||2
10170238|NCT03035916|11300256|FG002|NOT COMPLETED|Overall Study||0
10170239|NCT03035929|11300264|FG000|STARTED|Overall Study||10
10170240|NCT03035929|11300264|FG000|COMPLETED|Overall Study||10
10170241|NCT03035929|11300264|FG000|NOT COMPLETED|Overall Study||0
10170242|NCT03035942|11300272|FG000|STARTED|Overall Study||45
10170243|NCT03035942|11300273|FG001|STARTED|Overall Study||45
10170244|NCT03035942|11300274|FG002|STARTED|Overall Study||45
10170245|NCT03035942|11300272|FG000|COMPLETED|Overall Study||37
10170246|NCT03035942|11300273|FG001|COMPLETED|Overall Study||41
10170247|NCT03035942|11300274|FG002|COMPLETED|Overall Study||40
10170248|NCT03035942|11300272|FG000|NOT COMPLETED|Overall Study||8
10170249|NCT03035942|11300273|FG001|NOT COMPLETED|Overall Study||4
10170250|NCT03035942|11300274|FG002|NOT COMPLETED|Overall Study||5
10170251|NCT03035955|11300286|FG000|STARTED|Overall Study||10
10170252|NCT03035955|11300287|FG001|STARTED|Overall Study||10
10170253|NCT03035955|11300286|FG000|COMPLETED|Overall Study||9
10170254|NCT03035955|11300287|FG001|COMPLETED|Overall Study||9
10170255|NCT03035955|11300286|FG000|NOT COMPLETED|Overall Study||1
10170256|NCT03035955|11300287|FG001|NOT COMPLETED|Overall Study||1
10170257|NCT03036072|11300295|FG000|STARTED|Overall Study||12
10170258|NCT03036072|11300296|FG001|STARTED|Overall Study||13
10170259|NCT03036072|11300295|FG000|COMPLETED|Overall Study||12
10170260|NCT03036072|11300296|FG001|COMPLETED|Overall Study||10
10170261|NCT03036072|11300295|FG000|NOT COMPLETED|Overall Study||0
10170262|NCT03036072|11300296|FG001|NOT COMPLETED|Overall Study||3
10170263|NCT03036124|11300304|FG000|STARTED|Overall Study||2373
10170264|NCT03036124|11300305|FG001|STARTED|Overall Study||2371
10170265|NCT03036124|11300304|FG000|COMPLETED|Overall Study||2368
10170266|NCT03036124|11300305|FG001|COMPLETED|Overall Study||2365
10170267|NCT03036124|11300304|FG000|NOT COMPLETED|Overall Study||5
10170268|NCT03036124|11300305|FG001|NOT COMPLETED|Overall Study||6
10170269|NCT03036150|11300313|FG000|STARTED|Overall Study||2152
10170270|NCT03036150|11300314|FG001|STARTED|Overall Study||2152
10170271|NCT03036150|11300313|FG000|COMPLETED|Overall Study||2142
10170272|NCT03036150|11300314|FG001|COMPLETED|Overall Study||2147
10170273|NCT03036150|11300313|FG000|NOT COMPLETED|Overall Study||10
10170274|NCT03036150|11300314|FG001|NOT COMPLETED|Overall Study||5
10170275|NCT03036163|11300327|FG000|STARTED|Overall Study||6
10170276|NCT03036163|11300328|FG001|STARTED|Overall Study||6
10170277|NCT03036163|11300329|FG002|STARTED|Overall Study||6
10170278|NCT03036163|11300330|FG003|STARTED|Overall Study||6
10170279|NCT03036163|11300331|FG004|STARTED|Overall Study||6
10170280|NCT03036163|11300332|FG005|STARTED|Overall Study||5
10170281|NCT03036163|11300333|FG006|STARTED|Overall Study||5
10170282|NCT03036163|11300327|FG000|COMPLETED|Overall Study||6
10170283|NCT03036163|11300328|FG001|COMPLETED|Overall Study||6
10170284|NCT03036163|11300329|FG002|COMPLETED|Overall Study||6
10170285|NCT03036163|11300330|FG003|COMPLETED|Overall Study||6
10170286|NCT03036163|11300331|FG004|COMPLETED|Overall Study||6
10170287|NCT03036163|11300332|FG005|COMPLETED|Overall Study||5
10170288|NCT03036163|11300333|FG006|COMPLETED|Overall Study||5
10170289|NCT03036163|11300327|FG000|NOT COMPLETED|Overall Study||0
10170290|NCT03036163|11300328|FG001|NOT COMPLETED|Overall Study||0
10170291|NCT03036163|11300329|FG002|NOT COMPLETED|Overall Study||0
10170292|NCT03036163|11300330|FG003|NOT COMPLETED|Overall Study||0
10170293|NCT03036163|11300331|FG004|NOT COMPLETED|Overall Study||0
10170294|NCT03036163|11300332|FG005|NOT COMPLETED|Overall Study||0
10170295|NCT03036163|11300333|FG006|NOT COMPLETED|Overall Study||0
10170296|NCT03036215|11300351|FG000|STARTED|Overall Study||41
10170297|NCT03036215|11300352|FG001|STARTED|Overall Study||39
10170298|NCT03036215|11300351|FG000|COMPLETED|Overall Study||39
10170299|NCT03036215|11300352|FG001|COMPLETED|Overall Study||36
10170300|NCT03036215|11300351|FG000|NOT COMPLETED|Overall Study||2
10170301|NCT03036215|11300352|FG001|NOT COMPLETED|Overall Study||3
10170302|NCT03036293|11300365|FG000|STARTED|Overall Study||127
10170303|NCT03036293|11300366|FG001|STARTED|Overall Study||67
10170304|NCT03036293|11300367|FG002|STARTED|Overall Study||131
10170305|NCT03036293|11300368|FG003|STARTED|Overall Study||65
10170306|NCT03036293|11300365|FG000|COMPLETED|Overall Study||126
10170307|NCT03036293|11300366|FG001|COMPLETED|Overall Study||64
10170308|NCT03036293|11300367|FG002|COMPLETED|Overall Study||130
10170309|NCT03036293|11300368|FG003|COMPLETED|Overall Study||64
10170310|NCT03036293|11300365|FG000|NOT COMPLETED|Overall Study||1
10170311|NCT03036293|11300366|FG001|NOT COMPLETED|Overall Study||3
10170312|NCT03036293|11300367|FG002|NOT COMPLETED|Overall Study||1
10170313|NCT03036293|11300368|FG003|NOT COMPLETED|Overall Study||1
10170314|NCT03036384|11300380|FG000|STARTED|Overall Study||4
10170315|NCT03036384|11300381|FG001|STARTED|Overall Study||4
10170316|NCT03036384|11300382|FG002|STARTED|Overall Study||4
10170317|NCT03036384|11300383|FG003|STARTED|Overall Study||4
10170318|NCT03036384|11300384|FG004|STARTED|Overall Study||4
10170319|NCT03036384|11300385|FG005|STARTED|Overall Study||4
10170320|NCT03036384|11300386|FG006|STARTED|Overall Study||4
10170321|NCT03036384|11300387|FG007|STARTED|Overall Study||4
10170322|NCT03036384|11300388|FG008|STARTED|Overall Study||4
10170323|NCT03036384|11300389|FG009|STARTED|Overall Study||4
10170324|NCT03036384|11300380|FG000|COMPLETED|Overall Study||4
10170325|NCT03036384|11300381|FG001|COMPLETED|Overall Study||4
10170326|NCT03036384|11300382|FG002|COMPLETED|Overall Study||4
10170327|NCT03036384|11300383|FG003|COMPLETED|Overall Study||4
10170328|NCT03036384|11300384|FG004|COMPLETED|Overall Study||4
10170329|NCT03036384|11300385|FG005|COMPLETED|Overall Study||4
10170330|NCT03036384|11300386|FG006|COMPLETED|Overall Study||4
10170331|NCT03036384|11300387|FG007|COMPLETED|Overall Study||4
10170332|NCT03036384|11300388|FG008|COMPLETED|Overall Study||4
10170333|NCT03036384|11300389|FG009|COMPLETED|Overall Study||4
10170334|NCT03036384|11300380|FG000|NOT COMPLETED|Overall Study||0
10170335|NCT03036384|11300381|FG001|NOT COMPLETED|Overall Study||0
10170336|NCT03036384|11300382|FG002|NOT COMPLETED|Overall Study||0
10170337|NCT03036384|11300383|FG003|NOT COMPLETED|Overall Study||0
10170338|NCT03036384|11300384|FG004|NOT COMPLETED|Overall Study||0
10170339|NCT03036384|11300385|FG005|NOT COMPLETED|Overall Study||0
10170340|NCT03036384|11300386|FG006|NOT COMPLETED|Overall Study||0
10170341|NCT03036384|11300387|FG007|NOT COMPLETED|Overall Study||0
10170342|NCT03036384|11300388|FG008|NOT COMPLETED|Overall Study||0
10170343|NCT03036384|11300389|FG009|NOT COMPLETED|Overall Study||0
10170344|NCT03036813|11300410|FG000|STARTED|Overall Study||92
10170345|NCT03036813|11300411|FG001|STARTED|Overall Study||90
10170346|NCT03036813|11300412|FG002|STARTED|Overall Study||92
10170347|NCT03036813|11300410|FG000|COMPLETED|Overall Study||70
10170348|NCT03036813|11300411|FG001|COMPLETED|Overall Study||63
10170349|NCT03036813|11300412|FG002|COMPLETED|Overall Study||66
10170350|NCT03036813|11300410|FG000|NOT COMPLETED|Overall Study||22
10170351|NCT03036813|11300411|FG001|NOT COMPLETED|Overall Study||27
10170352|NCT03036813|11300412|FG002|NOT COMPLETED|Overall Study||26
10170353|NCT03036839|11300426|FG000|STARTED|Overall Study||45
10170354|NCT03036839|11300427|FG001|STARTED|Overall Study||31
10170355|NCT03036839|11300428|FG002|STARTED|Overall Study||19
10170356|NCT03036839|11300426|FG000|COMPLETED|Overall Study||42
10170357|NCT03036839|11300427|FG001|COMPLETED|Overall Study||31
10170358|NCT03036839|11300428|FG002|COMPLETED|Overall Study||14
10170359|NCT03036839|11300426|FG000|NOT COMPLETED|Overall Study||3
10170360|NCT03036839|11300427|FG001|NOT COMPLETED|Overall Study||0
10170361|NCT03036839|11300428|FG002|NOT COMPLETED|Overall Study||5
10170362|NCT03036852|11300442|FG000|STARTED|Overall Study||59
10170363|NCT03036852|11300442|FG000|COMPLETED|Overall Study||53
10170364|NCT03036852|11300442|FG000|NOT COMPLETED|Overall Study||6
10170365|NCT03037203|11300456|FG000|STARTED|Overall Study||28
10170366|NCT03037203|11300457|FG001|STARTED|Overall Study||28
10170367|NCT03037203|11300458|FG002|STARTED|Overall Study||10
10170368|NCT03037203|11300456|FG000|COMPLETED|Overall Study||27
10170369|NCT03037203|11300457|FG001|COMPLETED|Overall Study||26
10170370|NCT03037203|11300458|FG002|COMPLETED|Overall Study||9
10170371|NCT03037203|11300456|FG000|NOT COMPLETED|Overall Study||1
10170372|NCT03037203|11300457|FG001|NOT COMPLETED|Overall Study||2
10170373|NCT03037203|11300458|FG002|NOT COMPLETED|Overall Study||1
10170374|NCT03037281|11300478|FG000|STARTED|Overall Study||6
10170375|NCT03037281|11300479|FG001|STARTED|Overall Study||8
10170376|NCT03037281|11300478|FG000|COMPLETED|Overall Study||6
10170377|NCT03037281|11300479|FG001|COMPLETED|Overall Study||8
10170378|NCT03037281|11300478|FG000|NOT COMPLETED|Overall Study||0
10170379|NCT03037281|11300479|FG001|NOT COMPLETED|Overall Study||0
10170380|NCT03037307|11300490|FG000|STARTED|Period 1||7
10170381|NCT03037307|11300491|FG001|STARTED|Period 1||7
10170382|NCT03037307|11300492|FG002|STARTED|Period 1||8
10170383|NCT03037307|11300493|FG003|STARTED|Period 1||7
10170384|NCT03037307|11300494|FG004|STARTED|Period 1||7
10170385|NCT03037307|11300495|FG005|STARTED|Period 1||8
10170386|NCT03037307|11300490|FG000|COMPLETED|Period 1||7
10170387|NCT03037307|11300491|FG001|COMPLETED|Period 1||7
10170388|NCT03037307|11300492|FG002|COMPLETED|Period 1||8
10170389|NCT03037307|11300493|FG003|COMPLETED|Period 1||6
10170390|NCT03037307|11300494|FG004|COMPLETED|Period 1||7
10170391|NCT03037307|11300495|FG005|COMPLETED|Period 1||8
10170392|NCT03037307|11300490|FG000|NOT COMPLETED|Period 1||0
10170393|NCT03037307|11300491|FG001|NOT COMPLETED|Period 1||0
10170394|NCT03037307|11300492|FG002|NOT COMPLETED|Period 1||0
10170395|NCT03037307|11300493|FG003|NOT COMPLETED|Period 1||1
10170396|NCT03037307|11300494|FG004|NOT COMPLETED|Period 1||0
10170397|NCT03037307|11300495|FG005|NOT COMPLETED|Period 1||0
10170398|NCT03037307|11300490|FG000|STARTED|Wash Out Period 1||7
10170399|NCT03037307|11300491|FG001|STARTED|Wash Out Period 1||7
10170400|NCT03037307|11300492|FG002|STARTED|Wash Out Period 1||8
10170401|NCT03037307|11300493|FG003|STARTED|Wash Out Period 1||6
10170402|NCT03037307|11300494|FG004|STARTED|Wash Out Period 1||7
10170403|NCT03037307|11300495|FG005|STARTED|Wash Out Period 1||8
10170404|NCT03037307|11300490|FG000|COMPLETED|Wash Out Period 1||7
10170405|NCT03037307|11300491|FG001|COMPLETED|Wash Out Period 1||7
10170406|NCT03037307|11300492|FG002|COMPLETED|Wash Out Period 1||8
10170407|NCT03037307|11300493|FG003|COMPLETED|Wash Out Period 1||6
10170408|NCT03037307|11300494|FG004|COMPLETED|Wash Out Period 1||7
10170409|NCT03037307|11300495|FG005|COMPLETED|Wash Out Period 1||8
10170410|NCT03037307|11300490|FG000|NOT COMPLETED|Wash Out Period 1||0
10170411|NCT03037307|11300491|FG001|NOT COMPLETED|Wash Out Period 1||0
10170412|NCT03037307|11300492|FG002|NOT COMPLETED|Wash Out Period 1||0
10170413|NCT03037307|11300493|FG003|NOT COMPLETED|Wash Out Period 1||0
10170414|NCT03037307|11300494|FG004|NOT COMPLETED|Wash Out Period 1||0
10170415|NCT03037307|11300495|FG005|NOT COMPLETED|Wash Out Period 1||0
10170416|NCT03037307|11300490|FG000|STARTED|Period 2||7
10170417|NCT03037307|11300491|FG001|STARTED|Period 2||7
10170418|NCT03037307|11300492|FG002|STARTED|Period 2||8
10170419|NCT03037307|11300493|FG003|STARTED|Period 2||6
10170420|NCT03037307|11300494|FG004|STARTED|Period 2||7
10170421|NCT03037307|11300495|FG005|STARTED|Period 2||8
10170422|NCT03037307|11300490|FG000|COMPLETED|Period 2||7
10170423|NCT03037307|11300491|FG001|COMPLETED|Period 2||7
10170424|NCT03037307|11300492|FG002|COMPLETED|Period 2||8
10170425|NCT03037307|11300493|FG003|COMPLETED|Period 2||6
10170426|NCT03037307|11300494|FG004|COMPLETED|Period 2||7
10170427|NCT03037307|11300495|FG005|COMPLETED|Period 2||8
10170428|NCT03037307|11300490|FG000|NOT COMPLETED|Period 2||0
10170429|NCT03037307|11300491|FG001|NOT COMPLETED|Period 2||0
10170430|NCT03037307|11300492|FG002|NOT COMPLETED|Period 2||0
10170431|NCT03037307|11300493|FG003|NOT COMPLETED|Period 2||0
10170432|NCT03037307|11300494|FG004|NOT COMPLETED|Period 2||0
10170433|NCT03037307|11300495|FG005|NOT COMPLETED|Period 2||0
10170434|NCT03037307|11300490|FG000|STARTED|Wash Out Period 2||7
10170435|NCT03037307|11300491|FG001|STARTED|Wash Out Period 2||7
10170436|NCT03037307|11300492|FG002|STARTED|Wash Out Period 2||8
10170437|NCT03037307|11300493|FG003|STARTED|Wash Out Period 2||6
10170438|NCT03037307|11300494|FG004|STARTED|Wash Out Period 2||7
10170439|NCT03037307|11300495|FG005|STARTED|Wash Out Period 2||8
10170440|NCT03037307|11300490|FG000|COMPLETED|Wash Out Period 2||7
10170441|NCT03037307|11300491|FG001|COMPLETED|Wash Out Period 2||7
10170442|NCT03037307|11300492|FG002|COMPLETED|Wash Out Period 2||8
10170443|NCT03037307|11300493|FG003|COMPLETED|Wash Out Period 2||6
10170444|NCT03037307|11300494|FG004|COMPLETED|Wash Out Period 2||7
10170445|NCT03037307|11300495|FG005|COMPLETED|Wash Out Period 2||8
10170446|NCT03037307|11300490|FG000|NOT COMPLETED|Wash Out Period 2||0
10170447|NCT03037307|11300491|FG001|NOT COMPLETED|Wash Out Period 2||0
10170448|NCT03037307|11300492|FG002|NOT COMPLETED|Wash Out Period 2||0
10170449|NCT03037307|11300493|FG003|NOT COMPLETED|Wash Out Period 2||0
10170450|NCT03037307|11300494|FG004|NOT COMPLETED|Wash Out Period 2||0
10170451|NCT03037307|11300495|FG005|NOT COMPLETED|Wash Out Period 2||0
10170452|NCT03037307|11300490|FG000|STARTED|Period 3||7
10170453|NCT03037307|11300491|FG001|STARTED|Period 3||7
10170454|NCT03037307|11300492|FG002|STARTED|Period 3||8
10170455|NCT03037307|11300493|FG003|STARTED|Period 3||6
10170456|NCT03037307|11300494|FG004|STARTED|Period 3||7
10170457|NCT03037307|11300495|FG005|STARTED|Period 3||8
10170458|NCT03037307|11300490|FG000|COMPLETED|Period 3||7
10170459|NCT03037307|11300491|FG001|COMPLETED|Period 3||7
10170460|NCT03037307|11300492|FG002|COMPLETED|Period 3||8
10170461|NCT03037307|11300493|FG003|COMPLETED|Period 3||6
10170462|NCT03037307|11300494|FG004|COMPLETED|Period 3||7
10170463|NCT03037307|11300495|FG005|COMPLETED|Period 3||8
10170464|NCT03037307|11300490|FG000|NOT COMPLETED|Period 3||0
10170465|NCT03037307|11300491|FG001|NOT COMPLETED|Period 3||0
10170466|NCT03037307|11300492|FG002|NOT COMPLETED|Period 3||0
10170467|NCT03037307|11300493|FG003|NOT COMPLETED|Period 3||0
10170468|NCT03037307|11300494|FG004|NOT COMPLETED|Period 3||0
10170469|NCT03037307|11300495|FG005|NOT COMPLETED|Period 3||0
10170470|NCT03037489|11300506|FG000|STARTED|Overall Study||46
10170471|NCT03037489|11300507|FG001|STARTED|Overall Study||4
10170472|NCT03037489|11300506|FG000|COMPLETED|Overall Study||39
10170473|NCT03037489|11300507|FG001|COMPLETED|Overall Study||4
10170474|NCT03037489|11300506|FG000|NOT COMPLETED|Overall Study||7
10170475|NCT03037489|11300507|FG001|NOT COMPLETED|Overall Study||0
10170476|NCT03037541|11300515|FG000|STARTED|Overall Study||30
10170477|NCT03037541|11300516|FG001|STARTED|Overall Study||30
10170478|NCT03037541|11300515|FG000|COMPLETED|Overall Study||30
10170479|NCT03037541|11300516|FG001|COMPLETED|Overall Study||30
10170480|NCT03037541|11300515|FG000|NOT COMPLETED|Overall Study||0
10170481|NCT03037541|11300516|FG001|NOT COMPLETED|Overall Study||0
10170482|NCT03037580|11300524|FG000|STARTED|Overall Study||41
10170483|NCT03037580|11300525|FG001|STARTED|Overall Study||43
10170484|NCT03037580|11300524|FG000|COMPLETED|Overall Study||25
10170485|NCT03037580|11300525|FG001|COMPLETED|Overall Study||27
10170486|NCT03037580|11300524|FG000|NOT COMPLETED|Overall Study||16
10170487|NCT03037580|11300525|FG001|NOT COMPLETED|Overall Study||16
10170488|NCT03037619|11300533|FG000|STARTED|Overall Study||8
10170489|NCT03037619|11300534|FG001|STARTED|Overall Study|8 participants and 7 buddies|15
10170490|NCT03037619|11300533|FG000|COMPLETED|Overall Study||8
10170491|NCT03037619|11300534|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14
10170492|NCT03037619|11300533|FG000|NOT COMPLETED|Overall Study||0
10170493|NCT03037619|11300534|FG001|NOT COMPLETED|Overall Study||1
10170494|NCT03037905|11300542|FG000|STARTED|Overall Study||50
10170495|NCT03037905|11300543|FG001|STARTED|Overall Study||50
10170496|NCT03037905|11300542|FG000|COMPLETED|Overall Study||50
10170497|NCT03037905|11300543|FG001|COMPLETED|Overall Study||50
10170498|NCT03037905|11300542|FG000|NOT COMPLETED|Overall Study||0
10170499|NCT03037905|11300543|FG001|NOT COMPLETED|Overall Study||0
10170500|NCT03037983|11300553|FG000|STARTED|Overall Study||5
10170501|NCT03037983|11300554|FG001|STARTED|Overall Study||4
10170502|NCT03037983|11300553|FG000|COMPLETED|Overall Study||5
10170503|NCT03037983|11300554|FG001|COMPLETED|Overall Study||4
10170504|NCT03037983|11300553|FG000|NOT COMPLETED|Overall Study||0
10170505|NCT03037983|11300554|FG001|NOT COMPLETED|Overall Study||0
10170506|NCT03038113|11300574|FG000|STARTED|Overall Study||8
10170507|NCT03038113|11300575|FG001|STARTED|Overall Study||8
10170508|NCT03038113|11300576|FG002|STARTED|Overall Study||8
10170509|NCT03038113|11300577|FG003|STARTED|Overall Study||8
10170510|NCT03038113|11300578|FG004|STARTED|Overall Study||8
10170511|NCT03038113|11300579|FG005|STARTED|Overall Study||8
10170512|NCT03038113|11300580|FG006|STARTED|Overall Study||12
10170513|NCT03038113|11300581|FG007|STARTED|Overall Study||6
10170514|NCT03038113|11300582|FG008|STARTED|Overall Study||7
10170515|NCT03038113|11300583|FG009|STARTED|Overall Study||6
10170516|NCT03038113|11300584|FG010|STARTED|Overall Study||14
10170517|NCT03038113|11300585|FG011|STARTED|Overall Study||7
10170518|NCT03038113|11300586|FG012|STARTED|Overall Study||4
10170519|NCT03038113|11300587|FG013|STARTED|Overall Study||15
10170520|NCT03038113|11300574|FG000|COMPLETED|Overall Study||8
10170521|NCT03038113|11300575|FG001|COMPLETED|Overall Study||8
10170522|NCT03038113|11300576|FG002|COMPLETED|Overall Study||7
10170523|NCT03038113|11300577|FG003|COMPLETED|Overall Study||8
10170524|NCT03038113|11300578|FG004|COMPLETED|Overall Study||8
10170525|NCT03038113|11300579|FG005|COMPLETED|Overall Study||8
10170526|NCT03038113|11300580|FG006|COMPLETED|Overall Study||11
10170527|NCT03038113|11300581|FG007|COMPLETED|Overall Study||6
10170528|NCT03038113|11300582|FG008|COMPLETED|Overall Study||7
10170529|NCT03038113|11300583|FG009|COMPLETED|Overall Study||6
10170530|NCT03038113|11300584|FG010|COMPLETED|Overall Study||14
10170531|NCT03038113|11300585|FG011|COMPLETED|Overall Study||7
10170532|NCT03038113|11300586|FG012|COMPLETED|Overall Study||4
10170533|NCT03038113|11300587|FG013|COMPLETED|Overall Study||14
10170534|NCT03038113|11300574|FG000|NOT COMPLETED|Overall Study||0
10170535|NCT03038113|11300575|FG001|NOT COMPLETED|Overall Study||0
10170536|NCT03038113|11300576|FG002|NOT COMPLETED|Overall Study||1
10170537|NCT03038113|11300577|FG003|NOT COMPLETED|Overall Study||0
10170538|NCT03038113|11300578|FG004|NOT COMPLETED|Overall Study||0
10170539|NCT03038113|11300579|FG005|NOT COMPLETED|Overall Study||0
10170540|NCT03038113|11300580|FG006|NOT COMPLETED|Overall Study||1
10170541|NCT03038113|11300581|FG007|NOT COMPLETED|Overall Study||0
10170542|NCT03038113|11300582|FG008|NOT COMPLETED|Overall Study||0
10170543|NCT03038113|11300583|FG009|NOT COMPLETED|Overall Study||0
10170544|NCT03038113|11300584|FG010|NOT COMPLETED|Overall Study||0
10170545|NCT03038113|11300585|FG011|NOT COMPLETED|Overall Study||0
10170546|NCT03038113|11300586|FG012|NOT COMPLETED|Overall Study||0
10170547|NCT03038113|11300587|FG013|NOT COMPLETED|Overall Study||1
10170548|NCT03038126|11300636|FG000|STARTED|Overall Study||63
10170549|NCT03038126|11300637|FG001|STARTED|Overall Study||55
10170550|NCT03038126|11300636|FG000|COMPLETED|Overall Study||54
10170551|NCT03038126|11300637|FG001|COMPLETED|Overall Study||51
10170552|NCT03038126|11300636|FG000|NOT COMPLETED|Overall Study||9
10170553|NCT03038126|11300637|FG001|NOT COMPLETED|Overall Study||4
10170554|NCT03038308|11300643|FG000|STARTED|Overall Study||15
10170555|NCT03038308|11300643|FG000|COMPLETED|Overall Study||11
10170556|NCT03038308|11300643|FG000|NOT COMPLETED|Overall Study||4
10170557|NCT03038399|11300651|FG000|STARTED|Overall Study||11
10170558|NCT03038399|11300652|FG001|STARTED|Overall Study||12
10170559|NCT03038399|11300653|FG002|STARTED|Overall Study||12
10170560|NCT03038399|11300654|FG003|STARTED|Overall Study||11
10170561|NCT03038399|11300651|FG000|COMPLETED|Overall Study||10
10170562|NCT03038399|11300652|FG001|COMPLETED|Overall Study||11
10170563|NCT03038399|11300653|FG002|COMPLETED|Overall Study||11
10170564|NCT03038399|11300654|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
10170565|NCT03038399|11300651|FG000|NOT COMPLETED|Overall Study||1
10170566|NCT03038399|11300652|FG001|NOT COMPLETED|Overall Study||1
10170567|NCT03038399|11300653|FG002|NOT COMPLETED|Overall Study||1
10170568|NCT03038399|11300654|FG003|NOT COMPLETED|Overall Study||2
10170569|NCT03038620|11300668|FG000|STARTED|Overall Study||92
10170570|NCT03038620|11300669|FG001|STARTED|Overall Study||93
10170571|NCT03038620|11300668|FG000|COMPLETED|Overall Study||73
10170572|NCT03038620|11300669|FG001|COMPLETED|Overall Study||55
10170573|NCT03038620|11300668|FG000|NOT COMPLETED|Overall Study||19
10170574|NCT03038620|11300669|FG001|NOT COMPLETED|Overall Study||38
10170575|NCT03038815|11300677|FG000|STARTED|Controll Condition, 1 Hour||10
10170576|NCT03038815|11300678|FG001|STARTED|Controll Condition, 1 Hour||10
10170577|NCT03038815|11300677|FG000|COMPLETED|Controll Condition, 1 Hour||10
10170578|NCT03038815|11300678|FG001|COMPLETED|Controll Condition, 1 Hour||10
10170579|NCT03038815|11300677|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0
10170580|NCT03038815|11300678|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0
10170581|NCT03038815|11300677|FG000|STARTED|Intervention 1, 1 Hour||10
10170582|NCT03038815|11300678|FG001|STARTED|Intervention 1, 1 Hour||10
10170583|NCT03038815|11300677|FG000|COMPLETED|Intervention 1, 1 Hour||10
10170584|NCT03038815|11300678|FG001|COMPLETED|Intervention 1, 1 Hour||10
10170585|NCT03038815|11300677|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0
10170586|NCT03038815|11300678|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0
9712344|NCT01933932|10811942|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
9712345|NCT01933932|10811943|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
10170587|NCT03038815|11300677|FG000|STARTED|Intervention 2, 1 Hour||10
10170588|NCT03038815|11300678|FG001|STARTED|Intervention 2, 1 Hour||10
10170589|NCT03038815|11300677|FG000|COMPLETED|Intervention 2, 1 Hour||10
10170590|NCT03038815|11300678|FG001|COMPLETED|Intervention 2, 1 Hour||10
10170591|NCT03038815|11300677|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0
10170592|NCT03038815|11300678|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0
10170593|NCT03038867|11300687|FG000|STARTED|Overall Study||37
10170594|NCT03038867|11300688|FG001|STARTED|Overall Study||32
10170595|NCT03038867|11300687|FG000|COMPLETED|Overall Study||37
10170596|NCT03038867|11300688|FG001|COMPLETED|Overall Study||32
10170597|NCT03038867|11300687|FG000|NOT COMPLETED|Overall Study||0
10170598|NCT03038867|11300688|FG001|NOT COMPLETED|Overall Study||0
10170599|NCT03038880|11300697|FG000|STARTED|Overall Study||24
10170600|NCT03038880|11300698|FG001|STARTED|Overall Study||31
10170601|NCT03038880|11300699|FG002|STARTED|Overall Study||16
10170602|NCT03038880|11300697|FG000|COMPLETED|Overall Study||21
10170603|NCT03038880|11300698|FG001|COMPLETED|Overall Study||28
10170604|NCT03038880|11300699|FG002|COMPLETED|Overall Study||16
10170605|NCT03038880|11300697|FG000|NOT COMPLETED|Overall Study||3
10170606|NCT03038880|11300698|FG001|NOT COMPLETED|Overall Study||3
10170607|NCT03038880|11300699|FG002|NOT COMPLETED|Overall Study||0
10170608|NCT03039023|11300712|FG000|STARTED|Overall Study||19
10170609|NCT03039023|11300713|FG001|STARTED|Overall Study||20
10170610|NCT03039023|11300714|FG002|STARTED|Overall Study||17
10170611|NCT03039023|11300715|FG003|STARTED|Overall Study||20
10170612|NCT03039023|11300716|FG004|STARTED|Overall Study||10
10170613|NCT03039023|11300712|FG000|COMPLETED|Overall Study||18
10170614|NCT03039023|11300713|FG001|COMPLETED|Overall Study||20
10170615|NCT03039023|11300714|FG002|COMPLETED|Overall Study||16
10170616|NCT03039023|11300715|FG003|COMPLETED|Overall Study||18
10170617|NCT03039023|11300716|FG004|COMPLETED|Overall Study||10
10170618|NCT03039023|11300712|FG000|NOT COMPLETED|Overall Study||1
10170619|NCT03039023|11300713|FG001|NOT COMPLETED|Overall Study||0
10170620|NCT03039023|11300714|FG002|NOT COMPLETED|Overall Study||1
10170621|NCT03039023|11300715|FG003|NOT COMPLETED|Overall Study||2
10170622|NCT03039023|11300716|FG004|NOT COMPLETED|Overall Study||0
10170623|NCT03039088|11300730|FG000|STARTED|Overall Study||192
10170624|NCT03039088|11300731|FG001|STARTED|Overall Study||316
10170625|NCT03039088|11300730|FG000|COMPLETED|Overall Study||192
10170626|NCT03039088|11300731|FG001|COMPLETED|Overall Study||316
10170627|NCT03039088|11300730|FG000|NOT COMPLETED|Overall Study||0
10170628|NCT03039088|11300731|FG001|NOT COMPLETED|Overall Study||0
10170629|NCT03039179|11300739|FG000|STARTED|Overall Study||38
10170630|NCT03039179|11300740|FG001|STARTED|Overall Study||42
10170631|NCT03039179|11300739|FG000|COMPLETED|Overall Study||38
10170632|NCT03039179|11300740|FG001|COMPLETED|Overall Study||42
10170633|NCT03039179|11300739|FG000|NOT COMPLETED|Overall Study||0
10170634|NCT03039179|11300740|FG001|NOT COMPLETED|Overall Study||0
10170635|NCT03039192|11300748|FG000|STARTED|Overall Study||112
10170636|NCT03039192|11300749|FG001|STARTED|Overall Study||114
10170637|NCT03039192|11300748|FG000|Treated|Overall Study||112
10170638|NCT03039192|11300749|FG001|Treated|Overall Study||113
10170639|NCT03039192|11300748|FG000|COMPLETED|Overall Study||80
10170640|NCT03039192|11300749|FG001|COMPLETED|Overall Study||84
10170641|NCT03039192|11300748|FG000|NOT COMPLETED|Overall Study||32
10170642|NCT03039192|11300749|FG001|NOT COMPLETED|Overall Study||30
10170643|NCT03039283|11300755|FG000|STARTED|Overall Study||162
10170644|NCT03039283|11300755|FG000|COMPLETED|Overall Study||160
10170645|NCT03039283|11300755|FG000|NOT COMPLETED|Overall Study||2
10170646|NCT03039543|11300761|FG000|STARTED|Overall Study||54
10170647|NCT03039543|11300762|FG001|STARTED|Overall Study||54
10170648|NCT03039543|11300761|FG000|COMPLETED|Overall Study||53
10170649|NCT03039543|11300762|FG001|COMPLETED|Overall Study||51
10170650|NCT03039543|11300761|FG000|NOT COMPLETED|Overall Study||1
10170651|NCT03039543|11300762|FG001|NOT COMPLETED|Overall Study||3
10170652|NCT03039569|11300770|FG000|STARTED|Overall Study||40
10170653|NCT03039569|11300771|FG001|STARTED|Overall Study||39
10170654|NCT03039569|11300770|FG000|COMPLETED|Overall Study||35
10170655|NCT03039569|11300771|FG001|COMPLETED|Overall Study||35
10170656|NCT03039569|11300770|FG000|NOT COMPLETED|Overall Study||5
10170657|NCT03039569|11300771|FG001|NOT COMPLETED|Overall Study||4
10170658|NCT03039621|11300780|FG000|STARTED|Overall Study||143
10170659|NCT03039621|11300781|FG001|STARTED|Overall Study||144
10170660|NCT03039621|11300780|FG000|COMPLETED|Overall Study||131
10170661|NCT03039621|11300781|FG001|COMPLETED|Overall Study||128
10170662|NCT03039621|11300780|FG000|NOT COMPLETED|Overall Study||12
10170663|NCT03039621|11300781|FG001|NOT COMPLETED|Overall Study||16
10170664|NCT03039686|11300790|FG000|STARTED|Double-blind Period||56
10170665|NCT03039686|11300791|FG001|STARTED|Double-blind Period||55
10170666|NCT03039686|11300792|FG002|STARTED|Double-blind Period||55
10170667|NCT03039686|11300790|FG000|COMPLETED|Double-blind Period||29
10170668|NCT03039686|11300791|FG001|COMPLETED|Double-blind Period||26
10170669|NCT03039686|11300792|FG002|COMPLETED|Double-blind Period||32
10170670|NCT03039686|11300790|FG000|NOT COMPLETED|Double-blind Period||27
10170671|NCT03039686|11300791|FG001|NOT COMPLETED|Double-blind Period||29
10170672|NCT03039686|11300792|FG002|NOT COMPLETED|Double-blind Period||23
10170673|NCT03039686|11300790|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
10170674|NCT03039686|11300791|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
10170675|NCT03039686|11300792|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
10170676|NCT03039686|11300790|FG000|Completed DB, Did Not Start OL|Open Label Period||2
10170677|NCT03039686|11300791|FG001|Completed DB, Did Not Start OL|Open Label Period||2
10170678|NCT03039686|11300792|FG002|Completed DB, Did Not Start OL|Open Label Period||3
10170679|NCT03039686|11300790|FG000|COMPLETED|Open Label Period||0
10170680|NCT03039686|11300791|FG001|COMPLETED|Open Label Period||0
10170681|NCT03039686|11300792|FG002|COMPLETED|Open Label Period||0
10170682|NCT03039686|11300790|FG000|NOT COMPLETED|Open Label Period||0
10170683|NCT03039686|11300791|FG001|NOT COMPLETED|Open Label Period||38
10170684|NCT03039686|11300792|FG002|NOT COMPLETED|Open Label Period||42
10170685|NCT03039699|11300812|FG000|STARTED|Overall Study||127
10170686|NCT03039699|11300813|FG001|STARTED|Overall Study||132
10170687|NCT03039699|11300812|FG000|COMPLETED|Overall Study||105
10170688|NCT03039699|11300813|FG001|COMPLETED|Overall Study||97
10170689|NCT03039699|11300812|FG000|NOT COMPLETED|Overall Study||22
10170690|NCT03039699|11300813|FG001|NOT COMPLETED|Overall Study||35
10170691|NCT03039738|11300821|FG000|STARTED|Overall Study||206
10170692|NCT03039738|11300822|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
10170693|NCT03039738|11300821|FG000|COMPLETED|Overall Study||152
10170694|NCT03039738|11300822|FG001|COMPLETED|Overall Study||0
10170695|NCT03039738|11300821|FG000|NOT COMPLETED|Overall Study||54
10170696|NCT03039738|11300822|FG001|NOT COMPLETED|Overall Study||0
10061440|NCT02104739|11187054|FG001|STARTED|Third Intervention (1 Day)||4
10061441|NCT02104739|11187055|FG002|STARTED|Third Intervention (1 Day)||2
10061442|NCT02104739|11187056|FG003|STARTED|Third Intervention (1 Day)||7
10061443|NCT02104739|11187057|FG004|STARTED|Third Intervention (1 Day)||0
10061444|NCT02104739|11187058|FG005|STARTED|Third Intervention (1 Day)||2
10061445|NCT02104739|11187059|FG006|STARTED|Third Intervention (1 Day)||0
10061446|NCT02104739|11187053|FG000|COMPLETED|Third Intervention (1 Day)||1
10061447|NCT02104739|11187054|FG001|COMPLETED|Third Intervention (1 Day)||4
10061448|NCT02104739|11187055|FG002|COMPLETED|Third Intervention (1 Day)||2
10061449|NCT02104739|11187056|FG003|COMPLETED|Third Intervention (1 Day)||7
10061450|NCT02104739|11187057|FG004|COMPLETED|Third Intervention (1 Day)||0
10061451|NCT02104739|11187058|FG005|COMPLETED|Third Intervention (1 Day)||2
10061452|NCT02104739|11187059|FG006|COMPLETED|Third Intervention (1 Day)||0
10061453|NCT02104739|11187053|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10061454|NCT02104739|11187054|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10061455|NCT02104739|11187055|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10061456|NCT02104739|11187056|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10061457|NCT02104739|11187057|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10061458|NCT02104739|11187058|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10061459|NCT02104739|11187059|FG006|NOT COMPLETED|Third Intervention (1 Day)||0
9712346|NCT01933932|10811942|FG000|NOT COMPLETED|Overall Study||184
9712347|NCT01933932|10811943|FG001|NOT COMPLETED|Overall Study||178
9712348|NCT01927068|10811951|FG000|STARTED|Overall Study||370
9712349|NCT01927068|10811952|FG001|STARTED|Overall Study||129
9712350|NCT01927068|10811951|FG000|COMPLETED|Overall Study||262
9712351|NCT01927068|10811952|FG001|COMPLETED|Overall Study||121
9712352|NCT01927068|10811951|FG000|NOT COMPLETED|Overall Study||108
9712353|NCT01927068|10811952|FG001|NOT COMPLETED|Overall Study||8
9712354|NCT01883817|10811961|FG000|STARTED|Overall Study||14
10170697|NCT03040011|11300831|FG000|STARTED|Received Randomized Study Intervention||25
10170698|NCT03040011|11300832|FG001|STARTED|Received Randomized Study Intervention||25
10170699|NCT03040011|11300833|FG002|STARTED|Received Randomized Study Intervention||25
10170700|NCT03040011|11300831|FG000|COMPLETED|Received Randomized Study Intervention||25
10170701|NCT03040011|11300832|FG001|COMPLETED|Received Randomized Study Intervention||25
10170702|NCT03040011|11300833|FG002|COMPLETED|Received Randomized Study Intervention||25
10170703|NCT03040011|11300831|FG000|NOT COMPLETED|Received Randomized Study Intervention||0
10170704|NCT03040011|11300832|FG001|NOT COMPLETED|Received Randomized Study Intervention||0
10170705|NCT03040011|11300833|FG002|NOT COMPLETED|Received Randomized Study Intervention||0
10170706|NCT03040011|11300831|FG000|STARTED|Primary Outcome Follow Up||25
10170707|NCT03040011|11300832|FG001|STARTED|Primary Outcome Follow Up||25
10170708|NCT03040011|11300833|FG002|STARTED|Primary Outcome Follow Up||25
10170709|NCT03040011|11300831|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
10170710|NCT03040011|11300832|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
10170711|NCT03040011|11300833|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
10170712|NCT03040011|11300831|FG000|NOT COMPLETED|Primary Outcome Follow Up||4
10170713|NCT03040011|11300832|FG001|NOT COMPLETED|Primary Outcome Follow Up||1
10170714|NCT03040011|11300833|FG002|NOT COMPLETED|Primary Outcome Follow Up||1
10170715|NCT03040024|11300844|FG000|STARTED|Overall Study||21
10170716|NCT03040024|11300845|FG001|STARTED|Overall Study||26
10170717|NCT03040024|11300846|FG002|STARTED|Overall Study||24
10170718|NCT03040024|11300844|FG000|COMPLETED|Overall Study||21
10170719|NCT03040024|11300845|FG001|COMPLETED|Overall Study||24
10170720|NCT03040024|11300846|FG002|COMPLETED|Overall Study||23
10170721|NCT03040024|11300844|FG000|NOT COMPLETED|Overall Study||0
10170722|NCT03040024|11300845|FG001|NOT COMPLETED|Overall Study||2
10170723|NCT03040024|11300846|FG002|NOT COMPLETED|Overall Study||1
10170724|NCT03040154|11300856|FG000|STARTED|Overall Study||110
9712355|NCT01883817|10811962|FG001|STARTED|Overall Study||16
9712356|NCT01883817|10811961|FG000|COMPLETED|Overall Study||10
9712357|NCT01883817|10811962|FG001|COMPLETED|Overall Study||9
9712358|NCT01883817|10811961|FG000|NOT COMPLETED|Overall Study||4
9712359|NCT01883817|10811962|FG001|NOT COMPLETED|Overall Study||7
9712360|NCT01813435|10811970|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
9712361|NCT01813435|10811971|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
9712362|NCT01813435|10811970|FG000|COMPLETED|Overall Study||5810
9712363|NCT01813435|10811971|FG001|COMPLETED|Overall Study||6981
9712364|NCT01813435|10811970|FG000|NOT COMPLETED|Overall Study||2170
9712365|NCT01813435|10811971|FG001|NOT COMPLETED|Overall Study||1007
9731044|NCT00129480|10830951|FG001|COMPLETED|Overall Study||214
9731045|NCT00129480|10830950|FG000|NOT COMPLETED|Overall Study||0
9731046|NCT00129480|10830951|FG001|NOT COMPLETED|Overall Study||0
9731047|NCT00129545|10830960|FG000|STARTED|Overall Study||93
9731048|NCT00129545|10830961|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
9849581|NCT00866333|10962322|FG000|NOT COMPLETED|Overall Study||5
9849582|NCT00866333|10962323|FG001|NOT COMPLETED|Overall Study||7
9849583|NCT00866333|10962324|FG002|NOT COMPLETED|Overall Study||12
9849584|NCT00866359|10962334|FG000|STARTED|Treatment Phase (Days 1 to 85)||56
9849585|NCT00866359|10962335|FG001|STARTED|Treatment Phase (Days 1 to 85)||55
9849586|NCT00866359|10962336|FG002|STARTED|Treatment Phase (Days 1 to 85)||0
9849587|NCT00866359|10962337|FG003|STARTED|Treatment Phase (Days 1 to 85)||0
9849588|NCT00866359|10962334|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45
9849589|NCT00866359|10962335|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50
9849590|NCT00866359|10962336|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0
9849591|NCT00866359|10962337|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0
10170725|NCT03040154|11300857|FG001|STARTED|Overall Study||105
10170726|NCT03040154|11300856|FG000|COMPLETED|Overall Study||110
10170727|NCT03040154|11300857|FG001|COMPLETED|Overall Study||105
10170728|NCT03040154|11300856|FG000|NOT COMPLETED|Overall Study||0
10170729|NCT03040154|11300857|FG001|NOT COMPLETED|Overall Study||0
10170730|NCT03040336|11300865|FG000|STARTED|Overall Study||10
10170731|NCT03040336|11300866|FG001|STARTED|Overall Study||7
10170732|NCT03040336|11300865|FG000|COMPLETED|Overall Study||7
10170733|NCT03040336|11300866|FG001|COMPLETED|Overall Study||4
10170734|NCT03040336|11300865|FG000|NOT COMPLETED|Overall Study||3
10170735|NCT03040336|11300866|FG001|NOT COMPLETED|Overall Study||3
9849592|NCT00866359|10962334|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
9849593|NCT00866359|10962335|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
9849594|NCT00866359|10962336|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
9849595|NCT00866359|10962337|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
9849596|NCT00866359|10962334|FG000|STARTED|Extension Phase (Day 86 to 169)||0
9849597|NCT00866359|10962335|FG001|STARTED|Extension Phase (Day 86 to 169)||0
10170736|NCT03040362|11300873|FG000|STARTED|Overall Study||8
10170737|NCT03040362|11300873|FG000|Received at Least 1dose of Study Drug|Overall Study||8
10170738|NCT03040362|11300873|FG000|COMPLETED|Overall Study||8
10170739|NCT03040362|11300873|FG000|NOT COMPLETED|Overall Study||0
10170740|NCT03040414|11300879|FG000|STARTED|Overall Study||57
10170741|NCT03040414|11300880|FG001|STARTED|Overall Study||56
10170742|NCT03040414|11300879|FG000|Completed Period 1|Overall Study||56
10170743|NCT03040414|11300880|FG001|Completed Period 1|Overall Study||55
10170744|NCT03040414|11300879|FG000|Started Period 2|Overall Study||56
10170745|NCT03040414|11300880|FG001|Started Period 2|Overall Study||55
10170746|NCT03040414|11300879|FG000|COMPLETED|Overall Study||56
10170747|NCT03040414|11300880|FG001|COMPLETED|Overall Study||55
10170748|NCT03040414|11300879|FG000|NOT COMPLETED|Overall Study||1
10170749|NCT03040414|11300880|FG001|NOT COMPLETED|Overall Study||1
10170750|NCT03040427|11300889|FG000|STARTED|Overall Study||2
10170751|NCT03040427|11300890|FG001|STARTED|Overall Study||6
10170752|NCT03040427|11300891|FG002|STARTED|Overall Study||4
10170753|NCT03040427|11300889|FG000|COMPLETED|Overall Study||2
10170754|NCT03040427|11300890|FG001|COMPLETED|Overall Study||6
10170755|NCT03040427|11300891|FG002|COMPLETED|Overall Study||4
10170756|NCT03040427|11300889|FG000|NOT COMPLETED|Overall Study||0
10170757|NCT03040427|11300890|FG001|NOT COMPLETED|Overall Study||0
10170758|NCT03040427|11300891|FG002|NOT COMPLETED|Overall Study||0
10170759|NCT03040466|11300901|FG000|STARTED|Overall Study||65
10170760|NCT03040466|11300902|FG001|STARTED|Overall Study||115
10170761|NCT03040466|11300901|FG000|COMPLETED|Overall Study||65
10170762|NCT03040466|11300902|FG001|COMPLETED|Overall Study||115
10170763|NCT03040466|11300901|FG000|NOT COMPLETED|Overall Study||0
10170764|NCT03040466|11300902|FG001|NOT COMPLETED|Overall Study||0
10170765|NCT03040479|11300911|FG000|STARTED|Overall Study||8
10170766|NCT03040479|11300912|FG001|STARTED|Overall Study||8
10170767|NCT03040479|11300913|FG002|STARTED|Overall Study||8
10170768|NCT03040479|11300911|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10170769|NCT03040479|11300912|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10170770|NCT03040479|11300913|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
10170771|NCT03040479|11300911|FG000|COMPLETED|Overall Study||8
10170772|NCT03040479|11300912|FG001|COMPLETED|Overall Study||8
10170773|NCT03040479|11300913|FG002|COMPLETED|Overall Study||8
10170774|NCT03040479|11300911|FG000|NOT COMPLETED|Overall Study||0
10170775|NCT03040479|11300912|FG001|NOT COMPLETED|Overall Study||0
10170776|NCT03040479|11300913|FG002|NOT COMPLETED|Overall Study||0
10170777|NCT03040674|11300923|FG000|STARTED|Overall Study||489
10170778|NCT03040674|11300923|FG000|Participants Completing 3 Month Survey|Overall Study||351
10170779|NCT03040674|11300923|FG000|Participants Completing 6 Month Survey|Overall Study||241
10170780|NCT03040674|11300923|FG000|COMPLETED|Overall Study||241
10170781|NCT03040674|11300923|FG000|NOT COMPLETED|Overall Study||248
10170782|NCT03040687|11300931|FG000|STARTED|Overall Study||20
10170783|NCT03040687|11300932|FG001|STARTED|Overall Study||20
10170784|NCT03040687|11300933|FG002|STARTED|Overall Study||20
10170785|NCT03040687|11300931|FG000|COMPLETED|Overall Study||19
10170786|NCT03040687|11300932|FG001|COMPLETED|Overall Study||20
10170787|NCT03040687|11300933|FG002|COMPLETED|Overall Study||20
10170788|NCT03040687|11300931|FG000|NOT COMPLETED|Overall Study||1
10170789|NCT03040687|11300932|FG001|NOT COMPLETED|Overall Study||0
10170790|NCT03040687|11300933|FG002|NOT COMPLETED|Overall Study||0
10170791|NCT03040713|11300941|FG000|STARTED|Overall Study||16
10170792|NCT03040713|11300941|FG000|COMPLETED|Overall Study||13
10170793|NCT03040713|11300941|FG000|NOT COMPLETED|Overall Study||3
10170794|NCT03040804|11300945|FG000|STARTED|Overall Study||2
10170795|NCT03040804|11300945|FG000|COMPLETED|Overall Study||2
10170796|NCT03040804|11300945|FG000|NOT COMPLETED|Overall Study||0
10170797|NCT03040986|11300951|FG000|STARTED|Overall Study||6
10170798|NCT03040986|11300952|FG001|STARTED|Overall Study||2
10170799|NCT03040986|11300951|FG000|COMPLETED|Overall Study||0
10170800|NCT03040986|11300952|FG001|COMPLETED|Overall Study||0
10170801|NCT03040986|11300951|FG000|NOT COMPLETED|Overall Study||6
10170802|NCT03040986|11300952|FG001|NOT COMPLETED|Overall Study||2
10170803|NCT03041025|11300963|FG000|STARTED|Overall Study||8
10170804|NCT03041025|11300964|FG001|STARTED|Overall Study||3
10170805|NCT03041025|11300965|FG002|STARTED|Overall Study||24
10170806|NCT03041025|11300963|FG000|COMPLETED|Overall Study||7
10170807|NCT03041025|11300964|FG001|COMPLETED|Overall Study||3
10170808|NCT03041025|11300965|FG002|COMPLETED|Overall Study||22
10170809|NCT03041025|11300963|FG000|NOT COMPLETED|Overall Study||1
10170810|NCT03041025|11300964|FG001|NOT COMPLETED|Overall Study||0
10170811|NCT03041025|11300965|FG002|NOT COMPLETED|Overall Study||2
10170812|NCT03041038|11300978|FG000|STARTED|Overall Study||11
10170813|NCT03041038|11300979|FG001|STARTED|Overall Study||9
10170814|NCT03041038|11300978|FG000|Week 16|Overall Study||10
10170815|NCT03041038|11300979|FG001|Week 16|Overall Study||8
10170816|NCT03041038|11300978|FG000|Week 32|Overall Study||9
10170817|NCT03041038|11300979|FG001|Week 32|Overall Study||8
10170818|NCT03041038|11300978|FG000|COMPLETED|Overall Study||5
10170819|NCT03041038|11300979|FG001|COMPLETED|Overall Study||7
10170820|NCT03041038|11300978|FG000|NOT COMPLETED|Overall Study||6
10170821|NCT03041038|11300979|FG001|NOT COMPLETED|Overall Study||2
10170822|NCT03041090|11300989|FG000|STARTED|Overall Study||109
10170823|NCT03041090|11300990|FG001|STARTED|Overall Study||24
10170824|NCT03041090|11300989|FG000|COMPLETED|Overall Study||109
10170825|NCT03041090|11300990|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
10170826|NCT03041090|11300989|FG000|NOT COMPLETED|Overall Study||0
10170827|NCT03041090|11300990|FG001|NOT COMPLETED|Overall Study||3
10170828|NCT03041116|11300998|FG000|STARTED|Double-blind||41
10170829|NCT03041116|11300999|FG001|STARTED|Double-blind||43
10170830|NCT03041116|11300998|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41
10170831|NCT03041116|11300999|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43
10170832|NCT03041116|11300998|FG000|COMPLETED|Double-blind||41
10170833|NCT03041116|11300999|FG001|COMPLETED|Double-blind||37
10170834|NCT03041116|11300998|FG000|NOT COMPLETED|Double-blind||0
10170835|NCT03041116|11300999|FG001|NOT COMPLETED|Double-blind||6
10170836|NCT03041116|11300998|FG000|STARTED|Open-label||41
10170837|NCT03041116|11300999|FG001|STARTED|Open-label||37
10170838|NCT03041116|11300998|FG000|Received At Least 1 Dose of Study Drug|Open-label||41
10170839|NCT03041116|11300999|FG001|Received At Least 1 Dose of Study Drug|Open-label||37
10170840|NCT03041116|11300998|FG000|COMPLETED|Open-label||0
10170841|NCT03041116|11300999|FG001|COMPLETED|Open-label||0
10170842|NCT03041116|11300998|FG000|NOT COMPLETED|Open-label||41
10170843|NCT03041116|11300999|FG001|NOT COMPLETED|Open-label||37
10170844|NCT03041181|11301011|FG000|STARTED|Overall Study||1
10170845|NCT03041181|11301012|FG001|STARTED|Overall Study||2
10170846|NCT03041181|11301011|FG000|COMPLETED|Overall Study||0
10170847|NCT03041181|11301012|FG001|COMPLETED|Overall Study||0
10170848|NCT03041181|11301011|FG000|NOT COMPLETED|Overall Study||1
10170849|NCT03041181|11301012|FG001|NOT COMPLETED|Overall Study||2
10170850|NCT03041298|11301018|FG000|STARTED|Overall Study||1537
10170851|NCT03041298|11301018|FG000|COMPLETED|Overall Study||1537
10170852|NCT03041298|11301018|FG000|NOT COMPLETED|Overall Study||0
10170853|NCT03041441|11301022|FG000|STARTED|Overall Study||5
10170854|NCT03041441|11301022|FG000|COMPLETED|Overall Study||3
10170855|NCT03041441|11301022|FG000|NOT COMPLETED|Overall Study||2
10170856|NCT03041467|11301029|FG000|STARTED|Overall Study||170
10170857|NCT03041467|11301030|FG001|STARTED|Overall Study||160
10170858|NCT03041467|11301029|FG000|COMPLETED|Overall Study||0
10170859|NCT03041467|11301030|FG001|COMPLETED|Overall Study||0
10170860|NCT03041467|11301029|FG000|NOT COMPLETED|Overall Study||170
10170861|NCT03041467|11301030|FG001|NOT COMPLETED|Overall Study||160
10170862|NCT03041636|11301038|FG000|STARTED|Overall Study||1
10170863|NCT03041636|11301038|FG000|COMPLETED|Overall Study||1
10170864|NCT03041636|11301038|FG000|NOT COMPLETED|Overall Study||0
10170865|NCT03041792|11301044|FG000|STARTED|Overall Study||32
10170866|NCT03041792|11301045|FG001|STARTED|Overall Study||29
10170867|NCT03041792|11301044|FG000|Received Treatment|Overall Study||32
10170868|NCT03041792|11301045|FG001|Received Treatment|Overall Study||28
10170869|NCT03041792|11301044|FG000|COMPLETED|Overall Study||28
10170870|NCT03041792|11301045|FG001|COMPLETED|Overall Study||26
10170871|NCT03041792|11301044|FG000|NOT COMPLETED|Overall Study||4
10170872|NCT03041792|11301045|FG001|NOT COMPLETED|Overall Study||3
10170873|NCT03041896|11301055|FG000|STARTED|Overall Study||1486
10170874|NCT03041896|11301056|FG001|STARTED|Overall Study||1009
10170875|NCT03041896|11301057|FG002|STARTED|Overall Study||2299
10170876|NCT03041896|11301058|FG003|STARTED|Overall Study||256
10170877|NCT03041896|11301055|FG000|COMPLETED|Overall Study||1486
10170878|NCT03041896|11301056|FG001|COMPLETED|Overall Study||1009
10170879|NCT03041896|11301057|FG002|COMPLETED|Overall Study||2236
10170880|NCT03041896|11301058|FG003|COMPLETED|Overall Study||253
10170881|NCT03041896|11301055|FG000|NOT COMPLETED|Overall Study||0
10170882|NCT03041896|11301056|FG001|NOT COMPLETED|Overall Study||0
10170883|NCT03041896|11301057|FG002|NOT COMPLETED|Overall Study||63
10170884|NCT03041896|11301058|FG003|NOT COMPLETED|Overall Study||3
10170885|NCT03041909|11301075|FG000|STARTED|Overall Study||3
10170886|NCT03041909|11301076|FG001|STARTED|Overall Study||1
10170887|NCT03041909|11301077|FG002|STARTED|Overall Study||1
10170888|NCT03041909|11301075|FG000|COMPLETED|Overall Study||3
10170889|NCT03041909|11301076|FG001|COMPLETED|Overall Study||1
10170890|NCT03041909|11301077|FG002|COMPLETED|Overall Study||1
10170891|NCT03041909|11301075|FG000|NOT COMPLETED|Overall Study||0
10170892|NCT03041909|11301076|FG001|NOT COMPLETED|Overall Study||0
10170893|NCT03041909|11301077|FG002|NOT COMPLETED|Overall Study||0
10170894|NCT03042299|11301087|FG000|STARTED|Intervention Period 1 (6 Days)||7
10170895|NCT03042299|11301088|FG001|STARTED|Intervention Period 1 (6 Days)||7
10170896|NCT03042299|11301087|FG000|COMPLETED|Intervention Period 1 (6 Days)||7
10170897|NCT03042299|11301088|FG001|COMPLETED|Intervention Period 1 (6 Days)||7
10170898|NCT03042299|11301087|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10170899|NCT03042299|11301088|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10170900|NCT03042299|11301087|FG000|STARTED|Washout Period (at Least 6 Days)||7
10170901|NCT03042299|11301088|FG001|STARTED|Washout Period (at Least 6 Days)||7
10170902|NCT03042299|11301087|FG000|COMPLETED|Washout Period (at Least 6 Days)||7
10170903|NCT03042299|11301088|FG001|COMPLETED|Washout Period (at Least 6 Days)||7
10170904|NCT03042299|11301087|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
10170905|NCT03042299|11301088|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0
10170906|NCT03042299|11301087|FG000|STARTED|Intervention Period 2 (6 Days)||7
10170907|NCT03042299|11301088|FG001|STARTED|Intervention Period 2 (6 Days)||7
10170908|NCT03042299|11301087|FG000|COMPLETED|Intervention Period 2 (6 Days)||7
10170909|NCT03042299|11301088|FG001|COMPLETED|Intervention Period 2 (6 Days)||7
10170910|NCT03042299|11301087|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10170911|NCT03042299|11301088|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10170912|NCT03042312|11301096|FG000|STARTED|Overall Study||28
10170913|NCT03042312|11301097|FG001|STARTED|Overall Study||43
10170914|NCT03042312|11301096|FG000|Safety Population|Overall Study||23
10061460|NCT02104739|11187053|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10170915|NCT03042312|11301097|FG001|Safety Population|Overall Study||41
10170916|NCT03042312|11301096|FG000|COMPLETED|Overall Study||18
10170917|NCT03042312|11301097|FG001|COMPLETED|Overall Study||31
10170918|NCT03042312|11301096|FG000|NOT COMPLETED|Overall Study||10
10170919|NCT03042312|11301097|FG001|NOT COMPLETED|Overall Study||12
10170920|NCT03042559|11301105|FG000|STARTED|Overall Study||22
10170921|NCT03042559|11301106|FG001|STARTED|Overall Study||21
10170922|NCT03042559|11301105|FG000|COMPLETED|Overall Study||21
10170923|NCT03042559|11301106|FG001|COMPLETED|Overall Study||20
10170924|NCT03042559|11301105|FG000|NOT COMPLETED|Overall Study||1
10170925|NCT03042559|11301106|FG001|NOT COMPLETED|Overall Study||1
10170926|NCT03042702|11301112|FG000|STARTED|Overall Study||2
10170927|NCT03042702|11301112|FG000|COMPLETED|Overall Study||2
10170928|NCT03042702|11301112|FG000|NOT COMPLETED|Overall Study||0
10170929|NCT03042715|11301117|FG000|STARTED|Overall Study||6
10170930|NCT03042715|11301117|FG000|COMPLETED|Overall Study||5
10170931|NCT03042715|11301117|FG000|NOT COMPLETED|Overall Study||1
10170932|NCT03042767|11301123|FG000|STARTED|Overall Study||12
10170933|NCT03042767|11301124|FG001|STARTED|Overall Study||13
10170934|NCT03042767|11301123|FG000|COMPLETED|Overall Study||11
10170935|NCT03042767|11301124|FG001|COMPLETED|Overall Study||11
10170936|NCT03042767|11301123|FG000|NOT COMPLETED|Overall Study||1
10170937|NCT03042767|11301124|FG001|NOT COMPLETED|Overall Study||2
10170938|NCT03042910|11301130|FG000|STARTED|Overall Study||38
10170939|NCT03042910|11301130|FG000|Treated|Overall Study||37
10170940|NCT03042910|11301130|FG000|COMPLETED|Overall Study||31
10170941|NCT03042910|11301130|FG000|NOT COMPLETED|Overall Study||7
10170942|NCT03043079|11301137|FG000|STARTED|Overall Study||21
10170943|NCT03043079|11301138|FG001|STARTED|Overall Study||14
10170944|NCT03043079|11301139|FG002|STARTED|Overall Study||10
10170945|NCT03043079|11301137|FG000|COMPLETED|Overall Study||21
10170946|NCT03043079|11301138|FG001|COMPLETED|Overall Study||14
10170947|NCT03043079|11301139|FG002|COMPLETED|Overall Study||10
10170948|NCT03043079|11301137|FG000|NOT COMPLETED|Overall Study||0
10170949|NCT03043079|11301138|FG001|NOT COMPLETED|Overall Study||0
10170950|NCT03043079|11301139|FG002|NOT COMPLETED|Overall Study||0
10170951|NCT03043105|11301148|FG000|STARTED|Overall Study||25
10170952|NCT03043105|11301148|FG000|COMPLETED|Overall Study||25
10170953|NCT03043105|11301148|FG000|NOT COMPLETED|Overall Study||0
10170954|NCT03043274|11301154|FG000|STARTED|Overall Study||13
10170955|NCT03043274|11301155|FG001|STARTED|Overall Study||10
10170956|NCT03043274|11301154|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
10170957|NCT03043274|11301155|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
10170958|NCT03043274|11301154|FG000|NOT COMPLETED|Overall Study||0
10170959|NCT03043274|11301155|FG001|NOT COMPLETED|Overall Study||1
10170960|NCT03043365|11301163|FG000|STARTED|Weeks 0 to Week 8||20
10170961|NCT03043365|11301164|FG001|STARTED|Weeks 0 to Week 8||17
10170962|NCT03043365|11301163|FG000|COMPLETED|Weeks 0 to Week 8||17
10170963|NCT03043365|11301164|FG001|COMPLETED|Weeks 0 to Week 8||14
10170964|NCT03043365|11301163|FG000|NOT COMPLETED|Weeks 0 to Week 8||3
10170965|NCT03043365|11301164|FG001|NOT COMPLETED|Weeks 0 to Week 8||3
10170966|NCT03043365|11301163|FG000|STARTED|Week 8 to Week 16 - Washout Period||17
10170967|NCT03043365|11301164|FG001|STARTED|Week 8 to Week 16 - Washout Period||14
10061461|NCT02104739|11187054|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10061462|NCT02104739|11187055|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10061463|NCT02104739|11187056|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10061464|NCT02104739|11187057|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10061465|NCT02104739|11187058|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10061466|NCT02104739|11187059|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8
10061467|NCT02104739|11187053|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061468|NCT02104739|11187054|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061469|NCT02104739|11187055|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061470|NCT02104739|11187056|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061471|NCT02104739|11187057|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061472|NCT02104739|11187058|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061473|NCT02104739|11187059|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
10061474|NCT02104739|11187053|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10170968|NCT03043365|11301163|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16
10170969|NCT03043365|11301164|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14
10170970|NCT03043365|11301163|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
10170971|NCT03043365|11301164|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
10170972|NCT03043365|11301163|FG000|STARTED|Week 16 to Week 24||16
10170973|NCT03043365|11301164|FG001|STARTED|Week 16 to Week 24||14
10170974|NCT03043365|11301163|FG000|COMPLETED|Week 16 to Week 24||16
10170975|NCT03043365|11301164|FG001|COMPLETED|Week 16 to Week 24||14
10170976|NCT03043365|11301163|FG000|NOT COMPLETED|Week 16 to Week 24||0
10170977|NCT03043365|11301164|FG001|NOT COMPLETED|Week 16 to Week 24||0
10170978|NCT03043534|11301174|FG000|STARTED|Overall Study||15
10170979|NCT03043534|11301175|FG001|STARTED|Overall Study||14
10170980|NCT03043534|11301174|FG000|COMPLETED|Overall Study||15
10170981|NCT03043534|11301175|FG001|COMPLETED|Overall Study||14
10170982|NCT03043534|11301174|FG000|NOT COMPLETED|Overall Study||0
10061475|NCT02104739|11187054|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061476|NCT02104739|11187055|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10170983|NCT03043534|11301175|FG001|NOT COMPLETED|Overall Study||0
10170984|NCT03043560|11301183|FG000|STARTED|Overall Study||21
10170985|NCT03043560|11301184|FG001|STARTED|Overall Study||24
10170986|NCT03043560|11301183|FG000|COMPLETED|Overall Study||20
10170987|NCT03043560|11301184|FG001|COMPLETED|Overall Study||21
10170988|NCT03043560|11301183|FG000|NOT COMPLETED|Overall Study||1
10170989|NCT03043560|11301184|FG001|NOT COMPLETED|Overall Study||3
10170990|NCT03043651|11301190|FG000|STARTED|Overall Study||48
10170991|NCT03043651|11301190|FG000|COMPLETED|Overall Study||0
10170992|NCT03043651|11301190|FG000|NOT COMPLETED|Overall Study||48
9712366|NCT01700439|10811977|FG000|STARTED|Overall Study||889
9712367|NCT01700439|10811977|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
9712368|NCT01700439|10811977|FG000|Discharge|Overall Study||831
9712369|NCT01700439|10811977|FG000|3 Month|Overall Study||778
9712370|NCT01700439|10811977|FG000|1 Year|Overall Study||573
9712371|NCT01700439|10811977|FG000|2 Year|Overall Study||215
9712372|NCT01700439|10811977|FG000|COMPLETED|Overall Study||0
9712373|NCT01700439|10811977|FG000|NOT COMPLETED|Overall Study||889
9712374|NCT01690299|10811985|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
9712375|NCT01690299|10811986|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
9712376|NCT01690299|10811987|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
9712377|NCT01690299|10811988|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
9712378|NCT01690299|10811989|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
9712379|NCT01690299|10811990|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
9712380|NCT01690299|10811985|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
9712381|NCT01690299|10811986|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
9712382|NCT01690299|10811987|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
9712383|NCT01690299|10811988|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
9712384|NCT01690299|10811989|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
9712385|NCT01690299|10811990|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
9712386|NCT01690299|10811985|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
9712387|NCT01690299|10811986|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
9712388|NCT01690299|10811987|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
9712389|NCT01690299|10811988|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
9712390|NCT01690299|10811989|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
9712391|NCT01690299|10811990|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
9712392|NCT01690299|10811985|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
9712393|NCT01690299|10811986|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
9712394|NCT01690299|10811987|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
9712395|NCT01690299|10811988|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
9712396|NCT01690299|10811989|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
9712397|NCT01690299|10811990|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
9712398|NCT01690299|10811985|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0
9712399|NCT01690299|10811986|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0
9712400|NCT01690299|10811987|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0
9712401|NCT01690299|10811988|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
9712402|NCT01690299|10811989|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
9712403|NCT01690299|10811990|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
9712404|NCT01690299|10811985|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
9712405|NCT01690299|10811986|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
9712406|NCT01690299|10811987|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
9712407|NCT01690299|10811988|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
9712408|NCT01690299|10811989|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
9712409|NCT01690299|10811990|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
9712410|NCT01690299|10811985|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
9712411|NCT01690299|10811986|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
9712412|NCT01690299|10811987|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
9712413|NCT01690299|10811988|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
9712414|NCT01690299|10811989|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
9712415|NCT01690299|10811990|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
9712416|NCT01690299|10811985|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
9712417|NCT01690299|10811986|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
9849598|NCT00866359|10962336|FG002|STARTED|Extension Phase (Day 86 to 169)||45
10170993|NCT03043885|11301198|FG000|STARTED|Overall Study||10
10170994|NCT03043885|11301199|FG001|STARTED|Overall Study||10
10170995|NCT03043885|11301200|FG002|STARTED|Overall Study||10
10170996|NCT03043885|11301201|FG003|STARTED|Overall Study||10
10170997|NCT03043885|11301198|FG000|COMPLETED|Overall Study||10
10170998|NCT03043885|11301199|FG001|COMPLETED|Overall Study||10
10170999|NCT03043885|11301200|FG002|COMPLETED|Overall Study||10
10171000|NCT03043885|11301201|FG003|COMPLETED|Overall Study||10
10171001|NCT03043885|11301198|FG000|NOT COMPLETED|Overall Study||0
10171002|NCT03043885|11301199|FG001|NOT COMPLETED|Overall Study||0
10171003|NCT03043885|11301200|FG002|NOT COMPLETED|Overall Study||0
10171004|NCT03043885|11301201|FG003|NOT COMPLETED|Overall Study||0
10171005|NCT03044028|11301214|FG000|STARTED|Overall Study||22
10171006|NCT03044028|11301215|FG001|STARTED|Overall Study||22
10171007|NCT03044028|11301216|FG002|STARTED|Overall Study||22
10171008|NCT03044028|11301214|FG000|COMPLETED|Overall Study||12
10171009|NCT03044028|11301215|FG001|COMPLETED|Overall Study||12
10171010|NCT03044028|11301216|FG002|COMPLETED|Overall Study||22
10171011|NCT03044028|11301214|FG000|NOT COMPLETED|Overall Study||10
10171012|NCT03044028|11301215|FG001|NOT COMPLETED|Overall Study||10
10171013|NCT03044028|11301216|FG002|NOT COMPLETED|Overall Study||0
10171014|NCT03044106|11301225|FG000|STARTED|Visit 1||22
10171015|NCT03044106|11301226|FG001|STARTED|Visit 1||22
10171016|NCT03044106|11301225|FG000|COMPLETED|Visit 1||22
10171017|NCT03044106|11301226|FG001|COMPLETED|Visit 1||22
10171018|NCT03044106|11301225|FG000|NOT COMPLETED|Visit 1||0
10171019|NCT03044106|11301226|FG001|NOT COMPLETED|Visit 1||0
10171020|NCT03044106|11301225|FG000|STARTED|Washout (1 Week)||22
10171021|NCT03044106|11301226|FG001|STARTED|Washout (1 Week)||22
10171022|NCT03044106|11301225|FG000|COMPLETED|Washout (1 Week)||22
10171023|NCT03044106|11301226|FG001|COMPLETED|Washout (1 Week)||20
10171024|NCT03044106|11301225|FG000|NOT COMPLETED|Washout (1 Week)||0
9712418|NCT01690299|10811987|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
9712419|NCT01690299|10811988|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
9712420|NCT01690299|10811989|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
9712421|NCT01690299|10811990|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
9712422|NCT01525329|10812013|FG000|STARTED|Overall Study||4
9712423|NCT01525329|10812014|FG001|STARTED|Overall Study||14
9712424|NCT01525329|10812013|FG000|COMPLETED|Overall Study||4
9712425|NCT01525329|10812014|FG001|COMPLETED|Overall Study||14
9712426|NCT01525329|10812013|FG000|NOT COMPLETED|Overall Study||0
9712427|NCT01525329|10812014|FG001|NOT COMPLETED|Overall Study||0
9712428|NCT01482286|10812028|FG000|STARTED|Overall Study||7
9712429|NCT01482286|10812029|FG001|STARTED|Overall Study||7
9712430|NCT01482286|10812030|FG002|STARTED|Overall Study||8
9712431|NCT01482286|10812031|FG003|STARTED|Overall Study||10
9712432|NCT01482286|10812028|FG000|COMPLETED|Overall Study||4
9712433|NCT01482286|10812029|FG001|COMPLETED|Overall Study||4
9712434|NCT01482286|10812030|FG002|COMPLETED|Overall Study||4
9712435|NCT01482286|10812031|FG003|COMPLETED|Overall Study||5
9712436|NCT01482286|10812028|FG000|NOT COMPLETED|Overall Study||3
9712437|NCT01482286|10812029|FG001|NOT COMPLETED|Overall Study||3
9712438|NCT01482286|10812030|FG002|NOT COMPLETED|Overall Study||4
9712439|NCT01482286|10812031|FG003|NOT COMPLETED|Overall Study||5
9712440|NCT01452152|10812044|FG000|STARTED|Overall Study||5
9712441|NCT01452152|10812045|FG001|STARTED|Overall Study||0
9712442|NCT01452152|10812046|FG002|STARTED|Overall Study||4
9712443|NCT01452152|10812044|FG000|COMPLETED|Overall Study||0
9712444|NCT01452152|10812045|FG001|COMPLETED|Overall Study||0
9712445|NCT01452152|10812046|FG002|COMPLETED|Overall Study||0
9712446|NCT01452152|10812044|FG000|NOT COMPLETED|Overall Study||5
9712447|NCT01452152|10812045|FG001|NOT COMPLETED|Overall Study||0
9712448|NCT01452152|10812046|FG002|NOT COMPLETED|Overall Study||4
10171025|NCT03044106|11301226|FG001|NOT COMPLETED|Washout (1 Week)||2
10171026|NCT03044106|11301225|FG000|STARTED|Visit 2||22
10171027|NCT03044106|11301226|FG001|STARTED|Visit 2||20
10171028|NCT03044106|11301225|FG000|COMPLETED|Visit 2||22
10171029|NCT03044106|11301226|FG001|COMPLETED|Visit 2||20
10171030|NCT03044106|11301225|FG000|NOT COMPLETED|Visit 2||0
10171031|NCT03044106|11301226|FG001|NOT COMPLETED|Visit 2||0
10171032|NCT03044197|11301241|FG000|STARTED|Overall Study||12
10171033|NCT03044197|11301242|FG001|STARTED|Overall Study||12
10171034|NCT03044197|11301241|FG000|COMPLETED|Overall Study||9
10171035|NCT03044197|11301242|FG001|COMPLETED|Overall Study||11
10171036|NCT03044197|11301241|FG000|NOT COMPLETED|Overall Study||3
10171037|NCT03044197|11301242|FG001|NOT COMPLETED|Overall Study||1
10171038|NCT03044249|11301250|FG000|STARTED|Overall Study||42
10171039|NCT03044249|11301251|FG001|STARTED|Overall Study||39
10171040|NCT03044249|11301250|FG000|Received at Least One Dose of Study Drug|Overall Study||42
10171041|NCT03044249|11301251|FG001|Received at Least One Dose of Study Drug|Overall Study||39
10171042|NCT03044249|11301250|FG000|COMPLETED|Overall Study||32
10171043|NCT03044249|11301251|FG001|COMPLETED|Overall Study||25
10171044|NCT03044249|11301250|FG000|NOT COMPLETED|Overall Study||10
10171045|NCT03044249|11301251|FG001|NOT COMPLETED|Overall Study||14
10171046|NCT03044353|11301265|FG000|STARTED|Overall Study||6
10171047|NCT03044353|11301266|FG001|STARTED|Overall Study||1
10171048|NCT03044353|11301267|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
10061477|NCT02104739|11187056|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061478|NCT02104739|11187057|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061479|NCT02104739|11187058|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10061480|NCT02104739|11187059|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
10061481|NCT02104739|11187053|FG000|STARTED|Extension Phase (6 Weeks)||0
10061482|NCT02104739|11187054|FG001|STARTED|Extension Phase (6 Weeks)||0
10061483|NCT02104739|11187055|FG002|STARTED|Extension Phase (6 Weeks)||0
10061484|NCT02104739|11187056|FG003|STARTED|Extension Phase (6 Weeks)||0
10061485|NCT02104739|11187057|FG004|STARTED|Extension Phase (6 Weeks)||0
10061486|NCT02104739|11187058|FG005|STARTED|Extension Phase (6 Weeks)||0
10061487|NCT02104739|11187059|FG006|STARTED|Extension Phase (6 Weeks)||8
10061488|NCT02104739|11187053|FG000|COMPLETED|Extension Phase (6 Weeks)||0
10061489|NCT02104739|11187054|FG001|COMPLETED|Extension Phase (6 Weeks)||0
10061490|NCT02104739|11187055|FG002|COMPLETED|Extension Phase (6 Weeks)||0
10061491|NCT02104739|11187056|FG003|COMPLETED|Extension Phase (6 Weeks)||0
10061492|NCT02104739|11187057|FG004|COMPLETED|Extension Phase (6 Weeks)||0
10061493|NCT02104739|11187058|FG005|COMPLETED|Extension Phase (6 Weeks)||0
10061494|NCT02104739|11187059|FG006|COMPLETED|Extension Phase (6 Weeks)||7
10061495|NCT02104739|11187053|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0
10061496|NCT02104739|11187054|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0
10061497|NCT02104739|11187055|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0
10061498|NCT02104739|11187056|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0
10061499|NCT02104739|11187057|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0
10061500|NCT02104739|11187058|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0
10061501|NCT02104739|11187059|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1
10061502|NCT02104752|11187071|FG000|STARTED|Overall Study||18
10061503|NCT02104752|11187072|FG001|STARTED|Overall Study||21
10061504|NCT02104752|11187071|FG000|COMPLETED|Overall Study||17
10061505|NCT02104752|11187072|FG001|COMPLETED|Overall Study||19
10061506|NCT02104752|11187071|FG000|NOT COMPLETED|Overall Study||1
10061507|NCT02104752|11187072|FG001|NOT COMPLETED|Overall Study||2
10061508|NCT02104765|11187085|FG000|STARTED|Overall Study||8
10061509|NCT02104765|11187086|FG001|STARTED|Overall Study||6
10061510|NCT02104765|11187087|FG002|STARTED|Overall Study||6
10061511|NCT02104765|11187088|FG003|STARTED|Overall Study||7
10061512|NCT02104765|11187089|FG004|STARTED|Overall Study||8
10061513|NCT02104765|11187090|FG005|STARTED|Overall Study||2
10061514|NCT02104765|11187091|FG006|STARTED|Overall Study||8
10061515|NCT02104765|11187085|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10061516|NCT02104765|11187086|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10061517|NCT02104765|11187087|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10061518|NCT02104765|11187088|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
10061519|NCT02104765|11187089|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
10061520|NCT02104765|11187090|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2
10061521|NCT02104765|11187091|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8
10061522|NCT02104765|11187085|FG000|COMPLETED|Overall Study||8
10061523|NCT02104765|11187086|FG001|COMPLETED|Overall Study||6
10061524|NCT02104765|11187087|FG002|COMPLETED|Overall Study||5
10061525|NCT02104765|11187088|FG003|COMPLETED|Overall Study||6
10061526|NCT02104765|11187089|FG004|COMPLETED|Overall Study||7
10061527|NCT02104765|11187090|FG005|COMPLETED|Overall Study||2
10061528|NCT02104765|11187091|FG006|COMPLETED|Overall Study||7
10061529|NCT02104765|11187085|FG000|NOT COMPLETED|Overall Study||0
10061530|NCT02104765|11187086|FG001|NOT COMPLETED|Overall Study||0
10061531|NCT02104765|11187087|FG002|NOT COMPLETED|Overall Study||1
10061532|NCT02104765|11187088|FG003|NOT COMPLETED|Overall Study||1
10061533|NCT02104765|11187089|FG004|NOT COMPLETED|Overall Study||1
10061534|NCT02104765|11187090|FG005|NOT COMPLETED|Overall Study||0
10061535|NCT02104765|11187091|FG006|NOT COMPLETED|Overall Study||1
10061536|NCT02104804|11187115|FG000|STARTED|Overall Study|Number of patients who were randomized|234
10061537|NCT02104804|11187116|FG001|STARTED|Overall Study|Number of patients who were randomized|232
10061538|NCT02104804|11187115|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
10061539|NCT02104804|11187116|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
10061540|NCT02104804|11187115|FG000|NOT COMPLETED|Overall Study||16
10061541|NCT02104804|11187116|FG001|NOT COMPLETED|Overall Study||19
10061542|NCT02104817|11187124|FG000|STARTED|Overall Study||6539
10061543|NCT02104817|11187125|FG001|STARTED|Overall Study||6539
10061544|NCT02104817|11187124|FG000|COMPLETED|Overall Study||80
10061545|NCT02104817|11187125|FG001|COMPLETED|Overall Study||92
10061546|NCT02104817|11187124|FG000|NOT COMPLETED|Overall Study||6459
10061547|NCT02104817|11187125|FG001|NOT COMPLETED|Overall Study||6447
10061548|NCT02104830|11187134|FG000|STARTED|Overall Study||42
10061549|NCT02104830|11187135|FG001|STARTED|Overall Study||43
10061550|NCT02104830|11187136|FG002|STARTED|Overall Study||43
10061551|NCT02104830|11187134|FG000|COMPLETED|Overall Study||38
10061552|NCT02104830|11187135|FG001|COMPLETED|Overall Study||36
10061553|NCT02104830|11187136|FG002|COMPLETED|Overall Study||36
10061554|NCT02104830|11187134|FG000|NOT COMPLETED|Overall Study||4
10061555|NCT02104830|11187135|FG001|NOT COMPLETED|Overall Study||7
10171049|NCT03044353|11301265|FG000|COMPLETED|Overall Study||6
10171050|NCT03044353|11301266|FG001|COMPLETED|Overall Study||0
10171051|NCT03044353|11301267|FG002|COMPLETED|Overall Study||0
10171052|NCT03044353|11301265|FG000|NOT COMPLETED|Overall Study||0
10171053|NCT03044353|11301266|FG001|NOT COMPLETED|Overall Study||1
10171054|NCT03044353|11301267|FG002|NOT COMPLETED|Overall Study||0
10171055|NCT03044418|11301274|FG000|STARTED|Overall Study||30
10171056|NCT03044418|11301274|FG000|COMPLETED|Overall Study||30
10171057|NCT03044418|11301274|FG000|NOT COMPLETED|Overall Study||0
10171058|NCT03044431|11301278|FG000|STARTED|Overall Study||207
10171059|NCT03044431|11301278|FG000|COMPLETED|Overall Study||148
10171060|NCT03044431|11301278|FG000|NOT COMPLETED|Overall Study||59
10171061|NCT03044574|11301284|FG000|STARTED|Overall Study||204
10171062|NCT03044574|11301285|FG001|STARTED|Overall Study||203
10171063|NCT03044574|11301284|FG000|Inpatient Period|Overall Study||204
10171064|NCT03044574|11301285|FG001|Inpatient Period|Overall Study||203
10171065|NCT03044574|11301284|FG000|30 Days After Surgery|Overall Study||193
10171066|NCT03044574|11301285|FG001|30 Days After Surgery|Overall Study||194
10171067|NCT03044574|11301284|FG000|180 Days After Surgery|Overall Study||167
10171068|NCT03044574|11301285|FG001|180 Days After Surgery|Overall Study||158
10171069|NCT03044574|11301284|FG000|COMPLETED|Overall Study||167
10171070|NCT03044574|11301285|FG001|COMPLETED|Overall Study||158
10171071|NCT03044574|11301284|FG000|NOT COMPLETED|Overall Study||37
10171072|NCT03044574|11301285|FG001|NOT COMPLETED|Overall Study||45
10171073|NCT03044691|11301293|FG000|STARTED|Overall Study||0
10171074|NCT03044691|11301294|FG001|STARTED|Overall Study||84
10171075|NCT03044691|11301293|FG000|COMPLETED|Overall Study||0
10171076|NCT03044691|11301294|FG001|COMPLETED|Overall Study||84
10171077|NCT03044691|11301293|FG000|NOT COMPLETED|Overall Study||0
10171078|NCT03044691|11301294|FG001|NOT COMPLETED|Overall Study||0
10171079|NCT03044730|11301300|FG000|STARTED|3 Cycles of Pembro + Capecitab||30
10171080|NCT03044730|11301300|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
10171081|NCT03044730|11301300|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
10171082|NCT03044730|11301300|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
10171083|NCT03044730|11301300|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26
10171084|NCT03044730|11301300|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
10171085|NCT03044730|11301300|FG000|STARTED|Cycles 4 and Beyond||26
10171086|NCT03044730|11301300|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26
10171087|NCT03044730|11301300|FG000|Started Cycle 4|Cycles 4 and Beyond||20
10171088|NCT03044730|11301300|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
10171089|NCT03044730|11301300|FG000|COMPLETED|Cycles 4 and Beyond||16
10171090|NCT03044730|11301300|FG000|NOT COMPLETED|Cycles 4 and Beyond||10
10171091|NCT03044730|11301300|FG000|STARTED|On Follow-up for 2 Years||29
10171092|NCT03044730|11301300|FG000|COMPLETED|On Follow-up for 2 Years||4
10171093|NCT03044730|11301300|FG000|NOT COMPLETED|On Follow-up for 2 Years||25
10171094|NCT03044886|11301308|FG000|STARTED|Overall Study||120
10171095|NCT03044886|11301309|FG001|STARTED|Overall Study||120
10171096|NCT03044886|11301310|FG002|STARTED|Overall Study||120
10171097|NCT03044886|11301308|FG000|COMPLETED|Overall Study||105
10171098|NCT03044886|11301309|FG001|COMPLETED|Overall Study||110
10171099|NCT03044886|11301310|FG002|COMPLETED|Overall Study||108
10171100|NCT03044886|11301308|FG000|NOT COMPLETED|Overall Study||15
10171101|NCT03044886|11301309|FG001|NOT COMPLETED|Overall Study||10
10171102|NCT03044886|11301310|FG002|NOT COMPLETED|Overall Study||12
10171103|NCT03045081|11301320|FG000|STARTED|Overall Study||51
10171104|NCT03045081|11301321|FG001|STARTED|Overall Study||48
10171105|NCT03045081|11301320|FG000|COMPLETED|Overall Study||45
10171106|NCT03045081|11301321|FG001|COMPLETED|Overall Study||37
10171107|NCT03045081|11301320|FG000|NOT COMPLETED|Overall Study||6
10171108|NCT03045081|11301321|FG001|NOT COMPLETED|Overall Study||11
10171109|NCT03045302|11301327|FG000|STARTED|Overall Study||4
10171110|NCT03045302|11301327|FG000|COMPLETED|Overall Study||3
10171111|NCT03045302|11301327|FG000|NOT COMPLETED|Overall Study||1
10171112|NCT03045328|11301331|FG000|STARTED|Overall Study||22
10171113|NCT03045328|11301331|FG000|COMPLETED|Overall Study||20
10171114|NCT03045328|11301331|FG000|NOT COMPLETED|Overall Study||2
10171115|NCT03045809|11301335|FG000|STARTED|Overall Study||705
10171116|NCT03045809|11301335|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
10171117|NCT03045809|11301335|FG000|COMPLETED|Overall Study||705
10171118|NCT03045809|11301335|FG000|NOT COMPLETED|Overall Study||0
10171119|NCT03045861|11301345|FG000|STARTED|Part A (Up to 10 Days)||0
10171120|NCT03045861|11301346|FG001|STARTED|Part A (Up to 10 Days)||0
10171121|NCT03045861|11301347|FG002|STARTED|Part A (Up to 10 Days)||10
10171122|NCT03045861|11301348|FG003|STARTED|Part A (Up to 10 Days)||0
10171123|NCT03045861|11301345|FG000|COMPLETED|Part A (Up to 10 Days)||0
10171124|NCT03045861|11301346|FG001|COMPLETED|Part A (Up to 10 Days)||0
10171125|NCT03045861|11301347|FG002|COMPLETED|Part A (Up to 10 Days)||10
10171126|NCT03045861|11301348|FG003|COMPLETED|Part A (Up to 10 Days)||0
10171127|NCT03045861|11301345|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0
10171128|NCT03045861|11301346|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0
10171129|NCT03045861|11301347|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0
10171130|NCT03045861|11301348|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0
10171131|NCT03045861|11301345|FG000|STARTED|Part B (Up to 10 Days)||7
10171132|NCT03045861|11301346|FG001|STARTED|Part B (Up to 10 Days)||8
10171133|NCT03045861|11301347|FG002|STARTED|Part B (Up to 10 Days)||0
10171134|NCT03045861|11301348|FG003|STARTED|Part B (Up to 10 Days)||8
10171135|NCT03045861|11301345|FG000|COMPLETED|Part B (Up to 10 Days)||7
10171136|NCT03045861|11301346|FG001|COMPLETED|Part B (Up to 10 Days)||8
10171137|NCT03045861|11301347|FG002|COMPLETED|Part B (Up to 10 Days)||0
10171138|NCT03045861|11301348|FG003|COMPLETED|Part B (Up to 10 Days)||8
10171139|NCT03045861|11301345|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0
10171140|NCT03045861|11301346|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0
10171141|NCT03045861|11301347|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0
10171142|NCT03045861|11301348|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0
10171143|NCT03045887|11301369|FG000|STARTED|Part A, Period (1 Day)||7
10171144|NCT03045887|11301370|FG001|STARTED|Part A, Period (1 Day)||4
10171145|NCT03045887|11301371|FG002|STARTED|Part A, Period (1 Day)||5
10171146|NCT03045887|11301372|FG003|STARTED|Part A, Period (1 Day)||5
10171147|NCT03045887|11301373|FG004|STARTED|Part A, Period (1 Day)||4
10171148|NCT03045887|11301374|FG005|STARTED|Part A, Period (1 Day)||4
10171149|NCT03045887|11301375|FG006|STARTED|Part A, Period (1 Day)||4
10171150|NCT03045887|11301376|FG007|STARTED|Part A, Period (1 Day)||4
10171151|NCT03045887|11301377|FG008|STARTED|Part A, Period (1 Day)||0
10171152|NCT03045887|11301378|FG009|STARTED|Part A, Period (1 Day)||0
10171153|NCT03045887|11301369|FG000|COMPLETED|Part A, Period (1 Day)||7
10171154|NCT03045887|11301370|FG001|COMPLETED|Part A, Period (1 Day)||4
10171155|NCT03045887|11301371|FG002|COMPLETED|Part A, Period (1 Day)||5
10171156|NCT03045887|11301372|FG003|COMPLETED|Part A, Period (1 Day)||5
10171157|NCT03045887|11301373|FG004|COMPLETED|Part A, Period (1 Day)||4
10171158|NCT03045887|11301374|FG005|COMPLETED|Part A, Period (1 Day)||4
10171159|NCT03045887|11301375|FG006|COMPLETED|Part A, Period (1 Day)||4
10171160|NCT03045887|11301376|FG007|COMPLETED|Part A, Period (1 Day)||4
10171161|NCT03045887|11301377|FG008|COMPLETED|Part A, Period (1 Day)||0
10171162|NCT03045887|11301378|FG009|COMPLETED|Part A, Period (1 Day)||0
10171163|NCT03045887|11301369|FG000|NOT COMPLETED|Part A, Period (1 Day)||0
10171164|NCT03045887|11301370|FG001|NOT COMPLETED|Part A, Period (1 Day)||0
10171165|NCT03045887|11301371|FG002|NOT COMPLETED|Part A, Period (1 Day)||0
10171166|NCT03045887|11301372|FG003|NOT COMPLETED|Part A, Period (1 Day)||0
10171167|NCT03045887|11301373|FG004|NOT COMPLETED|Part A, Period (1 Day)||0
10171168|NCT03045887|11301374|FG005|NOT COMPLETED|Part A, Period (1 Day)||0
10171169|NCT03045887|11301375|FG006|NOT COMPLETED|Part A, Period (1 Day)||0
10171170|NCT03045887|11301376|FG007|NOT COMPLETED|Part A, Period (1 Day)||0
10171171|NCT03045887|11301377|FG008|NOT COMPLETED|Part A, Period (1 Day)||0
10171172|NCT03045887|11301378|FG009|NOT COMPLETED|Part A, Period (1 Day)||0
10171173|NCT03045887|11301369|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7
10171174|NCT03045887|11301370|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4
10171175|NCT03045887|11301371|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5
10171176|NCT03045887|11301372|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5
10171177|NCT03045887|11301373|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4
10171178|NCT03045887|11301374|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4
10171179|NCT03045887|11301375|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4
10171180|NCT03045887|11301376|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4
10171181|NCT03045887|11301377|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0
10171182|NCT03045887|11301378|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0
10171183|NCT03045887|11301369|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10171184|NCT03045887|11301370|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10171185|NCT03045887|11301371|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
10171186|NCT03045887|11301372|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10171187|NCT03045887|11301373|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10171188|NCT03045887|11301374|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10171189|NCT03045887|11301375|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10171190|NCT03045887|11301376|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10171191|NCT03045887|11301377|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171192|NCT03045887|11301378|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171193|NCT03045887|11301369|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
10171194|NCT03045887|11301370|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171195|NCT03045887|11301371|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171196|NCT03045887|11301372|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
10171197|NCT03045887|11301373|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171198|NCT03045887|11301374|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171199|NCT03045887|11301375|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171200|NCT03045887|11301376|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171201|NCT03045887|11301377|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171202|NCT03045887|11301378|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10171203|NCT03045887|11301369|FG000|STARTED|Part A, Period 2 (1 Day)||4
10171204|NCT03045887|11301370|FG001|STARTED|Part A, Period 2 (1 Day)||4
10171205|NCT03045887|11301371|FG002|STARTED|Part A, Period 2 (1 Day)||5
10171206|NCT03045887|11301372|FG003|STARTED|Part A, Period 2 (1 Day)||4
10171207|NCT03045887|11301373|FG004|STARTED|Part A, Period 2 (1 Day)||4
10171208|NCT03045887|11301374|FG005|STARTED|Part A, Period 2 (1 Day)||4
10171209|NCT03045887|11301375|FG006|STARTED|Part A, Period 2 (1 Day)||4
10171210|NCT03045887|11301376|FG007|STARTED|Part A, Period 2 (1 Day)||4
10171211|NCT03045887|11301377|FG008|STARTED|Part A, Period 2 (1 Day)||0
10171212|NCT03045887|11301378|FG009|STARTED|Part A, Period 2 (1 Day)||0
10171213|NCT03045887|11301369|FG000|COMPLETED|Part A, Period 2 (1 Day)||3
10171214|NCT03045887|11301370|FG001|COMPLETED|Part A, Period 2 (1 Day)||4
10171215|NCT03045887|11301371|FG002|COMPLETED|Part A, Period 2 (1 Day)||5
10171216|NCT03045887|11301372|FG003|COMPLETED|Part A, Period 2 (1 Day)||4
10171217|NCT03045887|11301373|FG004|COMPLETED|Part A, Period 2 (1 Day)||4
10171218|NCT03045887|11301374|FG005|COMPLETED|Part A, Period 2 (1 Day)||4
10171219|NCT03045887|11301375|FG006|COMPLETED|Part A, Period 2 (1 Day)||4
10171220|NCT03045887|11301376|FG007|COMPLETED|Part A, Period 2 (1 Day)||4
10171221|NCT03045887|11301377|FG008|COMPLETED|Part A, Period 2 (1 Day)||0
10171222|NCT03045887|11301378|FG009|COMPLETED|Part A, Period 2 (1 Day)||0
10171223|NCT03045887|11301369|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1
10171224|NCT03045887|11301370|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171225|NCT03045887|11301371|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171226|NCT03045887|11301372|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171227|NCT03045887|11301373|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171228|NCT03045887|11301374|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171229|NCT03045887|11301375|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171230|NCT03045887|11301376|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171231|NCT03045887|11301377|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171232|NCT03045887|11301378|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10171233|NCT03045887|11301369|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3
10171234|NCT03045887|11301370|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10171235|NCT03045887|11301371|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5
10171236|NCT03045887|11301372|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10171237|NCT03045887|11301373|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10171238|NCT03045887|11301374|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10171239|NCT03045887|11301375|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10171240|NCT03045887|11301376|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10171241|NCT03045887|11301377|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0
10171242|NCT03045887|11301378|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0
10171243|NCT03045887|11301369|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
10171244|NCT03045887|11301370|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10171245|NCT03045887|11301371|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10171246|NCT03045887|11301372|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
10171247|NCT03045887|11301373|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10171248|NCT03045887|11301374|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10171249|NCT03045887|11301375|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10171250|NCT03045887|11301376|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10171251|NCT03045887|11301377|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171252|NCT03045887|11301378|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171253|NCT03045887|11301369|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171254|NCT03045887|11301370|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171255|NCT03045887|11301371|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
10171256|NCT03045887|11301372|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
10171257|NCT03045887|11301373|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171258|NCT03045887|11301374|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171259|NCT03045887|11301375|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171260|NCT03045887|11301376|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171261|NCT03045887|11301377|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171262|NCT03045887|11301378|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10171263|NCT03045887|11301369|FG000|STARTED|Part A, Period 3 (1 Day)||3
10171264|NCT03045887|11301370|FG001|STARTED|Part A, Period 3 (1 Day)||4
10171265|NCT03045887|11301371|FG002|STARTED|Part A, Period 3 (1 Day)||4
10171266|NCT03045887|11301372|FG003|STARTED|Part A, Period 3 (1 Day)||2
10171267|NCT03045887|11301373|FG004|STARTED|Part A, Period 3 (1 Day)||4
10171268|NCT03045887|11301374|FG005|STARTED|Part A, Period 3 (1 Day)||4
10171269|NCT03045887|11301375|FG006|STARTED|Part A, Period 3 (1 Day)||4
10171270|NCT03045887|11301376|FG007|STARTED|Part A, Period 3 (1 Day)||4
10171271|NCT03045887|11301377|FG008|STARTED|Part A, Period 3 (1 Day)||0
10171272|NCT03045887|11301378|FG009|STARTED|Part A, Period 3 (1 Day)||0
10171273|NCT03045887|11301369|FG000|COMPLETED|Part A, Period 3 (1 Day)||3
10171274|NCT03045887|11301370|FG001|COMPLETED|Part A, Period 3 (1 Day)||4
10171275|NCT03045887|11301371|FG002|COMPLETED|Part A, Period 3 (1 Day)||4
10171276|NCT03045887|11301372|FG003|COMPLETED|Part A, Period 3 (1 Day)||2
10171277|NCT03045887|11301373|FG004|COMPLETED|Part A, Period 3 (1 Day)||4
10171278|NCT03045887|11301374|FG005|COMPLETED|Part A, Period 3 (1 Day)||4
10171279|NCT03045887|11301375|FG006|COMPLETED|Part A, Period 3 (1 Day)||4
10171280|NCT03045887|11301376|FG007|COMPLETED|Part A, Period 3 (1 Day)||4
10171281|NCT03045887|11301377|FG008|COMPLETED|Part A, Period 3 (1 Day)||0
10171282|NCT03045887|11301378|FG009|COMPLETED|Part A, Period 3 (1 Day)||0
10171283|NCT03045887|11301369|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171284|NCT03045887|11301370|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171285|NCT03045887|11301371|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171286|NCT03045887|11301372|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171287|NCT03045887|11301373|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171288|NCT03045887|11301374|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171289|NCT03045887|11301375|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171290|NCT03045887|11301376|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171291|NCT03045887|11301377|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171292|NCT03045887|11301378|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10171293|NCT03045887|11301369|FG000|STARTED|Part B (14 Days)||0
10171294|NCT03045887|11301370|FG001|STARTED|Part B (14 Days)||0
10171295|NCT03045887|11301371|FG002|STARTED|Part B (14 Days)||0
10171296|NCT03045887|11301372|FG003|STARTED|Part B (14 Days)||0
10171297|NCT03045887|11301373|FG004|STARTED|Part B (14 Days)||0
10171298|NCT03045887|11301374|FG005|STARTED|Part B (14 Days)||0
10171299|NCT03045887|11301375|FG006|STARTED|Part B (14 Days)||0
10171300|NCT03045887|11301376|FG007|STARTED|Part B (14 Days)||0
10171301|NCT03045887|11301377|FG008|STARTED|Part B (14 Days)||3
10171302|NCT03045887|11301378|FG009|STARTED|Part B (14 Days)||9
10171303|NCT03045887|11301369|FG000|COMPLETED|Part B (14 Days)||0
10171304|NCT03045887|11301370|FG001|COMPLETED|Part B (14 Days)||0
10171305|NCT03045887|11301371|FG002|COMPLETED|Part B (14 Days)||0
10171306|NCT03045887|11301372|FG003|COMPLETED|Part B (14 Days)||0
10171307|NCT03045887|11301373|FG004|COMPLETED|Part B (14 Days)||0
10171308|NCT03045887|11301374|FG005|COMPLETED|Part B (14 Days)||0
10171309|NCT03045887|11301375|FG006|COMPLETED|Part B (14 Days)||0
10171310|NCT03045887|11301376|FG007|COMPLETED|Part B (14 Days)||0
10171311|NCT03045887|11301377|FG008|COMPLETED|Part B (14 Days)||3
10171312|NCT03045887|11301378|FG009|COMPLETED|Part B (14 Days)||9
10171313|NCT03045887|11301369|FG000|NOT COMPLETED|Part B (14 Days)||0
10171314|NCT03045887|11301370|FG001|NOT COMPLETED|Part B (14 Days)||0
10171315|NCT03045887|11301371|FG002|NOT COMPLETED|Part B (14 Days)||0
10171316|NCT03045887|11301372|FG003|NOT COMPLETED|Part B (14 Days)||0
10171317|NCT03045887|11301373|FG004|NOT COMPLETED|Part B (14 Days)||0
10171318|NCT03045887|11301374|FG005|NOT COMPLETED|Part B (14 Days)||0
10171319|NCT03045887|11301375|FG006|NOT COMPLETED|Part B (14 Days)||0
10171320|NCT03045887|11301376|FG007|NOT COMPLETED|Part B (14 Days)||0
10171321|NCT03045887|11301377|FG008|NOT COMPLETED|Part B (14 Days)||0
10171322|NCT03045887|11301378|FG009|NOT COMPLETED|Part B (14 Days)||0
10171323|NCT03045926|11301405|FG000|STARTED|Overall Study||35
10171324|NCT03045926|11301405|FG000|COMPLETED|Overall Study||35
10171325|NCT03045926|11301405|FG000|NOT COMPLETED|Overall Study||0
10171326|NCT03046056|11301412|FG000|STARTED|Overall Study||28
10171327|NCT03046056|11301413|FG001|STARTED|Overall Study||32
10171328|NCT03046056|11301414|FG002|STARTED|Overall Study||18
10171329|NCT03046056|11301412|FG000|COMPLETED|Overall Study||16
10171330|NCT03046056|11301413|FG001|COMPLETED|Overall Study||16
10171331|NCT03046056|11301414|FG002|COMPLETED|Overall Study||11
10171332|NCT03046056|11301412|FG000|NOT COMPLETED|Overall Study||12
10171333|NCT03046056|11301413|FG001|NOT COMPLETED|Overall Study||16
10171334|NCT03046056|11301414|FG002|NOT COMPLETED|Overall Study||7
10171335|NCT03046212|11301424|FG000|STARTED|Overall Study||15
10171336|NCT03046212|11301425|FG001|STARTED|Overall Study||15
10171337|NCT03046212|11301424|FG000|COMPLETED|Overall Study||15
10171338|NCT03046212|11301425|FG001|COMPLETED|Overall Study||15
10171339|NCT03046212|11301424|FG000|NOT COMPLETED|Overall Study||0
10171340|NCT03046212|11301425|FG001|NOT COMPLETED|Overall Study||0
10171341|NCT03046225|11301433|FG000|STARTED|Overall Study||13
10171342|NCT03046225|11301434|FG001|STARTED|Overall Study||13
10171343|NCT03046225|11301433|FG000|COMPLETED|Overall Study||13
10171344|NCT03046225|11301434|FG001|COMPLETED|Overall Study||13
10171345|NCT03046225|11301433|FG000|NOT COMPLETED|Overall Study||0
10171346|NCT03046225|11301434|FG001|NOT COMPLETED|Overall Study||0
10171347|NCT03046446|11301440|FG000|STARTED|Overall Study||208
10171348|NCT03046446|11301440|FG000|Second Injection|Overall Study||179
10171349|NCT03046446|11301440|FG000|Completed at Week 12|Overall Study||10
10171350|NCT03046446|11301440|FG000|Completed at Week 24|Overall Study||6
10171351|NCT03046446|11301440|FG000|Completed at Week 52|Overall Study||133
10171352|NCT03046446|11301440|FG000|COMPLETED|Overall Study||149
10171353|NCT03046446|11301440|FG000|NOT COMPLETED|Overall Study||59
10171354|NCT03046472|11301446|FG000|STARTED|Overall Study||33
10171355|NCT03046472|11301447|FG001|STARTED|Overall Study||17
10171356|NCT03046472|11301446|FG000|COMPLETED|Overall Study||33
10171357|NCT03046472|11301447|FG001|COMPLETED|Overall Study||17
10171358|NCT03046472|11301446|FG000|NOT COMPLETED|Overall Study||0
10171359|NCT03046472|11301447|FG001|NOT COMPLETED|Overall Study||0
10171360|NCT03046966|11301455|FG000|STARTED|Overall Study||51
10171361|NCT03046966|11301456|FG001|STARTED|Overall Study||51
10171362|NCT03046966|11301455|FG000|COMPLETED|Overall Study||51
10171363|NCT03046966|11301456|FG001|COMPLETED|Overall Study||51
10171364|NCT03046966|11301455|FG000|NOT COMPLETED|Overall Study||0
10171365|NCT03046966|11301456|FG001|NOT COMPLETED|Overall Study||0
10171366|NCT03047174|11301464|FG000|STARTED|Overall Study||28
10171367|NCT03047174|11301465|FG001|STARTED|Overall Study||29
10171368|NCT03047174|11301464|FG000|COMPLETED|Overall Study||9
10171369|NCT03047174|11301465|FG001|COMPLETED|Overall Study||27
10171370|NCT03047174|11301464|FG000|NOT COMPLETED|Overall Study||19
10171371|NCT03047174|11301465|FG001|NOT COMPLETED|Overall Study||2
10171372|NCT03047447|11301488|FG000|STARTED|Overall Study||10
10171373|NCT03047447|11301489|FG001|STARTED|Overall Study||10
10171374|NCT03047447|11301490|FG002|STARTED|Overall Study||10
10171375|NCT03047447|11301488|FG000|COMPLETED|Overall Study||10
10171376|NCT03047447|11301489|FG001|COMPLETED|Overall Study||10
10171377|NCT03047447|11301490|FG002|COMPLETED|Overall Study||10
10171378|NCT03047447|11301488|FG000|NOT COMPLETED|Overall Study||0
10171379|NCT03047447|11301489|FG001|NOT COMPLETED|Overall Study||0
10171380|NCT03047447|11301490|FG002|NOT COMPLETED|Overall Study||0
10171381|NCT03047551|11301503|FG000|STARTED|Overall Study||319
10171382|NCT03047551|11301504|FG001|STARTED|Overall Study||315
10171383|NCT03047551|11301503|FG000|COMPLETED|Overall Study||317
10171384|NCT03047551|11301504|FG001|COMPLETED|Overall Study||312
10171385|NCT03047551|11301503|FG000|NOT COMPLETED|Overall Study||2
10171386|NCT03047551|11301504|FG001|NOT COMPLETED|Overall Study||3
10171387|NCT03047720|11301512|FG000|STARTED|First Intervention (6weeks)||12
10171388|NCT03047720|11301513|FG001|STARTED|First Intervention (6weeks)||0
10171389|NCT03047720|11301512|FG000|COMPLETED|First Intervention (6weeks)||5
10171390|NCT03047720|11301513|FG001|COMPLETED|First Intervention (6weeks)||0
10171391|NCT03047720|11301512|FG000|NOT COMPLETED|First Intervention (6weeks)||7
10171392|NCT03047720|11301513|FG001|NOT COMPLETED|First Intervention (6weeks)||0
10171393|NCT03047720|11301512|FG000|STARTED|Second Intervention (6weeks)||0
10171394|NCT03047720|11301513|FG001|STARTED|Second Intervention (6weeks)||0
10171395|NCT03047720|11301512|FG000|COMPLETED|Second Intervention (6weeks)||0
10171396|NCT03047720|11301513|FG001|COMPLETED|Second Intervention (6weeks)||0
10171397|NCT03047720|11301512|FG000|NOT COMPLETED|Second Intervention (6weeks)||0
10171398|NCT03047720|11301513|FG001|NOT COMPLETED|Second Intervention (6weeks)||0
10171399|NCT03047980|11301519|FG000|STARTED|Overall Study||10
10171400|NCT03047980|11301519|FG000|COMPLETED|Overall Study||9
10171401|NCT03047980|11301519|FG000|NOT COMPLETED|Overall Study||1
10171402|NCT03048006|11301523|FG000|STARTED|Overall Study||44456
10171403|NCT03048006|11301523|FG000|COMPLETED|Overall Study||44456
10171404|NCT03048006|11301523|FG000|NOT COMPLETED|Overall Study||0
10171405|NCT03048058|11301529|FG000|STARTED|Overall Study||10
10171406|NCT03048058|11301530|FG001|STARTED|Overall Study||10
10171407|NCT03048058|11301529|FG000|COMPLETED|Overall Study||6
10171408|NCT03048058|11301530|FG001|COMPLETED|Overall Study||6
10171409|NCT03048058|11301529|FG000|NOT COMPLETED|Overall Study||4
10171410|NCT03048058|11301530|FG001|NOT COMPLETED|Overall Study||4
10171411|NCT03048383|11301539|FG000|STARTED|Overall Study||28
10171412|NCT03048383|11301540|FG001|STARTED|Overall Study||21
10171413|NCT03048383|11301541|FG002|STARTED|Overall Study||22
10171414|NCT03048383|11301539|FG000|COMPLETED|Overall Study||15
10171415|NCT03048383|11301540|FG001|COMPLETED|Overall Study||13
10171416|NCT03048383|11301541|FG002|COMPLETED|Overall Study||10
10171417|NCT03048383|11301539|FG000|NOT COMPLETED|Overall Study||13
10171418|NCT03048383|11301540|FG001|NOT COMPLETED|Overall Study||8
10171419|NCT03048383|11301541|FG002|NOT COMPLETED|Overall Study||12
10171420|NCT03048500|11301549|FG000|STARTED|2 Cycles of Treatment||17
10171421|NCT03048500|11301549|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17
10171422|NCT03048500|11301549|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16
10171423|NCT03048500|11301549|FG000|COMPLETED|2 Cycles of Treatment||16
10171424|NCT03048500|11301549|FG000|NOT COMPLETED|2 Cycles of Treatment||1
10171425|NCT03048500|11301549|FG000|STARTED|Reached 1st Response/Continued Treatment||16
10171426|NCT03048500|11301549|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16
10171427|NCT03048500|11301549|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
10171428|NCT03048500|11301549|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9
10171429|NCT03048500|11301549|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
10171430|NCT03048500|11301549|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
10171431|NCT03048500|11301549|FG000|COMPLETED|Follow up for 3 Years||0
10171432|NCT03048500|11301549|FG000|NOT COMPLETED|Follow up for 3 Years||16
10171433|NCT03048747|11301553|FG000|STARTED|Overall Study||16
10171434|NCT03048747|11301553|FG000|COMPLETED|Overall Study||11
10171435|NCT03048747|11301553|FG000|NOT COMPLETED|Overall Study||5
10171436|NCT03049215|11301560|FG000|STARTED|Overall Study||1
10171437|NCT03049215|11301561|FG001|STARTED|Overall Study||0
10171438|NCT03049215|11301560|FG000|COMPLETED|Overall Study||1
10171439|NCT03049215|11301561|FG001|COMPLETED|Overall Study||0
10171440|NCT03049215|11301560|FG000|NOT COMPLETED|Overall Study||0
10171441|NCT03049215|11301561|FG001|NOT COMPLETED|Overall Study||0
10171442|NCT03049280|11301567|FG000|STARTED|Overall Study||33
10171443|NCT03049280|11301567|FG000|COMPLETED|Overall Study||32
10171444|NCT03049280|11301567|FG000|NOT COMPLETED|Overall Study||1
10171445|NCT03049488|11301579|FG000|STARTED|Overall Study||15
10171446|NCT03049488|11301580|FG001|STARTED|Overall Study||15
10171447|NCT03049488|11301581|FG002|STARTED|Overall Study||20
10171448|NCT03049488|11301582|FG003|STARTED|Overall Study||15
10171449|NCT03049488|11301583|FG004|STARTED|Overall Study||15
10171450|NCT03049488|11301584|FG005|STARTED|Overall Study||15
10171451|NCT03049488|11301579|FG000|Received First Product Administration|Overall Study||15
10171452|NCT03049488|11301580|FG001|Received First Product Administration|Overall Study||15
10171453|NCT03049488|11301581|FG002|Received First Product Administration|Overall Study||20
10171454|NCT03049488|11301582|FG003|Received First Product Administration|Overall Study||15
10171455|NCT03049488|11301583|FG004|Received First Product Administration|Overall Study||15
10171456|NCT03049488|11301584|FG005|Received First Product Administration|Overall Study||15
10171457|NCT03049488|11301579|FG000|Received Optional Second Dose|Overall Study||10
10171458|NCT03049488|11301580|FG001|Received Optional Second Dose|Overall Study||11
10171459|NCT03049488|11301581|FG002|Received Optional Second Dose|Overall Study||11
10171460|NCT03049488|11301582|FG003|Received Optional Second Dose|Overall Study||9
10171461|NCT03049488|11301583|FG004|Received Optional Second Dose|Overall Study||11
10171462|NCT03049488|11301584|FG005|Received Optional Second Dose|Overall Study||10
10171463|NCT03049488|11301579|FG000|COMPLETED|Overall Study||13
10171464|NCT03049488|11301580|FG001|COMPLETED|Overall Study||13
10171465|NCT03049488|11301581|FG002|COMPLETED|Overall Study||20
10171466|NCT03049488|11301582|FG003|COMPLETED|Overall Study||13
10171467|NCT03049488|11301583|FG004|COMPLETED|Overall Study||13
10171468|NCT03049488|11301584|FG005|COMPLETED|Overall Study||15
10171469|NCT03049488|11301579|FG000|NOT COMPLETED|Overall Study||2
10171470|NCT03049488|11301580|FG001|NOT COMPLETED|Overall Study||2
10171471|NCT03049488|11301581|FG002|NOT COMPLETED|Overall Study||0
10171472|NCT03049488|11301582|FG003|NOT COMPLETED|Overall Study||2
10171473|NCT03049488|11301583|FG004|NOT COMPLETED|Overall Study||2
10171474|NCT03049488|11301584|FG005|NOT COMPLETED|Overall Study||0
10171475|NCT03049501|11301601|FG000|STARTED|Overall Study||123
10171476|NCT03049501|11301602|FG001|STARTED|Overall Study||121
10171477|NCT03049501|11301601|FG000|6 Month Follow up|Overall Study||107
10171478|NCT03049501|11301602|FG001|6 Month Follow up|Overall Study||91
10171479|NCT03049501|11301601|FG000|12 Month Follow up|Overall Study||101
10171480|NCT03049501|11301602|FG001|12 Month Follow up|Overall Study||92
10171481|NCT03049501|11301601|FG000|COMPLETED|Overall Study||101
10171482|NCT03049501|11301602|FG001|COMPLETED|Overall Study||92
10171483|NCT03049501|11301601|FG000|NOT COMPLETED|Overall Study||22
10171484|NCT03049501|11301602|FG001|NOT COMPLETED|Overall Study||29
10171485|NCT03049748|11301610|FG000|STARTED|Overall Study||20
10171486|NCT03049748|11301611|FG001|STARTED|Overall Study||20
10171487|NCT03049748|11301610|FG000|COMPLETED|Overall Study||16
10171488|NCT03049748|11301611|FG001|COMPLETED|Overall Study||14
10171489|NCT03049748|11301610|FG000|NOT COMPLETED|Overall Study||4
10171490|NCT03049748|11301611|FG001|NOT COMPLETED|Overall Study||6
10171491|NCT03049852|11301620|FG000|STARTED|Overall Study||24
10171492|NCT03049852|11301621|FG001|STARTED|Overall Study||25
10171493|NCT03049852|11301622|FG002|STARTED|Overall Study||26
10171494|NCT03049852|11301620|FG000|COMPLETED|Overall Study||24
10171495|NCT03049852|11301621|FG001|COMPLETED|Overall Study||24
10171496|NCT03049852|11301622|FG002|COMPLETED|Overall Study||26
10171497|NCT03049852|11301620|FG000|NOT COMPLETED|Overall Study||0
10171498|NCT03049852|11301621|FG001|NOT COMPLETED|Overall Study||1
10171499|NCT03049852|11301622|FG002|NOT COMPLETED|Overall Study||0
10171500|NCT03049917|11301637|FG000|STARTED|Overall Study||90
10171501|NCT03049917|11301638|FG001|STARTED|Overall Study||89
10171502|NCT03049917|11301639|FG002|STARTED|Overall Study||93
10171503|NCT03049917|11301640|FG003|STARTED|Overall Study||92
10171504|NCT03049917|11301641|FG004|STARTED|Overall Study||88
10171505|NCT03049917|11301637|FG000|COMPLETED|Overall Study||31
10171506|NCT03049917|11301638|FG001|COMPLETED|Overall Study||31
10171507|NCT03049917|11301639|FG002|COMPLETED|Overall Study||44
10171508|NCT03049917|11301640|FG003|COMPLETED|Overall Study||51
10171509|NCT03049917|11301641|FG004|COMPLETED|Overall Study||54
10171510|NCT03049917|11301637|FG000|NOT COMPLETED|Overall Study||59
10171511|NCT03049917|11301638|FG001|NOT COMPLETED|Overall Study||58
10171512|NCT03049917|11301639|FG002|NOT COMPLETED|Overall Study||49
10171513|NCT03049917|11301640|FG003|NOT COMPLETED|Overall Study||41
10171514|NCT03049917|11301641|FG004|NOT COMPLETED|Overall Study||34
10171515|NCT03050203|11301677|FG000|STARTED|Overall Study||19
10171516|NCT03050203|11301678|FG001|STARTED|Overall Study||18
10171517|NCT03050203|11301677|FG000|COMPLETED|Overall Study||19
10171518|NCT03050203|11301678|FG001|COMPLETED|Overall Study||18
10171519|NCT03050203|11301677|FG000|NOT COMPLETED|Overall Study||0
10171520|NCT03050203|11301678|FG001|NOT COMPLETED|Overall Study||0
10171521|NCT03050216|11301684|FG000|STARTED|Overall Study||8
10171522|NCT03050216|11301684|FG000|COMPLETED|Overall Study||8
10171523|NCT03050216|11301684|FG000|NOT COMPLETED|Overall Study||0
10171524|NCT03050294|11301692|FG000|STARTED|Overall Study||6
10171525|NCT03050294|11301693|FG001|STARTED|Overall Study||6
10171526|NCT03050294|11301694|FG002|STARTED|Overall Study||6
10171527|NCT03050294|11301695|FG003|STARTED|Overall Study||6
10171528|NCT03050294|11301692|FG000|COMPLETED|Overall Study||6
10171529|NCT03050294|11301693|FG001|COMPLETED|Overall Study||6
10171530|NCT03050294|11301694|FG002|COMPLETED|Overall Study||6
10171531|NCT03050294|11301695|FG003|COMPLETED|Overall Study||6
10171532|NCT03050294|11301692|FG000|NOT COMPLETED|Overall Study||0
10171533|NCT03050294|11301693|FG001|NOT COMPLETED|Overall Study||0
10171534|NCT03050294|11301694|FG002|NOT COMPLETED|Overall Study||0
10171535|NCT03050294|11301695|FG003|NOT COMPLETED|Overall Study||0
10171536|NCT03050307|11301707|FG000|STARTED|Overall Study||115
10171537|NCT03050307|11301708|FG001|STARTED|Overall Study||119
10171538|NCT03050307|11301707|FG000|COMPLETED|Overall Study||107
10171539|NCT03050307|11301708|FG001|COMPLETED|Overall Study||110
10171540|NCT03050307|11301707|FG000|NOT COMPLETED|Overall Study||8
10171541|NCT03050307|11301708|FG001|NOT COMPLETED|Overall Study||9
10171542|NCT03050320|11301718|FG000|STARTED|Overall Study||21
10171543|NCT03050320|11301719|FG001|STARTED|Overall Study||22
10171544|NCT03050320|11301718|FG000|COMPLETED|Overall Study||20
10171545|NCT03050320|11301719|FG001|COMPLETED|Overall Study||21
10171546|NCT03050320|11301718|FG000|NOT COMPLETED|Overall Study||1
10171547|NCT03050320|11301719|FG001|NOT COMPLETED|Overall Study||1
10171548|NCT03050359|11301727|FG000|STARTED|Overall Study||265
10171549|NCT03050359|11301728|FG001|STARTED|Overall Study||268
10171550|NCT03050359|11301727|FG000|COMPLETED|Overall Study||248
10171551|NCT03050359|11301728|FG001|COMPLETED|Overall Study||248
10171552|NCT03050359|11301727|FG000|NOT COMPLETED|Overall Study||17
10171553|NCT03050359|11301728|FG001|NOT COMPLETED|Overall Study||20
10171554|NCT03050372|11301736|FG000|STARTED|Adaptation Night (Night #1 PSG)||6
10171555|NCT03050372|11301737|FG001|STARTED|Adaptation Night (Night #1 PSG)||6
10171556|NCT03050372|11301736|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
10171557|NCT03050372|11301737|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6
10171558|NCT03050372|11301736|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
10171559|NCT03050372|11301737|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
10171560|NCT03050372|11301736|FG000|STARTED|First Intervention (Nights #2 and #3)||5
10171561|NCT03050372|11301737|FG001|STARTED|First Intervention (Nights #2 and #3)||6
10171562|NCT03050372|11301736|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5
10171563|NCT03050372|11301737|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6
10171564|NCT03050372|11301736|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
10171565|NCT03050372|11301737|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
10171566|NCT03050372|11301736|FG000|STARTED|Second Intervention (Nights #4 and #5)||5
10171567|NCT03050372|11301737|FG001|STARTED|Second Intervention (Nights #4 and #5)||6
10171568|NCT03050372|11301736|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5
10171569|NCT03050372|11301737|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
10171570|NCT03050372|11301736|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
10171571|NCT03050372|11301737|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
10171572|NCT03050450|11301747|FG000|STARTED|Overall Study||6
10171573|NCT03050450|11301748|FG001|STARTED|Overall Study||0
10171574|NCT03050450|11301749|FG002|STARTED|Overall Study||0
10171575|NCT03050450|11301750|FG003|STARTED|Overall Study||0
10171576|NCT03050450|11301751|FG004|STARTED|Overall Study||0
10171577|NCT03050450|11301747|FG000|COMPLETED|Overall Study||5
10171578|NCT03050450|11301748|FG001|COMPLETED|Overall Study||0
10171579|NCT03050450|11301749|FG002|COMPLETED|Overall Study||0
10171580|NCT03050450|11301750|FG003|COMPLETED|Overall Study||0
10171581|NCT03050450|11301751|FG004|COMPLETED|Overall Study||0
10171582|NCT03050450|11301747|FG000|NOT COMPLETED|Overall Study||1
10171583|NCT03050450|11301748|FG001|NOT COMPLETED|Overall Study||0
10171584|NCT03050450|11301749|FG002|NOT COMPLETED|Overall Study||0
10171585|NCT03050450|11301750|FG003|NOT COMPLETED|Overall Study||0
10171586|NCT03050450|11301751|FG004|NOT COMPLETED|Overall Study||0
10171587|NCT03050541|11301766|FG000|STARTED|Overall Study||28
10171588|NCT03050541|11301767|FG001|STARTED|Overall Study||28
10171589|NCT03050541|11301768|FG002|STARTED|Overall Study||28
10171590|NCT03050541|11301766|FG000|COMPLETED|Overall Study||20
10171591|NCT03050541|11301767|FG001|COMPLETED|Overall Study||20
10171592|NCT03050541|11301768|FG002|COMPLETED|Overall Study||20
10171593|NCT03050541|11301766|FG000|NOT COMPLETED|Overall Study||8
10171594|NCT03050541|11301767|FG001|NOT COMPLETED|Overall Study||8
10171595|NCT03050541|11301768|FG002|NOT COMPLETED|Overall Study||8
10171596|NCT03050619|11301782|FG000|STARTED|Overall Study||129
10171597|NCT03050619|11301783|FG001|STARTED|Overall Study||3926
10171598|NCT03050619|11301784|FG002|STARTED|Overall Study||6416
10171599|NCT03050619|11301785|FG003|STARTED|Overall Study||14007
10171600|NCT03050619|11301786|FG004|STARTED|Overall Study||6079
10171601|NCT03050619|11301787|FG005|STARTED|Overall Study||1351
10171602|NCT03050619|11301782|FG000|COMPLETED|Overall Study||129
10171603|NCT03050619|11301783|FG001|COMPLETED|Overall Study||3926
10171604|NCT03050619|11301784|FG002|COMPLETED|Overall Study||6416
10171605|NCT03050619|11301785|FG003|COMPLETED|Overall Study||14007
10171606|NCT03050619|11301786|FG004|COMPLETED|Overall Study||6079
10171607|NCT03050619|11301787|FG005|COMPLETED|Overall Study||1351
10171608|NCT03050619|11301782|FG000|NOT COMPLETED|Overall Study||0
10171609|NCT03050619|11301783|FG001|NOT COMPLETED|Overall Study||0
10171610|NCT03050619|11301784|FG002|NOT COMPLETED|Overall Study||0
10171611|NCT03050619|11301785|FG003|NOT COMPLETED|Overall Study||0
10171612|NCT03050619|11301786|FG004|NOT COMPLETED|Overall Study||0
10171613|NCT03050619|11301787|FG005|NOT COMPLETED|Overall Study||0
10171614|NCT03050697|11301801|FG000|STARTED|Overall Study||12
10171615|NCT03050697|11301801|FG000|COMPLETED|Overall Study||12
10171616|NCT03050697|11301801|FG000|NOT COMPLETED|Overall Study||0
10171617|NCT03050775|11301819|FG000|STARTED|Overall Study||35
10171618|NCT03050775|11301820|FG001|STARTED|Overall Study||35
10171619|NCT03050775|11301819|FG000|COMPLETED|Overall Study||35
10171620|NCT03050775|11301820|FG001|COMPLETED|Overall Study||35
10171621|NCT03050775|11301819|FG000|NOT COMPLETED|Overall Study||0
10171622|NCT03050775|11301820|FG001|NOT COMPLETED|Overall Study||0
10171623|NCT03050801|11301832|FG000|STARTED|Experiment 1||3
10171624|NCT03050801|11301833|FG001|STARTED|Experiment 1||13
10171625|NCT03050801|11301834|FG002|STARTED|Experiment 1||8
10171626|NCT03050801|11301835|FG003|STARTED|Experiment 1||0
10171627|NCT03050801|11301836|FG004|STARTED|Experiment 1||0
10171628|NCT03050801|11301837|FG005|STARTED|Experiment 1||0
10171629|NCT03050801|11301832|FG000|COMPLETED|Experiment 1||3
10171630|NCT03050801|11301833|FG001|COMPLETED|Experiment 1||6
10171631|NCT03050801|11301834|FG002|COMPLETED|Experiment 1||6
10171632|NCT03050801|11301835|FG003|COMPLETED|Experiment 1||0
10171633|NCT03050801|11301836|FG004|COMPLETED|Experiment 1||0
10171634|NCT03050801|11301837|FG005|COMPLETED|Experiment 1||0
10171635|NCT03050801|11301832|FG000|NOT COMPLETED|Experiment 1||0
10171636|NCT03050801|11301833|FG001|NOT COMPLETED|Experiment 1||7
10171637|NCT03050801|11301834|FG002|NOT COMPLETED|Experiment 1||2
10171638|NCT03050801|11301835|FG003|NOT COMPLETED|Experiment 1||0
10171639|NCT03050801|11301836|FG004|NOT COMPLETED|Experiment 1||0
10171640|NCT03050801|11301837|FG005|NOT COMPLETED|Experiment 1||0
10171641|NCT03050801|11301832|FG000|STARTED|Experiment 2||0
10171642|NCT03050801|11301833|FG001|STARTED|Experiment 2||0
10171643|NCT03050801|11301834|FG002|STARTED|Experiment 2||0
10171644|NCT03050801|11301835|FG003|STARTED|Experiment 2||21
10171645|NCT03050801|11301836|FG004|STARTED|Experiment 2||19
10171646|NCT03050801|11301837|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
10171647|NCT03050801|11301832|FG000|COMPLETED|Experiment 2||0
10171648|NCT03050801|11301833|FG001|COMPLETED|Experiment 2||0
10171649|NCT03050801|11301834|FG002|COMPLETED|Experiment 2||0
10171650|NCT03050801|11301835|FG003|COMPLETED|Experiment 2||15
10171651|NCT03050801|11301836|FG004|COMPLETED|Experiment 2||15
10171652|NCT03050801|11301837|FG005|COMPLETED|Experiment 2||2
10171653|NCT03050801|11301832|FG000|NOT COMPLETED|Experiment 2||0
10171654|NCT03050801|11301833|FG001|NOT COMPLETED|Experiment 2||0
10171655|NCT03050801|11301834|FG002|NOT COMPLETED|Experiment 2||0
10171656|NCT03050801|11301835|FG003|NOT COMPLETED|Experiment 2||6
10171657|NCT03050801|11301836|FG004|NOT COMPLETED|Experiment 2||4
10171658|NCT03050801|11301837|FG005|NOT COMPLETED|Experiment 2||2
10171659|NCT03050918|11301856|FG000|STARTED|Overall Study||1534
10171660|NCT03050918|11301857|FG001|STARTED|Overall Study||1520
10171661|NCT03050918|11301856|FG000|COMPLETED|Overall Study||1534
10171662|NCT03050918|11301857|FG001|COMPLETED|Overall Study||1520
10171663|NCT03050918|11301856|FG000|NOT COMPLETED|Overall Study||0
10171664|NCT03050918|11301857|FG001|NOT COMPLETED|Overall Study||0
10171665|NCT03051100|11301865|FG000|STARTED|Overall Study||20
10171666|NCT03051100|11301866|FG001|STARTED|Overall Study||43
10171667|NCT03051100|11301865|FG000|COMPLETED|Overall Study||19
10171668|NCT03051100|11301866|FG001|COMPLETED|Overall Study||43
10171669|NCT03051100|11301865|FG000|NOT COMPLETED|Overall Study||1
10171670|NCT03051100|11301866|FG001|NOT COMPLETED|Overall Study||0
10171671|NCT03051165|11301872|FG000|STARTED|Overall Study||13
10171672|NCT03051165|11301872|FG000|Completed Some Baseline Assessments|Overall Study||1
10171673|NCT03051165|11301872|FG000|Completed Some Day 105 Assessments|Overall Study||1
10171674|NCT03051165|11301872|FG000|Began HGNS Treatment Withdrawal|Overall Study||0
10171675|NCT03051165|11301872|FG000|Completed Some Day 137 Assessments|Overall Study||0
10171676|NCT03051165|11301872|FG000|COMPLETED|Overall Study||0
10171677|NCT03051165|11301872|FG000|NOT COMPLETED|Overall Study||13
10171678|NCT03051256|11301879|FG000|STARTED|Overall Study||19
10171679|NCT03051256|11301880|FG001|STARTED|Overall Study||21
10171680|NCT03051256|11301881|FG002|STARTED|Overall Study||22
10171681|NCT03051256|11301879|FG000|COMPLETED|Overall Study||19
10171682|NCT03051256|11301880|FG001|COMPLETED|Overall Study||21
10171683|NCT03051256|11301881|FG002|COMPLETED|Overall Study||21
10171684|NCT03051256|11301879|FG000|NOT COMPLETED|Overall Study||0
10171685|NCT03051256|11301880|FG001|NOT COMPLETED|Overall Study||0
10171686|NCT03051256|11301881|FG002|NOT COMPLETED|Overall Study||1
10171687|NCT03051607|11301890|FG000|STARTED|Overall Study||66
10171688|NCT03051607|11301890|FG000|COMPLETED|Overall Study||0
10171689|NCT03051607|11301890|FG000|NOT COMPLETED|Overall Study||66
10171690|NCT03051620|11301894|FG000|STARTED|Overall Study||142
10171691|NCT03051620|11301894|FG000|COMPLETED|Overall Study||124
10171692|NCT03051620|11301894|FG000|NOT COMPLETED|Overall Study||18
10171693|NCT03051633|11301900|FG000|STARTED|Overall Study||342
10171694|NCT03051633|11301901|FG001|STARTED|Overall Study||186
10171695|NCT03051633|11301900|FG000|COMPLETED|Overall Study||249
10171696|NCT03051633|11301901|FG001|COMPLETED|Overall Study||179
10171697|NCT03051633|11301900|FG000|NOT COMPLETED|Overall Study||93
10171698|NCT03051633|11301901|FG001|NOT COMPLETED|Overall Study||7
10171699|NCT03051646|11301909|FG000|STARTED|Overall Study||6
10171700|NCT03051646|11301910|FG001|STARTED|Overall Study||6
10171701|NCT03051646|11301909|FG000|COMPLETED|Overall Study||6
10171702|NCT03051646|11301910|FG001|COMPLETED|Overall Study||6
10171703|NCT03051646|11301909|FG000|NOT COMPLETED|Overall Study||0
10171704|NCT03051646|11301910|FG001|NOT COMPLETED|Overall Study||0
10171705|NCT03051672|11301918|FG000|STARTED|Overall Study||8
10171706|NCT03051672|11301918|FG000|Began Treatment|Overall Study||8
10171707|NCT03051672|11301918|FG000|COMPLETED|Overall Study||8
10171708|NCT03051672|11301918|FG000|NOT COMPLETED|Overall Study||0
10171709|NCT03052257|11301925|FG000|STARTED|Overall Study||100
10171710|NCT03052257|11301926|FG001|STARTED|Overall Study||100
10171711|NCT03052257|11301925|FG000|COMPLETED|Overall Study||95
10171712|NCT03052257|11301926|FG001|COMPLETED|Overall Study||97
10171713|NCT03052257|11301925|FG000|NOT COMPLETED|Overall Study||5
10171714|NCT03052257|11301926|FG001|NOT COMPLETED|Overall Study||3
10171715|NCT03052322|11301934|FG000|STARTED|Overall Study||143
10171716|NCT03052322|11301935|FG001|STARTED|Overall Study||145
10171717|NCT03052322|11301934|FG000|COMPLETED|Overall Study||122
10171718|NCT03052322|11301935|FG001|COMPLETED|Overall Study||113
10171719|NCT03052322|11301934|FG000|NOT COMPLETED|Overall Study||21
10171720|NCT03052322|11301935|FG001|NOT COMPLETED|Overall Study||32
10171721|NCT03052426|11301944|FG000|STARTED|Overall Study||6
10171722|NCT03052426|11301945|FG001|STARTED|Overall Study||6
10171723|NCT03052426|11301946|FG002|STARTED|Overall Study||6
10171724|NCT03052426|11301944|FG000|COMPLETED|Overall Study||4
10171725|NCT03052426|11301945|FG001|COMPLETED|Overall Study||5
10171726|NCT03052426|11301946|FG002|COMPLETED|Overall Study||5
10171727|NCT03052426|11301944|FG000|NOT COMPLETED|Overall Study||2
10171728|NCT03052426|11301945|FG001|NOT COMPLETED|Overall Study||1
10171729|NCT03052426|11301946|FG002|NOT COMPLETED|Overall Study||1
10171730|NCT03052517|11301962|FG000|STARTED|Overall Study||1093
10171731|NCT03052517|11301963|FG001|STARTED|Overall Study||1085
10171732|NCT03052517|11301964|FG002|STARTED|Overall Study||360
10171733|NCT03052517|11301962|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
10171734|NCT03052517|11301963|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
10171735|NCT03052517|11301964|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
10171736|NCT03052517|11301962|FG000|COMPLETED|Overall Study||76
10171737|NCT03052517|11301963|FG001|COMPLETED|Overall Study||71
10171738|NCT03052517|11301964|FG002|COMPLETED|Overall Study||32
10171739|NCT03052517|11301962|FG000|NOT COMPLETED|Overall Study||1017
10171740|NCT03052517|11301963|FG001|NOT COMPLETED|Overall Study||1014
10171741|NCT03052517|11301964|FG002|NOT COMPLETED|Overall Study||328
10171742|NCT03052530|11301972|FG000|STARTED|Overall Study||61
10171743|NCT03052530|11301972|FG000|COMPLETED|Overall Study||61
10171744|NCT03052530|11301972|FG000|NOT COMPLETED|Overall Study||0
10171745|NCT03052725|11301978|FG000|STARTED|Overall Study||194
10171746|NCT03052725|11301979|FG001|STARTED|Overall Study||197
10171747|NCT03052725|11301978|FG000|Safety Analysis Set|Overall Study||194
10171748|NCT03052725|11301979|FG001|Safety Analysis Set|Overall Study||196
10171749|NCT03052725|11301978|FG000|COMPLETED|Overall Study||46
10171750|NCT03052725|11301979|FG001|COMPLETED|Overall Study||47
10171751|NCT03052725|11301978|FG000|NOT COMPLETED|Overall Study||148
10171752|NCT03052725|11301979|FG001|NOT COMPLETED|Overall Study||150
10171753|NCT03052751|11301986|FG000|STARTED|Dosing Period 1||22
10171754|NCT03052751|11301987|FG001|STARTED|Dosing Period 1||21
10171755|NCT03052751|11301988|FG002|STARTED|Dosing Period 1||0
10171756|NCT03052751|11301989|FG003|STARTED|Dosing Period 1||0
10171757|NCT03052751|11301990|FG004|STARTED|Dosing Period 1||0
10171758|NCT03052751|11301991|FG005|STARTED|Dosing Period 1||0
10171759|NCT03052751|11301986|FG000|Completed Period 1|Dosing Period 1||22
10171760|NCT03052751|11301987|FG001|Completed Period 1|Dosing Period 1||21
10171761|NCT03052751|11301988|FG002|Completed Period 1|Dosing Period 1||0
10171762|NCT03052751|11301989|FG003|Completed Period 1|Dosing Period 1||0
10171763|NCT03052751|11301990|FG004|Completed Period 1|Dosing Period 1||0
10171764|NCT03052751|11301991|FG005|Completed Period 1|Dosing Period 1||0
10171765|NCT03052751|11301986|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22
10171766|NCT03052751|11301987|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20
10171767|NCT03052751|11301988|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0
10171768|NCT03052751|11301989|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0
10171769|NCT03052751|11301990|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0
10171770|NCT03052751|11301991|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0
10171771|NCT03052751|11301986|FG000|COMPLETED|Dosing Period 1||22
10171772|NCT03052751|11301987|FG001|COMPLETED|Dosing Period 1||20
10171773|NCT03052751|11301988|FG002|COMPLETED|Dosing Period 1||0
10171774|NCT03052751|11301989|FG003|COMPLETED|Dosing Period 1||0
10171775|NCT03052751|11301990|FG004|COMPLETED|Dosing Period 1||0
10171776|NCT03052751|11301991|FG005|COMPLETED|Dosing Period 1||0
10171777|NCT03052751|11301986|FG000|NOT COMPLETED|Dosing Period 1||0
10171778|NCT03052751|11301987|FG001|NOT COMPLETED|Dosing Period 1||1
10171779|NCT03052751|11301988|FG002|NOT COMPLETED|Dosing Period 1||0
10171780|NCT03052751|11301989|FG003|NOT COMPLETED|Dosing Period 1||0
10171781|NCT03052751|11301990|FG004|NOT COMPLETED|Dosing Period 1||0
10171782|NCT03052751|11301991|FG005|NOT COMPLETED|Dosing Period 1||0
10171783|NCT03052751|11301986|FG000|STARTED|Dosing Period 2||0
10171784|NCT03052751|11301987|FG001|STARTED|Dosing Period 2||0
10171785|NCT03052751|11301988|FG002|STARTED|Dosing Period 2||11
10171786|NCT03052751|11301989|FG003|STARTED|Dosing Period 2||11
10171787|NCT03052751|11301990|FG004|STARTED|Dosing Period 2||10
10171788|NCT03052751|11301991|FG005|STARTED|Dosing Period 2||10
10171789|NCT03052751|11301986|FG000|COMPLETED|Dosing Period 2||0
10171790|NCT03052751|11301987|FG001|COMPLETED|Dosing Period 2||0
10171791|NCT03052751|11301988|FG002|COMPLETED|Dosing Period 2||8
10171792|NCT03052751|11301989|FG003|COMPLETED|Dosing Period 2||11
10171793|NCT03052751|11301990|FG004|COMPLETED|Dosing Period 2||10
10171794|NCT03052751|11301991|FG005|COMPLETED|Dosing Period 2||10
10171795|NCT03052751|11301986|FG000|NOT COMPLETED|Dosing Period 2||0
10171796|NCT03052751|11301987|FG001|NOT COMPLETED|Dosing Period 2||0
10171797|NCT03052751|11301988|FG002|NOT COMPLETED|Dosing Period 2||3
10171798|NCT03052751|11301989|FG003|NOT COMPLETED|Dosing Period 2||0
10171799|NCT03052751|11301990|FG004|NOT COMPLETED|Dosing Period 2||0
10171800|NCT03052751|11301991|FG005|NOT COMPLETED|Dosing Period 2||0
10171801|NCT03052751|11301986|FG000|STARTED|Observation Period||22
10171802|NCT03052751|11301987|FG001|STARTED|Observation Period||21
10171803|NCT03052751|11301988|FG002|STARTED|Observation Period||11
10171804|NCT03052751|11301989|FG003|STARTED|Observation Period||11
10171805|NCT03052751|11301990|FG004|STARTED|Observation Period||10
10171806|NCT03052751|11301991|FG005|STARTED|Observation Period||10
10171807|NCT03052751|11301986|FG000|COMPLETED|Observation Period||22
10171808|NCT03052751|11301987|FG001|COMPLETED|Observation Period||21
10171809|NCT03052751|11301988|FG002|COMPLETED|Observation Period||11
10171810|NCT03052751|11301989|FG003|COMPLETED|Observation Period||11
10171811|NCT03052751|11301990|FG004|COMPLETED|Observation Period||9
10171812|NCT03052751|11301991|FG005|COMPLETED|Observation Period||10
10171813|NCT03052751|11301986|FG000|NOT COMPLETED|Observation Period||0
10171814|NCT03052751|11301987|FG001|NOT COMPLETED|Observation Period||0
10171815|NCT03052751|11301988|FG002|NOT COMPLETED|Observation Period||0
10171816|NCT03052751|11301989|FG003|NOT COMPLETED|Observation Period||0
10171817|NCT03052751|11301990|FG004|NOT COMPLETED|Observation Period||1
10171818|NCT03052751|11301991|FG005|NOT COMPLETED|Observation Period||0
10171819|NCT03052764|11302003|FG000|STARTED|Double-Blind Treatment Period||80
10171820|NCT03052764|11302004|FG001|STARTED|Double-Blind Treatment Period||40
10171821|NCT03052764|11302003|FG000|mITT|Double-Blind Treatment Period||78
10171822|NCT03052764|11302004|FG001|mITT|Double-Blind Treatment Period||39
10171823|NCT03052764|11302003|FG000|COMPLETED|Double-Blind Treatment Period||70
10171824|NCT03052764|11302004|FG001|COMPLETED|Double-Blind Treatment Period||37
10171825|NCT03052764|11302003|FG000|NOT COMPLETED|Double-Blind Treatment Period||10
10171826|NCT03052764|11302004|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
10171827|NCT03052764|11302003|FG000|STARTED|Open-Label Re-Treatment Period||58
10171828|NCT03052764|11302004|FG001|STARTED|Open-Label Re-Treatment Period||33
10171829|NCT03052764|11302003|FG000|COMPLETED|Open-Label Re-Treatment Period||58
10171830|NCT03052764|11302004|FG001|COMPLETED|Open-Label Re-Treatment Period||33
10171831|NCT03052764|11302003|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0
10171832|NCT03052764|11302004|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0
10171833|NCT03052816|11302014|FG000|STARTED|Overall Study||33
10171834|NCT03052816|11302015|FG001|STARTED|Overall Study||33
10171835|NCT03052816|11302014|FG000|COMPLETED|Overall Study||30
10171836|NCT03052816|11302015|FG001|COMPLETED|Overall Study||33
10171837|NCT03052816|11302014|FG000|NOT COMPLETED|Overall Study||3
10171838|NCT03052816|11302015|FG001|NOT COMPLETED|Overall Study||0
10171839|NCT03052959|11302025|FG000|STARTED|Overall Study||59
10171840|NCT03052959|11302026|FG001|STARTED|Overall Study||66
10171841|NCT03052959|11302025|FG000|COMPLETED|Overall Study||55
10171842|NCT03052959|11302026|FG001|COMPLETED|Overall Study||61
10171843|NCT03052959|11302025|FG000|NOT COMPLETED|Overall Study||4
10171844|NCT03052959|11302026|FG001|NOT COMPLETED|Overall Study||5
10171845|NCT03052972|11302035|FG000|STARTED|Overall Study||18
10171846|NCT03052972|11302036|FG001|STARTED|Overall Study||5
10171847|NCT03052972|11302035|FG000|COMPLETED|Overall Study||18
10171848|NCT03052972|11302036|FG001|COMPLETED|Overall Study||5
10171849|NCT03052972|11302035|FG000|NOT COMPLETED|Overall Study||0
10171850|NCT03052972|11302036|FG001|NOT COMPLETED|Overall Study||0
10171851|NCT03053050|11302046|FG000|STARTED|Randomized Phase||324
10171852|NCT03053050|11302047|FG001|STARTED|Randomized Phase||323
10171853|NCT03053050|11302048|FG002|STARTED|Randomized Phase||161
10171854|NCT03053050|11302049|FG003|STARTED|Randomized Phase||0
10171855|NCT03053050|11302046|FG000|COMPLETED|Randomized Phase||0
10171856|NCT03053050|11302047|FG001|COMPLETED|Randomized Phase||0
10171857|NCT03053050|11302048|FG002|COMPLETED|Randomized Phase||0
10171858|NCT03053050|11302049|FG003|COMPLETED|Randomized Phase||0
10171859|NCT03053050|11302046|FG000|NOT COMPLETED|Randomized Phase||324
10171860|NCT03053050|11302047|FG001|NOT COMPLETED|Randomized Phase||323
10171861|NCT03053050|11302048|FG002|NOT COMPLETED|Randomized Phase||161
10171862|NCT03053050|11302049|FG003|NOT COMPLETED|Randomized Phase||0
10171863|NCT03053050|11302046|FG000|STARTED|Open-label Phase||0
10171864|NCT03053050|11302047|FG001|STARTED|Open-label Phase||0
10171865|NCT03053050|11302048|FG002|STARTED|Open-label Phase||0
10171866|NCT03053050|11302049|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
10171867|NCT03053050|11302046|FG000|COMPLETED|Open-label Phase||0
10171868|NCT03053050|11302047|FG001|COMPLETED|Open-label Phase||0
10171869|NCT03053050|11302048|FG002|COMPLETED|Open-label Phase||0
10171870|NCT03053050|11302049|FG003|COMPLETED|Open-label Phase||0
10171871|NCT03053050|11302046|FG000|NOT COMPLETED|Open-label Phase||0
10171872|NCT03053050|11302047|FG001|NOT COMPLETED|Open-label Phase||0
10171873|NCT03053050|11302048|FG002|NOT COMPLETED|Open-label Phase||0
10171874|NCT03053050|11302049|FG003|NOT COMPLETED|Open-label Phase||99
10171875|NCT03053063|11302061|FG000|STARTED|Randomized Phase||355
10171876|NCT03053063|11302062|FG001|STARTED|Randomized Phase||354
10171877|NCT03053063|11302063|FG002|STARTED|Randomized Phase||174
10171878|NCT03053063|11302064|FG003|STARTED|Randomized Phase||0
10171879|NCT03053063|11302061|FG000|COMPLETED|Randomized Phase||0
10171880|NCT03053063|11302062|FG001|COMPLETED|Randomized Phase||0
10171881|NCT03053063|11302063|FG002|COMPLETED|Randomized Phase||0
10171882|NCT03053063|11302064|FG003|COMPLETED|Randomized Phase||0
10171883|NCT03053063|11302061|FG000|NOT COMPLETED|Randomized Phase||355
10171884|NCT03053063|11302062|FG001|NOT COMPLETED|Randomized Phase||354
10171885|NCT03053063|11302063|FG002|NOT COMPLETED|Randomized Phase||174
10171886|NCT03053063|11302064|FG003|NOT COMPLETED|Randomized Phase||0
10171887|NCT03053063|11302061|FG000|STARTED|Open-Label Phase||0
10171888|NCT03053063|11302062|FG001|STARTED|Open-Label Phase||0
10171889|NCT03053063|11302063|FG002|STARTED|Open-Label Phase||0
10171890|NCT03053063|11302064|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
10171891|NCT03053063|11302061|FG000|COMPLETED|Open-Label Phase||0
10171892|NCT03053063|11302062|FG001|COMPLETED|Open-Label Phase||0
10171893|NCT03053063|11302063|FG002|COMPLETED|Open-Label Phase||0
10171894|NCT03053063|11302064|FG003|COMPLETED|Open-Label Phase||0
10171895|NCT03053063|11302061|FG000|NOT COMPLETED|Open-Label Phase||0
10171896|NCT03053063|11302062|FG001|NOT COMPLETED|Open-Label Phase||0
10171897|NCT03053063|11302063|FG002|NOT COMPLETED|Open-Label Phase||0
10171898|NCT03053063|11302064|FG003|NOT COMPLETED|Open-Label Phase||23
10171899|NCT03053180|11302073|FG000|STARTED|Overall Study||60
10171900|NCT03053180|11302073|FG000|COMPLETED|Overall Study||59
10171901|NCT03053180|11302073|FG000|NOT COMPLETED|Overall Study||1
10171902|NCT03053271|11302077|FG000|STARTED|Overall Study||4
10171903|NCT03053271|11302077|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
10171904|NCT03053271|11302077|FG000|NOT COMPLETED|Overall Study||4
10171905|NCT03053401|11302083|FG000|STARTED|Overall Study||26
10171906|NCT03053401|11302084|FG001|STARTED|Overall Study||26
10171907|NCT03053401|11302083|FG000|COMPLETED|Overall Study||26
10171908|NCT03053401|11302084|FG001|COMPLETED|Overall Study||26
10171909|NCT03053401|11302083|FG000|NOT COMPLETED|Overall Study||0
10171910|NCT03053401|11302084|FG001|NOT COMPLETED|Overall Study||0
10171911|NCT03053427|11302093|FG000|STARTED|Overall Study||186
10171912|NCT03053427|11302094|FG001|STARTED|Overall Study||189
10171913|NCT03053427|11302093|FG000|COMPLETED|Overall Study||173
10171914|NCT03053427|11302094|FG001|COMPLETED|Overall Study||173
10171915|NCT03053427|11302093|FG000|NOT COMPLETED|Overall Study||13
10171916|NCT03053427|11302094|FG001|NOT COMPLETED|Overall Study||16
10171917|NCT03053492|11302102|FG000|STARTED|Overall Study||33
10171918|NCT03053492|11302103|FG001|STARTED|Overall Study||33
10171919|NCT03053492|11302102|FG000|COMPLETED|Overall Study||25
10171920|NCT03053492|11302103|FG001|COMPLETED|Overall Study||27
10171921|NCT03053492|11302102|FG000|NOT COMPLETED|Overall Study||8
10171922|NCT03053492|11302103|FG001|NOT COMPLETED|Overall Study||6
10171923|NCT03054051|11302111|FG000|STARTED|Overall Study||30
10171924|NCT03054051|11302112|FG001|STARTED|Overall Study||30
10171925|NCT03054051|11302111|FG000|COMPLETED|Overall Study||30
10171926|NCT03054051|11302112|FG001|COMPLETED|Overall Study||30
10171927|NCT03054051|11302111|FG000|NOT COMPLETED|Overall Study||0
10171928|NCT03054051|11302112|FG001|NOT COMPLETED|Overall Study||0
9849599|NCT00866359|10962337|FG003|STARTED|Extension Phase (Day 86 to 169)||50
10171929|NCT03054064|11302120|FG000|STARTED|Overall Study||48
10171930|NCT03054064|11302120|FG000|Screen Failure|Overall Study||2
10171931|NCT03054064|11302120|FG000|COMPLETED|Overall Study||42
10171932|NCT03054064|11302120|FG000|NOT COMPLETED|Overall Study||6
10171933|NCT03054077|11302126|FG000|STARTED|Overall Study||12
10171934|NCT03054077|11302127|FG001|STARTED|Overall Study||12
10171935|NCT03054077|11302126|FG000|COMPLETED|Overall Study||12
10171936|NCT03054077|11302127|FG001|COMPLETED|Overall Study||12
10171937|NCT03054077|11302126|FG000|NOT COMPLETED|Overall Study||0
10171938|NCT03054077|11302127|FG001|NOT COMPLETED|Overall Study||0
10171939|NCT03054103|11302136|FG000|STARTED|Overall Study||41
10171940|NCT03054103|11302137|FG001|STARTED|Overall Study||29
10171941|NCT03054103|11302138|FG002|STARTED|Overall Study||35
10171942|NCT03054103|11302136|FG000|COMPLETED|Overall Study||41
10171943|NCT03054103|11302137|FG001|COMPLETED|Overall Study||29
10171944|NCT03054103|11302138|FG002|COMPLETED|Overall Study||35
10171945|NCT03054103|11302136|FG000|NOT COMPLETED|Overall Study||0
10171946|NCT03054103|11302137|FG001|NOT COMPLETED|Overall Study||0
10171947|NCT03054103|11302138|FG002|NOT COMPLETED|Overall Study||0
10171948|NCT03054337|11302152|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12
10171949|NCT03054337|11302153|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12
10171950|NCT03054337|11302154|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13
10171951|NCT03054337|11302155|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
10171952|NCT03054337|11302156|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4
10171953|NCT03054337|11302157|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
10171954|NCT03054337|11302152|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12
10171955|NCT03054337|11302153|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12
10171956|NCT03054337|11302154|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
10171957|NCT03054337|11302155|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5
10171958|NCT03054337|11302156|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4
10171959|NCT03054337|11302157|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5
10171960|NCT03054337|11302152|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10171961|NCT03054337|11302153|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10171962|NCT03054337|11302154|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10171963|NCT03054337|11302155|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10171964|NCT03054337|11302156|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10171965|NCT03054337|11302157|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10171966|NCT03054337|11302152|FG000|STARTED|Dose Adjustment and Maintenance Period||12
10171967|NCT03054337|11302153|FG001|STARTED|Dose Adjustment and Maintenance Period||12
10171968|NCT03054337|11302154|FG002|STARTED|Dose Adjustment and Maintenance Period||13
10171969|NCT03054337|11302155|FG003|STARTED|Dose Adjustment and Maintenance Period||5
10171970|NCT03054337|11302156|FG004|STARTED|Dose Adjustment and Maintenance Period||4
10171971|NCT03054337|11302157|FG005|STARTED|Dose Adjustment and Maintenance Period||5
10171972|NCT03054337|11302152|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11
10171973|NCT03054337|11302153|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10
10171974|NCT03054337|11302154|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
10171975|NCT03054337|11302155|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5
10171976|NCT03054337|11302156|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4
10171977|NCT03054337|11302157|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4
10171978|NCT03054337|11302152|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10171979|NCT03054337|11302153|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
10171980|NCT03054337|11302154|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10171981|NCT03054337|11302155|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10171982|NCT03054337|11302156|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10171983|NCT03054337|11302157|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10171984|NCT03054350|11302190|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15
10171985|NCT03054350|11302191|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15
10171986|NCT03054350|11302192|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15
10171987|NCT03054350|11302193|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
10171988|NCT03054350|11302194|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5
10171989|NCT03054350|11302195|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
10171990|NCT03054350|11302190|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11
10171991|NCT03054350|11302191|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13
10171992|NCT03054350|11302192|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
9712647|NCT01313351|10812096|FG000|STARTED|Overall Study||206
9712648|NCT01313351|10812096|FG000|COMPLETED|Overall Study||206
9712649|NCT01313351|10812096|FG000|NOT COMPLETED|Overall Study||0
10171993|NCT03054350|11302193|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3
10171994|NCT03054350|11302194|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1
10171995|NCT03054350|11302195|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2
10171996|NCT03054350|11302190|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
10171997|NCT03054350|11302191|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
10171998|NCT03054350|11302192|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
10171999|NCT03054350|11302193|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
10172000|NCT03054350|11302194|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
10172001|NCT03054350|11302195|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
10172002|NCT03054350|11302190|FG000|STARTED|Dose Adjustment and Maintenance Period||11
10172003|NCT03054350|11302191|FG001|STARTED|Dose Adjustment and Maintenance Period||13
10172004|NCT03054350|11302192|FG002|STARTED|Dose Adjustment and Maintenance Period||13
10172005|NCT03054350|11302193|FG003|STARTED|Dose Adjustment and Maintenance Period||3
10172006|NCT03054350|11302194|FG004|STARTED|Dose Adjustment and Maintenance Period||1
10172007|NCT03054350|11302195|FG005|STARTED|Dose Adjustment and Maintenance Period||2
10172008|NCT03054350|11302190|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10
10172009|NCT03054350|11302191|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13
10172010|NCT03054350|11302192|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
10172011|NCT03054350|11302193|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2
10172012|NCT03054350|11302194|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1
10172013|NCT03054350|11302195|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2
10172014|NCT03054350|11302190|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10172015|NCT03054350|11302191|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10172016|NCT03054350|11302192|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10172017|NCT03054350|11302193|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10172018|NCT03054350|11302194|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10172019|NCT03054350|11302195|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10172020|NCT03054428|11302229|FG000|STARTED|Overall Study||85
10172021|NCT03054428|11302230|FG001|STARTED|Overall Study||84
10172022|NCT03054428|11302231|FG002|STARTED|Overall Study||82
10172023|NCT03054428|11302229|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
10172024|NCT03054428|11302230|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
10172025|NCT03054428|11302231|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
10172026|NCT03054428|11302229|FG000|Completed Week 28 (End of Study)|Overall Study||2
10172027|NCT03054428|11302230|FG001|Completed Week 28 (End of Study)|Overall Study||4
10172028|NCT03054428|11302231|FG002|Completed Week 28 (End of Study)|Overall Study||3
10172029|NCT03054428|11302229|FG000|COMPLETED|Overall Study||2
10172030|NCT03054428|11302230|FG001|COMPLETED|Overall Study||4
10172031|NCT03054428|11302231|FG002|COMPLETED|Overall Study||3
10172032|NCT03054428|11302229|FG000|NOT COMPLETED|Overall Study||83
10172033|NCT03054428|11302230|FG001|NOT COMPLETED|Overall Study||80
10172034|NCT03054428|11302231|FG002|NOT COMPLETED|Overall Study||79
10172035|NCT03054506|11302242|FG000|STARTED|Overall Study||20
10172036|NCT03054506|11302243|FG001|STARTED|Overall Study||11
10172037|NCT03054506|11302244|FG002|STARTED|Overall Study||9
10172038|NCT03054506|11302242|FG000|COMPLETED|Overall Study||19
10172039|NCT03054506|11302243|FG001|COMPLETED|Overall Study||11
10172040|NCT03054506|11302244|FG002|COMPLETED|Overall Study||9
10172041|NCT03054506|11302242|FG000|NOT COMPLETED|Overall Study||1
10172042|NCT03054506|11302243|FG001|NOT COMPLETED|Overall Study||0
10172043|NCT03054506|11302244|FG002|NOT COMPLETED|Overall Study||0
10172044|NCT03054649|11302252|FG000|STARTED|Overall Study||27
10172045|NCT03054649|11302253|FG001|STARTED|Overall Study||27
10172046|NCT03054649|11302252|FG000|COMPLETED|Overall Study||27
10172047|NCT03054649|11302253|FG001|COMPLETED|Overall Study||27
10172048|NCT03054649|11302252|FG000|NOT COMPLETED|Overall Study||0
10172049|NCT03054649|11302253|FG001|NOT COMPLETED|Overall Study||0
10172050|NCT03054740|11302284|FG000|STARTED|Overall Study||15
10172051|NCT03054740|11302285|FG001|STARTED|Overall Study||15
10172052|NCT03054740|11302284|FG000|COMPLETED|Overall Study||15
10172053|NCT03054740|11302285|FG001|COMPLETED|Overall Study||15
10172054|NCT03054740|11302284|FG000|NOT COMPLETED|Overall Study||0
10172055|NCT03054740|11302285|FG001|NOT COMPLETED|Overall Study||0
10172056|NCT03054805|11302294|FG000|STARTED|Overall Study||58
10172057|NCT03054805|11302295|FG001|STARTED|Overall Study||51
10172058|NCT03054805|11302296|FG002|STARTED|Overall Study||44
10172059|NCT03054805|11302294|FG000|COMPLETED|Overall Study||42
10172060|NCT03054805|11302295|FG001|COMPLETED|Overall Study||41
10172061|NCT03054805|11302296|FG002|COMPLETED|Overall Study||42
10172062|NCT03054805|11302294|FG000|NOT COMPLETED|Overall Study||16
10172063|NCT03054805|11302295|FG001|NOT COMPLETED|Overall Study||10
10172064|NCT03054805|11302296|FG002|NOT COMPLETED|Overall Study||2
10172065|NCT03054844|11302306|FG000|STARTED|Overall Study||28
10172066|NCT03054844|11302307|FG001|STARTED|Overall Study||27
10172067|NCT03054844|11302306|FG000|COMPLETED|Overall Study||25
10172068|NCT03054844|11302307|FG001|COMPLETED|Overall Study||26
10172069|NCT03054844|11302306|FG000|NOT COMPLETED|Overall Study||3
10172070|NCT03054844|11302307|FG001|NOT COMPLETED|Overall Study||1
10172071|NCT03054857|11302315|FG000|STARTED|Overall Study||50
10172072|NCT03054857|11302316|FG001|STARTED|Overall Study||50
10172073|NCT03054857|11302315|FG000|COMPLETED|Overall Study||49
10172074|NCT03054857|11302316|FG001|COMPLETED|Overall Study||50
10172075|NCT03054857|11302315|FG000|NOT COMPLETED|Overall Study||1
10172076|NCT03054857|11302316|FG001|NOT COMPLETED|Overall Study||0
10172077|NCT03054870|11302326|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210
10172078|NCT03054870|11302326|FG000|COMPLETED|Day of Ventilation Imaging||205
10172079|NCT03054870|11302326|FG000|NOT COMPLETED|Day of Ventilation Imaging||5
10172080|NCT03054870|11302326|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118
10172081|NCT03054870|11302326|FG000|COMPLETED|24-hour Follow-up||118
10172082|NCT03054870|11302326|FG000|NOT COMPLETED|24-hour Follow-up||0
10172083|NCT03054870|11302326|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200
10172084|NCT03054870|11302326|FG000|COMPLETED|Blinded Read of Images||200
10172085|NCT03054870|11302326|FG000|NOT COMPLETED|Blinded Read of Images||0
10172086|NCT03054922|11302344|FG000|STARTED|Overall Study||20
10172087|NCT03054922|11302345|FG001|STARTED|Overall Study||19
10172088|NCT03054922|11302346|FG002|STARTED|Overall Study||20
10172089|NCT03054922|11302344|FG000|COMPLETED|Overall Study||20
10172090|NCT03054922|11302345|FG001|COMPLETED|Overall Study||19
10172091|NCT03054922|11302346|FG002|COMPLETED|Overall Study||20
10172092|NCT03054922|11302344|FG000|NOT COMPLETED|Overall Study||0
10172093|NCT03054922|11302345|FG001|NOT COMPLETED|Overall Study||0
10172094|NCT03054922|11302346|FG002|NOT COMPLETED|Overall Study||0
10172095|NCT03055000|11302357|FG000|STARTED|Overall Study||16
10172096|NCT03055000|11302358|FG001|STARTED|Overall Study||17
10172097|NCT03055000|11302359|FG002|STARTED|Overall Study||16
10172098|NCT03055000|11302357|FG000|COMPLETED|Overall Study||16
9712659|NCT01232283|10812112|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
9712660|NCT01232283|10812113|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
9712661|NCT01232283|10812114|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712662|NCT01232283|10812115|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712663|NCT01232283|10812116|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712664|NCT01232283|10812117|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712665|NCT01232283|10812118|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712666|NCT01232283|10812119|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712667|NCT01232283|10812120|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712668|NCT01232283|10812121|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
9712669|NCT01232283|10812112|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
9712670|NCT01232283|10812113|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
9712671|NCT01232283|10812114|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712672|NCT01232283|10812115|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712673|NCT01232283|10812116|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712674|NCT01232283|10812117|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712675|NCT01232283|10812118|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712676|NCT01232283|10812119|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712677|NCT01232283|10812120|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712678|NCT01232283|10812121|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
9712679|NCT01232283|10812112|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
9712680|NCT01232283|10812113|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
9712681|NCT01232283|10812114|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712682|NCT01232283|10812115|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712683|NCT01232283|10812116|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712684|NCT01232283|10812117|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712685|NCT01232283|10812118|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712686|NCT01232283|10812119|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712687|NCT01232283|10812120|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712688|NCT01232283|10812121|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712689|NCT01232283|10812112|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
9712690|NCT01232283|10812113|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
9712691|NCT01232283|10812114|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712692|NCT01232283|10812115|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712693|NCT01232283|10812116|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712694|NCT01232283|10812117|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712695|NCT01232283|10812118|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712696|NCT01232283|10812119|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712697|NCT01232283|10812120|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712698|NCT01232283|10812121|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
9712699|NCT01232283|10812112|FG000|STARTED|Maintenance Phase (Weeks16-32)||0
9712700|NCT01232283|10812113|FG001|STARTED|Maintenance Phase (Weeks16-32)||0
10172099|NCT03055000|11302358|FG001|COMPLETED|Overall Study||17
10172100|NCT03055000|11302359|FG002|COMPLETED|Overall Study||16
10172101|NCT03055000|11302357|FG000|NOT COMPLETED|Overall Study||0
10172102|NCT03055000|11302358|FG001|NOT COMPLETED|Overall Study||0
10172103|NCT03055000|11302359|FG002|NOT COMPLETED|Overall Study||0
10172104|NCT03055156|11302369|FG000|STARTED|Overall Study||281
10172105|NCT03055156|11302370|FG001|STARTED|Overall Study||273
10172106|NCT03055156|11302369|FG000|COMPLETED|Overall Study||281
10172107|NCT03055156|11302370|FG001|COMPLETED|Overall Study||273
10172108|NCT03055156|11302369|FG000|NOT COMPLETED|Overall Study||0
10172109|NCT03055156|11302370|FG001|NOT COMPLETED|Overall Study||0
10172110|NCT03055195|11302378|FG000|STARTED|Overall Study||16
10172111|NCT03055195|11302379|FG001|STARTED|Overall Study||18
10172112|NCT03055195|11302378|FG000|COMPLETED|Overall Study||4
10172113|NCT03055195|11302379|FG001|COMPLETED|Overall Study||4
10172114|NCT03055195|11302378|FG000|NOT COMPLETED|Overall Study||12
10172115|NCT03055195|11302379|FG001|NOT COMPLETED|Overall Study||14
10172116|NCT03055221|11302385|FG000|STARTED|Overall Study||16
10172117|NCT03055221|11302385|FG000|COMPLETED|Overall Study||0
10172118|NCT03055221|11302385|FG000|NOT COMPLETED|Overall Study||16
10172119|NCT03055260|11302391|FG000|STARTED|Overall Study||8
10172120|NCT03055260|11302392|FG001|STARTED|Overall Study||0
10172121|NCT03055260|11302391|FG000|COMPLETED|Overall Study||7
10172122|NCT03055260|11302392|FG001|COMPLETED|Overall Study||0
10172123|NCT03055260|11302391|FG000|NOT COMPLETED|Overall Study||1
10172124|NCT03055260|11302392|FG001|NOT COMPLETED|Overall Study||0
10172125|NCT03055338|11302401|FG000|STARTED|Overall Study||90
10172126|NCT03055338|11302402|FG001|STARTED|Overall Study||45
10172127|NCT03055338|11302403|FG002|STARTED|Overall Study||89
10172128|NCT03055338|11302401|FG000|COMPLETED|Overall Study||72
10172129|NCT03055338|11302402|FG001|COMPLETED|Overall Study||34
10172130|NCT03055338|11302403|FG002|COMPLETED|Overall Study||77
10172131|NCT03055338|11302401|FG000|NOT COMPLETED|Overall Study||18
10172132|NCT03055338|11302402|FG001|NOT COMPLETED|Overall Study||11
10172133|NCT03055338|11302403|FG002|NOT COMPLETED|Overall Study||12
10172134|NCT03055494|11302413|FG000|STARTED|Overall Study||54
10172135|NCT03055494|11302414|FG001|STARTED|Overall Study||28
10172136|NCT03055494|11302413|FG000|COMPLETED|Overall Study||44
10172137|NCT03055494|11302414|FG001|COMPLETED|Overall Study||27
10172138|NCT03055494|11302413|FG000|NOT COMPLETED|Overall Study||10
10172139|NCT03055494|11302414|FG001|NOT COMPLETED|Overall Study||1
10172140|NCT03055624|11302421|FG000|STARTED|Overall Study||9
10172141|NCT03055624|11302421|FG000|COMPLETED|Overall Study||0
10172142|NCT03055624|11302421|FG000|NOT COMPLETED|Overall Study||9
10172143|NCT03055650|11302425|FG000|STARTED|Overall Study||30
10172144|NCT03055650|11302425|FG000|COMPLETED|Overall Study||30
10172145|NCT03055650|11302425|FG000|NOT COMPLETED|Overall Study||0
10172146|NCT03055806|11302433|FG000|STARTED|Overall Study||48
10172147|NCT03055806|11302434|FG001|STARTED|Overall Study||48
10172148|NCT03055806|11302435|FG002|STARTED|Overall Study||71
10172149|NCT03055806|11302436|FG003|STARTED|Overall Study||72
10172150|NCT03055806|11302433|FG000|COMPLETED|Overall Study||42
10172151|NCT03055806|11302434|FG001|COMPLETED|Overall Study||41
10172152|NCT03055806|11302435|FG002|COMPLETED|Overall Study||58
10172153|NCT03055806|11302436|FG003|COMPLETED|Overall Study||57
10172154|NCT03055806|11302433|FG000|NOT COMPLETED|Overall Study||6
10172155|NCT03055806|11302434|FG001|NOT COMPLETED|Overall Study||7
10172156|NCT03055806|11302435|FG002|NOT COMPLETED|Overall Study||13
10172157|NCT03055806|11302436|FG003|NOT COMPLETED|Overall Study||15
10172158|NCT03055832|11302448|FG000|STARTED|Baseline||71
10172159|NCT03055832|11302449|FG001|STARTED|Baseline||71
10172160|NCT03055832|11302448|FG000|COMPLETED|Baseline||71
10172161|NCT03055832|11302449|FG001|COMPLETED|Baseline||71
10172162|NCT03055832|11302448|FG000|NOT COMPLETED|Baseline||0
10172163|NCT03055832|11302449|FG001|NOT COMPLETED|Baseline||0
10172164|NCT03055832|11302448|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71
10172165|NCT03055832|11302449|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71
10172166|NCT03055832|11302448|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71
9712701|NCT01232283|10812114|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
10172167|NCT03055832|11302449|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71
10172168|NCT03055832|11302448|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
10172169|NCT03055832|11302449|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
10172170|NCT03055832|11302448|FG000|STARTED|Day 1||71
10172171|NCT03055832|11302449|FG001|STARTED|Day 1||71
10172172|NCT03055832|11302448|FG000|COMPLETED|Day 1||71
10172173|NCT03055832|11302449|FG001|COMPLETED|Day 1||71
10172174|NCT03055832|11302448|FG000|NOT COMPLETED|Day 1||0
10172175|NCT03055832|11302449|FG001|NOT COMPLETED|Day 1||0
10172176|NCT03055832|11302448|FG000|STARTED|Week 2||71
10172177|NCT03055832|11302449|FG001|STARTED|Week 2||71
10172178|NCT03055832|11302448|FG000|COMPLETED|Week 2||70
10172179|NCT03055832|11302449|FG001|COMPLETED|Week 2||71
10172180|NCT03055832|11302448|FG000|NOT COMPLETED|Week 2||1
10172181|NCT03055832|11302449|FG001|NOT COMPLETED|Week 2||0
10172182|NCT03055832|11302448|FG000|STARTED|Week 4||70
10172183|NCT03055832|11302449|FG001|STARTED|Week 4||71
10172184|NCT03055832|11302448|FG000|COMPLETED|Week 4||70
10172185|NCT03055832|11302449|FG001|COMPLETED|Week 4||71
10172186|NCT03055832|11302448|FG000|NOT COMPLETED|Week 4||0
10172187|NCT03055832|11302449|FG001|NOT COMPLETED|Week 4||0
10172188|NCT03055858|11302469|FG000|STARTED|Overall Study||200
10172189|NCT03055858|11302469|FG000|IDE Cohort|Overall Study||50
10172190|NCT03055858|11302469|FG000|CAP Cohort|Overall Study||150
9712702|NCT01232283|10812115|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
9712703|NCT01232283|10812116|FG004|STARTED|Maintenance Phase (Weeks16-32)||0
9712704|NCT01232283|10812117|FG005|STARTED|Maintenance Phase (Weeks16-32)||0
9712705|NCT01232283|10812118|FG006|STARTED|Maintenance Phase (Weeks16-32)||0
9712706|NCT01232283|10812119|FG007|STARTED|Maintenance Phase (Weeks16-32)||0
9712707|NCT01232283|10812120|FG008|STARTED|Maintenance Phase (Weeks16-32)||0
9712708|NCT01232283|10812121|FG009|STARTED|Maintenance Phase (Weeks16-32)||0
9712709|NCT01232283|10812112|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0
9712710|NCT01232283|10812113|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0
9712711|NCT01232283|10812114|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194
9712712|NCT01232283|10812115|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100
9712713|NCT01232283|10812116|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0
9712714|NCT01232283|10812117|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0
10172191|NCT03055858|11302469|FG000|COMPLETED|Overall Study||194
10172192|NCT03055858|11302469|FG000|NOT COMPLETED|Overall Study||6
10172193|NCT03055897|11302473|FG000|STARTED|Overall Study||15
10172194|NCT03055897|11302473|FG000|COMPLETED|Overall Study||15
10172195|NCT03055897|11302473|FG000|NOT COMPLETED|Overall Study||0
10172196|NCT03055936|11302481|FG000|STARTED|Overall Study||14
10172197|NCT03055936|11302482|FG001|STARTED|Overall Study||14
10172198|NCT03055936|11302483|FG002|STARTED|Overall Study||14
10172199|NCT03055936|11302484|FG003|STARTED|Overall Study||14
10172200|NCT03055936|11302481|FG000|COMPLETED|Overall Study||12
10172201|NCT03055936|11302482|FG001|COMPLETED|Overall Study||13
10172202|NCT03055936|11302483|FG002|COMPLETED|Overall Study||12
10172203|NCT03055936|11302484|FG003|COMPLETED|Overall Study||13
10172204|NCT03055936|11302481|FG000|NOT COMPLETED|Overall Study||2
10172205|NCT03055936|11302482|FG001|NOT COMPLETED|Overall Study||1
10172206|NCT03055936|11302483|FG002|NOT COMPLETED|Overall Study||2
10172207|NCT03055936|11302484|FG003|NOT COMPLETED|Overall Study||1
10172208|NCT03055988|11302518|FG000|STARTED|Period 1||38
10172209|NCT03055988|11302519|FG001|STARTED|Period 1||38
10172210|NCT03055988|11302518|FG000|COMPLETED|Period 1||37
10172211|NCT03055988|11302519|FG001|COMPLETED|Period 1||33
10172212|NCT03055988|11302518|FG000|NOT COMPLETED|Period 1||1
10172213|NCT03055988|11302519|FG001|NOT COMPLETED|Period 1||5
10172214|NCT03055988|11302518|FG000|STARTED|Period 2||37
10172215|NCT03055988|11302519|FG001|STARTED|Period 2||33
10172216|NCT03055988|11302518|FG000|COMPLETED|Period 2||36
10172217|NCT03055988|11302519|FG001|COMPLETED|Period 2||31
10172218|NCT03055988|11302518|FG000|NOT COMPLETED|Period 2||1
10172219|NCT03055988|11302519|FG001|NOT COMPLETED|Period 2||2
10172220|NCT03056040|11302527|FG000|STARTED|Primary Evaluation Period||97
10172221|NCT03056040|11302528|FG001|STARTED|Primary Evaluation Period||98
10172222|NCT03056040|11302527|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
10172223|NCT03056040|11302528|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
10172224|NCT03056040|11302527|FG000|COMPLETED|Primary Evaluation Period||96
10172225|NCT03056040|11302528|FG001|COMPLETED|Primary Evaluation Period||95
10172226|NCT03056040|11302527|FG000|NOT COMPLETED|Primary Evaluation Period||1
10172227|NCT03056040|11302528|FG001|NOT COMPLETED|Primary Evaluation Period||3
10172228|NCT03056040|11302527|FG000|STARTED|Extension Period||96
10172229|NCT03056040|11302528|FG001|STARTED|Extension Period||95
10172230|NCT03056040|11302527|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||96
10172231|NCT03056040|11302528|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||95
10172232|NCT03056040|11302527|FG000|COMPLETED|Extension Period||0
10172233|NCT03056040|11302528|FG001|COMPLETED|Extension Period||0
10172234|NCT03056040|11302527|FG000|NOT COMPLETED|Extension Period||96
10172235|NCT03056040|11302528|FG001|NOT COMPLETED|Extension Period||95
10172236|NCT03056144|11302534|FG000|STARTED|Overall Study||1
10172237|NCT03056144|11302534|FG000|COMPLETED|Overall Study||1
10172238|NCT03056144|11302534|FG000|NOT COMPLETED|Overall Study||0
10172239|NCT03056300|11302538|FG000|STARTED|Overall Study||50
10172240|NCT03056300|11302538|FG000|COMPLETED|Overall Study||47
10172241|NCT03056300|11302538|FG000|NOT COMPLETED|Overall Study||3
10172242|NCT03056352|11302542|FG000|STARTED|Overall Study||21
10172243|NCT03056352|11302542|FG000|COMPLETED|Overall Study||20
10172244|NCT03056352|11302542|FG000|NOT COMPLETED|Overall Study||1
10172245|NCT03056456|11302546|FG000|STARTED|Period 1||6
10172246|NCT03056456|11302547|FG001|STARTED|Period 1||6
10172247|NCT03056456|11302548|FG002|STARTED|Period 1||6
10172248|NCT03056456|11302549|FG003|STARTED|Period 1||6
10172249|NCT03056456|11302546|FG000|Received One Dose of Study Drug|Period 1||6
10172250|NCT03056456|11302547|FG001|Received One Dose of Study Drug|Period 1||6
10172251|NCT03056456|11302548|FG002|Received One Dose of Study Drug|Period 1||6
10172252|NCT03056456|11302549|FG003|Received One Dose of Study Drug|Period 1||6
10172253|NCT03056456|11302546|FG000|COMPLETED|Period 1||6
10172254|NCT03056456|11302547|FG001|COMPLETED|Period 1||6
10172255|NCT03056456|11302548|FG002|COMPLETED|Period 1||6
10172256|NCT03056456|11302549|FG003|COMPLETED|Period 1||6
10172257|NCT03056456|11302546|FG000|NOT COMPLETED|Period 1||0
10172258|NCT03056456|11302547|FG001|NOT COMPLETED|Period 1||0
10172259|NCT03056456|11302548|FG002|NOT COMPLETED|Period 1||0
10172260|NCT03056456|11302549|FG003|NOT COMPLETED|Period 1||0
10172261|NCT03056456|11302546|FG000|STARTED|Period 2||6
10172262|NCT03056456|11302547|FG001|STARTED|Period 2||6
10172263|NCT03056456|11302548|FG002|STARTED|Period 2||6
10172264|NCT03056456|11302549|FG003|STARTED|Period 2||6
10172265|NCT03056456|11302546|FG000|COMPLETED|Period 2||6
10172266|NCT03056456|11302547|FG001|COMPLETED|Period 2||6
10172267|NCT03056456|11302548|FG002|COMPLETED|Period 2||6
10172268|NCT03056456|11302549|FG003|COMPLETED|Period 2||6
10172269|NCT03056456|11302546|FG000|NOT COMPLETED|Period 2||0
10172270|NCT03056456|11302547|FG001|NOT COMPLETED|Period 2||0
10172271|NCT03056456|11302548|FG002|NOT COMPLETED|Period 2||0
10172272|NCT03056456|11302549|FG003|NOT COMPLETED|Period 2||0
10172273|NCT03056456|11302546|FG000|STARTED|Period 3||6
10172274|NCT03056456|11302547|FG001|STARTED|Period 3||6
10172275|NCT03056456|11302548|FG002|STARTED|Period 3||6
10172276|NCT03056456|11302549|FG003|STARTED|Period 3||6
10172277|NCT03056456|11302546|FG000|COMPLETED|Period 3||6
10172278|NCT03056456|11302547|FG001|COMPLETED|Period 3||6
10172279|NCT03056456|11302548|FG002|COMPLETED|Period 3||6
10172280|NCT03056456|11302549|FG003|COMPLETED|Period 3||6
10172281|NCT03056456|11302546|FG000|NOT COMPLETED|Period 3||0
10172282|NCT03056456|11302547|FG001|NOT COMPLETED|Period 3||0
10172283|NCT03056456|11302548|FG002|NOT COMPLETED|Period 3||0
10172284|NCT03056456|11302549|FG003|NOT COMPLETED|Period 3||0
10172285|NCT03056456|11302546|FG000|STARTED|Period 4||6
10172286|NCT03056456|11302547|FG001|STARTED|Period 4||6
10172287|NCT03056456|11302548|FG002|STARTED|Period 4||6
10172288|NCT03056456|11302549|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
10172289|NCT03056456|11302546|FG000|COMPLETED|Period 4||6
10172290|NCT03056456|11302547|FG001|COMPLETED|Period 4||6
10172291|NCT03056456|11302548|FG002|COMPLETED|Period 4||6
10172292|NCT03056456|11302549|FG003|COMPLETED|Period 4||5
10172293|NCT03056456|11302546|FG000|NOT COMPLETED|Period 4||0
10172294|NCT03056456|11302547|FG001|NOT COMPLETED|Period 4||0
10172295|NCT03056456|11302548|FG002|NOT COMPLETED|Period 4||0
10172296|NCT03056456|11302549|FG003|NOT COMPLETED|Period 4||0
10172297|NCT03056573|11302564|FG000|STARTED|Overall Study||45
10172298|NCT03056573|11302565|FG001|STARTED|Overall Study||19
10172299|NCT03056573|11302564|FG000|COMPLETED|Overall Study||40
10172300|NCT03056573|11302565|FG001|COMPLETED|Overall Study||14
10172301|NCT03056573|11302564|FG000|NOT COMPLETED|Overall Study||5
10172302|NCT03056573|11302565|FG001|NOT COMPLETED|Overall Study||5
10172303|NCT03056690|11302573|FG000|STARTED|Overall Study||95
10172304|NCT03056690|11302574|FG001|STARTED|Overall Study||91
10172305|NCT03056690|11302573|FG000|Treated|Overall Study||94
10172306|NCT03056690|11302574|FG001|Treated|Overall Study||90
10172307|NCT03056690|11302573|FG000|COMPLETED|Overall Study||81
10172308|NCT03056690|11302574|FG001|COMPLETED|Overall Study||75
10172309|NCT03056690|11302573|FG000|NOT COMPLETED|Overall Study||14
10172310|NCT03056690|11302574|FG001|NOT COMPLETED|Overall Study||16
10172311|NCT03057132|11302580|FG000|STARTED|Overall Study||1
10172312|NCT03057132|11302580|FG000|COMPLETED|Overall Study||1
10172313|NCT03057132|11302580|FG000|NOT COMPLETED|Overall Study||0
10172314|NCT03057366|11302585|FG000|STARTED|Part A||8
10172315|NCT03057366|11302586|FG001|STARTED|Part A||0
10172316|NCT03057366|11302587|FG002|STARTED|Part A||0
10172317|NCT03057366|11302585|FG000|COMPLETED|Part A||8
10172318|NCT03057366|11302586|FG001|COMPLETED|Part A||0
10172319|NCT03057366|11302587|FG002|COMPLETED|Part A||0
10172320|NCT03057366|11302585|FG000|NOT COMPLETED|Part A||0
10172321|NCT03057366|11302586|FG001|NOT COMPLETED|Part A||0
10172322|NCT03057366|11302587|FG002|NOT COMPLETED|Part A||0
10172323|NCT03057366|11302585|FG000|STARTED|Part B||0
10172324|NCT03057366|11302586|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
10172325|NCT03057366|11302587|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
10172326|NCT03057366|11302585|FG000|COMPLETED|Part B||0
10172327|NCT03057366|11302586|FG001|COMPLETED|Part B||5
10172328|NCT03057366|11302587|FG002|COMPLETED|Part B||2
10172329|NCT03057366|11302585|FG000|NOT COMPLETED|Part B||0
10172330|NCT03057366|11302586|FG001|NOT COMPLETED|Part B||0
10172331|NCT03057366|11302587|FG002|NOT COMPLETED|Part B||0
10172332|NCT03057496|11302597|FG000|STARTED|Overall Study||49
10172333|NCT03057496|11302597|FG000|Started Home-use Trial|Overall Study||36
10172334|NCT03057496|11302597|FG000|COMPLETED|Overall Study||31
10172335|NCT03057496|11302597|FG000|NOT COMPLETED|Overall Study||18
10172339|NCT03057704|11302609|FG000|STARTED|Overall Study||25
10172340|NCT03057704|11302610|FG001|STARTED|Overall Study||25
10172341|NCT03057704|11302609|FG000|COMPLETED|Overall Study||25
10172342|NCT03057704|11302610|FG001|COMPLETED|Overall Study||25
10172343|NCT03057704|11302609|FG000|NOT COMPLETED|Overall Study||0
10172344|NCT03057704|11302610|FG001|NOT COMPLETED|Overall Study||0
10172345|NCT03057977|11302618|FG000|STARTED|Discontinuation From Treatment||1867
10172346|NCT03057977|11302619|FG001|STARTED|Discontinuation From Treatment||1863
10172347|NCT03057977|11302618|FG000|Treated|Discontinuation From Treatment||1863
10172348|NCT03057977|11302619|FG001|Treated|Discontinuation From Treatment||1863
10172349|NCT03057977|11302618|FG000|COMPLETED|Discontinuation From Treatment||1352
10172350|NCT03057977|11302619|FG001|COMPLETED|Discontinuation From Treatment||1381
10172351|NCT03057977|11302618|FG000|NOT COMPLETED|Discontinuation From Treatment||515
10172352|NCT03057977|11302619|FG001|NOT COMPLETED|Discontinuation From Treatment||482
10172353|NCT03057977|11302618|FG000|STARTED|Discontinuation From Trial||1867
10172354|NCT03057977|11302619|FG001|STARTED|Discontinuation From Trial||1863
10172355|NCT03057977|11302618|FG000|Treated|Discontinuation From Trial||1863
10172356|NCT03057977|11302619|FG001|Treated|Discontinuation From Trial||1863
10172357|NCT03057977|11302618|FG000|COMPLETED|Discontinuation From Trial||1847
10172358|NCT03057977|11302619|FG001|COMPLETED|Discontinuation From Trial||1841
10172359|NCT03057977|11302618|FG000|NOT COMPLETED|Discontinuation From Trial||20
10172360|NCT03057977|11302619|FG001|NOT COMPLETED|Discontinuation From Trial||22
10172361|NCT03058679|11302627|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
10172362|NCT03058679|11302628|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
10172363|NCT03058679|11302627|FG000|COMPLETED|Baseline to Week 6||81
10172364|NCT03058679|11302628|FG001|COMPLETED|Baseline to Week 6||77
10172365|NCT03058679|11302627|FG000|NOT COMPLETED|Baseline to Week 6||18
10172366|NCT03058679|11302628|FG001|NOT COMPLETED|Baseline to Week 6||15
10172367|NCT03058679|11302627|FG000|STARTED|Week 6 to Week 12||81
10172368|NCT03058679|11302628|FG001|STARTED|Week 6 to Week 12||77
10172369|NCT03058679|11302627|FG000|COMPLETED|Week 6 to Week 12||61
10172370|NCT03058679|11302628|FG001|COMPLETED|Week 6 to Week 12||60
10172371|NCT03058679|11302627|FG000|NOT COMPLETED|Week 6 to Week 12||20
10172372|NCT03058679|11302628|FG001|NOT COMPLETED|Week 6 to Week 12||17
10172373|NCT03058692|11302636|FG000|STARTED|Overall Study||61
10172374|NCT03058692|11302637|FG001|STARTED|Overall Study||59
10172375|NCT03058692|11302636|FG000|COMPLETED|Overall Study||58
10172376|NCT03058692|11302637|FG001|COMPLETED|Overall Study||57
10172377|NCT03058692|11302636|FG000|NOT COMPLETED|Overall Study||3
10172378|NCT03058692|11302637|FG001|NOT COMPLETED|Overall Study||2
10172379|NCT03058991|11302647|FG000|STARTED|Overall Study||39
10172380|NCT03058991|11302648|FG001|STARTED|Overall Study||32
10172381|NCT03058991|11302649|FG002|STARTED|Overall Study||37
10172382|NCT03058991|11302647|FG000|1-Week Follow Up|Overall Study||23
10172383|NCT03058991|11302648|FG001|1-Week Follow Up|Overall Study||27
10172384|NCT03058991|11302649|FG002|1-Week Follow Up|Overall Study||28
10172385|NCT03058991|11302647|FG000|COMPLETED|Overall Study||21
10172386|NCT03058991|11302648|FG001|COMPLETED|Overall Study||20
10172387|NCT03058991|11302649|FG002|COMPLETED|Overall Study||25
10172388|NCT03058991|11302647|FG000|NOT COMPLETED|Overall Study||18
10172389|NCT03058991|11302648|FG001|NOT COMPLETED|Overall Study||12
10172390|NCT03058991|11302649|FG002|NOT COMPLETED|Overall Study||12
10172391|NCT03059810|11302657|FG000|STARTED|Overall Study||63
10172392|NCT03059810|11302657|FG000|COMPLETED|Overall Study||63
10172393|NCT03059810|11302657|FG000|NOT COMPLETED|Overall Study||0
10172394|NCT03059901|11302663|FG000|STARTED|Overall Study||30
10172395|NCT03059901|11302664|FG001|STARTED|Overall Study||30
10172396|NCT03059901|11302663|FG000|COMPLETED|Overall Study||26
10172397|NCT03059901|11302664|FG001|COMPLETED|Overall Study||28
10172398|NCT03059901|11302663|FG000|NOT COMPLETED|Overall Study||4
10172399|NCT03059901|11302664|FG001|NOT COMPLETED|Overall Study||2
10172400|NCT03060447|11302672|FG000|STARTED|Overall Study||17
10172401|NCT03060447|11302673|FG001|STARTED|Overall Study||8
10172402|NCT03060447|11302672|FG000|COMPLETED|Overall Study||15
10172403|NCT03060447|11302673|FG001|COMPLETED|Overall Study||8
10172404|NCT03060447|11302672|FG000|NOT COMPLETED|Overall Study||2
10172405|NCT03060447|11302673|FG001|NOT COMPLETED|Overall Study||0
10172406|NCT03060486|11302685|FG000|STARTED|Overall Study||15
10172407|NCT03060486|11302685|FG000|COMPLETED|Overall Study||15
10172408|NCT03060486|11302685|FG000|NOT COMPLETED|Overall Study||0
10172409|NCT03060512|11302691|FG000|STARTED|Overall Study||137
9712715|NCT01232283|10812118|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0
9712716|NCT01232283|10812119|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0
9712717|NCT01232283|10812120|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0
9712718|NCT01232283|10812121|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0
9712719|NCT01232283|10812112|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712720|NCT01232283|10812113|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712721|NCT01232283|10812114|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
9712722|NCT01232283|10812115|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
9712723|NCT01232283|10812116|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712724|NCT01232283|10812117|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712725|NCT01232283|10812118|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712726|NCT01232283|10812119|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712727|NCT01232283|10812120|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712728|NCT01232283|10812121|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
9712729|NCT01232283|10812112|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712730|NCT01232283|10812113|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712731|NCT01232283|10812114|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712732|NCT01232283|10812115|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
9731049|NCT00129545|10830962|FG002|STARTED|Overall Study||244
10172410|NCT03060512|11302692|FG001|STARTED|Overall Study||139
10172411|NCT03060512|11302691|FG000|Treated With Movantik|Overall Study||136
10172412|NCT03060512|11302692|FG001|Treated With Movantik|Overall Study||135
10172413|NCT03060512|11302691|FG000|Treated With PEG 3350|Overall Study||130
10172414|NCT03060512|11302692|FG001|Treated With PEG 3350|Overall Study||138
10172415|NCT03060512|11302691|FG000|COMPLETED|Overall Study||130
10172416|NCT03060512|11302692|FG001|COMPLETED|Overall Study||130
10172417|NCT03060512|11302691|FG000|NOT COMPLETED|Overall Study||7
10172418|NCT03060512|11302692|FG001|NOT COMPLETED|Overall Study||9
10172419|NCT03060551|11302703|FG000|STARTED|Overall Study||20
10172420|NCT03060551|11302703|FG000|COMPLETED|Overall Study||18
10172421|NCT03060551|11302703|FG000|NOT COMPLETED|Overall Study||2
10172422|NCT03060759|11302709|FG000|STARTED|Overall Study||20
10172423|NCT03060759|11302710|FG001|STARTED|Overall Study||15
10172424|NCT03060759|11302709|FG000|COMPLETED|Overall Study||15
10172425|NCT03060759|11302710|FG001|COMPLETED|Overall Study||12
10172426|NCT03060759|11302709|FG000|NOT COMPLETED|Overall Study||5
10172427|NCT03060759|11302710|FG001|NOT COMPLETED|Overall Study||3
10172428|NCT03061097|11302718|FG000|STARTED|Overall Study||4
10172429|NCT03061097|11302719|FG001|STARTED|Overall Study||3
10172430|NCT03061097|11302718|FG000|COMPLETED|Overall Study||4
10172431|NCT03061097|11302719|FG001|COMPLETED|Overall Study||0
10172432|NCT03061097|11302718|FG000|NOT COMPLETED|Overall Study||0
10172433|NCT03061097|11302719|FG001|NOT COMPLETED|Overall Study||3
10172434|NCT03061175|11302727|FG000|STARTED|Baseline||47
10172435|NCT03061175|11302728|FG001|STARTED|Baseline||47
10172436|NCT03061175|11302727|FG000|COMPLETED|Baseline||46
10172437|NCT03061175|11302728|FG001|COMPLETED|Baseline||47
10172438|NCT03061175|11302727|FG000|NOT COMPLETED|Baseline||1
10172439|NCT03061175|11302728|FG001|NOT COMPLETED|Baseline||0
10172440|NCT03061175|11302727|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
10172441|NCT03061175|11302728|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
10172442|NCT03061175|11302727|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
10172443|NCT03061175|11302728|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
10172444|NCT03061175|11302727|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
10172445|NCT03061175|11302728|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
10172446|NCT03061175|11302727|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
10172447|NCT03061175|11302728|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
10172448|NCT03061175|11302727|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
10172449|NCT03061175|11302728|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
10172450|NCT03061175|11302727|FG000|NOT COMPLETED|Followup 2 at 6 Months||4
10172451|NCT03061175|11302728|FG001|NOT COMPLETED|Followup 2 at 6 Months||7
10172452|NCT03061188|11302738|FG000|STARTED|Completed 1st Cycle||0
10172453|NCT03061188|11302739|FG001|STARTED|Completed 1st Cycle||3
10172454|NCT03061188|11302740|FG002|STARTED|Completed 1st Cycle||6
10172455|NCT03061188|11302741|FG003|STARTED|Completed 1st Cycle||6
10172456|NCT03061188|11302738|FG000|COMPLETED|Completed 1st Cycle||0
10172457|NCT03061188|11302739|FG001|COMPLETED|Completed 1st Cycle||3
10172458|NCT03061188|11302740|FG002|COMPLETED|Completed 1st Cycle||6
10172459|NCT03061188|11302741|FG003|COMPLETED|Completed 1st Cycle||6
10172460|NCT03061188|11302738|FG000|NOT COMPLETED|Completed 1st Cycle||0
10172461|NCT03061188|11302739|FG001|NOT COMPLETED|Completed 1st Cycle||0
10172462|NCT03061188|11302740|FG002|NOT COMPLETED|Completed 1st Cycle||0
10172463|NCT03061188|11302741|FG003|NOT COMPLETED|Completed 1st Cycle||0
10172464|NCT03061188|11302738|FG000|STARTED|Went on to Cycle 2 and Beyond||0
10172465|NCT03061188|11302739|FG001|STARTED|Went on to Cycle 2 and Beyond||3
10172466|NCT03061188|11302740|FG002|STARTED|Went on to Cycle 2 and Beyond||6
10172467|NCT03061188|11302741|FG003|STARTED|Went on to Cycle 2 and Beyond||6
10172468|NCT03061188|11302738|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
10172469|NCT03061188|11302739|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
10172470|NCT03061188|11302740|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
10172471|NCT03061188|11302741|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
10172472|NCT03061188|11302738|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0
10172473|NCT03061188|11302739|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3
10172474|NCT03061188|11302740|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5
10172475|NCT03061188|11302741|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5
10172476|NCT03061188|11302738|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
10172477|NCT03061188|11302739|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
10172478|NCT03061188|11302740|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
10172479|NCT03061188|11302741|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
10172480|NCT03061188|11302738|FG000|STARTED|On Follow-up for 3 Years||0
10172481|NCT03061188|11302739|FG001|STARTED|On Follow-up for 3 Years||3
10172482|NCT03061188|11302740|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
10172483|NCT03061188|11302741|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
10172484|NCT03061188|11302738|FG000|COMPLETED|On Follow-up for 3 Years||0
10172485|NCT03061188|11302739|FG001|COMPLETED|On Follow-up for 3 Years||0
10172486|NCT03061188|11302740|FG002|COMPLETED|On Follow-up for 3 Years||1
10172487|NCT03061188|11302741|FG003|COMPLETED|On Follow-up for 3 Years||1
10172488|NCT03061188|11302738|FG000|NOT COMPLETED|On Follow-up for 3 Years||0
10172489|NCT03061188|11302739|FG001|NOT COMPLETED|On Follow-up for 3 Years||3
10172490|NCT03061188|11302740|FG002|NOT COMPLETED|On Follow-up for 3 Years||5
10172491|NCT03061188|11302741|FG003|NOT COMPLETED|On Follow-up for 3 Years||5
10172492|NCT03061214|11302759|FG000|STARTED|Overall Study||288
10172493|NCT03061214|11302760|FG001|STARTED|Overall Study||290
10172494|NCT03061214|11302761|FG002|STARTED|Overall Study||290
10172495|NCT03061214|11302759|FG000|Exposed|Overall Study||287
10172496|NCT03061214|11302760|FG001|Exposed|Overall Study||290
10172497|NCT03061214|11302761|FG002|Exposed|Overall Study||290
10172498|NCT03061214|11302759|FG000|Full Analysis Set (FAS)|Overall Study||288
10172499|NCT03061214|11302760|FG001|Full Analysis Set (FAS)|Overall Study||290
10172500|NCT03061214|11302761|FG002|Full Analysis Set (FAS)|Overall Study||290
10172501|NCT03061214|11302759|FG000|Safety Analysis Set (SAS)|Overall Study||287
10172502|NCT03061214|11302760|FG001|Safety Analysis Set (SAS)|Overall Study||290
10172503|NCT03061214|11302761|FG002|Safety Analysis Set (SAS)|Overall Study||290
10172504|NCT03061214|11302759|FG000|COMPLETED|Overall Study||263
10172505|NCT03061214|11302760|FG001|COMPLETED|Overall Study||262
10172506|NCT03061214|11302761|FG002|COMPLETED|Overall Study||280
10172507|NCT03061214|11302759|FG000|NOT COMPLETED|Overall Study||25
10172508|NCT03061214|11302760|FG001|NOT COMPLETED|Overall Study||28
10172509|NCT03061214|11302761|FG002|NOT COMPLETED|Overall Study||10
10172510|NCT03061331|11302771|FG000|STARTED|Treatment Period 1 (8 Weeks)||10
10172511|NCT03061331|11302772|FG001|STARTED|Treatment Period 1 (8 Weeks)||10
10172512|NCT03061331|11302771|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10
10172513|NCT03061331|11302772|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10
10172514|NCT03061331|11302771|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
10172515|NCT03061331|11302772|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
10172516|NCT03061331|11302771|FG000|STARTED|Washout Period (8 Weeks)||10
10172517|NCT03061331|11302772|FG001|STARTED|Washout Period (8 Weeks)||10
10172518|NCT03061331|11302771|FG000|COMPLETED|Washout Period (8 Weeks)||8
10172519|NCT03061331|11302772|FG001|COMPLETED|Washout Period (8 Weeks)||9
10172520|NCT03061331|11302771|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2
10172521|NCT03061331|11302772|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1
10172522|NCT03061331|11302771|FG000|STARTED|Treatment Period 2 (8 Weeks)||8
10172523|NCT03061331|11302772|FG001|STARTED|Treatment Period 2 (8 Weeks)||9
10172524|NCT03061331|11302771|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8
10172525|NCT03061331|11302772|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9
10172526|NCT03061331|11302771|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10172527|NCT03061331|11302772|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10172528|NCT03061513|11302780|FG000|STARTED|Overall Study||6
10172529|NCT03061513|11302781|FG001|STARTED|Overall Study||5
10172530|NCT03061513|11302780|FG000|COMPLETED|Overall Study||6
10172531|NCT03061513|11302781|FG001|COMPLETED|Overall Study||4
10172532|NCT03061513|11302780|FG000|NOT COMPLETED|Overall Study||0
10172533|NCT03061513|11302781|FG001|NOT COMPLETED|Overall Study||1
10172534|NCT03061812|11302789|FG000|STARTED|Overall Study||148
10172535|NCT03061812|11302790|FG001|STARTED|Overall Study||296
10172536|NCT03061812|11302789|FG000|COMPLETED|Overall Study||148
10172537|NCT03061812|11302790|FG001|COMPLETED|Overall Study||296
10172538|NCT03061812|11302789|FG000|NOT COMPLETED|Overall Study||0
10172539|NCT03061812|11302790|FG001|NOT COMPLETED|Overall Study||0
10172540|NCT03062228|11302796|FG000|STARTED|Overall Study||162
10172541|NCT03062228|11302796|FG000|COMPLETED|Overall Study||162
10172542|NCT03062228|11302796|FG000|NOT COMPLETED|Overall Study||0
10172543|NCT03062267|11302802|FG000|STARTED|Overall Study||12
10172544|NCT03062267|11302803|FG001|STARTED|Overall Study||37
10172545|NCT03062267|11302802|FG000|COMPLETED|Overall Study||10
10172546|NCT03062267|11302803|FG001|COMPLETED|Overall Study||32
10172547|NCT03062267|11302802|FG000|NOT COMPLETED|Overall Study||2
10172548|NCT03062267|11302803|FG001|NOT COMPLETED|Overall Study||5
10172549|NCT03062488|11302812|FG000|STARTED|Overall Study||51
10172550|NCT03062488|11302813|FG001|STARTED|Overall Study||51
10172551|NCT03062488|11302814|FG002|STARTED|Overall Study||41
10172552|NCT03062488|11302812|FG000|COMPLETED|Overall Study||51
10172553|NCT03062488|11302813|FG001|COMPLETED|Overall Study||51
10172554|NCT03062488|11302814|FG002|COMPLETED|Overall Study||41
10172555|NCT03062488|11302812|FG000|NOT COMPLETED|Overall Study||0
10172556|NCT03062488|11302813|FG001|NOT COMPLETED|Overall Study||0
10172557|NCT03062488|11302814|FG002|NOT COMPLETED|Overall Study||0
10172558|NCT03062605|11302824|FG000|STARTED|Overall Study||25
10172559|NCT03062605|11302825|FG001|STARTED|Overall Study||23
10172560|NCT03062605|11302824|FG000|COMPLETED|Overall Study||14
10172561|NCT03062605|11302825|FG001|COMPLETED|Overall Study||13
10172562|NCT03062605|11302824|FG000|NOT COMPLETED|Overall Study||11
10172563|NCT03062605|11302825|FG001|NOT COMPLETED|Overall Study||10
10172564|NCT03062891|11302833|FG000|STARTED|Overall Study||99
10172565|NCT03062891|11302834|FG001|STARTED|Overall Study||100
10172566|NCT03062891|11302833|FG000|Mid-intervention|Overall Study||68
10172567|NCT03062891|11302834|FG001|Mid-intervention|Overall Study||74
10172568|NCT03062891|11302833|FG000|End of Intervention|Overall Study||67
10172569|NCT03062891|11302834|FG001|End of Intervention|Overall Study||78
10172570|NCT03062891|11302833|FG000|Followup|Overall Study||47
10172571|NCT03062891|11302834|FG001|Followup|Overall Study||62
10172572|NCT03062891|11302833|FG000|COMPLETED|Overall Study||47
10172573|NCT03062891|11302834|FG001|COMPLETED|Overall Study||62
10172574|NCT03062891|11302833|FG000|NOT COMPLETED|Overall Study||52
10172575|NCT03062891|11302834|FG001|NOT COMPLETED|Overall Study||38
10172576|NCT03062917|11302846|FG000|STARTED|Overall Study||32
10172577|NCT03062917|11302847|FG001|STARTED|Overall Study||51
10172578|NCT03062917|11302848|FG002|STARTED|Overall Study||49
10172579|NCT03062917|11302849|FG003|STARTED|Overall Study||20
10172580|NCT03062917|11302850|FG004|STARTED|Overall Study||0
10172581|NCT03062917|11302846|FG000|COMPLETED|Overall Study||32
10172582|NCT03062917|11302847|FG001|COMPLETED|Overall Study||51
10172583|NCT03062917|11302848|FG002|COMPLETED|Overall Study||49
10172584|NCT03062917|11302849|FG003|COMPLETED|Overall Study||20
10172585|NCT03062917|11302850|FG004|COMPLETED|Overall Study||0
10172586|NCT03062917|11302846|FG000|NOT COMPLETED|Overall Study||0
10172587|NCT03062917|11302847|FG001|NOT COMPLETED|Overall Study||0
10172588|NCT03062917|11302848|FG002|NOT COMPLETED|Overall Study||0
10172589|NCT03062917|11302849|FG003|NOT COMPLETED|Overall Study||0
10172590|NCT03062917|11302850|FG004|NOT COMPLETED|Overall Study||0
10172591|NCT03063086|11302861|FG000|STARTED|Overall Study||19
10172592|NCT03063086|11302862|FG001|STARTED|Overall Study||20
10172593|NCT03063086|11302863|FG002|STARTED|Overall Study||18
10172594|NCT03063086|11302864|FG003|STARTED|Overall Study||20
10172595|NCT03063086|11302865|FG004|STARTED|Overall Study||20
10172596|NCT03063086|11302866|FG005|STARTED|Overall Study||19
10172597|NCT03063086|11302861|FG000|COMPLETED|Overall Study||16
10172598|NCT03063086|11302862|FG001|COMPLETED|Overall Study||19
10172599|NCT03063086|11302863|FG002|COMPLETED|Overall Study||17
10172600|NCT03063086|11302864|FG003|COMPLETED|Overall Study||17
10172601|NCT03063086|11302865|FG004|COMPLETED|Overall Study||20
10172602|NCT03063086|11302866|FG005|COMPLETED|Overall Study||18
10172603|NCT03063086|11302861|FG000|NOT COMPLETED|Overall Study||3
10172604|NCT03063086|11302862|FG001|NOT COMPLETED|Overall Study||1
10172605|NCT03063086|11302863|FG002|NOT COMPLETED|Overall Study||1
10172606|NCT03063086|11302864|FG003|NOT COMPLETED|Overall Study||3
10172607|NCT03063086|11302865|FG004|NOT COMPLETED|Overall Study||0
10172608|NCT03063086|11302866|FG005|NOT COMPLETED|Overall Study||1
10172609|NCT03063125|11302875|FG000|STARTED|Overall Study||25
10172610|NCT03063125|11302875|FG000|COMPLETED|Overall Study||23
10172611|NCT03063125|11302875|FG000|NOT COMPLETED|Overall Study||2
10172612|NCT03063255|11302881|FG000|STARTED|Overall Study||30
10172613|NCT03063255|11302882|FG001|STARTED|Overall Study||30
10172614|NCT03063255|11302881|FG000|COMPLETED|Overall Study||29
10172615|NCT03063255|11302882|FG001|COMPLETED|Overall Study||30
10172616|NCT03063255|11302881|FG000|NOT COMPLETED|Overall Study||1
10172617|NCT03063255|11302882|FG001|NOT COMPLETED|Overall Study||0
10172618|NCT03063294|11302890|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
10172619|NCT03063294|11302891|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
10172620|NCT03063294|11302890|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
10172621|NCT03063294|11302891|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
10172622|NCT03063294|11302890|FG000|NOT COMPLETED|Overall Study||0
10172623|NCT03063294|11302891|FG001|NOT COMPLETED|Overall Study||0
10172624|NCT03063385|11302899|FG000|STARTED|Overall Study||330
10172625|NCT03063385|11302900|FG001|STARTED|Overall Study||330
10172626|NCT03063385|11302899|FG000|3-month Follow-up|Overall Study||257
10172627|NCT03063385|11302900|FG001|3-month Follow-up|Overall Study||259
10172628|NCT03063385|11302899|FG000|6-month Follow-up|Overall Study||265
10172629|NCT03063385|11302900|FG001|6-month Follow-up|Overall Study||259
10172630|NCT03063385|11302899|FG000|12-month Follow-up|Overall Study||243
10172631|NCT03063385|11302900|FG001|12-month Follow-up|Overall Study||254
10172632|NCT03063385|11302899|FG000|COMPLETED|Overall Study||243
10172633|NCT03063385|11302900|FG001|COMPLETED|Overall Study||254
10172634|NCT03063385|11302899|FG000|NOT COMPLETED|Overall Study||87
10172635|NCT03063385|11302900|FG001|NOT COMPLETED|Overall Study||76
10172636|NCT03063437|11302908|FG000|STARTED|Overall Study||4
10172637|NCT03063437|11302909|FG001|STARTED|Overall Study||5
10172638|NCT03063437|11302908|FG000|COMPLETED|Overall Study||4
9712733|NCT01232283|10812116|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
9712734|NCT01232283|10812117|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
9712735|NCT01232283|10812118|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
9712736|NCT01232283|10812119|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
9712737|NCT01232283|10812120|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712738|NCT01232283|10812121|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712739|NCT01232283|10812112|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712740|NCT01232283|10812113|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712741|NCT01232283|10812114|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712742|NCT01232283|10812115|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712743|NCT01232283|10812116|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712744|NCT01232283|10812117|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712745|NCT01232283|10812118|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
9712746|NCT01232283|10812119|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
9712747|NCT01232283|10812120|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712748|NCT01232283|10812121|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
9712749|NCT01232283|10812112|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712750|NCT01232283|10812113|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712751|NCT01232283|10812114|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712752|NCT01232283|10812115|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712753|NCT01232283|10812116|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
9712754|NCT01232283|10812117|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
9712755|NCT01232283|10812118|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
9731050|NCT00129545|10830960|FG000|COMPLETED|Overall Study||67
10172639|NCT03063437|11302909|FG001|COMPLETED|Overall Study||5
10172640|NCT03063437|11302908|FG000|NOT COMPLETED|Overall Study||0
10172641|NCT03063437|11302909|FG001|NOT COMPLETED|Overall Study||0
10172642|NCT03063476|11302915|FG000|STARTED|Overall Study||2
10172643|NCT03063476|11302915|FG000|COMPLETED|Overall Study||2
10172644|NCT03063476|11302915|FG000|NOT COMPLETED|Overall Study||0
10172645|NCT03064152|11302921|FG000|STARTED|Overall Study||26
10172646|NCT03064152|11302922|FG001|STARTED|Overall Study||23
10172647|NCT03064152|11302921|FG000|COMPLETED|Overall Study||26
10172648|NCT03064152|11302922|FG001|COMPLETED|Overall Study||23
10172649|NCT03064152|11302921|FG000|NOT COMPLETED|Overall Study||0
10172650|NCT03064152|11302922|FG001|NOT COMPLETED|Overall Study||0
10172651|NCT03064438|11302930|FG000|STARTED|Overall Study||27
10172652|NCT03064438|11302931|FG001|STARTED|Overall Study||13
10172653|NCT03064438|11302930|FG000|COMPLETED|Overall Study||26
10172654|NCT03064438|11302931|FG001|COMPLETED|Overall Study||12
10172655|NCT03064438|11302930|FG000|NOT COMPLETED|Overall Study||1
10172656|NCT03064438|11302931|FG001|NOT COMPLETED|Overall Study||1
10172657|NCT03064451|11302937|FG000|STARTED|Overall Study||60
10172658|NCT03064451|11302937|FG000|Safety Population|Overall Study||52
10172659|NCT03064451|11302937|FG000|COMPLETED|Overall Study||46
9712756|NCT01232283|10812119|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
9712757|NCT01232283|10812120|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712758|NCT01232283|10812121|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712759|NCT01232283|10812112|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712760|NCT01232283|10812113|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712761|NCT01232283|10812114|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10172660|NCT03064451|11302937|FG000|NOT COMPLETED|Overall Study||14
10172661|NCT03064841|11302941|FG000|STARTED|Overall Study||1537
10172662|NCT03064841|11302941|FG000|COMPLETED|Overall Study||1520
10172663|NCT03064841|11302941|FG000|NOT COMPLETED|Overall Study||17
10172664|NCT03065023|11302949|FG000|STARTED|Overall Study||3
10172665|NCT03065023|11302950|FG001|STARTED|Overall Study||3
10172666|NCT03065023|11302951|FG002|STARTED|Overall Study||3
10172667|NCT03065023|11302952|FG003|STARTED|Overall Study||6
10172668|NCT03065023|11302953|FG004|STARTED|Overall Study|Group B not started for business reasons.|0
10172669|NCT03065023|11302949|FG000|COMPLETED|Overall Study||1
10172670|NCT03065023|11302950|FG001|COMPLETED|Overall Study||1
10172671|NCT03065023|11302951|FG002|COMPLETED|Overall Study||2
10172672|NCT03065023|11302952|FG003|COMPLETED|Overall Study||3
10172673|NCT03065023|11302953|FG004|COMPLETED|Overall Study||0
10172674|NCT03065023|11302949|FG000|NOT COMPLETED|Overall Study||2
10172675|NCT03065023|11302950|FG001|NOT COMPLETED|Overall Study||2
10172676|NCT03065023|11302951|FG002|NOT COMPLETED|Overall Study||1
10172677|NCT03065023|11302952|FG003|NOT COMPLETED|Overall Study||3
10172678|NCT03065023|11302953|FG004|NOT COMPLETED|Overall Study||0
10172679|NCT03065075|11302965|FG000|STARTED|Overall Study||76
9712762|NCT01232283|10812115|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712763|NCT01232283|10812116|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
9712764|NCT01232283|10812117|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
9712765|NCT01232283|10812118|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
9712766|NCT01232283|10812119|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
9712767|NCT01232283|10812120|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712768|NCT01232283|10812121|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
9712769|NCT01232283|10812112|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712770|NCT01232283|10812113|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712771|NCT01232283|10812114|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712772|NCT01232283|10812115|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712773|NCT01232283|10812116|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712774|NCT01232283|10812117|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712775|NCT01232283|10812118|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712776|NCT01232283|10812119|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
9712777|NCT01232283|10812120|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
9712778|NCT01232283|10812121|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
9712779|NCT01232283|10812112|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712780|NCT01232283|10812113|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712781|NCT01232283|10812114|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712782|NCT01232283|10812115|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712783|NCT01232283|10812116|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712784|NCT01232283|10812117|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712785|NCT01232283|10812118|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712786|NCT01232283|10812119|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712787|NCT01232283|10812120|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
9712788|NCT01232283|10812121|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
9712789|NCT01232283|10812112|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712790|NCT01232283|10812113|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712791|NCT01232283|10812114|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712792|NCT01232283|10812115|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712793|NCT01232283|10812116|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712794|NCT01232283|10812117|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712795|NCT01232283|10812118|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10172680|NCT03065075|11302966|FG001|STARTED|Overall Study||76
10172681|NCT03065075|11302965|FG000|Intent-to-treat Analysis|Overall Study||72
10172682|NCT03065075|11302966|FG001|Intent-to-treat Analysis|Overall Study||74
10172683|NCT03065075|11302965|FG000|As-treated Analysis|Overall Study||69
10172684|NCT03065075|11302966|FG001|As-treated Analysis|Overall Study||77
10172685|NCT03065075|11302965|FG000|COMPLETED|Overall Study||76
10172686|NCT03065075|11302966|FG001|COMPLETED|Overall Study||76
10172687|NCT03065075|11302965|FG000|NOT COMPLETED|Overall Study||0
10172688|NCT03065075|11302966|FG001|NOT COMPLETED|Overall Study||0
10172689|NCT03065179|11302972|FG000|STARTED|Overall Study||25
10172690|NCT03065179|11302972|FG000|COMPLETED|Overall Study||25
10172691|NCT03065179|11302972|FG000|NOT COMPLETED|Overall Study||0
10172692|NCT03065205|11302976|FG000|STARTED|Overall Study||65
10172693|NCT03065205|11302976|FG000|COMPLETED|Overall Study||53
10172694|NCT03065205|11302976|FG000|NOT COMPLETED|Overall Study||12
10172695|NCT03065283|11302983|FG000|STARTED|Overall Study||50
10172696|NCT03065283|11302984|FG001|STARTED|Overall Study||25
10172697|NCT03065283|11302983|FG000|COMPLETED|Overall Study||50
10172698|NCT03065283|11302984|FG001|COMPLETED|Overall Study||25
10172699|NCT03065283|11302983|FG000|NOT COMPLETED|Overall Study||0
10172700|NCT03065283|11302984|FG001|NOT COMPLETED|Overall Study||0
10172701|NCT03065400|11302990|FG000|STARTED|Overall Study||10
10172702|NCT03065400|11302990|FG000|COMPLETED|Overall Study||0
10172703|NCT03065400|11302990|FG000|NOT COMPLETED|Overall Study||10
10172704|NCT03065530|11302998|FG000|STARTED|Overall Study||30
10172705|NCT03065530|11302999|FG001|STARTED|Overall Study||30
10172706|NCT03065530|11303000|FG002|STARTED|Overall Study||30
10172707|NCT03065530|11303001|FG003|STARTED|Overall Study||30
10172708|NCT03065530|11302998|FG000|COMPLETED|Overall Study||28
10172709|NCT03065530|11302999|FG001|COMPLETED|Overall Study||29
10172710|NCT03065530|11303000|FG002|COMPLETED|Overall Study||29
10172711|NCT03065530|11303001|FG003|COMPLETED|Overall Study||28
10172712|NCT03065530|11302998|FG000|NOT COMPLETED|Overall Study||2
10172713|NCT03065530|11302999|FG001|NOT COMPLETED|Overall Study||1
10172714|NCT03065530|11303000|FG002|NOT COMPLETED|Overall Study||1
10172715|NCT03065530|11303001|FG003|NOT COMPLETED|Overall Study||2
10172716|NCT03065647|11303021|FG000|STARTED|Overall Study||3
10172717|NCT03065647|11303022|FG001|STARTED|Overall Study||12
10172718|NCT03065647|11303021|FG000|COMPLETED|Overall Study||3
10172719|NCT03065647|11303022|FG001|COMPLETED|Overall Study||12
10172720|NCT03065647|11303021|FG000|NOT COMPLETED|Overall Study||0
10172721|NCT03065647|11303022|FG001|NOT COMPLETED|Overall Study||0
10172722|NCT03066102|11303028|FG000|STARTED|Overall Study||30
10172723|NCT03066102|11303028|FG000|COMPLETED|Overall Study||30
10172724|NCT03066102|11303028|FG000|NOT COMPLETED|Overall Study||0
10172725|NCT03066193|11303032|FG000|STARTED|Overall Study||17
10172726|NCT03066193|11303032|FG000|COMPLETED|Overall Study||16
10172727|NCT03066193|11303032|FG000|NOT COMPLETED|Overall Study||1
10172728|NCT03066609|11303039|FG000|STARTED|INDUCTION||136
10172729|NCT03066609|11303040|FG001|STARTED|INDUCTION||272
10172730|NCT03066609|11303041|FG002|STARTED|INDUCTION||135
10172731|NCT03066609|11303042|FG003|STARTED|INDUCTION||0
10172732|NCT03066609|11303039|FG000|COMPLETED|INDUCTION||134
10172733|NCT03066609|11303040|FG001|COMPLETED|INDUCTION||270
10172734|NCT03066609|11303041|FG002|COMPLETED|INDUCTION||133
10172735|NCT03066609|11303042|FG003|COMPLETED|INDUCTION||0
10172736|NCT03066609|11303039|FG000|NOT COMPLETED|INDUCTION||2
10172737|NCT03066609|11303040|FG001|NOT COMPLETED|INDUCTION||2
10172738|NCT03066609|11303041|FG002|NOT COMPLETED|INDUCTION||2
10172739|NCT03066609|11303042|FG003|NOT COMPLETED|INDUCTION||0
10172740|NCT03066609|11303039|FG000|STARTED|MAINTENANCE||134
10172741|NCT03066609|11303040|FG001|STARTED|MAINTENANCE||270
10172742|NCT03066609|11303041|FG002|STARTED|MAINTENANCE||4
10172743|NCT03066609|11303042|FG003|STARTED|MAINTENANCE||129
10172744|NCT03066609|11303039|FG000|COMPLETED|MAINTENANCE||127
10172745|NCT03066609|11303040|FG001|COMPLETED|MAINTENANCE||266
10172746|NCT03066609|11303041|FG002|COMPLETED|MAINTENANCE||2
10172747|NCT03066609|11303042|FG003|COMPLETED|MAINTENANCE||126
10172748|NCT03066609|11303039|FG000|NOT COMPLETED|MAINTENANCE||7
10172749|NCT03066609|11303040|FG001|NOT COMPLETED|MAINTENANCE||4
10172750|NCT03066609|11303041|FG002|NOT COMPLETED|MAINTENANCE||2
10172751|NCT03066609|11303042|FG003|NOT COMPLETED|MAINTENANCE||3
10172752|NCT03066609|11303039|FG000|STARTED|OVERALL STUDY||136
10172753|NCT03066609|11303040|FG001|STARTED|OVERALL STUDY||272
10172754|NCT03066609|11303041|FG002|STARTED|OVERALL STUDY||6
10172755|NCT03066609|11303042|FG003|STARTED|OVERALL STUDY||129
10172756|NCT03066609|11303039|FG000|COMPLETED|OVERALL STUDY||126
10172757|NCT03066609|11303040|FG001|COMPLETED|OVERALL STUDY||264
10172758|NCT03066609|11303041|FG002|COMPLETED|OVERALL STUDY||2
10172759|NCT03066609|11303042|FG003|COMPLETED|OVERALL STUDY||124
10172760|NCT03066609|11303039|FG000|NOT COMPLETED|OVERALL STUDY||10
10172761|NCT03066609|11303040|FG001|NOT COMPLETED|OVERALL STUDY||8
10172762|NCT03066609|11303041|FG002|NOT COMPLETED|OVERALL STUDY||4
10172763|NCT03066609|11303042|FG003|NOT COMPLETED|OVERALL STUDY||5
10172764|NCT03066778|11303055|FG000|STARTED|Overall Study||228
10172765|NCT03066778|11303056|FG001|STARTED|Overall Study||225
10172766|NCT03066778|11303055|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
10172767|NCT03066778|11303056|FG001|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
10172768|NCT03066778|11303055|FG000|COMPLETED|Overall Study||0
10172769|NCT03066778|11303056|FG001|COMPLETED|Overall Study||0
10172770|NCT03066778|11303055|FG000|NOT COMPLETED|Overall Study||228
10172771|NCT03066778|11303056|FG001|NOT COMPLETED|Overall Study||225
10172772|NCT03066804|11303064|FG000|STARTED|Overall Study||1286
10172773|NCT03066804|11303065|FG001|STARTED|Overall Study||1286
10172774|NCT03066804|11303064|FG000|COMPLETED|Overall Study||1235
10172775|NCT03066804|11303065|FG001|COMPLETED|Overall Study||1236
10172776|NCT03066804|11303064|FG000|NOT COMPLETED|Overall Study||51
10172777|NCT03066804|11303065|FG001|NOT COMPLETED|Overall Study||50
10172778|NCT03066830|11303074|FG000|STARTED|Overall Study||254
10172779|NCT03066830|11303075|FG001|STARTED|Overall Study||253
10172780|NCT03066830|11303074|FG000|COMPLETED|Overall Study||221
10172781|NCT03066830|11303075|FG001|COMPLETED|Overall Study||231
10172782|NCT03066830|11303074|FG000|NOT COMPLETED|Overall Study||33
10172783|NCT03066830|11303075|FG001|NOT COMPLETED|Overall Study||22
10172784|NCT03066947|11303082|FG000|STARTED|Overall Study||24
10172785|NCT03066947|11303082|FG000|COMPLETED|Overall Study||14
10172786|NCT03066947|11303082|FG000|NOT COMPLETED|Overall Study||10
10172787|NCT03066999|11303089|FG000|STARTED|Overall Study||2
10172788|NCT03066999|11303090|FG001|STARTED|Overall Study||3
10172789|NCT03066999|11303089|FG000|COMPLETED|Overall Study||2
10172790|NCT03066999|11303090|FG001|COMPLETED|Overall Study||1
10172791|NCT03066999|11303089|FG000|NOT COMPLETED|Overall Study||0
10172792|NCT03066999|11303090|FG001|NOT COMPLETED|Overall Study||2
10172793|NCT03067311|11303099|FG000|STARTED|Overall Study||19
10172794|NCT03067311|11303100|FG001|STARTED|Overall Study||19
10172795|NCT03067311|11303099|FG000|COMPLETED|Overall Study||17
10172796|NCT03067311|11303100|FG001|COMPLETED|Overall Study||17
10172797|NCT03067311|11303099|FG000|NOT COMPLETED|Overall Study||2
10172798|NCT03067311|11303100|FG001|NOT COMPLETED|Overall Study||2
10172799|NCT03067441|11303108|FG000|STARTED|Overall Study||492
10172800|NCT03067441|11303109|FG001|STARTED|Overall Study||970
10172801|NCT03067441|11303108|FG000|COMPLETED|Overall Study||459
10172802|NCT03067441|11303109|FG001|COMPLETED|Overall Study||913
10172803|NCT03067441|11303108|FG000|NOT COMPLETED|Overall Study||33
10172804|NCT03067441|11303109|FG001|NOT COMPLETED|Overall Study||57
10172805|NCT03067506|11303118|FG000|STARTED|Overall Study||30
10172806|NCT03067506|11303118|FG000|COMPLETED|Overall Study||30
10172807|NCT03067506|11303118|FG000|NOT COMPLETED|Overall Study||0
10172808|NCT03067948|11303122|FG000|STARTED|Overall Study||32
10172809|NCT03067948|11303122|FG000|COMPLETED|Overall Study||32
10172810|NCT03067948|11303122|FG000|NOT COMPLETED|Overall Study||0
10172811|NCT03067987|11303128|FG000|STARTED|Overall Study||50
10172812|NCT03067987|11303129|FG001|STARTED|Overall Study||53
10172813|NCT03067987|11303128|FG000|COMPLETED|Overall Study||40
10172814|NCT03067987|11303129|FG001|COMPLETED|Overall Study||40
10172815|NCT03067987|11303128|FG000|NOT COMPLETED|Overall Study||10
10172816|NCT03067987|11303129|FG001|NOT COMPLETED|Overall Study||13
10172817|NCT03068091|11303135|FG000|STARTED|Overall Study||25
10172818|NCT03068091|11303135|FG000|COMPLETED|Overall Study||24
10172819|NCT03068091|11303135|FG000|NOT COMPLETED|Overall Study||1
10172820|NCT03068312|11303142|FG000|STARTED|Overall Study||19
10172821|NCT03068312|11303143|FG001|STARTED|Overall Study||19
10172822|NCT03068312|11303142|FG000|COMPLETED|Overall Study||19
10172823|NCT03068312|11303143|FG001|COMPLETED|Overall Study||19
9712796|NCT01232283|10812119|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
9712797|NCT01232283|10812120|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
9712798|NCT01232283|10812121|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
10172824|NCT03068312|11303142|FG000|NOT COMPLETED|Overall Study||0
9712799|NCT01231516|10812145|FG000|STARTED|Double-blind Phase (Up to Week [Wk] 48)||360
9712800|NCT01231516|10812146|FG001|STARTED|Double-blind Phase (Up to Week [Wk] 48)||364
9712801|NCT01231516|10812145|FG000|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||357
9712802|NCT01231516|10812146|FG001|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||362
10172825|NCT03068312|11303143|FG001|NOT COMPLETED|Overall Study||0
10172826|NCT03068455|11303151|FG000|STARTED|Pre-treatment Period||920
10172827|NCT03068455|11303152|FG001|STARTED|Pre-treatment Period||924
10172828|NCT03068455|11303151|FG000|COMPLETED|Pre-treatment Period||916
10172829|NCT03068455|11303152|FG001|COMPLETED|Pre-treatment Period||917
10172830|NCT03068455|11303151|FG000|NOT COMPLETED|Pre-treatment Period||4
10172831|NCT03068455|11303152|FG001|NOT COMPLETED|Pre-treatment Period||7
10172832|NCT03068455|11303151|FG000|STARTED|Treatment Period||916
10172833|NCT03068455|11303152|FG001|STARTED|Treatment Period||917
10172834|NCT03068455|11303151|FG000|COMPLETED|Treatment Period||364
10172835|NCT03068455|11303152|FG001|COMPLETED|Treatment Period||561
10172836|NCT03068455|11303151|FG000|NOT COMPLETED|Treatment Period||552
10172837|NCT03068455|11303152|FG001|NOT COMPLETED|Treatment Period||356
10172838|NCT03068468|11303160|FG000|STARTED|Placebo-Controlled Period||166
10172839|NCT03068468|11303161|FG001|STARTED|Placebo-Controlled Period||324
10172840|NCT03068468|11303162|FG002|STARTED|Placebo-Controlled Period||0
10172841|NCT03068468|11303163|FG003|STARTED|Placebo-Controlled Period||0
10172842|NCT03068468|11303160|FG000|Treated|Placebo-Controlled Period||165
10172843|NCT03068468|11303161|FG001|Treated|Placebo-Controlled Period||321
10172844|NCT03068468|11303162|FG002|Treated|Placebo-Controlled Period||0
10172845|NCT03068468|11303163|FG003|Treated|Placebo-Controlled Period||0
10172846|NCT03068468|11303160|FG000|COMPLETED|Placebo-Controlled Period||144
10172847|NCT03068468|11303161|FG001|COMPLETED|Placebo-Controlled Period||279
10172848|NCT03068468|11303162|FG002|COMPLETED|Placebo-Controlled Period||0
10172849|NCT03068468|11303163|FG003|COMPLETED|Placebo-Controlled Period||0
10172850|NCT03068468|11303160|FG000|NOT COMPLETED|Placebo-Controlled Period||22
10172851|NCT03068468|11303161|FG001|NOT COMPLETED|Placebo-Controlled Period||45
10172852|NCT03068468|11303162|FG002|NOT COMPLETED|Placebo-Controlled Period||0
10172853|NCT03068468|11303163|FG003|NOT COMPLETED|Placebo-Controlled Period||0
10172854|NCT03068468|11303160|FG000|STARTED|Open-Label Extension Period||0
10172855|NCT03068468|11303161|FG001|STARTED|Open-Label Extension Period||0
10172856|NCT03068468|11303162|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
10172857|NCT03068468|11303163|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
10172858|NCT03068468|11303160|FG000|COMPLETED|Open-Label Extension Period||0
10172859|NCT03068468|11303161|FG001|COMPLETED|Open-Label Extension Period||0
10172860|NCT03068468|11303162|FG002|COMPLETED|Open-Label Extension Period||0
10172861|NCT03068468|11303163|FG003|COMPLETED|Open-Label Extension Period||0
10172862|NCT03068468|11303160|FG000|NOT COMPLETED|Open-Label Extension Period||0
10172863|NCT03068468|11303161|FG001|NOT COMPLETED|Open-Label Extension Period||0
10172864|NCT03068468|11303162|FG002|NOT COMPLETED|Open-Label Extension Period||140
10172865|NCT03068468|11303163|FG003|NOT COMPLETED|Open-Label Extension Period||276
10172866|NCT03068611|11303173|FG000|STARTED|Overall Study||61
10172867|NCT03068611|11303174|FG001|STARTED|Overall Study||58
10172868|NCT03068611|11303173|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
10172869|NCT03068611|11303174|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
10172870|NCT03068611|11303173|FG000|NOT COMPLETED|Overall Study||31
10172871|NCT03068611|11303174|FG001|NOT COMPLETED|Overall Study||25
10172872|NCT03068754|11303182|FG000|STARTED|Randomized Treatment Period (RTP)||95
10172873|NCT03068754|11303183|FG001|STARTED|Randomized Treatment Period (RTP)||48
10172874|NCT03068754|11303184|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
10172875|NCT03068754|11303185|FG003|STARTED|Randomized Treatment Period (RTP)||0
10172876|NCT03068754|11303182|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
10172877|NCT03068754|11303183|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
10172878|NCT03068754|11303184|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
10172879|NCT03068754|11303185|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
10172880|NCT03068754|11303182|FG000|Safety Population|Randomized Treatment Period (RTP)||95
10172881|NCT03068754|11303183|FG001|Safety Population|Randomized Treatment Period (RTP)||47
10172882|NCT03068754|11303184|FG002|Safety Population|Randomized Treatment Period (RTP)||0
10172883|NCT03068754|11303185|FG003|Safety Population|Randomized Treatment Period (RTP)||0
10172884|NCT03068754|11303182|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
10172885|NCT03068754|11303183|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
10172886|NCT03068754|11303184|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
10172887|NCT03068754|11303185|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
10172888|NCT03068754|11303182|FG000|Completed Taper|Randomized Treatment Period (RTP)||58
10172889|NCT03068754|11303183|FG001|Completed Taper|Randomized Treatment Period (RTP)||28
10172890|NCT03068754|11303184|FG002|Completed Taper|Randomized Treatment Period (RTP)||0
10172891|NCT03068754|11303185|FG003|Completed Taper|Randomized Treatment Period (RTP)||0
10172892|NCT03068754|11303182|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
10172893|NCT03068754|11303183|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
10172894|NCT03068754|11303184|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
10172895|NCT03068754|11303185|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
10172896|NCT03068754|11303182|FG000|Completed RTP|Randomized Treatment Period (RTP)||27
10172897|NCT03068754|11303183|FG001|Completed RTP|Randomized Treatment Period (RTP)||9
10172898|NCT03068754|11303184|FG002|Completed RTP|Randomized Treatment Period (RTP)||0
10172899|NCT03068754|11303185|FG003|Completed RTP|Randomized Treatment Period (RTP)||0
10172900|NCT03068754|11303182|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
10172901|NCT03068754|11303183|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
10172902|NCT03068754|11303184|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
10172903|NCT03068754|11303185|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
10172904|NCT03068754|11303182|FG000|COMPLETED|Randomized Treatment Period (RTP)||28
10172905|NCT03068754|11303183|FG001|COMPLETED|Randomized Treatment Period (RTP)||9
10172906|NCT03068754|11303184|FG002|COMPLETED|Randomized Treatment Period (RTP)||0
10172907|NCT03068754|11303185|FG003|COMPLETED|Randomized Treatment Period (RTP)||0
10172908|NCT03068754|11303182|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67
10172909|NCT03068754|11303183|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39
10172910|NCT03068754|11303184|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0
10172911|NCT03068754|11303185|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0
10172912|NCT03068754|11303182|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
10172913|NCT03068754|11303183|FG001|STARTED|Open Label Extension Period (OLE)||0
10172914|NCT03068754|11303184|FG002|STARTED|Open Label Extension Period (OLE)||25
10172915|NCT03068754|11303185|FG003|STARTED|Open Label Extension Period (OLE)||8
10172916|NCT03068754|11303182|FG000|Completed Taper|Open Label Extension Period (OLE)||0
10172917|NCT03068754|11303183|FG001|Completed Taper|Open Label Extension Period (OLE)||0
10172918|NCT03068754|11303184|FG002|Completed Taper|Open Label Extension Period (OLE)||19
10172919|NCT03068754|11303185|FG003|Completed Taper|Open Label Extension Period (OLE)||7
10172920|NCT03068754|11303182|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0
10172921|NCT03068754|11303183|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0
10172922|NCT03068754|11303184|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3
10172923|NCT03068754|11303185|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2
10172924|NCT03068754|11303182|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
10172925|NCT03068754|11303183|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
10172926|NCT03068754|11303184|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
10172927|NCT03068754|11303185|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
10172928|NCT03068754|11303182|FG000|COMPLETED|Open Label Extension Period (OLE)||0
10172929|NCT03068754|11303183|FG001|COMPLETED|Open Label Extension Period (OLE)||0
10172930|NCT03068754|11303184|FG002|COMPLETED|Open Label Extension Period (OLE)||4
10172931|NCT03068754|11303185|FG003|COMPLETED|Open Label Extension Period (OLE)||2
10172932|NCT03068754|11303182|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0
10172933|NCT03068754|11303183|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0
10172934|NCT03068754|11303184|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21
10172935|NCT03068754|11303185|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6
10172936|NCT03068767|11303197|FG000|STARTED|Overall Study|from August 2017 to September 2018|75
10172937|NCT03068767|11303198|FG001|STARTED|Overall Study|from August 2017 to September 2018|74
10172938|NCT03068767|11303197|FG000|COMPLETED|Overall Study|December 2018|65
10172939|NCT03068767|11303198|FG001|COMPLETED|Overall Study|December 2018|71
10172940|NCT03068767|11303197|FG000|NOT COMPLETED|Overall Study||10
10172941|NCT03068767|11303198|FG001|NOT COMPLETED|Overall Study||3
10172942|NCT03068897|11303208|FG000|STARTED|Overall Study||80
10172943|NCT03068897|11303209|FG001|STARTED|Overall Study||80
10172944|NCT03068897|11303210|FG002|STARTED|Overall Study||80
10172945|NCT03068897|11303211|FG003|STARTED|Overall Study||80
10172946|NCT03068897|11303208|FG000|COMPLETED|Overall Study||76
10172947|NCT03068897|11303209|FG001|COMPLETED|Overall Study||76
10172948|NCT03068897|11303210|FG002|COMPLETED|Overall Study||79
10172949|NCT03068897|11303211|FG003|COMPLETED|Overall Study||74
10172950|NCT03068897|11303208|FG000|NOT COMPLETED|Overall Study||4
10172951|NCT03068897|11303209|FG001|NOT COMPLETED|Overall Study||4
10172952|NCT03068897|11303210|FG002|NOT COMPLETED|Overall Study||1
10172953|NCT03068897|11303211|FG003|NOT COMPLETED|Overall Study||6
10172954|NCT03068949|11303225|FG000|STARTED|Overall Study||113
10172955|NCT03068949|11303226|FG001|STARTED|Overall Study||102
10172956|NCT03068949|11303227|FG002|STARTED|Overall Study||122
10172957|NCT03068949|11303228|FG003|STARTED|Overall Study||76
10172958|NCT03068949|11303225|FG000|COMPLETED|Overall Study||105
10172959|NCT03068949|11303226|FG001|COMPLETED|Overall Study||90
10172960|NCT03068949|11303227|FG002|COMPLETED|Overall Study||113
10172961|NCT03068949|11303228|FG003|COMPLETED|Overall Study||63
10172962|NCT03068949|11303225|FG000|NOT COMPLETED|Overall Study||8
10172963|NCT03068949|11303226|FG001|NOT COMPLETED|Overall Study||12
10172964|NCT03068949|11303227|FG002|NOT COMPLETED|Overall Study||9
10172965|NCT03068949|11303228|FG003|NOT COMPLETED|Overall Study||13
9712803|NCT01231516|10812145|FG000|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||354
10172966|NCT03069313|11303238|FG000|STARTED|Overall Study||41
10172967|NCT03069313|11303238|FG000|COMPLETED|Overall Study||36
10172968|NCT03069313|11303238|FG000|NOT COMPLETED|Overall Study||5
10172969|NCT03069352|11303244|FG000|STARTED|Overall Study||68
10172970|NCT03069352|11303245|FG001|STARTED|Overall Study||143
10172971|NCT03069352|11303244|FG000|Received Treatment|Overall Study||68
10172972|NCT03069352|11303245|FG001|Received Treatment|Overall Study||142
10172973|NCT03069352|11303244|FG000|COMPLETED|Overall Study||56
10172974|NCT03069352|11303245|FG001|COMPLETED|Overall Study||103
10172975|NCT03069352|11303244|FG000|NOT COMPLETED|Overall Study||12
10172976|NCT03069352|11303245|FG001|NOT COMPLETED|Overall Study||40
10172977|NCT03069365|11303251|FG000|STARTED|Overall Study||101
10172978|NCT03069365|11303251|FG000|COMPLETED|Overall Study||100
10172979|NCT03069365|11303251|FG000|NOT COMPLETED|Overall Study||1
10172980|NCT03069482|11303257|FG000|STARTED|Overall Study||34
10172981|NCT03069482|11303258|FG001|STARTED|Overall Study||29
10172982|NCT03069482|11303257|FG000|COMPLETED|Overall Study||33
10172983|NCT03069482|11303258|FG001|COMPLETED|Overall Study||28
10172984|NCT03069482|11303257|FG000|NOT COMPLETED|Overall Study||1
10172985|NCT03069482|11303258|FG001|NOT COMPLETED|Overall Study||1
10172986|NCT03069677|11303269|FG000|STARTED|Overall Study||80
10172987|NCT03069677|11303270|FG001|STARTED|Overall Study||80
10172988|NCT03069677|11303269|FG000|COMPLETED|Overall Study||77
10172989|NCT03069677|11303270|FG001|COMPLETED|Overall Study||77
10172990|NCT03069677|11303269|FG000|NOT COMPLETED|Overall Study||3
10172991|NCT03069677|11303270|FG001|NOT COMPLETED|Overall Study||3
10172992|NCT03069716|11303278|FG000|STARTED|Run-in Period (2 Weeks)||49
10172993|NCT03069716|11303279|FG001|STARTED|Run-in Period (2 Weeks)||0
10172994|NCT03069716|11303280|FG002|STARTED|Run-in Period (2 Weeks)||0
10172995|NCT03069716|11303278|FG000|COMPLETED|Run-in Period (2 Weeks)||42
10172996|NCT03069716|11303279|FG001|COMPLETED|Run-in Period (2 Weeks)||0
10172997|NCT03069716|11303280|FG002|COMPLETED|Run-in Period (2 Weeks)||0
10172998|NCT03069716|11303278|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7
10172999|NCT03069716|11303279|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
10173000|NCT03069716|11303280|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
10173001|NCT03069716|11303278|FG000|STARTED|Randomized Treatment||0
10173002|NCT03069716|11303279|FG001|STARTED|Randomized Treatment||20
10173003|NCT03069716|11303280|FG002|STARTED|Randomized Treatment||22
10173004|NCT03069716|11303278|FG000|COMPLETED|Randomized Treatment||0
10173005|NCT03069716|11303279|FG001|COMPLETED|Randomized Treatment||18
10173006|NCT03069716|11303280|FG002|COMPLETED|Randomized Treatment||22
10173007|NCT03069716|11303278|FG000|NOT COMPLETED|Randomized Treatment||0
10173008|NCT03069716|11303279|FG001|NOT COMPLETED|Randomized Treatment||2
10173009|NCT03069716|11303280|FG002|NOT COMPLETED|Randomized Treatment||0
10173010|NCT03069989|11303289|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3
10173011|NCT03069989|11303290|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5
10173012|NCT03069989|11303289|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
10173013|NCT03069989|11303290|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
10173014|NCT03069989|11303289|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
10173015|NCT03069989|11303290|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
10173016|NCT03069989|11303289|FG000|STARTED|Wash Out Period (Up to 28 Days))||3
10173017|NCT03069989|11303290|FG001|STARTED|Wash Out Period (Up to 28 Days))||5
10173018|NCT03069989|11303289|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3
10173019|NCT03069989|11303290|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5
10173020|NCT03069989|11303289|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
10173021|NCT03069989|11303290|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
10173022|NCT03069989|11303289|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3
10173023|NCT03069989|11303290|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5
10173024|NCT03069989|11303289|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
10173025|NCT03069989|11303290|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
10173026|NCT03069989|11303289|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
10173027|NCT03069989|11303290|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
10173028|NCT03070171|11303299|FG000|STARTED|Treatment Period 1 + Washout||80
10173029|NCT03070171|11303300|FG001|STARTED|Treatment Period 1 + Washout||80
10173030|NCT03070171|11303299|FG000|COMPLETED|Treatment Period 1 + Washout||80
10173031|NCT03070171|11303300|FG001|COMPLETED|Treatment Period 1 + Washout||80
10173032|NCT03070171|11303299|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
10173033|NCT03070171|11303300|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
10173034|NCT03070171|11303299|FG000|STARTED|Treatment Period 2 + Washout||80
10173035|NCT03070171|11303300|FG001|STARTED|Treatment Period 2 + Washout||80
10173036|NCT03070171|11303299|FG000|COMPLETED|Treatment Period 2 + Washout||80
10173037|NCT03070171|11303300|FG001|COMPLETED|Treatment Period 2 + Washout||79
10173038|NCT03070171|11303299|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0
10173039|NCT03070171|11303300|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1
10173040|NCT03070171|11303299|FG000|STARTED|Treatment Period 3 + Washout||80
10173041|NCT03070171|11303300|FG001|STARTED|Treatment Period 3 + Washout||79
10173042|NCT03070171|11303299|FG000|COMPLETED|Treatment Period 3 + Washout||80
10173043|NCT03070171|11303300|FG001|COMPLETED|Treatment Period 3 + Washout||79
10173044|NCT03070171|11303299|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0
10173045|NCT03070171|11303300|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0
10173046|NCT03070171|11303299|FG000|STARTED|Treatment Period 4 + Washout||80
10173047|NCT03070171|11303300|FG001|STARTED|Treatment Period 4 + Washout||79
10173048|NCT03070171|11303299|FG000|COMPLETED|Treatment Period 4 + Washout||80
10173049|NCT03070171|11303300|FG001|COMPLETED|Treatment Period 4 + Washout||78
10173050|NCT03070171|11303299|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0
10173051|NCT03070171|11303300|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1
10173052|NCT03070431|11303306|FG000|STARTED|Overall Study||44
10173053|NCT03070431|11303306|FG000|COMPLETED|Overall Study||40
10173054|NCT03070431|11303306|FG000|NOT COMPLETED|Overall Study||4
10173055|NCT03070470|11303321|FG000|STARTED|Overall Study||10
10173056|NCT03070470|11303322|FG001|STARTED|Overall Study||10
10173057|NCT03070470|11303323|FG002|STARTED|Overall Study||10
10173058|NCT03070470|11303324|FG003|STARTED|Overall Study||10
10173059|NCT03070470|11303325|FG004|STARTED|Overall Study||10
10173060|NCT03070470|11303326|FG005|STARTED|Overall Study||10
10173061|NCT03070470|11303321|FG000|COMPLETED|Overall Study||10
10173062|NCT03070470|11303322|FG001|COMPLETED|Overall Study||9
10173063|NCT03070470|11303323|FG002|COMPLETED|Overall Study||10
10173064|NCT03070470|11303324|FG003|COMPLETED|Overall Study||10
10173065|NCT03070470|11303325|FG004|COMPLETED|Overall Study||10
10173066|NCT03070470|11303326|FG005|COMPLETED|Overall Study||8
10173067|NCT03070470|11303321|FG000|NOT COMPLETED|Overall Study||0
10173068|NCT03070470|11303322|FG001|NOT COMPLETED|Overall Study||1
10173069|NCT03070470|11303323|FG002|NOT COMPLETED|Overall Study||0
10173070|NCT03070470|11303324|FG003|NOT COMPLETED|Overall Study||0
10173071|NCT03070470|11303325|FG004|NOT COMPLETED|Overall Study||0
10173072|NCT03070470|11303326|FG005|NOT COMPLETED|Overall Study||2
10173073|NCT03070483|11303342|FG000|STARTED|Overall Study||5
10173074|NCT03070483|11303342|FG000|COMPLETED|Overall Study||3
10173075|NCT03070483|11303342|FG000|NOT COMPLETED|Overall Study||2
10173076|NCT03070548|11303347|FG000|STARTED|Overall Study||6
10173077|NCT03070548|11303347|FG000|COMPLETED|Overall Study||6
10173078|NCT03070548|11303347|FG000|NOT COMPLETED|Overall Study||0
10173079|NCT03070730|11303354|FG000|STARTED|Overall Study||0
10173080|NCT03070730|11303355|FG001|STARTED|Overall Study||0
9712804|NCT01231516|10812146|FG001|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||361
9712805|NCT01231516|10812145|FG000|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||299
9712806|NCT01231516|10812146|FG001|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||283
9712807|NCT01231516|10812145|FG000|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||61
9712808|NCT01231516|10812146|FG001|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||81
9712809|NCT01231516|10812145|FG000|STARTED|Open-label Phase:From Wk 48 up to Wk 480|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
9712810|NCT01231516|10812146|FG001|STARTED|Open-label Phase:From Wk 48 up to Wk 480|157 participants completed the Double-blind Phase but did not enter the Open-label Phase.|126
9712811|NCT01231516|10812145|FG000|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||227
9712812|NCT01231516|10812146|FG001|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||109
9712813|NCT01231516|10812145|FG000|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||68
9712814|NCT01231516|10812146|FG001|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||17
9712815|NCT01229943|10812154|FG000|STARTED|Overall Study||75
9712816|NCT01229943|10812155|FG001|STARTED|Overall Study||75
9712817|NCT01229943|10812154|FG000|COMPLETED|Overall Study||57
9712818|NCT01229943|10812155|FG001|COMPLETED|Overall Study||58
9712819|NCT01229943|10812154|FG000|NOT COMPLETED|Overall Study||18
10173081|NCT03070730|11303356|FG002|STARTED|Overall Study||0
10173082|NCT03070730|11303354|FG000|COMPLETED|Overall Study||0
10173083|NCT03070730|11303355|FG001|COMPLETED|Overall Study||0
10173084|NCT03070730|11303356|FG002|COMPLETED|Overall Study||0
10173085|NCT03070730|11303354|FG000|NOT COMPLETED|Overall Study||0
10173086|NCT03070730|11303355|FG001|NOT COMPLETED|Overall Study||0
10173087|NCT03070730|11303356|FG002|NOT COMPLETED|Overall Study||0
10173088|NCT03070782|11303370|FG000|STARTED|Overall Study||48
10173089|NCT03070782|11303371|FG001|STARTED|Overall Study||48
10173090|NCT03070782|11303372|FG002|STARTED|Overall Study||47
10173091|NCT03070782|11303373|FG003|STARTED|Overall Study||48
10173092|NCT03070782|11303374|FG004|STARTED|Overall Study||48
9712820|NCT01229943|10812155|FG001|NOT COMPLETED|Overall Study||17
9712821|NCT01194219|10812165|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562
9712822|NCT01194219|10812166|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282
9712823|NCT01194219|10812167|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0
9712824|NCT01194219|10812168|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0
9712825|NCT01194219|10812169|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0
9712826|NCT01194219|10812170|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10173093|NCT03070782|11303375|FG005|STARTED|Overall Study||47
10173094|NCT03070782|11303370|FG000|COMPLETED|Overall Study||41
10173095|NCT03070782|11303371|FG001|COMPLETED|Overall Study||47
10173096|NCT03070782|11303372|FG002|COMPLETED|Overall Study||43
10173097|NCT03070782|11303373|FG003|COMPLETED|Overall Study||43
10173098|NCT03070782|11303374|FG004|COMPLETED|Overall Study||36
10173099|NCT03070782|11303375|FG005|COMPLETED|Overall Study||40
10173100|NCT03070782|11303370|FG000|NOT COMPLETED|Overall Study||7
10173101|NCT03070782|11303371|FG001|NOT COMPLETED|Overall Study||1
10173102|NCT03070782|11303372|FG002|NOT COMPLETED|Overall Study||4
10173103|NCT03070782|11303373|FG003|NOT COMPLETED|Overall Study||5
10173104|NCT03070782|11303374|FG004|NOT COMPLETED|Overall Study||12
10173105|NCT03070782|11303375|FG005|NOT COMPLETED|Overall Study||7
10173106|NCT03070964|11303389|FG000|STARTED|Overall Study||14
10173107|NCT03070964|11303389|FG000|COMPLETED|Overall Study||0
10173108|NCT03070964|11303389|FG000|NOT COMPLETED|Overall Study||14
10173109|NCT03071094|11303395|FG000|STARTED|Overall Study||7
10173110|NCT03071094|11303396|FG001|STARTED|Overall Study||5
10173111|NCT03071094|11303395|FG000|COMPLETED|Overall Study||5
10173112|NCT03071094|11303396|FG001|COMPLETED|Overall Study||4
10173113|NCT03071094|11303395|FG000|NOT COMPLETED|Overall Study||2
10173114|NCT03071094|11303396|FG001|NOT COMPLETED|Overall Study||1
10173115|NCT03071263|11303404|FG000|STARTED|Overall Study||147
10173116|NCT03071263|11303405|FG001|STARTED|Overall Study||148
10173117|NCT03071263|11303404|FG000|COMPLETED|Overall Study||144
10173118|NCT03071263|11303405|FG001|COMPLETED|Overall Study||141
10173119|NCT03071263|11303404|FG000|NOT COMPLETED|Overall Study||3
10173120|NCT03071263|11303405|FG001|NOT COMPLETED|Overall Study||7
10173121|NCT03071276|11303411|FG000|STARTED|Overall Study||37
10173122|NCT03071276|11303411|FG000|COMPLETED|Overall Study||22
10173123|NCT03071276|11303411|FG000|NOT COMPLETED|Overall Study||15
10173124|NCT03071744|11303415|FG000|STARTED|Overall Study||6
10173125|NCT03071744|11303415|FG000|COMPLETED|Overall Study||4
10173126|NCT03071744|11303415|FG000|NOT COMPLETED|Overall Study||2
10173127|NCT03071887|11303419|FG000|STARTED|Overall Study||13
10173128|NCT03071887|11303419|FG000|COMPLETED|Overall Study||7
10173129|NCT03071887|11303419|FG000|NOT COMPLETED|Overall Study||6
10173130|NCT03072160|11303425|FG000|STARTED|Overall Study||13
10173131|NCT03072160|11303426|FG001|STARTED|Overall Study||4
10173132|NCT03072160|11303425|FG000|COMPLETED|Overall Study||2
10173133|NCT03072160|11303426|FG001|COMPLETED|Overall Study||0
10173134|NCT03072160|11303425|FG000|NOT COMPLETED|Overall Study||11
10173135|NCT03072160|11303426|FG001|NOT COMPLETED|Overall Study||4
10173136|NCT03072186|11303464|FG000|STARTED|Overall Study||23
10173137|NCT03072186|11303464|FG000|COMPLETED|Overall Study||17
9712827|NCT01194219|10812171|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0
9712828|NCT01194219|10812172|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0
9712829|NCT01194219|10812173|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0
9712830|NCT01194219|10812174|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0
9712831|NCT01194219|10812165|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
9712832|NCT01194219|10812166|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
9712833|NCT01194219|10812167|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712834|NCT01194219|10812168|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712835|NCT01194219|10812169|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712836|NCT01194219|10812170|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712837|NCT01194219|10812171|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712838|NCT01194219|10812172|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712839|NCT01194219|10812173|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712840|NCT01194219|10812174|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
9712841|NCT01194219|10812165|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
9712842|NCT01194219|10812166|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
9712843|NCT01194219|10812167|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712844|NCT01194219|10812168|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712845|NCT01194219|10812169|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712846|NCT01194219|10812170|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712847|NCT01194219|10812171|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712848|NCT01194219|10812172|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712849|NCT01194219|10812173|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712850|NCT01194219|10812174|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712851|NCT01194219|10812165|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
9712852|NCT01194219|10812166|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
9712853|NCT01194219|10812167|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712854|NCT01194219|10812168|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712855|NCT01194219|10812169|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712856|NCT01194219|10812170|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712857|NCT01194219|10812171|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712858|NCT01194219|10812172|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712859|NCT01194219|10812173|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712860|NCT01194219|10812174|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
9712861|NCT01194219|10812165|FG000|STARTED|Maintenance Phase Weeks16-32||0
9712862|NCT01194219|10812166|FG001|STARTED|Maintenance Phase Weeks16-32||0
9712863|NCT01194219|10812167|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
9712864|NCT01194219|10812168|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
9712865|NCT01194219|10812169|FG004|STARTED|Maintenance Phase Weeks16-32||0
9712866|NCT01194219|10812170|FG005|STARTED|Maintenance Phase Weeks16-32||0
9712867|NCT01194219|10812171|FG006|STARTED|Maintenance Phase Weeks16-32||0
9712868|NCT01194219|10812172|FG007|STARTED|Maintenance Phase Weeks16-32||0
10173138|NCT03072186|11303464|FG000|NOT COMPLETED|Overall Study||6
10173139|NCT03072550|11303468|FG000|STARTED|Overall Study||26
10173140|NCT03072550|11303468|FG000|COMPLETED|Overall Study||24
10173141|NCT03072550|11303468|FG000|NOT COMPLETED|Overall Study||2
10173142|NCT03072602|11303474|FG000|STARTED|Overall Study||39
10173143|NCT03072602|11303475|FG001|STARTED|Overall Study||42
10173144|NCT03072602|11303474|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
10173145|NCT03072602|11303475|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
10173146|NCT03072602|11303474|FG000|Ineligible Participants|Overall Study||8
10173147|NCT03072602|11303475|FG001|Ineligible Participants|Overall Study||5
10173148|NCT03072602|11303474|FG000|Participant Received Standardized Meals|Overall Study||39
10173149|NCT03072602|11303475|FG001|Participant Received Standardized Meals|Overall Study||42
10173150|NCT03072602|11303474|FG000|Study Dropouts|Overall Study||4
10173151|NCT03072602|11303475|FG001|Study Dropouts|Overall Study||3
10173152|NCT03072602|11303474|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35
10173153|NCT03072602|11303475|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39
10173154|NCT03072602|11303474|FG000|Unable to Complete the Protocol|Overall Study||1
10173155|NCT03072602|11303475|FG001|Unable to Complete the Protocol|Overall Study||1
10173156|NCT03072602|11303474|FG000|COMPLETED|Overall Study||34
10173157|NCT03072602|11303475|FG001|COMPLETED|Overall Study||38
10173158|NCT03072602|11303474|FG000|NOT COMPLETED|Overall Study||5
10173159|NCT03072602|11303475|FG001|NOT COMPLETED|Overall Study||4
10173160|NCT03072719|11303483|FG000|STARTED|Overall Study||60
10173161|NCT03072719|11303484|FG001|STARTED|Overall Study||60
10173162|NCT03072719|11303483|FG000|COMPLETED|Overall Study||59
10173163|NCT03072719|11303484|FG001|COMPLETED|Overall Study||59
10173164|NCT03072719|11303483|FG000|NOT COMPLETED|Overall Study||1
10173165|NCT03072719|11303484|FG001|NOT COMPLETED|Overall Study||1
10173166|NCT03072732|11303492|FG000|STARTED|Overall Study||20
10173167|NCT03072732|11303493|FG001|STARTED|Overall Study||20
10173168|NCT03072732|11303492|FG000|COMPLETED|Overall Study||20
10173169|NCT03072732|11303493|FG001|COMPLETED|Overall Study||20
10173170|NCT03072732|11303492|FG000|NOT COMPLETED|Overall Study||0
10173171|NCT03072732|11303493|FG001|NOT COMPLETED|Overall Study||0
10173172|NCT03072875|11303499|FG000|STARTED|Overall Study||26
10173173|NCT03072875|11303499|FG000|COMPLETED|Overall Study||25
10173174|NCT03072875|11303499|FG000|NOT COMPLETED|Overall Study||1
10173175|NCT03072953|11303504|FG000|STARTED|Overall Study||2
10173176|NCT03072953|11303504|FG000|COMPLETED|Overall Study||2
10173177|NCT03072953|11303504|FG000|NOT COMPLETED|Overall Study||0
10173178|NCT03073005|11303512|FG000|STARTED|Overall Study||33
10173179|NCT03073005|11303513|FG001|STARTED|Overall Study||37
10173180|NCT03073005|11303514|FG002|STARTED|Overall Study||36
10173181|NCT03073005|11303515|FG003|STARTED|Overall Study||37
10173182|NCT03073005|11303512|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
10173183|NCT03073005|11303513|FG001|Received Initial Training|Overall Study||29
10173184|NCT03073005|11303514|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
10173185|NCT03073005|11303515|FG003|Received Initial Training|Overall Study||33
10173186|NCT03073005|11303512|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
10173187|NCT03073005|11303513|FG001|COMPLETED|Overall Study||25
10173188|NCT03073005|11303514|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
10173189|NCT03073005|11303515|FG003|COMPLETED|Overall Study||24
10173190|NCT03073005|11303512|FG000|NOT COMPLETED|Overall Study||8
10173191|NCT03073005|11303513|FG001|NOT COMPLETED|Overall Study||12
10173192|NCT03073005|11303514|FG002|NOT COMPLETED|Overall Study||12
10173193|NCT03073005|11303515|FG003|NOT COMPLETED|Overall Study||13
10173194|NCT03073109|11303530|FG000|STARTED|Overall Study||100
10173195|NCT03073109|11303531|FG001|STARTED|Overall Study||70
10173196|NCT03073109|11303530|FG000|COMPLETED|Overall Study||90
10173197|NCT03073109|11303531|FG001|COMPLETED|Overall Study||68
10173198|NCT03073109|11303530|FG000|NOT COMPLETED|Overall Study||10
10173199|NCT03073109|11303531|FG001|NOT COMPLETED|Overall Study||2
10173200|NCT03073148|11303553|FG000|STARTED|Overall Study||21
10173201|NCT03073148|11303554|FG001|STARTED|Overall Study||10
10173202|NCT03073148|11303555|FG002|STARTED|Overall Study||4
10173203|NCT03073148|11303553|FG000|COMPLETED|Overall Study||21
10173204|NCT03073148|11303554|FG001|COMPLETED|Overall Study||10
10173205|NCT03073148|11303555|FG002|COMPLETED|Overall Study||0
10173206|NCT03073148|11303553|FG000|NOT COMPLETED|Overall Study||0
10173207|NCT03073148|11303554|FG001|NOT COMPLETED|Overall Study||0
10173208|NCT03073148|11303555|FG002|NOT COMPLETED|Overall Study||4
10173209|NCT03073200|11303566|FG000|STARTED|Double Blind Treatment Period||56
10173210|NCT03073200|11303567|FG001|STARTED|Double Blind Treatment Period||115
10173211|NCT03073200|11303568|FG002|STARTED|Double Blind Treatment Period||30
10173212|NCT03073200|11303569|FG003|STARTED|Double Blind Treatment Period||0
10173213|NCT03073200|11303570|FG004|STARTED|Double Blind Treatment Period||0
10173214|NCT03073200|11303571|FG005|STARTED|Double Blind Treatment Period||0
10173215|NCT03073200|11303572|FG006|STARTED|Double Blind Treatment Period||0
10173216|NCT03073200|11303573|FG007|STARTED|Double Blind Treatment Period||0
10173217|NCT03073200|11303574|FG008|STARTED|Double Blind Treatment Period||0
10173218|NCT03073200|11303575|FG009|STARTED|Double Blind Treatment Period||0
10173219|NCT03073200|11303576|FG010|STARTED|Double Blind Treatment Period||0
10173220|NCT03073200|11303577|FG011|STARTED|Double Blind Treatment Period||0
10173221|NCT03073200|11303578|FG012|STARTED|Double Blind Treatment Period||0
10173222|NCT03073200|11303579|FG013|STARTED|Double Blind Treatment Period||0
10173223|NCT03073200|11303580|FG014|STARTED|Double Blind Treatment Period||0
10173224|NCT03073200|11303566|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19
10173225|NCT03073200|11303567|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38
10173226|NCT03073200|11303568|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30
10173227|NCT03073200|11303569|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173228|NCT03073200|11303570|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173229|NCT03073200|11303571|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173230|NCT03073200|11303572|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173231|NCT03073200|11303573|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173232|NCT03073200|11303574|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173233|NCT03073200|11303575|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173234|NCT03073200|11303576|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173235|NCT03073200|11303577|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173236|NCT03073200|11303578|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173237|NCT03073200|11303579|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173238|NCT03073200|11303580|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10173239|NCT03073200|11303566|FG000|COMPLETED|Double Blind Treatment Period||54
10173240|NCT03073200|11303567|FG001|COMPLETED|Double Blind Treatment Period||114
10173241|NCT03073200|11303568|FG002|COMPLETED|Double Blind Treatment Period||30
10173242|NCT03073200|11303569|FG003|COMPLETED|Double Blind Treatment Period||0
10173243|NCT03073200|11303570|FG004|COMPLETED|Double Blind Treatment Period||0
10173244|NCT03073200|11303571|FG005|COMPLETED|Double Blind Treatment Period||0
10173245|NCT03073200|11303572|FG006|COMPLETED|Double Blind Treatment Period||0
10173246|NCT03073200|11303573|FG007|COMPLETED|Double Blind Treatment Period||0
10173247|NCT03073200|11303574|FG008|COMPLETED|Double Blind Treatment Period||0
10173248|NCT03073200|11303575|FG009|COMPLETED|Double Blind Treatment Period||0
10173249|NCT03073200|11303576|FG010|COMPLETED|Double Blind Treatment Period||0
10173250|NCT03073200|11303577|FG011|COMPLETED|Double Blind Treatment Period||0
10173251|NCT03073200|11303578|FG012|COMPLETED|Double Blind Treatment Period||0
10173252|NCT03073200|11303579|FG013|COMPLETED|Double Blind Treatment Period||0
10173253|NCT03073200|11303580|FG014|COMPLETED|Double Blind Treatment Period||0
10173254|NCT03073200|11303566|FG000|NOT COMPLETED|Double Blind Treatment Period||2
10173255|NCT03073200|11303567|FG001|NOT COMPLETED|Double Blind Treatment Period||1
10173256|NCT03073200|11303568|FG002|NOT COMPLETED|Double Blind Treatment Period||0
10173257|NCT03073200|11303569|FG003|NOT COMPLETED|Double Blind Treatment Period||0
10173258|NCT03073200|11303570|FG004|NOT COMPLETED|Double Blind Treatment Period||0
10173259|NCT03073200|11303571|FG005|NOT COMPLETED|Double Blind Treatment Period||0
10173260|NCT03073200|11303572|FG006|NOT COMPLETED|Double Blind Treatment Period||0
10173261|NCT03073200|11303573|FG007|NOT COMPLETED|Double Blind Treatment Period||0
10173262|NCT03073200|11303574|FG008|NOT COMPLETED|Double Blind Treatment Period||0
10173263|NCT03073200|11303575|FG009|NOT COMPLETED|Double Blind Treatment Period||0
10173264|NCT03073200|11303576|FG010|NOT COMPLETED|Double Blind Treatment Period||0
10173265|NCT03073200|11303577|FG011|NOT COMPLETED|Double Blind Treatment Period||0
10173266|NCT03073200|11303578|FG012|NOT COMPLETED|Double Blind Treatment Period||0
10173267|NCT03073200|11303579|FG013|NOT COMPLETED|Double Blind Treatment Period||0
10173268|NCT03073200|11303580|FG014|NOT COMPLETED|Double Blind Treatment Period||0
10173269|NCT03073200|11303566|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
10173270|NCT03073200|11303567|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
10173271|NCT03073200|11303568|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
10173272|NCT03073200|11303569|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53
10173273|NCT03073200|11303570|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113
10173274|NCT03073200|11303571|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28
10173275|NCT03073200|11303572|FG006|STARTED|Open-Label Maintenance Period||0
10173276|NCT03073200|11303573|FG007|STARTED|Open-Label Maintenance Period||0
10173277|NCT03073200|11303574|FG008|STARTED|Open-Label Maintenance Period||0
10173278|NCT03073200|11303575|FG009|STARTED|Open-Label Maintenance Period||0
10173279|NCT03073200|11303576|FG010|STARTED|Open-Label Maintenance Period||0
10173280|NCT03073200|11303577|FG011|STARTED|Open-Label Maintenance Period||0
10173281|NCT03073200|11303578|FG012|STARTED|Open-Label Maintenance Period||0
10173282|NCT03073200|11303579|FG013|STARTED|Open-Label Maintenance Period||0
10173283|NCT03073200|11303580|FG014|STARTED|Open-Label Maintenance Period||0
10173284|NCT03073200|11303566|FG000|COMPLETED|Open-Label Maintenance Period||0
10173285|NCT03073200|11303567|FG001|COMPLETED|Open-Label Maintenance Period||0
10173286|NCT03073200|11303568|FG002|COMPLETED|Open-Label Maintenance Period||0
10173287|NCT03073200|11303569|FG003|COMPLETED|Open-Label Maintenance Period||49
10173288|NCT03073200|11303570|FG004|COMPLETED|Open-Label Maintenance Period||109
10173289|NCT03073200|11303571|FG005|COMPLETED|Open-Label Maintenance Period||28
10173290|NCT03073200|11303572|FG006|COMPLETED|Open-Label Maintenance Period||0
10173291|NCT03073200|11303573|FG007|COMPLETED|Open-Label Maintenance Period||0
10173292|NCT03073200|11303574|FG008|COMPLETED|Open-Label Maintenance Period||0
10173293|NCT03073200|11303575|FG009|COMPLETED|Open-Label Maintenance Period||0
10173294|NCT03073200|11303576|FG010|COMPLETED|Open-Label Maintenance Period||0
10173295|NCT03073200|11303577|FG011|COMPLETED|Open-Label Maintenance Period||0
10173296|NCT03073200|11303578|FG012|COMPLETED|Open-Label Maintenance Period||0
10173297|NCT03073200|11303579|FG013|COMPLETED|Open-Label Maintenance Period||0
10173298|NCT03073200|11303580|FG014|COMPLETED|Open-Label Maintenance Period||0
10173299|NCT03073200|11303566|FG000|NOT COMPLETED|Open-Label Maintenance Period||0
10173300|NCT03073200|11303567|FG001|NOT COMPLETED|Open-Label Maintenance Period||0
10173301|NCT03073200|11303568|FG002|NOT COMPLETED|Open-Label Maintenance Period||0
10173302|NCT03073200|11303569|FG003|NOT COMPLETED|Open-Label Maintenance Period||4
10173303|NCT03073200|11303570|FG004|NOT COMPLETED|Open-Label Maintenance Period||4
10173304|NCT03073200|11303571|FG005|NOT COMPLETED|Open-Label Maintenance Period||0
10173305|NCT03073200|11303572|FG006|NOT COMPLETED|Open-Label Maintenance Period||0
10173306|NCT03073200|11303573|FG007|NOT COMPLETED|Open-Label Maintenance Period||0
10173307|NCT03073200|11303574|FG008|NOT COMPLETED|Open-Label Maintenance Period||0
10173308|NCT03073200|11303575|FG009|NOT COMPLETED|Open-Label Maintenance Period||0
10173309|NCT03073200|11303576|FG010|NOT COMPLETED|Open-Label Maintenance Period||0
10173310|NCT03073200|11303577|FG011|NOT COMPLETED|Open-Label Maintenance Period||0
10173311|NCT03073200|11303578|FG012|NOT COMPLETED|Open-Label Maintenance Period||0
10173312|NCT03073200|11303579|FG013|NOT COMPLETED|Open-Label Maintenance Period||0
10173313|NCT03073200|11303580|FG014|NOT COMPLETED|Open-Label Maintenance Period||0
10173314|NCT03073200|11303566|FG000|STARTED|Extension Period||0
10173315|NCT03073200|11303567|FG001|STARTED|Extension Period||0
10173316|NCT03073200|11303568|FG002|STARTED|Extension Period||0
10173317|NCT03073200|11303569|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0
10173318|NCT03073200|11303570|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0
10173319|NCT03073200|11303571|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0
10173320|NCT03073200|11303572|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34
10173321|NCT03073200|11303573|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68
10173322|NCT03073200|11303574|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9
10173323|NCT03073200|11303575|FG009|STARTED|Extension Period||0
10173324|NCT03073200|11303576|FG010|STARTED|Extension Period||0
10173325|NCT03073200|11303577|FG011|STARTED|Extension Period||0
10173326|NCT03073200|11303578|FG012|STARTED|Extension Period||0
10173327|NCT03073200|11303579|FG013|STARTED|Extension Period||0
10173328|NCT03073200|11303580|FG014|STARTED|Extension Period||0
10173329|NCT03073200|11303566|FG000|COMPLETED|Extension Period||0
10173330|NCT03073200|11303567|FG001|COMPLETED|Extension Period||0
10173331|NCT03073200|11303568|FG002|COMPLETED|Extension Period||0
10173332|NCT03073200|11303569|FG003|COMPLETED|Extension Period||0
10173333|NCT03073200|11303570|FG004|COMPLETED|Extension Period||0
10173334|NCT03073200|11303571|FG005|COMPLETED|Extension Period||0
10173335|NCT03073200|11303572|FG006|COMPLETED|Extension Period||31
10173336|NCT03073200|11303573|FG007|COMPLETED|Extension Period||62
10173337|NCT03073200|11303574|FG008|COMPLETED|Extension Period||7
10173338|NCT03073200|11303575|FG009|COMPLETED|Extension Period||0
10173339|NCT03073200|11303576|FG010|COMPLETED|Extension Period||0
10173340|NCT03073200|11303577|FG011|COMPLETED|Extension Period||0
10173341|NCT03073200|11303578|FG012|COMPLETED|Extension Period||0
10173342|NCT03073200|11303579|FG013|COMPLETED|Extension Period||0
10173343|NCT03073200|11303580|FG014|COMPLETED|Extension Period||0
10173344|NCT03073200|11303566|FG000|NOT COMPLETED|Extension Period||0
10173345|NCT03073200|11303567|FG001|NOT COMPLETED|Extension Period||0
10173346|NCT03073200|11303568|FG002|NOT COMPLETED|Extension Period||0
10173347|NCT03073200|11303569|FG003|NOT COMPLETED|Extension Period||0
10173348|NCT03073200|11303570|FG004|NOT COMPLETED|Extension Period||0
10173349|NCT03073200|11303571|FG005|NOT COMPLETED|Extension Period||0
10173350|NCT03073200|11303572|FG006|NOT COMPLETED|Extension Period||3
10173351|NCT03073200|11303573|FG007|NOT COMPLETED|Extension Period||6
10173352|NCT03073200|11303574|FG008|NOT COMPLETED|Extension Period||2
10173353|NCT03073200|11303575|FG009|NOT COMPLETED|Extension Period||0
10173354|NCT03073200|11303576|FG010|NOT COMPLETED|Extension Period||0
9712869|NCT01194219|10812173|FG008|STARTED|Maintenance Phase Weeks16-32||0
9712870|NCT01194219|10812174|FG009|STARTED|Maintenance Phase Weeks16-32||0
9712871|NCT01194219|10812165|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0
9712872|NCT01194219|10812166|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0
9712873|NCT01194219|10812167|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
9712874|NCT01194219|10812168|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
9712875|NCT01194219|10812169|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0
9712876|NCT01194219|10812170|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0
9712877|NCT01194219|10812171|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0
9712878|NCT01194219|10812172|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0
9712879|NCT01194219|10812173|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0
9712880|NCT01194219|10812174|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0
9712881|NCT01194219|10812165|FG000|COMPLETED|Maintenance Phase Weeks16-32||0
9712882|NCT01194219|10812166|FG001|COMPLETED|Maintenance Phase Weeks16-32||0
9712883|NCT01194219|10812167|FG002|COMPLETED|Maintenance Phase Weeks16-32||424
9712884|NCT01194219|10812168|FG003|COMPLETED|Maintenance Phase Weeks16-32||215
9712885|NCT01194219|10812169|FG004|COMPLETED|Maintenance Phase Weeks16-32||0
9712886|NCT01194219|10812170|FG005|COMPLETED|Maintenance Phase Weeks16-32||0
9712887|NCT01194219|10812171|FG006|COMPLETED|Maintenance Phase Weeks16-32||0
9712888|NCT01194219|10812172|FG007|COMPLETED|Maintenance Phase Weeks16-32||0
9849600|NCT00866359|10962334|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0
10173355|NCT03073200|11303577|FG011|NOT COMPLETED|Extension Period||0
10173356|NCT03073200|11303578|FG012|NOT COMPLETED|Extension Period||0
10173357|NCT03073200|11303579|FG013|NOT COMPLETED|Extension Period||0
10173358|NCT03073200|11303580|FG014|NOT COMPLETED|Extension Period||0
10173359|NCT03073200|11303566|FG000|STARTED|Randomized Withdrawal Period||0
10173360|NCT03073200|11303567|FG001|STARTED|Randomized Withdrawal Period||0
10173361|NCT03073200|11303568|FG002|STARTED|Randomized Withdrawal Period||0
10173362|NCT03073200|11303569|FG003|STARTED|Randomized Withdrawal Period||0
10173363|NCT03073200|11303570|FG004|STARTED|Randomized Withdrawal Period||0
10173364|NCT03073200|11303571|FG005|STARTED|Randomized Withdrawal Period||0
10173365|NCT03073200|11303572|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
10173366|NCT03073200|11303573|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
10173367|NCT03073200|11303574|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
10173368|NCT03073200|11303575|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
10173369|NCT03073200|11303576|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34
10173370|NCT03073200|11303577|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
10173371|NCT03073200|11303578|FG012|STARTED|Randomized Withdrawal Period||0
10173372|NCT03073200|11303579|FG013|STARTED|Randomized Withdrawal Period||0
10173373|NCT03073200|11303580|FG014|STARTED|Randomized Withdrawal Period||0
10173374|NCT03073200|11303566|FG000|COMPLETED|Randomized Withdrawal Period||0
10173375|NCT03073200|11303567|FG001|COMPLETED|Randomized Withdrawal Period||0
10173376|NCT03073200|11303568|FG002|COMPLETED|Randomized Withdrawal Period||0
10173377|NCT03073200|11303569|FG003|COMPLETED|Randomized Withdrawal Period||0
10173378|NCT03073200|11303570|FG004|COMPLETED|Randomized Withdrawal Period||0
10173379|NCT03073200|11303571|FG005|COMPLETED|Randomized Withdrawal Period||0
10173380|NCT03073200|11303572|FG006|COMPLETED|Randomized Withdrawal Period||0
10173381|NCT03073200|11303573|FG007|COMPLETED|Randomized Withdrawal Period||0
10173382|NCT03073200|11303574|FG008|COMPLETED|Randomized Withdrawal Period||0
10173383|NCT03073200|11303575|FG009|COMPLETED|Randomized Withdrawal Period||33
10173384|NCT03073200|11303576|FG010|COMPLETED|Randomized Withdrawal Period||32
10173385|NCT03073200|11303577|FG011|COMPLETED|Randomized Withdrawal Period||30
10173386|NCT03073200|11303578|FG012|COMPLETED|Randomized Withdrawal Period||0
10173387|NCT03073200|11303579|FG013|COMPLETED|Randomized Withdrawal Period||0
10173388|NCT03073200|11303580|FG014|COMPLETED|Randomized Withdrawal Period||0
10173389|NCT03073200|11303566|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
10173390|NCT03073200|11303567|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
10173391|NCT03073200|11303568|FG002|NOT COMPLETED|Randomized Withdrawal Period||0
10173392|NCT03073200|11303569|FG003|NOT COMPLETED|Randomized Withdrawal Period||0
10173393|NCT03073200|11303570|FG004|NOT COMPLETED|Randomized Withdrawal Period||0
10173394|NCT03073200|11303571|FG005|NOT COMPLETED|Randomized Withdrawal Period||0
10173395|NCT03073200|11303572|FG006|NOT COMPLETED|Randomized Withdrawal Period||0
9712889|NCT01194219|10812173|FG008|COMPLETED|Maintenance Phase Weeks16-32||0
9712890|NCT01194219|10812174|FG009|COMPLETED|Maintenance Phase Weeks16-32||0
9712891|NCT01194219|10812165|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712892|NCT01194219|10812166|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712893|NCT01194219|10812167|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70
10173396|NCT03073200|11303573|FG007|NOT COMPLETED|Randomized Withdrawal Period||0
10173397|NCT03073200|11303574|FG008|NOT COMPLETED|Randomized Withdrawal Period||0
10173398|NCT03073200|11303575|FG009|NOT COMPLETED|Randomized Withdrawal Period||0
10173399|NCT03073200|11303576|FG010|NOT COMPLETED|Randomized Withdrawal Period||2
10173400|NCT03073200|11303577|FG011|NOT COMPLETED|Randomized Withdrawal Period||3
10173401|NCT03073200|11303578|FG012|NOT COMPLETED|Randomized Withdrawal Period||0
10173402|NCT03073200|11303579|FG013|NOT COMPLETED|Randomized Withdrawal Period||0
10173403|NCT03073200|11303580|FG014|NOT COMPLETED|Randomized Withdrawal Period||0
10173404|NCT03073200|11303566|FG000|STARTED|Post-Treatment Follow-Up Period||0
10173405|NCT03073200|11303567|FG001|STARTED|Post-Treatment Follow-Up Period||0
10173406|NCT03073200|11303568|FG002|STARTED|Post-Treatment Follow-Up Period||0
10173407|NCT03073200|11303569|FG003|STARTED|Post-Treatment Follow-Up Period||0
10173408|NCT03073200|11303570|FG004|STARTED|Post-Treatment Follow-Up Period||0
10173409|NCT03073200|11303571|FG005|STARTED|Post-Treatment Follow-Up Period||0
10173410|NCT03073200|11303572|FG006|STARTED|Post-Treatment Follow-Up Period||0
10173411|NCT03073200|11303573|FG007|STARTED|Post-Treatment Follow-Up Period||0
10173412|NCT03073200|11303574|FG008|STARTED|Post-Treatment Follow-Up Period||0
10173413|NCT03073200|11303575|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
10173414|NCT03073200|11303576|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
10173415|NCT03073200|11303577|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
10173416|NCT03073200|11303578|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6
10173417|NCT03073200|11303579|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166
10173418|NCT03073200|11303580|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2
10173419|NCT03073200|11303566|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
10173420|NCT03073200|11303567|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
9712894|NCT01194219|10812168|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30
10173421|NCT03073200|11303568|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
10173422|NCT03073200|11303569|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
10173423|NCT03073200|11303570|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
10173424|NCT03073200|11303571|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
10173425|NCT03073200|11303572|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
10173426|NCT03073200|11303573|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
10173427|NCT03073200|11303574|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
10173428|NCT03073200|11303575|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
10173429|NCT03073200|11303576|FG010|COMPLETED|Post-Treatment Follow-Up Period||0
10173430|NCT03073200|11303577|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
10173431|NCT03073200|11303578|FG012|COMPLETED|Post-Treatment Follow-Up Period||6
10173432|NCT03073200|11303579|FG013|COMPLETED|Post-Treatment Follow-Up Period||139
10173433|NCT03073200|11303580|FG014|COMPLETED|Post-Treatment Follow-Up Period||1
10173434|NCT03073200|11303566|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173435|NCT03073200|11303567|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173436|NCT03073200|11303568|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173437|NCT03073200|11303569|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173438|NCT03073200|11303570|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173439|NCT03073200|11303571|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173440|NCT03073200|11303572|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173441|NCT03073200|11303573|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173442|NCT03073200|11303574|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173443|NCT03073200|11303575|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173444|NCT03073200|11303576|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173445|NCT03073200|11303577|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173446|NCT03073200|11303578|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10173447|NCT03073200|11303579|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27
10173448|NCT03073200|11303580|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1
10173449|NCT03073213|11303605|FG000|STARTED|Single Dose Period||12
10173450|NCT03073213|11303606|FG001|STARTED|Single Dose Period||0
10173451|NCT03073213|11303607|FG002|STARTED|Single Dose Period||0
10173452|NCT03073213|11303605|FG000|COMPLETED|Single Dose Period||12
10173453|NCT03073213|11303606|FG001|COMPLETED|Single Dose Period||0
10173454|NCT03073213|11303607|FG002|COMPLETED|Single Dose Period||0
10173455|NCT03073213|11303605|FG000|NOT COMPLETED|Single Dose Period||0
10173456|NCT03073213|11303606|FG001|NOT COMPLETED|Single Dose Period||0
10173457|NCT03073213|11303607|FG002|NOT COMPLETED|Single Dose Period||0
10173458|NCT03073213|11303605|FG000|STARTED|Multiple Dose Period||0
10173459|NCT03073213|11303606|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
9849601|NCT00866359|10962335|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0
9849602|NCT00866359|10962336|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44
9849603|NCT00866359|10962337|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47
9849604|NCT00866359|10962334|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
9849605|NCT00866359|10962335|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
9849606|NCT00866359|10962336|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
9849607|NCT00866359|10962337|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
9849608|NCT00866359|10962334|FG000|STARTED|Observational Follow-Up Phase||0
9849609|NCT00866359|10962335|FG001|STARTED|Observational Follow-Up Phase||0
9849610|NCT00866359|10962336|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
9849611|NCT00866359|10962337|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
9849612|NCT00866359|10962334|FG000|COMPLETED|Observational Follow-Up Phase||0
9849613|NCT00866359|10962335|FG001|COMPLETED|Observational Follow-Up Phase||0
9849614|NCT00866359|10962336|FG002|COMPLETED|Observational Follow-Up Phase||54
10173460|NCT03073213|11303607|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
10173461|NCT03073213|11303605|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0
10173462|NCT03073213|11303606|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7
10173463|NCT03073213|11303607|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2
10173464|NCT03073213|11303605|FG000|COMPLETED|Multiple Dose Period||0
10173465|NCT03073213|11303606|FG001|COMPLETED|Multiple Dose Period||14
9849615|NCT00866359|10962337|FG003|COMPLETED|Observational Follow-Up Phase||54
9849616|NCT00866359|10962334|FG000|NOT COMPLETED|Observational Follow-Up Phase||0
10173466|NCT03073213|11303607|FG002|COMPLETED|Multiple Dose Period||14
10173467|NCT03073213|11303605|FG000|NOT COMPLETED|Multiple Dose Period||0
10173468|NCT03073213|11303606|FG001|NOT COMPLETED|Multiple Dose Period||0
10173469|NCT03073213|11303607|FG002|NOT COMPLETED|Multiple Dose Period||1
10173470|NCT03073486|11303618|FG000|STARTED|Overall Study||493
10173471|NCT03073486|11303619|FG001|STARTED|Overall Study||251
10173472|NCT03073486|11303618|FG000|COMPLETED|Overall Study||405
10173473|NCT03073486|11303619|FG001|COMPLETED|Overall Study||207
10173474|NCT03073486|11303618|FG000|NOT COMPLETED|Overall Study||88
10173475|NCT03073486|11303619|FG001|NOT COMPLETED|Overall Study||44
10173476|NCT03073759|11303627|FG000|STARTED|Overall Study||2
10173477|NCT03073759|11303628|FG001|STARTED|Overall Study||2
10173478|NCT03073759|11303627|FG000|COMPLETED|Overall Study||2
10173479|NCT03073759|11303628|FG001|COMPLETED|Overall Study||2
9849617|NCT00866359|10962335|FG001|NOT COMPLETED|Observational Follow-Up Phase||0
9849618|NCT00866359|10962336|FG002|NOT COMPLETED|Observational Follow-Up Phase||0
9849619|NCT00866359|10962337|FG003|NOT COMPLETED|Observational Follow-Up Phase||0
9849620|NCT00866606|10962364|FG000|STARTED|Overall Study||35
9849621|NCT00866606|10962364|FG000|COMPLETED|Overall Study||31
9849622|NCT00866606|10962364|FG000|NOT COMPLETED|Overall Study||4
9849623|NCT00866619|10962372|FG000|STARTED|Overall Study||5948
9849624|NCT00866619|10962373|FG001|STARTED|Overall Study||4358
9849625|NCT00866619|10962374|FG002|STARTED|Overall Study||2974
9849626|NCT00866619|10962375|FG003|STARTED|Overall Study||2179
9849627|NCT00866619|10962372|FG000|COMPLETED|Overall Study||4102
9849628|NCT00866619|10962373|FG001|COMPLETED|Overall Study||3088
10173480|NCT03073759|11303627|FG000|NOT COMPLETED|Overall Study||0
10173481|NCT03073759|11303628|FG001|NOT COMPLETED|Overall Study||0
10173482|NCT03073798|11303635|FG000|STARTED|Overall Study||12
10173483|NCT03073798|11303635|FG000|COMPLETED|Overall Study||10
10173484|NCT03073798|11303635|FG000|NOT COMPLETED|Overall Study||2
10173485|NCT03073876|11303642|FG000|STARTED|Overall Study||12
10173486|NCT03073876|11303643|FG001|STARTED|Overall Study||11
10173487|NCT03073876|11303642|FG000|COMPLETED|Overall Study||12
10173488|NCT03073876|11303643|FG001|COMPLETED|Overall Study||11
10173489|NCT03073876|11303642|FG000|NOT COMPLETED|Overall Study||0
10173490|NCT03073876|11303643|FG001|NOT COMPLETED|Overall Study||0
10173491|NCT03074162|11303660|FG000|STARTED|Period 1 Including Washout 1||8
10173492|NCT03074162|11303661|FG001|STARTED|Period 1 Including Washout 1||8
10173493|NCT03074162|11303662|FG002|STARTED|Period 1 Including Washout 1||8
10173494|NCT03074162|11303663|FG003|STARTED|Period 1 Including Washout 1||8
10173495|NCT03074162|11303664|FG004|STARTED|Period 1 Including Washout 1||8
10173496|NCT03074162|11303665|FG005|STARTED|Period 1 Including Washout 1||8
10173497|NCT03074162|11303660|FG000|COMPLETED|Period 1 Including Washout 1||8
10173498|NCT03074162|11303661|FG001|COMPLETED|Period 1 Including Washout 1||8
10173499|NCT03074162|11303662|FG002|COMPLETED|Period 1 Including Washout 1||7
10173500|NCT03074162|11303663|FG003|COMPLETED|Period 1 Including Washout 1||8
10173501|NCT03074162|11303664|FG004|COMPLETED|Period 1 Including Washout 1||8
10173502|NCT03074162|11303665|FG005|COMPLETED|Period 1 Including Washout 1||8
10173503|NCT03074162|11303660|FG000|NOT COMPLETED|Period 1 Including Washout 1||0
10173504|NCT03074162|11303661|FG001|NOT COMPLETED|Period 1 Including Washout 1||0
10173505|NCT03074162|11303662|FG002|NOT COMPLETED|Period 1 Including Washout 1||1
10173506|NCT03074162|11303663|FG003|NOT COMPLETED|Period 1 Including Washout 1||0
10173507|NCT03074162|11303664|FG004|NOT COMPLETED|Period 1 Including Washout 1||0
10173508|NCT03074162|11303665|FG005|NOT COMPLETED|Period 1 Including Washout 1||0
10173509|NCT03074162|11303660|FG000|STARTED|Period 2 Including Washout 2||8
10173510|NCT03074162|11303661|FG001|STARTED|Period 2 Including Washout 2||8
10173511|NCT03074162|11303662|FG002|STARTED|Period 2 Including Washout 2||7
10173512|NCT03074162|11303663|FG003|STARTED|Period 2 Including Washout 2||8
10173513|NCT03074162|11303664|FG004|STARTED|Period 2 Including Washout 2||8
10173514|NCT03074162|11303665|FG005|STARTED|Period 2 Including Washout 2||8
10173515|NCT03074162|11303660|FG000|COMPLETED|Period 2 Including Washout 2||8
10173516|NCT03074162|11303661|FG001|COMPLETED|Period 2 Including Washout 2||8
10173517|NCT03074162|11303662|FG002|COMPLETED|Period 2 Including Washout 2||6
10173518|NCT03074162|11303663|FG003|COMPLETED|Period 2 Including Washout 2||8
10173519|NCT03074162|11303664|FG004|COMPLETED|Period 2 Including Washout 2||8
10173520|NCT03074162|11303665|FG005|COMPLETED|Period 2 Including Washout 2||7
10173521|NCT03074162|11303660|FG000|NOT COMPLETED|Period 2 Including Washout 2||0
10173522|NCT03074162|11303661|FG001|NOT COMPLETED|Period 2 Including Washout 2||0
10173523|NCT03074162|11303662|FG002|NOT COMPLETED|Period 2 Including Washout 2||1
10173524|NCT03074162|11303663|FG003|NOT COMPLETED|Period 2 Including Washout 2||0
10173525|NCT03074162|11303664|FG004|NOT COMPLETED|Period 2 Including Washout 2||0
10173526|NCT03074162|11303665|FG005|NOT COMPLETED|Period 2 Including Washout 2||1
10173527|NCT03074162|11303660|FG000|STARTED|Period 3||8
10173528|NCT03074162|11303661|FG001|STARTED|Period 3||8
10173529|NCT03074162|11303662|FG002|STARTED|Period 3||6
9849629|NCT00866619|10962374|FG002|COMPLETED|Overall Study||2085
9849630|NCT00866619|10962375|FG003|COMPLETED|Overall Study||1549
9849631|NCT00866619|10962372|FG000|NOT COMPLETED|Overall Study||1846
9849632|NCT00866619|10962373|FG001|NOT COMPLETED|Overall Study||1270
10173530|NCT03074162|11303663|FG003|STARTED|Period 3||8
10173531|NCT03074162|11303664|FG004|STARTED|Period 3||8
10173532|NCT03074162|11303665|FG005|STARTED|Period 3||7
10173533|NCT03074162|11303660|FG000|COMPLETED|Period 3||7
10173534|NCT03074162|11303661|FG001|COMPLETED|Period 3||8
10173535|NCT03074162|11303662|FG002|COMPLETED|Period 3||6
10173536|NCT03074162|11303663|FG003|COMPLETED|Period 3||8
10173537|NCT03074162|11303664|FG004|COMPLETED|Period 3||7
10173538|NCT03074162|11303665|FG005|COMPLETED|Period 3||7
10173539|NCT03074162|11303660|FG000|NOT COMPLETED|Period 3||1
10173540|NCT03074162|11303661|FG001|NOT COMPLETED|Period 3||0
10173541|NCT03074162|11303662|FG002|NOT COMPLETED|Period 3||0
10173542|NCT03074162|11303663|FG003|NOT COMPLETED|Period 3||0
10173543|NCT03074162|11303664|FG004|NOT COMPLETED|Period 3||1
10173544|NCT03074162|11303665|FG005|NOT COMPLETED|Period 3||0
10173545|NCT03074331|11303673|FG000|STARTED|Overall Study||130
10173546|NCT03074331|11303673|FG000|COMPLETED|Overall Study||123
10173547|NCT03074331|11303673|FG000|NOT COMPLETED|Overall Study||7
10173548|NCT03074409|11303679|FG000|STARTED|Overall Study||41
10173549|NCT03074409|11303680|FG001|STARTED|Overall Study||42
10173550|NCT03074409|11303679|FG000|COMPLETED|Overall Study||37
10173551|NCT03074409|11303680|FG001|COMPLETED|Overall Study||38
10173552|NCT03074409|11303679|FG000|NOT COMPLETED|Overall Study||4
10173553|NCT03074409|11303680|FG001|NOT COMPLETED|Overall Study||4
10173554|NCT03074500|11303689|FG000|STARTED|Overall Study||11
10173555|NCT03074500|11303690|FG001|STARTED|Overall Study||11
10173556|NCT03074500|11303691|FG002|STARTED|Overall Study||11
10173557|NCT03074500|11303689|FG000|COMPLETED|Overall Study||10
10173558|NCT03074500|11303690|FG001|COMPLETED|Overall Study||10
10173559|NCT03074500|11303691|FG002|COMPLETED|Overall Study||10
10173560|NCT03074500|11303689|FG000|NOT COMPLETED|Overall Study||1
10173561|NCT03074500|11303690|FG001|NOT COMPLETED|Overall Study||1
10173562|NCT03074500|11303691|FG002|NOT COMPLETED|Overall Study||1
10173563|NCT03074630|11303701|FG000|STARTED|Overall Study||12
10173564|NCT03074630|11303701|FG000|COMPLETED|Overall Study||11
10173565|NCT03074630|11303701|FG000|NOT COMPLETED|Overall Study||1
10173566|NCT03074682|11303709|FG000|STARTED|Overall Study||18
10173567|NCT03074682|11303710|FG001|STARTED|Overall Study||18
10173568|NCT03074682|11303711|FG002|STARTED|Overall Study||18
10173569|NCT03074682|11303709|FG000|COMPLETED|Overall Study||18
10173570|NCT03074682|11303710|FG001|COMPLETED|Overall Study||18
10173571|NCT03074682|11303711|FG002|COMPLETED|Overall Study||18
10173572|NCT03074682|11303709|FG000|NOT COMPLETED|Overall Study||0
10173573|NCT03074682|11303710|FG001|NOT COMPLETED|Overall Study||0
10173574|NCT03074682|11303711|FG002|NOT COMPLETED|Overall Study||0
10173575|NCT03075085|11303721|FG000|STARTED|Overall Study||352
10173576|NCT03075085|11303722|FG001|STARTED|Overall Study||344
10173577|NCT03075085|11303721|FG000|COMPLETED|Overall Study||247
10173578|NCT03075085|11303722|FG001|COMPLETED|Overall Study||232
10173579|NCT03075085|11303721|FG000|NOT COMPLETED|Overall Study||105
10173580|NCT03075085|11303722|FG001|NOT COMPLETED|Overall Study||112
10173581|NCT03075163|11303730|FG000|STARTED|Overall Study||150
10173582|NCT03075163|11303731|FG001|STARTED|Overall Study||150
10173583|NCT03075163|11303730|FG000|COMPLETED|Overall Study||12
10173584|NCT03075163|11303731|FG001|COMPLETED|Overall Study||12
10173585|NCT03075163|11303730|FG000|NOT COMPLETED|Overall Study||138
10173586|NCT03075163|11303731|FG001|NOT COMPLETED|Overall Study||138
10173587|NCT03075267|11303740|FG000|STARTED|Overall Study||32
10173588|NCT03075267|11303741|FG001|STARTED|Overall Study||32
10173589|NCT03075267|11303742|FG002|STARTED|Overall Study||32
10173590|NCT03075267|11303740|FG000|COMPLETED|Overall Study||31
10173591|NCT03075267|11303741|FG001|COMPLETED|Overall Study||32
10173592|NCT03075267|11303742|FG002|COMPLETED|Overall Study||32
10173593|NCT03075267|11303740|FG000|NOT COMPLETED|Overall Study||1
10173594|NCT03075267|11303741|FG001|NOT COMPLETED|Overall Study||0
10173595|NCT03075267|11303742|FG002|NOT COMPLETED|Overall Study||0
10173596|NCT03075410|11303759|FG000|STARTED|Part A-Period 1 (14 Days)||2
10173597|NCT03075410|11303760|FG001|STARTED|Part A-Period 1 (14 Days)||1
10173598|NCT03075410|11303761|FG002|STARTED|Part A-Period 1 (14 Days)||2
10173599|NCT03075410|11303762|FG003|STARTED|Part A-Period 1 (14 Days)||1
10173600|NCT03075410|11303763|FG004|STARTED|Part A-Period 1 (14 Days)||2
10173601|NCT03075410|11303764|FG005|STARTED|Part A-Period 1 (14 Days)||1
10173602|NCT03075410|11303765|FG006|STARTED|Part A-Period 1 (14 Days)||0
10173603|NCT03075410|11303766|FG007|STARTED|Part A-Period 1 (14 Days)||0
10173604|NCT03075410|11303767|FG008|STARTED|Part A-Period 1 (14 Days)||0
10173605|NCT03075410|11303759|FG000|COMPLETED|Part A-Period 1 (14 Days)||2
10173606|NCT03075410|11303760|FG001|COMPLETED|Part A-Period 1 (14 Days)||1
10173607|NCT03075410|11303761|FG002|COMPLETED|Part A-Period 1 (14 Days)||2
10173608|NCT03075410|11303762|FG003|COMPLETED|Part A-Period 1 (14 Days)||1
10173609|NCT03075410|11303763|FG004|COMPLETED|Part A-Period 1 (14 Days)||2
10173610|NCT03075410|11303764|FG005|COMPLETED|Part A-Period 1 (14 Days)||1
10173611|NCT03075410|11303765|FG006|COMPLETED|Part A-Period 1 (14 Days)||0
10173612|NCT03075410|11303766|FG007|COMPLETED|Part A-Period 1 (14 Days)||0
10173613|NCT03075410|11303767|FG008|COMPLETED|Part A-Period 1 (14 Days)||0
10173614|NCT03075410|11303759|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173615|NCT03075410|11303760|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173616|NCT03075410|11303761|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173617|NCT03075410|11303762|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173618|NCT03075410|11303763|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173619|NCT03075410|11303764|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173620|NCT03075410|11303765|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173621|NCT03075410|11303766|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173622|NCT03075410|11303767|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10173623|NCT03075410|11303759|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2
10173624|NCT03075410|11303760|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1
10173625|NCT03075410|11303761|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2
10173626|NCT03075410|11303762|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1
10173627|NCT03075410|11303763|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2
10173628|NCT03075410|11303764|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1
10173629|NCT03075410|11303765|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0
10173630|NCT03075410|11303766|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0
10173631|NCT03075410|11303767|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0
10173632|NCT03075410|11303759|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2
10173633|NCT03075410|11303760|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1
10173634|NCT03075410|11303761|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2
10173635|NCT03075410|11303762|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1
10173636|NCT03075410|11303763|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2
10173637|NCT03075410|11303764|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1
10173638|NCT03075410|11303765|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173639|NCT03075410|11303766|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173640|NCT03075410|11303767|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173641|NCT03075410|11303759|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173642|NCT03075410|11303760|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173643|NCT03075410|11303761|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173644|NCT03075410|11303762|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173645|NCT03075410|11303763|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173646|NCT03075410|11303764|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173647|NCT03075410|11303765|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173648|NCT03075410|11303766|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173649|NCT03075410|11303767|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10173650|NCT03075410|11303759|FG000|STARTED|Part A-Period 2 (14 Days)||2
10173651|NCT03075410|11303760|FG001|STARTED|Part A-Period 2 (14 Days)||1
10173652|NCT03075410|11303761|FG002|STARTED|Part A-Period 2 (14 Days)||2
10173653|NCT03075410|11303762|FG003|STARTED|Part A-Period 2 (14 Days)||1
10173654|NCT03075410|11303763|FG004|STARTED|Part A-Period 2 (14 Days)||2
10173655|NCT03075410|11303764|FG005|STARTED|Part A-Period 2 (14 Days)||1
10173656|NCT03075410|11303765|FG006|STARTED|Part A-Period 2 (14 Days)||0
10173657|NCT03075410|11303766|FG007|STARTED|Part A-Period 2 (14 Days)||0
10173658|NCT03075410|11303767|FG008|STARTED|Part A-Period 2 (14 Days)||0
10173659|NCT03075410|11303759|FG000|COMPLETED|Part A-Period 2 (14 Days)||1
10173660|NCT03075410|11303760|FG001|COMPLETED|Part A-Period 2 (14 Days)||1
10173661|NCT03075410|11303761|FG002|COMPLETED|Part A-Period 2 (14 Days)||1
10173662|NCT03075410|11303762|FG003|COMPLETED|Part A-Period 2 (14 Days)||1
10173663|NCT03075410|11303763|FG004|COMPLETED|Part A-Period 2 (14 Days)||2
10173664|NCT03075410|11303764|FG005|COMPLETED|Part A-Period 2 (14 Days)||1
10173665|NCT03075410|11303765|FG006|COMPLETED|Part A-Period 2 (14 Days)||0
10173666|NCT03075410|11303766|FG007|COMPLETED|Part A-Period 2 (14 Days)||0
10173667|NCT03075410|11303767|FG008|COMPLETED|Part A-Period 2 (14 Days)||0
10173668|NCT03075410|11303759|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1
10173669|NCT03075410|11303760|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10173670|NCT03075410|11303761|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1
10173671|NCT03075410|11303762|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10173672|NCT03075410|11303763|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10173673|NCT03075410|11303764|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10173674|NCT03075410|11303765|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10173675|NCT03075410|11303766|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10173676|NCT03075410|11303767|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10173677|NCT03075410|11303759|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1
10173678|NCT03075410|11303760|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1
10173679|NCT03075410|11303761|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1
10173680|NCT03075410|11303762|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1
10173681|NCT03075410|11303763|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2
10173682|NCT03075410|11303764|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1
10173683|NCT03075410|11303765|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0
10173684|NCT03075410|11303766|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0
10173685|NCT03075410|11303767|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0
10173686|NCT03075410|11303759|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10173687|NCT03075410|11303760|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10173688|NCT03075410|11303761|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10173689|NCT03075410|11303762|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10173690|NCT03075410|11303763|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2
10173691|NCT03075410|11303764|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10173692|NCT03075410|11303765|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173693|NCT03075410|11303766|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173694|NCT03075410|11303767|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173695|NCT03075410|11303759|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173696|NCT03075410|11303760|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173697|NCT03075410|11303761|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173698|NCT03075410|11303762|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173699|NCT03075410|11303763|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173700|NCT03075410|11303764|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173701|NCT03075410|11303765|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173702|NCT03075410|11303766|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173703|NCT03075410|11303767|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10173704|NCT03075410|11303759|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
10173705|NCT03075410|11303760|FG001|STARTED|Part A-Period 3 (14 Days)||1
10173706|NCT03075410|11303761|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
10173707|NCT03075410|11303762|FG003|STARTED|Part A-Period 3 (14 Days)||1
10173708|NCT03075410|11303763|FG004|STARTED|Part A-Period 3 (14 Days)||2
10173709|NCT03075410|11303764|FG005|STARTED|Part A-Period 3 (14 Days)||1
10173710|NCT03075410|11303765|FG006|STARTED|Part A-Period 3 (14 Days)||0
10173711|NCT03075410|11303766|FG007|STARTED|Part A-Period 3 (14 Days)||0
10173712|NCT03075410|11303767|FG008|STARTED|Part A-Period 3 (14 Days)||0
10173713|NCT03075410|11303759|FG000|COMPLETED|Part A-Period 3 (14 Days)||1
10173714|NCT03075410|11303760|FG001|COMPLETED|Part A-Period 3 (14 Days)||1
10173715|NCT03075410|11303761|FG002|COMPLETED|Part A-Period 3 (14 Days)||2
10173716|NCT03075410|11303762|FG003|COMPLETED|Part A-Period 3 (14 Days)||1
10173717|NCT03075410|11303763|FG004|COMPLETED|Part A-Period 3 (14 Days)||2
10173718|NCT03075410|11303764|FG005|COMPLETED|Part A-Period 3 (14 Days)||1
10173719|NCT03075410|11303765|FG006|COMPLETED|Part A-Period 3 (14 Days)||0
10173720|NCT03075410|11303766|FG007|COMPLETED|Part A-Period 3 (14 Days)||0
10173721|NCT03075410|11303767|FG008|COMPLETED|Part A-Period 3 (14 Days)||0
10173722|NCT03075410|11303759|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1
10173723|NCT03075410|11303760|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173724|NCT03075410|11303761|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173725|NCT03075410|11303762|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173726|NCT03075410|11303763|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173727|NCT03075410|11303764|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173728|NCT03075410|11303765|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173729|NCT03075410|11303766|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173730|NCT03075410|11303767|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10173731|NCT03075410|11303759|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1
10173732|NCT03075410|11303760|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1
10173733|NCT03075410|11303761|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2
10173734|NCT03075410|11303762|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1
10173735|NCT03075410|11303763|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2
10173736|NCT03075410|11303764|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1
10173737|NCT03075410|11303765|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0
10173738|NCT03075410|11303766|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0
10173739|NCT03075410|11303767|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0
10173740|NCT03075410|11303759|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10173741|NCT03075410|11303760|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10173742|NCT03075410|11303761|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2
10173743|NCT03075410|11303762|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10173744|NCT03075410|11303763|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2
10173745|NCT03075410|11303764|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10173746|NCT03075410|11303765|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173747|NCT03075410|11303766|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173748|NCT03075410|11303767|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173749|NCT03075410|11303759|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173750|NCT03075410|11303760|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173751|NCT03075410|11303761|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9712895|NCT01194219|10812169|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712896|NCT01194219|10812170|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712897|NCT01194219|10812171|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712898|NCT01194219|10812172|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712899|NCT01194219|10812173|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712900|NCT01194219|10812174|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0
9712901|NCT01194219|10812165|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
9712902|NCT01194219|10812166|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
9712903|NCT01194219|10812167|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
9712904|NCT01194219|10812168|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
9712905|NCT01194219|10812169|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
9712906|NCT01194219|10812170|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
9712907|NCT01194219|10812171|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
9712908|NCT01194219|10812172|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
9712909|NCT01194219|10812173|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
9712910|NCT01194219|10812174|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
9731051|NCT00129545|10830961|FG001|COMPLETED|Overall Study||299
10173752|NCT03075410|11303762|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173753|NCT03075410|11303763|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173754|NCT03075410|11303764|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173755|NCT03075410|11303765|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173756|NCT03075410|11303766|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173757|NCT03075410|11303767|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10173758|NCT03075410|11303759|FG000|STARTED|Part A-Period 4 (14 Days)||1
10173759|NCT03075410|11303760|FG001|STARTED|Part A-Period 4 (14 Days)||1
10173760|NCT03075410|11303761|FG002|STARTED|Part A-Period 4 (14 Days)||2
10173761|NCT03075410|11303762|FG003|STARTED|Part A-Period 4 (14 Days)||1
10173762|NCT03075410|11303763|FG004|STARTED|Part A-Period 4 (14 Days)||2
10173763|NCT03075410|11303764|FG005|STARTED|Part A-Period 4 (14 Days)||1
10173764|NCT03075410|11303765|FG006|STARTED|Part A-Period 4 (14 Days)||0
10173765|NCT03075410|11303766|FG007|STARTED|Part A-Period 4 (14 Days)||0
10173766|NCT03075410|11303767|FG008|STARTED|Part A-Period 4 (14 Days)||0
10173767|NCT03075410|11303759|FG000|COMPLETED|Part A-Period 4 (14 Days)||1
10173768|NCT03075410|11303760|FG001|COMPLETED|Part A-Period 4 (14 Days)||1
10173769|NCT03075410|11303761|FG002|COMPLETED|Part A-Period 4 (14 Days)||2
10173770|NCT03075410|11303762|FG003|COMPLETED|Part A-Period 4 (14 Days)||1
10173771|NCT03075410|11303763|FG004|COMPLETED|Part A-Period 4 (14 Days)||2
10173772|NCT03075410|11303764|FG005|COMPLETED|Part A-Period 4 (14 Days)||1
10173773|NCT03075410|11303765|FG006|COMPLETED|Part A-Period 4 (14 Days)||0
10173774|NCT03075410|11303766|FG007|COMPLETED|Part A-Period 4 (14 Days)||0
10173775|NCT03075410|11303767|FG008|COMPLETED|Part A-Period 4 (14 Days)||0
10173776|NCT03075410|11303759|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173777|NCT03075410|11303760|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173778|NCT03075410|11303761|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173779|NCT03075410|11303762|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173780|NCT03075410|11303763|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173781|NCT03075410|11303764|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173782|NCT03075410|11303765|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173783|NCT03075410|11303766|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173784|NCT03075410|11303767|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10173785|NCT03075410|11303759|FG000|STARTED|Part B (up to 28 Days)||0
10173786|NCT03075410|11303760|FG001|STARTED|Part B (up to 28 Days)||0
10173787|NCT03075410|11303761|FG002|STARTED|Part B (up to 28 Days)||0
10173788|NCT03075410|11303762|FG003|STARTED|Part B (up to 28 Days)||0
10173789|NCT03075410|11303763|FG004|STARTED|Part B (up to 28 Days)||0
10173790|NCT03075410|11303764|FG005|STARTED|Part B (up to 28 Days)||0
10173791|NCT03075410|11303765|FG006|STARTED|Part B (up to 28 Days)||4
10173792|NCT03075410|11303766|FG007|STARTED|Part B (up to 28 Days)||7
10173793|NCT03075410|11303767|FG008|STARTED|Part B (up to 28 Days)||8
10173794|NCT03075410|11303759|FG000|COMPLETED|Part B (up to 28 Days)||0
10173795|NCT03075410|11303760|FG001|COMPLETED|Part B (up to 28 Days)||0
10173796|NCT03075410|11303761|FG002|COMPLETED|Part B (up to 28 Days)||0
10173797|NCT03075410|11303762|FG003|COMPLETED|Part B (up to 28 Days)||0
10173798|NCT03075410|11303763|FG004|COMPLETED|Part B (up to 28 Days)||0
10173799|NCT03075410|11303764|FG005|COMPLETED|Part B (up to 28 Days)||0
10173800|NCT03075410|11303765|FG006|COMPLETED|Part B (up to 28 Days)||4
10173801|NCT03075410|11303766|FG007|COMPLETED|Part B (up to 28 Days)||7
10173802|NCT03075410|11303767|FG008|COMPLETED|Part B (up to 28 Days)||8
10173803|NCT03075410|11303759|FG000|NOT COMPLETED|Part B (up to 28 Days)||0
10173804|NCT03075410|11303760|FG001|NOT COMPLETED|Part B (up to 28 Days)||0
10173805|NCT03075410|11303761|FG002|NOT COMPLETED|Part B (up to 28 Days)||0
10173806|NCT03075410|11303762|FG003|NOT COMPLETED|Part B (up to 28 Days)||0
10173807|NCT03075410|11303763|FG004|NOT COMPLETED|Part B (up to 28 Days)||0
10173808|NCT03075410|11303764|FG005|NOT COMPLETED|Part B (up to 28 Days)||0
10173809|NCT03075410|11303765|FG006|NOT COMPLETED|Part B (up to 28 Days)||0
10173810|NCT03075410|11303766|FG007|NOT COMPLETED|Part B (up to 28 Days)||0
10173811|NCT03075410|11303767|FG008|NOT COMPLETED|Part B (up to 28 Days)||0
10173812|NCT03075449|11303791|FG000|STARTED|Overall Study||170
10173813|NCT03075449|11303791|FG000|COMPLETED|Overall Study||170
10173814|NCT03075449|11303791|FG000|NOT COMPLETED|Overall Study||0
10173815|NCT03075501|11303797|FG000|STARTED|Overall Study||89
10173816|NCT03075501|11303798|FG001|STARTED|Overall Study||44
10173817|NCT03075501|11303797|FG000|COMPLETED|Overall Study||74
10173818|NCT03075501|11303798|FG001|COMPLETED|Overall Study||35
10173819|NCT03075501|11303797|FG000|NOT COMPLETED|Overall Study||15
10173820|NCT03075501|11303798|FG001|NOT COMPLETED|Overall Study||9
10173821|NCT03075553|11303805|FG000|STARTED|Overall Study||12
10173822|NCT03075553|11303805|FG000|COMPLETED|Overall Study||12
10173823|NCT03075553|11303805|FG000|NOT COMPLETED|Overall Study||0
10173824|NCT03075644|11303811|FG000|STARTED|Overall Study||16
10173825|NCT03075644|11303812|FG001|STARTED|Overall Study||46
10173826|NCT03075644|11303811|FG000|Full Analysis Set (FAS)|Overall Study||16
10173827|NCT03075644|11303812|FG001|Full Analysis Set (FAS)|Overall Study||46
10173828|NCT03075644|11303811|FG000|Safety Analysis Set (SAS)|Overall Study||16
10173829|NCT03075644|11303812|FG001|Safety Analysis Set (SAS)|Overall Study||46
10173830|NCT03075644|11303811|FG000|COMPLETED|Overall Study||15
10173831|NCT03075644|11303812|FG001|COMPLETED|Overall Study||45
10173832|NCT03075644|11303811|FG000|NOT COMPLETED|Overall Study||1
10173833|NCT03075644|11303812|FG001|NOT COMPLETED|Overall Study||1
10173834|NCT03075761|11303821|FG000|STARTED|Overall Study||11
10173835|NCT03075761|11303822|FG001|STARTED|Overall Study||12
10173836|NCT03075761|11303821|FG000|COMPLETED|Overall Study||10
10173837|NCT03075761|11303822|FG001|COMPLETED|Overall Study||6
10173838|NCT03075761|11303821|FG000|NOT COMPLETED|Overall Study||1
9849633|NCT00866619|10962374|FG002|NOT COMPLETED|Overall Study||889
10173839|NCT03075761|11303822|FG001|NOT COMPLETED|Overall Study||6
10173840|NCT03075839|11303833|FG000|STARTED|Overall Study||33
10173841|NCT03075839|11303833|FG000|COMPLETED|Overall Study||29
10173842|NCT03075839|11303833|FG000|NOT COMPLETED|Overall Study||4
10173843|NCT03075878|11303837|FG000|STARTED|Overall Study||8
10173844|NCT03075878|11303837|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10173845|NCT03075878|11303837|FG000|COMPLETED|Overall Study||7
10173846|NCT03075878|11303837|FG000|NOT COMPLETED|Overall Study||1
10173847|NCT03075891|11303843|FG000|STARTED|Overall Study||135
10173848|NCT03075891|11303844|FG001|STARTED|Overall Study||138
10173849|NCT03075891|11303843|FG000|COMPLETED|Overall Study||126
10173850|NCT03075891|11303844|FG001|COMPLETED|Overall Study||125
10173851|NCT03075891|11303843|FG000|NOT COMPLETED|Overall Study||9
10173852|NCT03075891|11303844|FG001|NOT COMPLETED|Overall Study||13
10173853|NCT03075904|11303852|FG000|STARTED|Overall Study||8
10173854|NCT03075904|11303852|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10173855|NCT03075904|11303852|FG000|COMPLETED|Overall Study||4
10173856|NCT03075904|11303852|FG000|NOT COMPLETED|Overall Study||4
10173857|NCT03076190|11303858|FG000|STARTED|Overall Study||50
10173858|NCT03076190|11303859|FG001|STARTED|Overall Study||77
10173859|NCT03076190|11303858|FG000|COMPLETED|Overall Study||32
10173860|NCT03076190|11303859|FG001|COMPLETED|Overall Study||36
10173861|NCT03076190|11303858|FG000|NOT COMPLETED|Overall Study||18
9712911|NCT01194219|10812165|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712912|NCT01194219|10812166|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712913|NCT01194219|10812167|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712914|NCT01194219|10812168|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712915|NCT01194219|10812169|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712916|NCT01194219|10812170|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712917|NCT01194219|10812171|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
9712918|NCT01194219|10812172|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
9712919|NCT01194219|10812173|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712920|NCT01194219|10812174|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
9712921|NCT01194219|10812165|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712922|NCT01194219|10812166|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712923|NCT01194219|10812167|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712924|NCT01194219|10812168|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712925|NCT01194219|10812169|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
9712926|NCT01194219|10812170|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
9712927|NCT01194219|10812171|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
9712928|NCT01194219|10812172|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
9712929|NCT01194219|10812173|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712930|NCT01194219|10812174|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712931|NCT01194219|10812165|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712932|NCT01194219|10812166|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712933|NCT01194219|10812167|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712934|NCT01194219|10812168|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712935|NCT01194219|10812169|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
9712936|NCT01194219|10812170|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
9712937|NCT01194219|10812171|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
9712938|NCT01194219|10812172|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
9712939|NCT01194219|10812173|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712940|NCT01194219|10812174|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
9712941|NCT01194219|10812165|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0
9712942|NCT01194219|10812166|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0
9712943|NCT01194219|10812167|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0
9712944|NCT01194219|10812168|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0
9712945|NCT01194219|10812169|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0
9712946|NCT01194219|10812170|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0
9712947|NCT01194219|10812171|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0
9712948|NCT01194219|10812172|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0
9712949|NCT01194219|10812173|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306
9712950|NCT01194219|10812174|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153
9712951|NCT01194219|10812165|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9712952|NCT01194219|10812166|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9712953|NCT01194219|10812167|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9712954|NCT01194219|10812168|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9712955|NCT01194219|10812169|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9712956|NCT01194219|10812170|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9712957|NCT01194219|10812171|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9731052|NCT00129545|10830962|FG002|COMPLETED|Overall Study||133
10173862|NCT03076190|11303859|FG001|NOT COMPLETED|Overall Study||41
10173863|NCT03076333|11303868|FG000|STARTED|Overall Study||3
10173864|NCT03076333|11303868|FG000|COMPLETED|Overall Study||3
10173865|NCT03076333|11303868|FG000|NOT COMPLETED|Overall Study||0
10173866|NCT03076359|11303874|FG000|STARTED|Overall Study||170
10173867|NCT03076359|11303875|FG001|STARTED|Overall Study||150
10173868|NCT03076359|11303874|FG000|COMPLETED|Overall Study||170
10173869|NCT03076359|11303875|FG001|COMPLETED|Overall Study||150
10173870|NCT03076359|11303874|FG000|NOT COMPLETED|Overall Study||0
10173871|NCT03076359|11303875|FG001|NOT COMPLETED|Overall Study||0
10173872|NCT03076515|11303885|FG000|STARTED|Overall Study||58
10173873|NCT03076515|11303886|FG001|STARTED|Overall Study||62
10173874|NCT03076515|11303885|FG000|COMPLETED|Overall Study||33
10173875|NCT03076515|11303886|FG001|COMPLETED|Overall Study||33
10173876|NCT03076515|11303885|FG000|NOT COMPLETED|Overall Study||25
10173877|NCT03076515|11303886|FG001|NOT COMPLETED|Overall Study||29
10173878|NCT03076970|11303892|FG000|STARTED|Period 1||7
10173879|NCT03076970|11303893|FG001|STARTED|Period 1||7
10173880|NCT03076970|11303894|FG002|STARTED|Period 1||7
10173881|NCT03076970|11303895|FG003|STARTED|Period 1||7
10173882|NCT03076970|11303896|FG004|STARTED|Period 1||7
10173883|NCT03076970|11303897|FG005|STARTED|Period 1||7
10173884|NCT03076970|11303892|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
10173885|NCT03076970|11303893|FG001|Received at Least 1 Dose of Study Drug|Period 1||7
10173886|NCT03076970|11303894|FG002|Received at Least 1 Dose of Study Drug|Period 1||7
10173887|NCT03076970|11303895|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
10173888|NCT03076970|11303896|FG004|Received at Least 1 Dose of Study Drug|Period 1||7
9712958|NCT01194219|10812172|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
9712959|NCT01194219|10812173|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
9712960|NCT01194219|10812174|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
9712961|NCT01194219|10812165|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10173889|NCT03076970|11303897|FG005|Received at Least 1 Dose of Study Drug|Period 1||7
10173890|NCT03076970|11303892|FG000|COMPLETED|Period 1||7
10173891|NCT03076970|11303893|FG001|COMPLETED|Period 1||7
10173892|NCT03076970|11303894|FG002|COMPLETED|Period 1||7
10173893|NCT03076970|11303895|FG003|COMPLETED|Period 1||7
10173894|NCT03076970|11303896|FG004|COMPLETED|Period 1||7
10173895|NCT03076970|11303897|FG005|COMPLETED|Period 1||7
10173896|NCT03076970|11303892|FG000|NOT COMPLETED|Period 1||0
10173897|NCT03076970|11303893|FG001|NOT COMPLETED|Period 1||0
10173898|NCT03076970|11303894|FG002|NOT COMPLETED|Period 1||0
10173899|NCT03076970|11303895|FG003|NOT COMPLETED|Period 1||0
10173900|NCT03076970|11303896|FG004|NOT COMPLETED|Period 1||0
10173901|NCT03076970|11303897|FG005|NOT COMPLETED|Period 1||0
10173902|NCT03076970|11303892|FG000|STARTED|Washout Period 1||7
10173903|NCT03076970|11303893|FG001|STARTED|Washout Period 1||7
10173904|NCT03076970|11303894|FG002|STARTED|Washout Period 1||7
10173905|NCT03076970|11303895|FG003|STARTED|Washout Period 1||7
10173906|NCT03076970|11303896|FG004|STARTED|Washout Period 1||7
10173907|NCT03076970|11303897|FG005|STARTED|Washout Period 1||7
10173908|NCT03076970|11303892|FG000|COMPLETED|Washout Period 1||7
10173909|NCT03076970|11303893|FG001|COMPLETED|Washout Period 1||7
10173910|NCT03076970|11303894|FG002|COMPLETED|Washout Period 1||7
10173911|NCT03076970|11303895|FG003|COMPLETED|Washout Period 1||7
10173912|NCT03076970|11303896|FG004|COMPLETED|Washout Period 1||7
10173913|NCT03076970|11303897|FG005|COMPLETED|Washout Period 1||7
10173914|NCT03076970|11303892|FG000|NOT COMPLETED|Washout Period 1||0
10173915|NCT03076970|11303893|FG001|NOT COMPLETED|Washout Period 1||0
10173916|NCT03076970|11303894|FG002|NOT COMPLETED|Washout Period 1||0
10173917|NCT03076970|11303895|FG003|NOT COMPLETED|Washout Period 1||0
10173918|NCT03076970|11303896|FG004|NOT COMPLETED|Washout Period 1||0
10173919|NCT03076970|11303897|FG005|NOT COMPLETED|Washout Period 1||0
10173920|NCT03076970|11303892|FG000|STARTED|Period 2||7
10173921|NCT03076970|11303893|FG001|STARTED|Period 2||7
10173922|NCT03076970|11303894|FG002|STARTED|Period 2||7
10173923|NCT03076970|11303895|FG003|STARTED|Period 2||7
10173924|NCT03076970|11303896|FG004|STARTED|Period 2||7
10173925|NCT03076970|11303897|FG005|STARTED|Period 2||7
10173926|NCT03076970|11303892|FG000|COMPLETED|Period 2||7
10173927|NCT03076970|11303893|FG001|COMPLETED|Period 2||7
10173928|NCT03076970|11303894|FG002|COMPLETED|Period 2||7
10173929|NCT03076970|11303895|FG003|COMPLETED|Period 2||7
10173930|NCT03076970|11303896|FG004|COMPLETED|Period 2||7
10173931|NCT03076970|11303897|FG005|COMPLETED|Period 2||7
10173932|NCT03076970|11303892|FG000|NOT COMPLETED|Period 2||0
10173933|NCT03076970|11303893|FG001|NOT COMPLETED|Period 2||0
10173934|NCT03076970|11303894|FG002|NOT COMPLETED|Period 2||0
10173935|NCT03076970|11303895|FG003|NOT COMPLETED|Period 2||0
10173936|NCT03076970|11303896|FG004|NOT COMPLETED|Period 2||0
10173937|NCT03076970|11303897|FG005|NOT COMPLETED|Period 2||0
10173938|NCT03076970|11303892|FG000|STARTED|Washout Period 2||7
10173939|NCT03076970|11303893|FG001|STARTED|Washout Period 2||7
10173940|NCT03076970|11303894|FG002|STARTED|Washout Period 2||7
10173941|NCT03076970|11303895|FG003|STARTED|Washout Period 2||7
10173942|NCT03076970|11303896|FG004|STARTED|Washout Period 2||7
10173943|NCT03076970|11303897|FG005|STARTED|Washout Period 2||7
10173944|NCT03076970|11303892|FG000|COMPLETED|Washout Period 2||7
10173945|NCT03076970|11303893|FG001|COMPLETED|Washout Period 2||7
10173946|NCT03076970|11303894|FG002|COMPLETED|Washout Period 2||7
10173947|NCT03076970|11303895|FG003|COMPLETED|Washout Period 2||7
10173948|NCT03076970|11303896|FG004|COMPLETED|Washout Period 2||6
10173949|NCT03076970|11303897|FG005|COMPLETED|Washout Period 2||7
10173950|NCT03076970|11303892|FG000|NOT COMPLETED|Washout Period 2||0
10173951|NCT03076970|11303893|FG001|NOT COMPLETED|Washout Period 2||0
10173952|NCT03076970|11303894|FG002|NOT COMPLETED|Washout Period 2||0
10173953|NCT03076970|11303895|FG003|NOT COMPLETED|Washout Period 2||0
10173954|NCT03076970|11303896|FG004|NOT COMPLETED|Washout Period 2||1
10173955|NCT03076970|11303897|FG005|NOT COMPLETED|Washout Period 2||0
10173956|NCT03076970|11303892|FG000|STARTED|Period 3||7
9712962|NCT01194219|10812166|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712963|NCT01194219|10812167|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712964|NCT01194219|10812168|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712965|NCT01194219|10812169|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712966|NCT01194219|10812170|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712967|NCT01194219|10812171|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712968|NCT01194219|10812172|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712969|NCT01194219|10812173|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86
9712970|NCT01194219|10812174|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41
9712971|NCT01194219|10812165|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712972|NCT01194219|10812166|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712973|NCT01194219|10812167|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712974|NCT01194219|10812168|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712975|NCT01194219|10812169|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712976|NCT01194219|10812170|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712977|NCT01194219|10812171|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712978|NCT01194219|10812172|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
9712979|NCT01194219|10812173|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
9712980|NCT01194219|10812174|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
9712981|NCT01193842|10812202|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
9712982|NCT01193842|10812203|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712983|NCT01193842|10812204|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712984|NCT01193842|10812205|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712985|NCT01193842|10812206|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712986|NCT01193842|10812202|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
9712987|NCT01193842|10812203|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712988|NCT01193842|10812204|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712989|NCT01193842|10812205|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712990|NCT01193842|10812206|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712991|NCT01193842|10812202|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712992|NCT01193842|10812203|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712993|NCT01193842|10812204|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712994|NCT01193842|10812205|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712995|NCT01193842|10812206|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
9712996|NCT01193842|10812202|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
9712997|NCT01193842|10812203|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
9712998|NCT01193842|10812204|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
9712999|NCT01193842|10812205|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
9713000|NCT01193842|10812206|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
9713001|NCT01193842|10812202|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9713002|NCT01193842|10812203|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
9713003|NCT01193842|10812204|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9849634|NCT00866619|10962375|FG003|NOT COMPLETED|Overall Study||630
9849635|NCT00866658|10962412|FG000|STARTED|Overall Study|Randomized.|157
9849636|NCT00866658|10962413|FG001|STARTED|Overall Study||154
9849637|NCT00866658|10962412|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
9849638|NCT00866658|10962413|FG001|Safety Population|Overall Study||154
9849639|NCT00866658|10962412|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
9849640|NCT00866658|10962413|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154
9849641|NCT00866658|10962412|FG000|COMPLETED|Overall Study||144
9849642|NCT00866658|10962413|FG001|COMPLETED|Overall Study||133
9849643|NCT00866658|10962412|FG000|NOT COMPLETED|Overall Study||13
9849644|NCT00866658|10962413|FG001|NOT COMPLETED|Overall Study||21
9849645|NCT00866697|10962421|FG000|STARTED|Overall Study||468
9849646|NCT00866697|10962422|FG001|STARTED|Overall Study||472
9849647|NCT00866697|10962421|FG000|COMPLETED|Overall Study||254
9849648|NCT00866697|10962422|FG001|COMPLETED|Overall Study||244
9849649|NCT00866697|10962421|FG000|NOT COMPLETED|Overall Study||214
9849650|NCT00866697|10962422|FG001|NOT COMPLETED|Overall Study||228
9849651|NCT00866723|10962428|FG000|STARTED|Overall Study||5
9849652|NCT00866723|10962428|FG000|COMPLETED|Overall Study||0
9849653|NCT00866723|10962428|FG000|NOT COMPLETED|Overall Study||5
9849654|NCT00866749|10962432|FG000|STARTED|Overall Study||120
9849655|NCT00866749|10962432|FG000|COMPLETED|Overall Study||120
9849656|NCT00866749|10962432|FG000|NOT COMPLETED|Overall Study||0
9849657|NCT00866775|10962438|FG000|STARTED|Overall Study||65
9849658|NCT00866775|10962439|FG001|STARTED|Overall Study||128
9849659|NCT00866775|10962438|FG000|COMPLETED|Overall Study||29
9849660|NCT00866775|10962439|FG001|COMPLETED|Overall Study||76
9849661|NCT00866775|10962438|FG000|NOT COMPLETED|Overall Study||36
9849662|NCT00866775|10962439|FG001|NOT COMPLETED|Overall Study||52
9849663|NCT00866788|10962451|FG000|STARTED|Overall Study||21
9849664|NCT00866788|10962452|FG001|STARTED|Overall Study||23
9849665|NCT00866788|10962453|FG002|STARTED|Overall Study||25
9849666|NCT00866788|10962454|FG003|STARTED|Overall Study||21
10173957|NCT03076970|11303893|FG001|STARTED|Period 3||7
10173958|NCT03076970|11303894|FG002|STARTED|Period 3||7
10173959|NCT03076970|11303895|FG003|STARTED|Period 3||7
10173960|NCT03076970|11303896|FG004|STARTED|Period 3||6
10173961|NCT03076970|11303897|FG005|STARTED|Period 3||7
10173962|NCT03076970|11303892|FG000|COMPLETED|Period 3||7
10173963|NCT03076970|11303893|FG001|COMPLETED|Period 3||7
10173964|NCT03076970|11303894|FG002|COMPLETED|Period 3||7
10173965|NCT03076970|11303895|FG003|COMPLETED|Period 3||7
10173966|NCT03076970|11303896|FG004|COMPLETED|Period 3||5
10173967|NCT03076970|11303897|FG005|COMPLETED|Period 3||6
10173968|NCT03076970|11303892|FG000|NOT COMPLETED|Period 3||0
10173969|NCT03076970|11303893|FG001|NOT COMPLETED|Period 3||0
10173970|NCT03076970|11303894|FG002|NOT COMPLETED|Period 3||0
10173971|NCT03076970|11303895|FG003|NOT COMPLETED|Period 3||0
10173972|NCT03076970|11303896|FG004|NOT COMPLETED|Period 3||1
10173973|NCT03076970|11303897|FG005|NOT COMPLETED|Period 3||1
10173974|NCT03076970|11303892|FG000|STARTED|Washout Period 3||7
10173975|NCT03076970|11303893|FG001|STARTED|Washout Period 3||7
10173976|NCT03076970|11303894|FG002|STARTED|Washout Period 3||7
10173977|NCT03076970|11303895|FG003|STARTED|Washout Period 3||7
10173978|NCT03076970|11303896|FG004|STARTED|Washout Period 3||5
10173979|NCT03076970|11303897|FG005|STARTED|Washout Period 3||6
10173980|NCT03076970|11303892|FG000|COMPLETED|Washout Period 3||7
10173981|NCT03076970|11303893|FG001|COMPLETED|Washout Period 3||7
10173982|NCT03076970|11303894|FG002|COMPLETED|Washout Period 3||7
10173983|NCT03076970|11303895|FG003|COMPLETED|Washout Period 3||7
10173984|NCT03076970|11303896|FG004|COMPLETED|Washout Period 3||5
10173985|NCT03076970|11303897|FG005|COMPLETED|Washout Period 3||6
10173986|NCT03076970|11303892|FG000|NOT COMPLETED|Washout Period 3||0
10173987|NCT03076970|11303893|FG001|NOT COMPLETED|Washout Period 3||0
10173988|NCT03076970|11303894|FG002|NOT COMPLETED|Washout Period 3||0
10173989|NCT03076970|11303895|FG003|NOT COMPLETED|Washout Period 3||0
10173990|NCT03076970|11303896|FG004|NOT COMPLETED|Washout Period 3||0
10173991|NCT03076970|11303897|FG005|NOT COMPLETED|Washout Period 3||0
10173992|NCT03076983|11303910|FG000|STARTED|Overall Study||55
10173993|NCT03076983|11303911|FG001|STARTED|Overall Study||25
10173994|NCT03076983|11303910|FG000|COMPLETED|Overall Study||55
10173995|NCT03076983|11303911|FG001|COMPLETED|Overall Study||25
10173996|NCT03076983|11303910|FG000|NOT COMPLETED|Overall Study||0
9713004|NCT01193842|10812205|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9713005|NCT01193842|10812206|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9713006|NCT01193842|10812202|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9713007|NCT01193842|10812203|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
9713008|NCT01193842|10812204|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9713009|NCT01193842|10812205|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9713010|NCT01193842|10812206|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
9713011|NCT01193842|10812202|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
9713012|NCT01193842|10812203|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713013|NCT01193842|10812204|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713014|NCT01193842|10812205|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713015|NCT01193842|10812206|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713016|NCT01193842|10812202|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
9713017|NCT01193842|10812203|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713018|NCT01193842|10812204|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713019|NCT01193842|10812205|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713020|NCT01193842|10812206|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713021|NCT01193842|10812202|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
9713022|NCT01193842|10812203|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713023|NCT01193842|10812204|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713024|NCT01193842|10812205|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713025|NCT01193842|10812206|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
9713026|NCT01193842|10812202|FG000|STARTED|Phase I: VR-CHOP, DL 1||0
9713027|NCT01193842|10812203|FG001|STARTED|Phase I: VR-CHOP, DL 1||0
9713028|NCT01193842|10812204|FG002|STARTED|Phase I: VR-CHOP, DL 1||2
9713029|NCT01193842|10812205|FG003|STARTED|Phase I: VR-CHOP, DL 1||0
9849667|NCT00866788|10962451|FG000|COMPLETED|Overall Study||15
9849668|NCT00866788|10962452|FG001|COMPLETED|Overall Study||17
9849669|NCT00866788|10962453|FG002|COMPLETED|Overall Study||23
9849670|NCT00866788|10962454|FG003|COMPLETED|Overall Study||16
10173997|NCT03076983|11303911|FG001|NOT COMPLETED|Overall Study||0
9713030|NCT01193842|10812206|FG004|STARTED|Phase I: VR-CHOP, DL 1||0
9849671|NCT00866788|10962451|FG000|NOT COMPLETED|Overall Study||6
9849672|NCT00866788|10962452|FG001|NOT COMPLETED|Overall Study||6
9849673|NCT00866788|10962453|FG002|NOT COMPLETED|Overall Study||2
10173998|NCT03076996|11303917|FG000|STARTED|Overall Study||41
10173999|NCT03076996|11303917|FG000|COMPLETED|Overall Study||35
10174000|NCT03076996|11303917|FG000|NOT COMPLETED|Overall Study||6
10174001|NCT03077165|11303927|FG000|STARTED|Overall Study||21
10174002|NCT03077165|11303928|FG001|STARTED|Overall Study||22
10174003|NCT03077165|11303929|FG002|STARTED|Overall Study||20
10174004|NCT03077165|11303930|FG003|STARTED|Overall Study||19
10174005|NCT03077165|11303931|FG004|STARTED|Overall Study||19
10174006|NCT03077165|11303932|FG005|STARTED|Overall Study||20
10174007|NCT03077165|11303927|FG000|COMPLETED|Overall Study||20
10174008|NCT03077165|11303928|FG001|COMPLETED|Overall Study||22
10174009|NCT03077165|11303929|FG002|COMPLETED|Overall Study||20
10174010|NCT03077165|11303930|FG003|COMPLETED|Overall Study||19
10174011|NCT03077165|11303931|FG004|COMPLETED|Overall Study||16
10174012|NCT03077165|11303932|FG005|COMPLETED|Overall Study||20
10174013|NCT03077165|11303927|FG000|NOT COMPLETED|Overall Study||1
10174014|NCT03077165|11303928|FG001|NOT COMPLETED|Overall Study||0
10174015|NCT03077165|11303929|FG002|NOT COMPLETED|Overall Study||0
10174016|NCT03077165|11303930|FG003|NOT COMPLETED|Overall Study||0
10174017|NCT03077165|11303931|FG004|NOT COMPLETED|Overall Study||3
10174018|NCT03077165|11303932|FG005|NOT COMPLETED|Overall Study||0
10174019|NCT03077607|11303948|FG000|STARTED|Period 1 (15 Days)||19
10174020|NCT03077607|11303949|FG001|STARTED|Period 1 (15 Days)||17
10174021|NCT03077607|11303948|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19
10174022|NCT03077607|11303949|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17
10174023|NCT03077607|11303948|FG000|Received Talazoparib|Period 1 (15 Days)||19
10174024|NCT03077607|11303949|FG001|Received Talazoparib|Period 1 (15 Days)||17
9713031|NCT01193842|10812202|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0
9713032|NCT01193842|10812203|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0
9713033|NCT01193842|10812204|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1
9713034|NCT01193842|10812205|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0
9713035|NCT01193842|10812206|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0
10174025|NCT03077607|11303948|FG000|COMPLETED|Period 1 (15 Days)||17
10174026|NCT03077607|11303949|FG001|COMPLETED|Period 1 (15 Days)||17
10174027|NCT03077607|11303948|FG000|NOT COMPLETED|Period 1 (15 Days)||2
10174028|NCT03077607|11303949|FG001|NOT COMPLETED|Period 1 (15 Days)||0
10174029|NCT03077607|11303948|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10174030|NCT03077607|11303949|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10174031|NCT03077607|11303948|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10174032|NCT03077607|11303949|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10174033|NCT03077607|11303948|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
10174034|NCT03077607|11303949|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
10174035|NCT03077607|11303948|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
10174036|NCT03077607|11303949|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
10174037|NCT03077607|11303948|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
10174038|NCT03077607|11303949|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
10174039|NCT03077646|11303969|FG000|STARTED|Overall Study||76
10174040|NCT03077646|11303970|FG001|STARTED|Overall Study||75
10174041|NCT03077646|11303971|FG002|STARTED|Overall Study||74
10174042|NCT03077646|11303969|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
10174043|NCT03077646|11303970|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
10174044|NCT03077646|11303971|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
10174045|NCT03077646|11303969|FG000|NOT COMPLETED|Overall Study||29
10174046|NCT03077646|11303970|FG001|NOT COMPLETED|Overall Study||30
10174047|NCT03077646|11303971|FG002|NOT COMPLETED|Overall Study||31
10174048|NCT03077659|11303982|FG000|STARTED|Overall Study||3
10174049|NCT03077659|11303983|FG001|STARTED|Overall Study||3
10174050|NCT03077659|11303984|FG002|STARTED|Overall Study||10
10174051|NCT03077659|11303982|FG000|COMPLETED|Overall Study||3
10174052|NCT03077659|11303983|FG001|COMPLETED|Overall Study||3
10174053|NCT03077659|11303984|FG002|COMPLETED|Overall Study||9
10174054|NCT03077659|11303982|FG000|NOT COMPLETED|Overall Study||0
10174055|NCT03077659|11303983|FG001|NOT COMPLETED|Overall Study||0
10174056|NCT03077659|11303984|FG002|NOT COMPLETED|Overall Study||1
10174057|NCT03077711|11303997|FG000|STARTED|Overall Study||47
10174058|NCT03077711|11303998|FG001|STARTED|Overall Study||45
10174059|NCT03077711|11303997|FG000|COMPLETED|Overall Study||43
10174060|NCT03077711|11303998|FG001|COMPLETED|Overall Study||43
10174061|NCT03077711|11303997|FG000|NOT COMPLETED|Overall Study||4
10174062|NCT03077711|11303998|FG001|NOT COMPLETED|Overall Study||2
10174063|NCT03077724|11304008|FG000|STARTED|Overall Study||14
10174064|NCT03077724|11304009|FG001|STARTED|Overall Study||14
10174065|NCT03077724|11304008|FG000|COMPLETED|Overall Study||6
10174066|NCT03077724|11304009|FG001|COMPLETED|Overall Study||12
10174067|NCT03077724|11304008|FG000|NOT COMPLETED|Overall Study||8
10174068|NCT03077724|11304009|FG001|NOT COMPLETED|Overall Study||2
10174069|NCT03077893|11304017|FG000|STARTED|Overall Study||18
10174070|NCT03077893|11304018|FG001|STARTED|Overall Study||19
10174071|NCT03077893|11304017|FG000|COMPLETED|Overall Study||14
10174072|NCT03077893|11304018|FG001|COMPLETED|Overall Study||16
10174073|NCT03077893|11304017|FG000|NOT COMPLETED|Overall Study||4
10174074|NCT03077893|11304018|FG001|NOT COMPLETED|Overall Study||3
10174075|NCT03077919|11304027|FG000|STARTED|Overall Study||74
10174076|NCT03077919|11304028|FG001|STARTED|Overall Study||39
10174077|NCT03077919|11304027|FG000|Week 2 Visit|Overall Study||74
10174078|NCT03077919|11304028|FG001|Week 2 Visit|Overall Study||39
10174079|NCT03077919|11304027|FG000|Week 4 Visit|Overall Study||73
10174080|NCT03077919|11304028|FG001|Week 4 Visit|Overall Study||38
10174081|NCT03077919|11304027|FG000|Week 6 Visit|Overall Study||73
10174082|NCT03077919|11304028|FG001|Week 6 Visit|Overall Study||38
10174083|NCT03077919|11304027|FG000|Week 8 Visit|Overall Study||71
10174084|NCT03077919|11304028|FG001|Week 8 Visit|Overall Study||38
10174085|NCT03077919|11304027|FG000|Final CAPS|Overall Study||70
10174086|NCT03077919|11304028|FG001|Final CAPS|Overall Study||38
10174087|NCT03077919|11304027|FG000|COMPLETED|Overall Study||70
10174088|NCT03077919|11304028|FG001|COMPLETED|Overall Study||38
10174089|NCT03077919|11304027|FG000|NOT COMPLETED|Overall Study||4
10174090|NCT03077919|11304028|FG001|NOT COMPLETED|Overall Study||1
10174091|NCT03078075|11304036|FG000|STARTED|Overall Study||111
10174092|NCT03078075|11304037|FG001|STARTED|Overall Study||114
10174093|NCT03078075|11304038|FG002|STARTED|Overall Study||59
10174094|NCT03078075|11304039|FG003|STARTED|Overall Study||10
10174095|NCT03078075|11304040|FG004|STARTED|Overall Study||109
10174096|NCT03078075|11304036|FG000|COMPLETED|Overall Study||106
10174097|NCT03078075|11304037|FG001|COMPLETED|Overall Study||103
10174098|NCT03078075|11304038|FG002|COMPLETED|Overall Study||19
10174099|NCT03078075|11304039|FG003|COMPLETED|Overall Study||9
10174100|NCT03078075|11304040|FG004|COMPLETED|Overall Study||78
10174101|NCT03078075|11304036|FG000|NOT COMPLETED|Overall Study||5
10174102|NCT03078075|11304037|FG001|NOT COMPLETED|Overall Study||11
10174103|NCT03078075|11304038|FG002|NOT COMPLETED|Overall Study||40
10174104|NCT03078075|11304039|FG003|NOT COMPLETED|Overall Study||1
10174105|NCT03078075|11304040|FG004|NOT COMPLETED|Overall Study||31
10174106|NCT03078127|11304066|FG000|STARTED|First Intervention||4
10174107|NCT03078127|11304067|FG001|STARTED|First Intervention||3
10174108|NCT03078127|11304068|FG002|STARTED|First Intervention||3
10174109|NCT03078127|11304066|FG000|COMPLETED|First Intervention||4
10174110|NCT03078127|11304067|FG001|COMPLETED|First Intervention||3
10174111|NCT03078127|11304068|FG002|COMPLETED|First Intervention||3
10174112|NCT03078127|11304066|FG000|NOT COMPLETED|First Intervention||0
10174113|NCT03078127|11304067|FG001|NOT COMPLETED|First Intervention||0
10174114|NCT03078127|11304068|FG002|NOT COMPLETED|First Intervention||0
10174115|NCT03078127|11304066|FG000|STARTED|Washout (3-21 Days)||4
10174116|NCT03078127|11304067|FG001|STARTED|Washout (3-21 Days)||3
10174117|NCT03078127|11304068|FG002|STARTED|Washout (3-21 Days)||3
10174118|NCT03078127|11304066|FG000|COMPLETED|Washout (3-21 Days)||4
10174119|NCT03078127|11304067|FG001|COMPLETED|Washout (3-21 Days)||3
10174120|NCT03078127|11304068|FG002|COMPLETED|Washout (3-21 Days)||3
10174121|NCT03078127|11304066|FG000|NOT COMPLETED|Washout (3-21 Days)||0
10174122|NCT03078127|11304067|FG001|NOT COMPLETED|Washout (3-21 Days)||0
10174123|NCT03078127|11304068|FG002|NOT COMPLETED|Washout (3-21 Days)||0
10174124|NCT03078127|11304066|FG000|STARTED|Second Intervention||4
10174125|NCT03078127|11304067|FG001|STARTED|Second Intervention||3
10174126|NCT03078127|11304068|FG002|STARTED|Second Intervention||3
10174127|NCT03078127|11304066|FG000|COMPLETED|Second Intervention||4
10174128|NCT03078127|11304067|FG001|COMPLETED|Second Intervention||3
10174129|NCT03078127|11304068|FG002|COMPLETED|Second Intervention||3
10174130|NCT03078127|11304066|FG000|NOT COMPLETED|Second Intervention||0
10174131|NCT03078127|11304067|FG001|NOT COMPLETED|Second Intervention||0
10174132|NCT03078127|11304068|FG002|NOT COMPLETED|Second Intervention||0
10174133|NCT03078127|11304066|FG000|STARTED|Washout (3-21 Days)||4
10174134|NCT03078127|11304067|FG001|STARTED|Washout (3-21 Days)||3
10174135|NCT03078127|11304068|FG002|STARTED|Washout (3-21 Days)||3
10174136|NCT03078127|11304066|FG000|COMPLETED|Washout (3-21 Days)||4
10174137|NCT03078127|11304067|FG001|COMPLETED|Washout (3-21 Days)||3
10174138|NCT03078127|11304068|FG002|COMPLETED|Washout (3-21 Days)||3
10174139|NCT03078127|11304066|FG000|NOT COMPLETED|Washout (3-21 Days)||0
10174140|NCT03078127|11304067|FG001|NOT COMPLETED|Washout (3-21 Days)||0
10174141|NCT03078127|11304068|FG002|NOT COMPLETED|Washout (3-21 Days)||0
10174142|NCT03078127|11304066|FG000|STARTED|Third Intervention||4
10174143|NCT03078127|11304067|FG001|STARTED|Third Intervention||3
10174144|NCT03078127|11304068|FG002|STARTED|Third Intervention||3
10174145|NCT03078127|11304066|FG000|COMPLETED|Third Intervention||4
10174146|NCT03078127|11304067|FG001|COMPLETED|Third Intervention||3
10174147|NCT03078127|11304068|FG002|COMPLETED|Third Intervention||3
10174148|NCT03078127|11304066|FG000|NOT COMPLETED|Third Intervention||0
10174149|NCT03078127|11304067|FG001|NOT COMPLETED|Third Intervention||0
10174150|NCT03078127|11304068|FG002|NOT COMPLETED|Third Intervention||0
10174151|NCT03078504|11304079|FG000|STARTED|Overall Study||6
10174152|NCT03078504|11304079|FG000|COMPLETED|Overall Study||6
10174153|NCT03078504|11304079|FG000|NOT COMPLETED|Overall Study||0
10174154|NCT03078556|11304085|FG000|STARTED|Treatment Period 1 (4 Days)||39
10174155|NCT03078556|11304086|FG001|STARTED|Treatment Period 1 (4 Days)||39
10174156|NCT03078556|11304087|FG002|STARTED|Treatment Period 1 (4 Days)||38
10174157|NCT03078556|11304088|FG003|STARTED|Treatment Period 1 (4 Days)||38
10174158|NCT03078556|11304085|FG000|COMPLETED|Treatment Period 1 (4 Days)||39
10174159|NCT03078556|11304086|FG001|COMPLETED|Treatment Period 1 (4 Days)||38
10174160|NCT03078556|11304087|FG002|COMPLETED|Treatment Period 1 (4 Days)||38
10174161|NCT03078556|11304088|FG003|COMPLETED|Treatment Period 1 (4 Days)||38
10174162|NCT03078556|11304085|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10174163|NCT03078556|11304086|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
10174164|NCT03078556|11304087|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10174165|NCT03078556|11304088|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10174166|NCT03078556|11304085|FG000|STARTED|Washout Period 1 (7 Days)||39
10174167|NCT03078556|11304086|FG001|STARTED|Washout Period 1 (7 Days)||38
10174168|NCT03078556|11304087|FG002|STARTED|Washout Period 1 (7 Days)||38
10174169|NCT03078556|11304088|FG003|STARTED|Washout Period 1 (7 Days)||38
10174170|NCT03078556|11304085|FG000|COMPLETED|Washout Period 1 (7 Days)||37
10174171|NCT03078556|11304086|FG001|COMPLETED|Washout Period 1 (7 Days)||36
10174172|NCT03078556|11304087|FG002|COMPLETED|Washout Period 1 (7 Days)||37
10174173|NCT03078556|11304088|FG003|COMPLETED|Washout Period 1 (7 Days)||37
10174174|NCT03078556|11304085|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2
10174175|NCT03078556|11304086|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2
10174176|NCT03078556|11304087|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
10174177|NCT03078556|11304088|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
9713036|NCT01193842|10812202|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
9713037|NCT01193842|10812203|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
9713038|NCT01193842|10812204|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
9713039|NCT01193842|10812205|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
9713040|NCT01193842|10812206|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
9713041|NCT01193842|10812202|FG000|STARTED|Phase II: Randomized Groups||0
9713042|NCT01193842|10812203|FG001|STARTED|Phase II: Randomized Groups||0
9713043|NCT01193842|10812204|FG002|STARTED|Phase II: Randomized Groups||0
9713044|NCT01193842|10812205|FG003|STARTED|Phase II: Randomized Groups||45
9713045|NCT01193842|10812206|FG004|STARTED|Phase II: Randomized Groups||46
9713046|NCT01193842|10812202|FG000|COMPLETED|Phase II: Randomized Groups||0
9713047|NCT01193842|10812203|FG001|COMPLETED|Phase II: Randomized Groups||0
9713048|NCT01193842|10812204|FG002|COMPLETED|Phase II: Randomized Groups||0
9713049|NCT01193842|10812205|FG003|COMPLETED|Phase II: Randomized Groups||33
9713050|NCT01193842|10812206|FG004|COMPLETED|Phase II: Randomized Groups||36
9713051|NCT01193842|10812202|FG000|NOT COMPLETED|Phase II: Randomized Groups||0
9713052|NCT01193842|10812203|FG001|NOT COMPLETED|Phase II: Randomized Groups||0
9713053|NCT01193842|10812204|FG002|NOT COMPLETED|Phase II: Randomized Groups||0
9713054|NCT01193842|10812205|FG003|NOT COMPLETED|Phase II: Randomized Groups||12
9713055|NCT01193842|10812206|FG004|NOT COMPLETED|Phase II: Randomized Groups||10
9713056|NCT00855803|10812223|FG000|STARTED|Overall Study||35
10061556|NCT02104830|11187136|FG002|NOT COMPLETED|Overall Study||7
10061557|NCT02104895|11187146|FG000|STARTED|Overall Study||260
10061558|NCT02104895|11187147|FG001|STARTED|Overall Study||260
10061559|NCT02104895|11187146|FG000|COMPLETED|Overall Study||260
10061560|NCT02104895|11187147|FG001|COMPLETED|Overall Study||246
10061561|NCT02104895|11187146|FG000|NOT COMPLETED|Overall Study||0
10061562|NCT02104895|11187147|FG001|NOT COMPLETED|Overall Study||14
10061563|NCT02104947|11187155|FG000|STARTED|Overall Study||301
10061564|NCT02104947|11187156|FG001|STARTED|Overall Study||202
10061565|NCT02104947|11187155|FG000|COMPLETED|Overall Study||222
10061566|NCT02104947|11187156|FG001|COMPLETED|Overall Study||146
10061567|NCT02104947|11187155|FG000|NOT COMPLETED|Overall Study||79
10061568|NCT02104947|11187156|FG001|NOT COMPLETED|Overall Study||56
10061569|NCT02105012|11187166|FG000|STARTED|Overall Study||147
10061570|NCT02105012|11187166|FG000|BD MDI 320 µg|Overall Study||124
10061571|NCT02105012|11187166|FG000|BD MDI 160 µg|Overall Study||132
10061572|NCT02105012|11187166|FG000|BD MDI 80 µg|Overall Study||64
10061573|NCT02105012|11187166|FG000|BD MDI 40 µg|Overall Study||63
10061574|NCT02105012|11187166|FG000|Placebo MDI|Overall Study||127
10061575|NCT02105012|11187166|FG000|COMPLETED|Overall Study||114
10061576|NCT02105012|11187166|FG000|NOT COMPLETED|Overall Study||33
10061577|NCT02105246|11187180|FG000|STARTED|Overall Study||557
10061578|NCT02105246|11187181|FG001|STARTED|Overall Study||597
10061579|NCT02105246|11187180|FG000|COMPLETED|Overall Study||557
10061580|NCT02105246|11187181|FG001|COMPLETED|Overall Study||597
10061581|NCT02105246|11187180|FG000|NOT COMPLETED|Overall Study||0
10061582|NCT02105246|11187181|FG001|NOT COMPLETED|Overall Study||0
10061583|NCT02105272|11187193|FG000|STARTED|Overall Study||118
10061584|NCT02105272|11187194|FG001|STARTED|Overall Study||119
10061585|NCT02105272|11187193|FG000|COMPLETED|Overall Study||113
10061586|NCT02105272|11187194|FG001|COMPLETED|Overall Study||116
10061587|NCT02105272|11187193|FG000|NOT COMPLETED|Overall Study||5
10061588|NCT02105272|11187194|FG001|NOT COMPLETED|Overall Study||3
10061589|NCT02105285|11187203|FG000|STARTED|Overall Study||78
10061590|NCT02105285|11187204|FG001|STARTED|Overall Study||78
10061591|NCT02105285|11187205|FG002|STARTED|Overall Study||37
10061592|NCT02105285|11187203|FG000|COMPLETED|Overall Study||76
10061593|NCT02105285|11187204|FG001|COMPLETED|Overall Study||76
10061594|NCT02105285|11187205|FG002|COMPLETED|Overall Study||37
10061595|NCT02105285|11187203|FG000|NOT COMPLETED|Overall Study||2
10061596|NCT02105285|11187204|FG001|NOT COMPLETED|Overall Study||2
10061597|NCT02105285|11187205|FG002|NOT COMPLETED|Overall Study||0
10061598|NCT02105324|11187212|FG000|STARTED|Period 1||9
10061599|NCT02105324|11187213|FG001|STARTED|Period 1||10
10061600|NCT02105324|11187212|FG000|COMPLETED|Period 1||9
10061601|NCT02105324|11187213|FG001|COMPLETED|Period 1||10
10061602|NCT02105324|11187212|FG000|NOT COMPLETED|Period 1||0
10061603|NCT02105324|11187213|FG001|NOT COMPLETED|Period 1||0
10061604|NCT02105324|11187212|FG000|STARTED|Period 2||9
10061605|NCT02105324|11187213|FG001|STARTED|Period 2||10
10061606|NCT02105324|11187212|FG000|COMPLETED|Period 2||9
10061607|NCT02105324|11187213|FG001|COMPLETED|Period 2||10
10061608|NCT02105324|11187212|FG000|NOT COMPLETED|Period 2||0
10061609|NCT02105324|11187213|FG001|NOT COMPLETED|Period 2||0
10061610|NCT02105415|11187224|FG000|STARTED|Overall Study||76
10061611|NCT02105415|11187225|FG001|STARTED|Overall Study||84
10061612|NCT02105415|11187224|FG000|COMPLETED|Overall Study||73
10061613|NCT02105415|11187225|FG001|COMPLETED|Overall Study||79
10061614|NCT02105415|11187224|FG000|NOT COMPLETED|Overall Study||3
10061615|NCT02105415|11187225|FG001|NOT COMPLETED|Overall Study||5
10061616|NCT02105454|11187236|FG000|STARTED|Overall Study||79
10061617|NCT02105454|11187236|FG000|COMPLETED|Overall Study||78
10061618|NCT02105454|11187236|FG000|NOT COMPLETED|Overall Study||1
9713057|NCT00855803|10812223|FG000|COMPLETED|Overall Study||21
9713058|NCT00855803|10812223|FG000|NOT COMPLETED|Overall Study||14
10061619|NCT02105467|11187242|FG000|STARTED|Period 1||316
10061620|NCT02105467|11187243|FG001|STARTED|Period 1||105
10061621|NCT02105467|11187242|FG000|COMPLETED|Period 1||314
10174178|NCT03078556|11304085|FG000|STARTED|Treatment Period 2 (4 Days)||37
10174179|NCT03078556|11304086|FG001|STARTED|Treatment Period 2 (4 Days)||36
10174180|NCT03078556|11304087|FG002|STARTED|Treatment Period 2 (4 Days)||37
10174181|NCT03078556|11304088|FG003|STARTED|Treatment Period 2 (4 Days)||37
10174182|NCT03078556|11304085|FG000|COMPLETED|Treatment Period 2 (4 Days)||37
10174183|NCT03078556|11304086|FG001|COMPLETED|Treatment Period 2 (4 Days)||36
10174184|NCT03078556|11304087|FG002|COMPLETED|Treatment Period 2 (4 Days)||37
10174185|NCT03078556|11304088|FG003|COMPLETED|Treatment Period 2 (4 Days)||37
10174186|NCT03078556|11304085|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10174187|NCT03078556|11304086|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10174188|NCT03078556|11304087|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10174189|NCT03078556|11304088|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10174190|NCT03078556|11304085|FG000|STARTED|Washout Period 2 (7 Days)||9
10174191|NCT03078556|11304086|FG001|STARTED|Washout Period 2 (7 Days)||7
10174192|NCT03078556|11304087|FG002|STARTED|Washout Period 2 (7 Days)||7
10174193|NCT03078556|11304088|FG003|STARTED|Washout Period 2 (7 Days)||9
10174194|NCT03078556|11304085|FG000|COMPLETED|Washout Period 2 (7 Days)||9
10174195|NCT03078556|11304086|FG001|COMPLETED|Washout Period 2 (7 Days)||7
10174196|NCT03078556|11304087|FG002|COMPLETED|Washout Period 2 (7 Days)||7
10174197|NCT03078556|11304088|FG003|COMPLETED|Washout Period 2 (7 Days)||9
10174198|NCT03078556|11304085|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10174199|NCT03078556|11304086|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10174200|NCT03078556|11304087|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10174201|NCT03078556|11304088|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10174202|NCT03078556|11304085|FG000|STARTED|Treatment Period 3 (4 Days)||9
10174203|NCT03078556|11304086|FG001|STARTED|Treatment Period 3 (4 Days)||7
10174204|NCT03078556|11304087|FG002|STARTED|Treatment Period 3 (4 Days)||7
10174205|NCT03078556|11304088|FG003|STARTED|Treatment Period 3 (4 Days)||9
10174206|NCT03078556|11304085|FG000|COMPLETED|Treatment Period 3 (4 Days)||9
10174207|NCT03078556|11304086|FG001|COMPLETED|Treatment Period 3 (4 Days)||7
10174208|NCT03078556|11304087|FG002|COMPLETED|Treatment Period 3 (4 Days)||7
10174209|NCT03078556|11304088|FG003|COMPLETED|Treatment Period 3 (4 Days)||9
10174210|NCT03078556|11304085|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10174211|NCT03078556|11304086|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10174212|NCT03078556|11304087|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10174213|NCT03078556|11304088|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10174214|NCT03078582|11304115|FG000|STARTED|Overall Study||10
10174215|NCT03078582|11304116|FG001|STARTED|Overall Study||16
10174216|NCT03078582|11304115|FG000|COMPLETED|Overall Study||10
10174217|NCT03078582|11304116|FG001|COMPLETED|Overall Study||8
10174218|NCT03078582|11304115|FG000|NOT COMPLETED|Overall Study||0
10174219|NCT03078582|11304116|FG001|NOT COMPLETED|Overall Study||8
10174220|NCT03078595|11304124|FG000|STARTED|Overall Study||24
10174221|NCT03078595|11304125|FG001|STARTED|Overall Study||24
10174222|NCT03078595|11304124|FG000|COMPLETED|Overall Study||24
10174223|NCT03078595|11304125|FG001|COMPLETED|Overall Study||24
10174224|NCT03078595|11304124|FG000|NOT COMPLETED|Overall Study||0
10174225|NCT03078595|11304125|FG001|NOT COMPLETED|Overall Study||0
10174226|NCT03078647|11304134|FG000|STARTED|Overall Study||17
10174227|NCT03078647|11304135|FG001|STARTED|Overall Study||11
10174228|NCT03078647|11304136|FG002|STARTED|Overall Study||3
10174229|NCT03078647|11304134|FG000|COMPLETED|Overall Study||17
10174230|NCT03078647|11304135|FG001|COMPLETED|Overall Study||10
10174231|NCT03078647|11304136|FG002|COMPLETED|Overall Study||3
10174232|NCT03078647|11304134|FG000|NOT COMPLETED|Overall Study||0
10174233|NCT03078647|11304135|FG001|NOT COMPLETED|Overall Study||1
10174234|NCT03078647|11304136|FG002|NOT COMPLETED|Overall Study||0
10174235|NCT03078751|11304146|FG000|STARTED|Overall Study||26
10174236|NCT03078751|11304147|FG001|STARTED|Overall Study||28
10174237|NCT03078751|11304146|FG000|Untreated Participants|Overall Study||0
10174238|NCT03078751|11304147|FG001|Untreated Participants|Overall Study||4
10174239|NCT03078751|11304146|FG000|Safety Set|Overall Study||26
10174240|NCT03078751|11304147|FG001|Safety Set|Overall Study||24
10174241|NCT03078751|11304146|FG000|COMPLETED|Overall Study||13
10174242|NCT03078751|11304147|FG001|COMPLETED|Overall Study||0
10174243|NCT03078751|11304146|FG000|NOT COMPLETED|Overall Study||13
10174244|NCT03078751|11304147|FG001|NOT COMPLETED|Overall Study||28
10174245|NCT03078816|11304153|FG000|STARTED|Overall Study||5
10174246|NCT03078816|11304153|FG000|COMPLETED|Overall Study||4
10174247|NCT03078816|11304153|FG000|NOT COMPLETED|Overall Study||1
10174248|NCT03078907|11304159|FG000|STARTED|Overall Study||53
10174249|NCT03078907|11304160|FG001|STARTED|Overall Study||55
10174250|NCT03078907|11304159|FG000|COMPLETED|Overall Study||50
10174251|NCT03078907|11304160|FG001|COMPLETED|Overall Study||54
10174252|NCT03078907|11304159|FG000|NOT COMPLETED|Overall Study||3
10174253|NCT03078907|11304160|FG001|NOT COMPLETED|Overall Study||1
10174254|NCT03078946|11304168|FG000|STARTED|Overall Study||30
10174255|NCT03078946|11304169|FG001|STARTED|Overall Study||30
10174256|NCT03078946|11304168|FG000|COMPLETED|Overall Study||30
10174257|NCT03078946|11304169|FG001|COMPLETED|Overall Study||30
10174258|NCT03078946|11304168|FG000|NOT COMPLETED|Overall Study||0
10174259|NCT03078946|11304169|FG001|NOT COMPLETED|Overall Study||0
10174260|NCT03079375|11304178|FG000|STARTED|Overall Study||503
10174261|NCT03079375|11304179|FG001|STARTED|Overall Study||499
10174262|NCT03079375|11304180|FG002|STARTED|Overall Study||497
10174263|NCT03079375|11304178|FG000|COMPLETED|Overall Study||498
10174264|NCT03079375|11304179|FG001|COMPLETED|Overall Study||493
10174265|NCT03079375|11304180|FG002|COMPLETED|Overall Study||476
10174266|NCT03079375|11304178|FG000|NOT COMPLETED|Overall Study||5
10174267|NCT03079375|11304179|FG001|NOT COMPLETED|Overall Study||6
10174268|NCT03079375|11304180|FG002|NOT COMPLETED|Overall Study||21
10174269|NCT03079531|11304192|FG000|STARTED|Overall Study||24
10174270|NCT03079531|11304192|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23
10174271|NCT03079531|11304192|FG000|COMPLETED|Overall Study||17
10174272|NCT03079531|11304192|FG000|NOT COMPLETED|Overall Study||7
10174273|NCT03080142|11304198|FG000|STARTED|Overall Study||42
10174274|NCT03080142|11304199|FG001|STARTED|Overall Study||44
10174275|NCT03080142|11304198|FG000|COMPLETED|Overall Study||42
10174276|NCT03080142|11304199|FG001|COMPLETED|Overall Study||44
10174277|NCT03080142|11304198|FG000|NOT COMPLETED|Overall Study||0
10174278|NCT03080142|11304199|FG001|NOT COMPLETED|Overall Study||0
10174279|NCT03080454|11304205|FG000|STARTED|Baseline||26
10174280|NCT03080454|11304205|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
10174281|NCT03080454|11304205|FG000|NOT COMPLETED|Baseline||2
10174282|NCT03080454|11304205|FG000|STARTED|Sham Doublestim (5days)||24
10174283|NCT03080454|11304205|FG000|COMPLETED|Sham Doublestim (5days)||24
10174284|NCT03080454|11304205|FG000|NOT COMPLETED|Sham Doublestim (5days)||0
10174285|NCT03080454|11304205|FG000|STARTED|Sham FU (7days)||24
10174286|NCT03080454|11304205|FG000|COMPLETED|Sham FU (7days)||24
10174287|NCT03080454|11304205|FG000|NOT COMPLETED|Sham FU (7days)||0
10174288|NCT03080454|11304205|FG000|STARTED|Anodal Doublestim (5 Days)||24
10174289|NCT03080454|11304205|FG000|COMPLETED|Anodal Doublestim (5 Days)||23
10174290|NCT03080454|11304205|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1
10174291|NCT03080454|11304205|FG000|STARTED|Anodal FU (7 Days)||23
10174292|NCT03080454|11304205|FG000|COMPLETED|Anodal FU (7 Days)||19
10174293|NCT03080454|11304205|FG000|NOT COMPLETED|Anodal FU (7 Days)||4
10174294|NCT03080493|11304214|FG000|STARTED|Overall Study||61
10174295|NCT03080493|11304215|FG001|STARTED|Overall Study||60
10174296|NCT03080493|11304214|FG000|COMPLETED|Overall Study||60
10174297|NCT03080493|11304215|FG001|COMPLETED|Overall Study||58
10174298|NCT03080493|11304214|FG000|NOT COMPLETED|Overall Study||1
10174299|NCT03080493|11304215|FG001|NOT COMPLETED|Overall Study||2
10174300|NCT03080961|11304221|FG000|STARTED|Overall Study||46
10174301|NCT03080961|11304221|FG000|COMPLETED|Overall Study||43
10174302|NCT03080961|11304221|FG000|NOT COMPLETED|Overall Study||3
10174303|NCT03081117|11304232|FG000|STARTED|Overall Study||10
10174304|NCT03081117|11304233|FG001|STARTED|Overall Study||11
10174305|NCT03081117|11304232|FG000|Primary Outcome 1 (SAE)|Overall Study||10
10174306|NCT03081117|11304233|FG001|Primary Outcome 1 (SAE)|Overall Study||11
10174307|NCT03081117|11304232|FG000|Secondary Measures Collected at Week 24|Overall Study||8
10174308|NCT03081117|11304233|FG001|Secondary Measures Collected at Week 24|Overall Study||9
10174309|NCT03081117|11304232|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
10174310|NCT03081117|11304233|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
10174311|NCT03081117|11304232|FG000|COMPLETED|Overall Study||6
10174312|NCT03081117|11304233|FG001|COMPLETED|Overall Study||8
10174313|NCT03081117|11304232|FG000|NOT COMPLETED|Overall Study||4
10174314|NCT03081117|11304233|FG001|NOT COMPLETED|Overall Study||3
10174315|NCT03081884|11304239|FG000|STARTED|Overall Study||61
10174316|NCT03081884|11304239|FG000|COMPLETED|Overall Study||57
10174317|NCT03081884|11304239|FG000|NOT COMPLETED|Overall Study||4
10174318|NCT03082196|11304246|FG000|STARTED|Overall Study||142
10174319|NCT03082196|11304247|FG001|STARTED|Overall Study||142
10174320|NCT03082196|11304246|FG000|COMPLETED|Overall Study||133
10174321|NCT03082196|11304247|FG001|COMPLETED|Overall Study||129
10174322|NCT03082196|11304246|FG000|NOT COMPLETED|Overall Study||9
10174323|NCT03082196|11304247|FG001|NOT COMPLETED|Overall Study||13
10174324|NCT03082261|11304253|FG000|STARTED|Overall Study||269
10174325|NCT03082261|11304253|FG000|COMPLETED|Overall Study||149
10174326|NCT03082261|11304253|FG000|NOT COMPLETED|Overall Study||120
10174327|NCT03082586|11304263|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
10174328|NCT03082586|11304264|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
10174329|NCT03082586|11304265|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
10174330|NCT03082586|11304266|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
10174331|NCT03082586|11304267|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
10174332|NCT03082586|11304268|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
10174333|NCT03082586|11304263|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
10174334|NCT03082586|11304264|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
10174335|NCT03082586|11304265|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
10174336|NCT03082586|11304266|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
10174337|NCT03082586|11304267|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
10174338|NCT03082586|11304268|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
10174339|NCT03082586|11304263|FG000|NOT COMPLETED|Overall Study||0
10174340|NCT03082586|11304264|FG001|NOT COMPLETED|Overall Study||0
10174341|NCT03082586|11304265|FG002|NOT COMPLETED|Overall Study||0
10174342|NCT03082586|11304266|FG003|NOT COMPLETED|Overall Study||0
10174343|NCT03082586|11304267|FG004|NOT COMPLETED|Overall Study||0
10174344|NCT03082586|11304268|FG005|NOT COMPLETED|Overall Study||0
10174345|NCT03082599|11304290|FG000|STARTED|Overall Study||40
10174346|NCT03082599|11304291|FG001|STARTED|Overall Study||39
10174347|NCT03082599|11304290|FG000|COMPLETED|Overall Study||39
10174348|NCT03082599|11304291|FG001|COMPLETED|Overall Study||39
10174349|NCT03082599|11304290|FG000|NOT COMPLETED|Overall Study||1
10174350|NCT03082599|11304291|FG001|NOT COMPLETED|Overall Study||0
10174351|NCT03083093|11304299|FG000|STARTED|Overall Study||50
10174352|NCT03083093|11304300|FG001|STARTED|Overall Study||50
10174353|NCT03083093|11304299|FG000|COMPLETED|Overall Study||50
10174354|NCT03083093|11304300|FG001|COMPLETED|Overall Study||50
10174355|NCT03083093|11304299|FG000|NOT COMPLETED|Overall Study||0
10174356|NCT03083093|11304300|FG001|NOT COMPLETED|Overall Study||0
10174357|NCT03083132|11304308|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12
10174358|NCT03083132|11304309|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9
10174359|NCT03083132|11304308|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12
10174360|NCT03083132|11304309|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7
10174361|NCT03083132|11304308|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0
10174362|NCT03083132|11304309|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2
10174363|NCT03083132|11304308|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12
10174364|NCT03083132|11304309|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7
10174365|NCT03083132|11304308|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11
10174366|NCT03083132|11304309|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6
10174367|NCT03083132|11304308|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
10174368|NCT03083132|11304309|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
10174369|NCT03083379|11304317|FG000|STARTED|Overall Study||15
10174370|NCT03083379|11304318|FG001|STARTED|Overall Study||15
10174371|NCT03083379|11304317|FG000|COMPLETED|Overall Study||15
10174372|NCT03083379|11304318|FG001|COMPLETED|Overall Study||15
10174373|NCT03083379|11304317|FG000|NOT COMPLETED|Overall Study||0
10174374|NCT03083379|11304318|FG001|NOT COMPLETED|Overall Study||0
10174375|NCT03083470|11304329|FG000|STARTED|Overall Study||6
10174376|NCT03083470|11304330|FG001|STARTED|Overall Study||6
10174377|NCT03083470|11304331|FG002|STARTED|Overall Study||6
10174378|NCT03083470|11304332|FG003|STARTED|Overall Study||6
10174379|NCT03083470|11304333|FG004|STARTED|Overall Study||9
10174380|NCT03083470|11304329|FG000|COMPLETED|Overall Study||6
10174381|NCT03083470|11304330|FG001|COMPLETED|Overall Study||6
10174382|NCT03083470|11304331|FG002|COMPLETED|Overall Study||6
10174383|NCT03083470|11304332|FG003|COMPLETED|Overall Study||6
10174384|NCT03083470|11304333|FG004|COMPLETED|Overall Study||7
10174385|NCT03083470|11304329|FG000|NOT COMPLETED|Overall Study||0
10174386|NCT03083470|11304330|FG001|NOT COMPLETED|Overall Study||0
10174387|NCT03083470|11304331|FG002|NOT COMPLETED|Overall Study||0
10174388|NCT03083470|11304332|FG003|NOT COMPLETED|Overall Study||0
10174389|NCT03083470|11304333|FG004|NOT COMPLETED|Overall Study||2
10174390|NCT03083483|11304348|FG000|STARTED|Overall Study||24
10174391|NCT03083483|11304349|FG001|STARTED|Overall Study||22
10174392|NCT03083483|11304350|FG002|STARTED|Overall Study||23
10174393|NCT03083483|11304348|FG000|COMPLETED|Overall Study||20
10174394|NCT03083483|11304349|FG001|COMPLETED|Overall Study||20
10174395|NCT03083483|11304350|FG002|COMPLETED|Overall Study||20
10174396|NCT03083483|11304348|FG000|NOT COMPLETED|Overall Study||4
10174397|NCT03083483|11304349|FG001|NOT COMPLETED|Overall Study||2
10174398|NCT03083483|11304350|FG002|NOT COMPLETED|Overall Study||3
10174399|NCT03083639|11304360|FG000|STARTED|Intervention Period 1 (1 Day)||26
10174400|NCT03083639|11304361|FG001|STARTED|Intervention Period 1 (1 Day)||26
10174401|NCT03083639|11304360|FG000|COMPLETED|Intervention Period 1 (1 Day)||26
10174402|NCT03083639|11304361|FG001|COMPLETED|Intervention Period 1 (1 Day)||26
10174403|NCT03083639|11304360|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10174404|NCT03083639|11304361|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10174405|NCT03083639|11304360|FG000|STARTED|Washout Period (at Least 6 Days)||26
10174406|NCT03083639|11304361|FG001|STARTED|Washout Period (at Least 6 Days)||26
10174407|NCT03083639|11304360|FG000|COMPLETED|Washout Period (at Least 6 Days)||25
10174408|NCT03083639|11304361|FG001|COMPLETED|Washout Period (at Least 6 Days)||25
10174409|NCT03083639|11304360|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1
10174410|NCT03083639|11304361|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
10174411|NCT03083639|11304360|FG000|STARTED|Intervention Period 2 (1 Day)||25
10174412|NCT03083639|11304361|FG001|STARTED|Intervention Period 2 (1 Day)||25
10174413|NCT03083639|11304360|FG000|COMPLETED|Intervention Period 2 (1 Day)||25
10174414|NCT03083639|11304361|FG001|COMPLETED|Intervention Period 2 (1 Day)||25
10174415|NCT03083639|11304360|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
10174416|NCT03083639|11304361|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0
10174417|NCT03083769|11304369|FG000|STARTED|Overall Study||839
10174418|NCT03083769|11304370|FG001|STARTED|Overall Study||663
10174419|NCT03083769|11304369|FG000|COMPLETED|Overall Study||819
10174420|NCT03083769|11304370|FG001|COMPLETED|Overall Study||631
10174421|NCT03083769|11304369|FG000|NOT COMPLETED|Overall Study||20
10174422|NCT03083769|11304370|FG001|NOT COMPLETED|Overall Study||32
10174423|NCT03083847|11304386|FG000|STARTED|Pilot 1a||2
10174424|NCT03083847|11304387|FG001|STARTED|Pilot 1a||0
10174425|NCT03083847|11304388|FG002|STARTED|Pilot 1a||0
10174426|NCT03083847|11304389|FG003|STARTED|Pilot 1a||0
10174427|NCT03083847|11304390|FG004|STARTED|Pilot 1a||0
10174428|NCT03083847|11304391|FG005|STARTED|Pilot 1a||0
10174429|NCT03083847|11304392|FG006|STARTED|Pilot 1a||0
10174430|NCT03083847|11304393|FG007|STARTED|Pilot 1a||0
10174431|NCT03083847|11304394|FG008|STARTED|Pilot 1a||0
10174432|NCT03083847|11304395|FG009|STARTED|Pilot 1a||0
10174433|NCT03083847|11304386|FG000|COMPLETED|Pilot 1a||2
10174434|NCT03083847|11304387|FG001|COMPLETED|Pilot 1a||0
10174435|NCT03083847|11304388|FG002|COMPLETED|Pilot 1a||0
10174436|NCT03083847|11304389|FG003|COMPLETED|Pilot 1a||0
10174437|NCT03083847|11304390|FG004|COMPLETED|Pilot 1a||0
10174438|NCT03083847|11304391|FG005|COMPLETED|Pilot 1a||0
10174439|NCT03083847|11304392|FG006|COMPLETED|Pilot 1a||0
10174440|NCT03083847|11304393|FG007|COMPLETED|Pilot 1a||0
10174441|NCT03083847|11304394|FG008|COMPLETED|Pilot 1a||0
10174442|NCT03083847|11304395|FG009|COMPLETED|Pilot 1a||0
10174443|NCT03083847|11304386|FG000|NOT COMPLETED|Pilot 1a||0
10174444|NCT03083847|11304387|FG001|NOT COMPLETED|Pilot 1a||0
10174445|NCT03083847|11304388|FG002|NOT COMPLETED|Pilot 1a||0
10174446|NCT03083847|11304389|FG003|NOT COMPLETED|Pilot 1a||0
10174447|NCT03083847|11304390|FG004|NOT COMPLETED|Pilot 1a||0
10174448|NCT03083847|11304391|FG005|NOT COMPLETED|Pilot 1a||0
10174449|NCT03083847|11304392|FG006|NOT COMPLETED|Pilot 1a||0
10174450|NCT03083847|11304393|FG007|NOT COMPLETED|Pilot 1a||0
10174451|NCT03083847|11304394|FG008|NOT COMPLETED|Pilot 1a||0
10174452|NCT03083847|11304395|FG009|NOT COMPLETED|Pilot 1a||0
10174453|NCT03083847|11304386|FG000|STARTED|Pilot Ib & 5a||0
10174454|NCT03083847|11304387|FG001|STARTED|Pilot Ib & 5a||2
10174455|NCT03083847|11304388|FG002|STARTED|Pilot Ib & 5a||2
10174456|NCT03083847|11304389|FG003|STARTED|Pilot Ib & 5a||0
10174457|NCT03083847|11304390|FG004|STARTED|Pilot Ib & 5a||0
10174458|NCT03083847|11304391|FG005|STARTED|Pilot Ib & 5a||0
10174459|NCT03083847|11304392|FG006|STARTED|Pilot Ib & 5a||0
10174460|NCT03083847|11304393|FG007|STARTED|Pilot Ib & 5a||0
10174461|NCT03083847|11304394|FG008|STARTED|Pilot Ib & 5a||0
10174462|NCT03083847|11304395|FG009|STARTED|Pilot Ib & 5a||0
10174463|NCT03083847|11304386|FG000|COMPLETED|Pilot Ib & 5a||0
10174464|NCT03083847|11304387|FG001|COMPLETED|Pilot Ib & 5a||2
10174465|NCT03083847|11304388|FG002|COMPLETED|Pilot Ib & 5a||2
10174466|NCT03083847|11304389|FG003|COMPLETED|Pilot Ib & 5a||0
10174467|NCT03083847|11304390|FG004|COMPLETED|Pilot Ib & 5a||0
10174468|NCT03083847|11304391|FG005|COMPLETED|Pilot Ib & 5a||0
10174469|NCT03083847|11304392|FG006|COMPLETED|Pilot Ib & 5a||0
10174470|NCT03083847|11304393|FG007|COMPLETED|Pilot Ib & 5a||0
10174471|NCT03083847|11304394|FG008|COMPLETED|Pilot Ib & 5a||0
10174472|NCT03083847|11304395|FG009|COMPLETED|Pilot Ib & 5a||0
10174473|NCT03083847|11304386|FG000|NOT COMPLETED|Pilot Ib & 5a||0
10174474|NCT03083847|11304387|FG001|NOT COMPLETED|Pilot Ib & 5a||0
10174475|NCT03083847|11304388|FG002|NOT COMPLETED|Pilot Ib & 5a||0
10174476|NCT03083847|11304389|FG003|NOT COMPLETED|Pilot Ib & 5a||0
10174477|NCT03083847|11304390|FG004|NOT COMPLETED|Pilot Ib & 5a||0
10174478|NCT03083847|11304391|FG005|NOT COMPLETED|Pilot Ib & 5a||0
10174479|NCT03083847|11304392|FG006|NOT COMPLETED|Pilot Ib & 5a||0
10174480|NCT03083847|11304393|FG007|NOT COMPLETED|Pilot Ib & 5a||0
10174481|NCT03083847|11304394|FG008|NOT COMPLETED|Pilot Ib & 5a||0
10174482|NCT03083847|11304395|FG009|NOT COMPLETED|Pilot Ib & 5a||0
10174483|NCT03083847|11304386|FG000|STARTED|Pilot 1d & 5b||0
10174484|NCT03083847|11304387|FG001|STARTED|Pilot 1d & 5b||0
10174485|NCT03083847|11304388|FG002|STARTED|Pilot 1d & 5b||0
10174486|NCT03083847|11304389|FG003|STARTED|Pilot 1d & 5b||4
10174487|NCT03083847|11304390|FG004|STARTED|Pilot 1d & 5b||4
10174488|NCT03083847|11304391|FG005|STARTED|Pilot 1d & 5b||0
10174489|NCT03083847|11304392|FG006|STARTED|Pilot 1d & 5b||0
10174490|NCT03083847|11304393|FG007|STARTED|Pilot 1d & 5b||0
10174491|NCT03083847|11304394|FG008|STARTED|Pilot 1d & 5b||0
10174492|NCT03083847|11304395|FG009|STARTED|Pilot 1d & 5b||0
10174493|NCT03083847|11304386|FG000|COMPLETED|Pilot 1d & 5b||0
10174494|NCT03083847|11304387|FG001|COMPLETED|Pilot 1d & 5b||0
10174495|NCT03083847|11304388|FG002|COMPLETED|Pilot 1d & 5b||0
10174496|NCT03083847|11304389|FG003|COMPLETED|Pilot 1d & 5b||4
10174497|NCT03083847|11304390|FG004|COMPLETED|Pilot 1d & 5b||4
10174498|NCT03083847|11304391|FG005|COMPLETED|Pilot 1d & 5b||0
10174499|NCT03083847|11304392|FG006|COMPLETED|Pilot 1d & 5b||0
10174500|NCT03083847|11304393|FG007|COMPLETED|Pilot 1d & 5b||0
10174501|NCT03083847|11304394|FG008|COMPLETED|Pilot 1d & 5b||0
10174502|NCT03083847|11304395|FG009|COMPLETED|Pilot 1d & 5b||0
9713059|NCT00790803|10812227|FG000|STARTED|Overall Study||5
9713060|NCT00790803|10812227|FG000|COMPLETED|Overall Study||5
9713061|NCT00790803|10812227|FG000|NOT COMPLETED|Overall Study||0
9713062|NCT00740116|10812233|FG000|STARTED|Overall Study||50
9713063|NCT00740116|10812234|FG001|STARTED|Overall Study||50
9713064|NCT00740116|10812233|FG000|COMPLETED|Overall Study||48
10174503|NCT03083847|11304386|FG000|NOT COMPLETED|Pilot 1d & 5b||0
10174504|NCT03083847|11304387|FG001|NOT COMPLETED|Pilot 1d & 5b||0
10174505|NCT03083847|11304388|FG002|NOT COMPLETED|Pilot 1d & 5b||0
10174506|NCT03083847|11304389|FG003|NOT COMPLETED|Pilot 1d & 5b||0
10174507|NCT03083847|11304390|FG004|NOT COMPLETED|Pilot 1d & 5b||0
10174508|NCT03083847|11304391|FG005|NOT COMPLETED|Pilot 1d & 5b||0
10174509|NCT03083847|11304392|FG006|NOT COMPLETED|Pilot 1d & 5b||0
10174510|NCT03083847|11304393|FG007|NOT COMPLETED|Pilot 1d & 5b||0
10174511|NCT03083847|11304394|FG008|NOT COMPLETED|Pilot 1d & 5b||0
10174512|NCT03083847|11304395|FG009|NOT COMPLETED|Pilot 1d & 5b||0
10174513|NCT03083847|11304386|FG000|STARTED|Main||0
10174514|NCT03083847|11304387|FG001|STARTED|Main||0
10174515|NCT03083847|11304388|FG002|STARTED|Main||0
10174516|NCT03083847|11304389|FG003|STARTED|Main||0
10174517|NCT03083847|11304390|FG004|STARTED|Main||0
10174518|NCT03083847|11304391|FG005|STARTED|Main||9
10174519|NCT03083847|11304392|FG006|STARTED|Main||10
10174520|NCT03083847|11304393|FG007|STARTED|Main||10
10174521|NCT03083847|11304394|FG008|STARTED|Main||4
10174522|NCT03083847|11304395|FG009|STARTED|Main||8
10174523|NCT03083847|11304386|FG000|COMPLETED|Main||0
10174524|NCT03083847|11304387|FG001|COMPLETED|Main||0
10174525|NCT03083847|11304388|FG002|COMPLETED|Main||0
10174526|NCT03083847|11304389|FG003|COMPLETED|Main||0
10174527|NCT03083847|11304390|FG004|COMPLETED|Main||0
10174528|NCT03083847|11304391|FG005|COMPLETED|Main||8
10174529|NCT03083847|11304392|FG006|COMPLETED|Main||9
10174530|NCT03083847|11304393|FG007|COMPLETED|Main||6
10174531|NCT03083847|11304394|FG008|COMPLETED|Main||4
10174532|NCT03083847|11304395|FG009|COMPLETED|Main||8
10174533|NCT03083847|11304386|FG000|NOT COMPLETED|Main||0
10174534|NCT03083847|11304387|FG001|NOT COMPLETED|Main||0
10174535|NCT03083847|11304388|FG002|NOT COMPLETED|Main||0
10174536|NCT03083847|11304389|FG003|NOT COMPLETED|Main||0
10174537|NCT03083847|11304390|FG004|NOT COMPLETED|Main||0
10174538|NCT03083847|11304391|FG005|NOT COMPLETED|Main||1
10174539|NCT03083847|11304392|FG006|NOT COMPLETED|Main||1
10174540|NCT03083847|11304393|FG007|NOT COMPLETED|Main||4
10174541|NCT03083847|11304394|FG008|NOT COMPLETED|Main||0
10174542|NCT03083847|11304395|FG009|NOT COMPLETED|Main||0
10174543|NCT03083990|11304425|FG000|STARTED|Overall Study||50
10174544|NCT03083990|11304426|FG001|STARTED|Overall Study||50
10174545|NCT03083990|11304425|FG000|COMPLETED|Overall Study||49
10174546|NCT03083990|11304426|FG001|COMPLETED|Overall Study||50
10174547|NCT03083990|11304425|FG000|NOT COMPLETED|Overall Study||1
10174548|NCT03083990|11304426|FG001|NOT COMPLETED|Overall Study||0
10174549|NCT03084302|11304432|FG000|STARTED|Overall Study||120
10174550|NCT03084302|11304432|FG000|COMPLETED|Overall Study||105
10174551|NCT03084302|11304432|FG000|NOT COMPLETED|Overall Study||15
10174552|NCT03084315|11304439|FG000|STARTED|Overall Study||116
10174553|NCT03084315|11304440|FG001|STARTED|Overall Study||118
10174554|NCT03084315|11304439|FG000|COMPLETED|Overall Study||106
10174555|NCT03084315|11304440|FG001|COMPLETED|Overall Study||109
10174556|NCT03084315|11304439|FG000|NOT COMPLETED|Overall Study||10
10174557|NCT03084315|11304440|FG001|NOT COMPLETED|Overall Study||9
10174558|NCT03084796|11304452|FG000|STARTED|Overall Study||121
10174559|NCT03084796|11304453|FG001|STARTED|Overall Study||123
10174560|NCT03084796|11304454|FG002|STARTED|Overall Study||122
10174561|NCT03084796|11304455|FG003|STARTED|Overall Study||123
10174562|NCT03084796|11304456|FG004|STARTED|Overall Study||121
10174563|NCT03084796|11304457|FG005|STARTED|Overall Study||123
10174564|NCT03084796|11304452|FG000|COMPLETED|Overall Study||114
10174565|NCT03084796|11304453|FG001|COMPLETED|Overall Study||113
10174566|NCT03084796|11304454|FG002|COMPLETED|Overall Study||110
10174567|NCT03084796|11304455|FG003|COMPLETED|Overall Study||119
10174568|NCT03084796|11304456|FG004|COMPLETED|Overall Study||110
10174569|NCT03084796|11304457|FG005|COMPLETED|Overall Study||116
10174570|NCT03084796|11304452|FG000|NOT COMPLETED|Overall Study||7
10174571|NCT03084796|11304453|FG001|NOT COMPLETED|Overall Study||10
10061622|NCT02105467|11187243|FG001|COMPLETED|Period 1||105
10174572|NCT03084796|11304454|FG002|NOT COMPLETED|Overall Study||12
10174573|NCT03084796|11304455|FG003|NOT COMPLETED|Overall Study||4
10174574|NCT03084796|11304456|FG004|NOT COMPLETED|Overall Study||11
10174575|NCT03084796|11304457|FG005|NOT COMPLETED|Overall Study||7
10174576|NCT03085017|11304473|FG000|STARTED|Overall Study||30
9713065|NCT00740116|10812234|FG001|COMPLETED|Overall Study||45
10061623|NCT02105467|11187242|FG000|NOT COMPLETED|Period 1||2
10061624|NCT02105467|11187243|FG001|NOT COMPLETED|Period 1||0
10061625|NCT02105467|11187242|FG000|STARTED|Period 2||314
10061626|NCT02105467|11187243|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
10061627|NCT02105467|11187242|FG000|COMPLETED|Period 2||312
10061628|NCT02105467|11187243|FG001|COMPLETED|Period 2||102
10061629|NCT02105467|11187242|FG000|NOT COMPLETED|Period 2||2
10061630|NCT02105467|11187243|FG001|NOT COMPLETED|Period 2||2
10174577|NCT03085017|11304474|FG001|STARTED|Overall Study||27
10174578|NCT03085017|11304473|FG000|COMPLETED|Overall Study||30
10174579|NCT03085017|11304474|FG001|COMPLETED|Overall Study||24
10174580|NCT03085017|11304473|FG000|NOT COMPLETED|Overall Study||0
10174581|NCT03085017|11304474|FG001|NOT COMPLETED|Overall Study||3
10174582|NCT03085238|11304480|FG000|STARTED|Overall Study||23
10174583|NCT03085238|11304480|FG000|1 Month|Overall Study||23
10174584|NCT03085238|11304480|FG000|3 Months|Overall Study||22
10174585|NCT03085238|11304480|FG000|6 Months|Overall Study||19
10174586|NCT03085238|11304480|FG000|9 Months|Overall Study||16
10174587|NCT03085238|11304480|FG000|12 Months|Overall Study||14
10174588|NCT03085238|11304480|FG000|15 Months|Overall Study||11
10174589|NCT03085238|11304480|FG000|18 Months|Overall Study||7
10174590|NCT03085238|11304480|FG000|COMPLETED|Overall Study||19
10174591|NCT03085238|11304480|FG000|NOT COMPLETED|Overall Study||4
10174592|NCT03085758|11304496|FG000|STARTED|Overall Study||72
10174593|NCT03085758|11304497|FG001|STARTED|Overall Study||77
10174594|NCT03085758|11304498|FG002|STARTED|Overall Study||152
10174595|NCT03085758|11304496|FG000|COMPLETED|Overall Study||43
10174596|NCT03085758|11304497|FG001|COMPLETED|Overall Study||49
10174597|NCT03085758|11304498|FG002|COMPLETED|Overall Study||96
10174598|NCT03085758|11304496|FG000|NOT COMPLETED|Overall Study||29
10174599|NCT03085758|11304497|FG001|NOT COMPLETED|Overall Study||28
10174600|NCT03085758|11304498|FG002|NOT COMPLETED|Overall Study||56
10174601|NCT03085797|11304512|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201
10174602|NCT03085797|11304513|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206
10174603|NCT03085797|11304512|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
10174604|NCT03085797|11304513|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
10174605|NCT03085797|11304512|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
10174606|NCT03085797|11304513|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
10174607|NCT03085797|11304512|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
10174608|NCT03085797|11304513|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
10174609|NCT03085797|11304512|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
10174610|NCT03085797|11304513|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
10174611|NCT03085797|11304512|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
10174612|NCT03085797|11304513|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
10174613|NCT03085797|11304512|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
10174614|NCT03085797|11304513|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
10174615|NCT03085797|11304512|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
10174616|NCT03085797|11304513|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
9713066|NCT00740116|10812233|FG000|NOT COMPLETED|Overall Study||2
9713067|NCT00740116|10812234|FG001|NOT COMPLETED|Overall Study||5
9713068|NCT00565617|10812242|FG000|STARTED|Overall Study||6
9713069|NCT00565617|10812242|FG000|COMPLETED|Overall Study||5
9713070|NCT00565617|10812242|FG000|NOT COMPLETED|Overall Study||1
9713071|NCT00470704|10812248|FG000|STARTED|Overall Study||41
9713072|NCT00470704|10812249|FG001|STARTED|Overall Study||46
9713073|NCT00470704|10812248|FG000|Safety Population|Overall Study||41
9713074|NCT00470704|10812249|FG001|Safety Population|Overall Study||45
9713075|NCT00470704|10812248|FG000|Treated|Overall Study||40
9713076|NCT00470704|10812249|FG001|Treated|Overall Study||45
9713077|NCT00470704|10812248|FG000|COMPLETED|Overall Study||0
9713078|NCT00470704|10812249|FG001|COMPLETED|Overall Study||0
9713079|NCT00470704|10812248|FG000|NOT COMPLETED|Overall Study||41
9713080|NCT00470704|10812249|FG001|NOT COMPLETED|Overall Study||46
9713081|NCT00427193|10812257|FG000|STARTED|Overall Study||143
9713082|NCT00427193|10812258|FG001|STARTED|Overall Study||75
9713083|NCT00427193|10812257|FG000|COMPLETED|Overall Study||117
9713084|NCT00427193|10812258|FG001|COMPLETED|Overall Study||71
9713085|NCT00427193|10812257|FG000|NOT COMPLETED|Overall Study||26
9713086|NCT00427193|10812258|FG001|NOT COMPLETED|Overall Study||4
9713087|NCT00148733|10812268|FG000|STARTED|Overall Study||1314
9713088|NCT00148733|10812269|FG001|STARTED|Overall Study||1314
9713089|NCT00148733|10812268|FG000|COMPLETED|Overall Study||1300
9713090|NCT00148733|10812269|FG001|COMPLETED|Overall Study||1299
9713091|NCT00148733|10812268|FG000|NOT COMPLETED|Overall Study||14
9713092|NCT00148733|10812269|FG001|NOT COMPLETED|Overall Study||15
9713093|NCT00142584|10812277|FG000|STARTED|Overall Study||252
9713094|NCT00142584|10812278|FG001|STARTED|Overall Study||84
9713095|NCT00142584|10812277|FG000|COMPLETED|Overall Study||108
9713096|NCT00142584|10812278|FG001|COMPLETED|Overall Study||28
9713097|NCT00142584|10812277|FG000|NOT COMPLETED|Overall Study||144
9713098|NCT00142584|10812278|FG001|NOT COMPLETED|Overall Study||56
9731053|NCT00129545|10830960|FG000|NOT COMPLETED|Overall Study||26
9731054|NCT00129545|10830961|FG001|NOT COMPLETED|Overall Study||164
9731055|NCT00129545|10830962|FG002|NOT COMPLETED|Overall Study||111
9731056|NCT00129623|10830972|FG000|STARTED|Overall Study||83
9731057|NCT00129623|10830973|FG001|STARTED|Overall Study||77
9731058|NCT00129623|10830972|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
9731059|NCT00129623|10830973|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
9731060|NCT00129623|10830972|FG000|COMPLETED|Overall Study||73
9731061|NCT00129623|10830973|FG001|COMPLETED|Overall Study||65
9731062|NCT00129623|10830972|FG000|NOT COMPLETED|Overall Study||10
9731063|NCT00129623|10830973|FG001|NOT COMPLETED|Overall Study||12
9731064|NCT00129649|10830983|FG000|STARTED|Overall Study||258
9731065|NCT00129649|10830984|FG001|STARTED|Overall Study||246
9731066|NCT00129649|10830983|FG000|COMPLETED|Overall Study||182
9731067|NCT00129649|10830984|FG001|COMPLETED|Overall Study||181
9731068|NCT00129649|10830983|FG000|NOT COMPLETED|Overall Study||76
9731069|NCT00129649|10830984|FG001|NOT COMPLETED|Overall Study||65
9731070|NCT00129701|10830990|FG000|STARTED|Overall Study||104
9731071|NCT00129701|10830990|FG000|COMPLETED|Overall Study||71
9731072|NCT00129701|10830990|FG000|NOT COMPLETED|Overall Study||33
10174617|NCT03085797|11304512|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
10174618|NCT03085797|11304513|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
10174619|NCT03085797|11304512|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184
9731073|NCT00129727|10830997|FG000|STARTED|Overall Study||62
9731074|NCT00129727|10830997|FG000|COMPLETED|Overall Study||57
9731075|NCT00129727|10830997|FG000|NOT COMPLETED|Overall Study||5
9731076|NCT00129740|10831001|FG000|STARTED|Overall Study||148
9731077|NCT00129740|10831001|FG000|COMPLETED|Overall Study||148
9731078|NCT00129740|10831001|FG000|NOT COMPLETED|Overall Study||0
9731079|NCT00129766|10831007|FG000|STARTED|Overall Study||3306
9731080|NCT00129766|10831008|FG001|STARTED|Overall Study||3329
9731081|NCT00129766|10831007|FG000|COMPLETED|Overall Study||3246
10174620|NCT03085797|11304513|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189
10174621|NCT03085797|11304512|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
10174622|NCT03085797|11304513|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
10174623|NCT03085797|11304512|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
10174624|NCT03085797|11304513|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
10174625|NCT03085797|11304512|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65
10174626|NCT03085797|11304513|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68
10174627|NCT03085797|11304512|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
10174628|NCT03085797|11304513|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
10174629|NCT03085836|11304524|FG000|STARTED|Overall Study||12
10174630|NCT03085836|11304525|FG001|STARTED|Overall Study||11
10174631|NCT03085836|11304526|FG002|STARTED|Overall Study||10
10174632|NCT03085836|11304524|FG000|COMPLETED|Overall Study||12
10174633|NCT03085836|11304525|FG001|COMPLETED|Overall Study||11
10174634|NCT03085836|11304526|FG002|COMPLETED|Overall Study||10
10174635|NCT03085836|11304524|FG000|NOT COMPLETED|Overall Study||0
10174636|NCT03085836|11304525|FG001|NOT COMPLETED|Overall Study||0
10174637|NCT03085836|11304526|FG002|NOT COMPLETED|Overall Study||0
10174638|NCT03085914|11304541|FG000|STARTED|Overall Study||9
10174639|NCT03085914|11304542|FG001|STARTED|Overall Study||9
10174640|NCT03085914|11304543|FG002|STARTED|Overall Study||11
10174641|NCT03085914|11304544|FG003|STARTED|Overall Study||9
10174642|NCT03085914|11304545|FG004|STARTED|Overall Study||13
10174643|NCT03085914|11304546|FG005|STARTED|Overall Study||8
10174644|NCT03085914|11304547|FG006|STARTED|Overall Study||11
10174645|NCT03085914|11304541|FG000|COMPLETED|Overall Study||0
10174646|NCT03085914|11304542|FG001|COMPLETED|Overall Study||0
10174647|NCT03085914|11304543|FG002|COMPLETED|Overall Study||0
10174648|NCT03085914|11304544|FG003|COMPLETED|Overall Study||0
10174649|NCT03085914|11304545|FG004|COMPLETED|Overall Study||0
10174650|NCT03085914|11304546|FG005|COMPLETED|Overall Study||0
10174651|NCT03085914|11304547|FG006|COMPLETED|Overall Study||0
10174652|NCT03085914|11304541|FG000|NOT COMPLETED|Overall Study||9
10174653|NCT03085914|11304542|FG001|NOT COMPLETED|Overall Study||9
10174654|NCT03085914|11304543|FG002|NOT COMPLETED|Overall Study||11
10174655|NCT03085914|11304544|FG003|NOT COMPLETED|Overall Study||9
10174656|NCT03085914|11304545|FG004|NOT COMPLETED|Overall Study||13
10174657|NCT03085914|11304546|FG005|NOT COMPLETED|Overall Study||8
10174658|NCT03085914|11304547|FG006|NOT COMPLETED|Overall Study||11
10174659|NCT03085927|11304568|FG000|STARTED|Overall Study||69
10174660|NCT03085927|11304569|FG001|STARTED|Overall Study||67
10174661|NCT03085927|11304568|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65
10174662|NCT03085927|11304569|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63
10174663|NCT03085927|11304568|FG000|Time 2 Measures|Overall Study||65
10174664|NCT03085927|11304569|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62
10174665|NCT03085927|11304568|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63
10174666|NCT03085927|11304569|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61
10174667|NCT03085927|11304568|FG000|NOT COMPLETED|Overall Study||6
10174668|NCT03085927|11304569|FG001|NOT COMPLETED|Overall Study||6
10174669|NCT03086018|11304577|FG000|STARTED|Field Testing||30
10174670|NCT03086018|11304577|FG000|COMPLETED|Field Testing||30
10174671|NCT03086018|11304577|FG000|NOT COMPLETED|Field Testing||0
10174672|NCT03086018|11304577|FG000|STARTED|Final Testing for End of Trial||30
9713099|NCT04753710|10812288|FG000|STARTED|Overall||67
9713100|NCT04753710|10812289|FG001|STARTED|Overall||29
9713101|NCT04753710|10812288|FG000|COMPLETED|Overall||67
9713102|NCT04753710|10812289|FG001|COMPLETED|Overall||29
9713103|NCT04753710|10812288|FG000|NOT COMPLETED|Overall||0
9713104|NCT04753710|10812289|FG001|NOT COMPLETED|Overall||0
9713105|NCT04753710|10812288|FG000|STARTED|First Phase||27
9713106|NCT04753710|10812289|FG001|STARTED|First Phase||9
9713107|NCT04753710|10812288|FG000|COMPLETED|First Phase||27
9713108|NCT04753710|10812289|FG001|COMPLETED|First Phase||9
9713109|NCT04753710|10812288|FG000|NOT COMPLETED|First Phase||0
9713110|NCT04753710|10812289|FG001|NOT COMPLETED|First Phase||0
9713111|NCT04753710|10812288|FG000|STARTED|Second Phase||40
10174673|NCT03086018|11304577|FG000|COMPLETED|Final Testing for End of Trial||28
10174674|NCT03086018|11304577|FG000|NOT COMPLETED|Final Testing for End of Trial||2
10174675|NCT03086057|11304587|FG000|STARTED|Stage 1: PrEP Uptake||55
10174676|NCT03086057|11304588|FG001|STARTED|Stage 1: PrEP Uptake||55
10174677|NCT03086057|11304589|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
10174678|NCT03086057|11304590|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
10174679|NCT03086057|11304587|FG000|COMPLETED|Stage 1: PrEP Uptake||44
10174680|NCT03086057|11304588|FG001|COMPLETED|Stage 1: PrEP Uptake||45
10174681|NCT03086057|11304589|FG002|COMPLETED|Stage 1: PrEP Uptake||0
10174682|NCT03086057|11304590|FG003|COMPLETED|Stage 1: PrEP Uptake||0
9713112|NCT04753710|10812289|FG001|STARTED|Second Phase||20
9713113|NCT04753710|10812288|FG000|COMPLETED|Second Phase||40
9713114|NCT04753710|10812289|FG001|COMPLETED|Second Phase||20
9713115|NCT04753710|10812288|FG000|NOT COMPLETED|Second Phase||0
9713116|NCT04753710|10812289|FG001|NOT COMPLETED|Second Phase||0
9713117|NCT04570605|10812297|FG000|STARTED|Overall Study||15
10174683|NCT03086057|11304587|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11
10174684|NCT03086057|11304588|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10
10174685|NCT03086057|11304589|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0
10174686|NCT03086057|11304590|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0
10174687|NCT03086057|11304587|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
10174688|NCT03086057|11304588|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
10174689|NCT03086057|11304589|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
10174690|NCT03086057|11304590|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
10174691|NCT03086057|11304587|FG000|COMPLETED|Stage 2: PrEP Adherence||0
10174692|NCT03086057|11304588|FG001|COMPLETED|Stage 2: PrEP Adherence||0
10174693|NCT03086057|11304589|FG002|COMPLETED|Stage 2: PrEP Adherence||11
10174694|NCT03086057|11304590|FG003|COMPLETED|Stage 2: PrEP Adherence||16
10174695|NCT03086057|11304587|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0
10174696|NCT03086057|11304588|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0
10174697|NCT03086057|11304589|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6
10174698|NCT03086057|11304590|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2
10174699|NCT03086135|11304600|FG000|STARTED|Overall Study||51
10174700|NCT03086135|11304600|FG000|COMPLETED|Overall Study||48
10174701|NCT03086135|11304600|FG000|NOT COMPLETED|Overall Study||3
10174702|NCT03086213|11304604|FG000|STARTED|Overall Study||24
10174703|NCT03086213|11304605|FG001|STARTED|Overall Study||24
10174704|NCT03086213|11304604|FG000|COMPLETED|Overall Study||24
10174705|NCT03086213|11304605|FG001|COMPLETED|Overall Study||24
10174706|NCT03086213|11304604|FG000|NOT COMPLETED|Overall Study||0
10174707|NCT03086213|11304605|FG001|NOT COMPLETED|Overall Study||0
10174708|NCT03086265|11304613|FG000|STARTED|Overall Study||10
10174709|NCT03086265|11304614|FG001|STARTED|Overall Study||10
10174710|NCT03086265|11304613|FG000|COMPLETED|Overall Study||10
10174711|NCT03086265|11304614|FG001|COMPLETED|Overall Study||10
10174712|NCT03086265|11304613|FG000|NOT COMPLETED|Overall Study||0
10174713|NCT03086265|11304614|FG001|NOT COMPLETED|Overall Study||0
10174714|NCT03086330|11304622|FG000|STARTED|Overall Study||151
10174715|NCT03086330|11304623|FG001|STARTED|Overall Study||151
10174716|NCT03086330|11304622|FG000|Exposed|Overall Study||150
10174717|NCT03086330|11304623|FG001|Exposed|Overall Study||151
10174718|NCT03086330|11304622|FG000|COMPLETED|Overall Study||147
10174719|NCT03086330|11304623|FG001|COMPLETED|Overall Study||147
10174720|NCT03086330|11304622|FG000|NOT COMPLETED|Overall Study||4
10174721|NCT03086330|11304623|FG001|NOT COMPLETED|Overall Study||4
10174722|NCT03086343|11304631|FG000|STARTED|Overall Study||309
10174723|NCT03086343|11304632|FG001|STARTED|Overall Study||303
10174724|NCT03086343|11304631|FG000|COMPLETED|Overall Study||277
10174725|NCT03086343|11304632|FG001|COMPLETED|Overall Study||278
10174726|NCT03086343|11304631|FG000|NOT COMPLETED|Overall Study||32
10174727|NCT03086343|11304632|FG001|NOT COMPLETED|Overall Study||25
10174728|NCT03086356|11304638|FG000|STARTED|Overall Study||12
10174729|NCT03086356|11304638|FG000|COMPLETED|Overall Study||12
10174730|NCT03086356|11304638|FG000|NOT COMPLETED|Overall Study||0
10174731|NCT03086408|11304644|FG000|STARTED|Overall Study||10
10174732|NCT03086408|11304645|FG001|STARTED|Overall Study||10
10174733|NCT03086408|11304644|FG000|COMPLETED|Overall Study||10
10174734|NCT03086408|11304645|FG001|COMPLETED|Overall Study||10
10174735|NCT03086408|11304644|FG000|NOT COMPLETED|Overall Study||0
10174736|NCT03086408|11304645|FG001|NOT COMPLETED|Overall Study||0
10174737|NCT03086447|11304653|FG000|STARTED|Overall Study||132
10174738|NCT03086447|11304654|FG001|STARTED|Overall Study||130
10174739|NCT03086447|11304653|FG000|COMPLETED|Overall Study||121
10174740|NCT03086447|11304654|FG001|COMPLETED|Overall Study||110
10174741|NCT03086447|11304653|FG000|NOT COMPLETED|Overall Study||11
10174742|NCT03086447|11304654|FG001|NOT COMPLETED|Overall Study||20
10174743|NCT03086460|11304660|FG000|STARTED|Study Participants||67
10174744|NCT03086460|11304660|FG000|Treatment A|Study Participants||39
10174745|NCT03086460|11304660|FG000|Treatment B|Study Participants||35
10174746|NCT03086460|11304660|FG000|Treatment C|Study Participants||37
10174747|NCT03086460|11304660|FG000|Treatment D|Study Participants||40
10174748|NCT03086460|11304660|FG000|Treatment E|Study Participants||40
10174749|NCT03086460|11304660|FG000|Treatment F|Study Participants||41
10174750|NCT03086460|11304660|FG000|COMPLETED|Study Participants||58
10174751|NCT03086460|11304660|FG000|NOT COMPLETED|Study Participants||9
10174752|NCT03086460|11304660|FG000|STARTED|Treatment A||39
10174753|NCT03086460|11304660|FG000|COMPLETED|Treatment A||35
10174754|NCT03086460|11304660|FG000|NOT COMPLETED|Treatment A||4
10174755|NCT03086460|11304660|FG000|STARTED|Treatment B||35
10174756|NCT03086460|11304660|FG000|COMPLETED|Treatment B||35
10174757|NCT03086460|11304660|FG000|NOT COMPLETED|Treatment B||0
10174758|NCT03086460|11304660|FG000|STARTED|Treatment C||37
10174759|NCT03086460|11304660|FG000|COMPLETED|Treatment C||35
10174760|NCT03086460|11304660|FG000|NOT COMPLETED|Treatment C||2
10174761|NCT03086460|11304660|FG000|STARTED|Treatment D||40
10174762|NCT03086460|11304660|FG000|COMPLETED|Treatment D||40
10174763|NCT03086460|11304660|FG000|NOT COMPLETED|Treatment D||0
10174764|NCT03086460|11304660|FG000|STARTED|Treatment E||40
10174765|NCT03086460|11304660|FG000|COMPLETED|Treatment E||36
10174766|NCT03086460|11304660|FG000|NOT COMPLETED|Treatment E||4
10174767|NCT03086460|11304660|FG000|STARTED|Treatment F||41
10174768|NCT03086460|11304660|FG000|COMPLETED|Treatment F||41
10174769|NCT03086460|11304660|FG000|NOT COMPLETED|Treatment F||0
10174770|NCT03086551|11304677|FG000|STARTED|First Intervention||5
10174771|NCT03086551|11304678|FG001|STARTED|First Intervention||5
10174772|NCT03086551|11304677|FG000|COMPLETED|First Intervention||4
10174773|NCT03086551|11304678|FG001|COMPLETED|First Intervention||4
10174774|NCT03086551|11304677|FG000|NOT COMPLETED|First Intervention||1
10174775|NCT03086551|11304678|FG001|NOT COMPLETED|First Intervention||1
10174776|NCT03086551|11304677|FG000|STARTED|Washout||4
10174777|NCT03086551|11304678|FG001|STARTED|Washout||4
10174778|NCT03086551|11304677|FG000|COMPLETED|Washout||1
10174779|NCT03086551|11304678|FG001|COMPLETED|Washout||1
10174780|NCT03086551|11304677|FG000|NOT COMPLETED|Washout||3
10174781|NCT03086551|11304678|FG001|NOT COMPLETED|Washout||3
10174782|NCT03086551|11304677|FG000|STARTED|Second Intervention||1
10174783|NCT03086551|11304678|FG001|STARTED|Second Intervention||1
10174784|NCT03086551|11304677|FG000|COMPLETED|Second Intervention||1
10174785|NCT03086551|11304678|FG001|COMPLETED|Second Intervention||1
10174786|NCT03086551|11304677|FG000|NOT COMPLETED|Second Intervention||0
10174787|NCT03086551|11304678|FG001|NOT COMPLETED|Second Intervention||0
10174788|NCT03086707|11304686|FG000|STARTED|Overall Study||7
10174789|NCT03086707|11304687|FG001|STARTED|Overall Study||7
10174790|NCT03086707|11304686|FG000|COMPLETED|Overall Study||7
10174791|NCT03086707|11304687|FG001|COMPLETED|Overall Study||7
10174792|NCT03086707|11304686|FG000|NOT COMPLETED|Overall Study||0
10174793|NCT03086707|11304687|FG001|NOT COMPLETED|Overall Study||0
10174794|NCT03087019|11304697|FG000|STARTED|Overall Study||11
10174795|NCT03087019|11304698|FG001|STARTED|Overall Study||10
10174796|NCT03087019|11304697|FG000|COMPLETED|Overall Study||10
10174797|NCT03087019|11304698|FG001|COMPLETED|Overall Study||10
10174798|NCT03087019|11304697|FG000|NOT COMPLETED|Overall Study||1
10174799|NCT03087019|11304698|FG001|NOT COMPLETED|Overall Study||0
10174800|NCT03087513|11304704|FG000|STARTED|First Intervention||40
10174801|NCT03087513|11304704|FG000|COMPLETED|First Intervention||40
10174802|NCT03087513|11304704|FG000|NOT COMPLETED|First Intervention||0
10174803|NCT03087513|11304704|FG000|STARTED|Second Intervention After 3 hr Washout||40
10174804|NCT03087513|11304704|FG000|COMPLETED|Second Intervention After 3 hr Washout||38
10174805|NCT03087513|11304704|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2
10174806|NCT03087604|11304719|FG000|STARTED|Overall Study||50
10174807|NCT03087604|11304720|FG001|STARTED|Overall Study||50
10174808|NCT03087604|11304719|FG000|COMPLETED|Overall Study||50
10174809|NCT03087604|11304720|FG001|COMPLETED|Overall Study||50
10174810|NCT03087604|11304719|FG000|NOT COMPLETED|Overall Study||0
10174811|NCT03087604|11304720|FG001|NOT COMPLETED|Overall Study||0
10174812|NCT03087643|11304728|FG000|STARTED|Overall Study||26
10174813|NCT03087643|11304729|FG001|STARTED|Overall Study||25
10174814|NCT03087643|11304728|FG000|COMPLETED|Overall Study||22
10174815|NCT03087643|11304729|FG001|COMPLETED|Overall Study||19
10174816|NCT03087643|11304728|FG000|NOT COMPLETED|Overall Study||4
10174817|NCT03087643|11304729|FG001|NOT COMPLETED|Overall Study||6
10174818|NCT03087786|11304737|FG000|STARTED|Overall Study||50
10174819|NCT03087786|11304738|FG001|STARTED|Overall Study||50
10174820|NCT03087786|11304737|FG000|COMPLETED|Overall Study||48
10174821|NCT03087786|11304738|FG001|COMPLETED|Overall Study||50
10174822|NCT03087786|11304737|FG000|NOT COMPLETED|Overall Study||2
10174823|NCT03087786|11304738|FG001|NOT COMPLETED|Overall Study||0
10174824|NCT03087851|11304747|FG000|STARTED|Overall Study||20
10174825|NCT03087851|11304748|FG001|STARTED|Overall Study||20
10174826|NCT03087851|11304749|FG002|STARTED|Overall Study||21
10174827|NCT03087851|11304747|FG000|COMPLETED|Overall Study||20
10174828|NCT03087851|11304748|FG001|COMPLETED|Overall Study||19
10174829|NCT03087851|11304749|FG002|COMPLETED|Overall Study||19
10174830|NCT03087851|11304747|FG000|NOT COMPLETED|Overall Study||0
10174831|NCT03087851|11304748|FG001|NOT COMPLETED|Overall Study||1
10174832|NCT03087851|11304749|FG002|NOT COMPLETED|Overall Study||2
10174833|NCT03088267|11304757|FG000|STARTED|Overall Study||9
10174834|NCT03088267|11304758|FG001|STARTED|Overall Study||9
10174835|NCT03088267|11304757|FG000|COMPLETED|Overall Study||9
10174836|NCT03088267|11304758|FG001|COMPLETED|Overall Study||9
10174837|NCT03088267|11304757|FG000|NOT COMPLETED|Overall Study||0
10174838|NCT03088267|11304758|FG001|NOT COMPLETED|Overall Study||0
10174839|NCT03088345|11304767|FG000|STARTED|Overall Study||10
10174840|NCT03088345|11304768|FG001|STARTED|Overall Study||10
10174841|NCT03088345|11304767|FG000|COMPLETED|Overall Study||10
10174842|NCT03088345|11304768|FG001|COMPLETED|Overall Study||10
10174843|NCT03088345|11304767|FG000|NOT COMPLETED|Overall Study||0
10174844|NCT03088345|11304768|FG001|NOT COMPLETED|Overall Study||0
10174845|NCT03088748|11304776|FG000|STARTED|Overall Study||40
10174846|NCT03088748|11304777|FG001|STARTED|Overall Study||10
10174847|NCT03088748|11304776|FG000|COMPLETED|Overall Study||40
10174848|NCT03088748|11304777|FG001|COMPLETED|Overall Study||10
10174849|NCT03088748|11304776|FG000|NOT COMPLETED|Overall Study||0
10174850|NCT03088748|11304777|FG001|NOT COMPLETED|Overall Study||0
10174851|NCT03088800|11304786|FG000|STARTED|Overall Study||30
10174852|NCT03088800|11304787|FG001|STARTED|Overall Study||30
10174853|NCT03088800|11304788|FG002|STARTED|Overall Study||30
10174854|NCT03088800|11304786|FG000|COMPLETED|Overall Study||30
10174855|NCT03088800|11304787|FG001|COMPLETED|Overall Study||30
10174856|NCT03088800|11304788|FG002|COMPLETED|Overall Study||30
10174857|NCT03088800|11304786|FG000|NOT COMPLETED|Overall Study||0
10174858|NCT03088800|11304787|FG001|NOT COMPLETED|Overall Study||0
10174859|NCT03088800|11304788|FG002|NOT COMPLETED|Overall Study||0
10174860|NCT03088917|11304796|FG000|STARTED|Overall Study||106
10174861|NCT03088917|11304796|FG000|COMPLETED|Overall Study||10
10174862|NCT03088917|11304796|FG000|NOT COMPLETED|Overall Study||96
10174863|NCT03089047|11304804|FG000|STARTED|Overall Study||2
10174864|NCT03089047|11304805|FG001|STARTED|Overall Study||2
10174865|NCT03089047|11304804|FG000|COMPLETED|Overall Study||1
10174866|NCT03089047|11304805|FG001|COMPLETED|Overall Study||2
10174867|NCT03089047|11304804|FG000|NOT COMPLETED|Overall Study||1
10174868|NCT03089047|11304805|FG001|NOT COMPLETED|Overall Study||0
10174869|NCT03089216|11304815|FG000|STARTED|Overall Study||27
10174870|NCT03089216|11304816|FG001|STARTED|Overall Study||27
10174871|NCT03089216|11304817|FG002|STARTED|Overall Study||27
10174872|NCT03089216|11304818|FG003|STARTED|Overall Study||27
9713118|NCT04570605|10812298|FG001|STARTED|Overall Study||15
9713119|NCT04570605|10812297|FG000|COMPLETED|Overall Study||11
9713120|NCT04570605|10812298|FG001|COMPLETED|Overall Study||13
9713121|NCT04570605|10812297|FG000|NOT COMPLETED|Overall Study||4
9713122|NCT04570605|10812298|FG001|NOT COMPLETED|Overall Study||2
9713123|NCT04551898|10812308|FG000|STARTED|Overall Study||47
9713124|NCT04551898|10812309|FG001|STARTED|Overall Study||45
9713125|NCT04551898|10812310|FG002|STARTED|Overall Study||43
9713126|NCT04551898|10812311|FG003|STARTED|Overall Study||46
9713127|NCT04551898|10812308|FG000|COMPLETED|Overall Study||39
9713128|NCT04551898|10812309|FG001|COMPLETED|Overall Study||42
9713129|NCT04551898|10812310|FG002|COMPLETED|Overall Study||35
9713130|NCT04551898|10812311|FG003|COMPLETED|Overall Study||41
9713131|NCT04551898|10812308|FG000|NOT COMPLETED|Overall Study||8
9713132|NCT04551898|10812309|FG001|NOT COMPLETED|Overall Study||3
9713133|NCT04551898|10812310|FG002|NOT COMPLETED|Overall Study||8
9713134|NCT04551898|10812311|FG003|NOT COMPLETED|Overall Study||5
10174873|NCT03089216|11304815|FG000|COMPLETED|Overall Study||27
10174874|NCT03089216|11304816|FG001|COMPLETED|Overall Study||27
10174875|NCT03089216|11304817|FG002|COMPLETED|Overall Study||27
9713135|NCT04402866|10812333|FG000|STARTED|Overall Study||6
9713136|NCT04402866|10812334|FG001|STARTED|Overall Study||6
9713137|NCT04402866|10812335|FG002|STARTED|Overall Study||7
9713138|NCT04402866|10812336|FG003|STARTED|Overall Study||6
9713139|NCT04402866|10812337|FG004|STARTED|Overall Study||104
9713140|NCT04402866|10812338|FG005|STARTED|Overall Study||106
9713141|NCT04402866|10812333|FG000|Randomized and Treated With Study Drug|Overall Study||6
10174876|NCT03089216|11304818|FG003|COMPLETED|Overall Study||26
10174877|NCT03089216|11304815|FG000|NOT COMPLETED|Overall Study||0
10174878|NCT03089216|11304816|FG001|NOT COMPLETED|Overall Study||0
10174879|NCT03089216|11304817|FG002|NOT COMPLETED|Overall Study||0
10174880|NCT03089216|11304818|FG003|NOT COMPLETED|Overall Study||1
9713142|NCT04402866|10812334|FG001|Randomized and Treated With Study Drug|Overall Study||6
9713143|NCT04402866|10812335|FG002|Randomized and Treated With Study Drug|Overall Study||7
10174881|NCT03089580|11304832|FG000|STARTED|Overall Study||14
10174882|NCT03089580|11304832|FG000|COMPLETED|Overall Study||12
10174883|NCT03089580|11304832|FG000|NOT COMPLETED|Overall Study||2
10174884|NCT03089697|11304840|FG000|STARTED|Overall Study||13
10174885|NCT03089697|11304841|FG001|STARTED|Overall Study||12
10174886|NCT03089697|11304840|FG000|COMPLETED|Overall Study||11
10174887|NCT03089697|11304841|FG001|COMPLETED|Overall Study||10
10174888|NCT03089697|11304840|FG000|NOT COMPLETED|Overall Study||2
10174889|NCT03089697|11304841|FG001|NOT COMPLETED|Overall Study||2
10174890|NCT03089879|11304850|FG000|STARTED|Overall Study||7
10174891|NCT03089879|11304851|FG001|STARTED|Overall Study||2
9713144|NCT04402866|10812336|FG003|Randomized and Treated With Study Drug|Overall Study||6
9713145|NCT04402866|10812337|FG004|Randomized and Treated With Study Drug|Overall Study||102
9713146|NCT04402866|10812338|FG005|Randomized and Treated With Study Drug|Overall Study||103
9713147|NCT04402866|10812333|FG000|COMPLETED|Overall Study||4
9713148|NCT04402866|10812334|FG001|COMPLETED|Overall Study||5
9713149|NCT04402866|10812335|FG002|COMPLETED|Overall Study||6
9713150|NCT04402866|10812336|FG003|COMPLETED|Overall Study||6
9713151|NCT04402866|10812337|FG004|COMPLETED|Overall Study||89
9713152|NCT04402866|10812338|FG005|COMPLETED|Overall Study||92
9713153|NCT04402866|10812333|FG000|NOT COMPLETED|Overall Study||2
9713154|NCT04402866|10812334|FG001|NOT COMPLETED|Overall Study||1
9713155|NCT04402866|10812335|FG002|NOT COMPLETED|Overall Study||1
9713156|NCT04402866|10812336|FG003|NOT COMPLETED|Overall Study||0
9713157|NCT04402866|10812337|FG004|NOT COMPLETED|Overall Study||15
9713158|NCT04402866|10812338|FG005|NOT COMPLETED|Overall Study||14
9713159|NCT04327388|10812351|FG000|STARTED|Overall Study||161
9713160|NCT04327388|10812352|FG001|STARTED|Overall Study||173
9713161|NCT04327388|10812353|FG002|STARTED|Overall Study||86
9713162|NCT04327388|10812351|FG000|Treated|Overall Study||159
9713163|NCT04327388|10812352|FG001|Treated|Overall Study||173
9713164|NCT04327388|10812353|FG002|Treated|Overall Study||84
9713165|NCT04327388|10812351|FG000|Participants Who Received Second Dose|Overall Study||13
9713166|NCT04327388|10812352|FG001|Participants Who Received Second Dose|Overall Study||11
9713167|NCT04327388|10812353|FG002|Participants Who Received Second Dose|Overall Study||5
9713168|NCT04327388|10812351|FG000|COMPLETED|Overall Study||141
9713169|NCT04327388|10812352|FG001|COMPLETED|Overall Study||153
9713170|NCT04327388|10812353|FG002|COMPLETED|Overall Study||75
9713171|NCT04327388|10812351|FG000|NOT COMPLETED|Overall Study||20
9713172|NCT04327388|10812352|FG001|NOT COMPLETED|Overall Study||20
9713173|NCT04327388|10812353|FG002|NOT COMPLETED|Overall Study||11
9731082|NCT00129766|10831008|FG001|COMPLETED|Overall Study||3270
9731083|NCT00129766|10831007|FG000|NOT COMPLETED|Overall Study||60
9731084|NCT00129766|10831008|FG001|NOT COMPLETED|Overall Study||59
9731085|NCT00129935|10831017|FG000|STARTED|Overall Study||669
9731086|NCT00129935|10831018|FG001|STARTED|Overall Study||715
9731087|NCT00129935|10831017|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
9731088|NCT00129935|10831018|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
9731089|NCT00129935|10831017|FG000|NOT COMPLETED|Overall Study||36
9731090|NCT00129935|10831018|FG001|NOT COMPLETED|Overall Study||92
9731091|NCT00129961|10831026|FG000|STARTED|Overall Study||39
9731092|NCT00129961|10831027|FG001|STARTED|Overall Study||47
9731093|NCT00129961|10831026|FG000|COMPLETED|Overall Study||20
9731094|NCT00129961|10831027|FG001|COMPLETED|Overall Study||24
9731095|NCT00129961|10831026|FG000|NOT COMPLETED|Overall Study||19
9731096|NCT00129961|10831027|FG001|NOT COMPLETED|Overall Study||23
9731097|NCT00129987|10831035|FG000|STARTED|1st Educational Session||287
9731098|NCT00129987|10831036|FG001|STARTED|1st Educational Session||280
9731099|NCT00129987|10831035|FG000|COMPLETED|1st Educational Session||146
9731100|NCT00129987|10831036|FG001|COMPLETED|1st Educational Session||171
9731101|NCT00129987|10831035|FG000|NOT COMPLETED|1st Educational Session||141
9731102|NCT00129987|10831036|FG001|NOT COMPLETED|1st Educational Session||109
9731103|NCT00129987|10831035|FG000|STARTED|1 Year||146
9731104|NCT00129987|10831036|FG001|STARTED|1 Year||171
9731105|NCT00129987|10831035|FG000|COMPLETED|1 Year||114
9731106|NCT00129987|10831036|FG001|COMPLETED|1 Year||150
9731107|NCT00129987|10831035|FG000|NOT COMPLETED|1 Year||32
9731108|NCT00129987|10831036|FG001|NOT COMPLETED|1 Year||21
9731109|NCT00130039|10831044|FG000|STARTED|Overall Study||232
9731110|NCT00130039|10831045|FG001|STARTED|Overall Study||225
9731111|NCT00130039|10831044|FG000|COMPLETED|Overall Study|full analysis set|202
10061631|NCT02105467|11187242|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
10061632|NCT02105467|11187243|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
10061633|NCT02105467|11187242|FG000|COMPLETED|Period 3||0
10061634|NCT02105467|11187243|FG001|COMPLETED|Period 3||102
10061635|NCT02105467|11187242|FG000|NOT COMPLETED|Period 3||0
10061636|NCT02105467|11187243|FG001|NOT COMPLETED|Period 3||1
10061637|NCT02105558|11187252|FG000|STARTED|Overall Study||15
10061638|NCT02105558|11187253|FG001|STARTED|Overall Study||28
10061639|NCT02105558|11187252|FG000|COMPLETED|Overall Study||15
10061640|NCT02105558|11187253|FG001|COMPLETED|Overall Study||28
10061641|NCT02105558|11187252|FG000|NOT COMPLETED|Overall Study||0
10061642|NCT02105558|11187253|FG001|NOT COMPLETED|Overall Study||0
10061643|NCT02105662|11187259|FG000|STARTED|Overall Study||218
10061644|NCT02105662|11187259|FG000|COMPLETED|Overall Study||212
10174892|NCT03089879|11304852|FG002|STARTED|Overall Study||26
10174893|NCT03089879|11304850|FG000|COMPLETED|Overall Study||7
10174894|NCT03089879|11304851|FG001|COMPLETED|Overall Study||2
10174895|NCT03089879|11304852|FG002|COMPLETED|Overall Study||26
10061645|NCT02105662|11187259|FG000|NOT COMPLETED|Overall Study||6
10174896|NCT03089879|11304850|FG000|NOT COMPLETED|Overall Study||0
10174897|NCT03089879|11304851|FG001|NOT COMPLETED|Overall Study||0
10174898|NCT03089879|11304852|FG002|NOT COMPLETED|Overall Study||0
10174899|NCT03089944|11304861|FG000|STARTED|Overall Study||343
10174900|NCT03089944|11304861|FG000|COMPLETED|Overall Study||331
10174901|NCT03089944|11304861|FG000|NOT COMPLETED|Overall Study||12
10174902|NCT03090100|11304867|FG000|STARTED|Overall Study||534
10174903|NCT03090100|11304868|FG001|STARTED|Overall Study||514
10174904|NCT03090100|11304867|FG000|Treated|Overall Study||534
10174905|NCT03090100|11304868|FG001|Treated|Overall Study||511
10174906|NCT03090100|11304867|FG000|COMPLETED|Overall Study||507
10174907|NCT03090100|11304868|FG001|COMPLETED|Overall Study||466
10174908|NCT03090100|11304867|FG000|NOT COMPLETED|Overall Study||27
10174909|NCT03090100|11304868|FG001|NOT COMPLETED|Overall Study||48
10174910|NCT03090256|11304874|FG000|STARTED|Overall Study||68
10174911|NCT03090256|11304874|FG000|COMPLETED|Overall Study||68
10174912|NCT03090256|11304874|FG000|NOT COMPLETED|Overall Study||0
10174913|NCT03090620|11304881|FG000|STARTED|Overall Study||9
10174914|NCT03090620|11304882|FG001|STARTED|Overall Study||10
10174915|NCT03090620|11304881|FG000|COMPLETED|Overall Study||9
10174916|NCT03090620|11304882|FG001|COMPLETED|Overall Study||10
10174917|NCT03090620|11304881|FG000|NOT COMPLETED|Overall Study||0
10174918|NCT03090620|11304882|FG001|NOT COMPLETED|Overall Study||0
10174919|NCT03090958|11304888|FG000|STARTED|Overall Study||20
10174920|NCT03090958|11304888|FG000|COMPLETED|Overall Study||20
10174921|NCT03090958|11304888|FG000|NOT COMPLETED|Overall Study||0
10174922|NCT03091179|11304894|FG000|STARTED|Overall Study||10
10174923|NCT03091179|11304895|FG001|STARTED|Overall Study||10
10174924|NCT03091179|11304894|FG000|COMPLETED|Overall Study||10
10174925|NCT03091179|11304895|FG001|COMPLETED|Overall Study||10
10174926|NCT03091179|11304894|FG000|NOT COMPLETED|Overall Study||0
10174927|NCT03091179|11304895|FG001|NOT COMPLETED|Overall Study||0
10174928|NCT03091348|11304903|FG000|STARTED|Overall Study||2
10174929|NCT03091348|11304904|FG001|STARTED|Overall Study||2
10174930|NCT03091348|11304903|FG000|COMPLETED|Overall Study||0
10174931|NCT03091348|11304904|FG001|COMPLETED|Overall Study||1
10174932|NCT03091348|11304903|FG000|NOT COMPLETED|Overall Study||2
10174933|NCT03091348|11304904|FG001|NOT COMPLETED|Overall Study||1
10174934|NCT03091361|11304911|FG000|STARTED|Overall Study||30
10174935|NCT03091361|11304911|FG000|COMPLETED|Overall Study||30
10174936|NCT03091361|11304911|FG000|NOT COMPLETED|Overall Study||0
10174937|NCT03091400|11304917|FG000|STARTED|Phase 1 - 6 Weeks||5
10174938|NCT03091400|11304918|FG001|STARTED|Phase 1 - 6 Weeks||6
10174939|NCT03091400|11304917|FG000|COMPLETED|Phase 1 - 6 Weeks||5
10174940|NCT03091400|11304918|FG001|COMPLETED|Phase 1 - 6 Weeks||6
10174941|NCT03091400|11304917|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0
10174942|NCT03091400|11304918|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0
10174943|NCT03091400|11304917|FG000|STARTED|Washout - 2 Weeks||5
10174944|NCT03091400|11304918|FG001|STARTED|Washout - 2 Weeks||6
10174945|NCT03091400|11304917|FG000|COMPLETED|Washout - 2 Weeks||4
10174946|NCT03091400|11304918|FG001|COMPLETED|Washout - 2 Weeks||6
10174947|NCT03091400|11304917|FG000|NOT COMPLETED|Washout - 2 Weeks||1
10174948|NCT03091400|11304918|FG001|NOT COMPLETED|Washout - 2 Weeks||0
10174949|NCT03091400|11304917|FG000|STARTED|Phase 2 - 6 Weeks||4
10174950|NCT03091400|11304918|FG001|STARTED|Phase 2 - 6 Weeks||6
10174951|NCT03091400|11304917|FG000|COMPLETED|Phase 2 - 6 Weeks||4
10174952|NCT03091400|11304918|FG001|COMPLETED|Phase 2 - 6 Weeks||6
10174953|NCT03091400|11304917|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0
10174954|NCT03091400|11304918|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0
10174955|NCT03091439|11304926|FG000|STARTED|Overall Study||1
10174956|NCT03091439|11304927|FG001|STARTED|Overall Study||0
10174957|NCT03091439|11304926|FG000|COMPLETED|Overall Study||0
10174958|NCT03091439|11304927|FG001|COMPLETED|Overall Study||0
10174959|NCT03091439|11304926|FG000|NOT COMPLETED|Overall Study||1
10174960|NCT03091439|11304927|FG001|NOT COMPLETED|Overall Study||0
10174961|NCT03091478|11304933|FG000|STARTED|Overall Study||13
10174962|NCT03091478|11304933|FG000|COMPLETED|Overall Study||13
10174963|NCT03091478|11304933|FG000|NOT COMPLETED|Overall Study||0
10174964|NCT03091673|11304940|FG000|STARTED|First Dose||31
10174965|NCT03091673|11304941|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
10174966|NCT03091673|11304940|FG000|COMPLETED|First Dose||31
10174967|NCT03091673|11304941|FG001|COMPLETED|First Dose||0
10174968|NCT03091673|11304940|FG000|NOT COMPLETED|First Dose||0
10174969|NCT03091673|11304941|FG001|NOT COMPLETED|First Dose||0
10174970|NCT03091673|11304940|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
10174971|NCT03091673|11304941|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
10174972|NCT03091673|11304940|FG000|COMPLETED|Second Dose||0
10174973|NCT03091673|11304941|FG001|COMPLETED|Second Dose||11
10174974|NCT03091673|11304940|FG000|NOT COMPLETED|Second Dose||0
10174975|NCT03091673|11304941|FG001|NOT COMPLETED|Second Dose||0
10174976|NCT03091738|11304952|FG000|STARTED|Overall Study||10
10174977|NCT03091738|11304952|FG000|COMPLETED|Overall Study||8
10174978|NCT03091738|11304952|FG000|NOT COMPLETED|Overall Study||2
10174979|NCT03091751|11304956|FG000|STARTED|Overall Study||22
10174980|NCT03091751|11304956|FG000|COMPLETED|Overall Study||22
10174981|NCT03091751|11304956|FG000|NOT COMPLETED|Overall Study||0
10174982|NCT03091777|11304963|FG000|STARTED|Overall Study||289
10174983|NCT03091777|11304964|FG001|STARTED|Overall Study||288
10174984|NCT03091777|11304965|FG002|STARTED|Overall Study||294
10174985|NCT03091777|11304963|FG000|COMPLETED|Overall Study||257
10174986|NCT03091777|11304964|FG001|COMPLETED|Overall Study||255
10174987|NCT03091777|11304965|FG002|COMPLETED|Overall Study||257
10174988|NCT03091777|11304963|FG000|NOT COMPLETED|Overall Study||32
10174989|NCT03091777|11304964|FG001|NOT COMPLETED|Overall Study||33
10174990|NCT03091777|11304965|FG002|NOT COMPLETED|Overall Study||37
10174991|NCT03091920|11304976|FG000|STARTED|Overall Study||6
10174992|NCT03091920|11304977|FG001|STARTED|Overall Study||10
10174993|NCT03091920|11304978|FG002|STARTED|Overall Study||10
10174994|NCT03091920|11304976|FG000|COMPLETED|Overall Study||6
10174995|NCT03091920|11304977|FG001|COMPLETED|Overall Study||9
10174996|NCT03091920|11304978|FG002|COMPLETED|Overall Study||10
10174997|NCT03091920|11304976|FG000|NOT COMPLETED|Overall Study||0
10174998|NCT03091920|11304977|FG001|NOT COMPLETED|Overall Study||1
10174999|NCT03091920|11304978|FG002|NOT COMPLETED|Overall Study||0
10175000|NCT03092024|11304994|FG000|STARTED|Overall Study||24
10175001|NCT03092024|11304995|FG001|STARTED|Overall Study||16
10175002|NCT03092024|11304994|FG000|COMPLETED|Overall Study||24
10175003|NCT03092024|11304995|FG001|COMPLETED|Overall Study||16
10175004|NCT03092024|11304994|FG000|NOT COMPLETED|Overall Study||0
10175005|NCT03092024|11304995|FG001|NOT COMPLETED|Overall Study||0
10175006|NCT03092089|11305001|FG000|STARTED|Overall Study||15
10175007|NCT03092089|11305001|FG000|COMPLETED|Overall Study||15
10175008|NCT03092089|11305001|FG000|NOT COMPLETED|Overall Study||0
10175009|NCT03092375|11305009|FG000|STARTED|Overall Study||78
10175010|NCT03092375|11305010|FG001|STARTED|Overall Study||49
10175011|NCT03092375|11305011|FG002|STARTED|Overall Study||21
10175012|NCT03092375|11305012|FG003|STARTED|Overall Study||29
10175013|NCT03092375|11305009|FG000|COMPLETED|Overall Study||78
10175014|NCT03092375|11305010|FG001|COMPLETED|Overall Study||48
10175015|NCT03092375|11305011|FG002|COMPLETED|Overall Study||20
10175016|NCT03092375|11305012|FG003|COMPLETED|Overall Study||29
10175017|NCT03092375|11305009|FG000|NOT COMPLETED|Overall Study||0
10175018|NCT03092375|11305010|FG001|NOT COMPLETED|Overall Study||1
10175019|NCT03092375|11305011|FG002|NOT COMPLETED|Overall Study||1
10175020|NCT03092375|11305012|FG003|NOT COMPLETED|Overall Study||0
10175021|NCT03092479|11305031|FG000|STARTED|Overall Study||24
10175022|NCT03092479|11305032|FG001|STARTED|Overall Study||26
10175023|NCT03092479|11305031|FG000|COMPLETED|Overall Study||17
10175024|NCT03092479|11305032|FG001|COMPLETED|Overall Study||24
10175025|NCT03092479|11305031|FG000|NOT COMPLETED|Overall Study||7
10175026|NCT03092479|11305032|FG001|NOT COMPLETED|Overall Study||2
10175027|NCT03092726|11305040|FG000|STARTED|Overall Study||88
10175028|NCT03092726|11305041|FG001|STARTED|Overall Study||95
10175029|NCT03092726|11305040|FG000|Treated|Overall Study||88
10175030|NCT03092726|11305041|FG001|Treated|Overall Study||95
10175031|NCT03092726|11305040|FG000|COMPLETED|Overall Study||79
10175032|NCT03092726|11305041|FG001|COMPLETED|Overall Study||81
10175033|NCT03092726|11305040|FG000|NOT COMPLETED|Overall Study||9
10175034|NCT03092726|11305041|FG001|NOT COMPLETED|Overall Study||14
10175035|NCT03092752|11305047|FG000|STARTED|Overall Study||523585
10175036|NCT03092752|11305047|FG000|COMPLETED|Overall Study||162116
10175037|NCT03092752|11305047|FG000|NOT COMPLETED|Overall Study||361469
10175038|NCT03092791|11305076|FG000|STARTED|Overall Study||20
10175039|NCT03092791|11305077|FG001|STARTED|Overall Study||20
10175040|NCT03092791|11305078|FG002|STARTED|Overall Study||30
10175041|NCT03092791|11305079|FG003|STARTED|Overall Study||30
10175042|NCT03092791|11305080|FG004|STARTED|Overall Study||60
10175043|NCT03092791|11305081|FG005|STARTED|Overall Study||60
10175044|NCT03092791|11305082|FG006|STARTED|Overall Study||60
10175045|NCT03092791|11305083|FG007|STARTED|Overall Study||60
10175046|NCT03092791|11305076|FG000|COMPLETED|Overall Study||20
10175047|NCT03092791|11305077|FG001|COMPLETED|Overall Study||20
10175048|NCT03092791|11305078|FG002|COMPLETED|Overall Study||30
10175049|NCT03092791|11305079|FG003|COMPLETED|Overall Study||30
10175050|NCT03092791|11305080|FG004|COMPLETED|Overall Study||0
10175051|NCT03092791|11305081|FG005|COMPLETED|Overall Study||0
10175052|NCT03092791|11305082|FG006|COMPLETED|Overall Study||0
10175053|NCT03092791|11305083|FG007|COMPLETED|Overall Study||0
10175054|NCT03092791|11305076|FG000|NOT COMPLETED|Overall Study||0
10175055|NCT03092791|11305077|FG001|NOT COMPLETED|Overall Study||0
10175056|NCT03092791|11305078|FG002|NOT COMPLETED|Overall Study||0
10175057|NCT03092791|11305079|FG003|NOT COMPLETED|Overall Study||0
10175058|NCT03092791|11305080|FG004|NOT COMPLETED|Overall Study||60
10175059|NCT03092791|11305081|FG005|NOT COMPLETED|Overall Study||60
10175060|NCT03092791|11305082|FG006|NOT COMPLETED|Overall Study||60
10175061|NCT03092791|11305083|FG007|NOT COMPLETED|Overall Study||60
10175062|NCT03092934|11305105|FG000|STARTED|Overall Study||8
10175063|NCT03092934|11305106|FG001|STARTED|Overall Study||2
10175064|NCT03092934|11305107|FG002|STARTED|Overall Study||2
10175065|NCT03092934|11305108|FG003|STARTED|Overall Study||1
10175066|NCT03092934|11305105|FG000|Received at Least One Dose of Study Drug|Overall Study||8
10175067|NCT03092934|11305106|FG001|Received at Least One Dose of Study Drug|Overall Study||2
10175068|NCT03092934|11305107|FG002|Received at Least One Dose of Study Drug|Overall Study||2
10175069|NCT03092934|11305108|FG003|Received at Least One Dose of Study Drug|Overall Study||1
10175070|NCT03092934|11305105|FG000|COMPLETED|Overall Study||8
10175071|NCT03092934|11305106|FG001|COMPLETED|Overall Study||2
10175072|NCT03092934|11305107|FG002|COMPLETED|Overall Study||2
10175073|NCT03092934|11305108|FG003|COMPLETED|Overall Study||1
10175074|NCT03092934|11305105|FG000|NOT COMPLETED|Overall Study||0
10175075|NCT03092934|11305106|FG001|NOT COMPLETED|Overall Study||0
10175076|NCT03092934|11305107|FG002|NOT COMPLETED|Overall Study||0
10175077|NCT03092934|11305108|FG003|NOT COMPLETED|Overall Study||0
10175078|NCT03092960|11305120|FG000|STARTED|Overall Study||212
10175079|NCT03092960|11305121|FG001|STARTED|Overall Study||212
10175080|NCT03092960|11305120|FG000|COMPLETED|Overall Study||180
10175081|NCT03092960|11305121|FG001|COMPLETED|Overall Study||186
10175082|NCT03092960|11305120|FG000|NOT COMPLETED|Overall Study||32
10175083|NCT03092960|11305121|FG001|NOT COMPLETED|Overall Study||26
10175084|NCT03093025|11305130|FG000|STARTED|Overall Study||16
10175085|NCT03093025|11305131|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
10175086|NCT03093025|11305132|FG002|STARTED|Overall Study||18
10175087|NCT03093025|11305130|FG000|COMPLETED|Overall Study||12
10175088|NCT03093025|11305131|FG001|COMPLETED|Overall Study||15
10175089|NCT03093025|11305132|FG002|COMPLETED|Overall Study||16
10175090|NCT03093025|11305130|FG000|NOT COMPLETED|Overall Study||4
10175091|NCT03093025|11305131|FG001|NOT COMPLETED|Overall Study||2
10175092|NCT03093025|11305132|FG002|NOT COMPLETED|Overall Study||2
10175093|NCT03093181|11305143|FG000|STARTED|Overall Study||44
10175094|NCT03093181|11305144|FG001|STARTED|Overall Study||44
10175095|NCT03093181|11305145|FG002|STARTED|Overall Study||44
10175096|NCT03093181|11305143|FG000|COMPLETED|Overall Study||41
10175097|NCT03093181|11305144|FG001|COMPLETED|Overall Study||42
10175098|NCT03093181|11305145|FG002|COMPLETED|Overall Study||41
10175099|NCT03093181|11305143|FG000|NOT COMPLETED|Overall Study||3
10175100|NCT03093181|11305144|FG001|NOT COMPLETED|Overall Study||2
10175101|NCT03093181|11305145|FG002|NOT COMPLETED|Overall Study||3
10175102|NCT03093207|11305155|FG000|STARTED|Overall Study||17
10175103|NCT03093207|11305156|FG001|STARTED|Overall Study||17
10175104|NCT03093207|11305155|FG000|COMPLETED|Overall Study||17
10175105|NCT03093207|11305156|FG001|COMPLETED|Overall Study||17
10175106|NCT03093207|11305155|FG000|NOT COMPLETED|Overall Study||0
10175107|NCT03093207|11305156|FG001|NOT COMPLETED|Overall Study||0
10175108|NCT03093272|11305162|FG000|STARTED|Overall Study||9
10175109|NCT03093272|11305162|FG000|COMPLETED|Overall Study||9
10175110|NCT03093272|11305162|FG000|NOT COMPLETED|Overall Study||0
9713174|NCT03860259|10812363|FG000|STARTED|Overall Study||25
9713175|NCT03860259|10812364|FG001|STARTED|Overall Study||25
9713176|NCT03860259|10812363|FG000|COMPLETED|Overall Study||19
9713177|NCT03860259|10812364|FG001|COMPLETED|Overall Study||20
9713178|NCT03860259|10812363|FG000|NOT COMPLETED|Overall Study||6
9713179|NCT03860259|10812364|FG001|NOT COMPLETED|Overall Study||5
9713180|NCT03767634|10812373|FG000|STARTED|Overall Study||62145
9713181|NCT03767634|10812374|FG001|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
9713182|NCT03767634|10812375|FG002|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
9713183|NCT03767634|10812373|FG000|COMPLETED|Overall Study||62145
9713184|NCT03767634|10812374|FG001|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
9713185|NCT03767634|10812375|FG002|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
9713186|NCT03767634|10812373|FG000|NOT COMPLETED|Overall Study||0
9713187|NCT03767634|10812374|FG001|NOT COMPLETED|Overall Study||0
9713188|NCT03767634|10812375|FG002|NOT COMPLETED|Overall Study||0
9713232|NCT02993107|10812436|FG004|Withdrawal by Subject|Overall Study||6
9713233|NCT02993107|10812437|FG005|Withdrawal by Subject|Overall Study||2
9713234|NCT02993107|10812432|FG000|Lost to Follow-up|Overall Study||0
10175111|NCT03093324|11305168|FG000|STARTED|Overall Study||254
10175112|NCT03093324|11305169|FG001|STARTED|Overall Study||252
10175113|NCT03093324|11305168|FG000|Safety Population|Overall Study||253
10175114|NCT03093324|11305169|FG001|Safety Population|Overall Study||251
10175115|NCT03093324|11305168|FG000|COMPLETED|Overall Study||245
10175116|NCT03093324|11305169|FG001|COMPLETED|Overall Study||233
10175117|NCT03093324|11305168|FG000|NOT COMPLETED|Overall Study||9
10175118|NCT03093324|11305169|FG001|NOT COMPLETED|Overall Study||19
10175119|NCT03093415|11305178|FG000|STARTED|Assessed for Eligibility --> Enrollment||165
10175120|NCT03093415|11305179|FG001|STARTED|Assessed for Eligibility --> Enrollment||135
10175121|NCT03093415|11305180|FG002|STARTED|Assessed for Eligibility --> Enrollment||50
10175122|NCT03093415|11305178|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25
10175123|NCT03093415|11305179|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25
10175124|NCT03093415|11305180|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50
10175125|NCT03093415|11305178|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
10175126|NCT03093415|11305179|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
10175127|NCT03093415|11305180|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
10175128|NCT03093415|11305178|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
10175129|NCT03093415|11305179|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
10175130|NCT03093415|11305180|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
10175131|NCT03093415|11305178|FG000|COMPLETED|Enrollment to SVR12 Results||24
10175132|NCT03093415|11305179|FG001|COMPLETED|Enrollment to SVR12 Results||17
10175133|NCT03093415|11305180|FG002|COMPLETED|Enrollment to SVR12 Results||47
10175134|NCT03093415|11305178|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1
10175135|NCT03093415|11305179|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8
10175136|NCT03093415|11305180|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3
10175137|NCT03093454|11305190|FG000|STARTED|Overall Study||28
10175138|NCT03093454|11305191|FG001|STARTED|Overall Study||30
10175139|NCT03093454|11305190|FG000|COMPLETED|Overall Study||22
10175140|NCT03093454|11305191|FG001|COMPLETED|Overall Study||27
10175141|NCT03093454|11305190|FG000|NOT COMPLETED|Overall Study||6
10175142|NCT03093454|11305191|FG001|NOT COMPLETED|Overall Study||3
10175143|NCT03093662|11305199|FG000|STARTED|First Intervention (3 Minutes)||18
10175144|NCT03093662|11305200|FG001|STARTED|First Intervention (3 Minutes)||19
10175145|NCT03093662|11305199|FG000|COMPLETED|First Intervention (3 Minutes)||18
10175146|NCT03093662|11305200|FG001|COMPLETED|First Intervention (3 Minutes)||19
10175147|NCT03093662|11305199|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0
10175148|NCT03093662|11305200|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0
10175149|NCT03093662|11305199|FG000|STARTED|Washout Period (5 Minutes)||18
10175150|NCT03093662|11305200|FG001|STARTED|Washout Period (5 Minutes)||19
10175151|NCT03093662|11305199|FG000|COMPLETED|Washout Period (5 Minutes)||18
10175152|NCT03093662|11305200|FG001|COMPLETED|Washout Period (5 Minutes)||19
10175153|NCT03093662|11305199|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0
10175154|NCT03093662|11305200|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0
10175155|NCT03093662|11305199|FG000|STARTED|Second Intervention (3 Minutes)||18
10175156|NCT03093662|11305200|FG001|STARTED|Second Intervention (3 Minutes)||19
10175157|NCT03093662|11305199|FG000|COMPLETED|Second Intervention (3 Minutes)||18
10175158|NCT03093662|11305200|FG001|COMPLETED|Second Intervention (3 Minutes)||19
10175159|NCT03093662|11305199|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0
10175160|NCT03093662|11305200|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0
10175161|NCT03093870|11305209|FG000|STARTED|Overall Study||24
10175162|NCT03093870|11305210|FG001|STARTED|Overall Study||64
10175163|NCT03093870|11305211|FG002|STARTED|Overall Study||63
10175164|NCT03093870|11305209|FG000|COMPLETED|Overall Study||0
10175165|NCT03093870|11305210|FG001|COMPLETED|Overall Study||23
10175166|NCT03093870|11305211|FG002|COMPLETED|Overall Study||22
10175167|NCT03093870|11305209|FG000|NOT COMPLETED|Overall Study||24
10175168|NCT03093870|11305210|FG001|NOT COMPLETED|Overall Study||41
10175169|NCT03093870|11305211|FG002|NOT COMPLETED|Overall Study||41
10175170|NCT03094195|11305222|FG000|STARTED|Double-Blind Treatment Period (DB)||43
10175171|NCT03094195|11305223|FG001|STARTED|Double-Blind Treatment Period (DB)||43
10175172|NCT03094195|11305224|FG002|STARTED|Double-Blind Treatment Period (DB)||43
10175173|NCT03094195|11305225|FG003|STARTED|Double-Blind Treatment Period (DB)||0
10175174|NCT03094195|11305226|FG004|STARTED|Double-Blind Treatment Period (DB)||0
10175175|NCT03094195|11305227|FG005|STARTED|Double-Blind Treatment Period (DB)||0
10175176|NCT03094195|11305228|FG006|STARTED|Double-Blind Treatment Period (DB)||0
10175177|NCT03094195|11305229|FG007|STARTED|Double-Blind Treatment Period (DB)||0
10175178|NCT03094195|11305222|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28
10175179|NCT03094195|11305223|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
10175180|NCT03094195|11305224|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29
10175181|NCT03094195|11305225|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
10175182|NCT03094195|11305226|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
10175183|NCT03094195|11305227|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0
10175184|NCT03094195|11305228|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0
10175185|NCT03094195|11305229|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0
10175186|NCT03094195|11305222|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
10175187|NCT03094195|11305223|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
10175188|NCT03094195|11305224|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
10175189|NCT03094195|11305225|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10061646|NCT02105688|11187265|FG000|STARTED|Part A: Double-Blind||201
10061647|NCT02105688|11187266|FG001|STARTED|Part A: Double-Blind||100
10061648|NCT02105688|11187265|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181
10061649|NCT02105688|11187266|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83
10061650|NCT02105688|11187265|FG000|NOT COMPLETED|Part A: Double-Blind||20
10061651|NCT02105688|11187266|FG001|NOT COMPLETED|Part A: Double-Blind||17
10061652|NCT02105688|11187265|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
10061653|NCT02105688|11187266|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
10061654|NCT02105688|11187265|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
10061655|NCT02105688|11187266|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
10061656|NCT02105688|11187265|FG000|NOT COMPLETED|Part B: Observational Follow-up||37
10061657|NCT02105688|11187266|FG001|NOT COMPLETED|Part B: Observational Follow-up||20
10061658|NCT02105701|11187277|FG000|STARTED|Overall Study||105
10061659|NCT02105701|11187278|FG001|STARTED|Overall Study||104
10061660|NCT02105701|11187279|FG002|STARTED|Overall Study||105
10061661|NCT02105701|11187280|FG003|STARTED|Overall Study||106
10061662|NCT02105701|11187277|FG000|COMPLETED|Overall Study||101
10061663|NCT02105701|11187278|FG001|COMPLETED|Overall Study||103
10061664|NCT02105701|11187279|FG002|COMPLETED|Overall Study||102
10061665|NCT02105701|11187280|FG003|COMPLETED|Overall Study||104
10061666|NCT02105701|11187277|FG000|NOT COMPLETED|Overall Study||4
10061667|NCT02105701|11187278|FG001|NOT COMPLETED|Overall Study||1
10061668|NCT02105701|11187279|FG002|NOT COMPLETED|Overall Study||3
10061669|NCT02105701|11187280|FG003|NOT COMPLETED|Overall Study||2
10061670|NCT02105740|11187292|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
10061671|NCT02105740|11187293|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12
10061672|NCT02105740|11187292|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
10061673|NCT02105740|11187293|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
10061674|NCT02105740|11187292|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
10061675|NCT02105740|11187293|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
10061676|NCT02105740|11187292|FG000|NOT COMPLETED|Overall Study||0
10061677|NCT02105740|11187293|FG001|NOT COMPLETED|Overall Study||1
10061678|NCT02105948|11187305|FG000|STARTED|Overall Study||229
10061679|NCT02105948|11187306|FG001|STARTED|Overall Study||233
10061680|NCT02105948|11187307|FG002|STARTED|Overall Study||190
10061681|NCT02105948|11187308|FG003|STARTED|Overall Study||184
10061682|NCT02105948|11187305|FG000|Completed Investigational Product (IP)|Overall Study||185
10061683|NCT02105948|11187306|FG001|Completed Investigational Product (IP)|Overall Study||203
10061684|NCT02105948|11187307|FG002|Completed Investigational Product (IP)|Overall Study||148
10061685|NCT02105948|11187308|FG003|Completed Investigational Product (IP)|Overall Study||149
10061686|NCT02105948|11187305|FG000|Not Completed IP|Overall Study||44
10061687|NCT02105948|11187306|FG001|Not Completed IP|Overall Study||30
10061688|NCT02105948|11187307|FG002|Not Completed IP|Overall Study||42
10061689|NCT02105948|11187308|FG003|Not Completed IP|Overall Study||35
10061690|NCT02105948|11187305|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20
10061691|NCT02105948|11187306|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16
10061692|NCT02105948|11187307|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15
10061693|NCT02105948|11187308|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13
10061694|NCT02105948|11187305|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
10061695|NCT02105948|11187306|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10061696|NCT02105948|11187307|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
10061697|NCT02105948|11187308|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10061698|NCT02105948|11187305|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1
10061699|NCT02105948|11187306|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3
10061700|NCT02105948|11187307|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3
10061701|NCT02105948|11187308|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0
10061702|NCT02105948|11187305|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
10061703|NCT02105948|11187306|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
10061704|NCT02105948|11187307|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10061705|NCT02105948|11187308|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
10061706|NCT02105948|11187305|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
10061707|NCT02105948|11187306|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
10061708|NCT02105948|11187307|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
10061709|NCT02105948|11187308|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
10061710|NCT02105948|11187305|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
10061711|NCT02105948|11187306|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1
10061712|NCT02105948|11187307|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4
10061713|NCT02105948|11187308|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2
10061714|NCT02105948|11187305|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10061715|NCT02105948|11187306|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10061716|NCT02105948|11187307|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10175190|NCT03094195|11305226|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10175191|NCT03094195|11305227|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10175192|NCT03094195|11305228|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10175193|NCT03094195|11305229|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10175194|NCT03094195|11305222|FG000|STARTED|Treatment Withdrawal Period (TW)||0
10175195|NCT03094195|11305223|FG001|STARTED|Treatment Withdrawal Period (TW)||0
10175196|NCT03094195|11305224|FG002|STARTED|Treatment Withdrawal Period (TW)||0
10175197|NCT03094195|11305225|FG003|STARTED|Treatment Withdrawal Period (TW)||13
10175198|NCT03094195|11305226|FG004|STARTED|Treatment Withdrawal Period (TW)||13
10175199|NCT03094195|11305227|FG005|STARTED|Treatment Withdrawal Period (TW)||15
10175200|NCT03094195|11305228|FG006|STARTED|Treatment Withdrawal Period (TW)||13
10175201|NCT03094195|11305229|FG007|STARTED|Treatment Withdrawal Period (TW)||26
10175202|NCT03094195|11305222|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
10175203|NCT03094195|11305223|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
10175204|NCT03094195|11305224|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0
10175205|NCT03094195|11305225|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13
10175206|NCT03094195|11305226|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13
10175207|NCT03094195|11305227|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15
10175208|NCT03094195|11305228|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13
10175209|NCT03094195|11305229|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26
10175210|NCT03094195|11305222|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175211|NCT03094195|11305223|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175212|NCT03094195|11305224|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175213|NCT03094195|11305225|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175214|NCT03094195|11305226|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175215|NCT03094195|11305227|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175216|NCT03094195|11305228|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175217|NCT03094195|11305229|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10175218|NCT03094325|11305247|FG000|STARTED|Overall Study||10
10175219|NCT03094325|11305247|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10
10175220|NCT03094325|11305247|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10
10175221|NCT03094325|11305247|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10
10175222|NCT03094325|11305247|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10
10175223|NCT03094325|11305247|FG000|COMPLETED|Overall Study||10
10175224|NCT03094325|11305247|FG000|NOT COMPLETED|Overall Study||0
10175225|NCT03094611|11305253|FG000|STARTED|Overall Study||4
10175226|NCT03094611|11305253|FG000|COMPLETED|Overall Study||2
10175227|NCT03094611|11305253|FG000|NOT COMPLETED|Overall Study||2
10175228|NCT03094637|11305259|FG000|STARTED|Overall Study||17
10175229|NCT03094637|11305260|FG001|STARTED|Overall Study||20
10175230|NCT03094637|11305259|FG000|COMPLETED|Overall Study||17
10175231|NCT03094637|11305260|FG001|COMPLETED|Overall Study||20
10175232|NCT03094637|11305259|FG000|NOT COMPLETED|Overall Study||0
10175233|NCT03094637|11305260|FG001|NOT COMPLETED|Overall Study||0
10175234|NCT03094806|11305269|FG000|STARTED|Overall Study||44
10175235|NCT03094806|11305270|FG001|STARTED|Overall Study||47
10175236|NCT03094806|11305269|FG000|COMPLETED|Overall Study||44
10175237|NCT03094806|11305270|FG001|COMPLETED|Overall Study||47
10175238|NCT03094806|11305269|FG000|NOT COMPLETED|Overall Study||0
10175239|NCT03094806|11305270|FG001|NOT COMPLETED|Overall Study||0
10175240|NCT03095027|11305276|FG000|STARTED|Period 1, First Week of Wear||27
10175241|NCT03095027|11305277|FG001|STARTED|Period 1, First Week of Wear||24
10175242|NCT03095027|11305276|FG000|COMPLETED|Period 1, First Week of Wear||27
10175243|NCT03095027|11305277|FG001|COMPLETED|Period 1, First Week of Wear||24
10175244|NCT03095027|11305276|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10175245|NCT03095027|11305277|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
10175246|NCT03095027|11305276|FG000|STARTED|Period 2, Second Week of Wear||27
10175247|NCT03095027|11305277|FG001|STARTED|Period 2, Second Week of Wear||24
10175248|NCT03095027|11305276|FG000|COMPLETED|Period 2, Second Week of Wear||26
10175249|NCT03095027|11305277|FG001|COMPLETED|Period 2, Second Week of Wear||24
10175250|NCT03095027|11305276|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1
10175251|NCT03095027|11305277|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
10175252|NCT03095053|11305285|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
10175253|NCT03095053|11305286|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111
10175254|NCT03095053|11305285|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
10175255|NCT03095053|11305286|FG001|COMPLETED|Overall Study||111
10175256|NCT03095053|11305285|FG000|NOT COMPLETED|Overall Study||29
10175257|NCT03095053|11305286|FG001|NOT COMPLETED|Overall Study||0
10175258|NCT03095118|11305292|FG000|STARTED|Overall Study||12
10175259|NCT03095118|11305292|FG000|COMPLETED|Overall Study||10
10175260|NCT03095118|11305292|FG000|NOT COMPLETED|Overall Study||2
10175261|NCT03095508|11305298|FG000|STARTED|Overall Study||114
10175262|NCT03095508|11305299|FG001|STARTED|Overall Study||115
10175263|NCT03095508|11305298|FG000|Per Protocol Population|Overall Study||112
10175264|NCT03095508|11305299|FG001|Per Protocol Population|Overall Study||111
10175265|NCT03095508|11305298|FG000|Safety Population|Overall Study||114
10175266|NCT03095508|11305299|FG001|Safety Population|Overall Study||115
10175267|NCT03095508|11305298|FG000|ITT Population|Overall Study||114
10175268|NCT03095508|11305299|FG001|ITT Population|Overall Study||115
10175269|NCT03095508|11305298|FG000|COMPLETED|Overall Study||114
10175270|NCT03095508|11305299|FG001|COMPLETED|Overall Study||114
10175271|NCT03095508|11305298|FG000|NOT COMPLETED|Overall Study||0
10175272|NCT03095508|11305299|FG001|NOT COMPLETED|Overall Study||1
10175273|NCT03095521|11305307|FG000|STARTED|Overall Study||115
10175274|NCT03095521|11305308|FG001|STARTED|Overall Study||113
10175275|NCT03095521|11305307|FG000|Intent to Treat Population ITT|Overall Study||115
10175276|NCT03095521|11305308|FG001|Intent to Treat Population ITT|Overall Study||113
10175277|NCT03095521|11305307|FG000|Per Protocol Population PP|Overall Study||113
10175278|NCT03095521|11305308|FG001|Per Protocol Population PP|Overall Study||107
10175279|NCT03095521|11305307|FG000|Safety Population|Overall Study||115
10175280|NCT03095521|11305308|FG001|Safety Population|Overall Study||113
10175281|NCT03095521|11305307|FG000|COMPLETED|Overall Study||115
10175282|NCT03095521|11305308|FG001|COMPLETED|Overall Study||111
10175283|NCT03095521|11305307|FG000|NOT COMPLETED|Overall Study||0
10175284|NCT03095521|11305308|FG001|NOT COMPLETED|Overall Study||2
10175285|NCT03095599|11305316|FG000|STARTED|Overall Study||741
10175286|NCT03095599|11305317|FG001|STARTED|Overall Study||148
10175287|NCT03095599|11305316|FG000|Withdrawal Before Vaccination|Overall Study||1
10175288|NCT03095599|11305317|FG001|Withdrawal Before Vaccination|Overall Study||0
10175289|NCT03095599|11305316|FG000|Vaccinated|Overall Study||740
10175290|NCT03095599|11305317|FG001|Vaccinated|Overall Study||148
10175291|NCT03095599|11305316|FG000|COMPLETED|Overall Study||738
10175292|NCT03095599|11305317|FG001|COMPLETED|Overall Study||148
10175293|NCT03095599|11305316|FG000|NOT COMPLETED|Overall Study||3
10175294|NCT03095599|11305317|FG001|NOT COMPLETED|Overall Study||0
10175295|NCT03095638|11305327|FG000|STARTED|P1: Period 1 (4 Days)||7
10175296|NCT03095638|11305328|FG001|STARTED|P1: Period 1 (4 Days)||7
10175297|NCT03095638|11305329|FG002|STARTED|P1: Period 1 (4 Days)||0
10175298|NCT03095638|11305330|FG003|STARTED|P1: Period 1 (4 Days)||0
10175299|NCT03095638|11305331|FG004|STARTED|P1: Period 1 (4 Days)||0
10175300|NCT03095638|11305332|FG005|STARTED|P1: Period 1 (4 Days)||0
10175301|NCT03095638|11305333|FG006|STARTED|P1: Period 1 (4 Days)||0
10175302|NCT03095638|11305334|FG007|STARTED|P1: Period 1 (4 Days)||0
10175303|NCT03095638|11305327|FG000|COMPLETED|P1: Period 1 (4 Days)||7
10175304|NCT03095638|11305328|FG001|COMPLETED|P1: Period 1 (4 Days)||7
10175305|NCT03095638|11305329|FG002|COMPLETED|P1: Period 1 (4 Days)||0
10175306|NCT03095638|11305330|FG003|COMPLETED|P1: Period 1 (4 Days)||0
10175307|NCT03095638|11305331|FG004|COMPLETED|P1: Period 1 (4 Days)||0
10175308|NCT03095638|11305332|FG005|COMPLETED|P1: Period 1 (4 Days)||0
10175309|NCT03095638|11305333|FG006|COMPLETED|P1: Period 1 (4 Days)||0
10175310|NCT03095638|11305334|FG007|COMPLETED|P1: Period 1 (4 Days)||0
10175311|NCT03095638|11305327|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0
9713189|NCT03446573|10812386|FG000|STARTED|Overall Study||369
9713190|NCT03446573|10812387|FG001|STARTED|Overall Study||372
9713191|NCT03446573|10812386|FG000|COMPLETED|Overall Study||0
9713192|NCT03446573|10812387|FG001|COMPLETED|Overall Study||0
9713193|NCT03446573|10812386|FG000|NOT COMPLETED|Overall Study||369
9713194|NCT03446573|10812387|FG001|NOT COMPLETED|Overall Study||372
9713195|NCT03388138|10812398|FG000|STARTED|Overall Study||94
9713196|NCT03388138|10812399|FG001|STARTED|Overall Study||47
9713197|NCT03388138|10812398|FG000|COMPLETED|Overall Study||93
9713198|NCT03388138|10812399|FG001|COMPLETED|Overall Study||47
9713199|NCT03388138|10812398|FG000|NOT COMPLETED|Overall Study||1
9713200|NCT03388138|10812399|FG001|NOT COMPLETED|Overall Study||0
9713201|NCT03067610|10812405|FG000|STARTED|Overall Study||72
9713202|NCT03067610|10812405|FG000|COMPLETED|Overall Study||72
9713203|NCT03067610|10812405|FG000|NOT COMPLETED|Overall Study||0
9713204|NCT03027609|10812415|FG000|STARTED|Overall Study|Safety and ITT population|79
9713205|NCT03027609|10812416|FG001|STARTED|Overall Study|Safety and ITT population|79
9713206|NCT03027609|10812415|FG000|COMPLETED|Overall Study|Safety and ITT population|49
9713207|NCT03027609|10812416|FG001|COMPLETED|Overall Study|Safety and ITT population|62
9713208|NCT03027609|10812415|FG000|NOT COMPLETED|Overall Study||30
9713209|NCT03027609|10812416|FG001|NOT COMPLETED|Overall Study||17
9713210|NCT02993107|10812432|FG000|STARTED|Overall Study||113
9713211|NCT02993107|10812433|FG001|STARTED|Overall Study||120
9713212|NCT02993107|10812434|FG002|STARTED|Overall Study||50
9713213|NCT02993107|10812435|FG003|STARTED|Overall Study||35
9713214|NCT02993107|10812436|FG004|STARTED|Overall Study||34
9713215|NCT02993107|10812437|FG005|STARTED|Overall Study||36
9713216|NCT02993107|10812432|FG000|Adverse Event|Overall Study||12
9713217|NCT02993107|10812433|FG001|Adverse Event|Overall Study||4
9713218|NCT02993107|10812434|FG002|Adverse Event|Overall Study||1
9713219|NCT02993107|10812435|FG003|Adverse Event|Overall Study||1
9713220|NCT02993107|10812436|FG004|Adverse Event|Overall Study||3
9713221|NCT02993107|10812437|FG005|Adverse Event|Overall Study||5
9713222|NCT02993107|10812432|FG000|Physician Decision|Overall Study||1
9713223|NCT02993107|10812433|FG001|Physician Decision|Overall Study||0
9713224|NCT02993107|10812434|FG002|Physician Decision|Overall Study||1
9713225|NCT02993107|10812435|FG003|Physician Decision|Overall Study||0
9713226|NCT02993107|10812436|FG004|Physician Decision|Overall Study||0
9713227|NCT02993107|10812437|FG005|Physician Decision|Overall Study||0
9713228|NCT02993107|10812432|FG000|Withdrawal by Subject|Overall Study||32
9713229|NCT02993107|10812433|FG001|Withdrawal by Subject|Overall Study||7
9713230|NCT02993107|10812434|FG002|Withdrawal by Subject|Overall Study||7
9713231|NCT02993107|10812435|FG003|Withdrawal by Subject|Overall Study||3
10175312|NCT03095638|11305328|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0
10175313|NCT03095638|11305329|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0
10175314|NCT03095638|11305330|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0
10175315|NCT03095638|11305331|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0
10175316|NCT03095638|11305332|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0
10175317|NCT03095638|11305333|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0
10175318|NCT03095638|11305334|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0
10175319|NCT03095638|11305327|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
10175320|NCT03095638|11305328|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
10175321|NCT03095638|11305329|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10175322|NCT03095638|11305330|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10175323|NCT03095638|11305331|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10175324|NCT03095638|11305332|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10175325|NCT03095638|11305333|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10175326|NCT03095638|11305334|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10175327|NCT03095638|11305327|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
10175328|NCT03095638|11305328|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
10175329|NCT03095638|11305329|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175330|NCT03095638|11305330|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175331|NCT03095638|11305331|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175332|NCT03095638|11305332|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175333|NCT03095638|11305333|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175334|NCT03095638|11305334|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175335|NCT03095638|11305327|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175336|NCT03095638|11305328|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175337|NCT03095638|11305329|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175338|NCT03095638|11305330|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175339|NCT03095638|11305331|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175340|NCT03095638|11305332|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175341|NCT03095638|11305333|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175342|NCT03095638|11305334|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10175343|NCT03095638|11305327|FG000|STARTED|P1: Period 2 (4 Days)||7
10175344|NCT03095638|11305328|FG001|STARTED|P1: Period 2 (4 Days)||7
10175345|NCT03095638|11305329|FG002|STARTED|P1: Period 2 (4 Days)||0
10175346|NCT03095638|11305330|FG003|STARTED|P1: Period 2 (4 Days)||0
10175347|NCT03095638|11305331|FG004|STARTED|P1: Period 2 (4 Days)||0
10175348|NCT03095638|11305332|FG005|STARTED|P1: Period 2 (4 Days)||0
10175349|NCT03095638|11305333|FG006|STARTED|P1: Period 2 (4 Days)||0
10175350|NCT03095638|11305334|FG007|STARTED|P1: Period 2 (4 Days)||0
10175351|NCT03095638|11305327|FG000|COMPLETED|P1: Period 2 (4 Days)||7
10175352|NCT03095638|11305328|FG001|COMPLETED|P1: Period 2 (4 Days)||7
10175353|NCT03095638|11305329|FG002|COMPLETED|P1: Period 2 (4 Days)||0
10175354|NCT03095638|11305330|FG003|COMPLETED|P1: Period 2 (4 Days)||0
10175355|NCT03095638|11305331|FG004|COMPLETED|P1: Period 2 (4 Days)||0
10175356|NCT03095638|11305332|FG005|COMPLETED|P1: Period 2 (4 Days)||0
10175357|NCT03095638|11305333|FG006|COMPLETED|P1: Period 2 (4 Days)||0
10175358|NCT03095638|11305334|FG007|COMPLETED|P1: Period 2 (4 Days)||0
10175359|NCT03095638|11305327|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175360|NCT03095638|11305328|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175361|NCT03095638|11305329|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175362|NCT03095638|11305330|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175363|NCT03095638|11305331|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175364|NCT03095638|11305332|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175365|NCT03095638|11305333|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175366|NCT03095638|11305334|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0
10175367|NCT03095638|11305327|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
10175368|NCT03095638|11305328|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
10175369|NCT03095638|11305329|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10175370|NCT03095638|11305330|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10175371|NCT03095638|11305331|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10175372|NCT03095638|11305332|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10175373|NCT03095638|11305333|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10175374|NCT03095638|11305334|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10175375|NCT03095638|11305327|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
10175376|NCT03095638|11305328|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
10175377|NCT03095638|11305329|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175378|NCT03095638|11305330|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175379|NCT03095638|11305331|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175380|NCT03095638|11305332|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175381|NCT03095638|11305333|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175382|NCT03095638|11305334|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175383|NCT03095638|11305327|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175384|NCT03095638|11305328|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175385|NCT03095638|11305329|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175386|NCT03095638|11305330|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175387|NCT03095638|11305331|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175388|NCT03095638|11305332|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175389|NCT03095638|11305333|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175390|NCT03095638|11305334|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10175391|NCT03095638|11305327|FG000|STARTED|P2: Period 1 (4 Days)||0
10175392|NCT03095638|11305328|FG001|STARTED|P2: Period 1 (4 Days)||0
10175393|NCT03095638|11305329|FG002|STARTED|P2: Period 1 (4 Days)||4
10175394|NCT03095638|11305330|FG003|STARTED|P2: Period 1 (4 Days)||4
10175395|NCT03095638|11305331|FG004|STARTED|P2: Period 1 (4 Days)||4
10175396|NCT03095638|11305332|FG005|STARTED|P2: Period 1 (4 Days)||4
10175397|NCT03095638|11305333|FG006|STARTED|P2: Period 1 (4 Days)||4
10175398|NCT03095638|11305334|FG007|STARTED|P2: Period 1 (4 Days)||4
10175399|NCT03095638|11305327|FG000|COMPLETED|P2: Period 1 (4 Days)||0
10175400|NCT03095638|11305328|FG001|COMPLETED|P2: Period 1 (4 Days)||0
10175401|NCT03095638|11305329|FG002|COMPLETED|P2: Period 1 (4 Days)||4
10175402|NCT03095638|11305330|FG003|COMPLETED|P2: Period 1 (4 Days)||4
10175403|NCT03095638|11305331|FG004|COMPLETED|P2: Period 1 (4 Days)||4
10175404|NCT03095638|11305332|FG005|COMPLETED|P2: Period 1 (4 Days)||4
10175405|NCT03095638|11305333|FG006|COMPLETED|P2: Period 1 (4 Days)||4
10175406|NCT03095638|11305334|FG007|COMPLETED|P2: Period 1 (4 Days)||4
10175407|NCT03095638|11305327|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175408|NCT03095638|11305328|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175409|NCT03095638|11305329|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175410|NCT03095638|11305330|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175411|NCT03095638|11305331|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175412|NCT03095638|11305332|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175413|NCT03095638|11305333|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175414|NCT03095638|11305334|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0
10175415|NCT03095638|11305327|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
10175416|NCT03095638|11305328|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
10175417|NCT03095638|11305329|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10175418|NCT03095638|11305330|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10175419|NCT03095638|11305331|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10175420|NCT03095638|11305332|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10175421|NCT03095638|11305333|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10175422|NCT03095638|11305334|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10175423|NCT03095638|11305327|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175424|NCT03095638|11305328|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175425|NCT03095638|11305329|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10175426|NCT03095638|11305330|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10175427|NCT03095638|11305331|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10175428|NCT03095638|11305332|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10175429|NCT03095638|11305333|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10175430|NCT03095638|11305334|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10175431|NCT03095638|11305327|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175432|NCT03095638|11305328|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175433|NCT03095638|11305329|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175434|NCT03095638|11305330|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175435|NCT03095638|11305331|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175436|NCT03095638|11305332|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175437|NCT03095638|11305333|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175438|NCT03095638|11305334|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10175439|NCT03095638|11305327|FG000|STARTED|P2: Period 2 (4 Days)||0
10175440|NCT03095638|11305328|FG001|STARTED|P2: Period 2 (4 Days)||0
10175441|NCT03095638|11305329|FG002|STARTED|P2: Period 2 (4 Days)||4
10175442|NCT03095638|11305330|FG003|STARTED|P2: Period 2 (4 Days)||4
10175443|NCT03095638|11305331|FG004|STARTED|P2: Period 2 (4 Days)||4
10175444|NCT03095638|11305332|FG005|STARTED|P2: Period 2 (4 Days)||4
10175445|NCT03095638|11305333|FG006|STARTED|P2: Period 2 (4 Days)||4
10175446|NCT03095638|11305334|FG007|STARTED|P2: Period 2 (4 Days)||4
10175447|NCT03095638|11305327|FG000|COMPLETED|P2: Period 2 (4 Days)||0
10175448|NCT03095638|11305328|FG001|COMPLETED|P2: Period 2 (4 Days)||0
10175449|NCT03095638|11305329|FG002|COMPLETED|P2: Period 2 (4 Days)||4
10175450|NCT03095638|11305330|FG003|COMPLETED|P2: Period 2 (4 Days)||4
10175451|NCT03095638|11305331|FG004|COMPLETED|P2: Period 2 (4 Days)||4
10175452|NCT03095638|11305332|FG005|COMPLETED|P2: Period 2 (4 Days)||4
10175453|NCT03095638|11305333|FG006|COMPLETED|P2: Period 2 (4 Days)||4
10175454|NCT03095638|11305334|FG007|COMPLETED|P2: Period 2 (4 Days)||4
10175455|NCT03095638|11305327|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175456|NCT03095638|11305328|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175457|NCT03095638|11305329|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175458|NCT03095638|11305330|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175459|NCT03095638|11305331|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175460|NCT03095638|11305332|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175461|NCT03095638|11305333|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175462|NCT03095638|11305334|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0
10175463|NCT03095638|11305327|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
10175464|NCT03095638|11305328|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
10175465|NCT03095638|11305329|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10175466|NCT03095638|11305330|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10175467|NCT03095638|11305331|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10175468|NCT03095638|11305332|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10175469|NCT03095638|11305333|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10175470|NCT03095638|11305334|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10175471|NCT03095638|11305327|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175472|NCT03095638|11305328|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175473|NCT03095638|11305329|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10175474|NCT03095638|11305330|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10175475|NCT03095638|11305331|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10175476|NCT03095638|11305332|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10175477|NCT03095638|11305333|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10175478|NCT03095638|11305334|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10175479|NCT03095638|11305327|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175480|NCT03095638|11305328|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175481|NCT03095638|11305329|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175482|NCT03095638|11305330|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175483|NCT03095638|11305331|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175484|NCT03095638|11305332|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175485|NCT03095638|11305333|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175486|NCT03095638|11305334|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10175487|NCT03095638|11305327|FG000|STARTED|P2: Period 3 (4 Days)||0
10175488|NCT03095638|11305328|FG001|STARTED|P2: Period 3 (4 Days)||0
10175489|NCT03095638|11305329|FG002|STARTED|P2: Period 3 (4 Days)||4
10175490|NCT03095638|11305330|FG003|STARTED|P2: Period 3 (4 Days)||4
10175491|NCT03095638|11305331|FG004|STARTED|P2: Period 3 (4 Days)||4
10175492|NCT03095638|11305332|FG005|STARTED|P2: Period 3 (4 Days)||4
10175493|NCT03095638|11305333|FG006|STARTED|P2: Period 3 (4 Days)||4
10175494|NCT03095638|11305334|FG007|STARTED|P2: Period 3 (4 Days)||4
10175495|NCT03095638|11305327|FG000|COMPLETED|P2: Period 3 (4 Days)||0
10175496|NCT03095638|11305328|FG001|COMPLETED|P2: Period 3 (4 Days)||0
10175497|NCT03095638|11305329|FG002|COMPLETED|P2: Period 3 (4 Days)||4
10175498|NCT03095638|11305330|FG003|COMPLETED|P2: Period 3 (4 Days)||4
10175499|NCT03095638|11305331|FG004|COMPLETED|P2: Period 3 (4 Days)||4
10175500|NCT03095638|11305332|FG005|COMPLETED|P2: Period 3 (4 Days)||4
10175501|NCT03095638|11305333|FG006|COMPLETED|P2: Period 3 (4 Days)||4
10061717|NCT02105948|11187308|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1
10061718|NCT02105948|11187305|FG000|COMPLETED|Overall Study||202
10061719|NCT02105948|11187306|FG001|COMPLETED|Overall Study||213
10061720|NCT02105948|11187307|FG002|COMPLETED|Overall Study||162
10061721|NCT02105948|11187308|FG003|COMPLETED|Overall Study||157
10061722|NCT02105948|11187305|FG000|NOT COMPLETED|Overall Study||27
10061723|NCT02105948|11187306|FG001|NOT COMPLETED|Overall Study||20
10061724|NCT02105948|11187307|FG002|NOT COMPLETED|Overall Study||28
10061725|NCT02105948|11187308|FG003|NOT COMPLETED|Overall Study||27
10175502|NCT03095638|11305334|FG007|COMPLETED|P2: Period 3 (4 Days)||4
10175503|NCT03095638|11305327|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175504|NCT03095638|11305328|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175505|NCT03095638|11305329|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175506|NCT03095638|11305330|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175507|NCT03095638|11305331|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175508|NCT03095638|11305332|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175509|NCT03095638|11305333|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175510|NCT03095638|11305334|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0
10175511|NCT03095638|11305327|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
10175512|NCT03095638|11305328|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
10175513|NCT03095638|11305329|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10175514|NCT03095638|11305330|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10175515|NCT03095638|11305331|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10175516|NCT03095638|11305332|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10175517|NCT03095638|11305333|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10175518|NCT03095638|11305334|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10175519|NCT03095638|11305327|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175520|NCT03095638|11305328|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175521|NCT03095638|11305329|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10175522|NCT03095638|11305330|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10175523|NCT03095638|11305331|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10175524|NCT03095638|11305332|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10175525|NCT03095638|11305333|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10175526|NCT03095638|11305334|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10175527|NCT03095638|11305327|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175528|NCT03095638|11305328|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175529|NCT03095638|11305329|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9713235|NCT02993107|10812433|FG001|Lost to Follow-up|Overall Study||1
10061726|NCT02105961|11187322|FG000|STARTED|Overall Study||226
10061727|NCT02105961|11187323|FG001|STARTED|Overall Study||223
10061728|NCT02105961|11187324|FG002|STARTED|Overall Study||225
10175530|NCT03095638|11305330|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175531|NCT03095638|11305331|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175532|NCT03095638|11305332|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175533|NCT03095638|11305333|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175534|NCT03095638|11305334|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10175535|NCT03095651|11305362|FG000|STARTED|Overall Study||6
10175536|NCT03095651|11305363|FG001|STARTED|Overall Study||6
10175537|NCT03095651|11305364|FG002|STARTED|Overall Study||0
10175538|NCT03095651|11305365|FG003|STARTED|Overall Study||4
10175539|NCT03095651|11305366|FG004|STARTED|Overall Study||0
10175540|NCT03095651|11305367|FG005|STARTED|Overall Study||7
10175541|NCT03095651|11305368|FG006|STARTED|Overall Study||6
10175542|NCT03095651|11305369|FG007|STARTED|Overall Study||4
10175543|NCT03095651|11305362|FG000|COMPLETED|Overall Study||5
10175544|NCT03095651|11305363|FG001|COMPLETED|Overall Study||5
10175545|NCT03095651|11305364|FG002|COMPLETED|Overall Study||0
10175546|NCT03095651|11305365|FG003|COMPLETED|Overall Study||3
10175547|NCT03095651|11305366|FG004|COMPLETED|Overall Study||0
10175548|NCT03095651|11305367|FG005|COMPLETED|Overall Study||6
10175549|NCT03095651|11305368|FG006|COMPLETED|Overall Study||6
10175550|NCT03095651|11305369|FG007|COMPLETED|Overall Study||4
10175551|NCT03095651|11305362|FG000|NOT COMPLETED|Overall Study||1
10175552|NCT03095651|11305363|FG001|NOT COMPLETED|Overall Study||1
10175553|NCT03095651|11305364|FG002|NOT COMPLETED|Overall Study||0
10175554|NCT03095651|11305365|FG003|NOT COMPLETED|Overall Study||1
10175555|NCT03095651|11305366|FG004|NOT COMPLETED|Overall Study||0
10175556|NCT03095651|11305367|FG005|NOT COMPLETED|Overall Study||1
10175557|NCT03095651|11305368|FG006|NOT COMPLETED|Overall Study||0
10175558|NCT03095651|11305369|FG007|NOT COMPLETED|Overall Study||0
10175559|NCT03095885|11305387|FG000|STARTED|Overall Study||22
10175560|NCT03095885|11305387|FG000|COMPLETED|Overall Study||22
10175561|NCT03095885|11305387|FG000|NOT COMPLETED|Overall Study||0
10175562|NCT03095976|11305391|FG000|STARTED|Overall Study||4
10175563|NCT03095976|11305391|FG000|COMPLETED|Overall Study||4
10175564|NCT03095976|11305391|FG000|NOT COMPLETED|Overall Study||0
10175565|NCT03096314|11305397|FG000|STARTED|Screened Vitamin D Deficient||690
10175566|NCT03096314|11305398|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
10175567|NCT03096314|11305397|FG000|COMPLETED|Screened Vitamin D Deficient||681
10175568|NCT03096314|11305398|FG001|COMPLETED|Screened Vitamin D Deficient||656
10175569|NCT03096314|11305397|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9
10175570|NCT03096314|11305398|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12
10175571|NCT03096314|11305397|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
10175572|NCT03096314|11305398|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
10175573|NCT03096314|11305397|FG000|COMPLETED|Confirmed Vitamin D Deficient||531
10175574|NCT03096314|11305398|FG001|COMPLETED|Confirmed Vitamin D Deficient||528
10175575|NCT03096314|11305397|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7
10175576|NCT03096314|11305398|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12
10175577|NCT03096353|11305406|FG000|STARTED|Period 1||15
10175578|NCT03096353|11305407|FG001|STARTED|Period 1||13
10175579|NCT03096353|11305406|FG000|COMPLETED|Period 1||12
10175580|NCT03096353|11305407|FG001|COMPLETED|Period 1||12
10175581|NCT03096353|11305406|FG000|NOT COMPLETED|Period 1||3
10175582|NCT03096353|11305407|FG001|NOT COMPLETED|Period 1||1
10175583|NCT03096353|11305406|FG000|STARTED|Period 2||12
10175584|NCT03096353|11305407|FG001|STARTED|Period 2||12
10175585|NCT03096353|11305406|FG000|COMPLETED|Period 2||12
10175586|NCT03096353|11305407|FG001|COMPLETED|Period 2||12
10175587|NCT03096353|11305406|FG000|NOT COMPLETED|Period 2||0
10175588|NCT03096353|11305407|FG001|NOT COMPLETED|Period 2||0
10175589|NCT03096444|11305413|FG000|STARTED|Overall Study||13
10175590|NCT03096444|11305413|FG000|COMPLETED|Overall Study||13
10175591|NCT03096444|11305413|FG000|NOT COMPLETED|Overall Study||0
10175592|NCT03096483|11305425|FG000|STARTED|Overall Study||12
10175593|NCT03096483|11305425|FG000|COMPLETED|Overall Study||11
10175594|NCT03096483|11305425|FG000|NOT COMPLETED|Overall Study||1
10175595|NCT03096730|11305434|FG000|STARTED|Overall Study||30
10175596|NCT03096730|11305435|FG001|STARTED|Overall Study||30
10175597|NCT03096730|11305436|FG002|STARTED|Overall Study||30
10175598|NCT03096730|11305437|FG003|STARTED|Overall Study||30
10175599|NCT03096730|11305438|FG004|STARTED|Overall Study||30
10175600|NCT03096730|11305434|FG000|COMPLETED|Overall Study||27
10175601|NCT03096730|11305435|FG001|COMPLETED|Overall Study||27
10175602|NCT03096730|11305436|FG002|COMPLETED|Overall Study||27
10175603|NCT03096730|11305437|FG003|COMPLETED|Overall Study||27
10175604|NCT03096730|11305438|FG004|COMPLETED|Overall Study||27
10175605|NCT03096730|11305434|FG000|NOT COMPLETED|Overall Study||3
10175606|NCT03096730|11305435|FG001|NOT COMPLETED|Overall Study||3
10175607|NCT03096730|11305436|FG002|NOT COMPLETED|Overall Study||3
10175608|NCT03096730|11305437|FG003|NOT COMPLETED|Overall Study||3
10175609|NCT03096730|11305438|FG004|NOT COMPLETED|Overall Study||3
10175610|NCT03096847|11305453|FG000|STARTED|Overall Study||319
10175611|NCT03096847|11305454|FG001|STARTED|Overall Study||26
10175612|NCT03096847|11305455|FG002|STARTED|Overall Study||157
10175613|NCT03096847|11305453|FG000|Full Analysis Set|Overall Study||307
10175614|NCT03096847|11305454|FG001|Full Analysis Set|Overall Study||26
10175615|NCT03096847|11305455|FG002|Full Analysis Set|Overall Study||154
10175616|NCT03096847|11305453|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
10175617|NCT03096847|11305454|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
10175618|NCT03096847|11305455|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
10175619|NCT03096847|11305453|FG000|NOT COMPLETED|Overall Study||219
10175620|NCT03096847|11305454|FG001|NOT COMPLETED|Overall Study||20
10175621|NCT03096847|11305455|FG002|NOT COMPLETED|Overall Study||138
10175622|NCT03096873|11305473|FG000|STARTED|Overall Study||20
10175623|NCT03096873|11305474|FG001|STARTED|Overall Study||20
10175624|NCT03096873|11305473|FG000|COMPLETED|Overall Study||20
10175625|NCT03096873|11305474|FG001|COMPLETED|Overall Study||20
10175626|NCT03096873|11305473|FG000|NOT COMPLETED|Overall Study||0
10175627|NCT03096873|11305474|FG001|NOT COMPLETED|Overall Study||0
10175628|NCT03097029|11305482|FG000|STARTED|Overall Study||15
10175629|NCT03097029|11305482|FG000|COMPLETED|Overall Study||14
10175630|NCT03097029|11305482|FG000|NOT COMPLETED|Overall Study||1
10175631|NCT03097133|11305488|FG000|STARTED|Overall Study||115
10175632|NCT03097133|11305489|FG001|STARTED|Overall Study||115
10175633|NCT03097133|11305488|FG000|Treated|Overall Study||113
10175634|NCT03097133|11305489|FG001|Treated|Overall Study||114
10175635|NCT03097133|11305488|FG000|COMPLETED|Overall Study||85
10175636|NCT03097133|11305489|FG001|COMPLETED|Overall Study||81
10175637|NCT03097133|11305488|FG000|NOT COMPLETED|Overall Study||30
10175638|NCT03097133|11305489|FG001|NOT COMPLETED|Overall Study||34
10175639|NCT03097289|11305495|FG000|STARTED|Overall Study||32
10175640|NCT03097289|11305495|FG000|COMPLETED|Overall Study||26
10175641|NCT03097289|11305495|FG000|NOT COMPLETED|Overall Study||6
10175642|NCT03097315|11305500|FG000|STARTED|Overall Study||38
10175643|NCT03097315|11305500|FG000|Intention-to-Treat Population|Overall Study||38
10175644|NCT03097315|11305500|FG000|Safety Population|Overall Study||38
10175645|NCT03097315|11305500|FG000|COMPLETED|Overall Study||37
10175646|NCT03097315|11305500|FG000|NOT COMPLETED|Overall Study||1
10175647|NCT03097341|11305509|FG000|STARTED|Overall Study||4
10175648|NCT03097341|11305510|FG001|STARTED|Overall Study||4
10175649|NCT03097341|11305511|FG002|STARTED|Overall Study||4
10175650|NCT03097341|11305512|FG003|STARTED|Overall Study||4
10175651|NCT03097341|11305513|FG004|STARTED|Overall Study||5
10175652|NCT03097341|11305509|FG000|COMPLETED|Overall Study||4
10175653|NCT03097341|11305510|FG001|COMPLETED|Overall Study||4
10175654|NCT03097341|11305511|FG002|COMPLETED|Overall Study||4
10175655|NCT03097341|11305512|FG003|COMPLETED|Overall Study||4
10175656|NCT03097341|11305513|FG004|COMPLETED|Overall Study||5
10175657|NCT03097341|11305509|FG000|NOT COMPLETED|Overall Study||0
10175658|NCT03097341|11305510|FG001|NOT COMPLETED|Overall Study||0
10175659|NCT03097341|11305511|FG002|NOT COMPLETED|Overall Study||0
10175660|NCT03097341|11305512|FG003|NOT COMPLETED|Overall Study||0
10175661|NCT03097341|11305513|FG004|NOT COMPLETED|Overall Study||0
10175662|NCT03097484|11305527|FG000|STARTED|Overall Study||19
10175663|NCT03097484|11305528|FG001|STARTED|Overall Study||19
10175664|NCT03097484|11305527|FG000|COMPLETED|Overall Study||19
10175665|NCT03097484|11305528|FG001|COMPLETED|Overall Study||19
10175666|NCT03097484|11305527|FG000|NOT COMPLETED|Overall Study||0
10175667|NCT03097484|11305528|FG001|NOT COMPLETED|Overall Study||0
10175668|NCT03097588|11305534|FG000|STARTED|Overall Study||43
10175669|NCT03097588|11305534|FG000|COMPLETED|Overall Study||42
10175670|NCT03097588|11305534|FG000|NOT COMPLETED|Overall Study||1
10175671|NCT03097614|11305538|FG000|STARTED|Overall Study||57
10175672|NCT03097614|11305538|FG000|COMPLETED|Overall Study||54
10175673|NCT03097614|11305538|FG000|NOT COMPLETED|Overall Study||3
10175674|NCT03097653|11305544|FG000|STARTED|Overall Study||472
10175675|NCT03097653|11305545|FG001|STARTED|Overall Study||529
10175676|NCT03097653|11305544|FG000|COMPLETED|Overall Study||472
10175677|NCT03097653|11305545|FG001|COMPLETED|Overall Study||529
10175678|NCT03097653|11305544|FG000|NOT COMPLETED|Overall Study||0
10175679|NCT03097653|11305545|FG001|NOT COMPLETED|Overall Study||0
10175680|NCT03097783|11305553|FG000|STARTED|Overall Study||132
10175681|NCT03097783|11305554|FG001|STARTED|Overall Study||37
10175682|NCT03097783|11305553|FG000|COMPLETED|Overall Study||123
10175683|NCT03097783|11305554|FG001|COMPLETED|Overall Study||31
10175684|NCT03097783|11305553|FG000|NOT COMPLETED|Overall Study||9
10175685|NCT03097783|11305554|FG001|NOT COMPLETED|Overall Study||6
10175686|NCT03097861|11305563|FG000|STARTED|Overall Study||145
10175687|NCT03097861|11305564|FG001|STARTED|Overall Study||276
10175688|NCT03097861|11305565|FG002|STARTED|Overall Study||131
10175689|NCT03097861|11305563|FG000|Safety Population|Overall Study||143
10175690|NCT03097861|11305564|FG001|Safety Population|Overall Study||275
10175691|NCT03097861|11305565|FG002|Safety Population|Overall Study||130
10175692|NCT03097861|11305563|FG000|Modified Intent to Treat|Overall Study||143
10175693|NCT03097861|11305564|FG001|Modified Intent to Treat|Overall Study||275
10175694|NCT03097861|11305565|FG002|Modified Intent to Treat|Overall Study||130
10175695|NCT03097861|11305563|FG000|Completers|Overall Study||129
10175696|NCT03097861|11305564|FG001|Completers|Overall Study||255
10175697|NCT03097861|11305565|FG002|Completers|Overall Study||121
10175698|NCT03097861|11305563|FG000|Per-protocol Population (PP)|Overall Study||126
10175699|NCT03097861|11305564|FG001|Per-protocol Population (PP)|Overall Study||234
10175700|NCT03097861|11305565|FG002|Per-protocol Population (PP)|Overall Study||113
10175701|NCT03097861|11305563|FG000|COMPLETED|Overall Study||138
10175702|NCT03097861|11305564|FG001|COMPLETED|Overall Study||254
10175703|NCT03097861|11305565|FG002|COMPLETED|Overall Study||122
10175704|NCT03097861|11305563|FG000|NOT COMPLETED|Overall Study||7
10175705|NCT03097861|11305564|FG001|NOT COMPLETED|Overall Study||22
10175706|NCT03097861|11305565|FG002|NOT COMPLETED|Overall Study||9
10175707|NCT03098030|11305579|FG000|STARTED|Overall Study||12
10175708|NCT03098030|11305580|FG001|STARTED|Overall Study||187
10175709|NCT03098030|11305581|FG002|STARTED|Overall Study||190
10175710|NCT03098030|11305582|FG003|STARTED|Overall Study||94
10175711|NCT03098030|11305579|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
10175712|NCT03098030|11305580|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
10175713|NCT03098030|11305581|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
10175714|NCT03098030|11305582|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
10175715|NCT03098030|11305579|FG000|NOT COMPLETED|Overall Study||10
10175716|NCT03098030|11305580|FG001|NOT COMPLETED|Overall Study||163
10175717|NCT03098030|11305581|FG002|NOT COMPLETED|Overall Study||166
10175718|NCT03098030|11305582|FG003|NOT COMPLETED|Overall Study||85
10175719|NCT03098173|11305593|FG000|STARTED|Overall Study||81
10175720|NCT03098173|11305594|FG001|STARTED|Overall Study||81
10175721|NCT03098173|11305593|FG000|COMPLETED|Overall Study||80
10175722|NCT03098173|11305594|FG001|COMPLETED|Overall Study||79
10175723|NCT03098173|11305593|FG000|NOT COMPLETED|Overall Study||1
10175724|NCT03098173|11305594|FG001|NOT COMPLETED|Overall Study||2
10175725|NCT03098420|11305605|FG000|STARTED|Overall Study||7
10175726|NCT03098420|11305606|FG001|STARTED|Overall Study||9
10175727|NCT03098420|11305607|FG002|STARTED|Overall Study||13
10175728|NCT03098420|11305605|FG000|COMPLETED|Overall Study||7
10175729|NCT03098420|11305606|FG001|COMPLETED|Overall Study||9
10175730|NCT03098420|11305607|FG002|COMPLETED|Overall Study||13
10175731|NCT03098420|11305605|FG000|NOT COMPLETED|Overall Study||0
10175732|NCT03098420|11305606|FG001|NOT COMPLETED|Overall Study||0
10175733|NCT03098420|11305607|FG002|NOT COMPLETED|Overall Study||0
10175734|NCT03098433|11305615|FG000|STARTED|Overall Study||22
10175735|NCT03098433|11305615|FG000|COMPLETED|Overall Study||12
10175736|NCT03098433|11305615|FG000|NOT COMPLETED|Overall Study||10
10175737|NCT03098550|11305623|FG000|STARTED|Overall Study||41
10175738|NCT03098550|11305624|FG001|STARTED|Overall Study||21
10175739|NCT03098550|11305625|FG002|STARTED|Overall Study||43
10175740|NCT03098550|11305623|FG000|COMPLETED|Overall Study||0
10175741|NCT03098550|11305624|FG001|COMPLETED|Overall Study||1
10175742|NCT03098550|11305625|FG002|COMPLETED|Overall Study||0
10175743|NCT03098550|11305623|FG000|NOT COMPLETED|Overall Study||41
10175744|NCT03098550|11305624|FG001|NOT COMPLETED|Overall Study||20
10175745|NCT03098550|11305625|FG002|NOT COMPLETED|Overall Study||43
10175746|NCT03098615|11305637|FG000|STARTED|Overall Study||19
10175747|NCT03098615|11305637|FG000|COMPLETED|Overall Study||17
10175748|NCT03098615|11305637|FG000|NOT COMPLETED|Overall Study||2
10175749|NCT03098641|11305642|FG000|STARTED|Overall Study||272
10175750|NCT03098641|11305642|FG000|COMPLETED|Overall Study||220
10175751|NCT03098641|11305642|FG000|NOT COMPLETED|Overall Study||52
10175752|NCT03098745|11305646|FG000|STARTED|Day 1||7
10175753|NCT03098745|11305647|FG001|STARTED|Day 1||3
10175754|NCT03098745|11305648|FG002|STARTED|Day 1||8
10175755|NCT03098745|11305649|FG003|STARTED|Day 1||8
10175756|NCT03098745|11305650|FG004|STARTED|Day 1||10
10175757|NCT03098745|11305651|FG005|STARTED|Day 1||4
10175758|NCT03098745|11305646|FG000|COMPLETED|Day 1||7
10175759|NCT03098745|11305647|FG001|COMPLETED|Day 1||3
10175760|NCT03098745|11305648|FG002|COMPLETED|Day 1||8
10175761|NCT03098745|11305649|FG003|COMPLETED|Day 1||8
10175762|NCT03098745|11305650|FG004|COMPLETED|Day 1||10
10175763|NCT03098745|11305651|FG005|COMPLETED|Day 1||4
10175764|NCT03098745|11305646|FG000|NOT COMPLETED|Day 1||0
10175765|NCT03098745|11305647|FG001|NOT COMPLETED|Day 1||0
10175766|NCT03098745|11305648|FG002|NOT COMPLETED|Day 1||0
10175767|NCT03098745|11305649|FG003|NOT COMPLETED|Day 1||0
10175768|NCT03098745|11305650|FG004|NOT COMPLETED|Day 1||0
10175769|NCT03098745|11305651|FG005|NOT COMPLETED|Day 1||0
10175770|NCT03098745|11305646|FG000|STARTED|Day 2||7
10175771|NCT03098745|11305647|FG001|STARTED|Day 2||3
10175772|NCT03098745|11305648|FG002|STARTED|Day 2||8
10175773|NCT03098745|11305649|FG003|STARTED|Day 2||8
10175774|NCT03098745|11305650|FG004|STARTED|Day 2||10
10175775|NCT03098745|11305651|FG005|STARTED|Day 2||4
10175776|NCT03098745|11305646|FG000|COMPLETED|Day 2||7
10175777|NCT03098745|11305647|FG001|COMPLETED|Day 2||3
10175778|NCT03098745|11305648|FG002|COMPLETED|Day 2||8
10175779|NCT03098745|11305649|FG003|COMPLETED|Day 2||8
10175780|NCT03098745|11305650|FG004|COMPLETED|Day 2||10
10175781|NCT03098745|11305651|FG005|COMPLETED|Day 2||4
10175782|NCT03098745|11305646|FG000|NOT COMPLETED|Day 2||0
10175783|NCT03098745|11305647|FG001|NOT COMPLETED|Day 2||0
10175784|NCT03098745|11305648|FG002|NOT COMPLETED|Day 2||0
10175785|NCT03098745|11305649|FG003|NOT COMPLETED|Day 2||0
10175786|NCT03098745|11305650|FG004|NOT COMPLETED|Day 2||0
10175787|NCT03098745|11305651|FG005|NOT COMPLETED|Day 2||0
10175788|NCT03098745|11305646|FG000|STARTED|Day 3||7
10175789|NCT03098745|11305647|FG001|STARTED|Day 3||3
10175790|NCT03098745|11305648|FG002|STARTED|Day 3||8
10175791|NCT03098745|11305649|FG003|STARTED|Day 3||8
10175792|NCT03098745|11305650|FG004|STARTED|Day 3||10
10175793|NCT03098745|11305651|FG005|STARTED|Day 3||4
10175794|NCT03098745|11305646|FG000|COMPLETED|Day 3||7
10175795|NCT03098745|11305647|FG001|COMPLETED|Day 3||3
10175796|NCT03098745|11305648|FG002|COMPLETED|Day 3||8
10175797|NCT03098745|11305649|FG003|COMPLETED|Day 3||8
10175798|NCT03098745|11305650|FG004|COMPLETED|Day 3||10
10175799|NCT03098745|11305651|FG005|COMPLETED|Day 3||4
10175800|NCT03098745|11305646|FG000|NOT COMPLETED|Day 3||0
10175801|NCT03098745|11305647|FG001|NOT COMPLETED|Day 3||0
10175802|NCT03098745|11305648|FG002|NOT COMPLETED|Day 3||0
10175803|NCT03098745|11305649|FG003|NOT COMPLETED|Day 3||0
10175804|NCT03098745|11305650|FG004|NOT COMPLETED|Day 3||0
10175805|NCT03098745|11305651|FG005|NOT COMPLETED|Day 3||0
10175806|NCT03098966|11305660|FG000|STARTED|Overall Study||368
10175807|NCT03098966|11305660|FG000|COMPLETED|Overall Study||368
10175808|NCT03098966|11305660|FG000|NOT COMPLETED|Overall Study||0
10175809|NCT03098979|11305670|FG000|STARTED|Overall Study||76
10175810|NCT03098979|11305671|FG001|STARTED|Overall Study||27
10175811|NCT03098979|11305672|FG002|STARTED|Overall Study||50
10175812|NCT03098979|11305673|FG003|STARTED|Overall Study||51
10175813|NCT03098979|11305674|FG004|STARTED|Overall Study||50
10175814|NCT03098979|11305675|FG005|STARTED|Overall Study||51
10175815|NCT03098979|11305670|FG000|COMPLETED|Overall Study||70
10175816|NCT03098979|11305671|FG001|COMPLETED|Overall Study||25
10175817|NCT03098979|11305672|FG002|COMPLETED|Overall Study||46
10175818|NCT03098979|11305673|FG003|COMPLETED|Overall Study||46
10175819|NCT03098979|11305674|FG004|COMPLETED|Overall Study||41
10175820|NCT03098979|11305675|FG005|COMPLETED|Overall Study||47
10175821|NCT03098979|11305670|FG000|NOT COMPLETED|Overall Study||6
10175822|NCT03098979|11305671|FG001|NOT COMPLETED|Overall Study||2
10175823|NCT03098979|11305672|FG002|NOT COMPLETED|Overall Study||4
10175824|NCT03098979|11305673|FG003|NOT COMPLETED|Overall Study||5
10175825|NCT03098979|11305674|FG004|NOT COMPLETED|Overall Study||9
10175826|NCT03098979|11305675|FG005|NOT COMPLETED|Overall Study||4
10175827|NCT03099096|11305689|FG000|STARTED|Overall Study||159
10175828|NCT03099096|11305689|FG000|COMPLETED|Overall Study||157
10175829|NCT03099096|11305689|FG000|NOT COMPLETED|Overall Study||2
10175830|NCT03099161|11305696|FG000|STARTED|Overall Study||3
10175831|NCT03099161|11305697|FG001|STARTED|Overall Study||4
10175832|NCT03099161|11305698|FG002|STARTED|Overall Study||3
10175833|NCT03099161|11305696|FG000|COMPLETED|Overall Study||0
10175834|NCT03099161|11305697|FG001|COMPLETED|Overall Study||0
10175835|NCT03099161|11305698|FG002|COMPLETED|Overall Study||0
10175836|NCT03099161|11305696|FG000|NOT COMPLETED|Overall Study||3
10175837|NCT03099161|11305697|FG001|NOT COMPLETED|Overall Study||4
10175838|NCT03099161|11305698|FG002|NOT COMPLETED|Overall Study||3
10175839|NCT03099187|11305708|FG000|STARTED|Double-blind Treatment||127
10175840|NCT03099187|11305709|FG001|STARTED|Double-blind Treatment||126
10175841|NCT03099187|11305710|FG002|STARTED|Double-blind Treatment||0
10175842|NCT03099187|11305711|FG003|STARTED|Double-blind Treatment||0
10175843|NCT03099187|11305708|FG000|COMPLETED|Double-blind Treatment||94
10175844|NCT03099187|11305709|FG001|COMPLETED|Double-blind Treatment||110
10175845|NCT03099187|11305710|FG002|COMPLETED|Double-blind Treatment||0
10175846|NCT03099187|11305711|FG003|COMPLETED|Double-blind Treatment||0
10175847|NCT03099187|11305708|FG000|NOT COMPLETED|Double-blind Treatment||33
10175848|NCT03099187|11305709|FG001|NOT COMPLETED|Double-blind Treatment||16
10175849|NCT03099187|11305710|FG002|NOT COMPLETED|Double-blind Treatment||0
10175850|NCT03099187|11305711|FG003|NOT COMPLETED|Double-blind Treatment||0
10175851|NCT03099187|11305708|FG000|STARTED|12-month Safety Follow-up||0
10175852|NCT03099187|11305709|FG001|STARTED|12-month Safety Follow-up||0
10175853|NCT03099187|11305710|FG002|STARTED|12-month Safety Follow-up||94
10175854|NCT03099187|11305711|FG003|STARTED|12-month Safety Follow-up||110
10175855|NCT03099187|11305708|FG000|COMPLETED|12-month Safety Follow-up||0
10175856|NCT03099187|11305709|FG001|COMPLETED|12-month Safety Follow-up||0
10175857|NCT03099187|11305710|FG002|COMPLETED|12-month Safety Follow-up||75
10175858|NCT03099187|11305711|FG003|COMPLETED|12-month Safety Follow-up||84
10175859|NCT03099187|11305708|FG000|NOT COMPLETED|12-month Safety Follow-up||0
10175860|NCT03099187|11305709|FG001|NOT COMPLETED|12-month Safety Follow-up||0
10175861|NCT03099187|11305710|FG002|NOT COMPLETED|12-month Safety Follow-up||19
10175862|NCT03099187|11305711|FG003|NOT COMPLETED|12-month Safety Follow-up||26
10175863|NCT03099369|11305723|FG000|STARTED|Overall Study||11
10175864|NCT03099369|11305724|FG001|STARTED|Overall Study||9
10175865|NCT03099369|11305723|FG000|COMPLETED|Overall Study||5
10175866|NCT03099369|11305724|FG001|COMPLETED|Overall Study||5
10175867|NCT03099369|11305723|FG000|NOT COMPLETED|Overall Study||6
10175868|NCT03099369|11305724|FG001|NOT COMPLETED|Overall Study||4
10175869|NCT03099538|11305731|FG000|STARTED|Overall Study||4
10175870|NCT03099538|11305731|FG000|COMPLETED|Overall Study||1
10175871|NCT03099538|11305731|FG000|NOT COMPLETED|Overall Study||3
10175872|NCT03099655|11305735|FG000|STARTED|Overall Study||440
10175873|NCT03099655|11305735|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
10175874|NCT03099655|11305735|FG000|NOT COMPLETED|Overall Study||61
10175875|NCT03099694|11305744|FG000|STARTED|Overall Study||170
10175876|NCT03099694|11305745|FG001|STARTED|Overall Study||170
10175877|NCT03099694|11305744|FG000|COMPLETED|Overall Study||150
10175878|NCT03099694|11305745|FG001|COMPLETED|Overall Study||152
10175879|NCT03099694|11305744|FG000|NOT COMPLETED|Overall Study||20
10175880|NCT03099694|11305745|FG001|NOT COMPLETED|Overall Study||18
10175881|NCT03100058|11305761|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10175882|NCT03100058|11305762|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10175883|NCT03100058|11305763|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10175884|NCT03100058|11305764|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77
10175885|NCT03100058|11305765|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10175886|NCT03100058|11305766|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39
10175887|NCT03100058|11305767|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10175888|NCT03100058|11305768|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76
10175889|NCT03100058|11305769|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78
10175890|NCT03100058|11305770|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10175891|NCT03100058|11305771|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10175892|NCT03100058|11305772|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10175893|NCT03100058|11305773|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10175894|NCT03100058|11305761|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
10175895|NCT03100058|11305762|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
10175896|NCT03100058|11305763|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
10175897|NCT03100058|11305764|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
10175898|NCT03100058|11305765|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
10175899|NCT03100058|11305766|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
10175900|NCT03100058|11305767|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
10175901|NCT03100058|11305768|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
10175902|NCT03100058|11305769|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
10175903|NCT03100058|11305770|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175904|NCT03100058|11305771|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175905|NCT03100058|11305772|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175906|NCT03100058|11305773|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175907|NCT03100058|11305761|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
10175908|NCT03100058|11305762|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
10175909|NCT03100058|11305763|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
10175910|NCT03100058|11305764|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
10175911|NCT03100058|11305765|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
10175912|NCT03100058|11305766|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
10175913|NCT03100058|11305767|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
10175914|NCT03100058|11305768|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
10175915|NCT03100058|11305769|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
10175916|NCT03100058|11305770|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175917|NCT03100058|11305771|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175918|NCT03100058|11305772|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175919|NCT03100058|11305773|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10175920|NCT03100058|11305761|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175921|NCT03100058|11305762|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175922|NCT03100058|11305763|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175923|NCT03100058|11305764|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175924|NCT03100058|11305765|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175925|NCT03100058|11305766|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175926|NCT03100058|11305767|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175927|NCT03100058|11305768|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175928|NCT03100058|11305769|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10175929|NCT03100058|11305770|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
10175930|NCT03100058|11305771|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
10175931|NCT03100058|11305772|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
10175932|NCT03100058|11305773|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
10175933|NCT03100058|11305761|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175934|NCT03100058|11305762|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175935|NCT03100058|11305763|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175936|NCT03100058|11305764|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175937|NCT03100058|11305765|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175938|NCT03100058|11305766|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175939|NCT03100058|11305767|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175940|NCT03100058|11305768|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175941|NCT03100058|11305769|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175942|NCT03100058|11305770|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
10175943|NCT03100058|11305771|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
10175944|NCT03100058|11305772|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
10175945|NCT03100058|11305773|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
10175946|NCT03100058|11305761|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175947|NCT03100058|11305762|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175948|NCT03100058|11305763|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175949|NCT03100058|11305764|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175950|NCT03100058|11305765|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175951|NCT03100058|11305766|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175952|NCT03100058|11305767|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175953|NCT03100058|11305768|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175954|NCT03100058|11305769|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10175955|NCT03100058|11305770|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
10175956|NCT03100058|11305771|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
10175957|NCT03100058|11305772|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
10175958|NCT03100058|11305773|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
10175959|NCT03100123|11305804|FG000|STARTED|Overall Study||0
10175960|NCT03100123|11305805|FG001|STARTED|Overall Study||1
10175961|NCT03100123|11305804|FG000|COMPLETED|Overall Study||0
10175962|NCT03100123|11305805|FG001|COMPLETED|Overall Study||1
10175963|NCT03100123|11305804|FG000|NOT COMPLETED|Overall Study||0
10175964|NCT03100123|11305805|FG001|NOT COMPLETED|Overall Study||0
10175965|NCT03100344|11305820|FG000|STARTED|Overall Study||57
10175966|NCT03100344|11305821|FG001|STARTED|Overall Study||55
10175967|NCT03100344|11305822|FG002|STARTED|Overall Study||57
10175968|NCT03100344|11305823|FG003|STARTED|Overall Study||57
10175969|NCT03100344|11305820|FG000|COMPLETED|Overall Study||43
10175970|NCT03100344|11305821|FG001|COMPLETED|Overall Study||44
10175971|NCT03100344|11305822|FG002|COMPLETED|Overall Study||50
10175972|NCT03100344|11305823|FG003|COMPLETED|Overall Study||45
10175973|NCT03100344|11305820|FG000|NOT COMPLETED|Overall Study||14
10175974|NCT03100344|11305821|FG001|NOT COMPLETED|Overall Study||11
10175975|NCT03100344|11305822|FG002|NOT COMPLETED|Overall Study||7
10175976|NCT03100344|11305823|FG003|NOT COMPLETED|Overall Study||12
10175977|NCT03100500|11305834|FG000|STARTED|Overall Study||51
10175978|NCT03100500|11305834|FG000|COMPLETED|Overall Study||51
10175979|NCT03100500|11305834|FG000|NOT COMPLETED|Overall Study||0
10175980|NCT03100825|11305838|FG000|STARTED|Overall Study||94
10175981|NCT03100825|11305838|FG000|COMPLETED|Overall Study||86
10175982|NCT03100825|11305838|FG000|NOT COMPLETED|Overall Study||8
10175983|NCT03100838|11305842|FG000|STARTED|Overall Study||16
10175984|NCT03100838|11305843|FG001|STARTED|Overall Study||16
10175985|NCT03100838|11305844|FG002|STARTED|Overall Study||16
10175986|NCT03100838|11305845|FG003|STARTED|Overall Study||16
10175987|NCT03100838|11305842|FG000|COMPLETED|Overall Study||14
10175988|NCT03100838|11305843|FG001|COMPLETED|Overall Study||14
10175989|NCT03100838|11305844|FG002|COMPLETED|Overall Study||14
10175990|NCT03100838|11305845|FG003|COMPLETED|Overall Study||15
10175991|NCT03100838|11305842|FG000|NOT COMPLETED|Overall Study||2
10175992|NCT03100838|11305843|FG001|NOT COMPLETED|Overall Study||2
10175993|NCT03100838|11305844|FG002|NOT COMPLETED|Overall Study||2
10175994|NCT03100838|11305845|FG003|NOT COMPLETED|Overall Study||1
10175995|NCT03100864|11305855|FG000|STARTED|Overall Study||8
10175996|NCT03100864|11305855|FG000|COMPLETED|Overall Study||8
10175997|NCT03100864|11305855|FG000|NOT COMPLETED|Overall Study||0
10175998|NCT03100942|11305863|FG000|STARTED|Randomized Treatment Period||38
10175999|NCT03100942|11305864|FG001|STARTED|Randomized Treatment Period||38
10176000|NCT03100942|11305865|FG002|STARTED|Randomized Treatment Period||39
10176001|NCT03100942|11305866|FG003|STARTED|Randomized Treatment Period||37
10176002|NCT03100942|11305867|FG004|STARTED|Randomized Treatment Period||0
10176003|NCT03100942|11305868|FG005|STARTED|Randomized Treatment Period||0
10176004|NCT03100942|11305869|FG006|STARTED|Randomized Treatment Period||0
10176005|NCT03100942|11305863|FG000|COMPLETED|Randomized Treatment Period||26
10176006|NCT03100942|11305864|FG001|COMPLETED|Randomized Treatment Period||29
10176007|NCT03100942|11305865|FG002|COMPLETED|Randomized Treatment Period||33
10176008|NCT03100942|11305866|FG003|COMPLETED|Randomized Treatment Period||32
10176009|NCT03100942|11305867|FG004|COMPLETED|Randomized Treatment Period||0
10176010|NCT03100942|11305868|FG005|COMPLETED|Randomized Treatment Period||0
10176011|NCT03100942|11305869|FG006|COMPLETED|Randomized Treatment Period||0
10176012|NCT03100942|11305863|FG000|NOT COMPLETED|Randomized Treatment Period||12
10176013|NCT03100942|11305864|FG001|NOT COMPLETED|Randomized Treatment Period||9
10176014|NCT03100942|11305865|FG002|NOT COMPLETED|Randomized Treatment Period||6
10176015|NCT03100942|11305866|FG003|NOT COMPLETED|Randomized Treatment Period||5
10176016|NCT03100942|11305867|FG004|NOT COMPLETED|Randomized Treatment Period||0
10176017|NCT03100942|11305868|FG005|NOT COMPLETED|Randomized Treatment Period||0
10176018|NCT03100942|11305869|FG006|NOT COMPLETED|Randomized Treatment Period||0
10176019|NCT03100942|11305863|FG000|STARTED|Placebo Arm Re-Randomized||0
10176020|NCT03100942|11305864|FG001|STARTED|Placebo Arm Re-Randomized||0
10176021|NCT03100942|11305865|FG002|STARTED|Placebo Arm Re-Randomized||0
10176022|NCT03100942|11305866|FG003|STARTED|Placebo Arm Re-Randomized||0
10176023|NCT03100942|11305867|FG004|STARTED|Placebo Arm Re-Randomized||10
10176024|NCT03100942|11305868|FG005|STARTED|Placebo Arm Re-Randomized||12
10176025|NCT03100942|11305869|FG006|STARTED|Placebo Arm Re-Randomized||10
10176026|NCT03100942|11305863|FG000|COMPLETED|Placebo Arm Re-Randomized||0
10176027|NCT03100942|11305864|FG001|COMPLETED|Placebo Arm Re-Randomized||0
10176028|NCT03100942|11305865|FG002|COMPLETED|Placebo Arm Re-Randomized||0
10176029|NCT03100942|11305866|FG003|COMPLETED|Placebo Arm Re-Randomized||0
10176030|NCT03100942|11305867|FG004|COMPLETED|Placebo Arm Re-Randomized||10
10176031|NCT03100942|11305868|FG005|COMPLETED|Placebo Arm Re-Randomized||12
10176032|NCT03100942|11305869|FG006|COMPLETED|Placebo Arm Re-Randomized||9
10176033|NCT03100942|11305863|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0
10176034|NCT03100942|11305864|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0
10176035|NCT03100942|11305865|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0
10176036|NCT03100942|11305866|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0
10176037|NCT03100942|11305867|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0
10176038|NCT03100942|11305868|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0
10176039|NCT03100942|11305869|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1
10176040|NCT03100968|11305884|FG000|STARTED|Overall Study||75
10176041|NCT03100968|11305885|FG001|STARTED|Overall Study||75
10176042|NCT03100968|11305884|FG000|COMPLETED|Overall Study||75
10176043|NCT03100968|11305885|FG001|COMPLETED|Overall Study||75
10176044|NCT03100968|11305884|FG000|NOT COMPLETED|Overall Study||0
10176045|NCT03100968|11305885|FG001|NOT COMPLETED|Overall Study||0
10176046|NCT03101020|11305893|FG000|STARTED|Overall Study||10
10176047|NCT03101020|11305894|FG001|STARTED|Overall Study||10
10176048|NCT03101020|11305893|FG000|COMPLETED|Overall Study||9
9713236|NCT02993107|10812434|FG002|Lost to Follow-up|Overall Study||0
9713237|NCT02993107|10812435|FG003|Lost to Follow-up|Overall Study||0
9713238|NCT02993107|10812436|FG004|Lost to Follow-up|Overall Study||0
9713239|NCT02993107|10812437|FG005|Lost to Follow-up|Overall Study||1
9713240|NCT02993107|10812432|FG000|Sponsor Decision|Overall Study||4
10061729|NCT02105961|11187322|FG000|Completed Investigational Product (IP)|Overall Study||170
10061730|NCT02105961|11187323|FG001|Completed Investigational Product (IP)|Overall Study||196
10061731|NCT02105961|11187324|FG002|Completed Investigational Product (IP)|Overall Study||183
10061732|NCT02105961|11187322|FG000|Not Completed IP|Overall Study||56
10061733|NCT02105961|11187323|FG001|Not Completed IP|Overall Study||27
10061734|NCT02105961|11187324|FG002|Not Completed IP|Overall Study||42
10061735|NCT02105961|11187322|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27
10061736|NCT02105961|11187323|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9
10061737|NCT02105961|11187324|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25
10176049|NCT03101020|11305894|FG001|COMPLETED|Overall Study||7
10176050|NCT03101020|11305893|FG000|NOT COMPLETED|Overall Study||1
10176051|NCT03101020|11305894|FG001|NOT COMPLETED|Overall Study||3
10176052|NCT03101033|11305902|FG000|STARTED|Overall Study||32
10176053|NCT03101033|11305903|FG001|STARTED|Overall Study||60
10176054|NCT03101033|11305902|FG000|COMPLETED|Overall Study||27
10176055|NCT03101033|11305903|FG001|COMPLETED|Overall Study||51
10176056|NCT03101033|11305902|FG000|NOT COMPLETED|Overall Study||5
10176057|NCT03101033|11305903|FG001|NOT COMPLETED|Overall Study||9
10176058|NCT03101111|11305911|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
10176059|NCT03101111|11305912|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8
10176060|NCT03101111|11305911|FG000|COMPLETED|Overall Study|End of Study Visit|23
10176061|NCT03101111|11305912|FG001|COMPLETED|Overall Study|End of Study Visit|7
10176062|NCT03101111|11305911|FG000|NOT COMPLETED|Overall Study||3
10176063|NCT03101111|11305912|FG001|NOT COMPLETED|Overall Study||1
10176064|NCT03101150|11305924|FG000|STARTED|Overall Study||86
10176065|NCT03101150|11305925|FG001|STARTED|Overall Study||93
10176066|NCT03101150|11305924|FG000|COMPLETED|Overall Study||81
10176067|NCT03101150|11305925|FG001|COMPLETED|Overall Study||83
10176068|NCT03101150|11305924|FG000|NOT COMPLETED|Overall Study||5
10176069|NCT03101150|11305925|FG001|NOT COMPLETED|Overall Study||10
10176070|NCT03101241|11305933|FG000|STARTED|Overall Study||48
10176071|NCT03101241|11305934|FG001|STARTED|Overall Study||47
10176072|NCT03101241|11305933|FG000|COMPLETED|Overall Study||37
10176073|NCT03101241|11305934|FG001|COMPLETED|Overall Study||42
10176074|NCT03101241|11305933|FG000|NOT COMPLETED|Overall Study||11
10176075|NCT03101241|11305934|FG001|NOT COMPLETED|Overall Study||5
10176076|NCT03101267|11305943|FG000|STARTED|Primary Study Period||50
10176077|NCT03101267|11305944|FG001|STARTED|Primary Study Period||50
10176078|NCT03101267|11305945|FG002|STARTED|Primary Study Period||50
10176079|NCT03101267|11305943|FG000|COMPLETED|Primary Study Period||47
10176080|NCT03101267|11305944|FG001|COMPLETED|Primary Study Period||48
10176081|NCT03101267|11305945|FG002|COMPLETED|Primary Study Period||47
10176082|NCT03101267|11305943|FG000|NOT COMPLETED|Primary Study Period||3
10176083|NCT03101267|11305944|FG001|NOT COMPLETED|Primary Study Period||2
10176084|NCT03101267|11305945|FG002|NOT COMPLETED|Primary Study Period||3
10176085|NCT03101267|11305943|FG000|STARTED|Pollinosis Symptoms Survey Period||47
10176086|NCT03101267|11305944|FG001|STARTED|Pollinosis Symptoms Survey Period||48
10176087|NCT03101267|11305945|FG002|STARTED|Pollinosis Symptoms Survey Period||47
10176088|NCT03101267|11305943|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47
10176089|NCT03101267|11305944|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48
10176090|NCT03101267|11305945|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47
10176091|NCT03101267|11305943|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
10176092|NCT03101267|11305944|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
10176093|NCT03101267|11305945|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
10176094|NCT03101293|11305955|FG000|STARTED|Intervention Period 1||7
10176095|NCT03101293|11305956|FG001|STARTED|Intervention Period 1||8
10176096|NCT03101293|11305955|FG000|COMPLETED|Intervention Period 1||7
10176097|NCT03101293|11305956|FG001|COMPLETED|Intervention Period 1||8
10176098|NCT03101293|11305955|FG000|NOT COMPLETED|Intervention Period 1||0
10176099|NCT03101293|11305956|FG001|NOT COMPLETED|Intervention Period 1||0
10176100|NCT03101293|11305955|FG000|STARTED|Washout Period (at Least 7 Days)||7
10176101|NCT03101293|11305956|FG001|STARTED|Washout Period (at Least 7 Days)||8
10176102|NCT03101293|11305955|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
10176103|NCT03101293|11305956|FG001|COMPLETED|Washout Period (at Least 7 Days)||8
10176104|NCT03101293|11305955|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1
10176105|NCT03101293|11305956|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10176106|NCT03101293|11305955|FG000|STARTED|Intervention Period 2||6
10176107|NCT03101293|11305956|FG001|STARTED|Intervention Period 2||8
10176108|NCT03101293|11305955|FG000|COMPLETED|Intervention Period 2||6
10176109|NCT03101293|11305956|FG001|COMPLETED|Intervention Period 2||8
10176110|NCT03101293|11305955|FG000|NOT COMPLETED|Intervention Period 2||0
10176111|NCT03101293|11305956|FG001|NOT COMPLETED|Intervention Period 2||0
10176112|NCT03101358|11305966|FG000|STARTED|Overall Study||4
10176113|NCT03101358|11305967|FG001|STARTED|Overall Study||3
10176114|NCT03101358|11305968|FG002|STARTED|Overall Study||5
10176115|NCT03101358|11305969|FG003|STARTED|Overall Study||11
10176116|NCT03101358|11305966|FG000|Completed All Dosing|Overall Study||3
10176117|NCT03101358|11305967|FG001|Completed All Dosing|Overall Study||3
10176118|NCT03101358|11305968|FG002|Completed All Dosing|Overall Study||3
10176119|NCT03101358|11305969|FG003|Completed All Dosing|Overall Study||10
10176120|NCT03101358|11305966|FG000|COMPLETED|Overall Study||1
10176121|NCT03101358|11305967|FG001|COMPLETED|Overall Study||3
10176122|NCT03101358|11305968|FG002|COMPLETED|Overall Study||3
10176123|NCT03101358|11305969|FG003|COMPLETED|Overall Study||5
10176124|NCT03101358|11305966|FG000|NOT COMPLETED|Overall Study||3
10176125|NCT03101358|11305967|FG001|NOT COMPLETED|Overall Study||0
10176126|NCT03101358|11305968|FG002|NOT COMPLETED|Overall Study||2
10176127|NCT03101358|11305969|FG003|NOT COMPLETED|Overall Study||6
10176128|NCT03101371|11305982|FG000|STARTED|Overall Study||48
10176129|NCT03101371|11305983|FG001|STARTED|Overall Study||51
10176130|NCT03101371|11305982|FG000|COMPLETED|Overall Study||45
10176131|NCT03101371|11305983|FG001|COMPLETED|Overall Study||45
10176132|NCT03101371|11305982|FG000|NOT COMPLETED|Overall Study||3
10176133|NCT03101371|11305983|FG001|NOT COMPLETED|Overall Study||6
10176134|NCT03101462|11305991|FG000|STARTED|Overall Study||19
10176135|NCT03101462|11305992|FG001|STARTED|Overall Study||19
10176136|NCT03101462|11305991|FG000|COMPLETED|Overall Study||18
10176137|NCT03101462|11305992|FG001|COMPLETED|Overall Study||18
10176138|NCT03101462|11305991|FG000|NOT COMPLETED|Overall Study||1
10176139|NCT03101462|11305992|FG001|NOT COMPLETED|Overall Study||1
10176140|NCT03101514|11305998|FG000|STARTED|Overall Study||53
10176141|NCT03101514|11305998|FG000|COMPLETED|Overall Study||46
10176142|NCT03101514|11305998|FG000|NOT COMPLETED|Overall Study||7
10176143|NCT03101592|11306005|FG000|STARTED|Overall Study||3123
10176144|NCT03101592|11306006|FG001|STARTED|Overall Study||2896
10176145|NCT03101592|11306007|FG002|STARTED|Overall Study||3099
10176146|NCT03101592|11306005|FG000|COMPLETED|Overall Study||3012
10176147|NCT03101592|11306006|FG001|COMPLETED|Overall Study||2726
10176148|NCT03101592|11306007|FG002|COMPLETED|Overall Study||2981
10176149|NCT03101592|11306005|FG000|NOT COMPLETED|Overall Study||111
10176150|NCT03101592|11306006|FG001|NOT COMPLETED|Overall Study||170
10176151|NCT03101592|11306007|FG002|NOT COMPLETED|Overall Study||118
10176152|NCT03102190|11306021|FG000|STARTED|Overall Study||6
10176153|NCT03102190|11306021|FG000|COMPLETED|Overall Study||6
10176154|NCT03102190|11306021|FG000|NOT COMPLETED|Overall Study||0
10176155|NCT03102411|11306025|FG000|STARTED|Overall Study||1881
10176156|NCT03102411|11306025|FG000|COMPLETED|Overall Study||1718
10176157|NCT03102411|11306025|FG000|NOT COMPLETED|Overall Study||163
10176158|NCT03102437|11306032|FG000|STARTED|Overall Study||70
10176159|NCT03102437|11306033|FG001|STARTED|Overall Study||36
10176160|NCT03102437|11306032|FG000|COMPLETED|Overall Study||65
10176161|NCT03102437|11306033|FG001|COMPLETED|Overall Study||36
10176162|NCT03102437|11306032|FG000|NOT COMPLETED|Overall Study||5
10176163|NCT03102437|11306033|FG001|NOT COMPLETED|Overall Study||0
10176164|NCT03102645|11306041|FG000|STARTED|Overall Study||8
10176165|NCT03102645|11306042|FG001|STARTED|Overall Study||8
10176166|NCT03102645|11306041|FG000|COMPLETED|Overall Study||8
10176167|NCT03102645|11306042|FG001|COMPLETED|Overall Study||8
10176168|NCT03102645|11306041|FG000|NOT COMPLETED|Overall Study||0
10176169|NCT03102645|11306042|FG001|NOT COMPLETED|Overall Study||0
10176170|NCT03102710|11306052|FG000|STARTED|Overall Study||28
10176171|NCT03102710|11306053|FG001|STARTED|Overall Study||30
10176172|NCT03102710|11306054|FG002|STARTED|Overall Study||27
10176173|NCT03102710|11306052|FG000|COMPLETED|Overall Study||27
10176174|NCT03102710|11306053|FG001|COMPLETED|Overall Study||27
10176175|NCT03102710|11306054|FG002|COMPLETED|Overall Study||27
10176176|NCT03102710|11306052|FG000|NOT COMPLETED|Overall Study||1
10176177|NCT03102710|11306053|FG001|NOT COMPLETED|Overall Study||3
10176178|NCT03102710|11306054|FG002|NOT COMPLETED|Overall Study||0
10176179|NCT03102736|11306064|FG000|STARTED|Overall Study||7
10176180|NCT03102736|11306065|FG001|STARTED|Overall Study||9
10176181|NCT03102736|11306064|FG000|COMPLETED|Overall Study||7
10176182|NCT03102736|11306065|FG001|COMPLETED|Overall Study||9
10176183|NCT03102736|11306064|FG000|NOT COMPLETED|Overall Study||0
10176184|NCT03102736|11306065|FG001|NOT COMPLETED|Overall Study||0
10176185|NCT03102762|11306073|FG000|STARTED|Overall Study||35
10176186|NCT03102762|11306074|FG001|STARTED|Overall Study||35
10176187|NCT03102762|11306073|FG000|COMPLETED|Overall Study||34
10176188|NCT03102762|11306074|FG001|COMPLETED|Overall Study||35
10176189|NCT03102762|11306073|FG000|NOT COMPLETED|Overall Study||1
10176190|NCT03102762|11306074|FG001|NOT COMPLETED|Overall Study||0
10176191|NCT03102879|11306083|FG000|STARTED|Overall Study||18
10176192|NCT03102879|11306084|FG001|STARTED|Overall Study||18
10176193|NCT03102879|11306083|FG000|COMPLETED|Overall Study||18
10176194|NCT03102879|11306084|FG001|COMPLETED|Overall Study||18
10176195|NCT03102879|11306083|FG000|NOT COMPLETED|Overall Study||0
10176196|NCT03102879|11306084|FG001|NOT COMPLETED|Overall Study||0
10176197|NCT03102918|11306096|FG000|STARTED|Overall Study||5
10176198|NCT03102918|11306097|FG001|STARTED|Overall Study||5
10176199|NCT03102918|11306096|FG000|COMPLETED|Overall Study||4
10176200|NCT03102918|11306097|FG001|COMPLETED|Overall Study||5
10176201|NCT03102918|11306096|FG000|NOT COMPLETED|Overall Study||1
10176202|NCT03102918|11306097|FG001|NOT COMPLETED|Overall Study||0
10176203|NCT03103061|11306103|FG000|STARTED|Overall Study||24
10176204|NCT03103061|11306103|FG000|COMPLETED|Overall Study||24
10176205|NCT03103061|11306103|FG000|NOT COMPLETED|Overall Study||0
10176206|NCT03103100|11306110|FG000|STARTED|Overall Study||25
10176207|NCT03103100|11306111|FG001|STARTED|Overall Study||25
10176208|NCT03103100|11306112|FG002|STARTED|Overall Study||25
10176209|NCT03103100|11306110|FG000|COMPLETED|Overall Study||23
10176210|NCT03103100|11306111|FG001|COMPLETED|Overall Study||25
10176211|NCT03103100|11306112|FG002|COMPLETED|Overall Study||23
10176212|NCT03103100|11306110|FG000|NOT COMPLETED|Overall Study||2
10176213|NCT03103100|11306111|FG001|NOT COMPLETED|Overall Study||0
10176214|NCT03103100|11306112|FG002|NOT COMPLETED|Overall Study||2
10176215|NCT03103282|11306120|FG000|STARTED|Overall Study||65
10176216|NCT03103282|11306120|FG000|COMPLETED|Overall Study||65
10176217|NCT03103282|11306120|FG000|NOT COMPLETED|Overall Study||0
10176218|NCT03103438|11306131|FG000|STARTED|Overall Study||1
10176219|NCT03103438|11306132|FG001|STARTED|Overall Study||3
10176220|NCT03103438|11306133|FG002|STARTED|Overall Study||3
10176221|NCT03103438|11306134|FG003|STARTED|Overall Study||3
10176222|NCT03103438|11306135|FG004|STARTED|Overall Study||3
10176223|NCT03103438|11306136|FG005|STARTED|Overall Study||3
10176224|NCT03103438|11306137|FG006|STARTED|Overall Study||3
10176225|NCT03103438|11306131|FG000|COMPLETED|Overall Study||1
10176226|NCT03103438|11306132|FG001|COMPLETED|Overall Study||3
10176227|NCT03103438|11306133|FG002|COMPLETED|Overall Study||3
10176228|NCT03103438|11306134|FG003|COMPLETED|Overall Study||3
10176229|NCT03103438|11306135|FG004|COMPLETED|Overall Study||3
10176230|NCT03103438|11306136|FG005|COMPLETED|Overall Study||3
10176231|NCT03103438|11306137|FG006|COMPLETED|Overall Study||3
10176232|NCT03103438|11306131|FG000|NOT COMPLETED|Overall Study||0
10176233|NCT03103438|11306132|FG001|NOT COMPLETED|Overall Study||0
10176234|NCT03103438|11306133|FG002|NOT COMPLETED|Overall Study||0
10176235|NCT03103438|11306134|FG003|NOT COMPLETED|Overall Study||0
10176236|NCT03103438|11306135|FG004|NOT COMPLETED|Overall Study||0
10176237|NCT03103438|11306136|FG005|NOT COMPLETED|Overall Study||0
10176238|NCT03103438|11306137|FG006|NOT COMPLETED|Overall Study||0
10176239|NCT03103503|11306153|FG000|STARTED|Overall Study||901
10176240|NCT03103503|11306153|FG000|COMPLETED|Overall Study||0
10176241|NCT03103503|11306153|FG000|NOT COMPLETED|Overall Study||901
10176242|NCT03103763|11306160|FG000|STARTED|Overall Study||44
10176243|NCT03103763|11306161|FG001|STARTED|Overall Study||44
10176244|NCT03103763|11306162|FG002|STARTED|Overall Study||44
10176245|NCT03103763|11306160|FG000|COMPLETED|Overall Study||29
10176246|NCT03103763|11306161|FG001|COMPLETED|Overall Study||36
10176247|NCT03103763|11306162|FG002|COMPLETED|Overall Study||37
10176248|NCT03103763|11306160|FG000|NOT COMPLETED|Overall Study||15
10176249|NCT03103763|11306161|FG001|NOT COMPLETED|Overall Study||8
10176250|NCT03103763|11306162|FG002|NOT COMPLETED|Overall Study||7
10176251|NCT03103906|11306172|FG000|STARTED|Overall Study||40
10176252|NCT03103906|11306173|FG001|STARTED|Overall Study||42
10176253|NCT03103906|11306172|FG000|COMPLETED|Overall Study||36
10176254|NCT03103906|11306173|FG001|COMPLETED|Overall Study||39
10176255|NCT03103906|11306172|FG000|NOT COMPLETED|Overall Study||4
10176256|NCT03103906|11306173|FG001|NOT COMPLETED|Overall Study||3
10176257|NCT03103919|11306181|FG000|STARTED|Overall Study||20
10176258|NCT03103919|11306182|FG001|STARTED|Overall Study||19
10176259|NCT03103919|11306181|FG000|COMPLETED|Overall Study||18
10176260|NCT03103919|11306182|FG001|COMPLETED|Overall Study||17
10176261|NCT03103919|11306181|FG000|NOT COMPLETED|Overall Study||2
10176262|NCT03103919|11306182|FG001|NOT COMPLETED|Overall Study||2
10176263|NCT03104192|11306194|FG000|STARTED|Overall Study||9
10176264|NCT03104192|11306195|FG001|STARTED|Overall Study||27
10176265|NCT03104192|11306196|FG002|STARTED|Overall Study||16
10176266|NCT03104192|11306197|FG003|STARTED|Overall Study||17
10176267|NCT03104192|11306194|FG000|COMPLETED|Overall Study||9
9713241|NCT02993107|10812433|FG001|Sponsor Decision|Overall Study||0
9713242|NCT02993107|10812434|FG002|Sponsor Decision|Overall Study||1
9713243|NCT02993107|10812435|FG003|Sponsor Decision|Overall Study||1
9713244|NCT02993107|10812436|FG004|Sponsor Decision|Overall Study||0
9713245|NCT02993107|10812437|FG005|Sponsor Decision|Overall Study||4
9713246|NCT02993107|10812432|FG000|Protocol Deviation|Overall Study||0
9713247|NCT02993107|10812433|FG001|Protocol Deviation|Overall Study||0
9713248|NCT02993107|10812434|FG002|Protocol Deviation|Overall Study||0
9713249|NCT02993107|10812435|FG003|Protocol Deviation|Overall Study||0
9713250|NCT02993107|10812436|FG004|Protocol Deviation|Overall Study||1
9713251|NCT02993107|10812437|FG005|Protocol Deviation|Overall Study||0
10176268|NCT03104192|11306195|FG001|COMPLETED|Overall Study||23
10176269|NCT03104192|11306196|FG002|COMPLETED|Overall Study||14
10176270|NCT03104192|11306197|FG003|COMPLETED|Overall Study||14
10176271|NCT03104192|11306194|FG000|NOT COMPLETED|Overall Study||0
10176272|NCT03104192|11306195|FG001|NOT COMPLETED|Overall Study||4
10176273|NCT03104192|11306196|FG002|NOT COMPLETED|Overall Study||2
10176274|NCT03104192|11306197|FG003|NOT COMPLETED|Overall Study||3
10176275|NCT03104322|11306213|FG000|STARTED|Overall Study||7
10176276|NCT03104322|11306213|FG000|COMPLETED|Overall Study||6
10176277|NCT03104322|11306213|FG000|NOT COMPLETED|Overall Study||1
10176278|NCT03104647|11306217|FG000|STARTED|Overall Study||20
10176279|NCT03104647|11306217|FG000|COMPLETED|Overall Study||20
10176280|NCT03104647|11306217|FG000|NOT COMPLETED|Overall Study||0
10176281|NCT03104725|11306223|FG000|STARTED|Overall Study||2
10176282|NCT03104725|11306224|FG001|STARTED|Overall Study||4
9713252|NCT02993107|10812432|FG000|Other Reasons|Overall Study||2
9713253|NCT02993107|10812433|FG001|Other Reasons|Overall Study||1
10176283|NCT03104725|11306223|FG000|COMPLETED|Overall Study||2
10176284|NCT03104725|11306224|FG001|COMPLETED|Overall Study||4
10176285|NCT03104725|11306223|FG000|NOT COMPLETED|Overall Study||0
10176286|NCT03104725|11306224|FG001|NOT COMPLETED|Overall Study||0
10176287|NCT03104738|11306232|FG000|STARTED|Overall Study||20
10176288|NCT03104738|11306233|FG001|STARTED|Overall Study||20
10176289|NCT03104738|11306232|FG000|COMPLETED|Overall Study||20
10176290|NCT03104738|11306233|FG001|COMPLETED|Overall Study||20
10176291|NCT03104738|11306232|FG000|NOT COMPLETED|Overall Study||0
10176292|NCT03104738|11306233|FG001|NOT COMPLETED|Overall Study||0
10176293|NCT03104816|11306242|FG000|STARTED|Overall Study||11
10176294|NCT03104816|11306243|FG001|STARTED|Overall Study||11
10176295|NCT03104816|11306244|FG002|STARTED|Overall Study||6
10176296|NCT03104816|11306242|FG000|COMPLETED|Overall Study||9
10176297|NCT03104816|11306243|FG001|COMPLETED|Overall Study||9
10176298|NCT03104816|11306244|FG002|COMPLETED|Overall Study||4
10176299|NCT03104816|11306242|FG000|NOT COMPLETED|Overall Study||2
10176300|NCT03104816|11306243|FG001|NOT COMPLETED|Overall Study||2
10176301|NCT03104816|11306244|FG002|NOT COMPLETED|Overall Study||2
10176302|NCT03104985|11306254|FG000|STARTED|Overall Study||34
10176303|NCT03104985|11306255|FG001|STARTED|Overall Study||34
10176304|NCT03104985|11306254|FG000|COMPLETED|Overall Study||34
10176305|NCT03104985|11306255|FG001|COMPLETED|Overall Study||34
10176306|NCT03104985|11306254|FG000|NOT COMPLETED|Overall Study||0
10176307|NCT03104985|11306255|FG001|NOT COMPLETED|Overall Study||0
9713254|NCT02993107|10812434|FG002|Other Reasons|Overall Study||1
9713255|NCT02993107|10812435|FG003|Other Reasons|Overall Study||1
9713256|NCT02993107|10812436|FG004|Other Reasons|Overall Study||2
9713257|NCT02993107|10812437|FG005|Other Reasons|Overall Study||3
9713258|NCT02993107|10812432|FG000|COMPLETED|Overall Study||62
9713259|NCT02993107|10812433|FG001|COMPLETED|Overall Study||107
9713260|NCT02993107|10812434|FG002|COMPLETED|Overall Study||39
9713261|NCT02993107|10812435|FG003|COMPLETED|Overall Study||29
9713262|NCT02993107|10812436|FG004|COMPLETED|Overall Study||22
9713263|NCT02993107|10812437|FG005|COMPLETED|Overall Study||21
9713264|NCT02993107|10812432|FG000|NOT COMPLETED|Overall Study||51
9713265|NCT02993107|10812433|FG001|NOT COMPLETED|Overall Study||13
9713266|NCT02993107|10812434|FG002|NOT COMPLETED|Overall Study||11
9713267|NCT02993107|10812435|FG003|NOT COMPLETED|Overall Study||6
9713268|NCT02993107|10812436|FG004|NOT COMPLETED|Overall Study||12
9713269|NCT02993107|10812437|FG005|NOT COMPLETED|Overall Study||15
9713270|NCT02981082|10812465|FG000|STARTED|Overall Study||4
9713271|NCT02981082|10812466|FG001|STARTED|Overall Study||2
9713272|NCT02981082|10812465|FG000|COMPLETED|Overall Study||1
9713273|NCT02981082|10812466|FG001|COMPLETED|Overall Study||1
9713274|NCT02981082|10812465|FG000|NOT COMPLETED|Overall Study||3
9713275|NCT02981082|10812466|FG001|NOT COMPLETED|Overall Study||1
9713276|NCT02924129|10812474|FG000|STARTED|Overall Study||67
9713277|NCT02924129|10812475|FG001|STARTED|Overall Study||67
9713278|NCT02924129|10812474|FG000|COMPLETED|Overall Study||62
9713279|NCT02924129|10812475|FG001|COMPLETED|Overall Study||63
9713280|NCT02924129|10812474|FG000|NOT COMPLETED|Overall Study||5
9713281|NCT02924129|10812475|FG001|NOT COMPLETED|Overall Study||4
9713282|NCT02741700|10812483|FG000|STARTED|Overall Study||152
9713283|NCT02741700|10812484|FG001|STARTED|Overall Study||154
9713284|NCT02741700|10812483|FG000|COMPLETED|Overall Study||126
9713285|NCT02741700|10812484|FG001|COMPLETED|Overall Study||135
9713286|NCT02741700|10812483|FG000|NOT COMPLETED|Overall Study||26
9713287|NCT02741700|10812484|FG001|NOT COMPLETED|Overall Study||19
9713288|NCT02635776|10812492|FG000|STARTED|Overall Study||416
9713289|NCT02635776|10812493|FG001|STARTED|Overall Study||139
9713290|NCT02635776|10812492|FG000|COMPLETED|Overall Study||314
9713291|NCT02635776|10812493|FG001|COMPLETED|Overall Study||128
9713292|NCT02635776|10812492|FG000|NOT COMPLETED|Overall Study||102
9713293|NCT02635776|10812493|FG001|NOT COMPLETED|Overall Study||11
9713294|NCT02609724|10812504|FG000|STARTED|Overall Study||65
9713295|NCT02609724|10812505|FG001|STARTED|Overall Study||64
9713296|NCT02609724|10812506|FG002|STARTED|Overall Study||65
9713297|NCT02609724|10812504|FG000|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
9713298|NCT02609724|10812505|FG001|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
9713299|NCT02609724|10812506|FG002|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||64
9713300|NCT02609724|10812504|FG000|COMPLETED|Overall Study|post follow-up phase|60
9713301|NCT02609724|10812505|FG001|COMPLETED|Overall Study|post follow-up phase|61
9713302|NCT02609724|10812506|FG002|COMPLETED|Overall Study|post follow-up phase|61
9713303|NCT02609724|10812504|FG000|NOT COMPLETED|Overall Study||5
9713304|NCT02609724|10812505|FG001|NOT COMPLETED|Overall Study||3
9713305|NCT02609724|10812506|FG002|NOT COMPLETED|Overall Study||4
9713306|NCT02359994|10812516|FG000|STARTED|Overall Population Study||161
9713307|NCT02359994|10812517|FG001|STARTED|Overall Population Study||163
9713308|NCT02359994|10812516|FG000|Treated|Overall Population Study||160
9713309|NCT02359994|10812517|FG001|Treated|Overall Population Study||162
9713310|NCT02359994|10812516|FG000|COMPLETED|Overall Population Study||156
9713311|NCT02359994|10812517|FG001|COMPLETED|Overall Population Study||155
9713312|NCT02359994|10812516|FG000|NOT COMPLETED|Overall Population Study||5
9713313|NCT02359994|10812517|FG001|NOT COMPLETED|Overall Population Study||8
9731112|NCT00130039|10831045|FG001|COMPLETED|Overall Study|full analysis set|207
10176308|NCT03105297|11306261|FG000|STARTED|Baseline Phase (Day 1)||91
10176309|NCT03105297|11306261|FG000|COMPLETED|Baseline Phase (Day 1)||70
10176310|NCT03105297|11306261|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21
10176311|NCT03105297|11306261|FG000|STARTED|Active Phase (Day 2-29)||70
10176312|NCT03105297|11306261|FG000|COMPLETED|Active Phase (Day 2-29)||70
10176313|NCT03105297|11306261|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0
10176314|NCT03105297|11306261|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
10176315|NCT03105297|11306261|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55
10176316|NCT03105297|11306261|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
10176317|NCT03105297|11306261|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
10176318|NCT03105362|11306272|FG000|STARTED|Overall Study||4
10176319|NCT03105362|11306272|FG000|Completed 1 Week of Study|Overall Study||4
10176320|NCT03105362|11306272|FG000|Completed 2 Weeks of Study|Overall Study||3
10176321|NCT03105362|11306272|FG000|Completed 2 Week Questionaire|Overall Study||2
10176322|NCT03105362|11306272|FG000|COMPLETED|Overall Study||2
10176323|NCT03105362|11306272|FG000|NOT COMPLETED|Overall Study||2
10176324|NCT03105479|11306279|FG000|STARTED|Overall Study||1
10176325|NCT03105479|11306280|FG001|STARTED|Overall Study||0
10176326|NCT03105479|11306281|FG002|STARTED|Overall Study||0
9713314|NCT02359994|10812516|FG000|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the PerClot group who completed either the 6 week or 3 month visit in the Overall Population Study.|85
9713315|NCT02359994|10812517|FG001|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the Arista group who completed either the 6 week or 3 month visit in the Overall Population Study.|93
9713316|NCT02359994|10812516|FG000|COMPLETED|Extended Oncology 24-Month Survival||65
9713317|NCT02359994|10812517|FG001|COMPLETED|Extended Oncology 24-Month Survival||72
9713318|NCT02359994|10812516|FG000|NOT COMPLETED|Extended Oncology 24-Month Survival||20
9713319|NCT02359994|10812517|FG001|NOT COMPLETED|Extended Oncology 24-Month Survival||21
9713320|NCT02336230|10812523|FG000|STARTED|Overall Study||55
9713321|NCT02336230|10812523|FG000|Full Analysis Set (FAS)|Overall Study||55
9713322|NCT02336230|10812523|FG000|Safety Analysis Population|Overall Study||54
9713323|NCT02336230|10812523|FG000|COMPLETED|Overall Study||42
9713324|NCT02336230|10812523|FG000|NOT COMPLETED|Overall Study||13
9713325|NCT01557751|10812527|FG000|STARTED|Overall Study||156
9713326|NCT01557751|10812527|FG000|COMPLETED|Overall Study||153
9713327|NCT01557751|10812527|FG000|NOT COMPLETED|Overall Study||3
9713328|NCT01363401|10812533|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
9713329|NCT01363401|10812534|FG001|STARTED|Overall Study||31
9713330|NCT01363401|10812533|FG000|COMPLETED|Overall Study||39
9713331|NCT01363401|10812534|FG001|COMPLETED|Overall Study||27
9713332|NCT01363401|10812533|FG000|NOT COMPLETED|Overall Study||2
9713333|NCT01363401|10812534|FG001|NOT COMPLETED|Overall Study||4
9731113|NCT00130039|10831044|FG000|NOT COMPLETED|Overall Study||30
9731114|NCT00130039|10831045|FG001|NOT COMPLETED|Overall Study||18
9731115|NCT00130117|10831053|FG000|STARTED|Overall Study||11
9731116|NCT00130117|10831054|FG001|STARTED|Overall Study||9
9731117|NCT00130117|10831053|FG000|COMPLETED|Overall Study||7
9731118|NCT00130117|10831054|FG001|COMPLETED|Overall Study||6
9731119|NCT00130117|10831053|FG000|NOT COMPLETED|Overall Study||4
9731120|NCT00130117|10831054|FG001|NOT COMPLETED|Overall Study||3
9731121|NCT00130208|10831063|FG000|STARTED|Maintenance Period (26 Weeks)||524
9731122|NCT00130208|10831064|FG001|STARTED|Maintenance Period (26 Weeks)||532
9731123|NCT00130208|10831063|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
9731124|NCT00130208|10831064|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
9731125|NCT00130208|10831063|FG000|COMPLETED|Maintenance Period (26 Weeks)||500
9731126|NCT00130208|10831064|FG001|COMPLETED|Maintenance Period (26 Weeks)||502
9731127|NCT00130208|10831063|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24
9731128|NCT00130208|10831064|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30
9731129|NCT00130208|10831063|FG000|STARTED|Washout Period (8 Weeks)||500
9731130|NCT00130208|10831064|FG001|STARTED|Washout Period (8 Weeks)||502
9731131|NCT00130208|10831063|FG000|COMPLETED|Washout Period (8 Weeks)||494
9731132|NCT00130208|10831064|FG001|COMPLETED|Washout Period (8 Weeks)||490
9731133|NCT00130208|10831063|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6
9731134|NCT00130208|10831064|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12
9731135|NCT00130247|10831072|FG000|STARTED|Overall Study||196
9731136|NCT00130247|10831073|FG001|STARTED|Overall Study||198
9731137|NCT00130247|10831072|FG000|COMPLETED|Overall Study||194
9731138|NCT00130247|10831073|FG001|COMPLETED|Overall Study||194
9731139|NCT00130247|10831072|FG000|NOT COMPLETED|Overall Study||2
9731140|NCT00130247|10831073|FG001|NOT COMPLETED|Overall Study||4
9731141|NCT00130286|10831083|FG000|STARTED|Overall Study||22
9731142|NCT00130286|10831084|FG001|STARTED|Overall Study||19
9731143|NCT00130286|10831085|FG002|STARTED|Overall Study||17
9731144|NCT00130286|10831086|FG003|STARTED|Overall Study||19
9731145|NCT00130286|10831083|FG000|COMPLETED|Overall Study||22
9731146|NCT00130286|10831084|FG001|COMPLETED|Overall Study||16
9731147|NCT00130286|10831085|FG002|COMPLETED|Overall Study||13
9731148|NCT00130286|10831086|FG003|COMPLETED|Overall Study||17
9731149|NCT00130286|10831083|FG000|NOT COMPLETED|Overall Study||0
9731150|NCT00130286|10831084|FG001|NOT COMPLETED|Overall Study||3
9731151|NCT00130286|10831085|FG002|NOT COMPLETED|Overall Study||4
9731152|NCT00130286|10831086|FG003|NOT COMPLETED|Overall Study||2
9731153|NCT00130520|10831096|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
10176327|NCT03105479|11306282|FG003|STARTED|Overall Study||0
10176328|NCT03105479|11306283|FG004|STARTED|Overall Study||0
10176329|NCT03105479|11306284|FG005|STARTED|Overall Study||0
10176330|NCT03105479|11306285|FG006|STARTED|Overall Study||0
10176331|NCT03105479|11306279|FG000|COMPLETED|Overall Study||1
10176332|NCT03105479|11306280|FG001|COMPLETED|Overall Study||0
10176333|NCT03105479|11306281|FG002|COMPLETED|Overall Study||0
10176334|NCT03105479|11306282|FG003|COMPLETED|Overall Study||0
10176335|NCT03105479|11306283|FG004|COMPLETED|Overall Study||0
10176336|NCT03105479|11306284|FG005|COMPLETED|Overall Study||0
10176337|NCT03105479|11306285|FG006|COMPLETED|Overall Study||0
10176338|NCT03105479|11306279|FG000|NOT COMPLETED|Overall Study||0
10176339|NCT03105479|11306280|FG001|NOT COMPLETED|Overall Study||0
10176340|NCT03105479|11306281|FG002|NOT COMPLETED|Overall Study||0
10176341|NCT03105479|11306282|FG003|NOT COMPLETED|Overall Study||0
10176342|NCT03105479|11306283|FG004|NOT COMPLETED|Overall Study||0
10176343|NCT03105479|11306284|FG005|NOT COMPLETED|Overall Study||0
10176344|NCT03105479|11306285|FG006|NOT COMPLETED|Overall Study||0
10176345|NCT03105518|11306292|FG000|STARTED|Overall Study||100
10176346|NCT03105518|11306292|FG000|COMPLETED|Overall Study||100
10176347|NCT03105518|11306292|FG000|NOT COMPLETED|Overall Study||0
10176348|NCT03106077|11306296|FG000|STARTED|Overall Study||96
10176349|NCT03106077|11306297|FG001|STARTED|Overall Study||0
10176350|NCT03106077|11306296|FG000|COMPLETED|Overall Study||2
10176351|NCT03106077|11306297|FG001|COMPLETED|Overall Study||0
10176352|NCT03106077|11306296|FG000|NOT COMPLETED|Overall Study||94
10176353|NCT03106077|11306297|FG001|NOT COMPLETED|Overall Study||0
10176354|NCT03106337|11306302|FG000|STARTED|Overall Study||35
10176355|NCT03106337|11306302|FG000|COMPLETED|Overall Study||35
10176356|NCT03106337|11306302|FG000|NOT COMPLETED|Overall Study||0
10176357|NCT03106636|11306309|FG000|STARTED|Overall Study||226
10176358|NCT03106636|11306310|FG001|STARTED|Overall Study||190
10176359|NCT03106636|11306309|FG000|COMPLETED|Overall Study||182
10176360|NCT03106636|11306310|FG001|COMPLETED|Overall Study||164
10176361|NCT03106636|11306309|FG000|NOT COMPLETED|Overall Study||44
10176362|NCT03106636|11306310|FG001|NOT COMPLETED|Overall Study||26
10176363|NCT03106753|11306318|FG000|STARTED|Overall Study||17
10176364|NCT03106753|11306319|FG001|STARTED|Overall Study||17
10176365|NCT03106753|11306318|FG000|COMPLETED|Overall Study||17
10176366|NCT03106753|11306319|FG001|COMPLETED|Overall Study||16
10176367|NCT03106753|11306318|FG000|NOT COMPLETED|Overall Study||0
10176368|NCT03106753|11306319|FG001|NOT COMPLETED|Overall Study||1
10176369|NCT03106844|11306327|FG000|STARTED|Overall Study||50
10176370|NCT03106844|11306327|FG000|COMPLETED|Overall Study||49
10176371|NCT03106844|11306327|FG000|NOT COMPLETED|Overall Study||1
10176372|NCT03106870|11306333|FG000|STARTED|Overall Study||31
10176373|NCT03106870|11306334|FG001|STARTED|Overall Study||31
10176374|NCT03106870|11306333|FG000|COMPLETED|Overall Study||31
10176375|NCT03106870|11306334|FG001|COMPLETED|Overall Study||31
10176376|NCT03106870|11306333|FG000|NOT COMPLETED|Overall Study||0
10176377|NCT03106870|11306334|FG001|NOT COMPLETED|Overall Study||0
10176378|NCT03107026|11306343|FG000|STARTED|Overall Study||163
10176379|NCT03107026|11306344|FG001|STARTED|Overall Study||161
10176380|NCT03107026|11306345|FG002|STARTED|Overall Study||162
9713334|NCT00961064|10812540|FG000|STARTED|Overall Study||30
9713335|NCT00961064|10812540|FG000|COMPLETED|Overall Study||30
9713336|NCT00961064|10812540|FG000|NOT COMPLETED|Overall Study||0
10176381|NCT03107026|11306343|FG000|COMPLETED|Overall Study||131
10176382|NCT03107026|11306344|FG001|COMPLETED|Overall Study||123
10176383|NCT03107026|11306345|FG002|COMPLETED|Overall Study||106
10176384|NCT03107026|11306343|FG000|NOT COMPLETED|Overall Study||32
10176385|NCT03107026|11306344|FG001|NOT COMPLETED|Overall Study||38
10176386|NCT03107026|11306345|FG002|NOT COMPLETED|Overall Study||56
10176387|NCT03107052|11306356|FG000|STARTED|Overall Study||145
10176388|NCT03107052|11306357|FG001|STARTED|Overall Study||60
10176389|NCT03107052|11306358|FG002|STARTED|Overall Study||70
10176390|NCT03107052|11306356|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
10176391|NCT03107052|11306357|FG001|Safety Analysis Set|Overall Study||60
10176392|NCT03107052|11306358|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
10176393|NCT03107052|11306356|FG000|COMPLETED|Overall Study||26
10176394|NCT03107052|11306357|FG001|COMPLETED|Overall Study||14
10176395|NCT03107052|11306358|FG002|COMPLETED|Overall Study||29
10176396|NCT03107052|11306356|FG000|NOT COMPLETED|Overall Study||119
10176397|NCT03107052|11306357|FG001|NOT COMPLETED|Overall Study||46
10176398|NCT03107052|11306358|FG002|NOT COMPLETED|Overall Study||41
10176399|NCT03107091|11306366|FG000|STARTED|Overall Study||6
10176400|NCT03107091|11306366|FG000|COMPLETED|Overall Study||5
10176401|NCT03107091|11306366|FG000|NOT COMPLETED|Overall Study||1
10176402|NCT03107377|11306373|FG000|STARTED|Overall Study||426
9713340|NCT03825393|10812550|FG000|STARTED|Overall Study||100
10176403|NCT03107377|11306374|FG001|STARTED|Overall Study||434
10176404|NCT03107377|11306373|FG000|COMPLETED|Overall Study||335
10176405|NCT03107377|11306374|FG001|COMPLETED|Overall Study||335
9713341|NCT03825393|10812551|FG001|STARTED|Overall Study||100
10176406|NCT03107377|11306373|FG000|NOT COMPLETED|Overall Study||91
10176407|NCT03107377|11306374|FG001|NOT COMPLETED|Overall Study||99
10176408|NCT03107715|11306382|FG000|STARTED|Overall Study||132
10176409|NCT03107715|11306383|FG001|STARTED|Overall Study||111
10176410|NCT03107715|11306382|FG000|COMPLETED|Overall Study||128
10176411|NCT03107715|11306383|FG001|COMPLETED|Overall Study||104
10176412|NCT03107715|11306382|FG000|NOT COMPLETED|Overall Study||4
10176413|NCT03107715|11306383|FG001|NOT COMPLETED|Overall Study||7
10176414|NCT03107754|11306391|FG000|STARTED|Overall Study||48
10176415|NCT03107754|11306392|FG001|STARTED|Overall Study||50
10176416|NCT03107754|11306391|FG000|COMPLETED|Overall Study||48
10176417|NCT03107754|11306392|FG001|COMPLETED|Overall Study||50
10176418|NCT03107754|11306391|FG000|NOT COMPLETED|Overall Study||0
10176419|NCT03107754|11306392|FG001|NOT COMPLETED|Overall Study||0
10176420|NCT03107793|11306398|FG000|STARTED|Induction Period (16 Weeks)||500
10176421|NCT03107793|11306399|FG001|STARTED|Induction Period (16 Weeks)||0
10176422|NCT03107793|11306400|FG002|STARTED|Induction Period (16 Weeks)||0
10176423|NCT03107793|11306398|FG000|COMPLETED|Induction Period (16 Weeks)||490
10176424|NCT03107793|11306399|FG001|COMPLETED|Induction Period (16 Weeks)||0
10176425|NCT03107793|11306400|FG002|COMPLETED|Induction Period (16 Weeks)||0
10176426|NCT03107793|11306398|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10
10176427|NCT03107793|11306399|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0
10176428|NCT03107793|11306400|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
10176429|NCT03107793|11306398|FG000|STARTED|Maintenance Period (16-48 Week)||0
10176430|NCT03107793|11306399|FG001|STARTED|Maintenance Period (16-48 Week)||220
10176431|NCT03107793|11306400|FG002|STARTED|Maintenance Period (16-48 Week)||221
10176432|NCT03107793|11306398|FG000|COMPLETED|Maintenance Period (16-48 Week)||0
10176433|NCT03107793|11306399|FG001|COMPLETED|Maintenance Period (16-48 Week)||174
10176434|NCT03107793|11306400|FG002|COMPLETED|Maintenance Period (16-48 Week)||193
10176435|NCT03107793|11306398|FG000|NOT COMPLETED|Maintenance Period (16-48 Week)||0
10176436|NCT03107793|11306399|FG001|NOT COMPLETED|Maintenance Period (16-48 Week)||46
10176437|NCT03107793|11306400|FG002|NOT COMPLETED|Maintenance Period (16-48 Week)||28
10176438|NCT03108027|11306407|FG000|STARTED|Period 1||7
10176439|NCT03108027|11306408|FG001|STARTED|Period 1||6
10176440|NCT03108027|11306409|FG002|STARTED|Period 1||6
10176441|NCT03108027|11306410|FG003|STARTED|Period 1||6
10176442|NCT03108027|11306411|FG004|STARTED|Period 1||6
10176443|NCT03108027|11306412|FG005|STARTED|Period 1||6
10176444|NCT03108027|11306407|FG000|COMPLETED|Period 1||7
10176445|NCT03108027|11306408|FG001|COMPLETED|Period 1||6
10176446|NCT03108027|11306409|FG002|COMPLETED|Period 1||6
10176447|NCT03108027|11306410|FG003|COMPLETED|Period 1||4
10176448|NCT03108027|11306411|FG004|COMPLETED|Period 1||6
10176449|NCT03108027|11306412|FG005|COMPLETED|Period 1||6
10176450|NCT03108027|11306407|FG000|NOT COMPLETED|Period 1||0
10176451|NCT03108027|11306408|FG001|NOT COMPLETED|Period 1||0
10176452|NCT03108027|11306409|FG002|NOT COMPLETED|Period 1||0
10176453|NCT03108027|11306410|FG003|NOT COMPLETED|Period 1||2
10176454|NCT03108027|11306411|FG004|NOT COMPLETED|Period 1||0
10176455|NCT03108027|11306412|FG005|NOT COMPLETED|Period 1||0
10176456|NCT03108027|11306407|FG000|STARTED|Period 2||7
10176457|NCT03108027|11306408|FG001|STARTED|Period 2||6
10176458|NCT03108027|11306409|FG002|STARTED|Period 2||6
10176459|NCT03108027|11306410|FG003|STARTED|Period 2||4
10176460|NCT03108027|11306411|FG004|STARTED|Period 2||6
10176461|NCT03108027|11306412|FG005|STARTED|Period 2||6
10176462|NCT03108027|11306407|FG000|COMPLETED|Period 2||7
10176463|NCT03108027|11306408|FG001|COMPLETED|Period 2||6
10176464|NCT03108027|11306409|FG002|COMPLETED|Period 2||6
10176465|NCT03108027|11306410|FG003|COMPLETED|Period 2||4
10176466|NCT03108027|11306411|FG004|COMPLETED|Period 2||6
10176467|NCT03108027|11306412|FG005|COMPLETED|Period 2||6
10176468|NCT03108027|11306407|FG000|NOT COMPLETED|Period 2||0
10176469|NCT03108027|11306408|FG001|NOT COMPLETED|Period 2||0
10176470|NCT03108027|11306409|FG002|NOT COMPLETED|Period 2||0
10176471|NCT03108027|11306410|FG003|NOT COMPLETED|Period 2||0
10176472|NCT03108027|11306411|FG004|NOT COMPLETED|Period 2||0
10176473|NCT03108027|11306412|FG005|NOT COMPLETED|Period 2||0
10176474|NCT03108027|11306407|FG000|STARTED|Period 3||7
10176475|NCT03108027|11306408|FG001|STARTED|Period 3||6
10176476|NCT03108027|11306409|FG002|STARTED|Period 3||6
10176477|NCT03108027|11306410|FG003|STARTED|Period 3||4
10176478|NCT03108027|11306411|FG004|STARTED|Period 3||6
10176479|NCT03108027|11306412|FG005|STARTED|Period 3||6
10176480|NCT03108027|11306407|FG000|COMPLETED|Period 3||7
10176481|NCT03108027|11306408|FG001|COMPLETED|Period 3||5
10176482|NCT03108027|11306409|FG002|COMPLETED|Period 3||6
10176483|NCT03108027|11306410|FG003|COMPLETED|Period 3||4
10176484|NCT03108027|11306411|FG004|COMPLETED|Period 3||6
10176485|NCT03108027|11306412|FG005|COMPLETED|Period 3||6
10176486|NCT03108027|11306407|FG000|NOT COMPLETED|Period 3||0
10176487|NCT03108027|11306408|FG001|NOT COMPLETED|Period 3||1
10176488|NCT03108027|11306409|FG002|NOT COMPLETED|Period 3||0
10176489|NCT03108027|11306410|FG003|NOT COMPLETED|Period 3||0
10176490|NCT03108027|11306411|FG004|NOT COMPLETED|Period 3||0
10176491|NCT03108027|11306412|FG005|NOT COMPLETED|Period 3||0
10176492|NCT03108157|11306422|FG000|STARTED|Overall Study||176
10176493|NCT03108157|11306423|FG001|STARTED|Overall Study||176
10176494|NCT03108157|11306422|FG000|COMPLETED|Overall Study||161
10176495|NCT03108157|11306423|FG001|COMPLETED|Overall Study||172
10176496|NCT03108157|11306422|FG000|NOT COMPLETED|Overall Study||15
10176497|NCT03108157|11306423|FG001|NOT COMPLETED|Overall Study||4
10176498|NCT03108469|11306432|FG000|STARTED|Overall Study||15
10176499|NCT03108469|11306433|FG001|STARTED|Overall Study||15
10176500|NCT03108469|11306432|FG000|COMPLETED|Overall Study||11
10176501|NCT03108469|11306433|FG001|COMPLETED|Overall Study||11
10176502|NCT03108469|11306432|FG000|NOT COMPLETED|Overall Study||4
10176503|NCT03108469|11306433|FG001|NOT COMPLETED|Overall Study||4
10176504|NCT03108482|11306443|FG000|STARTED|Overall Study||183
10176505|NCT03108482|11306444|FG001|STARTED|Overall Study||183
10176506|NCT03108482|11306445|FG002|STARTED|Overall Study||182
10176507|NCT03108482|11306446|FG003|STARTED|Overall Study||89
10176508|NCT03108482|11306443|FG000|COMPLETED|Overall Study||183
10176509|NCT03108482|11306444|FG001|COMPLETED|Overall Study||179
10176510|NCT03108482|11306445|FG002|COMPLETED|Overall Study||180
10176511|NCT03108482|11306446|FG003|COMPLETED|Overall Study||86
10176512|NCT03108482|11306443|FG000|NOT COMPLETED|Overall Study||0
10176513|NCT03108482|11306444|FG001|NOT COMPLETED|Overall Study||4
10176514|NCT03108482|11306445|FG002|NOT COMPLETED|Overall Study||2
10176515|NCT03108482|11306446|FG003|NOT COMPLETED|Overall Study||3
10176516|NCT03108521|11306458|FG000|STARTED|Overall Study||83
10176517|NCT03108521|11306459|FG001|STARTED|Overall Study||36
10176518|NCT03108521|11306458|FG000|COMPLETED|Overall Study||71
10176519|NCT03108521|11306459|FG001|COMPLETED|Overall Study||36
10176520|NCT03108521|11306458|FG000|NOT COMPLETED|Overall Study||12
10176521|NCT03108521|11306459|FG001|NOT COMPLETED|Overall Study||0
10176522|NCT03108924|11306473|FG000|STARTED|Overall Study||6
10176523|NCT03108924|11306474|FG001|STARTED|Overall Study||6
10176524|NCT03108924|11306475|FG002|STARTED|Overall Study||6
10176525|NCT03108924|11306476|FG003|STARTED|Overall Study||6
10176526|NCT03108924|11306473|FG000|COMPLETED|Overall Study||6
10176527|NCT03108924|11306474|FG001|COMPLETED|Overall Study||6
10176528|NCT03108924|11306475|FG002|COMPLETED|Overall Study||6
10176529|NCT03108924|11306476|FG003|COMPLETED|Overall Study||6
10176530|NCT03108924|11306473|FG000|NOT COMPLETED|Overall Study||0
10176531|NCT03108924|11306474|FG001|NOT COMPLETED|Overall Study||0
10176532|NCT03108924|11306475|FG002|NOT COMPLETED|Overall Study||0
10176533|NCT03108924|11306476|FG003|NOT COMPLETED|Overall Study||0
10176534|NCT03109015|11306497|FG000|STARTED|Overall Study||4
10176535|NCT03109015|11306498|FG001|STARTED|Overall Study||3
10176536|NCT03109015|11306497|FG000|COMPLETED|Overall Study||4
10176537|NCT03109015|11306498|FG001|COMPLETED|Overall Study||3
10176538|NCT03109015|11306497|FG000|NOT COMPLETED|Overall Study||0
10176539|NCT03109015|11306498|FG001|NOT COMPLETED|Overall Study||0
10176540|NCT03109184|11306506|FG000|STARTED|Overall Study||60
10176541|NCT03109184|11306507|FG001|STARTED|Overall Study||59
10176542|NCT03109184|11306506|FG000|COMPLETED|Overall Study||53
10176543|NCT03109184|11306507|FG001|COMPLETED|Overall Study||52
10176544|NCT03109184|11306506|FG000|NOT COMPLETED|Overall Study||7
10176545|NCT03109184|11306507|FG001|NOT COMPLETED|Overall Study||7
10176546|NCT03109769|11306515|FG000|STARTED|Overall Study||22
10176547|NCT03109769|11306516|FG001|STARTED|Overall Study||22
10176548|NCT03109769|11306515|FG000|COMPLETED|Overall Study||22
10176549|NCT03109769|11306516|FG001|COMPLETED|Overall Study||22
10176550|NCT03109769|11306515|FG000|NOT COMPLETED|Overall Study||0
10176551|NCT03109769|11306516|FG001|NOT COMPLETED|Overall Study||0
10176552|NCT03109951|11306522|FG000|STARTED|Overall Study||187
10176553|NCT03109951|11306522|FG000|COMPLETED|Overall Study||187
10176554|NCT03109951|11306522|FG000|NOT COMPLETED|Overall Study||0
10176555|NCT03110003|11306528|FG000|STARTED|Overall Study||21
10176556|NCT03110003|11306529|FG001|STARTED|Overall Study||24
10176557|NCT03110003|11306528|FG000|COMPLETED|Overall Study||21
10176558|NCT03110003|11306529|FG001|COMPLETED|Overall Study||24
10176559|NCT03110003|11306528|FG000|NOT COMPLETED|Overall Study||0
10176560|NCT03110003|11306529|FG001|NOT COMPLETED|Overall Study||0
10176561|NCT03110029|11306537|FG000|STARTED|Overall Study||7
10176562|NCT03110029|11306538|FG001|STARTED|Overall Study||6
10176563|NCT03110029|11306537|FG000|COMPLETED|Overall Study||6
10176564|NCT03110029|11306538|FG001|COMPLETED|Overall Study||5
10176565|NCT03110029|11306537|FG000|NOT COMPLETED|Overall Study||1
10176566|NCT03110029|11306538|FG001|NOT COMPLETED|Overall Study||1
10176567|NCT03110185|11306546|FG000|STARTED|Overall Study||27
10176568|NCT03110185|11306547|FG001|STARTED|Overall Study||64
10176569|NCT03110185|11306546|FG000|COMPLETED|Overall Study||17
10176570|NCT03110185|11306547|FG001|COMPLETED|Overall Study||33
10176571|NCT03110185|11306546|FG000|NOT COMPLETED|Overall Study||10
10176572|NCT03110185|11306547|FG001|NOT COMPLETED|Overall Study||31
10176573|NCT03110458|11306559|FG000|STARTED|Overall Study||37
10176574|NCT03110458|11306560|FG001|STARTED|Overall Study||36
10176575|NCT03110458|11306561|FG002|STARTED|Overall Study||34
10176576|NCT03110458|11306559|FG000|COMPLETED|Overall Study||31
10176577|NCT03110458|11306560|FG001|COMPLETED|Overall Study||32
10176578|NCT03110458|11306561|FG002|COMPLETED|Overall Study||31
10176579|NCT03110458|11306559|FG000|NOT COMPLETED|Overall Study||6
10176580|NCT03110458|11306560|FG001|NOT COMPLETED|Overall Study||4
10176581|NCT03110458|11306561|FG002|NOT COMPLETED|Overall Study||3
10176582|NCT03110471|11306571|FG000|STARTED|Overall Study||30
10176583|NCT03110471|11306572|FG001|STARTED|Overall Study||30
10176584|NCT03110471|11306571|FG000|COMPLETED|Overall Study||30
10176585|NCT03110471|11306572|FG001|COMPLETED|Overall Study||30
10176586|NCT03110471|11306571|FG000|NOT COMPLETED|Overall Study||0
10176587|NCT03110471|11306572|FG001|NOT COMPLETED|Overall Study||0
10176588|NCT03110562|11306578|FG000|STARTED|Overall Study||195
10176589|NCT03110562|11306579|FG001|STARTED|Overall Study||207
10176590|NCT03110562|11306578|FG000|Treated|Overall Study||195
10176591|NCT03110562|11306579|FG001|Treated|Overall Study||204
10176592|NCT03110562|11306578|FG000|COMPLETED|Overall Study||0
10176593|NCT03110562|11306579|FG001|COMPLETED|Overall Study||0
10176594|NCT03110562|11306578|FG000|NOT COMPLETED|Overall Study||195
10176595|NCT03110562|11306579|FG001|NOT COMPLETED|Overall Study||207
10176596|NCT03110601|11306585|FG000|STARTED|Conventional SCS Parameters||25
10176597|NCT03110601|11306585|FG000|COMPLETED|Conventional SCS Parameters||24
10176598|NCT03110601|11306585|FG000|NOT COMPLETED|Conventional SCS Parameters||1
10176599|NCT03110601|11306585|FG000|STARTED|Washout Period||24
10176600|NCT03110601|11306585|FG000|COMPLETED|Washout Period||23
10176601|NCT03110601|11306585|FG000|NOT COMPLETED|Washout Period||1
10176602|NCT03110601|11306585|FG000|STARTED|Stimgenics SCS Parameters||23
10176603|NCT03110601|11306585|FG000|COMPLETED|Stimgenics SCS Parameters||20
10176604|NCT03110601|11306585|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3
10176605|NCT03110692|11306594|FG000|STARTED|Overall Study||679
10176606|NCT03110692|11306595|FG001|STARTED|Overall Study||509
10176607|NCT03110692|11306594|FG000|COMPLETED|Overall Study||679
10176608|NCT03110692|11306595|FG001|COMPLETED|Overall Study||509
10176609|NCT03110692|11306594|FG000|NOT COMPLETED|Overall Study||0
10176610|NCT03110692|11306595|FG001|NOT COMPLETED|Overall Study||0
10176611|NCT03110770|11306606|FG000|STARTED|Overall Study||30
10176612|NCT03110770|11306607|FG001|STARTED|Overall Study||30
10176613|NCT03110770|11306608|FG002|STARTED|Overall Study||30
10176614|NCT03110770|11306609|FG003|STARTED|Overall Study||1170
10176615|NCT03110770|11306610|FG004|STARTED|Overall Study||1168
10176616|NCT03110770|11306606|FG000|Received First Product Administration|Overall Study||30
10176617|NCT03110770|11306607|FG001|Received First Product Administration|Overall Study||30
10176618|NCT03110770|11306608|FG002|Received First Product Administration|Overall Study||30
10176619|NCT03110770|11306609|FG003|Received First Product Administration|Overall Study||1162
10176620|NCT03110770|11306610|FG004|Received First Product Administration|Overall Study||1161
10176621|NCT03110770|11306606|FG000|Received Second Product Administration|Overall Study||30
10176622|NCT03110770|11306607|FG001|Received Second Product Administration|Overall Study||29
10176623|NCT03110770|11306608|FG002|Received Second Product Administration|Overall Study||29
10176624|NCT03110770|11306609|FG003|Received Second Product Administration|Overall Study||1126
10176625|NCT03110770|11306610|FG004|Received Second Product Administration|Overall Study||1127
10176626|NCT03110770|11306606|FG000|Received Third Product Administration|Overall Study||29
10176627|NCT03110770|11306607|FG001|Received Third Product Administration|Overall Study||27
10176628|NCT03110770|11306608|FG002|Received Third Product Administration|Overall Study||28
10176629|NCT03110770|11306609|FG003|Received Third Product Administration|Overall Study||1107
10176630|NCT03110770|11306610|FG004|Received Third Product Administration|Overall Study||1107
10176631|NCT03110770|11306606|FG000|COMPLETED|Overall Study||24
10176632|NCT03110770|11306607|FG001|COMPLETED|Overall Study||30
10176633|NCT03110770|11306608|FG002|COMPLETED|Overall Study||28
10176634|NCT03110770|11306609|FG003|COMPLETED|Overall Study||1037
10176635|NCT03110770|11306610|FG004|COMPLETED|Overall Study||1045
10176636|NCT03110770|11306606|FG000|NOT COMPLETED|Overall Study||6
10176637|NCT03110770|11306607|FG001|NOT COMPLETED|Overall Study||0
10176638|NCT03110770|11306608|FG002|NOT COMPLETED|Overall Study||2
10176639|NCT03110770|11306609|FG003|NOT COMPLETED|Overall Study||133
10176640|NCT03110770|11306610|FG004|NOT COMPLETED|Overall Study||123
10176641|NCT03111108|11306626|FG000|STARTED|Overall Study||53
10176642|NCT03111108|11306627|FG001|STARTED|Overall Study||64
10176643|NCT03111108|11306626|FG000|COMPLETED|Overall Study||52
10176644|NCT03111108|11306627|FG001|COMPLETED|Overall Study||63
10176645|NCT03111108|11306626|FG000|NOT COMPLETED|Overall Study||1
10176646|NCT03111108|11306627|FG001|NOT COMPLETED|Overall Study||1
10176647|NCT03111316|11306637|FG000|STARTED|Overall Study||26
10176648|NCT03111316|11306638|FG001|STARTED|Overall Study||24
10176649|NCT03111316|11306639|FG002|STARTED|Overall Study||25
10176650|NCT03111316|11306640|FG003|STARTED|Overall Study||25
10176651|NCT03111316|11306637|FG000|COMPLETED|Overall Study||26
10176652|NCT03111316|11306638|FG001|COMPLETED|Overall Study||24
10176653|NCT03111316|11306639|FG002|COMPLETED|Overall Study||25
10176654|NCT03111316|11306640|FG003|COMPLETED|Overall Study||25
10176655|NCT03111316|11306637|FG000|NOT COMPLETED|Overall Study||0
10176656|NCT03111316|11306638|FG001|NOT COMPLETED|Overall Study||0
10176657|NCT03111316|11306639|FG002|NOT COMPLETED|Overall Study||0
10176658|NCT03111316|11306640|FG003|NOT COMPLETED|Overall Study||0
10176659|NCT03111381|11306652|FG000|STARTED|Overall Study||46
10176660|NCT03111381|11306653|FG001|STARTED|Overall Study||48
10176661|NCT03111381|11306652|FG000|COMPLETED|Overall Study||46
10176662|NCT03111381|11306653|FG001|COMPLETED|Overall Study||48
10176663|NCT03111381|11306652|FG000|NOT COMPLETED|Overall Study||0
10176664|NCT03111381|11306653|FG001|NOT COMPLETED|Overall Study||0
10176665|NCT03111407|11306661|FG000|STARTED|Overall Study||45
10176666|NCT03111407|11306662|FG001|STARTED|Overall Study||27
10176667|NCT03111407|11306661|FG000|COMPLETED|Overall Study||44
10176668|NCT03111407|11306662|FG001|COMPLETED|Overall Study||26
10176669|NCT03111407|11306661|FG000|NOT COMPLETED|Overall Study||1
10176670|NCT03111407|11306662|FG001|NOT COMPLETED|Overall Study||1
10176671|NCT03111550|11306672|FG000|STARTED|Overall Study|First eye|77
10176672|NCT03111550|11306673|FG001|STARTED|Overall Study|First eye|73
10176673|NCT03111550|11306674|FG002|STARTED|Overall Study|First eye|79
10176674|NCT03111550|11306672|FG000|COMPLETED|Overall Study||73
10176675|NCT03111550|11306673|FG001|COMPLETED|Overall Study||71
10176676|NCT03111550|11306674|FG002|COMPLETED|Overall Study||76
10176677|NCT03111550|11306672|FG000|NOT COMPLETED|Overall Study||4
10176678|NCT03111550|11306673|FG001|NOT COMPLETED|Overall Study||2
10176679|NCT03111550|11306674|FG002|NOT COMPLETED|Overall Study||3
10176680|NCT03111628|11306682|FG000|STARTED|Overall Study||18
10176681|NCT03111628|11306682|FG000|COMPLETED|Overall Study||18
10176682|NCT03111628|11306682|FG000|NOT COMPLETED|Overall Study||0
10176683|NCT03111940|11306689|FG000|STARTED|Overall Study||21
10176684|NCT03111940|11306690|FG001|STARTED|Overall Study||14
10176685|NCT03111940|11306689|FG000|COMPLETED|Overall Study||21
10176686|NCT03111940|11306690|FG001|COMPLETED|Overall Study||14
10176687|NCT03111940|11306689|FG000|NOT COMPLETED|Overall Study||0
10176688|NCT03111940|11306690|FG001|NOT COMPLETED|Overall Study||0
10176689|NCT03112473|11306702|FG000|STARTED|Overall Study||30
10176690|NCT03112473|11306703|FG001|STARTED|Overall Study||30
10176691|NCT03112473|11306704|FG002|STARTED|Overall Study||30
10176692|NCT03112473|11306705|FG003|STARTED|Overall Study||30
10176693|NCT03112473|11306702|FG000|COMPLETED|Overall Study||30
10176694|NCT03112473|11306703|FG001|COMPLETED|Overall Study||30
10176695|NCT03112473|11306704|FG002|COMPLETED|Overall Study||30
10176696|NCT03112473|11306705|FG003|COMPLETED|Overall Study||30
10176697|NCT03112473|11306702|FG000|NOT COMPLETED|Overall Study||0
10176698|NCT03112473|11306703|FG001|NOT COMPLETED|Overall Study||0
10176699|NCT03112473|11306704|FG002|NOT COMPLETED|Overall Study||0
10176700|NCT03112473|11306705|FG003|NOT COMPLETED|Overall Study||0
10176701|NCT03112863|11306720|FG000|STARTED|Overall Study||21
10176702|NCT03112863|11306721|FG001|STARTED|Overall Study||23
10176703|NCT03112863|11306720|FG000|COMPLETED|Overall Study||21
10176704|NCT03112863|11306721|FG001|COMPLETED|Overall Study||23
10176705|NCT03112863|11306720|FG000|NOT COMPLETED|Overall Study||0
10176706|NCT03112863|11306721|FG001|NOT COMPLETED|Overall Study||0
10176707|NCT03113656|11306729|FG000|STARTED|Overall Study||9
10176708|NCT03113656|11306730|FG001|STARTED|Overall Study||7
10176709|NCT03113656|11306729|FG000|COMPLETED|Overall Study||9
10176710|NCT03113656|11306730|FG001|COMPLETED|Overall Study||7
10176711|NCT03113656|11306729|FG000|NOT COMPLETED|Overall Study||0
10176712|NCT03113656|11306730|FG001|NOT COMPLETED|Overall Study||0
10176713|NCT03113916|11306738|FG000|STARTED|Overall Study||99
10176714|NCT03113916|11306739|FG001|STARTED|Overall Study||96
10176715|NCT03113916|11306738|FG000|COMPLETED|Overall Study||88
10176716|NCT03113916|11306739|FG001|COMPLETED|Overall Study||84
10176717|NCT03113916|11306738|FG000|NOT COMPLETED|Overall Study||11
10176718|NCT03113916|11306739|FG001|NOT COMPLETED|Overall Study||12
10176719|NCT03114124|11306752|FG000|STARTED|Overall Study||15
10176720|NCT03114124|11306753|FG001|STARTED|Overall Study||15
10176721|NCT03114124|11306752|FG000|COMPLETED|Overall Study||15
10176722|NCT03114124|11306753|FG001|COMPLETED|Overall Study||15
10176723|NCT03114124|11306752|FG000|NOT COMPLETED|Overall Study||0
10176724|NCT03114124|11306753|FG001|NOT COMPLETED|Overall Study||0
10176725|NCT03114488|11306759|FG000|STARTED|Time Period 1||19
10176726|NCT03114488|11306760|FG001|STARTED|Time Period 1||22
10176727|NCT03114488|11306759|FG000|COMPLETED|Time Period 1||19
10176728|NCT03114488|11306760|FG001|COMPLETED|Time Period 1||22
10176729|NCT03114488|11306759|FG000|NOT COMPLETED|Time Period 1||0
10176730|NCT03114488|11306760|FG001|NOT COMPLETED|Time Period 1||0
10176731|NCT03114488|11306759|FG000|STARTED|Time Period 2||19
10176732|NCT03114488|11306760|FG001|STARTED|Time Period 2||22
10176733|NCT03114488|11306759|FG000|COMPLETED|Time Period 2||18
10176734|NCT03114488|11306760|FG001|COMPLETED|Time Period 2||19
10176735|NCT03114488|11306759|FG000|NOT COMPLETED|Time Period 2||1
10176736|NCT03114488|11306760|FG001|NOT COMPLETED|Time Period 2||3
10176737|NCT03114657|11306772|FG000|STARTED|Overall Study||399
10176738|NCT03114657|11306773|FG001|STARTED|Overall Study||407
10176739|NCT03114657|11306772|FG000|COMPLETED|Overall Study||0
10176740|NCT03114657|11306773|FG001|COMPLETED|Overall Study||0
10176741|NCT03114657|11306772|FG000|NOT COMPLETED|Overall Study||399
10176742|NCT03114657|11306773|FG001|NOT COMPLETED|Overall Study||407
10176743|NCT03114683|11306780|FG000|STARTED|Overall Study||96
10176744|NCT03114683|11306780|FG000|COMPLETED|Overall Study||52
10176745|NCT03114683|11306780|FG000|NOT COMPLETED|Overall Study||44
10176746|NCT03114969|11306793|FG000|STARTED|Overall Study||50
9713342|NCT03825393|10812550|FG000|COMPLETED|Overall Study||100
9713343|NCT03825393|10812551|FG001|COMPLETED|Overall Study||100
9713344|NCT03825393|10812550|FG000|NOT COMPLETED|Overall Study||0
10176747|NCT03114969|11306794|FG001|STARTED|Overall Study||50
10176748|NCT03114969|11306795|FG002|STARTED|Overall Study||50
10176749|NCT03114969|11306796|FG003|STARTED|Overall Study||50
10176750|NCT03114969|11306797|FG004|STARTED|Overall Study||51
10176751|NCT03114969|11306798|FG005|STARTED|Overall Study||49
10176752|NCT03114969|11306799|FG006|STARTED|Overall Study||50
10176753|NCT03114969|11306800|FG007|STARTED|Overall Study||50
10176754|NCT03114969|11306801|FG008|STARTED|Overall Study||50
10176755|NCT03114969|11306793|FG000|COMPLETED|Overall Study||50
10176756|NCT03114969|11306794|FG001|COMPLETED|Overall Study||50
10176757|NCT03114969|11306795|FG002|COMPLETED|Overall Study||46
10176758|NCT03114969|11306796|FG003|COMPLETED|Overall Study||48
10176759|NCT03114969|11306797|FG004|COMPLETED|Overall Study||51
10176760|NCT03114969|11306798|FG005|COMPLETED|Overall Study||48
10176761|NCT03114969|11306799|FG006|COMPLETED|Overall Study||49
10176762|NCT03114969|11306800|FG007|COMPLETED|Overall Study||50
10176763|NCT03114969|11306801|FG008|COMPLETED|Overall Study||48
10176764|NCT03114969|11306793|FG000|NOT COMPLETED|Overall Study||0
10176765|NCT03114969|11306794|FG001|NOT COMPLETED|Overall Study||0
10176766|NCT03114969|11306795|FG002|NOT COMPLETED|Overall Study||4
10176767|NCT03114969|11306796|FG003|NOT COMPLETED|Overall Study||2
10176768|NCT03114969|11306797|FG004|NOT COMPLETED|Overall Study||0
10176769|NCT03114969|11306798|FG005|NOT COMPLETED|Overall Study||1
10176770|NCT03114969|11306799|FG006|NOT COMPLETED|Overall Study||1
10176771|NCT03114969|11306800|FG007|NOT COMPLETED|Overall Study||0
10176772|NCT03114969|11306801|FG008|NOT COMPLETED|Overall Study||2
10176773|NCT03114995|11306831|FG000|STARTED|Overall Study||31
10176774|NCT03114995|11306832|FG001|STARTED|Overall Study||31
10176775|NCT03114995|11306833|FG002|STARTED|Overall Study||78
10176776|NCT03114995|11306831|FG000|COMPLETED|Overall Study||30
10176777|NCT03114995|11306832|FG001|COMPLETED|Overall Study||30
10176778|NCT03114995|11306833|FG002|COMPLETED|Overall Study||78
10176779|NCT03114995|11306831|FG000|NOT COMPLETED|Overall Study||1
10176780|NCT03114995|11306832|FG001|NOT COMPLETED|Overall Study||1
10176781|NCT03114995|11306833|FG002|NOT COMPLETED|Overall Study||0
10176782|NCT03115112|11306843|FG000|STARTED|Overall Study||192
10176783|NCT03115112|11306844|FG001|STARTED|Overall Study||194
10176784|NCT03115112|11306843|FG000|Intention-to-treat|Overall Study||191
10176785|NCT03115112|11306844|FG001|Intention-to-treat|Overall Study||193
10176786|NCT03115112|11306843|FG000|COMPLETED|Overall Study||180
10176787|NCT03115112|11306844|FG001|COMPLETED|Overall Study||189
10176788|NCT03115112|11306843|FG000|NOT COMPLETED|Overall Study||12
10176789|NCT03115112|11306844|FG001|NOT COMPLETED|Overall Study||5
10176790|NCT03115177|11306854|FG000|STARTED|Overall Study||27
10176791|NCT03115177|11306855|FG001|STARTED|Overall Study||29
10176792|NCT03115177|11306854|FG000|COMPLETED|Overall Study||27
10176793|NCT03115177|11306855|FG001|COMPLETED|Overall Study||29
10176794|NCT03115177|11306854|FG000|NOT COMPLETED|Overall Study||0
10176795|NCT03115177|11306855|FG001|NOT COMPLETED|Overall Study||0
10176796|NCT03115411|11306861|FG000|STARTED|Overall Study||23
10176797|NCT03115411|11306861|FG000|COMPLETED|Overall Study||23
10176798|NCT03115411|11306861|FG000|NOT COMPLETED|Overall Study||0
10176799|NCT03115476|11306868|FG000|STARTED|Main Trials (LP0084-119x)||407
10176800|NCT03115476|11306869|FG001|STARTED|Main Trials (LP0084-119x)||418
10176801|NCT03115476|11306870|FG002|STARTED|Main Trials (LP0084-119x)||409
10176802|NCT03115476|11306868|FG000|COMPLETED|Main Trials (LP0084-119x)||407
10176803|NCT03115476|11306869|FG001|COMPLETED|Main Trials (LP0084-119x)||418
9713345|NCT03825393|10812551|FG001|NOT COMPLETED|Overall Study||0
9731154|NCT00130520|10831096|FG000|Completion of at Least One Cycle|Overall Study||39
9731155|NCT00130520|10831096|FG000|COMPLETED|Overall Study||1
9731156|NCT00130520|10831096|FG000|NOT COMPLETED|Overall Study||39
9731157|NCT00130533|10831102|FG000|STARTED|Overall Study||448
9731158|NCT00130533|10831103|FG001|STARTED|Overall Study||428
9731159|NCT00130533|10831102|FG000|COMPLETED|Overall Study||337
9731160|NCT00130533|10831103|FG001|COMPLETED|Overall Study||398
9731161|NCT00130533|10831102|FG000|NOT COMPLETED|Overall Study||111
9731162|NCT00130533|10831103|FG001|NOT COMPLETED|Overall Study||30
9731163|NCT00130637|10831109|FG000|STARTED|Overall Study||6
9731164|NCT00130637|10831109|FG000|COMPLETED|Overall Study||3
9731165|NCT00130637|10831109|FG000|NOT COMPLETED|Overall Study||3
9731166|NCT00130689|10831113|FG000|STARTED|Overall Study||43
9731167|NCT00130689|10831113|FG000|Eligible|Overall Study||37
9731168|NCT00130689|10831113|FG000|Treated|Overall Study||35
9731169|NCT00130689|10831113|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
9731170|NCT00130689|10831113|FG000|NOT COMPLETED|Overall Study||43
9731171|NCT00130728|10831119|FG000|STARTED|Overall Study||319
9731172|NCT00130728|10831120|FG001|STARTED|Overall Study||317
9731173|NCT00130728|10831119|FG000|Received Study Drug (Safety Population)|Overall Study||313
9731174|NCT00130728|10831120|FG001|Received Study Drug (Safety Population)|Overall Study||313
9731175|NCT00130728|10831119|FG000|COMPLETED|Overall Study||57
9731176|NCT00130728|10831120|FG001|COMPLETED|Overall Study||57
9731177|NCT00130728|10831119|FG000|NOT COMPLETED|Overall Study||262
9731178|NCT00130728|10831120|FG001|NOT COMPLETED|Overall Study||260
9731179|NCT00130780|10831128|FG000|STARTED|Overall Study||51
9731180|NCT00130780|10831129|FG001|STARTED|Overall Study||20
9731181|NCT00130780|10831128|FG000|COMPLETED|Overall Study||51
9731182|NCT00130780|10831129|FG001|COMPLETED|Overall Study||20
9731183|NCT00130780|10831128|FG000|NOT COMPLETED|Overall Study||0
9731184|NCT00130780|10831129|FG001|NOT COMPLETED|Overall Study||0
9731185|NCT00130793|10831137|FG000|STARTED|Overall Study||183
10176804|NCT03115476|11306870|FG002|COMPLETED|Main Trials (LP0084-119x)||409
10176805|NCT03115476|11306868|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0
9731186|NCT00130793|10831138|FG001|STARTED|Overall Study||185
9731187|NCT00130793|10831137|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
9731188|NCT00130793|10831138|FG001|Vaccinated|Overall Study||185
9731949|NCT00138034|10831936|FG001|STARTED|Overall Study||23
10176806|NCT03115476|11306869|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0
10176807|NCT03115476|11306870|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0
10176808|NCT03115476|11306868|FG000|STARTED|LP0084-1369||191
10176809|NCT03115476|11306869|FG001|STARTED|LP0084-1369||210
10176810|NCT03115476|11306870|FG002|STARTED|LP0084-1369||162
10176811|NCT03115476|11306868|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
10176812|NCT03115476|11306869|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
10176813|NCT03115476|11306870|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
10176814|NCT03115476|11306868|FG000|NOT COMPLETED|LP0084-1369||191
10176815|NCT03115476|11306869|FG001|NOT COMPLETED|LP0084-1369||210
10176816|NCT03115476|11306870|FG002|NOT COMPLETED|LP0084-1369||162
10176817|NCT03115580|11306880|FG000|STARTED|Overall Study||35
10176818|NCT03115580|11306881|FG001|STARTED|Overall Study||36
10176819|NCT03115580|11306880|FG000|COMPLETED|Overall Study||35
9713346|NCT03813719|10812559|FG000|STARTED|Overall Study||250
9713347|NCT03813719|10812559|FG000|COMPLETED|Overall Study||250
9713348|NCT03813719|10812559|FG000|NOT COMPLETED|Overall Study||0
9713349|NCT03798756|10812565|FG000|STARTED|Overall Study||9274
9713350|NCT03798756|10812565|FG000|COMPLETED|Overall Study||9274
9713351|NCT03798756|10812565|FG000|NOT COMPLETED|Overall Study||0
9713382|NCT04374149|10812611|FG000|STARTED|Overall Study||10
9713383|NCT04374149|10812612|FG001|STARTED|Overall Study||10
9713384|NCT04374149|10812611|FG000|COMPLETED|Overall Study||10
9713385|NCT04374149|10812612|FG001|COMPLETED|Overall Study||10
9713386|NCT04374149|10812611|FG000|NOT COMPLETED|Overall Study||0
9713387|NCT04374149|10812612|FG001|NOT COMPLETED|Overall Study||0
9713388|NCT04348500|10812620|FG000|STARTED|Overall Study||8
9713389|NCT04348500|10812621|FG001|STARTED|Overall Study||9
9713390|NCT04348500|10812620|FG000|Treated|Overall Study||8
9713391|NCT04348500|10812621|FG001|Treated|Overall Study||8
9713392|NCT04348500|10812620|FG000|COMPLETED|Overall Study||6
9713393|NCT04348500|10812621|FG001|COMPLETED|Overall Study||6
9713394|NCT04348500|10812620|FG000|NOT COMPLETED|Overall Study||2
9713395|NCT04348500|10812621|FG001|NOT COMPLETED|Overall Study||3
9713396|NCT04347941|10812629|FG000|STARTED|Overall Study||12
9713397|NCT04347941|10812630|FG001|STARTED|Overall Study||12
9713398|NCT04347941|10812629|FG000|COMPLETED|Overall Study||12
9713399|NCT04347941|10812630|FG001|COMPLETED|Overall Study||12
9713400|NCT04347941|10812629|FG000|NOT COMPLETED|Overall Study||0
9713401|NCT04347941|10812630|FG001|NOT COMPLETED|Overall Study||0
9713402|NCT04308694|10812639|FG000|STARTED|Overall Study||20
9713403|NCT04308694|10812639|FG000|COMPLETED|Overall Study||16
9713404|NCT04308694|10812639|FG000|NOT COMPLETED|Overall Study||4
10176820|NCT03115580|11306881|FG001|COMPLETED|Overall Study||36
10176821|NCT03115580|11306880|FG000|NOT COMPLETED|Overall Study||0
10176822|NCT03115580|11306881|FG001|NOT COMPLETED|Overall Study||0
10176823|NCT03115801|11306889|FG000|STARTED|Overall Study||4
10176824|NCT03115801|11306890|FG001|STARTED|Overall Study||2
10176825|NCT03115801|11306889|FG000|COMPLETED|Overall Study||1
10176826|NCT03115801|11306890|FG001|COMPLETED|Overall Study||0
10176827|NCT03115801|11306889|FG000|NOT COMPLETED|Overall Study||3
10176828|NCT03115801|11306890|FG001|NOT COMPLETED|Overall Study||2
10176829|NCT03115827|11306896|FG000|STARTED|Overall Study||15
10176830|NCT03115827|11306896|FG000|COMPLETED|Overall Study||12
10176831|NCT03115827|11306896|FG000|NOT COMPLETED|Overall Study||3
10176832|NCT03116152|11306902|FG000|STARTED|Overall Study||95
10176833|NCT03116152|11306903|FG001|STARTED|Overall Study||95
10176834|NCT03116152|11306902|FG000|Treated|Overall Study||94
10176835|NCT03116152|11306903|FG001|Treated|Overall Study||87
10176836|NCT03116152|11306902|FG000|COMPLETED|Overall Study||4
10176837|NCT03116152|11306903|FG001|COMPLETED|Overall Study||0
10176838|NCT03116152|11306902|FG000|NOT COMPLETED|Overall Study||91
10176839|NCT03116152|11306903|FG001|NOT COMPLETED|Overall Study||95
10176840|NCT03116230|11306911|FG000|STARTED|Overall Study||19
10176841|NCT03116230|11306912|FG001|STARTED|Overall Study||19
10176842|NCT03116230|11306911|FG000|COMPLETED|Overall Study||15
10176843|NCT03116230|11306912|FG001|COMPLETED|Overall Study||17
10176844|NCT03116230|11306911|FG000|NOT COMPLETED|Overall Study||4
10176845|NCT03116230|11306912|FG001|NOT COMPLETED|Overall Study||2
10176846|NCT03116698|11306922|FG000|STARTED|Overall Study||62
10176847|NCT03116698|11306923|FG001|STARTED|Overall Study||57
10176848|NCT03116698|11306924|FG002|STARTED|Overall Study||62
10176849|NCT03116698|11306925|FG003|STARTED|Overall Study||57
10176850|NCT03116698|11306922|FG000|COMPLETED|Overall Study||56
10176851|NCT03116698|11306923|FG001|COMPLETED|Overall Study||51
10176852|NCT03116698|11306924|FG002|COMPLETED|Overall Study||54
10176853|NCT03116698|11306925|FG003|COMPLETED|Overall Study||55
10176854|NCT03116698|11306922|FG000|NOT COMPLETED|Overall Study||6
10176855|NCT03116698|11306923|FG001|NOT COMPLETED|Overall Study||6
10176856|NCT03116698|11306924|FG002|NOT COMPLETED|Overall Study||8
10176857|NCT03116698|11306925|FG003|NOT COMPLETED|Overall Study||2
10176858|NCT03116828|11306937|FG000|STARTED|Overall Study||44
10176859|NCT03116828|11306938|FG001|STARTED|Overall Study||58
10176860|NCT03116828|11306937|FG000|COMPLETED|Overall Study||36
10176861|NCT03116828|11306938|FG001|COMPLETED|Overall Study||37
10176862|NCT03116828|11306937|FG000|NOT COMPLETED|Overall Study||8
10176863|NCT03116828|11306938|FG001|NOT COMPLETED|Overall Study||21
10176864|NCT03116841|11306944|FG000|STARTED|Overall Study||3
10176865|NCT03116841|11306944|FG000|COMPLETED|Overall Study||3
10176866|NCT03116841|11306944|FG000|NOT COMPLETED|Overall Study||0
10176867|NCT03117140|11306952|FG000|STARTED|Overall Study||40
10176868|NCT03117140|11306953|FG001|STARTED|Overall Study||40
10176869|NCT03117140|11306954|FG002|STARTED|Overall Study||40
10176870|NCT03117140|11306955|FG003|STARTED|Overall Study||40
10176871|NCT03117140|11306952|FG000|COMPLETED|Overall Study||40
10176872|NCT03117140|11306953|FG001|COMPLETED|Overall Study||40
10176873|NCT03117140|11306954|FG002|COMPLETED|Overall Study||40
10176874|NCT03117140|11306955|FG003|COMPLETED|Overall Study||40
10176875|NCT03117140|11306952|FG000|NOT COMPLETED|Overall Study||0
10176876|NCT03117140|11306953|FG001|NOT COMPLETED|Overall Study||0
10176877|NCT03117140|11306954|FG002|NOT COMPLETED|Overall Study||0
10176878|NCT03117140|11306955|FG003|NOT COMPLETED|Overall Study||0
10176879|NCT03117361|11306968|FG000|STARTED|Overall Study||10
10176880|NCT03117361|11306968|FG000|COMPLETED|Overall Study||0
10176881|NCT03117361|11306968|FG000|NOT COMPLETED|Overall Study||10
10176882|NCT03117517|11306974|FG000|STARTED|Overall Study||53
10176883|NCT03117517|11306975|FG001|STARTED|Overall Study||53
10176884|NCT03117517|11306974|FG000|COMPLETED|Overall Study||48
10176885|NCT03117517|11306975|FG001|COMPLETED|Overall Study||49
10176886|NCT03117517|11306974|FG000|NOT COMPLETED|Overall Study||5
10176887|NCT03117517|11306975|FG001|NOT COMPLETED|Overall Study||4
10176888|NCT03117569|11306987|FG000|STARTED|Overall Study||127
10176889|NCT03117569|11306988|FG001|STARTED|Overall Study||253
10176890|NCT03117569|11306987|FG000|COMPLETED|Overall Study||123
10176891|NCT03117569|11306988|FG001|COMPLETED|Overall Study||241
10176892|NCT03117569|11306987|FG000|NOT COMPLETED|Overall Study||4
10176893|NCT03117569|11306988|FG001|NOT COMPLETED|Overall Study||12
10176894|NCT03117634|11307000|FG000|STARTED|Overall Study||41
10176895|NCT03117634|11307001|FG001|STARTED|Overall Study||13
10176896|NCT03117634|11307000|FG000|COMPLETED|Overall Study||39
10176897|NCT03117634|11307001|FG001|COMPLETED|Overall Study||13
10176898|NCT03117634|11307000|FG000|NOT COMPLETED|Overall Study||2
10176899|NCT03117634|11307001|FG001|NOT COMPLETED|Overall Study||0
10176900|NCT03117738|11307009|FG000|STARTED|Overall Study||11
10176901|NCT03117738|11307010|FG001|STARTED|Overall Study||10
10176902|NCT03117738|11307009|FG000|COMPLETED|Overall Study||7
10176903|NCT03117738|11307010|FG001|COMPLETED|Overall Study||5
10176904|NCT03117738|11307009|FG000|NOT COMPLETED|Overall Study||4
10176905|NCT03117738|11307010|FG001|NOT COMPLETED|Overall Study||5
10176906|NCT03118297|11307018|FG000|STARTED|Overall Study||32
10176907|NCT03118297|11307019|FG001|STARTED|Overall Study||33
10176908|NCT03118297|11307018|FG000|COMPLETED|Overall Study||32
10176909|NCT03118297|11307019|FG001|COMPLETED|Overall Study||31
10176910|NCT03118297|11307018|FG000|NOT COMPLETED|Overall Study||0
10176911|NCT03118297|11307019|FG001|NOT COMPLETED|Overall Study||2
10176912|NCT03118466|11307025|FG000|STARTED|Overall Study||40
10176913|NCT03118466|11307025|FG000|COMPLETED|Overall Study||40
10176914|NCT03118466|11307025|FG000|NOT COMPLETED|Overall Study||0
10176915|NCT03118518|11307031|FG000|STARTED|Overall Study||108
10176916|NCT03118518|11307032|FG001|STARTED|Overall Study||102
10176917|NCT03118518|11307031|FG000|Subject Treated According to Randomization Assignment|Overall Study||104
10176918|NCT03118518|11307032|FG001|Subject Treated According to Randomization Assignment|Overall Study||99
10176919|NCT03118518|11307031|FG000|COMPLETED|Overall Study||102
10176920|NCT03118518|11307032|FG001|COMPLETED|Overall Study||91
10176921|NCT03118518|11307031|FG000|NOT COMPLETED|Overall Study||6
10176922|NCT03118518|11307032|FG001|NOT COMPLETED|Overall Study||11
10176923|NCT03118596|11307040|FG000|STARTED|Overall Study||90
10176924|NCT03118596|11307041|FG001|STARTED|Overall Study||90
10176925|NCT03118596|11307040|FG000|Treated|Overall Study||2
10176926|NCT03118596|11307041|FG001|Treated|Overall Study||0
10176927|NCT03118596|11307040|FG000|Failed|Overall Study||0
10176928|NCT03118596|11307041|FG001|Failed|Overall Study||4
10176929|NCT03118596|11307040|FG000|COMPLETED|Overall Study||90
10176930|NCT03118596|11307041|FG001|COMPLETED|Overall Study||86
10176931|NCT03118596|11307040|FG000|NOT COMPLETED|Overall Study||0
10176932|NCT03118596|11307041|FG001|NOT COMPLETED|Overall Study||4
10176933|NCT03118739|11307049|FG000|STARTED|Overall Study||32
10176934|NCT03118739|11307050|FG001|STARTED|Overall Study||28
10176935|NCT03118739|11307049|FG000|Completed 12 Weeks of Treatment|Overall Study||26
10176936|NCT03118739|11307050|FG001|Completed 12 Weeks of Treatment|Overall Study||25
10176937|NCT03118739|11307049|FG000|Completed 24 Weeks of Treatment|Overall Study||24
10176938|NCT03118739|11307050|FG001|Completed 24 Weeks of Treatment|Overall Study||25
10176939|NCT03118739|11307049|FG000|COMPLETED|Overall Study||25
10176940|NCT03118739|11307050|FG001|COMPLETED|Overall Study||24
10176941|NCT03118739|11307049|FG000|NOT COMPLETED|Overall Study||7
10176942|NCT03118739|11307050|FG001|NOT COMPLETED|Overall Study||4
10176943|NCT03118765|11307061|FG000|STARTED|Overall Study||30
10176944|NCT03118765|11307062|FG001|STARTED|Overall Study||32
10176945|NCT03118765|11307063|FG002|STARTED|Overall Study||31
10176946|NCT03118765|11307064|FG003|STARTED|Overall Study||32
10176947|NCT03118765|11307065|FG004|STARTED|Overall Study||30
10176948|NCT03118765|11307061|FG000|COMPLETED|Overall Study||26
10176949|NCT03118765|11307062|FG001|COMPLETED|Overall Study||30
10176950|NCT03118765|11307063|FG002|COMPLETED|Overall Study||26
10176951|NCT03118765|11307064|FG003|COMPLETED|Overall Study||29
10176952|NCT03118765|11307065|FG004|COMPLETED|Overall Study||28
10176953|NCT03118765|11307061|FG000|NOT COMPLETED|Overall Study||4
10176954|NCT03118765|11307062|FG001|NOT COMPLETED|Overall Study||2
10176955|NCT03118765|11307063|FG002|NOT COMPLETED|Overall Study||5
10176956|NCT03118765|11307064|FG003|NOT COMPLETED|Overall Study||3
10176957|NCT03118765|11307065|FG004|NOT COMPLETED|Overall Study||2
10176958|NCT03118843|11307078|FG000|STARTED|Overall Study||31
10176959|NCT03118843|11307078|FG000|COMPLETED|Overall Study||31
10176960|NCT03118843|11307078|FG000|NOT COMPLETED|Overall Study||0
10176961|NCT03118934|11307085|FG000|STARTED|Overall Study||34
10176962|NCT03118934|11307086|FG001|STARTED|Overall Study||31
9849674|NCT00866788|10962454|FG003|NOT COMPLETED|Overall Study||5
9849675|NCT00866814|10962467|FG000|STARTED|Overall Study||119
9849676|NCT00866814|10962467|FG000|COMPLETED|Overall Study||99
9849677|NCT00866814|10962467|FG000|NOT COMPLETED|Overall Study||20
9849678|NCT00866879|10962473|FG000|STARTED|Overall Study||90
9849679|NCT00866879|10962474|FG001|STARTED|Overall Study||185
10176963|NCT03118934|11307087|FG002|STARTED|Overall Study||34
10176964|NCT03118934|11307088|FG003|STARTED|Overall Study||29
10176965|NCT03118934|11307089|FG004|STARTED|Overall Study||29
10176966|NCT03118934|11307090|FG005|STARTED|Overall Study||25
10176967|NCT03118934|11307085|FG000|Safety Analysis Set|Overall Study||34
10176968|NCT03118934|11307086|FG001|Safety Analysis Set|Overall Study||29
10176969|NCT03118934|11307087|FG002|Safety Analysis Set|Overall Study||34
10176970|NCT03118934|11307088|FG003|Safety Analysis Set|Overall Study||29
10176971|NCT03118934|11307089|FG004|Safety Analysis Set|Overall Study||26
10176972|NCT03118934|11307090|FG005|Safety Analysis Set|Overall Study||25
10176973|NCT03118934|11307085|FG000|COMPLETED|Overall Study||34
10176974|NCT03118934|11307086|FG001|COMPLETED|Overall Study||30
10176975|NCT03118934|11307087|FG002|COMPLETED|Overall Study||33
10176976|NCT03118934|11307088|FG003|COMPLETED|Overall Study||28
10176977|NCT03118934|11307089|FG004|COMPLETED|Overall Study||27
10176978|NCT03118934|11307090|FG005|COMPLETED|Overall Study||23
10176979|NCT03118934|11307085|FG000|NOT COMPLETED|Overall Study||0
10176980|NCT03118934|11307086|FG001|NOT COMPLETED|Overall Study||1
10176981|NCT03118934|11307087|FG002|NOT COMPLETED|Overall Study||1
10176982|NCT03118934|11307088|FG003|NOT COMPLETED|Overall Study||1
10176983|NCT03118934|11307089|FG004|NOT COMPLETED|Overall Study||2
10176984|NCT03118934|11307090|FG005|NOT COMPLETED|Overall Study||2
10176985|NCT03118947|11307100|FG000|STARTED|Overall Study||78
10176986|NCT03118947|11307100|FG000|COMPLETED|Overall Study||49
10176987|NCT03118947|11307100|FG000|NOT COMPLETED|Overall Study||29
10176988|NCT03119025|11307104|FG000|STARTED|Overall Study||10
10176989|NCT03119025|11307104|FG000|COMPLETED|Overall Study||10
10176990|NCT03119025|11307104|FG000|NOT COMPLETED|Overall Study||0
10176991|NCT03119168|11307110|FG000|STARTED|Overall Study||129
10176992|NCT03119168|11307111|FG001|STARTED|Overall Study||139
10176993|NCT03119168|11307110|FG000|COMPLETED|Overall Study||129
10176994|NCT03119168|11307111|FG001|COMPLETED|Overall Study||139
10176995|NCT03119168|11307110|FG000|NOT COMPLETED|Overall Study||0
10176996|NCT03119168|11307111|FG001|NOT COMPLETED|Overall Study||0
10176997|NCT03119181|11307121|FG000|STARTED|Overall Study||19
10176998|NCT03119181|11307122|FG001|STARTED|Overall Study||21
9849680|NCT00866879|10962473|FG000|COMPLETED|Overall Study||90
10176999|NCT03119181|11307121|FG000|COMPLETED|Overall Study||19
10177000|NCT03119181|11307122|FG001|COMPLETED|Overall Study||21
10177001|NCT03119181|11307121|FG000|NOT COMPLETED|Overall Study||0
10177002|NCT03119181|11307122|FG001|NOT COMPLETED|Overall Study||0
10177003|NCT03119389|11307130|FG000|STARTED|Overall Study||6791
10177004|NCT03119389|11307131|FG001|STARTED|Overall Study||7627
10177005|NCT03119389|11307130|FG000|COMPLETED|Overall Study||6791
10177006|NCT03119389|11307131|FG001|COMPLETED|Overall Study||7627
10177007|NCT03119389|11307130|FG000|NOT COMPLETED|Overall Study||0
10177008|NCT03119389|11307131|FG001|NOT COMPLETED|Overall Study||0
10177009|NCT03119571|11307141|FG000|STARTED|Overall Study||31
10177010|NCT03119571|11307142|FG001|STARTED|Overall Study||34
10177011|NCT03119571|11307141|FG000|COMPLETED|Overall Study||31
10177012|NCT03119571|11307142|FG001|COMPLETED|Overall Study||34
10177013|NCT03119571|11307141|FG000|NOT COMPLETED|Overall Study||0
10177014|NCT03119571|11307142|FG001|NOT COMPLETED|Overall Study||0
10177015|NCT03119610|11307150|FG000|STARTED|Overall Study||13
10177016|NCT03119610|11307151|FG001|STARTED|Overall Study||10
10177017|NCT03119610|11307150|FG000|COMPLETED|Overall Study||12
10177018|NCT03119610|11307151|FG001|COMPLETED|Overall Study||9
10177019|NCT03119610|11307150|FG000|NOT COMPLETED|Overall Study||1
10177020|NCT03119610|11307151|FG001|NOT COMPLETED|Overall Study||1
10177021|NCT03119649|11307162|FG000|STARTED|Overall Study||11
10177022|NCT03119649|11307163|FG001|STARTED|Overall Study||10
10177023|NCT03119649|11307164|FG002|STARTED|Overall Study||10
10177024|NCT03119649|11307165|FG003|STARTED|Overall Study||14
10177025|NCT03119649|11307166|FG004|STARTED|Overall Study||14
10177026|NCT03119649|11307162|FG000|COMPLETED|Overall Study||11
10177027|NCT03119649|11307163|FG001|COMPLETED|Overall Study||10
10177028|NCT03119649|11307164|FG002|COMPLETED|Overall Study||10
10177029|NCT03119649|11307165|FG003|COMPLETED|Overall Study||14
10177030|NCT03119649|11307166|FG004|COMPLETED|Overall Study||14
10177031|NCT03119649|11307162|FG000|NOT COMPLETED|Overall Study||0
10177032|NCT03119649|11307163|FG001|NOT COMPLETED|Overall Study||0
10177033|NCT03119649|11307164|FG002|NOT COMPLETED|Overall Study||0
10177034|NCT03119649|11307165|FG003|NOT COMPLETED|Overall Study||0
10177035|NCT03119649|11307166|FG004|NOT COMPLETED|Overall Study||0
10177036|NCT03119688|11307182|FG000|STARTED|Overall Study||48
10177037|NCT03119688|11307182|FG000|COMPLETED|Overall Study||44
10177038|NCT03119688|11307182|FG000|NOT COMPLETED|Overall Study||4
10177039|NCT03119701|11307201|FG000|STARTED|6-day Dosing||29
10177040|NCT03119701|11307202|FG001|STARTED|6-day Dosing||11
10177041|NCT03119701|11307201|FG000|COMPLETED|6-day Dosing||22
10177042|NCT03119701|11307202|FG001|COMPLETED|6-day Dosing||8
10177043|NCT03119701|11307201|FG000|NOT COMPLETED|6-day Dosing||7
10177044|NCT03119701|11307202|FG001|NOT COMPLETED|6-day Dosing||3
10177045|NCT03119701|11307201|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
10177046|NCT03119701|11307202|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
10177047|NCT03119701|11307201|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22
10177048|NCT03119701|11307202|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9
10177049|NCT03119701|11307201|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
10177050|NCT03119701|11307202|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
10177051|NCT03119831|11307211|FG000|STARTED|Overall Study||14
10177052|NCT03119831|11307212|FG001|STARTED|Overall Study||14
10177053|NCT03119831|11307213|FG002|STARTED|Overall Study||14
10177054|NCT03119831|11307211|FG000|COMPLETED|Overall Study||14
10177055|NCT03119831|11307212|FG001|COMPLETED|Overall Study||14
10177056|NCT03119831|11307213|FG002|COMPLETED|Overall Study||14
10177057|NCT03119831|11307211|FG000|NOT COMPLETED|Overall Study||0
10177058|NCT03119831|11307212|FG001|NOT COMPLETED|Overall Study||0
10177059|NCT03119831|11307213|FG002|NOT COMPLETED|Overall Study||0
10177060|NCT03120013|11307224|FG000|STARTED|First Intervention (2 Weeks)||10
10177061|NCT03120013|11307225|FG001|STARTED|First Intervention (2 Weeks)||11
10177062|NCT03120013|11307224|FG000|Received Intervention|First Intervention (2 Weeks)||10
10177063|NCT03120013|11307225|FG001|Received Intervention|First Intervention (2 Weeks)||11
10177064|NCT03120013|11307224|FG000|COMPLETED|First Intervention (2 Weeks)||10
10177065|NCT03120013|11307225|FG001|COMPLETED|First Intervention (2 Weeks)||10
10177066|NCT03120013|11307224|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10177067|NCT03120013|11307225|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
10177068|NCT03120013|11307224|FG000|STARTED|Washout (6 Months)||10
10177069|NCT03120013|11307225|FG001|STARTED|Washout (6 Months)||10
10177070|NCT03120013|11307224|FG000|COMPLETED|Washout (6 Months)||10
10177071|NCT03120013|11307225|FG001|COMPLETED|Washout (6 Months)||10
10177072|NCT03120013|11307224|FG000|NOT COMPLETED|Washout (6 Months)||0
10177073|NCT03120013|11307225|FG001|NOT COMPLETED|Washout (6 Months)||0
10177074|NCT03120013|11307224|FG000|STARTED|Second Intervention (2 Weeks)||10
10177075|NCT03120013|11307225|FG001|STARTED|Second Intervention (2 Weeks)||10
10177076|NCT03120013|11307224|FG000|COMPLETED|Second Intervention (2 Weeks)||10
10177077|NCT03120013|11307225|FG001|COMPLETED|Second Intervention (2 Weeks)||10
10177078|NCT03120013|11307224|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10177079|NCT03120013|11307225|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10177080|NCT03120351|11307233|FG000|STARTED|Overall Study||40
10177081|NCT03120351|11307234|FG001|STARTED|Overall Study||40
10177082|NCT03120351|11307233|FG000|COMPLETED|Overall Study||39
10177083|NCT03120351|11307234|FG001|COMPLETED|Overall Study||39
10177084|NCT03120351|11307233|FG000|NOT COMPLETED|Overall Study||1
10177085|NCT03120351|11307234|FG001|NOT COMPLETED|Overall Study||1
10177086|NCT03120520|11307244|FG000|STARTED|Overall Study||31
10177087|NCT03120520|11307245|FG001|STARTED|Overall Study||31
10177088|NCT03120520|11307246|FG002|STARTED|Overall Study||30
10177089|NCT03120520|11307247|FG003|STARTED|Overall Study||32
10177090|NCT03120520|11307244|FG000|COMPLETED|Overall Study||27
10177091|NCT03120520|11307245|FG001|COMPLETED|Overall Study||27
10177092|NCT03120520|11307246|FG002|COMPLETED|Overall Study||26
10177093|NCT03120520|11307247|FG003|COMPLETED|Overall Study||29
10177094|NCT03120520|11307244|FG000|NOT COMPLETED|Overall Study||4
10177095|NCT03120520|11307245|FG001|NOT COMPLETED|Overall Study||4
10177096|NCT03120520|11307246|FG002|NOT COMPLETED|Overall Study||4
10177097|NCT03120520|11307247|FG003|NOT COMPLETED|Overall Study||3
10177098|NCT03120832|11307260|FG000|STARTED|Overall Study||3
10177099|NCT03120832|11307261|FG001|STARTED|Overall Study||3
10177100|NCT03120832|11307262|FG002|STARTED|Overall Study||6
10177101|NCT03120832|11307260|FG000|COMPLETED|Overall Study||3
10177102|NCT03120832|11307261|FG001|COMPLETED|Overall Study||3
10177103|NCT03120832|11307262|FG002|COMPLETED|Overall Study||6
10177104|NCT03120832|11307260|FG000|NOT COMPLETED|Overall Study||0
10177105|NCT03120832|11307261|FG001|NOT COMPLETED|Overall Study||0
10177106|NCT03120832|11307262|FG002|NOT COMPLETED|Overall Study||0
10177107|NCT03121144|11307270|FG000|STARTED|Overall Study||34
10177108|NCT03121144|11307270|FG000|COMPLETED|Overall Study||34
10177109|NCT03121144|11307270|FG000|NOT COMPLETED|Overall Study||0
10177110|NCT03121365|11307276|FG000|STARTED|Baseline||55
10177111|NCT03121365|11307277|FG001|STARTED|Baseline||49
10177112|NCT03121365|11307276|FG000|COMPLETED|Baseline||54
10177113|NCT03121365|11307277|FG001|COMPLETED|Baseline||48
10177114|NCT03121365|11307276|FG000|NOT COMPLETED|Baseline||1
10177115|NCT03121365|11307277|FG001|NOT COMPLETED|Baseline||1
10177116|NCT03121365|11307276|FG000|STARTED|1 Months||54
10177117|NCT03121365|11307277|FG001|STARTED|1 Months||48
10177118|NCT03121365|11307276|FG000|COMPLETED|1 Months||52
10177119|NCT03121365|11307277|FG001|COMPLETED|1 Months||45
10177120|NCT03121365|11307276|FG000|NOT COMPLETED|1 Months||2
10177121|NCT03121365|11307277|FG001|NOT COMPLETED|1 Months||3
10177122|NCT03121365|11307276|FG000|STARTED|4 Months||54
10177123|NCT03121365|11307277|FG001|STARTED|4 Months||45
10177124|NCT03121365|11307276|FG000|COMPLETED|4 Months||51
10177125|NCT03121365|11307277|FG001|COMPLETED|4 Months||44
10177126|NCT03121365|11307276|FG000|NOT COMPLETED|4 Months||3
10177127|NCT03121365|11307277|FG001|NOT COMPLETED|4 Months||1
10177128|NCT03121365|11307276|FG000|STARTED|7 Months||54
10177129|NCT03121365|11307277|FG001|STARTED|7 Months||45
10177130|NCT03121365|11307276|FG000|COMPLETED|7 Months||44
10177131|NCT03121365|11307277|FG001|COMPLETED|7 Months||37
10177132|NCT03121365|11307276|FG000|NOT COMPLETED|7 Months||10
10177133|NCT03121365|11307277|FG001|NOT COMPLETED|7 Months||8
10177134|NCT03121612|11307287|FG000|STARTED|Overall Study||26
10177135|NCT03121612|11307288|FG001|STARTED|Overall Study||25
10177136|NCT03121612|11307287|FG000|COMPLETED|Overall Study||26
10177137|NCT03121612|11307288|FG001|COMPLETED|Overall Study||25
10177138|NCT03121612|11307287|FG000|NOT COMPLETED|Overall Study||0
10177139|NCT03121612|11307288|FG001|NOT COMPLETED|Overall Study||0
10177140|NCT03121820|11307298|FG000|STARTED|First Period||9
10177141|NCT03121820|11307299|FG001|STARTED|First Period||9
10177142|NCT03121820|11307298|FG000|COMPLETED|First Period||9
10177143|NCT03121820|11307299|FG001|COMPLETED|First Period||9
10177144|NCT03121820|11307298|FG000|NOT COMPLETED|First Period||0
10177145|NCT03121820|11307299|FG001|NOT COMPLETED|First Period||0
10177146|NCT03121820|11307298|FG000|STARTED|Second Period (After Washout)||9
10177147|NCT03121820|11307299|FG001|STARTED|Second Period (After Washout)||9
10177148|NCT03121820|11307298|FG000|COMPLETED|Second Period (After Washout)||9
10177149|NCT03121820|11307299|FG001|COMPLETED|Second Period (After Washout)||9
10177150|NCT03121820|11307298|FG000|NOT COMPLETED|Second Period (After Washout)||0
10177151|NCT03121820|11307299|FG001|NOT COMPLETED|Second Period (After Washout)||0
10177152|NCT03121950|11307307|FG000|STARTED|Overall Study||17
10177153|NCT03121950|11307308|FG001|STARTED|Overall Study||3
10177154|NCT03121950|11307307|FG000|COMPLETED|Overall Study||6
10177155|NCT03121950|11307308|FG001|COMPLETED|Overall Study||1
10177156|NCT03121950|11307307|FG000|NOT COMPLETED|Overall Study||11
10177157|NCT03121950|11307308|FG001|NOT COMPLETED|Overall Study||2
10177158|NCT03122145|11307318|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
10177159|NCT03122145|11307319|FG001|STARTED|Overall Study||12
10177160|NCT03122145|11307318|FG000|COMPLETED|Overall Study||34
10177161|NCT03122145|11307319|FG001|COMPLETED|Overall Study||12
10177162|NCT03122145|11307318|FG000|NOT COMPLETED|Overall Study||3
10177163|NCT03122145|11307319|FG001|NOT COMPLETED|Overall Study||0
10177164|NCT03122171|11307325|FG000|STARTED|Overall Study||6
10177165|NCT03122171|11307325|FG000|COMPLETED|Overall Study||5
10177166|NCT03122171|11307325|FG000|NOT COMPLETED|Overall Study||1
10177167|NCT03122184|11307331|FG000|STARTED|Overall Study||24
10177168|NCT03122184|11307332|FG001|STARTED|Overall Study||23
10177169|NCT03122184|11307331|FG000|COMPLETED|Overall Study||16
10177170|NCT03122184|11307332|FG001|COMPLETED|Overall Study||17
9713352|NCT03790917|10812570|FG000|STARTED|Overall Study||201
9713353|NCT03790917|10812570|FG000|COMPLETED|Overall Study||200
9713354|NCT03790917|10812570|FG000|NOT COMPLETED|Overall Study||1
9713355|NCT03790306|10812575|FG000|STARTED|Overall Study||207
9713356|NCT03790306|10812575|FG000|COMPLETED|Overall Study||207
9713357|NCT03790306|10812575|FG000|NOT COMPLETED|Overall Study||0
9713405|NCT03999411|10812646|FG000|STARTED|Overall Study||13
9713406|NCT03999411|10812647|FG001|STARTED|Overall Study||13
9713407|NCT03999411|10812648|FG002|STARTED|Overall Study||13
9713408|NCT03999411|10812646|FG000|COMPLETED|Overall Study||12
9713409|NCT03999411|10812647|FG001|COMPLETED|Overall Study||11
9713410|NCT03999411|10812648|FG002|COMPLETED|Overall Study||13
9713411|NCT03999411|10812646|FG000|NOT COMPLETED|Overall Study||1
9713412|NCT03999411|10812647|FG001|NOT COMPLETED|Overall Study||2
9713413|NCT03999411|10812648|FG002|NOT COMPLETED|Overall Study||0
9713414|NCT03803605|10812657|FG000|STARTED|Overall Study||15
9713415|NCT03803605|10812657|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8
9713416|NCT03803605|10812657|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8
9713417|NCT03803605|10812657|FG000|COMPLETED|Overall Study||8
9713418|NCT03803605|10812657|FG000|NOT COMPLETED|Overall Study||7
9713419|NCT03799198|10812664|FG000|STARTED|Overall Study||100
9713420|NCT03799198|10812665|FG001|STARTED|Overall Study||100
9713421|NCT03799198|10812664|FG000|Full Analysis Set (FAS)|Overall Study||100
9713422|NCT03799198|10812665|FG001|Full Analysis Set (FAS)|Overall Study||100
9713423|NCT03799198|10812664|FG000|COMPLETED|Overall Study||96
9713424|NCT03799198|10812665|FG001|COMPLETED|Overall Study||91
9713425|NCT03799198|10812664|FG000|NOT COMPLETED|Overall Study||4
9713426|NCT03799198|10812665|FG001|NOT COMPLETED|Overall Study||9
9713427|NCT03770728|10812675|FG000|STARTED|Overall Study||79
9713428|NCT03770728|10812676|FG001|STARTED|Overall Study||78
9713429|NCT03770728|10812677|FG002|STARTED|Overall Study||77
9713430|NCT03770728|10812678|FG003|STARTED|Overall Study||78
9713431|NCT03770728|10812675|FG000|Safety Population|Overall Study||79
9713432|NCT03770728|10812676|FG001|Safety Population|Overall Study||78
9713433|NCT03770728|10812677|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80
9713434|NCT03770728|10812678|FG003|Safety Population|Overall Study||75
9713435|NCT03770728|10812675|FG000|COMPLETED|Overall Study||41
9713436|NCT03770728|10812676|FG001|COMPLETED|Overall Study||47
9713437|NCT03770728|10812677|FG002|COMPLETED|Overall Study||45
9713438|NCT03770728|10812678|FG003|COMPLETED|Overall Study||43
9713439|NCT03770728|10812675|FG000|NOT COMPLETED|Overall Study||38
9713440|NCT03770728|10812676|FG001|NOT COMPLETED|Overall Study||31
9713441|NCT03770728|10812677|FG002|NOT COMPLETED|Overall Study||32
9713442|NCT03770728|10812678|FG003|NOT COMPLETED|Overall Study||35
9713443|NCT03760146|10812696|FG000|STARTED|Overall Study||1514
9713444|NCT03760146|10812697|FG001|STARTED|Overall Study||1495
9713445|NCT03760146|10812698|FG002|STARTED|Overall Study||334
9713446|NCT03760146|10812699|FG003|STARTED|Overall Study||111
9713447|NCT03760146|10812700|FG004|STARTED|Overall Study||336
9713448|NCT03760146|10812701|FG005|STARTED|Overall Study||112
9713449|NCT03760146|10812696|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
9713450|NCT03760146|10812697|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
9713451|NCT03760146|10812698|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
9713452|NCT03760146|10812699|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
9713453|NCT03760146|10812700|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
9713454|NCT03760146|10812701|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
9713455|NCT03760146|10812696|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
9713456|NCT03760146|10812697|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
9713457|NCT03760146|10812698|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
9713458|NCT03760146|10812699|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
9713459|NCT03760146|10812700|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
9713460|NCT03760146|10812701|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
9713461|NCT03760146|10812696|FG000|Vaccination 1|Overall Study||1507
9713462|NCT03760146|10812697|FG001|Vaccination 1|Overall Study||1490
9713463|NCT03760146|10812698|FG002|Vaccination 1|Overall Study||334
9713464|NCT03760146|10812699|FG003|Vaccination 1|Overall Study||111
9713465|NCT03760146|10812700|FG004|Vaccination 1|Overall Study||335
9713466|NCT03760146|10812701|FG005|Vaccination 1|Overall Study||112
9713467|NCT03760146|10812696|FG000|Vaccination 2|Overall Study||1461
9713468|NCT03760146|10812697|FG001|Vaccination 2|Overall Study||1446
9713469|NCT03760146|10812698|FG002|Vaccination 2|Overall Study||0
9713470|NCT03760146|10812699|FG003|Vaccination 2|Overall Study||0
10177171|NCT03122184|11307331|FG000|NOT COMPLETED|Overall Study||8
10177172|NCT03122184|11307332|FG001|NOT COMPLETED|Overall Study||6
10177173|NCT03122223|11307342|FG000|STARTED|Overall Study||50
10177174|NCT03122223|11307343|FG001|STARTED|Overall Study||50
10177175|NCT03122223|11307344|FG002|STARTED|Overall Study||50
10177176|NCT03122223|11307345|FG003|STARTED|Overall Study||10
10177177|NCT03122223|11307342|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49
10177178|NCT03122223|11307343|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48
10177179|NCT03122223|11307344|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47
10177180|NCT03122223|11307345|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8
10177181|NCT03122223|11307342|FG000|Month 12 Immunogenicity Cohort|Overall Study||47
10177182|NCT03122223|11307343|FG001|Month 12 Immunogenicity Cohort|Overall Study||45
10177183|NCT03122223|11307344|FG002|Month 12 Immunogenicity Cohort|Overall Study||46
10177184|NCT03122223|11307345|FG003|Month 12 Immunogenicity Cohort|Overall Study||10
10177185|NCT03122223|11307342|FG000|COMPLETED|Overall Study||47
10177186|NCT03122223|11307343|FG001|COMPLETED|Overall Study||45
10177187|NCT03122223|11307344|FG002|COMPLETED|Overall Study||46
10177188|NCT03122223|11307345|FG003|COMPLETED|Overall Study||10
10177189|NCT03122223|11307342|FG000|NOT COMPLETED|Overall Study||3
10177190|NCT03122223|11307343|FG001|NOT COMPLETED|Overall Study||5
10177191|NCT03122223|11307344|FG002|NOT COMPLETED|Overall Study||4
10177192|NCT03122223|11307345|FG003|NOT COMPLETED|Overall Study||0
10177193|NCT03122457|11307355|FG000|STARTED|Overall Study||22
10177194|NCT03122457|11307355|FG000|COMPLETED|Overall Study||16
10177195|NCT03122457|11307355|FG000|NOT COMPLETED|Overall Study||6
10177196|NCT03122535|11307359|FG000|STARTED|Overall Study||115
10177197|NCT03122535|11307360|FG001|STARTED|Overall Study||115
10177198|NCT03122535|11307359|FG000|3 Months|Overall Study||92
10177199|NCT03122535|11307360|FG001|3 Months|Overall Study||92
10177200|NCT03122535|11307359|FG000|12 Months|Overall Study||42
10177201|NCT03122535|11307360|FG001|12 Months|Overall Study||42
10177202|NCT03122535|11307359|FG000|COMPLETED|Overall Study||42
10177203|NCT03122535|11307360|FG001|COMPLETED|Overall Study||42
10177204|NCT03122535|11307359|FG000|NOT COMPLETED|Overall Study||73
10177205|NCT03122535|11307360|FG001|NOT COMPLETED|Overall Study||73
10177206|NCT03122548|11307366|FG000|STARTED|Overall Study||5
10177207|NCT03122548|11307366|FG000|COMPLETED|Overall Study||0
10177208|NCT03122548|11307366|FG000|NOT COMPLETED|Overall Study||5
10177209|NCT03122587|11307373|FG000|STARTED|Overall Study||13
10177210|NCT03122587|11307374|FG001|STARTED|Overall Study||12
10177211|NCT03122587|11307375|FG002|STARTED|Overall Study||13
10177212|NCT03122587|11307373|FG000|COMPLETED|Overall Study||11
10177213|NCT03122587|11307374|FG001|COMPLETED|Overall Study||10
10177214|NCT03122587|11307375|FG002|COMPLETED|Overall Study||12
10177215|NCT03122587|11307373|FG000|NOT COMPLETED|Overall Study||2
10177216|NCT03122587|11307374|FG001|NOT COMPLETED|Overall Study||2
10177217|NCT03122587|11307375|FG002|NOT COMPLETED|Overall Study||1
10177218|NCT03122860|11307389|FG000|STARTED|Overall Study||117
10177219|NCT03122860|11307390|FG001|STARTED|Overall Study||116
10177220|NCT03122860|11307391|FG002|STARTED|Overall Study||117
10177221|NCT03122860|11307392|FG003|STARTED|Overall Study||116
10177222|NCT03122860|11307393|FG004|STARTED|Overall Study||117
10177223|NCT03122860|11307394|FG005|STARTED|Overall Study||117
10177224|NCT03122860|11307389|FG000|Full Analysis Set|Overall Study||116
10177225|NCT03122860|11307390|FG001|Full Analysis Set|Overall Study||115
10177226|NCT03122860|11307391|FG002|Full Analysis Set|Overall Study||115
10177227|NCT03122860|11307392|FG003|Full Analysis Set|Overall Study||116
10177228|NCT03122860|11307393|FG004|Full Analysis Set|Overall Study||116
10177229|NCT03122860|11307394|FG005|Full Analysis Set|Overall Study||117
10177230|NCT03122860|11307389|FG000|COMPLETED|Overall Study||107
10177231|NCT03122860|11307390|FG001|COMPLETED|Overall Study||111
10177232|NCT03122860|11307391|FG002|COMPLETED|Overall Study||105
10177233|NCT03122860|11307392|FG003|COMPLETED|Overall Study||105
10177234|NCT03122860|11307393|FG004|COMPLETED|Overall Study||102
10177235|NCT03122860|11307394|FG005|COMPLETED|Overall Study||105
10177236|NCT03122860|11307389|FG000|NOT COMPLETED|Overall Study||10
10177237|NCT03122860|11307390|FG001|NOT COMPLETED|Overall Study||5
10177238|NCT03122860|11307391|FG002|NOT COMPLETED|Overall Study||12
10177239|NCT03122860|11307392|FG003|NOT COMPLETED|Overall Study||11
10177240|NCT03122860|11307393|FG004|NOT COMPLETED|Overall Study||15
10177241|NCT03122860|11307394|FG005|NOT COMPLETED|Overall Study||12
10177242|NCT03123055|11307409|FG000|STARTED|Overall Study||28
10177243|NCT03123055|11307409|FG000|COMPLETED|Overall Study||28
10177244|NCT03123055|11307409|FG000|NOT COMPLETED|Overall Study||0
10177245|NCT03123068|11307416|FG000|STARTED|Overall Study||22
10177246|NCT03123068|11307417|FG001|STARTED|Overall Study||20
10177247|NCT03123068|11307416|FG000|COMPLETED|Overall Study||22
10177248|NCT03123068|11307417|FG001|COMPLETED|Overall Study||20
10177249|NCT03123068|11307416|FG000|NOT COMPLETED|Overall Study||0
10177250|NCT03123068|11307417|FG001|NOT COMPLETED|Overall Study||0
10177251|NCT03123120|11307425|FG000|STARTED|Overall Study||8
10177252|NCT03123120|11307426|FG001|STARTED|Overall Study||14
10177253|NCT03123120|11307425|FG000|Safety Analysis Set (SAF)|Overall Study||7
10177254|NCT03123120|11307426|FG001|Safety Analysis Set (SAF)|Overall Study||15
10177255|NCT03123120|11307425|FG000|COMPLETED|Overall Study||8
10177256|NCT03123120|11307426|FG001|COMPLETED|Overall Study||12
10177257|NCT03123120|11307425|FG000|NOT COMPLETED|Overall Study||0
10177258|NCT03123120|11307426|FG001|NOT COMPLETED|Overall Study||2
10177259|NCT03123263|11307434|FG000|STARTED|Overall Study||60
10177260|NCT03123263|11307434|FG000|COMPLETED|Overall Study||60
10177261|NCT03123263|11307434|FG000|NOT COMPLETED|Overall Study||0
10177262|NCT03123354|11307441|FG000|STARTED|Overall Study||44
10177263|NCT03123354|11307441|FG000|COMPLETED|Overall Study||38
10177264|NCT03123354|11307441|FG000|NOT COMPLETED|Overall Study||6
10177265|NCT03123471|11307447|FG000|STARTED|Placebo-controlled Phase||102
10177266|NCT03123471|11307448|FG001|STARTED|Placebo-controlled Phase||201
10177267|NCT03123471|11307447|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
10177268|NCT03123471|11307448|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
10177269|NCT03123471|11307447|FG000|COMPLETED|Placebo-controlled Phase||84
10177270|NCT03123471|11307448|FG001|COMPLETED|Placebo-controlled Phase||168
10177271|NCT03123471|11307447|FG000|NOT COMPLETED|Placebo-controlled Phase||18
10177272|NCT03123471|11307448|FG001|NOT COMPLETED|Placebo-controlled Phase||33
10177273|NCT03123471|11307447|FG000|STARTED|Apremilast Extension Phase||84
10177274|NCT03123471|11307448|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
10177275|NCT03123471|11307447|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
10177276|NCT03123471|11307448|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
10177277|NCT03123471|11307447|FG000|COMPLETED|Apremilast Extension Phase||76
10177278|NCT03123471|11307448|FG001|COMPLETED|Apremilast Extension Phase||140
10177279|NCT03123471|11307447|FG000|NOT COMPLETED|Apremilast Extension Phase||8
10177280|NCT03123471|11307448|FG001|NOT COMPLETED|Apremilast Extension Phase||25
10177281|NCT03123588|11307462|FG000|STARTED|Overall Study||6
10177282|NCT03123588|11307463|FG001|STARTED|Overall Study||6
10177283|NCT03123588|11307462|FG000|COMPLETED|Overall Study||0
10177284|NCT03123588|11307463|FG001|COMPLETED|Overall Study||0
10177285|NCT03123588|11307462|FG000|NOT COMPLETED|Overall Study||6
10177286|NCT03123588|11307463|FG001|NOT COMPLETED|Overall Study||6
10177287|NCT03123614|11307472|FG000|STARTED|Overall Study||57
10177288|NCT03123614|11307473|FG001|STARTED|Overall Study||74
10177289|NCT03123614|11307472|FG000|COMPLETED|Overall Study||57
10177290|NCT03123614|11307473|FG001|COMPLETED|Overall Study||74
10177291|NCT03123614|11307472|FG000|NOT COMPLETED|Overall Study||0
10177292|NCT03123614|11307473|FG001|NOT COMPLETED|Overall Study||0
10177293|NCT03123848|11307479|FG000|STARTED|Overall Study||8
10177294|NCT03123848|11307479|FG000|COMPLETED|Overall Study||8
10177295|NCT03123848|11307479|FG000|NOT COMPLETED|Overall Study||0
10177296|NCT03123861|11307487|FG000|STARTED|Overall Study||22
10177297|NCT03123861|11307488|FG001|STARTED|Overall Study||23
10177298|NCT03123861|11307487|FG000|Received Intervention|Overall Study||21
10177299|NCT03123861|11307488|FG001|Received Intervention|Overall Study||22
10177300|NCT03123861|11307487|FG000|COMPLETED|Overall Study||19
10177301|NCT03123861|11307488|FG001|COMPLETED|Overall Study||20
10177302|NCT03123861|11307487|FG000|NOT COMPLETED|Overall Study||3
10177303|NCT03123861|11307488|FG001|NOT COMPLETED|Overall Study||3
10177304|NCT03123874|11307496|FG000|STARTED|Overall Study||27
10177305|NCT03123874|11307497|FG001|STARTED|Overall Study||25
10177306|NCT03123874|11307496|FG000|COMPLETED|Overall Study||27
10177307|NCT03123874|11307497|FG001|COMPLETED|Overall Study||25
10177308|NCT03123874|11307496|FG000|NOT COMPLETED|Overall Study||0
10177309|NCT03123874|11307497|FG001|NOT COMPLETED|Overall Study||0
10177310|NCT03123939|11307507|FG000|STARTED|Overall Study||74
10177311|NCT03123939|11307507|FG000|CTL019 Infused|Overall Study||69
10177312|NCT03123939|11307507|FG000|Full Analysis Set (FAS)|Overall Study||69
10177313|NCT03123939|11307507|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
10177314|NCT03123939|11307507|FG000|Safety Set (SAF)|Overall Study||69
10177315|NCT03123939|11307507|FG000|COMPLETED|Overall Study||33
10177316|NCT03123939|11307507|FG000|NOT COMPLETED|Overall Study||41
10177317|NCT03124069|11307511|FG000|STARTED|Overall Study||37
10177318|NCT03124069|11307511|FG000|COMPLETED|Overall Study||37
10177319|NCT03124069|11307511|FG000|NOT COMPLETED|Overall Study||0
10177320|NCT03124108|11307520|FG000|STARTED|Overall Study||15
10177321|NCT03124108|11307521|FG001|STARTED|Overall Study||15
10177322|NCT03124108|11307522|FG002|STARTED|Overall Study||15
10177323|NCT03124108|11307520|FG000|COMPLETED|Overall Study||15
10177324|NCT03124108|11307521|FG001|COMPLETED|Overall Study||14
10177325|NCT03124108|11307522|FG002|COMPLETED|Overall Study||15
10177326|NCT03124108|11307520|FG000|NOT COMPLETED|Overall Study||0
10177327|NCT03124108|11307521|FG001|NOT COMPLETED|Overall Study||1
10177328|NCT03124108|11307522|FG002|NOT COMPLETED|Overall Study||0
9713358|NCT03727373|10812580|FG000|STARTED|Overall Study||8
9713359|NCT03727373|10812580|FG000|COMPLETED|Overall Study||8
9713360|NCT03727373|10812580|FG000|NOT COMPLETED|Overall Study||0
9713471|NCT03760146|10812700|FG004|Vaccination 2|Overall Study||0
9713472|NCT03760146|10812701|FG005|Vaccination 2|Overall Study||0
9713473|NCT03760146|10812696|FG000|Safety Population|Overall Study||1507
9713474|NCT03760146|10812697|FG001|Safety Population|Overall Study||1490
9713475|NCT03760146|10812698|FG002|Safety Population|Overall Study||334
9713476|NCT03760146|10812699|FG003|Safety Population|Overall Study||111
9713477|NCT03760146|10812700|FG004|Safety Population|Overall Study||335
9713478|NCT03760146|10812701|FG005|Safety Population|Overall Study||112
9713479|NCT03760146|10812696|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
9713480|NCT03760146|10812697|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0
9713481|NCT03760146|10812698|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321
9713482|NCT03760146|10812699|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0
9713483|NCT03760146|10812700|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317
9713484|NCT03760146|10812701|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0
9713485|NCT03760146|10812696|FG000|COMPLETED|Overall Study||1418
10177329|NCT03124121|11307534|FG000|STARTED|Overall Study||42
10177330|NCT03124121|11307535|FG001|STARTED|Overall Study||70
10177331|NCT03124121|11307534|FG000|COMPLETED|Overall Study||39
10177332|NCT03124121|11307535|FG001|COMPLETED|Overall Study||67
10177333|NCT03124121|11307534|FG000|NOT COMPLETED|Overall Study||3
10177334|NCT03124121|11307535|FG001|NOT COMPLETED|Overall Study||3
10177335|NCT03124199|11307543|FG000|STARTED|Overall Study||40
10177336|NCT03124199|11307543|FG000|COMPLETED|Overall Study||36
10177337|NCT03124199|11307543|FG000|NOT COMPLETED|Overall Study||4
10177338|NCT03124342|11307549|FG000|STARTED|Overall Study||111
10177339|NCT03124342|11307550|FG001|STARTED|Overall Study||121
10177340|NCT03124342|11307549|FG000|COMPLETED|Overall Study||111
10177341|NCT03124342|11307550|FG001|COMPLETED|Overall Study||121
10177342|NCT03124342|11307549|FG000|NOT COMPLETED|Overall Study||0
10177343|NCT03124342|11307550|FG001|NOT COMPLETED|Overall Study||0
10177344|NCT03124368|11307559|FG000|STARTED|Overall Study||2
10177345|NCT03124368|11307560|FG001|STARTED|Overall Study||4
10177346|NCT03124368|11307559|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10177347|NCT03124368|11307560|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10177348|NCT03124368|11307559|FG000|COMPLETED|Overall Study||2
10177349|NCT03124368|11307560|FG001|COMPLETED|Overall Study||4
10177350|NCT03124368|11307559|FG000|NOT COMPLETED|Overall Study||0
10177351|NCT03124368|11307560|FG001|NOT COMPLETED|Overall Study||0
10177352|NCT03124381|11307573|FG000|STARTED|Overall Study||65
10177353|NCT03124381|11307574|FG001|STARTED|Overall Study||61
10177354|NCT03124381|11307573|FG000|COMPLETED|Overall Study||56
10177355|NCT03124381|11307574|FG001|COMPLETED|Overall Study||55
10177356|NCT03124381|11307573|FG000|NOT COMPLETED|Overall Study||9
10177357|NCT03124381|11307574|FG001|NOT COMPLETED|Overall Study||6
10177358|NCT03124407|11307584|FG000|STARTED|Overall Study||40
10177359|NCT03124407|11307585|FG001|STARTED|Overall Study||20
10177360|NCT03124407|11307586|FG002|STARTED|Overall Study||40
10177361|NCT03124407|11307587|FG003|STARTED|Overall Study||20
10177362|NCT03124407|11307584|FG000|COMPLETED|Overall Study||39
10177363|NCT03124407|11307585|FG001|COMPLETED|Overall Study||20
10177364|NCT03124407|11307586|FG002|COMPLETED|Overall Study||39
10177365|NCT03124407|11307587|FG003|COMPLETED|Overall Study||20
10177366|NCT03124407|11307584|FG000|NOT COMPLETED|Overall Study||1
10177367|NCT03124407|11307585|FG001|NOT COMPLETED|Overall Study||0
10177368|NCT03124407|11307586|FG002|NOT COMPLETED|Overall Study||1
10177369|NCT03124407|11307587|FG003|NOT COMPLETED|Overall Study||0
10177370|NCT03124459|11307607|FG000|STARTED|Part 1-Open Label Dose Escalation||6
10177371|NCT03124459|11307608|FG001|STARTED|Part 1-Open Label Dose Escalation||6
10177372|NCT03124459|11307609|FG002|STARTED|Part 1-Open Label Dose Escalation||6
10177373|NCT03124459|11307610|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10177374|NCT03124459|11307611|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10177375|NCT03124459|11307612|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10177376|NCT03124459|11307607|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6
10177377|NCT03124459|11307608|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6
10177378|NCT03124459|11307609|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6
10177379|NCT03124459|11307610|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10177380|NCT03124459|11307611|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10177381|NCT03124459|11307612|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10177382|NCT03124459|11307607|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10177383|NCT03124459|11307608|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10177384|NCT03124459|11307609|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10177385|NCT03124459|11307610|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10177386|NCT03124459|11307611|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10177387|NCT03124459|11307612|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10177388|NCT03124459|11307607|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10177389|NCT03124459|11307608|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10177390|NCT03124459|11307609|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10177391|NCT03124459|11307610|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
10177392|NCT03124459|11307611|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
10177393|NCT03124459|11307612|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10177394|NCT03124459|11307607|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0
10177395|NCT03124459|11307608|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0
10177396|NCT03124459|11307609|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0
10177397|NCT03124459|11307610|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9
10177398|NCT03124459|11307611|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5
10177399|NCT03124459|11307612|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0
10177400|NCT03124459|11307607|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10177401|NCT03124459|11307608|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10177402|NCT03124459|11307609|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10177403|NCT03124459|11307610|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
10177404|NCT03124459|11307611|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
10177405|NCT03124459|11307612|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10177406|NCT03124459|11307607|FG000|STARTED|Part 2- Open Label ACE-083||0
10177407|NCT03124459|11307608|FG001|STARTED|Part 2- Open Label ACE-083||0
10177408|NCT03124459|11307609|FG002|STARTED|Part 2- Open Label ACE-083||0
10177409|NCT03124459|11307610|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
10177410|NCT03124459|11307611|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
10177411|NCT03124459|11307612|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
10177412|NCT03124459|11307607|FG000|COMPLETED|Part 2- Open Label ACE-083||0
10177413|NCT03124459|11307608|FG001|COMPLETED|Part 2- Open Label ACE-083||0
10177414|NCT03124459|11307609|FG002|COMPLETED|Part 2- Open Label ACE-083||0
10177415|NCT03124459|11307610|FG003|COMPLETED|Part 2- Open Label ACE-083||0
10177416|NCT03124459|11307611|FG004|COMPLETED|Part 2- Open Label ACE-083||0
10177417|NCT03124459|11307612|FG005|COMPLETED|Part 2- Open Label ACE-083||17
10177418|NCT03124459|11307607|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0
10177419|NCT03124459|11307608|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0
10177420|NCT03124459|11307609|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0
10177421|NCT03124459|11307610|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0
10177422|NCT03124459|11307611|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0
10177423|NCT03124459|11307612|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23
10177424|NCT03124537|11307627|FG000|STARTED|Overall Study||41
10177425|NCT03124537|11307628|FG001|STARTED|Overall Study||45
10177426|NCT03124537|11307627|FG000|COMPLETED|Overall Study||31
10177427|NCT03124537|11307628|FG001|COMPLETED|Overall Study||32
10177428|NCT03124537|11307627|FG000|NOT COMPLETED|Overall Study||10
10177429|NCT03124537|11307628|FG001|NOT COMPLETED|Overall Study||13
10177430|NCT03124550|11307634|FG000|STARTED|Overall Study||18
10177431|NCT03124550|11307634|FG000|COMPLETED|Overall Study||18
10177432|NCT03124550|11307634|FG000|NOT COMPLETED|Overall Study||0
10177433|NCT03124563|11307640|FG000|STARTED|Overall Study||32
10177434|NCT03124563|11307641|FG001|STARTED|Overall Study||31
10177435|NCT03124563|11307640|FG000|Pre-test|Overall Study||30
10177436|NCT03124563|11307641|FG001|Pre-test|Overall Study||30
10177437|NCT03124563|11307640|FG000|COMPLETED|Overall Study||30
10177438|NCT03124563|11307641|FG001|COMPLETED|Overall Study||29
10177439|NCT03124563|11307640|FG000|NOT COMPLETED|Overall Study||2
10177440|NCT03124563|11307641|FG001|NOT COMPLETED|Overall Study||2
10177441|NCT03124602|11307647|FG000|STARTED|Overall Study||35
10177442|NCT03124602|11307647|FG000|COMPLETED|Overall Study||25
10177443|NCT03124602|11307647|FG000|NOT COMPLETED|Overall Study||10
10177444|NCT03124693|11307651|FG000|STARTED|Overall Study||90
10177445|NCT03124693|11307651|FG000|COMPLETED|Overall Study||90
10177446|NCT03124693|11307651|FG000|NOT COMPLETED|Overall Study||0
10177447|NCT03124758|11307655|FG000|STARTED|Overall Study||354
10177448|NCT03124758|11307655|FG000|COMPLETED|Overall Study||354
10177449|NCT03124758|11307655|FG000|NOT COMPLETED|Overall Study||0
10177450|NCT03124771|11307659|FG000|STARTED|Overall Study||132
10177451|NCT03124771|11307659|FG000|COMPLETED|Overall Study||132
10177452|NCT03124771|11307659|FG000|NOT COMPLETED|Overall Study||0
10177453|NCT03124784|11307663|FG000|STARTED|Overall Study||27
10177454|NCT03124784|11307663|FG000|COMPLETED|Overall Study||25
10177455|NCT03124784|11307663|FG000|NOT COMPLETED|Overall Study||2
10177456|NCT03124797|11307667|FG000|STARTED|Overall Study||18
10177457|NCT03124797|11307667|FG000|COMPLETED|Overall Study||18
10177458|NCT03124797|11307667|FG000|NOT COMPLETED|Overall Study||0
10177459|NCT03124823|11307671|FG000|STARTED|Overall Study||11
10177460|NCT03124823|11307671|FG000|COMPLETED|Overall Study||11
10177461|NCT03124823|11307671|FG000|NOT COMPLETED|Overall Study||0
10177462|NCT03124836|11307675|FG000|STARTED|Overall Study||28
10177463|NCT03124836|11307675|FG000|COMPLETED|Overall Study||28
10177464|NCT03124836|11307675|FG000|NOT COMPLETED|Overall Study||0
10177465|NCT03124901|11307679|FG000|STARTED|Overall Study||147
10177466|NCT03124901|11307679|FG000|COMPLETED|Overall Study||147
10177467|NCT03124901|11307679|FG000|NOT COMPLETED|Overall Study||0
10177468|NCT03124927|11307683|FG000|STARTED|Overall Study||25
10177469|NCT03124927|11307683|FG000|COMPLETED|Overall Study||25
10177470|NCT03124927|11307683|FG000|NOT COMPLETED|Overall Study||0
10177471|NCT03124966|11307687|FG000|STARTED|Overall Study||118
9849681|NCT00866879|10962474|FG001|COMPLETED|Overall Study||185
9849682|NCT00866879|10962473|FG000|NOT COMPLETED|Overall Study||0
10177472|NCT03124966|11307687|FG000|COMPLETED|Overall Study||118
10177473|NCT03124966|11307687|FG000|NOT COMPLETED|Overall Study||0
10177474|NCT03124979|11307691|FG000|STARTED|Overall Study||13
10177475|NCT03124979|11307691|FG000|COMPLETED|Overall Study||13
10177476|NCT03124979|11307691|FG000|NOT COMPLETED|Overall Study||0
10177477|NCT03125005|11307695|FG000|STARTED|Overall Study||51
10177478|NCT03125005|11307695|FG000|COMPLETED|Overall Study||51
9849683|NCT00866879|10962474|FG001|NOT COMPLETED|Overall Study||0
10177479|NCT03125005|11307695|FG000|NOT COMPLETED|Overall Study||0
10177480|NCT03125018|11307699|FG000|STARTED|Overall Study||13
10177481|NCT03125018|11307699|FG000|COMPLETED|Overall Study||13
10177482|NCT03125018|11307699|FG000|NOT COMPLETED|Overall Study||0
10177483|NCT03125031|11307703|FG000|STARTED|Overall Study||44
10177484|NCT03125031|11307704|FG001|STARTED|Overall Study||44
10177485|NCT03125031|11307703|FG000|COMPLETED|Overall Study||44
10177486|NCT03125031|11307704|FG001|COMPLETED|Overall Study||44
10177487|NCT03125031|11307703|FG000|NOT COMPLETED|Overall Study||0
10177488|NCT03125031|11307704|FG001|NOT COMPLETED|Overall Study||0
10177489|NCT03125200|11307716|FG000|STARTED|Overall Study||2
10177490|NCT03125200|11307717|FG001|STARTED|Overall Study||2
10177491|NCT03125200|11307718|FG002|STARTED|Overall Study||2
10177492|NCT03125200|11307719|FG003|STARTED|Overall Study||5
10177493|NCT03125200|11307720|FG004|STARTED|Overall Study||4
10177494|NCT03125200|11307721|FG005|STARTED|Overall Study||3
10177495|NCT03125200|11307722|FG006|STARTED|Overall Study||3
10177496|NCT03125200|11307716|FG000|COMPLETED|Overall Study||0
10177497|NCT03125200|11307717|FG001|COMPLETED|Overall Study||0
10177498|NCT03125200|11307718|FG002|COMPLETED|Overall Study||0
10177499|NCT03125200|11307719|FG003|COMPLETED|Overall Study||0
10177500|NCT03125200|11307720|FG004|COMPLETED|Overall Study||0
10177501|NCT03125200|11307721|FG005|COMPLETED|Overall Study||0
10177502|NCT03125200|11307722|FG006|COMPLETED|Overall Study||0
10177503|NCT03125200|11307716|FG000|NOT COMPLETED|Overall Study||2
10177504|NCT03125200|11307717|FG001|NOT COMPLETED|Overall Study||2
10177505|NCT03125200|11307718|FG002|NOT COMPLETED|Overall Study||2
10177506|NCT03125200|11307719|FG003|NOT COMPLETED|Overall Study||5
10177507|NCT03125200|11307720|FG004|NOT COMPLETED|Overall Study||4
10177508|NCT03125200|11307721|FG005|NOT COMPLETED|Overall Study||3
10177509|NCT03125200|11307722|FG006|NOT COMPLETED|Overall Study||3
10177510|NCT03125226|11307741|FG000|STARTED|Overall Study||12
10177511|NCT03125226|11307741|FG000|COMPLETED|Overall Study||12
10177512|NCT03125226|11307741|FG000|NOT COMPLETED|Overall Study||0
10177513|NCT03125395|11307745|FG000|STARTED|Overall Study||57
10177514|NCT03125395|11307745|FG000|Study 115B FAS|Overall Study||60
10177515|NCT03125395|11307745|FG000|Study 116 FAS|Overall Study||57
10177516|NCT03125395|11307745|FG000|Study 116 LCI Substudy Set|Overall Study||31
10177517|NCT03125395|11307745|FG000|COMPLETED|Overall Study||47
10177518|NCT03125395|11307745|FG000|NOT COMPLETED|Overall Study||10
10177519|NCT03125629|11307749|FG000|STARTED|Overall Study||53
10177520|NCT03125629|11307749|FG000|COMPLETED|Overall Study||50
10177521|NCT03125629|11307749|FG000|NOT COMPLETED|Overall Study||3
10177522|NCT03125915|11307765|FG000|STARTED|Baseline and Intervention||32
10177523|NCT03125915|11307766|FG001|STARTED|Baseline and Intervention||40
10177524|NCT03125915|11307767|FG002|STARTED|Baseline and Intervention||34
10177525|NCT03125915|11307768|FG003|STARTED|Baseline and Intervention||34
10177526|NCT03125915|11307765|FG000|COMPLETED|Baseline and Intervention||32
10177527|NCT03125915|11307766|FG001|COMPLETED|Baseline and Intervention||40
10177528|NCT03125915|11307767|FG002|COMPLETED|Baseline and Intervention||34
10177529|NCT03125915|11307768|FG003|COMPLETED|Baseline and Intervention||34
10177530|NCT03125915|11307765|FG000|NOT COMPLETED|Baseline and Intervention||0
10177531|NCT03125915|11307766|FG001|NOT COMPLETED|Baseline and Intervention||0
10177532|NCT03125915|11307767|FG002|NOT COMPLETED|Baseline and Intervention||0
10177533|NCT03125915|11307768|FG003|NOT COMPLETED|Baseline and Intervention||0
10177534|NCT03125915|11307765|FG000|STARTED|1 Month Follow up||32
10177535|NCT03125915|11307766|FG001|STARTED|1 Month Follow up||40
10177536|NCT03125915|11307767|FG002|STARTED|1 Month Follow up||34
10177537|NCT03125915|11307768|FG003|STARTED|1 Month Follow up||34
10177538|NCT03125915|11307765|FG000|COMPLETED|1 Month Follow up||29
10177539|NCT03125915|11307766|FG001|COMPLETED|1 Month Follow up||37
10177540|NCT03125915|11307767|FG002|COMPLETED|1 Month Follow up||32
10177541|NCT03125915|11307768|FG003|COMPLETED|1 Month Follow up||31
10177542|NCT03125915|11307765|FG000|NOT COMPLETED|1 Month Follow up||3
9713361|NCT05017493|10812586|FG000|STARTED|Overall Study||483
9713362|NCT05017493|10812587|FG001|STARTED|Overall Study||178
9713363|NCT05017493|10812586|FG000|Treatment & Care|Overall Study||483
9713364|NCT05017493|10812587|FG001|Treatment & Care|Overall Study||178
9713365|NCT05017493|10812586|FG000|Follow up|Overall Study||483
9713366|NCT05017493|10812587|FG001|Follow up|Overall Study||178
9713367|NCT05017493|10812586|FG000|Mortality Check|Overall Study||483
9713368|NCT05017493|10812587|FG001|Mortality Check|Overall Study||178
9713369|NCT05017493|10812586|FG000|COMPLETED|Overall Study||361
9713370|NCT05017493|10812587|FG001|COMPLETED|Overall Study||178
9713371|NCT05017493|10812586|FG000|NOT COMPLETED|Overall Study||122
9713372|NCT05017493|10812587|FG001|NOT COMPLETED|Overall Study||0
9713373|NCT04870138|10812596|FG000|STARTED|Overall Study||5
9713374|NCT04870138|10812597|FG001|STARTED|Overall Study||5
9713375|NCT04870138|10812598|FG002|STARTED|Overall Study||6
9713376|NCT04870138|10812596|FG000|COMPLETED|Overall Study||5
9713377|NCT04870138|10812597|FG001|COMPLETED|Overall Study||5
9713378|NCT04870138|10812598|FG002|COMPLETED|Overall Study||6
9713379|NCT04870138|10812596|FG000|NOT COMPLETED|Overall Study||0
10177543|NCT03125915|11307766|FG001|NOT COMPLETED|1 Month Follow up||3
10177544|NCT03125915|11307767|FG002|NOT COMPLETED|1 Month Follow up||2
10177545|NCT03125915|11307768|FG003|NOT COMPLETED|1 Month Follow up||3
10177546|NCT03125915|11307765|FG000|STARTED|3 Month Follow-up||32
9713380|NCT04870138|10812597|FG001|NOT COMPLETED|Overall Study||0
9713381|NCT04870138|10812598|FG002|NOT COMPLETED|Overall Study||0
9713486|NCT03760146|10812697|FG001|COMPLETED|Overall Study||1417
9713487|NCT03760146|10812698|FG002|COMPLETED|Overall Study||323
9713488|NCT03760146|10812699|FG003|COMPLETED|Overall Study||109
9713489|NCT03760146|10812700|FG004|COMPLETED|Overall Study||319
10177547|NCT03125915|11307766|FG001|STARTED|3 Month Follow-up||40
10177548|NCT03125915|11307767|FG002|STARTED|3 Month Follow-up||34
10177549|NCT03125915|11307768|FG003|STARTED|3 Month Follow-up||34
10177550|NCT03125915|11307765|FG000|COMPLETED|3 Month Follow-up||26
10177551|NCT03125915|11307766|FG001|COMPLETED|3 Month Follow-up||36
10177552|NCT03125915|11307767|FG002|COMPLETED|3 Month Follow-up||30
10177553|NCT03125915|11307768|FG003|COMPLETED|3 Month Follow-up||32
10177554|NCT03125915|11307765|FG000|NOT COMPLETED|3 Month Follow-up||6
10177555|NCT03125915|11307766|FG001|NOT COMPLETED|3 Month Follow-up||4
10177556|NCT03125915|11307767|FG002|NOT COMPLETED|3 Month Follow-up||4
10177557|NCT03125915|11307768|FG003|NOT COMPLETED|3 Month Follow-up||2
10177558|NCT03125915|11307765|FG000|STARTED|6 Month Follow-up||32
10177559|NCT03125915|11307766|FG001|STARTED|6 Month Follow-up||40
10177560|NCT03125915|11307767|FG002|STARTED|6 Month Follow-up||34
10177561|NCT03125915|11307768|FG003|STARTED|6 Month Follow-up||34
10177562|NCT03125915|11307765|FG000|COMPLETED|6 Month Follow-up||25
10177563|NCT03125915|11307766|FG001|COMPLETED|6 Month Follow-up||37
10177564|NCT03125915|11307767|FG002|COMPLETED|6 Month Follow-up||28
10177565|NCT03125915|11307768|FG003|COMPLETED|6 Month Follow-up||31
10177566|NCT03125915|11307765|FG000|NOT COMPLETED|6 Month Follow-up||7
10177567|NCT03125915|11307766|FG001|NOT COMPLETED|6 Month Follow-up||3
10177568|NCT03125915|11307767|FG002|NOT COMPLETED|6 Month Follow-up||6
10177569|NCT03125915|11307768|FG003|NOT COMPLETED|6 Month Follow-up||3
10177570|NCT03125941|11307780|FG000|STARTED|Overall Study||65
10177571|NCT03125941|11307781|FG001|STARTED|Overall Study||65
10177572|NCT03125941|11307780|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
10177573|NCT03125941|11307781|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
10177574|NCT03125941|11307780|FG000|COMPLETED|Overall Study||64
10177575|NCT03125941|11307781|FG001|COMPLETED|Overall Study||63
10177576|NCT03125941|11307780|FG000|NOT COMPLETED|Overall Study||1
10177577|NCT03125941|11307781|FG001|NOT COMPLETED|Overall Study||2
10177578|NCT03126227|11307789|FG000|STARTED|Overall Study||338
10177579|NCT03126227|11307790|FG001|STARTED|Overall Study||168
10177580|NCT03126227|11307789|FG000|COMPLETED|Overall Study||260
10177581|NCT03126227|11307790|FG001|COMPLETED|Overall Study||158
10177582|NCT03126227|11307789|FG000|NOT COMPLETED|Overall Study||78
10177583|NCT03126227|11307790|FG001|NOT COMPLETED|Overall Study||10
10177584|NCT03126344|11307799|FG000|STARTED|Overall Study||33
10177585|NCT03126344|11307800|FG001|STARTED|Overall Study||33
10177586|NCT03126344|11307801|FG002|STARTED|Overall Study||33
10177587|NCT03126344|11307799|FG000|COMPLETED|Overall Study||33
10177588|NCT03126344|11307800|FG001|COMPLETED|Overall Study||33
10177589|NCT03126344|11307801|FG002|COMPLETED|Overall Study||28
10177590|NCT03126344|11307799|FG000|NOT COMPLETED|Overall Study||0
10177591|NCT03126344|11307800|FG001|NOT COMPLETED|Overall Study||0
10177592|NCT03126344|11307801|FG002|NOT COMPLETED|Overall Study||5
10177593|NCT03126370|11307809|FG000|STARTED|TDF With a Boosted PI||10
10177594|NCT03126370|11307809|FG000|COMPLETED|TDF With a Boosted PI||10
10177595|NCT03126370|11307809|FG000|NOT COMPLETED|TDF With a Boosted PI||0
10177596|NCT03126370|11307809|FG000|STARTED|TAF With a Boosted PI||10
10177597|NCT03126370|11307809|FG000|COMPLETED|TAF With a Boosted PI||10
10177598|NCT03126370|11307809|FG000|NOT COMPLETED|TAF With a Boosted PI||0
10177599|NCT03126370|11307809|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10
10177600|NCT03126370|11307809|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
10177601|NCT03126370|11307809|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
10177602|NCT03126370|11307809|FG000|STARTED|TAF With a Boosted PI||10
10177603|NCT03126370|11307809|FG000|COMPLETED|TAF With a Boosted PI||10
10177604|NCT03126370|11307809|FG000|NOT COMPLETED|TAF With a Boosted PI||0
10177605|NCT03126448|11307820|FG000|STARTED|Overall Study||56
10177606|NCT03126448|11307821|FG001|STARTED|Overall Study||49
10177607|NCT03126448|11307822|FG002|STARTED|Overall Study||37
10177608|NCT03126448|11307820|FG000|COMPLETED|Overall Study||43
10177609|NCT03126448|11307821|FG001|COMPLETED|Overall Study||41
10177610|NCT03126448|11307822|FG002|COMPLETED|Overall Study||27
10177611|NCT03126448|11307820|FG000|NOT COMPLETED|Overall Study||13
10177612|NCT03126448|11307821|FG001|NOT COMPLETED|Overall Study||8
10177613|NCT03126448|11307822|FG002|NOT COMPLETED|Overall Study||10
10177629|NCT03126682|11307851|FG000|STARTED|Overall Study||5
10177630|NCT03126682|11307852|FG001|STARTED|Overall Study||5
10177631|NCT03126682|11307851|FG000|COMPLETED|Overall Study||5
10177632|NCT03126682|11307852|FG001|COMPLETED|Overall Study||5
10177633|NCT03126682|11307851|FG000|NOT COMPLETED|Overall Study||0
10177634|NCT03126682|11307852|FG001|NOT COMPLETED|Overall Study||0
10177635|NCT03126760|11307860|FG000|STARTED|Overall Study||18
10177636|NCT03126760|11307861|FG001|STARTED|Overall Study||17
10177637|NCT03126760|11307860|FG000|Modified Intent to Treat (mITT)|Overall Study||18
10177638|NCT03126760|11307861|FG001|Modified Intent to Treat (mITT)|Overall Study||17
10177639|NCT03126760|11307860|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
10177640|NCT03126760|11307861|FG001|Completed Treatment|Overall Study||17
10177641|NCT03126760|11307860|FG000|COMPLETED|Overall Study||18
10177642|NCT03126760|11307861|FG001|COMPLETED|Overall Study||17
9713490|NCT03760146|10812701|FG005|COMPLETED|Overall Study||104
9713491|NCT03760146|10812696|FG000|NOT COMPLETED|Overall Study||96
9713492|NCT03760146|10812697|FG001|NOT COMPLETED|Overall Study||78
9713493|NCT03760146|10812698|FG002|NOT COMPLETED|Overall Study||11
9713494|NCT03760146|10812699|FG003|NOT COMPLETED|Overall Study||2
9713495|NCT03760146|10812700|FG004|NOT COMPLETED|Overall Study||17
9713496|NCT03760146|10812701|FG005|NOT COMPLETED|Overall Study||8
9713497|NCT03760081|10812721|FG000|STARTED|Overall Study||6
9713498|NCT03760081|10812722|FG001|STARTED|Overall Study||13
9713499|NCT03760081|10812721|FG000|COMPLETED|Overall Study||0
9713500|NCT03760081|10812722|FG001|COMPLETED|Overall Study||1
9713501|NCT03760081|10812721|FG000|NOT COMPLETED|Overall Study||6
9713502|NCT03760081|10812722|FG001|NOT COMPLETED|Overall Study||12
9713503|NCT03737110|10812732|FG000|STARTED|Run-in (RI) Period||86
9713504|NCT03737110|10812733|FG001|STARTED|Run-in (RI) Period||0
9713505|NCT03737110|10812734|FG002|STARTED|Run-in (RI) Period||0
9713506|NCT03737110|10812732|FG000|Continue to RW Period|Run-in (RI) Period||61
9713507|NCT03737110|10812733|FG001|Continue to RW Period|Run-in (RI) Period||0
9713508|NCT03737110|10812734|FG002|Continue to RW Period|Run-in (RI) Period||0
9713509|NCT03737110|10812732|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15
9713510|NCT03737110|10812733|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0
9713511|NCT03737110|10812734|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0
9713512|NCT03737110|10812732|FG000|COMPLETED|Run-in (RI) Period||76
9713513|NCT03737110|10812733|FG001|COMPLETED|Run-in (RI) Period||0
9713514|NCT03737110|10812734|FG002|COMPLETED|Run-in (RI) Period||0
9713515|NCT03737110|10812732|FG000|NOT COMPLETED|Run-in (RI) Period||10
9713516|NCT03737110|10812733|FG001|NOT COMPLETED|Run-in (RI) Period||0
9713517|NCT03737110|10812734|FG002|NOT COMPLETED|Run-in (RI) Period||0
9713518|NCT03737110|10812732|FG000|STARTED|Randomized Withdrawal (RW) Period||0
9713519|NCT03737110|10812733|FG001|STARTED|Randomized Withdrawal (RW) Period||30
9713520|NCT03737110|10812734|FG002|STARTED|Randomized Withdrawal (RW) Period||31
9713521|NCT03737110|10812732|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0
9713522|NCT03737110|10812733|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29
9713523|NCT03737110|10812734|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30
9713524|NCT03737110|10812732|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
9713525|NCT03737110|10812733|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
9713526|NCT03737110|10812734|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
9713527|NCT03737110|10812732|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
9713528|NCT03737110|10812733|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
9713529|NCT03737110|10812734|FG002|STARTED|Long-Term Extension (LTE) Period||30
9713530|NCT03737110|10812732|FG000|COMPLETED|Long-Term Extension (LTE) Period||0
9713531|NCT03737110|10812733|FG001|COMPLETED|Long-Term Extension (LTE) Period||0
9713532|NCT03737110|10812734|FG002|COMPLETED|Long-Term Extension (LTE) Period||0
9713533|NCT03737110|10812732|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||15
9713534|NCT03737110|10812733|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||29
9713535|NCT03737110|10812734|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||30
9713536|NCT03713684|10812756|FG000|STARTED|Overall Study||92
9713537|NCT03713684|10812757|FG001|STARTED|Overall Study||92
9713538|NCT03713684|10812758|FG002|STARTED|Overall Study||93
9713539|NCT03713684|10812759|FG003|STARTED|Overall Study||93
9713540|NCT03713684|10812756|FG000|Safety Population|Overall Study||92
9713541|NCT03713684|10812757|FG001|Safety Population|Overall Study||92
9713542|NCT03713684|10812758|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96
9713543|NCT03713684|10812759|FG003|Safety Population|Overall Study||90
9713544|NCT03713684|10812756|FG000|Completed 30-Week Core Treatment Period|Overall Study||50
9713545|NCT03713684|10812757|FG001|Completed 30-Week Core Treatment Period|Overall Study||52
9713546|NCT03713684|10812758|FG002|Completed 30-Week Core Treatment Period|Overall Study||51
9713547|NCT03713684|10812759|FG003|Completed 30-Week Core Treatment Period|Overall Study||49
9713548|NCT03713684|10812756|FG000|COMPLETED|Overall Study||6
9713549|NCT03713684|10812757|FG001|COMPLETED|Overall Study||5
9713550|NCT03713684|10812758|FG002|COMPLETED|Overall Study||5
9713551|NCT03713684|10812759|FG003|COMPLETED|Overall Study||6
9713552|NCT03713684|10812756|FG000|NOT COMPLETED|Overall Study||86
9713553|NCT03713684|10812757|FG001|NOT COMPLETED|Overall Study||87
9713554|NCT03713684|10812758|FG002|NOT COMPLETED|Overall Study||88
9713555|NCT03713684|10812759|FG003|NOT COMPLETED|Overall Study||87
9713556|NCT03644550|10812769|FG000|STARTED|Overall Study||18
9713557|NCT03644550|10812769|FG000|COMPLETED|Overall Study||0
9713558|NCT03644550|10812769|FG000|NOT COMPLETED|Overall Study||18
9713559|NCT03557970|10812776|FG000|STARTED|Overall Study||1
9713560|NCT03557970|10812777|FG001|STARTED|Overall Study||2
9713561|NCT03557970|10812776|FG000|COMPLETED|Overall Study||0
10177643|NCT03126760|11307860|FG000|NOT COMPLETED|Overall Study||0
10177644|NCT03126760|11307861|FG001|NOT COMPLETED|Overall Study||0
10177645|NCT03126786|11307869|FG000|STARTED|Overall Study||36
10177646|NCT03126786|11307870|FG001|STARTED|Overall Study||35
10177647|NCT03126786|11307869|FG000|COMPLETED|Overall Study||30
10177648|NCT03126786|11307870|FG001|COMPLETED|Overall Study||33
10177649|NCT03126786|11307869|FG000|NOT COMPLETED|Overall Study||6
10177650|NCT03126786|11307870|FG001|NOT COMPLETED|Overall Study||2
10177651|NCT03127228|11307878|FG000|STARTED|Overall Study||12
10177652|NCT03127228|11307879|FG001|STARTED|Overall Study||12
10177653|NCT03127228|11307878|FG000|COMPLETED|Overall Study||12
10177654|NCT03127228|11307879|FG001|COMPLETED|Overall Study||12
10177655|NCT03127228|11307878|FG000|NOT COMPLETED|Overall Study||0
10177656|NCT03127228|11307879|FG001|NOT COMPLETED|Overall Study||0
10177657|NCT03127358|11307888|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3
10177658|NCT03127358|11307889|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3
10177659|NCT03127358|11307890|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5
10177660|NCT03127358|11307888|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3
10177661|NCT03127358|11307889|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3
10177662|NCT03127358|11307890|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5
10177663|NCT03127358|11307888|FG000|NOT COMPLETED|Overall Study||0
10177664|NCT03127358|11307889|FG001|NOT COMPLETED|Overall Study||0
10177665|NCT03127358|11307890|FG002|NOT COMPLETED|Overall Study||0
10177666|NCT03127384|11307904|FG000|STARTED|Overall Study||49
10177667|NCT03127384|11307904|FG000|Completed 3 Month Visit|Overall Study||47
10177668|NCT03127384|11307904|FG000|COMPLETED|Overall Study||43
10177669|NCT03127384|11307904|FG000|NOT COMPLETED|Overall Study||6
10177670|NCT03127514|11307912|FG000|STARTED|Overall Study||48
10177671|NCT03127514|11307913|FG001|STARTED|Overall Study||89
10177672|NCT03127514|11307912|FG000|COMPLETED|Overall Study||38
10177673|NCT03127514|11307913|FG001|COMPLETED|Overall Study||67
10177674|NCT03127514|11307912|FG000|NOT COMPLETED|Overall Study||10
10177675|NCT03127514|11307913|FG001|NOT COMPLETED|Overall Study||22
9713562|NCT03557970|10812777|FG001|COMPLETED|Overall Study||0
9713563|NCT03557970|10812776|FG000|NOT COMPLETED|Overall Study||1
9713564|NCT03557970|10812777|FG001|NOT COMPLETED|Overall Study||2
9713565|NCT03369197|10812785|FG000|STARTED|Overall Study||53
9713566|NCT03369197|10812786|FG001|STARTED|Overall Study||57
9713567|NCT03369197|10812785|FG000|COMPLETED|Overall Study||53
9713568|NCT03369197|10812786|FG001|COMPLETED|Overall Study||57
9713569|NCT03369197|10812785|FG000|NOT COMPLETED|Overall Study||0
9713570|NCT03369197|10812786|FG001|NOT COMPLETED|Overall Study||0
9731189|NCT00130793|10831137|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
9731190|NCT00130793|10831138|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
9731191|NCT00130793|10831137|FG000|NOT COMPLETED|Overall Study||3
9731192|NCT00130793|10831138|FG001|NOT COMPLETED|Overall Study||4
9731193|NCT00130832|10831147|FG000|STARTED|Overall Study||372
9731194|NCT00130832|10831148|FG001|STARTED|Overall Study||363
9731195|NCT00130832|10831147|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
9731196|NCT00130832|10831148|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
9731197|NCT00130832|10831147|FG000|NOT COMPLETED|Overall Study||16
9731198|NCT00130832|10831148|FG001|NOT COMPLETED|Overall Study||17
9731199|NCT00130923|10831156|FG000|STARTED|Overall Study||49
9731200|NCT00130923|10831157|FG001|STARTED|Overall Study||46
9731201|NCT00130923|10831156|FG000|COMPLETED|Overall Study||36
9731202|NCT00130923|10831157|FG001|COMPLETED|Overall Study||32
9731203|NCT00130923|10831156|FG000|NOT COMPLETED|Overall Study||13
9731204|NCT00130923|10831157|FG001|NOT COMPLETED|Overall Study||14
9731205|NCT00131248|10831164|FG000|STARTED|Intervention 1 (3-day Course)||9
9731206|NCT00131248|10831165|FG001|STARTED|Intervention 1 (3-day Course)||9
9731207|NCT00131248|10831164|FG000|COMPLETED|Intervention 1 (3-day Course)||8
9731208|NCT00131248|10831165|FG001|COMPLETED|Intervention 1 (3-day Course)||9
9731209|NCT00131248|10831164|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1
9731210|NCT00131248|10831165|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0
9731211|NCT00131248|10831164|FG000|STARTED|Washout (24 Hour)||8
9731212|NCT00131248|10831165|FG001|STARTED|Washout (24 Hour)||9
9731213|NCT00131248|10831164|FG000|COMPLETED|Washout (24 Hour)||8
9731214|NCT00131248|10831165|FG001|COMPLETED|Washout (24 Hour)||9
9731215|NCT00131248|10831164|FG000|NOT COMPLETED|Washout (24 Hour)||0
9731216|NCT00131248|10831165|FG001|NOT COMPLETED|Washout (24 Hour)||0
9731217|NCT00131248|10831164|FG000|STARTED|Intervention 2 (7-day Course)||8
9731218|NCT00131248|10831165|FG001|STARTED|Intervention 2 (7-day Course)||9
9731219|NCT00131248|10831164|FG000|COMPLETED|Intervention 2 (7-day Course)||8
9731220|NCT00131248|10831165|FG001|COMPLETED|Intervention 2 (7-day Course)||9
9731221|NCT00131248|10831164|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0
9731222|NCT00131248|10831165|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0
9731223|NCT00131248|10831164|FG000|STARTED|Washout 2 (24 Hours)||8
9731224|NCT00131248|10831165|FG001|STARTED|Washout 2 (24 Hours)||9
9731225|NCT00131248|10831164|FG000|COMPLETED|Washout 2 (24 Hours)||8
9731226|NCT00131248|10831165|FG001|COMPLETED|Washout 2 (24 Hours)||9
9731227|NCT00131248|10831164|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0
10177676|NCT03127644|11307922|FG000|STARTED|Overall Study||34
10177677|NCT03127644|11307923|FG001|STARTED|Overall Study||36
10177678|NCT03127644|11307924|FG002|STARTED|Overall Study||33
10177679|NCT03127644|11307922|FG000|COMPLETED|Overall Study||34
10177680|NCT03127644|11307923|FG001|COMPLETED|Overall Study||36
10177681|NCT03127644|11307924|FG002|COMPLETED|Overall Study||31
10177682|NCT03127644|11307922|FG000|NOT COMPLETED|Overall Study||0
10177683|NCT03127644|11307923|FG001|NOT COMPLETED|Overall Study||0
10177684|NCT03127644|11307924|FG002|NOT COMPLETED|Overall Study||2
10177685|NCT03127943|11307934|FG000|STARTED|First Intervention||12
10177686|NCT03127943|11307935|FG001|STARTED|First Intervention||12
10177687|NCT03127943|11307934|FG000|COMPLETED|First Intervention||12
10177688|NCT03127943|11307935|FG001|COMPLETED|First Intervention||12
10177689|NCT03127943|11307934|FG000|NOT COMPLETED|First Intervention||0
10177690|NCT03127943|11307935|FG001|NOT COMPLETED|First Intervention||0
10177691|NCT03127943|11307934|FG000|STARTED|Washout (1 Week)||12
10177692|NCT03127943|11307935|FG001|STARTED|Washout (1 Week)||12
10177693|NCT03127943|11307934|FG000|COMPLETED|Washout (1 Week)||12
10177694|NCT03127943|11307935|FG001|COMPLETED|Washout (1 Week)||12
10177695|NCT03127943|11307934|FG000|NOT COMPLETED|Washout (1 Week)||0
10177696|NCT03127943|11307935|FG001|NOT COMPLETED|Washout (1 Week)||0
10177697|NCT03127943|11307934|FG000|STARTED|Second Intervention||12
10177698|NCT03127943|11307935|FG001|STARTED|Second Intervention||12
10177699|NCT03127943|11307934|FG000|COMPLETED|Second Intervention||12
10177700|NCT03127943|11307935|FG001|COMPLETED|Second Intervention||12
10177701|NCT03127943|11307934|FG000|NOT COMPLETED|Second Intervention||0
10177702|NCT03127943|11307935|FG001|NOT COMPLETED|Second Intervention||0
10177703|NCT03127956|11307941|FG000|STARTED|Overall Study||748
10177704|NCT03127956|11307941|FG000|COMPLETED|Overall Study||431
10177705|NCT03127956|11307941|FG000|NOT COMPLETED|Overall Study||317
10177706|NCT03128008|11307945|FG000|STARTED|Overall Study||10
10177707|NCT03128008|11307945|FG000|COMPLETED|Overall Study|9 participants are in follow up|1
10177708|NCT03128008|11307945|FG000|NOT COMPLETED|Overall Study||9
10177709|NCT03128086|11307952|FG000|STARTED|Overall Study||50
10177710|NCT03128086|11307953|FG001|STARTED|Overall Study||44
10177711|NCT03128086|11307952|FG000|COMPLETED|Overall Study||50
10177712|NCT03128086|11307953|FG001|COMPLETED|Overall Study||44
10177713|NCT03128086|11307952|FG000|NOT COMPLETED|Overall Study||0
10177714|NCT03128086|11307953|FG001|NOT COMPLETED|Overall Study||0
10177715|NCT03128099|11307962|FG000|STARTED|Overall Study||21
10177716|NCT03128099|11307963|FG001|STARTED|Overall Study||4
10177717|NCT03128099|11307964|FG002|STARTED|Overall Study||22
10177718|NCT03128099|11307962|FG000|Hour 1 (Low Dose) Started|Overall Study||21
10177719|NCT03128099|11307963|FG001|Hour 1 (Low Dose) Started|Overall Study||4
10177720|NCT03128099|11307964|FG002|Hour 1 (Low Dose) Started|Overall Study||22
10177721|NCT03128099|11307962|FG000|Hour 1 (Low Dose) Completed|Overall Study||19
10177722|NCT03128099|11307963|FG001|Hour 1 (Low Dose) Completed|Overall Study||4
10177723|NCT03128099|11307964|FG002|Hour 1 (Low Dose) Completed|Overall Study||21
10177724|NCT03128099|11307962|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
10177725|NCT03128099|11307963|FG001|Hour 2 (High Dose)Started|Overall Study||4
10177726|NCT03128099|11307964|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
10177727|NCT03128099|11307962|FG000|Hour 2 (High Dose) Completed|Overall Study||0
10177728|NCT03128099|11307963|FG001|Hour 2 (High Dose) Completed|Overall Study||0
10177729|NCT03128099|11307964|FG002|Hour 2 (High Dose) Completed|Overall Study||0
10177730|NCT03128099|11307962|FG000|COMPLETED|Overall Study||19
10177731|NCT03128099|11307963|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
10177732|NCT03128099|11307964|FG002|COMPLETED|Overall Study||21
10177733|NCT03128099|11307962|FG000|NOT COMPLETED|Overall Study||2
10177734|NCT03128099|11307963|FG001|NOT COMPLETED|Overall Study||4
10177735|NCT03128099|11307964|FG002|NOT COMPLETED|Overall Study||1
10177736|NCT03128307|11307970|FG000|STARTED|Overall Study||604
10177737|NCT03128307|11307970|FG000|COMPLETED|Overall Study||570
10177738|NCT03128307|11307970|FG000|NOT COMPLETED|Overall Study||34
10177739|NCT03128372|11307974|FG000|STARTED|Overall Study||32
10177740|NCT03128372|11307974|FG000|COMPLETED|Overall Study||32
10177741|NCT03128372|11307974|FG000|NOT COMPLETED|Overall Study||0
10177742|NCT03128723|11307978|FG000|STARTED|Overall Study||45
10177743|NCT03128723|11307978|FG000|COMPLETED|Overall Study||43
10177744|NCT03128723|11307978|FG000|NOT COMPLETED|Overall Study||2
10177745|NCT03128892|11307982|FG000|STARTED|Overall Study||34
10177746|NCT03128892|11307982|FG000|COMPLETED|Overall Study||31
10177747|NCT03128892|11307982|FG000|NOT COMPLETED|Overall Study||3
10177748|NCT03129178|11307988|FG000|STARTED|Overall Study||13
10177749|NCT03129178|11307989|FG001|STARTED|Overall Study||13
10177750|NCT03129178|11307988|FG000|COMPLETED|Overall Study||12
10177751|NCT03129178|11307989|FG001|COMPLETED|Overall Study||11
10177752|NCT03129178|11307988|FG000|NOT COMPLETED|Overall Study||1
10177753|NCT03129178|11307989|FG001|NOT COMPLETED|Overall Study||2
10177754|NCT03129568|11307996|FG000|STARTED|Overall Study||5
10177755|NCT03129568|11307996|FG000|COMPLETED|Overall Study||5
10177756|NCT03129568|11307996|FG000|NOT COMPLETED|Overall Study||0
10177757|NCT03129945|11308002|FG000|STARTED|Overall Study||15
10177758|NCT03129945|11308003|FG001|STARTED|Overall Study||21
10177759|NCT03129945|11308002|FG000|COMPLETED|Overall Study||15
10177760|NCT03129945|11308003|FG001|COMPLETED|Overall Study||21
10177761|NCT03129945|11308002|FG000|NOT COMPLETED|Overall Study||0
10177762|NCT03129945|11308003|FG001|NOT COMPLETED|Overall Study||0
10177763|NCT03130257|11308012|FG000|STARTED|Overall Study||172
10177764|NCT03130257|11308013|FG001|STARTED|Overall Study||170
10177765|NCT03130257|11308014|FG002|STARTED|Overall Study||168
10177766|NCT03130257|11308012|FG000|COMPLETED|Overall Study||171
10177767|NCT03130257|11308013|FG001|COMPLETED|Overall Study||170
10177768|NCT03130257|11308014|FG002|COMPLETED|Overall Study||166
10177769|NCT03130257|11308012|FG000|NOT COMPLETED|Overall Study||1
10177770|NCT03130257|11308013|FG001|NOT COMPLETED|Overall Study||0
10177771|NCT03130257|11308014|FG002|NOT COMPLETED|Overall Study||2
10177772|NCT03130738|11308025|FG000|STARTED|Overall Study||23
10177773|NCT03130738|11308026|FG001|STARTED|Overall Study||22
10177774|NCT03130738|11308027|FG002|STARTED|Overall Study||20
10177775|NCT03130738|11308025|FG000|COMPLETED|Overall Study||20
10177776|NCT03130738|11308026|FG001|COMPLETED|Overall Study||20
10177777|NCT03130738|11308027|FG002|COMPLETED|Overall Study||14
10177778|NCT03130738|11308025|FG000|NOT COMPLETED|Overall Study||3
10177779|NCT03130738|11308026|FG001|NOT COMPLETED|Overall Study||2
10177780|NCT03130738|11308027|FG002|NOT COMPLETED|Overall Study||6
10177781|NCT03131167|11308048|FG000|STARTED|Overall Study||6
10177782|NCT03131167|11308049|FG001|STARTED|Overall Study||5
10177783|NCT03131167|11308050|FG002|STARTED|Overall Study||5
10177784|NCT03131167|11308051|FG003|STARTED|Overall Study||5
9713571|NCT03368196|10812792|FG000|STARTED|Overall Study||12
9713572|NCT03368196|10812792|FG000|COMPLETED|Overall Study||12
9713573|NCT03368196|10812792|FG000|NOT COMPLETED|Overall Study||0
9713577|NCT02979587|10812801|FG000|STARTED|Overall Study||50
9713578|NCT02979587|10812801|FG000|Catheterized|Overall Study||50
9713579|NCT02979587|10812801|FG000|Implanted|Overall Study||50
9713580|NCT02979587|10812801|FG000|Implanted > 24 Hours|Overall Study||48
9713581|NCT02979587|10812801|FG000|COMPLETED|Overall Study||48
9713582|NCT02979587|10812801|FG000|NOT COMPLETED|Overall Study||2
9713583|NCT02964039|10812812|FG000|STARTED|Overall Study||18
9713584|NCT02964039|10812813|FG001|STARTED|Overall Study||18
9713585|NCT02964039|10812814|FG002|STARTED|Overall Study||18
9713586|NCT02964039|10812812|FG000|Received Allocated Intervention|Overall Study||15
9713587|NCT02964039|10812813|FG001|Received Allocated Intervention|Overall Study||17
9713588|NCT02964039|10812814|FG002|Received Allocated Intervention|Overall Study||14
9713589|NCT02964039|10812812|FG000|COMPLETED|Overall Study||14
9713590|NCT02964039|10812813|FG001|COMPLETED|Overall Study||17
9849684|NCT00866905|10962480|FG000|STARTED|Overall Study||168
9849685|NCT00866905|10962480|FG000|COMPLETED|Overall Study||135
9849686|NCT00866905|10962480|FG000|NOT COMPLETED|Overall Study||33
9849687|NCT00867009|10962486|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
9849688|NCT00867009|10962486|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113
9849689|NCT00867009|10962486|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
9849690|NCT00867009|10962486|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
9849691|NCT00867009|10962486|FG000|NOT COMPLETED|Induction Period||62
9849692|NCT00867009|10962486|FG000|STARTED|Maintenance Period||51
9849693|NCT00867009|10962486|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
9849694|NCT00867009|10962486|FG000|NOT COMPLETED|Maintenance Period||4
9849695|NCT00867035|10962492|FG000|STARTED|Baseline to 1 Hour||13
9849696|NCT00867035|10962493|FG001|STARTED|Baseline to 1 Hour||9
9849697|NCT00867035|10962492|FG000|COMPLETED|Baseline to 1 Hour||12
9849698|NCT00867035|10962493|FG001|COMPLETED|Baseline to 1 Hour||8
9849699|NCT00867035|10962492|FG000|NOT COMPLETED|Baseline to 1 Hour||1
9849700|NCT00867035|10962493|FG001|NOT COMPLETED|Baseline to 1 Hour||1
9849701|NCT00867035|10962492|FG000|STARTED|Baseline to 2 Hours||12
9849702|NCT00867035|10962493|FG001|STARTED|Baseline to 2 Hours||8
9849703|NCT00867035|10962492|FG000|COMPLETED|Baseline to 2 Hours||12
9849704|NCT00867035|10962493|FG001|COMPLETED|Baseline to 2 Hours||8
9849705|NCT00867035|10962492|FG000|NOT COMPLETED|Baseline to 2 Hours||0
9849706|NCT00867035|10962493|FG001|NOT COMPLETED|Baseline to 2 Hours||0
9849707|NCT00867035|10962492|FG000|STARTED|Baseline to 4 Hours||12
9849708|NCT00867035|10962493|FG001|STARTED|Baseline to 4 Hours||8
10061738|NCT02105961|11187322|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1
10061739|NCT02105961|11187323|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1
10061740|NCT02105961|11187324|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10061741|NCT02105961|11187322|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
10061742|NCT02105961|11187323|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10061743|NCT02105961|11187324|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10061744|NCT02105961|11187322|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2
10061745|NCT02105961|11187323|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0
10061746|NCT02105961|11187324|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1
9849709|NCT00867035|10962492|FG000|COMPLETED|Baseline to 4 Hours||12
9849710|NCT00867035|10962493|FG001|COMPLETED|Baseline to 4 Hours||8
9849711|NCT00867035|10962492|FG000|NOT COMPLETED|Baseline to 4 Hours||0
9849712|NCT00867035|10962493|FG001|NOT COMPLETED|Baseline to 4 Hours||0
9849713|NCT00867035|10962492|FG000|STARTED|Baseline to 1 Week||12
9849714|NCT00867035|10962493|FG001|STARTED|Baseline to 1 Week||8
9713591|NCT02964039|10812814|FG002|COMPLETED|Overall Study||13
9713592|NCT02964039|10812812|FG000|NOT COMPLETED|Overall Study||4
10177785|NCT03131167|11308052|FG004|STARTED|Overall Study||6
10177786|NCT03131167|11308053|FG005|STARTED|Overall Study||5
10177787|NCT03131167|11308054|FG006|STARTED|Overall Study||5
10177788|NCT03131167|11308055|FG007|STARTED|Overall Study||5
10177789|NCT03131167|11308056|FG008|STARTED|Overall Study||2
10177790|NCT03131167|11308057|FG009|STARTED|Overall Study||5
10177791|NCT03131167|11308058|FG010|STARTED|Overall Study||4
10177792|NCT03131167|11308059|FG011|STARTED|Overall Study||5
10177793|NCT03131167|11308060|FG012|STARTED|Overall Study||5
10177794|NCT03131167|11308048|FG000|COMPLETED|Overall Study||6
10177795|NCT03131167|11308049|FG001|COMPLETED|Overall Study||5
10177796|NCT03131167|11308050|FG002|COMPLETED|Overall Study||5
10177797|NCT03131167|11308051|FG003|COMPLETED|Overall Study||5
10177798|NCT03131167|11308052|FG004|COMPLETED|Overall Study||6
10177799|NCT03131167|11308053|FG005|COMPLETED|Overall Study||4
10177800|NCT03131167|11308054|FG006|COMPLETED|Overall Study||5
10177801|NCT03131167|11308055|FG007|COMPLETED|Overall Study||5
10177802|NCT03131167|11308056|FG008|COMPLETED|Overall Study||2
10177803|NCT03131167|11308057|FG009|COMPLETED|Overall Study||5
10177804|NCT03131167|11308058|FG010|COMPLETED|Overall Study||4
10177805|NCT03131167|11308059|FG011|COMPLETED|Overall Study||5
10177806|NCT03131167|11308060|FG012|COMPLETED|Overall Study||5
10177807|NCT03131167|11308048|FG000|NOT COMPLETED|Overall Study||0
10177808|NCT03131167|11308049|FG001|NOT COMPLETED|Overall Study||0
10177809|NCT03131167|11308050|FG002|NOT COMPLETED|Overall Study||0
10177810|NCT03131167|11308051|FG003|NOT COMPLETED|Overall Study||0
10177811|NCT03131167|11308052|FG004|NOT COMPLETED|Overall Study||0
10177812|NCT03131167|11308053|FG005|NOT COMPLETED|Overall Study||1
10177813|NCT03131167|11308054|FG006|NOT COMPLETED|Overall Study||0
10177814|NCT03131167|11308055|FG007|NOT COMPLETED|Overall Study||0
10177815|NCT03131167|11308056|FG008|NOT COMPLETED|Overall Study||0
10177816|NCT03131167|11308057|FG009|NOT COMPLETED|Overall Study||0
10177817|NCT03131167|11308058|FG010|NOT COMPLETED|Overall Study||0
10177818|NCT03131167|11308059|FG011|NOT COMPLETED|Overall Study||0
10177819|NCT03131167|11308060|FG012|NOT COMPLETED|Overall Study||0
10177820|NCT03131206|11308093|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
10177821|NCT03131206|11308094|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177822|NCT03131206|11308095|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177823|NCT03131206|11308096|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177824|NCT03131206|11308093|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
10177825|NCT03131206|11308094|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177826|NCT03131206|11308095|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177827|NCT03131206|11308096|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177828|NCT03131206|11308093|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177829|NCT03131206|11308094|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177830|NCT03131206|11308095|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177831|NCT03131206|11308096|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10177832|NCT03131206|11308093|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177833|NCT03131206|11308094|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177834|NCT03131206|11308095|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177835|NCT03131206|11308096|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177836|NCT03131206|11308093|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177837|NCT03131206|11308094|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177838|NCT03131206|11308095|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177839|NCT03131206|11308096|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177840|NCT03131206|11308093|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177841|NCT03131206|11308094|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177842|NCT03131206|11308095|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177843|NCT03131206|11308096|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10177844|NCT03131453|11308113|FG000|STARTED|Overall Study||456
10177845|NCT03131453|11308114|FG001|STARTED|Overall Study||233
10177846|NCT03131453|11308115|FG002|STARTED|Overall Study||456
10177847|NCT03131453|11308113|FG000|Patient Misrandomized|Overall Study||1
10177848|NCT03131453|11308114|FG001|Patient Misrandomized|Overall Study||0
10177849|NCT03131453|11308115|FG002|Patient Misrandomized|Overall Study||0
10177850|NCT03131453|11308113|FG000|COMPLETED|Overall Study||0
10177851|NCT03131453|11308114|FG001|COMPLETED|Overall Study||0
10177852|NCT03131453|11308115|FG002|COMPLETED|Overall Study||0
10177853|NCT03131453|11308113|FG000|NOT COMPLETED|Overall Study||456
10177854|NCT03131453|11308114|FG001|NOT COMPLETED|Overall Study||233
10177855|NCT03131453|11308115|FG002|NOT COMPLETED|Overall Study||456
10177856|NCT03131479|11308128|FG000|STARTED|Overall Study||10
10177857|NCT03131479|11308129|FG001|STARTED|Overall Study||10
10177858|NCT03131479|11308130|FG002|STARTED|Overall Study||11
10177859|NCT03131479|11308131|FG003|STARTED|Overall Study||12
10177860|NCT03131479|11308132|FG004|STARTED|Overall Study||10
10177861|NCT03131479|11308128|FG000|Safety Analysis Set (SS)|Overall Study||10
10177862|NCT03131479|11308129|FG001|Safety Analysis Set (SS)|Overall Study||10
10177863|NCT03131479|11308130|FG002|Safety Analysis Set (SS)|Overall Study||11
10177864|NCT03131479|11308131|FG003|Safety Analysis Set (SS)|Overall Study||12
10177865|NCT03131479|11308132|FG004|Safety Analysis Set (SS)|Overall Study||10
10177866|NCT03131479|11308128|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
10177867|NCT03131479|11308129|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
10177868|NCT03131479|11308130|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
10177869|NCT03131479|11308131|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
10177870|NCT03131479|11308132|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
10177871|NCT03131479|11308128|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10
10177872|NCT03131479|11308129|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10
10177873|NCT03131479|11308130|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11
10177874|NCT03131479|11308131|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12
10177875|NCT03131479|11308132|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10
10177876|NCT03131479|11308128|FG000|COMPLETED|Overall Study||10
10177877|NCT03131479|11308129|FG001|COMPLETED|Overall Study||10
10177878|NCT03131479|11308130|FG002|COMPLETED|Overall Study||10
10177879|NCT03131479|11308131|FG003|COMPLETED|Overall Study||10
10177880|NCT03131479|11308132|FG004|COMPLETED|Overall Study||10
10177881|NCT03131479|11308128|FG000|NOT COMPLETED|Overall Study||0
10177882|NCT03131479|11308129|FG001|NOT COMPLETED|Overall Study||0
10177883|NCT03131479|11308130|FG002|NOT COMPLETED|Overall Study||1
10177884|NCT03131479|11308131|FG003|NOT COMPLETED|Overall Study||2
10177885|NCT03131479|11308132|FG004|NOT COMPLETED|Overall Study||0
10177886|NCT03131570|11308146|FG000|STARTED|Overall Study||12
10177887|NCT03131570|11308147|FG001|STARTED|Overall Study||11
10177888|NCT03131570|11308146|FG000|COMPLETED|Overall Study||11
10177889|NCT03131570|11308147|FG001|COMPLETED|Overall Study||11
10177890|NCT03131570|11308146|FG000|NOT COMPLETED|Overall Study||1
10177891|NCT03131570|11308147|FG001|NOT COMPLETED|Overall Study||0
10177892|NCT03131596|11308155|FG000|STARTED|Overall Study||100
10177893|NCT03131596|11308156|FG001|STARTED|Overall Study||100
10177894|NCT03131596|11308155|FG000|COMPLETED|Overall Study||94
10177895|NCT03131596|11308156|FG001|COMPLETED|Overall Study||97
10177896|NCT03131596|11308155|FG000|NOT COMPLETED|Overall Study||6
10177897|NCT03131596|11308156|FG001|NOT COMPLETED|Overall Study||3
10177898|NCT03131648|11308164|FG000|STARTED|Initial Treatment Period||603
10177899|NCT03131648|11308165|FG001|STARTED|Initial Treatment Period||199
10177900|NCT03131648|11308166|FG002|STARTED|Initial Treatment Period||0
10177901|NCT03131648|11308167|FG003|STARTED|Initial Treatment Period||0
9713593|NCT02964039|10812813|FG001|NOT COMPLETED|Overall Study||1
9713594|NCT02964039|10812814|FG002|NOT COMPLETED|Overall Study||5
9713595|NCT02930889|10812822|FG000|STARTED|Overall Study||21
9713596|NCT02930889|10812822|FG000|COMPLETED|Overall Study||5
9713597|NCT02930889|10812822|FG000|NOT COMPLETED|Overall Study||16
9713598|NCT02919618|10812826|FG000|STARTED|Overall Study||19
9713599|NCT02919618|10812826|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19
9713600|NCT02919618|10812826|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18
9713601|NCT02919618|10812826|FG000|COMPLETED|Overall Study||18
9713602|NCT02919618|10812826|FG000|NOT COMPLETED|Overall Study||1
9713603|NCT02844946|10812843|FG000|STARTED|Overall Study||27
9713604|NCT02844946|10812844|FG001|STARTED|Overall Study||12
9713605|NCT02844946|10812843|FG000|COMPLETED|Overall Study||20
9713606|NCT02844946|10812844|FG001|COMPLETED|Overall Study||12
9713607|NCT02844946|10812843|FG000|NOT COMPLETED|Overall Study||7
9713608|NCT02844946|10812844|FG001|NOT COMPLETED|Overall Study||0
9713609|NCT02675114|10812852|FG000|STARTED|Overall Study||497
9713610|NCT02675114|10812853|FG001|STARTED|Overall Study||503
9713611|NCT02675114|10812852|FG000|As Treated|Overall Study||454
9713612|NCT02675114|10812853|FG001|As Treated|Overall Study||496
9713613|NCT02675114|10812852|FG000|Valve Implant|Overall Study||453
9713614|NCT02675114|10812853|FG001|Valve Implant|Overall Study||495
9713615|NCT02675114|10812852|FG000|COMPLETED|Overall Study||424
9713616|NCT02675114|10812853|FG001|COMPLETED|Overall Study||490
9713617|NCT02675114|10812852|FG000|NOT COMPLETED|Overall Study||73
9713618|NCT02675114|10812853|FG001|NOT COMPLETED|Overall Study||13
9713619|NCT02564796|10812861|FG000|STARTED|Overall Study||2
9713620|NCT02564796|10812862|FG001|STARTED|Overall Study||2
9713621|NCT02564796|10812861|FG000|COMPLETED|Overall Study||0
9713622|NCT02564796|10812862|FG001|COMPLETED|Overall Study||0
9713623|NCT02564796|10812861|FG000|NOT COMPLETED|Overall Study||2
9713624|NCT02564796|10812862|FG001|NOT COMPLETED|Overall Study||2
9713625|NCT02562716|10812870|FG000|STARTED|Overall Study||55
9713626|NCT02562716|10812871|FG001|STARTED|Overall Study||47
9713627|NCT02562716|10812870|FG000|Participants Assessed for AEs|Overall Study||53
9713628|NCT02562716|10812871|FG001|Participants Assessed for AEs|Overall Study||45
9713629|NCT02562716|10812870|FG000|COMPLETED|Overall Study||27
9713630|NCT02562716|10812871|FG001|COMPLETED|Overall Study||19
9713631|NCT02562716|10812870|FG000|NOT COMPLETED|Overall Study||28
9713632|NCT02562716|10812871|FG001|NOT COMPLETED|Overall Study||28
9713633|NCT01803854|10812879|FG000|STARTED|Overall Study||1275
9713634|NCT01803854|10812879|FG000|COMPLETED|Overall Study||1275
9713635|NCT01803854|10812879|FG000|NOT COMPLETED|Overall Study||0
9713636|NCT01472081|10812890|FG000|STARTED|Overall Study||7
9713637|NCT01472081|10812891|FG001|STARTED|Overall Study||26
9713638|NCT01472081|10812892|FG002|STARTED|Overall Study||20
9713639|NCT01472081|10812893|FG003|STARTED|Overall Study||47
9713640|NCT01472081|10812894|FG004|STARTED|Overall Study||47
9713641|NCT01472081|10812895|FG005|STARTED|Overall Study||6
9713642|NCT01472081|10812890|FG000|COMPLETED|Overall Study||0
9713643|NCT01472081|10812891|FG001|COMPLETED|Overall Study||0
9713644|NCT01472081|10812892|FG002|COMPLETED|Overall Study||0
10177902|NCT03131648|11308168|FG004|STARTED|Initial Treatment Period||0
10177903|NCT03131648|11308169|FG005|STARTED|Initial Treatment Period||0
10177904|NCT03131648|11308170|FG006|STARTED|Initial Treatment Period||0
9713645|NCT01472081|10812893|FG003|COMPLETED|Overall Study||1
9713646|NCT01472081|10812894|FG004|COMPLETED|Overall Study||0
10177905|NCT03131648|11308171|FG007|STARTED|Initial Treatment Period||0
10177906|NCT03131648|11308164|FG000|COMPLETED|Initial Treatment Period||550
10177907|NCT03131648|11308165|FG001|COMPLETED|Initial Treatment Period||179
10177908|NCT03131648|11308166|FG002|COMPLETED|Initial Treatment Period||0
10177909|NCT03131648|11308167|FG003|COMPLETED|Initial Treatment Period||0
10177910|NCT03131648|11308168|FG004|COMPLETED|Initial Treatment Period||0
10177911|NCT03131648|11308169|FG005|COMPLETED|Initial Treatment Period||0
10177912|NCT03131648|11308170|FG006|COMPLETED|Initial Treatment Period||0
10177913|NCT03131648|11308171|FG007|COMPLETED|Initial Treatment Period||0
10177914|NCT03131648|11308164|FG000|NOT COMPLETED|Initial Treatment Period||53
10177915|NCT03131648|11308165|FG001|NOT COMPLETED|Initial Treatment Period||20
10177916|NCT03131648|11308166|FG002|NOT COMPLETED|Initial Treatment Period||0
10177917|NCT03131648|11308167|FG003|NOT COMPLETED|Initial Treatment Period||0
10177918|NCT03131648|11308168|FG004|NOT COMPLETED|Initial Treatment Period||0
10177919|NCT03131648|11308169|FG005|NOT COMPLETED|Initial Treatment Period||0
10177920|NCT03131648|11308170|FG006|NOT COMPLETED|Initial Treatment Period||0
10177921|NCT03131648|11308171|FG007|NOT COMPLETED|Initial Treatment Period||0
10177922|NCT03131648|11308164|FG000|STARTED|Open-label Treatment||0
10177923|NCT03131648|11308165|FG001|STARTED|Open-label Treatment||0
10177924|NCT03131648|11308166|FG002|STARTED|Open-label Treatment||0
10177925|NCT03131648|11308167|FG003|STARTED|Open-label Treatment||0
10177926|NCT03131648|11308168|FG004|STARTED|Open-label Treatment||0
10177927|NCT03131648|11308169|FG005|STARTED|Open-label Treatment||0
10177928|NCT03131648|11308170|FG006|STARTED|Open-label Treatment||564
10177929|NCT03131648|11308171|FG007|STARTED|Open-label Treatment||0
10177930|NCT03131648|11308164|FG000|COMPLETED|Open-label Treatment||0
10177931|NCT03131648|11308165|FG001|COMPLETED|Open-label Treatment||0
10177932|NCT03131648|11308166|FG002|COMPLETED|Open-label Treatment||0
10177933|NCT03131648|11308167|FG003|COMPLETED|Open-label Treatment||0
10177934|NCT03131648|11308168|FG004|COMPLETED|Open-label Treatment||0
10177935|NCT03131648|11308169|FG005|COMPLETED|Open-label Treatment||0
10177936|NCT03131648|11308170|FG006|COMPLETED|Open-label Treatment||446
10177937|NCT03131648|11308171|FG007|COMPLETED|Open-label Treatment||0
10177938|NCT03131648|11308164|FG000|NOT COMPLETED|Open-label Treatment||0
10177939|NCT03131648|11308165|FG001|NOT COMPLETED|Open-label Treatment||0
10177940|NCT03131648|11308166|FG002|NOT COMPLETED|Open-label Treatment||0
10177941|NCT03131648|11308167|FG003|NOT COMPLETED|Open-label Treatment||0
10177942|NCT03131648|11308168|FG004|NOT COMPLETED|Open-label Treatment||0
10177943|NCT03131648|11308169|FG005|NOT COMPLETED|Open-label Treatment||0
10177944|NCT03131648|11308170|FG006|NOT COMPLETED|Open-label Treatment||118
10177945|NCT03131648|11308171|FG007|NOT COMPLETED|Open-label Treatment||0
10177946|NCT03131648|11308164|FG000|STARTED|Maintenance Treatment Period||0
10177947|NCT03131648|11308165|FG001|STARTED|Maintenance Treatment Period||0
10177948|NCT03131648|11308166|FG002|STARTED|Maintenance Treatment Period||71
10177949|NCT03131648|11308167|FG003|STARTED|Maintenance Treatment Period||78
10177950|NCT03131648|11308168|FG004|STARTED|Maintenance Treatment Period||36
10177951|NCT03131648|11308169|FG005|STARTED|Maintenance Treatment Period||29
9713647|NCT01472081|10812895|FG005|COMPLETED|Overall Study||0
9713648|NCT01472081|10812890|FG000|NOT COMPLETED|Overall Study||7
9713649|NCT01472081|10812891|FG001|NOT COMPLETED|Overall Study||26
9713650|NCT01472081|10812892|FG002|NOT COMPLETED|Overall Study||20
9713651|NCT01472081|10812893|FG003|NOT COMPLETED|Overall Study||46
9713652|NCT01472081|10812894|FG004|NOT COMPLETED|Overall Study||47
9713653|NCT01472081|10812895|FG005|NOT COMPLETED|Overall Study||6
9713654|NCT01309672|10812908|FG000|STARTED|Overall Study||41
9713655|NCT01309672|10812908|FG000|Received Protocol Treatment|Overall Study||40
9713656|NCT01309672|10812908|FG000|COMPLETED|Overall Study||4
9713657|NCT01309672|10812908|FG000|NOT COMPLETED|Overall Study||37
9713658|NCT01131169|10812915|FG000|STARTED|Overall Study||47
9713659|NCT01131169|10812916|FG001|STARTED|Overall Study||19
9713660|NCT01131169|10812915|FG000|COMPLETED|Overall Study||47
9713661|NCT01131169|10812916|FG001|COMPLETED|Overall Study||19
9713662|NCT01131169|10812915|FG000|NOT COMPLETED|Overall Study||0
9713663|NCT01131169|10812916|FG001|NOT COMPLETED|Overall Study||0
9713664|NCT00774345|10812925|FG000|STARTED|Pre-treatment||160
9713665|NCT00774345|10812926|FG001|STARTED|Pre-treatment||157
9713666|NCT00774345|10812925|FG000|COMPLETED|Pre-treatment||158
9713667|NCT00774345|10812926|FG001|COMPLETED|Pre-treatment||157
9713668|NCT00774345|10812925|FG000|NOT COMPLETED|Pre-treatment||2
9713669|NCT00774345|10812926|FG001|NOT COMPLETED|Pre-treatment||0
9713670|NCT00774345|10812925|FG000|STARTED|Treatment||158
10177952|NCT03131648|11308170|FG006|STARTED|Maintenance Treatment Period||0
10177953|NCT03131648|11308171|FG007|STARTED|Maintenance Treatment Period||0
10177954|NCT03131648|11308164|FG000|COMPLETED|Maintenance Treatment Period||0
10177955|NCT03131648|11308165|FG001|COMPLETED|Maintenance Treatment Period||0
10177956|NCT03131648|11308166|FG002|COMPLETED|Maintenance Treatment Period||44
10177957|NCT03131648|11308167|FG003|COMPLETED|Maintenance Treatment Period||53
10177958|NCT03131648|11308168|FG004|COMPLETED|Maintenance Treatment Period||21
10177959|NCT03131648|11308169|FG005|COMPLETED|Maintenance Treatment Period||15
10177960|NCT03131648|11308170|FG006|COMPLETED|Maintenance Treatment Period||0
10177961|NCT03131648|11308171|FG007|COMPLETED|Maintenance Treatment Period||0
10177962|NCT03131648|11308164|FG000|NOT COMPLETED|Maintenance Treatment Period||0
10177963|NCT03131648|11308165|FG001|NOT COMPLETED|Maintenance Treatment Period||0
10177964|NCT03131648|11308166|FG002|NOT COMPLETED|Maintenance Treatment Period||27
9713671|NCT00774345|10812926|FG001|STARTED|Treatment||157
9713672|NCT00774345|10812925|FG000|Participants Escalated to 5mg|Treatment||129
9713673|NCT00774345|10812926|FG001|Participants Escalated to 5mg|Treatment||149
9713674|NCT00774345|10812925|FG000|Participants Escalated to 10mg|Treatment||68
9713675|NCT00774345|10812926|FG001|Participants Escalated to 10mg|Treatment||88
10177965|NCT03131648|11308167|FG003|NOT COMPLETED|Maintenance Treatment Period||25
10177966|NCT03131648|11308168|FG004|NOT COMPLETED|Maintenance Treatment Period||15
10177967|NCT03131648|11308169|FG005|NOT COMPLETED|Maintenance Treatment Period||14
10177968|NCT03131648|11308170|FG006|NOT COMPLETED|Maintenance Treatment Period||0
10177969|NCT03131648|11308171|FG007|NOT COMPLETED|Maintenance Treatment Period||0
10177970|NCT03131648|11308164|FG000|STARTED|Open-label (Short Term Extension)||0
10177971|NCT03131648|11308165|FG001|STARTED|Open-label (Short Term Extension)||0
10177972|NCT03131648|11308166|FG002|STARTED|Open-label (Short Term Extension)||0
10177973|NCT03131648|11308167|FG003|STARTED|Open-label (Short Term Extension)||0
10177974|NCT03131648|11308168|FG004|STARTED|Open-label (Short Term Extension)||0
10177975|NCT03131648|11308169|FG005|STARTED|Open-label (Short Term Extension)||0
10177976|NCT03131648|11308170|FG006|STARTED|Open-label (Short Term Extension)||0
10177977|NCT03131648|11308171|FG007|STARTED|Open-label (Short Term Extension)||65
10177978|NCT03131648|11308164|FG000|COMPLETED|Open-label (Short Term Extension)||0
10177979|NCT03131648|11308165|FG001|COMPLETED|Open-label (Short Term Extension)||0
10177980|NCT03131648|11308166|FG002|COMPLETED|Open-label (Short Term Extension)||0
10177981|NCT03131648|11308167|FG003|COMPLETED|Open-label (Short Term Extension)||0
10177982|NCT03131648|11308168|FG004|COMPLETED|Open-label (Short Term Extension)||0
10177983|NCT03131648|11308169|FG005|COMPLETED|Open-label (Short Term Extension)||0
10177984|NCT03131648|11308170|FG006|COMPLETED|Open-label (Short Term Extension)||0
10177985|NCT03131648|11308171|FG007|COMPLETED|Open-label (Short Term Extension)||62
10177986|NCT03131648|11308164|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0
10177987|NCT03131648|11308165|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0
10177988|NCT03131648|11308166|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0
10177989|NCT03131648|11308167|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0
10177990|NCT03131648|11308168|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0
10177991|NCT03131648|11308169|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0
10177992|NCT03131648|11308170|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0
10177993|NCT03131648|11308171|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3
10177994|NCT03131687|11308194|FG000|STARTED|Overall Study||51
10177995|NCT03131687|11308195|FG001|STARTED|Overall Study||53
10177996|NCT03131687|11308196|FG002|STARTED|Overall Study||55
10177997|NCT03131687|11308197|FG003|STARTED|Overall Study||52
10177998|NCT03131687|11308198|FG004|STARTED|Overall Study||53
10177999|NCT03131687|11308199|FG005|STARTED|Overall Study||54
10178000|NCT03131687|11308194|FG000|Received at Least One Dose of Study Drug|Overall Study||51
10178001|NCT03131687|11308195|FG001|Received at Least One Dose of Study Drug|Overall Study||52
10178002|NCT03131687|11308196|FG002|Received at Least One Dose of Study Drug|Overall Study||55
10178003|NCT03131687|11308197|FG003|Received at Least One Dose of Study Drug|Overall Study||51
10178004|NCT03131687|11308198|FG004|Received at Least One Dose of Study Drug|Overall Study||53
10178005|NCT03131687|11308199|FG005|Received at Least One Dose of Study Drug|Overall Study||54
10178006|NCT03131687|11308194|FG000|COMPLETED|Overall Study||45
10178007|NCT03131687|11308195|FG001|COMPLETED|Overall Study||44
10178008|NCT03131687|11308196|FG002|COMPLETED|Overall Study||52
10178009|NCT03131687|11308197|FG003|COMPLETED|Overall Study||48
10178010|NCT03131687|11308198|FG004|COMPLETED|Overall Study||45
10178011|NCT03131687|11308199|FG005|COMPLETED|Overall Study||49
10178012|NCT03131687|11308194|FG000|NOT COMPLETED|Overall Study||6
10178013|NCT03131687|11308195|FG001|NOT COMPLETED|Overall Study||9
10178014|NCT03131687|11308196|FG002|NOT COMPLETED|Overall Study||3
10178015|NCT03131687|11308197|FG003|NOT COMPLETED|Overall Study||4
10178016|NCT03131687|11308198|FG004|NOT COMPLETED|Overall Study||8
10178017|NCT03131687|11308199|FG005|NOT COMPLETED|Overall Study||5
10178018|NCT03131713|11308228|FG000|STARTED|Overall Study||50
10178019|NCT03131713|11308229|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
10178020|NCT03131713|11308228|FG000|COMPLETED|Overall Study||45
10178021|NCT03131713|11308229|FG001|COMPLETED|Overall Study||51
10178022|NCT03131713|11308228|FG000|NOT COMPLETED|Overall Study||5
10178023|NCT03131713|11308229|FG001|NOT COMPLETED|Overall Study||0
10178024|NCT03131895|11308239|FG000|STARTED|Intervention Period 1 (2 Days)||28
10178025|NCT03131895|11308240|FG001|STARTED|Intervention Period 1 (2 Days)||28
10178026|NCT03131895|11308241|FG002|STARTED|Intervention Period 1 (2 Days)||30
10178027|NCT03131895|11308242|FG003|STARTED|Intervention Period 1 (2 Days)||30
10178028|NCT03131895|11308239|FG000|COMPLETED|Intervention Period 1 (2 Days)||28
10178029|NCT03131895|11308240|FG001|COMPLETED|Intervention Period 1 (2 Days)||28
10178030|NCT03131895|11308241|FG002|COMPLETED|Intervention Period 1 (2 Days)||30
10178031|NCT03131895|11308242|FG003|COMPLETED|Intervention Period 1 (2 Days)||30
10178032|NCT03131895|11308239|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10178033|NCT03131895|11308240|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10178034|NCT03131895|11308241|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10178035|NCT03131895|11308242|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10178036|NCT03131895|11308239|FG000|STARTED|Washout Period (at Least 5 Days)||28
10178037|NCT03131895|11308240|FG001|STARTED|Washout Period (at Least 5 Days)||28
10178038|NCT03131895|11308241|FG002|STARTED|Washout Period (at Least 5 Days)||30
10178039|NCT03131895|11308242|FG003|STARTED|Washout Period (at Least 5 Days)||30
10178040|NCT03131895|11308239|FG000|COMPLETED|Washout Period (at Least 5 Days)||27
10178041|NCT03131895|11308240|FG001|COMPLETED|Washout Period (at Least 5 Days)||23
10178042|NCT03131895|11308241|FG002|COMPLETED|Washout Period (at Least 5 Days)||26
10178043|NCT03131895|11308242|FG003|COMPLETED|Washout Period (at Least 5 Days)||25
10178044|NCT03131895|11308239|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1
10178045|NCT03131895|11308240|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5
10178046|NCT03131895|11308241|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4
10178047|NCT03131895|11308242|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5
10178048|NCT03131895|11308239|FG000|STARTED|Intervention Period 2 (2 Days)||27
10178049|NCT03131895|11308240|FG001|STARTED|Intervention Period 2 (2 Days)||23
10178050|NCT03131895|11308241|FG002|STARTED|Intervention Period 2 (2 Days)||26
10178051|NCT03131895|11308242|FG003|STARTED|Intervention Period 2 (2 Days)||25
10178052|NCT03131895|11308239|FG000|COMPLETED|Intervention Period 2 (2 Days)||26
10178053|NCT03131895|11308240|FG001|COMPLETED|Intervention Period 2 (2 Days)||22
10178054|NCT03131895|11308241|FG002|COMPLETED|Intervention Period 2 (2 Days)||26
10178055|NCT03131895|11308242|FG003|COMPLETED|Intervention Period 2 (2 Days)||25
10178056|NCT03131895|11308239|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
10178057|NCT03131895|11308240|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1
10178058|NCT03131895|11308241|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10178059|NCT03131895|11308242|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10178060|NCT03131999|11308254|FG000|STARTED|Overall Study||8
10178061|NCT03131999|11308255|FG001|STARTED|Overall Study||8
10178062|NCT03131999|11308254|FG000|COMPLETED|Overall Study||8
10178063|NCT03131999|11308255|FG001|COMPLETED|Overall Study||7
10178064|NCT03131999|11308254|FG000|NOT COMPLETED|Overall Study||0
10178065|NCT03131999|11308255|FG001|NOT COMPLETED|Overall Study||1
10178066|NCT03132220|11308263|FG000|STARTED|Overall Study||65
10178067|NCT03132220|11308264|FG001|STARTED|Overall Study||66
10178068|NCT03132220|11308263|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
10178069|NCT03132220|11308264|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
10178070|NCT03132220|11308263|FG000|COMPLETED|Overall Study||47
10178071|NCT03132220|11308264|FG001|COMPLETED|Overall Study||54
10178072|NCT03132220|11308263|FG000|NOT COMPLETED|Overall Study||18
10178073|NCT03132220|11308264|FG001|NOT COMPLETED|Overall Study||12
10178074|NCT03132246|11308272|FG000|STARTED|Overall Study||260
10178075|NCT03132246|11308272|FG000|COMPLETED|Overall Study||156
10178076|NCT03132246|11308272|FG000|NOT COMPLETED|Overall Study||104
10178077|NCT03132298|11308281|FG000|STARTED|Overall Study||48
10178078|NCT03132298|11308282|FG001|STARTED|Overall Study||48
10178079|NCT03132298|11308281|FG000|COMPLETED|Overall Study||36
10178080|NCT03132298|11308282|FG001|COMPLETED|Overall Study||35
10178081|NCT03132298|11308281|FG000|NOT COMPLETED|Overall Study||12
10178082|NCT03132298|11308282|FG001|NOT COMPLETED|Overall Study||13
10178083|NCT03132571|11308290|FG000|STARTED|Overall Study||3
10178084|NCT03132571|11308291|FG001|STARTED|Overall Study||2
10178085|NCT03132571|11308290|FG000|COMPLETED|Overall Study||3
10178086|NCT03132571|11308291|FG001|COMPLETED|Overall Study||2
10178087|NCT03132571|11308290|FG000|NOT COMPLETED|Overall Study||0
10178088|NCT03132571|11308291|FG001|NOT COMPLETED|Overall Study||0
10178089|NCT03133481|11308299|FG000|STARTED|Overall Study||45
10178090|NCT03133481|11308300|FG001|STARTED|Overall Study||49
10178091|NCT03133481|11308299|FG000|COMPLETED|Overall Study||45
10178092|NCT03133481|11308300|FG001|COMPLETED|Overall Study||45
10178093|NCT03133481|11308299|FG000|NOT COMPLETED|Overall Study||0
10178094|NCT03133481|11308300|FG001|NOT COMPLETED|Overall Study||4
10178095|NCT03133676|11308315|FG000|STARTED|Overall Study||6
10178096|NCT03133676|11308316|FG001|STARTED|Overall Study||3
10178097|NCT03133676|11308317|FG002|STARTED|Overall Study||3
10178098|NCT03133676|11308318|FG003|STARTED|Overall Study||6
10178099|NCT03133676|11308319|FG004|STARTED|Overall Study||6
10178100|NCT03133676|11308320|FG005|STARTED|Overall Study||9
10178101|NCT03133676|11308321|FG006|STARTED|Overall Study||9
10178102|NCT03133676|11308322|FG007|STARTED|Overall Study||9
10178103|NCT03133676|11308323|FG008|STARTED|Overall Study||9
10178104|NCT03133676|11308315|FG000|COMPLETED|Overall Study||6
10178105|NCT03133676|11308316|FG001|COMPLETED|Overall Study||3
10178106|NCT03133676|11308317|FG002|COMPLETED|Overall Study||3
10178107|NCT03133676|11308318|FG003|COMPLETED|Overall Study||6
10178108|NCT03133676|11308319|FG004|COMPLETED|Overall Study||6
10178109|NCT03133676|11308320|FG005|COMPLETED|Overall Study||9
10178110|NCT03133676|11308321|FG006|COMPLETED|Overall Study||9
10178111|NCT03133676|11308322|FG007|COMPLETED|Overall Study||9
10178112|NCT03133676|11308323|FG008|COMPLETED|Overall Study||9
10178113|NCT03133676|11308315|FG000|NOT COMPLETED|Overall Study||0
10178114|NCT03133676|11308316|FG001|NOT COMPLETED|Overall Study||0
10178115|NCT03133676|11308317|FG002|NOT COMPLETED|Overall Study||0
10178116|NCT03133676|11308318|FG003|NOT COMPLETED|Overall Study||0
10178117|NCT03133676|11308319|FG004|NOT COMPLETED|Overall Study||0
10178118|NCT03133676|11308320|FG005|NOT COMPLETED|Overall Study||0
10178119|NCT03133676|11308321|FG006|NOT COMPLETED|Overall Study||0
10178120|NCT03133676|11308322|FG007|NOT COMPLETED|Overall Study||0
10178121|NCT03133676|11308323|FG008|NOT COMPLETED|Overall Study||0
10178122|NCT03133767|11308352|FG000|STARTED|Overall Study||79
10178123|NCT03133767|11308353|FG001|STARTED|Overall Study||78
10178124|NCT03133767|11308352|FG000|COMPLETED|Overall Study||41
10178125|NCT03133767|11308353|FG001|COMPLETED|Overall Study||53
10178126|NCT03133767|11308352|FG000|NOT COMPLETED|Overall Study||38
10178127|NCT03133767|11308353|FG001|NOT COMPLETED|Overall Study||25
10178128|NCT03134092|11308362|FG000|STARTED|Overall Study||434
10178129|NCT03134092|11308363|FG001|STARTED|Overall Study||435
10178130|NCT03134092|11308364|FG002|STARTED|Overall Study||433
10178131|NCT03134092|11308362|FG000|COMPLETED|Overall Study||434
10178132|NCT03134092|11308363|FG001|COMPLETED|Overall Study||435
10178133|NCT03134092|11308364|FG002|COMPLETED|Overall Study||433
10178134|NCT03134092|11308362|FG000|NOT COMPLETED|Overall Study||0
10178135|NCT03134092|11308363|FG001|NOT COMPLETED|Overall Study||0
10178136|NCT03134092|11308364|FG002|NOT COMPLETED|Overall Study||0
10178137|NCT03134144|11308378|FG000|STARTED|Overall Study||15
10178138|NCT03134144|11308379|FG001|STARTED|Overall Study||30
10178139|NCT03134144|11308378|FG000|COMPLETED|Overall Study||15
10178140|NCT03134144|11308379|FG001|COMPLETED|Overall Study||30
10178141|NCT03134144|11308378|FG000|NOT COMPLETED|Overall Study||0
10178142|NCT03134144|11308379|FG001|NOT COMPLETED|Overall Study||0
9713676|NCT00774345|10812925|FG000|COMPLETED|Treatment||0
9713677|NCT00774345|10812926|FG001|COMPLETED|Treatment||0
9713678|NCT00774345|10812925|FG000|NOT COMPLETED|Treatment||158
9713679|NCT00774345|10812926|FG001|NOT COMPLETED|Treatment||157
9713680|NCT00457951|10812935|FG000|STARTED|Overall Study||13
9713681|NCT00457951|10812936|FG001|STARTED|Overall Study||66
9713682|NCT00457951|10812937|FG002|STARTED|Overall Study||72
9713683|NCT00457951|10812935|FG000|COMPLETED|Overall Study||13
9713684|NCT00457951|10812936|FG001|COMPLETED|Overall Study||50
9713685|NCT00457951|10812937|FG002|COMPLETED|Overall Study||60
9713686|NCT00457951|10812935|FG000|NOT COMPLETED|Overall Study||0
9713687|NCT00457951|10812936|FG001|NOT COMPLETED|Overall Study||16
9713688|NCT00457951|10812937|FG002|NOT COMPLETED|Overall Study||12
10178143|NCT03134183|11308392|FG000|STARTED|Overall Study||36
10178144|NCT03134183|11308393|FG001|STARTED|Overall Study||34
10178145|NCT03134183|11308392|FG000|COMPLETED|Overall Study||35
10178146|NCT03134183|11308393|FG001|COMPLETED|Overall Study||33
10178147|NCT03134183|11308392|FG000|NOT COMPLETED|Overall Study||1
10178148|NCT03134183|11308393|FG001|NOT COMPLETED|Overall Study||1
10178149|NCT03134209|11308402|FG000|STARTED|Overall Study||53
10178150|NCT03134209|11308403|FG001|STARTED|Overall Study||54
10178151|NCT03134209|11308404|FG002|STARTED|Overall Study||53
10178152|NCT03134209|11308402|FG000|COMPLETED|Overall Study||53
10178153|NCT03134209|11308403|FG001|COMPLETED|Overall Study||54
10178154|NCT03134209|11308404|FG002|COMPLETED|Overall Study||53
10178155|NCT03134209|11308402|FG000|NOT COMPLETED|Overall Study||0
10178156|NCT03134209|11308403|FG001|NOT COMPLETED|Overall Study||0
10178157|NCT03134209|11308404|FG002|NOT COMPLETED|Overall Study||0
10178158|NCT03134222|11308415|FG000|STARTED|Treatment Period (Up to Week 12)||19
10178159|NCT03134222|11308416|FG001|STARTED|Treatment Period (Up to Week 12)||18
10178160|NCT03134222|11308417|FG002|STARTED|Treatment Period (Up to Week 12)||10
10178161|NCT03134222|11308418|FG003|STARTED|Treatment Period (Up to Week 12)||0
10178162|NCT03134222|11308419|FG004|STARTED|Treatment Period (Up to Week 12)||0
10178163|NCT03134222|11308415|FG000|COMPLETED|Treatment Period (Up to Week 12)||14
10178164|NCT03134222|11308416|FG001|COMPLETED|Treatment Period (Up to Week 12)||14
10178165|NCT03134222|11308417|FG002|COMPLETED|Treatment Period (Up to Week 12)||8
10178166|NCT03134222|11308418|FG003|COMPLETED|Treatment Period (Up to Week 12)||0
10178167|NCT03134222|11308419|FG004|COMPLETED|Treatment Period (Up to Week 12)||0
10178168|NCT03134222|11308415|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5
10178169|NCT03134222|11308416|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4
10178170|NCT03134222|11308417|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2
10178171|NCT03134222|11308418|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0
10178172|NCT03134222|11308419|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0
10178173|NCT03134222|11308415|FG000|STARTED|Treatment Period (Week 12 to 48)||14
10178174|NCT03134222|11308416|FG001|STARTED|Treatment Period (Week 12 to 48)||14
10178175|NCT03134222|11308417|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
10178176|NCT03134222|11308418|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
10178177|NCT03134222|11308419|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
10178178|NCT03134222|11308415|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12
10178179|NCT03134222|11308416|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11
10178180|NCT03134222|11308417|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0
10178181|NCT03134222|11308418|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3
10178182|NCT03134222|11308419|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3
10178183|NCT03134222|11308415|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
10178184|NCT03134222|11308416|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
10178185|NCT03134222|11308417|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
10178186|NCT03134222|11308418|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
10178187|NCT03134222|11308419|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
10178188|NCT03134248|11308429|FG000|STARTED|Week 1||7
10178189|NCT03134248|11308430|FG001|STARTED|Week 1||8
10178190|NCT03134248|11308431|FG002|STARTED|Week 1||9
10178191|NCT03134248|11308432|FG003|STARTED|Week 1||7
10178192|NCT03134248|11308433|FG004|STARTED|Week 1||9
10178193|NCT03134248|11308434|FG005|STARTED|Week 1||9
10178194|NCT03134248|11308429|FG000|COMPLETED|Week 1||7
10178195|NCT03134248|11308430|FG001|COMPLETED|Week 1||8
10178196|NCT03134248|11308431|FG002|COMPLETED|Week 1||9
10178197|NCT03134248|11308432|FG003|COMPLETED|Week 1||7
10178198|NCT03134248|11308433|FG004|COMPLETED|Week 1||9
10178199|NCT03134248|11308434|FG005|COMPLETED|Week 1||9
10178200|NCT03134248|11308429|FG000|NOT COMPLETED|Week 1||0
10178201|NCT03134248|11308430|FG001|NOT COMPLETED|Week 1||0
10178202|NCT03134248|11308431|FG002|NOT COMPLETED|Week 1||0
10178203|NCT03134248|11308432|FG003|NOT COMPLETED|Week 1||0
10178204|NCT03134248|11308433|FG004|NOT COMPLETED|Week 1||0
10178205|NCT03134248|11308434|FG005|NOT COMPLETED|Week 1||0
10178206|NCT03134248|11308429|FG000|STARTED|Week 2||7
10178207|NCT03134248|11308430|FG001|STARTED|Week 2||8
10178208|NCT03134248|11308431|FG002|STARTED|Week 2||9
10178209|NCT03134248|11308432|FG003|STARTED|Week 2||7
10178210|NCT03134248|11308433|FG004|STARTED|Week 2||9
10178211|NCT03134248|11308434|FG005|STARTED|Week 2||9
10178212|NCT03134248|11308429|FG000|COMPLETED|Week 2||7
10178213|NCT03134248|11308430|FG001|COMPLETED|Week 2||8
10178214|NCT03134248|11308431|FG002|COMPLETED|Week 2||9
10178215|NCT03134248|11308432|FG003|COMPLETED|Week 2||7
10178216|NCT03134248|11308433|FG004|COMPLETED|Week 2||9
10178217|NCT03134248|11308434|FG005|COMPLETED|Week 2||9
10178218|NCT03134248|11308429|FG000|NOT COMPLETED|Week 2||0
10178219|NCT03134248|11308430|FG001|NOT COMPLETED|Week 2||0
9713689|NCT00345943|10812946|FG000|STARTED|Overall Study||38
9713690|NCT00345943|10812947|FG001|STARTED|Overall Study||33
9713691|NCT00345943|10812946|FG000|COMPLETED|Overall Study||33
9713692|NCT00345943|10812947|FG001|COMPLETED|Overall Study||28
9713693|NCT00345943|10812946|FG000|NOT COMPLETED|Overall Study||5
9713694|NCT00345943|10812947|FG001|NOT COMPLETED|Overall Study||5
9713695|NCT00258427|10812957|FG000|STARTED|Overall Study||3
9713696|NCT00258427|10812958|FG001|STARTED|Overall Study||8
9713697|NCT00258427|10812959|FG002|STARTED|Overall Study||2
9713698|NCT00258427|10812960|FG003|STARTED|Overall Study||1
9713699|NCT00258427|10812957|FG000|COMPLETED|Overall Study||3
9713700|NCT00258427|10812958|FG001|COMPLETED|Overall Study||8
9713701|NCT00258427|10812959|FG002|COMPLETED|Overall Study||2
9713702|NCT00258427|10812960|FG003|COMPLETED|Overall Study||1
9713703|NCT00258427|10812957|FG000|NOT COMPLETED|Overall Study||0
9713704|NCT00258427|10812958|FG001|NOT COMPLETED|Overall Study||0
9713705|NCT00258427|10812959|FG002|NOT COMPLETED|Overall Study||0
9713706|NCT00258427|10812960|FG003|NOT COMPLETED|Overall Study||0
9731228|NCT00131248|10831165|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0
9731229|NCT00131248|10831164|FG000|STARTED|Intervention 3 (4-day Course)||8
9731230|NCT00131248|10831165|FG001|STARTED|Intervention 3 (4-day Course)||9
9731231|NCT00131248|10831164|FG000|COMPLETED|Intervention 3 (4-day Course)||8
9731232|NCT00131248|10831165|FG001|COMPLETED|Intervention 3 (4-day Course)||9
9731233|NCT00131248|10831164|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0
9731234|NCT00131248|10831165|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0
9731235|NCT00131352|10831173|FG000|STARTED|Initial Treatment Period|Safety population|123
9731236|NCT00131352|10831174|FG001|STARTED|Initial Treatment Period|Safety population|130
9731237|NCT00131352|10831173|FG000|Intent to Treat Population|Initial Treatment Period||124
9731238|NCT00131352|10831174|FG001|Intent to Treat Population|Initial Treatment Period||129
9731239|NCT00131352|10831173|FG000|COMPLETED|Initial Treatment Period||114
9731240|NCT00131352|10831174|FG001|COMPLETED|Initial Treatment Period||118
9731241|NCT00131352|10831173|FG000|NOT COMPLETED|Initial Treatment Period||9
9731242|NCT00131352|10831174|FG001|NOT COMPLETED|Initial Treatment Period||12
9731243|NCT00131352|10831173|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
9731244|NCT00131352|10831174|FG001|STARTED|Repeat Treatment Period||0
9731245|NCT00131352|10831173|FG000|COMPLETED|Repeat Treatment Period||158
9731246|NCT00131352|10831174|FG001|COMPLETED|Repeat Treatment Period||0
10178220|NCT03134248|11308431|FG002|NOT COMPLETED|Week 2||0
10178221|NCT03134248|11308432|FG003|NOT COMPLETED|Week 2||0
10178222|NCT03134248|11308433|FG004|NOT COMPLETED|Week 2||0
10178223|NCT03134248|11308434|FG005|NOT COMPLETED|Week 2||0
10178224|NCT03134248|11308429|FG000|STARTED|Week 3||7
10178225|NCT03134248|11308430|FG001|STARTED|Week 3||8
10178226|NCT03134248|11308431|FG002|STARTED|Week 3||9
10178227|NCT03134248|11308432|FG003|STARTED|Week 3||7
10178228|NCT03134248|11308433|FG004|STARTED|Week 3||9
10178229|NCT03134248|11308434|FG005|STARTED|Week 3||9
10178230|NCT03134248|11308429|FG000|COMPLETED|Week 3||7
10178231|NCT03134248|11308430|FG001|COMPLETED|Week 3||8
10178232|NCT03134248|11308431|FG002|COMPLETED|Week 3||9
10178233|NCT03134248|11308432|FG003|COMPLETED|Week 3||7
10178234|NCT03134248|11308433|FG004|COMPLETED|Week 3||9
10178235|NCT03134248|11308434|FG005|COMPLETED|Week 3||9
10178236|NCT03134248|11308429|FG000|NOT COMPLETED|Week 3||0
10178237|NCT03134248|11308430|FG001|NOT COMPLETED|Week 3||0
10178238|NCT03134248|11308431|FG002|NOT COMPLETED|Week 3||0
10178239|NCT03134248|11308432|FG003|NOT COMPLETED|Week 3||0
10178240|NCT03134248|11308433|FG004|NOT COMPLETED|Week 3||0
10178241|NCT03134248|11308434|FG005|NOT COMPLETED|Week 3||0
10178242|NCT03134313|11308444|FG000|STARTED|Overall Study||25
10178243|NCT03134313|11308444|FG000|COMPLETED|Overall Study||25
10178244|NCT03134313|11308444|FG000|NOT COMPLETED|Overall Study||0
10178245|NCT03134326|11308448|FG000|STARTED|Overall Study||21
10178246|NCT03134326|11308448|FG000|COMPLETED|Overall Study||21
10178247|NCT03134326|11308448|FG000|NOT COMPLETED|Overall Study||0
10178248|NCT03134599|11308452|FG000|STARTED|Week 1||10
10178249|NCT03134599|11308453|FG001|STARTED|Week 1||10
10178250|NCT03134599|11308454|FG002|STARTED|Week 1||10
10178251|NCT03134599|11308455|FG003|STARTED|Week 1||11
10178252|NCT03134599|11308456|FG004|STARTED|Week 1||10
10178253|NCT03134599|11308457|FG005|STARTED|Week 1||9
10178254|NCT03134599|11308452|FG000|COMPLETED|Week 1||10
10178255|NCT03134599|11308453|FG001|COMPLETED|Week 1||10
10178256|NCT03134599|11308454|FG002|COMPLETED|Week 1||10
10178257|NCT03134599|11308455|FG003|COMPLETED|Week 1||11
10178258|NCT03134599|11308456|FG004|COMPLETED|Week 1||9
10178259|NCT03134599|11308457|FG005|COMPLETED|Week 1||9
10178260|NCT03134599|11308452|FG000|NOT COMPLETED|Week 1||0
10178261|NCT03134599|11308453|FG001|NOT COMPLETED|Week 1||0
10178262|NCT03134599|11308454|FG002|NOT COMPLETED|Week 1||0
10178263|NCT03134599|11308455|FG003|NOT COMPLETED|Week 1||0
10178264|NCT03134599|11308456|FG004|NOT COMPLETED|Week 1||1
10178265|NCT03134599|11308457|FG005|NOT COMPLETED|Week 1||0
10178266|NCT03134599|11308452|FG000|STARTED|Week 2||10
10178267|NCT03134599|11308453|FG001|STARTED|Week 2||10
10178268|NCT03134599|11308454|FG002|STARTED|Week 2||10
10178269|NCT03134599|11308455|FG003|STARTED|Week 2||11
10178270|NCT03134599|11308456|FG004|STARTED|Week 2||9
10178271|NCT03134599|11308457|FG005|STARTED|Week 2||9
10178272|NCT03134599|11308452|FG000|COMPLETED|Week 2||9
10178273|NCT03134599|11308453|FG001|COMPLETED|Week 2||10
10178274|NCT03134599|11308454|FG002|COMPLETED|Week 2||10
10178275|NCT03134599|11308455|FG003|COMPLETED|Week 2||10
10178276|NCT03134599|11308456|FG004|COMPLETED|Week 2||8
10178277|NCT03134599|11308457|FG005|COMPLETED|Week 2||9
10178278|NCT03134599|11308452|FG000|NOT COMPLETED|Week 2||1
10178279|NCT03134599|11308453|FG001|NOT COMPLETED|Week 2||0
10178280|NCT03134599|11308454|FG002|NOT COMPLETED|Week 2||0
10178281|NCT03134599|11308455|FG003|NOT COMPLETED|Week 2||1
10178282|NCT03134599|11308456|FG004|NOT COMPLETED|Week 2||1
10178283|NCT03134599|11308457|FG005|NOT COMPLETED|Week 2||0
10178284|NCT03134599|11308452|FG000|STARTED|Week 3||9
10178285|NCT03134599|11308453|FG001|STARTED|Week 3||10
10178286|NCT03134599|11308454|FG002|STARTED|Week 3||10
10178287|NCT03134599|11308455|FG003|STARTED|Week 3||10
10178288|NCT03134599|11308456|FG004|STARTED|Week 3||8
10178289|NCT03134599|11308457|FG005|STARTED|Week 3||9
10178290|NCT03134599|11308452|FG000|COMPLETED|Week 3||9
10178291|NCT03134599|11308453|FG001|COMPLETED|Week 3||10
10178292|NCT03134599|11308454|FG002|COMPLETED|Week 3||10
10178293|NCT03134599|11308455|FG003|COMPLETED|Week 3||9
10178294|NCT03134599|11308456|FG004|COMPLETED|Week 3||8
10178295|NCT03134599|11308457|FG005|COMPLETED|Week 3||8
10178296|NCT03134599|11308452|FG000|NOT COMPLETED|Week 3||0
10178297|NCT03134599|11308453|FG001|NOT COMPLETED|Week 3||0
10178298|NCT03134599|11308454|FG002|NOT COMPLETED|Week 3||0
10178299|NCT03134599|11308455|FG003|NOT COMPLETED|Week 3||1
10178300|NCT03134599|11308456|FG004|NOT COMPLETED|Week 3||0
10178301|NCT03134599|11308457|FG005|NOT COMPLETED|Week 3||1
10178302|NCT03134703|11308467|FG000|STARTED|Overall Study||6
10178303|NCT03134703|11308468|FG001|STARTED|Overall Study||5
10178304|NCT03134703|11308467|FG000|COMPLETED|Overall Study||0
10178305|NCT03134703|11308468|FG001|COMPLETED|Overall Study||3
10178306|NCT03134703|11308467|FG000|NOT COMPLETED|Overall Study||6
10178307|NCT03134703|11308468|FG001|NOT COMPLETED|Overall Study||2
10178308|NCT03134768|11308474|FG000|STARTED|Overall Study||50
10178309|NCT03134768|11308474|FG000|COMPLETED|Overall Study||50
10178310|NCT03134768|11308474|FG000|NOT COMPLETED|Overall Study||0
10178311|NCT03134911|11308480|FG000|STARTED|Overall Study||535
10178312|NCT03134911|11308480|FG000|COMPLETED|Overall Study||501
10178313|NCT03134911|11308480|FG000|NOT COMPLETED|Overall Study||34
10178314|NCT03134963|11308492|FG000|STARTED|Overall Study||12
10178315|NCT03134963|11308493|FG001|STARTED|Overall Study||13
10178316|NCT03134963|11308494|FG002|STARTED|Overall Study||3
10178317|NCT03134963|11308495|FG003|STARTED|Overall Study||14
10178318|NCT03134963|11308492|FG000|COMPLETED|Overall Study||12
10178319|NCT03134963|11308493|FG001|COMPLETED|Overall Study||13
10178320|NCT03134963|11308494|FG002|COMPLETED|Overall Study||3
10178321|NCT03134963|11308495|FG003|COMPLETED|Overall Study||14
10178322|NCT03134963|11308492|FG000|NOT COMPLETED|Overall Study||0
10178323|NCT03134963|11308493|FG001|NOT COMPLETED|Overall Study||0
10178324|NCT03134963|11308494|FG002|NOT COMPLETED|Overall Study||0
10178325|NCT03134963|11308495|FG003|NOT COMPLETED|Overall Study||0
10178326|NCT03134989|11308505|FG000|STARTED|Overall Study||80
10178327|NCT03134989|11308505|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80
10178328|NCT03134989|11308505|FG000|NOT COMPLETED|Overall Study||0
10178329|NCT03135015|11308512|FG000|STARTED|Overall Study||11
10178330|NCT03135015|11308513|FG001|STARTED|Overall Study||11
10178331|NCT03135015|11308512|FG000|Water Control|Overall Study||9
10178332|NCT03135015|11308513|FG001|Water Control|Overall Study||11
10178333|NCT03135015|11308512|FG000|Placebo Capsules|Overall Study||9
10178334|NCT03135015|11308513|FG001|Placebo Capsules|Overall Study||11
10178335|NCT03135015|11308512|FG000|2g Capsules|Overall Study||9
10178336|NCT03135015|11308513|FG001|2g Capsules|Overall Study||11
10178337|NCT03135015|11308512|FG000|4g Capsules|Overall Study||9
10178338|NCT03135015|11308513|FG001|4g Capsules|Overall Study||11
10178339|NCT03135015|11308512|FG000|2g Tablets|Overall Study||9
10178340|NCT03135015|11308513|FG001|2g Tablets|Overall Study||11
10178341|NCT03135015|11308512|FG000|4g Tablets|Overall Study||9
10178342|NCT03135015|11308513|FG001|4g Tablets|Overall Study||11
9713707|NCT03722810|10812972|FG000|STARTED|Overall Study||157
9713708|NCT03722810|10812973|FG001|STARTED|Overall Study||160
9713709|NCT03722810|10812972|FG000|COMPLETED|Overall Study||150
9713710|NCT03722810|10812973|FG001|COMPLETED|Overall Study||156
9713711|NCT03722810|10812972|FG000|NOT COMPLETED|Overall Study||7
9713712|NCT03722810|10812973|FG001|NOT COMPLETED|Overall Study||4
9713713|NCT00000125|10812988|FG000|STARTED|Overall Study||819
9713714|NCT00000125|10812989|FG001|STARTED|Overall Study||817
9713715|NCT00000125|10812988|FG000|Completed OHTS Phase I, June 2002|Overall Study||706
9713716|NCT00000125|10812989|FG001|Completed OHTS Phase I, June 2002|Overall Study||702
9713717|NCT00000125|10812988|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
9713718|NCT00000125|10812989|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
9713719|NCT00000125|10812988|FG000|NOT COMPLETED|Overall Study||239
9713720|NCT00000125|10812989|FG001|NOT COMPLETED|Overall Study||238
9713721|NCT00000134|10812998|FG000|STARTED|Overall Study||89
9713722|NCT00000134|10812999|FG001|STARTED|Overall Study||94
9713723|NCT00000134|10813000|FG002|STARTED|Overall Study||96
9713724|NCT00000134|10812998|FG000|COMPLETED|Overall Study||89
9713725|NCT00000134|10812999|FG001|COMPLETED|Overall Study||94
9713726|NCT00000134|10813000|FG002|COMPLETED|Overall Study||96
9713727|NCT00000134|10812998|FG000|NOT COMPLETED|Overall Study||0
9713728|NCT00000134|10812999|FG001|NOT COMPLETED|Overall Study||0
9713729|NCT00000134|10813000|FG002|NOT COMPLETED|Overall Study||0
9713730|NCT00000135|10813010|FG000|STARTED|Overall Study||104
9713731|NCT00000135|10813011|FG001|STARTED|Overall Study||105
9713732|NCT00000135|10813010|FG000|COMPLETED|Overall Study||77
9713733|NCT00000135|10813011|FG001|COMPLETED|Overall Study||91
9713734|NCT00000135|10813010|FG000|NOT COMPLETED|Overall Study||27
9713735|NCT00000135|10813011|FG001|NOT COMPLETED|Overall Study||14
9713736|NCT00000136|10813019|FG000|STARTED|Overall Study||107
9713737|NCT00000136|10813020|FG001|STARTED|Overall Study||127
9713738|NCT00000136|10813019|FG000|COMPLETED|Overall Study||107
9713739|NCT00000136|10813020|FG001|COMPLETED|Overall Study||127
9713740|NCT00000136|10813019|FG000|NOT COMPLETED|Overall Study||0
9713741|NCT00000136|10813020|FG001|NOT COMPLETED|Overall Study||0
9713742|NCT00000142|10813029|FG000|STARTED|Overall Study||26
9713743|NCT00000142|10813030|FG001|STARTED|Overall Study||26
9713744|NCT00000142|10813031|FG002|STARTED|Overall Study||12
9713745|NCT00000142|10813029|FG000|COMPLETED|Overall Study||26
9713746|NCT00000142|10813030|FG001|COMPLETED|Overall Study||26
9713747|NCT00000142|10813031|FG002|COMPLETED|Overall Study||12
9713748|NCT00000142|10813029|FG000|NOT COMPLETED|Overall Study||0
9713749|NCT00000142|10813030|FG001|NOT COMPLETED|Overall Study||0
9713750|NCT00000142|10813031|FG002|NOT COMPLETED|Overall Study||0
9713751|NCT00000143|10813041|FG000|STARTED|Overall Study||31
9713752|NCT00000143|10813042|FG001|STARTED|Overall Study||30
9713753|NCT00000143|10813041|FG000|COMPLETED|Overall Study||31
9713754|NCT00000143|10813042|FG001|COMPLETED|Overall Study||30
9713755|NCT00000143|10813041|FG000|NOT COMPLETED|Overall Study||0
9713756|NCT00000143|10813042|FG001|NOT COMPLETED|Overall Study||0
9713757|NCT00000371|10813050|FG000|STARTED|Overall Study||27
9713758|NCT00000371|10813051|FG001|STARTED|Overall Study||28
9713759|NCT00000371|10813050|FG000|COMPLETED|Overall Study||14
9713760|NCT00000371|10813051|FG001|COMPLETED|Overall Study||12
9713761|NCT00000371|10813050|FG000|NOT COMPLETED|Overall Study||13
9713762|NCT00000371|10813051|FG001|NOT COMPLETED|Overall Study||16
9713763|NCT00000378|10813059|FG000|STARTED|Overall Study||58
9713764|NCT00000378|10813060|FG001|STARTED|Overall Study||52
9713765|NCT00000378|10813059|FG000|COMPLETED|Overall Study||42
9713766|NCT00000378|10813060|FG001|COMPLETED|Overall Study||38
9713767|NCT00000378|10813059|FG000|NOT COMPLETED|Overall Study||16
9713768|NCT00000378|10813060|FG001|NOT COMPLETED|Overall Study||14
9713769|NCT00000392|10813068|FG000|STARTED|Overall Study||106
9713770|NCT00000392|10813069|FG001|STARTED|Overall Study||109
9713771|NCT00000392|10813068|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
9713772|NCT00000392|10813069|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
9713773|NCT00000392|10813068|FG000|NOT COMPLETED|Overall Study||40
9713774|NCT00000392|10813069|FG001|NOT COMPLETED|Overall Study||32
9713775|NCT00000479|10813079|FG000|STARTED|Overall Study||9968
10178343|NCT03135015|11308512|FG000|COMPLETED|Overall Study||9
10178344|NCT03135015|11308513|FG001|COMPLETED|Overall Study||11
10178345|NCT03135015|11308512|FG000|NOT COMPLETED|Overall Study||2
10178346|NCT03135015|11308513|FG001|NOT COMPLETED|Overall Study||0
10178347|NCT03135028|11308563|FG000|STARTED|Overall Study||9
10178348|NCT03135028|11308563|FG000|COMPLETED|Overall Study||0
10178349|NCT03135028|11308563|FG000|NOT COMPLETED|Overall Study||9
10178350|NCT03135210|11308569|FG000|STARTED|Overall Study||2
10178351|NCT03135210|11308570|FG001|STARTED|Overall Study||2
10178352|NCT03135210|11308569|FG000|COMPLETED|Overall Study||2
10178353|NCT03135210|11308570|FG001|COMPLETED|Overall Study||1
10178354|NCT03135210|11308569|FG000|NOT COMPLETED|Overall Study||0
9713776|NCT00000479|10813080|FG001|STARTED|Overall Study||9971
9713777|NCT00000479|10813081|FG002|STARTED|Overall Study||9966
9713778|NCT00000479|10813082|FG003|STARTED|Overall Study||9971
9713779|NCT00000479|10813079|FG000|COMPLETED|Overall Study||9968
9713780|NCT00000479|10813080|FG001|COMPLETED|Overall Study||9971
9713781|NCT00000479|10813081|FG002|COMPLETED|Overall Study||9966
9713782|NCT00000479|10813082|FG003|COMPLETED|Overall Study||9971
9713783|NCT00000479|10813079|FG000|NOT COMPLETED|Overall Study||0
9713784|NCT00000479|10813080|FG001|NOT COMPLETED|Overall Study||0
9713785|NCT00000479|10813081|FG002|NOT COMPLETED|Overall Study||0
9713786|NCT00000479|10813082|FG003|NOT COMPLETED|Overall Study||0
9713787|NCT00000575|10813095|FG000|STARTED|Overall Study||311
9713788|NCT00000575|10813096|FG001|STARTED|Overall Study||312
9713789|NCT00000575|10813097|FG002|STARTED|Overall Study||418
9713790|NCT00000575|10813095|FG000|COMPLETED|Overall Study||311
9713791|NCT00000575|10813096|FG001|COMPLETED|Overall Study||312
9713792|NCT00000575|10813097|FG002|COMPLETED|Overall Study||418
9713793|NCT00000575|10813095|FG000|NOT COMPLETED|Overall Study||0
9713794|NCT00000575|10813096|FG001|NOT COMPLETED|Overall Study||0
9713795|NCT00000575|10813097|FG002|NOT COMPLETED|Overall Study||0
9713796|NCT00000620|10813107|FG000|STARTED|Overall Study||1178
9713797|NCT00000620|10813108|FG001|STARTED|Overall Study||1193
9713798|NCT00000620|10813109|FG002|STARTED|Overall Study||1374
9713799|NCT00000620|10813110|FG003|STARTED|Overall Study||1383
9713800|NCT00000620|10813111|FG004|STARTED|Overall Study||1184
9713801|NCT00000620|10813112|FG005|STARTED|Overall Study||1178
9713802|NCT00000620|10813113|FG006|STARTED|Overall Study||1391
9713803|NCT00000620|10813114|FG007|STARTED|Overall Study||1370
9713804|NCT00000620|10813107|FG000|COMPLETED|Overall Study||1016
9713805|NCT00000620|10813108|FG001|COMPLETED|Overall Study||1057
9713806|NCT00000620|10813109|FG002|COMPLETED|Overall Study||1204
9713807|NCT00000620|10813110|FG003|COMPLETED|Overall Study||1205
9713808|NCT00000620|10813111|FG004|COMPLETED|Overall Study||1049
9713809|NCT00000620|10813112|FG005|COMPLETED|Overall Study||1026
9713810|NCT00000620|10813113|FG006|COMPLETED|Overall Study||1242
9713811|NCT00000620|10813114|FG007|COMPLETED|Overall Study||1224
9713812|NCT00000620|10813107|FG000|NOT COMPLETED|Overall Study||162
9713813|NCT00000620|10813108|FG001|NOT COMPLETED|Overall Study||136
9713814|NCT00000620|10813109|FG002|NOT COMPLETED|Overall Study||170
9713815|NCT00000620|10813110|FG003|NOT COMPLETED|Overall Study||178
9713816|NCT00000620|10813111|FG004|NOT COMPLETED|Overall Study||135
9713817|NCT00000620|10813112|FG005|NOT COMPLETED|Overall Study||152
9713818|NCT00000620|10813113|FG006|NOT COMPLETED|Overall Study||149
9713819|NCT00000620|10813114|FG007|NOT COMPLETED|Overall Study||146
9713820|NCT00001151|10813126|FG000|STARTED|Overall Study||6
9713821|NCT00001151|10813126|FG000|COMPLETED|Overall Study||1
9713822|NCT00001151|10813126|FG000|NOT COMPLETED|Overall Study||5
9713823|NCT00001213|10813130|FG000|STARTED|Overall Study||328
9713824|NCT00001213|10813130|FG000|COMPLETED|Overall Study||310
9713825|NCT00001213|10813130|FG000|NOT COMPLETED|Overall Study||18
9713826|NCT00001262|10813137|FG000|STARTED|Overall Study||35
9713827|NCT00001262|10813138|FG001|STARTED|Overall Study||22
9713828|NCT00001262|10813139|FG002|STARTED|Overall Study||3
9713829|NCT00001262|10813137|FG000|COMPLETED|Overall Study||25
9713830|NCT00001262|10813138|FG001|COMPLETED|Overall Study||8
9713831|NCT00001262|10813139|FG002|COMPLETED|Overall Study||3
9713832|NCT00001262|10813137|FG000|NOT COMPLETED|Overall Study||10
9713833|NCT00001262|10813138|FG001|NOT COMPLETED|Overall Study||14
9713834|NCT00001262|10813139|FG002|NOT COMPLETED|Overall Study||0
9713835|NCT00001304|10813149|FG000|STARTED|Overall Study||13
9713836|NCT00001304|10813150|FG001|STARTED|Overall Study||14
9713837|NCT00001304|10813149|FG000|COMPLETED|Overall Study||13
9713838|NCT00001304|10813150|FG001|COMPLETED|Overall Study||14
9713839|NCT00001304|10813149|FG000|NOT COMPLETED|Overall Study||0
9713840|NCT00001304|10813150|FG001|NOT COMPLETED|Overall Study||0
9713841|NCT00001305|10813156|FG000|STARTED|Overall Study||42
9713842|NCT00001305|10813156|FG000|COMPLETED|Overall Study||42
9713843|NCT00001305|10813156|FG000|NOT COMPLETED|Overall Study||0
9713844|NCT00001566|10813160|FG000|STARTED|Overall Study||42
9713845|NCT00001566|10813160|FG000|Completed Immunotherapy|Overall Study||23
9713846|NCT00001566|10813160|FG000|COMPLETED|Overall Study||23
9713847|NCT00001566|10813160|FG000|NOT COMPLETED|Overall Study||19
9713848|NCT00001575|10813164|FG000|STARTED|Overall Study||87
9713849|NCT00001575|10813164|FG000|Treated|Overall Study||65
9713850|NCT00001575|10813164|FG000|COMPLETED|Overall Study||42
9713851|NCT00001575|10813164|FG000|NOT COMPLETED|Overall Study||45
9713852|NCT00001586|10813170|FG000|STARTED|Overall Study||49
9713853|NCT00001586|10813171|FG001|STARTED|Overall Study||56
9713854|NCT00001586|10813170|FG000|COMPLETED|Overall Study||49
10178355|NCT03135210|11308570|FG001|NOT COMPLETED|Overall Study||1
10178356|NCT03135379|11308578|FG000|STARTED|Overall Study||62
10178357|NCT03135379|11308579|FG001|STARTED|Overall Study||62
10178358|NCT03135379|11308578|FG000|COMPLETED|Overall Study||61
10178359|NCT03135379|11308579|FG001|COMPLETED|Overall Study||59
10178360|NCT03135379|11308578|FG000|NOT COMPLETED|Overall Study||1
10178361|NCT03135379|11308579|FG001|NOT COMPLETED|Overall Study||3
10178362|NCT03135431|11308587|FG000|STARTED|Overall Study||20
10178363|NCT03135431|11308588|FG001|STARTED|Overall Study||20
10178364|NCT03135431|11308587|FG000|COMPLETED|Overall Study||18
10178365|NCT03135431|11308588|FG001|COMPLETED|Overall Study||20
10178366|NCT03135431|11308587|FG000|NOT COMPLETED|Overall Study||2
10178367|NCT03135431|11308588|FG001|NOT COMPLETED|Overall Study||0
10178368|NCT03135522|11308596|FG000|STARTED|Overall Study||17
10178369|NCT03135522|11308597|FG001|STARTED|Overall Study||17
10178370|NCT03135522|11308596|FG000|COMPLETED|Overall Study||16
10178371|NCT03135522|11308597|FG001|COMPLETED|Overall Study||17
10178372|NCT03135522|11308596|FG000|NOT COMPLETED|Overall Study||1
10178373|NCT03135522|11308597|FG001|NOT COMPLETED|Overall Study||0
10178374|NCT03135535|11308603|FG000|STARTED|Overall Study||30
10178375|NCT03135535|11308603|FG000|COMPLETED|Overall Study||30
10178376|NCT03135535|11308603|FG000|NOT COMPLETED|Overall Study||0
10178377|NCT03135548|11308610|FG000|STARTED|Overall Study||19
10178378|NCT03135548|11308611|FG001|STARTED|Overall Study||19
10178379|NCT03135548|11308612|FG002|STARTED|Overall Study||21
10178380|NCT03135548|11308610|FG000|COMPLETED|Overall Study||14
10178381|NCT03135548|11308611|FG001|COMPLETED|Overall Study||15
10178382|NCT03135548|11308612|FG002|COMPLETED|Overall Study||18
10178383|NCT03135548|11308610|FG000|NOT COMPLETED|Overall Study||5
10178384|NCT03135548|11308611|FG001|NOT COMPLETED|Overall Study||4
10178385|NCT03135548|11308612|FG002|NOT COMPLETED|Overall Study||3
10178386|NCT03135899|11308628|FG000|STARTED|Overall Study||1
10178387|NCT03135899|11308629|FG001|STARTED|Overall Study||1
10178388|NCT03135899|11308630|FG002|STARTED|Overall Study||1
10178389|NCT03135899|11308631|FG003|STARTED|Overall Study||1
10178390|NCT03135899|11308632|FG004|STARTED|Overall Study||8
10178391|NCT03135899|11308633|FG005|STARTED|Overall Study||9
10178392|NCT03135899|11308634|FG006|STARTED|Overall Study||8
10178393|NCT03135899|11308635|FG007|STARTED|Overall Study||8
10178394|NCT03135899|11308628|FG000|COMPLETED|Overall Study||1
10178395|NCT03135899|11308629|FG001|COMPLETED|Overall Study||1
10178396|NCT03135899|11308630|FG002|COMPLETED|Overall Study||1
10178397|NCT03135899|11308631|FG003|COMPLETED|Overall Study||1
10178398|NCT03135899|11308632|FG004|COMPLETED|Overall Study||8
10178399|NCT03135899|11308633|FG005|COMPLETED|Overall Study||7
10178400|NCT03135899|11308634|FG006|COMPLETED|Overall Study||7
10178401|NCT03135899|11308635|FG007|COMPLETED|Overall Study||8
10178402|NCT03135899|11308628|FG000|NOT COMPLETED|Overall Study||0
10178403|NCT03135899|11308629|FG001|NOT COMPLETED|Overall Study||0
10178404|NCT03135899|11308630|FG002|NOT COMPLETED|Overall Study||0
10178405|NCT03135899|11308631|FG003|NOT COMPLETED|Overall Study||0
10178406|NCT03135899|11308632|FG004|NOT COMPLETED|Overall Study||0
10178407|NCT03135899|11308633|FG005|NOT COMPLETED|Overall Study||2
10178408|NCT03135899|11308634|FG006|NOT COMPLETED|Overall Study||1
10178409|NCT03135899|11308635|FG007|NOT COMPLETED|Overall Study||0
10178410|NCT03136068|11308651|FG000|STARTED|Overall Study||88
10178411|NCT03136068|11308652|FG001|STARTED|Overall Study||90
10178412|NCT03136068|11308651|FG000|COMPLETED|Overall Study||86
10178413|NCT03136068|11308652|FG001|COMPLETED|Overall Study||89
10178414|NCT03136068|11308651|FG000|NOT COMPLETED|Overall Study||2
10178415|NCT03136068|11308652|FG001|NOT COMPLETED|Overall Study||1
10178416|NCT03136107|11308658|FG000|STARTED|Overall Study||26
10178417|NCT03136107|11308658|FG000|Test Product|Overall Study||26
10178418|NCT03136107|11308658|FG000|Reference Product|Overall Study||26
10178419|NCT03136107|11308658|FG000|Negative Control|Overall Study||26
10178420|NCT03136107|11308658|FG000|COMPLETED|Overall Study||25
10178421|NCT03136107|11308658|FG000|NOT COMPLETED|Overall Study||1
10178422|NCT03136159|11308668|FG000|STARTED|Overall Study||190
10178423|NCT03136159|11308669|FG001|STARTED|Overall Study||190
10178424|NCT03136159|11308668|FG000|COMPLETED|Overall Study||185
10178425|NCT03136159|11308669|FG001|COMPLETED|Overall Study||190
10178426|NCT03136159|11308668|FG000|NOT COMPLETED|Overall Study||5
10178427|NCT03136159|11308669|FG001|NOT COMPLETED|Overall Study||0
10178428|NCT03136198|11308677|FG000|STARTED|Overall Study||66
10178429|NCT03136198|11308678|FG001|STARTED|Overall Study||64
10178430|NCT03136198|11308677|FG000|COMPLETED|Overall Study||66
10178431|NCT03136198|11308678|FG001|COMPLETED|Overall Study||63
10178432|NCT03136198|11308677|FG000|NOT COMPLETED|Overall Study||0
10178433|NCT03136198|11308678|FG001|NOT COMPLETED|Overall Study||1
10178434|NCT03136328|11308684|FG000|STARTED|Overall Study||11
10178435|NCT03136328|11308684|FG000|COMPLETED|Overall Study||11
10178436|NCT03136328|11308684|FG000|NOT COMPLETED|Overall Study||0
10178437|NCT03136367|11308692|FG000|STARTED|T1 Consultation||66
10178438|NCT03136367|11308693|FG001|STARTED|T1 Consultation||248
10178439|NCT03136367|11308694|FG002|STARTED|T1 Consultation||257
10178440|NCT03136367|11308692|FG000|COMPLETED|T1 Consultation|received the intervention|64
10178441|NCT03136367|11308693|FG001|COMPLETED|T1 Consultation||241
10178442|NCT03136367|11308694|FG002|COMPLETED|T1 Consultation||256
10178443|NCT03136367|11308692|FG000|NOT COMPLETED|T1 Consultation||2
10178444|NCT03136367|11308693|FG001|NOT COMPLETED|T1 Consultation||7
10178445|NCT03136367|11308694|FG002|NOT COMPLETED|T1 Consultation||1
10178446|NCT03136367|11308692|FG000|STARTED|T2 Post-consultation||64
10178447|NCT03136367|11308693|FG001|STARTED|T2 Post-consultation||241
10178448|NCT03136367|11308694|FG002|STARTED|T2 Post-consultation||256
10178449|NCT03136367|11308692|FG000|COMPLETED|T2 Post-consultation||61
10178450|NCT03136367|11308693|FG001|COMPLETED|T2 Post-consultation||235
10178451|NCT03136367|11308694|FG002|COMPLETED|T2 Post-consultation||225
10178452|NCT03136367|11308692|FG000|NOT COMPLETED|T2 Post-consultation||3
10178453|NCT03136367|11308693|FG001|NOT COMPLETED|T2 Post-consultation||6
10178454|NCT03136367|11308694|FG002|NOT COMPLETED|T2 Post-consultation||31
10178455|NCT03136367|11308692|FG000|STARTED|T3 1 Week After Surgery||61
10178456|NCT03136367|11308693|FG001|STARTED|T3 1 Week After Surgery||235
10178457|NCT03136367|11308694|FG002|STARTED|T3 1 Week After Surgery||225
10178458|NCT03136367|11308692|FG000|COMPLETED|T3 1 Week After Surgery||51
10178459|NCT03136367|11308693|FG001|COMPLETED|T3 1 Week After Surgery||203
10178460|NCT03136367|11308694|FG002|COMPLETED|T3 1 Week After Surgery||194
10178461|NCT03136367|11308692|FG000|NOT COMPLETED|T3 1 Week After Surgery||10
10178462|NCT03136367|11308693|FG001|NOT COMPLETED|T3 1 Week After Surgery||32
10178463|NCT03136367|11308694|FG002|NOT COMPLETED|T3 1 Week After Surgery||31
10178464|NCT03136367|11308692|FG000|STARTED|T4 12 Weeks After Surgery||51
10178465|NCT03136367|11308693|FG001|STARTED|T4 12 Weeks After Surgery||203
10178466|NCT03136367|11308694|FG002|STARTED|T4 12 Weeks After Surgery||194
10178467|NCT03136367|11308692|FG000|COMPLETED|T4 12 Weeks After Surgery||49
10178468|NCT03136367|11308693|FG001|COMPLETED|T4 12 Weeks After Surgery||198
10178469|NCT03136367|11308694|FG002|COMPLETED|T4 12 Weeks After Surgery||185
10178470|NCT03136367|11308692|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2
10178471|NCT03136367|11308693|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5
10178472|NCT03136367|11308694|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9
10178473|NCT03136367|11308692|FG000|STARTED|T5 1 Year After Surgery||49
10178474|NCT03136367|11308693|FG001|STARTED|T5 1 Year After Surgery||198
10178475|NCT03136367|11308694|FG002|STARTED|T5 1 Year After Surgery||185
10178476|NCT03136367|11308692|FG000|COMPLETED|T5 1 Year After Surgery||13
10178477|NCT03136367|11308693|FG001|COMPLETED|T5 1 Year After Surgery||62
10178478|NCT03136367|11308694|FG002|COMPLETED|T5 1 Year After Surgery||56
10178479|NCT03136367|11308692|FG000|NOT COMPLETED|T5 1 Year After Surgery||36
10178480|NCT03136367|11308693|FG001|NOT COMPLETED|T5 1 Year After Surgery||136
10178481|NCT03136367|11308694|FG002|NOT COMPLETED|T5 1 Year After Surgery||129
10178482|NCT03136380|11308707|FG000|STARTED|Part 1, Period 1 (3 Days)||6
10178483|NCT03136380|11308708|FG001|STARTED|Part 1, Period 1 (3 Days)||6
10178484|NCT03136380|11308709|FG002|STARTED|Part 1, Period 1 (3 Days)||6
10178485|NCT03136380|11308710|FG003|STARTED|Part 1, Period 1 (3 Days)||0
10178486|NCT03136380|11308711|FG004|STARTED|Part 1, Period 1 (3 Days)||0
10178487|NCT03136380|11308707|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6
10178488|NCT03136380|11308708|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6
10178489|NCT03136380|11308709|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6
10178490|NCT03136380|11308710|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0
10178491|NCT03136380|11308711|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0
10178492|NCT03136380|11308707|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10178493|NCT03136380|11308708|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10178494|NCT03136380|11308709|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10178495|NCT03136380|11308710|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10178496|NCT03136380|11308711|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10178497|NCT03136380|11308707|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6
10178498|NCT03136380|11308708|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6
10178499|NCT03136380|11308709|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6
10178500|NCT03136380|11308710|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0
10178501|NCT03136380|11308711|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0
10178502|NCT03136380|11308707|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
10178503|NCT03136380|11308708|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
10178504|NCT03136380|11308709|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
10178505|NCT03136380|11308710|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10178506|NCT03136380|11308711|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10178507|NCT03136380|11308707|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10178508|NCT03136380|11308708|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10178509|NCT03136380|11308709|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10178510|NCT03136380|11308710|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10178511|NCT03136380|11308711|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10178512|NCT03136380|11308707|FG000|STARTED|Part 1, Period 2 (3 Days)||6
10178513|NCT03136380|11308708|FG001|STARTED|Part 1, Period 2 (3 Days)||6
10178514|NCT03136380|11308709|FG002|STARTED|Part 1, Period 2 (3 Days)||6
10178515|NCT03136380|11308710|FG003|STARTED|Part 1, Period 2 (3 Days)||0
10178516|NCT03136380|11308711|FG004|STARTED|Part 1, Period 2 (3 Days)||0
10178517|NCT03136380|11308707|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6
10178518|NCT03136380|11308708|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6
10178519|NCT03136380|11308709|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6
10178520|NCT03136380|11308710|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0
10178521|NCT03136380|11308711|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0
10178522|NCT03136380|11308707|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10178523|NCT03136380|11308708|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10178524|NCT03136380|11308709|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10178525|NCT03136380|11308710|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10178526|NCT03136380|11308711|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10178527|NCT03136380|11308707|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6
10178528|NCT03136380|11308708|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6
10178529|NCT03136380|11308709|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6
10178530|NCT03136380|11308710|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0
10178531|NCT03136380|11308711|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0
10178532|NCT03136380|11308707|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
10178533|NCT03136380|11308708|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
10178534|NCT03136380|11308709|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
10178535|NCT03136380|11308710|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10178536|NCT03136380|11308711|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10178537|NCT03136380|11308707|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10178538|NCT03136380|11308708|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
10178539|NCT03136380|11308709|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10178540|NCT03136380|11308710|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10178541|NCT03136380|11308711|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10178542|NCT03136380|11308707|FG000|STARTED|Part 1, Period 3 (4 Days)||6
10178543|NCT03136380|11308708|FG001|STARTED|Part 1, Period 3 (4 Days)||5
10178544|NCT03136380|11308709|FG002|STARTED|Part 1, Period 3 (4 Days)||6
10178545|NCT03136380|11308710|FG003|STARTED|Part 1, Period 3 (4 Days)||0
10178546|NCT03136380|11308711|FG004|STARTED|Part 1, Period 3 (4 Days)||0
10178547|NCT03136380|11308707|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6
10178548|NCT03136380|11308708|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5
10178549|NCT03136380|11308709|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6
10178550|NCT03136380|11308710|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0
10178551|NCT03136380|11308711|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0
10178552|NCT03136380|11308707|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10178553|NCT03136380|11308708|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10178554|NCT03136380|11308709|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10178555|NCT03136380|11308710|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10178556|NCT03136380|11308711|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10178557|NCT03136380|11308707|FG000|STARTED|Part 2, Period 1 (3 Days)||0
10178558|NCT03136380|11308708|FG001|STARTED|Part 2, Period 1 (3 Days)||0
10178559|NCT03136380|11308709|FG002|STARTED|Part 2, Period 1 (3 Days)||0
10178560|NCT03136380|11308710|FG003|STARTED|Part 2, Period 1 (3 Days)||8
10178561|NCT03136380|11308711|FG004|STARTED|Part 2, Period 1 (3 Days)||8
10178562|NCT03136380|11308707|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
10178563|NCT03136380|11308708|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
10178564|NCT03136380|11308709|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
10178565|NCT03136380|11308710|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8
10178566|NCT03136380|11308711|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8
10178567|NCT03136380|11308707|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10178568|NCT03136380|11308708|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10178569|NCT03136380|11308709|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10178570|NCT03136380|11308710|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10178571|NCT03136380|11308711|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10178572|NCT03136380|11308707|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
10178573|NCT03136380|11308708|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
10178574|NCT03136380|11308709|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
10178575|NCT03136380|11308710|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8
10178576|NCT03136380|11308711|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8
10178577|NCT03136380|11308707|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178578|NCT03136380|11308708|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178579|NCT03136380|11308709|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178580|NCT03136380|11308710|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
10178581|NCT03136380|11308711|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
10178582|NCT03136380|11308707|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178583|NCT03136380|11308708|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178584|NCT03136380|11308709|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178585|NCT03136380|11308710|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178586|NCT03136380|11308711|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10178587|NCT03136380|11308707|FG000|STARTED|Part 2, Period 2 (3 Days)||0
10178588|NCT03136380|11308708|FG001|STARTED|Part 2, Period 2 (3 Days)||0
10178589|NCT03136380|11308709|FG002|STARTED|Part 2, Period 2 (3 Days)||0
10178590|NCT03136380|11308710|FG003|STARTED|Part 2, Period 2 (3 Days)||8
10178591|NCT03136380|11308711|FG004|STARTED|Part 2, Period 2 (3 Days)||8
10178592|NCT03136380|11308707|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
10178593|NCT03136380|11308708|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
10178594|NCT03136380|11308709|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
10178595|NCT03136380|11308710|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8
10178596|NCT03136380|11308711|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8
10178597|NCT03136380|11308707|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10178598|NCT03136380|11308708|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10178599|NCT03136380|11308709|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10178600|NCT03136380|11308710|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10178601|NCT03136380|11308711|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10178602|NCT03136484|11308731|FG000|STARTED|Overall Study||394
10178603|NCT03136484|11308732|FG001|STARTED|Overall Study||394
10178604|NCT03136484|11308731|FG000|Exposed|Overall Study||392
10178605|NCT03136484|11308732|FG001|Exposed|Overall Study||394
10178606|NCT03136484|11308731|FG000|COMPLETED|Overall Study||367
10178607|NCT03136484|11308732|FG001|COMPLETED|Overall Study||372
10178608|NCT03136484|11308731|FG000|NOT COMPLETED|Overall Study||27
10178609|NCT03136484|11308732|FG001|NOT COMPLETED|Overall Study||22
10178610|NCT03136861|11308745|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
10178611|NCT03136861|11308746|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
10178612|NCT03136861|11308747|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178613|NCT03136861|11308748|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178614|NCT03136861|11308749|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178615|NCT03136861|11308750|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178616|NCT03136861|11308751|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178617|NCT03136861|11308745|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
10178618|NCT03136861|11308746|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
10178619|NCT03136861|11308747|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178620|NCT03136861|11308748|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178621|NCT03136861|11308749|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178622|NCT03136861|11308750|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178623|NCT03136861|11308751|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178624|NCT03136861|11308745|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
10178625|NCT03136861|11308746|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
10178626|NCT03136861|11308747|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178627|NCT03136861|11308748|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9713855|NCT00001586|10813171|FG001|COMPLETED|Overall Study||56
9713856|NCT00001586|10813170|FG000|NOT COMPLETED|Overall Study||0
9713857|NCT00001586|10813171|FG001|NOT COMPLETED|Overall Study||0
9713858|NCT00001596|10813179|FG000|STARTED|Overall Study||23
9713859|NCT00001596|10813180|FG001|STARTED|Overall Study||12
9713860|NCT00001596|10813179|FG000|COMPLETED|Overall Study||6
9713861|NCT00001596|10813180|FG001|COMPLETED|Overall Study||2
9713862|NCT00001596|10813179|FG000|NOT COMPLETED|Overall Study||17
9713863|NCT00001596|10813180|FG001|NOT COMPLETED|Overall Study||10
9713864|NCT00001656|10813188|FG000|STARTED|Overall Study||13
9713865|NCT00001656|10813189|FG001|STARTED|Overall Study||12
9713866|NCT00001656|10813188|FG000|COMPLETED|Overall Study||12
9713867|NCT00001656|10813189|FG001|COMPLETED|Overall Study||12
9713868|NCT00001656|10813188|FG000|NOT COMPLETED|Overall Study||1
9713869|NCT00001656|10813189|FG001|NOT COMPLETED|Overall Study||0
9713870|NCT00001703|10813195|FG000|STARTED|Overall Study||6
9713871|NCT00001703|10813195|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
9713872|NCT00001703|10813195|FG000|COMPLETED|Overall Study||1
9713873|NCT00001703|10813195|FG000|NOT COMPLETED|Overall Study||5
9713874|NCT00001723|10813201|FG000|STARTED|Overall Study||100
9713875|NCT00001723|10813202|FG001|STARTED|Overall Study||100
9713876|NCT00001723|10813201|FG000|COMPLETED|Overall Study||87
9713877|NCT00001723|10813202|FG001|COMPLETED|Overall Study||84
9713878|NCT00001723|10813201|FG000|NOT COMPLETED|Overall Study||13
9713879|NCT00001723|10813202|FG001|NOT COMPLETED|Overall Study||16
9713880|NCT00001832|10813226|FG000|STARTED|Apheresis Period||170
9713881|NCT00001832|10813227|FG001|STARTED|Apheresis Period||0
9713882|NCT00001832|10813228|FG002|STARTED|Apheresis Period||0
9713883|NCT00001832|10813229|FG003|STARTED|Apheresis Period||0
9713884|NCT00001832|10813230|FG004|STARTED|Apheresis Period||0
9713885|NCT00001832|10813231|FG005|STARTED|Apheresis Period||0
9713886|NCT00001832|10813232|FG006|STARTED|Apheresis Period||0
9713887|NCT00001832|10813233|FG007|STARTED|Apheresis Period||0
9713888|NCT00001832|10813234|FG008|STARTED|Apheresis Period||0
9713889|NCT00001832|10813235|FG009|STARTED|Apheresis Period||0
9713890|NCT00001832|10813236|FG010|STARTED|Apheresis Period||0
9713891|NCT00001832|10813237|FG011|STARTED|Apheresis Period||0
9713892|NCT00001832|10813238|FG012|STARTED|Apheresis Period||0
9713893|NCT00001832|10813239|FG013|STARTED|Apheresis Period||0
9713894|NCT00001832|10813240|FG014|STARTED|Apheresis Period||0
9713895|NCT00001832|10813226|FG000|COMPLETED|Apheresis Period||110
9713896|NCT00001832|10813227|FG001|COMPLETED|Apheresis Period||0
9713897|NCT00001832|10813228|FG002|COMPLETED|Apheresis Period||0
9713898|NCT00001832|10813229|FG003|COMPLETED|Apheresis Period||0
9713899|NCT00001832|10813230|FG004|COMPLETED|Apheresis Period||0
9713900|NCT00001832|10813231|FG005|COMPLETED|Apheresis Period||0
9713901|NCT00001832|10813232|FG006|COMPLETED|Apheresis Period||0
9713902|NCT00001832|10813233|FG007|COMPLETED|Apheresis Period||0
9713903|NCT00001832|10813234|FG008|COMPLETED|Apheresis Period||0
9713904|NCT00001832|10813235|FG009|COMPLETED|Apheresis Period||0
9713905|NCT00001832|10813236|FG010|COMPLETED|Apheresis Period||0
9713906|NCT00001832|10813237|FG011|COMPLETED|Apheresis Period||0
9713907|NCT00001832|10813238|FG012|COMPLETED|Apheresis Period||0
9713908|NCT00001832|10813239|FG013|COMPLETED|Apheresis Period||0
9713909|NCT00001832|10813240|FG014|COMPLETED|Apheresis Period||0
9713910|NCT00001832|10813226|FG000|NOT COMPLETED|Apheresis Period||60
9713911|NCT00001832|10813227|FG001|NOT COMPLETED|Apheresis Period||0
9713912|NCT00001832|10813228|FG002|NOT COMPLETED|Apheresis Period||0
9713913|NCT00001832|10813229|FG003|NOT COMPLETED|Apheresis Period||0
9713914|NCT00001832|10813230|FG004|NOT COMPLETED|Apheresis Period||0
9713915|NCT00001832|10813231|FG005|NOT COMPLETED|Apheresis Period||0
9713916|NCT00001832|10813232|FG006|NOT COMPLETED|Apheresis Period||0
9713917|NCT00001832|10813233|FG007|NOT COMPLETED|Apheresis Period||0
9713918|NCT00001832|10813234|FG008|NOT COMPLETED|Apheresis Period||0
9713919|NCT00001832|10813235|FG009|NOT COMPLETED|Apheresis Period||0
9849715|NCT00867035|10962492|FG000|COMPLETED|Baseline to 1 Week||11
9849716|NCT00867035|10962493|FG001|COMPLETED|Baseline to 1 Week||8
9713920|NCT00001832|10813236|FG010|NOT COMPLETED|Apheresis Period||0
9713921|NCT00001832|10813237|FG011|NOT COMPLETED|Apheresis Period||0
9713922|NCT00001832|10813238|FG012|NOT COMPLETED|Apheresis Period||0
9713923|NCT00001832|10813239|FG013|NOT COMPLETED|Apheresis Period||0
9713924|NCT00001832|10813240|FG014|NOT COMPLETED|Apheresis Period||0
9713925|NCT00001832|10813226|FG000|STARTED|Treatment Period||0
10178628|NCT03136861|11308749|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178629|NCT03136861|11308750|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178630|NCT03136861|11308751|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10178631|NCT03136861|11308745|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10178632|NCT03136861|11308746|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10178633|NCT03136861|11308747|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
10178634|NCT03136861|11308748|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
10178635|NCT03136861|11308749|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
10178636|NCT03136861|11308750|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
10178637|NCT03136861|11308751|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
10178638|NCT03136861|11308745|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10178639|NCT03136861|11308746|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10178640|NCT03136861|11308747|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
10178641|NCT03136861|11308748|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
10178642|NCT03136861|11308749|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
10178643|NCT03136861|11308750|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
10178644|NCT03136861|11308751|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
10178645|NCT03136861|11308745|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10178646|NCT03136861|11308746|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10178647|NCT03136861|11308747|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
10178648|NCT03136861|11308748|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
10178649|NCT03136861|11308749|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
10178650|NCT03136861|11308750|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10178651|NCT03136861|11308751|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
10178652|NCT03136913|11308762|FG000|STARTED|Overall Study||13
10178653|NCT03136913|11308762|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
10178654|NCT03136913|11308762|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
10178655|NCT03136913|11308762|FG000|NOT COMPLETED|Overall Study||5
10178656|NCT03137069|11308775|FG000|STARTED|Overall Study||13
10178657|NCT03137069|11308776|FG001|STARTED|Overall Study||28
10178658|NCT03137069|11308777|FG002|STARTED|Overall Study||23
10178659|NCT03137069|11308778|FG003|STARTED|Overall Study||23
10178660|NCT03137069|11308779|FG004|STARTED|Overall Study||24
10178661|NCT03137069|11308780|FG005|STARTED|Overall Study||23
10178662|NCT03137069|11308775|FG000|COMPLETED|Overall Study||12
10178663|NCT03137069|11308776|FG001|COMPLETED|Overall Study||22
10178664|NCT03137069|11308777|FG002|COMPLETED|Overall Study||20
10178665|NCT03137069|11308778|FG003|COMPLETED|Overall Study||17
10178666|NCT03137069|11308779|FG004|COMPLETED|Overall Study||22
10178667|NCT03137069|11308780|FG005|COMPLETED|Overall Study||21
10178668|NCT03137069|11308775|FG000|NOT COMPLETED|Overall Study||1
10178669|NCT03137069|11308776|FG001|NOT COMPLETED|Overall Study||6
10178670|NCT03137069|11308777|FG002|NOT COMPLETED|Overall Study||3
10178671|NCT03137069|11308778|FG003|NOT COMPLETED|Overall Study||6
10178672|NCT03137069|11308779|FG004|NOT COMPLETED|Overall Study||2
10178673|NCT03137069|11308780|FG005|NOT COMPLETED|Overall Study||2
10178674|NCT03137121|11308800|FG000|STARTED|Overall Study||15
10178675|NCT03137121|11308801|FG001|STARTED|Overall Study||15
10178676|NCT03137121|11308800|FG000|COMPLETED|Overall Study||15
10178677|NCT03137121|11308801|FG001|COMPLETED|Overall Study||14
10178678|NCT03137121|11308800|FG000|NOT COMPLETED|Overall Study||0
10178679|NCT03137121|11308801|FG001|NOT COMPLETED|Overall Study||1
10178680|NCT03137303|11308809|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231
10178681|NCT03137303|11308810|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171
10178682|NCT03137303|11308809|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
10178683|NCT03137303|11308810|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
10178684|NCT03137303|11308809|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
10178685|NCT03137303|11308810|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
10178686|NCT03137303|11308809|FG000|STARTED|T1: 3-month Follow-up||231
10178687|NCT03137303|11308810|FG001|STARTED|T1: 3-month Follow-up||171
10178688|NCT03137303|11308809|FG000|COMPLETED|T1: 3-month Follow-up||225
10178689|NCT03137303|11308810|FG001|COMPLETED|T1: 3-month Follow-up||161
10178690|NCT03137303|11308809|FG000|NOT COMPLETED|T1: 3-month Follow-up||6
10178691|NCT03137303|11308810|FG001|NOT COMPLETED|T1: 3-month Follow-up||10
10178692|NCT03137303|11308809|FG000|STARTED|T2: 6-month Follow-up||230
10178693|NCT03137303|11308810|FG001|STARTED|T2: 6-month Follow-up||167
10178694|NCT03137303|11308809|FG000|COMPLETED|T2: 6-month Follow-up||225
10178695|NCT03137303|11308810|FG001|COMPLETED|T2: 6-month Follow-up||162
10178696|NCT03137303|11308809|FG000|NOT COMPLETED|T2: 6-month Follow-up||5
10178697|NCT03137303|11308810|FG001|NOT COMPLETED|T2: 6-month Follow-up||5
10178698|NCT03137303|11308809|FG000|STARTED|T3: 9-month Follow-up||230
10178699|NCT03137303|11308810|FG001|STARTED|T3: 9-month Follow-up||167
10178700|NCT03137303|11308809|FG000|COMPLETED|T3: 9-month Follow-up||225
10178701|NCT03137303|11308810|FG001|COMPLETED|T3: 9-month Follow-up||163
10178702|NCT03137303|11308809|FG000|NOT COMPLETED|T3: 9-month Follow-up||5
10178703|NCT03137303|11308810|FG001|NOT COMPLETED|T3: 9-month Follow-up||4
10178704|NCT03137303|11308809|FG000|STARTED|T4: 12-month Follow-up||229
10178705|NCT03137303|11308810|FG001|STARTED|T4: 12-month Follow-up||167
10178706|NCT03137303|11308809|FG000|COMPLETED|T4: 12-month Follow-up||222
9713926|NCT00001832|10813227|FG001|STARTED|Treatment Period||3
9713927|NCT00001832|10813228|FG002|STARTED|Treatment Period||3
10178707|NCT03137303|11308810|FG001|COMPLETED|T4: 12-month Follow-up||162
10178708|NCT03137303|11308809|FG000|NOT COMPLETED|T4: 12-month Follow-up||7
10178709|NCT03137303|11308810|FG001|NOT COMPLETED|T4: 12-month Follow-up||5
10178710|NCT03137459|11308818|FG000|STARTED|2-month Assessment||455
10178711|NCT03137459|11308819|FG001|STARTED|2-month Assessment||454
10178712|NCT03137459|11308818|FG000|COMPLETED|2-month Assessment||387
10178713|NCT03137459|11308819|FG001|COMPLETED|2-month Assessment||412
10178714|NCT03137459|11308818|FG000|NOT COMPLETED|2-month Assessment||68
10178715|NCT03137459|11308819|FG001|NOT COMPLETED|2-month Assessment||42
10178716|NCT03137459|11308818|FG000|STARTED|4-month Assessment||442
10178717|NCT03137459|11308819|FG001|STARTED|4-month Assessment||451
10178718|NCT03137459|11308818|FG000|COMPLETED|4-month Assessment||364
10178719|NCT03137459|11308819|FG001|COMPLETED|4-month Assessment||405
10178720|NCT03137459|11308818|FG000|NOT COMPLETED|4-month Assessment||78
10178721|NCT03137459|11308819|FG001|NOT COMPLETED|4-month Assessment||46
10178722|NCT03137459|11308818|FG000|STARTED|6-months||434
10178723|NCT03137459|11308819|FG001|STARTED|6-months||447
10178724|NCT03137459|11308818|FG000|COMPLETED|6-months||413
10178725|NCT03137459|11308819|FG001|COMPLETED|6-months||430
10178726|NCT03137459|11308818|FG000|NOT COMPLETED|6-months||21
10178727|NCT03137459|11308819|FG001|NOT COMPLETED|6-months||17
10178728|NCT03137784|11308826|FG000|STARTED|Overall Study||24
10178729|NCT03137784|11308827|FG001|STARTED|Overall Study||25
10178730|NCT03137784|11308828|FG002|STARTED|Overall Study||25
10178731|NCT03137784|11308829|FG003|STARTED|Overall Study||24
10178732|NCT03137784|11308830|FG004|STARTED|Overall Study||25
10178733|NCT03137784|11308831|FG005|STARTED|Overall Study||25
10178734|NCT03137784|11308826|FG000|COMPLETED|Overall Study||22
10178735|NCT03137784|11308827|FG001|COMPLETED|Overall Study||24
10178736|NCT03137784|11308828|FG002|COMPLETED|Overall Study||25
10178737|NCT03137784|11308829|FG003|COMPLETED|Overall Study||24
10178738|NCT03137784|11308830|FG004|COMPLETED|Overall Study||24
10178739|NCT03137784|11308831|FG005|COMPLETED|Overall Study||25
10178740|NCT03137784|11308826|FG000|NOT COMPLETED|Overall Study||2
10178741|NCT03137784|11308827|FG001|NOT COMPLETED|Overall Study||1
10178742|NCT03137784|11308828|FG002|NOT COMPLETED|Overall Study||0
10178743|NCT03137784|11308829|FG003|NOT COMPLETED|Overall Study||0
10178744|NCT03137784|11308830|FG004|NOT COMPLETED|Overall Study||1
10178745|NCT03137784|11308831|FG005|NOT COMPLETED|Overall Study||0
10178746|NCT03137992|11308839|FG000|STARTED|Period 1 (Visit 2)||62
10178747|NCT03137992|11308840|FG001|STARTED|Period 1 (Visit 2)||63
10178748|NCT03137992|11308841|FG002|STARTED|Period 1 (Visit 2)||63
10178749|NCT03137992|11308842|FG003|STARTED|Period 1 (Visit 2)||63
10178750|NCT03137992|11308843|FG004|STARTED|Period 1 (Visit 2)||62
10178751|NCT03137992|11308844|FG005|STARTED|Period 1 (Visit 2)||61
10178752|NCT03137992|11308839|FG000|COMPLETED|Period 1 (Visit 2)||62
10178753|NCT03137992|11308840|FG001|COMPLETED|Period 1 (Visit 2)||63
10178754|NCT03137992|11308841|FG002|COMPLETED|Period 1 (Visit 2)||63
9713928|NCT00001832|10813229|FG003|STARTED|Treatment Period||3
9713929|NCT00001832|10813230|FG004|STARTED|Treatment Period||6
9713930|NCT00001832|10813231|FG005|STARTED|Treatment Period||51
9713931|NCT00001832|10813232|FG006|STARTED|Treatment Period||4
9713932|NCT00001832|10813233|FG007|STARTED|Treatment Period||7
9713933|NCT00001832|10813234|FG008|STARTED|Treatment Period||8
9713934|NCT00001832|10813235|FG009|STARTED|Treatment Period||6
9713935|NCT00001832|10813236|FG010|STARTED|Treatment Period||1
9713936|NCT00001832|10813237|FG011|STARTED|Treatment Period||7
9713937|NCT00001832|10813238|FG012|STARTED|Treatment Period||6
9713938|NCT00001832|10813239|FG013|STARTED|Treatment Period||3
9713939|NCT00001832|10813240|FG014|STARTED|Treatment Period||2
9713940|NCT00001832|10813226|FG000|COMPLETED|Treatment Period||0
9713941|NCT00001832|10813227|FG001|COMPLETED|Treatment Period||3
9713942|NCT00001832|10813228|FG002|COMPLETED|Treatment Period||3
9713943|NCT00001832|10813229|FG003|COMPLETED|Treatment Period||3
9849717|NCT00867035|10962492|FG000|NOT COMPLETED|Baseline to 1 Week||1
9849718|NCT00867035|10962493|FG001|NOT COMPLETED|Baseline to 1 Week||0
9849719|NCT00867087|10962499|FG000|STARTED|Overall Study||63
9849720|NCT00867087|10962499|FG000|COMPLETED|Overall Study||21
9849721|NCT00867087|10962499|FG000|NOT COMPLETED|Overall Study||42
9849722|NCT00867100|10962516|FG000|STARTED|Overall Study||5
9849723|NCT00867100|10962517|FG001|STARTED|Overall Study||5
9849724|NCT00867100|10962518|FG002|STARTED|Overall Study||8
9849725|NCT00867100|10962519|FG003|STARTED|Overall Study||8
10178755|NCT03137992|11308842|FG003|COMPLETED|Period 1 (Visit 2)||63
10178756|NCT03137992|11308843|FG004|COMPLETED|Period 1 (Visit 2)||62
10178757|NCT03137992|11308844|FG005|COMPLETED|Period 1 (Visit 2)||61
10178758|NCT03137992|11308839|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
10178759|NCT03137992|11308840|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
10178760|NCT03137992|11308841|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
10178761|NCT03137992|11308842|FG003|NOT COMPLETED|Period 1 (Visit 2)||0
10178762|NCT03137992|11308843|FG004|NOT COMPLETED|Period 1 (Visit 2)||0
10178763|NCT03137992|11308844|FG005|NOT COMPLETED|Period 1 (Visit 2)||0
10178764|NCT03137992|11308839|FG000|STARTED|Washout Period 1||62
10178765|NCT03137992|11308840|FG001|STARTED|Washout Period 1||63
10178766|NCT03137992|11308841|FG002|STARTED|Washout Period 1||63
10178767|NCT03137992|11308842|FG003|STARTED|Washout Period 1||63
10178768|NCT03137992|11308843|FG004|STARTED|Washout Period 1||62
10178769|NCT03137992|11308844|FG005|STARTED|Washout Period 1||61
10178770|NCT03137992|11308839|FG000|COMPLETED|Washout Period 1||59
10178771|NCT03137992|11308840|FG001|COMPLETED|Washout Period 1||59
10178772|NCT03137992|11308841|FG002|COMPLETED|Washout Period 1||61
9849726|NCT00867100|10962520|FG004|STARTED|Overall Study||14
10178773|NCT03137992|11308842|FG003|COMPLETED|Washout Period 1||63
10178774|NCT03137992|11308843|FG004|COMPLETED|Washout Period 1||60
10178775|NCT03137992|11308844|FG005|COMPLETED|Washout Period 1||59
9713944|NCT00001832|10813230|FG004|COMPLETED|Treatment Period||6
9713945|NCT00001832|10813231|FG005|COMPLETED|Treatment Period||50
9713946|NCT00001832|10813232|FG006|COMPLETED|Treatment Period||4
9713947|NCT00001832|10813233|FG007|COMPLETED|Treatment Period||6
9713948|NCT00001832|10813234|FG008|COMPLETED|Treatment Period||8
9713949|NCT00001832|10813235|FG009|COMPLETED|Treatment Period||6
9713950|NCT00001832|10813236|FG010|COMPLETED|Treatment Period||1
9713951|NCT00001832|10813237|FG011|COMPLETED|Treatment Period||7
9713952|NCT00001832|10813238|FG012|COMPLETED|Treatment Period||6
9713953|NCT00001832|10813239|FG013|COMPLETED|Treatment Period||3
9713954|NCT00001832|10813240|FG014|COMPLETED|Treatment Period||2
9713955|NCT00001832|10813226|FG000|NOT COMPLETED|Treatment Period||0
9713956|NCT00001832|10813227|FG001|NOT COMPLETED|Treatment Period||0
9713957|NCT00001832|10813228|FG002|NOT COMPLETED|Treatment Period||0
9713958|NCT00001832|10813229|FG003|NOT COMPLETED|Treatment Period||0
9713959|NCT00001832|10813230|FG004|NOT COMPLETED|Treatment Period||0
9713960|NCT00001832|10813231|FG005|NOT COMPLETED|Treatment Period||1
9713961|NCT00001832|10813232|FG006|NOT COMPLETED|Treatment Period||0
9713962|NCT00001832|10813233|FG007|NOT COMPLETED|Treatment Period||1
9713963|NCT00001832|10813234|FG008|NOT COMPLETED|Treatment Period||0
9713964|NCT00001832|10813235|FG009|NOT COMPLETED|Treatment Period||0
9713965|NCT00001832|10813236|FG010|NOT COMPLETED|Treatment Period||0
9713966|NCT00001832|10813237|FG011|NOT COMPLETED|Treatment Period||0
9713967|NCT00001832|10813238|FG012|NOT COMPLETED|Treatment Period||0
9713968|NCT00001832|10813239|FG013|NOT COMPLETED|Treatment Period||0
9713969|NCT00001832|10813240|FG014|NOT COMPLETED|Treatment Period||0
9713970|NCT00001849|10813270|FG000|STARTED|Overall Study||68
9713971|NCT00001849|10813270|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
9713972|NCT00001849|10813270|FG000|NOT COMPLETED|Overall Study||14
9713973|NCT00001880|10813283|FG000|STARTED|Overall Study||42
9713974|NCT00001880|10813283|FG000|COMPLETED|Overall Study||28
9713975|NCT00001880|10813283|FG000|NOT COMPLETED|Overall Study||14
9713976|NCT00001941|10813287|FG000|STARTED|Overall Study||3
9713977|NCT00001941|10813288|FG001|STARTED|Overall Study||5
9713978|NCT00001941|10813289|FG002|STARTED|Overall Study||3
9713979|NCT00001941|10813290|FG003|STARTED|Overall Study||3
9713980|NCT00001941|10813291|FG004|STARTED|Overall Study||20
9713981|NCT00001941|10813287|FG000|COMPLETED|Overall Study||3
9713982|NCT00001941|10813288|FG001|COMPLETED|Overall Study||5
9713983|NCT00001941|10813289|FG002|COMPLETED|Overall Study||3
9713984|NCT00001941|10813290|FG003|COMPLETED|Overall Study||3
9713985|NCT00001941|10813291|FG004|COMPLETED|Overall Study||19
9713986|NCT00001941|10813287|FG000|NOT COMPLETED|Overall Study||0
9713987|NCT00001941|10813288|FG001|NOT COMPLETED|Overall Study||0
9713988|NCT00001941|10813289|FG002|NOT COMPLETED|Overall Study||0
9713989|NCT00001941|10813290|FG003|NOT COMPLETED|Overall Study||0
9713990|NCT00001941|10813291|FG004|NOT COMPLETED|Overall Study||1
9713991|NCT00001959|10813296|FG000|STARTED|Overall Study||21
9713992|NCT00001959|10813296|FG000|COMPLETED|Overall Study||18
9713993|NCT00001959|10813296|FG000|NOT COMPLETED|Overall Study||3
9713994|NCT00001962|10813300|FG000|STARTED|Overall Study||100
9713995|NCT00001962|10813300|FG000|COMPLETED|Overall Study||72
9713996|NCT00001962|10813300|FG000|NOT COMPLETED|Overall Study||28
9713997|NCT00001984|10813304|FG000|STARTED|Overall Study||5
9713998|NCT00001984|10813304|FG000|COMPLETED|Overall Study||5
9713999|NCT00001984|10813304|FG000|NOT COMPLETED|Overall Study||0
9714000|NCT00002525|10813310|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
9714001|NCT00002525|10813311|FG001|STARTED|Overall Study||428
9714002|NCT00002525|10813310|FG000|Treated|Overall Study||419
9714003|NCT00002525|10813311|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
9714004|NCT00002525|10813310|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
9714005|NCT00002525|10813311|FG001|Dukes' B3 or C Stage|Overall Study||158
9714006|NCT00002525|10813310|FG000|Dukes' B2 Stage|Overall Study||150
9714007|NCT00002525|10813311|FG001|Dukes' B2 Stage|Overall Study||139
9714008|NCT00002525|10813310|FG000|COMPLETED|Overall Study||241
9714009|NCT00002525|10813311|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
9714010|NCT00002525|10813310|FG000|NOT COMPLETED|Overall Study||186
9714011|NCT00002525|10813311|FG001|NOT COMPLETED|Overall Study||0
9714018|NCT00002558|10813330|FG000|STARTED|Overall Study||92
9714019|NCT00002558|10813331|FG001|STARTED|Overall Study||16
9714020|NCT00002558|10813330|FG000|COMPLETED|Overall Study||92
9714021|NCT00002558|10813331|FG001|COMPLETED|Overall Study||15
9714022|NCT00002558|10813330|FG000|NOT COMPLETED|Overall Study||0
9714023|NCT00002558|10813331|FG001|NOT COMPLETED|Overall Study||1
10178776|NCT03137992|11308839|FG000|NOT COMPLETED|Washout Period 1||3
10178777|NCT03137992|11308840|FG001|NOT COMPLETED|Washout Period 1||4
10178778|NCT03137992|11308841|FG002|NOT COMPLETED|Washout Period 1||2
10178779|NCT03137992|11308842|FG003|NOT COMPLETED|Washout Period 1||0
10178780|NCT03137992|11308843|FG004|NOT COMPLETED|Washout Period 1||2
10178781|NCT03137992|11308844|FG005|NOT COMPLETED|Washout Period 1||2
10178782|NCT03137992|11308839|FG000|STARTED|Period 2 (Visit 3)||59
10178783|NCT03137992|11308840|FG001|STARTED|Period 2 (Visit 3)||59
10178784|NCT03137992|11308841|FG002|STARTED|Period 2 (Visit 3)||61
10178785|NCT03137992|11308842|FG003|STARTED|Period 2 (Visit 3)||63
10178786|NCT03137992|11308843|FG004|STARTED|Period 2 (Visit 3)||60
10178787|NCT03137992|11308844|FG005|STARTED|Period 2 (Visit 3)||59
10178788|NCT03137992|11308839|FG000|COMPLETED|Period 2 (Visit 3)||56
10178789|NCT03137992|11308840|FG001|COMPLETED|Period 2 (Visit 3)||52
10178790|NCT03137992|11308841|FG002|COMPLETED|Period 2 (Visit 3)||58
10178791|NCT03137992|11308842|FG003|COMPLETED|Period 2 (Visit 3)||58
10178792|NCT03137992|11308843|FG004|COMPLETED|Period 2 (Visit 3)||56
10178793|NCT03137992|11308844|FG005|COMPLETED|Period 2 (Visit 3)||51
10178794|NCT03137992|11308839|FG000|NOT COMPLETED|Period 2 (Visit 3)||3
10178795|NCT03137992|11308840|FG001|NOT COMPLETED|Period 2 (Visit 3)||7
10178796|NCT03137992|11308841|FG002|NOT COMPLETED|Period 2 (Visit 3)||3
10178797|NCT03137992|11308842|FG003|NOT COMPLETED|Period 2 (Visit 3)||5
10178798|NCT03137992|11308843|FG004|NOT COMPLETED|Period 2 (Visit 3)||4
10178799|NCT03137992|11308844|FG005|NOT COMPLETED|Period 2 (Visit 3)||8
10178800|NCT03137992|11308839|FG000|STARTED|Washout Period 2||56
10178801|NCT03137992|11308840|FG001|STARTED|Washout Period 2||52
10178802|NCT03137992|11308841|FG002|STARTED|Washout Period 2||58
10178803|NCT03137992|11308842|FG003|STARTED|Washout Period 2||58
10178804|NCT03137992|11308843|FG004|STARTED|Washout Period 2||56
10178805|NCT03137992|11308844|FG005|STARTED|Washout Period 2||51
10178806|NCT03137992|11308839|FG000|COMPLETED|Washout Period 2||54
10178807|NCT03137992|11308840|FG001|COMPLETED|Washout Period 2||50
10178808|NCT03137992|11308841|FG002|COMPLETED|Washout Period 2||58
10178809|NCT03137992|11308842|FG003|COMPLETED|Washout Period 2||57
10178810|NCT03137992|11308843|FG004|COMPLETED|Washout Period 2||53
10178811|NCT03137992|11308844|FG005|COMPLETED|Washout Period 2||50
10178812|NCT03137992|11308839|FG000|NOT COMPLETED|Washout Period 2||2
10178813|NCT03137992|11308840|FG001|NOT COMPLETED|Washout Period 2||2
10178814|NCT03137992|11308841|FG002|NOT COMPLETED|Washout Period 2||0
10178815|NCT03137992|11308842|FG003|NOT COMPLETED|Washout Period 2||1
10178816|NCT03137992|11308843|FG004|NOT COMPLETED|Washout Period 2||3
10178817|NCT03137992|11308844|FG005|NOT COMPLETED|Washout Period 2||1
10178818|NCT03137992|11308839|FG000|STARTED|Period 3 (Visit 04)||54
10178819|NCT03137992|11308840|FG001|STARTED|Period 3 (Visit 04)||50
10178820|NCT03137992|11308841|FG002|STARTED|Period 3 (Visit 04)||58
10178821|NCT03137992|11308842|FG003|STARTED|Period 3 (Visit 04)||57
10178822|NCT03137992|11308843|FG004|STARTED|Period 3 (Visit 04)||53
10178823|NCT03137992|11308844|FG005|STARTED|Period 3 (Visit 04)||50
10178824|NCT03137992|11308839|FG000|COMPLETED|Period 3 (Visit 04)||48
10178825|NCT03137992|11308840|FG001|COMPLETED|Period 3 (Visit 04)||48
10178826|NCT03137992|11308841|FG002|COMPLETED|Period 3 (Visit 04)||55
10178827|NCT03137992|11308842|FG003|COMPLETED|Period 3 (Visit 04)||57
10178828|NCT03137992|11308843|FG004|COMPLETED|Period 3 (Visit 04)||50
10178829|NCT03137992|11308844|FG005|COMPLETED|Period 3 (Visit 04)||47
10178830|NCT03137992|11308839|FG000|NOT COMPLETED|Period 3 (Visit 04)||6
10178831|NCT03137992|11308840|FG001|NOT COMPLETED|Period 3 (Visit 04)||2
10178832|NCT03137992|11308841|FG002|NOT COMPLETED|Period 3 (Visit 04)||3
10178833|NCT03137992|11308842|FG003|NOT COMPLETED|Period 3 (Visit 04)||0
10178834|NCT03137992|11308843|FG004|NOT COMPLETED|Period 3 (Visit 04)||3
10178835|NCT03137992|11308844|FG005|NOT COMPLETED|Period 3 (Visit 04)||3
10178836|NCT03137992|11308839|FG000|STARTED|Part 2 (Open-label Extension)||22
10178837|NCT03137992|11308840|FG001|STARTED|Part 2 (Open-label Extension)||17
10178838|NCT03137992|11308841|FG002|STARTED|Part 2 (Open-label Extension)||21
10178839|NCT03137992|11308842|FG003|STARTED|Part 2 (Open-label Extension)||25
10178840|NCT03137992|11308843|FG004|STARTED|Part 2 (Open-label Extension)||18
10178841|NCT03137992|11308844|FG005|STARTED|Part 2 (Open-label Extension)||22
10178842|NCT03137992|11308839|FG000|COMPLETED|Part 2 (Open-label Extension)||20
10178843|NCT03137992|11308840|FG001|COMPLETED|Part 2 (Open-label Extension)||17
10178844|NCT03137992|11308841|FG002|COMPLETED|Part 2 (Open-label Extension)||20
10178845|NCT03137992|11308842|FG003|COMPLETED|Part 2 (Open-label Extension)||24
10178846|NCT03137992|11308843|FG004|COMPLETED|Part 2 (Open-label Extension)||18
10178847|NCT03137992|11308844|FG005|COMPLETED|Part 2 (Open-label Extension)||21
10178848|NCT03137992|11308839|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2
10178849|NCT03137992|11308840|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0
10178850|NCT03137992|11308841|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1
10178851|NCT03137992|11308842|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1
10178852|NCT03137992|11308843|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0
10178853|NCT03137992|11308844|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1
10178854|NCT03138330|11308852|FG000|STARTED|Overall Study||95
10178855|NCT03138330|11308852|FG000|COMPLETED|Overall Study||91
10178856|NCT03138330|11308852|FG000|NOT COMPLETED|Overall Study||4
10178857|NCT03138382|11308858|FG000|STARTED|Overall Study||10
10178858|NCT03138382|11308859|FG001|STARTED|Overall Study||10
10178859|NCT03138382|11308858|FG000|COMPLETED|Overall Study||10
10178860|NCT03138382|11308859|FG001|COMPLETED|Overall Study||10
10178861|NCT03138382|11308858|FG000|NOT COMPLETED|Overall Study||0
10178862|NCT03138382|11308859|FG001|NOT COMPLETED|Overall Study||0
10178863|NCT03138577|11308872|FG000|STARTED|Overall Study||3
10178864|NCT03138577|11308873|FG001|STARTED|Overall Study||3
10178865|NCT03138577|11308874|FG002|STARTED|Overall Study||3
10178866|NCT03138577|11308875|FG003|STARTED|Overall Study||3
10178867|NCT03138577|11308876|FG004|STARTED|Overall Study||3
10178868|NCT03138577|11308877|FG005|STARTED|Overall Study||3
10178869|NCT03138577|11308878|FG006|STARTED|Overall Study||3
10178870|NCT03138577|11308872|FG000|COMPLETED|Overall Study||3
10178871|NCT03138577|11308873|FG001|COMPLETED|Overall Study||3
10178872|NCT03138577|11308874|FG002|COMPLETED|Overall Study||3
10178873|NCT03138577|11308875|FG003|COMPLETED|Overall Study||3
10178874|NCT03138577|11308876|FG004|COMPLETED|Overall Study||3
10178875|NCT03138577|11308877|FG005|COMPLETED|Overall Study||3
10178876|NCT03138577|11308878|FG006|COMPLETED|Overall Study||3
10178877|NCT03138577|11308872|FG000|NOT COMPLETED|Overall Study||0
10178878|NCT03138577|11308873|FG001|NOT COMPLETED|Overall Study||0
10178879|NCT03138577|11308874|FG002|NOT COMPLETED|Overall Study||0
10178880|NCT03138577|11308875|FG003|NOT COMPLETED|Overall Study||0
10178881|NCT03138577|11308876|FG004|NOT COMPLETED|Overall Study||0
10178882|NCT03138577|11308877|FG005|NOT COMPLETED|Overall Study||0
10178883|NCT03138577|11308878|FG006|NOT COMPLETED|Overall Study||0
10178884|NCT03138655|11308904|FG000|STARTED|Overall Study||10
10178885|NCT03138655|11308905|FG001|STARTED|Overall Study||9
10178886|NCT03138655|11308906|FG002|STARTED|Overall Study||11
10178887|NCT03138655|11308907|FG003|STARTED|Overall Study||10
10178888|NCT03138655|11308908|FG004|STARTED|Overall Study||13
10178889|NCT03138655|11308909|FG005|STARTED|Overall Study||12
10178890|NCT03138655|11308910|FG006|STARTED|Overall Study||12
10178891|NCT03138655|11308911|FG007|STARTED|Overall Study||12
10178892|NCT03138655|11308904|FG000|COMPLETED|Overall Study||7
10178893|NCT03138655|11308905|FG001|COMPLETED|Overall Study||7
10178894|NCT03138655|11308906|FG002|COMPLETED|Overall Study||9
10178895|NCT03138655|11308907|FG003|COMPLETED|Overall Study||7
10178896|NCT03138655|11308908|FG004|COMPLETED|Overall Study||11
10178897|NCT03138655|11308909|FG005|COMPLETED|Overall Study||7
10178898|NCT03138655|11308910|FG006|COMPLETED|Overall Study||9
10178899|NCT03138655|11308911|FG007|COMPLETED|Overall Study||10
10178900|NCT03138655|11308904|FG000|NOT COMPLETED|Overall Study||3
10178901|NCT03138655|11308905|FG001|NOT COMPLETED|Overall Study||2
10178902|NCT03138655|11308906|FG002|NOT COMPLETED|Overall Study||2
10178903|NCT03138655|11308907|FG003|NOT COMPLETED|Overall Study||3
10178904|NCT03138655|11308908|FG004|NOT COMPLETED|Overall Study||2
10178905|NCT03138655|11308909|FG005|NOT COMPLETED|Overall Study||5
10178906|NCT03138655|11308910|FG006|NOT COMPLETED|Overall Study||3
10178907|NCT03138655|11308911|FG007|NOT COMPLETED|Overall Study||2
10178908|NCT03138798|11308935|FG000|STARTED|Overall Study||173
10178909|NCT03138798|11308936|FG001|STARTED|Overall Study||175
10178910|NCT03138798|11308935|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6
10178911|NCT03138798|11308936|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4
10178912|NCT03138798|11308935|FG000|COMPLETED|Overall Study||167
10178913|NCT03138798|11308936|FG001|COMPLETED|Overall Study||171
10178914|NCT03138798|11308935|FG000|NOT COMPLETED|Overall Study||6
10178915|NCT03138798|11308936|FG001|NOT COMPLETED|Overall Study||4
10178916|NCT03138876|11308943|FG000|STARTED|Overall Study||20
10178917|NCT03138876|11308943|FG000|COMPLETED|Overall Study||20
10178918|NCT03138876|11308943|FG000|NOT COMPLETED|Overall Study||0
10178919|NCT03138967|11308949|FG000|STARTED|Overall Study||26
10178920|NCT03138967|11308950|FG001|STARTED|Overall Study||28
10178921|NCT03138967|11308949|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25
10178922|NCT03138967|11308950|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25
10178923|NCT03138967|11308949|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25
10178924|NCT03138967|11308950|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24
10178925|NCT03138967|11308949|FG000|COMPLETED|Overall Study||25
10178926|NCT03138967|11308950|FG001|COMPLETED|Overall Study||24
10178927|NCT03138967|11308949|FG000|NOT COMPLETED|Overall Study||1
10178928|NCT03138967|11308950|FG001|NOT COMPLETED|Overall Study||4
10178929|NCT03139032|11308956|FG000|STARTED|Overall Study||1
10178930|NCT03139032|11308956|FG000|COMPLETED|Overall Study||1
10178931|NCT03139032|11308956|FG000|NOT COMPLETED|Overall Study||0
10178932|NCT03139240|11308965|FG000|STARTED|Overall Study||48
10178933|NCT03139240|11308966|FG001|STARTED|Overall Study||48
10178934|NCT03139240|11308967|FG002|STARTED|Overall Study||38
10178935|NCT03139240|11308968|FG003|STARTED|Overall Study||38
10178936|NCT03139240|11308965|FG000|COMPLETED|Overall Study||48
10178937|NCT03139240|11308966|FG001|COMPLETED|Overall Study||47
10178938|NCT03139240|11308967|FG002|COMPLETED|Overall Study||37
10178939|NCT03139240|11308968|FG003|COMPLETED|Overall Study||38
10178940|NCT03139240|11308965|FG000|NOT COMPLETED|Overall Study||0
10178941|NCT03139240|11308966|FG001|NOT COMPLETED|Overall Study||1
10178942|NCT03139240|11308967|FG002|NOT COMPLETED|Overall Study||1
10178943|NCT03139240|11308968|FG003|NOT COMPLETED|Overall Study||0
10178944|NCT03139279|11308978|FG000|STARTED|Overall Study||58
10178945|NCT03139279|11308979|FG001|STARTED|Overall Study||56
10178946|NCT03139279|11308978|FG000|COMPLETED|Overall Study||51
10178947|NCT03139279|11308979|FG001|COMPLETED|Overall Study||50
10178948|NCT03139279|11308978|FG000|NOT COMPLETED|Overall Study||7
10178949|NCT03139279|11308979|FG001|NOT COMPLETED|Overall Study||6
10178950|NCT03139448|11308987|FG000|STARTED|Overall Study||85
10178951|NCT03139448|11308988|FG001|STARTED|Overall Study||89
10178952|NCT03139448|11308987|FG000|Intervention Started|Overall Study||79
10178953|NCT03139448|11308988|FG001|Intervention Started|Overall Study||70
10178954|NCT03139448|11308987|FG000|COMPLETED|Overall Study||73
10178955|NCT03139448|11308988|FG001|COMPLETED|Overall Study||63
10178956|NCT03139448|11308987|FG000|NOT COMPLETED|Overall Study||12
10178957|NCT03139448|11308988|FG001|NOT COMPLETED|Overall Study||26
10178958|NCT03139552|11308994|FG000|STARTED|Overall Study||150
10178959|NCT03139552|11308994|FG000|COMPLETED|Overall Study||147
10178960|NCT03139552|11308994|FG000|NOT COMPLETED|Overall Study||3
10178961|NCT03139578|11309005|FG000|STARTED|Period 1||12
10178962|NCT03139578|11309006|FG001|STARTED|Period 1||13
10178963|NCT03139578|11309007|FG002|STARTED|Period 1||12
10178964|NCT03139578|11309008|FG003|STARTED|Period 1||13
10178965|NCT03139578|11309005|FG000|Discontinued|Period 1||0
10178966|NCT03139578|11309006|FG001|Discontinued|Period 1||0
10178967|NCT03139578|11309007|FG002|Discontinued|Period 1||0
10178968|NCT03139578|11309008|FG003|Discontinued|Period 1||0
10178969|NCT03139578|11309005|FG000|COMPLETED|Period 1||12
10178970|NCT03139578|11309006|FG001|COMPLETED|Period 1||13
10178971|NCT03139578|11309007|FG002|COMPLETED|Period 1||12
10178972|NCT03139578|11309008|FG003|COMPLETED|Period 1||13
10178973|NCT03139578|11309005|FG000|NOT COMPLETED|Period 1||0
10178974|NCT03139578|11309006|FG001|NOT COMPLETED|Period 1||0
10178975|NCT03139578|11309007|FG002|NOT COMPLETED|Period 1||0
10178976|NCT03139578|11309008|FG003|NOT COMPLETED|Period 1||0
10178977|NCT03139578|11309005|FG000|STARTED|Period 2||12
10178978|NCT03139578|11309006|FG001|STARTED|Period 2||13
10178979|NCT03139578|11309007|FG002|STARTED|Period 2||12
10178980|NCT03139578|11309008|FG003|STARTED|Period 2||13
10178981|NCT03139578|11309005|FG000|Discontinued|Period 2||0
10178982|NCT03139578|11309006|FG001|Discontinued|Period 2||0
10178983|NCT03139578|11309007|FG002|Discontinued|Period 2||0
10178984|NCT03139578|11309008|FG003|Discontinued|Period 2||0
10178985|NCT03139578|11309005|FG000|COMPLETED|Period 2||12
10178986|NCT03139578|11309006|FG001|COMPLETED|Period 2||13
10178987|NCT03139578|11309007|FG002|COMPLETED|Period 2||12
10178988|NCT03139578|11309008|FG003|COMPLETED|Period 2||13
10178989|NCT03139578|11309005|FG000|NOT COMPLETED|Period 2||0
10178990|NCT03139578|11309006|FG001|NOT COMPLETED|Period 2||0
10178991|NCT03139578|11309007|FG002|NOT COMPLETED|Period 2||0
10178992|NCT03139578|11309008|FG003|NOT COMPLETED|Period 2||0
10178993|NCT03139604|11309020|FG000|STARTED|Overall Study||219
10178994|NCT03139604|11309021|FG001|STARTED|Overall Study||220
10178995|NCT03139604|11309020|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
10178996|NCT03139604|11309021|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
10178997|NCT03139604|11309020|FG000|NOT COMPLETED|Overall Study||219
9714024|NCT00002597|10813339|FG000|STARTED|Overall Study||1013
9714025|NCT00002597|10813340|FG001|STARTED|Overall Study||1015
9714026|NCT00002597|10813339|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
9714027|NCT00002597|10813340|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
9714028|NCT00002597|10813339|FG000|NOT COMPLETED|Overall Study||26
9714029|NCT00002597|10813340|FG001|NOT COMPLETED|Overall Study||23
9714030|NCT00002601|10813346|FG000|STARTED|Overall Study||13
9714031|NCT00002601|10813346|FG000|COMPLETED|Overall Study||13
9714032|NCT00002601|10813346|FG000|NOT COMPLETED|Overall Study||0
9714033|NCT00002651|10813354|FG000|STARTED|Induction||3040
9714034|NCT00002651|10813355|FG001|STARTED|Induction||0
9714035|NCT00002651|10813356|FG002|STARTED|Induction||0
9714036|NCT00002651|10813354|FG000|Eligible|Induction||2950
9714037|NCT00002651|10813355|FG001|Eligible|Induction||0
9714038|NCT00002651|10813356|FG002|Eligible|Induction||0
9714039|NCT00002651|10813354|FG000|Eligible and Began Protocol Therapy|Induction||2950
9714040|NCT00002651|10813355|FG001|Eligible and Began Protocol Therapy|Induction||0
9714041|NCT00002651|10813356|FG002|Eligible and Began Protocol Therapy|Induction||0
9714042|NCT00002651|10813354|FG000|COMPLETED|Induction||1697
9714043|NCT00002651|10813355|FG001|COMPLETED|Induction||0
9714044|NCT00002651|10813356|FG002|COMPLETED|Induction||0
9714045|NCT00002651|10813354|FG000|NOT COMPLETED|Induction||1343
9714046|NCT00002651|10813355|FG001|NOT COMPLETED|Induction||0
9714047|NCT00002651|10813356|FG002|NOT COMPLETED|Induction||0
9714048|NCT00002651|10813354|FG000|STARTED|Consolidation and Randomization||0
10178998|NCT03139604|11309021|FG001|NOT COMPLETED|Overall Study||220
10178999|NCT03140254|11309028|FG000|STARTED|Overall Study||145
10179000|NCT03140254|11309028|FG000|Treatment IP - Groin|Overall Study||51
10179001|NCT03140254|11309028|FG000|Treatment IP - Abdomen|Overall Study||48
10179002|NCT03140254|11309028|FG000|Treatment AC - Groin|Overall Study||51
10179003|NCT03140254|11309028|FG000|Treatment AC - Abdomen|Overall Study||48
10179004|NCT03140254|11309028|FG000|Treatment VC - Groin|Overall Study||18
10179005|NCT03140254|11309028|FG000|Treatment VC - Abdomen|Overall Study||19
10179006|NCT03140254|11309028|FG000|COMPLETED|Overall Study||144
10179007|NCT03140254|11309028|FG000|NOT COMPLETED|Overall Study||1
10179008|NCT03140631|11309036|FG000|STARTED|Overall Study||73
10179009|NCT03140631|11309037|FG001|STARTED|Overall Study||77
10179010|NCT03140631|11309036|FG000|COMPLETED|Overall Study||73
10179011|NCT03140631|11309037|FG001|COMPLETED|Overall Study||77
10179012|NCT03140631|11309036|FG000|NOT COMPLETED|Overall Study||0
10179013|NCT03140631|11309037|FG001|NOT COMPLETED|Overall Study||0
10179014|NCT03140722|11309046|FG000|STARTED|Overall Study||0
10179015|NCT03140722|11309047|FG001|STARTED|Overall Study||2
10179016|NCT03140722|11309046|FG000|COMPLETED|Overall Study||0
10179017|NCT03140722|11309047|FG001|COMPLETED|Overall Study||2
10179018|NCT03140722|11309046|FG000|NOT COMPLETED|Overall Study||0
10179019|NCT03140722|11309047|FG001|NOT COMPLETED|Overall Study||0
10179020|NCT03141086|11309055|FG000|STARTED|Overall Study||7
10179021|NCT03141086|11309056|FG001|STARTED|Overall Study||17
10179022|NCT03141086|11309055|FG000|COMPLETED|Overall Study||6
10179023|NCT03141086|11309056|FG001|COMPLETED|Overall Study||12
10179024|NCT03141086|11309055|FG000|NOT COMPLETED|Overall Study||1
10179025|NCT03141086|11309056|FG001|NOT COMPLETED|Overall Study||5
10179026|NCT03141151|11309064|FG000|STARTED|Overall Study||59
10179027|NCT03141151|11309065|FG001|STARTED|Overall Study||58
10179028|NCT03141151|11309064|FG000|COMPLETED|Overall Study||53
10179029|NCT03141151|11309065|FG001|COMPLETED|Overall Study||54
10179030|NCT03141151|11309064|FG000|NOT COMPLETED|Overall Study||6
9714049|NCT00002651|10813355|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
9714050|NCT00002651|10813356|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
9714051|NCT00002651|10813354|FG000|Eligible|Consolidation and Randomization||0
9714052|NCT00002651|10813355|FG001|Eligible|Consolidation and Randomization||765
9714053|NCT00002651|10813356|FG002|Eligible|Consolidation and Randomization||770
9714054|NCT00002651|10813354|FG000|Assessable for Toxicity|Consolidation and Randomization||0
9714055|NCT00002651|10813355|FG001|Assessable for Toxicity|Consolidation and Randomization||732
9714056|NCT00002651|10813356|FG002|Assessable for Toxicity|Consolidation and Randomization||702
9714057|NCT00002651|10813354|FG000|COMPLETED|Consolidation and Randomization||0
10061747|NCT02105961|11187322|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10061748|NCT02105961|11187323|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10061749|NCT02105961|11187324|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10061750|NCT02105961|11187322|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
10061751|NCT02105961|11187323|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3
10061752|NCT02105961|11187324|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1
10061753|NCT02105961|11187322|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
10061754|NCT02105961|11187323|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
10061755|NCT02105961|11187324|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
10061756|NCT02105961|11187322|FG000|Withdrew IP Due to: Site Closed|Overall Study||1
10061757|NCT02105961|11187323|FG001|Withdrew IP Due to: Site Closed|Overall Study||0
10061758|NCT02105961|11187324|FG002|Withdrew IP Due to: Site Closed|Overall Study||1
10061759|NCT02105961|11187322|FG000|COMPLETED|Overall Study||185
10061760|NCT02105961|11187323|FG001|COMPLETED|Overall Study||206
10061761|NCT02105961|11187324|FG002|COMPLETED|Overall Study||195
10061762|NCT02105961|11187322|FG000|NOT COMPLETED|Overall Study||41
10061763|NCT02105961|11187323|FG001|NOT COMPLETED|Overall Study||17
10061764|NCT02105961|11187324|FG002|NOT COMPLETED|Overall Study||30
10061765|NCT02105974|11187335|FG000|STARTED|2 Week Run-in Period||2423
10061766|NCT02105974|11187336|FG001|STARTED|2 Week Run-in Period||0
10061767|NCT02105974|11187337|FG002|STARTED|2 Week Run-in Period||0
10179031|NCT03141151|11309065|FG001|NOT COMPLETED|Overall Study||4
10179032|NCT03141242|11309073|FG000|STARTED|Overall Study||55
10179033|NCT03141242|11309074|FG001|STARTED|Overall Study||55
10179034|NCT03141242|11309073|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
10179035|NCT03141242|11309074|FG001|Received Allocated Intervenion|Overall Study||55
10179036|NCT03141242|11309073|FG000|6 Month Interview|Overall Study||51
10179037|NCT03141242|11309074|FG001|6 Month Interview|Overall Study||49
10179038|NCT03141242|11309073|FG000|COMPLETED|Overall Study||55
10179039|NCT03141242|11309074|FG001|COMPLETED|Overall Study||55
10179040|NCT03141242|11309073|FG000|NOT COMPLETED|Overall Study||0
10179041|NCT03141242|11309074|FG001|NOT COMPLETED|Overall Study||0
10179042|NCT03141281|11309085|FG000|STARTED|Overall Study||57
10179043|NCT03141281|11309086|FG001|STARTED|Overall Study||59
10179044|NCT03141281|11309087|FG002|STARTED|Overall Study||56
10179045|NCT03141281|11309088|FG003|STARTED|Overall Study||58
10179046|NCT03141281|11309085|FG000|Post-Test|Overall Study||50
10179047|NCT03141281|11309086|FG001|Post-Test|Overall Study||47
10179048|NCT03141281|11309087|FG002|Post-Test|Overall Study||50
10179049|NCT03141281|11309088|FG003|Post-Test|Overall Study||56
10179050|NCT03141281|11309085|FG000|COMPLETED|Overall Study||45
10179051|NCT03141281|11309086|FG001|COMPLETED|Overall Study||38
10179052|NCT03141281|11309087|FG002|COMPLETED|Overall Study||42
10179053|NCT03141281|11309088|FG003|COMPLETED|Overall Study||47
10179054|NCT03141281|11309085|FG000|NOT COMPLETED|Overall Study||12
10179055|NCT03141281|11309086|FG001|NOT COMPLETED|Overall Study||21
10179056|NCT03141281|11309087|FG002|NOT COMPLETED|Overall Study||14
10179057|NCT03141281|11309088|FG003|NOT COMPLETED|Overall Study||11
10179058|NCT03141307|11309100|FG000|STARTED|In-Hospital||471
10179059|NCT03141307|11309101|FG001|STARTED|In-Hospital||240
10179060|NCT03141307|11309100|FG000|COMPLETED|In-Hospital||467
10179061|NCT03141307|11309101|FG001|COMPLETED|In-Hospital||238
10179062|NCT03141307|11309100|FG000|NOT COMPLETED|In-Hospital||4
10179063|NCT03141307|11309101|FG001|NOT COMPLETED|In-Hospital||2
10179064|NCT03141307|11309100|FG000|STARTED|Follow-Up||467
10179065|NCT03141307|11309101|FG001|STARTED|Follow-Up||238
10179066|NCT03141307|11309100|FG000|COMPLETED|Follow-Up||370
10179067|NCT03141307|11309101|FG001|COMPLETED|Follow-Up||184
10179068|NCT03141307|11309100|FG000|NOT COMPLETED|Follow-Up||97
10179069|NCT03141307|11309101|FG001|NOT COMPLETED|Follow-Up||54
10179070|NCT03141372|11309109|FG000|STARTED|Overall Study||42
10179071|NCT03141372|11309110|FG001|STARTED|Overall Study||42
10179072|NCT03141372|11309109|FG000|COMPLETED|Overall Study||42
10179073|NCT03141372|11309110|FG001|COMPLETED|Overall Study||40
10179074|NCT03141372|11309109|FG000|NOT COMPLETED|Overall Study||0
10179075|NCT03141372|11309110|FG001|NOT COMPLETED|Overall Study||2
10179076|NCT03141528|11309120|FG000|STARTED|Overall Study||122
10179077|NCT03141528|11309121|FG001|STARTED|Overall Study||118
10179078|NCT03141528|11309120|FG000|COMPLETED|Overall Study||75
10179079|NCT03141528|11309121|FG001|COMPLETED|Overall Study||77
10179080|NCT03141528|11309120|FG000|NOT COMPLETED|Overall Study||47
10179081|NCT03141528|11309121|FG001|NOT COMPLETED|Overall Study||41
10179082|NCT03141788|11309127|FG000|STARTED|Overall Study||52
10179083|NCT03141788|11309127|FG000|COMPLETED|Overall Study||44
10179084|NCT03141788|11309127|FG000|NOT COMPLETED|Overall Study||8
10179085|NCT03141905|11309136|FG000|STARTED|Overall Study||176
10179086|NCT03141905|11309137|FG001|STARTED|Overall Study||166
10179087|NCT03141905|11309136|FG000|COMPLETED|Overall Study||152
10179088|NCT03141905|11309137|FG001|COMPLETED|Overall Study||147
10179089|NCT03141905|11309136|FG000|NOT COMPLETED|Overall Study||24
10179090|NCT03141905|11309137|FG001|NOT COMPLETED|Overall Study||19
10179091|NCT03141931|11309146|FG000|STARTED|Overall Study||61
10179092|NCT03141931|11309147|FG001|STARTED|Overall Study||58
10179093|NCT03141931|11309146|FG000|COMPLETED|Overall Study||49
10179094|NCT03141931|11309147|FG001|COMPLETED|Overall Study||52
10179095|NCT03141931|11309146|FG000|NOT COMPLETED|Overall Study||12
10179096|NCT03141931|11309147|FG001|NOT COMPLETED|Overall Study||6
10179097|NCT03142438|11309153|FG000|STARTED|Overall Study||57
10179098|NCT03142438|11309153|FG000|COMPLETED|Overall Study||57
10179099|NCT03142438|11309153|FG000|NOT COMPLETED|Overall Study||0
10179100|NCT03142451|11309159|FG000|STARTED|Overall Study||495
10179101|NCT03142451|11309160|FG001|STARTED|Overall Study||256
10179102|NCT03142451|11309159|FG000|COMPLETED|Overall Study||437
10179103|NCT03142451|11309160|FG001|COMPLETED|Overall Study||232
10179104|NCT03142451|11309159|FG000|NOT COMPLETED|Overall Study||58
10179105|NCT03142451|11309160|FG001|NOT COMPLETED|Overall Study||24
10179106|NCT03142750|11309168|FG000|STARTED|Overall Study||14
10179107|NCT03142750|11309169|FG001|STARTED|Overall Study||10
10179108|NCT03142750|11309168|FG000|COMPLETED|Overall Study||10
10179109|NCT03142750|11309169|FG001|COMPLETED|Overall Study||9
10179110|NCT03142750|11309168|FG000|NOT COMPLETED|Overall Study||4
10179111|NCT03142750|11309169|FG001|NOT COMPLETED|Overall Study||1
10179112|NCT03142932|11309181|FG000|STARTED|Overall Study||52
10179113|NCT03142932|11309182|FG001|STARTED|Overall Study||50
10179114|NCT03142932|11309181|FG000|COMPLETED|Overall Study||50
10179115|NCT03142932|11309182|FG001|COMPLETED|Overall Study||39
10179116|NCT03142932|11309181|FG000|NOT COMPLETED|Overall Study||2
10179117|NCT03142932|11309182|FG001|NOT COMPLETED|Overall Study||11
10179118|NCT03143101|11309191|FG000|STARTED|Overall Study||67
10179119|NCT03143101|11309192|FG001|STARTED|Overall Study||66
10179120|NCT03143101|11309193|FG002|STARTED|Overall Study||67
10179121|NCT03143101|11309191|FG000|COMPLETED|Overall Study||65
10179122|NCT03143101|11309192|FG001|COMPLETED|Overall Study||63
10179123|NCT03143101|11309193|FG002|COMPLETED|Overall Study||67
10179124|NCT03143101|11309191|FG000|NOT COMPLETED|Overall Study||2
10179125|NCT03143101|11309192|FG001|NOT COMPLETED|Overall Study||3
10179126|NCT03143101|11309193|FG002|NOT COMPLETED|Overall Study||0
10179127|NCT03143166|11309201|FG000|STARTED|Period 1||36
10179128|NCT03143166|11309201|FG000|COMPLETED|Period 1||36
10179129|NCT03143166|11309201|FG000|NOT COMPLETED|Period 1||0
10179130|NCT03143166|11309201|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36
10179131|NCT03143166|11309201|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
10179132|NCT03143166|11309201|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
10179133|NCT03143569|11309209|FG000|STARTED|Overall Study||10
10179134|NCT03143569|11309210|FG001|STARTED|Overall Study||10
10179135|NCT03143569|11309209|FG000|COMPLETED|Overall Study||10
10179136|NCT03143569|11309210|FG001|COMPLETED|Overall Study||8
10179137|NCT03143569|11309209|FG000|NOT COMPLETED|Overall Study||0
10179138|NCT03143569|11309210|FG001|NOT COMPLETED|Overall Study||2
10179139|NCT03143855|11309220|FG000|STARTED|Overall Study||17
10179140|NCT03143855|11309221|FG001|STARTED|Overall Study||10
10179141|NCT03143855|11309220|FG000|COMPLETED|Overall Study||12
10179142|NCT03143855|11309221|FG001|COMPLETED|Overall Study||6
10179143|NCT03143855|11309220|FG000|NOT COMPLETED|Overall Study||5
10179144|NCT03143855|11309221|FG001|NOT COMPLETED|Overall Study||4
10179145|NCT03143894|11309229|FG000|STARTED|First Intervention (5 Days)||3
10179146|NCT03143894|11309230|FG001|STARTED|First Intervention (5 Days)||4
10179147|NCT03143894|11309229|FG000|COMPLETED|First Intervention (5 Days)||3
10179148|NCT03143894|11309230|FG001|COMPLETED|First Intervention (5 Days)||4
10179149|NCT03143894|11309229|FG000|NOT COMPLETED|First Intervention (5 Days)||0
10179150|NCT03143894|11309230|FG001|NOT COMPLETED|First Intervention (5 Days)||0
10179151|NCT03143894|11309229|FG000|STARTED|Washout (4 Weeks)||3
10179152|NCT03143894|11309230|FG001|STARTED|Washout (4 Weeks)||4
10179153|NCT03143894|11309229|FG000|COMPLETED|Washout (4 Weeks)||3
10179154|NCT03143894|11309230|FG001|COMPLETED|Washout (4 Weeks)||4
10179155|NCT03143894|11309229|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10179156|NCT03143894|11309230|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10179157|NCT03143894|11309229|FG000|STARTED|Second Intervention (5 Days)||3
10179158|NCT03143894|11309230|FG001|STARTED|Second Intervention (5 Days)||4
10179159|NCT03143894|11309229|FG000|COMPLETED|Second Intervention (5 Days)||3
10179160|NCT03143894|11309230|FG001|COMPLETED|Second Intervention (5 Days)||3
10179161|NCT03143894|11309229|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
10179162|NCT03143894|11309230|FG001|NOT COMPLETED|Second Intervention (5 Days)||1
10179163|NCT03144089|11309240|FG000|STARTED|Overall Study||28
10179164|NCT03144089|11309241|FG001|STARTED|Overall Study||28
10179165|NCT03144089|11309240|FG000|COMPLETED|Overall Study||28
10179166|NCT03144089|11309241|FG001|COMPLETED|Overall Study||28
10179167|NCT03144089|11309240|FG000|NOT COMPLETED|Overall Study||0
10179168|NCT03144089|11309241|FG001|NOT COMPLETED|Overall Study||0
10179169|NCT03144180|11309251|FG000|STARTED|Overall Study||16
10179170|NCT03144180|11309252|FG001|STARTED|Overall Study||16
10179171|NCT03144180|11309251|FG000|COMPLETED|Overall Study||14
10179172|NCT03144180|11309252|FG001|COMPLETED|Overall Study||10
10179173|NCT03144180|11309251|FG000|NOT COMPLETED|Overall Study||2
10179174|NCT03144180|11309252|FG001|NOT COMPLETED|Overall Study||6
10179175|NCT03144518|11309262|FG000|STARTED|Primary Outcome (Mood)||52
10179176|NCT03144518|11309263|FG001|STARTED|Primary Outcome (Mood)||51
10179177|NCT03144518|11309262|FG000|COMPLETED|Primary Outcome (Mood)||52
10179178|NCT03144518|11309263|FG001|COMPLETED|Primary Outcome (Mood)||51
10179179|NCT03144518|11309262|FG000|NOT COMPLETED|Primary Outcome (Mood)||0
10179180|NCT03144518|11309263|FG001|NOT COMPLETED|Primary Outcome (Mood)||0
10179181|NCT03144518|11309262|FG000|STARTED|4 Weeks Post-Vaccination||52
10179182|NCT03144518|11309263|FG001|STARTED|4 Weeks Post-Vaccination||51
10179183|NCT03144518|11309262|FG000|COMPLETED|4 Weeks Post-Vaccination||51
10179184|NCT03144518|11309263|FG001|COMPLETED|4 Weeks Post-Vaccination||51
10179185|NCT03144518|11309262|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1
10179186|NCT03144518|11309263|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0
10179187|NCT03144518|11309262|FG000|STARTED|16 Week Post-Vaccination||52
10179188|NCT03144518|11309263|FG001|STARTED|16 Week Post-Vaccination||51
10179189|NCT03144518|11309262|FG000|COMPLETED|16 Week Post-Vaccination||49
10179190|NCT03144518|11309263|FG001|COMPLETED|16 Week Post-Vaccination||49
10179191|NCT03144518|11309262|FG000|NOT COMPLETED|16 Week Post-Vaccination||3
10179192|NCT03144518|11309263|FG001|NOT COMPLETED|16 Week Post-Vaccination||2
10179193|NCT03144635|11309270|FG000|STARTED|Overall Study||80
10179194|NCT03144635|11309270|FG000|COMPLETED|Overall Study||0
10179195|NCT03144635|11309270|FG000|NOT COMPLETED|Overall Study||80
10179196|NCT03144804|11309276|FG000|STARTED|Overall Study||36
10179197|NCT03144804|11309276|FG000|COMPLETED|Overall Study||32
10179198|NCT03144804|11309276|FG000|NOT COMPLETED|Overall Study||4
10179199|NCT03145064|11309280|FG000|STARTED|Overall Study||41
9714058|NCT00002651|10813355|FG001|COMPLETED|Consolidation and Randomization||29
9714059|NCT00002651|10813356|FG002|COMPLETED|Consolidation and Randomization||22
9714060|NCT00002651|10813354|FG000|NOT COMPLETED|Consolidation and Randomization||0
9714061|NCT00002651|10813355|FG001|NOT COMPLETED|Consolidation and Randomization||838
9714062|NCT00002651|10813356|FG002|NOT COMPLETED|Consolidation and Randomization||860
9714063|NCT00002766|10813366|FG000|STARTED|Overall Study||81
9714064|NCT00002766|10813367|FG001|STARTED|Overall Study||89
9714065|NCT00002766|10813366|FG000|COMPLETED|Overall Study||78
10179200|NCT03145064|11309280|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
10179201|NCT03145064|11309280|FG000|COMPLETED|Overall Study||0
10179202|NCT03145064|11309280|FG000|NOT COMPLETED|Overall Study||41
10179203|NCT03145207|11309285|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
10179204|NCT03145207|11309285|FG000|COMPLETED|Overall Study||12
10179205|NCT03145207|11309285|FG000|NOT COMPLETED|Overall Study||2
10179206|NCT03145259|11309300|FG000|STARTED|Overall Study||12
9714066|NCT00002766|10813367|FG001|COMPLETED|Overall Study||85
9714067|NCT00002766|10813366|FG000|NOT COMPLETED|Overall Study||3
9714068|NCT00002766|10813367|FG001|NOT COMPLETED|Overall Study||4
9714069|NCT00002842|10813373|FG000|STARTED|Overall Study||49
9714070|NCT00002842|10813373|FG000|COMPLETED|Overall Study||22
10179207|NCT03145259|11309300|FG000|COMPLETED|Overall Study||12
10179208|NCT03145259|11309300|FG000|NOT COMPLETED|Overall Study||0
10179209|NCT03145818|11309311|FG000|STARTED|Overall Study||99
10179210|NCT03145818|11309312|FG001|STARTED|Overall Study||8
10179211|NCT03145818|11309313|FG002|STARTED|Overall Study||10
10179212|NCT03145818|11309314|FG003|STARTED|Overall Study||9
10179213|NCT03145818|11309311|FG000|COMPLETED|Overall Study||8
10179214|NCT03145818|11309312|FG001|COMPLETED|Overall Study||0
10179215|NCT03145818|11309313|FG002|COMPLETED|Overall Study||10
10179216|NCT03145818|11309314|FG003|COMPLETED|Overall Study||9
10179217|NCT03145818|11309311|FG000|NOT COMPLETED|Overall Study||91
10179218|NCT03145818|11309312|FG001|NOT COMPLETED|Overall Study||8
10179219|NCT03145818|11309313|FG002|NOT COMPLETED|Overall Study||0
10179220|NCT03145818|11309314|FG003|NOT COMPLETED|Overall Study||0
10179221|NCT03146403|11309324|FG000|STARTED|Overall Study||16
10179222|NCT03146403|11309325|FG001|STARTED|Overall Study||17
10179223|NCT03146403|11309324|FG000|COMPLETED|Overall Study||14
10179224|NCT03146403|11309325|FG001|COMPLETED|Overall Study||14
10179225|NCT03146403|11309324|FG000|NOT COMPLETED|Overall Study||2
10179226|NCT03146403|11309325|FG001|NOT COMPLETED|Overall Study||3
10179227|NCT03146585|11309334|FG000|STARTED|Overall Study||25
10179228|NCT03146585|11309335|FG001|STARTED|Overall Study||10
10179229|NCT03146585|11309336|FG002|STARTED|Overall Study||5
10179230|NCT03146585|11309334|FG000|COMPLETED|Overall Study||25
10179231|NCT03146585|11309335|FG001|COMPLETED|Overall Study||10
10179232|NCT03146585|11309336|FG002|COMPLETED|Overall Study||5
10179233|NCT03146585|11309334|FG000|NOT COMPLETED|Overall Study||0
10179234|NCT03146585|11309335|FG001|NOT COMPLETED|Overall Study||0
10179235|NCT03146585|11309336|FG002|NOT COMPLETED|Overall Study||0
10179236|NCT03146663|11309346|FG000|STARTED|Overall Study||25
10179237|NCT03146663|11309347|FG001|STARTED|Overall Study||28
10179238|NCT03146663|11309346|FG000|COMPLETED|Overall Study||24
10179239|NCT03146663|11309347|FG001|COMPLETED|Overall Study||27
10179240|NCT03146663|11309346|FG000|NOT COMPLETED|Overall Study||1
10179241|NCT03146663|11309347|FG001|NOT COMPLETED|Overall Study||1
10179242|NCT03146741|11309354|FG000|STARTED|Overall Study||20
10179243|NCT03146741|11309354|FG000|COMPLETED|Overall Study||10
10179244|NCT03146741|11309354|FG000|NOT COMPLETED|Overall Study||10
10179245|NCT03146806|11309358|FG000|STARTED|Overall Study||10
10179246|NCT03146806|11309358|FG000|COMPLETED|Overall Study||10
10179247|NCT03146806|11309358|FG000|NOT COMPLETED|Overall Study||0
10179248|NCT03147248|11309380|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
10179249|NCT03147248|11309381|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
10179250|NCT03147248|11309382|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
10179251|NCT03147248|11309383|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12
10179252|NCT03147248|11309384|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
10179253|NCT03147248|11309385|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
10179254|NCT03147248|11309380|FG000|COMPLETED|Overall Study||12
10179255|NCT03147248|11309381|FG001|COMPLETED|Overall Study||9
10179256|NCT03147248|11309382|FG002|COMPLETED|Overall Study||10
10179257|NCT03147248|11309383|FG003|COMPLETED|Overall Study||10
10179258|NCT03147248|11309384|FG004|COMPLETED|Overall Study||141
10179259|NCT03147248|11309385|FG005|COMPLETED|Overall Study||145
10179260|NCT03147248|11309380|FG000|NOT COMPLETED|Overall Study||1
10179261|NCT03147248|11309381|FG001|NOT COMPLETED|Overall Study||2
10179262|NCT03147248|11309382|FG002|NOT COMPLETED|Overall Study||2
10179263|NCT03147248|11309383|FG003|NOT COMPLETED|Overall Study||2
10179264|NCT03147248|11309384|FG004|NOT COMPLETED|Overall Study||26
10179265|NCT03147248|11309385|FG005|NOT COMPLETED|Overall Study||31
10179266|NCT03147495|11309401|FG000|STARTED|Overall Study||40
10179267|NCT03147495|11309402|FG001|STARTED|Overall Study||46
10179268|NCT03147495|11309401|FG000|COMPLETED|Overall Study||40
10179269|NCT03147495|11309402|FG001|COMPLETED|Overall Study||40
10179270|NCT03147495|11309401|FG000|NOT COMPLETED|Overall Study||0
10179271|NCT03147495|11309402|FG001|NOT COMPLETED|Overall Study||6
10179272|NCT03147690|11309408|FG000|STARTED|Overall Study||74
10179273|NCT03147690|11309408|FG000|COMPLETED|Overall Study||71
10179274|NCT03147690|11309408|FG000|NOT COMPLETED|Overall Study||3
10179275|NCT03148067|11309425|FG000|STARTED|Overall Study||225
10179276|NCT03148067|11309425|FG000|COMPLETED|Overall Study||221
10179277|NCT03148067|11309425|FG000|NOT COMPLETED|Overall Study||4
10179278|NCT03148236|11309432|FG000|STARTED|Overall Study||10
10179279|NCT03148236|11309433|FG001|STARTED|Overall Study||10
10179280|NCT03148236|11309432|FG000|COMPLETED|Overall Study||10
10179281|NCT03148236|11309433|FG001|COMPLETED|Overall Study||10
10179282|NCT03148236|11309432|FG000|NOT COMPLETED|Overall Study||0
10179283|NCT03148236|11309433|FG001|NOT COMPLETED|Overall Study||0
10179284|NCT03148262|11309441|FG000|STARTED|Overall Study||31
10179285|NCT03148262|11309442|FG001|STARTED|Overall Study||32
10179286|NCT03148262|11309441|FG000|COMPLETED|Overall Study||28
10179287|NCT03148262|11309442|FG001|COMPLETED|Overall Study||31
10179288|NCT03148262|11309441|FG000|NOT COMPLETED|Overall Study||3
10179289|NCT03148262|11309442|FG001|NOT COMPLETED|Overall Study||1
10179290|NCT03148470|11309450|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
10179291|NCT03148470|11309451|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
10179292|NCT03148470|11309450|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
10179293|NCT03148470|11309451|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
10179294|NCT03148470|11309450|FG000|NOT COMPLETED|Overall Study||1
10179295|NCT03148470|11309451|FG001|NOT COMPLETED|Overall Study||0
9714071|NCT00002842|10813373|FG000|NOT COMPLETED|Overall Study||27
9714072|NCT00002850|10813380|FG000|STARTED|Overall Study||69
9714073|NCT00002850|10813381|FG001|STARTED|Overall Study||76
9714074|NCT00002850|10813382|FG002|STARTED|Overall Study||67
9714075|NCT00002850|10813380|FG000|COMPLETED|Overall Study||64
9714076|NCT00002850|10813381|FG001|COMPLETED|Overall Study||74
9714077|NCT00002850|10813382|FG002|COMPLETED|Overall Study||63
9714078|NCT00002850|10813380|FG000|NOT COMPLETED|Overall Study||5
9714079|NCT00002850|10813381|FG001|NOT COMPLETED|Overall Study||2
9714080|NCT00002850|10813382|FG002|NOT COMPLETED|Overall Study||4
9731247|NCT00131352|10831173|FG000|NOT COMPLETED|Repeat Treatment Period||2
9731248|NCT00131352|10831174|FG001|NOT COMPLETED|Repeat Treatment Period||0
9731249|NCT00131365|10831182|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
9731250|NCT00131365|10831182|FG000|COMPLETED|Overall Study||5
9731251|NCT00131365|10831182|FG000|NOT COMPLETED|Overall Study||4
9731252|NCT00131378|10831191|FG000|STARTED|Overall Study||40
9731253|NCT00131378|10831192|FG001|STARTED|Overall Study||40
9731254|NCT00131378|10831193|FG002|STARTED|Overall Study||32
9731255|NCT00131378|10831194|FG003|STARTED|Overall Study||30
9731256|NCT00131378|10831191|FG000|COMPLETED|Overall Study||29
9731257|NCT00131378|10831192|FG001|COMPLETED|Overall Study||22
9731258|NCT00131378|10831193|FG002|COMPLETED|Overall Study||22
9731259|NCT00131378|10831194|FG003|COMPLETED|Overall Study||21
9731260|NCT00131378|10831191|FG000|NOT COMPLETED|Overall Study||11
9731261|NCT00131378|10831192|FG001|NOT COMPLETED|Overall Study||18
9731262|NCT00131378|10831193|FG002|NOT COMPLETED|Overall Study||10
9731263|NCT00131378|10831194|FG003|NOT COMPLETED|Overall Study||9
9731264|NCT00131456|10831208|FG000|STARTED|Overall Study||52
9731265|NCT00131456|10831209|FG001|STARTED|Overall Study||51
9731266|NCT00131456|10831208|FG000|COMPLETED|Overall Study||33
9731267|NCT00131456|10831209|FG001|COMPLETED|Overall Study||31
9731268|NCT00131456|10831208|FG000|NOT COMPLETED|Overall Study||19
9731269|NCT00131456|10831209|FG001|NOT COMPLETED|Overall Study||20
9731270|NCT00131469|10831217|FG000|STARTED|Overall Study||38
9731271|NCT00131469|10831218|FG001|STARTED|Overall Study||40
9731272|NCT00131469|10831217|FG000|COMPLETED|Overall Study||29
9731273|NCT00131469|10831218|FG001|COMPLETED|Overall Study||27
9731274|NCT00131469|10831217|FG000|NOT COMPLETED|Overall Study||9
9731275|NCT00131469|10831218|FG001|NOT COMPLETED|Overall Study||13
9731276|NCT00131508|10831226|FG000|STARTED|Overall Study||12
9731277|NCT00131508|10831227|FG001|STARTED|Overall Study||13
9731278|NCT00131508|10831226|FG000|COMPLETED|Overall Study||9
9731279|NCT00131508|10831227|FG001|COMPLETED|Overall Study||5
9731280|NCT00131508|10831226|FG000|NOT COMPLETED|Overall Study||3
9731281|NCT00131508|10831227|FG001|NOT COMPLETED|Overall Study||8
9731282|NCT00131573|10831235|FG000|STARTED|Overall Study||46
9731283|NCT00131573|10831236|FG001|STARTED|Overall Study||39
9731284|NCT00131573|10831235|FG000|COMPLETED|Overall Study||13
9731285|NCT00131573|10831236|FG001|COMPLETED|Overall Study||13
9731286|NCT00131573|10831235|FG000|NOT COMPLETED|Overall Study||33
9731287|NCT00131573|10831236|FG001|NOT COMPLETED|Overall Study||26
9731288|NCT00131664|10831246|FG000|STARTED|First Period (First 6 Months)||136
9731289|NCT00131664|10831247|FG001|STARTED|First Period (First 6 Months)||135
9731290|NCT00131664|10831248|FG002|STARTED|First Period (First 6 Months)||120
9731291|NCT00131664|10831249|FG003|STARTED|First Period (First 6 Months)||0
9731292|NCT00131664|10831250|FG004|STARTED|First Period (First 6 Months)||0
9731293|NCT00131664|10831251|FG005|STARTED|First Period (First 6 Months)||0
9731294|NCT00131664|10831246|FG000|COMPLETED|First Period (First 6 Months)||111
9731295|NCT00131664|10831247|FG001|COMPLETED|First Period (First 6 Months)||117
9731296|NCT00131664|10831248|FG002|COMPLETED|First Period (First 6 Months)||104
9731297|NCT00131664|10831249|FG003|COMPLETED|First Period (First 6 Months)||0
9731298|NCT00131664|10831250|FG004|COMPLETED|First Period (First 6 Months)||0
9731299|NCT00131664|10831251|FG005|COMPLETED|First Period (First 6 Months)||0
9731300|NCT00131664|10831246|FG000|NOT COMPLETED|First Period (First 6 Months)||25
9731301|NCT00131664|10831247|FG001|NOT COMPLETED|First Period (First 6 Months)||18
9731302|NCT00131664|10831248|FG002|NOT COMPLETED|First Period (First 6 Months)||16
9731303|NCT00131664|10831249|FG003|NOT COMPLETED|First Period (First 6 Months)||0
9731304|NCT00131664|10831250|FG004|NOT COMPLETED|First Period (First 6 Months)||0
9731305|NCT00131664|10831251|FG005|NOT COMPLETED|First Period (First 6 Months)||0
9731306|NCT00131664|10831246|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
9731307|NCT00131664|10831247|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
10179296|NCT03148691|11309468|FG000|STARTED|Overall Study||50
10179297|NCT03148691|11309469|FG001|STARTED|Overall Study||103
10179298|NCT03148691|11309470|FG002|STARTED|Overall Study||100
10179299|NCT03148691|11309468|FG000|COMPLETED|Overall Study||47
10179300|NCT03148691|11309469|FG001|COMPLETED|Overall Study||101
10179301|NCT03148691|11309470|FG002|COMPLETED|Overall Study||92
10179302|NCT03148691|11309468|FG000|NOT COMPLETED|Overall Study||3
10179303|NCT03148691|11309469|FG001|NOT COMPLETED|Overall Study||2
10179304|NCT03148691|11309470|FG002|NOT COMPLETED|Overall Study||8
10179305|NCT03149042|11309478|FG000|STARTED|Overall Study||75
10179306|NCT03149042|11309478|FG000|COMPLETED|Overall Study||52
10179307|NCT03149042|11309478|FG000|NOT COMPLETED|Overall Study||23
10179308|NCT03149055|11309483|FG000|STARTED|Overall Study||99
10179309|NCT03149055|11309483|FG000|COMPLETED|Overall Study||95
10179310|NCT03149055|11309483|FG000|NOT COMPLETED|Overall Study||4
10179311|NCT03149172|11309490|FG000|STARTED|Overall Study||8
10179312|NCT03149172|11309491|FG001|STARTED|Overall Study||6
10179313|NCT03149172|11309492|FG002|STARTED|Overall Study||7
10179314|NCT03149172|11309490|FG000|COMPLETED|Overall Study||6
10179315|NCT03149172|11309491|FG001|COMPLETED|Overall Study||5
10179316|NCT03149172|11309492|FG002|COMPLETED|Overall Study||5
10179317|NCT03149172|11309490|FG000|NOT COMPLETED|Overall Study||2
10179318|NCT03149172|11309491|FG001|NOT COMPLETED|Overall Study||1
10179319|NCT03149172|11309492|FG002|NOT COMPLETED|Overall Study||2
10179320|NCT03149328|11309502|FG000|STARTED|Overall Study||284
10179321|NCT03149328|11309503|FG001|STARTED|Overall Study||259
10179322|NCT03149328|11309502|FG000|COMPLETED|Overall Study||200
10179323|NCT03149328|11309503|FG001|COMPLETED|Overall Study||213
10179324|NCT03149328|11309502|FG000|NOT COMPLETED|Overall Study||84
10179325|NCT03149328|11309503|FG001|NOT COMPLETED|Overall Study||46
10179326|NCT03149848|11309509|FG000|STARTED|Period 1 (Day 1 to Day 14)||15
10179327|NCT03149848|11309509|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14
10179328|NCT03149848|11309509|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
10179329|NCT03149848|11309509|FG000|STARTED|Period 2 (Day 15 to Day 28)||14
10179330|NCT03149848|11309509|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12
10179331|NCT03149848|11309509|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
10179332|NCT03149887|11309518|FG000|STARTED|Overall Study||27
10179333|NCT03149887|11309519|FG001|STARTED|Overall Study||27
10179334|NCT03149887|11309518|FG000|COMPLETED|Overall Study||27
10179335|NCT03149887|11309519|FG001|COMPLETED|Overall Study||27
10179336|NCT03149887|11309518|FG000|NOT COMPLETED|Overall Study||0
10179337|NCT03149887|11309519|FG001|NOT COMPLETED|Overall Study||0
10179338|NCT03149991|11309527|FG000|STARTED|Overall Study||25
10179339|NCT03149991|11309528|FG001|STARTED|Overall Study||26
10179340|NCT03149991|11309527|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25
10179341|NCT03149991|11309528|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24
10179342|NCT03149991|11309527|FG000|Exited|Overall Study||4
10179343|NCT03149991|11309528|FG001|Exited|Overall Study||2
10179344|NCT03149991|11309527|FG000|COMPLETED|Overall Study||21
10179345|NCT03149991|11309528|FG001|COMPLETED|Overall Study||24
10179346|NCT03149991|11309527|FG000|NOT COMPLETED|Overall Study||4
10179347|NCT03149991|11309528|FG001|NOT COMPLETED|Overall Study||2
10179348|NCT03150043|11309534|FG000|STARTED|Overall Study||65
10179349|NCT03150043|11309534|FG000|COMPLETED|Overall Study||65
10179350|NCT03150043|11309534|FG000|NOT COMPLETED|Overall Study||0
10179351|NCT03150056|11309545|FG000|STARTED|Overall Study||10
10179352|NCT03150056|11309546|FG001|STARTED|Overall Study||6
10179353|NCT03150056|11309547|FG002|STARTED|Overall Study||4
10179354|NCT03150056|11309548|FG003|STARTED|Overall Study||10
10179355|NCT03150056|11309549|FG004|STARTED|Overall Study||22
10179356|NCT03150056|11309550|FG005|STARTED|Overall Study||21
10179357|NCT03150056|11309545|FG000|COMPLETED|Overall Study||0
10179358|NCT03150056|11309546|FG001|COMPLETED|Overall Study||1
10179359|NCT03150056|11309547|FG002|COMPLETED|Overall Study||0
10179360|NCT03150056|11309548|FG003|COMPLETED|Overall Study||1
10179361|NCT03150056|11309549|FG004|COMPLETED|Overall Study||6
10179362|NCT03150056|11309550|FG005|COMPLETED|Overall Study||3
10179363|NCT03150056|11309545|FG000|NOT COMPLETED|Overall Study||10
10179364|NCT03150056|11309546|FG001|NOT COMPLETED|Overall Study||5
10179365|NCT03150056|11309547|FG002|NOT COMPLETED|Overall Study||4
10179366|NCT03150056|11309548|FG003|NOT COMPLETED|Overall Study||9
10179367|NCT03150056|11309549|FG004|NOT COMPLETED|Overall Study||16
10179368|NCT03150056|11309550|FG005|NOT COMPLETED|Overall Study||18
10179369|NCT03150082|11309567|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
10179370|NCT03150082|11309568|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
10179371|NCT03150082|11309567|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
10179372|NCT03150082|11309568|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
10179373|NCT03150082|11309567|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
10179374|NCT03150082|11309568|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
10179375|NCT03150082|11309567|FG000|STARTED|Washout Period (Up to 4 Weeks)||12
10179376|NCT03150082|11309568|FG001|STARTED|Washout Period (Up to 4 Weeks)||13
10179377|NCT03150082|11309567|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12
10179378|NCT03150082|11309568|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13
10179379|NCT03150082|11309567|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10179380|NCT03150082|11309568|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10179381|NCT03150082|11309567|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
10179382|NCT03150082|11309568|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
10179383|NCT03150082|11309567|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
10179384|NCT03150082|11309568|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
10179385|NCT03150082|11309567|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
10179386|NCT03150082|11309568|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
10179387|NCT03150108|11309578|FG000|STARTED|Overall Study||12
10179388|NCT03150108|11309579|FG001|STARTED|Overall Study||12
10179389|NCT03150108|11309578|FG000|COMPLETED|Overall Study||12
10179390|NCT03150108|11309579|FG001|COMPLETED|Overall Study||12
10179391|NCT03150108|11309578|FG000|NOT COMPLETED|Overall Study||0
10179392|NCT03150108|11309579|FG001|NOT COMPLETED|Overall Study||0
10179393|NCT03150199|11309596|FG000|STARTED|Overall Study||30
10179394|NCT03150199|11309597|FG001|STARTED|Overall Study||30
10179395|NCT03150199|11309596|FG000|COMPLETED|Overall Study||30
10179396|NCT03150199|11309597|FG001|COMPLETED|Overall Study||30
10179397|NCT03150199|11309596|FG000|NOT COMPLETED|Overall Study||0
10179398|NCT03150199|11309597|FG001|NOT COMPLETED|Overall Study||0
10179399|NCT03150485|11309604|FG000|STARTED|Overall Study||2
10179400|NCT03150485|11309605|FG001|STARTED|Overall Study||9
10179401|NCT03150485|11309606|FG002|STARTED|Overall Study||4
10179402|NCT03150485|11309607|FG003|STARTED|Overall Study||5
10179403|NCT03150485|11309608|FG004|STARTED|Overall Study||2
10179404|NCT03150485|11309609|FG005|STARTED|Overall Study||1
10179405|NCT03150485|11309604|FG000|COMPLETED|Overall Study||2
10179406|NCT03150485|11309605|FG001|COMPLETED|Overall Study||8
9714081|NCT03666988|10813396|FG000|STARTED|Part 1 (Up to 28 Months)||3
9714082|NCT03666988|10813397|FG001|STARTED|Part 1 (Up to 28 Months)||16
10179407|NCT03150485|11309606|FG002|COMPLETED|Overall Study||4
10179408|NCT03150485|11309607|FG003|COMPLETED|Overall Study||5
10179409|NCT03150485|11309608|FG004|COMPLETED|Overall Study||2
10179410|NCT03150485|11309609|FG005|COMPLETED|Overall Study||1
10179411|NCT03150485|11309604|FG000|NOT COMPLETED|Overall Study||0
10179412|NCT03150485|11309605|FG001|NOT COMPLETED|Overall Study||1
10179413|NCT03150485|11309606|FG002|NOT COMPLETED|Overall Study||0
10179414|NCT03150485|11309607|FG003|NOT COMPLETED|Overall Study||0
10179415|NCT03150485|11309608|FG004|NOT COMPLETED|Overall Study||0
10179416|NCT03150485|11309609|FG005|NOT COMPLETED|Overall Study||0
10179417|NCT03150589|11309616|FG000|STARTED|Overall Study||351
10179418|NCT03150589|11309617|FG001|STARTED|Overall Study||354
10179419|NCT03150589|11309616|FG000|COMPLETED|Overall Study||307
10179420|NCT03150589|11309617|FG001|COMPLETED|Overall Study||327
10179421|NCT03150589|11309616|FG000|NOT COMPLETED|Overall Study||44
10179422|NCT03150589|11309617|FG001|NOT COMPLETED|Overall Study||27
10179423|NCT03150719|11309625|FG000|STARTED|Overall Study||47
10179424|NCT03150719|11309626|FG001|STARTED|Overall Study||50
10179425|NCT03150719|11309625|FG000|COMPLETED|Overall Study||46
10179426|NCT03150719|11309626|FG001|COMPLETED|Overall Study||48
10179427|NCT03150719|11309625|FG000|NOT COMPLETED|Overall Study||1
10179428|NCT03150719|11309626|FG001|NOT COMPLETED|Overall Study||2
9714083|NCT03666988|10813398|FG002|STARTED|Part 1 (Up to 28 Months)||12
9714084|NCT03666988|10813399|FG003|STARTED|Part 1 (Up to 28 Months)||0
9714085|NCT03666988|10813400|FG004|STARTED|Part 1 (Up to 28 Months)||0
9714086|NCT03666988|10813401|FG005|STARTED|Part 1 (Up to 28 Months)||0
9714087|NCT03666988|10813396|FG000|COMPLETED|Part 1 (Up to 28 Months)||0
9714088|NCT03666988|10813397|FG001|COMPLETED|Part 1 (Up to 28 Months)||0
9714089|NCT03666988|10813398|FG002|COMPLETED|Part 1 (Up to 28 Months)||0
9714090|NCT03666988|10813399|FG003|COMPLETED|Part 1 (Up to 28 Months)||0
9714091|NCT03666988|10813400|FG004|COMPLETED|Part 1 (Up to 28 Months)||0
9714092|NCT03666988|10813401|FG005|COMPLETED|Part 1 (Up to 28 Months)||0
9714093|NCT03666988|10813396|FG000|NOT COMPLETED|Part 1 (Up to 28 Months)||3
9714094|NCT03666988|10813397|FG001|NOT COMPLETED|Part 1 (Up to 28 Months)||16
9714095|NCT03666988|10813398|FG002|NOT COMPLETED|Part 1 (Up to 28 Months)||12
9714096|NCT03666988|10813399|FG003|NOT COMPLETED|Part 1 (Up to 28 Months)||0
9714097|NCT03666988|10813400|FG004|NOT COMPLETED|Part 1 (Up to 28 Months)||0
9714098|NCT03666988|10813401|FG005|NOT COMPLETED|Part 1 (Up to 28 Months)||0
9714099|NCT03666988|10813396|FG000|STARTED|Part 2 (Up to 48 Months)||0
9714100|NCT03666988|10813397|FG001|STARTED|Part 2 (Up to 48 Months)||0
9714101|NCT03666988|10813398|FG002|STARTED|Part 2 (Up to 48 Months)||0
9714102|NCT03666988|10813399|FG003|STARTED|Part 2 (Up to 48 Months)||0
9714103|NCT03666988|10813400|FG004|STARTED|Part 2 (Up to 48 Months)||0
9714104|NCT03666988|10813401|FG005|STARTED|Part 2 (Up to 48 Months)||0
9714105|NCT03666988|10813396|FG000|COMPLETED|Part 2 (Up to 48 Months)||0
9714106|NCT03666988|10813397|FG001|COMPLETED|Part 2 (Up to 48 Months)||0
9714107|NCT03666988|10813398|FG002|COMPLETED|Part 2 (Up to 48 Months)||0
9714108|NCT03666988|10813399|FG003|COMPLETED|Part 2 (Up to 48 Months)||0
9714109|NCT03666988|10813400|FG004|COMPLETED|Part 2 (Up to 48 Months)||0
9714110|NCT03666988|10813401|FG005|COMPLETED|Part 2 (Up to 48 Months)||0
9714111|NCT03666988|10813396|FG000|NOT COMPLETED|Part 2 (Up to 48 Months)||0
9714112|NCT03666988|10813397|FG001|NOT COMPLETED|Part 2 (Up to 48 Months)||0
9714113|NCT03666988|10813398|FG002|NOT COMPLETED|Part 2 (Up to 48 Months)||0
9714114|NCT03666988|10813399|FG003|NOT COMPLETED|Part 2 (Up to 48 Months)||0
9714115|NCT03666988|10813400|FG004|NOT COMPLETED|Part 2 (Up to 48 Months)||0
9714116|NCT03666988|10813401|FG005|NOT COMPLETED|Part 2 (Up to 48 Months)||0
9714117|NCT03552029|10813421|FG000|STARTED|Overall Study||4
9714118|NCT03552029|10813422|FG001|STARTED|Overall Study||6
9714119|NCT03552029|10813421|FG000|COMPLETED|Overall Study||0
9714120|NCT03552029|10813422|FG001|COMPLETED|Overall Study||0
9714121|NCT03552029|10813421|FG000|NOT COMPLETED|Overall Study||4
9714122|NCT03552029|10813422|FG001|NOT COMPLETED|Overall Study||6
9714123|NCT03549104|10813430|FG000|STARTED|Overall Study||26
9714124|NCT03549104|10813431|FG001|STARTED|Overall Study||25
9714125|NCT03549104|10813430|FG000|COMPLETED|Overall Study||18
9714126|NCT03549104|10813431|FG001|COMPLETED|Overall Study||21
9714127|NCT03549104|10813430|FG000|NOT COMPLETED|Overall Study||8
9714128|NCT03549104|10813431|FG001|NOT COMPLETED|Overall Study||4
9714129|NCT03462719|10813439|FG000|STARTED|Overall Study||106
9714130|NCT03462719|10813440|FG001|STARTED|Overall Study||105
9714131|NCT03462719|10813439|FG000|COMPLETED|Overall Study||11
9714132|NCT03462719|10813440|FG001|COMPLETED|Overall Study||11
9714133|NCT03462719|10813439|FG000|NOT COMPLETED|Overall Study||95
9714134|NCT03462719|10813440|FG001|NOT COMPLETED|Overall Study||94
9714135|NCT03332589|10813449|FG000|STARTED|Overall Study||4
9714136|NCT03332589|10813450|FG001|STARTED|Overall Study||0
9714137|NCT03332589|10813451|FG002|STARTED|Overall Study||0
9714138|NCT03332589|10813449|FG000|COMPLETED|Overall Study||0
9714139|NCT03332589|10813450|FG001|COMPLETED|Overall Study||0
9714140|NCT03332589|10813451|FG002|COMPLETED|Overall Study||0
9714141|NCT03332589|10813449|FG000|NOT COMPLETED|Overall Study||4
9714142|NCT03332589|10813450|FG001|NOT COMPLETED|Overall Study||0
9714143|NCT03332589|10813451|FG002|NOT COMPLETED|Overall Study||0
9731308|NCT00131664|10831248|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
9731309|NCT00131664|10831249|FG003|STARTED|Second Period (Additional Drug Added)||21
9731310|NCT00131664|10831250|FG004|STARTED|Second Period (Additional Drug Added)||16
9731311|NCT00131664|10831251|FG005|STARTED|Second Period (Additional Drug Added)||25
9731312|NCT00131664|10831246|FG000|COMPLETED|Second Period (Additional Drug Added)||81
9731313|NCT00131664|10831247|FG001|COMPLETED|Second Period (Additional Drug Added)||97
9731314|NCT00131664|10831248|FG002|COMPLETED|Second Period (Additional Drug Added)||76
9731315|NCT00131664|10831249|FG003|COMPLETED|Second Period (Additional Drug Added)||19
9731316|NCT00131664|10831250|FG004|COMPLETED|Second Period (Additional Drug Added)||15
9731317|NCT00131664|10831251|FG005|COMPLETED|Second Period (Additional Drug Added)||22
9731318|NCT00131664|10831246|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9
9731319|NCT00131664|10831247|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4
9731950|NCT00138034|10831935|FG000|COMPLETED|Overall Study||23
10179429|NCT03150758|11309632|FG000|STARTED|Overall Study||6
10179430|NCT03150758|11309632|FG000|COMPLETED|Overall Study||6
10179431|NCT03150758|11309632|FG000|NOT COMPLETED|Overall Study||0
10179432|NCT03150875|11309638|FG000|STARTED|Overall Study||145
10179433|NCT03150875|11309639|FG001|STARTED|Overall Study||145
10179434|NCT03150875|11309638|FG000|Treated|Overall Study||144
10179435|NCT03150875|11309639|FG001|Treated|Overall Study||130
10179436|NCT03150875|11309638|FG000|Crossover to Certain Treatment|Overall Study||0
10179437|NCT03150875|11309639|FG001|Crossover to Certain Treatment|Overall Study||0
10179438|NCT03150875|11309638|FG000|COMPLETED|Overall Study||0
10179439|NCT03150875|11309639|FG001|COMPLETED|Overall Study||0
10179440|NCT03150875|11309638|FG000|NOT COMPLETED|Overall Study||145
10179441|NCT03150875|11309639|FG001|NOT COMPLETED|Overall Study||145
10179442|NCT03151148|11309647|FG000|STARTED|Overall Study||36
10179443|NCT03151148|11309648|FG001|STARTED|Overall Study||18
10179444|NCT03151148|11309647|FG000|COMPLETED|Overall Study||34
10179445|NCT03151148|11309648|FG001|COMPLETED|Overall Study||18
10179446|NCT03151148|11309647|FG000|NOT COMPLETED|Overall Study||2
10179447|NCT03151148|11309648|FG001|NOT COMPLETED|Overall Study||0
10179448|NCT03151265|11309657|FG000|STARTED|Overall Study||20
10179449|NCT03151265|11309658|FG001|STARTED|Overall Study||20
10179450|NCT03151265|11309657|FG000|COMPLETED|Overall Study||20
10179451|NCT03151265|11309658|FG001|COMPLETED|Overall Study||20
10179452|NCT03151265|11309657|FG000|NOT COMPLETED|Overall Study||0
10179453|NCT03151265|11309658|FG001|NOT COMPLETED|Overall Study||0
10179454|NCT03151395|11309664|FG000|STARTED|Overall Study||197
10179455|NCT03151395|11309664|FG000|COMPLETED|Overall Study||182
10179456|NCT03151395|11309664|FG000|NOT COMPLETED|Overall Study||15
10179457|NCT03151434|11309671|FG000|STARTED|Overall Study||53
10179458|NCT03151434|11309672|FG001|STARTED|Overall Study||47
10179459|NCT03151434|11309673|FG002|STARTED|Overall Study||47
10179460|NCT03151434|11309671|FG000|COMPLETED|Overall Study||40
10179461|NCT03151434|11309672|FG001|COMPLETED|Overall Study||40
10179462|NCT03151434|11309673|FG002|COMPLETED|Overall Study||40
10179463|NCT03151434|11309671|FG000|NOT COMPLETED|Overall Study||13
10179464|NCT03151434|11309672|FG001|NOT COMPLETED|Overall Study||7
10179465|NCT03151434|11309673|FG002|NOT COMPLETED|Overall Study||7
10179466|NCT03151551|11309686|FG000|STARTED|Open-Label Treatment Period||283
10179467|NCT03151551|11309687|FG001|STARTED|Open-Label Treatment Period||283
10179468|NCT03151551|11309686|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
10179469|NCT03151551|11309687|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
10179470|NCT03151551|11309686|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
10179471|NCT03151551|11309687|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
10179472|NCT03151551|11309686|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
10179473|NCT03151551|11309687|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
10179474|NCT03151551|11309686|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
10179475|NCT03151551|11309687|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
10179476|NCT03151551|11309686|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
10179477|NCT03151551|11309687|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
10179478|NCT03151551|11309686|FG000|COMPLETED|Open-Label Treatment Period||265
10179479|NCT03151551|11309687|FG001|COMPLETED|Open-Label Treatment Period||259
10179480|NCT03151551|11309686|FG000|NOT COMPLETED|Open-Label Treatment Period||18
10179481|NCT03151551|11309687|FG001|NOT COMPLETED|Open-Label Treatment Period||24
10179482|NCT03151551|11309686|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
10179483|NCT03151551|11309687|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
10179484|NCT03151551|11309686|FG000|COMPLETED|Post-Treatment Follow-Up Period||240
10179485|NCT03151551|11309687|FG001|COMPLETED|Post-Treatment Follow-Up Period||230
10179486|NCT03151551|11309686|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25
10179487|NCT03151551|11309687|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28
10179488|NCT03152019|11309697|FG000|STARTED|Overall Study||25
10179489|NCT03152019|11309698|FG001|STARTED|Overall Study||25
10179490|NCT03152019|11309697|FG000|COMPLETED|Overall Study||25
10179491|NCT03152019|11309698|FG001|COMPLETED|Overall Study||24
10179492|NCT03152019|11309697|FG000|NOT COMPLETED|Overall Study||0
10179493|NCT03152019|11309698|FG001|NOT COMPLETED|Overall Study||1
10179494|NCT03152084|11309706|FG000|STARTED|Overall Study||17
10179495|NCT03152084|11309707|FG001|STARTED|Overall Study||7
10179496|NCT03152084|11309706|FG000|COMPLETED|Overall Study||17
10179497|NCT03152084|11309707|FG001|COMPLETED|Overall Study||7
10179498|NCT03152084|11309706|FG000|NOT COMPLETED|Overall Study||0
10179499|NCT03152084|11309707|FG001|NOT COMPLETED|Overall Study||0
10179500|NCT03152110|11309713|FG000|STARTED|Overall Study||10
10179501|NCT03152110|11309713|FG000|COMPLETED|Overall Study||7
10179502|NCT03152110|11309713|FG000|NOT COMPLETED|Overall Study||3
10179503|NCT03152136|11309721|FG000|STARTED|Overall Study||32
10179504|NCT03152136|11309722|FG001|STARTED|Overall Study||15
10179505|NCT03152136|11309723|FG002|STARTED|Overall Study||15
10179506|NCT03152136|11309721|FG000|COMPLETED|Overall Study||29
10179507|NCT03152136|11309722|FG001|COMPLETED|Overall Study||15
10179508|NCT03152136|11309723|FG002|COMPLETED|Overall Study||14
10179509|NCT03152136|11309721|FG000|NOT COMPLETED|Overall Study||3
10179510|NCT03152136|11309722|FG001|NOT COMPLETED|Overall Study||0
10179511|NCT03152136|11309723|FG002|NOT COMPLETED|Overall Study||1
10179512|NCT03152552|11309735|FG000|STARTED|Treatment Period 1 (12 Weeks)||15
10179513|NCT03152552|11309736|FG001|STARTED|Treatment Period 1 (12 Weeks)||16
10179514|NCT03152552|11309737|FG002|STARTED|Treatment Period 1 (12 Weeks)||31
10179515|NCT03152552|11309738|FG003|STARTED|Treatment Period 1 (12 Weeks)||30
10179516|NCT03152552|11309739|FG004|STARTED|Treatment Period 1 (12 Weeks)||33
10179517|NCT03152552|11309735|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
10179518|NCT03152552|11309736|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
10179519|NCT03152552|11309737|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
10179520|NCT03152552|11309738|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
10179521|NCT03152552|11309739|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
9714144|NCT03091192|10813461|FG000|STARTED|Overall Study||33
9714145|NCT03091192|10813462|FG001|STARTED|Overall Study||27
9714146|NCT03091192|10813461|FG000|COMPLETED|Overall Study||0
9714147|NCT03091192|10813462|FG001|COMPLETED|Overall Study||0
9714148|NCT03091192|10813461|FG000|NOT COMPLETED|Overall Study||33
9849727|NCT00867100|10962521|FG005|STARTED|Overall Study||6
9849728|NCT00867100|10962522|FG006|STARTED|Overall Study||7
10179522|NCT03152552|11309735|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7
10179523|NCT03152552|11309736|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5
10179524|NCT03152552|11309737|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10
10179525|NCT03152552|11309738|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10
10179526|NCT03152552|11309739|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12
10179527|NCT03152552|11309735|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
10179528|NCT03152552|11309736|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
10179529|NCT03152552|11309737|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
10179530|NCT03152552|11309738|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
10179531|NCT03152552|11309739|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
10179532|NCT03152552|11309735|FG000|STARTED|Treatment Period 2 (24 Weeks)||7
10179533|NCT03152552|11309736|FG001|STARTED|Treatment Period 2 (24 Weeks)||5
10179534|NCT03152552|11309737|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
10179535|NCT03152552|11309738|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
10179536|NCT03152552|11309739|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
10179537|NCT03152552|11309735|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1
10179538|NCT03152552|11309736|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0
10179539|NCT03152552|11309737|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0
10179540|NCT03152552|11309738|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0
10179541|NCT03152552|11309739|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0
10179542|NCT03152552|11309735|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
10179543|NCT03152552|11309736|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
10179544|NCT03152552|11309737|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
10179545|NCT03152552|11309738|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
10179546|NCT03152552|11309739|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
10179547|NCT03152591|11309754|FG000|STARTED|Overall Study||15
10179548|NCT03152591|11309755|FG001|STARTED|Overall Study||14
10179549|NCT03152591|11309754|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14
10179550|NCT03152591|11309755|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10179551|NCT03152591|11309754|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15
10179552|NCT03152591|11309755|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14
10179553|NCT03152591|11309754|FG000|COMPLETED|Overall Study||15
10179554|NCT03152591|11309755|FG001|COMPLETED|Overall Study||14
10179555|NCT03152591|11309754|FG000|NOT COMPLETED|Overall Study||0
10179556|NCT03152591|11309755|FG001|NOT COMPLETED|Overall Study||0
10179557|NCT03153956|11309763|FG000|STARTED|Overall Study||39
10179558|NCT03153956|11309764|FG001|STARTED|Overall Study||38
10179559|NCT03153956|11309763|FG000|COMPLETED|Overall Study||39
10179560|NCT03153956|11309764|FG001|COMPLETED|Overall Study||38
10179561|NCT03153956|11309763|FG000|NOT COMPLETED|Overall Study||0
10179562|NCT03153956|11309764|FG001|NOT COMPLETED|Overall Study||0
10179563|NCT03154047|11309770|FG000|STARTED|Overall Study||80
10179564|NCT03154047|11309770|FG000|Number of Patients Dosed|Overall Study||80
10179565|NCT03154047|11309770|FG000|COMPLETED|Overall Study||0
10179566|NCT03154047|11309770|FG000|NOT COMPLETED|Overall Study||80
10179567|NCT03154086|11309789|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179568|NCT03154086|11309790|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179569|NCT03154086|11309791|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179570|NCT03154086|11309792|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179571|NCT03154086|11309793|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179572|NCT03154086|11309794|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179573|NCT03154086|11309795|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179574|NCT03154086|11309796|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179575|NCT03154086|11309797|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179576|NCT03154086|11309798|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179577|NCT03154086|11309799|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179578|NCT03154086|11309800|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179579|NCT03154086|11309801|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179580|NCT03154086|11309802|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179581|NCT03154086|11309803|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179582|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179583|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179584|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179585|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10179586|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179587|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179588|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179589|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179590|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179591|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179592|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179593|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179594|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179595|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179596|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179597|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179598|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179599|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179600|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179601|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179602|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179603|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179604|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179605|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179606|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179607|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179608|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179609|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179610|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179611|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10179612|NCT03154086|11309789|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10179613|NCT03154086|11309790|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10179614|NCT03154086|11309791|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10179615|NCT03154086|11309792|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10179616|NCT03154086|11309793|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179617|NCT03154086|11309794|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179618|NCT03154086|11309795|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179619|NCT03154086|11309796|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179620|NCT03154086|11309797|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179621|NCT03154086|11309798|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179622|NCT03154086|11309799|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179623|NCT03154086|11309800|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179624|NCT03154086|11309801|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179625|NCT03154086|11309802|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179626|NCT03154086|11309803|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179627|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10179628|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10179629|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10179630|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
10179631|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179632|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179633|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179634|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179635|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179636|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179637|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179638|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179639|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179640|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179641|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179642|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179643|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179644|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179645|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
10179646|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179647|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179648|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179649|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179650|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179651|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179652|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179653|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179654|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179655|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179656|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10179657|NCT03154086|11309789|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10179658|NCT03154086|11309790|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10179659|NCT03154086|11309791|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10179660|NCT03154086|11309792|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
10179661|NCT03154086|11309793|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179662|NCT03154086|11309794|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179663|NCT03154086|11309795|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179664|NCT03154086|11309796|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179665|NCT03154086|11309797|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179666|NCT03154086|11309798|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179667|NCT03154086|11309799|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179668|NCT03154086|11309800|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179669|NCT03154086|11309801|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179670|NCT03154086|11309802|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179671|NCT03154086|11309803|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179672|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10179673|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10179674|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10179675|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10179676|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179677|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179678|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179679|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179680|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179681|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179682|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179683|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179684|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179685|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179686|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179687|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179688|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179689|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179690|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179691|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179692|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179693|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179694|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179695|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179696|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179697|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179698|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179699|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179700|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179701|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10179702|NCT03154086|11309789|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10179703|NCT03154086|11309790|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10179704|NCT03154086|11309791|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10179705|NCT03154086|11309792|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10179706|NCT03154086|11309793|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179707|NCT03154086|11309794|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179708|NCT03154086|11309795|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179709|NCT03154086|11309796|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179710|NCT03154086|11309797|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179711|NCT03154086|11309798|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179712|NCT03154086|11309799|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179713|NCT03154086|11309800|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179714|NCT03154086|11309801|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179715|NCT03154086|11309802|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179716|NCT03154086|11309803|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179717|NCT03154086|11309789|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10179718|NCT03154086|11309790|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
10179719|NCT03154086|11309791|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10179720|NCT03154086|11309792|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10179721|NCT03154086|11309793|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179722|NCT03154086|11309794|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179723|NCT03154086|11309795|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179724|NCT03154086|11309796|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179725|NCT03154086|11309797|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179726|NCT03154086|11309798|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179727|NCT03154086|11309799|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179728|NCT03154086|11309800|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179729|NCT03154086|11309801|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179730|NCT03154086|11309802|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179731|NCT03154086|11309803|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179732|NCT03154086|11309789|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179733|NCT03154086|11309790|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
10179734|NCT03154086|11309791|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179735|NCT03154086|11309792|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179736|NCT03154086|11309793|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179737|NCT03154086|11309794|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179738|NCT03154086|11309795|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179739|NCT03154086|11309796|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9714149|NCT03091192|10813462|FG001|NOT COMPLETED|Overall Study||27
9714150|NCT02717611|10813468|FG000|STARTED|Overall Study||60
9714151|NCT02717611|10813468|FG000|COMPLETED|Overall Study||0
9714152|NCT02717611|10813468|FG000|NOT COMPLETED|Overall Study||60
9714153|NCT02301156|10813474|FG000|STARTED|Overall Study||64
9714154|NCT02301156|10813475|FG001|STARTED|Overall Study||62
9714155|NCT02301156|10813474|FG000|Intent to Treat (ITT) Population|Overall Study||64
9714156|NCT02301156|10813475|FG001|Intent to Treat (ITT) Population|Overall Study||62
9714157|NCT02301156|10813474|FG000|Safety Population|Overall Study||59
9714158|NCT02301156|10813475|FG001|Safety Population|Overall Study||58
9714159|NCT02301156|10813474|FG000|COMPLETED|Overall Study||11
9714160|NCT02301156|10813475|FG001|COMPLETED|Overall Study||10
9714161|NCT02301156|10813474|FG000|NOT COMPLETED|Overall Study||53
9714162|NCT02301156|10813475|FG001|NOT COMPLETED|Overall Study||52
9714163|NCT02296125|10813483|FG000|STARTED|Overall Study||279
9714164|NCT02296125|10813484|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
9714165|NCT02296125|10813485|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
9714166|NCT02296125|10813486|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
9714167|NCT02296125|10813483|FG000|COMPLETED|Overall Study||61
9714168|NCT02296125|10813484|FG001|COMPLETED|Overall Study||13
9714169|NCT02296125|10813485|FG002|COMPLETED|Overall Study||15
9714170|NCT02296125|10813486|FG003|COMPLETED|Overall Study||3
9714171|NCT02296125|10813483|FG000|NOT COMPLETED|Overall Study||218
9714172|NCT02296125|10813484|FG001|NOT COMPLETED|Overall Study||264
9714173|NCT02296125|10813485|FG002|NOT COMPLETED|Overall Study||56
9714174|NCT02296125|10813486|FG003|NOT COMPLETED|Overall Study||62
9714175|NCT02087423|10813500|FG000|STARTED|Overall Study|Treated|111
9714176|NCT02087423|10813501|FG001|STARTED|Overall Study|Treated|265
9714177|NCT02087423|10813502|FG002|STARTED|Overall Study|Treated|68
9714178|NCT02087423|10813500|FG000|Completed 12 Months of Treatment|Overall Study||18
9714179|NCT02087423|10813501|FG001|Completed 12 Months of Treatment|Overall Study||60
9714180|NCT02087423|10813502|FG002|Completed 12 Months of Treatment|Overall Study||26
9714181|NCT02087423|10813500|FG000|COMPLETED|Overall Study||0
9714182|NCT02087423|10813501|FG001|COMPLETED|Overall Study||0
9714183|NCT02087423|10813502|FG002|COMPLETED|Overall Study||0
9714184|NCT02087423|10813500|FG000|NOT COMPLETED|Overall Study||111
9714185|NCT02087423|10813501|FG001|NOT COMPLETED|Overall Study||265
9714186|NCT02087423|10813502|FG002|NOT COMPLETED|Overall Study||68
10061768|NCT02105974|11187335|FG000|COMPLETED|2 Week Run-in Period||1622
10061769|NCT02105974|11187336|FG001|COMPLETED|2 Week Run-in Period||0
10061770|NCT02105974|11187337|FG002|COMPLETED|2 Week Run-in Period||0
10061771|NCT02105974|11187335|FG000|NOT COMPLETED|2 Week Run-in Period||801
10061772|NCT02105974|11187336|FG001|NOT COMPLETED|2 Week Run-in Period||0
10061773|NCT02105974|11187337|FG002|NOT COMPLETED|2 Week Run-in Period||0
10061774|NCT02105974|11187335|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0
10061775|NCT02105974|11187336|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806
10061776|NCT02105974|11187337|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814
10061777|NCT02105974|11187335|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
10061778|NCT02105974|11187336|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
10061779|NCT02105974|11187337|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
10061780|NCT02105974|11187335|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
10061781|NCT02105974|11187336|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
10061782|NCT02105974|11187337|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
10061783|NCT02105974|11187335|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
10061784|NCT02105974|11187336|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
10061785|NCT02105974|11187337|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
10061786|NCT02105987|11187345|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
10061787|NCT02105987|11187346|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
10061788|NCT02105987|11187347|FG002|STARTED|Early Switch Phase (24 Weeks)||0
10061789|NCT02105987|11187348|FG003|STARTED|Early Switch Phase (24 Weeks)||0
10061790|NCT02105987|11187349|FG004|STARTED|Early Switch Phase (24 Weeks)||0
10061791|NCT02105987|11187350|FG005|STARTED|Early Switch Phase (24 Weeks)||0
10061792|NCT02105987|11187345|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239
10061793|NCT02105987|11187346|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244
10061794|NCT02105987|11187347|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0
9714187|NCT01946204|10813514|FG000|STARTED|Overall Study||401
10179740|NCT03154086|11309797|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179741|NCT03154086|11309798|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179742|NCT03154086|11309799|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179743|NCT03154086|11309800|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179744|NCT03154086|11309801|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179745|NCT03154086|11309802|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179746|NCT03154086|11309803|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10179747|NCT03154086|11309789|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10179748|NCT03154086|11309790|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
10179749|NCT03154086|11309791|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10179750|NCT03154086|11309792|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10179751|NCT03154086|11309793|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179752|NCT03154086|11309794|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179753|NCT03154086|11309795|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179754|NCT03154086|11309796|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179755|NCT03154086|11309797|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9714188|NCT01946204|10813515|FG001|STARTED|Overall Study||806
9714189|NCT01946204|10813514|FG000|Treated|Overall Study||398
9714190|NCT01946204|10813515|FG001|Treated|Overall Study||803
9714191|NCT01946204|10813514|FG000|COMPLETED|Overall Study||0
9714192|NCT01946204|10813515|FG001|COMPLETED|Overall Study||0
9714193|NCT01946204|10813514|FG000|NOT COMPLETED|Overall Study||401
9714194|NCT01946204|10813515|FG001|NOT COMPLETED|Overall Study||806
9714195|NCT01626079|10813524|FG000|STARTED|Overall Study||302
9714196|NCT01626079|10813525|FG001|STARTED|Overall Study||312
9714197|NCT01626079|10813526|FG002|STARTED|Overall Study||162
9714198|NCT01626079|10813524|FG000|COMPLETED|Overall Study||152
9714199|NCT01626079|10813525|FG001|COMPLETED|Overall Study||111
9714200|NCT01626079|10813526|FG002|COMPLETED|Overall Study||110
9714201|NCT01626079|10813524|FG000|NOT COMPLETED|Overall Study||150
9714202|NCT01626079|10813525|FG001|NOT COMPLETED|Overall Study||201
9714203|NCT01626079|10813526|FG002|NOT COMPLETED|Overall Study||52
9714204|NCT01612351|10813537|FG000|STARTED|Chemotherapy||40
9714205|NCT01612351|10813537|FG000|COMPLETED|Chemotherapy||40
9714206|NCT01612351|10813537|FG000|NOT COMPLETED|Chemotherapy||0
9714207|NCT01612351|10813537|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
9714208|NCT01612351|10813537|FG000|COMPLETED|Transoral Surgery||39
9714209|NCT01612351|10813537|FG000|NOT COMPLETED|Transoral Surgery||0
9714210|NCT01612351|10813537|FG000|STARTED|Post-Operative Treatment||39
9714211|NCT01612351|10813537|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
9714212|NCT01612351|10813537|FG000|NOT COMPLETED|Post-Operative Treatment||0
9714213|NCT01590628|10813548|FG000|STARTED|Overall Study||13
9714214|NCT01590628|10813549|FG001|STARTED|Overall Study||3
9714215|NCT01590628|10813548|FG000|COMPLETED|Overall Study||11
9714216|NCT01590628|10813549|FG001|COMPLETED|Overall Study||3
9714217|NCT01590628|10813548|FG000|NOT COMPLETED|Overall Study||2
9714218|NCT01590628|10813549|FG001|NOT COMPLETED|Overall Study||0
9714219|NCT01533714|10813565|FG000|STARTED|Overall Study||10
9714220|NCT01533714|10813566|FG001|STARTED|Overall Study||15
9714221|NCT01533714|10813567|FG002|STARTED|Overall Study||11
9714222|NCT01533714|10813568|FG003|STARTED|Overall Study||15
9714223|NCT01533714|10813569|FG004|STARTED|Overall Study||28
9714224|NCT01533714|10813570|FG005|STARTED|Overall Study||24
9714225|NCT01533714|10813565|FG000|COMPLETED|Overall Study||10
9714226|NCT01533714|10813566|FG001|COMPLETED|Overall Study||12
9714227|NCT01533714|10813567|FG002|COMPLETED|Overall Study||7
9714228|NCT01533714|10813568|FG003|COMPLETED|Overall Study||11
9714229|NCT01533714|10813569|FG004|COMPLETED|Overall Study||21
9714230|NCT01533714|10813570|FG005|COMPLETED|Overall Study||21
9714231|NCT01533714|10813565|FG000|NOT COMPLETED|Overall Study||0
9714232|NCT01533714|10813566|FG001|NOT COMPLETED|Overall Study||3
9714233|NCT01533714|10813567|FG002|NOT COMPLETED|Overall Study||4
9714234|NCT01533714|10813568|FG003|NOT COMPLETED|Overall Study||4
9714235|NCT01533714|10813569|FG004|NOT COMPLETED|Overall Study||7
9714236|NCT01533714|10813570|FG005|NOT COMPLETED|Overall Study||3
9714237|NCT00002931|10813584|FG000|STARTED|Overall Study||48
9714238|NCT00002931|10813584|FG000|COMPLETED|Overall Study||46
9714239|NCT00002931|10813584|FG000|NOT COMPLETED|Overall Study||2
9714240|NCT00003138|10813590|FG000|STARTED|Step 1||61
9714241|NCT00003138|10813591|FG001|STARTED|Step 1||57
9714242|NCT00003138|10813590|FG000|Patients With Complete Data|Step 1||57
9714243|NCT00003138|10813591|FG001|Patients With Complete Data|Step 1||53
9714244|NCT00003138|10813590|FG000|Treated|Step 1||56
9714245|NCT00003138|10813591|FG001|Treated|Step 1||53
9714246|NCT00003138|10813590|FG000|Eligible and Treated|Step 1||52
9714247|NCT00003138|10813591|FG001|Eligible and Treated|Step 1||50
9714248|NCT00003138|10813590|FG000|Patients With QOL Data at 4 Months|Step 1||42
9714249|NCT00003138|10813591|FG001|Patients With QOL Data at 4 Months|Step 1||42
9714250|NCT00003138|10813590|FG000|Patients With Transfusion Data|Step 1||37
9714251|NCT00003138|10813591|FG001|Patients With Transfusion Data|Step 1||42
10179756|NCT03154086|11309798|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9714252|NCT00003138|10813590|FG000|COMPLETED|Step 1||0
9714253|NCT00003138|10813591|FG001|COMPLETED|Step 1||0
9714254|NCT00003138|10813590|FG000|NOT COMPLETED|Step 1||61
9714255|NCT00003138|10813591|FG001|NOT COMPLETED|Step 1||57
10179757|NCT03154086|11309799|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179758|NCT03154086|11309800|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179759|NCT03154086|11309801|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179760|NCT03154086|11309802|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179761|NCT03154086|11309803|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179762|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10179763|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10179764|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10179765|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10179766|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179767|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179768|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179769|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179770|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179771|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179772|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179773|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179774|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179775|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179776|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179777|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179778|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179779|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179780|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179781|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179782|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179783|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179784|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179785|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179786|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179787|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179788|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179789|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179790|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179791|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10179792|NCT03154086|11309789|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10179793|NCT03154086|11309790|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10179794|NCT03154086|11309791|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10179795|NCT03154086|11309792|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10179796|NCT03154086|11309793|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179797|NCT03154086|11309794|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179798|NCT03154086|11309795|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179799|NCT03154086|11309796|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179800|NCT03154086|11309797|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179801|NCT03154086|11309798|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179802|NCT03154086|11309799|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179803|NCT03154086|11309800|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179804|NCT03154086|11309801|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179805|NCT03154086|11309802|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179806|NCT03154086|11309803|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179807|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10179808|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10179809|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
10179810|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10179811|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179812|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179813|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179814|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179815|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179816|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179817|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179818|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179819|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179820|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179821|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179822|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179823|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179824|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
10179825|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179826|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179827|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179828|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179829|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179830|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179831|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179832|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179833|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179834|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179835|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179836|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10179837|NCT03154086|11309789|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
10179838|NCT03154086|11309790|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10179839|NCT03154086|11309791|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10179840|NCT03154086|11309792|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10179841|NCT03154086|11309793|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179842|NCT03154086|11309794|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179843|NCT03154086|11309795|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179844|NCT03154086|11309796|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179845|NCT03154086|11309797|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179846|NCT03154086|11309798|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179847|NCT03154086|11309799|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179848|NCT03154086|11309800|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179849|NCT03154086|11309801|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179850|NCT03154086|11309802|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179851|NCT03154086|11309803|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179852|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10179853|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10179854|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10179855|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10179856|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179857|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179858|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179859|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179860|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179861|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179862|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179863|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179864|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179865|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179866|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179867|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10179868|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179869|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179870|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179871|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179872|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179873|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179874|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179875|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179876|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179877|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179878|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179879|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179880|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179881|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10179882|NCT03154086|11309789|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179883|NCT03154086|11309790|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179884|NCT03154086|11309791|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179885|NCT03154086|11309792|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179886|NCT03154086|11309793|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
10179887|NCT03154086|11309794|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
10179888|NCT03154086|11309795|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179889|NCT03154086|11309796|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179890|NCT03154086|11309797|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179891|NCT03154086|11309798|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179892|NCT03154086|11309799|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179893|NCT03154086|11309800|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179894|NCT03154086|11309801|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179895|NCT03154086|11309802|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179896|NCT03154086|11309803|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179897|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179898|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179899|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179900|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179901|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
10179902|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
10179903|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179904|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9714256|NCT00003138|10813590|FG000|STARTED|Step 2 (Cross Over)||26
9714257|NCT00003138|10813591|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
9714258|NCT00003138|10813590|FG000|COMPLETED|Step 2 (Cross Over)||0
9714259|NCT00003138|10813591|FG001|COMPLETED|Step 2 (Cross Over)||0
9714260|NCT00003138|10813590|FG000|NOT COMPLETED|Step 2 (Cross Over)||26
9714261|NCT00003138|10813591|FG001|NOT COMPLETED|Step 2 (Cross Over)||0
9714262|NCT00003138|10813590|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
9714263|NCT00003138|10813591|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
9714264|NCT00003138|10813590|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
9714265|NCT00003138|10813591|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
9714266|NCT00003138|10813590|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
9714267|NCT00003138|10813591|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
9714268|NCT00003138|10813590|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
9714269|NCT00003138|10813591|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
9714270|NCT00003138|10813590|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
9714271|NCT00003138|10813591|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
9714272|NCT00003138|10813590|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
9714273|NCT00003138|10813591|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
9714274|NCT00003138|10813590|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
9714275|NCT00003138|10813591|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
9714276|NCT00003199|10813600|FG000|STARTED|Overall Study||50
9714277|NCT00003199|10813600|FG000|COMPLETED|Overall Study||28
9714278|NCT00003199|10813600|FG000|NOT COMPLETED|Overall Study||22
10061795|NCT02105987|11187348|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0
10061796|NCT02105987|11187349|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0
10061797|NCT02105987|11187350|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0
10061798|NCT02105987|11187345|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
10061799|NCT02105987|11187346|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
10061800|NCT02105987|11187347|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10061801|NCT02105987|11187348|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10061802|NCT02105987|11187349|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10061803|NCT02105987|11187350|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10061804|NCT02105987|11187345|FG000|STARTED|Late Switch Phase (24 Weeks)||0
10061805|NCT02105987|11187346|FG001|STARTED|Late Switch Phase (24 Weeks)||0
10061806|NCT02105987|11187347|FG002|STARTED|Late Switch Phase (24 Weeks)||275
10061807|NCT02105987|11187348|FG003|STARTED|Late Switch Phase (24 Weeks)||244
10061808|NCT02105987|11187349|FG004|STARTED|Late Switch Phase (24 Weeks)||0
10179905|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179906|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179907|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179908|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179909|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179910|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9714279|NCT00003222|10813606|FG000|STARTED|Overall Study||13
9714280|NCT00003222|10813607|FG001|STARTED|Overall Study||28
9714281|NCT00003222|10813606|FG000|COMPLETED|Overall Study||13
9714282|NCT00003222|10813607|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
9714283|NCT00003222|10813606|FG000|NOT COMPLETED|Overall Study||0
9714284|NCT00003222|10813607|FG001|NOT COMPLETED|Overall Study||1
9714285|NCT00003224|10813619|FG000|STARTED|Overall Study||4
9714286|NCT00003224|10813620|FG001|STARTED|Overall Study||5
9714287|NCT00003224|10813621|FG002|STARTED|Overall Study||4
9714288|NCT00003224|10813622|FG003|STARTED|Overall Study||2
9714289|NCT00003224|10813623|FG004|STARTED|Overall Study||4
9714290|NCT00003224|10813624|FG005|STARTED|Overall Study||3
9714291|NCT00003224|10813619|FG000|COMPLETED|Overall Study||4
9714292|NCT00003224|10813620|FG001|COMPLETED|Overall Study||5
9714293|NCT00003224|10813621|FG002|COMPLETED|Overall Study||4
9714294|NCT00003224|10813622|FG003|COMPLETED|Overall Study||2
9714295|NCT00003224|10813623|FG004|COMPLETED|Overall Study||4
9714296|NCT00003224|10813624|FG005|COMPLETED|Overall Study||3
9714297|NCT00003224|10813619|FG000|NOT COMPLETED|Overall Study||0
9714298|NCT00003224|10813620|FG001|NOT COMPLETED|Overall Study||0
9714299|NCT00003224|10813621|FG002|NOT COMPLETED|Overall Study||0
9714300|NCT00003224|10813622|FG003|NOT COMPLETED|Overall Study||0
9714301|NCT00003224|10813623|FG004|NOT COMPLETED|Overall Study||0
9714302|NCT00003224|10813624|FG005|NOT COMPLETED|Overall Study||0
9714303|NCT00003270|10813636|FG000|STARTED|Overall Study||20
9714304|NCT00003270|10813636|FG000|COMPLETED|Overall Study||20
9714305|NCT00003270|10813636|FG000|NOT COMPLETED|Overall Study||0
9731320|NCT00131664|10831248|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3
9731321|NCT00131664|10831249|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2
9731322|NCT00131664|10831250|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1
9731323|NCT00131664|10831251|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3
9731324|NCT00131677|10831264|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
9731325|NCT00131677|10831265|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
9731326|NCT00131677|10831264|FG000|COMPLETED|Overall Study||171
9731327|NCT00131677|10831265|FG001|COMPLETED|Overall Study||160
9731328|NCT00131677|10831264|FG000|NOT COMPLETED|Overall Study||30
9731329|NCT00131677|10831265|FG001|NOT COMPLETED|Overall Study||39
9731330|NCT00131885|10831280|FG000|STARTED|Time 1: First Intervention||9
9731331|NCT00131885|10831281|FG001|STARTED|Time 1: First Intervention||9
9731332|NCT00131885|10831282|FG002|STARTED|Time 1: First Intervention||9
9731333|NCT00131885|10831283|FG003|STARTED|Time 1: First Intervention||9
9731334|NCT00131885|10831280|FG000|COMPLETED|Time 1: First Intervention||9
9731335|NCT00131885|10831281|FG001|COMPLETED|Time 1: First Intervention||9
9731336|NCT00131885|10831282|FG002|COMPLETED|Time 1: First Intervention||9
9731337|NCT00131885|10831283|FG003|COMPLETED|Time 1: First Intervention||9
9731338|NCT00131885|10831280|FG000|NOT COMPLETED|Time 1: First Intervention||0
9731339|NCT00131885|10831281|FG001|NOT COMPLETED|Time 1: First Intervention||0
9731340|NCT00131885|10831282|FG002|NOT COMPLETED|Time 1: First Intervention||0
9731341|NCT00131885|10831283|FG003|NOT COMPLETED|Time 1: First Intervention||0
9731342|NCT00131885|10831280|FG000|STARTED|Time 2: Second Intervention||9
9731343|NCT00131885|10831281|FG001|STARTED|Time 2: Second Intervention||9
9731344|NCT00131885|10831282|FG002|STARTED|Time 2: Second Intervention||9
9731345|NCT00131885|10831283|FG003|STARTED|Time 2: Second Intervention||9
9731346|NCT00131885|10831280|FG000|COMPLETED|Time 2: Second Intervention||9
9731347|NCT00131885|10831281|FG001|COMPLETED|Time 2: Second Intervention||9
9731348|NCT00131885|10831282|FG002|COMPLETED|Time 2: Second Intervention||9
9731349|NCT00131885|10831283|FG003|COMPLETED|Time 2: Second Intervention||9
9731350|NCT00131885|10831280|FG000|NOT COMPLETED|Time 2: Second Intervention||0
9731351|NCT00131885|10831281|FG001|NOT COMPLETED|Time 2: Second Intervention||0
9731352|NCT00131885|10831282|FG002|NOT COMPLETED|Time 2: Second Intervention||0
9731353|NCT00131885|10831283|FG003|NOT COMPLETED|Time 2: Second Intervention||0
9731354|NCT00131911|10831295|FG000|STARTED|Overall Study||51
9731355|NCT00131911|10831296|FG001|STARTED|Overall Study||42
9731356|NCT00131911|10831295|FG000|COMPLETED|Overall Study||50
9849729|NCT00867100|10962523|FG007|STARTED|Overall Study||3
10179911|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179912|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179913|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179914|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179915|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179916|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179917|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179918|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179919|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179920|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179921|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179922|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179923|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179924|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179925|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179926|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10179927|NCT03154086|11309789|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179928|NCT03154086|11309790|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179929|NCT03154086|11309791|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179930|NCT03154086|11309792|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179931|NCT03154086|11309793|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
10179932|NCT03154086|11309794|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
10179933|NCT03154086|11309795|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179934|NCT03154086|11309796|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179935|NCT03154086|11309797|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179936|NCT03154086|11309798|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179937|NCT03154086|11309799|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179938|NCT03154086|11309800|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179939|NCT03154086|11309801|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179940|NCT03154086|11309802|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179941|NCT03154086|11309803|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179942|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179943|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179944|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179945|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179946|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
10179947|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
10179948|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179949|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179950|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179951|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179952|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179953|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179954|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179955|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179956|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179957|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179958|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179959|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179960|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179961|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179962|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179963|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179964|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179965|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179966|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179967|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179968|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179969|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179970|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179971|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10179972|NCT03154086|11309789|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179973|NCT03154086|11309790|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179974|NCT03154086|11309791|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179975|NCT03154086|11309792|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179976|NCT03154086|11309793|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
10179977|NCT03154086|11309794|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
10179978|NCT03154086|11309795|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179979|NCT03154086|11309796|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179980|NCT03154086|11309797|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179981|NCT03154086|11309798|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179982|NCT03154086|11309799|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179983|NCT03154086|11309800|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179984|NCT03154086|11309801|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179985|NCT03154086|11309802|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179986|NCT03154086|11309803|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179987|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179988|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179989|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179990|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179991|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
10179992|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
10179993|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179994|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179995|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179996|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179997|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179998|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10179999|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180000|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180001|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180002|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180003|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180004|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180005|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180006|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180007|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9714306|NCT04848662|10813642|FG000|STARTED|Period 1 (First Treatment Intervention)||6
9714307|NCT04848662|10813643|FG001|STARTED|Period 1 (First Treatment Intervention)||6
9714308|NCT04848662|10813642|FG000|COMPLETED|Period 1 (First Treatment Intervention)||6
9714309|NCT04848662|10813643|FG001|COMPLETED|Period 1 (First Treatment Intervention)||6
9714310|NCT04848662|10813642|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
9714311|NCT04848662|10813643|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
9714312|NCT04848662|10813642|FG000|STARTED|Period 2 (Second Treatment Intervention)||6
9714313|NCT04848662|10813643|FG001|STARTED|Period 2 (Second Treatment Intervention)||6
9714314|NCT04848662|10813642|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||5
9714315|NCT04848662|10813643|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||6
9714316|NCT04848662|10813642|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
9714317|NCT04848662|10813643|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
9714318|NCT04697693|10813649|FG000|STARTED|Overall Study||1
9714319|NCT04697693|10813649|FG000|COMPLETED|Overall Study||1
9714320|NCT04697693|10813649|FG000|NOT COMPLETED|Overall Study||0
9714321|NCT03969719|10813656|FG000|STARTED|Overall Study||54
9714322|NCT03969719|10813657|FG001|STARTED|Overall Study||55
9714323|NCT03969719|10813658|FG002|STARTED|Overall Study||55
9714324|NCT03969719|10813656|FG000|COMPLETED|Overall Study||50
9714325|NCT03969719|10813657|FG001|COMPLETED|Overall Study||46
9714326|NCT03969719|10813658|FG002|COMPLETED|Overall Study||50
9714327|NCT03969719|10813656|FG000|NOT COMPLETED|Overall Study||4
9714328|NCT03969719|10813657|FG001|NOT COMPLETED|Overall Study||9
9714329|NCT03969719|10813658|FG002|NOT COMPLETED|Overall Study||5
9714330|NCT03883477|10813668|FG000|STARTED|Overall Study||13
9714331|NCT03883477|10813669|FG001|STARTED|Overall Study||13
9714332|NCT03883477|10813668|FG000|COMPLETED|Overall Study||12
9714333|NCT03883477|10813669|FG001|COMPLETED|Overall Study||12
9714334|NCT03883477|10813668|FG000|NOT COMPLETED|Overall Study||1
9714335|NCT03883477|10813669|FG001|NOT COMPLETED|Overall Study||1
9714336|NCT03813108|10813681|FG000|STARTED|Overall Study||10
9714337|NCT03813108|10813682|FG001|STARTED|Overall Study||10
9714338|NCT03813108|10813683|FG002|STARTED|Overall Study||20
9714339|NCT03813108|10813684|FG003|STARTED|Overall Study||3
9714340|NCT03813108|10813685|FG004|STARTED|Overall Study||0
9714341|NCT03813108|10813686|FG005|STARTED|Overall Study||0
9714342|NCT03813108|10813681|FG000|COMPLETED|Overall Study||8
9714343|NCT03813108|10813682|FG001|COMPLETED|Overall Study||9
9714344|NCT03813108|10813683|FG002|COMPLETED|Overall Study||0
9714345|NCT03813108|10813684|FG003|COMPLETED|Overall Study||3
9714346|NCT03813108|10813685|FG004|COMPLETED|Overall Study||0
9714347|NCT03813108|10813686|FG005|COMPLETED|Overall Study||0
9714348|NCT03813108|10813681|FG000|NOT COMPLETED|Overall Study||2
9714349|NCT03813108|10813682|FG001|NOT COMPLETED|Overall Study||1
9714350|NCT03813108|10813683|FG002|NOT COMPLETED|Overall Study||20
9714351|NCT03813108|10813684|FG003|NOT COMPLETED|Overall Study||0
9714352|NCT03813108|10813685|FG004|NOT COMPLETED|Overall Study||0
9714353|NCT03813108|10813686|FG005|NOT COMPLETED|Overall Study||0
9714354|NCT03809611|10813698|FG000|STARTED|Overall Study||62
9714355|NCT03809611|10813699|FG001|STARTED|Overall Study||62
9714356|NCT03809611|10813698|FG000|COMPLETED|Overall Study||61
9714357|NCT03809611|10813699|FG001|COMPLETED|Overall Study||61
9714358|NCT03809611|10813698|FG000|NOT COMPLETED|Overall Study||1
9714359|NCT03809611|10813699|FG001|NOT COMPLETED|Overall Study||1
9714416|NCT03180736|10813777|FG001|COMPLETED|Overall Study||33
9714417|NCT03180736|10813776|FG000|NOT COMPLETED|Overall Study||91
9714418|NCT03180736|10813777|FG001|NOT COMPLETED|Overall Study||120
10180008|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180009|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180010|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180011|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180012|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180013|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180014|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180015|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180016|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10180017|NCT03154086|11309789|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180018|NCT03154086|11309790|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180019|NCT03154086|11309791|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180020|NCT03154086|11309792|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180021|NCT03154086|11309793|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180022|NCT03154086|11309794|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180023|NCT03154086|11309795|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10180024|NCT03154086|11309796|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10180025|NCT03154086|11309797|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
10180026|NCT03154086|11309798|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180027|NCT03154086|11309799|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180028|NCT03154086|11309800|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180029|NCT03154086|11309801|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180030|NCT03154086|11309802|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180031|NCT03154086|11309803|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180032|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180033|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180034|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180035|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180036|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180037|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180038|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10180039|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10180040|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
10180041|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180042|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180043|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180044|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180045|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180046|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180047|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180048|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180049|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180050|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180051|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180052|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180053|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180054|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180055|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180056|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180057|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180058|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180059|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180060|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180061|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10180062|NCT03154086|11309789|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180063|NCT03154086|11309790|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180064|NCT03154086|11309791|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180065|NCT03154086|11309792|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180066|NCT03154086|11309793|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180067|NCT03154086|11309794|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180068|NCT03154086|11309795|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10180069|NCT03154086|11309796|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10180070|NCT03154086|11309797|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
10180071|NCT03154086|11309798|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180072|NCT03154086|11309799|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180073|NCT03154086|11309800|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180074|NCT03154086|11309801|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180075|NCT03154086|11309802|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180076|NCT03154086|11309803|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180077|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180078|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180079|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180080|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180081|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180082|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180083|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10180084|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10180085|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
10180086|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180087|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180088|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180089|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180090|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180091|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180092|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180093|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180094|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180095|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180096|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180097|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180098|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180099|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180100|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180101|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180102|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180103|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180104|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180105|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180106|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10180107|NCT03154086|11309789|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180108|NCT03154086|11309790|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180109|NCT03154086|11309791|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180110|NCT03154086|11309792|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180111|NCT03154086|11309793|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180112|NCT03154086|11309794|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180113|NCT03154086|11309795|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10180114|NCT03154086|11309796|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10180115|NCT03154086|11309797|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
10180116|NCT03154086|11309798|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180117|NCT03154086|11309799|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180118|NCT03154086|11309800|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180119|NCT03154086|11309801|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180120|NCT03154086|11309802|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180121|NCT03154086|11309803|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180122|NCT03154086|11309789|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180123|NCT03154086|11309790|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180124|NCT03154086|11309791|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180125|NCT03154086|11309792|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180126|NCT03154086|11309793|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180127|NCT03154086|11309794|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180128|NCT03154086|11309795|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10180129|NCT03154086|11309796|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10180130|NCT03154086|11309797|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
10180131|NCT03154086|11309798|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180132|NCT03154086|11309799|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180133|NCT03154086|11309800|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180134|NCT03154086|11309801|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180135|NCT03154086|11309802|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180136|NCT03154086|11309803|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180137|NCT03154086|11309789|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180138|NCT03154086|11309790|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180139|NCT03154086|11309791|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180140|NCT03154086|11309792|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180141|NCT03154086|11309793|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180142|NCT03154086|11309794|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180143|NCT03154086|11309795|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180144|NCT03154086|11309796|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10180145|NCT03154086|11309797|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10180146|NCT03154086|11309798|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180147|NCT03154086|11309799|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180148|NCT03154086|11309800|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180149|NCT03154086|11309801|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180150|NCT03154086|11309802|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180151|NCT03154086|11309803|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10180152|NCT03154086|11309789|FG000|STARTED|Part B (Up to 25 Days)||0
10180153|NCT03154086|11309790|FG001|STARTED|Part B (Up to 25 Days)||0
10180154|NCT03154086|11309791|FG002|STARTED|Part B (Up to 25 Days)||0
10180155|NCT03154086|11309792|FG003|STARTED|Part B (Up to 25 Days)||0
10180156|NCT03154086|11309793|FG004|STARTED|Part B (Up to 25 Days)||0
10180157|NCT03154086|11309794|FG005|STARTED|Part B (Up to 25 Days)||0
10180158|NCT03154086|11309795|FG006|STARTED|Part B (Up to 25 Days)||0
10180159|NCT03154086|11309796|FG007|STARTED|Part B (Up to 25 Days)||0
10180160|NCT03154086|11309797|FG008|STARTED|Part B (Up to 25 Days)||0
10180161|NCT03154086|11309798|FG009|STARTED|Part B (Up to 25 Days)||10
10180162|NCT03154086|11309799|FG010|STARTED|Part B (Up to 25 Days)||6
10180163|NCT03154086|11309800|FG011|STARTED|Part B (Up to 25 Days)||6
10180164|NCT03154086|11309801|FG012|STARTED|Part B (Up to 25 Days)||6
10180165|NCT03154086|11309802|FG013|STARTED|Part B (Up to 25 Days)||6
10180166|NCT03154086|11309803|FG014|STARTED|Part B (Up to 25 Days)||6
10180167|NCT03154086|11309789|FG000|COMPLETED|Part B (Up to 25 Days)||0
10180168|NCT03154086|11309790|FG001|COMPLETED|Part B (Up to 25 Days)||0
10180169|NCT03154086|11309791|FG002|COMPLETED|Part B (Up to 25 Days)||0
10180170|NCT03154086|11309792|FG003|COMPLETED|Part B (Up to 25 Days)||0
10180171|NCT03154086|11309793|FG004|COMPLETED|Part B (Up to 25 Days)||0
10180172|NCT03154086|11309794|FG005|COMPLETED|Part B (Up to 25 Days)||0
10180173|NCT03154086|11309795|FG006|COMPLETED|Part B (Up to 25 Days)||0
10180174|NCT03154086|11309796|FG007|COMPLETED|Part B (Up to 25 Days)||0
10180175|NCT03154086|11309797|FG008|COMPLETED|Part B (Up to 25 Days)||0
10180176|NCT03154086|11309798|FG009|COMPLETED|Part B (Up to 25 Days)||10
10180177|NCT03154086|11309799|FG010|COMPLETED|Part B (Up to 25 Days)||5
10180178|NCT03154086|11309800|FG011|COMPLETED|Part B (Up to 25 Days)||6
10180179|NCT03154086|11309801|FG012|COMPLETED|Part B (Up to 25 Days)||6
10180180|NCT03154086|11309802|FG013|COMPLETED|Part B (Up to 25 Days)||6
10180181|NCT03154086|11309803|FG014|COMPLETED|Part B (Up to 25 Days)||6
10180182|NCT03154086|11309789|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0
10180183|NCT03154086|11309790|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0
10180184|NCT03154086|11309791|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0
10180185|NCT03154086|11309792|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0
10180186|NCT03154086|11309793|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0
10180187|NCT03154086|11309794|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0
10180188|NCT03154086|11309795|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0
10180189|NCT03154086|11309796|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0
10180190|NCT03154086|11309797|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0
10180191|NCT03154086|11309798|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0
10180192|NCT03154086|11309799|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1
10180193|NCT03154086|11309800|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0
10180194|NCT03154086|11309801|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0
10180195|NCT03154086|11309802|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0
10180196|NCT03154086|11309803|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0
10180197|NCT03154333|11309861|FG000|STARTED|Overall Study||28
10180198|NCT03154333|11309862|FG001|STARTED|Overall Study||26
10180199|NCT03154333|11309861|FG000|COMPLETED|Overall Study||21
10180200|NCT03154333|11309862|FG001|COMPLETED|Overall Study||21
10180201|NCT03154333|11309861|FG000|NOT COMPLETED|Overall Study||7
10180202|NCT03154333|11309862|FG001|NOT COMPLETED|Overall Study||5
10180203|NCT03154476|11309871|FG000|STARTED|Overall Study||10
10180204|NCT03154476|11309872|FG001|STARTED|Overall Study||10
10180205|NCT03154476|11309871|FG000|COMPLETED|Overall Study||6
10180206|NCT03154476|11309872|FG001|COMPLETED|Overall Study||6
10180207|NCT03154476|11309871|FG000|NOT COMPLETED|Overall Study||4
10180208|NCT03154476|11309872|FG001|NOT COMPLETED|Overall Study||4
10180209|NCT03154658|11309880|FG000|STARTED|Overall Study||33
10180210|NCT03154658|11309881|FG001|STARTED|Overall Study||33
10180211|NCT03154658|11309880|FG000|COMPLETED|Overall Study||32
10180212|NCT03154658|11309881|FG001|COMPLETED|Overall Study||32
10180213|NCT03154658|11309880|FG000|NOT COMPLETED|Overall Study||1
10180214|NCT03154658|11309881|FG001|NOT COMPLETED|Overall Study||1
10180215|NCT03154710|11309889|FG000|STARTED|Overall Study||27
10180216|NCT03154710|11309890|FG001|STARTED|Overall Study||25
10180217|NCT03154710|11309889|FG000|COMPLETED|Overall Study||20
10180218|NCT03154710|11309890|FG001|COMPLETED|Overall Study||20
10180219|NCT03154710|11309889|FG000|NOT COMPLETED|Overall Study||7
10180220|NCT03154710|11309890|FG001|NOT COMPLETED|Overall Study||5
10180221|NCT03155178|11309900|FG000|STARTED|Overall Study||69
10180222|NCT03155178|11309901|FG001|STARTED|Overall Study||69
10180223|NCT03155178|11309902|FG002|STARTED|Overall Study||69
10180224|NCT03155178|11309903|FG003|STARTED|Overall Study||69
10180225|NCT03155178|11309900|FG000|COMPLETED|Overall Study||62
10180226|NCT03155178|11309901|FG001|COMPLETED|Overall Study||62
10180227|NCT03155178|11309902|FG002|COMPLETED|Overall Study||62
10180228|NCT03155178|11309903|FG003|COMPLETED|Overall Study||62
10180229|NCT03155178|11309900|FG000|NOT COMPLETED|Overall Study||7
10180230|NCT03155178|11309901|FG001|NOT COMPLETED|Overall Study||7
10180231|NCT03155178|11309902|FG002|NOT COMPLETED|Overall Study||7
10180232|NCT03155178|11309903|FG003|NOT COMPLETED|Overall Study||7
10180233|NCT03155269|11309919|FG000|STARTED|Overall Study||57
10180234|NCT03155269|11309920|FG001|STARTED|Overall Study||57
10180235|NCT03155269|11309919|FG000|COMPLETED|Overall Study||52
10180236|NCT03155269|11309920|FG001|COMPLETED|Overall Study||50
10180237|NCT03155269|11309919|FG000|NOT COMPLETED|Overall Study||5
10180238|NCT03155269|11309920|FG001|NOT COMPLETED|Overall Study||7
10180239|NCT03155724|11309926|FG000|STARTED|Overall Study||53
10180240|NCT03155724|11309926|FG000|COMPLETED|Overall Study||42
10180241|NCT03155724|11309926|FG000|NOT COMPLETED|Overall Study||11
10180242|NCT03155945|11309932|FG000|STARTED|Overall Study||6
10180243|NCT03155945|11309933|FG001|STARTED|Overall Study||8
10180244|NCT03155945|11309932|FG000|COMPLETED|Overall Study||6
10180245|NCT03155945|11309933|FG001|COMPLETED|Overall Study||5
10180246|NCT03155945|11309932|FG000|NOT COMPLETED|Overall Study||0
10180247|NCT03155945|11309933|FG001|NOT COMPLETED|Overall Study||3
10180248|NCT03156270|11309939|FG000|STARTED|Overall Study||20
10180249|NCT03156270|11309939|FG000|COMPLETED|Overall Study||18
10180250|NCT03156270|11309939|FG000|NOT COMPLETED|Overall Study||2
10180251|NCT03156543|11309947|FG000|STARTED|Overall Study||9
10180252|NCT03156543|11309948|FG001|STARTED|Overall Study||23
10180253|NCT03156543|11309947|FG000|COMPLETED|Overall Study||8
10180254|NCT03156543|11309948|FG001|COMPLETED|Overall Study||23
10180255|NCT03156543|11309947|FG000|NOT COMPLETED|Overall Study||1
10180256|NCT03156543|11309948|FG001|NOT COMPLETED|Overall Study||0
10180257|NCT03156621|11309956|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24
10180258|NCT03156621|11309957|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45
10180259|NCT03156621|11309956|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24
10180260|NCT03156621|11309957|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45
10180261|NCT03156621|11309956|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
10180262|NCT03156621|11309957|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
10180263|NCT03156621|11309956|FG000|STARTED|Open-Label Treatment Period (OLTP)||24
10180264|NCT03156621|11309957|FG001|STARTED|Open-Label Treatment Period (OLTP)||45
10180265|NCT03156621|11309956|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24
10180266|NCT03156621|11309957|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42
10180267|NCT03156621|11309956|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
10180268|NCT03156621|11309957|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
10180269|NCT03157089|11309968|FG000|STARTED|Overall Study||12
10180270|NCT03157089|11309969|FG001|STARTED|Overall Study||12
10180271|NCT03157089|11309968|FG000|Treated|Overall Study||12
10180272|NCT03157089|11309969|FG001|Treated|Overall Study||12
10180273|NCT03157089|11309968|FG000|COMPLETED|Overall Study||0
10180274|NCT03157089|11309969|FG001|COMPLETED|Overall Study||0
10180275|NCT03157089|11309968|FG000|NOT COMPLETED|Overall Study||12
10180276|NCT03157089|11309969|FG001|NOT COMPLETED|Overall Study||12
10180277|NCT03157232|11309976|FG000|STARTED|Overall Study||18
10180278|NCT03157232|11309976|FG000|COMPLETED|Overall Study||18
10180279|NCT03157232|11309976|FG000|NOT COMPLETED|Overall Study||0
10180280|NCT03157531|11309980|FG000|STARTED|Overall Study||97
10180281|NCT03157531|11309980|FG000|Analyzed at 30 Days For MAEs|Overall Study||93
10180282|NCT03157531|11309980|FG000|COMPLETED|Overall Study||91
10180283|NCT03157531|11309980|FG000|NOT COMPLETED|Overall Study||6
10180284|NCT03157583|11309984|FG000|STARTED|Overall Study||8
10180285|NCT03157583|11309984|FG000|COMPLETED|Overall Study||7
10180286|NCT03157583|11309984|FG000|NOT COMPLETED|Overall Study||1
10180287|NCT03158012|11310004|FG000|STARTED|Overall Study||8
10180288|NCT03158012|11310005|FG001|STARTED|Overall Study||7
10180289|NCT03158012|11310004|FG000|COMPLETED|Overall Study||8
10180290|NCT03158012|11310005|FG001|COMPLETED|Overall Study||6
10180291|NCT03158012|11310004|FG000|NOT COMPLETED|Overall Study||0
10180292|NCT03158012|11310005|FG001|NOT COMPLETED|Overall Study||1
10180293|NCT03158038|11310013|FG000|STARTED|Overall Study||240
10180294|NCT03158038|11310014|FG001|STARTED|Overall Study||60
10180295|NCT03158038|11310013|FG000|COMPLETED|Overall Study||240
10180296|NCT03158038|11310014|FG001|COMPLETED|Overall Study||60
10180297|NCT03158038|11310013|FG000|NOT COMPLETED|Overall Study||0
10180298|NCT03158038|11310014|FG001|NOT COMPLETED|Overall Study||0
10180299|NCT03158116|11310020|FG000|STARTED|Overall Study||5
10180300|NCT03158116|11310020|FG000|COMPLETED|Overall Study||5
10180301|NCT03158116|11310020|FG000|NOT COMPLETED|Overall Study||0
10180302|NCT03158220|11310026|FG000|STARTED|Overall Study||570
10180303|NCT03158220|11310027|FG001|STARTED|Overall Study||642
10180304|NCT03158220|11310026|FG000|Vaccination 1|Overall Study||570
10180305|NCT03158220|11310027|FG001|Vaccination 1|Overall Study||640
10180306|NCT03158220|11310026|FG000|Vaccination 2|Overall Study||563
10180307|NCT03158220|11310027|FG001|Vaccination 2|Overall Study||635
10180308|NCT03158220|11310026|FG000|Vaccination 3|Overall Study||556
10180309|NCT03158220|11310027|FG001|Vaccination 3|Overall Study||629
10180310|NCT03158220|11310026|FG000|COMPLETED|Overall Study||553
10180311|NCT03158220|11310027|FG001|COMPLETED|Overall Study||626
10180312|NCT03158220|11310026|FG000|NOT COMPLETED|Overall Study||17
10180313|NCT03158220|11310027|FG001|NOT COMPLETED|Overall Study||16
10180314|NCT03158272|11310037|FG000|STARTED|Overall Study||3
10180315|NCT03158272|11310038|FG001|STARTED|Overall Study||4
10180316|NCT03158272|11310039|FG002|STARTED|Overall Study||6
10180317|NCT03158272|11310040|FG003|STARTED|Overall Study||6
10180318|NCT03158272|11310037|FG000|COMPLETED|Overall Study||0
10180319|NCT03158272|11310038|FG001|COMPLETED|Overall Study||0
10180320|NCT03158272|11310039|FG002|COMPLETED|Overall Study||0
10180321|NCT03158272|11310040|FG003|COMPLETED|Overall Study||0
10180322|NCT03158272|11310037|FG000|NOT COMPLETED|Overall Study||3
10180323|NCT03158272|11310038|FG001|NOT COMPLETED|Overall Study||4
10180324|NCT03158272|11310039|FG002|NOT COMPLETED|Overall Study||6
10180325|NCT03158272|11310040|FG003|NOT COMPLETED|Overall Study||6
10180326|NCT03158311|11310055|FG000|STARTED|Overall Study||474
10180327|NCT03158311|11310056|FG001|STARTED|Overall Study||476
10180328|NCT03158311|11310057|FG002|STARTED|Overall Study||476
10180329|NCT03158311|11310055|FG000|Full Analysis Set (FAS)|Overall Study||474
10180330|NCT03158311|11310056|FG001|Full Analysis Set (FAS)|Overall Study||476
10180331|NCT03158311|11310057|FG002|Full Analysis Set (FAS)|Overall Study||475
10180332|NCT03158311|11310055|FG000|Safety Set (SAF)|Overall Study||474
10180333|NCT03158311|11310056|FG001|Safety Set (SAF)|Overall Study||476
10180334|NCT03158311|11310057|FG002|Safety Set (SAF)|Overall Study||475
10180335|NCT03158311|11310055|FG000|COMPLETED|Overall Study||452
10180336|NCT03158311|11310056|FG001|COMPLETED|Overall Study||460
10180337|NCT03158311|11310057|FG002|COMPLETED|Overall Study||448
10180338|NCT03158311|11310055|FG000|NOT COMPLETED|Overall Study||22
10180339|NCT03158311|11310056|FG001|NOT COMPLETED|Overall Study||16
10180340|NCT03158311|11310057|FG002|NOT COMPLETED|Overall Study||28
10180341|NCT03158714|11310068|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
10180342|NCT03158714|11310069|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
10180343|NCT03158714|11310070|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606
10180344|NCT03158714|11310068|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445
10180345|NCT03158714|11310069|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398
10180346|NCT03158714|11310070|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606
10180347|NCT03158714|11310068|FG000|NOT COMPLETED|Overall Study||181
10180348|NCT03158714|11310069|FG001|NOT COMPLETED|Overall Study||228
10180349|NCT03158714|11310070|FG002|NOT COMPLETED|Overall Study||0
10180350|NCT03159091|11310080|FG000|STARTED|Overall Study||121
10180351|NCT03159091|11310081|FG001|STARTED|Overall Study||117
10180352|NCT03159091|11310080|FG000|COMPLETED|Overall Study||116
10180353|NCT03159091|11310081|FG001|COMPLETED|Overall Study||113
10180354|NCT03159091|11310080|FG000|NOT COMPLETED|Overall Study||5
10180355|NCT03159091|11310081|FG001|NOT COMPLETED|Overall Study||4
10180356|NCT03159143|11310087|FG000|STARTED|Overall Study||22
10180357|NCT03159143|11310087|FG000|COMPLETED|Overall Study||22
10180358|NCT03159143|11310087|FG000|NOT COMPLETED|Overall Study||0
10180359|NCT03159260|11310093|FG000|STARTED|Overall Study||28
10180360|NCT03159260|11310094|FG001|STARTED|Overall Study||29
10180361|NCT03159260|11310093|FG000|COMPLETED|Overall Study||25
10180362|NCT03159260|11310094|FG001|COMPLETED|Overall Study||25
10180363|NCT03159260|11310093|FG000|NOT COMPLETED|Overall Study||3
10180364|NCT03159260|11310094|FG001|NOT COMPLETED|Overall Study||4
10180365|NCT03159299|11310102|FG000|STARTED|Overall Study||26
10180366|NCT03159299|11310103|FG001|STARTED|Overall Study||21
10180367|NCT03159299|11310102|FG000|COMPLETED|Overall Study||24
10180368|NCT03159299|11310103|FG001|COMPLETED|Overall Study||20
10180369|NCT03159299|11310102|FG000|NOT COMPLETED|Overall Study||2
10180370|NCT03159299|11310103|FG001|NOT COMPLETED|Overall Study||1
10180371|NCT03159455|11310115|FG000|STARTED|Overall Study||9
10180372|NCT03159455|11310116|FG001|STARTED|Overall Study||9
10180373|NCT03159455|11310117|FG002|STARTED|Overall Study||9
10180374|NCT03159455|11310118|FG003|STARTED|Overall Study||9
10180375|NCT03159455|11310119|FG004|STARTED|Overall Study||3
10180376|NCT03159455|11310120|FG005|STARTED|Overall Study||9
10180377|NCT03159455|11310115|FG000|COMPLETED|Overall Study||9
10180378|NCT03159455|11310116|FG001|COMPLETED|Overall Study||9
10180379|NCT03159455|11310117|FG002|COMPLETED|Overall Study||9
10180380|NCT03159455|11310118|FG003|COMPLETED|Overall Study||9
10180381|NCT03159455|11310119|FG004|COMPLETED|Overall Study||3
10180382|NCT03159455|11310120|FG005|COMPLETED|Overall Study||8
10180383|NCT03159455|11310115|FG000|NOT COMPLETED|Overall Study||0
10180384|NCT03159455|11310116|FG001|NOT COMPLETED|Overall Study||0
10180385|NCT03159455|11310117|FG002|NOT COMPLETED|Overall Study||0
10180386|NCT03159455|11310118|FG003|NOT COMPLETED|Overall Study||0
10180387|NCT03159455|11310119|FG004|NOT COMPLETED|Overall Study||0
10180388|NCT03159455|11310120|FG005|NOT COMPLETED|Overall Study||1
10180389|NCT03159468|11310144|FG000|STARTED|Overall Study||35
10180390|NCT03159468|11310145|FG001|STARTED|Overall Study||35
10180391|NCT03159468|11310146|FG002|STARTED|Overall Study||37
10180392|NCT03159468|11310147|FG003|STARTED|Overall Study||34
10180393|NCT03159468|11310148|FG004|STARTED|Overall Study||34
10180394|NCT03159468|11310149|FG005|STARTED|Overall Study||34
10180395|NCT03159468|11310144|FG000|COMPLETED|Overall Study||35
10180396|NCT03159468|11310145|FG001|COMPLETED|Overall Study||35
10180397|NCT03159468|11310146|FG002|COMPLETED|Overall Study||34
10180398|NCT03159468|11310147|FG003|COMPLETED|Overall Study||34
10180399|NCT03159468|11310148|FG004|COMPLETED|Overall Study||34
10180400|NCT03159468|11310149|FG005|COMPLETED|Overall Study||34
10180401|NCT03159468|11310144|FG000|NOT COMPLETED|Overall Study||0
10180402|NCT03159468|11310145|FG001|NOT COMPLETED|Overall Study||0
10180403|NCT03159468|11310146|FG002|NOT COMPLETED|Overall Study||3
10180404|NCT03159468|11310147|FG003|NOT COMPLETED|Overall Study||0
10180405|NCT03159468|11310148|FG004|NOT COMPLETED|Overall Study||0
10180406|NCT03159468|11310149|FG005|NOT COMPLETED|Overall Study||0
10180407|NCT03159611|11310165|FG000|STARTED|Overall Study||95
10180408|NCT03159611|11310166|FG001|STARTED|Overall Study||87
10180409|NCT03159611|11310165|FG000|COMPLETED|Overall Study||72
10180410|NCT03159611|11310166|FG001|COMPLETED|Overall Study||72
10180411|NCT03159611|11310165|FG000|NOT COMPLETED|Overall Study||23
10180412|NCT03159611|11310166|FG001|NOT COMPLETED|Overall Study||15
10180413|NCT03159624|11310174|FG000|STARTED|Overall Study||21
10180414|NCT03159624|11310175|FG001|STARTED|Overall Study||26
10180415|NCT03159624|11310174|FG000|COMPLETED|Overall Study||21
10180416|NCT03159624|11310175|FG001|COMPLETED|Overall Study||25
10180417|NCT03159624|11310174|FG000|NOT COMPLETED|Overall Study||0
9714360|NCT03721705|10813708|FG000|STARTED|Overall Study||95
9714361|NCT03721705|10813709|FG001|STARTED|Overall Study||95
9714362|NCT03721705|10813708|FG000|COMPLETED|Overall Study||85
9714363|NCT03721705|10813709|FG001|COMPLETED|Overall Study||77
9714364|NCT03721705|10813708|FG000|NOT COMPLETED|Overall Study||10
9714365|NCT03721705|10813709|FG001|NOT COMPLETED|Overall Study||18
9714366|NCT03505021|10813717|FG000|STARTED|Overall Study||329
9714367|NCT03505021|10813718|FG001|STARTED|Overall Study||167
9714368|NCT03505021|10813717|FG000|COMPLETED|Overall Study||217
9714369|NCT03505021|10813718|FG001|COMPLETED|Overall Study||112
9714370|NCT03505021|10813717|FG000|NOT COMPLETED|Overall Study||112
9714371|NCT03505021|10813718|FG001|NOT COMPLETED|Overall Study||55
9714372|NCT03405714|10813728|FG000|STARTED|Overall Study||12
9714373|NCT03405714|10813729|FG001|STARTED|Overall Study||12
9714374|NCT03405714|10813730|FG002|STARTED|Overall Study||13
9714375|NCT03405714|10813731|FG003|STARTED|Overall Study||13
9714376|NCT03405714|10813728|FG000|COMPLETED|Overall Study||12
9714377|NCT03405714|10813729|FG001|COMPLETED|Overall Study||12
9714378|NCT03405714|10813730|FG002|COMPLETED|Overall Study||13
9714379|NCT03405714|10813731|FG003|COMPLETED|Overall Study||13
9714380|NCT03405714|10813728|FG000|NOT COMPLETED|Overall Study||0
9714381|NCT03405714|10813729|FG001|NOT COMPLETED|Overall Study||0
9714382|NCT03405714|10813730|FG002|NOT COMPLETED|Overall Study||0
9714383|NCT03405714|10813731|FG003|NOT COMPLETED|Overall Study||0
9714384|NCT03366194|10813747|FG000|STARTED|Overall Study||36
9714385|NCT03366194|10813747|FG000|COMPLETED|Overall Study||34
9714386|NCT03366194|10813747|FG000|NOT COMPLETED|Overall Study||2
9714387|NCT03272139|10813754|FG000|STARTED|Overall Study||63
9714388|NCT03272139|10813755|FG001|STARTED|Overall Study||63
9714389|NCT03272139|10813754|FG000|COMPLETED|Overall Study||63
9714390|NCT03272139|10813755|FG001|COMPLETED|Overall Study||63
9714391|NCT03272139|10813754|FG000|NOT COMPLETED|Overall Study||0
9714392|NCT03272139|10813755|FG001|NOT COMPLETED|Overall Study||0
9714393|NCT03203473|10813761|FG000|STARTED|Induction Phase||85
9714394|NCT03203473|10813762|FG001|STARTED|Induction Phase||0
9714395|NCT03203473|10813763|FG002|STARTED|Induction Phase||0
9714396|NCT03203473|10813761|FG000|COMPLETED|Induction Phase||69
9714397|NCT03203473|10813762|FG001|COMPLETED|Induction Phase||0
9714398|NCT03203473|10813763|FG002|COMPLETED|Induction Phase||0
9714399|NCT03203473|10813761|FG000|NOT COMPLETED|Induction Phase||16
9714400|NCT03203473|10813762|FG001|NOT COMPLETED|Induction Phase||0
9714401|NCT03203473|10813763|FG002|NOT COMPLETED|Induction Phase||0
9714402|NCT03203473|10813761|FG000|STARTED|Arm Allocation Phase||0
9714403|NCT03203473|10813762|FG001|STARTED|Arm Allocation Phase||12
9714404|NCT03203473|10813763|FG002|STARTED|Arm Allocation Phase||57
9714405|NCT03203473|10813761|FG000|COMPLETED|Arm Allocation Phase||0
9714406|NCT03203473|10813762|FG001|COMPLETED|Arm Allocation Phase||0
9714407|NCT03203473|10813763|FG002|COMPLETED|Arm Allocation Phase||0
9714408|NCT03203473|10813761|FG000|NOT COMPLETED|Arm Allocation Phase||0
9714409|NCT03203473|10813762|FG001|NOT COMPLETED|Arm Allocation Phase||12
9849730|NCT00867100|10962524|FG008|STARTED|Overall Study||6
9849731|NCT00867100|10962525|FG009|STARTED|Overall Study||6
9849732|NCT00867100|10962526|FG010|STARTED|Overall Study||4
9849733|NCT00867100|10962527|FG011|STARTED|Overall Study||6
9849734|NCT00867100|10962528|FG012|STARTED|Overall Study||6
9849735|NCT00867100|10962516|FG000|COMPLETED|Overall Study||5
9849736|NCT00867100|10962517|FG001|COMPLETED|Overall Study||4
9849737|NCT00867100|10962518|FG002|COMPLETED|Overall Study||8
9849738|NCT00867100|10962519|FG003|COMPLETED|Overall Study||8
9849739|NCT00867100|10962520|FG004|COMPLETED|Overall Study||14
9849740|NCT00867100|10962521|FG005|COMPLETED|Overall Study||6
9849741|NCT00867100|10962522|FG006|COMPLETED|Overall Study||6
9849742|NCT00867100|10962523|FG007|COMPLETED|Overall Study||3
9849743|NCT00867100|10962524|FG008|COMPLETED|Overall Study||6
9849744|NCT00867100|10962525|FG009|COMPLETED|Overall Study||6
9849745|NCT00867100|10962526|FG010|COMPLETED|Overall Study||3
9849746|NCT00867100|10962527|FG011|COMPLETED|Overall Study||6
9849747|NCT00867100|10962528|FG012|COMPLETED|Overall Study||6
9849748|NCT00867100|10962516|FG000|NOT COMPLETED|Overall Study||0
9849749|NCT00867100|10962517|FG001|NOT COMPLETED|Overall Study||1
9849750|NCT00867100|10962518|FG002|NOT COMPLETED|Overall Study||0
9849751|NCT00867100|10962519|FG003|NOT COMPLETED|Overall Study||0
9849752|NCT00867100|10962520|FG004|NOT COMPLETED|Overall Study||0
9849753|NCT00867100|10962521|FG005|NOT COMPLETED|Overall Study||0
9849754|NCT00867100|10962522|FG006|NOT COMPLETED|Overall Study||1
9849755|NCT00867100|10962523|FG007|NOT COMPLETED|Overall Study||0
9849756|NCT00867100|10962524|FG008|NOT COMPLETED|Overall Study||0
9849757|NCT00867100|10962525|FG009|NOT COMPLETED|Overall Study||0
9849758|NCT00867100|10962526|FG010|NOT COMPLETED|Overall Study||1
9849759|NCT00867100|10962527|FG011|NOT COMPLETED|Overall Study||0
9849760|NCT00867100|10962528|FG012|NOT COMPLETED|Overall Study||0
9849761|NCT00867113|10962560|FG000|STARTED|Treatment Period||91
9849762|NCT00867113|10962560|FG000|Safety Set|Treatment Period||91
9849763|NCT00867113|10962560|FG000|Full Analysis Set (FAS)|Treatment Period||91
9714410|NCT03203473|10813763|FG002|NOT COMPLETED|Arm Allocation Phase||57
9714411|NCT03180736|10813776|FG000|STARTED|Overall Study||151
9714412|NCT03180736|10813777|FG001|STARTED|Overall Study||153
9714413|NCT03180736|10813776|FG000|Treated|Overall Study||149
9714414|NCT03180736|10813777|FG001|Treated|Overall Study||150
9714415|NCT03180736|10813776|FG000|COMPLETED|Overall Study||60
10180418|NCT03159624|11310175|FG001|NOT COMPLETED|Overall Study||1
10180419|NCT03160027|11310185|FG000|STARTED|Overall Study||6
10180420|NCT03160027|11310186|FG001|STARTED|Overall Study||4
10180421|NCT03160027|11310187|FG002|STARTED|Overall Study||6
10180422|NCT03160027|11310188|FG003|STARTED|Overall Study||4
10180423|NCT03160027|11310185|FG000|COMPLETED|Overall Study||6
10180424|NCT03160027|11310186|FG001|COMPLETED|Overall Study||4
10180425|NCT03160027|11310187|FG002|COMPLETED|Overall Study||6
10180426|NCT03160027|11310188|FG003|COMPLETED|Overall Study||4
10180427|NCT03160027|11310185|FG000|NOT COMPLETED|Overall Study||0
10180428|NCT03160027|11310186|FG001|NOT COMPLETED|Overall Study||0
10180429|NCT03160027|11310187|FG002|NOT COMPLETED|Overall Study||0
10180430|NCT03160027|11310188|FG003|NOT COMPLETED|Overall Study||0
10180431|NCT03160170|11310201|FG000|STARTED|Overall Study||10
10180432|NCT03160170|11310202|FG001|STARTED|Overall Study||10
10180433|NCT03160170|11310201|FG000|COMPLETED|Overall Study||10
10180434|NCT03160170|11310202|FG001|COMPLETED|Overall Study||10
10180435|NCT03160170|11310201|FG000|NOT COMPLETED|Overall Study||0
10180436|NCT03160170|11310202|FG001|NOT COMPLETED|Overall Study||0
10180437|NCT03160287|11310208|FG000|STARTED|Overall Study||24
10180438|NCT03160287|11310208|FG000|COMPLETED|Overall Study||22
10180439|NCT03160287|11310208|FG000|NOT COMPLETED|Overall Study||2
10180440|NCT03160560|11310216|FG000|STARTED|First Intervention (3 Weeks)||25
10180441|NCT03160560|11310217|FG001|STARTED|First Intervention (3 Weeks)||25
10180442|NCT03160560|11310218|FG002|STARTED|First Intervention (3 Weeks)||25
10180443|NCT03160560|11310219|FG003|STARTED|First Intervention (3 Weeks)||25
10180444|NCT03160560|11310216|FG000|COMPLETED|First Intervention (3 Weeks)||23
10180445|NCT03160560|11310217|FG001|COMPLETED|First Intervention (3 Weeks)||24
10180446|NCT03160560|11310218|FG002|COMPLETED|First Intervention (3 Weeks)||24
10180447|NCT03160560|11310219|FG003|COMPLETED|First Intervention (3 Weeks)||25
10180448|NCT03160560|11310216|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2
10180449|NCT03160560|11310217|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
10180450|NCT03160560|11310218|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1
10180451|NCT03160560|11310219|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0
10180452|NCT03160560|11310216|FG000|STARTED|Washout (2 Weeks)||23
10180453|NCT03160560|11310217|FG001|STARTED|Washout (2 Weeks)||24
10180454|NCT03160560|11310218|FG002|STARTED|Washout (2 Weeks)||24
10180455|NCT03160560|11310219|FG003|STARTED|Washout (2 Weeks)||25
10180456|NCT03160560|11310216|FG000|COMPLETED|Washout (2 Weeks)||23
10180457|NCT03160560|11310217|FG001|COMPLETED|Washout (2 Weeks)||24
10180458|NCT03160560|11310218|FG002|COMPLETED|Washout (2 Weeks)||24
10180459|NCT03160560|11310219|FG003|COMPLETED|Washout (2 Weeks)||25
10180460|NCT03160560|11310216|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10180461|NCT03160560|11310217|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10180462|NCT03160560|11310218|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10180463|NCT03160560|11310219|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10180464|NCT03160560|11310216|FG000|STARTED|Second Intervention (3 Weeks)||23
10180465|NCT03160560|11310217|FG001|STARTED|Second Intervention (3 Weeks)||24
10180466|NCT03160560|11310218|FG002|STARTED|Second Intervention (3 Weeks)||24
10180467|NCT03160560|11310219|FG003|STARTED|Second Intervention (3 Weeks)||25
10180468|NCT03160560|11310216|FG000|COMPLETED|Second Intervention (3 Weeks)||22
10180469|NCT03160560|11310217|FG001|COMPLETED|Second Intervention (3 Weeks)||24
10180470|NCT03160560|11310218|FG002|COMPLETED|Second Intervention (3 Weeks)||24
10180471|NCT03160560|11310219|FG003|COMPLETED|Second Intervention (3 Weeks)||25
10180472|NCT03160560|11310216|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
10180473|NCT03160560|11310217|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10180474|NCT03160560|11310218|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0
10180475|NCT03160560|11310219|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0
10180476|NCT03160573|11310233|FG000|STARTED|First Sequence (3 Weeks)||23
10180477|NCT03160573|11310234|FG001|STARTED|First Sequence (3 Weeks)||26
10180478|NCT03160573|11310235|FG002|STARTED|First Sequence (3 Weeks)||25
10180479|NCT03160573|11310236|FG003|STARTED|First Sequence (3 Weeks)||25
10180480|NCT03160573|11310233|FG000|COMPLETED|First Sequence (3 Weeks)||22
10180481|NCT03160573|11310234|FG001|COMPLETED|First Sequence (3 Weeks)||23
10180482|NCT03160573|11310235|FG002|COMPLETED|First Sequence (3 Weeks)||23
10180483|NCT03160573|11310236|FG003|COMPLETED|First Sequence (3 Weeks)||23
10180484|NCT03160573|11310233|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1
10180485|NCT03160573|11310234|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3
10180486|NCT03160573|11310235|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2
10180487|NCT03160573|11310236|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2
10180488|NCT03160573|11310233|FG000|STARTED|Washout (2 Weeks)||22
9714419|NCT03051659|10813790|FG000|STARTED|Treatment Period||44
9714420|NCT03051659|10813791|FG001|STARTED|Treatment Period||46
9714421|NCT03051659|10813790|FG000|COMPLETED|Treatment Period||44
9714422|NCT03051659|10813791|FG001|COMPLETED|Treatment Period||44
9714423|NCT03051659|10813790|FG000|NOT COMPLETED|Treatment Period||0
9714424|NCT03051659|10813791|FG001|NOT COMPLETED|Treatment Period||2
9714425|NCT03051659|10813790|FG000|STARTED|Survival Follow-up||44
9714426|NCT03051659|10813791|FG001|STARTED|Survival Follow-up||44
9714427|NCT03051659|10813790|FG000|COMPLETED|Survival Follow-up||21
9714428|NCT03051659|10813791|FG001|COMPLETED|Survival Follow-up||22
9714429|NCT03051659|10813790|FG000|NOT COMPLETED|Survival Follow-up||23
10180489|NCT03160573|11310234|FG001|STARTED|Washout (2 Weeks)||23
9714430|NCT03051659|10813791|FG001|NOT COMPLETED|Survival Follow-up||22
10180490|NCT03160573|11310235|FG002|STARTED|Washout (2 Weeks)||23
10180491|NCT03160573|11310236|FG003|STARTED|Washout (2 Weeks)||23
10180492|NCT03160573|11310233|FG000|COMPLETED|Washout (2 Weeks)||22
10180493|NCT03160573|11310234|FG001|COMPLETED|Washout (2 Weeks)||23
10180494|NCT03160573|11310235|FG002|COMPLETED|Washout (2 Weeks)||23
10180495|NCT03160573|11310236|FG003|COMPLETED|Washout (2 Weeks)||23
10180496|NCT03160573|11310233|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10180497|NCT03160573|11310234|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10180498|NCT03160573|11310235|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10180499|NCT03160573|11310236|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10180500|NCT03160573|11310233|FG000|STARTED|Second Sequence (3 Weeks)||22
10180501|NCT03160573|11310234|FG001|STARTED|Second Sequence (3 Weeks)||23
10180502|NCT03160573|11310235|FG002|STARTED|Second Sequence (3 Weeks)||23
10180503|NCT03160573|11310236|FG003|STARTED|Second Sequence (3 Weeks)||23
10180504|NCT03160573|11310233|FG000|COMPLETED|Second Sequence (3 Weeks)||22
10180505|NCT03160573|11310234|FG001|COMPLETED|Second Sequence (3 Weeks)||23
10180506|NCT03160573|11310235|FG002|COMPLETED|Second Sequence (3 Weeks)||23
10180507|NCT03160573|11310236|FG003|COMPLETED|Second Sequence (3 Weeks)||23
10180508|NCT03160573|11310233|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0
10180509|NCT03160573|11310234|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0
10180510|NCT03160573|11310235|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0
10180511|NCT03160573|11310236|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0
10180512|NCT03160703|11310250|FG000|STARTED|Overall Study||55
10180513|NCT03160703|11310251|FG001|STARTED|Overall Study||55
10180514|NCT03160703|11310252|FG002|STARTED|Overall Study||55
10180515|NCT03160703|11310253|FG003|STARTED|Overall Study||55
10180516|NCT03160703|11310250|FG000|COMPLETED|Overall Study||55
10180517|NCT03160703|11310251|FG001|COMPLETED|Overall Study||55
10180518|NCT03160703|11310252|FG002|COMPLETED|Overall Study||55
10180519|NCT03160703|11310253|FG003|COMPLETED|Overall Study||54
10180520|NCT03160703|11310250|FG000|NOT COMPLETED|Overall Study||0
10180521|NCT03160703|11310251|FG001|NOT COMPLETED|Overall Study||0
10180522|NCT03160703|11310252|FG002|NOT COMPLETED|Overall Study||0
10180523|NCT03160703|11310253|FG003|NOT COMPLETED|Overall Study||1
10180524|NCT03160716|11310263|FG000|STARTED|Overall Study||60
10180525|NCT03160716|11310263|FG000|COMPLETED|Overall Study||59
10180526|NCT03160716|11310263|FG000|NOT COMPLETED|Overall Study||1
10180527|NCT03160885|11310269|FG000|STARTED|Initial Treatment Period||593
10180528|NCT03160885|11310270|FG001|STARTED|Initial Treatment Period||201
10180529|NCT03160885|11310271|FG002|STARTED|Initial Treatment Period||0
10180530|NCT03160885|11310272|FG003|STARTED|Initial Treatment Period||0
10180531|NCT03160885|11310273|FG004|STARTED|Initial Treatment Period||0
10180532|NCT03160885|11310274|FG005|STARTED|Initial Treatment Period||0
10180533|NCT03160885|11310275|FG006|STARTED|Initial Treatment Period||0
10180534|NCT03160885|11310269|FG000|COMPLETED|Initial Treatment Period||558
10180535|NCT03160885|11310270|FG001|COMPLETED|Initial Treatment Period||179
10180536|NCT03160885|11310271|FG002|COMPLETED|Initial Treatment Period||0
10180537|NCT03160885|11310272|FG003|COMPLETED|Initial Treatment Period||0
10180538|NCT03160885|11310273|FG004|COMPLETED|Initial Treatment Period||0
10180539|NCT03160885|11310274|FG005|COMPLETED|Initial Treatment Period||0
10180540|NCT03160885|11310275|FG006|COMPLETED|Initial Treatment Period||0
10180541|NCT03160885|11310269|FG000|NOT COMPLETED|Initial Treatment Period||35
10180542|NCT03160885|11310270|FG001|NOT COMPLETED|Initial Treatment Period||22
10180543|NCT03160885|11310271|FG002|NOT COMPLETED|Initial Treatment Period||0
10180544|NCT03160885|11310272|FG003|NOT COMPLETED|Initial Treatment Period||0
10180545|NCT03160885|11310273|FG004|NOT COMPLETED|Initial Treatment Period||0
10180546|NCT03160885|11310274|FG005|NOT COMPLETED|Initial Treatment Period||0
10180547|NCT03160885|11310275|FG006|NOT COMPLETED|Initial Treatment Period||0
10180548|NCT03160885|11310269|FG000|STARTED|Open-label Treatment||0
10180549|NCT03160885|11310270|FG001|STARTED|Open-label Treatment||0
10180550|NCT03160885|11310271|FG002|STARTED|Open-label Treatment||0
10180551|NCT03160885|11310272|FG003|STARTED|Open-label Treatment||0
10180552|NCT03160885|11310273|FG004|STARTED|Open-label Treatment||0
10180553|NCT03160885|11310274|FG005|STARTED|Open-label Treatment||0
10180554|NCT03160885|11310275|FG006|STARTED|Open-label Treatment||560
10180555|NCT03160885|11310269|FG000|COMPLETED|Open-label Treatment||0
10180556|NCT03160885|11310270|FG001|COMPLETED|Open-label Treatment||0
10180557|NCT03160885|11310271|FG002|COMPLETED|Open-label Treatment||0
10180558|NCT03160885|11310272|FG003|COMPLETED|Open-label Treatment||0
10180559|NCT03160885|11310273|FG004|COMPLETED|Open-label Treatment||0
10180560|NCT03160885|11310274|FG005|COMPLETED|Open-label Treatment||0
10180561|NCT03160885|11310275|FG006|COMPLETED|Open-label Treatment||423
10180562|NCT03160885|11310269|FG000|NOT COMPLETED|Open-label Treatment||0
10180563|NCT03160885|11310270|FG001|NOT COMPLETED|Open-label Treatment||0
10180564|NCT03160885|11310271|FG002|NOT COMPLETED|Open-label Treatment||0
10180565|NCT03160885|11310272|FG003|NOT COMPLETED|Open-label Treatment||0
10180566|NCT03160885|11310273|FG004|NOT COMPLETED|Open-label Treatment||0
10180567|NCT03160885|11310274|FG005|NOT COMPLETED|Open-label Treatment||0
10180568|NCT03160885|11310275|FG006|NOT COMPLETED|Open-label Treatment||137
10180569|NCT03160885|11310269|FG000|STARTED|Maintenance Treatment Period||0
10180570|NCT03160885|11310270|FG001|STARTED|Maintenance Treatment Period||0
10180571|NCT03160885|11310271|FG002|STARTED|Maintenance Treatment Period||91
10180572|NCT03160885|11310272|FG003|STARTED|Maintenance Treatment Period||90
10180573|NCT03160885|11310273|FG004|STARTED|Maintenance Treatment Period||46
10180574|NCT03160885|11310274|FG005|STARTED|Maintenance Treatment Period||31
10180575|NCT03160885|11310275|FG006|STARTED|Maintenance Treatment Period||0
10180576|NCT03160885|11310269|FG000|COMPLETED|Maintenance Treatment Period||0
10180577|NCT03160885|11310270|FG001|COMPLETED|Maintenance Treatment Period||0
10180578|NCT03160885|11310271|FG002|COMPLETED|Maintenance Treatment Period||52
10180579|NCT03160885|11310272|FG003|COMPLETED|Maintenance Treatment Period||50
10180580|NCT03160885|11310273|FG004|COMPLETED|Maintenance Treatment Period||15
10180581|NCT03160885|11310274|FG005|COMPLETED|Maintenance Treatment Period||16
10180582|NCT03160885|11310275|FG006|COMPLETED|Maintenance Treatment Period||0
10180583|NCT03160885|11310269|FG000|NOT COMPLETED|Maintenance Treatment Period||0
10180584|NCT03160885|11310270|FG001|NOT COMPLETED|Maintenance Treatment Period||0
10180585|NCT03160885|11310271|FG002|NOT COMPLETED|Maintenance Treatment Period||39
10180586|NCT03160885|11310272|FG003|NOT COMPLETED|Maintenance Treatment Period||40
10180587|NCT03160885|11310273|FG004|NOT COMPLETED|Maintenance Treatment Period||31
10180588|NCT03160885|11310274|FG005|NOT COMPLETED|Maintenance Treatment Period||15
10180589|NCT03160885|11310275|FG006|NOT COMPLETED|Maintenance Treatment Period||0
10180590|NCT03160898|11310296|FG000|STARTED|Overall Study||115
10180591|NCT03160898|11310297|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
10180592|NCT03160898|11310298|FG002|STARTED|Overall Study||113
10180593|NCT03160898|11310299|FG003|STARTED|Overall Study||117
10180594|NCT03160898|11310296|FG000|COMPLETED|Overall Study||95
10180595|NCT03160898|11310297|FG001|COMPLETED|Overall Study||100
10180596|NCT03160898|11310298|FG002|COMPLETED|Overall Study||97
10180597|NCT03160898|11310299|FG003|COMPLETED|Overall Study||98
10180598|NCT03160898|11310296|FG000|NOT COMPLETED|Overall Study||20
10180599|NCT03160898|11310297|FG001|NOT COMPLETED|Overall Study||13
10180600|NCT03160898|11310298|FG002|NOT COMPLETED|Overall Study||16
10180601|NCT03160898|11310299|FG003|NOT COMPLETED|Overall Study||19
10180602|NCT03161158|11310312|FG000|STARTED|Overall Study||18
10180603|NCT03161158|11310313|FG001|STARTED|Overall Study||19
10180604|NCT03161158|11310312|FG000|COMPLETED|Overall Study||9
10180605|NCT03161158|11310313|FG001|COMPLETED|Overall Study||13
10180606|NCT03161158|11310312|FG000|NOT COMPLETED|Overall Study||9
10180607|NCT03161158|11310313|FG001|NOT COMPLETED|Overall Study||6
10180608|NCT03161327|11310319|FG000|STARTED|Overall Study||238
10180609|NCT03161327|11310319|FG000|COMPLETED|Overall Study||238
10180610|NCT03161327|11310319|FG000|NOT COMPLETED|Overall Study||0
10180611|NCT03161405|11310324|FG000|STARTED|First Intervention Period (3 Days)||12
10180612|NCT03161405|11310324|FG000|COMPLETED|First Intervention Period (3 Days)||12
10180613|NCT03161405|11310324|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0
10180614|NCT03161405|11310324|FG000|STARTED|Washout Period (at Least 4 Days)||12
10180615|NCT03161405|11310324|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
10180616|NCT03161405|11310324|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
10180617|NCT03161405|11310324|FG000|STARTED|Second Intervention Period (6 Days)||12
10180618|NCT03161405|11310324|FG000|COMPLETED|Second Intervention Period (6 Days)||11
10180619|NCT03161405|11310324|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1
10180620|NCT03161483|11310335|FG000|STARTED|Overall Study||83
10180621|NCT03161483|11310336|FG001|STARTED|Overall Study||42
10180622|NCT03161483|11310337|FG002|STARTED|Overall Study||82
10180623|NCT03161483|11310338|FG003|STARTED|Overall Study||81
10180624|NCT03161483|11310335|FG000|COMPLETED|Overall Study||73
10180625|NCT03161483|11310336|FG001|COMPLETED|Overall Study||39
10180626|NCT03161483|11310337|FG002|COMPLETED|Overall Study||62
10180627|NCT03161483|11310338|FG003|COMPLETED|Overall Study||73
10180628|NCT03161483|11310335|FG000|NOT COMPLETED|Overall Study||10
10180629|NCT03161483|11310336|FG001|NOT COMPLETED|Overall Study||3
10180630|NCT03161483|11310337|FG002|NOT COMPLETED|Overall Study||20
10180631|NCT03161483|11310338|FG003|NOT COMPLETED|Overall Study||8
10180632|NCT03161938|11310350|FG000|STARTED|Overall Study||32
10180633|NCT03161938|11310351|FG001|STARTED|Overall Study||32
10180634|NCT03161938|11310350|FG000|COMPLETED|Overall Study||32
10180635|NCT03161938|11310351|FG001|COMPLETED|Overall Study||32
10180636|NCT03161938|11310350|FG000|NOT COMPLETED|Overall Study||0
10180637|NCT03161938|11310351|FG001|NOT COMPLETED|Overall Study||0
10180638|NCT03162055|11310359|FG000|STARTED|Overall Study||559
10180639|NCT03162055|11310360|FG001|STARTED|Overall Study||560
10180640|NCT03162055|11310359|FG000|Received Treatment|Overall Study||557
10180641|NCT03162055|11310360|FG001|Received Treatment|Overall Study||560
10180642|NCT03162055|11310359|FG000|Safety Analysis Set|Overall Study||552
10180643|NCT03162055|11310360|FG001|Safety Analysis Set|Overall Study||552
10180644|NCT03162055|11310359|FG000|Full Analysis Set (FAS)|Overall Study||552
10180645|NCT03162055|11310360|FG001|Full Analysis Set (FAS)|Overall Study||552
10180646|NCT03162055|11310359|FG000|Per Protocol (PP) Analysis Set|Overall Study||506
10180647|NCT03162055|11310360|FG001|Per Protocol (PP) Analysis Set|Overall Study||510
10180648|NCT03162055|11310359|FG000|COMPLETED|Overall Study||497
10180649|NCT03162055|11310360|FG001|COMPLETED|Overall Study||517
10180650|NCT03162055|11310359|FG000|NOT COMPLETED|Overall Study||62
10180651|NCT03162055|11310360|FG001|NOT COMPLETED|Overall Study||43
10180652|NCT03162328|11310366|FG000|STARTED|Screening Period||84
10180653|NCT03162328|11310367|FG001|STARTED|Screening Period||0
10180654|NCT03162328|11310368|FG002|STARTED|Screening Period||0
10180655|NCT03162328|11310366|FG000|COMPLETED|Screening Period||62
10180656|NCT03162328|11310367|FG001|COMPLETED|Screening Period||0
10180657|NCT03162328|11310368|FG002|COMPLETED|Screening Period||0
10180658|NCT03162328|11310366|FG000|NOT COMPLETED|Screening Period||22
10180659|NCT03162328|11310367|FG001|NOT COMPLETED|Screening Period||0
10180660|NCT03162328|11310368|FG002|NOT COMPLETED|Screening Period||0
10180661|NCT03162328|11310366|FG000|STARTED|Study Period||0
10180662|NCT03162328|11310367|FG001|STARTED|Study Period||30
10180663|NCT03162328|11310368|FG002|STARTED|Study Period||32
10180664|NCT03162328|11310366|FG000|COMPLETED|Study Period||0
10180665|NCT03162328|11310367|FG001|COMPLETED|Study Period||30
10180666|NCT03162328|11310368|FG002|COMPLETED|Study Period||31
10180667|NCT03162328|11310366|FG000|NOT COMPLETED|Study Period||0
10180668|NCT03162328|11310367|FG001|NOT COMPLETED|Study Period||0
10180669|NCT03162328|11310368|FG002|NOT COMPLETED|Study Period||1
10180670|NCT03162354|11310381|FG000|STARTED|Overall Study||183
10180671|NCT03162354|11310382|FG001|STARTED|Overall Study||237
10180672|NCT03162354|11310381|FG000|COMPLETED|Overall Study||183
10180673|NCT03162354|11310382|FG001|COMPLETED|Overall Study||237
10180674|NCT03162354|11310381|FG000|NOT COMPLETED|Overall Study||0
10180675|NCT03162354|11310382|FG001|NOT COMPLETED|Overall Study||0
10180676|NCT03162458|11310395|FG000|STARTED|Overall Study||71
10180677|NCT03162458|11310396|FG001|STARTED|Overall Study||71
10180678|NCT03162458|11310395|FG000|COMPLETED|Overall Study||71
10180679|NCT03162458|11310396|FG001|COMPLETED|Overall Study||71
10180680|NCT03162458|11310395|FG000|NOT COMPLETED|Overall Study||0
10180681|NCT03162458|11310396|FG001|NOT COMPLETED|Overall Study||0
10180682|NCT03162614|11310408|FG000|STARTED|Overall Study||26
10180683|NCT03162614|11310409|FG001|STARTED|Overall Study||26
10180684|NCT03162614|11310410|FG002|STARTED|Overall Study||26
10180685|NCT03162614|11310411|FG003|STARTED|Overall Study||26
10180686|NCT03162614|11310412|FG004|STARTED|Overall Study||26
10180687|NCT03162614|11310413|FG005|STARTED|Overall Study||24
10180688|NCT03162614|11310408|FG000|COMPLETED|Overall Study||20
10180689|NCT03162614|11310409|FG001|COMPLETED|Overall Study||21
10180690|NCT03162614|11310410|FG002|COMPLETED|Overall Study||22
10180691|NCT03162614|11310411|FG003|COMPLETED|Overall Study||19
10180692|NCT03162614|11310412|FG004|COMPLETED|Overall Study||21
10180693|NCT03162614|11310413|FG005|COMPLETED|Overall Study||24
10180694|NCT03162614|11310408|FG000|NOT COMPLETED|Overall Study||6
10180695|NCT03162614|11310409|FG001|NOT COMPLETED|Overall Study||5
10180696|NCT03162614|11310410|FG002|NOT COMPLETED|Overall Study||4
10180697|NCT03162614|11310411|FG003|NOT COMPLETED|Overall Study||7
10180698|NCT03162614|11310412|FG004|NOT COMPLETED|Overall Study||5
10180699|NCT03162614|11310413|FG005|NOT COMPLETED|Overall Study||0
10180700|NCT03162796|11310430|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126
10180701|NCT03162796|11310431|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127
10180702|NCT03162796|11310432|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128
10180703|NCT03162796|11310430|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
10180704|NCT03162796|11310431|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
10180705|NCT03162796|11310432|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
10180706|NCT03162796|11310430|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
10180707|NCT03162796|11310431|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
10180708|NCT03162796|11310432|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
10180709|NCT03162796|11310430|FG000|STARTED|Active Treatment Period: Week 24 - 52||114
10180710|NCT03162796|11310431|FG001|STARTED|Active Treatment Period: Week 24 - 52||123
10180711|NCT03162796|11310432|FG002|STARTED|Active Treatment Period: Week 24 - 52||125
10180712|NCT03162796|11310430|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107
10180713|NCT03162796|11310431|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116
10180714|NCT03162796|11310432|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124
10180715|NCT03162796|11310430|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
10180716|NCT03162796|11310431|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
10180717|NCT03162796|11310432|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
10180718|NCT03162796|11310430|FG000|STARTED|Safety Follow-up: Week 52 - 60||107
10180719|NCT03162796|11310431|FG001|STARTED|Safety Follow-up: Week 52 - 60||116
10180720|NCT03162796|11310432|FG002|STARTED|Safety Follow-up: Week 52 - 60||124
10180721|NCT03162796|11310430|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106
10180722|NCT03162796|11310431|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114
10180723|NCT03162796|11310432|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123
10180724|NCT03162796|11310430|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
10180725|NCT03162796|11310431|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
10180726|NCT03162796|11310432|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
10180727|NCT03163017|11310445|FG000|STARTED|Overall Study||30
10180728|NCT03163017|11310445|FG000|COMPLETED|Overall Study||30
10180729|NCT03163017|11310445|FG000|NOT COMPLETED|Overall Study||0
10180730|NCT03163134|11310451|FG000|STARTED|Overall Study||85
10180731|NCT03163134|11310452|FG001|STARTED|Overall Study||85
10180732|NCT03163134|11310451|FG000|COMPLETED|Overall Study||85
10180733|NCT03163134|11310452|FG001|COMPLETED|Overall Study||85
10180734|NCT03163134|11310451|FG000|NOT COMPLETED|Overall Study||0
10180735|NCT03163134|11310452|FG001|NOT COMPLETED|Overall Study||0
10180736|NCT03163303|11310460|FG000|STARTED|Overall Study||85
10180737|NCT03163303|11310461|FG001|STARTED|Overall Study||94
10180738|NCT03163303|11310460|FG000|COMPLETED|Overall Study||85
10180739|NCT03163303|11310461|FG001|COMPLETED|Overall Study||94
10180740|NCT03163303|11310460|FG000|NOT COMPLETED|Overall Study||0
10180741|NCT03163303|11310461|FG001|NOT COMPLETED|Overall Study||0
10180742|NCT03163342|11310467|FG000|STARTED|Overall Study||20
10180743|NCT03163342|11310467|FG000|COMPLETED|Overall Study||20
10180744|NCT03163342|11310467|FG000|NOT COMPLETED|Overall Study||0
10180745|NCT03163446|11310473|FG000|STARTED|Overall Study||73
10180746|NCT03163446|11310474|FG001|STARTED|Overall Study||48
10180747|NCT03163446|11310473|FG000|COMPLETED|Overall Study||45
10180748|NCT03163446|11310474|FG001|COMPLETED|Overall Study||31
10180749|NCT03163446|11310473|FG000|NOT COMPLETED|Overall Study||28
10180750|NCT03163446|11310474|FG001|NOT COMPLETED|Overall Study||17
10180751|NCT03163472|11310488|FG000|STARTED|Overall Study||15
10180752|NCT03163472|11310489|FG001|STARTED|Overall Study||15
10180753|NCT03163472|11310488|FG000|COMPLETED|Overall Study||15
10180754|NCT03163472|11310489|FG001|COMPLETED|Overall Study||15
10180755|NCT03163472|11310488|FG000|NOT COMPLETED|Overall Study||0
10180756|NCT03163472|11310489|FG001|NOT COMPLETED|Overall Study||0
10180757|NCT03163758|11310499|FG000|STARTED|Overall Study||21
10180758|NCT03163758|11310500|FG001|STARTED|Overall Study||21
10180759|NCT03163758|11310499|FG000|COMPLETED|Overall Study||13
10180760|NCT03163758|11310500|FG001|COMPLETED|Overall Study||14
10180761|NCT03163758|11310499|FG000|NOT COMPLETED|Overall Study||8
10180762|NCT03163758|11310500|FG001|NOT COMPLETED|Overall Study||7
10180763|NCT03164538|11310508|FG000|STARTED|Overall Study||35
10180764|NCT03164538|11310509|FG001|STARTED|Overall Study||35
10180765|NCT03164538|11310508|FG000|COMPLETED|Overall Study||28
10180766|NCT03164538|11310509|FG001|COMPLETED|Overall Study||29
10180767|NCT03164538|11310508|FG000|NOT COMPLETED|Overall Study||7
10180768|NCT03164538|11310509|FG001|NOT COMPLETED|Overall Study||6
10180769|NCT03164551|11310517|FG000|STARTED|Overall Study||200
10180770|NCT03164551|11310518|FG001|STARTED|Overall Study||208
10180771|NCT03164551|11310517|FG000|COMPLETED|Overall Study||171
10180772|NCT03164551|11310518|FG001|COMPLETED|Overall Study||192
10180773|NCT03164551|11310517|FG000|NOT COMPLETED|Overall Study||29
10180774|NCT03164551|11310518|FG001|NOT COMPLETED|Overall Study||16
10180775|NCT03164629|11310526|FG000|STARTED|Overall Study||25
10180776|NCT03164629|11310527|FG001|STARTED|Overall Study||25
10180777|NCT03164629|11310526|FG000|COMPLETED|Overall Study||25
10180778|NCT03164629|11310527|FG001|COMPLETED|Overall Study||25
10180779|NCT03164629|11310526|FG000|NOT COMPLETED|Overall Study||0
10180780|NCT03164629|11310527|FG001|NOT COMPLETED|Overall Study||0
10180781|NCT03165045|11310533|FG000|STARTED|Visit 1||1351
10180782|NCT03165045|11310533|FG000|COMPLETED|Visit 1||1322
10180783|NCT03165045|11310533|FG000|NOT COMPLETED|Visit 1||29
10180784|NCT03165045|11310533|FG000|STARTED|Visit 2||1322
10180785|NCT03165045|11310533|FG000|COMPLETED|Visit 2||1140
10180786|NCT03165045|11310533|FG000|NOT COMPLETED|Visit 2||182
10180787|NCT03165058|11310541|FG000|STARTED|Overall Study||21
10180788|NCT03165058|11310542|FG001|STARTED|Overall Study||11
10180789|NCT03165058|11310541|FG000|COMPLETED|Overall Study||21
10180790|NCT03165058|11310542|FG001|COMPLETED|Overall Study||11
10180791|NCT03165058|11310541|FG000|NOT COMPLETED|Overall Study||0
10180792|NCT03165058|11310542|FG001|NOT COMPLETED|Overall Study||0
10180793|NCT03165110|11310548|FG000|STARTED|Overall Study||47
10180794|NCT03165110|11310548|FG000|COMPLETED|Overall Study||46
10180795|NCT03165110|11310548|FG000|NOT COMPLETED|Overall Study||1
10180796|NCT03165175|11310554|FG000|STARTED|1-month to 3-month||41
10180797|NCT03165175|11310555|FG001|STARTED|1-month to 3-month||39
10180798|NCT03165175|11310554|FG000|COMPLETED|1-month to 3-month||35
10180799|NCT03165175|11310555|FG001|COMPLETED|1-month to 3-month||39
10180800|NCT03165175|11310554|FG000|NOT COMPLETED|1-month to 3-month||6
10180801|NCT03165175|11310555|FG001|NOT COMPLETED|1-month to 3-month||0
10180802|NCT03165175|11310554|FG000|STARTED|Baseline to 3-month||35
10180803|NCT03165175|11310555|FG001|STARTED|Baseline to 3-month||39
10180804|NCT03165175|11310554|FG000|COMPLETED|Baseline to 3-month||31
10180805|NCT03165175|11310555|FG001|COMPLETED|Baseline to 3-month||39
10180806|NCT03165175|11310554|FG000|NOT COMPLETED|Baseline to 3-month||4
10180807|NCT03165175|11310555|FG001|NOT COMPLETED|Baseline to 3-month||0
10180808|NCT03165617|11310563|FG000|STARTED|Overall Study||2258
10180809|NCT03165617|11310564|FG001|STARTED|Overall Study||2256
10180810|NCT03165617|11310563|FG000|COMPLETED|Overall Study||2249
10180811|NCT03165617|11310564|FG001|COMPLETED|Overall Study||2247
10180812|NCT03165617|11310563|FG000|NOT COMPLETED|Overall Study||9
10180813|NCT03165617|11310564|FG001|NOT COMPLETED|Overall Study||9
10180814|NCT03165981|11310590|FG000|STARTED|Overall Study||110
10180815|NCT03165981|11310591|FG001|STARTED|Overall Study||111
10180816|NCT03165981|11310590|FG000|Per Protocol Population|Overall Study||99
10180817|NCT03165981|11310591|FG001|Per Protocol Population|Overall Study||107
10180818|NCT03165981|11310590|FG000|COMPLETED|Overall Study||99
10180819|NCT03165981|11310591|FG001|COMPLETED|Overall Study||107
10180820|NCT03165981|11310590|FG000|NOT COMPLETED|Overall Study||11
10180821|NCT03165981|11310591|FG001|NOT COMPLETED|Overall Study||4
10180822|NCT03166124|11310599|FG000|STARTED|Treatment Period 1||20
10180823|NCT03166124|11310600|FG001|STARTED|Treatment Period 1||20
10180824|NCT03166124|11310601|FG002|STARTED|Treatment Period 1||19
10180825|NCT03166124|11310602|FG003|STARTED|Treatment Period 1||21
10180826|NCT03166124|11310599|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20
10180827|NCT03166124|11310600|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20
10180828|NCT03166124|11310601|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18
10180829|NCT03166124|11310602|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21
10180830|NCT03166124|11310599|FG000|COMPLETED|Treatment Period 1||20
10180831|NCT03166124|11310600|FG001|COMPLETED|Treatment Period 1||20
10180832|NCT03166124|11310601|FG002|COMPLETED|Treatment Period 1||18
10180833|NCT03166124|11310602|FG003|COMPLETED|Treatment Period 1||21
10180834|NCT03166124|11310599|FG000|NOT COMPLETED|Treatment Period 1||0
10180835|NCT03166124|11310600|FG001|NOT COMPLETED|Treatment Period 1||0
10180836|NCT03166124|11310601|FG002|NOT COMPLETED|Treatment Period 1||1
10180837|NCT03166124|11310602|FG003|NOT COMPLETED|Treatment Period 1||0
10180838|NCT03166124|11310599|FG000|STARTED|Wash-out Period||20
10180839|NCT03166124|11310600|FG001|STARTED|Wash-out Period||20
10180840|NCT03166124|11310601|FG002|STARTED|Wash-out Period||18
10180841|NCT03166124|11310602|FG003|STARTED|Wash-out Period||21
10180842|NCT03166124|11310599|FG000|COMPLETED|Wash-out Period||20
10180843|NCT03166124|11310600|FG001|COMPLETED|Wash-out Period||18
10180844|NCT03166124|11310601|FG002|COMPLETED|Wash-out Period||17
10180845|NCT03166124|11310602|FG003|COMPLETED|Wash-out Period||20
10180846|NCT03166124|11310599|FG000|NOT COMPLETED|Wash-out Period||0
10180847|NCT03166124|11310600|FG001|NOT COMPLETED|Wash-out Period||2
10180848|NCT03166124|11310601|FG002|NOT COMPLETED|Wash-out Period||1
10180849|NCT03166124|11310602|FG003|NOT COMPLETED|Wash-out Period||1
10180850|NCT03166124|11310599|FG000|STARTED|Treatment Period 2||20
10180851|NCT03166124|11310600|FG001|STARTED|Treatment Period 2||18
10180852|NCT03166124|11310601|FG002|STARTED|Treatment Period 2||17
10180853|NCT03166124|11310602|FG003|STARTED|Treatment Period 2||20
10180854|NCT03166124|11310599|FG000|COMPLETED|Treatment Period 2||20
10180855|NCT03166124|11310600|FG001|COMPLETED|Treatment Period 2||18
10180856|NCT03166124|11310601|FG002|COMPLETED|Treatment Period 2||17
10180857|NCT03166124|11310602|FG003|COMPLETED|Treatment Period 2||20
10180858|NCT03166124|11310599|FG000|NOT COMPLETED|Treatment Period 2||0
10180859|NCT03166124|11310600|FG001|NOT COMPLETED|Treatment Period 2||0
10180860|NCT03166124|11310601|FG002|NOT COMPLETED|Treatment Period 2||0
10180861|NCT03166124|11310602|FG003|NOT COMPLETED|Treatment Period 2||0
10180862|NCT03166215|11310615|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
10180863|NCT03166215|11310616|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
10180864|NCT03166215|11310617|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
10180865|NCT03166215|11310615|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
10180866|NCT03166215|11310616|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
10180867|NCT03166215|11310617|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
10180868|NCT03166215|11310615|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
10180869|NCT03166215|11310616|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
10180870|NCT03166215|11310617|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
10180871|NCT03166215|11310615|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
10180872|NCT03166215|11310616|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
10180873|NCT03166215|11310617|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
10180874|NCT03166215|11310615|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10180875|NCT03166215|11310616|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10180876|NCT03166215|11310617|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
10180877|NCT03166215|11310615|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10180878|NCT03166215|11310616|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10180879|NCT03166215|11310617|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
10180880|NCT03166735|11310633|FG000|STARTED|Overall Study||33
10180881|NCT03166735|11310634|FG001|STARTED|Overall Study||16
10180882|NCT03166735|11310635|FG002|STARTED|Overall Study||16
10180883|NCT03166735|11310636|FG003|STARTED|Overall Study||17
10180884|NCT03166735|11310637|FG004|STARTED|Overall Study||32
10180885|NCT03166735|11310633|FG000|Treated|Overall Study||32
10180886|NCT03166735|11310634|FG001|Treated|Overall Study||16
10180887|NCT03166735|11310635|FG002|Treated|Overall Study||16
10180888|NCT03166735|11310636|FG003|Treated|Overall Study||17
10180889|NCT03166735|11310637|FG004|Treated|Overall Study||32
10180890|NCT03166735|11310633|FG000|COMPLETED|Overall Study||32
10180891|NCT03166735|11310634|FG001|COMPLETED|Overall Study||13
10180892|NCT03166735|11310635|FG002|COMPLETED|Overall Study||13
10180893|NCT03166735|11310636|FG003|COMPLETED|Overall Study||16
10180894|NCT03166735|11310637|FG004|COMPLETED|Overall Study||28
10180895|NCT03166735|11310633|FG000|NOT COMPLETED|Overall Study||1
10180896|NCT03166735|11310634|FG001|NOT COMPLETED|Overall Study||3
10180897|NCT03166735|11310635|FG002|NOT COMPLETED|Overall Study||3
10180898|NCT03166735|11310636|FG003|NOT COMPLETED|Overall Study||1
10180899|NCT03166735|11310637|FG004|NOT COMPLETED|Overall Study||4
10180900|NCT03167073|11310652|FG000|STARTED|Overall Study||85
10180901|NCT03167073|11310653|FG001|STARTED|Overall Study||85
10180902|NCT03167073|11310652|FG000|COMPLETED|Overall Study||84
10180903|NCT03167073|11310653|FG001|COMPLETED|Overall Study||85
10180904|NCT03167073|11310652|FG000|NOT COMPLETED|Overall Study||1
10180905|NCT03167073|11310653|FG001|NOT COMPLETED|Overall Study||0
10180906|NCT03167151|11310662|FG000|STARTED|Overall Study||3
10180907|NCT03167151|11310663|FG001|STARTED|Overall Study||3
10180908|NCT03167151|11310664|FG002|STARTED|Overall Study||3
10180909|NCT03167151|11310662|FG000|COMPLETED|Overall Study||2
10180910|NCT03167151|11310663|FG001|COMPLETED|Overall Study||2
10180911|NCT03167151|11310664|FG002|COMPLETED|Overall Study||2
10180912|NCT03167151|11310662|FG000|NOT COMPLETED|Overall Study||1
10180913|NCT03167151|11310663|FG001|NOT COMPLETED|Overall Study||1
10180914|NCT03167151|11310664|FG002|NOT COMPLETED|Overall Study||1
10180915|NCT03167359|11310672|FG000|STARTED|Overall Study||74
10180916|NCT03167359|11310672|FG000|COMPLETED|Overall Study||72
10180917|NCT03167359|11310672|FG000|NOT COMPLETED|Overall Study||2
10180918|NCT03167411|11310678|FG000|STARTED|Overall Study||10
10180919|NCT03167411|11310679|FG001|STARTED|Overall Study||10
10180920|NCT03167411|11310678|FG000|COMPLETED|Overall Study||10
10180921|NCT03167411|11310679|FG001|COMPLETED|Overall Study||9
10180922|NCT03167411|11310678|FG000|NOT COMPLETED|Overall Study||0
10180923|NCT03167411|11310679|FG001|NOT COMPLETED|Overall Study||1
10180924|NCT03167541|11310685|FG000|STARTED|First Intervention||9
10180925|NCT03167541|11310686|FG001|STARTED|First Intervention||9
10180926|NCT03167541|11310685|FG000|COMPLETED|First Intervention||9
10180927|NCT03167541|11310686|FG001|COMPLETED|First Intervention||9
10180928|NCT03167541|11310685|FG000|NOT COMPLETED|First Intervention||0
10180929|NCT03167541|11310686|FG001|NOT COMPLETED|First Intervention||0
10180930|NCT03167541|11310685|FG000|STARTED|Washout: 5-8 Days||9
10180931|NCT03167541|11310686|FG001|STARTED|Washout: 5-8 Days||9
10180932|NCT03167541|11310685|FG000|COMPLETED|Washout: 5-8 Days||9
10180933|NCT03167541|11310686|FG001|COMPLETED|Washout: 5-8 Days||9
10180934|NCT03167541|11310685|FG000|NOT COMPLETED|Washout: 5-8 Days||0
10180935|NCT03167541|11310686|FG001|NOT COMPLETED|Washout: 5-8 Days||0
10180936|NCT03167541|11310685|FG000|STARTED|Second Intervention||9
10180937|NCT03167541|11310686|FG001|STARTED|Second Intervention||9
10180938|NCT03167541|11310685|FG000|COMPLETED|Second Intervention||9
10180939|NCT03167541|11310686|FG001|COMPLETED|Second Intervention||9
10180940|NCT03167541|11310685|FG000|NOT COMPLETED|Second Intervention||0
10180941|NCT03167541|11310686|FG001|NOT COMPLETED|Second Intervention||0
9714431|NCT03048552|10813801|FG000|STARTED|Overall Study||4
9714432|NCT03048552|10813802|FG001|STARTED|Overall Study||18
9714433|NCT03048552|10813803|FG002|STARTED|Overall Study||4
9714434|NCT03048552|10813804|FG003|STARTED|Overall Study|Fewer caregivers were enrolled in Family CONNECT arm than youth as 2 caregivers had multiple children in the Family CONNECT arm: one caregiver had n=2 children and 1 caregiver had n=3 children.|15
9714435|NCT03048552|10813801|FG000|COMPLETED|Overall Study||4
9714436|NCT03048552|10813802|FG001|COMPLETED|Overall Study||18
9714437|NCT03048552|10813803|FG002|COMPLETED|Overall Study||4
9714438|NCT03048552|10813804|FG003|COMPLETED|Overall Study||15
9714439|NCT03048552|10813801|FG000|NOT COMPLETED|Overall Study||0
10180942|NCT03168022|11310693|FG000|STARTED|Overall Study||21
10180943|NCT03168022|11310694|FG001|STARTED|Overall Study||22
10180944|NCT03168022|11310693|FG000|COMPLETED|Overall Study||21
10180945|NCT03168022|11310694|FG001|COMPLETED|Overall Study||21
10180946|NCT03168022|11310693|FG000|NOT COMPLETED|Overall Study||0
10180947|NCT03168022|11310694|FG001|NOT COMPLETED|Overall Study||1
10180948|NCT03168295|11310705|FG000|STARTED|Overall Study||3
10180949|NCT03168295|11310706|FG001|STARTED|Overall Study||3
10180950|NCT03168295|11310707|FG002|STARTED|Overall Study||4
10180951|NCT03168295|11310708|FG003|STARTED|Overall Study||4
10180952|NCT03168295|11310709|FG004|STARTED|Overall Study||20
10180953|NCT03168295|11310705|FG000|COMPLETED|Overall Study||3
10180954|NCT03168295|11310706|FG001|COMPLETED|Overall Study||3
10180955|NCT03168295|11310707|FG002|COMPLETED|Overall Study||4
10180956|NCT03168295|11310708|FG003|COMPLETED|Overall Study||4
10180957|NCT03168295|11310709|FG004|COMPLETED|Overall Study||20
10180958|NCT03168295|11310705|FG000|NOT COMPLETED|Overall Study||0
10180959|NCT03168295|11310706|FG001|NOT COMPLETED|Overall Study||0
10180960|NCT03168295|11310707|FG002|NOT COMPLETED|Overall Study||0
10180961|NCT03168295|11310708|FG003|NOT COMPLETED|Overall Study||0
10180962|NCT03168295|11310709|FG004|NOT COMPLETED|Overall Study||0
10180963|NCT03168308|11310722|FG000|STARTED|Overall Study||48
10180964|NCT03168308|11310723|FG001|STARTED|Overall Study||44
9714440|NCT03048552|10813802|FG001|NOT COMPLETED|Overall Study||0
9714441|NCT03048552|10813803|FG002|NOT COMPLETED|Overall Study||0
9714442|NCT03048552|10813804|FG003|NOT COMPLETED|Overall Study||0
9714443|NCT02949219|10813814|FG000|STARTED|Overall Study||41
9714444|NCT02949219|10813814|FG000|COMPLETED|Overall Study||40
9714445|NCT02949219|10813814|FG000|NOT COMPLETED|Overall Study||1
9714446|NCT02886884|10813822|FG000|STARTED|Treatment||3
9714447|NCT02886884|10813823|FG001|STARTED|Treatment||3
9714448|NCT02886884|10813824|FG002|STARTED|Treatment||5
9714449|NCT02886884|10813825|FG003|STARTED|Treatment||5
9714450|NCT02886884|10813822|FG000|COMPLETED|Treatment||3
9714451|NCT02886884|10813823|FG001|COMPLETED|Treatment||3
9714452|NCT02886884|10813824|FG002|COMPLETED|Treatment||5
9714453|NCT02886884|10813825|FG003|COMPLETED|Treatment||5
9714454|NCT02886884|10813822|FG000|NOT COMPLETED|Treatment||0
9714455|NCT02886884|10813823|FG001|NOT COMPLETED|Treatment||0
9714456|NCT02886884|10813824|FG002|NOT COMPLETED|Treatment||0
9714457|NCT02886884|10813825|FG003|NOT COMPLETED|Treatment||0
9714458|NCT02886884|10813822|FG000|STARTED|Follow-up||3
9714459|NCT02886884|10813823|FG001|STARTED|Follow-up||3
9714460|NCT02886884|10813824|FG002|STARTED|Follow-up||5
9714461|NCT02886884|10813825|FG003|STARTED|Follow-up||5
9714462|NCT02886884|10813822|FG000|COMPLETED|Follow-up||3
9714463|NCT02886884|10813823|FG001|COMPLETED|Follow-up||3
9714464|NCT02886884|10813824|FG002|COMPLETED|Follow-up||5
9714465|NCT02886884|10813825|FG003|COMPLETED|Follow-up||4
9714466|NCT02886884|10813822|FG000|NOT COMPLETED|Follow-up||0
9714467|NCT02886884|10813823|FG001|NOT COMPLETED|Follow-up||0
9714468|NCT02886884|10813824|FG002|NOT COMPLETED|Follow-up||0
9714469|NCT02886884|10813825|FG003|NOT COMPLETED|Follow-up||1
9714470|NCT02845453|10813837|FG000|STARTED|Overall Study||13
9714471|NCT02845453|10813838|FG001|STARTED|Overall Study||11
9714472|NCT02845453|10813837|FG000|Took One Dose of Study Medication|Overall Study||11
9714473|NCT02845453|10813838|FG001|Took One Dose of Study Medication|Overall Study||10
9714474|NCT02845453|10813837|FG000|Took One Week of Study Medication|Overall Study||10
9714475|NCT02845453|10813838|FG001|Took One Week of Study Medication|Overall Study||9
9714476|NCT02845453|10813837|FG000|COMPLETED|Overall Study||7
9714477|NCT02845453|10813838|FG001|COMPLETED|Overall Study||6
9714478|NCT02845453|10813837|FG000|NOT COMPLETED|Overall Study||6
9714479|NCT02845453|10813838|FG001|NOT COMPLETED|Overall Study||5
9714480|NCT02739542|10813846|FG000|STARTED|Overall Study||44
9714481|NCT02739542|10813847|FG001|STARTED|Overall Study||43
9714482|NCT02739542|10813846|FG000|COMPLETED|Overall Study||30
9714483|NCT02739542|10813847|FG001|COMPLETED|Overall Study||29
9714484|NCT02739542|10813846|FG000|NOT COMPLETED|Overall Study||14
9714485|NCT02739542|10813847|FG001|NOT COMPLETED|Overall Study||14
9714486|NCT02717832|10813853|FG000|STARTED|Overall Study||20
9714487|NCT02717832|10813853|FG000|COMPLETED|Overall Study||17
9714488|NCT02717832|10813853|FG000|NOT COMPLETED|Overall Study||3
9731357|NCT00131911|10831296|FG001|COMPLETED|Overall Study||42
9731358|NCT00131911|10831295|FG000|NOT COMPLETED|Overall Study||1
9731359|NCT00131911|10831296|FG001|NOT COMPLETED|Overall Study||0
9731360|NCT00131937|10831301|FG000|STARTED|Overall Study||14
9731361|NCT00131937|10831301|FG000|COMPLETED|Overall Study||0
10180965|NCT03168308|11310722|FG000|COMPLETED|Overall Study||48
9731362|NCT00131937|10831301|FG000|NOT COMPLETED|Overall Study||14
9731363|NCT00132002|10831305|FG000|STARTED|Overall Study||14
10180966|NCT03168308|11310723|FG001|COMPLETED|Overall Study||44
10180967|NCT03168308|11310722|FG000|NOT COMPLETED|Overall Study||0
10180968|NCT03168308|11310723|FG001|NOT COMPLETED|Overall Study||0
10180969|NCT03168321|11310731|FG000|STARTED|Overall Study||402
10180970|NCT03168321|11310732|FG001|STARTED|Overall Study||411
10180971|NCT03168321|11310731|FG000|COMPLETED|Overall Study||347
9731364|NCT00132002|10831305|FG000|COMPLETED|Overall Study||14
9731365|NCT00132002|10831305|FG000|NOT COMPLETED|Overall Study||0
9731366|NCT00132028|10831309|FG000|STARTED|Overall Study||27
9731367|NCT00132028|10831309|FG000|Eligible|Overall Study||25
9731368|NCT00132028|10831309|FG000|Eligible and Began Protocol Therapy|Overall Study||25
10180972|NCT03168321|11310732|FG001|COMPLETED|Overall Study||356
10180973|NCT03168321|11310731|FG000|NOT COMPLETED|Overall Study||55
10180974|NCT03168321|11310732|FG001|NOT COMPLETED|Overall Study||55
10180975|NCT03168334|11310740|FG000|STARTED|Overall Study||397
10180976|NCT03168334|11310741|FG001|STARTED|Overall Study||404
10180977|NCT03168334|11310740|FG000|COMPLETED|Overall Study||345
10180978|NCT03168334|11310741|FG001|COMPLETED|Overall Study||366
10180979|NCT03168334|11310740|FG000|NOT COMPLETED|Overall Study||52
10180980|NCT03168334|11310741|FG001|NOT COMPLETED|Overall Study||38
10180981|NCT03168425|11310749|FG000|STARTED|Overall Study||94
10180982|NCT03168425|11310750|FG001|STARTED|Overall Study||96
10180983|NCT03168425|11310749|FG000|COMPLETED|Overall Study||87
10180984|NCT03168425|11310750|FG001|COMPLETED|Overall Study||85
10180985|NCT03168425|11310749|FG000|NOT COMPLETED|Overall Study||7
10180986|NCT03168425|11310750|FG001|NOT COMPLETED|Overall Study||11
10180987|NCT03168542|11310757|FG000|STARTED|Overall Study||7
10180988|NCT03168542|11310758|FG001|STARTED|Overall Study||5
10180989|NCT03168542|11310759|FG002|STARTED|Overall Study||9
10180990|NCT03168542|11310757|FG000|COMPLETED|Overall Study||7
10180991|NCT03168542|11310758|FG001|COMPLETED|Overall Study||5
10180992|NCT03168542|11310759|FG002|COMPLETED|Overall Study||9
10180993|NCT03168542|11310757|FG000|NOT COMPLETED|Overall Study||0
10180994|NCT03168542|11310758|FG001|NOT COMPLETED|Overall Study||0
10180995|NCT03168542|11310759|FG002|NOT COMPLETED|Overall Study||0
10180996|NCT03168711|11310766|FG000|STARTED|Overall Study||14
10180997|NCT03168711|11310767|FG001|STARTED|Overall Study||9
10180998|NCT03168711|11310766|FG000|COMPLETED|Overall Study||12
10180999|NCT03168711|11310767|FG001|COMPLETED|Overall Study||7
10181000|NCT03168711|11310766|FG000|NOT COMPLETED|Overall Study||2
10181001|NCT03168711|11310767|FG001|NOT COMPLETED|Overall Study||2
10181002|NCT03168841|11310773|FG000|STARTED|Overall Study||40
10181003|NCT03168841|11310773|FG000|COMPLETED|Overall Study||36
10181004|NCT03168841|11310773|FG000|NOT COMPLETED|Overall Study||4
10181005|NCT03168919|11310777|FG000|STARTED|Overall Study||5
10181006|NCT03168919|11310777|FG000|COMPLETED|Overall Study||3
10181007|NCT03168919|11310777|FG000|NOT COMPLETED|Overall Study||2
10181008|NCT03169062|11310785|FG000|STARTED|Overall Study||10
10181009|NCT03169062|11310785|FG000|COMPLETED|Overall Study||10
10181010|NCT03169062|11310785|FG000|NOT COMPLETED|Overall Study||0
10181011|NCT03169153|11310789|FG000|STARTED|Period 1, First 30 Days of Wear||42
10181012|NCT03169153|11310790|FG001|STARTED|Period 1, First 30 Days of Wear||39
10181013|NCT03169153|11310789|FG000|COMPLETED|Period 1, First 30 Days of Wear||39
10181014|NCT03169153|11310790|FG001|COMPLETED|Period 1, First 30 Days of Wear||35
10181015|NCT03169153|11310789|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
10181016|NCT03169153|11310790|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4
10181017|NCT03169153|11310789|FG000|STARTED|Period 2, Second 30 Days of Wear||39
10181018|NCT03169153|11310790|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
10181019|NCT03169153|11310789|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37
10181020|NCT03169153|11310790|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32
10181021|NCT03169153|11310789|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10181022|NCT03169153|11310790|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10181023|NCT03169244|11310798|FG000|STARTED|Overall Study||22
10181024|NCT03169244|11310799|FG001|STARTED|Overall Study||20
10181025|NCT03169244|11310798|FG000|Randomly Assigned|Overall Study||22
10181026|NCT03169244|11310799|FG001|Randomly Assigned|Overall Study||20
10181027|NCT03169244|11310798|FG000|Received Intervention|Overall Study||22
10181028|NCT03169244|11310799|FG001|Received Intervention|Overall Study||18
10181029|NCT03169244|11310798|FG000|COMPLETED|Overall Study||17
10181030|NCT03169244|11310799|FG001|COMPLETED|Overall Study||16
10181031|NCT03169244|11310798|FG000|NOT COMPLETED|Overall Study||5
10181032|NCT03169244|11310799|FG001|NOT COMPLETED|Overall Study||4
10181033|NCT03169816|11310807|FG000|STARTED|Overall Study||33
10181034|NCT03169816|11310808|FG001|STARTED|Overall Study||16
10181035|NCT03169816|11310807|FG000|COMPLETED|Overall Study||6
10181036|NCT03169816|11310808|FG001|COMPLETED|Overall Study||3
9714489|NCT02677324|10813858|FG000|STARTED|Overall Study||33
9714490|NCT02677324|10813858|FG000|COMPLETED|Overall Study||21
9714491|NCT02677324|10813858|FG000|NOT COMPLETED|Overall Study||12
9714492|NCT02563028|10813864|FG000|STARTED|Overall Study||20
9714493|NCT02563028|10813864|FG000|COMPLETED|Overall Study||18
9714494|NCT02563028|10813864|FG000|NOT COMPLETED|Overall Study||2
9714495|NCT02552212|10813870|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158
9714496|NCT02552212|10813871|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159
9714497|NCT02552212|10813872|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0
9714498|NCT02552212|10813870|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
9714499|NCT02552212|10813871|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
9714500|NCT02552212|10813872|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
10181037|NCT03169816|11310807|FG000|NOT COMPLETED|Overall Study||27
10181038|NCT03169816|11310808|FG001|NOT COMPLETED|Overall Study||13
10181039|NCT03170154|11310814|FG000|STARTED|Overall Study||350
10181040|NCT03170154|11310814|FG000|Rotational Stability Sub-study|Overall Study||141
10181041|NCT03170154|11310814|FG000|COMPLETED|Overall Study||342
9714501|NCT02552212|10813870|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
10181042|NCT03170154|11310814|FG000|NOT COMPLETED|Overall Study||8
10181043|NCT03170193|11310830|FG000|STARTED|Overall Study||12
10181044|NCT03170193|11310831|FG001|STARTED|Overall Study||6
10181045|NCT03170193|11310832|FG002|STARTED|Overall Study||6
10181046|NCT03170193|11310833|FG003|STARTED|Overall Study||6
10181047|NCT03170193|11310834|FG004|STARTED|Overall Study||6
10181048|NCT03170193|11310835|FG005|STARTED|Overall Study||6
10181049|NCT03170193|11310836|FG006|STARTED|Overall Study||6
10181050|NCT03170193|11310830|FG000|COMPLETED|Overall Study||11
10181051|NCT03170193|11310831|FG001|COMPLETED|Overall Study||5
10181052|NCT03170193|11310832|FG002|COMPLETED|Overall Study||6
10181053|NCT03170193|11310833|FG003|COMPLETED|Overall Study||5
10181054|NCT03170193|11310834|FG004|COMPLETED|Overall Study||6
10181055|NCT03170193|11310835|FG005|COMPLETED|Overall Study||6
10181056|NCT03170193|11310836|FG006|COMPLETED|Overall Study||6
10181057|NCT03170193|11310830|FG000|NOT COMPLETED|Overall Study||1
10181058|NCT03170193|11310831|FG001|NOT COMPLETED|Overall Study||1
10181059|NCT03170193|11310832|FG002|NOT COMPLETED|Overall Study||0
10181060|NCT03170193|11310833|FG003|NOT COMPLETED|Overall Study||1
10181061|NCT03170193|11310834|FG004|NOT COMPLETED|Overall Study||0
10181062|NCT03170193|11310835|FG005|NOT COMPLETED|Overall Study||0
10181063|NCT03170193|11310836|FG006|NOT COMPLETED|Overall Study||0
10181064|NCT03170219|11310860|FG000|STARTED|Overall Study||7
10181065|NCT03170219|11310861|FG001|STARTED|Overall Study||4
10181066|NCT03170219|11310860|FG000|COMPLETED|Overall Study||7
10181067|NCT03170219|11310861|FG001|COMPLETED|Overall Study||4
10181068|NCT03170219|11310860|FG000|NOT COMPLETED|Overall Study||0
10181069|NCT03170219|11310861|FG001|NOT COMPLETED|Overall Study||0
10181070|NCT03170232|11310869|FG000|STARTED|Overall Study||27
10181071|NCT03170232|11310870|FG001|STARTED|Overall Study||27
10181072|NCT03170232|11310869|FG000|COMPLETED|Overall Study||0
10181073|NCT03170232|11310870|FG001|COMPLETED|Overall Study||0
10181074|NCT03170232|11310869|FG000|NOT COMPLETED|Overall Study||27
10181075|NCT03170232|11310870|FG001|NOT COMPLETED|Overall Study||27
10181076|NCT03170271|11310878|FG000|STARTED|Overall Study||431
10181077|NCT03170271|11310879|FG001|STARTED|Overall Study||229
10181078|NCT03170271|11310878|FG000|Received Treatment|Overall Study||427
10181079|NCT03170271|11310879|FG001|Received Treatment|Overall Study||229
10181080|NCT03170271|11310878|FG000|COMPLETED|Overall Study||398
10181081|NCT03170271|11310879|FG001|COMPLETED|Overall Study||218
10181082|NCT03170271|11310878|FG000|NOT COMPLETED|Overall Study||33
10181083|NCT03170271|11310879|FG001|NOT COMPLETED|Overall Study||11
10181084|NCT03170388|11310890|FG000|STARTED|Overall Study||147
10181085|NCT03170388|11310891|FG001|STARTED|Overall Study||150
10181086|NCT03170388|11310892|FG002|STARTED|Overall Study||146
10181087|NCT03170388|11310893|FG003|STARTED|Overall Study||150
10181088|NCT03170388|11310894|FG004|STARTED|Overall Study||148
10181089|NCT03170388|11310890|FG000|COMPLETED|Overall Study||125
10181090|NCT03170388|11310891|FG001|COMPLETED|Overall Study||132
10181091|NCT03170388|11310892|FG002|COMPLETED|Overall Study||133
10181092|NCT03170388|11310893|FG003|COMPLETED|Overall Study||132
10181093|NCT03170388|11310894|FG004|COMPLETED|Overall Study||127
10181094|NCT03170388|11310890|FG000|NOT COMPLETED|Overall Study||22
10181095|NCT03170388|11310891|FG001|NOT COMPLETED|Overall Study||18
10181096|NCT03170388|11310892|FG002|NOT COMPLETED|Overall Study||13
10181097|NCT03170388|11310893|FG003|NOT COMPLETED|Overall Study||18
9714502|NCT02552212|10813871|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
9714503|NCT02552212|10813872|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
9714504|NCT02552212|10813870|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143
9714505|NCT02552212|10813871|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142
9714506|NCT02552212|10813872|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0
9714507|NCT02552212|10813870|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
9714508|NCT02552212|10813871|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
9714509|NCT02552212|10813872|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
9714510|NCT02552212|10813870|FG000|STARTED|SFE Period (Week 52 - 156)||0
9714511|NCT02552212|10813871|FG001|STARTED|SFE Period (Week 52 - 156)||0
9714512|NCT02552212|10813872|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
9714513|NCT02552212|10813870|FG000|COMPLETED|SFE Period (Week 52 - 156)||0
9714514|NCT02552212|10813871|FG001|COMPLETED|SFE Period (Week 52 - 156)||0
9714515|NCT02552212|10813872|FG002|COMPLETED|SFE Period (Week 52 - 156)||206
9714516|NCT02552212|10813870|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0
9714517|NCT02552212|10813871|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0
9714518|NCT02552212|10813872|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37
9714519|NCT02439749|10813890|FG000|STARTED|Overall Study||182
9714520|NCT02439749|10813891|FG001|STARTED|Overall Study||184
9714521|NCT02439749|10813890|FG000|COMPLETED|Overall Study||153
9714522|NCT02439749|10813891|FG001|COMPLETED|Overall Study||147
9714523|NCT02439749|10813890|FG000|NOT COMPLETED|Overall Study||29
9714524|NCT02439749|10813891|FG001|NOT COMPLETED|Overall Study||37
9714525|NCT02435511|10813899|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202
9714526|NCT02435511|10813900|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209
9714527|NCT02435511|10813899|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
9714528|NCT02435511|10813900|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
9714529|NCT02435511|10813899|FG000|NOT COMPLETED|Overall Study||44
9714530|NCT02435511|10813900|FG001|NOT COMPLETED|Overall Study||35
9714531|NCT02411448|10813909|FG000|STARTED|Overall Study||14
9714532|NCT02411448|10813910|FG001|STARTED|Overall Study||224
9714533|NCT02411448|10813911|FG002|STARTED|Overall Study||225
9714534|NCT02411448|10813909|FG000|Received at Least One Dose of Study Drug|Overall Study||14
9714535|NCT02411448|10813910|FG001|Received at Least One Dose of Study Drug|Overall Study||221
9714536|NCT02411448|10813911|FG002|Received at Least One Dose of Study Drug|Overall Study||225
9714537|NCT02411448|10813909|FG000|COMPLETED|Overall Study||10
9714538|NCT02411448|10813910|FG001|COMPLETED|Overall Study||141
9714539|NCT02411448|10813911|FG002|COMPLETED|Overall Study||173
10181098|NCT03170388|11310894|FG004|NOT COMPLETED|Overall Study||21
10181099|NCT03170544|11310918|FG000|STARTED|Part 1||10
10181100|NCT03170544|11310919|FG001|STARTED|Part 1||6
10181101|NCT03170544|11310920|FG002|STARTED|Part 1||6
10181102|NCT03170544|11310921|FG003|STARTED|Part 1||7
10181103|NCT03170544|11310922|FG004|STARTED|Part 1||6
10181104|NCT03170544|11310923|FG005|STARTED|Part 1||6
10181105|NCT03170544|11310924|FG006|STARTED|Part 1||0
10181106|NCT03170544|11310925|FG007|STARTED|Part 1||0
10181107|NCT03170544|11310926|FG008|STARTED|Part 1||0
10181108|NCT03170544|11310927|FG009|STARTED|Part 1||0
10181109|NCT03170544|11310928|FG010|STARTED|Part 1||0
10181110|NCT03170544|11310929|FG011|STARTED|Part 1||0
10181111|NCT03170544|11310918|FG000|COMPLETED|Part 1||9
10181112|NCT03170544|11310919|FG001|COMPLETED|Part 1||6
10181113|NCT03170544|11310920|FG002|COMPLETED|Part 1||6
10181114|NCT03170544|11310921|FG003|COMPLETED|Part 1||6
10181115|NCT03170544|11310922|FG004|COMPLETED|Part 1||6
10181116|NCT03170544|11310923|FG005|COMPLETED|Part 1||6
10181117|NCT03170544|11310924|FG006|COMPLETED|Part 1||0
10181118|NCT03170544|11310925|FG007|COMPLETED|Part 1||0
10181119|NCT03170544|11310926|FG008|COMPLETED|Part 1||0
10181120|NCT03170544|11310927|FG009|COMPLETED|Part 1||0
10181121|NCT03170544|11310928|FG010|COMPLETED|Part 1||0
10181122|NCT03170544|11310929|FG011|COMPLETED|Part 1||0
10181123|NCT03170544|11310918|FG000|NOT COMPLETED|Part 1||1
10181124|NCT03170544|11310919|FG001|NOT COMPLETED|Part 1||0
10181125|NCT03170544|11310920|FG002|NOT COMPLETED|Part 1||0
10181126|NCT03170544|11310921|FG003|NOT COMPLETED|Part 1||1
10181127|NCT03170544|11310922|FG004|NOT COMPLETED|Part 1||0
10181128|NCT03170544|11310923|FG005|NOT COMPLETED|Part 1||0
9714540|NCT02411448|10813909|FG000|NOT COMPLETED|Overall Study||4
9714541|NCT02411448|10813910|FG001|NOT COMPLETED|Overall Study||83
9714542|NCT02411448|10813911|FG002|NOT COMPLETED|Overall Study||52
9714543|NCT02371369|10813925|FG000|STARTED|Part 1||61
9714544|NCT02371369|10813926|FG001|STARTED|Part 1||59
9714545|NCT02371369|10813925|FG000|COMPLETED|Part 1||52
9714546|NCT02371369|10813926|FG001|COMPLETED|Part 1||48
9714547|NCT02371369|10813925|FG000|NOT COMPLETED|Part 1||9
9714548|NCT02371369|10813926|FG001|NOT COMPLETED|Part 1||11
9714549|NCT02371369|10813925|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
9714550|NCT02371369|10813926|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
9714551|NCT02371369|10813925|FG000|COMPLETED|Part 2||0
9714552|NCT02371369|10813926|FG001|COMPLETED|Part 2||0
9714553|NCT02371369|10813925|FG000|NOT COMPLETED|Part 2||48
9714554|NCT02371369|10813926|FG001|NOT COMPLETED|Part 2||30
9714555|NCT02282917|10813948|FG000|STARTED|Overall Study||7
9714556|NCT02282917|10813948|FG000|COMPLETED|Overall Study||5
9714557|NCT02282917|10813948|FG000|NOT COMPLETED|Overall Study||2
9714558|NCT01849783|10813952|FG000|STARTED|Overall Study||41
9714559|NCT01849783|10813952|FG000|COMPLETED|Overall Study||19
9714560|NCT01849783|10813952|FG000|NOT COMPLETED|Overall Study||22
9714561|NCT01741480|10813964|FG000|STARTED|Overall Study||285
9714562|NCT01741480|10813965|FG001|STARTED|Overall Study||286
9714563|NCT01741480|10813964|FG000|COMPLETED|Overall Study||285
9714564|NCT01741480|10813965|FG001|COMPLETED|Overall Study||286
9714565|NCT01741480|10813964|FG000|NOT COMPLETED|Overall Study||0
9714566|NCT01741480|10813965|FG001|NOT COMPLETED|Overall Study||0
9714567|NCT01737021|10813973|FG000|STARTED|Overall Study||22
9714568|NCT01737021|10813974|FG001|STARTED|Overall Study||9
9714569|NCT01737021|10813973|FG000|COMPLETED|Overall Study||17
9714570|NCT01737021|10813974|FG001|COMPLETED|Overall Study||6
9714571|NCT01737021|10813973|FG000|NOT COMPLETED|Overall Study||5
10181129|NCT03170544|11310924|FG006|NOT COMPLETED|Part 1||0
10181130|NCT03170544|11310925|FG007|NOT COMPLETED|Part 1||0
10181131|NCT03170544|11310926|FG008|NOT COMPLETED|Part 1||0
10181132|NCT03170544|11310927|FG009|NOT COMPLETED|Part 1||0
10181133|NCT03170544|11310928|FG010|NOT COMPLETED|Part 1||0
10181134|NCT03170544|11310929|FG011|NOT COMPLETED|Part 1||0
10181135|NCT03170544|11310918|FG000|STARTED|Part 2||0
10181136|NCT03170544|11310919|FG001|STARTED|Part 2||0
10181137|NCT03170544|11310920|FG002|STARTED|Part 2||0
10181138|NCT03170544|11310921|FG003|STARTED|Part 2||0
10181139|NCT03170544|11310922|FG004|STARTED|Part 2||0
10181140|NCT03170544|11310923|FG005|STARTED|Part 2||0
10181141|NCT03170544|11310924|FG006|STARTED|Part 2||4
10181142|NCT03170544|11310925|FG007|STARTED|Part 2||0
10181143|NCT03170544|11310926|FG008|STARTED|Part 2||0
10181144|NCT03170544|11310927|FG009|STARTED|Part 2||0
10181145|NCT03170544|11310928|FG010|STARTED|Part 2||0
10181146|NCT03170544|11310929|FG011|STARTED|Part 2||0
10181147|NCT03170544|11310918|FG000|COMPLETED|Part 2||0
10181148|NCT03170544|11310919|FG001|COMPLETED|Part 2||0
10181149|NCT03170544|11310920|FG002|COMPLETED|Part 2||0
10181150|NCT03170544|11310921|FG003|COMPLETED|Part 2||0
10181151|NCT03170544|11310922|FG004|COMPLETED|Part 2||0
10181152|NCT03170544|11310923|FG005|COMPLETED|Part 2||0
10181153|NCT03170544|11310924|FG006|COMPLETED|Part 2||4
10181154|NCT03170544|11310925|FG007|COMPLETED|Part 2||0
10181155|NCT03170544|11310926|FG008|COMPLETED|Part 2||0
10181156|NCT03170544|11310927|FG009|COMPLETED|Part 2||0
10181157|NCT03170544|11310928|FG010|COMPLETED|Part 2||0
10181158|NCT03170544|11310929|FG011|COMPLETED|Part 2||0
10181159|NCT03170544|11310918|FG000|NOT COMPLETED|Part 2||0
10181160|NCT03170544|11310919|FG001|NOT COMPLETED|Part 2||0
10181161|NCT03170544|11310920|FG002|NOT COMPLETED|Part 2||0
10181162|NCT03170544|11310921|FG003|NOT COMPLETED|Part 2||0
10181163|NCT03170544|11310922|FG004|NOT COMPLETED|Part 2||0
10181164|NCT03170544|11310923|FG005|NOT COMPLETED|Part 2||0
10181165|NCT03170544|11310924|FG006|NOT COMPLETED|Part 2||0
10181166|NCT03170544|11310925|FG007|NOT COMPLETED|Part 2||0
10181167|NCT03170544|11310926|FG008|NOT COMPLETED|Part 2||0
10181168|NCT03170544|11310927|FG009|NOT COMPLETED|Part 2||0
10181169|NCT03170544|11310928|FG010|NOT COMPLETED|Part 2||0
10181170|NCT03170544|11310929|FG011|NOT COMPLETED|Part 2||0
10181171|NCT03170544|11310918|FG000|STARTED|Part 3||0
10181172|NCT03170544|11310919|FG001|STARTED|Part 3||0
10181173|NCT03170544|11310920|FG002|STARTED|Part 3||0
10181174|NCT03170544|11310921|FG003|STARTED|Part 3||0
10181175|NCT03170544|11310922|FG004|STARTED|Part 3||0
10181176|NCT03170544|11310923|FG005|STARTED|Part 3||0
10181177|NCT03170544|11310924|FG006|STARTED|Part 3||0
10181178|NCT03170544|11310925|FG007|STARTED|Part 3||4
10181179|NCT03170544|11310926|FG008|STARTED|Part 3||6
10181180|NCT03170544|11310927|FG009|STARTED|Part 3||6
10181181|NCT03170544|11310928|FG010|STARTED|Part 3||0
10181182|NCT03170544|11310929|FG011|STARTED|Part 3||0
10181183|NCT03170544|11310918|FG000|COMPLETED|Part 3||0
10181184|NCT03170544|11310919|FG001|COMPLETED|Part 3||0
10181185|NCT03170544|11310920|FG002|COMPLETED|Part 3||0
10181186|NCT03170544|11310921|FG003|COMPLETED|Part 3||0
10181187|NCT03170544|11310922|FG004|COMPLETED|Part 3||0
10181188|NCT03170544|11310923|FG005|COMPLETED|Part 3||0
10181189|NCT03170544|11310924|FG006|COMPLETED|Part 3||0
10181190|NCT03170544|11310925|FG007|COMPLETED|Part 3||4
10181191|NCT03170544|11310926|FG008|COMPLETED|Part 3||6
10181192|NCT03170544|11310927|FG009|COMPLETED|Part 3||6
10181193|NCT03170544|11310928|FG010|COMPLETED|Part 3||0
10181194|NCT03170544|11310929|FG011|COMPLETED|Part 3||0
10181195|NCT03170544|11310918|FG000|NOT COMPLETED|Part 3||0
10181196|NCT03170544|11310919|FG001|NOT COMPLETED|Part 3||0
10181197|NCT03170544|11310920|FG002|NOT COMPLETED|Part 3||0
10181198|NCT03170544|11310921|FG003|NOT COMPLETED|Part 3||0
10181199|NCT03170544|11310922|FG004|NOT COMPLETED|Part 3||0
10181200|NCT03170544|11310923|FG005|NOT COMPLETED|Part 3||0
10181201|NCT03170544|11310924|FG006|NOT COMPLETED|Part 3||0
10181202|NCT03170544|11310925|FG007|NOT COMPLETED|Part 3||0
10181203|NCT03170544|11310926|FG008|NOT COMPLETED|Part 3||0
10181204|NCT03170544|11310927|FG009|NOT COMPLETED|Part 3||0
10181205|NCT03170544|11310928|FG010|NOT COMPLETED|Part 3||0
10181206|NCT03170544|11310929|FG011|NOT COMPLETED|Part 3||0
10181207|NCT03170544|11310918|FG000|STARTED|Part 4||0
10181208|NCT03170544|11310919|FG001|STARTED|Part 4||0
10181209|NCT03170544|11310920|FG002|STARTED|Part 4||0
10181210|NCT03170544|11310921|FG003|STARTED|Part 4||0
10181211|NCT03170544|11310922|FG004|STARTED|Part 4||0
10181212|NCT03170544|11310923|FG005|STARTED|Part 4||0
10181213|NCT03170544|11310924|FG006|STARTED|Part 4||0
10181214|NCT03170544|11310925|FG007|STARTED|Part 4||0
10181215|NCT03170544|11310926|FG008|STARTED|Part 4||0
10181216|NCT03170544|11310927|FG009|STARTED|Part 4||0
10181217|NCT03170544|11310928|FG010|STARTED|Part 4||3
10181218|NCT03170544|11310929|FG011|STARTED|Part 4||6
10181219|NCT03170544|11310918|FG000|COMPLETED|Part 4||0
10181220|NCT03170544|11310919|FG001|COMPLETED|Part 4||0
10181221|NCT03170544|11310920|FG002|COMPLETED|Part 4||0
10181222|NCT03170544|11310921|FG003|COMPLETED|Part 4||0
10181223|NCT03170544|11310922|FG004|COMPLETED|Part 4||0
10181224|NCT03170544|11310923|FG005|COMPLETED|Part 4||0
10181225|NCT03170544|11310924|FG006|COMPLETED|Part 4||0
10181226|NCT03170544|11310925|FG007|COMPLETED|Part 4||0
10181227|NCT03170544|11310926|FG008|COMPLETED|Part 4||0
10181228|NCT03170544|11310927|FG009|COMPLETED|Part 4||0
10181229|NCT03170544|11310928|FG010|COMPLETED|Part 4||3
10181230|NCT03170544|11310929|FG011|COMPLETED|Part 4||6
10181231|NCT03170544|11310918|FG000|NOT COMPLETED|Part 4||0
10181232|NCT03170544|11310919|FG001|NOT COMPLETED|Part 4||0
10181233|NCT03170544|11310920|FG002|NOT COMPLETED|Part 4||0
10181234|NCT03170544|11310921|FG003|NOT COMPLETED|Part 4||0
10181235|NCT03170544|11310922|FG004|NOT COMPLETED|Part 4||0
10181236|NCT03170544|11310923|FG005|NOT COMPLETED|Part 4||0
10181237|NCT03170544|11310924|FG006|NOT COMPLETED|Part 4||0
10181238|NCT03170544|11310925|FG007|NOT COMPLETED|Part 4||0
10181239|NCT03170544|11310926|FG008|NOT COMPLETED|Part 4||0
10181240|NCT03170544|11310927|FG009|NOT COMPLETED|Part 4||0
10181241|NCT03170544|11310928|FG010|NOT COMPLETED|Part 4||0
10181242|NCT03170544|11310929|FG011|NOT COMPLETED|Part 4||0
10181243|NCT03170609|11311019|FG000|STARTED|Overall Study||53
10181244|NCT03170609|11311020|FG001|STARTED|Overall Study||52
10181245|NCT03170609|11311021|FG002|STARTED|Overall Study||52
10181246|NCT03170609|11311022|FG003|STARTED|Overall Study||52
10181247|NCT03170609|11311023|FG004|STARTED|Overall Study||52
10181248|NCT03170609|11311024|FG005|STARTED|Overall Study||52
10181249|NCT03170609|11311025|FG006|STARTED|Overall Study||52
10181250|NCT03170609|11311019|FG000|Vaccinated|Overall Study||52
10181251|NCT03170609|11311020|FG001|Vaccinated|Overall Study||52
10181252|NCT03170609|11311021|FG002|Vaccinated|Overall Study||52
10181253|NCT03170609|11311022|FG003|Vaccinated|Overall Study||52
10181254|NCT03170609|11311023|FG004|Vaccinated|Overall Study||52
10181255|NCT03170609|11311024|FG005|Vaccinated|Overall Study||52
10181256|NCT03170609|11311025|FG006|Vaccinated|Overall Study||52
10181257|NCT03170609|11311019|FG000|COMPLETED|Overall Study||50
10181258|NCT03170609|11311020|FG001|COMPLETED|Overall Study||50
10181259|NCT03170609|11311021|FG002|COMPLETED|Overall Study||46
10181260|NCT03170609|11311022|FG003|COMPLETED|Overall Study||50
10181261|NCT03170609|11311023|FG004|COMPLETED|Overall Study||51
10181262|NCT03170609|11311024|FG005|COMPLETED|Overall Study||50
10181263|NCT03170609|11311025|FG006|COMPLETED|Overall Study||51
10181264|NCT03170609|11311019|FG000|NOT COMPLETED|Overall Study||3
10181265|NCT03170609|11311020|FG001|NOT COMPLETED|Overall Study||2
10181266|NCT03170609|11311021|FG002|NOT COMPLETED|Overall Study||6
10181267|NCT03170609|11311022|FG003|NOT COMPLETED|Overall Study||2
10181268|NCT03170609|11311023|FG004|NOT COMPLETED|Overall Study||1
10181269|NCT03170609|11311024|FG005|NOT COMPLETED|Overall Study||2
10181270|NCT03170609|11311025|FG006|NOT COMPLETED|Overall Study||1
10181271|NCT03170661|11311043|FG000|STARTED|Overall Study||49
10181272|NCT03170661|11311044|FG001|STARTED|Overall Study||49
10181273|NCT03170661|11311043|FG000|COMPLETED|Overall Study||49
10181274|NCT03170661|11311044|FG001|COMPLETED|Overall Study||49
10181275|NCT03170661|11311043|FG000|NOT COMPLETED|Overall Study||0
10181276|NCT03170661|11311044|FG001|NOT COMPLETED|Overall Study||0
10181277|NCT03171051|11311052|FG000|STARTED|Overall Study||10
10181278|NCT03171051|11311052|FG000|COMPLETED|Overall Study||10
10181279|NCT03171051|11311052|FG000|NOT COMPLETED|Overall Study||0
10181280|NCT03171415|11311062|FG000|STARTED|Overall Study||6
10181281|NCT03171415|11311063|FG001|STARTED|Overall Study||6
10181282|NCT03171415|11311064|FG002|STARTED|Overall Study||6
10181283|NCT03171415|11311065|FG003|STARTED|Overall Study||6
10181284|NCT03171415|11311066|FG004|STARTED|Overall Study||9
10181285|NCT03171415|11311062|FG000|COMPLETED|Overall Study||6
10181286|NCT03171415|11311063|FG001|COMPLETED|Overall Study||6
10181287|NCT03171415|11311064|FG002|COMPLETED|Overall Study||6
10181288|NCT03171415|11311065|FG003|COMPLETED|Overall Study||6
10181289|NCT03171415|11311066|FG004|COMPLETED|Overall Study||7
10181290|NCT03171415|11311062|FG000|NOT COMPLETED|Overall Study||0
10181291|NCT03171415|11311063|FG001|NOT COMPLETED|Overall Study||0
10181292|NCT03171415|11311064|FG002|NOT COMPLETED|Overall Study||0
10181293|NCT03171415|11311065|FG003|NOT COMPLETED|Overall Study||0
10181294|NCT03171415|11311066|FG004|NOT COMPLETED|Overall Study||2
10181295|NCT03172130|11311091|FG000|STARTED|Overall Study||12
10181296|NCT03172130|11311092|FG001|STARTED|Overall Study||10
10181297|NCT03172130|11311091|FG000|COMPLETED|Overall Study||9
10181298|NCT03172130|11311092|FG001|COMPLETED|Overall Study||9
10181299|NCT03172130|11311091|FG000|NOT COMPLETED|Overall Study||3
10181300|NCT03172130|11311092|FG001|NOT COMPLETED|Overall Study||1
10181301|NCT03172325|11311100|FG000|STARTED|Overall Study||68
10181302|NCT03172325|11311101|FG001|STARTED|Overall Study||68
10181303|NCT03172325|11311100|FG000|COMPLETED|Overall Study||64
10181304|NCT03172325|11311101|FG001|COMPLETED|Overall Study||64
10181305|NCT03172325|11311100|FG000|NOT COMPLETED|Overall Study||4
10181306|NCT03172325|11311101|FG001|NOT COMPLETED|Overall Study||4
10181307|NCT03172364|11311109|FG000|STARTED|Overall Study||55
10181308|NCT03172364|11311110|FG001|STARTED|Overall Study||58
10181309|NCT03172364|11311109|FG000|COMPLETED|Overall Study||53
10181310|NCT03172364|11311110|FG001|COMPLETED|Overall Study||57
10181311|NCT03172364|11311109|FG000|NOT COMPLETED|Overall Study||2
10181312|NCT03172364|11311110|FG001|NOT COMPLETED|Overall Study||1
10181313|NCT03172481|11311118|FG000|STARTED|Open-label||156
10181314|NCT03172481|11311119|FG001|STARTED|Open-label||0
10181315|NCT03172481|11311118|FG000|COMPLETED|Open-label||148
10181316|NCT03172481|11311119|FG001|COMPLETED|Open-label||0
10181317|NCT03172481|11311118|FG000|NOT COMPLETED|Open-label||8
10181318|NCT03172481|11311119|FG001|NOT COMPLETED|Open-label||0
10181319|NCT03172481|11311118|FG000|STARTED|Double-blind||75
10181320|NCT03172481|11311119|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
10181321|NCT03172481|11311118|FG000|COMPLETED|Double-blind||74
10181322|NCT03172481|11311119|FG001|COMPLETED|Double-blind||73
10181323|NCT03172481|11311118|FG000|NOT COMPLETED|Double-blind||1
10181324|NCT03172481|11311119|FG001|NOT COMPLETED|Double-blind||0
10181325|NCT03172494|11311128|FG000|STARTED|Overall Study||361
10181326|NCT03172494|11311129|FG001|STARTED|Overall Study||179
10181327|NCT03172494|11311130|FG002|STARTED|Overall Study||180
10181328|NCT03172494|11311128|FG000|Full Analysis Set (FAS)|Overall Study||361
10181329|NCT03172494|11311129|FG001|Full Analysis Set (FAS)|Overall Study||179
10181330|NCT03172494|11311130|FG002|Full Analysis Set (FAS)|Overall Study||180
10181331|NCT03172494|11311128|FG000|Safety Analysis Set (SAS)|Overall Study||358
10181332|NCT03172494|11311129|FG001|Safety Analysis Set (SAS)|Overall Study||175
10181333|NCT03172494|11311130|FG002|Safety Analysis Set (SAS)|Overall Study||180
10181334|NCT03172494|11311128|FG000|Exposed|Overall Study||358
10181335|NCT03172494|11311129|FG001|Exposed|Overall Study||175
10181336|NCT03172494|11311130|FG002|Exposed|Overall Study||180
10181337|NCT03172494|11311128|FG000|COMPLETED|Overall Study||341
10181338|NCT03172494|11311129|FG001|COMPLETED|Overall Study||167
10181339|NCT03172494|11311130|FG002|COMPLETED|Overall Study||151
10181340|NCT03172494|11311128|FG000|NOT COMPLETED|Overall Study||20
10181341|NCT03172494|11311129|FG001|NOT COMPLETED|Overall Study||12
10181342|NCT03172494|11311130|FG002|NOT COMPLETED|Overall Study||29
10181343|NCT03172702|11311139|FG000|STARTED|Overall Study||150
10181344|NCT03172702|11311139|FG000|Received Treatment in CP|Overall Study||150
10181345|NCT03172702|11311139|FG000|Received Treatment in MP|Overall Study||150
10181346|NCT03172702|11311139|FG000|COMPLETED|Overall Study||122
10181347|NCT03172702|11311139|FG000|NOT COMPLETED|Overall Study||28
10181348|NCT03172884|11311148|FG000|STARTED|Overall Study||8
10181349|NCT03172884|11311149|FG001|STARTED|Overall Study||6
10181350|NCT03172884|11311150|FG002|STARTED|Overall Study||8
10181351|NCT03172884|11311151|FG003|STARTED|Overall Study||8
10181352|NCT03172884|11311148|FG000|COMPLETED|Overall Study||8
10181353|NCT03172884|11311149|FG001|COMPLETED|Overall Study||6
10181354|NCT03172884|11311150|FG002|COMPLETED|Overall Study||8
10181355|NCT03172884|11311151|FG003|COMPLETED|Overall Study||8
10181356|NCT03172884|11311148|FG000|NOT COMPLETED|Overall Study||0
10181357|NCT03172884|11311149|FG001|NOT COMPLETED|Overall Study||0
10181358|NCT03172884|11311150|FG002|NOT COMPLETED|Overall Study||0
10181359|NCT03172884|11311151|FG003|NOT COMPLETED|Overall Study||0
10181360|NCT03173170|11311161|FG000|STARTED|First Intervention Period (6 Days)||10
10181361|NCT03173170|11311161|FG000|COMPLETED|First Intervention Period (6 Days)||10
10181362|NCT03173170|11311161|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0
10181363|NCT03173170|11311161|FG000|STARTED|Washout Period (at Least 7 Days)||10
10181364|NCT03173170|11311161|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
10181365|NCT03173170|11311161|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10181366|NCT03173170|11311161|FG000|STARTED|Intervention Period 2 (9 Days)||10
10181367|NCT03173170|11311161|FG000|COMPLETED|Intervention Period 2 (9 Days)||10
10181368|NCT03173170|11311161|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0
10181369|NCT03173313|11311171|FG000|STARTED|Overall Study||58
10181370|NCT03173313|11311172|FG001|STARTED|Overall Study||53
10181371|NCT03173313|11311171|FG000|Informed Consent Signed|Overall Study||58
10181372|NCT03173313|11311172|FG001|Informed Consent Signed|Overall Study||53
10181373|NCT03173313|11311171|FG000|Randomized|Overall Study||58
10181374|NCT03173313|11311172|FG001|Randomized|Overall Study||53
10181375|NCT03173313|11311171|FG000|Cooled|Overall Study||54
10181376|NCT03173313|11311172|FG001|Cooled|Overall Study||0
10181377|NCT03173313|11311171|FG000|4-6 Day Follow-up|Overall Study||57
10181378|NCT03173313|11311172|FG001|4-6 Day Follow-up|Overall Study||53
10181379|NCT03173313|11311171|FG000|30-day Follow-up|Overall Study||52
10181380|NCT03173313|11311172|FG001|30-day Follow-up|Overall Study||51
10181381|NCT03173313|11311171|FG000|12-month Follow-up|Overall Study||49
10181382|NCT03173313|11311172|FG001|12-month Follow-up|Overall Study||48
10181383|NCT03173313|11311171|FG000|COMPLETED|Overall Study||49
10181384|NCT03173313|11311172|FG001|COMPLETED|Overall Study||48
10181385|NCT03173313|11311171|FG000|NOT COMPLETED|Overall Study||9
10181386|NCT03173313|11311172|FG001|NOT COMPLETED|Overall Study||5
10181387|NCT03173547|11311180|FG000|STARTED|Overall Study||40
10181388|NCT03173547|11311181|FG001|STARTED|Overall Study||40
10181389|NCT03173547|11311180|FG000|COMPLETED|Overall Study||36
10181390|NCT03173547|11311181|FG001|COMPLETED|Overall Study||38
10181391|NCT03173547|11311180|FG000|NOT COMPLETED|Overall Study||4
10181392|NCT03173547|11311181|FG001|NOT COMPLETED|Overall Study||2
10181393|NCT03173560|11311189|FG000|STARTED|Overall Study||172
10181394|NCT03173560|11311190|FG001|STARTED|Overall Study||171
10181395|NCT03173560|11311189|FG000|Treated Participants|Overall Study||172
10181396|NCT03173560|11311190|FG001|Treated Participants|Overall Study||169
10181397|NCT03173560|11311189|FG000|Safety Set|Overall Study||173
10181398|NCT03173560|11311190|FG001|Safety Set|Overall Study||168
10181399|NCT03173560|11311189|FG000|COMPLETED|Overall Study||67
10181400|NCT03173560|11311190|FG001|COMPLETED|Overall Study||54
10181401|NCT03173560|11311189|FG000|NOT COMPLETED|Overall Study||105
10181402|NCT03173560|11311190|FG001|NOT COMPLETED|Overall Study||117
10181403|NCT03174132|11311196|FG000|STARTED|Overall Study||70
10181404|NCT03174132|11311196|FG000|COMPLETED|Overall Study||70
10181405|NCT03174132|11311196|FG000|NOT COMPLETED|Overall Study||0
10181406|NCT03174158|11311204|FG000|STARTED|Overall Study||39
10181407|NCT03174158|11311205|FG001|STARTED|Overall Study||39
10181408|NCT03174158|11311206|FG002|STARTED|Overall Study||36
10181409|NCT03174158|11311207|FG003|STARTED|Overall Study||39
10181410|NCT03174158|11311204|FG000|COMPLETED|Overall Study||35
10181411|NCT03174158|11311205|FG001|COMPLETED|Overall Study||37
10181412|NCT03174158|11311206|FG002|COMPLETED|Overall Study||34
10181413|NCT03174158|11311207|FG003|COMPLETED|Overall Study||38
10181414|NCT03174158|11311204|FG000|NOT COMPLETED|Overall Study||4
10181415|NCT03174158|11311205|FG001|NOT COMPLETED|Overall Study||2
10181416|NCT03174158|11311206|FG002|NOT COMPLETED|Overall Study||2
10181417|NCT03174158|11311207|FG003|NOT COMPLETED|Overall Study||1
10181418|NCT03174366|11311225|FG000|STARTED|Overall Study||7
10181419|NCT03174366|11311225|FG000|COMPLETED|Overall Study||7
10181420|NCT03174366|11311225|FG000|NOT COMPLETED|Overall Study||0
10181421|NCT03174925|11311229|FG000|STARTED|Overall Study||55
10181422|NCT03174925|11311229|FG000|COMPLETED|Overall Study||52
10181423|NCT03174925|11311229|FG000|NOT COMPLETED|Overall Study||3
10181424|NCT03175120|11311235|FG000|STARTED|Overall Study||302
10181425|NCT03175120|11311236|FG001|STARTED|Overall Study||151
10181426|NCT03175120|11311235|FG000|Treated|Overall Study||301
10181427|NCT03175120|11311236|FG001|Treated|Overall Study||151
10181428|NCT03175120|11311235|FG000|Full Analysis Set (FAS)|Overall Study||302
10181429|NCT03175120|11311236|FG001|Full Analysis Set (FAS)|Overall Study||151
10181430|NCT03175120|11311235|FG000|Safety Analysis Set (SAS)|Overall Study||301
10181431|NCT03175120|11311236|FG001|Safety Analysis Set (SAS)|Overall Study||151
10181432|NCT03175120|11311235|FG000|COMPLETED|Overall Study||290
10181433|NCT03175120|11311236|FG001|COMPLETED|Overall Study||139
10181434|NCT03175120|11311235|FG000|NOT COMPLETED|Overall Study||12
10181435|NCT03175120|11311236|FG001|NOT COMPLETED|Overall Study||12
10181436|NCT03175172|11311242|FG000|STARTED|Overall Study||10
10181437|NCT03175172|11311242|FG000|COMPLETED|Overall Study||0
10181438|NCT03175172|11311242|FG000|NOT COMPLETED|Overall Study||10
10181439|NCT03175562|11311246|FG000|STARTED|Overall Study||240
10181440|NCT03175562|11311246|FG000|Test Product|Overall Study||240
10181441|NCT03175562|11311246|FG000|Negative Control|Overall Study||240
10181442|NCT03175562|11311246|FG000|COMPLETED|Overall Study||224
10181443|NCT03175562|11311246|FG000|NOT COMPLETED|Overall Study||16
10181444|NCT03175731|11311255|FG000|STARTED|Overall Study||53
10181445|NCT03175731|11311256|FG001|STARTED|Overall Study||53
10181446|NCT03175731|11311255|FG000|COMPLETED|Overall Study||46
10181447|NCT03175731|11311256|FG001|COMPLETED|Overall Study||48
10181448|NCT03175731|11311255|FG000|NOT COMPLETED|Overall Study||7
10181449|NCT03175731|11311256|FG001|NOT COMPLETED|Overall Study||5
10181450|NCT03176238|11311264|FG000|STARTED|Overall Study||199
10181451|NCT03176238|11311265|FG001|STARTED|Overall Study||36
10181452|NCT03176238|11311264|FG000|COMPLETED|Overall Study||0
10181453|NCT03176238|11311265|FG001|COMPLETED|Overall Study||0
10181454|NCT03176238|11311264|FG000|NOT COMPLETED|Overall Study||199
10181455|NCT03176238|11311265|FG001|NOT COMPLETED|Overall Study||36
10181456|NCT03176407|11311275|FG000|STARTED|Overall Study||30
10181457|NCT03176407|11311275|FG000|COMPLETED|Overall Study||27
10181458|NCT03176407|11311275|FG000|NOT COMPLETED|Overall Study||3
10181459|NCT03176459|11311283|FG000|STARTED|Overall Study||96
10181460|NCT03176459|11311284|FG001|STARTED|Overall Study||90
10181461|NCT03176459|11311283|FG000|COMPLETED|Overall Study||91
10181462|NCT03176459|11311284|FG001|COMPLETED|Overall Study||83
10181463|NCT03176459|11311283|FG000|NOT COMPLETED|Overall Study||5
10181464|NCT03176459|11311284|FG001|NOT COMPLETED|Overall Study||7
10181465|NCT03176654|11311292|FG000|STARTED|Overall Study||13
10181466|NCT03176654|11311293|FG001|STARTED|Overall Study||15
10181467|NCT03176654|11311292|FG000|COMPLETED|Overall Study||13
10181468|NCT03176654|11311293|FG001|COMPLETED|Overall Study||15
10181469|NCT03176654|11311292|FG000|NOT COMPLETED|Overall Study||0
10181470|NCT03176654|11311293|FG001|NOT COMPLETED|Overall Study||0
10181471|NCT03176784|11311303|FG000|STARTED|Overall Study||314
10181472|NCT03176784|11311304|FG001|STARTED|Overall Study||315
10181473|NCT03176784|11311305|FG002|STARTED|Overall Study||311
10181474|NCT03176784|11311306|FG003|STARTED|Overall Study||311
10181475|NCT03176784|11311303|FG000|COMPLETED|Overall Study||209
10181476|NCT03176784|11311304|FG001|COMPLETED|Overall Study||202
10181477|NCT03176784|11311305|FG002|COMPLETED|Overall Study||198
10181478|NCT03176784|11311306|FG003|COMPLETED|Overall Study||241
10181479|NCT03176784|11311303|FG000|NOT COMPLETED|Overall Study||105
10181480|NCT03176784|11311304|FG001|NOT COMPLETED|Overall Study||113
10181481|NCT03176784|11311305|FG002|NOT COMPLETED|Overall Study||113
10181482|NCT03176784|11311306|FG003|NOT COMPLETED|Overall Study||70
10181483|NCT03177395|11311320|FG000|STARTED|Overall Study||6
10181484|NCT03177395|11311321|FG001|STARTED|Overall Study||6
10181485|NCT03177395|11311322|FG002|STARTED|Overall Study||6
10181486|NCT03177395|11311323|FG003|STARTED|Overall Study||6
10181487|NCT03177395|11311320|FG000|COMPLETED|Overall Study||6
10181488|NCT03177395|11311321|FG001|COMPLETED|Overall Study||6
10181489|NCT03177395|11311322|FG002|COMPLETED|Overall Study||6
10181490|NCT03177395|11311323|FG003|COMPLETED|Overall Study||6
10181491|NCT03177395|11311320|FG000|NOT COMPLETED|Overall Study||0
10181492|NCT03177395|11311321|FG001|NOT COMPLETED|Overall Study||0
10181493|NCT03177395|11311322|FG002|NOT COMPLETED|Overall Study||0
10181494|NCT03177395|11311323|FG003|NOT COMPLETED|Overall Study||0
10181495|NCT03177512|11311337|FG000|STARTED|Overall Study||40
10181496|NCT03177512|11311338|FG001|STARTED|Overall Study||21
10181497|NCT03177512|11311337|FG000|COMPLETED|Overall Study||31
10181498|NCT03177512|11311338|FG001|COMPLETED|Overall Study||18
10181499|NCT03177512|11311337|FG000|NOT COMPLETED|Overall Study||9
9714572|NCT01737021|10813974|FG001|NOT COMPLETED|Overall Study||3
10181500|NCT03177512|11311338|FG001|NOT COMPLETED|Overall Study||3
10181501|NCT03177603|11311348|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
10181502|NCT03177603|11311349|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181503|NCT03177603|11311350|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181504|NCT03177603|11311351|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181505|NCT03177603|11311348|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
10181506|NCT03177603|11311349|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181507|NCT03177603|11311350|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181508|NCT03177603|11311351|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181509|NCT03177603|11311348|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181510|NCT03177603|11311349|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181511|NCT03177603|11311350|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181512|NCT03177603|11311351|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10181513|NCT03177603|11311348|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181514|NCT03177603|11311349|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
10181515|NCT03177603|11311350|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181516|NCT03177603|11311351|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181517|NCT03177603|11311348|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181518|NCT03177603|11311349|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
10181519|NCT03177603|11311350|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181520|NCT03177603|11311351|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181521|NCT03177603|11311348|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181522|NCT03177603|11311349|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181523|NCT03177603|11311350|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181524|NCT03177603|11311351|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10181525|NCT03177603|11311348|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181526|NCT03177603|11311349|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181527|NCT03177603|11311350|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
10181528|NCT03177603|11311351|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181529|NCT03177603|11311348|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181530|NCT03177603|11311349|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181531|NCT03177603|11311350|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
10181532|NCT03177603|11311351|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181533|NCT03177603|11311348|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181534|NCT03177603|11311349|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181535|NCT03177603|11311350|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181536|NCT03177603|11311351|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10181537|NCT03177603|11311348|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181538|NCT03177603|11311349|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181539|NCT03177603|11311350|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181540|NCT03177603|11311351|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
10181541|NCT03177603|11311348|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181542|NCT03177603|11311349|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181543|NCT03177603|11311350|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181544|NCT03177603|11311351|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
10181545|NCT03177603|11311348|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181546|NCT03177603|11311349|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181547|NCT03177603|11311350|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181548|NCT03177603|11311351|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10181549|NCT03177798|11311363|FG000|STARTED|Overall Study||5
10181550|NCT03177798|11311364|FG001|STARTED|Overall Study||6
10181551|NCT03177798|11311363|FG000|Intervention 1|Overall Study||5
10181552|NCT03177798|11311364|FG001|Intervention 1|Overall Study||6
10181553|NCT03177798|11311363|FG000|Washout|Overall Study||5
10181554|NCT03177798|11311364|FG001|Washout|Overall Study||6
10181555|NCT03177798|11311363|FG000|Intervention 2|Overall Study||5
10181556|NCT03177798|11311364|FG001|Intervention 2|Overall Study||6
10181557|NCT03177798|11311363|FG000|COMPLETED|Overall Study||5
10181558|NCT03177798|11311364|FG001|COMPLETED|Overall Study||6
10181559|NCT03177798|11311363|FG000|NOT COMPLETED|Overall Study||0
10181560|NCT03177798|11311364|FG001|NOT COMPLETED|Overall Study||0
10181561|NCT03178266|11311374|FG000|STARTED|Overall Study||21
10181562|NCT03178266|11311375|FG001|STARTED|Overall Study||20
10181563|NCT03178266|11311374|FG000|COMPLETED|Overall Study||21
10181564|NCT03178266|11311375|FG001|COMPLETED|Overall Study||16
10181565|NCT03178266|11311374|FG000|NOT COMPLETED|Overall Study||0
10181566|NCT03178266|11311375|FG001|NOT COMPLETED|Overall Study||4
10181567|NCT03178344|11311381|FG000|STARTED|First Session||10
10181568|NCT03178344|11311382|FG001|STARTED|First Session||10
10181569|NCT03178344|11311381|FG000|COMPLETED|First Session||10
10181570|NCT03178344|11311382|FG001|COMPLETED|First Session||10
10181571|NCT03178344|11311381|FG000|NOT COMPLETED|First Session||0
10181572|NCT03178344|11311382|FG001|NOT COMPLETED|First Session||0
10181573|NCT03178344|11311381|FG000|STARTED|Washout Period (5-9 Days)||10
10181574|NCT03178344|11311382|FG001|STARTED|Washout Period (5-9 Days)||10
10181575|NCT03178344|11311381|FG000|COMPLETED|Washout Period (5-9 Days)||10
10181576|NCT03178344|11311382|FG001|COMPLETED|Washout Period (5-9 Days)||10
10181577|NCT03178344|11311381|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0
10181578|NCT03178344|11311382|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0
10181579|NCT03178344|11311381|FG000|STARTED|Second Session||10
10181580|NCT03178344|11311382|FG001|STARTED|Second Session||10
10181581|NCT03178344|11311381|FG000|COMPLETED|Second Session||10
10181582|NCT03178344|11311382|FG001|COMPLETED|Second Session||10
10181583|NCT03178344|11311381|FG000|NOT COMPLETED|Second Session||0
10181584|NCT03178344|11311382|FG001|NOT COMPLETED|Second Session||0
10181585|NCT03178669|11311393|FG000|STARTED|Overall Study||40
10181586|NCT03178669|11311394|FG001|STARTED|Overall Study||43
10181587|NCT03178669|11311395|FG002|STARTED|Overall Study||42
10181588|NCT03178669|11311396|FG003|STARTED|Overall Study||42
10181589|NCT03178669|11311397|FG004|STARTED|Overall Study||44
10181590|NCT03178669|11311393|FG000|Completed Week 6|Overall Study||35
10181591|NCT03178669|11311394|FG001|Completed Week 6|Overall Study||42
10181592|NCT03178669|11311395|FG002|Completed Week 6|Overall Study||36
10181593|NCT03178669|11311396|FG003|Completed Week 6|Overall Study||38
10181594|NCT03178669|11311397|FG004|Completed Week 6|Overall Study||42
10181595|NCT03178669|11311393|FG000|COMPLETED|Overall Study||35
10181596|NCT03178669|11311394|FG001|COMPLETED|Overall Study||42
10181597|NCT03178669|11311395|FG002|COMPLETED|Overall Study||35
10181598|NCT03178669|11311396|FG003|COMPLETED|Overall Study||38
10181599|NCT03178669|11311397|FG004|COMPLETED|Overall Study||40
10181600|NCT03178669|11311393|FG000|NOT COMPLETED|Overall Study||5
10181601|NCT03178669|11311394|FG001|NOT COMPLETED|Overall Study||1
10181602|NCT03178669|11311395|FG002|NOT COMPLETED|Overall Study||7
10181603|NCT03178669|11311396|FG003|NOT COMPLETED|Overall Study||4
10181604|NCT03178669|11311397|FG004|NOT COMPLETED|Overall Study||4
10181605|NCT03178773|11311411|FG000|STARTED|Overall Study||86
10181606|NCT03178773|11311412|FG001|STARTED|Overall Study||80
10181607|NCT03178773|11311411|FG000|3month Phone Follow up|Overall Study||49
10181608|NCT03178773|11311412|FG001|3month Phone Follow up|Overall Study||51
10181609|NCT03178773|11311411|FG000|6month in Person Follow up|Overall Study||54
10181610|NCT03178773|11311412|FG001|6month in Person Follow up|Overall Study||46
10181611|NCT03178773|11311411|FG000|9month Follow up Phone|Overall Study||36
10181612|NCT03178773|11311412|FG001|9month Follow up Phone|Overall Study||51
10181613|NCT03178773|11311411|FG000|COMPLETED|Overall Study||47
10181614|NCT03178773|11311412|FG001|COMPLETED|Overall Study||40
10181615|NCT03178773|11311411|FG000|NOT COMPLETED|Overall Study||39
10181616|NCT03178773|11311412|FG001|NOT COMPLETED|Overall Study||40
10181617|NCT03178851|11311422|FG000|STARTED|Overall Study||92
10181618|NCT03178851|11311423|FG001|STARTED|Overall Study||11
10181619|NCT03178851|11311424|FG002|STARTED|Overall Study||52
10181620|NCT03178851|11311422|FG000|COMPLETED|Overall Study||0
10181621|NCT03178851|11311423|FG001|COMPLETED|Overall Study||0
10181622|NCT03178851|11311424|FG002|COMPLETED|Overall Study||0
10181623|NCT03178851|11311422|FG000|NOT COMPLETED|Overall Study||92
10181624|NCT03178851|11311423|FG001|NOT COMPLETED|Overall Study||11
10181625|NCT03178851|11311424|FG002|NOT COMPLETED|Overall Study||52
10181626|NCT03178942|11311435|FG000|STARTED|Overall Study||129
10181627|NCT03178942|11311436|FG001|STARTED|Overall Study||125
10181628|NCT03178942|11311435|FG000|COMPLETED|Overall Study||126
10181629|NCT03178942|11311436|FG001|COMPLETED|Overall Study||123
10181630|NCT03178942|11311435|FG000|NOT COMPLETED|Overall Study||3
10181631|NCT03178942|11311436|FG001|NOT COMPLETED|Overall Study||2
10181632|NCT03179319|11311444|FG000|STARTED|Overall Study||40
10181633|NCT03179319|11311445|FG001|STARTED|Overall Study||20
10181634|NCT03179319|11311444|FG000|3 Month Visit|Overall Study||37
10181635|NCT03179319|11311445|FG001|3 Month Visit|Overall Study||20
10181636|NCT03179319|11311444|FG000|COMPLETED|Overall Study||34
10181637|NCT03179319|11311445|FG001|COMPLETED|Overall Study||20
10181638|NCT03179319|11311444|FG000|NOT COMPLETED|Overall Study||6
10181639|NCT03179319|11311445|FG001|NOT COMPLETED|Overall Study||0
10181640|NCT03179345|11311455|FG000|STARTED|Overall Study||8
10181641|NCT03179345|11311456|FG001|STARTED|Overall Study||8
10181642|NCT03179345|11311457|FG002|STARTED|Overall Study||8
10181643|NCT03179345|11311458|FG003|STARTED|Overall Study||8
10181644|NCT03179345|11311455|FG000|Received Gralise®|Overall Study||8
10181645|NCT03179345|11311456|FG001|Received Gralise®|Overall Study||7
10181646|NCT03179345|11311457|FG002|Received Gralise®|Overall Study||7
10181647|NCT03179345|11311458|FG003|Received Gralise®|Overall Study||6
10181648|NCT03179345|11311455|FG000|Received Neurontin®|Overall Study||8
10181649|NCT03179345|11311456|FG001|Received Neurontin®|Overall Study||8
10181650|NCT03179345|11311457|FG002|Received Neurontin®|Overall Study||7
10181651|NCT03179345|11311458|FG003|Received Neurontin®|Overall Study||8
10181652|NCT03179345|11311455|FG000|Received Lyrica®|Overall Study||8
10181653|NCT03179345|11311456|FG001|Received Lyrica®|Overall Study||7
10181654|NCT03179345|11311457|FG002|Received Lyrica®|Overall Study||8
10181655|NCT03179345|11311458|FG003|Received Lyrica®|Overall Study||8
10181656|NCT03179345|11311455|FG000|Received Placebo|Overall Study||8
10181657|NCT03179345|11311456|FG001|Received Placebo|Overall Study||7
10181658|NCT03179345|11311457|FG002|Received Placebo|Overall Study||7
10181659|NCT03179345|11311458|FG003|Received Placebo|Overall Study||8
10181660|NCT03179345|11311455|FG000|COMPLETED|Overall Study||8
10181661|NCT03179345|11311456|FG001|COMPLETED|Overall Study||7
10181662|NCT03179345|11311457|FG002|COMPLETED|Overall Study||7
10181663|NCT03179345|11311458|FG003|COMPLETED|Overall Study||6
10181664|NCT03179345|11311455|FG000|NOT COMPLETED|Overall Study||0
10181665|NCT03179345|11311456|FG001|NOT COMPLETED|Overall Study||1
10181666|NCT03179345|11311457|FG002|NOT COMPLETED|Overall Study||1
10181667|NCT03179345|11311458|FG003|NOT COMPLETED|Overall Study||2
10181668|NCT03179410|11311474|FG000|STARTED|Overall Study||15
10181669|NCT03179410|11311474|FG000|COMPLETED|Overall Study||15
10181670|NCT03179410|11311474|FG000|NOT COMPLETED|Overall Study||0
10181671|NCT03179787|11311478|FG000|STARTED|Overall Study||528
10181672|NCT03179787|11311478|FG000|COMPLETED|Overall Study||510
10181673|NCT03179787|11311478|FG000|NOT COMPLETED|Overall Study||18
10181674|NCT03179891|11311482|FG000|STARTED|First Intervention||13
10181675|NCT03179891|11311483|FG001|STARTED|First Intervention||22
10181676|NCT03179891|11311482|FG000|COMPLETED|First Intervention||11
10181677|NCT03179891|11311483|FG001|COMPLETED|First Intervention||20
10181678|NCT03179891|11311482|FG000|NOT COMPLETED|First Intervention||2
10181679|NCT03179891|11311483|FG001|NOT COMPLETED|First Intervention||2
10181680|NCT03179891|11311482|FG000|STARTED|Second Intervention (After 14 Days)||11
10181681|NCT03179891|11311483|FG001|STARTED|Second Intervention (After 14 Days)||20
10181682|NCT03179891|11311482|FG000|COMPLETED|Second Intervention (After 14 Days)||11
10181683|NCT03179891|11311483|FG001|COMPLETED|Second Intervention (After 14 Days)||20
10181684|NCT03179891|11311482|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0
10181685|NCT03179891|11311483|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0
10181686|NCT03180138|11311495|FG000|STARTED|Overall Study||204
10181687|NCT03180138|11311496|FG001|STARTED|Overall Study||201
10181688|NCT03180138|11311497|FG002|STARTED|Overall Study||203
10181689|NCT03180138|11311495|FG000|COMPLETED|Overall Study||182
10181690|NCT03180138|11311496|FG001|COMPLETED|Overall Study||188
10181691|NCT03180138|11311497|FG002|COMPLETED|Overall Study||179
10181692|NCT03180138|11311495|FG000|NOT COMPLETED|Overall Study||22
10181693|NCT03180138|11311496|FG001|NOT COMPLETED|Overall Study||13
10181694|NCT03180138|11311497|FG002|NOT COMPLETED|Overall Study||24
10181695|NCT03180385|11311507|FG000|STARTED|Overall Study||0
10181696|NCT03180385|11311508|FG001|STARTED|Overall Study||2
10181697|NCT03180385|11311507|FG000|COMPLETED|Overall Study||0
10181698|NCT03180385|11311508|FG001|COMPLETED|Overall Study||2
10181699|NCT03180385|11311507|FG000|NOT COMPLETED|Overall Study||0
10181700|NCT03180385|11311508|FG001|NOT COMPLETED|Overall Study||0
10181701|NCT03180489|11311516|FG000|STARTED|Overall Study||33
10181702|NCT03180489|11311517|FG001|STARTED|Overall Study||29
10181703|NCT03180489|11311516|FG000|COMPLETED|Overall Study||25
10181704|NCT03180489|11311517|FG001|COMPLETED|Overall Study||25
10181705|NCT03180489|11311516|FG000|NOT COMPLETED|Overall Study||8
10181706|NCT03180489|11311517|FG001|NOT COMPLETED|Overall Study||4
10181707|NCT03180515|11311523|FG000|STARTED|Aim 1||12
10181708|NCT03180515|11311523|FG000|COMPLETED|Aim 1||12
10181709|NCT03180515|11311523|FG000|NOT COMPLETED|Aim 1||0
10181710|NCT03180515|11311523|FG000|STARTED|Aim 2||12
10181711|NCT03180515|11311523|FG000|COMPLETED|Aim 2||12
10181712|NCT03180515|11311523|FG000|NOT COMPLETED|Aim 2||0
10181713|NCT03180515|11311523|FG000|STARTED|Aim 3||1
10181714|NCT03180515|11311523|FG000|COMPLETED|Aim 3||1
10181715|NCT03180515|11311523|FG000|NOT COMPLETED|Aim 3||0
10181716|NCT03180528|11311539|FG000|STARTED|Overall Study||30
10181717|NCT03180528|11311539|FG000|COMPLETED|Overall Study||27
10181718|NCT03180528|11311539|FG000|NOT COMPLETED|Overall Study||3
10181719|NCT03180619|11311546|FG000|STARTED|Overall Study||78
10181720|NCT03180619|11311547|FG001|STARTED|Overall Study||15
10181721|NCT03180619|11311548|FG002|STARTED|Overall Study||31
10181722|NCT03180619|11311546|FG000|COMPLETED|Overall Study||67
10181723|NCT03180619|11311547|FG001|COMPLETED|Overall Study||14
10181724|NCT03180619|11311548|FG002|COMPLETED|Overall Study||25
10181725|NCT03180619|11311546|FG000|NOT COMPLETED|Overall Study||11
10181726|NCT03180619|11311547|FG001|NOT COMPLETED|Overall Study||1
10181727|NCT03180619|11311548|FG002|NOT COMPLETED|Overall Study||6
10181728|NCT05091047|11311563|FG000|STARTED|Overall Study||8
10181729|NCT05091047|11311563|FG000|COMPLETED|Overall Study||8
10181730|NCT05091047|11311563|FG000|NOT COMPLETED|Overall Study||0
10181743|NCT04450108|11311587|FG000|STARTED|Overall Study||122
9714573|NCT01505465|10813982|FG000|STARTED|Overall Study||25
9714574|NCT01505465|10813983|FG001|STARTED|Overall Study||25
9714575|NCT01505465|10813982|FG000|COMPLETED|Overall Study||19
9714576|NCT01505465|10813983|FG001|COMPLETED|Overall Study||18
9714577|NCT01505465|10813982|FG000|NOT COMPLETED|Overall Study||6
9714578|NCT01505465|10813983|FG001|NOT COMPLETED|Overall Study||7
9714579|NCT01333943|10813991|FG000|STARTED|Overall Study||47
9714580|NCT01333943|10813992|FG001|STARTED|Overall Study||47
9714581|NCT01333943|10813991|FG000|COMPLETED|Overall Study||46
9714582|NCT01333943|10813992|FG001|COMPLETED|Overall Study||47
9714583|NCT01333943|10813991|FG000|NOT COMPLETED|Overall Study||1
9714584|NCT01333943|10813992|FG001|NOT COMPLETED|Overall Study||0
9714585|NCT01322646|10814000|FG000|STARTED|Overall Study||86
9714586|NCT01322646|10814001|FG001|STARTED|Overall Study||86
9714587|NCT01322646|10814000|FG000|COMPLETED|Overall Study||83
9714588|NCT01322646|10814001|FG001|COMPLETED|Overall Study||84
9714589|NCT01322646|10814000|FG000|NOT COMPLETED|Overall Study||3
9714590|NCT01322646|10814001|FG001|NOT COMPLETED|Overall Study||2
9714591|NCT01090024|10814007|FG000|STARTED|Period 1||6
9714592|NCT01090024|10814008|FG001|STARTED|Period 1||6
9714593|NCT01090024|10814009|FG002|STARTED|Period 1||6
9714594|NCT01090024|10814010|FG003|STARTED|Period 1||6
9714595|NCT01090024|10814011|FG004|STARTED|Period 1||6
9714596|NCT01090024|10814012|FG005|STARTED|Period 1||6
9714597|NCT01090024|10814013|FG006|STARTED|Period 1||6
9714598|NCT01090024|10814014|FG007|STARTED|Period 1||6
9714599|NCT01090024|10814015|FG008|STARTED|Period 1||6
9714600|NCT01090024|10814016|FG009|STARTED|Period 1||6
9714601|NCT01090024|10814017|FG010|STARTED|Period 1||6
9714602|NCT01090024|10814018|FG011|STARTED|Period 1||6
9714603|NCT01090024|10814019|FG012|STARTED|Period 1||6
9714604|NCT01090024|10814020|FG013|STARTED|Period 1||6
9714605|NCT01090024|10814021|FG014|STARTED|Period 1||6
9714606|NCT01090024|10814022|FG015|STARTED|Period 1||6
9714607|NCT01090024|10814023|FG016|STARTED|Period 1||6
9714608|NCT01090024|10814024|FG017|STARTED|Period 1||6
9714609|NCT01090024|10814007|FG000|COMPLETED|Period 1||6
9714610|NCT01090024|10814008|FG001|COMPLETED|Period 1||5
9714611|NCT01090024|10814009|FG002|COMPLETED|Period 1||6
9714612|NCT01090024|10814010|FG003|COMPLETED|Period 1||5
9714613|NCT01090024|10814011|FG004|COMPLETED|Period 1||6
9714614|NCT01090024|10814012|FG005|COMPLETED|Period 1||6
9714615|NCT01090024|10814013|FG006|COMPLETED|Period 1||6
9714616|NCT01090024|10814014|FG007|COMPLETED|Period 1||6
9714617|NCT01090024|10814015|FG008|COMPLETED|Period 1||6
9714618|NCT01090024|10814016|FG009|COMPLETED|Period 1||5
9714619|NCT01090024|10814017|FG010|COMPLETED|Period 1||6
9714620|NCT01090024|10814018|FG011|COMPLETED|Period 1||5
9714621|NCT01090024|10814019|FG012|COMPLETED|Period 1||6
9714622|NCT01090024|10814020|FG013|COMPLETED|Period 1||6
9714623|NCT01090024|10814021|FG014|COMPLETED|Period 1||5
9714624|NCT01090024|10814022|FG015|COMPLETED|Period 1||6
9714625|NCT01090024|10814023|FG016|COMPLETED|Period 1||6
9714626|NCT01090024|10814024|FG017|COMPLETED|Period 1||5
9714627|NCT01090024|10814007|FG000|NOT COMPLETED|Period 1||0
9714628|NCT01090024|10814008|FG001|NOT COMPLETED|Period 1||1
9714629|NCT01090024|10814009|FG002|NOT COMPLETED|Period 1||0
9714630|NCT01090024|10814010|FG003|NOT COMPLETED|Period 1||1
9714631|NCT01090024|10814011|FG004|NOT COMPLETED|Period 1||0
9714632|NCT01090024|10814012|FG005|NOT COMPLETED|Period 1||0
9714633|NCT01090024|10814013|FG006|NOT COMPLETED|Period 1||0
9714634|NCT01090024|10814014|FG007|NOT COMPLETED|Period 1||0
9714635|NCT01090024|10814015|FG008|NOT COMPLETED|Period 1||0
9714636|NCT01090024|10814016|FG009|NOT COMPLETED|Period 1||1
9714637|NCT01090024|10814017|FG010|NOT COMPLETED|Period 1||0
9714638|NCT01090024|10814018|FG011|NOT COMPLETED|Period 1||1
9714639|NCT01090024|10814019|FG012|NOT COMPLETED|Period 1||0
9714640|NCT01090024|10814020|FG013|NOT COMPLETED|Period 1||0
9714641|NCT01090024|10814021|FG014|NOT COMPLETED|Period 1||1
9714642|NCT01090024|10814022|FG015|NOT COMPLETED|Period 1||0
9714643|NCT01090024|10814023|FG016|NOT COMPLETED|Period 1||0
9714644|NCT01090024|10814024|FG017|NOT COMPLETED|Period 1||1
9714645|NCT01090024|10814007|FG000|STARTED|Period 2||6
9714646|NCT01090024|10814008|FG001|STARTED|Period 2||5
9714647|NCT01090024|10814009|FG002|STARTED|Period 2||6
9714648|NCT01090024|10814010|FG003|STARTED|Period 2||5
9714649|NCT01090024|10814011|FG004|STARTED|Period 2||6
9714650|NCT01090024|10814012|FG005|STARTED|Period 2||6
9714651|NCT01090024|10814013|FG006|STARTED|Period 2||6
9714652|NCT01090024|10814014|FG007|STARTED|Period 2||6
9714653|NCT01090024|10814015|FG008|STARTED|Period 2||6
10181744|NCT04450108|11311587|FG000|COMPLETED|Overall Study||120
10181745|NCT04450108|11311587|FG000|NOT COMPLETED|Overall Study||2
10181746|NCT04448756|11311594|FG000|STARTED|Overall Study||49
10181731|NCT04957498|11311569|FG000|STARTED|Overall Study||20
10181732|NCT04957498|11311570|FG001|STARTED|Overall Study||20
10181733|NCT04957498|11311569|FG000|COMPLETED|Overall Study||19
10181734|NCT04957498|11311570|FG001|COMPLETED|Overall Study||18
10181735|NCT04957498|11311569|FG000|NOT COMPLETED|Overall Study||1
10181736|NCT04957498|11311570|FG001|NOT COMPLETED|Overall Study||2
10181747|NCT04448756|11311595|FG001|STARTED|Overall Study||54
10181748|NCT04448756|11311596|FG002|STARTED|Overall Study||46
10181749|NCT04448756|11311594|FG000|COMPLETED|Overall Study||46
10181750|NCT04448756|11311595|FG001|COMPLETED|Overall Study||49
10181751|NCT04448756|11311596|FG002|COMPLETED|Overall Study||45
10181752|NCT04448756|11311594|FG000|NOT COMPLETED|Overall Study||3
10181753|NCT04448756|11311595|FG001|NOT COMPLETED|Overall Study||5
10181754|NCT04448756|11311596|FG002|NOT COMPLETED|Overall Study||1
10181755|NCT04397718|11311606|FG000|STARTED|Overall Study||34
10181756|NCT04397718|11311607|FG001|STARTED|Overall Study||62
10181757|NCT04397718|11311606|FG000|COMPLETED|Overall Study||27
10181758|NCT04397718|11311607|FG001|COMPLETED|Overall Study||47
10181759|NCT04397718|11311606|FG000|NOT COMPLETED|Overall Study||7
10181760|NCT04397718|11311607|FG001|NOT COMPLETED|Overall Study||15
10181761|NCT04352127|11311616|FG000|STARTED|Overall Study||29
10181762|NCT04352127|11311617|FG001|STARTED|Overall Study||26
10181763|NCT04352127|11311618|FG002|STARTED|Overall Study||50
10181764|NCT04352127|11311616|FG000|COMPLETED|Overall Study||25
10181765|NCT04352127|11311617|FG001|COMPLETED|Overall Study||25
10181766|NCT04352127|11311618|FG002|COMPLETED|Overall Study||50
10181767|NCT04352127|11311616|FG000|NOT COMPLETED|Overall Study||4
10181768|NCT04352127|11311617|FG001|NOT COMPLETED|Overall Study||1
10181769|NCT04352127|11311618|FG002|NOT COMPLETED|Overall Study||0
10181770|NCT04253756|11311626|FG000|STARTED|Overall Study||26
10181771|NCT04253756|11311626|FG000|Procedure 1: 18 Guage|Overall Study||12
10181772|NCT04253756|11311626|FG000|Procedure 1: 20 Gauge|Overall Study||14
10181773|NCT04253756|11311626|FG000|Procedure 2: 18 Gauge|Overall Study||9
10181774|NCT04253756|11311626|FG000|Procedure 2: 20 Gauge|Overall Study||7
10181775|NCT04253756|11311626|FG000|Procedure 3: 18 Gauge|Overall Study||6
10181776|NCT04253756|11311626|FG000|Procedure 3: 20 Gauge|Overall Study||5
10181777|NCT04253756|11311626|FG000|Procedure 4: 18 Gauge|Overall Study||5
10181778|NCT04253756|11311626|FG000|Procedure 4: 20 Gauge|Overall Study||3
10181779|NCT04253756|11311626|FG000|Procedure 5: 18 Gauge|Overall Study||2
10181780|NCT04253756|11311626|FG000|Procedure 5: 20 Gauge|Overall Study||3
10181781|NCT04253756|11311626|FG000|Procedure 6: 18 Gauge|Overall Study||1
10181782|NCT04253756|11311626|FG000|Procedure 6: 20 Gauge|Overall Study||2
10181783|NCT04253756|11311626|FG000|Procedure 7: 18 Gauge|Overall Study||1
10181784|NCT04253756|11311626|FG000|Procedure 7: 20 Gauge|Overall Study||1
10181785|NCT04253756|11311626|FG000|Procedure 8: 18 Gauge|Overall Study||0
10181786|NCT04253756|11311626|FG000|Procedure 8: 20 Gauge|Overall Study||2
10181787|NCT04253756|11311626|FG000|COMPLETED|Overall Study||21
10181788|NCT04253756|11311626|FG000|NOT COMPLETED|Overall Study||5
10181789|NCT04157751|11311634|FG000|STARTED|Overall Study||265
10181790|NCT04157751|11311635|FG001|STARTED|Overall Study||265
10181791|NCT04157751|11311634|FG000|Treated|Overall Study||264
10181792|NCT04157751|11311635|FG001|Treated|Overall Study||260
10181793|NCT04157751|11311634|FG000|COMPLETED|Overall Study||202
10181794|NCT04157751|11311635|FG001|COMPLETED|Overall Study||208
10181795|NCT04157751|11311634|FG000|NOT COMPLETED|Overall Study||63
10181796|NCT04157751|11311635|FG001|NOT COMPLETED|Overall Study||57
10181797|NCT03975920|11311644|FG000|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|84
10181798|NCT03975920|11311645|FG001|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|87
10181799|NCT03975920|11311644|FG000|1-Month Follow-up Survey|Overall Study||80
10181800|NCT03975920|11311645|FG001|1-Month Follow-up Survey|Overall Study||85
10181801|NCT03975920|11311644|FG000|3-Month Follow-up Survey|Overall Study||78
10181802|NCT03975920|11311645|FG001|3-Month Follow-up Survey|Overall Study||84
10181803|NCT03975920|11311644|FG000|6-Month Follow-up Survey|Overall Study||80
10181804|NCT03975920|11311645|FG001|6-Month Follow-up Survey|Overall Study||83
10181805|NCT03975920|11311644|FG000|COMPLETED|Overall Study||80
10181806|NCT03975920|11311645|FG001|COMPLETED|Overall Study||83
10181807|NCT03975920|11311644|FG000|NOT COMPLETED|Overall Study||4
10181808|NCT03975920|11311645|FG001|NOT COMPLETED|Overall Study||4
10181809|NCT03917472|11311653|FG000|STARTED|Overall Study||346
10181810|NCT03917472|11311654|FG001|STARTED|Overall Study||171
10181811|NCT03917472|11311653|FG000|COMPLETED|Overall Study||311
10181812|NCT03917472|11311654|FG001|COMPLETED|Overall Study||156
10181813|NCT03917472|11311653|FG000|NOT COMPLETED|Overall Study||35
10181814|NCT03917472|11311654|FG001|NOT COMPLETED|Overall Study||15
10181823|NCT03746483|11311672|FG000|STARTED|Overall Study||21
10181824|NCT03746483|11311673|FG001|STARTED|Overall Study||20
10181825|NCT03746483|11311672|FG000|COMPLETED|Overall Study||15
10181826|NCT03746483|11311673|FG001|COMPLETED|Overall Study||17
10181827|NCT03746483|11311672|FG000|NOT COMPLETED|Overall Study||6
10181828|NCT03746483|11311673|FG001|NOT COMPLETED|Overall Study||3
10181829|NCT03717155|11311681|FG000|STARTED|Overall Study||43
10181830|NCT03717155|11311681|FG000|COMPLETED|Overall Study||43
10181831|NCT03717155|11311681|FG000|NOT COMPLETED|Overall Study||0
10181832|NCT03694327|11311687|FG000|STARTED|Overall Study||79
10181833|NCT03694327|11311688|FG001|STARTED|Overall Study||79
10181834|NCT03694327|11311687|FG000|COMPLETED|Overall Study||66
10181835|NCT03694327|11311688|FG001|COMPLETED|Overall Study||56
10181836|NCT03694327|11311687|FG000|NOT COMPLETED|Overall Study||13
9714654|NCT01090024|10814016|FG009|STARTED|Period 2||5
9714655|NCT01090024|10814017|FG010|STARTED|Period 2||6
9714656|NCT01090024|10814018|FG011|STARTED|Period 2||5
9714657|NCT01090024|10814019|FG012|STARTED|Period 2||6
9714658|NCT01090024|10814020|FG013|STARTED|Period 2||6
9714659|NCT01090024|10814021|FG014|STARTED|Period 2||5
9714660|NCT01090024|10814022|FG015|STARTED|Period 2||6
9714661|NCT01090024|10814023|FG016|STARTED|Period 2||6
9714662|NCT01090024|10814024|FG017|STARTED|Period 2||5
9714663|NCT01090024|10814007|FG000|COMPLETED|Period 2||5
9714664|NCT01090024|10814008|FG001|COMPLETED|Period 2||5
9714665|NCT01090024|10814009|FG002|COMPLETED|Period 2||6
9714666|NCT01090024|10814010|FG003|COMPLETED|Period 2||4
10181837|NCT03694327|11311688|FG001|NOT COMPLETED|Overall Study||23
10181838|NCT03624036|11311698|FG000|STARTED|Overall Study||7
10181839|NCT03624036|11311699|FG001|STARTED|Overall Study||3
10181840|NCT03624036|11311700|FG002|STARTED|Overall Study||3
10181841|NCT03624036|11311701|FG003|STARTED|Overall Study||3
10181842|NCT03624036|11311698|FG000|COMPLETED|Overall Study||0
9714667|NCT01090024|10814011|FG004|COMPLETED|Period 2||6
9714668|NCT01090024|10814012|FG005|COMPLETED|Period 2||6
9714669|NCT01090024|10814013|FG006|COMPLETED|Period 2||6
9714670|NCT01090024|10814014|FG007|COMPLETED|Period 2||6
10181843|NCT03624036|11311699|FG001|COMPLETED|Overall Study||0
10181844|NCT03624036|11311700|FG002|COMPLETED|Overall Study||0
10181845|NCT03624036|11311701|FG003|COMPLETED|Overall Study||0
10181846|NCT03624036|11311698|FG000|NOT COMPLETED|Overall Study||7
10181847|NCT03624036|11311699|FG001|NOT COMPLETED|Overall Study||3
10181848|NCT03624036|11311700|FG002|NOT COMPLETED|Overall Study||3
10181849|NCT03624036|11311701|FG003|NOT COMPLETED|Overall Study||3
10181860|NCT03137160|11311720|FG000|STARTED|Overall Study||4
10181861|NCT03137160|11311720|FG000|COMPLETED|Overall Study||2
10181862|NCT03137160|11311720|FG000|NOT COMPLETED|Overall Study||2
10181863|NCT03057951|11311726|FG000|STARTED|Overall Study||2991
10181864|NCT03057951|11311727|FG001|STARTED|Overall Study||2997
10181865|NCT03057951|11311726|FG000|Treated|Overall Study||2989
10181866|NCT03057951|11311727|FG001|Treated|Overall Study||2996
10181867|NCT03057951|11311726|FG000|COMPLETED|Overall Study||2046
10181868|NCT03057951|11311727|FG001|COMPLETED|Overall Study||2051
10181869|NCT03057951|11311726|FG000|NOT COMPLETED|Overall Study||945
10181870|NCT03057951|11311727|FG001|NOT COMPLETED|Overall Study||946
10181871|NCT03007888|11311733|FG000|STARTED|First Intervention (14 Days)||15
10181872|NCT03007888|11311734|FG001|STARTED|First Intervention (14 Days)||13
10181873|NCT03007888|11311733|FG000|COMPLETED|First Intervention (14 Days)||14
10181874|NCT03007888|11311734|FG001|COMPLETED|First Intervention (14 Days)||13
10181875|NCT03007888|11311733|FG000|NOT COMPLETED|First Intervention (14 Days)||1
10181876|NCT03007888|11311734|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10181877|NCT03007888|11311733|FG000|STARTED|Washout (7 Days)||14
10181878|NCT03007888|11311734|FG001|STARTED|Washout (7 Days)||13
10181879|NCT03007888|11311733|FG000|COMPLETED|Washout (7 Days)||14
10181880|NCT03007888|11311734|FG001|COMPLETED|Washout (7 Days)||13
10181881|NCT03007888|11311733|FG000|NOT COMPLETED|Washout (7 Days)||0
10181882|NCT03007888|11311734|FG001|NOT COMPLETED|Washout (7 Days)||0
10181883|NCT03007888|11311733|FG000|STARTED|Second Interventions (14 Days)||14
10181884|NCT03007888|11311734|FG001|STARTED|Second Interventions (14 Days)||13
10181885|NCT03007888|11311733|FG000|COMPLETED|Second Interventions (14 Days)||14
10181886|NCT03007888|11311734|FG001|COMPLETED|Second Interventions (14 Days)||13
10181887|NCT03007888|11311733|FG000|NOT COMPLETED|Second Interventions (14 Days)||0
10181888|NCT03007888|11311734|FG001|NOT COMPLETED|Second Interventions (14 Days)||0
10181889|NCT02971033|11311746|FG000|STARTED|Overall Study||1
10181890|NCT02971033|11311747|FG001|STARTED|Overall Study||1
10181891|NCT02971033|11311748|FG002|STARTED|Overall Study||0
10181892|NCT02971033|11311746|FG000|COMPLETED|Overall Study||1
10181893|NCT02971033|11311747|FG001|COMPLETED|Overall Study||1
10181894|NCT02971033|11311748|FG002|COMPLETED|Overall Study||0
10181895|NCT02971033|11311746|FG000|NOT COMPLETED|Overall Study||0
10181896|NCT02971033|11311747|FG001|NOT COMPLETED|Overall Study||0
10181897|NCT02971033|11311748|FG002|NOT COMPLETED|Overall Study||0
10181898|NCT02961374|11311756|FG000|STARTED|Overall Study||46
10181899|NCT02961374|11311756|FG000|COMPLETED|Overall Study||42
10181900|NCT02961374|11311756|FG000|NOT COMPLETED|Overall Study||4
10181901|NCT02949934|11311766|FG000|STARTED|Natural Drinking Period||16
10181902|NCT02949934|11311767|FG001|STARTED|Natural Drinking Period||12
10181903|NCT02949934|11311768|FG002|STARTED|Natural Drinking Period||17
10181904|NCT02949934|11311769|FG003|STARTED|Natural Drinking Period||16
10181905|NCT02949934|11311770|FG004|STARTED|Natural Drinking Period||15
10181906|NCT02949934|11311771|FG005|STARTED|Natural Drinking Period||14
10181907|NCT02949934|11311766|FG000|COMPLETED|Natural Drinking Period||15
10181908|NCT02949934|11311767|FG001|COMPLETED|Natural Drinking Period||12
10181909|NCT02949934|11311768|FG002|COMPLETED|Natural Drinking Period||17
10181910|NCT02949934|11311769|FG003|COMPLETED|Natural Drinking Period||15
10181911|NCT02949934|11311770|FG004|COMPLETED|Natural Drinking Period||14
10181912|NCT02949934|11311771|FG005|COMPLETED|Natural Drinking Period||14
10181913|NCT02949934|11311766|FG000|NOT COMPLETED|Natural Drinking Period||1
10181914|NCT02949934|11311767|FG001|NOT COMPLETED|Natural Drinking Period||0
10181915|NCT02949934|11311768|FG002|NOT COMPLETED|Natural Drinking Period||0
10181916|NCT02949934|11311769|FG003|NOT COMPLETED|Natural Drinking Period||1
10181917|NCT02949934|11311770|FG004|NOT COMPLETED|Natural Drinking Period||1
10181918|NCT02949934|11311771|FG005|NOT COMPLETED|Natural Drinking Period||0
10181919|NCT02949934|11311766|FG000|STARTED|Neuroimaging||15
10181920|NCT02949934|11311767|FG001|STARTED|Neuroimaging||12
10181921|NCT02949934|11311768|FG002|STARTED|Neuroimaging||17
10181922|NCT02949934|11311769|FG003|STARTED|Neuroimaging||15
10181923|NCT02949934|11311770|FG004|STARTED|Neuroimaging||14
10181924|NCT02949934|11311771|FG005|STARTED|Neuroimaging||14
10181925|NCT02949934|11311766|FG000|COMPLETED|Neuroimaging||12
10181926|NCT02949934|11311767|FG001|COMPLETED|Neuroimaging||12
10181927|NCT02949934|11311768|FG002|COMPLETED|Neuroimaging||15
10181928|NCT02949934|11311769|FG003|COMPLETED|Neuroimaging||15
10181929|NCT02949934|11311770|FG004|COMPLETED|Neuroimaging||12
10181930|NCT02949934|11311771|FG005|COMPLETED|Neuroimaging||12
10181931|NCT02949934|11311766|FG000|NOT COMPLETED|Neuroimaging||3
10181932|NCT02949934|11311767|FG001|NOT COMPLETED|Neuroimaging||0
10181933|NCT02949934|11311768|FG002|NOT COMPLETED|Neuroimaging||2
10181934|NCT02949934|11311769|FG003|NOT COMPLETED|Neuroimaging||0
10181935|NCT02949934|11311770|FG004|NOT COMPLETED|Neuroimaging||2
10181936|NCT02949934|11311771|FG005|NOT COMPLETED|Neuroimaging||2
10181937|NCT02949934|11311766|FG000|STARTED|Bar Laboratory||13
10181938|NCT02949934|11311767|FG001|STARTED|Bar Laboratory||12
10181939|NCT02949934|11311768|FG002|STARTED|Bar Laboratory||17
10181940|NCT02949934|11311769|FG003|STARTED|Bar Laboratory||15
10181941|NCT02949934|11311770|FG004|STARTED|Bar Laboratory||13
10181942|NCT02949934|11311771|FG005|STARTED|Bar Laboratory||14
10181943|NCT02949934|11311766|FG000|COMPLETED|Bar Laboratory||12
10181944|NCT02949934|11311767|FG001|COMPLETED|Bar Laboratory||7
10181945|NCT02949934|11311768|FG002|COMPLETED|Bar Laboratory||10
10181946|NCT02949934|11311769|FG003|COMPLETED|Bar Laboratory||11
10181947|NCT02949934|11311770|FG004|COMPLETED|Bar Laboratory||7
10181948|NCT02949934|11311771|FG005|COMPLETED|Bar Laboratory||13
10181949|NCT02949934|11311766|FG000|NOT COMPLETED|Bar Laboratory||1
10181950|NCT02949934|11311767|FG001|NOT COMPLETED|Bar Laboratory||5
10181951|NCT02949934|11311768|FG002|NOT COMPLETED|Bar Laboratory||7
10181952|NCT02949934|11311769|FG003|NOT COMPLETED|Bar Laboratory||4
10181953|NCT02949934|11311770|FG004|NOT COMPLETED|Bar Laboratory||6
10181954|NCT02949934|11311771|FG005|NOT COMPLETED|Bar Laboratory||1
10181955|NCT02796001|11311788|FG000|STARTED|Overall Study||20
10181956|NCT02796001|11311789|FG001|STARTED|Overall Study||22
10181957|NCT02796001|11311790|FG002|STARTED|Overall Study||4
10181958|NCT02796001|11311788|FG000|COMPLETED|Overall Study||20
10181959|NCT02796001|11311789|FG001|COMPLETED|Overall Study||22
10181960|NCT02796001|11311790|FG002|COMPLETED|Overall Study||4
10181961|NCT02796001|11311788|FG000|NOT COMPLETED|Overall Study||0
10181962|NCT02796001|11311789|FG001|NOT COMPLETED|Overall Study||0
10181963|NCT02796001|11311790|FG002|NOT COMPLETED|Overall Study||0
10181970|NCT02658656|11311809|FG000|STARTED|Screening||78
10181971|NCT02658656|11311810|FG001|STARTED|Screening||83
10181972|NCT02658656|11311811|FG002|STARTED|Screening||263
10181973|NCT02658656|11311809|FG000|COMPLETED|Screening||78
10181974|NCT02658656|11311810|FG001|COMPLETED|Screening||83
10181975|NCT02658656|11311811|FG002|COMPLETED|Screening||0
10181976|NCT02658656|11311809|FG000|NOT COMPLETED|Screening||0
10181977|NCT02658656|11311810|FG001|NOT COMPLETED|Screening||0
10181978|NCT02658656|11311811|FG002|NOT COMPLETED|Screening||263
10181979|NCT02658656|11311809|FG000|STARTED|Randomization||78
10181980|NCT02658656|11311810|FG001|STARTED|Randomization||83
10181981|NCT02658656|11311811|FG002|STARTED|Randomization||0
10181982|NCT02658656|11311809|FG000|COMPLETED|Randomization||45
10181983|NCT02658656|11311810|FG001|COMPLETED|Randomization||57
10181984|NCT02658656|11311811|FG002|COMPLETED|Randomization||0
10181985|NCT02658656|11311809|FG000|NOT COMPLETED|Randomization||33
10181986|NCT02658656|11311810|FG001|NOT COMPLETED|Randomization||26
10181987|NCT02658656|11311811|FG002|NOT COMPLETED|Randomization||0
10181988|NCT02536170|11311821|FG000|STARTED|Overall Study||36
10181989|NCT02536170|11311822|FG001|STARTED|Overall Study||36
10181990|NCT02536170|11311823|FG002|STARTED|Overall Study||36
10181991|NCT02536170|11311821|FG000|COMPLETED|Overall Study||36
10181992|NCT02536170|11311822|FG001|COMPLETED|Overall Study||36
10181993|NCT02536170|11311823|FG002|COMPLETED|Overall Study||36
10181994|NCT02536170|11311821|FG000|NOT COMPLETED|Overall Study||0
10181995|NCT02536170|11311822|FG001|NOT COMPLETED|Overall Study||0
10181996|NCT02536170|11311823|FG002|NOT COMPLETED|Overall Study||0
10181997|NCT02094261|11311831|FG000|STARTED|Overall Study||210
10181998|NCT02094261|11311831|FG000|COMPLETED|Overall Study||0
10181999|NCT02094261|11311831|FG000|NOT COMPLETED|Overall Study||210
10182000|NCT01920932|11311835|FG000|STARTED|Overall Study||77
10182001|NCT01920932|11311835|FG000|COMPLETED|Overall Study||75
10182002|NCT01920932|11311835|FG000|NOT COMPLETED|Overall Study||2
10182003|NCT01801189|11311858|FG000|STARTED|Overall Study||28
10182004|NCT01801189|11311859|FG001|STARTED|Overall Study||33
10182005|NCT01801189|11311858|FG000|COMPLETED|Overall Study||28
10182006|NCT01801189|11311859|FG001|COMPLETED|Overall Study||33
10182007|NCT01801189|11311858|FG000|NOT COMPLETED|Overall Study||0
10182008|NCT01801189|11311859|FG001|NOT COMPLETED|Overall Study||0
10182009|NCT01667081|11311867|FG000|STARTED|Overall Study||1909
10182010|NCT01667081|11311868|FG001|STARTED|Overall Study||526
10182011|NCT01667081|11311867|FG000|COMPLETED|Overall Study||132
10182012|NCT01667081|11311868|FG001|COMPLETED|Overall Study||169
10182013|NCT01667081|11311867|FG000|NOT COMPLETED|Overall Study||1777
10182014|NCT01667081|11311868|FG001|NOT COMPLETED|Overall Study||357
10182015|NCT01197950|11311888|FG000|STARTED|Overall Study||99
10182016|NCT01197950|11311889|FG001|STARTED|Overall Study||103
10182017|NCT01197950|11311890|FG002|STARTED|Overall Study||101
10182018|NCT01197950|11311888|FG000|COMPLETED|Overall Study|women's request (9), high workload (3), returned home (1), partus in one hour (1), other (2)|83
10182019|NCT01197950|11311889|FG001|COMPLETED|Overall Study|women's request (11) high workload (4) returned to home (1)|87
10182020|NCT01197950|11311890|FG002|COMPLETED|Overall Study|woman's request (11) high workload (1) returned to home (2) other (4)|83
10182021|NCT01197950|11311888|FG000|NOT COMPLETED|Overall Study||16
10182022|NCT01197950|11311889|FG001|NOT COMPLETED|Overall Study||16
10182023|NCT01197950|11311890|FG002|NOT COMPLETED|Overall Study||18
10182024|NCT00846742|11311898|FG000|STARTED|Overall Study||85
10182025|NCT00846742|11311898|FG000|With Radiation Therapy (RT)|Overall Study||17
10182026|NCT00846742|11311898|FG000|Without Radiation Therapy (RT)|Overall Study||68
10182027|NCT00846742|11311898|FG000|COMPLETED|Overall Study||84
10182028|NCT00846742|11311898|FG000|NOT COMPLETED|Overall Study||1
10182029|NCT00634504|11311905|FG000|STARTED|Overall Study||11
10182030|NCT00634504|11311906|FG001|STARTED|Overall Study||9
10182031|NCT00634504|11311905|FG000|COMPLETED|Overall Study||10
10182032|NCT00634504|11311906|FG001|COMPLETED|Overall Study||9
10182033|NCT00634504|11311905|FG000|NOT COMPLETED|Overall Study||1
10182034|NCT00634504|11311906|FG001|NOT COMPLETED|Overall Study||0
10182043|NCT00392821|11311924|FG000|STARTED|Overall Study||3
10182044|NCT00392821|11311925|FG001|STARTED|Overall Study||6
10182045|NCT00392821|11311926|FG002|STARTED|Overall Study||69
10182046|NCT00392821|11311924|FG000|COMPLETED|Overall Study||0
10182047|NCT00392821|11311925|FG001|COMPLETED|Overall Study||0
10182048|NCT00392821|11311926|FG002|COMPLETED|Overall Study||0
10182049|NCT00392821|11311924|FG000|NOT COMPLETED|Overall Study||3
10182050|NCT00392821|11311925|FG001|NOT COMPLETED|Overall Study||6
10182051|NCT00392821|11311926|FG002|NOT COMPLETED|Overall Study||69
10182052|NCT00352027|11311932|FG000|STARTED|Overall Study||80
10182053|NCT00352027|11311932|FG000|COMPLETED|Overall Study||77
10182054|NCT00352027|11311932|FG000|NOT COMPLETED|Overall Study||3
10182055|NCT00104676|11311960|FG000|STARTED|Overall Study||98
10182056|NCT00104676|11311961|FG001|STARTED|Overall Study||105
10182057|NCT00104676|11311960|FG000|COMPLETED|Overall Study||91
10182058|NCT00104676|11311961|FG001|COMPLETED|Overall Study||91
10182059|NCT00104676|11311960|FG000|NOT COMPLETED|Overall Study||7
10182060|NCT00104676|11311961|FG001|NOT COMPLETED|Overall Study||14
10182061|NCT04426500|11311970|FG000|STARTED|Overall Study||28
10182062|NCT04426500|11311971|FG001|STARTED|Overall Study||64
10182063|NCT04426500|11311972|FG002|STARTED|Overall Study||56
10182064|NCT04426500|11311970|FG000|COMPLETED|Overall Study||28
10182065|NCT04426500|11311971|FG001|COMPLETED|Overall Study||64
10182066|NCT04426500|11311972|FG002|COMPLETED|Overall Study||56
10182067|NCT04426500|11311970|FG000|NOT COMPLETED|Overall Study||0
10182068|NCT04426500|11311971|FG001|NOT COMPLETED|Overall Study||0
10182069|NCT04426500|11311972|FG002|NOT COMPLETED|Overall Study||0
10182070|NCT04042103|11311980|FG000|STARTED|Overall Study||21
10182071|NCT04042103|11311980|FG000|COMPLETED|Overall Study||19
10182072|NCT04042103|11311980|FG000|NOT COMPLETED|Overall Study||2
10182073|NCT04004208|11311986|FG000|STARTED|Overall Study||75
10182074|NCT04004208|11311987|FG001|STARTED|Overall Study||38
10182075|NCT04004208|11311986|FG000|SAF|Overall Study||75
10182076|NCT04004208|11311987|FG001|SAF|Overall Study||38
10182077|NCT04004208|11311986|FG000|PKS|Overall Study||75
9849764|NCT00867113|10962560|FG000|COMPLETED|Treatment Period||46
9849765|NCT00867113|10962560|FG000|NOT COMPLETED|Treatment Period||45
9849766|NCT00867113|10962560|FG000|STARTED|Post Treatment After Survival Follow-up||68
10182078|NCT04004208|11311987|FG001|PKS|Overall Study||0
10182079|NCT04004208|11311986|FG000|AAS|Overall Study||75
10182080|NCT04004208|11311987|FG001|AAS|Overall Study||0
10182081|NCT04004208|11311986|FG000|COMPLETED|Overall Study||68
10182082|NCT04004208|11311987|FG001|COMPLETED|Overall Study||36
10182083|NCT04004208|11311986|FG000|NOT COMPLETED|Overall Study||7
10182084|NCT04004208|11311987|FG001|NOT COMPLETED|Overall Study||2
10182085|NCT03817190|11311995|FG000|STARTED|Overall Study||110
10182086|NCT03817190|11311996|FG001|STARTED|Overall Study||109
10182087|NCT03817190|11311995|FG000|COMPLETED|Overall Study||50
10182088|NCT03817190|11311996|FG001|COMPLETED|Overall Study||50
10182089|NCT03817190|11311995|FG000|NOT COMPLETED|Overall Study||60
10182090|NCT03817190|11311996|FG001|NOT COMPLETED|Overall Study||59
10182091|NCT03447782|11312002|FG000|STARTED|Overall Study||45
10182092|NCT03447782|11312002|FG000|COMPLETED|Overall Study||25
10182093|NCT03447782|11312002|FG000|NOT COMPLETED|Overall Study||20
10182094|NCT03041311|11312008|FG000|STARTED|Overall Study||54
10182095|NCT03041311|11312009|FG001|STARTED|Overall Study||53
10182096|NCT03041311|11312008|FG000|COMPLETED|Overall Study||0
10182097|NCT03041311|11312009|FG001|COMPLETED|Overall Study||0
10182098|NCT03041311|11312008|FG000|NOT COMPLETED|Overall Study||54
10182099|NCT03041311|11312009|FG001|NOT COMPLETED|Overall Study||53
10182100|NCT03020914|11312025|FG000|STARTED|Overall Study||10
10182101|NCT03020914|11312026|FG001|STARTED|Overall Study||9
10182102|NCT03020914|11312025|FG000|COMPLETED|Overall Study||9
10182103|NCT03020914|11312026|FG001|COMPLETED|Overall Study||9
10182104|NCT03020914|11312025|FG000|NOT COMPLETED|Overall Study||1
10182105|NCT03020914|11312026|FG001|NOT COMPLETED|Overall Study||0
10182106|NCT02803307|11312034|FG000|STARTED|Overall Study||20
10182107|NCT02803307|11312035|FG001|STARTED|Overall Study||20
10182108|NCT02803307|11312034|FG000|COMPLETED|Overall Study||20
10182109|NCT02803307|11312035|FG001|COMPLETED|Overall Study||20
10182110|NCT02803307|11312034|FG000|NOT COMPLETED|Overall Study||0
10182111|NCT02803307|11312035|FG001|NOT COMPLETED|Overall Study||0
10182112|NCT02698891|11312041|FG000|STARTED|Overall Study||127
10182113|NCT02698891|11312041|FG000|Treated|Overall Study||125
10182114|NCT02698891|11312041|FG000|COMPLETED|Overall Study||115
10182115|NCT02698891|11312041|FG000|NOT COMPLETED|Overall Study||12
10182116|NCT02537678|11312047|FG000|STARTED|Baseline to Post-treatment|91 parents/guardians and 91 children started.|91
10182117|NCT02537678|11312048|FG001|STARTED|Baseline to Post-treatment|92 parents/guardians and 92 children started.|92
10182118|NCT02537678|11312047|FG000|Completed Post-treatment|Baseline to Post-treatment|61 parents/guardians and 61 children completed post-treatment.|61
10182119|NCT02537678|11312048|FG001|Completed Post-treatment|Baseline to Post-treatment|71 parents/guardians and 71 children completed post-treatment.|71
10182120|NCT02537678|11312047|FG000|COMPLETED|Baseline to Post-treatment|61 parent/guardian-child dyads completed.|61
10182121|NCT02537678|11312048|FG001|COMPLETED|Baseline to Post-treatment|71 parent/guardian-child dyads completed.|71
10182122|NCT02537678|11312047|FG000|NOT COMPLETED|Baseline to Post-treatment||30
10182123|NCT02537678|11312048|FG001|NOT COMPLETED|Baseline to Post-treatment||21
10182124|NCT02537678|11312047|FG000|STARTED|Post-treatment to 6 Month Assessment|61 parents/guardians and 61 children started.|61
10182125|NCT02537678|11312048|FG001|STARTED|Post-treatment to 6 Month Assessment|71 parents/guardians and 71 children started.|71
10182126|NCT02537678|11312047|FG000|COMPLETED|Post-treatment to 6 Month Assessment|53 parents/guardians and 53 children completed.|53
10182127|NCT02537678|11312048|FG001|COMPLETED|Post-treatment to 6 Month Assessment|64 parents/guardians and 64 children completed.|64
10182128|NCT02537678|11312047|FG000|NOT COMPLETED|Post-treatment to 6 Month Assessment||8
10182129|NCT02537678|11312048|FG001|NOT COMPLETED|Post-treatment to 6 Month Assessment||7
10182130|NCT02537678|11312047|FG000|STARTED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children started.|53
10182131|NCT02537678|11312048|FG001|STARTED|6 Month to 12 Month Assessment|64 parent/guardians and 64 children started.|64
10182132|NCT02537678|11312047|FG000|COMPLETED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children completed.|53
10182133|NCT02537678|11312048|FG001|COMPLETED|6 Month to 12 Month Assessment|63 parent/guardians and 63 children completed.|63
10182134|NCT02537678|11312047|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||0
10182135|NCT02537678|11312048|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||1
10182136|NCT02400476|11312064|FG000|STARTED|Overall Study||137
10182137|NCT02400476|11312065|FG001|STARTED|Overall Study||64
10182138|NCT02400476|11312066|FG002|STARTED|Overall Study||136
10182139|NCT02400476|11312067|FG003|STARTED|Overall Study||104
10182140|NCT02400476|11312068|FG004|STARTED|Overall Study||60
10182141|NCT02400476|11312069|FG005|STARTED|Overall Study||62
10182142|NCT02400476|11312064|FG000|COMPLETED|Overall Study||76
10182143|NCT02400476|11312065|FG001|COMPLETED|Overall Study||52
10182144|NCT02400476|11312066|FG002|COMPLETED|Overall Study||95
10182145|NCT02400476|11312067|FG003|COMPLETED|Overall Study||74
10182146|NCT02400476|11312068|FG004|COMPLETED|Overall Study||45
10182147|NCT02400476|11312069|FG005|COMPLETED|Overall Study||46
10182148|NCT02400476|11312064|FG000|NOT COMPLETED|Overall Study||61
10182149|NCT02400476|11312065|FG001|NOT COMPLETED|Overall Study||12
10182150|NCT02400476|11312066|FG002|NOT COMPLETED|Overall Study||41
10182151|NCT02400476|11312067|FG003|NOT COMPLETED|Overall Study||30
10182152|NCT02400476|11312068|FG004|NOT COMPLETED|Overall Study||15
10182153|NCT02400476|11312069|FG005|NOT COMPLETED|Overall Study||16
10182154|NCT02362035|11312083|FG000|STARTED|Overall Study||161
10182155|NCT02362035|11312083|FG000|COMPLETED|Overall Study||0
10182156|NCT02362035|11312083|FG000|NOT COMPLETED|Overall Study||161
10182165|NCT01818986|11312096|FG000|STARTED|Overall Study||20
10182166|NCT01818986|11312096|FG000|COMPLETED|Overall Study||20
10182167|NCT01818986|11312096|FG000|NOT COMPLETED|Overall Study||0
10182168|NCT01507545|11312102|FG000|STARTED|Overall Study||84
10182169|NCT01507545|11312103|FG001|STARTED|Overall Study||42
10182170|NCT01507545|11312102|FG000|Treated/Safety Set|Overall Study||82
10182171|NCT01507545|11312103|FG001|Treated/Safety Set|Overall Study||40
10182172|NCT01507545|11312102|FG000|COMPLETED|Overall Study||0
10182173|NCT01507545|11312103|FG001|COMPLETED|Overall Study||0
10182174|NCT01507545|11312102|FG000|NOT COMPLETED|Overall Study||84
10182175|NCT01507545|11312103|FG001|NOT COMPLETED|Overall Study||42
10182176|NCT01463670|11312109|FG000|STARTED|Overall Study||11
10182177|NCT01463670|11312109|FG000|COMPLETED|Overall Study||11
10182178|NCT01463670|11312109|FG000|NOT COMPLETED|Overall Study||0
10182179|NCT00920816|11312117|FG000|STARTED|Overall Study||192
10182180|NCT00920816|11312118|FG001|STARTED|Overall Study||96
10182181|NCT00920816|11312119|FG002|STARTED|Overall Study||135
10182182|NCT00920816|11312120|FG003|STARTED|Overall Study||69
10182183|NCT00920816|11312117|FG000|Treated|Overall Study||189
10182184|NCT00920816|11312118|FG001|Treated|Overall Study||96
10182185|NCT00920816|11312119|FG002|Treated|Overall Study||135
10182186|NCT00920816|11312120|FG003|Treated|Overall Study||69
10182187|NCT00920816|11312117|FG000|Participants From China (Excluded From Safety Analysis)|Overall Study||16
10182188|NCT00920816|11312118|FG001|Participants From China (Excluded From Safety Analysis)|Overall Study||8
10182189|NCT00920816|11312119|FG002|Participants From China (Excluded From Safety Analysis)|Overall Study||124
10182190|NCT00920816|11312120|FG003|Participants From China (Excluded From Safety Analysis)|Overall Study||64
10182191|NCT00920816|11312117|FG000|COMPLETED|Overall Study||0
10182192|NCT00920816|11312118|FG001|COMPLETED|Overall Study||0
10182193|NCT00920816|11312119|FG002|COMPLETED|Overall Study||0
10182194|NCT00920816|11312120|FG003|COMPLETED|Overall Study||0
10182195|NCT00920816|11312117|FG000|NOT COMPLETED|Overall Study||192
10182196|NCT00920816|11312118|FG001|NOT COMPLETED|Overall Study||96
10182197|NCT00920816|11312119|FG002|NOT COMPLETED|Overall Study||135
10182198|NCT00920816|11312120|FG003|NOT COMPLETED|Overall Study||69
10182199|NCT00565851|11312138|FG000|STARTED|Surgical Assignment||316
10182200|NCT00565851|11312139|FG001|STARTED|Surgical Assignment||456
10182201|NCT00565851|11312140|FG002|STARTED|Surgical Assignment||33
10182202|NCT00565851|11312141|FG003|STARTED|Surgical Assignment||165
10182203|NCT00565851|11312142|FG004|STARTED|Surgical Assignment||6
10182204|NCT00565851|11312143|FG005|STARTED|Surgical Assignment||34
10182205|NCT00565851|11312144|FG006|STARTED|Surgical Assignment||5
10182206|NCT00565851|11312145|FG007|STARTED|Surgical Assignment||37
10182207|NCT00565851|11312138|FG000|Randomized - Yes Surgery|Surgical Assignment||0
10182208|NCT00565851|11312139|FG001|Randomized - Yes Surgery|Surgical Assignment||0
10182209|NCT00565851|11312140|FG002|Randomized - Yes Surgery|Surgical Assignment||33
10182210|NCT00565851|11312141|FG003|Randomized - Yes Surgery|Surgical Assignment||165
10182211|NCT00565851|11312142|FG004|Randomized - Yes Surgery|Surgical Assignment||0
10182212|NCT00565851|11312143|FG005|Randomized - Yes Surgery|Surgical Assignment||0
10182213|NCT00565851|11312144|FG006|Randomized - Yes Surgery|Surgical Assignment||5
10182214|NCT00565851|11312145|FG007|Randomized - Yes Surgery|Surgical Assignment||37
10182215|NCT00565851|11312138|FG000|Randomized - no Surgery|Surgical Assignment||33
10182216|NCT00565851|11312139|FG001|Randomized - no Surgery|Surgical Assignment||172
10182217|NCT00565851|11312140|FG002|Randomized - no Surgery|Surgical Assignment||0
9849767|NCT00867113|10962560|FG000|COMPLETED|Post Treatment After Survival Follow-up||57
9849768|NCT00867113|10962560|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11
9849769|NCT00867139|10962567|FG000|STARTED|Overall Study||2
9849770|NCT00867139|10962568|FG001|STARTED|Overall Study||1
9849771|NCT00867139|10962569|FG002|STARTED|Overall Study||4
9849772|NCT00867139|10962567|FG000|COMPLETED|Overall Study||2
10182218|NCT00565851|11312141|FG003|Randomized - no Surgery|Surgical Assignment||0
10182219|NCT00565851|11312142|FG004|Randomized - no Surgery|Surgical Assignment||6
10182220|NCT00565851|11312143|FG005|Randomized - no Surgery|Surgical Assignment||34
10182221|NCT00565851|11312144|FG006|Randomized - no Surgery|Surgical Assignment||0
10182222|NCT00565851|11312145|FG007|Randomized - no Surgery|Surgical Assignment||0
10182223|NCT00565851|11312138|FG000|Not Surgical Candidate|Surgical Assignment||283
10182224|NCT00565851|11312139|FG001|Not Surgical Candidate|Surgical Assignment||284
10182225|NCT00565851|11312140|FG002|Not Surgical Candidate|Surgical Assignment||0
10182226|NCT00565851|11312141|FG003|Not Surgical Candidate|Surgical Assignment||0
10182227|NCT00565851|11312142|FG004|Not Surgical Candidate|Surgical Assignment||0
10182228|NCT00565851|11312143|FG005|Not Surgical Candidate|Surgical Assignment||0
10182229|NCT00565851|11312144|FG006|Not Surgical Candidate|Surgical Assignment||0
10182230|NCT00565851|11312145|FG007|Not Surgical Candidate|Surgical Assignment||0
10182231|NCT00565851|11312138|FG000|COMPLETED|Surgical Assignment||313
10182232|NCT00565851|11312139|FG001|COMPLETED|Surgical Assignment||454
10182233|NCT00565851|11312140|FG002|COMPLETED|Surgical Assignment||31
10182234|NCT00565851|11312141|FG003|COMPLETED|Surgical Assignment||154
10182235|NCT00565851|11312142|FG004|COMPLETED|Surgical Assignment||6
10182236|NCT00565851|11312143|FG005|COMPLETED|Surgical Assignment||34
10182237|NCT00565851|11312144|FG006|COMPLETED|Surgical Assignment||5
10182238|NCT00565851|11312145|FG007|COMPLETED|Surgical Assignment||35
10182239|NCT00565851|11312138|FG000|NOT COMPLETED|Surgical Assignment||3
10182240|NCT00565851|11312139|FG001|NOT COMPLETED|Surgical Assignment||2
10182241|NCT00565851|11312140|FG002|NOT COMPLETED|Surgical Assignment||2
10182242|NCT00565851|11312141|FG003|NOT COMPLETED|Surgical Assignment||11
10182243|NCT00565851|11312142|FG004|NOT COMPLETED|Surgical Assignment||0
10182244|NCT00565851|11312143|FG005|NOT COMPLETED|Surgical Assignment||0
10182245|NCT00565851|11312144|FG006|NOT COMPLETED|Surgical Assignment||0
10182246|NCT00565851|11312145|FG007|NOT COMPLETED|Surgical Assignment||2
10182247|NCT00565851|11312138|FG000|STARTED|Chemotherapy Assignment||316
10182248|NCT00565851|11312139|FG001|STARTED|Chemotherapy Assignment||456
10182249|NCT00565851|11312140|FG002|STARTED|Chemotherapy Assignment||33
10182250|NCT00565851|11312141|FG003|STARTED|Chemotherapy Assignment||165
10182251|NCT00565851|11312142|FG004|STARTED|Chemotherapy Assignment||6
10182252|NCT00565851|11312143|FG005|STARTED|Chemotherapy Assignment||34
10182253|NCT00565851|11312144|FG006|STARTED|Chemotherapy Assignment||5
10182254|NCT00565851|11312145|FG007|STARTED|Chemotherapy Assignment||37
10182255|NCT00565851|11312138|FG000|Randomized to Chemo|Chemotherapy Assignment||310
10182256|NCT00565851|11312139|FG001|Randomized to Chemo|Chemotherapy Assignment||311
10182257|NCT00565851|11312140|FG002|Randomized to Chemo|Chemotherapy Assignment||27
10182258|NCT00565851|11312141|FG003|Randomized to Chemo|Chemotherapy Assignment||26
10182259|NCT00565851|11312142|FG004|Randomized to Chemo|Chemotherapy Assignment||0
10182260|NCT00565851|11312143|FG005|Randomized to Chemo|Chemotherapy Assignment||0
10182261|NCT00565851|11312144|FG006|Randomized to Chemo|Chemotherapy Assignment||0
10182262|NCT00565851|11312145|FG007|Randomized to Chemo|Chemotherapy Assignment||0
10182263|NCT00565851|11312138|FG000|Pre-specified Chemo|Chemotherapy Assignment||6
10182264|NCT00565851|11312139|FG001|Pre-specified Chemo|Chemotherapy Assignment||145
10182265|NCT00565851|11312140|FG002|Pre-specified Chemo|Chemotherapy Assignment||6
10182266|NCT00565851|11312141|FG003|Pre-specified Chemo|Chemotherapy Assignment||139
10182267|NCT00565851|11312142|FG004|Pre-specified Chemo|Chemotherapy Assignment||6
10182268|NCT00565851|11312143|FG005|Pre-specified Chemo|Chemotherapy Assignment||34
10182269|NCT00565851|11312144|FG006|Pre-specified Chemo|Chemotherapy Assignment||5
10182270|NCT00565851|11312145|FG007|Pre-specified Chemo|Chemotherapy Assignment||37
10182271|NCT00565851|11312138|FG000|COMPLETED|Chemotherapy Assignment||307
10182272|NCT00565851|11312139|FG001|COMPLETED|Chemotherapy Assignment||433
10182273|NCT00565851|11312140|FG002|COMPLETED|Chemotherapy Assignment||30
10182274|NCT00565851|11312141|FG003|COMPLETED|Chemotherapy Assignment||129
10182275|NCT00565851|11312142|FG004|COMPLETED|Chemotherapy Assignment||6
10182276|NCT00565851|11312143|FG005|COMPLETED|Chemotherapy Assignment||31
10182277|NCT00565851|11312144|FG006|COMPLETED|Chemotherapy Assignment||5
10182278|NCT00565851|11312145|FG007|COMPLETED|Chemotherapy Assignment||34
10182279|NCT00565851|11312138|FG000|NOT COMPLETED|Chemotherapy Assignment||9
10182280|NCT00565851|11312139|FG001|NOT COMPLETED|Chemotherapy Assignment||23
10182281|NCT00565851|11312140|FG002|NOT COMPLETED|Chemotherapy Assignment||3
9714671|NCT01090024|10814015|FG008|COMPLETED|Period 2||6
9714672|NCT01090024|10814016|FG009|COMPLETED|Period 2||5
9714673|NCT01090024|10814017|FG010|COMPLETED|Period 2||6
9714674|NCT01090024|10814018|FG011|COMPLETED|Period 2||5
9714675|NCT01090024|10814019|FG012|COMPLETED|Period 2||6
9714676|NCT01090024|10814020|FG013|COMPLETED|Period 2||6
9714677|NCT01090024|10814021|FG014|COMPLETED|Period 2||5
9714678|NCT01090024|10814022|FG015|COMPLETED|Period 2||6
9714679|NCT01090024|10814023|FG016|COMPLETED|Period 2||6
9714680|NCT01090024|10814024|FG017|COMPLETED|Period 2||5
9714681|NCT01090024|10814007|FG000|NOT COMPLETED|Period 2||1
9714682|NCT01090024|10814008|FG001|NOT COMPLETED|Period 2||0
9714683|NCT01090024|10814009|FG002|NOT COMPLETED|Period 2||0
9714684|NCT01090024|10814010|FG003|NOT COMPLETED|Period 2||1
9714685|NCT01090024|10814011|FG004|NOT COMPLETED|Period 2||0
9714686|NCT01090024|10814012|FG005|NOT COMPLETED|Period 2||0
9714687|NCT01090024|10814013|FG006|NOT COMPLETED|Period 2||0
9714688|NCT01090024|10814014|FG007|NOT COMPLETED|Period 2||0
9714689|NCT01090024|10814015|FG008|NOT COMPLETED|Period 2||0
9714690|NCT01090024|10814016|FG009|NOT COMPLETED|Period 2||0
9714691|NCT01090024|10814017|FG010|NOT COMPLETED|Period 2||0
9714692|NCT01090024|10814018|FG011|NOT COMPLETED|Period 2||0
9714693|NCT01090024|10814019|FG012|NOT COMPLETED|Period 2||0
9714694|NCT01090024|10814020|FG013|NOT COMPLETED|Period 2||0
9714695|NCT01090024|10814021|FG014|NOT COMPLETED|Period 2||0
9714696|NCT01090024|10814022|FG015|NOT COMPLETED|Period 2||0
9714697|NCT01090024|10814023|FG016|NOT COMPLETED|Period 2||0
9714698|NCT01090024|10814024|FG017|NOT COMPLETED|Period 2||0
9714699|NCT01090024|10814007|FG000|STARTED|Period 3||5
9714700|NCT01090024|10814008|FG001|STARTED|Period 3||5
9714701|NCT01090024|10814009|FG002|STARTED|Period 3||6
9714702|NCT01090024|10814010|FG003|STARTED|Period 3||4
9714703|NCT01090024|10814011|FG004|STARTED|Period 3||6
9714704|NCT01090024|10814012|FG005|STARTED|Period 3||6
9714705|NCT01090024|10814013|FG006|STARTED|Period 3||6
9714706|NCT01090024|10814014|FG007|STARTED|Period 3||6
9714707|NCT01090024|10814015|FG008|STARTED|Period 3||6
9849773|NCT00867139|10962568|FG001|COMPLETED|Overall Study||1
9849774|NCT00867139|10962569|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
9849775|NCT00867139|10962567|FG000|NOT COMPLETED|Overall Study||0
9849776|NCT00867139|10962568|FG001|NOT COMPLETED|Overall Study||0
9714708|NCT01090024|10814016|FG009|STARTED|Period 3||5
9714709|NCT01090024|10814017|FG010|STARTED|Period 3||6
9714710|NCT01090024|10814018|FG011|STARTED|Period 3||5
9714711|NCT01090024|10814019|FG012|STARTED|Period 3||6
9714712|NCT01090024|10814020|FG013|STARTED|Period 3||6
9714713|NCT01090024|10814021|FG014|STARTED|Period 3||5
9714714|NCT01090024|10814022|FG015|STARTED|Period 3||6
9714715|NCT01090024|10814023|FG016|STARTED|Period 3||6
9714716|NCT01090024|10814024|FG017|STARTED|Period 3||5
9714717|NCT01090024|10814007|FG000|Treated|Period 3||5
10182282|NCT00565851|11312141|FG003|NOT COMPLETED|Chemotherapy Assignment||36
10182283|NCT00565851|11312142|FG004|NOT COMPLETED|Chemotherapy Assignment||0
10182284|NCT00565851|11312143|FG005|NOT COMPLETED|Chemotherapy Assignment||3
10182285|NCT00565851|11312144|FG006|NOT COMPLETED|Chemotherapy Assignment||0
10182286|NCT00565851|11312145|FG007|NOT COMPLETED|Chemotherapy Assignment||3
10182287|NCT03180645|11312170|FG000|STARTED|Overall Study||24
10182288|NCT03180645|11312171|FG001|STARTED|Overall Study||24
10182289|NCT03180645|11312172|FG002|STARTED|Overall Study||24
10182290|NCT03180645|11312170|FG000|COMPLETED|Overall Study||24
10182291|NCT03180645|11312171|FG001|COMPLETED|Overall Study||23
10182292|NCT03180645|11312172|FG002|COMPLETED|Overall Study||22
10182293|NCT03180645|11312170|FG000|NOT COMPLETED|Overall Study||0
10182294|NCT03180645|11312171|FG001|NOT COMPLETED|Overall Study||1
10182295|NCT03180645|11312172|FG002|NOT COMPLETED|Overall Study||2
10182296|NCT03180801|11312187|FG000|STARTED|Overall Study||50
10182297|NCT03180801|11312188|FG001|STARTED|Overall Study||52
10182298|NCT03180801|11312189|FG002|STARTED|Overall Study||51
10182299|NCT03180801|11312187|FG000|Safety Population|Overall Study||50
10182300|NCT03180801|11312188|FG001|Safety Population|Overall Study||52
9714718|NCT01090024|10814008|FG001|Treated|Period 3||5
9714719|NCT01090024|10814009|FG002|Treated|Period 3||6
9714720|NCT01090024|10814010|FG003|Treated|Period 3||4
9714721|NCT01090024|10814011|FG004|Treated|Period 3||6
9714722|NCT01090024|10814012|FG005|Treated|Period 3||6
9714723|NCT01090024|10814013|FG006|Treated|Period 3||6
9714724|NCT01090024|10814014|FG007|Treated|Period 3||6
9714725|NCT01090024|10814015|FG008|Treated|Period 3||6
9714726|NCT01090024|10814016|FG009|Treated|Period 3||5
9714727|NCT01090024|10814017|FG010|Treated|Period 3||6
9714728|NCT01090024|10814018|FG011|Treated|Period 3||5
9714729|NCT01090024|10814019|FG012|Treated|Period 3||6
9714730|NCT01090024|10814020|FG013|Treated|Period 3||6
9714731|NCT01090024|10814021|FG014|Treated|Period 3||5
9714732|NCT01090024|10814022|FG015|Treated|Period 3||5
9714733|NCT01090024|10814023|FG016|Treated|Period 3||6
9714734|NCT01090024|10814024|FG017|Treated|Period 3||5
9714735|NCT01090024|10814007|FG000|COMPLETED|Period 3||5
9714736|NCT01090024|10814008|FG001|COMPLETED|Period 3||5
9714737|NCT01090024|10814009|FG002|COMPLETED|Period 3||6
9714738|NCT01090024|10814010|FG003|COMPLETED|Period 3||4
9714739|NCT01090024|10814011|FG004|COMPLETED|Period 3||6
9714740|NCT01090024|10814012|FG005|COMPLETED|Period 3||5
9714741|NCT01090024|10814013|FG006|COMPLETED|Period 3||6
9714742|NCT01090024|10814014|FG007|COMPLETED|Period 3||6
9849777|NCT00867139|10962569|FG002|NOT COMPLETED|Overall Study||1
9849778|NCT00867217|10962587|FG000|STARTED|Overall Study||80
9849779|NCT00867217|10962588|FG001|STARTED|Overall Study||80
9849780|NCT00867217|10962587|FG000|COMPLETED|Overall Study||77
9849781|NCT00867217|10962588|FG001|COMPLETED|Overall Study||70
9849782|NCT00867217|10962587|FG000|NOT COMPLETED|Overall Study||3
9849783|NCT00867217|10962588|FG001|NOT COMPLETED|Overall Study||10
9849784|NCT00867308|10962596|FG000|STARTED|Overall Study||9
9849785|NCT00867308|10962597|FG001|STARTED|Overall Study||18
9849786|NCT00867308|10962596|FG000|COMPLETED|Overall Study||0
9849787|NCT00867308|10962597|FG001|COMPLETED|Overall Study||0
9849788|NCT00867308|10962596|FG000|NOT COMPLETED|Overall Study||9
9849789|NCT00867308|10962597|FG001|NOT COMPLETED|Overall Study||18
9849790|NCT00867334|10962605|FG000|STARTED|Overall Study||6
9849791|NCT00867334|10962606|FG001|STARTED|Overall Study||1
9849792|NCT00867334|10962605|FG000|COMPLETED|Overall Study||4
9849793|NCT00867334|10962606|FG001|COMPLETED|Overall Study||0
9849794|NCT00867334|10962605|FG000|NOT COMPLETED|Overall Study||2
9849795|NCT00867334|10962606|FG001|NOT COMPLETED|Overall Study||1
9849796|NCT00867360|10962614|FG000|STARTED|Overall Study||4
9849797|NCT00867360|10962615|FG001|STARTED|Overall Study||6
9849798|NCT00867360|10962614|FG000|COMPLETED|Overall Study||3
9849799|NCT00867360|10962615|FG001|COMPLETED|Overall Study||5
9849800|NCT00867360|10962614|FG000|NOT COMPLETED|Overall Study||1
9849801|NCT00867360|10962615|FG001|NOT COMPLETED|Overall Study||1
9849802|NCT00867451|10962624|FG000|STARTED|Overall Study||4
9849803|NCT00867451|10962625|FG001|STARTED|Overall Study||4
9849804|NCT00867451|10962624|FG000|COMPLETED|Overall Study||4
9849805|NCT00867451|10962625|FG001|COMPLETED|Overall Study||4
9849806|NCT00867451|10962624|FG000|NOT COMPLETED|Overall Study||0
9849807|NCT00867451|10962625|FG001|NOT COMPLETED|Overall Study||0
9849808|NCT00867490|10962635|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186
9849809|NCT00867490|10962635|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176
9849810|NCT00867490|10962635|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
9849811|NCT00867490|10962635|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
9849812|NCT00867490|10962635|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
9849813|NCT00867490|10962635|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
9849814|NCT00867490|10962635|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
9849815|NCT00867490|10962635|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
10182301|NCT03180801|11312189|FG002|Safety Population|Overall Study||51
9714743|NCT01090024|10814015|FG008|COMPLETED|Period 3||5
9714744|NCT01090024|10814016|FG009|COMPLETED|Period 3||5
9714745|NCT01090024|10814017|FG010|COMPLETED|Period 3||6
9714746|NCT01090024|10814018|FG011|COMPLETED|Period 3||5
9714747|NCT01090024|10814019|FG012|COMPLETED|Period 3||6
9714748|NCT01090024|10814020|FG013|COMPLETED|Period 3||6
9714749|NCT01090024|10814021|FG014|COMPLETED|Period 3||5
10182302|NCT03180801|11312187|FG000|Intention to Treat|Overall Study||42
10182303|NCT03180801|11312188|FG001|Intention to Treat|Overall Study||40
10182304|NCT03180801|11312189|FG002|Intention to Treat|Overall Study||41
10182305|NCT03180801|11312187|FG000|COMPLETED|Overall Study||42
9714750|NCT01090024|10814022|FG015|COMPLETED|Period 3||5
9714751|NCT01090024|10814023|FG016|COMPLETED|Period 3||6
9714752|NCT01090024|10814024|FG017|COMPLETED|Period 3||5
9714753|NCT01090024|10814007|FG000|NOT COMPLETED|Period 3||0
9714754|NCT01090024|10814008|FG001|NOT COMPLETED|Period 3||0
9714755|NCT01090024|10814009|FG002|NOT COMPLETED|Period 3||0
9714756|NCT01090024|10814010|FG003|NOT COMPLETED|Period 3||0
9714757|NCT01090024|10814011|FG004|NOT COMPLETED|Period 3||0
9714758|NCT01090024|10814012|FG005|NOT COMPLETED|Period 3||1
9714759|NCT01090024|10814013|FG006|NOT COMPLETED|Period 3||0
9714760|NCT01090024|10814014|FG007|NOT COMPLETED|Period 3||0
9714761|NCT01090024|10814015|FG008|NOT COMPLETED|Period 3||1
9714762|NCT01090024|10814016|FG009|NOT COMPLETED|Period 3||0
9714763|NCT01090024|10814017|FG010|NOT COMPLETED|Period 3||0
9714764|NCT01090024|10814018|FG011|NOT COMPLETED|Period 3||0
9714765|NCT01090024|10814019|FG012|NOT COMPLETED|Period 3||0
9714766|NCT01090024|10814020|FG013|NOT COMPLETED|Period 3||0
9714767|NCT01090024|10814021|FG014|NOT COMPLETED|Period 3||0
9714768|NCT01090024|10814022|FG015|NOT COMPLETED|Period 3||1
9714769|NCT01090024|10814023|FG016|NOT COMPLETED|Period 3||0
9714770|NCT01090024|10814024|FG017|NOT COMPLETED|Period 3||0
9714774|NCT00943722|10814043|FG000|STARTED|Base Study||648
9714775|NCT00943722|10814044|FG001|STARTED|Base Study||643
9714776|NCT00943722|10814045|FG002|STARTED|Base Study||644
9714777|NCT00943722|10814046|FG003|STARTED|Base Study||669
9714778|NCT00943722|10814047|FG004|STARTED|Base Study||470
9714779|NCT00943722|10814048|FG005|STARTED|Base Study||0
9714780|NCT00943722|10814049|FG006|STARTED|Base Study||0
9714781|NCT00943722|10814043|FG000|Vaccination 1|Base Study||646
9714782|NCT00943722|10814044|FG001|Vaccination 1|Base Study||642
9714783|NCT00943722|10814045|FG002|Vaccination 1|Base Study||644
9714784|NCT00943722|10814046|FG003|Vaccination 1|Base Study||666
9714785|NCT00943722|10814047|FG004|Vaccination 1|Base Study||468
9714786|NCT00943722|10814048|FG005|Vaccination 1|Base Study||0
9714787|NCT00943722|10814049|FG006|Vaccination 1|Base Study||0
9714788|NCT00943722|10814043|FG000|Vaccination 2|Base Study||637
9714789|NCT00943722|10814044|FG001|Vaccination 2|Base Study||633
9714790|NCT00943722|10814045|FG002|Vaccination 2|Base Study||638
9714791|NCT00943722|10814046|FG003|Vaccination 2|Base Study||658
9714792|NCT00943722|10814047|FG004|Vaccination 2|Base Study||462
9714793|NCT00943722|10814048|FG005|Vaccination 2|Base Study||0
9714794|NCT00943722|10814049|FG006|Vaccination 2|Base Study||0
9714795|NCT00943722|10814043|FG000|Vaccination 3|Base Study||635
9714796|NCT00943722|10814044|FG001|Vaccination 3|Base Study||627
10182306|NCT03180801|11312188|FG001|COMPLETED|Overall Study||40
10182307|NCT03180801|11312189|FG002|COMPLETED|Overall Study||41
10182308|NCT03180801|11312187|FG000|NOT COMPLETED|Overall Study||8
10182309|NCT03180801|11312188|FG001|NOT COMPLETED|Overall Study||12
10182310|NCT03180801|11312189|FG002|NOT COMPLETED|Overall Study||10
10182311|NCT03181009|11312202|FG000|STARTED|Overall Study||30
10182312|NCT03181009|11312203|FG001|STARTED|Overall Study||30
10182313|NCT03181009|11312202|FG000|COMPLETED|Overall Study||30
10182314|NCT03181009|11312203|FG001|COMPLETED|Overall Study||28
10182315|NCT03181009|11312202|FG000|NOT COMPLETED|Overall Study||0
10182316|NCT03181009|11312203|FG001|NOT COMPLETED|Overall Study||2
10182317|NCT03181308|11312211|FG000|STARTED|Overall Study||3
10182318|NCT03181308|11312212|FG001|STARTED|Overall Study||8
10182319|NCT03181308|11312211|FG000|COMPLETED|Overall Study||3
10182320|NCT03181308|11312212|FG001|COMPLETED|Overall Study||8
10182321|NCT03181308|11312211|FG000|NOT COMPLETED|Overall Study||0
10182322|NCT03181308|11312212|FG001|NOT COMPLETED|Overall Study||0
10182323|NCT03181451|11312221|FG000|STARTED|Overall Study||12
10182324|NCT03181451|11312222|FG001|STARTED|Overall Study||13
10182325|NCT03181451|11312223|FG002|STARTED|Overall Study||12
10182326|NCT03181451|11312221|FG000|COMPLETED|Overall Study||12
10182327|NCT03181451|11312222|FG001|COMPLETED|Overall Study||11
10182328|NCT03181451|11312223|FG002|COMPLETED|Overall Study||12
10182329|NCT03181451|11312221|FG000|NOT COMPLETED|Overall Study||0
10182330|NCT03181451|11312222|FG001|NOT COMPLETED|Overall Study||2
10182331|NCT03181451|11312223|FG002|NOT COMPLETED|Overall Study||0
10182332|NCT03181503|11312235|FG000|STARTED|Overall Study||36
10182333|NCT03181503|11312236|FG001|STARTED|Overall Study||34
9714797|NCT00943722|10814045|FG002|Vaccination 3|Base Study||637
10182334|NCT03181503|11312235|FG000|Treated|Overall Study||36
10182335|NCT03181503|11312236|FG001|Treated|Overall Study||34
10182336|NCT03181503|11312235|FG000|COMPLETED|Overall Study||29
10182337|NCT03181503|11312236|FG001|COMPLETED|Overall Study||31
9714798|NCT00943722|10814046|FG003|Vaccination 3|Base Study||653
9714799|NCT00943722|10814047|FG004|Vaccination 3|Base Study||455
9714800|NCT00943722|10814048|FG005|Vaccination 3|Base Study||0
9714801|NCT00943722|10814049|FG006|Vaccination 3|Base Study||0
9714802|NCT00943722|10814043|FG000|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||643
9714803|NCT00943722|10814044|FG001|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||639
10182338|NCT03181503|11312235|FG000|NOT COMPLETED|Overall Study||7
10182339|NCT03181503|11312236|FG001|NOT COMPLETED|Overall Study||3
10182340|NCT03181594|11312245|FG000|STARTED|Initial Study Protocol (12-month FU)||100
10182341|NCT03181594|11312245|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99
10182342|NCT03181594|11312245|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98
10182343|NCT03181594|11312245|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98
10182344|NCT03181594|11312245|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95
10182345|NCT03181594|11312245|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91
10182346|NCT03181594|11312245|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91
10182347|NCT03181594|11312245|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
10182348|NCT03181594|11312245|FG000|STARTED|Long-term Extension (15-24 Month FU)||62
10182349|NCT03181594|11312245|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
10182350|NCT03181594|11312245|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
10182351|NCT03181594|11312245|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
10182352|NCT03181594|11312245|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
10182353|NCT03181594|11312245|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57
10182354|NCT03181594|11312245|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
10182355|NCT03181724|11312251|FG000|STARTED|Overall Study||45
10182356|NCT03181724|11312252|FG001|STARTED|Overall Study||45
10182357|NCT03181724|11312251|FG000|COMPLETED|Overall Study||45
10182358|NCT03181724|11312252|FG001|COMPLETED|Overall Study||45
10182359|NCT03181724|11312251|FG000|NOT COMPLETED|Overall Study||0
10182360|NCT03181724|11312252|FG001|NOT COMPLETED|Overall Study||0
10182361|NCT03181932|11312260|FG000|STARTED|Period 1 (Double-blind Period)||90
10182362|NCT03181932|11312261|FG001|STARTED|Period 1 (Double-blind Period)||98
10182363|NCT03181932|11312260|FG000|COMPLETED|Period 1 (Double-blind Period)||79
10182364|NCT03181932|11312261|FG001|COMPLETED|Period 1 (Double-blind Period)||85
10182365|NCT03181932|11312260|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11
10182366|NCT03181932|11312261|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13
10182367|NCT03181932|11312260|FG000|STARTED|Period 2 (Open-label Period)||75
10182368|NCT03181932|11312261|FG001|STARTED|Period 2 (Open-label Period)||83
10182369|NCT03181932|11312260|FG000|COMPLETED|Period 2 (Open-label Period)||67
10182370|NCT03181932|11312261|FG001|COMPLETED|Period 2 (Open-label Period)||70
10182371|NCT03181932|11312260|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8
10182372|NCT03181932|11312261|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13
10182373|NCT03181958|11312271|FG000|STARTED|Overall Study||497
10182374|NCT03181958|11312272|FG001|STARTED|Overall Study||501
10182375|NCT03181958|11312273|FG002|STARTED|Overall Study||495
10182376|NCT03181958|11312271|FG000|COMPLETED|Overall Study||480
10182377|NCT03181958|11312272|FG001|COMPLETED|Overall Study||480
10182378|NCT03181958|11312273|FG002|COMPLETED|Overall Study||480
10182379|NCT03181958|11312271|FG000|NOT COMPLETED|Overall Study||17
10182380|NCT03181958|11312272|FG001|NOT COMPLETED|Overall Study||21
10182381|NCT03181958|11312273|FG002|NOT COMPLETED|Overall Study||15
10182382|NCT03182582|11312281|FG000|STARTED|Treatment 1||12
10182383|NCT03182582|11312282|FG001|STARTED|Treatment 1||10
10182384|NCT03182582|11312281|FG000|COMPLETED|Treatment 1||12
10182385|NCT03182582|11312282|FG001|COMPLETED|Treatment 1||10
10182386|NCT03182582|11312281|FG000|NOT COMPLETED|Treatment 1||0
10182387|NCT03182582|11312282|FG001|NOT COMPLETED|Treatment 1||0
10182388|NCT03182582|11312281|FG000|STARTED|Treatment 2||12
10182389|NCT03182582|11312282|FG001|STARTED|Treatment 2||10
10182390|NCT03182582|11312281|FG000|COMPLETED|Treatment 2||12
10182391|NCT03182582|11312282|FG001|COMPLETED|Treatment 2||10
10182392|NCT03182582|11312281|FG000|NOT COMPLETED|Treatment 2||0
10182393|NCT03182582|11312282|FG001|NOT COMPLETED|Treatment 2||0
10182394|NCT03182725|11312295|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16
10182395|NCT03182725|11312296|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10
10182396|NCT03182725|11312295|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16
10182397|NCT03182725|11312296|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7
10182398|NCT03182725|11312295|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
10182399|NCT03182725|11312296|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
10182400|NCT03182725|11312295|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16
10182401|NCT03182725|11312296|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
10182402|NCT03182725|11312295|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
10182403|NCT03182725|11312296|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
10182404|NCT03182725|11312295|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
10182405|NCT03182725|11312296|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
10182406|NCT03182738|11312304|FG000|STARTED|Overall Study||50
10182407|NCT03182738|11312305|FG001|STARTED|Overall Study||50
10182408|NCT03182738|11312304|FG000|COMPLETED|Overall Study||41
10182409|NCT03182738|11312305|FG001|COMPLETED|Overall Study||45
10182410|NCT03182738|11312304|FG000|NOT COMPLETED|Overall Study||9
10182411|NCT03182738|11312305|FG001|NOT COMPLETED|Overall Study||5
10182412|NCT03182920|11312313|FG000|STARTED|Period 1||9
10182413|NCT03182920|11312314|FG001|STARTED|Period 1||9
10182414|NCT03182920|11312315|FG002|STARTED|Period 1||17
10182415|NCT03182920|11312313|FG000|COMPLETED|Period 1||9
10182416|NCT03182920|11312314|FG001|COMPLETED|Period 1||9
10182417|NCT03182920|11312315|FG002|COMPLETED|Period 1||17
10182418|NCT03182920|11312313|FG000|NOT COMPLETED|Period 1||0
10182419|NCT03182920|11312314|FG001|NOT COMPLETED|Period 1||0
10182420|NCT03182920|11312315|FG002|NOT COMPLETED|Period 1||0
10182421|NCT03182920|11312313|FG000|STARTED|Washout Period||9
10182422|NCT03182920|11312314|FG001|STARTED|Washout Period||9
10182423|NCT03182920|11312315|FG002|STARTED|Washout Period||0
10182424|NCT03182920|11312313|FG000|COMPLETED|Washout Period||9
10182425|NCT03182920|11312314|FG001|COMPLETED|Washout Period||9
10182426|NCT03182920|11312315|FG002|COMPLETED|Washout Period||0
10182427|NCT03182920|11312313|FG000|NOT COMPLETED|Washout Period||0
10182428|NCT03182920|11312314|FG001|NOT COMPLETED|Washout Period||0
10182429|NCT03182920|11312315|FG002|NOT COMPLETED|Washout Period||0
10182430|NCT03182920|11312313|FG000|STARTED|Period 2||9
10182431|NCT03182920|11312314|FG001|STARTED|Period 2||9
10182432|NCT03182920|11312315|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
10182433|NCT03182920|11312313|FG000|COMPLETED|Period 2||9
10182434|NCT03182920|11312314|FG001|COMPLETED|Period 2||9
10182435|NCT03182920|11312315|FG002|COMPLETED|Period 2||0
10182436|NCT03182920|11312313|FG000|NOT COMPLETED|Period 2||0
10182437|NCT03182920|11312314|FG001|NOT COMPLETED|Period 2||0
10182438|NCT03182920|11312315|FG002|NOT COMPLETED|Period 2||0
10182439|NCT03182933|11312324|FG000|STARTED|Overall Study||32
10182440|NCT03182933|11312325|FG001|STARTED|Overall Study||32
10182441|NCT03182933|11312324|FG000|COMPLETED|Overall Study||31
10182442|NCT03182933|11312325|FG001|COMPLETED|Overall Study||32
10182443|NCT03182933|11312324|FG000|NOT COMPLETED|Overall Study||1
10182444|NCT03182933|11312325|FG001|NOT COMPLETED|Overall Study||0
10182445|NCT03183063|11312334|FG000|STARTED|Overall Study||20
10182446|NCT03183063|11312335|FG001|STARTED|Overall Study||4
10182447|NCT03183063|11312336|FG002|STARTED|Overall Study||115
10182448|NCT03183063|11312334|FG000|COMPLETED|Overall Study||15
10182449|NCT03183063|11312335|FG001|COMPLETED|Overall Study||0
10182450|NCT03183063|11312336|FG002|COMPLETED|Overall Study||111
10182451|NCT03183063|11312334|FG000|NOT COMPLETED|Overall Study||5
10182452|NCT03183063|11312335|FG001|NOT COMPLETED|Overall Study||4
10182453|NCT03183063|11312336|FG002|NOT COMPLETED|Overall Study||4
10182454|NCT03183518|11312350|FG000|STARTED|Overall Study||36
10182455|NCT03183518|11312350|FG000|Test Product|Overall Study||36
10182456|NCT03183518|11312350|FG000|Negative Control|Overall Study||36
10182457|NCT03183518|11312350|FG000|COMPLETED|Overall Study||33
10182458|NCT03183518|11312350|FG000|NOT COMPLETED|Overall Study||3
10182459|NCT03183869|11312357|FG000|STARTED|Overall Study||4
10182460|NCT03183869|11312358|FG001|STARTED|Overall Study||7
10182461|NCT03183869|11312357|FG000|COMPLETED|Overall Study||0
10182462|NCT03183869|11312358|FG001|COMPLETED|Overall Study||2
10182463|NCT03183869|11312357|FG000|NOT COMPLETED|Overall Study||4
10182464|NCT03183869|11312358|FG001|NOT COMPLETED|Overall Study||5
10182465|NCT03183908|11312366|FG000|STARTED|Overall Study||378
10182466|NCT03183908|11312367|FG001|STARTED|Overall Study||379
10182467|NCT03183908|11312366|FG000|COMPLETED|Overall Study||378
10182468|NCT03183908|11312367|FG001|COMPLETED|Overall Study||377
10182469|NCT03183908|11312366|FG000|NOT COMPLETED|Overall Study||0
10182470|NCT03183908|11312367|FG001|NOT COMPLETED|Overall Study||2
10182471|NCT03184077|11312379|FG000|STARTED|Overall Study||166
10182472|NCT03184077|11312380|FG001|STARTED|Overall Study||152
10182473|NCT03184077|11312379|FG000|COMPLETED|Overall Study||145
10182474|NCT03184077|11312380|FG001|COMPLETED|Overall Study||131
10182475|NCT03184077|11312379|FG000|NOT COMPLETED|Overall Study||21
10182476|NCT03184077|11312380|FG001|NOT COMPLETED|Overall Study||21
10182477|NCT03184428|11312386|FG000|STARTED|Overall Study||3785
10182478|NCT03184428|11312386|FG000|COMPLETED|Overall Study||2963
10182479|NCT03184428|11312386|FG000|NOT COMPLETED|Overall Study||822
10182480|NCT03184441|11312402|FG000|STARTED|Overall Study||11
10182481|NCT03184441|11312402|FG000|COMPLETED|Overall Study|Last subject completed study|10
10182482|NCT03184441|11312402|FG000|NOT COMPLETED|Overall Study||1
10182483|NCT03184519|11312409|FG000|STARTED|Overall Study||156
10182484|NCT03184519|11312409|FG000|COMPLETED|Overall Study||129
10182485|NCT03184519|11312409|FG000|NOT COMPLETED|Overall Study||27
10182486|NCT03184558|11312413|FG000|STARTED|Overall Study||29
10182487|NCT03184558|11312413|FG000|COMPLETED|Overall Study||0
10182488|NCT03184558|11312413|FG000|NOT COMPLETED|Overall Study||29
10182489|NCT03184701|11312417|FG000|STARTED|Overall Study||45
10182490|NCT03184701|11312417|FG000|COMPLETED|Overall Study||28
10182491|NCT03184701|11312417|FG000|NOT COMPLETED|Overall Study||17
10182492|NCT03184987|11312424|FG000|STARTED|Overall Study||47
10182493|NCT03184987|11312425|FG001|STARTED|Overall Study||9
10182494|NCT03184987|11312426|FG002|STARTED|Overall Study||55
10182495|NCT03184987|11312424|FG000|COMPLETED|Overall Study||46
10182496|NCT03184987|11312425|FG001|COMPLETED|Overall Study||8
10182497|NCT03184987|11312426|FG002|COMPLETED|Overall Study||51
10182498|NCT03184987|11312424|FG000|NOT COMPLETED|Overall Study||1
10182499|NCT03184987|11312425|FG001|NOT COMPLETED|Overall Study||1
10182500|NCT03184987|11312426|FG002|NOT COMPLETED|Overall Study||4
10182501|NCT03185065|11312438|FG000|STARTED|Period 1 (6 Weeks)||35
10182502|NCT03185065|11312439|FG001|STARTED|Period 1 (6 Weeks)||34
10182503|NCT03185065|11312440|FG002|STARTED|Period 1 (6 Weeks)||35
10182504|NCT03185065|11312441|FG003|STARTED|Period 1 (6 Weeks)||37
10182505|NCT03185065|11312438|FG000|COMPLETED|Period 1 (6 Weeks)||32
10182506|NCT03185065|11312439|FG001|COMPLETED|Period 1 (6 Weeks)||33
10182507|NCT03185065|11312440|FG002|COMPLETED|Period 1 (6 Weeks)||32
10182508|NCT03185065|11312441|FG003|COMPLETED|Period 1 (6 Weeks)||36
10182509|NCT03185065|11312438|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3
10182510|NCT03185065|11312439|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1
10182511|NCT03185065|11312440|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3
10182512|NCT03185065|11312441|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1
10182513|NCT03185065|11312438|FG000|STARTED|Washout (2 Weeks)||32
10182514|NCT03185065|11312439|FG001|STARTED|Washout (2 Weeks)||33
10182515|NCT03185065|11312440|FG002|STARTED|Washout (2 Weeks)||32
10182516|NCT03185065|11312441|FG003|STARTED|Washout (2 Weeks)||36
10182517|NCT03185065|11312438|FG000|COMPLETED|Washout (2 Weeks)||32
10182518|NCT03185065|11312439|FG001|COMPLETED|Washout (2 Weeks)||31
10182519|NCT03185065|11312440|FG002|COMPLETED|Washout (2 Weeks)||32
10182520|NCT03185065|11312441|FG003|COMPLETED|Washout (2 Weeks)||35
10182521|NCT03185065|11312438|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10182522|NCT03185065|11312439|FG001|NOT COMPLETED|Washout (2 Weeks)||2
10182523|NCT03185065|11312440|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10182524|NCT03185065|11312441|FG003|NOT COMPLETED|Washout (2 Weeks)||1
10182525|NCT03185065|11312438|FG000|STARTED|Period 2 (6 Weeks)||32
10182526|NCT03185065|11312439|FG001|STARTED|Period 2 (6 Weeks)||31
10182527|NCT03185065|11312440|FG002|STARTED|Period 2 (6 Weeks)||32
10182528|NCT03185065|11312441|FG003|STARTED|Period 2 (6 Weeks)||35
10182529|NCT03185065|11312438|FG000|COMPLETED|Period 2 (6 Weeks)||32
10182530|NCT03185065|11312439|FG001|COMPLETED|Period 2 (6 Weeks)||31
10182531|NCT03185065|11312440|FG002|COMPLETED|Period 2 (6 Weeks)||32
10182532|NCT03185065|11312441|FG003|COMPLETED|Period 2 (6 Weeks)||34
10182533|NCT03185065|11312438|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
10182534|NCT03185065|11312439|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
10182535|NCT03185065|11312440|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0
10182536|NCT03185065|11312441|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1
10182537|NCT03185065|11312438|FG000|STARTED|Washout (2 Weeks)||32
10182538|NCT03185065|11312439|FG001|STARTED|Washout (2 Weeks)||31
10182539|NCT03185065|11312440|FG002|STARTED|Washout (2 Weeks)||32
10182540|NCT03185065|11312441|FG003|STARTED|Washout (2 Weeks)||34
10182541|NCT03185065|11312438|FG000|COMPLETED|Washout (2 Weeks)||31
10182542|NCT03185065|11312439|FG001|COMPLETED|Washout (2 Weeks)||29
10182543|NCT03185065|11312440|FG002|COMPLETED|Washout (2 Weeks)||31
10182544|NCT03185065|11312441|FG003|COMPLETED|Washout (2 Weeks)||32
10182545|NCT03185065|11312438|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10182546|NCT03185065|11312439|FG001|NOT COMPLETED|Washout (2 Weeks)||2
10182547|NCT03185065|11312440|FG002|NOT COMPLETED|Washout (2 Weeks)||1
10182548|NCT03185065|11312441|FG003|NOT COMPLETED|Washout (2 Weeks)||2
10182549|NCT03185065|11312438|FG000|STARTED|Period 3 (6 Weeks)||31
10182550|NCT03185065|11312439|FG001|STARTED|Period 3 (6 Weeks)||29
10182551|NCT03185065|11312440|FG002|STARTED|Period 3 (6 Weeks)||31
10182552|NCT03185065|11312441|FG003|STARTED|Period 3 (6 Weeks)||32
10182553|NCT03185065|11312438|FG000|COMPLETED|Period 3 (6 Weeks)||31
10182554|NCT03185065|11312439|FG001|COMPLETED|Period 3 (6 Weeks)||29
10182555|NCT03185065|11312440|FG002|COMPLETED|Period 3 (6 Weeks)||29
10182556|NCT03185065|11312441|FG003|COMPLETED|Period 3 (6 Weeks)||32
10182557|NCT03185065|11312438|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0
10182558|NCT03185065|11312439|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0
10182559|NCT03185065|11312440|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2
10182560|NCT03185065|11312441|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0
10182561|NCT03185065|11312438|FG000|STARTED|Washout (2 Weeks)||31
10182562|NCT03185065|11312439|FG001|STARTED|Washout (2 Weeks)||29
10182563|NCT03185065|11312440|FG002|STARTED|Washout (2 Weeks)||29
10182564|NCT03185065|11312441|FG003|STARTED|Washout (2 Weeks)||32
10182565|NCT03185065|11312438|FG000|COMPLETED|Washout (2 Weeks)||31
10182566|NCT03185065|11312439|FG001|COMPLETED|Washout (2 Weeks)||28
10182567|NCT03185065|11312440|FG002|COMPLETED|Washout (2 Weeks)||27
10182568|NCT03185065|11312441|FG003|COMPLETED|Washout (2 Weeks)||32
10182569|NCT03185065|11312438|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10182570|NCT03185065|11312439|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10182571|NCT03185065|11312440|FG002|NOT COMPLETED|Washout (2 Weeks)||2
10182572|NCT03185065|11312441|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10182573|NCT03185065|11312438|FG000|STARTED|Period 4 (6 Weeks)||31
10182574|NCT03185065|11312439|FG001|STARTED|Period 4 (6 Weeks)||28
10182575|NCT03185065|11312440|FG002|STARTED|Period 4 (6 Weeks)||27
10182576|NCT03185065|11312441|FG003|STARTED|Period 4 (6 Weeks)||32
10182577|NCT03185065|11312438|FG000|COMPLETED|Period 4 (6 Weeks)||31
10182578|NCT03185065|11312439|FG001|COMPLETED|Period 4 (6 Weeks)||27
10182579|NCT03185065|11312440|FG002|COMPLETED|Period 4 (6 Weeks)||26
10182580|NCT03185065|11312441|FG003|COMPLETED|Period 4 (6 Weeks)||31
10182581|NCT03185065|11312438|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0
10182582|NCT03185065|11312439|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1
10182583|NCT03185065|11312440|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1
10182584|NCT03185065|11312441|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1
10182585|NCT03185182|11312452|FG000|STARTED|Overall Study||5
10182586|NCT03185182|11312452|FG000|COMPLETED|Overall Study||5
10182587|NCT03185182|11312452|FG000|NOT COMPLETED|Overall Study||0
10182588|NCT03185455|11312459|FG000|STARTED|Overall Study||103
10182589|NCT03185455|11312460|FG001|STARTED|Overall Study||103
10182590|NCT03185455|11312459|FG000|COMPLETED|Overall Study||103
10182591|NCT03185455|11312460|FG001|COMPLETED|Overall Study||103
10182592|NCT03185455|11312459|FG000|NOT COMPLETED|Overall Study||0
10182593|NCT03185455|11312460|FG001|NOT COMPLETED|Overall Study||0
10182594|NCT03185481|11312466|FG000|STARTED|Overall Study||5
10182595|NCT03185481|11312466|FG000|COMPLETED|Overall Study||0
10182596|NCT03185481|11312466|FG000|NOT COMPLETED|Overall Study||5
10182597|NCT03185546|11312478|FG000|STARTED|Baseline Through Week 12||6
10182598|NCT03185546|11312479|FG001|STARTED|Baseline Through Week 12||10
10182599|NCT03185546|11312480|FG002|STARTED|Baseline Through Week 12||5
10182600|NCT03185546|11312481|FG003|STARTED|Baseline Through Week 12||5
10182601|NCT03185546|11312482|FG004|STARTED|Baseline Through Week 12||6
10182602|NCT03185546|11312483|FG005|STARTED|Baseline Through Week 12||6
10182603|NCT03185546|11312484|FG006|STARTED|Baseline Through Week 12||7
10182604|NCT03185546|11312485|FG007|STARTED|Baseline Through Week 12||5
10182605|NCT03185546|11312478|FG000|COMPLETED|Baseline Through Week 12||2
10182606|NCT03185546|11312479|FG001|COMPLETED|Baseline Through Week 12||7
10182607|NCT03185546|11312480|FG002|COMPLETED|Baseline Through Week 12||4
10182608|NCT03185546|11312481|FG003|COMPLETED|Baseline Through Week 12||4
10182609|NCT03185546|11312482|FG004|COMPLETED|Baseline Through Week 12||5
10182610|NCT03185546|11312483|FG005|COMPLETED|Baseline Through Week 12||4
10182611|NCT03185546|11312484|FG006|COMPLETED|Baseline Through Week 12||4
10182612|NCT03185546|11312485|FG007|COMPLETED|Baseline Through Week 12||2
10182613|NCT03185546|11312478|FG000|NOT COMPLETED|Baseline Through Week 12||4
10182614|NCT03185546|11312479|FG001|NOT COMPLETED|Baseline Through Week 12||3
10182615|NCT03185546|11312480|FG002|NOT COMPLETED|Baseline Through Week 12||1
10182616|NCT03185546|11312481|FG003|NOT COMPLETED|Baseline Through Week 12||1
10182617|NCT03185546|11312482|FG004|NOT COMPLETED|Baseline Through Week 12||1
10182618|NCT03185546|11312483|FG005|NOT COMPLETED|Baseline Through Week 12||2
10182619|NCT03185546|11312484|FG006|NOT COMPLETED|Baseline Through Week 12||3
10182620|NCT03185546|11312485|FG007|NOT COMPLETED|Baseline Through Week 12||3
10182621|NCT03185546|11312478|FG000|STARTED|Week 12 Through Day 30 Follow up||2
10182622|NCT03185546|11312479|FG001|STARTED|Week 12 Through Day 30 Follow up||7
10182623|NCT03185546|11312480|FG002|STARTED|Week 12 Through Day 30 Follow up||4
10182624|NCT03185546|11312481|FG003|STARTED|Week 12 Through Day 30 Follow up||4
10182625|NCT03185546|11312482|FG004|STARTED|Week 12 Through Day 30 Follow up||5
10182626|NCT03185546|11312483|FG005|STARTED|Week 12 Through Day 30 Follow up||4
10182627|NCT03185546|11312484|FG006|STARTED|Week 12 Through Day 30 Follow up||4
10182628|NCT03185546|11312485|FG007|STARTED|Week 12 Through Day 30 Follow up||2
10182629|NCT03185546|11312478|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2
10182630|NCT03185546|11312479|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7
10182631|NCT03185546|11312480|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4
10182632|NCT03185546|11312481|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3
10182633|NCT03185546|11312482|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5
10182634|NCT03185546|11312483|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4
10182635|NCT03185546|11312484|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3
10182636|NCT03185546|11312485|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2
10182637|NCT03185546|11312478|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10182638|NCT03185546|11312479|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10182639|NCT03185546|11312480|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10182640|NCT03185546|11312481|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
10182641|NCT03185546|11312482|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10182642|NCT03185546|11312483|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10182643|NCT03185546|11312484|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
10182644|NCT03185546|11312485|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10182645|NCT03186261|11312506|FG000|STARTED|Overall Study||22
10182646|NCT03186261|11312507|FG001|STARTED|Overall Study||22
10182647|NCT03186261|11312506|FG000|COMPLETED|Overall Study||22
10182648|NCT03186261|11312507|FG001|COMPLETED|Overall Study||22
10182649|NCT03186261|11312506|FG000|NOT COMPLETED|Overall Study||0
10182650|NCT03186261|11312507|FG001|NOT COMPLETED|Overall Study||0
10182651|NCT03186378|11312515|FG000|STARTED|Overall Study||17
10182652|NCT03186378|11312516|FG001|STARTED|Overall Study||16
10182653|NCT03186378|11312515|FG000|COMPLETED|Overall Study||16
10182654|NCT03186378|11312516|FG001|COMPLETED|Overall Study||16
10182655|NCT03186378|11312515|FG000|NOT COMPLETED|Overall Study||1
10182656|NCT03186378|11312516|FG001|NOT COMPLETED|Overall Study||0
10182657|NCT03186677|11312527|FG000|STARTED|Period 1||3
10182658|NCT03186677|11312528|FG001|STARTED|Period 1||3
10182659|NCT03186677|11312529|FG002|STARTED|Period 1||3
10182660|NCT03186677|11312530|FG003|STARTED|Period 1||0
10182661|NCT03186677|11312531|FG004|STARTED|Period 1||0
10182662|NCT03186677|11312527|FG000|COMPLETED|Period 1||3
10182663|NCT03186677|11312528|FG001|COMPLETED|Period 1||3
10182664|NCT03186677|11312529|FG002|COMPLETED|Period 1||3
10182665|NCT03186677|11312530|FG003|COMPLETED|Period 1||0
10182666|NCT03186677|11312531|FG004|COMPLETED|Period 1||0
10182667|NCT03186677|11312527|FG000|NOT COMPLETED|Period 1||0
10182668|NCT03186677|11312528|FG001|NOT COMPLETED|Period 1||0
10182669|NCT03186677|11312529|FG002|NOT COMPLETED|Period 1||0
10182670|NCT03186677|11312530|FG003|NOT COMPLETED|Period 1||0
10182671|NCT03186677|11312531|FG004|NOT COMPLETED|Period 1||0
10182672|NCT03186677|11312527|FG000|STARTED|Period 2||0
10182673|NCT03186677|11312528|FG001|STARTED|Period 2||0
10182674|NCT03186677|11312529|FG002|STARTED|Period 2||0
10182675|NCT03186677|11312530|FG003|STARTED|Period 2||5
10182676|NCT03186677|11312531|FG004|STARTED|Period 2||2
10182677|NCT03186677|11312527|FG000|COMPLETED|Period 2||0
10182678|NCT03186677|11312528|FG001|COMPLETED|Period 2||0
10182679|NCT03186677|11312529|FG002|COMPLETED|Period 2||0
10182680|NCT03186677|11312530|FG003|COMPLETED|Period 2||5
10182681|NCT03186677|11312531|FG004|COMPLETED|Period 2||2
10182682|NCT03186677|11312527|FG000|NOT COMPLETED|Period 2||0
10182683|NCT03186677|11312528|FG001|NOT COMPLETED|Period 2||0
10182684|NCT03186677|11312529|FG002|NOT COMPLETED|Period 2||0
10182685|NCT03186677|11312530|FG003|NOT COMPLETED|Period 2||0
10182686|NCT03186677|11312531|FG004|NOT COMPLETED|Period 2||0
10182687|NCT03186781|11312549|FG000|STARTED|Overall Study||5
10182688|NCT03186781|11312550|FG001|STARTED|Overall Study||5
10182689|NCT03186781|11312551|FG002|STARTED|Overall Study||10
10182690|NCT03186781|11312552|FG003|STARTED|Overall Study||10
10182691|NCT03186781|11312553|FG004|STARTED|Overall Study||10
10182692|NCT03186781|11312554|FG005|STARTED|Overall Study||10
10182693|NCT03186781|11312549|FG000|Received First Product Administration|Overall Study||5
10182694|NCT03186781|11312550|FG001|Received First Product Administration|Overall Study||5
10182695|NCT03186781|11312551|FG002|Received First Product Administration|Overall Study||10
10182696|NCT03186781|11312552|FG003|Received First Product Administration|Overall Study||10
10182697|NCT03186781|11312553|FG004|Received First Product Administration|Overall Study||10
10182698|NCT03186781|11312554|FG005|Received First Product Administration|Overall Study||10
10182699|NCT03186781|11312549|FG000|Received All Product Administrations|Overall Study||5
10182700|NCT03186781|11312550|FG001|Received All Product Administrations|Overall Study||5
10182701|NCT03186781|11312551|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
10182702|NCT03186781|11312552|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
10182703|NCT03186781|11312553|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
10182704|NCT03186781|11312554|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
10182705|NCT03186781|11312549|FG000|COMPLETED|Overall Study||5
10182706|NCT03186781|11312550|FG001|COMPLETED|Overall Study||5
10182707|NCT03186781|11312551|FG002|COMPLETED|Overall Study||9
10182708|NCT03186781|11312552|FG003|COMPLETED|Overall Study||10
10182709|NCT03186781|11312553|FG004|COMPLETED|Overall Study||7
10182710|NCT03186781|11312554|FG005|COMPLETED|Overall Study||10
10182711|NCT03186781|11312549|FG000|NOT COMPLETED|Overall Study||0
10182712|NCT03186781|11312550|FG001|NOT COMPLETED|Overall Study||0
10182713|NCT03186781|11312551|FG002|NOT COMPLETED|Overall Study||1
10182714|NCT03186781|11312552|FG003|NOT COMPLETED|Overall Study||0
10182715|NCT03186781|11312553|FG004|NOT COMPLETED|Overall Study||3
10182716|NCT03186781|11312554|FG005|NOT COMPLETED|Overall Study||0
10182717|NCT03187002|11312574|FG000|STARTED|Overall Study||55
10182718|NCT03187002|11312575|FG001|STARTED|Overall Study||54
10182719|NCT03187002|11312574|FG000|COMPLETED|Overall Study||55
10182720|NCT03187002|11312575|FG001|COMPLETED|Overall Study||54
10182721|NCT03187002|11312574|FG000|NOT COMPLETED|Overall Study||0
10182722|NCT03187002|11312575|FG001|NOT COMPLETED|Overall Study||0
10182723|NCT03187119|11312583|FG000|STARTED|Overall Study||22
10182724|NCT03187119|11312584|FG001|STARTED|Overall Study||23
10182725|NCT03187119|11312583|FG000|COMPLETED|Overall Study||20
10182726|NCT03187119|11312584|FG001|COMPLETED|Overall Study||18
10182727|NCT03187119|11312583|FG000|NOT COMPLETED|Overall Study||2
10182728|NCT03187119|11312584|FG001|NOT COMPLETED|Overall Study||5
10182729|NCT03187132|11312592|FG000|STARTED|Inpatient Trauma Only||12
10182730|NCT03187132|11312593|FG001|STARTED|Inpatient Trauma Only||12
10182731|NCT03187132|11312592|FG000|COMPLETED|Inpatient Trauma Only||8
10182732|NCT03187132|11312593|FG001|COMPLETED|Inpatient Trauma Only||0
10182733|NCT03187132|11312592|FG000|NOT COMPLETED|Inpatient Trauma Only||4
10182734|NCT03187132|11312593|FG001|NOT COMPLETED|Inpatient Trauma Only||12
10182735|NCT03187132|11312592|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
10182736|NCT03187132|11312593|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
10182737|NCT03187132|11312592|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
10182738|NCT03187132|11312593|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
10182739|NCT03187132|11312592|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
10182740|NCT03187132|11312593|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
10182741|NCT03187132|11312592|FG000|STARTED|Inpatient Trauma+Pain Clinic||11
10182742|NCT03187132|11312593|FG001|STARTED|Inpatient Trauma+Pain Clinic||7
10182743|NCT03187132|11312592|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8
10182744|NCT03187132|11312593|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0
10182745|NCT03187132|11312592|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
10182746|NCT03187132|11312593|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
10182747|NCT03187132|11312592|FG000|STARTED|Pain Clinic Only, Fully Remote||76
10182748|NCT03187132|11312593|FG001|STARTED|Pain Clinic Only, Fully Remote||118
10182749|NCT03187132|11312592|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43
10182750|NCT03187132|11312593|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64
10182751|NCT03187132|11312592|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
10182752|NCT03187132|11312593|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
10182753|NCT03187197|11312602|FG000|STARTED|Overall Study||153
10182754|NCT03187197|11312603|FG001|STARTED|Overall Study||1097
10182755|NCT03187197|11312604|FG002|STARTED|Overall Study||55
10182756|NCT03187197|11312602|FG000|Started (Eligible Participants as FAS)|Overall Study||139
10182757|NCT03187197|11312603|FG001|Started (Eligible Participants as FAS)|Overall Study||1052
10182758|NCT03187197|11312604|FG002|Started (Eligible Participants as FAS)|Overall Study||54
10182759|NCT03187197|11312602|FG000|COMPLETED|Overall Study||107
10182760|NCT03187197|11312603|FG001|COMPLETED|Overall Study||704
10182761|NCT03187197|11312604|FG002|COMPLETED|Overall Study||32
10182762|NCT03187197|11312602|FG000|NOT COMPLETED|Overall Study||46
10182763|NCT03187197|11312603|FG001|NOT COMPLETED|Overall Study||393
10182764|NCT03187197|11312604|FG002|NOT COMPLETED|Overall Study||23
10182765|NCT03187301|11312612|FG000|STARTED|Titration Period||7
10182766|NCT03187301|11312613|FG001|STARTED|Titration Period||7
10182767|NCT03187301|11312614|FG002|STARTED|Titration Period||7
10182768|NCT03187301|11312615|FG003|STARTED|Titration Period||6
10182769|NCT03187301|11312616|FG004|STARTED|Titration Period||7
10182770|NCT03187301|11312617|FG005|STARTED|Titration Period||7
10182771|NCT03187301|11312618|FG006|STARTED|Titration Period||7
10182772|NCT03187301|11312612|FG000|COMPLETED|Titration Period||7
10182773|NCT03187301|11312613|FG001|COMPLETED|Titration Period||7
10182774|NCT03187301|11312614|FG002|COMPLETED|Titration Period||7
10182775|NCT03187301|11312615|FG003|COMPLETED|Titration Period||6
10182776|NCT03187301|11312616|FG004|COMPLETED|Titration Period||7
10182777|NCT03187301|11312617|FG005|COMPLETED|Titration Period||7
10182778|NCT03187301|11312618|FG006|COMPLETED|Titration Period||0
10182779|NCT03187301|11312612|FG000|NOT COMPLETED|Titration Period||0
10182780|NCT03187301|11312613|FG001|NOT COMPLETED|Titration Period||0
10182781|NCT03187301|11312614|FG002|NOT COMPLETED|Titration Period||0
10182782|NCT03187301|11312615|FG003|NOT COMPLETED|Titration Period||0
10182783|NCT03187301|11312616|FG004|NOT COMPLETED|Titration Period||0
10182784|NCT03187301|11312617|FG005|NOT COMPLETED|Titration Period||0
10182785|NCT03187301|11312618|FG006|NOT COMPLETED|Titration Period||7
10182786|NCT03187301|11312612|FG000|STARTED|Pre-Intervention||7
10182787|NCT03187301|11312613|FG001|STARTED|Pre-Intervention||7
10182788|NCT03187301|11312614|FG002|STARTED|Pre-Intervention||7
10182789|NCT03187301|11312615|FG003|STARTED|Pre-Intervention||6
10182790|NCT03187301|11312616|FG004|STARTED|Pre-Intervention||7
10182791|NCT03187301|11312617|FG005|STARTED|Pre-Intervention||7
10182792|NCT03187301|11312618|FG006|STARTED|Pre-Intervention||0
10182793|NCT03187301|11312612|FG000|COMPLETED|Pre-Intervention||6
10182794|NCT03187301|11312613|FG001|COMPLETED|Pre-Intervention||7
10182795|NCT03187301|11312614|FG002|COMPLETED|Pre-Intervention||7
10182796|NCT03187301|11312615|FG003|COMPLETED|Pre-Intervention||6
10182797|NCT03187301|11312616|FG004|COMPLETED|Pre-Intervention||7
10182798|NCT03187301|11312617|FG005|COMPLETED|Pre-Intervention||7
10182799|NCT03187301|11312618|FG006|COMPLETED|Pre-Intervention||0
10182800|NCT03187301|11312612|FG000|NOT COMPLETED|Pre-Intervention||1
10182801|NCT03187301|11312613|FG001|NOT COMPLETED|Pre-Intervention||0
10182802|NCT03187301|11312614|FG002|NOT COMPLETED|Pre-Intervention||0
10182803|NCT03187301|11312615|FG003|NOT COMPLETED|Pre-Intervention||0
10182804|NCT03187301|11312616|FG004|NOT COMPLETED|Pre-Intervention||0
10182805|NCT03187301|11312617|FG005|NOT COMPLETED|Pre-Intervention||0
10182806|NCT03187301|11312618|FG006|NOT COMPLETED|Pre-Intervention||0
10182807|NCT03187301|11312612|FG000|STARTED|First Intervention||6
10182808|NCT03187301|11312613|FG001|STARTED|First Intervention||7
10182809|NCT03187301|11312614|FG002|STARTED|First Intervention||7
10182810|NCT03187301|11312615|FG003|STARTED|First Intervention||6
10182811|NCT03187301|11312616|FG004|STARTED|First Intervention||7
10182812|NCT03187301|11312617|FG005|STARTED|First Intervention||7
10182813|NCT03187301|11312618|FG006|STARTED|First Intervention||0
10182814|NCT03187301|11312612|FG000|COMPLETED|First Intervention||6
10182815|NCT03187301|11312613|FG001|COMPLETED|First Intervention||7
10182816|NCT03187301|11312614|FG002|COMPLETED|First Intervention||7
10182817|NCT03187301|11312615|FG003|COMPLETED|First Intervention||6
10182818|NCT03187301|11312616|FG004|COMPLETED|First Intervention||7
10182819|NCT03187301|11312617|FG005|COMPLETED|First Intervention||7
10182820|NCT03187301|11312618|FG006|COMPLETED|First Intervention||0
10182821|NCT03187301|11312612|FG000|NOT COMPLETED|First Intervention||0
10182822|NCT03187301|11312613|FG001|NOT COMPLETED|First Intervention||0
10182823|NCT03187301|11312614|FG002|NOT COMPLETED|First Intervention||0
10182824|NCT03187301|11312615|FG003|NOT COMPLETED|First Intervention||0
10182825|NCT03187301|11312616|FG004|NOT COMPLETED|First Intervention||0
10182826|NCT03187301|11312617|FG005|NOT COMPLETED|First Intervention||0
10182827|NCT03187301|11312618|FG006|NOT COMPLETED|First Intervention||0
10182828|NCT03187301|11312612|FG000|STARTED|First Washout||6
10182829|NCT03187301|11312613|FG001|STARTED|First Washout||7
10182830|NCT03187301|11312614|FG002|STARTED|First Washout||7
10182831|NCT03187301|11312615|FG003|STARTED|First Washout||6
10182832|NCT03187301|11312616|FG004|STARTED|First Washout||7
10182833|NCT03187301|11312617|FG005|STARTED|First Washout||7
10182834|NCT03187301|11312618|FG006|STARTED|First Washout||0
10182835|NCT03187301|11312612|FG000|COMPLETED|First Washout||6
10182836|NCT03187301|11312613|FG001|COMPLETED|First Washout||7
10182837|NCT03187301|11312614|FG002|COMPLETED|First Washout||7
10182838|NCT03187301|11312615|FG003|COMPLETED|First Washout||6
10182839|NCT03187301|11312616|FG004|COMPLETED|First Washout||7
10182840|NCT03187301|11312617|FG005|COMPLETED|First Washout||7
10182841|NCT03187301|11312618|FG006|COMPLETED|First Washout||0
10182842|NCT03187301|11312612|FG000|NOT COMPLETED|First Washout||0
10182843|NCT03187301|11312613|FG001|NOT COMPLETED|First Washout||0
10182844|NCT03187301|11312614|FG002|NOT COMPLETED|First Washout||0
10182845|NCT03187301|11312615|FG003|NOT COMPLETED|First Washout||0
10182846|NCT03187301|11312616|FG004|NOT COMPLETED|First Washout||0
10182847|NCT03187301|11312617|FG005|NOT COMPLETED|First Washout||0
10182848|NCT03187301|11312618|FG006|NOT COMPLETED|First Washout||0
10182849|NCT03187301|11312612|FG000|STARTED|Second Intervention||6
10182850|NCT03187301|11312613|FG001|STARTED|Second Intervention||7
10182851|NCT03187301|11312614|FG002|STARTED|Second Intervention||7
10182852|NCT03187301|11312615|FG003|STARTED|Second Intervention||6
10182853|NCT03187301|11312616|FG004|STARTED|Second Intervention||7
10182854|NCT03187301|11312617|FG005|STARTED|Second Intervention||7
10182855|NCT03187301|11312618|FG006|STARTED|Second Intervention||0
10182856|NCT03187301|11312612|FG000|COMPLETED|Second Intervention||6
10182857|NCT03187301|11312613|FG001|COMPLETED|Second Intervention||7
10182858|NCT03187301|11312614|FG002|COMPLETED|Second Intervention||7
10182859|NCT03187301|11312615|FG003|COMPLETED|Second Intervention||6
10182860|NCT03187301|11312616|FG004|COMPLETED|Second Intervention||7
10182861|NCT03187301|11312617|FG005|COMPLETED|Second Intervention||7
10182862|NCT03187301|11312618|FG006|COMPLETED|Second Intervention||0
10182863|NCT03187301|11312612|FG000|NOT COMPLETED|Second Intervention||0
10182864|NCT03187301|11312613|FG001|NOT COMPLETED|Second Intervention||0
10182865|NCT03187301|11312614|FG002|NOT COMPLETED|Second Intervention||0
10182866|NCT03187301|11312615|FG003|NOT COMPLETED|Second Intervention||0
10182867|NCT03187301|11312616|FG004|NOT COMPLETED|Second Intervention||0
10182868|NCT03187301|11312617|FG005|NOT COMPLETED|Second Intervention||0
10182869|NCT03187301|11312618|FG006|NOT COMPLETED|Second Intervention||0
10182870|NCT03187301|11312612|FG000|STARTED|Second Washout||6
10182871|NCT03187301|11312613|FG001|STARTED|Second Washout||7
10182872|NCT03187301|11312614|FG002|STARTED|Second Washout||7
10182873|NCT03187301|11312615|FG003|STARTED|Second Washout||6
10182874|NCT03187301|11312616|FG004|STARTED|Second Washout||7
10182875|NCT03187301|11312617|FG005|STARTED|Second Washout||7
10182876|NCT03187301|11312618|FG006|STARTED|Second Washout||0
10182877|NCT03187301|11312612|FG000|COMPLETED|Second Washout||6
10182878|NCT03187301|11312613|FG001|COMPLETED|Second Washout||7
10182879|NCT03187301|11312614|FG002|COMPLETED|Second Washout||7
10182880|NCT03187301|11312615|FG003|COMPLETED|Second Washout||6
10182881|NCT03187301|11312616|FG004|COMPLETED|Second Washout||7
10182882|NCT03187301|11312617|FG005|COMPLETED|Second Washout||7
10182883|NCT03187301|11312618|FG006|COMPLETED|Second Washout||0
10182884|NCT03187301|11312612|FG000|NOT COMPLETED|Second Washout||0
10182885|NCT03187301|11312613|FG001|NOT COMPLETED|Second Washout||0
10182886|NCT03187301|11312614|FG002|NOT COMPLETED|Second Washout||0
10182887|NCT03187301|11312615|FG003|NOT COMPLETED|Second Washout||0
10182888|NCT03187301|11312616|FG004|NOT COMPLETED|Second Washout||0
10182889|NCT03187301|11312617|FG005|NOT COMPLETED|Second Washout||0
10182890|NCT03187301|11312618|FG006|NOT COMPLETED|Second Washout||0
10182891|NCT03187301|11312612|FG000|STARTED|Third Intervention||6
10182892|NCT03187301|11312613|FG001|STARTED|Third Intervention||7
10182893|NCT03187301|11312614|FG002|STARTED|Third Intervention||7
10182894|NCT03187301|11312615|FG003|STARTED|Third Intervention||6
10182895|NCT03187301|11312616|FG004|STARTED|Third Intervention||7
10182896|NCT03187301|11312617|FG005|STARTED|Third Intervention||7
10182897|NCT03187301|11312618|FG006|STARTED|Third Intervention||0
10182898|NCT03187301|11312612|FG000|COMPLETED|Third Intervention||6
10182899|NCT03187301|11312613|FG001|COMPLETED|Third Intervention||7
10182900|NCT03187301|11312614|FG002|COMPLETED|Third Intervention||7
10182901|NCT03187301|11312615|FG003|COMPLETED|Third Intervention||6
10182902|NCT03187301|11312616|FG004|COMPLETED|Third Intervention||7
10182903|NCT03187301|11312617|FG005|COMPLETED|Third Intervention||7
10182904|NCT03187301|11312618|FG006|COMPLETED|Third Intervention||0
10182905|NCT03187301|11312612|FG000|NOT COMPLETED|Third Intervention||0
10182906|NCT03187301|11312613|FG001|NOT COMPLETED|Third Intervention||0
10182907|NCT03187301|11312614|FG002|NOT COMPLETED|Third Intervention||0
10182908|NCT03187301|11312615|FG003|NOT COMPLETED|Third Intervention||0
10182909|NCT03187301|11312616|FG004|NOT COMPLETED|Third Intervention||0
10182910|NCT03187301|11312617|FG005|NOT COMPLETED|Third Intervention||0
10182911|NCT03187301|11312618|FG006|NOT COMPLETED|Third Intervention||0
10182912|NCT03187418|11312639|FG000|STARTED|Overall Study||52
10182913|NCT03187418|11312639|FG000|COMPLETED|Overall Study||52
10182914|NCT03187418|11312639|FG000|NOT COMPLETED|Overall Study||0
10182915|NCT03187678|11312643|FG000|STARTED|Period 1 (Oral Selexipag)||20
10182916|NCT03187678|11312643|FG000|COMPLETED|Period 1 (Oral Selexipag)||20
10182917|NCT03187678|11312643|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0
10182918|NCT03187678|11312643|FG000|STARTED|Period 2 (Intravenous Selexipag)||20
10182919|NCT03187678|11312643|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20
10182920|NCT03187678|11312643|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
10182921|NCT03187678|11312643|FG000|STARTED|Period 3 (Oral Selexipag)||20
10182922|NCT03187678|11312643|FG000|COMPLETED|Period 3 (Oral Selexipag)||20
10182923|NCT03187678|11312643|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0
10182924|NCT03187730|11312649|FG000|STARTED|Overall Study||208
10182925|NCT03187730|11312650|FG001|STARTED|Overall Study||202
10182926|NCT03187730|11312649|FG000|COMPLETED|Overall Study||129
10182927|NCT03187730|11312650|FG001|COMPLETED|Overall Study||154
10182928|NCT03187730|11312649|FG000|NOT COMPLETED|Overall Study||79
10182929|NCT03187730|11312650|FG001|NOT COMPLETED|Overall Study||48
10182930|NCT03187756|11312656|FG000|STARTED|Overall Study||6
10182931|NCT03187756|11312656|FG000|COMPLETED|Overall Study||2
10182932|NCT03187756|11312656|FG000|NOT COMPLETED|Overall Study||4
10182933|NCT03188055|11312662|FG000|STARTED|Overall Study||48
10182934|NCT03188055|11312663|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
10182935|NCT03188055|11312664|FG002|STARTED|Overall Study||62
10182936|NCT03188055|11312665|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
10182937|NCT03188055|11312666|FG004|STARTED|Overall Study||59
10182938|NCT03188055|11312667|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
10182939|NCT03188055|11312662|FG000|Patients Who Provided Self-Consent|Overall Study||0
10182940|NCT03188055|11312663|FG001|Patients Who Provided Self-Consent|Overall Study||24
10182941|NCT03188055|11312664|FG002|Patients Who Provided Self-Consent|Overall Study||0
10182942|NCT03188055|11312665|FG003|Patients Who Provided Self-Consent|Overall Study||19
10182943|NCT03188055|11312666|FG004|Patients Who Provided Self-Consent|Overall Study||0
10182944|NCT03188055|11312667|FG005|Patients Who Provided Self-Consent|Overall Study||0
10182945|NCT03188055|11312662|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0
10182946|NCT03188055|11312663|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0
10182947|NCT03188055|11312664|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0
10182948|NCT03188055|11312665|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0
10182949|NCT03188055|11312666|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0
10182950|NCT03188055|11312667|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99
10182951|NCT03188055|11312662|FG000|MDS Post-Intervention Survey Responses|Overall Study||0
10182952|NCT03188055|11312663|FG001|MDS Post-Intervention Survey Responses|Overall Study||0
10182953|NCT03188055|11312664|FG002|MDS Post-Intervention Survey Responses|Overall Study||0
10182954|NCT03188055|11312665|FG003|MDS Post-Intervention Survey Responses|Overall Study||0
10182955|NCT03188055|11312666|FG004|MDS Post-Intervention Survey Responses|Overall Study||0
10182956|NCT03188055|11312667|FG005|MDS Post-Intervention Survey Responses|Overall Study||134
10182957|NCT03188055|11312662|FG000|Patient Survey 1|Overall Study||0
10182958|NCT03188055|11312663|FG001|Patient Survey 1|Overall Study||16
10182959|NCT03188055|11312664|FG002|Patient Survey 1|Overall Study||0
10182960|NCT03188055|11312665|FG003|Patient Survey 1|Overall Study||13
10182961|NCT03188055|11312666|FG004|Patient Survey 1|Overall Study||0
10182962|NCT03188055|11312667|FG005|Patient Survey 1|Overall Study||0
10182963|NCT03188055|11312662|FG000|Nurse Survey 1|Overall Study||0
10182964|NCT03188055|11312663|FG001|Nurse Survey 1|Overall Study||32
10182965|NCT03188055|11312664|FG002|Nurse Survey 1|Overall Study||0
10182966|NCT03188055|11312665|FG003|Nurse Survey 1|Overall Study||27
10182967|NCT03188055|11312666|FG004|Nurse Survey 1|Overall Study||0
10182968|NCT03188055|11312667|FG005|Nurse Survey 1|Overall Study||0
10182969|NCT03188055|11312662|FG000|Family Survey 1|Overall Study||0
9849816|NCT00867490|10962635|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
9849817|NCT00867503|10962642|FG000|STARTED|Overall Study||10
9849818|NCT00867503|10962642|FG000|COMPLETED|Overall Study||9
9849819|NCT00867503|10962642|FG000|NOT COMPLETED|Overall Study||1
9849820|NCT00867529|10962648|FG000|STARTED|Overall Study||63
9849821|NCT00867529|10962648|FG000|COMPLETED|Overall Study||63
9849822|NCT00867529|10962648|FG000|NOT COMPLETED|Overall Study||0
10182970|NCT03188055|11312663|FG001|Family Survey 1|Overall Study||37
10182971|NCT03188055|11312664|FG002|Family Survey 1|Overall Study||0
10182972|NCT03188055|11312665|FG003|Family Survey 1|Overall Study||38
10182973|NCT03188055|11312666|FG004|Family Survey 1|Overall Study||0
10182974|NCT03188055|11312667|FG005|Family Survey 1|Overall Study||0
10182975|NCT03188055|11312662|FG000|Family Survey 2|Overall Study||0
10182976|NCT03188055|11312663|FG001|Family Survey 2|Overall Study||34
10182977|NCT03188055|11312664|FG002|Family Survey 2|Overall Study||0
10182978|NCT03188055|11312665|FG003|Family Survey 2|Overall Study||35
10182979|NCT03188055|11312666|FG004|Family Survey 2|Overall Study||0
10182980|NCT03188055|11312667|FG005|Family Survey 2|Overall Study||0
10182981|NCT03188055|11312662|FG000|Family Survey 3|Overall Study||0
10182982|NCT03188055|11312663|FG001|Family Survey 3|Overall Study||29
10182983|NCT03188055|11312664|FG002|Family Survey 3|Overall Study||0
10182984|NCT03188055|11312665|FG003|Family Survey 3|Overall Study||26
10182985|NCT03188055|11312666|FG004|Family Survey 3|Overall Study||0
10182986|NCT03188055|11312667|FG005|Family Survey 3|Overall Study||0
10182987|NCT03188055|11312662|FG000|COMPLETED|Overall Study||48
10182988|NCT03188055|11312663|FG001|COMPLETED|Overall Study||29
10182989|NCT03188055|11312664|FG002|COMPLETED|Overall Study||43
10182990|NCT03188055|11312665|FG003|COMPLETED|Overall Study||26
10182991|NCT03188055|11312666|FG004|COMPLETED|Overall Study||59
10182992|NCT03188055|11312667|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
10182993|NCT03188055|11312662|FG000|NOT COMPLETED|Overall Study||0
10182994|NCT03188055|11312663|FG001|NOT COMPLETED|Overall Study||19
10182995|NCT03188055|11312664|FG002|NOT COMPLETED|Overall Study||19
10182996|NCT03188055|11312665|FG003|NOT COMPLETED|Overall Study||12
10182997|NCT03188055|11312666|FG004|NOT COMPLETED|Overall Study||0
10182998|NCT03188055|11312667|FG005|NOT COMPLETED|Overall Study||
10182999|NCT03188120|11312678|FG000|STARTED|Overall Study||193
10183000|NCT03188120|11312678|FG000|COMPLETED|Overall Study||146
9714804|NCT00943722|10814045|FG002|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||641
9714805|NCT00943722|10814046|FG003|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||662
9714806|NCT00943722|10814047|FG004|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||466
9714807|NCT00943722|10814048|FG005|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
9714808|NCT00943722|10814049|FG006|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
9714809|NCT00943722|10814043|FG000|COMPLETED|Base Study||623
9714810|NCT00943722|10814044|FG001|COMPLETED|Base Study||621
9714811|NCT00943722|10814045|FG002|COMPLETED|Base Study||631
9714812|NCT00943722|10814046|FG003|COMPLETED|Base Study||647
9714813|NCT00943722|10814047|FG004|COMPLETED|Base Study||444
9714814|NCT00943722|10814048|FG005|COMPLETED|Base Study||0
9714815|NCT00943722|10814049|FG006|COMPLETED|Base Study||0
9714816|NCT00943722|10814043|FG000|NOT COMPLETED|Base Study||25
9714817|NCT00943722|10814044|FG001|NOT COMPLETED|Base Study||22
9714818|NCT00943722|10814045|FG002|NOT COMPLETED|Base Study||13
9714819|NCT00943722|10814046|FG003|NOT COMPLETED|Base Study||22
10183001|NCT03188120|11312678|FG000|NOT COMPLETED|Overall Study||47
9714820|NCT00943722|10814047|FG004|NOT COMPLETED|Base Study||26
10183002|NCT03188185|11312684|FG000|STARTED|Stage 1||198
10183003|NCT03188185|11312685|FG001|STARTED|Stage 1||80
10183004|NCT03188185|11312686|FG002|STARTED|Stage 1||0
10183005|NCT03188185|11312687|FG003|STARTED|Stage 1||0
10183006|NCT03188185|11312684|FG000|COMPLETED|Stage 1||179
10183007|NCT03188185|11312685|FG001|COMPLETED|Stage 1||64
10183008|NCT03188185|11312686|FG002|COMPLETED|Stage 1||0
10183009|NCT03188185|11312687|FG003|COMPLETED|Stage 1||0
10183010|NCT03188185|11312684|FG000|NOT COMPLETED|Stage 1||19
10183011|NCT03188185|11312685|FG001|NOT COMPLETED|Stage 1||16
10183012|NCT03188185|11312686|FG002|NOT COMPLETED|Stage 1||0
10183013|NCT03188185|11312687|FG003|NOT COMPLETED|Stage 1||0
10183014|NCT03188185|11312684|FG000|STARTED|Stage 2||0
10183015|NCT03188185|11312685|FG001|STARTED|Stage 2||0
10183016|NCT03188185|11312686|FG002|STARTED|Stage 2||64
10183017|NCT03188185|11312687|FG003|STARTED|Stage 2||63
10183018|NCT03188185|11312684|FG000|COMPLETED|Stage 2||0
10183019|NCT03188185|11312685|FG001|COMPLETED|Stage 2||0
10183020|NCT03188185|11312686|FG002|COMPLETED|Stage 2||55
10183021|NCT03188185|11312687|FG003|COMPLETED|Stage 2||57
10183022|NCT03188185|11312684|FG000|NOT COMPLETED|Stage 2||0
10183023|NCT03188185|11312685|FG001|NOT COMPLETED|Stage 2||0
10183024|NCT03188185|11312686|FG002|NOT COMPLETED|Stage 2||9
10183025|NCT03188185|11312687|FG003|NOT COMPLETED|Stage 2||6
10183026|NCT03188263|11312699|FG000|STARTED|Overall Study||10
10183027|NCT03188263|11312700|FG001|STARTED|Overall Study||0
10183028|NCT03188263|11312699|FG000|COMPLETED|Overall Study||6
10183029|NCT03188263|11312700|FG001|COMPLETED|Overall Study||0
10183030|NCT03188263|11312699|FG000|NOT COMPLETED|Overall Study||4
10183031|NCT03188263|11312700|FG001|NOT COMPLETED|Overall Study||0
10183032|NCT03188523|11312708|FG000|STARTED|Overall Study||6
10183033|NCT03188523|11312709|FG001|STARTED|Overall Study||6
10183034|NCT03188523|11312710|FG002|STARTED|Overall Study||0
10183035|NCT03188523|11312711|FG003|STARTED|Overall Study||0
10183036|NCT03188523|11312708|FG000|COMPLETED|Overall Study||6
10183037|NCT03188523|11312709|FG001|COMPLETED|Overall Study||6
10183038|NCT03188523|11312710|FG002|COMPLETED|Overall Study||0
10183039|NCT03188523|11312711|FG003|COMPLETED|Overall Study||0
10183040|NCT03188523|11312708|FG000|NOT COMPLETED|Overall Study||0
10183041|NCT03188523|11312709|FG001|NOT COMPLETED|Overall Study||0
10183042|NCT03188523|11312710|FG002|NOT COMPLETED|Overall Study||0
10183043|NCT03188523|11312711|FG003|NOT COMPLETED|Overall Study||0
10183044|NCT03188536|11312717|FG000|STARTED|Overall Study||282
10183045|NCT03188536|11312717|FG000|COMPLETED|Overall Study||276
10183046|NCT03188536|11312717|FG000|NOT COMPLETED|Overall Study||6
10183047|NCT03188718|11312721|FG000|STARTED|Overall Study||45
10183048|NCT03188718|11312721|FG000|COMPLETED|Overall Study||37
10183049|NCT03188718|11312721|FG000|NOT COMPLETED|Overall Study||8
10183050|NCT03188991|11312729|FG000|STARTED|Overall Study||3
10183051|NCT03188991|11312730|FG001|STARTED|Overall Study||3
10183052|NCT03188991|11312731|FG002|STARTED|Overall Study||3
10183053|NCT03188991|11312732|FG003|STARTED|Overall Study||11
10183054|NCT03188991|11312729|FG000|COMPLETED|Overall Study||3
10183055|NCT03188991|11312730|FG001|COMPLETED|Overall Study||3
10183056|NCT03188991|11312731|FG002|COMPLETED|Overall Study||3
10183057|NCT03188991|11312732|FG003|COMPLETED|Overall Study||10
10183058|NCT03188991|11312729|FG000|NOT COMPLETED|Overall Study||0
10183059|NCT03188991|11312730|FG001|NOT COMPLETED|Overall Study||0
10183060|NCT03188991|11312731|FG002|NOT COMPLETED|Overall Study||0
10183061|NCT03188991|11312732|FG003|NOT COMPLETED|Overall Study||1
10183062|NCT03189134|11312742|FG000|STARTED|Overall Study||6
10183063|NCT03189134|11312742|FG000|COMPLETED|Overall Study||6
10183064|NCT03189134|11312742|FG000|NOT COMPLETED|Overall Study||0
10183065|NCT03189446|11312746|FG000|STARTED|Overall Study||32
10183066|NCT03189446|11312746|FG000|COMPLETED|Overall Study||27
10183067|NCT03189446|11312746|FG000|NOT COMPLETED|Overall Study||5
10183068|NCT03189524|11312753|FG000|STARTED|Overall Study||11
10183069|NCT03189524|11312754|FG001|STARTED|Overall Study||10
10183070|NCT03189524|11312755|FG002|STARTED|Overall Study||23
10183071|NCT03189524|11312753|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
10183072|NCT03189524|11312754|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10183073|NCT03189524|11312755|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23
10183074|NCT03189524|11312753|FG000|COMPLETED|Overall Study||0
10183075|NCT03189524|11312754|FG001|COMPLETED|Overall Study||0
10183076|NCT03189524|11312755|FG002|COMPLETED|Overall Study||0
10183077|NCT03189524|11312753|FG000|NOT COMPLETED|Overall Study||11
10183078|NCT03189524|11312754|FG001|NOT COMPLETED|Overall Study||10
10183079|NCT03189524|11312755|FG002|NOT COMPLETED|Overall Study||23
10183080|NCT03189589|11312769|FG000|STARTED|Overall Study||6
10183081|NCT03189589|11312770|FG001|STARTED|Overall Study||6
10183082|NCT03189589|11312769|FG000|COMPLETED|Overall Study||6
10183083|NCT03189589|11312770|FG001|COMPLETED|Overall Study||6
10183084|NCT03189589|11312769|FG000|NOT COMPLETED|Overall Study||0
10183085|NCT03189589|11312770|FG001|NOT COMPLETED|Overall Study||0
10183086|NCT03189745|11312778|FG000|STARTED|Overall Study||170
10183087|NCT03189745|11312779|FG001|STARTED|Overall Study||59
10183088|NCT03189745|11312778|FG000|COMPLETED|Overall Study||169
10183089|NCT03189745|11312779|FG001|COMPLETED|Overall Study||58
10183090|NCT03189745|11312778|FG000|NOT COMPLETED|Overall Study||1
10183091|NCT03189745|11312779|FG001|NOT COMPLETED|Overall Study||1
10183092|NCT03190005|11312792|FG000|STARTED|Overall Study||5
10183093|NCT03190005|11312793|FG001|STARTED|Overall Study||5
10183094|NCT03190005|11312794|FG002|STARTED|Overall Study||5
10183095|NCT03190005|11312795|FG003|STARTED|Overall Study||5
10183096|NCT03190005|11312796|FG004|STARTED|Overall Study||5
10183097|NCT03190005|11312797|FG005|STARTED|Overall Study||5
10183098|NCT03190005|11312798|FG006|STARTED|Overall Study||5
10183099|NCT03190005|11312792|FG000|COMPLETED|Overall Study||5
10183100|NCT03190005|11312793|FG001|COMPLETED|Overall Study||5
10183101|NCT03190005|11312794|FG002|COMPLETED|Overall Study||5
10183102|NCT03190005|11312795|FG003|COMPLETED|Overall Study||5
10183103|NCT03190005|11312796|FG004|COMPLETED|Overall Study||5
10183104|NCT03190005|11312797|FG005|COMPLETED|Overall Study||5
10183105|NCT03190005|11312798|FG006|COMPLETED|Overall Study||5
10183106|NCT03190005|11312792|FG000|NOT COMPLETED|Overall Study||0
10183107|NCT03190005|11312793|FG001|NOT COMPLETED|Overall Study||0
10183108|NCT03190005|11312794|FG002|NOT COMPLETED|Overall Study||0
10183109|NCT03190005|11312795|FG003|NOT COMPLETED|Overall Study||0
10183110|NCT03190005|11312796|FG004|NOT COMPLETED|Overall Study||0
10183111|NCT03190005|11312797|FG005|NOT COMPLETED|Overall Study||0
10183112|NCT03190005|11312798|FG006|NOT COMPLETED|Overall Study||0
10183113|NCT03190083|11312814|FG000|STARTED|Overall Study||16
10183114|NCT03190083|11312814|FG000|COMPLETED|Overall Study||16
10183115|NCT03190083|11312814|FG000|NOT COMPLETED|Overall Study||0
10183116|NCT03190213|11312818|FG000|STARTED|Overall Study||6
10183117|NCT03190213|11312818|FG000|COMPLETED|Overall Study||6
10183118|NCT03190213|11312818|FG000|NOT COMPLETED|Overall Study||0
10183119|NCT03190993|11312824|FG000|STARTED|Overall Study||10
10183120|NCT03190993|11312825|FG001|STARTED|Overall Study||10
10183121|NCT03190993|11312824|FG000|COMPLETED|Overall Study||10
10183122|NCT03190993|11312825|FG001|COMPLETED|Overall Study||10
10183123|NCT03190993|11312824|FG000|NOT COMPLETED|Overall Study||0
10183124|NCT03190993|11312825|FG001|NOT COMPLETED|Overall Study||0
10183125|NCT03191396|11312833|FG000|STARTED|Overall Study||290
10183126|NCT03191396|11312834|FG001|STARTED|Overall Study||287
10183127|NCT03191396|11312833|FG000|COMPLETED|Overall Study||287
10183128|NCT03191396|11312834|FG001|COMPLETED|Overall Study||282
10183129|NCT03191396|11312833|FG000|NOT COMPLETED|Overall Study||3
9714821|NCT00943722|10814048|FG005|NOT COMPLETED|Base Study||0
9714822|NCT00943722|10814049|FG006|NOT COMPLETED|Base Study||0
9714823|NCT00943722|10814043|FG000|STARTED|First Extension Study: EXT 1||0
9714824|NCT00943722|10814044|FG001|STARTED|First Extension Study: EXT 1||0
9714825|NCT00943722|10814045|FG002|STARTED|First Extension Study: EXT 1||0
9714826|NCT00943722|10814046|FG003|STARTED|First Extension Study: EXT 1||0
9714827|NCT00943722|10814047|FG004|STARTED|First Extension Study: EXT 1||0
9714828|NCT00943722|10814048|FG005|STARTED|First Extension Study: EXT 1||1604
9714829|NCT00943722|10814049|FG006|STARTED|First Extension Study: EXT 1||568
9714830|NCT00943722|10814043|FG000|COMPLETED|First Extension Study: EXT 1||0
9714831|NCT00943722|10814044|FG001|COMPLETED|First Extension Study: EXT 1||0
9714832|NCT00943722|10814045|FG002|COMPLETED|First Extension Study: EXT 1||0
9714833|NCT00943722|10814046|FG003|COMPLETED|First Extension Study: EXT 1||0
9714834|NCT00943722|10814047|FG004|COMPLETED|First Extension Study: EXT 1||0
9714835|NCT00943722|10814048|FG005|COMPLETED|First Extension Study: EXT 1||1489
9714836|NCT00943722|10814049|FG006|COMPLETED|First Extension Study: EXT 1||527
9714837|NCT00943722|10814043|FG000|NOT COMPLETED|First Extension Study: EXT 1||0
9714838|NCT00943722|10814044|FG001|NOT COMPLETED|First Extension Study: EXT 1||0
9714839|NCT00943722|10814045|FG002|NOT COMPLETED|First Extension Study: EXT 1||0
9714840|NCT00943722|10814046|FG003|NOT COMPLETED|First Extension Study: EXT 1||0
9714841|NCT00943722|10814047|FG004|NOT COMPLETED|First Extension Study: EXT 1||0
9714842|NCT00943722|10814048|FG005|NOT COMPLETED|First Extension Study: EXT 1||115
9714843|NCT00943722|10814049|FG006|NOT COMPLETED|First Extension Study: EXT 1||41
9714844|NCT00943722|10814043|FG000|STARTED|Second Extension Study: EXT 2||0
9714845|NCT00943722|10814044|FG001|STARTED|Second Extension Study: EXT 2||0
9714846|NCT00943722|10814045|FG002|STARTED|Second Extension Study: EXT 2||0
9714847|NCT00943722|10814046|FG003|STARTED|Second Extension Study: EXT 2||0
9714848|NCT00943722|10814047|FG004|STARTED|Second Extension Study: EXT 2||0
9714849|NCT00943722|10814048|FG005|STARTED|Second Extension Study: EXT 2||971
9714850|NCT00943722|10814049|FG006|STARTED|Second Extension Study: EXT 2||301
9714851|NCT00943722|10814043|FG000|COMPLETED|Second Extension Study: EXT 2||0
9714852|NCT00943722|10814044|FG001|COMPLETED|Second Extension Study: EXT 2||0
9714853|NCT00943722|10814045|FG002|COMPLETED|Second Extension Study: EXT 2||0
9714854|NCT00943722|10814046|FG003|COMPLETED|Second Extension Study: EXT 2||0
9714855|NCT00943722|10814047|FG004|COMPLETED|Second Extension Study: EXT 2||0
9714856|NCT00943722|10814048|FG005|COMPLETED|Second Extension Study: EXT 2||720
9714857|NCT00943722|10814049|FG006|COMPLETED|Second Extension Study: EXT 2||202
9714858|NCT00943722|10814043|FG000|NOT COMPLETED|Second Extension Study: EXT 2||0
9714859|NCT00943722|10814044|FG001|NOT COMPLETED|Second Extension Study: EXT 2||0
9714860|NCT00943722|10814045|FG002|NOT COMPLETED|Second Extension Study: EXT 2||0
9714861|NCT00943722|10814046|FG003|NOT COMPLETED|Second Extension Study: EXT 2||0
9714862|NCT00943722|10814047|FG004|NOT COMPLETED|Second Extension Study: EXT 2||0
9714863|NCT00943722|10814048|FG005|NOT COMPLETED|Second Extension Study: EXT 2||251
9714864|NCT00943722|10814049|FG006|NOT COMPLETED|Second Extension Study: EXT 2||99
10183130|NCT03191396|11312834|FG001|NOT COMPLETED|Overall Study||5
9714865|NCT00676663|10814074|FG000|STARTED|Overall Study||66
10183131|NCT03191552|11312843|FG000|STARTED|Overall Study||9
10183132|NCT03191552|11312844|FG001|STARTED|Overall Study||9
10183133|NCT03191552|11312845|FG002|STARTED|Overall Study||8
10183134|NCT03191552|11312843|FG000|COMPLETED|Overall Study||8
10183135|NCT03191552|11312844|FG001|COMPLETED|Overall Study||8
10183136|NCT03191552|11312845|FG002|COMPLETED|Overall Study||8
10183137|NCT03191552|11312843|FG000|NOT COMPLETED|Overall Study||1
10183138|NCT03191552|11312844|FG001|NOT COMPLETED|Overall Study||1
10183139|NCT03191552|11312845|FG002|NOT COMPLETED|Overall Study||0
10183140|NCT03191630|11312859|FG000|STARTED|Overall Study||30
10183141|NCT03191630|11312860|FG001|STARTED|Overall Study||30
10183142|NCT03191630|11312859|FG000|COMPLETED|Overall Study||23
10183143|NCT03191630|11312860|FG001|COMPLETED|Overall Study||23
10183144|NCT03191630|11312859|FG000|NOT COMPLETED|Overall Study||7
10183145|NCT03191630|11312860|FG001|NOT COMPLETED|Overall Study||7
10183146|NCT03191799|11312868|FG000|STARTED|Overall Study||195
10183147|NCT03191799|11312868|FG000|Received at Least One Dose of Emicizumab|Overall Study||193
10183148|NCT03191799|11312868|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
10183149|NCT03191799|11312868|FG000|COMPLETED|Overall Study||186
10183150|NCT03191799|11312868|FG000|NOT COMPLETED|Overall Study||9
10183151|NCT03192137|11312874|FG000|STARTED|Overall Study||173
10183152|NCT03192137|11312875|FG001|STARTED|Overall Study||87
10183153|NCT03192137|11312874|FG000|COMPLETED|Overall Study||123
10183154|NCT03192137|11312875|FG001|COMPLETED|Overall Study||29
10183155|NCT03192137|11312874|FG000|NOT COMPLETED|Overall Study||50
10183156|NCT03192137|11312875|FG001|NOT COMPLETED|Overall Study||58
10183157|NCT03192150|11312883|FG000|STARTED|Overall Study||163
10183158|NCT03192150|11312884|FG001|STARTED|Overall Study||83
10183159|NCT03192150|11312883|FG000|COMPLETED|Overall Study||108
10183160|NCT03192150|11312884|FG001|COMPLETED|Overall Study||29
10183161|NCT03192150|11312883|FG000|NOT COMPLETED|Overall Study||55
10183162|NCT03192150|11312884|FG001|NOT COMPLETED|Overall Study||54
10183163|NCT03192176|11312898|FG000|STARTED|Overall Study||44
10183164|NCT03192176|11312899|FG001|STARTED|Overall Study||45
10183165|NCT03192176|11312900|FG002|STARTED|Overall Study||44
10183166|NCT03192176|11312901|FG003|STARTED|Overall Study||45
10183167|NCT03192176|11312902|FG004|STARTED|Overall Study||44
10183168|NCT03192176|11312903|FG005|STARTED|Overall Study||45
10183169|NCT03192176|11312904|FG006|STARTED|Overall Study||45
10183170|NCT03192176|11312905|FG007|STARTED|Overall Study||44
10183171|NCT03192176|11312898|FG000|Treated|Overall Study||43
10183172|NCT03192176|11312899|FG001|Treated|Overall Study||45
10183173|NCT03192176|11312900|FG002|Treated|Overall Study||43
10183174|NCT03192176|11312901|FG003|Treated|Overall Study||45
10183175|NCT03192176|11312902|FG004|Treated|Overall Study||44
10183176|NCT03192176|11312903|FG005|Treated|Overall Study||43
10183177|NCT03192176|11312904|FG006|Treated|Overall Study||45
10183178|NCT03192176|11312905|FG007|Treated|Overall Study||44
10183179|NCT03192176|11312898|FG000|COMPLETED|Overall Study||37
10183180|NCT03192176|11312899|FG001|COMPLETED|Overall Study||40
10183181|NCT03192176|11312900|FG002|COMPLETED|Overall Study||38
10183182|NCT03192176|11312901|FG003|COMPLETED|Overall Study||33
10183183|NCT03192176|11312902|FG004|COMPLETED|Overall Study||32
10183184|NCT03192176|11312903|FG005|COMPLETED|Overall Study||34
10183185|NCT03192176|11312904|FG006|COMPLETED|Overall Study||36
10183186|NCT03192176|11312905|FG007|COMPLETED|Overall Study||37
10183187|NCT03192176|11312898|FG000|NOT COMPLETED|Overall Study||7
10183188|NCT03192176|11312899|FG001|NOT COMPLETED|Overall Study||5
10183189|NCT03192176|11312900|FG002|NOT COMPLETED|Overall Study||6
10183190|NCT03192176|11312901|FG003|NOT COMPLETED|Overall Study||12
10183191|NCT03192176|11312902|FG004|NOT COMPLETED|Overall Study||12
10183192|NCT03192176|11312903|FG005|NOT COMPLETED|Overall Study||11
10183193|NCT03192176|11312904|FG006|NOT COMPLETED|Overall Study||9
10183194|NCT03192176|11312905|FG007|NOT COMPLETED|Overall Study||7
10183195|NCT03192306|11312926|FG000|STARTED|Overall Study||227
10183196|NCT03192306|11312927|FG001|STARTED|Overall Study||224
10183197|NCT03192306|11312926|FG000|Modified Intent to Treat (MITT)|Overall Study||76
10183198|NCT03192306|11312927|FG001|Modified Intent to Treat (MITT)|Overall Study||80
10183199|NCT03192306|11312926|FG000|COMPLETED|Overall Study||75
10183200|NCT03192306|11312927|FG001|COMPLETED|Overall Study||79
10183201|NCT03192306|11312926|FG000|NOT COMPLETED|Overall Study||152
10183202|NCT03192306|11312927|FG001|NOT COMPLETED|Overall Study||145
10183203|NCT03192475|11312935|FG000|STARTED|Overall Study||162
10183204|NCT03192475|11312936|FG001|STARTED|Overall Study||160
10183205|NCT03192475|11312935|FG000|COMPLETED|Overall Study||149
10183206|NCT03192475|11312936|FG001|COMPLETED|Overall Study||151
10183207|NCT03192475|11312935|FG000|NOT COMPLETED|Overall Study||13
10183208|NCT03192475|11312936|FG001|NOT COMPLETED|Overall Study||9
10183209|NCT03192488|11312943|FG000|STARTED|First Intervention (d1)||1
10183210|NCT03192488|11312944|FG001|STARTED|First Intervention (d1)||5
10183211|NCT03192488|11312945|FG002|STARTED|First Intervention (d1)||2
10183212|NCT03192488|11312946|FG003|STARTED|First Intervention (d1)||1
10183213|NCT03192488|11312947|FG004|STARTED|First Intervention (d1)||1
10183214|NCT03192488|11312948|FG005|STARTED|First Intervention (d1)||1
10183215|NCT03192488|11312943|FG000|COMPLETED|First Intervention (d1)||1
10183216|NCT03192488|11312944|FG001|COMPLETED|First Intervention (d1)||5
10183217|NCT03192488|11312945|FG002|COMPLETED|First Intervention (d1)||2
10183218|NCT03192488|11312946|FG003|COMPLETED|First Intervention (d1)||1
10183219|NCT03192488|11312947|FG004|COMPLETED|First Intervention (d1)||1
10183220|NCT03192488|11312948|FG005|COMPLETED|First Intervention (d1)||1
10183221|NCT03192488|11312943|FG000|NOT COMPLETED|First Intervention (d1)||0
10183222|NCT03192488|11312944|FG001|NOT COMPLETED|First Intervention (d1)||0
10183223|NCT03192488|11312945|FG002|NOT COMPLETED|First Intervention (d1)||0
10183224|NCT03192488|11312946|FG003|NOT COMPLETED|First Intervention (d1)||0
10183225|NCT03192488|11312947|FG004|NOT COMPLETED|First Intervention (d1)||0
10183226|NCT03192488|11312948|FG005|NOT COMPLETED|First Intervention (d1)||0
10183227|NCT03192488|11312943|FG000|STARTED|First Washout (>6d)||1
10183228|NCT03192488|11312944|FG001|STARTED|First Washout (>6d)||5
10183229|NCT03192488|11312945|FG002|STARTED|First Washout (>6d)||2
10183230|NCT03192488|11312946|FG003|STARTED|First Washout (>6d)||1
10183231|NCT03192488|11312947|FG004|STARTED|First Washout (>6d)||1
10183232|NCT03192488|11312948|FG005|STARTED|First Washout (>6d)||1
10183233|NCT03192488|11312943|FG000|COMPLETED|First Washout (>6d)||1
10183234|NCT03192488|11312944|FG001|COMPLETED|First Washout (>6d)||5
10183235|NCT03192488|11312945|FG002|COMPLETED|First Washout (>6d)||1
10183236|NCT03192488|11312946|FG003|COMPLETED|First Washout (>6d)||1
10183237|NCT03192488|11312947|FG004|COMPLETED|First Washout (>6d)||1
10183238|NCT03192488|11312948|FG005|COMPLETED|First Washout (>6d)||0
10183239|NCT03192488|11312943|FG000|NOT COMPLETED|First Washout (>6d)||0
10183240|NCT03192488|11312944|FG001|NOT COMPLETED|First Washout (>6d)||0
10183241|NCT03192488|11312945|FG002|NOT COMPLETED|First Washout (>6d)||1
10183242|NCT03192488|11312946|FG003|NOT COMPLETED|First Washout (>6d)||0
10183243|NCT03192488|11312947|FG004|NOT COMPLETED|First Washout (>6d)||0
10183244|NCT03192488|11312948|FG005|NOT COMPLETED|First Washout (>6d)||1
10183245|NCT03192488|11312943|FG000|STARTED|Second Intervention (d1)||1
10183246|NCT03192488|11312944|FG001|STARTED|Second Intervention (d1)||5
10183247|NCT03192488|11312945|FG002|STARTED|Second Intervention (d1)||1
10183248|NCT03192488|11312946|FG003|STARTED|Second Intervention (d1)||1
10183249|NCT03192488|11312947|FG004|STARTED|Second Intervention (d1)||1
10183250|NCT03192488|11312948|FG005|STARTED|Second Intervention (d1)||0
10183251|NCT03192488|11312943|FG000|COMPLETED|Second Intervention (d1)||1
10183252|NCT03192488|11312944|FG001|COMPLETED|Second Intervention (d1)||5
10183253|NCT03192488|11312945|FG002|COMPLETED|Second Intervention (d1)||1
10183254|NCT03192488|11312946|FG003|COMPLETED|Second Intervention (d1)||1
10183255|NCT03192488|11312947|FG004|COMPLETED|Second Intervention (d1)||1
10183256|NCT03192488|11312948|FG005|COMPLETED|Second Intervention (d1)||0
10183257|NCT03192488|11312943|FG000|NOT COMPLETED|Second Intervention (d1)||0
10183258|NCT03192488|11312944|FG001|NOT COMPLETED|Second Intervention (d1)||0
10183259|NCT03192488|11312945|FG002|NOT COMPLETED|Second Intervention (d1)||0
10183260|NCT03192488|11312946|FG003|NOT COMPLETED|Second Intervention (d1)||0
10183261|NCT03192488|11312947|FG004|NOT COMPLETED|Second Intervention (d1)||0
10183262|NCT03192488|11312948|FG005|NOT COMPLETED|Second Intervention (d1)||0
10183263|NCT03192488|11312943|FG000|STARTED|Second Washout (>6d)||1
10183264|NCT03192488|11312944|FG001|STARTED|Second Washout (>6d)||5
10183265|NCT03192488|11312945|FG002|STARTED|Second Washout (>6d)||1
10183266|NCT03192488|11312946|FG003|STARTED|Second Washout (>6d)||1
10183267|NCT03192488|11312947|FG004|STARTED|Second Washout (>6d)||1
10183268|NCT03192488|11312948|FG005|STARTED|Second Washout (>6d)||0
10183269|NCT03192488|11312943|FG000|COMPLETED|Second Washout (>6d)||1
10183270|NCT03192488|11312944|FG001|COMPLETED|Second Washout (>6d)||5
10183271|NCT03192488|11312945|FG002|COMPLETED|Second Washout (>6d)||1
10183272|NCT03192488|11312946|FG003|COMPLETED|Second Washout (>6d)||1
10183273|NCT03192488|11312947|FG004|COMPLETED|Second Washout (>6d)||1
10183274|NCT03192488|11312948|FG005|COMPLETED|Second Washout (>6d)||0
10183275|NCT03192488|11312943|FG000|NOT COMPLETED|Second Washout (>6d)||0
10183276|NCT03192488|11312944|FG001|NOT COMPLETED|Second Washout (>6d)||0
10183277|NCT03192488|11312945|FG002|NOT COMPLETED|Second Washout (>6d)||0
10183278|NCT03192488|11312946|FG003|NOT COMPLETED|Second Washout (>6d)||0
10183279|NCT03192488|11312947|FG004|NOT COMPLETED|Second Washout (>6d)||0
10183280|NCT03192488|11312948|FG005|NOT COMPLETED|Second Washout (>6d)||0
10183281|NCT03192488|11312943|FG000|STARTED|Third Intervention (d1)||1
10183282|NCT03192488|11312944|FG001|STARTED|Third Intervention (d1)||5
10183283|NCT03192488|11312945|FG002|STARTED|Third Intervention (d1)||1
10183284|NCT03192488|11312946|FG003|STARTED|Third Intervention (d1)||1
10183285|NCT03192488|11312947|FG004|STARTED|Third Intervention (d1)||1
10183286|NCT03192488|11312948|FG005|STARTED|Third Intervention (d1)||0
10183287|NCT03192488|11312943|FG000|COMPLETED|Third Intervention (d1)||1
10183288|NCT03192488|11312944|FG001|COMPLETED|Third Intervention (d1)||5
10183289|NCT03192488|11312945|FG002|COMPLETED|Third Intervention (d1)||1
10183290|NCT03192488|11312946|FG003|COMPLETED|Third Intervention (d1)||1
10183291|NCT03192488|11312947|FG004|COMPLETED|Third Intervention (d1)||0
10183292|NCT03192488|11312948|FG005|COMPLETED|Third Intervention (d1)||0
10183293|NCT03192488|11312943|FG000|NOT COMPLETED|Third Intervention (d1)||0
10183294|NCT03192488|11312944|FG001|NOT COMPLETED|Third Intervention (d1)||0
10183295|NCT03192488|11312945|FG002|NOT COMPLETED|Third Intervention (d1)||0
10183296|NCT03192488|11312946|FG003|NOT COMPLETED|Third Intervention (d1)||0
10183297|NCT03192488|11312947|FG004|NOT COMPLETED|Third Intervention (d1)||1
10183298|NCT03192488|11312948|FG005|NOT COMPLETED|Third Intervention (d1)||0
10183299|NCT03192826|11312965|FG000|STARTED|Overall Study||27
10183300|NCT03192826|11312966|FG001|STARTED|Overall Study||27
10183301|NCT03192826|11312967|FG002|STARTED|Overall Study||25
10183302|NCT03192826|11312965|FG000|COMPLETED|Overall Study||27
10183303|NCT03192826|11312966|FG001|COMPLETED|Overall Study||27
10183304|NCT03192826|11312967|FG002|COMPLETED|Overall Study||25
10183305|NCT03192826|11312965|FG000|NOT COMPLETED|Overall Study||0
10183306|NCT03192826|11312966|FG001|NOT COMPLETED|Overall Study||0
10183307|NCT03192826|11312967|FG002|NOT COMPLETED|Overall Study||0
10183308|NCT03192904|11312977|FG000|STARTED|Overall Study||35
10183309|NCT03192904|11312978|FG001|STARTED|Overall Study||35
10183310|NCT03192904|11312977|FG000|COMPLETED|Overall Study||32
10183311|NCT03192904|11312978|FG001|COMPLETED|Overall Study||33
10183312|NCT03192904|11312977|FG000|NOT COMPLETED|Overall Study||3
10183313|NCT03192904|11312978|FG001|NOT COMPLETED|Overall Study||2
10183314|NCT03193021|11312986|FG000|STARTED|Overall Study||100
10183315|NCT03193021|11312987|FG001|STARTED|Overall Study||104
10183316|NCT03193021|11312986|FG000|COMPLETED|Overall Study||99
10183317|NCT03193021|11312987|FG001|COMPLETED|Overall Study||103
10183318|NCT03193021|11312986|FG000|NOT COMPLETED|Overall Study||1
10183319|NCT03193021|11312987|FG001|NOT COMPLETED|Overall Study||1
10183320|NCT03193047|11312995|FG000|STARTED|Overall Study||31
10183321|NCT03193047|11312996|FG001|STARTED|Overall Study||28
10183322|NCT03193047|11312995|FG000|COMPLETED|Overall Study||29
10183323|NCT03193047|11312996|FG001|COMPLETED|Overall Study||28
10183324|NCT03193047|11312995|FG000|NOT COMPLETED|Overall Study||2
10183325|NCT03193047|11312996|FG001|NOT COMPLETED|Overall Study||0
10183326|NCT03193398|11313006|FG000|STARTED|Overall Study||53
10183327|NCT03193398|11313007|FG001|STARTED|Overall Study||51
10183328|NCT03193398|11313006|FG000|COMPLETED|Overall Study||38
10183329|NCT03193398|11313007|FG001|COMPLETED|Overall Study||35
10183330|NCT03193398|11313006|FG000|NOT COMPLETED|Overall Study||15
10183331|NCT03193398|11313007|FG001|NOT COMPLETED|Overall Study||16
10183332|NCT03193593|11313020|FG000|STARTED|Overall Study||18
10183333|NCT03193593|11313021|FG001|STARTED|Overall Study||4
10183334|NCT03193593|11313022|FG002|STARTED|Overall Study||4
10183335|NCT03193593|11313023|FG003|STARTED|Overall Study||4
10183336|NCT03193593|11313024|FG004|STARTED|Overall Study||8
10183337|NCT03193593|11313025|FG005|STARTED|Overall Study||16
10183338|NCT03193593|11313026|FG006|STARTED|Overall Study||12
10183339|NCT03193593|11313020|FG000|COMPLETED|Overall Study||14
10183340|NCT03193593|11313021|FG001|COMPLETED|Overall Study||3
10183341|NCT03193593|11313022|FG002|COMPLETED|Overall Study||3
10183342|NCT03193593|11313023|FG003|COMPLETED|Overall Study||4
10183343|NCT03193593|11313024|FG004|COMPLETED|Overall Study||7
10183344|NCT03193593|11313025|FG005|COMPLETED|Overall Study||13
10183345|NCT03193593|11313026|FG006|COMPLETED|Overall Study||8
10183346|NCT03193593|11313020|FG000|NOT COMPLETED|Overall Study||4
10183347|NCT03193593|11313021|FG001|NOT COMPLETED|Overall Study||1
10183348|NCT03193593|11313022|FG002|NOT COMPLETED|Overall Study||1
10183349|NCT03193593|11313023|FG003|NOT COMPLETED|Overall Study||0
10183350|NCT03193593|11313024|FG004|NOT COMPLETED|Overall Study||1
10183351|NCT03193593|11313025|FG005|NOT COMPLETED|Overall Study||3
10183352|NCT03193593|11313026|FG006|NOT COMPLETED|Overall Study||4
10183353|NCT03193736|11313042|FG000|STARTED|Overall Study||26
10183354|NCT03193736|11313042|FG000|Received Implant|Overall Study||25
10183355|NCT03193736|11313042|FG000|COMPLETED|Overall Study||21
10183356|NCT03193736|11313042|FG000|NOT COMPLETED|Overall Study||5
10183357|NCT03194217|11313050|FG000|STARTED|Overall Study||60
10183358|NCT03194217|11313051|FG001|STARTED|Overall Study||60
10183359|NCT03194217|11313052|FG002|STARTED|Overall Study||60
10183360|NCT03194217|11313053|FG003|STARTED|Overall Study||64
10183361|NCT03194217|11313050|FG000|COMPLETED|Overall Study||60
10183362|NCT03194217|11313051|FG001|COMPLETED|Overall Study||57
10183363|NCT03194217|11313052|FG002|COMPLETED|Overall Study||56
10183364|NCT03194217|11313053|FG003|COMPLETED|Overall Study||60
10183365|NCT03194217|11313050|FG000|NOT COMPLETED|Overall Study||0
10183366|NCT03194217|11313051|FG001|NOT COMPLETED|Overall Study||3
10183367|NCT03194217|11313052|FG002|NOT COMPLETED|Overall Study||4
10183368|NCT03194217|11313053|FG003|NOT COMPLETED|Overall Study||4
10183369|NCT03194334|11313066|FG000|STARTED|0-3 Months||10
10183370|NCT03194334|11313067|FG001|STARTED|0-3 Months||15
10183371|NCT03194334|11313068|FG002|STARTED|0-3 Months||15
10183372|NCT03194334|11313066|FG000|COMPLETED|0-3 Months||10
10183373|NCT03194334|11313067|FG001|COMPLETED|0-3 Months||15
10183374|NCT03194334|11313068|FG002|COMPLETED|0-3 Months||14
10183375|NCT03194334|11313066|FG000|NOT COMPLETED|0-3 Months||0
10183376|NCT03194334|11313067|FG001|NOT COMPLETED|0-3 Months||0
10183377|NCT03194334|11313068|FG002|NOT COMPLETED|0-3 Months||1
10183378|NCT03194334|11313066|FG000|STARTED|3-6 Months||10
10183379|NCT03194334|11313067|FG001|STARTED|3-6 Months||15
10183380|NCT03194334|11313068|FG002|STARTED|3-6 Months||14
10183381|NCT03194334|11313066|FG000|COMPLETED|3-6 Months||10
10183382|NCT03194334|11313067|FG001|COMPLETED|3-6 Months||15
10183383|NCT03194334|11313068|FG002|COMPLETED|3-6 Months||14
10183384|NCT03194334|11313066|FG000|NOT COMPLETED|3-6 Months||0
10183385|NCT03194334|11313067|FG001|NOT COMPLETED|3-6 Months||0
10183386|NCT03194334|11313068|FG002|NOT COMPLETED|3-6 Months||0
10183387|NCT03194373|11313077|FG000|STARTED|Overall Study||20
10183388|NCT03194373|11313077|FG000|Received Palbociclib and Carboplatin|Overall Study||19
10183389|NCT03194373|11313077|FG000|COMPLETED|Overall Study||18
10183390|NCT03194373|11313077|FG000|NOT COMPLETED|Overall Study||2
10183391|NCT03194464|11313081|FG000|STARTED|Overall Study||15
10183392|NCT03194464|11313081|FG000|COMPLETED|Overall Study||13
10183393|NCT03194464|11313081|FG000|NOT COMPLETED|Overall Study||2
10183394|NCT03194490|11313089|FG000|STARTED|Overall Study||20
10183395|NCT03194490|11313090|FG001|STARTED|Overall Study||23
10183396|NCT03194490|11313089|FG000|COMPLETED|Overall Study||18
10183397|NCT03194490|11313090|FG001|COMPLETED|Overall Study||20
10183398|NCT03194490|11313089|FG000|NOT COMPLETED|Overall Study||2
10183399|NCT03194490|11313090|FG001|NOT COMPLETED|Overall Study||3
10183400|NCT03194503|11313099|FG000|STARTED|Overall Study||458
10183401|NCT03194503|11313100|FG001|STARTED|Overall Study||1054
10183402|NCT03194503|11313099|FG000|COMPLETED|Overall Study||458
10183403|NCT03194503|11313100|FG001|COMPLETED|Overall Study||1054
10183404|NCT03194503|11313099|FG000|NOT COMPLETED|Overall Study||0
10183405|NCT03194503|11313100|FG001|NOT COMPLETED|Overall Study||0
10183406|NCT03194698|11313110|FG000|STARTED|Overall Study||10
10183407|NCT03194698|11313111|FG001|STARTED|Overall Study||10
10183408|NCT03194698|11313110|FG000|COMPLETED|Overall Study||10
10183409|NCT03194698|11313111|FG001|COMPLETED|Overall Study||10
10183410|NCT03194698|11313110|FG000|NOT COMPLETED|Overall Study||0
10183411|NCT03194698|11313111|FG001|NOT COMPLETED|Overall Study||0
10183412|NCT03194737|11313119|FG000|STARTED|Overall Study||52
10183413|NCT03194737|11313120|FG001|STARTED|Overall Study||49
10183414|NCT03194737|11313119|FG000|COMPLETED|Overall Study||47
10183415|NCT03194737|11313120|FG001|COMPLETED|Overall Study||49
10183416|NCT03194737|11313119|FG000|NOT COMPLETED|Overall Study||5
10183417|NCT03194737|11313120|FG001|NOT COMPLETED|Overall Study||0
10183418|NCT03194776|11313128|FG000|STARTED|Overall Study||23
10183419|NCT03194776|11313129|FG001|STARTED|Overall Study||23
10183420|NCT03194776|11313128|FG000|COMPLETED|Overall Study||23
10183421|NCT03194776|11313129|FG001|COMPLETED|Overall Study||23
10183422|NCT03194776|11313128|FG000|NOT COMPLETED|Overall Study||0
10183423|NCT03194776|11313129|FG001|NOT COMPLETED|Overall Study||0
10183424|NCT03195010|11313138|FG000|STARTED|Overall Study||2
10183425|NCT03195010|11313139|FG001|STARTED|Overall Study||2
10183426|NCT03195010|11313138|FG000|COMPLETED|Overall Study||2
10183427|NCT03195010|11313139|FG001|COMPLETED|Overall Study||2
10183428|NCT03195010|11313138|FG000|NOT COMPLETED|Overall Study||0
10183429|NCT03195010|11313139|FG001|NOT COMPLETED|Overall Study||0
10183430|NCT03195517|11313147|FG000|STARTED|Overall Study||33
10183431|NCT03195517|11313147|FG000|COMPLETED|Overall Study||33
10183432|NCT03195517|11313147|FG000|NOT COMPLETED|Overall Study||0
10183433|NCT03196076|11313158|FG000|STARTED|Overall Study||5
10183434|NCT03196076|11313159|FG001|STARTED|Overall Study||20
10183435|NCT03196076|11313160|FG002|STARTED|Overall Study||0
10183436|NCT03196076|11313158|FG000|COMPLETED|Overall Study||5
10183437|NCT03196076|11313159|FG001|COMPLETED|Overall Study||20
10183438|NCT03196076|11313160|FG002|COMPLETED|Overall Study||0
10183439|NCT03196076|11313158|FG000|NOT COMPLETED|Overall Study||0
10183440|NCT03196076|11313159|FG001|NOT COMPLETED|Overall Study||0
10183441|NCT03196076|11313160|FG002|NOT COMPLETED|Overall Study||0
10183442|NCT03196193|11313170|FG000|STARTED|Overall Study||121
10183443|NCT03196193|11313171|FG001|STARTED|Overall Study||119
10183444|NCT03196193|11313170|FG000|COMPLETED|Overall Study||118
10183445|NCT03196193|11313171|FG001|COMPLETED|Overall Study||119
10183446|NCT03196193|11313170|FG000|NOT COMPLETED|Overall Study||3
10183447|NCT03196193|11313171|FG001|NOT COMPLETED|Overall Study||0
10183448|NCT03196232|11313177|FG000|STARTED|Overall Study||3
10183449|NCT03196232|11313177|FG000|COMPLETED|Overall Study||3
10183450|NCT03196232|11313177|FG000|NOT COMPLETED|Overall Study||0
10183451|NCT03196284|11313183|FG000|STARTED|Main Part||17
10183452|NCT03196284|11313184|FG001|STARTED|Main Part||9
10183453|NCT03196284|11313185|FG002|STARTED|Main Part||0
10183454|NCT03196284|11313183|FG000|Concizumab 0.15 mg/kg|Main Part||15
10183455|NCT03196284|11313184|FG001|Concizumab 0.15 mg/kg|Main Part||0
10183456|NCT03196284|11313185|FG002|Concizumab 0.15 mg/kg|Main Part||0
10183457|NCT03196284|11313183|FG000|Concizumab 0.20 mg/kg|Main Part||2
10183458|NCT03196284|11313184|FG001|Concizumab 0.20 mg/kg|Main Part||0
10183459|NCT03196284|11313185|FG002|Concizumab 0.20 mg/kg|Main Part||0
10183460|NCT03196284|11313183|FG000|Concizumab 0.25 mg/kg|Main Part||0
10183461|NCT03196284|11313184|FG001|Concizumab 0.25 mg/kg|Main Part||0
10183462|NCT03196284|11313185|FG002|Concizumab 0.25 mg/kg|Main Part||0
10183463|NCT03196284|11313183|FG000|COMPLETED|Main Part||17
10183464|NCT03196284|11313184|FG001|COMPLETED|Main Part||8
10183465|NCT03196284|11313185|FG002|COMPLETED|Main Part||0
10183466|NCT03196284|11313183|FG000|NOT COMPLETED|Main Part||0
10183467|NCT03196284|11313184|FG001|NOT COMPLETED|Main Part||1
10183468|NCT03196284|11313185|FG002|NOT COMPLETED|Main Part||0
10183469|NCT03196284|11313183|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0
10183470|NCT03196284|11313184|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0
10183471|NCT03196284|11313185|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25
10183472|NCT03196284|11313183|FG000|Concizumab 0.15 mg/kg|Extension Part||0
10183473|NCT03196284|11313184|FG001|Concizumab 0.15 mg/kg|Extension Part||0
10183474|NCT03196284|11313185|FG002|Concizumab 0.15 mg/kg|Extension Part||12
10183475|NCT03196284|11313183|FG000|Concizumab 0.20 mg/kg|Extension Part||0
10183476|NCT03196284|11313184|FG001|Concizumab 0.20 mg/kg|Extension Part||0
10183477|NCT03196284|11313185|FG002|Concizumab 0.20 mg/kg|Extension Part||9
10183478|NCT03196284|11313183|FG000|Concizumab 0.25 mg/kg|Extension Part||0
10183479|NCT03196284|11313184|FG001|Concizumab 0.25 mg/kg|Extension Part||0
10183480|NCT03196284|11313185|FG002|Concizumab 0.25 mg/kg|Extension Part||4
10183481|NCT03196284|11313183|FG000|COMPLETED|Extension Part||0
10183482|NCT03196284|11313184|FG001|COMPLETED|Extension Part||0
10183483|NCT03196284|11313185|FG002|COMPLETED|Extension Part||22
10183484|NCT03196284|11313183|FG000|NOT COMPLETED|Extension Part||0
10183485|NCT03196284|11313184|FG001|NOT COMPLETED|Extension Part||0
10183486|NCT03196284|11313185|FG002|NOT COMPLETED|Extension Part||3
10183487|NCT03196297|11313205|FG000|STARTED|Main Period||36
10183488|NCT03196297|11313205|FG000|Full Analysis Set (FAS)|Main Period||36
10183489|NCT03196297|11313205|FG000|Subject Analysis Set (SAS)|Main Period||36
10183490|NCT03196297|11313205|FG000|COMPLETED|Main Period||32
10183491|NCT03196297|11313205|FG000|NOT COMPLETED|Main Period||4
10183492|NCT03196297|11313205|FG000|STARTED|Extension Period||32
10183493|NCT03196297|11313205|FG000|FAS|Extension Period||32
10183494|NCT03196297|11313205|FG000|SAS|Extension Period||32
10183495|NCT03196297|11313205|FG000|COMPLETED|Extension Period||29
10183496|NCT03196297|11313205|FG000|NOT COMPLETED|Extension Period||3
10183497|NCT03196349|11313224|FG000|STARTED|Overall Study||17
10183498|NCT03196349|11313225|FG001|STARTED|Overall Study||14
10183499|NCT03196349|11313226|FG002|STARTED|Overall Study||13
10183500|NCT03196349|11313224|FG000|COMPLETED|Overall Study||0
10183501|NCT03196349|11313225|FG001|COMPLETED|Overall Study||0
10183502|NCT03196349|11313226|FG002|COMPLETED|Overall Study||0
10183503|NCT03196349|11313224|FG000|NOT COMPLETED|Overall Study||17
10183504|NCT03196349|11313225|FG001|NOT COMPLETED|Overall Study||14
10183505|NCT03196349|11313226|FG002|NOT COMPLETED|Overall Study||13
10183506|NCT03196505|11313236|FG000|STARTED|Overall Study||115
10183507|NCT03196505|11313237|FG001|STARTED|Overall Study||116
10183508|NCT03196505|11313236|FG000|COMPLETED|Overall Study||89
10183509|NCT03196505|11313237|FG001|COMPLETED|Overall Study||90
10183510|NCT03196505|11313236|FG000|NOT COMPLETED|Overall Study||26
10183511|NCT03196505|11313237|FG001|NOT COMPLETED|Overall Study||26
10183512|NCT03196635|11313243|FG000|STARTED|Overall Study||31
10183513|NCT03196635|11313243|FG000|COMPLETED|Overall Study||30
10183514|NCT03196635|11313243|FG000|NOT COMPLETED|Overall Study||1
10183515|NCT03196791|11313263|FG000|STARTED|Overall Study||98
10183516|NCT03196791|11313264|FG001|STARTED|Overall Study||98
10183517|NCT03196791|11313263|FG000|COMPLETED|Overall Study||88
10183518|NCT03196791|11313264|FG001|COMPLETED|Overall Study||93
10183519|NCT03196791|11313263|FG000|NOT COMPLETED|Overall Study||10
10183520|NCT03196791|11313264|FG001|NOT COMPLETED|Overall Study||5
10183521|NCT03196973|11313273|FG000|STARTED|Overall Study||197
10183522|NCT03196973|11313274|FG001|STARTED|Overall Study||196
10183523|NCT03196973|11313275|FG002|STARTED|Overall Study||100
10183524|NCT03196973|11313273|FG000|COMPLETED|Overall Study||188
10183525|NCT03196973|11313274|FG001|COMPLETED|Overall Study||184
10183526|NCT03196973|11313275|FG002|COMPLETED|Overall Study||95
10183527|NCT03196973|11313273|FG000|NOT COMPLETED|Overall Study||9
10183528|NCT03196973|11313274|FG001|NOT COMPLETED|Overall Study||12
10183529|NCT03196973|11313275|FG002|NOT COMPLETED|Overall Study||5
10183530|NCT03197025|11313283|FG000|STARTED|Overall Study||1
10183531|NCT03197025|11313283|FG000|COMPLETED|Overall Study||1
10183532|NCT03197025|11313283|FG000|NOT COMPLETED|Overall Study||0
10183533|NCT03197038|11313289|FG000|STARTED|Overall Study||22
10183534|NCT03197038|11313290|FG001|STARTED|Overall Study||17
10183535|NCT03197038|11313289|FG000|COMPLETED|Overall Study||18
10183536|NCT03197038|11313290|FG001|COMPLETED|Overall Study||17
10183537|NCT03197038|11313289|FG000|NOT COMPLETED|Overall Study||4
10183538|NCT03197038|11313290|FG001|NOT COMPLETED|Overall Study||0
10183539|NCT03197129|11313298|FG000|STARTED|Overall Study||60
10183540|NCT03197129|11313299|FG001|STARTED|Overall Study||62
10183541|NCT03197129|11313298|FG000|COMPLETED|Overall Study||56
10183542|NCT03197129|11313299|FG001|COMPLETED|Overall Study||57
10183543|NCT03197129|11313298|FG000|NOT COMPLETED|Overall Study||4
10183544|NCT03197129|11313299|FG001|NOT COMPLETED|Overall Study||5
10183545|NCT03197324|11313307|FG000|STARTED|Overall Study||10
10183546|NCT03197324|11313308|FG001|STARTED|Overall Study||10
10183547|NCT03197324|11313307|FG000|COMPLETED|Overall Study||10
10183548|NCT03197324|11313308|FG001|COMPLETED|Overall Study||9
10183549|NCT03197324|11313307|FG000|NOT COMPLETED|Overall Study||0
10183550|NCT03197324|11313308|FG001|NOT COMPLETED|Overall Study||1
10183551|NCT03197376|11313318|FG000|STARTED|Primary and Booster Phase||502
10183552|NCT03197376|11313319|FG001|STARTED|Primary and Booster Phase||501
10183553|NCT03197376|11313320|FG002|STARTED|Primary and Booster Phase||500
10183554|NCT03197376|11313321|FG003|STARTED|Primary and Booster Phase||747
10183555|NCT03197376|11313318|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502
10183556|NCT03197376|11313319|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501
10183557|NCT03197376|11313320|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500
10183558|NCT03197376|11313321|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747
10183559|NCT03197376|11313318|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495
10183560|NCT03197376|11313319|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495
10183561|NCT03197376|11313320|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491
10183562|NCT03197376|11313321|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738
10183563|NCT03197376|11313318|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492
10183564|NCT03197376|11313319|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493
10183565|NCT03197376|11313320|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490
10183566|NCT03197376|11313321|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731
10183567|NCT03197376|11313318|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251
10183568|NCT03197376|11313319|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243
10183569|NCT03197376|11313320|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257
10183570|NCT03197376|11313321|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364
10183571|NCT03197376|11313318|FG000|Booster Cohort|Primary and Booster Phase||150
10183572|NCT03197376|11313319|FG001|Booster Cohort|Primary and Booster Phase||151
10183573|NCT03197376|11313320|FG002|Booster Cohort|Primary and Booster Phase||150
10183574|NCT03197376|11313321|FG003|Booster Cohort|Primary and Booster Phase||224
10183575|NCT03197376|11313318|FG000|Received Booster Vaccine|Primary and Booster Phase||145
10183576|NCT03197376|11313319|FG001|Received Booster Vaccine|Primary and Booster Phase||144
10183577|NCT03197376|11313320|FG002|Received Booster Vaccine|Primary and Booster Phase||139
10183578|NCT03197376|11313321|FG003|Received Booster Vaccine|Primary and Booster Phase||213
10183579|NCT03197376|11313318|FG000|COMPLETED|Primary and Booster Phase||487
10183580|NCT03197376|11313319|FG001|COMPLETED|Primary and Booster Phase||488
10183581|NCT03197376|11313320|FG002|COMPLETED|Primary and Booster Phase||480
10183582|NCT03197376|11313321|FG003|COMPLETED|Primary and Booster Phase||722
10183583|NCT03197376|11313318|FG000|NOT COMPLETED|Primary and Booster Phase||15
10183584|NCT03197376|11313319|FG001|NOT COMPLETED|Primary and Booster Phase||13
10183585|NCT03197376|11313320|FG002|NOT COMPLETED|Primary and Booster Phase||20
10183586|NCT03197376|11313321|FG003|NOT COMPLETED|Primary and Booster Phase||25
10183587|NCT03197376|11313318|FG000|STARTED|Immune Persistence Phase||132
10183588|NCT03197376|11313319|FG001|STARTED|Immune Persistence Phase||133
10183589|NCT03197376|11313320|FG002|STARTED|Immune Persistence Phase||128
10183590|NCT03197376|11313321|FG003|STARTED|Immune Persistence Phase||195
10183591|NCT03197376|11313318|FG000|COMPLETED|Immune Persistence Phase||127
10183592|NCT03197376|11313319|FG001|COMPLETED|Immune Persistence Phase||129
10183593|NCT03197376|11313320|FG002|COMPLETED|Immune Persistence Phase||123
10183594|NCT03197376|11313321|FG003|COMPLETED|Immune Persistence Phase||190
9714866|NCT00676663|10814075|FG001|STARTED|Overall Study||64
9714867|NCT00676663|10814074|FG000|COMPLETED|Overall Study||21
9714868|NCT00676663|10814075|FG001|COMPLETED|Overall Study||26
10183595|NCT03197376|11313318|FG000|NOT COMPLETED|Immune Persistence Phase||5
10183596|NCT03197376|11313319|FG001|NOT COMPLETED|Immune Persistence Phase||4
10183597|NCT03197376|11313320|FG002|NOT COMPLETED|Immune Persistence Phase||5
10183598|NCT03197376|11313321|FG003|NOT COMPLETED|Immune Persistence Phase||5
10183599|NCT03197389|11313360|FG000|STARTED|Overall Study||16
10183600|NCT03197389|11313361|FG001|STARTED|Overall Study||5
10183601|NCT03197389|11313362|FG002|STARTED|Overall Study||18
10183602|NCT03197389|11313363|FG003|STARTED|Overall Study||9
10183603|NCT03197389|11313364|FG004|STARTED|Overall Study||1
10183604|NCT03197389|11313365|FG005|STARTED|Overall Study||5
10183605|NCT03197389|11313360|FG000|COMPLETED|Overall Study||16
10183606|NCT03197389|11313361|FG001|COMPLETED|Overall Study||5
10183607|NCT03197389|11313362|FG002|COMPLETED|Overall Study||18
10183608|NCT03197389|11313363|FG003|COMPLETED|Overall Study||9
10183609|NCT03197389|11313364|FG004|COMPLETED|Overall Study||1
10183610|NCT03197389|11313365|FG005|COMPLETED|Overall Study||5
10183611|NCT03197389|11313360|FG000|NOT COMPLETED|Overall Study||0
10183612|NCT03197389|11313361|FG001|NOT COMPLETED|Overall Study||0
10183613|NCT03197389|11313362|FG002|NOT COMPLETED|Overall Study||0
10183614|NCT03197389|11313363|FG003|NOT COMPLETED|Overall Study||0
10183615|NCT03197389|11313364|FG004|NOT COMPLETED|Overall Study||0
10183616|NCT03197389|11313365|FG005|NOT COMPLETED|Overall Study||0
10183617|NCT03197558|11313379|FG000|STARTED|Overall Study||30
10183618|NCT03197558|11313379|FG000|COMPLETED|Overall Study||29
10183619|NCT03197558|11313379|FG000|NOT COMPLETED|Overall Study||1
10183620|NCT03197883|11313385|FG000|STARTED|Overall Study||50
10183621|NCT03197883|11313386|FG001|STARTED|Overall Study||50
10183622|NCT03197883|11313385|FG000|COMPLETED|Overall Study||47
10183623|NCT03197883|11313386|FG001|COMPLETED|Overall Study||44
10183624|NCT03197883|11313385|FG000|NOT COMPLETED|Overall Study||3
10183625|NCT03197883|11313386|FG001|NOT COMPLETED|Overall Study||6
10183626|NCT03198000|11313395|FG000|STARTED|Overall Study||41
10183627|NCT03198000|11313396|FG001|STARTED|Overall Study||38
10183628|NCT03198000|11313397|FG002|STARTED|Overall Study||41
10183629|NCT03198000|11313395|FG000|COMPLETED|Overall Study||41
10183630|NCT03198000|11313396|FG001|COMPLETED|Overall Study||38
10183631|NCT03198000|11313397|FG002|COMPLETED|Overall Study||41
10183632|NCT03198000|11313395|FG000|NOT COMPLETED|Overall Study||0
10183633|NCT03198000|11313396|FG001|NOT COMPLETED|Overall Study||0
10183634|NCT03198000|11313397|FG002|NOT COMPLETED|Overall Study||0
10183635|NCT03198221|11313409|FG000|STARTED|Overall Study||3
10183636|NCT03198221|11313410|FG001|STARTED|Overall Study||2
10183637|NCT03198221|11313411|FG002|STARTED|Overall Study||7
10183638|NCT03198221|11313412|FG003|STARTED|Overall Study||2
10183639|NCT03198221|11313409|FG000|COMPLETED|Overall Study||3
10183640|NCT03198221|11313410|FG001|COMPLETED|Overall Study||2
10183641|NCT03198221|11313411|FG002|COMPLETED|Overall Study||7
10183642|NCT03198221|11313412|FG003|COMPLETED|Overall Study||2
10183643|NCT03198221|11313409|FG000|NOT COMPLETED|Overall Study||0
9714869|NCT00676663|10814074|FG000|NOT COMPLETED|Overall Study||45
9714870|NCT00676663|10814075|FG001|NOT COMPLETED|Overall Study||38
9714871|NCT00391365|10814085|FG000|STARTED|Overall Study||103
9714872|NCT00391365|10814086|FG001|STARTED|Overall Study||170
9714873|NCT00391365|10814085|FG000|COMPLETED|Overall Study||78
9714874|NCT00391365|10814086|FG001|COMPLETED|Overall Study||151
9714875|NCT00391365|10814085|FG000|NOT COMPLETED|Overall Study||25
10183644|NCT03198221|11313410|FG001|NOT COMPLETED|Overall Study||0
10183645|NCT03198221|11313411|FG002|NOT COMPLETED|Overall Study||0
10183646|NCT03198221|11313412|FG003|NOT COMPLETED|Overall Study||0
10183647|NCT03198507|11313424|FG000|STARTED|Overall Study||228
10183648|NCT03198507|11313425|FG001|STARTED|Overall Study||227
10183649|NCT03198507|11313424|FG000|COMPLETED|Overall Study||227
10183650|NCT03198507|11313425|FG001|COMPLETED|Overall Study||227
10183651|NCT03198507|11313424|FG000|NOT COMPLETED|Overall Study||1
10183652|NCT03198507|11313425|FG001|NOT COMPLETED|Overall Study||0
10183653|NCT03198520|11313431|FG000|STARTED|Overall Study||46
10183654|NCT03198520|11313431|FG000|COMPLETED|Overall Study||40
10183655|NCT03198520|11313431|FG000|NOT COMPLETED|Overall Study||6
10183656|NCT03198715|11313448|FG000|STARTED|Overall Study||6
10183657|NCT03198715|11313449|FG001|STARTED|Overall Study||12
10183658|NCT03198715|11313450|FG002|STARTED|Overall Study||12
10183659|NCT03198715|11313451|FG003|STARTED|Overall Study||3
10183660|NCT03198715|11313452|FG004|STARTED|Overall Study||9
10183661|NCT03198715|11313448|FG000|COMPLETED|Overall Study||6
10183662|NCT03198715|11313449|FG001|COMPLETED|Overall Study||11
10183663|NCT03198715|11313450|FG002|COMPLETED|Overall Study||10
10183664|NCT03198715|11313451|FG003|COMPLETED|Overall Study||3
10183665|NCT03198715|11313452|FG004|COMPLETED|Overall Study||7
10183666|NCT03198715|11313448|FG000|NOT COMPLETED|Overall Study||0
10183667|NCT03198715|11313449|FG001|NOT COMPLETED|Overall Study||1
10183668|NCT03198715|11313450|FG002|NOT COMPLETED|Overall Study||2
10183669|NCT03198715|11313451|FG003|NOT COMPLETED|Overall Study||0
9714876|NCT00391365|10814086|FG001|NOT COMPLETED|Overall Study||19
9731369|NCT00132028|10831309|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
9731370|NCT00132028|10831309|FG000|NOT COMPLETED|Overall Study||27
10183670|NCT03198715|11313452|FG004|NOT COMPLETED|Overall Study||2
10183671|NCT03198754|11313466|FG000|STARTED|Overall Study||38
10183672|NCT03198754|11313467|FG001|STARTED|Overall Study||35
10183673|NCT03198754|11313466|FG000|COMPLETED|Overall Study||27
10183674|NCT03198754|11313467|FG001|COMPLETED|Overall Study||27
10183675|NCT03198754|11313466|FG000|NOT COMPLETED|Overall Study||11
10183676|NCT03198754|11313467|FG001|NOT COMPLETED|Overall Study||8
10183677|NCT03198767|11313480|FG000|STARTED|Overall Study||8
10183678|NCT03198767|11313481|FG001|STARTED|Overall Study||8
10183679|NCT03198767|11313482|FG002|STARTED|Overall Study||8
10183680|NCT03198767|11313483|FG003|STARTED|Overall Study||6
10183681|NCT03198767|11313484|FG004|STARTED|Overall Study||8
10183682|NCT03198767|11313485|FG005|STARTED|Overall Study||8
10183683|NCT03198767|11313486|FG006|STARTED|Overall Study||8
10183684|NCT03198767|11313480|FG000|COMPLETED|Overall Study||8
10183685|NCT03198767|11313481|FG001|COMPLETED|Overall Study||8
10183686|NCT03198767|11313482|FG002|COMPLETED|Overall Study||8
10183687|NCT03198767|11313483|FG003|COMPLETED|Overall Study||0
10183688|NCT03198767|11313484|FG004|COMPLETED|Overall Study||8
10183689|NCT03198767|11313485|FG005|COMPLETED|Overall Study||8
10183690|NCT03198767|11313486|FG006|COMPLETED|Overall Study||8
10183691|NCT03198767|11313480|FG000|NOT COMPLETED|Overall Study||0
10183692|NCT03198767|11313481|FG001|NOT COMPLETED|Overall Study||0
10183693|NCT03198767|11313482|FG002|NOT COMPLETED|Overall Study||0
10183694|NCT03198767|11313483|FG003|NOT COMPLETED|Overall Study||6
10183695|NCT03198767|11313484|FG004|NOT COMPLETED|Overall Study||0
10183696|NCT03198767|11313485|FG005|NOT COMPLETED|Overall Study||0
10183697|NCT03198767|11313486|FG006|NOT COMPLETED|Overall Study||0
10183698|NCT03198871|11313503|FG000|STARTED|Overall Study||90
10183699|NCT03198871|11313504|FG001|STARTED|Overall Study||90
10183700|NCT03198871|11313503|FG000|COMPLETED|Overall Study||76
10183701|NCT03198871|11313504|FG001|COMPLETED|Overall Study||78
10183702|NCT03198871|11313503|FG000|NOT COMPLETED|Overall Study||14
10183703|NCT03198871|11313504|FG001|NOT COMPLETED|Overall Study||12
10183704|NCT03198884|11313510|FG000|STARTED|Overall Study||20
10183705|NCT03198884|11313510|FG000|COMPLETED|Overall Study||20
10183706|NCT03198884|11313510|FG000|NOT COMPLETED|Overall Study||0
10183707|NCT03199079|11313526|FG000|STARTED|Overall Study||10
10183708|NCT03199079|11313527|FG001|STARTED|Overall Study||10
10183709|NCT03199079|11313526|FG000|COMPLETED|Overall Study||10
10183710|NCT03199079|11313527|FG001|COMPLETED|Overall Study||10
10183711|NCT03199079|11313526|FG000|NOT COMPLETED|Overall Study||0
10183712|NCT03199079|11313527|FG001|NOT COMPLETED|Overall Study||0
10183713|NCT03199118|11313535|FG000|STARTED|Overall Study||14
10183714|NCT03199118|11313536|FG001|STARTED|Overall Study||14
10183715|NCT03199118|11313535|FG000|COMPLETED|Overall Study|6 months follow-up|14
10183716|NCT03199118|11313536|FG001|COMPLETED|Overall Study|6 months follow-up|14
10183717|NCT03199118|11313535|FG000|NOT COMPLETED|Overall Study||0
10183718|NCT03199118|11313536|FG001|NOT COMPLETED|Overall Study||0
10183719|NCT03199872|11313547|FG000|STARTED|Overall Study||22
10183720|NCT03199872|11313547|FG000|COMPLETED|Overall Study||22
10183721|NCT03199872|11313547|FG000|NOT COMPLETED|Overall Study||0
10183722|NCT03199911|11313553|FG000|STARTED|Overall Study||208
10183723|NCT03199911|11313554|FG001|STARTED|Overall Study||193
10183724|NCT03199911|11313553|FG000|Did Not Proceed With Surgery|Overall Study||2
10183725|NCT03199911|11313554|FG001|Did Not Proceed With Surgery|Overall Study||1
10183726|NCT03199911|11313553|FG000|Received Allocated Treatment|Overall Study||206
10183727|NCT03199911|11313554|FG001|Received Allocated Treatment|Overall Study||192
10183728|NCT03199911|11313553|FG000|Lost to Follow-up|Overall Study||5
10183729|NCT03199911|11313554|FG001|Lost to Follow-up|Overall Study||5
10183730|NCT03199911|11313553|FG000|Primary Outcome Analyzed|Overall Study||201
10183731|NCT03199911|11313554|FG001|Primary Outcome Analyzed|Overall Study||187
10183732|NCT03199911|11313553|FG000|COMPLETED|Overall Study||201
10183733|NCT03199911|11313554|FG001|COMPLETED|Overall Study||187
10183734|NCT03199911|11313553|FG000|NOT COMPLETED|Overall Study||7
10183735|NCT03199911|11313554|FG001|NOT COMPLETED|Overall Study||6
10183736|NCT03199963|11313562|FG000|STARTED|Blinded Phase - Overall Study||149
10183737|NCT03199963|11313563|FG001|STARTED|Blinded Phase - Overall Study||74
10183738|NCT03199963|11313562|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149
10183739|NCT03199963|11313563|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73
10183740|NCT03199963|11313562|FG000|COMPLETED|Blinded Phase - Overall Study||16
10183741|NCT03199963|11313563|FG001|COMPLETED|Blinded Phase - Overall Study||8
10183742|NCT03199963|11313562|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133
10183743|NCT03199963|11313563|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66
10183744|NCT03199963|11313562|FG000|STARTED|Optional Open-Label Phase - BHR-700||7
10183745|NCT03199963|11313563|FG001|STARTED|Optional Open-Label Phase - BHR-700||6
10183746|NCT03199963|11313562|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0
10183747|NCT03199963|11313563|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0
10183748|NCT03199963|11313562|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7
10183749|NCT03199963|11313563|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6
10183750|NCT03200366|11313574|FG000|STARTED|Baseline Interview With Randomization||123
10183751|NCT03200366|11313575|FG001|STARTED|Baseline Interview With Randomization||120
10183752|NCT03200366|11313576|FG002|STARTED|Baseline Interview With Randomization||128
10183753|NCT03200366|11313574|FG000|COMPLETED|Baseline Interview With Randomization||123
10183754|NCT03200366|11313575|FG001|COMPLETED|Baseline Interview With Randomization||120
10183755|NCT03200366|11313576|FG002|COMPLETED|Baseline Interview With Randomization||128
10183756|NCT03200366|11313574|FG000|NOT COMPLETED|Baseline Interview With Randomization||0
10183757|NCT03200366|11313575|FG001|NOT COMPLETED|Baseline Interview With Randomization||0
10183758|NCT03200366|11313576|FG002|NOT COMPLETED|Baseline Interview With Randomization||0
10183759|NCT03200366|11313574|FG000|STARTED|Tailored DVD Intervention Given||123
10183760|NCT03200366|11313575|FG001|STARTED|Tailored DVD Intervention Given||120
10183761|NCT03200366|11313576|FG002|STARTED|Tailored DVD Intervention Given||0
10183762|NCT03200366|11313574|FG000|COMPLETED|Tailored DVD Intervention Given||123
10183763|NCT03200366|11313575|FG001|COMPLETED|Tailored DVD Intervention Given||120
10183764|NCT03200366|11313576|FG002|COMPLETED|Tailored DVD Intervention Given||0
10183765|NCT03200366|11313574|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0
10183766|NCT03200366|11313575|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0
10183767|NCT03200366|11313576|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0
10183768|NCT03200366|11313574|FG000|STARTED|Patient Navigation Intervention Given||0
10183769|NCT03200366|11313575|FG001|STARTED|Patient Navigation Intervention Given||120
10183770|NCT03200366|11313576|FG002|STARTED|Patient Navigation Intervention Given||0
10183771|NCT03200366|11313574|FG000|COMPLETED|Patient Navigation Intervention Given||0
10183772|NCT03200366|11313575|FG001|COMPLETED|Patient Navigation Intervention Given||89
10183773|NCT03200366|11313576|FG002|COMPLETED|Patient Navigation Intervention Given||0
10183774|NCT03200366|11313574|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0
10183775|NCT03200366|11313575|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31
10183776|NCT03200366|11313576|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0
10183777|NCT03200366|11313574|FG000|STARTED|6 Month Post-Baseline Interview||123
9714877|NCT04617860|10814096|FG000|STARTED|Overall Study||8
9714878|NCT04617860|10814097|FG001|STARTED|Overall Study||10
9714879|NCT04617860|10814098|FG002|STARTED|Overall Study||18
9714880|NCT04617860|10814096|FG000|Dose Modified to 8 mg|Overall Study||8
9714881|NCT04617860|10814097|FG001|Dose Modified to 8 mg|Overall Study||1
9714882|NCT04617860|10814098|FG002|Dose Modified to 8 mg|Overall Study||0
9714883|NCT04617860|10814096|FG000|Dose Modified to 16 mg|Overall Study||8
9714884|NCT04617860|10814097|FG001|Dose Modified to 16 mg|Overall Study||9
9714885|NCT04617860|10814098|FG002|Dose Modified to 16 mg|Overall Study||8
9714886|NCT04617860|10814096|FG000|Dose Modified to 32 mg|Overall Study||2
9714887|NCT04617860|10814097|FG001|Dose Modified to 32 mg|Overall Study||4
9714888|NCT04617860|10814098|FG002|Dose Modified to 32 mg|Overall Study||11
9714889|NCT04617860|10814096|FG000|COMPLETED|Overall Study||0
9714890|NCT04617860|10814097|FG001|COMPLETED|Overall Study||0
9714891|NCT04617860|10814098|FG002|COMPLETED|Overall Study||0
9714892|NCT04617860|10814096|FG000|NOT COMPLETED|Overall Study||8
9714893|NCT04617860|10814097|FG001|NOT COMPLETED|Overall Study||10
9714894|NCT04617860|10814098|FG002|NOT COMPLETED|Overall Study||18
9714895|NCT04617847|10814110|FG000|STARTED|Overall Study||3
9714896|NCT04617847|10814111|FG001|STARTED|Overall Study||24
9714897|NCT04617847|10814110|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3
9714898|NCT04617847|10814111|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1
9714899|NCT04617847|10814110|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0
9714900|NCT04617847|10814111|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5
9714901|NCT04617847|10814110|FG000|COMPLETED|Overall Study||0
9714902|NCT04617847|10814111|FG001|COMPLETED|Overall Study||0
10183778|NCT03200366|11313575|FG001|STARTED|6 Month Post-Baseline Interview||118
10183779|NCT03200366|11313576|FG002|STARTED|6 Month Post-Baseline Interview||128
9714903|NCT04617847|10814110|FG000|NOT COMPLETED|Overall Study||3
9714904|NCT04617847|10814111|FG001|NOT COMPLETED|Overall Study||24
9714927|NCT04063657|10814130|FG000|STARTED|Overall Study||1
9849823|NCT00867659|10962652|FG000|STARTED|Overall Study|October 2009|20
9714928|NCT04063657|10814131|FG001|STARTED|Overall Study||0
9714929|NCT04063657|10814130|FG000|COMPLETED|Overall Study||0
9714930|NCT04063657|10814131|FG001|COMPLETED|Overall Study||0
9714931|NCT04063657|10814130|FG000|NOT COMPLETED|Overall Study||1
9714932|NCT04063657|10814131|FG001|NOT COMPLETED|Overall Study||0
10183780|NCT03200366|11313574|FG000|COMPLETED|6 Month Post-Baseline Interview||93
10183781|NCT03200366|11313575|FG001|COMPLETED|6 Month Post-Baseline Interview||95
10183782|NCT03200366|11313576|FG002|COMPLETED|6 Month Post-Baseline Interview||109
10183783|NCT03200366|11313574|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30
10183784|NCT03200366|11313575|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23
10183785|NCT03200366|11313576|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19
10183786|NCT03200366|11313574|FG000|STARTED|9 Month Post-Baseline Interview||121
10183787|NCT03200366|11313575|FG001|STARTED|9 Month Post-Baseline Interview||116
10183788|NCT03200366|11313576|FG002|STARTED|9 Month Post-Baseline Interview||127
10183789|NCT03200366|11313574|FG000|COMPLETED|9 Month Post-Baseline Interview||97
10183790|NCT03200366|11313575|FG001|COMPLETED|9 Month Post-Baseline Interview||95
10183791|NCT03200366|11313576|FG002|COMPLETED|9 Month Post-Baseline Interview||116
10183792|NCT03200366|11313574|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24
10183793|NCT03200366|11313575|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21
10183794|NCT03200366|11313576|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11
10183795|NCT03200535|11313590|FG000|STARTED|Overall Study||1863
10183796|NCT03200535|11313591|FG001|STARTED|Overall Study||1863
10183797|NCT03200535|11313592|FG002|STARTED|Overall Study||1862
10183798|NCT03200535|11313593|FG003|STARTED|Overall Study||1000
10183799|NCT03200535|11313590|FG000|COMPLETED|Overall Study||1863
10183800|NCT03200535|11313591|FG001|COMPLETED|Overall Study||1863
10183801|NCT03200535|11313592|FG002|COMPLETED|Overall Study||1862
10183802|NCT03200535|11313593|FG003|COMPLETED|Overall Study||1000
10183803|NCT03200535|11313590|FG000|NOT COMPLETED|Overall Study||0
10183804|NCT03200535|11313591|FG001|NOT COMPLETED|Overall Study||0
10183805|NCT03200535|11313592|FG002|NOT COMPLETED|Overall Study||0
10183806|NCT03200535|11313593|FG003|NOT COMPLETED|Overall Study||0
10183807|NCT03200860|11313605|FG000|STARTED|Overall Study||41
10183808|NCT03200860|11313606|FG001|STARTED|Overall Study||39
10183809|NCT03200860|11313605|FG000|COMPLETED|Overall Study||40
10183810|NCT03200860|11313606|FG001|COMPLETED|Overall Study||39
10183811|NCT03200860|11313605|FG000|NOT COMPLETED|Overall Study||1
10183812|NCT03200860|11313606|FG001|NOT COMPLETED|Overall Study||0
10183813|NCT03200912|11313615|FG000|STARTED|Overall Study||170
10183814|NCT03200912|11313616|FG001|STARTED|Overall Study||169
10183815|NCT03200912|11313617|FG002|STARTED|Overall Study||168
10183816|NCT03200912|11313615|FG000|COMPLETED|Overall Study||166
10183817|NCT03200912|11313616|FG001|COMPLETED|Overall Study||166
10183818|NCT03200912|11313617|FG002|COMPLETED|Overall Study||164
10183819|NCT03200912|11313615|FG000|NOT COMPLETED|Overall Study||4
10183820|NCT03200912|11313616|FG001|NOT COMPLETED|Overall Study||3
10183821|NCT03200912|11313617|FG002|NOT COMPLETED|Overall Study||4
10183822|NCT03200925|11313627|FG000|STARTED|Overall Study||120
10183823|NCT03200925|11313628|FG001|STARTED|Overall Study||120
10183824|NCT03200925|11313627|FG000|COMPLETED|Overall Study||120
10183825|NCT03200925|11313628|FG001|COMPLETED|Overall Study||120
10183826|NCT03200925|11313627|FG000|NOT COMPLETED|Overall Study||0
10183827|NCT03200925|11313628|FG001|NOT COMPLETED|Overall Study||0
10183828|NCT03201003|11313636|FG000|STARTED|Overall Study||132
10183829|NCT03201003|11313637|FG001|STARTED|Overall Study||43
10183830|NCT03201003|11313636|FG000|COMPLETED|Overall Study||106
10183831|NCT03201003|11313637|FG001|COMPLETED|Overall Study||40
10183832|NCT03201003|11313636|FG000|NOT COMPLETED|Overall Study||26
10183833|NCT03201003|11313637|FG001|NOT COMPLETED|Overall Study||3
10183834|NCT03201211|11313646|FG000|STARTED|Overall Study||27
10183835|NCT03201211|11313647|FG001|STARTED|Overall Study||26
10183836|NCT03201211|11313648|FG002|STARTED|Overall Study||28
10183837|NCT03201211|11313646|FG000|COMPLETED|Overall Study||25
10183838|NCT03201211|11313647|FG001|COMPLETED|Overall Study||25
10183839|NCT03201211|11313648|FG002|COMPLETED|Overall Study||27
10183840|NCT03201211|11313646|FG000|NOT COMPLETED|Overall Study||2
10183841|NCT03201211|11313647|FG001|NOT COMPLETED|Overall Study||1
10183842|NCT03201211|11313648|FG002|NOT COMPLETED|Overall Study||1
10183843|NCT03201562|11313659|FG000|STARTED|Overall Study||18
10183844|NCT03201562|11313660|FG001|STARTED|Overall Study||20
10183845|NCT03201562|11313661|FG002|STARTED|Overall Study||20
10183846|NCT03201562|11313659|FG000|COMPLETED|Overall Study||18
10183847|NCT03201562|11313660|FG001|COMPLETED|Overall Study||19
10183848|NCT03201562|11313661|FG002|COMPLETED|Overall Study||16
10183849|NCT03201562|11313659|FG000|NOT COMPLETED|Overall Study||0
10183850|NCT03201562|11313660|FG001|NOT COMPLETED|Overall Study||1
10183851|NCT03201562|11313661|FG002|NOT COMPLETED|Overall Study||4
10183852|NCT03201809|11313671|FG000|STARTED|Overall Study||6
10183853|NCT03201809|11313672|FG001|STARTED|Overall Study||6
10183854|NCT03201809|11313671|FG000|COMPLETED|Overall Study||4
10183855|NCT03201809|11313672|FG001|COMPLETED|Overall Study||6
10183856|NCT03201809|11313671|FG000|NOT COMPLETED|Overall Study||2
10183857|NCT03201809|11313672|FG001|NOT COMPLETED|Overall Study||0
10183858|NCT03201900|11313678|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91
10183859|NCT03201900|11313678|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89
10183860|NCT03201900|11313678|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
10183861|NCT03201900|11313678|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
10183862|NCT03201900|11313678|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
10183863|NCT03201900|11313678|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38
10183864|NCT03201900|11313678|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
10183865|NCT03202134|11313684|FG000|STARTED|Overall Study||55
10183866|NCT03202134|11313685|FG001|STARTED|Overall Study||149
10183867|NCT03202134|11313684|FG000|COMPLETED|Overall Study||55
10183868|NCT03202134|11313685|FG001|COMPLETED|Overall Study||149
10183869|NCT03202134|11313684|FG000|NOT COMPLETED|Overall Study||0
10183870|NCT03202134|11313685|FG001|NOT COMPLETED|Overall Study||0
10183871|NCT03202264|11313693|FG000|STARTED|Overall Study||30
10183872|NCT03202264|11313693|FG000|COMPLETED|Overall Study||14
10183873|NCT03202264|11313693|FG000|NOT COMPLETED|Overall Study||16
10183874|NCT03202472|11313697|FG000|STARTED|Overall Study||50
10183875|NCT03202472|11313697|FG000|COMPLETED|Overall Study||50
10183876|NCT03202472|11313697|FG000|NOT COMPLETED|Overall Study||0
10183877|NCT03202511|11313701|FG000|STARTED|Overall Study||8
10183878|NCT03202511|11313702|FG001|STARTED|Overall Study||7
10183879|NCT03202511|11313701|FG000|COMPLETED|Overall Study||7
10183880|NCT03202511|11313702|FG001|COMPLETED|Overall Study||7
10183881|NCT03202511|11313701|FG000|NOT COMPLETED|Overall Study||1
10183882|NCT03202511|11313702|FG001|NOT COMPLETED|Overall Study||0
10183883|NCT03202550|11313710|FG000|STARTED|Overall Study||13
10183884|NCT03202550|11313711|FG001|STARTED|Overall Study||11
10183885|NCT03202550|11313710|FG000|COMPLETED|Overall Study||13
10183886|NCT03202550|11313711|FG001|COMPLETED|Overall Study||11
10183887|NCT03202550|11313710|FG000|NOT COMPLETED|Overall Study||0
10183888|NCT03202550|11313711|FG001|NOT COMPLETED|Overall Study||0
10183889|NCT03203291|11313717|FG000|STARTED|Overall Study||12
10183890|NCT03203291|11313717|FG000|COMPLETED|Overall Study||11
10183891|NCT03203291|11313717|FG000|NOT COMPLETED|Overall Study||1
10183892|NCT03203447|11313723|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
10183893|NCT03203447|11313724|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
10183894|NCT03203447|11313723|FG000|COMPLETED|Overall Study||0
10183895|NCT03203447|11313724|FG001|COMPLETED|Overall Study||0
10183896|NCT03203447|11313723|FG000|NOT COMPLETED|Overall Study||162
10183897|NCT03203447|11313724|FG001|NOT COMPLETED|Overall Study||163
10183898|NCT03203564|11313734|FG000|STARTED|Overall Study||8
10183899|NCT03203564|11313735|FG001|STARTED|Overall Study||8
10183900|NCT03203564|11313736|FG002|STARTED|Overall Study||8
9714905|NCT04426318|10814121|FG000|STARTED|Overall Study||346
9714906|NCT04426318|10814122|FG001|STARTED|Overall Study||320
9714907|NCT04426318|10814121|FG000|Failed Attention Checks|Overall Study||4
9714908|NCT04426318|10814122|FG001|Failed Attention Checks|Overall Study||6
9714909|NCT04426318|10814121|FG000|Downloaded HMP App|Overall Study||329
9714910|NCT04426318|10814122|FG001|Downloaded HMP App|Overall Study||0
9714911|NCT04426318|10814121|FG000|Completed T2 Assessment|Overall Study||281
9714912|NCT04426318|10814122|FG001|Completed T2 Assessment|Overall Study||280
9714913|NCT04426318|10814121|FG000|Completed T3 Assessment|Overall Study||261
9714914|NCT04426318|10814122|FG001|Completed T3 Assessment|Overall Study||274
9714915|NCT04426318|10814121|FG000|Completed T4 Assessment|Overall Study||261
9714916|NCT04426318|10814122|FG001|Completed T4 Assessment|Overall Study||275
9714917|NCT04426318|10814121|FG000|Completed T5 Assessment|Overall Study||284
9714918|NCT04426318|10814122|FG001|Completed T5 Assessment|Overall Study||293
9714919|NCT04426318|10814121|FG000|Completed T6 Assessment|Overall Study||286
9714920|NCT04426318|10814122|FG001|Completed T6 Assessment|Overall Study||293
9714921|NCT04426318|10814121|FG000|Final Intent to Treat Sample|Overall Study||344
9714922|NCT04426318|10814122|FG001|Final Intent to Treat Sample|Overall Study||318
9714923|NCT04426318|10814121|FG000|COMPLETED|Overall Study||344
9714924|NCT04426318|10814122|FG001|COMPLETED|Overall Study||318
9714925|NCT04426318|10814121|FG000|NOT COMPLETED|Overall Study||2
9714926|NCT04426318|10814122|FG001|NOT COMPLETED|Overall Study||2
9714933|NCT04042623|10814137|FG000|STARTED|Overall Study||1
9714934|NCT04042623|10814137|FG000|COMPLETED|Overall Study||0
9714935|NCT04042623|10814137|FG000|NOT COMPLETED|Overall Study||1
9714936|NCT03882047|10814144|FG000|STARTED|Overall Study||104
9714937|NCT03882047|10814145|FG001|STARTED|Overall Study||105
9714938|NCT03882047|10814146|FG002|STARTED|Overall Study||104
9714939|NCT03882047|10814144|FG000|Treated|Overall Study||104
9714940|NCT03882047|10814145|FG001|Treated|Overall Study||104
9714941|NCT03882047|10814146|FG002|Treated|Overall Study||103
9714942|NCT03882047|10814144|FG000|COMPLETED|Overall Study||98
9714943|NCT03882047|10814145|FG001|COMPLETED|Overall Study||95
9714944|NCT03882047|10814146|FG002|COMPLETED|Overall Study||88
9714945|NCT03882047|10814144|FG000|NOT COMPLETED|Overall Study||6
9714946|NCT03882047|10814145|FG001|NOT COMPLETED|Overall Study||10
9714947|NCT03882047|10814146|FG002|NOT COMPLETED|Overall Study||16
10183901|NCT03203564|11313737|FG003|STARTED|Overall Study||9
10183902|NCT03203564|11313734|FG000|COMPLETED|Overall Study||8
10183903|NCT03203564|11313735|FG001|COMPLETED|Overall Study||8
10183904|NCT03203564|11313736|FG002|COMPLETED|Overall Study||8
10183905|NCT03203564|11313737|FG003|COMPLETED|Overall Study||9
10183906|NCT03203564|11313734|FG000|NOT COMPLETED|Overall Study||0
10183907|NCT03203564|11313735|FG001|NOT COMPLETED|Overall Study||0
10183908|NCT03203564|11313736|FG002|NOT COMPLETED|Overall Study||0
10183909|NCT03203564|11313737|FG003|NOT COMPLETED|Overall Study||0
9714948|NCT03879772|10814159|FG000|STARTED|Overall Study||137
9714949|NCT03879772|10814160|FG001|STARTED|Overall Study||135
9714950|NCT03879772|10814161|FG002|STARTED|Overall Study||133
9714951|NCT03879772|10814162|FG003|STARTED|Overall Study||138
9714952|NCT03879772|10814163|FG004|STARTED|Overall Study||136
9714953|NCT03879772|10814159|FG000|COMPLETED|Overall Study||133
9714954|NCT03879772|10814160|FG001|COMPLETED|Overall Study||132
9714955|NCT03879772|10814161|FG002|COMPLETED|Overall Study||123
9714956|NCT03879772|10814162|FG003|COMPLETED|Overall Study||130
9714957|NCT03879772|10814163|FG004|COMPLETED|Overall Study||128
10183910|NCT03203681|11313747|FG000|STARTED|Overall Study||60
10183911|NCT03203681|11313747|FG000|3 Month|Overall Study||44
10183912|NCT03203681|11313747|FG000|6 Months|Overall Study||33
10183913|NCT03203681|11313747|FG000|COMPLETED|Overall Study||33
10183914|NCT03203681|11313747|FG000|NOT COMPLETED|Overall Study||27
10183915|NCT03204279|11313753|FG000|STARTED|Overall Study||34
10183916|NCT03204279|11313754|FG001|STARTED|Overall Study||33
10183917|NCT03204279|11313753|FG000|COMPLETED|Overall Study||34
10183918|NCT03204279|11313754|FG001|COMPLETED|Overall Study||32
10183919|NCT03204279|11313753|FG000|NOT COMPLETED|Overall Study||0
10183920|NCT03204279|11313754|FG001|NOT COMPLETED|Overall Study||1
10183921|NCT03204526|11313761|FG000|STARTED|Overall Study||15
10183922|NCT03204526|11313761|FG000|COMPLETED|Overall Study||15
10183923|NCT03204526|11313761|FG000|NOT COMPLETED|Overall Study||0
10183924|NCT03204942|11313768|FG000|STARTED|Overall Study||23
10183925|NCT03204942|11313769|FG001|STARTED|Overall Study||23
10183926|NCT03204942|11313770|FG002|STARTED|Overall Study||23
10183927|NCT03204942|11313768|FG000|COMPLETED|Overall Study||23
10183928|NCT03204942|11313769|FG001|COMPLETED|Overall Study||23
10183929|NCT03204942|11313770|FG002|COMPLETED|Overall Study||23
10183930|NCT03204942|11313768|FG000|NOT COMPLETED|Overall Study||0
10061809|NCT02105987|11187350|FG005|STARTED|Late Switch Phase (24 Weeks)||0
10061810|NCT02105987|11187345|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0
10061811|NCT02105987|11187346|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0
10061812|NCT02105987|11187347|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230
10061813|NCT02105987|11187348|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230
10061814|NCT02105987|11187349|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0
10061815|NCT02105987|11187350|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0
10061816|NCT02105987|11187345|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10061817|NCT02105987|11187346|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10061818|NCT02105987|11187347|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
10061819|NCT02105987|11187348|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
10061820|NCT02105987|11187349|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10061821|NCT02105987|11187350|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10061822|NCT02105987|11187345|FG000|STARTED|Continuation Phase||0
10061823|NCT02105987|11187346|FG001|STARTED|Continuation Phase||0
10061824|NCT02105987|11187347|FG002|STARTED|Continuation Phase||0
10061825|NCT02105987|11187348|FG003|STARTED|Continuation Phase||0
10061826|NCT02105987|11187349|FG004|STARTED|Continuation Phase||14
10061827|NCT02105987|11187350|FG005|STARTED|Continuation Phase||23
10061828|NCT02105987|11187345|FG000|COMPLETED|Continuation Phase||0
10061829|NCT02105987|11187346|FG001|COMPLETED|Continuation Phase||0
10061830|NCT02105987|11187347|FG002|COMPLETED|Continuation Phase||0
10061831|NCT02105987|11187348|FG003|COMPLETED|Continuation Phase||0
10061832|NCT02105987|11187349|FG004|COMPLETED|Continuation Phase||13
10061833|NCT02105987|11187350|FG005|COMPLETED|Continuation Phase||23
10061834|NCT02105987|11187345|FG000|NOT COMPLETED|Continuation Phase||0
10061835|NCT02105987|11187346|FG001|NOT COMPLETED|Continuation Phase||0
10061836|NCT02105987|11187347|FG002|NOT COMPLETED|Continuation Phase||0
10061837|NCT02105987|11187348|FG003|NOT COMPLETED|Continuation Phase||0
10061838|NCT02105987|11187349|FG004|NOT COMPLETED|Continuation Phase||1
10061839|NCT02105987|11187350|FG005|NOT COMPLETED|Continuation Phase||0
10061840|NCT02106065|11187359|FG000|STARTED|Overall Study||6
10061841|NCT02106065|11187360|FG001|STARTED|Overall Study||11
10061842|NCT02106065|11187361|FG002|STARTED|Overall Study||15
10061843|NCT02106065|11187359|FG000|6 Month Completion|Overall Study||3
10061844|NCT02106065|11187360|FG001|6 Month Completion|Overall Study||8
10061845|NCT02106065|11187361|FG002|6 Month Completion|Overall Study||5
10061846|NCT02106065|11187359|FG000|COMPLETED|Overall Study||3
10061847|NCT02106065|11187360|FG001|COMPLETED|Overall Study||8
10061848|NCT02106065|11187361|FG002|COMPLETED|Overall Study||5
10061849|NCT02106065|11187359|FG000|NOT COMPLETED|Overall Study||3
10061850|NCT02106065|11187360|FG001|NOT COMPLETED|Overall Study||3
10061851|NCT02106065|11187361|FG002|NOT COMPLETED|Overall Study||10
10061852|NCT02106156|11187372|FG000|STARTED|Overall Study||9620
10061853|NCT02106156|11187373|FG001|STARTED|Overall Study||90
10061854|NCT02106156|11187374|FG002|STARTED|Overall Study||518
10061855|NCT02106156|11187372|FG000|COMPLETED|Overall Study||7071
10061856|NCT02106156|11187373|FG001|COMPLETED|Overall Study||50
10061857|NCT02106156|11187374|FG002|COMPLETED|Overall Study||518
10061858|NCT02106156|11187372|FG000|NOT COMPLETED|Overall Study||2549
10061859|NCT02106156|11187373|FG001|NOT COMPLETED|Overall Study||40
10061860|NCT02106156|11187374|FG002|NOT COMPLETED|Overall Study||0
10061861|NCT02106325|11187383|FG000|STARTED|Phase 1||5
10061862|NCT02106325|11187384|FG001|STARTED|Phase 1||3
10061863|NCT02106325|11187383|FG000|COMPLETED|Phase 1||3
10183931|NCT03204942|11313769|FG001|NOT COMPLETED|Overall Study||0
10183932|NCT03204942|11313770|FG002|NOT COMPLETED|Overall Study||0
10183933|NCT03204981|11313783|FG000|STARTED|Overall Study||52
10183934|NCT03204981|11313783|FG000|COMPLETED|Overall Study||46
10183935|NCT03204981|11313783|FG000|NOT COMPLETED|Overall Study||6
10183936|NCT03205046|11313791|FG000|STARTED|Overall Study||13
10183937|NCT03205046|11313792|FG001|STARTED|Overall Study||12
10183938|NCT03205046|11313791|FG000|COMPLETED|Overall Study||0
10183939|NCT03205046|11313792|FG001|COMPLETED|Overall Study||2
10183940|NCT03205046|11313791|FG000|NOT COMPLETED|Overall Study||13
10183941|NCT03205046|11313792|FG001|NOT COMPLETED|Overall Study||10
10183942|NCT03205150|11313801|FG000|STARTED|Overall Study||43
10183943|NCT03205150|11313802|FG001|STARTED|Overall Study||43
10183944|NCT03205150|11313803|FG002|STARTED|Overall Study||21
10183945|NCT03205150|11313801|FG000|Safety Analysis Set|Overall Study||43
10183946|NCT03205150|11313802|FG001|Safety Analysis Set|Overall Study||43
10183947|NCT03205150|11313803|FG002|Safety Analysis Set|Overall Study||21
10183948|NCT03205150|11313801|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
10183949|NCT03205150|11313802|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
10183950|NCT03205150|11313803|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
10183951|NCT03205150|11313801|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
10183952|NCT03205150|11313802|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
10183953|NCT03205150|11313803|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
10183954|NCT03205150|11313801|FG000|COMPLETED|Overall Study||41
10183955|NCT03205150|11313802|FG001|COMPLETED|Overall Study||36
10183956|NCT03205150|11313803|FG002|COMPLETED|Overall Study||19
10183957|NCT03205150|11313801|FG000|NOT COMPLETED|Overall Study||2
10183958|NCT03205150|11313802|FG001|NOT COMPLETED|Overall Study||7
10183959|NCT03205150|11313803|FG002|NOT COMPLETED|Overall Study||2
10183960|NCT03205488|11313815|FG000|STARTED|Overall Study||25
10183961|NCT03205488|11313816|FG001|STARTED|Overall Study||25
10183962|NCT03205488|11313817|FG002|STARTED|Overall Study||26
10183963|NCT03205488|11313815|FG000|COMPLETED|Overall Study||24
10183964|NCT03205488|11313816|FG001|COMPLETED|Overall Study||23
10183965|NCT03205488|11313817|FG002|COMPLETED|Overall Study||21
10183966|NCT03205488|11313815|FG000|NOT COMPLETED|Overall Study||1
10183967|NCT03205488|11313816|FG001|NOT COMPLETED|Overall Study||2
10183968|NCT03205488|11313817|FG002|NOT COMPLETED|Overall Study||5
10183969|NCT03205566|11313831|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
10183970|NCT03205566|11313832|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
10183971|NCT03205566|11313831|FG000|COMPLETED|Phase 1||18
10183972|NCT03205566|11313832|FG001|COMPLETED|Phase 1||18
10183973|NCT03205566|11313831|FG000|NOT COMPLETED|Phase 1||1
10183974|NCT03205566|11313832|FG001|NOT COMPLETED|Phase 1||1
10183975|NCT03205566|11313831|FG000|STARTED|Phase 2||18
10183976|NCT03205566|11313832|FG001|STARTED|Phase 2||18
10183977|NCT03205566|11313831|FG000|COMPLETED|Phase 2||18
10183978|NCT03205566|11313832|FG001|COMPLETED|Phase 2||18
10183979|NCT03205566|11313831|FG000|NOT COMPLETED|Phase 2||0
10183980|NCT03205566|11313832|FG001|NOT COMPLETED|Phase 2||0
10183981|NCT03206749|11313845|FG000|STARTED|Overall Study||80
10183982|NCT03206749|11313846|FG001|STARTED|Overall Study||81
10183983|NCT03206749|11313847|FG002|STARTED|Overall Study||82
10183984|NCT03206749|11313845|FG000|COMPLETED|Overall Study||75
10183985|NCT03206749|11313846|FG001|COMPLETED|Overall Study||78
10183986|NCT03206749|11313847|FG002|COMPLETED|Overall Study||75
10183987|NCT03206749|11313845|FG000|NOT COMPLETED|Overall Study||5
10183988|NCT03206749|11313846|FG001|NOT COMPLETED|Overall Study||3
10183989|NCT03206749|11313847|FG002|NOT COMPLETED|Overall Study||7
10183990|NCT03206788|11313858|FG000|STARTED|Overall Study||2
10183991|NCT03206788|11313859|FG001|STARTED|Overall Study||5
10183992|NCT03206788|11313858|FG000|COMPLETED|Overall Study||2
10183993|NCT03206788|11313859|FG001|COMPLETED|Overall Study||2
10183994|NCT03206788|11313858|FG000|NOT COMPLETED|Overall Study||0
10183995|NCT03206788|11313859|FG001|NOT COMPLETED|Overall Study||3
10183996|NCT03206918|11313865|FG000|STARTED|Overall Study||91
10183997|NCT03206918|11313865|FG000|COMPLETED|Overall Study||0
10183998|NCT03206918|11313865|FG000|NOT COMPLETED|Overall Study||91
10183999|NCT03206970|11313870|FG000|STARTED|Overall Study||86
10184000|NCT03206970|11313870|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
10184001|NCT03206970|11313870|FG000|COMPLETED|Overall Study||0
10184002|NCT03206970|11313870|FG000|NOT COMPLETED|Overall Study||86
10184003|NCT03207022|11313876|FG000|STARTED|Overall Study||12
10184004|NCT03207022|11313877|FG001|STARTED|Overall Study||12
10184005|NCT03207022|11313876|FG000|COMPLETED|Overall Study||12
10184006|NCT03207022|11313877|FG001|COMPLETED|Overall Study||12
10184007|NCT03207022|11313876|FG000|NOT COMPLETED|Overall Study||0
10184008|NCT03207022|11313877|FG001|NOT COMPLETED|Overall Study||0
10184009|NCT03207035|11313885|FG000|STARTED|Overall Study||10
10184010|NCT03207035|11313886|FG001|STARTED|Overall Study||10
10184011|NCT03207035|11313885|FG000|COMPLETED|Overall Study||10
10184012|NCT03207035|11313886|FG001|COMPLETED|Overall Study||10
10184013|NCT03207035|11313885|FG000|NOT COMPLETED|Overall Study||0
10184014|NCT03207035|11313886|FG001|NOT COMPLETED|Overall Study||0
10184015|NCT03207074|11313892|FG000|STARTED|Overall Study||150
10184016|NCT03207074|11313892|FG000|COMPLETED|Overall Study||150
10184017|NCT03207074|11313892|FG000|NOT COMPLETED|Overall Study||0
10184018|NCT03207243|11313898|FG000|STARTED|Overall Study||82
10184019|NCT03207243|11313899|FG001|STARTED|Overall Study||83
10184020|NCT03207243|11313898|FG000|COMPLETED|Overall Study||23
10184021|NCT03207243|11313899|FG001|COMPLETED|Overall Study||39
10184022|NCT03207243|11313898|FG000|NOT COMPLETED|Overall Study||59
10184023|NCT03207243|11313899|FG001|NOT COMPLETED|Overall Study||44
10184024|NCT03207386|11313906|FG000|STARTED|Overall Study||2647
10184025|NCT03207386|11313906|FG000|COMPLETED|Overall Study||1487
10184026|NCT03207386|11313906|FG000|NOT COMPLETED|Overall Study||1160
10184027|NCT03207399|11313913|FG000|STARTED|Overall Study||1
10184028|NCT03207399|11313913|FG000|COMPLETED|Overall Study||1
10184029|NCT03207399|11313913|FG000|NOT COMPLETED|Overall Study||0
10184030|NCT03207438|11313921|FG000|STARTED|Overall Study||167
10184031|NCT03207438|11313922|FG001|STARTED|Overall Study||166
10184032|NCT03207438|11313923|FG002|STARTED|Overall Study||875
10184033|NCT03207438|11313924|FG003|STARTED|Overall Study||582
10184034|NCT03207438|11313921|FG000|COMPLETED|Overall Study||148
10184035|NCT03207438|11313922|FG001|COMPLETED|Overall Study||145
10184036|NCT03207438|11313923|FG002|COMPLETED|Overall Study||643
10184037|NCT03207438|11313924|FG003|COMPLETED|Overall Study||470
10184038|NCT03207438|11313921|FG000|NOT COMPLETED|Overall Study||19
10184039|NCT03207438|11313922|FG001|NOT COMPLETED|Overall Study||21
10184040|NCT03207438|11313923|FG002|NOT COMPLETED|Overall Study||232
10184041|NCT03207438|11313924|FG003|NOT COMPLETED|Overall Study||112
10184042|NCT03207750|11313939|FG000|STARTED|Overall Study||632
10184043|NCT03207750|11313940|FG001|STARTED|Overall Study||640
10184044|NCT03207750|11313939|FG000|COMPLETED|Overall Study||574
10184045|NCT03207750|11313940|FG001|COMPLETED|Overall Study||574
10184046|NCT03207750|11313939|FG000|NOT COMPLETED|Overall Study||58
10184047|NCT03207750|11313940|FG001|NOT COMPLETED|Overall Study||66
10184048|NCT03207763|11313948|FG000|STARTED|Overall Study||8
10184049|NCT03207763|11313949|FG001|STARTED|Overall Study||25
10184050|NCT03207763|11313948|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5
10184051|NCT03207763|11313949|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23
10184052|NCT03207763|11313948|FG000|Completed Patches 2 and 3 Study|Overall Study||5
10184053|NCT03207763|11313949|FG001|Completed Patches 2 and 3 Study|Overall Study||23
10184054|NCT03207763|11313948|FG000|COMPLETED|Overall Study||7
10184055|NCT03207763|11313949|FG001|COMPLETED|Overall Study||25
10184056|NCT03207763|11313948|FG000|NOT COMPLETED|Overall Study||1
10184057|NCT03207763|11313949|FG001|NOT COMPLETED|Overall Study||0
10184058|NCT03208088|11313964|FG000|STARTED|Period 1||10
10184059|NCT03208088|11313965|FG001|STARTED|Period 1||9
10184060|NCT03208088|11313966|FG002|STARTED|Period 1||10
10184061|NCT03208088|11313967|FG003|STARTED|Period 1||9
10184062|NCT03208088|11313968|FG004|STARTED|Period 1||9
10184063|NCT03208088|11313969|FG005|STARTED|Period 1||9
10184064|NCT03208088|11313970|FG006|STARTED|Period 1||8
10184065|NCT03208088|11313971|FG007|STARTED|Period 1||10
10184066|NCT03208088|11313972|FG008|STARTED|Period 1||8
10184067|NCT03208088|11313973|FG009|STARTED|Period 1||9
10184068|NCT03208088|11313964|FG000|COMPLETED|Period 1||10
10184069|NCT03208088|11313965|FG001|COMPLETED|Period 1||9
10184070|NCT03208088|11313966|FG002|COMPLETED|Period 1||10
10184071|NCT03208088|11313967|FG003|COMPLETED|Period 1||9
10184072|NCT03208088|11313968|FG004|COMPLETED|Period 1||9
10184073|NCT03208088|11313969|FG005|COMPLETED|Period 1||9
10184074|NCT03208088|11313970|FG006|COMPLETED|Period 1||8
10184075|NCT03208088|11313971|FG007|COMPLETED|Period 1||10
10184076|NCT03208088|11313972|FG008|COMPLETED|Period 1||8
10184077|NCT03208088|11313973|FG009|COMPLETED|Period 1||9
10184078|NCT03208088|11313964|FG000|NOT COMPLETED|Period 1||0
10184079|NCT03208088|11313965|FG001|NOT COMPLETED|Period 1||0
10184080|NCT03208088|11313966|FG002|NOT COMPLETED|Period 1||0
10184081|NCT03208088|11313967|FG003|NOT COMPLETED|Period 1||0
10184082|NCT03208088|11313968|FG004|NOT COMPLETED|Period 1||0
10184083|NCT03208088|11313969|FG005|NOT COMPLETED|Period 1||0
10184084|NCT03208088|11313970|FG006|NOT COMPLETED|Period 1||0
10184085|NCT03208088|11313971|FG007|NOT COMPLETED|Period 1||0
10184086|NCT03208088|11313972|FG008|NOT COMPLETED|Period 1||0
10184087|NCT03208088|11313973|FG009|NOT COMPLETED|Period 1||0
10184088|NCT03208088|11313964|FG000|STARTED|Period 2||10
10184089|NCT03208088|11313965|FG001|STARTED|Period 2||9
10184090|NCT03208088|11313966|FG002|STARTED|Period 2||10
10184091|NCT03208088|11313967|FG003|STARTED|Period 2||9
10184092|NCT03208088|11313968|FG004|STARTED|Period 2||9
10184093|NCT03208088|11313969|FG005|STARTED|Period 2||9
10184094|NCT03208088|11313970|FG006|STARTED|Period 2||8
10184095|NCT03208088|11313971|FG007|STARTED|Period 2||10
10184096|NCT03208088|11313972|FG008|STARTED|Period 2||8
10184097|NCT03208088|11313973|FG009|STARTED|Period 2||9
10184098|NCT03208088|11313964|FG000|COMPLETED|Period 2||10
10184099|NCT03208088|11313965|FG001|COMPLETED|Period 2||9
10184100|NCT03208088|11313966|FG002|COMPLETED|Period 2||10
10184101|NCT03208088|11313967|FG003|COMPLETED|Period 2||9
10184102|NCT03208088|11313968|FG004|COMPLETED|Period 2||9
10184103|NCT03208088|11313969|FG005|COMPLETED|Period 2||9
10184104|NCT03208088|11313970|FG006|COMPLETED|Period 2||8
10184105|NCT03208088|11313971|FG007|COMPLETED|Period 2||10
10184106|NCT03208088|11313972|FG008|COMPLETED|Period 2||7
10184107|NCT03208088|11313973|FG009|COMPLETED|Period 2||9
10184108|NCT03208088|11313964|FG000|NOT COMPLETED|Period 2||0
10184109|NCT03208088|11313965|FG001|NOT COMPLETED|Period 2||0
10184110|NCT03208088|11313966|FG002|NOT COMPLETED|Period 2||0
10184111|NCT03208088|11313967|FG003|NOT COMPLETED|Period 2||0
10184112|NCT03208088|11313968|FG004|NOT COMPLETED|Period 2||0
10184113|NCT03208088|11313969|FG005|NOT COMPLETED|Period 2||0
10184114|NCT03208088|11313970|FG006|NOT COMPLETED|Period 2||0
10184115|NCT03208088|11313971|FG007|NOT COMPLETED|Period 2||0
10184116|NCT03208088|11313972|FG008|NOT COMPLETED|Period 2||1
10184117|NCT03208088|11313973|FG009|NOT COMPLETED|Period 2||0
10184118|NCT03208088|11313964|FG000|STARTED|Period 3||10
10184119|NCT03208088|11313965|FG001|STARTED|Period 3||9
10184120|NCT03208088|11313966|FG002|STARTED|Period 3||10
10184121|NCT03208088|11313967|FG003|STARTED|Period 3||9
10184122|NCT03208088|11313968|FG004|STARTED|Period 3||9
10184123|NCT03208088|11313969|FG005|STARTED|Period 3||9
10184124|NCT03208088|11313970|FG006|STARTED|Period 3||8
10184125|NCT03208088|11313971|FG007|STARTED|Period 3||10
10184126|NCT03208088|11313972|FG008|STARTED|Period 3||7
10184127|NCT03208088|11313973|FG009|STARTED|Period 3||9
10184128|NCT03208088|11313964|FG000|COMPLETED|Period 3||10
10184129|NCT03208088|11313965|FG001|COMPLETED|Period 3||9
10184130|NCT03208088|11313966|FG002|COMPLETED|Period 3||10
10184131|NCT03208088|11313967|FG003|COMPLETED|Period 3||8
10184132|NCT03208088|11313968|FG004|COMPLETED|Period 3||9
10184133|NCT03208088|11313969|FG005|COMPLETED|Period 3||9
10184134|NCT03208088|11313970|FG006|COMPLETED|Period 3||8
10184135|NCT03208088|11313971|FG007|COMPLETED|Period 3||10
10184136|NCT03208088|11313972|FG008|COMPLETED|Period 3||7
10184137|NCT03208088|11313973|FG009|COMPLETED|Period 3||9
10184138|NCT03208088|11313964|FG000|NOT COMPLETED|Period 3||0
10184139|NCT03208088|11313965|FG001|NOT COMPLETED|Period 3||0
10184140|NCT03208088|11313966|FG002|NOT COMPLETED|Period 3||0
10184141|NCT03208088|11313967|FG003|NOT COMPLETED|Period 3||1
10184142|NCT03208088|11313968|FG004|NOT COMPLETED|Period 3||0
10184143|NCT03208088|11313969|FG005|NOT COMPLETED|Period 3||0
10184144|NCT03208088|11313970|FG006|NOT COMPLETED|Period 3||0
10184145|NCT03208088|11313971|FG007|NOT COMPLETED|Period 3||0
10184146|NCT03208088|11313972|FG008|NOT COMPLETED|Period 3||0
10184147|NCT03208088|11313973|FG009|NOT COMPLETED|Period 3||0
10184148|NCT03208088|11313964|FG000|STARTED|Period 4||10
10184149|NCT03208088|11313965|FG001|STARTED|Period 4||9
10184150|NCT03208088|11313966|FG002|STARTED|Period 4||10
10184151|NCT03208088|11313967|FG003|STARTED|Period 4||8
10184152|NCT03208088|11313968|FG004|STARTED|Period 4||9
10184153|NCT03208088|11313969|FG005|STARTED|Period 4||9
10184154|NCT03208088|11313970|FG006|STARTED|Period 4||8
10184155|NCT03208088|11313971|FG007|STARTED|Period 4||10
10184156|NCT03208088|11313972|FG008|STARTED|Period 4||7
10184157|NCT03208088|11313973|FG009|STARTED|Period 4||9
10184158|NCT03208088|11313964|FG000|COMPLETED|Period 4||10
10184159|NCT03208088|11313965|FG001|COMPLETED|Period 4||9
10184160|NCT03208088|11313966|FG002|COMPLETED|Period 4||10
10184161|NCT03208088|11313967|FG003|COMPLETED|Period 4||7
10184162|NCT03208088|11313968|FG004|COMPLETED|Period 4||9
10184163|NCT03208088|11313969|FG005|COMPLETED|Period 4||9
10184164|NCT03208088|11313970|FG006|COMPLETED|Period 4||8
10184165|NCT03208088|11313971|FG007|COMPLETED|Period 4||10
10184166|NCT03208088|11313972|FG008|COMPLETED|Period 4||7
10184167|NCT03208088|11313973|FG009|COMPLETED|Period 4||9
10184168|NCT03208088|11313964|FG000|NOT COMPLETED|Period 4||0
10184169|NCT03208088|11313965|FG001|NOT COMPLETED|Period 4||0
10184170|NCT03208088|11313966|FG002|NOT COMPLETED|Period 4||0
10184171|NCT03208088|11313967|FG003|NOT COMPLETED|Period 4||1
10184172|NCT03208088|11313968|FG004|NOT COMPLETED|Period 4||0
10184173|NCT03208088|11313969|FG005|NOT COMPLETED|Period 4||0
10184174|NCT03208088|11313970|FG006|NOT COMPLETED|Period 4||0
10184175|NCT03208088|11313971|FG007|NOT COMPLETED|Period 4||0
10184176|NCT03208088|11313972|FG008|NOT COMPLETED|Period 4||0
10184177|NCT03208088|11313973|FG009|NOT COMPLETED|Period 4||0
10184178|NCT03208088|11313964|FG000|STARTED|Period 5||10
10184179|NCT03208088|11313965|FG001|STARTED|Period 5||9
10184180|NCT03208088|11313966|FG002|STARTED|Period 5||10
10184181|NCT03208088|11313967|FG003|STARTED|Period 5||7
10184182|NCT03208088|11313968|FG004|STARTED|Period 5||9
10184183|NCT03208088|11313969|FG005|STARTED|Period 5||9
10184184|NCT03208088|11313970|FG006|STARTED|Period 5||8
10184185|NCT03208088|11313971|FG007|STARTED|Period 5||10
10184186|NCT03208088|11313972|FG008|STARTED|Period 5||7
10184187|NCT03208088|11313973|FG009|STARTED|Period 5||9
10184188|NCT03208088|11313964|FG000|COMPLETED|Period 5||10
10184189|NCT03208088|11313965|FG001|COMPLETED|Period 5||9
10184190|NCT03208088|11313966|FG002|COMPLETED|Period 5||10
10184191|NCT03208088|11313967|FG003|COMPLETED|Period 5||7
10184192|NCT03208088|11313968|FG004|COMPLETED|Period 5||9
10184193|NCT03208088|11313969|FG005|COMPLETED|Period 5||9
10184194|NCT03208088|11313970|FG006|COMPLETED|Period 5||8
10184195|NCT03208088|11313971|FG007|COMPLETED|Period 5||10
10184196|NCT03208088|11313972|FG008|COMPLETED|Period 5||7
10184197|NCT03208088|11313973|FG009|COMPLETED|Period 5||9
10184198|NCT03208088|11313964|FG000|NOT COMPLETED|Period 5||0
10184199|NCT03208088|11313965|FG001|NOT COMPLETED|Period 5||0
10184200|NCT03208088|11313966|FG002|NOT COMPLETED|Period 5||0
10184201|NCT03208088|11313967|FG003|NOT COMPLETED|Period 5||0
10184202|NCT03208088|11313968|FG004|NOT COMPLETED|Period 5||0
10184203|NCT03208088|11313969|FG005|NOT COMPLETED|Period 5||0
10184204|NCT03208088|11313970|FG006|NOT COMPLETED|Period 5||0
10184205|NCT03208088|11313971|FG007|NOT COMPLETED|Period 5||0
10184206|NCT03208088|11313972|FG008|NOT COMPLETED|Period 5||0
10184207|NCT03208088|11313973|FG009|NOT COMPLETED|Period 5||0
10184208|NCT03208166|11313987|FG000|STARTED|Overall Study||1
10184209|NCT03208166|11313988|FG001|STARTED|Overall Study||1
10184210|NCT03208166|11313987|FG000|COMPLETED|Overall Study||1
10184211|NCT03208166|11313988|FG001|COMPLETED|Overall Study||1
10184212|NCT03208166|11313987|FG000|NOT COMPLETED|Overall Study||0
10184213|NCT03208166|11313988|FG001|NOT COMPLETED|Overall Study||0
10184214|NCT03208192|11313996|FG000|STARTED|Overall Study||32
10184215|NCT03208192|11313997|FG001|STARTED|Overall Study||36
10184216|NCT03208192|11313996|FG000|COMPLETED|Overall Study||32
10184217|NCT03208192|11313997|FG001|COMPLETED|Overall Study||36
10184218|NCT03208192|11313996|FG000|NOT COMPLETED|Overall Study||0
10184219|NCT03208192|11313997|FG001|NOT COMPLETED|Overall Study||0
10184220|NCT03208673|11314005|FG000|STARTED|Overall Study||32
10184221|NCT03208673|11314005|FG000|COMPLETED|Overall Study||32
10184222|NCT03208673|11314005|FG000|NOT COMPLETED|Overall Study||0
10184223|NCT03208933|11314009|FG000|STARTED|Overall Study||60
10184224|NCT03208933|11314009|FG000|COMPLETED|Overall Study||47
10184225|NCT03208933|11314009|FG000|NOT COMPLETED|Overall Study||13
10184226|NCT03209050|11314013|FG000|STARTED|Overall Study||30
10184227|NCT03209050|11314013|FG000|COMPLETED|Overall Study||27
10184228|NCT03209050|11314013|FG000|NOT COMPLETED|Overall Study||3
10184229|NCT03209362|11314020|FG000|STARTED|Overall Study||39
10184230|NCT03209362|11314021|FG001|STARTED|Overall Study||41
10184231|NCT03209362|11314020|FG000|COMPLETED|Overall Study||37
10184232|NCT03209362|11314021|FG001|COMPLETED|Overall Study||38
10184233|NCT03209362|11314020|FG000|NOT COMPLETED|Overall Study||2
10184234|NCT03209362|11314021|FG001|NOT COMPLETED|Overall Study||3
10184235|NCT03209492|11314027|FG000|STARTED|Overall Study||333
10184236|NCT03209492|11314027|FG000|COMPLETED|Overall Study||328
10184237|NCT03209492|11314027|FG000|NOT COMPLETED|Overall Study||5
10184238|NCT03209505|11314031|FG000|STARTED|Overall Study||10
10184239|NCT03209505|11314032|FG001|STARTED|Overall Study||10
10184240|NCT03209505|11314031|FG000|COMPLETED|Overall Study||10
10184241|NCT03209505|11314032|FG001|COMPLETED|Overall Study||10
10184242|NCT03209505|11314031|FG000|NOT COMPLETED|Overall Study||0
10184243|NCT03209505|11314032|FG001|NOT COMPLETED|Overall Study||0
10184244|NCT03209518|11314038|FG000|STARTED|Overall Study||312
10184245|NCT03209518|11314038|FG000|COMPLETED|Overall Study||310
10184246|NCT03209518|11314038|FG000|NOT COMPLETED|Overall Study||2
10184247|NCT03209570|11314044|FG000|STARTED|Overall Study||24
10184248|NCT03209570|11314045|FG001|STARTED|Overall Study||25
10184249|NCT03209570|11314044|FG000|COMPLETED|Overall Study||14
10184250|NCT03209570|11314045|FG001|COMPLETED|Overall Study||12
10184251|NCT03209570|11314044|FG000|NOT COMPLETED|Overall Study||10
10184252|NCT03209570|11314045|FG001|NOT COMPLETED|Overall Study||13
10184253|NCT03209882|11314053|FG000|STARTED|Overall Study||6
10184254|NCT03209882|11314054|FG001|STARTED|Overall Study||3
10184255|NCT03209882|11314053|FG000|COMPLETED|Overall Study||6
10184256|NCT03209882|11314054|FG001|COMPLETED|Overall Study||3
10184257|NCT03209882|11314053|FG000|NOT COMPLETED|Overall Study||0
10184258|NCT03209882|11314054|FG001|NOT COMPLETED|Overall Study||0
10184259|NCT03209973|11314062|FG000|STARTED|Overall Study||70
10184260|NCT03209973|11314062|FG000|Completed Primary Outcome Period|Overall Study||66
10184261|NCT03209973|11314062|FG000|COMPLETED|Overall Study||0
10184262|NCT03209973|11314062|FG000|NOT COMPLETED|Overall Study||70
10184263|NCT03210155|11314070|FG000|STARTED|Overall Study||0
10184264|NCT03210155|11314071|FG001|STARTED|Overall Study||1
10184265|NCT03210155|11314070|FG000|COMPLETED|Overall Study||0
10184266|NCT03210155|11314071|FG001|COMPLETED|Overall Study||1
10184267|NCT03210155|11314070|FG000|NOT COMPLETED|Overall Study||0
10184268|NCT03210155|11314071|FG001|NOT COMPLETED|Overall Study||0
10184269|NCT03210220|11314079|FG000|STARTED|Overall Study||20
10184270|NCT03210220|11314080|FG001|STARTED|Overall Study||20
10184271|NCT03210220|11314079|FG000|COMPLETED|Overall Study||19
10184272|NCT03210220|11314080|FG001|COMPLETED|Overall Study||20
10184273|NCT03210220|11314079|FG000|NOT COMPLETED|Overall Study||1
10184274|NCT03210220|11314080|FG001|NOT COMPLETED|Overall Study||0
10184275|NCT03210259|11314088|FG000|STARTED|12-Week Run-in Period||21
10184276|NCT03210259|11314089|FG001|STARTED|12-Week Run-in Period||118
10184277|NCT03210259|11314090|FG002|STARTED|12-Week Run-in Period||120
10184278|NCT03210259|11314088|FG000|COMPLETED|12-Week Run-in Period||0
10184279|NCT03210259|11314089|FG001|COMPLETED|12-Week Run-in Period||118
10184280|NCT03210259|11314090|FG002|COMPLETED|12-Week Run-in Period||120
10184281|NCT03210259|11314088|FG000|NOT COMPLETED|12-Week Run-in Period||21
10184282|NCT03210259|11314089|FG001|NOT COMPLETED|12-Week Run-in Period||0
10184283|NCT03210259|11314090|FG002|NOT COMPLETED|12-Week Run-in Period||0
10184284|NCT03210259|11314088|FG000|STARTED|48-Week Randomized Responder Period||0
10184285|NCT03210259|11314089|FG001|STARTED|48-Week Randomized Responder Period||118
10184286|NCT03210259|11314090|FG002|STARTED|48-Week Randomized Responder Period||120
10184287|NCT03210259|11314088|FG000|COMPLETED|48-Week Randomized Responder Period||0
10184288|NCT03210259|11314089|FG001|COMPLETED|48-Week Randomized Responder Period||107
10184289|NCT03210259|11314090|FG002|COMPLETED|48-Week Randomized Responder Period||91
10184290|NCT03210259|11314088|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0
10184291|NCT03210259|11314089|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11
10184292|NCT03210259|11314090|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29
10184293|NCT03210337|11314099|FG000|STARTED|Overall Study||78
10184294|NCT03210337|11314100|FG001|STARTED|Overall Study||79
10184295|NCT03210337|11314099|FG000|COMPLETED|Overall Study||70
10184296|NCT03210337|11314100|FG001|COMPLETED|Overall Study||74
10184297|NCT03210337|11314099|FG000|NOT COMPLETED|Overall Study||8
10184298|NCT03210337|11314100|FG001|NOT COMPLETED|Overall Study||5
10184299|NCT03210376|11314108|FG000|STARTED|Overall Study||50
10184300|NCT03210376|11314109|FG001|STARTED|Overall Study||50
10184301|NCT03210376|11314108|FG000|COMPLETED|Overall Study||50
10184302|NCT03210376|11314109|FG001|COMPLETED|Overall Study||50
10184303|NCT03210376|11314108|FG000|NOT COMPLETED|Overall Study||0
10184304|NCT03210376|11314109|FG001|NOT COMPLETED|Overall Study||0
10184305|NCT03210519|11314117|FG000|STARTED|Overall Study||11
10184306|NCT03210519|11314118|FG001|STARTED|Overall Study||10
10184307|NCT03210519|11314117|FG000|COMPLETED|Overall Study||9
10184308|NCT03210519|11314118|FG001|COMPLETED|Overall Study||10
10184309|NCT03210519|11314117|FG000|NOT COMPLETED|Overall Study||2
10184310|NCT03210519|11314118|FG001|NOT COMPLETED|Overall Study||0
10184311|NCT03210701|11314124|FG000|STARTED|Overall Study||123
10184312|NCT03210701|11314124|FG000|COMPLETED|Overall Study||123
10184313|NCT03210701|11314124|FG000|NOT COMPLETED|Overall Study||0
10184314|NCT03210961|11314143|FG000|STARTED|Overall Study||4
10184315|NCT03210961|11314144|FG001|STARTED|Overall Study||9
10184316|NCT03210961|11314145|FG002|STARTED|Overall Study||1
10184317|NCT03210961|11314146|FG003|STARTED|Overall Study||2
10184318|NCT03210961|11314147|FG004|STARTED|Overall Study||6
10184319|NCT03210961|11314148|FG005|STARTED|Overall Study||6
10184320|NCT03210961|11314149|FG006|STARTED|Overall Study||8
10184321|NCT03210961|11314150|FG007|STARTED|Overall Study||7
10184322|NCT03210961|11314151|FG008|STARTED|Overall Study||8
10184323|NCT03210961|11314152|FG009|STARTED|Overall Study||6
10184324|NCT03210961|11314153|FG010|STARTED|Overall Study||7
10184325|NCT03210961|11314154|FG011|STARTED|Overall Study||5
10184326|NCT03210961|11314155|FG012|STARTED|Overall Study||14
10184327|NCT03210961|11314156|FG013|STARTED|Overall Study||15
10184328|NCT03210961|11314157|FG014|STARTED|Overall Study||11
10184329|NCT03210961|11314143|FG000|COMPLETED|Overall Study||4
10184330|NCT03210961|11314144|FG001|COMPLETED|Overall Study||9
10184331|NCT03210961|11314145|FG002|COMPLETED|Overall Study||1
10184332|NCT03210961|11314146|FG003|COMPLETED|Overall Study||1
10184333|NCT03210961|11314147|FG004|COMPLETED|Overall Study||6
10184334|NCT03210961|11314148|FG005|COMPLETED|Overall Study||6
10184335|NCT03210961|11314149|FG006|COMPLETED|Overall Study||7
10184336|NCT03210961|11314150|FG007|COMPLETED|Overall Study||7
10184337|NCT03210961|11314151|FG008|COMPLETED|Overall Study||8
10184338|NCT03210961|11314152|FG009|COMPLETED|Overall Study||6
10184339|NCT03210961|11314153|FG010|COMPLETED|Overall Study||6
10184340|NCT03210961|11314154|FG011|COMPLETED|Overall Study||5
10184341|NCT03210961|11314155|FG012|COMPLETED|Overall Study||12
10184342|NCT03210961|11314156|FG013|COMPLETED|Overall Study||11
10184343|NCT03210961|11314157|FG014|COMPLETED|Overall Study||9
10184344|NCT03210961|11314143|FG000|NOT COMPLETED|Overall Study||0
10184345|NCT03210961|11314144|FG001|NOT COMPLETED|Overall Study||0
10184346|NCT03210961|11314145|FG002|NOT COMPLETED|Overall Study||0
10184347|NCT03210961|11314146|FG003|NOT COMPLETED|Overall Study||1
10184348|NCT03210961|11314147|FG004|NOT COMPLETED|Overall Study||0
10184349|NCT03210961|11314148|FG005|NOT COMPLETED|Overall Study||0
10184350|NCT03210961|11314149|FG006|NOT COMPLETED|Overall Study||1
10184351|NCT03210961|11314150|FG007|NOT COMPLETED|Overall Study||0
10184352|NCT03210961|11314151|FG008|NOT COMPLETED|Overall Study||0
10184353|NCT03210961|11314152|FG009|NOT COMPLETED|Overall Study||0
10184354|NCT03210961|11314153|FG010|NOT COMPLETED|Overall Study||1
10184355|NCT03210961|11314154|FG011|NOT COMPLETED|Overall Study||0
10184356|NCT03210961|11314155|FG012|NOT COMPLETED|Overall Study||2
10184357|NCT03210961|11314156|FG013|NOT COMPLETED|Overall Study||4
10184358|NCT03210961|11314157|FG014|NOT COMPLETED|Overall Study||2
10184359|NCT03211117|11314208|FG000|STARTED|Overall Study||0
10184360|NCT03211117|11314209|FG001|STARTED|Overall Study||3
10184361|NCT03211117|11314208|FG000|COMPLETED|Overall Study||0
10184362|NCT03211117|11314209|FG001|COMPLETED|Overall Study||3
10184363|NCT03211117|11314208|FG000|NOT COMPLETED|Overall Study||0
10184364|NCT03211117|11314209|FG001|NOT COMPLETED|Overall Study||0
10184365|NCT03211156|11314217|FG000|STARTED|Overall Study||49
10184366|NCT03211156|11314218|FG001|STARTED|Overall Study||48
10184367|NCT03211156|11314217|FG000|Received Study Drug|Overall Study||47
10184368|NCT03211156|11314218|FG001|Received Study Drug|Overall Study||45
10184369|NCT03211156|11314217|FG000|COMPLETED|Overall Study||47
10184370|NCT03211156|11314218|FG001|COMPLETED|Overall Study||45
10184371|NCT03211156|11314217|FG000|NOT COMPLETED|Overall Study||2
10184372|NCT03211156|11314218|FG001|NOT COMPLETED|Overall Study||3
10184373|NCT03211234|11314227|FG000|STARTED|Overall Study||17
10184374|NCT03211234|11314228|FG001|STARTED|Overall Study||31
10184375|NCT03211234|11314229|FG002|STARTED|Overall Study||28
10184376|NCT03211234|11314227|FG000|COMPLETED|Overall Study||16
10184377|NCT03211234|11314228|FG001|COMPLETED|Overall Study||30
10184378|NCT03211234|11314229|FG002|COMPLETED|Overall Study||25
10184379|NCT03211234|11314227|FG000|NOT COMPLETED|Overall Study||1
10184380|NCT03211234|11314228|FG001|NOT COMPLETED|Overall Study||1
10184381|NCT03211234|11314229|FG002|NOT COMPLETED|Overall Study||3
10184382|NCT03212261|11314237|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
10184383|NCT03212261|11314237|FG000|Remained Eligible|Overall Study||35
10184384|NCT03212261|11314237|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
10184385|NCT03212261|11314237|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
10184386|NCT03212261|11314237|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
10184387|NCT03212261|11314237|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
10184388|NCT03212261|11314237|FG000|COMPLETED|Overall Study||21
10184389|NCT03212261|11314237|FG000|NOT COMPLETED|Overall Study||16
10184390|NCT03212326|11314242|FG000|STARTED|Overall Study||24
10184391|NCT03212326|11314242|FG000|COMPLETED|Overall Study||20
10184392|NCT03212326|11314242|FG000|NOT COMPLETED|Overall Study||4
10184393|NCT03212365|11314248|FG000|STARTED|Overall Study||151
10184394|NCT03212365|11314249|FG001|STARTED|Overall Study||144
10184395|NCT03212365|11314248|FG000|COMPLETED|Overall Study||128
10184396|NCT03212365|11314249|FG001|COMPLETED|Overall Study||130
10184397|NCT03212365|11314248|FG000|NOT COMPLETED|Overall Study||23
10184398|NCT03212365|11314249|FG001|NOT COMPLETED|Overall Study||14
10184399|NCT03212521|11314255|FG000|STARTED|Overall Study||230
10184400|NCT03212521|11314255|FG000|COMPLETED|Overall Study||223
10184401|NCT03212521|11314255|FG000|NOT COMPLETED|Overall Study||7
10184402|NCT03212638|11314261|FG000|STARTED|Period 1||8
10184403|NCT03212638|11314262|FG001|STARTED|Period 1||8
10184404|NCT03212638|11314263|FG002|STARTED|Period 1||8
10184405|NCT03212638|11314264|FG003|STARTED|Period 1||0
10184406|NCT03212638|11314265|FG004|STARTED|Period 1||0
10184407|NCT03212638|11314261|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
10184408|NCT03212638|11314262|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
10184409|NCT03212638|11314263|FG002|Received at Least 1 Dose of Study Drug|Period 1||8
10184410|NCT03212638|11314264|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
10184411|NCT03212638|11314265|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
10184412|NCT03212638|11314261|FG000|COMPLETED|Period 1||8
10184413|NCT03212638|11314262|FG001|COMPLETED|Period 1||8
10184414|NCT03212638|11314263|FG002|COMPLETED|Period 1||8
10184415|NCT03212638|11314264|FG003|COMPLETED|Period 1||0
10184416|NCT03212638|11314265|FG004|COMPLETED|Period 1||0
10184417|NCT03212638|11314261|FG000|NOT COMPLETED|Period 1||0
10184418|NCT03212638|11314262|FG001|NOT COMPLETED|Period 1||0
10184419|NCT03212638|11314263|FG002|NOT COMPLETED|Period 1||0
10184420|NCT03212638|11314264|FG003|NOT COMPLETED|Period 1||0
10184421|NCT03212638|11314265|FG004|NOT COMPLETED|Period 1||0
10184422|NCT03212638|11314261|FG000|STARTED|Period 2||8
10184423|NCT03212638|11314262|FG001|STARTED|Period 2||8
10184424|NCT03212638|11314263|FG002|STARTED|Period 2||8
10184425|NCT03212638|11314264|FG003|STARTED|Period 2||0
10184426|NCT03212638|11314265|FG004|STARTED|Period 2||0
10184427|NCT03212638|11314261|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
10184428|NCT03212638|11314262|FG001|Received at Least 1 Dose of Study Drug|Period 2||8
10184429|NCT03212638|11314263|FG002|Received at Least 1 Dose of Study Drug|Period 2||8
10184430|NCT03212638|11314264|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
10184431|NCT03212638|11314265|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
10184432|NCT03212638|11314261|FG000|COMPLETED|Period 2||8
10184433|NCT03212638|11314262|FG001|COMPLETED|Period 2||8
10184434|NCT03212638|11314263|FG002|COMPLETED|Period 2||8
10184435|NCT03212638|11314264|FG003|COMPLETED|Period 2||0
10184436|NCT03212638|11314265|FG004|COMPLETED|Period 2||0
10184437|NCT03212638|11314261|FG000|NOT COMPLETED|Period 2||0
10184438|NCT03212638|11314262|FG001|NOT COMPLETED|Period 2||0
10184439|NCT03212638|11314263|FG002|NOT COMPLETED|Period 2||0
10184440|NCT03212638|11314264|FG003|NOT COMPLETED|Period 2||0
10184441|NCT03212638|11314265|FG004|NOT COMPLETED|Period 2||0
10184442|NCT03212638|11314261|FG000|STARTED|Period 3||8
10184443|NCT03212638|11314262|FG001|STARTED|Period 3||8
10184444|NCT03212638|11314263|FG002|STARTED|Period 3||8
10184445|NCT03212638|11314264|FG003|STARTED|Period 3||0
10184446|NCT03212638|11314265|FG004|STARTED|Period 3||0
10184447|NCT03212638|11314261|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
10184448|NCT03212638|11314262|FG001|Received at Least 1 Dose of Study Drug|Period 3||8
10184449|NCT03212638|11314263|FG002|Received at Least 1 Dose of Study Drug|Period 3||8
10184450|NCT03212638|11314264|FG003|Received at Least 1 Dose of Study Drug|Period 3||0
10184451|NCT03212638|11314265|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
10184452|NCT03212638|11314261|FG000|COMPLETED|Period 3||8
10184453|NCT03212638|11314262|FG001|COMPLETED|Period 3||8
10184454|NCT03212638|11314263|FG002|COMPLETED|Period 3||8
10184455|NCT03212638|11314264|FG003|COMPLETED|Period 3||0
9714958|NCT03879772|10814159|FG000|NOT COMPLETED|Overall Study||4
9714959|NCT03879772|10814160|FG001|NOT COMPLETED|Overall Study||3
9714960|NCT03879772|10814161|FG002|NOT COMPLETED|Overall Study||10
9714961|NCT03879772|10814162|FG003|NOT COMPLETED|Overall Study||8
9714962|NCT03879772|10814163|FG004|NOT COMPLETED|Overall Study||8
9714963|NCT03861559|10814177|FG000|STARTED|Overall Study||101
9714964|NCT03861559|10814178|FG001|STARTED|Overall Study||100
9714965|NCT03861559|10814177|FG000|COMPLETED|Overall Study||99
9714966|NCT03861559|10814178|FG001|COMPLETED|Overall Study||95
9714967|NCT03861559|10814177|FG000|NOT COMPLETED|Overall Study||2
9714968|NCT03861559|10814178|FG001|NOT COMPLETED|Overall Study||5
9714969|NCT03855228|10814188|FG000|STARTED|Overall Study||169
9714970|NCT03855228|10814189|FG001|STARTED|Overall Study||176
9714971|NCT03855228|10814190|FG002|STARTED|Overall Study||182
9714972|NCT03855228|10814191|FG003|STARTED|Overall Study||177
9714973|NCT03855228|10814188|FG000|Treated|Overall Study||169
9714974|NCT03855228|10814189|FG001|Treated|Overall Study||176
9714975|NCT03855228|10814190|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
9714976|NCT03855228|10814191|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
9714977|NCT03855228|10814188|FG000|COMPLETED|Overall Study||166
10184456|NCT03212638|11314265|FG004|COMPLETED|Period 3||0
10184457|NCT03212638|11314261|FG000|NOT COMPLETED|Period 3||0
10184458|NCT03212638|11314262|FG001|NOT COMPLETED|Period 3||0
10184459|NCT03212638|11314263|FG002|NOT COMPLETED|Period 3||0
10184460|NCT03212638|11314264|FG003|NOT COMPLETED|Period 3||0
10184461|NCT03212638|11314265|FG004|NOT COMPLETED|Period 3||0
10184462|NCT03212638|11314261|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
10184463|NCT03212638|11314262|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
10184464|NCT03212638|11314263|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
10184465|NCT03212638|11314264|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
10184466|NCT03212638|11314265|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
9714978|NCT03855228|10814189|FG001|COMPLETED|Overall Study||167
10184467|NCT03212638|11314261|FG000|Received at Least 1 Dose of Study Drug|Period 4||0
10184468|NCT03212638|11314262|FG001|Received at Least 1 Dose of Study Drug|Period 4||0
10184469|NCT03212638|11314263|FG002|Received at Least 1 Dose of Study Drug|Period 4||0
10184470|NCT03212638|11314264|FG003|Received at Least 1 Dose of Study Drug|Period 4||9
10184471|NCT03212638|11314265|FG004|Received at Least 1 Dose of Study Drug|Period 4||9
10184472|NCT03212638|11314261|FG000|COMPLETED|Period 4||0
10184473|NCT03212638|11314262|FG001|COMPLETED|Period 4||0
10184474|NCT03212638|11314263|FG002|COMPLETED|Period 4||0
10184475|NCT03212638|11314264|FG003|COMPLETED|Period 4||9
10184476|NCT03212638|11314265|FG004|COMPLETED|Period 4||9
10184477|NCT03212638|11314261|FG000|NOT COMPLETED|Period 4||0
10184478|NCT03212638|11314262|FG001|NOT COMPLETED|Period 4||0
10184479|NCT03212638|11314263|FG002|NOT COMPLETED|Period 4||0
10184480|NCT03212638|11314264|FG003|NOT COMPLETED|Period 4||0
10184481|NCT03212638|11314265|FG004|NOT COMPLETED|Period 4||0
10184482|NCT03212638|11314261|FG000|STARTED|Period 5||0
10184483|NCT03212638|11314262|FG001|STARTED|Period 5||0
10184484|NCT03212638|11314263|FG002|STARTED|Period 5||0
10184485|NCT03212638|11314264|FG003|STARTED|Period 5||9
9714979|NCT03855228|10814190|FG002|COMPLETED|Overall Study||174
9714980|NCT03855228|10814191|FG003|COMPLETED|Overall Study||158
9714981|NCT03855228|10814188|FG000|NOT COMPLETED|Overall Study||3
9714982|NCT03855228|10814189|FG001|NOT COMPLETED|Overall Study||9
9714983|NCT03855228|10814190|FG002|NOT COMPLETED|Overall Study||8
9714984|NCT03855228|10814191|FG003|NOT COMPLETED|Overall Study||19
9714985|NCT03855189|10814204|FG000|STARTED|Overall Study||113
9714986|NCT03855189|10814205|FG001|STARTED|Overall Study||116
9714987|NCT03855189|10814206|FG002|STARTED|Overall Study||116
9714988|NCT03855189|10814204|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
9714989|NCT03855189|10814205|FG001|Treated|Overall Study||116
9714990|NCT03855189|10814206|FG002|Treated|Overall Study||116
9714991|NCT03855189|10814204|FG000|COMPLETED|Overall Study||103
9714992|NCT03855189|10814205|FG001|COMPLETED|Overall Study||109
9714993|NCT03855189|10814206|FG002|COMPLETED|Overall Study||110
9714994|NCT03855189|10814204|FG000|NOT COMPLETED|Overall Study||10
9714995|NCT03855189|10814205|FG001|NOT COMPLETED|Overall Study||7
9714996|NCT03855189|10814206|FG002|NOT COMPLETED|Overall Study||6
9714997|NCT03764631|10814216|FG000|STARTED|Overall Study||751
9714998|NCT03764631|10814217|FG001|STARTED|Overall Study||751
9714999|NCT03764631|10814216|FG000|COMPLETED|Overall Study||710
9715000|NCT03764631|10814217|FG001|COMPLETED|Overall Study||698
9715001|NCT03764631|10814216|FG000|NOT COMPLETED|Overall Study||41
9715002|NCT03764631|10814217|FG001|NOT COMPLETED|Overall Study||53
9715003|NCT03764072|10814229|FG000|STARTED|Overall Study||46
9715004|NCT03764072|10814230|FG001|STARTED|Overall Study||42
9715005|NCT03764072|10814231|FG002|STARTED|Overall Study||44
9715006|NCT03764072|10814232|FG003|STARTED|Overall Study||45
9715007|NCT03764072|10814233|FG004|STARTED|Overall Study||46
9715008|NCT03764072|10814234|FG005|STARTED|Overall Study||27
9715009|NCT03764072|10814229|FG000|COMPLETED|Overall Study||46
9715010|NCT03764072|10814230|FG001|COMPLETED|Overall Study||42
9715011|NCT03764072|10814231|FG002|COMPLETED|Overall Study||43
9715012|NCT03764072|10814232|FG003|COMPLETED|Overall Study||45
9715013|NCT03764072|10814233|FG004|COMPLETED|Overall Study||45
9715014|NCT03764072|10814234|FG005|COMPLETED|Overall Study||26
9715015|NCT03764072|10814229|FG000|NOT COMPLETED|Overall Study||0
9715016|NCT03764072|10814230|FG001|NOT COMPLETED|Overall Study||0
9715017|NCT03764072|10814231|FG002|NOT COMPLETED|Overall Study||1
9715018|NCT03764072|10814232|FG003|NOT COMPLETED|Overall Study||0
9715019|NCT03764072|10814233|FG004|NOT COMPLETED|Overall Study||1
9715020|NCT03764072|10814234|FG005|NOT COMPLETED|Overall Study||1
9731371|NCT00132041|10831313|FG000|STARTED|Baseline||51
9731372|NCT00132041|10831313|FG000|Eligible|Baseline||45
9731373|NCT00132041|10831313|FG000|COMPLETED|Baseline||45
9731374|NCT00132041|10831313|FG000|NOT COMPLETED|Baseline||6
9731375|NCT00132041|10831313|FG000|STARTED|3 Months Post Ablation||45
9731376|NCT00132041|10831313|FG000|COMPLETED|3 Months Post Ablation||42
9731377|NCT00132041|10831313|FG000|NOT COMPLETED|3 Months Post Ablation||3
9731378|NCT00132041|10831313|FG000|STARTED|6 Months Post Ablation||42
9731379|NCT00132041|10831313|FG000|COMPLETED|6 Months Post Ablation||32
9731380|NCT00132041|10831313|FG000|NOT COMPLETED|6 Months Post Ablation||10
9731381|NCT00132041|10831313|FG000|STARTED|9 Months Post Ablation||32
9731382|NCT00132041|10831313|FG000|COMPLETED|9 Months Post Ablation||30
9731383|NCT00132041|10831313|FG000|NOT COMPLETED|9 Months Post Ablation||2
9731384|NCT00132041|10831313|FG000|STARTED|12 Months Post Ablation||30
9731385|NCT00132041|10831313|FG000|COMPLETED|12 Months Post Ablation||26
9731386|NCT00132041|10831313|FG000|NOT COMPLETED|12 Months Post Ablation||4
9731387|NCT00132041|10831313|FG000|STARTED|15 Months Post Ablation||26
9731388|NCT00132041|10831313|FG000|COMPLETED|15 Months Post Ablation||18
9731389|NCT00132041|10831313|FG000|NOT COMPLETED|15 Months Post Ablation||8
9731390|NCT00132041|10831313|FG000|STARTED|18 Months Post Ablation||18
9731391|NCT00132041|10831313|FG000|COMPLETED|18 Months Post Ablation||12
9731392|NCT00132041|10831313|FG000|NOT COMPLETED|18 Months Post Ablation||6
9731393|NCT00132132|10831325|FG000|STARTED|Overall Study||15
9731394|NCT00132132|10831326|FG001|STARTED|Overall Study||15
10184486|NCT03212638|11314265|FG004|STARTED|Period 5||9
10184487|NCT03212638|11314261|FG000|Received at Least 1 Dose of Study Drug|Period 5||0
10184488|NCT03212638|11314262|FG001|Received at Least 1 Dose of Study Drug|Period 5||0
10184489|NCT03212638|11314263|FG002|Received at Least 1 Dose of Study Drug|Period 5||0
9731395|NCT00132132|10831325|FG000|COMPLETED|Overall Study||8
9731396|NCT00132132|10831326|FG001|COMPLETED|Overall Study||13
9731397|NCT00132132|10831325|FG000|NOT COMPLETED|Overall Study||7
9731398|NCT00132132|10831326|FG001|NOT COMPLETED|Overall Study||2
9731399|NCT00132301|10831334|FG000|STARTED|Overall Study||141
9731400|NCT00132301|10831335|FG001|STARTED|Overall Study||157
10184490|NCT03212638|11314264|FG003|Received at Least 1 Dose of Study Drug|Period 5||9
10184491|NCT03212638|11314265|FG004|Received at Least 1 Dose of Study Drug|Period 5||9
10184492|NCT03212638|11314261|FG000|COMPLETED|Period 5||0
10184493|NCT03212638|11314262|FG001|COMPLETED|Period 5||0
10184494|NCT03212638|11314263|FG002|COMPLETED|Period 5||0
10184495|NCT03212638|11314264|FG003|COMPLETED|Period 5||9
10184496|NCT03212638|11314265|FG004|COMPLETED|Period 5||9
10184497|NCT03212638|11314261|FG000|NOT COMPLETED|Period 5||0
10184498|NCT03212638|11314262|FG001|NOT COMPLETED|Period 5||0
10184499|NCT03212638|11314263|FG002|NOT COMPLETED|Period 5||0
10184500|NCT03212638|11314264|FG003|NOT COMPLETED|Period 5||0
10184501|NCT03212638|11314265|FG004|NOT COMPLETED|Period 5||0
10184502|NCT03212690|11314277|FG000|STARTED|Overall Study||57
10184503|NCT03212690|11314277|FG000|COMPLETED|Overall Study||56
10184504|NCT03212690|11314277|FG000|NOT COMPLETED|Overall Study||1
10184505|NCT03213210|11314281|FG000|STARTED|Overall Study||5
10184506|NCT03213210|11314281|FG000|6-month Follow-up|Overall Study||3
10184507|NCT03213210|11314281|FG000|COMPLETED|Overall Study||0
10184508|NCT03213210|11314281|FG000|NOT COMPLETED|Overall Study||5
10184509|NCT03213366|11314287|FG000|STARTED|Overall Study||81
10184510|NCT03213366|11314288|FG001|STARTED|Overall Study||71
10184511|NCT03213366|11314287|FG000|COMPLETED|Overall Study||72
10184512|NCT03213366|11314288|FG001|COMPLETED|Overall Study||67
9849824|NCT00867659|10962652|FG000|COMPLETED|Overall Study|January 2010|20
9849825|NCT00867659|10962652|FG000|NOT COMPLETED|Overall Study||0
9849826|NCT00867789|10962659|FG000|STARTED|Overall Study||70
9849827|NCT00867789|10962660|FG001|STARTED|Overall Study||70
9849828|NCT00867789|10962659|FG000|COMPLETED|Overall Study||68
9849829|NCT00867789|10962660|FG001|COMPLETED|Overall Study||70
9849830|NCT00867789|10962659|FG000|NOT COMPLETED|Overall Study||2
9849831|NCT00867789|10962660|FG001|NOT COMPLETED|Overall Study||0
9849832|NCT00867815|10962666|FG000|STARTED|Overall Study||10
9849833|NCT00867815|10962666|FG000|COMPLETED|Overall Study||9
10184513|NCT03213366|11314287|FG000|NOT COMPLETED|Overall Study||9
9715021|NCT03645408|10814255|FG000|STARTED|Overall Study||1
9715022|NCT03645408|10814256|FG001|STARTED|Overall Study||2
9715023|NCT03645408|10814255|FG000|COMPLETED|Overall Study||1
9715024|NCT03645408|10814256|FG001|COMPLETED|Overall Study||2
9715025|NCT03645408|10814255|FG000|NOT COMPLETED|Overall Study||0
9715026|NCT03645408|10814256|FG001|NOT COMPLETED|Overall Study||0
9715027|NCT03578809|10814266|FG000|STARTED|Overall Study||94
9715028|NCT03578809|10814267|FG001|STARTED|Overall Study||185
9715029|NCT03578809|10814268|FG002|STARTED|Overall Study||112
9715030|NCT03578809|10814269|FG003|STARTED|Overall Study||202
9715031|NCT03578809|10814266|FG000|Treated|Overall Study||90
9715032|NCT03578809|10814267|FG001|Treated|Overall Study||179
9715033|NCT03578809|10814268|FG002|Treated|Overall Study||111
9715034|NCT03578809|10814269|FG003|Treated|Overall Study||195
9715035|NCT03578809|10814266|FG000|COMPLETED|Overall Study||88
9715036|NCT03578809|10814267|FG001|COMPLETED|Overall Study||171
9715037|NCT03578809|10814268|FG002|COMPLETED|Overall Study||108
9715038|NCT03578809|10814269|FG003|COMPLETED|Overall Study||193
9715039|NCT03578809|10814266|FG000|NOT COMPLETED|Overall Study||6
9715040|NCT03578809|10814267|FG001|NOT COMPLETED|Overall Study||14
9715041|NCT03578809|10814268|FG002|NOT COMPLETED|Overall Study||4
9715042|NCT03578809|10814269|FG003|NOT COMPLETED|Overall Study||9
9715043|NCT03571204|10814285|FG000|STARTED|Overall Study||8
9715044|NCT03571204|10814286|FG001|STARTED|Overall Study||8
9715045|NCT03571204|10814287|FG002|STARTED|Overall Study||5
9715046|NCT03571204|10814285|FG000|COMPLETED|Overall Study||7
9715047|NCT03571204|10814286|FG001|COMPLETED|Overall Study||6
9715048|NCT03571204|10814287|FG002|COMPLETED|Overall Study||5
10184514|NCT03213366|11314288|FG001|NOT COMPLETED|Overall Study||4
10184515|NCT03213405|11314298|FG000|STARTED|Overall Study||6
10184516|NCT03213405|11314299|FG001|STARTED|Overall Study||6
10184517|NCT03213405|11314300|FG002|STARTED|Overall Study||6
10184518|NCT03213405|11314301|FG003|STARTED|Overall Study||6
9715049|NCT03571204|10814285|FG000|NOT COMPLETED|Overall Study||1
9715050|NCT03571204|10814286|FG001|NOT COMPLETED|Overall Study||2
9715051|NCT03571204|10814287|FG002|NOT COMPLETED|Overall Study||0
9715052|NCT03523091|10814298|FG000|STARTED|Overall Study||1
10184519|NCT03213405|11314298|FG000|COMPLETED|Overall Study||6
10184520|NCT03213405|11314299|FG001|COMPLETED|Overall Study||6
10184521|NCT03213405|11314300|FG002|COMPLETED|Overall Study||6
9715053|NCT03523091|10814299|FG001|STARTED|Overall Study||5
9715054|NCT03523091|10814298|FG000|COMPLETED|Overall Study||0
10184522|NCT03213405|11314301|FG003|COMPLETED|Overall Study||6
10184523|NCT03213405|11314298|FG000|NOT COMPLETED|Overall Study||0
10184524|NCT03213405|11314299|FG001|NOT COMPLETED|Overall Study||0
10184525|NCT03213405|11314300|FG002|NOT COMPLETED|Overall Study||0
10184526|NCT03213405|11314301|FG003|NOT COMPLETED|Overall Study||0
10184527|NCT03213509|11314313|FG000|STARTED|Overall Study||80
10184528|NCT03213509|11314314|FG001|STARTED|Overall Study||90
10184529|NCT03213509|11314313|FG000|COMPLETED|Overall Study||76
10184530|NCT03213509|11314314|FG001|COMPLETED|Overall Study||85
10184531|NCT03213509|11314313|FG000|NOT COMPLETED|Overall Study||4
10184532|NCT03213509|11314314|FG001|NOT COMPLETED|Overall Study||5
10184533|NCT03213626|11314321|FG000|STARTED|Overall Study||7
10184534|NCT03213626|11314321|FG000|COMPLETED|Overall Study||0
10184535|NCT03213626|11314321|FG000|NOT COMPLETED|Overall Study||7
10184536|NCT03213938|11314327|FG000|STARTED|Overall Study||220
10184537|NCT03213938|11314328|FG001|STARTED|Overall Study||220
10184538|NCT03213938|11314327|FG000|COMPLETED|Overall Study||206
10184539|NCT03213938|11314328|FG001|COMPLETED|Overall Study||208
10184540|NCT03213938|11314327|FG000|NOT COMPLETED|Overall Study||14
10184541|NCT03213938|11314328|FG001|NOT COMPLETED|Overall Study||12
10184542|NCT03214081|11314334|FG000|STARTED|Overall Study||1237
10184543|NCT03214081|11314334|FG000|COMPLETED|Overall Study||1174
10184544|NCT03214081|11314334|FG000|NOT COMPLETED|Overall Study||63
10184545|NCT03214094|11314338|FG000|STARTED|Overall Study||1119
10184546|NCT03214094|11314338|FG000|COMPLETED|Overall Study||1059
10184547|NCT03214094|11314338|FG000|NOT COMPLETED|Overall Study||60
10184548|NCT03214198|11314342|FG000|STARTED|Overall Study||1304
10184549|NCT03214198|11314342|FG000|COMPLETED|Overall Study||1268
10184550|NCT03214198|11314342|FG000|NOT COMPLETED|Overall Study||36
10184551|NCT03214224|11314346|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
10184552|NCT03214224|11314346|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
10184553|NCT03214224|11314346|FG000|NOT COMPLETED|Overall Study||9
10184554|NCT03214367|11314356|FG000|STARTED|Lead-in Period||1316
10184555|NCT03214367|11314357|FG001|STARTED|Lead-in Period||0
10184556|NCT03214367|11314358|FG002|STARTED|Lead-in Period||0
10184557|NCT03214367|11314359|FG003|STARTED|Lead-in Period||0
10184558|NCT03214367|11314360|FG004|STARTED|Lead-in Period||76
10184559|NCT03214367|11314361|FG005|STARTED|Lead-in Period||0
10184560|NCT03214367|11314362|FG006|STARTED|Lead-in Period||0
10184561|NCT03214367|11314363|FG007|STARTED|Lead-in Period||0
10184562|NCT03214367|11314356|FG000|COMPLETED|Lead-in Period||1222
10184563|NCT03214367|11314357|FG001|COMPLETED|Lead-in Period||0
10184564|NCT03214367|11314358|FG002|COMPLETED|Lead-in Period||0
10184565|NCT03214367|11314359|FG003|COMPLETED|Lead-in Period||0
10184566|NCT03214367|11314360|FG004|COMPLETED|Lead-in Period||74
10184567|NCT03214367|11314361|FG005|COMPLETED|Lead-in Period||0
10184568|NCT03214367|11314362|FG006|COMPLETED|Lead-in Period||0
10184569|NCT03214367|11314363|FG007|COMPLETED|Lead-in Period||0
10184570|NCT03214367|11314356|FG000|NOT COMPLETED|Lead-in Period||94
10184571|NCT03214367|11314357|FG001|NOT COMPLETED|Lead-in Period||0
10184572|NCT03214367|11314358|FG002|NOT COMPLETED|Lead-in Period||0
10184573|NCT03214367|11314359|FG003|NOT COMPLETED|Lead-in Period||0
10184574|NCT03214367|11314360|FG004|NOT COMPLETED|Lead-in Period||2
10184575|NCT03214367|11314361|FG005|NOT COMPLETED|Lead-in Period||0
10184576|NCT03214367|11314362|FG006|NOT COMPLETED|Lead-in Period||0
10184577|NCT03214367|11314363|FG007|NOT COMPLETED|Lead-in Period||0
10184578|NCT03214367|11314356|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10184579|NCT03214367|11314357|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
10184580|NCT03214367|11314358|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
10184581|NCT03214367|11314359|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
10184582|NCT03214367|11314360|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10184583|NCT03214367|11314361|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
10184584|NCT03214367|11314362|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
10184585|NCT03214367|11314363|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
10184586|NCT03214367|11314356|FG000|COMPLETED|Treatment Period||0
10184587|NCT03214367|11314357|FG001|COMPLETED|Treatment Period||408
10184588|NCT03214367|11314358|FG002|COMPLETED|Treatment Period||418
10184589|NCT03214367|11314359|FG003|COMPLETED|Treatment Period||310
10184590|NCT03214367|11314360|FG004|COMPLETED|Treatment Period||0
10184591|NCT03214367|11314361|FG005|COMPLETED|Treatment Period||28
10184592|NCT03214367|11314362|FG006|COMPLETED|Treatment Period||19
10184593|NCT03214367|11314363|FG007|COMPLETED|Treatment Period||21
10184594|NCT03214367|11314356|FG000|NOT COMPLETED|Treatment Period||0
10184595|NCT03214367|11314357|FG001|NOT COMPLETED|Treatment Period||34
10184596|NCT03214367|11314358|FG002|NOT COMPLETED|Treatment Period||33
10184597|NCT03214367|11314359|FG003|NOT COMPLETED|Treatment Period||19
10184598|NCT03214367|11314360|FG004|NOT COMPLETED|Treatment Period||0
10184599|NCT03214367|11314361|FG005|NOT COMPLETED|Treatment Period||3
10184600|NCT03214367|11314362|FG006|NOT COMPLETED|Treatment Period||2
10184601|NCT03214367|11314363|FG007|NOT COMPLETED|Treatment Period||1
10184602|NCT03214380|11314381|FG000|STARTED|Lead-in||750
10184603|NCT03214380|11314382|FG001|STARTED|Lead-in||0
10184604|NCT03214380|11314383|FG002|STARTED|Lead-in||0
10184605|NCT03214380|11314384|FG003|STARTED|Lead-in||183
10184606|NCT03214380|11314385|FG004|STARTED|Lead-in||0
10184607|NCT03214380|11314386|FG005|STARTED|Lead-in||0
10184608|NCT03214380|11314381|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
10184609|NCT03214380|11314382|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10184610|NCT03214380|11314383|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10184611|NCT03214380|11314384|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
10184612|NCT03214380|11314385|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10184613|NCT03214380|11314386|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10184614|NCT03214380|11314381|FG000|COMPLETED|Lead-in||673
10184615|NCT03214380|11314382|FG001|COMPLETED|Lead-in||0
10184616|NCT03214380|11314383|FG002|COMPLETED|Lead-in||0
10184617|NCT03214380|11314384|FG003|COMPLETED|Lead-in||164
10184618|NCT03214380|11314385|FG004|COMPLETED|Lead-in||0
10184619|NCT03214380|11314386|FG005|COMPLETED|Lead-in||0
10184620|NCT03214380|11314381|FG000|NOT COMPLETED|Lead-in||77
10184621|NCT03214380|11314382|FG001|NOT COMPLETED|Lead-in||0
10184622|NCT03214380|11314383|FG002|NOT COMPLETED|Lead-in||0
10184623|NCT03214380|11314384|FG003|NOT COMPLETED|Lead-in||19
10184624|NCT03214380|11314385|FG004|NOT COMPLETED|Lead-in||0
10184625|NCT03214380|11314386|FG005|NOT COMPLETED|Lead-in||0
10184626|NCT03214380|11314381|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10184627|NCT03214380|11314382|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
10184628|NCT03214380|11314383|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
10184629|NCT03214380|11314384|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10184630|NCT03214380|11314385|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
10184631|NCT03214380|11314386|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
10184632|NCT03214380|11314381|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0
10184633|NCT03214380|11314382|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337
10184634|NCT03214380|11314383|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336
10184635|NCT03214380|11314384|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
10184636|NCT03214380|11314385|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82
10184637|NCT03214380|11314386|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82
10184638|NCT03214380|11314381|FG000|COMPLETED|Treatment Period||0
10184639|NCT03214380|11314382|FG001|COMPLETED|Treatment Period||319
10184640|NCT03214380|11314383|FG002|COMPLETED|Treatment Period||320
10184641|NCT03214380|11314384|FG003|COMPLETED|Treatment Period||0
10184642|NCT03214380|11314385|FG004|COMPLETED|Treatment Period||73
10184643|NCT03214380|11314386|FG005|COMPLETED|Treatment Period||71
10184644|NCT03214380|11314381|FG000|NOT COMPLETED|Treatment Period||0
10184645|NCT03214380|11314382|FG001|NOT COMPLETED|Treatment Period||18
10184646|NCT03214380|11314383|FG002|NOT COMPLETED|Treatment Period||16
10184647|NCT03214380|11314384|FG003|NOT COMPLETED|Treatment Period||0
10184648|NCT03214380|11314385|FG004|NOT COMPLETED|Treatment Period||9
10184649|NCT03214380|11314386|FG005|NOT COMPLETED|Treatment Period||11
10184650|NCT03214406|11314400|FG000|STARTED|Overall Study||88
10184651|NCT03214406|11314401|FG001|STARTED|Overall Study||93
10184652|NCT03214406|11314400|FG000|COMPLETED|Overall Study||78
10184653|NCT03214406|11314401|FG001|COMPLETED|Overall Study||78
10184654|NCT03214406|11314400|FG000|NOT COMPLETED|Overall Study||10
10184655|NCT03214406|11314401|FG001|NOT COMPLETED|Overall Study||15
10184656|NCT03214588|11314410|FG000|STARTED|Overall Study||27
10184657|NCT03214588|11314411|FG001|STARTED|Overall Study||14
10184658|NCT03214588|11314412|FG002|STARTED|Overall Study||26
10184659|NCT03214588|11314410|FG000|COMPLETED|Overall Study||26
10184660|NCT03214588|11314411|FG001|COMPLETED|Overall Study||13
10184661|NCT03214588|11314412|FG002|COMPLETED|Overall Study||24
10184662|NCT03214588|11314410|FG000|NOT COMPLETED|Overall Study||1
10184663|NCT03214588|11314411|FG001|NOT COMPLETED|Overall Study||1
10184664|NCT03214588|11314412|FG002|NOT COMPLETED|Overall Study||2
10184665|NCT03214640|11314424|FG000|STARTED|Overall Study||31
10184666|NCT03214640|11314425|FG001|STARTED|Overall Study||32
10184667|NCT03214640|11314426|FG002|STARTED|Overall Study||31
10184668|NCT03214640|11314427|FG003|STARTED|Overall Study||34
10184669|NCT03214640|11314424|FG000|COMPLETED|Overall Study||30
10184670|NCT03214640|11314425|FG001|COMPLETED|Overall Study||30
10184671|NCT03214640|11314426|FG002|COMPLETED|Overall Study||30
10184672|NCT03214640|11314427|FG003|COMPLETED|Overall Study||30
10184673|NCT03214640|11314424|FG000|NOT COMPLETED|Overall Study||1
10184674|NCT03214640|11314425|FG001|NOT COMPLETED|Overall Study||2
10184675|NCT03214640|11314426|FG002|NOT COMPLETED|Overall Study||1
10184676|NCT03214640|11314427|FG003|NOT COMPLETED|Overall Study||4
10184677|NCT03214952|11314437|FG000|STARTED|Overall Study||3183
10184678|NCT03214952|11314437|FG000|COMPLETED|Overall Study||3125
10184679|NCT03214952|11314437|FG000|NOT COMPLETED|Overall Study||58
10184680|NCT03215667|11314441|FG000|STARTED|Overall Study||9
10184681|NCT03215667|11314441|FG000|COMPLETED|Overall Study||5
10184682|NCT03215667|11314441|FG000|NOT COMPLETED|Overall Study||4
10184683|NCT03215758|11314447|FG000|STARTED|Overall Study||339
10184684|NCT03215758|11314448|FG001|STARTED|Overall Study||336
10184685|NCT03215758|11314447|FG000|COMPLETED|Overall Study||334
10184686|NCT03215758|11314448|FG001|COMPLETED|Overall Study||328
10184687|NCT03215758|11314447|FG000|NOT COMPLETED|Overall Study||5
10184688|NCT03215758|11314448|FG001|NOT COMPLETED|Overall Study||8
10184689|NCT03215771|11314454|FG000|STARTED|Overall Study||16
10184690|NCT03215771|11314454|FG000|Stroke Subjects|Overall Study||8
10184691|NCT03215771|11314454|FG000|TBI Subjects|Overall Study||8
10184692|NCT03215771|11314454|FG000|COMPLETED|Overall Study||13
10184693|NCT03215771|11314454|FG000|NOT COMPLETED|Overall Study||3
10184694|NCT03215901|11314462|FG000|STARTED|Overall Study||199
10184695|NCT03215901|11314463|FG001|STARTED|Overall Study||112
10184696|NCT03215901|11314464|FG002|STARTED|Overall Study||116
10184697|NCT03215901|11314462|FG000|COMPLETED|Overall Study||199
10184698|NCT03215901|11314463|FG001|COMPLETED|Overall Study||112
10184699|NCT03215901|11314464|FG002|COMPLETED|Overall Study||116
10184700|NCT03215901|11314462|FG000|NOT COMPLETED|Overall Study||0
10184701|NCT03215901|11314463|FG001|NOT COMPLETED|Overall Study||0
10184702|NCT03215901|11314464|FG002|NOT COMPLETED|Overall Study||0
10184703|NCT03216200|11314472|FG000|STARTED|Overall Study||5
10184704|NCT03216200|11314472|FG000|COMPLETED|Overall Study||5
10184705|NCT03216200|11314472|FG000|NOT COMPLETED|Overall Study||0
10184706|NCT03216226|11314478|FG000|STARTED|Overall Study||57
10184707|NCT03216226|11314479|FG001|STARTED|Overall Study||55
10184708|NCT03216226|11314478|FG000|Randomized and Treated|Overall Study||57
10184709|NCT03216226|11314479|FG001|Randomized and Treated|Overall Study||54
10184710|NCT03216226|11314478|FG000|COMPLETED|Overall Study||52
10184711|NCT03216226|11314479|FG001|COMPLETED|Overall Study||50
10184712|NCT03216226|11314478|FG000|NOT COMPLETED|Overall Study||5
10184713|NCT03216226|11314479|FG001|NOT COMPLETED|Overall Study||5
10184714|NCT03216265|11314488|FG000|STARTED|Overall Study||22
10184715|NCT03216265|11314489|FG001|STARTED|Overall Study||22
10184716|NCT03216265|11314490|FG002|STARTED|Overall Study||22
10184717|NCT03216265|11314488|FG000|COMPLETED|Overall Study||20
10184718|NCT03216265|11314489|FG001|COMPLETED|Overall Study||21
10184719|NCT03216265|11314490|FG002|COMPLETED|Overall Study||19
10184720|NCT03216265|11314488|FG000|NOT COMPLETED|Overall Study||2
10184721|NCT03216265|11314489|FG001|NOT COMPLETED|Overall Study||1
10184722|NCT03216265|11314490|FG002|NOT COMPLETED|Overall Study||3
10184723|NCT03216382|11314507|FG000|STARTED|Overall Study||41
10184724|NCT03216382|11314508|FG001|STARTED|Overall Study||54
10184725|NCT03216382|11314507|FG000|COMPLETED|Overall Study||34
10184726|NCT03216382|11314508|FG001|COMPLETED|Overall Study||44
10184727|NCT03216382|11314507|FG000|NOT COMPLETED|Overall Study||7
10184728|NCT03216382|11314508|FG001|NOT COMPLETED|Overall Study||10
10184729|NCT03216512|11314516|FG000|STARTED|Overall Study||17
10184730|NCT03216512|11314517|FG001|STARTED|Overall Study||14
10184731|NCT03216512|11314516|FG000|COMPLETED|Overall Study||17
10184732|NCT03216512|11314517|FG001|COMPLETED|Overall Study||13
10184733|NCT03216512|11314516|FG000|NOT COMPLETED|Overall Study||0
10184734|NCT03216512|11314517|FG001|NOT COMPLETED|Overall Study||1
10184735|NCT03216746|11314529|FG000|STARTED|Overall Study||72
10184736|NCT03216746|11314530|FG001|STARTED|Overall Study||79
10184737|NCT03216746|11314531|FG002|STARTED|Overall Study||68
10184738|NCT03216746|11314532|FG003|STARTED|Overall Study||69
10184739|NCT03216746|11314529|FG000|COMPLETED|Overall Study||66
10184740|NCT03216746|11314530|FG001|COMPLETED|Overall Study||71
10184741|NCT03216746|11314531|FG002|COMPLETED|Overall Study||63
10184742|NCT03216746|11314532|FG003|COMPLETED|Overall Study||63
10184743|NCT03216746|11314529|FG000|NOT COMPLETED|Overall Study||6
10184744|NCT03216746|11314530|FG001|NOT COMPLETED|Overall Study||8
10184745|NCT03216746|11314531|FG002|NOT COMPLETED|Overall Study||5
10184746|NCT03216746|11314532|FG003|NOT COMPLETED|Overall Study||6
10184747|NCT03216850|11314542|FG000|STARTED|Overall Study||15
10184748|NCT03216850|11314542|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
10184749|NCT03216850|11314542|FG000|NOT COMPLETED|Overall Study||6
10184750|NCT03216902|11314552|FG000|STARTED|Overall Study||22
10184751|NCT03216902|11314553|FG001|STARTED|Overall Study||44
10184752|NCT03216902|11314554|FG002|STARTED|Overall Study||43
10184753|NCT03216902|11314555|FG003|STARTED|Overall Study||43
10184754|NCT03216902|11314556|FG004|STARTED|Overall Study||44
10184755|NCT03216902|11314557|FG005|STARTED|Overall Study||45
10184756|NCT03216902|11314552|FG000|COMPLETED|Overall Study||20
10184757|NCT03216902|11314553|FG001|COMPLETED|Overall Study||43
10184758|NCT03216902|11314554|FG002|COMPLETED|Overall Study||42
10184759|NCT03216902|11314555|FG003|COMPLETED|Overall Study||43
10184760|NCT03216902|11314556|FG004|COMPLETED|Overall Study||43
10184761|NCT03216902|11314557|FG005|COMPLETED|Overall Study||42
10184762|NCT03216902|11314552|FG000|NOT COMPLETED|Overall Study||2
10184763|NCT03216902|11314553|FG001|NOT COMPLETED|Overall Study||1
10184764|NCT03216902|11314554|FG002|NOT COMPLETED|Overall Study||1
10184765|NCT03216902|11314555|FG003|NOT COMPLETED|Overall Study||0
10184766|NCT03216902|11314556|FG004|NOT COMPLETED|Overall Study||1
10184767|NCT03216902|11314557|FG005|NOT COMPLETED|Overall Study||3
10184768|NCT03216954|11314579|FG000|STARTED|Overall Study||4
10184769|NCT03216954|11314580|FG001|STARTED|Overall Study||3
10184770|NCT03216954|11314581|FG002|STARTED|Overall Study||3
10184771|NCT03216954|11314582|FG003|STARTED|Overall Study||3
10184772|NCT03216954|11314583|FG004|STARTED|Overall Study||1
10184773|NCT03216954|11314579|FG000|COMPLETED|Overall Study||2
10184774|NCT03216954|11314580|FG001|COMPLETED|Overall Study||2
10184775|NCT03216954|11314581|FG002|COMPLETED|Overall Study||2
10184776|NCT03216954|11314582|FG003|COMPLETED|Overall Study||3
10184777|NCT03216954|11314583|FG004|COMPLETED|Overall Study||0
10184778|NCT03216954|11314579|FG000|NOT COMPLETED|Overall Study||2
10184779|NCT03216954|11314580|FG001|NOT COMPLETED|Overall Study||1
10184780|NCT03216954|11314581|FG002|NOT COMPLETED|Overall Study||1
10184781|NCT03216954|11314582|FG003|NOT COMPLETED|Overall Study||0
10184782|NCT03216954|11314583|FG004|NOT COMPLETED|Overall Study||1
10184783|NCT03217968|11314591|FG000|STARTED|Overall Study||59
10184784|NCT03217968|11314591|FG000|COMPLETED|Overall Study||48
10184785|NCT03217968|11314591|FG000|NOT COMPLETED|Overall Study||11
10184786|NCT03218397|11314597|FG000|STARTED|Overall Study||249
10184787|NCT03218397|11314598|FG001|STARTED|Overall Study||251
10184788|NCT03218397|11314597|FG000|COMPLETED|Overall Study||226
10184789|NCT03218397|11314598|FG001|COMPLETED|Overall Study||222
10184790|NCT03218397|11314597|FG000|NOT COMPLETED|Overall Study||23
10184791|NCT03218397|11314598|FG001|NOT COMPLETED|Overall Study||29
10184792|NCT03218566|11314604|FG000|STARTED|Overall Study||119
10184793|NCT03218566|11314604|FG000|COMPLETED|Overall Study||110
10184794|NCT03218566|11314604|FG000|NOT COMPLETED|Overall Study||9
10184795|NCT03218592|11314611|FG000|STARTED|Phase 1: 1 Dose||12
10184796|NCT03218592|11314612|FG001|STARTED|Phase 1: 1 Dose||12
10184797|NCT03218592|11314613|FG002|STARTED|Phase 1: 1 Dose||12
10184798|NCT03218592|11314611|FG000|COMPLETED|Phase 1: 1 Dose||12
10184799|NCT03218592|11314612|FG001|COMPLETED|Phase 1: 1 Dose||12
10184800|NCT03218592|11314613|FG002|COMPLETED|Phase 1: 1 Dose||12
10184801|NCT03218592|11314611|FG000|NOT COMPLETED|Phase 1: 1 Dose||0
10184802|NCT03218592|11314612|FG001|NOT COMPLETED|Phase 1: 1 Dose||0
10184803|NCT03218592|11314613|FG002|NOT COMPLETED|Phase 1: 1 Dose||0
10184804|NCT03218592|11314611|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12
10184805|NCT03218592|11314612|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12
10184806|NCT03218592|11314613|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12
10184807|NCT03218592|11314611|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12
10184808|NCT03218592|11314612|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12
10184809|NCT03218592|11314613|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12
10184810|NCT03218592|11314611|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
10184811|NCT03218592|11314612|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
10184812|NCT03218592|11314613|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
10184813|NCT03218592|11314611|FG000|STARTED|Phase 3: 0 Doses Per Week||4
10184814|NCT03218592|11314612|FG001|STARTED|Phase 3: 0 Doses Per Week||4
10184815|NCT03218592|11314613|FG002|STARTED|Phase 3: 0 Doses Per Week||4
10184816|NCT03218592|11314611|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
10184817|NCT03218592|11314612|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
10184818|NCT03218592|11314613|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
10184819|NCT03218592|11314611|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4
10184820|NCT03218592|11314612|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4
10184821|NCT03218592|11314613|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4
10184822|NCT03218592|11314611|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
10184823|NCT03218592|11314612|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
10184824|NCT03218592|11314613|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
10184825|NCT03218592|11314611|FG000|STARTED|Phase 3: 1 Dose Per Period||4
10184826|NCT03218592|11314612|FG001|STARTED|Phase 3: 1 Dose Per Period||4
10184827|NCT03218592|11314613|FG002|STARTED|Phase 3: 1 Dose Per Period||4
10184828|NCT03218592|11314611|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
10184829|NCT03218592|11314612|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
10184830|NCT03218592|11314613|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
10184831|NCT03218592|11314611|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4
10184832|NCT03218592|11314612|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4
10184833|NCT03218592|11314613|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4
9715055|NCT03523091|10814299|FG001|COMPLETED|Overall Study||1
9715056|NCT03523091|10814298|FG000|NOT COMPLETED|Overall Study||1
10061864|NCT02106325|11187384|FG001|COMPLETED|Phase 1||1
10184834|NCT03218592|11314611|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
10184835|NCT03218592|11314612|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
10184836|NCT03218592|11314613|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
10184837|NCT03218592|11314611|FG000|STARTED|Phase 3: 3 Doses Per Week||4
10184838|NCT03218592|11314612|FG001|STARTED|Phase 3: 3 Doses Per Week||4
10184839|NCT03218592|11314613|FG002|STARTED|Phase 3: 3 Doses Per Week||4
10184840|NCT03218592|11314611|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
10184841|NCT03218592|11314612|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
10184842|NCT03218592|11314613|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
10184843|NCT03218592|11314611|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4
10184844|NCT03218592|11314612|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4
10184845|NCT03218592|11314613|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4
10061865|NCT02106325|11187383|FG000|NOT COMPLETED|Phase 1||2
10184846|NCT03218592|11314611|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
10184847|NCT03218592|11314612|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
10184848|NCT03218592|11314613|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
10184849|NCT03218787|11314626|FG000|STARTED|Overall Study||2047
10184850|NCT03218787|11314626|FG000|COMPLETED|Overall Study||1841
10184851|NCT03218787|11314626|FG000|NOT COMPLETED|Overall Study||206
10184852|NCT03219216|11314632|FG000|STARTED|Overall Study||75
10184853|NCT03219216|11314633|FG001|STARTED|Overall Study||25
10184854|NCT03219216|11314632|FG000|COMPLETED|Overall Study||75
10184855|NCT03219216|11314633|FG001|COMPLETED|Overall Study||24
10184856|NCT03219216|11314632|FG000|NOT COMPLETED|Overall Study||0
10184857|NCT03219216|11314633|FG001|NOT COMPLETED|Overall Study||1
10184858|NCT03219294|11314640|FG000|STARTED|Overall Study||58
10184859|NCT03219294|11314641|FG001|STARTED|Overall Study||58
10184860|NCT03219294|11314640|FG000|COMPLETED|Overall Study||58
10184861|NCT03219294|11314641|FG001|COMPLETED|Overall Study||58
10184862|NCT03219294|11314640|FG000|NOT COMPLETED|Overall Study||0
10184863|NCT03219294|11314641|FG001|NOT COMPLETED|Overall Study||0
10184864|NCT03219320|11314651|FG000|STARTED|Overall Study||75
10184865|NCT03219320|11314652|FG001|STARTED|Overall Study||77
10184866|NCT03219320|11314653|FG002|STARTED|Overall Study||77
10184867|NCT03219320|11314654|FG003|STARTED|Overall Study||72
10184868|NCT03219320|11314651|FG000|COMPLETED|Overall Study||73
10184869|NCT03219320|11314652|FG001|COMPLETED|Overall Study||74
10184870|NCT03219320|11314653|FG002|COMPLETED|Overall Study||72
10184871|NCT03219320|11314654|FG003|COMPLETED|Overall Study||69
10184872|NCT03219320|11314651|FG000|NOT COMPLETED|Overall Study||2
10184873|NCT03219320|11314652|FG001|NOT COMPLETED|Overall Study||3
10184874|NCT03219320|11314653|FG002|NOT COMPLETED|Overall Study||5
10184875|NCT03219320|11314654|FG003|NOT COMPLETED|Overall Study||3
10184876|NCT03219723|11314664|FG000|STARTED|Overall Study||560
10184877|NCT03219723|11314664|FG000|COMPLETED|Overall Study||550
10184878|NCT03219723|11314664|FG000|NOT COMPLETED|Overall Study||10
10184879|NCT03219840|11314668|FG000|STARTED|Overall Study||38
10184880|NCT03219840|11314669|FG001|STARTED|Overall Study||31
9715057|NCT03523091|10814299|FG001|NOT COMPLETED|Overall Study||4
9715058|NCT03503474|10814307|FG000|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a positive test result at the coordinating laboratory. There is no intervention as this is an observational study only.|103
9715059|NCT03503474|10814308|FG001|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a negative test result at the coordinating laboratory. There is no intervention as this is an observational study only.|3050
9715060|NCT03503474|10814307|FG000|COMPLETED|Overall Study||103
9715061|NCT03503474|10814308|FG001|COMPLETED|Overall Study||3050
9715062|NCT03503474|10814307|FG000|NOT COMPLETED|Overall Study||0
9715063|NCT03503474|10814308|FG001|NOT COMPLETED|Overall Study||0
9715064|NCT03476317|10814317|FG000|STARTED|Overall Study|Group 1 study was not completed|0
9715065|NCT03476317|10814318|FG001|STARTED|Overall Study|Group 1 study was not completed|0
10184881|NCT03219840|11314668|FG000|Day 1 Visit for 1st Period|Overall Study||37
10184882|NCT03219840|11314669|FG001|Day 1 Visit for 1st Period|Overall Study||31
10184883|NCT03219840|11314668|FG000|1st Intervention Period of 21 Days|Overall Study||34
10184884|NCT03219840|11314669|FG001|1st Intervention Period of 21 Days|Overall Study||31
10184885|NCT03219840|11314668|FG000|Day 22 Visit for 1st Period|Overall Study||34
10184886|NCT03219840|11314669|FG001|Day 22 Visit for 1st Period|Overall Study||31
10184887|NCT03219840|11314668|FG000|Washout Period of 21 Days|Overall Study||34
10184888|NCT03219840|11314669|FG001|Washout Period of 21 Days|Overall Study||31
10184889|NCT03219840|11314668|FG000|Day 1 Visit for 2nd Period|Overall Study||34
10184890|NCT03219840|11314669|FG001|Day 1 Visit for 2nd Period|Overall Study||31
10184891|NCT03219840|11314668|FG000|2nd Intervention Period of 21 Days|Overall Study||34
9715066|NCT03476317|10814319|FG002|STARTED|Overall Study||10
9715067|NCT03476317|10814317|FG000|COMPLETED|Overall Study|Group 1 study was not completed|0
9715068|NCT03476317|10814318|FG001|COMPLETED|Overall Study|Group 1 study was not completed|0
10184892|NCT03219840|11314669|FG001|2nd Intervention Period of 21 Days|Overall Study||31
10184893|NCT03219840|11314668|FG000|Day 22 Visit for 2nd Period|Overall Study||34
10184894|NCT03219840|11314669|FG001|Day 22 Visit for 2nd Period|Overall Study||31
10184895|NCT03219840|11314668|FG000|COMPLETED|Overall Study||34
10184896|NCT03219840|11314669|FG001|COMPLETED|Overall Study||31
10184897|NCT03219840|11314668|FG000|NOT COMPLETED|Overall Study||4
10184898|NCT03219840|11314669|FG001|NOT COMPLETED|Overall Study||0
10184899|NCT03219866|11314677|FG000|STARTED|Overall Study||21
10184900|NCT03219866|11314678|FG001|STARTED|Overall Study||19
10184901|NCT03219866|11314677|FG000|COMPLETED|Overall Study||21
10184902|NCT03219866|11314678|FG001|COMPLETED|Overall Study||19
10184903|NCT03219866|11314677|FG000|NOT COMPLETED|Overall Study||0
10184904|NCT03219866|11314678|FG001|NOT COMPLETED|Overall Study||0
10184905|NCT03219892|11314686|FG000|STARTED|Overall Study||20
10184906|NCT03219892|11314687|FG001|STARTED|Overall Study||10
10184907|NCT03219892|11314686|FG000|COMPLETED|Overall Study||20
10184908|NCT03219892|11314687|FG001|COMPLETED|Overall Study||10
10184909|NCT03219892|11314686|FG000|NOT COMPLETED|Overall Study||0
10184910|NCT03219892|11314687|FG001|NOT COMPLETED|Overall Study||0
10184911|NCT03220048|11314696|FG000|STARTED|Overall Study||11
10184912|NCT03220048|11314697|FG001|STARTED|Overall Study||27
10184913|NCT03220048|11314698|FG002|STARTED|Overall Study||28
10184914|NCT03220048|11314696|FG000|COMPLETED|Overall Study||11
10184915|NCT03220048|11314697|FG001|COMPLETED|Overall Study||25
10184916|NCT03220048|11314698|FG002|COMPLETED|Overall Study||27
10184917|NCT03220048|11314696|FG000|NOT COMPLETED|Overall Study||0
10184918|NCT03220048|11314697|FG001|NOT COMPLETED|Overall Study||2
10184919|NCT03220048|11314698|FG002|NOT COMPLETED|Overall Study||1
10184920|NCT03220204|11314714|FG000|STARTED|Overall Study||15
10184921|NCT03220204|11314715|FG001|STARTED|Overall Study||15
10184922|NCT03220204|11314716|FG002|STARTED|Overall Study||15
10184923|NCT03220204|11314714|FG000|COMPLETED|Overall Study||14
10184924|NCT03220204|11314715|FG001|COMPLETED|Overall Study||13
9715069|NCT03476317|10814319|FG002|COMPLETED|Overall Study||10
9715070|NCT03476317|10814317|FG000|NOT COMPLETED|Overall Study||0
9715071|NCT03476317|10814318|FG001|NOT COMPLETED|Overall Study||0
9715072|NCT03476317|10814319|FG002|NOT COMPLETED|Overall Study||0
9731401|NCT00132301|10831334|FG000|COMPLETED|Overall Study||121
10184925|NCT03220204|11314716|FG002|COMPLETED|Overall Study||12
10184926|NCT03220204|11314714|FG000|NOT COMPLETED|Overall Study||1
10184927|NCT03220204|11314715|FG001|NOT COMPLETED|Overall Study||2
10184928|NCT03220204|11314716|FG002|NOT COMPLETED|Overall Study||3
10184929|NCT03220217|11314730|FG000|STARTED|Overall Study||8
10184930|NCT03220217|11314731|FG001|STARTED|Overall Study||10
10184931|NCT03220217|11314732|FG002|STARTED|Overall Study||11
10184932|NCT03220217|11314730|FG000|COMPLETED|Overall Study||8
10184933|NCT03220217|11314731|FG001|COMPLETED|Overall Study||9
10184934|NCT03220217|11314732|FG002|COMPLETED|Overall Study||10
10184935|NCT03220217|11314730|FG000|NOT COMPLETED|Overall Study||0
10184936|NCT03220217|11314731|FG001|NOT COMPLETED|Overall Study||1
10184937|NCT03220217|11314732|FG002|NOT COMPLETED|Overall Study||1
10184938|NCT03220230|11314761|FG000|STARTED|Overall Study||4240
10184939|NCT03220230|11314761|FG000|COMPLETED|Overall Study||4240
10184940|NCT03220230|11314761|FG000|NOT COMPLETED|Overall Study||0
10184941|NCT03220412|11314767|FG000|STARTED|Overall Study||54
10184942|NCT03220412|11314768|FG001|STARTED|Overall Study||50
10184943|NCT03220412|11314767|FG000|COMPLETED|Overall Study||54
10184944|NCT03220412|11314768|FG001|COMPLETED|Overall Study||50
10184945|NCT03220412|11314767|FG000|NOT COMPLETED|Overall Study||0
10184946|NCT03220412|11314768|FG001|NOT COMPLETED|Overall Study||0
10184947|NCT03220737|11314783|FG000|STARTED|Main Study (Day 1 - 181)||163
10184948|NCT03220737|11314784|FG001|STARTED|Main Study (Day 1 - 181)||26
10184949|NCT03220737|11314785|FG002|STARTED|Main Study (Day 1 - 181)||158
10184950|NCT03220737|11314786|FG003|STARTED|Main Study (Day 1 - 181)||27
10184951|NCT03220737|11314787|FG004|STARTED|Main Study (Day 1 - 181)||150
10184952|NCT03220737|11314788|FG005|STARTED|Main Study (Day 1 - 181)||26
10184953|NCT03220737|11314789|FG006|STARTED|Main Study (Day 1 - 181)||2688
10184954|NCT03220737|11314783|FG000|COMPLETED|Main Study (Day 1 - 181)||157
10184955|NCT03220737|11314784|FG001|COMPLETED|Main Study (Day 1 - 181)||24
10184956|NCT03220737|11314785|FG002|COMPLETED|Main Study (Day 1 - 181)||146
10184957|NCT03220737|11314786|FG003|COMPLETED|Main Study (Day 1 - 181)||24
10184958|NCT03220737|11314787|FG004|COMPLETED|Main Study (Day 1 - 181)||130
10184959|NCT03220737|11314788|FG005|COMPLETED|Main Study (Day 1 - 181)||25
10184960|NCT03220737|11314789|FG006|COMPLETED|Main Study (Day 1 - 181)||2687
10184961|NCT03220737|11314783|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6
10184962|NCT03220737|11314784|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2
10184963|NCT03220737|11314785|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12
10184964|NCT03220737|11314786|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3
10184965|NCT03220737|11314787|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20
10184966|NCT03220737|11314788|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1
10184967|NCT03220737|11314789|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1
10184968|NCT03220737|11314783|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
10184969|NCT03220737|11314784|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
10184970|NCT03220737|11314785|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
10184971|NCT03220737|11314786|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
10184972|NCT03220737|11314787|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
10184973|NCT03220737|11314788|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
10184974|NCT03220737|11314789|FG006|STARTED|Placebo Crossover (Day 181-365)||0
10184975|NCT03220737|11314783|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13
10184976|NCT03220737|11314784|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0
10184977|NCT03220737|11314785|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11
10184978|NCT03220737|11314786|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0
10184979|NCT03220737|11314787|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5
10184980|NCT03220737|11314788|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0
10184981|NCT03220737|11314789|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0
10184982|NCT03220737|11314783|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10184983|NCT03220737|11314784|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10184984|NCT03220737|11314785|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10184985|NCT03220737|11314786|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10184986|NCT03220737|11314787|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
10184987|NCT03220737|11314788|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10184988|NCT03220737|11314789|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10184989|NCT03220737|11314783|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
10184990|NCT03220737|11314784|FG001|STARTED|Long-term Follow-up (Day 365-730)||0
10184991|NCT03220737|11314785|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
10184992|NCT03220737|11314786|FG003|STARTED|Long-term Follow-up (Day 365-730)||0
10184993|NCT03220737|11314787|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
10184994|NCT03220737|11314788|FG005|STARTED|Long-term Follow-up (Day 365-730)||0
10184995|NCT03220737|11314789|FG006|STARTED|Long-term Follow-up (Day 365-730)||0
10184996|NCT03220737|11314783|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62
10184997|NCT03220737|11314784|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0
10184998|NCT03220737|11314785|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0
10184999|NCT03220737|11314786|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0
10185000|NCT03220737|11314787|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0
10185001|NCT03220737|11314788|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0
10185002|NCT03220737|11314789|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0
10185003|NCT03220737|11314783|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
10185004|NCT03220737|11314784|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10185005|NCT03220737|11314785|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10185006|NCT03220737|11314786|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10185007|NCT03220737|11314787|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10185008|NCT03220737|11314788|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10185009|NCT03220737|11314789|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10185010|NCT03220958|11314813|FG000|STARTED|Overall Study||81
10185011|NCT03220958|11314814|FG001|STARTED|Overall Study||79
9715073|NCT03391960|10814327|FG000|STARTED|Overall Study|Units were not assessed for this Arm/Group. Data was collected from the health care worker surveys for the retrospective study to monitor compliance with the scrub-the-hub protocol (signed informed consent and were enrolled)|165
9715074|NCT03391960|10814328|FG001|STARTED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
9715075|NCT03391960|10814327|FG000|COMPLETED|Overall Study||165
9715076|NCT03391960|10814328|FG001|COMPLETED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
9715077|NCT03391960|10814327|FG000|NOT COMPLETED|Overall Study||0
9715078|NCT03391960|10814328|FG001|NOT COMPLETED|Overall Study||
9715079|NCT03362190|10814347|FG000|STARTED|Overall Study||10
9715080|NCT03362190|10814348|FG001|STARTED|Overall Study||10
9715081|NCT03362190|10814349|FG002|STARTED|Overall Study||22
9715082|NCT03362190|10814350|FG003|STARTED|Overall Study||22
9715083|NCT03362190|10814347|FG000|COMPLETED|Overall Study||10
9715084|NCT03362190|10814348|FG001|COMPLETED|Overall Study||10
9715085|NCT03362190|10814349|FG002|COMPLETED|Overall Study||22
9715086|NCT03362190|10814350|FG003|COMPLETED|Overall Study||20
9715087|NCT03362190|10814347|FG000|NOT COMPLETED|Overall Study||0
9715088|NCT03362190|10814348|FG001|NOT COMPLETED|Overall Study||0
9715089|NCT03362190|10814349|FG002|NOT COMPLETED|Overall Study||0
9715090|NCT03362190|10814350|FG003|NOT COMPLETED|Overall Study||2
9715091|NCT03252522|10814365|FG000|STARTED|Overall Study||78
9715092|NCT03252522|10814366|FG001|STARTED|Overall Study||57
9715093|NCT03252522|10814367|FG002|STARTED|Overall Study||0
10061866|NCT02106325|11187384|FG001|NOT COMPLETED|Phase 1||2
10061867|NCT02106325|11187383|FG000|STARTED|Phase 2||4
10061868|NCT02106325|11187384|FG001|STARTED|Phase 2||4
10061869|NCT02106325|11187383|FG000|COMPLETED|Phase 2||2
10061870|NCT02106325|11187384|FG001|COMPLETED|Phase 2||1
10061871|NCT02106325|11187383|FG000|NOT COMPLETED|Phase 2||2
10061872|NCT02106325|11187384|FG001|NOT COMPLETED|Phase 2||3
10061873|NCT02106325|11187383|FG000|STARTED|Phase 3||2
10061874|NCT02106325|11187384|FG001|STARTED|Phase 3||3
10061875|NCT02106325|11187383|FG000|COMPLETED|Phase 3||0
10061876|NCT02106325|11187384|FG001|COMPLETED|Phase 3||2
10061877|NCT02106325|11187383|FG000|NOT COMPLETED|Phase 3||2
10061878|NCT02106325|11187384|FG001|NOT COMPLETED|Phase 3||1
10061879|NCT02106351|11187393|FG000|STARTED|Treatment Cycle 1||71
10185012|NCT03220958|11314813|FG000|COMPLETED|Overall Study||81
10185013|NCT03220958|11314814|FG001|COMPLETED|Overall Study||79
10185014|NCT03220958|11314813|FG000|NOT COMPLETED|Overall Study||0
10185015|NCT03220958|11314814|FG001|NOT COMPLETED|Overall Study||0
10185016|NCT03221192|11314820|FG000|STARTED|Overall Study||27
10185017|NCT03221192|11314820|FG000|COMPLETED|Overall Study||27
10185018|NCT03221192|11314820|FG000|NOT COMPLETED|Overall Study||0
10185019|NCT03221387|11314824|FG000|STARTED|Overall Study||30
10185020|NCT03221387|11314824|FG000|COMPLETED|Overall Study||28
10185021|NCT03221387|11314824|FG000|NOT COMPLETED|Overall Study||2
10185022|NCT03221595|11314830|FG000|STARTED|Overall Study||51
10185023|NCT03221595|11314831|FG001|STARTED|Overall Study||59
10185024|NCT03221595|11314830|FG000|COMPLETED|Overall Study||51
10185025|NCT03221595|11314831|FG001|COMPLETED|Overall Study||59
10185026|NCT03221595|11314830|FG000|NOT COMPLETED|Overall Study||0
10185027|NCT03221595|11314831|FG001|NOT COMPLETED|Overall Study||0
10185028|NCT03221738|11314837|FG000|STARTED|Overall Study||10
10185029|NCT03221738|11314837|FG000|COMPLETED|Overall Study||10
10185030|NCT03221738|11314837|FG000|NOT COMPLETED|Overall Study||0
10185031|NCT03221764|11314841|FG000|STARTED|Overall Study||20
10185032|NCT03221764|11314841|FG000|COMPLETED|Overall Study||20
10185033|NCT03221764|11314841|FG000|NOT COMPLETED|Overall Study||0
10185034|NCT03222037|11314845|FG000|STARTED|Period 1||21
10185035|NCT03222037|11314846|FG001|STARTED|Period 1||22
9715094|NCT03252522|10814365|FG000|COMPLETED|Overall Study||69
9715095|NCT03252522|10814366|FG001|COMPLETED|Overall Study||54
9715096|NCT03252522|10814367|FG002|COMPLETED|Overall Study||0
9715097|NCT03252522|10814365|FG000|NOT COMPLETED|Overall Study||9
9715098|NCT03252522|10814366|FG001|NOT COMPLETED|Overall Study||3
9715099|NCT03252522|10814367|FG002|NOT COMPLETED|Overall Study||0
9715100|NCT03235544|10814382|FG000|STARTED|Overall Study||12
9715101|NCT03235544|10814383|FG001|STARTED|Overall Study||41
9715102|NCT03235544|10814384|FG002|STARTED|Overall Study||31
9715103|NCT03235544|10814385|FG003|STARTED|Overall Study||77
9715104|NCT03235544|10814382|FG000|COMPLETED|Overall Study||0
9715105|NCT03235544|10814383|FG001|COMPLETED|Overall Study||0
9715106|NCT03235544|10814384|FG002|COMPLETED|Overall Study||0
9715107|NCT03235544|10814385|FG003|COMPLETED|Overall Study||0
10185036|NCT03222037|11314845|FG000|COMPLETED|Period 1||21
10185037|NCT03222037|11314846|FG001|COMPLETED|Period 1||22
10185038|NCT03222037|11314845|FG000|NOT COMPLETED|Period 1||0
10185039|NCT03222037|11314846|FG001|NOT COMPLETED|Period 1||0
10185040|NCT03222037|11314845|FG000|STARTED|Period 2||21
10185041|NCT03222037|11314846|FG001|STARTED|Period 2||22
10185042|NCT03222037|11314845|FG000|COMPLETED|Period 2||21
10185043|NCT03222037|11314846|FG001|COMPLETED|Period 2||22
10185044|NCT03222037|11314845|FG000|NOT COMPLETED|Period 2||0
10185045|NCT03222037|11314846|FG001|NOT COMPLETED|Period 2||0
10185046|NCT03222141|11314852|FG000|STARTED|Overall Study||583
10185047|NCT03222141|11314852|FG000|COMPLETED|Overall Study||565
10185048|NCT03222141|11314852|FG000|NOT COMPLETED|Overall Study||18
10185049|NCT03222349|11314857|FG000|STARTED|Overall Study||11
10185050|NCT03222349|11314858|FG001|STARTED|Overall Study||13
10185051|NCT03222349|11314857|FG000|COMPLETED|Overall Study||3
10185052|NCT03222349|11314858|FG001|COMPLETED|Overall Study||6
10185053|NCT03222349|11314857|FG000|NOT COMPLETED|Overall Study||8
10185054|NCT03222349|11314858|FG001|NOT COMPLETED|Overall Study||7
10185055|NCT03222414|11314873|FG000|STARTED|Overall Study||0
10185056|NCT03222414|11314874|FG001|STARTED|Overall Study||1
10185057|NCT03222414|11314873|FG000|COMPLETED|Overall Study||0
10185058|NCT03222414|11314874|FG001|COMPLETED|Overall Study||1
10185059|NCT03222414|11314873|FG000|NOT COMPLETED|Overall Study||0
10185060|NCT03222414|11314874|FG001|NOT COMPLETED|Overall Study||0
10185061|NCT03222427|11314880|FG000|STARTED|Overall Study||8
10185062|NCT03222427|11314880|FG000|Received One Dose of Study Drug|Overall Study||8
10185063|NCT03222427|11314880|FG000|COMPLETED|Overall Study||8
10185064|NCT03222427|11314880|FG000|NOT COMPLETED|Overall Study||0
9715108|NCT03235544|10814382|FG000|NOT COMPLETED|Overall Study||12
9715109|NCT03235544|10814383|FG001|NOT COMPLETED|Overall Study||41
9715110|NCT03235544|10814384|FG002|NOT COMPLETED|Overall Study||31
10061880|NCT02106351|11187394|FG001|STARTED|Treatment Cycle 1||70
10185065|NCT03222505|11314887|FG000|STARTED|Overall Study||5
10185066|NCT03222505|11314888|FG001|STARTED|Overall Study||7
10185067|NCT03222505|11314887|FG000|COMPLETED|Overall Study||5
10185068|NCT03222505|11314888|FG001|COMPLETED|Overall Study||7
10185069|NCT03222505|11314887|FG000|NOT COMPLETED|Overall Study||0
10185070|NCT03222505|11314888|FG001|NOT COMPLETED|Overall Study||0
10185071|NCT03222583|11314897|FG000|STARTED|Overall Study||363
10061881|NCT02106351|11187395|FG002|STARTED|Treatment Cycle 1||71
10185072|NCT03222583|11314898|FG001|STARTED|Overall Study||183
10185073|NCT03222583|11314897|FG000|Received Double-blind Treatment|Overall Study||362
10185074|NCT03222583|11314898|FG001|Received Double-blind Treatment|Overall Study||183
10185075|NCT03222583|11314897|FG000|Completed Double-blind Period|Overall Study||360
10185076|NCT03222583|11314898|FG001|Completed Double-blind Period|Overall Study||183
10185077|NCT03222583|11314897|FG000|Entered Open-label Period|Overall Study||0
10185078|NCT03222583|11314898|FG001|Entered Open-label Period|Overall Study||182
10185079|NCT03222583|11314897|FG000|Completed Open-label Period|Overall Study||0
10185080|NCT03222583|11314898|FG001|Completed Open-label Period|Overall Study||181
10185081|NCT03222583|11314897|FG000|COMPLETED|Overall Study||358
10185082|NCT03222583|11314898|FG001|COMPLETED|Overall Study||177
10185083|NCT03222583|11314897|FG000|NOT COMPLETED|Overall Study||5
10185084|NCT03222583|11314898|FG001|NOT COMPLETED|Overall Study||6
10185085|NCT03223246|11314906|FG000|STARTED|48-72 Hours||83
10185086|NCT03223246|11314907|FG001|STARTED|48-72 Hours||66
10185087|NCT03223246|11314906|FG000|COMPLETED|48-72 Hours||62
10185088|NCT03223246|11314907|FG001|COMPLETED|48-72 Hours||35
10185089|NCT03223246|11314906|FG000|NOT COMPLETED|48-72 Hours||21
10185090|NCT03223246|11314907|FG001|NOT COMPLETED|48-72 Hours||31
10185091|NCT03223246|11314906|FG000|STARTED|5-7 Days||83
10185092|NCT03223246|11314907|FG001|STARTED|5-7 Days||66
10185093|NCT03223246|11314906|FG000|COMPLETED|5-7 Days||41
10185094|NCT03223246|11314907|FG001|COMPLETED|5-7 Days||35
10185095|NCT03223246|11314906|FG000|NOT COMPLETED|5-7 Days||42
10185096|NCT03223246|11314907|FG001|NOT COMPLETED|5-7 Days||31
10185097|NCT03223272|11314913|FG000|STARTED|Overall Study||7
10185098|NCT03223272|11314913|FG000|COMPLETED|Overall Study||6
10185099|NCT03223272|11314913|FG000|NOT COMPLETED|Overall Study||1
10185100|NCT03223337|11314921|FG000|STARTED|Part 1 (Up to 16 Days)||8
10185101|NCT03223337|11314922|FG001|STARTED|Part 1 (Up to 16 Days)||8
10185102|NCT03223337|11314923|FG002|STARTED|Part 1 (Up to 16 Days)||0
10185103|NCT03223337|11314924|FG003|STARTED|Part 1 (Up to 16 Days)||0
10185104|NCT03223337|11314921|FG000|COMPLETED|Part 1 (Up to 16 Days)||8
10185105|NCT03223337|11314922|FG001|COMPLETED|Part 1 (Up to 16 Days)||8
10185106|NCT03223337|11314923|FG002|COMPLETED|Part 1 (Up to 16 Days)||0
10185107|NCT03223337|11314924|FG003|COMPLETED|Part 1 (Up to 16 Days)||0
10185108|NCT03223337|11314921|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10185109|NCT03223337|11314922|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10185110|NCT03223337|11314923|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10185111|NCT03223337|11314924|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10185112|NCT03223337|11314921|FG000|STARTED|Part 2 (Up to 16 Days)||0
10185113|NCT03223337|11314922|FG001|STARTED|Part 2 (Up to 16 Days)||0
10185114|NCT03223337|11314923|FG002|STARTED|Part 2 (Up to 16 Days)||12
10185115|NCT03223337|11314924|FG003|STARTED|Part 2 (Up to 16 Days)||9
10185116|NCT03223337|11314921|FG000|COMPLETED|Part 2 (Up to 16 Days)||0
10185117|NCT03223337|11314922|FG001|COMPLETED|Part 2 (Up to 16 Days)||0
10185118|NCT03223337|11314923|FG002|COMPLETED|Part 2 (Up to 16 Days)||12
10185119|NCT03223337|11314924|FG003|COMPLETED|Part 2 (Up to 16 Days)||9
10185120|NCT03223337|11314921|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10185121|NCT03223337|11314922|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10185122|NCT03223337|11314923|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10185123|NCT03223337|11314924|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10185124|NCT03223649|11314936|FG000|STARTED|Overall Study||52
10185125|NCT03223649|11314937|FG001|STARTED|Overall Study||57
10185126|NCT03223649|11314936|FG000|COMPLETED|Overall Study||42
10185127|NCT03223649|11314937|FG001|COMPLETED|Overall Study||51
10185128|NCT03223649|11314936|FG000|NOT COMPLETED|Overall Study||10
10185129|NCT03223649|11314937|FG001|NOT COMPLETED|Overall Study||6
10185130|NCT03223909|11314946|FG000|STARTED|Overall Study||120
10185131|NCT03223909|11314947|FG001|STARTED|Overall Study||109
10185132|NCT03223909|11314948|FG002|STARTED|Overall Study||97
10185133|NCT03223909|11314946|FG000|COMPLETED|Overall Study||72
10185134|NCT03223909|11314947|FG001|COMPLETED|Overall Study||64
10185135|NCT03223909|11314948|FG002|COMPLETED|Overall Study||81
10185136|NCT03223909|11314946|FG000|NOT COMPLETED|Overall Study||48
10185137|NCT03223909|11314947|FG001|NOT COMPLETED|Overall Study||45
10185138|NCT03223909|11314948|FG002|NOT COMPLETED|Overall Study||16
10185139|NCT03224130|11314958|FG000|STARTED|Overall Study||483
10185140|NCT03224130|11314959|FG001|STARTED|Overall Study||483
10185141|NCT03224130|11314958|FG000|COMPLETED|Overall Study||483
10185142|NCT03224130|11314959|FG001|COMPLETED|Overall Study||482
10185143|NCT03224130|11314958|FG000|NOT COMPLETED|Overall Study||0
10185144|NCT03224130|11314959|FG001|NOT COMPLETED|Overall Study||1
10185145|NCT03224182|11314967|FG000|STARTED|Overall Study||81
10185146|NCT03224182|11314968|FG001|STARTED|Overall Study||37
10185147|NCT03224182|11314967|FG000|Safety Population|Overall Study||73
10185148|NCT03224182|11314968|FG001|Safety Population|Overall Study||36
10185149|NCT03224182|11314967|FG000|COMPLETED|Overall Study||0
10185150|NCT03224182|11314968|FG001|COMPLETED|Overall Study||1
10185151|NCT03224182|11314967|FG000|NOT COMPLETED|Overall Study||81
10185152|NCT03224182|11314968|FG001|NOT COMPLETED|Overall Study||36
10185153|NCT03224234|11314978|FG000|STARTED|Main Study||40
10185154|NCT03224234|11314979|FG001|STARTED|Main Study||40
10185155|NCT03224234|11314978|FG000|COMPLETED|Main Study||35
10185156|NCT03224234|11314979|FG001|COMPLETED|Main Study||35
10185157|NCT03224234|11314978|FG000|NOT COMPLETED|Main Study||5
10185158|NCT03224234|11314979|FG001|NOT COMPLETED|Main Study||5
10185159|NCT03224234|11314978|FG000|STARTED|Pilot||11
10185160|NCT03224234|11314979|FG001|STARTED|Pilot||7
10185161|NCT03224234|11314978|FG000|COMPLETED|Pilot||11
10185162|NCT03224234|11314979|FG001|COMPLETED|Pilot||7
10185163|NCT03224234|11314978|FG000|NOT COMPLETED|Pilot||0
10185164|NCT03224234|11314979|FG001|NOT COMPLETED|Pilot||0
10185165|NCT03224299|11314991|FG000|STARTED|Overall Study||131
10185166|NCT03224299|11314992|FG001|STARTED|Overall Study||424
10185167|NCT03224299|11314991|FG000|Treated With IP#1|Overall Study||65
10185168|NCT03224299|11314992|FG001|Treated With IP#1|Overall Study||101
10185169|NCT03224299|11314991|FG000|Treated With IP#2|Overall Study||66
10185170|NCT03224299|11314992|FG001|Treated With IP#2|Overall Study||107
10185171|NCT03224299|11314991|FG000|Treated With AC|Overall Study||66
10185172|NCT03224299|11314992|FG001|Treated With AC|Overall Study||110
10185173|NCT03224299|11314991|FG000|Treated With NC|Overall Study||65
10185174|NCT03224299|11314992|FG001|Treated With NC|Overall Study||106
10185175|NCT03224299|11314991|FG000|COMPLETED|Overall Study||131
10185176|NCT03224299|11314992|FG001|COMPLETED|Overall Study||424
10185177|NCT03224299|11314991|FG000|NOT COMPLETED|Overall Study||0
10185178|NCT03224299|11314992|FG001|NOT COMPLETED|Overall Study||0
10185179|NCT03224325|11315013|FG000|STARTED|Overall Study||13
10185180|NCT03224325|11315014|FG001|STARTED|Overall Study||6
10185181|NCT03224325|11315015|FG002|STARTED|Overall Study||6
10185182|NCT03224325|11315016|FG003|STARTED|Overall Study||6
10185183|NCT03224325|11315017|FG004|STARTED|Overall Study||6
10185184|NCT03224325|11315018|FG005|STARTED|Overall Study||6
10185185|NCT03224325|11315019|FG006|STARTED|Overall Study||7
10185186|NCT03224325|11315013|FG000|COMPLETED|Overall Study||12
10185187|NCT03224325|11315014|FG001|COMPLETED|Overall Study||6
10185188|NCT03224325|11315015|FG002|COMPLETED|Overall Study||6
10185189|NCT03224325|11315016|FG003|COMPLETED|Overall Study||5
10185190|NCT03224325|11315017|FG004|COMPLETED|Overall Study||6
10185191|NCT03224325|11315018|FG005|COMPLETED|Overall Study||6
10185192|NCT03224325|11315019|FG006|COMPLETED|Overall Study||6
10185193|NCT03224325|11315013|FG000|NOT COMPLETED|Overall Study||1
10185194|NCT03224325|11315014|FG001|NOT COMPLETED|Overall Study||0
10185195|NCT03224325|11315015|FG002|NOT COMPLETED|Overall Study||0
10185196|NCT03224325|11315016|FG003|NOT COMPLETED|Overall Study||1
10185197|NCT03224325|11315017|FG004|NOT COMPLETED|Overall Study||0
10185198|NCT03224325|11315018|FG005|NOT COMPLETED|Overall Study||0
10185199|NCT03224325|11315019|FG006|NOT COMPLETED|Overall Study||1
10185200|NCT03224351|11315049|FG000|STARTED|Overall Study||10
10185201|NCT03224351|11315050|FG001|STARTED|Overall Study||11
10185202|NCT03224351|11315051|FG002|STARTED|Overall Study||20
10185203|NCT03224351|11315052|FG003|STARTED|Overall Study||22
10185204|NCT03224351|11315053|FG004|STARTED|Overall Study||11
10185205|NCT03224351|11315054|FG005|STARTED|Overall Study||18
10185206|NCT03224351|11315055|FG006|STARTED|Overall Study||6
10185207|NCT03224351|11315056|FG007|STARTED|Overall Study||19
10185208|NCT03224351|11315049|FG000|COMPLETED|Overall Study||10
10185209|NCT03224351|11315050|FG001|COMPLETED|Overall Study||11
10185210|NCT03224351|11315051|FG002|COMPLETED|Overall Study||20
10185211|NCT03224351|11315052|FG003|COMPLETED|Overall Study||22
10185212|NCT03224351|11315053|FG004|COMPLETED|Overall Study||11
10185213|NCT03224351|11315054|FG005|COMPLETED|Overall Study||18
10185214|NCT03224351|11315055|FG006|COMPLETED|Overall Study||6
10185215|NCT03224351|11315056|FG007|COMPLETED|Overall Study||19
10185216|NCT03224351|11315049|FG000|NOT COMPLETED|Overall Study||0
10185217|NCT03224351|11315050|FG001|NOT COMPLETED|Overall Study||0
10185218|NCT03224351|11315051|FG002|NOT COMPLETED|Overall Study||0
10185219|NCT03224351|11315052|FG003|NOT COMPLETED|Overall Study||0
10185220|NCT03224351|11315053|FG004|NOT COMPLETED|Overall Study||0
10185221|NCT03224351|11315054|FG005|NOT COMPLETED|Overall Study||0
10185222|NCT03224351|11315055|FG006|NOT COMPLETED|Overall Study||0
10185223|NCT03224351|11315056|FG007|NOT COMPLETED|Overall Study||0
10185224|NCT03224390|11315084|FG000|STARTED|Overall Study||56
10185225|NCT03224390|11315085|FG001|STARTED|Overall Study||56
10185226|NCT03224390|11315084|FG000|COMPLETED|Overall Study||29
10185227|NCT03224390|11315085|FG001|COMPLETED|Overall Study||21
10185228|NCT03224390|11315084|FG000|NOT COMPLETED|Overall Study||27
10185229|NCT03224390|11315085|FG001|NOT COMPLETED|Overall Study||35
10185230|NCT03224403|11315097|FG000|STARTED|Overall Study||59
10185231|NCT03224403|11315098|FG001|STARTED|Overall Study||249
10185232|NCT03224403|11315099|FG002|STARTED|Overall Study||232
10185233|NCT03224403|11315100|FG003|STARTED|Overall Study||124
10185234|NCT03224403|11315097|FG000|COMPLETED|Overall Study||59
10185235|NCT03224403|11315098|FG001|COMPLETED|Overall Study||249
10185236|NCT03224403|11315099|FG002|COMPLETED|Overall Study||232
10185237|NCT03224403|11315100|FG003|COMPLETED|Overall Study||124
10185238|NCT03224403|11315097|FG000|NOT COMPLETED|Overall Study||0
10185239|NCT03224403|11315098|FG001|NOT COMPLETED|Overall Study||0
10185240|NCT03224403|11315099|FG002|NOT COMPLETED|Overall Study||0
10185241|NCT03224403|11315100|FG003|NOT COMPLETED|Overall Study||0
10185242|NCT03224520|11315114|FG000|STARTED|Overall Study||371
10185243|NCT03224520|11315115|FG001|STARTED|Overall Study||370
10185244|NCT03224520|11315116|FG002|STARTED|Overall Study||374
10185245|NCT03224520|11315117|FG003|STARTED|Overall Study||372
10185246|NCT03224520|11315114|FG000|COMPLETED|Overall Study||205
10185247|NCT03224520|11315115|FG001|COMPLETED|Overall Study||207
10185248|NCT03224520|11315116|FG002|COMPLETED|Overall Study||190
10185249|NCT03224520|11315117|FG003|COMPLETED|Overall Study||199
10185250|NCT03224520|11315114|FG000|NOT COMPLETED|Overall Study||166
10185251|NCT03224520|11315115|FG001|NOT COMPLETED|Overall Study||163
10185252|NCT03224520|11315116|FG002|NOT COMPLETED|Overall Study||184
10185253|NCT03224520|11315117|FG003|NOT COMPLETED|Overall Study||173
10185254|NCT03224585|11315129|FG000|STARTED|Overall Study||2
10185255|NCT03224585|11315130|FG001|STARTED|Overall Study||3
10185256|NCT03224585|11315129|FG000|COMPLETED|Overall Study||2
10185257|NCT03224585|11315130|FG001|COMPLETED|Overall Study||3
10185258|NCT03224585|11315129|FG000|NOT COMPLETED|Overall Study||0
10185259|NCT03224585|11315130|FG001|NOT COMPLETED|Overall Study||0
10185260|NCT03224598|11315138|FG000|STARTED|Overall Study||9
10185261|NCT03224598|11315139|FG001|STARTED|Overall Study||17
10185262|NCT03224598|11315140|FG002|STARTED|Overall Study||13
10185263|NCT03224598|11315138|FG000|COMPLETED|Overall Study||9
10185264|NCT03224598|11315139|FG001|COMPLETED|Overall Study||14
10185265|NCT03224598|11315140|FG002|COMPLETED|Overall Study||13
10185266|NCT03224598|11315138|FG000|NOT COMPLETED|Overall Study||0
10185267|NCT03224598|11315139|FG001|NOT COMPLETED|Overall Study||3
10185268|NCT03224598|11315140|FG002|NOT COMPLETED|Overall Study||0
9715111|NCT03235544|10814385|FG003|NOT COMPLETED|Overall Study||77
9715112|NCT03225833|10814402|FG000|STARTED|Overall Study||16
9715113|NCT03225833|10814403|FG001|STARTED|Overall Study||9
9715114|NCT03225833|10814404|FG002|STARTED|Overall Study||9
9715115|NCT03225833|10814405|FG003|STARTED|Overall Study||9
9715116|NCT03225833|10814406|FG004|STARTED|Overall Study||8
9715117|NCT03225833|10814407|FG005|STARTED|Overall Study||10
9715118|NCT03225833|10814402|FG000|Single Dose Period Only|Overall Study||1
9715119|NCT03225833|10814403|FG001|Single Dose Period Only|Overall Study||1
9715120|NCT03225833|10814404|FG002|Single Dose Period Only|Overall Study||2
9715121|NCT03225833|10814405|FG003|Single Dose Period Only|Overall Study||0
9715122|NCT03225833|10814406|FG004|Single Dose Period Only|Overall Study||0
9715123|NCT03225833|10814407|FG005|Single Dose Period Only|Overall Study||4
9715124|NCT03225833|10814402|FG000|Multiple Dose Period Only|Overall Study||0
9715125|NCT03225833|10814403|FG001|Multiple Dose Period Only|Overall Study||0
9715126|NCT03225833|10814404|FG002|Multiple Dose Period Only|Overall Study||0
9715127|NCT03225833|10814405|FG003|Multiple Dose Period Only|Overall Study||0
9715128|NCT03225833|10814406|FG004|Multiple Dose Period Only|Overall Study||0
9715129|NCT03225833|10814407|FG005|Multiple Dose Period Only|Overall Study||1
9715130|NCT03225833|10814402|FG000|Single Dose and Multiple Dose Periods|Overall Study||15
9715131|NCT03225833|10814403|FG001|Single Dose and Multiple Dose Periods|Overall Study||8
9715132|NCT03225833|10814404|FG002|Single Dose and Multiple Dose Periods|Overall Study||7
9715133|NCT03225833|10814405|FG003|Single Dose and Multiple Dose Periods|Overall Study||9
9715134|NCT03225833|10814406|FG004|Single Dose and Multiple Dose Periods|Overall Study||8
9715135|NCT03225833|10814407|FG005|Single Dose and Multiple Dose Periods|Overall Study||5
9715136|NCT03225833|10814402|FG000|COMPLETED|Overall Study||11
9849834|NCT00867815|10962666|FG000|NOT COMPLETED|Overall Study||1
9849835|NCT00867932|10962670|FG000|STARTED|Overall Study||7
9849836|NCT00867932|10962670|FG000|Induction Phase|Overall Study||7
9849837|NCT00867932|10962670|FG000|Maintenance Phase|Overall Study||7
9849838|NCT00867932|10962670|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
9849839|NCT00867932|10962670|FG000|Intent-to-Treat (ITT) Population|Overall Study||7
9849840|NCT00867932|10962670|FG000|COMPLETED|Overall Study||7
9849841|NCT00867932|10962670|FG000|NOT COMPLETED|Overall Study||0
9849842|NCT00868101|10962676|FG000|STARTED|Overall Study||12
9849843|NCT00868101|10962677|FG001|STARTED|Overall Study||10
9849844|NCT00868101|10962676|FG000|COMPLETED|Overall Study||12
9849845|NCT00868101|10962677|FG001|COMPLETED|Overall Study||10
9849846|NCT00868101|10962676|FG000|NOT COMPLETED|Overall Study||0
9849847|NCT00868101|10962677|FG001|NOT COMPLETED|Overall Study||0
9849848|NCT00868140|10962687|FG000|STARTED|Overall Study||26
9849849|NCT00868140|10962688|FG001|STARTED|Overall Study||25
9849850|NCT00868140|10962687|FG000|COMPLETED|Overall Study||26
9849851|NCT00868140|10962688|FG001|COMPLETED|Overall Study||25
9715137|NCT03225833|10814403|FG001|COMPLETED|Overall Study||8
9849852|NCT00868140|10962687|FG000|NOT COMPLETED|Overall Study||0
10185269|NCT03225001|11315148|FG000|STARTED|Overall Study||197
10185270|NCT03225001|11315148|FG000|Valve-Implanted|Overall Study||195
10185271|NCT03225001|11315148|FG000|COMPLETED|Overall Study||188
10185272|NCT03225001|11315148|FG000|NOT COMPLETED|Overall Study||9
10185273|NCT03225313|11315155|FG000|STARTED|Overall Study|25 Patients|25
10185274|NCT03225313|11315156|FG001|STARTED|Overall Study|25 Patients|25
10185275|NCT03225313|11315157|FG002|STARTED|Overall Study|25 Patients|25
10185276|NCT03225313|11315155|FG000|COMPLETED|Overall Study|25 Patients|25
10185277|NCT03225313|11315156|FG001|COMPLETED|Overall Study|25 Patients|25
10185278|NCT03225313|11315157|FG002|COMPLETED|Overall Study|25 Patients|25
10185279|NCT03225313|11315155|FG000|NOT COMPLETED|Overall Study||0
10185280|NCT03225313|11315156|FG001|NOT COMPLETED|Overall Study||0
10185281|NCT03225313|11315157|FG002|NOT COMPLETED|Overall Study||0
10185282|NCT03225573|11315167|FG000|STARTED|Overall Study||60
10185283|NCT03225573|11315167|FG000|COMPLETED|Overall Study||60
10185284|NCT03225573|11315167|FG000|NOT COMPLETED|Overall Study||0
10185285|NCT03225599|11315171|FG000|STARTED|Overall Study||9
10185286|NCT03225599|11315171|FG000|COMPLETED|Overall Study||7
10185287|NCT03225599|11315171|FG000|NOT COMPLETED|Overall Study||2
10185288|NCT03225859|11315175|FG000|STARTED|Overall Study||12
10185289|NCT03225859|11315175|FG000|COMPLETED|Overall Study||11
10185290|NCT03225859|11315175|FG000|NOT COMPLETED|Overall Study||1
10185291|NCT03226223|11315181|FG000|STARTED|Overall Study||10
10185292|NCT03226223|11315182|FG001|STARTED|Overall Study||8
10185293|NCT03226223|11315181|FG000|COMPLETED|Overall Study||8
10185294|NCT03226223|11315182|FG001|COMPLETED|Overall Study||6
10185295|NCT03226223|11315181|FG000|NOT COMPLETED|Overall Study||2
10185296|NCT03226223|11315182|FG001|NOT COMPLETED|Overall Study||2
10185297|NCT03226249|11315188|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30
10185298|NCT03226249|11315188|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
10185299|NCT03226249|11315188|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
10185300|NCT03226249|11315188|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
10185301|NCT03226249|11315188|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30
10185302|NCT03226249|11315188|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
10185303|NCT03226249|11315188|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
10185304|NCT03226249|11315188|FG000|STARTED|2 Cycles of AVD + PET#3||30
10185305|NCT03226249|11315188|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30
10185306|NCT03226249|11315188|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30
10185307|NCT03226249|11315188|FG000|PET#3|2 Cycles of AVD + PET#3||30
10185308|NCT03226249|11315188|FG000|COMPLETED|2 Cycles of AVD + PET#3||30
10185309|NCT03226249|11315188|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0
10185310|NCT03226249|11315188|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
10185311|NCT03226249|11315188|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
10185312|NCT03226249|11315188|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
10185313|NCT03226249|11315188|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
10185314|NCT03226249|11315188|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
10185315|NCT03226249|11315188|FG000|STARTED|PEM Consolidation (1-2 Years)||29
10185316|NCT03226249|11315188|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0
10185317|NCT03226249|11315188|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
10185318|NCT03226249|11315188|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
10185319|NCT03226249|11315188|FG000|COMPLETED|Survival Follow-up||0
10185320|NCT03226249|11315188|FG000|NOT COMPLETED|Survival Follow-up||30
10185321|NCT03226275|11315196|FG000|STARTED|Treatment Period 1 (8 Days)||8
10185322|NCT03226275|11315197|FG001|STARTED|Treatment Period 1 (8 Days)||8
10185323|NCT03226275|11315198|FG002|STARTED|Treatment Period 1 (8 Days)||8
10185324|NCT03226275|11315199|FG003|STARTED|Treatment Period 1 (8 Days)||8
10185325|NCT03226275|11315196|FG000|COMPLETED|Treatment Period 1 (8 Days)||8
10185326|NCT03226275|11315197|FG001|COMPLETED|Treatment Period 1 (8 Days)||8
10185327|NCT03226275|11315198|FG002|COMPLETED|Treatment Period 1 (8 Days)||7
10185328|NCT03226275|11315199|FG003|COMPLETED|Treatment Period 1 (8 Days)||7
10185329|NCT03226275|11315196|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10185330|NCT03226275|11315197|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10185331|NCT03226275|11315198|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1
10185332|NCT03226275|11315199|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1
10185333|NCT03226275|11315196|FG000|STARTED|Treatment Period 2 (8 Days)||8
10185334|NCT03226275|11315197|FG001|STARTED|Treatment Period 2 (8 Days)||8
10185335|NCT03226275|11315198|FG002|STARTED|Treatment Period 2 (8 Days)||7
10185336|NCT03226275|11315199|FG003|STARTED|Treatment Period 2 (8 Days)||7
10185337|NCT03226275|11315196|FG000|COMPLETED|Treatment Period 2 (8 Days)||8
10185338|NCT03226275|11315197|FG001|COMPLETED|Treatment Period 2 (8 Days)||8
10185339|NCT03226275|11315198|FG002|COMPLETED|Treatment Period 2 (8 Days)||7
9715138|NCT03225833|10814404|FG002|COMPLETED|Overall Study||7
9715139|NCT03225833|10814405|FG003|COMPLETED|Overall Study||9
9715140|NCT03225833|10814406|FG004|COMPLETED|Overall Study||7
9715141|NCT03225833|10814407|FG005|COMPLETED|Overall Study||0
9715142|NCT03225833|10814402|FG000|NOT COMPLETED|Overall Study||5
9715143|NCT03225833|10814403|FG001|NOT COMPLETED|Overall Study||1
9715144|NCT03225833|10814404|FG002|NOT COMPLETED|Overall Study||2
9715145|NCT03225833|10814405|FG003|NOT COMPLETED|Overall Study||0
9715146|NCT03225833|10814406|FG004|NOT COMPLETED|Overall Study||1
10185340|NCT03226275|11315199|FG003|COMPLETED|Treatment Period 2 (8 Days)||7
9715147|NCT03225833|10814407|FG005|NOT COMPLETED|Overall Study||10
10185341|NCT03226275|11315196|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10185342|NCT03226275|11315197|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10185343|NCT03226275|11315198|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10185344|NCT03226275|11315199|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10185345|NCT03226353|11315209|FG000|STARTED|Overall Study||77
10185346|NCT03226353|11315209|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2
10185347|NCT03226353|11315209|FG000|Other Habitual Lens Types|Overall Study||75
10185348|NCT03226353|11315209|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
10185349|NCT03226353|11315209|FG000|NOT COMPLETED|Overall Study||6
10185350|NCT03226366|11315220|FG000|STARTED|Overall Study||911
10185351|NCT03226366|11315221|FG001|STARTED|Overall Study||495
10185352|NCT03226366|11315222|FG002|STARTED|Overall Study||1183
10185353|NCT03226366|11315223|FG003|STARTED|Overall Study||641
10185354|NCT03226366|11315220|FG000|COMPLETED|Overall Study||911
10185355|NCT03226366|11315221|FG001|COMPLETED|Overall Study||495
10185356|NCT03226366|11315222|FG002|COMPLETED|Overall Study||1183
10185357|NCT03226366|11315223|FG003|COMPLETED|Overall Study||641
10185358|NCT03226366|11315220|FG000|NOT COMPLETED|Overall Study||0
10185359|NCT03226366|11315221|FG001|NOT COMPLETED|Overall Study||0
10185360|NCT03226366|11315222|FG002|NOT COMPLETED|Overall Study||0
10185361|NCT03226366|11315223|FG003|NOT COMPLETED|Overall Study||0
10185362|NCT03226392|11315235|FG000|STARTED|Overall Study||352
10185363|NCT03226392|11315236|FG001|STARTED|Overall Study||352
10185364|NCT03226392|11315235|FG000|FAS|Overall Study||352
10185365|NCT03226392|11315236|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
10185366|NCT03226392|11315235|FG000|COMPLETED|Overall Study||341
10185367|NCT03226392|11315236|FG001|COMPLETED|Overall Study||344
10185368|NCT03226392|11315235|FG000|NOT COMPLETED|Overall Study||11
10185369|NCT03226392|11315236|FG001|NOT COMPLETED|Overall Study||8
10185370|NCT03226457|11315242|FG000|STARTED|Treatment 1: 6 Weeks||12
10185371|NCT03226457|11315243|FG001|STARTED|Treatment 1: 6 Weeks||11
10185372|NCT03226457|11315242|FG000|COMPLETED|Treatment 1: 6 Weeks||12
10185373|NCT03226457|11315243|FG001|COMPLETED|Treatment 1: 6 Weeks||11
10185374|NCT03226457|11315242|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0
10185375|NCT03226457|11315243|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0
10185376|NCT03226457|11315242|FG000|STARTED|Washout Period: Minimum 2 Weeks||12
10185377|NCT03226457|11315243|FG001|STARTED|Washout Period: Minimum 2 Weeks||11
10185378|NCT03226457|11315242|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12
10185379|NCT03226457|11315243|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11
10185380|NCT03226457|11315242|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
10185381|NCT03226457|11315243|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
10185382|NCT03226457|11315242|FG000|STARTED|Treatment 2: 6 Weeks||12
10185383|NCT03226457|11315243|FG001|STARTED|Treatment 2: 6 Weeks||11
10185384|NCT03226457|11315242|FG000|COMPLETED|Treatment 2: 6 Weeks||12
10185385|NCT03226457|11315243|FG001|COMPLETED|Treatment 2: 6 Weeks||11
10185386|NCT03226457|11315242|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0
10185387|NCT03226457|11315243|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0
10185388|NCT03226652|11315249|FG000|STARTED|Overall Study||101
10185389|NCT03226652|11315249|FG000|COMPLETED|Overall Study||101
10185390|NCT03226652|11315249|FG000|NOT COMPLETED|Overall Study||0
10185391|NCT03226691|11315253|FG000|STARTED|Overall Study||15
10185392|NCT03226691|11315253|FG000|COMPLETED|Overall Study||15
10185393|NCT03226691|11315253|FG000|NOT COMPLETED|Overall Study||0
10185394|NCT03226769|11315259|FG000|STARTED|Overall Study||29
10185395|NCT03226769|11315260|FG001|STARTED|Overall Study||28
10185396|NCT03226769|11315259|FG000|COMPLETED|Overall Study||29
10185397|NCT03226769|11315260|FG001|COMPLETED|Overall Study||27
10185398|NCT03226769|11315259|FG000|NOT COMPLETED|Overall Study||0
10185399|NCT03226769|11315260|FG001|NOT COMPLETED|Overall Study||1
10185400|NCT03226899|11315268|FG000|STARTED|Overall Study||118
10185401|NCT03226899|11315269|FG001|STARTED|Overall Study||124
10185402|NCT03226899|11315268|FG000|COMPLETED|Overall Study||0
10185403|NCT03226899|11315269|FG001|COMPLETED|Overall Study||0
10185404|NCT03226899|11315268|FG000|NOT COMPLETED|Overall Study||118
10185405|NCT03226899|11315269|FG001|NOT COMPLETED|Overall Study||124
10185406|NCT03227445|11315275|FG000|STARTED|Period 1 (28 Days)||60
10185407|NCT03227445|11315276|FG001|STARTED|Period 1 (28 Days)||59
10185408|NCT03227445|11315277|FG002|STARTED|Period 1 (28 Days)||60
10185409|NCT03227445|11315278|FG003|STARTED|Period 1 (28 Days)||60
10185410|NCT03227445|11315275|FG000|COMPLETED|Period 1 (28 Days)||58
10185411|NCT03227445|11315276|FG001|COMPLETED|Period 1 (28 Days)||57
10185412|NCT03227445|11315277|FG002|COMPLETED|Period 1 (28 Days)||59
10185413|NCT03227445|11315278|FG003|COMPLETED|Period 1 (28 Days)||58
10185414|NCT03227445|11315275|FG000|NOT COMPLETED|Period 1 (28 Days)||2
10185415|NCT03227445|11315276|FG001|NOT COMPLETED|Period 1 (28 Days)||2
10185416|NCT03227445|11315277|FG002|NOT COMPLETED|Period 1 (28 Days)||1
10185417|NCT03227445|11315278|FG003|NOT COMPLETED|Period 1 (28 Days)||2
10185418|NCT03227445|11315275|FG000|STARTED|Period 2 (28 Days)||58
10185419|NCT03227445|11315276|FG001|STARTED|Period 2 (28 Days)||57
10185420|NCT03227445|11315277|FG002|STARTED|Period 2 (28 Days)||59
10185421|NCT03227445|11315278|FG003|STARTED|Period 2 (28 Days)||58
10185422|NCT03227445|11315275|FG000|COMPLETED|Period 2 (28 Days)||57
10185423|NCT03227445|11315276|FG001|COMPLETED|Period 2 (28 Days)||56
10185424|NCT03227445|11315277|FG002|COMPLETED|Period 2 (28 Days)||57
10185425|NCT03227445|11315278|FG003|COMPLETED|Period 2 (28 Days)||55
10185426|NCT03227445|11315275|FG000|NOT COMPLETED|Period 2 (28 Days)||1
10185427|NCT03227445|11315276|FG001|NOT COMPLETED|Period 2 (28 Days)||1
10185428|NCT03227445|11315277|FG002|NOT COMPLETED|Period 2 (28 Days)||2
10185429|NCT03227445|11315278|FG003|NOT COMPLETED|Period 2 (28 Days)||3
10185430|NCT03227692|11315289|FG000|STARTED|Overall Study||47
10185431|NCT03227692|11315290|FG001|STARTED|Overall Study||46
10185432|NCT03227692|11315289|FG000|COMPLETED|Overall Study||42
10185433|NCT03227692|11315290|FG001|COMPLETED|Overall Study||41
10185434|NCT03227692|11315289|FG000|NOT COMPLETED|Overall Study||5
10185435|NCT03227692|11315290|FG001|NOT COMPLETED|Overall Study||5
10185436|NCT03227861|11315296|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109
10185437|NCT03227861|11315296|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97
10185438|NCT03227861|11315296|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
10185439|NCT03227861|11315296|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
10185440|NCT03227861|11315296|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0
10185441|NCT03227861|11315296|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
10185442|NCT03228017|11315304|FG000|STARTED|Overall Study||45
10185443|NCT03228017|11315305|FG001|STARTED|Overall Study||18
10185444|NCT03228017|11315304|FG000|COMPLETED|Overall Study||45
10185445|NCT03228017|11315305|FG001|COMPLETED|Overall Study||18
10185446|NCT03228017|11315304|FG000|NOT COMPLETED|Overall Study||0
10185447|NCT03228017|11315305|FG001|NOT COMPLETED|Overall Study||0
10185448|NCT03228212|11315311|FG000|STARTED|Period 1||65
10185449|NCT03228212|11315312|FG001|STARTED|Period 1||65
10185450|NCT03228212|11315311|FG000|COMPLETED|Period 1||64
10185451|NCT03228212|11315312|FG001|COMPLETED|Period 1||64
10185452|NCT03228212|11315311|FG000|NOT COMPLETED|Period 1||1
10185453|NCT03228212|11315312|FG001|NOT COMPLETED|Period 1||1
10185454|NCT03228212|11315311|FG000|STARTED|Period 2||64
10185455|NCT03228212|11315312|FG001|STARTED|Period 2||64
10185456|NCT03228212|11315311|FG000|COMPLETED|Period 2||63
10185457|NCT03228212|11315312|FG001|COMPLETED|Period 2||64
10185458|NCT03228212|11315311|FG000|NOT COMPLETED|Period 2||1
10185459|NCT03228212|11315312|FG001|NOT COMPLETED|Period 2||0
10185460|NCT03228212|11315311|FG000|STARTED|Period 3||63
10185461|NCT03228212|11315312|FG001|STARTED|Period 3||64
10185462|NCT03228212|11315311|FG000|COMPLETED|Period 3||63
9715148|NCT03167242|10814438|FG000|STARTED|Overall Study||12
9715149|NCT03167242|10814439|FG001|STARTED|Overall Study||51
9715150|NCT03167242|10814440|FG002|STARTED|Overall Study||51
9715151|NCT03167242|10814441|FG003|STARTED|Overall Study||51
9715152|NCT03167242|10814442|FG004|STARTED|Overall Study||54
9715153|NCT03167242|10814443|FG005|STARTED|Overall Study||51
9715154|NCT03167242|10814444|FG006|STARTED|Overall Study||52
9715155|NCT03167242|10814445|FG007|STARTED|Overall Study||27
9715156|NCT03167242|10814446|FG008|STARTED|Overall Study||53
9715157|NCT03167242|10814447|FG009|STARTED|Overall Study||53
9715158|NCT03167242|10814448|FG010|STARTED|Overall Study||45
9715159|NCT03167242|10814449|FG011|STARTED|Overall Study||24
9715160|NCT03167242|10814438|FG000|Full Analysis Set (FAS)|Overall Study||12
9715161|NCT03167242|10814439|FG001|Full Analysis Set (FAS)|Overall Study||51
9715162|NCT03167242|10814440|FG002|Full Analysis Set (FAS)|Overall Study||51
9715163|NCT03167242|10814441|FG003|Full Analysis Set (FAS)|Overall Study||51
9715164|NCT03167242|10814442|FG004|Full Analysis Set (FAS)|Overall Study||54
9715165|NCT03167242|10814443|FG005|Full Analysis Set (FAS)|Overall Study||51
9715166|NCT03167242|10814444|FG006|Full Analysis Set (FAS)|Overall Study||52
9715167|NCT03167242|10814445|FG007|Full Analysis Set (FAS)|Overall Study||27
9715168|NCT03167242|10814446|FG008|Full Analysis Set (FAS)|Overall Study||52
9715169|NCT03167242|10814447|FG009|Full Analysis Set (FAS)|Overall Study||53
9715170|NCT03167242|10814448|FG010|Full Analysis Set (FAS)|Overall Study||45
9715171|NCT03167242|10814449|FG011|Full Analysis Set (FAS)|Overall Study||24
9715172|NCT03167242|10814438|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12
9715173|NCT03167242|10814439|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47
9715174|NCT03167242|10814440|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51
9715175|NCT03167242|10814441|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46
9715176|NCT03167242|10814442|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48
9715177|NCT03167242|10814443|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46
9715178|NCT03167242|10814444|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45
9715179|NCT03167242|10814445|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24
9715180|NCT03167242|10814446|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48
9715181|NCT03167242|10814447|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46
9715182|NCT03167242|10814448|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41
9715183|NCT03167242|10814449|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24
9715184|NCT03167242|10814438|FG000|Per-Protocol Set (PPS)|Overall Study||12
9715185|NCT03167242|10814439|FG001|Per-Protocol Set (PPS)|Overall Study||50
9715186|NCT03167242|10814440|FG002|Per-Protocol Set (PPS)|Overall Study||48
9715187|NCT03167242|10814441|FG003|Per-Protocol Set (PPS)|Overall Study||48
9715188|NCT03167242|10814442|FG004|Per-Protocol Set (PPS)|Overall Study||47
9715189|NCT03167242|10814443|FG005|Per-Protocol Set (PPS)|Overall Study||44
9715190|NCT03167242|10814444|FG006|Per-Protocol Set (PPS)|Overall Study||43
9715191|NCT03167242|10814445|FG007|Per-Protocol Set (PPS)|Overall Study||25
9715192|NCT03167242|10814446|FG008|Per-Protocol Set (PPS)|Overall Study||48
9715193|NCT03167242|10814447|FG009|Per-Protocol Set (PPS)|Overall Study||46
9715194|NCT03167242|10814448|FG010|Per-Protocol Set (PPS)|Overall Study||40
10061882|NCT02106351|11187393|FG000|Received Treatment in TC 1|Treatment Cycle 1||70
10061883|NCT02106351|11187394|FG001|Received Treatment in TC 1|Treatment Cycle 1||70
9715195|NCT03167242|10814449|FG011|Per-Protocol Set (PPS)|Overall Study||22
10185463|NCT03228212|11315312|FG001|COMPLETED|Period 3||64
10185464|NCT03228212|11315311|FG000|NOT COMPLETED|Period 3||0
10185465|NCT03228212|11315312|FG001|NOT COMPLETED|Period 3||0
10185466|NCT03228420|11315320|FG000|STARTED|Overall Study||113
10185467|NCT03228420|11315321|FG001|STARTED|Overall Study||103
10185468|NCT03228420|11315320|FG000|Month-1|Overall Study||95
10185469|NCT03228420|11315321|FG001|Month-1|Overall Study||101
10185470|NCT03228420|11315320|FG000|Month-3|Overall Study||93
10185471|NCT03228420|11315321|FG001|Month-3|Overall Study||98
10185472|NCT03228420|11315320|FG000|COMPLETED|Overall Study||93
10185473|NCT03228420|11315321|FG001|COMPLETED|Overall Study||98
10185474|NCT03228420|11315320|FG000|NOT COMPLETED|Overall Study||20
10185475|NCT03228420|11315321|FG001|NOT COMPLETED|Overall Study||5
10185476|NCT03228433|11315333|FG000|STARTED|Overall Study||10
10185477|NCT03228433|11315334|FG001|STARTED|Overall Study||6
10185478|NCT03228433|11315335|FG002|STARTED|Overall Study||6
10185479|NCT03228433|11315336|FG003|STARTED|Overall Study||6
10185480|NCT03228433|11315337|FG004|STARTED|Overall Study||6
10185481|NCT03228433|11315338|FG005|STARTED|Overall Study||6
10185482|NCT03228433|11315333|FG000|COMPLETED|Overall Study||9
10185483|NCT03228433|11315334|FG001|COMPLETED|Overall Study||6
10185484|NCT03228433|11315335|FG002|COMPLETED|Overall Study||6
10185485|NCT03228433|11315336|FG003|COMPLETED|Overall Study||5
10185486|NCT03228433|11315337|FG004|COMPLETED|Overall Study||6
10185487|NCT03228433|11315338|FG005|COMPLETED|Overall Study||6
10185488|NCT03228433|11315333|FG000|NOT COMPLETED|Overall Study||1
10185489|NCT03228433|11315334|FG001|NOT COMPLETED|Overall Study||0
10185490|NCT03228433|11315335|FG002|NOT COMPLETED|Overall Study||0
10185491|NCT03228433|11315336|FG003|NOT COMPLETED|Overall Study||1
10185492|NCT03228433|11315337|FG004|NOT COMPLETED|Overall Study||0
10185493|NCT03228433|11315338|FG005|NOT COMPLETED|Overall Study||0
10185494|NCT03228836|11315360|FG000|STARTED|Overall Study||28
10185495|NCT03228836|11315360|FG000|Treated|Overall Study||28
10185496|NCT03228836|11315360|FG000|COMPLETED|Overall Study||11
10185497|NCT03228836|11315360|FG000|NOT COMPLETED|Overall Study||17
10185498|NCT03228914|11315364|FG000|STARTED|Overall Study||20
10185499|NCT03228914|11315365|FG001|STARTED|Overall Study||20
10185500|NCT03228914|11315364|FG000|COMPLETED|Overall Study||20
10185501|NCT03228914|11315365|FG001|COMPLETED|Overall Study||20
10185502|NCT03228914|11315364|FG000|NOT COMPLETED|Overall Study||0
10185503|NCT03228914|11315365|FG001|NOT COMPLETED|Overall Study||0
10185504|NCT03229109|11315375|FG000|STARTED|Overall Study||50
10185505|NCT03229109|11315376|FG001|STARTED|Overall Study||50
9849853|NCT00868140|10962688|FG001|NOT COMPLETED|Overall Study||0
9849854|NCT00868166|10962698|FG000|STARTED|Overall Study||259
9849855|NCT00868166|10962699|FG001|STARTED|Overall Study||253
10185506|NCT03229109|11315377|FG002|STARTED|Overall Study||50
10185507|NCT03229109|11315378|FG003|STARTED|Overall Study||51
10185508|NCT03229109|11315375|FG000|COMPLETED|Overall Study||50
10185509|NCT03229109|11315376|FG001|COMPLETED|Overall Study||50
10185510|NCT03229109|11315377|FG002|COMPLETED|Overall Study||50
9715196|NCT03167242|10814438|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
9715197|NCT03167242|10814439|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
9715198|NCT03167242|10814440|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
9715199|NCT03167242|10814441|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
9715200|NCT03167242|10814442|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
9715201|NCT03167242|10814443|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
9715202|NCT03167242|10814444|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
9715203|NCT03167242|10814445|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
9715204|NCT03167242|10814446|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
9715205|NCT03167242|10814447|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
9715206|NCT03167242|10814448|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
9715207|NCT03167242|10814449|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
9715208|NCT03167242|10814438|FG000|COMPLETED|Overall Study||12
9715209|NCT03167242|10814439|FG001|COMPLETED|Overall Study||50
10185511|NCT03229109|11315378|FG003|COMPLETED|Overall Study||50
10185512|NCT03229109|11315375|FG000|NOT COMPLETED|Overall Study||0
10185513|NCT03229109|11315376|FG001|NOT COMPLETED|Overall Study||0
10185514|NCT03229109|11315377|FG002|NOT COMPLETED|Overall Study||0
10185515|NCT03229109|11315378|FG003|NOT COMPLETED|Overall Study||1
10185516|NCT03229252|11315391|FG000|STARTED|Overall Study||31
10185517|NCT03229252|11315392|FG001|STARTED|Overall Study||15
10185518|NCT03229252|11315393|FG002|STARTED|Overall Study||45
10185519|NCT03229252|11315391|FG000|COMPLETED|Overall Study||29
10185520|NCT03229252|11315392|FG001|COMPLETED|Overall Study||15
10185521|NCT03229252|11315393|FG002|COMPLETED|Overall Study||39
10185522|NCT03229252|11315391|FG000|NOT COMPLETED|Overall Study||2
10185523|NCT03229252|11315392|FG001|NOT COMPLETED|Overall Study||0
10185524|NCT03229252|11315393|FG002|NOT COMPLETED|Overall Study||6
10185525|NCT03229486|11315403|FG000|STARTED|Overall Study||20
10185526|NCT03229486|11315404|FG001|STARTED|Overall Study||20
10185527|NCT03229486|11315403|FG000|COMPLETED|Overall Study||20
10185528|NCT03229486|11315404|FG001|COMPLETED|Overall Study||19
10185529|NCT03229486|11315403|FG000|NOT COMPLETED|Overall Study||0
10185530|NCT03229486|11315404|FG001|NOT COMPLETED|Overall Study||1
10185531|NCT03229759|11315410|FG000|STARTED|Overall Study||99
10185532|NCT03229759|11315410|FG000|Participants Treated|Overall Study||69
10185533|NCT03229759|11315410|FG000|Treated With Investigational Product|Overall Study||45
10185534|NCT03229759|11315410|FG000|Treated With Vehicle Control|Overall Study||47
10185535|NCT03229759|11315410|FG000|Treated With Saline Control|Overall Study||46
10185536|NCT03229759|11315410|FG000|COMPLETED|Overall Study||69
10185537|NCT03229759|11315410|FG000|NOT COMPLETED|Overall Study||30
10185538|NCT03230175|11315416|FG000|STARTED|Overall Study||32
10185539|NCT03230175|11315416|FG000|COMPLETED|Overall Study||30
10185540|NCT03230175|11315416|FG000|NOT COMPLETED|Overall Study||2
10185541|NCT03230864|11315423|FG000|STARTED|Prospective Confirmation (PC) Period||68
10185542|NCT03230864|11315424|FG001|STARTED|Prospective Confirmation (PC) Period||51
10185543|NCT03230864|11315425|FG002|STARTED|Prospective Confirmation (PC) Period||0
10185544|NCT03230864|11315426|FG003|STARTED|Prospective Confirmation (PC) Period||0
10185545|NCT03230864|11315423|FG000|COMPLETED|Prospective Confirmation (PC) Period||36
10185546|NCT03230864|11315424|FG001|COMPLETED|Prospective Confirmation (PC) Period||32
10185547|NCT03230864|11315425|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
10185548|NCT03230864|11315426|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
10185549|NCT03230864|11315423|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32
10185550|NCT03230864|11315424|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19
10185551|NCT03230864|11315425|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10185552|NCT03230864|11315426|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10185553|NCT03230864|11315423|FG000|STARTED|Double Blind Treatment (DBT) Period||0
10185554|NCT03230864|11315424|FG001|STARTED|Double Blind Treatment (DBT) Period||0
10185555|NCT03230864|11315425|FG002|STARTED|Double Blind Treatment (DBT) Period||35
10185556|NCT03230864|11315426|FG003|STARTED|Double Blind Treatment (DBT) Period||33
10185557|NCT03230864|11315423|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0
10185558|NCT03230864|11315424|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0
10185559|NCT03230864|11315425|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27
10185560|NCT03230864|11315426|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31
10185561|NCT03230864|11315423|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
10185562|NCT03230864|11315424|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
10185563|NCT03230864|11315425|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
10185564|NCT03230864|11315426|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
10185565|NCT03231228|11315438|FG000|STARTED|Overall Study||33
10185566|NCT03231228|11315439|FG001|STARTED|Overall Study||28
10185567|NCT03231228|11315438|FG000|COMPLETED|Overall Study||30
10185568|NCT03231228|11315439|FG001|COMPLETED|Overall Study||28
10185569|NCT03231228|11315438|FG000|NOT COMPLETED|Overall Study||3
10185570|NCT03231228|11315439|FG001|NOT COMPLETED|Overall Study||0
10185571|NCT03231345|11315445|FG000|STARTED|Overall Study||35
10185572|NCT03231345|11315445|FG000|COMPLETED|Overall Study||35
10185573|NCT03231345|11315445|FG000|NOT COMPLETED|Overall Study||0
10185574|NCT03231371|11315449|FG000|STARTED|Overall Study||22
10185575|NCT03231371|11315449|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
10185576|NCT03231371|11315449|FG000|COMPLETED|Overall Study||9
10185577|NCT03231371|11315449|FG000|NOT COMPLETED|Overall Study||13
10185578|NCT03231709|11315455|FG000|STARTED|Treatment Period 1||30
10185579|NCT03231709|11315456|FG001|STARTED|Treatment Period 1||30
10185580|NCT03231709|11315455|FG000|COMPLETED|Treatment Period 1||30
10185581|NCT03231709|11315456|FG001|COMPLETED|Treatment Period 1||29
10185582|NCT03231709|11315455|FG000|NOT COMPLETED|Treatment Period 1||0
10185583|NCT03231709|11315456|FG001|NOT COMPLETED|Treatment Period 1||1
10185584|NCT03231709|11315455|FG000|STARTED|Treatment Period 2||30
10185585|NCT03231709|11315456|FG001|STARTED|Treatment Period 2||29
10185586|NCT03231709|11315455|FG000|COMPLETED|Treatment Period 2||30
10185587|NCT03231709|11315456|FG001|COMPLETED|Treatment Period 2||28
10185588|NCT03231709|11315455|FG000|NOT COMPLETED|Treatment Period 2||0
10185589|NCT03231709|11315456|FG001|NOT COMPLETED|Treatment Period 2||1
10185590|NCT03231800|11315468|FG000|STARTED|Overall Study||48
10185591|NCT03231800|11315469|FG001|STARTED|Overall Study||47
10185592|NCT03231800|11315468|FG000|Safety Population|Overall Study||47
10185593|NCT03231800|11315469|FG001|Safety Population|Overall Study||47
10185594|NCT03231800|11315468|FG000|COMPLETED|Overall Study||45
10185595|NCT03231800|11315469|FG001|COMPLETED|Overall Study||44
10185596|NCT03231800|11315468|FG000|NOT COMPLETED|Overall Study||3
10185597|NCT03231800|11315469|FG001|NOT COMPLETED|Overall Study||3
10185598|NCT03231917|11315477|FG000|STARTED|Overall Study||60
10185599|NCT03231917|11315478|FG001|STARTED|Overall Study||61
10185600|NCT03231917|11315477|FG000|COMPLETED|Overall Study||60
10185601|NCT03231917|11315478|FG001|COMPLETED|Overall Study||61
10185602|NCT03231917|11315477|FG000|NOT COMPLETED|Overall Study||0
10185603|NCT03231917|11315478|FG001|NOT COMPLETED|Overall Study||0
10185604|NCT03231943|11315491|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2
9715210|NCT03167242|10814440|FG002|COMPLETED|Overall Study||48
9715211|NCT03167242|10814441|FG003|COMPLETED|Overall Study||50
9715212|NCT03167242|10814442|FG004|COMPLETED|Overall Study||53
9715213|NCT03167242|10814443|FG005|COMPLETED|Overall Study||49
9715214|NCT03167242|10814444|FG006|COMPLETED|Overall Study||50
10185605|NCT03231943|11315492|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2
10185606|NCT03231943|11315493|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2
10185607|NCT03231943|11315494|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2
10185608|NCT03231943|11315495|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2
10185609|NCT03231943|11315496|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2
10185610|NCT03231943|11315497|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2
9715215|NCT03167242|10814445|FG007|COMPLETED|Overall Study||26
10185611|NCT03231943|11315498|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2
10185612|NCT03231943|11315499|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0
10185613|NCT03231943|11315500|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0
10185614|NCT03231943|11315501|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0
10185615|NCT03231943|11315502|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0
10185616|NCT03231943|11315503|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0
10185617|NCT03231943|11315491|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185618|NCT03231943|11315492|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185619|NCT03231943|11315493|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185620|NCT03231943|11315494|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185621|NCT03231943|11315495|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185622|NCT03231943|11315496|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185623|NCT03231943|11315497|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185624|NCT03231943|11315498|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10185625|NCT03231943|11315499|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185626|NCT03231943|11315500|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185627|NCT03231943|11315501|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185628|NCT03231943|11315502|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185629|NCT03231943|11315503|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185630|NCT03231943|11315491|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185631|NCT03231943|11315492|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185632|NCT03231943|11315493|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185633|NCT03231943|11315494|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185634|NCT03231943|11315495|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185635|NCT03231943|11315496|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185636|NCT03231943|11315497|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185637|NCT03231943|11315498|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185638|NCT03231943|11315499|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185639|NCT03231943|11315500|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185640|NCT03231943|11315501|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185641|NCT03231943|11315502|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185642|NCT03231943|11315503|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10185643|NCT03231943|11315491|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2
10185644|NCT03231943|11315492|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2
10185645|NCT03231943|11315493|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2
10185646|NCT03231943|11315494|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2
10185647|NCT03231943|11315495|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2
10185648|NCT03231943|11315496|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2
10185649|NCT03231943|11315497|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2
10185650|NCT03231943|11315498|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2
10185651|NCT03231943|11315499|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0
10185652|NCT03231943|11315500|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0
10185653|NCT03231943|11315501|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0
10185654|NCT03231943|11315502|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0
10185655|NCT03231943|11315503|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0
10185656|NCT03231943|11315491|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10185657|NCT03231943|11315492|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
10185658|NCT03231943|11315493|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
10185659|NCT03231943|11315494|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10185660|NCT03231943|11315495|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10185661|NCT03231943|11315496|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10185662|NCT03231943|11315497|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10185663|NCT03231943|11315498|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10185664|NCT03231943|11315499|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185665|NCT03231943|11315500|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185666|NCT03231943|11315501|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185667|NCT03231943|11315502|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185668|NCT03231943|11315503|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185669|NCT03231943|11315491|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185670|NCT03231943|11315492|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
10185671|NCT03231943|11315493|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
10185672|NCT03231943|11315494|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185673|NCT03231943|11315495|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185674|NCT03231943|11315496|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185675|NCT03231943|11315497|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185676|NCT03231943|11315498|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185677|NCT03231943|11315499|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185678|NCT03231943|11315500|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185679|NCT03231943|11315501|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185680|NCT03231943|11315502|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185681|NCT03231943|11315503|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10185682|NCT03231943|11315491|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2
10185683|NCT03231943|11315492|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2
10185684|NCT03231943|11315493|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2
10185685|NCT03231943|11315494|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2
10185686|NCT03231943|11315495|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2
10185687|NCT03231943|11315496|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2
10185688|NCT03231943|11315497|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2
10185689|NCT03231943|11315498|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2
10185690|NCT03231943|11315499|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0
10185691|NCT03231943|11315500|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0
10185692|NCT03231943|11315501|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0
10185693|NCT03231943|11315502|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0
10185694|NCT03231943|11315503|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0
10185695|NCT03231943|11315491|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
10185696|NCT03231943|11315492|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10185697|NCT03231943|11315493|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10185698|NCT03231943|11315494|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10185699|NCT03231943|11315495|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10185700|NCT03231943|11315496|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10185701|NCT03231943|11315497|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10185702|NCT03231943|11315498|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10185703|NCT03231943|11315499|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185704|NCT03231943|11315500|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185705|NCT03231943|11315501|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185706|NCT03231943|11315502|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185707|NCT03231943|11315503|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185708|NCT03231943|11315491|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
10185709|NCT03231943|11315492|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185710|NCT03231943|11315493|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185711|NCT03231943|11315494|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185712|NCT03231943|11315495|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185713|NCT03231943|11315496|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185714|NCT03231943|11315497|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185715|NCT03231943|11315498|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185716|NCT03231943|11315499|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185717|NCT03231943|11315500|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185718|NCT03231943|11315501|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185719|NCT03231943|11315502|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185720|NCT03231943|11315503|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10185721|NCT03231943|11315491|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2
10185722|NCT03231943|11315492|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2
10185723|NCT03231943|11315493|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2
10185724|NCT03231943|11315494|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2
10185725|NCT03231943|11315495|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2
10185726|NCT03231943|11315496|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2
10185727|NCT03231943|11315497|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2
10185728|NCT03231943|11315498|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2
10185729|NCT03231943|11315499|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0
10185730|NCT03231943|11315500|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0
10185731|NCT03231943|11315501|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0
10185732|NCT03231943|11315502|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0
10185733|NCT03231943|11315503|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0
10185734|NCT03231943|11315491|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185735|NCT03231943|11315492|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185736|NCT03231943|11315493|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185737|NCT03231943|11315494|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185738|NCT03231943|11315495|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185739|NCT03231943|11315496|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185740|NCT03231943|11315497|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185741|NCT03231943|11315498|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10185742|NCT03231943|11315499|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185743|NCT03231943|11315500|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185744|NCT03231943|11315501|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185745|NCT03231943|11315502|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185746|NCT03231943|11315503|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185747|NCT03231943|11315491|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185748|NCT03231943|11315492|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185749|NCT03231943|11315493|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185750|NCT03231943|11315494|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185751|NCT03231943|11315495|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185752|NCT03231943|11315496|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185753|NCT03231943|11315497|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185754|NCT03231943|11315498|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185755|NCT03231943|11315499|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185756|NCT03231943|11315500|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185757|NCT03231943|11315501|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185758|NCT03231943|11315502|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185759|NCT03231943|11315503|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10185760|NCT03231943|11315491|FG000|STARTED|Part 2||0
10185761|NCT03231943|11315492|FG001|STARTED|Part 2||0
10185762|NCT03231943|11315493|FG002|STARTED|Part 2||0
10185763|NCT03231943|11315494|FG003|STARTED|Part 2||0
10185764|NCT03231943|11315495|FG004|STARTED|Part 2||0
10185765|NCT03231943|11315496|FG005|STARTED|Part 2||0
10185766|NCT03231943|11315497|FG006|STARTED|Part 2||0
10185767|NCT03231943|11315498|FG007|STARTED|Part 2||0
10185768|NCT03231943|11315499|FG008|STARTED|Part 2||6
10185769|NCT03231943|11315500|FG009|STARTED|Part 2||6
10185770|NCT03231943|11315501|FG010|STARTED|Part 2||25
10185771|NCT03231943|11315502|FG011|STARTED|Part 2||7
10185772|NCT03231943|11315503|FG012|STARTED|Part 2||14
10185773|NCT03231943|11315491|FG000|COMPLETED|Part 2||0
10185774|NCT03231943|11315492|FG001|COMPLETED|Part 2||0
10185775|NCT03231943|11315493|FG002|COMPLETED|Part 2||0
10185776|NCT03231943|11315494|FG003|COMPLETED|Part 2||0
10185777|NCT03231943|11315495|FG004|COMPLETED|Part 2||0
10185778|NCT03231943|11315496|FG005|COMPLETED|Part 2||0
10185779|NCT03231943|11315497|FG006|COMPLETED|Part 2||0
10185780|NCT03231943|11315498|FG007|COMPLETED|Part 2||0
10185781|NCT03231943|11315499|FG008|COMPLETED|Part 2||6
10185782|NCT03231943|11315500|FG009|COMPLETED|Part 2||6
10185783|NCT03231943|11315501|FG010|COMPLETED|Part 2||24
10185784|NCT03231943|11315502|FG011|COMPLETED|Part 2||6
10185785|NCT03231943|11315503|FG012|COMPLETED|Part 2||14
10185786|NCT03231943|11315491|FG000|NOT COMPLETED|Part 2||0
10185787|NCT03231943|11315492|FG001|NOT COMPLETED|Part 2||0
10185788|NCT03231943|11315493|FG002|NOT COMPLETED|Part 2||0
10185789|NCT03231943|11315494|FG003|NOT COMPLETED|Part 2||0
10185790|NCT03231943|11315495|FG004|NOT COMPLETED|Part 2||0
10185791|NCT03231943|11315496|FG005|NOT COMPLETED|Part 2||0
10185792|NCT03231943|11315497|FG006|NOT COMPLETED|Part 2||0
10185793|NCT03231943|11315498|FG007|NOT COMPLETED|Part 2||0
10185794|NCT03231943|11315499|FG008|NOT COMPLETED|Part 2||0
10185795|NCT03231943|11315500|FG009|NOT COMPLETED|Part 2||0
10185796|NCT03231943|11315501|FG010|NOT COMPLETED|Part 2||1
10185797|NCT03231943|11315502|FG011|NOT COMPLETED|Part 2||1
10185798|NCT03231943|11315503|FG012|NOT COMPLETED|Part 2||0
10185799|NCT03231969|11315537|FG000|STARTED|Overall Study||30
10185800|NCT03231969|11315538|FG001|STARTED|Overall Study||30
10185801|NCT03231969|11315539|FG002|STARTED|Overall Study||31
10185802|NCT03231969|11315540|FG003|STARTED|Overall Study||30
10185803|NCT03231969|11315537|FG000|COMPLETED|Overall Study||28
10185804|NCT03231969|11315538|FG001|COMPLETED|Overall Study||28
10185805|NCT03231969|11315539|FG002|COMPLETED|Overall Study||30
10185806|NCT03231969|11315540|FG003|COMPLETED|Overall Study||30
10185807|NCT03231969|11315537|FG000|NOT COMPLETED|Overall Study||2
10185808|NCT03231969|11315538|FG001|NOT COMPLETED|Overall Study||2
10185809|NCT03231969|11315539|FG002|NOT COMPLETED|Overall Study||1
10185810|NCT03231969|11315540|FG003|NOT COMPLETED|Overall Study||0
10185811|NCT03232281|11315552|FG000|STARTED|Overall Study||150
10185812|NCT03232281|11315553|FG001|STARTED|Overall Study||150
10185813|NCT03232281|11315552|FG000|Received Treatment|Overall Study||149
10185814|NCT03232281|11315553|FG001|Received Treatment|Overall Study||150
10185815|NCT03232281|11315552|FG000|Completed Week 12|Overall Study||143
10185816|NCT03232281|11315553|FG001|Completed Week 12|Overall Study||148
10185817|NCT03232281|11315552|FG000|Completed Week 24|Overall Study||143
10185818|NCT03232281|11315553|FG001|Completed Week 24|Overall Study||144
10185819|NCT03232281|11315552|FG000|COMPLETED|Overall Study||143
10185820|NCT03232281|11315553|FG001|COMPLETED|Overall Study||144
10185821|NCT03232281|11315552|FG000|NOT COMPLETED|Overall Study||7
10185822|NCT03232281|11315553|FG001|NOT COMPLETED|Overall Study||6
10185823|NCT03232333|11315559|FG000|STARTED|Overall Study||53
10185824|NCT03232333|11315559|FG000|COMPLETED|Overall Study||38
10185825|NCT03232333|11315559|FG000|NOT COMPLETED|Overall Study||15
10185826|NCT03232567|11315567|FG000|STARTED|Overall Study||15
10185827|NCT03232567|11315568|FG001|STARTED|Overall Study||15
10185828|NCT03232567|11315569|FG002|STARTED|Overall Study||15
10185829|NCT03232567|11315570|FG003|STARTED|Overall Study||15
10185830|NCT03232567|11315567|FG000|COMPLETED|Overall Study||15
10185831|NCT03232567|11315568|FG001|COMPLETED|Overall Study||14
10185832|NCT03232567|11315569|FG002|COMPLETED|Overall Study||15
10185833|NCT03232567|11315570|FG003|COMPLETED|Overall Study||15
10185834|NCT03232567|11315567|FG000|NOT COMPLETED|Overall Study||0
10185835|NCT03232567|11315568|FG001|NOT COMPLETED|Overall Study||1
10185836|NCT03232567|11315569|FG002|NOT COMPLETED|Overall Study||0
10185837|NCT03232567|11315570|FG003|NOT COMPLETED|Overall Study||0
10185838|NCT03232580|11315580|FG000|STARTED|Overall Study||5
10185839|NCT03232580|11315580|FG000|COMPLETED|Overall Study||5
10185840|NCT03232580|11315580|FG000|NOT COMPLETED|Overall Study||0
10185841|NCT03232645|11315584|FG000|STARTED|Overall Study||62
10185842|NCT03232645|11315584|FG000|COMPLETED|Overall Study||58
10185843|NCT03232645|11315584|FG000|NOT COMPLETED|Overall Study||4
10185844|NCT03232749|11315589|FG000|STARTED|Overall Study||25
10185845|NCT03232749|11315589|FG000|COMPLETED|Overall Study||21
10185846|NCT03232749|11315589|FG000|NOT COMPLETED|Overall Study||4
10185847|NCT03232827|11315593|FG000|STARTED|Flavored-sweetened (FS)||80
10185848|NCT03232827|11315593|FG000|COMPLETED|Flavored-sweetened (FS)||80
10185849|NCT03232827|11315593|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0
10185850|NCT03232827|11315593|FG000|STARTED|Unflavored-sweetened (US)||86
10185851|NCT03232827|11315593|FG000|COMPLETED|Unflavored-sweetened (US)||86
10185852|NCT03232827|11315593|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0
10185853|NCT03232827|11315593|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66
10185854|NCT03232827|11315593|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66
10185855|NCT03232827|11315593|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
10185856|NCT03232827|11315593|FG000|STARTED|Flavored-very Low Sweetened||66
10185857|NCT03232827|11315593|FG000|COMPLETED|Flavored-very Low Sweetened||66
10185858|NCT03232827|11315593|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0
10185859|NCT03232983|11315603|FG000|STARTED|Period 1||7
10185860|NCT03232983|11315604|FG001|STARTED|Period 1||7
10185861|NCT03232983|11315605|FG002|STARTED|Period 1||7
10185862|NCT03232983|11315606|FG003|STARTED|Period 1||7
10185863|NCT03232983|11315603|FG000|Received at Least One Dose of Study Drug|Period 1||7
10185864|NCT03232983|11315604|FG001|Received at Least One Dose of Study Drug|Period 1||7
10185865|NCT03232983|11315605|FG002|Received at Least One Dose of Study Drug|Period 1||7
10185866|NCT03232983|11315606|FG003|Received at Least One Dose of Study Drug|Period 1||7
10185867|NCT03232983|11315603|FG000|COMPLETED|Period 1||7
10185868|NCT03232983|11315604|FG001|COMPLETED|Period 1||7
10185869|NCT03232983|11315605|FG002|COMPLETED|Period 1||6
10185870|NCT03232983|11315606|FG003|COMPLETED|Period 1||7
10185871|NCT03232983|11315603|FG000|NOT COMPLETED|Period 1||0
10185872|NCT03232983|11315604|FG001|NOT COMPLETED|Period 1||0
10185873|NCT03232983|11315605|FG002|NOT COMPLETED|Period 1||1
10185874|NCT03232983|11315606|FG003|NOT COMPLETED|Period 1||0
10185875|NCT03232983|11315603|FG000|STARTED|Washout Period 1||7
10185876|NCT03232983|11315604|FG001|STARTED|Washout Period 1||7
10185877|NCT03232983|11315605|FG002|STARTED|Washout Period 1||6
10185878|NCT03232983|11315606|FG003|STARTED|Washout Period 1||7
10185879|NCT03232983|11315603|FG000|COMPLETED|Washout Period 1||7
10185880|NCT03232983|11315604|FG001|COMPLETED|Washout Period 1||7
10185881|NCT03232983|11315605|FG002|COMPLETED|Washout Period 1||6
10185882|NCT03232983|11315606|FG003|COMPLETED|Washout Period 1||7
10185883|NCT03232983|11315603|FG000|NOT COMPLETED|Washout Period 1||0
10185884|NCT03232983|11315604|FG001|NOT COMPLETED|Washout Period 1||0
10185885|NCT03232983|11315605|FG002|NOT COMPLETED|Washout Period 1||0
10185886|NCT03232983|11315606|FG003|NOT COMPLETED|Washout Period 1||0
10185887|NCT03232983|11315603|FG000|STARTED|Period 2||7
10185888|NCT03232983|11315604|FG001|STARTED|Period 2||7
10185889|NCT03232983|11315605|FG002|STARTED|Period 2||6
10185890|NCT03232983|11315606|FG003|STARTED|Period 2||7
10185891|NCT03232983|11315603|FG000|COMPLETED|Period 2||7
10185892|NCT03232983|11315604|FG001|COMPLETED|Period 2||7
10185893|NCT03232983|11315605|FG002|COMPLETED|Period 2||6
10185894|NCT03232983|11315606|FG003|COMPLETED|Period 2||7
10185895|NCT03232983|11315603|FG000|NOT COMPLETED|Period 2||0
10185896|NCT03232983|11315604|FG001|NOT COMPLETED|Period 2||0
10185897|NCT03232983|11315605|FG002|NOT COMPLETED|Period 2||0
10185898|NCT03232983|11315606|FG003|NOT COMPLETED|Period 2||0
10185899|NCT03232983|11315603|FG000|STARTED|Washout Period 2||7
10185900|NCT03232983|11315604|FG001|STARTED|Washout Period 2||7
10185901|NCT03232983|11315605|FG002|STARTED|Washout Period 2||6
10185902|NCT03232983|11315606|FG003|STARTED|Washout Period 2||7
10185903|NCT03232983|11315603|FG000|COMPLETED|Washout Period 2||7
10185904|NCT03232983|11315604|FG001|COMPLETED|Washout Period 2||7
10185905|NCT03232983|11315605|FG002|COMPLETED|Washout Period 2||5
10185906|NCT03232983|11315606|FG003|COMPLETED|Washout Period 2||6
10185907|NCT03232983|11315603|FG000|NOT COMPLETED|Washout Period 2||0
9849856|NCT00868166|10962698|FG000|COMPLETED|Overall Study||147
9849857|NCT00868166|10962699|FG001|COMPLETED|Overall Study||139
10185908|NCT03232983|11315604|FG001|NOT COMPLETED|Washout Period 2||0
10185909|NCT03232983|11315605|FG002|NOT COMPLETED|Washout Period 2||1
10185910|NCT03232983|11315606|FG003|NOT COMPLETED|Washout Period 2||1
10185911|NCT03232983|11315603|FG000|STARTED|Period 3||7
10185912|NCT03232983|11315604|FG001|STARTED|Period 3||7
10185913|NCT03232983|11315605|FG002|STARTED|Period 3||5
10185914|NCT03232983|11315606|FG003|STARTED|Period 3||6
10185915|NCT03232983|11315603|FG000|COMPLETED|Period 3||7
10185916|NCT03232983|11315604|FG001|COMPLETED|Period 3||7
10185917|NCT03232983|11315605|FG002|COMPLETED|Period 3||5
10185918|NCT03232983|11315606|FG003|COMPLETED|Period 3||6
10185919|NCT03232983|11315603|FG000|NOT COMPLETED|Period 3||0
10185920|NCT03232983|11315604|FG001|NOT COMPLETED|Period 3||0
10185921|NCT03232983|11315605|FG002|NOT COMPLETED|Period 3||0
9715216|NCT03167242|10814446|FG008|COMPLETED|Overall Study||52
9849858|NCT00868166|10962698|FG000|NOT COMPLETED|Overall Study||112
9849859|NCT00868166|10962699|FG001|NOT COMPLETED|Overall Study||114
10185922|NCT03232983|11315606|FG003|NOT COMPLETED|Period 3||0
10185923|NCT03232983|11315603|FG000|STARTED|Washout Period 3||7
10185924|NCT03232983|11315604|FG001|STARTED|Washout Period 3||7
10185925|NCT03232983|11315605|FG002|STARTED|Washout Period 3||5
10185926|NCT03232983|11315606|FG003|STARTED|Washout Period 3||6
10185927|NCT03232983|11315603|FG000|COMPLETED|Washout Period 3||7
10185928|NCT03232983|11315604|FG001|COMPLETED|Washout Period 3||7
10185929|NCT03232983|11315605|FG002|COMPLETED|Washout Period 3||5
10185930|NCT03232983|11315606|FG003|COMPLETED|Washout Period 3||6
10185931|NCT03232983|11315603|FG000|NOT COMPLETED|Washout Period 3||0
10185932|NCT03232983|11315604|FG001|NOT COMPLETED|Washout Period 3||0
10185933|NCT03232983|11315605|FG002|NOT COMPLETED|Washout Period 3||0
10185934|NCT03232983|11315606|FG003|NOT COMPLETED|Washout Period 3||0
10185935|NCT03232983|11315603|FG000|STARTED|Period 4||7
10185936|NCT03232983|11315604|FG001|STARTED|Period 4||7
10185937|NCT03232983|11315605|FG002|STARTED|Period 4||5
10185938|NCT03232983|11315606|FG003|STARTED|Period 4||6
10185939|NCT03232983|11315603|FG000|COMPLETED|Period 4||6
10185940|NCT03232983|11315604|FG001|COMPLETED|Period 4||7
10185941|NCT03232983|11315605|FG002|COMPLETED|Period 4||5
10185942|NCT03232983|11315606|FG003|COMPLETED|Period 4||6
10185943|NCT03232983|11315603|FG000|NOT COMPLETED|Period 4||1
10185944|NCT03232983|11315604|FG001|NOT COMPLETED|Period 4||0
10185945|NCT03232983|11315605|FG002|NOT COMPLETED|Period 4||0
10185946|NCT03232983|11315606|FG003|NOT COMPLETED|Period 4||0
10185947|NCT03233009|11315618|FG000|STARTED|Overall Study||40
10185948|NCT03233009|11315618|FG000|Test Product 1|Overall Study||39
10185949|NCT03233009|11315618|FG000|Test Product 2|Overall Study||39
10185950|NCT03233009|11315618|FG000|Test Product 3|Overall Study||39
10185951|NCT03233009|11315618|FG000|Test Product 4|Overall Study||39
10185952|NCT03233009|11315618|FG000|Reference Product|Overall Study||39
10185953|NCT03233009|11315618|FG000|COMPLETED|Overall Study||39
10185954|NCT03233009|11315618|FG000|NOT COMPLETED|Overall Study||1
10185955|NCT03233230|11315635|FG000|STARTED|Overall Study||97
10185956|NCT03233230|11315636|FG001|STARTED|Overall Study||98
10185957|NCT03233230|11315637|FG002|STARTED|Overall Study||96
10185958|NCT03233230|11315638|FG003|STARTED|Overall Study||99
10185959|NCT03233230|11315635|FG000|COMPLETED|Overall Study||82
10185960|NCT03233230|11315636|FG001|COMPLETED|Overall Study||83
10185961|NCT03233230|11315637|FG002|COMPLETED|Overall Study||84
10185962|NCT03233230|11315638|FG003|COMPLETED|Overall Study||91
10185963|NCT03233230|11315635|FG000|NOT COMPLETED|Overall Study||15
10185964|NCT03233230|11315636|FG001|NOT COMPLETED|Overall Study||15
10185965|NCT03233230|11315637|FG002|NOT COMPLETED|Overall Study||12
10185966|NCT03233230|11315638|FG003|NOT COMPLETED|Overall Study||8
10185967|NCT03233308|11315648|FG000|STARTED|Overall Study||20
10185968|NCT03233308|11315648|FG000|COMPLETED|Overall Study||18
10185969|NCT03233308|11315648|FG000|NOT COMPLETED|Overall Study||2
10185970|NCT03233438|11315661|FG000|STARTED|Overall Study||48
10185971|NCT03233438|11315662|FG001|STARTED|Overall Study||43
10185972|NCT03233438|11315661|FG000|COMPLETED|Overall Study||42
10185973|NCT03233438|11315662|FG001|COMPLETED|Overall Study||32
10185974|NCT03233438|11315661|FG000|NOT COMPLETED|Overall Study||6
10185975|NCT03233438|11315662|FG001|NOT COMPLETED|Overall Study||11
10185976|NCT03233529|11315668|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40
10185977|NCT03233529|11315668|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
10185978|NCT03233529|11315668|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
10185979|NCT03233529|11315668|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39
10185980|NCT03233529|11315668|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
10185981|NCT03233529|11315668|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
10185982|NCT03233737|11315681|FG000|STARTED|Overall Study||10
10185983|NCT03233737|11315682|FG001|STARTED|Overall Study||10
10185984|NCT03233737|11315683|FG002|STARTED|Overall Study||5
10185985|NCT03233737|11315684|FG003|STARTED|Overall Study||24
10185986|NCT03233737|11315685|FG004|STARTED|Overall Study||26
10185987|NCT03233737|11315681|FG000|COMPLETED|Overall Study||10
10185988|NCT03233737|11315682|FG001|COMPLETED|Overall Study||10
10185989|NCT03233737|11315683|FG002|COMPLETED|Overall Study||5
10185990|NCT03233737|11315684|FG003|COMPLETED|Overall Study||24
10185991|NCT03233737|11315685|FG004|COMPLETED|Overall Study||26
10185992|NCT03233737|11315681|FG000|NOT COMPLETED|Overall Study||0
10185993|NCT03233737|11315682|FG001|NOT COMPLETED|Overall Study||0
10185994|NCT03233737|11315683|FG002|NOT COMPLETED|Overall Study||0
10185995|NCT03233737|11315684|FG003|NOT COMPLETED|Overall Study||0
10185996|NCT03233737|11315685|FG004|NOT COMPLETED|Overall Study||0
10185997|NCT03234036|11315701|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
10185998|NCT03234036|11315702|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
10185999|NCT03234036|11315703|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186000|NCT03234036|11315704|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186001|NCT03234036|11315701|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
10186002|NCT03234036|11315702|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
10186003|NCT03234036|11315703|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186004|NCT03234036|11315704|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186005|NCT03234036|11315701|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186006|NCT03234036|11315702|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186007|NCT03234036|11315703|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186008|NCT03234036|11315704|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10186009|NCT03234036|11315701|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
10186010|NCT03234036|11315702|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
10186011|NCT03234036|11315703|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
10186012|NCT03234036|11315704|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
10186013|NCT03234036|11315701|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
10186014|NCT03234036|11315702|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
10186015|NCT03234036|11315703|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10186016|NCT03234036|11315704|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10186017|NCT03234036|11315701|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
10186018|NCT03234036|11315702|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
10186019|NCT03234036|11315703|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10186020|NCT03234036|11315704|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10186021|NCT03234036|11315701|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
10186022|NCT03234036|11315702|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
10186023|NCT03234036|11315703|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186024|NCT03234036|11315704|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186025|NCT03234036|11315701|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
10186026|NCT03234036|11315702|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
10186027|NCT03234036|11315703|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186028|NCT03234036|11315704|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186029|NCT03234036|11315701|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186030|NCT03234036|11315702|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186031|NCT03234036|11315703|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186032|NCT03234036|11315704|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10186033|NCT03234036|11315701|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
10186034|NCT03234036|11315702|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
10186035|NCT03234036|11315703|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186036|NCT03234036|11315704|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186037|NCT03234036|11315701|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
10186038|NCT03234036|11315702|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
10186039|NCT03234036|11315703|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186040|NCT03234036|11315704|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186041|NCT03234036|11315701|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186042|NCT03234036|11315702|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186043|NCT03234036|11315703|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186044|NCT03234036|11315704|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10186045|NCT03234036|11315701|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10186046|NCT03234036|11315702|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10186047|NCT03234036|11315703|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186048|NCT03234036|11315704|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186049|NCT03234036|11315701|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10186050|NCT03234036|11315702|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10186051|NCT03234036|11315703|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186052|NCT03234036|11315704|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186053|NCT03234036|11315701|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186054|NCT03234036|11315702|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186055|NCT03234036|11315703|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186056|NCT03234036|11315704|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10186057|NCT03234036|11315701|FG000|STARTED|Part 2 (Up to 25 Days)||0
10186058|NCT03234036|11315702|FG001|STARTED|Part 2 (Up to 25 Days)||0
10186059|NCT03234036|11315703|FG002|STARTED|Part 2 (Up to 25 Days)||3
10186060|NCT03234036|11315704|FG003|STARTED|Part 2 (Up to 25 Days)||7
10186061|NCT03234036|11315701|FG000|COMPLETED|Part 2 (Up to 25 Days)||0
10186062|NCT03234036|11315702|FG001|COMPLETED|Part 2 (Up to 25 Days)||0
10186063|NCT03234036|11315703|FG002|COMPLETED|Part 2 (Up to 25 Days)||3
10186064|NCT03234036|11315704|FG003|COMPLETED|Part 2 (Up to 25 Days)||7
10186065|NCT03234036|11315701|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10186066|NCT03234036|11315702|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10186067|NCT03234036|11315703|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10186068|NCT03234036|11315704|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10186069|NCT03234374|11315722|FG000|STARTED|Overall Study||35
10186070|NCT03234374|11315723|FG001|STARTED|Overall Study||17
10186071|NCT03234374|11315722|FG000|COMPLETED|Overall Study||34
10186072|NCT03234374|11315723|FG001|COMPLETED|Overall Study||16
9715217|NCT03167242|10814447|FG009|COMPLETED|Overall Study||53
9715218|NCT03167242|10814448|FG010|COMPLETED|Overall Study||43
9715219|NCT03167242|10814449|FG011|COMPLETED|Overall Study||23
9715220|NCT03167242|10814438|FG000|NOT COMPLETED|Overall Study||0
9715221|NCT03167242|10814439|FG001|NOT COMPLETED|Overall Study||1
9715222|NCT03167242|10814440|FG002|NOT COMPLETED|Overall Study||3
9715223|NCT03167242|10814441|FG003|NOT COMPLETED|Overall Study||1
9715224|NCT03167242|10814442|FG004|NOT COMPLETED|Overall Study||1
9715225|NCT03167242|10814443|FG005|NOT COMPLETED|Overall Study||2
9715226|NCT03167242|10814444|FG006|NOT COMPLETED|Overall Study||2
9715227|NCT03167242|10814445|FG007|NOT COMPLETED|Overall Study||1
9715228|NCT03167242|10814446|FG008|NOT COMPLETED|Overall Study||1
9715229|NCT03167242|10814447|FG009|NOT COMPLETED|Overall Study||0
9715230|NCT03167242|10814448|FG010|NOT COMPLETED|Overall Study||2
9715231|NCT03167242|10814449|FG011|NOT COMPLETED|Overall Study||1
9731402|NCT00132301|10831335|FG001|COMPLETED|Overall Study||144
9731403|NCT00132301|10831334|FG000|NOT COMPLETED|Overall Study||20
9731404|NCT00132301|10831335|FG001|NOT COMPLETED|Overall Study||13
9731405|NCT00132314|10831343|FG000|STARTED|Overall Study||190
9731406|NCT00132314|10831344|FG001|STARTED|Overall Study||192
9731407|NCT00132314|10831343|FG000|Received Treatment|Overall Study||188
9731408|NCT00132314|10831344|FG001|Received Treatment|Overall Study||185
9731409|NCT00132314|10831343|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
9731410|NCT00132314|10831344|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
9731411|NCT00132314|10831343|FG000|COMPLETED|Overall Study||117
9731412|NCT00132314|10831344|FG001|COMPLETED|Overall Study||120
9731413|NCT00132314|10831343|FG000|NOT COMPLETED|Overall Study||73
9731414|NCT00132314|10831344|FG001|NOT COMPLETED|Overall Study||72
9731415|NCT00132496|10831352|FG000|STARTED|Overall Study||54
9731416|NCT00132496|10831353|FG001|STARTED|Overall Study||57
9731417|NCT00132496|10831352|FG000|COMPLETED|Overall Study||52
9731418|NCT00132496|10831353|FG001|COMPLETED|Overall Study||55
10061884|NCT02106351|11187395|FG002|Received Treatment in TC 1|Treatment Cycle 1||70
10061885|NCT02106351|11187393|FG000|COMPLETED|Treatment Cycle 1||66
10061886|NCT02106351|11187394|FG001|COMPLETED|Treatment Cycle 1||67
10061887|NCT02106351|11187395|FG002|COMPLETED|Treatment Cycle 1||67
10061888|NCT02106351|11187393|FG000|NOT COMPLETED|Treatment Cycle 1||5
10061889|NCT02106351|11187394|FG001|NOT COMPLETED|Treatment Cycle 1||3
10061890|NCT02106351|11187395|FG002|NOT COMPLETED|Treatment Cycle 1||4
10061891|NCT02106351|11187393|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
10186073|NCT03234374|11315722|FG000|NOT COMPLETED|Overall Study||1
10186074|NCT03234374|11315723|FG001|NOT COMPLETED|Overall Study||1
10186075|NCT03234465|11315731|FG000|STARTED|Overall Study||100
10186076|NCT03234465|11315732|FG001|STARTED|Overall Study||100
10186077|NCT03234465|11315731|FG000|COMPLETED|Overall Study||67
10186078|NCT03234465|11315732|FG001|COMPLETED|Overall Study||60
10186079|NCT03234465|11315731|FG000|NOT COMPLETED|Overall Study||33
10186080|NCT03234465|11315732|FG001|NOT COMPLETED|Overall Study||40
10186081|NCT03234608|11315740|FG000|STARTED|Overall Study||127
10186082|NCT03234608|11315741|FG001|STARTED|Overall Study||117
10186083|NCT03234608|11315740|FG000|COMPLETED|Overall Study||104
10186084|NCT03234608|11315741|FG001|COMPLETED|Overall Study||96
10186085|NCT03234608|11315740|FG000|NOT COMPLETED|Overall Study||23
10186086|NCT03234608|11315741|FG001|NOT COMPLETED|Overall Study||21
10186087|NCT03235050|11315752|FG000|STARTED|Overall Study||112
10186088|NCT03235050|11315753|FG001|STARTED|Overall Study||110
10186089|NCT03235050|11315754|FG002|STARTED|Overall Study||100
10186090|NCT03235050|11315755|FG003|STARTED|Overall Study||256
10186091|NCT03235050|11315756|FG004|STARTED|Overall Study||256
10186092|NCT03235050|11315752|FG000|COMPLETED|Overall Study||108
10186093|NCT03235050|11315753|FG001|COMPLETED|Overall Study||105
10186094|NCT03235050|11315754|FG002|COMPLETED|Overall Study||96
10186095|NCT03235050|11315755|FG003|COMPLETED|Overall Study||242
10186096|NCT03235050|11315756|FG004|COMPLETED|Overall Study||245
10186097|NCT03235050|11315752|FG000|NOT COMPLETED|Overall Study||4
10186098|NCT03235050|11315753|FG001|NOT COMPLETED|Overall Study||5
10186099|NCT03235050|11315754|FG002|NOT COMPLETED|Overall Study||4
10186100|NCT03235050|11315755|FG003|NOT COMPLETED|Overall Study||14
10186101|NCT03235050|11315756|FG004|NOT COMPLETED|Overall Study||11
10186102|NCT03235089|11315768|FG000|STARTED|Overall Study||31
10186103|NCT03235089|11315769|FG001|STARTED|Overall Study||31
10186104|NCT03235089|11315768|FG000|COMPLETED|Overall Study||28
10186105|NCT03235089|11315769|FG001|COMPLETED|Overall Study||28
10186106|NCT03235089|11315768|FG000|NOT COMPLETED|Overall Study||3
10186107|NCT03235089|11315769|FG001|NOT COMPLETED|Overall Study||3
10186108|NCT03235115|11315776|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9
10186109|NCT03235115|11315777|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6
10186110|NCT03235115|11315778|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7
10186111|NCT03235115|11315779|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6
10186112|NCT03235115|11315780|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6
10186113|NCT03235115|11315781|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6
10186114|NCT03235115|11315776|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9
10186115|NCT03235115|11315777|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6
10186116|NCT03235115|11315778|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7
10186117|NCT03235115|11315779|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6
10186118|NCT03235115|11315780|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6
10186119|NCT03235115|11315781|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5
10186120|NCT03235115|11315776|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10186121|NCT03235115|11315777|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10186122|NCT03235115|11315778|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10186123|NCT03235115|11315779|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10186124|NCT03235115|11315780|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10186125|NCT03235115|11315781|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
10186126|NCT03235115|11315776|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9
10186127|NCT03235115|11315777|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6
10186128|NCT03235115|11315778|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7
10186129|NCT03235115|11315779|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6
10186130|NCT03235115|11315780|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6
10186131|NCT03235115|11315781|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5
10186132|NCT03235115|11315776|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
10186133|NCT03235115|11315777|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
10186134|NCT03235115|11315778|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
10186135|NCT03235115|11315779|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
10186136|NCT03235115|11315780|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
10186137|NCT03235115|11315781|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
10186138|NCT03235115|11315776|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10186139|NCT03235115|11315777|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10186140|NCT03235115|11315778|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10186141|NCT03235115|11315779|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10186142|NCT03235115|11315780|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10186143|NCT03235115|11315781|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10186144|NCT03235115|11315776|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
10186145|NCT03235115|11315777|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
10186146|NCT03235115|11315778|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
10186147|NCT03235115|11315779|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
10186148|NCT03235115|11315780|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
10186149|NCT03235115|11315781|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
10186150|NCT03235115|11315776|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
10186151|NCT03235115|11315777|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
10061892|NCT02106351|11187394|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
9715232|NCT03137537|10814487|FG000|STARTED|Overall Study||12
9715233|NCT03137537|10814488|FG001|STARTED|Overall Study||11
9715234|NCT03137537|10814487|FG000|COMPLETED|Overall Study||12
9715235|NCT03137537|10814488|FG001|COMPLETED|Overall Study||10
9715236|NCT03137537|10814487|FG000|NOT COMPLETED|Overall Study||0
9715237|NCT03137537|10814488|FG001|NOT COMPLETED|Overall Study||1
9715238|NCT03126019|10814496|FG000|STARTED|Overall Study||23
9715239|NCT03126019|10814497|FG001|STARTED|Overall Study||103
9715240|NCT03126019|10814496|FG000|COMPLETED|Overall Study||0
9715241|NCT03126019|10814497|FG001|COMPLETED|Overall Study||0
9715242|NCT03126019|10814496|FG000|NOT COMPLETED|Overall Study||23
9715243|NCT03126019|10814497|FG001|NOT COMPLETED|Overall Study||103
9715244|NCT03113383|10814504|FG000|STARTED|Overall Study||4
9715245|NCT03113383|10814505|FG001|STARTED|Overall Study||0
9715246|NCT03113383|10814504|FG000|COMPLETED|Overall Study||0
9715247|NCT03113383|10814505|FG001|COMPLETED|Overall Study||0
9715248|NCT03113383|10814504|FG000|NOT COMPLETED|Overall Study||4
9715249|NCT03113383|10814505|FG001|NOT COMPLETED|Overall Study||0
9715256|NCT03028896|10814522|FG000|STARTED|Overall Study||66
9715257|NCT03028896|10814523|FG001|STARTED|Overall Study||66
9715258|NCT03028896|10814522|FG000|COMPLETED|Overall Study||63
9715259|NCT03028896|10814523|FG001|COMPLETED|Overall Study||66
9715260|NCT03028896|10814522|FG000|NOT COMPLETED|Overall Study||3
9715261|NCT03028896|10814523|FG001|NOT COMPLETED|Overall Study||0
9715262|NCT03008369|10814529|FG000|STARTED|Overall Study||3
9715263|NCT03008369|10814529|FG000|COMPLETED|Overall Study||3
9715264|NCT03008369|10814529|FG000|NOT COMPLETED|Overall Study||0
9715265|NCT02978326|10814536|FG000|STARTED|Part A (Up to 75 Days)||1
9715266|NCT02978326|10814537|FG001|STARTED|Part A (Up to 75 Days)||0
9715267|NCT02978326|10814538|FG002|STARTED|Part A (Up to 75 Days)||0
9715268|NCT02978326|10814536|FG000|COMPLETED|Part A (Up to 75 Days)||1
9715269|NCT02978326|10814537|FG001|COMPLETED|Part A (Up to 75 Days)||0
9715270|NCT02978326|10814538|FG002|COMPLETED|Part A (Up to 75 Days)||0
9715271|NCT02978326|10814536|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0
9715272|NCT02978326|10814537|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0
9715273|NCT02978326|10814538|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0
9715274|NCT02978326|10814536|FG000|STARTED|Part B (Up to 45 Days)||0
9715275|NCT02978326|10814537|FG001|STARTED|Part B (Up to 45 Days)||76
9715276|NCT02978326|10814538|FG002|STARTED|Part B (Up to 45 Days)||77
9715277|NCT02978326|10814536|FG000|Received Study Drug|Part B (Up to 45 Days)||0
9715278|NCT02978326|10814537|FG001|Received Study Drug|Part B (Up to 45 Days)||73
9715279|NCT02978326|10814538|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78
9715280|NCT02978326|10814536|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0
9715281|NCT02978326|10814537|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73
9715282|NCT02978326|10814538|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78
9715283|NCT02978326|10814536|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0
9715284|NCT02978326|10814537|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74
9715285|NCT02978326|10814538|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76
9715286|NCT02978326|10814536|FG000|COMPLETED|Part B (Up to 45 Days)||0
9715287|NCT02978326|10814537|FG001|COMPLETED|Part B (Up to 45 Days)||69
9715288|NCT02978326|10814538|FG002|COMPLETED|Part B (Up to 45 Days)||73
9715289|NCT02978326|10814536|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0
9715290|NCT02978326|10814537|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7
9715291|NCT02978326|10814538|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4
9715292|NCT02970929|10814548|FG000|STARTED|Overall Study||157
9715293|NCT02970929|10814548|FG000|Subjects Who Received Study Medication|Overall Study||156
9715294|NCT02970929|10814548|FG000|COMPLETED|Overall Study||105
9715295|NCT02970929|10814548|FG000|NOT COMPLETED|Overall Study||52
9715296|NCT02963493|10814554|FG000|STARTED|Overall Study||157
9715297|NCT02963493|10814554|FG000|COMPLETED|Overall Study||157
9715298|NCT02963493|10814554|FG000|NOT COMPLETED|Overall Study||0
9715299|NCT02899078|10814565|FG000|STARTED|Overall Study||31
9715300|NCT02899078|10814565|FG000|COMPLETED|Overall Study||28
9715301|NCT02899078|10814565|FG000|NOT COMPLETED|Overall Study||3
9715302|NCT02873975|10814572|FG000|STARTED|Overall Study||8
9715303|NCT02873975|10814573|FG001|STARTED|Overall Study||10
9715304|NCT02873975|10814574|FG002|STARTED|Overall Study||9
9715305|NCT02873975|10814572|FG000|COMPLETED|Overall Study||8
9715306|NCT02873975|10814573|FG001|COMPLETED|Overall Study||10
9715307|NCT02873975|10814574|FG002|COMPLETED|Overall Study||9
9715308|NCT02873975|10814572|FG000|NOT COMPLETED|Overall Study||0
9715309|NCT02873975|10814573|FG001|NOT COMPLETED|Overall Study||0
9715310|NCT02873975|10814574|FG002|NOT COMPLETED|Overall Study||0
9715311|NCT02797951|10814582|FG000|STARTED|Overall Study||165
9715312|NCT02797951|10814582|FG000|Received at Least One Dose of Study Drug|Overall Study||164
9715313|NCT02797951|10814582|FG000|COMPLETED|Overall Study||116
9715314|NCT02797951|10814582|FG000|NOT COMPLETED|Overall Study||49
9715315|NCT02753751|10814588|FG000|STARTED|Overall Study||2971
10186152|NCT03235115|11315778|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
10186153|NCT03235115|11315779|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
10186154|NCT03235115|11315780|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
10186155|NCT03235115|11315781|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
10186156|NCT03235115|11315776|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10186157|NCT03235115|11315777|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10186158|NCT03235115|11315778|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10186159|NCT03235115|11315779|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10186160|NCT03235115|11315780|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10186161|NCT03235115|11315781|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10186162|NCT03235154|11315789|FG000|STARTED|Overall Study||11
10186163|NCT03235154|11315789|FG000|Completed Epclusa. Treatment|Overall Study||8
9715316|NCT02753751|10814589|FG001|STARTED|Overall Study||3059
9715317|NCT02753751|10814588|FG000|COMPLETED|Overall Study||2971
9715318|NCT02753751|10814589|FG001|COMPLETED|Overall Study||3059
9715319|NCT02753751|10814588|FG000|NOT COMPLETED|Overall Study||0
9715320|NCT02753751|10814589|FG001|NOT COMPLETED|Overall Study||0
9715321|NCT02748057|10814597|FG000|STARTED|Overall Study||114
9715322|NCT02748057|10814598|FG001|STARTED|Overall Study||21
9715323|NCT02748057|10814597|FG000|COMPLETED|Overall Study||109
9715324|NCT02748057|10814598|FG001|COMPLETED|Overall Study||19
9715325|NCT02748057|10814597|FG000|NOT COMPLETED|Overall Study||5
9715326|NCT02748057|10814598|FG001|NOT COMPLETED|Overall Study||2
9715327|NCT02741271|10814606|FG000|STARTED|Overall Study||91
9715328|NCT02741271|10814607|FG001|STARTED|Overall Study||90
9715329|NCT02741271|10814606|FG000|COMPLETED|Overall Study||89
9715330|NCT02741271|10814607|FG001|COMPLETED|Overall Study||88
9715331|NCT02741271|10814606|FG000|NOT COMPLETED|Overall Study||2
9715332|NCT02741271|10814607|FG001|NOT COMPLETED|Overall Study||2
9715333|NCT02741245|10814620|FG000|STARTED|Overall Study||35
9715334|NCT02741245|10814621|FG001|STARTED|Overall Study||72
9715335|NCT02741245|10814622|FG002|STARTED|Overall Study||71
9715336|NCT02741245|10814623|FG003|STARTED|Overall Study||71
9715337|NCT02741245|10814624|FG004|STARTED|Overall Study||72
9715338|NCT02741245|10814620|FG000|COMPLETED|Overall Study||35
9715339|NCT02741245|10814621|FG001|COMPLETED|Overall Study||71
9715340|NCT02741245|10814622|FG002|COMPLETED|Overall Study||71
9715341|NCT02741245|10814623|FG003|COMPLETED|Overall Study||67
9715342|NCT02741245|10814624|FG004|COMPLETED|Overall Study||70
9715343|NCT02741245|10814620|FG000|NOT COMPLETED|Overall Study||0
9715344|NCT02741245|10814621|FG001|NOT COMPLETED|Overall Study||1
9715345|NCT02741245|10814622|FG002|NOT COMPLETED|Overall Study||0
9715346|NCT02741245|10814623|FG003|NOT COMPLETED|Overall Study||4
9715347|NCT02741245|10814624|FG004|NOT COMPLETED|Overall Study||2
9715348|NCT02688608|10814636|FG000|STARTED|Overall Study||6
9715349|NCT02688608|10814636|FG000|COMPLETED|Overall Study||5
9715350|NCT02688608|10814636|FG000|NOT COMPLETED|Overall Study||1
9715351|NCT02675231|10814643|FG000|STARTED|Overall Study||79
9715352|NCT02675231|10814644|FG001|STARTED|Overall Study||79
9715353|NCT02675231|10814645|FG002|STARTED|Overall Study||79
9715354|NCT02675231|10814643|FG000|Received at Least One Dose of Drug|Overall Study||78
9715355|NCT02675231|10814644|FG001|Received at Least One Dose of Drug|Overall Study||77
9715356|NCT02675231|10814645|FG002|Received at Least One Dose of Drug|Overall Study||72
9715357|NCT02675231|10814643|FG000|COMPLETED|Overall Study||53
9715358|NCT02675231|10814644|FG001|COMPLETED|Overall Study||43
9715359|NCT02675231|10814645|FG002|COMPLETED|Overall Study||53
9715360|NCT02675231|10814643|FG000|NOT COMPLETED|Overall Study||26
9715361|NCT02675231|10814644|FG001|NOT COMPLETED|Overall Study||36
9715362|NCT02675231|10814645|FG002|NOT COMPLETED|Overall Study||26
9715363|NCT02634268|10814656|FG000|STARTED|Overall Study||346
9715364|NCT02634268|10814657|FG001|STARTED|Overall Study||338
9715365|NCT02634268|10814656|FG000|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|287
9731419|NCT00132496|10831352|FG000|NOT COMPLETED|Overall Study||2
9731420|NCT00132496|10831353|FG001|NOT COMPLETED|Overall Study||2
10061893|NCT02106351|11187395|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
10061894|NCT02106351|11187393|FG000|COMPLETED|Treatment Cycle 2||0
10061895|NCT02106351|11187394|FG001|COMPLETED|Treatment Cycle 2||83
10061896|NCT02106351|11187395|FG002|COMPLETED|Treatment Cycle 2||87
10061897|NCT02106351|11187393|FG000|NOT COMPLETED|Treatment Cycle 2||0
10061898|NCT02106351|11187394|FG001|NOT COMPLETED|Treatment Cycle 2||5
10061899|NCT02106351|11187395|FG002|NOT COMPLETED|Treatment Cycle 2||3
10061900|NCT02106351|11187393|FG000|STARTED|Treatment Cycle 3||0
10061901|NCT02106351|11187394|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
10186164|NCT03235154|11315789|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7
10186165|NCT03235154|11315789|FG000|COMPLETED|Overall Study||7
10186166|NCT03235154|11315789|FG000|NOT COMPLETED|Overall Study||4
10186167|NCT03235180|11315795|FG000|STARTED|Overall Study||9
10186168|NCT03235180|11315795|FG000|COMPLETED|Overall Study||9
10186169|NCT03235180|11315795|FG000|NOT COMPLETED|Overall Study||0
10186170|NCT03235284|11315802|FG000|STARTED|Overall Study||15
10186171|NCT03235284|11315803|FG001|STARTED|Overall Study||15
10186172|NCT03235284|11315804|FG002|STARTED|Overall Study||15
10186173|NCT03235284|11315802|FG000|COMPLETED|Overall Study||14
10186174|NCT03235284|11315803|FG001|COMPLETED|Overall Study||13
10186175|NCT03235284|11315804|FG002|COMPLETED|Overall Study||14
10186176|NCT03235284|11315802|FG000|NOT COMPLETED|Overall Study||1
10186177|NCT03235284|11315803|FG001|NOT COMPLETED|Overall Study||2
10186178|NCT03235284|11315804|FG002|NOT COMPLETED|Overall Study||1
10186179|NCT03235349|11315812|FG000|STARTED|Overall Study||160
10186180|NCT03235349|11315812|FG000|COMPLETED|Overall Study||158
10186181|NCT03235349|11315812|FG000|NOT COMPLETED|Overall Study||2
10186182|NCT03235414|11315816|FG000|STARTED|Overall Study||101
10186183|NCT03235414|11315816|FG000|COMPLETED|Overall Study||101
10186184|NCT03235414|11315816|FG000|NOT COMPLETED|Overall Study||0
10186185|NCT03235479|11315822|FG000|STARTED|Overall Study||582
10186186|NCT03235479|11315823|FG001|STARTED|Overall Study||580
10186187|NCT03235479|11315822|FG000|Treated|Overall Study||546
10186188|NCT03235479|11315823|FG001|Treated|Overall Study||549
10186189|NCT03235479|11315822|FG000|COMPLETED|Overall Study||541
10186190|NCT03235479|11315823|FG001|COMPLETED|Overall Study||540
10186191|NCT03235479|11315822|FG000|NOT COMPLETED|Overall Study||41
10186192|NCT03235479|11315823|FG001|NOT COMPLETED|Overall Study||40
10186193|NCT03235726|11315837|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
10186194|NCT03235726|11315838|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186195|NCT03235726|11315839|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186196|NCT03235726|11315840|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
10186197|NCT03235726|11315841|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186198|NCT03235726|11315842|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186199|NCT03235726|11315843|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186200|NCT03235726|11315844|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186201|NCT03235726|11315845|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186202|NCT03235726|11315846|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10186203|NCT03235726|11315837|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
10186204|NCT03235726|11315838|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186205|NCT03235726|11315839|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186206|NCT03235726|11315840|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
10186207|NCT03235726|11315841|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186208|NCT03235726|11315842|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186209|NCT03235726|11315843|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186210|NCT03235726|11315844|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186211|NCT03235726|11315845|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186212|NCT03235726|11315846|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186213|NCT03235726|11315837|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186214|NCT03235726|11315838|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186215|NCT03235726|11315839|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186216|NCT03235726|11315840|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186217|NCT03235726|11315841|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186218|NCT03235726|11315842|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186219|NCT03235726|11315843|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186220|NCT03235726|11315844|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186221|NCT03235726|11315845|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186222|NCT03235726|11315846|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10186223|NCT03235726|11315837|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186224|NCT03235726|11315838|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
10186225|NCT03235726|11315839|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186226|NCT03235726|11315840|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
10186227|NCT03235726|11315841|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186228|NCT03235726|11315842|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186229|NCT03235726|11315843|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186230|NCT03235726|11315844|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186231|NCT03235726|11315845|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186232|NCT03235726|11315846|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10186233|NCT03235726|11315837|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186234|NCT03235726|11315838|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
10186235|NCT03235726|11315839|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186236|NCT03235726|11315840|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
10186237|NCT03235726|11315841|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186238|NCT03235726|11315842|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186239|NCT03235726|11315843|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186240|NCT03235726|11315844|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186241|NCT03235726|11315845|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186242|NCT03235726|11315846|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186243|NCT03235726|11315837|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186244|NCT03235726|11315838|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186245|NCT03235726|11315839|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186246|NCT03235726|11315840|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186247|NCT03235726|11315841|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186248|NCT03235726|11315842|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186249|NCT03235726|11315843|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186250|NCT03235726|11315844|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186251|NCT03235726|11315845|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186252|NCT03235726|11315846|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10186253|NCT03235726|11315837|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186254|NCT03235726|11315838|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186255|NCT03235726|11315839|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
10186256|NCT03235726|11315840|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
10186257|NCT03235726|11315841|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186258|NCT03235726|11315842|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186259|NCT03235726|11315843|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186260|NCT03235726|11315844|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186261|NCT03235726|11315845|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186262|NCT03235726|11315846|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186263|NCT03235726|11315837|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186264|NCT03235726|11315838|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186265|NCT03235726|11315839|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
10186266|NCT03235726|11315840|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
10186267|NCT03235726|11315841|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186268|NCT03235726|11315842|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186269|NCT03235726|11315843|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186270|NCT03235726|11315844|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186271|NCT03235726|11315845|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186272|NCT03235726|11315846|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186273|NCT03235726|11315837|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186274|NCT03235726|11315838|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186275|NCT03235726|11315839|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186276|NCT03235726|11315840|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186277|NCT03235726|11315841|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186278|NCT03235726|11315842|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186279|NCT03235726|11315843|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186280|NCT03235726|11315844|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186281|NCT03235726|11315845|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186282|NCT03235726|11315846|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10186283|NCT03235726|11315837|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186284|NCT03235726|11315838|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186285|NCT03235726|11315839|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186286|NCT03235726|11315840|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186287|NCT03235726|11315841|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
10186288|NCT03235726|11315842|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
10186289|NCT03235726|11315843|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
10186290|NCT03235726|11315844|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186291|NCT03235726|11315845|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186292|NCT03235726|11315846|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186293|NCT03235726|11315837|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186294|NCT03235726|11315838|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186295|NCT03235726|11315839|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186296|NCT03235726|11315840|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186297|NCT03235726|11315841|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
10186298|NCT03235726|11315842|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
10186299|NCT03235726|11315843|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
10186300|NCT03235726|11315844|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186301|NCT03235726|11315845|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186302|NCT03235726|11315846|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186303|NCT03235726|11315837|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186304|NCT03235726|11315838|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186305|NCT03235726|11315839|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186306|NCT03235726|11315840|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186307|NCT03235726|11315841|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
10186308|NCT03235726|11315842|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9715366|NCT02634268|10814657|FG001|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|291
9715367|NCT02634268|10814656|FG000|NOT COMPLETED|Overall Study||59
9715368|NCT02634268|10814657|FG001|NOT COMPLETED|Overall Study||47
9715369|NCT02605967|10814665|FG000|STARTED|Overall Study||82
9715370|NCT02605967|10814666|FG001|STARTED|Overall Study||40
9715371|NCT02605967|10814665|FG000|Safety Set|Overall Study||82
9715372|NCT02605967|10814666|FG001|Safety Set|Overall Study||39
9715373|NCT02605967|10814665|FG000|Crossover to Spartalizumab|Overall Study||0
9715374|NCT02605967|10814666|FG001|Crossover to Spartalizumab|Overall Study||27
9715375|NCT02605967|10814665|FG000|COMPLETED|Overall Study||0
9715376|NCT02605967|10814666|FG001|COMPLETED|Overall Study||0
9715377|NCT02605967|10814665|FG000|NOT COMPLETED|Overall Study||82
9715378|NCT02605967|10814666|FG001|NOT COMPLETED|Overall Study||40
9715379|NCT02584634|10814678|FG000|STARTED|Overall Study||12
9715380|NCT02584634|10814679|FG001|STARTED|Overall Study||31
10186309|NCT03235726|11315843|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186310|NCT03235726|11315844|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186311|NCT03235726|11315845|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186312|NCT03235726|11315846|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10186313|NCT03235726|11315837|FG000|STARTED|Part 2 (Cohort A - Day 1)||0
10186314|NCT03235726|11315838|FG001|STARTED|Part 2 (Cohort A - Day 1)||0
10186315|NCT03235726|11315839|FG002|STARTED|Part 2 (Cohort A - Day 1)||0
10186316|NCT03235726|11315840|FG003|STARTED|Part 2 (Cohort A - Day 1)||0
10186317|NCT03235726|11315841|FG004|STARTED|Part 2 (Cohort A - Day 1)||0
10186318|NCT03235726|11315842|FG005|STARTED|Part 2 (Cohort A - Day 1)||0
10186319|NCT03235726|11315843|FG006|STARTED|Part 2 (Cohort A - Day 1)||0
10186320|NCT03235726|11315844|FG007|STARTED|Part 2 (Cohort A - Day 1)||6
10186321|NCT03235726|11315845|FG008|STARTED|Part 2 (Cohort A - Day 1)||2
10186322|NCT03235726|11315846|FG009|STARTED|Part 2 (Cohort A - Day 1)||0
10186323|NCT03235726|11315837|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186324|NCT03235726|11315838|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186325|NCT03235726|11315839|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186326|NCT03235726|11315840|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186327|NCT03235726|11315841|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186328|NCT03235726|11315842|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186329|NCT03235726|11315843|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186330|NCT03235726|11315844|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6
10186331|NCT03235726|11315845|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2
10186332|NCT03235726|11315846|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0
10186333|NCT03235726|11315837|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186334|NCT03235726|11315838|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186335|NCT03235726|11315839|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186336|NCT03235726|11315840|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186337|NCT03235726|11315841|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186338|NCT03235726|11315842|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186339|NCT03235726|11315843|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186340|NCT03235726|11315844|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186341|NCT03235726|11315845|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186342|NCT03235726|11315846|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10186343|NCT03235726|11315837|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186344|NCT03235726|11315838|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186345|NCT03235726|11315839|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186346|NCT03235726|11315840|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186347|NCT03235726|11315841|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186348|NCT03235726|11315842|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186349|NCT03235726|11315843|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186350|NCT03235726|11315844|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186351|NCT03235726|11315845|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10186352|NCT03235726|11315846|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
10186353|NCT03235726|11315837|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186354|NCT03235726|11315838|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186355|NCT03235726|11315839|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186356|NCT03235726|11315840|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186357|NCT03235726|11315841|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186358|NCT03235726|11315842|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186359|NCT03235726|11315843|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186360|NCT03235726|11315844|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186361|NCT03235726|11315845|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186362|NCT03235726|11315846|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
10186363|NCT03235726|11315837|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186364|NCT03235726|11315838|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186365|NCT03235726|11315839|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186366|NCT03235726|11315840|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186367|NCT03235726|11315841|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186368|NCT03235726|11315842|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186369|NCT03235726|11315843|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186370|NCT03235726|11315844|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186371|NCT03235726|11315845|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186372|NCT03235726|11315846|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10186373|NCT03236168|11315881|FG000|STARTED|Overall Study||118
10186374|NCT03236168|11315881|FG000|COMPLETED|Overall Study||107
10186375|NCT03236168|11315881|FG000|NOT COMPLETED|Overall Study||11
10186376|NCT03236246|11315887|FG000|STARTED|24-Week Dose Titration Period||104
10186377|NCT03236246|11315888|FG001|STARTED|24-Week Dose Titration Period||102
10186378|NCT03236246|11315887|FG000|COMPLETED|24-Week Dose Titration Period||80
10186379|NCT03236246|11315888|FG001|COMPLETED|24-Week Dose Titration Period||75
10186380|NCT03236246|11315887|FG000|NOT COMPLETED|24-Week Dose Titration Period||24
10186381|NCT03236246|11315888|FG001|NOT COMPLETED|24-Week Dose Titration Period||27
10186382|NCT03236246|11315887|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
10186383|NCT03236246|11315888|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
10186384|NCT03236246|11315887|FG000|COMPLETED|24-Week Dose Maintenance Period||73
10186385|NCT03236246|11315888|FG001|COMPLETED|24-Week Dose Maintenance Period||66
10186386|NCT03236246|11315887|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3
10186387|NCT03236246|11315888|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6
10186388|NCT03236506|11315897|FG000|STARTED|Overall Study||39
10186389|NCT03236506|11315898|FG001|STARTED|Overall Study||42
10186390|NCT03236506|11315899|FG002|STARTED|Overall Study||47
10186391|NCT03236506|11315897|FG000|COMPLETED|Overall Study||33
10186392|NCT03236506|11315898|FG001|COMPLETED|Overall Study||37
10186393|NCT03236506|11315899|FG002|COMPLETED|Overall Study||40
10186394|NCT03236506|11315897|FG000|NOT COMPLETED|Overall Study||6
10186395|NCT03236506|11315898|FG001|NOT COMPLETED|Overall Study||5
10186396|NCT03236506|11315899|FG002|NOT COMPLETED|Overall Study||7
10186397|NCT03236779|11315909|FG000|STARTED|Overall Study||51
10186398|NCT03236779|11315910|FG001|STARTED|Overall Study||51
10186399|NCT03236779|11315909|FG000|COMPLETED|Overall Study||38
10186400|NCT03236779|11315910|FG001|COMPLETED|Overall Study||30
10186401|NCT03236779|11315909|FG000|NOT COMPLETED|Overall Study||13
10186402|NCT03236779|11315910|FG001|NOT COMPLETED|Overall Study||21
10186403|NCT03237013|11315921|FG000|STARTED|Baseline to Immediate Post-treatment||73
10186404|NCT03237013|11315922|FG001|STARTED|Baseline to Immediate Post-treatment||73
10186405|NCT03237013|11315923|FG002|STARTED|Baseline to Immediate Post-treatment||73
10186406|NCT03237013|11315921|FG000|COMPLETED|Baseline to Immediate Post-treatment||73
10186407|NCT03237013|11315922|FG001|COMPLETED|Baseline to Immediate Post-treatment||73
10186408|NCT03237013|11315923|FG002|COMPLETED|Baseline to Immediate Post-treatment||73
10186409|NCT03237013|11315921|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0
10186410|NCT03237013|11315922|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0
10186411|NCT03237013|11315923|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0
10186412|NCT03237013|11315921|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73
10186413|NCT03237013|11315922|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73
10186414|NCT03237013|11315923|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73
10186415|NCT03237013|11315921|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
10186416|NCT03237013|11315922|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
10186417|NCT03237013|11315923|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
10186418|NCT03237013|11315921|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
10186419|NCT03237013|11315922|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
10186420|NCT03237013|11315923|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
10186421|NCT03237065|11315933|FG000|STARTED|Overall Study||61
10186422|NCT03237065|11315934|FG001|STARTED|Overall Study||61
10186423|NCT03237065|11315933|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
10186424|NCT03237065|11315934|FG001|Safety Analysis Set|Overall Study||57
10186425|NCT03237065|11315933|FG000|COMPLETED|Overall Study||57
10186426|NCT03237065|11315934|FG001|COMPLETED|Overall Study||57
10186427|NCT03237065|11315933|FG000|NOT COMPLETED|Overall Study||4
10186428|NCT03237065|11315934|FG001|NOT COMPLETED|Overall Study||4
10186429|NCT03237156|11315944|FG000|STARTED|Overall Study||6
10186430|NCT03237156|11315945|FG001|STARTED|Overall Study||6
10186431|NCT03237156|11315946|FG002|STARTED|Overall Study||6
10186432|NCT03237156|11315947|FG003|STARTED|Overall Study||6
10186433|NCT03237156|11315944|FG000|COMPLETED|Overall Study||6
10186434|NCT03237156|11315945|FG001|COMPLETED|Overall Study||6
10186435|NCT03237156|11315946|FG002|COMPLETED|Overall Study||6
10186436|NCT03237156|11315947|FG003|COMPLETED|Overall Study||6
10186437|NCT03237156|11315944|FG000|NOT COMPLETED|Overall Study||0
10186438|NCT03237156|11315945|FG001|NOT COMPLETED|Overall Study||0
10186439|NCT03237156|11315946|FG002|NOT COMPLETED|Overall Study||0
10186440|NCT03237156|11315947|FG003|NOT COMPLETED|Overall Study||0
10186441|NCT03237481|11315963|FG000|STARTED|Overall Study||164
10186442|NCT03237481|11315964|FG001|STARTED|Overall Study||172
10186443|NCT03237481|11315965|FG002|STARTED|Overall Study||82
10186444|NCT03237481|11315963|FG000|COMPLETED|Overall Study||159
10186445|NCT03237481|11315964|FG001|COMPLETED|Overall Study||170
10186446|NCT03237481|11315965|FG002|COMPLETED|Overall Study||81
10186447|NCT03237481|11315963|FG000|NOT COMPLETED|Overall Study||5
10186448|NCT03237481|11315964|FG001|NOT COMPLETED|Overall Study||2
10186449|NCT03237481|11315965|FG002|NOT COMPLETED|Overall Study||1
10186450|NCT03237845|11315975|FG000|STARTED|Overall Study||594
10186451|NCT03237845|11315976|FG001|STARTED|Overall Study||592
10186452|NCT03237845|11315975|FG000|Treated|Overall Study||543
10186453|NCT03237845|11315976|FG001|Treated|Overall Study||543
10186454|NCT03237845|11315975|FG000|COMPLETED|Overall Study||538
10186455|NCT03237845|11315976|FG001|COMPLETED|Overall Study||542
10186456|NCT03237845|11315975|FG000|NOT COMPLETED|Overall Study||56
10186457|NCT03237845|11315976|FG001|NOT COMPLETED|Overall Study||50
10186458|NCT03237871|11315982|FG000|STARTED|Overall Study||17
10186459|NCT03237871|11315982|FG000|COMPLETED|Overall Study||11
10186460|NCT03237871|11315982|FG000|NOT COMPLETED|Overall Study||6
10186461|NCT03238001|11315986|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436
10186462|NCT03238001|11315986|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
10186463|NCT03238001|11315986|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
10186464|NCT03238001|11315986|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
10186465|NCT03238001|11315986|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
10186466|NCT03238001|11315986|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
10186467|NCT03238352|11316001|FG000|STARTED|Overall Study||43
10186468|NCT03238352|11316002|FG001|STARTED|Overall Study||23
10186469|NCT03238352|11316003|FG002|STARTED|Overall Study||23
10186470|NCT03238352|11316001|FG000|COMPLETED|Overall Study||43
10186471|NCT03238352|11316002|FG001|COMPLETED|Overall Study||20
10186472|NCT03238352|11316003|FG002|COMPLETED|Overall Study||22
10186473|NCT03238352|11316001|FG000|NOT COMPLETED|Overall Study||0
10186474|NCT03238352|11316002|FG001|NOT COMPLETED|Overall Study||3
10186475|NCT03238352|11316003|FG002|NOT COMPLETED|Overall Study||1
10186476|NCT03238417|11316013|FG000|STARTED|Overall||1330
10186477|NCT03238417|11316014|FG001|STARTED|Overall||2632
10186478|NCT03238417|11316013|FG000|COMPLETED|Overall||327
10186479|NCT03238417|11316014|FG001|COMPLETED|Overall||644
10186480|NCT03238417|11316013|FG000|NOT COMPLETED|Overall||1003
10186481|NCT03238417|11316014|FG001|NOT COMPLETED|Overall||1988
10186482|NCT03238417|11316013|FG000|STARTED|Baseline||513
10186483|NCT03238417|11316014|FG001|STARTED|Baseline||934
10186484|NCT03238417|11316013|FG000|COMPLETED|Baseline||124
10186485|NCT03238417|11316014|FG001|COMPLETED|Baseline||217
10186486|NCT03238417|11316013|FG000|NOT COMPLETED|Baseline||389
10186487|NCT03238417|11316014|FG001|NOT COMPLETED|Baseline||717
10186488|NCT03238417|11316013|FG000|STARTED|12-month||400
10186489|NCT03238417|11316014|FG001|STARTED|12-month||911
10186490|NCT03238417|11316013|FG000|COMPLETED|12-month||81
10186491|NCT03238417|11316014|FG001|COMPLETED|12-month||205
10186492|NCT03238417|11316013|FG000|NOT COMPLETED|12-month||319
10186493|NCT03238417|11316014|FG001|NOT COMPLETED|12-month||706
10186494|NCT03238417|11316013|FG000|STARTED|24-month||417
10186495|NCT03238417|11316014|FG001|STARTED|24-month||847
10186496|NCT03238417|11316013|FG000|COMPLETED|24-month||122
10186497|NCT03238417|11316014|FG001|COMPLETED|24-month||222
10186498|NCT03238417|11316013|FG000|NOT COMPLETED|24-month||295
10186499|NCT03238417|11316014|FG001|NOT COMPLETED|24-month||625
10186500|NCT03238651|11316025|FG000|STARTED|Overall Study||3
10186501|NCT03238651|11316026|FG001|STARTED|Overall Study||6
10186502|NCT03238651|11316027|FG002|STARTED|Overall Study||4
10186503|NCT03238651|11316028|FG003|STARTED|Overall Study||3
10186504|NCT03238651|11316029|FG004|STARTED|Overall Study||1
10186505|NCT03238651|11316025|FG000|COMPLETED|Overall Study||0
10186506|NCT03238651|11316026|FG001|COMPLETED|Overall Study||0
10186507|NCT03238651|11316027|FG002|COMPLETED|Overall Study||0
10186508|NCT03238651|11316028|FG003|COMPLETED|Overall Study||0
10186509|NCT03238651|11316029|FG004|COMPLETED|Overall Study||0
10186510|NCT03238651|11316025|FG000|NOT COMPLETED|Overall Study||3
10186511|NCT03238651|11316026|FG001|NOT COMPLETED|Overall Study||6
10186512|NCT03238651|11316027|FG002|NOT COMPLETED|Overall Study||4
10186513|NCT03238651|11316028|FG003|NOT COMPLETED|Overall Study||3
10186514|NCT03238651|11316029|FG004|NOT COMPLETED|Overall Study||1
10186515|NCT03238781|11316045|FG000|STARTED|Overall Study||137
10186516|NCT03238781|11316046|FG001|STARTED|Overall Study||104
10186517|NCT03238781|11316047|FG002|STARTED|Overall Study||102
10186518|NCT03238781|11316045|FG000|COMPLETED|Overall Study||111
10186519|NCT03238781|11316046|FG001|COMPLETED|Overall Study||87
10186520|NCT03238781|11316047|FG002|COMPLETED|Overall Study||82
10186521|NCT03238781|11316045|FG000|NOT COMPLETED|Overall Study||26
10186522|NCT03238781|11316046|FG001|NOT COMPLETED|Overall Study||17
10186523|NCT03238781|11316047|FG002|NOT COMPLETED|Overall Study||20
10186524|NCT03238911|11316057|FG000|STARTED|Overall Study||62
10186525|NCT03238911|11316058|FG001|STARTED|Overall Study||61
10186526|NCT03238911|11316057|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
10186527|NCT03238911|11316058|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
10186528|NCT03238911|11316057|FG000|COMPLETED|Overall Study||59
10186529|NCT03238911|11316058|FG001|COMPLETED|Overall Study||58
10186530|NCT03238911|11316057|FG000|NOT COMPLETED|Overall Study||3
10186531|NCT03238911|11316058|FG001|NOT COMPLETED|Overall Study||3
10186532|NCT03238924|11316067|FG000|STARTED|Overall Study||8
10186533|NCT03238924|11316068|FG001|STARTED|Overall Study||9
10186534|NCT03238924|11316067|FG000|COMPLETED|Overall Study||6
10186535|NCT03238924|11316068|FG001|COMPLETED|Overall Study||7
10186536|NCT03238924|11316067|FG000|NOT COMPLETED|Overall Study||2
10186537|NCT03238924|11316068|FG001|NOT COMPLETED|Overall Study||2
10186538|NCT03238963|11316076|FG000|STARTED|Overall Study||40
10186539|NCT03238963|11316077|FG001|STARTED|Overall Study||39
10186540|NCT03238963|11316076|FG000|COMPLETED|Overall Study||35
10186541|NCT03238963|11316077|FG001|COMPLETED|Overall Study||37
10186542|NCT03238963|11316076|FG000|NOT COMPLETED|Overall Study||5
10186543|NCT03238963|11316077|FG001|NOT COMPLETED|Overall Study||2
10186544|NCT03239106|11316083|FG000|STARTED|Overall Study||10
10186545|NCT03239106|11316083|FG000|COMPLETED|Overall Study||3
10186546|NCT03239106|11316083|FG000|NOT COMPLETED|Overall Study||7
10186547|NCT03239470|11316088|FG000|STARTED|Blood Donation||5
10186548|NCT03239470|11316089|FG001|STARTED|Blood Donation||0
10186549|NCT03239470|11316088|FG000|COMPLETED|Blood Donation||5
10186550|NCT03239470|11316089|FG001|COMPLETED|Blood Donation||0
10186551|NCT03239470|11316088|FG000|NOT COMPLETED|Blood Donation||0
10186552|NCT03239470|11316089|FG001|NOT COMPLETED|Blood Donation||0
10186553|NCT03239470|11316088|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5
10186554|NCT03239470|11316089|FG001|STARTED|Polyclonal Treg Infusion||0
10186555|NCT03239470|11316088|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4
10186556|NCT03239470|11316089|FG001|COMPLETED|Polyclonal Treg Infusion||0
10186557|NCT03239470|11316088|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1
10186558|NCT03239470|11316089|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0
9715381|NCT02584634|10814678|FG000|COMPLETED|Overall Study||0
9715382|NCT02584634|10814679|FG001|COMPLETED|Overall Study||0
9715383|NCT02584634|10814678|FG000|NOT COMPLETED|Overall Study||12
9715384|NCT02584634|10814679|FG001|NOT COMPLETED|Overall Study||31
9715388|NCT02570503|10814694|FG000|STARTED|Overall Study||34
9715389|NCT02570503|10814695|FG001|STARTED|Overall Study||30
9715390|NCT02570503|10814694|FG000|COMPLETED|Overall Study||34
9715391|NCT02570503|10814695|FG001|COMPLETED|Overall Study||30
9715392|NCT02570503|10814694|FG000|NOT COMPLETED|Overall Study||0
9715393|NCT02570503|10814695|FG001|NOT COMPLETED|Overall Study||0
9715394|NCT02553265|10814701|FG000|STARTED|Enrollment||9
9715395|NCT02553265|10814702|FG001|STARTED|Enrollment||7
9715396|NCT02553265|10814703|FG002|STARTED|Enrollment||6
9715397|NCT02553265|10814701|FG000|COMPLETED|Enrollment||9
9715398|NCT02553265|10814702|FG001|COMPLETED|Enrollment||7
9715399|NCT02553265|10814703|FG002|COMPLETED|Enrollment||5
9715400|NCT02553265|10814701|FG000|NOT COMPLETED|Enrollment||0
9715401|NCT02553265|10814702|FG001|NOT COMPLETED|Enrollment||0
9715402|NCT02553265|10814703|FG002|NOT COMPLETED|Enrollment||1
9715403|NCT02553265|10814701|FG000|STARTED|First Intervention (28 Days)||9
9715404|NCT02553265|10814702|FG001|STARTED|First Intervention (28 Days)||7
9715405|NCT02553265|10814703|FG002|STARTED|First Intervention (28 Days)||5
9715406|NCT02553265|10814701|FG000|COMPLETED|First Intervention (28 Days)||8
9715407|NCT02553265|10814702|FG001|COMPLETED|First Intervention (28 Days)||7
9715408|NCT02553265|10814703|FG002|COMPLETED|First Intervention (28 Days)||4
9715409|NCT02553265|10814701|FG000|NOT COMPLETED|First Intervention (28 Days)||1
9715410|NCT02553265|10814702|FG001|NOT COMPLETED|First Intervention (28 Days)||0
9715411|NCT02553265|10814703|FG002|NOT COMPLETED|First Intervention (28 Days)||1
9715412|NCT02553265|10814701|FG000|STARTED|Second Intervention (28 Days)||8
9715413|NCT02553265|10814702|FG001|STARTED|Second Intervention (28 Days)||7
9715414|NCT02553265|10814703|FG002|STARTED|Second Intervention (28 Days)||4
9715415|NCT02553265|10814701|FG000|COMPLETED|Second Intervention (28 Days)||7
9715416|NCT02553265|10814702|FG001|COMPLETED|Second Intervention (28 Days)||7
9715417|NCT02553265|10814703|FG002|COMPLETED|Second Intervention (28 Days)||4
9715418|NCT02553265|10814701|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
9715419|NCT02553265|10814702|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
9715420|NCT02553265|10814703|FG002|NOT COMPLETED|Second Intervention (28 Days)||0
9715421|NCT02553265|10814701|FG000|STARTED|Third Intervention (28 Days)||7
9715422|NCT02553265|10814702|FG001|STARTED|Third Intervention (28 Days)||7
9715423|NCT02553265|10814703|FG002|STARTED|Third Intervention (28 Days)||4
9715424|NCT02553265|10814701|FG000|COMPLETED|Third Intervention (28 Days)||6
9715425|NCT02553265|10814702|FG001|COMPLETED|Third Intervention (28 Days)||7
9715426|NCT02553265|10814703|FG002|COMPLETED|Third Intervention (28 Days)||3
9715427|NCT02553265|10814701|FG000|NOT COMPLETED|Third Intervention (28 Days)||1
9715428|NCT02553265|10814702|FG001|NOT COMPLETED|Third Intervention (28 Days)||0
9715429|NCT02553265|10814703|FG002|NOT COMPLETED|Third Intervention (28 Days)||1
9715430|NCT02550288|10814719|FG000|STARTED|Overall Study||35
9715431|NCT02550288|10814720|FG001|STARTED|Overall Study||68
9715432|NCT02550288|10814721|FG002|STARTED|Overall Study||69
9715433|NCT02550288|10814722|FG003|STARTED|Overall Study||68
9715434|NCT02550288|10814723|FG004|STARTED|Overall Study||69
9715435|NCT02550288|10814719|FG000|COMPLETED|Overall Study||33
9715436|NCT02550288|10814720|FG001|COMPLETED|Overall Study||65
9715437|NCT02550288|10814721|FG002|COMPLETED|Overall Study||68
9715438|NCT02550288|10814722|FG003|COMPLETED|Overall Study||65
9715439|NCT02550288|10814723|FG004|COMPLETED|Overall Study||66
9715440|NCT02550288|10814719|FG000|NOT COMPLETED|Overall Study||2
9715441|NCT02550288|10814720|FG001|NOT COMPLETED|Overall Study||3
9715442|NCT02550288|10814721|FG002|NOT COMPLETED|Overall Study||1
9715443|NCT02550288|10814722|FG003|NOT COMPLETED|Overall Study||3
9715444|NCT02550288|10814723|FG004|NOT COMPLETED|Overall Study||3
9715445|NCT02510040|10814738|FG000|STARTED|Overall Study||81
9715446|NCT02510040|10814739|FG001|STARTED|Overall Study||114
9715447|NCT02510040|10814740|FG002|STARTED|Overall Study||22
9715448|NCT02510040|10814738|FG000|COMPLETED|Overall Study||63
9715449|NCT02510040|10814739|FG001|COMPLETED|Overall Study||111
9715450|NCT02510040|10814740|FG002|COMPLETED|Overall Study||21
9715451|NCT02510040|10814738|FG000|NOT COMPLETED|Overall Study||18
9715452|NCT02510040|10814739|FG001|NOT COMPLETED|Overall Study||3
9715453|NCT02510040|10814740|FG002|NOT COMPLETED|Overall Study||1
9715454|NCT02499328|10814768|FG000|STARTED|Overall Study||4
10186559|NCT03239483|11316095|FG000|STARTED|Overall Study||19
10186560|NCT03239483|11316096|FG001|STARTED|Overall Study||9
10186561|NCT03239483|11316095|FG000|COMPLETED|Overall Study||17
10186562|NCT03239483|11316096|FG001|COMPLETED|Overall Study||9
10186563|NCT03239483|11316095|FG000|NOT COMPLETED|Overall Study||2
10186564|NCT03239483|11316096|FG001|NOT COMPLETED|Overall Study||0
10186565|NCT03239496|11316106|FG000|STARTED|Overall Study||200
10186566|NCT03239496|11316107|FG001|STARTED|Overall Study||178
10186567|NCT03239496|11316108|FG002|STARTED|Overall Study||178
10186568|NCT03239496|11316109|FG003|STARTED|Overall Study||217
10186569|NCT03239496|11316106|FG000|COMPLETED|Overall Study||186
10186570|NCT03239496|11316107|FG001|COMPLETED|Overall Study||168
10186571|NCT03239496|11316108|FG002|COMPLETED|Overall Study||166
10186572|NCT03239496|11316109|FG003|COMPLETED|Overall Study||203
10186573|NCT03239496|11316106|FG000|NOT COMPLETED|Overall Study||14
10186574|NCT03239496|11316107|FG001|NOT COMPLETED|Overall Study||10
10186575|NCT03239496|11316108|FG002|NOT COMPLETED|Overall Study||12
10186576|NCT03239496|11316109|FG003|NOT COMPLETED|Overall Study||14
10186577|NCT03239522|11316123|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6
10186578|NCT03239522|11316123|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
10186579|NCT03239522|11316123|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
10186580|NCT03239522|11316123|FG000|STARTED|Washout Period (Up to 7 Days)||6
10186581|NCT03239522|11316123|FG000|COMPLETED|Washout Period (Up to 7 Days)||6
10186582|NCT03239522|11316123|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0
10186583|NCT03239522|11316123|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6
10186584|NCT03239522|11316123|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
10186585|NCT03239522|11316123|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
10186586|NCT03239574|11316134|FG000|STARTED|Overall Study||34
10186587|NCT03239574|11316134|FG000|COMPLETED|Overall Study||34
10186588|NCT03239574|11316134|FG000|NOT COMPLETED|Overall Study||0
10186589|NCT03239665|11316140|FG000|STARTED|Overall Study||175
10186590|NCT03239665|11316141|FG001|STARTED|Overall Study||160
10186591|NCT03239665|11316140|FG000|Met Inclusion Criteria|Overall Study||150
10186592|NCT03239665|11316141|FG001|Met Inclusion Criteria|Overall Study||144
10186593|NCT03239665|11316140|FG000|Submitted Survey Data|Overall Study||147
10186594|NCT03239665|11316141|FG001|Submitted Survey Data|Overall Study||140
10186595|NCT03239665|11316140|FG000|COMPLETED|Overall Study||147
10186596|NCT03239665|11316141|FG001|COMPLETED|Overall Study||140
10186597|NCT03239665|11316140|FG000|NOT COMPLETED|Overall Study||28
10186598|NCT03239665|11316141|FG001|NOT COMPLETED|Overall Study||20
10186599|NCT03239873|11316149|FG000|STARTED|Overall Study||300
10186600|NCT03239873|11316150|FG001|STARTED|Overall Study||300
10186601|NCT03239873|11316149|FG000|Vaccination 1|Overall Study||299
10186602|NCT03239873|11316150|FG001|Vaccination 1|Overall Study||300
10186603|NCT03239873|11316149|FG000|Vaccination 2|Overall Study||276
10186604|NCT03239873|11316150|FG001|Vaccination 2|Overall Study||282
10186605|NCT03239873|11316149|FG000|COMPLETED|Overall Study||268
10186606|NCT03239873|11316150|FG001|COMPLETED|Overall Study||273
10186607|NCT03239873|11316149|FG000|NOT COMPLETED|Overall Study||32
10186608|NCT03239873|11316150|FG001|NOT COMPLETED|Overall Study||27
10186609|NCT03240081|11316158|FG000|STARTED|Overall Study||25
10186610|NCT03240081|11316159|FG001|STARTED|Overall Study||25
10186611|NCT03240081|11316158|FG000|COMPLETED|Overall Study||25
10186612|NCT03240081|11316159|FG001|COMPLETED|Overall Study||22
10186613|NCT03240081|11316158|FG000|NOT COMPLETED|Overall Study||0
10186614|NCT03240081|11316159|FG001|NOT COMPLETED|Overall Study||3
10186615|NCT03240133|11316168|FG000|STARTED|Overall Study||33
10186616|NCT03240133|11316169|FG001|STARTED|Overall Study||14
10186617|NCT03240133|11316170|FG002|STARTED|Overall Study||11
10186618|NCT03240133|11316168|FG000|Completed Period 1|Overall Study||33
10186619|NCT03240133|11316169|FG001|Completed Period 1|Overall Study||14
10186620|NCT03240133|11316170|FG002|Completed Period 1|Overall Study||11
10186621|NCT03240133|11316168|FG000|Completed Period 2|Overall Study||32
10186622|NCT03240133|11316169|FG001|Completed Period 2|Overall Study||11
10186623|NCT03240133|11316170|FG002|Completed Period 2|Overall Study||11
10186624|NCT03240133|11316168|FG000|Completed Period 3|Overall Study||30
10186625|NCT03240133|11316169|FG001|Completed Period 3|Overall Study||11
10186626|NCT03240133|11316170|FG002|Completed Period 3|Overall Study||11
10186627|NCT03240133|11316168|FG000|COMPLETED|Overall Study||30
10186628|NCT03240133|11316169|FG001|COMPLETED|Overall Study||11
10186629|NCT03240133|11316170|FG002|COMPLETED|Overall Study||10
10186630|NCT03240133|11316168|FG000|NOT COMPLETED|Overall Study||3
10186631|NCT03240133|11316169|FG001|NOT COMPLETED|Overall Study||3
10186632|NCT03240133|11316170|FG002|NOT COMPLETED|Overall Study||1
10186633|NCT03240575|11316198|FG000|STARTED|Overall Study||146
10186634|NCT03240575|11316199|FG001|STARTED|Overall Study||145
10186635|NCT03240575|11316200|FG002|STARTED|Overall Study||6
10186636|NCT03240575|11316201|FG003|STARTED|Overall Study||5
10186637|NCT03240575|11316198|FG000|COMPLETED|Overall Study||144
10186638|NCT03240575|11316199|FG001|COMPLETED|Overall Study||131
10186639|NCT03240575|11316200|FG002|COMPLETED|Overall Study||6
10186640|NCT03240575|11316201|FG003|COMPLETED|Overall Study||3
10186641|NCT03240575|11316198|FG000|NOT COMPLETED|Overall Study||2
10186642|NCT03240575|11316199|FG001|NOT COMPLETED|Overall Study||14
10186643|NCT03240575|11316200|FG002|NOT COMPLETED|Overall Study||0
10186644|NCT03240575|11316201|FG003|NOT COMPLETED|Overall Study||2
10186645|NCT03241030|11316211|FG000|STARTED|Overall Study||50
10186646|NCT03241030|11316212|FG001|STARTED|Overall Study||52
10186647|NCT03241030|11316211|FG000|COMPLETED|Overall Study||49
10186648|NCT03241030|11316212|FG001|COMPLETED|Overall Study||51
10186649|NCT03241030|11316211|FG000|NOT COMPLETED|Overall Study||1
10186650|NCT03241030|11316212|FG001|NOT COMPLETED|Overall Study||1
10186651|NCT03241342|11316221|FG000|STARTED|Overall Study||163
10186652|NCT03241342|11316222|FG001|STARTED|Overall Study||163
10186653|NCT03241342|11316223|FG002|STARTED|Overall Study||165
10186654|NCT03241342|11316221|FG000|COMPLETED|Overall Study||141
10186655|NCT03241342|11316222|FG001|COMPLETED|Overall Study||132
10186656|NCT03241342|11316223|FG002|COMPLETED|Overall Study||138
10186657|NCT03241342|11316221|FG000|NOT COMPLETED|Overall Study||22
10186658|NCT03241342|11316222|FG001|NOT COMPLETED|Overall Study||31
10186659|NCT03241342|11316223|FG002|NOT COMPLETED|Overall Study||27
10186660|NCT03241368|11316231|FG000|STARTED|Overall Study||158
10186661|NCT03241368|11316231|FG000|COMPLETED|Overall Study||119
10186662|NCT03241368|11316231|FG000|NOT COMPLETED|Overall Study||39
9715455|NCT02499328|10814769|FG001|STARTED|Overall Study||7
9715456|NCT02499328|10814770|FG002|STARTED|Overall Study||10
10061902|NCT02106351|11187395|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
10061903|NCT02106351|11187393|FG000|COMPLETED|Treatment Cycle 3||0
10186663|NCT03241485|11316238|FG000|STARTED|Overall Study||42
9715457|NCT02499328|10814771|FG003|STARTED|Overall Study||11
9715458|NCT02499328|10814772|FG004|STARTED|Overall Study||15
9715459|NCT02499328|10814773|FG005|STARTED|Overall Study||9
9715460|NCT02499328|10814774|FG006|STARTED|Overall Study||7
9715461|NCT02499328|10814775|FG007|STARTED|Overall Study||6
9715462|NCT02499328|10814776|FG008|STARTED|Overall Study||14
9715463|NCT02499328|10814777|FG009|STARTED|Overall Study||24
9715464|NCT02499328|10814778|FG010|STARTED|Overall Study||20
9715465|NCT02499328|10814779|FG011|STARTED|Overall Study||54
9715466|NCT02499328|10814780|FG012|STARTED|Overall Study||25
9715467|NCT02499328|10814781|FG013|STARTED|Overall Study||17
9715468|NCT02499328|10814782|FG014|STARTED|Overall Study||10
9715469|NCT02499328|10814783|FG015|STARTED|Overall Study||1
9715470|NCT02499328|10814784|FG016|STARTED|Overall Study||1
9715471|NCT02499328|10814785|FG017|STARTED|Overall Study||55
9715472|NCT02499328|10814786|FG018|STARTED|Overall Study||50
9715473|NCT02499328|10814768|FG000|COMPLETED|Overall Study||0
9715474|NCT02499328|10814769|FG001|COMPLETED|Overall Study||0
9715475|NCT02499328|10814770|FG002|COMPLETED|Overall Study||0
9715476|NCT02499328|10814771|FG003|COMPLETED|Overall Study||0
9715477|NCT02499328|10814772|FG004|COMPLETED|Overall Study||0
9715478|NCT02499328|10814773|FG005|COMPLETED|Overall Study||0
9715479|NCT02499328|10814774|FG006|COMPLETED|Overall Study||0
9715480|NCT02499328|10814775|FG007|COMPLETED|Overall Study||0
9715481|NCT02499328|10814776|FG008|COMPLETED|Overall Study||0
9715482|NCT02499328|10814777|FG009|COMPLETED|Overall Study||0
9715483|NCT02499328|10814778|FG010|COMPLETED|Overall Study||0
9715484|NCT02499328|10814779|FG011|COMPLETED|Overall Study||0
9715485|NCT02499328|10814780|FG012|COMPLETED|Overall Study||0
10186664|NCT03241485|11316239|FG001|STARTED|Overall Study||37
10186665|NCT03241485|11316238|FG000|COMPLETED|Overall Study||37
10186666|NCT03241485|11316239|FG001|COMPLETED|Overall Study||33
9715486|NCT02499328|10814781|FG013|COMPLETED|Overall Study||0
9715487|NCT02499328|10814782|FG014|COMPLETED|Overall Study||0
9715488|NCT02499328|10814783|FG015|COMPLETED|Overall Study||0
9715489|NCT02499328|10814784|FG016|COMPLETED|Overall Study||0
9715490|NCT02499328|10814785|FG017|COMPLETED|Overall Study||0
9715491|NCT02499328|10814786|FG018|COMPLETED|Overall Study||1
9715492|NCT02499328|10814768|FG000|NOT COMPLETED|Overall Study||4
9715493|NCT02499328|10814769|FG001|NOT COMPLETED|Overall Study||7
10186667|NCT03241485|11316238|FG000|NOT COMPLETED|Overall Study||5
10186668|NCT03241485|11316239|FG001|NOT COMPLETED|Overall Study||4
10186669|NCT03241810|11316251|FG000|STARTED|Overall Study||11
10186670|NCT03241810|11316252|FG001|STARTED|Overall Study||11
10186671|NCT03241810|11316251|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
9715494|NCT02499328|10814770|FG002|NOT COMPLETED|Overall Study||10
10186672|NCT03241810|11316252|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
10186673|NCT03241810|11316251|FG000|NOT COMPLETED|Overall Study||0
10186674|NCT03241810|11316252|FG001|NOT COMPLETED|Overall Study||0
10186675|NCT03241862|11316259|FG000|STARTED|Overall Study||20
10186676|NCT03241862|11316259|FG000|COMPLETED|Overall Study||20
10186677|NCT03241862|11316259|FG000|NOT COMPLETED|Overall Study||0
10186678|NCT03241927|11316263|FG000|STARTED|Overall Study||1
10186679|NCT03241927|11316264|FG001|STARTED|Overall Study||0
10186680|NCT03241927|11316263|FG000|COMPLETED|Overall Study||0
10186681|NCT03241927|11316264|FG001|COMPLETED|Overall Study||0
10186682|NCT03241927|11316263|FG000|NOT COMPLETED|Overall Study||1
10186683|NCT03241927|11316264|FG001|NOT COMPLETED|Overall Study||0
10186684|NCT03242018|11316273|FG000|STARTED|Overall Study||93
10186685|NCT03242018|11316274|FG001|STARTED|Overall Study||92
10186686|NCT03242018|11316275|FG002|STARTED|Overall Study||92
10186687|NCT03242018|11316273|FG000|COMPLETED|Overall Study||75
10186688|NCT03242018|11316274|FG001|COMPLETED|Overall Study||78
10186689|NCT03242018|11316275|FG002|COMPLETED|Overall Study||78
10186690|NCT03242018|11316273|FG000|NOT COMPLETED|Overall Study||18
10186691|NCT03242018|11316274|FG001|NOT COMPLETED|Overall Study||14
10186692|NCT03242018|11316275|FG002|NOT COMPLETED|Overall Study||14
10186693|NCT03242148|11316284|FG000|STARTED|Overall Study||38
10186694|NCT03242148|11316284|FG000|COMPLETED|Overall Study||38
10186695|NCT03242148|11316284|FG000|NOT COMPLETED|Overall Study||0
10186696|NCT03242252|11316291|FG000|STARTED|Overall Study||260
10186697|NCT03242252|11316292|FG001|STARTED|Overall Study||263
10186698|NCT03242252|11316293|FG002|STARTED|Overall Study||264
10186699|NCT03242252|11316291|FG000|COMPLETED|Overall Study||224
10186700|NCT03242252|11316292|FG001|COMPLETED|Overall Study||240
10186701|NCT03242252|11316293|FG002|COMPLETED|Overall Study||232
10186702|NCT03242252|11316291|FG000|NOT COMPLETED|Overall Study||36
10186703|NCT03242252|11316292|FG001|NOT COMPLETED|Overall Study||23
10186704|NCT03242252|11316293|FG002|NOT COMPLETED|Overall Study||32
10186705|NCT03242408|11316307|FG000|STARTED|Overall Study||100
10186706|NCT03242408|11316307|FG000|COMPLETED|Overall Study||98
10186707|NCT03242408|11316307|FG000|NOT COMPLETED|Overall Study||2
10186708|NCT03242434|11316313|FG000|STARTED|Overall Study||15
10186709|NCT03242434|11316314|FG001|STARTED|Overall Study||3
10186710|NCT03242434|11316313|FG000|COMPLETED|Overall Study||15
10186711|NCT03242434|11316314|FG001|COMPLETED|Overall Study||1
10186712|NCT03242434|11316313|FG000|NOT COMPLETED|Overall Study||0
10186713|NCT03242434|11316314|FG001|NOT COMPLETED|Overall Study||2
10186714|NCT03242590|11316321|FG000|STARTED|Overall Study||95
10186715|NCT03242590|11316321|FG000|COMPLETED|Overall Study||95
10186716|NCT03242590|11316321|FG000|NOT COMPLETED|Overall Study||0
10186717|NCT03242759|11316327|FG000|STARTED|Overall Study||88
10186718|NCT03242759|11316328|FG001|STARTED|Overall Study||13
10186719|NCT03242759|11316327|FG000|COMPLETED|Overall Study||53
10186720|NCT03242759|11316328|FG001|COMPLETED|Overall Study||6
10186721|NCT03242759|11316327|FG000|NOT COMPLETED|Overall Study||35
10186722|NCT03242759|11316328|FG001|NOT COMPLETED|Overall Study||7
10186723|NCT03242863|11316334|FG000|STARTED|Study Week 1||13
10186724|NCT03242863|11316335|FG001|STARTED|Study Week 1||16
10186725|NCT03242863|11316336|FG002|STARTED|Study Week 1||4
10186726|NCT03242863|11316337|FG003|STARTED|Study Week 1||4
10186727|NCT03242863|11316338|FG004|STARTED|Study Week 1||15
10186728|NCT03242863|11316339|FG005|STARTED|Study Week 1||5
10186729|NCT03242863|11316334|FG000|COMPLETED|Study Week 1||13
10186730|NCT03242863|11316335|FG001|COMPLETED|Study Week 1||15
10186731|NCT03242863|11316336|FG002|COMPLETED|Study Week 1||4
10186732|NCT03242863|11316337|FG003|COMPLETED|Study Week 1||4
10186733|NCT03242863|11316338|FG004|COMPLETED|Study Week 1||12
10186734|NCT03242863|11316339|FG005|COMPLETED|Study Week 1||5
10186735|NCT03242863|11316334|FG000|NOT COMPLETED|Study Week 1||0
10186736|NCT03242863|11316335|FG001|NOT COMPLETED|Study Week 1||1
10186737|NCT03242863|11316336|FG002|NOT COMPLETED|Study Week 1||0
10186738|NCT03242863|11316337|FG003|NOT COMPLETED|Study Week 1||0
10186739|NCT03242863|11316338|FG004|NOT COMPLETED|Study Week 1||3
10186740|NCT03242863|11316339|FG005|NOT COMPLETED|Study Week 1||0
10186741|NCT03242863|11316334|FG000|STARTED|Study Week 2||13
10186742|NCT03242863|11316335|FG001|STARTED|Study Week 2||15
10186743|NCT03242863|11316336|FG002|STARTED|Study Week 2||4
10186744|NCT03242863|11316337|FG003|STARTED|Study Week 2||4
10186745|NCT03242863|11316338|FG004|STARTED|Study Week 2||12
9715495|NCT02499328|10814771|FG003|NOT COMPLETED|Overall Study||11
9715496|NCT02499328|10814772|FG004|NOT COMPLETED|Overall Study||15
10186746|NCT03242863|11316339|FG005|STARTED|Study Week 2||5
10186747|NCT03242863|11316334|FG000|COMPLETED|Study Week 2||13
10186748|NCT03242863|11316335|FG001|COMPLETED|Study Week 2||15
10186749|NCT03242863|11316336|FG002|COMPLETED|Study Week 2||4
10186750|NCT03242863|11316337|FG003|COMPLETED|Study Week 2||4
10186751|NCT03242863|11316338|FG004|COMPLETED|Study Week 2||12
10186752|NCT03242863|11316339|FG005|COMPLETED|Study Week 2||5
10186753|NCT03242863|11316334|FG000|NOT COMPLETED|Study Week 2||0
10186754|NCT03242863|11316335|FG001|NOT COMPLETED|Study Week 2||0
10186755|NCT03242863|11316336|FG002|NOT COMPLETED|Study Week 2||0
10186756|NCT03242863|11316337|FG003|NOT COMPLETED|Study Week 2||0
10186757|NCT03242863|11316338|FG004|NOT COMPLETED|Study Week 2||0
10186758|NCT03242863|11316339|FG005|NOT COMPLETED|Study Week 2||0
10186759|NCT03242863|11316334|FG000|STARTED|Study Week 3||13
10186760|NCT03242863|11316335|FG001|STARTED|Study Week 3||15
10186761|NCT03242863|11316336|FG002|STARTED|Study Week 3||4
10186762|NCT03242863|11316337|FG003|STARTED|Study Week 3||4
10186763|NCT03242863|11316338|FG004|STARTED|Study Week 3||12
10186764|NCT03242863|11316339|FG005|STARTED|Study Week 3||5
10186765|NCT03242863|11316334|FG000|COMPLETED|Study Week 3||13
10186766|NCT03242863|11316335|FG001|COMPLETED|Study Week 3||15
10186767|NCT03242863|11316336|FG002|COMPLETED|Study Week 3||4
10186768|NCT03242863|11316337|FG003|COMPLETED|Study Week 3||4
10186769|NCT03242863|11316338|FG004|COMPLETED|Study Week 3||12
10186770|NCT03242863|11316339|FG005|COMPLETED|Study Week 3||5
10186771|NCT03242863|11316334|FG000|NOT COMPLETED|Study Week 3||0
10186772|NCT03242863|11316335|FG001|NOT COMPLETED|Study Week 3||0
10186773|NCT03242863|11316336|FG002|NOT COMPLETED|Study Week 3||0
10186774|NCT03242863|11316337|FG003|NOT COMPLETED|Study Week 3||0
10186775|NCT03242863|11316338|FG004|NOT COMPLETED|Study Week 3||0
10186776|NCT03242863|11316339|FG005|NOT COMPLETED|Study Week 3||0
10186777|NCT03242928|11316349|FG000|STARTED|Overall Study||31
10186778|NCT03242928|11316350|FG001|STARTED|Overall Study||37
10186779|NCT03242928|11316349|FG000|COMPLETED|Overall Study||22
10186780|NCT03242928|11316350|FG001|COMPLETED|Overall Study||32
10186781|NCT03242928|11316349|FG000|NOT COMPLETED|Overall Study||9
10186782|NCT03242928|11316350|FG001|NOT COMPLETED|Overall Study||5
10186783|NCT03242941|11316356|FG000|STARTED|Overall Study||16
10186784|NCT03242941|11316356|FG000|COMPLETED|Overall Study||14
10186785|NCT03242941|11316356|FG000|NOT COMPLETED|Overall Study||2
10186786|NCT03242954|11316365|FG000|STARTED|Overall Study||43
10186787|NCT03242954|11316366|FG001|STARTED|Overall Study||45
10186788|NCT03242954|11316367|FG002|STARTED|Overall Study||41
10186789|NCT03242954|11316368|FG003|STARTED|Overall Study||125
10186790|NCT03242954|11316365|FG000|COMPLETED|Overall Study||43
10186791|NCT03242954|11316366|FG001|COMPLETED|Overall Study||45
10186792|NCT03242954|11316367|FG002|COMPLETED|Overall Study||41
10186793|NCT03242954|11316368|FG003|COMPLETED|Overall Study||125
10186794|NCT03242954|11316365|FG000|NOT COMPLETED|Overall Study||0
10186795|NCT03242954|11316366|FG001|NOT COMPLETED|Overall Study||0
10186796|NCT03242954|11316367|FG002|NOT COMPLETED|Overall Study||0
10186797|NCT03242954|11316368|FG003|NOT COMPLETED|Overall Study||0
10186798|NCT03243084|11316380|FG000|STARTED|Session 1||11
10186799|NCT03243084|11316381|FG001|STARTED|Session 1||10
10186800|NCT03243084|11316380|FG000|COMPLETED|Session 1||11
10186801|NCT03243084|11316381|FG001|COMPLETED|Session 1||10
10186802|NCT03243084|11316380|FG000|NOT COMPLETED|Session 1||0
10186803|NCT03243084|11316381|FG001|NOT COMPLETED|Session 1||0
10186804|NCT03243084|11316380|FG000|STARTED|Washout (1-3 Weeks)||11
10186805|NCT03243084|11316381|FG001|STARTED|Washout (1-3 Weeks)||10
10186806|NCT03243084|11316380|FG000|COMPLETED|Washout (1-3 Weeks)||10
10186807|NCT03243084|11316381|FG001|COMPLETED|Washout (1-3 Weeks)||10
10186808|NCT03243084|11316380|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1
10186809|NCT03243084|11316381|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0
10186810|NCT03243084|11316380|FG000|STARTED|Session 2||10
10186811|NCT03243084|11316381|FG001|STARTED|Session 2||10
10186812|NCT03243084|11316380|FG000|COMPLETED|Session 2||10
10186813|NCT03243084|11316381|FG001|COMPLETED|Session 2||10
10186814|NCT03243084|11316380|FG000|NOT COMPLETED|Session 2||0
10186815|NCT03243084|11316381|FG001|NOT COMPLETED|Session 2||0
10186816|NCT03243305|11316388|FG000|STARTED|Overall Study||1384
10186817|NCT03243305|11316388|FG000|COMPLETED|Overall Study||449
10186818|NCT03243305|11316388|FG000|NOT COMPLETED|Overall Study||935
10186819|NCT03243630|11316392|FG000|STARTED|Overall Study||24
10186820|NCT03243630|11316392|FG000|Menthol E-liquid Saline|Overall Study||22
10186821|NCT03243630|11316392|FG000|Menthol E-liquid Higher|Overall Study||22
10186822|NCT03243630|11316392|FG000|Menthol E-liquid Lower|Overall Study||22
10186823|NCT03243630|11316392|FG000|Green Apple E-liquid Saline|Overall Study||20
10186824|NCT03243630|11316392|FG000|Green Apple E-liquid Higher|Overall Study||20
10186825|NCT03243630|11316392|FG000|Green Apple E-liquid Lower|Overall Study||20
10186826|NCT03243630|11316392|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21
10186827|NCT03243630|11316392|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21
10186828|NCT03243630|11316392|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21
10186829|NCT03243630|11316392|FG000|COMPLETED|Overall Study||22
10186830|NCT03243630|11316392|FG000|NOT COMPLETED|Overall Study||2
10186831|NCT03243981|11316400|FG000|STARTED|Overall Study||5
10186832|NCT03243981|11316400|FG000|COMPLETED|Overall Study||5
10186833|NCT03243981|11316400|FG000|NOT COMPLETED|Overall Study||0
10186834|NCT03244618|11316411|FG000|STARTED|Overall Study||132
10186835|NCT03244618|11316412|FG001|STARTED|Overall Study||131
10186836|NCT03244618|11316411|FG000|Week 2|Overall Study||128
10186837|NCT03244618|11316412|FG001|Week 2|Overall Study||125
10186838|NCT03244618|11316411|FG000|COMPLETED|Overall Study||125
10186839|NCT03244618|11316412|FG001|COMPLETED|Overall Study||122
10186840|NCT03244618|11316411|FG000|NOT COMPLETED|Overall Study||7
10186841|NCT03244618|11316412|FG001|NOT COMPLETED|Overall Study||9
10186842|NCT03244800|11316422|FG000|STARTED|Overall Study||13
10186843|NCT03244800|11316423|FG001|STARTED|Overall Study||26
10186844|NCT03244800|11316424|FG002|STARTED|Overall Study||6
10186845|NCT03244800|11316425|FG003|STARTED|Overall Study||20
10186846|NCT03244800|11316422|FG000|COMPLETED|Overall Study||13
10186847|NCT03244800|11316423|FG001|COMPLETED|Overall Study||25
10186848|NCT03244800|11316424|FG002|COMPLETED|Overall Study||6
10186849|NCT03244800|11316425|FG003|COMPLETED|Overall Study||18
10186850|NCT03244800|11316422|FG000|NOT COMPLETED|Overall Study||0
10186851|NCT03244800|11316423|FG001|NOT COMPLETED|Overall Study||1
10186852|NCT03244800|11316424|FG002|NOT COMPLETED|Overall Study||0
10186853|NCT03244800|11316425|FG003|NOT COMPLETED|Overall Study||2
10186854|NCT03244865|11316438|FG000|STARTED|Overall Study||35
10186855|NCT03244865|11316438|FG000|COMPLETED|Overall Study||35
10186856|NCT03244865|11316438|FG000|NOT COMPLETED|Overall Study||0
10186857|NCT03244917|11316444|FG000|STARTED|Overall Study||201
10186858|NCT03244917|11316445|FG001|STARTED|Overall Study||229
10186859|NCT03244917|11316444|FG000|COMPLETED|Overall Study||199
10186860|NCT03244917|11316445|FG001|COMPLETED|Overall Study||227
10186861|NCT03244917|11316444|FG000|NOT COMPLETED|Overall Study||2
10186862|NCT03244917|11316445|FG001|NOT COMPLETED|Overall Study||2
10186863|NCT03245372|11316453|FG000|STARTED|Overall Study||15
10186864|NCT03245372|11316454|FG001|STARTED|Overall Study||15
10186865|NCT03245372|11316453|FG000|COMPLETED|Overall Study||15
10186866|NCT03245372|11316454|FG001|COMPLETED|Overall Study||15
10186867|NCT03245372|11316453|FG000|NOT COMPLETED|Overall Study||0
10186868|NCT03245372|11316454|FG001|NOT COMPLETED|Overall Study||0
10186869|NCT03245398|11316462|FG000|STARTED|Overall Study||93
10186870|NCT03245398|11316463|FG001|STARTED|Overall Study||93
10186871|NCT03245398|11316462|FG000|COMPLETED|Overall Study||92
10186872|NCT03245398|11316463|FG001|COMPLETED|Overall Study||93
10186873|NCT03245398|11316462|FG000|NOT COMPLETED|Overall Study||1
10186874|NCT03245398|11316463|FG001|NOT COMPLETED|Overall Study||0
10186875|NCT03245463|11316473|FG000|STARTED|Overall Study||12
10186876|NCT03245463|11316474|FG001|STARTED|Overall Study||12
10186877|NCT03245463|11316473|FG000|COMPLETED|Overall Study||12
10186878|NCT03245463|11316474|FG001|COMPLETED|Overall Study||12
10186879|NCT03245463|11316473|FG000|NOT COMPLETED|Overall Study||0
10186880|NCT03245463|11316474|FG001|NOT COMPLETED|Overall Study||0
10186881|NCT03245619|11316497|FG000|STARTED|Part A (Up to Day 22)||5
10186882|NCT03245619|11316498|FG001|STARTED|Part A (Up to Day 22)||6
10186883|NCT03245619|11316499|FG002|STARTED|Part A (Up to Day 22)||6
10186884|NCT03245619|11316500|FG003|STARTED|Part A (Up to Day 22)||1
10186885|NCT03245619|11316501|FG004|STARTED|Part A (Up to Day 22)||0
10186886|NCT03245619|11316502|FG005|STARTED|Part A (Up to Day 22)||0
10186887|NCT03245619|11316503|FG006|STARTED|Part A (Up to Day 22)||0
10186888|NCT03245619|11316504|FG007|STARTED|Part A (Up to Day 22)||0
10186889|NCT03245619|11316505|FG008|STARTED|Part A (Up to Day 22)||0
10186890|NCT03245619|11316506|FG009|STARTED|Part A (Up to Day 22)||0
10186891|NCT03245619|11316507|FG010|STARTED|Part A (Up to Day 22)||0
10186892|NCT03245619|11316508|FG011|STARTED|Part A (Up to Day 22)||0
10186893|NCT03245619|11316509|FG012|STARTED|Part A (Up to Day 22)||0
10186894|NCT03245619|11316510|FG013|STARTED|Part A (Up to Day 22)||0
10186895|NCT03245619|11316511|FG014|STARTED|Part A (Up to Day 22)||0
10186896|NCT03245619|11316512|FG015|STARTED|Part A (Up to Day 22)||0
10186897|NCT03245619|11316513|FG016|STARTED|Part A (Up to Day 22)||0
10186898|NCT03245619|11316497|FG000|COMPLETED|Part A (Up to Day 22)||1
10186899|NCT03245619|11316498|FG001|COMPLETED|Part A (Up to Day 22)||0
10186900|NCT03245619|11316499|FG002|COMPLETED|Part A (Up to Day 22)||0
10186901|NCT03245619|11316500|FG003|COMPLETED|Part A (Up to Day 22)||1
10186902|NCT03245619|11316501|FG004|COMPLETED|Part A (Up to Day 22)||0
10186903|NCT03245619|11316502|FG005|COMPLETED|Part A (Up to Day 22)||0
10186904|NCT03245619|11316503|FG006|COMPLETED|Part A (Up to Day 22)||0
10186905|NCT03245619|11316504|FG007|COMPLETED|Part A (Up to Day 22)||0
10186906|NCT03245619|11316505|FG008|COMPLETED|Part A (Up to Day 22)||0
10186907|NCT03245619|11316506|FG009|COMPLETED|Part A (Up to Day 22)||0
10186908|NCT03245619|11316507|FG010|COMPLETED|Part A (Up to Day 22)||0
10186909|NCT03245619|11316508|FG011|COMPLETED|Part A (Up to Day 22)||0
9715497|NCT02499328|10814773|FG005|NOT COMPLETED|Overall Study||9
9715498|NCT02499328|10814774|FG006|NOT COMPLETED|Overall Study||7
9715499|NCT02499328|10814775|FG007|NOT COMPLETED|Overall Study||6
9715500|NCT02499328|10814776|FG008|NOT COMPLETED|Overall Study||14
9715501|NCT02499328|10814777|FG009|NOT COMPLETED|Overall Study||24
9715502|NCT02499328|10814778|FG010|NOT COMPLETED|Overall Study||20
9715503|NCT02499328|10814779|FG011|NOT COMPLETED|Overall Study||54
9715504|NCT02499328|10814780|FG012|NOT COMPLETED|Overall Study||25
10186910|NCT03245619|11316509|FG012|COMPLETED|Part A (Up to Day 22)||0
10186911|NCT03245619|11316510|FG013|COMPLETED|Part A (Up to Day 22)||0
10186912|NCT03245619|11316511|FG014|COMPLETED|Part A (Up to Day 22)||0
9715505|NCT02499328|10814781|FG013|NOT COMPLETED|Overall Study||17
9715506|NCT02499328|10814782|FG014|NOT COMPLETED|Overall Study||10
10186913|NCT03245619|11316512|FG015|COMPLETED|Part A (Up to Day 22)||0
10186914|NCT03245619|11316513|FG016|COMPLETED|Part A (Up to Day 22)||0
10186915|NCT03245619|11316497|FG000|NOT COMPLETED|Part A (Up to Day 22)||4
10186916|NCT03245619|11316498|FG001|NOT COMPLETED|Part A (Up to Day 22)||6
10186917|NCT03245619|11316499|FG002|NOT COMPLETED|Part A (Up to Day 22)||6
10186918|NCT03245619|11316500|FG003|NOT COMPLETED|Part A (Up to Day 22)||0
10186919|NCT03245619|11316501|FG004|NOT COMPLETED|Part A (Up to Day 22)||0
10186920|NCT03245619|11316502|FG005|NOT COMPLETED|Part A (Up to Day 22)||0
10186921|NCT03245619|11316503|FG006|NOT COMPLETED|Part A (Up to Day 22)||0
10186922|NCT03245619|11316504|FG007|NOT COMPLETED|Part A (Up to Day 22)||0
10186923|NCT03245619|11316505|FG008|NOT COMPLETED|Part A (Up to Day 22)||0
10186924|NCT03245619|11316506|FG009|NOT COMPLETED|Part A (Up to Day 22)||0
10186925|NCT03245619|11316507|FG010|NOT COMPLETED|Part A (Up to Day 22)||0
10186926|NCT03245619|11316508|FG011|NOT COMPLETED|Part A (Up to Day 22)||0
10186927|NCT03245619|11316509|FG012|NOT COMPLETED|Part A (Up to Day 22)||0
10186928|NCT03245619|11316510|FG013|NOT COMPLETED|Part A (Up to Day 22)||0
10186929|NCT03245619|11316511|FG014|NOT COMPLETED|Part A (Up to Day 22)||0
10186930|NCT03245619|11316512|FG015|NOT COMPLETED|Part A (Up to Day 22)||0
10186931|NCT03245619|11316513|FG016|NOT COMPLETED|Part A (Up to Day 22)||0
10186932|NCT03245619|11316497|FG000|STARTED|Part B (Up to 34 Days)||0
10186933|NCT03245619|11316498|FG001|STARTED|Part B (Up to 34 Days)||0
10186934|NCT03245619|11316499|FG002|STARTED|Part B (Up to 34 Days)||0
10186935|NCT03245619|11316500|FG003|STARTED|Part B (Up to 34 Days)||0
10186936|NCT03245619|11316501|FG004|STARTED|Part B (Up to 34 Days)||0
10186937|NCT03245619|11316502|FG005|STARTED|Part B (Up to 34 Days)||0
10186938|NCT03245619|11316503|FG006|STARTED|Part B (Up to 34 Days)||0
10186939|NCT03245619|11316504|FG007|STARTED|Part B (Up to 34 Days)||0
10186940|NCT03245619|11316505|FG008|STARTED|Part B (Up to 34 Days)||0
10186941|NCT03245619|11316506|FG009|STARTED|Part B (Up to 34 Days)||0
10186942|NCT03245619|11316507|FG010|STARTED|Part B (Up to 34 Days)||0
10186943|NCT03245619|11316508|FG011|STARTED|Part B (Up to 34 Days)||0
10186944|NCT03245619|11316509|FG012|STARTED|Part B (Up to 34 Days)||0
10186945|NCT03245619|11316510|FG013|STARTED|Part B (Up to 34 Days)||0
10186946|NCT03245619|11316511|FG014|STARTED|Part B (Up to 34 Days)||0
10186947|NCT03245619|11316512|FG015|STARTED|Part B (Up to 34 Days)||0
10186948|NCT03245619|11316513|FG016|STARTED|Part B (Up to 34 Days)||0
10186949|NCT03245619|11316497|FG000|COMPLETED|Part B (Up to 34 Days)||0
10186950|NCT03245619|11316498|FG001|COMPLETED|Part B (Up to 34 Days)||0
10186951|NCT03245619|11316499|FG002|COMPLETED|Part B (Up to 34 Days)||0
10186952|NCT03245619|11316500|FG003|COMPLETED|Part B (Up to 34 Days)||0
10186953|NCT03245619|11316501|FG004|COMPLETED|Part B (Up to 34 Days)||0
10186954|NCT03245619|11316502|FG005|COMPLETED|Part B (Up to 34 Days)||0
10186955|NCT03245619|11316503|FG006|COMPLETED|Part B (Up to 34 Days)||0
10186956|NCT03245619|11316504|FG007|COMPLETED|Part B (Up to 34 Days)||0
10186957|NCT03245619|11316505|FG008|COMPLETED|Part B (Up to 34 Days)||0
10186958|NCT03245619|11316506|FG009|COMPLETED|Part B (Up to 34 Days)||0
10186959|NCT03245619|11316507|FG010|COMPLETED|Part B (Up to 34 Days)||0
10186960|NCT03245619|11316508|FG011|COMPLETED|Part B (Up to 34 Days)||0
10186961|NCT03245619|11316509|FG012|COMPLETED|Part B (Up to 34 Days)||0
10186962|NCT03245619|11316510|FG013|COMPLETED|Part B (Up to 34 Days)||0
10186963|NCT03245619|11316511|FG014|COMPLETED|Part B (Up to 34 Days)||0
10186964|NCT03245619|11316512|FG015|COMPLETED|Part B (Up to 34 Days)||0
10186965|NCT03245619|11316513|FG016|COMPLETED|Part B (Up to 34 Days)||0
10186966|NCT03245619|11316497|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0
10186967|NCT03245619|11316498|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0
10186968|NCT03245619|11316499|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0
10186969|NCT03245619|11316500|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0
10186970|NCT03245619|11316501|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0
10186971|NCT03245619|11316502|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0
10186972|NCT03245619|11316503|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0
10186973|NCT03245619|11316504|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0
10186974|NCT03245619|11316505|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0
10186975|NCT03245619|11316506|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0
10186976|NCT03245619|11316507|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0
10186977|NCT03245619|11316508|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0
10186978|NCT03245619|11316509|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0
10186979|NCT03245619|11316510|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0
10186980|NCT03245619|11316511|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0
10186981|NCT03245619|11316512|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0
10186982|NCT03245619|11316513|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0
10186983|NCT03245619|11316497|FG000|STARTED|Part C (Up to 34 Days)||0
10186984|NCT03245619|11316498|FG001|STARTED|Part C (Up to 34 Days)||0
10186985|NCT03245619|11316499|FG002|STARTED|Part C (Up to 34 Days)||0
10186986|NCT03245619|11316500|FG003|STARTED|Part C (Up to 34 Days)||0
10186987|NCT03245619|11316501|FG004|STARTED|Part C (Up to 34 Days)||0
10186988|NCT03245619|11316502|FG005|STARTED|Part C (Up to 34 Days)||0
10186989|NCT03245619|11316503|FG006|STARTED|Part C (Up to 34 Days)||0
10186990|NCT03245619|11316504|FG007|STARTED|Part C (Up to 34 Days)||0
10186991|NCT03245619|11316505|FG008|STARTED|Part C (Up to 34 Days)||0
10186992|NCT03245619|11316506|FG009|STARTED|Part C (Up to 34 Days)||0
10186993|NCT03245619|11316507|FG010|STARTED|Part C (Up to 34 Days)||0
10186994|NCT03245619|11316508|FG011|STARTED|Part C (Up to 34 Days)||0
10186995|NCT03245619|11316509|FG012|STARTED|Part C (Up to 34 Days)||0
10186996|NCT03245619|11316510|FG013|STARTED|Part C (Up to 34 Days)||0
10186997|NCT03245619|11316511|FG014|STARTED|Part C (Up to 34 Days)||0
10186998|NCT03245619|11316512|FG015|STARTED|Part C (Up to 34 Days)||0
10186999|NCT03245619|11316513|FG016|STARTED|Part C (Up to 34 Days)||0
10187000|NCT03245619|11316497|FG000|COMPLETED|Part C (Up to 34 Days)||0
10187001|NCT03245619|11316498|FG001|COMPLETED|Part C (Up to 34 Days)||0
10187002|NCT03245619|11316499|FG002|COMPLETED|Part C (Up to 34 Days)||0
10187003|NCT03245619|11316500|FG003|COMPLETED|Part C (Up to 34 Days)||0
10187004|NCT03245619|11316501|FG004|COMPLETED|Part C (Up to 34 Days)||0
10187005|NCT03245619|11316502|FG005|COMPLETED|Part C (Up to 34 Days)||0
10187006|NCT03245619|11316503|FG006|COMPLETED|Part C (Up to 34 Days)||0
10187007|NCT03245619|11316504|FG007|COMPLETED|Part C (Up to 34 Days)||0
10187008|NCT03245619|11316505|FG008|COMPLETED|Part C (Up to 34 Days)||0
10187009|NCT03245619|11316506|FG009|COMPLETED|Part C (Up to 34 Days)||0
10187010|NCT03245619|11316507|FG010|COMPLETED|Part C (Up to 34 Days)||0
10187011|NCT03245619|11316508|FG011|COMPLETED|Part C (Up to 34 Days)||0
10187012|NCT03245619|11316509|FG012|COMPLETED|Part C (Up to 34 Days)||0
10187013|NCT03245619|11316510|FG013|COMPLETED|Part C (Up to 34 Days)||0
10187014|NCT03245619|11316511|FG014|COMPLETED|Part C (Up to 34 Days)||0
10187015|NCT03245619|11316512|FG015|COMPLETED|Part C (Up to 34 Days)||0
10187016|NCT03245619|11316513|FG016|COMPLETED|Part C (Up to 34 Days)||0
10187017|NCT03245619|11316497|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0
10187018|NCT03245619|11316498|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0
10187019|NCT03245619|11316499|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0
10187020|NCT03245619|11316500|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0
10187021|NCT03245619|11316501|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0
10187022|NCT03245619|11316502|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0
10187023|NCT03245619|11316503|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0
10187024|NCT03245619|11316504|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0
10187025|NCT03245619|11316505|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0
10187026|NCT03245619|11316506|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0
10187027|NCT03245619|11316507|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0
10187028|NCT03245619|11316508|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0
10187029|NCT03245619|11316509|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0
10187030|NCT03245619|11316510|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0
10187031|NCT03245619|11316511|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0
10187032|NCT03245619|11316512|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0
10187033|NCT03245619|11316513|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0
10187034|NCT03245723|11316574|FG000|STARTED|Overall Study||32
10187035|NCT03245723|11316575|FG001|STARTED|Overall Study||18
10187036|NCT03245723|11316574|FG000|COMPLETED|Overall Study||27
10187037|NCT03245723|11316575|FG001|COMPLETED|Overall Study||17
10187038|NCT03245723|11316574|FG000|NOT COMPLETED|Overall Study||5
10187039|NCT03245723|11316575|FG001|NOT COMPLETED|Overall Study||1
10187040|NCT03245736|11316581|FG000|STARTED|Overall Study||5
10187041|NCT03245736|11316581|FG000|COMPLETED|Overall Study||0
10187042|NCT03245736|11316581|FG000|NOT COMPLETED|Overall Study||5
10187043|NCT03245762|11316587|FG000|STARTED|Overall Study||10
10187044|NCT03245762|11316588|FG001|STARTED|Overall Study||5
10187045|NCT03245762|11316587|FG000|COMPLETED|Overall Study||10
10187046|NCT03245762|11316588|FG001|COMPLETED|Overall Study||5
10187047|NCT03245762|11316587|FG000|NOT COMPLETED|Overall Study||0
10187048|NCT03245762|11316588|FG001|NOT COMPLETED|Overall Study||0
10187049|NCT03246061|11316596|FG000|STARTED|Overall Study||66
10187050|NCT03246061|11316597|FG001|STARTED|Overall Study||74
10187051|NCT03246061|11316596|FG000|Interim Analysis|Overall Study||51
10187052|NCT03246061|11316597|FG001|Interim Analysis|Overall Study||53
10187053|NCT03246061|11316596|FG000|COMPLETED|Overall Study||51
10187054|NCT03246061|11316597|FG001|COMPLETED|Overall Study||53
10187055|NCT03246061|11316596|FG000|NOT COMPLETED|Overall Study||15
10187056|NCT03246061|11316597|FG001|NOT COMPLETED|Overall Study||21
10187057|NCT03246152|11316605|FG000|STARTED|Overall Study||31
10187058|NCT03246152|11316605|FG000|COMPLETED|Overall Study||28
10187059|NCT03246152|11316605|FG000|NOT COMPLETED|Overall Study||3
10187060|NCT03246646|11316611|FG000|STARTED|Overall Study||26
10187061|NCT03246646|11316612|FG001|STARTED|Overall Study||26
10187062|NCT03246646|11316611|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
10187063|NCT03246646|11316612|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
10187064|NCT03246646|11316611|FG000|NOT COMPLETED|Overall Study||11
10187065|NCT03246646|11316612|FG001|NOT COMPLETED|Overall Study||0
10187066|NCT03246672|11316618|FG000|STARTED|Overall Study||30
10187067|NCT03246672|11316618|FG000|Completed First Phone Call|Overall Study||29
10187068|NCT03246672|11316618|FG000|COMPLETED|Overall Study||28
10187069|NCT03246672|11316618|FG000|NOT COMPLETED|Overall Study||2
10187070|NCT03246724|11316626|FG000|STARTED|Overall Study||99
10187071|NCT03246724|11316627|FG001|STARTED|Overall Study||91
10187072|NCT03246724|11316628|FG002|STARTED|Overall Study||85
10187073|NCT03246724|11316629|FG003|STARTED|Overall Study||52
9715507|NCT02499328|10814783|FG015|NOT COMPLETED|Overall Study||1
10187074|NCT03246724|11316626|FG000|COMPLETED|Overall Study||85
10187075|NCT03246724|11316627|FG001|COMPLETED|Overall Study||84
10187076|NCT03246724|11316628|FG002|COMPLETED|Overall Study||70
10187077|NCT03246724|11316629|FG003|COMPLETED|Overall Study||44
10187078|NCT03246724|11316626|FG000|NOT COMPLETED|Overall Study||14
10187079|NCT03246724|11316627|FG001|NOT COMPLETED|Overall Study||7
10187080|NCT03246724|11316628|FG002|NOT COMPLETED|Overall Study||15
10187081|NCT03246724|11316629|FG003|NOT COMPLETED|Overall Study||8
10187082|NCT03247322|11316641|FG000|STARTED|Overall Study||68
10187083|NCT03247322|11316642|FG001|STARTED|Overall Study||68
10187084|NCT03247322|11316641|FG000|COMPLETED|Overall Study||66
10187085|NCT03247322|11316642|FG001|COMPLETED|Overall Study||68
10187086|NCT03247322|11316641|FG000|NOT COMPLETED|Overall Study||2
10187087|NCT03247322|11316642|FG001|NOT COMPLETED|Overall Study||0
10187088|NCT03247517|11316653|FG000|STARTED|Overall Study||104
10187089|NCT03247517|11316654|FG001|STARTED|Overall Study||98
10187090|NCT03247517|11316655|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
10187091|NCT03247517|11316653|FG000|COMPLETED|Overall Study||96
10187092|NCT03247517|11316654|FG001|COMPLETED|Overall Study||78
10187093|NCT03247517|11316655|FG002|COMPLETED|Overall Study||92
10187094|NCT03247517|11316653|FG000|NOT COMPLETED|Overall Study||8
10187095|NCT03247517|11316654|FG001|NOT COMPLETED|Overall Study||20
10187096|NCT03247517|11316655|FG002|NOT COMPLETED|Overall Study||14
10187097|NCT03247530|11316666|FG000|STARTED|Overall Study||159
10187098|NCT03247530|11316667|FG001|STARTED|Overall Study||154
10187099|NCT03247530|11316668|FG002|STARTED|Overall Study||161
10187100|NCT03247530|11316666|FG000|COMPLETED|Overall Study||132
10187101|NCT03247530|11316667|FG001|COMPLETED|Overall Study||126
10187102|NCT03247530|11316668|FG002|COMPLETED|Overall Study||141
10187103|NCT03247530|11316666|FG000|NOT COMPLETED|Overall Study||27
10187104|NCT03247530|11316667|FG001|NOT COMPLETED|Overall Study||28
10187105|NCT03247530|11316668|FG002|NOT COMPLETED|Overall Study||20
10187106|NCT03247543|11316682|FG000|STARTED|Overall Study||102
10187107|NCT03247543|11316683|FG001|STARTED|Overall Study||107
10187108|NCT03247543|11316684|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
10187109|NCT03247543|11316682|FG000|COMPLETED|Overall Study||85
10187110|NCT03247543|11316683|FG001|COMPLETED|Overall Study||88
10187111|NCT03247543|11316684|FG002|COMPLETED|Overall Study||78
10187112|NCT03247543|11316682|FG000|NOT COMPLETED|Overall Study||17
10187113|NCT03247543|11316683|FG001|NOT COMPLETED|Overall Study||19
10187114|NCT03247543|11316684|FG002|NOT COMPLETED|Overall Study||23
10187115|NCT03247556|11316697|FG000|STARTED|Overall Study||97
10187116|NCT03247556|11316698|FG001|STARTED|Overall Study||100
10187117|NCT03247556|11316699|FG002|STARTED|Overall Study||99
10187118|NCT03247556|11316697|FG000|COMPLETED|Overall Study||85
10187119|NCT03247556|11316698|FG001|COMPLETED|Overall Study||88
10187120|NCT03247556|11316699|FG002|COMPLETED|Overall Study||81
10187121|NCT03247556|11316697|FG000|NOT COMPLETED|Overall Study||12
10187122|NCT03247556|11316698|FG001|NOT COMPLETED|Overall Study||12
10187123|NCT03247556|11316699|FG002|NOT COMPLETED|Overall Study||18
10187124|NCT03247673|11316710|FG000|STARTED|Overall Study||46
10187125|NCT03247673|11316711|FG001|STARTED|Overall Study||47
10187126|NCT03247673|11316712|FG002|STARTED|Overall Study||48
10187127|NCT03247673|11316710|FG000|COMPLETED|Overall Study||45
10187128|NCT03247673|11316711|FG001|COMPLETED|Overall Study||47
10187129|NCT03247673|11316712|FG002|COMPLETED|Overall Study||44
10187130|NCT03247673|11316710|FG000|NOT COMPLETED|Overall Study||1
10187131|NCT03247673|11316711|FG001|NOT COMPLETED|Overall Study||0
10187132|NCT03247673|11316712|FG002|NOT COMPLETED|Overall Study||4
10187133|NCT03247686|11316722|FG000|STARTED|Overall Study||8
10187134|NCT03247686|11316723|FG001|STARTED|Overall Study||20
10187135|NCT03247686|11316722|FG000|COMPLETED|Overall Study||7
10187136|NCT03247686|11316723|FG001|COMPLETED|Overall Study||18
10187137|NCT03247686|11316722|FG000|NOT COMPLETED|Overall Study||1
10187138|NCT03247686|11316723|FG001|NOT COMPLETED|Overall Study||2
10187139|NCT03247738|11316734|FG000|STARTED|Overall Study||25
10187140|NCT03247738|11316735|FG001|STARTED|Overall Study||25
10187141|NCT03247738|11316734|FG000|COMPLETED|Overall Study||25
10187142|NCT03247738|11316735|FG001|COMPLETED|Overall Study||25
10187143|NCT03247738|11316734|FG000|NOT COMPLETED|Overall Study||0
10187144|NCT03247738|11316735|FG001|NOT COMPLETED|Overall Study||0
10187145|NCT03247790|11316741|FG000|STARTED|Period 1: Migraine Attack||16
10187146|NCT03247790|11316741|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
10187147|NCT03247790|11316741|FG000|COMPLETED|Period 1: Migraine Attack||16
10187148|NCT03247790|11316741|FG000|NOT COMPLETED|Period 1: Migraine Attack||0
10187149|NCT03247790|11316741|FG000|STARTED|Period 2: Inter-ictal Period||16
10187150|NCT03247790|11316741|FG000|COMPLETED|Period 2: Inter-ictal Period||16
10187151|NCT03247790|11316741|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0
10187152|NCT03247816|11316747|FG000|STARTED|Overall Study||59
10187153|NCT03247816|11316747|FG000|COMPLETED|Overall Study||30
10187154|NCT03247816|11316747|FG000|NOT COMPLETED|Overall Study||29
10187155|NCT03247985|11316755|FG000|STARTED|Overall Study||19
10187156|NCT03247985|11316756|FG001|STARTED|Overall Study||19
10187157|NCT03247985|11316755|FG000|COMPLETED|Overall Study||19
10187158|NCT03247985|11316756|FG001|COMPLETED|Overall Study||19
10187159|NCT03247985|11316755|FG000|NOT COMPLETED|Overall Study||0
10187160|NCT03247985|11316756|FG001|NOT COMPLETED|Overall Study||0
10187161|NCT03248037|11316764|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
10187162|NCT03248037|11316765|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
10187163|NCT03248037|11316764|FG000|COMPLETED|Overall Study||74
10187164|NCT03248037|11316765|FG001|COMPLETED|Overall Study||87
10187165|NCT03248037|11316764|FG000|NOT COMPLETED|Overall Study||21
10187166|NCT03248037|11316765|FG001|NOT COMPLETED|Overall Study||9
10187167|NCT03248440|11316773|FG000|STARTED|Overall Study||131
10187168|NCT03248440|11316774|FG001|STARTED|Overall Study||132
10187169|NCT03248440|11316773|FG000|COMPLETED|Overall Study||116
10187170|NCT03248440|11316774|FG001|COMPLETED|Overall Study||120
10187171|NCT03248440|11316773|FG000|NOT COMPLETED|Overall Study||15
10187172|NCT03248440|11316774|FG001|NOT COMPLETED|Overall Study||12
10187173|NCT03248492|11316785|FG000|STARTED|Overall Study||50
10187174|NCT03248492|11316786|FG001|STARTED|Overall Study||48
10187175|NCT03248492|11316787|FG002|STARTED|Overall Study||21
10187176|NCT03248492|11316788|FG003|STARTED|Overall Study||130
10187177|NCT03248492|11316789|FG004|STARTED|Overall Study||4
10187178|NCT03248492|11316785|FG000|COMPLETED|Overall Study||0
10187179|NCT03248492|11316786|FG001|COMPLETED|Overall Study||0
10187180|NCT03248492|11316787|FG002|COMPLETED|Overall Study||0
10187181|NCT03248492|11316788|FG003|COMPLETED|Overall Study||0
10187182|NCT03248492|11316789|FG004|COMPLETED|Overall Study||0
10187183|NCT03248492|11316785|FG000|NOT COMPLETED|Overall Study||50
10187184|NCT03248492|11316786|FG001|NOT COMPLETED|Overall Study||48
10187185|NCT03248492|11316787|FG002|NOT COMPLETED|Overall Study||21
10187186|NCT03248492|11316788|FG003|NOT COMPLETED|Overall Study||130
10187187|NCT03248492|11316789|FG004|NOT COMPLETED|Overall Study||4
10187188|NCT03248882|11316814|FG000|STARTED|Overall Study||61
10187189|NCT03248882|11316815|FG001|STARTED|Overall Study||63
10187190|NCT03248882|11316816|FG002|STARTED|Overall Study||62
10187191|NCT03248882|11316817|FG003|STARTED|Overall Study||58
10187192|NCT03248882|11316818|FG004|STARTED|Overall Study||61
10187193|NCT03248882|11316814|FG000|Received Treatment|Overall Study||61
10187194|NCT03248882|11316815|FG001|Received Treatment|Overall Study||63
10187195|NCT03248882|11316816|FG002|Received Treatment|Overall Study||62
10187196|NCT03248882|11316817|FG003|Received Treatment|Overall Study||58
10187197|NCT03248882|11316818|FG004|Received Treatment|Overall Study||61
10187198|NCT03248882|11316814|FG000|COMPLETED|Overall Study||54
10187199|NCT03248882|11316815|FG001|COMPLETED|Overall Study||58
10187200|NCT03248882|11316816|FG002|COMPLETED|Overall Study||55
10187201|NCT03248882|11316817|FG003|COMPLETED|Overall Study||48
10187202|NCT03248882|11316818|FG004|COMPLETED|Overall Study||48
10187203|NCT03248882|11316814|FG000|NOT COMPLETED|Overall Study||7
10187204|NCT03248882|11316815|FG001|NOT COMPLETED|Overall Study||5
10187205|NCT03248882|11316816|FG002|NOT COMPLETED|Overall Study||7
10187206|NCT03248882|11316817|FG003|NOT COMPLETED|Overall Study||10
10187207|NCT03248882|11316818|FG004|NOT COMPLETED|Overall Study||13
10187208|NCT03248947|11316830|FG000|STARTED|Overall Study||71
10187209|NCT03248947|11316830|FG000|COMPLETED|Overall Study||63
10187210|NCT03248947|11316830|FG000|NOT COMPLETED|Overall Study||8
10187211|NCT03249116|11316841|FG000|STARTED|Overall Study||25
10187212|NCT03249116|11316842|FG001|STARTED|Overall Study||25
10187213|NCT03249116|11316843|FG002|STARTED|Overall Study||25
10187214|NCT03249116|11316841|FG000|COMPLETED|Overall Study||25
10187215|NCT03249116|11316842|FG001|COMPLETED|Overall Study||25
10187216|NCT03249116|11316843|FG002|COMPLETED|Overall Study||25
10187217|NCT03249116|11316841|FG000|NOT COMPLETED|Overall Study||0
10187218|NCT03249116|11316842|FG001|NOT COMPLETED|Overall Study||0
10187219|NCT03249116|11316843|FG002|NOT COMPLETED|Overall Study||0
10187220|NCT03249272|11316855|FG000|STARTED|Overall Study||19
10187221|NCT03249272|11316856|FG001|STARTED|Overall Study||6
10187222|NCT03249272|11316857|FG002|STARTED|Overall Study||6
10187223|NCT03249272|11316855|FG000|COMPLETED|Overall Study||19
10187224|NCT03249272|11316856|FG001|COMPLETED|Overall Study||6
10187225|NCT03249272|11316857|FG002|COMPLETED|Overall Study||6
10187226|NCT03249272|11316855|FG000|NOT COMPLETED|Overall Study||0
10187227|NCT03249272|11316856|FG001|NOT COMPLETED|Overall Study||0
10187228|NCT03249272|11316857|FG002|NOT COMPLETED|Overall Study||0
10187229|NCT03249454|11316877|FG000|STARTED|Overall Study||1
10187230|NCT03249454|11316878|FG001|STARTED|Overall Study||1
10187231|NCT03249454|11316879|FG002|STARTED|Overall Study||2
10187232|NCT03249454|11316880|FG003|STARTED|Overall Study||1
10187233|NCT03249454|11316881|FG004|STARTED|Overall Study||1
10187234|NCT03249454|11316882|FG005|STARTED|Overall Study||2
10187235|NCT03249454|11316883|FG006|STARTED|Overall Study||1
10187236|NCT03249454|11316884|FG007|STARTED|Overall Study||1
10187237|NCT03249454|11316885|FG008|STARTED|Overall Study||1
10187238|NCT03249454|11316886|FG009|STARTED|Overall Study||1
10187239|NCT03249454|11316887|FG010|STARTED|Overall Study||1
10187240|NCT03249454|11316877|FG000|First Intervention (1 Day)|Overall Study||1
10187241|NCT03249454|11316878|FG001|First Intervention (1 Day)|Overall Study||1
10187242|NCT03249454|11316879|FG002|First Intervention (1 Day)|Overall Study||2
10187243|NCT03249454|11316880|FG003|First Intervention (1 Day)|Overall Study||1
10187244|NCT03249454|11316881|FG004|First Intervention (1 Day)|Overall Study||1
10187245|NCT03249454|11316882|FG005|First Intervention (1 Day)|Overall Study||2
10187246|NCT03249454|11316883|FG006|First Intervention (1 Day)|Overall Study||1
10187247|NCT03249454|11316884|FG007|First Intervention (1 Day)|Overall Study||1
10187248|NCT03249454|11316885|FG008|First Intervention (1 Day)|Overall Study||1
10187249|NCT03249454|11316886|FG009|First Intervention (1 Day)|Overall Study||0
10187250|NCT03249454|11316887|FG010|First Intervention (1 Day)|Overall Study||0
10187251|NCT03249454|11316877|FG000|Washout (1 Week)|Overall Study||1
9715508|NCT02499328|10814784|FG016|NOT COMPLETED|Overall Study||1
9715509|NCT02499328|10814785|FG017|NOT COMPLETED|Overall Study||55
9715510|NCT02499328|10814786|FG018|NOT COMPLETED|Overall Study||49
9715511|NCT02463981|10814871|FG000|STARTED|Overall Study||21
9715512|NCT02463981|10814872|FG001|STARTED|Overall Study||16
9715513|NCT02463981|10814871|FG000|COMPLETED|Overall Study||18
9715514|NCT02463981|10814872|FG001|COMPLETED|Overall Study||14
9715515|NCT02463981|10814871|FG000|NOT COMPLETED|Overall Study||3
9715516|NCT02463981|10814872|FG001|NOT COMPLETED|Overall Study||2
9715517|NCT02460224|10814907|FG000|STARTED|Overall Study||17
9715518|NCT02460224|10814908|FG001|STARTED|Overall Study||12
9715519|NCT02460224|10814909|FG002|STARTED|Overall Study||6
9715520|NCT02460224|10814910|FG003|STARTED|Overall Study||6
9715521|NCT02460224|10814911|FG004|STARTED|Overall Study||6
9715522|NCT02460224|10814912|FG005|STARTED|Overall Study||30
9715523|NCT02460224|10814913|FG006|STARTED|Overall Study||30
9715524|NCT02460224|10814914|FG007|STARTED|Overall Study||5
9715525|NCT02460224|10814915|FG008|STARTED|Overall Study||6
9715526|NCT02460224|10814916|FG009|STARTED|Overall Study||11
9715527|NCT02460224|10814917|FG010|STARTED|Overall Study||5
9715528|NCT02460224|10814918|FG011|STARTED|Overall Study||6
9715529|NCT02460224|10814919|FG012|STARTED|Overall Study||6
9715530|NCT02460224|10814920|FG013|STARTED|Overall Study||6
9715531|NCT02460224|10814921|FG014|STARTED|Overall Study||5
9715532|NCT02460224|10814922|FG015|STARTED|Overall Study||6
9715533|NCT02460224|10814923|FG016|STARTED|Overall Study||20
9715534|NCT02460224|10814924|FG017|STARTED|Overall Study||6
9715535|NCT02460224|10814925|FG018|STARTED|Overall Study||12
9715536|NCT02460224|10814926|FG019|STARTED|Overall Study||7
9715537|NCT02460224|10814927|FG020|STARTED|Overall Study||6
9715538|NCT02460224|10814928|FG021|STARTED|Overall Study||12
9715539|NCT02460224|10814929|FG022|STARTED|Overall Study||6
9715540|NCT02460224|10814930|FG023|STARTED|Overall Study||11
9715541|NCT02460224|10814931|FG024|STARTED|Overall Study||6
9715542|NCT02460224|10814932|FG025|STARTED|Overall Study||6
9715543|NCT02460224|10814933|FG026|STARTED|Overall Study||121
10187252|NCT03249454|11316878|FG001|Washout (1 Week)|Overall Study||1
10187253|NCT03249454|11316879|FG002|Washout (1 Week)|Overall Study||2
10187254|NCT03249454|11316880|FG003|Washout (1 Week)|Overall Study||1
10187255|NCT03249454|11316881|FG004|Washout (1 Week)|Overall Study||1
10187256|NCT03249454|11316882|FG005|Washout (1 Week)|Overall Study||2
10187257|NCT03249454|11316883|FG006|Washout (1 Week)|Overall Study||1
10187258|NCT03249454|11316884|FG007|Washout (1 Week)|Overall Study||1
10187259|NCT03249454|11316885|FG008|Washout (1 Week)|Overall Study||1
10187260|NCT03249454|11316886|FG009|Washout (1 Week)|Overall Study||0
10187261|NCT03249454|11316887|FG010|Washout (1 Week)|Overall Study||0
10187262|NCT03249454|11316877|FG000|Second Intervention (1 Day)|Overall Study||1
10187263|NCT03249454|11316878|FG001|Second Intervention (1 Day)|Overall Study||1
10187264|NCT03249454|11316879|FG002|Second Intervention (1 Day)|Overall Study||2
10187265|NCT03249454|11316880|FG003|Second Intervention (1 Day)|Overall Study||1
10187266|NCT03249454|11316881|FG004|Second Intervention (1 Day)|Overall Study||1
10187267|NCT03249454|11316882|FG005|Second Intervention (1 Day)|Overall Study||2
10187268|NCT03249454|11316883|FG006|Second Intervention (1 Day)|Overall Study||1
10187269|NCT03249454|11316884|FG007|Second Intervention (1 Day)|Overall Study||1
10187270|NCT03249454|11316885|FG008|Second Intervention (1 Day)|Overall Study||1
10187271|NCT03249454|11316886|FG009|Second Intervention (1 Day)|Overall Study||0
10187272|NCT03249454|11316887|FG010|Second Intervention (1 Day)|Overall Study||0
10187273|NCT03249454|11316877|FG000|Washout (1 Week)|Overall Study||1
10187274|NCT03249454|11316878|FG001|Washout (1 Week)|Overall Study||1
10187275|NCT03249454|11316879|FG002|Washout (1 Week)|Overall Study||2
10187276|NCT03249454|11316880|FG003|Washout (1 Week)|Overall Study||1
10187277|NCT03249454|11316881|FG004|Washout (1 Week)|Overall Study||1
10187278|NCT03249454|11316882|FG005|Washout (1 Week)|Overall Study||2
10187279|NCT03249454|11316883|FG006|Washout (1 Week)|Overall Study||1
10187280|NCT03249454|11316884|FG007|Washout (1 Week)|Overall Study||1
10187281|NCT03249454|11316885|FG008|Washout (1 Week)|Overall Study||1
10187282|NCT03249454|11316886|FG009|Washout (1 Week)|Overall Study||0
10187283|NCT03249454|11316887|FG010|Washout (1 Week)|Overall Study||0
10187284|NCT03249454|11316877|FG000|Third Intervention (1 Day)|Overall Study||1
10187285|NCT03249454|11316878|FG001|Third Intervention (1 Day)|Overall Study||1
10187286|NCT03249454|11316879|FG002|Third Intervention (1 Day)|Overall Study||2
10187287|NCT03249454|11316880|FG003|Third Intervention (1 Day)|Overall Study||1
10187288|NCT03249454|11316881|FG004|Third Intervention (1 Day)|Overall Study||1
10187289|NCT03249454|11316882|FG005|Third Intervention (1 Day)|Overall Study||2
10187290|NCT03249454|11316883|FG006|Third Intervention (1 Day)|Overall Study||1
10187291|NCT03249454|11316884|FG007|Third Intervention (1 Day)|Overall Study||1
10187292|NCT03249454|11316885|FG008|Third Intervention (1 Day)|Overall Study||1
10187293|NCT03249454|11316886|FG009|Third Intervention (1 Day)|Overall Study||0
10187294|NCT03249454|11316887|FG010|Third Intervention (1 Day)|Overall Study||0
10187295|NCT03249454|11316877|FG000|Washout (1 Week)|Overall Study||1
10187296|NCT03249454|11316878|FG001|Washout (1 Week)|Overall Study||1
10187297|NCT03249454|11316879|FG002|Washout (1 Week)|Overall Study||2
10187298|NCT03249454|11316880|FG003|Washout (1 Week)|Overall Study||1
10187299|NCT03249454|11316881|FG004|Washout (1 Week)|Overall Study||1
10187300|NCT03249454|11316882|FG005|Washout (1 Week)|Overall Study||2
10187301|NCT03249454|11316883|FG006|Washout (1 Week)|Overall Study||1
10187302|NCT03249454|11316884|FG007|Washout (1 Week)|Overall Study||1
10187303|NCT03249454|11316885|FG008|Washout (1 Week)|Overall Study||1
10187304|NCT03249454|11316886|FG009|Washout (1 Week)|Overall Study||0
10187305|NCT03249454|11316887|FG010|Washout (1 Week)|Overall Study||0
10187306|NCT03249454|11316877|FG000|Fourth Intervention (1 Day)|Overall Study||1
10187307|NCT03249454|11316878|FG001|Fourth Intervention (1 Day)|Overall Study||1
10187308|NCT03249454|11316879|FG002|Fourth Intervention (1 Day)|Overall Study||2
10187309|NCT03249454|11316880|FG003|Fourth Intervention (1 Day)|Overall Study||1
10187310|NCT03249454|11316881|FG004|Fourth Intervention (1 Day)|Overall Study||1
10187311|NCT03249454|11316882|FG005|Fourth Intervention (1 Day)|Overall Study||2
10187312|NCT03249454|11316883|FG006|Fourth Intervention (1 Day)|Overall Study||1
10187313|NCT03249454|11316884|FG007|Fourth Intervention (1 Day)|Overall Study||1
10187314|NCT03249454|11316885|FG008|Fourth Intervention (1 Day)|Overall Study||1
10187315|NCT03249454|11316886|FG009|Fourth Intervention (1 Day)|Overall Study||0
10187316|NCT03249454|11316887|FG010|Fourth Intervention (1 Day)|Overall Study||0
10187317|NCT03249454|11316877|FG000|Washout (1 Week)|Overall Study||1
10187318|NCT03249454|11316878|FG001|Washout (1 Week)|Overall Study||1
10187319|NCT03249454|11316879|FG002|Washout (1 Week)|Overall Study||2
10187320|NCT03249454|11316880|FG003|Washout (1 Week)|Overall Study||1
10187321|NCT03249454|11316881|FG004|Washout (1 Week)|Overall Study||1
10187322|NCT03249454|11316882|FG005|Washout (1 Week)|Overall Study||2
10187323|NCT03249454|11316883|FG006|Washout (1 Week)|Overall Study||1
10187324|NCT03249454|11316884|FG007|Washout (1 Week)|Overall Study||1
10187325|NCT03249454|11316885|FG008|Washout (1 Week)|Overall Study||1
10187326|NCT03249454|11316886|FG009|Washout (1 Week)|Overall Study||0
10187327|NCT03249454|11316887|FG010|Washout (1 Week)|Overall Study||0
10187328|NCT03249454|11316877|FG000|Fifth Intervention (1 Day)|Overall Study||1
10187329|NCT03249454|11316878|FG001|Fifth Intervention (1 Day)|Overall Study||1
10187330|NCT03249454|11316879|FG002|Fifth Intervention (1 Day)|Overall Study||2
10187331|NCT03249454|11316880|FG003|Fifth Intervention (1 Day)|Overall Study||1
10187332|NCT03249454|11316881|FG004|Fifth Intervention (1 Day)|Overall Study||1
10187333|NCT03249454|11316882|FG005|Fifth Intervention (1 Day)|Overall Study||2
10187334|NCT03249454|11316883|FG006|Fifth Intervention (1 Day)|Overall Study||1
10187335|NCT03249454|11316884|FG007|Fifth Intervention (1 Day)|Overall Study||1
10187336|NCT03249454|11316885|FG008|Fifth Intervention (1 Day)|Overall Study||1
10187337|NCT03249454|11316886|FG009|Fifth Intervention (1 Day)|Overall Study||0
10187338|NCT03249454|11316887|FG010|Fifth Intervention (1 Day)|Overall Study||0
10187339|NCT03249454|11316877|FG000|COMPLETED|Overall Study||1
10187340|NCT03249454|11316878|FG001|COMPLETED|Overall Study||1
10187341|NCT03249454|11316879|FG002|COMPLETED|Overall Study||2
10187342|NCT03249454|11316880|FG003|COMPLETED|Overall Study||1
10187343|NCT03249454|11316881|FG004|COMPLETED|Overall Study||1
10187344|NCT03249454|11316882|FG005|COMPLETED|Overall Study||2
10187345|NCT03249454|11316883|FG006|COMPLETED|Overall Study||1
10187346|NCT03249454|11316884|FG007|COMPLETED|Overall Study||1
10187347|NCT03249454|11316885|FG008|COMPLETED|Overall Study||1
10187348|NCT03249454|11316886|FG009|COMPLETED|Overall Study||0
10187349|NCT03249454|11316887|FG010|COMPLETED|Overall Study||0
10187350|NCT03249454|11316877|FG000|NOT COMPLETED|Overall Study||0
10187351|NCT03249454|11316878|FG001|NOT COMPLETED|Overall Study||0
10187352|NCT03249454|11316879|FG002|NOT COMPLETED|Overall Study||0
10187353|NCT03249454|11316880|FG003|NOT COMPLETED|Overall Study||0
10187354|NCT03249454|11316881|FG004|NOT COMPLETED|Overall Study||0
10187355|NCT03249454|11316882|FG005|NOT COMPLETED|Overall Study||0
10187356|NCT03249454|11316883|FG006|NOT COMPLETED|Overall Study||0
10187357|NCT03249454|11316884|FG007|NOT COMPLETED|Overall Study||0
10187358|NCT03249454|11316885|FG008|NOT COMPLETED|Overall Study||0
10187359|NCT03249454|11316886|FG009|NOT COMPLETED|Overall Study||1
10187360|NCT03249454|11316887|FG010|NOT COMPLETED|Overall Study||1
10187361|NCT03249584|11316900|FG000|STARTED|Overall Study||184
10187362|NCT03249584|11316901|FG001|STARTED|Overall Study||22
10187363|NCT03249584|11316900|FG000|Month 3|Overall Study||132
10187364|NCT03249584|11316901|FG001|Month 3|Overall Study||15
10187365|NCT03249584|11316900|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42
10187366|NCT03249584|11316901|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15
10187367|NCT03249584|11316900|FG000|Month 6|Overall Study||101
10187368|NCT03249584|11316901|FG001|Month 6|Overall Study||13
10187369|NCT03249584|11316900|FG000|COMPLETED|Overall Study||51
10187370|NCT03249584|11316901|FG001|COMPLETED|Overall Study||8
10187371|NCT03249584|11316900|FG000|NOT COMPLETED|Overall Study||133
10187372|NCT03249584|11316901|FG001|NOT COMPLETED|Overall Study||14
10187373|NCT03249779|11316906|FG000|STARTED|Overall Study||8
10187374|NCT03249779|11316906|FG000|COMPLETED|Overall Study||8
10187375|NCT03249779|11316906|FG000|NOT COMPLETED|Overall Study||0
10187376|NCT03249909|11316913|FG000|STARTED|Overall Study||78
10187377|NCT03249909|11316914|FG001|STARTED|Overall Study||15
10187378|NCT03249909|11316915|FG002|STARTED|Overall Study||16
10187379|NCT03249909|11316913|FG000|COMPLETED|Overall Study||72
10187380|NCT03249909|11316914|FG001|COMPLETED|Overall Study||14
10187381|NCT03249909|11316915|FG002|COMPLETED|Overall Study||16
10187382|NCT03249909|11316913|FG000|NOT COMPLETED|Overall Study||6
10187383|NCT03249909|11316914|FG001|NOT COMPLETED|Overall Study||1
10187384|NCT03249909|11316915|FG002|NOT COMPLETED|Overall Study||0
10187385|NCT03249935|11316926|FG000|STARTED|Overall Study||100
10187386|NCT03249935|11316926|FG000|COMPLETED|Overall Study||55
10187387|NCT03249935|11316926|FG000|NOT COMPLETED|Overall Study||45
10187388|NCT03250182|11316932|FG000|STARTED|Overall Study||30
10187389|NCT03250182|11316932|FG000|COMPLETED|Overall Study||29
10187390|NCT03250182|11316932|FG000|NOT COMPLETED|Overall Study||1
10187391|NCT03250234|11316938|FG000|STARTED|Overall Study||6
10187392|NCT03250234|11316939|FG001|STARTED|Overall Study||6
10187393|NCT03250234|11316938|FG000|COMPLETED|Overall Study||6
10187394|NCT03250234|11316939|FG001|COMPLETED|Overall Study||6
10187395|NCT03250234|11316938|FG000|NOT COMPLETED|Overall Study||0
10187396|NCT03250234|11316939|FG001|NOT COMPLETED|Overall Study||0
10187397|NCT03250689|11316947|FG000|STARTED|Overall Study||5
10187398|NCT03250689|11316948|FG001|STARTED|Overall Study||14
10187399|NCT03250689|11316947|FG000|COMPLETED|Overall Study||5
10187400|NCT03250689|11316948|FG001|COMPLETED|Overall Study||14
10187401|NCT03250689|11316947|FG000|NOT COMPLETED|Overall Study||0
10187402|NCT03250689|11316948|FG001|NOT COMPLETED|Overall Study||0
10187403|NCT03250845|11316955|FG000|STARTED|Multigam 5% Infusion (Baseline)||30
10187404|NCT03250845|11316955|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30
10187405|NCT03250845|11316955|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
10187406|NCT03250845|11316955|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
10187407|NCT03250845|11316955|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
10187408|NCT03250845|11316955|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
10187409|NCT03251482|11316966|FG000|STARTED|Overall Study||39
10187410|NCT03251482|11316967|FG001|STARTED|Overall Study||41
10187411|NCT03251482|11316968|FG002|STARTED|Overall Study||43
10187412|NCT03251482|11316969|FG003|STARTED|Overall Study||122
10187413|NCT03251482|11316970|FG004|STARTED|Overall Study||63
10187414|NCT03251482|11316966|FG000|Treated|Overall Study||38
10187415|NCT03251482|11316967|FG001|Treated|Overall Study||40
10187416|NCT03251482|11316968|FG002|Treated|Overall Study||42
10187417|NCT03251482|11316969|FG003|Treated|Overall Study||122
10187418|NCT03251482|11316970|FG004|Treated|Overall Study||63
10187419|NCT03251482|11316966|FG000|COMPLETED|Overall Study||39
10187420|NCT03251482|11316967|FG001|COMPLETED|Overall Study||40
10187421|NCT03251482|11316968|FG002|COMPLETED|Overall Study||43
10187422|NCT03251482|11316969|FG003|COMPLETED|Overall Study||122
10187423|NCT03251482|11316970|FG004|COMPLETED|Overall Study||63
10187424|NCT03251482|11316966|FG000|NOT COMPLETED|Overall Study||0
10187425|NCT03251482|11316967|FG001|NOT COMPLETED|Overall Study||1
10187426|NCT03251482|11316968|FG002|NOT COMPLETED|Overall Study||0
10187427|NCT03251482|11316969|FG003|NOT COMPLETED|Overall Study||0
10187428|NCT03251482|11316970|FG004|NOT COMPLETED|Overall Study||0
10187429|NCT03251937|11316982|FG000|STARTED|Overall Study||40
10187430|NCT03251937|11316982|FG000|COMPLETED|Overall Study||37
10187431|NCT03251937|11316982|FG000|NOT COMPLETED|Overall Study||3
10187432|NCT03251963|11316988|FG000|STARTED|Overall Study||65
10187433|NCT03251963|11316989|FG001|STARTED|Overall Study||66
10187434|NCT03251963|11316988|FG000|COMPLETED|Overall Study||56
10187435|NCT03251963|11316989|FG001|COMPLETED|Overall Study||61
10187436|NCT03251963|11316988|FG000|NOT COMPLETED|Overall Study||9
10187437|NCT03251963|11316989|FG001|NOT COMPLETED|Overall Study||5
10187438|NCT03252015|11316999|FG000|STARTED|Overall Study||12
10187439|NCT03252015|11317000|FG001|STARTED|Overall Study||28
10187440|NCT03252015|11317001|FG002|STARTED|Overall Study||15
10187441|NCT03252015|11317002|FG003|STARTED|Overall Study||15
10187442|NCT03252015|11316999|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10187443|NCT03252015|11317000|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
10187444|NCT03252015|11317001|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10187445|NCT03252015|11317002|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15
10187446|NCT03252015|11316999|FG000|COMPLETED|Overall Study||11
10187447|NCT03252015|11317000|FG001|COMPLETED|Overall Study||27
10187448|NCT03252015|11317001|FG002|COMPLETED|Overall Study||14
10187449|NCT03252015|11317002|FG003|COMPLETED|Overall Study||14
10187450|NCT03252015|11316999|FG000|NOT COMPLETED|Overall Study||1
10187451|NCT03252015|11317000|FG001|NOT COMPLETED|Overall Study||1
10187452|NCT03252015|11317001|FG002|NOT COMPLETED|Overall Study||1
10187453|NCT03252015|11317002|FG003|NOT COMPLETED|Overall Study||1
10187454|NCT03252145|11317028|FG000|STARTED|Overall Study||13
10187455|NCT03252145|11317029|FG001|STARTED|Overall Study||15
10187456|NCT03252145|11317028|FG000|COMPLETED|Overall Study||11
10187457|NCT03252145|11317029|FG001|COMPLETED|Overall Study||13
10187458|NCT03252145|11317028|FG000|NOT COMPLETED|Overall Study||2
10187459|NCT03252145|11317029|FG001|NOT COMPLETED|Overall Study||2
10187460|NCT03252353|11317037|FG000|STARTED|Overall Study||28
10187461|NCT03252353|11317038|FG001|STARTED|Overall Study||28
10187462|NCT03252353|11317037|FG000|COMPLETED|Overall Study||28
10187463|NCT03252353|11317038|FG001|COMPLETED|Overall Study||28
10187464|NCT03252353|11317037|FG000|NOT COMPLETED|Overall Study||0
10187465|NCT03252353|11317038|FG001|NOT COMPLETED|Overall Study||0
10187466|NCT03252431|11317049|FG000|STARTED|Overall Study||197
10187467|NCT03252431|11317050|FG001|STARTED|Overall Study||196
10187468|NCT03252431|11317049|FG000|COMPLETED|Overall Study||186
10187469|NCT03252431|11317050|FG001|COMPLETED|Overall Study||187
10187470|NCT03252431|11317049|FG000|NOT COMPLETED|Overall Study||11
10187471|NCT03252431|11317050|FG001|NOT COMPLETED|Overall Study||9
10187472|NCT03252964|11317056|FG000|STARTED|Overall Study||52
10187473|NCT03252964|11317056|FG000|COMPLETED|Overall Study||20
10187474|NCT03252964|11317056|FG000|NOT COMPLETED|Overall Study||32
10187475|NCT03253094|11317066|FG000|STARTED|Overall Study||32
10187476|NCT03253094|11317067|FG001|STARTED|Overall Study||30
10187477|NCT03253094|11317068|FG002|STARTED|Overall Study||28
10187478|NCT03253094|11317069|FG003|STARTED|Overall Study||32
10187479|NCT03253094|11317070|FG004|STARTED|Overall Study||32
10187480|NCT03253094|11317071|FG005|STARTED|Overall Study||32
10187481|NCT03253094|11317066|FG000|Subjects Discontinued|Overall Study||4
10187482|NCT03253094|11317067|FG001|Subjects Discontinued|Overall Study||3
10187483|NCT03253094|11317068|FG002|Subjects Discontinued|Overall Study||6
10187484|NCT03253094|11317069|FG003|Subjects Discontinued|Overall Study||4
10187485|NCT03253094|11317070|FG004|Subjects Discontinued|Overall Study||5
10187486|NCT03253094|11317071|FG005|Subjects Discontinued|Overall Study||4
10187487|NCT03253094|11317066|FG000|COMPLETED|Overall Study||28
10187488|NCT03253094|11317067|FG001|COMPLETED|Overall Study||27
10187489|NCT03253094|11317068|FG002|COMPLETED|Overall Study||22
10187490|NCT03253094|11317069|FG003|COMPLETED|Overall Study||28
10187491|NCT03253094|11317070|FG004|COMPLETED|Overall Study||27
10187492|NCT03253094|11317071|FG005|COMPLETED|Overall Study||28
10187493|NCT03253094|11317066|FG000|NOT COMPLETED|Overall Study||4
10187494|NCT03253094|11317067|FG001|NOT COMPLETED|Overall Study||3
10187495|NCT03253094|11317068|FG002|NOT COMPLETED|Overall Study||6
10187496|NCT03253094|11317069|FG003|NOT COMPLETED|Overall Study||4
10187497|NCT03253094|11317070|FG004|NOT COMPLETED|Overall Study||5
10187498|NCT03253094|11317071|FG005|NOT COMPLETED|Overall Study||4
10187499|NCT03254108|11317090|FG000|STARTED|Overall Study||13
10187500|NCT03254108|11317091|FG001|STARTED|Overall Study||12
10187501|NCT03254108|11317092|FG002|STARTED|Overall Study||12
10187502|NCT03254108|11317093|FG003|STARTED|Overall Study||12
10187503|NCT03254108|11317094|FG004|STARTED|Overall Study||12
10187504|NCT03254108|11317090|FG000|Received Treatment|Overall Study||13
10187505|NCT03254108|11317091|FG001|Received Treatment|Overall Study||12
10187506|NCT03254108|11317092|FG002|Received Treatment|Overall Study||12
10187507|NCT03254108|11317093|FG003|Received Treatment|Overall Study||11
10187508|NCT03254108|11317094|FG004|Received Treatment|Overall Study||12
10187509|NCT03254108|11317090|FG000|COMPLETED|Overall Study||13
10187510|NCT03254108|11317091|FG001|COMPLETED|Overall Study||10
10187511|NCT03254108|11317092|FG002|COMPLETED|Overall Study||12
10187512|NCT03254108|11317093|FG003|COMPLETED|Overall Study||11
10187513|NCT03254108|11317094|FG004|COMPLETED|Overall Study||9
10187514|NCT03254108|11317090|FG000|NOT COMPLETED|Overall Study||0
10187515|NCT03254108|11317091|FG001|NOT COMPLETED|Overall Study||2
10187516|NCT03254108|11317092|FG002|NOT COMPLETED|Overall Study||0
10187517|NCT03254108|11317093|FG003|NOT COMPLETED|Overall Study||1
10187518|NCT03254108|11317094|FG004|NOT COMPLETED|Overall Study||3
10187519|NCT03254134|11317108|FG000|STARTED|Overall Study||5745
10187520|NCT03254134|11317109|FG001|STARTED|Overall Study||16745
10187521|NCT03254134|11317108|FG000|COMPLETED|Overall Study||5146
10187522|NCT03254134|11317109|FG001|COMPLETED|Overall Study||13115
10187523|NCT03254134|11317108|FG000|NOT COMPLETED|Overall Study||599
10187524|NCT03254134|11317109|FG001|NOT COMPLETED|Overall Study||3630
10187525|NCT03254147|11317115|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
10187526|NCT03254147|11317115|FG000|COMPLETED|Overall Study||53969
10187527|NCT03254147|11317115|FG000|NOT COMPLETED|Overall Study||0
10187528|NCT03254459|11317121|FG000|STARTED|Overall Study||50
10187529|NCT03254459|11317122|FG001|STARTED|Overall Study||50
10187530|NCT03254459|11317121|FG000|COMPLETED|Overall Study||40
10187531|NCT03254459|11317122|FG001|COMPLETED|Overall Study||27
10187532|NCT03254459|11317121|FG000|NOT COMPLETED|Overall Study||10
10187533|NCT03254459|11317122|FG001|NOT COMPLETED|Overall Study||23
10187534|NCT03254602|11317128|FG000|STARTED|Overall Study||33
10187535|NCT03254602|11317128|FG000|COMPLETED|Overall Study||29
10187536|NCT03254602|11317128|FG000|NOT COMPLETED|Overall Study||4
10187537|NCT03254719|11317132|FG000|STARTED|Overall Study||40
10187538|NCT03254719|11317132|FG000|COMPLETED|Overall Study||40
10187539|NCT03254719|11317132|FG000|NOT COMPLETED|Overall Study||0
10187540|NCT03255187|11317138|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35
10187541|NCT03255187|11317139|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35
10187542|NCT03255187|11317138|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34
10187543|NCT03255187|11317139|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32
10187544|NCT03255187|11317138|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
10187545|NCT03255187|11317139|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
10187546|NCT03255187|11317138|FG000|STARTED|Period From First to Second Follow-up||34
10187547|NCT03255187|11317139|FG001|STARTED|Period From First to Second Follow-up||32
10187548|NCT03255187|11317138|FG000|COMPLETED|Period From First to Second Follow-up||34
10187549|NCT03255187|11317139|FG001|COMPLETED|Period From First to Second Follow-up||31
10187550|NCT03255187|11317138|FG000|NOT COMPLETED|Period From First to Second Follow-up||0
10187551|NCT03255187|11317139|FG001|NOT COMPLETED|Period From First to Second Follow-up||1
10187552|NCT03255187|11317138|FG000|STARTED|Period From Second to Third Follow-up||34
10187553|NCT03255187|11317139|FG001|STARTED|Period From Second to Third Follow-up||31
10187554|NCT03255187|11317138|FG000|COMPLETED|Period From Second to Third Follow-up||34
10187555|NCT03255187|11317139|FG001|COMPLETED|Period From Second to Third Follow-up||31
10187556|NCT03255187|11317138|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0
10187557|NCT03255187|11317139|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0
10187558|NCT03255187|11317138|FG000|STARTED|Period From Third to Fourth Follow-up||34
10187559|NCT03255187|11317139|FG001|STARTED|Period From Third to Fourth Follow-up||31
10187560|NCT03255187|11317138|FG000|COMPLETED|Period From Third to Fourth Follow-up||34
10187561|NCT03255187|11317139|FG001|COMPLETED|Period From Third to Fourth Follow-up||31
10187562|NCT03255187|11317138|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0
10187563|NCT03255187|11317139|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0
10187564|NCT03255187|11317138|FG000|STARTED|Period at Fourth Follow-up||34
10187565|NCT03255187|11317139|FG001|STARTED|Period at Fourth Follow-up||31
10187566|NCT03255187|11317138|FG000|COMPLETED|Period at Fourth Follow-up||34
10187567|NCT03255187|11317139|FG001|COMPLETED|Period at Fourth Follow-up||31
10187568|NCT03255187|11317138|FG000|NOT COMPLETED|Period at Fourth Follow-up||0
10187569|NCT03255187|11317139|FG001|NOT COMPLETED|Period at Fourth Follow-up||0
10187570|NCT03255291|11317151|FG000|STARTED|Overall Study||93
10187571|NCT03255291|11317152|FG001|STARTED|Overall Study||90
10187572|NCT03255291|11317153|FG002|STARTED|Overall Study||91
10187573|NCT03255291|11317154|FG003|STARTED|Overall Study||90
10187574|NCT03255291|11317155|FG004|STARTED|Overall Study||95
10187575|NCT03255291|11317156|FG005|STARTED|Overall Study||95
10187576|NCT03255291|11317151|FG000|COMPLETED|Overall Study||80
10187577|NCT03255291|11317152|FG001|COMPLETED|Overall Study||78
10187578|NCT03255291|11317153|FG002|COMPLETED|Overall Study||85
10187579|NCT03255291|11317154|FG003|COMPLETED|Overall Study||84
10187580|NCT03255291|11317155|FG004|COMPLETED|Overall Study||88
10187581|NCT03255291|11317156|FG005|COMPLETED|Overall Study||85
10187582|NCT03255291|11317151|FG000|NOT COMPLETED|Overall Study||13
10187583|NCT03255291|11317152|FG001|NOT COMPLETED|Overall Study||12
10187584|NCT03255291|11317153|FG002|NOT COMPLETED|Overall Study||6
10187585|NCT03255291|11317154|FG003|NOT COMPLETED|Overall Study||6
10187586|NCT03255291|11317155|FG004|NOT COMPLETED|Overall Study||7
10187587|NCT03255291|11317156|FG005|NOT COMPLETED|Overall Study||10
10187588|NCT03255382|11317176|FG000|STARTED|Overall Study||60
10187589|NCT03255382|11317177|FG001|STARTED|Overall Study||60
10187590|NCT03255382|11317176|FG000|COMPLETED|Overall Study||47
10187591|NCT03255382|11317177|FG001|COMPLETED|Overall Study||60
10187592|NCT03255382|11317176|FG000|NOT COMPLETED|Overall Study||13
10187593|NCT03255382|11317177|FG001|NOT COMPLETED|Overall Study||0
10187594|NCT03255655|11317186|FG000|STARTED|Overall Study||29
10187595|NCT03255655|11317187|FG001|STARTED|Overall Study||12
10187596|NCT03255655|11317186|FG000|COMPLETED|Overall Study||22
10187597|NCT03255655|11317187|FG001|COMPLETED|Overall Study||8
9715544|NCT02460224|10814934|FG027|STARTED|Overall Study||21
9715545|NCT02460224|10814935|FG028|STARTED|Overall Study||93
9715546|NCT02460224|10814907|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13
9715547|NCT02460224|10814908|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
9715548|NCT02460224|10814909|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9849860|NCT00868192|10962705|FG000|STARTED|Overall Study||38
9849861|NCT00868192|10962705|FG000|COMPLETED|Overall Study||34
9849862|NCT00868192|10962705|FG000|NOT COMPLETED|Overall Study||4
9849863|NCT00868218|10962713|FG000|STARTED|Overall Study||15
9849864|NCT00868218|10962714|FG001|STARTED|Overall Study||15
9849865|NCT00868218|10962715|FG002|STARTED|Overall Study||15
9849866|NCT00868218|10962716|FG003|STARTED|Overall Study||15
9849867|NCT00868218|10962713|FG000|COMPLETED|Overall Study||15
9849868|NCT00868218|10962714|FG001|COMPLETED|Overall Study||15
9849869|NCT00868218|10962715|FG002|COMPLETED|Overall Study||15
9849870|NCT00868218|10962716|FG003|COMPLETED|Overall Study||15
10187598|NCT03255655|11317186|FG000|NOT COMPLETED|Overall Study||7
10187599|NCT03255655|11317187|FG001|NOT COMPLETED|Overall Study||4
9849871|NCT00868218|10962713|FG000|NOT COMPLETED|Overall Study||0
10187600|NCT03255733|11317193|FG000|STARTED|Overall Study||29
10187601|NCT03255733|11317193|FG000|COMPLETED|Overall Study||25
10187602|NCT03255733|11317193|FG000|NOT COMPLETED|Overall Study||4
10187603|NCT03255824|11317199|FG000|STARTED|Overall Study||69
10187604|NCT03255824|11317200|FG001|STARTED|Overall Study||75
10187605|NCT03255824|11317199|FG000|COMPLETED|Overall Study||67
10187606|NCT03255824|11317200|FG001|COMPLETED|Overall Study||74
10187607|NCT03255824|11317199|FG000|NOT COMPLETED|Overall Study||2
10187608|NCT03255824|11317200|FG001|NOT COMPLETED|Overall Study||1
10187609|NCT03255902|11317206|FG000|STARTED|Overall Study||7
10187610|NCT03255902|11317206|FG000|COMPLETED|Overall Study||5
10187611|NCT03255902|11317206|FG000|NOT COMPLETED|Overall Study||2
10187612|NCT03255941|11317214|FG000|STARTED|Overall Study||177
10187613|NCT03255941|11317215|FG001|STARTED|Overall Study||178
10187614|NCT03255941|11317216|FG002|STARTED|Overall Study||53
10187615|NCT03255941|11317217|FG003|STARTED|Overall Study||52
10187616|NCT03255941|11317214|FG000|Deemed Eligible to Receive DMPA|Overall Study||140
10187617|NCT03255941|11317215|FG001|Deemed Eligible to Receive DMPA|Overall Study||134
10187618|NCT03255941|11317216|FG002|Deemed Eligible to Receive DMPA|Overall Study||48
10187619|NCT03255941|11317217|FG003|Deemed Eligible to Receive DMPA|Overall Study||46
10187620|NCT03255941|11317214|FG000|COMPLETED|Overall Study||139
10187621|NCT03255941|11317215|FG001|COMPLETED|Overall Study||132
10187622|NCT03255941|11317216|FG002|COMPLETED|Overall Study||48
10187623|NCT03255941|11317217|FG003|COMPLETED|Overall Study||46
10187624|NCT03255941|11317214|FG000|NOT COMPLETED|Overall Study||38
10187625|NCT03255941|11317215|FG001|NOT COMPLETED|Overall Study||46
10187626|NCT03255941|11317216|FG002|NOT COMPLETED|Overall Study||5
10187627|NCT03255941|11317217|FG003|NOT COMPLETED|Overall Study||6
10187628|NCT03255980|11317243|FG000|STARTED|Overall Study||20
10187629|NCT03255980|11317244|FG001|STARTED|Overall Study||20
10187630|NCT03255980|11317245|FG002|STARTED|Overall Study||20
10187631|NCT03255980|11317246|FG003|STARTED|Overall Study||20
10187632|NCT03255980|11317243|FG000|COMPLETED|Overall Study||17
10187633|NCT03255980|11317244|FG001|COMPLETED|Overall Study||12
10187634|NCT03255980|11317245|FG002|COMPLETED|Overall Study||14
10187635|NCT03255980|11317246|FG003|COMPLETED|Overall Study||8
10187636|NCT03255980|11317243|FG000|NOT COMPLETED|Overall Study||3
10187637|NCT03255980|11317244|FG001|NOT COMPLETED|Overall Study||8
10187638|NCT03255980|11317245|FG002|NOT COMPLETED|Overall Study||6
10187639|NCT03255980|11317246|FG003|NOT COMPLETED|Overall Study||12
10187640|NCT03256136|11317260|FG000|STARTED|Overall Study||3
10187641|NCT03256136|11317261|FG001|STARTED|Overall Study||1
10187642|NCT03256136|11317262|FG002|STARTED|Overall Study||4
10187643|NCT03256136|11317263|FG003|STARTED|Overall Study||1
10187644|NCT03256136|11317260|FG000|COMPLETED|Overall Study||3
10187645|NCT03256136|11317261|FG001|COMPLETED|Overall Study||1
10187646|NCT03256136|11317262|FG002|COMPLETED|Overall Study||4
10187647|NCT03256136|11317263|FG003|COMPLETED|Overall Study||1
10187648|NCT03256136|11317260|FG000|NOT COMPLETED|Overall Study||0
10187649|NCT03256136|11317261|FG001|NOT COMPLETED|Overall Study||0
10187650|NCT03256136|11317262|FG002|NOT COMPLETED|Overall Study||0
10187651|NCT03256136|11317263|FG003|NOT COMPLETED|Overall Study||0
9715549|NCT02460224|10814910|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715550|NCT02460224|10814911|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715551|NCT02460224|10814912|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25
9715552|NCT02460224|10814913|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24
9715553|NCT02460224|10814914|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
9715554|NCT02460224|10814915|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10187652|NCT03256162|11317275|FG000|STARTED|Overall Study||13
10187653|NCT03256162|11317276|FG001|STARTED|Overall Study||12
10187654|NCT03256162|11317275|FG000|COMPLETED|Overall Study||8
10187655|NCT03256162|11317276|FG001|COMPLETED|Overall Study||8
10187656|NCT03256162|11317275|FG000|NOT COMPLETED|Overall Study||5
10187657|NCT03256162|11317276|FG001|NOT COMPLETED|Overall Study||4
10187658|NCT03256253|11317282|FG000|STARTED|Overall Study||18
10187659|NCT03256253|11317282|FG000|COMPLETED|Overall Study||6
10187660|NCT03256253|11317282|FG000|NOT COMPLETED|Overall Study||12
10187661|NCT03256526|11317289|FG000|STARTED|Overall Study||19
10187662|NCT03256526|11317290|FG001|STARTED|Overall Study||17
10187663|NCT03256526|11317291|FG002|STARTED|Overall Study||17
10187664|NCT03256526|11317289|FG000|COMPLETED|Overall Study||17
10187665|NCT03256526|11317290|FG001|COMPLETED|Overall Study||17
10187666|NCT03256526|11317291|FG002|COMPLETED|Overall Study||14
10187667|NCT03256526|11317289|FG000|NOT COMPLETED|Overall Study||2
10187668|NCT03256526|11317290|FG001|NOT COMPLETED|Overall Study||0
10187669|NCT03256526|11317291|FG002|NOT COMPLETED|Overall Study||3
10187670|NCT03256552|11317299|FG000|STARTED|Overall Study||66
10187671|NCT03256552|11317299|FG000|GP MDI 28.8 µg|Overall Study||61
10187672|NCT03256552|11317299|FG000|GP MDI 14.4 µg|Overall Study||63
10187673|NCT03256552|11317299|FG000|GP MDI 7.2 µg|Overall Study||62
10187674|NCT03256552|11317299|FG000|Placebo MDI|Overall Study||65
10187675|NCT03256552|11317299|FG000|COMPLETED|Overall Study||61
10187676|NCT03256552|11317299|FG000|NOT COMPLETED|Overall Study||5
10187677|NCT03256578|11317311|FG000|STARTED|Overall Study||204
10187678|NCT03256578|11317312|FG001|STARTED|Overall Study||206
10187679|NCT03256578|11317311|FG000|COMPLETED|Overall Study||138
10187680|NCT03256578|11317312|FG001|COMPLETED|Overall Study||150
10187681|NCT03256578|11317311|FG000|NOT COMPLETED|Overall Study||66
10187682|NCT03256578|11317312|FG001|NOT COMPLETED|Overall Study||56
10187683|NCT03256695|11317318|FG000|STARTED|Overall Study||405
10187684|NCT03256695|11317318|FG000|Used ABS eMDPI at Least Once|Overall Study||390
10187685|NCT03256695|11317318|FG000|COMPLETED|Overall Study||366
10187686|NCT03256695|11317318|FG000|NOT COMPLETED|Overall Study||39
10187687|NCT03256799|11317322|FG000|STARTED|Overall Study||1
10187688|NCT03256799|11317322|FG000|COMPLETED|Overall Study||1
10187689|NCT03256799|11317322|FG000|NOT COMPLETED|Overall Study||0
10187690|NCT03256851|11317328|FG000|STARTED|Overall Study||10
10187691|NCT03256851|11317329|FG001|STARTED|Overall Study||10
10187692|NCT03256851|11317328|FG000|COMPLETED|Overall Study||9
10187693|NCT03256851|11317329|FG001|COMPLETED|Overall Study||10
10187694|NCT03256851|11317328|FG000|NOT COMPLETED|Overall Study||1
10187695|NCT03256851|11317329|FG001|NOT COMPLETED|Overall Study||0
10187696|NCT03256968|11317335|FG000|STARTED|Overall Study||1
10187697|NCT03256968|11317335|FG000|COMPLETED|Overall Study||1
10187698|NCT03256968|11317335|FG000|NOT COMPLETED|Overall Study||0
10187699|NCT03257189|11317339|FG000|STARTED|Overall Study||30
10187700|NCT03257189|11317339|FG000|COMPLETED|Overall Study||30
10187701|NCT03257189|11317339|FG000|NOT COMPLETED|Overall Study||0
10187702|NCT03257202|11317343|FG000|STARTED|Overall Study||12
10187703|NCT03257202|11317343|FG000|COMPLETED|Overall Study||12
10187704|NCT03257202|11317343|FG000|NOT COMPLETED|Overall Study||0
10187705|NCT03257358|11317355|FG000|STARTED|Overall Study||165
10187706|NCT03257358|11317356|FG001|STARTED|Overall Study||217
10187707|NCT03257358|11317355|FG000|Never Received Treatment|Overall Study||2
10187708|NCT03257358|11317356|FG001|Never Received Treatment|Overall Study||0
10187709|NCT03257358|11317355|FG000|COMPLETED|Overall Study||94
10187710|NCT03257358|11317356|FG001|COMPLETED|Overall Study||183
10187711|NCT03257358|11317355|FG000|NOT COMPLETED|Overall Study||71
10187712|NCT03257358|11317356|FG001|NOT COMPLETED|Overall Study||34
10187713|NCT03257371|11317362|FG000|STARTED|Overall Study||10
10187714|NCT03257371|11317362|FG000|COMPLETED|Overall Study||9
10187715|NCT03257371|11317362|FG000|NOT COMPLETED|Overall Study||1
10187716|NCT03257410|11317368|FG000|STARTED|Overall Study||86
10187717|NCT03257410|11317369|FG001|STARTED|Overall Study||86
10187718|NCT03257410|11317368|FG000|COMPLETED|Overall Study||65
10187719|NCT03257410|11317369|FG001|COMPLETED|Overall Study||65
10187720|NCT03257410|11317368|FG000|NOT COMPLETED|Overall Study||21
10187721|NCT03257410|11317369|FG001|NOT COMPLETED|Overall Study||21
10187722|NCT03257657|11317377|FG000|STARTED|Overall Study||22
10187723|NCT03257657|11317378|FG001|STARTED|Overall Study||20
10187724|NCT03257657|11317377|FG000|COMPLETED|Overall Study||22
10187725|NCT03257657|11317378|FG001|COMPLETED|Overall Study||15
10187726|NCT03257657|11317377|FG000|NOT COMPLETED|Overall Study||0
10187727|NCT03257657|11317378|FG001|NOT COMPLETED|Overall Study||5
10187728|NCT03257813|11317387|FG000|STARTED|Overall Study||30
10187729|NCT03257813|11317388|FG001|STARTED|Overall Study||30
10187730|NCT03257813|11317387|FG000|COMPLETED|Overall Study||24
10187731|NCT03257813|11317388|FG001|COMPLETED|Overall Study||27
10187732|NCT03257813|11317387|FG000|NOT COMPLETED|Overall Study||6
10187733|NCT03257813|11317388|FG001|NOT COMPLETED|Overall Study||3
10187734|NCT03257865|11317399|FG000|STARTED|Overall Study||163
10187735|NCT03257865|11317400|FG001|STARTED|Overall Study||170
10187736|NCT03257865|11317399|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
10187737|NCT03257865|11317400|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
10187738|NCT03257865|11317399|FG000|COMPLETED|Overall Study||128
10187739|NCT03257865|11317400|FG001|COMPLETED|Overall Study||135
10187740|NCT03257865|11317399|FG000|NOT COMPLETED|Overall Study||35
10187741|NCT03257865|11317400|FG001|NOT COMPLETED|Overall Study||35
10187742|NCT03257995|11317406|FG000|STARTED|Overall Study||9
10187743|NCT03257995|11317407|FG001|STARTED|Overall Study||9
10187744|NCT03257995|11317408|FG002|STARTED|Overall Study||9
10187745|NCT03257995|11317409|FG003|STARTED|Overall Study||9
10187746|NCT03257995|11317410|FG004|STARTED|Overall Study||9
10187747|NCT03257995|11317411|FG005|STARTED|Overall Study||9
10187748|NCT03257995|11317406|FG000|COMPLETED|Overall Study||9
10187749|NCT03257995|11317407|FG001|COMPLETED|Overall Study||8
10187750|NCT03257995|11317408|FG002|COMPLETED|Overall Study||9
10187751|NCT03257995|11317409|FG003|COMPLETED|Overall Study||9
10187752|NCT03257995|11317410|FG004|COMPLETED|Overall Study||9
10187753|NCT03257995|11317411|FG005|COMPLETED|Overall Study||7
10187754|NCT03257995|11317406|FG000|NOT COMPLETED|Overall Study||0
10187755|NCT03257995|11317407|FG001|NOT COMPLETED|Overall Study||1
10187756|NCT03257995|11317408|FG002|NOT COMPLETED|Overall Study||0
10187757|NCT03257995|11317409|FG003|NOT COMPLETED|Overall Study||0
10187758|NCT03257995|11317410|FG004|NOT COMPLETED|Overall Study||0
10187759|NCT03257995|11317411|FG005|NOT COMPLETED|Overall Study||2
10187760|NCT03258645|11317423|FG000|STARTED|Overall Study||1489
10187761|NCT03258645|11317423|FG000|COMPLETED|Overall Study||1489
10187762|NCT03258645|11317423|FG000|NOT COMPLETED|Overall Study||0
10187763|NCT03258710|11317433|FG000|STARTED|Overall Study||75
10187764|NCT03258710|11317433|FG000|COMPLETED|Overall Study||72
10187765|NCT03258710|11317433|FG000|NOT COMPLETED|Overall Study||3
10187766|NCT03258762|11317439|FG000|STARTED|Overall Study||7
10187767|NCT03258762|11317440|FG001|STARTED|Overall Study||7
10187768|NCT03258762|11317439|FG000|COMPLETED|Overall Study||7
10187769|NCT03258762|11317440|FG001|COMPLETED|Overall Study||6
10187770|NCT03258762|11317439|FG000|NOT COMPLETED|Overall Study||0
10187771|NCT03258762|11317440|FG001|NOT COMPLETED|Overall Study||1
10187772|NCT03258814|11317449|FG000|STARTED|Overall Study||4
10187773|NCT03258814|11317450|FG001|STARTED|Overall Study||3
10187774|NCT03258814|11317451|FG002|STARTED|Overall Study||10
10187775|NCT03258814|11317449|FG000|COMPLETED|Overall Study||0
10187776|NCT03258814|11317450|FG001|COMPLETED|Overall Study||0
10187777|NCT03258814|11317451|FG002|COMPLETED|Overall Study||0
10187778|NCT03258814|11317449|FG000|NOT COMPLETED|Overall Study||4
10187779|NCT03258814|11317450|FG001|NOT COMPLETED|Overall Study||3
10187780|NCT03258814|11317451|FG002|NOT COMPLETED|Overall Study||10
10187781|NCT03259087|11317463|FG000|STARTED|Part 1 and Period 1 of Part 2||8
10187782|NCT03259087|11317464|FG001|STARTED|Part 1 and Period 1 of Part 2||8
10187783|NCT03259087|11317465|FG002|STARTED|Part 1 and Period 1 of Part 2||8
10187784|NCT03259087|11317466|FG003|STARTED|Part 1 and Period 1 of Part 2||10
10187785|NCT03259087|11317467|FG004|STARTED|Part 1 and Period 1 of Part 2||8
10187786|NCT03259087|11317463|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8
10187787|NCT03259087|11317464|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8
10187788|NCT03259087|11317465|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8
10187789|NCT03259087|11317466|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10
10187790|NCT03259087|11317467|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7
10187791|NCT03259087|11317463|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10187792|NCT03259087|11317464|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10187793|NCT03259087|11317465|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10187794|NCT03259087|11317466|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10187795|NCT03259087|11317467|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
10187796|NCT03259087|11317463|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10187797|NCT03259087|11317464|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10187798|NCT03259087|11317465|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10187799|NCT03259087|11317466|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10187800|NCT03259087|11317467|FG004|STARTED|Period 2 of Part 2||7
10187801|NCT03259087|11317463|FG000|COMPLETED|Period 2 of Part 2||0
10187802|NCT03259087|11317464|FG001|COMPLETED|Period 2 of Part 2||0
10187803|NCT03259087|11317465|FG002|COMPLETED|Period 2 of Part 2||0
10187804|NCT03259087|11317466|FG003|COMPLETED|Period 2 of Part 2||0
10187805|NCT03259087|11317467|FG004|COMPLETED|Period 2 of Part 2||6
10187806|NCT03259087|11317463|FG000|NOT COMPLETED|Period 2 of Part 2||0
10187807|NCT03259087|11317464|FG001|NOT COMPLETED|Period 2 of Part 2||0
10187808|NCT03259087|11317465|FG002|NOT COMPLETED|Period 2 of Part 2||0
10187809|NCT03259087|11317466|FG003|NOT COMPLETED|Period 2 of Part 2||0
10187810|NCT03259087|11317467|FG004|NOT COMPLETED|Period 2 of Part 2||1
10187811|NCT03259139|11317495|FG000|STARTED|Overall Study||42
10187812|NCT03259139|11317496|FG001|STARTED|Overall Study||42
10187813|NCT03259139|11317497|FG002|STARTED|Overall Study||42
10187814|NCT03259139|11317498|FG003|STARTED|Overall Study||42
10187815|NCT03259139|11317499|FG004|STARTED|Overall Study||41
10187816|NCT03259139|11317500|FG005|STARTED|Overall Study||41
10187817|NCT03259139|11317495|FG000|Eligible|Overall Study||41
10187818|NCT03259139|11317496|FG001|Eligible|Overall Study||41
10187819|NCT03259139|11317497|FG002|Eligible|Overall Study||41
10187820|NCT03259139|11317498|FG003|Eligible|Overall Study||41
10187821|NCT03259139|11317499|FG004|Eligible|Overall Study||41
10187822|NCT03259139|11317500|FG005|Eligible|Overall Study||41
10187823|NCT03259139|11317495|FG000|Outlier Elimination|Overall Study||41
10187824|NCT03259139|11317496|FG001|Outlier Elimination|Overall Study||41
10187825|NCT03259139|11317497|FG002|Outlier Elimination|Overall Study||41
10187826|NCT03259139|11317498|FG003|Outlier Elimination|Overall Study||41
10187827|NCT03259139|11317499|FG004|Outlier Elimination|Overall Study||39
10187828|NCT03259139|11317500|FG005|Outlier Elimination|Overall Study||39
10187829|NCT03259139|11317495|FG000|Found Handgun|Overall Study||38
10187830|NCT03259139|11317496|FG001|Found Handgun|Overall Study||38
10187831|NCT03259139|11317497|FG002|Found Handgun|Overall Study||37
10187832|NCT03259139|11317498|FG003|Found Handgun|Overall Study||37
10187833|NCT03259139|11317499|FG004|Found Handgun|Overall Study||35
10187834|NCT03259139|11317500|FG005|Found Handgun|Overall Study||35
10187835|NCT03259139|11317495|FG000|COMPLETED|Overall Study||38
10187836|NCT03259139|11317496|FG001|COMPLETED|Overall Study||38
10187837|NCT03259139|11317497|FG002|COMPLETED|Overall Study||37
10187838|NCT03259139|11317498|FG003|COMPLETED|Overall Study||37
10187839|NCT03259139|11317499|FG004|COMPLETED|Overall Study||35
10187840|NCT03259139|11317500|FG005|COMPLETED|Overall Study||35
10187841|NCT03259139|11317495|FG000|NOT COMPLETED|Overall Study||4
10187842|NCT03259139|11317496|FG001|NOT COMPLETED|Overall Study||4
10187843|NCT03259139|11317497|FG002|NOT COMPLETED|Overall Study||5
10187844|NCT03259139|11317498|FG003|NOT COMPLETED|Overall Study||5
10187845|NCT03259139|11317499|FG004|NOT COMPLETED|Overall Study||6
10187846|NCT03259139|11317500|FG005|NOT COMPLETED|Overall Study||6
10187847|NCT03259308|11317520|FG000|STARTED|Overall Study||56
10187848|NCT03259308|11317521|FG001|STARTED|Overall Study||111
10187849|NCT03259308|11317522|FG002|STARTED|Overall Study||112
10187850|NCT03259308|11317520|FG000|COMPLETED|Overall Study||49
10187851|NCT03259308|11317521|FG001|COMPLETED|Overall Study||103
10187852|NCT03259308|11317522|FG002|COMPLETED|Overall Study||105
10187853|NCT03259308|11317520|FG000|NOT COMPLETED|Overall Study||7
10187854|NCT03259308|11317521|FG001|NOT COMPLETED|Overall Study||8
10187855|NCT03259308|11317522|FG002|NOT COMPLETED|Overall Study||7
10187856|NCT03259334|11317533|FG000|STARTED|Overall Study||76
10187857|NCT03259334|11317534|FG001|STARTED|Overall Study||153
10187858|NCT03259334|11317535|FG002|STARTED|Overall Study||151
10187859|NCT03259334|11317533|FG000|Treated|Overall Study||76
10187860|NCT03259334|11317534|FG001|Treated|Overall Study||151
10187861|NCT03259334|11317535|FG002|Treated|Overall Study||151
10187862|NCT03259334|11317533|FG000|COMPLETED|Overall Study||66
10187863|NCT03259334|11317534|FG001|COMPLETED|Overall Study||136
10187864|NCT03259334|11317535|FG002|COMPLETED|Overall Study||138
10187865|NCT03259334|11317533|FG000|NOT COMPLETED|Overall Study||10
10187866|NCT03259334|11317534|FG001|NOT COMPLETED|Overall Study||17
10187867|NCT03259334|11317535|FG002|NOT COMPLETED|Overall Study||13
10187868|NCT03259490|11317545|FG000|STARTED|Period 1||15
10187869|NCT03259490|11317546|FG001|STARTED|Period 1||15
10187870|NCT03259490|11317545|FG000|COMPLETED|Period 1||15
10187871|NCT03259490|11317546|FG001|COMPLETED|Period 1||14
10187872|NCT03259490|11317545|FG000|NOT COMPLETED|Period 1||0
10187873|NCT03259490|11317546|FG001|NOT COMPLETED|Period 1||1
10187874|NCT03259490|11317545|FG000|STARTED|Period 2||15
10187875|NCT03259490|11317546|FG001|STARTED|Period 2||14
10187876|NCT03259490|11317545|FG000|COMPLETED|Period 2||14
10187877|NCT03259490|11317546|FG001|COMPLETED|Period 2||14
10187878|NCT03259490|11317545|FG000|NOT COMPLETED|Period 2||1
10187879|NCT03259490|11317546|FG001|NOT COMPLETED|Period 2||0
10187880|NCT03259555|11317554|FG000|STARTED|Overall Study||158
10187881|NCT03259555|11317555|FG001|STARTED|Overall Study||164
10187882|NCT03259555|11317554|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158
10187883|NCT03259555|11317555|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163
10187884|NCT03259555|11317554|FG000|COMPLETED|Overall Study||124
10187885|NCT03259555|11317555|FG001|COMPLETED|Overall Study||134
10187886|NCT03259555|11317554|FG000|NOT COMPLETED|Overall Study||34
10187887|NCT03259555|11317555|FG001|NOT COMPLETED|Overall Study||30
10187888|NCT03259789|11317564|FG000|STARTED|Overall Study||158
10187889|NCT03259789|11317565|FG001|STARTED|Overall Study||159
10187890|NCT03259789|11317566|FG002|STARTED|Overall Study||34
10187891|NCT03259789|11317564|FG000|COMPLETED|Overall Study||141
10187892|NCT03259789|11317565|FG001|COMPLETED|Overall Study||142
10187893|NCT03259789|11317566|FG002|COMPLETED|Overall Study||28
10187894|NCT03259789|11317564|FG000|NOT COMPLETED|Overall Study||17
10187895|NCT03259789|11317565|FG001|NOT COMPLETED|Overall Study||17
10187896|NCT03259789|11317566|FG002|NOT COMPLETED|Overall Study||6
10187897|NCT03260205|11317580|FG000|STARTED|Overall Study||46
10187898|NCT03260205|11317581|FG001|STARTED|Overall Study||40
10187899|NCT03260205|11317582|FG002|STARTED|Overall Study||37
10187900|NCT03260205|11317583|FG003|STARTED|Overall Study||37
10187901|NCT03260205|11317584|FG004|STARTED|Overall Study||39
10187902|NCT03260205|11317580|FG000|Received Treatment|Overall Study||45
10187903|NCT03260205|11317581|FG001|Received Treatment|Overall Study||39
10187904|NCT03260205|11317582|FG002|Received Treatment|Overall Study||35
10187905|NCT03260205|11317583|FG003|Received Treatment|Overall Study||34
10187906|NCT03260205|11317584|FG004|Received Treatment|Overall Study||38
10187907|NCT03260205|11317580|FG000|COMPLETED|Overall Study||37
10187908|NCT03260205|11317581|FG001|COMPLETED|Overall Study||32
10187909|NCT03260205|11317582|FG002|COMPLETED|Overall Study||26
10187910|NCT03260205|11317583|FG003|COMPLETED|Overall Study||30
10187911|NCT03260205|11317584|FG004|COMPLETED|Overall Study||25
10187912|NCT03260205|11317580|FG000|NOT COMPLETED|Overall Study||9
10187913|NCT03260205|11317581|FG001|NOT COMPLETED|Overall Study||8
10187914|NCT03260205|11317582|FG002|NOT COMPLETED|Overall Study||11
10187915|NCT03260205|11317583|FG003|NOT COMPLETED|Overall Study||7
10187916|NCT03260205|11317584|FG004|NOT COMPLETED|Overall Study||14
10187917|NCT03260426|11317603|FG000|STARTED|Overall Study||50
10187918|NCT03260426|11317604|FG001|STARTED|Overall Study||50
10187919|NCT03260426|11317603|FG000|COMPLETED|Overall Study||50
10187920|NCT03260426|11317604|FG001|COMPLETED|Overall Study||50
10187921|NCT03260426|11317603|FG000|NOT COMPLETED|Overall Study||0
10187922|NCT03260426|11317604|FG001|NOT COMPLETED|Overall Study||0
10187923|NCT03260595|11317613|FG000|STARTED|Overall Study||20
10187924|NCT03260595|11317614|FG001|STARTED|Overall Study||10
10187925|NCT03260595|11317615|FG002|STARTED|Overall Study||2
10187926|NCT03260595|11317613|FG000|COMPLETED|Overall Study||20
10187927|NCT03260595|11317614|FG001|COMPLETED|Overall Study||10
10187928|NCT03260595|11317615|FG002|COMPLETED|Overall Study||2
10187929|NCT03260595|11317613|FG000|NOT COMPLETED|Overall Study||0
10187930|NCT03260595|11317614|FG001|NOT COMPLETED|Overall Study||0
10187931|NCT03260595|11317615|FG002|NOT COMPLETED|Overall Study||0
10187932|NCT03260699|11317625|FG000|STARTED|Overall Study||5
10187933|NCT03260699|11317626|FG001|STARTED|Overall Study||4
10187934|NCT03260699|11317625|FG000|COMPLETED|Overall Study||5
10187935|NCT03260699|11317626|FG001|COMPLETED|Overall Study||2
10187936|NCT03260699|11317625|FG000|NOT COMPLETED|Overall Study||0
10187937|NCT03260699|11317626|FG001|NOT COMPLETED|Overall Study||2
10187938|NCT03260790|11317634|FG000|STARTED|Overall Study||8
10187939|NCT03260790|11317635|FG001|STARTED|Overall Study||9
10187940|NCT03260790|11317634|FG000|COMPLETED|Overall Study||8
10187941|NCT03260790|11317635|FG001|COMPLETED|Overall Study||9
10187942|NCT03260790|11317634|FG000|NOT COMPLETED|Overall Study||0
10187943|NCT03260790|11317635|FG001|NOT COMPLETED|Overall Study||0
10187944|NCT03261037|11317645|FG000|STARTED|Overall Study||68
10187945|NCT03261037|11317646|FG001|STARTED|Overall Study||62
10187946|NCT03261037|11317647|FG002|STARTED|Overall Study||9
10187947|NCT03261037|11317648|FG003|STARTED|Overall Study||39
10187948|NCT03261037|11317645|FG000|COMPLETED|Overall Study||64
10187949|NCT03261037|11317646|FG001|COMPLETED|Overall Study||41
10187950|NCT03261037|11317647|FG002|COMPLETED|Overall Study||9
10187951|NCT03261037|11317648|FG003|COMPLETED|Overall Study||11
10187952|NCT03261037|11317645|FG000|NOT COMPLETED|Overall Study||4
10187953|NCT03261037|11317646|FG001|NOT COMPLETED|Overall Study||21
10187954|NCT03261037|11317647|FG002|NOT COMPLETED|Overall Study||0
10187955|NCT03261037|11317648|FG003|NOT COMPLETED|Overall Study||28
10187956|NCT03261167|11317661|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
10187957|NCT03261167|11317662|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
10187958|NCT03261167|11317661|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
10187959|NCT03261167|11317662|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
10187960|NCT03261167|11317661|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
10187961|NCT03261167|11317662|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
10187962|NCT03261167|11317661|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
10187963|NCT03261167|11317662|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
10187964|NCT03261167|11317661|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
10187965|NCT03261167|11317662|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
10187966|NCT03261167|11317661|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
10187967|NCT03261167|11317662|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
10187968|NCT03261167|11317661|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
10187969|NCT03261167|11317662|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
10187970|NCT03261167|11317661|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
10187971|NCT03261167|11317662|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
10187972|NCT03261167|11317661|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
10187973|NCT03261167|11317662|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
10187974|NCT03261167|11317661|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
10187975|NCT03261167|11317662|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
10187976|NCT03261167|11317661|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
10187977|NCT03261167|11317662|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
10187978|NCT03261167|11317661|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
10187979|NCT03261167|11317662|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
10187980|NCT03261336|11317674|FG000|STARTED|Overall Study||1
10187981|NCT03261336|11317674|FG000|COMPLETED|Overall Study||0
10187982|NCT03261336|11317674|FG000|NOT COMPLETED|Overall Study||1
10187983|NCT03261947|11317683|FG000|STARTED|Overall Study||12
10187984|NCT03261947|11317684|FG001|STARTED|Overall Study||15
10187985|NCT03261947|11317685|FG002|STARTED|Overall Study||35
10187986|NCT03261947|11317686|FG003|STARTED|Overall Study||21
10187987|NCT03261947|11317687|FG004|STARTED|Overall Study||18
10187988|NCT03261947|11317683|FG000|COMPLETED|Overall Study||0
10187989|NCT03261947|11317684|FG001|COMPLETED|Overall Study||2
10187990|NCT03261947|11317685|FG002|COMPLETED|Overall Study||5
10187991|NCT03261947|11317686|FG003|COMPLETED|Overall Study||0
10187992|NCT03261947|11317687|FG004|COMPLETED|Overall Study||1
10187993|NCT03261947|11317683|FG000|NOT COMPLETED|Overall Study||12
10187994|NCT03261947|11317684|FG001|NOT COMPLETED|Overall Study||13
10187995|NCT03261947|11317685|FG002|NOT COMPLETED|Overall Study||30
10187996|NCT03261947|11317686|FG003|NOT COMPLETED|Overall Study||21
10187997|NCT03261947|11317687|FG004|NOT COMPLETED|Overall Study||17
10187998|NCT03261960|11317705|FG000|STARTED|Overall Study||190
10187999|NCT03261960|11317706|FG001|STARTED|Overall Study||199
10188000|NCT03261960|11317705|FG000|COMPLETED|Overall Study||176
10188001|NCT03261960|11317706|FG001|COMPLETED|Overall Study||185
10188002|NCT03261960|11317705|FG000|NOT COMPLETED|Overall Study||14
10188003|NCT03261960|11317706|FG001|NOT COMPLETED|Overall Study||14
10188004|NCT03261973|11317712|FG000|STARTED|Overall Study||47
10188005|NCT03261973|11317712|FG000|COMPLETED|Overall Study||43
10188006|NCT03261973|11317712|FG000|NOT COMPLETED|Overall Study||4
10188007|NCT03261999|11317716|FG000|STARTED|Overall Study||144
10188008|NCT03261999|11317716|FG000|ITT|Overall Study||144
10188009|NCT03261999|11317716|FG000|PP|Overall Study||132
10188010|NCT03261999|11317716|FG000|COMPLETED|Overall Study||129
10188011|NCT03261999|11317716|FG000|NOT COMPLETED|Overall Study||15
10188012|NCT03262012|11317724|FG000|STARTED|Overall Study||139
10188013|NCT03262012|11317725|FG001|STARTED|Overall Study||138
10188014|NCT03262012|11317726|FG002|STARTED|Overall Study||70
10188015|NCT03262012|11317727|FG003|STARTED|Overall Study||69
10188016|NCT03262012|11317724|FG000|COMPLETED|Overall Study||112
10188017|NCT03262012|11317725|FG001|COMPLETED|Overall Study||102
10188018|NCT03262012|11317726|FG002|COMPLETED|Overall Study||56
10188019|NCT03262012|11317727|FG003|COMPLETED|Overall Study||54
10188020|NCT03262012|11317724|FG000|NOT COMPLETED|Overall Study||27
10188021|NCT03262012|11317725|FG001|NOT COMPLETED|Overall Study||36
10188022|NCT03262012|11317726|FG002|NOT COMPLETED|Overall Study||14
10188023|NCT03262012|11317727|FG003|NOT COMPLETED|Overall Study||15
10188024|NCT03262038|11317739|FG000|STARTED|Overall Study||18
10188025|NCT03262038|11317740|FG001|STARTED|Overall Study||28
10188026|NCT03262038|11317739|FG000|COMPLETED|Overall Study||18
10188027|NCT03262038|11317740|FG001|COMPLETED|Overall Study||27
10188028|NCT03262038|11317739|FG000|NOT COMPLETED|Overall Study||0
10188029|NCT03262038|11317740|FG001|NOT COMPLETED|Overall Study||1
10188030|NCT03262233|11317750|FG000|STARTED|Overall Study||53
10188031|NCT03262233|11317751|FG001|STARTED|Overall Study||53
10188032|NCT03262233|11317752|FG002|STARTED|Overall Study||59
9715555|NCT02460224|10814916|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
9715556|NCT02460224|10814917|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
9715557|NCT02460224|10814918|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715558|NCT02460224|10814919|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715559|NCT02460224|10814920|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715560|NCT02460224|10814921|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
9715561|NCT02460224|10814922|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715562|NCT02460224|10814923|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20
9715563|NCT02460224|10814924|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715564|NCT02460224|10814925|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
9715565|NCT02460224|10814926|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7
9715566|NCT02460224|10814927|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715567|NCT02460224|10814928|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
9715568|NCT02460224|10814929|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715569|NCT02460224|10814930|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
9715570|NCT02460224|10814931|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
9715571|NCT02460224|10814932|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10061904|NCT02106351|11187394|FG001|COMPLETED|Treatment Cycle 3||45
10061905|NCT02106351|11187395|FG002|COMPLETED|Treatment Cycle 3||53
10061906|NCT02106351|11187393|FG000|NOT COMPLETED|Treatment Cycle 3||0
10061907|NCT02106351|11187394|FG001|NOT COMPLETED|Treatment Cycle 3||4
10061908|NCT02106351|11187395|FG002|NOT COMPLETED|Treatment Cycle 3||5
10061909|NCT02106351|11187393|FG000|STARTED|Treatment Cycle 4||0
10061910|NCT02106351|11187394|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
10061911|NCT02106351|11187395|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
10188033|NCT03262233|11317753|FG003|STARTED|Overall Study||61
10188034|NCT03262233|11317750|FG000|COMPLETED|Overall Study||35
10188035|NCT03262233|11317751|FG001|COMPLETED|Overall Study||32
10188036|NCT03262233|11317752|FG002|COMPLETED|Overall Study||34
10188037|NCT03262233|11317753|FG003|COMPLETED|Overall Study||32
10188038|NCT03262233|11317750|FG000|NOT COMPLETED|Overall Study||18
10188039|NCT03262233|11317751|FG001|NOT COMPLETED|Overall Study||21
10188040|NCT03262233|11317752|FG002|NOT COMPLETED|Overall Study||25
10188041|NCT03262233|11317753|FG003|NOT COMPLETED|Overall Study||29
10188042|NCT03262389|11317764|FG000|STARTED|Overall Study||10
10188043|NCT03262389|11317764|FG000|COMPLETED|Overall Study||7
10188044|NCT03262389|11317764|FG000|NOT COMPLETED|Overall Study||3
10188045|NCT03262441|11317768|FG000|STARTED|Overall Study||5
10188046|NCT03262441|11317768|FG000|COMPLETED|Overall Study||4
10188047|NCT03262441|11317768|FG000|NOT COMPLETED|Overall Study||1
10188048|NCT03263442|11317774|FG000|STARTED|Inpatient Phase||30
10188049|NCT03263442|11317775|FG001|STARTED|Inpatient Phase||34
10188050|NCT03263442|11317774|FG000|COMPLETED|Inpatient Phase||28
10188051|NCT03263442|11317775|FG001|COMPLETED|Inpatient Phase||33
10188052|NCT03263442|11317774|FG000|NOT COMPLETED|Inpatient Phase||2
10188053|NCT03263442|11317775|FG001|NOT COMPLETED|Inpatient Phase||1
10188054|NCT03263442|11317774|FG000|STARTED|1-month Follow-Up||28
10188055|NCT03263442|11317775|FG001|STARTED|1-month Follow-Up||33
10188056|NCT03263442|11317774|FG000|COMPLETED|1-month Follow-Up||27
10188057|NCT03263442|11317775|FG001|COMPLETED|1-month Follow-Up||33
10188058|NCT03263442|11317774|FG000|NOT COMPLETED|1-month Follow-Up||1
10188059|NCT03263442|11317775|FG001|NOT COMPLETED|1-month Follow-Up||0
10188060|NCT03263442|11317774|FG000|STARTED|3-month Follow-Up||27
10188061|NCT03263442|11317775|FG001|STARTED|3-month Follow-Up||33
10188062|NCT03263442|11317774|FG000|COMPLETED|3-month Follow-Up||26
10188063|NCT03263442|11317775|FG001|COMPLETED|3-month Follow-Up||30
10188064|NCT03263442|11317774|FG000|NOT COMPLETED|3-month Follow-Up||1
10188065|NCT03263442|11317775|FG001|NOT COMPLETED|3-month Follow-Up||3
10188066|NCT03263442|11317774|FG000|STARTED|6-month Follow-Up||26
10188067|NCT03263442|11317775|FG001|STARTED|6-month Follow-Up||30
10188068|NCT03263442|11317774|FG000|COMPLETED|6-month Follow-Up||24
10188069|NCT03263442|11317775|FG001|COMPLETED|6-month Follow-Up||28
10188070|NCT03263442|11317774|FG000|NOT COMPLETED|6-month Follow-Up||2
10188071|NCT03263442|11317775|FG001|NOT COMPLETED|6-month Follow-Up||2
10188072|NCT03263702|11317785|FG000|STARTED|Overall Study||38
10188073|NCT03263702|11317786|FG001|STARTED|Overall Study||26
10188074|NCT03263702|11317785|FG000|COMPLETED|Overall Study||35
10188075|NCT03263702|11317786|FG001|COMPLETED|Overall Study||22
10188076|NCT03263702|11317785|FG000|NOT COMPLETED|Overall Study||3
10188077|NCT03263702|11317786|FG001|NOT COMPLETED|Overall Study||4
10188078|NCT03263780|11317792|FG000|STARTED|Overall Study||21
10188079|NCT03263780|11317792|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
10188080|NCT03263780|11317792|FG000|NOT COMPLETED|Overall Study||10
10188081|NCT03264066|11317802|FG000|STARTED|Overall Study||20
10188082|NCT03264066|11317803|FG001|STARTED|Overall Study||20
10188083|NCT03264066|11317804|FG002|STARTED|Overall Study||17
10188084|NCT03264066|11317805|FG003|STARTED|Overall Study||20
10188085|NCT03264066|11317806|FG004|STARTED|Overall Study||7
10188086|NCT03264066|11317807|FG005|STARTED|Overall Study||3
10188087|NCT03264066|11317802|FG000|COMPLETED|Overall Study||0
10188088|NCT03264066|11317803|FG001|COMPLETED|Overall Study||0
10188089|NCT03264066|11317804|FG002|COMPLETED|Overall Study||0
10188090|NCT03264066|11317805|FG003|COMPLETED|Overall Study||0
10188091|NCT03264066|11317806|FG004|COMPLETED|Overall Study||0
10188092|NCT03264066|11317807|FG005|COMPLETED|Overall Study||0
10188093|NCT03264066|11317802|FG000|NOT COMPLETED|Overall Study||20
10188094|NCT03264066|11317803|FG001|NOT COMPLETED|Overall Study||20
10188095|NCT03264066|11317804|FG002|NOT COMPLETED|Overall Study||17
10188096|NCT03264066|11317805|FG003|NOT COMPLETED|Overall Study||20
10188097|NCT03264066|11317806|FG004|NOT COMPLETED|Overall Study||7
10188098|NCT03264066|11317807|FG005|NOT COMPLETED|Overall Study||3
10188099|NCT03264092|11317825|FG000|STARTED|Overall Study||17
10188100|NCT03264092|11317826|FG001|STARTED|Overall Study||20
10188101|NCT03264092|11317827|FG002|STARTED|Overall Study||18
10188102|NCT03264092|11317825|FG000|COMPLETED|Overall Study||17
10188103|NCT03264092|11317826|FG001|COMPLETED|Overall Study||20
10188104|NCT03264092|11317827|FG002|COMPLETED|Overall Study||18
9715572|NCT02460224|10814933|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
9715573|NCT02460224|10814934|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
9715574|NCT02460224|10814935|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
9715575|NCT02460224|10814907|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4
9715576|NCT02460224|10814908|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0
10188105|NCT03264092|11317825|FG000|NOT COMPLETED|Overall Study||0
10188106|NCT03264092|11317826|FG001|NOT COMPLETED|Overall Study||0
10188107|NCT03264092|11317827|FG002|NOT COMPLETED|Overall Study||0
10188108|NCT03264157|11317843|FG000|STARTED|Overall Study||81
10188109|NCT03264157|11317844|FG001|STARTED|Overall Study||81
10188110|NCT03264157|11317843|FG000|COMPLETED|Overall Study||68
10188111|NCT03264157|11317844|FG001|COMPLETED|Overall Study||74
10188112|NCT03264157|11317843|FG000|NOT COMPLETED|Overall Study||13
10188113|NCT03264157|11317844|FG001|NOT COMPLETED|Overall Study||7
10188114|NCT03264248|11317852|FG000|STARTED|Overall Study||9
10188115|NCT03264248|11317852|FG000|COMPLETED|Overall Study||9
10188116|NCT03264248|11317852|FG000|NOT COMPLETED|Overall Study||0
10188117|NCT03264456|11317856|FG000|STARTED|Overall Study||18
10188118|NCT03264456|11317856|FG000|COMPLETED|Overall Study||14
10188119|NCT03264456|11317856|FG000|NOT COMPLETED|Overall Study||4
10188120|NCT03265119|11317862|FG000|STARTED|Overall Study||34
10188121|NCT03265119|11317863|FG001|STARTED|Overall Study||35
10188122|NCT03265119|11317862|FG000|COMPLETED|Overall Study||24
10188123|NCT03265119|11317863|FG001|COMPLETED|Overall Study||28
10188124|NCT03265119|11317862|FG000|NOT COMPLETED|Overall Study||10
10188125|NCT03265119|11317863|FG001|NOT COMPLETED|Overall Study||7
10188126|NCT03265132|11317871|FG000|STARTED|Overall Study||6
10188127|NCT03265132|11317872|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
10188128|NCT03265132|11317871|FG000|COMPLETED|Overall Study||6
10188129|NCT03265132|11317872|FG001|COMPLETED|Overall Study||0
10188130|NCT03265132|11317871|FG000|NOT COMPLETED|Overall Study||0
10188131|NCT03265132|11317872|FG001|NOT COMPLETED|Overall Study||6
10188132|NCT03265600|11317882|FG000|STARTED|Overall Study||92
10188133|NCT03265600|11317883|FG001|STARTED|Overall Study||44
10188134|NCT03265600|11317882|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
10188135|NCT03265600|11317883|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
10188136|NCT03265600|11317882|FG000|NOT COMPLETED|Overall Study||24
10188137|NCT03265600|11317883|FG001|NOT COMPLETED|Overall Study||12
10188138|NCT03265938|11317889|FG000|STARTED|Overall Study||100
10188139|NCT03265938|11317889|FG000|COMPLETED|Overall Study||92
10188140|NCT03265938|11317889|FG000|NOT COMPLETED|Overall Study||8
10188141|NCT03266094|11317894|FG000|STARTED|Overall Study||60
10188142|NCT03266094|11317894|FG000|COMPLETED|Overall Study||58
10188143|NCT03266094|11317894|FG000|NOT COMPLETED|Overall Study||2
10188144|NCT03266107|11317900|FG000|STARTED|Enrollment to Procedure||50
10188145|NCT03266107|11317900|FG000|COMPLETED|Enrollment to Procedure||47
10188146|NCT03266107|11317900|FG000|NOT COMPLETED|Enrollment to Procedure||3
10188147|NCT03266107|11317900|FG000|STARTED|3-Month Follow-up Visit||47
10188148|NCT03266107|11317900|FG000|COMPLETED|3-Month Follow-up Visit||46
10188149|NCT03266107|11317900|FG000|NOT COMPLETED|3-Month Follow-up Visit||1
10188150|NCT03266107|11317900|FG000|STARTED|12-Month Follow-up Visit||46
10188151|NCT03266107|11317900|FG000|COMPLETED|12-Month Follow-up Visit||45
10188152|NCT03266107|11317900|FG000|NOT COMPLETED|12-Month Follow-up Visit||1
10188153|NCT03266172|11317909|FG000|STARTED|Part A: Period 1(2 Days)||16
10188154|NCT03266172|11317910|FG001|STARTED|Part A: Period 1(2 Days)||0
10188155|NCT03266172|11317911|FG002|STARTED|Part A: Period 1(2 Days)||0
10188156|NCT03266172|11317909|FG000|COMPLETED|Part A: Period 1(2 Days)||15
10188157|NCT03266172|11317910|FG001|COMPLETED|Part A: Period 1(2 Days)||0
10188158|NCT03266172|11317911|FG002|COMPLETED|Part A: Period 1(2 Days)||0
10188159|NCT03266172|11317909|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1
10188160|NCT03266172|11317910|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0
10188161|NCT03266172|11317911|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0
10188162|NCT03266172|11317909|FG000|STARTED|Part A: Washout Period (7 Days)||15
10188163|NCT03266172|11317910|FG001|STARTED|Part A: Washout Period (7 Days)||0
10188164|NCT03266172|11317911|FG002|STARTED|Part A: Washout Period (7 Days)||0
10188165|NCT03266172|11317909|FG000|COMPLETED|Part A: Washout Period (7 Days)||13
10188166|NCT03266172|11317910|FG001|COMPLETED|Part A: Washout Period (7 Days)||0
10188167|NCT03266172|11317911|FG002|COMPLETED|Part A: Washout Period (7 Days)||0
10188168|NCT03266172|11317909|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2
10188169|NCT03266172|11317910|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0
10188170|NCT03266172|11317911|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0
10188171|NCT03266172|11317909|FG000|STARTED|Part A: Period 2 (2 Days)||13
10188172|NCT03266172|11317910|FG001|STARTED|Part A: Period 2 (2 Days)||0
10188173|NCT03266172|11317911|FG002|STARTED|Part A: Period 2 (2 Days)||0
10188174|NCT03266172|11317909|FG000|COMPLETED|Part A: Period 2 (2 Days)||13
10188175|NCT03266172|11317910|FG001|COMPLETED|Part A: Period 2 (2 Days)||0
10188176|NCT03266172|11317911|FG002|COMPLETED|Part A: Period 2 (2 Days)||0
10188177|NCT03266172|11317909|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0
10188178|NCT03266172|11317910|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0
10188179|NCT03266172|11317911|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0
10188180|NCT03266172|11317909|FG000|STARTED|Part A: Washout (7 Days)||13
10188181|NCT03266172|11317910|FG001|STARTED|Part A: Washout (7 Days)||0
10188182|NCT03266172|11317911|FG002|STARTED|Part A: Washout (7 Days)||0
10188183|NCT03266172|11317909|FG000|COMPLETED|Part A: Washout (7 Days)||13
10188184|NCT03266172|11317910|FG001|COMPLETED|Part A: Washout (7 Days)||0
10188185|NCT03266172|11317911|FG002|COMPLETED|Part A: Washout (7 Days)||0
10188186|NCT03266172|11317909|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
10188187|NCT03266172|11317910|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
10188188|NCT03266172|11317911|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
10188189|NCT03266172|11317909|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
10188190|NCT03266172|11317910|FG001|STARTED|Part A: Period 3 (2 Days)||0
10188191|NCT03266172|11317911|FG002|STARTED|Part A: Period 3 (2 Days)||0
10188192|NCT03266172|11317909|FG000|COMPLETED|Part A: Period 3 (2 Days)||16
10188193|NCT03266172|11317910|FG001|COMPLETED|Part A: Period 3 (2 Days)||0
10188194|NCT03266172|11317911|FG002|COMPLETED|Part A: Period 3 (2 Days)||0
10188195|NCT03266172|11317909|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0
10188196|NCT03266172|11317910|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0
10188197|NCT03266172|11317911|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0
10188198|NCT03266172|11317909|FG000|STARTED|Part A: Washout (7 Days)||16
10188199|NCT03266172|11317910|FG001|STARTED|Part A: Washout (7 Days)||0
10188200|NCT03266172|11317911|FG002|STARTED|Part A: Washout (7 Days)||0
10188201|NCT03266172|11317909|FG000|COMPLETED|Part A: Washout (7 Days)||16
10188202|NCT03266172|11317910|FG001|COMPLETED|Part A: Washout (7 Days)||0
10188203|NCT03266172|11317911|FG002|COMPLETED|Part A: Washout (7 Days)||0
10188204|NCT03266172|11317909|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
10188205|NCT03266172|11317910|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
10188206|NCT03266172|11317911|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
10188207|NCT03266172|11317909|FG000|STARTED|Part A: Period 4 (2 Days)||16
10188208|NCT03266172|11317910|FG001|STARTED|Part A: Period 4 (2 Days)||0
10188209|NCT03266172|11317911|FG002|STARTED|Part A: Period 4 (2 Days)||0
10188210|NCT03266172|11317909|FG000|COMPLETED|Part A: Period 4 (2 Days)||16
10188211|NCT03266172|11317910|FG001|COMPLETED|Part A: Period 4 (2 Days)||0
10188212|NCT03266172|11317911|FG002|COMPLETED|Part A: Period 4 (2 Days)||0
10188213|NCT03266172|11317909|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0
10188214|NCT03266172|11317910|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0
10188215|NCT03266172|11317911|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0
10188216|NCT03266172|11317909|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
9715577|NCT02460224|10814909|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715578|NCT02460224|10814910|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715579|NCT02460224|10814911|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715580|NCT02460224|10814912|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5
9715581|NCT02460224|10814913|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6
9715582|NCT02460224|10814914|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715583|NCT02460224|10814915|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715584|NCT02460224|10814916|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715585|NCT02460224|10814917|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715586|NCT02460224|10814918|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715587|NCT02460224|10814919|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715588|NCT02460224|10814920|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715589|NCT02460224|10814921|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715590|NCT02460224|10814922|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715591|NCT02460224|10814923|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715592|NCT02460224|10814924|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715593|NCT02460224|10814925|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715594|NCT02460224|10814926|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715595|NCT02460224|10814927|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715596|NCT02460224|10814928|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715597|NCT02460224|10814929|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715598|NCT02460224|10814930|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715599|NCT02460224|10814931|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715600|NCT02460224|10814932|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715601|NCT02460224|10814933|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715602|NCT02460224|10814934|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715603|NCT02460224|10814935|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0
9715604|NCT02460224|10814907|FG000|COMPLETED|Overall Study||0
9715605|NCT02460224|10814908|FG001|COMPLETED|Overall Study||0
9715606|NCT02460224|10814909|FG002|COMPLETED|Overall Study||0
9715607|NCT02460224|10814910|FG003|COMPLETED|Overall Study||0
9715608|NCT02460224|10814911|FG004|COMPLETED|Overall Study||0
9715609|NCT02460224|10814912|FG005|COMPLETED|Overall Study||0
9715610|NCT02460224|10814913|FG006|COMPLETED|Overall Study||0
9715611|NCT02460224|10814914|FG007|COMPLETED|Overall Study||0
9715612|NCT02460224|10814915|FG008|COMPLETED|Overall Study||0
9715613|NCT02460224|10814916|FG009|COMPLETED|Overall Study||0
9715614|NCT02460224|10814917|FG010|COMPLETED|Overall Study||0
9715615|NCT02460224|10814918|FG011|COMPLETED|Overall Study||0
9715616|NCT02460224|10814919|FG012|COMPLETED|Overall Study||0
9715617|NCT02460224|10814920|FG013|COMPLETED|Overall Study||0
9715618|NCT02460224|10814921|FG014|COMPLETED|Overall Study||0
9715619|NCT02460224|10814922|FG015|COMPLETED|Overall Study||0
9715620|NCT02460224|10814923|FG016|COMPLETED|Overall Study||0
9715621|NCT02460224|10814924|FG017|COMPLETED|Overall Study||0
9715622|NCT02460224|10814925|FG018|COMPLETED|Overall Study||0
9715623|NCT02460224|10814926|FG019|COMPLETED|Overall Study||0
9715624|NCT02460224|10814927|FG020|COMPLETED|Overall Study||0
9715625|NCT02460224|10814928|FG021|COMPLETED|Overall Study||0
9715626|NCT02460224|10814929|FG022|COMPLETED|Overall Study||0
9715627|NCT02460224|10814930|FG023|COMPLETED|Overall Study||0
9715628|NCT02460224|10814931|FG024|COMPLETED|Overall Study||0
9715629|NCT02460224|10814932|FG025|COMPLETED|Overall Study||0
9715630|NCT02460224|10814933|FG026|COMPLETED|Overall Study||0
9715631|NCT02460224|10814934|FG027|COMPLETED|Overall Study||0
9715632|NCT02460224|10814935|FG028|COMPLETED|Overall Study||0
9715633|NCT02460224|10814907|FG000|NOT COMPLETED|Overall Study||17
9715634|NCT02460224|10814908|FG001|NOT COMPLETED|Overall Study||12
9715635|NCT02460224|10814909|FG002|NOT COMPLETED|Overall Study||6
9715636|NCT02460224|10814910|FG003|NOT COMPLETED|Overall Study||6
9715637|NCT02460224|10814911|FG004|NOT COMPLETED|Overall Study||6
9715638|NCT02460224|10814912|FG005|NOT COMPLETED|Overall Study||30
9715639|NCT02460224|10814913|FG006|NOT COMPLETED|Overall Study||30
9715640|NCT02460224|10814914|FG007|NOT COMPLETED|Overall Study||5
9715641|NCT02460224|10814915|FG008|NOT COMPLETED|Overall Study||6
9715642|NCT02460224|10814916|FG009|NOT COMPLETED|Overall Study||11
9715643|NCT02460224|10814917|FG010|NOT COMPLETED|Overall Study||5
9715644|NCT02460224|10814918|FG011|NOT COMPLETED|Overall Study||6
9715645|NCT02460224|10814919|FG012|NOT COMPLETED|Overall Study||6
9715646|NCT02460224|10814920|FG013|NOT COMPLETED|Overall Study||6
9715647|NCT02460224|10814921|FG014|NOT COMPLETED|Overall Study||5
9715648|NCT02460224|10814922|FG015|NOT COMPLETED|Overall Study||6
9715649|NCT02460224|10814923|FG016|NOT COMPLETED|Overall Study||20
9715650|NCT02460224|10814924|FG017|NOT COMPLETED|Overall Study||6
9715651|NCT02460224|10814925|FG018|NOT COMPLETED|Overall Study||12
9715652|NCT02460224|10814926|FG019|NOT COMPLETED|Overall Study||7
9715653|NCT02460224|10814927|FG020|NOT COMPLETED|Overall Study||6
9715654|NCT02460224|10814928|FG021|NOT COMPLETED|Overall Study||12
9715655|NCT02460224|10814929|FG022|NOT COMPLETED|Overall Study||6
9715656|NCT02460224|10814930|FG023|NOT COMPLETED|Overall Study||11
10188217|NCT03266172|11317910|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
10188218|NCT03266172|11317911|FG002|STARTED|Part B: Period 1 (4 Days)||0
10188219|NCT03266172|11317909|FG000|COMPLETED|Part B: Period 1 (4 Days)||0
10188220|NCT03266172|11317910|FG001|COMPLETED|Part B: Period 1 (4 Days)||10
10188221|NCT03266172|11317911|FG002|COMPLETED|Part B: Period 1 (4 Days)||0
10188222|NCT03266172|11317909|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0
10188223|NCT03266172|11317910|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0
10188224|NCT03266172|11317911|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0
10188225|NCT03266172|11317909|FG000|STARTED|Part B: Washout (7 Days)||0
10188226|NCT03266172|11317910|FG001|STARTED|Part B: Washout (7 Days)||10
10188227|NCT03266172|11317911|FG002|STARTED|Part B: Washout (7 Days)||0
10188228|NCT03266172|11317909|FG000|COMPLETED|Part B: Washout (7 Days)||0
10188229|NCT03266172|11317910|FG001|COMPLETED|Part B: Washout (7 Days)||10
10188230|NCT03266172|11317911|FG002|COMPLETED|Part B: Washout (7 Days)||0
10188231|NCT03266172|11317909|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
10188232|NCT03266172|11317910|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0
10188233|NCT03266172|11317911|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
9849872|NCT00868218|10962714|FG001|NOT COMPLETED|Overall Study||0
9849873|NCT00868218|10962715|FG002|NOT COMPLETED|Overall Study||0
9849874|NCT00868218|10962716|FG003|NOT COMPLETED|Overall Study||0
10061912|NCT02106351|11187393|FG000|COMPLETED|Treatment Cycle 4||0
9715657|NCT02460224|10814931|FG024|NOT COMPLETED|Overall Study||6
9849875|NCT00868231|10962730|FG000|STARTED|Treatment Period 1||5
9849876|NCT00868231|10962731|FG001|STARTED|Treatment Period 1||5
10188234|NCT03266172|11317909|FG000|STARTED|Part B: Period 2 (4 Days)||0
9715658|NCT02460224|10814932|FG025|NOT COMPLETED|Overall Study||6
9715659|NCT02460224|10814933|FG026|NOT COMPLETED|Overall Study||121
9715660|NCT02460224|10814934|FG027|NOT COMPLETED|Overall Study||21
9715661|NCT02460224|10814935|FG028|NOT COMPLETED|Overall Study||93
9715662|NCT02460159|10815009|FG000|STARTED|Overall Study||117
9715663|NCT02460159|10815010|FG001|STARTED|Overall Study||18
9715664|NCT02460159|10815009|FG000|COMPLETED|Overall Study||111
9715665|NCT02460159|10815010|FG001|COMPLETED|Overall Study||17
9715666|NCT02460159|10815009|FG000|NOT COMPLETED|Overall Study||6
9715667|NCT02460159|10815010|FG001|NOT COMPLETED|Overall Study||1
9715668|NCT02457910|10815022|FG000|STARTED|Overall Study||3
9715669|NCT02457910|10815023|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
9715670|NCT02457910|10815024|FG002|STARTED|Overall Study||3
9715671|NCT02457910|10815025|FG003|STARTED|Overall Study||2
9715672|NCT02457910|10815026|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
9715673|NCT02457910|10815027|FG005|STARTED|Overall Study||12
9715674|NCT02457910|10815022|FG000|COMPLETED|Overall Study||0
9715675|NCT02457910|10815023|FG001|COMPLETED|Overall Study||0
9715676|NCT02457910|10815024|FG002|COMPLETED|Overall Study||0
9715677|NCT02457910|10815025|FG003|COMPLETED|Overall Study||0
9715678|NCT02457910|10815026|FG004|COMPLETED|Overall Study||0
9715679|NCT02457910|10815027|FG005|COMPLETED|Overall Study||1
9715680|NCT02457910|10815022|FG000|NOT COMPLETED|Overall Study||3
9715681|NCT02457910|10815023|FG001|NOT COMPLETED|Overall Study||5
9715682|NCT02457910|10815024|FG002|NOT COMPLETED|Overall Study||3
9715683|NCT02457910|10815025|FG003|NOT COMPLETED|Overall Study||2
9715684|NCT02457910|10815026|FG004|NOT COMPLETED|Overall Study||5
9715685|NCT02457910|10815027|FG005|NOT COMPLETED|Overall Study||11
9715686|NCT02407236|10815052|FG000|STARTED|Induction Study (8 Weeks)||319
9715687|NCT02407236|10815053|FG001|STARTED|Induction Study (8 Weeks)||320
9715688|NCT02407236|10815054|FG002|STARTED|Induction Study (8 Weeks)||322
9715689|NCT02407236|10815055|FG003|STARTED|Induction Study (8 Weeks)||0
9715690|NCT02407236|10815056|FG004|STARTED|Induction Study (8 Weeks)||0
9715691|NCT02407236|10815057|FG005|STARTED|Induction Study (8 Weeks)||0
9715692|NCT02407236|10815058|FG006|STARTED|Induction Study (8 Weeks)||0
9715693|NCT02407236|10815059|FG007|STARTED|Induction Study (8 Weeks)||0
9715694|NCT02407236|10815052|FG000|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
9715695|NCT02407236|10815053|FG001|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
9715696|NCT02407236|10815054|FG002|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
9715697|NCT02407236|10815055|FG003|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
9715698|NCT02407236|10815056|FG004|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
9715699|NCT02407236|10815057|FG005|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
9715700|NCT02407236|10815058|FG006|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
9715701|NCT02407236|10815059|FG007|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
9715702|NCT02407236|10815052|FG000|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
9715703|NCT02407236|10815053|FG001|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
9715704|NCT02407236|10815054|FG002|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
9715705|NCT02407236|10815055|FG003|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
9715706|NCT02407236|10815056|FG004|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
9715707|NCT02407236|10815057|FG005|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
9715708|NCT02407236|10815058|FG006|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
9715709|NCT02407236|10815059|FG007|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
9715710|NCT02407236|10815052|FG000|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
9715711|NCT02407236|10815053|FG001|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
9715712|NCT02407236|10815054|FG002|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
9715713|NCT02407236|10815055|FG003|Completed Safety Follow-up|Induction Study (8 Weeks)||0
9715714|NCT02407236|10815056|FG004|Completed Safety Follow-up|Induction Study (8 Weeks)||0
9715715|NCT02407236|10815057|FG005|Completed Safety Follow-up|Induction Study (8 Weeks)||0
9715716|NCT02407236|10815058|FG006|Completed Safety Follow-up|Induction Study (8 Weeks)||0
9715717|NCT02407236|10815059|FG007|Completed Safety Follow-up|Induction Study (8 Weeks)||0
9715718|NCT02407236|10815052|FG000|Safety Analysis Set|Induction Study (8 Weeks)||319
9715719|NCT02407236|10815053|FG001|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
9715720|NCT02407236|10815054|FG002|Safety Analysis Set|Induction Study (8 Weeks)||320
9715721|NCT02407236|10815055|FG003|Safety Analysis Set|Induction Study (8 Weeks)||0
9715722|NCT02407236|10815056|FG004|Safety Analysis Set|Induction Study (8 Weeks)||0
9715723|NCT02407236|10815057|FG005|Safety Analysis Set|Induction Study (8 Weeks)||0
9715724|NCT02407236|10815058|FG006|Safety Analysis Set|Induction Study (8 Weeks)||0
9715725|NCT02407236|10815059|FG007|Safety Analysis Set|Induction Study (8 Weeks)||0
9715726|NCT02407236|10815052|FG000|Non-responders at Week 8|Induction Study (8 Weeks)||184
9715727|NCT02407236|10815053|FG001|Non-responders at Week 8|Induction Study (8 Weeks)||132
9715728|NCT02407236|10815054|FG002|Non-responders at Week 8|Induction Study (8 Weeks)||101
9715729|NCT02407236|10815055|FG003|Non-responders at Week 8|Induction Study (8 Weeks)||0
9715730|NCT02407236|10815056|FG004|Non-responders at Week 8|Induction Study (8 Weeks)||0
9715731|NCT02407236|10815057|FG005|Non-responders at Week 8|Induction Study (8 Weeks)||0
9715732|NCT02407236|10815058|FG006|Non-responders at Week 8|Induction Study (8 Weeks)||0
9715733|NCT02407236|10815059|FG007|Non-responders at Week 8|Induction Study (8 Weeks)||0
9715734|NCT02407236|10815052|FG000|COMPLETED|Induction Study (8 Weeks)||296
9715735|NCT02407236|10815053|FG001|COMPLETED|Induction Study (8 Weeks)||309
9715736|NCT02407236|10815054|FG002|COMPLETED|Induction Study (8 Weeks)||307
9715737|NCT02407236|10815055|FG003|COMPLETED|Induction Study (8 Weeks)||0
9715738|NCT02407236|10815056|FG004|COMPLETED|Induction Study (8 Weeks)||0
9715739|NCT02407236|10815057|FG005|COMPLETED|Induction Study (8 Weeks)||0
9715740|NCT02407236|10815058|FG006|COMPLETED|Induction Study (8 Weeks)||0
9715741|NCT02407236|10815059|FG007|COMPLETED|Induction Study (8 Weeks)||0
9715742|NCT02407236|10815052|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23
9715743|NCT02407236|10815053|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11
9715744|NCT02407236|10815054|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15
9715745|NCT02407236|10815055|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0
9715746|NCT02407236|10815056|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0
9715747|NCT02407236|10815057|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0
9715748|NCT02407236|10815058|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0
9715749|NCT02407236|10815059|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0
9715750|NCT02407236|10815052|FG000|STARTED|Maintenance Study (44 Weeks)||0
9715751|NCT02407236|10815053|FG001|STARTED|Maintenance Study (44 Weeks)||0
9715752|NCT02407236|10815054|FG002|STARTED|Maintenance Study (44 Weeks)||0
9715753|NCT02407236|10815055|FG003|STARTED|Maintenance Study (44 Weeks)||175
9715754|NCT02407236|10815056|FG004|STARTED|Maintenance Study (44 Weeks)||172
9715755|NCT02407236|10815057|FG005|STARTED|Maintenance Study (44 Weeks)||176
9715756|NCT02407236|10815058|FG006|STARTED|Maintenance Study (44 Weeks)||103
9849877|NCT00868231|10962732|FG002|STARTED|Treatment Period 1||5
9849878|NCT00868231|10962733|FG003|STARTED|Treatment Period 1||5
9849879|NCT00868231|10962734|FG004|STARTED|Treatment Period 1||5
9849880|NCT00868231|10962735|FG005|STARTED|Treatment Period 1||5
9849881|NCT00868231|10962730|FG000|COMPLETED|Treatment Period 1||5
9849882|NCT00868231|10962731|FG001|COMPLETED|Treatment Period 1||5
9849883|NCT00868231|10962732|FG002|COMPLETED|Treatment Period 1||5
9849884|NCT00868231|10962733|FG003|COMPLETED|Treatment Period 1||5
9849885|NCT00868231|10962734|FG004|COMPLETED|Treatment Period 1||4
9849886|NCT00868231|10962735|FG005|COMPLETED|Treatment Period 1||5
9849887|NCT00868231|10962730|FG000|NOT COMPLETED|Treatment Period 1||0
9849888|NCT00868231|10962731|FG001|NOT COMPLETED|Treatment Period 1||0
9849889|NCT00868231|10962732|FG002|NOT COMPLETED|Treatment Period 1||0
9849890|NCT00868231|10962733|FG003|NOT COMPLETED|Treatment Period 1||0
9849891|NCT00868231|10962734|FG004|NOT COMPLETED|Treatment Period 1||1
9849892|NCT00868231|10962735|FG005|NOT COMPLETED|Treatment Period 1||0
9849893|NCT00868231|10962730|FG000|STARTED|Treatment Period 2||5
9849894|NCT00868231|10962731|FG001|STARTED|Treatment Period 2||5
9849895|NCT00868231|10962732|FG002|STARTED|Treatment Period 2||5
9849896|NCT00868231|10962733|FG003|STARTED|Treatment Period 2||5
9849897|NCT00868231|10962734|FG004|STARTED|Treatment Period 2||4
9849898|NCT00868231|10962735|FG005|STARTED|Treatment Period 2||5
9849899|NCT00868231|10962730|FG000|COMPLETED|Treatment Period 2||4
9849900|NCT00868231|10962731|FG001|COMPLETED|Treatment Period 2||5
9849901|NCT00868231|10962732|FG002|COMPLETED|Treatment Period 2||5
9849902|NCT00868231|10962733|FG003|COMPLETED|Treatment Period 2||5
9849903|NCT00868231|10962734|FG004|COMPLETED|Treatment Period 2||4
9849904|NCT00868231|10962735|FG005|COMPLETED|Treatment Period 2||5
9849905|NCT00868231|10962730|FG000|NOT COMPLETED|Treatment Period 2||1
9715757|NCT02407236|10815059|FG007|STARTED|Maintenance Study (44 Weeks)||157
9715758|NCT02407236|10815052|FG000|COMPLETED|Maintenance Study (44 Weeks)||0
9715759|NCT02407236|10815053|FG001|COMPLETED|Maintenance Study (44 Weeks)||0
9715760|NCT02407236|10815054|FG002|COMPLETED|Maintenance Study (44 Weeks)||0
9715761|NCT02407236|10815055|FG003|COMPLETED|Maintenance Study (44 Weeks)||165
9715762|NCT02407236|10815056|FG004|COMPLETED|Maintenance Study (44 Weeks)||161
9715763|NCT02407236|10815057|FG005|COMPLETED|Maintenance Study (44 Weeks)||168
9715764|NCT02407236|10815058|FG006|COMPLETED|Maintenance Study (44 Weeks)||94
9715765|NCT02407236|10815059|FG007|COMPLETED|Maintenance Study (44 Weeks)||149
9715766|NCT02407236|10815052|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0
9715767|NCT02407236|10815053|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0
9715768|NCT02407236|10815054|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0
9715769|NCT02407236|10815055|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||10
9715770|NCT02407236|10815056|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||11
9715771|NCT02407236|10815057|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||8
9715772|NCT02407236|10815058|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||9
9715773|NCT02407236|10815059|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||8
9715774|NCT02320396|10815079|FG000|STARTED|Overall Study||224
9715775|NCT02320396|10815080|FG001|STARTED|Overall Study||225
9715776|NCT02320396|10815079|FG000|Treated (Full Analysis Set)|Overall Study||223
9715777|NCT02320396|10815080|FG001|Treated (Full Analysis Set)|Overall Study||225
9715778|NCT02320396|10815079|FG000|COMPLETED|Overall Study||220
9715779|NCT02320396|10815080|FG001|COMPLETED|Overall Study||221
9715780|NCT02320396|10815079|FG000|NOT COMPLETED|Overall Study||4
9715781|NCT02320396|10815080|FG001|NOT COMPLETED|Overall Study||4
9731421|NCT00132678|10831361|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0
9731422|NCT00132678|10831362|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0
9731423|NCT00132678|10831363|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440
9731424|NCT00132678|10831361|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0
9731425|NCT00132678|10831362|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0
9731426|NCT00132678|10831363|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382
9731427|NCT00132678|10831361|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
9849906|NCT00868231|10962731|FG001|NOT COMPLETED|Treatment Period 2||0
10061913|NCT02106351|11187394|FG001|COMPLETED|Treatment Cycle 4||21
10061914|NCT02106351|11187395|FG002|COMPLETED|Treatment Cycle 4||31
10061915|NCT02106351|11187393|FG000|NOT COMPLETED|Treatment Cycle 4||0
10061916|NCT02106351|11187394|FG001|NOT COMPLETED|Treatment Cycle 4||1
10061917|NCT02106351|11187395|FG002|NOT COMPLETED|Treatment Cycle 4||2
10061918|NCT02106390|11187412|FG000|STARTED|Overall Study||252
10061919|NCT02106390|11187413|FG001|STARTED|Overall Study||250
10061920|NCT02106390|11187414|FG002|STARTED|Overall Study||248
10061921|NCT02106390|11187412|FG000|COMPLETED|Overall Study||203
9731428|NCT00132678|10831362|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
9731429|NCT00132678|10831363|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
9731430|NCT00132678|10831361|FG000|STARTED|Period III (Open-Label Stabilization)||501
9731431|NCT00132678|10831362|FG001|STARTED|Period III (Open-Label Stabilization)||0
9731432|NCT00132678|10831363|FG002|STARTED|Period III (Open-Label Stabilization)||0
9731433|NCT00132678|10831361|FG000|COMPLETED|Period III (Open-Label Stabilization)||303
9731434|NCT00132678|10831362|FG001|COMPLETED|Period III (Open-Label Stabilization)||0
9731435|NCT00132678|10831363|FG002|COMPLETED|Period III (Open-Label Stabilization)||0
9731436|NCT00132678|10831361|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198
9731437|NCT00132678|10831362|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0
9731438|NCT00132678|10831363|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0
9731439|NCT00132678|10831361|FG000|STARTED|Period IV (Double-Blind Treatment)||154
9731440|NCT00132678|10831362|FG001|STARTED|Period IV (Double-Blind Treatment)||149
9731441|NCT00132678|10831363|FG002|STARTED|Period IV (Double-Blind Treatment)||0
9731442|NCT00132678|10831361|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117
9731443|NCT00132678|10831362|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109
9731444|NCT00132678|10831363|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0
9731445|NCT00132678|10831361|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
9731446|NCT00132678|10831362|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
9731447|NCT00132678|10831363|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
9731448|NCT00132691|10831373|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
9731449|NCT00132691|10831374|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
9731450|NCT00132691|10831373|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
9731451|NCT00132691|10831374|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
9731452|NCT00132691|10831373|FG000|NOT COMPLETED|Overall Study||11
9731453|NCT00132691|10831374|FG001|NOT COMPLETED|Overall Study||12
10061922|NCT02106390|11187413|FG001|COMPLETED|Overall Study||202
9731454|NCT00132730|10831389|FG000|STARTED|Period I - Placebo Run-in (Base)||150
9731455|NCT00132730|10831390|FG001|STARTED|Period I - Placebo Run-in (Base)||148
9731456|NCT00132730|10831391|FG002|STARTED|Period I - Placebo Run-in (Base)||153
9731457|NCT00132730|10831392|FG003|STARTED|Period I - Placebo Run-in (Base)||153
9731458|NCT00132730|10831393|FG004|STARTED|Period I - Placebo Run-in (Base)||0
9731459|NCT00132730|10831394|FG005|STARTED|Period I - Placebo Run-in (Base)||0
9731460|NCT00132730|10831389|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150
9849907|NCT00868231|10962732|FG002|NOT COMPLETED|Treatment Period 2||0
10061923|NCT02106390|11187414|FG002|COMPLETED|Overall Study||205
9715782|NCT02282345|10815088|FG000|STARTED|Overall Study||13
9715783|NCT02282345|10815089|FG001|STARTED|Overall Study||20
9715784|NCT02282345|10815088|FG000|COMPLETED|Overall Study||13
9715785|NCT02282345|10815089|FG001|COMPLETED|Overall Study||19
9715786|NCT02282345|10815088|FG000|NOT COMPLETED|Overall Study||0
9715787|NCT02282345|10815089|FG001|NOT COMPLETED|Overall Study||1
9715788|NCT02230410|10815098|FG000|STARTED|Overall Study||18
9715789|NCT02230410|10815098|FG000|COMPLETED|Overall Study||15
9715790|NCT02230410|10815098|FG000|NOT COMPLETED|Overall Study||3
9715791|NCT02053246|10815102|FG000|STARTED|Overall Study||11
9715792|NCT02053246|10815102|FG000|COMPLETED|Overall Study||7
9715793|NCT02053246|10815102|FG000|NOT COMPLETED|Overall Study||4
9715794|NCT01980940|10815114|FG000|STARTED|Overall Study||5
9715795|NCT01980940|10815115|FG001|STARTED|Overall Study||5
9715796|NCT01980940|10815116|FG002|STARTED|Overall Study||5
9715797|NCT01980940|10815117|FG003|STARTED|Overall Study||3
9715798|NCT01980940|10815118|FG004|STARTED|Overall Study||2
9715799|NCT01980940|10815119|FG005|STARTED|Overall Study||2
9715800|NCT01980940|10815120|FG006|STARTED|Overall Study||24
9715801|NCT01980940|10815121|FG007|STARTED|Overall Study||24
9715802|NCT01980940|10815114|FG000|Treated|Overall Study||5
9715803|NCT01980940|10815115|FG001|Treated|Overall Study||5
9715804|NCT01980940|10815116|FG002|Treated|Overall Study||5
9715805|NCT01980940|10815117|FG003|Treated|Overall Study||3
9715806|NCT01980940|10815118|FG004|Treated|Overall Study||2
9715807|NCT01980940|10815119|FG005|Treated|Overall Study||2
9715808|NCT01980940|10815120|FG006|Treated|Overall Study||24
9715809|NCT01980940|10815121|FG007|Treated|Overall Study||24
9715810|NCT01980940|10815114|FG000|COMPLETED|Overall Study||5
9715811|NCT01980940|10815115|FG001|COMPLETED|Overall Study||5
9715812|NCT01980940|10815116|FG002|COMPLETED|Overall Study||5
9715813|NCT01980940|10815117|FG003|COMPLETED|Overall Study||3
9715814|NCT01980940|10815118|FG004|COMPLETED|Overall Study||2
9715815|NCT01980940|10815119|FG005|COMPLETED|Overall Study||0
9715816|NCT01980940|10815120|FG006|COMPLETED|Overall Study||24
9715817|NCT01980940|10815121|FG007|COMPLETED|Overall Study||24
9715818|NCT01980940|10815114|FG000|NOT COMPLETED|Overall Study||0
9715819|NCT01980940|10815115|FG001|NOT COMPLETED|Overall Study||0
9715820|NCT01980940|10815116|FG002|NOT COMPLETED|Overall Study||0
9715821|NCT01980940|10815117|FG003|NOT COMPLETED|Overall Study||0
9715822|NCT01980940|10815118|FG004|NOT COMPLETED|Overall Study||0
9715823|NCT01980940|10815119|FG005|NOT COMPLETED|Overall Study||2
9715824|NCT01980940|10815120|FG006|NOT COMPLETED|Overall Study||0
9715825|NCT01980940|10815121|FG007|NOT COMPLETED|Overall Study||0
9715826|NCT01923298|10815145|FG000|STARTED|Overall Study||14
9715827|NCT01923298|10815145|FG000|COMPLETED|Overall Study||14
9715828|NCT01923298|10815145|FG000|NOT COMPLETED|Overall Study||0
9715829|NCT01918033|10815152|FG000|STARTED|Overall Study||203
9715830|NCT01918033|10815153|FG001|STARTED|Overall Study||203
9715831|NCT01918033|10815154|FG002|STARTED|Overall Study||202
9715832|NCT01918033|10815152|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202
9715833|NCT01918033|10815153|FG001|Treated|Overall Study||203
9715834|NCT01918033|10815154|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201
9715835|NCT01918033|10815152|FG000|COMPLETED|Overall Study||198
9715836|NCT01918033|10815153|FG001|COMPLETED|Overall Study||201
9715837|NCT01918033|10815154|FG002|COMPLETED|Overall Study||199
9715838|NCT01918033|10815152|FG000|NOT COMPLETED|Overall Study||5
9715839|NCT01918033|10815153|FG001|NOT COMPLETED|Overall Study||2
9715840|NCT01918033|10815154|FG002|NOT COMPLETED|Overall Study||3
9715841|NCT01916980|10815164|FG000|STARTED|Overall Study||65
9715842|NCT01916980|10815165|FG001|STARTED|Overall Study||29
9715843|NCT01916980|10815164|FG000|COMPLETED|Overall Study||58
9715844|NCT01916980|10815165|FG001|COMPLETED|Overall Study||25
9715845|NCT01916980|10815164|FG000|NOT COMPLETED|Overall Study||7
9715846|NCT01916980|10815165|FG001|NOT COMPLETED|Overall Study||4
9715847|NCT01916967|10815174|FG000|STARTED|Overall Study||80
9715848|NCT01916967|10815175|FG001|STARTED|Overall Study||79
9715849|NCT01916967|10815176|FG002|STARTED|Overall Study||80
9715850|NCT01916967|10815174|FG000|COMPLETED|Overall Study||80
9715851|NCT01916967|10815175|FG001|COMPLETED|Overall Study||78
9715852|NCT01916967|10815176|FG002|COMPLETED|Overall Study||71
9715853|NCT01916967|10815174|FG000|NOT COMPLETED|Overall Study||0
9715854|NCT01916967|10815175|FG001|NOT COMPLETED|Overall Study||1
9715855|NCT01916967|10815176|FG002|NOT COMPLETED|Overall Study||9
9715856|NCT01910402|10815188|FG000|STARTED|Randomized Phase||248
9715857|NCT01910402|10815189|FG001|STARTED|Randomized Phase||247
9715858|NCT01910402|10815188|FG000|COMPLETED|Randomized Phase||206
9715859|NCT01910402|10815189|FG001|COMPLETED|Randomized Phase||192
9715860|NCT01910402|10815188|FG000|NOT COMPLETED|Randomized Phase||42
9715861|NCT01910402|10815189|FG001|NOT COMPLETED|Randomized Phase||55
9715862|NCT01910402|10815188|FG000|STARTED|Continuation Phase||120
9715863|NCT01910402|10815189|FG001|STARTED|Continuation Phase||0
9715864|NCT01910402|10815188|FG000|COMPLETED|Continuation Phase||30
9715865|NCT01910402|10815189|FG001|COMPLETED|Continuation Phase||0
9715866|NCT01910402|10815188|FG000|NOT COMPLETED|Continuation Phase||90
9715867|NCT01910402|10815189|FG001|NOT COMPLETED|Continuation Phase||0
9715868|NCT01893320|10815199|FG000|STARTED|Overall Study||7
9715869|NCT01893320|10815200|FG001|STARTED|Overall Study||59
9715870|NCT01893320|10815199|FG000|COMPLETED|Overall Study||7
9715871|NCT01893320|10815200|FG001|COMPLETED|Overall Study||59
9715872|NCT01893320|10815199|FG000|NOT COMPLETED|Overall Study||0
9715873|NCT01893320|10815200|FG001|NOT COMPLETED|Overall Study||0
9715874|NCT01870401|10815208|FG000|STARTED|Overall Study||287
9715875|NCT01870401|10815209|FG001|STARTED|Overall Study||155
9715876|NCT01870401|10815208|FG000|COMPLETED|Overall Study||137
9715877|NCT01870401|10815209|FG001|COMPLETED|Overall Study||59
9715878|NCT01870401|10815208|FG000|NOT COMPLETED|Overall Study||150
9715879|NCT01870401|10815209|FG001|NOT COMPLETED|Overall Study||96
9715880|NCT01867606|10815219|FG000|STARTED|Overall Study||26
9715881|NCT01867606|10815220|FG001|STARTED|Overall Study||32
9715882|NCT01867606|10815219|FG000|COMPLETED|Overall Study||16
9715883|NCT01867606|10815220|FG001|COMPLETED|Overall Study||17
9715884|NCT01867606|10815219|FG000|NOT COMPLETED|Overall Study||10
9715885|NCT01867606|10815220|FG001|NOT COMPLETED|Overall Study||15
9715886|NCT01857063|10815234|FG000|STARTED|Period 1 (7 Days)||110
9715887|NCT01857063|10815235|FG001|STARTED|Period 1 (7 Days)||110
9715888|NCT01857063|10815234|FG000|COMPLETED|Period 1 (7 Days)||108
9715889|NCT01857063|10815235|FG001|COMPLETED|Period 1 (7 Days)||106
9715890|NCT01857063|10815234|FG000|NOT COMPLETED|Period 1 (7 Days)||2
9715891|NCT01857063|10815235|FG001|NOT COMPLETED|Period 1 (7 Days)||4
9715892|NCT01857063|10815234|FG000|STARTED|Period 2 (7 Days)||108
9715893|NCT01857063|10815235|FG001|STARTED|Period 2 (7 Days)||106
9715894|NCT01857063|10815234|FG000|COMPLETED|Period 2 (7 Days)||104
9715895|NCT01857063|10815235|FG001|COMPLETED|Period 2 (7 Days)||104
9715896|NCT01857063|10815234|FG000|NOT COMPLETED|Period 2 (7 Days)||4
9715897|NCT01857063|10815235|FG001|NOT COMPLETED|Period 2 (7 Days)||2
9715898|NCT01854268|10815241|FG000|STARTED|Overall Study||25
9715899|NCT01854268|10815241|FG000|COMPLETED|Overall Study||25
9715900|NCT01854268|10815241|FG000|NOT COMPLETED|Overall Study||0
9715901|NCT01852812|10815248|FG000|STARTED|Overall Study||51
9715902|NCT01852812|10815249|FG001|STARTED|Overall Study||18
9715903|NCT01852812|10815250|FG002|STARTED|Overall Study||18
9715904|NCT01852812|10815248|FG000|COMPLETED|Overall Study||51
9715905|NCT01852812|10815249|FG001|COMPLETED|Overall Study||17
9715906|NCT01852812|10815250|FG002|COMPLETED|Overall Study||17
9715907|NCT01852812|10815248|FG000|NOT COMPLETED|Overall Study||0
9715908|NCT01852812|10815249|FG001|NOT COMPLETED|Overall Study||1
9715909|NCT01852812|10815250|FG002|NOT COMPLETED|Overall Study||1
10061924|NCT02106390|11187412|FG000|NOT COMPLETED|Overall Study||49
10061925|NCT02106390|11187413|FG001|NOT COMPLETED|Overall Study||48
10061926|NCT02106390|11187414|FG002|NOT COMPLETED|Overall Study||43
9715910|NCT01828021|10815258|FG000|STARTED|Overall Study||25
9715911|NCT01828021|10815258|FG000|COMPLETED|Overall Study||0
9715912|NCT01828021|10815258|FG000|NOT COMPLETED|Overall Study||25
9715913|NCT01709318|10815269|FG000|STARTED|Overall Study||82
9715914|NCT01709318|10815270|FG001|STARTED|Overall Study||85
9715915|NCT01709318|10815271|FG002|STARTED|Overall Study||77
9715916|NCT01709318|10815272|FG003|STARTED|Overall Study||78
9715917|NCT01709318|10815273|FG004|STARTED|Overall Study||78
9715918|NCT01709318|10815274|FG005|STARTED|Overall Study||84
9715919|NCT01709318|10815275|FG006|STARTED|Overall Study||182
9715920|NCT01709318|10815269|FG000|Treated|Overall Study||79
9715921|NCT01709318|10815270|FG001|Treated|Overall Study||85
9715922|NCT01709318|10815271|FG002|Treated|Overall Study||78
9715923|NCT01709318|10815272|FG003|Treated|Overall Study||77
9715924|NCT01709318|10815273|FG004|Treated|Overall Study||77
9715925|NCT01709318|10815274|FG005|Treated|Overall Study||86
9715926|NCT01709318|10815275|FG006|Treated|Overall Study||178
9715927|NCT01709318|10815269|FG000|COMPLETED|Overall Study||73
9715928|NCT01709318|10815270|FG001|COMPLETED|Overall Study||78
9715929|NCT01709318|10815271|FG002|COMPLETED|Overall Study||71
9715930|NCT01709318|10815272|FG003|COMPLETED|Overall Study||72
9715931|NCT01709318|10815273|FG004|COMPLETED|Overall Study||74
9715932|NCT01709318|10815274|FG005|COMPLETED|Overall Study||80
9715933|NCT01709318|10815275|FG006|COMPLETED|Overall Study||171
9715934|NCT01709318|10815269|FG000|NOT COMPLETED|Overall Study||9
9715935|NCT01709318|10815270|FG001|NOT COMPLETED|Overall Study||7
9715936|NCT01709318|10815271|FG002|NOT COMPLETED|Overall Study||6
10061927|NCT02106403|11187425|FG000|STARTED|Visit 1, Treatment Period 1||8
10061928|NCT02106403|11187426|FG001|STARTED|Visit 1, Treatment Period 1||8
9715937|NCT01709318|10815272|FG003|NOT COMPLETED|Overall Study||6
9715938|NCT01709318|10815273|FG004|NOT COMPLETED|Overall Study||4
9715939|NCT01709318|10815274|FG005|NOT COMPLETED|Overall Study||4
9715940|NCT01709318|10815275|FG006|NOT COMPLETED|Overall Study||11
9715941|NCT01698918|10815291|FG000|STARTED|First Line Treatment (Core+Extension)||202
9715942|NCT01698918|10815291|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11
9715943|NCT01698918|10815291|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13
9715944|NCT01698918|10815291|FG000|COMPLETED|First Line Treatment (Core+Extension)||29
9715945|NCT01698918|10815291|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173
9715946|NCT01698918|10815291|FG000|STARTED|Second Line Treatment (Core+Extension)||53
9715947|NCT01698918|10815291|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7
9715948|NCT01698918|10815291|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46
9715949|NCT01673620|10815305|FG000|STARTED|Overall Study||47
9715950|NCT01673620|10815306|FG001|STARTED|Overall Study||22
9715951|NCT01673620|10815305|FG000|COMPLETED|Overall Study||46
9715952|NCT01673620|10815306|FG001|COMPLETED|Overall Study||22
9715953|NCT01673620|10815305|FG000|NOT COMPLETED|Overall Study||1
9715954|NCT01673620|10815306|FG001|NOT COMPLETED|Overall Study||0
9715955|NCT01660243|10815316|FG000|STARTED|Overall Study||10
9715956|NCT01660243|10815317|FG001|STARTED|Overall Study||13
9715957|NCT01660243|10815318|FG002|STARTED|Overall Study||11
9715958|NCT01660243|10815319|FG003|STARTED|Overall Study||11
9715959|NCT01660243|10815316|FG000|COMPLETED|Overall Study||8
9715960|NCT01660243|10815317|FG001|COMPLETED|Overall Study||13
9715961|NCT01660243|10815318|FG002|COMPLETED|Overall Study||9
9715962|NCT01660243|10815319|FG003|COMPLETED|Overall Study||10
9715963|NCT01660243|10815316|FG000|NOT COMPLETED|Overall Study||2
9715964|NCT01660243|10815317|FG001|NOT COMPLETED|Overall Study||0
9715965|NCT01660243|10815318|FG002|NOT COMPLETED|Overall Study||2
9715966|NCT01660243|10815319|FG003|NOT COMPLETED|Overall Study||1
9715967|NCT01617187|10815333|FG000|STARTED|Randomization Through Start Treatment|Randomized|98
9715968|NCT01617187|10815334|FG001|STARTED|Randomization Through Start Treatment|Randomized|113
9715969|NCT01617187|10815335|FG002|STARTED|Randomization Through Start Treatment|Randomized|46
9715970|NCT01617187|10815336|FG003|STARTED|Randomization Through Start Treatment|Randomized|103
9715971|NCT01617187|10815333|FG000|COMPLETED|Randomization Through Start Treatment||97
9715972|NCT01617187|10815334|FG001|COMPLETED|Randomization Through Start Treatment||113
9715973|NCT01617187|10815335|FG002|COMPLETED|Randomization Through Start Treatment||46
9715974|NCT01617187|10815336|FG003|COMPLETED|Randomization Through Start Treatment||101
9715975|NCT01617187|10815333|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
9715976|NCT01617187|10815334|FG001|NOT COMPLETED|Randomization Through Start Treatment||0
9715977|NCT01617187|10815335|FG002|NOT COMPLETED|Randomization Through Start Treatment||0
9715978|NCT01617187|10815336|FG003|NOT COMPLETED|Randomization Through Start Treatment||2
9715979|NCT01617187|10815333|FG000|STARTED|Treatment Through Study Completion|Treated|97
9715980|NCT01617187|10815334|FG001|STARTED|Treatment Through Study Completion|Treated|113
9715981|NCT01617187|10815335|FG002|STARTED|Treatment Through Study Completion|Treated|46
9715982|NCT01617187|10815336|FG003|STARTED|Treatment Through Study Completion|Treated|101
9715983|NCT01617187|10815333|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
9715984|NCT01617187|10815334|FG001|COMPLETED|Treatment Through Study Completion||102
9715985|NCT01617187|10815335|FG002|COMPLETED|Treatment Through Study Completion||41
9715986|NCT01617187|10815336|FG003|COMPLETED|Treatment Through Study Completion||91
9715987|NCT01617187|10815333|FG000|NOT COMPLETED|Treatment Through Study Completion||11
9715988|NCT01617187|10815334|FG001|NOT COMPLETED|Treatment Through Study Completion||11
9715989|NCT01617187|10815335|FG002|NOT COMPLETED|Treatment Through Study Completion||5
9715990|NCT01617187|10815336|FG003|NOT COMPLETED|Treatment Through Study Completion||10
9715991|NCT01611883|10815348|FG000|STARTED|Overall Study||75
9715992|NCT01611883|10815349|FG001|STARTED|Overall Study||77
9715993|NCT01611883|10815348|FG000|COMPLETED|Overall Study||74
9715994|NCT01611883|10815349|FG001|COMPLETED|Overall Study||76
9715995|NCT01611883|10815348|FG000|NOT COMPLETED|Overall Study||1
9715996|NCT01611883|10815349|FG001|NOT COMPLETED|Overall Study||1
9715997|NCT01572675|10815357|FG000|STARTED|Overall Study||268
9715998|NCT01572675|10815358|FG001|STARTED|Overall Study||279
9715999|NCT01572675|10815357|FG000|COMPLETED|Overall Study||31
9716000|NCT01572675|10815358|FG001|COMPLETED|Overall Study||56
9716001|NCT01572675|10815357|FG000|NOT COMPLETED|Overall Study||237
9716002|NCT01572675|10815358|FG001|NOT COMPLETED|Overall Study||223
9716003|NCT01554163|10815379|FG000|STARTED|Overall Study||120
9716004|NCT01554163|10815380|FG001|STARTED|Overall Study||119
9716005|NCT01554163|10815379|FG000|Number Treated|Overall Study||119
9716006|NCT01554163|10815380|FG001|Number Treated|Overall Study||119
9716007|NCT01554163|10815379|FG000|COMPLETED|Overall Study||112
9716008|NCT01554163|10815380|FG001|COMPLETED|Overall Study||109
9716009|NCT01554163|10815379|FG000|NOT COMPLETED|Overall Study||8
9716010|NCT01554163|10815380|FG001|NOT COMPLETED|Overall Study||10
9716011|NCT01502371|10815391|FG000|STARTED|Overall Study||120
9716012|NCT01502371|10815392|FG001|STARTED|Overall Study||113
9716013|NCT01502371|10815393|FG002|STARTED|Overall Study||108
9716014|NCT01502371|10815394|FG003|STARTED|Overall Study||125
9716015|NCT01502371|10815395|FG004|STARTED|Overall Study||112
9716016|NCT01502371|10815391|FG000|COMPLETED|Overall Study||79
9716017|NCT01502371|10815392|FG001|COMPLETED|Overall Study||81
9716018|NCT01502371|10815393|FG002|COMPLETED|Overall Study||83
9716019|NCT01502371|10815394|FG003|COMPLETED|Overall Study||88
9716020|NCT01502371|10815395|FG004|COMPLETED|Overall Study||60
9716021|NCT01502371|10815391|FG000|NOT COMPLETED|Overall Study||41
9716022|NCT01502371|10815392|FG001|NOT COMPLETED|Overall Study||32
9716023|NCT01502371|10815393|FG002|NOT COMPLETED|Overall Study||25
9716024|NCT01502371|10815394|FG003|NOT COMPLETED|Overall Study||37
9716025|NCT01502371|10815395|FG004|NOT COMPLETED|Overall Study||52
9716026|NCT01490190|10815408|FG000|STARTED|Overall Study||252
9716027|NCT01490190|10815408|FG000|COMPLETED|Overall Study||204
9716028|NCT01490190|10815408|FG000|NOT COMPLETED|Overall Study||48
9716029|NCT01471340|10815414|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
9716030|NCT01471340|10815415|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
9716031|NCT01471340|10815414|FG000|COMPLETED|Overall Study||5862
9716032|NCT01471340|10815415|FG001|COMPLETED|Overall Study||5855
9716033|NCT01471340|10815414|FG000|NOT COMPLETED|Overall Study||6
9716034|NCT01471340|10815415|FG001|NOT COMPLETED|Overall Study||6
9716035|NCT01462370|10815421|FG000|STARTED|Overall Study||69
9716036|NCT01462370|10815422|FG001|STARTED|Overall Study||70
9716037|NCT01462370|10815421|FG000|COMPLETED|Overall Study||68
9716038|NCT01462370|10815422|FG001|COMPLETED|Overall Study||65
9716039|NCT01462370|10815421|FG000|NOT COMPLETED|Overall Study||1
9716040|NCT01462370|10815422|FG001|NOT COMPLETED|Overall Study||5
9716041|NCT01436253|10815428|FG000|STARTED|Overall Study||2196
9716042|NCT01436253|10815428|FG000|COMPLETED|Overall Study||1897
9716043|NCT01436253|10815428|FG000|NOT COMPLETED|Overall Study||299
9716044|NCT01414192|10815436|FG000|STARTED|Overall Study||490
9716045|NCT01414192|10815437|FG001|STARTED|Overall Study||575
9716046|NCT01414192|10815438|FG002|STARTED|Overall Study||424
9716047|NCT01414192|10815439|FG003|STARTED|Overall Study||1726
9716048|NCT01414192|10815436|FG000|COMPLETED|Overall Study||490
9716049|NCT01414192|10815437|FG001|COMPLETED|Overall Study||575
9716050|NCT01414192|10815438|FG002|COMPLETED|Overall Study||424
9716051|NCT01414192|10815439|FG003|COMPLETED|Overall Study||1726
9716052|NCT01414192|10815436|FG000|NOT COMPLETED|Overall Study||0
9716053|NCT01414192|10815437|FG001|NOT COMPLETED|Overall Study||0
9716054|NCT01414192|10815438|FG002|NOT COMPLETED|Overall Study||0
9716055|NCT01414192|10815439|FG003|NOT COMPLETED|Overall Study||0
9716056|NCT01390415|10815455|FG000|STARTED|Overall Study||99
9716057|NCT01390415|10815456|FG001|STARTED|Overall Study||37
9716058|NCT01390415|10815455|FG000|COMPLETED|Overall Study||99
9716059|NCT01390415|10815456|FG001|COMPLETED|Overall Study||37
9716060|NCT01390415|10815455|FG000|NOT COMPLETED|Overall Study||0
9716061|NCT01390415|10815456|FG001|NOT COMPLETED|Overall Study||0
9716062|NCT01381679|10815462|FG000|STARTED|Overall Study||1682
9716063|NCT01381679|10815462|FG000|COMPLETED|Overall Study||794
9716064|NCT01381679|10815462|FG000|NOT COMPLETED|Overall Study||888
9716065|NCT01370603|10815468|FG000|STARTED|Period 1||164
9716066|NCT01370603|10815469|FG001|STARTED|Period 1||164
9716067|NCT01370603|10815468|FG000|COMPLETED|Period 1||150
9716068|NCT01370603|10815469|FG001|COMPLETED|Period 1||154
9716069|NCT01370603|10815468|FG000|NOT COMPLETED|Period 1||14
9716070|NCT01370603|10815469|FG001|NOT COMPLETED|Period 1||10
9716071|NCT01370603|10815468|FG000|STARTED|Crossover Washout||150
9716072|NCT01370603|10815469|FG001|STARTED|Crossover Washout||154
9716073|NCT01370603|10815468|FG000|COMPLETED|Crossover Washout||141
9716074|NCT01370603|10815469|FG001|COMPLETED|Crossover Washout||150
9716075|NCT01370603|10815468|FG000|NOT COMPLETED|Crossover Washout||9
9716076|NCT01370603|10815469|FG001|NOT COMPLETED|Crossover Washout||4
9716077|NCT01370603|10815468|FG000|STARTED|Period 2||141
9716078|NCT01370603|10815469|FG001|STARTED|Period 2||150
9716079|NCT01370603|10815468|FG000|COMPLETED|Period 2||138
9716080|NCT01370603|10815469|FG001|COMPLETED|Period 2||146
9716081|NCT01370603|10815468|FG000|NOT COMPLETED|Period 2||3
9716082|NCT01370603|10815469|FG001|NOT COMPLETED|Period 2||4
9716083|NCT01370590|10815477|FG000|STARTED|Period 1||203
9716084|NCT01370590|10815478|FG001|STARTED|Period 1||203
9716085|NCT01370590|10815477|FG000|COMPLETED|Period 1||187
9716086|NCT01370590|10815478|FG001|COMPLETED|Period 1||192
9716087|NCT01370590|10815477|FG000|NOT COMPLETED|Period 1||16
9716088|NCT01370590|10815478|FG001|NOT COMPLETED|Period 1||11
9716089|NCT01370590|10815477|FG000|STARTED|Crossover Washout Period||187
9849908|NCT00868231|10962733|FG003|NOT COMPLETED|Treatment Period 2||0
9849909|NCT00868231|10962734|FG004|NOT COMPLETED|Treatment Period 2||0
9716090|NCT01370590|10815478|FG001|STARTED|Crossover Washout Period||192
9716091|NCT01370590|10815477|FG000|COMPLETED|Crossover Washout Period||181
9716092|NCT01370590|10815478|FG001|COMPLETED|Crossover Washout Period||186
9716093|NCT01370590|10815477|FG000|NOT COMPLETED|Crossover Washout Period||6
9716094|NCT01370590|10815478|FG001|NOT COMPLETED|Crossover Washout Period||6
9716095|NCT01370590|10815477|FG000|STARTED|Period 2||181
9716096|NCT01370590|10815478|FG001|STARTED|Period 2||186
9716097|NCT01370590|10815477|FG000|COMPLETED|Period 2||180
9716098|NCT01370590|10815478|FG001|COMPLETED|Period 2||184
9716099|NCT01370590|10815477|FG000|NOT COMPLETED|Period 2||1
9716100|NCT01370590|10815478|FG001|NOT COMPLETED|Period 2||2
9716101|NCT01368185|10815484|FG000|STARTED|Overall Study||1705
9716102|NCT01368185|10815484|FG000|COMPLETED|Overall Study||1705
9716103|NCT01368185|10815484|FG000|NOT COMPLETED|Overall Study||0
9716104|NCT01349907|10815490|FG000|STARTED|Overall Study|Enrolled and Treated|241
9716105|NCT01349907|10815491|FG001|STARTED|Overall Study|Enrolled and Treated|81
9716106|NCT01349907|10815490|FG000|COMPLETED|Overall Study||102
9716107|NCT01349907|10815491|FG001|COMPLETED|Overall Study||38
9716108|NCT01349907|10815490|FG000|NOT COMPLETED|Overall Study||139
9716109|NCT01349907|10815491|FG001|NOT COMPLETED|Overall Study||43
9716110|NCT01345786|10815501|FG000|STARTED|Overall Study|Number randomized|41
9716111|NCT01345786|10815502|FG001|STARTED|Overall Study|Number randomized|41
9716112|NCT01345786|10815503|FG002|STARTED|Overall Study|Number randomized|38
9716113|NCT01345786|10815504|FG003|STARTED|Overall Study|Number randomized|38
9716114|NCT01345786|10815501|FG000|Treated|Overall Study||41
9716115|NCT01345786|10815502|FG001|Treated|Overall Study||41
9716116|NCT01345786|10815503|FG002|Treated|Overall Study||37
9716117|NCT01345786|10815504|FG003|Treated|Overall Study||37
9716118|NCT01345786|10815501|FG000|COMPLETED|Overall Study||35
9716119|NCT01345786|10815502|FG001|COMPLETED|Overall Study||33
9716120|NCT01345786|10815503|FG002|COMPLETED|Overall Study||33
9716121|NCT01345786|10815504|FG003|COMPLETED|Overall Study||35
9716122|NCT01345786|10815501|FG000|NOT COMPLETED|Overall Study||6
9716123|NCT01345786|10815502|FG001|NOT COMPLETED|Overall Study||8
9716124|NCT01345786|10815503|FG002|NOT COMPLETED|Overall Study||5
9716125|NCT01345786|10815504|FG003|NOT COMPLETED|Overall Study||3
9716126|NCT01306929|10815514|FG000|STARTED|Overall Study||134
9716127|NCT01306929|10815514|FG000|COMPLETED|Overall Study||40
9716128|NCT01306929|10815514|FG000|NOT COMPLETED|Overall Study||94
9716129|NCT01294696|10815520|FG000|STARTED|Overall Study||1261
9716130|NCT01294696|10815520|FG000|COMPLETED|Overall Study||1187
9716131|NCT01294696|10815520|FG000|NOT COMPLETED|Overall Study||74
9716132|NCT01277822|10815527|FG000|STARTED|Overall Study||168
9716133|NCT01277822|10815528|FG001|STARTED|Overall Study||166
9716134|NCT01277822|10815527|FG000|COMPLETED|Overall Study||153
9716135|NCT01277822|10815528|FG001|COMPLETED|Overall Study||155
9716136|NCT01277822|10815527|FG000|NOT COMPLETED|Overall Study||15
9716137|NCT01277822|10815528|FG001|NOT COMPLETED|Overall Study||11
9716138|NCT01244763|10815540|FG000|STARTED|Overall Study||24
9716139|NCT01244763|10815541|FG001|STARTED|Overall Study||24
9716140|NCT01244763|10815542|FG002|STARTED|Overall Study||24
9716141|NCT01244763|10815543|FG003|STARTED|Overall Study||24
9716142|NCT01244763|10815544|FG004|STARTED|Overall Study||24
9716143|NCT01244763|10815545|FG005|STARTED|Overall Study||25
9716144|NCT01244763|10815540|FG000|Safety Population|Overall Study||24
9716145|NCT01244763|10815541|FG001|Safety Population|Overall Study||24
9716146|NCT01244763|10815542|FG002|Safety Population|Overall Study||24
9716147|NCT01244763|10815543|FG003|Safety Population|Overall Study||24
9716148|NCT01244763|10815544|FG004|Safety Population|Overall Study||24
9716149|NCT01244763|10815545|FG005|Safety Population|Overall Study||25
9716150|NCT01244763|10815540|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
9716151|NCT01244763|10815541|FG001|Efficacy Evaluable (EE) Population|Overall Study||24
9716152|NCT01244763|10815542|FG002|Efficacy Evaluable (EE) Population|Overall Study||23
9716153|NCT01244763|10815543|FG003|Efficacy Evaluable (EE) Population|Overall Study||24
9716154|NCT01244763|10815544|FG004|Efficacy Evaluable (EE) Population|Overall Study||24
9716155|NCT01244763|10815545|FG005|Efficacy Evaluable (EE) Population|Overall Study||25
9716156|NCT01244763|10815540|FG000|COMPLETED|Overall Study||21
9716157|NCT01244763|10815541|FG001|COMPLETED|Overall Study||21
9716158|NCT01244763|10815542|FG002|COMPLETED|Overall Study||22
9716159|NCT01244763|10815543|FG003|COMPLETED|Overall Study||23
9716160|NCT01244763|10815544|FG004|COMPLETED|Overall Study||21
9716161|NCT01244763|10815545|FG005|COMPLETED|Overall Study||21
9716162|NCT01244763|10815540|FG000|NOT COMPLETED|Overall Study||3
9716163|NCT01244763|10815541|FG001|NOT COMPLETED|Overall Study||3
9716164|NCT01244763|10815542|FG002|NOT COMPLETED|Overall Study||2
9716165|NCT01244763|10815543|FG003|NOT COMPLETED|Overall Study||1
9716166|NCT01244763|10815544|FG004|NOT COMPLETED|Overall Study||3
9716167|NCT01244763|10815545|FG005|NOT COMPLETED|Overall Study||4
9716168|NCT01208207|10815562|FG000|STARTED|Part I||702
9716169|NCT01208207|10815563|FG001|STARTED|Part I||156
9716170|NCT01208207|10815564|FG002|STARTED|Part I||157
9716171|NCT01208207|10815565|FG003|STARTED|Part I||0
9716172|NCT01208207|10815566|FG004|STARTED|Part I||0
9716173|NCT01208207|10815567|FG005|STARTED|Part I||0
9716174|NCT01208207|10815568|FG006|STARTED|Part I||0
9716175|NCT01208207|10815562|FG000|COMPLETED|Part I||632
9716176|NCT01208207|10815563|FG001|COMPLETED|Part I||145
9716177|NCT01208207|10815564|FG002|COMPLETED|Part I||142
9716178|NCT01208207|10815565|FG003|COMPLETED|Part I||0
9716179|NCT01208207|10815566|FG004|COMPLETED|Part I||0
9716180|NCT01208207|10815567|FG005|COMPLETED|Part I||0
9716181|NCT01208207|10815568|FG006|COMPLETED|Part I||0
9716182|NCT01208207|10815562|FG000|NOT COMPLETED|Part I||70
9716183|NCT01208207|10815563|FG001|NOT COMPLETED|Part I||11
9716184|NCT01208207|10815564|FG002|NOT COMPLETED|Part I||15
9716185|NCT01208207|10815565|FG003|NOT COMPLETED|Part I||0
9716186|NCT01208207|10815566|FG004|NOT COMPLETED|Part I||0
9716187|NCT01208207|10815567|FG005|NOT COMPLETED|Part I||0
9716188|NCT01208207|10815568|FG006|NOT COMPLETED|Part I||0
9716189|NCT01208207|10815562|FG000|STARTED|Part II||0
9716190|NCT01208207|10815563|FG001|STARTED|Part II||0
9716191|NCT01208207|10815564|FG002|STARTED|Part II||0
9716192|NCT01208207|10815565|FG003|STARTED|Part II||314
9716193|NCT01208207|10815566|FG004|STARTED|Part II||318
9716194|NCT01208207|10815567|FG005|STARTED|Part II||145
9716195|NCT01208207|10815568|FG006|STARTED|Part II||142
9716196|NCT01208207|10815562|FG000|COMPLETED|Part II||0
9716197|NCT01208207|10815563|FG001|COMPLETED|Part II||0
9716198|NCT01208207|10815564|FG002|COMPLETED|Part II||0
9716199|NCT01208207|10815565|FG003|COMPLETED|Part II||282
9716200|NCT01208207|10815566|FG004|COMPLETED|Part II||295
9716201|NCT01208207|10815567|FG005|COMPLETED|Part II||129
9716202|NCT01208207|10815568|FG006|COMPLETED|Part II||131
9716203|NCT01208207|10815562|FG000|NOT COMPLETED|Part II||0
9716204|NCT01208207|10815563|FG001|NOT COMPLETED|Part II||0
9716205|NCT01208207|10815564|FG002|NOT COMPLETED|Part II||0
9716206|NCT01208207|10815565|FG003|NOT COMPLETED|Part II||32
9716207|NCT01208207|10815566|FG004|NOT COMPLETED|Part II||23
9716208|NCT01208207|10815567|FG005|NOT COMPLETED|Part II||16
9716209|NCT01208207|10815568|FG006|NOT COMPLETED|Part II||11
9716210|NCT01208181|10815593|FG000|STARTED|Part 1||818
9716211|NCT01208181|10815594|FG001|STARTED|Part 1||468
9716212|NCT01208181|10815595|FG002|STARTED|Part 1||0
9716213|NCT01208181|10815596|FG003|STARTED|Part 1||0
9716214|NCT01208181|10815597|FG004|STARTED|Part 1||118
9716215|NCT01208181|10815593|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
9716216|NCT01208181|10815594|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
9716217|NCT01208181|10815595|FG002|COMPLETED|Part 1||0
9716218|NCT01208181|10815596|FG003|COMPLETED|Part 1||0
9716219|NCT01208181|10815597|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
9716220|NCT01208181|10815593|FG000|NOT COMPLETED|Part 1||99
9716221|NCT01208181|10815594|FG001|NOT COMPLETED|Part 1||55
9716222|NCT01208181|10815595|FG002|NOT COMPLETED|Part 1||0
9716223|NCT01208181|10815596|FG003|NOT COMPLETED|Part 1||0
9716224|NCT01208181|10815597|FG004|NOT COMPLETED|Part 1||22
9716225|NCT01208181|10815593|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
9716226|NCT01208181|10815594|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
9716227|NCT01208181|10815595|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
9716228|NCT01208181|10815596|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
9716229|NCT01208181|10815597|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
9716230|NCT01208181|10815593|FG000|COMPLETED|Part 2||0
9716231|NCT01208181|10815594|FG001|COMPLETED|Part 2||0
9716232|NCT01208181|10815595|FG002|COMPLETED|Part 2||334
9716233|NCT01208181|10815596|FG003|COMPLETED|Part 2||343
9716234|NCT01208181|10815597|FG004|COMPLETED|Part 2||0
9716235|NCT01208181|10815593|FG000|NOT COMPLETED|Part 2||0
9716236|NCT01208181|10815594|FG001|NOT COMPLETED|Part 2||0
9716237|NCT01208181|10815595|FG002|NOT COMPLETED|Part 2||16
9716238|NCT01208181|10815596|FG003|NOT COMPLETED|Part 2||20
9716239|NCT01208181|10815597|FG004|NOT COMPLETED|Part 2||0
9716240|NCT01206517|10815620|FG000|STARTED|Overall Study||6
9716241|NCT01206517|10815621|FG001|STARTED|Overall Study||6
9716242|NCT01206517|10815622|FG002|STARTED|Overall Study||6
9716243|NCT01206517|10815623|FG003|STARTED|Overall Study||4
9716244|NCT01206517|10815624|FG004|STARTED|Overall Study||4
9716245|NCT01206517|10815625|FG005|STARTED|Overall Study||4
9716246|NCT01206517|10815620|FG000|COMPLETED|Overall Study||6
9716247|NCT01206517|10815621|FG001|COMPLETED|Overall Study||6
9716248|NCT01206517|10815622|FG002|COMPLETED|Overall Study||4
9716249|NCT01206517|10815623|FG003|COMPLETED|Overall Study||4
9716250|NCT01206517|10815624|FG004|COMPLETED|Overall Study||3
9716251|NCT01206517|10815625|FG005|COMPLETED|Overall Study||4
9716252|NCT01206517|10815620|FG000|NOT COMPLETED|Overall Study||0
9716253|NCT01206517|10815621|FG001|NOT COMPLETED|Overall Study||0
9716254|NCT01206517|10815622|FG002|NOT COMPLETED|Overall Study||2
9716255|NCT01206517|10815623|FG003|NOT COMPLETED|Overall Study||0
9716256|NCT01206517|10815624|FG004|NOT COMPLETED|Overall Study||1
9716257|NCT01206517|10815625|FG005|NOT COMPLETED|Overall Study||0
9716258|NCT01190267|10815638|FG000|STARTED|Overall Study||196
9716259|NCT01190267|10815639|FG001|STARTED|Overall Study||8
9716260|NCT01190267|10815638|FG000|COMPLETED|Overall Study||155
9716261|NCT01190267|10815639|FG001|COMPLETED|Overall Study||4
9716262|NCT01190267|10815638|FG000|NOT COMPLETED|Overall Study||41
9716263|NCT01190267|10815639|FG001|NOT COMPLETED|Overall Study||4
9716264|NCT01190254|10815648|FG000|STARTED|Overall Study||102
9716265|NCT01190254|10815649|FG001|STARTED|Overall Study||98
9716266|NCT01190254|10815650|FG002|STARTED|Overall Study||106
9716267|NCT01190254|10815648|FG000|Treated|Overall Study||102
9716268|NCT01190254|10815649|FG001|Treated|Overall Study||98
9716269|NCT01190254|10815650|FG002|Treated|Overall Study||106
9716270|NCT01190254|10815648|FG000|COMPLETED|Overall Study||81
9716271|NCT01190254|10815649|FG001|COMPLETED|Overall Study||81
9716272|NCT01190254|10815650|FG002|COMPLETED|Overall Study||84
9716273|NCT01190254|10815648|FG000|NOT COMPLETED|Overall Study||21
9716274|NCT01190254|10815649|FG001|NOT COMPLETED|Overall Study||17
9716275|NCT01190254|10815650|FG002|NOT COMPLETED|Overall Study||22
9716276|NCT01154036|10815661|FG000|STARTED|Phase I||120
9716277|NCT01154036|10815662|FG001|STARTED|Phase I||483
9716278|NCT01154036|10815663|FG002|STARTED|Phase I||944
9716279|NCT01154036|10815664|FG003|STARTED|Phase I||0
9716280|NCT01154036|10815665|FG004|STARTED|Phase I||0
9716281|NCT01154036|10815666|FG005|STARTED|Phase I||0
9716282|NCT01154036|10815667|FG006|STARTED|Phase I||0
9716283|NCT01154036|10815668|FG007|STARTED|Phase I||0
9716284|NCT01154036|10815661|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
9716285|NCT01154036|10815662|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
9716286|NCT01154036|10815663|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
9716287|NCT01154036|10815664|FG003|COMPLETED|Phase I||0
9716288|NCT01154036|10815665|FG004|COMPLETED|Phase I||0
9716289|NCT01154036|10815666|FG005|COMPLETED|Phase I||0
9716290|NCT01154036|10815667|FG006|COMPLETED|Phase I||0
9716291|NCT01154036|10815668|FG007|COMPLETED|Phase I||0
9716292|NCT01154036|10815661|FG000|NOT COMPLETED|Phase I||3
9716293|NCT01154036|10815662|FG001|NOT COMPLETED|Phase I||28
9716294|NCT01154036|10815663|FG002|NOT COMPLETED|Phase I||56
9716295|NCT01154036|10815664|FG003|NOT COMPLETED|Phase I||0
9716296|NCT01154036|10815665|FG004|NOT COMPLETED|Phase I||0
9716297|NCT01154036|10815666|FG005|NOT COMPLETED|Phase I||0
9716298|NCT01154036|10815667|FG006|NOT COMPLETED|Phase I||0
9716299|NCT01154036|10815668|FG007|NOT COMPLETED|Phase I||0
9716300|NCT01154036|10815661|FG000|STARTED|Phase II||0
9716301|NCT01154036|10815662|FG001|STARTED|Phase II||0
9716302|NCT01154036|10815663|FG002|STARTED|Phase II||0
9716303|NCT01154036|10815664|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
9716304|NCT01154036|10815665|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
9716305|NCT01154036|10815666|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
9716306|NCT01154036|10815667|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
9716307|NCT01154036|10815668|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
9716308|NCT01154036|10815661|FG000|COMPLETED|Phase II||0
9716309|NCT01154036|10815662|FG001|COMPLETED|Phase II||0
9716310|NCT01154036|10815663|FG002|COMPLETED|Phase II||0
9716311|NCT01154036|10815664|FG003|COMPLETED|Phase II||27
9716312|NCT01154036|10815665|FG004|COMPLETED|Phase II||116
9716313|NCT01154036|10815666|FG005|COMPLETED|Phase II||121
9716314|NCT01154036|10815667|FG006|COMPLETED|Phase II||225
9716315|NCT01154036|10815668|FG007|COMPLETED|Phase II||200
9716316|NCT01154036|10815661|FG000|NOT COMPLETED|Phase II||0
9716317|NCT01154036|10815662|FG001|NOT COMPLETED|Phase II||0
9716318|NCT01154036|10815663|FG002|NOT COMPLETED|Phase II||0
9716319|NCT01154036|10815664|FG003|NOT COMPLETED|Phase II||1
9716320|NCT01154036|10815665|FG004|NOT COMPLETED|Phase II||8
9716321|NCT01154036|10815666|FG005|NOT COMPLETED|Phase II||5
9716322|NCT01154036|10815667|FG006|NOT COMPLETED|Phase II||9
9716323|NCT01154036|10815668|FG007|NOT COMPLETED|Phase II||6
9716324|NCT01101464|10815690|FG000|STARTED|Day 1 Through AM Dose of Day 5||4
9716325|NCT01101464|10815691|FG001|STARTED|Day 1 Through AM Dose of Day 5||4
9716326|NCT01101464|10815690|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4
9716327|NCT01101464|10815691|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4
9716328|NCT01101464|10815690|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
9716329|NCT01101464|10815691|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
9716330|NCT01101464|10815690|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
9716331|NCT01101464|10815691|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
9716332|NCT01101464|10815690|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
9716333|NCT01101464|10815691|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
9716334|NCT01101464|10815690|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
9716335|NCT01101464|10815691|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
9716336|NCT01098071|10815699|FG000|STARTED|Overall Study||34
9716337|NCT01098071|10815699|FG000|COMPLETED|Overall Study||19
9716338|NCT01098071|10815699|FG000|NOT COMPLETED|Overall Study||15
9716339|NCT01077830|10815705|FG000|STARTED|Overall Study||677
9716340|NCT01077830|10815706|FG001|STARTED|Overall Study||682
9716341|NCT01077830|10815705|FG000|COMPLETED|Overall Study||677
9716342|NCT01077830|10815706|FG001|COMPLETED|Overall Study||682
9716343|NCT01077830|10815705|FG000|NOT COMPLETED|Overall Study||0
9716344|NCT01077830|10815706|FG001|NOT COMPLETED|Overall Study||0
9716345|NCT01070966|10815712|FG000|STARTED|Participants for Safety Evaluation||2089
9716346|NCT01070966|10815712|FG000|COMPLETED|Participants for Safety Evaluation||2011
9716347|NCT01070966|10815712|FG000|NOT COMPLETED|Participants for Safety Evaluation||78
9716348|NCT01070966|10815712|FG000|STARTED|Participants for Efficacy Evaluation||2011
9716349|NCT01070966|10815712|FG000|COMPLETED|Participants for Efficacy Evaluation||1929
9716350|NCT01070966|10815712|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82
9716351|NCT01070953|10815723|FG000|STARTED|Participants for Safety Evaluation||4467
9716352|NCT01070953|10815723|FG000|COMPLETED|Participants for Safety Evaluation||3536
9716353|NCT01070953|10815723|FG000|NOT COMPLETED|Participants for Safety Evaluation||931
9716354|NCT01070953|10815723|FG000|STARTED|Participants for Efficacy Evaluation||3536
9716355|NCT01070953|10815723|FG000|COMPLETED|Participants for Efficacy Evaluation||3309
9716356|NCT01070953|10815723|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227
9716357|NCT01030341|10815733|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
9716358|NCT01030341|10815733|FG000|COMPLETED|Overall Study|42 participants completed the study|42
9716359|NCT01030341|10815733|FG000|NOT COMPLETED|Overall Study||3
10061929|NCT02106403|11187427|FG002|STARTED|Visit 1, Treatment Period 1||9
10061930|NCT02106403|11187428|FG003|STARTED|Visit 1, Treatment Period 1||8
10061931|NCT02106403|11187429|FG004|STARTED|Visit 1, Treatment Period 1||8
10061932|NCT02106403|11187430|FG005|STARTED|Visit 1, Treatment Period 1||9
10061933|NCT02106403|11187425|FG000|COMPLETED|Visit 1, Treatment Period 1||8
10061934|NCT02106403|11187426|FG001|COMPLETED|Visit 1, Treatment Period 1||8
10061935|NCT02106403|11187427|FG002|COMPLETED|Visit 1, Treatment Period 1||9
10061936|NCT02106403|11187428|FG003|COMPLETED|Visit 1, Treatment Period 1||8
10061937|NCT02106403|11187429|FG004|COMPLETED|Visit 1, Treatment Period 1||8
10061938|NCT02106403|11187430|FG005|COMPLETED|Visit 1, Treatment Period 1||9
10061939|NCT02106403|11187425|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0
10061940|NCT02106403|11187426|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0
10188235|NCT03266172|11317910|FG001|STARTED|Part B: Period 2 (4 Days)||10
9716360|NCT00979901|10815741|FG000|STARTED|Overall Study||352
9716361|NCT00979901|10815742|FG001|STARTED|Overall Study||348
9716362|NCT00979901|10815743|FG002|STARTED|Overall Study||602
9716363|NCT00979901|10815744|FG003|STARTED|Overall Study||275
9716364|NCT00979901|10815741|FG000|COMPLETED|Overall Study||334
9716365|NCT00979901|10815742|FG001|COMPLETED|Overall Study||336
9716366|NCT00979901|10815743|FG002|COMPLETED|Overall Study||573
9716367|NCT00979901|10815744|FG003|COMPLETED|Overall Study||159
9716368|NCT00979901|10815741|FG000|NOT COMPLETED|Overall Study||18
9716369|NCT00979901|10815742|FG001|NOT COMPLETED|Overall Study||12
9716370|NCT00979901|10815743|FG002|NOT COMPLETED|Overall Study||29
9716371|NCT00979901|10815744|FG003|NOT COMPLETED|Overall Study||116
9716372|NCT00963599|10815757|FG000|STARTED|Overall Study||149
9716373|NCT00963599|10815758|FG001|STARTED|Overall Study||155
9716374|NCT00963599|10815759|FG002|STARTED|Overall Study||301
9716375|NCT00963599|10815760|FG003|STARTED|Overall Study||302
9716376|NCT00963599|10815757|FG000|COMPLETED|Overall Study||143
9716377|NCT00963599|10815758|FG001|COMPLETED|Overall Study||149
9716378|NCT00963599|10815759|FG002|COMPLETED|Overall Study||292
9716379|NCT00963599|10815760|FG003|COMPLETED|Overall Study||288
9716380|NCT00963599|10815757|FG000|NOT COMPLETED|Overall Study||6
9716381|NCT00963599|10815758|FG001|NOT COMPLETED|Overall Study||6
9716382|NCT00963599|10815759|FG002|NOT COMPLETED|Overall Study||9
9716383|NCT00963599|10815760|FG003|NOT COMPLETED|Overall Study||14
9716384|NCT00954915|10815770|FG000|STARTED|Overall Study||1
9716385|NCT00954915|10815770|FG000|COMPLETED|Overall Study||1
9716386|NCT00954915|10815770|FG000|NOT COMPLETED|Overall Study||0
9716387|NCT00953680|10815775|FG000|STARTED|Period 1||38
9716388|NCT00953680|10815776|FG001|STARTED|Period 1||39
9716389|NCT00953680|10815775|FG000|COMPLETED|Period 1||38
9716390|NCT00953680|10815776|FG001|COMPLETED|Period 1||38
9716391|NCT00953680|10815775|FG000|NOT COMPLETED|Period 1||0
9716392|NCT00953680|10815776|FG001|NOT COMPLETED|Period 1||1
9716393|NCT00953680|10815775|FG000|STARTED|Period 2||38
9716394|NCT00953680|10815776|FG001|STARTED|Period 2||38
9716395|NCT00953680|10815775|FG000|COMPLETED|Period 2||38
9716396|NCT00953680|10815776|FG001|COMPLETED|Period 2||38
9716397|NCT00953680|10815775|FG000|NOT COMPLETED|Period 2||0
9716398|NCT00953680|10815776|FG001|NOT COMPLETED|Period 2||0
9716399|NCT00945035|10815782|FG000|STARTED|Period 1||18
9716400|NCT00945035|10815783|FG001|STARTED|Period 1||18
9716401|NCT00945035|10815782|FG000|COMPLETED|Period 1||18
9716402|NCT00945035|10815783|FG001|COMPLETED|Period 1||18
9716403|NCT00945035|10815782|FG000|NOT COMPLETED|Period 1||0
9716404|NCT00945035|10815783|FG001|NOT COMPLETED|Period 1||0
9716405|NCT00945035|10815782|FG000|STARTED|Period 2||18
9716406|NCT00945035|10815783|FG001|STARTED|Period 2||18
9716407|NCT00945035|10815782|FG000|COMPLETED|Period 2||18
9716408|NCT00945035|10815783|FG001|COMPLETED|Period 2||18
9716409|NCT00945035|10815782|FG000|NOT COMPLETED|Period 2||0
9716410|NCT00945035|10815783|FG001|NOT COMPLETED|Period 2||0
9716411|NCT00943852|10815789|FG000|STARTED|First Period of Treatment Intervention||2
9716412|NCT00943852|10815790|FG001|STARTED|First Period of Treatment Intervention||1
9716413|NCT00943852|10815791|FG002|STARTED|First Period of Treatment Intervention||1
9716414|NCT00943852|10815792|FG003|STARTED|First Period of Treatment Intervention||2
9716415|NCT00943852|10815793|FG004|STARTED|First Period of Treatment Intervention||1
9716416|NCT00943852|10815794|FG005|STARTED|First Period of Treatment Intervention||1
9716417|NCT00943852|10815795|FG006|STARTED|First Period of Treatment Intervention||2
9716418|NCT00943852|10815796|FG007|STARTED|First Period of Treatment Intervention||1
9716419|NCT00943852|10815797|FG008|STARTED|First Period of Treatment Intervention||1
9716420|NCT00943852|10815798|FG009|STARTED|First Period of Treatment Intervention||1
9716421|NCT00943852|10815789|FG000|COMPLETED|First Period of Treatment Intervention||2
9716422|NCT00943852|10815790|FG001|COMPLETED|First Period of Treatment Intervention||1
9716423|NCT00943852|10815791|FG002|COMPLETED|First Period of Treatment Intervention||1
9716424|NCT00943852|10815792|FG003|COMPLETED|First Period of Treatment Intervention||2
9716425|NCT00943852|10815793|FG004|COMPLETED|First Period of Treatment Intervention||1
9716426|NCT00943852|10815794|FG005|COMPLETED|First Period of Treatment Intervention||1
9716427|NCT00943852|10815795|FG006|COMPLETED|First Period of Treatment Intervention||2
9716428|NCT00943852|10815796|FG007|COMPLETED|First Period of Treatment Intervention||1
9716429|NCT00943852|10815797|FG008|COMPLETED|First Period of Treatment Intervention||1
9716430|NCT00943852|10815798|FG009|COMPLETED|First Period of Treatment Intervention||1
9716431|NCT00943852|10815789|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
9716432|NCT00943852|10815790|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
9716433|NCT00943852|10815791|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
9716434|NCT00943852|10815792|FG003|NOT COMPLETED|First Period of Treatment Intervention||0
9716435|NCT00943852|10815793|FG004|NOT COMPLETED|First Period of Treatment Intervention||0
9716436|NCT00943852|10815794|FG005|NOT COMPLETED|First Period of Treatment Intervention||0
9716437|NCT00943852|10815795|FG006|NOT COMPLETED|First Period of Treatment Intervention||0
9716438|NCT00943852|10815796|FG007|NOT COMPLETED|First Period of Treatment Intervention||0
9716439|NCT00943852|10815797|FG008|NOT COMPLETED|First Period of Treatment Intervention||0
9716440|NCT00943852|10815798|FG009|NOT COMPLETED|First Period of Treatment Intervention||0
9716441|NCT00943852|10815789|FG000|STARTED|Washout Period After Period 1 Treatment||2
9716442|NCT00943852|10815790|FG001|STARTED|Washout Period After Period 1 Treatment||1
9716443|NCT00943852|10815791|FG002|STARTED|Washout Period After Period 1 Treatment||1
9716444|NCT00943852|10815792|FG003|STARTED|Washout Period After Period 1 Treatment||2
9849910|NCT00868231|10962735|FG005|NOT COMPLETED|Treatment Period 2||0
9716445|NCT00943852|10815793|FG004|STARTED|Washout Period After Period 1 Treatment||1
9716446|NCT00943852|10815794|FG005|STARTED|Washout Period After Period 1 Treatment||1
9716447|NCT00943852|10815795|FG006|STARTED|Washout Period After Period 1 Treatment||2
9716448|NCT00943852|10815796|FG007|STARTED|Washout Period After Period 1 Treatment||1
9716449|NCT00943852|10815797|FG008|STARTED|Washout Period After Period 1 Treatment||1
9716450|NCT00943852|10815798|FG009|STARTED|Washout Period After Period 1 Treatment||1
9716451|NCT00943852|10815789|FG000|COMPLETED|Washout Period After Period 1 Treatment||2
9716452|NCT00943852|10815790|FG001|COMPLETED|Washout Period After Period 1 Treatment||1
9716453|NCT00943852|10815791|FG002|COMPLETED|Washout Period After Period 1 Treatment||1
10061941|NCT02106403|11187427|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0
10061942|NCT02106403|11187428|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0
10061943|NCT02106403|11187429|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0
10061944|NCT02106403|11187430|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0
10061945|NCT02106403|11187425|FG000|STARTED|Visit 1, Treatment Period 2||8
10061946|NCT02106403|11187426|FG001|STARTED|Visit 1, Treatment Period 2||8
10061947|NCT02106403|11187427|FG002|STARTED|Visit 1, Treatment Period 2||9
10061948|NCT02106403|11187428|FG003|STARTED|Visit 1, Treatment Period 2||8
10061949|NCT02106403|11187429|FG004|STARTED|Visit 1, Treatment Period 2||8
10061950|NCT02106403|11187430|FG005|STARTED|Visit 1, Treatment Period 2||9
10061951|NCT02106403|11187425|FG000|COMPLETED|Visit 1, Treatment Period 2||8
10061952|NCT02106403|11187426|FG001|COMPLETED|Visit 1, Treatment Period 2||8
10061953|NCT02106403|11187427|FG002|COMPLETED|Visit 1, Treatment Period 2||9
10061954|NCT02106403|11187428|FG003|COMPLETED|Visit 1, Treatment Period 2||8
10061955|NCT02106403|11187429|FG004|COMPLETED|Visit 1, Treatment Period 2||8
10061956|NCT02106403|11187430|FG005|COMPLETED|Visit 1, Treatment Period 2||9
10061957|NCT02106403|11187425|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0
10061958|NCT02106403|11187426|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0
10061959|NCT02106403|11187427|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0
10061960|NCT02106403|11187428|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0
10061961|NCT02106403|11187429|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0
10061962|NCT02106403|11187430|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0
10061963|NCT02106403|11187425|FG000|STARTED|Visit 1, Treatment Period 3||8
10061964|NCT02106403|11187426|FG001|STARTED|Visit 1, Treatment Period 3||8
10061965|NCT02106403|11187427|FG002|STARTED|Visit 1, Treatment Period 3||9
10061966|NCT02106403|11187428|FG003|STARTED|Visit 1, Treatment Period 3||8
10061967|NCT02106403|11187429|FG004|STARTED|Visit 1, Treatment Period 3||8
10061968|NCT02106403|11187430|FG005|STARTED|Visit 1, Treatment Period 3||9
10061969|NCT02106403|11187425|FG000|COMPLETED|Visit 1, Treatment Period 3||8
10061970|NCT02106403|11187426|FG001|COMPLETED|Visit 1, Treatment Period 3||8
10061971|NCT02106403|11187427|FG002|COMPLETED|Visit 1, Treatment Period 3||9
10061972|NCT02106403|11187428|FG003|COMPLETED|Visit 1, Treatment Period 3||8
10061973|NCT02106403|11187429|FG004|COMPLETED|Visit 1, Treatment Period 3||8
10061974|NCT02106403|11187430|FG005|COMPLETED|Visit 1, Treatment Period 3||9
10061975|NCT02106403|11187425|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0
10061976|NCT02106403|11187426|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0
10061977|NCT02106403|11187427|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0
10061978|NCT02106403|11187428|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0
10061979|NCT02106403|11187429|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0
10061980|NCT02106403|11187430|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0
10061981|NCT02106403|11187425|FG000|STARTED|Follow-Up Visit 2||8
10061982|NCT02106403|11187426|FG001|STARTED|Follow-Up Visit 2||8
10061983|NCT02106403|11187427|FG002|STARTED|Follow-Up Visit 2||9
10061984|NCT02106403|11187428|FG003|STARTED|Follow-Up Visit 2||8
10061985|NCT02106403|11187429|FG004|STARTED|Follow-Up Visit 2||8
10061986|NCT02106403|11187430|FG005|STARTED|Follow-Up Visit 2||9
10061987|NCT02106403|11187425|FG000|COMPLETED|Follow-Up Visit 2||8
10061988|NCT02106403|11187426|FG001|COMPLETED|Follow-Up Visit 2||8
10188236|NCT03266172|11317911|FG002|STARTED|Part B: Period 2 (4 Days)||0
10188237|NCT03266172|11317909|FG000|COMPLETED|Part B: Period 2 (4 Days)||0
10188238|NCT03266172|11317910|FG001|COMPLETED|Part B: Period 2 (4 Days)||10
10188239|NCT03266172|11317911|FG002|COMPLETED|Part B: Period 2 (4 Days)||0
10188240|NCT03266172|11317909|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0
10188241|NCT03266172|11317910|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0
10188242|NCT03266172|11317911|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0
10188243|NCT03266172|11317909|FG000|STARTED|Part B: Washout (7 Days)||0
10188244|NCT03266172|11317910|FG001|STARTED|Part B: Washout (7 Days)||10
10188245|NCT03266172|11317911|FG002|STARTED|Part B: Washout (7 Days)||0
10188246|NCT03266172|11317909|FG000|COMPLETED|Part B: Washout (7 Days)||0
10188247|NCT03266172|11317910|FG001|COMPLETED|Part B: Washout (7 Days)||8
10188248|NCT03266172|11317911|FG002|COMPLETED|Part B: Washout (7 Days)||0
10188249|NCT03266172|11317909|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
10188250|NCT03266172|11317910|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2
10188251|NCT03266172|11317911|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
10188252|NCT03266172|11317909|FG000|STARTED|Part B: Period 3 (4 Days)||0
10188253|NCT03266172|11317910|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
10188254|NCT03266172|11317911|FG002|STARTED|Part B: Period 3 (4 Days)||0
10188255|NCT03266172|11317909|FG000|COMPLETED|Part B: Period 3 (4 Days)||0
10188256|NCT03266172|11317910|FG001|COMPLETED|Part B: Period 3 (4 Days)||6
10188257|NCT03266172|11317911|FG002|COMPLETED|Part B: Period 3 (4 Days)||0
10188258|NCT03266172|11317909|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0
9716454|NCT00943852|10815792|FG003|COMPLETED|Washout Period After Period 1 Treatment||1
9716455|NCT00943852|10815793|FG004|COMPLETED|Washout Period After Period 1 Treatment||1
9716456|NCT00943852|10815794|FG005|COMPLETED|Washout Period After Period 1 Treatment||1
9716457|NCT00943852|10815795|FG006|COMPLETED|Washout Period After Period 1 Treatment||2
9716458|NCT00943852|10815796|FG007|COMPLETED|Washout Period After Period 1 Treatment||1
9716459|NCT00943852|10815797|FG008|COMPLETED|Washout Period After Period 1 Treatment||1
9716460|NCT00943852|10815798|FG009|COMPLETED|Washout Period After Period 1 Treatment||1
9716461|NCT00943852|10815789|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716462|NCT00943852|10815790|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716463|NCT00943852|10815791|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716464|NCT00943852|10815792|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1
9716465|NCT00943852|10815793|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716466|NCT00943852|10815794|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716467|NCT00943852|10815795|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716468|NCT00943852|10815796|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716469|NCT00943852|10815797|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716470|NCT00943852|10815798|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0
9716471|NCT00943852|10815789|FG000|STARTED|Second Period of Treatment Intervention||2
9716472|NCT00943852|10815790|FG001|STARTED|Second Period of Treatment Intervention||1
9716473|NCT00943852|10815791|FG002|STARTED|Second Period of Treatment Intervention||1
9716474|NCT00943852|10815792|FG003|STARTED|Second Period of Treatment Intervention||1
9716475|NCT00943852|10815793|FG004|STARTED|Second Period of Treatment Intervention||1
9716476|NCT00943852|10815794|FG005|STARTED|Second Period of Treatment Intervention||1
9716477|NCT00943852|10815795|FG006|STARTED|Second Period of Treatment Intervention||2
9716478|NCT00943852|10815796|FG007|STARTED|Second Period of Treatment Intervention||1
9716479|NCT00943852|10815797|FG008|STARTED|Second Period of Treatment Intervention||1
9716480|NCT00943852|10815798|FG009|STARTED|Second Period of Treatment Intervention||1
9716481|NCT00943852|10815789|FG000|COMPLETED|Second Period of Treatment Intervention||2
9716482|NCT00943852|10815790|FG001|COMPLETED|Second Period of Treatment Intervention||1
9716483|NCT00943852|10815791|FG002|COMPLETED|Second Period of Treatment Intervention||1
9716484|NCT00943852|10815792|FG003|COMPLETED|Second Period of Treatment Intervention||1
9716485|NCT00943852|10815793|FG004|COMPLETED|Second Period of Treatment Intervention||1
9716486|NCT00943852|10815794|FG005|COMPLETED|Second Period of Treatment Intervention||1
9716487|NCT00943852|10815795|FG006|COMPLETED|Second Period of Treatment Intervention||2
9716488|NCT00943852|10815796|FG007|COMPLETED|Second Period of Treatment Intervention||1
9716489|NCT00943852|10815797|FG008|COMPLETED|Second Period of Treatment Intervention||1
9716490|NCT00943852|10815798|FG009|COMPLETED|Second Period of Treatment Intervention||1
9716491|NCT00943852|10815789|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
9716492|NCT00943852|10815790|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
9716493|NCT00943852|10815791|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
9716494|NCT00943852|10815792|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0
9716495|NCT00943852|10815793|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0
9716496|NCT00943852|10815794|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0
9716497|NCT00943852|10815795|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0
9716498|NCT00943852|10815796|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0
9716499|NCT00943852|10815797|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0
9716500|NCT00943852|10815798|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0
9716501|NCT00943852|10815789|FG000|STARTED|Washout Period After Period 2 Treatment||2
9716502|NCT00943852|10815790|FG001|STARTED|Washout Period After Period 2 Treatment||1
9716503|NCT00943852|10815791|FG002|STARTED|Washout Period After Period 2 Treatment||1
9716504|NCT00943852|10815792|FG003|STARTED|Washout Period After Period 2 Treatment||1
9716505|NCT00943852|10815793|FG004|STARTED|Washout Period After Period 2 Treatment||1
9716506|NCT00943852|10815794|FG005|STARTED|Washout Period After Period 2 Treatment||1
9716507|NCT00943852|10815795|FG006|STARTED|Washout Period After Period 2 Treatment||2
9716508|NCT00943852|10815796|FG007|STARTED|Washout Period After Period 2 Treatment||1
9716509|NCT00943852|10815797|FG008|STARTED|Washout Period After Period 2 Treatment||1
9716510|NCT00943852|10815798|FG009|STARTED|Washout Period After Period 2 Treatment||1
9716511|NCT00943852|10815789|FG000|COMPLETED|Washout Period After Period 2 Treatment||2
9716512|NCT00943852|10815790|FG001|COMPLETED|Washout Period After Period 2 Treatment||1
9716513|NCT00943852|10815791|FG002|COMPLETED|Washout Period After Period 2 Treatment||1
9716514|NCT00943852|10815792|FG003|COMPLETED|Washout Period After Period 2 Treatment||1
9716515|NCT00943852|10815793|FG004|COMPLETED|Washout Period After Period 2 Treatment||1
9716516|NCT00943852|10815794|FG005|COMPLETED|Washout Period After Period 2 Treatment||0
9716517|NCT00943852|10815795|FG006|COMPLETED|Washout Period After Period 2 Treatment||2
9716518|NCT00943852|10815796|FG007|COMPLETED|Washout Period After Period 2 Treatment||1
9716519|NCT00943852|10815797|FG008|COMPLETED|Washout Period After Period 2 Treatment||1
9716520|NCT00943852|10815798|FG009|COMPLETED|Washout Period After Period 2 Treatment||1
9716521|NCT00943852|10815789|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716522|NCT00943852|10815790|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716523|NCT00943852|10815791|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716524|NCT00943852|10815792|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716525|NCT00943852|10815793|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716526|NCT00943852|10815794|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1
9716527|NCT00943852|10815795|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716528|NCT00943852|10815796|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716529|NCT00943852|10815797|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716530|NCT00943852|10815798|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0
9716531|NCT00943852|10815789|FG000|STARTED|Third Period of Treatment Intervention||2
9716532|NCT00943852|10815790|FG001|STARTED|Third Period of Treatment Intervention||1
9716533|NCT00943852|10815791|FG002|STARTED|Third Period of Treatment Intervention||1
9716534|NCT00943852|10815792|FG003|STARTED|Third Period of Treatment Intervention||1
9716535|NCT00943852|10815793|FG004|STARTED|Third Period of Treatment Intervention||1
9716536|NCT00943852|10815794|FG005|STARTED|Third Period of Treatment Intervention||0
9716537|NCT00943852|10815795|FG006|STARTED|Third Period of Treatment Intervention||2
9716538|NCT00943852|10815796|FG007|STARTED|Third Period of Treatment Intervention||1
9716539|NCT00943852|10815797|FG008|STARTED|Third Period of Treatment Intervention||1
9716540|NCT00943852|10815798|FG009|STARTED|Third Period of Treatment Intervention||1
9716541|NCT00943852|10815789|FG000|COMPLETED|Third Period of Treatment Intervention||2
9716542|NCT00943852|10815790|FG001|COMPLETED|Third Period of Treatment Intervention||1
9716543|NCT00943852|10815791|FG002|COMPLETED|Third Period of Treatment Intervention||1
9716544|NCT00943852|10815792|FG003|COMPLETED|Third Period of Treatment Intervention||1
9716545|NCT00943852|10815793|FG004|COMPLETED|Third Period of Treatment Intervention||1
9716546|NCT00943852|10815794|FG005|COMPLETED|Third Period of Treatment Intervention||0
9716547|NCT00943852|10815795|FG006|COMPLETED|Third Period of Treatment Intervention||2
9716548|NCT00943852|10815796|FG007|COMPLETED|Third Period of Treatment Intervention||1
9716549|NCT00943852|10815797|FG008|COMPLETED|Third Period of Treatment Intervention||1
9716550|NCT00943852|10815798|FG009|COMPLETED|Third Period of Treatment Intervention||1
9716551|NCT00943852|10815789|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
9716552|NCT00943852|10815790|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
9716553|NCT00943852|10815791|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
9716554|NCT00943852|10815792|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0
9716555|NCT00943852|10815793|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0
9716556|NCT00943852|10815794|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0
9716557|NCT00943852|10815795|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0
9716558|NCT00943852|10815796|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0
9716559|NCT00943852|10815797|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0
9716560|NCT00943852|10815798|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0
9716561|NCT00943852|10815789|FG000|STARTED|Washout Period After Period 3 Treatment||2
9716562|NCT00943852|10815790|FG001|STARTED|Washout Period After Period 3 Treatment||1
9716563|NCT00943852|10815791|FG002|STARTED|Washout Period After Period 3 Treatment||1
9716564|NCT00943852|10815792|FG003|STARTED|Washout Period After Period 3 Treatment||1
9716565|NCT00943852|10815793|FG004|STARTED|Washout Period After Period 3 Treatment||1
9716566|NCT00943852|10815794|FG005|STARTED|Washout Period After Period 3 Treatment||0
9716567|NCT00943852|10815795|FG006|STARTED|Washout Period After Period 3 Treatment||2
9716568|NCT00943852|10815796|FG007|STARTED|Washout Period After Period 3 Treatment||1
9716569|NCT00943852|10815797|FG008|STARTED|Washout Period After Period 3 Treatment||1
9716570|NCT00943852|10815798|FG009|STARTED|Washout Period After Period 3 Treatment||1
9716571|NCT00943852|10815789|FG000|COMPLETED|Washout Period After Period 3 Treatment||2
9716572|NCT00943852|10815790|FG001|COMPLETED|Washout Period After Period 3 Treatment||1
9716573|NCT00943852|10815791|FG002|COMPLETED|Washout Period After Period 3 Treatment||1
9716574|NCT00943852|10815792|FG003|COMPLETED|Washout Period After Period 3 Treatment||1
9716575|NCT00943852|10815793|FG004|COMPLETED|Washout Period After Period 3 Treatment||1
9716576|NCT00943852|10815794|FG005|COMPLETED|Washout Period After Period 3 Treatment||0
9716577|NCT00943852|10815795|FG006|COMPLETED|Washout Period After Period 3 Treatment||1
9716578|NCT00943852|10815796|FG007|COMPLETED|Washout Period After Period 3 Treatment||1
9716579|NCT00943852|10815797|FG008|COMPLETED|Washout Period After Period 3 Treatment||1
9716580|NCT00943852|10815798|FG009|COMPLETED|Washout Period After Period 3 Treatment||1
9716581|NCT00943852|10815789|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716582|NCT00943852|10815790|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716583|NCT00943852|10815791|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716584|NCT00943852|10815792|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716585|NCT00943852|10815793|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716586|NCT00943852|10815794|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716587|NCT00943852|10815795|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1
9716588|NCT00943852|10815796|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716589|NCT00943852|10815797|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716590|NCT00943852|10815798|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0
9716591|NCT00943852|10815789|FG000|STARTED|Fourth Period of Treatment Intervention||2
9716592|NCT00943852|10815790|FG001|STARTED|Fourth Period of Treatment Intervention||1
9716593|NCT00943852|10815791|FG002|STARTED|Fourth Period of Treatment Intervention||1
9716594|NCT00943852|10815792|FG003|STARTED|Fourth Period of Treatment Intervention||1
9716595|NCT00943852|10815793|FG004|STARTED|Fourth Period of Treatment Intervention||1
9716596|NCT00943852|10815794|FG005|STARTED|Fourth Period of Treatment Intervention||0
9716597|NCT00943852|10815795|FG006|STARTED|Fourth Period of Treatment Intervention||1
9716598|NCT00943852|10815796|FG007|STARTED|Fourth Period of Treatment Intervention||1
9716599|NCT00943852|10815797|FG008|STARTED|Fourth Period of Treatment Intervention||1
9716600|NCT00943852|10815798|FG009|STARTED|Fourth Period of Treatment Intervention||1
9716601|NCT00943852|10815789|FG000|COMPLETED|Fourth Period of Treatment Intervention||2
9716602|NCT00943852|10815790|FG001|COMPLETED|Fourth Period of Treatment Intervention||1
9716603|NCT00943852|10815791|FG002|COMPLETED|Fourth Period of Treatment Intervention||1
9849911|NCT00868231|10962730|FG000|STARTED|Treatment Period 3||4
9849912|NCT00868231|10962731|FG001|STARTED|Treatment Period 3||5
9849913|NCT00868231|10962732|FG002|STARTED|Treatment Period 3||5
9849914|NCT00868231|10962733|FG003|STARTED|Treatment Period 3||5
9849915|NCT00868231|10962734|FG004|STARTED|Treatment Period 3||4
9849916|NCT00868231|10962735|FG005|STARTED|Treatment Period 3||5
9849917|NCT00868231|10962730|FG000|COMPLETED|Treatment Period 3||4
9849918|NCT00868231|10962731|FG001|COMPLETED|Treatment Period 3||5
9849919|NCT00868231|10962732|FG002|COMPLETED|Treatment Period 3||4
9849920|NCT00868231|10962733|FG003|COMPLETED|Treatment Period 3||5
9849921|NCT00868231|10962734|FG004|COMPLETED|Treatment Period 3||4
9849922|NCT00868231|10962735|FG005|COMPLETED|Treatment Period 3||5
9849923|NCT00868231|10962730|FG000|NOT COMPLETED|Treatment Period 3||0
9849924|NCT00868231|10962731|FG001|NOT COMPLETED|Treatment Period 3||0
9849925|NCT00868231|10962732|FG002|NOT COMPLETED|Treatment Period 3||1
9849926|NCT00868231|10962733|FG003|NOT COMPLETED|Treatment Period 3||0
9849927|NCT00868231|10962734|FG004|NOT COMPLETED|Treatment Period 3||0
9849928|NCT00868231|10962735|FG005|NOT COMPLETED|Treatment Period 3||0
9849929|NCT00868296|10962745|FG000|STARTED|Overall Study||12
9849930|NCT00868296|10962746|FG001|STARTED|Overall Study||46
9849931|NCT00868296|10962745|FG000|COMPLETED|Overall Study||12
9849932|NCT00868296|10962746|FG001|COMPLETED|Overall Study||43
9849933|NCT00868296|10962745|FG000|NOT COMPLETED|Overall Study||0
9849934|NCT00868296|10962746|FG001|NOT COMPLETED|Overall Study||3
9849935|NCT00868309|10962754|FG000|STARTED|Overall Study||6
9849936|NCT00868309|10962755|FG001|STARTED|Overall Study||6
9849937|NCT00868309|10962754|FG000|COMPLETED|Overall Study||6
9849938|NCT00868309|10962755|FG001|COMPLETED|Overall Study||6
9849939|NCT00868309|10962754|FG000|NOT COMPLETED|Overall Study||0
9849940|NCT00868309|10962755|FG001|NOT COMPLETED|Overall Study||0
9849941|NCT00868348|10962763|FG000|STARTED|Overall Study||30
9849942|NCT00868348|10962764|FG001|STARTED|Overall Study||30
9849943|NCT00868348|10962763|FG000|COMPLETED|Overall Study||30
9849944|NCT00868348|10962764|FG001|COMPLETED|Overall Study||30
9849945|NCT00868348|10962763|FG000|NOT COMPLETED|Overall Study||0
9849946|NCT00868348|10962764|FG001|NOT COMPLETED|Overall Study||0
9849947|NCT00868374|10962772|FG000|STARTED|Overall Study||12
9849948|NCT00868374|10962773|FG001|STARTED|Overall Study||11
9849949|NCT00868374|10962772|FG000|COMPLETED|Overall Study||5
9849950|NCT00868374|10962773|FG001|COMPLETED|Overall Study||4
9849951|NCT00868374|10962772|FG000|NOT COMPLETED|Overall Study||7
9849952|NCT00868374|10962773|FG001|NOT COMPLETED|Overall Study||7
9849953|NCT00868439|10962781|FG000|STARTED|Overall Study||56
9849954|NCT00868439|10962782|FG001|STARTED|Overall Study||49
9849955|NCT00868439|10962781|FG000|COMPLETED|Overall Study||48
9849956|NCT00868439|10962782|FG001|COMPLETED|Overall Study||40
9849957|NCT00868439|10962781|FG000|NOT COMPLETED|Overall Study||8
9849958|NCT00868439|10962782|FG001|NOT COMPLETED|Overall Study||9
9849959|NCT00868452|10962790|FG000|STARTED|Overall Study||183
9849960|NCT00868452|10962791|FG001|STARTED|Overall Study||165
9849961|NCT00868452|10962790|FG000|COMPLETED|Overall Study||143
9849962|NCT00868452|10962791|FG001|COMPLETED|Overall Study||136
9849963|NCT00868452|10962790|FG000|NOT COMPLETED|Overall Study||40
9849964|NCT00868452|10962791|FG001|NOT COMPLETED|Overall Study||29
9849965|NCT00868517|10962801|FG000|STARTED|Overall Study||12
9849966|NCT00868517|10962802|FG001|STARTED|Overall Study||12
9849967|NCT00868517|10962803|FG002|STARTED|Overall Study||11
9849968|NCT00868517|10962801|FG000|COMPLETED|Overall Study||8
9849969|NCT00868517|10962802|FG001|COMPLETED|Overall Study||8
9849970|NCT00868517|10962803|FG002|COMPLETED|Overall Study||9
9849971|NCT00868517|10962801|FG000|NOT COMPLETED|Overall Study||4
9849972|NCT00868517|10962802|FG001|NOT COMPLETED|Overall Study||4
9849973|NCT00868517|10962803|FG002|NOT COMPLETED|Overall Study||2
9849974|NCT00868530|10962811|FG000|STARTED|Overall Study||53
9849975|NCT00868530|10962811|FG000|COMPLETED|Overall Study||49
9849976|NCT00868530|10962811|FG000|NOT COMPLETED|Overall Study||4
9849977|NCT00868608|10962818|FG000|STARTED|Overall Study||72
9849978|NCT00868608|10962819|FG001|STARTED|Overall Study||4
9849979|NCT00868608|10962820|FG002|STARTED|Overall Study||5
9849980|NCT00868608|10962818|FG000|COMPLETED|Overall Study||49
9849981|NCT00868608|10962819|FG001|COMPLETED|Overall Study||1
9849982|NCT00868608|10962820|FG002|COMPLETED|Overall Study||0
9849983|NCT00868608|10962818|FG000|NOT COMPLETED|Overall Study||23
9849984|NCT00868608|10962819|FG001|NOT COMPLETED|Overall Study||3
9849985|NCT00868608|10962820|FG002|NOT COMPLETED|Overall Study||5
9849986|NCT00868699|10962831|FG000|STARTED|Overall Study||170
9849987|NCT00868699|10962832|FG001|STARTED|Overall Study||169
9849988|NCT00868699|10962833|FG002|STARTED|Overall Study||166
9849989|NCT00868699|10962831|FG000|Intent-to-Treat Population|Overall Study||162
9849990|NCT00868699|10962832|FG001|Intent-to-Treat Population|Overall Study||162
9849991|NCT00868699|10962833|FG002|Intent-to-Treat Population|Overall Study||161
9849992|NCT00868699|10962831|FG000|Safety Population|Overall Study||168
9849993|NCT00868699|10962832|FG001|Safety Population|Overall Study||167
9716604|NCT00943852|10815792|FG003|COMPLETED|Fourth Period of Treatment Intervention||1
9716605|NCT00943852|10815793|FG004|COMPLETED|Fourth Period of Treatment Intervention||1
9716606|NCT00943852|10815794|FG005|COMPLETED|Fourth Period of Treatment Intervention||0
9716607|NCT00943852|10815795|FG006|COMPLETED|Fourth Period of Treatment Intervention||1
9716608|NCT00943852|10815796|FG007|COMPLETED|Fourth Period of Treatment Intervention||1
9716609|NCT00943852|10815797|FG008|COMPLETED|Fourth Period of Treatment Intervention||1
9716610|NCT00943852|10815798|FG009|COMPLETED|Fourth Period of Treatment Intervention||1
9716611|NCT00943852|10815789|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716612|NCT00943852|10815790|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716613|NCT00943852|10815791|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716614|NCT00943852|10815792|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716615|NCT00943852|10815793|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716616|NCT00943852|10815794|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716617|NCT00943852|10815795|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716618|NCT00943852|10815796|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716619|NCT00943852|10815797|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716620|NCT00943852|10815798|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0
9716621|NCT00943852|10815789|FG000|STARTED|Washout Period After Period 4 Treatment||2
9716622|NCT00943852|10815790|FG001|STARTED|Washout Period After Period 4 Treatment||1
9716623|NCT00943852|10815791|FG002|STARTED|Washout Period After Period 4 Treatment||1
9716624|NCT00943852|10815792|FG003|STARTED|Washout Period After Period 4 Treatment||1
9716625|NCT00943852|10815793|FG004|STARTED|Washout Period After Period 4 Treatment||1
9716626|NCT00943852|10815794|FG005|STARTED|Washout Period After Period 4 Treatment||0
9716627|NCT00943852|10815795|FG006|STARTED|Washout Period After Period 4 Treatment||1
9716628|NCT00943852|10815796|FG007|STARTED|Washout Period After Period 4 Treatment||1
9716629|NCT00943852|10815797|FG008|STARTED|Washout Period After Period 4 Treatment||1
9716630|NCT00943852|10815798|FG009|STARTED|Washout Period After Period 4 Treatment||1
9716631|NCT00943852|10815789|FG000|COMPLETED|Washout Period After Period 4 Treatment||1
9716632|NCT00943852|10815790|FG001|COMPLETED|Washout Period After Period 4 Treatment||1
9716633|NCT00943852|10815791|FG002|COMPLETED|Washout Period After Period 4 Treatment||0
9849994|NCT00868699|10962833|FG002|Safety Population|Overall Study||164
9849995|NCT00868699|10962831|FG000|COMPLETED|Overall Study||127
9849996|NCT00868699|10962832|FG001|COMPLETED|Overall Study||124
9849997|NCT00868699|10962833|FG002|COMPLETED|Overall Study||123
9849998|NCT00868699|10962831|FG000|NOT COMPLETED|Overall Study||43
9849999|NCT00868699|10962832|FG001|NOT COMPLETED|Overall Study||45
9850000|NCT00868699|10962833|FG002|NOT COMPLETED|Overall Study||43
9850001|NCT00868712|10962844|FG000|STARTED|Overall Study||31
9850002|NCT00868712|10962845|FG001|STARTED|Overall Study||11
9850003|NCT00868712|10962846|FG002|STARTED|Overall Study||28
9850004|NCT00868712|10962844|FG000|COMPLETED|Overall Study||31
9850005|NCT00868712|10962845|FG001|COMPLETED|Overall Study||11
9850006|NCT00868712|10962846|FG002|COMPLETED|Overall Study||28
9850007|NCT00868712|10962844|FG000|NOT COMPLETED|Overall Study||0
9850008|NCT00868712|10962845|FG001|NOT COMPLETED|Overall Study||0
9850009|NCT00868712|10962846|FG002|NOT COMPLETED|Overall Study||0
9850010|NCT00868751|10962854|FG000|STARTED|Overall Study||1
9850011|NCT00868751|10962854|FG000|COMPLETED|Overall Study||0
9850012|NCT00868751|10962854|FG000|NOT COMPLETED|Overall Study||1
9850013|NCT00868790|10962858|FG000|STARTED|Period 1||11
9850014|NCT00868790|10962859|FG001|STARTED|Period 1||8
9850015|NCT00868790|10962860|FG002|STARTED|Period 1||4
9850016|NCT00868790|10962861|FG003|STARTED|Period 1||4
9850017|NCT00868790|10962862|FG004|STARTED|Period 1||19
9850018|NCT00868790|10962863|FG005|STARTED|Period 1||3
9850019|NCT00868790|10962864|FG006|STARTED|Period 1||4
9850020|NCT00868790|10962865|FG007|STARTED|Period 1||20
9850021|NCT00868790|10962866|FG008|STARTED|Period 1||11
9850022|NCT00868790|10962867|FG009|STARTED|Period 1||3
9850023|NCT00868790|10962868|FG010|STARTED|Period 1||9
9850024|NCT00868790|10962869|FG011|STARTED|Period 1||4
9850025|NCT00868790|10962870|FG012|STARTED|Period 1||7
9850026|NCT00868790|10962871|FG013|STARTED|Period 1||11
9850027|NCT00868790|10962858|FG000|COMPLETED|Period 1||9
9850028|NCT00868790|10962859|FG001|COMPLETED|Period 1||7
9850029|NCT00868790|10962860|FG002|COMPLETED|Period 1||4
9850030|NCT00868790|10962861|FG003|COMPLETED|Period 1||4
9716634|NCT00943852|10815792|FG003|COMPLETED|Washout Period After Period 4 Treatment||0
9716635|NCT00943852|10815793|FG004|COMPLETED|Washout Period After Period 4 Treatment||1
9716636|NCT00943852|10815794|FG005|COMPLETED|Washout Period After Period 4 Treatment||0
9716637|NCT00943852|10815795|FG006|COMPLETED|Washout Period After Period 4 Treatment||0
9716638|NCT00943852|10815796|FG007|COMPLETED|Washout Period After Period 4 Treatment||0
9716639|NCT00943852|10815797|FG008|COMPLETED|Washout Period After Period 4 Treatment||1
9716640|NCT00943852|10815798|FG009|COMPLETED|Washout Period After Period 4 Treatment||1
9716641|NCT00943852|10815789|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1
9716642|NCT00943852|10815790|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0
9716643|NCT00943852|10815791|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1
9716644|NCT00943852|10815792|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1
9716645|NCT00943852|10815793|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0
9716646|NCT00943852|10815794|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0
9716647|NCT00943852|10815795|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1
9716648|NCT00943852|10815796|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1
9716649|NCT00943852|10815797|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0
9716650|NCT00943852|10815798|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0
9716651|NCT00943852|10815789|FG000|STARTED|Fifth Period of Treatment Intervention||1
9716652|NCT00943852|10815790|FG001|STARTED|Fifth Period of Treatment Intervention||1
9716653|NCT00943852|10815791|FG002|STARTED|Fifth Period of Treatment Intervention||0
9716654|NCT00943852|10815792|FG003|STARTED|Fifth Period of Treatment Intervention||0
9716655|NCT00943852|10815793|FG004|STARTED|Fifth Period of Treatment Intervention||1
9716656|NCT00943852|10815794|FG005|STARTED|Fifth Period of Treatment Intervention||0
9716657|NCT00943852|10815795|FG006|STARTED|Fifth Period of Treatment Intervention||0
9716658|NCT00943852|10815796|FG007|STARTED|Fifth Period of Treatment Intervention||0
9716659|NCT00943852|10815797|FG008|STARTED|Fifth Period of Treatment Intervention||1
9716660|NCT00943852|10815798|FG009|STARTED|Fifth Period of Treatment Intervention||1
9716661|NCT00943852|10815789|FG000|COMPLETED|Fifth Period of Treatment Intervention||1
9716662|NCT00943852|10815790|FG001|COMPLETED|Fifth Period of Treatment Intervention||1
9716663|NCT00943852|10815791|FG002|COMPLETED|Fifth Period of Treatment Intervention||0
9716664|NCT00943852|10815792|FG003|COMPLETED|Fifth Period of Treatment Intervention||0
9716665|NCT00943852|10815793|FG004|COMPLETED|Fifth Period of Treatment Intervention||1
9716666|NCT00943852|10815794|FG005|COMPLETED|Fifth Period of Treatment Intervention||0
9716667|NCT00943852|10815795|FG006|COMPLETED|Fifth Period of Treatment Intervention||0
9716668|NCT00943852|10815796|FG007|COMPLETED|Fifth Period of Treatment Intervention||0
9716669|NCT00943852|10815797|FG008|COMPLETED|Fifth Period of Treatment Intervention||1
9716670|NCT00943852|10815798|FG009|COMPLETED|Fifth Period of Treatment Intervention||1
9716671|NCT00943852|10815789|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716672|NCT00943852|10815790|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716673|NCT00943852|10815791|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716674|NCT00943852|10815792|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716675|NCT00943852|10815793|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716676|NCT00943852|10815794|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716677|NCT00943852|10815795|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716678|NCT00943852|10815796|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716679|NCT00943852|10815797|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716680|NCT00943852|10815798|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0
9716681|NCT00927953|10815810|FG000|STARTED|Overall Study||6
9716682|NCT00927953|10815811|FG001|STARTED|Overall Study||7
9716683|NCT00927953|10815810|FG000|COMPLETED|Overall Study||4
9716684|NCT00927953|10815811|FG001|COMPLETED|Overall Study||6
9716685|NCT00927953|10815810|FG000|NOT COMPLETED|Overall Study||2
9716686|NCT00927953|10815811|FG001|NOT COMPLETED|Overall Study||1
9716687|NCT00909389|10815818|FG000|STARTED|Overall Study||4748
9716688|NCT00909389|10815818|FG000|COMPLETED|Overall Study||4615
9716689|NCT00909389|10815818|FG000|NOT COMPLETED|Overall Study||133
9716690|NCT00820027|10815826|FG000|STARTED|Overall Study||224
9716691|NCT00820027|10815827|FG001|STARTED|Overall Study||230
9716692|NCT00820027|10815828|FG002|STARTED|Overall Study||224
9716693|NCT00820027|10815829|FG003|STARTED|Overall Study||98
9716694|NCT00820027|10815826|FG000|COMPLETED|Overall Study||198
9716695|NCT00820027|10815827|FG001|COMPLETED|Overall Study||216
9716696|NCT00820027|10815828|FG002|COMPLETED|Overall Study||203
9716697|NCT00820027|10815829|FG003|COMPLETED|Overall Study||85
9716698|NCT00820027|10815826|FG000|NOT COMPLETED|Overall Study||26
9716699|NCT00820027|10815827|FG001|NOT COMPLETED|Overall Study||14
9716700|NCT00820027|10815828|FG002|NOT COMPLETED|Overall Study||21
9716701|NCT00820027|10815829|FG003|NOT COMPLETED|Overall Study||13
9731461|NCT00132730|10831390|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148
9731462|NCT00132730|10831391|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153
9731463|NCT00132730|10831392|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153
9731464|NCT00132730|10831393|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0
9731465|NCT00132730|10831394|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0
9731466|NCT00132730|10831389|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
9731467|NCT00132730|10831390|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
9731468|NCT00132730|10831391|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
9850031|NCT00868790|10962862|FG004|COMPLETED|Period 1||18
9850032|NCT00868790|10962863|FG005|COMPLETED|Period 1||2
9716702|NCT00788710|10815843|FG000|STARTED|Overall Study||144
9716703|NCT00788710|10815844|FG001|STARTED|Overall Study||142
9716704|NCT00788710|10815845|FG002|STARTED|Overall Study||144
9716705|NCT00788710|10815843|FG000|COMPLETED|Overall Study||139
9716706|NCT00788710|10815844|FG001|COMPLETED|Overall Study||134
9716707|NCT00788710|10815845|FG002|COMPLETED|Overall Study||138
9716708|NCT00788710|10815843|FG000|NOT COMPLETED|Overall Study||5
9716709|NCT00788710|10815844|FG001|NOT COMPLETED|Overall Study||8
9716710|NCT00788710|10815845|FG002|NOT COMPLETED|Overall Study||6
9716711|NCT00783224|10815857|FG000|STARTED|Overall Study||32
9716712|NCT00783224|10815858|FG001|STARTED|Overall Study||34
9716713|NCT00783224|10815859|FG002|STARTED|Overall Study||143
9716714|NCT00783224|10815860|FG003|STARTED|Overall Study||142
9716715|NCT00783224|10815857|FG000|COMPLETED|Overall Study||32
9716716|NCT00783224|10815858|FG001|COMPLETED|Overall Study||34
9716717|NCT00783224|10815859|FG002|COMPLETED|Overall Study||142
9716718|NCT00783224|10815860|FG003|COMPLETED|Overall Study||140
9716719|NCT00783224|10815857|FG000|NOT COMPLETED|Overall Study||0
9716720|NCT00783224|10815858|FG001|NOT COMPLETED|Overall Study||0
9716721|NCT00783224|10815859|FG002|NOT COMPLETED|Overall Study||1
9716722|NCT00783224|10815860|FG003|NOT COMPLETED|Overall Study||2
9716723|NCT00780403|10815869|FG000|STARTED|First Intervention||109
9716724|NCT00780403|10815870|FG001|STARTED|First Intervention||111
9716725|NCT00780403|10815869|FG000|COMPLETED|First Intervention||109
9716726|NCT00780403|10815870|FG001|COMPLETED|First Intervention||111
9716727|NCT00780403|10815869|FG000|NOT COMPLETED|First Intervention||0
9716728|NCT00780403|10815870|FG001|NOT COMPLETED|First Intervention||0
9716729|NCT00780403|10815869|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
9716730|NCT00780403|10815870|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111
9716731|NCT00780403|10815869|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
9716732|NCT00780403|10815870|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111
9716733|NCT00780403|10815869|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
9716734|NCT00780403|10815870|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
9716735|NCT00780403|10815869|FG000|STARTED|Second Intervention||109
9716736|NCT00780403|10815870|FG001|STARTED|Second Intervention||111
9716737|NCT00780403|10815869|FG000|COMPLETED|Second Intervention||109
9716738|NCT00780403|10815870|FG001|COMPLETED|Second Intervention||111
9716739|NCT00780403|10815869|FG000|NOT COMPLETED|Second Intervention||0
9716740|NCT00780403|10815870|FG001|NOT COMPLETED|Second Intervention||0
9716741|NCT00779116|10815877|FG000|STARTED|First Intervention||109
9716742|NCT00779116|10815878|FG001|STARTED|First Intervention||108
9716743|NCT00779116|10815877|FG000|COMPLETED|First Intervention||109
9716744|NCT00779116|10815878|FG001|COMPLETED|First Intervention||108
9716745|NCT00779116|10815877|FG000|NOT COMPLETED|First Intervention||0
9716746|NCT00779116|10815878|FG001|NOT COMPLETED|First Intervention||0
9716747|NCT00779116|10815877|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
9716748|NCT00779116|10815878|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108
9716749|NCT00779116|10815877|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
9716750|NCT00779116|10815878|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108
9716751|NCT00779116|10815877|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
9716752|NCT00779116|10815878|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
9716753|NCT00779116|10815877|FG000|STARTED|Second Intervention||109
9716754|NCT00779116|10815878|FG001|STARTED|Second Intervention||108
9716755|NCT00779116|10815877|FG000|COMPLETED|Second Intervention||109
9716756|NCT00779116|10815878|FG001|COMPLETED|Second Intervention||108
9716757|NCT00779116|10815877|FG000|NOT COMPLETED|Second Intervention||0
9716758|NCT00779116|10815878|FG001|NOT COMPLETED|Second Intervention||0
9716759|NCT00778700|10815889|FG000|STARTED|Overall Study||50
9716760|NCT00778700|10815890|FG001|STARTED|Overall Study||51
9716761|NCT00778700|10815891|FG002|STARTED|Overall Study||49
9716762|NCT00778700|10815892|FG003|STARTED|Overall Study||49
9716763|NCT00778700|10815889|FG000|COMPLETED|Overall Study||32
9716764|NCT00778700|10815890|FG001|COMPLETED|Overall Study||44
9716765|NCT00778700|10815891|FG002|COMPLETED|Overall Study||43
9716766|NCT00778700|10815892|FG003|COMPLETED|Overall Study||36
9716767|NCT00778700|10815889|FG000|NOT COMPLETED|Overall Study||18
9716768|NCT00778700|10815890|FG001|NOT COMPLETED|Overall Study||7
9716769|NCT00778700|10815891|FG002|NOT COMPLETED|Overall Study||6
9716770|NCT00778700|10815892|FG003|NOT COMPLETED|Overall Study||13
9716771|NCT00764478|10815909|FG000|STARTED|Overall Study||122
9716772|NCT00764478|10815910|FG001|STARTED|Overall Study||119
9716773|NCT00764478|10815911|FG002|STARTED|Overall Study||126
9716774|NCT00764478|10815909|FG000|COMPLETED|Overall Study||107
9716775|NCT00764478|10815910|FG001|COMPLETED|Overall Study||97
9716776|NCT00764478|10815911|FG002|COMPLETED|Overall Study||118
9716777|NCT00764478|10815909|FG000|NOT COMPLETED|Overall Study||15
9716778|NCT00764478|10815910|FG001|NOT COMPLETED|Overall Study||22
9716779|NCT00764478|10815911|FG002|NOT COMPLETED|Overall Study||8
9716780|NCT00761527|10815919|FG000|STARTED|Overall Study||2980
9716781|NCT00761527|10815919|FG000|Received One Dose of Study Medication|Overall Study||2978
9716782|NCT00761527|10815919|FG000|COMPLETED|Overall Study||2958
9716783|NCT00761527|10815919|FG000|NOT COMPLETED|Overall Study||22
9716784|NCT00757627|10815923|FG000|STARTED|Overall Study||500
9716785|NCT00757627|10815923|FG000|COMPLETED|Overall Study||419
9716786|NCT00757627|10815923|FG000|NOT COMPLETED|Overall Study||81
9716787|NCT00756938|10815935|FG000|STARTED|12-week Base Study||33
9716788|NCT00756938|10815936|FG001|STARTED|12-week Base Study||34
9716789|NCT00756938|10815937|FG002|STARTED|12-week Base Study||34
9716790|NCT00756938|10815938|FG003|STARTED|12-week Base Study||0
9716791|NCT00756938|10815935|FG000|COMPLETED|12-week Base Study||31
9716792|NCT00756938|10815936|FG001|COMPLETED|12-week Base Study||34
9716793|NCT00756938|10815937|FG002|COMPLETED|12-week Base Study||32
9716794|NCT00756938|10815938|FG003|COMPLETED|12-week Base Study||0
9716795|NCT00756938|10815935|FG000|NOT COMPLETED|12-week Base Study||2
9716796|NCT00756938|10815936|FG001|NOT COMPLETED|12-week Base Study||0
9716797|NCT00756938|10815937|FG002|NOT COMPLETED|12-week Base Study||2
9716798|NCT00756938|10815938|FG003|NOT COMPLETED|12-week Base Study||0
9716799|NCT00756938|10815935|FG000|STARTED|Optional Extension||0
9716800|NCT00756938|10815936|FG001|STARTED|Optional Extension||0
9716801|NCT00756938|10815937|FG002|STARTED|Optional Extension||0
9716802|NCT00756938|10815938|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
9716803|NCT00756938|10815935|FG000|COMPLETED|Optional Extension||0
9716804|NCT00756938|10815936|FG001|COMPLETED|Optional Extension||0
9716805|NCT00756938|10815937|FG002|COMPLETED|Optional Extension||0
9716806|NCT00756938|10815938|FG003|COMPLETED|Optional Extension||53
9716807|NCT00756938|10815935|FG000|NOT COMPLETED|Optional Extension||0
9716808|NCT00756938|10815936|FG001|NOT COMPLETED|Optional Extension||0
9716809|NCT00756938|10815937|FG002|NOT COMPLETED|Optional Extension||0
9716810|NCT00756938|10815938|FG003|NOT COMPLETED|Optional Extension||37
9716811|NCT00730132|10815956|FG000|STARTED|Overall Study||712
9716812|NCT00730132|10815956|FG000|COMPLETED|Overall Study||557
9716813|NCT00730132|10815956|FG000|NOT COMPLETED|Overall Study||155
9716814|NCT00728416|10815965|FG000|STARTED|Overall Study||168
9716815|NCT00728416|10815966|FG001|STARTED|Overall Study||165
9716816|NCT00728416|10815965|FG000|COMPLETED|Overall Study||166
9716817|NCT00728416|10815966|FG001|COMPLETED|Overall Study||163
9716818|NCT00728416|10815965|FG000|NOT COMPLETED|Overall Study||2
9716819|NCT00728416|10815966|FG001|NOT COMPLETED|Overall Study||2
9716820|NCT00724477|10815972|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
9716821|NCT00724477|10815972|FG000|COMPLETED|Overall Study||1663
9716822|NCT00724477|10815972|FG000|NOT COMPLETED|Overall Study||0
9716823|NCT00723736|10815976|FG000|STARTED|Overall Study||100
9716824|NCT00723736|10815976|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
9716825|NCT00723736|10815976|FG000|NOT COMPLETED|Overall Study||1
9716826|NCT00705081|10815982|FG000|STARTED|Overall Study||255
9716827|NCT00705081|10815983|FG001|STARTED|Overall Study||198
9716828|NCT00705081|10815982|FG000|COMPLETED|Overall Study||255
9716829|NCT00705081|10815983|FG001|COMPLETED|Overall Study||198
9716830|NCT00705081|10815982|FG000|NOT COMPLETED|Overall Study||0
9716831|NCT00705081|10815983|FG001|NOT COMPLETED|Overall Study||0
9716832|NCT00704769|10815989|FG000|STARTED|Overall Study||591
9716833|NCT00704769|10815989|FG000|COMPLETED|Overall Study||591
9716834|NCT00704769|10815989|FG000|NOT COMPLETED|Overall Study||0
9716835|NCT00704535|10815993|FG000|STARTED|Overall Study||4105
9716836|NCT00704535|10815993|FG000|COMPLETED|Overall Study||3959
9716837|NCT00704535|10815993|FG000|NOT COMPLETED|Overall Study||146
9716838|NCT00694369|10816002|FG000|STARTED|Overall Study||46
9716839|NCT00694369|10816003|FG001|STARTED|Overall Study||191
9716840|NCT00694369|10816004|FG002|STARTED|Overall Study||97
9716841|NCT00694369|10816005|FG003|STARTED|Overall Study||192
9716842|NCT00694369|10816006|FG004|STARTED|Overall Study||62
9716843|NCT00694369|10816002|FG000|COMPLETED|Overall Study||45
9716844|NCT00694369|10816003|FG001|COMPLETED|Overall Study||188
9716845|NCT00694369|10816004|FG002|COMPLETED|Overall Study||95
9716846|NCT00694369|10816005|FG003|COMPLETED|Overall Study||189
9716847|NCT00694369|10816006|FG004|COMPLETED|Overall Study||56
9716848|NCT00694369|10816002|FG000|NOT COMPLETED|Overall Study||1
9716849|NCT00694369|10816003|FG001|NOT COMPLETED|Overall Study||3
9716850|NCT00694369|10816004|FG002|NOT COMPLETED|Overall Study||2
9716851|NCT00694369|10816005|FG003|NOT COMPLETED|Overall Study||3
9716852|NCT00694369|10816006|FG004|NOT COMPLETED|Overall Study||6
9716853|NCT00671528|10816021|FG000|STARTED|Overall Study||1
9716854|NCT00671528|10816022|FG001|STARTED|Overall Study||1
9716855|NCT00671528|10816023|FG002|STARTED|Overall Study||1
9716856|NCT00671528|10816021|FG000|COMPLETED|Overall Study||1
9716857|NCT00671528|10816022|FG001|COMPLETED|Overall Study||1
9716858|NCT00671528|10816023|FG002|COMPLETED|Overall Study||1
9716859|NCT00671528|10816021|FG000|NOT COMPLETED|Overall Study||0
9716860|NCT00671528|10816022|FG001|NOT COMPLETED|Overall Study||0
9716861|NCT00671528|10816023|FG002|NOT COMPLETED|Overall Study||0
9716862|NCT00667823|10816031|FG000|STARTED|Overall Study||550
9716863|NCT00667823|10816031|FG000|COMPLETED|Overall Study||334
9716864|NCT00667823|10816031|FG000|NOT COMPLETED|Overall Study||216
9716865|NCT00652327|10816037|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
9716866|NCT00652327|10816038|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
9716867|NCT00652327|10816037|FG000|COMPLETED|Overall Study||42
9716868|NCT00652327|10816038|FG001|COMPLETED|Overall Study||36
9716869|NCT00652327|10816037|FG000|NOT COMPLETED|Overall Study||0
9716870|NCT00652327|10816038|FG001|NOT COMPLETED|Overall Study||5
9716871|NCT00604500|10816044|FG000|STARTED|Overall Study||272
9716872|NCT00604500|10816044|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
9716873|NCT00604500|10816044|FG000|NOT COMPLETED|Overall Study||11
9716874|NCT00568178|10816050|FG000|STARTED|Double Blind Base Study||122
9716875|NCT00568178|10816051|FG001|STARTED|Double Blind Base Study||124
9716876|NCT00568178|10816052|FG002|STARTED|Double Blind Base Study||30
9716877|NCT00568178|10816053|FG003|STARTED|Double Blind Base Study||30
9716878|NCT00568178|10816054|FG004|STARTED|Double Blind Base Study||0
9716879|NCT00568178|10816055|FG005|STARTED|Double Blind Base Study||0
9716880|NCT00568178|10816050|FG000|COMPLETED|Double Blind Base Study||116
9716881|NCT00568178|10816051|FG001|COMPLETED|Double Blind Base Study||118
9716882|NCT00568178|10816052|FG002|COMPLETED|Double Blind Base Study||29
9716883|NCT00568178|10816053|FG003|COMPLETED|Double Blind Base Study||25
9716884|NCT00568178|10816054|FG004|COMPLETED|Double Blind Base Study||0
9716885|NCT00568178|10816055|FG005|COMPLETED|Double Blind Base Study||0
9716886|NCT00568178|10816050|FG000|NOT COMPLETED|Double Blind Base Study||6
9716887|NCT00568178|10816051|FG001|NOT COMPLETED|Double Blind Base Study||6
9716888|NCT00568178|10816052|FG002|NOT COMPLETED|Double Blind Base Study||1
9716889|NCT00568178|10816053|FG003|NOT COMPLETED|Double Blind Base Study||5
9716890|NCT00568178|10816054|FG004|NOT COMPLETED|Double Blind Base Study||0
9716891|NCT00568178|10816055|FG005|NOT COMPLETED|Double Blind Base Study||0
9716892|NCT00568178|10816050|FG000|STARTED|Open Label Extension||0
9716893|NCT00568178|10816051|FG001|STARTED|Open Label Extension||0
9716894|NCT00568178|10816052|FG002|STARTED|Open Label Extension||0
9716895|NCT00568178|10816053|FG003|STARTED|Open Label Extension||0
9716896|NCT00568178|10816054|FG004|STARTED|Open Label Extension||134
9716897|NCT00568178|10816055|FG005|STARTED|Open Label Extension||134
9716898|NCT00568178|10816050|FG000|COMPLETED|Open Label Extension||0
9716899|NCT00568178|10816051|FG001|COMPLETED|Open Label Extension||0
9716900|NCT00568178|10816052|FG002|COMPLETED|Open Label Extension||0
9716901|NCT00568178|10816053|FG003|COMPLETED|Open Label Extension||0
9716902|NCT00568178|10816054|FG004|COMPLETED|Open Label Extension||55
9716903|NCT00568178|10816055|FG005|COMPLETED|Open Label Extension||54
9716904|NCT00568178|10816050|FG000|NOT COMPLETED|Open Label Extension||0
9716905|NCT00568178|10816051|FG001|NOT COMPLETED|Open Label Extension||0
9716906|NCT00568178|10816052|FG002|NOT COMPLETED|Open Label Extension||0
9716907|NCT00568178|10816053|FG003|NOT COMPLETED|Open Label Extension||0
9716908|NCT00568178|10816054|FG004|NOT COMPLETED|Open Label Extension||79
9716909|NCT00568178|10816055|FG005|NOT COMPLETED|Open Label Extension||80
9716910|NCT00545844|10816069|FG000|STARTED|Overall Study||313
9716911|NCT00545844|10816069|FG000|COMPLETED|Overall Study||301
9716912|NCT00545844|10816069|FG000|NOT COMPLETED|Overall Study||12
9716913|NCT00511433|10816077|FG000|STARTED|Overall Study||32
9716914|NCT00511433|10816078|FG001|STARTED|Overall Study||16
9716915|NCT00511433|10816077|FG000|COMPLETED|Overall Study||26
9716916|NCT00511433|10816078|FG001|COMPLETED|Overall Study||15
9716917|NCT00511433|10816077|FG000|NOT COMPLETED|Overall Study||6
9716918|NCT00511433|10816078|FG001|NOT COMPLETED|Overall Study||1
9716919|NCT00511355|10816088|FG000|STARTED|Overall Study||60
9716920|NCT00511355|10816089|FG001|STARTED|Overall Study||61
9716921|NCT00511355|10816088|FG000|COMPLETED|Overall Study||53
9716922|NCT00511355|10816089|FG001|COMPLETED|Overall Study||52
9716923|NCT00511355|10816088|FG000|NOT COMPLETED|Overall Study||7
9716924|NCT00511355|10816089|FG001|NOT COMPLETED|Overall Study||9
9716925|NCT00511342|10816099|FG000|STARTED|Overall Study||56
9716926|NCT00511342|10816100|FG001|STARTED|Overall Study||54
9716927|NCT00511342|10816099|FG000|COMPLETED|Overall Study||43
9716928|NCT00511342|10816100|FG001|COMPLETED|Overall Study||32
9716929|NCT00511342|10816099|FG000|NOT COMPLETED|Overall Study||13
9716930|NCT00511342|10816100|FG001|NOT COMPLETED|Overall Study||22
9716931|NCT00511199|10816108|FG000|STARTED|Overall Study||1591
9716932|NCT00511199|10816109|FG001|STARTED|Overall Study||535
9716933|NCT00511199|10816108|FG000|COMPLETED|Overall Study||1142
9716934|NCT00511199|10816109|FG001|COMPLETED|Overall Study||410
9716935|NCT00511199|10816108|FG000|NOT COMPLETED|Overall Study||449
9716936|NCT00511199|10816109|FG001|NOT COMPLETED|Overall Study||125
9716937|NCT00491504|10816121|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
9716938|NCT00491504|10816122|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
9716939|NCT00491504|10816123|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
9716940|NCT00491504|10816124|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
9716941|NCT00491504|10816121|FG000|COMPLETED|Overall Study||77
9716942|NCT00491504|10816122|FG001|COMPLETED|Overall Study||77
9716943|NCT00491504|10816123|FG002|COMPLETED|Overall Study||74
9716944|NCT00491504|10816124|FG003|COMPLETED|Overall Study||73
9716945|NCT00491504|10816121|FG000|NOT COMPLETED|Overall Study||0
9716946|NCT00491504|10816122|FG001|NOT COMPLETED|Overall Study||1
9716947|NCT00491504|10816123|FG002|NOT COMPLETED|Overall Study||4
9716948|NCT00491504|10816124|FG003|NOT COMPLETED|Overall Study||4
9716949|NCT00468312|10816134|FG000|STARTED|Overall Study||220
9716950|NCT00468312|10816135|FG001|STARTED|Overall Study||209
9716951|NCT00468312|10816134|FG000|COMPLETED|Overall Study||216
9716952|NCT00468312|10816135|FG001|COMPLETED|Overall Study||204
9716953|NCT00468312|10816134|FG000|NOT COMPLETED|Overall Study||4
9716954|NCT00468312|10816135|FG001|NOT COMPLETED|Overall Study||5
9716955|NCT00453063|10816143|FG000|STARTED|Overall Study||211
9716956|NCT00453063|10816144|FG001|STARTED|Overall Study||215
9716957|NCT00453063|10816143|FG000|COMPLETED|Overall Study||208
9716958|NCT00453063|10816144|FG001|COMPLETED|Overall Study||212
9716959|NCT00453063|10816143|FG000|NOT COMPLETED|Overall Study||3
9716960|NCT00453063|10816144|FG001|NOT COMPLETED|Overall Study||3
9716961|NCT00447603|10816150|FG000|STARTED|Screening||40
9716962|NCT00447603|10816151|FG001|STARTED|Screening||0
9716963|NCT00447603|10816152|FG002|STARTED|Screening||0
9716964|NCT00447603|10816150|FG000|COMPLETED|Screening||19
9716965|NCT00447603|10816151|FG001|COMPLETED|Screening||0
9716966|NCT00447603|10816152|FG002|COMPLETED|Screening||0
9716967|NCT00447603|10816150|FG000|NOT COMPLETED|Screening||21
9716968|NCT00447603|10816151|FG001|NOT COMPLETED|Screening||0
9716969|NCT00447603|10816152|FG002|NOT COMPLETED|Screening||0
9716970|NCT00447603|10816150|FG000|STARTED|Filter Period||0
9716971|NCT00447603|10816151|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
9716972|NCT00447603|10816152|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
9716973|NCT00447603|10816150|FG000|COMPLETED|Filter Period||0
9716974|NCT00447603|10816151|FG001|COMPLETED|Filter Period||0
9716975|NCT00447603|10816152|FG002|COMPLETED|Filter Period||0
9716976|NCT00447603|10816150|FG000|NOT COMPLETED|Filter Period||0
9716977|NCT00447603|10816151|FG001|NOT COMPLETED|Filter Period||4
9716978|NCT00447603|10816152|FG002|NOT COMPLETED|Filter Period||15
9716979|NCT00442351|10816162|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
9716980|NCT00442351|10816163|FG001|STARTED|Overall Study||9
9716981|NCT00442351|10816162|FG000|COMPLETED|Overall Study||10
9716982|NCT00442351|10816163|FG001|COMPLETED|Overall Study||3
9716983|NCT00442351|10816162|FG000|NOT COMPLETED|Overall Study||7
9716984|NCT00442351|10816163|FG001|NOT COMPLETED|Overall Study||6
9716985|NCT00423488|10816171|FG000|STARTED|Overall Study||42
9716986|NCT00423488|10816172|FG001|STARTED|Overall Study||51
9716987|NCT00423488|10816171|FG000|COMPLETED|Overall Study||37
9716988|NCT00423488|10816172|FG001|COMPLETED|Overall Study||50
9716989|NCT00423488|10816171|FG000|NOT COMPLETED|Overall Study||5
9716990|NCT00423488|10816172|FG001|NOT COMPLETED|Overall Study||1
9716991|NCT00413972|10816182|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
9716992|NCT00413972|10816183|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
9716993|NCT00413972|10816184|FG002|STARTED|Overall Study||98
9716994|NCT00413972|10816185|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
9716995|NCT00413972|10816182|FG000|COMPLETED|Overall Study||91
9716996|NCT00413972|10816183|FG001|COMPLETED|Overall Study||90
9716997|NCT00413972|10816184|FG002|COMPLETED|Overall Study||88
9716998|NCT00413972|10816185|FG003|COMPLETED|Overall Study||95
9716999|NCT00413972|10816182|FG000|NOT COMPLETED|Overall Study||7
9717000|NCT00413972|10816183|FG001|NOT COMPLETED|Overall Study||8
9717001|NCT00413972|10816184|FG002|NOT COMPLETED|Overall Study||10
9717002|NCT00413972|10816185|FG003|NOT COMPLETED|Overall Study||3
9717003|NCT00413062|10816197|FG000|STARTED|Overall Study||1666
9717004|NCT00413062|10816198|FG001|STARTED|Overall Study||554
9717005|NCT00413062|10816197|FG000|COMPLETED|Overall Study||988
9717006|NCT00413062|10816198|FG001|COMPLETED|Overall Study||344
9717007|NCT00413062|10816197|FG000|NOT COMPLETED|Overall Study||678
9717008|NCT00413062|10816198|FG001|NOT COMPLETED|Overall Study||210
9717009|NCT00391170|10816208|FG000|STARTED|Overall Study||27
9717010|NCT00391170|10816209|FG001|STARTED|Overall Study||27
9717011|NCT00391170|10816208|FG000|COMPLETED|Overall Study||21
9717012|NCT00391170|10816209|FG001|COMPLETED|Overall Study||23
9717013|NCT00391170|10816208|FG000|NOT COMPLETED|Overall Study||6
9717014|NCT00391170|10816209|FG001|NOT COMPLETED|Overall Study||4
9717015|NCT00359138|10816218|FG000|STARTED|Overall Study||12
9717016|NCT00359138|10816219|FG001|STARTED|Overall Study||12
9717017|NCT00359138|10816220|FG002|STARTED|Overall Study||12
9717018|NCT00359138|10816218|FG000|COMPLETED|Overall Study||12
9717019|NCT00359138|10816219|FG001|COMPLETED|Overall Study||12
9717020|NCT00359138|10816220|FG002|COMPLETED|Overall Study||12
9717021|NCT00359138|10816218|FG000|NOT COMPLETED|Overall Study||0
9717022|NCT00359138|10816219|FG001|NOT COMPLETED|Overall Study||0
9717023|NCT00359138|10816220|FG002|NOT COMPLETED|Overall Study||0
9717024|NCT00350701|10816231|FG000|STARTED|Overall Study||17
9717025|NCT00350701|10816232|FG001|STARTED|Overall Study||17
9717026|NCT00350701|10816233|FG002|STARTED|Overall Study||15
9717027|NCT00350701|10816231|FG000|COMPLETED|Overall Study||17
9717028|NCT00350701|10816232|FG001|COMPLETED|Overall Study||17
9717029|NCT00350701|10816233|FG002|COMPLETED|Overall Study||15
9717030|NCT00350701|10816231|FG000|NOT COMPLETED|Overall Study||0
9717031|NCT00350701|10816232|FG001|NOT COMPLETED|Overall Study||0
9717032|NCT00350701|10816233|FG002|NOT COMPLETED|Overall Study||0
9717033|NCT00319449|10816243|FG000|STARTED|Overall Study||10
9717034|NCT00319449|10816244|FG001|STARTED|Overall Study||12
9717035|NCT00319449|10816243|FG000|COMPLETED|Overall Study||8
9717036|NCT00319449|10816244|FG001|COMPLETED|Overall Study||12
9717037|NCT00319449|10816243|FG000|NOT COMPLETED|Overall Study||2
9717038|NCT00319449|10816244|FG001|NOT COMPLETED|Overall Study||0
9717039|NCT00305344|10816250|FG000|STARTED|Overall Study||23
9717040|NCT00305344|10816250|FG000|COMPLETED|Overall Study||23
9717041|NCT00305344|10816250|FG000|NOT COMPLETED|Overall Study||0
9717042|NCT00289887|10816256|FG000|STARTED|Overall Study||127
9717043|NCT00289887|10816257|FG001|STARTED|Overall Study||134
9717044|NCT00289887|10816256|FG000|COMPLETED|Overall Study||105
9717045|NCT00289887|10816257|FG001|COMPLETED|Overall Study||105
9717046|NCT00289887|10816256|FG000|NOT COMPLETED|Overall Study||22
9717047|NCT00289887|10816257|FG001|NOT COMPLETED|Overall Study||29
9717048|NCT00281320|10816265|FG000|STARTED|Overall Study||61
9717049|NCT00281320|10816266|FG001|STARTED|Overall Study||61
9717050|NCT00281320|10816265|FG000|COMPLETED|Overall Study||36
9717051|NCT00281320|10816266|FG001|COMPLETED|Overall Study||40
9717052|NCT00281320|10816265|FG000|NOT COMPLETED|Overall Study||25
9717053|NCT00281320|10816266|FG001|NOT COMPLETED|Overall Study||21
9717054|NCT00276016|10816284|FG000|STARTED|Intervention 1||7
9717055|NCT00276016|10816285|FG001|STARTED|Intervention 1||7
9717056|NCT00276016|10816286|FG002|STARTED|Intervention 1||7
9717057|NCT00276016|10816287|FG003|STARTED|Intervention 1||6
9717058|NCT00276016|10816288|FG004|STARTED|Intervention 1||6
9717059|NCT00276016|10816289|FG005|STARTED|Intervention 1||6
9717060|NCT00276016|10816284|FG000|COMPLETED|Intervention 1||7
9717061|NCT00276016|10816285|FG001|COMPLETED|Intervention 1||6
9717062|NCT00276016|10816286|FG002|COMPLETED|Intervention 1||7
9717063|NCT00276016|10816287|FG003|COMPLETED|Intervention 1||6
9717064|NCT00276016|10816288|FG004|COMPLETED|Intervention 1||6
9717065|NCT00276016|10816289|FG005|COMPLETED|Intervention 1||6
9717066|NCT00276016|10816284|FG000|NOT COMPLETED|Intervention 1||0
9717067|NCT00276016|10816285|FG001|NOT COMPLETED|Intervention 1||1
9717068|NCT00276016|10816286|FG002|NOT COMPLETED|Intervention 1||0
9717069|NCT00276016|10816287|FG003|NOT COMPLETED|Intervention 1||0
9717070|NCT00276016|10816288|FG004|NOT COMPLETED|Intervention 1||0
9717071|NCT00276016|10816289|FG005|NOT COMPLETED|Intervention 1||0
9717072|NCT00276016|10816284|FG000|STARTED|Wash Out 1||7
9717073|NCT00276016|10816285|FG001|STARTED|Wash Out 1||6
9717074|NCT00276016|10816286|FG002|STARTED|Wash Out 1||7
9717075|NCT00276016|10816287|FG003|STARTED|Wash Out 1||6
9717076|NCT00276016|10816288|FG004|STARTED|Wash Out 1||6
9717077|NCT00276016|10816289|FG005|STARTED|Wash Out 1||6
9717078|NCT00276016|10816284|FG000|COMPLETED|Wash Out 1||7
9717079|NCT00276016|10816285|FG001|COMPLETED|Wash Out 1||6
9717080|NCT00276016|10816286|FG002|COMPLETED|Wash Out 1||7
9717081|NCT00276016|10816287|FG003|COMPLETED|Wash Out 1||6
9717082|NCT00276016|10816288|FG004|COMPLETED|Wash Out 1||6
9717083|NCT00276016|10816289|FG005|COMPLETED|Wash Out 1||6
9717084|NCT00276016|10816284|FG000|NOT COMPLETED|Wash Out 1||0
9717085|NCT00276016|10816285|FG001|NOT COMPLETED|Wash Out 1||0
9717086|NCT00276016|10816286|FG002|NOT COMPLETED|Wash Out 1||0
9717087|NCT00276016|10816287|FG003|NOT COMPLETED|Wash Out 1||0
9717088|NCT00276016|10816288|FG004|NOT COMPLETED|Wash Out 1||0
9717089|NCT00276016|10816289|FG005|NOT COMPLETED|Wash Out 1||0
9717090|NCT00276016|10816284|FG000|STARTED|Intervention 2||7
9717091|NCT00276016|10816285|FG001|STARTED|Intervention 2||6
9717092|NCT00276016|10816286|FG002|STARTED|Intervention 2||7
9717093|NCT00276016|10816287|FG003|STARTED|Intervention 2||6
9717094|NCT00276016|10816288|FG004|STARTED|Intervention 2||6
9717095|NCT00276016|10816289|FG005|STARTED|Intervention 2||6
9717096|NCT00276016|10816284|FG000|COMPLETED|Intervention 2||7
9717097|NCT00276016|10816285|FG001|COMPLETED|Intervention 2||6
9717098|NCT00276016|10816286|FG002|COMPLETED|Intervention 2||7
9717099|NCT00276016|10816287|FG003|COMPLETED|Intervention 2||6
9717100|NCT00276016|10816288|FG004|COMPLETED|Intervention 2||6
9717101|NCT00276016|10816289|FG005|COMPLETED|Intervention 2||6
9717102|NCT00276016|10816284|FG000|NOT COMPLETED|Intervention 2||0
9717103|NCT00276016|10816285|FG001|NOT COMPLETED|Intervention 2||0
9717104|NCT00276016|10816286|FG002|NOT COMPLETED|Intervention 2||0
9850033|NCT00868790|10962864|FG006|COMPLETED|Period 1||4
9850034|NCT00868790|10962865|FG007|COMPLETED|Period 1||17
9850035|NCT00868790|10962866|FG008|COMPLETED|Period 1||10
9850036|NCT00868790|10962867|FG009|COMPLETED|Period 1||3
9850037|NCT00868790|10962868|FG010|COMPLETED|Period 1||9
9850038|NCT00868790|10962869|FG011|COMPLETED|Period 1||4
9850039|NCT00868790|10962870|FG012|COMPLETED|Period 1||7
9850040|NCT00868790|10962871|FG013|COMPLETED|Period 1||9
9850041|NCT00868790|10962858|FG000|NOT COMPLETED|Period 1||2
9850042|NCT00868790|10962859|FG001|NOT COMPLETED|Period 1||1
9850043|NCT00868790|10962860|FG002|NOT COMPLETED|Period 1||0
9850044|NCT00868790|10962861|FG003|NOT COMPLETED|Period 1||0
9850045|NCT00868790|10962862|FG004|NOT COMPLETED|Period 1||1
9850046|NCT00868790|10962863|FG005|NOT COMPLETED|Period 1||1
9850047|NCT00868790|10962864|FG006|NOT COMPLETED|Period 1||0
9850048|NCT00868790|10962865|FG007|NOT COMPLETED|Period 1||3
9850049|NCT00868790|10962866|FG008|NOT COMPLETED|Period 1||1
9850050|NCT00868790|10962867|FG009|NOT COMPLETED|Period 1||0
9850051|NCT00868790|10962868|FG010|NOT COMPLETED|Period 1||0
9850052|NCT00868790|10962869|FG011|NOT COMPLETED|Period 1||0
9850053|NCT00868790|10962870|FG012|NOT COMPLETED|Period 1||0
9850054|NCT00868790|10962871|FG013|NOT COMPLETED|Period 1||2
9850055|NCT00868790|10962858|FG000|STARTED|Period 2||9
9850056|NCT00868790|10962859|FG001|STARTED|Period 2||7
9850057|NCT00868790|10962860|FG002|STARTED|Period 2||4
9850058|NCT00868790|10962861|FG003|STARTED|Period 2||4
9717105|NCT00276016|10816287|FG003|NOT COMPLETED|Intervention 2||0
9717106|NCT00276016|10816288|FG004|NOT COMPLETED|Intervention 2||0
9717107|NCT00276016|10816289|FG005|NOT COMPLETED|Intervention 2||0
9717108|NCT00276016|10816284|FG000|STARTED|Wash Out 2||7
9717109|NCT00276016|10816285|FG001|STARTED|Wash Out 2||6
9717110|NCT00276016|10816286|FG002|STARTED|Wash Out 2||7
9850059|NCT00868790|10962862|FG004|STARTED|Period 2||18
9850060|NCT00868790|10962863|FG005|STARTED|Period 2||2
9850061|NCT00868790|10962864|FG006|STARTED|Period 2||4
9850062|NCT00868790|10962865|FG007|STARTED|Period 2||17
9850063|NCT00868790|10962866|FG008|STARTED|Period 2||10
9850064|NCT00868790|10962867|FG009|STARTED|Period 2||3
9850065|NCT00868790|10962868|FG010|STARTED|Period 2||9
9850066|NCT00868790|10962869|FG011|STARTED|Period 2||4
9850067|NCT00868790|10962870|FG012|STARTED|Period 2||7
9717111|NCT00276016|10816287|FG003|STARTED|Wash Out 2||6
9717112|NCT00276016|10816288|FG004|STARTED|Wash Out 2||6
9717113|NCT00276016|10816289|FG005|STARTED|Wash Out 2||6
9717114|NCT00276016|10816284|FG000|COMPLETED|Wash Out 2||7
9717115|NCT00276016|10816285|FG001|COMPLETED|Wash Out 2||6
9717116|NCT00276016|10816286|FG002|COMPLETED|Wash Out 2||7
9717117|NCT00276016|10816287|FG003|COMPLETED|Wash Out 2||6
9717118|NCT00276016|10816288|FG004|COMPLETED|Wash Out 2||6
9717119|NCT00276016|10816289|FG005|COMPLETED|Wash Out 2||6
9717120|NCT00276016|10816284|FG000|NOT COMPLETED|Wash Out 2||0
9717121|NCT00276016|10816285|FG001|NOT COMPLETED|Wash Out 2||0
9717122|NCT00276016|10816286|FG002|NOT COMPLETED|Wash Out 2||0
9717123|NCT00276016|10816287|FG003|NOT COMPLETED|Wash Out 2||0
9717124|NCT00276016|10816288|FG004|NOT COMPLETED|Wash Out 2||0
9717125|NCT00276016|10816289|FG005|NOT COMPLETED|Wash Out 2||0
9717126|NCT00276016|10816284|FG000|STARTED|Intervention 3||7
9717127|NCT00276016|10816285|FG001|STARTED|Intervention 3||6
9717128|NCT00276016|10816286|FG002|STARTED|Intervention 3||7
9717129|NCT00276016|10816287|FG003|STARTED|Intervention 3||6
9717130|NCT00276016|10816288|FG004|STARTED|Intervention 3||6
9717131|NCT00276016|10816289|FG005|STARTED|Intervention 3||6
9717132|NCT00276016|10816284|FG000|COMPLETED|Intervention 3||7
9717133|NCT00276016|10816285|FG001|COMPLETED|Intervention 3||6
9717134|NCT00276016|10816286|FG002|COMPLETED|Intervention 3||7
9717135|NCT00276016|10816287|FG003|COMPLETED|Intervention 3||6
9717136|NCT00276016|10816288|FG004|COMPLETED|Intervention 3||6
9717137|NCT00276016|10816289|FG005|COMPLETED|Intervention 3||6
9717138|NCT00276016|10816284|FG000|NOT COMPLETED|Intervention 3||0
9717139|NCT00276016|10816285|FG001|NOT COMPLETED|Intervention 3||0
9717140|NCT00276016|10816286|FG002|NOT COMPLETED|Intervention 3||0
9717141|NCT00276016|10816287|FG003|NOT COMPLETED|Intervention 3||0
9717142|NCT00276016|10816288|FG004|NOT COMPLETED|Intervention 3||0
9717143|NCT00276016|10816289|FG005|NOT COMPLETED|Intervention 3||0
9717144|NCT00265343|10816300|FG000|STARTED|Overall Study||134
9717145|NCT00265343|10816301|FG001|STARTED|Overall Study||172
9717146|NCT00265343|10816300|FG000|COMPLETED|Overall Study||113
9717147|NCT00265343|10816301|FG001|COMPLETED|Overall Study||153
9717148|NCT00265343|10816300|FG000|NOT COMPLETED|Overall Study||21
9717149|NCT00265343|10816301|FG001|NOT COMPLETED|Overall Study||19
9717150|NCT00264147|10816312|FG000|STARTED|Treatment I Period||161
9717151|NCT00264147|10816313|FG001|STARTED|Treatment I Period||154
9717152|NCT00264147|10816314|FG002|STARTED|Treatment I Period||151
9717153|NCT00264147|10816315|FG003|STARTED|Treatment I Period||140
9717154|NCT00264147|10816316|FG004|STARTED|Treatment I Period||155
9717155|NCT00264147|10816317|FG005|STARTED|Treatment I Period||0
9717156|NCT00264147|10816312|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
9717157|NCT00264147|10816313|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
9717158|NCT00264147|10816314|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
9717159|NCT00264147|10816315|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
9717160|NCT00264147|10816316|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
9717161|NCT00264147|10816317|FG005|COMPLETED|Treatment I Period||0
9717162|NCT00264147|10816312|FG000|NOT COMPLETED|Treatment I Period||98
9717163|NCT00264147|10816313|FG001|NOT COMPLETED|Treatment I Period||83
9717164|NCT00264147|10816314|FG002|NOT COMPLETED|Treatment I Period||77
9717165|NCT00264147|10816315|FG003|NOT COMPLETED|Treatment I Period||72
9717166|NCT00264147|10816316|FG004|NOT COMPLETED|Treatment I Period||56
9717167|NCT00264147|10816317|FG005|NOT COMPLETED|Treatment I Period||0
9717168|NCT00264147|10816312|FG000|STARTED|Treatment II Period||0
9717169|NCT00264147|10816313|FG001|STARTED|Treatment II Period||0
9717170|NCT00264147|10816314|FG002|STARTED|Treatment II Period||0
9717171|NCT00264147|10816315|FG003|STARTED|Treatment II Period||0
9717172|NCT00264147|10816316|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
9717173|NCT00264147|10816317|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
9717174|NCT00264147|10816312|FG000|COMPLETED|Treatment II Period||0
9717175|NCT00264147|10816313|FG001|COMPLETED|Treatment II Period||0
9717176|NCT00264147|10816314|FG002|COMPLETED|Treatment II Period||0
9717177|NCT00264147|10816315|FG003|COMPLETED|Treatment II Period||0
9717178|NCT00264147|10816316|FG004|COMPLETED|Treatment II Period||147
9717179|NCT00264147|10816317|FG005|COMPLETED|Treatment II Period||116
9717180|NCT00264147|10816312|FG000|NOT COMPLETED|Treatment II Period||0
9717181|NCT00264147|10816313|FG001|NOT COMPLETED|Treatment II Period||0
9717182|NCT00264147|10816314|FG002|NOT COMPLETED|Treatment II Period||0
9717183|NCT00264147|10816315|FG003|NOT COMPLETED|Treatment II Period||0
9717184|NCT00264147|10816316|FG004|NOT COMPLETED|Treatment II Period||33
9717185|NCT00264147|10816317|FG005|NOT COMPLETED|Treatment II Period||33
9717186|NCT00202878|10816333|FG000|STARTED|Overall Study||9067
9717187|NCT00202878|10816334|FG001|STARTED|Overall Study||9077
9717188|NCT00202878|10816333|FG000|COMPLETED|Overall Study||6868
9717189|NCT00202878|10816334|FG001|COMPLETED|Overall Study||6860
9717190|NCT00202878|10816333|FG000|NOT COMPLETED|Overall Study||2199
9717191|NCT00202878|10816334|FG001|NOT COMPLETED|Overall Study||2217
9731951|NCT00138034|10831936|FG001|COMPLETED|Overall Study||20
9850068|NCT00868790|10962871|FG013|STARTED|Period 2||9
9717192|NCT00174265|10816342|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
9717193|NCT00174265|10816343|FG001|STARTED|Overall Study||110
9717194|NCT00174265|10816342|FG000|COMPLETED|Overall Study||57
9717195|NCT00174265|10816343|FG001|COMPLETED|Overall Study||89
9717196|NCT00174265|10816342|FG000|NOT COMPLETED|Overall Study||29
9717197|NCT00174265|10816343|FG001|NOT COMPLETED|Overall Study||21
9717198|NCT00159783|10816352|FG000|STARTED|Overall Study||32
9717199|NCT00159783|10816353|FG001|STARTED|Overall Study||79
9717200|NCT00159783|10816354|FG002|STARTED|Overall Study||107
9717201|NCT00159783|10816352|FG000|COMPLETED|Overall Study||13
9717202|NCT00159783|10816353|FG001|COMPLETED|Overall Study||52
9717203|NCT00159783|10816354|FG002|COMPLETED|Overall Study||68
9717204|NCT00159783|10816352|FG000|NOT COMPLETED|Overall Study||19
9717205|NCT00159783|10816353|FG001|NOT COMPLETED|Overall Study||27
9717206|NCT00159783|10816354|FG002|NOT COMPLETED|Overall Study||39
9717213|NCT00092677|10816376|FG000|STARTED|Overall Study||944
9717214|NCT00092677|10816377|FG001|STARTED|Overall Study||929
9717215|NCT00092677|10816376|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
9717216|NCT00092677|10816377|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
9717217|NCT00092677|10816376|FG000|NOT COMPLETED|Overall Study||5
9717218|NCT00092677|10816377|FG001|NOT COMPLETED|Overall Study||11
9717219|NCT00090259|10816385|FG000|STARTED|Overall Study||1913
9717220|NCT00090259|10816386|FG001|STARTED|Overall Study||1921
9717221|NCT00090259|10816385|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
9717222|NCT00090259|10816386|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
9717223|NCT00090259|10816385|FG000|NOT COMPLETED|Overall Study||62
9717224|NCT00090259|10816386|FG001|NOT COMPLETED|Overall Study||48
9717225|NCT00003298|10816392|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39
9717226|NCT00003298|10816392|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
9717227|NCT00003298|10816392|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
9717228|NCT00003298|10816392|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
9717229|NCT00003298|10816392|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
9717230|NCT00003298|10816392|FG000|STARTED|Surgery||35
9717231|NCT00003298|10816392|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
9717232|NCT00003298|10816392|FG000|NOT COMPLETED|Surgery||7
9717233|NCT00003298|10816392|FG000|STARTED|Re-register to Step 2 After Surgery||28
9717234|NCT00003298|10816392|FG000|COMPLETED|Re-register to Step 2 After Surgery||10
9717235|NCT00003298|10816392|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18
9717236|NCT00003298|10816392|FG000|STARTED|Step 2 (Adjuvant Therapy)||10
9717237|NCT00003298|10816392|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
9717238|NCT00003298|10816392|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4
9717239|NCT00003298|10816392|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
9717240|NCT00003377|10816402|FG000|STARTED|Period I||3
9717241|NCT00003377|10816403|FG001|STARTED|Period I||3
9717242|NCT00003377|10816404|FG002|STARTED|Period I||3
9717243|NCT00003377|10816405|FG003|STARTED|Period I||3
9717244|NCT00003377|10816406|FG004|STARTED|Period I||0
9717245|NCT00003377|10816402|FG000|COMPLETED|Period I||3
9717246|NCT00003377|10816403|FG001|COMPLETED|Period I||3
9717247|NCT00003377|10816404|FG002|COMPLETED|Period I||2
9717248|NCT00003377|10816405|FG003|COMPLETED|Period I||2
9717249|NCT00003377|10816406|FG004|COMPLETED|Period I||0
9717250|NCT00003377|10816402|FG000|NOT COMPLETED|Period I||0
9717251|NCT00003377|10816403|FG001|NOT COMPLETED|Period I||0
9717252|NCT00003377|10816404|FG002|NOT COMPLETED|Period I||1
9717253|NCT00003377|10816405|FG003|NOT COMPLETED|Period I||1
9717254|NCT00003377|10816406|FG004|NOT COMPLETED|Period I||0
9717255|NCT00003377|10816402|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0
9717256|NCT00003377|10816403|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0
9717257|NCT00003377|10816404|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0
9717258|NCT00003377|10816405|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0
9717259|NCT00003377|10816406|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
9717260|NCT00003377|10816402|FG000|COMPLETED|Period II||0
9717261|NCT00003377|10816403|FG001|COMPLETED|Period II||0
9717262|NCT00003377|10816404|FG002|COMPLETED|Period II||0
9717263|NCT00003377|10816405|FG003|COMPLETED|Period II||0
9717264|NCT00003377|10816406|FG004|COMPLETED|Period II||16
9717265|NCT00003377|10816402|FG000|NOT COMPLETED|Period II||0
9717266|NCT00003377|10816403|FG001|NOT COMPLETED|Period II||0
9717267|NCT00003377|10816404|FG002|NOT COMPLETED|Period II||0
9717268|NCT00003377|10816405|FG003|NOT COMPLETED|Period II||0
9717269|NCT00003377|10816406|FG004|NOT COMPLETED|Period II||1
9717270|NCT00003389|10816421|FG000|STARTED|Overall Study||428
9717271|NCT00003389|10816422|FG001|STARTED|Overall Study||426
9717272|NCT00003389|10816421|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414
9717273|NCT00003389|10816422|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422
9717274|NCT00003389|10816421|FG000|Eligible Patients|Overall Study||395
9717275|NCT00003389|10816422|FG001|Eligible Patients|Overall Study||399
9717276|NCT00003389|10816421|FG000|COMPLETED|Overall Study||330
9717277|NCT00003389|10816422|FG001|COMPLETED|Overall Study||366
9717278|NCT00003389|10816421|FG000|NOT COMPLETED|Overall Study||98
9717279|NCT00003389|10816422|FG001|NOT COMPLETED|Overall Study||60
9717280|NCT00003404|10816428|FG000|STARTED|Overall Study||46
9717281|NCT00003404|10816428|FG000|COMPLETED|Overall Study||46
9717282|NCT00003404|10816428|FG000|NOT COMPLETED|Overall Study||0
9717283|NCT00003453|10816433|FG000|STARTED|Overall Study||6
9717284|NCT00003453|10816433|FG000|COMPLETED|Overall Study|One patient was not evaluable|5
9717285|NCT00003453|10816433|FG000|NOT COMPLETED|Overall Study||1
9717286|NCT00003456|10816437|FG000|STARTED|Overall Study||40
9717287|NCT00003456|10816437|FG000|COMPLETED|Overall Study||32
9717288|NCT00003456|10816437|FG000|NOT COMPLETED|Overall Study||8
9717289|NCT00003457|10816441|FG000|STARTED|Overall Study||40
9717290|NCT00003457|10816441|FG000|COMPLETED|Overall Study||31
9717291|NCT00003457|10816441|FG000|NOT COMPLETED|Overall Study||9
9717292|NCT00003459|10816445|FG000|STARTED|Overall Study||40
9717293|NCT00003459|10816445|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31
9717294|NCT00003459|10816445|FG000|NOT COMPLETED|Overall Study||9
9717295|NCT00003460|10816449|FG000|STARTED|Overall Study||13
9717296|NCT00003460|10816449|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12
9717297|NCT00003460|10816449|FG000|NOT COMPLETED|Overall Study||1
9717298|NCT00003468|10816453|FG000|STARTED|Overall Study||11
9717299|NCT00003468|10816453|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9
9717300|NCT00003468|10816453|FG000|NOT COMPLETED|Overall Study||2
9717301|NCT00003469|10816457|FG000|STARTED|Overall Study||4
9717302|NCT00003469|10816457|FG000|COMPLETED|Overall Study||4
9717303|NCT00003469|10816457|FG000|NOT COMPLETED|Overall Study||0
9717304|NCT00003470|10816461|FG000|STARTED|Overall Study||27
9717305|NCT00003470|10816461|FG000|COMPLETED|Overall Study||21
9717306|NCT00003470|10816461|FG000|NOT COMPLETED|Overall Study||6
9717307|NCT00003471|10816465|FG000|STARTED|Overall Study||7
9717308|NCT00003471|10816465|FG000|COMPLETED|Overall Study||3
9717309|NCT00003471|10816465|FG000|NOT COMPLETED|Overall Study||4
9717310|NCT00003472|10816469|FG000|STARTED|Overall Study||13
9717311|NCT00003472|10816469|FG000|COMPLETED|Overall Study||10
9717312|NCT00003472|10816469|FG000|NOT COMPLETED|Overall Study||3
9717313|NCT00003473|10816473|FG000|STARTED|Overall Study||20
9717314|NCT00003473|10816473|FG000|COMPLETED|Overall Study||17
9717315|NCT00003473|10816473|FG000|NOT COMPLETED|Overall Study||3
9717316|NCT00003474|10816477|FG000|STARTED|Overall Study||40
9717317|NCT00003474|10816477|FG000|COMPLETED|Overall Study||26
9717318|NCT00003474|10816477|FG000|NOT COMPLETED|Overall Study||14
9717319|NCT00003475|10816481|FG000|STARTED|Overall Study||40
9717320|NCT00003475|10816481|FG000|COMPLETED|Overall Study||27
9717321|NCT00003475|10816481|FG000|NOT COMPLETED|Overall Study||13
9717322|NCT00003476|10816486|FG000|STARTED|Overall Study||8
9717323|NCT00003476|10816486|FG000|COMPLETED|Overall Study||7
9717324|NCT00003476|10816486|FG000|NOT COMPLETED|Overall Study||1
9717325|NCT00003477|10816490|FG000|STARTED|Overall Study||12
9717326|NCT00003477|10816490|FG000|COMPLETED|Overall Study||8
9717327|NCT00003477|10816490|FG000|NOT COMPLETED|Overall Study||4
9717328|NCT00003483|10816494|FG000|STARTED|Overall Study||3
9717329|NCT00003483|10816494|FG000|COMPLETED|Overall Study||2
9717330|NCT00003483|10816494|FG000|NOT COMPLETED|Overall Study||1
9717331|NCT00003487|10816498|FG000|STARTED|Overall Study||8
9717332|NCT00003487|10816498|FG000|COMPLETED|Overall Study||6
9717333|NCT00003487|10816498|FG000|NOT COMPLETED|Overall Study||2
9717334|NCT00003492|10816502|FG000|STARTED|Overall Study||9
9717335|NCT00003492|10816502|FG000|COMPLETED|Overall Study||3
9717336|NCT00003492|10816502|FG000|NOT COMPLETED|Overall Study||6
9717337|NCT00003498|10816506|FG000|STARTED|Overall Study||5
9717338|NCT00003498|10816506|FG000|COMPLETED|Overall Study||1
9717339|NCT00003498|10816506|FG000|NOT COMPLETED|Overall Study||4
9717340|NCT00003499|10816510|FG000|STARTED|Overall Study||31
9717341|NCT00003499|10816510|FG000|COMPLETED|Overall Study||23
9717342|NCT00003499|10816510|FG000|NOT COMPLETED|Overall Study||8
9717343|NCT00003508|10816514|FG000|STARTED|Overall Study||8
9717344|NCT00003508|10816514|FG000|COMPLETED|Overall Study||3
9717345|NCT00003508|10816514|FG000|NOT COMPLETED|Overall Study||5
9717346|NCT00003509|10816518|FG000|STARTED|Overall Study||13
9717347|NCT00003509|10816518|FG000|COMPLETED|Overall Study||8
9717348|NCT00003509|10816518|FG000|NOT COMPLETED|Overall Study||5
9717349|NCT00003511|10816522|FG000|STARTED|Overall Study||5
9717350|NCT00003511|10816522|FG000|COMPLETED|Overall Study||1
9717351|NCT00003511|10816522|FG000|NOT COMPLETED|Overall Study||4
9717352|NCT00003526|10816526|FG000|STARTED|Overall Study||8
9717353|NCT00003526|10816526|FG000|COMPLETED|Overall Study||2
9717354|NCT00003526|10816526|FG000|NOT COMPLETED|Overall Study||6
9717355|NCT00003531|10816530|FG000|STARTED|Overall Study||15
9717356|NCT00003531|10816530|FG000|COMPLETED|Overall Study||5
9717357|NCT00003531|10816530|FG000|NOT COMPLETED|Overall Study||10
9717358|NCT00003535|10816534|FG000|STARTED|Overall Study||9
9717359|NCT00003535|10816534|FG000|COMPLETED|Overall Study||4
9717360|NCT00003535|10816534|FG000|NOT COMPLETED|Overall Study||5
9717361|NCT00003537|10816538|FG000|STARTED|Overall Study||19
9717362|NCT00003537|10816538|FG000|COMPLETED|Overall Study||18
9717363|NCT00003537|10816538|FG000|NOT COMPLETED|Overall Study||1
9717364|NCT00003590|10816542|FG000|STARTED|Overall Study||29
9717365|NCT00003590|10816542|FG000|Eligible|Overall Study||28
9717366|NCT00003590|10816542|FG000|Eligible and Began Protocol Therapy|Overall Study||28
9717367|NCT00003590|10816542|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
9717368|NCT00003590|10816542|FG000|NOT COMPLETED|Overall Study||22
9717369|NCT00003631|10816549|FG000|STARTED|Overall Study||50
9717370|NCT00003631|10816550|FG001|STARTED|Overall Study||44
9717371|NCT00003631|10816551|FG002|STARTED|Overall Study||24
9717372|NCT00003631|10816549|FG000|COMPLETED|Overall Study||47
9717373|NCT00003631|10816550|FG001|COMPLETED|Overall Study||43
9717374|NCT00003631|10816551|FG002|COMPLETED|Overall Study||15
9717375|NCT00003631|10816549|FG000|NOT COMPLETED|Overall Study||3
9717376|NCT00003631|10816550|FG001|NOT COMPLETED|Overall Study||1
9717377|NCT00003631|10816551|FG002|NOT COMPLETED|Overall Study||9
9717378|NCT00003644|10816561|FG000|STARTED|Overall Study||289
9717379|NCT00003644|10816562|FG001|STARTED|Overall Study||282
9717380|NCT00003644|10816561|FG000|COMPLETED|Overall Study||274
9717381|NCT00003644|10816562|FG001|COMPLETED|Overall Study||268
9717382|NCT00003644|10816561|FG000|NOT COMPLETED|Overall Study||15
9717383|NCT00003644|10816562|FG001|NOT COMPLETED|Overall Study||14
9717384|NCT00003645|10816572|FG000|STARTED|Overall Study||30
9717385|NCT00003645|10816573|FG001|STARTED|Overall Study||34
9717386|NCT00003645|10816572|FG000|COMPLETED|Overall Study||18
9850069|NCT00868790|10962858|FG000|COMPLETED|Period 2||9
9850070|NCT00868790|10962859|FG001|COMPLETED|Period 2||6
9850071|NCT00868790|10962860|FG002|COMPLETED|Period 2||4
9850072|NCT00868790|10962861|FG003|COMPLETED|Period 2||4
9850073|NCT00868790|10962862|FG004|COMPLETED|Period 2||18
9850074|NCT00868790|10962863|FG005|COMPLETED|Period 2||1
9850075|NCT00868790|10962864|FG006|COMPLETED|Period 2||4
9850076|NCT00868790|10962865|FG007|COMPLETED|Period 2||17
9850077|NCT00868790|10962866|FG008|COMPLETED|Period 2||8
9850078|NCT00868790|10962867|FG009|COMPLETED|Period 2||3
9850079|NCT00868790|10962868|FG010|COMPLETED|Period 2||9
9850080|NCT00868790|10962869|FG011|COMPLETED|Period 2||4
9850081|NCT00868790|10962870|FG012|COMPLETED|Period 2||7
9850082|NCT00868790|10962871|FG013|COMPLETED|Period 2||8
9850083|NCT00868790|10962858|FG000|NOT COMPLETED|Period 2||0
10061989|NCT02106403|11187427|FG002|COMPLETED|Follow-Up Visit 2||9
9717387|NCT00003645|10816573|FG001|COMPLETED|Overall Study||22
9717388|NCT00003645|10816572|FG000|NOT COMPLETED|Overall Study||12
9717389|NCT00003645|10816573|FG001|NOT COMPLETED|Overall Study||12
9850084|NCT00868790|10962859|FG001|NOT COMPLETED|Period 2||1
9850085|NCT00868790|10962860|FG002|NOT COMPLETED|Period 2||0
9850086|NCT00868790|10962861|FG003|NOT COMPLETED|Period 2||0
9850087|NCT00868790|10962862|FG004|NOT COMPLETED|Period 2||0
10061990|NCT02106403|11187428|FG003|COMPLETED|Follow-Up Visit 2||8
10061991|NCT02106403|11187429|FG004|COMPLETED|Follow-Up Visit 2||8
10061992|NCT02106403|11187430|FG005|COMPLETED|Follow-Up Visit 2||9
10061993|NCT02106403|11187425|FG000|NOT COMPLETED|Follow-Up Visit 2||0
10061994|NCT02106403|11187426|FG001|NOT COMPLETED|Follow-Up Visit 2||0
10061995|NCT02106403|11187427|FG002|NOT COMPLETED|Follow-Up Visit 2||0
10061996|NCT02106403|11187428|FG003|NOT COMPLETED|Follow-Up Visit 2||0
10061997|NCT02106403|11187429|FG004|NOT COMPLETED|Follow-Up Visit 2||0
10061998|NCT02106403|11187430|FG005|NOT COMPLETED|Follow-Up Visit 2||0
10061999|NCT02106403|11187425|FG000|STARTED|Follow-Up Visit 3||8
10062000|NCT02106403|11187426|FG001|STARTED|Follow-Up Visit 3||8
10062001|NCT02106403|11187427|FG002|STARTED|Follow-Up Visit 3||9
10062002|NCT02106403|11187428|FG003|STARTED|Follow-Up Visit 3||8
10062003|NCT02106403|11187429|FG004|STARTED|Follow-Up Visit 3||8
10062004|NCT02106403|11187430|FG005|STARTED|Follow-Up Visit 3||9
10062005|NCT02106403|11187425|FG000|COMPLETED|Follow-Up Visit 3||8
10062006|NCT02106403|11187426|FG001|COMPLETED|Follow-Up Visit 3||8
10062007|NCT02106403|11187427|FG002|COMPLETED|Follow-Up Visit 3||9
10062008|NCT02106403|11187428|FG003|COMPLETED|Follow-Up Visit 3||8
10062009|NCT02106403|11187429|FG004|COMPLETED|Follow-Up Visit 3||8
10062010|NCT02106403|11187430|FG005|COMPLETED|Follow-Up Visit 3||8
10062011|NCT02106403|11187425|FG000|NOT COMPLETED|Follow-Up Visit 3||0
10062012|NCT02106403|11187426|FG001|NOT COMPLETED|Follow-Up Visit 3||0
10062013|NCT02106403|11187427|FG002|NOT COMPLETED|Follow-Up Visit 3||0
10062014|NCT02106403|11187428|FG003|NOT COMPLETED|Follow-Up Visit 3||0
10062015|NCT02106403|11187429|FG004|NOT COMPLETED|Follow-Up Visit 3||0
10062016|NCT02106403|11187430|FG005|NOT COMPLETED|Follow-Up Visit 3||1
10062017|NCT02106442|11187440|FG000|STARTED|Overall Study||579
10062018|NCT02106442|11187440|FG000|COMPLETED|Overall Study||542
10062019|NCT02106442|11187440|FG000|NOT COMPLETED|Overall Study||37
10062020|NCT02106455|11187444|FG000|STARTED|Overall Study||315
10062021|NCT02106455|11187444|FG000|COMPLETED|Overall Study||307
10062022|NCT02106455|11187444|FG000|NOT COMPLETED|Overall Study||8
10062023|NCT02106494|11187450|FG000|STARTED|Overall Study||471
10062024|NCT02106494|11187451|FG001|STARTED|Overall Study||471
10062025|NCT02106494|11187450|FG000|Safety Population|Overall Study||456
10062026|NCT02106494|11187451|FG001|Safety Population|Overall Study||459
10062027|NCT02106494|11187450|FG000|Efficacy Population|Overall Study||450
10062028|NCT02106494|11187451|FG001|Efficacy Population|Overall Study||452
10062029|NCT02106494|11187450|FG000|COMPLETED|Overall Study||445
10062030|NCT02106494|11187451|FG001|COMPLETED|Overall Study||446
10062031|NCT02106494|11187450|FG000|NOT COMPLETED|Overall Study||26
10062032|NCT02106494|11187451|FG001|NOT COMPLETED|Overall Study||25
10062033|NCT02106728|11187461|FG000|STARTED|Overall Study||70
9717390|NCT00003659|10816581|FG000|STARTED|Overall Study||39
9717391|NCT00003659|10816581|FG000|COMPLETED|Overall Study||36
9717392|NCT00003659|10816581|FG000|NOT COMPLETED|Overall Study||3
9717393|NCT00003702|10816587|FG000|STARTED|Overall Study||120
9717394|NCT00003702|10816588|FG001|STARTED|Overall Study||120
9717395|NCT00003702|10816587|FG000|COMPLETED|Overall Study||107
9717396|NCT00003702|10816588|FG001|COMPLETED|Overall Study||109
9717397|NCT00003702|10816587|FG000|NOT COMPLETED|Overall Study||13
9717398|NCT00003702|10816588|FG001|NOT COMPLETED|Overall Study||11
9717399|NCT00003782|10816598|FG000|STARTED|Overall Study||1783
9717400|NCT00003782|10816599|FG001|STARTED|Overall Study||1784
9717401|NCT00003782|10816600|FG002|STARTED|Overall Study||1784
9717402|NCT00003782|10816598|FG000|COMPLETED|Overall Study||1753
9717403|NCT00003782|10816599|FG001|COMPLETED|Overall Study||1753
9717404|NCT00003782|10816600|FG002|COMPLETED|Overall Study||1758
9717405|NCT00003782|10816598|FG000|NOT COMPLETED|Overall Study||30
9850088|NCT00868790|10962863|FG005|NOT COMPLETED|Period 2||1
9850089|NCT00868790|10962864|FG006|NOT COMPLETED|Period 2||0
9850090|NCT00868790|10962865|FG007|NOT COMPLETED|Period 2||0
9850091|NCT00868790|10962866|FG008|NOT COMPLETED|Period 2||2
9850092|NCT00868790|10962867|FG009|NOT COMPLETED|Period 2||0
9850093|NCT00868790|10962868|FG010|NOT COMPLETED|Period 2||0
9850094|NCT00868790|10962869|FG011|NOT COMPLETED|Period 2||0
9850095|NCT00868790|10962870|FG012|NOT COMPLETED|Period 2||0
9850096|NCT00868790|10962871|FG013|NOT COMPLETED|Period 2||1
9850097|NCT00868790|10962858|FG000|STARTED|Period 3||9
9850098|NCT00868790|10962859|FG001|STARTED|Period 3||6
9850099|NCT00868790|10962860|FG002|STARTED|Period 3||4
9850100|NCT00868790|10962861|FG003|STARTED|Period 3||4
9850101|NCT00868790|10962862|FG004|STARTED|Period 3||18
9850102|NCT00868790|10962863|FG005|STARTED|Period 3||1
9850103|NCT00868790|10962864|FG006|STARTED|Period 3||4
9850104|NCT00868790|10962865|FG007|STARTED|Period 3||17
9850105|NCT00868790|10962866|FG008|STARTED|Period 3||8
9850106|NCT00868790|10962867|FG009|STARTED|Period 3||3
9850107|NCT00868790|10962868|FG010|STARTED|Period 3||9
9850108|NCT00868790|10962869|FG011|STARTED|Period 3||4
9850109|NCT00868790|10962870|FG012|STARTED|Period 3||7
9850110|NCT00868790|10962871|FG013|STARTED|Period 3||8
9850111|NCT00868790|10962858|FG000|COMPLETED|Period 3||9
9850112|NCT00868790|10962859|FG001|COMPLETED|Period 3||6
9850113|NCT00868790|10962860|FG002|COMPLETED|Period 3||4
9850114|NCT00868790|10962861|FG003|COMPLETED|Period 3||3
9850115|NCT00868790|10962862|FG004|COMPLETED|Period 3||18
9850116|NCT00868790|10962863|FG005|COMPLETED|Period 3||1
9850117|NCT00868790|10962864|FG006|COMPLETED|Period 3||4
9850118|NCT00868790|10962865|FG007|COMPLETED|Period 3||17
9850119|NCT00868790|10962866|FG008|COMPLETED|Period 3||8
9850120|NCT00868790|10962867|FG009|COMPLETED|Period 3||2
9850121|NCT00868790|10962868|FG010|COMPLETED|Period 3||8
9850122|NCT00868790|10962869|FG011|COMPLETED|Period 3||4
9850123|NCT00868790|10962870|FG012|COMPLETED|Period 3||7
9850124|NCT00868790|10962871|FG013|COMPLETED|Period 3||8
9850125|NCT00868790|10962858|FG000|NOT COMPLETED|Period 3||0
9850126|NCT00868790|10962859|FG001|NOT COMPLETED|Period 3||0
9850127|NCT00868790|10962860|FG002|NOT COMPLETED|Period 3||0
9850128|NCT00868790|10962861|FG003|NOT COMPLETED|Period 3||1
9850129|NCT00868790|10962862|FG004|NOT COMPLETED|Period 3||0
9850130|NCT00868790|10962863|FG005|NOT COMPLETED|Period 3||0
9850131|NCT00868790|10962864|FG006|NOT COMPLETED|Period 3||0
9850132|NCT00868790|10962865|FG007|NOT COMPLETED|Period 3||0
9850133|NCT00868790|10962866|FG008|NOT COMPLETED|Period 3||0
9850134|NCT00868790|10962867|FG009|NOT COMPLETED|Period 3||1
9850135|NCT00868790|10962868|FG010|NOT COMPLETED|Period 3||1
9850136|NCT00868790|10962869|FG011|NOT COMPLETED|Period 3||0
9850137|NCT00868790|10962870|FG012|NOT COMPLETED|Period 3||0
9850138|NCT00868790|10962871|FG013|NOT COMPLETED|Period 3||0
9850139|NCT00868790|10962858|FG000|STARTED|Period 4||9
9850140|NCT00868790|10962859|FG001|STARTED|Period 4||6
9850141|NCT00868790|10962860|FG002|STARTED|Period 4||4
9850142|NCT00868790|10962861|FG003|STARTED|Period 4||3
9850143|NCT00868790|10962862|FG004|STARTED|Period 4||18
9850144|NCT00868790|10962863|FG005|STARTED|Period 4||1
9850145|NCT00868790|10962864|FG006|STARTED|Period 4||4
9850146|NCT00868790|10962865|FG007|STARTED|Period 4||17
9850147|NCT00868790|10962866|FG008|STARTED|Period 4||8
9850148|NCT00868790|10962867|FG009|STARTED|Period 4||2
9850149|NCT00868790|10962868|FG010|STARTED|Period 4||8
10062034|NCT02106728|11187462|FG001|STARTED|Overall Study||47
9717406|NCT00003782|10816599|FG001|NOT COMPLETED|Overall Study||31
9717407|NCT00003782|10816600|FG002|NOT COMPLETED|Overall Study||26
9717408|NCT00003816|10816613|FG000|STARTED|Overall Study||55
9850150|NCT00868790|10962869|FG011|STARTED|Period 4||4
9850151|NCT00868790|10962870|FG012|STARTED|Period 4||7
9850152|NCT00868790|10962871|FG013|STARTED|Period 4||8
9850153|NCT00868790|10962858|FG000|COMPLETED|Period 4||7
9850154|NCT00868790|10962859|FG001|COMPLETED|Period 4||6
9850155|NCT00868790|10962860|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
9850156|NCT00868790|10962861|FG003|COMPLETED|Period 4||3
9850157|NCT00868790|10962862|FG004|COMPLETED|Period 4||18
9850158|NCT00868790|10962863|FG005|COMPLETED|Period 4||1
9850159|NCT00868790|10962864|FG006|COMPLETED|Period 4||4
9850160|NCT00868790|10962865|FG007|COMPLETED|Period 4||14
9850161|NCT00868790|10962866|FG008|COMPLETED|Period 4||6
9850162|NCT00868790|10962867|FG009|COMPLETED|Period 4||2
9850163|NCT00868790|10962868|FG010|COMPLETED|Period 4||5
9850164|NCT00868790|10962869|FG011|COMPLETED|Period 4||3
9850165|NCT00868790|10962870|FG012|COMPLETED|Period 4||6
9850166|NCT00868790|10962871|FG013|COMPLETED|Period 4||7
9850167|NCT00868790|10962858|FG000|NOT COMPLETED|Period 4||2
9850168|NCT00868790|10962859|FG001|NOT COMPLETED|Period 4||0
9850169|NCT00868790|10962860|FG002|NOT COMPLETED|Period 4||1
9850170|NCT00868790|10962861|FG003|NOT COMPLETED|Period 4||0
9850171|NCT00868790|10962862|FG004|NOT COMPLETED|Period 4||0
9850172|NCT00868790|10962863|FG005|NOT COMPLETED|Period 4||0
9850173|NCT00868790|10962864|FG006|NOT COMPLETED|Period 4||0
9850174|NCT00868790|10962865|FG007|NOT COMPLETED|Period 4||3
9850175|NCT00868790|10962866|FG008|NOT COMPLETED|Period 4||2
9850176|NCT00868790|10962867|FG009|NOT COMPLETED|Period 4||0
9850177|NCT00868790|10962868|FG010|NOT COMPLETED|Period 4||3
9850178|NCT00868790|10962869|FG011|NOT COMPLETED|Period 4||1
9850179|NCT00868790|10962870|FG012|NOT COMPLETED|Period 4||1
9850180|NCT00868790|10962871|FG013|NOT COMPLETED|Period 4||1
9850181|NCT00868790|10962858|FG000|STARTED|Post-study||7
9850182|NCT00868790|10962859|FG001|STARTED|Post-study||6
10062035|NCT02106728|11187461|FG000|COMPLETED|Overall Study||70
10062036|NCT02106728|11187462|FG001|COMPLETED|Overall Study||47
10062037|NCT02106728|11187461|FG000|NOT COMPLETED|Overall Study||0
10062038|NCT02106728|11187462|FG001|NOT COMPLETED|Overall Study||0
10062039|NCT02106832|11187478|FG000|STARTED|Overall Study||171
10062040|NCT02106832|11187479|FG001|STARTED|Overall Study||176
10062041|NCT02106832|11187480|FG002|STARTED|Overall Study||86
10062042|NCT02106832|11187481|FG003|STARTED|Overall Study||88
10062043|NCT02106832|11187478|FG000|Participants Received Treatment|Overall Study||171
10062044|NCT02106832|11187479|FG001|Participants Received Treatment|Overall Study||174
10062045|NCT02106832|11187480|FG002|Participants Received Treatment|Overall Study||86
10062046|NCT02106832|11187481|FG003|Participants Received Treatment|Overall Study||88
10062047|NCT02106832|11187478|FG000|COMPLETED|Overall Study||148
10062048|NCT02106832|11187479|FG001|COMPLETED|Overall Study||151
10062049|NCT02106832|11187480|FG002|COMPLETED|Overall Study||70
10062050|NCT02106832|11187481|FG003|COMPLETED|Overall Study||73
10062051|NCT02106832|11187478|FG000|NOT COMPLETED|Overall Study||23
10062052|NCT02106832|11187479|FG001|NOT COMPLETED|Overall Study||25
10062053|NCT02106832|11187480|FG002|NOT COMPLETED|Overall Study||16
10062054|NCT02106832|11187481|FG003|NOT COMPLETED|Overall Study||15
10062055|NCT02106884|11187495|FG000|STARTED|Overall Study||72
10062056|NCT02106884|11187496|FG001|STARTED|Overall Study||74
10062057|NCT02106884|11187495|FG000|COMPLETED|Overall Study||72
10062058|NCT02106884|11187496|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
10062059|NCT02106884|11187495|FG000|NOT COMPLETED|Overall Study||0
10062060|NCT02106884|11187496|FG001|NOT COMPLETED|Overall Study||1
10062061|NCT02106910|11187507|FG000|STARTED|Overall Study||49
10062062|NCT02106910|11187508|FG001|STARTED|Overall Study||89
10062063|NCT02106910|11187507|FG000|COMPLETED|Overall Study||48
10062064|NCT02106910|11187508|FG001|COMPLETED|Overall Study||88
10062065|NCT02106910|11187507|FG000|NOT COMPLETED|Overall Study||1
10062066|NCT02106910|11187508|FG001|NOT COMPLETED|Overall Study||1
10062067|NCT02106923|11187518|FG000|STARTED|Overall Study||12
10062068|NCT02106923|11187519|FG001|STARTED|Overall Study||12
10062069|NCT02106923|11187520|FG002|STARTED|Overall Study||12
10062070|NCT02106923|11187521|FG003|STARTED|Overall Study||12
10062071|NCT02106923|11187522|FG004|STARTED|Overall Study||12
10062072|NCT02106923|11187523|FG005|STARTED|Overall Study||12
10062073|NCT02106923|11187518|FG000|COMPLETED|Overall Study||12
10062074|NCT02106923|11187519|FG001|COMPLETED|Overall Study||12
10062075|NCT02106923|11187520|FG002|COMPLETED|Overall Study||12
10062076|NCT02106923|11187521|FG003|COMPLETED|Overall Study||12
10062077|NCT02106923|11187522|FG004|COMPLETED|Overall Study||12
10062078|NCT02106923|11187523|FG005|COMPLETED|Overall Study||11
10062079|NCT02106923|11187518|FG000|NOT COMPLETED|Overall Study||0
10062080|NCT02106923|11187519|FG001|NOT COMPLETED|Overall Study||0
10062081|NCT02106923|11187520|FG002|NOT COMPLETED|Overall Study||0
10062082|NCT02106923|11187521|FG003|NOT COMPLETED|Overall Study||0
10062083|NCT02106923|11187522|FG004|NOT COMPLETED|Overall Study||0
10062084|NCT02106923|11187523|FG005|NOT COMPLETED|Overall Study||1
10062085|NCT02106962|11187539|FG000|STARTED|Overall Study||8
10062086|NCT02106962|11187540|FG001|STARTED|Overall Study||9
10062087|NCT02106962|11187539|FG000|COMPLETED|Overall Study||8
10062088|NCT02106962|11187540|FG001|COMPLETED|Overall Study||9
9850183|NCT00868790|10962860|FG002|STARTED|Post-study||3
10062089|NCT02106962|11187539|FG000|NOT COMPLETED|Overall Study||0
10062090|NCT02106962|11187540|FG001|NOT COMPLETED|Overall Study||0
10062091|NCT02106975|11187550|FG000|STARTED|Overall Study||84
10062092|NCT02106975|11187551|FG001|STARTED|Overall Study||83
10062093|NCT02106975|11187550|FG000|COMPLETED|Overall Study||59
10062094|NCT02106975|11187551|FG001|COMPLETED|Overall Study||44
10062095|NCT02106975|11187550|FG000|NOT COMPLETED|Overall Study||25
10062096|NCT02106975|11187551|FG001|NOT COMPLETED|Overall Study||39
10062097|NCT02107014|11187557|FG000|STARTED|Overall Study||9
9850184|NCT00868790|10962861|FG003|STARTED|Post-study||3
9850185|NCT00868790|10962862|FG004|STARTED|Post-study||18
10062098|NCT02107014|11187557|FG000|COMPLETED|Overall Study||8
10062099|NCT02107014|11187557|FG000|NOT COMPLETED|Overall Study||1
10062100|NCT02107092|11187561|FG000|STARTED|Overall Study||123
10062101|NCT02107092|11187561|FG000|COMPLETED|Overall Study||79
10062102|NCT02107092|11187561|FG000|NOT COMPLETED|Overall Study||44
10062103|NCT02107131|11187567|FG000|STARTED|Overall Study||20
10062104|NCT02107131|11187568|FG001|STARTED|Overall Study||20
10062105|NCT02107131|11187567|FG000|COMPLETED|Overall Study||12
9850186|NCT00868790|10962863|FG005|STARTED|Post-study||1
9850187|NCT00868790|10962864|FG006|STARTED|Post-study||4
9850188|NCT00868790|10962865|FG007|STARTED|Post-study||14
9850189|NCT00868790|10962866|FG008|STARTED|Post-study||6
9850190|NCT00868790|10962867|FG009|STARTED|Post-study||2
9850191|NCT00868790|10962868|FG010|STARTED|Post-study||5
9850192|NCT00868790|10962869|FG011|STARTED|Post-study||3
9850193|NCT00868790|10962870|FG012|STARTED|Post-study||6
9850194|NCT00868790|10962871|FG013|STARTED|Post-study||7
9963986|NCT01490060|11083834|FG000|STARTED|Cycle 1||11
9963987|NCT01490060|11083835|FG001|STARTED|Cycle 1||13
9963988|NCT01490060|11083836|FG002|STARTED|Cycle 1||12
9963989|NCT01490060|11083837|FG003|STARTED|Cycle 1||11
9963990|NCT01490060|11083834|FG000|COMPLETED|Cycle 1||11
9963991|NCT01490060|11083835|FG001|COMPLETED|Cycle 1||12
9963992|NCT01490060|11083836|FG002|COMPLETED|Cycle 1||9
9963993|NCT01490060|11083837|FG003|COMPLETED|Cycle 1||8
9963994|NCT01490060|11083834|FG000|NOT COMPLETED|Cycle 1||0
9963995|NCT01490060|11083835|FG001|NOT COMPLETED|Cycle 1||1
9963996|NCT01490060|11083836|FG002|NOT COMPLETED|Cycle 1||3
9963997|NCT01490060|11083837|FG003|NOT COMPLETED|Cycle 1||3
9963998|NCT01490060|11083834|FG000|STARTED|Cycle 2||11
9963999|NCT01490060|11083835|FG001|STARTED|Cycle 2||12
9964000|NCT01490060|11083836|FG002|STARTED|Cycle 2||9
9964001|NCT01490060|11083837|FG003|STARTED|Cycle 2||8
9964002|NCT01490060|11083834|FG000|COMPLETED|Cycle 2||9
9964003|NCT01490060|11083835|FG001|COMPLETED|Cycle 2||11
9964004|NCT01490060|11083836|FG002|COMPLETED|Cycle 2||8
9964005|NCT01490060|11083837|FG003|COMPLETED|Cycle 2||8
9964006|NCT01490060|11083834|FG000|NOT COMPLETED|Cycle 2||2
9964007|NCT01490060|11083835|FG001|NOT COMPLETED|Cycle 2||1
9964008|NCT01490060|11083836|FG002|NOT COMPLETED|Cycle 2||1
9964009|NCT01490060|11083837|FG003|NOT COMPLETED|Cycle 2||0
9964010|NCT01490073|11083847|FG000|STARTED|Overall Study||12
9964011|NCT01490073|11083848|FG001|STARTED|Overall Study||12
9964012|NCT01490073|11083847|FG000|COMPLETED|Overall Study||12
9964013|NCT01490073|11083848|FG001|COMPLETED|Overall Study||12
9964014|NCT01490073|11083847|FG000|NOT COMPLETED|Overall Study||0
9964015|NCT01490073|11083848|FG001|NOT COMPLETED|Overall Study||0
9964016|NCT01490086|11083859|FG000|STARTED|Overall Study||58
9964017|NCT01490086|11083860|FG001|STARTED|Overall Study||59
9964018|NCT01490086|11083861|FG002|STARTED|Overall Study||58
10062106|NCT02107131|11187568|FG001|COMPLETED|Overall Study||11
10062107|NCT02107131|11187567|FG000|NOT COMPLETED|Overall Study||8
10062108|NCT02107131|11187568|FG001|NOT COMPLETED|Overall Study||9
10062109|NCT02107157|11187579|FG000|STARTED|Overall Study||11
10062110|NCT02107157|11187580|FG001|STARTED|Overall Study||12
10062111|NCT02107157|11187581|FG002|STARTED|Overall Study||4
10062112|NCT02107157|11187579|FG000|COMPLETED|Overall Study||6
10062113|NCT02107157|11187580|FG001|COMPLETED|Overall Study||11
10062114|NCT02107157|11187581|FG002|COMPLETED|Overall Study||4
10062115|NCT02107157|11187579|FG000|NOT COMPLETED|Overall Study||5
10062116|NCT02107157|11187580|FG001|NOT COMPLETED|Overall Study||1
10062117|NCT02107157|11187581|FG002|NOT COMPLETED|Overall Study||0
10188259|NCT03266172|11317910|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0
10188260|NCT03266172|11317911|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0
10188261|NCT03266172|11317909|FG000|STARTED|Part C: Period 1(2 Days)||0
10188262|NCT03266172|11317910|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
10188263|NCT03266172|11317911|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
10188264|NCT03266172|11317909|FG000|COMPLETED|Part C: Period 1(2 Days)||0
10188265|NCT03266172|11317910|FG001|COMPLETED|Part C: Period 1(2 Days)||0
10188266|NCT03266172|11317911|FG002|COMPLETED|Part C: Period 1(2 Days)||15
10188267|NCT03266172|11317909|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0
10188268|NCT03266172|11317910|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0
10188269|NCT03266172|11317911|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0
10188270|NCT03266172|11317909|FG000|STARTED|Part C Washout Period (7 Days)||0
10188271|NCT03266172|11317910|FG001|STARTED|Part C Washout Period (7 Days)||0
10188272|NCT03266172|11317911|FG002|STARTED|Part C Washout Period (7 Days)||15
10188273|NCT03266172|11317909|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10188274|NCT03266172|11317910|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10188275|NCT03266172|11317911|FG002|COMPLETED|Part C Washout Period (7 Days)||15
10188276|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188277|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188278|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188279|NCT03266172|11317909|FG000|STARTED|Part C Period 2(2 Days)||0
10188280|NCT03266172|11317910|FG001|STARTED|Part C Period 2(2 Days)||0
10188281|NCT03266172|11317911|FG002|STARTED|Part C Period 2(2 Days)||15
10188282|NCT03266172|11317909|FG000|COMPLETED|Part C Period 2(2 Days)||0
10188283|NCT03266172|11317910|FG001|COMPLETED|Part C Period 2(2 Days)||0
10188284|NCT03266172|11317911|FG002|COMPLETED|Part C Period 2(2 Days)||15
9850195|NCT00868790|10962858|FG000|COMPLETED|Post-study||7
9964019|NCT01490086|11083862|FG003|STARTED|Overall Study||20
9964020|NCT01490086|11083863|FG004|STARTED|Overall Study||39
9964021|NCT01490086|11083859|FG000|COMPLETED|Overall Study||50
9964022|NCT01490086|11083860|FG001|COMPLETED|Overall Study||44
9964023|NCT01490086|11083861|FG002|COMPLETED|Overall Study||51
9964024|NCT01490086|11083862|FG003|COMPLETED|Overall Study||13
9964025|NCT01490086|11083863|FG004|COMPLETED|Overall Study||28
9964026|NCT01490086|11083859|FG000|NOT COMPLETED|Overall Study||8
9964027|NCT01490086|11083860|FG001|NOT COMPLETED|Overall Study||15
9850196|NCT00868790|10962859|FG001|COMPLETED|Post-study||6
9850197|NCT00868790|10962860|FG002|COMPLETED|Post-study||3
9850198|NCT00868790|10962861|FG003|COMPLETED|Post-study||3
9850199|NCT00868790|10962862|FG004|COMPLETED|Post-study||17
9850200|NCT00868790|10962863|FG005|COMPLETED|Post-study||1
9850201|NCT00868790|10962864|FG006|COMPLETED|Post-study||4
9850202|NCT00868790|10962865|FG007|COMPLETED|Post-study||12
9850203|NCT00868790|10962866|FG008|COMPLETED|Post-study||6
9850204|NCT00868790|10962867|FG009|COMPLETED|Post-study||1
9850205|NCT00868790|10962868|FG010|COMPLETED|Post-study||5
9850206|NCT00868790|10962869|FG011|COMPLETED|Post-study||3
9850207|NCT00868790|10962870|FG012|COMPLETED|Post-study||6
9850208|NCT00868790|10962871|FG013|COMPLETED|Post-study||7
9850209|NCT00868790|10962858|FG000|NOT COMPLETED|Post-study||0
9850210|NCT00868790|10962859|FG001|NOT COMPLETED|Post-study||0
9850211|NCT00868790|10962860|FG002|NOT COMPLETED|Post-study||0
9850212|NCT00868790|10962861|FG003|NOT COMPLETED|Post-study||0
9850213|NCT00868790|10962862|FG004|NOT COMPLETED|Post-study||1
9850214|NCT00868790|10962863|FG005|NOT COMPLETED|Post-study||0
9850215|NCT00868790|10962864|FG006|NOT COMPLETED|Post-study||0
9850216|NCT00868790|10962865|FG007|NOT COMPLETED|Post-study||2
9850217|NCT00868790|10962866|FG008|NOT COMPLETED|Post-study||0
9850218|NCT00868790|10962867|FG009|NOT COMPLETED|Post-study||1
9850219|NCT00868790|10962868|FG010|NOT COMPLETED|Post-study||0
9850220|NCT00868790|10962869|FG011|NOT COMPLETED|Post-study||0
9850221|NCT00868790|10962870|FG012|NOT COMPLETED|Post-study||0
9850222|NCT00868790|10962871|FG013|NOT COMPLETED|Post-study||0
9850223|NCT00868959|10962887|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
9850224|NCT00868959|10962887|FG000|COMPLETED|Overall Study||559
9850225|NCT00868959|10962887|FG000|NOT COMPLETED|Overall Study||258
9850226|NCT00869024|10962893|FG000|STARTED|Overall Study||16
9850227|NCT00869024|10962894|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
9850228|NCT00869024|10962893|FG000|COMPLETED|Overall Study||14
9850229|NCT00869024|10962894|FG001|COMPLETED|Overall Study||4
9850230|NCT00869024|10962893|FG000|NOT COMPLETED|Overall Study||2
9850231|NCT00869024|10962894|FG001|NOT COMPLETED|Overall Study||5
9850232|NCT00869050|10962900|FG000|STARTED|Overall Study||41
9850233|NCT00869050|10962900|FG000|COMPLETED|Overall Study||38
9850234|NCT00869050|10962900|FG000|NOT COMPLETED|Overall Study||3
9850235|NCT00869089|10962904|FG000|STARTED|Overall Study||5
9850236|NCT00869089|10962904|FG000|COMPLETED|Overall Study||2
9850237|NCT00869089|10962904|FG000|NOT COMPLETED|Overall Study||3
9850238|NCT00869141|10962910|FG000|STARTED|Overall Study||26
9850239|NCT00869141|10962911|FG001|STARTED|Overall Study||26
9850240|NCT00869141|10962910|FG000|COMPLETED|Overall Study||26
9850241|NCT00869141|10962911|FG001|COMPLETED|Overall Study||26
9850242|NCT00869141|10962910|FG000|NOT COMPLETED|Overall Study||0
9850243|NCT00869141|10962911|FG001|NOT COMPLETED|Overall Study||0
9850244|NCT00869167|10962921|FG000|STARTED|Overall Study||2
9850245|NCT00869167|10962922|FG001|STARTED|Overall Study||1
9850246|NCT00869167|10962921|FG000|COMPLETED|Overall Study||2
9850247|NCT00869167|10962922|FG001|COMPLETED|Overall Study||0
9850248|NCT00869167|10962921|FG000|NOT COMPLETED|Overall Study||0
9850249|NCT00869167|10962922|FG001|NOT COMPLETED|Overall Study||1
9850250|NCT00869206|10962932|FG000|STARTED|Overall Study||911
9850251|NCT00869206|10962933|FG001|STARTED|Overall Study||911
9850252|NCT00869206|10962932|FG000|COMPLETED|Overall Study||882
9850253|NCT00869206|10962933|FG001|COMPLETED|Overall Study||884
9850254|NCT00869206|10962932|FG000|NOT COMPLETED|Overall Study||29
9850255|NCT00869206|10962933|FG001|NOT COMPLETED|Overall Study||27
9850256|NCT00869323|10962945|FG000|STARTED|Induction Therapy||3
9850257|NCT00869323|10962945|FG000|COMPLETED|Induction Therapy||3
9850258|NCT00869323|10962945|FG000|NOT COMPLETED|Induction Therapy||0
9850259|NCT00869323|10962945|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
9850260|NCT00869323|10962945|FG000|COMPLETED|Maintenance Therapy||1
9850261|NCT00869323|10962945|FG000|NOT COMPLETED|Maintenance Therapy||1
9850262|NCT00869349|10962951|FG000|STARTED|Overall Study||39
9850263|NCT00869349|10962952|FG001|STARTED|Overall Study||40
9850264|NCT00869349|10962951|FG000|COMPLETED|Overall Study||32
9850265|NCT00869349|10962952|FG001|COMPLETED|Overall Study||36
9850266|NCT00869349|10962951|FG000|NOT COMPLETED|Overall Study||7
9850267|NCT00869349|10962952|FG001|NOT COMPLETED|Overall Study||4
9850268|NCT00869362|10962960|FG000|STARTED|Overall Study||15
9850269|NCT00869362|10962961|FG001|STARTED|Overall Study||16
9850270|NCT00869362|10962960|FG000|COMPLETED|Overall Study||14
9850271|NCT00869362|10962961|FG001|COMPLETED|Overall Study||11
9850272|NCT00869362|10962960|FG000|NOT COMPLETED|Overall Study||1
9850273|NCT00869362|10962961|FG001|NOT COMPLETED|Overall Study||5
9850274|NCT00869375|10962970|FG000|STARTED|Overall Study||3
9850275|NCT00869375|10962971|FG001|STARTED|Overall Study||3
9850276|NCT00869375|10962970|FG000|COMPLETED|Overall Study||3
9850277|NCT00869375|10962971|FG001|COMPLETED|Overall Study||3
9850278|NCT00869375|10962970|FG000|NOT COMPLETED|Overall Study||0
9850279|NCT00869375|10962971|FG001|NOT COMPLETED|Overall Study||0
9850280|NCT00869401|10962982|FG000|STARTED|Overall Study||3
9850281|NCT00869401|10962983|FG001|STARTED|Overall Study||3
9850282|NCT00869401|10962984|FG002|STARTED|Overall Study||7
9850283|NCT00869401|10962985|FG003|STARTED|Overall Study||138
9850284|NCT00869401|10962986|FG004|STARTED|Overall Study||66
9850285|NCT00869401|10962982|FG000|COMPLETED|Overall Study||3
9850286|NCT00869401|10962983|FG001|COMPLETED|Overall Study||3
9850287|NCT00869401|10962984|FG002|COMPLETED|Overall Study||7
9850288|NCT00869401|10962985|FG003|COMPLETED|Overall Study||133
9850289|NCT00869401|10962986|FG004|COMPLETED|Overall Study||63
9850290|NCT00869401|10962982|FG000|NOT COMPLETED|Overall Study||0
9850291|NCT00869401|10962983|FG001|NOT COMPLETED|Overall Study||0
9850292|NCT00869401|10962984|FG002|NOT COMPLETED|Overall Study||0
9850293|NCT00869401|10962985|FG003|NOT COMPLETED|Overall Study||5
9850294|NCT00869401|10962986|FG004|NOT COMPLETED|Overall Study||3
9850295|NCT00869440|10963002|FG000|STARTED|Overall Study||25
9850296|NCT00869440|10963003|FG001|STARTED|Overall Study||25
9850297|NCT00869440|10963004|FG002|STARTED|Overall Study||25
9850298|NCT00869440|10963005|FG003|STARTED|Overall Study||25
9850299|NCT00869440|10963002|FG000|COMPLETED|Overall Study||23
9850300|NCT00869440|10963003|FG001|COMPLETED|Overall Study||24
9850301|NCT00869440|10963004|FG002|COMPLETED|Overall Study||25
9850302|NCT00869440|10963005|FG003|COMPLETED|Overall Study||25
9850303|NCT00869440|10963002|FG000|NOT COMPLETED|Overall Study||2
9850304|NCT00869440|10963003|FG001|NOT COMPLETED|Overall Study||1
9850305|NCT00869440|10963004|FG002|NOT COMPLETED|Overall Study||0
9850306|NCT00869440|10963005|FG003|NOT COMPLETED|Overall Study||0
9850307|NCT00869518|10963017|FG000|STARTED|Overall Study||6
9850308|NCT00869518|10963018|FG001|STARTED|Overall Study||6
9850309|NCT00869518|10963017|FG000|COMPLETED|Overall Study||5
9850310|NCT00869518|10963018|FG001|COMPLETED|Overall Study||5
9850311|NCT00869518|10963017|FG000|NOT COMPLETED|Overall Study||1
9850312|NCT00869518|10963018|FG001|NOT COMPLETED|Overall Study||1
9850313|NCT00869557|10963026|FG000|STARTED|Randomized Phase||48
9850314|NCT00869557|10963027|FG001|STARTED|Randomized Phase||23
9850315|NCT00869557|10963026|FG000|COMPLETED|Randomized Phase||45
9850316|NCT00869557|10963027|FG001|COMPLETED|Randomized Phase||21
9850317|NCT00869557|10963026|FG000|NOT COMPLETED|Randomized Phase||3
9850318|NCT00869557|10963027|FG001|NOT COMPLETED|Randomized Phase||2
9850319|NCT00869557|10963026|FG000|STARTED|Extension Phase||45
9850320|NCT00869557|10963027|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
9850321|NCT00869557|10963026|FG000|COMPLETED|Extension Phase||35
9850322|NCT00869557|10963027|FG001|COMPLETED|Extension Phase||11
9850323|NCT00869557|10963026|FG000|NOT COMPLETED|Extension Phase||10
9850324|NCT00869557|10963027|FG001|NOT COMPLETED|Extension Phase||3
9850325|NCT00869609|10963036|FG000|STARTED|Overall Study||31
9850326|NCT00869609|10963037|FG001|STARTED|Overall Study||29
9850327|NCT00869609|10963036|FG000|COMPLETED|Overall Study||25
9850328|NCT00869609|10963037|FG001|COMPLETED|Overall Study||26
9850329|NCT00869609|10963036|FG000|NOT COMPLETED|Overall Study||6
9850330|NCT00869609|10963037|FG001|NOT COMPLETED|Overall Study||3
9850331|NCT00869622|10963045|FG000|STARTED|Overall Study||40
9850332|NCT00869622|10963046|FG001|STARTED|Overall Study||40
9850333|NCT00869622|10963045|FG000|COMPLETED|Overall Study||27
9850334|NCT00869622|10963046|FG001|COMPLETED|Overall Study||26
9850335|NCT00869622|10963045|FG000|NOT COMPLETED|Overall Study||13
9850336|NCT00869622|10963046|FG001|NOT COMPLETED|Overall Study||14
9850337|NCT00869778|10963056|FG000|STARTED|Overall Study||120
9850338|NCT00869778|10963057|FG001|STARTED|Overall Study||120
9850339|NCT00869778|10963058|FG002|STARTED|Overall Study||120
9850340|NCT00869778|10963056|FG000|COMPLETED|Overall Study||108
9850341|NCT00869778|10963057|FG001|COMPLETED|Overall Study||113
9850342|NCT00869778|10963058|FG002|COMPLETED|Overall Study||110
9850343|NCT00869778|10963056|FG000|NOT COMPLETED|Overall Study||12
9850344|NCT00869778|10963057|FG001|NOT COMPLETED|Overall Study||7
9850345|NCT00869778|10963058|FG002|NOT COMPLETED|Overall Study||10
9850346|NCT00869791|10963069|FG000|STARTED|Period 1 Treatment for 7 Days||14
9850347|NCT00869791|10963070|FG001|STARTED|Period 1 Treatment for 7 Days||13
9850348|NCT00869791|10963069|FG000|COMPLETED|Period 1 Treatment for 7 Days||14
9850349|NCT00869791|10963070|FG001|COMPLETED|Period 1 Treatment for 7 Days||13
9850350|NCT00869791|10963069|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0
9850351|NCT00869791|10963070|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0
9850352|NCT00869791|10963069|FG000|STARTED|Period 2 Treatment for 7 Days||14
9850353|NCT00869791|10963070|FG001|STARTED|Period 2 Treatment for 7 Days||13
9850354|NCT00869791|10963069|FG000|COMPLETED|Period 2 Treatment for 7 Days||14
9850355|NCT00869791|10963070|FG001|COMPLETED|Period 2 Treatment for 7 Days||13
9850356|NCT00869791|10963069|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0
9850357|NCT00869791|10963070|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0
9850358|NCT00869947|10963078|FG000|STARTED|Overall Study||8
9850359|NCT00869947|10963079|FG001|STARTED|Overall Study||8
9850360|NCT00869947|10963078|FG000|COMPLETED|Overall Study||8
9850361|NCT00869947|10963079|FG001|COMPLETED|Overall Study||8
9850362|NCT00869947|10963078|FG000|NOT COMPLETED|Overall Study||0
10062118|NCT02107196|11187591|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
10062119|NCT02107196|11187592|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
9850363|NCT00869947|10963079|FG001|NOT COMPLETED|Overall Study||0
9850364|NCT00869960|10963087|FG000|STARTED|Overall Study||24
9850365|NCT00869960|10963087|FG000|COMPLETED|Overall Study||22
9850366|NCT00869960|10963087|FG000|NOT COMPLETED|Overall Study||2
9850367|NCT00869999|10963091|FG000|STARTED|Overall Study||26
9850368|NCT00869999|10963091|FG000|COMPLETED|Overall Study||24
9850369|NCT00869999|10963091|FG000|NOT COMPLETED|Overall Study||2
9850370|NCT00870103|10963095|FG000|STARTED|Overall Study||64
9850371|NCT00870103|10963095|FG000|COMPLETED|Overall Study||60
9850372|NCT00870103|10963095|FG000|NOT COMPLETED|Overall Study||4
9850373|NCT00870194|10963101|FG000|STARTED|Overall Study||127
9850374|NCT00870194|10963102|FG001|STARTED|Overall Study||128
9850375|NCT00870194|10963101|FG000|Per Protocol Set|Overall Study||97
9850376|NCT00870194|10963102|FG001|Per Protocol Set|Overall Study||111
9850377|NCT00870194|10963101|FG000|COMPLETED|Overall Study||101
9850378|NCT00870194|10963102|FG001|COMPLETED|Overall Study||114
9850379|NCT00870194|10963101|FG000|NOT COMPLETED|Overall Study||26
9850380|NCT00870194|10963102|FG001|NOT COMPLETED|Overall Study||14
9850381|NCT00870233|10963108|FG000|STARTED|Overall Study||120
9850382|NCT00870233|10963108|FG000|COMPLETED|Overall Study||96
9850383|NCT00870233|10963108|FG000|NOT COMPLETED|Overall Study||24
9850384|NCT00870363|10963117|FG000|STARTED|Overall Study||10
9850385|NCT00870363|10963118|FG001|STARTED|Overall Study||11
9850386|NCT00870363|10963119|FG002|STARTED|Overall Study||11
9850387|NCT00870363|10963120|FG003|STARTED|Overall Study||12
9850388|NCT00870363|10963117|FG000|COMPLETED|Overall Study||10
9850389|NCT00870363|10963118|FG001|COMPLETED|Overall Study||8
9850390|NCT00870363|10963119|FG002|COMPLETED|Overall Study||8
9850391|NCT00870363|10963120|FG003|COMPLETED|Overall Study||12
9850392|NCT00870363|10963117|FG000|NOT COMPLETED|Overall Study||0
9850393|NCT00870363|10963118|FG001|NOT COMPLETED|Overall Study||3
9850394|NCT00870363|10963119|FG002|NOT COMPLETED|Overall Study||3
9850395|NCT00870363|10963120|FG003|NOT COMPLETED|Overall Study||0
9850396|NCT00870467|10963132|FG000|STARTED|Double-blind||171
9850397|NCT00870467|10963133|FG001|STARTED|Double-blind||163
9850398|NCT00870467|10963134|FG002|STARTED|Double-blind||0
9850399|NCT00870467|10963135|FG003|STARTED|Double-blind||0
9850400|NCT00870467|10963136|FG004|STARTED|Double-blind||0
9850401|NCT00870467|10963137|FG005|STARTED|Double-blind||0
9850402|NCT00870467|10963132|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
9850403|NCT00870467|10963133|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
9850404|NCT00870467|10963134|FG002|COMPLETED|Double-blind||0
9850405|NCT00870467|10963135|FG003|COMPLETED|Double-blind||0
9850406|NCT00870467|10963136|FG004|COMPLETED|Double-blind||0
9850407|NCT00870467|10963137|FG005|COMPLETED|Double-blind||0
9850408|NCT00870467|10963132|FG000|NOT COMPLETED|Double-blind||16
9850409|NCT00870467|10963133|FG001|NOT COMPLETED|Double-blind||12
9850410|NCT00870467|10963134|FG002|NOT COMPLETED|Double-blind||0
9850411|NCT00870467|10963135|FG003|NOT COMPLETED|Double-blind||0
9850412|NCT00870467|10963136|FG004|NOT COMPLETED|Double-blind||0
9850413|NCT00870467|10963137|FG005|NOT COMPLETED|Double-blind||0
9850414|NCT00870467|10963132|FG000|STARTED|Open-label||0
9850415|NCT00870467|10963133|FG001|STARTED|Open-label||0
9850416|NCT00870467|10963134|FG002|STARTED|Open-label||145
9850417|NCT00870467|10963135|FG003|STARTED|Open-label||127
9850418|NCT00870467|10963136|FG004|STARTED|Open-label||10
9850419|NCT00870467|10963137|FG005|STARTED|Open-label||24
9850420|NCT00870467|10963132|FG000|COMPLETED|Open-label||0
9850421|NCT00870467|10963133|FG001|COMPLETED|Open-label||0
9850422|NCT00870467|10963134|FG002|COMPLETED|Open-label||132
9850423|NCT00870467|10963135|FG003|COMPLETED|Open-label||120
9850424|NCT00870467|10963136|FG004|COMPLETED|Open-label||5
9850425|NCT00870467|10963137|FG005|COMPLETED|Open-label||21
9850426|NCT00870467|10963132|FG000|NOT COMPLETED|Open-label||0
9850427|NCT00870467|10963133|FG001|NOT COMPLETED|Open-label||0
9850428|NCT00870467|10963134|FG002|NOT COMPLETED|Open-label||13
9850429|NCT00870467|10963135|FG003|NOT COMPLETED|Open-label||7
9850430|NCT00870467|10963136|FG004|NOT COMPLETED|Open-label||5
9850431|NCT00870467|10963137|FG005|NOT COMPLETED|Open-label||3
9850432|NCT00870545|10963149|FG000|STARTED|Overall Study||86
9850433|NCT00870545|10963149|FG000|COMPLETED|Overall Study||69
9850434|NCT00870545|10963149|FG000|NOT COMPLETED|Overall Study||17
9850435|NCT00870584|10963155|FG000|STARTED|Overall Study||136
9850436|NCT00870584|10963156|FG001|STARTED|Overall Study||135
9850437|NCT00870584|10963155|FG000|COMPLETED|Overall Study||120
9850438|NCT00870584|10963156|FG001|COMPLETED|Overall Study||122
9850439|NCT00870584|10963155|FG000|NOT COMPLETED|Overall Study||16
9850440|NCT00870584|10963156|FG001|NOT COMPLETED|Overall Study||13
9850441|NCT00870727|10963164|FG000|STARTED|Overall Study||17
9850442|NCT00870727|10963165|FG001|STARTED|Overall Study||16
9850443|NCT00870727|10963164|FG000|COMPLETED|Overall Study||16
9850444|NCT00870727|10963165|FG001|COMPLETED|Overall Study||11
9850445|NCT00870727|10963164|FG000|NOT COMPLETED|Overall Study||1
9850446|NCT00870727|10963165|FG001|NOT COMPLETED|Overall Study||5
9850447|NCT00870740|10963177|FG000|STARTED|Overall Study|number randomized and dosed|86
9850448|NCT00870740|10963178|FG001|STARTED|Overall Study|number randomized and dosed|84
9850449|NCT00870740|10963179|FG002|STARTED|Overall Study|number randomized and dosed|86
9850450|NCT00870740|10963180|FG003|STARTED|Overall Study|number randomized and dosed|86
9850451|NCT00870740|10963181|FG004|STARTED|Overall Study|number randomized and dosed|88
9850452|NCT00870740|10963182|FG005|STARTED|Overall Study|number randomized and dosed|87
9850453|NCT00870740|10963177|FG000|COMPLETED|Overall Study||74
9850454|NCT00870740|10963178|FG001|COMPLETED|Overall Study||75
9850455|NCT00870740|10963179|FG002|COMPLETED|Overall Study||76
9850456|NCT00870740|10963180|FG003|COMPLETED|Overall Study||74
9850457|NCT00870740|10963181|FG004|COMPLETED|Overall Study||77
9850458|NCT00870740|10963182|FG005|COMPLETED|Overall Study||70
9850459|NCT00870740|10963177|FG000|NOT COMPLETED|Overall Study||12
9850460|NCT00870740|10963178|FG001|NOT COMPLETED|Overall Study||9
9850461|NCT00870740|10963179|FG002|NOT COMPLETED|Overall Study||10
9850462|NCT00870740|10963180|FG003|NOT COMPLETED|Overall Study||12
9850463|NCT00870740|10963181|FG004|NOT COMPLETED|Overall Study||11
9850464|NCT00870740|10963182|FG005|NOT COMPLETED|Overall Study||17
9850465|NCT00870870|10963211|FG000|STARTED|Overall Study||4
9850466|NCT00870870|10963212|FG001|STARTED|Overall Study||6
9850467|NCT00870870|10963213|FG002|STARTED|Overall Study||29
9850468|NCT00870870|10963214|FG003|STARTED|Overall Study||25
9850469|NCT00870870|10963211|FG000|COMPLETED|Overall Study||4
9850470|NCT00870870|10963212|FG001|COMPLETED|Overall Study||5
9850471|NCT00870870|10963213|FG002|COMPLETED|Overall Study||26
9850472|NCT00870870|10963214|FG003|COMPLETED|Overall Study||20
9850473|NCT00870870|10963211|FG000|NOT COMPLETED|Overall Study||0
9850474|NCT00870870|10963212|FG001|NOT COMPLETED|Overall Study||1
9850475|NCT00870870|10963213|FG002|NOT COMPLETED|Overall Study||3
9850476|NCT00870870|10963214|FG003|NOT COMPLETED|Overall Study||5
9850477|NCT00870896|10963229|FG000|STARTED|Overall Study||5
9850478|NCT00870896|10963229|FG000|COMPLETED|Overall Study||5
9850479|NCT00870896|10963229|FG000|NOT COMPLETED|Overall Study||0
9850480|NCT00871000|10963237|FG000|STARTED|Overall Study||151
9850481|NCT00871000|10963238|FG001|STARTED|Overall Study||152
9850482|NCT00871000|10963237|FG000|COMPLETED|Overall Study||150
9850483|NCT00871000|10963238|FG001|COMPLETED|Overall Study||152
9850484|NCT00871000|10963237|FG000|NOT COMPLETED|Overall Study||1
9850485|NCT00871000|10963238|FG001|NOT COMPLETED|Overall Study||0
9850486|NCT00871117|10963246|FG000|STARTED|Overall Study||239
9850487|NCT00871117|10963247|FG001|STARTED|Overall Study||237
9850488|NCT00871117|10963246|FG000|COMPLETED|Overall Study||234
9850489|NCT00871117|10963247|FG001|COMPLETED|Overall Study||227
9850490|NCT00871117|10963246|FG000|NOT COMPLETED|Overall Study||5
9850491|NCT00871117|10963247|FG001|NOT COMPLETED|Overall Study||10
9850492|NCT00871143|10963256|FG000|STARTED|Overall Study||21
9850493|NCT00871143|10963257|FG001|STARTED|Overall Study||25
9850494|NCT00871143|10963256|FG000|COMPLETED|Overall Study||21
9850495|NCT00871143|10963257|FG001|COMPLETED|Overall Study||25
9850496|NCT00871143|10963256|FG000|NOT COMPLETED|Overall Study||0
9850497|NCT00871143|10963257|FG001|NOT COMPLETED|Overall Study||0
9850498|NCT00871169|10963263|FG000|STARTED|Overall Study||61
9850499|NCT00871169|10963263|FG000|COMPLETED|Overall Study||58
9850500|NCT00871169|10963263|FG000|NOT COMPLETED|Overall Study||3
9850501|NCT00871234|10963267|FG000|STARTED|Overall Study||28
9850502|NCT00871234|10963267|FG000|COMPLETED|Overall Study||23
9850503|NCT00871234|10963267|FG000|NOT COMPLETED|Overall Study||5
10062120|NCT02107196|11187591|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
10062121|NCT02107196|11187592|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
10062122|NCT02107196|11187591|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
10062123|NCT02107196|11187592|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
10062124|NCT02107196|11187591|FG000|COMPLETED|12-week Treatment Period||227
10062125|NCT02107196|11187592|FG001|COMPLETED|12-week Treatment Period||225
10062126|NCT02107196|11187591|FG000|NOT COMPLETED|12-week Treatment Period||44
10062127|NCT02107196|11187592|FG001|NOT COMPLETED|12-week Treatment Period||39
9850504|NCT00871260|10963271|FG000|STARTED|Overall Study||20
9850505|NCT00871260|10963271|FG000|COMPLETED|Overall Study||20
9850506|NCT00871260|10963271|FG000|NOT COMPLETED|Overall Study||0
9850507|NCT00871286|10963277|FG000|STARTED|Overall Study||20
9850508|NCT00871286|10963278|FG001|STARTED|Overall Study||20
9850509|NCT00871286|10963277|FG000|COMPLETED|Overall Study||20
9850510|NCT00871286|10963278|FG001|COMPLETED|Overall Study||14
9850511|NCT00871286|10963277|FG000|NOT COMPLETED|Overall Study||0
9850512|NCT00871286|10963278|FG001|NOT COMPLETED|Overall Study||6
9964028|NCT01490086|11083861|FG002|NOT COMPLETED|Overall Study||7
9964029|NCT01490086|11083862|FG003|NOT COMPLETED|Overall Study||7
9964030|NCT01490086|11083863|FG004|NOT COMPLETED|Overall Study||11
9964031|NCT01490125|11083875|FG000|STARTED|Period I||43
9964032|NCT01490125|11083876|FG001|STARTED|Period I||42
9964033|NCT01490125|11083877|FG002|STARTED|Period I||41
9964034|NCT01490125|11083878|FG003|STARTED|Period I||38
9964035|NCT01490125|11083879|FG004|STARTED|Period I||40
9964036|NCT01490125|11083880|FG005|STARTED|Period I||42
9964037|NCT01490125|11083875|FG000|COMPLETED|Period I||37
9964038|NCT01490125|11083876|FG001|COMPLETED|Period I||37
9964039|NCT01490125|11083877|FG002|COMPLETED|Period I||37
9964040|NCT01490125|11083878|FG003|COMPLETED|Period I||33
9964041|NCT01490125|11083879|FG004|COMPLETED|Period I||36
9964042|NCT01490125|11083880|FG005|COMPLETED|Period I||37
9964043|NCT01490125|11083875|FG000|NOT COMPLETED|Period I||6
9964044|NCT01490125|11083876|FG001|NOT COMPLETED|Period I||5
9964045|NCT01490125|11083877|FG002|NOT COMPLETED|Period I||4
9964046|NCT01490125|11083878|FG003|NOT COMPLETED|Period I||5
9964047|NCT01490125|11083879|FG004|NOT COMPLETED|Period I||4
9964048|NCT01490125|11083880|FG005|NOT COMPLETED|Period I||5
9964049|NCT01490125|11083875|FG000|STARTED|Period II||37
9964050|NCT01490125|11083876|FG001|STARTED|Period II||37
9964051|NCT01490125|11083877|FG002|STARTED|Period II||37
9964052|NCT01490125|11083878|FG003|STARTED|Period II||33
9964053|NCT01490125|11083879|FG004|STARTED|Period II||36
9964054|NCT01490125|11083880|FG005|STARTED|Period II||37
9850513|NCT00871338|10963286|FG000|STARTED|Prior to Booster||142
9850514|NCT00871338|10963287|FG001|STARTED|Prior to Booster||142
9850515|NCT00871338|10963286|FG000|COMPLETED|Prior to Booster||140
9850516|NCT00871338|10963287|FG001|COMPLETED|Prior to Booster||139
9850517|NCT00871338|10963286|FG000|NOT COMPLETED|Prior to Booster||2
9850518|NCT00871338|10963287|FG001|NOT COMPLETED|Prior to Booster||3
9850519|NCT00871338|10963286|FG000|STARTED|After Booster||139
9850520|NCT00871338|10963287|FG001|STARTED|After Booster||135
9850521|NCT00871338|10963286|FG000|COMPLETED|After Booster||139
9850522|NCT00871338|10963287|FG001|COMPLETED|After Booster||135
9850523|NCT00871338|10963286|FG000|NOT COMPLETED|After Booster||0
9850524|NCT00871338|10963287|FG001|NOT COMPLETED|After Booster||0
9850525|NCT00871377|10963293|FG000|STARTED|First Intervention (10 Weeks)||3
9850526|NCT00871377|10963294|FG001|STARTED|First Intervention (10 Weeks)||4
9850527|NCT00871377|10963295|FG002|STARTED|First Intervention (10 Weeks)||4
9850528|NCT00871377|10963296|FG003|STARTED|First Intervention (10 Weeks)||4
9850529|NCT00871377|10963297|FG004|STARTED|First Intervention (10 Weeks)||4
9850530|NCT00871377|10963298|FG005|STARTED|First Intervention (10 Weeks)||5
9850531|NCT00871377|10963293|FG000|COMPLETED|First Intervention (10 Weeks)||3
9850532|NCT00871377|10963294|FG001|COMPLETED|First Intervention (10 Weeks)||4
9850533|NCT00871377|10963295|FG002|COMPLETED|First Intervention (10 Weeks)||3
9850534|NCT00871377|10963296|FG003|COMPLETED|First Intervention (10 Weeks)||4
9850535|NCT00871377|10963297|FG004|COMPLETED|First Intervention (10 Weeks)||4
9850536|NCT00871377|10963298|FG005|COMPLETED|First Intervention (10 Weeks)||4
9850537|NCT00871377|10963293|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0
9850538|NCT00871377|10963294|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0
9850539|NCT00871377|10963295|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1
9850540|NCT00871377|10963296|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0
9850541|NCT00871377|10963297|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0
9850542|NCT00871377|10963298|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1
9850543|NCT00871377|10963293|FG000|STARTED|Washout (6 Weeks)||3
9850544|NCT00871377|10963294|FG001|STARTED|Washout (6 Weeks)||4
9850545|NCT00871377|10963295|FG002|STARTED|Washout (6 Weeks)||3
9850546|NCT00871377|10963296|FG003|STARTED|Washout (6 Weeks)||4
9850547|NCT00871377|10963297|FG004|STARTED|Washout (6 Weeks)||4
9850548|NCT00871377|10963298|FG005|STARTED|Washout (6 Weeks)||4
9850549|NCT00871377|10963293|FG000|COMPLETED|Washout (6 Weeks)||2
9850550|NCT00871377|10963294|FG001|COMPLETED|Washout (6 Weeks)||4
9850551|NCT00871377|10963295|FG002|COMPLETED|Washout (6 Weeks)||3
9850552|NCT00871377|10963296|FG003|COMPLETED|Washout (6 Weeks)||4
9850553|NCT00871377|10963297|FG004|COMPLETED|Washout (6 Weeks)||4
9850554|NCT00871377|10963298|FG005|COMPLETED|Washout (6 Weeks)||4
9850555|NCT00871377|10963293|FG000|NOT COMPLETED|Washout (6 Weeks)||1
9850556|NCT00871377|10963294|FG001|NOT COMPLETED|Washout (6 Weeks)||0
9850557|NCT00871377|10963295|FG002|NOT COMPLETED|Washout (6 Weeks)||0
9850558|NCT00871377|10963296|FG003|NOT COMPLETED|Washout (6 Weeks)||0
9850559|NCT00871377|10963297|FG004|NOT COMPLETED|Washout (6 Weeks)||0
9850560|NCT00871377|10963298|FG005|NOT COMPLETED|Washout (6 Weeks)||0
9850561|NCT00871377|10963293|FG000|STARTED|Second Intervention (10 Weeks)||2
9850562|NCT00871377|10963294|FG001|STARTED|Second Intervention (10 Weeks)||4
9850563|NCT00871377|10963295|FG002|STARTED|Second Intervention (10 Weeks)||3
9850564|NCT00871377|10963296|FG003|STARTED|Second Intervention (10 Weeks)||4
9850565|NCT00871377|10963297|FG004|STARTED|Second Intervention (10 Weeks)||4
9850566|NCT00871377|10963298|FG005|STARTED|Second Intervention (10 Weeks)||4
9850567|NCT00871377|10963293|FG000|COMPLETED|Second Intervention (10 Weeks)||2
9850568|NCT00871377|10963294|FG001|COMPLETED|Second Intervention (10 Weeks)||4
9850569|NCT00871377|10963295|FG002|COMPLETED|Second Intervention (10 Weeks)||3
9850570|NCT00871377|10963296|FG003|COMPLETED|Second Intervention (10 Weeks)||4
9850571|NCT00871377|10963297|FG004|COMPLETED|Second Intervention (10 Weeks)||4
9850572|NCT00871377|10963298|FG005|COMPLETED|Second Intervention (10 Weeks)||4
9850573|NCT00871377|10963293|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0
9850574|NCT00871377|10963294|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0
9850575|NCT00871377|10963295|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0
9850576|NCT00871377|10963296|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0
9850577|NCT00871377|10963297|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0
9850578|NCT00871377|10963298|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0
9850579|NCT00871377|10963293|FG000|STARTED|Washout (6 Weeks)||2
9850580|NCT00871377|10963294|FG001|STARTED|Washout (6 Weeks)||4
9850581|NCT00871377|10963295|FG002|STARTED|Washout (6 Weeks)||3
9850582|NCT00871377|10963296|FG003|STARTED|Washout (6 Weeks)||4
9850583|NCT00871377|10963297|FG004|STARTED|Washout (6 Weeks)||4
9850584|NCT00871377|10963298|FG005|STARTED|Washout (6 Weeks)||4
9850585|NCT00871377|10963293|FG000|COMPLETED|Washout (6 Weeks)||2
9850586|NCT00871377|10963294|FG001|COMPLETED|Washout (6 Weeks)||4
9850587|NCT00871377|10963295|FG002|COMPLETED|Washout (6 Weeks)||3
9850588|NCT00871377|10963296|FG003|COMPLETED|Washout (6 Weeks)||4
9850589|NCT00871377|10963297|FG004|COMPLETED|Washout (6 Weeks)||4
9850590|NCT00871377|10963298|FG005|COMPLETED|Washout (6 Weeks)||3
9850591|NCT00871377|10963293|FG000|NOT COMPLETED|Washout (6 Weeks)||0
9850592|NCT00871377|10963294|FG001|NOT COMPLETED|Washout (6 Weeks)||0
9850593|NCT00871377|10963295|FG002|NOT COMPLETED|Washout (6 Weeks)||0
9850594|NCT00871377|10963296|FG003|NOT COMPLETED|Washout (6 Weeks)||0
9850595|NCT00871377|10963297|FG004|NOT COMPLETED|Washout (6 Weeks)||0
9850596|NCT00871377|10963298|FG005|NOT COMPLETED|Washout (6 Weeks)||1
9850597|NCT00871377|10963293|FG000|STARTED|Third Intervention (10 Weeks)||2
9850598|NCT00871377|10963294|FG001|STARTED|Third Intervention (10 Weeks)||4
9850599|NCT00871377|10963295|FG002|STARTED|Third Intervention (10 Weeks)||3
9850600|NCT00871377|10963296|FG003|STARTED|Third Intervention (10 Weeks)||4
9850601|NCT00871377|10963297|FG004|STARTED|Third Intervention (10 Weeks)||4
9850602|NCT00871377|10963298|FG005|STARTED|Third Intervention (10 Weeks)||3
9850603|NCT00871377|10963293|FG000|COMPLETED|Third Intervention (10 Weeks)||2
9850604|NCT00871377|10963294|FG001|COMPLETED|Third Intervention (10 Weeks)||4
9850605|NCT00871377|10963295|FG002|COMPLETED|Third Intervention (10 Weeks)||3
9850606|NCT00871377|10963296|FG003|COMPLETED|Third Intervention (10 Weeks)||3
9850607|NCT00871377|10963297|FG004|COMPLETED|Third Intervention (10 Weeks)||4
9850608|NCT00871377|10963298|FG005|COMPLETED|Third Intervention (10 Weeks)||3
9850609|NCT00871377|10963293|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0
9850610|NCT00871377|10963294|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0
9850611|NCT00871377|10963295|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0
9850612|NCT00871377|10963296|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1
9850613|NCT00871377|10963297|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0
9850614|NCT00871377|10963298|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0
9850615|NCT00871403|10963309|FG000|STARTED|Combination Treatment Phase||9
9850616|NCT00871403|10963310|FG001|STARTED|Combination Treatment Phase||62
9850617|NCT00871403|10963311|FG002|STARTED|Combination Treatment Phase||35
9850618|NCT00871403|10963309|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
9850619|NCT00871403|10963310|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
9850620|NCT00871403|10963311|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
9850621|NCT00871403|10963309|FG000|NOT COMPLETED|Combination Treatment Phase||9
9850622|NCT00871403|10963310|FG001|NOT COMPLETED|Combination Treatment Phase||49
9850623|NCT00871403|10963311|FG002|NOT COMPLETED|Combination Treatment Phase||12
9850624|NCT00871403|10963309|FG000|STARTED|Monotherapy Treatment Phase||0
9850625|NCT00871403|10963310|FG001|STARTED|Monotherapy Treatment Phase||13
9850626|NCT00871403|10963311|FG002|STARTED|Monotherapy Treatment Phase||1
9850627|NCT00871403|10963309|FG000|COMPLETED|Monotherapy Treatment Phase||0
9850628|NCT00871403|10963310|FG001|COMPLETED|Monotherapy Treatment Phase||0
9850629|NCT00871403|10963311|FG002|COMPLETED|Monotherapy Treatment Phase||0
9850630|NCT00871403|10963309|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0
9850631|NCT00871403|10963310|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13
9850632|NCT00871403|10963311|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1
9850633|NCT00871429|10963318|FG000|STARTED|Overall Study||99
9850634|NCT00871429|10963318|FG000|COMPLETED|Overall Study||75
9850635|NCT00871429|10963318|FG000|NOT COMPLETED|Overall Study||24
10062128|NCT02107196|11187591|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
10062129|NCT02107196|11187592|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
10062130|NCT02107196|11187591|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
10062131|NCT02107196|11187592|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
10188285|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0
9964055|NCT01490125|11083875|FG000|COMPLETED|Period II||34
9964056|NCT01490125|11083876|FG001|COMPLETED|Period II||33
9964057|NCT01490125|11083877|FG002|COMPLETED|Period II||34
9964058|NCT01490125|11083878|FG003|COMPLETED|Period II||30
9964059|NCT01490125|11083879|FG004|COMPLETED|Period II||32
9964060|NCT01490125|11083880|FG005|COMPLETED|Period II||35
9964061|NCT01490125|11083875|FG000|NOT COMPLETED|Period II||3
9964062|NCT01490125|11083876|FG001|NOT COMPLETED|Period II||4
9964063|NCT01490125|11083877|FG002|NOT COMPLETED|Period II||3
9964064|NCT01490125|11083878|FG003|NOT COMPLETED|Period II||3
9964065|NCT01490125|11083879|FG004|NOT COMPLETED|Period II||4
9964066|NCT01490125|11083880|FG005|NOT COMPLETED|Period II||2
9964067|NCT01490125|11083875|FG000|STARTED|Period III||34
9964068|NCT01490125|11083876|FG001|STARTED|Period III||33
9964069|NCT01490125|11083877|FG002|STARTED|Period III||34
9964070|NCT01490125|11083878|FG003|STARTED|Period III||30
9964071|NCT01490125|11083879|FG004|STARTED|Period III||32
9964072|NCT01490125|11083880|FG005|STARTED|Period III||35
9964073|NCT01490125|11083875|FG000|COMPLETED|Period III||31
9964074|NCT01490125|11083876|FG001|COMPLETED|Period III||32
9964075|NCT01490125|11083877|FG002|COMPLETED|Period III||34
9964076|NCT01490125|11083878|FG003|COMPLETED|Period III||28
9964077|NCT01490125|11083879|FG004|COMPLETED|Period III||31
9964078|NCT01490125|11083880|FG005|COMPLETED|Period III||35
9964079|NCT01490125|11083875|FG000|NOT COMPLETED|Period III||3
9964080|NCT01490125|11083876|FG001|NOT COMPLETED|Period III||1
9964081|NCT01490125|11083877|FG002|NOT COMPLETED|Period III||0
9964082|NCT01490125|11083878|FG003|NOT COMPLETED|Period III||2
9964083|NCT01490125|11083879|FG004|NOT COMPLETED|Period III||1
9964084|NCT01490125|11083880|FG005|NOT COMPLETED|Period III||0
9964085|NCT01490151|11083888|FG000|STARTED|Overall Study||22
9964086|NCT01490151|11083888|FG000|COMPLETED|Overall Study||22
9964087|NCT01490151|11083888|FG000|NOT COMPLETED|Overall Study||0
9964088|NCT01490294|11083898|FG000|STARTED|Overall Study||58
9850636|NCT00871494|10963326|FG000|STARTED|Overall Study||76
9850637|NCT00871494|10963326|FG000|COMPLETED|Overall Study||62
9850638|NCT00871494|10963326|FG000|NOT COMPLETED|Overall Study||14
9850639|NCT00871572|10963334|FG000|STARTED|Overall Study||10
9850640|NCT00871572|10963335|FG001|STARTED|Overall Study||17
9850641|NCT00871572|10963336|FG002|STARTED|Overall Study||34
9850642|NCT00871572|10963337|FG003|STARTED|Overall Study||26
9850643|NCT00871572|10963334|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9
9964089|NCT01490294|11083899|FG001|STARTED|Overall Study||60
9964090|NCT01490294|11083900|FG002|STARTED|Overall Study||59
9964091|NCT01490294|11083901|FG003|STARTED|Overall Study||55
9964092|NCT01490294|11083898|FG000|Participant Received Treatment|Overall Study||54
9964093|NCT01490294|11083899|FG001|Participant Received Treatment|Overall Study||60
9964094|NCT01490294|11083900|FG002|Participant Received Treatment|Overall Study||58
9964095|NCT01490294|11083901|FG003|Participant Received Treatment|Overall Study||54
9964096|NCT01490294|11083898|FG000|COMPLETED|Overall Study||53
9964097|NCT01490294|11083899|FG001|COMPLETED|Overall Study||60
9964098|NCT01490294|11083900|FG002|COMPLETED|Overall Study||58
9964099|NCT01490294|11083901|FG003|COMPLETED|Overall Study||54
9964100|NCT01490294|11083898|FG000|NOT COMPLETED|Overall Study||5
9964101|NCT01490294|11083899|FG001|NOT COMPLETED|Overall Study||0
9964102|NCT01490294|11083900|FG002|NOT COMPLETED|Overall Study||1
9964103|NCT01490294|11083901|FG003|NOT COMPLETED|Overall Study||1
9964104|NCT01490359|11083913|FG000|STARTED|Overall Study||609
9964105|NCT01490359|11083914|FG001|STARTED|Overall Study||572
9964106|NCT01490359|11083913|FG000|Followed-up at 6 mo|Overall Study||558
9964107|NCT01490359|11083914|FG001|Followed-up at 6 mo|Overall Study||535
9964108|NCT01490359|11083913|FG000|Followed-up at 12 mo|Overall Study||569
9964109|NCT01490359|11083914|FG001|Followed-up at 12 mo|Overall Study||537
9964110|NCT01490359|11083913|FG000|COMPLETED|Overall Study||585
9964111|NCT01490359|11083914|FG001|COMPLETED|Overall Study||555
9964112|NCT01490359|11083913|FG000|NOT COMPLETED|Overall Study||24
9964113|NCT01490359|11083914|FG001|NOT COMPLETED|Overall Study||17
9964114|NCT01490450|11083925|FG000|STARTED|Period 1||41
9964115|NCT01490450|11083926|FG001|STARTED|Period 1||41
9964116|NCT01490450|11083927|FG002|STARTED|Period 1||42
9964117|NCT01490450|11083928|FG003|STARTED|Period 1||41
9964118|NCT01490450|11083925|FG000|COMPLETED|Period 1||38
9964119|NCT01490450|11083926|FG001|COMPLETED|Period 1||40
9964120|NCT01490450|11083927|FG002|COMPLETED|Period 1||38
9964121|NCT01490450|11083928|FG003|COMPLETED|Period 1||33
9964122|NCT01490450|11083925|FG000|NOT COMPLETED|Period 1||3
9964123|NCT01490450|11083926|FG001|NOT COMPLETED|Period 1||1
9964124|NCT01490450|11083927|FG002|NOT COMPLETED|Period 1||4
9964125|NCT01490450|11083928|FG003|NOT COMPLETED|Period 1||8
9964126|NCT01490450|11083925|FG000|STARTED|Period 2||38
9964127|NCT01490450|11083926|FG001|STARTED|Period 2||40
9964128|NCT01490450|11083927|FG002|STARTED|Period 2||37
9964129|NCT01490450|11083928|FG003|STARTED|Period 2||32
9964130|NCT01490450|11083925|FG000|COMPLETED|Period 2||36
9964131|NCT01490450|11083926|FG001|COMPLETED|Period 2||39
9964132|NCT01490450|11083927|FG002|COMPLETED|Period 2||37
9964133|NCT01490450|11083928|FG003|COMPLETED|Period 2||28
9964134|NCT01490450|11083925|FG000|NOT COMPLETED|Period 2||2
9964135|NCT01490450|11083926|FG001|NOT COMPLETED|Period 2||1
9964136|NCT01490450|11083927|FG002|NOT COMPLETED|Period 2||0
9964137|NCT01490450|11083928|FG003|NOT COMPLETED|Period 2||4
9964138|NCT01490580|11083943|FG000|STARTED|Overall Study||82
9964139|NCT01490580|11083944|FG001|STARTED|Overall Study||91
9964140|NCT01490580|11083943|FG000|COMPLETED|Overall Study||82
9964141|NCT01490580|11083944|FG001|COMPLETED|Overall Study||89
9964142|NCT01490580|11083943|FG000|NOT COMPLETED|Overall Study||0
9964143|NCT01490580|11083944|FG001|NOT COMPLETED|Overall Study||2
9964144|NCT01490632|11083959|FG000|STARTED|Part A: Initial Treatment Period||34
9964145|NCT01490632|11083960|FG001|STARTED|Part A: Initial Treatment Period||32
9964146|NCT01490632|11083961|FG002|STARTED|Part A: Initial Treatment Period||72
9964147|NCT01490632|11083962|FG003|STARTED|Part A: Initial Treatment Period||64
9964148|NCT01490632|11083963|FG004|STARTED|Part A: Initial Treatment Period||69
9964149|NCT01490632|11083964|FG005|STARTED|Part A: Initial Treatment Period||0
9964150|NCT01490632|11083965|FG006|STARTED|Part A: Initial Treatment Period||0
9964151|NCT01490632|11083966|FG007|STARTED|Part A: Initial Treatment Period||0
9964152|NCT01490632|11083967|FG008|STARTED|Part A: Initial Treatment Period||0
9964153|NCT01490632|11083968|FG009|STARTED|Part A: Initial Treatment Period||0
9964154|NCT01490632|11083969|FG010|STARTED|Part A: Initial Treatment Period||0
9964155|NCT01490632|11083970|FG011|STARTED|Part A: Initial Treatment Period||0
9964156|NCT01490632|11083971|FG012|STARTED|Part A: Initial Treatment Period||0
9964157|NCT01490632|11083972|FG013|STARTED|Part A: Initial Treatment Period||0
9964158|NCT01490632|11083973|FG014|STARTED|Part A: Initial Treatment Period||0
9964159|NCT01490632|11083974|FG015|STARTED|Part A: Initial Treatment Period||0
9964160|NCT01490632|11083975|FG016|STARTED|Part A: Initial Treatment Period||0
9964161|NCT01490632|11083976|FG017|STARTED|Part A: Initial Treatment Period||0
9850644|NCT00871572|10963335|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17
9850645|NCT00871572|10963336|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34
9850646|NCT00871572|10963337|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25
9850647|NCT00871572|10963334|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
9850648|NCT00871572|10963335|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
9964162|NCT01490632|11083977|FG018|STARTED|Part A: Initial Treatment Period||0
9964163|NCT01490632|11083978|FG019|STARTED|Part A: Initial Treatment Period||0
9850649|NCT00871572|10963336|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34
9850650|NCT00871572|10963337|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
9850651|NCT00871572|10963334|FG000|COMPLETED|Overall Study||8
9850652|NCT00871572|10963335|FG001|COMPLETED|Overall Study||11
9850653|NCT00871572|10963336|FG002|COMPLETED|Overall Study||30
9850654|NCT00871572|10963337|FG003|COMPLETED|Overall Study||19
9850655|NCT00871572|10963334|FG000|NOT COMPLETED|Overall Study||2
9850656|NCT00871572|10963335|FG001|NOT COMPLETED|Overall Study||6
9850657|NCT00871572|10963336|FG002|NOT COMPLETED|Overall Study||4
9850658|NCT00871572|10963337|FG003|NOT COMPLETED|Overall Study||7
9850659|NCT00871624|10963349|FG000|STARTED|Overall Study||18
9850660|NCT00871624|10963350|FG001|STARTED|Overall Study||18
9850661|NCT00871624|10963349|FG000|COMPLETED|Overall Study||16
9850662|NCT00871624|10963350|FG001|COMPLETED|Overall Study||17
9850663|NCT00871624|10963349|FG000|NOT COMPLETED|Overall Study||2
9850664|NCT00871624|10963350|FG001|NOT COMPLETED|Overall Study||1
9850665|NCT00871689|10963358|FG000|STARTED|Overall Study||2
9850666|NCT00871689|10963358|FG000|COMPLETED|Overall Study||2
9850667|NCT00871689|10963358|FG000|NOT COMPLETED|Overall Study||0
9850668|NCT00871715|10963365|FG000|STARTED|Overall Study||119
9850669|NCT00871715|10963366|FG001|STARTED|Overall Study||120
9850670|NCT00871715|10963367|FG002|STARTED|Overall Study||122
9850671|NCT00871715|10963365|FG000|Post-Intervention|Overall Study||112
9850672|NCT00871715|10963366|FG001|Post-Intervention|Overall Study||115
9850673|NCT00871715|10963367|FG002|Post-Intervention|Overall Study||115
9850674|NCT00871715|10963365|FG000|6-mo Follow-up|Overall Study||110
9850675|NCT00871715|10963366|FG001|6-mo Follow-up|Overall Study||113
9850676|NCT00871715|10963367|FG002|6-mo Follow-up|Overall Study||112
9850677|NCT00871715|10963365|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
9850678|NCT00871715|10963366|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
9850679|NCT00871715|10963367|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
9850680|NCT00871715|10963365|FG000|NOT COMPLETED|Overall Study||15
9850681|NCT00871715|10963366|FG001|NOT COMPLETED|Overall Study||16
9850682|NCT00871715|10963367|FG002|NOT COMPLETED|Overall Study||26
9850683|NCT00871728|10963376|FG000|STARTED|Overall Study||132
9850684|NCT00871728|10963376|FG000|Treated|Overall Study||130
9850685|NCT00871728|10963376|FG000|COMPLETED|Overall Study||112
9850686|NCT00871728|10963376|FG000|NOT COMPLETED|Overall Study||20
9850687|NCT00871741|10963382|FG000|STARTED|Overall Study||9
9850688|NCT00871741|10963383|FG001|STARTED|Overall Study||7
9850689|NCT00871741|10963382|FG000|COMPLETED|Overall Study||0
9964164|NCT01490632|11083959|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
9964165|NCT01490632|11083960|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
9964166|NCT01490632|11083961|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
9964167|NCT01490632|11083962|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
9964168|NCT01490632|11083963|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
9964169|NCT01490632|11083964|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964170|NCT01490632|11083965|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964171|NCT01490632|11083966|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964172|NCT01490632|11083967|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964173|NCT01490632|11083968|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964174|NCT01490632|11083969|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964175|NCT01490632|11083970|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964176|NCT01490632|11083971|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964177|NCT01490632|11083972|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964178|NCT01490632|11083973|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964179|NCT01490632|11083974|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964180|NCT01490632|11083975|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964181|NCT01490632|11083976|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964182|NCT01490632|11083977|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964183|NCT01490632|11083978|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
9964184|NCT01490632|11083959|FG000|COMPLETED|Part A: Initial Treatment Period||27
9964185|NCT01490632|11083960|FG001|COMPLETED|Part A: Initial Treatment Period||28
9964186|NCT01490632|11083961|FG002|COMPLETED|Part A: Initial Treatment Period||67
9964187|NCT01490632|11083962|FG003|COMPLETED|Part A: Initial Treatment Period||55
9964188|NCT01490632|11083963|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
9964189|NCT01490632|11083964|FG005|COMPLETED|Part A: Initial Treatment Period||0
9964190|NCT01490632|11083965|FG006|COMPLETED|Part A: Initial Treatment Period||0
9964191|NCT01490632|11083966|FG007|COMPLETED|Part A: Initial Treatment Period||0
9964192|NCT01490632|11083967|FG008|COMPLETED|Part A: Initial Treatment Period||0
9964193|NCT01490632|11083968|FG009|COMPLETED|Part A: Initial Treatment Period||0
9964194|NCT01490632|11083969|FG010|COMPLETED|Part A: Initial Treatment Period||0
9964195|NCT01490632|11083970|FG011|COMPLETED|Part A: Initial Treatment Period||0
9850690|NCT00871741|10963383|FG001|COMPLETED|Overall Study||0
9850691|NCT00871741|10963382|FG000|NOT COMPLETED|Overall Study||9
9850692|NCT00871741|10963383|FG001|NOT COMPLETED|Overall Study||7
9850693|NCT00871780|10963389|FG000|STARTED|Overall Study|number enrolled|224
9850694|NCT00871780|10963389|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
9964196|NCT01490632|11083971|FG012|COMPLETED|Part A: Initial Treatment Period||0
9964197|NCT01490632|11083972|FG013|COMPLETED|Part A: Initial Treatment Period||0
9964198|NCT01490632|11083973|FG014|COMPLETED|Part A: Initial Treatment Period||0
9964199|NCT01490632|11083974|FG015|COMPLETED|Part A: Initial Treatment Period||0
9964200|NCT01490632|11083975|FG016|COMPLETED|Part A: Initial Treatment Period||0
9964201|NCT01490632|11083976|FG017|COMPLETED|Part A: Initial Treatment Period||0
9964202|NCT01490632|11083977|FG018|COMPLETED|Part A: Initial Treatment Period||0
9964203|NCT01490632|11083978|FG019|COMPLETED|Part A: Initial Treatment Period||0
9964204|NCT01490632|11083959|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7
9964205|NCT01490632|11083960|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4
9964206|NCT01490632|11083961|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5
9964207|NCT01490632|11083962|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9
9964208|NCT01490632|11083963|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17
9964209|NCT01490632|11083964|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0
9964210|NCT01490632|11083965|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0
9964211|NCT01490632|11083966|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0
9964212|NCT01490632|11083967|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0
9964213|NCT01490632|11083968|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0
9964214|NCT01490632|11083969|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0
9964215|NCT01490632|11083970|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0
9964216|NCT01490632|11083971|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0
9964217|NCT01490632|11083972|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0
9964218|NCT01490632|11083973|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0
9964219|NCT01490632|11083974|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0
9964220|NCT01490632|11083975|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0
9964221|NCT01490632|11083976|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0
9964222|NCT01490632|11083977|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0
9964223|NCT01490632|11083978|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0
9964224|NCT01490632|11083959|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
9964225|NCT01490632|11083960|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
9964226|NCT01490632|11083961|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
9964227|NCT01490632|11083962|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
9964228|NCT01490632|11083963|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
9964229|NCT01490632|11083964|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
9964230|NCT01490632|11083965|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
9964231|NCT01490632|11083966|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
9964232|NCT01490632|11083967|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
9964233|NCT01490632|11083968|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
10062132|NCT02107196|11187591|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
10062133|NCT02107196|11187592|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
10062134|NCT02107196|11187591|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
10062135|NCT02107196|11187592|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
10062136|NCT02107196|11187591|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
10062137|NCT02107196|11187592|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
10062138|NCT02107274|11187600|FG000|STARTED|Treatment vs. Placebo||39
10062139|NCT02107274|11187601|FG001|STARTED|Treatment vs. Placebo||39
10062140|NCT02107274|11187600|FG000|COMPLETED|Treatment vs. Placebo||36
10062141|NCT02107274|11187601|FG001|COMPLETED|Treatment vs. Placebo||37
10062142|NCT02107274|11187600|FG000|NOT COMPLETED|Treatment vs. Placebo||3
10062143|NCT02107274|11187601|FG001|NOT COMPLETED|Treatment vs. Placebo||2
10062144|NCT02107274|11187600|FG000|STARTED|Control Phase||36
10062145|NCT02107274|11187601|FG001|STARTED|Control Phase||37
9850695|NCT00871780|10963389|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
9850696|NCT00871780|10963389|FG000|COMPLETED|Overall Study||197
9850697|NCT00871780|10963389|FG000|NOT COMPLETED|Overall Study||27
9850698|NCT00871819|10963396|FG000|STARTED|Overall Study||20
9850699|NCT00871819|10963396|FG000|COMPLETED|Overall Study||20
9850700|NCT00871819|10963396|FG000|NOT COMPLETED|Overall Study||0
9850701|NCT00871845|10963402|FG000|STARTED|Overall Study||11
9850702|NCT00871845|10963403|FG001|STARTED|Overall Study||25
9850703|NCT00871845|10963402|FG000|COMPLETED|Overall Study||11
9850704|NCT00871845|10963403|FG001|COMPLETED|Overall Study||25
9964234|NCT01490632|11083969|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
9964235|NCT01490632|11083970|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
9964236|NCT01490632|11083971|FG012|STARTED|Part B: Extension or Step-Up Period||0
10062146|NCT02107274|11187600|FG000|COMPLETED|Control Phase||33
10062147|NCT02107274|11187601|FG001|COMPLETED|Control Phase||35
10062148|NCT02107274|11187600|FG000|NOT COMPLETED|Control Phase||3
10062149|NCT02107274|11187601|FG001|NOT COMPLETED|Control Phase||2
10062150|NCT02107300|11187609|FG000|STARTED|Overall Study||16
10062151|NCT02107300|11187610|FG001|STARTED|Overall Study||15
10062152|NCT02107300|11187609|FG000|COMPLETED|Overall Study||16
10062153|NCT02107300|11187610|FG001|COMPLETED|Overall Study||15
10062154|NCT02107300|11187609|FG000|NOT COMPLETED|Overall Study||0
10062155|NCT02107300|11187610|FG001|NOT COMPLETED|Overall Study||0
10062156|NCT02107313|11187616|FG000|STARTED|Overall Study||9
10062157|NCT02107313|11187617|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
10062158|NCT02107313|11187616|FG000|COMPLETED|Overall Study||9
10062159|NCT02107313|11187617|FG001|COMPLETED|Overall Study||8
10062160|NCT02107313|11187616|FG000|NOT COMPLETED|Overall Study||0
10062161|NCT02107313|11187617|FG001|NOT COMPLETED|Overall Study||1
10062162|NCT02107339|11187625|FG000|STARTED|Overall Study||63
10062163|NCT02107339|11187626|FG001|STARTED|Overall Study||57
10062164|NCT02107339|11187625|FG000|COMPLETED|Overall Study||62
10062165|NCT02107339|11187626|FG001|COMPLETED|Overall Study||53
10062166|NCT02107339|11187625|FG000|NOT COMPLETED|Overall Study||1
10062167|NCT02107339|11187626|FG001|NOT COMPLETED|Overall Study||4
10062168|NCT02107443|11187634|FG000|STARTED|Overall Study||296
10062169|NCT02107443|11187635|FG001|STARTED|Overall Study||250
10062170|NCT02107443|11187634|FG000|COMPLETED|Overall Study||198
10062171|NCT02107443|11187635|FG001|COMPLETED|Overall Study||167
10062172|NCT02107443|11187634|FG000|NOT COMPLETED|Overall Study||98
10062173|NCT02107443|11187635|FG001|NOT COMPLETED|Overall Study||83
10062174|NCT02107482|11187642|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
10062175|NCT02107482|11187642|FG000|COMPLETED|Overall Study||17
10062176|NCT02107482|11187642|FG000|NOT COMPLETED|Overall Study||4
10062177|NCT02107599|11187646|FG000|STARTED|Overall Study||96
10062178|NCT02107599|11187646|FG000|COMPLETED|Overall Study||96
10062179|NCT02107599|11187646|FG000|NOT COMPLETED|Overall Study||0
10062180|NCT02107703|11187655|FG000|STARTED|Overall Study||446
10062181|NCT02107703|11187656|FG001|STARTED|Overall Study||223
10062182|NCT02107703|11187655|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441
10062183|NCT02107703|11187656|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223
10062184|NCT02107703|11187655|FG000|COMPLETED|Overall Study||85
10062185|NCT02107703|11187656|FG001|COMPLETED|Overall Study||48
10062186|NCT02107703|11187655|FG000|NOT COMPLETED|Overall Study||361
10062187|NCT02107703|11187656|FG001|NOT COMPLETED|Overall Study||175
10062188|NCT02107859|11187665|FG000|STARTED|Overall Study||61
10062189|NCT02107859|11187665|FG000|As-treated Population|Overall Study||61
10062190|NCT02107859|11187665|FG000|Intent-to-treat (ITT) Population|Overall Study||60
10062191|NCT02107859|11187665|FG000|COMPLETED|Overall Study||0
10062192|NCT02107859|11187665|FG000|NOT COMPLETED|Overall Study||61
10062193|NCT02107898|11187671|FG000|STARTED|Overall Study|Randomized|72
10062194|NCT02107898|11187672|FG001|STARTED|Overall Study|Randomized|144
10062195|NCT02107898|11187671|FG000|Treated|Overall Study||72
10062196|NCT02107898|11187672|FG001|Treated|Overall Study||143
10062197|NCT02107898|11187671|FG000|COMPLETED|Overall Study||66
10062198|NCT02107898|11187672|FG001|COMPLETED|Overall Study||132
10062199|NCT02107898|11187671|FG000|NOT COMPLETED|Overall Study||6
10062200|NCT02107898|11187672|FG001|NOT COMPLETED|Overall Study||12
10062201|NCT02108171|11187680|FG000|STARTED|Overall Study||40
10062202|NCT02108171|11187681|FG001|STARTED|Overall Study||41
10062203|NCT02108171|11187680|FG000|COMPLETED|Overall Study||40
10062204|NCT02108171|11187681|FG001|COMPLETED|Overall Study||41
10062205|NCT02108171|11187680|FG000|NOT COMPLETED|Overall Study||0
10062206|NCT02108171|11187681|FG001|NOT COMPLETED|Overall Study||0
10062207|NCT02108223|11187691|FG000|STARTED|Overall Study||52
10062208|NCT02108223|11187692|FG001|STARTED|Overall Study||50
10062209|NCT02108223|11187693|FG002|STARTED|Overall Study||35
10062210|NCT02108223|11187691|FG000|COMPLETED|Overall Study||52
10062211|NCT02108223|11187692|FG001|COMPLETED|Overall Study||50
10062212|NCT02108223|11187693|FG002|COMPLETED|Overall Study||35
9964237|NCT01490632|11083972|FG013|STARTED|Part B: Extension or Step-Up Period||0
9964238|NCT01490632|11083973|FG014|STARTED|Part B: Extension or Step-Up Period||0
9964239|NCT01490632|11083974|FG015|STARTED|Part B: Extension or Step-Up Period||0
9964240|NCT01490632|11083975|FG016|STARTED|Part B: Extension or Step-Up Period||0
9964241|NCT01490632|11083976|FG017|STARTED|Part B: Extension or Step-Up Period||0
9964242|NCT01490632|11083977|FG018|STARTED|Part B: Extension or Step-Up Period||0
9964243|NCT01490632|11083978|FG019|STARTED|Part B: Extension or Step-Up Period||0
9964244|NCT01490632|11083959|FG000|COMPLETED|Part B: Extension or Step-Up Period||0
9964245|NCT01490632|11083960|FG001|COMPLETED|Part B: Extension or Step-Up Period||0
9964246|NCT01490632|11083961|FG002|COMPLETED|Part B: Extension or Step-Up Period||0
9964247|NCT01490632|11083962|FG003|COMPLETED|Part B: Extension or Step-Up Period||0
9964248|NCT01490632|11083963|FG004|COMPLETED|Part B: Extension or Step-Up Period||0
9964249|NCT01490632|11083964|FG005|COMPLETED|Part B: Extension or Step-Up Period||25
9964250|NCT01490632|11083965|FG006|COMPLETED|Part B: Extension or Step-Up Period||51
9964251|NCT01490632|11083966|FG007|COMPLETED|Part B: Extension or Step-Up Period||13
9964252|NCT01490632|11083967|FG008|COMPLETED|Part B: Extension or Step-Up Period||6
9964253|NCT01490632|11083968|FG009|COMPLETED|Part B: Extension or Step-Up Period||25
9964254|NCT01490632|11083969|FG010|COMPLETED|Part B: Extension or Step-Up Period||22
9964255|NCT01490632|11083970|FG011|COMPLETED|Part B: Extension or Step-Up Period||0
9964256|NCT01490632|11083971|FG012|COMPLETED|Part B: Extension or Step-Up Period||0
9964257|NCT01490632|11083972|FG013|COMPLETED|Part B: Extension or Step-Up Period||0
9964258|NCT01490632|11083973|FG014|COMPLETED|Part B: Extension or Step-Up Period||0
9964259|NCT01490632|11083974|FG015|COMPLETED|Part B: Extension or Step-Up Period||0
9964260|NCT01490632|11083975|FG016|COMPLETED|Part B: Extension or Step-Up Period||0
9964261|NCT01490632|11083976|FG017|COMPLETED|Part B: Extension or Step-Up Period||0
9964262|NCT01490632|11083977|FG018|COMPLETED|Part B: Extension or Step-Up Period||0
9964263|NCT01490632|11083978|FG019|COMPLETED|Part B: Extension or Step-Up Period||0
9964264|NCT01490632|11083959|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964265|NCT01490632|11083960|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964266|NCT01490632|11083961|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964267|NCT01490632|11083962|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964268|NCT01490632|11083963|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964269|NCT01490632|11083964|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4
9964270|NCT01490632|11083965|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13
9964271|NCT01490632|11083966|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6
9964272|NCT01490632|11083967|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10
9964273|NCT01490632|11083968|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25
9964274|NCT01490632|11083969|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21
9964275|NCT01490632|11083970|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8
9964276|NCT01490632|11083971|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964277|NCT01490632|11083972|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964278|NCT01490632|11083973|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964279|NCT01490632|11083974|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964280|NCT01490632|11083975|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964281|NCT01490632|11083976|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964282|NCT01490632|11083977|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964283|NCT01490632|11083978|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0
9964284|NCT01490632|11083959|FG000|STARTED|Part C: Washout or Step-Down Period||0
9964285|NCT01490632|11083960|FG001|STARTED|Part C: Washout or Step-Down Period||0
9964286|NCT01490632|11083961|FG002|STARTED|Part C: Washout or Step-Down Period||0
9964287|NCT01490632|11083962|FG003|STARTED|Part C: Washout or Step-Down Period||0
9964288|NCT01490632|11083963|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
9964289|NCT01490632|11083964|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
9964290|NCT01490632|11083965|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
9964291|NCT01490632|11083966|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
9964292|NCT01490632|11083967|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
9964293|NCT01490632|11083968|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
9964294|NCT01490632|11083969|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
9964295|NCT01490632|11083970|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
9964296|NCT01490632|11083971|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
9964297|NCT01490632|11083972|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
9964298|NCT01490632|11083973|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
9964299|NCT01490632|11083974|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
9964300|NCT01490632|11083975|FG016|STARTED|Part C: Washout or Step-Down Period||0
9964301|NCT01490632|11083976|FG017|STARTED|Part C: Washout or Step-Down Period||0
9964302|NCT01490632|11083977|FG018|STARTED|Part C: Washout or Step-Down Period||0
9964303|NCT01490632|11083978|FG019|STARTED|Part C: Washout or Step-Down Period||0
9964304|NCT01490632|11083959|FG000|COMPLETED|Part C: Washout or Step-Down Period||0
9964305|NCT01490632|11083960|FG001|COMPLETED|Part C: Washout or Step-Down Period||0
9964306|NCT01490632|11083961|FG002|COMPLETED|Part C: Washout or Step-Down Period||0
9964307|NCT01490632|11083962|FG003|COMPLETED|Part C: Washout or Step-Down Period||0
9964308|NCT01490632|11083963|FG004|COMPLETED|Part C: Washout or Step-Down Period||0
9964309|NCT01490632|11083964|FG005|COMPLETED|Part C: Washout or Step-Down Period||0
9964310|NCT01490632|11083965|FG006|COMPLETED|Part C: Washout or Step-Down Period||0
9964311|NCT01490632|11083966|FG007|COMPLETED|Part C: Washout or Step-Down Period||0
9964312|NCT01490632|11083967|FG008|COMPLETED|Part C: Washout or Step-Down Period||0
9964313|NCT01490632|11083968|FG009|COMPLETED|Part C: Washout or Step-Down Period||0
9964314|NCT01490632|11083969|FG010|COMPLETED|Part C: Washout or Step-Down Period||0
9964315|NCT01490632|11083970|FG011|COMPLETED|Part C: Washout or Step-Down Period||0
9967891|NCT01517373|11088251|FG000|NOT COMPLETED|Run-in Period||57
9964316|NCT01490632|11083971|FG012|COMPLETED|Part C: Washout or Step-Down Period||10
9964317|NCT01490632|11083972|FG013|COMPLETED|Part C: Washout or Step-Down Period||6
9964318|NCT01490632|11083973|FG014|COMPLETED|Part C: Washout or Step-Down Period||37
9964319|NCT01490632|11083974|FG015|COMPLETED|Part C: Washout or Step-Down Period||18
10062213|NCT02108223|11187691|FG000|NOT COMPLETED|Overall Study||0
10062214|NCT02108223|11187692|FG001|NOT COMPLETED|Overall Study||0
10062215|NCT02108223|11187693|FG002|NOT COMPLETED|Overall Study||0
10062216|NCT02108262|11187708|FG000|STARTED|Overall Study||9
10062217|NCT02108262|11187709|FG001|STARTED|Overall Study||419
10062218|NCT02108262|11187710|FG002|STARTED|Overall Study||421
10062219|NCT02108262|11187711|FG003|STARTED|Overall Study||418
10062220|NCT02108262|11187708|FG000|COMPLETED|Overall Study||9
10062221|NCT02108262|11187709|FG001|COMPLETED|Overall Study||375
10062222|NCT02108262|11187710|FG002|COMPLETED|Overall Study||379
10062223|NCT02108262|11187711|FG003|COMPLETED|Overall Study||376
10062224|NCT02108262|11187708|FG000|NOT COMPLETED|Overall Study||0
10062225|NCT02108262|11187709|FG001|NOT COMPLETED|Overall Study||44
10062226|NCT02108262|11187710|FG002|NOT COMPLETED|Overall Study||42
10062227|NCT02108262|11187711|FG003|NOT COMPLETED|Overall Study||42
10062228|NCT02108288|11187723|FG000|STARTED|Overall Study||10
10062229|NCT02108288|11187724|FG001|STARTED|Overall Study||10
10062230|NCT02108288|11187725|FG002|STARTED|Overall Study||10
10062231|NCT02108288|11187723|FG000|COMPLETED|Overall Study||10
10062232|NCT02108288|11187724|FG001|COMPLETED|Overall Study||10
10062233|NCT02108288|11187725|FG002|COMPLETED|Overall Study||10
10062234|NCT02108288|11187723|FG000|NOT COMPLETED|Overall Study||0
10062235|NCT02108288|11187724|FG001|NOT COMPLETED|Overall Study||0
10062236|NCT02108288|11187725|FG002|NOT COMPLETED|Overall Study||0
10062237|NCT02108457|11187735|FG000|STARTED|Overall Study||3
10062238|NCT02108457|11187736|FG001|STARTED|Overall Study||12
10062239|NCT02108457|11187735|FG000|COMPLETED|Overall Study||3
10062240|NCT02108457|11187736|FG001|COMPLETED|Overall Study||10
10062241|NCT02108457|11187735|FG000|NOT COMPLETED|Overall Study||0
10062242|NCT02108457|11187736|FG001|NOT COMPLETED|Overall Study||2
10062243|NCT02108522|11187742|FG000|STARTED|Screening Period||82
9964320|NCT01490632|11083975|FG016|COMPLETED|Part C: Washout or Step-Down Period||0
9964321|NCT01490632|11083976|FG017|COMPLETED|Part C: Washout or Step-Down Period||0
9964322|NCT01490632|11083977|FG018|COMPLETED|Part C: Washout or Step-Down Period||0
9964323|NCT01490632|11083978|FG019|COMPLETED|Part C: Washout or Step-Down Period||0
9964324|NCT01490632|11083959|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964325|NCT01490632|11083960|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964326|NCT01490632|11083961|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964327|NCT01490632|11083962|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964328|NCT01490632|11083963|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964329|NCT01490632|11083964|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10062244|NCT02108522|11187742|FG000|COMPLETED|Screening Period||58
10062245|NCT02108522|11187742|FG000|NOT COMPLETED|Screening Period||24
10062246|NCT02108522|11187742|FG000|STARTED|Period 1: Initial Cohort||50
10062247|NCT02108522|11187742|FG000|COMPLETED|Period 1: Initial Cohort||28
10062248|NCT02108522|11187742|FG000|NOT COMPLETED|Period 1: Initial Cohort||22
10062249|NCT02108522|11187742|FG000|STARTED|Period 2: Expansion Cohort||8
10062250|NCT02108522|11187742|FG000|COMPLETED|Period 2: Expansion Cohort||2
10062251|NCT02108522|11187742|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6
10062252|NCT02108600|11187748|FG000|STARTED|Overall Study||17
10062253|NCT02108600|11187749|FG001|STARTED|Overall Study||16
10062254|NCT02108600|11187748|FG000|COMPLETED|Overall Study||14
10062255|NCT02108600|11187749|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
10062256|NCT02108600|11187748|FG000|NOT COMPLETED|Overall Study||3
10062257|NCT02108600|11187749|FG001|NOT COMPLETED|Overall Study||1
10062258|NCT02108691|11187757|FG000|STARTED|Overall Study||40
10062259|NCT02108691|11187758|FG001|STARTED|Overall Study||40
10062260|NCT02108691|11187757|FG000|COMPLETED|Overall Study||32
10062261|NCT02108691|11187758|FG001|COMPLETED|Overall Study||31
10062262|NCT02108691|11187757|FG000|NOT COMPLETED|Overall Study||8
10062263|NCT02108691|11187758|FG001|NOT COMPLETED|Overall Study||9
10062264|NCT02108821|11187764|FG000|STARTED|Overall Study||23
10062265|NCT02108821|11187764|FG000|COMPLETED|Overall Study||23
10062266|NCT02108821|11187764|FG000|NOT COMPLETED|Overall Study||0
10062267|NCT02108912|11187772|FG000|STARTED|Overall Study||9
10062268|NCT02108912|11187773|FG001|STARTED|Overall Study||7
10062269|NCT02108912|11187772|FG000|COMPLETED|Overall Study||6
10062270|NCT02108912|11187773|FG001|COMPLETED|Overall Study||6
10062271|NCT02108912|11187772|FG000|NOT COMPLETED|Overall Study||3
10062272|NCT02108912|11187773|FG001|NOT COMPLETED|Overall Study||1
10062273|NCT02108951|11187779|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
10062274|NCT02108951|11187779|FG000|COMPLETED|Overall Study||4
10062275|NCT02108951|11187779|FG000|NOT COMPLETED|Overall Study||16
10062276|NCT02108977|11187785|FG000|STARTED|Overall Study||18
10062277|NCT02108977|11187786|FG001|STARTED|Overall Study||20
10062278|NCT02108977|11187785|FG000|COMPLETED|Overall Study||8
10062279|NCT02108977|11187786|FG001|COMPLETED|Overall Study||19
10062280|NCT02108977|11187785|FG000|NOT COMPLETED|Overall Study||10
10062281|NCT02108977|11187786|FG001|NOT COMPLETED|Overall Study||1
10062282|NCT02109029|11187797|FG000|STARTED|Part A||2
10062283|NCT02109029|11187798|FG001|STARTED|Part A||2
10062284|NCT02109029|11187799|FG002|STARTED|Part A||4
9964330|NCT01490632|11083965|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964331|NCT01490632|11083966|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964332|NCT01490632|11083967|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964333|NCT01490632|11083968|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964334|NCT01490632|11083969|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964335|NCT01490632|11083970|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964336|NCT01490632|11083971|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5
9964337|NCT01490632|11083972|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10
9964338|NCT01490632|11083973|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18
9964339|NCT01490632|11083974|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37
9964340|NCT01490632|11083975|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964341|NCT01490632|11083976|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964342|NCT01490632|11083977|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964343|NCT01490632|11083978|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0
9964344|NCT01490632|11083959|FG000|STARTED|Part D: Re-Treatment Period||0
9964345|NCT01490632|11083960|FG001|STARTED|Part D: Re-Treatment Period||0
9964346|NCT01490632|11083961|FG002|STARTED|Part D: Re-Treatment Period||0
9964347|NCT01490632|11083962|FG003|STARTED|Part D: Re-Treatment Period||0
9964348|NCT01490632|11083963|FG004|STARTED|Part D: Re-Treatment Period||0
9964349|NCT01490632|11083964|FG005|STARTED|Part D: Re-Treatment Period||0
9964350|NCT01490632|11083965|FG006|STARTED|Part D: Re-Treatment Period||0
9964351|NCT01490632|11083966|FG007|STARTED|Part D: Re-Treatment Period||0
9964352|NCT01490632|11083967|FG008|STARTED|Part D: Re-Treatment Period||0
9964353|NCT01490632|11083968|FG009|STARTED|Part D: Re-Treatment Period||0
9964354|NCT01490632|11083969|FG010|STARTED|Part D: Re-Treatment Period||0
9964355|NCT01490632|11083970|FG011|STARTED|Part D: Re-Treatment Period||0
9964356|NCT01490632|11083971|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
9964357|NCT01490632|11083972|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
9964358|NCT01490632|11083973|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
9964359|NCT01490632|11083974|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
9964360|NCT01490632|11083975|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
9964361|NCT01490632|11083976|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
9964362|NCT01490632|11083977|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
9964363|NCT01490632|11083978|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
9964364|NCT01490632|11083959|FG000|COMPLETED|Part D: Re-Treatment Period||0
9964365|NCT01490632|11083960|FG001|COMPLETED|Part D: Re-Treatment Period||0
9964366|NCT01490632|11083961|FG002|COMPLETED|Part D: Re-Treatment Period||0
9964367|NCT01490632|11083962|FG003|COMPLETED|Part D: Re-Treatment Period||0
9964368|NCT01490632|11083963|FG004|COMPLETED|Part D: Re-Treatment Period||0
9964369|NCT01490632|11083964|FG005|COMPLETED|Part D: Re-Treatment Period||0
9964370|NCT01490632|11083965|FG006|COMPLETED|Part D: Re-Treatment Period||0
9964371|NCT01490632|11083966|FG007|COMPLETED|Part D: Re-Treatment Period||0
9964372|NCT01490632|11083967|FG008|COMPLETED|Part D: Re-Treatment Period||0
9964373|NCT01490632|11083968|FG009|COMPLETED|Part D: Re-Treatment Period||0
9964374|NCT01490632|11083969|FG010|COMPLETED|Part D: Re-Treatment Period||0
9964375|NCT01490632|11083970|FG011|COMPLETED|Part D: Re-Treatment Period||0
9964376|NCT01490632|11083971|FG012|COMPLETED|Part D: Re-Treatment Period||0
9964377|NCT01490632|11083972|FG013|COMPLETED|Part D: Re-Treatment Period||0
9964378|NCT01490632|11083973|FG014|COMPLETED|Part D: Re-Treatment Period||0
9964379|NCT01490632|11083974|FG015|COMPLETED|Part D: Re-Treatment Period||0
9964380|NCT01490632|11083975|FG016|COMPLETED|Part D: Re-Treatment Period||3
9964381|NCT01490632|11083976|FG017|COMPLETED|Part D: Re-Treatment Period||8
9964382|NCT01490632|11083977|FG018|COMPLETED|Part D: Re-Treatment Period||12
9964383|NCT01490632|11083978|FG019|COMPLETED|Part D: Re-Treatment Period||30
9964384|NCT01490632|11083959|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0
9964385|NCT01490632|11083960|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0
9964386|NCT01490632|11083961|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0
9964387|NCT01490632|11083962|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0
9964388|NCT01490632|11083963|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0
9964389|NCT01490632|11083964|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0
9964390|NCT01490632|11083965|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0
9964391|NCT01490632|11083966|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0
9964392|NCT01490632|11083967|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0
9964393|NCT01490632|11083968|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0
9964394|NCT01490632|11083969|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0
9964395|NCT01490632|11083970|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0
9964396|NCT01490632|11083971|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0
9964397|NCT01490632|11083972|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0
9964398|NCT01490632|11083973|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0
9964399|NCT01490632|11083974|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0
9964400|NCT01490632|11083975|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0
9964401|NCT01490632|11083976|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5
9964402|NCT01490632|11083977|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7
9964403|NCT01490632|11083978|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7
9964404|NCT01490684|11084021|FG000|STARTED|Overall Study||162
9964405|NCT01490684|11084021|FG000|COMPLETED|Overall Study||162
9964406|NCT01490684|11084021|FG000|NOT COMPLETED|Overall Study||0
9964407|NCT01490697|11084027|FG000|STARTED|Overall Study||16
9964408|NCT01490697|11084028|FG001|STARTED|Overall Study||18
9964409|NCT01490697|11084027|FG000|COMPLETED|Overall Study||15
9964410|NCT01490697|11084028|FG001|COMPLETED|Overall Study||16
9964411|NCT01490697|11084027|FG000|NOT COMPLETED|Overall Study||1
9964412|NCT01490697|11084028|FG001|NOT COMPLETED|Overall Study||2
9964413|NCT01490723|11084034|FG000|STARTED|Overall Study||20
9964414|NCT01490723|11084034|FG000|COMPLETED|Overall Study||20
9964415|NCT01490723|11084034|FG000|NOT COMPLETED|Overall Study||0
9964416|NCT01490788|11084038|FG000|STARTED|Overall Study||5
9964417|NCT01490788|11084039|FG001|STARTED|Overall Study||5
9964418|NCT01490788|11084040|FG002|STARTED|Overall Study||5
9964419|NCT01490788|11084041|FG003|STARTED|Overall Study||5
9964420|NCT01490788|11084042|FG004|STARTED|Overall Study||5
9964421|NCT01490788|11084043|FG005|STARTED|Overall Study||5
9964422|NCT01490788|11084038|FG000|COMPLETED|Overall Study||4
9964423|NCT01490788|11084039|FG001|COMPLETED|Overall Study||5
9964424|NCT01490788|11084040|FG002|COMPLETED|Overall Study||5
9964425|NCT01490788|11084041|FG003|COMPLETED|Overall Study||5
9964426|NCT01490788|11084042|FG004|COMPLETED|Overall Study||5
9964427|NCT01490788|11084043|FG005|COMPLETED|Overall Study||5
9964428|NCT01490788|11084038|FG000|NOT COMPLETED|Overall Study||1
9964429|NCT01490788|11084039|FG001|NOT COMPLETED|Overall Study||0
9964430|NCT01490788|11084040|FG002|NOT COMPLETED|Overall Study||0
9964431|NCT01490788|11084041|FG003|NOT COMPLETED|Overall Study||0
9964432|NCT01490788|11084042|FG004|NOT COMPLETED|Overall Study||0
9964433|NCT01490788|11084043|FG005|NOT COMPLETED|Overall Study||0
9964434|NCT01490814|11084053|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
9964435|NCT01490814|11084054|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
9964436|NCT01490814|11084053|FG000|COMPLETED|Overall Study|374 received ablation|374
9964437|NCT01490814|11084054|FG001|COMPLETED|Overall Study|376 received ablation|376
9964438|NCT01490814|11084053|FG000|NOT COMPLETED|Overall Study||4
9964439|NCT01490814|11084054|FG001|NOT COMPLETED|Overall Study||8
9964440|NCT01490840|11084062|FG000|STARTED|Phase 1||94
9964441|NCT01490840|11084063|FG001|STARTED|Phase 1||84
9964442|NCT01490840|11084062|FG000|Modified Full Analysis Set|Phase 1||56
9964443|NCT01490840|11084063|FG001|Modified Full Analysis Set|Phase 1||83
9964444|NCT01490840|11084062|FG000|COMPLETED|Phase 1||84
9964445|NCT01490840|11084063|FG001|COMPLETED|Phase 1||78
9964446|NCT01490840|11084062|FG000|NOT COMPLETED|Phase 1||10
9964447|NCT01490840|11084063|FG001|NOT COMPLETED|Phase 1||6
9964448|NCT01490840|11084062|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
9964449|NCT01490840|11084063|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
9964450|NCT01490840|11084062|FG000|COMPLETED|Phase 2||75
9964451|NCT01490840|11084063|FG001|COMPLETED|Phase 2||68
9964452|NCT01490840|11084062|FG000|NOT COMPLETED|Phase 2||6
9964453|NCT01490840|11084063|FG001|NOT COMPLETED|Phase 2||6
9964454|NCT01490866|11084069|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70
9964455|NCT01490866|11084069|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49
9964456|NCT01490866|11084069|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
9964457|NCT01490866|11084069|FG000|STARTED|Axitinib Maintenance Therapy||49
9964458|NCT01490866|11084069|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
9964459|NCT01490866|11084069|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49
9964460|NCT01490892|11084076|FG000|STARTED|Overall Study||219
9964461|NCT01490892|11084076|FG000|COMPLETED|Overall Study||219
9964462|NCT01490892|11084076|FG000|NOT COMPLETED|Overall Study||0
9964463|NCT01490918|11084083|FG000|STARTED|Overall Study||65
9964464|NCT01490918|11084084|FG001|STARTED|Overall Study||66
9964465|NCT01490918|11084085|FG002|STARTED|Overall Study||34
9964466|NCT01490918|11084083|FG000|COMPLETED|Overall Study||52
9964467|NCT01490918|11084084|FG001|COMPLETED|Overall Study||52
9964468|NCT01490918|11084085|FG002|COMPLETED|Overall Study||22
9964469|NCT01490918|11084083|FG000|NOT COMPLETED|Overall Study||13
9964470|NCT01490918|11084084|FG001|NOT COMPLETED|Overall Study||14
9964471|NCT01490918|11084085|FG002|NOT COMPLETED|Overall Study||12
9964472|NCT01490931|11084097|FG000|STARTED|Overall Study||25
9964473|NCT01490931|11084097|FG000|COMPLETED|Overall Study||25
9964474|NCT01490931|11084097|FG000|NOT COMPLETED|Overall Study||0
9964475|NCT01491022|11084103|FG000|STARTED|Intervention 1||10
9964476|NCT01491022|11084104|FG001|STARTED|Intervention 1||12
9964477|NCT01491022|11084103|FG000|COMPLETED|Intervention 1||9
9964478|NCT01491022|11084104|FG001|COMPLETED|Intervention 1||11
9964479|NCT01491022|11084103|FG000|NOT COMPLETED|Intervention 1||1
9964480|NCT01491022|11084104|FG001|NOT COMPLETED|Intervention 1||1
9964481|NCT01491022|11084103|FG000|STARTED|2 Week Washout||9
9964482|NCT01491022|11084104|FG001|STARTED|2 Week Washout||11
9964483|NCT01491022|11084103|FG000|COMPLETED|2 Week Washout||9
9964484|NCT01491022|11084104|FG001|COMPLETED|2 Week Washout||11
9964485|NCT01491022|11084103|FG000|NOT COMPLETED|2 Week Washout||0
9964486|NCT01491022|11084104|FG001|NOT COMPLETED|2 Week Washout||0
9964487|NCT01491022|11084103|FG000|STARTED|Intervention 2||9
9964488|NCT01491022|11084104|FG001|STARTED|Intervention 2||11
9964489|NCT01491022|11084103|FG000|COMPLETED|Intervention 2||8
9964490|NCT01491022|11084104|FG001|COMPLETED|Intervention 2||11
9964491|NCT01491022|11084103|FG000|NOT COMPLETED|Intervention 2||1
9964492|NCT01491022|11084104|FG001|NOT COMPLETED|Intervention 2||0
9964493|NCT01491035|11084122|FG000|STARTED|Overall Study||6
9964494|NCT01491035|11084123|FG001|STARTED|Overall Study||6
9964495|NCT01491035|11084124|FG002|STARTED|Overall Study||6
9964496|NCT01491035|11084125|FG003|STARTED|Overall Study||6
9964497|NCT01491035|11084126|FG004|STARTED|Overall Study||6
9964498|NCT01491035|11084127|FG005|STARTED|Overall Study||6
9964499|NCT01491035|11084128|FG006|STARTED|Overall Study||6
9964500|NCT01491035|11084129|FG007|STARTED|Overall Study||6
9964501|NCT01491035|11084122|FG000|COMPLETED|Overall Study||6
9964502|NCT01491035|11084123|FG001|COMPLETED|Overall Study||6
9964503|NCT01491035|11084124|FG002|COMPLETED|Overall Study||6
9964504|NCT01491035|11084125|FG003|COMPLETED|Overall Study||6
9964505|NCT01491035|11084126|FG004|COMPLETED|Overall Study||5
9964506|NCT01491035|11084127|FG005|COMPLETED|Overall Study||6
9964507|NCT01491035|11084128|FG006|COMPLETED|Overall Study||6
9964508|NCT01491035|11084129|FG007|COMPLETED|Overall Study||6
9964509|NCT01491035|11084122|FG000|NOT COMPLETED|Overall Study||0
9964510|NCT01491035|11084123|FG001|NOT COMPLETED|Overall Study||0
9964511|NCT01491035|11084124|FG002|NOT COMPLETED|Overall Study||0
9964512|NCT01491035|11084125|FG003|NOT COMPLETED|Overall Study||0
9964513|NCT01491035|11084126|FG004|NOT COMPLETED|Overall Study||1
9964514|NCT01491035|11084127|FG005|NOT COMPLETED|Overall Study||0
9964515|NCT01491035|11084128|FG006|NOT COMPLETED|Overall Study||0
9964516|NCT01491035|11084129|FG007|NOT COMPLETED|Overall Study||0
9964517|NCT01491113|11084152|FG000|STARTED|Overall Study||6
9964518|NCT01491113|11084153|FG001|STARTED|Overall Study||6
9964519|NCT01491113|11084154|FG002|STARTED|Overall Study||6
9964520|NCT01491113|11084155|FG003|STARTED|Overall Study||6
9964521|NCT01491113|11084156|FG004|STARTED|Overall Study||6
9964522|NCT01491113|11084152|FG000|COMPLETED|Overall Study||6
9964523|NCT01491113|11084153|FG001|COMPLETED|Overall Study||6
9964524|NCT01491113|11084154|FG002|COMPLETED|Overall Study||6
9964525|NCT01491113|11084155|FG003|COMPLETED|Overall Study||6
9964526|NCT01491113|11084156|FG004|COMPLETED|Overall Study||6
9964527|NCT01491113|11084152|FG000|NOT COMPLETED|Overall Study||0
9964528|NCT01491113|11084153|FG001|NOT COMPLETED|Overall Study||0
9964529|NCT01491113|11084154|FG002|NOT COMPLETED|Overall Study||0
9964530|NCT01491113|11084155|FG003|NOT COMPLETED|Overall Study||0
9964531|NCT01491113|11084156|FG004|NOT COMPLETED|Overall Study||0
9964532|NCT01491178|11084170|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
9964533|NCT01491178|11084170|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
9964534|NCT01491178|11084170|FG000|NOT COMPLETED|Overall Study||2794
9964535|NCT01491490|11084176|FG000|STARTED|Overall Study||1
9964536|NCT01491490|11084177|FG001|STARTED|Overall Study||1
9964537|NCT01491490|11084176|FG000|COMPLETED|Overall Study||1
9964538|NCT01491490|11084177|FG001|COMPLETED|Overall Study||1
9964539|NCT01491490|11084176|FG000|NOT COMPLETED|Overall Study||0
9964540|NCT01491490|11084177|FG001|NOT COMPLETED|Overall Study||0
9964541|NCT01491607|11084187|FG000|STARTED|Overall Study||200
9964542|NCT01491607|11084187|FG000|COMPLETED|Overall Study||190
9964543|NCT01491607|11084187|FG000|NOT COMPLETED|Overall Study||10
9964544|NCT01491633|11084253|FG000|STARTED|Overall Study||5
9964545|NCT01491633|11084253|FG000|COMPLETED|Overall Study||0
9964546|NCT01491633|11084253|FG000|NOT COMPLETED|Overall Study||5
9964547|NCT01491672|11084260|FG000|STARTED|Overall Study||58
9964548|NCT01491672|11084261|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
9964549|NCT01491672|11084262|FG002|STARTED|Overall Study||14
9964550|NCT01491672|11084260|FG000|Safety Set|Overall Study||58
9964551|NCT01491672|11084261|FG001|Safety Set|Overall Study||61
9964552|NCT01491672|11084262|FG002|Safety Set|Overall Study||14
9964553|NCT01491672|11084260|FG000|COMPLETED|Overall Study||2
9964554|NCT01491672|11084261|FG001|COMPLETED|Overall Study||2
9964555|NCT01491672|11084262|FG002|COMPLETED|Overall Study||3
9964556|NCT01491672|11084260|FG000|NOT COMPLETED|Overall Study||56
9964557|NCT01491672|11084261|FG001|NOT COMPLETED|Overall Study||60
9964558|NCT01491672|11084262|FG002|NOT COMPLETED|Overall Study||11
9964559|NCT01491737|11084274|FG000|STARTED|Overall Study||129
9964560|NCT01491737|11084275|FG001|STARTED|Overall Study||129
9964561|NCT01491737|11084274|FG000|Received at Least One Dose of Study Drug|Overall Study||127
9964562|NCT01491737|11084275|FG001|Received at Least One Dose of Study Drug|Overall Study||124
9964563|NCT01491737|11084274|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120
9964564|NCT01491737|11084275|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116
9964565|NCT01491737|11084274|FG000|COMPLETED|Overall Study||0
9964566|NCT01491737|11084275|FG001|COMPLETED|Overall Study||0
9964567|NCT01491737|11084274|FG000|NOT COMPLETED|Overall Study||129
9964568|NCT01491737|11084275|FG001|NOT COMPLETED|Overall Study||129
9964569|NCT01491802|11084281|FG000|STARTED|Overall Study||9
9964570|NCT01491802|11084282|FG001|STARTED|Overall Study||8
9964571|NCT01491802|11084281|FG000|COMPLETED|Overall Study||8
9964572|NCT01491802|11084282|FG001|COMPLETED|Overall Study||6
9964573|NCT01491802|11084281|FG000|NOT COMPLETED|Overall Study||1
9964574|NCT01491802|11084282|FG001|NOT COMPLETED|Overall Study||2
9964575|NCT01491841|11084289|FG000|STARTED|Overall Study||33
9964576|NCT01491841|11084289|FG000|COMPLETED|Overall Study||22
9964577|NCT01491841|11084289|FG000|NOT COMPLETED|Overall Study||11
9964578|NCT01491854|11084301|FG000|STARTED|Overall Study||130
9964579|NCT01491854|11084301|FG000|COMPLETED|Overall Study||0
9964580|NCT01491854|11084301|FG000|NOT COMPLETED|Overall Study||130
9964581|NCT01491919|11084308|FG000|STARTED|Overall Study||13
9964582|NCT01491919|11084309|FG001|STARTED|Overall Study||10
9964583|NCT01491919|11084310|FG002|STARTED|Overall Study||3
9964584|NCT01491919|11084308|FG000|COMPLETED|Overall Study||12
9964585|NCT01491919|11084309|FG001|COMPLETED|Overall Study||8
9964586|NCT01491919|11084310|FG002|COMPLETED|Overall Study||2
9964587|NCT01491919|11084308|FG000|NOT COMPLETED|Overall Study||1
9964588|NCT01491919|11084309|FG001|NOT COMPLETED|Overall Study||2
9964589|NCT01491919|11084310|FG002|NOT COMPLETED|Overall Study||1
9964590|NCT01491945|11084320|FG000|STARTED|Overall Study||76
9964591|NCT01491945|11084320|FG000|COMPLETED|Overall Study||25
9964592|NCT01491945|11084320|FG000|NOT COMPLETED|Overall Study||51
9964593|NCT01491958|11084327|FG000|STARTED|Overall Study||40
9964594|NCT01491958|11084328|FG001|STARTED|Overall Study||40
9964595|NCT01491958|11084327|FG000|COMPLETED|Overall Study||40
9964596|NCT01491958|11084328|FG001|COMPLETED|Overall Study||40
9964597|NCT01491958|11084327|FG000|NOT COMPLETED|Overall Study||0
9964598|NCT01491958|11084328|FG001|NOT COMPLETED|Overall Study||0
9964599|NCT01491984|11084335|FG000|STARTED|Overall Study||49
9964600|NCT01491984|11084336|FG001|STARTED|Overall Study||45
9964601|NCT01491984|11084335|FG000|COMPLETED|Overall Study||47
9964602|NCT01491984|11084336|FG001|COMPLETED|Overall Study||44
9964603|NCT01491984|11084335|FG000|NOT COMPLETED|Overall Study||2
9964604|NCT01491984|11084336|FG001|NOT COMPLETED|Overall Study||1
9964605|NCT01492088|11084345|FG000|STARTED|Overall Study||3
9964606|NCT01492088|11084346|FG001|STARTED|Overall Study||16
9964607|NCT01492088|11084347|FG002|STARTED|Overall Study||17
9964608|NCT01492088|11084345|FG000|COMPLETED|Overall Study||0
9964609|NCT01492088|11084346|FG001|COMPLETED|Overall Study||2
9964610|NCT01492088|11084347|FG002|COMPLETED|Overall Study||3
9964611|NCT01492088|11084345|FG000|NOT COMPLETED|Overall Study||3
9964612|NCT01492088|11084346|FG001|NOT COMPLETED|Overall Study||14
9964613|NCT01492088|11084347|FG002|NOT COMPLETED|Overall Study||14
10062285|NCT02109029|11187800|FG003|STARTED|Part A||4
10062286|NCT02109029|11187801|FG004|STARTED|Part A||0
10062287|NCT02109029|11187802|FG005|STARTED|Part A||0
10062288|NCT02109029|11187797|FG000|Received One Dose of Study Drug|Part A||2
10062289|NCT02109029|11187798|FG001|Received One Dose of Study Drug|Part A||2
10062290|NCT02109029|11187799|FG002|Received One Dose of Study Drug|Part A||4
10062291|NCT02109029|11187800|FG003|Received One Dose of Study Drug|Part A||4
10062292|NCT02109029|11187801|FG004|Received One Dose of Study Drug|Part A||0
10062293|NCT02109029|11187802|FG005|Received One Dose of Study Drug|Part A||0
10062294|NCT02109029|11187797|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
10062295|NCT02109029|11187798|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
10062296|NCT02109029|11187799|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
10062297|NCT02109029|11187800|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
10062298|NCT02109029|11187801|FG004|COMPLETED|Part A||0
10062299|NCT02109029|11187802|FG005|COMPLETED|Part A||0
10062300|NCT02109029|11187797|FG000|NOT COMPLETED|Part A||0
10062301|NCT02109029|11187798|FG001|NOT COMPLETED|Part A||0
10062302|NCT02109029|11187799|FG002|NOT COMPLETED|Part A||0
10062303|NCT02109029|11187800|FG003|NOT COMPLETED|Part A||0
10062304|NCT02109029|11187801|FG004|NOT COMPLETED|Part A||0
10062305|NCT02109029|11187802|FG005|NOT COMPLETED|Part A||0
10062306|NCT02109029|11187797|FG000|STARTED|Part B||0
10062307|NCT02109029|11187798|FG001|STARTED|Part B||0
10062308|NCT02109029|11187799|FG002|STARTED|Part B||0
10062309|NCT02109029|11187800|FG003|STARTED|Part B||0
10062310|NCT02109029|11187801|FG004|STARTED|Part B|New participants entered Part B.|6
10062311|NCT02109029|11187802|FG005|STARTED|Part B|New participants entered Part B.|6
10062312|NCT02109029|11187797|FG000|Received at Least One Dose of Study Drug|Part B||0
10062313|NCT02109029|11187798|FG001|Received at Least One Dose of Study Drug|Part B||0
10062314|NCT02109029|11187799|FG002|Received at Least One Dose of Study Drug|Part B||0
10062315|NCT02109029|11187800|FG003|Received at Least One Dose of Study Drug|Part B||0
10062316|NCT02109029|11187801|FG004|Received at Least One Dose of Study Drug|Part B||6
10062317|NCT02109029|11187802|FG005|Received at Least One Dose of Study Drug|Part B||6
10062318|NCT02109029|11187797|FG000|COMPLETED|Part B||0
10062319|NCT02109029|11187798|FG001|COMPLETED|Part B||0
10062320|NCT02109029|11187799|FG002|COMPLETED|Part B||0
10062321|NCT02109029|11187800|FG003|COMPLETED|Part B||0
10062322|NCT02109029|11187801|FG004|COMPLETED|Part B||5
10062323|NCT02109029|11187802|FG005|COMPLETED|Part B||5
10062324|NCT02109029|11187797|FG000|NOT COMPLETED|Part B||0
10062325|NCT02109029|11187798|FG001|NOT COMPLETED|Part B||0
10062326|NCT02109029|11187799|FG002|NOT COMPLETED|Part B||0
10062327|NCT02109029|11187800|FG003|NOT COMPLETED|Part B||0
10062328|NCT02109029|11187801|FG004|NOT COMPLETED|Part B||1
10062329|NCT02109029|11187802|FG005|NOT COMPLETED|Part B||1
10062330|NCT02109042|11187813|FG000|STARTED|Overall Study||15
10062331|NCT02109042|11187813|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10062332|NCT02109042|11187813|FG000|Received 180 mg Loading Dose|Overall Study||15
10062333|NCT02109042|11187813|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
10062334|NCT02109042|11187813|FG000|COMPLETED|Overall Study||0
10062335|NCT02109042|11187813|FG000|NOT COMPLETED|Overall Study||15
9964614|NCT01492101|11084360|FG000|STARTED|Overall Study||429
10062336|NCT02109107|11187818|FG000|STARTED|Overall Study||54
10062337|NCT02109107|11187818|FG000|COMPLETED|Overall Study||52
9964615|NCT01492101|11084361|FG001|STARTED|Overall Study||423
9964616|NCT01492101|11084360|FG000|COMPLETED|Overall Study||92
9964617|NCT01492101|11084361|FG001|COMPLETED|Overall Study||81
9964618|NCT01492101|11084360|FG000|NOT COMPLETED|Overall Study||337
9964619|NCT01492101|11084361|FG001|NOT COMPLETED|Overall Study||342
9964620|NCT01492309|11084369|FG000|STARTED|Overall Study||11
9964621|NCT01492309|11084370|FG001|STARTED|Overall Study||11
9964622|NCT01492309|11084369|FG000|COMPLETED|Overall Study||11
9964623|NCT01492309|11084370|FG001|COMPLETED|Overall Study||11
9964624|NCT01492309|11084369|FG000|NOT COMPLETED|Overall Study||0
9964625|NCT01492309|11084370|FG001|NOT COMPLETED|Overall Study||0
9964626|NCT01492400|11084378|FG000|STARTED|Overall Study||181
9964627|NCT01492400|11084379|FG001|STARTED|Overall Study||182
9964628|NCT01492400|11084378|FG000|COMPLETED|Overall Study||165
9964629|NCT01492400|11084379|FG001|COMPLETED|Overall Study||166
9964630|NCT01492400|11084378|FG000|NOT COMPLETED|Overall Study||16
9964631|NCT01492400|11084379|FG001|NOT COMPLETED|Overall Study||16
9964632|NCT01492426|11084387|FG000|STARTED|Treatment||402
9964633|NCT01492426|11084388|FG001|STARTED|Treatment||200
9964634|NCT01492426|11084387|FG000|COMPLETED|Treatment||319
9964635|NCT01492426|11084388|FG001|COMPLETED|Treatment||160
9964636|NCT01492426|11084387|FG000|NOT COMPLETED|Treatment||83
9964637|NCT01492426|11084388|FG001|NOT COMPLETED|Treatment||40
9964638|NCT01492426|11084387|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
9964639|NCT01492426|11084388|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
9964640|NCT01492426|11084387|FG000|COMPLETED|Follow-Up||359
9964641|NCT01492426|11084388|FG001|COMPLETED|Follow-Up||181
9964642|NCT01492426|11084387|FG000|NOT COMPLETED|Follow-Up||25
9964643|NCT01492426|11084388|FG001|NOT COMPLETED|Follow-Up||10
9964644|NCT01492439|11084400|FG000|STARTED|Overall Study||19
9964645|NCT01492439|11084401|FG001|STARTED|Overall Study||18
9964646|NCT01492439|11084400|FG000|Post-intervention|Overall Study||18
9964647|NCT01492439|11084401|FG001|Post-intervention|Overall Study||13
9964648|NCT01492439|11084400|FG000|COMPLETED|Overall Study||15
9964649|NCT01492439|11084401|FG001|COMPLETED|Overall Study||9
9964650|NCT01492439|11084400|FG000|NOT COMPLETED|Overall Study||4
9964651|NCT01492439|11084401|FG001|NOT COMPLETED|Overall Study||9
9964652|NCT01492582|11084409|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
9964653|NCT01492582|11084410|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046
9964654|NCT01492582|11084409|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254
9964655|NCT01492582|11084410|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
9964656|NCT01492582|11084409|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182
9964657|NCT01492582|11084410|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0
9964658|NCT01492582|11084409|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
9964659|NCT01492582|11084410|FG001|COMPLETED|Overall Study|Returned evaluable survey|982
9964660|NCT01492582|11084409|FG000|NOT COMPLETED|Overall Study||69
9964661|NCT01492582|11084410|FG001|NOT COMPLETED|Overall Study||64
9964662|NCT01492673|11084433|FG000|STARTED|Overall Study||9
9964663|NCT01492673|11084433|FG000|COMPLETED|Overall Study||9
9964664|NCT01492673|11084433|FG000|NOT COMPLETED|Overall Study||0
9964665|NCT01492686|11084439|FG000|STARTED|Double-blind Phase||69
9964666|NCT01492686|11084440|FG001|STARTED|Double-blind Phase||68
9964667|NCT01492686|11084439|FG000|COMPLETED|Double-blind Phase||67
9964668|NCT01492686|11084440|FG001|COMPLETED|Double-blind Phase||60
9964669|NCT01492686|11084439|FG000|NOT COMPLETED|Double-blind Phase||2
9964670|NCT01492686|11084440|FG001|NOT COMPLETED|Double-blind Phase||8
9964671|NCT01492686|11084439|FG000|STARTED|Open-label Phase||65
9964672|NCT01492686|11084440|FG001|STARTED|Open-label Phase||58
9964673|NCT01492686|11084439|FG000|COMPLETED|Open-label Phase||53
9964674|NCT01492686|11084440|FG001|COMPLETED|Open-label Phase||40
9964675|NCT01492686|11084439|FG000|NOT COMPLETED|Open-label Phase||12
9964676|NCT01492686|11084440|FG001|NOT COMPLETED|Open-label Phase||18
9964677|NCT01493024|11084452|FG000|STARTED|Overall Study||30
9964678|NCT01493024|11084453|FG001|STARTED|Overall Study||12
9964679|NCT01493024|11084454|FG002|STARTED|Overall Study||24
9964680|NCT01493024|11084455|FG003|STARTED|Overall Study||24
9964681|NCT01493024|11084452|FG000|COMPLETED|Overall Study||30
9964682|NCT01493024|11084453|FG001|COMPLETED|Overall Study||12
9964683|NCT01493024|11084454|FG002|COMPLETED|Overall Study||24
9964684|NCT01493024|11084455|FG003|COMPLETED|Overall Study||24
9964685|NCT01493024|11084452|FG000|NOT COMPLETED|Overall Study||0
9964686|NCT01493024|11084453|FG001|NOT COMPLETED|Overall Study||0
9964687|NCT01493024|11084454|FG002|NOT COMPLETED|Overall Study||0
9964688|NCT01493024|11084455|FG003|NOT COMPLETED|Overall Study||0
9964689|NCT01493089|11084468|FG000|STARTED|Overall Study||122
9964690|NCT01493089|11084469|FG001|STARTED|Overall Study||117
9964691|NCT01493089|11084468|FG000|COMPLETED|Overall Study||119
9964692|NCT01493089|11084469|FG001|COMPLETED|Overall Study||114
9964693|NCT01493089|11084468|FG000|NOT COMPLETED|Overall Study||3
9964694|NCT01493089|11084469|FG001|NOT COMPLETED|Overall Study||3
9964695|NCT01493167|11084477|FG000|STARTED|Overall Study||97
9964696|NCT01493167|11084477|FG000|COMPLETED|Overall Study||97
9964697|NCT01493167|11084477|FG000|NOT COMPLETED|Overall Study||0
9964698|NCT01493180|11084483|FG000|STARTED|Overall Study||51
9964699|NCT01493180|11084484|FG001|STARTED|Overall Study||51
9964700|NCT01493180|11084483|FG000|COMPLETED|Overall Study||48
9964701|NCT01493180|11084484|FG001|COMPLETED|Overall Study||49
9964702|NCT01493180|11084483|FG000|NOT COMPLETED|Overall Study||3
9964703|NCT01493180|11084484|FG001|NOT COMPLETED|Overall Study||2
9964704|NCT01493284|11084490|FG000|STARTED|Overall Study||222
9964705|NCT01493284|11084490|FG000|COMPLETED|Overall Study||161
9964706|NCT01493284|11084490|FG000|NOT COMPLETED|Overall Study||61
9964707|NCT01493414|11084494|FG000|STARTED|Overall Study||2233
9964708|NCT01493414|11084494|FG000|COMPLETED|Overall Study||1283
9964709|NCT01493414|11084494|FG000|NOT COMPLETED|Overall Study||950
9964710|NCT01493427|11084502|FG000|STARTED|Overall Study||199
9964711|NCT01493427|11084502|FG000|COMPLETED|Overall Study||179
9964712|NCT01493427|11084502|FG000|NOT COMPLETED|Overall Study||20
9964713|NCT01493531|11084509|FG000|STARTED|Overall Study||204
9964714|NCT01493531|11084510|FG001|STARTED|Overall Study||200
9964715|NCT01493531|11084511|FG002|STARTED|Overall Study||206
9964716|NCT01493531|11084509|FG000|COMPLETED|Overall Study||163
9964717|NCT01493531|11084510|FG001|COMPLETED|Overall Study||150
9964718|NCT01493531|11084511|FG002|COMPLETED|Overall Study||158
9964719|NCT01493531|11084509|FG000|NOT COMPLETED|Overall Study||41
10062338|NCT02109107|11187818|FG000|NOT COMPLETED|Overall Study||2
10062339|NCT02109133|11187824|FG000|STARTED|Overall Study||33
10062340|NCT02109133|11187825|FG001|STARTED|Overall Study||34
10062341|NCT02109133|11187824|FG000|COMPLETED|Overall Study||32
10062342|NCT02109133|11187825|FG001|COMPLETED|Overall Study||34
10062343|NCT02109133|11187824|FG000|NOT COMPLETED|Overall Study||1
9964720|NCT01493531|11084510|FG001|NOT COMPLETED|Overall Study||50
9964721|NCT01493531|11084511|FG002|NOT COMPLETED|Overall Study||48
9964722|NCT01493557|11084522|FG000|STARTED|Not Randomized to Management Strategies||0
10062344|NCT02109133|11187825|FG001|NOT COMPLETED|Overall Study||0
10062345|NCT02109159|11187835|FG000|STARTED|Overall Study||4178
10062346|NCT02109159|11187836|FG001|STARTED|Overall Study||4175
10062347|NCT02109159|11187835|FG000|COMPLETED|Overall Study||4178
10062348|NCT02109159|11187836|FG001|COMPLETED|Overall Study||4175
10062349|NCT02109159|11187835|FG000|NOT COMPLETED|Overall Study||0
10062350|NCT02109159|11187836|FG001|NOT COMPLETED|Overall Study||0
10062351|NCT02109419|11187842|FG000|STARTED|Overall Study||57
10062352|NCT02109419|11187842|FG000|COMPLETED|Overall Study||57
10062353|NCT02109419|11187842|FG000|NOT COMPLETED|Overall Study||0
10062354|NCT02109432|11187848|FG000|STARTED|Overall Study||7
10062355|NCT02109432|11187848|FG000|COMPLETED|Overall Study||6
10062356|NCT02109432|11187848|FG000|NOT COMPLETED|Overall Study||1
10062357|NCT02109445|11187852|FG000|STARTED|Overall Study||3
10062358|NCT02109445|11187852|FG000|COMPLETED|Overall Study||0
10062359|NCT02109445|11187852|FG000|NOT COMPLETED|Overall Study||3
10062360|NCT02109458|11187856|FG000|STARTED|Overall Study||24
10062361|NCT02109458|11187856|FG000|COMPLETED|Overall Study||24
10062362|NCT02109458|11187856|FG000|NOT COMPLETED|Overall Study||0
10062363|NCT02109484|11187868|FG000|STARTED|Overall Study||5
10062364|NCT02109484|11187869|FG001|STARTED|Overall Study||13
10062365|NCT02109484|11187870|FG002|STARTED|Overall Study||12
10062366|NCT02109484|11187871|FG003|STARTED|Overall Study||12
10062367|NCT02109484|11187872|FG004|STARTED|Overall Study||50
10062368|NCT02109484|11187873|FG005|STARTED|Overall Study||12
10062369|NCT02109484|11187874|FG006|STARTED|Overall Study||50
10062370|NCT02109484|11187875|FG007|STARTED|Overall Study||50
10062371|NCT02109484|11187868|FG000|COMPLETED|Overall Study||5
10062372|NCT02109484|11187869|FG001|COMPLETED|Overall Study||13
10062373|NCT02109484|11187870|FG002|COMPLETED|Overall Study||12
10062374|NCT02109484|11187871|FG003|COMPLETED|Overall Study||11
10062375|NCT02109484|11187872|FG004|COMPLETED|Overall Study||46
10062376|NCT02109484|11187873|FG005|COMPLETED|Overall Study||11
10062377|NCT02109484|11187874|FG006|COMPLETED|Overall Study||47
10062378|NCT02109484|11187875|FG007|COMPLETED|Overall Study||47
10062379|NCT02109484|11187868|FG000|NOT COMPLETED|Overall Study||0
10062380|NCT02109484|11187869|FG001|NOT COMPLETED|Overall Study||0
10062381|NCT02109484|11187870|FG002|NOT COMPLETED|Overall Study||0
10062382|NCT02109484|11187871|FG003|NOT COMPLETED|Overall Study||1
10062383|NCT02109484|11187872|FG004|NOT COMPLETED|Overall Study||4
10062384|NCT02109484|11187873|FG005|NOT COMPLETED|Overall Study||1
10062385|NCT02109484|11187874|FG006|NOT COMPLETED|Overall Study||3
10062386|NCT02109484|11187875|FG007|NOT COMPLETED|Overall Study||3
10062387|NCT02109497|11187910|FG000|STARTED|Overall Study||18
10062388|NCT02109497|11187910|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
10062389|NCT02109497|11187910|FG000|NOT COMPLETED|Overall Study||1
10062390|NCT02109562|11187917|FG000|STARTED|Overall Study||116
10062391|NCT02109562|11187918|FG001|STARTED|Overall Study||119
10062392|NCT02109562|11187919|FG002|STARTED|Overall Study||119
10062393|NCT02109562|11187917|FG000|Safety|Overall Study||115
10062394|NCT02109562|11187918|FG001|Safety|Overall Study||117
10062395|NCT02109562|11187919|FG002|Safety|Overall Study||118
10062396|NCT02109562|11187917|FG000|Intent to Treat (ITT)|Overall Study||111
10062397|NCT02109562|11187918|FG001|Intent to Treat (ITT)|Overall Study||114
10062398|NCT02109562|11187919|FG002|Intent to Treat (ITT)|Overall Study||112
10062399|NCT02109562|11187917|FG000|COMPLETED|Overall Study||90
10062400|NCT02109562|11187918|FG001|COMPLETED|Overall Study||85
10062401|NCT02109562|11187919|FG002|COMPLETED|Overall Study||84
10062402|NCT02109562|11187917|FG000|NOT COMPLETED|Overall Study||26
10062403|NCT02109562|11187918|FG001|NOT COMPLETED|Overall Study||34
10062404|NCT02109562|11187919|FG002|NOT COMPLETED|Overall Study||35
10062405|NCT02109640|11187929|FG000|STARTED|Overall Study||27
9964723|NCT01493557|11084523|FG001|STARTED|Not Randomized to Management Strategies||0
9964724|NCT01493557|11084524|FG002|STARTED|Not Randomized to Management Strategies||950
9964725|NCT01493557|11084522|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0
9964726|NCT01493557|11084523|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0
9964727|NCT01493557|11084524|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
9964728|NCT01493557|11084522|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
9964729|NCT01493557|11084523|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
9964730|NCT01493557|11084524|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
9964731|NCT01493557|11084522|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
9964732|NCT01493557|11084523|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
9964733|NCT01493557|11084524|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
9964734|NCT01493557|11084522|FG000|COMPLETED|Not Randomized to Management Strategies||0
9964735|NCT01493557|11084523|FG001|COMPLETED|Not Randomized to Management Strategies||0
9964736|NCT01493557|11084524|FG002|COMPLETED|Not Randomized to Management Strategies||816
9964737|NCT01493557|11084522|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0
9964738|NCT01493557|11084523|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0
9964739|NCT01493557|11084524|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134
9964740|NCT01493557|11084522|FG000|STARTED|Randomized to Management Strategies||59
9964741|NCT01493557|11084523|FG001|STARTED|Randomized to Management Strategies||58
9964742|NCT01493557|11084524|FG002|STARTED|Randomized to Management Strategies||0
9964743|NCT01493557|11084522|FG000|COMPLETED|Randomized to Management Strategies||44
9964744|NCT01493557|11084523|FG001|COMPLETED|Randomized to Management Strategies||47
9964745|NCT01493557|11084524|FG002|COMPLETED|Randomized to Management Strategies||0
9964746|NCT01493557|11084522|FG000|NOT COMPLETED|Randomized to Management Strategies||15
9964747|NCT01493557|11084523|FG001|NOT COMPLETED|Randomized to Management Strategies||11
9964748|NCT01493557|11084524|FG002|NOT COMPLETED|Randomized to Management Strategies||0
9964749|NCT01493557|11084522|FG000|STARTED|Adding the Second Strategy||14
9964750|NCT01493557|11084523|FG001|STARTED|Adding the Second Strategy||15
9964751|NCT01493557|11084524|FG002|STARTED|Adding the Second Strategy||0
9964752|NCT01493557|11084522|FG000|COMPLETED|Adding the Second Strategy||12
9964753|NCT01493557|11084523|FG001|COMPLETED|Adding the Second Strategy||11
9964754|NCT01493557|11084524|FG002|COMPLETED|Adding the Second Strategy||0
9964755|NCT01493557|11084522|FG000|NOT COMPLETED|Adding the Second Strategy||2
9964756|NCT01493557|11084523|FG001|NOT COMPLETED|Adding the Second Strategy||4
9964757|NCT01493557|11084524|FG002|NOT COMPLETED|Adding the Second Strategy||0
9964758|NCT01493596|11084538|FG000|STARTED|Overall Study||8
9964759|NCT01493596|11084539|FG001|STARTED|Overall Study||8
9964760|NCT01493596|11084540|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
9964761|NCT01493596|11084541|FG003|STARTED|Overall Study||8
9964762|NCT01493596|11084542|FG004|STARTED|Overall Study||8
9964763|NCT01493596|11084543|FG005|STARTED|Overall Study||8
9964764|NCT01493596|11084544|FG006|STARTED|Overall Study||8
9964765|NCT01493596|11084538|FG000|COMPLETED|Overall Study||8
9964766|NCT01493596|11084539|FG001|COMPLETED|Overall Study||8
9964767|NCT01493596|11084540|FG002|COMPLETED|Overall Study||7
9964768|NCT01493596|11084541|FG003|COMPLETED|Overall Study||8
9964769|NCT01493596|11084542|FG004|COMPLETED|Overall Study||8
9964770|NCT01493596|11084543|FG005|COMPLETED|Overall Study||8
9964771|NCT01493596|11084544|FG006|COMPLETED|Overall Study||8
9964772|NCT01493596|11084538|FG000|NOT COMPLETED|Overall Study||0
9964773|NCT01493596|11084539|FG001|NOT COMPLETED|Overall Study||0
9964774|NCT01493596|11084540|FG002|NOT COMPLETED|Overall Study||0
9964775|NCT01493596|11084541|FG003|NOT COMPLETED|Overall Study||0
9964776|NCT01493596|11084542|FG004|NOT COMPLETED|Overall Study||0
9964777|NCT01493596|11084543|FG005|NOT COMPLETED|Overall Study||0
9964778|NCT01493596|11084544|FG006|NOT COMPLETED|Overall Study||0
9964779|NCT01493687|11084560|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451
9964780|NCT01493687|11084561|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232
9964781|NCT01493687|11084560|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414
9964782|NCT01493687|11084561|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210
9964783|NCT01493687|11084560|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
9964784|NCT01493687|11084561|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
9964785|NCT01493687|11084560|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
9964786|NCT01493687|11084561|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210
9964787|NCT01493687|11084560|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351
9964788|NCT01493687|11084561|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175
9964789|NCT01493687|11084560|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
9964790|NCT01493687|11084561|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
9964791|NCT01493687|11084560|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
9964792|NCT01493687|11084561|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175
9964793|NCT01493687|11084560|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350
9964794|NCT01493687|11084561|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174
9964795|NCT01493687|11084560|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
9964796|NCT01493687|11084561|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
9964797|NCT01493778|11084573|FG000|STARTED|Overall Study||60
9964798|NCT01493778|11084573|FG000|COMPLETED|Overall Study||52
9964799|NCT01493778|11084573|FG000|NOT COMPLETED|Overall Study||8
9964800|NCT01493947|11084588|FG000|STARTED|Period A Efficacy and Safety Data||478
9964801|NCT01493947|11084589|FG001|STARTED|Period A Efficacy and Safety Data||484
9964802|NCT01493947|11084588|FG000|COMPLETED|Period A Efficacy and Safety Data||446
9964803|NCT01493947|11084589|FG001|COMPLETED|Period A Efficacy and Safety Data||456
9964804|NCT01493947|11084588|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32
9964805|NCT01493947|11084589|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28
9964806|NCT01493947|11084588|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
9964807|NCT01493947|11084589|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
9964808|NCT01493947|11084588|FG000|COMPLETED|Period B Extension Period||366
9964809|NCT01493947|11084589|FG001|COMPLETED|Period B Extension Period||326
9964810|NCT01493947|11084588|FG000|NOT COMPLETED|Period B Extension Period||33
9964811|NCT01493947|11084589|FG001|NOT COMPLETED|Period B Extension Period||32
9964812|NCT01493960|11084600|FG000|STARTED|Overall Study||87
9964813|NCT01493960|11084601|FG001|STARTED|Overall Study||44
9964814|NCT01493960|11084600|FG000|Received Study Drug|Overall Study||87
9964815|NCT01493960|11084601|FG001|Received Study Drug|Overall Study||43
9964816|NCT01493960|11084600|FG000|COMPLETED|Overall Study||55
9964817|NCT01493960|11084601|FG001|COMPLETED|Overall Study||26
9964818|NCT01493960|11084600|FG000|NOT COMPLETED|Overall Study||32
9964819|NCT01493960|11084601|FG001|NOT COMPLETED|Overall Study||18
9964820|NCT01494038|11084609|FG000|STARTED|Overall Study||477
9964821|NCT01494038|11084610|FG001|STARTED|Overall Study||479
9964822|NCT01494038|11084609|FG000|COMPLETED|Overall Study||389
9964823|NCT01494038|11084610|FG001|COMPLETED|Overall Study||396
9964824|NCT01494038|11084609|FG000|NOT COMPLETED|Overall Study||88
9964825|NCT01494038|11084610|FG001|NOT COMPLETED|Overall Study||83
9964826|NCT01494051|11084633|FG000|STARTED|Overall Study||6
9964827|NCT01494051|11084634|FG001|STARTED|Overall Study||7
9964828|NCT01494051|11084633|FG000|COMPLETED|Overall Study||6
9964829|NCT01494051|11084634|FG001|COMPLETED|Overall Study||7
9964830|NCT01494051|11084633|FG000|NOT COMPLETED|Overall Study||0
9964831|NCT01494051|11084634|FG001|NOT COMPLETED|Overall Study||0
9964832|NCT01494298|11084642|FG000|STARTED|Overall Study||56
9964833|NCT01494298|11084643|FG001|STARTED|Overall Study||55
9964834|NCT01494298|11084642|FG000|COMPLETED|Overall Study||54
9964835|NCT01494298|11084643|FG001|COMPLETED|Overall Study||47
9964836|NCT01494298|11084642|FG000|NOT COMPLETED|Overall Study||2
9964837|NCT01494298|11084643|FG001|NOT COMPLETED|Overall Study||8
9964838|NCT01494350|11084651|FG000|STARTED|Overall Study||50
9964839|NCT01494350|11084651|FG000|COMPLETED|Overall Study||49
9964840|NCT01494350|11084651|FG000|NOT COMPLETED|Overall Study||1
9964841|NCT01494467|11084657|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459
9964842|NCT01494467|11084658|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229
9964843|NCT01494467|11084657|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429
9964844|NCT01494467|11084658|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208
9964845|NCT01494467|11084657|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
9964846|NCT01494467|11084658|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
9964847|NCT01494467|11084657|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
9964848|NCT01494467|11084658|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208
9964849|NCT01494467|11084657|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353
9964850|NCT01494467|11084658|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159
9964851|NCT01494467|11084657|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
9964852|NCT01494467|11084658|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
9964853|NCT01494467|11084657|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353
9964854|NCT01494467|11084658|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159
9964855|NCT01494467|11084657|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353
9964856|NCT01494467|11084658|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159
9964857|NCT01494467|11084657|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
9964858|NCT01494467|11084658|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
9964859|NCT01494506|11084673|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
9964860|NCT01494506|11084674|FG001|STARTED|Overall Study||149
9964861|NCT01494506|11084675|FG002|STARTED|Overall Study||117
9964862|NCT01494506|11084673|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
9964863|NCT01494506|11084674|FG001|Treated Population|Overall Study||134
9964864|NCT01494506|11084675|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
9964865|NCT01494506|11084673|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
9964866|NCT01494506|11084674|FG001|COMPLETED|Overall Study||6
9964867|NCT01494506|11084675|FG002|COMPLETED|Overall Study||14
9964868|NCT01494506|11084673|FG000|NOT COMPLETED|Overall Study||148
9964869|NCT01494506|11084674|FG001|NOT COMPLETED|Overall Study||143
9964870|NCT01494506|11084675|FG002|NOT COMPLETED|Overall Study||103
9964871|NCT01494532|11084691|FG000|STARTED|Overall Study||75
9964872|NCT01494532|11084692|FG001|STARTED|Overall Study||25
9964873|NCT01494532|11084693|FG002|STARTED|Overall Study||76
9964874|NCT01494532|11084694|FG003|STARTED|Overall Study||75
9964875|NCT01494532|11084695|FG004|STARTED|Overall Study||76
9964876|NCT01494532|11084696|FG005|STARTED|Overall Study||25
9964877|NCT01494532|11084691|FG000|COMPLETED|Overall Study||65
9964878|NCT01494532|11084692|FG001|COMPLETED|Overall Study||21
9964879|NCT01494532|11084693|FG002|COMPLETED|Overall Study||59
9964880|NCT01494532|11084694|FG003|COMPLETED|Overall Study||60
9964881|NCT01494532|11084695|FG004|COMPLETED|Overall Study||64
9964882|NCT01494532|11084696|FG005|COMPLETED|Overall Study||25
9964883|NCT01494532|11084691|FG000|NOT COMPLETED|Overall Study||10
9964884|NCT01494532|11084692|FG001|NOT COMPLETED|Overall Study||4
9964885|NCT01494532|11084693|FG002|NOT COMPLETED|Overall Study||17
9964886|NCT01494532|11084694|FG003|NOT COMPLETED|Overall Study||15
9964887|NCT01494532|11084695|FG004|NOT COMPLETED|Overall Study||12
9964888|NCT01494532|11084696|FG005|NOT COMPLETED|Overall Study||0
9964889|NCT01494545|11084711|FG000|STARTED|Overall Study||102
9964890|NCT01494545|11084711|FG000|COMPLETED|Overall Study||92
9964891|NCT01494545|11084711|FG000|NOT COMPLETED|Overall Study||10
9964892|NCT01494584|11084718|FG000|STARTED|Overall Study||5
9964893|NCT01494584|11084718|FG000|COMPLETED|Overall Study||4
9964894|NCT01494584|11084718|FG000|NOT COMPLETED|Overall Study||1
9964895|NCT01494610|11084741|FG000|STARTED|Period 1||31
9964896|NCT01494610|11084742|FG001|STARTED|Period 1||29
9964897|NCT01494610|11084741|FG000|COMPLETED|Period 1||30
9964898|NCT01494610|11084742|FG001|COMPLETED|Period 1||28
9964899|NCT01494610|11084741|FG000|NOT COMPLETED|Period 1||1
9964900|NCT01494610|11084742|FG001|NOT COMPLETED|Period 1||1
9964901|NCT01494610|11084741|FG000|STARTED|Period 2||30
9964902|NCT01494610|11084742|FG001|STARTED|Period 2||28
9964903|NCT01494610|11084741|FG000|COMPLETED|Period 2||30
9964904|NCT01494610|11084742|FG001|COMPLETED|Period 2||28
9964905|NCT01494610|11084741|FG000|NOT COMPLETED|Period 2||0
9964906|NCT01494610|11084742|FG001|NOT COMPLETED|Period 2||0
9964907|NCT01494610|11084741|FG000|STARTED|Period 3||30
9964908|NCT01494610|11084742|FG001|STARTED|Period 3||28
9964909|NCT01494610|11084741|FG000|COMPLETED|Period 3||28
9964910|NCT01494610|11084742|FG001|COMPLETED|Period 3||28
9964911|NCT01494610|11084741|FG000|NOT COMPLETED|Period 3||2
9964912|NCT01494610|11084742|FG001|NOT COMPLETED|Period 3||0
9964913|NCT01494610|11084741|FG000|STARTED|Period 4||28
9964914|NCT01494610|11084742|FG001|STARTED|Period 4||28
9964915|NCT01494610|11084741|FG000|COMPLETED|Period 4||27
9964916|NCT01494610|11084742|FG001|COMPLETED|Period 4||28
9964917|NCT01494610|11084741|FG000|NOT COMPLETED|Period 4||1
9964918|NCT01494610|11084742|FG001|NOT COMPLETED|Period 4||0
9964919|NCT01494649|11084756|FG000|STARTED|Overall Study||59
9964920|NCT01494649|11084757|FG001|STARTED|Overall Study||59
9964921|NCT01494649|11084756|FG000|COMPLETED|Overall Study||59
9964922|NCT01494649|11084757|FG001|COMPLETED|Overall Study||58
9964923|NCT01494649|11084756|FG000|NOT COMPLETED|Overall Study||0
9964924|NCT01494649|11084757|FG001|NOT COMPLETED|Overall Study||1
9964925|NCT01494753|11084767|FG000|STARTED|Day0-Day42||15
9964926|NCT01494753|11084768|FG001|STARTED|Day0-Day42||15
9964927|NCT01494753|11084767|FG000|COMPLETED|Day0-Day42||15
9964928|NCT01494753|11084768|FG001|COMPLETED|Day0-Day42||15
9964929|NCT01494753|11084767|FG000|NOT COMPLETED|Day0-Day42||0
9964930|NCT01494753|11084768|FG001|NOT COMPLETED|Day0-Day42||0
9964931|NCT01494753|11084767|FG000|STARTED|Day42-Day84||15
9964932|NCT01494753|11084768|FG001|STARTED|Day42-Day84||15
9964933|NCT01494753|11084767|FG000|COMPLETED|Day42-Day84||15
9964934|NCT01494753|11084768|FG001|COMPLETED|Day42-Day84||15
9964935|NCT01494753|11084767|FG000|NOT COMPLETED|Day42-Day84||0
9964936|NCT01494753|11084768|FG001|NOT COMPLETED|Day42-Day84||0
9964937|NCT01494818|11084776|FG000|STARTED|Overall Study||39
9964938|NCT01494818|11084777|FG001|STARTED|Overall Study||39
9964939|NCT01494818|11084776|FG000|COMPLETED|Overall Study||37
9964940|NCT01494818|11084777|FG001|COMPLETED|Overall Study||37
9964941|NCT01494818|11084776|FG000|NOT COMPLETED|Overall Study||2
9964942|NCT01494818|11084777|FG001|NOT COMPLETED|Overall Study||2
9964943|NCT01494922|11084783|FG000|STARTED|Overall Study||14
9964944|NCT01494922|11084783|FG000|COMPLETED|Overall Study||13
9964945|NCT01494922|11084783|FG000|NOT COMPLETED|Overall Study||1
9964946|NCT01494987|11084789|FG000|STARTED|Overall Study||216
9964947|NCT01494987|11084790|FG001|STARTED|Overall Study||215
9964948|NCT01494987|11084789|FG000|COMPLETED|Overall Study||188
9964949|NCT01494987|11084790|FG001|COMPLETED|Overall Study||187
9964950|NCT01494987|11084789|FG000|NOT COMPLETED|Overall Study||28
9964951|NCT01494987|11084790|FG001|NOT COMPLETED|Overall Study||28
9964952|NCT01495000|11084798|FG000|STARTED|Overall Study||124
9964953|NCT01495000|11084799|FG001|STARTED|Overall Study||126
9964954|NCT01495000|11084798|FG000|COMPLETED|Overall Study||111
9964955|NCT01495000|11084799|FG001|COMPLETED|Overall Study||114
9964956|NCT01495000|11084798|FG000|NOT COMPLETED|Overall Study||13
9964957|NCT01495000|11084799|FG001|NOT COMPLETED|Overall Study||12
9964958|NCT01495221|11084805|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9
9964959|NCT01495221|11084805|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
9964960|NCT01495221|11084805|FG000|NOT COMPLETED|Overall Study||0
9964961|NCT01495286|11084809|FG000|STARTED|Overall Study||30
9964962|NCT01495286|11084809|FG000|COMPLETED|Overall Study||30
9964963|NCT01495286|11084809|FG000|NOT COMPLETED|Overall Study||0
9964964|NCT01495481|11084813|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
9964965|NCT01495481|11084813|FG000|COMPLETED|Adenosine||22
9964966|NCT01495481|11084813|FG000|NOT COMPLETED|Adenosine||0
9964967|NCT01495481|11084813|FG000|STARTED|Washout||22
9964968|NCT01495481|11084813|FG000|COMPLETED|Washout||22
9964969|NCT01495481|11084813|FG000|NOT COMPLETED|Washout||0
9964970|NCT01495481|11084813|FG000|STARTED|Dexmedetomidine||22
9964971|NCT01495481|11084813|FG000|COMPLETED|Dexmedetomidine||22
9964972|NCT01495481|11084813|FG000|NOT COMPLETED|Dexmedetomidine||0
9964973|NCT01495572|11084823|FG000|STARTED|Overall Study||0
9964974|NCT01495572|11084824|FG001|STARTED|Overall Study||5
9964975|NCT01495572|11084823|FG000|COMPLETED|Overall Study||0
9964976|NCT01495572|11084824|FG001|COMPLETED|Overall Study||5
9964977|NCT01495572|11084823|FG000|NOT COMPLETED|Overall Study||0
9964978|NCT01495572|11084824|FG001|NOT COMPLETED|Overall Study||0
9964979|NCT01495585|11084834|FG000|STARTED|Overall Study||4
9964980|NCT01495585|11084835|FG001|STARTED|Overall Study||6
9964981|NCT01495585|11084836|FG002|STARTED|Overall Study||4
9964982|NCT01495585|11084834|FG000|Open Label Lonafarnib 200 mg|Overall Study||2
9964983|NCT01495585|11084835|FG001|Open Label Lonafarnib 200 mg|Overall Study||0
9964984|NCT01495585|11084836|FG002|Open Label Lonafarnib 200 mg|Overall Study||0
9964985|NCT01495585|11084834|FG000|COMPLETED|Overall Study||4
9964986|NCT01495585|11084835|FG001|COMPLETED|Overall Study||6
9964987|NCT01495585|11084836|FG002|COMPLETED|Overall Study||4
9964988|NCT01495585|11084834|FG000|NOT COMPLETED|Overall Study||0
9964989|NCT01495585|11084835|FG001|NOT COMPLETED|Overall Study||0
9964990|NCT01495585|11084836|FG002|NOT COMPLETED|Overall Study||0
9964991|NCT01495689|11084846|FG000|STARTED|Overall Study||26
9964992|NCT01495689|11084847|FG001|STARTED|Overall Study||23
9964993|NCT01495689|11084846|FG000|COMPLETED|Overall Study||16
9964994|NCT01495689|11084847|FG001|COMPLETED|Overall Study||16
9964995|NCT01495689|11084846|FG000|NOT COMPLETED|Overall Study||10
9964996|NCT01495689|11084847|FG001|NOT COMPLETED|Overall Study||7
9964997|NCT01495702|11084855|FG000|STARTED|Randomized Phase||292
9964998|NCT01495702|11084856|FG001|STARTED|Randomized Phase||147
9964999|NCT01495702|11084855|FG000|COMPLETED|Randomized Phase||266
9965000|NCT01495702|11084856|FG001|COMPLETED|Randomized Phase||119
9965001|NCT01495702|11084855|FG000|NOT COMPLETED|Randomized Phase||26
9965002|NCT01495702|11084856|FG001|NOT COMPLETED|Randomized Phase||28
9965003|NCT01495702|11084855|FG000|STARTED|Extension Phase||26
10062406|NCT02109640|11187930|FG001|STARTED|Overall Study||23
10062407|NCT02109640|11187929|FG000|COMPLETED|Overall Study||27
10062408|NCT02109640|11187930|FG001|COMPLETED|Overall Study||23
10062409|NCT02109640|11187929|FG000|NOT COMPLETED|Overall Study||0
10062410|NCT02109640|11187930|FG001|NOT COMPLETED|Overall Study||0
10062411|NCT02109731|11187936|FG000|STARTED|Overall Study||15
10062412|NCT02109731|11187936|FG000|COMPLETED|Overall Study||15
10062413|NCT02109731|11187936|FG000|NOT COMPLETED|Overall Study||0
10062414|NCT02109939|11187942|FG000|STARTED|Overall Study||681
10062415|NCT02109939|11187943|FG001|STARTED|Overall Study||717
10062416|NCT02109939|11187942|FG000|COMPLETED|Overall Study||560
10062417|NCT02109939|11187943|FG001|COMPLETED|Overall Study||607
10062418|NCT02109939|11187942|FG000|NOT COMPLETED|Overall Study||121
10062419|NCT02109939|11187943|FG001|NOT COMPLETED|Overall Study||110
10062420|NCT02110095|11187953|FG000|STARTED|Overall Study||15
10062421|NCT02110095|11187953|FG000|COMPLETED|Overall Study||8
10062422|NCT02110095|11187953|FG000|NOT COMPLETED|Overall Study||7
10062423|NCT02110108|11187957|FG000|STARTED|Overall Study||10
10062424|NCT02110108|11187957|FG000|RevLite Single Wavelength|Overall Study||10
10062425|NCT02110108|11187957|FG000|RevLite Combo Wavelength|Overall Study||10
10062426|NCT02110108|11187957|FG000|COMPLETED|Overall Study||7
10062427|NCT02110108|11187957|FG000|NOT COMPLETED|Overall Study||3
10062428|NCT02110121|11187967|FG000|STARTED|Overall Study||58
10062429|NCT02110121|11187968|FG001|STARTED|Overall Study||5
10062430|NCT02110121|11187967|FG000|COMPLETED|Overall Study||42
10062431|NCT02110121|11187968|FG001|COMPLETED|Overall Study||5
10062432|NCT02110121|11187967|FG000|NOT COMPLETED|Overall Study||16
10062433|NCT02110121|11187968|FG001|NOT COMPLETED|Overall Study||0
10062434|NCT02110147|11187974|FG000|STARTED|Overall Study||4
10062435|NCT02110147|11187974|FG000|COMPLETED|Overall Study||4
10062436|NCT02110147|11187974|FG000|NOT COMPLETED|Overall Study||0
10062437|NCT02110225|11187981|FG000|STARTED|Overall Study||20
10062438|NCT02110225|11187982|FG001|STARTED|Overall Study||20
10062439|NCT02110225|11187983|FG002|STARTED|Overall Study||10
10062440|NCT02110225|11187981|FG000|COMPLETED|Overall Study||20
10062441|NCT02110225|11187982|FG001|COMPLETED|Overall Study||19
10062442|NCT02110225|11187983|FG002|COMPLETED|Overall Study||10
10062443|NCT02110225|11187981|FG000|NOT COMPLETED|Overall Study||0
10062444|NCT02110225|11187982|FG001|NOT COMPLETED|Overall Study||1
9965004|NCT01495702|11084856|FG001|STARTED|Extension Phase||2
9965005|NCT01495702|11084855|FG000|COMPLETED|Extension Phase||26
9965006|NCT01495702|11084856|FG001|COMPLETED|Extension Phase||2
9965007|NCT01495702|11084855|FG000|NOT COMPLETED|Extension Phase||0
9965008|NCT01495702|11084856|FG001|NOT COMPLETED|Extension Phase||0
10188286|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0
9965009|NCT01495793|11084863|FG000|STARTED|Overall Study||24
10062445|NCT02110225|11187983|FG002|NOT COMPLETED|Overall Study||0
10062446|NCT02110238|11187994|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
10062447|NCT02110238|11187995|FG001|STARTED|12 Week Pivotal Phase||209
10062448|NCT02110238|11187994|FG000|COMPLETED|12 Week Pivotal Phase||202
9965010|NCT01495793|11084863|FG000|COMPLETED|Overall Study||22
9965011|NCT01495793|11084863|FG000|NOT COMPLETED|Overall Study||2
9965012|NCT01495819|11084867|FG000|STARTED|Overall Study||34
9965013|NCT01495819|11084867|FG000|Nicotine 0.0125|Overall Study||31
9965014|NCT01495819|11084867|FG000|Nicotine 0.025|Overall Study||32
9965015|NCT01495819|11084867|FG000|Nicotine 0.05|Overall Study||33
9965016|NCT01495819|11084867|FG000|Nicotine 0.1|Overall Study||31
9965017|NCT01495819|11084867|FG000|NIcotine 0.2|Overall Study||33
9965018|NCT01495819|11084867|FG000|COMPLETED|Overall Study||30
9965019|NCT01495819|11084867|FG000|NOT COMPLETED|Overall Study||4
9965020|NCT01495858|11084879|FG000|STARTED|Overall Study||107
9965021|NCT01495858|11084880|FG001|STARTED|Overall Study||106
9965022|NCT01495858|11084881|FG002|STARTED|Overall Study||54
9965023|NCT01495858|11084879|FG000|COMPLETED|Overall Study||107
9965024|NCT01495858|11084880|FG001|COMPLETED|Overall Study||106
9965025|NCT01495858|11084881|FG002|COMPLETED|Overall Study||54
9965026|NCT01495858|11084879|FG000|NOT COMPLETED|Overall Study||0
9965027|NCT01495858|11084880|FG001|NOT COMPLETED|Overall Study||0
9965028|NCT01495858|11084881|FG002|NOT COMPLETED|Overall Study||0
9965029|NCT01495923|11084891|FG000|STARTED|Overall Study||73
9965030|NCT01495923|11084892|FG001|STARTED|Overall Study||72
9965031|NCT01495923|11084891|FG000|COMPLETED|Overall Study||73
9965032|NCT01495923|11084892|FG001|COMPLETED|Overall Study||72
9965033|NCT01495923|11084891|FG000|NOT COMPLETED|Overall Study||0
9965034|NCT01495923|11084892|FG001|NOT COMPLETED|Overall Study||0
9965035|NCT01495975|11084902|FG000|STARTED|Overall Study||15
9965036|NCT01495975|11084903|FG001|STARTED|Overall Study||14
9965037|NCT01495975|11084902|FG000|COMPLETED|Overall Study||14
9965038|NCT01495975|11084903|FG001|COMPLETED|Overall Study||14
9965039|NCT01495975|11084902|FG000|NOT COMPLETED|Overall Study||1
9965040|NCT01495975|11084903|FG001|NOT COMPLETED|Overall Study||0
9965041|NCT01496066|11084911|FG000|STARTED|Overall Study||403
9965042|NCT01496066|11084912|FG001|STARTED|Overall Study||197
9965043|NCT01496066|11084911|FG000|COMPLETED|Overall Study||391
9965044|NCT01496066|11084912|FG001|COMPLETED|Overall Study||188
9965045|NCT01496066|11084911|FG000|NOT COMPLETED|Overall Study||12
9965046|NCT01496066|11084912|FG001|NOT COMPLETED|Overall Study||9
9965047|NCT01496131|11084927|FG000|STARTED|Overall Study||14
9965048|NCT01496131|11084928|FG001|STARTED|Overall Study||14
9965049|NCT01496131|11084927|FG000|COMPLETED|Overall Study||14
9965050|NCT01496131|11084928|FG001|COMPLETED|Overall Study||14
9965051|NCT01496131|11084927|FG000|NOT COMPLETED|Overall Study||0
9965052|NCT01496131|11084928|FG001|NOT COMPLETED|Overall Study||0
9965053|NCT01496157|11084934|FG000|STARTED|Overall Study||13
9965054|NCT01496157|11084934|FG000|COMPLETED|Overall Study||13
9965055|NCT01496157|11084934|FG000|NOT COMPLETED|Overall Study||0
9965056|NCT01496183|11084940|FG000|STARTED|Overall Study||9
9965057|NCT01496183|11084941|FG001|STARTED|Overall Study||15
9965058|NCT01496183|11084940|FG000|COMPLETED|Overall Study||6
9965059|NCT01496183|11084941|FG001|COMPLETED|Overall Study||13
9965060|NCT01496183|11084940|FG000|NOT COMPLETED|Overall Study||3
9965061|NCT01496183|11084941|FG001|NOT COMPLETED|Overall Study||2
9965062|NCT01496248|11084948|FG000|STARTED|Overall Study||35
9965063|NCT01496248|11084948|FG000|COMPLETED|Overall Study||25
9965064|NCT01496248|11084948|FG000|NOT COMPLETED|Overall Study||10
9965065|NCT01496274|11084954|FG000|STARTED|Overall Study||40
9965066|NCT01496274|11084955|FG001|STARTED|Overall Study||23
9965067|NCT01496274|11084954|FG000|COMPLETED|Overall Study||37
9965068|NCT01496274|11084955|FG001|COMPLETED|Overall Study||18
9965069|NCT01496274|11084954|FG000|NOT COMPLETED|Overall Study||3
9965070|NCT01496274|11084955|FG001|NOT COMPLETED|Overall Study||5
9965071|NCT01496287|11084976|FG000|STARTED|Overall Study||70
9965072|NCT01496287|11084976|FG000|COMPLETED|Overall Study||64
9965073|NCT01496287|11084976|FG000|NOT COMPLETED|Overall Study||6
9965074|NCT01496313|11084983|FG000|STARTED|Overall Study||40
9965075|NCT01496313|11084984|FG001|STARTED|Overall Study||41
9965076|NCT01496313|11084983|FG000|COMPLETED|Overall Study||35
9965077|NCT01496313|11084984|FG001|COMPLETED|Overall Study||26
9965078|NCT01496313|11084983|FG000|NOT COMPLETED|Overall Study||5
9965079|NCT01496313|11084984|FG001|NOT COMPLETED|Overall Study||15
9965080|NCT01496352|11084992|FG000|STARTED|Overall Study||24
9965081|NCT01496352|11084993|FG001|STARTED|Overall Study||6
9965082|NCT01496352|11084992|FG000|COMPLETED|Overall Study||24
9965083|NCT01496352|11084993|FG001|COMPLETED|Overall Study||6
9965084|NCT01496352|11084992|FG000|NOT COMPLETED|Overall Study||0
9965085|NCT01496352|11084993|FG001|NOT COMPLETED|Overall Study||0
9965086|NCT01496365|11085015|FG000|STARTED|Overall Study||112
9965087|NCT01496365|11085016|FG001|STARTED|Overall Study||56
9965088|NCT01496365|11085017|FG002|STARTED|Overall Study||57
9965089|NCT01496365|11085018|FG003|STARTED|Overall Study||57
9965090|NCT01496365|11085019|FG004|STARTED|Overall Study||57
9965091|NCT01496365|11085020|FG005|STARTED|Overall Study||56
9965092|NCT01496365|11085021|FG006|STARTED|Overall Study||57
9965093|NCT01496365|11085015|FG000|COMPLETED|Overall Study||97
9965094|NCT01496365|11085016|FG001|COMPLETED|Overall Study||41
9965095|NCT01496365|11085017|FG002|COMPLETED|Overall Study||51
9965096|NCT01496365|11085018|FG003|COMPLETED|Overall Study||53
9965097|NCT01496365|11085019|FG004|COMPLETED|Overall Study||44
9965098|NCT01496365|11085020|FG005|COMPLETED|Overall Study||46
9965099|NCT01496365|11085021|FG006|COMPLETED|Overall Study||51
9965100|NCT01496365|11085015|FG000|NOT COMPLETED|Overall Study||15
9965101|NCT01496365|11085016|FG001|NOT COMPLETED|Overall Study||15
9965102|NCT01496365|11085017|FG002|NOT COMPLETED|Overall Study||6
9965103|NCT01496365|11085018|FG003|NOT COMPLETED|Overall Study||4
9965104|NCT01496365|11085019|FG004|NOT COMPLETED|Overall Study||13
9965105|NCT01496365|11085020|FG005|NOT COMPLETED|Overall Study||10
9965106|NCT01496365|11085021|FG006|NOT COMPLETED|Overall Study||6
9965107|NCT01496430|11085040|FG000|STARTED|Overall Study||35
9965108|NCT01496430|11085041|FG001|STARTED|Overall Study||35
9965109|NCT01496430|11085042|FG002|STARTED|Overall Study||35
9965110|NCT01496430|11085040|FG000|COMPLETED|Overall Study||29
9965111|NCT01496430|11085041|FG001|COMPLETED|Overall Study||30
9965112|NCT01496430|11085042|FG002|COMPLETED|Overall Study||25
9965113|NCT01496430|11085040|FG000|NOT COMPLETED|Overall Study||6
10062449|NCT02110238|11187995|FG001|COMPLETED|12 Week Pivotal Phase||200
10062450|NCT02110238|11187994|FG000|NOT COMPLETED|12 Week Pivotal Phase||10
10062451|NCT02110238|11187995|FG001|NOT COMPLETED|12 Week Pivotal Phase||9
10062452|NCT02110238|11187994|FG000|STARTED|14 Week Blinded Extension Phase||202
10062453|NCT02110238|11187995|FG001|STARTED|14 Week Blinded Extension Phase||200
10062454|NCT02110238|11187994|FG000|COMPLETED|14 Week Blinded Extension Phase||190
10062455|NCT02110238|11187995|FG001|COMPLETED|14 Week Blinded Extension Phase||188
10062456|NCT02110238|11187994|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12
10062457|NCT02110238|11187995|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12
10062458|NCT02110264|11188004|FG000|STARTED|Overall Study||53
10062459|NCT02110264|11188005|FG001|STARTED|Overall Study||50
10062460|NCT02110264|11188006|FG002|STARTED|Overall Study||48
10062461|NCT02110264|11188004|FG000|COMPLETED|Overall Study||35
10062462|NCT02110264|11188005|FG001|COMPLETED|Overall Study||38
10062463|NCT02110264|11188006|FG002|COMPLETED|Overall Study||39
10062464|NCT02110264|11188004|FG000|NOT COMPLETED|Overall Study||18
10062465|NCT02110264|11188005|FG001|NOT COMPLETED|Overall Study||12
10062466|NCT02110264|11188006|FG002|NOT COMPLETED|Overall Study||9
10062467|NCT02110381|11188016|FG000|STARTED|Single Modality||9
10062468|NCT02110381|11188017|FG001|STARTED|Single Modality||9
10062469|NCT02110381|11188016|FG000|COMPLETED|Single Modality||7
10062470|NCT02110381|11188017|FG001|COMPLETED|Single Modality||8
10062471|NCT02110381|11188016|FG000|NOT COMPLETED|Single Modality||2
10062472|NCT02110381|11188017|FG001|NOT COMPLETED|Single Modality||1
10062473|NCT02110381|11188016|FG000|STARTED|Dual Modality||7
10062474|NCT02110381|11188017|FG001|STARTED|Dual Modality||8
10062475|NCT02110381|11188016|FG000|Began Active Treatment|Dual Modality||7
10062476|NCT02110381|11188017|FG001|Began Active Treatment|Dual Modality||7
10062477|NCT02110381|11188016|FG000|COMPLETED|Dual Modality||5
10062478|NCT02110381|11188017|FG001|COMPLETED|Dual Modality||7
10062479|NCT02110381|11188016|FG000|NOT COMPLETED|Dual Modality||2
10062480|NCT02110381|11188017|FG001|NOT COMPLETED|Dual Modality||1
10062481|NCT02110485|11188026|FG000|STARTED|Overall Study||98
10062482|NCT02110485|11188027|FG001|STARTED|Overall Study||102
10062483|NCT02110485|11188026|FG000|COMPLETED|Overall Study||91
10062484|NCT02110485|11188027|FG001|COMPLETED|Overall Study||83
10062485|NCT02110485|11188026|FG000|NOT COMPLETED|Overall Study||7
10062486|NCT02110485|11188027|FG001|NOT COMPLETED|Overall Study||19
10062487|NCT02110693|11188033|FG000|STARTED|Overall Study||1026
10062488|NCT02110693|11188034|FG001|STARTED|Overall Study||1031
10062489|NCT02110693|11188033|FG000|COMPLETED|Overall Study||998
10062490|NCT02110693|11188034|FG001|COMPLETED|Overall Study||1002
10062491|NCT02110693|11188033|FG000|NOT COMPLETED|Overall Study||28
10062492|NCT02110693|11188034|FG001|NOT COMPLETED|Overall Study||29
10062493|NCT02110706|11188056|FG000|STARTED|Overall Study||25
10062494|NCT02110706|11188057|FG001|STARTED|Overall Study||27
10062495|NCT02110706|11188056|FG000|No. Completing Study Through Week 52|Overall Study||23
10062496|NCT02110706|11188057|FG001|No. Completing Study Through Week 52|Overall Study||24
10062497|NCT02110706|11188056|FG000|COMPLETED|Overall Study||20
10062498|NCT02110706|11188057|FG001|COMPLETED|Overall Study||23
10062499|NCT02110706|11188056|FG000|NOT COMPLETED|Overall Study||5
10062500|NCT02110706|11188057|FG001|NOT COMPLETED|Overall Study||4
10062501|NCT02110732|11188067|FG000|STARTED|Overall Study||20
10062502|NCT02110732|11188068|FG001|STARTED|Overall Study||20
10062503|NCT02110732|11188067|FG000|COMPLETED|Overall Study||14
10062504|NCT02110732|11188068|FG001|COMPLETED|Overall Study||17
10062505|NCT02110732|11188067|FG000|NOT COMPLETED|Overall Study||6
10062506|NCT02110732|11188068|FG001|NOT COMPLETED|Overall Study||3
10062507|NCT02110758|11188079|FG000|STARTED|Baseline: August 2011-July 2013||0
10062508|NCT02110758|11188080|FG001|STARTED|Baseline: August 2011-July 2013||0
10062509|NCT02110758|11188081|FG002|STARTED|Baseline: August 2011-July 2013||9832
10062510|NCT02110758|11188082|FG003|STARTED|Baseline: August 2011-July 2013||18994
10062511|NCT02110758|11188083|FG004|STARTED|Baseline: August 2011-July 2013||308
10062512|NCT02110758|11188079|FG000|COMPLETED|Baseline: August 2011-July 2013||0
10062513|NCT02110758|11188080|FG001|COMPLETED|Baseline: August 2011-July 2013||0
10062514|NCT02110758|11188081|FG002|COMPLETED|Baseline: August 2011-July 2013||9832
10062515|NCT02110758|11188082|FG003|COMPLETED|Baseline: August 2011-July 2013||18994
10062516|NCT02110758|11188083|FG004|COMPLETED|Baseline: August 2011-July 2013||308
10062517|NCT02110758|11188079|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0
10062518|NCT02110758|11188080|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0
10062519|NCT02110758|11188081|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0
10062520|NCT02110758|11188082|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0
10062521|NCT02110758|11188083|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0
10062522|NCT02110758|11188079|FG000|STARTED|Start-Up: August 2013-June 2014||175
10062523|NCT02110758|11188080|FG001|STARTED|Start-Up: August 2013-June 2014||431
9965114|NCT01496430|11085041|FG001|NOT COMPLETED|Overall Study||5
9965115|NCT01496430|11085042|FG002|NOT COMPLETED|Overall Study||10
9965116|NCT01496456|11085050|FG000|STARTED|Overall Study||17
9965117|NCT01496456|11085050|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16
9965118|NCT01496456|11085050|FG000|1-yr Recall|Overall Study||12
9965119|NCT01496456|11085050|FG000|2-yr Recall|Overall Study||10
9965120|NCT01496456|11085050|FG000|3-yr Final Recall|Overall Study||9
9965121|NCT01496456|11085050|FG000|COMPLETED|Overall Study||9
9965122|NCT01496456|11085050|FG000|NOT COMPLETED|Overall Study||8
9965123|NCT01496469|11085059|FG000|STARTED|Overall Study||60
9965124|NCT01496469|11085060|FG001|STARTED|Overall Study||61
9965125|NCT01496469|11085059|FG000|COMPLETED|Overall Study||50
9965126|NCT01496469|11085060|FG001|COMPLETED|Overall Study||53
9965127|NCT01496469|11085059|FG000|NOT COMPLETED|Overall Study||10
9965128|NCT01496469|11085060|FG001|NOT COMPLETED|Overall Study||8
9967892|NCT01517373|11088252|FG001|NOT COMPLETED|Run-in Period||0
9967893|NCT01517373|11088253|FG002|NOT COMPLETED|Run-in Period||0
9967894|NCT01517373|11088254|FG003|NOT COMPLETED|Run-in Period||0
9967895|NCT01517373|11088255|FG004|NOT COMPLETED|Run-in Period||0
9967896|NCT01517373|11088256|FG005|NOT COMPLETED|Run-in Period||0
9967897|NCT01517373|11088251|FG000|STARTED|Treatment Period||0
9967898|NCT01517373|11088252|FG001|STARTED|Treatment Period||61
9967899|NCT01517373|11088253|FG002|STARTED|Treatment Period||60
9967900|NCT01517373|11088254|FG003|STARTED|Treatment Period||61
9967901|NCT01517373|11088255|FG004|STARTED|Treatment Period||61
9967902|NCT01517373|11088256|FG005|STARTED|Treatment Period||61
9967903|NCT01517373|11088251|FG000|COMPLETED|Treatment Period||0
10188287|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0
9967904|NCT01517373|11088252|FG001|COMPLETED|Treatment Period||57
9967905|NCT01517373|11088253|FG002|COMPLETED|Treatment Period||54
9967906|NCT01517373|11088254|FG003|COMPLETED|Treatment Period||54
9967907|NCT01517373|11088255|FG004|COMPLETED|Treatment Period||55
9967908|NCT01517373|11088256|FG005|COMPLETED|Treatment Period||54
9967909|NCT01517373|11088251|FG000|NOT COMPLETED|Treatment Period||0
9967910|NCT01517373|11088252|FG001|NOT COMPLETED|Treatment Period||4
9967911|NCT01517373|11088253|FG002|NOT COMPLETED|Treatment Period||6
9967912|NCT01517373|11088254|FG003|NOT COMPLETED|Treatment Period||7
9967913|NCT01517373|11088255|FG004|NOT COMPLETED|Treatment Period||6
9967914|NCT01517373|11088256|FG005|NOT COMPLETED|Treatment Period||7
9967915|NCT01517412|11088271|FG000|STARTED|Overall Study||225
9967916|NCT01517412|11088272|FG001|STARTED|Overall Study||226
9967917|NCT01517412|11088271|FG000|COMPLETED|Overall Study||189
9967918|NCT01517412|11088272|FG001|COMPLETED|Overall Study||202
9967919|NCT01517412|11088271|FG000|NOT COMPLETED|Overall Study||36
9967920|NCT01517412|11088272|FG001|NOT COMPLETED|Overall Study||24
9967921|NCT01517529|11088278|FG000|STARTED|Overall Study||10
9967922|NCT01517529|11088278|FG000|COMPLETED|Overall Study||10
9967923|NCT01517529|11088278|FG000|NOT COMPLETED|Overall Study||0
9967924|NCT01517750|11088286|FG000|STARTED|Overall Study||21
9967925|NCT01517750|11088287|FG001|STARTED|Overall Study||19
9967926|NCT01517750|11088288|FG002|STARTED|Overall Study||21
9967927|NCT01517750|11088289|FG003|STARTED|Overall Study||19
9967928|NCT01517750|11088286|FG000|COMPLETED|Overall Study||20
9967929|NCT01517750|11088287|FG001|COMPLETED|Overall Study||17
9967930|NCT01517750|11088288|FG002|COMPLETED|Overall Study||17
9967931|NCT01517750|11088289|FG003|COMPLETED|Overall Study||18
9967932|NCT01517750|11088286|FG000|NOT COMPLETED|Overall Study||1
9967933|NCT01517750|11088287|FG001|NOT COMPLETED|Overall Study||2
9967934|NCT01517750|11088288|FG002|NOT COMPLETED|Overall Study||4
9967935|NCT01517750|11088289|FG003|NOT COMPLETED|Overall Study||1
9967936|NCT01517867|11088305|FG000|STARTED|Overall Study||81
9967937|NCT01517867|11088306|FG001|STARTED|Overall Study||80
9967938|NCT01517867|11088305|FG000|COMPLETED|Overall Study||18
9967939|NCT01517867|11088306|FG001|COMPLETED|Overall Study||15
9967940|NCT01517867|11088305|FG000|NOT COMPLETED|Overall Study||63
9967941|NCT01517867|11088306|FG001|NOT COMPLETED|Overall Study||65
9967942|NCT01517893|11088314|FG000|STARTED|Overall Study||8
9967943|NCT01517893|11088315|FG001|STARTED|Overall Study||7
9967944|NCT01517893|11088314|FG000|COMPLETED|Overall Study||5
9967945|NCT01517893|11088315|FG001|COMPLETED|Overall Study||7
9967946|NCT01517893|11088314|FG000|NOT COMPLETED|Overall Study||3
9967947|NCT01517893|11088315|FG001|NOT COMPLETED|Overall Study||0
9967948|NCT01517984|11088324|FG000|STARTED|Overall Study||5
9967949|NCT01517984|11088325|FG001|STARTED|Overall Study||26
9967950|NCT01517984|11088326|FG002|STARTED|Overall Study||14
9967951|NCT01517984|11088327|FG003|STARTED|Overall Study||7
9967952|NCT01517984|11088324|FG000|COMPLETED|Overall Study||0
9967953|NCT01517984|11088325|FG001|COMPLETED|Overall Study||3
9967954|NCT01517984|11088326|FG002|COMPLETED|Overall Study||10
9967955|NCT01517984|11088327|FG003|COMPLETED|Overall Study||6
9967956|NCT01517984|11088324|FG000|NOT COMPLETED|Overall Study||5
9967957|NCT01517984|11088325|FG001|NOT COMPLETED|Overall Study||23
9967958|NCT01517984|11088326|FG002|NOT COMPLETED|Overall Study||4
9967959|NCT01517984|11088327|FG003|NOT COMPLETED|Overall Study||1
9967960|NCT01518153|11088334|FG000|STARTED|Stem Cell Transplant||16
9967961|NCT01518153|11088335|FG001|STARTED|Stem Cell Transplant||0
9967962|NCT01518153|11088336|FG002|STARTED|Stem Cell Transplant||0
9967963|NCT01518153|11088334|FG000|COMPLETED|Stem Cell Transplant||7
9967964|NCT01518153|11088335|FG001|COMPLETED|Stem Cell Transplant||0
9967965|NCT01518153|11088336|FG002|COMPLETED|Stem Cell Transplant||0
9967966|NCT01518153|11088334|FG000|NOT COMPLETED|Stem Cell Transplant||9
9967967|NCT01518153|11088335|FG001|NOT COMPLETED|Stem Cell Transplant||0
9965129|NCT01496612|11085066|FG000|STARTED|1st Intervention||3
9965130|NCT01496612|11085067|FG001|STARTED|1st Intervention||4
9965131|NCT01496612|11085066|FG000|COMPLETED|1st Intervention||1
9965132|NCT01496612|11085067|FG001|COMPLETED|1st Intervention||4
9965133|NCT01496612|11085066|FG000|NOT COMPLETED|1st Intervention||2
9965134|NCT01496612|11085067|FG001|NOT COMPLETED|1st Intervention||0
9965135|NCT01496612|11085066|FG000|STARTED|2nd Intervention||1
9965136|NCT01496612|11085067|FG001|STARTED|2nd Intervention||4
9965137|NCT01496612|11085066|FG000|COMPLETED|2nd Intervention||1
9965138|NCT01496612|11085067|FG001|COMPLETED|2nd Intervention||4
9965139|NCT01496612|11085066|FG000|NOT COMPLETED|2nd Intervention||0
9965140|NCT01496612|11085067|FG001|NOT COMPLETED|2nd Intervention||0
9965141|NCT01496807|11085075|FG000|STARTED|Overall Study||31
9965142|NCT01496807|11085075|FG000|COMPLETED|Overall Study||1
9965143|NCT01496807|11085075|FG000|NOT COMPLETED|Overall Study||30
9965144|NCT01496846|11085085|FG000|STARTED|IANB Articaine (All Participants)||28
9965145|NCT01496846|11085086|FG001|STARTED|IANB Articaine (All Participants)||24
9965146|NCT01496846|11085087|FG002|STARTED|IANB Articaine (All Participants)||36
9965147|NCT01496846|11085088|FG003|STARTED|IANB Articaine (All Participants)||40
9965148|NCT01496846|11085089|FG004|STARTED|IANB Articaine (All Participants)||35
9965149|NCT01496846|11085090|FG005|STARTED|IANB Articaine (All Participants)||38
9965150|NCT01496846|11085085|FG000|COMPLETED|IANB Articaine (All Participants)||27
9965151|NCT01496846|11085086|FG001|COMPLETED|IANB Articaine (All Participants)||23
9965152|NCT01496846|11085087|FG002|COMPLETED|IANB Articaine (All Participants)||36
9965153|NCT01496846|11085088|FG003|COMPLETED|IANB Articaine (All Participants)||40
9965154|NCT01496846|11085089|FG004|COMPLETED|IANB Articaine (All Participants)||35
9965155|NCT01496846|11085090|FG005|COMPLETED|IANB Articaine (All Participants)||38
9965156|NCT01496846|11085085|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1
9965157|NCT01496846|11085086|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1
9965158|NCT01496846|11085087|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0
9965159|NCT01496846|11085088|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0
9965160|NCT01496846|11085089|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0
9965161|NCT01496846|11085090|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0
9965162|NCT01496846|11085085|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
9965163|NCT01496846|11085086|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
9965164|NCT01496846|11085087|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
9965165|NCT01496846|11085088|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
9965166|NCT01496846|11085089|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
9965167|NCT01496846|11085090|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
9965168|NCT01496846|11085085|FG000|COMPLETED|Supplemental Buccal Infiltration||0
9965169|NCT01496846|11085086|FG001|COMPLETED|Supplemental Buccal Infiltration||0
9965170|NCT01496846|11085087|FG002|COMPLETED|Supplemental Buccal Infiltration||36
9965171|NCT01496846|11085088|FG003|COMPLETED|Supplemental Buccal Infiltration||40
9965172|NCT01496846|11085089|FG004|COMPLETED|Supplemental Buccal Infiltration||35
9965173|NCT01496846|11085090|FG005|COMPLETED|Supplemental Buccal Infiltration||38
9965174|NCT01496846|11085085|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0
9965175|NCT01496846|11085086|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0
9965176|NCT01496846|11085087|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0
9965177|NCT01496846|11085088|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0
9965178|NCT01496846|11085089|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0
9965179|NCT01496846|11085090|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0
9965180|NCT01496885|11085101|FG000|STARTED|Overall Study||120
9965181|NCT01496885|11085101|FG000|COMPLETED|Overall Study||97
9965182|NCT01496885|11085101|FG000|NOT COMPLETED|Overall Study||23
9965183|NCT01497067|11085105|FG000|STARTED|Overall Study||657
9965184|NCT01497067|11085105|FG000|COMPLETED|Overall Study||575
9965185|NCT01497067|11085105|FG000|NOT COMPLETED|Overall Study||82
9965186|NCT01497197|11085112|FG000|STARTED|Overall Study||89
9965187|NCT01497197|11085113|FG001|STARTED|Overall Study||85
9965188|NCT01497197|11085112|FG000|COMPLETED|Overall Study||72
9965189|NCT01497197|11085113|FG001|COMPLETED|Overall Study||70
9965190|NCT01497197|11085112|FG000|NOT COMPLETED|Overall Study||17
9965191|NCT01497197|11085113|FG001|NOT COMPLETED|Overall Study||15
9965192|NCT01497262|11085119|FG000|STARTED|Overall Study||162
9965193|NCT01497262|11085119|FG000|COMPLETED|Overall Study||151
9965194|NCT01497262|11085119|FG000|NOT COMPLETED|Overall Study||11
9965195|NCT01497275|11085123|FG000|STARTED|Overall Study||5
9965196|NCT01497275|11085123|FG000|COMPLETED|Overall Study||3
9965197|NCT01497275|11085123|FG000|NOT COMPLETED|Overall Study||2
9965198|NCT01497366|11085129|FG000|STARTED|Overall Study||263
9965199|NCT01497366|11085130|FG001|STARTED|Overall Study||264
9965200|NCT01497366|11085129|FG000|Randomized But Not Treated|Overall Study||7
9965201|NCT01497366|11085130|FG001|Randomized But Not Treated|Overall Study||21
9965202|NCT01497366|11085129|FG000|COMPLETED|Overall Study||224
9965203|NCT01497366|11085130|FG001|COMPLETED|Overall Study||176
9965204|NCT01497366|11085129|FG000|NOT COMPLETED|Overall Study||39
9965205|NCT01497366|11085130|FG001|NOT COMPLETED|Overall Study||88
9965206|NCT01497496|11085137|FG000|STARTED|Overall Study||29
9965207|NCT01497496|11085137|FG000|COMPLETED|Overall Study||29
9965208|NCT01497496|11085137|FG000|NOT COMPLETED|Overall Study||0
9965209|NCT01497613|11085143|FG000|STARTED|Overall Study||150
9965210|NCT01497613|11085144|FG001|STARTED|Overall Study||150
9965211|NCT01497613|11085143|FG000|COMPLETED|Overall Study||113
9965212|NCT01497613|11085144|FG001|COMPLETED|Overall Study||131
9965213|NCT01497613|11085143|FG000|NOT COMPLETED|Overall Study||37
9965214|NCT01497613|11085144|FG001|NOT COMPLETED|Overall Study||19
9965215|NCT01497665|11085150|FG000|STARTED|Overall Study||16
9965216|NCT01497665|11085150|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
9965217|NCT01497665|11085150|FG000|COMPLETED|Overall Study||16
9965218|NCT01497665|11085150|FG000|NOT COMPLETED|Overall Study||0
9965219|NCT01497756|11085154|FG000|STARTED|Overall Study||10
9965220|NCT01497756|11085154|FG000|COMPLETED|Overall Study||10
9965221|NCT01497756|11085154|FG000|NOT COMPLETED|Overall Study||0
9965222|NCT01497808|11085162|FG000|STARTED|Overall Study||6
9965223|NCT01497808|11085163|FG001|STARTED|Overall Study||4
9965224|NCT01497808|11085164|FG002|STARTED|Overall Study||6
9965225|NCT01497808|11085165|FG003|STARTED|Overall Study||6
9965226|NCT01497808|11085162|FG000|COMPLETED|Overall Study||6
9965227|NCT01497808|11085163|FG001|COMPLETED|Overall Study||4
9965228|NCT01497808|11085164|FG002|COMPLETED|Overall Study||6
9965229|NCT01497808|11085165|FG003|COMPLETED|Overall Study||6
9965230|NCT01497808|11085162|FG000|NOT COMPLETED|Overall Study||0
9965231|NCT01497808|11085163|FG001|NOT COMPLETED|Overall Study||0
9965232|NCT01497808|11085164|FG002|NOT COMPLETED|Overall Study||0
9965233|NCT01497808|11085165|FG003|NOT COMPLETED|Overall Study||0
9965234|NCT01497860|11085175|FG000|STARTED|Overall Study||12
9965235|NCT01497860|11085175|FG000|COMPLETED|Overall Study||12
9965236|NCT01497860|11085175|FG000|NOT COMPLETED|Overall Study||0
9965237|NCT01497899|11085183|FG000|STARTED|Double-Blind Phase||113
9965238|NCT01497899|11085184|FG001|STARTED|Double-Blind Phase||58
9965239|NCT01497899|11085185|FG002|STARTED|Double-Blind Phase||0
9965240|NCT01497899|11085186|FG003|STARTED|Double-Blind Phase||0
9965241|NCT01497899|11085183|FG000|COMPLETED|Double-Blind Phase||107
9965242|NCT01497899|11085184|FG001|COMPLETED|Double-Blind Phase||53
9965243|NCT01497899|11085185|FG002|COMPLETED|Double-Blind Phase||0
9965244|NCT01497899|11085186|FG003|COMPLETED|Double-Blind Phase||0
9965245|NCT01497899|11085183|FG000|NOT COMPLETED|Double-Blind Phase||6
9965246|NCT01497899|11085184|FG001|NOT COMPLETED|Double-Blind Phase||5
9965247|NCT01497899|11085185|FG002|NOT COMPLETED|Double-Blind Phase||0
9965248|NCT01497899|11085186|FG003|NOT COMPLETED|Double-Blind Phase||0
9965249|NCT01497899|11085183|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
9965250|NCT01497899|11085184|FG001|STARTED|Open-Label Extension Phase||53
9965251|NCT01497899|11085185|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
9965252|NCT01497899|11085186|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
9965253|NCT01497899|11085183|FG000|COMPLETED|Open-Label Extension Phase||86
9965254|NCT01497899|11085184|FG001|COMPLETED|Open-Label Extension Phase||46
9965255|NCT01497899|11085185|FG002|COMPLETED|Open-Label Extension Phase||61
9965256|NCT01497899|11085186|FG003|COMPLETED|Open-Label Extension Phase||33
9965257|NCT01497899|11085183|FG000|NOT COMPLETED|Open-Label Extension Phase||19
9965258|NCT01497899|11085184|FG001|NOT COMPLETED|Open-Label Extension Phase||7
10062524|NCT02110758|11188081|FG002|STARTED|Start-Up: August 2013-June 2014||8057
10062525|NCT02110758|11188082|FG003|STARTED|Start-Up: August 2013-June 2014||12883
10062526|NCT02110758|11188083|FG004|STARTED|Start-Up: August 2013-June 2014||0
10062527|NCT02110758|11188079|FG000|COMPLETED|Start-Up: August 2013-June 2014||175
10062528|NCT02110758|11188080|FG001|COMPLETED|Start-Up: August 2013-June 2014||431
10062529|NCT02110758|11188081|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057
10062530|NCT02110758|11188082|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883
10188288|NCT03266172|11317909|FG000|STARTED|Part C Washout Period (7 Days)||0
10188289|NCT03266172|11317910|FG001|STARTED|Part C Washout Period (7 Days)||0
10188290|NCT03266172|11317911|FG002|STARTED|Part C Washout Period (7 Days)||15
9965259|NCT01497899|11085185|FG002|NOT COMPLETED|Open-Label Extension Phase||9
9965260|NCT01497899|11085186|FG003|NOT COMPLETED|Open-Label Extension Phase||5
9965261|NCT01497938|11085195|FG000|STARTED|Overall Study||121
9965262|NCT01497938|11085196|FG001|STARTED|Overall Study||126
9965263|NCT01497938|11085195|FG000|COMPLETED|Overall Study||116
9965264|NCT01497938|11085196|FG001|COMPLETED|Overall Study||124
9965265|NCT01497938|11085195|FG000|NOT COMPLETED|Overall Study||5
9965266|NCT01497938|11085196|FG001|NOT COMPLETED|Overall Study||2
9965267|NCT01498068|11085204|FG000|STARTED|Overall Study||16
10062531|NCT02110758|11188083|FG004|COMPLETED|Start-Up: August 2013-June 2014||0
10062532|NCT02110758|11188079|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10062533|NCT02110758|11188080|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10188291|NCT03266172|11317909|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10188292|NCT03266172|11317910|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10188293|NCT03266172|11317911|FG002|COMPLETED|Part C Washout Period (7 Days)||15
10188294|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188295|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188296|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188297|NCT03266172|11317909|FG000|STARTED|Part C Period 3(2 Days)||0
10188298|NCT03266172|11317910|FG001|STARTED|Part C Period 3(2 Days)||0
10188299|NCT03266172|11317911|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
10188300|NCT03266172|11317909|FG000|COMPLETED|Part C Period 3(2 Days)||0
9965268|NCT01498068|11085205|FG001|STARTED|Overall Study||20
9965269|NCT01498068|11085204|FG000|COMPLETED|Overall Study||15
9965270|NCT01498068|11085205|FG001|COMPLETED|Overall Study||19
9965271|NCT01498068|11085204|FG000|NOT COMPLETED|Overall Study||1
9965272|NCT01498068|11085205|FG001|NOT COMPLETED|Overall Study||1
9965273|NCT01498120|11085211|FG000|STARTED|Overall Study||14
9965274|NCT01498120|11085211|FG000|COMPLETED|Overall Study||1
9965275|NCT01498120|11085211|FG000|NOT COMPLETED|Overall Study||13
9965276|NCT01498185|11085220|FG000|STARTED|Overall Study||13
9965277|NCT01498185|11085221|FG001|STARTED|Overall Study||13
9965278|NCT01498185|11085222|FG002|STARTED|Overall Study||15
9965279|NCT01498185|11085223|FG003|STARTED|Overall Study||14
9965280|NCT01498185|11085224|FG004|STARTED|Overall Study||15
9965281|NCT01498185|11085220|FG000|COMPLETED|Overall Study||12
9965282|NCT01498185|11085221|FG001|COMPLETED|Overall Study||12
9965283|NCT01498185|11085222|FG002|COMPLETED|Overall Study||15
9965284|NCT01498185|11085223|FG003|COMPLETED|Overall Study||11
9965285|NCT01498185|11085224|FG004|COMPLETED|Overall Study||12
9965286|NCT01498185|11085220|FG000|NOT COMPLETED|Overall Study||1
9965287|NCT01498185|11085221|FG001|NOT COMPLETED|Overall Study||1
9965288|NCT01498185|11085222|FG002|NOT COMPLETED|Overall Study||0
9965289|NCT01498185|11085223|FG003|NOT COMPLETED|Overall Study||3
9965290|NCT01498185|11085224|FG004|NOT COMPLETED|Overall Study||3
9965291|NCT01498289|11085242|FG000|STARTED|Overall Study||98
9965292|NCT01498289|11085243|FG001|STARTED|Overall Study||104
9965293|NCT01498289|11085242|FG000|Participants Assessed for AEs|Overall Study||91
9965294|NCT01498289|11085243|FG001|Participants Assessed for AEs|Overall Study||98
9965295|NCT01498289|11085242|FG000|COMPLETED|Overall Study||0
9965296|NCT01498289|11085243|FG001|COMPLETED|Overall Study||0
9965297|NCT01498289|11085242|FG000|NOT COMPLETED|Overall Study||98
9965298|NCT01498289|11085243|FG001|NOT COMPLETED|Overall Study||104
9965299|NCT01498419|11085257|FG000|STARTED|Overall Study||60
9965300|NCT01498419|11085258|FG001|STARTED|Overall Study||62
9965301|NCT01498419|11085259|FG002|STARTED|Overall Study||59
9965302|NCT01498419|11085260|FG003|STARTED|Overall Study||26
9965303|NCT01498419|11085257|FG000|COMPLETED|Overall Study||42
9965304|NCT01498419|11085258|FG001|COMPLETED|Overall Study||39
9965305|NCT01498419|11085259|FG002|COMPLETED|Overall Study||41
9965306|NCT01498419|11085260|FG003|COMPLETED|Overall Study||7
9965307|NCT01498419|11085257|FG000|NOT COMPLETED|Overall Study||18
9965308|NCT01498419|11085258|FG001|NOT COMPLETED|Overall Study||23
9965309|NCT01498419|11085259|FG002|NOT COMPLETED|Overall Study||18
9965310|NCT01498419|11085260|FG003|NOT COMPLETED|Overall Study||19
9965311|NCT01498445|11085276|FG000|STARTED|Overall Study||4
9965312|NCT01498445|11085277|FG001|STARTED|Overall Study||3
9965313|NCT01498445|11085278|FG002|STARTED|Overall Study||8
9965314|NCT01498445|11085279|FG003|STARTED|Overall Study||8
9965315|NCT01498445|11085280|FG004|STARTED|Overall Study||4
9965316|NCT01498445|11085281|FG005|STARTED|Overall Study||5
9965317|NCT01498445|11085276|FG000|COMPLETED|Overall Study||4
9965318|NCT01498445|11085277|FG001|COMPLETED|Overall Study||3
9965319|NCT01498445|11085278|FG002|COMPLETED|Overall Study||7
9965320|NCT01498445|11085279|FG003|COMPLETED|Overall Study||6
9965321|NCT01498445|11085280|FG004|COMPLETED|Overall Study||3
9965322|NCT01498445|11085281|FG005|COMPLETED|Overall Study||4
9965323|NCT01498445|11085276|FG000|NOT COMPLETED|Overall Study||0
9965324|NCT01498445|11085277|FG001|NOT COMPLETED|Overall Study||0
9965325|NCT01498445|11085278|FG002|NOT COMPLETED|Overall Study||1
9965326|NCT01498445|11085279|FG003|NOT COMPLETED|Overall Study||2
9965327|NCT01498445|11085280|FG004|NOT COMPLETED|Overall Study||1
9965328|NCT01498445|11085281|FG005|NOT COMPLETED|Overall Study||1
9965329|NCT01498549|11085295|FG000|STARTED|Overall Study||39
9965330|NCT01498549|11085295|FG000|Atomoxetine 40 mg|Overall Study||39
9965331|NCT01498549|11085295|FG000|Atomoxetine 80 mg|Overall Study||37
9965332|NCT01498549|11085295|FG000|Sugar Pill 0 mg|Overall Study||36
9965333|NCT01498549|11085295|FG000|COMPLETED|Overall Study||35
9965334|NCT01498549|11085295|FG000|NOT COMPLETED|Overall Study||4
9965335|NCT01498575|11085306|FG000|STARTED|Overall Sample||610
9965336|NCT01498575|11085307|FG001|STARTED|Overall Sample||414
9965337|NCT01498575|11085306|FG000|COMPLETED|Overall Sample||550
9965338|NCT01498575|11085307|FG001|COMPLETED|Overall Sample||400
9965339|NCT01498575|11085306|FG000|NOT COMPLETED|Overall Sample||60
9965340|NCT01498575|11085307|FG001|NOT COMPLETED|Overall Sample||14
9965341|NCT01498575|11085306|FG000|STARTED|On the Road Driving Assessment (ODA)||128
9965342|NCT01498575|11085307|FG001|STARTED|On the Road Driving Assessment (ODA)||89
9965343|NCT01498575|11085306|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86
9965344|NCT01498575|11085307|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65
9965345|NCT01498575|11085306|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
9965346|NCT01498575|11085307|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
9965347|NCT01498588|11085313|FG000|STARTED|Overall Study||7
9965348|NCT01498588|11085313|FG000|COMPLETED|Overall Study||7
9965349|NCT01498588|11085313|FG000|NOT COMPLETED|Overall Study||0
9965350|NCT01498601|11085319|FG000|STARTED|Overall Study||51
9965351|NCT01498601|11085320|FG001|STARTED|Overall Study||32
9965352|NCT01498601|11085319|FG000|COMPLETED|Overall Study||51
9965353|NCT01498601|11085320|FG001|COMPLETED|Overall Study||32
9965354|NCT01498601|11085319|FG000|NOT COMPLETED|Overall Study||0
9965355|NCT01498601|11085320|FG001|NOT COMPLETED|Overall Study||0
9965356|NCT01498640|11085326|FG000|STARTED|Overall Study||52
9965357|NCT01498640|11085326|FG000|COMPLETED|Overall Study||47
9965358|NCT01498640|11085326|FG000|NOT COMPLETED|Overall Study||5
9965359|NCT01498653|11085336|FG000|STARTED|Overall Study||155
9965360|NCT01498653|11085337|FG001|STARTED|Overall Study||154
9965361|NCT01498653|11085336|FG000|COMPLETED|Overall Study||136
9965362|NCT01498653|11085337|FG001|COMPLETED|Overall Study||119
9965363|NCT01498653|11085336|FG000|NOT COMPLETED|Overall Study||19
9965364|NCT01498653|11085337|FG001|NOT COMPLETED|Overall Study||35
9965365|NCT01498679|11085345|FG000|STARTED|Overall Study||154
9965366|NCT01498679|11085346|FG001|STARTED|Overall Study||153
9965367|NCT01498679|11085345|FG000|COMPLETED|Overall Study||65
9965368|NCT01498679|11085346|FG001|COMPLETED|Overall Study||131
9965369|NCT01498679|11085345|FG000|NOT COMPLETED|Overall Study||89
9965370|NCT01498679|11085346|FG001|NOT COMPLETED|Overall Study||22
9965371|NCT01498692|11085352|FG000|STARTED|Overall Study||94
9965372|NCT01498692|11085352|FG000|COMPLETED|Overall Study||86
9965373|NCT01498692|11085352|FG000|NOT COMPLETED|Overall Study||8
9965374|NCT01498744|11085358|FG000|STARTED|Overall Study||22
9965375|NCT01498744|11085359|FG001|STARTED|Overall Study||31
9965376|NCT01498744|11085358|FG000|COMPLETED|Overall Study||22
9965377|NCT01498744|11085359|FG001|COMPLETED|Overall Study||31
9965378|NCT01498744|11085358|FG000|NOT COMPLETED|Overall Study||0
9965379|NCT01498744|11085359|FG001|NOT COMPLETED|Overall Study||0
9965380|NCT01498822|11085367|FG000|STARTED|Overall Study||175
9965381|NCT01498822|11085368|FG001|STARTED|Overall Study||178
9965382|NCT01498822|11085367|FG000|COMPLETED|Overall Study||121
9965383|NCT01498822|11085368|FG001|COMPLETED|Overall Study||122
9965384|NCT01498822|11085367|FG000|NOT COMPLETED|Overall Study||54
9965385|NCT01498822|11085368|FG001|NOT COMPLETED|Overall Study||56
9965386|NCT01498887|11085378|FG000|STARTED|Overall Study||200
9965387|NCT01498887|11085379|FG001|STARTED|Overall Study||147
9965388|NCT01498887|11085378|FG000|Safety Set|Overall Study||200
9965389|NCT01498887|11085379|FG001|Safety Set|Overall Study||147
9965390|NCT01498887|11085378|FG000|Intent-to-treat|Overall Study||185
9965391|NCT01498887|11085379|FG001|Intent-to-treat|Overall Study||135
9965392|NCT01498887|11085378|FG000|COMPLETED|Overall Study||184
9965393|NCT01498887|11085379|FG001|COMPLETED|Overall Study||136
10062534|NCT02110758|11188081|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10062535|NCT02110758|11188082|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10062536|NCT02110758|11188083|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10062537|NCT02110758|11188079|FG000|STARTED|Intervention: July 2014-December 2015||0
10062538|NCT02110758|11188080|FG001|STARTED|Intervention: July 2014-December 2015||0
10062539|NCT02110758|11188081|FG002|STARTED|Intervention: July 2014-December 2015||10106
10062540|NCT02110758|11188082|FG003|STARTED|Intervention: July 2014-December 2015||33012
10062541|NCT02110758|11188083|FG004|STARTED|Intervention: July 2014-December 2015||0
10062542|NCT02110758|11188079|FG000|COMPLETED|Intervention: July 2014-December 2015||0
10062543|NCT02110758|11188080|FG001|COMPLETED|Intervention: July 2014-December 2015||0
10062544|NCT02110758|11188081|FG002|COMPLETED|Intervention: July 2014-December 2015||10106
10062545|NCT02110758|11188082|FG003|COMPLETED|Intervention: July 2014-December 2015||33012
10062546|NCT02110758|11188083|FG004|COMPLETED|Intervention: July 2014-December 2015||0
10062547|NCT02110758|11188079|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0
10062548|NCT02110758|11188080|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0
10062549|NCT02110758|11188081|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0
10062550|NCT02110758|11188082|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0
10062551|NCT02110758|11188083|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0
10062552|NCT02110758|11188079|FG000|STARTED|Follow-Up: January-July 2016||81
10062553|NCT02110758|11188080|FG001|STARTED|Follow-Up: January-July 2016||179
10062554|NCT02110758|11188081|FG002|STARTED|Follow-Up: January-July 2016||6451
10062555|NCT02110758|11188082|FG003|STARTED|Follow-Up: January-July 2016||24392
10062556|NCT02110758|11188083|FG004|STARTED|Follow-Up: January-July 2016||349
10062557|NCT02110758|11188079|FG000|COMPLETED|Follow-Up: January-July 2016||81
10062558|NCT02110758|11188080|FG001|COMPLETED|Follow-Up: January-July 2016||179
10062559|NCT02110758|11188081|FG002|COMPLETED|Follow-Up: January-July 2016||6451
10062560|NCT02110758|11188082|FG003|COMPLETED|Follow-Up: January-July 2016||24392
10062561|NCT02110758|11188083|FG004|COMPLETED|Follow-Up: January-July 2016||349
10062562|NCT02110758|11188079|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0
10062563|NCT02110758|11188080|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0
10062564|NCT02110758|11188081|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0
10062565|NCT02110758|11188082|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0
10062566|NCT02110758|11188083|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0
10062567|NCT02110901|11188097|FG000|STARTED|Overall Study||209
10062568|NCT02110901|11188098|FG001|STARTED|Overall Study||102
10062569|NCT02110901|11188097|FG000|COMPLETED|Overall Study||179
10062570|NCT02110901|11188098|FG001|COMPLETED|Overall Study||88
10062571|NCT02110901|11188097|FG000|NOT COMPLETED|Overall Study||30
10062572|NCT02110901|11188098|FG001|NOT COMPLETED|Overall Study||14
10062573|NCT02111083|11188107|FG000|STARTED|First Intervention (1 Day)||19
10062574|NCT02111083|11188108|FG001|STARTED|First Intervention (1 Day)||19
10062575|NCT02111083|11188107|FG000|COMPLETED|First Intervention (1 Day)||19
10062576|NCT02111083|11188108|FG001|COMPLETED|First Intervention (1 Day)||19
10062577|NCT02111083|11188107|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9965394|NCT01498887|11085378|FG000|NOT COMPLETED|Overall Study||16
9965395|NCT01498887|11085379|FG001|NOT COMPLETED|Overall Study||11
9965396|NCT01498952|11085388|FG000|STARTED|Overall Study||3
9965397|NCT01498952|11085389|FG001|STARTED|Overall Study||3
9965398|NCT01498952|11085390|FG002|STARTED|Overall Study||0
9965399|NCT01498952|11085391|FG003|STARTED|Overall Study||0
9965400|NCT01498952|11085392|FG004|STARTED|Overall Study||0
9965401|NCT01498952|11085388|FG000|COMPLETED|Overall Study||1
9965402|NCT01498952|11085389|FG001|COMPLETED|Overall Study||1
9965403|NCT01498952|11085390|FG002|COMPLETED|Overall Study||0
9965404|NCT01498952|11085391|FG003|COMPLETED|Overall Study||0
9965405|NCT01498952|11085392|FG004|COMPLETED|Overall Study||0
9965406|NCT01498952|11085388|FG000|NOT COMPLETED|Overall Study||2
9965407|NCT01498952|11085389|FG001|NOT COMPLETED|Overall Study||2
9965408|NCT01498952|11085390|FG002|NOT COMPLETED|Overall Study||0
9965409|NCT01498952|11085391|FG003|NOT COMPLETED|Overall Study||0
9965410|NCT01498952|11085392|FG004|NOT COMPLETED|Overall Study||0
9965411|NCT01498978|11085405|FG000|STARTED|Overall Study||10
9965412|NCT01498978|11085405|FG000|COMPLETED|Overall Study||8
9965413|NCT01498978|11085405|FG000|NOT COMPLETED|Overall Study||2
9965414|NCT01499043|11085411|FG000|STARTED|Overall Study||6
9965415|NCT01499043|11085411|FG000|COMPLETED|Overall Study||0
9965416|NCT01499043|11085411|FG000|NOT COMPLETED|Overall Study||6
9965417|NCT01499134|11085422|FG000|STARTED|Overall Study||9
9965418|NCT01499134|11085423|FG001|STARTED|Overall Study||8
9965419|NCT01499134|11085422|FG000|COMPLETED|Overall Study||9
9965420|NCT01499134|11085423|FG001|COMPLETED|Overall Study||7
9965421|NCT01499134|11085422|FG000|NOT COMPLETED|Overall Study||0
9965422|NCT01499134|11085423|FG001|NOT COMPLETED|Overall Study||1
9965423|NCT01499147|11085431|FG000|STARTED|Overall Study||33
9965424|NCT01499147|11085432|FG001|STARTED|Overall Study||17
9965425|NCT01499147|11085431|FG000|COMPLETED|Overall Study||18
9965426|NCT01499147|11085432|FG001|COMPLETED|Overall Study||12
9965427|NCT01499147|11085431|FG000|NOT COMPLETED|Overall Study||15
9965428|NCT01499147|11085432|FG001|NOT COMPLETED|Overall Study||5
9965429|NCT01499173|11085442|FG000|STARTED|Overall Study||101
9965430|NCT01499173|11085442|FG000|COMPLETED|Overall Study||64
9965431|NCT01499173|11085442|FG000|NOT COMPLETED|Overall Study||37
9965432|NCT01499199|11085447|FG000|STARTED|Overall Study||13
9965433|NCT01499199|11085447|FG000|COMPLETED|Overall Study||11
9965434|NCT01499199|11085447|FG000|NOT COMPLETED|Overall Study||2
9965435|NCT01499277|11085453|FG000|STARTED|Overall Study||506
9965436|NCT01499277|11085454|FG001|STARTED|Overall Study||255
9965437|NCT01499277|11085453|FG000|COMPLETED|Overall Study||459
9965438|NCT01499277|11085454|FG001|COMPLETED|Overall Study||223
9965439|NCT01499277|11085453|FG000|NOT COMPLETED|Overall Study||47
9965440|NCT01499277|11085454|FG001|NOT COMPLETED|Overall Study||32
9965441|NCT01499290|11085462|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
9965442|NCT01499290|11085463|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
9965443|NCT01499290|11085462|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
9965444|NCT01499290|11085463|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
9965445|NCT01499290|11085462|FG000|NOT COMPLETED|Overall Study||55
9965446|NCT01499290|11085463|FG001|NOT COMPLETED|Overall Study||35
9965447|NCT01499303|11085490|FG000|STARTED|Overall Study||21
9965448|NCT01499303|11085491|FG001|STARTED|Overall Study||47
9965449|NCT01499303|11085490|FG000|COMPLETED|Overall Study||18
9965450|NCT01499303|11085491|FG001|COMPLETED|Overall Study||40
9965451|NCT01499303|11085490|FG000|NOT COMPLETED|Overall Study||3
9965452|NCT01499303|11085491|FG001|NOT COMPLETED|Overall Study||7
9965453|NCT01499355|11085497|FG000|STARTED|Run-In Period||276
9965454|NCT01499355|11085498|FG001|STARTED|Run-In Period||0
9965455|NCT01499355|11085499|FG002|STARTED|Run-In Period||0
9965456|NCT01499355|11085500|FG003|STARTED|Run-In Period||0
9965457|NCT01499355|11085497|FG000|COMPLETED|Run-In Period||245
9965458|NCT01499355|11085498|FG001|COMPLETED|Run-In Period||0
9965459|NCT01499355|11085499|FG002|COMPLETED|Run-In Period||0
9965460|NCT01499355|11085500|FG003|COMPLETED|Run-In Period||0
9965461|NCT01499355|11085497|FG000|NOT COMPLETED|Run-In Period||31
9965462|NCT01499355|11085498|FG001|NOT COMPLETED|Run-In Period||0
9965463|NCT01499355|11085499|FG002|NOT COMPLETED|Run-In Period||0
9965464|NCT01499355|11085500|FG003|NOT COMPLETED|Run-In Period||0
9965465|NCT01499355|11085497|FG000|STARTED|Double-Blind Period||0
9965466|NCT01499355|11085498|FG001|STARTED|Double-Blind Period||63
9965467|NCT01499355|11085499|FG002|STARTED|Double-Blind Period||63
9965468|NCT01499355|11085500|FG003|STARTED|Double-Blind Period||62
9965469|NCT01499355|11085497|FG000|COMPLETED|Double-Blind Period||0
9965470|NCT01499355|11085498|FG001|COMPLETED|Double-Blind Period||40
9965471|NCT01499355|11085499|FG002|COMPLETED|Double-Blind Period||38
9965472|NCT01499355|11085500|FG003|COMPLETED|Double-Blind Period||39
9965473|NCT01499355|11085497|FG000|NOT COMPLETED|Double-Blind Period||0
9965474|NCT01499355|11085498|FG001|NOT COMPLETED|Double-Blind Period||23
9965475|NCT01499355|11085499|FG002|NOT COMPLETED|Double-Blind Period||25
9965476|NCT01499355|11085500|FG003|NOT COMPLETED|Double-Blind Period||23
9965477|NCT01499368|11085513|FG000|STARTED|Overall Study||165
9965478|NCT01499368|11085514|FG001|STARTED|Overall Study||163
9965479|NCT01499368|11085515|FG002|STARTED|Overall Study||167
9965480|NCT01499368|11085513|FG000|COMPLETED|Overall Study||138
9965481|NCT01499368|11085514|FG001|COMPLETED|Overall Study||145
9965482|NCT01499368|11085515|FG002|COMPLETED|Overall Study||146
9965483|NCT01499368|11085513|FG000|NOT COMPLETED|Overall Study||27
9965484|NCT01499368|11085514|FG001|NOT COMPLETED|Overall Study||18
9965485|NCT01499368|11085515|FG002|NOT COMPLETED|Overall Study||21
9965486|NCT01499498|11085523|FG000|STARTED|Overall Study||13
9965487|NCT01499498|11085523|FG000|COMPLETED|Overall Study||13
9965488|NCT01499498|11085523|FG000|NOT COMPLETED|Overall Study||0
9965489|NCT01499511|11085532|FG000|STARTED|Overall Study||885
9965490|NCT01499511|11085533|FG001|STARTED|Overall Study||833
9965491|NCT01499511|11085532|FG000|COMPLETED|Overall Study||884
9965492|NCT01499511|11085533|FG001|COMPLETED|Overall Study||833
9965493|NCT01499511|11085532|FG000|NOT COMPLETED|Overall Study||1
9965494|NCT01499511|11085533|FG001|NOT COMPLETED|Overall Study||0
9965495|NCT01499576|11085540|FG000|STARTED|Overall Study||126
9965496|NCT01499576|11085540|FG000|COMPLETED|Overall Study||105
9965497|NCT01499576|11085540|FG000|NOT COMPLETED|Overall Study||21
9965498|NCT01499654|11085545|FG000|STARTED|Overall Study||64
9965499|NCT01499654|11085545|FG000|COMPLETED|Overall Study||64
9965500|NCT01499654|11085545|FG000|NOT COMPLETED|Overall Study||0
9965501|NCT01499667|11085558|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
9965502|NCT01499667|11085559|FG001|STARTED|Overall Study||42
9965503|NCT01499667|11085560|FG002|STARTED|Overall Study||50
9965504|NCT01499667|11085558|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
9965505|NCT01499667|11085559|FG001|Full Analysis Set (FAS)|Overall Study||42
9965506|NCT01499667|11085560|FG002|Full Analysis Set (FAS)|Overall Study||50
9965507|NCT01499667|11085558|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
9965508|NCT01499667|11085559|FG001|Modified Full Analysis Set|Overall Study||29
9965509|NCT01499667|11085560|FG002|Modified Full Analysis Set|Overall Study||39
9965510|NCT01499667|11085558|FG000|COMPLETED|Overall Study||41
9965511|NCT01499667|11085559|FG001|COMPLETED|Overall Study||31
9965512|NCT01499667|11085560|FG002|COMPLETED|Overall Study||40
9965513|NCT01499667|11085558|FG000|NOT COMPLETED|Overall Study||9
9965514|NCT01499667|11085559|FG001|NOT COMPLETED|Overall Study||11
9965515|NCT01499667|11085560|FG002|NOT COMPLETED|Overall Study||10
9965516|NCT01499810|11085568|FG000|STARTED|Overall Study||53
9965517|NCT01499810|11085568|FG000|COMPLETED|Overall Study||41
9965518|NCT01499810|11085568|FG000|NOT COMPLETED|Overall Study||12
9965519|NCT01499849|11085575|FG000|STARTED|Overall Study|Number of randomized patients|266
9965520|NCT01499849|11085576|FG001|STARTED|Overall Study||266
9965521|NCT01499849|11085575|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
9965522|NCT01499849|11085576|FG001|COMPLETED|Overall Study||40
9965523|NCT01499849|11085575|FG000|NOT COMPLETED|Overall Study||224
9965524|NCT01499849|11085576|FG001|NOT COMPLETED|Overall Study||226
9965525|NCT01499862|11085582|FG000|STARTED|Overall Study||3
9965526|NCT01499862|11085582|FG000|COMPLETED|Overall Study||3
9965527|NCT01499862|11085582|FG000|NOT COMPLETED|Overall Study||0
9965528|NCT01499940|11085600|FG000|STARTED|Overall Study||9
9965529|NCT01499940|11085600|FG000|COMPLETED|Overall Study||0
9965530|NCT01499940|11085600|FG000|NOT COMPLETED|Overall Study||9
9965531|NCT01500031|11085604|FG000|STARTED|Overall Study||92
9965532|NCT01500031|11085604|FG000|COMPLETED|Overall Study||87
9965533|NCT01500031|11085604|FG000|NOT COMPLETED|Overall Study||5
9965534|NCT01500057|11085610|FG000|STARTED|Overall Study||31
9965535|NCT01500057|11085611|FG001|STARTED|Overall Study||35
9965536|NCT01500057|11085610|FG000|COMPLETED|Overall Study||25
9965537|NCT01500057|11085611|FG001|COMPLETED|Overall Study||31
9965538|NCT01500057|11085610|FG000|NOT COMPLETED|Overall Study||6
9965539|NCT01500057|11085611|FG001|NOT COMPLETED|Overall Study||4
9965540|NCT01500083|11085619|FG000|STARTED|Overall Study||16
9965541|NCT01500083|11085620|FG001|STARTED|Overall Study||74
9965542|NCT01500083|11085619|FG000|COMPLETED|Overall Study||4
9965543|NCT01500083|11085620|FG001|COMPLETED|Overall Study||31
9965544|NCT01500083|11085619|FG000|NOT COMPLETED|Overall Study||12
9965545|NCT01500083|11085620|FG001|NOT COMPLETED|Overall Study||43
9965546|NCT01500096|11085630|FG000|STARTED|Overall Study||32
9965547|NCT01500096|11085631|FG001|STARTED|Overall Study||17
9965548|NCT01500096|11085632|FG002|STARTED|Overall Study||31
9965549|NCT01500096|11085633|FG003|STARTED|Overall Study||16
9965550|NCT01500096|11085630|FG000|COMPLETED|Overall Study||31
9965551|NCT01500096|11085631|FG001|COMPLETED|Overall Study||17
9965552|NCT01500096|11085632|FG002|COMPLETED|Overall Study||31
9965553|NCT01500096|11085633|FG003|COMPLETED|Overall Study||14
9965554|NCT01500096|11085630|FG000|NOT COMPLETED|Overall Study||1
9965555|NCT01500096|11085631|FG001|NOT COMPLETED|Overall Study||0
9965556|NCT01500096|11085632|FG002|NOT COMPLETED|Overall Study||0
9965557|NCT01500096|11085633|FG003|NOT COMPLETED|Overall Study||2
9965558|NCT01500135|11085645|FG000|STARTED|Overall Study||100
9965559|NCT01500135|11085646|FG001|STARTED|Overall Study||50
9965560|NCT01500135|11085645|FG000|COMPLETED|Overall Study||83
9965561|NCT01500135|11085646|FG001|COMPLETED|Overall Study||39
9965562|NCT01500135|11085645|FG000|NOT COMPLETED|Overall Study||17
9965563|NCT01500135|11085646|FG001|NOT COMPLETED|Overall Study||11
9965564|NCT01500187|11085654|FG000|STARTED|Overall Study||23
9965565|NCT01500187|11085655|FG001|STARTED|Overall Study||15
9965566|NCT01500187|11085654|FG000|COMPLETED|Overall Study||17
9965567|NCT01500187|11085655|FG001|COMPLETED|Overall Study||15
9965568|NCT01500187|11085654|FG000|NOT COMPLETED|Overall Study||6
9965569|NCT01500187|11085655|FG001|NOT COMPLETED|Overall Study||0
9965570|NCT01500200|11085664|FG000|STARTED|Stage 1||98
9965571|NCT01500200|11085665|FG001|STARTED|Stage 1||24
9965572|NCT01500200|11085666|FG002|STARTED|Stage 1||19
9965573|NCT01500200|11085667|FG003|STARTED|Stage 1||0
9965574|NCT01500200|11085668|FG004|STARTED|Stage 1||0
9965575|NCT01500200|11085669|FG005|STARTED|Stage 1||0
9965576|NCT01500200|11085664|FG000|COMPLETED|Stage 1||90
9965577|NCT01500200|11085665|FG001|COMPLETED|Stage 1||18
9965578|NCT01500200|11085666|FG002|COMPLETED|Stage 1||13
9965579|NCT01500200|11085667|FG003|COMPLETED|Stage 1||0
9965580|NCT01500200|11085668|FG004|COMPLETED|Stage 1||0
9965581|NCT01500200|11085669|FG005|COMPLETED|Stage 1||0
9965582|NCT01500200|11085664|FG000|NOT COMPLETED|Stage 1||8
9965583|NCT01500200|11085665|FG001|NOT COMPLETED|Stage 1||6
9965584|NCT01500200|11085666|FG002|NOT COMPLETED|Stage 1||6
9965585|NCT01500200|11085667|FG003|NOT COMPLETED|Stage 1||0
9965586|NCT01500200|11085668|FG004|NOT COMPLETED|Stage 1||0
9965587|NCT01500200|11085669|FG005|NOT COMPLETED|Stage 1||0
9965588|NCT01500200|11085664|FG000|STARTED|Stage 2||0
9965589|NCT01500200|11085665|FG001|STARTED|Stage 2||0
9965590|NCT01500200|11085666|FG002|STARTED|Stage 2||0
9965591|NCT01500200|11085667|FG003|STARTED|Stage 2||20
9965592|NCT01500200|11085668|FG004|STARTED|Stage 2||23
9965593|NCT01500200|11085669|FG005|STARTED|Stage 2||22
9965594|NCT01500200|11085664|FG000|COMPLETED|Stage 2||0
9965595|NCT01500200|11085665|FG001|COMPLETED|Stage 2||0
9965596|NCT01500200|11085666|FG002|COMPLETED|Stage 2||0
9965597|NCT01500200|11085667|FG003|COMPLETED|Stage 2||20
9965598|NCT01500200|11085668|FG004|COMPLETED|Stage 2||18
9965599|NCT01500200|11085669|FG005|COMPLETED|Stage 2||18
9965600|NCT01500200|11085664|FG000|NOT COMPLETED|Stage 2||0
9965601|NCT01500200|11085665|FG001|NOT COMPLETED|Stage 2||0
9965602|NCT01500200|11085666|FG002|NOT COMPLETED|Stage 2||0
9965603|NCT01500200|11085667|FG003|NOT COMPLETED|Stage 2||0
9965604|NCT01500200|11085668|FG004|NOT COMPLETED|Stage 2||5
9965605|NCT01500200|11085669|FG005|NOT COMPLETED|Stage 2||4
9965606|NCT01500213|11085685|FG000|STARTED|Overall Study|Number of randomized patients|278
9965607|NCT01500213|11085686|FG001|STARTED|Overall Study||277
9965608|NCT01500213|11085685|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
9965609|NCT01500213|11085686|FG001|COMPLETED|Overall Study||53
10062578|NCT02111083|11188108|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10062579|NCT02111083|11188107|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
10062580|NCT02111083|11188108|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
10062581|NCT02111083|11188107|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
10062582|NCT02111083|11188108|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
10062583|NCT02111083|11188107|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10062584|NCT02111083|11188108|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10062585|NCT02111083|11188107|FG000|STARTED|Second Intervention (1 Day)||19
10062586|NCT02111083|11188108|FG001|STARTED|Second Intervention (1 Day)||19
10062587|NCT02111083|11188107|FG000|COMPLETED|Second Intervention (1 Day)||19
10062588|NCT02111083|11188108|FG001|COMPLETED|Second Intervention (1 Day)||19
10062589|NCT02111083|11188107|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10062590|NCT02111083|11188108|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10062591|NCT02111083|11188107|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
10062592|NCT02111083|11188108|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
10062593|NCT02111083|11188107|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
10062594|NCT02111083|11188108|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
10062595|NCT02111083|11188107|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10062596|NCT02111083|11188108|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10062597|NCT02111083|11188107|FG000|STARTED|Third Intervention (1 Day)||19
10062598|NCT02111083|11188108|FG001|STARTED|Third Intervention (1 Day)||19
10062599|NCT02111083|11188107|FG000|COMPLETED|Third Intervention (1 Day)||19
10062600|NCT02111083|11188108|FG001|COMPLETED|Third Intervention (1 Day)||19
10062601|NCT02111083|11188107|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10062602|NCT02111083|11188108|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10062603|NCT02111083|11188107|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
10062604|NCT02111083|11188108|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
10062605|NCT02111083|11188107|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18
10062606|NCT02111083|11188108|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18
10062607|NCT02111083|11188107|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
10062608|NCT02111083|11188108|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
10062609|NCT02111083|11188107|FG000|STARTED|Fourth Intervention (1 Day)||18
10062610|NCT02111083|11188108|FG001|STARTED|Fourth Intervention (1 Day)||18
10062611|NCT02111083|11188107|FG000|COMPLETED|Fourth Intervention (1 Day)||18
10062612|NCT02111083|11188108|FG001|COMPLETED|Fourth Intervention (1 Day)||18
10062613|NCT02111083|11188107|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10062614|NCT02111083|11188108|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10062615|NCT02111096|11188117|FG000|STARTED|Overall Study||65
10062616|NCT02111096|11188118|FG001|STARTED|Overall Study||41
10062617|NCT02111096|11188119|FG002|STARTED|Overall Study||68
10062618|NCT02111096|11188117|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65
10062619|NCT02111096|11188118|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
10062620|NCT02111096|11188119|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68
10062621|NCT02111096|11188117|FG000|COMPLETED|Overall Study||1
9965610|NCT01500213|11085685|FG000|NOT COMPLETED|Overall Study||217
9965611|NCT01500213|11085686|FG001|NOT COMPLETED|Overall Study||224
9965612|NCT01500226|11085694|FG000|STARTED|Overall Study|Number of randomized patients|684
9965613|NCT01500226|11085695|FG001|STARTED|Overall Study||685
9965614|NCT01500226|11085694|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
9965615|NCT01500226|11085695|FG001|COMPLETED|Overall Study||191
9965616|NCT01500226|11085694|FG000|NOT COMPLETED|Overall Study||499
9965617|NCT01500226|11085695|FG001|NOT COMPLETED|Overall Study||494
9965618|NCT01500252|11085703|FG000|STARTED|Overall Study||21
9965619|NCT01500252|11085704|FG001|STARTED|Overall Study||17
9965620|NCT01500252|11085703|FG000|One Years|Overall Study||20
9965621|NCT01500252|11085704|FG001|One Years|Overall Study||16
9965622|NCT01500252|11085703|FG000|Five Years|Overall Study||17
9965623|NCT01500252|11085704|FG001|Five Years|Overall Study||13
9965624|NCT01500252|11085703|FG000|Ten Years|Overall Study||12
9965625|NCT01500252|11085704|FG001|Ten Years|Overall Study||11
9965626|NCT01500252|11085703|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
9965627|NCT01500252|11085704|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
9965628|NCT01500252|11085703|FG000|NOT COMPLETED|Overall Study||9
9965629|NCT01500252|11085704|FG001|NOT COMPLETED|Overall Study||6
9965630|NCT01500278|11085713|FG000|STARTED|Week 0 - Week 12||457
9965631|NCT01500278|11085714|FG001|STARTED|Week 0 - Week 12||458
9965632|NCT01500278|11085713|FG000|COMPLETED|Week 0 - Week 12||426
9965633|NCT01500278|11085714|FG001|COMPLETED|Week 0 - Week 12||428
9965634|NCT01500278|11085713|FG000|NOT COMPLETED|Week 0 - Week 12||31
9965635|NCT01500278|11085714|FG001|NOT COMPLETED|Week 0 - Week 12||30
9965636|NCT01500278|11085713|FG000|STARTED|Week 13 - Week 104||426
9965637|NCT01500278|11085714|FG001|STARTED|Week 13 - Week 104||428
9965638|NCT01500278|11085713|FG000|COMPLETED|Week 13 - Week 104||287
9965639|NCT01500278|11085714|FG001|COMPLETED|Week 13 - Week 104||302
9965640|NCT01500278|11085713|FG000|NOT COMPLETED|Week 13 - Week 104||139
9965641|NCT01500278|11085714|FG001|NOT COMPLETED|Week 13 - Week 104||126
9965642|NCT01500317|11085725|FG000|STARTED|Overall Study||13
9965643|NCT01500317|11085726|FG001|STARTED|Overall Study||12
9965644|NCT01500317|11085727|FG002|STARTED|Overall Study||13
9965645|NCT01500317|11085725|FG000|COMPLETED|Overall Study||10
9965646|NCT01500317|11085726|FG001|COMPLETED|Overall Study||10
9965647|NCT01500317|11085727|FG002|COMPLETED|Overall Study||13
9965648|NCT01500317|11085725|FG000|NOT COMPLETED|Overall Study||3
9965649|NCT01500317|11085726|FG001|NOT COMPLETED|Overall Study||2
9965650|NCT01500317|11085727|FG002|NOT COMPLETED|Overall Study||0
9965651|NCT01500382|11085739|FG000|STARTED|Treatment Period 1||1
9965652|NCT01500382|11085740|FG001|STARTED|Treatment Period 1||1
9965653|NCT01500382|11085741|FG002|STARTED|Treatment Period 1||1
9965654|NCT01500382|11085742|FG003|STARTED|Treatment Period 1||1
9965655|NCT01500382|11085739|FG000|COMPLETED|Treatment Period 1||1
9965656|NCT01500382|11085740|FG001|COMPLETED|Treatment Period 1||1
9965657|NCT01500382|11085741|FG002|COMPLETED|Treatment Period 1||1
9965658|NCT01500382|11085742|FG003|COMPLETED|Treatment Period 1||1
9965659|NCT01500382|11085739|FG000|NOT COMPLETED|Treatment Period 1||0
9965660|NCT01500382|11085740|FG001|NOT COMPLETED|Treatment Period 1||0
9965661|NCT01500382|11085741|FG002|NOT COMPLETED|Treatment Period 1||0
9965662|NCT01500382|11085742|FG003|NOT COMPLETED|Treatment Period 1||0
9965663|NCT01500382|11085739|FG000|STARTED|Washout Period||1
9965664|NCT01500382|11085740|FG001|STARTED|Washout Period||1
9965665|NCT01500382|11085741|FG002|STARTED|Washout Period||1
9965666|NCT01500382|11085742|FG003|STARTED|Washout Period||1
9965667|NCT01500382|11085739|FG000|COMPLETED|Washout Period||1
9965668|NCT01500382|11085740|FG001|COMPLETED|Washout Period||1
9965669|NCT01500382|11085741|FG002|COMPLETED|Washout Period||0
9965670|NCT01500382|11085742|FG003|COMPLETED|Washout Period||1
9965671|NCT01500382|11085739|FG000|NOT COMPLETED|Washout Period||0
9965672|NCT01500382|11085740|FG001|NOT COMPLETED|Washout Period||0
9965673|NCT01500382|11085741|FG002|NOT COMPLETED|Washout Period||1
9965674|NCT01500382|11085742|FG003|NOT COMPLETED|Washout Period||0
9965675|NCT01500382|11085739|FG000|STARTED|Treatment Period 2||1
9965676|NCT01500382|11085740|FG001|STARTED|Treatment Period 2||1
9965677|NCT01500382|11085741|FG002|STARTED|Treatment Period 2||0
9965678|NCT01500382|11085742|FG003|STARTED|Treatment Period 2||1
9965679|NCT01500382|11085739|FG000|COMPLETED|Treatment Period 2||1
9965680|NCT01500382|11085740|FG001|COMPLETED|Treatment Period 2||1
9965681|NCT01500382|11085741|FG002|COMPLETED|Treatment Period 2||0
9965682|NCT01500382|11085742|FG003|COMPLETED|Treatment Period 2||1
9965683|NCT01500382|11085739|FG000|NOT COMPLETED|Treatment Period 2||0
9965684|NCT01500382|11085740|FG001|NOT COMPLETED|Treatment Period 2||0
9965685|NCT01500382|11085741|FG002|NOT COMPLETED|Treatment Period 2||0
9965686|NCT01500382|11085742|FG003|NOT COMPLETED|Treatment Period 2||0
9965687|NCT01500434|11085752|FG000|STARTED|Overall Study||102
9965688|NCT01500434|11085752|FG000|COMPLETED|Overall Study||95
9965689|NCT01500434|11085752|FG000|NOT COMPLETED|Overall Study||7
9965690|NCT01500525|11085758|FG000|STARTED|Overall Study||286
9965691|NCT01500525|11085759|FG001|STARTED|Overall Study||301
9965692|NCT01500525|11085758|FG000|COMPLETED|Overall Study||286
9965693|NCT01500525|11085759|FG001|COMPLETED|Overall Study||301
9965694|NCT01500525|11085758|FG000|NOT COMPLETED|Overall Study||0
9965695|NCT01500525|11085759|FG001|NOT COMPLETED|Overall Study||0
9965696|NCT01500629|11085767|FG000|STARTED|Period 1 (Single Dose)||11
9965697|NCT01500629|11085768|FG001|STARTED|Period 1 (Single Dose)||10
9965698|NCT01500629|11085767|FG000|COMPLETED|Period 1 (Single Dose)||11
9965699|NCT01500629|11085768|FG001|COMPLETED|Period 1 (Single Dose)||10
9965700|NCT01500629|11085767|FG000|NOT COMPLETED|Period 1 (Single Dose)||0
10062622|NCT02111096|11188118|FG001|COMPLETED|Overall Study||0
9965701|NCT01500629|11085768|FG001|NOT COMPLETED|Period 1 (Single Dose)||0
9965702|NCT01500629|11085767|FG000|STARTED|Washout Period of 14 to 30 Days||11
9965703|NCT01500629|11085768|FG001|STARTED|Washout Period of 14 to 30 Days||10
9965704|NCT01500629|11085767|FG000|COMPLETED|Washout Period of 14 to 30 Days||10
9965705|NCT01500629|11085768|FG001|COMPLETED|Washout Period of 14 to 30 Days||10
9965706|NCT01500629|11085767|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1
9965707|NCT01500629|11085768|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0
9965708|NCT01500629|11085767|FG000|STARTED|Period 2 (Single Dose)||10
9965709|NCT01500629|11085768|FG001|STARTED|Period 2 (Single Dose)||10
9965710|NCT01500629|11085767|FG000|COMPLETED|Period 2 (Single Dose)||10
9965711|NCT01500629|11085768|FG001|COMPLETED|Period 2 (Single Dose)||10
9965712|NCT01500629|11085767|FG000|NOT COMPLETED|Period 2 (Single Dose)||0
9965713|NCT01500629|11085768|FG001|NOT COMPLETED|Period 2 (Single Dose)||0
9965714|NCT01500694|11085783|FG000|STARTED|Overall Study||131
9965715|NCT01500694|11085784|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
9965716|NCT01500694|11085783|FG000|COMPLETED|Overall Study||79
9965717|NCT01500694|11085784|FG001|COMPLETED|Overall Study||54
9965718|NCT01500694|11085783|FG000|NOT COMPLETED|Overall Study||52
9965719|NCT01500694|11085784|FG001|NOT COMPLETED|Overall Study||29
9965720|NCT01500720|11085792|FG000|STARTED|Overall Study|Randomized|90
9965721|NCT01500720|11085793|FG001|STARTED|Overall Study|Randomized|89
9965722|NCT01500720|11085792|FG000|Treated|Overall Study||89
9965723|NCT01500720|11085793|FG001|Treated|Overall Study||88
9965724|NCT01500720|11085792|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
9965725|NCT01500720|11085793|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
9965726|NCT01500720|11085792|FG000|NOT COMPLETED|Overall Study||5
9965727|NCT01500720|11085793|FG001|NOT COMPLETED|Overall Study||9
9965728|NCT01500746|11085801|FG000|STARTED|Overall Study||4
9965729|NCT01500746|11085802|FG001|STARTED|Overall Study||4
9965730|NCT01500746|11085801|FG000|COMPLETED|Overall Study||4
9965731|NCT01500746|11085802|FG001|COMPLETED|Overall Study||4
9965732|NCT01500746|11085801|FG000|NOT COMPLETED|Overall Study||0
9965733|NCT01500746|11085802|FG001|NOT COMPLETED|Overall Study||0
9965734|NCT01500759|11085810|FG000|STARTED|Overall Study||3686
9965735|NCT01500759|11085811|FG001|STARTED|Overall Study||3190
9965736|NCT01500759|11085810|FG000|COMPLETED|Overall Study||3686
9965737|NCT01500759|11085811|FG001|COMPLETED|Overall Study||3190
9965738|NCT01500759|11085810|FG000|NOT COMPLETED|Overall Study||0
9965739|NCT01500759|11085811|FG001|NOT COMPLETED|Overall Study||0
9965740|NCT01501110|11085828|FG000|STARTED|Overall Study||34
9965741|NCT01501110|11085829|FG001|STARTED|Overall Study||34
9965742|NCT01501110|11085828|FG000|COMPLETED|Overall Study||34
9965743|NCT01501110|11085829|FG001|COMPLETED|Overall Study||33
9965744|NCT01501110|11085828|FG000|NOT COMPLETED|Overall Study||0
9965745|NCT01501110|11085829|FG001|NOT COMPLETED|Overall Study||1
9965746|NCT01501162|11085837|FG000|STARTED|Overall Study||65
9965747|NCT01501162|11085838|FG001|STARTED|Overall Study||65
9965748|NCT01501162|11085837|FG000|COMPLETED|Overall Study||57
9965749|NCT01501162|11085838|FG001|COMPLETED|Overall Study||60
9965750|NCT01501162|11085837|FG000|NOT COMPLETED|Overall Study||8
9965751|NCT01501162|11085838|FG001|NOT COMPLETED|Overall Study||5
9965752|NCT01501929|11085844|FG000|STARTED|First Intervention||8
9965753|NCT01501929|11085845|FG001|STARTED|First Intervention||17
9965754|NCT01501929|11085844|FG000|COMPLETED|First Intervention||8
9965755|NCT01501929|11085845|FG001|COMPLETED|First Intervention||17
9965756|NCT01501929|11085844|FG000|NOT COMPLETED|First Intervention||0
9965757|NCT01501929|11085845|FG001|NOT COMPLETED|First Intervention||0
9965758|NCT01501929|11085844|FG000|STARTED|Second Intervention||8
9965759|NCT01501929|11085845|FG001|STARTED|Second Intervention||17
9965760|NCT01501929|11085844|FG000|COMPLETED|Second Intervention||8
9965761|NCT01501929|11085845|FG001|COMPLETED|Second Intervention||17
9965762|NCT01501929|11085844|FG000|NOT COMPLETED|Second Intervention||0
9965763|NCT01501929|11085845|FG001|NOT COMPLETED|Second Intervention||0
9965764|NCT01502033|11085851|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10
9965765|NCT01502033|11085851|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7
9965766|NCT01502033|11085851|FG000|NOT COMPLETED|Overall Study||3
9965767|NCT01502072|11085860|FG000|STARTED|Overall Study||14
9965768|NCT01502072|11085861|FG001|STARTED|Overall Study||10
9965769|NCT01502072|11085862|FG002|STARTED|Overall Study||20
9965770|NCT01502072|11085860|FG000|COMPLETED|Overall Study||13
9965771|NCT01502072|11085861|FG001|COMPLETED|Overall Study||9
9965772|NCT01502072|11085862|FG002|COMPLETED|Overall Study||20
9965773|NCT01502072|11085860|FG000|NOT COMPLETED|Overall Study||1
9965774|NCT01502072|11085861|FG001|NOT COMPLETED|Overall Study||1
9965775|NCT01502072|11085862|FG002|NOT COMPLETED|Overall Study||0
9965776|NCT01502228|11085870|FG000|STARTED|Overall Study||14
9965777|NCT01502228|11085870|FG000|COMPLETED|Overall Study||13
9965778|NCT01502228|11085870|FG000|NOT COMPLETED|Overall Study||1
9965779|NCT01502293|11085877|FG000|STARTED|Overall Study||30
9965780|NCT01502293|11085878|FG001|STARTED|Overall Study||17
9965781|NCT01502293|11085879|FG002|STARTED|Overall Study||4
9965782|NCT01502293|11085877|FG000|COMPLETED|Overall Study||5
9965783|NCT01502293|11085878|FG001|COMPLETED|Overall Study||0
9965784|NCT01502293|11085879|FG002|COMPLETED|Overall Study||0
9965785|NCT01502293|11085877|FG000|NOT COMPLETED|Overall Study||25
9965786|NCT01502293|11085878|FG001|NOT COMPLETED|Overall Study||17
9965787|NCT01502293|11085879|FG002|NOT COMPLETED|Overall Study||4
9965788|NCT01502306|11085893|FG000|STARTED|Overall Study||1004
9965789|NCT01502306|11085894|FG001|STARTED|Overall Study||1405
9965790|NCT01502306|11085895|FG002|STARTED|Overall Study||1407
9965791|NCT01502306|11085893|FG000|COMPLETED|Overall Study||1004
9965792|NCT01502306|11085894|FG001|COMPLETED|Overall Study||1405
9965793|NCT01502306|11085895|FG002|COMPLETED|Overall Study||1407
9965794|NCT01502306|11085893|FG000|NOT COMPLETED|Overall Study||0
9965795|NCT01502306|11085894|FG001|NOT COMPLETED|Overall Study||0
9965796|NCT01502306|11085895|FG002|NOT COMPLETED|Overall Study||0
9965797|NCT01502332|11085905|FG000|STARTED|Overall Study||157
9965798|NCT01502332|11085906|FG001|STARTED|Overall Study||163
9965799|NCT01502332|11085905|FG000|COMPLETED|Overall Study||157
9965800|NCT01502332|11085906|FG001|COMPLETED|Overall Study||163
9965801|NCT01502332|11085905|FG000|NOT COMPLETED|Overall Study||0
9965802|NCT01502332|11085906|FG001|NOT COMPLETED|Overall Study||0
9965803|NCT01502410|11085916|FG000|STARTED|Overall Study||10
9965804|NCT01502410|11085917|FG001|STARTED|Overall Study||10
9965805|NCT01502410|11085918|FG002|STARTED|Overall Study||0
9965806|NCT01502410|11085919|FG003|STARTED|Overall Study||0
9965807|NCT01502410|11085916|FG000|COMPLETED|Overall Study||0
9965808|NCT01502410|11085917|FG001|COMPLETED|Overall Study||0
9965809|NCT01502410|11085918|FG002|COMPLETED|Overall Study||0
9965810|NCT01502410|11085919|FG003|COMPLETED|Overall Study||0
9965811|NCT01502410|11085916|FG000|NOT COMPLETED|Overall Study||10
9965812|NCT01502410|11085917|FG001|NOT COMPLETED|Overall Study||10
9965813|NCT01502410|11085918|FG002|NOT COMPLETED|Overall Study||0
9965814|NCT01502410|11085919|FG003|NOT COMPLETED|Overall Study||0
9965815|NCT01502423|11085930|FG000|STARTED|Overall Study||31
9965816|NCT01502423|11085931|FG001|STARTED|Overall Study||30
9965817|NCT01502423|11085930|FG000|COMPLETED|Overall Study||31
9965818|NCT01502423|11085931|FG001|COMPLETED|Overall Study||29
9965819|NCT01502423|11085930|FG000|NOT COMPLETED|Overall Study||0
9965820|NCT01502423|11085931|FG001|NOT COMPLETED|Overall Study||1
9965821|NCT01502631|11085939|FG000|STARTED|Overall Study||30
9965822|NCT01502631|11085940|FG001|STARTED|Overall Study||31
9965823|NCT01502631|11085939|FG000|COMPLETED|Overall Study||10
9965824|NCT01502631|11085940|FG001|COMPLETED|Overall Study||11
9965825|NCT01502631|11085939|FG000|NOT COMPLETED|Overall Study||20
9965826|NCT01502631|11085940|FG001|NOT COMPLETED|Overall Study||20
9965827|NCT01502644|11085949|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81
9965828|NCT01502644|11085950|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0
9965829|NCT01502644|11085951|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0
9965830|NCT01502644|11085952|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0
9965831|NCT01502644|11085949|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
9965832|NCT01502644|11085950|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
9965833|NCT01502644|11085951|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
9965834|NCT01502644|11085952|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
9965835|NCT01502644|11085949|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
9965836|NCT01502644|11085950|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
9965837|NCT01502644|11085951|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
9965838|NCT01502644|11085952|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
9965839|NCT01502644|11085949|FG000|STARTED|Assigned to NA Groups||0
9965840|NCT01502644|11085950|FG001|STARTED|Assigned to NA Groups||30
9965841|NCT01502644|11085951|FG002|STARTED|Assigned to NA Groups||10
9965842|NCT01502644|11085952|FG003|STARTED|Assigned to NA Groups||32
9965843|NCT01502644|11085949|FG000|COMPLETED|Assigned to NA Groups||0
9965844|NCT01502644|11085950|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
9965845|NCT01502644|11085951|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
9965846|NCT01502644|11085952|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
9965847|NCT01502644|11085949|FG000|NOT COMPLETED|Assigned to NA Groups||0
9965848|NCT01502644|11085950|FG001|NOT COMPLETED|Assigned to NA Groups||6
9965849|NCT01502644|11085951|FG002|NOT COMPLETED|Assigned to NA Groups||3
9965850|NCT01502644|11085952|FG003|NOT COMPLETED|Assigned to NA Groups||8
9965851|NCT01502709|11085962|FG000|STARTED|Overall Study||5
9965852|NCT01502709|11085963|FG001|STARTED|Overall Study||0
9965853|NCT01502709|11085962|FG000|COMPLETED|Overall Study||1
9965854|NCT01502709|11085963|FG001|COMPLETED|Overall Study||0
9965855|NCT01502709|11085962|FG000|NOT COMPLETED|Overall Study||4
9965856|NCT01502709|11085963|FG001|NOT COMPLETED|Overall Study||0
9965857|NCT01502761|11085974|FG000|STARTED|Overall Study||4
9965858|NCT01502761|11085975|FG001|STARTED|Overall Study||0
9965859|NCT01502761|11085976|FG002|STARTED|Overall Study||0
9965860|NCT01502761|11085977|FG003|STARTED|Overall Study||0
9965861|NCT01502761|11085974|FG000|COMPLETED|Overall Study||4
9965862|NCT01502761|11085975|FG001|COMPLETED|Overall Study||0
9965863|NCT01502761|11085976|FG002|COMPLETED|Overall Study||0
9965864|NCT01502761|11085977|FG003|COMPLETED|Overall Study||0
9965865|NCT01502761|11085974|FG000|NOT COMPLETED|Overall Study||0
9965866|NCT01502761|11085975|FG001|NOT COMPLETED|Overall Study||0
9965867|NCT01502761|11085976|FG002|NOT COMPLETED|Overall Study||0
9965868|NCT01502761|11085977|FG003|NOT COMPLETED|Overall Study||0
9965869|NCT01502787|11085987|FG000|STARTED|Overall Study||11
9965870|NCT01502787|11085988|FG001|STARTED|Overall Study||10
9965871|NCT01502787|11085987|FG000|COMPLETED|Overall Study||11
9965872|NCT01502787|11085988|FG001|COMPLETED|Overall Study||10
9965873|NCT01502787|11085987|FG000|NOT COMPLETED|Overall Study||0
9965874|NCT01502787|11085988|FG001|NOT COMPLETED|Overall Study||0
9965875|NCT01502813|11085998|FG000|STARTED|Overall Study||40
9965876|NCT01502813|11085998|FG000|COMPLETED|Overall Study||40
9965877|NCT01502813|11085998|FG000|NOT COMPLETED|Overall Study||0
9965878|NCT01502956|11086004|FG000|STARTED|Overall Study||192
9965879|NCT01502956|11086005|FG001|STARTED|Overall Study||194
9965880|NCT01502956|11086004|FG000|COMPLETED|Overall Study||168
9965881|NCT01502956|11086005|FG001|COMPLETED|Overall Study||168
9965882|NCT01502956|11086004|FG000|NOT COMPLETED|Overall Study||24
9965883|NCT01502956|11086005|FG001|NOT COMPLETED|Overall Study||26
9965884|NCT01503021|11086013|FG000|STARTED|Overall Study||360
9965885|NCT01503021|11086014|FG001|STARTED|Overall Study||358
9965886|NCT01503021|11086013|FG000|Dosed|Overall Study||351
9965887|NCT01503021|11086014|FG001|Dosed|Overall Study||352
9965888|NCT01503021|11086013|FG000|Completed Treatment|Overall Study||333
9965889|NCT01503021|11086014|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
9965890|NCT01503021|11086013|FG000|COMPLETED|Overall Study||333
9965891|NCT01503021|11086014|FG001|COMPLETED|Overall Study||332
9965892|NCT01503021|11086013|FG000|NOT COMPLETED|Overall Study||27
9965893|NCT01503021|11086014|FG001|NOT COMPLETED|Overall Study||26
9965894|NCT01503164|11086027|FG000|STARTED|Overall Study||55
9965895|NCT01503164|11086028|FG001|STARTED|Overall Study||56
9965896|NCT01503164|11086027|FG000|COMPLETED|Overall Study||53
9965897|NCT01503164|11086028|FG001|COMPLETED|Overall Study||55
9965898|NCT01503164|11086027|FG000|NOT COMPLETED|Overall Study||2
9965899|NCT01503164|11086028|FG001|NOT COMPLETED|Overall Study||1
9965900|NCT01503229|11086034|FG000|STARTED|Overall Study||30
9965901|NCT01503229|11086034|FG000|COMPLETED|Overall Study||29
9965902|NCT01503229|11086034|FG000|NOT COMPLETED|Overall Study||1
9965903|NCT01503333|11086040|FG000|STARTED|Overall Study||777
9965904|NCT01503333|11086041|FG001|STARTED|Overall Study||766
9965905|NCT01503333|11086040|FG000|Completed Baseline|Overall Study||766
9965906|NCT01503333|11086041|FG001|Completed Baseline|Overall Study||753
9965907|NCT01503333|11086040|FG000|Completed Post-intervention|Overall Study||680
9965908|NCT01503333|11086041|FG001|Completed Post-intervention|Overall Study||706
9965909|NCT01503333|11086040|FG000|COMPLETED|Overall Study||437
9965910|NCT01503333|11086041|FG001|COMPLETED|Overall Study||461
9965911|NCT01503333|11086040|FG000|NOT COMPLETED|Overall Study||340
9965912|NCT01503333|11086041|FG001|NOT COMPLETED|Overall Study||305
9965913|NCT01503749|11086058|FG000|STARTED|Overall Study||3
9965914|NCT01503749|11086059|FG001|STARTED|Overall Study||3
9965915|NCT01503749|11086060|FG002|STARTED|Overall Study||3
9965916|NCT01503749|11086058|FG000|COMPLETED|Overall Study||3
9965917|NCT01503749|11086059|FG001|COMPLETED|Overall Study||3
9965918|NCT01503749|11086060|FG002|COMPLETED|Overall Study||3
9965919|NCT01503749|11086058|FG000|NOT COMPLETED|Overall Study||0
9965920|NCT01503749|11086059|FG001|NOT COMPLETED|Overall Study||0
9965921|NCT01503749|11086060|FG002|NOT COMPLETED|Overall Study||0
9965922|NCT01504204|11086070|FG000|STARTED|Overall Study||10
9965923|NCT01504204|11086071|FG001|STARTED|Overall Study||10
9965924|NCT01504204|11086070|FG000|COMPLETED|Overall Study||9
9965925|NCT01504204|11086071|FG001|COMPLETED|Overall Study||9
9965926|NCT01504204|11086070|FG000|NOT COMPLETED|Overall Study||1
9965927|NCT01504204|11086071|FG001|NOT COMPLETED|Overall Study||1
9965928|NCT01504412|11086082|FG000|STARTED|Overall Study||89
9965929|NCT01504412|11086083|FG001|STARTED|Overall Study||87
9965930|NCT01504412|11086084|FG002|STARTED|Overall Study||90
9965931|NCT01504412|11086085|FG003|STARTED|Overall Study||94
9965932|NCT01504412|11086086|FG004|STARTED|Overall Study||90
9965933|NCT01504412|11086082|FG000|COMPLETED|Overall Study||84
9965934|NCT01504412|11086083|FG001|COMPLETED|Overall Study||75
9965935|NCT01504412|11086084|FG002|COMPLETED|Overall Study||86
9965936|NCT01504412|11086085|FG003|COMPLETED|Overall Study||75
9965937|NCT01504412|11086086|FG004|COMPLETED|Overall Study||77
9965938|NCT01504412|11086082|FG000|NOT COMPLETED|Overall Study||5
9965939|NCT01504412|11086083|FG001|NOT COMPLETED|Overall Study||12
9965940|NCT01504412|11086084|FG002|NOT COMPLETED|Overall Study||4
9965941|NCT01504412|11086085|FG003|NOT COMPLETED|Overall Study||19
9965942|NCT01504412|11086086|FG004|NOT COMPLETED|Overall Study||13
9967968|NCT01518153|11088336|FG002|NOT COMPLETED|Stem Cell Transplant||0
9967969|NCT01518153|11088334|FG000|STARTED|Donor Lymphocyte Infusion||0
9967970|NCT01518153|11088335|FG001|STARTED|Donor Lymphocyte Infusion||3
9967971|NCT01518153|11088336|FG002|STARTED|Donor Lymphocyte Infusion||4
9967972|NCT01518153|11088334|FG000|COMPLETED|Donor Lymphocyte Infusion||0
9967973|NCT01518153|11088335|FG001|COMPLETED|Donor Lymphocyte Infusion||1
9967974|NCT01518153|11088336|FG002|COMPLETED|Donor Lymphocyte Infusion||3
9967975|NCT01518153|11088334|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0
9967976|NCT01518153|11088335|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2
9967977|NCT01518153|11088336|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1
10062623|NCT02111096|11188119|FG002|COMPLETED|Overall Study||2
10062624|NCT02111096|11188117|FG000|NOT COMPLETED|Overall Study||64
10062625|NCT02111096|11188118|FG001|NOT COMPLETED|Overall Study||41
10062626|NCT02111096|11188119|FG002|NOT COMPLETED|Overall Study||66
10062627|NCT02111174|11188132|FG000|STARTED|Treatment and Primary Outcome||18
10062628|NCT02111174|11188133|FG001|STARTED|Treatment and Primary Outcome||18
9965943|NCT01504477|11086098|FG000|STARTED|Overall Study||6
9965944|NCT01504477|11086098|FG000|COMPLETED|Overall Study||6
9965945|NCT01504477|11086098|FG000|NOT COMPLETED|Overall Study||0
9965946|NCT01504672|11086104|FG000|STARTED|Overall Study||230
9965947|NCT01504672|11086105|FG001|STARTED|Overall Study||230
9965948|NCT01504672|11086104|FG000|COMPLETED|Overall Study||212
9965949|NCT01504672|11086105|FG001|COMPLETED|Overall Study||217
9965950|NCT01504672|11086104|FG000|NOT COMPLETED|Overall Study||18
9965951|NCT01504672|11086105|FG001|NOT COMPLETED|Overall Study||13
9965952|NCT01504711|11086113|FG000|STARTED|Overall Study||30
9965953|NCT01504711|11086113|FG000|COMPLETED|Overall Study||27
9965954|NCT01504711|11086113|FG000|NOT COMPLETED|Overall Study||3
9965955|NCT01504841|11086120|FG000|STARTED|Overall Study||20
9965956|NCT01504841|11086121|FG001|STARTED|Overall Study||6
9965957|NCT01504841|11086122|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
9965958|NCT01504841|11086120|FG000|COMPLETED|Overall Study||19
9965959|NCT01504841|11086121|FG001|COMPLETED|Overall Study||5
10062629|NCT02111174|11188132|FG000|COMPLETED|Treatment and Primary Outcome||15
10062630|NCT02111174|11188133|FG001|COMPLETED|Treatment and Primary Outcome||16
10062631|NCT02111174|11188132|FG000|NOT COMPLETED|Treatment and Primary Outcome||3
10062632|NCT02111174|11188133|FG001|NOT COMPLETED|Treatment and Primary Outcome||2
10062633|NCT02111174|11188132|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
10062634|NCT02111174|11188133|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
10062635|NCT02111174|11188132|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
10062636|NCT02111174|11188133|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
10062637|NCT02111174|11188132|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
10062638|NCT02111174|11188133|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
10062639|NCT02111174|11188132|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
10062640|NCT02111174|11188133|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
10062641|NCT02111187|11188141|FG000|STARTED|Overall Study||7
10062642|NCT02111187|11188142|FG001|STARTED|Overall Study||7
10062643|NCT02111187|11188141|FG000|COMPLETED|Overall Study||7
10062644|NCT02111187|11188142|FG001|COMPLETED|Overall Study||7
10062645|NCT02111187|11188141|FG000|NOT COMPLETED|Overall Study||0
10062646|NCT02111187|11188142|FG001|NOT COMPLETED|Overall Study||0
10062647|NCT02111200|11188152|FG000|STARTED|Overall Study||3
10062648|NCT02111200|11188153|FG001|STARTED|Overall Study||2
10062649|NCT02111200|11188154|FG002|STARTED|Overall Study||1
10062650|NCT02111200|11188155|FG003|STARTED|Overall Study||1
10062651|NCT02111200|11188152|FG000|COMPLETED|Overall Study||3
10062652|NCT02111200|11188153|FG001|COMPLETED|Overall Study||2
10062653|NCT02111200|11188154|FG002|COMPLETED|Overall Study||1
10062654|NCT02111200|11188155|FG003|COMPLETED|Overall Study||1
10062655|NCT02111200|11188152|FG000|NOT COMPLETED|Overall Study||0
10062656|NCT02111200|11188153|FG001|NOT COMPLETED|Overall Study||0
10062657|NCT02111200|11188154|FG002|NOT COMPLETED|Overall Study||0
10062658|NCT02111200|11188155|FG003|NOT COMPLETED|Overall Study||0
10062659|NCT02111213|11188165|FG000|STARTED|Overall Study||122
10062660|NCT02111213|11188166|FG001|STARTED|Overall Study||123
10062661|NCT02111213|11188165|FG000|COMPLETED|Overall Study||116
10062662|NCT02111213|11188166|FG001|COMPLETED|Overall Study||117
10062663|NCT02111213|11188165|FG000|NOT COMPLETED|Overall Study||6
10062664|NCT02111213|11188166|FG001|NOT COMPLETED|Overall Study||6
10062665|NCT02111252|11188172|FG000|STARTED|Overall Study||55
10062666|NCT02111252|11188172|FG000|COMPLETED|Overall Study||55
10062667|NCT02111252|11188172|FG000|NOT COMPLETED|Overall Study||0
10062668|NCT02111369|11188176|FG000|STARTED|Overall Study||18
10062669|NCT02111369|11188176|FG000|COMPLETED|Overall Study||15
10062670|NCT02111369|11188176|FG000|NOT COMPLETED|Overall Study||3
10062671|NCT02111447|11188184|FG000|STARTED|Overall Study||0
10188301|NCT03266172|11317910|FG001|COMPLETED|Part C Period 3(2 Days)||0
10188302|NCT03266172|11317911|FG002|COMPLETED|Part C Period 3(2 Days)||16
10188303|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0
10188304|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0
10188305|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0
10188306|NCT03266172|11317909|FG000|STARTED|Part C Washout Period (7 Days)||0
10188307|NCT03266172|11317910|FG001|STARTED|Part C Washout Period (7 Days)||0
10188308|NCT03266172|11317911|FG002|STARTED|Part C Washout Period (7 Days)||16
10188309|NCT03266172|11317909|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10188310|NCT03266172|11317910|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10188311|NCT03266172|11317911|FG002|COMPLETED|Part C Washout Period (7 Days)||16
10188312|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188313|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188314|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188315|NCT03266172|11317909|FG000|STARTED|Part C Period 4(2 Days)||0
10188316|NCT03266172|11317910|FG001|STARTED|Part C Period 4(2 Days)||0
10188317|NCT03266172|11317911|FG002|STARTED|Part C Period 4(2 Days)||16
9965960|NCT01504841|11086122|FG002|COMPLETED|Overall Study||0
9965961|NCT01504841|11086120|FG000|NOT COMPLETED|Overall Study||1
9965962|NCT01504841|11086121|FG001|NOT COMPLETED|Overall Study||1
10062672|NCT02111447|11188185|FG001|STARTED|Overall Study||5
10062673|NCT02111447|11188186|FG002|STARTED|Overall Study||1
10062674|NCT02111447|11188187|FG003|STARTED|Overall Study||0
10062675|NCT02111447|11188184|FG000|COMPLETED|Overall Study||0
10062676|NCT02111447|11188185|FG001|COMPLETED|Overall Study||5
10062677|NCT02111447|11188186|FG002|COMPLETED|Overall Study||1
9965963|NCT01504841|11086122|FG002|NOT COMPLETED|Overall Study||0
9965964|NCT01504854|11086131|FG000|STARTED|Overall Study||64
9965965|NCT01504854|11086132|FG001|STARTED|Overall Study||55
9965966|NCT01504854|11086131|FG000|COMPLETED|Overall Study||56
9965967|NCT01504854|11086132|FG001|COMPLETED|Overall Study||48
9965968|NCT01504854|11086131|FG000|NOT COMPLETED|Overall Study||8
9965969|NCT01504854|11086132|FG001|NOT COMPLETED|Overall Study||7
9965970|NCT01504867|11086140|FG000|STARTED|Overall Study||202
9965971|NCT01504867|11086141|FG001|STARTED|Overall Study||198
9965972|NCT01504867|11086140|FG000|COMPLETED|Overall Study||195
9965973|NCT01504867|11086141|FG001|COMPLETED|Overall Study||195
9965974|NCT01504867|11086140|FG000|NOT COMPLETED|Overall Study||7
9965975|NCT01504867|11086141|FG001|NOT COMPLETED|Overall Study||3
9965976|NCT01504958|11086150|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
9965977|NCT01504958|11086151|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
9965978|NCT01504958|11086152|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
9965979|NCT01504958|11086150|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
9965980|NCT01504958|11086151|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
9965981|NCT01504958|11086152|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
9965982|NCT01504958|11086150|FG000|NOT COMPLETED|Overall Study||0
9965983|NCT01504958|11086151|FG001|NOT COMPLETED|Overall Study||0
9965984|NCT01504958|11086152|FG002|NOT COMPLETED|Overall Study||0
9965985|NCT01504971|11086160|FG000|STARTED|Overall Study||95
9965986|NCT01504971|11086160|FG000|COMPLETED|Overall Study||82
9965987|NCT01504971|11086160|FG000|NOT COMPLETED|Overall Study||13
9965988|NCT01504997|11086168|FG000|STARTED|Overall Study||18
9965989|NCT01504997|11086168|FG000|COMPLETED|Overall Study||18
9965990|NCT01504997|11086168|FG000|NOT COMPLETED|Overall Study||0
9965991|NCT01505010|11086174|FG000|STARTED|Overall Study||9
9965992|NCT01505010|11086175|FG001|STARTED|Overall Study||8
9965993|NCT01505010|11086174|FG000|COMPLETED|Overall Study||9
9965994|NCT01505010|11086175|FG001|COMPLETED|Overall Study||6
9965995|NCT01505010|11086174|FG000|NOT COMPLETED|Overall Study||0
9965996|NCT01505010|11086175|FG001|NOT COMPLETED|Overall Study||2
9965997|NCT01505114|11086185|FG000|STARTED|Overall Study||148
9965998|NCT01505114|11086186|FG001|STARTED|Overall Study||148
9965999|NCT01505114|11086187|FG002|STARTED|Overall Study||147
9966000|NCT01505114|11086188|FG003|STARTED|Overall Study||151
9966001|NCT01505114|11086185|FG000|COMPLETED|Overall Study||123
9966002|NCT01505114|11086186|FG001|COMPLETED|Overall Study||135
9966003|NCT01505114|11086187|FG002|COMPLETED|Overall Study||129
9966004|NCT01505114|11086188|FG003|COMPLETED|Overall Study||128
9966005|NCT01505114|11086185|FG000|NOT COMPLETED|Overall Study||25
9966006|NCT01505114|11086186|FG001|NOT COMPLETED|Overall Study||13
9966007|NCT01505114|11086187|FG002|NOT COMPLETED|Overall Study||18
9966008|NCT01505114|11086188|FG003|NOT COMPLETED|Overall Study||23
9966009|NCT01505166|11086201|FG000|STARTED|Overall Study||3
9966010|NCT01505166|11086202|FG001|STARTED|Overall Study||0
9966011|NCT01505166|11086203|FG002|STARTED|Overall Study||0
9966012|NCT01505166|11086201|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
9966013|NCT01505166|11086202|FG001|COMPLETED|Overall Study||0
9966014|NCT01505166|11086203|FG002|COMPLETED|Overall Study||0
9966015|NCT01505166|11086201|FG000|NOT COMPLETED|Overall Study||0
9966016|NCT01505166|11086202|FG001|NOT COMPLETED|Overall Study||0
9966017|NCT01505166|11086203|FG002|NOT COMPLETED|Overall Study||0
9966018|NCT01505179|11086215|FG000|STARTED|Overall Study||6
9966019|NCT01505179|11086216|FG001|STARTED|Overall Study||4
9966020|NCT01505179|11086215|FG000|COMPLETED|Overall Study||6
9966021|NCT01505179|11086216|FG001|COMPLETED|Overall Study||4
9966022|NCT01505179|11086215|FG000|NOT COMPLETED|Overall Study||0
9966023|NCT01505179|11086216|FG001|NOT COMPLETED|Overall Study||0
9966024|NCT01505374|11086222|FG000|STARTED|Overall Study||30
9966025|NCT01505374|11086223|FG001|STARTED|Overall Study||30
9966026|NCT01505374|11086222|FG000|COMPLETED|Overall Study||29
9966027|NCT01505374|11086223|FG001|COMPLETED|Overall Study||30
9966028|NCT01505374|11086222|FG000|NOT COMPLETED|Overall Study||1
9966029|NCT01505374|11086223|FG001|NOT COMPLETED|Overall Study||0
9966030|NCT01505387|11086232|FG000|STARTED|Overall Study||25
9966031|NCT01505387|11086233|FG001|STARTED|Overall Study||25
9966032|NCT01505387|11086232|FG000|Treated|Overall Study||24
9966033|NCT01505387|11086233|FG001|Treated|Overall Study||24
9966034|NCT01505387|11086232|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
9966035|NCT01505387|11086233|FG001|COMPLETED|Overall Study||24
9966036|NCT01505387|11086232|FG000|NOT COMPLETED|Overall Study||2
9966037|NCT01505387|11086233|FG001|NOT COMPLETED|Overall Study||1
9966038|NCT01505491|11086242|FG000|STARTED|Overall Study||67
9966039|NCT01505491|11086243|FG001|STARTED|Overall Study||62
9966040|NCT01505491|11086244|FG002|STARTED|Overall Study||64
9966041|NCT01505491|11086242|FG000|COMPLETED|Overall Study||65
9966042|NCT01505491|11086243|FG001|COMPLETED|Overall Study||61
9966043|NCT01505491|11086244|FG002|COMPLETED|Overall Study||59
9966044|NCT01505491|11086242|FG000|NOT COMPLETED|Overall Study||2
9966045|NCT01505491|11086243|FG001|NOT COMPLETED|Overall Study||1
9966046|NCT01505491|11086244|FG002|NOT COMPLETED|Overall Study||5
9966047|NCT01505530|11086255|FG000|STARTED|Overall Study||41
9966048|NCT01505530|11086256|FG001|STARTED|Overall Study||43
9966049|NCT01505530|11086257|FG002|STARTED|Overall Study||41
9966050|NCT01505530|11086255|FG000|Received At Least One Dose of Study Drug|Overall Study||41
9966051|NCT01505530|11086256|FG001|Received At Least One Dose of Study Drug|Overall Study||42
9966052|NCT01505530|11086257|FG002|Received At Least One Dose of Study Drug|Overall Study||41
9966053|NCT01505530|11086255|FG000|Completed One Cycle of Study Drug|Overall Study||29
9966054|NCT01505530|11086256|FG001|Completed One Cycle of Study Drug|Overall Study||27
9966055|NCT01505530|11086257|FG002|Completed One Cycle of Study Drug|Overall Study||31
9966056|NCT01505530|11086255|FG000|COMPLETED|Overall Study||0
9966057|NCT01505530|11086256|FG001|COMPLETED|Overall Study||0
9966058|NCT01505530|11086257|FG002|COMPLETED|Overall Study||0
9966059|NCT01505530|11086255|FG000|NOT COMPLETED|Overall Study||41
9966060|NCT01505530|11086256|FG001|NOT COMPLETED|Overall Study||43
9966061|NCT01505530|11086257|FG002|NOT COMPLETED|Overall Study||41
9966062|NCT01505634|11086268|FG000|STARTED|Overall Study||101
9966063|NCT01505634|11086269|FG001|STARTED|Overall Study||101
9966064|NCT01505634|11086270|FG002|STARTED|Overall Study||100
9966065|NCT01505634|11086268|FG000|Treated|Overall Study||99
9966066|NCT01505634|11086269|FG001|Treated|Overall Study||99
9966067|NCT01505634|11086270|FG002|Treated|Overall Study||100
9966068|NCT01505634|11086268|FG000|COMPLETED|Overall Study||92
9966069|NCT01505634|11086269|FG001|COMPLETED|Overall Study||91
9966070|NCT01505634|11086270|FG002|COMPLETED|Overall Study||94
9966071|NCT01505634|11086268|FG000|NOT COMPLETED|Overall Study||9
9966072|NCT01505634|11086269|FG001|NOT COMPLETED|Overall Study||10
9966073|NCT01505634|11086270|FG002|NOT COMPLETED|Overall Study||6
9966074|NCT01505647|11086280|FG000|STARTED|Day 1 Through Day 42 Follow-up||332
9966075|NCT01505647|11086281|FG001|STARTED|Day 1 Through Day 42 Follow-up||166
9966076|NCT01505647|11086280|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331
9966077|NCT01505647|11086281|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166
9966078|NCT01505647|11086280|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329
9966079|NCT01505647|11086281|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166
10062678|NCT02111447|11188187|FG003|COMPLETED|Overall Study||0
10062679|NCT02111447|11188184|FG000|NOT COMPLETED|Overall Study||0
10062680|NCT02111447|11188185|FG001|NOT COMPLETED|Overall Study||0
10062681|NCT02111447|11188186|FG002|NOT COMPLETED|Overall Study||0
10062682|NCT02111447|11188187|FG003|NOT COMPLETED|Overall Study||0
10062683|NCT02111564|11188199|FG000|STARTED|Overall Study||6007
10062684|NCT02111564|11188200|FG001|STARTED|Overall Study||6012
10062685|NCT02111564|11188199|FG000|Treated|Overall Study||5982
10062686|NCT02111564|11188200|FG001|Treated|Overall Study||5980
10062687|NCT02111564|11188199|FG000|COMPLETED|Overall Study||5876
10062688|NCT02111564|11188200|FG001|COMPLETED|Overall Study||5869
10062689|NCT02111564|11188199|FG000|NOT COMPLETED|Overall Study||131
10062690|NCT02111564|11188200|FG001|NOT COMPLETED|Overall Study||143
10062691|NCT02111577|11188208|FG000|STARTED|Overall Study||787
10062692|NCT02111577|11188209|FG001|STARTED|Overall Study||395
10062693|NCT02111577|11188208|FG000|COMPLETED|Overall Study||188
10062694|NCT02111577|11188209|FG001|COMPLETED|Overall Study||106
10062695|NCT02111577|11188208|FG000|NOT COMPLETED|Overall Study||599
10062696|NCT02111577|11188209|FG001|NOT COMPLETED|Overall Study||289
10062697|NCT02111603|11188217|FG000|STARTED|Overall Study||13
10062698|NCT02111603|11188217|FG000|COMPLETED|Overall Study||12
10062699|NCT02111603|11188217|FG000|NOT COMPLETED|Overall Study||1
10062700|NCT02111746|11188223|FG000|STARTED|Overall Study||172
10062701|NCT02111746|11188224|FG001|STARTED|Overall Study||171
10062702|NCT02111746|11188223|FG000|COMPLETED|Overall Study||169
10062703|NCT02111746|11188224|FG001|COMPLETED|Overall Study||169
10062704|NCT02111746|11188223|FG000|NOT COMPLETED|Overall Study||3
10062705|NCT02111746|11188224|FG001|NOT COMPLETED|Overall Study||2
10062706|NCT02111772|11188232|FG000|STARTED|Overall Study||12
10062707|NCT02111772|11188233|FG001|STARTED|Overall Study||14
10062708|NCT02111772|11188232|FG000|COMPLETED|Overall Study||12
10062709|NCT02111772|11188233|FG001|COMPLETED|Overall Study||14
10062710|NCT02111772|11188232|FG000|NOT COMPLETED|Overall Study||0
10062711|NCT02111772|11188233|FG001|NOT COMPLETED|Overall Study||0
10062712|NCT02111785|11188243|FG000|STARTED|Overall Study||3
10062713|NCT02111785|11188244|FG001|STARTED|Overall Study||5
10062714|NCT02111785|11188245|FG002|STARTED|Overall Study||1
10062715|NCT02111785|11188246|FG003|STARTED|Overall Study||1
10062716|NCT02111785|11188243|FG000|COMPLETED|Overall Study||3
10062717|NCT02111785|11188244|FG001|COMPLETED|Overall Study||4
10062718|NCT02111785|11188245|FG002|COMPLETED|Overall Study||1
10062719|NCT02111785|11188246|FG003|COMPLETED|Overall Study||1
10062720|NCT02111785|11188243|FG000|NOT COMPLETED|Overall Study||0
10062721|NCT02111785|11188244|FG001|NOT COMPLETED|Overall Study||1
10062722|NCT02111785|11188245|FG002|NOT COMPLETED|Overall Study||0
10062723|NCT02111785|11188246|FG003|NOT COMPLETED|Overall Study||0
10062724|NCT02111798|11188264|FG000|STARTED|Overall Study||31
10062725|NCT02111798|11188265|FG001|STARTED|Overall Study||32
10062726|NCT02111798|11188266|FG002|STARTED|Overall Study||10
10062727|NCT02111798|11188267|FG003|STARTED|Overall Study||10
10062728|NCT02111798|11188264|FG000|COMPLETED|Overall Study||20
10062729|NCT02111798|11188265|FG001|COMPLETED|Overall Study||16
10062730|NCT02111798|11188266|FG002|COMPLETED|Overall Study||10
10062731|NCT02111798|11188267|FG003|COMPLETED|Overall Study||7
10062732|NCT02111798|11188264|FG000|NOT COMPLETED|Overall Study||11
10062733|NCT02111798|11188265|FG001|NOT COMPLETED|Overall Study||16
10062734|NCT02111798|11188266|FG002|NOT COMPLETED|Overall Study||0
10062735|NCT02111798|11188267|FG003|NOT COMPLETED|Overall Study||3
10062736|NCT02111811|11188280|FG000|STARTED|Treatment Phase||139
10062737|NCT02111811|11188281|FG001|STARTED|Treatment Phase||114
10062738|NCT02111811|11188280|FG000|COMPLETED|Treatment Phase||115
10062739|NCT02111811|11188281|FG001|COMPLETED|Treatment Phase||96
10062740|NCT02111811|11188280|FG000|NOT COMPLETED|Treatment Phase||24
10062741|NCT02111811|11188281|FG001|NOT COMPLETED|Treatment Phase||18
10062742|NCT02111811|11188280|FG000|STARTED|Follow up Period (Aim 2)||139
10062743|NCT02111811|11188281|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
10062744|NCT02111811|11188280|FG000|COMPLETED|Follow up Period (Aim 2)||111
10062745|NCT02111811|11188281|FG001|COMPLETED|Follow up Period (Aim 2)||97
10062746|NCT02111811|11188280|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28
10062747|NCT02111811|11188281|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17
10062748|NCT02111863|11188287|FG000|STARTED|Overall Study||6
10062749|NCT02111863|11188287|FG000|COMPLETED|Overall Study||6
10062750|NCT02111863|11188287|FG000|NOT COMPLETED|Overall Study||0
10062751|NCT02111980|11188291|FG000|STARTED|Overall Study||50
10062752|NCT02111980|11188291|FG000|COMPLETED|Overall Study||50
10062753|NCT02111980|11188291|FG000|NOT COMPLETED|Overall Study||0
10062754|NCT02111993|11188300|FG000|STARTED|Overall Study||30
10062755|NCT02111993|11188301|FG001|STARTED|Overall Study||30
10062756|NCT02111993|11188300|FG000|COMPLETED|Overall Study||25
10062757|NCT02111993|11188301|FG001|COMPLETED|Overall Study||26
10062758|NCT02111993|11188300|FG000|NOT COMPLETED|Overall Study||5
10062759|NCT02111993|11188301|FG001|NOT COMPLETED|Overall Study||4
10062760|NCT02112045|11188311|FG000|STARTED|Overall Study||45
10062761|NCT02112045|11188312|FG001|STARTED|Overall Study||45
10062762|NCT02112045|11188311|FG000|COMPLETED|Overall Study||44
10062763|NCT02112045|11188312|FG001|COMPLETED|Overall Study||45
10062764|NCT02112045|11188311|FG000|NOT COMPLETED|Overall Study||1
10062765|NCT02112045|11188312|FG001|NOT COMPLETED|Overall Study||0
10062766|NCT02112370|11188320|FG000|STARTED|Overall Study||74
10062767|NCT02112370|11188321|FG001|STARTED|Overall Study||74
10062768|NCT02112370|11188320|FG000|COMPLETED|Overall Study||74
10062769|NCT02112370|11188321|FG001|COMPLETED|Overall Study||74
10062770|NCT02112370|11188320|FG000|NOT COMPLETED|Overall Study||0
10062771|NCT02112370|11188321|FG001|NOT COMPLETED|Overall Study||0
10062772|NCT02112448|11188329|FG000|STARTED|Overall Study||38
10062773|NCT02112448|11188330|FG001|STARTED|Overall Study||40
10062774|NCT02112448|11188329|FG000|COMPLETED|Overall Study||30
10062775|NCT02112448|11188330|FG001|COMPLETED|Overall Study||30
10062776|NCT02112448|11188329|FG000|NOT COMPLETED|Overall Study||8
10062777|NCT02112448|11188330|FG001|NOT COMPLETED|Overall Study||10
10062778|NCT02112838|11188341|FG000|STARTED|Overall Study||25
10062779|NCT02112838|11188342|FG001|STARTED|Overall Study||26
10062780|NCT02112838|11188343|FG002|STARTED|Overall Study||25
10062781|NCT02112838|11188341|FG000|COMPLETED|Overall Study||20
10062782|NCT02112838|11188342|FG001|COMPLETED|Overall Study||24
10062783|NCT02112838|11188343|FG002|COMPLETED|Overall Study||24
10062784|NCT02112838|11188341|FG000|NOT COMPLETED|Overall Study||5
10062785|NCT02112838|11188342|FG001|NOT COMPLETED|Overall Study||2
10062786|NCT02112838|11188343|FG002|NOT COMPLETED|Overall Study||1
10062787|NCT02112877|11188353|FG000|STARTED|Overall Study||30
10062788|NCT02112877|11188354|FG001|STARTED|Overall Study||170
10062789|NCT02112877|11188353|FG000|COMPLETED|Overall Study||28
10062790|NCT02112877|11188354|FG001|COMPLETED|Overall Study||157
10062791|NCT02112877|11188353|FG000|NOT COMPLETED|Overall Study||2
10062792|NCT02112877|11188354|FG001|NOT COMPLETED|Overall Study||13
10062793|NCT02112994|11188362|FG000|STARTED|Overall Study||6
10062794|NCT02112994|11188363|FG001|STARTED|Overall Study||16
10062795|NCT02112994|11188364|FG002|STARTED|Overall Study||9
10062796|NCT02112994|11188362|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10062797|NCT02112994|11188363|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10062798|NCT02112994|11188364|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
10062799|NCT02112994|11188362|FG000|Received 0.35 mg/kg QOW|Overall Study||0
10062800|NCT02112994|11188363|FG001|Received 0.35 mg/kg QOW|Overall Study||0
10062801|NCT02112994|11188364|FG002|Received 0.35 mg/kg QOW|Overall Study||1
10062802|NCT02112994|11188362|FG000|Received 1 mg/kg QOW|Overall Study||6
10062803|NCT02112994|11188363|FG001|Received 1 mg/kg QOW|Overall Study||16
10062804|NCT02112994|11188364|FG002|Received 1 mg/kg QOW|Overall Study||9
10062805|NCT02112994|11188362|FG000|Received 1 mg/kg QW|Overall Study||1
10062806|NCT02112994|11188363|FG001|Received 1 mg/kg QW|Overall Study||1
10062807|NCT02112994|11188364|FG002|Received 1 mg/kg QW|Overall Study||0
10062808|NCT02112994|11188362|FG000|Received 3 mg/kg QOW|Overall Study||3
10062809|NCT02112994|11188363|FG001|Received 3 mg/kg QOW|Overall Study||5
10062810|NCT02112994|11188364|FG002|Received 3 mg/kg QOW|Overall Study||3
10062811|NCT02112994|11188362|FG000|Received 3 mg/kg QW|Overall Study||2
10062812|NCT02112994|11188363|FG001|Received 3 mg/kg QW|Overall Study||1
10062813|NCT02112994|11188364|FG002|Received 3 mg/kg QW|Overall Study||1
10062814|NCT02112994|11188362|FG000|Completed 96-week Treatment Period|Overall Study||6
10062815|NCT02112994|11188363|FG001|Completed 96-week Treatment Period|Overall Study||14
10062816|NCT02112994|11188364|FG002|Completed 96-week Treatment Period|Overall Study||8
10062817|NCT02112994|11188362|FG000|COMPLETED|Overall Study||6
10062818|NCT02112994|11188363|FG001|COMPLETED|Overall Study||14
10062819|NCT02112994|11188364|FG002|COMPLETED|Overall Study||6
10062820|NCT02112994|11188362|FG000|NOT COMPLETED|Overall Study||0
10062821|NCT02112994|11188363|FG001|NOT COMPLETED|Overall Study||2
10062822|NCT02112994|11188364|FG002|NOT COMPLETED|Overall Study||3
10062823|NCT02113007|11188376|FG000|STARTED|Overall Study||2
10062824|NCT02113007|11188376|FG000|COMPLETED|Overall Study||0
10062825|NCT02113007|11188376|FG000|NOT COMPLETED|Overall Study||2
10062826|NCT02113124|11188382|FG000|STARTED|Overall Study||18
10062827|NCT02113124|11188383|FG001|STARTED|Overall Study||25
10062828|NCT02113124|11188382|FG000|COMPLETED|Overall Study||17
10062829|NCT02113124|11188383|FG001|COMPLETED|Overall Study||24
10062830|NCT02113124|11188382|FG000|NOT COMPLETED|Overall Study||1
10062831|NCT02113124|11188383|FG001|NOT COMPLETED|Overall Study||1
10062832|NCT02113189|11188392|FG000|STARTED|Overall Study||4
10062833|NCT02113189|11188393|FG001|STARTED|Overall Study||4
10062834|NCT02113189|11188394|FG002|STARTED|Overall Study||5
10062835|NCT02113189|11188392|FG000|COMPLETED|Overall Study||2
10062836|NCT02113189|11188393|FG001|COMPLETED|Overall Study||3
10062837|NCT02113189|11188394|FG002|COMPLETED|Overall Study||2
10062838|NCT02113189|11188392|FG000|NOT COMPLETED|Overall Study||2
10062839|NCT02113189|11188393|FG001|NOT COMPLETED|Overall Study||1
10062840|NCT02113189|11188394|FG002|NOT COMPLETED|Overall Study||3
10062841|NCT02113241|11188407|FG000|STARTED|Overall Study||12
10062842|NCT02113241|11188408|FG001|STARTED|Overall Study||12
10062843|NCT02113241|11188407|FG000|COMPLETED|Overall Study||12
10062844|NCT02113241|11188408|FG001|COMPLETED|Overall Study||11
10062845|NCT02113241|11188407|FG000|NOT COMPLETED|Overall Study||0
10062846|NCT02113241|11188408|FG001|NOT COMPLETED|Overall Study||1
10062847|NCT02113410|11188416|FG000|STARTED|Overall Study||65
10062848|NCT02113410|11188417|FG001|STARTED|Overall Study||66
10062849|NCT02113410|11188416|FG000|COMPLETED|Overall Study||49
10062850|NCT02113410|11188417|FG001|COMPLETED|Overall Study||63
10062851|NCT02113410|11188416|FG000|NOT COMPLETED|Overall Study||16
10062852|NCT02113410|11188417|FG001|NOT COMPLETED|Overall Study||3
10062853|NCT02113436|11188427|FG000|STARTED|Period 1: 8 Weeks||150
10062854|NCT02113436|11188428|FG001|STARTED|Period 1: 8 Weeks||150
10062855|NCT02113436|11188429|FG002|STARTED|Period 1: 8 Weeks||0
10062856|NCT02113436|11188430|FG003|STARTED|Period 1: 8 Weeks||0
10062857|NCT02113436|11188427|FG000|COMPLETED|Period 1: 8 Weeks||142
10062858|NCT02113436|11188428|FG001|COMPLETED|Period 1: 8 Weeks||148
10062859|NCT02113436|11188429|FG002|COMPLETED|Period 1: 8 Weeks||0
10062860|NCT02113436|11188430|FG003|COMPLETED|Period 1: 8 Weeks||0
10062861|NCT02113436|11188427|FG000|NOT COMPLETED|Period 1: 8 Weeks||8
10062862|NCT02113436|11188428|FG001|NOT COMPLETED|Period 1: 8 Weeks||2
10062863|NCT02113436|11188429|FG002|NOT COMPLETED|Period 1: 8 Weeks||0
10062864|NCT02113436|11188430|FG003|NOT COMPLETED|Period 1: 8 Weeks||0
10062865|NCT02113436|11188427|FG000|STARTED|Period 2: 16 Weeks||0
10062866|NCT02113436|11188428|FG001|STARTED|Period 2: 16 Weeks||0
10062867|NCT02113436|11188429|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
10062868|NCT02113436|11188430|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
10062869|NCT02113436|11188427|FG000|COMPLETED|Period 2: 16 Weeks||0
10062870|NCT02113436|11188428|FG001|COMPLETED|Period 2: 16 Weeks||0
10062871|NCT02113436|11188429|FG002|COMPLETED|Period 2: 16 Weeks||132
10062872|NCT02113436|11188430|FG003|COMPLETED|Period 2: 16 Weeks||136
10062873|NCT02113436|11188427|FG000|NOT COMPLETED|Period 2: 16 Weeks||0
10062874|NCT02113436|11188428|FG001|NOT COMPLETED|Period 2: 16 Weeks||0
10062875|NCT02113436|11188429|FG002|NOT COMPLETED|Period 2: 16 Weeks||9
10062876|NCT02113436|11188430|FG003|NOT COMPLETED|Period 2: 16 Weeks||11
10062877|NCT02113449|11188439|FG000|STARTED|Overall Study||147
10062878|NCT02113449|11188439|FG000|COMPLETED|Overall Study||143
10062879|NCT02113449|11188439|FG000|NOT COMPLETED|Overall Study||4
10062880|NCT02113579|11188449|FG000|STARTED|Overall Study||186
10062881|NCT02113579|11188450|FG001|STARTED|Overall Study||189
10062882|NCT02113579|11188449|FG000|COMPLETED|Overall Study||176
10062883|NCT02113579|11188450|FG001|COMPLETED|Overall Study||185
10062884|NCT02113579|11188449|FG000|NOT COMPLETED|Overall Study||10
10062885|NCT02113579|11188450|FG001|NOT COMPLETED|Overall Study||4
10062886|NCT02113956|11188458|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150
10062887|NCT02113956|11188459|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152
10062888|NCT02113956|11188458|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
10062889|NCT02113956|11188459|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
10062890|NCT02113956|11188458|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
10062891|NCT02113956|11188459|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
10062892|NCT02113956|11188458|FG000|STARTED|3 Month Post-intervention||141
10062893|NCT02113956|11188459|FG001|STARTED|3 Month Post-intervention||148
10062894|NCT02113956|11188458|FG000|COMPLETED|3 Month Post-intervention||137
10062895|NCT02113956|11188459|FG001|COMPLETED|3 Month Post-intervention||146
10062896|NCT02113956|11188458|FG000|NOT COMPLETED|3 Month Post-intervention||4
10062897|NCT02113956|11188459|FG001|NOT COMPLETED|3 Month Post-intervention||2
10062898|NCT02114151|11188465|FG000|STARTED|Overall Study||103
10062899|NCT02114151|11188465|FG000|COMPLETED|Overall Study||96
10062900|NCT02114151|11188465|FG000|NOT COMPLETED|Overall Study||7
10062901|NCT02114164|11188471|FG000|STARTED|Overall Study||50
10062902|NCT02114164|11188472|FG001|STARTED|Overall Study||50
10062903|NCT02114164|11188471|FG000|COMPLETED|Overall Study||50
10062904|NCT02114164|11188472|FG001|COMPLETED|Overall Study||50
10062905|NCT02114164|11188471|FG000|NOT COMPLETED|Overall Study||0
10062906|NCT02114164|11188472|FG001|NOT COMPLETED|Overall Study||0
10062907|NCT02114177|11188480|FG000|STARTED|Overall Study||155
10062908|NCT02114177|11188481|FG001|STARTED|Overall Study||155
10062909|NCT02114177|11188480|FG000|COMPLETED|Overall Study||146
10062910|NCT02114177|11188481|FG001|COMPLETED|Overall Study||151
10062911|NCT02114177|11188480|FG000|NOT COMPLETED|Overall Study||9
10062912|NCT02114177|11188481|FG001|NOT COMPLETED|Overall Study||4
10062913|NCT02114203|11188490|FG000|STARTED|Overall Study||7
10062914|NCT02114203|11188491|FG001|STARTED|Overall Study||16
10062915|NCT02114203|11188492|FG002|STARTED|Overall Study||7
10062916|NCT02114203|11188490|FG000|COMPLETED|Overall Study||7
10062917|NCT02114203|11188491|FG001|COMPLETED|Overall Study||14
10062918|NCT02114203|11188492|FG002|COMPLETED|Overall Study||7
10062919|NCT02114203|11188490|FG000|NOT COMPLETED|Overall Study||0
10062920|NCT02114203|11188491|FG001|NOT COMPLETED|Overall Study||2
10062921|NCT02114203|11188492|FG002|NOT COMPLETED|Overall Study||0
10062922|NCT02114216|11188503|FG000|STARTED|Overall Study||16
10062923|NCT02114216|11188504|FG001|STARTED|Overall Study||45
10062924|NCT02114216|11188505|FG002|STARTED|Overall Study||14
10062925|NCT02114216|11188503|FG000|COMPLETED|Overall Study||16
10062926|NCT02114216|11188504|FG001|COMPLETED|Overall Study||45
10062927|NCT02114216|11188505|FG002|COMPLETED|Overall Study||14
10062928|NCT02114216|11188503|FG000|NOT COMPLETED|Overall Study||0
10062929|NCT02114216|11188504|FG001|NOT COMPLETED|Overall Study||0
10062930|NCT02114216|11188505|FG002|NOT COMPLETED|Overall Study||0
10062931|NCT02114268|11188522|FG000|STARTED|Overall Study||34
10062932|NCT02114268|11188523|FG001|STARTED|Overall Study||6
10062933|NCT02114268|11188524|FG002|STARTED|Overall Study||6
10062934|NCT02114268|11188525|FG003|STARTED|Overall Study||6
10062935|NCT02114268|11188526|FG004|STARTED|Overall Study||6
10062936|NCT02114268|11188527|FG005|STARTED|Overall Study||78
10062937|NCT02114268|11188522|FG000|COMPLETED|Overall Study||28
10062938|NCT02114268|11188523|FG001|COMPLETED|Overall Study||5
10062939|NCT02114268|11188524|FG002|COMPLETED|Overall Study||5
10062940|NCT02114268|11188525|FG003|COMPLETED|Overall Study||6
10062941|NCT02114268|11188526|FG004|COMPLETED|Overall Study||6
10062942|NCT02114268|11188527|FG005|COMPLETED|Overall Study||75
10062943|NCT02114268|11188522|FG000|NOT COMPLETED|Overall Study||6
10062944|NCT02114268|11188523|FG001|NOT COMPLETED|Overall Study||1
10062945|NCT02114268|11188524|FG002|NOT COMPLETED|Overall Study||1
10062946|NCT02114268|11188525|FG003|NOT COMPLETED|Overall Study||0
10062947|NCT02114268|11188526|FG004|NOT COMPLETED|Overall Study||0
10062948|NCT02114268|11188527|FG005|NOT COMPLETED|Overall Study||3
10062949|NCT02114307|11188548|FG000|STARTED|Overall Study||11
10062950|NCT02114307|11188549|FG001|STARTED|Overall Study||11
10062951|NCT02114307|11188548|FG000|COMPLETED|Overall Study||10
10062952|NCT02114307|11188549|FG001|COMPLETED|Overall Study||11
10062953|NCT02114307|11188548|FG000|NOT COMPLETED|Overall Study||1
10062954|NCT02114307|11188549|FG001|NOT COMPLETED|Overall Study||0
10062955|NCT02114385|11188559|FG000|STARTED|Overall Study||249
10062956|NCT02114385|11188560|FG001|STARTED|Overall Study||251
10062957|NCT02114385|11188559|FG000|Vaccinated|Overall Study||249
10062958|NCT02114385|11188560|FG001|Vaccinated|Overall Study||251
10062959|NCT02114385|11188559|FG000|COMPLETED|Overall Study||246
10062960|NCT02114385|11188560|FG001|COMPLETED|Overall Study||243
10062961|NCT02114385|11188559|FG000|NOT COMPLETED|Overall Study||3
10062962|NCT02114385|11188560|FG001|NOT COMPLETED|Overall Study||8
10062963|NCT02114515|11188568|FG000|STARTED|Overall Study||511
10062964|NCT02114515|11188569|FG001|STARTED|Overall Study||518
10062965|NCT02114515|11188568|FG000|COMPLETED|Overall Study||378
10062966|NCT02114515|11188569|FG001|COMPLETED|Overall Study||368
10062967|NCT02114515|11188568|FG000|NOT COMPLETED|Overall Study||133
10062968|NCT02114515|11188569|FG001|NOT COMPLETED|Overall Study||150
10062969|NCT02114606|11188575|FG000|STARTED|Overall Study||86
10062970|NCT02114606|11188575|FG000|COMPLETED|Overall Study||80
10062971|NCT02114606|11188575|FG000|NOT COMPLETED|Overall Study||6
10062972|NCT02114684|11188581|FG000|STARTED|Overall Study||98
10062973|NCT02114684|11188582|FG001|STARTED|Overall Study||98
10062974|NCT02114684|11188581|FG000|COMPLETED|Overall Study||86
10062975|NCT02114684|11188582|FG001|COMPLETED|Overall Study||88
10062976|NCT02114684|11188581|FG000|NOT COMPLETED|Overall Study||12
10062977|NCT02114684|11188582|FG001|NOT COMPLETED|Overall Study||10
10062978|NCT02114879|11188594|FG000|STARTED|Overall Study||115
10062979|NCT02114879|11188595|FG001|STARTED|Overall Study||114
10062980|NCT02114879|11188594|FG000|COMPLETED|Overall Study||96
10062981|NCT02114879|11188595|FG001|COMPLETED|Overall Study||90
10062982|NCT02114879|11188594|FG000|NOT COMPLETED|Overall Study||19
10062983|NCT02114879|11188595|FG001|NOT COMPLETED|Overall Study||24
10062984|NCT02114892|11188603|FG000|STARTED|Overall Study||12
10062985|NCT02114892|11188604|FG001|STARTED|Overall Study||12
10062986|NCT02114892|11188603|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
10062987|NCT02114892|11188604|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
10062988|NCT02114892|11188603|FG000|NOT COMPLETED|Overall Study||1
10062989|NCT02114892|11188604|FG001|NOT COMPLETED|Overall Study||2
10188318|NCT03266172|11317909|FG000|COMPLETED|Part C Period 4(2 Days)||0
10188319|NCT03266172|11317910|FG001|COMPLETED|Part C Period 4(2 Days)||0
10188320|NCT03266172|11317911|FG002|COMPLETED|Part C Period 4(2 Days)||16
10188321|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0
10188322|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0
10188323|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0
10188324|NCT03266172|11317909|FG000|STARTED|Part C Washout Period (7 Days)||0
10188325|NCT03266172|11317910|FG001|STARTED|Part C Washout Period (7 Days)||0
10188326|NCT03266172|11317911|FG002|STARTED|Part C Washout Period (7 Days)||16
10188327|NCT03266172|11317909|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10188328|NCT03266172|11317910|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10188329|NCT03266172|11317911|FG002|COMPLETED|Part C Washout Period (7 Days)||15
10188330|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188331|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10062990|NCT02114931|11188612|FG000|STARTED|Overall Study||230
10062991|NCT02114931|11188613|FG001|STARTED|Overall Study||237
10062992|NCT02114931|11188612|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
10062993|NCT02114931|11188613|FG001|Received Treatment|Overall Study||237
10062994|NCT02114931|11188612|FG000|COMPLETED|Overall Study||205
10062995|NCT02114931|11188613|FG001|COMPLETED|Overall Study||207
10062996|NCT02114931|11188612|FG000|NOT COMPLETED|Overall Study||25
10062997|NCT02114931|11188613|FG001|NOT COMPLETED|Overall Study||30
10062998|NCT02115048|11188621|FG000|STARTED|Overall Study||23
10062999|NCT02115048|11188622|FG001|STARTED|Overall Study||21
10063000|NCT02115048|11188621|FG000|COMPLETED|Overall Study||23
10063001|NCT02115048|11188622|FG001|COMPLETED|Overall Study||21
10063002|NCT02115048|11188621|FG000|NOT COMPLETED|Overall Study||0
10063003|NCT02115048|11188622|FG001|NOT COMPLETED|Overall Study||0
10063004|NCT02115113|11188628|FG000|STARTED|Participants in Run-in Period||0
10063005|NCT02115113|11188629|FG001|STARTED|Participants in Run-in Period||0
10063006|NCT02115113|11188630|FG002|STARTED|Participants in Run-in Period||78
10063007|NCT02115113|11188628|FG000|COMPLETED|Participants in Run-in Period||0
10063008|NCT02115113|11188629|FG001|COMPLETED|Participants in Run-in Period||0
10063009|NCT02115113|11188630|FG002|COMPLETED|Participants in Run-in Period||68
10063010|NCT02115113|11188628|FG000|NOT COMPLETED|Participants in Run-in Period||0
10063011|NCT02115113|11188629|FG001|NOT COMPLETED|Participants in Run-in Period||0
10063012|NCT02115113|11188630|FG002|NOT COMPLETED|Participants in Run-in Period||10
10063013|NCT02115113|11188628|FG000|STARTED|Participants Randomized||24
10063014|NCT02115113|11188629|FG001|STARTED|Participants Randomized||26
10063015|NCT02115113|11188630|FG002|STARTED|Participants Randomized||0
10063016|NCT02115113|11188628|FG000|COMPLETED|Participants Randomized||22
10063017|NCT02115113|11188629|FG001|COMPLETED|Participants Randomized||26
10063018|NCT02115113|11188630|FG002|COMPLETED|Participants Randomized||0
10063019|NCT02115113|11188628|FG000|NOT COMPLETED|Participants Randomized||2
10063020|NCT02115113|11188629|FG001|NOT COMPLETED|Participants Randomized||0
10063021|NCT02115113|11188630|FG002|NOT COMPLETED|Participants Randomized||0
10063022|NCT02115139|11188639|FG000|STARTED|Overall Study||58
10063023|NCT02115139|11188639|FG000|COMPLETED|Overall Study||51
10063024|NCT02115139|11188639|FG000|NOT COMPLETED|Overall Study||7
10063025|NCT02115256|11188645|FG000|STARTED|Overall Study||3
10063026|NCT02115256|11188646|FG001|STARTED|Overall Study||3
10063027|NCT02115256|11188645|FG000|COMPLETED|Overall Study||3
10063028|NCT02115256|11188646|FG001|COMPLETED|Overall Study||2
10063029|NCT02115256|11188645|FG000|NOT COMPLETED|Overall Study||0
10063030|NCT02115256|11188646|FG001|NOT COMPLETED|Overall Study||1
10063031|NCT02115269|11188652|FG000|STARTED|Overall Study||759
10063032|NCT02115269|11188652|FG000|COMPLETED|Overall Study||702
10063033|NCT02115269|11188652|FG000|NOT COMPLETED|Overall Study||57
10063034|NCT02115282|11188669|FG000|STARTED|Overall Study||305
10063035|NCT02115282|11188670|FG001|STARTED|Overall Study||303
10063036|NCT02115282|11188669|FG000|Eligible|Overall Study||265
10063037|NCT02115282|11188670|FG001|Eligible|Overall Study||257
10063038|NCT02115282|11188669|FG000|Treated|Overall Study||296
10063039|NCT02115282|11188670|FG001|Treated|Overall Study||293
10063040|NCT02115282|11188669|FG000|COMPLETED|Overall Study||0
10063041|NCT02115282|11188670|FG001|COMPLETED|Overall Study||0
10063042|NCT02115282|11188669|FG000|NOT COMPLETED|Overall Study||305
10063043|NCT02115282|11188670|FG001|NOT COMPLETED|Overall Study||303
10063044|NCT02115308|11188680|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
10063045|NCT02115308|11188681|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
10063046|NCT02115308|11188680|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
10063047|NCT02115308|11188681|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
10063048|NCT02115308|11188680|FG000|NOT COMPLETED|Overall Study||2
10063049|NCT02115308|11188681|FG001|NOT COMPLETED|Overall Study||2
10063050|NCT02115321|11188693|FG000|STARTED|Overall Study||30
10063051|NCT02115321|11188694|FG001|STARTED|Overall Study||10
10063052|NCT02115321|11188693|FG000|COMPLETED|Overall Study||29
10063053|NCT02115321|11188694|FG001|COMPLETED|Overall Study||10
10063054|NCT02115321|11188693|FG000|NOT COMPLETED|Overall Study||1
10063055|NCT02115321|11188694|FG001|NOT COMPLETED|Overall Study||0
10063056|NCT02115347|11188702|FG000|STARTED|Overall Study||8
10063057|NCT02115347|11188703|FG001|STARTED|Overall Study||8
10063058|NCT02115347|11188704|FG002|STARTED|Overall Study||0
10063059|NCT02115347|11188702|FG000|COMPLETED|Overall Study||8
10063060|NCT02115347|11188703|FG001|COMPLETED|Overall Study||8
10063061|NCT02115347|11188704|FG002|COMPLETED|Overall Study||0
10063062|NCT02115347|11188702|FG000|NOT COMPLETED|Overall Study||0
10063063|NCT02115347|11188703|FG001|NOT COMPLETED|Overall Study||0
10063064|NCT02115347|11188704|FG002|NOT COMPLETED|Overall Study||0
10063065|NCT02115373|11188713|FG000|STARTED|Overall Study||4
10063066|NCT02115373|11188714|FG001|STARTED|Overall Study||13
10063067|NCT02115373|11188715|FG002|STARTED|Overall Study||49
10063068|NCT02115373|11188713|FG000|COMPLETED|Overall Study||4
10063069|NCT02115373|11188714|FG001|COMPLETED|Overall Study||13
10063070|NCT02115373|11188715|FG002|COMPLETED|Overall Study||49
10063071|NCT02115373|11188713|FG000|NOT COMPLETED|Overall Study||0
10063072|NCT02115373|11188714|FG001|NOT COMPLETED|Overall Study||0
10063073|NCT02115373|11188715|FG002|NOT COMPLETED|Overall Study||0
10063074|NCT02115386|11188730|FG000|STARTED|Overall Study||7
10063075|NCT02115386|11188730|FG000|COMPLETED|Overall Study||0
10063076|NCT02115386|11188730|FG000|NOT COMPLETED|Overall Study||7
10063077|NCT02115542|11188734|FG000|STARTED|Overall Study||39
10063078|NCT02115542|11188734|FG000|COMPLETED|Overall Study||39
10063079|NCT02115542|11188734|FG000|NOT COMPLETED|Overall Study||0
10063080|NCT02115581|11188740|FG000|STARTED|Overall Study||17
10063081|NCT02115581|11188741|FG001|STARTED|Overall Study||21
10063082|NCT02115581|11188740|FG000|COMPLETED|Overall Study||17
10063083|NCT02115581|11188741|FG001|COMPLETED|Overall Study||21
10063084|NCT02115581|11188740|FG000|NOT COMPLETED|Overall Study||0
10063085|NCT02115581|11188741|FG001|NOT COMPLETED|Overall Study||0
10063086|NCT02115607|11188747|FG000|STARTED|Overall Study||17
10063087|NCT02115607|11188747|FG000|COMPLETED|Overall Study||16
10063088|NCT02115607|11188747|FG000|NOT COMPLETED|Overall Study||1
10063089|NCT02115633|11188753|FG000|STARTED|Overall Study||15
10063090|NCT02115633|11188754|FG001|STARTED|Overall Study||16
10063091|NCT02115633|11188753|FG000|COMPLETED|Overall Study||15
10063092|NCT02115633|11188754|FG001|COMPLETED|Overall Study||16
10063093|NCT02115633|11188753|FG000|NOT COMPLETED|Overall Study||0
10063094|NCT02115633|11188754|FG001|NOT COMPLETED|Overall Study||0
10063095|NCT02115646|11188763|FG000|STARTED|Overall Study||29
10063096|NCT02115646|11188763|FG000|COMPLETED|Overall Study||22
10063097|NCT02115646|11188763|FG000|NOT COMPLETED|Overall Study||7
10063098|NCT02115750|11188774|FG000|STARTED|Part 1||323
10063099|NCT02115750|11188775|FG001|STARTED|Part 1||324
10063100|NCT02115750|11188774|FG000|COMPLETED|Part 1||301
10063101|NCT02115750|11188775|FG001|COMPLETED|Part 1||312
10063102|NCT02115750|11188774|FG000|NOT COMPLETED|Part 1||22
10063103|NCT02115750|11188775|FG001|NOT COMPLETED|Part 1||12
10063104|NCT02115750|11188774|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280
10063105|NCT02115750|11188775|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284
10063106|NCT02115750|11188774|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
10063107|NCT02115750|11188775|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
10063108|NCT02115750|11188774|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
10063109|NCT02115750|11188775|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
10063110|NCT02115815|11188790|FG000|STARTED|Overall Study||24
10063111|NCT02115815|11188791|FG001|STARTED|Overall Study||20
10063112|NCT02115815|11188792|FG002|STARTED|Overall Study||20
10063113|NCT02115815|11188793|FG003|STARTED|Overall Study||20
10063114|NCT02115815|11188794|FG004|STARTED|Overall Study||20
10063115|NCT02115815|11188795|FG005|STARTED|Overall Study||22
10063116|NCT02115815|11188796|FG006|STARTED|Overall Study||20
10063117|NCT02115815|11188790|FG000|COMPLETED|Overall Study||22
10063118|NCT02115815|11188791|FG001|COMPLETED|Overall Study||20
10063119|NCT02115815|11188792|FG002|COMPLETED|Overall Study||20
10063120|NCT02115815|11188793|FG003|COMPLETED|Overall Study||20
10063121|NCT02115815|11188794|FG004|COMPLETED|Overall Study||20
10063122|NCT02115815|11188795|FG005|COMPLETED|Overall Study||20
10063123|NCT02115815|11188796|FG006|COMPLETED|Overall Study||20
10063124|NCT02115815|11188790|FG000|NOT COMPLETED|Overall Study||2
10063125|NCT02115815|11188791|FG001|NOT COMPLETED|Overall Study||0
10063126|NCT02115815|11188792|FG002|NOT COMPLETED|Overall Study||0
10063127|NCT02115815|11188793|FG003|NOT COMPLETED|Overall Study||0
10063128|NCT02115815|11188794|FG004|NOT COMPLETED|Overall Study||0
10063129|NCT02115815|11188795|FG005|NOT COMPLETED|Overall Study||2
10063130|NCT02115815|11188796|FG006|NOT COMPLETED|Overall Study||0
10063131|NCT02115828|11188812|FG000|STARTED|Overall Study||9
10063132|NCT02115828|11188812|FG000|COMPLETED|Overall Study||9
10063133|NCT02115828|11188812|FG000|NOT COMPLETED|Overall Study||0
10063134|NCT02115984|11188818|FG000|STARTED|Overall Study||57
10063135|NCT02115984|11188819|FG001|STARTED|Overall Study||23
10063136|NCT02115984|11188818|FG000|COMPLETED|Overall Study||51
10063137|NCT02115984|11188819|FG001|COMPLETED|Overall Study||16
10063138|NCT02115984|11188818|FG000|NOT COMPLETED|Overall Study||6
10063139|NCT02115984|11188819|FG001|NOT COMPLETED|Overall Study||7
10063140|NCT02116205|11188829|FG000|STARTED|Overall Study||31
10063141|NCT02116205|11188830|FG001|STARTED|Overall Study||33
10063142|NCT02116205|11188831|FG002|STARTED|Overall Study||33
10063143|NCT02116205|11188832|FG003|STARTED|Overall Study||33
10063144|NCT02116205|11188829|FG000|COMPLETED|Overall Study||29
10063145|NCT02116205|11188830|FG001|COMPLETED|Overall Study||26
10063146|NCT02116205|11188831|FG002|COMPLETED|Overall Study||29
10063147|NCT02116205|11188832|FG003|COMPLETED|Overall Study||27
10063148|NCT02116205|11188829|FG000|NOT COMPLETED|Overall Study||2
10063149|NCT02116205|11188830|FG001|NOT COMPLETED|Overall Study||7
10063150|NCT02116205|11188831|FG002|NOT COMPLETED|Overall Study||4
10063151|NCT02116205|11188832|FG003|NOT COMPLETED|Overall Study||6
10063152|NCT02116309|11188844|FG000|STARTED|Overall Study||482
10063153|NCT02116309|11188845|FG001|STARTED|Overall Study||478
10063154|NCT02116309|11188844|FG000|COMPLETED|Overall Study||482
10063155|NCT02116309|11188845|FG001|COMPLETED|Overall Study||477
10063156|NCT02116309|11188844|FG000|NOT COMPLETED|Overall Study||0
10063157|NCT02116309|11188845|FG001|NOT COMPLETED|Overall Study||1
10063158|NCT02116322|11188851|FG000|STARTED|Overall Study||1
10063159|NCT02116322|11188851|FG000|COMPLETED|Overall Study||1
10063160|NCT02116322|11188851|FG000|NOT COMPLETED|Overall Study||0
10063161|NCT02116361|11188859|FG000|STARTED|Overall Study||69
10063162|NCT02116361|11188860|FG001|STARTED|Overall Study||65
10063163|NCT02116361|11188861|FG002|STARTED|Overall Study||59
10063164|NCT02116361|11188862|FG003|STARTED|Overall Study||65
10063165|NCT02116361|11188859|FG000|COMPLETED|Overall Study||38
10063166|NCT02116361|11188860|FG001|COMPLETED|Overall Study||34
10063167|NCT02116361|11188861|FG002|COMPLETED|Overall Study||33
10063168|NCT02116361|11188862|FG003|COMPLETED|Overall Study||34
10063169|NCT02116361|11188859|FG000|NOT COMPLETED|Overall Study||31
10063170|NCT02116361|11188860|FG001|NOT COMPLETED|Overall Study||31
10063171|NCT02116361|11188861|FG002|NOT COMPLETED|Overall Study||26
10063172|NCT02116361|11188862|FG003|NOT COMPLETED|Overall Study||31
10063173|NCT02116530|11188874|FG000|STARTED|Overall Study||192
10063174|NCT02116530|11188875|FG001|STARTED|Overall Study||188
10063175|NCT02116530|11188874|FG000|COMPLETED|Overall Study||183
10063176|NCT02116530|11188875|FG001|COMPLETED|Overall Study||184
10063177|NCT02116530|11188874|FG000|NOT COMPLETED|Overall Study||9
10063178|NCT02116530|11188875|FG001|NOT COMPLETED|Overall Study||4
10063179|NCT02116582|11188881|FG000|STARTED|Overall Study||215
10063180|NCT02116582|11188881|FG000|Treated|Overall Study||214
10063181|NCT02116582|11188881|FG000|COMPLETED|Overall Study||0
10063182|NCT02116582|11188881|FG000|NOT COMPLETED|Overall Study||215
10063183|NCT02116608|11188888|FG000|STARTED|Overall Study||9
10063184|NCT02116608|11188889|FG001|STARTED|Overall Study||9
10063185|NCT02116608|11188890|FG002|STARTED|Overall Study||8
10063186|NCT02116608|11188888|FG000|COMPLETED|Overall Study||9
10063187|NCT02116608|11188889|FG001|COMPLETED|Overall Study||7
10063188|NCT02116608|11188890|FG002|COMPLETED|Overall Study||7
10063189|NCT02116608|11188888|FG000|NOT COMPLETED|Overall Study||0
10063190|NCT02116608|11188889|FG001|NOT COMPLETED|Overall Study||2
10063191|NCT02116608|11188890|FG002|NOT COMPLETED|Overall Study||1
10063192|NCT02116621|11188900|FG000|STARTED|Baseline||108
10063193|NCT02116621|11188901|FG001|STARTED|Baseline||107
10063194|NCT02116621|11188900|FG000|Completed Baseline Visit|Baseline||108
10063195|NCT02116621|11188901|FG001|Completed Baseline Visit|Baseline||103
10063196|NCT02116621|11188900|FG000|Completed Intervention Period|Baseline||95
10063197|NCT02116621|11188901|FG001|Completed Intervention Period|Baseline||103
10063198|NCT02116621|11188900|FG000|COMPLETED|Baseline||108
10063199|NCT02116621|11188901|FG001|COMPLETED|Baseline||103
10063200|NCT02116621|11188900|FG000|NOT COMPLETED|Baseline||0
10063201|NCT02116621|11188901|FG001|NOT COMPLETED|Baseline||4
10063202|NCT02116621|11188900|FG000|STARTED|Three Month Follow-up||108
10063203|NCT02116621|11188901|FG001|STARTED|Three Month Follow-up||103
10063204|NCT02116621|11188900|FG000|COMPLETED|Three Month Follow-up||89
10063205|NCT02116621|11188901|FG001|COMPLETED|Three Month Follow-up||96
10063206|NCT02116621|11188900|FG000|NOT COMPLETED|Three Month Follow-up||19
10063207|NCT02116621|11188901|FG001|NOT COMPLETED|Three Month Follow-up||7
10063208|NCT02116621|11188900|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
10063209|NCT02116621|11188901|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
10063210|NCT02116621|11188900|FG000|COMPLETED|Six Month Follow-up||99
10063211|NCT02116621|11188901|FG001|COMPLETED|Six Month Follow-up||97
10063212|NCT02116621|11188900|FG000|NOT COMPLETED|Six Month Follow-up||4
10063213|NCT02116621|11188901|FG001|NOT COMPLETED|Six Month Follow-up||3
10063214|NCT02116621|11188900|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
10063215|NCT02116621|11188901|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
10063216|NCT02116621|11188900|FG000|COMPLETED|Twelve Month Follow-up||84
10063217|NCT02116621|11188901|FG001|COMPLETED|Twelve Month Follow-up||86
10063218|NCT02116621|11188900|FG000|NOT COMPLETED|Twelve Month Follow-up||16
10063219|NCT02116621|11188901|FG001|NOT COMPLETED|Twelve Month Follow-up||12
10063220|NCT02116660|11188909|FG000|STARTED|Overall Study||6
10063221|NCT02116660|11188910|FG001|STARTED|Overall Study||5
10063222|NCT02116660|11188909|FG000|COMPLETED|Overall Study||4
10063223|NCT02116660|11188910|FG001|COMPLETED|Overall Study||1
10063224|NCT02116660|11188909|FG000|NOT COMPLETED|Overall Study||2
10063225|NCT02116660|11188910|FG001|NOT COMPLETED|Overall Study||4
10063226|NCT02116777|11188925|FG000|STARTED|Overall Study||3
10063227|NCT02116777|11188926|FG001|STARTED|Overall Study||3
10063228|NCT02116777|11188927|FG002|STARTED|Overall Study||3
10063229|NCT02116777|11188928|FG003|STARTED|Overall Study||13
10063230|NCT02116777|11188929|FG004|STARTED|Overall Study||6
10063231|NCT02116777|11188930|FG005|STARTED|Overall Study||3
10063232|NCT02116777|11188931|FG006|STARTED|Overall Study||9
10063233|NCT02116777|11188925|FG000|COMPLETED|Overall Study||0
10063234|NCT02116777|11188926|FG001|COMPLETED|Overall Study||0
10063235|NCT02116777|11188927|FG002|COMPLETED|Overall Study||0
10063236|NCT02116777|11188928|FG003|COMPLETED|Overall Study||0
10063237|NCT02116777|11188929|FG004|COMPLETED|Overall Study||0
10063238|NCT02116777|11188930|FG005|COMPLETED|Overall Study||0
10063239|NCT02116777|11188931|FG006|COMPLETED|Overall Study||0
10063240|NCT02116777|11188925|FG000|NOT COMPLETED|Overall Study||3
10063241|NCT02116777|11188926|FG001|NOT COMPLETED|Overall Study||3
10063242|NCT02116777|11188927|FG002|NOT COMPLETED|Overall Study||3
10063243|NCT02116777|11188928|FG003|NOT COMPLETED|Overall Study||13
10063244|NCT02116777|11188929|FG004|NOT COMPLETED|Overall Study||6
10063245|NCT02116777|11188930|FG005|NOT COMPLETED|Overall Study||3
10063246|NCT02116777|11188931|FG006|NOT COMPLETED|Overall Study||9
10063247|NCT02116803|11188952|FG000|STARTED|Overall Study||10
10063248|NCT02116803|11188953|FG001|STARTED|Overall Study||2
10063249|NCT02116803|11188952|FG000|COMPLETED|Overall Study||0
10063250|NCT02116803|11188953|FG001|COMPLETED|Overall Study||0
10063251|NCT02116803|11188952|FG000|NOT COMPLETED|Overall Study||10
10063252|NCT02116803|11188953|FG001|NOT COMPLETED|Overall Study||2
10063253|NCT02116972|11188962|FG000|STARTED|Overall Study||102
10063254|NCT02116972|11188963|FG001|STARTED|Overall Study||104
10063255|NCT02116972|11188964|FG002|STARTED|Overall Study||104
10063256|NCT02116972|11188962|FG000|COMPLETED|Overall Study||83
10063257|NCT02116972|11188963|FG001|COMPLETED|Overall Study||87
10063258|NCT02116972|11188964|FG002|COMPLETED|Overall Study||85
10063259|NCT02116972|11188962|FG000|NOT COMPLETED|Overall Study||19
10063260|NCT02116972|11188963|FG001|NOT COMPLETED|Overall Study||17
10063261|NCT02116972|11188964|FG002|NOT COMPLETED|Overall Study||19
10063262|NCT02117024|11188976|FG000|STARTED|Overall Study||45
10063263|NCT02117024|11188977|FG001|STARTED|Overall Study||21
10063264|NCT02117024|11188976|FG000|COMPLETED|Overall Study||1
10063265|NCT02117024|11188977|FG001|COMPLETED|Overall Study||1
10063266|NCT02117024|11188976|FG000|NOT COMPLETED|Overall Study||44
10063267|NCT02117024|11188977|FG001|NOT COMPLETED|Overall Study||20
10063268|NCT02117193|11188983|FG000|STARTED|Overall Study||10
10063269|NCT02117193|11188983|FG000|Alcohol Intake + Normal Sleep|Overall Study||10
10063270|NCT02117193|11188983|FG000|Placebo Intake + Normal Sleep|Overall Study||10
10063271|NCT02117193|11188983|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10
10063272|NCT02117193|11188983|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10
10063273|NCT02117193|11188983|FG000|COMPLETED|Overall Study||10
10063274|NCT02117193|11188983|FG000|NOT COMPLETED|Overall Study||0
10063275|NCT02117310|11189002|FG000|STARTED|Overall Study||5
10063276|NCT02117310|11189002|FG000|COMPLETED|Overall Study||5
10063277|NCT02117310|11189002|FG000|NOT COMPLETED|Overall Study||0
10063278|NCT02117349|11189008|FG000|STARTED|Overall Study||37
10063279|NCT02117349|11189009|FG001|STARTED|Overall Study||18
10063280|NCT02117349|11189008|FG000|Intent-to-treat Population|Overall Study||37
10063281|NCT02117349|11189009|FG001|Intent-to-treat Population|Overall Study||18
10063282|NCT02117349|11189008|FG000|Safety Population|Overall Study||36
10063283|NCT02117349|11189009|FG001|Safety Population|Overall Study||18
10063284|NCT02117349|11189008|FG000|Modified Intent-to-treat (mITT)|Overall Study||36
10063285|NCT02117349|11189009|FG001|Modified Intent-to-treat (mITT)|Overall Study||18
10063286|NCT02117349|11189008|FG000|COMPLETED|Overall Study||34
10063287|NCT02117349|11189009|FG001|COMPLETED|Overall Study||17
10063288|NCT02117349|11189008|FG000|NOT COMPLETED|Overall Study||3
10063289|NCT02117349|11189009|FG001|NOT COMPLETED|Overall Study||1
10063290|NCT02117414|11189017|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175
10063291|NCT02117414|11189018|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88
10063292|NCT02117414|11189017|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
10063293|NCT02117414|11189018|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
10063294|NCT02117414|11189017|FG000|NOT COMPLETED|Overall Study||15
10063295|NCT02117414|11189018|FG001|NOT COMPLETED|Overall Study||6
10063296|NCT02117427|11189029|FG000|STARTED|Overall Study||6
10063297|NCT02117427|11189030|FG001|STARTED|Overall Study||5
10063298|NCT02117427|11189031|FG002|STARTED|Overall Study||0
10063299|NCT02117427|11189029|FG000|Run in Phase & Harvest|Overall Study||6
10063300|NCT02117427|11189030|FG001|Run in Phase & Harvest|Overall Study||4
10063301|NCT02117427|11189031|FG002|Run in Phase & Harvest|Overall Study||0
10063302|NCT02117427|11189029|FG000|Implantation & Efficacy|Overall Study||6
10063303|NCT02117427|11189030|FG001|Implantation & Efficacy|Overall Study||4
10063304|NCT02117427|11189031|FG002|Implantation & Efficacy|Overall Study||0
10063305|NCT02117427|11189029|FG000|Safety Follow-up|Overall Study||1
10063306|NCT02117427|11189030|FG001|Safety Follow-up|Overall Study||0
10063307|NCT02117427|11189031|FG002|Safety Follow-up|Overall Study||0
10063308|NCT02117427|11189029|FG000|Long Term Safety Follow-up|Overall Study||1
10063309|NCT02117427|11189030|FG001|Long Term Safety Follow-up|Overall Study||0
10063310|NCT02117427|11189031|FG002|Long Term Safety Follow-up|Overall Study||0
10063311|NCT02117427|11189029|FG000|COMPLETED|Overall Study||1
10063312|NCT02117427|11189030|FG001|COMPLETED|Overall Study||0
10063313|NCT02117427|11189031|FG002|COMPLETED|Overall Study||0
10063314|NCT02117427|11189029|FG000|NOT COMPLETED|Overall Study||5
10063315|NCT02117427|11189030|FG001|NOT COMPLETED|Overall Study||5
10063316|NCT02117427|11189031|FG002|NOT COMPLETED|Overall Study||0
10063317|NCT02117479|11189039|FG000|STARTED|Overall Study||161
10063318|NCT02117479|11189040|FG001|STARTED|Overall Study||160
10063319|NCT02117479|11189039|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
10063320|NCT02117479|11189040|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
10063321|NCT02117479|11189039|FG000|NOT COMPLETED|Overall Study||156
10063322|NCT02117479|11189040|FG001|NOT COMPLETED|Overall Study||156
10063323|NCT02117544|11189046|FG000|STARTED|Period 1||54
10063324|NCT02117544|11189047|FG001|STARTED|Period 1||55
10063325|NCT02117544|11189046|FG000|Treated|Period 1||52
10063326|NCT02117544|11189047|FG001|Treated|Period 1||55
10063327|NCT02117544|11189046|FG000|COMPLETED|Period 1||52
10063328|NCT02117544|11189047|FG001|COMPLETED|Period 1||55
10063329|NCT02117544|11189046|FG000|NOT COMPLETED|Period 1||2
10063330|NCT02117544|11189047|FG001|NOT COMPLETED|Period 1||0
10063331|NCT02117544|11189046|FG000|STARTED|Period 2||52
10063332|NCT02117544|11189047|FG001|STARTED|Period 2||55
10063333|NCT02117544|11189046|FG000|COMPLETED|Period 2||52
10063334|NCT02117544|11189047|FG001|COMPLETED|Period 2||55
10063335|NCT02117544|11189046|FG000|NOT COMPLETED|Period 2||0
10063336|NCT02117544|11189047|FG001|NOT COMPLETED|Period 2||0
10063337|NCT02117570|11189057|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
10063338|NCT02117570|11189058|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
10063339|NCT02117570|11189059|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
10063340|NCT02117570|11189057|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
10063341|NCT02117570|11189058|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
10063342|NCT02117570|11189059|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
10063343|NCT02117570|11189057|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
10063344|NCT02117570|11189058|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
10063345|NCT02117570|11189059|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
10063346|NCT02117570|11189057|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
10063347|NCT02117570|11189058|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
10063348|NCT02117570|11189059|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
10063349|NCT02117570|11189057|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
10063350|NCT02117570|11189058|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
10063351|NCT02117570|11189059|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
10063352|NCT02117570|11189057|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
10063353|NCT02117570|11189058|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
10063354|NCT02117570|11189059|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
10063355|NCT02117570|11189057|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
10063356|NCT02117570|11189058|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
10063357|NCT02117570|11189059|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
10063358|NCT02117570|11189057|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
10063359|NCT02117570|11189058|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
10063360|NCT02117570|11189059|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
10063361|NCT02117570|11189057|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
10063362|NCT02117570|11189058|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
10063363|NCT02117570|11189059|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
10063364|NCT02117570|11189057|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
10063365|NCT02117570|11189058|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
10063366|NCT02117570|11189059|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
10063367|NCT02117570|11189057|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
10063368|NCT02117570|11189058|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
10063369|NCT02117570|11189059|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
10063370|NCT02117570|11189057|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
10063371|NCT02117570|11189058|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
10063372|NCT02117570|11189059|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
10063373|NCT02117648|11189070|FG000|STARTED|Abemaciclib Alone Period 1||26
10063374|NCT02117648|11189070|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
10063375|NCT02117648|11189070|FG000|COMPLETED|Abemaciclib Alone Period 1||24
10063376|NCT02117648|11189070|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2
10063377|NCT02117648|11189070|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24
10063378|NCT02117648|11189070|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
10063379|NCT02117648|11189070|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
10063380|NCT02117648|11189070|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
10063381|NCT02117648|11189070|FG000|STARTED|Abemaciclib Safety-Extension Phase||20
10063382|NCT02117648|11189070|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0
10063383|NCT02117648|11189070|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
10063384|NCT02117687|11189080|FG000|STARTED|Overall Study||40
10063385|NCT02117687|11189081|FG001|STARTED|Overall Study||40
10063386|NCT02117687|11189080|FG000|COMPLETED|Overall Study||39
10063387|NCT02117687|11189081|FG001|COMPLETED|Overall Study||36
10063388|NCT02117687|11189080|FG000|NOT COMPLETED|Overall Study||1
10063389|NCT02117687|11189081|FG001|NOT COMPLETED|Overall Study||4
10063390|NCT02117713|11189087|FG000|STARTED|Week 48||34
10063391|NCT02117713|11189087|FG000|COMPLETED|Week 48||26
10063392|NCT02117713|11189087|FG000|NOT COMPLETED|Week 48||8
10063393|NCT02117713|11189087|FG000|STARTED|Long Term Follow-up Treatment||26
10063394|NCT02117713|11189087|FG000|COMPLETED|Long Term Follow-up Treatment||20
10063395|NCT02117713|11189087|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6
10063396|NCT02117934|11189101|FG000|STARTED|Overall Study||5592
10063397|NCT02117934|11189102|FG001|STARTED|Overall Study||2782
10063398|NCT02117934|11189101|FG000|COMPLETED|Overall Study||5092
10063399|NCT02117934|11189102|FG001|COMPLETED|Overall Study||2567
10063400|NCT02117934|11189101|FG000|NOT COMPLETED|Overall Study||500
10063401|NCT02117934|11189102|FG001|NOT COMPLETED|Overall Study||215
10063402|NCT02117999|11189110|FG000|STARTED|Overall Study||20
10063403|NCT02117999|11189111|FG001|STARTED|Overall Study||10
10063404|NCT02117999|11189110|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20
10063405|NCT02117999|11189111|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10
10063406|NCT02117999|11189110|FG000|COMPLETED|Overall Study||20
10063407|NCT02117999|11189111|FG001|COMPLETED|Overall Study||10
10063408|NCT02117999|11189110|FG000|NOT COMPLETED|Overall Study||0
10063409|NCT02117999|11189111|FG001|NOT COMPLETED|Overall Study||0
10063410|NCT02118012|11189121|FG000|STARTED|Overall Study||12
10063411|NCT02118012|11189122|FG001|STARTED|Overall Study||12
10063412|NCT02118012|11189121|FG000|Day 5|Overall Study||12
10063413|NCT02118012|11189122|FG001|Day 5|Overall Study||11
10063414|NCT02118012|11189121|FG000|Day 14|Overall Study||12
10063415|NCT02118012|11189122|FG001|Day 14|Overall Study||10
10063416|NCT02118012|11189121|FG000|COMPLETED|Overall Study||12
10063417|NCT02118012|11189122|FG001|COMPLETED|Overall Study||10
10063418|NCT02118012|11189121|FG000|NOT COMPLETED|Overall Study||0
10063419|NCT02118012|11189122|FG001|NOT COMPLETED|Overall Study||2
10063420|NCT02118337|11189137|FG000|STARTED|Overall Study||4
10063421|NCT02118337|11189138|FG001|STARTED|Overall Study||5
10063422|NCT02118337|11189139|FG002|STARTED|Overall Study||3
10063423|NCT02118337|11189140|FG003|STARTED|Overall Study||3
10063424|NCT02118337|11189141|FG004|STARTED|Overall Study||9
10063425|NCT02118337|11189142|FG005|STARTED|Overall Study||6
10063426|NCT02118337|11189143|FG006|STARTED|Overall Study||4
10063427|NCT02118337|11189144|FG007|STARTED|Overall Study||42
10063428|NCT02118337|11189145|FG008|STARTED|Overall Study||21
10063429|NCT02118337|11189137|FG000|COMPLETED|Overall Study||0
10063430|NCT02118337|11189138|FG001|COMPLETED|Overall Study||0
10063431|NCT02118337|11189139|FG002|COMPLETED|Overall Study||0
10063432|NCT02118337|11189140|FG003|COMPLETED|Overall Study||0
10063433|NCT02118337|11189141|FG004|COMPLETED|Overall Study||0
10063434|NCT02118337|11189142|FG005|COMPLETED|Overall Study||0
10063435|NCT02118337|11189143|FG006|COMPLETED|Overall Study||0
10063436|NCT02118337|11189144|FG007|COMPLETED|Overall Study||0
10063437|NCT02118337|11189145|FG008|COMPLETED|Overall Study||0
10063438|NCT02118337|11189137|FG000|NOT COMPLETED|Overall Study||4
10063439|NCT02118337|11189138|FG001|NOT COMPLETED|Overall Study||5
10063440|NCT02118337|11189139|FG002|NOT COMPLETED|Overall Study||3
10063441|NCT02118337|11189140|FG003|NOT COMPLETED|Overall Study||3
10063442|NCT02118337|11189141|FG004|NOT COMPLETED|Overall Study||9
10063443|NCT02118337|11189142|FG005|NOT COMPLETED|Overall Study||6
10063444|NCT02118337|11189143|FG006|NOT COMPLETED|Overall Study||4
10063445|NCT02118337|11189144|FG007|NOT COMPLETED|Overall Study||42
10063446|NCT02118337|11189145|FG008|NOT COMPLETED|Overall Study||21
10063447|NCT02118428|11189171|FG000|STARTED|Overall Study||113
10063448|NCT02118428|11189172|FG001|STARTED|Overall Study||113
10063449|NCT02118428|11189173|FG002|STARTED|Overall Study||1
10063450|NCT02118428|11189171|FG000|Received Study Transfusion|Overall Study||111
10063451|NCT02118428|11189172|FG001|Received Study Transfusion|Overall Study||112
10063452|NCT02118428|11189173|FG002|Received Study Transfusion|Overall Study||0
10063453|NCT02118428|11189171|FG000|COMPLETED|Overall Study||100
10063454|NCT02118428|11189172|FG001|COMPLETED|Overall Study||104
10063455|NCT02118428|11189173|FG002|COMPLETED|Overall Study||0
10063456|NCT02118428|11189171|FG000|NOT COMPLETED|Overall Study||13
10063457|NCT02118428|11189172|FG001|NOT COMPLETED|Overall Study||9
10063458|NCT02118428|11189173|FG002|NOT COMPLETED|Overall Study||1
10063459|NCT02118441|11189181|FG000|STARTED|Overall Study||65
10063460|NCT02118441|11189182|FG001|STARTED|Overall Study||64
10063461|NCT02118441|11189181|FG000|COMPLETED|Overall Study||62
10063462|NCT02118441|11189182|FG001|COMPLETED|Overall Study||63
10063463|NCT02118441|11189181|FG000|NOT COMPLETED|Overall Study||3
10063464|NCT02118441|11189182|FG001|NOT COMPLETED|Overall Study||1
10063465|NCT02118597|11189189|FG000|STARTED|Overall Study||19
10063466|NCT02118597|11189189|FG000|COMPLETED|Overall Study||3
10063467|NCT02118597|11189189|FG000|NOT COMPLETED|Overall Study||16
10063468|NCT02118714|11189193|FG000|STARTED|Overall Study||20
10063469|NCT02118714|11189193|FG000|COMPLETED|Overall Study||17
10063470|NCT02118714|11189193|FG000|NOT COMPLETED|Overall Study||3
10063471|NCT02118766|11189199|FG000|STARTED|Overall Study||507
10063472|NCT02118766|11189200|FG001|STARTED|Overall Study||256
10063473|NCT02118766|11189199|FG000|Treated|Overall Study||503
10063474|NCT02118766|11189200|FG001|Treated|Overall Study||256
10063475|NCT02118766|11189199|FG000|COMPLETED|Overall Study||477
10063476|NCT02118766|11189200|FG001|COMPLETED|Overall Study||225
10063477|NCT02118766|11189199|FG000|NOT COMPLETED|Overall Study||30
10063478|NCT02118766|11189200|FG001|NOT COMPLETED|Overall Study||31
10063479|NCT02118792|11189208|FG000|STARTED|Overall Study||514
10063480|NCT02118792|11189209|FG001|STARTED|Overall Study||250
10063481|NCT02118792|11189208|FG000|Treated|Overall Study||513
10063482|NCT02118792|11189209|FG001|Treated|Overall Study||250
10188332|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
10188333|NCT03266172|11317909|FG000|STARTED|Part C Period 5(2 Days)||0
10188334|NCT03266172|11317910|FG001|STARTED|Part C Period 5(2 Days)||0
10188335|NCT03266172|11317911|FG002|STARTED|Part C Period 5(2 Days)||15
10188336|NCT03266172|11317909|FG000|COMPLETED|Part C Period 5(2 Days)||0
10188337|NCT03266172|11317910|FG001|COMPLETED|Part C Period 5(2 Days)||0
10188338|NCT03266172|11317911|FG002|COMPLETED|Part C Period 5(2 Days)||15
10188339|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0
10188340|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0
10188341|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0
10188342|NCT03266172|11317909|FG000|STARTED|Part C Washout Period (7 Days)||0
10188343|NCT03266172|11317910|FG001|STARTED|Part C Washout Period (7 Days)||0
10188344|NCT03266172|11317911|FG002|STARTED|Part C Washout Period (7 Days)||15
10188345|NCT03266172|11317909|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10188346|NCT03266172|11317910|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10188347|NCT03266172|11317911|FG002|COMPLETED|Part C Washout Period (7 Days)||14
10188348|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188349|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10188350|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
10188351|NCT03266172|11317909|FG000|STARTED|Part C Period 6(2 Days)||0
10188352|NCT03266172|11317910|FG001|STARTED|Part C Period 6(2 Days)||0
10188353|NCT03266172|11317911|FG002|STARTED|Part C Period 6(2 Days)||14
10188354|NCT03266172|11317909|FG000|COMPLETED|Part C Period 6(2 Days)||0
10063483|NCT02118792|11189208|FG000|COMPLETED|Overall Study||483
10063484|NCT02118792|11189209|FG001|COMPLETED|Overall Study||213
10063485|NCT02118792|11189208|FG000|NOT COMPLETED|Overall Study||31
10063486|NCT02118792|11189209|FG001|NOT COMPLETED|Overall Study||37
10063487|NCT02118831|11189220|FG000|STARTED|Overall Study||21
10063488|NCT02118831|11189221|FG001|STARTED|Overall Study||15
10063489|NCT02118831|11189222|FG002|STARTED|Overall Study||20
10063490|NCT02118831|11189220|FG000|COMPLETED|Overall Study||21
10063491|NCT02118831|11189221|FG001|COMPLETED|Overall Study||15
10063492|NCT02118831|11189222|FG002|COMPLETED|Overall Study||20
10063493|NCT02118831|11189220|FG000|NOT COMPLETED|Overall Study||0
10063494|NCT02118831|11189221|FG001|NOT COMPLETED|Overall Study||0
10063495|NCT02118831|11189222|FG002|NOT COMPLETED|Overall Study||0
10063496|NCT02118896|11189240|FG000|STARTED|Overall Study||47
10063497|NCT02118896|11189241|FG001|STARTED|Overall Study||47
10063498|NCT02118896|11189242|FG002|STARTED|Overall Study||67
10063499|NCT02118896|11189243|FG003|STARTED|Overall Study||79
10063500|NCT02118896|11189244|FG004|STARTED|Overall Study||130
10063501|NCT02118896|11189245|FG005|STARTED|Overall Study||191
10063502|NCT02118896|11189246|FG006|STARTED|Overall Study||85
10063503|NCT02118896|11189247|FG007|STARTED|Overall Study||107
10063504|NCT02118896|11189248|FG008|STARTED|Overall Study||88
10063505|NCT02118896|11189249|FG009|STARTED|Overall Study||9
10063506|NCT02118896|11189240|FG000|COMPLETED|Overall Study||30
10063507|NCT02118896|11189241|FG001|COMPLETED|Overall Study||32
10063508|NCT02118896|11189242|FG002|COMPLETED|Overall Study||53
10063509|NCT02118896|11189243|FG003|COMPLETED|Overall Study||55
10063510|NCT02118896|11189244|FG004|COMPLETED|Overall Study||113
10063511|NCT02118896|11189245|FG005|COMPLETED|Overall Study||163
10063512|NCT02118896|11189246|FG006|COMPLETED|Overall Study||83
10063513|NCT02118896|11189247|FG007|COMPLETED|Overall Study||105
10063514|NCT02118896|11189248|FG008|COMPLETED|Overall Study||84
10063515|NCT02118896|11189249|FG009|COMPLETED|Overall Study||7
10063516|NCT02118896|11189240|FG000|NOT COMPLETED|Overall Study||17
10063517|NCT02118896|11189241|FG001|NOT COMPLETED|Overall Study||15
10063518|NCT02118896|11189242|FG002|NOT COMPLETED|Overall Study||14
10063519|NCT02118896|11189243|FG003|NOT COMPLETED|Overall Study||24
10063520|NCT02118896|11189244|FG004|NOT COMPLETED|Overall Study||17
10063521|NCT02118896|11189245|FG005|NOT COMPLETED|Overall Study||28
10063522|NCT02118896|11189246|FG006|NOT COMPLETED|Overall Study||2
10063523|NCT02118896|11189247|FG007|NOT COMPLETED|Overall Study||2
10063524|NCT02118896|11189248|FG008|NOT COMPLETED|Overall Study||4
10063525|NCT02118896|11189249|FG009|NOT COMPLETED|Overall Study||2
10063526|NCT02118961|11189274|FG000|STARTED|Overall Study||224
10063527|NCT02118961|11189275|FG001|STARTED|Overall Study||222
10063528|NCT02118961|11189274|FG000|COMPLETED|Overall Study||223
10063529|NCT02118961|11189275|FG001|COMPLETED|Overall Study||222
10063530|NCT02118961|11189274|FG000|NOT COMPLETED|Overall Study||1
10063531|NCT02118961|11189275|FG001|NOT COMPLETED|Overall Study||0
10063532|NCT02119026|11189283|FG000|STARTED|1st-line Treatment||58
10063533|NCT02119026|11189284|FG001|STARTED|1st-line Treatment||62
10063534|NCT02119026|11189283|FG000|COMPLETED|1st-line Treatment||32
10063535|NCT02119026|11189284|FG001|COMPLETED|1st-line Treatment||24
10063536|NCT02119026|11189283|FG000|NOT COMPLETED|1st-line Treatment||26
10063537|NCT02119026|11189284|FG001|NOT COMPLETED|1st-line Treatment||38
10063538|NCT02119026|11189283|FG000|STARTED|2nd-line Treatment||32
10063539|NCT02119026|11189284|FG001|STARTED|2nd-line Treatment||24
10063540|NCT02119026|11189283|FG000|COMPLETED|2nd-line Treatment||23
10063541|NCT02119026|11189284|FG001|COMPLETED|2nd-line Treatment||22
10063542|NCT02119026|11189283|FG000|NOT COMPLETED|2nd-line Treatment||9
10063543|NCT02119026|11189284|FG001|NOT COMPLETED|2nd-line Treatment||2
10063544|NCT02119104|11189290|FG000|STARTED|Overall Study||1087
10063545|NCT02119104|11189290|FG000|COMPLETED|Overall Study||1071
10063546|NCT02119104|11189290|FG000|NOT COMPLETED|Overall Study||16
10063547|NCT02119156|11189297|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39
10063548|NCT02119156|11189298|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29
10063549|NCT02119156|11189299|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12
10063550|NCT02119156|11189297|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
10063551|NCT02119156|11189298|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
10063552|NCT02119156|11189299|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
10063553|NCT02119156|11189297|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
10063554|NCT02119156|11189298|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
10063555|NCT02119156|11189299|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
10063556|NCT02119156|11189297|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
10063557|NCT02119156|11189298|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
10063558|NCT02119156|11189299|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
10063559|NCT02119156|11189297|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
10063560|NCT02119156|11189298|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
10063561|NCT02119156|11189299|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
10063562|NCT02119156|11189297|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
10063563|NCT02119156|11189298|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
10063564|NCT02119156|11189299|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
10063565|NCT02119260|11189321|FG000|STARTED|Overall Study||9
10063566|NCT02119260|11189322|FG001|STARTED|Overall Study||12
10063567|NCT02119260|11189323|FG002|STARTED|Overall Study||8
10063568|NCT02119260|11189324|FG003|STARTED|Overall Study||10
10063569|NCT02119260|11189325|FG004|STARTED|Overall Study||13
10063570|NCT02119260|11189326|FG005|STARTED|Overall Study||6
10063571|NCT02119260|11189327|FG006|STARTED|Overall Study||2
10063572|NCT02119260|11189321|FG000|COMPLETED|Overall Study||8
10063573|NCT02119260|11189322|FG001|COMPLETED|Overall Study||11
10063574|NCT02119260|11189323|FG002|COMPLETED|Overall Study||7
10063575|NCT02119260|11189324|FG003|COMPLETED|Overall Study||10
10063576|NCT02119260|11189325|FG004|COMPLETED|Overall Study||13
10063577|NCT02119260|11189326|FG005|COMPLETED|Overall Study||6
10063578|NCT02119260|11189327|FG006|COMPLETED|Overall Study||2
10063579|NCT02119260|11189321|FG000|NOT COMPLETED|Overall Study||1
10063580|NCT02119260|11189322|FG001|NOT COMPLETED|Overall Study||1
10063581|NCT02119260|11189323|FG002|NOT COMPLETED|Overall Study||1
10063582|NCT02119260|11189324|FG003|NOT COMPLETED|Overall Study||0
10063583|NCT02119260|11189325|FG004|NOT COMPLETED|Overall Study||0
10063584|NCT02119260|11189326|FG005|NOT COMPLETED|Overall Study||0
10063585|NCT02119260|11189327|FG006|NOT COMPLETED|Overall Study||0
10063586|NCT02119286|11189355|FG000|STARTED|Overall Study||206
10063587|NCT02119286|11189356|FG001|STARTED|Overall Study||206
10063588|NCT02119286|11189357|FG002|STARTED|Overall Study||207
10063589|NCT02119286|11189355|FG000|COMPLETED|Overall Study||180
10063590|NCT02119286|11189356|FG001|COMPLETED|Overall Study||195
10063591|NCT02119286|11189357|FG002|COMPLETED|Overall Study||200
10063592|NCT02119286|11189355|FG000|NOT COMPLETED|Overall Study||26
10063593|NCT02119286|11189356|FG001|NOT COMPLETED|Overall Study||11
10063594|NCT02119286|11189357|FG002|NOT COMPLETED|Overall Study||7
10063595|NCT02119299|11189365|FG000|STARTED|Overall Study||76
10063596|NCT02119299|11189365|FG000|COMPLETED|Overall Study||67
10063597|NCT02119299|11189365|FG000|NOT COMPLETED|Overall Study||9
10063598|NCT02119325|11189369|FG000|STARTED|Period 1||48
10063599|NCT02119325|11189370|FG001|STARTED|Period 1||48
10063600|NCT02119325|11189369|FG000|COMPLETED|Period 1||48
10063601|NCT02119325|11189370|FG001|COMPLETED|Period 1||48
10063602|NCT02119325|11189369|FG000|NOT COMPLETED|Period 1||0
10063603|NCT02119325|11189370|FG001|NOT COMPLETED|Period 1||0
10063604|NCT02119325|11189369|FG000|STARTED|Washout Period 1||48
10063605|NCT02119325|11189370|FG001|STARTED|Washout Period 1||48
10063606|NCT02119325|11189369|FG000|COMPLETED|Washout Period 1||48
10063607|NCT02119325|11189370|FG001|COMPLETED|Washout Period 1||47
10063608|NCT02119325|11189369|FG000|NOT COMPLETED|Washout Period 1||0
10063609|NCT02119325|11189370|FG001|NOT COMPLETED|Washout Period 1||1
10063610|NCT02119325|11189369|FG000|STARTED|Period 2||48
10063611|NCT02119325|11189370|FG001|STARTED|Period 2||47
10063612|NCT02119325|11189369|FG000|COMPLETED|Period 2||48
10063613|NCT02119325|11189370|FG001|COMPLETED|Period 2||47
10063614|NCT02119325|11189369|FG000|NOT COMPLETED|Period 2||0
10063615|NCT02119325|11189370|FG001|NOT COMPLETED|Period 2||0
10063616|NCT02119442|11189378|FG000|STARTED|Overall Study||90
10063617|NCT02119442|11189378|FG000|COMPLETED|Overall Study||90
10063618|NCT02119442|11189378|FG000|NOT COMPLETED|Overall Study||0
10063619|NCT02119455|11189384|FG000|STARTED|Overall Study||20
10063620|NCT02119455|11189385|FG001|STARTED|Overall Study||20
10063621|NCT02119455|11189384|FG000|COMPLETED|Overall Study||20
10063622|NCT02119455|11189385|FG001|COMPLETED|Overall Study||17
10063623|NCT02119455|11189384|FG000|NOT COMPLETED|Overall Study||0
10063624|NCT02119455|11189385|FG001|NOT COMPLETED|Overall Study||3
10063625|NCT02119650|11189393|FG000|STARTED|Overall Study||39
10063626|NCT02119650|11189394|FG001|STARTED|Overall Study||37
10063627|NCT02119650|11189393|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
10063628|NCT02119650|11189394|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
10063629|NCT02119650|11189393|FG000|NOT COMPLETED|Overall Study||25
10063630|NCT02119650|11189394|FG001|NOT COMPLETED|Overall Study||26
10063631|NCT02119663|11189402|FG000|STARTED|Overall Study||43
10063632|NCT02119663|11189403|FG001|STARTED|Overall Study||43
10063633|NCT02119663|11189402|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
10063634|NCT02119663|11189403|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
10063635|NCT02119663|11189402|FG000|NOT COMPLETED|Overall Study||40
10063636|NCT02119663|11189403|FG001|NOT COMPLETED|Overall Study||41
10063637|NCT02119676|11189413|FG000|STARTED|Overall Study||87
10063638|NCT02119676|11189414|FG001|STARTED|Overall Study||88
10063639|NCT02119676|11189415|FG002|STARTED|Overall Study||110
10063640|NCT02119676|11189416|FG003|STARTED|Overall Study||111
10063641|NCT02119676|11189413|FG000|Treated Patients|Overall Study||85
10063642|NCT02119676|11189414|FG001|Treated Patients|Overall Study||86
10063643|NCT02119676|11189415|FG002|Treated Patients|Overall Study||106
10063644|NCT02119676|11189416|FG003|Treated Patients|Overall Study||106
10063645|NCT02119676|11189413|FG000|COMPLETED|Overall Study||4
10063646|NCT02119676|11189414|FG001|COMPLETED|Overall Study||2
10063647|NCT02119676|11189415|FG002|COMPLETED|Overall Study||13
10063648|NCT02119676|11189416|FG003|COMPLETED|Overall Study||10
10063649|NCT02119676|11189413|FG000|NOT COMPLETED|Overall Study||83
10063650|NCT02119676|11189414|FG001|NOT COMPLETED|Overall Study||86
10063651|NCT02119676|11189415|FG002|NOT COMPLETED|Overall Study||97
10063652|NCT02119676|11189416|FG003|NOT COMPLETED|Overall Study||101
10063653|NCT02119819|11189432|FG000|STARTED|Overall Study||66
10063654|NCT02119819|11189433|FG001|STARTED|Overall Study||71
10063655|NCT02119819|11189434|FG002|STARTED|Overall Study||73
10063656|NCT02119819|11189435|FG003|STARTED|Overall Study||70
10063657|NCT02119819|11189436|FG004|STARTED|Overall Study||69
10063658|NCT02119819|11189437|FG005|STARTED|Overall Study||71
10063659|NCT02119819|11189432|FG000|COMPLETED|Overall Study||57
10063660|NCT02119819|11189433|FG001|COMPLETED|Overall Study||66
10063661|NCT02119819|11189434|FG002|COMPLETED|Overall Study||69
10063662|NCT02119819|11189435|FG003|COMPLETED|Overall Study||63
10063663|NCT02119819|11189436|FG004|COMPLETED|Overall Study||62
10063664|NCT02119819|11189437|FG005|COMPLETED|Overall Study||56
10063665|NCT02119819|11189432|FG000|NOT COMPLETED|Overall Study||9
10063666|NCT02119819|11189433|FG001|NOT COMPLETED|Overall Study||5
10063667|NCT02119819|11189434|FG002|NOT COMPLETED|Overall Study||4
10063668|NCT02119819|11189435|FG003|NOT COMPLETED|Overall Study||7
10063669|NCT02119819|11189436|FG004|NOT COMPLETED|Overall Study||7
10063670|NCT02119819|11189437|FG005|NOT COMPLETED|Overall Study||15
10063671|NCT02119871|11189453|FG000|STARTED|Overall Study||10
10063672|NCT02119871|11189454|FG001|STARTED|Overall Study||10
10063673|NCT02119871|11189453|FG000|COMPLETED|Overall Study||10
10063674|NCT02119871|11189454|FG001|COMPLETED|Overall Study||10
10063675|NCT02119871|11189453|FG000|NOT COMPLETED|Overall Study||0
10063676|NCT02119871|11189454|FG001|NOT COMPLETED|Overall Study||0
10063677|NCT02119936|11189460|FG000|STARTED|Overall Study||10
10063678|NCT02119936|11189460|FG000|COMPLETED|Overall Study||0
10063679|NCT02119936|11189460|FG000|NOT COMPLETED|Overall Study||10
10063680|NCT02120001|11189466|FG000|STARTED|Overall Study||17
10063681|NCT02120001|11189467|FG001|STARTED|Overall Study||19
10063682|NCT02120001|11189466|FG000|COMPLETED|Overall Study||17
10063683|NCT02120001|11189467|FG001|COMPLETED|Overall Study||19
10063684|NCT02120001|11189466|FG000|NOT COMPLETED|Overall Study||0
10063685|NCT02120001|11189467|FG001|NOT COMPLETED|Overall Study||0
10063686|NCT02120027|11189475|FG000|STARTED|Overall Study||277
10063687|NCT02120027|11189476|FG001|STARTED|Overall Study||279
10063688|NCT02120027|11189475|FG000|COMPLETED|Overall Study||161
10063689|NCT02120027|11189476|FG001|COMPLETED|Overall Study||160
10063690|NCT02120027|11189475|FG000|NOT COMPLETED|Overall Study||116
10063691|NCT02120027|11189476|FG001|NOT COMPLETED|Overall Study||119
10063692|NCT02120157|11189482|FG000|STARTED|Overall Study||32
10063693|NCT02120157|11189482|FG000|Completed 180 Days|Overall Study||30
10063694|NCT02120157|11189482|FG000|COMPLETED|Overall Study||24
10063695|NCT02120157|11189482|FG000|NOT COMPLETED|Overall Study||8
10063696|NCT02120261|11189490|FG000|STARTED|Overall Study||23
10063697|NCT02120261|11189491|FG001|STARTED|Overall Study||25
10063698|NCT02120261|11189490|FG000|COMPLETED|Overall Study||23
10063699|NCT02120261|11189491|FG001|COMPLETED|Overall Study||25
10063700|NCT02120261|11189490|FG000|NOT COMPLETED|Overall Study||0
10063701|NCT02120261|11189491|FG001|NOT COMPLETED|Overall Study||0
10063702|NCT02120287|11189497|FG000|STARTED|Overall Study||16
10063703|NCT02120287|11189497|FG000|COMPLETED|Overall Study||16
10063704|NCT02120287|11189497|FG000|NOT COMPLETED|Overall Study||0
10063705|NCT02120300|11189505|FG000|STARTED|Overall Study||101
10063706|NCT02120300|11189506|FG001|STARTED|Overall Study||5
10063707|NCT02120300|11189507|FG002|STARTED|Overall Study||10
10063708|NCT02120300|11189508|FG003|STARTED|Overall Study||6
10063709|NCT02120300|11189505|FG000|COMPLETED|Overall Study||98
10063710|NCT02120300|11189506|FG001|COMPLETED|Overall Study||5
10063711|NCT02120300|11189507|FG002|COMPLETED|Overall Study||10
10063712|NCT02120300|11189508|FG003|COMPLETED|Overall Study||5
10063713|NCT02120300|11189505|FG000|NOT COMPLETED|Overall Study||3
10063714|NCT02120300|11189506|FG001|NOT COMPLETED|Overall Study||0
10063715|NCT02120300|11189507|FG002|NOT COMPLETED|Overall Study||0
10063716|NCT02120300|11189508|FG003|NOT COMPLETED|Overall Study||1
10063717|NCT02120417|11189522|FG000|STARTED|Overall Study||76
10063718|NCT02120417|11189523|FG001|STARTED|Overall Study||73
10063719|NCT02120417|11189522|FG000|COMPLETED|Overall Study||16
10063720|NCT02120417|11189523|FG001|COMPLETED|Overall Study||5
10063721|NCT02120417|11189522|FG000|NOT COMPLETED|Overall Study||60
10063722|NCT02120417|11189523|FG001|NOT COMPLETED|Overall Study||68
10063723|NCT02120443|11189529|FG000|STARTED|Overall Study||43
10063724|NCT02120443|11189529|FG000|COMPLETED|Overall Study||43
10063725|NCT02120443|11189529|FG000|NOT COMPLETED|Overall Study||0
10063726|NCT02120456|11189542|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10063727|NCT02120456|11189543|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10063728|NCT02120456|11189544|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10063729|NCT02120456|11189545|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10063730|NCT02120456|11189546|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10063731|NCT02120456|11189547|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9
10063732|NCT02120456|11189548|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10063733|NCT02120456|11189549|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10063734|NCT02120456|11189550|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10063735|NCT02120456|11189542|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10063736|NCT02120456|11189543|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10063737|NCT02120456|11189544|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10063738|NCT02120456|11189545|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10063739|NCT02120456|11189546|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10063740|NCT02120456|11189547|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
10063741|NCT02120456|11189548|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063742|NCT02120456|11189549|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063743|NCT02120456|11189550|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063744|NCT02120456|11189542|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063745|NCT02120456|11189543|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063746|NCT02120456|11189544|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063747|NCT02120456|11189545|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063748|NCT02120456|11189546|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063749|NCT02120456|11189547|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063750|NCT02120456|11189548|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063751|NCT02120456|11189549|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063752|NCT02120456|11189550|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10063753|NCT02120456|11189542|FG000|STARTED|Part 2 Double-blind Phase||0
10063754|NCT02120456|11189543|FG001|STARTED|Part 2 Double-blind Phase||0
10063755|NCT02120456|11189544|FG002|STARTED|Part 2 Double-blind Phase||0
10063756|NCT02120456|11189545|FG003|STARTED|Part 2 Double-blind Phase||0
10063757|NCT02120456|11189546|FG004|STARTED|Part 2 Double-blind Phase||0
10063758|NCT02120456|11189547|FG005|STARTED|Part 2 Double-blind Phase||0
10063759|NCT02120456|11189548|FG006|STARTED|Part 2 Double-blind Phase||32
10063760|NCT02120456|11189549|FG007|STARTED|Part 2 Double-blind Phase||60
10063761|NCT02120456|11189550|FG008|STARTED|Part 2 Double-blind Phase||63
10063762|NCT02120456|11189542|FG000|COMPLETED|Part 2 Double-blind Phase||0
10063763|NCT02120456|11189543|FG001|COMPLETED|Part 2 Double-blind Phase||0
10063764|NCT02120456|11189544|FG002|COMPLETED|Part 2 Double-blind Phase||0
10063765|NCT02120456|11189545|FG003|COMPLETED|Part 2 Double-blind Phase||0
10063766|NCT02120456|11189546|FG004|COMPLETED|Part 2 Double-blind Phase||0
10063767|NCT02120456|11189547|FG005|COMPLETED|Part 2 Double-blind Phase||0
10063768|NCT02120456|11189548|FG006|COMPLETED|Part 2 Double-blind Phase||30
10063769|NCT02120456|11189549|FG007|COMPLETED|Part 2 Double-blind Phase||60
10063770|NCT02120456|11189550|FG008|COMPLETED|Part 2 Double-blind Phase||62
10063771|NCT02120456|11189542|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
10063772|NCT02120456|11189543|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
10063773|NCT02120456|11189544|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
10063774|NCT02120456|11189545|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
10063775|NCT02120456|11189546|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
10063776|NCT02120456|11189547|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
10063777|NCT02120456|11189548|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2
10063778|NCT02120456|11189549|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
10063779|NCT02120456|11189550|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1
10063780|NCT02120625|11189570|FG000|STARTED|Overall Study||8
10063781|NCT02120625|11189570|FG000|COMPLETED|Overall Study||6
10063782|NCT02120625|11189570|FG000|NOT COMPLETED|Overall Study||2
10063783|NCT02120664|11189579|FG000|STARTED|Overall Study||10
10063784|NCT02120664|11189580|FG001|STARTED|Overall Study||4
10063785|NCT02120664|11189581|FG002|STARTED|Overall Study||7
10063786|NCT02120664|11189582|FG003|STARTED|Overall Study||4
10063787|NCT02120664|11189583|FG004|STARTED|Overall Study||10
10063788|NCT02120664|11189579|FG000|COMPLETED|Overall Study||10
10063789|NCT02120664|11189580|FG001|COMPLETED|Overall Study||4
10063790|NCT02120664|11189581|FG002|COMPLETED|Overall Study||7
10063791|NCT02120664|11189582|FG003|COMPLETED|Overall Study||3
10063792|NCT02120664|11189583|FG004|COMPLETED|Overall Study||10
10063793|NCT02120664|11189579|FG000|NOT COMPLETED|Overall Study||0
10063794|NCT02120664|11189580|FG001|NOT COMPLETED|Overall Study||0
10063795|NCT02120664|11189581|FG002|NOT COMPLETED|Overall Study||0
10063796|NCT02120664|11189582|FG003|NOT COMPLETED|Overall Study||1
10063797|NCT02120664|11189583|FG004|NOT COMPLETED|Overall Study||0
10063798|NCT02120716|11189598|FG000|STARTED|Overall Study||31
10063799|NCT02120716|11189599|FG001|STARTED|Overall Study||19
10063800|NCT02120716|11189598|FG000|COMPLETED|Overall Study||30
10063801|NCT02120716|11189599|FG001|COMPLETED|Overall Study||19
10063802|NCT02120716|11189598|FG000|NOT COMPLETED|Overall Study||1
10063803|NCT02120716|11189599|FG001|NOT COMPLETED|Overall Study||0
10063804|NCT02120781|11189607|FG000|STARTED|Overall Study||15
10063805|NCT02120781|11189608|FG001|STARTED|Overall Study||6
10063806|NCT02120781|11189607|FG000|COMPLETED|Overall Study||11
10063807|NCT02120781|11189608|FG001|COMPLETED|Overall Study||5
10063808|NCT02120781|11189607|FG000|NOT COMPLETED|Overall Study||4
10063809|NCT02120781|11189608|FG001|NOT COMPLETED|Overall Study||1
10063810|NCT02120794|11189614|FG000|STARTED|Overall Study||194
10063811|NCT02120794|11189614|FG000|COMPLETED|Overall Study||136
10063812|NCT02120794|11189614|FG000|NOT COMPLETED|Overall Study||58
10063813|NCT02120833|11189620|FG000|STARTED|Overall Study||39
10063814|NCT02120833|11189621|FG001|STARTED|Overall Study||12
10063815|NCT02120833|11189620|FG000|COMPLETED|Overall Study||35
10063816|NCT02120833|11189621|FG001|COMPLETED|Overall Study||11
10063817|NCT02120833|11189620|FG000|NOT COMPLETED|Overall Study||4
10063818|NCT02120833|11189621|FG001|NOT COMPLETED|Overall Study||1
10063819|NCT02120898|11189630|FG000|STARTED|Overall Study||187
10063820|NCT02120898|11189631|FG001|STARTED|Overall Study||187
10063821|NCT02120898|11189632|FG002|STARTED|Overall Study||93
10063822|NCT02120898|11189630|FG000|Safety Population|Overall Study||187
10063823|NCT02120898|11189631|FG001|Safety Population|Overall Study||187
10063824|NCT02120898|11189632|FG002|Safety Population|Overall Study||93
10063825|NCT02120898|11189630|FG000|Intent-to-Treat (ITT) Population|Overall Study||183
10063826|NCT02120898|11189631|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
10063827|NCT02120898|11189632|FG002|Intent-to-Treat (ITT) Population|Overall Study||93
10063828|NCT02120898|11189630|FG000|COMPLETED|Overall Study||178
10063829|NCT02120898|11189631|FG001|COMPLETED|Overall Study||181
10063830|NCT02120898|11189632|FG002|COMPLETED|Overall Study||89
10063831|NCT02120898|11189630|FG000|NOT COMPLETED|Overall Study||9
10063832|NCT02120898|11189631|FG001|NOT COMPLETED|Overall Study||6
10063833|NCT02120898|11189632|FG002|NOT COMPLETED|Overall Study||4
10063834|NCT02120924|11189643|FG000|STARTED|Overall Study||404
10063835|NCT02120924|11189644|FG001|STARTED|Overall Study||403
10063836|NCT02120924|11189645|FG002|STARTED|Overall Study||202
10063837|NCT02120924|11189643|FG000|COMPLETED|Overall Study||362
10063838|NCT02120924|11189644|FG001|COMPLETED|Overall Study||357
10063839|NCT02120924|11189645|FG002|COMPLETED|Overall Study||173
10063840|NCT02120924|11189643|FG000|NOT COMPLETED|Overall Study||42
10063841|NCT02120924|11189644|FG001|NOT COMPLETED|Overall Study||46
10063842|NCT02120924|11189645|FG002|NOT COMPLETED|Overall Study||29
10063843|NCT02120950|11189656|FG000|STARTED|Overall Study||157
10063844|NCT02120950|11189657|FG001|STARTED|Overall Study||161
10063845|NCT02120950|11189658|FG002|STARTED|Overall Study||15
10063846|NCT02120950|11189656|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
10063847|NCT02120950|11189657|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
10063848|NCT02120950|11189658|FG002|COMPLETED|Overall Study||0
10063849|NCT02120950|11189656|FG000|NOT COMPLETED|Overall Study||20
10063850|NCT02120950|11189657|FG001|NOT COMPLETED|Overall Study||14
10063851|NCT02120950|11189658|FG002|NOT COMPLETED|Overall Study||15
10063852|NCT02121002|11189668|FG000|STARTED|Overall Study||392
10063853|NCT02121002|11189669|FG001|STARTED|Overall Study||393
10063854|NCT02121002|11189670|FG002|STARTED|Overall Study||391
10063855|NCT02121002|11189668|FG000|COMPLETED|Overall Study||385
10063856|NCT02121002|11189669|FG001|COMPLETED|Overall Study||389
10063857|NCT02121002|11189670|FG002|COMPLETED|Overall Study||381
10188355|NCT03266172|11317910|FG001|COMPLETED|Part C Period 6(2 Days)||0
10188356|NCT03266172|11317911|FG002|COMPLETED|Part C Period 6(2 Days)||14
10188357|NCT03266172|11317909|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0
10188358|NCT03266172|11317910|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0
10188359|NCT03266172|11317911|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0
10188360|NCT03266419|11317963|FG000|STARTED|Overall Study||51
10188361|NCT03266419|11317964|FG001|STARTED|Overall Study||49
10188362|NCT03266419|11317963|FG000|COMPLETED|Overall Study||51
10188363|NCT03266419|11317964|FG001|COMPLETED|Overall Study||49
10188364|NCT03266419|11317963|FG000|NOT COMPLETED|Overall Study||0
10188365|NCT03266419|11317964|FG001|NOT COMPLETED|Overall Study||0
10188366|NCT03266588|11317973|FG000|STARTED|Observational Period||1605
10188367|NCT03266588|11317974|FG001|STARTED|Observational Period||786
10188368|NCT03266588|11317975|FG002|STARTED|Observational Period||476
10188369|NCT03266588|11317973|FG000|COMPLETED|Observational Period||1089
10188370|NCT03266588|11317974|FG001|COMPLETED|Observational Period||511
10188371|NCT03266588|11317975|FG002|COMPLETED|Observational Period||308
10188372|NCT03266588|11317973|FG000|NOT COMPLETED|Observational Period||516
10188373|NCT03266588|11317974|FG001|NOT COMPLETED|Observational Period||275
10188374|NCT03266588|11317975|FG002|NOT COMPLETED|Observational Period||168
10188375|NCT03266588|11317973|FG000|STARTED|Long-term Treatment Period||1089
10188376|NCT03266588|11317974|FG001|STARTED|Long-term Treatment Period||511
10188377|NCT03266588|11317975|FG002|STARTED|Long-term Treatment Period||308
10188378|NCT03266588|11317973|FG000|Treated|Long-term Treatment Period||1033
10188379|NCT03266588|11317974|FG001|Treated|Long-term Treatment Period||481
10188380|NCT03266588|11317975|FG002|Treated|Long-term Treatment Period||286
10188381|NCT03266588|11317973|FG000|COMPLETED|Long-term Treatment Period||683
10188382|NCT03266588|11317974|FG001|COMPLETED|Long-term Treatment Period||271
10188383|NCT03266588|11317975|FG002|COMPLETED|Long-term Treatment Period||243
10188384|NCT03266588|11317973|FG000|NOT COMPLETED|Long-term Treatment Period||406
10188385|NCT03266588|11317974|FG001|NOT COMPLETED|Long-term Treatment Period||240
10188386|NCT03266588|11317975|FG002|NOT COMPLETED|Long-term Treatment Period||65
10188387|NCT03267212|11317983|FG000|STARTED|First Intervention|Non-invasive ventilation|6
10188388|NCT03267212|11317984|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
10188389|NCT03267212|11317983|FG000|High SCI|First Intervention||2
10188390|NCT03267212|11317984|FG001|High SCI|First Intervention||5
10188391|NCT03267212|11317983|FG000|Low SCI|First Intervention||4
10188392|NCT03267212|11317984|FG001|Low SCI|First Intervention||4
10188393|NCT03267212|11317983|FG000|COMPLETED|First Intervention||5
10188394|NCT03267212|11317984|FG001|COMPLETED|First Intervention||6
10188395|NCT03267212|11317983|FG000|NOT COMPLETED|First Intervention||1
10188396|NCT03267212|11317984|FG001|NOT COMPLETED|First Intervention||3
10188397|NCT03267212|11317983|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5
10188398|NCT03267212|11317984|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6
10188399|NCT03267212|11317983|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
10188400|NCT03267212|11317984|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
10188401|NCT03267212|11317983|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
10188402|NCT03267212|11317984|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
10188403|NCT03267212|11317983|FG000|STARTED|Second Intervention||4
10188404|NCT03267212|11317984|FG001|STARTED|Second Intervention||6
10063858|NCT02121002|11189668|FG000|NOT COMPLETED|Overall Study||7
10063859|NCT02121002|11189669|FG001|NOT COMPLETED|Overall Study||4
10063860|NCT02121002|11189670|FG002|NOT COMPLETED|Overall Study||10
10063861|NCT02121041|11189680|FG000|STARTED|Overall Study||14
10063862|NCT02121041|11189681|FG001|STARTED|Overall Study||14
10063863|NCT02121041|11189680|FG000|COMPLETED|Overall Study||13
10063864|NCT02121041|11189681|FG001|COMPLETED|Overall Study||8
10063865|NCT02121041|11189680|FG000|NOT COMPLETED|Overall Study||1
10063866|NCT02121041|11189681|FG001|NOT COMPLETED|Overall Study||6
10063867|NCT02121067|11189687|FG000|STARTED|Overall Study||50
10063868|NCT02121067|11189687|FG000|COMPLETED|Overall Study||50
10063869|NCT02121067|11189687|FG000|NOT COMPLETED|Overall Study||0
10063870|NCT02121210|11189694|FG000|STARTED|Overall Study||65
10063871|NCT02121210|11189695|FG001|STARTED|Overall Study||67
10063872|NCT02121210|11189694|FG000|COMPLETED|Overall Study||58
10063873|NCT02121210|11189695|FG001|COMPLETED|Overall Study||58
10063874|NCT02121210|11189694|FG000|NOT COMPLETED|Overall Study||7
10063875|NCT02121210|11189695|FG001|NOT COMPLETED|Overall Study||9
10063876|NCT02121262|11189703|FG000|STARTED|Overall Study||139
10063877|NCT02121262|11189704|FG001|STARTED|Overall Study||145
10063878|NCT02121262|11189703|FG000|Treated|Overall Study||129
10063879|NCT02121262|11189704|FG001|Treated|Overall Study||145
10063880|NCT02121262|11189703|FG000|Modified Intent-to-treat Population|Overall Study||127
10063881|NCT02121262|11189704|FG001|Modified Intent-to-treat Population|Overall Study||145
10063882|NCT02121262|11189703|FG000|COMPLETED|Overall Study||108
10063883|NCT02121262|11189704|FG001|COMPLETED|Overall Study||135
10063884|NCT02121262|11189703|FG000|NOT COMPLETED|Overall Study||31
10063885|NCT02121262|11189704|FG001|NOT COMPLETED|Overall Study||10
10063886|NCT02121301|11189713|FG000|STARTED|Overall Study||30
10063887|NCT02121301|11189714|FG001|STARTED|Overall Study||30
10063888|NCT02121301|11189715|FG002|STARTED|Overall Study||31
10063889|NCT02121301|11189713|FG000|COMPLETED|Overall Study||29
10063890|NCT02121301|11189714|FG001|COMPLETED|Overall Study||26
10063891|NCT02121301|11189715|FG002|COMPLETED|Overall Study||30
10063892|NCT02121301|11189713|FG000|NOT COMPLETED|Overall Study||1
10063893|NCT02121301|11189714|FG001|NOT COMPLETED|Overall Study||4
10063894|NCT02121301|11189715|FG002|NOT COMPLETED|Overall Study||1
10063895|NCT02121392|11189725|FG000|STARTED|Prior to Intervention||83
10063896|NCT02121392|11189726|FG001|STARTED|Prior to Intervention||82
10063897|NCT02121392|11189725|FG000|COMPLETED|Prior to Intervention||35
10063898|NCT02121392|11189726|FG001|COMPLETED|Prior to Intervention||41
10063899|NCT02121392|11189725|FG000|NOT COMPLETED|Prior to Intervention||48
10063900|NCT02121392|11189726|FG001|NOT COMPLETED|Prior to Intervention||41
9717409|NCT00003816|10816614|FG001|STARTED|Overall Study||69
9717410|NCT00003816|10816615|FG002|STARTED|Overall Study||199
9717411|NCT00003816|10816616|FG003|STARTED|Overall Study||23
9717412|NCT00003816|10816617|FG004|STARTED|Overall Study||15
9717413|NCT00003816|10816613|FG000|COMPLETED|Overall Study||55
9717414|NCT00003816|10816614|FG001|COMPLETED|Overall Study||69
9717415|NCT00003816|10816615|FG002|COMPLETED|Overall Study||199
9717416|NCT00003816|10816616|FG003|COMPLETED|Overall Study||23
9717417|NCT00003816|10816617|FG004|COMPLETED|Overall Study||15
9717418|NCT00003816|10816613|FG000|NOT COMPLETED|Overall Study||0
10063901|NCT02121392|11189725|FG000|STARTED|After Placement of AC Block vs Sham||35
10063902|NCT02121392|11189726|FG001|STARTED|After Placement of AC Block vs Sham||41
10063903|NCT02121392|11189725|FG000|COMPLETED|After Placement of AC Block vs Sham||32
10063904|NCT02121392|11189726|FG001|COMPLETED|After Placement of AC Block vs Sham||38
10063905|NCT02121392|11189725|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3
10063906|NCT02121392|11189726|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3
10063907|NCT02121418|11189732|FG000|STARTED|Overall Study||12
10063908|NCT02121418|11189732|FG000|COMPLETED|Overall Study||12
10063909|NCT02121418|11189732|FG000|NOT COMPLETED|Overall Study||0
10063910|NCT02121483|11189739|FG000|STARTED|Overall Study||9
10063911|NCT02121483|11189740|FG001|STARTED|Overall Study||8
10063912|NCT02121483|11189741|FG002|STARTED|Overall Study||10
10063913|NCT02121483|11189739|FG000|COMPLETED|Overall Study||9
10063914|NCT02121483|11189740|FG001|COMPLETED|Overall Study||8
10063915|NCT02121483|11189741|FG002|COMPLETED|Overall Study||10
10063916|NCT02121483|11189739|FG000|NOT COMPLETED|Overall Study||0
10063917|NCT02121483|11189740|FG001|NOT COMPLETED|Overall Study||0
10063918|NCT02121483|11189741|FG002|NOT COMPLETED|Overall Study||0
10188405|NCT03267212|11317983|FG000|COMPLETED|Second Intervention||4
10188406|NCT03267212|11317984|FG001|COMPLETED|Second Intervention||6
10188407|NCT03267212|11317983|FG000|NOT COMPLETED|Second Intervention||0
10188408|NCT03267212|11317984|FG001|NOT COMPLETED|Second Intervention||0
10188409|NCT03267264|11317994|FG000|STARTED|Overall Study||66
10188410|NCT03267264|11317995|FG001|STARTED|Overall Study||49
10188411|NCT03267264|11317996|FG002|STARTED|Overall Study||68
10188412|NCT03267264|11317997|FG003|STARTED|Overall Study||65
10188413|NCT03267264|11317994|FG000|Sequence A(Nucleus)|Overall Study||34
10188414|NCT03267264|11317995|FG001|Sequence A(Nucleus)|Overall Study||25
10188415|NCT03267264|11317996|FG002|Sequence A(Nucleus)|Overall Study||33
10188416|NCT03267264|11317997|FG003|Sequence A(Nucleus)|Overall Study||33
10188417|NCT03267264|11317994|FG000|Sequence B(Comparator)|Overall Study||32
10188418|NCT03267264|11317995|FG001|Sequence B(Comparator)|Overall Study||24
10188419|NCT03267264|11317996|FG002|Sequence B(Comparator)|Overall Study||33
10188420|NCT03267264|11317997|FG003|Sequence B(Comparator)|Overall Study||32
10188421|NCT03267264|11317994|FG000|COMPLETED|Overall Study||65
10188422|NCT03267264|11317995|FG001|COMPLETED|Overall Study||49
10188423|NCT03267264|11317996|FG002|COMPLETED|Overall Study||66
9717419|NCT00003816|10816614|FG001|NOT COMPLETED|Overall Study||0
9717420|NCT00003816|10816615|FG002|NOT COMPLETED|Overall Study||0
9717421|NCT00003816|10816616|FG003|NOT COMPLETED|Overall Study||0
10188424|NCT03267264|11317997|FG003|COMPLETED|Overall Study||61
10063919|NCT02121509|11189751|FG000|STARTED|Treatment Period-1 (4 Days)||30
10063920|NCT02121509|11189752|FG001|STARTED|Treatment Period-1 (4 Days)||28
10063921|NCT02121509|11189753|FG002|STARTED|Treatment Period-1 (4 Days)||8
10063922|NCT02121509|11189754|FG003|STARTED|Treatment Period-1 (4 Days)||8
10063923|NCT02121509|11189751|FG000|COMPLETED|Treatment Period-1 (4 Days)||30
10063924|NCT02121509|11189752|FG001|COMPLETED|Treatment Period-1 (4 Days)||28
10063925|NCT02121509|11189753|FG002|COMPLETED|Treatment Period-1 (4 Days)||8
10063926|NCT02121509|11189754|FG003|COMPLETED|Treatment Period-1 (4 Days)||8
10063927|NCT02121509|11189751|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10063928|NCT02121509|11189752|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10063929|NCT02121509|11189753|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10063930|NCT02121509|11189754|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10063931|NCT02121509|11189751|FG000|STARTED|Washout Period (35 Days)||30
10063932|NCT02121509|11189752|FG001|STARTED|Washout Period (35 Days)||28
10063933|NCT02121509|11189753|FG002|STARTED|Washout Period (35 Days)||8
10063934|NCT02121509|11189754|FG003|STARTED|Washout Period (35 Days)||8
10063935|NCT02121509|11189751|FG000|COMPLETED|Washout Period (35 Days)||28
10063936|NCT02121509|11189752|FG001|COMPLETED|Washout Period (35 Days)||24
10063937|NCT02121509|11189753|FG002|COMPLETED|Washout Period (35 Days)||8
10063938|NCT02121509|11189754|FG003|COMPLETED|Washout Period (35 Days)||8
10063939|NCT02121509|11189751|FG000|NOT COMPLETED|Washout Period (35 Days)||2
10063940|NCT02121509|11189752|FG001|NOT COMPLETED|Washout Period (35 Days)||4
10063941|NCT02121509|11189753|FG002|NOT COMPLETED|Washout Period (35 Days)||0
10063942|NCT02121509|11189754|FG003|NOT COMPLETED|Washout Period (35 Days)||0
10063943|NCT02121509|11189751|FG000|STARTED|Treatment Period-2 (4 Days)||28
10063944|NCT02121509|11189752|FG001|STARTED|Treatment Period-2 (4 Days)||24
10063945|NCT02121509|11189753|FG002|STARTED|Treatment Period-2 (4 Days)||8
10063946|NCT02121509|11189754|FG003|STARTED|Treatment Period-2 (4 Days)||8
10063947|NCT02121509|11189751|FG000|COMPLETED|Treatment Period-2 (4 Days)||28
10063948|NCT02121509|11189752|FG001|COMPLETED|Treatment Period-2 (4 Days)||24
10063949|NCT02121509|11189753|FG002|COMPLETED|Treatment Period-2 (4 Days)||8
10063950|NCT02121509|11189754|FG003|COMPLETED|Treatment Period-2 (4 Days)||8
10063951|NCT02121509|11189751|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10063952|NCT02121509|11189752|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10063953|NCT02121509|11189753|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10063954|NCT02121509|11189754|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10063955|NCT02121522|11189764|FG000|STARTED|Overall Study||14
10063956|NCT02121522|11189764|FG000|COMPLETED|Overall Study||13
10063957|NCT02121522|11189764|FG000|NOT COMPLETED|Overall Study||1
10063958|NCT02121535|11189770|FG000|STARTED|Period 1 (8 Trial Days)||36
10063959|NCT02121535|11189771|FG001|STARTED|Period 1 (8 Trial Days)||36
10063960|NCT02121535|11189770|FG000|COMPLETED|Period 1 (8 Trial Days)||36
10063961|NCT02121535|11189771|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
10063962|NCT02121535|11189770|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0
10063963|NCT02121535|11189771|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1
10063964|NCT02121535|11189770|FG000|STARTED|Period 2 (8 Trial Days)||36
10063965|NCT02121535|11189771|FG001|STARTED|Period 2 (8 Trial Days)||35
10063966|NCT02121535|11189770|FG000|COMPLETED|Period 2 (8 Trial Days)||36
10063967|NCT02121535|11189771|FG001|COMPLETED|Period 2 (8 Trial Days)||35
10063968|NCT02121535|11189770|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0
10063969|NCT02121535|11189771|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0
10063970|NCT02121535|11189770|FG000|STARTED|Period 3 (8 Trial Days)||36
10063971|NCT02121535|11189771|FG001|STARTED|Period 3 (8 Trial Days)||35
10063972|NCT02121535|11189770|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
10063973|NCT02121535|11189771|FG001|COMPLETED|Period 3 (8 Trial Days)||35
10063974|NCT02121535|11189770|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1
10063975|NCT02121535|11189771|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0
10063976|NCT02121535|11189770|FG000|STARTED|Period 4 (8 Trial Days)||35
10063977|NCT02121535|11189771|FG001|STARTED|Period 4 (8 Trial Days)||35
10063978|NCT02121535|11189770|FG000|COMPLETED|Period 4 (8 Trial Days)||35
10063979|NCT02121535|11189771|FG001|COMPLETED|Period 4 (8 Trial Days)||35
10063980|NCT02121535|11189770|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0
10063981|NCT02121535|11189771|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0
10063982|NCT02121756|11189780|FG000|STARTED|Overall Study||21
10063983|NCT02121756|11189781|FG001|STARTED|Overall Study||19
10063984|NCT02121756|11189780|FG000|COMPLETED|Overall Study||15
10063985|NCT02121756|11189781|FG001|COMPLETED|Overall Study||17
10063986|NCT02121756|11189780|FG000|NOT COMPLETED|Overall Study||6
10063987|NCT02121756|11189781|FG001|NOT COMPLETED|Overall Study||2
10063988|NCT02121795|11189792|FG000|STARTED|Double-Blind Phase||334
10063989|NCT02121795|11189793|FG001|STARTED|Double-Blind Phase||334
10063990|NCT02121795|11189792|FG000|Safety Analysis Set|Double-Blind Phase||333
10063991|NCT02121795|11189793|FG001|Safety Analysis Set|Double-Blind Phase||330
10063992|NCT02121795|11189792|FG000|COMPLETED|Double-Blind Phase||296
10063993|NCT02121795|11189793|FG001|COMPLETED|Double-Blind Phase||300
10063994|NCT02121795|11189792|FG000|NOT COMPLETED|Double-Blind Phase||38
10063995|NCT02121795|11189793|FG001|NOT COMPLETED|Double-Blind Phase||34
10188425|NCT03267264|11317994|FG000|NOT COMPLETED|Overall Study||1
10188426|NCT03267264|11317995|FG001|NOT COMPLETED|Overall Study||0
10063996|NCT02121795|11189792|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
10063997|NCT02121795|11189793|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
10063998|NCT02121795|11189792|FG000|COMPLETED|Open-Label Phase||21
10063999|NCT02121795|11189793|FG001|COMPLETED|Open-Label Phase||21
10064000|NCT02121795|11189792|FG000|NOT COMPLETED|Open-Label Phase||12
10064001|NCT02121795|11189793|FG001|NOT COMPLETED|Open-Label Phase||10
10064002|NCT02121808|11189801|FG000|STARTED|Overall Study||20
10064003|NCT02121808|11189801|FG000|COMPLETED|Overall Study||17
10064004|NCT02121808|11189801|FG000|NOT COMPLETED|Overall Study||3
10064005|NCT02121834|11189817|FG000|STARTED|Overall Study||12
10064006|NCT02121834|11189818|FG001|STARTED|Overall Study||11
10064007|NCT02121834|11189819|FG002|STARTED|Overall Study||9
10064008|NCT02121834|11189820|FG003|STARTED|Overall Study||10
10064009|NCT02121834|11189821|FG004|STARTED|Overall Study||9
10064010|NCT02121834|11189822|FG005|STARTED|Overall Study||9
10064011|NCT02121834|11189823|FG006|STARTED|Overall Study||3
10064012|NCT02121834|11189817|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10064013|NCT02121834|11189818|FG001|Received at Least One Dose of Study Drug|Overall Study||11
10064014|NCT02121834|11189819|FG002|Received at Least One Dose of Study Drug|Overall Study||9
10064015|NCT02121834|11189820|FG003|Received at Least One Dose of Study Drug|Overall Study||10
10064016|NCT02121834|11189821|FG004|Received at Least One Dose of Study Drug|Overall Study||9
10064017|NCT02121834|11189822|FG005|Received at Least One Dose of Study Drug|Overall Study||9
10064018|NCT02121834|11189823|FG006|Received at Least One Dose of Study Drug|Overall Study||3
10064019|NCT02121834|11189817|FG000|COMPLETED|Overall Study||12
10064020|NCT02121834|11189818|FG001|COMPLETED|Overall Study||9
10064021|NCT02121834|11189819|FG002|COMPLETED|Overall Study||7
10064022|NCT02121834|11189820|FG003|COMPLETED|Overall Study||10
10064023|NCT02121834|11189821|FG004|COMPLETED|Overall Study||9
10064024|NCT02121834|11189822|FG005|COMPLETED|Overall Study||9
10064025|NCT02121834|11189823|FG006|COMPLETED|Overall Study||3
10064026|NCT02121834|11189817|FG000|NOT COMPLETED|Overall Study||0
10064027|NCT02121834|11189818|FG001|NOT COMPLETED|Overall Study||2
10064028|NCT02121834|11189819|FG002|NOT COMPLETED|Overall Study||2
10064029|NCT02121834|11189820|FG003|NOT COMPLETED|Overall Study||0
10064030|NCT02121834|11189821|FG004|NOT COMPLETED|Overall Study||0
10064031|NCT02121834|11189822|FG005|NOT COMPLETED|Overall Study||0
10064032|NCT02121834|11189823|FG006|NOT COMPLETED|Overall Study||0
10064033|NCT02121847|11189849|FG000|STARTED|Overall Study||40
10064034|NCT02121847|11189849|FG000|COMPLETED|Overall Study||37
10064035|NCT02121847|11189849|FG000|NOT COMPLETED|Overall Study||3
10064036|NCT02121860|11189857|FG000|STARTED|Overall Study||8
10064037|NCT02121860|11189858|FG001|STARTED|Overall Study||12
10064038|NCT02121860|11189859|FG002|STARTED|Overall Study||8
10064039|NCT02121860|11189860|FG003|STARTED|Overall Study||8
10064040|NCT02121860|11189857|FG000|COMPLETED|Overall Study||8
10064041|NCT02121860|11189858|FG001|COMPLETED|Overall Study||12
10064042|NCT02121860|11189859|FG002|COMPLETED|Overall Study||8
10064043|NCT02121860|11189860|FG003|COMPLETED|Overall Study||8
10064044|NCT02121860|11189857|FG000|NOT COMPLETED|Overall Study||0
10064045|NCT02121860|11189858|FG001|NOT COMPLETED|Overall Study||0
10064046|NCT02121860|11189859|FG002|NOT COMPLETED|Overall Study||0
10064047|NCT02121860|11189860|FG003|NOT COMPLETED|Overall Study||0
10064048|NCT02121912|11189869|FG000|STARTED|Overall Study||25
10064049|NCT02121912|11189870|FG001|STARTED|Overall Study||25
10064050|NCT02121912|11189869|FG000|COMPLETED|Overall Study||21
10064051|NCT02121912|11189870|FG001|COMPLETED|Overall Study||25
10064052|NCT02121912|11189869|FG000|NOT COMPLETED|Overall Study||4
10064053|NCT02121912|11189870|FG001|NOT COMPLETED|Overall Study||0
10064054|NCT02122146|11189884|FG000|STARTED|Part 1: Dose Escalation||2
10064055|NCT02122146|11189885|FG001|STARTED|Part 1: Dose Escalation||2
10064056|NCT02122146|11189886|FG002|STARTED|Part 1: Dose Escalation||4
10064057|NCT02122146|11189887|FG003|STARTED|Part 1: Dose Escalation||4
10064058|NCT02122146|11189888|FG004|STARTED|Part 1: Dose Escalation||4
10064059|NCT02122146|11189889|FG005|STARTED|Part 1: Dose Escalation||6
10064060|NCT02122146|11189890|FG006|STARTED|Part 1: Dose Escalation||1
10064061|NCT02122146|11189891|FG007|STARTED|Part 1: Dose Escalation||8
10064062|NCT02122146|11189884|FG000|COMPLETED|Part 1: Dose Escalation||1
10064063|NCT02122146|11189885|FG001|COMPLETED|Part 1: Dose Escalation||1
10064064|NCT02122146|11189886|FG002|COMPLETED|Part 1: Dose Escalation||2
10064065|NCT02122146|11189887|FG003|COMPLETED|Part 1: Dose Escalation||3
10064066|NCT02122146|11189888|FG004|COMPLETED|Part 1: Dose Escalation||3
10064067|NCT02122146|11189889|FG005|COMPLETED|Part 1: Dose Escalation||5
10064068|NCT02122146|11189890|FG006|COMPLETED|Part 1: Dose Escalation||0
10064069|NCT02122146|11189891|FG007|COMPLETED|Part 1: Dose Escalation||6
10064070|NCT02122146|11189884|FG000|NOT COMPLETED|Part 1: Dose Escalation||1
10064071|NCT02122146|11189885|FG001|NOT COMPLETED|Part 1: Dose Escalation||1
10064072|NCT02122146|11189886|FG002|NOT COMPLETED|Part 1: Dose Escalation||2
10064073|NCT02122146|11189887|FG003|NOT COMPLETED|Part 1: Dose Escalation||1
10064074|NCT02122146|11189888|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
10064075|NCT02122146|11189889|FG005|NOT COMPLETED|Part 1: Dose Escalation||1
10064076|NCT02122146|11189890|FG006|NOT COMPLETED|Part 1: Dose Escalation||1
10064077|NCT02122146|11189891|FG007|NOT COMPLETED|Part 1: Dose Escalation||2
10064078|NCT02122146|11189884|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064079|NCT02122146|11189885|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064080|NCT02122146|11189886|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064081|NCT02122146|11189887|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064082|NCT02122146|11189888|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064083|NCT02122146|11189889|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064084|NCT02122146|11189890|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064085|NCT02122146|11189891|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10064086|NCT02122146|11189884|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0
10064087|NCT02122146|11189885|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0
10064088|NCT02122146|11189886|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0
10188427|NCT03267264|11317996|FG002|NOT COMPLETED|Overall Study||2
10064089|NCT02122146|11189887|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0
10064090|NCT02122146|11189888|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0
10064091|NCT02122146|11189889|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0
10064092|NCT02122146|11189890|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0
10064093|NCT02122146|11189891|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0
10064094|NCT02122146|11189884|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064095|NCT02122146|11189885|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064096|NCT02122146|11189886|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064097|NCT02122146|11189887|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064098|NCT02122146|11189888|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064099|NCT02122146|11189889|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064100|NCT02122146|11189890|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064101|NCT02122146|11189891|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10064102|NCT02122146|11189884|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064103|NCT02122146|11189885|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064104|NCT02122146|11189886|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064105|NCT02122146|11189887|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064106|NCT02122146|11189888|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064107|NCT02122146|11189889|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064108|NCT02122146|11189890|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064109|NCT02122146|11189891|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10064110|NCT02122146|11189884|FG000|COMPLETED|Part 3: Expansion||0
10064111|NCT02122146|11189885|FG001|COMPLETED|Part 3: Expansion||0
10064112|NCT02122146|11189886|FG002|COMPLETED|Part 3: Expansion||0
10064113|NCT02122146|11189887|FG003|COMPLETED|Part 3: Expansion||0
10064114|NCT02122146|11189888|FG004|COMPLETED|Part 3: Expansion||0
10064115|NCT02122146|11189889|FG005|COMPLETED|Part 3: Expansion||0
10064116|NCT02122146|11189890|FG006|COMPLETED|Part 3: Expansion||0
10064117|NCT02122146|11189891|FG007|COMPLETED|Part 3: Expansion||0
10064118|NCT02122146|11189884|FG000|NOT COMPLETED|Part 3: Expansion||0
10064119|NCT02122146|11189885|FG001|NOT COMPLETED|Part 3: Expansion||0
10064120|NCT02122146|11189886|FG002|NOT COMPLETED|Part 3: Expansion||0
10064121|NCT02122146|11189887|FG003|NOT COMPLETED|Part 3: Expansion||0
10064122|NCT02122146|11189888|FG004|NOT COMPLETED|Part 3: Expansion||0
10064123|NCT02122146|11189889|FG005|NOT COMPLETED|Part 3: Expansion||0
10064124|NCT02122146|11189890|FG006|NOT COMPLETED|Part 3: Expansion||0
10064125|NCT02122146|11189891|FG007|NOT COMPLETED|Part 3: Expansion||0
10064126|NCT02122341|11189912|FG000|STARTED|Overall Study||17
10064127|NCT02122341|11189913|FG001|STARTED|Overall Study||18
10064128|NCT02122341|11189912|FG000|COMPLETED|Overall Study||17
10064129|NCT02122341|11189913|FG001|COMPLETED|Overall Study||18
10064130|NCT02122341|11189912|FG000|NOT COMPLETED|Overall Study||0
10064131|NCT02122341|11189913|FG001|NOT COMPLETED|Overall Study||0
10064132|NCT02122380|11189921|FG000|STARTED|First Intervention (30 Days)||11
10064133|NCT02122380|11189922|FG001|STARTED|First Intervention (30 Days)||12
10064134|NCT02122380|11189921|FG000|COMPLETED|First Intervention (30 Days)||10
10064135|NCT02122380|11189922|FG001|COMPLETED|First Intervention (30 Days)||11
10064136|NCT02122380|11189921|FG000|NOT COMPLETED|First Intervention (30 Days)||1
10064137|NCT02122380|11189922|FG001|NOT COMPLETED|First Intervention (30 Days)||1
10064138|NCT02122380|11189921|FG000|STARTED|Washout (8 Weeks)||10
10064139|NCT02122380|11189922|FG001|STARTED|Washout (8 Weeks)||11
10064140|NCT02122380|11189921|FG000|COMPLETED|Washout (8 Weeks)||9
10064141|NCT02122380|11189922|FG001|COMPLETED|Washout (8 Weeks)||9
10064142|NCT02122380|11189921|FG000|NOT COMPLETED|Washout (8 Weeks)||1
10064143|NCT02122380|11189922|FG001|NOT COMPLETED|Washout (8 Weeks)||2
10064144|NCT02122380|11189921|FG000|STARTED|Second Intervention (30 Days)||9
10064145|NCT02122380|11189922|FG001|STARTED|Second Intervention (30 Days)||9
10064146|NCT02122380|11189921|FG000|COMPLETED|Second Intervention (30 Days)||9
10064147|NCT02122380|11189922|FG001|COMPLETED|Second Intervention (30 Days)||7
10064148|NCT02122380|11189921|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10064149|NCT02122380|11189922|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
10064150|NCT02122406|11189929|FG000|STARTED|Overall Study||200
10064151|NCT02122406|11189929|FG000|COMPLETED|Overall Study||200
10064152|NCT02122406|11189929|FG000|NOT COMPLETED|Overall Study||0
10064153|NCT02122445|11189933|FG000|STARTED|Overall Study||20
10064154|NCT02122445|11189933|FG000|COMPLETED|Overall Study||20
10064155|NCT02122445|11189933|FG000|NOT COMPLETED|Overall Study||0
10064156|NCT02122471|11189940|FG000|STARTED|Overall Study||445
10064157|NCT02122471|11189941|FG001|STARTED|Overall Study||443
10064158|NCT02122471|11189942|FG002|STARTED|Overall Study||449
10064159|NCT02122471|11189940|FG000|COMPLETED|Overall Study||406
10064160|NCT02122471|11189941|FG001|COMPLETED|Overall Study||392
10064161|NCT02122471|11189942|FG002|COMPLETED|Overall Study||405
10064162|NCT02122471|11189940|FG000|NOT COMPLETED|Overall Study||39
10064163|NCT02122471|11189941|FG001|NOT COMPLETED|Overall Study||51
10064164|NCT02122471|11189942|FG002|NOT COMPLETED|Overall Study||44
10064165|NCT02122549|11189951|FG000|STARTED|Overall Study||59
10064166|NCT02122549|11189951|FG000|COMPLETED|Overall Study||59
10064167|NCT02122549|11189951|FG000|NOT COMPLETED|Overall Study||0
10064168|NCT02122770|11189959|FG000|STARTED|Part A: Drug-drug Interaction 2||13
10064169|NCT02122770|11189960|FG001|STARTED|Part A: Drug-drug Interaction 2||13
10064170|NCT02122770|11189961|FG002|STARTED|Part A: Drug-drug Interaction 2||6
10064171|NCT02122770|11189962|FG003|STARTED|Part A: Drug-drug Interaction 2||19
10064172|NCT02122770|11189963|FG004|STARTED|Part A: Drug-drug Interaction 2||0
10064173|NCT02122770|11189964|FG005|STARTED|Part A: Drug-drug Interaction 2||0
10064174|NCT02122770|11189959|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9
10064175|NCT02122770|11189960|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7
10064176|NCT02122770|11189961|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4
10064177|NCT02122770|11189962|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16
10064178|NCT02122770|11189963|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0
10064179|NCT02122770|11189964|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0
10064180|NCT02122770|11189959|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
10064181|NCT02122770|11189960|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
10064182|NCT02122770|11189961|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
10064183|NCT02122770|11189962|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
10064184|NCT02122770|11189963|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
10064185|NCT02122770|11189964|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
10064186|NCT02122770|11189959|FG000|STARTED|Part B: Standard of Care||0
10064187|NCT02122770|11189960|FG001|STARTED|Part B: Standard of Care||0
10064188|NCT02122770|11189961|FG002|STARTED|Part B: Standard of Care||0
10064189|NCT02122770|11189962|FG003|STARTED|Part B: Standard of Care||0
10064190|NCT02122770|11189963|FG004|STARTED|Part B: Standard of Care||23
10064191|NCT02122770|11189964|FG005|STARTED|Part B: Standard of Care||13
10064192|NCT02122770|11189959|FG000|COMPLETED|Part B: Standard of Care||0
10064193|NCT02122770|11189960|FG001|COMPLETED|Part B: Standard of Care||0
10064194|NCT02122770|11189961|FG002|COMPLETED|Part B: Standard of Care||0
10064195|NCT02122770|11189962|FG003|COMPLETED|Part B: Standard of Care||0
10064196|NCT02122770|11189963|FG004|COMPLETED|Part B: Standard of Care||0
10064197|NCT02122770|11189964|FG005|COMPLETED|Part B: Standard of Care||0
10064198|NCT02122770|11189959|FG000|NOT COMPLETED|Part B: Standard of Care||0
10064199|NCT02122770|11189960|FG001|NOT COMPLETED|Part B: Standard of Care||0
10064200|NCT02122770|11189961|FG002|NOT COMPLETED|Part B: Standard of Care||0
10064201|NCT02122770|11189962|FG003|NOT COMPLETED|Part B: Standard of Care||0
10064202|NCT02122770|11189963|FG004|NOT COMPLETED|Part B: Standard of Care||23
10064203|NCT02122770|11189964|FG005|NOT COMPLETED|Part B: Standard of Care||13
10064204|NCT02122783|11189989|FG000|STARTED|Overall Study||2
10064205|NCT02122783|11189990|FG001|STARTED|Overall Study||3
10064206|NCT02122783|11189989|FG000|COMPLETED|Overall Study||2
10064207|NCT02122783|11189990|FG001|COMPLETED|Overall Study||2
10064208|NCT02122783|11189989|FG000|NOT COMPLETED|Overall Study||0
10064209|NCT02122783|11189990|FG001|NOT COMPLETED|Overall Study||1
10064210|NCT02122796|11190001|FG000|STARTED|Visit 1||15
10064211|NCT02122796|11190002|FG001|STARTED|Visit 1||15
10064212|NCT02122796|11190001|FG000|COMPLETED|Visit 1||15
10064213|NCT02122796|11190002|FG001|COMPLETED|Visit 1||15
10064214|NCT02122796|11190001|FG000|NOT COMPLETED|Visit 1||0
10064215|NCT02122796|11190002|FG001|NOT COMPLETED|Visit 1||0
10064216|NCT02122796|11190001|FG000|STARTED|Visit 2||15
10064217|NCT02122796|11190002|FG001|STARTED|Visit 2||15
10064218|NCT02122796|11190001|FG000|COMPLETED|Visit 2||12
10064219|NCT02122796|11190002|FG001|COMPLETED|Visit 2||14
10064220|NCT02122796|11190001|FG000|NOT COMPLETED|Visit 2||3
10064221|NCT02122796|11190002|FG001|NOT COMPLETED|Visit 2||1
10064222|NCT02122887|11190011|FG000|STARTED|Overall Study||60
10064223|NCT02122887|11190012|FG001|STARTED|Overall Study||41
10064224|NCT02122887|11190011|FG000|COMPLETED|Overall Study||40
10064225|NCT02122887|11190012|FG001|COMPLETED|Overall Study||39
10064226|NCT02122887|11190011|FG000|NOT COMPLETED|Overall Study||20
10064227|NCT02122887|11190012|FG001|NOT COMPLETED|Overall Study||2
10064228|NCT02122952|11190020|FG000|STARTED|Overall Study||3
10064229|NCT02122952|11190021|FG001|STARTED|Overall Study||12
10064230|NCT02122952|11190020|FG000|COMPLETED|Overall Study||3
10064231|NCT02122952|11190021|FG001|COMPLETED|Overall Study||12
10064232|NCT02122952|11190020|FG000|NOT COMPLETED|Overall Study||0
10064233|NCT02122952|11190021|FG001|NOT COMPLETED|Overall Study||0
10064234|NCT02123017|11190030|FG000|STARTED|Overall Study||8
10064235|NCT02123017|11190031|FG001|STARTED|Overall Study||12
10064236|NCT02123017|11190032|FG002|STARTED|Overall Study||12
10064237|NCT02123017|11190030|FG000|COMPLETED|Overall Study||8
10064238|NCT02123017|11190031|FG001|COMPLETED|Overall Study||12
10064239|NCT02123017|11190032|FG002|COMPLETED|Overall Study||12
10064240|NCT02123017|11190030|FG000|NOT COMPLETED|Overall Study||0
10064241|NCT02123017|11190031|FG001|NOT COMPLETED|Overall Study||0
10064242|NCT02123017|11190032|FG002|NOT COMPLETED|Overall Study||0
10064243|NCT02123134|11190042|FG000|STARTED|Overall Study||28
10064244|NCT02123134|11190043|FG001|STARTED|Overall Study||27
10064245|NCT02123134|11190042|FG000|COMPLETED|Overall Study||25
10064246|NCT02123134|11190043|FG001|COMPLETED|Overall Study||24
10064247|NCT02123134|11190042|FG000|NOT COMPLETED|Overall Study||3
10064248|NCT02123134|11190043|FG001|NOT COMPLETED|Overall Study||3
10064249|NCT02123251|11190051|FG000|STARTED|Overall Study||159
10064250|NCT02123251|11190052|FG001|STARTED|Overall Study||161
10064251|NCT02123251|11190051|FG000|COMPLETED|Overall Study||125
10064252|NCT02123251|11190052|FG001|COMPLETED|Overall Study||131
10064253|NCT02123251|11190051|FG000|NOT COMPLETED|Overall Study||34
10064254|NCT02123251|11190052|FG001|NOT COMPLETED|Overall Study||30
10064255|NCT02123329|11190061|FG000|STARTED|3 Month Outcome Measure||147
10064256|NCT02123329|11190062|FG001|STARTED|3 Month Outcome Measure||167
10064257|NCT02123329|11190061|FG000|COMPLETED|3 Month Outcome Measure||98
10064258|NCT02123329|11190062|FG001|COMPLETED|3 Month Outcome Measure||101
10188428|NCT03267264|11317997|FG003|NOT COMPLETED|Overall Study||4
10064259|NCT02123329|11190061|FG000|NOT COMPLETED|3 Month Outcome Measure||49
10064260|NCT02123329|11190062|FG001|NOT COMPLETED|3 Month Outcome Measure||66
10064261|NCT02123329|11190061|FG000|STARTED|6 Month Outcome Measure||147
10064262|NCT02123329|11190062|FG001|STARTED|6 Month Outcome Measure||167
10064263|NCT02123329|11190061|FG000|COMPLETED|6 Month Outcome Measure||99
10064264|NCT02123329|11190062|FG001|COMPLETED|6 Month Outcome Measure||100
10064265|NCT02123329|11190061|FG000|NOT COMPLETED|6 Month Outcome Measure||48
10064266|NCT02123329|11190062|FG001|NOT COMPLETED|6 Month Outcome Measure||67
10064267|NCT02123329|11190061|FG000|STARTED|12 Month Outcome Measure||147
10064268|NCT02123329|11190062|FG001|STARTED|12 Month Outcome Measure||167
10064269|NCT02123329|11190061|FG000|COMPLETED|12 Month Outcome Measure||83
10064270|NCT02123329|11190062|FG001|COMPLETED|12 Month Outcome Measure||88
10064271|NCT02123329|11190061|FG000|NOT COMPLETED|12 Month Outcome Measure||64
10064272|NCT02123329|11190062|FG001|NOT COMPLETED|12 Month Outcome Measure||79
10064273|NCT02123446|11190068|FG000|STARTED|Period 1 (7 Days)||14
10064274|NCT02123446|11190069|FG001|STARTED|Period 1 (7 Days)||14
10064275|NCT02123446|11190068|FG000|COMPLETED|Period 1 (7 Days)||14
10064276|NCT02123446|11190069|FG001|COMPLETED|Period 1 (7 Days)||14
10064277|NCT02123446|11190068|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10064278|NCT02123446|11190069|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10064279|NCT02123446|11190068|FG000|STARTED|Washout Period (1 Day)||14
10064280|NCT02123446|11190069|FG001|STARTED|Washout Period (1 Day)||14
10064281|NCT02123446|11190068|FG000|COMPLETED|Washout Period (1 Day)||13
10064282|NCT02123446|11190069|FG001|COMPLETED|Washout Period (1 Day)||14
10064283|NCT02123446|11190068|FG000|NOT COMPLETED|Washout Period (1 Day)||1
10064284|NCT02123446|11190069|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10064285|NCT02123446|11190068|FG000|STARTED|Period 2 (7 Days)||13
10064286|NCT02123446|11190069|FG001|STARTED|Period 2 (7 Days)||14
10064287|NCT02123446|11190068|FG000|COMPLETED|Period 2 (7 Days)||13
10188429|NCT03267511|11318014|FG000|STARTED|Overall Study||31
10188430|NCT03267511|11318015|FG001|STARTED|Overall Study||31
10188431|NCT03267511|11318016|FG002|STARTED|Overall Study||30
10188432|NCT03267511|11318017|FG003|STARTED|Overall Study||31
10188433|NCT03267511|11318014|FG000|COMPLETED|Overall Study||31
10188434|NCT03267511|11318015|FG001|COMPLETED|Overall Study||31
10188435|NCT03267511|11318016|FG002|COMPLETED|Overall Study||30
10188436|NCT03267511|11318017|FG003|COMPLETED|Overall Study||30
10188437|NCT03267511|11318014|FG000|NOT COMPLETED|Overall Study||0
10188438|NCT03267511|11318015|FG001|NOT COMPLETED|Overall Study||0
10188439|NCT03267511|11318016|FG002|NOT COMPLETED|Overall Study||0
10188440|NCT03267511|11318017|FG003|NOT COMPLETED|Overall Study||1
10188441|NCT03267576|11318031|FG000|STARTED|Period 1: Day 0 to 27||31
10188442|NCT03267576|11318032|FG001|STARTED|Period 1: Day 0 to 27||32
10188443|NCT03267576|11318031|FG000|COMPLETED|Period 1: Day 0 to 27||31
10188444|NCT03267576|11318032|FG001|COMPLETED|Period 1: Day 0 to 27||32
10188445|NCT03267576|11318031|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0
10188446|NCT03267576|11318032|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0
10188447|NCT03267576|11318031|FG000|STARTED|Washout Period: 16 Days||31
10188448|NCT03267576|11318032|FG001|STARTED|Washout Period: 16 Days||32
10188449|NCT03267576|11318031|FG000|COMPLETED|Washout Period: 16 Days||31
10188450|NCT03267576|11318032|FG001|COMPLETED|Washout Period: 16 Days||32
10188451|NCT03267576|11318031|FG000|NOT COMPLETED|Washout Period: 16 Days||0
10188452|NCT03267576|11318032|FG001|NOT COMPLETED|Washout Period: 16 Days||0
10188453|NCT03267576|11318031|FG000|STARTED|Period 2: Day 44 to 71||31
10188454|NCT03267576|11318032|FG001|STARTED|Period 2: Day 44 to 71||32
10188455|NCT03267576|11318031|FG000|COMPLETED|Period 2: Day 44 to 71||30
10188456|NCT03267576|11318032|FG001|COMPLETED|Period 2: Day 44 to 71||30
10188457|NCT03267576|11318031|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1
10188458|NCT03267576|11318032|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2
10064288|NCT02123446|11190069|FG001|COMPLETED|Period 2 (7 Days)||14
10064289|NCT02123446|11190068|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10064290|NCT02123446|11190069|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10064291|NCT02123459|11190075|FG000|STARTED|Period 1 (7 Days)||14
10064292|NCT02123459|11190076|FG001|STARTED|Period 1 (7 Days)||14
10064293|NCT02123459|11190075|FG000|COMPLETED|Period 1 (7 Days)||14
10064294|NCT02123459|11190076|FG001|COMPLETED|Period 1 (7 Days)||14
10064295|NCT02123459|11190075|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10064296|NCT02123459|11190076|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10064297|NCT02123459|11190075|FG000|STARTED|Washout Period (1 Day)||14
10064298|NCT02123459|11190076|FG001|STARTED|Washout Period (1 Day)||14
10064299|NCT02123459|11190075|FG000|COMPLETED|Washout Period (1 Day)||13
10064300|NCT02123459|11190076|FG001|COMPLETED|Washout Period (1 Day)||14
10064301|NCT02123459|11190075|FG000|NOT COMPLETED|Washout Period (1 Day)||1
10064302|NCT02123459|11190076|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10064303|NCT02123459|11190075|FG000|STARTED|Period 2 (7 Days)||13
10064304|NCT02123459|11190076|FG001|STARTED|Period 2 (7 Days)||14
10064305|NCT02123459|11190075|FG000|COMPLETED|Period 2 (7 Days)||13
10064306|NCT02123459|11190076|FG001|COMPLETED|Period 2 (7 Days)||14
10064307|NCT02123459|11190075|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10064308|NCT02123459|11190076|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10064309|NCT02123472|11190082|FG000|STARTED|Period 1 (7 Days)||14
10064310|NCT02123472|11190083|FG001|STARTED|Period 1 (7 Days)||14
10064311|NCT02123472|11190082|FG000|COMPLETED|Period 1 (7 Days)||14
10064312|NCT02123472|11190083|FG001|COMPLETED|Period 1 (7 Days)||14
10064313|NCT02123472|11190082|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10064314|NCT02123472|11190083|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10064315|NCT02123472|11190082|FG000|STARTED|Washout Period (1 Day)||14
10064316|NCT02123472|11190083|FG001|STARTED|Washout Period (1 Day)||14
10064317|NCT02123472|11190082|FG000|COMPLETED|Washout Period (1 Day)||14
10064318|NCT02123472|11190083|FG001|COMPLETED|Washout Period (1 Day)||14
10064319|NCT02123472|11190082|FG000|NOT COMPLETED|Washout Period (1 Day)||0
10064320|NCT02123472|11190083|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10064321|NCT02123472|11190082|FG000|STARTED|Period 2 (7 Days)||14
10064322|NCT02123472|11190083|FG001|STARTED|Period 2 (7 Days)||14
10064323|NCT02123472|11190082|FG000|COMPLETED|Period 2 (7 Days)||14
10064324|NCT02123472|11190083|FG001|COMPLETED|Period 2 (7 Days)||13
10064325|NCT02123472|11190082|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10064326|NCT02123472|11190083|FG001|NOT COMPLETED|Period 2 (7 Days)||1
10064327|NCT02123485|11190091|FG000|STARTED|Overall Study||18
10064328|NCT02123485|11190092|FG001|STARTED|Overall Study||17
10064329|NCT02123485|11190091|FG000|COMPLETED|Overall Study||17
10064330|NCT02123485|11190092|FG001|COMPLETED|Overall Study||17
10064331|NCT02123485|11190091|FG000|NOT COMPLETED|Overall Study||1
10064332|NCT02123485|11190092|FG001|NOT COMPLETED|Overall Study||0
10064333|NCT02123511|11190100|FG000|STARTED|Overall Study||18
10064334|NCT02123511|11190101|FG001|STARTED|Overall Study||16
10064335|NCT02123511|11190100|FG000|Eligible Patients|Overall Study||17
10064336|NCT02123511|11190101|FG001|Eligible Patients|Overall Study||15
10064337|NCT02123511|11190100|FG000|COMPLETED|Overall Study||16
10064338|NCT02123511|11190101|FG001|COMPLETED|Overall Study||12
10064339|NCT02123511|11190100|FG000|NOT COMPLETED|Overall Study||2
10064340|NCT02123511|11190101|FG001|NOT COMPLETED|Overall Study||4
10064341|NCT02123576|11190109|FG000|STARTED|Overall Study||6
10064342|NCT02123576|11190110|FG001|STARTED|Overall Study||6
10064343|NCT02123576|11190109|FG000|COMPLETED|Overall Study||5
10064344|NCT02123576|11190110|FG001|COMPLETED|Overall Study||6
10064345|NCT02123576|11190109|FG000|NOT COMPLETED|Overall Study||1
10064346|NCT02123576|11190110|FG001|NOT COMPLETED|Overall Study||0
10064347|NCT02123745|11190116|FG000|STARTED|Overall Study||71
10064348|NCT02123745|11190116|FG000|COMPLETED|Overall Study||71
10064349|NCT02123745|11190116|FG000|NOT COMPLETED|Overall Study||0
10064350|NCT02123797|11190122|FG000|STARTED|Baseline Intervention||178
10064351|NCT02123797|11190123|FG001|STARTED|Baseline Intervention||348
10064352|NCT02123797|11190124|FG002|STARTED|Baseline Intervention||100
10064353|NCT02123797|11190125|FG003|STARTED|Baseline Intervention||144
10064354|NCT02123797|11190126|FG004|STARTED|Baseline Intervention||11
10064355|NCT02123797|11190122|FG000|COMPLETED|Baseline Intervention||156
10064356|NCT02123797|11190123|FG001|COMPLETED|Baseline Intervention||306
10064357|NCT02123797|11190124|FG002|COMPLETED|Baseline Intervention||100
10064358|NCT02123797|11190125|FG003|COMPLETED|Baseline Intervention||144
10064359|NCT02123797|11190126|FG004|COMPLETED|Baseline Intervention||11
10064360|NCT02123797|11190122|FG000|NOT COMPLETED|Baseline Intervention||22
10064361|NCT02123797|11190123|FG001|NOT COMPLETED|Baseline Intervention||42
10064362|NCT02123797|11190124|FG002|NOT COMPLETED|Baseline Intervention||0
10064363|NCT02123797|11190125|FG003|NOT COMPLETED|Baseline Intervention||0
10064364|NCT02123797|11190126|FG004|NOT COMPLETED|Baseline Intervention||0
10064365|NCT02123797|11190122|FG000|STARTED|3-month Follow up (Cumulative Counts)||156
10064366|NCT02123797|11190123|FG001|STARTED|3-month Follow up (Cumulative Counts)||306
10064367|NCT02123797|11190124|FG002|STARTED|3-month Follow up (Cumulative Counts)||100
10064368|NCT02123797|11190125|FG003|STARTED|3-month Follow up (Cumulative Counts)||144
10064369|NCT02123797|11190126|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
10064370|NCT02123797|11190122|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99
10064371|NCT02123797|11190123|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189
10064372|NCT02123797|11190124|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50
10064373|NCT02123797|11190125|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62
10064374|NCT02123797|11190126|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8
10064375|NCT02123797|11190122|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
10064376|NCT02123797|11190123|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
10064377|NCT02123797|11190124|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
10064378|NCT02123797|11190125|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
10064379|NCT02123797|11190126|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
10064380|NCT02123797|11190122|FG000|STARTED|6-month Follow up (Cumulative Counts)||156
10064381|NCT02123797|11190123|FG001|STARTED|6-month Follow up (Cumulative Counts)||306
10064382|NCT02123797|11190124|FG002|STARTED|6-month Follow up (Cumulative Counts)||100
10064383|NCT02123797|11190125|FG003|STARTED|6-month Follow up (Cumulative Counts)||144
10064384|NCT02123797|11190126|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
10064385|NCT02123797|11190122|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101
10064386|NCT02123797|11190123|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178
10064387|NCT02123797|11190124|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34
10064388|NCT02123797|11190125|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31
10064389|NCT02123797|11190126|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5
10064390|NCT02123797|11190122|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
10064391|NCT02123797|11190123|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
10064392|NCT02123797|11190124|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
10064393|NCT02123797|11190125|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
10064394|NCT02123797|11190126|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
10064395|NCT02123849|11190148|FG000|STARTED|Overall Study||27
10064396|NCT02123849|11190149|FG001|STARTED|Overall Study||27
10064397|NCT02123849|11190148|FG000|COMPLETED|Overall Study||23
10064398|NCT02123849|11190149|FG001|COMPLETED|Overall Study||18
10064399|NCT02123849|11190148|FG000|NOT COMPLETED|Overall Study||4
10064400|NCT02123849|11190149|FG001|NOT COMPLETED|Overall Study||9
10064401|NCT02123966|11190157|FG000|STARTED|Overall Study||10
10064402|NCT02123966|11190157|FG000|COMPLETED|Overall Study||9
10064403|NCT02123966|11190157|FG000|NOT COMPLETED|Overall Study||1
10064404|NCT02124018|11190164|FG000|STARTED|Overall Study||371
10064405|NCT02124018|11190165|FG001|STARTED|Overall Study||111
10064406|NCT02124018|11190166|FG002|STARTED|Overall Study||41
10064407|NCT02124018|11190164|FG000|COMPLETED|Overall Study||371
10064408|NCT02124018|11190165|FG001|COMPLETED|Overall Study||111
10064409|NCT02124018|11190166|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
10064410|NCT02124018|11190164|FG000|NOT COMPLETED|Overall Study||0
10064411|NCT02124018|11190165|FG001|NOT COMPLETED|Overall Study||0
10064412|NCT02124018|11190166|FG002|NOT COMPLETED|Overall Study||0
10064413|NCT02124044|11190179|FG000|STARTED|Overall Study||20
10064414|NCT02124044|11190180|FG001|STARTED|Overall Study||10
10064415|NCT02124044|11190179|FG000|COMPLETED|Overall Study||20
10064416|NCT02124044|11190180|FG001|COMPLETED|Overall Study||9
10064417|NCT02124044|11190179|FG000|NOT COMPLETED|Overall Study||0
10064418|NCT02124044|11190180|FG001|NOT COMPLETED|Overall Study||1
10064419|NCT02124083|11190186|FG000|STARTED|Overall Study||12
10064420|NCT02124083|11190186|FG000|COMPLETED|Overall Study||11
10064421|NCT02124083|11190186|FG000|NOT COMPLETED|Overall Study||1
10064422|NCT02124122|11190192|FG000|STARTED|Overall Study||41
10064423|NCT02124122|11190193|FG001|STARTED|Overall Study||19
10064424|NCT02124122|11190192|FG000|COMPLETED|Overall Study||41
10064425|NCT02124122|11190193|FG001|COMPLETED|Overall Study||19
10064426|NCT02124122|11190192|FG000|NOT COMPLETED|Overall Study||0
10064427|NCT02124122|11190193|FG001|NOT COMPLETED|Overall Study||0
10064428|NCT02124161|11190201|FG000|STARTED|Overall Study||441
10064429|NCT02124161|11190202|FG001|STARTED|Overall Study||441
10064430|NCT02124161|11190201|FG000|Vaccination 1|Overall Study||439
10064431|NCT02124161|11190202|FG001|Vaccination 1|Overall Study||437
10064432|NCT02124161|11190201|FG000|Vaccination 2|Overall Study||431
10064433|NCT02124161|11190202|FG001|Vaccination 2|Overall Study||432
10064434|NCT02124161|11190201|FG000|COMPLETED|Overall Study||425
10064435|NCT02124161|11190202|FG001|COMPLETED|Overall Study||426
10064436|NCT02124161|11190201|FG000|NOT COMPLETED|Overall Study||16
10064437|NCT02124161|11190202|FG001|NOT COMPLETED|Overall Study||15
10064438|NCT02124265|11190215|FG000|STARTED|Overall Study||3
10064439|NCT02124265|11190215|FG000|COMPLETED|Overall Study||2
10064440|NCT02124265|11190215|FG000|NOT COMPLETED|Overall Study||1
10064441|NCT02124304|11190221|FG000|STARTED|Overall Study||15
10064442|NCT02124304|11190222|FG001|STARTED|Overall Study||15
10064443|NCT02124304|11190221|FG000|COMPLETED|Overall Study||15
10064444|NCT02124304|11190222|FG001|COMPLETED|Overall Study||15
10064445|NCT02124304|11190221|FG000|NOT COMPLETED|Overall Study||0
10064446|NCT02124304|11190222|FG001|NOT COMPLETED|Overall Study||0
10064447|NCT02124460|11190230|FG000|STARTED|Overall Study||361
10064448|NCT02124460|11190231|FG001|STARTED|Overall Study||360
10064449|NCT02124460|11190230|FG000|COMPLETED|Overall Study||328
10064450|NCT02124460|11190231|FG001|COMPLETED|Overall Study||336
10064451|NCT02124460|11190230|FG000|NOT COMPLETED|Overall Study||33
10064452|NCT02124460|11190231|FG001|NOT COMPLETED|Overall Study||24
10064453|NCT02124512|11190240|FG000|STARTED|Overall Study||6
10064454|NCT02124512|11190241|FG001|STARTED|Overall Study||6
10064455|NCT02124512|11190240|FG000|COMPLETED|Overall Study||6
10064456|NCT02124512|11190241|FG001|COMPLETED|Overall Study||6
10064457|NCT02124512|11190240|FG000|NOT COMPLETED|Overall Study||0
10064458|NCT02124512|11190241|FG001|NOT COMPLETED|Overall Study||0
10064459|NCT02124564|11190247|FG000|STARTED|Treatment Period||19
10064460|NCT02124564|11190247|FG000|Started Treatment Period|Treatment Period||19
10064461|NCT02124564|11190247|FG000|Started Titration Period|Treatment Period||19
10064462|NCT02124564|11190247|FG000|Started AED Withdrawal Period|Treatment Period||19
10064463|NCT02124564|11190247|FG000|Started Monotherapy Period|Treatment Period||17
10064464|NCT02124564|11190247|FG000|Started Evaluation Period|Treatment Period||17
10064465|NCT02124564|11190247|FG000|Started Follow-Up Period|Treatment Period||13
10064466|NCT02124564|11190247|FG000|COMPLETED|Treatment Period||12
10064467|NCT02124564|11190247|FG000|NOT COMPLETED|Treatment Period||7
10064468|NCT02124564|11190247|FG000|STARTED|Taper Period||2
10064469|NCT02124564|11190247|FG000|COMPLETED|Taper Period||2
10064470|NCT02124564|11190247|FG000|NOT COMPLETED|Taper Period||0
10064471|NCT02124603|11190252|FG000|STARTED|Overall Study||120
10064472|NCT02124603|11190252|FG000|COMPLETED|Overall Study||120
10064473|NCT02124603|11190252|FG000|NOT COMPLETED|Overall Study||0
10064474|NCT02124707|11190257|FG000|STARTED|Overall Study||14
10064475|NCT02124707|11190257|FG000|COMPLETED|Overall Study||7
10064476|NCT02124707|11190257|FG000|NOT COMPLETED|Overall Study||7
10064477|NCT02124746|11190265|FG000|STARTED|Overall Study||30
10064478|NCT02124746|11190266|FG001|STARTED|Overall Study||22
10064479|NCT02124746|11190267|FG002|STARTED|Overall Study||22
10064480|NCT02124746|11190265|FG000|COMPLETED|Overall Study||11
10064481|NCT02124746|11190266|FG001|COMPLETED|Overall Study||4
10064482|NCT02124746|11190267|FG002|COMPLETED|Overall Study||0
10064483|NCT02124746|11190265|FG000|NOT COMPLETED|Overall Study||19
10064484|NCT02124746|11190266|FG001|NOT COMPLETED|Overall Study||18
10064485|NCT02124746|11190267|FG002|NOT COMPLETED|Overall Study||22
10064486|NCT02124759|11190278|FG000|STARTED|Overall Study||6
10064487|NCT02124759|11190279|FG001|STARTED|Overall Study||7
10064488|NCT02124759|11190280|FG002|STARTED|Overall Study||7
10064489|NCT02124759|11190278|FG000|Subjects Randomized to Intervention|Overall Study||4
10064490|NCT02124759|11190279|FG001|Subjects Randomized to Intervention|Overall Study||5
10064491|NCT02124759|11190280|FG002|Subjects Randomized to Intervention|Overall Study||4
10064492|NCT02124759|11190278|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4
10064493|NCT02124759|11190279|FG001|Low Fat Diet|Overall Study||4
10064494|NCT02124759|11190280|FG002|Low Fat Diet|Overall Study||4
10064495|NCT02124759|11190278|FG000|High Fat Diet|Overall Study|1 subject did not complete|2
10064496|NCT02124759|11190279|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5
10064497|NCT02124759|11190280|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4
10064498|NCT02124759|11190278|FG000|COMPLETED|Overall Study||1
10064499|NCT02124759|11190279|FG001|COMPLETED|Overall Study||4
10064500|NCT02124759|11190280|FG002|COMPLETED|Overall Study||3
10064501|NCT02124759|11190278|FG000|NOT COMPLETED|Overall Study||5
10064502|NCT02124759|11190279|FG001|NOT COMPLETED|Overall Study||3
10064503|NCT02124759|11190280|FG002|NOT COMPLETED|Overall Study||4
10064504|NCT02124772|11190306|FG000|STARTED|Overall Study||3
10064505|NCT02124772|11190307|FG001|STARTED|Overall Study||19
10064506|NCT02124772|11190308|FG002|STARTED|Overall Study||12
10064507|NCT02124772|11190309|FG003|STARTED|Overall Study||16
10064508|NCT02124772|11190310|FG004|STARTED|Overall Study||11
10064509|NCT02124772|11190311|FG005|STARTED|Overall Study||10
10064510|NCT02124772|11190312|FG006|STARTED|Overall Study||10
10064511|NCT02124772|11190313|FG007|STARTED|Overall Study||10
10064512|NCT02124772|11190314|FG008|STARTED|Overall Study||3
10064513|NCT02124772|11190315|FG009|STARTED|Overall Study||9
10064514|NCT02124772|11190316|FG010|STARTED|Overall Study||6
10064515|NCT02124772|11190317|FG011|STARTED|Overall Study||20
10064516|NCT02124772|11190318|FG012|STARTED|Overall Study||10
10064517|NCT02124772|11190306|FG000|COMPLETED|Overall Study||0
10064518|NCT02124772|11190307|FG001|COMPLETED|Overall Study||5
10064519|NCT02124772|11190308|FG002|COMPLETED|Overall Study||6
10064520|NCT02124772|11190309|FG003|COMPLETED|Overall Study||3
10064521|NCT02124772|11190310|FG004|COMPLETED|Overall Study||2
10064522|NCT02124772|11190311|FG005|COMPLETED|Overall Study||2
10064523|NCT02124772|11190312|FG006|COMPLETED|Overall Study||2
10064524|NCT02124772|11190313|FG007|COMPLETED|Overall Study||1
10064525|NCT02124772|11190314|FG008|COMPLETED|Overall Study||2
10064526|NCT02124772|11190315|FG009|COMPLETED|Overall Study||2
10064527|NCT02124772|11190316|FG010|COMPLETED|Overall Study||4
10064528|NCT02124772|11190317|FG011|COMPLETED|Overall Study||14
10064529|NCT02124772|11190318|FG012|COMPLETED|Overall Study||8
10064530|NCT02124772|11190306|FG000|NOT COMPLETED|Overall Study||3
10064531|NCT02124772|11190307|FG001|NOT COMPLETED|Overall Study||14
10064532|NCT02124772|11190308|FG002|NOT COMPLETED|Overall Study||6
10064533|NCT02124772|11190309|FG003|NOT COMPLETED|Overall Study||13
10064534|NCT02124772|11190310|FG004|NOT COMPLETED|Overall Study||9
10064535|NCT02124772|11190311|FG005|NOT COMPLETED|Overall Study||8
10064536|NCT02124772|11190312|FG006|NOT COMPLETED|Overall Study||8
10064537|NCT02124772|11190313|FG007|NOT COMPLETED|Overall Study||9
10064538|NCT02124772|11190314|FG008|NOT COMPLETED|Overall Study||1
10064539|NCT02124772|11190315|FG009|NOT COMPLETED|Overall Study||7
10064540|NCT02124772|11190316|FG010|NOT COMPLETED|Overall Study||2
10064541|NCT02124772|11190317|FG011|NOT COMPLETED|Overall Study||6
10064542|NCT02124772|11190318|FG012|NOT COMPLETED|Overall Study||2
10064543|NCT02124798|11190370|FG000|STARTED|Overall Study||95
10064544|NCT02124798|11190370|FG000|COMPLETED|Overall Study||91
10064545|NCT02124798|11190370|FG000|NOT COMPLETED|Overall Study||4
10064546|NCT02124811|11190376|FG000|STARTED|Overall Study||5
10064547|NCT02124811|11190377|FG001|STARTED|Overall Study||5
10064548|NCT02124811|11190376|FG000|COMPLETED|Overall Study||2
10064549|NCT02124811|11190377|FG001|COMPLETED|Overall Study||3
10064550|NCT02124811|11190376|FG000|NOT COMPLETED|Overall Study||3
10064551|NCT02124811|11190377|FG001|NOT COMPLETED|Overall Study||2
10064552|NCT02124863|11190383|FG000|STARTED|Overall Study||67
10064553|NCT02124863|11190383|FG000|COMPLETED|Overall Study||50
10064554|NCT02124863|11190383|FG000|NOT COMPLETED|Overall Study||17
10064555|NCT02124889|11190391|FG000|STARTED|Overall Study||12
10064556|NCT02124889|11190392|FG001|STARTED|Overall Study||12
10064557|NCT02124889|11190391|FG000|COMPLETED|Overall Study||12
10064558|NCT02124889|11190392|FG001|COMPLETED|Overall Study||12
10064559|NCT02124889|11190391|FG000|NOT COMPLETED|Overall Study||0
10064560|NCT02124889|11190392|FG001|NOT COMPLETED|Overall Study||0
10064561|NCT02125279|11190398|FG000|STARTED|Overall Study||54
10064562|NCT02125279|11190398|FG000|COMPLETED|Overall Study||41
10064563|NCT02125279|11190398|FG000|NOT COMPLETED|Overall Study||13
10064564|NCT02125292|11190404|FG000|STARTED|First Intervention (1 Hour)||3
10064565|NCT02125292|11190405|FG001|STARTED|First Intervention (1 Hour)||3
10064566|NCT02125292|11190406|FG002|STARTED|First Intervention (1 Hour)||3
10064567|NCT02125292|11190407|FG003|STARTED|First Intervention (1 Hour)||3
10064568|NCT02125292|11190408|FG004|STARTED|First Intervention (1 Hour)||3
10064569|NCT02125292|11190409|FG005|STARTED|First Intervention (1 Hour)||3
10064570|NCT02125292|11190404|FG000|COMPLETED|First Intervention (1 Hour)||3
10064571|NCT02125292|11190405|FG001|COMPLETED|First Intervention (1 Hour)||3
10064572|NCT02125292|11190406|FG002|COMPLETED|First Intervention (1 Hour)||3
10064573|NCT02125292|11190407|FG003|COMPLETED|First Intervention (1 Hour)||3
10064574|NCT02125292|11190408|FG004|COMPLETED|First Intervention (1 Hour)||3
10064575|NCT02125292|11190409|FG005|COMPLETED|First Intervention (1 Hour)||3
10064576|NCT02125292|11190404|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
10064577|NCT02125292|11190405|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
10064578|NCT02125292|11190406|FG002|NOT COMPLETED|First Intervention (1 Hour)||0
10064579|NCT02125292|11190407|FG003|NOT COMPLETED|First Intervention (1 Hour)||0
10064580|NCT02125292|11190408|FG004|NOT COMPLETED|First Intervention (1 Hour)||0
10064581|NCT02125292|11190409|FG005|NOT COMPLETED|First Intervention (1 Hour)||0
10064582|NCT02125292|11190404|FG000|STARTED|Washout (2 Hours)||3
10064583|NCT02125292|11190405|FG001|STARTED|Washout (2 Hours)||3
10064584|NCT02125292|11190406|FG002|STARTED|Washout (2 Hours)||3
10064585|NCT02125292|11190407|FG003|STARTED|Washout (2 Hours)||3
10064586|NCT02125292|11190408|FG004|STARTED|Washout (2 Hours)||3
10064587|NCT02125292|11190409|FG005|STARTED|Washout (2 Hours)||3
10064588|NCT02125292|11190404|FG000|COMPLETED|Washout (2 Hours)||3
10064589|NCT02125292|11190405|FG001|COMPLETED|Washout (2 Hours)||3
10064590|NCT02125292|11190406|FG002|COMPLETED|Washout (2 Hours)||3
10064591|NCT02125292|11190407|FG003|COMPLETED|Washout (2 Hours)||3
10064592|NCT02125292|11190408|FG004|COMPLETED|Washout (2 Hours)||3
10064593|NCT02125292|11190409|FG005|COMPLETED|Washout (2 Hours)||3
10064594|NCT02125292|11190404|FG000|NOT COMPLETED|Washout (2 Hours)||0
10064595|NCT02125292|11190405|FG001|NOT COMPLETED|Washout (2 Hours)||0
10064596|NCT02125292|11190406|FG002|NOT COMPLETED|Washout (2 Hours)||0
10064597|NCT02125292|11190407|FG003|NOT COMPLETED|Washout (2 Hours)||0
10064598|NCT02125292|11190408|FG004|NOT COMPLETED|Washout (2 Hours)||0
10064599|NCT02125292|11190409|FG005|NOT COMPLETED|Washout (2 Hours)||0
10064600|NCT02125292|11190404|FG000|STARTED|Second Intervention (1 Hour)||3
10064601|NCT02125292|11190405|FG001|STARTED|Second Intervention (1 Hour)||3
10064602|NCT02125292|11190406|FG002|STARTED|Second Intervention (1 Hour)||3
10064603|NCT02125292|11190407|FG003|STARTED|Second Intervention (1 Hour)||3
10064604|NCT02125292|11190408|FG004|STARTED|Second Intervention (1 Hour)||3
10064605|NCT02125292|11190409|FG005|STARTED|Second Intervention (1 Hour)||3
10064606|NCT02125292|11190404|FG000|COMPLETED|Second Intervention (1 Hour)||3
10064607|NCT02125292|11190405|FG001|COMPLETED|Second Intervention (1 Hour)||3
10064608|NCT02125292|11190406|FG002|COMPLETED|Second Intervention (1 Hour)||3
10064609|NCT02125292|11190407|FG003|COMPLETED|Second Intervention (1 Hour)||3
10064610|NCT02125292|11190408|FG004|COMPLETED|Second Intervention (1 Hour)||3
10064611|NCT02125292|11190409|FG005|COMPLETED|Second Intervention (1 Hour)||3
10064612|NCT02125292|11190404|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0
10064613|NCT02125292|11190405|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0
10064614|NCT02125292|11190406|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0
10064615|NCT02125292|11190407|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0
10064616|NCT02125292|11190408|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0
10064617|NCT02125292|11190409|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0
10064618|NCT02125292|11190404|FG000|STARTED|Washout (2 Hours)||3
10064619|NCT02125292|11190405|FG001|STARTED|Washout (2 Hours)||3
10064620|NCT02125292|11190406|FG002|STARTED|Washout (2 Hours)||3
10064621|NCT02125292|11190407|FG003|STARTED|Washout (2 Hours)||3
10064622|NCT02125292|11190408|FG004|STARTED|Washout (2 Hours)||3
10064623|NCT02125292|11190409|FG005|STARTED|Washout (2 Hours)||3
10064624|NCT02125292|11190404|FG000|COMPLETED|Washout (2 Hours)||3
10064625|NCT02125292|11190405|FG001|COMPLETED|Washout (2 Hours)||3
10064626|NCT02125292|11190406|FG002|COMPLETED|Washout (2 Hours)||3
10064627|NCT02125292|11190407|FG003|COMPLETED|Washout (2 Hours)||3
10064628|NCT02125292|11190408|FG004|COMPLETED|Washout (2 Hours)||3
10064629|NCT02125292|11190409|FG005|COMPLETED|Washout (2 Hours)||3
10188459|NCT03267940|11318044|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
10188460|NCT03267940|11318045|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
10064630|NCT02125292|11190404|FG000|NOT COMPLETED|Washout (2 Hours)||0
10064631|NCT02125292|11190405|FG001|NOT COMPLETED|Washout (2 Hours)||0
10064632|NCT02125292|11190406|FG002|NOT COMPLETED|Washout (2 Hours)||0
10064633|NCT02125292|11190407|FG003|NOT COMPLETED|Washout (2 Hours)||0
10064634|NCT02125292|11190408|FG004|NOT COMPLETED|Washout (2 Hours)||0
10064635|NCT02125292|11190409|FG005|NOT COMPLETED|Washout (2 Hours)||0
10064636|NCT02125292|11190404|FG000|STARTED|Third Intervention (1 Hour)||3
10064637|NCT02125292|11190405|FG001|STARTED|Third Intervention (1 Hour)||3
10064638|NCT02125292|11190406|FG002|STARTED|Third Intervention (1 Hour)||3
10064639|NCT02125292|11190407|FG003|STARTED|Third Intervention (1 Hour)||3
10064640|NCT02125292|11190408|FG004|STARTED|Third Intervention (1 Hour)||3
10064641|NCT02125292|11190409|FG005|STARTED|Third Intervention (1 Hour)||3
10064642|NCT02125292|11190404|FG000|COMPLETED|Third Intervention (1 Hour)||3
10064643|NCT02125292|11190405|FG001|COMPLETED|Third Intervention (1 Hour)||3
10064644|NCT02125292|11190406|FG002|COMPLETED|Third Intervention (1 Hour)||3
10064645|NCT02125292|11190407|FG003|COMPLETED|Third Intervention (1 Hour)||3
10064646|NCT02125292|11190408|FG004|COMPLETED|Third Intervention (1 Hour)||3
10064647|NCT02125292|11190409|FG005|COMPLETED|Third Intervention (1 Hour)||3
10064648|NCT02125292|11190404|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0
10064649|NCT02125292|11190405|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0
10064650|NCT02125292|11190406|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0
10064651|NCT02125292|11190407|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0
10064652|NCT02125292|11190408|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0
10064653|NCT02125292|11190409|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0
10064654|NCT02125331|11190420|FG000|STARTED|Overall Study||58
10064655|NCT02125331|11190421|FG001|STARTED|Overall Study||25
10064656|NCT02125331|11190420|FG000|COMPLETED|Overall Study||53
10064657|NCT02125331|11190421|FG001|COMPLETED|Overall Study||25
10064658|NCT02125331|11190420|FG000|NOT COMPLETED|Overall Study||5
10064659|NCT02125331|11190421|FG001|NOT COMPLETED|Overall Study||0
10064660|NCT02125604|11190427|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
10064661|NCT02125604|11190427|FG000|COMPLETED|Overall Study||180
10064662|NCT02125604|11190427|FG000|NOT COMPLETED|Overall Study||31
10064663|NCT02125721|11190431|FG000|STARTED|Overall Study||10
10064664|NCT02125721|11190431|FG000|COMPLETED|Overall Study||10
10064665|NCT02125721|11190431|FG000|NOT COMPLETED|Overall Study||0
10064666|NCT02125734|11190437|FG000|STARTED|Period 1||40
10064667|NCT02125734|11190438|FG001|STARTED|Period 1||48
10064668|NCT02125734|11190437|FG000|COMPLETED|Period 1||40
10064669|NCT02125734|11190438|FG001|COMPLETED|Period 1||48
10064670|NCT02125734|11190437|FG000|NOT COMPLETED|Period 1||0
10064671|NCT02125734|11190438|FG001|NOT COMPLETED|Period 1||0
10064672|NCT02125734|11190437|FG000|STARTED|Period 2||40
10064673|NCT02125734|11190438|FG001|STARTED|Period 2||48
10064674|NCT02125734|11190437|FG000|COMPLETED|Period 2||40
10064675|NCT02125734|11190438|FG001|COMPLETED|Period 2||47
10064676|NCT02125734|11190437|FG000|NOT COMPLETED|Period 2||0
10064677|NCT02125734|11190438|FG001|NOT COMPLETED|Period 2||1
10064678|NCT02125838|11190446|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
10064679|NCT02125838|11190447|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
10064680|NCT02125838|11190446|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50
10064681|NCT02125838|11190447|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50
10064682|NCT02125838|11190446|FG000|NOT COMPLETED|Overall Study||4
10064683|NCT02125838|11190447|FG001|NOT COMPLETED|Overall Study||4
10064684|NCT02125877|11190455|FG000|STARTED|Overall Study||86
10064685|NCT02125877|11190456|FG001|STARTED|Overall Study||87
10064686|NCT02125877|11190455|FG000|Pharmacokinetic Analysis Set|Overall Study||83
10064687|NCT02125877|11190456|FG001|Pharmacokinetic Analysis Set|Overall Study||83
10064688|NCT02125877|11190455|FG000|Pharmacokinetic Subset A|Overall Study||16
10064689|NCT02125877|11190456|FG001|Pharmacokinetic Subset A|Overall Study||15
10064690|NCT02125877|11190455|FG000|Safety Set|Overall Study||86
10064691|NCT02125877|11190456|FG001|Safety Set|Overall Study||87
10064692|NCT02125877|11190455|FG000|COMPLETED|Overall Study||73
10064693|NCT02125877|11190456|FG001|COMPLETED|Overall Study||77
10064694|NCT02125877|11190455|FG000|NOT COMPLETED|Overall Study||13
10064695|NCT02125877|11190456|FG001|NOT COMPLETED|Overall Study||10
10064696|NCT02126306|11190464|FG000|STARTED|Overall Study||10
10064697|NCT02126306|11190465|FG001|STARTED|Overall Study||13
10064698|NCT02126306|11190464|FG000|COMPLETED|Overall Study||10
10064699|NCT02126306|11190465|FG001|COMPLETED|Overall Study||13
10064700|NCT02126306|11190464|FG000|NOT COMPLETED|Overall Study||0
10064701|NCT02126306|11190465|FG001|NOT COMPLETED|Overall Study||0
10064702|NCT02126319|11190473|FG000|STARTED|Overall Study||61
10064703|NCT02126319|11190474|FG001|STARTED|Overall Study||67
10064704|NCT02126319|11190473|FG000|COMPLETED|Overall Study||40
10064705|NCT02126319|11190474|FG001|COMPLETED|Overall Study||43
10064706|NCT02126319|11190473|FG000|NOT COMPLETED|Overall Study||21
10064707|NCT02126319|11190474|FG001|NOT COMPLETED|Overall Study||24
10064708|NCT02126670|11190486|FG000|STARTED|Overall Study||26
10064709|NCT02126670|11190487|FG001|STARTED|Overall Study||24
10064710|NCT02126670|11190488|FG002|STARTED|Overall Study||25
10064711|NCT02126670|11190489|FG003|STARTED|Overall Study||25
10064712|NCT02126670|11190486|FG000|COMPLETED|Overall Study||25
10064713|NCT02126670|11190487|FG001|COMPLETED|Overall Study||24
10064714|NCT02126670|11190488|FG002|COMPLETED|Overall Study||25
10064715|NCT02126670|11190489|FG003|COMPLETED|Overall Study||24
10064716|NCT02126670|11190486|FG000|NOT COMPLETED|Overall Study||1
10064717|NCT02126670|11190487|FG001|NOT COMPLETED|Overall Study||0
10064718|NCT02126670|11190488|FG002|NOT COMPLETED|Overall Study||0
10064719|NCT02126670|11190489|FG003|NOT COMPLETED|Overall Study||1
10064720|NCT02126748|11190502|FG000|STARTED|Overall Study||33
10064721|NCT02126748|11190503|FG001|STARTED|Overall Study||34
10064722|NCT02126748|11190504|FG002|STARTED|Overall Study||36
10064723|NCT02126748|11190502|FG000|COMPLETED|Overall Study||31
10064724|NCT02126748|11190503|FG001|COMPLETED|Overall Study||31
10064725|NCT02126748|11190504|FG002|COMPLETED|Overall Study||31
10064726|NCT02126748|11190502|FG000|NOT COMPLETED|Overall Study||2
10064727|NCT02126748|11190503|FG001|NOT COMPLETED|Overall Study||3
10064728|NCT02126748|11190504|FG002|NOT COMPLETED|Overall Study||5
10064729|NCT02126826|11190519|FG000|STARTED|Overall Study||9
10064730|NCT02126826|11190520|FG001|STARTED|Overall Study||9
10064731|NCT02126826|11190521|FG002|STARTED|Overall Study||9
10064732|NCT02126826|11190522|FG003|STARTED|Overall Study||9
10064733|NCT02126826|11190523|FG004|STARTED|Overall Study||5
10188461|NCT03267940|11318046|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10188462|NCT03267940|11318047|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10188463|NCT03267940|11318048|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10188464|NCT03267940|11318049|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10188465|NCT03267940|11318044|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
10188466|NCT03267940|11318045|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
10188467|NCT03267940|11318046|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10188468|NCT03267940|11318047|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10188469|NCT03267940|11318048|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10188470|NCT03267940|11318049|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10188471|NCT03267940|11318044|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
10188472|NCT03267940|11318045|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
10188473|NCT03267940|11318046|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188474|NCT03267940|11318047|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188475|NCT03267940|11318048|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188476|NCT03267940|11318049|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188477|NCT03267940|11318044|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
10188478|NCT03267940|11318045|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
10188479|NCT03267940|11318046|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188480|NCT03267940|11318047|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188481|NCT03267940|11318048|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188482|NCT03267940|11318049|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10188483|NCT03267940|11318044|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0
10188484|NCT03267940|11318045|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0
10188485|NCT03267940|11318046|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24
10188486|NCT03267940|11318047|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22
10188487|NCT03267940|11318048|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11
10188488|NCT03267940|11318049|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10
10188489|NCT03267940|11318044|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
10188490|NCT03267940|11318045|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
10188491|NCT03267940|11318046|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
10188492|NCT03267940|11318047|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
10188493|NCT03267940|11318048|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
10188494|NCT03267940|11318049|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
10188495|NCT03267940|11318044|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10188496|NCT03267940|11318045|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10188497|NCT03267940|11318046|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
10188498|NCT03267940|11318047|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10188499|NCT03267940|11318048|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
10188500|NCT03267940|11318049|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10188501|NCT03267940|11318044|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10188502|NCT03267940|11318045|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10188503|NCT03267940|11318046|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
10188504|NCT03267940|11318047|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
10188505|NCT03267940|11318048|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
10188506|NCT03267940|11318049|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
10188507|NCT03268343|11318067|FG000|STARTED|Overall Study||12
10188508|NCT03268343|11318068|FG001|STARTED|Overall Study||12
10188509|NCT03268343|11318067|FG000|COMPLETED|Overall Study||12
10188510|NCT03268343|11318068|FG001|COMPLETED|Overall Study||12
10188511|NCT03268343|11318067|FG000|NOT COMPLETED|Overall Study||0
10064734|NCT02126826|11190524|FG005|STARTED|Overall Study||9
10064735|NCT02126826|11190525|FG006|STARTED|Overall Study||8
10064736|NCT02126826|11190519|FG000|COMPLETED|Overall Study||9
10064737|NCT02126826|11190520|FG001|COMPLETED|Overall Study||9
10064738|NCT02126826|11190521|FG002|COMPLETED|Overall Study||9
10064739|NCT02126826|11190522|FG003|COMPLETED|Overall Study||8
10064740|NCT02126826|11190523|FG004|COMPLETED|Overall Study||5
10064741|NCT02126826|11190524|FG005|COMPLETED|Overall Study||9
10064742|NCT02126826|11190525|FG006|COMPLETED|Overall Study||8
10064743|NCT02126826|11190519|FG000|NOT COMPLETED|Overall Study||0
10064744|NCT02126826|11190520|FG001|NOT COMPLETED|Overall Study||0
10064745|NCT02126826|11190521|FG002|NOT COMPLETED|Overall Study||0
10064746|NCT02126826|11190522|FG003|NOT COMPLETED|Overall Study||1
10064747|NCT02126826|11190523|FG004|NOT COMPLETED|Overall Study||0
10064748|NCT02126826|11190524|FG005|NOT COMPLETED|Overall Study||0
10064749|NCT02126826|11190525|FG006|NOT COMPLETED|Overall Study||0
10064750|NCT02126839|11190548|FG000|STARTED|Overall Study||92
10064751|NCT02126839|11190549|FG001|STARTED|Overall Study||94
10064752|NCT02126839|11190548|FG000|Safety Population|Overall Study||92
10064753|NCT02126839|11190549|FG001|Safety Population|Overall Study||93
10064754|NCT02126839|11190548|FG000|Full Analysis Set|Overall Study||92
10064755|NCT02126839|11190549|FG001|Full Analysis Set|Overall Study||92
10064756|NCT02126839|11190548|FG000|COMPLETED|Overall Study||82
10064757|NCT02126839|11190549|FG001|COMPLETED|Overall Study||80
10064758|NCT02126839|11190548|FG000|NOT COMPLETED|Overall Study||10
10064759|NCT02126839|11190549|FG001|NOT COMPLETED|Overall Study||14
10064760|NCT02126969|11190557|FG000|STARTED|Overall Study||23
10064761|NCT02126969|11190558|FG001|STARTED|Overall Study||22
10064762|NCT02126969|11190557|FG000|COMPLETED|Overall Study||22
10064763|NCT02126969|11190558|FG001|COMPLETED|Overall Study||20
10064764|NCT02126969|11190557|FG000|NOT COMPLETED|Overall Study||1
10064765|NCT02126969|11190558|FG001|NOT COMPLETED|Overall Study||2
10064766|NCT02127125|11190573|FG000|STARTED|Overall Study||6
10064767|NCT02127125|11190574|FG001|STARTED|Overall Study||8
10064768|NCT02127125|11190575|FG002|STARTED|Overall Study||9
10064769|NCT02127125|11190576|FG003|STARTED|Overall Study||11
10064770|NCT02127125|11190577|FG004|STARTED|Overall Study||12
10064771|NCT02127125|11190578|FG005|STARTED|Overall Study||12
10064772|NCT02127125|11190579|FG006|STARTED|Overall Study||2
10064773|NCT02127125|11190580|FG007|STARTED|Overall Study||0
10064774|NCT02127125|11190581|FG008|STARTED|Overall Study||1
10064775|NCT02127125|11190573|FG000|COMPLETED|Overall Study||6
10064776|NCT02127125|11190574|FG001|COMPLETED|Overall Study||8
10064777|NCT02127125|11190575|FG002|COMPLETED|Overall Study||8
10064778|NCT02127125|11190576|FG003|COMPLETED|Overall Study||10
10064779|NCT02127125|11190577|FG004|COMPLETED|Overall Study||9
10064780|NCT02127125|11190578|FG005|COMPLETED|Overall Study||9
10064781|NCT02127125|11190579|FG006|COMPLETED|Overall Study||2
10064782|NCT02127125|11190580|FG007|COMPLETED|Overall Study||0
10064783|NCT02127125|11190581|FG008|COMPLETED|Overall Study||1
10064784|NCT02127125|11190573|FG000|NOT COMPLETED|Overall Study||0
10064785|NCT02127125|11190574|FG001|NOT COMPLETED|Overall Study||0
10064786|NCT02127125|11190575|FG002|NOT COMPLETED|Overall Study||1
10064787|NCT02127125|11190576|FG003|NOT COMPLETED|Overall Study||1
10064788|NCT02127125|11190577|FG004|NOT COMPLETED|Overall Study||3
10064789|NCT02127125|11190578|FG005|NOT COMPLETED|Overall Study||3
10064790|NCT02127125|11190579|FG006|NOT COMPLETED|Overall Study||0
10064791|NCT02127125|11190580|FG007|NOT COMPLETED|Overall Study||0
10064792|NCT02127125|11190581|FG008|NOT COMPLETED|Overall Study||0
10064793|NCT02127281|11190603|FG000|STARTED|Overall Study||80
10064794|NCT02127281|11190604|FG001|STARTED|Overall Study||80
10064795|NCT02127281|11190603|FG000|COMPLETED|Overall Study||79
10064796|NCT02127281|11190604|FG001|COMPLETED|Overall Study||80
10064797|NCT02127281|11190603|FG000|NOT COMPLETED|Overall Study||1
10064798|NCT02127281|11190604|FG001|NOT COMPLETED|Overall Study||0
10064799|NCT02127307|11190610|FG000|STARTED|Overall Study||964
10064800|NCT02127307|11190610|FG000|COMPLETED|Overall Study||656
10064801|NCT02127307|11190610|FG000|NOT COMPLETED|Overall Study||308
10064802|NCT02127372|11190616|FG000|STARTED|Overall Study|Signed Consent|15
10064803|NCT02127372|11190617|FG001|STARTED|Overall Study|Signed Consent|28
10064804|NCT02127372|11190616|FG000|Started Study Treatment|Overall Study||15
10064805|NCT02127372|11190617|FG001|Started Study Treatment|Overall Study||28
10064806|NCT02127372|11190616|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
10064807|NCT02127372|11190617|FG001|COMPLETED|Overall Study||28
10064808|NCT02127372|11190616|FG000|NOT COMPLETED|Overall Study||1
10064809|NCT02127372|11190617|FG001|NOT COMPLETED|Overall Study||0
10064810|NCT02127567|11190624|FG000|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
10064811|NCT02127567|11190624|FG000|COMPLETED|Overall Study||41
10064812|NCT02127567|11190624|FG000|NOT COMPLETED|Overall Study||0
10064813|NCT02127632|11190634|FG000|STARTED|Overall Study||50
10064814|NCT02127632|11190635|FG001|STARTED|Overall Study||50
10064815|NCT02127632|11190634|FG000|COMPLETED|Overall Study||50
10064816|NCT02127632|11190635|FG001|COMPLETED|Overall Study||50
10064817|NCT02127632|11190634|FG000|NOT COMPLETED|Overall Study||0
10064818|NCT02127632|11190635|FG001|NOT COMPLETED|Overall Study||0
10064819|NCT02127710|11190644|FG000|STARTED|Overall Study||46
10064820|NCT02127710|11190645|FG001|STARTED|Overall Study||47
10064821|NCT02127710|11190646|FG002|STARTED|Overall Study||16
10064822|NCT02127710|11190644|FG000|COMPLETED|Overall Study||46
10064823|NCT02127710|11190645|FG001|COMPLETED|Overall Study||47
10064824|NCT02127710|11190646|FG002|COMPLETED|Overall Study||16
10064825|NCT02127710|11190644|FG000|NOT COMPLETED|Overall Study||0
10064826|NCT02127710|11190645|FG001|NOT COMPLETED|Overall Study||0
10064827|NCT02127710|11190646|FG002|NOT COMPLETED|Overall Study||0
10064828|NCT02127723|11190657|FG000|STARTED|Overall Study||20
10064829|NCT02127723|11190657|FG000|COMPLETED|Overall Study||19
10064830|NCT02127723|11190657|FG000|NOT COMPLETED|Overall Study||1
10064831|NCT02127892|11190665|FG000|STARTED|Overall Study||7
10064832|NCT02127892|11190666|FG001|STARTED|Overall Study||2
10064833|NCT02127892|11190667|FG002|STARTED|Overall Study||0
10064834|NCT02127892|11190668|FG003|STARTED|Overall Study||0
10064835|NCT02127892|11190665|FG000|COMPLETED|Overall Study||6
10064836|NCT02127892|11190666|FG001|COMPLETED|Overall Study||1
10064837|NCT02127892|11190667|FG002|COMPLETED|Overall Study||0
10064838|NCT02127892|11190668|FG003|COMPLETED|Overall Study||0
10064839|NCT02127892|11190665|FG000|NOT COMPLETED|Overall Study||1
10064840|NCT02127892|11190666|FG001|NOT COMPLETED|Overall Study||1
10064841|NCT02127892|11190667|FG002|NOT COMPLETED|Overall Study||0
10064842|NCT02127892|11190668|FG003|NOT COMPLETED|Overall Study||0
10064843|NCT02127931|11190678|FG000|STARTED|Overall Study||18
10064844|NCT02127931|11190678|FG000|COMPLETED|Overall Study||17
10064845|NCT02127931|11190678|FG000|NOT COMPLETED|Overall Study||1
10064846|NCT02127970|11190685|FG000|STARTED|Overall Study||349
10064847|NCT02127970|11190686|FG001|STARTED|Overall Study||349
10064848|NCT02127970|11190685|FG000|COMPLETED|Overall Study||323
10064849|NCT02127970|11190686|FG001|COMPLETED|Overall Study||322
10064850|NCT02127970|11190685|FG000|NOT COMPLETED|Overall Study||26
10064851|NCT02127970|11190686|FG001|NOT COMPLETED|Overall Study||27
10064852|NCT02128074|11190692|FG000|STARTED|Overall Study||32
10064853|NCT02128074|11190692|FG000|COMPLETED|Overall Study||26
10064854|NCT02128074|11190692|FG000|NOT COMPLETED|Overall Study||6
10064855|NCT02128217|11190698|FG000|STARTED|Overall Study||17
10064856|NCT02128217|11190699|FG001|STARTED|Overall Study||27
10064857|NCT02128217|11190698|FG000|COMPLETED|Overall Study||17
10064858|NCT02128217|11190699|FG001|COMPLETED|Overall Study||26
10064859|NCT02128217|11190698|FG000|NOT COMPLETED|Overall Study||0
10064860|NCT02128217|11190699|FG001|NOT COMPLETED|Overall Study||1
10064861|NCT02128230|11190710|FG000|STARTED|Overall Study||20
10064862|NCT02128230|11190710|FG000|COMPLETED|Overall Study||1
10064863|NCT02128230|11190710|FG000|NOT COMPLETED|Overall Study||19
10064864|NCT02128269|11190714|FG000|STARTED|Treatment Period||9
10064865|NCT02128269|11190714|FG000|COMPLETED|Treatment Period||7
10064866|NCT02128269|11190714|FG000|NOT COMPLETED|Treatment Period||2
10064867|NCT02128269|11190714|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
10064868|NCT02128269|11190714|FG000|COMPLETED|Follow-up||9
10064869|NCT02128269|11190714|FG000|NOT COMPLETED|Follow-up||0
10064870|NCT02128490|11190723|FG000|STARTED|Overall Study||38
10064871|NCT02128490|11190724|FG001|STARTED|Overall Study||37
10064872|NCT02128490|11190725|FG002|STARTED|Overall Study||39
10064873|NCT02128490|11190726|FG003|STARTED|Overall Study||37
10064874|NCT02128490|11190727|FG004|STARTED|Overall Study||38
10064875|NCT02128490|11190723|FG000|COMPLETED|Overall Study||33
10064876|NCT02128490|11190724|FG001|COMPLETED|Overall Study||31
10064877|NCT02128490|11190725|FG002|COMPLETED|Overall Study||34
10064878|NCT02128490|11190726|FG003|COMPLETED|Overall Study||31
10064879|NCT02128490|11190727|FG004|COMPLETED|Overall Study||31
10064880|NCT02128490|11190723|FG000|NOT COMPLETED|Overall Study||5
10064881|NCT02128490|11190724|FG001|NOT COMPLETED|Overall Study||6
10064882|NCT02128490|11190725|FG002|NOT COMPLETED|Overall Study||5
10064883|NCT02128490|11190726|FG003|NOT COMPLETED|Overall Study||6
10064884|NCT02128490|11190727|FG004|NOT COMPLETED|Overall Study||7
10064885|NCT02128542|11190741|FG000|STARTED|Overall Study||47
10064886|NCT02128542|11190742|FG001|STARTED|Overall Study||19
10064887|NCT02128542|11190741|FG000|COMPLETED|Overall Study||43
10064888|NCT02128542|11190742|FG001|COMPLETED|Overall Study||19
10064889|NCT02128542|11190741|FG000|NOT COMPLETED|Overall Study||4
10064890|NCT02128542|11190742|FG001|NOT COMPLETED|Overall Study||0
10064891|NCT02128724|11190754|FG000|STARTED|Overall Study||4
10064892|NCT02128724|11190755|FG001|STARTED|Overall Study||4
10064893|NCT02128724|11190756|FG002|STARTED|Overall Study||3
10064894|NCT02128724|11190757|FG003|STARTED|Overall Study||10
10064895|NCT02128724|11190754|FG000|COMPLETED|Overall Study||3
10064896|NCT02128724|11190755|FG001|COMPLETED|Overall Study||3
10064897|NCT02128724|11190756|FG002|COMPLETED|Overall Study||3
10064898|NCT02128724|11190757|FG003|COMPLETED|Overall Study||7
10064899|NCT02128724|11190754|FG000|NOT COMPLETED|Overall Study||1
10064900|NCT02128724|11190755|FG001|NOT COMPLETED|Overall Study||1
10064901|NCT02128724|11190756|FG002|NOT COMPLETED|Overall Study||0
10064902|NCT02128724|11190757|FG003|NOT COMPLETED|Overall Study||3
10064903|NCT02128763|11190768|FG000|STARTED|Overall Study||349
10064904|NCT02128763|11190769|FG001|STARTED|Overall Study||186
10064905|NCT02128763|11190768|FG000|COMPLETED|Overall Study||329
10064906|NCT02128763|11190769|FG001|COMPLETED|Overall Study||170
10064907|NCT02128763|11190768|FG000|NOT COMPLETED|Overall Study||20
10064908|NCT02128763|11190769|FG001|NOT COMPLETED|Overall Study||16
10064909|NCT02128828|11190778|FG000|STARTED|Overall Study||20
10064910|NCT02128828|11190778|FG000|COMPLETED|Overall Study||17
10064911|NCT02128828|11190778|FG000|NOT COMPLETED|Overall Study||3
10064912|NCT02128867|11190785|FG000|STARTED|Overall Study||53
10064913|NCT02128867|11190786|FG001|STARTED|Overall Study||52
10064914|NCT02128867|11190787|FG002|STARTED|Overall Study||54
10064915|NCT02128867|11190785|FG000|COMPLETED|Overall Study||50
10064916|NCT02128867|11190786|FG001|COMPLETED|Overall Study||50
10064917|NCT02128867|11190787|FG002|COMPLETED|Overall Study||50
10064918|NCT02128867|11190785|FG000|NOT COMPLETED|Overall Study||3
10064919|NCT02128867|11190786|FG001|NOT COMPLETED|Overall Study||2
10064920|NCT02128867|11190787|FG002|NOT COMPLETED|Overall Study||4
10064921|NCT02128919|11190797|FG000|STARTED|Overall Study||17
10064922|NCT02128919|11190798|FG001|STARTED|Overall Study||16
10064923|NCT02128919|11190797|FG000|COMPLETED|Overall Study||14
10064924|NCT02128919|11190798|FG001|COMPLETED|Overall Study||15
10064925|NCT02128919|11190797|FG000|NOT COMPLETED|Overall Study||3
10064926|NCT02128919|11190798|FG001|NOT COMPLETED|Overall Study||1
10064927|NCT02128932|11190808|FG000|STARTED|Overall Study||362
10064928|NCT02128932|11190809|FG001|STARTED|Overall Study||360
10064929|NCT02128932|11190810|FG002|STARTED|Overall Study||360
10064930|NCT02128932|11190808|FG000|COMPLETED|Overall Study||335
10064931|NCT02128932|11190809|FG001|COMPLETED|Overall Study||341
10064932|NCT02128932|11190810|FG002|COMPLETED|Overall Study||342
10064933|NCT02128932|11190808|FG000|NOT COMPLETED|Overall Study||27
10064934|NCT02128932|11190809|FG001|NOT COMPLETED|Overall Study||19
10064935|NCT02128932|11190810|FG002|NOT COMPLETED|Overall Study||18
10064936|NCT02128997|11190820|FG000|STARTED|Overall Study||67
10064937|NCT02128997|11190821|FG001|STARTED|Overall Study||69
10064938|NCT02128997|11190820|FG000|COMPLETED|Overall Study||61
10064939|NCT02128997|11190821|FG001|COMPLETED|Overall Study||58
10064940|NCT02128997|11190820|FG000|NOT COMPLETED|Overall Study||6
10064941|NCT02128997|11190821|FG001|NOT COMPLETED|Overall Study||11
10064942|NCT02129062|11190827|FG000|STARTED|Overall Study||3
10064943|NCT02129062|11190827|FG000|COMPLETED|Overall Study||0
10064944|NCT02129062|11190827|FG000|NOT COMPLETED|Overall Study||3
10064945|NCT02129075|11190833|FG000|STARTED|Overall Study||30
10064946|NCT02129075|11190834|FG001|STARTED|Overall Study||30
10064947|NCT02129075|11190833|FG000|COMPLETED|Overall Study||30
10064948|NCT02129075|11190834|FG001|COMPLETED|Overall Study||30
10064949|NCT02129075|11190833|FG000|NOT COMPLETED|Overall Study||0
10064950|NCT02129075|11190834|FG001|NOT COMPLETED|Overall Study||0
10064951|NCT02129192|11190844|FG000|STARTED|Period 1 Including Washout Period||36
10064952|NCT02129192|11190845|FG001|STARTED|Period 1 Including Washout Period||36
10064953|NCT02129192|11190844|FG000|COMPLETED|Period 1 Including Washout Period||36
10064954|NCT02129192|11190845|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
10064955|NCT02129192|11190844|FG000|NOT COMPLETED|Period 1 Including Washout Period||0
10064956|NCT02129192|11190845|FG001|NOT COMPLETED|Period 1 Including Washout Period||1
10064957|NCT02129192|11190844|FG000|STARTED|Period 2 Including Washout Period||36
10064958|NCT02129192|11190845|FG001|STARTED|Period 2 Including Washout Period||35
10064959|NCT02129192|11190844|FG000|COMPLETED|Period 2 Including Washout Period||36
10064960|NCT02129192|11190845|FG001|COMPLETED|Period 2 Including Washout Period||35
10064961|NCT02129192|11190844|FG000|NOT COMPLETED|Period 2 Including Washout Period||0
10064962|NCT02129192|11190845|FG001|NOT COMPLETED|Period 2 Including Washout Period||0
10064963|NCT02129192|11190844|FG000|STARTED|Period 3 Including Washout Period||36
10064964|NCT02129192|11190845|FG001|STARTED|Period 3 Including Washout Period||35
10064965|NCT02129192|11190844|FG000|COMPLETED|Period 3 Including Washout Period||36
10064966|NCT02129192|11190845|FG001|COMPLETED|Period 3 Including Washout Period||35
10064967|NCT02129192|11190844|FG000|NOT COMPLETED|Period 3 Including Washout Period||0
10064968|NCT02129192|11190845|FG001|NOT COMPLETED|Period 3 Including Washout Period||0
10064969|NCT02129192|11190844|FG000|STARTED|Period 4 Including Washout Period||36
10064970|NCT02129192|11190845|FG001|STARTED|Period 4 Including Washout Period||35
10064971|NCT02129192|11190844|FG000|COMPLETED|Period 4 Including Washout Period||36
10064972|NCT02129192|11190845|FG001|COMPLETED|Period 4 Including Washout Period||35
10064973|NCT02129192|11190844|FG000|NOT COMPLETED|Period 4 Including Washout Period||0
10064974|NCT02129192|11190845|FG001|NOT COMPLETED|Period 4 Including Washout Period||0
10064975|NCT02129192|11190844|FG000|STARTED|Period 5||36
10064976|NCT02129192|11190845|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0
10064977|NCT02129192|11190844|FG000|COMPLETED|Period 5||36
10064978|NCT02129192|11190845|FG001|COMPLETED|Period 5||0
10064979|NCT02129192|11190844|FG000|NOT COMPLETED|Period 5||0
10064980|NCT02129192|11190845|FG001|NOT COMPLETED|Period 5||0
10064981|NCT02129205|11190864|FG000|STARTED|Overall Study||2
10064982|NCT02129205|11190865|FG001|STARTED|Overall Study||2
10064983|NCT02129205|11190866|FG002|STARTED|Overall Study||2
10064984|NCT02129205|11190867|FG003|STARTED|Overall Study||2
10064985|NCT02129205|11190868|FG004|STARTED|Overall Study||7
10064986|NCT02129205|11190869|FG005|STARTED|Overall Study||11
10064987|NCT02129205|11190870|FG006|STARTED|Overall Study||6
10064988|NCT02129205|11190871|FG007|STARTED|Overall Study||6
10064989|NCT02129205|11190872|FG008|STARTED|Overall Study||2
10064990|NCT02129205|11190873|FG009|STARTED|Overall Study||0
10064991|NCT02129205|11190864|FG000|COMPLETED|Overall Study||1
10064992|NCT02129205|11190865|FG001|COMPLETED|Overall Study||2
10064993|NCT02129205|11190866|FG002|COMPLETED|Overall Study||2
10064994|NCT02129205|11190867|FG003|COMPLETED|Overall Study||2
10064995|NCT02129205|11190868|FG004|COMPLETED|Overall Study||4
10064996|NCT02129205|11190869|FG005|COMPLETED|Overall Study||7
10064997|NCT02129205|11190870|FG006|COMPLETED|Overall Study||2
10064998|NCT02129205|11190871|FG007|COMPLETED|Overall Study||4
10064999|NCT02129205|11190872|FG008|COMPLETED|Overall Study||0
10188512|NCT03268343|11318068|FG001|NOT COMPLETED|Overall Study||0
10065000|NCT02129205|11190873|FG009|COMPLETED|Overall Study||0
10065001|NCT02129205|11190864|FG000|NOT COMPLETED|Overall Study||1
10065002|NCT02129205|11190865|FG001|NOT COMPLETED|Overall Study||0
10065003|NCT02129205|11190866|FG002|NOT COMPLETED|Overall Study||0
10065004|NCT02129205|11190867|FG003|NOT COMPLETED|Overall Study||0
10065005|NCT02129205|11190868|FG004|NOT COMPLETED|Overall Study||3
10065006|NCT02129205|11190869|FG005|NOT COMPLETED|Overall Study||4
10065007|NCT02129205|11190870|FG006|NOT COMPLETED|Overall Study||4
10065008|NCT02129205|11190871|FG007|NOT COMPLETED|Overall Study||2
10065009|NCT02129205|11190872|FG008|NOT COMPLETED|Overall Study||2
10065010|NCT02129205|11190873|FG009|NOT COMPLETED|Overall Study||0
10065011|NCT02129426|11190899|FG000|STARTED|Overall Study||7
10065012|NCT02129426|11190900|FG001|STARTED|Overall Study||13
10065013|NCT02129426|11190899|FG000|COMPLETED|Overall Study||0
10065014|NCT02129426|11190900|FG001|COMPLETED|Overall Study||0
10065015|NCT02129426|11190899|FG000|NOT COMPLETED|Overall Study||7
10065016|NCT02129426|11190900|FG001|NOT COMPLETED|Overall Study||13
10065017|NCT02129478|11190906|FG000|STARTED|Overall Study||15
10065018|NCT02129478|11190906|FG000|COMPLETED|Overall Study||15
10065019|NCT02129478|11190906|FG000|NOT COMPLETED|Overall Study||0
10188513|NCT03268590|11318075|FG000|STARTED|Overall Study||33
10188514|NCT03268590|11318075|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
10188515|NCT03268590|11318075|FG000|NOT COMPLETED|Overall Study||1
10188516|NCT03268746|11318082|FG000|STARTED|Overall Study||45
10188517|NCT03268746|11318082|FG000|COMPLETED|Overall Study||44
10188518|NCT03268746|11318082|FG000|NOT COMPLETED|Overall Study||1
10188519|NCT03268941|11318097|FG000|STARTED|Part 1 (Days 1 to 9)||12
10188520|NCT03268941|11318098|FG001|STARTED|Part 1 (Days 1 to 9)||14
10188521|NCT03268941|11318099|FG002|STARTED|Part 1 (Days 1 to 9)||12
10188522|NCT03268941|11318100|FG003|STARTED|Part 1 (Days 1 to 9)||13
10188523|NCT03268941|11318101|FG004|STARTED|Part 1 (Days 1 to 9)||0
10188524|NCT03268941|11318102|FG005|STARTED|Part 1 (Days 1 to 9)||0
10188525|NCT03268941|11318103|FG006|STARTED|Part 1 (Days 1 to 9)||0
10188526|NCT03268941|11318097|FG000|COMPLETED|Part 1 (Days 1 to 9)||11
10188527|NCT03268941|11318098|FG001|COMPLETED|Part 1 (Days 1 to 9)||14
10188528|NCT03268941|11318099|FG002|COMPLETED|Part 1 (Days 1 to 9)||12
10188529|NCT03268941|11318100|FG003|COMPLETED|Part 1 (Days 1 to 9)||11
10188530|NCT03268941|11318101|FG004|COMPLETED|Part 1 (Days 1 to 9)||0
10188531|NCT03268941|11318102|FG005|COMPLETED|Part 1 (Days 1 to 9)||0
10188532|NCT03268941|11318103|FG006|COMPLETED|Part 1 (Days 1 to 9)||0
10188533|NCT03268941|11318097|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1
10188534|NCT03268941|11318098|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10188535|NCT03268941|11318099|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10188536|NCT03268941|11318100|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2
10188537|NCT03268941|11318101|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10188538|NCT03268941|11318102|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10188539|NCT03268941|11318103|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10188540|NCT03268941|11318097|FG000|STARTED|Part 2: Days 17 to 25||0
10188541|NCT03268941|11318098|FG001|STARTED|Part 2: Days 17 to 25||0
10188542|NCT03268941|11318099|FG002|STARTED|Part 2: Days 17 to 25||0
10188543|NCT03268941|11318100|FG003|STARTED|Part 2: Days 17 to 25||0
10188544|NCT03268941|11318101|FG004|STARTED|Part 2: Days 17 to 25||6
10188545|NCT03268941|11318102|FG005|STARTED|Part 2: Days 17 to 25||0
10188546|NCT03268941|11318103|FG006|STARTED|Part 2: Days 17 to 25||15
10188547|NCT03268941|11318097|FG000|Treated|Part 2: Days 17 to 25||0
10188548|NCT03268941|11318098|FG001|Treated|Part 2: Days 17 to 25||0
10188549|NCT03268941|11318099|FG002|Treated|Part 2: Days 17 to 25||0
10188550|NCT03268941|11318100|FG003|Treated|Part 2: Days 17 to 25||0
10065020|NCT02129556|11190913|FG000|STARTED|Overall Study||3
10065021|NCT02129556|11190914|FG001|STARTED|Overall Study||3
10065022|NCT02129556|11190915|FG002|STARTED|Overall Study||40
10065023|NCT02129556|11190916|FG003|STARTED|Overall Study||12
10065024|NCT02129556|11190913|FG000|COMPLETED|Overall Study||3
10065025|NCT02129556|11190914|FG001|COMPLETED|Overall Study||3
10065026|NCT02129556|11190915|FG002|COMPLETED|Overall Study||37
10065027|NCT02129556|11190916|FG003|COMPLETED|Overall Study||12
10065028|NCT02129556|11190913|FG000|NOT COMPLETED|Overall Study||0
10065029|NCT02129556|11190914|FG001|NOT COMPLETED|Overall Study||0
10065030|NCT02129556|11190915|FG002|NOT COMPLETED|Overall Study||3
10065031|NCT02129556|11190916|FG003|NOT COMPLETED|Overall Study||0
10065032|NCT02129608|11190928|FG000|STARTED|Overall Study||15
10065033|NCT02129608|11190929|FG001|STARTED|Overall Study||14
10065034|NCT02129608|11190930|FG002|STARTED|Overall Study||15
10065035|NCT02129608|11190928|FG000|End of Treatment|Overall Study||15
10065036|NCT02129608|11190929|FG001|End of Treatment|Overall Study||13
10065037|NCT02129608|11190930|FG002|End of Treatment|Overall Study||12
10065038|NCT02129608|11190928|FG000|COMPLETED|Overall Study||15
10065039|NCT02129608|11190929|FG001|COMPLETED|Overall Study||13
10065040|NCT02129608|11190930|FG002|COMPLETED|Overall Study||12
10065041|NCT02129608|11190928|FG000|NOT COMPLETED|Overall Study||0
10065042|NCT02129608|11190929|FG001|NOT COMPLETED|Overall Study||1
10065043|NCT02129608|11190930|FG002|NOT COMPLETED|Overall Study||3
10065044|NCT02129660|11190943|FG000|STARTED|Overall Study||21
10065045|NCT02129660|11190944|FG001|STARTED|Overall Study||20
10065046|NCT02129660|11190945|FG002|STARTED|Overall Study||22
10065047|NCT02129660|11190946|FG003|STARTED|Overall Study||20
10065048|NCT02129660|11190947|FG004|STARTED|Overall Study||22
10065049|NCT02129660|11190943|FG000|COMPLETED|Overall Study||19
10065050|NCT02129660|11190944|FG001|COMPLETED|Overall Study||20
10065051|NCT02129660|11190945|FG002|COMPLETED|Overall Study||21
10065052|NCT02129660|11190946|FG003|COMPLETED|Overall Study||20
10065053|NCT02129660|11190947|FG004|COMPLETED|Overall Study||20
10065054|NCT02129660|11190943|FG000|NOT COMPLETED|Overall Study||2
10065055|NCT02129660|11190944|FG001|NOT COMPLETED|Overall Study||0
10065056|NCT02129660|11190945|FG002|NOT COMPLETED|Overall Study||1
10065057|NCT02129660|11190946|FG003|NOT COMPLETED|Overall Study||0
10065058|NCT02129660|11190947|FG004|NOT COMPLETED|Overall Study||2
10065059|NCT02129725|11190962|FG000|STARTED|Overall Study||8
10065060|NCT02129725|11190963|FG001|STARTED|Overall Study||7
10065061|NCT02129725|11190962|FG000|COMPLETED|Overall Study||6
10065062|NCT02129725|11190963|FG001|COMPLETED|Overall Study||4
10065063|NCT02129725|11190962|FG000|NOT COMPLETED|Overall Study||2
10065064|NCT02129725|11190963|FG001|NOT COMPLETED|Overall Study||3
10065065|NCT02129777|11190974|FG000|STARTED|Double-Blind Period||24
10065066|NCT02129777|11190975|FG001|STARTED|Double-Blind Period||24
10065067|NCT02129777|11190976|FG002|STARTED|Double-Blind Period||24
10065068|NCT02129777|11190977|FG003|STARTED|Double-Blind Period||25
10065069|NCT02129777|11190978|FG004|STARTED|Double-Blind Period||25
10065070|NCT02129777|11190979|FG005|STARTED|Double-Blind Period||0
10065071|NCT02129777|11190980|FG006|STARTED|Double-Blind Period||0
10065072|NCT02129777|11190974|FG000|COMPLETED|Double-Blind Period||17
10065073|NCT02129777|11190975|FG001|COMPLETED|Double-Blind Period||16
10065074|NCT02129777|11190976|FG002|COMPLETED|Double-Blind Period||20
10065075|NCT02129777|11190977|FG003|COMPLETED|Double-Blind Period||18
10065076|NCT02129777|11190978|FG004|COMPLETED|Double-Blind Period||18
10065077|NCT02129777|11190979|FG005|COMPLETED|Double-Blind Period||0
10065078|NCT02129777|11190980|FG006|COMPLETED|Double-Blind Period||0
10065079|NCT02129777|11190974|FG000|NOT COMPLETED|Double-Blind Period||7
10065080|NCT02129777|11190975|FG001|NOT COMPLETED|Double-Blind Period||8
10065081|NCT02129777|11190976|FG002|NOT COMPLETED|Double-Blind Period||4
10065082|NCT02129777|11190977|FG003|NOT COMPLETED|Double-Blind Period||7
10065083|NCT02129777|11190978|FG004|NOT COMPLETED|Double-Blind Period||7
10065084|NCT02129777|11190979|FG005|NOT COMPLETED|Double-Blind Period||0
10065085|NCT02129777|11190980|FG006|NOT COMPLETED|Double-Blind Period||0
10065086|NCT02129777|11190974|FG000|STARTED|Open-Label Period||0
10065087|NCT02129777|11190975|FG001|STARTED|Open-Label Period||0
10065088|NCT02129777|11190976|FG002|STARTED|Open-Label Period||0
10065089|NCT02129777|11190977|FG003|STARTED|Open-Label Period||0
10065090|NCT02129777|11190978|FG004|STARTED|Open-Label Period||0
10065091|NCT02129777|11190979|FG005|STARTED|Open-Label Period||12
10065092|NCT02129777|11190980|FG006|STARTED|Open-Label Period||48
10065093|NCT02129777|11190974|FG000|COMPLETED|Open-Label Period||0
10065094|NCT02129777|11190975|FG001|COMPLETED|Open-Label Period||0
10065095|NCT02129777|11190976|FG002|COMPLETED|Open-Label Period||0
10065096|NCT02129777|11190977|FG003|COMPLETED|Open-Label Period||0
10065097|NCT02129777|11190978|FG004|COMPLETED|Open-Label Period||0
10065098|NCT02129777|11190979|FG005|COMPLETED|Open-Label Period||0
10065099|NCT02129777|11190980|FG006|COMPLETED|Open-Label Period||0
10065100|NCT02129777|11190974|FG000|NOT COMPLETED|Open-Label Period||0
10065101|NCT02129777|11190975|FG001|NOT COMPLETED|Open-Label Period||0
10065102|NCT02129777|11190976|FG002|NOT COMPLETED|Open-Label Period||0
10065103|NCT02129777|11190977|FG003|NOT COMPLETED|Open-Label Period||0
10065104|NCT02129777|11190978|FG004|NOT COMPLETED|Open-Label Period||0
10065105|NCT02129777|11190979|FG005|NOT COMPLETED|Open-Label Period||12
10065106|NCT02129777|11190980|FG006|NOT COMPLETED|Open-Label Period||48
10065107|NCT02129803|11191001|FG000|STARTED|Overall Study||12
10065108|NCT02129803|11191002|FG001|STARTED|Overall Study||12
10065109|NCT02129803|11191001|FG000|COMPLETED|Overall Study||6
10065110|NCT02129803|11191002|FG001|COMPLETED|Overall Study||9
10065111|NCT02129803|11191001|FG000|NOT COMPLETED|Overall Study||6
10065112|NCT02129803|11191002|FG001|NOT COMPLETED|Overall Study||3
10065113|NCT02130024|11191010|FG000|STARTED|Overall Study||142
10065114|NCT02130024|11191011|FG001|STARTED|Overall Study||139
10065115|NCT02130024|11191010|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141
10065116|NCT02130024|11191011|FG001|Safety Set|Overall Study||139
10065117|NCT02130024|11191010|FG000|Full Analysis Set (FAS)|Overall Study||141
10065118|NCT02130024|11191011|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
10065119|NCT02130024|11191010|FG000|COMPLETED|Overall Study||117
10065120|NCT02130024|11191011|FG001|COMPLETED|Overall Study||108
10065121|NCT02130024|11191010|FG000|NOT COMPLETED|Overall Study||25
10065122|NCT02130024|11191011|FG001|NOT COMPLETED|Overall Study||31
10065123|NCT02130063|11191019|FG000|STARTED|Overall Study||342
10065124|NCT02130063|11191020|FG001|STARTED|Overall Study||169
10065125|NCT02130063|11191019|FG000|COMPLETED|Overall Study||317
10065126|NCT02130063|11191020|FG001|COMPLETED|Overall Study||152
10065127|NCT02130063|11191019|FG000|NOT COMPLETED|Overall Study||25
10065128|NCT02130063|11191020|FG001|NOT COMPLETED|Overall Study||17
10065129|NCT02130193|11191028|FG000|STARTED|Part A: 4-week Open-label Period||9
10065130|NCT02130193|11191029|FG001|STARTED|Part A: 4-week Open-label Period||0
10065131|NCT02130193|11191030|FG002|STARTED|Part A: 4-week Open-label Period||0
10065132|NCT02130193|11191028|FG000|COMPLETED|Part A: 4-week Open-label Period||9
10065133|NCT02130193|11191029|FG001|COMPLETED|Part A: 4-week Open-label Period||0
10065134|NCT02130193|11191030|FG002|COMPLETED|Part A: 4-week Open-label Period||0
10065135|NCT02130193|11191028|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0
10065136|NCT02130193|11191029|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0
10065137|NCT02130193|11191030|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0
10065138|NCT02130193|11191028|FG000|STARTED|Part B: 52-week Double-blind Period||0
10065139|NCT02130193|11191029|FG001|STARTED|Part B: 52-week Double-blind Period||48
10065140|NCT02130193|11191030|FG002|STARTED|Part B: 52-week Double-blind Period||45
10065141|NCT02130193|11191028|FG000|COMPLETED|Part B: 52-week Double-blind Period||0
10065142|NCT02130193|11191029|FG001|COMPLETED|Part B: 52-week Double-blind Period||38
10065143|NCT02130193|11191030|FG002|COMPLETED|Part B: 52-week Double-blind Period||37
10065144|NCT02130193|11191028|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0
10065145|NCT02130193|11191029|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10
10065146|NCT02130193|11191030|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8
10065147|NCT02130258|11191041|FG000|STARTED|Overall Study||9
10065148|NCT02130258|11191042|FG001|STARTED|Overall Study||11
10065149|NCT02130258|11191041|FG000|COMPLETED|Overall Study||9
10065150|NCT02130258|11191042|FG001|COMPLETED|Overall Study||11
10065151|NCT02130258|11191041|FG000|NOT COMPLETED|Overall Study||0
10065152|NCT02130258|11191042|FG001|NOT COMPLETED|Overall Study||0
10065153|NCT02130284|11191048|FG000|STARTED|Overall Study||80
10065154|NCT02130284|11191048|FG000|COMPLETED|Overall Study||71
10065155|NCT02130284|11191048|FG000|NOT COMPLETED|Overall Study||9
10065156|NCT02130297|11191052|FG000|STARTED|Overall Study||30
10065157|NCT02130297|11191052|FG000|COMPLETED|Overall Study||26
10065158|NCT02130297|11191052|FG000|NOT COMPLETED|Overall Study||4
10065159|NCT02130427|11191056|FG000|STARTED|Overall Study||74
10065160|NCT02130427|11191056|FG000|COMPLETED|Overall Study||44
10065161|NCT02130427|11191056|FG000|NOT COMPLETED|Overall Study||30
10065162|NCT02130557|11191062|FG000|STARTED|Overall Study||268
10065163|NCT02130557|11191063|FG001|STARTED|Overall Study||268
10065164|NCT02130557|11191062|FG000|Treated|Overall Study||268
10065165|NCT02130557|11191063|FG001|Treated|Overall Study||265
10065166|NCT02130557|11191062|FG000|mITT Population|Overall Study||246
10065167|NCT02130557|11191063|FG001|mITT Population|Overall Study||241
10065168|NCT02130557|11191062|FG000|COMPLETED|Overall Study||232
10065169|NCT02130557|11191063|FG001|COMPLETED|Overall Study||231
10065170|NCT02130557|11191062|FG000|NOT COMPLETED|Overall Study||36
10065171|NCT02130557|11191063|FG001|NOT COMPLETED|Overall Study||37
10065172|NCT02130570|11191071|FG000|STARTED|Overall Study||987
10065173|NCT02130570|11191072|FG001|STARTED|Overall Study||692
10065174|NCT02130570|11191071|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
10065175|NCT02130570|11191072|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
10065176|NCT02130570|11191071|FG000|NOT COMPLETED|Overall Study||9
10065177|NCT02130570|11191072|FG001|NOT COMPLETED|Overall Study||13
10065178|NCT02130583|11191081|FG000|STARTED|Overall Study||26
10065179|NCT02130583|11191082|FG001|STARTED|Overall Study||26
10065180|NCT02130583|11191081|FG000|COMPLETED|Overall Study||17
10065181|NCT02130583|11191082|FG001|COMPLETED|Overall Study||19
10065182|NCT02130583|11191081|FG000|NOT COMPLETED|Overall Study||9
10065183|NCT02130583|11191082|FG001|NOT COMPLETED|Overall Study||7
10065184|NCT02130635|11191097|FG000|STARTED|Part A-Safety and Tolerability||7
10065185|NCT02130635|11191098|FG001|STARTED|Part A-Safety and Tolerability||21
10065186|NCT02130635|11191099|FG002|STARTED|Part A-Safety and Tolerability||0
10065187|NCT02130635|11191100|FG003|STARTED|Part A-Safety and Tolerability||0
10065188|NCT02130635|11191101|FG004|STARTED|Part A-Safety and Tolerability||0
10065189|NCT02130635|11191102|FG005|STARTED|Part A-Safety and Tolerability||0
10065190|NCT02130635|11191103|FG006|STARTED|Part A-Safety and Tolerability||0
10065191|NCT02130635|11191104|FG007|STARTED|Part A-Safety and Tolerability||0
10065192|NCT02130635|11191105|FG008|STARTED|Part A-Safety and Tolerability||0
10065193|NCT02130635|11191097|FG000|COMPLETED|Part A-Safety and Tolerability||7
10065194|NCT02130635|11191098|FG001|COMPLETED|Part A-Safety and Tolerability||21
10065195|NCT02130635|11191099|FG002|COMPLETED|Part A-Safety and Tolerability||0
10065196|NCT02130635|11191100|FG003|COMPLETED|Part A-Safety and Tolerability||0
10065197|NCT02130635|11191101|FG004|COMPLETED|Part A-Safety and Tolerability||0
10065198|NCT02130635|11191102|FG005|COMPLETED|Part A-Safety and Tolerability||0
10065199|NCT02130635|11191103|FG006|COMPLETED|Part A-Safety and Tolerability||0
10065200|NCT02130635|11191104|FG007|COMPLETED|Part A-Safety and Tolerability||0
10065201|NCT02130635|11191105|FG008|COMPLETED|Part A-Safety and Tolerability||0
10065202|NCT02130635|11191097|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0
10065203|NCT02130635|11191098|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0
10065204|NCT02130635|11191099|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0
10065205|NCT02130635|11191100|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0
10065206|NCT02130635|11191101|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0
10065207|NCT02130635|11191102|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0
10065208|NCT02130635|11191103|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0
10065209|NCT02130635|11191104|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0
10065210|NCT02130635|11191105|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0
10065211|NCT02130635|11191097|FG000|STARTED|Part B-Dose-Response Relationship||0
10065212|NCT02130635|11191098|FG001|STARTED|Part B-Dose-Response Relationship||0
10065213|NCT02130635|11191099|FG002|STARTED|Part B-Dose-Response Relationship||5
10065214|NCT02130635|11191100|FG003|STARTED|Part B-Dose-Response Relationship||5
10065215|NCT02130635|11191101|FG004|STARTED|Part B-Dose-Response Relationship||5
10065216|NCT02130635|11191102|FG005|STARTED|Part B-Dose-Response Relationship||5
10065217|NCT02130635|11191103|FG006|STARTED|Part B-Dose-Response Relationship||6
10065218|NCT02130635|11191104|FG007|STARTED|Part B-Dose-Response Relationship||5
10065219|NCT02130635|11191105|FG008|STARTED|Part B-Dose-Response Relationship||5
10065220|NCT02130635|11191097|FG000|COMPLETED|Part B-Dose-Response Relationship||0
10065221|NCT02130635|11191098|FG001|COMPLETED|Part B-Dose-Response Relationship||0
10065222|NCT02130635|11191099|FG002|COMPLETED|Part B-Dose-Response Relationship||5
10065223|NCT02130635|11191100|FG003|COMPLETED|Part B-Dose-Response Relationship||5
10065224|NCT02130635|11191101|FG004|COMPLETED|Part B-Dose-Response Relationship||5
10065225|NCT02130635|11191102|FG005|COMPLETED|Part B-Dose-Response Relationship||5
10065226|NCT02130635|11191103|FG006|COMPLETED|Part B-Dose-Response Relationship||6
10065227|NCT02130635|11191104|FG007|COMPLETED|Part B-Dose-Response Relationship||5
10065228|NCT02130635|11191105|FG008|COMPLETED|Part B-Dose-Response Relationship||5
10065229|NCT02130635|11191097|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065230|NCT02130635|11191098|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065231|NCT02130635|11191099|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065232|NCT02130635|11191100|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065233|NCT02130635|11191101|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065234|NCT02130635|11191102|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065235|NCT02130635|11191103|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065236|NCT02130635|11191104|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065237|NCT02130635|11191105|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0
10065238|NCT02130765|11191136|FG000|STARTED|Overall Study||11
10065239|NCT02130765|11191137|FG001|STARTED|Overall Study||8
10065240|NCT02130765|11191138|FG002|STARTED|Overall Study||26
10065241|NCT02130765|11191139|FG003|STARTED|Overall Study||19
10065242|NCT02130765|11191136|FG000|COMPLETED|Overall Study||7
10065243|NCT02130765|11191137|FG001|COMPLETED|Overall Study||8
10065244|NCT02130765|11191138|FG002|COMPLETED|Overall Study||26
10065245|NCT02130765|11191139|FG003|COMPLETED|Overall Study||19
10065246|NCT02130765|11191136|FG000|NOT COMPLETED|Overall Study||4
10065247|NCT02130765|11191137|FG001|NOT COMPLETED|Overall Study||0
10065248|NCT02130765|11191138|FG002|NOT COMPLETED|Overall Study||0
10065249|NCT02130765|11191139|FG003|NOT COMPLETED|Overall Study||0
10065250|NCT02130986|11191153|FG000|STARTED|Overall Study||830
10065251|NCT02130986|11191154|FG001|STARTED|Overall Study||834
10065252|NCT02130986|11191153|FG000|COMPLETED|Overall Study||675
10065253|NCT02130986|11191154|FG001|COMPLETED|Overall Study||670
10065254|NCT02130986|11191153|FG000|NOT COMPLETED|Overall Study||155
10065255|NCT02130986|11191154|FG001|NOT COMPLETED|Overall Study||164
10065256|NCT02130999|11191162|FG000|STARTED|Overall Study||6
10065257|NCT02130999|11191163|FG001|STARTED|Overall Study||8
10065258|NCT02130999|11191162|FG000|COMPLETED|Overall Study||6
10065259|NCT02130999|11191163|FG001|COMPLETED|Overall Study||8
10065260|NCT02130999|11191162|FG000|NOT COMPLETED|Overall Study||0
10065261|NCT02130999|11191163|FG001|NOT COMPLETED|Overall Study||0
10065262|NCT02131064|11191176|FG000|STARTED|Overall Study||221
10065263|NCT02131064|11191177|FG001|STARTED|Overall Study||223
10065264|NCT02131064|11191176|FG000|COMPLETED|Overall Study||196
10065265|NCT02131064|11191177|FG001|COMPLETED|Overall Study||189
10065266|NCT02131064|11191176|FG000|NOT COMPLETED|Overall Study||25
10065267|NCT02131064|11191177|FG001|NOT COMPLETED|Overall Study||34
10065268|NCT02131129|11191186|FG000|STARTED|Overall Study||10
10065269|NCT02131129|11191187|FG001|STARTED|Overall Study||10
10065270|NCT02131129|11191186|FG000|COMPLETED|Overall Study||9
10065271|NCT02131129|11191187|FG001|COMPLETED|Overall Study||10
10065272|NCT02131129|11191186|FG000|NOT COMPLETED|Overall Study||1
10065273|NCT02131129|11191187|FG001|NOT COMPLETED|Overall Study||0
10065274|NCT02131233|11191195|FG000|STARTED|Overall Study|Enrolled participants|533
10065275|NCT02131233|11191196|FG001|STARTED|Overall Study|Enrolled participants|269
10065276|NCT02131233|11191195|FG000|Treated|Overall Study||531
10065277|NCT02131233|11191196|FG001|Treated|Overall Study||266
10065278|NCT02131233|11191195|FG000|COMPLETED|Overall Study|Completed to Week 96|467
10065279|NCT02131233|11191196|FG001|COMPLETED|Overall Study|Completed to Week 96|227
10065280|NCT02131233|11191195|FG000|NOT COMPLETED|Overall Study||66
10065281|NCT02131233|11191196|FG001|NOT COMPLETED|Overall Study||42
10065282|NCT02131259|11191202|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
10065283|NCT02131259|11191202|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
10065284|NCT02131259|11191202|FG000|NOT COMPLETED|Overall Study||1225
10065285|NCT02131272|11191208|FG000|STARTED|Overall Study||20
10065286|NCT02131272|11191209|FG001|STARTED|Overall Study||22
10065287|NCT02131272|11191208|FG000|COMPLETED|Overall Study||19
10065288|NCT02131272|11191209|FG001|COMPLETED|Overall Study||20
10065289|NCT02131272|11191208|FG000|NOT COMPLETED|Overall Study||1
10065290|NCT02131272|11191209|FG001|NOT COMPLETED|Overall Study||2
10065291|NCT02131311|11191215|FG000|STARTED|Overall Study||90
10065292|NCT02131311|11191215|FG000|COMPLETED|Overall Study||86
10065293|NCT02131311|11191215|FG000|NOT COMPLETED|Overall Study||4
10065294|NCT02131324|11191222|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
10065295|NCT02131324|11191223|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
10065296|NCT02131324|11191222|FG000|Analyzed|Overall Study||22
10065297|NCT02131324|11191223|FG001|Analyzed|Overall Study||24
10065298|NCT02131324|11191222|FG000|COMPLETED|Overall Study||22
10065299|NCT02131324|11191223|FG001|COMPLETED|Overall Study||23
10065300|NCT02131324|11191222|FG000|NOT COMPLETED|Overall Study||2
10188551|NCT03268941|11318101|FG004|Treated|Part 2: Days 17 to 25||6
10188552|NCT03268941|11318102|FG005|Treated|Part 2: Days 17 to 25||0
10188553|NCT03268941|11318103|FG006|Treated|Part 2: Days 17 to 25||13
10188554|NCT03268941|11318097|FG000|COMPLETED|Part 2: Days 17 to 25||0
10188555|NCT03268941|11318098|FG001|COMPLETED|Part 2: Days 17 to 25||0
10188556|NCT03268941|11318099|FG002|COMPLETED|Part 2: Days 17 to 25||0
10188557|NCT03268941|11318100|FG003|COMPLETED|Part 2: Days 17 to 25||0
10188558|NCT03268941|11318101|FG004|COMPLETED|Part 2: Days 17 to 25||6
10188559|NCT03268941|11318102|FG005|COMPLETED|Part 2: Days 17 to 25||0
10188560|NCT03268941|11318103|FG006|COMPLETED|Part 2: Days 17 to 25||13
10188561|NCT03268941|11318097|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0
10188562|NCT03268941|11318098|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0
10188563|NCT03268941|11318099|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0
10188564|NCT03268941|11318100|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0
10188565|NCT03268941|11318101|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0
10188566|NCT03268941|11318102|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0
10188567|NCT03268941|11318103|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2
10188568|NCT03268941|11318097|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10188569|NCT03268941|11318098|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10188570|NCT03268941|11318099|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10188571|NCT03268941|11318100|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10188572|NCT03268941|11318101|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10188573|NCT03268941|11318102|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6
10188574|NCT03268941|11318103|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10188575|NCT03268941|11318097|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188576|NCT03268941|11318098|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188577|NCT03268941|11318099|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188578|NCT03268941|11318100|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188579|NCT03268941|11318101|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188580|NCT03268941|11318102|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
10188581|NCT03268941|11318103|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188582|NCT03268941|11318097|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188583|NCT03268941|11318098|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188584|NCT03268941|11318099|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188585|NCT03268941|11318100|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188586|NCT03268941|11318101|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188587|NCT03268941|11318102|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10188588|NCT03268941|11318103|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10065301|NCT02131324|11191223|FG001|NOT COMPLETED|Overall Study||3
10065302|NCT02131402|11191229|FG000|STARTED|Overall Study||60
10065303|NCT02131402|11191229|FG000|COMPLETED|Overall Study||60
10065304|NCT02131402|11191229|FG000|NOT COMPLETED|Overall Study||0
10065305|NCT02131532|11191292|FG000|STARTED|Overall Study||12
10065306|NCT02131532|11191292|FG000|COMPLETED|Overall Study||8
10065307|NCT02131532|11191292|FG000|NOT COMPLETED|Overall Study||4
10065308|NCT02131636|11191299|FG000|STARTED|Overall Study||222
10065309|NCT02131636|11191300|FG001|STARTED|Overall Study||218
10065310|NCT02131636|11191299|FG000|COMPLETED|Overall Study||210
10065311|NCT02131636|11191300|FG001|COMPLETED|Overall Study||213
10065312|NCT02131636|11191299|FG000|NOT COMPLETED|Overall Study||12
10065313|NCT02131636|11191300|FG001|NOT COMPLETED|Overall Study||5
10065314|NCT02131662|11191311|FG000|STARTED|Overall Study||62
10065315|NCT02131662|11191312|FG001|STARTED|Overall Study||61
10065316|NCT02131662|11191313|FG002|STARTED|Overall Study||63
10065317|NCT02131662|11191314|FG003|STARTED|Overall Study||62
10065318|NCT02131662|11191315|FG004|STARTED|Overall Study||61
10065319|NCT02131662|11191311|FG000|Treated|Overall Study||60
10065320|NCT02131662|11191312|FG001|Treated|Overall Study||61
10065321|NCT02131662|11191313|FG002|Treated|Overall Study||61
10065322|NCT02131662|11191314|FG003|Treated|Overall Study||60
10065323|NCT02131662|11191315|FG004|Treated|Overall Study||58
10065324|NCT02131662|11191311|FG000|Completed Treatment|Overall Study||57
10065325|NCT02131662|11191312|FG001|Completed Treatment|Overall Study||60
10065326|NCT02131662|11191313|FG002|Completed Treatment|Overall Study||61
10065327|NCT02131662|11191314|FG003|Completed Treatment|Overall Study||56
10065328|NCT02131662|11191315|FG004|Completed Treatment|Overall Study||52
10065329|NCT02131662|11191311|FG000|Completed Follow-up|Overall Study||54
10065330|NCT02131662|11191312|FG001|Completed Follow-up|Overall Study||47
10065331|NCT02131662|11191313|FG002|Completed Follow-up|Overall Study||56
10065332|NCT02131662|11191314|FG003|Completed Follow-up|Overall Study||42
10065333|NCT02131662|11191315|FG004|Completed Follow-up|Overall Study||44
10065334|NCT02131662|11191311|FG000|COMPLETED|Overall Study||54
10065335|NCT02131662|11191312|FG001|COMPLETED|Overall Study||47
10065336|NCT02131662|11191313|FG002|COMPLETED|Overall Study||56
10065337|NCT02131662|11191314|FG003|COMPLETED|Overall Study||41
10065338|NCT02131662|11191315|FG004|COMPLETED|Overall Study||43
10065339|NCT02131662|11191311|FG000|NOT COMPLETED|Overall Study||8
10065340|NCT02131662|11191312|FG001|NOT COMPLETED|Overall Study||14
10065341|NCT02131662|11191313|FG002|NOT COMPLETED|Overall Study||7
10065342|NCT02131662|11191314|FG003|NOT COMPLETED|Overall Study||21
10065343|NCT02131662|11191315|FG004|NOT COMPLETED|Overall Study||18
10065344|NCT02131766|11191331|FG000|STARTED|Overall Study||44
10065345|NCT02131766|11191331|FG000|COMPLETED|Overall Study||40
10065346|NCT02131766|11191331|FG000|NOT COMPLETED|Overall Study||4
10065347|NCT02132117|11191340|FG000|STARTED|Overall Study||224
10065348|NCT02132117|11191341|FG001|STARTED|Overall Study||221
10065349|NCT02132117|11191340|FG000|COMPLETED|Overall Study||213
10065350|NCT02132117|11191341|FG001|COMPLETED|Overall Study||216
10065351|NCT02132117|11191340|FG000|NOT COMPLETED|Overall Study||11
10065352|NCT02132117|11191341|FG001|NOT COMPLETED|Overall Study||5
10065353|NCT02132130|11191351|FG000|STARTED|Overall Study||3
10065354|NCT02132130|11191352|FG001|STARTED|Overall Study||12
10065355|NCT02132130|11191353|FG002|STARTED|Overall Study||4
10065356|NCT02132130|11191354|FG003|STARTED|Overall Study||3
10065357|NCT02132130|11191351|FG000|COMPLETED|Overall Study||3
10065358|NCT02132130|11191352|FG001|COMPLETED|Overall Study||10
10065359|NCT02132130|11191353|FG002|COMPLETED|Overall Study||4
10065360|NCT02132130|11191354|FG003|COMPLETED|Overall Study||2
10065361|NCT02132130|11191351|FG000|NOT COMPLETED|Overall Study||0
10065362|NCT02132130|11191352|FG001|NOT COMPLETED|Overall Study||2
10065363|NCT02132130|11191353|FG002|NOT COMPLETED|Overall Study||0
10065364|NCT02132130|11191354|FG003|NOT COMPLETED|Overall Study||1
10065365|NCT02132169|11191370|FG000|STARTED|Overall Study||341
10065366|NCT02132169|11191371|FG001|STARTED|Overall Study||171
10065367|NCT02132169|11191370|FG000|COMPLETED|Overall Study||326
10065368|NCT02132169|11191371|FG001|COMPLETED|Overall Study||162
10065369|NCT02132169|11191370|FG000|NOT COMPLETED|Overall Study||15
10065370|NCT02132169|11191371|FG001|NOT COMPLETED|Overall Study||9
10065371|NCT02132195|11191380|FG000|STARTED|Initial Assignment||15
10065372|NCT02132195|11191381|FG001|STARTED|Initial Assignment||16
10065373|NCT02132195|11191382|FG002|STARTED|Initial Assignment||0
10065374|NCT02132195|11191380|FG000|COMPLETED|Initial Assignment||1
10065375|NCT02132195|11191381|FG001|COMPLETED|Initial Assignment||16
10065376|NCT02132195|11191382|FG002|COMPLETED|Initial Assignment||0
10065377|NCT02132195|11191380|FG000|NOT COMPLETED|Initial Assignment||14
10065378|NCT02132195|11191381|FG001|NOT COMPLETED|Initial Assignment||0
10065379|NCT02132195|11191382|FG002|NOT COMPLETED|Initial Assignment||0
10065380|NCT02132195|11191380|FG000|STARTED|Rescue Therapy||0
10065381|NCT02132195|11191381|FG001|STARTED|Rescue Therapy||0
10065382|NCT02132195|11191382|FG002|STARTED|Rescue Therapy||13
10065383|NCT02132195|11191380|FG000|COMPLETED|Rescue Therapy||0
10065384|NCT02132195|11191381|FG001|COMPLETED|Rescue Therapy||0
10065385|NCT02132195|11191382|FG002|COMPLETED|Rescue Therapy||2
10065386|NCT02132195|11191380|FG000|NOT COMPLETED|Rescue Therapy||0
10065387|NCT02132195|11191381|FG001|NOT COMPLETED|Rescue Therapy||0
10065388|NCT02132195|11191382|FG002|NOT COMPLETED|Rescue Therapy||11
10065389|NCT02132247|11191392|FG000|STARTED|Overall Study||52
10065390|NCT02132247|11191393|FG001|STARTED|Overall Study||52
10065391|NCT02132247|11191392|FG000|COMPLETED|Overall Study||51
10065392|NCT02132247|11191393|FG001|COMPLETED|Overall Study||52
10065393|NCT02132247|11191392|FG000|NOT COMPLETED|Overall Study||1
10065394|NCT02132247|11191393|FG001|NOT COMPLETED|Overall Study||0
10065395|NCT02132312|11191401|FG000|STARTED|Overall Study||37
10065396|NCT02132312|11191402|FG001|STARTED|Overall Study||41
10065397|NCT02132312|11191401|FG000|COMPLETED|Overall Study||31
10065398|NCT02132312|11191402|FG001|COMPLETED|Overall Study||38
10065399|NCT02132312|11191401|FG000|NOT COMPLETED|Overall Study||6
10065400|NCT02132312|11191402|FG001|NOT COMPLETED|Overall Study||3
10065401|NCT02132468|11191408|FG000|STARTED|Overall Study||18
10065402|NCT02132468|11191408|FG000|COMPLETED|Overall Study||11
10065403|NCT02132468|11191408|FG000|NOT COMPLETED|Overall Study||7
10065404|NCT02132520|11191415|FG000|STARTED|Overall Study||0
10065405|NCT02132520|11191416|FG001|STARTED|Overall Study||1
10065406|NCT02132520|11191417|FG002|STARTED|Overall Study||2
10065407|NCT02132520|11191415|FG000|COMPLETED|Overall Study||0
10065408|NCT02132520|11191416|FG001|COMPLETED|Overall Study||1
10065409|NCT02132520|11191417|FG002|COMPLETED|Overall Study||2
10065410|NCT02132520|11191415|FG000|NOT COMPLETED|Overall Study||0
10065411|NCT02132520|11191416|FG001|NOT COMPLETED|Overall Study||0
10065412|NCT02132520|11191417|FG002|NOT COMPLETED|Overall Study||0
10065413|NCT02132533|11191426|FG000|STARTED|Overall Study||46
10065414|NCT02132533|11191427|FG001|STARTED|Overall Study||42
10065415|NCT02132533|11191426|FG000|COMPLETED|Overall Study||46
10065416|NCT02132533|11191427|FG001|COMPLETED|Overall Study||42
10065417|NCT02132533|11191426|FG000|NOT COMPLETED|Overall Study||0
10065418|NCT02132533|11191427|FG001|NOT COMPLETED|Overall Study||0
10065419|NCT02132572|11191433|FG000|STARTED|Overall Study||201
10065420|NCT02132572|11191433|FG000|COMPLETED|Overall Study||201
10065421|NCT02132572|11191433|FG000|NOT COMPLETED|Overall Study||0
10065422|NCT02132598|11191437|FG000|STARTED|Overall Study||5
10065423|NCT02132598|11191437|FG000|COMPLETED|Overall Study||5
10065424|NCT02132598|11191437|FG000|NOT COMPLETED|Overall Study||0
10065425|NCT02132637|11191443|FG000|STARTED|Study Period 1||34
10065426|NCT02132637|11191444|FG001|STARTED|Study Period 1||34
10065427|NCT02132637|11191443|FG000|Received at Least One Dose of Study Drug|Study Period 1||34
10065428|NCT02132637|11191444|FG001|Received at Least One Dose of Study Drug|Study Period 1||34
10065429|NCT02132637|11191443|FG000|COMPLETED|Study Period 1||33
10065430|NCT02132637|11191444|FG001|COMPLETED|Study Period 1||30
10065431|NCT02132637|11191443|FG000|NOT COMPLETED|Study Period 1||1
10065432|NCT02132637|11191444|FG001|NOT COMPLETED|Study Period 1||4
10065433|NCT02132637|11191443|FG000|STARTED|Study Period 2 (Crossover)||33
10065434|NCT02132637|11191444|FG001|STARTED|Study Period 2 (Crossover)||30
10065435|NCT02132637|11191443|FG000|COMPLETED|Study Period 2 (Crossover)||31
10065436|NCT02132637|11191444|FG001|COMPLETED|Study Period 2 (Crossover)||29
10065437|NCT02132637|11191443|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2
10065438|NCT02132637|11191444|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1
10065439|NCT02132676|11191452|FG000|STARTED|Overall Study||727
10065440|NCT02132676|11191453|FG001|STARTED|Overall Study||809
10065441|NCT02132676|11191452|FG000|COMPLETED|Overall Study||727
10065442|NCT02132676|11191453|FG001|COMPLETED|Overall Study||809
10065443|NCT02132676|11191452|FG000|NOT COMPLETED|Overall Study||0
10065444|NCT02132676|11191453|FG001|NOT COMPLETED|Overall Study||0
10065445|NCT02132754|11191494|FG000|STARTED|Overall Study||1
10065446|NCT02132754|11191495|FG001|STARTED|Overall Study||1
10065447|NCT02132754|11191496|FG002|STARTED|Overall Study||1
10065448|NCT02132754|11191497|FG003|STARTED|Overall Study||1
10065449|NCT02132754|11191498|FG004|STARTED|Overall Study||1
10065450|NCT02132754|11191499|FG005|STARTED|Overall Study||1
10065451|NCT02132754|11191500|FG006|STARTED|Overall Study||1
10065452|NCT02132754|11191501|FG007|STARTED|Overall Study||1
10065453|NCT02132754|11191502|FG008|STARTED|Overall Study||1
10065454|NCT02132754|11191503|FG009|STARTED|Overall Study||6
10065455|NCT02132754|11191504|FG010|STARTED|Overall Study||3
10065456|NCT02132754|11191505|FG011|STARTED|Overall Study||3
10065457|NCT02132754|11191506|FG012|STARTED|Overall Study||4
10065458|NCT02132754|11191507|FG013|STARTED|Overall Study||3
10065459|NCT02132754|11191508|FG014|STARTED|Overall Study||3
10065460|NCT02132754|11191509|FG015|STARTED|Overall Study||5
10065461|NCT02132754|11191510|FG016|STARTED|Overall Study||4
10065462|NCT02132754|11191511|FG017|STARTED|Overall Study||3
10065463|NCT02132754|11191512|FG018|STARTED|Overall Study||3
10065464|NCT02132754|11191513|FG019|STARTED|Overall Study||4
10065465|NCT02132754|11191514|FG020|STARTED|Overall Study||3
10065466|NCT02132754|11191515|FG021|STARTED|Overall Study||5
10065467|NCT02132754|11191516|FG022|STARTED|Overall Study||3
10065468|NCT02132754|11191517|FG023|STARTED|Overall Study||3
10065469|NCT02132754|11191518|FG024|STARTED|Overall Study||3
10065470|NCT02132754|11191519|FG025|STARTED|Overall Study||3
10065471|NCT02132754|11191520|FG026|STARTED|Overall Study||4
10065472|NCT02132754|11191521|FG027|STARTED|Overall Study||3
10065473|NCT02132754|11191522|FG028|STARTED|Overall Study||3
10065474|NCT02132754|11191523|FG029|STARTED|Overall Study||3
10065475|NCT02132754|11191524|FG030|STARTED|Overall Study||3
10065476|NCT02132754|11191525|FG031|STARTED|Overall Study||3
10065477|NCT02132754|11191526|FG032|STARTED|Overall Study||4
10065478|NCT02132754|11191527|FG033|STARTED|Overall Study||23
10065479|NCT02132754|11191494|FG000|Treated|Overall Study||1
10065480|NCT02132754|11191495|FG001|Treated|Overall Study||1
10065481|NCT02132754|11191496|FG002|Treated|Overall Study||1
10065482|NCT02132754|11191497|FG003|Treated|Overall Study||1
10065483|NCT02132754|11191498|FG004|Treated|Overall Study||1
10065484|NCT02132754|11191499|FG005|Treated|Overall Study||1
10065485|NCT02132754|11191500|FG006|Treated|Overall Study||1
10065486|NCT02132754|11191501|FG007|Treated|Overall Study||1
10065487|NCT02132754|11191502|FG008|Treated|Overall Study||1
10065488|NCT02132754|11191503|FG009|Treated|Overall Study||6
10065489|NCT02132754|11191504|FG010|Treated|Overall Study||3
10065490|NCT02132754|11191505|FG011|Treated|Overall Study||3
10065491|NCT02132754|11191506|FG012|Treated|Overall Study||3
10065492|NCT02132754|11191507|FG013|Treated|Overall Study||3
10065493|NCT02132754|11191508|FG014|Treated|Overall Study||3
10065494|NCT02132754|11191509|FG015|Treated|Overall Study||5
10065495|NCT02132754|11191510|FG016|Treated|Overall Study||4
10065496|NCT02132754|11191511|FG017|Treated|Overall Study||3
10065497|NCT02132754|11191512|FG018|Treated|Overall Study||3
10065498|NCT02132754|11191513|FG019|Treated|Overall Study||3
10065499|NCT02132754|11191514|FG020|Treated|Overall Study||3
10065500|NCT02132754|11191515|FG021|Treated|Overall Study||4
10065501|NCT02132754|11191516|FG022|Treated|Overall Study||3
10065502|NCT02132754|11191517|FG023|Treated|Overall Study||3
10065503|NCT02132754|11191518|FG024|Treated|Overall Study||3
10065504|NCT02132754|11191519|FG025|Treated|Overall Study||3
10065505|NCT02132754|11191520|FG026|Treated|Overall Study||4
10065506|NCT02132754|11191521|FG027|Treated|Overall Study||3
10065507|NCT02132754|11191522|FG028|Treated|Overall Study||3
10065508|NCT02132754|11191523|FG029|Treated|Overall Study||3
10065509|NCT02132754|11191524|FG030|Treated|Overall Study||3
10065510|NCT02132754|11191525|FG031|Treated|Overall Study||3
10065511|NCT02132754|11191526|FG032|Treated|Overall Study||4
10065512|NCT02132754|11191527|FG033|Treated|Overall Study||23
10065513|NCT02132754|11191494|FG000|COMPLETED|Overall Study||0
10065514|NCT02132754|11191495|FG001|COMPLETED|Overall Study||0
10065515|NCT02132754|11191496|FG002|COMPLETED|Overall Study||0
10065516|NCT02132754|11191497|FG003|COMPLETED|Overall Study||0
10065517|NCT02132754|11191498|FG004|COMPLETED|Overall Study||0
10065518|NCT02132754|11191499|FG005|COMPLETED|Overall Study||0
10065519|NCT02132754|11191500|FG006|COMPLETED|Overall Study||0
10065520|NCT02132754|11191501|FG007|COMPLETED|Overall Study||0
10065521|NCT02132754|11191502|FG008|COMPLETED|Overall Study||0
10065522|NCT02132754|11191503|FG009|COMPLETED|Overall Study||0
10065523|NCT02132754|11191504|FG010|COMPLETED|Overall Study||0
10065524|NCT02132754|11191505|FG011|COMPLETED|Overall Study||0
10065525|NCT02132754|11191506|FG012|COMPLETED|Overall Study||0
10065526|NCT02132754|11191507|FG013|COMPLETED|Overall Study||0
10065527|NCT02132754|11191508|FG014|COMPLETED|Overall Study||0
10065528|NCT02132754|11191509|FG015|COMPLETED|Overall Study||0
10065529|NCT02132754|11191510|FG016|COMPLETED|Overall Study||0
10065530|NCT02132754|11191511|FG017|COMPLETED|Overall Study||0
10065531|NCT02132754|11191512|FG018|COMPLETED|Overall Study||0
10065532|NCT02132754|11191513|FG019|COMPLETED|Overall Study||0
10065533|NCT02132754|11191514|FG020|COMPLETED|Overall Study||0
10065534|NCT02132754|11191515|FG021|COMPLETED|Overall Study||0
10065535|NCT02132754|11191516|FG022|COMPLETED|Overall Study||0
10065536|NCT02132754|11191517|FG023|COMPLETED|Overall Study||0
10065537|NCT02132754|11191518|FG024|COMPLETED|Overall Study||0
10065538|NCT02132754|11191519|FG025|COMPLETED|Overall Study||0
10065539|NCT02132754|11191520|FG026|COMPLETED|Overall Study||0
10065540|NCT02132754|11191521|FG027|COMPLETED|Overall Study||0
10065541|NCT02132754|11191522|FG028|COMPLETED|Overall Study||0
10065542|NCT02132754|11191523|FG029|COMPLETED|Overall Study||0
10065543|NCT02132754|11191524|FG030|COMPLETED|Overall Study||0
10065544|NCT02132754|11191525|FG031|COMPLETED|Overall Study||0
10065545|NCT02132754|11191526|FG032|COMPLETED|Overall Study||0
10065546|NCT02132754|11191527|FG033|COMPLETED|Overall Study||0
10065547|NCT02132754|11191494|FG000|NOT COMPLETED|Overall Study||1
10065548|NCT02132754|11191495|FG001|NOT COMPLETED|Overall Study||1
10065549|NCT02132754|11191496|FG002|NOT COMPLETED|Overall Study||1
10065550|NCT02132754|11191497|FG003|NOT COMPLETED|Overall Study||1
10065551|NCT02132754|11191498|FG004|NOT COMPLETED|Overall Study||1
10065552|NCT02132754|11191499|FG005|NOT COMPLETED|Overall Study||1
10065553|NCT02132754|11191500|FG006|NOT COMPLETED|Overall Study||1
10065554|NCT02132754|11191501|FG007|NOT COMPLETED|Overall Study||1
10065555|NCT02132754|11191502|FG008|NOT COMPLETED|Overall Study||1
10065556|NCT02132754|11191503|FG009|NOT COMPLETED|Overall Study||6
10065557|NCT02132754|11191504|FG010|NOT COMPLETED|Overall Study||3
10065558|NCT02132754|11191505|FG011|NOT COMPLETED|Overall Study||3
10065559|NCT02132754|11191506|FG012|NOT COMPLETED|Overall Study||4
10065560|NCT02132754|11191507|FG013|NOT COMPLETED|Overall Study||3
10065561|NCT02132754|11191508|FG014|NOT COMPLETED|Overall Study||3
10065562|NCT02132754|11191509|FG015|NOT COMPLETED|Overall Study||5
10065563|NCT02132754|11191510|FG016|NOT COMPLETED|Overall Study||4
10065564|NCT02132754|11191511|FG017|NOT COMPLETED|Overall Study||3
10065565|NCT02132754|11191512|FG018|NOT COMPLETED|Overall Study||3
10065566|NCT02132754|11191513|FG019|NOT COMPLETED|Overall Study||4
10065567|NCT02132754|11191514|FG020|NOT COMPLETED|Overall Study||3
10065568|NCT02132754|11191515|FG021|NOT COMPLETED|Overall Study||5
10065569|NCT02132754|11191516|FG022|NOT COMPLETED|Overall Study||3
10065570|NCT02132754|11191517|FG023|NOT COMPLETED|Overall Study||3
10065571|NCT02132754|11191518|FG024|NOT COMPLETED|Overall Study||3
10065572|NCT02132754|11191519|FG025|NOT COMPLETED|Overall Study||3
10065573|NCT02132754|11191520|FG026|NOT COMPLETED|Overall Study||4
10065574|NCT02132754|11191521|FG027|NOT COMPLETED|Overall Study||3
10065575|NCT02132754|11191522|FG028|NOT COMPLETED|Overall Study||3
10065576|NCT02132754|11191523|FG029|NOT COMPLETED|Overall Study||3
10065577|NCT02132754|11191524|FG030|NOT COMPLETED|Overall Study||3
10065578|NCT02132754|11191525|FG031|NOT COMPLETED|Overall Study||3
10065579|NCT02132754|11191526|FG032|NOT COMPLETED|Overall Study||4
10065580|NCT02132754|11191527|FG033|NOT COMPLETED|Overall Study||23
10065581|NCT02132767|11191639|FG000|STARTED|Overall Study||262
10065582|NCT02132767|11191640|FG001|STARTED|Overall Study||261
10065583|NCT02132767|11191639|FG000|COMPLETED|Overall Study||245
10065584|NCT02132767|11191640|FG001|COMPLETED|Overall Study||246
10065585|NCT02132767|11191639|FG000|NOT COMPLETED|Overall Study||17
10065586|NCT02132767|11191640|FG001|NOT COMPLETED|Overall Study||15
10065587|NCT02132832|11191648|FG000|STARTED|Overall Study||19
10065588|NCT02132832|11191649|FG001|STARTED|Overall Study||23
10065589|NCT02132832|11191648|FG000|COMPLETED|Overall Study||16
10065590|NCT02132832|11191649|FG001|COMPLETED|Overall Study||16
10065591|NCT02132832|11191648|FG000|NOT COMPLETED|Overall Study||3
10065592|NCT02132832|11191649|FG001|NOT COMPLETED|Overall Study||7
10065593|NCT02132910|11191657|FG000|STARTED|Overall Study||34
10065594|NCT02132910|11191658|FG001|STARTED|Overall Study||34
10065595|NCT02132910|11191657|FG000|COMPLETED|Overall Study||34
10065596|NCT02132910|11191658|FG001|COMPLETED|Overall Study||34
10065597|NCT02132910|11191657|FG000|NOT COMPLETED|Overall Study||0
10065598|NCT02132910|11191658|FG001|NOT COMPLETED|Overall Study||0
10065599|NCT02132936|11191668|FG000|STARTED|Overall Study||185
10065600|NCT02132936|11191669|FG001|STARTED|Overall Study||47
10065601|NCT02132936|11191670|FG002|STARTED|Overall Study||188
10065602|NCT02132936|11191671|FG003|STARTED|Overall Study||43
10065603|NCT02132936|11191668|FG000|COMPLETED|Overall Study||175
10065604|NCT02132936|11191669|FG001|COMPLETED|Overall Study||38
10065605|NCT02132936|11191670|FG002|COMPLETED|Overall Study||174
10065606|NCT02132936|11191671|FG003|COMPLETED|Overall Study||29
10065607|NCT02132936|11191668|FG000|NOT COMPLETED|Overall Study||10
10065608|NCT02132936|11191669|FG001|NOT COMPLETED|Overall Study||9
10065609|NCT02132936|11191670|FG002|NOT COMPLETED|Overall Study||14
10065610|NCT02132936|11191671|FG003|NOT COMPLETED|Overall Study||14
10065611|NCT02132949|11191684|FG000|STARTED|Overall Study||199
10065612|NCT02132949|11191685|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201
10065613|NCT02132949|11191684|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198
10065614|NCT02132949|11191685|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1
10065615|NCT02132949|11191684|FG000|Received Any Cohort B Study Treatment|Overall Study||0
10065616|NCT02132949|11191685|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198
10065617|NCT02132949|11191684|FG000|Underwent Surgery|Overall Study||187
10065618|NCT02132949|11191685|FG001|Underwent Surgery|Overall Study||194
10065619|NCT02132949|11191684|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182
10065620|NCT02132949|11191685|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189
10065621|NCT02132949|11191684|FG000|Started Adjuvant Treatment|Overall Study||181
10065622|NCT02132949|11191685|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190
10065623|NCT02132949|11191684|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163
10065624|NCT02132949|11191685|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176
10065625|NCT02132949|11191684|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
10065626|NCT02132949|11191685|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
10065627|NCT02132949|11191684|FG000|COMPLETED|Overall Study||158
10065628|NCT02132949|11191685|FG001|COMPLETED|Overall Study||173
10065629|NCT02132949|11191684|FG000|NOT COMPLETED|Overall Study||41
10065630|NCT02132949|11191685|FG001|NOT COMPLETED|Overall Study||28
10065631|NCT02133001|11191693|FG000|STARTED|Double Blind (Day 1-25)||32
10065632|NCT02133001|11191694|FG001|STARTED|Double Blind (Day 1-25)||36
10065633|NCT02133001|11191693|FG000|Safety|Double Blind (Day 1-25)||31
10065634|NCT02133001|11191694|FG001|Safety|Double Blind (Day 1-25)||35
10065635|NCT02133001|11191693|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
10065636|NCT02133001|11191694|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
10065637|NCT02133001|11191693|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10
10065638|NCT02133001|11191694|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9
10065639|NCT02133001|11191693|FG000|STARTED|Follow-Up Phase (Day 26-81)||22
10065640|NCT02133001|11191694|FG001|STARTED|Follow-Up Phase (Day 26-81)||27
10065641|NCT02133001|11191693|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20
10065642|NCT02133001|11191694|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24
10065643|NCT02133001|11191693|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
10065644|NCT02133001|11191694|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
10065645|NCT02133066|11191704|FG000|STARTED|Overall Study||64
10065646|NCT02133066|11191705|FG001|STARTED|Overall Study||64
10065647|NCT02133066|11191704|FG000|COMPLETED|Overall Study||64
10065648|NCT02133066|11191705|FG001|COMPLETED|Overall Study||64
10065649|NCT02133066|11191704|FG000|NOT COMPLETED|Overall Study||0
10065650|NCT02133066|11191705|FG001|NOT COMPLETED|Overall Study||0
10065651|NCT02133131|11191718|FG000|STARTED|Overall Study||31
10065652|NCT02133131|11191719|FG001|STARTED|Overall Study||30
10065653|NCT02133131|11191720|FG002|STARTED|Overall Study||20
10065654|NCT02133131|11191721|FG003|STARTED|Overall Study||21
10065655|NCT02133131|11191722|FG004|STARTED|Overall Study||15
10065656|NCT02133131|11191723|FG005|STARTED|Overall Study||14
10065657|NCT02133131|11191724|FG006|STARTED|Overall Study||12
10065658|NCT02133131|11191718|FG000|COMPLETED|Overall Study||26
10188589|NCT03269435|11318124|FG000|STARTED|Overall Study||51
10065659|NCT02133131|11191719|FG001|COMPLETED|Overall Study||25
10065660|NCT02133131|11191720|FG002|COMPLETED|Overall Study||19
10065661|NCT02133131|11191721|FG003|COMPLETED|Overall Study||15
10065662|NCT02133131|11191722|FG004|COMPLETED|Overall Study||0
10065663|NCT02133131|11191723|FG005|COMPLETED|Overall Study||0
10065664|NCT02133131|11191724|FG006|COMPLETED|Overall Study||0
10065665|NCT02133131|11191718|FG000|NOT COMPLETED|Overall Study||5
10065666|NCT02133131|11191719|FG001|NOT COMPLETED|Overall Study||5
10065667|NCT02133131|11191720|FG002|NOT COMPLETED|Overall Study||1
10065668|NCT02133131|11191721|FG003|NOT COMPLETED|Overall Study||6
10065669|NCT02133131|11191722|FG004|NOT COMPLETED|Overall Study||15
10065670|NCT02133131|11191723|FG005|NOT COMPLETED|Overall Study||14
10065671|NCT02133131|11191724|FG006|NOT COMPLETED|Overall Study||12
10065672|NCT02133235|11191742|FG000|STARTED|Overall Study||55
10065673|NCT02133235|11191743|FG001|STARTED|Overall Study||57
10065674|NCT02133235|11191742|FG000|COMPLETED|Overall Study||55
10065675|NCT02133235|11191743|FG001|COMPLETED|Overall Study||57
10065676|NCT02133235|11191742|FG000|NOT COMPLETED|Overall Study||0
10065677|NCT02133235|11191743|FG001|NOT COMPLETED|Overall Study||0
10065678|NCT02133352|11191755|FG000|STARTED|Main Study (180 Day)||10
10065679|NCT02133352|11191755|FG000|COMPLETED|Main Study (180 Day)||10
10065680|NCT02133352|11191755|FG000|NOT COMPLETED|Main Study (180 Day)||0
10065681|NCT02133352|11191755|FG000|STARTED|Longer Term Extension||10
10065682|NCT02133352|11191755|FG000|COMPLETED|Longer Term Extension||4
10065683|NCT02133352|11191755|FG000|NOT COMPLETED|Longer Term Extension||6
10065684|NCT02133508|11191759|FG000|STARTED|Overall Study||156
10065685|NCT02133508|11191759|FG000|COMPLETED|Overall Study||141
10065686|NCT02133508|11191759|FG000|NOT COMPLETED|Overall Study||15
10065687|NCT02133664|11191765|FG000|STARTED|Overall Study||26
10065688|NCT02133664|11191766|FG001|STARTED|Overall Study||28
10065689|NCT02133664|11191765|FG000|COMPLETED|Overall Study||21
10065690|NCT02133664|11191766|FG001|COMPLETED|Overall Study||21
10065691|NCT02133664|11191765|FG000|NOT COMPLETED|Overall Study||5
10065692|NCT02133664|11191766|FG001|NOT COMPLETED|Overall Study||7
10065693|NCT02133742|11191772|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11
10065694|NCT02133742|11191772|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
10065695|NCT02133742|11191772|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
10065696|NCT02133742|11191772|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
10065697|NCT02133742|11191772|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
10065698|NCT02133742|11191772|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
10065699|NCT02133781|11191781|FG000|STARTED|Overall Study||6
10065700|NCT02133781|11191782|FG001|STARTED|Overall Study||24
10065701|NCT02133781|11191783|FG002|STARTED|Overall Study||21
10065702|NCT02133781|11191781|FG000|COMPLETED|Overall Study||6
10065703|NCT02133781|11191782|FG001|COMPLETED|Overall Study||24
10065704|NCT02133781|11191783|FG002|COMPLETED|Overall Study||21
9850705|NCT00871845|10963402|FG000|NOT COMPLETED|Overall Study||0
9850706|NCT00871845|10963403|FG001|NOT COMPLETED|Overall Study||0
9850707|NCT00871858|10963415|FG000|STARTED|Overall Study||61
9850708|NCT00871858|10963416|FG001|STARTED|Overall Study||59
9850709|NCT00871858|10963415|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
9850710|NCT00871858|10963416|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
9850711|NCT00871858|10963415|FG000|COMPLETED|Overall Study||56
9850712|NCT00871858|10963416|FG001|COMPLETED|Overall Study||52
9850713|NCT00871858|10963415|FG000|NOT COMPLETED|Overall Study||5
10065705|NCT02133781|11191781|FG000|NOT COMPLETED|Overall Study||0
10065706|NCT02133781|11191782|FG001|NOT COMPLETED|Overall Study||0
10065707|NCT02133781|11191783|FG002|NOT COMPLETED|Overall Study||0
10065708|NCT02134015|11191793|FG000|STARTED|Overall Study||71
10065709|NCT02134015|11191794|FG001|STARTED|Overall Study||74
10065710|NCT02134015|11191793|FG000|COMPLETED|Overall Study||0
10065711|NCT02134015|11191794|FG001|COMPLETED|Overall Study||0
10065712|NCT02134015|11191793|FG000|NOT COMPLETED|Overall Study||71
10065713|NCT02134015|11191794|FG001|NOT COMPLETED|Overall Study||74
10065714|NCT02134119|11191802|FG000|STARTED|Overall Study||30
10065715|NCT02134119|11191803|FG001|STARTED|Overall Study||15
10065716|NCT02134119|11191802|FG000|COMPLETED|Overall Study||30
10065717|NCT02134119|11191803|FG001|COMPLETED|Overall Study||15
10065718|NCT02134119|11191802|FG000|NOT COMPLETED|Overall Study||0
10065719|NCT02134119|11191803|FG001|NOT COMPLETED|Overall Study||0
10065720|NCT02134184|11191812|FG000|STARTED|Overall Study||33
10065721|NCT02134184|11191813|FG001|STARTED|Overall Study||37
10065722|NCT02134184|11191814|FG002|STARTED|Overall Study||8
10065723|NCT02134184|11191812|FG000|COMPLETED|Overall Study||33
10065724|NCT02134184|11191813|FG001|COMPLETED|Overall Study||37
10065725|NCT02134184|11191814|FG002|COMPLETED|Overall Study||8
10065726|NCT02134184|11191812|FG000|NOT COMPLETED|Overall Study||0
10065727|NCT02134184|11191813|FG001|NOT COMPLETED|Overall Study||0
10065728|NCT02134184|11191814|FG002|NOT COMPLETED|Overall Study||0
10065729|NCT02134210|11191824|FG000|STARTED|Part One: Weeks 0-12||260
10065730|NCT02134210|11191825|FG001|STARTED|Part One: Weeks 0-12||261
10065731|NCT02134210|11191824|FG000|COMPLETED|Part One: Weeks 0-12||241
10065732|NCT02134210|11191825|FG001|COMPLETED|Part One: Weeks 0-12||255
10065733|NCT02134210|11191824|FG000|NOT COMPLETED|Part One: Weeks 0-12||19
10065734|NCT02134210|11191825|FG001|NOT COMPLETED|Part One: Weeks 0-12||6
10065735|NCT02134210|11191824|FG000|STARTED|Part Two: Weeks 13-48||241
10065736|NCT02134210|11191825|FG001|STARTED|Part Two: Weeks 13-48||255
10065737|NCT02134210|11191824|FG000|COMPLETED|Part Two: Weeks 13-48||211
10065738|NCT02134210|11191825|FG001|COMPLETED|Part Two: Weeks 13-48||227
10065739|NCT02134210|11191824|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30
10065740|NCT02134210|11191825|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28
10065741|NCT02134314|11191833|FG000|STARTED|Overall Study||35
10065742|NCT02134314|11191834|FG001|STARTED|Overall Study||35
10065743|NCT02134314|11191833|FG000|COMPLETED|Overall Study||34
10065744|NCT02134314|11191834|FG001|COMPLETED|Overall Study||34
10065745|NCT02134314|11191833|FG000|NOT COMPLETED|Overall Study||1
10065746|NCT02134314|11191834|FG001|NOT COMPLETED|Overall Study||1
10065747|NCT02134353|11191843|FG000|STARTED|Overall Study||209
10065748|NCT02134353|11191844|FG001|STARTED|Overall Study||214
10065749|NCT02134353|11191843|FG000|COMPLETED|Overall Study||183
10065750|NCT02134353|11191844|FG001|COMPLETED|Overall Study||190
10065751|NCT02134353|11191843|FG000|NOT COMPLETED|Overall Study||26
10065752|NCT02134353|11191844|FG001|NOT COMPLETED|Overall Study||24
10065753|NCT02134522|11191850|FG000|STARTED|Overall Study||1
10065754|NCT02134522|11191850|FG000|COMPLETED|Overall Study||1
10065755|NCT02134522|11191850|FG000|NOT COMPLETED|Overall Study||0
10065756|NCT02134587|11191854|FG000|STARTED|Overall Study||203
10065757|NCT02134587|11191854|FG000|COMPLETED|Overall Study||173
10065758|NCT02134587|11191854|FG000|NOT COMPLETED|Overall Study||30
10065759|NCT02134756|11191865|FG000|STARTED|Overall Study||15
10065760|NCT02134756|11191866|FG001|STARTED|Overall Study||15
10065761|NCT02134756|11191865|FG000|COMPLETED|Overall Study||14
10065762|NCT02134756|11191866|FG001|COMPLETED|Overall Study||13
10065763|NCT02134756|11191865|FG000|NOT COMPLETED|Overall Study||1
10065764|NCT02134756|11191866|FG001|NOT COMPLETED|Overall Study||2
10065765|NCT02134951|11191874|FG000|STARTED|Overall Study||39
10065766|NCT02134951|11191875|FG001|STARTED|Overall Study||20
10065767|NCT02134951|11191874|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
10065768|NCT02134951|11191875|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
10065769|NCT02134951|11191874|FG000|NOT COMPLETED|Overall Study||0
10065770|NCT02134951|11191875|FG001|NOT COMPLETED|Overall Study||0
10065771|NCT02134977|11191881|FG000|STARTED|Overall Study||2816
10065772|NCT02134977|11191881|FG000|COMPLETED|Overall Study||2714
10065773|NCT02134977|11191881|FG000|NOT COMPLETED|Overall Study||102
10065774|NCT02135016|11191888|FG000|STARTED|Overall Study||15
10065775|NCT02135016|11191889|FG001|STARTED|Overall Study||15
10065776|NCT02135016|11191890|FG002|STARTED|Overall Study||15
10065777|NCT02135016|11191888|FG000|COMPLETED|Overall Study||15
10065778|NCT02135016|11191889|FG001|COMPLETED|Overall Study||15
10065779|NCT02135016|11191890|FG002|COMPLETED|Overall Study||15
10065780|NCT02135016|11191888|FG000|NOT COMPLETED|Overall Study||0
10065781|NCT02135016|11191889|FG001|NOT COMPLETED|Overall Study||0
10065782|NCT02135016|11191890|FG002|NOT COMPLETED|Overall Study||0
10065783|NCT02135094|11191900|FG000|STARTED|Overall Study||25
10065784|NCT02135094|11191901|FG001|STARTED|Overall Study||8
10065785|NCT02135094|11191900|FG000|Week 2|Overall Study||25
10065786|NCT02135094|11191901|FG001|Week 2|Overall Study||8
10065787|NCT02135094|11191900|FG000|Week 3|Overall Study||25
10065788|NCT02135094|11191901|FG001|Week 3|Overall Study||8
10065789|NCT02135094|11191900|FG000|Week 4|Overall Study||25
10065790|NCT02135094|11191901|FG001|Week 4|Overall Study||8
10065791|NCT02135094|11191900|FG000|COMPLETED|Overall Study||25
10065792|NCT02135094|11191901|FG001|COMPLETED|Overall Study||8
10065793|NCT02135094|11191900|FG000|NOT COMPLETED|Overall Study||0
10065794|NCT02135094|11191901|FG001|NOT COMPLETED|Overall Study||0
10065795|NCT02135107|11191909|FG000|STARTED|Treatment Period||437
10065796|NCT02135107|11191910|FG001|STARTED|Treatment Period||80
10065797|NCT02135107|11191911|FG002|STARTED|Treatment Period||0
10065798|NCT02135107|11191912|FG003|STARTED|Treatment Period||0
10065799|NCT02135107|11191909|FG000|COMPLETED|Treatment Period||305
10065800|NCT02135107|11191910|FG001|COMPLETED|Treatment Period||54
10065801|NCT02135107|11191911|FG002|COMPLETED|Treatment Period||0
10065802|NCT02135107|11191912|FG003|COMPLETED|Treatment Period||0
10065803|NCT02135107|11191909|FG000|NOT COMPLETED|Treatment Period||132
10065804|NCT02135107|11191910|FG001|NOT COMPLETED|Treatment Period||26
10065805|NCT02135107|11191911|FG002|NOT COMPLETED|Treatment Period||0
10065806|NCT02135107|11191912|FG003|NOT COMPLETED|Treatment Period||0
10065807|NCT02135107|11191909|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0
10065808|NCT02135107|11191910|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0
10065809|NCT02135107|11191911|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
10065810|NCT02135107|11191912|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
10065811|NCT02135107|11191909|FG000|COMPLETED|Maintenance Therapy Period||0
10065812|NCT02135107|11191910|FG001|COMPLETED|Maintenance Therapy Period||0
10065813|NCT02135107|11191911|FG002|COMPLETED|Maintenance Therapy Period||163
10065814|NCT02135107|11191912|FG003|COMPLETED|Maintenance Therapy Period||161
10065815|NCT02135107|11191909|FG000|NOT COMPLETED|Maintenance Therapy Period||0
10065816|NCT02135107|11191910|FG001|NOT COMPLETED|Maintenance Therapy Period||0
10065817|NCT02135107|11191911|FG002|NOT COMPLETED|Maintenance Therapy Period||15
10065818|NCT02135107|11191912|FG003|NOT COMPLETED|Maintenance Therapy Period||20
10065819|NCT02135146|11191926|FG000|STARTED|Overall Study||20
10065820|NCT02135146|11191927|FG001|STARTED|Overall Study||20
10065821|NCT02135146|11191926|FG000|COMPLETED|Overall Study||20
10065822|NCT02135146|11191927|FG001|COMPLETED|Overall Study||20
10065823|NCT02135146|11191926|FG000|NOT COMPLETED|Overall Study||0
10065824|NCT02135146|11191927|FG001|NOT COMPLETED|Overall Study||0
10065825|NCT02135432|11191935|FG000|STARTED|Overall Study||8
10065826|NCT02135432|11191936|FG001|STARTED|Overall Study||4
10065827|NCT02135432|11191935|FG000|COMPLETED|Overall Study||8
10065828|NCT02135432|11191936|FG001|COMPLETED|Overall Study||4
10065829|NCT02135432|11191935|FG000|NOT COMPLETED|Overall Study||0
10065830|NCT02135432|11191936|FG001|NOT COMPLETED|Overall Study||0
10065831|NCT02135445|11191945|FG000|STARTED|Overall Study||65
10065832|NCT02135445|11191946|FG001|STARTED|Overall Study||38
10065833|NCT02135445|11191945|FG000|COMPLETED|Overall Study||63
10065834|NCT02135445|11191946|FG001|COMPLETED|Overall Study||38
10065835|NCT02135445|11191945|FG000|NOT COMPLETED|Overall Study||2
10065836|NCT02135445|11191946|FG001|NOT COMPLETED|Overall Study||0
10065837|NCT02135614|11191954|FG000|STARTED|Overall Study||94
10065838|NCT02135614|11191955|FG001|STARTED|Overall Study||95
10065839|NCT02135614|11191954|FG000|COMPLETED|Overall Study||86
10065840|NCT02135614|11191955|FG001|COMPLETED|Overall Study||90
10065841|NCT02135614|11191954|FG000|NOT COMPLETED|Overall Study||8
10065842|NCT02135614|11191955|FG001|NOT COMPLETED|Overall Study||5
10065843|NCT02135653|11191963|FG000|STARTED|Overall Study||35
10065844|NCT02135653|11191964|FG001|STARTED|Overall Study||33
10065845|NCT02135653|11191963|FG000|COMPLETED|Overall Study||22
10065846|NCT02135653|11191964|FG001|COMPLETED|Overall Study||28
10065847|NCT02135653|11191963|FG000|NOT COMPLETED|Overall Study||13
10065848|NCT02135653|11191964|FG001|NOT COMPLETED|Overall Study||5
10065849|NCT02135692|11191972|FG000|STARTED|Overall Study||339
10065850|NCT02135692|11191972|FG000|COMPLETED|Overall Study||0
10065851|NCT02135692|11191972|FG000|NOT COMPLETED|Overall Study||339
10065852|NCT02135848|11191978|FG000|STARTED|Overall Study||26
10065853|NCT02135848|11191979|FG001|STARTED|Overall Study||20
10065854|NCT02135848|11191978|FG000|COMPLETED|Overall Study||23
10065855|NCT02135848|11191979|FG001|COMPLETED|Overall Study||19
10065856|NCT02135848|11191978|FG000|NOT COMPLETED|Overall Study||3
10065857|NCT02135848|11191979|FG001|NOT COMPLETED|Overall Study||1
10065858|NCT02135861|11191995|FG000|STARTED|Overall Study||21
10065859|NCT02135861|11191996|FG001|STARTED|Overall Study||12
10065860|NCT02135861|11191997|FG002|STARTED|Overall Study||3
10065861|NCT02135861|11191995|FG000|COMPLETED|Overall Study||21
10065862|NCT02135861|11191996|FG001|COMPLETED|Overall Study||12
10065863|NCT02135861|11191997|FG002|COMPLETED|Overall Study||3
10065864|NCT02135861|11191995|FG000|NOT COMPLETED|Overall Study||0
10065865|NCT02135861|11191996|FG001|NOT COMPLETED|Overall Study||0
10065866|NCT02135861|11191997|FG002|NOT COMPLETED|Overall Study||0
10065867|NCT02135900|11192007|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
10065868|NCT02135900|11192007|FG000|COMPLETED|Overall Study||32
10065869|NCT02135900|11192007|FG000|NOT COMPLETED|Overall Study||0
10065870|NCT02136004|11192013|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
10065871|NCT02136004|11192013|FG000|COMPLETED|Overall Study||219
10065872|NCT02136004|11192013|FG000|NOT COMPLETED|Overall Study||1
10065873|NCT02136238|11192019|FG000|STARTED|Overall Study||4
10065874|NCT02136238|11192020|FG001|STARTED|Overall Study||4
10065875|NCT02136238|11192021|FG002|STARTED|Overall Study||10
10065876|NCT02136238|11192019|FG000|COMPLETED|Overall Study||4
10065877|NCT02136238|11192020|FG001|COMPLETED|Overall Study||4
10065878|NCT02136238|11192021|FG002|COMPLETED|Overall Study||10
10065879|NCT02136238|11192019|FG000|NOT COMPLETED|Overall Study||0
10065880|NCT02136238|11192020|FG001|NOT COMPLETED|Overall Study||0
10065881|NCT02136238|11192021|FG002|NOT COMPLETED|Overall Study||0
10065882|NCT02136420|11192036|FG000|STARTED|Overall Study||10
10065883|NCT02136420|11192037|FG001|STARTED|Overall Study||0
10065884|NCT02136420|11192038|FG002|STARTED|Overall Study||0
10065885|NCT02136420|11192039|FG003|STARTED|Overall Study||0
10065886|NCT02136420|11192040|FG004|STARTED|Overall Study||10
10065887|NCT02136420|11192041|FG005|STARTED|Overall Study||0
10065888|NCT02136420|11192042|FG006|STARTED|Overall Study||0
10065889|NCT02136420|11192043|FG007|STARTED|Overall Study||0
10065890|NCT02136420|11192044|FG008|STARTED|Overall Study||5
10065891|NCT02136420|11192045|FG009|STARTED|Overall Study||5
10065892|NCT02136420|11192036|FG000|COMPLETED|Overall Study||9
10065893|NCT02136420|11192037|FG001|COMPLETED|Overall Study||0
10065894|NCT02136420|11192038|FG002|COMPLETED|Overall Study||0
10065895|NCT02136420|11192039|FG003|COMPLETED|Overall Study||0
10065896|NCT02136420|11192040|FG004|COMPLETED|Overall Study||10
10065897|NCT02136420|11192041|FG005|COMPLETED|Overall Study||0
10065898|NCT02136420|11192042|FG006|COMPLETED|Overall Study||0
10065899|NCT02136420|11192043|FG007|COMPLETED|Overall Study||0
10065900|NCT02136420|11192044|FG008|COMPLETED|Overall Study||5
10065901|NCT02136420|11192045|FG009|COMPLETED|Overall Study||5
10065902|NCT02136420|11192036|FG000|NOT COMPLETED|Overall Study||1
10065903|NCT02136420|11192037|FG001|NOT COMPLETED|Overall Study||0
10065904|NCT02136420|11192038|FG002|NOT COMPLETED|Overall Study||0
10065905|NCT02136420|11192039|FG003|NOT COMPLETED|Overall Study||0
10065906|NCT02136420|11192040|FG004|NOT COMPLETED|Overall Study||0
10065907|NCT02136420|11192041|FG005|NOT COMPLETED|Overall Study||0
10065908|NCT02136420|11192042|FG006|NOT COMPLETED|Overall Study||0
10065909|NCT02136420|11192043|FG007|NOT COMPLETED|Overall Study||0
10065910|NCT02136420|11192044|FG008|NOT COMPLETED|Overall Study||0
10065911|NCT02136420|11192045|FG009|NOT COMPLETED|Overall Study||0
10065912|NCT02136498|11192062|FG000|STARTED|Overall Study||33
10065913|NCT02136498|11192063|FG001|STARTED|Overall Study||33
10065914|NCT02136498|11192062|FG000|COMPLETED|Overall Study||33
10065915|NCT02136498|11192063|FG001|COMPLETED|Overall Study||33
10065916|NCT02136498|11192062|FG000|NOT COMPLETED|Overall Study||0
10065917|NCT02136498|11192063|FG001|NOT COMPLETED|Overall Study||0
10065918|NCT02136576|11192072|FG000|STARTED|Overall Study||13
10065919|NCT02136576|11192073|FG001|STARTED|Overall Study||13
10065920|NCT02136576|11192074|FG002|STARTED|Overall Study||13
10065921|NCT02136576|11192072|FG000|COMPLETED|Overall Study||11
10065922|NCT02136576|11192073|FG001|COMPLETED|Overall Study||13
10065923|NCT02136576|11192074|FG002|COMPLETED|Overall Study||13
10065924|NCT02136576|11192072|FG000|NOT COMPLETED|Overall Study||2
10065925|NCT02136576|11192073|FG001|NOT COMPLETED|Overall Study||0
10065926|NCT02136576|11192074|FG002|NOT COMPLETED|Overall Study||0
10065927|NCT02136680|11192084|FG000|STARTED|Overall Study||112
10065928|NCT02136680|11192085|FG001|STARTED|Overall Study||85
10065929|NCT02136680|11192084|FG000|Interview 1|Overall Study||112
10065930|NCT02136680|11192085|FG001|Interview 1|Overall Study||85
10065931|NCT02136680|11192084|FG000|Interview 2|Overall Study||97
10065932|NCT02136680|11192085|FG001|Interview 2|Overall Study||70
10065933|NCT02136680|11192084|FG000|Interview 3|Overall Study||80
10065934|NCT02136680|11192085|FG001|Interview 3|Overall Study||56
10065935|NCT02136680|11192084|FG000|COMPLETED|Overall Study||80
10065936|NCT02136680|11192085|FG001|COMPLETED|Overall Study||56
10065937|NCT02136680|11192084|FG000|NOT COMPLETED|Overall Study||32
10065938|NCT02136680|11192085|FG001|NOT COMPLETED|Overall Study||29
10065939|NCT02136810|11192091|FG000|STARTED|Overall Study||200
10065940|NCT02136810|11192091|FG000|COMPLETED|Overall Study||200
10065941|NCT02136810|11192091|FG000|NOT COMPLETED|Overall Study||0
10065942|NCT02136914|11192097|FG000|STARTED|Overall Study||63
10065943|NCT02136914|11192098|FG001|STARTED|Overall Study||63
10065944|NCT02136914|11192097|FG000|Received Study Drug|Overall Study||60
10065945|NCT02136914|11192098|FG001|Received Study Drug|Overall Study||63
10065946|NCT02136914|11192097|FG000|COMPLETED|Overall Study||42
10065947|NCT02136914|11192098|FG001|COMPLETED|Overall Study||42
10065948|NCT02136914|11192097|FG000|NOT COMPLETED|Overall Study||21
10065949|NCT02136914|11192098|FG001|NOT COMPLETED|Overall Study||21
10065950|NCT02137226|11192106|FG000|STARTED|Period 1 (Initial Randomization)||324
10065951|NCT02137226|11192107|FG001|STARTED|Period 1 (Initial Randomization)||321
10065952|NCT02137226|11192108|FG002|STARTED|Period 1 (Initial Randomization)||0
10065953|NCT02137226|11192109|FG003|STARTED|Period 1 (Initial Randomization)||0
10065954|NCT02137226|11192110|FG004|STARTED|Period 1 (Initial Randomization)||0
10065955|NCT02137226|11192106|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
10065956|NCT02137226|11192107|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
10065957|NCT02137226|11192108|FG002|COMPLETED|Period 1 (Initial Randomization)||0
10065958|NCT02137226|11192109|FG003|COMPLETED|Period 1 (Initial Randomization)||0
10065959|NCT02137226|11192110|FG004|COMPLETED|Period 1 (Initial Randomization)||0
10065960|NCT02137226|11192106|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20
10065961|NCT02137226|11192107|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16
10065962|NCT02137226|11192108|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0
10065963|NCT02137226|11192109|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0
10065964|NCT02137226|11192110|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0
10065965|NCT02137226|11192106|FG000|STARTED|Period 2 (Re - Randomization)||0
10065966|NCT02137226|11192107|FG001|STARTED|Period 2 (Re - Randomization)||0
10065967|NCT02137226|11192108|FG002|STARTED|Period 2 (Re - Randomization)||298
10065968|NCT02137226|11192109|FG003|STARTED|Period 2 (Re - Randomization)||148
10065969|NCT02137226|11192110|FG004|STARTED|Period 2 (Re - Randomization)||147
10065970|NCT02137226|11192106|FG000|COMPLETED|Period 2 (Re - Randomization)||0
10065971|NCT02137226|11192107|FG001|COMPLETED|Period 2 (Re - Randomization)||0
10065972|NCT02137226|11192108|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
10065973|NCT02137226|11192109|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
10065974|NCT02137226|11192110|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
10065975|NCT02137226|11192106|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0
10065976|NCT02137226|11192107|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0
10065977|NCT02137226|11192108|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17
10065978|NCT02137226|11192109|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8
10065979|NCT02137226|11192110|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9
10065980|NCT02137369|11192120|FG000|STARTED|Overall Study||49
10065981|NCT02137369|11192121|FG001|STARTED|Overall Study||11
10065982|NCT02137369|11192120|FG000|COMPLETED|Overall Study||41
10065983|NCT02137369|11192121|FG001|COMPLETED|Overall Study||9
10065984|NCT02137369|11192120|FG000|NOT COMPLETED|Overall Study||8
10065985|NCT02137369|11192121|FG001|NOT COMPLETED|Overall Study||2
10065986|NCT02137382|11192128|FG000|STARTED|Cross-over Period 1||20
10065987|NCT02137382|11192129|FG001|STARTED|Cross-over Period 1||21
10065988|NCT02137382|11192128|FG000|COMPLETED|Cross-over Period 1||18
10065989|NCT02137382|11192129|FG001|COMPLETED|Cross-over Period 1||21
10065990|NCT02137382|11192128|FG000|NOT COMPLETED|Cross-over Period 1||2
10065991|NCT02137382|11192129|FG001|NOT COMPLETED|Cross-over Period 1||0
10065992|NCT02137382|11192128|FG000|STARTED|Wash Out||18
10065993|NCT02137382|11192129|FG001|STARTED|Wash Out||21
10065994|NCT02137382|11192128|FG000|COMPLETED|Wash Out||18
10065995|NCT02137382|11192129|FG001|COMPLETED|Wash Out||21
10065996|NCT02137382|11192128|FG000|NOT COMPLETED|Wash Out||0
10065997|NCT02137382|11192129|FG001|NOT COMPLETED|Wash Out||0
10065998|NCT02137382|11192128|FG000|STARTED|Cross-over Period 2||18
10065999|NCT02137382|11192129|FG001|STARTED|Cross-over Period 2||21
10066000|NCT02137382|11192128|FG000|COMPLETED|Cross-over Period 2||18
10066001|NCT02137382|11192129|FG001|COMPLETED|Cross-over Period 2||21
10066002|NCT02137382|11192128|FG000|NOT COMPLETED|Cross-over Period 2||0
10066003|NCT02137382|11192129|FG001|NOT COMPLETED|Cross-over Period 2||0
10066004|NCT02137447|11192136|FG000|STARTED|Overall Study||10
10066005|NCT02137447|11192136|FG000|COMPLETED|Overall Study||10
10066006|NCT02137447|11192136|FG000|NOT COMPLETED|Overall Study||0
10066007|NCT02137486|11192142|FG000|STARTED|Overall Study||112
10066008|NCT02137486|11192143|FG001|STARTED|Overall Study||102
10066009|NCT02137486|11192142|FG000|COMPLETED|Overall Study||112
10066010|NCT02137486|11192143|FG001|COMPLETED|Overall Study||102
10066011|NCT02137486|11192142|FG000|NOT COMPLETED|Overall Study||0
10066012|NCT02137486|11192143|FG001|NOT COMPLETED|Overall Study||0
10066013|NCT02137499|11192157|FG000|STARTED|Overall Study||10
10066014|NCT02137499|11192158|FG001|STARTED|Overall Study||10
10066015|NCT02137499|11192159|FG002|STARTED|Overall Study||10
10066016|NCT02137499|11192160|FG003|STARTED|Overall Study||10
10066017|NCT02137499|11192157|FG000|COMPLETED|Overall Study||10
10066018|NCT02137499|11192158|FG001|COMPLETED|Overall Study||10
10066019|NCT02137499|11192159|FG002|COMPLETED|Overall Study||10
10066020|NCT02137499|11192160|FG003|COMPLETED|Overall Study||10
10066021|NCT02137499|11192157|FG000|NOT COMPLETED|Overall Study||0
10066022|NCT02137499|11192158|FG001|NOT COMPLETED|Overall Study||0
10066023|NCT02137499|11192159|FG002|NOT COMPLETED|Overall Study||0
10066024|NCT02137499|11192160|FG003|NOT COMPLETED|Overall Study||0
10066025|NCT02137512|11192170|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30
10066026|NCT02137512|11192170|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
10066027|NCT02137512|11192170|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
10066028|NCT02137512|11192170|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30
10066029|NCT02137512|11192170|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30
10066030|NCT02137512|11192170|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
10066031|NCT02137512|11192170|FG000|STARTED|2-Week 24/7 Closed-Loop||30
10066032|NCT02137512|11192170|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30
10066033|NCT02137512|11192170|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
10066034|NCT02137512|11192170|FG000|STARTED|5-Month 24/7 Closed-Loop||14
10066035|NCT02137512|11192170|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14
10066036|NCT02137512|11192170|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
10066037|NCT02137538|11192180|FG000|STARTED|Overall Study||39
10066038|NCT02137538|11192181|FG001|STARTED|Overall Study||40
10066039|NCT02137538|11192180|FG000|COMPLETED|Overall Study||23
10066040|NCT02137538|11192181|FG001|COMPLETED|Overall Study||26
10066041|NCT02137538|11192180|FG000|NOT COMPLETED|Overall Study||16
10066042|NCT02137538|11192181|FG001|NOT COMPLETED|Overall Study||14
10066043|NCT02137603|11192189|FG000|STARTED|Overall Study||18
10066044|NCT02137603|11192190|FG001|STARTED|Overall Study||18
10066045|NCT02137603|11192189|FG000|COMPLETED|Overall Study||16
10066046|NCT02137603|11192190|FG001|COMPLETED|Overall Study||18
10066047|NCT02137603|11192189|FG000|NOT COMPLETED|Overall Study||2
10066048|NCT02137603|11192190|FG001|NOT COMPLETED|Overall Study||0
10066049|NCT02137772|11192198|FG000|STARTED|Overall Study|Randomized participants|376
10066050|NCT02137772|11192199|FG001|STARTED|Overall Study|Randomized participants|194
10066051|NCT02137772|11192198|FG000|Treated Participants|Overall Study||373
10066052|NCT02137772|11192199|FG001|Treated Participants|Overall Study||192
10066053|NCT02137772|11192198|FG000|COMPLETED|Overall Study||244
10066054|NCT02137772|11192199|FG001|COMPLETED|Overall Study||119
10066055|NCT02137772|11192198|FG000|NOT COMPLETED|Overall Study||132
10066056|NCT02137772|11192199|FG001|NOT COMPLETED|Overall Study||75
10066057|NCT02137785|11192207|FG000|STARTED|Overall Study||135
10066058|NCT02137785|11192208|FG001|STARTED|Overall Study||134
10066059|NCT02137785|11192207|FG000|COMPLETED|Overall Study||132
10066060|NCT02137785|11192208|FG001|COMPLETED|Overall Study||130
10066061|NCT02137785|11192207|FG000|NOT COMPLETED|Overall Study||3
10066062|NCT02137785|11192208|FG001|NOT COMPLETED|Overall Study||4
10066063|NCT02137837|11192217|FG000|STARTED|Overall Study||13
10066064|NCT02137837|11192218|FG001|STARTED|Overall Study||12
10066065|NCT02137837|11192219|FG002|STARTED|Overall Study||12
10066066|NCT02137837|11192217|FG000|Received Protocol Therapy|Overall Study||13
10066067|NCT02137837|11192218|FG001|Received Protocol Therapy|Overall Study||11
10066068|NCT02137837|11192219|FG002|Received Protocol Therapy|Overall Study||12
10188590|NCT03269435|11318125|FG001|STARTED|Overall Study||48
10188591|NCT03269435|11318124|FG000|COMPLETED|Overall Study||51
10188592|NCT03269435|11318125|FG001|COMPLETED|Overall Study||48
10188593|NCT03269435|11318124|FG000|NOT COMPLETED|Overall Study||0
10188594|NCT03269435|11318125|FG001|NOT COMPLETED|Overall Study||0
10188595|NCT03269552|11318131|FG000|STARTED|Overall Study||4
10188596|NCT03269552|11318131|FG000|COMPLETED|Overall Study||2
10188597|NCT03269552|11318131|FG000|NOT COMPLETED|Overall Study||2
10188598|NCT03270085|11318138|FG000|STARTED|Overall Study||15
10188599|NCT03270085|11318139|FG001|STARTED|Overall Study||15
10188600|NCT03270085|11318138|FG000|COMPLETED|Overall Study||14
10188601|NCT03270085|11318139|FG001|COMPLETED|Overall Study||15
10188602|NCT03270085|11318138|FG000|NOT COMPLETED|Overall Study||1
10188603|NCT03270085|11318139|FG001|NOT COMPLETED|Overall Study||0
10188604|NCT03270332|11318147|FG000|STARTED|Overall Study||5
10066069|NCT02137837|11192217|FG000|COMPLETED|Overall Study||0
10066070|NCT02137837|11192218|FG001|COMPLETED|Overall Study||0
10066071|NCT02137837|11192219|FG002|COMPLETED|Overall Study||0
10066072|NCT02137837|11192217|FG000|NOT COMPLETED|Overall Study||13
10066073|NCT02137837|11192218|FG001|NOT COMPLETED|Overall Study||12
10066074|NCT02137837|11192219|FG002|NOT COMPLETED|Overall Study||12
10066075|NCT02138006|11192234|FG000|STARTED|Overall Study||48
10066076|NCT02138006|11192235|FG001|STARTED|Overall Study||54
10066077|NCT02138006|11192234|FG000|COMPLETED|Overall Study||48
10066078|NCT02138006|11192235|FG001|COMPLETED|Overall Study||54
10066079|NCT02138006|11192234|FG000|NOT COMPLETED|Overall Study||0
10066080|NCT02138006|11192235|FG001|NOT COMPLETED|Overall Study||0
10066081|NCT02138097|11192259|FG000|STARTED|Overall Study||155345
10066082|NCT02138097|11192260|FG001|STARTED|Overall Study||459722
10066083|NCT02138097|11192259|FG000|COMPLETED|Overall Study||155345
10066084|NCT02138097|11192260|FG001|COMPLETED|Overall Study||459722
10066085|NCT02138097|11192259|FG000|NOT COMPLETED|Overall Study||0
10066086|NCT02138097|11192260|FG001|NOT COMPLETED|Overall Study||0
10066087|NCT02138110|11192284|FG000|STARTED|Enrolled in Study||20
10066088|NCT02138110|11192284|FG000|COMPLETED|Enrolled in Study||20
10066089|NCT02138110|11192284|FG000|NOT COMPLETED|Enrolled in Study||0
10066090|NCT02138110|11192284|FG000|STARTED|Enrolled for Scaffold Implantation||20
10066091|NCT02138110|11192284|FG000|COMPLETED|Enrolled for Scaffold Implantation||19
10066092|NCT02138110|11192284|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1
10066093|NCT02138110|11192284|FG000|STARTED|Overall Scaffold Implantation||19
10066094|NCT02138110|11192284|FG000|6-month Follow-Up|Overall Scaffold Implantation||16
10066095|NCT02138110|11192284|FG000|COMPLETED|Overall Scaffold Implantation||16
10066096|NCT02138110|11192284|FG000|NOT COMPLETED|Overall Scaffold Implantation||3
10066097|NCT02138136|11192288|FG000|STARTED|Overall Study||419
10066098|NCT02138136|11192288|FG000|Safety Analysis Set|Overall Study||419
10066099|NCT02138136|11192288|FG000|Modified Intent to Treat (mITT)|Overall Study||418
10066100|NCT02138136|11192288|FG000|COMPLETED|Overall Study||280
10066101|NCT02138136|11192288|FG000|NOT COMPLETED|Overall Study||139
10066102|NCT02138214|11192296|FG000|STARTED|Overall Study||30
10066103|NCT02138214|11192297|FG001|STARTED|Overall Study||30
10066104|NCT02138214|11192298|FG002|STARTED|Overall Study||30
10066105|NCT02138214|11192296|FG000|Analyzed for Baseline Measures|Overall Study||30
10066106|NCT02138214|11192297|FG001|Analyzed for Baseline Measures|Overall Study||29
10066107|NCT02138214|11192298|FG002|Analyzed for Baseline Measures|Overall Study||30
10066108|NCT02138214|11192296|FG000|COMPLETED|Overall Study||30
10066109|NCT02138214|11192297|FG001|COMPLETED|Overall Study||26
10066110|NCT02138214|11192298|FG002|COMPLETED|Overall Study||26
10066111|NCT02138214|11192296|FG000|NOT COMPLETED|Overall Study||0
10066112|NCT02138214|11192297|FG001|NOT COMPLETED|Overall Study||4
10066113|NCT02138214|11192298|FG002|NOT COMPLETED|Overall Study||4
10066114|NCT02138227|11192307|FG000|STARTED|Overall Study||55
10066115|NCT02138227|11192308|FG001|STARTED|Overall Study||218
10066116|NCT02138227|11192307|FG000|COMPLETED|Overall Study||55
10066117|NCT02138227|11192308|FG001|COMPLETED|Overall Study||218
10066118|NCT02138227|11192307|FG000|NOT COMPLETED|Overall Study||0
10066119|NCT02138227|11192308|FG001|NOT COMPLETED|Overall Study||0
10066120|NCT02138240|11192339|FG000|STARTED|Overall Study||34
10066121|NCT02138240|11192339|FG000|COMPLETED|Overall Study||34
10066122|NCT02138240|11192339|FG000|NOT COMPLETED|Overall Study||0
10066123|NCT02138253|11192345|FG000|STARTED|Overall Study||41
10066124|NCT02138253|11192346|FG001|STARTED|Overall Study||23
10066125|NCT02138253|11192345|FG000|COMPLETED|Overall Study||32
10066126|NCT02138253|11192346|FG001|COMPLETED|Overall Study||19
10066127|NCT02138253|11192345|FG000|NOT COMPLETED|Overall Study||9
10066128|NCT02138253|11192346|FG001|NOT COMPLETED|Overall Study||4
10066129|NCT02138461|11192354|FG000|STARTED|Overall Study||101
10066130|NCT02138461|11192355|FG001|STARTED|Overall Study||110
10066131|NCT02138461|11192354|FG000|COMPLETED|Overall Study||101
10066132|NCT02138461|11192355|FG001|COMPLETED|Overall Study||110
10066133|NCT02138461|11192354|FG000|NOT COMPLETED|Overall Study||0
10066134|NCT02138461|11192355|FG001|NOT COMPLETED|Overall Study||0
10066135|NCT02138578|11192364|FG000|STARTED|Overall Study||1
10066136|NCT02138578|11192365|FG001|STARTED|Overall Study||0
10066137|NCT02138578|11192366|FG002|STARTED|Overall Study||3
10066138|NCT02138578|11192364|FG000|COMPLETED|Overall Study||1
10066139|NCT02138578|11192365|FG001|COMPLETED|Overall Study||0
10066140|NCT02138578|11192366|FG002|COMPLETED|Overall Study||3
10066141|NCT02138578|11192364|FG000|NOT COMPLETED|Overall Study||0
10066142|NCT02138578|11192365|FG001|NOT COMPLETED|Overall Study||0
10066143|NCT02138578|11192366|FG002|NOT COMPLETED|Overall Study||0
10066144|NCT02138747|11192378|FG000|STARTED|Treatment Period 1||156
10066145|NCT02138747|11192379|FG001|STARTED|Treatment Period 1||157
10066146|NCT02138747|11192380|FG002|STARTED|Treatment Period 1||31
10066147|NCT02138747|11192381|FG003|STARTED|Treatment Period 1||32
10066148|NCT02138747|11192378|FG000|COMPLETED|Treatment Period 1||136
10066149|NCT02138747|11192379|FG001|COMPLETED|Treatment Period 1||132
10066150|NCT02138747|11192380|FG002|COMPLETED|Treatment Period 1||27
10066151|NCT02138747|11192381|FG003|COMPLETED|Treatment Period 1||28
10066152|NCT02138747|11192378|FG000|NOT COMPLETED|Treatment Period 1||20
10066153|NCT02138747|11192379|FG001|NOT COMPLETED|Treatment Period 1||25
10066154|NCT02138747|11192380|FG002|NOT COMPLETED|Treatment Period 1||4
10066155|NCT02138747|11192381|FG003|NOT COMPLETED|Treatment Period 1||4
10066156|NCT02138747|11192378|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
10066157|NCT02138747|11192379|FG001|STARTED|Treatment Period 2||132
10066158|NCT02138747|11192380|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
10066159|NCT02138747|11192381|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
10066160|NCT02138747|11192378|FG000|COMPLETED|Treatment Period 2||121
10066161|NCT02138747|11192379|FG001|COMPLETED|Treatment Period 2||125
10066162|NCT02138747|11192380|FG002|COMPLETED|Treatment Period 2||24
10066163|NCT02138747|11192381|FG003|COMPLETED|Treatment Period 2||24
10066164|NCT02138747|11192378|FG000|NOT COMPLETED|Treatment Period 2||17
10066165|NCT02138747|11192379|FG001|NOT COMPLETED|Treatment Period 2||7
10066166|NCT02138747|11192380|FG002|NOT COMPLETED|Treatment Period 2||2
10066167|NCT02138747|11192381|FG003|NOT COMPLETED|Treatment Period 2||3
10066168|NCT02138786|11192394|FG000|STARTED|Overall Study||3
10066169|NCT02138786|11192395|FG001|STARTED|Overall Study||15
10066170|NCT02138786|11192396|FG002|STARTED|Overall Study||8
10066171|NCT02138786|11192394|FG000|COMPLETED|Overall Study||0
10066172|NCT02138786|11192395|FG001|COMPLETED|Overall Study||0
10066173|NCT02138786|11192396|FG002|COMPLETED|Overall Study||0
10066174|NCT02138786|11192394|FG000|NOT COMPLETED|Overall Study||3
10066175|NCT02138786|11192395|FG001|NOT COMPLETED|Overall Study||15
10066176|NCT02138786|11192396|FG002|NOT COMPLETED|Overall Study||8
10066177|NCT02138825|11192404|FG000|STARTED|Main Study Treatment|safety population|73
10066178|NCT02138825|11192405|FG001|STARTED|Main Study Treatment|safety population|74
10066179|NCT02138825|11192404|FG000|COMPLETED|Main Study Treatment||33
10066180|NCT02138825|11192405|FG001|COMPLETED|Main Study Treatment||39
10066181|NCT02138825|11192404|FG000|NOT COMPLETED|Main Study Treatment||40
10066182|NCT02138825|11192405|FG001|NOT COMPLETED|Main Study Treatment||35
10066183|NCT02138825|11192404|FG000|STARTED|Long-term Extension||32
10066184|NCT02138825|11192405|FG001|STARTED|Long-term Extension||38
10066185|NCT02138825|11192404|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
10066186|NCT02138825|11192405|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
10066187|NCT02138825|11192404|FG000|NOT COMPLETED|Long-term Extension||32
10066188|NCT02138825|11192405|FG001|NOT COMPLETED|Long-term Extension||38
10066189|NCT02138825|11192404|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
10066190|NCT02138825|11192405|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
10066191|NCT02138825|11192404|FG000|COMPLETED|Safety Follow-up||50
10066192|NCT02138825|11192405|FG001|COMPLETED|Safety Follow-up||47
10066193|NCT02138825|11192404|FG000|NOT COMPLETED|Safety Follow-up||22
10066194|NCT02138825|11192405|FG001|NOT COMPLETED|Safety Follow-up||17
10066195|NCT02138838|11192418|FG000|STARTED|Overall Study||28
10066196|NCT02138838|11192419|FG001|STARTED|Overall Study||27
10066197|NCT02138838|11192418|FG000|Received Study Drug|Overall Study||28
10066198|NCT02138838|11192419|FG001|Received Study Drug|Overall Study||25
10066199|NCT02138838|11192418|FG000|COMPLETED|Overall Study||20
10066200|NCT02138838|11192419|FG001|COMPLETED|Overall Study||16
10066201|NCT02138838|11192418|FG000|NOT COMPLETED|Overall Study||8
10066202|NCT02138838|11192419|FG001|NOT COMPLETED|Overall Study||11
10066203|NCT02138890|11192427|FG000|STARTED|Overall Study||31
10066204|NCT02138890|11192428|FG001|STARTED|Overall Study||15
10066205|NCT02138890|11192427|FG000|COMPLETED|Overall Study||30
10066206|NCT02138890|11192428|FG001|COMPLETED|Overall Study||15
10066207|NCT02138890|11192427|FG000|NOT COMPLETED|Overall Study||1
10066208|NCT02138890|11192428|FG001|NOT COMPLETED|Overall Study||0
10066209|NCT02138916|11192438|FG000|STARTED|Overall Study||554
10066210|NCT02138916|11192439|FG001|STARTED|Overall Study||552
10066211|NCT02138916|11192440|FG002|STARTED|Overall Study||550
10066212|NCT02138916|11192438|FG000|COMPLETED|Overall Study||497
10066213|NCT02138916|11192439|FG001|COMPLETED|Overall Study||492
10066214|NCT02138916|11192440|FG002|COMPLETED|Overall Study||491
10066215|NCT02138916|11192438|FG000|NOT COMPLETED|Overall Study||57
10066216|NCT02138916|11192439|FG001|NOT COMPLETED|Overall Study||60
10066217|NCT02138916|11192440|FG002|NOT COMPLETED|Overall Study||59
10066218|NCT02139007|11192450|FG000|STARTED|Study Site Recruitment||4
10066219|NCT02139007|11192451|FG001|STARTED|Study Site Recruitment||5
10066220|NCT02139007|11192450|FG000|COMPLETED|Study Site Recruitment||1
10066221|NCT02139007|11192451|FG001|COMPLETED|Study Site Recruitment||1
10066222|NCT02139007|11192450|FG000|NOT COMPLETED|Study Site Recruitment||3
10066223|NCT02139007|11192451|FG001|NOT COMPLETED|Study Site Recruitment||4
10066224|NCT02139007|11192450|FG000|STARTED|Patient Participant Recruitment||13
10066225|NCT02139007|11192451|FG001|STARTED|Patient Participant Recruitment||14
10066226|NCT02139007|11192450|FG000|COMPLETED|Patient Participant Recruitment||11
10066227|NCT02139007|11192451|FG001|COMPLETED|Patient Participant Recruitment||13
10066228|NCT02139007|11192450|FG000|NOT COMPLETED|Patient Participant Recruitment||2
10066229|NCT02139007|11192451|FG001|NOT COMPLETED|Patient Participant Recruitment||1
10066230|NCT02139046|11192465|FG000|STARTED|Overall Study||358
10066231|NCT02139046|11192466|FG001|STARTED|Overall Study||359
10066232|NCT02139046|11192467|FG002|STARTED|Overall Study||357
10066233|NCT02139046|11192468|FG003|STARTED|Overall Study||358
10066234|NCT02139046|11192469|FG004|STARTED|Overall Study||358
10066235|NCT02139046|11192465|FG000|Safety Analysis Set|Overall Study||356
10066236|NCT02139046|11192466|FG001|Safety Analysis Set|Overall Study||358
10066237|NCT02139046|11192467|FG002|Safety Analysis Set|Overall Study||355
10066238|NCT02139046|11192468|FG003|Safety Analysis Set|Overall Study||357
10066239|NCT02139046|11192469|FG004|Safety Analysis Set|Overall Study||357
10066240|NCT02139046|11192465|FG000|Full Analysis Set|Overall Study||357
10066241|NCT02139046|11192466|FG001|Full Analysis Set|Overall Study||357
10066242|NCT02139046|11192467|FG002|Full Analysis Set|Overall Study||355
10066243|NCT02139046|11192468|FG003|Full Analysis Set|Overall Study||357
10066244|NCT02139046|11192469|FG004|Full Analysis Set|Overall Study||357
10066245|NCT02139046|11192465|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296
10066246|NCT02139046|11192466|FG001|COMPLETED|Overall Study||305
10066247|NCT02139046|11192467|FG002|COMPLETED|Overall Study||298
10066248|NCT02139046|11192468|FG003|COMPLETED|Overall Study||290
10066249|NCT02139046|11192469|FG004|COMPLETED|Overall Study||301
10066250|NCT02139046|11192465|FG000|NOT COMPLETED|Overall Study||62
10066251|NCT02139046|11192466|FG001|NOT COMPLETED|Overall Study||54
10066252|NCT02139046|11192467|FG002|NOT COMPLETED|Overall Study||59
10066253|NCT02139046|11192468|FG003|NOT COMPLETED|Overall Study||68
10066254|NCT02139046|11192469|FG004|NOT COMPLETED|Overall Study||57
10066255|NCT02139124|11192486|FG000|STARTED|Overall Study||78
10066256|NCT02139124|11192487|FG001|STARTED|Overall Study||77
10066257|NCT02139124|11192488|FG002|STARTED|Overall Study||73
10066258|NCT02139124|11192489|FG003|STARTED|Overall Study||73
10066259|NCT02139124|11192490|FG004|STARTED|Overall Study||74
10066260|NCT02139124|11192486|FG000|COMPLETED|Overall Study||69
10066261|NCT02139124|11192487|FG001|COMPLETED|Overall Study||73
10066262|NCT02139124|11192488|FG002|COMPLETED|Overall Study||69
10066263|NCT02139124|11192489|FG003|COMPLETED|Overall Study||61
10066264|NCT02139124|11192490|FG004|COMPLETED|Overall Study||61
10066265|NCT02139124|11192486|FG000|NOT COMPLETED|Overall Study||9
10066266|NCT02139124|11192487|FG001|NOT COMPLETED|Overall Study||4
10066267|NCT02139124|11192488|FG002|NOT COMPLETED|Overall Study||4
10066268|NCT02139124|11192489|FG003|NOT COMPLETED|Overall Study||12
10066269|NCT02139124|11192490|FG004|NOT COMPLETED|Overall Study||13
10066270|NCT02139137|11192504|FG000|STARTED|Overall Study||22
10066271|NCT02139137|11192505|FG001|STARTED|Overall Study||20
10066272|NCT02139137|11192504|FG000|COMPLETED|Overall Study||15
10066273|NCT02139137|11192505|FG001|COMPLETED|Overall Study||10
10066274|NCT02139137|11192504|FG000|NOT COMPLETED|Overall Study||7
10066275|NCT02139137|11192505|FG001|NOT COMPLETED|Overall Study||10
10066276|NCT02139176|11192513|FG000|STARTED|Overall Study||100
10066277|NCT02139176|11192514|FG001|STARTED|Overall Study||100
10066278|NCT02139176|11192513|FG000|COMPLETED|Overall Study||100
10066279|NCT02139176|11192514|FG001|COMPLETED|Overall Study||100
10066280|NCT02139176|11192513|FG000|NOT COMPLETED|Overall Study||0
10066281|NCT02139176|11192514|FG001|NOT COMPLETED|Overall Study||0
10066282|NCT02139228|11192523|FG000|STARTED|Overall Study||215
10066283|NCT02139228|11192524|FG001|STARTED|Overall Study||211
10066284|NCT02139228|11192523|FG000|COMPLETED|Overall Study||215
10066285|NCT02139228|11192524|FG001|COMPLETED|Overall Study||211
10066286|NCT02139228|11192523|FG000|NOT COMPLETED|Overall Study||0
10066287|NCT02139228|11192524|FG001|NOT COMPLETED|Overall Study||0
10066288|NCT02139280|11192532|FG000|STARTED|Overall Study||34
10066289|NCT02139280|11192533|FG001|STARTED|Overall Study||20
10066290|NCT02139280|11192532|FG000|COMPLETED|Overall Study||32
10066291|NCT02139280|11192533|FG001|COMPLETED|Overall Study||20
10066292|NCT02139280|11192532|FG000|NOT COMPLETED|Overall Study||2
10066293|NCT02139280|11192533|FG001|NOT COMPLETED|Overall Study||0
10066294|NCT02139306|11192541|FG000|STARTED|Overall Study||140
10066295|NCT02139306|11192542|FG001|STARTED|Overall Study||139
10066296|NCT02139306|11192541|FG000|COMPLETED|Overall Study||127
10066297|NCT02139306|11192542|FG001|COMPLETED|Overall Study||125
10066298|NCT02139306|11192541|FG000|NOT COMPLETED|Overall Study||13
10066299|NCT02139306|11192542|FG001|NOT COMPLETED|Overall Study||14
10066300|NCT02139358|11192549|FG000|STARTED|Overall Study||15
10066301|NCT02139358|11192549|FG000|COMPLETED|Overall Study||15
10066302|NCT02139358|11192549|FG000|NOT COMPLETED|Overall Study||0
10066303|NCT02139592|11192553|FG000|STARTED|Overall Study||292
10066304|NCT02139592|11192553|FG000|COMPLETED|Overall Study||284
10066305|NCT02139592|11192553|FG000|NOT COMPLETED|Overall Study||8
10066306|NCT02139644|11192562|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
10066307|NCT02139644|11192563|FG001|STARTED|Run-In Period (Pre-assignment)||0
10066308|NCT02139644|11192564|FG002|STARTED|Run-In Period (Pre-assignment)||0
10066309|NCT02139644|11192565|FG003|STARTED|Run-In Period (Pre-assignment)||0
10066310|NCT02139644|11192566|FG004|STARTED|Run-In Period (Pre-assignment)||0
10066311|NCT02139644|11192567|FG005|STARTED|Run-In Period (Pre-assignment)||0
10066312|NCT02139644|11192562|FG000|COMPLETED|Run-In Period (Pre-assignment)||647
10066313|NCT02139644|11192563|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
10066314|NCT02139644|11192564|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
10066315|NCT02139644|11192565|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
10066316|NCT02139644|11192566|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
10066317|NCT02139644|11192567|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
10066318|NCT02139644|11192562|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140
10066319|NCT02139644|11192563|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066320|NCT02139644|11192564|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066321|NCT02139644|11192565|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066322|NCT02139644|11192566|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066323|NCT02139644|11192567|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066324|NCT02139644|11192562|FG000|STARTED|Treatment Period||0
10066325|NCT02139644|11192563|FG001|STARTED|Treatment Period|Randomized|129
10066326|NCT02139644|11192564|FG002|STARTED|Treatment Period|Randomized|129
10066327|NCT02139644|11192565|FG003|STARTED|Treatment Period|Randomized|130
10066328|NCT02139644|11192566|FG004|STARTED|Treatment Period|Randomized|129
10066329|NCT02139644|11192567|FG005|STARTED|Treatment Period|Randomized|130
10188605|NCT03270332|11318148|FG001|STARTED|Overall Study||5
10066330|NCT02139644|11192562|FG000|COMPLETED|Treatment Period||0
10066331|NCT02139644|11192563|FG001|COMPLETED|Treatment Period||126
10066332|NCT02139644|11192564|FG002|COMPLETED|Treatment Period||121
10066333|NCT02139644|11192565|FG003|COMPLETED|Treatment Period||121
10066334|NCT02139644|11192566|FG004|COMPLETED|Treatment Period||121
10066335|NCT02139644|11192567|FG005|COMPLETED|Treatment Period||113
10066336|NCT02139644|11192562|FG000|NOT COMPLETED|Treatment Period||0
10066337|NCT02139644|11192563|FG001|NOT COMPLETED|Treatment Period||3
10066338|NCT02139644|11192564|FG002|NOT COMPLETED|Treatment Period||8
10066339|NCT02139644|11192565|FG003|NOT COMPLETED|Treatment Period||9
10066340|NCT02139644|11192566|FG004|NOT COMPLETED|Treatment Period||8
10066341|NCT02139644|11192567|FG005|NOT COMPLETED|Treatment Period||17
10066342|NCT02139800|11192581|FG000|STARTED|Overall Study||224
10066343|NCT02139800|11192582|FG001|STARTED|Overall Study||236
10066344|NCT02139800|11192581|FG000|COMPLETED|Overall Study||211
10066345|NCT02139800|11192582|FG001|COMPLETED|Overall Study||215
10066346|NCT02139800|11192581|FG000|NOT COMPLETED|Overall Study||13
10066347|NCT02139800|11192582|FG001|NOT COMPLETED|Overall Study||21
10066348|NCT02139826|11192588|FG000|STARTED|Overall Study||12
10066349|NCT02139826|11192588|FG000|COMPLETED|Overall Study||11
10066350|NCT02139826|11192588|FG000|NOT COMPLETED|Overall Study||1
10066351|NCT02139878|11192598|FG000|STARTED|First Intervention (7 Days)||10
10066352|NCT02139878|11192599|FG001|STARTED|First Intervention (7 Days)||10
10066353|NCT02139878|11192598|FG000|COMPLETED|First Intervention (7 Days)||9
10066354|NCT02139878|11192599|FG001|COMPLETED|First Intervention (7 Days)||10
10066355|NCT02139878|11192598|FG000|NOT COMPLETED|First Intervention (7 Days)||1
10066356|NCT02139878|11192599|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10066357|NCT02139878|11192598|FG000|STARTED|Washout Period (8 Days)||9
10066358|NCT02139878|11192599|FG001|STARTED|Washout Period (8 Days)||10
10066359|NCT02139878|11192598|FG000|COMPLETED|Washout Period (8 Days)||9
10066360|NCT02139878|11192599|FG001|COMPLETED|Washout Period (8 Days)||10
10066361|NCT02139878|11192598|FG000|NOT COMPLETED|Washout Period (8 Days)||0
10066362|NCT02139878|11192599|FG001|NOT COMPLETED|Washout Period (8 Days)||0
10066363|NCT02139878|11192598|FG000|STARTED|Second Intervention (7 Days)||9
10066364|NCT02139878|11192599|FG001|STARTED|Second Intervention (7 Days)||10
10066365|NCT02139878|11192598|FG000|COMPLETED|Second Intervention (7 Days)||9
10066366|NCT02139878|11192599|FG001|COMPLETED|Second Intervention (7 Days)||10
10066367|NCT02139878|11192598|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10066368|NCT02139878|11192599|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10066369|NCT02139943|11192608|FG000|STARTED|Overall Study||117
10066370|NCT02139943|11192609|FG001|STARTED|Overall Study||117
10066371|NCT02139943|11192610|FG002|STARTED|Overall Study||117
10066372|NCT02139943|11192608|FG000|COMPLETED|Overall Study||107
10066373|NCT02139943|11192609|FG001|COMPLETED|Overall Study||111
10066374|NCT02139943|11192610|FG002|COMPLETED|Overall Study||110
10066375|NCT02139943|11192608|FG000|NOT COMPLETED|Overall Study||10
10066376|NCT02139943|11192609|FG001|NOT COMPLETED|Overall Study||6
10066377|NCT02139943|11192610|FG002|NOT COMPLETED|Overall Study||7
10066378|NCT02139969|11192618|FG000|STARTED|Overall Study||956
10066379|NCT02139969|11192618|FG000|COMPLETED|Overall Study||956
10066380|NCT02139969|11192618|FG000|NOT COMPLETED|Overall Study||0
10066381|NCT02139982|11192632|FG000|STARTED|Overall Study||8
10066382|NCT02139982|11192633|FG001|STARTED|Overall Study||8
10066383|NCT02139982|11192634|FG002|STARTED|Overall Study||8
10066384|NCT02139982|11192635|FG003|STARTED|Overall Study||8
10066385|NCT02139982|11192636|FG004|STARTED|Overall Study||13
10066386|NCT02139982|11192637|FG005|STARTED|Overall Study||13
10066387|NCT02139982|11192638|FG006|STARTED|Overall Study||13
10066388|NCT02139982|11192639|FG007|STARTED|Overall Study||13
10066389|NCT02139982|11192640|FG008|STARTED|Overall Study||13
10066390|NCT02139982|11192641|FG009|STARTED|Overall Study||13
10066391|NCT02139982|11192632|FG000|COMPLETED|Overall Study||8
10066392|NCT02139982|11192633|FG001|COMPLETED|Overall Study||7
10066393|NCT02139982|11192634|FG002|COMPLETED|Overall Study||8
10188606|NCT03270332|11318147|FG000|COMPLETED|Overall Study||5
10188607|NCT03270332|11318148|FG001|COMPLETED|Overall Study||4
10188608|NCT03270332|11318147|FG000|NOT COMPLETED|Overall Study||0
10188609|NCT03270332|11318148|FG001|NOT COMPLETED|Overall Study||1
10188610|NCT03270436|11318158|FG000|STARTED|Baseline||213
10188611|NCT03270436|11318159|FG001|STARTED|Baseline||167
10188612|NCT03270436|11318158|FG000|COMPLETED|Baseline||212
10188613|NCT03270436|11318159|FG001|COMPLETED|Baseline||166
10188614|NCT03270436|11318158|FG000|NOT COMPLETED|Baseline||1
10188615|NCT03270436|11318159|FG001|NOT COMPLETED|Baseline||1
10188616|NCT03270436|11318158|FG000|STARTED|Immediate Post-Intervention||213
10188617|NCT03270436|11318159|FG001|STARTED|Immediate Post-Intervention||167
10188618|NCT03270436|11318158|FG000|COMPLETED|Immediate Post-Intervention||172
10188619|NCT03270436|11318159|FG001|COMPLETED|Immediate Post-Intervention||111
10188620|NCT03270436|11318158|FG000|NOT COMPLETED|Immediate Post-Intervention||41
10188621|NCT03270436|11318159|FG001|NOT COMPLETED|Immediate Post-Intervention||56
10188622|NCT03270436|11318158|FG000|STARTED|6 Months Post-Intervention||213
10188623|NCT03270436|11318159|FG001|STARTED|6 Months Post-Intervention||167
10188624|NCT03270436|11318158|FG000|COMPLETED|6 Months Post-Intervention||173
10188625|NCT03270436|11318159|FG001|COMPLETED|6 Months Post-Intervention||116
10188626|NCT03270436|11318158|FG000|NOT COMPLETED|6 Months Post-Intervention||40
10188627|NCT03270436|11318159|FG001|NOT COMPLETED|6 Months Post-Intervention||51
10188628|NCT03270514|11318167|FG000|STARTED|Overall Study||29
10188629|NCT03270514|11318168|FG001|STARTED|Overall Study||31
10188630|NCT03270514|11318167|FG000|COMPLETED|Overall Study||29
10188631|NCT03270514|11318168|FG001|COMPLETED|Overall Study||31
10188632|NCT03270514|11318167|FG000|NOT COMPLETED|Overall Study||0
10188633|NCT03270514|11318168|FG001|NOT COMPLETED|Overall Study||0
10188634|NCT03270644|11318174|FG000|STARTED|Day 1 Lasmiditan Reference||44
10066394|NCT02139982|11192635|FG003|COMPLETED|Overall Study||7
10066395|NCT02139982|11192636|FG004|COMPLETED|Overall Study||13
10188635|NCT03270644|11318174|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
10188636|NCT03270644|11318174|FG000|COMPLETED|Day 1 Lasmiditan Reference||43
10188637|NCT03270644|11318174|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1
10188638|NCT03270644|11318174|FG000|STARTED|Day 4 - 10 Propranolol Reference||43
10188639|NCT03270644|11318174|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
10188640|NCT03270644|11318174|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
10188641|NCT03270644|11318174|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42
10188642|NCT03270644|11318174|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
10188643|NCT03270657|11318185|FG000|STARTED|Overall Study||5
10188644|NCT03270657|11318185|FG000|COMPLETED|Overall Study||4
10188645|NCT03270657|11318185|FG000|NOT COMPLETED|Overall Study||1
10188646|NCT03270943|11318191|FG000|STARTED|Intervention Refinement||6
10188647|NCT03270943|11318192|FG001|STARTED|Intervention Refinement||9
10188648|NCT03270943|11318191|FG000|COMPLETED|Intervention Refinement||6
10188649|NCT03270943|11318192|FG001|COMPLETED|Intervention Refinement||6
10188650|NCT03270943|11318191|FG000|NOT COMPLETED|Intervention Refinement||0
10188651|NCT03270943|11318192|FG001|NOT COMPLETED|Intervention Refinement||3
10188652|NCT03270943|11318191|FG000|STARTED|Randomized (Willingness to be)||30
10188653|NCT03270943|11318192|FG001|STARTED|Randomized (Willingness to be)||32
10188654|NCT03270943|11318191|FG000|COMPLETED|Randomized (Willingness to be)||30
10188655|NCT03270943|11318192|FG001|COMPLETED|Randomized (Willingness to be)||31
10188656|NCT03270943|11318191|FG000|NOT COMPLETED|Randomized (Willingness to be)||0
10188657|NCT03270943|11318192|FG001|NOT COMPLETED|Randomized (Willingness to be)||1
10188658|NCT03271307|11318203|FG000|STARTED|Overall Study||1951
10188659|NCT03271307|11318204|FG001|STARTED|Overall Study||1837
10188660|NCT03271307|11318205|FG002|STARTED|Overall Study||2097
10188661|NCT03271307|11318206|FG003|STARTED|Overall Study||135
10188662|NCT03271307|11318207|FG004|STARTED|Overall Study||349
10188663|NCT03271307|11318203|FG000|COMPLETED|Overall Study||1951
10188664|NCT03271307|11318204|FG001|COMPLETED|Overall Study||1837
10188665|NCT03271307|11318205|FG002|COMPLETED|Overall Study||2097
10188666|NCT03271307|11318206|FG003|COMPLETED|Overall Study||107
10188667|NCT03271307|11318207|FG004|COMPLETED|Overall Study||258
10188668|NCT03271307|11318203|FG000|NOT COMPLETED|Overall Study||0
10188669|NCT03271307|11318204|FG001|NOT COMPLETED|Overall Study||0
10188670|NCT03271307|11318205|FG002|NOT COMPLETED|Overall Study||0
10188671|NCT03271307|11318206|FG003|NOT COMPLETED|Overall Study||28
10188672|NCT03271307|11318207|FG004|NOT COMPLETED|Overall Study||91
10188673|NCT03271424|11318225|FG000|STARTED|November 2015||20
10188674|NCT03271424|11318226|FG001|STARTED|November 2015||0
10188675|NCT03271424|11318227|FG002|STARTED|November 2015||0
10188676|NCT03271424|11318225|FG000|COMPLETED|November 2015||20
10188677|NCT03271424|11318226|FG001|COMPLETED|November 2015||0
10188678|NCT03271424|11318227|FG002|COMPLETED|November 2015||0
10188679|NCT03271424|11318225|FG000|NOT COMPLETED|November 2015||0
10188680|NCT03271424|11318226|FG001|NOT COMPLETED|November 2015||0
10188681|NCT03271424|11318227|FG002|NOT COMPLETED|November 2015||0
10188682|NCT03271424|11318225|FG000|STARTED|December 2015||0
10188683|NCT03271424|11318226|FG001|STARTED|December 2015||35
10188684|NCT03271424|11318227|FG002|STARTED|December 2015||0
10188685|NCT03271424|11318225|FG000|COMPLETED|December 2015||0
10188686|NCT03271424|11318226|FG001|COMPLETED|December 2015||35
10188687|NCT03271424|11318227|FG002|COMPLETED|December 2015||0
10188688|NCT03271424|11318225|FG000|NOT COMPLETED|December 2015||0
10188689|NCT03271424|11318226|FG001|NOT COMPLETED|December 2015||0
10188690|NCT03271424|11318227|FG002|NOT COMPLETED|December 2015||0
10188691|NCT03271424|11318225|FG000|STARTED|April-May 2016||0
10188692|NCT03271424|11318226|FG001|STARTED|April-May 2016||0
10188693|NCT03271424|11318227|FG002|STARTED|April-May 2016||40
10188694|NCT03271424|11318225|FG000|COMPLETED|April-May 2016||0
10188695|NCT03271424|11318226|FG001|COMPLETED|April-May 2016||0
10188696|NCT03271424|11318227|FG002|COMPLETED|April-May 2016||40
10188697|NCT03271424|11318225|FG000|NOT COMPLETED|April-May 2016||0
10188698|NCT03271424|11318226|FG001|NOT COMPLETED|April-May 2016||0
10188699|NCT03271424|11318227|FG002|NOT COMPLETED|April-May 2016||0
10188700|NCT03271528|11318239|FG000|STARTED|Medication Dispense/Exposure Period 1||13
10188701|NCT03271528|11318240|FG001|STARTED|Medication Dispense/Exposure Period 1||14
10188702|NCT03271528|11318239|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11
10188703|NCT03271528|11318240|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12
10188704|NCT03271528|11318239|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
10188705|NCT03271528|11318240|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
10188706|NCT03271528|11318239|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11
10066396|NCT02139982|11192637|FG005|COMPLETED|Overall Study||13
10066397|NCT02139982|11192638|FG006|COMPLETED|Overall Study||13
10066398|NCT02139982|11192639|FG007|COMPLETED|Overall Study||13
10066399|NCT02139982|11192640|FG008|COMPLETED|Overall Study||13
10066400|NCT02139982|11192641|FG009|COMPLETED|Overall Study||13
10066401|NCT02139982|11192632|FG000|NOT COMPLETED|Overall Study||0
10066402|NCT02139982|11192633|FG001|NOT COMPLETED|Overall Study||1
10066403|NCT02139982|11192634|FG002|NOT COMPLETED|Overall Study||0
10066404|NCT02139982|11192635|FG003|NOT COMPLETED|Overall Study||1
10066405|NCT02139982|11192636|FG004|NOT COMPLETED|Overall Study||0
10066406|NCT02139982|11192637|FG005|NOT COMPLETED|Overall Study||0
10066407|NCT02139982|11192638|FG006|NOT COMPLETED|Overall Study||0
10066408|NCT02139982|11192639|FG007|NOT COMPLETED|Overall Study||0
10066409|NCT02139982|11192640|FG008|NOT COMPLETED|Overall Study||0
10066410|NCT02139982|11192641|FG009|NOT COMPLETED|Overall Study||0
10066411|NCT02140060|11192669|FG000|STARTED|Overall Study||44
10066412|NCT02140060|11192670|FG001|STARTED|Overall Study||44
10066413|NCT02140060|11192671|FG002|STARTED|Overall Study||44
10066414|NCT02140060|11192672|FG003|STARTED|Overall Study||45
10066415|NCT02140060|11192673|FG004|STARTED|Overall Study||45
10066416|NCT02140060|11192674|FG005|STARTED|Overall Study||44
10066417|NCT02140060|11192669|FG000|COMPLETED|Overall Study||44
10066418|NCT02140060|11192670|FG001|COMPLETED|Overall Study||44
10066419|NCT02140060|11192671|FG002|COMPLETED|Overall Study||44
10066420|NCT02140060|11192672|FG003|COMPLETED|Overall Study||43
10066421|NCT02140060|11192673|FG004|COMPLETED|Overall Study||44
10066422|NCT02140060|11192674|FG005|COMPLETED|Overall Study||43
10066423|NCT02140060|11192669|FG000|NOT COMPLETED|Overall Study||0
10066424|NCT02140060|11192670|FG001|NOT COMPLETED|Overall Study||0
10066425|NCT02140060|11192671|FG002|NOT COMPLETED|Overall Study||0
10066426|NCT02140060|11192672|FG003|NOT COMPLETED|Overall Study||2
10066427|NCT02140060|11192673|FG004|NOT COMPLETED|Overall Study||1
10066428|NCT02140060|11192674|FG005|NOT COMPLETED|Overall Study||1
10066429|NCT02140164|11192689|FG000|STARTED|Overall Study||7
10066430|NCT02140164|11192689|FG000|COMPLETED|Overall Study||5
10066431|NCT02140164|11192689|FG000|NOT COMPLETED|Overall Study||2
10066432|NCT02140372|11192693|FG000|STARTED|Overall Study||10
10066433|NCT02140372|11192693|FG000|COMPLETED|Overall Study||10
10066434|NCT02140372|11192693|FG000|NOT COMPLETED|Overall Study||0
10066435|NCT02140411|11192697|FG000|STARTED|Overall Study||21
10066436|NCT02140411|11192697|FG000|COMPLETED|Overall Study||20
10066437|NCT02140411|11192697|FG000|NOT COMPLETED|Overall Study||1
10066438|NCT02140567|11192701|FG000|STARTED|Overall Study||140
10066439|NCT02140567|11192701|FG000|COMPLETED|Overall Study||134
10066440|NCT02140567|11192701|FG000|NOT COMPLETED|Overall Study||6
10066441|NCT02140593|11192708|FG000|STARTED|Overall Study||63
10066442|NCT02140593|11192709|FG001|STARTED|Overall Study||65
10066443|NCT02140593|11192708|FG000|COMPLETED|Overall Study||63
10066444|NCT02140593|11192709|FG001|COMPLETED|Overall Study||65
9850714|NCT00871858|10963416|FG001|NOT COMPLETED|Overall Study||7
9850715|NCT00871871|10963424|FG000|STARTED|Part I||18
9850716|NCT00871871|10963425|FG001|STARTED|Part I||18
9850717|NCT00871871|10963426|FG002|STARTED|Part I||0
9850718|NCT00871871|10963427|FG003|STARTED|Part I||0
9850719|NCT00871871|10963424|FG000|COMPLETED|Part I||15
10066445|NCT02140593|11192708|FG000|NOT COMPLETED|Overall Study||0
10066446|NCT02140593|11192709|FG001|NOT COMPLETED|Overall Study||0
10066447|NCT02140645|11192721|FG000|STARTED|Overall Study||5732
10066448|NCT02140645|11192722|FG001|STARTED|Overall Study||64695
10066449|NCT02140645|11192723|FG002|STARTED|Overall Study||4441
10066450|NCT02140645|11192724|FG003|STARTED|Overall Study||14363
10066451|NCT02140645|11192725|FG004|STARTED|Overall Study||3436
10066452|NCT02140645|11192726|FG005|STARTED|Overall Study||73946
10066453|NCT02140645|11192721|FG000|COMPLETED|Overall Study||243
10066454|NCT02140645|11192722|FG001|COMPLETED|Overall Study||3041
10066455|NCT02140645|11192723|FG002|COMPLETED|Overall Study||205
10066456|NCT02140645|11192724|FG003|COMPLETED|Overall Study||530
10066457|NCT02140645|11192725|FG004|COMPLETED|Overall Study||150
10066458|NCT02140645|11192726|FG005|COMPLETED|Overall Study||3050
10066459|NCT02140645|11192721|FG000|NOT COMPLETED|Overall Study||5489
10066460|NCT02140645|11192722|FG001|NOT COMPLETED|Overall Study||61654
10066461|NCT02140645|11192723|FG002|NOT COMPLETED|Overall Study||4236
10066462|NCT02140645|11192724|FG003|NOT COMPLETED|Overall Study||13833
10066463|NCT02140645|11192725|FG004|NOT COMPLETED|Overall Study||3286
10066464|NCT02140645|11192726|FG005|NOT COMPLETED|Overall Study||70896
10066465|NCT02140762|11192737|FG000|STARTED|Overall Study||154
10066466|NCT02140762|11192738|FG001|STARTED|Overall Study||151
10066467|NCT02140762|11192737|FG000|COMPLETED|Overall Study||137
10066468|NCT02140762|11192738|FG001|COMPLETED|Overall Study||139
10066469|NCT02140762|11192737|FG000|NOT COMPLETED|Overall Study||17
10066470|NCT02140762|11192738|FG001|NOT COMPLETED|Overall Study||12
10066471|NCT02140775|11192751|FG000|STARTED|Overall Study||87
10066472|NCT02140775|11192752|FG001|STARTED|Overall Study||29
10066473|NCT02140775|11192751|FG000|COMPLETED|Overall Study||57
10066474|NCT02140775|11192752|FG001|COMPLETED|Overall Study||22
10066475|NCT02140775|11192751|FG000|NOT COMPLETED|Overall Study||30
10066476|NCT02140775|11192752|FG001|NOT COMPLETED|Overall Study||7
10066477|NCT02140957|11192762|FG000|STARTED|Overall Study||129
10066478|NCT02140957|11192763|FG001|STARTED|Overall Study||122
10066479|NCT02140957|11192762|FG000|COMPLETED|Overall Study||102
10066480|NCT02140957|11192763|FG001|COMPLETED|Overall Study||99
10066481|NCT02140957|11192762|FG000|NOT COMPLETED|Overall Study||27
10066482|NCT02140957|11192763|FG001|NOT COMPLETED|Overall Study||23
10066483|NCT02140970|11192771|FG000|STARTED|Overall Study||24
10066484|NCT02140970|11192772|FG001|STARTED|Overall Study||25
10066485|NCT02140970|11192771|FG000|Received Intervention|Overall Study||23
10066486|NCT02140970|11192772|FG001|Received Intervention|Overall Study||25
10066487|NCT02140970|11192771|FG000|Analyzed|Overall Study||22
10066488|NCT02140970|11192772|FG001|Analyzed|Overall Study||22
10066489|NCT02140970|11192771|FG000|COMPLETED|Overall Study||22
10066490|NCT02140970|11192772|FG001|COMPLETED|Overall Study||22
10066491|NCT02140970|11192771|FG000|NOT COMPLETED|Overall Study||2
10066492|NCT02140970|11192772|FG001|NOT COMPLETED|Overall Study||3
10066493|NCT02141204|11192780|FG000|STARTED|Overall Study||224
10066494|NCT02141204|11192781|FG001|STARTED|Overall Study||225
10066495|NCT02141204|11192780|FG000|COMPLETED|Overall Study||209
9850720|NCT00871871|10963425|FG001|COMPLETED|Part I||15
10066496|NCT02141204|11192781|FG001|COMPLETED|Overall Study||210
10066497|NCT02141204|11192780|FG000|NOT COMPLETED|Overall Study||15
10066498|NCT02141204|11192781|FG001|NOT COMPLETED|Overall Study||15
10066499|NCT02141217|11192789|FG000|STARTED|Overall Study||234
10066500|NCT02141217|11192790|FG001|STARTED|Overall Study||237
10066501|NCT02141217|11192789|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234
10066502|NCT02141217|11192790|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237
10066503|NCT02141217|11192789|FG000|ITT Population-Actual Treatment Received|Overall Study||236
10066504|NCT02141217|11192790|FG001|ITT Population-Actual Treatment Received|Overall Study||235
10066505|NCT02141217|11192789|FG000|COMPLETED|Overall Study||223
10066506|NCT02141217|11192790|FG001|COMPLETED|Overall Study||229
10066507|NCT02141217|11192789|FG000|NOT COMPLETED|Overall Study||11
10066508|NCT02141217|11192790|FG001|NOT COMPLETED|Overall Study||8
10066509|NCT02141295|11192802|FG000|STARTED|Overall Study||8
10066510|NCT02141295|11192803|FG001|STARTED|Overall Study||94
10066511|NCT02141295|11192804|FG002|STARTED|Overall Study||95
10066512|NCT02141295|11192802|FG000|COMPLETED|Overall Study||2
10066513|NCT02141295|11192803|FG001|COMPLETED|Overall Study||0
10066514|NCT02141295|11192804|FG002|COMPLETED|Overall Study||0
10066515|NCT02141295|11192802|FG000|NOT COMPLETED|Overall Study||6
10066516|NCT02141295|11192803|FG001|NOT COMPLETED|Overall Study||94
10066517|NCT02141295|11192804|FG002|NOT COMPLETED|Overall Study||95
10066518|NCT02141360|11192816|FG000|STARTED|Overall Study||11
10066519|NCT02141360|11192817|FG001|STARTED|Overall Study||6
10066520|NCT02141360|11192818|FG002|STARTED|Overall Study||6
10066521|NCT02141360|11192816|FG000|COMPLETED|Overall Study||4
10066522|NCT02141360|11192817|FG001|COMPLETED|Overall Study||6
10066523|NCT02141360|11192818|FG002|COMPLETED|Overall Study||6
10066524|NCT02141360|11192816|FG000|NOT COMPLETED|Overall Study||7
10066525|NCT02141360|11192817|FG001|NOT COMPLETED|Overall Study||0
10066526|NCT02141360|11192818|FG002|NOT COMPLETED|Overall Study||0
10066527|NCT02141399|11192826|FG000|STARTED|Overall Study||1485
10066528|NCT02141399|11192826|FG000|COMPLETED|Overall Study||741
10066529|NCT02141399|11192826|FG000|NOT COMPLETED|Overall Study||744
10066530|NCT02141451|11192834|FG000|STARTED|Overall Study||3
10066531|NCT02141451|11192835|FG001|STARTED|Overall Study||4
10066532|NCT02141451|11192836|FG002|STARTED|Overall Study||7
10066533|NCT02141451|11192837|FG003|STARTED|Overall Study||16
10066534|NCT02141451|11192834|FG000|COMPLETED|Overall Study||3
10066535|NCT02141451|11192835|FG001|COMPLETED|Overall Study||2
10066536|NCT02141451|11192836|FG002|COMPLETED|Overall Study||2
10066537|NCT02141451|11192837|FG003|COMPLETED|Overall Study||7
10066538|NCT02141451|11192834|FG000|NOT COMPLETED|Overall Study||0
10066539|NCT02141451|11192835|FG001|NOT COMPLETED|Overall Study||2
10066540|NCT02141451|11192836|FG002|NOT COMPLETED|Overall Study||5
10066541|NCT02141451|11192837|FG003|NOT COMPLETED|Overall Study||9
10066542|NCT02141490|11192853|FG000|STARTED|Overall Study||34
10066543|NCT02141490|11192854|FG001|STARTED|Overall Study||6
10066544|NCT02141490|11192855|FG002|STARTED|Overall Study||3
10066545|NCT02141490|11192853|FG000|COMPLETED|Overall Study||30
10066546|NCT02141490|11192854|FG001|COMPLETED|Overall Study||6
10066547|NCT02141490|11192855|FG002|COMPLETED|Overall Study||3
10066548|NCT02141490|11192853|FG000|NOT COMPLETED|Overall Study||4
10066549|NCT02141490|11192854|FG001|NOT COMPLETED|Overall Study||0
10066550|NCT02141490|11192855|FG002|NOT COMPLETED|Overall Study||0
10066551|NCT02141516|11192868|FG000|STARTED|Overall Study||40
10066552|NCT02141516|11192869|FG001|STARTED|Overall Study||112
10066553|NCT02141516|11192870|FG002|STARTED|Overall Study||87
10066554|NCT02141516|11192868|FG000|COMPLETED|Overall Study||40
10066555|NCT02141516|11192869|FG001|COMPLETED|Overall Study||107
10066556|NCT02141516|11192870|FG002|COMPLETED|Overall Study||87
10066557|NCT02141516|11192868|FG000|NOT COMPLETED|Overall Study||0
10066558|NCT02141516|11192869|FG001|NOT COMPLETED|Overall Study||5
10066559|NCT02141516|11192870|FG002|NOT COMPLETED|Overall Study||0
10066560|NCT02141555|11192884|FG000|STARTED|Overall Study||2
10066561|NCT02141555|11192885|FG001|STARTED|Overall Study||2
10066562|NCT02141555|11192884|FG000|COMPLETED|Overall Study||2
10066563|NCT02141555|11192885|FG001|COMPLETED|Overall Study||2
10066564|NCT02141555|11192884|FG000|NOT COMPLETED|Overall Study||0
10066565|NCT02141555|11192885|FG001|NOT COMPLETED|Overall Study||0
10066566|NCT02141581|11192894|FG000|STARTED|Overall Study||42
10066567|NCT02141581|11192895|FG001|STARTED|Overall Study||19
10066568|NCT02141581|11192896|FG002|STARTED|Overall Study||25
10066569|NCT02141581|11192894|FG000|COMPLETED|Overall Study||42
10066570|NCT02141581|11192895|FG001|COMPLETED|Overall Study||19
10066571|NCT02141581|11192896|FG002|COMPLETED|Overall Study||25
10066572|NCT02141581|11192894|FG000|NOT COMPLETED|Overall Study||0
10066573|NCT02141581|11192895|FG001|NOT COMPLETED|Overall Study||0
10066574|NCT02141581|11192896|FG002|NOT COMPLETED|Overall Study||0
10066575|NCT02141620|11192904|FG000|STARTED|Treatment Condition 1 (7 Days)||8
10066576|NCT02141620|11192905|FG001|STARTED|Treatment Condition 1 (7 Days)||7
10066577|NCT02141620|11192904|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
10066578|NCT02141620|11192905|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
10066579|NCT02141620|11192904|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
10066580|NCT02141620|11192905|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
10066581|NCT02141620|11192904|FG000|STARTED|Treatment Condition 2 (7 Days)||7
10066582|NCT02141620|11192905|FG001|STARTED|Treatment Condition 2 (7 Days)||7
10066583|NCT02141620|11192904|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7
10066584|NCT02141620|11192905|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7
10066585|NCT02141620|11192904|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
10066586|NCT02141620|11192905|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
10066587|NCT02141633|11192913|FG000|STARTED|Overall Study||16
10066588|NCT02141633|11192914|FG001|STARTED|Overall Study||15
10066589|NCT02141633|11192913|FG000|COMPLETED|Overall Study||15
10066590|NCT02141633|11192914|FG001|COMPLETED|Overall Study||15
10066591|NCT02141633|11192913|FG000|NOT COMPLETED|Overall Study||1
10066592|NCT02141633|11192914|FG001|NOT COMPLETED|Overall Study||0
10066593|NCT02141659|11192926|FG000|STARTED|Overall Study||3
10066594|NCT02141659|11192927|FG001|STARTED|Overall Study||4
10066595|NCT02141659|11192928|FG002|STARTED|Overall Study||3
10066596|NCT02141659|11192929|FG003|STARTED|Overall Study||3
10066597|NCT02141659|11192930|FG004|STARTED|Overall Study||15
10066598|NCT02141659|11192931|FG005|STARTED|Overall Study||15
10066599|NCT02141659|11192926|FG000|COMPLETED|Overall Study||3
10066600|NCT02141659|11192927|FG001|COMPLETED|Overall Study||3
10066601|NCT02141659|11192928|FG002|COMPLETED|Overall Study||3
10066602|NCT02141659|11192929|FG003|COMPLETED|Overall Study||3
10066603|NCT02141659|11192930|FG004|COMPLETED|Overall Study||13
10066604|NCT02141659|11192931|FG005|COMPLETED|Overall Study||13
10066605|NCT02141659|11192926|FG000|NOT COMPLETED|Overall Study||0
10066606|NCT02141659|11192927|FG001|NOT COMPLETED|Overall Study||1
10066607|NCT02141659|11192928|FG002|NOT COMPLETED|Overall Study||0
10066608|NCT02141659|11192929|FG003|NOT COMPLETED|Overall Study||0
10066609|NCT02141659|11192930|FG004|NOT COMPLETED|Overall Study||2
10066610|NCT02141659|11192931|FG005|NOT COMPLETED|Overall Study||2
10066611|NCT02141672|11192948|FG000|STARTED|Overall Study||89
10066612|NCT02141672|11192949|FG001|STARTED|Overall Study||88
10066613|NCT02141672|11192950|FG002|STARTED|Overall Study||88
10066614|NCT02141672|11192948|FG000|COMPLETED|Overall Study||73
10066615|NCT02141672|11192949|FG001|COMPLETED|Overall Study||80
10066616|NCT02141672|11192950|FG002|COMPLETED|Overall Study||70
10066617|NCT02141672|11192948|FG000|NOT COMPLETED|Overall Study||16
10066618|NCT02141672|11192949|FG001|NOT COMPLETED|Overall Study||8
10066619|NCT02141672|11192950|FG002|NOT COMPLETED|Overall Study||18
10066620|NCT02141854|11192963|FG000|STARTED|Run-In Period (Pre-assignment)||882
10066621|NCT02141854|11192964|FG001|STARTED|Run-In Period (Pre-assignment)||0
10066622|NCT02141854|11192965|FG002|STARTED|Run-In Period (Pre-assignment)||0
10066623|NCT02141854|11192966|FG003|STARTED|Run-In Period (Pre-assignment)||0
10066624|NCT02141854|11192967|FG004|STARTED|Run-In Period (Pre-assignment)||0
10066625|NCT02141854|11192968|FG005|STARTED|Run-In Period (Pre-assignment)||0
10066626|NCT02141854|11192963|FG000|COMPLETED|Run-In Period (Pre-assignment)||728
10066627|NCT02141854|11192964|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
10066628|NCT02141854|11192965|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
10066629|NCT02141854|11192966|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
10066630|NCT02141854|11192967|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
10066631|NCT02141854|11192968|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
10066632|NCT02141854|11192963|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154
10066633|NCT02141854|11192964|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066634|NCT02141854|11192965|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066635|NCT02141854|11192966|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066636|NCT02141854|11192967|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066637|NCT02141854|11192968|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10066638|NCT02141854|11192963|FG000|STARTED|Treatment Period||0
10066639|NCT02141854|11192964|FG001|STARTED|Treatment Period||146
10066640|NCT02141854|11192965|FG002|STARTED|Treatment Period||145
10066641|NCT02141854|11192966|FG003|STARTED|Treatment Period||146
10066642|NCT02141854|11192967|FG004|STARTED|Treatment Period||146
10066643|NCT02141854|11192968|FG005|STARTED|Treatment Period||145
10066644|NCT02141854|11192963|FG000|Intent to Treat Population|Treatment Period||0
10066645|NCT02141854|11192964|FG001|Intent to Treat Population|Treatment Period||146
10066646|NCT02141854|11192965|FG002|Intent to Treat Population|Treatment Period||145
10066647|NCT02141854|11192966|FG003|Intent to Treat Population|Treatment Period||146
10066648|NCT02141854|11192967|FG004|Intent to Treat Population|Treatment Period||146
10066649|NCT02141854|11192968|FG005|Intent to Treat Population|Treatment Period||145
10066650|NCT02141854|11192963|FG000|Safety Population|Treatment Period||0
10066651|NCT02141854|11192964|FG001|Safety Population|Treatment Period||145
10066652|NCT02141854|11192965|FG002|Safety Population|Treatment Period||143
10066653|NCT02141854|11192966|FG003|Safety Population|Treatment Period||146
10066654|NCT02141854|11192967|FG004|Safety Population|Treatment Period||145
10066655|NCT02141854|11192968|FG005|Safety Population|Treatment Period||144
10066656|NCT02141854|11192963|FG000|Full Analysis Set|Treatment Period||0
10066657|NCT02141854|11192964|FG001|Full Analysis Set|Treatment Period||145
10066658|NCT02141854|11192965|FG002|Full Analysis Set|Treatment Period||141
10066659|NCT02141854|11192966|FG003|Full Analysis Set|Treatment Period||146
10066660|NCT02141854|11192967|FG004|Full Analysis Set|Treatment Period||145
10066661|NCT02141854|11192968|FG005|Full Analysis Set|Treatment Period||143
10066662|NCT02141854|11192963|FG000|COMPLETED|Treatment Period||0
10066663|NCT02141854|11192964|FG001|COMPLETED|Treatment Period||136
10066664|NCT02141854|11192965|FG002|COMPLETED|Treatment Period||136
10066665|NCT02141854|11192966|FG003|COMPLETED|Treatment Period||135
10066666|NCT02141854|11192967|FG004|COMPLETED|Treatment Period||136
10066667|NCT02141854|11192968|FG005|COMPLETED|Treatment Period||107
10066668|NCT02141854|11192963|FG000|NOT COMPLETED|Treatment Period||0
10066669|NCT02141854|11192964|FG001|NOT COMPLETED|Treatment Period||10
10066670|NCT02141854|11192965|FG002|NOT COMPLETED|Treatment Period||9
10066671|NCT02141854|11192966|FG003|NOT COMPLETED|Treatment Period||11
10066672|NCT02141854|11192967|FG004|NOT COMPLETED|Treatment Period||10
10066673|NCT02141854|11192968|FG005|NOT COMPLETED|Treatment Period||38
10066674|NCT02141867|11192980|FG000|STARTED|Overall Study||4021
10066675|NCT02141867|11192980|FG000|COMPLETED|Overall Study||3927
10066676|NCT02141867|11192980|FG000|NOT COMPLETED|Overall Study||94
10066677|NCT02141984|11192984|FG000|STARTED|Overall Study||28
10066678|NCT02141984|11192984|FG000|COMPLETED|Overall Study||26
10066679|NCT02141984|11192984|FG000|NOT COMPLETED|Overall Study||2
10066680|NCT02141997|11192992|FG000|STARTED|Overall Study||56
10066681|NCT02141997|11192993|FG001|STARTED|Overall Study||55
10066682|NCT02141997|11192994|FG002|STARTED|Overall Study||56
10066683|NCT02141997|11192995|FG003|STARTED|Overall Study||55
10066684|NCT02141997|11192992|FG000|COMPLETED|Overall Study||53
10066685|NCT02141997|11192993|FG001|COMPLETED|Overall Study||49
10066686|NCT02141997|11192994|FG002|COMPLETED|Overall Study||53
10066687|NCT02141997|11192995|FG003|COMPLETED|Overall Study||54
10066688|NCT02141997|11192992|FG000|NOT COMPLETED|Overall Study||3
10066689|NCT02141997|11192993|FG001|NOT COMPLETED|Overall Study||6
10066690|NCT02141997|11192994|FG002|NOT COMPLETED|Overall Study||3
10066691|NCT02141997|11192995|FG003|NOT COMPLETED|Overall Study||1
10066692|NCT02142049|11193010|FG000|STARTED|Overall Study||3
10066693|NCT02142049|11193011|FG001|STARTED|Overall Study||3
10066694|NCT02142049|11193012|FG002|STARTED|Overall Study||3
10066695|NCT02142049|11193013|FG003|STARTED|Overall Study||6
10066696|NCT02142049|11193014|FG004|STARTED|Overall Study||20
10066697|NCT02142049|11193010|FG000|COMPLETED|Overall Study||3
10066698|NCT02142049|11193011|FG001|COMPLETED|Overall Study||3
10066699|NCT02142049|11193012|FG002|COMPLETED|Overall Study||3
10066700|NCT02142049|11193013|FG003|COMPLETED|Overall Study||6
10066701|NCT02142049|11193014|FG004|COMPLETED|Overall Study||20
10066702|NCT02142049|11193010|FG000|NOT COMPLETED|Overall Study||0
10066703|NCT02142049|11193011|FG001|NOT COMPLETED|Overall Study||0
10066704|NCT02142049|11193012|FG002|NOT COMPLETED|Overall Study||0
10066705|NCT02142049|11193013|FG003|NOT COMPLETED|Overall Study||0
10066706|NCT02142049|11193014|FG004|NOT COMPLETED|Overall Study||0
10066707|NCT02142153|11193041|FG000|STARTED|Overall Study||6
10066708|NCT02142153|11193042|FG001|STARTED|Overall Study||2
10066709|NCT02142153|11193043|FG002|STARTED|Overall Study||6
10066710|NCT02142153|11193044|FG003|STARTED|Overall Study||2
10066711|NCT02142153|11193045|FG004|STARTED|Overall Study||6
10066712|NCT02142153|11193046|FG005|STARTED|Overall Study||2
10066713|NCT02142153|11193047|FG006|STARTED|Overall Study||6
10066714|NCT02142153|11193048|FG007|STARTED|Overall Study||2
10066715|NCT02142153|11193049|FG008|STARTED|Overall Study||6
10066716|NCT02142153|11193050|FG009|STARTED|Overall Study||2
10066717|NCT02142153|11193041|FG000|COMPLETED|Overall Study||6
10066718|NCT02142153|11193042|FG001|COMPLETED|Overall Study||2
10066719|NCT02142153|11193043|FG002|COMPLETED|Overall Study||6
10066720|NCT02142153|11193044|FG003|COMPLETED|Overall Study||2
10066721|NCT02142153|11193045|FG004|COMPLETED|Overall Study||6
10066722|NCT02142153|11193046|FG005|COMPLETED|Overall Study||2
10066723|NCT02142153|11193047|FG006|COMPLETED|Overall Study||6
10066724|NCT02142153|11193048|FG007|COMPLETED|Overall Study||2
10066725|NCT02142153|11193049|FG008|COMPLETED|Overall Study||6
10066726|NCT02142153|11193050|FG009|COMPLETED|Overall Study||2
10066727|NCT02142153|11193041|FG000|NOT COMPLETED|Overall Study||0
10066728|NCT02142153|11193042|FG001|NOT COMPLETED|Overall Study||0
10066729|NCT02142153|11193043|FG002|NOT COMPLETED|Overall Study||0
10066730|NCT02142153|11193044|FG003|NOT COMPLETED|Overall Study||0
10066731|NCT02142153|11193045|FG004|NOT COMPLETED|Overall Study||0
10066732|NCT02142153|11193046|FG005|NOT COMPLETED|Overall Study||0
10066733|NCT02142153|11193047|FG006|NOT COMPLETED|Overall Study||0
10066734|NCT02142153|11193048|FG007|NOT COMPLETED|Overall Study||0
10066735|NCT02142153|11193049|FG008|NOT COMPLETED|Overall Study||0
10066736|NCT02142153|11193050|FG009|NOT COMPLETED|Overall Study||0
10066737|NCT02142283|11193084|FG000|STARTED|Overall Study||107
10066738|NCT02142283|11193085|FG001|STARTED|Overall Study||99
10066739|NCT02142283|11193084|FG000|COMPLETED|Overall Study||86
10066740|NCT02142283|11193085|FG001|COMPLETED|Overall Study||78
10066741|NCT02142283|11193084|FG000|NOT COMPLETED|Overall Study||21
10066742|NCT02142283|11193085|FG001|NOT COMPLETED|Overall Study||21
10066743|NCT02142361|11193091|FG000|STARTED|Overall Study||20
10066744|NCT02142361|11193092|FG001|STARTED|Overall Study||20
10066745|NCT02142361|11193093|FG002|STARTED|Overall Study||20
10066746|NCT02142361|11193091|FG000|COMPLETED|Overall Study||20
10066747|NCT02142361|11193092|FG001|COMPLETED|Overall Study||20
10066748|NCT02142361|11193093|FG002|COMPLETED|Overall Study||20
10066749|NCT02142361|11193091|FG000|NOT COMPLETED|Overall Study||0
10066750|NCT02142361|11193092|FG001|NOT COMPLETED|Overall Study||0
10066751|NCT02142361|11193093|FG002|NOT COMPLETED|Overall Study||0
10066752|NCT02142387|11193106|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
10066753|NCT02142387|11193107|FG001|STARTED|Overall Study||16271
10066754|NCT02142387|11193106|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
10066755|NCT02142387|11193107|FG001|COMPLETED|Overall Study||8641
10066756|NCT02142387|11193106|FG000|NOT COMPLETED|Overall Study||1065
10066757|NCT02142387|11193107|FG001|NOT COMPLETED|Overall Study||7630
10066758|NCT02142504|11193116|FG000|STARTED|Overall Study||153
10066759|NCT02142504|11193117|FG001|STARTED|Overall Study||147
10066760|NCT02142504|11193118|FG002|STARTED|Overall Study||154
10066761|NCT02142504|11193116|FG000|Randomized and Received Treatment|Overall Study||153
10188707|NCT03271528|11318240|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12
10066762|NCT02142504|11193117|FG001|Randomized and Received Treatment|Overall Study||145
10066763|NCT02142504|11193118|FG002|Randomized and Received Treatment|Overall Study||154
10066764|NCT02142504|11193116|FG000|Received Booster (Second Vaccination)|Overall Study||126
10066765|NCT02142504|11193117|FG001|Received Booster (Second Vaccination)|Overall Study||109
10066766|NCT02142504|11193118|FG002|Received Booster (Second Vaccination)|Overall Study||116
10066767|NCT02142504|11193116|FG000|COMPLETED|Overall Study||122
10066768|NCT02142504|11193117|FG001|COMPLETED|Overall Study||105
10066769|NCT02142504|11193118|FG002|COMPLETED|Overall Study||111
10066770|NCT02142504|11193116|FG000|NOT COMPLETED|Overall Study||31
10066771|NCT02142504|11193117|FG001|NOT COMPLETED|Overall Study||42
10066772|NCT02142504|11193118|FG002|NOT COMPLETED|Overall Study||43
10066773|NCT02142608|11193126|FG000|STARTED|Overall Study||18
10066774|NCT02142608|11193126|FG000|COMPLETED|Overall Study||18
10066775|NCT02142608|11193126|FG000|NOT COMPLETED|Overall Study||0
10066776|NCT02142712|11193134|FG000|STARTED|Overall Study||1
10066777|NCT02142712|11193135|FG001|STARTED|Overall Study||1
10066778|NCT02142712|11193136|FG002|STARTED|Overall Study||1
10066779|NCT02142712|11193137|FG003|STARTED|Overall Study||0
10066780|NCT02142712|11193134|FG000|COMPLETED|Overall Study||0
10066781|NCT02142712|11193135|FG001|COMPLETED|Overall Study||0
10066782|NCT02142712|11193136|FG002|COMPLETED|Overall Study||0
10066783|NCT02142712|11193137|FG003|COMPLETED|Overall Study||0
10066784|NCT02142712|11193134|FG000|NOT COMPLETED|Overall Study||1
10066785|NCT02142712|11193135|FG001|NOT COMPLETED|Overall Study||1
10066786|NCT02142712|11193136|FG002|NOT COMPLETED|Overall Study||1
10066787|NCT02142712|11193137|FG003|NOT COMPLETED|Overall Study||0
10066788|NCT02142894|11193146|FG000|STARTED|Overall Study||33
10066789|NCT02142894|11193146|FG000|COMPLETED|Overall Study||25
10066790|NCT02142894|11193146|FG000|NOT COMPLETED|Overall Study||8
10066791|NCT02143024|11193152|FG000|STARTED|Overall Study||15
10066792|NCT02143024|11193153|FG001|STARTED|Overall Study||8
10066793|NCT02143024|11193152|FG000|Received Treatment|Overall Study||13
10066794|NCT02143024|11193153|FG001|Received Treatment|Overall Study||7
10066795|NCT02143024|11193152|FG000|COMPLETED|Overall Study||13
10066796|NCT02143024|11193153|FG001|COMPLETED|Overall Study||7
10066797|NCT02143024|11193152|FG000|NOT COMPLETED|Overall Study||2
10066798|NCT02143024|11193153|FG001|NOT COMPLETED|Overall Study||1
10066799|NCT02143102|11193161|FG000|STARTED|Overall Study||97
10066800|NCT02143102|11193162|FG001|STARTED|Overall Study||28
10066801|NCT02143102|11193161|FG000|COMPLETED|Overall Study||86
10066802|NCT02143102|11193162|FG001|COMPLETED|Overall Study||28
10066803|NCT02143102|11193161|FG000|NOT COMPLETED|Overall Study||11
10066804|NCT02143102|11193162|FG001|NOT COMPLETED|Overall Study||0
10066805|NCT02143141|11193170|FG000|STARTED|Overall Study||7
10066806|NCT02143141|11193171|FG001|STARTED|Overall Study||6
10066807|NCT02143141|11193170|FG000|COMPLETED|Overall Study||6
10066808|NCT02143141|11193171|FG001|COMPLETED|Overall Study||6
10066809|NCT02143141|11193170|FG000|NOT COMPLETED|Overall Study||1
10066810|NCT02143141|11193171|FG001|NOT COMPLETED|Overall Study||0
10066811|NCT02143310|11193177|FG000|STARTED|Overall Study||209
10066812|NCT02143310|11193177|FG000|COMPLETED|Overall Study||102
10066813|NCT02143310|11193177|FG000|NOT COMPLETED|Overall Study||107
10066814|NCT02143583|11193184|FG000|STARTED|Overall Study||62
10066815|NCT02143583|11193185|FG001|STARTED|Overall Study||66
10066816|NCT02143583|11193186|FG002|STARTED|Overall Study||68
10066817|NCT02143583|11193184|FG000|COMPLETED|Overall Study||61
10066818|NCT02143583|11193185|FG001|COMPLETED|Overall Study||66
10066819|NCT02143583|11193186|FG002|COMPLETED|Overall Study||66
10066820|NCT02143583|11193184|FG000|NOT COMPLETED|Overall Study||1
10066821|NCT02143583|11193185|FG001|NOT COMPLETED|Overall Study||0
10066822|NCT02143583|11193186|FG002|NOT COMPLETED|Overall Study||2
10066823|NCT02143648|11193197|FG000|STARTED|Overall Study||128
10066824|NCT02143648|11193198|FG001|STARTED|Overall Study||120
10066825|NCT02143648|11193199|FG002|STARTED|Overall Study||125
10066826|NCT02143648|11193197|FG000|COMPLETED|Overall Study||74
10066827|NCT02143648|11193198|FG001|COMPLETED|Overall Study||78
10066828|NCT02143648|11193199|FG002|COMPLETED|Overall Study||101
10066829|NCT02143648|11193197|FG000|NOT COMPLETED|Overall Study||54
10066830|NCT02143648|11193198|FG001|NOT COMPLETED|Overall Study||42
10066831|NCT02143648|11193199|FG002|NOT COMPLETED|Overall Study||24
10066832|NCT02143713|11193211|FG000|STARTED|Treatment Period (6 Months)||102
10066833|NCT02143713|11193212|FG001|STARTED|Treatment Period (6 Months)||111
10066834|NCT02143713|11193213|FG002|STARTED|Treatment Period (6 Months)||142
10066835|NCT02143713|11193214|FG003|STARTED|Treatment Period (6 Months)||140
10066836|NCT02143713|11193211|FG000|Received Elagolix|Treatment Period (6 Months)||102
10066837|NCT02143713|11193212|FG001|Received Elagolix|Treatment Period (6 Months)||111
10066838|NCT02143713|11193213|FG002|Received Elagolix|Treatment Period (6 Months)||142
10066839|NCT02143713|11193214|FG003|Received Elagolix|Treatment Period (6 Months)||140
10066840|NCT02143713|11193211|FG000|COMPLETED|Treatment Period (6 Months)||82
10066841|NCT02143713|11193212|FG001|COMPLETED|Treatment Period (6 Months)||99
10066842|NCT02143713|11193213|FG002|COMPLETED|Treatment Period (6 Months)||120
10066843|NCT02143713|11193214|FG003|COMPLETED|Treatment Period (6 Months)||112
10066844|NCT02143713|11193211|FG000|NOT COMPLETED|Treatment Period (6 Months)||20
10066845|NCT02143713|11193212|FG001|NOT COMPLETED|Treatment Period (6 Months)||12
10066846|NCT02143713|11193213|FG002|NOT COMPLETED|Treatment Period (6 Months)||22
10066847|NCT02143713|11193214|FG003|NOT COMPLETED|Treatment Period (6 Months)||28
10066848|NCT02143713|11193211|FG000|STARTED|Post-treatment Follow-up (12 Months)||85
10066849|NCT02143713|11193212|FG001|STARTED|Post-treatment Follow-up (12 Months)||105
10066850|NCT02143713|11193213|FG002|STARTED|Post-treatment Follow-up (12 Months)||125
10066851|NCT02143713|11193214|FG003|STARTED|Post-treatment Follow-up (12 Months)||122
10066852|NCT02143713|11193211|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73
10066853|NCT02143713|11193212|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81
10066854|NCT02143713|11193213|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96
10066855|NCT02143713|11193214|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95
10066856|NCT02143713|11193211|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
10066857|NCT02143713|11193212|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
10066858|NCT02143713|11193213|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
10066859|NCT02143713|11193214|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
10066860|NCT02143778|11193225|FG000|STARTED|Overall Study||246
10066861|NCT02143778|11193225|FG000|COMPLETED|Overall Study||243
10066862|NCT02143778|11193225|FG000|NOT COMPLETED|Overall Study||3
10066863|NCT02143843|11193230|FG000|STARTED|Overall Study||75
10066864|NCT02143843|11193230|FG000|COMPLETED|Overall Study||63
10066865|NCT02143843|11193230|FG000|NOT COMPLETED|Overall Study||12
10066866|NCT02143947|11193236|FG000|STARTED|Overall Study||36
10066867|NCT02143947|11193237|FG001|STARTED|Overall Study||44
10066868|NCT02143947|11193236|FG000|COMPLETED|Overall Study||32
10066869|NCT02143947|11193237|FG001|COMPLETED|Overall Study||42
10066870|NCT02143947|11193236|FG000|NOT COMPLETED|Overall Study||4
10066871|NCT02143947|11193237|FG001|NOT COMPLETED|Overall Study||2
10066872|NCT02143973|11193245|FG000|STARTED|Overall Study||167
10066873|NCT02143973|11193245|FG000|COMPLETED|Overall Study||101
10066874|NCT02143973|11193245|FG000|NOT COMPLETED|Overall Study||66
10066875|NCT02144012|11193251|FG000|STARTED|Overall Study||34
10066876|NCT02144012|11193252|FG001|STARTED|Overall Study||15
10066877|NCT02144012|11193251|FG000|COMPLETED|Overall Study||0
10066878|NCT02144012|11193252|FG001|COMPLETED|Overall Study||0
10066879|NCT02144012|11193251|FG000|NOT COMPLETED|Overall Study||34
10066880|NCT02144012|11193252|FG001|NOT COMPLETED|Overall Study||15
10066881|NCT02144077|11193260|FG000|STARTED|Overall Study||138
10066882|NCT02144077|11193261|FG001|STARTED|Overall Study||143
10066883|NCT02144077|11193260|FG000|COMPLETED|Overall Study||128
10066884|NCT02144077|11193261|FG001|COMPLETED|Overall Study||132
10066885|NCT02144077|11193260|FG000|NOT COMPLETED|Overall Study||10
10066886|NCT02144077|11193261|FG001|NOT COMPLETED|Overall Study||11
10066887|NCT02144220|11193267|FG000|STARTED|Overall Study||277
10066888|NCT02144220|11193267|FG000|COMPLETED|Overall Study||258
10066889|NCT02144220|11193267|FG000|NOT COMPLETED|Overall Study||19
10066890|NCT02144233|11193273|FG000|STARTED|Overall Study||39
10066891|NCT02144233|11193274|FG001|STARTED|Overall Study||38
10066892|NCT02144233|11193273|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
10066893|NCT02144233|11193274|FG001|COMPLETED|Overall Study||38
10066894|NCT02144233|11193273|FG000|NOT COMPLETED|Overall Study||0
10066895|NCT02144233|11193274|FG001|NOT COMPLETED|Overall Study||0
10066896|NCT02144259|11193283|FG000|STARTED|Overall Study||33
10066897|NCT02144259|11193284|FG001|STARTED|Overall Study||33
10066898|NCT02144259|11193285|FG002|STARTED|Overall Study||34
10066899|NCT02144259|11193283|FG000|COMPLETED|Overall Study||23
10066900|NCT02144259|11193284|FG001|COMPLETED|Overall Study||28
10066901|NCT02144259|11193285|FG002|COMPLETED|Overall Study||16
10066902|NCT02144259|11193283|FG000|NOT COMPLETED|Overall Study||10
10066903|NCT02144259|11193284|FG001|NOT COMPLETED|Overall Study||5
10066904|NCT02144259|11193285|FG002|NOT COMPLETED|Overall Study||18
10066905|NCT02144285|11193303|FG000|STARTED|Overall Study||14
10066906|NCT02144285|11193304|FG001|STARTED|Overall Study||6
10066907|NCT02144285|11193305|FG002|STARTED|Overall Study||6
10066908|NCT02144285|11193306|FG003|STARTED|Overall Study||6
10066909|NCT02144285|11193307|FG004|STARTED|Overall Study||6
10066910|NCT02144285|11193308|FG005|STARTED|Overall Study||6
10066911|NCT02144285|11193309|FG006|STARTED|Overall Study||6
10066912|NCT02144285|11193310|FG007|STARTED|Overall Study||6
10066913|NCT02144285|11193311|FG008|STARTED|Overall Study||2
10066914|NCT02144285|11193312|FG009|STARTED|Overall Study||6
10066915|NCT02144285|11193303|FG000|Received At Least One Dose of Study Drug|Overall Study||14
10066916|NCT02144285|11193304|FG001|Received At Least One Dose of Study Drug|Overall Study||6
10066917|NCT02144285|11193305|FG002|Received At Least One Dose of Study Drug|Overall Study||6
10066918|NCT02144285|11193306|FG003|Received At Least One Dose of Study Drug|Overall Study||6
10066919|NCT02144285|11193307|FG004|Received At Least One Dose of Study Drug|Overall Study||6
10066920|NCT02144285|11193308|FG005|Received At Least One Dose of Study Drug|Overall Study||6
10066921|NCT02144285|11193309|FG006|Received At Least One Dose of Study Drug|Overall Study||6
10066922|NCT02144285|11193310|FG007|Received At Least One Dose of Study Drug|Overall Study||6
10066923|NCT02144285|11193311|FG008|Received At Least One Dose of Study Drug|Overall Study||2
10066924|NCT02144285|11193312|FG009|Received At Least One Dose of Study Drug|Overall Study||6
10066925|NCT02144285|11193303|FG000|COMPLETED|Overall Study||14
10066926|NCT02144285|11193304|FG001|COMPLETED|Overall Study||6
10066927|NCT02144285|11193305|FG002|COMPLETED|Overall Study||6
10066928|NCT02144285|11193306|FG003|COMPLETED|Overall Study||6
10066929|NCT02144285|11193307|FG004|COMPLETED|Overall Study||5
10066930|NCT02144285|11193308|FG005|COMPLETED|Overall Study||6
10066931|NCT02144285|11193309|FG006|COMPLETED|Overall Study||6
10066932|NCT02144285|11193310|FG007|COMPLETED|Overall Study||6
10066933|NCT02144285|11193311|FG008|COMPLETED|Overall Study||2
10066934|NCT02144285|11193312|FG009|COMPLETED|Overall Study||6
10066935|NCT02144285|11193303|FG000|NOT COMPLETED|Overall Study||0
10066936|NCT02144285|11193304|FG001|NOT COMPLETED|Overall Study||0
10066937|NCT02144285|11193305|FG002|NOT COMPLETED|Overall Study||0
10066938|NCT02144285|11193306|FG003|NOT COMPLETED|Overall Study||0
10066939|NCT02144285|11193307|FG004|NOT COMPLETED|Overall Study||1
10066940|NCT02144285|11193308|FG005|NOT COMPLETED|Overall Study||0
10066941|NCT02144285|11193309|FG006|NOT COMPLETED|Overall Study||0
10066942|NCT02144285|11193310|FG007|NOT COMPLETED|Overall Study||0
10066943|NCT02144285|11193311|FG008|NOT COMPLETED|Overall Study||0
10066944|NCT02144285|11193312|FG009|NOT COMPLETED|Overall Study||0
10066945|NCT02144337|11193350|FG000|STARTED|Baseline 0 Months||8
10066946|NCT02144337|11193351|FG001|STARTED|Baseline 0 Months||5
10066947|NCT02144337|11193350|FG000|COMPLETED|Baseline 0 Months||8
10066948|NCT02144337|11193351|FG001|COMPLETED|Baseline 0 Months||5
10066949|NCT02144337|11193350|FG000|NOT COMPLETED|Baseline 0 Months||0
10066950|NCT02144337|11193351|FG001|NOT COMPLETED|Baseline 0 Months||0
10066951|NCT02144337|11193350|FG000|STARTED|T2 Follow-up (Post-intervention)||8
10066952|NCT02144337|11193351|FG001|STARTED|T2 Follow-up (Post-intervention)||5
10066953|NCT02144337|11193350|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4
10066954|NCT02144337|11193351|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4
10066955|NCT02144337|11193350|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
10066956|NCT02144337|11193351|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
10066957|NCT02144337|11193350|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
10066958|NCT02144337|11193351|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
10066959|NCT02144337|11193350|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
10066960|NCT02144337|11193351|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
10066961|NCT02144337|11193350|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
10066962|NCT02144337|11193351|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
10066963|NCT02139540|11193360|FG000|STARTED|Overall Study||11
10066964|NCT02139540|11193361|FG001|STARTED|Overall Study||10
10066965|NCT02139540|11193360|FG000|COMPLETED|Overall Study||10
10066966|NCT02139540|11193361|FG001|COMPLETED|Overall Study||10
10066967|NCT02139540|11193360|FG000|NOT COMPLETED|Overall Study||1
10066968|NCT02139540|11193361|FG001|NOT COMPLETED|Overall Study||0
10066969|NCT02144519|11193369|FG000|STARTED|Year 1||895
10066970|NCT02144519|11193370|FG001|STARTED|Year 1||870
10066971|NCT02144519|11193369|FG000|COMPLETED|Year 1||895
10066972|NCT02144519|11193370|FG001|COMPLETED|Year 1||870
10066973|NCT02144519|11193369|FG000|NOT COMPLETED|Year 1||0
10066974|NCT02144519|11193370|FG001|NOT COMPLETED|Year 1||0
10066975|NCT02144519|11193369|FG000|STARTED|Year 2||763
10066976|NCT02144519|11193370|FG001|STARTED|Year 2||864
10066977|NCT02144519|11193369|FG000|COMPLETED|Year 2||763
10066978|NCT02144519|11193370|FG001|COMPLETED|Year 2||864
10066979|NCT02144519|11193369|FG000|NOT COMPLETED|Year 2||0
10066980|NCT02144519|11193370|FG001|NOT COMPLETED|Year 2||0
10066981|NCT02144519|11193369|FG000|STARTED|Year 3||894
10066982|NCT02144519|11193370|FG001|STARTED|Year 3||760
10066983|NCT02144519|11193369|FG000|COMPLETED|Year 3||894
10066984|NCT02144519|11193370|FG001|COMPLETED|Year 3||760
10066985|NCT02144519|11193369|FG000|NOT COMPLETED|Year 3||0
10066986|NCT02144519|11193370|FG001|NOT COMPLETED|Year 3||0
10066987|NCT02144597|11193379|FG000|STARTED|Overall Study||10
10066988|NCT02144597|11193380|FG001|STARTED|Overall Study||10
10066989|NCT02144597|11193381|FG002|STARTED|Overall Study||10
10066990|NCT02144597|11193379|FG000|COMPLETED|Overall Study||4
10066991|NCT02144597|11193380|FG001|COMPLETED|Overall Study||6
10066992|NCT02144597|11193381|FG002|COMPLETED|Overall Study||6
10066993|NCT02144597|11193379|FG000|NOT COMPLETED|Overall Study||6
10066994|NCT02144597|11193380|FG001|NOT COMPLETED|Overall Study||4
10066995|NCT02144597|11193381|FG002|NOT COMPLETED|Overall Study||4
10066996|NCT02144610|11193391|FG000|STARTED|Overall Study||23
10066997|NCT02144610|11193392|FG001|STARTED|Overall Study||23
10066998|NCT02144610|11193391|FG000|COMPLETED|Overall Study||0
10066999|NCT02144610|11193392|FG001|COMPLETED|Overall Study||1
10067000|NCT02144610|11193391|FG000|NOT COMPLETED|Overall Study||23
10067001|NCT02144610|11193392|FG001|NOT COMPLETED|Overall Study||22
10067002|NCT02144675|11193400|FG000|STARTED|Overall Study||13
10067003|NCT02144675|11193401|FG001|STARTED|Overall Study||14
10067004|NCT02144675|11193400|FG000|COMPLETED|Overall Study||13
10067005|NCT02144675|11193401|FG001|COMPLETED|Overall Study||14
10067006|NCT02144675|11193400|FG000|NOT COMPLETED|Overall Study||0
10067007|NCT02144675|11193401|FG001|NOT COMPLETED|Overall Study||0
10067008|NCT02144701|11193409|FG000|STARTED|Overall Study||22
10067009|NCT02144701|11193410|FG001|STARTED|Overall Study||11
10067010|NCT02144701|11193409|FG000|COMPLETED|Overall Study||13
10067011|NCT02144701|11193410|FG001|COMPLETED|Overall Study||8
10067012|NCT02144701|11193409|FG000|NOT COMPLETED|Overall Study||9
10067013|NCT02144701|11193410|FG001|NOT COMPLETED|Overall Study||3
10067014|NCT02144714|11193419|FG000|STARTED|Overall Study||63
10067015|NCT02144714|11193420|FG001|STARTED|Overall Study||63
10067016|NCT02144714|11193421|FG002|STARTED|Overall Study||63
10067017|NCT02144714|11193419|FG000|COMPLETED|Overall Study||63
10067018|NCT02144714|11193420|FG001|COMPLETED|Overall Study||63
10067019|NCT02144714|11193421|FG002|COMPLETED|Overall Study||63
10067020|NCT02144714|11193419|FG000|NOT COMPLETED|Overall Study||0
10067021|NCT02144714|11193420|FG001|NOT COMPLETED|Overall Study||0
10067022|NCT02144714|11193421|FG002|NOT COMPLETED|Overall Study||0
10067023|NCT02145026|11193429|FG000|STARTED|Overall Study||100
10067024|NCT02145026|11193429|FG000|COMPLETED|Overall Study||88
10067025|NCT02145026|11193429|FG000|NOT COMPLETED|Overall Study||12
10188708|NCT03271528|11318239|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9
10188709|NCT03271528|11318240|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11
10188710|NCT03271528|11318239|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
10188711|NCT03271528|11318240|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
10188712|NCT03271528|11318239|FG000|STARTED|Medication Dispense/Exposure Period 2||9
10188713|NCT03271528|11318240|FG001|STARTED|Medication Dispense/Exposure Period 2||11
10188714|NCT03271528|11318239|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8
10188715|NCT03271528|11318240|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11
10188716|NCT03271528|11318239|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
10188717|NCT03271528|11318240|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
10188718|NCT03271528|11318239|FG000|STARTED|Alcohol Self-Administration Trial 2||8
10188719|NCT03271528|11318240|FG001|STARTED|Alcohol Self-Administration Trial 2||11
10188720|NCT03271528|11318239|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8
10188721|NCT03271528|11318240|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11
10188722|NCT03271528|11318239|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
10188723|NCT03271528|11318240|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
10188724|NCT03273153|11318248|FG000|STARTED|Overall Study||224
10188725|NCT03273153|11318249|FG001|STARTED|Overall Study||222
10188726|NCT03273153|11318248|FG000|COMPLETED|Overall Study||0
10188727|NCT03273153|11318249|FG001|COMPLETED|Overall Study||0
10188728|NCT03273153|11318248|FG000|NOT COMPLETED|Overall Study||224
10188729|NCT03273153|11318249|FG001|NOT COMPLETED|Overall Study||222
10188730|NCT03273166|11318255|FG000|STARTED|Overall Study||82
10188731|NCT03273166|11318255|FG000|COMPLETED|Overall Study||51
10188732|NCT03273166|11318255|FG000|NOT COMPLETED|Overall Study||31
10188733|NCT03273257|11318262|FG000|STARTED|Overall Study||7
10188734|NCT03273257|11318263|FG001|STARTED|Overall Study||7
10188735|NCT03273257|11318262|FG000|Started Treatment|Overall Study||7
10188736|NCT03273257|11318263|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
10188737|NCT03273257|11318262|FG000|Underwent PEA|Overall Study||6
10188738|NCT03273257|11318263|FG001|Underwent PEA|Overall Study||5
10188739|NCT03273257|11318262|FG000|COMPLETED|Overall Study||3
10188740|NCT03273257|11318263|FG001|COMPLETED|Overall Study||3
10188741|NCT03273257|11318262|FG000|NOT COMPLETED|Overall Study||4
10188742|NCT03273257|11318263|FG001|NOT COMPLETED|Overall Study||4
10188743|NCT03273270|11318271|FG000|STARTED|Overall Study||12
10188744|NCT03273270|11318272|FG001|STARTED|Overall Study||8
10188745|NCT03273270|11318271|FG000|COMPLETED|Overall Study||12
10188746|NCT03273270|11318272|FG001|COMPLETED|Overall Study||8
10188747|NCT03273270|11318271|FG000|NOT COMPLETED|Overall Study||0
10188748|NCT03273270|11318272|FG001|NOT COMPLETED|Overall Study||0
10188749|NCT03273283|11318280|FG000|STARTED|Overall Study||99
10188750|NCT03273283|11318281|FG001|STARTED|Overall Study||101
10188751|NCT03273283|11318280|FG000|COMPLETED|Overall Study||72
10188752|NCT03273283|11318281|FG001|COMPLETED|Overall Study||81
10188753|NCT03273283|11318280|FG000|NOT COMPLETED|Overall Study||27
10188754|NCT03273283|11318281|FG001|NOT COMPLETED|Overall Study||20
10188755|NCT03273387|11318289|FG000|STARTED|Overall Study||13
10188756|NCT03273387|11318290|FG001|STARTED|Overall Study||13
10188757|NCT03273387|11318289|FG000|COMPLETED|Overall Study||10
10188758|NCT03273387|11318290|FG001|COMPLETED|Overall Study||10
10188759|NCT03273387|11318289|FG000|NOT COMPLETED|Overall Study||3
10188760|NCT03273387|11318290|FG001|NOT COMPLETED|Overall Study||3
10188761|NCT03273426|11318298|FG000|STARTED|Overall Study||20
10188762|NCT03273426|11318299|FG001|STARTED|Overall Study||20
10188763|NCT03273426|11318298|FG000|COMPLETED|Overall Study||20
10188764|NCT03273426|11318299|FG001|COMPLETED|Overall Study||20
10188765|NCT03273426|11318298|FG000|NOT COMPLETED|Overall Study||0
10067026|NCT02145039|11193433|FG000|STARTED|Overall Study||2
10067027|NCT02145039|11193433|FG000|COMPLETED|Overall Study||2
10067028|NCT02145039|11193433|FG000|NOT COMPLETED|Overall Study||0
10067029|NCT02145078|11193437|FG000|STARTED|Overall Study||4
10067030|NCT02145078|11193437|FG000|COMPLETED|Overall Study||0
10067031|NCT02145078|11193437|FG000|NOT COMPLETED|Overall Study||4
10067032|NCT02145156|11193444|FG000|STARTED|Overall Study||430
10067033|NCT02145156|11193445|FG001|STARTED|Overall Study||425
10067034|NCT02145156|11193446|FG002|STARTED|Overall Study||439
10067035|NCT02145156|11193444|FG000|COMPLETED|Overall Study||370
10067036|NCT02145156|11193445|FG001|COMPLETED|Overall Study||373
10067037|NCT02145156|11193446|FG002|COMPLETED|Overall Study||398
10067038|NCT02145156|11193444|FG000|NOT COMPLETED|Overall Study||60
10067039|NCT02145156|11193445|FG001|NOT COMPLETED|Overall Study||52
10067040|NCT02145156|11193446|FG002|NOT COMPLETED|Overall Study||41
10067041|NCT02145182|11193456|FG000|STARTED|Overall Study||142
10067042|NCT02145182|11193457|FG001|STARTED|Overall Study||146
10067043|NCT02145182|11193456|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
10067044|NCT02145182|11193457|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146
10067045|NCT02145182|11193456|FG000|COMPLETED|Overall Study||124
10067046|NCT02145182|11193457|FG001|COMPLETED|Overall Study||130
10067047|NCT02145182|11193456|FG000|NOT COMPLETED|Overall Study||18
10067048|NCT02145182|11193457|FG001|NOT COMPLETED|Overall Study||16
10067049|NCT02145247|11193465|FG000|STARTED|Overall Study||20
10067050|NCT02145247|11193466|FG001|STARTED|Overall Study||19
10067051|NCT02145247|11193465|FG000|COMPLETED|Overall Study||20
10067052|NCT02145247|11193466|FG001|COMPLETED|Overall Study||19
10067053|NCT02145247|11193465|FG000|NOT COMPLETED|Overall Study||0
10067054|NCT02145247|11193466|FG001|NOT COMPLETED|Overall Study||0
10067055|NCT02145299|11193474|FG000|STARTED|Overall Study||6
10067056|NCT02145299|11193475|FG001|STARTED|Overall Study||2
10067057|NCT02145299|11193474|FG000|COMPLETED|Overall Study||6
10067058|NCT02145299|11193475|FG001|COMPLETED|Overall Study||2
10067059|NCT02145299|11193474|FG000|NOT COMPLETED|Overall Study||0
10067060|NCT02145299|11193475|FG001|NOT COMPLETED|Overall Study||0
10067061|NCT02145429|11193483|FG000|STARTED|Overall Study||91
10067062|NCT02145429|11193484|FG001|STARTED|Overall Study||90
10067063|NCT02145429|11193483|FG000|COMPLETED|Overall Study||75
10067064|NCT02145429|11193484|FG001|COMPLETED|Overall Study||79
10067065|NCT02145429|11193483|FG000|NOT COMPLETED|Overall Study||16
10067066|NCT02145429|11193484|FG001|NOT COMPLETED|Overall Study||11
10067067|NCT02145468|11193492|FG000|STARTED|Overall Study||1758
10067068|NCT02145468|11193493|FG001|STARTED|Overall Study||1731
10067069|NCT02145468|11193492|FG000|COMPLETED|Overall Study||1753
10067070|NCT02145468|11193493|FG001|COMPLETED|Overall Study||1723
10067071|NCT02145468|11193492|FG000|NOT COMPLETED|Overall Study||5
10067072|NCT02145468|11193493|FG001|NOT COMPLETED|Overall Study||8
10067073|NCT02145676|11193502|FG000|STARTED|Overall Study||17
10067074|NCT02145676|11193503|FG001|STARTED|Overall Study||18
10067075|NCT02145676|11193504|FG002|STARTED|Overall Study||18
10067076|NCT02145676|11193502|FG000|COMPLETED|Overall Study||17
10067077|NCT02145676|11193503|FG001|COMPLETED|Overall Study||18
10067078|NCT02145676|11193504|FG002|COMPLETED|Overall Study||18
10067079|NCT02145676|11193502|FG000|NOT COMPLETED|Overall Study||0
10067080|NCT02145676|11193503|FG001|NOT COMPLETED|Overall Study||0
10067081|NCT02145676|11193504|FG002|NOT COMPLETED|Overall Study||0
10067082|NCT02145754|11193512|FG000|STARTED|Overall Study||235
10067083|NCT02145754|11193512|FG000|COMPLETED|Overall Study||235
10067084|NCT02145754|11193512|FG000|NOT COMPLETED|Overall Study||0
10067085|NCT02146001|11193518|FG000|STARTED|Overall Study||19
10067086|NCT02146001|11193519|FG001|STARTED|Overall Study||19
10067087|NCT02146001|11193518|FG000|COMPLETED|Overall Study||19
10067088|NCT02146001|11193519|FG001|COMPLETED|Overall Study||19
10067089|NCT02146001|11193518|FG000|NOT COMPLETED|Overall Study||0
10067090|NCT02146001|11193519|FG001|NOT COMPLETED|Overall Study||0
10067091|NCT02146105|11193525|FG000|STARTED|Overall Study||45
10067092|NCT02146105|11193525|FG000|COMPLETED|Overall Study||39
10067093|NCT02146105|11193525|FG000|NOT COMPLETED|Overall Study||6
10067094|NCT02146131|11193531|FG000|STARTED|Overall Study||170
10067095|NCT02146131|11193532|FG001|STARTED|Overall Study||169
10067096|NCT02146131|11193531|FG000|COMPLETED|Overall Study||109
10067097|NCT02146131|11193532|FG001|COMPLETED|Overall Study||113
10067098|NCT02146131|11193531|FG000|NOT COMPLETED|Overall Study||61
10067099|NCT02146131|11193532|FG001|NOT COMPLETED|Overall Study||56
10067100|NCT02146248|11193538|FG000|STARTED|Overall Study||11
10067101|NCT02146248|11193538|FG000|Enrolled|Overall Study||11
10067102|NCT02146248|11193538|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
10067103|NCT02146248|11193538|FG000|HSG 1|Overall Study||10
10067104|NCT02146248|11193538|FG000|HSG 2|Overall Study||10
10067105|NCT02146248|11193538|FG000|HSG 3|Overall Study||9
10067106|NCT02146248|11193538|FG000|HSG 4|Overall Study||7
10067107|NCT02146248|11193538|FG000|HSG 5|Overall Study||1
10067108|NCT02146248|11193538|FG000|COMPLETED|Overall Study||9
10067109|NCT02146248|11193538|FG000|NOT COMPLETED|Overall Study||2
10067110|NCT02146274|11193546|FG000|STARTED|Overall Study||1877
10067111|NCT02146274|11193546|FG000|COMPLETED|Overall Study||1804
10067112|NCT02146274|11193546|FG000|NOT COMPLETED|Overall Study||73
10067113|NCT02146326|11193557|FG000|STARTED|Overall Study||89
10067114|NCT02146326|11193558|FG001|STARTED|Overall Study||103
10067115|NCT02146326|11193559|FG002|STARTED|Overall Study||211
10067116|NCT02146326|11193560|FG003|STARTED|Overall Study||258
10067117|NCT02146326|11193557|FG000|Baseline|Overall Study||89
10188766|NCT03273426|11318299|FG001|NOT COMPLETED|Overall Study||0
10188767|NCT03273543|11318308|FG000|STARTED|Overall Study||10
10188768|NCT03273543|11318309|FG001|STARTED|Overall Study||10
10188769|NCT03273543|11318308|FG000|COMPLETED|Overall Study||10
10188770|NCT03273543|11318309|FG001|COMPLETED|Overall Study||10
10188771|NCT03273543|11318308|FG000|NOT COMPLETED|Overall Study||0
10188772|NCT03273543|11318309|FG001|NOT COMPLETED|Overall Study||0
10188773|NCT03273673|11318317|FG000|STARTED|Overall Study||18
10188774|NCT03273673|11318318|FG001|STARTED|Overall Study||22
10188775|NCT03273673|11318317|FG000|COMPLETED|Overall Study||14
10188776|NCT03273673|11318318|FG001|COMPLETED|Overall Study||22
10188777|NCT03273673|11318317|FG000|NOT COMPLETED|Overall Study||4
10188778|NCT03273673|11318318|FG001|NOT COMPLETED|Overall Study||0
10188779|NCT03273946|11318324|FG000|STARTED|Overall Study||158
10188780|NCT03273946|11318324|FG000|COMPLETED|Overall Study||149
10188781|NCT03273946|11318324|FG000|NOT COMPLETED|Overall Study||9
10188782|NCT03274076|11318330|FG000|STARTED|24 Weeks Double Blind||10
10188783|NCT03274076|11318331|FG001|STARTED|24 Weeks Double Blind||5
10188784|NCT03274076|11318332|FG002|STARTED|24 Weeks Double Blind||0
10188785|NCT03274076|11318333|FG003|STARTED|24 Weeks Double Blind||0
10188786|NCT03274076|11318330|FG000|COMPLETED|24 Weeks Double Blind||10
10188787|NCT03274076|11318331|FG001|COMPLETED|24 Weeks Double Blind||4
10188788|NCT03274076|11318332|FG002|COMPLETED|24 Weeks Double Blind||0
10188789|NCT03274076|11318333|FG003|COMPLETED|24 Weeks Double Blind||0
10188790|NCT03274076|11318330|FG000|NOT COMPLETED|24 Weeks Double Blind||0
10188791|NCT03274076|11318331|FG001|NOT COMPLETED|24 Weeks Double Blind||1
10188792|NCT03274076|11318332|FG002|NOT COMPLETED|24 Weeks Double Blind||0
10188793|NCT03274076|11318333|FG003|NOT COMPLETED|24 Weeks Double Blind||0
10188794|NCT03274076|11318330|FG000|STARTED|24 Weeks Open Label||0
10188795|NCT03274076|11318331|FG001|STARTED|24 Weeks Open Label||0
10188796|NCT03274076|11318332|FG002|STARTED|24 Weeks Open Label||10
10188797|NCT03274076|11318333|FG003|STARTED|24 Weeks Open Label||4
10188798|NCT03274076|11318330|FG000|COMPLETED|24 Weeks Open Label||0
10188799|NCT03274076|11318331|FG001|COMPLETED|24 Weeks Open Label||0
10188800|NCT03274076|11318332|FG002|COMPLETED|24 Weeks Open Label||8
10188801|NCT03274076|11318333|FG003|COMPLETED|24 Weeks Open Label||3
10188802|NCT03274076|11318330|FG000|NOT COMPLETED|24 Weeks Open Label||0
10188803|NCT03274076|11318331|FG001|NOT COMPLETED|24 Weeks Open Label||0
10188804|NCT03274076|11318332|FG002|NOT COMPLETED|24 Weeks Open Label||2
10188805|NCT03274076|11318333|FG003|NOT COMPLETED|24 Weeks Open Label||1
10188806|NCT03274440|11318352|FG000|STARTED|Overall Study||3
10188807|NCT03274440|11318353|FG001|STARTED|Overall Study||2
10188808|NCT03274440|11318354|FG002|STARTED|Overall Study||4
10188809|NCT03274440|11318355|FG003|STARTED|Overall Study||1
10188810|NCT03274440|11318356|FG004|STARTED|Overall Study||1
10188811|NCT03274440|11318357|FG005|STARTED|Overall Study||3
10188812|NCT03274440|11318352|FG000|COMPLETED|Overall Study||2
10188813|NCT03274440|11318353|FG001|COMPLETED|Overall Study||2
10188814|NCT03274440|11318354|FG002|COMPLETED|Overall Study||4
10188815|NCT03274440|11318355|FG003|COMPLETED|Overall Study||0
10188816|NCT03274440|11318356|FG004|COMPLETED|Overall Study||1
10188817|NCT03274440|11318357|FG005|COMPLETED|Overall Study||3
10188818|NCT03274440|11318352|FG000|NOT COMPLETED|Overall Study||1
10188819|NCT03274440|11318353|FG001|NOT COMPLETED|Overall Study||0
10188820|NCT03274440|11318354|FG002|NOT COMPLETED|Overall Study||0
10188821|NCT03274440|11318355|FG003|NOT COMPLETED|Overall Study||1
10188822|NCT03274440|11318356|FG004|NOT COMPLETED|Overall Study||0
10188823|NCT03274440|11318357|FG005|NOT COMPLETED|Overall Study||0
10188824|NCT03274453|11318369|FG000|STARTED|Overall Study||38
10188825|NCT03274453|11318370|FG001|STARTED|Overall Study||30
10188826|NCT03274453|11318371|FG002|STARTED|Overall Study||32
10188827|NCT03274453|11318372|FG003|STARTED|Overall Study||29
10188828|NCT03274453|11318369|FG000|COMPLETED|Overall Study||34
10188829|NCT03274453|11318370|FG001|COMPLETED|Overall Study||24
10188830|NCT03274453|11318371|FG002|COMPLETED|Overall Study||28
10188831|NCT03274453|11318372|FG003|COMPLETED|Overall Study||25
10188832|NCT03274453|11318369|FG000|NOT COMPLETED|Overall Study||4
10188833|NCT03274453|11318370|FG001|NOT COMPLETED|Overall Study||6
10188834|NCT03274453|11318371|FG002|NOT COMPLETED|Overall Study||4
10188835|NCT03274453|11318372|FG003|NOT COMPLETED|Overall Study||4
10188836|NCT03274466|11318384|FG000|STARTED|Overall Study||147
10188837|NCT03274466|11318385|FG001|STARTED|Overall Study||147
10188838|NCT03274466|11318384|FG000|COMPLETED|Overall Study||124
10188839|NCT03274466|11318385|FG001|COMPLETED|Overall Study||118
10188840|NCT03274466|11318384|FG000|NOT COMPLETED|Overall Study||23
10188841|NCT03274466|11318385|FG001|NOT COMPLETED|Overall Study||29
10188842|NCT03274518|11318393|FG000|STARTED|First Intervention||8
10188843|NCT03274518|11318394|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
10188844|NCT03274518|11318393|FG000|COMPLETED|First Intervention||8
10188845|NCT03274518|11318394|FG001|COMPLETED|First Intervention||8
10188846|NCT03274518|11318393|FG000|NOT COMPLETED|First Intervention||0
10188847|NCT03274518|11318394|FG001|NOT COMPLETED|First Intervention||0
10067118|NCT02146326|11193558|FG001|Baseline|Overall Study||103
10067119|NCT02146326|11193559|FG002|Baseline|Overall Study||211
10067120|NCT02146326|11193560|FG003|Baseline|Overall Study||258
10067121|NCT02146326|11193557|FG000|3 Months|Overall Study||71
10067122|NCT02146326|11193558|FG001|3 Months|Overall Study||83
10067123|NCT02146326|11193559|FG002|3 Months|Overall Study||0
10067124|NCT02146326|11193560|FG003|3 Months|Overall Study||0
10067125|NCT02146326|11193557|FG000|6 Months|Overall Study||71
10067126|NCT02146326|11193558|FG001|6 Months|Overall Study||71
10067127|NCT02146326|11193559|FG002|6 Months|Overall Study||186
10067128|NCT02146326|11193560|FG003|6 Months|Overall Study||235
10067129|NCT02146326|11193557|FG000|12 Months|Overall Study||61
10067130|NCT02146326|11193558|FG001|12 Months|Overall Study||66
10067131|NCT02146326|11193559|FG002|12 Months|Overall Study||168
10067132|NCT02146326|11193560|FG003|12 Months|Overall Study||210
10067133|NCT02146326|11193557|FG000|COMPLETED|Overall Study||61
10067134|NCT02146326|11193558|FG001|COMPLETED|Overall Study||66
10067135|NCT02146326|11193559|FG002|COMPLETED|Overall Study||168
10067136|NCT02146326|11193560|FG003|COMPLETED|Overall Study||210
10067137|NCT02146326|11193557|FG000|NOT COMPLETED|Overall Study||28
10067138|NCT02146326|11193558|FG001|NOT COMPLETED|Overall Study||37
10067139|NCT02146326|11193559|FG002|NOT COMPLETED|Overall Study||43
10067140|NCT02146326|11193560|FG003|NOT COMPLETED|Overall Study||48
10067141|NCT02146352|11193576|FG000|STARTED|Overall Study||30
10067142|NCT02146352|11193576|FG000|30 or 60 Days Post-procedure|Overall Study||30
10067143|NCT02146352|11193576|FG000|7 Days Post-stent Removal|Overall Study||28
10067144|NCT02146352|11193576|FG000|COMPLETED|Overall Study||28
10067145|NCT02146352|11193576|FG000|NOT COMPLETED|Overall Study||2
10067146|NCT02146365|11193586|FG000|STARTED|Overall Study||49
10067147|NCT02146365|11193587|FG001|STARTED|Overall Study||49
10067148|NCT02146365|11193588|FG002|STARTED|Overall Study||50
10067149|NCT02146365|11193589|FG003|STARTED|Overall Study||50
10067150|NCT02146365|11193590|FG004|STARTED|Overall Study||24
10067151|NCT02146365|11193591|FG005|STARTED|Overall Study||25
10067152|NCT02146365|11193592|FG006|STARTED|Overall Study||25
10067153|NCT02146365|11193593|FG007|STARTED|Overall Study||25
10067154|NCT02146365|11193586|FG000|COMPLETED|Overall Study||45
10067155|NCT02146365|11193587|FG001|COMPLETED|Overall Study||45
10067156|NCT02146365|11193588|FG002|COMPLETED|Overall Study||43
10067157|NCT02146365|11193589|FG003|COMPLETED|Overall Study||41
10067158|NCT02146365|11193590|FG004|COMPLETED|Overall Study||22
10067159|NCT02146365|11193591|FG005|COMPLETED|Overall Study||24
10067160|NCT02146365|11193592|FG006|COMPLETED|Overall Study||25
10067161|NCT02146365|11193593|FG007|COMPLETED|Overall Study||24
10067162|NCT02146365|11193586|FG000|NOT COMPLETED|Overall Study||4
10067163|NCT02146365|11193587|FG001|NOT COMPLETED|Overall Study||4
10067164|NCT02146365|11193588|FG002|NOT COMPLETED|Overall Study||7
10067165|NCT02146365|11193589|FG003|NOT COMPLETED|Overall Study||9
10067166|NCT02146365|11193590|FG004|NOT COMPLETED|Overall Study||2
10067167|NCT02146365|11193591|FG005|NOT COMPLETED|Overall Study||1
10067168|NCT02146365|11193592|FG006|NOT COMPLETED|Overall Study||0
10067169|NCT02146365|11193593|FG007|NOT COMPLETED|Overall Study||1
10067170|NCT02146430|11193615|FG000|STARTED|Overall Study||323
10067171|NCT02146430|11193616|FG001|STARTED|Overall Study||323
10067172|NCT02146430|11193617|FG002|STARTED|Overall Study||324
10067173|NCT02146430|11193618|FG003|STARTED|Overall Study||323
10067174|NCT02146430|11193615|FG000|Safety Analysis Set|Overall Study||318
10067175|NCT02146430|11193616|FG001|Safety Analysis Set|Overall Study||318
10067176|NCT02146430|11193617|FG002|Safety Analysis Set|Overall Study||320
10067177|NCT02146430|11193618|FG003|Safety Analysis Set|Overall Study||320
10067178|NCT02146430|11193615|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318
10067179|NCT02146430|11193616|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317
10067180|NCT02146430|11193617|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319
10067181|NCT02146430|11193618|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319
10067182|NCT02146430|11193615|FG000|COMPLETED|Overall Study||256
10067183|NCT02146430|11193616|FG001|COMPLETED|Overall Study||236
10067184|NCT02146430|11193617|FG002|COMPLETED|Overall Study||242
10067185|NCT02146430|11193618|FG003|COMPLETED|Overall Study||224
10067186|NCT02146430|11193615|FG000|NOT COMPLETED|Overall Study||67
10067187|NCT02146430|11193616|FG001|NOT COMPLETED|Overall Study||87
10067188|NCT02146430|11193617|FG002|NOT COMPLETED|Overall Study||82
10067189|NCT02146430|11193618|FG003|NOT COMPLETED|Overall Study||99
10067190|NCT02146482|11193634|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
10067191|NCT02146482|11193635|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
10067192|NCT02146482|11193634|FG000|COMPLETED|Overall Study||21
10067193|NCT02146482|11193635|FG001|COMPLETED|Overall Study||25
10067194|NCT02146482|11193634|FG000|NOT COMPLETED|Overall Study||0
10067195|NCT02146482|11193635|FG001|NOT COMPLETED|Overall Study||0
10067196|NCT02146599|11193641|FG000|STARTED|Overall Study||301
10067197|NCT02146599|11193641|FG000|COMPLETED|Overall Study||296
10067198|NCT02146599|11193641|FG000|NOT COMPLETED|Overall Study||5
10067199|NCT02146833|11193645|FG000|STARTED|Overall Study||20
10067200|NCT02146833|11193645|FG000|COMPLETED|Overall Study||9
10067201|NCT02146833|11193645|FG000|NOT COMPLETED|Overall Study||11
10067202|NCT02147067|11193651|FG000|STARTED|Overall Study||13
10067203|NCT02147067|11193652|FG001|STARTED|Overall Study||13
10067204|NCT02147067|11193651|FG000|COMPLETED|Overall Study||11
10067205|NCT02147067|11193652|FG001|COMPLETED|Overall Study||11
10067206|NCT02147067|11193651|FG000|NOT COMPLETED|Overall Study||2
10067207|NCT02147067|11193652|FG001|NOT COMPLETED|Overall Study||2
10067208|NCT02147093|11193660|FG000|STARTED|Period 1||20
10067209|NCT02147093|11193661|FG001|STARTED|Period 1||20
10067210|NCT02147093|11193660|FG000|COMPLETED|Period 1||20
10067211|NCT02147093|11193661|FG001|COMPLETED|Period 1||19
10067212|NCT02147093|11193660|FG000|NOT COMPLETED|Period 1||0
10067213|NCT02147093|11193661|FG001|NOT COMPLETED|Period 1||1
10067214|NCT02147093|11193660|FG000|STARTED|Period 2||20
10067215|NCT02147093|11193661|FG001|STARTED|Period 2||19
10067216|NCT02147093|11193660|FG000|COMPLETED|Period 2||18
10067217|NCT02147093|11193661|FG001|COMPLETED|Period 2||19
10067218|NCT02147093|11193660|FG000|NOT COMPLETED|Period 2||2
10067219|NCT02147093|11193661|FG001|NOT COMPLETED|Period 2||0
10067220|NCT02147132|11193667|FG000|STARTED|Overall Study||2
10067221|NCT02147132|11193668|FG001|STARTED|Overall Study||2
10067222|NCT02147132|11193669|FG002|STARTED|Overall Study||1
10067223|NCT02147132|11193670|FG003|STARTED|Overall Study||2
10067224|NCT02147132|11193667|FG000|COMPLETED|Overall Study||1
10067225|NCT02147132|11193668|FG001|COMPLETED|Overall Study||2
10067226|NCT02147132|11193669|FG002|COMPLETED|Overall Study||1
10067227|NCT02147132|11193670|FG003|COMPLETED|Overall Study||2
10067228|NCT02147132|11193667|FG000|NOT COMPLETED|Overall Study||1
10067229|NCT02147132|11193668|FG001|NOT COMPLETED|Overall Study||0
10067230|NCT02147132|11193669|FG002|NOT COMPLETED|Overall Study||0
10067231|NCT02147132|11193670|FG003|NOT COMPLETED|Overall Study||0
10067232|NCT02147158|11193686|FG000|STARTED|Treatment Course 1||55
10067233|NCT02147158|11193687|FG001|STARTED|Treatment Course 1||47
10067234|NCT02147158|11193688|FG002|STARTED|Treatment Course 1||107
10067235|NCT02147158|11193689|FG003|STARTED|Treatment Course 1||110
10067236|NCT02147158|11193690|FG004|STARTED|Treatment Course 1||55
10067237|NCT02147158|11193691|FG005|STARTED|Treatment Course 1||58
10067238|NCT02147158|11193686|FG000|COMPLETED|Treatment Course 1||51
10067239|NCT02147158|11193687|FG001|COMPLETED|Treatment Course 1||38
10067240|NCT02147158|11193688|FG002|COMPLETED|Treatment Course 1||99
10067241|NCT02147158|11193689|FG003|COMPLETED|Treatment Course 1||97
10067242|NCT02147158|11193690|FG004|COMPLETED|Treatment Course 1||49
10067243|NCT02147158|11193691|FG005|COMPLETED|Treatment Course 1||50
10067244|NCT02147158|11193686|FG000|NOT COMPLETED|Treatment Course 1||4
10067245|NCT02147158|11193687|FG001|NOT COMPLETED|Treatment Course 1||9
10067246|NCT02147158|11193688|FG002|NOT COMPLETED|Treatment Course 1||8
10067247|NCT02147158|11193689|FG003|NOT COMPLETED|Treatment Course 1||13
10067248|NCT02147158|11193690|FG004|NOT COMPLETED|Treatment Course 1||6
10067249|NCT02147158|11193691|FG005|NOT COMPLETED|Treatment Course 1||8
10067250|NCT02147158|11193686|FG000|STARTED|Off-Treatment Interval 1||51
10067251|NCT02147158|11193687|FG001|STARTED|Off-Treatment Interval 1||38
10067252|NCT02147158|11193688|FG002|STARTED|Off-Treatment Interval 1||99
10067253|NCT02147158|11193689|FG003|STARTED|Off-Treatment Interval 1||97
10067254|NCT02147158|11193690|FG004|STARTED|Off-Treatment Interval 1||49
10067255|NCT02147158|11193691|FG005|STARTED|Off-Treatment Interval 1||50
10067256|NCT02147158|11193686|FG000|COMPLETED|Off-Treatment Interval 1||41
10067257|NCT02147158|11193687|FG001|COMPLETED|Off-Treatment Interval 1||34
10067258|NCT02147158|11193688|FG002|COMPLETED|Off-Treatment Interval 1||84
10067259|NCT02147158|11193689|FG003|COMPLETED|Off-Treatment Interval 1||82
10067260|NCT02147158|11193690|FG004|COMPLETED|Off-Treatment Interval 1||41
10067261|NCT02147158|11193691|FG005|COMPLETED|Off-Treatment Interval 1||45
10067262|NCT02147158|11193686|FG000|NOT COMPLETED|Off-Treatment Interval 1||10
10067263|NCT02147158|11193687|FG001|NOT COMPLETED|Off-Treatment Interval 1||4
10067264|NCT02147158|11193688|FG002|NOT COMPLETED|Off-Treatment Interval 1||15
10067265|NCT02147158|11193689|FG003|NOT COMPLETED|Off-Treatment Interval 1||15
10067266|NCT02147158|11193690|FG004|NOT COMPLETED|Off-Treatment Interval 1||8
10067267|NCT02147158|11193691|FG005|NOT COMPLETED|Off-Treatment Interval 1||5
10067268|NCT02147158|11193686|FG000|STARTED|Treatment Course 2||41
10067269|NCT02147158|11193687|FG001|STARTED|Treatment Course 2||34
10067270|NCT02147158|11193688|FG002|STARTED|Treatment Course 2||84
10067271|NCT02147158|11193689|FG003|STARTED|Treatment Course 2||82
10067272|NCT02147158|11193690|FG004|STARTED|Treatment Course 2||41
10067273|NCT02147158|11193691|FG005|STARTED|Treatment Course 2||45
10067274|NCT02147158|11193686|FG000|COMPLETED|Treatment Course 2||40
10067275|NCT02147158|11193687|FG001|COMPLETED|Treatment Course 2||29
10067276|NCT02147158|11193688|FG002|COMPLETED|Treatment Course 2||79
10067277|NCT02147158|11193689|FG003|COMPLETED|Treatment Course 2||77
10067278|NCT02147158|11193690|FG004|COMPLETED|Treatment Course 2||41
10067279|NCT02147158|11193691|FG005|COMPLETED|Treatment Course 2||43
10067280|NCT02147158|11193686|FG000|NOT COMPLETED|Treatment Course 2||1
10067281|NCT02147158|11193687|FG001|NOT COMPLETED|Treatment Course 2||5
10067282|NCT02147158|11193688|FG002|NOT COMPLETED|Treatment Course 2||5
10067283|NCT02147158|11193689|FG003|NOT COMPLETED|Treatment Course 2||5
10067284|NCT02147158|11193690|FG004|NOT COMPLETED|Treatment Course 2||0
10067285|NCT02147158|11193691|FG005|NOT COMPLETED|Treatment Course 2||2
10067286|NCT02147158|11193686|FG000|STARTED|Off-Treatment Interval 2||40
10067287|NCT02147158|11193687|FG001|STARTED|Off-Treatment Interval 2||29
10067288|NCT02147158|11193688|FG002|STARTED|Off-Treatment Interval 2||79
10067289|NCT02147158|11193689|FG003|STARTED|Off-Treatment Interval 2||77
10067290|NCT02147158|11193690|FG004|STARTED|Off-Treatment Interval 2||41
10067291|NCT02147158|11193691|FG005|STARTED|Off-Treatment Interval 2||43
10067292|NCT02147158|11193686|FG000|COMPLETED|Off-Treatment Interval 2||36
10067293|NCT02147158|11193687|FG001|COMPLETED|Off-Treatment Interval 2||25
10067294|NCT02147158|11193688|FG002|COMPLETED|Off-Treatment Interval 2||69
10067295|NCT02147158|11193689|FG003|COMPLETED|Off-Treatment Interval 2||66
10067296|NCT02147158|11193690|FG004|COMPLETED|Off-Treatment Interval 2||39
10067297|NCT02147158|11193691|FG005|COMPLETED|Off-Treatment Interval 2||39
10067298|NCT02147158|11193686|FG000|NOT COMPLETED|Off-Treatment Interval 2||4
10067299|NCT02147158|11193687|FG001|NOT COMPLETED|Off-Treatment Interval 2||4
10067300|NCT02147158|11193688|FG002|NOT COMPLETED|Off-Treatment Interval 2||10
10067301|NCT02147158|11193689|FG003|NOT COMPLETED|Off-Treatment Interval 2||11
10067302|NCT02147158|11193690|FG004|NOT COMPLETED|Off-Treatment Interval 2||2
10067303|NCT02147158|11193691|FG005|NOT COMPLETED|Off-Treatment Interval 2||4
10067304|NCT02147197|11193711|FG000|STARTED|Overall Study||56
10067305|NCT02147197|11193712|FG001|STARTED|Overall Study||53
10067306|NCT02147197|11193713|FG002|STARTED|Overall Study||48
10067307|NCT02147197|11193711|FG000|COMPLETED|Overall Study||47
10067308|NCT02147197|11193712|FG001|COMPLETED|Overall Study||47
10067309|NCT02147197|11193713|FG002|COMPLETED|Overall Study||39
10067310|NCT02147197|11193711|FG000|NOT COMPLETED|Overall Study||9
10067311|NCT02147197|11193712|FG001|NOT COMPLETED|Overall Study||6
10067312|NCT02147197|11193713|FG002|NOT COMPLETED|Overall Study||9
10067313|NCT02147288|11193723|FG000|STARTED|Overall Study||22
10067314|NCT02147288|11193724|FG001|STARTED|Overall Study||24
10067315|NCT02147288|11193725|FG002|STARTED|Overall Study||0
10067316|NCT02147288|11193726|FG003|STARTED|Overall Study||0
10067317|NCT02147288|11193727|FG004|STARTED|Overall Study||0
10067318|NCT02147288|11193728|FG005|STARTED|Overall Study||0
10067319|NCT02147288|11193729|FG006|STARTED|Overall Study||0
10067320|NCT02147288|11193730|FG007|STARTED|Overall Study||0
10067321|NCT02147288|11193731|FG008|STARTED|Overall Study||0
10067322|NCT02147288|11193732|FG009|STARTED|Overall Study||0
10067323|NCT02147288|11193723|FG000|COMPLETED|Overall Study||21
10067324|NCT02147288|11193724|FG001|COMPLETED|Overall Study||22
10067325|NCT02147288|11193725|FG002|COMPLETED|Overall Study||0
10067326|NCT02147288|11193726|FG003|COMPLETED|Overall Study||0
10067327|NCT02147288|11193727|FG004|COMPLETED|Overall Study||0
10067328|NCT02147288|11193728|FG005|COMPLETED|Overall Study||0
10067329|NCT02147288|11193729|FG006|COMPLETED|Overall Study||0
10067330|NCT02147288|11193730|FG007|COMPLETED|Overall Study||0
10067331|NCT02147288|11193731|FG008|COMPLETED|Overall Study||0
10067332|NCT02147288|11193732|FG009|COMPLETED|Overall Study||0
10067333|NCT02147288|11193723|FG000|NOT COMPLETED|Overall Study||1
10067334|NCT02147288|11193724|FG001|NOT COMPLETED|Overall Study||2
10067335|NCT02147288|11193725|FG002|NOT COMPLETED|Overall Study||0
10067336|NCT02147288|11193726|FG003|NOT COMPLETED|Overall Study||0
10067337|NCT02147288|11193727|FG004|NOT COMPLETED|Overall Study||0
10067338|NCT02147288|11193728|FG005|NOT COMPLETED|Overall Study||0
10067339|NCT02147288|11193729|FG006|NOT COMPLETED|Overall Study||0
10067340|NCT02147288|11193730|FG007|NOT COMPLETED|Overall Study||0
10067341|NCT02147288|11193731|FG008|NOT COMPLETED|Overall Study||0
10067342|NCT02147288|11193732|FG009|NOT COMPLETED|Overall Study||0
10067343|NCT02147301|11193738|FG000|STARTED|Overall Study||17
10067344|NCT02147301|11193738|FG000|COMPLETED|Overall Study||17
10067345|NCT02147301|11193738|FG000|NOT COMPLETED|Overall Study||0
10067346|NCT02147353|11193744|FG000|STARTED|Overall Study||21
10067347|NCT02147353|11193745|FG001|STARTED|Overall Study||21
10067348|NCT02147353|11193744|FG000|COMPLETED|Overall Study||12
10067349|NCT02147353|11193745|FG001|COMPLETED|Overall Study||21
10067350|NCT02147353|11193744|FG000|NOT COMPLETED|Overall Study||9
10067351|NCT02147353|11193745|FG001|NOT COMPLETED|Overall Study||0
10067352|NCT02147522|11193753|FG000|STARTED|Overall Study||178
10067353|NCT02147522|11193754|FG001|STARTED|Overall Study||170
10067354|NCT02147522|11193753|FG000|COMPLETED|Overall Study||122
10067355|NCT02147522|11193754|FG001|COMPLETED|Overall Study||122
10067356|NCT02147522|11193753|FG000|NOT COMPLETED|Overall Study||56
10067357|NCT02147522|11193754|FG001|NOT COMPLETED|Overall Study||48
10067358|NCT02147561|11193760|FG000|STARTED|Overall Study||280
10067359|NCT02147561|11193760|FG000|COMPLETED|Overall Study||276
10067360|NCT02147561|11193760|FG000|NOT COMPLETED|Overall Study||4
10067361|NCT02147587|11193766|FG000|STARTED|Overall Study||57
10067362|NCT02147587|11193767|FG001|STARTED|Overall Study||55
10067363|NCT02147587|11193766|FG000|COMPLETED|Overall Study||46
10067364|NCT02147587|11193767|FG001|COMPLETED|Overall Study||50
10067365|NCT02147587|11193766|FG000|NOT COMPLETED|Overall Study||11
10067366|NCT02147587|11193767|FG001|NOT COMPLETED|Overall Study||5
10067367|NCT02147613|11193775|FG000|STARTED|Overall Study||10
10067368|NCT02147613|11193776|FG001|STARTED|Overall Study||9
10067369|NCT02147613|11193775|FG000|COMPLETED|Overall Study||9
10067370|NCT02147613|11193776|FG001|COMPLETED|Overall Study||6
10067371|NCT02147613|11193775|FG000|NOT COMPLETED|Overall Study||1
10067372|NCT02147613|11193776|FG001|NOT COMPLETED|Overall Study||3
10067373|NCT02147626|11193784|FG000|STARTED|Overall Study||75
10067374|NCT02147626|11193785|FG001|STARTED|Overall Study||76
10067375|NCT02147626|11193784|FG000|COMPLETED|Overall Study||70
10067376|NCT02147626|11193785|FG001|COMPLETED|Overall Study||69
10067377|NCT02147626|11193784|FG000|NOT COMPLETED|Overall Study||5
10067378|NCT02147626|11193785|FG001|NOT COMPLETED|Overall Study||7
10067379|NCT02147691|11193793|FG000|STARTED|Overall Study||10
10067380|NCT02147691|11193794|FG001|STARTED|Overall Study||12
10067381|NCT02147691|11193793|FG000|COMPLETED|Overall Study||6
10067382|NCT02147691|11193794|FG001|COMPLETED|Overall Study||11
10067383|NCT02147691|11193793|FG000|NOT COMPLETED|Overall Study||4
10067384|NCT02147691|11193794|FG001|NOT COMPLETED|Overall Study||1
10067385|NCT02147769|11193800|FG000|STARTED|Overall Study||111
10067386|NCT02147769|11193800|FG000|COMPLETED|Overall Study||111
10067387|NCT02147769|11193800|FG000|NOT COMPLETED|Overall Study||0
10067388|NCT02147899|11193807|FG000|STARTED|Overall Study||71
10067389|NCT02147899|11193808|FG001|STARTED|Overall Study||72
10067390|NCT02147899|11193809|FG002|STARTED|Overall Study||72
10067391|NCT02147899|11193807|FG000|COMPLETED|Overall Study||71
10067392|NCT02147899|11193808|FG001|COMPLETED|Overall Study||72
10067393|NCT02147899|11193809|FG002|COMPLETED|Overall Study||72
10067394|NCT02147899|11193807|FG000|NOT COMPLETED|Overall Study||0
10067395|NCT02147899|11193808|FG001|NOT COMPLETED|Overall Study||0
10067396|NCT02147899|11193809|FG002|NOT COMPLETED|Overall Study||0
10067397|NCT02147990|11193820|FG000|STARTED|Overall Study||154
10067398|NCT02147990|11193821|FG001|STARTED|Overall Study||100
10067399|NCT02147990|11193822|FG002|STARTED|Overall Study||63
10067400|NCT02147990|11193820|FG000|COMPLETED|Overall Study||154
10067401|NCT02147990|11193821|FG001|COMPLETED|Overall Study||100
10067402|NCT02147990|11193822|FG002|COMPLETED|Overall Study||63
10067403|NCT02147990|11193820|FG000|NOT COMPLETED|Overall Study||0
10067404|NCT02147990|11193821|FG001|NOT COMPLETED|Overall Study||0
10067405|NCT02147990|11193822|FG002|NOT COMPLETED|Overall Study||0
10067406|NCT02148107|11193834|FG000|STARTED|Overall Study||8
10067407|NCT02148107|11193835|FG001|STARTED|Overall Study||7
10067408|NCT02148107|11193836|FG002|STARTED|Overall Study||3
10067409|NCT02148107|11193834|FG000|COMPLETED|Overall Study||8
10067410|NCT02148107|11193835|FG001|COMPLETED|Overall Study||7
10067411|NCT02148107|11193836|FG002|COMPLETED|Overall Study||3
10067412|NCT02148107|11193834|FG000|NOT COMPLETED|Overall Study||0
10067413|NCT02148107|11193835|FG001|NOT COMPLETED|Overall Study||0
10067414|NCT02148107|11193836|FG002|NOT COMPLETED|Overall Study||0
10067415|NCT02148211|11193844|FG000|STARTED|Overall Study||507
10067416|NCT02148211|11193844|FG000|COMPLETED|Overall Study||155
10067417|NCT02148211|11193844|FG000|NOT COMPLETED|Overall Study||352
10067418|NCT02148250|11193848|FG000|STARTED|Screening||17
10067419|NCT02148250|11193849|FG001|STARTED|Screening||0
10067420|NCT02148250|11193848|FG000|COMPLETED|Screening||12
10067421|NCT02148250|11193849|FG001|COMPLETED|Screening||0
10067422|NCT02148250|11193848|FG000|NOT COMPLETED|Screening||5
10067423|NCT02148250|11193849|FG001|NOT COMPLETED|Screening||0
10067424|NCT02148250|11193848|FG000|STARTED|Period 1||6
10067425|NCT02148250|11193849|FG001|STARTED|Period 1||6
10067426|NCT02148250|11193848|FG000|COMPLETED|Period 1||6
10067427|NCT02148250|11193849|FG001|COMPLETED|Period 1||6
10067428|NCT02148250|11193848|FG000|NOT COMPLETED|Period 1||0
10067429|NCT02148250|11193849|FG001|NOT COMPLETED|Period 1||0
10067430|NCT02148250|11193848|FG000|STARTED|Period 2||6
10067431|NCT02148250|11193849|FG001|STARTED|Period 2||6
10067432|NCT02148250|11193848|FG000|COMPLETED|Period 2||6
10067433|NCT02148250|11193849|FG001|COMPLETED|Period 2||6
10067434|NCT02148250|11193848|FG000|NOT COMPLETED|Period 2||0
10067435|NCT02148250|11193849|FG001|NOT COMPLETED|Period 2||0
10067436|NCT02148302|11193858|FG000|STARTED|Overall Study||57
10067437|NCT02148302|11193859|FG001|STARTED|Overall Study||66
10067438|NCT02148302|11193858|FG000|COMPLETED|Overall Study||57
10067439|NCT02148302|11193859|FG001|COMPLETED|Overall Study||66
10067440|NCT02148302|11193858|FG000|NOT COMPLETED|Overall Study||0
10067441|NCT02148302|11193859|FG001|NOT COMPLETED|Overall Study||0
10067442|NCT02148445|11193867|FG000|STARTED|Overall Study||198
10067443|NCT02148445|11193868|FG001|STARTED|Overall Study||200
10067444|NCT02148445|11193867|FG000|COMPLETED|Overall Study||197
10067445|NCT02148445|11193868|FG001|COMPLETED|Overall Study||197
10067446|NCT02148445|11193867|FG000|NOT COMPLETED|Overall Study||1
10067447|NCT02148445|11193868|FG001|NOT COMPLETED|Overall Study||3
10067448|NCT02148523|11193879|FG000|STARTED|Overall Study||67
10067449|NCT02148523|11193880|FG001|STARTED|Overall Study||67
10067450|NCT02148523|11193881|FG002|STARTED|Overall Study||67
10067451|NCT02148523|11193879|FG000|COMPLETED|Overall Study||67
10067452|NCT02148523|11193880|FG001|COMPLETED|Overall Study||67
10067453|NCT02148523|11193881|FG002|COMPLETED|Overall Study||67
10067454|NCT02148523|11193879|FG000|NOT COMPLETED|Overall Study||0
10067455|NCT02148523|11193880|FG001|NOT COMPLETED|Overall Study||0
10067456|NCT02148523|11193881|FG002|NOT COMPLETED|Overall Study||0
10067457|NCT02148588|11193889|FG000|STARTED|Overall Study||8
10067458|NCT02148588|11193889|FG000|COMPLETED|Overall Study||8
10067459|NCT02148588|11193889|FG000|NOT COMPLETED|Overall Study||0
10067460|NCT02148718|11193893|FG000|STARTED|Overall Study||86
10067461|NCT02148718|11193893|FG000|COMPLETED|Overall Study||55
10067462|NCT02148718|11193893|FG000|NOT COMPLETED|Overall Study||31
10067463|NCT02148809|11193897|FG000|STARTED|Overall Study||14
10067464|NCT02148809|11193897|FG000|COMPLETED|Overall Study||14
10067465|NCT02148809|11193897|FG000|NOT COMPLETED|Overall Study||0
10067466|NCT02148835|11193904|FG000|STARTED|Overall Study||22
10067467|NCT02148835|11193905|FG001|STARTED|Overall Study||22
10067468|NCT02148835|11193904|FG000|COMPLETED|Overall Study||22
10067469|NCT02148835|11193905|FG001|COMPLETED|Overall Study||22
10067470|NCT02148835|11193904|FG000|NOT COMPLETED|Overall Study||0
10067471|NCT02148835|11193905|FG001|NOT COMPLETED|Overall Study||0
10067472|NCT02148874|11193913|FG000|STARTED|Overall Study||201
10067473|NCT02148874|11193914|FG001|STARTED|Overall Study||86
10067474|NCT02148874|11193913|FG000|COMPLETED|Overall Study||194
10067475|NCT02148874|11193914|FG001|COMPLETED|Overall Study||84
10067476|NCT02148874|11193913|FG000|NOT COMPLETED|Overall Study||7
10067477|NCT02148874|11193914|FG001|NOT COMPLETED|Overall Study||2
10067478|NCT02148952|11193922|FG000|STARTED|Assessing Eligibility and Consent||83166
10067479|NCT02148952|11193923|FG001|STARTED|Assessing Eligibility and Consent||80773
10067480|NCT02148952|11193922|FG000|COMPLETED|Assessing Eligibility and Consent||80063
10067481|NCT02148952|11193923|FG001|COMPLETED|Assessing Eligibility and Consent||77626
10067482|NCT02148952|11193922|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103
10067483|NCT02148952|11193923|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147
10067484|NCT02148952|11193922|FG000|STARTED|Follow-Up||80063
10067485|NCT02148952|11193923|FG001|STARTED|Follow-Up||77626
10067486|NCT02148952|11193922|FG000|COMPLETED|Follow-Up||79798
10067487|NCT02148952|11193923|FG001|COMPLETED|Follow-Up||77347
10067488|NCT02148952|11193922|FG000|NOT COMPLETED|Follow-Up||265
10067489|NCT02148952|11193923|FG001|NOT COMPLETED|Follow-Up||279
10067490|NCT02149108|11193939|FG000|STARTED|Overall Study|Randomised patients.|382
10067491|NCT02149108|11193940|FG001|STARTED|Overall Study|Randomised patients.|386
10067492|NCT02149108|11193939|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
10067493|NCT02149108|11193940|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
10067494|NCT02149108|11193939|FG000|NOT COMPLETED|Overall Study||380
10067495|NCT02149108|11193940|FG001|NOT COMPLETED|Overall Study||383
10067496|NCT02149173|11193946|FG000|STARTED|Overall Study||29
10067497|NCT02149173|11193946|FG000|COMPLETED|Overall Study||29
10067498|NCT02149173|11193946|FG000|NOT COMPLETED|Overall Study||0
10067499|NCT02149199|11193959|FG000|STARTED|Overall Study||1277
10067500|NCT02149199|11193960|FG001|STARTED|Overall Study||1277
10067501|NCT02149199|11193961|FG002|STARTED|Overall Study||1282
10067502|NCT02149199|11193959|FG000|COMPLETED|Overall Study||1144
10067503|NCT02149199|11193960|FG001|COMPLETED|Overall Study||1084
10067504|NCT02149199|11193961|FG002|COMPLETED|Overall Study||1135
10067505|NCT02149199|11193959|FG000|NOT COMPLETED|Overall Study||133
10067506|NCT02149199|11193960|FG001|NOT COMPLETED|Overall Study||193
10067507|NCT02149199|11193961|FG002|NOT COMPLETED|Overall Study||147
10067508|NCT02149264|11193969|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
10067509|NCT02149264|11193969|FG000|COMPLETED|Overall Study||139
10067510|NCT02149264|11193969|FG000|NOT COMPLETED|Overall Study||20
10067511|NCT02149290|11193973|FG000|STARTED|Overall Study||198
10067512|NCT02149290|11193973|FG000|COMPLETED|Overall Study||198
10067513|NCT02149290|11193973|FG000|NOT COMPLETED|Overall Study||0
10067514|NCT02149303|11193979|FG000|STARTED|Overall Study||191
10067515|NCT02149303|11193979|FG000|COMPLETED|Overall Study||191
10067516|NCT02149303|11193979|FG000|NOT COMPLETED|Overall Study||0
10067517|NCT02149342|11193983|FG000|STARTED|Overall Study|14 patients|14
10067518|NCT02149342|11193983|FG000|COMPLETED|Overall Study|14 patients|14
10067519|NCT02149342|11193983|FG000|NOT COMPLETED|Overall Study||0
10067520|NCT02149420|11193993|FG000|STARTED|Core Study||9
10067521|NCT02149420|11193994|FG001|STARTED|Core Study||6
10067522|NCT02149420|11193995|FG002|STARTED|Core Study||12
10067523|NCT02149420|11193993|FG000|Safety Analysis Set|Core Study||9
10067524|NCT02149420|11193994|FG001|Safety Analysis Set|Core Study||6
10067525|NCT02149420|11193995|FG002|Safety Analysis Set|Core Study||12
10067526|NCT02149420|11193993|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
10067527|NCT02149420|11193994|FG001|PK Analysis Set|Core Study||6
10067528|NCT02149420|11193995|FG002|PK Analysis Set|Core Study||12
10067529|NCT02149420|11193993|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9
10067530|NCT02149420|11193994|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6
10067531|NCT02149420|11193995|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12
10067532|NCT02149420|11193993|FG000|COMPLETED|Core Study||9
10067533|NCT02149420|11193994|FG001|COMPLETED|Core Study||5
10067534|NCT02149420|11193995|FG002|COMPLETED|Core Study||10
10067535|NCT02149420|11193993|FG000|NOT COMPLETED|Core Study||0
10188848|NCT03274518|11318393|FG000|STARTED|Washout Period||8
10188849|NCT03274518|11318394|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
10188850|NCT03274518|11318393|FG000|COMPLETED|Washout Period||8
10188851|NCT03274518|11318394|FG001|COMPLETED|Washout Period||8
10188852|NCT03274518|11318393|FG000|NOT COMPLETED|Washout Period||0
10188853|NCT03274518|11318394|FG001|NOT COMPLETED|Washout Period||0
10188854|NCT03274518|11318393|FG000|STARTED|Second Intervention||8
10188855|NCT03274518|11318394|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
10188856|NCT03274518|11318393|FG000|COMPLETED|Second Intervention||8
10188857|NCT03274518|11318394|FG001|COMPLETED|Second Intervention||8
10188858|NCT03274518|11318393|FG000|NOT COMPLETED|Second Intervention||0
10188859|NCT03274518|11318394|FG001|NOT COMPLETED|Second Intervention||0
10188860|NCT03274856|11318402|FG000|STARTED|Overall Study||10
10188861|NCT03274856|11318403|FG001|STARTED|Overall Study||9
10067536|NCT02149420|11193994|FG001|NOT COMPLETED|Core Study||1
10067537|NCT02149420|11193995|FG002|NOT COMPLETED|Core Study||2
10067538|NCT02149420|11193993|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
10067539|NCT02149420|11193994|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
10067540|NCT02149420|11193995|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
10067541|NCT02149420|11193993|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
10067542|NCT02149420|11193994|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10067543|NCT02149420|11193995|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10067544|NCT02149420|11193993|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
10067545|NCT02149420|11193994|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10067546|NCT02149420|11193995|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10067547|NCT02149524|11194010|FG000|STARTED|Overall Study||438
10067548|NCT02149524|11194011|FG001|STARTED|Overall Study||437
10067549|NCT02149524|11194010|FG000|COMPLETED|Overall Study||384
10067550|NCT02149524|11194011|FG001|COMPLETED|Overall Study||380
10067551|NCT02149524|11194010|FG000|NOT COMPLETED|Overall Study||54
10067552|NCT02149524|11194011|FG001|NOT COMPLETED|Overall Study||57
10067553|NCT02149810|11194019|FG000|STARTED|Overall Study||48
10067554|NCT02149810|11194020|FG001|STARTED|Overall Study||47
10067555|NCT02149810|11194019|FG000|Baseline|Overall Study||47
10067556|NCT02149810|11194020|FG001|Baseline|Overall Study||44
10067557|NCT02149810|11194019|FG000|Week 4|Overall Study||43
10067558|NCT02149810|11194020|FG001|Week 4|Overall Study||42
10067559|NCT02149810|11194019|FG000|Week 8|Overall Study||40
10067560|NCT02149810|11194020|FG001|Week 8|Overall Study||43
10067561|NCT02149810|11194019|FG000|Week 12|Overall Study||40
10067562|NCT02149810|11194020|FG001|Week 12|Overall Study||43
10067563|NCT02149810|11194019|FG000|Week 24|Overall Study||31
10067564|NCT02149810|11194020|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0
10067565|NCT02149810|11194019|FG000|COMPLETED|Overall Study||40
10067566|NCT02149810|11194020|FG001|COMPLETED|Overall Study||43
10067567|NCT02149810|11194019|FG000|NOT COMPLETED|Overall Study||8
10067568|NCT02149810|11194020|FG001|NOT COMPLETED|Overall Study||4
10067569|NCT02149836|11194026|FG000|STARTED|Overall Study||18
10067570|NCT02149836|11194026|FG000|COMPLETED|Overall Study||17
10067571|NCT02149836|11194026|FG000|NOT COMPLETED|Overall Study||1
10067572|NCT02149875|11194033|FG000|STARTED|Overall Study||27
10067573|NCT02149875|11194034|FG001|STARTED|Overall Study||28
10067574|NCT02149875|11194035|FG002|STARTED|Overall Study||29
10067575|NCT02149875|11194033|FG000|COMPLETED|Overall Study||20
10067576|NCT02149875|11194034|FG001|COMPLETED|Overall Study||20
10067577|NCT02149875|11194035|FG002|COMPLETED|Overall Study||20
10067578|NCT02149875|11194033|FG000|NOT COMPLETED|Overall Study||7
10067579|NCT02149875|11194034|FG001|NOT COMPLETED|Overall Study||8
10067580|NCT02149875|11194035|FG002|NOT COMPLETED|Overall Study||9
10067581|NCT02150044|11194043|FG000|STARTED|Overall Study||29
10067582|NCT02150044|11194043|FG000|Lead-In Subjects|Overall Study||16
10067583|NCT02150044|11194043|FG000|Study Cohort|Overall Study||13
10067584|NCT02150044|11194043|FG000|COMPLETED|Overall Study||29
10067585|NCT02150044|11194043|FG000|NOT COMPLETED|Overall Study||0
10067586|NCT02150057|11194049|FG000|STARTED|Overall Study||25
10067587|NCT02150057|11194050|FG001|STARTED|Overall Study||26
10067588|NCT02150057|11194049|FG000|COMPLETED|Overall Study||19
10067589|NCT02150057|11194050|FG001|COMPLETED|Overall Study||22
10067590|NCT02150057|11194049|FG000|NOT COMPLETED|Overall Study||6
10067591|NCT02150057|11194050|FG001|NOT COMPLETED|Overall Study||4
10067592|NCT02150109|11194056|FG000|STARTED|Overall Study||372
10067593|NCT02150109|11194056|FG000|COMPLETED|Overall Study||372
10067594|NCT02150109|11194056|FG000|NOT COMPLETED|Overall Study||0
10067595|NCT02150213|11194066|FG000|STARTED|Overall Study||59
10067596|NCT02150213|11194066|FG000|COMPLETED|Overall Study||57
10067597|NCT02150213|11194066|FG000|NOT COMPLETED|Overall Study||2
10067598|NCT02150343|11194074|FG000|STARTED|Overall Study||180
10067599|NCT02150343|11194075|FG001|STARTED|Overall Study||178
10067600|NCT02150343|11194076|FG002|STARTED|Overall Study||178
10067601|NCT02150343|11194077|FG003|STARTED|Overall Study||178
10067602|NCT02150343|11194074|FG000|COMPLETED|Overall Study||159
10067603|NCT02150343|11194075|FG001|COMPLETED|Overall Study||158
10067604|NCT02150343|11194076|FG002|COMPLETED|Overall Study||166
10067605|NCT02150343|11194077|FG003|COMPLETED|Overall Study||168
10067606|NCT02150343|11194074|FG000|NOT COMPLETED|Overall Study||21
10067607|NCT02150343|11194075|FG001|NOT COMPLETED|Overall Study||20
10067608|NCT02150343|11194076|FG002|NOT COMPLETED|Overall Study||12
10067609|NCT02150343|11194077|FG003|NOT COMPLETED|Overall Study||10
10067610|NCT02150460|11194089|FG000|STARTED|Overall Study||50
10067611|NCT02150460|11194090|FG001|STARTED|Overall Study||50
10067612|NCT02150460|11194089|FG000|COMPLETED|Overall Study||50
10067613|NCT02150460|11194090|FG001|COMPLETED|Overall Study||50
10067614|NCT02150460|11194089|FG000|NOT COMPLETED|Overall Study||0
10067615|NCT02150460|11194090|FG001|NOT COMPLETED|Overall Study||0
10067616|NCT02150499|11194098|FG000|STARTED|Overall Study||9
10067617|NCT02150499|11194099|FG001|STARTED|Overall Study||9
10067618|NCT02150499|11194098|FG000|COMPLETED|Overall Study||9
10067619|NCT02150499|11194099|FG001|COMPLETED|Overall Study||9
10067620|NCT02150499|11194098|FG000|NOT COMPLETED|Overall Study||0
10067621|NCT02150499|11194099|FG001|NOT COMPLETED|Overall Study||0
10067622|NCT02150759|11194107|FG000|STARTED|Overall Study||23
10067623|NCT02150759|11194108|FG001|STARTED|Overall Study||23
10067624|NCT02150759|11194107|FG000|COMPLETED|Overall Study||22
10067625|NCT02150759|11194108|FG001|COMPLETED|Overall Study||21
10067626|NCT02150759|11194107|FG000|NOT COMPLETED|Overall Study||1
10067627|NCT02150759|11194108|FG001|NOT COMPLETED|Overall Study||2
10067628|NCT02150837|11194116|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
10067629|NCT02150837|11194117|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
10067630|NCT02150837|11194116|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
10067631|NCT02150837|11194117|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
10067632|NCT02150837|11194116|FG000|NOT COMPLETED|Overall Study||25
10067633|NCT02150837|11194117|FG001|NOT COMPLETED|Overall Study||125
10067634|NCT02150954|11194125|FG000|STARTED|Overall Study||58
10067635|NCT02150954|11194126|FG001|STARTED|Overall Study||59
10067636|NCT02150954|11194125|FG000|COMPLETED|Overall Study||57
10067637|NCT02150954|11194126|FG001|COMPLETED|Overall Study||59
10067638|NCT02150954|11194125|FG000|NOT COMPLETED|Overall Study||1
10067639|NCT02150954|11194126|FG001|NOT COMPLETED|Overall Study||0
10067640|NCT02151058|11194135|FG000|STARTED|Overall Study||45
10067641|NCT02151058|11194136|FG001|STARTED|Overall Study||91
10067642|NCT02151058|11194137|FG002|STARTED|Overall Study||91
10067643|NCT02151058|11194135|FG000|COMPLETED|Overall Study||43
10067644|NCT02151058|11194136|FG001|COMPLETED|Overall Study||90
10067645|NCT02151058|11194137|FG002|COMPLETED|Overall Study||86
10067646|NCT02151058|11194135|FG000|NOT COMPLETED|Overall Study||2
10067647|NCT02151058|11194136|FG001|NOT COMPLETED|Overall Study||1
10067648|NCT02151058|11194137|FG002|NOT COMPLETED|Overall Study||5
10067649|NCT02151110|11194153|FG000|STARTED|Overall Study||12
10067650|NCT02151110|11194154|FG001|STARTED|Overall Study||2
10067651|NCT02151110|11194155|FG002|STARTED|Overall Study||2
10067652|NCT02151110|11194156|FG003|STARTED|Overall Study||8
10067653|NCT02151110|11194157|FG004|STARTED|Overall Study||8
10067654|NCT02151110|11194158|FG005|STARTED|Overall Study||8
10067655|NCT02151110|11194159|FG006|STARTED|Overall Study||8
10067656|NCT02151110|11194160|FG007|STARTED|Overall Study||8
10067657|NCT02151110|11194153|FG000|COMPLETED|Overall Study||12
10067658|NCT02151110|11194154|FG001|COMPLETED|Overall Study||2
10067659|NCT02151110|11194155|FG002|COMPLETED|Overall Study||2
10067660|NCT02151110|11194156|FG003|COMPLETED|Overall Study||8
10067661|NCT02151110|11194157|FG004|COMPLETED|Overall Study||8
10067662|NCT02151110|11194158|FG005|COMPLETED|Overall Study||8
10067663|NCT02151110|11194159|FG006|COMPLETED|Overall Study||8
10067664|NCT02151110|11194160|FG007|COMPLETED|Overall Study||5
10067665|NCT02151110|11194153|FG000|NOT COMPLETED|Overall Study||0
10188862|NCT03274856|11318402|FG000|COMPLETED|Overall Study||10
10188863|NCT03274856|11318403|FG001|COMPLETED|Overall Study||9
10188864|NCT03274856|11318402|FG000|NOT COMPLETED|Overall Study||0
10188865|NCT03274856|11318403|FG001|NOT COMPLETED|Overall Study||0
10067666|NCT02151110|11194154|FG001|NOT COMPLETED|Overall Study||0
10067667|NCT02151110|11194155|FG002|NOT COMPLETED|Overall Study||0
10067668|NCT02151110|11194156|FG003|NOT COMPLETED|Overall Study||0
10067669|NCT02151110|11194157|FG004|NOT COMPLETED|Overall Study||0
10067670|NCT02151110|11194158|FG005|NOT COMPLETED|Overall Study||0
10067671|NCT02151110|11194159|FG006|NOT COMPLETED|Overall Study||0
10067672|NCT02151110|11194160|FG007|NOT COMPLETED|Overall Study||3
10067673|NCT02151149|11194187|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71
10067674|NCT02151149|11194188|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72
10067675|NCT02151149|11194187|FG000|Treated Population|Treatment Period||68
10067676|NCT02151149|11194188|FG001|Treated Population|Treatment Period||70
10067677|NCT02151149|11194187|FG000|COMPLETED|Treatment Period||1
10067678|NCT02151149|11194188|FG001|COMPLETED|Treatment Period||1
10067679|NCT02151149|11194187|FG000|NOT COMPLETED|Treatment Period||70
10067680|NCT02151149|11194188|FG001|NOT COMPLETED|Treatment Period||71
10067681|NCT02151149|11194187|FG000|STARTED|Follow-Up Period||58
10067682|NCT02151149|11194188|FG001|STARTED|Follow-Up Period||55
10067683|NCT02151149|11194187|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
10067684|NCT02151149|11194188|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
10067685|NCT02151149|11194187|FG000|NOT COMPLETED|Follow-Up Period||39
10067686|NCT02151149|11194188|FG001|NOT COMPLETED|Follow-Up Period||37
10067687|NCT02151253|11194194|FG000|STARTED|Overall Study||13
10067688|NCT02151253|11194195|FG001|STARTED|Overall Study||15
10067689|NCT02151253|11194194|FG000|COMPLETED|Overall Study||13
10067690|NCT02151253|11194195|FG001|COMPLETED|Overall Study||15
10067691|NCT02151253|11194194|FG000|NOT COMPLETED|Overall Study||0
10067692|NCT02151253|11194195|FG001|NOT COMPLETED|Overall Study||0
10067693|NCT02151266|11194204|FG000|STARTED|Overall Study||19
10067694|NCT02151266|11194205|FG001|STARTED|Overall Study||29
10067695|NCT02151266|11194206|FG002|STARTED|Overall Study||21
10067696|NCT02151266|11194204|FG000|COMPLETED|Overall Study||11
10067697|NCT02151266|11194205|FG001|COMPLETED|Overall Study||14
10067698|NCT02151266|11194206|FG002|COMPLETED|Overall Study||14
10067699|NCT02151266|11194204|FG000|NOT COMPLETED|Overall Study||8
10067700|NCT02151266|11194205|FG001|NOT COMPLETED|Overall Study||15
10067701|NCT02151266|11194206|FG002|NOT COMPLETED|Overall Study||7
10067702|NCT02151331|11194216|FG000|STARTED|Overall Study||77
10067703|NCT02151331|11194217|FG001|STARTED|Overall Study||92
10067704|NCT02151331|11194216|FG000|COMPLETED|Overall Study||45
10067705|NCT02151331|11194217|FG001|COMPLETED|Overall Study||52
10067706|NCT02151331|11194216|FG000|NOT COMPLETED|Overall Study||32
10067707|NCT02151331|11194217|FG001|NOT COMPLETED|Overall Study||40
10067708|NCT02151448|11194223|FG000|STARTED|Phase 1||9
10067709|NCT02151448|11194223|FG000|COMPLETED|Phase 1||9
10067710|NCT02151448|11194223|FG000|NOT COMPLETED|Phase 1||0
10067711|NCT02151448|11194223|FG000|STARTED|Phase 2||55
10067712|NCT02151448|11194223|FG000|COMPLETED|Phase 2||55
10067713|NCT02151448|11194223|FG000|NOT COMPLETED|Phase 2||0
10067714|NCT02151461|11194235|FG000|STARTED|Overall Study||24
10067715|NCT02151461|11194236|FG001|STARTED|Overall Study||25
10067716|NCT02151461|11194237|FG002|STARTED|Overall Study||24
10067717|NCT02151461|11194238|FG003|STARTED|Overall Study||23
10067718|NCT02151461|11194235|FG000|COMPLETED|Overall Study||18
10067719|NCT02151461|11194236|FG001|COMPLETED|Overall Study||24
10067720|NCT02151461|11194237|FG002|COMPLETED|Overall Study||21
10067721|NCT02151461|11194238|FG003|COMPLETED|Overall Study||19
10067722|NCT02151461|11194235|FG000|NOT COMPLETED|Overall Study||6
10067723|NCT02151461|11194236|FG001|NOT COMPLETED|Overall Study||1
10067724|NCT02151461|11194237|FG002|NOT COMPLETED|Overall Study||3
10067725|NCT02151461|11194238|FG003|NOT COMPLETED|Overall Study||4
10067726|NCT02151487|11194252|FG000|STARTED|Overall Study||27
10067727|NCT02151487|11194253|FG001|STARTED|Overall Study||27
10067728|NCT02151487|11194254|FG002|STARTED|Overall Study||20
10067729|NCT02151487|11194255|FG003|STARTED|Overall Study||23
10067730|NCT02151487|11194252|FG000|COMPLETED|Overall Study||25
10067731|NCT02151487|11194253|FG001|COMPLETED|Overall Study||22
10067732|NCT02151487|11194254|FG002|COMPLETED|Overall Study||16
10067733|NCT02151487|11194255|FG003|COMPLETED|Overall Study||20
10067734|NCT02151487|11194252|FG000|NOT COMPLETED|Overall Study||2
10067735|NCT02151487|11194253|FG001|NOT COMPLETED|Overall Study||5
10067736|NCT02151487|11194254|FG002|NOT COMPLETED|Overall Study||4
10067737|NCT02151487|11194255|FG003|NOT COMPLETED|Overall Study||3
10067738|NCT02151591|11194267|FG000|STARTED|Overall Study||13
10067739|NCT02151591|11194268|FG001|STARTED|Overall Study||13
10067740|NCT02151591|11194267|FG000|COMPLETED|Overall Study||7
10067741|NCT02151591|11194268|FG001|COMPLETED|Overall Study||10
10067742|NCT02151591|11194267|FG000|NOT COMPLETED|Overall Study||6
10067743|NCT02151591|11194268|FG001|NOT COMPLETED|Overall Study||3
10067744|NCT02151643|11194279|FG000|STARTED|Overall Study||26
10067745|NCT02151643|11194280|FG001|STARTED|Overall Study||25
10067746|NCT02151643|11194281|FG002|STARTED|Overall Study||25
10067747|NCT02151643|11194282|FG003|STARTED|Overall Study||39
10067748|NCT02151643|11194283|FG004|STARTED|Overall Study||38
10067749|NCT02151643|11194279|FG000|COMPLETED|Overall Study||20
10067750|NCT02151643|11194280|FG001|COMPLETED|Overall Study||21
10067751|NCT02151643|11194281|FG002|COMPLETED|Overall Study||21
10067752|NCT02151643|11194282|FG003|COMPLETED|Overall Study||32
10067753|NCT02151643|11194283|FG004|COMPLETED|Overall Study||35
10067754|NCT02151643|11194279|FG000|NOT COMPLETED|Overall Study||6
10067755|NCT02151643|11194280|FG001|NOT COMPLETED|Overall Study||4
10067756|NCT02151643|11194281|FG002|NOT COMPLETED|Overall Study||4
10067757|NCT02151643|11194282|FG003|NOT COMPLETED|Overall Study||7
10067758|NCT02151643|11194283|FG004|NOT COMPLETED|Overall Study||3
10067759|NCT02151682|11194297|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
10067760|NCT02151682|11194298|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
10067761|NCT02151682|11194299|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10067762|NCT02151682|11194300|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10067763|NCT02151682|11194301|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10067764|NCT02151682|11194302|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10067765|NCT02151682|11194297|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
10067766|NCT02151682|11194298|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
10067767|NCT02151682|11194299|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067768|NCT02151682|11194300|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067769|NCT02151682|11194301|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067770|NCT02151682|11194302|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067771|NCT02151682|11194297|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
10067772|NCT02151682|11194298|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
10067773|NCT02151682|11194299|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067774|NCT02151682|11194300|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067775|NCT02151682|11194301|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067776|NCT02151682|11194302|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10067777|NCT02151682|11194297|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
10067778|NCT02151682|11194298|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
10067779|NCT02151682|11194299|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
10067780|NCT02151682|11194300|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
10067781|NCT02151682|11194301|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
10067782|NCT02151682|11194302|FG005|STARTED|Part 2: Tapent. Extension or Observation||0
10067783|NCT02151682|11194297|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0
10067784|NCT02151682|11194298|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0
10067785|NCT02151682|11194299|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
10067786|NCT02151682|11194300|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14
10067787|NCT02151682|11194301|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14
10067788|NCT02151682|11194302|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0
10067789|NCT02151682|11194297|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10067790|NCT02151682|11194298|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10067791|NCT02151682|11194299|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
10067792|NCT02151682|11194300|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
10067793|NCT02151682|11194301|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10067794|NCT02151682|11194302|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10067795|NCT02151682|11194297|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
10067796|NCT02151682|11194298|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
10067797|NCT02151682|11194299|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
10067798|NCT02151682|11194300|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
10067799|NCT02151682|11194301|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
10067800|NCT02151682|11194302|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
10067801|NCT02151682|11194297|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067802|NCT02151682|11194298|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067803|NCT02151682|11194299|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067804|NCT02151682|11194300|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067805|NCT02151682|11194301|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067806|NCT02151682|11194302|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
10067807|NCT02151682|11194297|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067808|NCT02151682|11194298|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067809|NCT02151682|11194299|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067810|NCT02151682|11194300|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067811|NCT02151682|11194301|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10067812|NCT02151682|11194302|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
10067813|NCT02151773|11194320|FG000|STARTED|Overall Study||3493
10067814|NCT02151773|11194320|FG000|COMPLETED|Overall Study||3429
10067815|NCT02151773|11194320|FG000|NOT COMPLETED|Overall Study||64
10067816|NCT02151786|11194324|FG000|STARTED|Overall Study||1120
10067817|NCT02151786|11194324|FG000|COMPLETED|Overall Study||1084
10067818|NCT02151786|11194324|FG000|NOT COMPLETED|Overall Study||36
10067819|NCT02151851|11194330|FG000|STARTED|Overall Study||114
10067820|NCT02151851|11194331|FG001|STARTED|Overall Study||316
10067821|NCT02151851|11194330|FG000|Included in the Safety Set|Overall Study||113
10067822|NCT02151851|11194331|FG001|Included in the Safety Set|Overall Study||316
10067823|NCT02151851|11194330|FG000|COMPLETED|Overall Study||38
10067824|NCT02151851|11194331|FG001|COMPLETED|Overall Study||186
10067825|NCT02151851|11194330|FG000|NOT COMPLETED|Overall Study||76
10067826|NCT02151851|11194331|FG001|NOT COMPLETED|Overall Study||130
10067827|NCT02151877|11194339|FG000|STARTED|Overall Study||12
10067828|NCT02151877|11194340|FG001|STARTED|Overall Study||12
10067829|NCT02151877|11194339|FG000|COMPLETED|Overall Study||12
10067830|NCT02151877|11194340|FG001|COMPLETED|Overall Study||12
10067831|NCT02151877|11194339|FG000|NOT COMPLETED|Overall Study||0
10067832|NCT02151877|11194340|FG001|NOT COMPLETED|Overall Study||0
10067833|NCT02151903|11194350|FG000|STARTED|Overall Study||3
10067834|NCT02151903|11194351|FG001|STARTED|Overall Study||2
10067835|NCT02151903|11194350|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10067836|NCT02151903|11194351|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
10067837|NCT02151903|11194350|FG000|COMPLETED|Overall Study||0
10067838|NCT02151903|11194351|FG001|COMPLETED|Overall Study||1
10067839|NCT02151903|11194350|FG000|NOT COMPLETED|Overall Study||3
10067840|NCT02151903|11194351|FG001|NOT COMPLETED|Overall Study||1
10067841|NCT02151994|11194360|FG000|STARTED|Single Ascending Dose (SAD)||18
10067842|NCT02151994|11194361|FG001|STARTED|Single Ascending Dose (SAD)||6
10067843|NCT02151994|11194362|FG002|STARTED|Single Ascending Dose (SAD)||6
10067844|NCT02151994|11194363|FG003|STARTED|Single Ascending Dose (SAD)||6
10067845|NCT02151994|11194364|FG004|STARTED|Single Ascending Dose (SAD)||6
10067846|NCT02151994|11194365|FG005|STARTED|Single Ascending Dose (SAD)||6
10067847|NCT02151994|11194366|FG006|STARTED|Single Ascending Dose (SAD)||6
10067848|NCT02151994|11194367|FG007|STARTED|Single Ascending Dose (SAD)||6
10067849|NCT02151994|11194368|FG008|STARTED|Single Ascending Dose (SAD)||0
10067850|NCT02151994|11194369|FG009|STARTED|Single Ascending Dose (SAD)||6
10067851|NCT02151994|11194370|FG010|STARTED|Single Ascending Dose (SAD)||6
10067852|NCT02151994|11194371|FG011|STARTED|Single Ascending Dose (SAD)||0
10067853|NCT02151994|11194372|FG012|STARTED|Single Ascending Dose (SAD)||0
10067854|NCT02151994|11194360|FG000|COMPLETED|Single Ascending Dose (SAD)||18
10067855|NCT02151994|11194361|FG001|COMPLETED|Single Ascending Dose (SAD)||6
10067856|NCT02151994|11194362|FG002|COMPLETED|Single Ascending Dose (SAD)||6
10067857|NCT02151994|11194363|FG003|COMPLETED|Single Ascending Dose (SAD)||6
10067858|NCT02151994|11194364|FG004|COMPLETED|Single Ascending Dose (SAD)||6
10067859|NCT02151994|11194365|FG005|COMPLETED|Single Ascending Dose (SAD)||6
10067860|NCT02151994|11194366|FG006|COMPLETED|Single Ascending Dose (SAD)||6
10067861|NCT02151994|11194367|FG007|COMPLETED|Single Ascending Dose (SAD)||6
10067862|NCT02151994|11194368|FG008|COMPLETED|Single Ascending Dose (SAD)||0
10067863|NCT02151994|11194369|FG009|COMPLETED|Single Ascending Dose (SAD)||6
10067864|NCT02151994|11194370|FG010|COMPLETED|Single Ascending Dose (SAD)||6
10067865|NCT02151994|11194371|FG011|COMPLETED|Single Ascending Dose (SAD)||0
10067866|NCT02151994|11194372|FG012|COMPLETED|Single Ascending Dose (SAD)||0
10067867|NCT02151994|11194360|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067868|NCT02151994|11194361|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067869|NCT02151994|11194362|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
10188866|NCT03274986|11318413|FG000|STARTED|Overall Study||107
10188867|NCT03274986|11318414|FG001|STARTED|Overall Study||113
10188868|NCT03274986|11318413|FG000|Successful Implantation, as Treated|Overall Study||107
10188869|NCT03274986|11318414|FG001|Successful Implantation, as Treated|Overall Study||113
10188870|NCT03274986|11318413|FG000|COMPLETED|Overall Study||107
10188871|NCT03274986|11318414|FG001|COMPLETED|Overall Study||111
10188872|NCT03274986|11318413|FG000|NOT COMPLETED|Overall Study||0
10188873|NCT03274986|11318414|FG001|NOT COMPLETED|Overall Study||2
10188874|NCT03274999|11318427|FG000|STARTED|First Intervention (Day 0)||5
10188875|NCT03274999|11318428|FG001|STARTED|First Intervention (Day 0)||5
10188876|NCT03274999|11318427|FG000|COMPLETED|First Intervention (Day 0)||5
10188877|NCT03274999|11318428|FG001|COMPLETED|First Intervention (Day 0)||5
10188878|NCT03274999|11318427|FG000|NOT COMPLETED|First Intervention (Day 0)||0
10188879|NCT03274999|11318428|FG001|NOT COMPLETED|First Intervention (Day 0)||0
10188880|NCT03274999|11318427|FG000|STARTED|Second Intervention (Day 14)||5
10188881|NCT03274999|11318428|FG001|STARTED|Second Intervention (Day 14)||5
10188882|NCT03274999|11318427|FG000|COMPLETED|Second Intervention (Day 14)||5
10188883|NCT03274999|11318428|FG001|COMPLETED|Second Intervention (Day 14)||5
10188884|NCT03274999|11318427|FG000|NOT COMPLETED|Second Intervention (Day 14)||0
10188885|NCT03274999|11318428|FG001|NOT COMPLETED|Second Intervention (Day 14)||0
10188886|NCT03275246|11318434|FG000|STARTED|Overall Study||8
10188887|NCT03275246|11318434|FG000|COMPLETED|Overall Study||2
10188888|NCT03275246|11318434|FG000|NOT COMPLETED|Overall Study||6
10188889|NCT03275389|11318448|FG000|STARTED|Overall Study||45
10188890|NCT03275389|11318449|FG001|STARTED|Overall Study||46
10188891|NCT03275389|11318450|FG002|STARTED|Overall Study||47
10188892|NCT03275389|11318451|FG003|STARTED|Overall Study||47
10188893|NCT03275389|11318452|FG004|STARTED|Overall Study||48
10188894|NCT03275389|11318453|FG005|STARTED|Overall Study||47
10067870|NCT02151994|11194363|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067871|NCT02151994|11194364|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067872|NCT02151994|11194365|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067873|NCT02151994|11194366|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067874|NCT02151994|11194367|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0
10188895|NCT03275389|11318454|FG006|STARTED|Overall Study||47
10188896|NCT03275389|11318455|FG007|STARTED|Overall Study||48
10067875|NCT02151994|11194368|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067876|NCT02151994|11194369|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067877|NCT02151994|11194370|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067878|NCT02151994|11194371|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067879|NCT02151994|11194372|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0
10067880|NCT02151994|11194360|FG000|STARTED|Multiple Ascending Dose (MAD)||10
10067881|NCT02151994|11194361|FG001|STARTED|Multiple Ascending Dose (MAD)||0
10067882|NCT02151994|11194362|FG002|STARTED|Multiple Ascending Dose (MAD)||0
10067883|NCT02151994|11194363|FG003|STARTED|Multiple Ascending Dose (MAD)||6
10067884|NCT02151994|11194364|FG004|STARTED|Multiple Ascending Dose (MAD)||6
10067885|NCT02151994|11194365|FG005|STARTED|Multiple Ascending Dose (MAD)||6
10067886|NCT02151994|11194366|FG006|STARTED|Multiple Ascending Dose (MAD)||6
10067887|NCT02151994|11194367|FG007|STARTED|Multiple Ascending Dose (MAD)||0
10067888|NCT02151994|11194368|FG008|STARTED|Multiple Ascending Dose (MAD)||6
10067889|NCT02151994|11194369|FG009|STARTED|Multiple Ascending Dose (MAD)||0
10067890|NCT02151994|11194370|FG010|STARTED|Multiple Ascending Dose (MAD)||0
10067891|NCT02151994|11194371|FG011|STARTED|Multiple Ascending Dose (MAD)||0
10067892|NCT02151994|11194372|FG012|STARTED|Multiple Ascending Dose (MAD)||0
10067893|NCT02151994|11194360|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10
10067894|NCT02151994|11194361|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
10067895|NCT02151994|11194362|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0
10067896|NCT02151994|11194363|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6
10067897|NCT02151994|11194364|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6
10067898|NCT02151994|11194365|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6
10067899|NCT02151994|11194366|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6
10067900|NCT02151994|11194367|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0
10067901|NCT02151994|11194368|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6
10067902|NCT02151994|11194369|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0
10067903|NCT02151994|11194370|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0
10067904|NCT02151994|11194371|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0
10067905|NCT02151994|11194372|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0
10067906|NCT02151994|11194360|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067907|NCT02151994|11194361|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067908|NCT02151994|11194362|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067909|NCT02151994|11194363|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067910|NCT02151994|11194364|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067911|NCT02151994|11194365|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067912|NCT02151994|11194366|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067913|NCT02151994|11194367|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067914|NCT02151994|11194368|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067915|NCT02151994|11194369|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067916|NCT02151994|11194370|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067917|NCT02151994|11194371|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067918|NCT02151994|11194372|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10067919|NCT02151994|11194360|FG000|STARTED|Food Effect (FE): Fasted||0
10067920|NCT02151994|11194361|FG001|STARTED|Food Effect (FE): Fasted||0
10067921|NCT02151994|11194362|FG002|STARTED|Food Effect (FE): Fasted||0
10067922|NCT02151994|11194363|FG003|STARTED|Food Effect (FE): Fasted||0
10067923|NCT02151994|11194364|FG004|STARTED|Food Effect (FE): Fasted||0
10067924|NCT02151994|11194365|FG005|STARTED|Food Effect (FE): Fasted||0
10067925|NCT02151994|11194366|FG006|STARTED|Food Effect (FE): Fasted||0
10067926|NCT02151994|11194367|FG007|STARTED|Food Effect (FE): Fasted||0
10067927|NCT02151994|11194368|FG008|STARTED|Food Effect (FE): Fasted||0
10067928|NCT02151994|11194369|FG009|STARTED|Food Effect (FE): Fasted||0
10067929|NCT02151994|11194370|FG010|STARTED|Food Effect (FE): Fasted||0
10067930|NCT02151994|11194371|FG011|STARTED|Food Effect (FE): Fasted||12
10067931|NCT02151994|11194372|FG012|STARTED|Food Effect (FE): Fasted||0
10067932|NCT02151994|11194360|FG000|COMPLETED|Food Effect (FE): Fasted||0
10067933|NCT02151994|11194361|FG001|COMPLETED|Food Effect (FE): Fasted||0
10067934|NCT02151994|11194362|FG002|COMPLETED|Food Effect (FE): Fasted||0
10067935|NCT02151994|11194363|FG003|COMPLETED|Food Effect (FE): Fasted||0
10067936|NCT02151994|11194364|FG004|COMPLETED|Food Effect (FE): Fasted||0
10067937|NCT02151994|11194365|FG005|COMPLETED|Food Effect (FE): Fasted||0
10067938|NCT02151994|11194366|FG006|COMPLETED|Food Effect (FE): Fasted||0
10067939|NCT02151994|11194367|FG007|COMPLETED|Food Effect (FE): Fasted||0
10067940|NCT02151994|11194368|FG008|COMPLETED|Food Effect (FE): Fasted||0
10067941|NCT02151994|11194369|FG009|COMPLETED|Food Effect (FE): Fasted||0
10067942|NCT02151994|11194370|FG010|COMPLETED|Food Effect (FE): Fasted||0
10067943|NCT02151994|11194371|FG011|COMPLETED|Food Effect (FE): Fasted||12
10067944|NCT02151994|11194372|FG012|COMPLETED|Food Effect (FE): Fasted||0
10067945|NCT02151994|11194360|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0
10067946|NCT02151994|11194361|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0
10067947|NCT02151994|11194362|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0
10067948|NCT02151994|11194363|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0
10067949|NCT02151994|11194364|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0
10067950|NCT02151994|11194365|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0
10067951|NCT02151994|11194366|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0
10067952|NCT02151994|11194367|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0
10067953|NCT02151994|11194368|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0
10067954|NCT02151994|11194369|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0
10067955|NCT02151994|11194370|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0
10067956|NCT02151994|11194371|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0
10067957|NCT02151994|11194372|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0
10067958|NCT02151994|11194360|FG000|STARTED|Food Effect (FE): Fed||0
10067959|NCT02151994|11194361|FG001|STARTED|Food Effect (FE): Fed||0
10067960|NCT02151994|11194362|FG002|STARTED|Food Effect (FE): Fed||0
10067961|NCT02151994|11194363|FG003|STARTED|Food Effect (FE): Fed||0
10067962|NCT02151994|11194364|FG004|STARTED|Food Effect (FE): Fed||0
10067963|NCT02151994|11194365|FG005|STARTED|Food Effect (FE): Fed||0
10067964|NCT02151994|11194366|FG006|STARTED|Food Effect (FE): Fed||0
10067965|NCT02151994|11194367|FG007|STARTED|Food Effect (FE): Fed||0
10067966|NCT02151994|11194368|FG008|STARTED|Food Effect (FE): Fed||0
10067967|NCT02151994|11194369|FG009|STARTED|Food Effect (FE): Fed||0
10067968|NCT02151994|11194370|FG010|STARTED|Food Effect (FE): Fed||0
10067969|NCT02151994|11194371|FG011|STARTED|Food Effect (FE): Fed||0
10067970|NCT02151994|11194372|FG012|STARTED|Food Effect (FE): Fed||12
10067971|NCT02151994|11194360|FG000|COMPLETED|Food Effect (FE): Fed||0
10067972|NCT02151994|11194361|FG001|COMPLETED|Food Effect (FE): Fed||0
10067973|NCT02151994|11194362|FG002|COMPLETED|Food Effect (FE): Fed||0
10067974|NCT02151994|11194363|FG003|COMPLETED|Food Effect (FE): Fed||0
10067975|NCT02151994|11194364|FG004|COMPLETED|Food Effect (FE): Fed||0
10067976|NCT02151994|11194365|FG005|COMPLETED|Food Effect (FE): Fed||0
10067977|NCT02151994|11194366|FG006|COMPLETED|Food Effect (FE): Fed||0
10067978|NCT02151994|11194367|FG007|COMPLETED|Food Effect (FE): Fed||0
10067979|NCT02151994|11194368|FG008|COMPLETED|Food Effect (FE): Fed||0
10067980|NCT02151994|11194369|FG009|COMPLETED|Food Effect (FE): Fed||0
10067981|NCT02151994|11194370|FG010|COMPLETED|Food Effect (FE): Fed||0
10067982|NCT02151994|11194371|FG011|COMPLETED|Food Effect (FE): Fed||0
10067983|NCT02151994|11194372|FG012|COMPLETED|Food Effect (FE): Fed||12
10067984|NCT02151994|11194360|FG000|NOT COMPLETED|Food Effect (FE): Fed||0
10067985|NCT02151994|11194361|FG001|NOT COMPLETED|Food Effect (FE): Fed||0
10067986|NCT02151994|11194362|FG002|NOT COMPLETED|Food Effect (FE): Fed||0
10067987|NCT02151994|11194363|FG003|NOT COMPLETED|Food Effect (FE): Fed||0
10067988|NCT02151994|11194364|FG004|NOT COMPLETED|Food Effect (FE): Fed||0
10067989|NCT02151994|11194365|FG005|NOT COMPLETED|Food Effect (FE): Fed||0
10067990|NCT02151994|11194366|FG006|NOT COMPLETED|Food Effect (FE): Fed||0
10067991|NCT02151994|11194367|FG007|NOT COMPLETED|Food Effect (FE): Fed||0
10067992|NCT02151994|11194368|FG008|NOT COMPLETED|Food Effect (FE): Fed||0
10067993|NCT02151994|11194369|FG009|NOT COMPLETED|Food Effect (FE): Fed||0
10067994|NCT02151994|11194370|FG010|NOT COMPLETED|Food Effect (FE): Fed||0
10067995|NCT02151994|11194371|FG011|NOT COMPLETED|Food Effect (FE): Fed||0
10067996|NCT02151994|11194372|FG012|NOT COMPLETED|Food Effect (FE): Fed||0
10067997|NCT02152007|11194409|FG000|STARTED|Overall Study||15
10067998|NCT02152007|11194409|FG000|COMPLETED|Overall Study||14
10067999|NCT02152007|11194409|FG000|NOT COMPLETED|Overall Study||1
10068000|NCT02152085|11194416|FG000|STARTED|Overall Study||14
10068001|NCT02152085|11194417|FG001|STARTED|Overall Study||15
10068002|NCT02152085|11194416|FG000|COMPLETED|Overall Study||13
10068003|NCT02152085|11194417|FG001|COMPLETED|Overall Study||14
10068004|NCT02152085|11194416|FG000|NOT COMPLETED|Overall Study||1
10068005|NCT02152085|11194417|FG001|NOT COMPLETED|Overall Study||1
10068006|NCT02152137|11194423|FG000|STARTED|Overall Study||19
10068007|NCT02152137|11194423|FG000|Originally Assigned to Arm A|Overall Study||16
10068008|NCT02152137|11194423|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
10068009|NCT02152137|11194423|FG000|COMPLETED|Overall Study||15
10068010|NCT02152137|11194423|FG000|NOT COMPLETED|Overall Study||4
10068011|NCT02152163|11194429|FG000|STARTED|Overall Study||51
10068012|NCT02152163|11194430|FG001|STARTED|Overall Study||48
10068013|NCT02152163|11194429|FG000|COMPLETED|Overall Study||39
10068014|NCT02152163|11194430|FG001|COMPLETED|Overall Study||35
10068015|NCT02152163|11194429|FG000|NOT COMPLETED|Overall Study||12
10068016|NCT02152163|11194430|FG001|NOT COMPLETED|Overall Study||13
10068017|NCT02152345|11194438|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
10068018|NCT02152345|11194439|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
10068019|NCT02152345|11194438|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
10068020|NCT02152345|11194439|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
10068021|NCT02152345|11194438|FG000|NOT COMPLETED|Overall Study||4
10068022|NCT02152345|11194439|FG001|NOT COMPLETED|Overall Study||5
10068023|NCT02152371|11194447|FG000|STARTED|Overall Study||150
10068024|NCT02152371|11194448|FG001|STARTED|Overall Study||150
10068025|NCT02152371|11194447|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150
10068026|NCT02152371|11194448|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150
10068027|NCT02152371|11194447|FG000|COMPLETED|Overall Study||138
10068028|NCT02152371|11194448|FG001|COMPLETED|Overall Study||134
10068029|NCT02152371|11194447|FG000|NOT COMPLETED|Overall Study||12
10068030|NCT02152371|11194448|FG001|NOT COMPLETED|Overall Study||16
10068031|NCT02152384|11194454|FG000|STARTED|Run In (1-5 Week Transition)||14
10068032|NCT02152384|11194455|FG001|STARTED|Run In (1-5 Week Transition)||14
10068033|NCT02152384|11194454|FG000|COMPLETED|Run In (1-5 Week Transition)||14
10068034|NCT02152384|11194455|FG001|COMPLETED|Run In (1-5 Week Transition)||14
10068035|NCT02152384|11194454|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0
10068036|NCT02152384|11194455|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0
10068037|NCT02152384|11194454|FG000|STARTED|Period 1||14
10068038|NCT02152384|11194455|FG001|STARTED|Period 1||14
10068039|NCT02152384|11194454|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
10068040|NCT02152384|11194455|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
10068041|NCT02152384|11194454|FG000|COMPLETED|Period 1||13
10068042|NCT02152384|11194455|FG001|COMPLETED|Period 1||12
10068043|NCT02152384|11194454|FG000|NOT COMPLETED|Period 1||1
10068044|NCT02152384|11194455|FG001|NOT COMPLETED|Period 1||2
10068045|NCT02152384|11194454|FG000|STARTED|Period 2||13
10068046|NCT02152384|11194455|FG001|STARTED|Period 2||12
10068047|NCT02152384|11194454|FG000|COMPLETED|Period 2||13
10068048|NCT02152384|11194455|FG001|COMPLETED|Period 2||12
10068049|NCT02152384|11194454|FG000|NOT COMPLETED|Period 2||0
10068050|NCT02152384|11194455|FG001|NOT COMPLETED|Period 2||0
10068051|NCT02152540|11194467|FG000|STARTED|Overall Study||17
10068052|NCT02152540|11194468|FG001|STARTED|Overall Study||16
10068053|NCT02152540|11194467|FG000|COMPLETED|Overall Study||17
10068054|NCT02152540|11194468|FG001|COMPLETED|Overall Study||16
10188897|NCT03275389|11318456|FG008|STARTED|Overall Study||46
10188898|NCT03275389|11318457|FG009|STARTED|Overall Study||47
10188899|NCT03275389|11318448|FG000|COMPLETED|Overall Study||34
10188900|NCT03275389|11318449|FG001|COMPLETED|Overall Study||30
10188901|NCT03275389|11318450|FG002|COMPLETED|Overall Study||24
10188902|NCT03275389|11318451|FG003|COMPLETED|Overall Study||25
10188903|NCT03275389|11318452|FG004|COMPLETED|Overall Study||32
10188904|NCT03275389|11318453|FG005|COMPLETED|Overall Study||29
10188905|NCT03275389|11318454|FG006|COMPLETED|Overall Study||22
10188906|NCT03275389|11318455|FG007|COMPLETED|Overall Study||30
10188907|NCT03275389|11318456|FG008|COMPLETED|Overall Study||31
10188908|NCT03275389|11318457|FG009|COMPLETED|Overall Study||29
10188909|NCT03275389|11318448|FG000|NOT COMPLETED|Overall Study||11
10188910|NCT03275389|11318449|FG001|NOT COMPLETED|Overall Study||16
10188911|NCT03275389|11318450|FG002|NOT COMPLETED|Overall Study||23
10188912|NCT03275389|11318451|FG003|NOT COMPLETED|Overall Study||22
10188913|NCT03275389|11318452|FG004|NOT COMPLETED|Overall Study||16
10188914|NCT03275389|11318453|FG005|NOT COMPLETED|Overall Study||18
10188915|NCT03275389|11318454|FG006|NOT COMPLETED|Overall Study||25
10188916|NCT03275389|11318455|FG007|NOT COMPLETED|Overall Study||18
10188917|NCT03275389|11318456|FG008|NOT COMPLETED|Overall Study||15
10188918|NCT03275389|11318457|FG009|NOT COMPLETED|Overall Study||18
10188919|NCT03275623|11318481|FG000|STARTED|Overall Study||30
10188920|NCT03275623|11318482|FG001|STARTED|Overall Study||30
10188921|NCT03275623|11318481|FG000|COMPLETED|Overall Study||25
10188922|NCT03275623|11318482|FG001|COMPLETED|Overall Study||28
10188923|NCT03275623|11318481|FG000|NOT COMPLETED|Overall Study||5
10188924|NCT03275623|11318482|FG001|NOT COMPLETED|Overall Study||2
10188925|NCT03275766|11318492|FG000|STARTED|Overall Study||12
10188926|NCT03275766|11318493|FG001|STARTED|Overall Study||12
10188927|NCT03275766|11318494|FG002|STARTED|Overall Study||11
10188928|NCT03275766|11318495|FG003|STARTED|Overall Study||10
10188929|NCT03275766|11318492|FG000|Received Intervention|Overall Study||9
10188930|NCT03275766|11318493|FG001|Received Intervention|Overall Study||11
10188931|NCT03275766|11318494|FG002|Received Intervention|Overall Study||10
10188932|NCT03275766|11318495|FG003|Received Intervention|Overall Study||9
10188933|NCT03275766|11318492|FG000|COMPLETED|Overall Study||7
10188934|NCT03275766|11318493|FG001|COMPLETED|Overall Study||5
10188935|NCT03275766|11318494|FG002|COMPLETED|Overall Study||7
10188936|NCT03275766|11318495|FG003|COMPLETED|Overall Study||4
10188937|NCT03275766|11318492|FG000|NOT COMPLETED|Overall Study||5
10188938|NCT03275766|11318493|FG001|NOT COMPLETED|Overall Study||7
10188939|NCT03275766|11318494|FG002|NOT COMPLETED|Overall Study||4
10188940|NCT03275766|11318495|FG003|NOT COMPLETED|Overall Study||6
10188941|NCT03275870|11318505|FG000|STARTED|Overall Study||17
10188942|NCT03275870|11318505|FG000|COMPLETED|Overall Study||3
10188943|NCT03275870|11318505|FG000|NOT COMPLETED|Overall Study||14
10188944|NCT03276026|11318511|FG000|STARTED|Overall Study||35
10188945|NCT03276026|11318512|FG001|STARTED|Overall Study||33
10188946|NCT03276026|11318511|FG000|COMPLETED|Overall Study||34
10188947|NCT03276026|11318512|FG001|COMPLETED|Overall Study||33
10188948|NCT03276026|11318511|FG000|NOT COMPLETED|Overall Study||1
10188949|NCT03276026|11318512|FG001|NOT COMPLETED|Overall Study||0
10188950|NCT03276078|11318518|FG000|STARTED|Overall Study||20
10188951|NCT03276078|11318518|FG000|COMPLETED|Overall Study||19
10068055|NCT02152540|11194467|FG000|NOT COMPLETED|Overall Study||0
10068056|NCT02152540|11194468|FG001|NOT COMPLETED|Overall Study||0
10068057|NCT02152605|11194483|FG000|STARTED|Overall Study||248
10068058|NCT02152605|11194484|FG001|STARTED|Overall Study||248
10188952|NCT03276078|11318518|FG000|NOT COMPLETED|Overall Study||1
10188953|NCT03276494|11318522|FG000|STARTED|Overall Study||6
10068059|NCT02152605|11194483|FG000|COMPLETED|Overall Study||229
10068060|NCT02152605|11194484|FG001|COMPLETED|Overall Study||230
10068061|NCT02152605|11194483|FG000|NOT COMPLETED|Overall Study||19
10068062|NCT02152605|11194484|FG001|NOT COMPLETED|Overall Study||18
10188954|NCT03276494|11318522|FG000|COMPLETED|Overall Study||5
10188955|NCT03276494|11318522|FG000|NOT COMPLETED|Overall Study||1
10188956|NCT03276637|11318526|FG000|STARTED|Overall Study||93
10068063|NCT02152631|11194493|FG000|STARTED|Overall Study||270
10068064|NCT02152631|11194494|FG001|STARTED|Overall Study||183
10068065|NCT02152631|11194493|FG000|Received at Least One Dose of Study Drug|Overall Study||265
10068066|NCT02152631|11194494|FG001|Received at Least One Dose of Study Drug|Overall Study||175
10068067|NCT02152631|11194493|FG000|Off Treatment|Overall Study||246
10068068|NCT02152631|11194494|FG001|Off Treatment|Overall Study||172
10068069|NCT02152631|11194493|FG000|Death Due to Any Cause|Overall Study||30
10068070|NCT02152631|11194494|FG001|Death Due to Any Cause|Overall Study||20
10068071|NCT02152631|11194493|FG000|Progressive Disease|Overall Study||174
10068072|NCT02152631|11194494|FG001|Progressive Disease|Overall Study||137
10068073|NCT02152631|11194493|FG000|COMPLETED|Overall Study||204
10068074|NCT02152631|11194494|FG001|COMPLETED|Overall Study||157
10068075|NCT02152631|11194493|FG000|NOT COMPLETED|Overall Study||66
10068076|NCT02152631|11194494|FG001|NOT COMPLETED|Overall Study||26
10068077|NCT02152696|11194503|FG000|STARTED|Overall Study||86
10068078|NCT02152696|11194504|FG001|STARTED|Overall Study||87
10068079|NCT02152696|11194505|FG002|STARTED|Overall Study||82
10068080|NCT02152696|11194503|FG000|COMPLETED|Overall Study||86
10068081|NCT02152696|11194504|FG001|COMPLETED|Overall Study||86
10068082|NCT02152696|11194505|FG002|COMPLETED|Overall Study||81
10068083|NCT02152696|11194503|FG000|NOT COMPLETED|Overall Study||0
10068084|NCT02152696|11194504|FG001|NOT COMPLETED|Overall Study||1
10068085|NCT02152696|11194505|FG002|NOT COMPLETED|Overall Study||1
10068086|NCT02152761|11194517|FG000|STARTED|Epoch: Treatment Epoch||75
10068087|NCT02152761|11194518|FG001|STARTED|Epoch: Treatment Epoch||70
10068088|NCT02152761|11194519|FG002|STARTED|Epoch: Treatment Epoch||34
10068089|NCT02152761|11194520|FG003|STARTED|Epoch: Treatment Epoch||72
10068090|NCT02152761|11194517|FG000|COMPLETED|Epoch: Treatment Epoch||64
10068091|NCT02152761|11194518|FG001|COMPLETED|Epoch: Treatment Epoch||50
10068092|NCT02152761|11194519|FG002|COMPLETED|Epoch: Treatment Epoch||29
10068093|NCT02152761|11194520|FG003|COMPLETED|Epoch: Treatment Epoch||64
10068094|NCT02152761|11194517|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11
10068095|NCT02152761|11194518|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20
10068096|NCT02152761|11194519|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5
10068097|NCT02152761|11194520|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8
10068098|NCT02152761|11194517|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67
10068099|NCT02152761|11194518|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54
10068100|NCT02152761|11194519|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30
10068101|NCT02152761|11194520|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68
10068102|NCT02152761|11194517|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
10068103|NCT02152761|11194518|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
10068104|NCT02152761|11194519|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
10068105|NCT02152761|11194520|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
10068106|NCT02152761|11194517|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
10068107|NCT02152761|11194518|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
10068108|NCT02152761|11194519|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
10068109|NCT02152761|11194520|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
10068110|NCT02152826|11194538|FG000|STARTED|Overall Study||45
10068111|NCT02152826|11194539|FG001|STARTED|Overall Study||35
10068112|NCT02152826|11194538|FG000|COMPLETED|Overall Study||44
10068113|NCT02152826|11194539|FG001|COMPLETED|Overall Study||34
10068114|NCT02152826|11194538|FG000|NOT COMPLETED|Overall Study||1
10068115|NCT02152826|11194539|FG001|NOT COMPLETED|Overall Study||1
10068116|NCT02153073|11194545|FG000|STARTED|Overall Study||3084
10068117|NCT02153073|11194545|FG000|COMPLETED|Overall Study||2786
10068118|NCT02153073|11194545|FG000|NOT COMPLETED|Overall Study||298
10068119|NCT02153086|11194549|FG000|STARTED|Overall Study||236
10068120|NCT02153086|11194549|FG000|COMPLETED|Overall Study||232
10068121|NCT02153086|11194549|FG000|NOT COMPLETED|Overall Study||4
10068122|NCT02153099|11194560|FG000|STARTED|Overall Study||6
10068123|NCT02153099|11194561|FG001|STARTED|Overall Study||6
10068124|NCT02153099|11194562|FG002|STARTED|Overall Study||6
10068125|NCT02153099|11194563|FG003|STARTED|Overall Study||6
10068126|NCT02153099|11194564|FG004|STARTED|Overall Study||6
10068127|NCT02153099|11194565|FG005|STARTED|Overall Study||6
10068128|NCT02153099|11194566|FG006|STARTED|Overall Study||12
10068129|NCT02153099|11194560|FG000|COMPLETED|Overall Study||6
10068130|NCT02153099|11194561|FG001|COMPLETED|Overall Study||6
10068131|NCT02153099|11194562|FG002|COMPLETED|Overall Study||6
10068132|NCT02153099|11194563|FG003|COMPLETED|Overall Study||6
10068133|NCT02153099|11194564|FG004|COMPLETED|Overall Study||6
10068134|NCT02153099|11194565|FG005|COMPLETED|Overall Study||6
10068135|NCT02153099|11194566|FG006|COMPLETED|Overall Study||12
10068136|NCT02153099|11194560|FG000|NOT COMPLETED|Overall Study||0
10068137|NCT02153099|11194561|FG001|NOT COMPLETED|Overall Study||0
10068138|NCT02153099|11194562|FG002|NOT COMPLETED|Overall Study||0
10068139|NCT02153099|11194563|FG003|NOT COMPLETED|Overall Study||0
10068140|NCT02153099|11194564|FG004|NOT COMPLETED|Overall Study||0
10068141|NCT02153099|11194565|FG005|NOT COMPLETED|Overall Study||0
10068142|NCT02153099|11194566|FG006|NOT COMPLETED|Overall Study||0
10068143|NCT02153112|11194592|FG000|STARTED|Overall Study||61
10068144|NCT02153112|11194593|FG001|STARTED|Overall Study||59
10068145|NCT02153112|11194594|FG002|STARTED|Overall Study||61
10068146|NCT02153112|11194595|FG003|STARTED|Overall Study||59
10068147|NCT02153112|11194596|FG004|STARTED|Overall Study||60
10068148|NCT02153112|11194597|FG005|STARTED|Overall Study||60
10068149|NCT02153112|11194598|FG006|STARTED|Overall Study||60
10068150|NCT02153112|11194599|FG007|STARTED|Overall Study||60
10068151|NCT02153112|11194600|FG008|STARTED|Overall Study||180
10068152|NCT02153112|11194601|FG009|STARTED|Overall Study||180
10068153|NCT02153112|11194592|FG000|COMPLETED|Overall Study||57
10068154|NCT02153112|11194593|FG001|COMPLETED|Overall Study||57
10068155|NCT02153112|11194594|FG002|COMPLETED|Overall Study||58
10068156|NCT02153112|11194595|FG003|COMPLETED|Overall Study||57
10068157|NCT02153112|11194596|FG004|COMPLETED|Overall Study||57
10068158|NCT02153112|11194597|FG005|COMPLETED|Overall Study||58
10068159|NCT02153112|11194598|FG006|COMPLETED|Overall Study||52
10068160|NCT02153112|11194599|FG007|COMPLETED|Overall Study||58
10068161|NCT02153112|11194600|FG008|COMPLETED|Overall Study||165
10068162|NCT02153112|11194601|FG009|COMPLETED|Overall Study||166
10068163|NCT02153112|11194592|FG000|NOT COMPLETED|Overall Study||4
10068164|NCT02153112|11194593|FG001|NOT COMPLETED|Overall Study||2
10068165|NCT02153112|11194594|FG002|NOT COMPLETED|Overall Study||3
10068166|NCT02153112|11194595|FG003|NOT COMPLETED|Overall Study||2
10068167|NCT02153112|11194596|FG004|NOT COMPLETED|Overall Study||3
10068168|NCT02153112|11194597|FG005|NOT COMPLETED|Overall Study||2
10068169|NCT02153112|11194598|FG006|NOT COMPLETED|Overall Study||8
10068170|NCT02153112|11194599|FG007|NOT COMPLETED|Overall Study||2
10068171|NCT02153112|11194600|FG008|NOT COMPLETED|Overall Study||15
10068172|NCT02153112|11194601|FG009|NOT COMPLETED|Overall Study||14
10068173|NCT02153346|11194625|FG000|STARTED|Overall Study||101
10068174|NCT02153346|11194625|FG000|COMPLETED|Overall Study||90
10068175|NCT02153346|11194625|FG000|NOT COMPLETED|Overall Study||11
10068176|NCT02153359|11194630|FG000|STARTED|Intervention 1 (1 Month)||11
10068177|NCT02153359|11194631|FG001|STARTED|Intervention 1 (1 Month)||12
10068178|NCT02153359|11194630|FG000|COMPLETED|Intervention 1 (1 Month)||11
10068179|NCT02153359|11194631|FG001|COMPLETED|Intervention 1 (1 Month)||12
10068180|NCT02153359|11194630|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0
10068181|NCT02153359|11194631|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0
10068182|NCT02153359|11194630|FG000|STARTED|Washout (at Least 1 Month)||11
10068183|NCT02153359|11194631|FG001|STARTED|Washout (at Least 1 Month)||12
10068184|NCT02153359|11194630|FG000|COMPLETED|Washout (at Least 1 Month)||11
10068185|NCT02153359|11194631|FG001|COMPLETED|Washout (at Least 1 Month)||12
10068186|NCT02153359|11194630|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0
10068187|NCT02153359|11194631|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0
10068188|NCT02153359|11194630|FG000|STARTED|Intervention 2 (1 Month)||11
10068189|NCT02153359|11194631|FG001|STARTED|Intervention 2 (1 Month)||12
10068190|NCT02153359|11194630|FG000|COMPLETED|Intervention 2 (1 Month)||11
10068191|NCT02153359|11194631|FG001|COMPLETED|Intervention 2 (1 Month)||10
10068192|NCT02153359|11194630|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0
10068193|NCT02153359|11194631|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2
10188957|NCT03276637|11318526|FG000|Completed Pre Survey|Overall Study||93
10188958|NCT03276637|11318526|FG000|Underwent Sequencing|Overall Study||75
10188959|NCT03276637|11318526|FG000|Completed Post Survey|Overall Study||69
10188960|NCT03276637|11318526|FG000|COMPLETED|Overall Study||69
10188961|NCT03276637|11318526|FG000|NOT COMPLETED|Overall Study||24
10188962|NCT03276871|11318533|FG000|STARTED|Overall Study||21
10188963|NCT03276871|11318534|FG001|STARTED|Overall Study||19
10188964|NCT03276871|11318533|FG000|COMPLETED|Overall Study||21
10188965|NCT03276871|11318534|FG001|COMPLETED|Overall Study||19
10188966|NCT03276871|11318533|FG000|NOT COMPLETED|Overall Study||0
10188967|NCT03276871|11318534|FG001|NOT COMPLETED|Overall Study||0
10188968|NCT03276975|11318542|FG000|STARTED|Overall Study||8
10188969|NCT03276975|11318543|FG001|STARTED|Overall Study||7
10188970|NCT03276975|11318542|FG000|Crossover At 2 Months|Overall Study||0
10188971|NCT03276975|11318543|FG001|Crossover At 2 Months|Overall Study||7
10188972|NCT03276975|11318542|FG000|COMPLETED|Overall Study||7
10188973|NCT03276975|11318543|FG001|COMPLETED|Overall Study||7
10188974|NCT03276975|11318542|FG000|NOT COMPLETED|Overall Study||1
10188975|NCT03276975|11318543|FG001|NOT COMPLETED|Overall Study||0
10188976|NCT03277274|11318552|FG000|STARTED|Overall Study||8
10188977|NCT03277274|11318553|FG001|STARTED|Overall Study||10
10188978|NCT03277274|11318554|FG002|STARTED|Overall Study||7
10188979|NCT03277274|11318552|FG000|COMPLETED|Overall Study||8
10068194|NCT02153398|11194645|FG000|STARTED|Overall Study||10
10068195|NCT02153398|11194646|FG001|STARTED|Overall Study||10
10068196|NCT02153398|11194647|FG002|STARTED|Overall Study||10
10068197|NCT02153398|11194648|FG003|STARTED|Overall Study||10
10068198|NCT02153398|11194649|FG004|STARTED|Overall Study||10
10068199|NCT02153398|11194645|FG000|COMPLETED|Overall Study||9
10068200|NCT02153398|11194646|FG001|COMPLETED|Overall Study||10
10068201|NCT02153398|11194647|FG002|COMPLETED|Overall Study||9
10068202|NCT02153398|11194648|FG003|COMPLETED|Overall Study||9
10068203|NCT02153398|11194649|FG004|COMPLETED|Overall Study||10
10068204|NCT02153398|11194645|FG000|NOT COMPLETED|Overall Study||1
10068205|NCT02153398|11194646|FG001|NOT COMPLETED|Overall Study||0
10068206|NCT02153398|11194647|FG002|NOT COMPLETED|Overall Study||1
10068207|NCT02153398|11194648|FG003|NOT COMPLETED|Overall Study||1
10188980|NCT03277274|11318553|FG001|COMPLETED|Overall Study||10
10188981|NCT03277274|11318554|FG002|COMPLETED|Overall Study||7
10068208|NCT02153398|11194649|FG004|NOT COMPLETED|Overall Study||0
10068209|NCT02153476|11194663|FG000|STARTED|Overall Study||23
10068210|NCT02153476|11194664|FG001|STARTED|Overall Study||22
10068211|NCT02153476|11194663|FG000|COMPLETED|Overall Study||22
10068212|NCT02153476|11194664|FG001|COMPLETED|Overall Study||22
10068213|NCT02153476|11194663|FG000|NOT COMPLETED|Overall Study||1
10068214|NCT02153476|11194664|FG001|NOT COMPLETED|Overall Study||0
10068215|NCT02153489|11194670|FG000|STARTED|Period 1||15
10068216|NCT02153489|11194671|FG001|STARTED|Period 1||15
10068217|NCT02153489|11194670|FG000|COMPLETED|Period 1||15
10068218|NCT02153489|11194671|FG001|COMPLETED|Period 1||15
10068219|NCT02153489|11194670|FG000|NOT COMPLETED|Period 1||0
10068220|NCT02153489|11194671|FG001|NOT COMPLETED|Period 1||0
10068221|NCT02153489|11194670|FG000|STARTED|Period 2||15
10068222|NCT02153489|11194671|FG001|STARTED|Period 2||15
10068223|NCT02153489|11194670|FG000|COMPLETED|Period 2||15
10068224|NCT02153489|11194671|FG001|COMPLETED|Period 2||15
10068225|NCT02153489|11194670|FG000|NOT COMPLETED|Period 2||0
10068226|NCT02153489|11194671|FG001|NOT COMPLETED|Period 2||0
10068227|NCT02153528|11194679|FG000|STARTED|Overall Study||348
10068228|NCT02153528|11194680|FG001|STARTED|Overall Study||353
10068229|NCT02153528|11194679|FG000|COMPLETED|Overall Study||348
10068230|NCT02153528|11194680|FG001|COMPLETED|Overall Study||353
10068231|NCT02153528|11194679|FG000|NOT COMPLETED|Overall Study||0
10068232|NCT02153528|11194680|FG001|NOT COMPLETED|Overall Study||0
10068233|NCT02153671|11194690|FG000|STARTED|Overall Study||19
10068234|NCT02153671|11194691|FG001|STARTED|Overall Study||24
10068235|NCT02153671|11194690|FG000|COMPLETED|Overall Study||19
10068236|NCT02153671|11194691|FG001|COMPLETED|Overall Study||24
10068237|NCT02153671|11194690|FG000|NOT COMPLETED|Overall Study||0
10068238|NCT02153671|11194691|FG001|NOT COMPLETED|Overall Study||0
10068239|NCT02153710|11194699|FG000|STARTED|Overall Study||28
10068240|NCT02153710|11194700|FG001|STARTED|Overall Study||30
10068241|NCT02153710|11194699|FG000|COMPLETED|Overall Study||28
10068242|NCT02153710|11194700|FG001|COMPLETED|Overall Study||30
10068243|NCT02153710|11194699|FG000|NOT COMPLETED|Overall Study||0
10068244|NCT02153710|11194700|FG001|NOT COMPLETED|Overall Study||0
10068245|NCT02153723|11194706|FG000|STARTED|Overall Study||10
10068246|NCT02153723|11194706|FG000|COMPLETED|Overall Study||10
10068247|NCT02153723|11194706|FG000|NOT COMPLETED|Overall Study||0
10068248|NCT02153736|11194712|FG000|STARTED|Overall Study||7
10068249|NCT02153736|11194713|FG001|STARTED|Overall Study||7
10068250|NCT02153736|11194712|FG000|COMPLETED|Overall Study||5
10068251|NCT02153736|11194713|FG001|COMPLETED|Overall Study||5
10068252|NCT02153736|11194712|FG000|NOT COMPLETED|Overall Study||2
10068253|NCT02153736|11194713|FG001|NOT COMPLETED|Overall Study||2
10068254|NCT02153788|11194721|FG000|STARTED|Overall Study||25
10068255|NCT02153788|11194722|FG001|STARTED|Overall Study||19
10068256|NCT02153788|11194721|FG000|COMPLETED|Overall Study||23
10068257|NCT02153788|11194722|FG001|COMPLETED|Overall Study||18
10068258|NCT02153788|11194721|FG000|NOT COMPLETED|Overall Study||2
10068259|NCT02153788|11194722|FG001|NOT COMPLETED|Overall Study||1
10068260|NCT02153827|11194730|FG000|STARTED|Overall Study||25
10068261|NCT02153827|11194731|FG001|STARTED|Overall Study||23
10068262|NCT02153827|11194730|FG000|COMPLETED|Overall Study||22
10068263|NCT02153827|11194731|FG001|COMPLETED|Overall Study||14
10068264|NCT02153827|11194730|FG000|NOT COMPLETED|Overall Study||3
10068265|NCT02153827|11194731|FG001|NOT COMPLETED|Overall Study||9
10068266|NCT02153905|11194739|FG000|STARTED|Overall Study||1
10068267|NCT02153905|11194740|FG001|STARTED|Overall Study||2
10068268|NCT02153905|11194739|FG000|COMPLETED|Overall Study||0
10068269|NCT02153905|11194740|FG001|COMPLETED|Overall Study||2
10068270|NCT02153905|11194739|FG000|NOT COMPLETED|Overall Study||1
10068271|NCT02153905|11194740|FG001|NOT COMPLETED|Overall Study||0
10068272|NCT02153918|11194746|FG000|STARTED|Overall Study||27
10068273|NCT02153918|11194746|FG000|COMPLETED|Overall Study||26
10068274|NCT02153918|11194746|FG000|NOT COMPLETED|Overall Study||1
10068275|NCT02153983|11194756|FG000|STARTED|Overall Study||19
10068276|NCT02153983|11194757|FG001|STARTED|Overall Study||21
10068277|NCT02153983|11194758|FG002|STARTED|Overall Study||4
10068278|NCT02153983|11194759|FG003|STARTED|Overall Study||13
10068279|NCT02153983|11194760|FG004|STARTED|Overall Study||19
10068280|NCT02153983|11194761|FG005|STARTED|Overall Study||1
10068281|NCT02153983|11194756|FG000|COMPLETED|Overall Study||19
10068282|NCT02153983|11194757|FG001|COMPLETED|Overall Study||18
10068283|NCT02153983|11194758|FG002|COMPLETED|Overall Study||2
10068284|NCT02153983|11194759|FG003|COMPLETED|Overall Study||13
10068285|NCT02153983|11194760|FG004|COMPLETED|Overall Study||19
10068286|NCT02153983|11194761|FG005|COMPLETED|Overall Study||1
10068287|NCT02153983|11194756|FG000|NOT COMPLETED|Overall Study||0
10068288|NCT02153983|11194757|FG001|NOT COMPLETED|Overall Study||3
10068289|NCT02153983|11194758|FG002|NOT COMPLETED|Overall Study||2
10068290|NCT02153983|11194759|FG003|NOT COMPLETED|Overall Study||0
10068291|NCT02153983|11194760|FG004|NOT COMPLETED|Overall Study||0
10068292|NCT02153983|11194761|FG005|NOT COMPLETED|Overall Study||0
10068293|NCT02154048|11194778|FG000|STARTED|Overall Study||2
10068294|NCT02154048|11194779|FG001|STARTED|Overall Study||2
10068295|NCT02154048|11194780|FG002|STARTED|Overall Study||1
10068296|NCT02154048|11194778|FG000|COMPLETED|Overall Study||2
10068297|NCT02154048|11194779|FG001|COMPLETED|Overall Study||2
10068298|NCT02154048|11194780|FG002|COMPLETED|Overall Study||1
10068299|NCT02154048|11194778|FG000|NOT COMPLETED|Overall Study||0
10068300|NCT02154048|11194779|FG001|NOT COMPLETED|Overall Study||0
10068301|NCT02154048|11194780|FG002|NOT COMPLETED|Overall Study||0
10068302|NCT02154061|11194790|FG000|STARTED|Overall Study||16
10068303|NCT02154061|11194791|FG001|STARTED|Overall Study||17
10068304|NCT02154061|11194790|FG000|COMPLETED|Overall Study||14
10068305|NCT02154061|11194791|FG001|COMPLETED|Overall Study||17
10068306|NCT02154061|11194790|FG000|NOT COMPLETED|Overall Study||2
10068307|NCT02154061|11194791|FG001|NOT COMPLETED|Overall Study||0
10068308|NCT02154139|11194797|FG000|STARTED|Overall Study||651
10068309|NCT02154139|11194797|FG000|COMPLETED|Overall Study||644
10068310|NCT02154139|11194797|FG000|NOT COMPLETED|Overall Study||7
10068311|NCT02154243|11194804|FG000|STARTED|Overall Study||5
10068312|NCT02154243|11194805|FG001|STARTED|Overall Study||4
10068313|NCT02154243|11194806|FG002|STARTED|Overall Study||4
10068314|NCT02154243|11194804|FG000|COMPLETED|Overall Study||5
10068315|NCT02154243|11194805|FG001|COMPLETED|Overall Study||4
10068316|NCT02154243|11194806|FG002|COMPLETED|Overall Study||4
10068317|NCT02154243|11194804|FG000|NOT COMPLETED|Overall Study||0
10068318|NCT02154243|11194805|FG001|NOT COMPLETED|Overall Study||0
10068319|NCT02154243|11194806|FG002|NOT COMPLETED|Overall Study||0
10068320|NCT02154347|11194816|FG000|STARTED|Double-blind Period||60
10068321|NCT02154347|11194817|FG001|STARTED|Double-blind Period||118
10068322|NCT02154347|11194816|FG000|COMPLETED|Double-blind Period||57
10068323|NCT02154347|11194817|FG001|COMPLETED|Double-blind Period||114
10068324|NCT02154347|11194816|FG000|NOT COMPLETED|Double-blind Period||3
10068325|NCT02154347|11194817|FG001|NOT COMPLETED|Double-blind Period||4
10068326|NCT02154347|11194816|FG000|STARTED|Open-label Period||57
10068327|NCT02154347|11194817|FG001|STARTED|Open-label Period||113
10068328|NCT02154347|11194816|FG000|COMPLETED|Open-label Period||50
10068329|NCT02154347|11194817|FG001|COMPLETED|Open-label Period||88
10068330|NCT02154347|11194816|FG000|NOT COMPLETED|Open-label Period||7
10068331|NCT02154347|11194817|FG001|NOT COMPLETED|Open-label Period||25
10068332|NCT02154386|11194826|FG000|STARTED|Overall Study||23
10068333|NCT02154386|11194827|FG001|STARTED|Overall Study||23
10068334|NCT02154386|11194826|FG000|COMPLETED|Overall Study||22
10068335|NCT02154386|11194827|FG001|COMPLETED|Overall Study||21
10068336|NCT02154386|11194826|FG000|NOT COMPLETED|Overall Study||1
10068337|NCT02154386|11194827|FG001|NOT COMPLETED|Overall Study||2
10068338|NCT02154425|11194833|FG000|STARTED|Screening Period||18
10068339|NCT02154425|11194833|FG000|COMPLETED|Screening Period||17
10068340|NCT02154425|11194833|FG000|NOT COMPLETED|Screening Period||1
10068341|NCT02154425|11194833|FG000|STARTED|Sampling Period||17
10068342|NCT02154425|11194833|FG000|COMPLETED|Sampling Period||17
10068343|NCT02154425|11194833|FG000|NOT COMPLETED|Sampling Period||0
10068344|NCT02154477|11194843|FG000|STARTED|Overall Study||6
10068345|NCT02154477|11194844|FG001|STARTED|Overall Study||8
10068346|NCT02154477|11194843|FG000|COMPLETED|Overall Study||6
10068347|NCT02154477|11194844|FG001|COMPLETED|Overall Study||8
10068348|NCT02154477|11194843|FG000|NOT COMPLETED|Overall Study||0
10068349|NCT02154477|11194844|FG001|NOT COMPLETED|Overall Study||0
10068350|NCT02154581|11194852|FG000|STARTED|Overall Study||21
10068351|NCT02154581|11194853|FG001|STARTED|Overall Study||20
10068352|NCT02154581|11194852|FG000|COMPLETED|Overall Study||14
10068353|NCT02154581|11194853|FG001|COMPLETED|Overall Study||12
10068354|NCT02154581|11194852|FG000|NOT COMPLETED|Overall Study||7
10068355|NCT02154581|11194853|FG001|NOT COMPLETED|Overall Study||8
10068356|NCT02154672|11194861|FG000|STARTED|Overall Study||1
10068357|NCT02154672|11194861|FG000|COMPLETED|Overall Study||1
10068358|NCT02154672|11194861|FG000|NOT COMPLETED|Overall Study||0
10068359|NCT02154763|11194867|FG000|STARTED|Overall Study||60
10068360|NCT02154763|11194868|FG001|STARTED|Overall Study||60
10068361|NCT02154763|11194867|FG000|COMPLETED|Overall Study||46
10068362|NCT02154763|11194868|FG001|COMPLETED|Overall Study||46
10068363|NCT02154763|11194867|FG000|NOT COMPLETED|Overall Study||14
10068364|NCT02154763|11194868|FG001|NOT COMPLETED|Overall Study||14
10068365|NCT02154906|11194878|FG000|STARTED|Overall Study||21
10068366|NCT02154906|11194879|FG001|STARTED|Overall Study||20
10068367|NCT02154906|11194878|FG000|COMPLETED|Overall Study||19
10068368|NCT02154906|11194879|FG001|COMPLETED|Overall Study||17
10068369|NCT02154906|11194878|FG000|NOT COMPLETED|Overall Study||2
10068370|NCT02154906|11194879|FG001|NOT COMPLETED|Overall Study||3
10068371|NCT02155010|11194887|FG000|STARTED|Overall Study||37
10068372|NCT02155010|11194888|FG001|STARTED|Overall Study||37
10068373|NCT02155010|11194887|FG000|COMPLETED|Overall Study||31
10068374|NCT02155010|11194888|FG001|COMPLETED|Overall Study||31
10068375|NCT02155010|11194887|FG000|NOT COMPLETED|Overall Study||6
10068376|NCT02155010|11194888|FG001|NOT COMPLETED|Overall Study||6
10068377|NCT02155101|11194896|FG000|STARTED|Overall Study||39
10068378|NCT02155101|11194897|FG001|STARTED|Overall Study||81
10068379|NCT02155101|11194896|FG000|COMPLETED|Overall Study||39
10068380|NCT02155101|11194897|FG001|COMPLETED|Overall Study||80
10068381|NCT02155101|11194896|FG000|NOT COMPLETED|Overall Study||0
10068382|NCT02155101|11194897|FG001|NOT COMPLETED|Overall Study||1
10068383|NCT02155257|11194906|FG000|STARTED|Overall Study||10
10068384|NCT02155257|11194907|FG001|STARTED|Overall Study||10
10068385|NCT02155257|11194908|FG002|STARTED|Overall Study||10
10068386|NCT02155257|11194906|FG000|COMPLETED|Overall Study||10
10068387|NCT02155257|11194907|FG001|COMPLETED|Overall Study||10
10068388|NCT02155257|11194908|FG002|COMPLETED|Overall Study||10
10068389|NCT02155257|11194906|FG000|NOT COMPLETED|Overall Study||0
10068390|NCT02155257|11194907|FG001|NOT COMPLETED|Overall Study||0
10068391|NCT02155257|11194908|FG002|NOT COMPLETED|Overall Study||0
10068392|NCT02155283|11194916|FG000|STARTED|Overall Study||16
10068393|NCT02155283|11194916|FG000|COMPLETED|Overall Study||9
10068394|NCT02155283|11194916|FG000|NOT COMPLETED|Overall Study||7
10068395|NCT02155309|11194922|FG000|STARTED|Overall Study||13
10068396|NCT02155309|11194923|FG001|STARTED|Overall Study||10
10068397|NCT02155309|11194924|FG002|STARTED|Overall Study||13
10068398|NCT02155309|11194922|FG000|COMPLETED|Overall Study||13
10068399|NCT02155309|11194923|FG001|COMPLETED|Overall Study||10
10068400|NCT02155309|11194924|FG002|COMPLETED|Overall Study||12
10068401|NCT02155309|11194922|FG000|NOT COMPLETED|Overall Study||0
10068402|NCT02155309|11194923|FG001|NOT COMPLETED|Overall Study||0
10068403|NCT02155309|11194924|FG002|NOT COMPLETED|Overall Study||1
10068404|NCT02155322|11194931|FG000|STARTED|Overall Study||33
10068405|NCT02155322|11194931|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
10068406|NCT02155322|11194931|FG000|COMPLETED|Overall Study||19
10068407|NCT02155322|11194931|FG000|NOT COMPLETED|Overall Study||14
10068408|NCT02155335|11194935|FG000|STARTED|Period 1||50
10068409|NCT02155335|11194936|FG001|STARTED|Period 1||50
10068410|NCT02155335|11194935|FG000|Treated|Period 1||50
10068411|NCT02155335|11194936|FG001|Treated|Period 1||49
10068412|NCT02155335|11194935|FG000|COMPLETED|Period 1||50
10068413|NCT02155335|11194936|FG001|COMPLETED|Period 1||49
10068414|NCT02155335|11194935|FG000|NOT COMPLETED|Period 1||0
10068415|NCT02155335|11194936|FG001|NOT COMPLETED|Period 1||1
10068416|NCT02155335|11194935|FG000|STARTED|Period 2||50
10068417|NCT02155335|11194936|FG001|STARTED|Period 2||49
10068418|NCT02155335|11194935|FG000|COMPLETED|Period 2||50
10068419|NCT02155335|11194936|FG001|COMPLETED|Period 2||49
10068420|NCT02155335|11194935|FG000|NOT COMPLETED|Period 2||0
10068421|NCT02155335|11194936|FG001|NOT COMPLETED|Period 2||0
10068422|NCT02155465|11194947|FG000|STARTED|Overall Study||3
10068423|NCT02155465|11194948|FG001|STARTED|Overall Study||3
10068424|NCT02155465|11194949|FG002|STARTED|Overall Study||6
10068425|NCT02155465|11194950|FG003|STARTED|Overall Study||2
10068426|NCT02155465|11194951|FG004|STARTED|Overall Study||1
10068427|NCT02155465|11194952|FG005|STARTED|Overall Study||2
10068428|NCT02155465|11194953|FG006|STARTED|Overall Study||5
10068429|NCT02155465|11194947|FG000|COMPLETED|Overall Study||3
10068430|NCT02155465|11194948|FG001|COMPLETED|Overall Study||3
10068431|NCT02155465|11194949|FG002|COMPLETED|Overall Study||6
10068432|NCT02155465|11194950|FG003|COMPLETED|Overall Study||2
10068433|NCT02155465|11194951|FG004|COMPLETED|Overall Study||1
10068434|NCT02155465|11194952|FG005|COMPLETED|Overall Study||2
10068435|NCT02155465|11194953|FG006|COMPLETED|Overall Study||5
10068436|NCT02155465|11194947|FG000|NOT COMPLETED|Overall Study||0
10068437|NCT02155465|11194948|FG001|NOT COMPLETED|Overall Study||0
10068438|NCT02155465|11194949|FG002|NOT COMPLETED|Overall Study||0
10068439|NCT02155465|11194950|FG003|NOT COMPLETED|Overall Study||0
10068440|NCT02155465|11194951|FG004|NOT COMPLETED|Overall Study||0
10068441|NCT02155465|11194952|FG005|NOT COMPLETED|Overall Study||0
10068442|NCT02155465|11194953|FG006|NOT COMPLETED|Overall Study||0
10068443|NCT02155543|11194979|FG000|STARTED|Overall Study||9
10068444|NCT02155543|11194980|FG001|STARTED|Overall Study||9
10068445|NCT02155543|11194981|FG002|STARTED|Overall Study||9
10068446|NCT02155543|11194982|FG003|STARTED|Overall Study||9
10068447|NCT02155543|11194983|FG004|STARTED|Overall Study||3
10068448|NCT02155543|11194984|FG005|STARTED|Overall Study||3
10068449|NCT02155543|11194985|FG006|STARTED|Overall Study||9
10068450|NCT02155543|11194979|FG000|COMPLETED|Overall Study||9
10068451|NCT02155543|11194980|FG001|COMPLETED|Overall Study||9
10068452|NCT02155543|11194981|FG002|COMPLETED|Overall Study||9
10068453|NCT02155543|11194982|FG003|COMPLETED|Overall Study||9
10068454|NCT02155543|11194983|FG004|COMPLETED|Overall Study||3
10068455|NCT02155543|11194984|FG005|COMPLETED|Overall Study||3
10068456|NCT02155543|11194985|FG006|COMPLETED|Overall Study||9
10068457|NCT02155543|11194979|FG000|NOT COMPLETED|Overall Study||0
10068458|NCT02155543|11194980|FG001|NOT COMPLETED|Overall Study||0
10068459|NCT02155543|11194981|FG002|NOT COMPLETED|Overall Study||0
10068460|NCT02155543|11194982|FG003|NOT COMPLETED|Overall Study||0
10068461|NCT02155543|11194983|FG004|NOT COMPLETED|Overall Study||0
10068462|NCT02155543|11194984|FG005|NOT COMPLETED|Overall Study||0
10068463|NCT02155543|11194985|FG006|NOT COMPLETED|Overall Study||0
10068464|NCT02155608|11195000|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32
10068465|NCT02155608|11195001|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30
10068466|NCT02155608|11195000|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
10068467|NCT02155608|11195001|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
10068468|NCT02155608|11195000|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
10068469|NCT02155608|11195001|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
10068470|NCT02155608|11195000|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32
10068471|NCT02155608|11195001|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29
10068472|NCT02155608|11195000|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31
10068473|NCT02155608|11195001|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28
10068474|NCT02155608|11195000|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
10068475|NCT02155608|11195001|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
10068476|NCT02155660|11195017|FG000|STARTED|Overall Study||562
10068477|NCT02155660|11195018|FG001|STARTED|Overall Study||562
10068478|NCT02155660|11195019|FG002|STARTED|Overall Study||562
10068479|NCT02155660|11195020|FG003|STARTED|Overall Study||568
10068480|NCT02155660|11195017|FG000|COMPLETED|Overall Study||504
10068481|NCT02155660|11195018|FG001|COMPLETED|Overall Study||489
10068482|NCT02155660|11195019|FG002|COMPLETED|Overall Study||502
10068483|NCT02155660|11195020|FG003|COMPLETED|Overall Study||507
10068484|NCT02155660|11195017|FG000|NOT COMPLETED|Overall Study||58
10068485|NCT02155660|11195018|FG001|NOT COMPLETED|Overall Study||73
10068486|NCT02155660|11195019|FG002|NOT COMPLETED|Overall Study||60
10068487|NCT02155660|11195020|FG003|NOT COMPLETED|Overall Study||61
10068488|NCT02155712|11195032|FG000|STARTED|Primary Objective||319
10068489|NCT02155712|11195033|FG001|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
10068490|NCT02155712|11195032|FG000|COMPLETED|Primary Objective||259
10068491|NCT02155712|11195033|FG001|COMPLETED|Primary Objective||0
10068492|NCT02155712|11195032|FG000|NOT COMPLETED|Primary Objective||60
10068493|NCT02155712|11195033|FG001|NOT COMPLETED|Primary Objective||0
10068494|NCT02155712|11195032|FG000|STARTED|Secondary Objectives||319
10068495|NCT02155712|11195033|FG001|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
10068496|NCT02155712|11195032|FG000|COMPLETED|Secondary Objectives||0
10068497|NCT02155712|11195033|FG001|COMPLETED|Secondary Objectives||0
10068498|NCT02155712|11195032|FG000|NOT COMPLETED|Secondary Objectives||319
10068499|NCT02155712|11195033|FG001|NOT COMPLETED|Secondary Objectives||134
10068500|NCT02155725|11195041|FG000|STARTED|Treatment Period||224
10068501|NCT02155725|11195042|FG001|STARTED|Treatment Period||213
10068502|NCT02155725|11195041|FG000|COMPLETED|Treatment Period||224
10068503|NCT02155725|11195042|FG001|COMPLETED|Treatment Period||213
10068504|NCT02155725|11195041|FG000|NOT COMPLETED|Treatment Period||0
10068505|NCT02155725|11195042|FG001|NOT COMPLETED|Treatment Period||0
10068506|NCT02155725|11195041|FG000|STARTED|Follow-up Period||224
10068507|NCT02155725|11195042|FG001|STARTED|Follow-up Period||213
10068508|NCT02155725|11195041|FG000|COMPLETED|Follow-up Period||207
10068509|NCT02155725|11195042|FG001|COMPLETED|Follow-up Period||202
10068510|NCT02155725|11195041|FG000|NOT COMPLETED|Follow-up Period||17
10068511|NCT02155725|11195042|FG001|NOT COMPLETED|Follow-up Period||11
10068512|NCT02155738|11195058|FG000|STARTED|Overall Study||50
10068513|NCT02155738|11195059|FG001|STARTED|Overall Study||52
10068514|NCT02155738|11195060|FG002|STARTED|Overall Study||51
10068515|NCT02155738|11195061|FG003|STARTED|Overall Study||51
10068516|NCT02155738|11195058|FG000|COMPLETED|Overall Study||49
10068517|NCT02155738|11195059|FG001|COMPLETED|Overall Study||52
10068518|NCT02155738|11195060|FG002|COMPLETED|Overall Study||51
10068519|NCT02155738|11195061|FG003|COMPLETED|Overall Study||50
10068520|NCT02155738|11195058|FG000|NOT COMPLETED|Overall Study||1
10068521|NCT02155738|11195059|FG001|NOT COMPLETED|Overall Study||0
10068522|NCT02155738|11195060|FG002|NOT COMPLETED|Overall Study||0
10068523|NCT02155738|11195061|FG003|NOT COMPLETED|Overall Study||1
10068524|NCT02155829|11195073|FG000|STARTED|Overall Study||37
10068525|NCT02155829|11195074|FG001|STARTED|Overall Study||38
10068526|NCT02155829|11195073|FG000|COMPLETED|Overall Study||31
10068527|NCT02155829|11195074|FG001|COMPLETED|Overall Study||35
10068528|NCT02155829|11195073|FG000|NOT COMPLETED|Overall Study||6
10068529|NCT02155829|11195074|FG001|NOT COMPLETED|Overall Study||3
10068530|NCT02155881|11195083|FG000|STARTED|Overall Study||40
10068531|NCT02155881|11195084|FG001|STARTED|Overall Study||40
10068532|NCT02155881|11195083|FG000|COMPLETED|Overall Study||38
10068533|NCT02155881|11195084|FG001|COMPLETED|Overall Study||36
10068534|NCT02155881|11195083|FG000|NOT COMPLETED|Overall Study||2
10068535|NCT02155881|11195084|FG001|NOT COMPLETED|Overall Study||4
10068536|NCT02155985|11195093|FG000|STARTED|Overall Study||40
10068537|NCT02155985|11195094|FG001|STARTED|Overall Study||41
10068538|NCT02155985|11195095|FG002|STARTED|Overall Study||40
10068539|NCT02155985|11195093|FG000|COMPLETED|Overall Study||39
10068540|NCT02155985|11195094|FG001|COMPLETED|Overall Study||41
10068541|NCT02155985|11195095|FG002|COMPLETED|Overall Study||39
10068542|NCT02155985|11195093|FG000|NOT COMPLETED|Overall Study||1
10068543|NCT02155985|11195094|FG001|NOT COMPLETED|Overall Study||0
10068544|NCT02155985|11195095|FG002|NOT COMPLETED|Overall Study||1
10068545|NCT02156076|11195107|FG000|STARTED|Treatment Period||7
10068546|NCT02156076|11195108|FG001|STARTED|Treatment Period||7
10068547|NCT02156076|11195109|FG002|STARTED|Treatment Period||6
10068548|NCT02156076|11195110|FG003|STARTED|Treatment Period||6
10068549|NCT02156076|11195107|FG000|COMPLETED|Treatment Period||7
10068550|NCT02156076|11195108|FG001|COMPLETED|Treatment Period||5
10068551|NCT02156076|11195109|FG002|COMPLETED|Treatment Period||4
10068552|NCT02156076|11195110|FG003|COMPLETED|Treatment Period||4
10068553|NCT02156076|11195107|FG000|NOT COMPLETED|Treatment Period||0
10068554|NCT02156076|11195108|FG001|NOT COMPLETED|Treatment Period||2
10068555|NCT02156076|11195109|FG002|NOT COMPLETED|Treatment Period||2
10068556|NCT02156076|11195110|FG003|NOT COMPLETED|Treatment Period||2
10068557|NCT02156076|11195107|FG000|STARTED|Follow-up Period||7
10068558|NCT02156076|11195108|FG001|STARTED|Follow-up Period||5
10068559|NCT02156076|11195109|FG002|STARTED|Follow-up Period||4
10068560|NCT02156076|11195110|FG003|STARTED|Follow-up Period||4
10068561|NCT02156076|11195107|FG000|COMPLETED|Follow-up Period||6
10068562|NCT02156076|11195108|FG001|COMPLETED|Follow-up Period||5
10068563|NCT02156076|11195109|FG002|COMPLETED|Follow-up Period||4
10068564|NCT02156076|11195110|FG003|COMPLETED|Follow-up Period||4
10068565|NCT02156076|11195107|FG000|NOT COMPLETED|Follow-up Period||1
10068566|NCT02156076|11195108|FG001|NOT COMPLETED|Follow-up Period||0
10068567|NCT02156076|11195109|FG002|NOT COMPLETED|Follow-up Period||0
10068568|NCT02156076|11195110|FG003|NOT COMPLETED|Follow-up Period||0
10068569|NCT02156154|11195122|FG000|STARTED|Overall Study||291
10068570|NCT02156154|11195123|FG001|STARTED|Overall Study||289
10068571|NCT02156154|11195122|FG000|COMPLETED|Overall Study||287
10068572|NCT02156154|11195123|FG001|COMPLETED|Overall Study||283
10068573|NCT02156154|11195122|FG000|NOT COMPLETED|Overall Study||4
10068574|NCT02156154|11195123|FG001|NOT COMPLETED|Overall Study||6
10068575|NCT02156167|11195129|FG000|STARTED|Overall Study||15
10068576|NCT02156167|11195129|FG000|COMPLETED|Overall Study||15
10068577|NCT02156167|11195129|FG000|NOT COMPLETED|Overall Study||0
10068578|NCT02156258|11195136|FG000|STARTED|Overall Study||674
10068579|NCT02156258|11195137|FG001|STARTED|Overall Study||203
10068580|NCT02156258|11195138|FG002|STARTED|Overall Study||355
10068581|NCT02156258|11195136|FG000|COMPLETED|Overall Study||642
10068582|NCT02156258|11195137|FG001|COMPLETED|Overall Study||124
10068583|NCT02156258|11195138|FG002|COMPLETED|Overall Study||244
10068584|NCT02156258|11195136|FG000|NOT COMPLETED|Overall Study||32
10068585|NCT02156258|11195137|FG001|NOT COMPLETED|Overall Study||79
10068586|NCT02156258|11195138|FG002|NOT COMPLETED|Overall Study||111
10068587|NCT02156271|11195148|FG000|STARTED|Overall Study||26
10068588|NCT02156271|11195149|FG001|STARTED|Overall Study||13
10068589|NCT02156271|11195148|FG000|COMPLETED|Overall Study||22
10068590|NCT02156271|11195149|FG001|COMPLETED|Overall Study||10
10068591|NCT02156271|11195148|FG000|NOT COMPLETED|Overall Study||4
10068592|NCT02156271|11195149|FG001|NOT COMPLETED|Overall Study||3
10068593|NCT02156466|11195160|FG000|STARTED|Overall Study||8
10068594|NCT02156466|11195161|FG001|STARTED|Overall Study||8
10068595|NCT02156466|11195162|FG002|STARTED|Overall Study||8
10068596|NCT02156466|11195163|FG003|STARTED|Overall Study||9
10068597|NCT02156466|11195164|FG004|STARTED|Overall Study||8
10068598|NCT02156466|11195160|FG000|COMPLETED|Overall Study||8
10068599|NCT02156466|11195161|FG001|COMPLETED|Overall Study||8
10068600|NCT02156466|11195162|FG002|COMPLETED|Overall Study||7
10068601|NCT02156466|11195163|FG003|COMPLETED|Overall Study||7
10068602|NCT02156466|11195164|FG004|COMPLETED|Overall Study||8
10068603|NCT02156466|11195160|FG000|NOT COMPLETED|Overall Study||0
10068604|NCT02156466|11195161|FG001|NOT COMPLETED|Overall Study||0
10068605|NCT02156466|11195162|FG002|NOT COMPLETED|Overall Study||1
10068606|NCT02156466|11195163|FG003|NOT COMPLETED|Overall Study||2
10068607|NCT02156466|11195164|FG004|NOT COMPLETED|Overall Study||0
10068608|NCT02156492|11195188|FG000|STARTED|Period 1||16
10068609|NCT02156492|11195189|FG001|STARTED|Period 1||24
10068610|NCT02156492|11195190|FG002|STARTED|Period 1||22
10068611|NCT02156492|11195188|FG000|Received at Least One Dose of Study Drug|Period 1||16
10068612|NCT02156492|11195189|FG001|Received at Least One Dose of Study Drug|Period 1||24
10068613|NCT02156492|11195190|FG002|Received at Least One Dose of Study Drug|Period 1||22
10068614|NCT02156492|11195188|FG000|COMPLETED|Period 1||16
10068615|NCT02156492|11195189|FG001|COMPLETED|Period 1||23
10068616|NCT02156492|11195190|FG002|COMPLETED|Period 1||22
10068617|NCT02156492|11195188|FG000|NOT COMPLETED|Period 1||0
10068618|NCT02156492|11195189|FG001|NOT COMPLETED|Period 1||1
10068619|NCT02156492|11195190|FG002|NOT COMPLETED|Period 1||0
10068620|NCT02156492|11195188|FG000|STARTED|Period 2||16
10068621|NCT02156492|11195189|FG001|STARTED|Period 2||23
10068622|NCT02156492|11195190|FG002|STARTED|Period 2||22
10068623|NCT02156492|11195188|FG000|COMPLETED|Period 2||16
10068624|NCT02156492|11195189|FG001|COMPLETED|Period 2||23
10068625|NCT02156492|11195190|FG002|COMPLETED|Period 2||22
10068626|NCT02156492|11195188|FG000|NOT COMPLETED|Period 2||0
10068627|NCT02156492|11195189|FG001|NOT COMPLETED|Period 2||0
10068628|NCT02156492|11195190|FG002|NOT COMPLETED|Period 2||0
10068629|NCT02156492|11195188|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
10068630|NCT02156492|11195189|FG001|STARTED|Period 3||23
10068631|NCT02156492|11195190|FG002|STARTED|Period 3||22
10068632|NCT02156492|11195188|FG000|COMPLETED|Period 3||0
10068633|NCT02156492|11195189|FG001|COMPLETED|Period 3||22
10068634|NCT02156492|11195190|FG002|COMPLETED|Period 3||22
10068635|NCT02156492|11195188|FG000|NOT COMPLETED|Period 3||0
10068636|NCT02156492|11195189|FG001|NOT COMPLETED|Period 3||1
10068637|NCT02156492|11195190|FG002|NOT COMPLETED|Period 3||0
10068638|NCT02156674|11195208|FG000|STARTED|Overall Study||1
10068639|NCT02156674|11195208|FG000|COMPLETED|Overall Study||1
10068640|NCT02156674|11195208|FG000|NOT COMPLETED|Overall Study||0
10068641|NCT02156687|11195214|FG000|STARTED|Overall Study||30
10068642|NCT02156687|11195215|FG001|STARTED|Overall Study||29
10068643|NCT02156687|11195214|FG000|COMPLETED|Overall Study||20
10068644|NCT02156687|11195215|FG001|COMPLETED|Overall Study||24
10068645|NCT02156687|11195214|FG000|NOT COMPLETED|Overall Study||10
10068646|NCT02156687|11195215|FG001|NOT COMPLETED|Overall Study||5
10068647|NCT02156804|11195221|FG000|STARTED|Overall Study||1009
10068648|NCT02156804|11195221|FG000|COMPLETED|Overall Study||1008
10068649|NCT02156804|11195221|FG000|NOT COMPLETED|Overall Study||1
10068650|NCT02156908|11195227|FG000|STARTED|Overall Study||5
10068651|NCT02156908|11195228|FG001|STARTED|Overall Study||3
10068652|NCT02156908|11195227|FG000|COMPLETED|Overall Study||5
10068653|NCT02156908|11195228|FG001|COMPLETED|Overall Study||3
10068654|NCT02156908|11195227|FG000|NOT COMPLETED|Overall Study||0
10068655|NCT02156908|11195228|FG001|NOT COMPLETED|Overall Study||0
10068656|NCT02157103|11195235|FG000|STARTED|Overall Study||3
10068657|NCT02157103|11195235|FG000|COMPLETED|Overall Study||3
10068658|NCT02157103|11195235|FG000|NOT COMPLETED|Overall Study||0
10068659|NCT02157168|11195242|FG000|STARTED|Overall Study||746
10068660|NCT02157168|11195243|FG001|STARTED|Overall Study||159
10068661|NCT02157168|11195244|FG002|STARTED|Overall Study||1362
10068662|NCT02157168|11195242|FG000|COMPLETED|Overall Study||746
10068663|NCT02157168|11195243|FG001|COMPLETED|Overall Study||159
10068664|NCT02157168|11195244|FG002|COMPLETED|Overall Study||1362
10068665|NCT02157168|11195242|FG000|NOT COMPLETED|Overall Study||0
10068666|NCT02157168|11195243|FG001|NOT COMPLETED|Overall Study||0
10068667|NCT02157168|11195244|FG002|NOT COMPLETED|Overall Study||0
10068668|NCT02157298|11195257|FG000|STARTED|Overall Study||123
10068669|NCT02157298|11195258|FG001|STARTED|Overall Study||60
10068670|NCT02157298|11195257|FG000|COMPLETED|Overall Study||119
10068671|NCT02157298|11195258|FG001|COMPLETED|Overall Study||58
10068672|NCT02157298|11195257|FG000|NOT COMPLETED|Overall Study||4
10068673|NCT02157298|11195258|FG001|NOT COMPLETED|Overall Study||2
10068674|NCT02157376|11195266|FG000|STARTED|Overall Study||155
10068675|NCT02157376|11195267|FG001|STARTED|Overall Study||156
10068676|NCT02157376|11195266|FG000|COMPLETED|Overall Study||133
9717422|NCT00003816|10816617|FG004|NOT COMPLETED|Overall Study||0
10068677|NCT02157376|11195267|FG001|COMPLETED|Overall Study||138
10068678|NCT02157376|11195266|FG000|NOT COMPLETED|Overall Study||22
10068679|NCT02157376|11195267|FG001|NOT COMPLETED|Overall Study||18
10068680|NCT02157506|11195278|FG000|STARTED|Overall Study||12
10068681|NCT02157506|11195279|FG001|STARTED|Overall Study||6
10068682|NCT02157506|11195280|FG002|STARTED|Overall Study||9
9717423|NCT00003820|10816629|FG000|STARTED|Cycle 1 (Initial Treatment)||23
9717424|NCT00003820|10816630|FG001|STARTED|Cycle 1 (Initial Treatment)||16
9717425|NCT00003820|10816629|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23
9717426|NCT00003820|10816630|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16
9717427|NCT00003820|10816629|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
10068683|NCT02157506|11195281|FG003|STARTED|Overall Study||12
10068684|NCT02157506|11195282|FG004|STARTED|Overall Study||7
10068685|NCT02157506|11195278|FG000|COMPLETED|Overall Study||12
10068686|NCT02157506|11195279|FG001|COMPLETED|Overall Study||5
10068687|NCT02157506|11195280|FG002|COMPLETED|Overall Study||8
10068688|NCT02157506|11195281|FG003|COMPLETED|Overall Study||12
10068689|NCT02157506|11195282|FG004|COMPLETED|Overall Study||7
10068690|NCT02157506|11195278|FG000|NOT COMPLETED|Overall Study||0
10068691|NCT02157506|11195279|FG001|NOT COMPLETED|Overall Study||1
10068692|NCT02157506|11195280|FG002|NOT COMPLETED|Overall Study||1
10068693|NCT02157506|11195281|FG003|NOT COMPLETED|Overall Study||0
10068694|NCT02157506|11195282|FG004|NOT COMPLETED|Overall Study||0
10068695|NCT02157519|11195296|FG000|STARTED|Overall Study||91
10068696|NCT02157519|11195297|FG001|STARTED|Overall Study||90
10068697|NCT02157519|11195296|FG000|MEMScap Collected|Overall Study||84
10068698|NCT02157519|11195297|FG001|MEMScap Collected|Overall Study||86
10068699|NCT02157519|11195296|FG000|COMPLETED|Overall Study||80
10068700|NCT02157519|11195297|FG001|COMPLETED|Overall Study||89
10068701|NCT02157519|11195296|FG000|NOT COMPLETED|Overall Study||11
10068702|NCT02157519|11195297|FG001|NOT COMPLETED|Overall Study||1
10068703|NCT02157623|11195303|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
10068704|NCT02157623|11195303|FG000|COMPLETED|Overall Study||3
10068705|NCT02157623|11195303|FG000|NOT COMPLETED|Overall Study||0
10068706|NCT02157779|11195315|FG000|STARTED|Overall Study||47
10068707|NCT02157779|11195316|FG001|STARTED|Overall Study||45
10068708|NCT02157779|11195315|FG000|COMPLETED|Overall Study||23
10068709|NCT02157779|11195316|FG001|COMPLETED|Overall Study||34
10068710|NCT02157779|11195315|FG000|NOT COMPLETED|Overall Study||24
10068711|NCT02157779|11195316|FG001|NOT COMPLETED|Overall Study||11
10068712|NCT02157909|11195327|FG000|STARTED|Overall Study||66
10068713|NCT02157909|11195328|FG001|STARTED|Overall Study||66
10068714|NCT02157909|11195327|FG000|COMPLETED|Overall Study||66
10068715|NCT02157909|11195328|FG001|COMPLETED|Overall Study||66
10068716|NCT02157909|11195327|FG000|NOT COMPLETED|Overall Study||0
10068717|NCT02157909|11195328|FG001|NOT COMPLETED|Overall Study||0
10068718|NCT02157935|11195337|FG000|STARTED|Overall Study||606
10068719|NCT02157935|11195338|FG001|STARTED|Overall Study||613
10068720|NCT02157935|11195337|FG000|COMPLETED|Overall Study||567
10068721|NCT02157935|11195338|FG001|COMPLETED|Overall Study||548
10068722|NCT02157935|11195337|FG000|NOT COMPLETED|Overall Study||39
10068723|NCT02157935|11195338|FG001|NOT COMPLETED|Overall Study||65
10068724|NCT02157948|11195346|FG000|STARTED|Overall Study||197
10068725|NCT02157948|11195347|FG001|STARTED|Overall Study||197
10068726|NCT02157948|11195346|FG000|Received Treatment|Overall Study||196
10068727|NCT02157948|11195347|FG001|Received Treatment|Overall Study||196
10068728|NCT02157948|11195346|FG000|COMPLETED|Overall Study||188
10068729|NCT02157948|11195347|FG001|COMPLETED|Overall Study||188
10068730|NCT02157948|11195346|FG000|NOT COMPLETED|Overall Study||9
10068731|NCT02157948|11195347|FG001|NOT COMPLETED|Overall Study||9
10068732|NCT02158039|11195353|FG000|STARTED|Overall Study||33
10068733|NCT02158039|11195353|FG000|COMPLETED|Overall Study||23
10068734|NCT02158039|11195353|FG000|NOT COMPLETED|Overall Study||10
10068735|NCT02158247|11195359|FG000|STARTED|Overall Study||181
10068736|NCT02158247|11195359|FG000|COMPLETED|Overall Study||176
10068737|NCT02158247|11195359|FG000|NOT COMPLETED|Overall Study||5
10068738|NCT02158273|11195377|FG000|STARTED|Overall Study||25
10068739|NCT02158273|11195378|FG001|STARTED|Overall Study||25
10068740|NCT02158273|11195377|FG000|COMPLETED|Overall Study||22
10068741|NCT02158273|11195378|FG001|COMPLETED|Overall Study||22
10068742|NCT02158273|11195377|FG000|NOT COMPLETED|Overall Study||3
10068743|NCT02158273|11195378|FG001|NOT COMPLETED|Overall Study||3
10068744|NCT02158364|11195384|FG000|STARTED|Overall Study||3331
10068745|NCT02158364|11195384|FG000|COMPLETED|Overall Study||3271
10068746|NCT02158364|11195384|FG000|NOT COMPLETED|Overall Study||60
10068747|NCT02158442|11195390|FG000|STARTED|Overall Study||8
10068748|NCT02158442|11195391|FG001|STARTED|Overall Study||7
10068749|NCT02158442|11195390|FG000|COMPLETED|Overall Study||6
10068750|NCT02158442|11195391|FG001|COMPLETED|Overall Study||7
10068751|NCT02158442|11195390|FG000|NOT COMPLETED|Overall Study||2
10068752|NCT02158442|11195391|FG001|NOT COMPLETED|Overall Study||0
10068753|NCT02158494|11195399|FG000|STARTED|Overall Study||22
10068754|NCT02158494|11195400|FG001|STARTED|Overall Study||22
10068755|NCT02158494|11195399|FG000|COMPLETED|Overall Study||22
10068756|NCT02158494|11195400|FG001|COMPLETED|Overall Study||21
10068757|NCT02158494|11195399|FG000|NOT COMPLETED|Overall Study||0
10068758|NCT02158494|11195400|FG001|NOT COMPLETED|Overall Study||1
10068759|NCT02158520|11195413|FG000|STARTED|Overall Study||12
10068760|NCT02158520|11195414|FG001|STARTED|Overall Study||12
10068761|NCT02158520|11195413|FG000|AE Evaluated Prior to Crossover|Overall Study||12
10068762|NCT02158520|11195414|FG001|AE Evaluated Prior to Crossover|Overall Study||12
10068763|NCT02158520|11195413|FG000|Eligible for Crossover|Overall Study||8
10068764|NCT02158520|11195414|FG001|Eligible for Crossover|Overall Study||8
10068765|NCT02158520|11195413|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7
10068766|NCT02158520|11195414|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7
10068767|NCT02158520|11195413|FG000|Crossover Cohort|Overall Study||4
10068768|NCT02158520|11195414|FG001|Crossover Cohort|Overall Study||6
10068769|NCT02158520|11195413|FG000|COMPLETED|Overall Study||12
10068770|NCT02158520|11195414|FG001|COMPLETED|Overall Study||12
10068771|NCT02158520|11195413|FG000|NOT COMPLETED|Overall Study||0
10068772|NCT02158520|11195414|FG001|NOT COMPLETED|Overall Study||0
10068773|NCT02158533|11195425|FG000|STARTED|Stage 1||265
10068774|NCT02158533|11195426|FG001|STARTED|Stage 1||59
10068775|NCT02158533|11195427|FG002|STARTED|Stage 1||60
10068776|NCT02158533|11195428|FG003|STARTED|Stage 1||0
10068777|NCT02158533|11195429|FG004|STARTED|Stage 1||0
10068778|NCT02158533|11195430|FG005|STARTED|Stage 1||0
10068779|NCT02158533|11195425|FG000|COMPLETED|Stage 1||251
10068780|NCT02158533|11195426|FG001|COMPLETED|Stage 1||51
10068781|NCT02158533|11195427|FG002|COMPLETED|Stage 1||52
10068782|NCT02158533|11195428|FG003|COMPLETED|Stage 1||0
10068783|NCT02158533|11195429|FG004|COMPLETED|Stage 1||0
10068784|NCT02158533|11195430|FG005|COMPLETED|Stage 1||0
10068785|NCT02158533|11195425|FG000|NOT COMPLETED|Stage 1||14
10068786|NCT02158533|11195426|FG001|NOT COMPLETED|Stage 1||8
10068787|NCT02158533|11195427|FG002|NOT COMPLETED|Stage 1||8
10068788|NCT02158533|11195428|FG003|NOT COMPLETED|Stage 1||0
10068789|NCT02158533|11195429|FG004|NOT COMPLETED|Stage 1||0
10068790|NCT02158533|11195430|FG005|NOT COMPLETED|Stage 1||0
10068791|NCT02158533|11195425|FG000|STARTED|Stage 2||0
10068792|NCT02158533|11195426|FG001|STARTED|Stage 2||0
10068793|NCT02158533|11195427|FG002|STARTED|Stage 2||0
10068794|NCT02158533|11195428|FG003|STARTED|Stage 2||56
10068795|NCT02158533|11195429|FG004|STARTED|Stage 2||56
10068796|NCT02158533|11195430|FG005|STARTED|Stage 2||56
10068797|NCT02158533|11195425|FG000|COMPLETED|Stage 2||0
10068798|NCT02158533|11195426|FG001|COMPLETED|Stage 2||0
10068799|NCT02158533|11195427|FG002|COMPLETED|Stage 2||0
10068800|NCT02158533|11195428|FG003|COMPLETED|Stage 2||53
10068801|NCT02158533|11195429|FG004|COMPLETED|Stage 2||52
10068802|NCT02158533|11195430|FG005|COMPLETED|Stage 2||50
10068803|NCT02158533|11195425|FG000|NOT COMPLETED|Stage 2||0
10068804|NCT02158533|11195426|FG001|NOT COMPLETED|Stage 2||0
10068805|NCT02158533|11195427|FG002|NOT COMPLETED|Stage 2||0
10068806|NCT02158533|11195428|FG003|NOT COMPLETED|Stage 2||3
10068807|NCT02158533|11195429|FG004|NOT COMPLETED|Stage 2||4
10068808|NCT02158533|11195430|FG005|NOT COMPLETED|Stage 2||6
10068809|NCT02158546|11195448|FG000|STARTED|Overall Study||152
10068810|NCT02158546|11195449|FG001|STARTED|Overall Study||153
10068811|NCT02158546|11195450|FG002|STARTED|Overall Study||18
10068812|NCT02158546|11195451|FG003|STARTED|Overall Study||19
10068813|NCT02158546|11195448|FG000|COMPLETED|Overall Study||133
10068814|NCT02158546|11195449|FG001|COMPLETED|Overall Study||136
10068815|NCT02158546|11195450|FG002|COMPLETED|Overall Study||14
10068816|NCT02158546|11195451|FG003|COMPLETED|Overall Study||13
10068817|NCT02158546|11195448|FG000|NOT COMPLETED|Overall Study||19
10068818|NCT02158546|11195449|FG001|NOT COMPLETED|Overall Study||17
10068819|NCT02158546|11195450|FG002|NOT COMPLETED|Overall Study||4
10068820|NCT02158546|11195451|FG003|NOT COMPLETED|Overall Study||6
10068821|NCT02158572|11195461|FG000|STARTED|Overall Study||2032
10068822|NCT02158572|11195461|FG000|COMPLETED|Overall Study||989
10068823|NCT02158572|11195461|FG000|NOT COMPLETED|Overall Study||1043
10068824|NCT02158663|11195467|FG000|STARTED|Overall Study||22
10068825|NCT02158663|11195468|FG001|STARTED|Overall Study||22
10068826|NCT02158663|11195467|FG000|COMPLETED|Overall Study||17
10068827|NCT02158663|11195468|FG001|COMPLETED|Overall Study||18
10068828|NCT02158663|11195467|FG000|NOT COMPLETED|Overall Study||5
10068829|NCT02158663|11195468|FG001|NOT COMPLETED|Overall Study||4
10068830|NCT02158728|11195476|FG000|STARTED|Overall Study||80
10068831|NCT02158728|11195476|FG000|COMPLETED|Overall Study||53
10068832|NCT02158728|11195476|FG000|NOT COMPLETED|Overall Study||27
10068833|NCT02158806|11195482|FG000|STARTED|Overall Study||125
10068834|NCT02158806|11195483|FG001|STARTED|Overall Study||126
10068835|NCT02158806|11195482|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
10068836|NCT02158806|11195483|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
10068837|NCT02158806|11195482|FG000|NOT COMPLETED|Overall Study||4
10068838|NCT02158806|11195483|FG001|NOT COMPLETED|Overall Study||5
10068839|NCT02158884|11195489|FG000|STARTED|Baseline Assessment||91
10068840|NCT02158884|11195489|FG000|COMPLETED|Baseline Assessment||87
10068841|NCT02158884|11195489|FG000|NOT COMPLETED|Baseline Assessment||4
10068842|NCT02158884|11195489|FG000|STARTED|Intervention: IDEO and PT Program||87
10068843|NCT02158884|11195489|FG000|COMPLETED|Intervention: IDEO and PT Program||81
10068844|NCT02158884|11195489|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6
10068845|NCT02158884|11195489|FG000|STARTED|Post Intervention (~4 Weeks)||81
10068846|NCT02158884|11195489|FG000|COMPLETED|Post Intervention (~4 Weeks)||71
10068847|NCT02158884|11195489|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10
10068848|NCT02158884|11195489|FG000|STARTED|6 Month Assessment||81
10068849|NCT02158884|11195489|FG000|COMPLETED|6 Month Assessment||61
10068850|NCT02158884|11195489|FG000|NOT COMPLETED|6 Month Assessment||20
10068851|NCT02158884|11195489|FG000|STARTED|12 Month Assessment||81
10068852|NCT02158884|11195489|FG000|COMPLETED|12 Month Assessment||64
10068853|NCT02158884|11195489|FG000|NOT COMPLETED|12 Month Assessment||17
10068854|NCT02158936|11195496|FG000|STARTED|Overall Study||179
10068855|NCT02158936|11195497|FG001|STARTED|Overall Study||177
10068856|NCT02158936|11195496|FG000|Treated|Overall Study||177
10068857|NCT02158936|11195497|FG001|Treated|Overall Study||177
10068858|NCT02158936|11195496|FG000|Untreated|Overall Study||2
10068859|NCT02158936|11195497|FG001|Untreated|Overall Study||0
10068860|NCT02158936|11195496|FG000|COMPLETED|Overall Study||0
10068861|NCT02158936|11195497|FG001|COMPLETED|Overall Study||0
10068862|NCT02158936|11195496|FG000|NOT COMPLETED|Overall Study||179
10068863|NCT02158936|11195497|FG001|NOT COMPLETED|Overall Study||177
10068864|NCT02158949|11195505|FG000|STARTED|Overall Study||24
10068865|NCT02158949|11195506|FG001|STARTED|Overall Study||24
10068866|NCT02158949|11195505|FG000|COMPLETED|Overall Study||18
10068867|NCT02158949|11195506|FG001|COMPLETED|Overall Study||13
10068868|NCT02158949|11195505|FG000|NOT COMPLETED|Overall Study||6
10068869|NCT02158949|11195506|FG001|NOT COMPLETED|Overall Study||11
10068870|NCT02158975|11195512|FG000|STARTED|Overall Study||13
10068871|NCT02158975|11195512|FG000|COMPLETED|Overall Study||12
10068872|NCT02158975|11195512|FG000|NOT COMPLETED|Overall Study||1
10068873|NCT02159053|11195520|FG000|STARTED|Overall Study||116
10068874|NCT02159053|11195521|FG001|STARTED|Overall Study||117
10068875|NCT02159053|11195522|FG002|STARTED|Overall Study||117
10068876|NCT02159053|11195520|FG000|Paticipants Week 16 Onwards|Overall Study||116
10068877|NCT02159053|11195521|FG001|Paticipants Week 16 Onwards|Overall Study||117
10068878|NCT02159053|11195522|FG002|Paticipants Week 16 Onwards|Overall Study||113
10068879|NCT02159053|11195520|FG000|COMPLETED|Overall Study||96
10068880|NCT02159053|11195521|FG001|COMPLETED|Overall Study||96
10068881|NCT02159053|11195522|FG002|COMPLETED|Overall Study||97
10068882|NCT02159053|11195520|FG000|NOT COMPLETED|Overall Study||20
10068883|NCT02159053|11195521|FG001|NOT COMPLETED|Overall Study||21
10068884|NCT02159053|11195522|FG002|NOT COMPLETED|Overall Study||20
10068885|NCT02159079|11195534|FG000|STARTED|Overall Study||15
10068886|NCT02159079|11195535|FG001|STARTED|Overall Study||15
10068887|NCT02159079|11195534|FG000|COMPLETED|Overall Study||15
10068888|NCT02159079|11195535|FG001|COMPLETED|Overall Study||15
10068889|NCT02159079|11195534|FG000|NOT COMPLETED|Overall Study||0
10068890|NCT02159079|11195535|FG001|NOT COMPLETED|Overall Study||0
10068891|NCT02159118|11195543|FG000|STARTED|Overall Study||22
10068892|NCT02159118|11195544|FG001|STARTED|Overall Study||22
10068893|NCT02159118|11195543|FG000|COMPLETED|Overall Study||22
10068894|NCT02159118|11195544|FG001|COMPLETED|Overall Study||22
10068895|NCT02159118|11195543|FG000|NOT COMPLETED|Overall Study||0
10068896|NCT02159118|11195544|FG001|NOT COMPLETED|Overall Study||0
10068897|NCT02159183|11195552|FG000|STARTED|Analysis After the 36 Months Follow-up||22
10068898|NCT02159183|11195553|FG001|STARTED|Analysis After the 36 Months Follow-up||21
10068899|NCT02159183|11195552|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19
10068900|NCT02159183|11195553|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19
10068901|NCT02159183|11195552|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
10068902|NCT02159183|11195553|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
10068903|NCT02159183|11195552|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22
10068904|NCT02159183|11195553|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21
10068905|NCT02159183|11195552|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
10068906|NCT02159183|11195553|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
10068907|NCT02159183|11195552|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
10068908|NCT02159183|11195553|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
10068909|NCT02159352|11195561|FG000|STARTED|Overall Study||14
10068910|NCT02159352|11195562|FG001|STARTED|Overall Study||14
10068911|NCT02159352|11195561|FG000|Phase 1 (Day 1- 4)|Overall Study||14
10068912|NCT02159352|11195562|FG001|Phase 1 (Day 1- 4)|Overall Study||14
10068913|NCT02159352|11195561|FG000|Phase 2 (Day 5-14)|Overall Study||11
10068914|NCT02159352|11195562|FG001|Phase 2 (Day 5-14)|Overall Study||12
10068915|NCT02159352|11195561|FG000|COMPLETED|Overall Study||11
10068916|NCT02159352|11195562|FG001|COMPLETED|Overall Study||12
10068917|NCT02159352|11195561|FG000|NOT COMPLETED|Overall Study||3
10068918|NCT02159352|11195562|FG001|NOT COMPLETED|Overall Study||2
10068919|NCT02159365|11195587|FG000|STARTED|Overall Study||70
10068920|NCT02159365|11195587|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0
10068921|NCT02159365|11195587|FG000|NOT COMPLETED|Overall Study||70
10068922|NCT02159469|11195591|FG000|STARTED|Overall Study||150
10068923|NCT02159469|11195591|FG000|Completed 12 Week|Overall Study||137
10068924|NCT02159469|11195591|FG000|COMPLETED|Overall Study||97
10068925|NCT02159469|11195591|FG000|NOT COMPLETED|Overall Study||53
10068926|NCT02159482|11195596|FG000|STARTED|Overall Study||11
10068927|NCT02159482|11195596|FG000|COMPLETED|Overall Study||6
10068928|NCT02159482|11195596|FG000|NOT COMPLETED|Overall Study||5
10068929|NCT02159521|11195600|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81
10068930|NCT02159521|11195600|FG000|Received EkoSonic® Treatment|Overall Study||78
10068931|NCT02159521|11195600|FG000|COMPLETED|Overall Study||63
10068932|NCT02159521|11195600|FG000|NOT COMPLETED|Overall Study||18
10188982|NCT03277274|11318552|FG000|NOT COMPLETED|Overall Study||0
10188983|NCT03277274|11318553|FG001|NOT COMPLETED|Overall Study||0
10188984|NCT03277274|11318554|FG002|NOT COMPLETED|Overall Study||0
10188985|NCT03277352|11318562|FG000|STARTED|Overall Study||10
10188986|NCT03277352|11318562|FG000|COMPLETED|Overall Study||0
10188987|NCT03277352|11318562|FG000|NOT COMPLETED|Overall Study||10
10188988|NCT03277378|11318569|FG000|STARTED|Overall Study||135
10188989|NCT03277378|11318570|FG001|STARTED|Overall Study||135
10188990|NCT03277378|11318569|FG000|Received Lead Implant|Overall Study||129
10188991|NCT03277378|11318570|FG001|Received Lead Implant|Overall Study||123
10188992|NCT03277378|11318569|FG000|Completed Initial Trial|Overall Study||126
10188993|NCT03277378|11318570|FG001|Completed Initial Trial|Overall Study||122
10188994|NCT03277378|11318569|FG000|Qualified for Permanent Implant|Overall Study||103
10188995|NCT03277378|11318570|FG001|Qualified for Permanent Implant|Overall Study||93
10188996|NCT03277378|11318569|FG000|Not Qualified for Permanent Implant|Overall Study||19
10188997|NCT03277378|11318570|FG001|Not Qualified for Permanent Implant|Overall Study||20
10188998|NCT03277378|11318569|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8
10188999|NCT03277378|11318570|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12
10189000|NCT03277378|11318569|FG000|Exit Study|Overall Study||11
10189001|NCT03277378|11318570|FG001|Exit Study|Overall Study||8
10068933|NCT02159547|11195606|FG000|STARTED|Overall Study||112
10068934|NCT02159547|11195607|FG001|STARTED|Overall Study||112
10068935|NCT02159547|11195606|FG000|COMPLETED|Overall Study||112
10068936|NCT02159547|11195607|FG001|COMPLETED|Overall Study||112
10068937|NCT02159547|11195606|FG000|NOT COMPLETED|Overall Study||0
10068938|NCT02159547|11195607|FG001|NOT COMPLETED|Overall Study||0
10068939|NCT02159703|11195614|FG000|STARTED|Overall Study||60
10068940|NCT02159703|11195614|FG000|COMPLETED|Overall Study||60
10068941|NCT02159703|11195614|FG000|NOT COMPLETED|Overall Study||0
10068942|NCT02159729|11195620|FG000|STARTED|Overall Study||140
10189002|NCT03277378|11318569|FG000|COMPLETED|Overall Study||111
10189003|NCT03277378|11318570|FG001|COMPLETED|Overall Study||101
10189004|NCT03277378|11318569|FG000|NOT COMPLETED|Overall Study||24
10189005|NCT03277378|11318570|FG001|NOT COMPLETED|Overall Study||34
10189006|NCT03277794|11318582|FG000|STARTED|Overall Study||31
10189007|NCT03277794|11318583|FG001|STARTED|Overall Study||34
10189008|NCT03277794|11318582|FG000|COMPLETED|Overall Study||28
10189009|NCT03277794|11318583|FG001|COMPLETED|Overall Study||30
10189010|NCT03277794|11318582|FG000|NOT COMPLETED|Overall Study||3
10189011|NCT03277794|11318583|FG001|NOT COMPLETED|Overall Study||4
10189012|NCT03277846|11318592|FG000|STARTED|Overall Study||50
10189013|NCT03277846|11318593|FG001|STARTED|Overall Study||51
10189014|NCT03277846|11318592|FG000|COMPLETED|Overall Study||38
10189015|NCT03277846|11318593|FG001|COMPLETED|Overall Study||40
10189016|NCT03277846|11318592|FG000|NOT COMPLETED|Overall Study||12
10189017|NCT03277846|11318593|FG001|NOT COMPLETED|Overall Study||11
10189018|NCT03278028|11318601|FG000|STARTED|Overall Study||81
10189019|NCT03278028|11318602|FG001|STARTED|Overall Study||78
10189020|NCT03278028|11318601|FG000|COMPLETED|Overall Study||77
10189021|NCT03278028|11318602|FG001|COMPLETED|Overall Study||76
10189022|NCT03278028|11318601|FG000|NOT COMPLETED|Overall Study||4
10189023|NCT03278028|11318602|FG001|NOT COMPLETED|Overall Study||2
10189024|NCT03278067|11318611|FG000|STARTED|Overall Study||16433
10189025|NCT03278067|11318612|FG001|STARTED|Overall Study||3310
10189026|NCT03278067|11318613|FG002|STARTED|Overall Study||4196
10189027|NCT03278067|11318611|FG000|COMPLETED|Overall Study||16433
10189028|NCT03278067|11318612|FG001|COMPLETED|Overall Study||3310
10189029|NCT03278067|11318613|FG002|COMPLETED|Overall Study||4196
10189030|NCT03278067|11318611|FG000|NOT COMPLETED|Overall Study||0
10189031|NCT03278067|11318612|FG001|NOT COMPLETED|Overall Study||0
10189032|NCT03278067|11318613|FG002|NOT COMPLETED|Overall Study||0
10189033|NCT03278106|11318626|FG000|STARTED|Overall Study||28
10189034|NCT03278106|11318626|FG000|COMPLETED|Overall Study||27
10189035|NCT03278106|11318626|FG000|NOT COMPLETED|Overall Study||1
10189036|NCT03278223|11318632|FG000|STARTED|Overall Study||125
10189037|NCT03278223|11318633|FG001|STARTED|Overall Study||69
10189038|NCT03278223|11318632|FG000|COMPLETED|Overall Study||122
10189039|NCT03278223|11318633|FG001|COMPLETED|Overall Study||65
10189040|NCT03278223|11318632|FG000|NOT COMPLETED|Overall Study||3
10189041|NCT03278223|11318633|FG001|NOT COMPLETED|Overall Study||4
10189042|NCT03278613|11318641|FG000|STARTED|Overall Study||111
10189043|NCT03278613|11318642|FG001|STARTED|Overall Study||55
10189044|NCT03278613|11318641|FG000|COMPLETED|Overall Study||108
10189045|NCT03278613|11318642|FG001|COMPLETED|Overall Study||54
10189046|NCT03278613|11318641|FG000|NOT COMPLETED|Overall Study||3
10189047|NCT03278613|11318642|FG001|NOT COMPLETED|Overall Study||1
10189048|NCT03278886|11318650|FG000|STARTED|Overall Study||8
10189049|NCT03278886|11318651|FG001|STARTED|Overall Study||3
10189050|NCT03278886|11318650|FG000|COMPLETED|Overall Study||8
10189051|NCT03278886|11318651|FG001|COMPLETED|Overall Study||2
10189052|NCT03278886|11318650|FG000|NOT COMPLETED|Overall Study||0
10189053|NCT03278886|11318651|FG001|NOT COMPLETED|Overall Study||1
10189054|NCT03279237|11318657|FG000|STARTED|Overall Study||25
10189055|NCT03279237|11318657|FG000|Chemo-radiation|Overall Study||23
10189056|NCT03279237|11318657|FG000|Surgical Resection|Overall Study||20
10189057|NCT03279237|11318657|FG000|COMPLETED|Overall Study||20
10189058|NCT03279237|11318657|FG000|NOT COMPLETED|Overall Study||5
10189059|NCT03279458|11318661|FG000|STARTED|Overall Study||40
10189060|NCT03279458|11318661|FG000|COMPLETED|Overall Study||40
10189061|NCT03279458|11318661|FG000|NOT COMPLETED|Overall Study||0
10189062|NCT03279731|11318669|FG000|STARTED|Overall Study||19
10189063|NCT03279731|11318670|FG001|STARTED|Overall Study||17
10189064|NCT03279731|11318669|FG000|COMPLETED|Overall Study||13
10189065|NCT03279731|11318670|FG001|COMPLETED|Overall Study||14
10189066|NCT03279731|11318669|FG000|NOT COMPLETED|Overall Study||6
10068943|NCT02159729|11195621|FG001|STARTED|Overall Study||65
10068944|NCT02159729|11195620|FG000|COMPLETED|Overall Study||98
10068945|NCT02159729|11195621|FG001|COMPLETED|Overall Study||44
10189067|NCT03279731|11318670|FG001|NOT COMPLETED|Overall Study||3
10189068|NCT03280108|11318680|FG000|STARTED|Overall Study||129
10189069|NCT03280108|11318681|FG001|STARTED|Overall Study||114
10189070|NCT03280108|11318680|FG000|COMPLETED|Overall Study||127
10189071|NCT03280108|11318681|FG001|COMPLETED|Overall Study||114
10189072|NCT03280108|11318680|FG000|NOT COMPLETED|Overall Study||2
10189073|NCT03280108|11318681|FG001|NOT COMPLETED|Overall Study||0
10189074|NCT03280121|11318692|FG000|STARTED|Overall Study||14
10189075|NCT03280121|11318692|FG000|COMPLETED|Overall Study||8
10189076|NCT03280121|11318692|FG000|NOT COMPLETED|Overall Study||6
10189077|NCT03280264|11318696|FG000|STARTED|Overall Study||18
10189078|NCT03280264|11318696|FG000|COMPLETED|Overall Study||15
10068946|NCT02159729|11195620|FG000|NOT COMPLETED|Overall Study||42
10068947|NCT02159729|11195621|FG001|NOT COMPLETED|Overall Study||21
10068948|NCT02159768|11195627|FG000|STARTED|Overall Study|Started 16 July 2014|30
10068949|NCT02159768|11195627|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30
10068950|NCT02159768|11195627|FG000|NOT COMPLETED|Overall Study||0
10068951|NCT02159807|11195634|FG000|STARTED|Overall Study||67
10068952|NCT02159807|11195635|FG001|STARTED|Overall Study||52
10068953|NCT02159807|11195636|FG002|STARTED|Overall Study||51
10068954|NCT02159807|11195634|FG000|COMPLETED|Overall Study||66
10068955|NCT02159807|11195635|FG001|COMPLETED|Overall Study||51
10068956|NCT02159807|11195636|FG002|COMPLETED|Overall Study||48
10068957|NCT02159807|11195634|FG000|NOT COMPLETED|Overall Study||1
10068958|NCT02159807|11195635|FG001|NOT COMPLETED|Overall Study||1
10068959|NCT02159807|11195636|FG002|NOT COMPLETED|Overall Study||3
10068960|NCT02159859|11195644|FG000|STARTED|Overall Study||7
10068961|NCT02159859|11195644|FG000|COMPLETED|Overall Study||7
10068962|NCT02159859|11195644|FG000|NOT COMPLETED|Overall Study||0
10068963|NCT02159872|11195648|FG000|STARTED|Overall Study||48
10068964|NCT02159872|11195648|FG000|COMPLETED|Overall Study||48
10068965|NCT02159872|11195648|FG000|NOT COMPLETED|Overall Study||0
10068966|NCT02159898|11195654|FG000|STARTED|Overall Study||30
10068967|NCT02159898|11195655|FG001|STARTED|Overall Study||30
10068968|NCT02159898|11195654|FG000|COMPLETED|Overall Study||29
10068969|NCT02159898|11195655|FG001|COMPLETED|Overall Study||30
10068970|NCT02159898|11195654|FG000|NOT COMPLETED|Overall Study||1
10068971|NCT02159898|11195655|FG001|NOT COMPLETED|Overall Study||0
10068972|NCT02159950|11195665|FG000|STARTED|Overall Study||0
10068973|NCT02159950|11195666|FG001|STARTED|Overall Study||2
10068974|NCT02159950|11195665|FG000|COMPLETED|Overall Study||0
10068975|NCT02159950|11195666|FG001|COMPLETED|Overall Study||0
10068976|NCT02159950|11195665|FG000|NOT COMPLETED|Overall Study||0
10068977|NCT02159950|11195666|FG001|NOT COMPLETED|Overall Study||2
10068978|NCT02159976|11195674|FG000|STARTED|Overall Study||195
10068979|NCT02159976|11195675|FG001|STARTED|Overall Study||195
10068980|NCT02159976|11195674|FG000|COMPLETED|Overall Study||165
10068981|NCT02159976|11195675|FG001|COMPLETED|Overall Study||170
10068982|NCT02159976|11195674|FG000|NOT COMPLETED|Overall Study||30
10068983|NCT02159976|11195675|FG001|NOT COMPLETED|Overall Study||25
10068984|NCT02160002|11195685|FG000|STARTED|Overall Study||187
10068985|NCT02160002|11195686|FG001|STARTED|Overall Study||179
10068986|NCT02160002|11195685|FG000|Primary Outcome|Overall Study||185
10068987|NCT02160002|11195686|FG001|Primary Outcome|Overall Study||178
10068988|NCT02160002|11195685|FG000|COMPLETED|Overall Study||185
10068989|NCT02160002|11195686|FG001|COMPLETED|Overall Study||178
10068990|NCT02160002|11195685|FG000|NOT COMPLETED|Overall Study||2
10068991|NCT02160002|11195686|FG001|NOT COMPLETED|Overall Study||1
10068992|NCT02160041|11195692|FG000|STARTED|Overall Study||84
10068993|NCT02160041|11195692|FG000|COMPLETED|Overall Study||0
10068994|NCT02160041|11195692|FG000|NOT COMPLETED|Overall Study||84
10068995|NCT02160145|11195698|FG000|STARTED|Prerandomization Single-blind Period||1519
10068996|NCT02160145|11195699|FG001|STARTED|Prerandomization Single-blind Period||0
10068997|NCT02160145|11195700|FG002|STARTED|Prerandomization Single-blind Period||0
10068998|NCT02160145|11195698|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
10068999|NCT02160145|11195699|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
10069000|NCT02160145|11195700|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
10069001|NCT02160145|11195698|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
10069002|NCT02160145|11195699|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
10069003|NCT02160145|11195700|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
10069004|NCT02160145|11195698|FG000|Randomized|Prerandomization Single-blind Period||1370
10069005|NCT02160145|11195699|FG001|Randomized|Prerandomization Single-blind Period||0
10069006|NCT02160145|11195700|FG002|Randomized|Prerandomization Single-blind Period||0
10069007|NCT02160145|11195698|FG000|COMPLETED|Prerandomization Single-blind Period||1370
10069008|NCT02160145|11195699|FG001|COMPLETED|Prerandomization Single-blind Period||0
10069009|NCT02160145|11195700|FG002|COMPLETED|Prerandomization Single-blind Period||0
10069010|NCT02160145|11195698|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149
10069011|NCT02160145|11195699|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0
10069012|NCT02160145|11195700|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0
10069013|NCT02160145|11195698|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
10069014|NCT02160145|11195699|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
10069015|NCT02160145|11195700|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
10069016|NCT02160145|11195698|FG000|On-treatment Completers|Randomized Double-blind Period||0
10069017|NCT02160145|11195699|FG001|On-treatment Completers|Randomized Double-blind Period||578
10069018|NCT02160145|11195700|FG002|On-treatment Completers|Randomized Double-blind Period||637
10069019|NCT02160145|11195698|FG000|Off-treatment Completers|Randomized Double-blind Period||0
10069020|NCT02160145|11195699|FG001|Off-treatment Completers|Randomized Double-blind Period||76
10069021|NCT02160145|11195700|FG002|Off-treatment Completers|Randomized Double-blind Period||22
10069022|NCT02160145|11195698|FG000|COMPLETED|Randomized Double-blind Period||0
10069023|NCT02160145|11195699|FG001|COMPLETED|Randomized Double-blind Period||654
10069024|NCT02160145|11195700|FG002|COMPLETED|Randomized Double-blind Period||659
10069025|NCT02160145|11195698|FG000|NOT COMPLETED|Randomized Double-blind Period||0
10069026|NCT02160145|11195699|FG001|NOT COMPLETED|Randomized Double-blind Period||29
10069027|NCT02160145|11195700|FG002|NOT COMPLETED|Randomized Double-blind Period||28
10069028|NCT02160288|11195709|FG000|STARTED|Overall Study||1
10069029|NCT02160288|11195710|FG001|STARTED|Overall Study||0
10069030|NCT02160288|11195709|FG000|COMPLETED|Overall Study||1
10069031|NCT02160288|11195710|FG001|COMPLETED|Overall Study||0
10069032|NCT02160288|11195709|FG000|NOT COMPLETED|Overall Study||0
10069033|NCT02160288|11195710|FG001|NOT COMPLETED|Overall Study||0
10069034|NCT02160314|11195718|FG000|STARTED|Overall Study||73
10069035|NCT02160314|11195719|FG001|STARTED|Overall Study||72
10069036|NCT02160314|11195718|FG000|COMPLETED|Overall Study||72
10069037|NCT02160314|11195719|FG001|COMPLETED|Overall Study||59
10069038|NCT02160314|11195718|FG000|NOT COMPLETED|Overall Study||1
10069039|NCT02160314|11195719|FG001|NOT COMPLETED|Overall Study||13
10069040|NCT02160535|11195725|FG000|STARTED|Overall Study||13
10069041|NCT02160535|11195725|FG000|COMPLETED|Overall Study||10
10069042|NCT02160535|11195725|FG000|NOT COMPLETED|Overall Study||3
10069043|NCT02160626|11195732|FG000|STARTED|Overall Study||58
10069044|NCT02160626|11195733|FG001|STARTED|Overall Study||57
10069045|NCT02160626|11195734|FG002|STARTED|Overall Study||57
10069046|NCT02160626|11195732|FG000|COMPLETED|Overall Study||57
10069047|NCT02160626|11195733|FG001|COMPLETED|Overall Study||56
10069048|NCT02160626|11195734|FG002|COMPLETED|Overall Study||56
10069049|NCT02160626|11195732|FG000|NOT COMPLETED|Overall Study||1
10069050|NCT02160626|11195733|FG001|NOT COMPLETED|Overall Study||1
10069051|NCT02160626|11195734|FG002|NOT COMPLETED|Overall Study||1
10069052|NCT02160730|11195744|FG000|STARTED|Overall Study||4
10069053|NCT02160730|11195744|FG000|COMPLETED|Overall Study||4
10069054|NCT02160730|11195744|FG000|NOT COMPLETED|Overall Study||0
10189079|NCT03280264|11318696|FG000|NOT COMPLETED|Overall Study||3
10189080|NCT03280381|11318703|FG000|STARTED|Overall Study||101
10189081|NCT03280381|11318704|FG001|STARTED|Overall Study||99
10189082|NCT03280381|11318703|FG000|COMPLETED|Overall Study||101
10189083|NCT03280381|11318704|FG001|COMPLETED|Overall Study||97
10189084|NCT03280381|11318703|FG000|NOT COMPLETED|Overall Study||0
10189085|NCT03280381|11318704|FG001|NOT COMPLETED|Overall Study||2
10189086|NCT03280537|11318713|FG000|STARTED|Overall Study||65
10189087|NCT03280537|11318714|FG001|STARTED|Overall Study||62
10189088|NCT03280537|11318713|FG000|COMPLETED|Overall Study||63
10189089|NCT03280537|11318714|FG001|COMPLETED|Overall Study||58
10189090|NCT03280537|11318713|FG000|NOT COMPLETED|Overall Study||2
10189091|NCT03280537|11318714|FG001|NOT COMPLETED|Overall Study||4
10189092|NCT03280550|11318722|FG000|STARTED|Overall Study||66
10189093|NCT03280550|11318723|FG001|STARTED|Overall Study||72
10189094|NCT03280550|11318722|FG000|COMPLETED|Overall Study||64
10189095|NCT03280550|11318723|FG001|COMPLETED|Overall Study||69
10189096|NCT03280550|11318722|FG000|NOT COMPLETED|Overall Study||2
10189097|NCT03280550|11318723|FG001|NOT COMPLETED|Overall Study||3
10189098|NCT03280615|11318731|FG000|STARTED|Overall Study||50
10189099|NCT03280615|11318732|FG001|STARTED|Overall Study||50
10189100|NCT03280615|11318731|FG000|COMPLETED|Overall Study||46
10189101|NCT03280615|11318732|FG001|COMPLETED|Overall Study||45
10189102|NCT03280615|11318731|FG000|NOT COMPLETED|Overall Study||4
10189103|NCT03280615|11318732|FG001|NOT COMPLETED|Overall Study||5
10189104|NCT03281200|11318738|FG000|STARTED|Overall Study||172
10189105|NCT03281200|11318738|FG000|COMPLETED|Overall Study||172
10189106|NCT03281200|11318738|FG000|NOT COMPLETED|Overall Study||0
10189107|NCT03281538|11318742|FG000|STARTED|Overall Study||288
10189108|NCT03281538|11318742|FG000|COMPLETED|Overall Study||133
10189109|NCT03281538|11318742|FG000|NOT COMPLETED|Overall Study||155
10189110|NCT03281577|11318750|FG000|STARTED|Overall Study||10
10189111|NCT03281577|11318751|FG001|STARTED|Overall Study||10
10189112|NCT03281577|11318752|FG002|STARTED|Overall Study||9
10189113|NCT03281577|11318753|FG003|STARTED|Overall Study||7
10189114|NCT03281577|11318750|FG000|COMPLETED|Overall Study||9
10189115|NCT03281577|11318751|FG001|COMPLETED|Overall Study||10
10189116|NCT03281577|11318752|FG002|COMPLETED|Overall Study||9
10189117|NCT03281577|11318753|FG003|COMPLETED|Overall Study||6
10189118|NCT03281577|11318750|FG000|NOT COMPLETED|Overall Study||1
10189119|NCT03281577|11318751|FG001|NOT COMPLETED|Overall Study||0
10189120|NCT03281577|11318752|FG002|NOT COMPLETED|Overall Study||0
10189121|NCT03281577|11318753|FG003|NOT COMPLETED|Overall Study||1
10189122|NCT03281668|11318766|FG000|STARTED|Overall Study||29
10189123|NCT03281668|11318766|FG000|COMPLETED|Overall Study||21
10189124|NCT03281668|11318766|FG000|NOT COMPLETED|Overall Study||8
10189125|NCT03281876|11318772|FG000|STARTED|Overall Study||304
10189126|NCT03281876|11318773|FG001|STARTED|Overall Study||302
10189127|NCT03281876|11318772|FG000|COMPLETED|Overall Study||281
10189128|NCT03281876|11318773|FG001|COMPLETED|Overall Study||263
10189129|NCT03281876|11318772|FG000|NOT COMPLETED|Overall Study||23
10189130|NCT03281876|11318773|FG001|NOT COMPLETED|Overall Study||39
10189131|NCT03282071|11318781|FG000|STARTED|Overall Study||75
10189132|NCT03282071|11318782|FG001|STARTED|Overall Study||69
10189133|NCT03282071|11318781|FG000|COMPLETED|Overall Study||65
10189134|NCT03282071|11318782|FG001|COMPLETED|Overall Study||60
10069055|NCT02160782|11195749|FG000|STARTED|Open-label Period: Maralixibat||31
10069056|NCT02160782|11195750|FG001|STARTED|Open-label Period: Maralixibat||0
10069057|NCT02160782|11195751|FG002|STARTED|Open-label Period: Maralixibat||0
10069058|NCT02160782|11195752|FG003|STARTED|Open-label Period: Maralixibat||0
10189135|NCT03282071|11318781|FG000|NOT COMPLETED|Overall Study||10
10189136|NCT03282071|11318782|FG001|NOT COMPLETED|Overall Study||9
10189137|NCT03282227|11318790|FG000|STARTED|Overall Study||342
10069059|NCT02160782|11195753|FG004|STARTED|Open-label Period: Maralixibat||0
10069060|NCT02160782|11195749|FG000|COMPLETED|Open-label Period: Maralixibat||29
10069061|NCT02160782|11195750|FG001|COMPLETED|Open-label Period: Maralixibat||0
10069062|NCT02160782|11195751|FG002|COMPLETED|Open-label Period: Maralixibat||0
10069063|NCT02160782|11195752|FG003|COMPLETED|Open-label Period: Maralixibat||0
10069064|NCT02160782|11195753|FG004|COMPLETED|Open-label Period: Maralixibat||0
10069065|NCT02160782|11195749|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2
10069066|NCT02160782|11195750|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0
10069067|NCT02160782|11195751|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0
10069068|NCT02160782|11195752|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0
10069069|NCT02160782|11195753|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0
10069070|NCT02160782|11195749|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
10069071|NCT02160782|11195750|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
10069072|NCT02160782|11195751|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
10069073|NCT02160782|11195752|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
10069074|NCT02160782|11195753|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
10069075|NCT02160782|11195749|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069076|NCT02160782|11195750|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
10069077|NCT02160782|11195751|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
10069078|NCT02160782|11195752|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069079|NCT02160782|11195753|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069080|NCT02160782|11195749|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069081|NCT02160782|11195750|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069082|NCT02160782|11195751|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069083|NCT02160782|11195752|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069084|NCT02160782|11195753|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10069085|NCT02160782|11195749|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0
10069086|NCT02160782|11195750|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0
10069087|NCT02160782|11195751|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0
10069088|NCT02160782|11195752|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29
10069089|NCT02160782|11195753|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0
10069090|NCT02160782|11195749|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069091|NCT02160782|11195750|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069092|NCT02160782|11195751|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069093|NCT02160782|11195752|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23
10069094|NCT02160782|11195753|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069095|NCT02160782|11195749|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069096|NCT02160782|11195750|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069097|NCT02160782|11195751|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069098|NCT02160782|11195752|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
10069099|NCT02160782|11195753|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10069100|NCT02160782|11195749|FG000|STARTED|Long-term Extension Period: Maralixibat||0
10069101|NCT02160782|11195750|FG001|STARTED|Long-term Extension Period: Maralixibat||0
10069102|NCT02160782|11195751|FG002|STARTED|Long-term Extension Period: Maralixibat||0
10069103|NCT02160782|11195752|FG003|STARTED|Long-term Extension Period: Maralixibat||0
10069104|NCT02160782|11195753|FG004|STARTED|Long-term Extension Period: Maralixibat||23
10069105|NCT02160782|11195749|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0
10069106|NCT02160782|11195750|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0
10069107|NCT02160782|11195751|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0
10069108|NCT02160782|11195752|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0
10069109|NCT02160782|11195753|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14
10069110|NCT02160782|11195749|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10069111|NCT02160782|11195750|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10069112|NCT02160782|11195751|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10069113|NCT02160782|11195752|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10069114|NCT02160782|11195753|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
10069115|NCT02160808|11195779|FG000|STARTED|Overall Study||87
10069116|NCT02160808|11195780|FG001|STARTED|Overall Study||83
10069117|NCT02160808|11195779|FG000|COMPLETED|Overall Study||87
10069118|NCT02160808|11195780|FG001|COMPLETED|Overall Study||83
10069119|NCT02160808|11195779|FG000|NOT COMPLETED|Overall Study||0
10069120|NCT02160808|11195780|FG001|NOT COMPLETED|Overall Study||0
10069121|NCT02160847|11195788|FG000|STARTED|Overall Study||16
10069122|NCT02160847|11195789|FG001|STARTED|Overall Study||16
10069123|NCT02160847|11195788|FG000|COMPLETED|Overall Study||16
10069124|NCT02160847|11195789|FG001|COMPLETED|Overall Study||16
10069125|NCT02160847|11195788|FG000|NOT COMPLETED|Overall Study||0
10069126|NCT02160847|11195789|FG001|NOT COMPLETED|Overall Study||0
10189138|NCT03282227|11318790|FG000|Completed at Least 6 Months|Overall Study||257
10189139|NCT03282227|11318790|FG000|COMPLETED|Overall Study||127
10189140|NCT03282227|11318790|FG000|NOT COMPLETED|Overall Study||215
10189141|NCT03282357|11318794|FG000|STARTED|Overall Study||181
10189142|NCT03282357|11318794|FG000|Safety Evaluation Set|Overall Study||176
10189143|NCT03282357|11318794|FG000|COMPLETED|Overall Study||164
10189144|NCT03282357|11318794|FG000|NOT COMPLETED|Overall Study||17
10189145|NCT03282591|11318801|FG000|STARTED|Overall Study||92
10189146|NCT03282591|11318802|FG001|STARTED|Overall Study||93
10069127|NCT02160873|11195797|FG000|STARTED|Overall Study||6
10069128|NCT02160873|11195798|FG001|STARTED|Overall Study||6
10069129|NCT02160873|11195797|FG000|COMPLETED|Overall Study||6
10069130|NCT02160873|11195798|FG001|COMPLETED|Overall Study||6
10069131|NCT02160873|11195797|FG000|NOT COMPLETED|Overall Study||0
10069132|NCT02160873|11195798|FG001|NOT COMPLETED|Overall Study||0
10069133|NCT02160899|11195816|FG000|STARTED|Overall Study||26
10069134|NCT02160899|11195817|FG001|STARTED|Overall Study||4
10069135|NCT02160899|11195818|FG002|STARTED|Overall Study||21
10069136|NCT02160899|11195819|FG003|STARTED|Overall Study||3
10069137|NCT02160899|11195820|FG004|STARTED|Overall Study||2
10069138|NCT02160899|11195821|FG005|STARTED|Overall Study||8
10069139|NCT02160899|11195816|FG000|COMPLETED|Overall Study||26
10069140|NCT02160899|11195817|FG001|COMPLETED|Overall Study||3
10069141|NCT02160899|11195818|FG002|COMPLETED|Overall Study||21
10069142|NCT02160899|11195819|FG003|COMPLETED|Overall Study||2
10069143|NCT02160899|11195820|FG004|COMPLETED|Overall Study||0
10069144|NCT02160899|11195821|FG005|COMPLETED|Overall Study||8
10069145|NCT02160899|11195816|FG000|NOT COMPLETED|Overall Study||0
10069146|NCT02160899|11195817|FG001|NOT COMPLETED|Overall Study||1
10069147|NCT02160899|11195818|FG002|NOT COMPLETED|Overall Study||0
10069148|NCT02160899|11195819|FG003|NOT COMPLETED|Overall Study||1
10069149|NCT02160899|11195820|FG004|NOT COMPLETED|Overall Study||2
10069150|NCT02160899|11195821|FG005|NOT COMPLETED|Overall Study||0
10069151|NCT02160977|11195837|FG000|STARTED|One Week After Surgery||45
10069152|NCT02160977|11195838|FG001|STARTED|One Week After Surgery||45
10069153|NCT02160977|11195837|FG000|COMPLETED|One Week After Surgery||45
10069154|NCT02160977|11195838|FG001|COMPLETED|One Week After Surgery||45
10069155|NCT02160977|11195837|FG000|NOT COMPLETED|One Week After Surgery||0
10069156|NCT02160977|11195838|FG001|NOT COMPLETED|One Week After Surgery||0
10069157|NCT02160977|11195837|FG000|STARTED|Six Weeks After Surgery||45
10069158|NCT02160977|11195838|FG001|STARTED|Six Weeks After Surgery||45
10069159|NCT02160977|11195837|FG000|COMPLETED|Six Weeks After Surgery||44
10069160|NCT02160977|11195838|FG001|COMPLETED|Six Weeks After Surgery||45
10069161|NCT02160977|11195837|FG000|NOT COMPLETED|Six Weeks After Surgery||1
10069162|NCT02160977|11195838|FG001|NOT COMPLETED|Six Weeks After Surgery||0
10069163|NCT02160977|11195837|FG000|STARTED|Three Months After Surgery||44
10069164|NCT02160977|11195838|FG001|STARTED|Three Months After Surgery||45
10069165|NCT02160977|11195837|FG000|COMPLETED|Three Months After Surgery||44
10069166|NCT02160977|11195838|FG001|COMPLETED|Three Months After Surgery||43
10069167|NCT02160977|11195837|FG000|NOT COMPLETED|Three Months After Surgery||0
10069168|NCT02160977|11195838|FG001|NOT COMPLETED|Three Months After Surgery||2
10069169|NCT02160977|11195837|FG000|STARTED|Six Months After Surgery||44
10069170|NCT02160977|11195838|FG001|STARTED|Six Months After Surgery||43
10069171|NCT02160977|11195837|FG000|COMPLETED|Six Months After Surgery||42
10069172|NCT02160977|11195838|FG001|COMPLETED|Six Months After Surgery||42
10069173|NCT02160977|11195837|FG000|NOT COMPLETED|Six Months After Surgery||2
10069174|NCT02160977|11195838|FG001|NOT COMPLETED|Six Months After Surgery||1
10069175|NCT02160990|11195846|FG000|STARTED|Overall Study||10
10069176|NCT02160990|11195847|FG001|STARTED|Overall Study||10
10069177|NCT02160990|11195846|FG000|COMPLETED|Overall Study||10
10069178|NCT02160990|11195847|FG001|COMPLETED|Overall Study||10
10069179|NCT02160990|11195846|FG000|NOT COMPLETED|Overall Study||0
10069180|NCT02160990|11195847|FG001|NOT COMPLETED|Overall Study||0
10069181|NCT02161133|11195855|FG000|STARTED|Overall Study||135
10069182|NCT02161133|11195856|FG001|STARTED|Overall Study||133
10069183|NCT02161133|11195855|FG000|COMPLETED|Overall Study||116
10069184|NCT02161133|11195856|FG001|COMPLETED|Overall Study||122
10069185|NCT02161133|11195855|FG000|NOT COMPLETED|Overall Study||19
10069186|NCT02161133|11195856|FG001|NOT COMPLETED|Overall Study||11
10069187|NCT02161146|11195867|FG000|STARTED|Overall Study||47
10069188|NCT02161146|11195868|FG001|STARTED|Overall Study||47
10069189|NCT02161146|11195869|FG002|STARTED|Overall Study||49
10069190|NCT02161146|11195870|FG003|STARTED|Overall Study||48
10069191|NCT02161146|11195871|FG004|STARTED|Overall Study||49
10069192|NCT02161146|11195867|FG000|COMPLETED|Overall Study||46
10069193|NCT02161146|11195868|FG001|COMPLETED|Overall Study||43
10069194|NCT02161146|11195869|FG002|COMPLETED|Overall Study||49
10069195|NCT02161146|11195870|FG003|COMPLETED|Overall Study||45
10069196|NCT02161146|11195871|FG004|COMPLETED|Overall Study||48
10069197|NCT02161146|11195867|FG000|NOT COMPLETED|Overall Study||1
10069198|NCT02161146|11195868|FG001|NOT COMPLETED|Overall Study||4
10069199|NCT02161146|11195869|FG002|NOT COMPLETED|Overall Study||0
10069200|NCT02161146|11195870|FG003|NOT COMPLETED|Overall Study||3
10069201|NCT02161146|11195871|FG004|NOT COMPLETED|Overall Study||1
10069202|NCT02161185|11195881|FG000|STARTED|Test Dose Phase||7
10069203|NCT02161185|11195881|FG000|COMPLETED|Test Dose Phase||7
10069204|NCT02161185|11195881|FG000|NOT COMPLETED|Test Dose Phase||0
10069205|NCT02161185|11195881|FG000|STARTED|Treatment Phase||7
10069206|NCT02161185|11195881|FG000|COMPLETED|Treatment Phase||0
10069207|NCT02161185|11195881|FG000|NOT COMPLETED|Treatment Phase||7
10069208|NCT02161406|11195887|FG000|STARTED|Overall Study||44
10069209|NCT02161406|11195888|FG001|STARTED|Overall Study||44
10069210|NCT02161406|11195887|FG000|COMPLETED|Overall Study||34
10069211|NCT02161406|11195888|FG001|COMPLETED|Overall Study||35
10069212|NCT02161406|11195887|FG000|NOT COMPLETED|Overall Study||10
10069213|NCT02161406|11195888|FG001|NOT COMPLETED|Overall Study||9
10069214|NCT02161458|11195898|FG000|STARTED|Overall Study||22
10069215|NCT02161458|11195899|FG001|STARTED|Overall Study||35
10069216|NCT02161458|11195900|FG002|STARTED|Overall Study||33
10069217|NCT02161458|11195901|FG003|STARTED|Overall Study||8
10069218|NCT02161458|11195898|FG000|COMPLETED|Overall Study||22
10069219|NCT02161458|11195899|FG001|COMPLETED|Overall Study||29
10069220|NCT02161458|11195900|FG002|COMPLETED|Overall Study||28
10069221|NCT02161458|11195901|FG003|COMPLETED|Overall Study||8
10069222|NCT02161458|11195898|FG000|NOT COMPLETED|Overall Study||0
10069223|NCT02161458|11195899|FG001|NOT COMPLETED|Overall Study||6
10069224|NCT02161458|11195900|FG002|NOT COMPLETED|Overall Study||5
10069225|NCT02161458|11195901|FG003|NOT COMPLETED|Overall Study||0
10069226|NCT02161484|11195913|FG000|STARTED|Overall Study||5
10069227|NCT02161484|11195914|FG001|STARTED|Overall Study||5
10069228|NCT02161484|11195913|FG000|COMPLETED|Overall Study||1
10069229|NCT02161484|11195914|FG001|COMPLETED|Overall Study||2
10069230|NCT02161484|11195913|FG000|NOT COMPLETED|Overall Study||4
10069231|NCT02161484|11195914|FG001|NOT COMPLETED|Overall Study||3
10069232|NCT02161536|11195923|FG000|STARTED|Overall Study||6
10069233|NCT02161536|11195924|FG001|STARTED|Overall Study||21
10069234|NCT02161536|11195925|FG002|STARTED|Overall Study||20
10069235|NCT02161536|11195923|FG000|COMPLETED|Overall Study||6
10069236|NCT02161536|11195924|FG001|COMPLETED|Overall Study||21
10069237|NCT02161536|11195925|FG002|COMPLETED|Overall Study||20
10069238|NCT02161536|11195923|FG000|NOT COMPLETED|Overall Study||0
10069239|NCT02161536|11195924|FG001|NOT COMPLETED|Overall Study||0
10069240|NCT02161536|11195925|FG002|NOT COMPLETED|Overall Study||0
10069241|NCT02161549|11195935|FG000|STARTED|Overall Study||40
10069242|NCT02161549|11195936|FG001|STARTED|Overall Study||31
10069243|NCT02161549|11195935|FG000|COMPLETED|Overall Study||34
10069244|NCT02161549|11195936|FG001|COMPLETED|Overall Study||29
10069245|NCT02161549|11195935|FG000|NOT COMPLETED|Overall Study||6
10069246|NCT02161549|11195936|FG001|NOT COMPLETED|Overall Study||2
10069247|NCT02161562|11195944|FG000|STARTED|Overall Study||178
10069248|NCT02161562|11195945|FG001|STARTED|Overall Study||136
10069249|NCT02161562|11195944|FG000|COMPLETED|Overall Study||152
10069250|NCT02161562|11195945|FG001|COMPLETED|Overall Study||119
10069251|NCT02161562|11195944|FG000|NOT COMPLETED|Overall Study||26
10069252|NCT02161562|11195945|FG001|NOT COMPLETED|Overall Study||17
10069253|NCT02161575|11195964|FG000|STARTED|Overall Study||103
10069254|NCT02161575|11195964|FG000|Full Analysis Set (FAS) Population|Overall Study||100
10069255|NCT02161575|11195964|FG000|Safety (SAF) Population|Overall Study||100
10069256|NCT02161575|11195964|FG000|COMPLETED|Overall Study||92
10069257|NCT02161575|11195964|FG000|NOT COMPLETED|Overall Study||11
10069258|NCT02161705|11195970|FG000|STARTED|Overall Study||9
10069259|NCT02161705|11195971|FG001|STARTED|Overall Study||9
10069260|NCT02161705|11195970|FG000|COMPLETED|Overall Study||9
10069261|NCT02161705|11195971|FG001|COMPLETED|Overall Study||9
10069262|NCT02161705|11195970|FG000|NOT COMPLETED|Overall Study||0
10069263|NCT02161705|11195971|FG001|NOT COMPLETED|Overall Study||0
10069264|NCT02161718|11195979|FG000|STARTED|Open-Label ALKS 3831 Period||255
10069265|NCT02161718|11195980|FG001|STARTED|Open-Label ALKS 3831 Period||0
10069266|NCT02161718|11195981|FG002|STARTED|Open-Label ALKS 3831 Period||0
10069267|NCT02161718|11195979|FG000|COMPLETED|Open-Label ALKS 3831 Period||234
10069268|NCT02161718|11195980|FG001|COMPLETED|Open-Label ALKS 3831 Period||0
10069269|NCT02161718|11195981|FG002|COMPLETED|Open-Label ALKS 3831 Period||0
10069270|NCT02161718|11195979|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21
10069271|NCT02161718|11195980|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0
10069272|NCT02161718|11195981|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0
10069273|NCT02161718|11195979|FG000|STARTED|Post- Randomization Period||0
10069274|NCT02161718|11195980|FG001|STARTED|Post- Randomization Period||112
10069275|NCT02161718|11195981|FG002|STARTED|Post- Randomization Period||117
10069276|NCT02161718|11195979|FG000|COMPLETED|Post- Randomization Period||0
10069277|NCT02161718|11195980|FG001|COMPLETED|Post- Randomization Period||53
10069278|NCT02161718|11195981|FG002|COMPLETED|Post- Randomization Period||58
10069279|NCT02161718|11195979|FG000|NOT COMPLETED|Post- Randomization Period||0
10069280|NCT02161718|11195980|FG001|NOT COMPLETED|Post- Randomization Period||59
10069281|NCT02161718|11195981|FG002|NOT COMPLETED|Post- Randomization Period||59
10069282|NCT02161731|11195988|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
10069283|NCT02161731|11195989|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
10069284|NCT02161731|11195988|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
10069285|NCT02161731|11195989|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
10069286|NCT02161731|11195988|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
10069287|NCT02161731|11195989|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
10069288|NCT02161731|11195988|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
10069289|NCT02161731|11195989|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
10069290|NCT02161731|11195988|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
10069291|NCT02161731|11195989|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
10069292|NCT02161731|11195988|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
10069293|NCT02161731|11195989|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
10069294|NCT02161731|11195988|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
10069295|NCT02161731|11195989|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
10069296|NCT02161731|11195988|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
10069297|NCT02161731|11195989|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
10069298|NCT02161757|11195999|FG000|STARTED|Randomised Through Start Treatment||401
10069299|NCT02161757|11196000|FG001|STARTED|Randomised Through Start Treatment||406
10069300|NCT02161757|11196001|FG002|STARTED|Randomised Through Start Treatment||400
10069301|NCT02161757|11195999|FG000|COMPLETED|Randomised Through Start Treatment||398
10069302|NCT02161757|11196000|FG001|COMPLETED|Randomised Through Start Treatment||404
10069303|NCT02161757|11196001|FG002|COMPLETED|Randomised Through Start Treatment||400
10069304|NCT02161757|11195999|FG000|NOT COMPLETED|Randomised Through Start Treatment||3
10069305|NCT02161757|11196000|FG001|NOT COMPLETED|Randomised Through Start Treatment||2
10069306|NCT02161757|11196001|FG002|NOT COMPLETED|Randomised Through Start Treatment||0
10069307|NCT02161757|11195999|FG000|STARTED|Treatment Through Study Completion||398
10069308|NCT02161757|11196000|FG001|STARTED|Treatment Through Study Completion||404
10069309|NCT02161757|11196001|FG002|STARTED|Treatment Through Study Completion||400
10069310|NCT02161757|11195999|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
10069311|NCT02161757|11196000|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
10069312|NCT02161757|11196001|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
10069313|NCT02161757|11195999|FG000|COMPLETED|Treatment Through Study Completion||341
10069314|NCT02161757|11196000|FG001|COMPLETED|Treatment Through Study Completion||361
10069315|NCT02161757|11196001|FG002|COMPLETED|Treatment Through Study Completion||361
10069316|NCT02161757|11195999|FG000|NOT COMPLETED|Treatment Through Study Completion||57
10069317|NCT02161757|11196000|FG001|NOT COMPLETED|Treatment Through Study Completion||43
10069318|NCT02161757|11196001|FG002|NOT COMPLETED|Treatment Through Study Completion||39
10069319|NCT02162433|11196013|FG000|STARTED|Overall Study||23
10069320|NCT02162433|11196014|FG001|STARTED|Overall Study||23
10069321|NCT02162433|11196015|FG002|STARTED|Overall Study||23
10069322|NCT02162433|11196016|FG003|STARTED|Overall Study||23
10069323|NCT02162433|11196013|FG000|COMPLETED|Overall Study||22
10069324|NCT02162433|11196014|FG001|COMPLETED|Overall Study||21
10069325|NCT02162433|11196015|FG002|COMPLETED|Overall Study||21
10069326|NCT02162433|11196016|FG003|COMPLETED|Overall Study||22
10069327|NCT02162433|11196013|FG000|NOT COMPLETED|Overall Study||1
10069328|NCT02162433|11196014|FG001|NOT COMPLETED|Overall Study||2
10069329|NCT02162433|11196015|FG002|NOT COMPLETED|Overall Study||2
10069330|NCT02162433|11196016|FG003|NOT COMPLETED|Overall Study||1
10189147|NCT03282591|11318801|FG000|COMPLETED|Overall Study||88
10189148|NCT03282591|11318802|FG001|COMPLETED|Overall Study||89
10189149|NCT03282591|11318801|FG000|NOT COMPLETED|Overall Study||4
10189150|NCT03282591|11318802|FG001|NOT COMPLETED|Overall Study||4
10189151|NCT03282682|11318812|FG000|STARTED|Overall Study||6
10189152|NCT03282682|11318813|FG001|STARTED|Overall Study||8
10189153|NCT03282682|11318814|FG002|STARTED|Overall Study||8
10189154|NCT03282682|11318812|FG000|COMPLETED|Overall Study||6
10189155|NCT03282682|11318813|FG001|COMPLETED|Overall Study||8
10189156|NCT03282682|11318814|FG002|COMPLETED|Overall Study||8
10189157|NCT03282682|11318812|FG000|NOT COMPLETED|Overall Study||0
10069331|NCT02162446|11196026|FG000|STARTED|Overall Study||12
10069332|NCT02162446|11196026|FG000|COMPLETED|Overall Study||12
10069333|NCT02162446|11196026|FG000|NOT COMPLETED|Overall Study||0
10069334|NCT02162576|11196035|FG000|STARTED|Overall Study||95
10069335|NCT02162576|11196035|FG000|COMPLETED|Overall Study||95
10069336|NCT02162576|11196035|FG000|NOT COMPLETED|Overall Study||0
10069337|NCT02162667|11196042|FG000|STARTED|Neoadjuvant Period||278
10069338|NCT02162667|11196043|FG001|STARTED|Neoadjuvant Period||284
9717428|NCT00003820|10816630|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
9717429|NCT00003820|10816629|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
10069339|NCT02162667|11196042|FG000|COMPLETED|Neoadjuvant Period||264
10069340|NCT02162667|11196043|FG001|COMPLETED|Neoadjuvant Period||267
10069341|NCT02162667|11196042|FG000|NOT COMPLETED|Neoadjuvant Period||14
10069342|NCT02162667|11196043|FG001|NOT COMPLETED|Neoadjuvant Period||17
10069343|NCT02162667|11196042|FG000|STARTED|Adjuvant Period||260
10069344|NCT02162667|11196043|FG001|STARTED|Adjuvant Period||268
10069345|NCT02162667|11196042|FG000|COMPLETED|Adjuvant Period||248
10069346|NCT02162667|11196043|FG001|COMPLETED|Adjuvant Period||255
10069347|NCT02162667|11196042|FG000|NOT COMPLETED|Adjuvant Period||12
10069348|NCT02162667|11196043|FG001|NOT COMPLETED|Adjuvant Period||13
10069349|NCT02162680|11196056|FG000|STARTED|Overall Study||33
10069350|NCT02162680|11196057|FG001|STARTED|Overall Study||33
10069351|NCT02162680|11196058|FG002|STARTED|Overall Study||32
10069352|NCT02162680|11196056|FG000|COMPLETED|Overall Study||33
10069353|NCT02162680|11196057|FG001|COMPLETED|Overall Study||33
10069354|NCT02162680|11196058|FG002|COMPLETED|Overall Study||32
10189158|NCT03282682|11318813|FG001|NOT COMPLETED|Overall Study||0
10189159|NCT03282682|11318814|FG002|NOT COMPLETED|Overall Study||0
10189160|NCT03283098|11318824|FG000|STARTED|Overall Study||8
10189161|NCT03283098|11318825|FG001|STARTED|Overall Study||25
10189162|NCT03283098|11318824|FG000|COMPLETED|Overall Study||8
10189163|NCT03283098|11318825|FG001|COMPLETED|Overall Study||24
10189164|NCT03283098|11318824|FG000|NOT COMPLETED|Overall Study||0
10189165|NCT03283098|11318825|FG001|NOT COMPLETED|Overall Study||1
10189166|NCT03283319|11318837|FG000|STARTED|Overall Study||62
10189167|NCT03283319|11318838|FG001|STARTED|Overall Study||60
10189168|NCT03283319|11318839|FG002|STARTED|Overall Study||62
10189169|NCT03283319|11318840|FG003|STARTED|Overall Study||61
10189170|NCT03283319|11318841|FG004|STARTED|Overall Study||60
10189171|NCT03283319|11318842|FG005|STARTED|Overall Study||61
10189172|NCT03283319|11318837|FG000|COMPLETED|Overall Study||55
10189173|NCT03283319|11318838|FG001|COMPLETED|Overall Study||54
10189174|NCT03283319|11318839|FG002|COMPLETED|Overall Study||55
10189175|NCT03283319|11318840|FG003|COMPLETED|Overall Study||54
10189176|NCT03283319|11318841|FG004|COMPLETED|Overall Study||56
10189177|NCT03283319|11318842|FG005|COMPLETED|Overall Study||57
10189178|NCT03283319|11318837|FG000|NOT COMPLETED|Overall Study||7
10189179|NCT03283319|11318838|FG001|NOT COMPLETED|Overall Study||6
10189180|NCT03283319|11318839|FG002|NOT COMPLETED|Overall Study||7
10189181|NCT03283319|11318840|FG003|NOT COMPLETED|Overall Study||7
10189182|NCT03283319|11318841|FG004|NOT COMPLETED|Overall Study||4
10189183|NCT03283319|11318842|FG005|NOT COMPLETED|Overall Study||4
10189184|NCT03283436|11318858|FG000|STARTED|Overall Study||50
10189185|NCT03283436|11318859|FG001|STARTED|Overall Study||50
10189186|NCT03283436|11318858|FG000|COMPLETED|Overall Study||44
10189187|NCT03283436|11318859|FG001|COMPLETED|Overall Study||50
10189188|NCT03283436|11318858|FG000|NOT COMPLETED|Overall Study||6
10189189|NCT03283436|11318859|FG001|NOT COMPLETED|Overall Study||0
10189190|NCT03283553|11318867|FG000|STARTED|Patient Participant Flow||69
10189191|NCT03283553|11318868|FG001|STARTED|Patient Participant Flow||63
10189192|NCT03283553|11318867|FG000|Patient Baseline Interview|Patient Participant Flow||69
10189193|NCT03283553|11318868|FG001|Patient Baseline Interview|Patient Participant Flow||62
10189194|NCT03283553|11318867|FG000|Patient 3-Month Interview|Patient Participant Flow||67
10189195|NCT03283553|11318868|FG001|Patient 3-Month Interview|Patient Participant Flow||60
10189196|NCT03283553|11318867|FG000|Patient 9-Month Interview|Patient Participant Flow||63
10189197|NCT03283553|11318868|FG001|Patient 9-Month Interview|Patient Participant Flow||57
10189198|NCT03283553|11318867|FG000|Patient 12-Month Interview|Patient Participant Flow||59
10189199|NCT03283553|11318868|FG001|Patient 12-Month Interview|Patient Participant Flow||50
10189200|NCT03283553|11318867|FG000|COMPLETED|Patient Participant Flow||59
10189201|NCT03283553|11318868|FG001|COMPLETED|Patient Participant Flow||50
10189202|NCT03283553|11318867|FG000|NOT COMPLETED|Patient Participant Flow||10
10189203|NCT03283553|11318868|FG001|NOT COMPLETED|Patient Participant Flow||13
10189204|NCT03283553|11318867|FG000|STARTED|Care Partner Participant Flow||69
10189205|NCT03283553|11318868|FG001|STARTED|Care Partner Participant Flow||63
10189206|NCT03283553|11318867|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69
10189207|NCT03283553|11318868|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63
10189208|NCT03283553|11318867|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69
10189209|NCT03283553|11318868|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60
10189210|NCT03283553|11318867|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64
10189211|NCT03283553|11318868|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55
10189212|NCT03283553|11318867|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59
10189213|NCT03283553|11318868|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48
10189214|NCT03283553|11318867|FG000|COMPLETED|Care Partner Participant Flow||59
10189215|NCT03283553|11318868|FG001|COMPLETED|Care Partner Participant Flow||48
10189216|NCT03283553|11318867|FG000|NOT COMPLETED|Care Partner Participant Flow||10
10189217|NCT03283553|11318868|FG001|NOT COMPLETED|Care Partner Participant Flow||15
10189218|NCT03283696|11318878|FG000|STARTED|Overall Study||16
10189219|NCT03283696|11318879|FG001|STARTED|Overall Study||8
10189220|NCT03283696|11318878|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
10189221|NCT03283696|11318879|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10189222|NCT03283696|11318878|FG000|COMPLETED|Overall Study||9
10189223|NCT03283696|11318879|FG001|COMPLETED|Overall Study||2
10069355|NCT02162680|11196056|FG000|NOT COMPLETED|Overall Study||0
10069356|NCT02162680|11196057|FG001|NOT COMPLETED|Overall Study||0
10069357|NCT02162680|11196058|FG002|NOT COMPLETED|Overall Study||0
10069358|NCT02162719|11196068|FG000|STARTED|Overall Study||62
10069359|NCT02162719|11196069|FG001|STARTED|Overall Study||62
10069360|NCT02162719|11196068|FG000|COMPLETED|Overall Study||0
10069361|NCT02162719|11196069|FG001|COMPLETED|Overall Study||0
10069362|NCT02162719|11196068|FG000|NOT COMPLETED|Overall Study||62
10069363|NCT02162719|11196069|FG001|NOT COMPLETED|Overall Study||62
10069364|NCT02162758|11196077|FG000|STARTED|Overall Study||3
10069365|NCT02162758|11196078|FG001|STARTED|Overall Study||3
10069366|NCT02162758|11196077|FG000|COMPLETED|Overall Study||3
10069367|NCT02162758|11196078|FG001|COMPLETED|Overall Study||2
10069368|NCT02162758|11196077|FG000|NOT COMPLETED|Overall Study||0
10069369|NCT02162758|11196078|FG001|NOT COMPLETED|Overall Study||1
10069370|NCT02162771|11196086|FG000|STARTED|Core Study Period (Part 2)||70
10069371|NCT02162771|11196087|FG001|STARTED|Core Study Period (Part 2)||70
10069372|NCT02162771|11196086|FG000|COMPLETED|Core Study Period (Part 2)||62
10069373|NCT02162771|11196087|FG001|COMPLETED|Core Study Period (Part 2)||62
10069374|NCT02162771|11196086|FG000|NOT COMPLETED|Core Study Period (Part 2)||8
10069375|NCT02162771|11196087|FG001|NOT COMPLETED|Core Study Period (Part 2)||8
10069376|NCT02162771|11196086|FG000|STARTED|Maintenance Study Period (Part 2)||62
10069377|NCT02162771|11196087|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
10069378|NCT02162771|11196086|FG000|COMPLETED|Maintenance Study Period (Part 2)||46
10069379|NCT02162771|11196087|FG001|COMPLETED|Maintenance Study Period (Part 2)||38
10069380|NCT02162771|11196086|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16
10069381|NCT02162771|11196087|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22
10069382|NCT02162862|11196096|FG000|STARTED|Overall Study||31
10189224|NCT03283696|11318878|FG000|NOT COMPLETED|Overall Study||7
10189225|NCT03283696|11318879|FG001|NOT COMPLETED|Overall Study||6
10189226|NCT03283787|11318888|FG000|STARTED|Overall Study||20
10189227|NCT03283787|11318889|FG001|STARTED|Overall Study||20
10189228|NCT03283787|11318890|FG002|STARTED|Overall Study||20
10189229|NCT03283787|11318888|FG000|COMPLETED|Overall Study||17
10189230|NCT03283787|11318889|FG001|COMPLETED|Overall Study||13
10189231|NCT03283787|11318890|FG002|COMPLETED|Overall Study||13
10189232|NCT03283787|11318888|FG000|NOT COMPLETED|Overall Study||3
10189233|NCT03283787|11318889|FG001|NOT COMPLETED|Overall Study||7
10189234|NCT03283787|11318890|FG002|NOT COMPLETED|Overall Study||7
10189235|NCT03284229|11318901|FG000|STARTED|Overall Study||28
10189236|NCT03284229|11318901|FG000|COMPLETED|Overall Study||25
10189237|NCT03284229|11318901|FG000|NOT COMPLETED|Overall Study||3
10189238|NCT03284359|11318908|FG000|STARTED|Overall Study||93
10189239|NCT03284359|11318909|FG001|STARTED|Overall Study||89
10189240|NCT03284359|11318908|FG000|COMPLETED|Overall Study||93
10189241|NCT03284359|11318909|FG001|COMPLETED|Overall Study||89
10189242|NCT03284359|11318908|FG000|NOT COMPLETED|Overall Study||0
10189243|NCT03284359|11318909|FG001|NOT COMPLETED|Overall Study||0
10189244|NCT03284398|11318917|FG000|STARTED|Overall Study||2753
10189245|NCT03284398|11318918|FG001|STARTED|Overall Study||970
10189246|NCT03284398|11318917|FG000|COMPLETED|Overall Study||2753
10189247|NCT03284398|11318918|FG001|COMPLETED|Overall Study||970
10189248|NCT03284398|11318917|FG000|NOT COMPLETED|Overall Study||0
10189249|NCT03284398|11318918|FG001|NOT COMPLETED|Overall Study||0
10189250|NCT03284411|11318930|FG000|STARTED|Overall Study||30
10189251|NCT03284411|11318930|FG000|COMPLETED|Overall Study||30
10189252|NCT03284411|11318930|FG000|NOT COMPLETED|Overall Study||0
10189253|NCT03284424|11318937|FG000|STARTED|Overall Study||105
10189254|NCT03284424|11318938|FG001|STARTED|Overall Study||54
10189255|NCT03284424|11318937|FG000|COMPLETED|Overall Study||0
10189256|NCT03284424|11318938|FG001|COMPLETED|Overall Study||0
10189257|NCT03284424|11318937|FG000|NOT COMPLETED|Overall Study||105
10189258|NCT03284424|11318938|FG001|NOT COMPLETED|Overall Study||54
10189259|NCT03284710|11318947|FG000|STARTED|Overall Study||36
10189260|NCT03284710|11318948|FG001|STARTED|Overall Study||36
10189261|NCT03284710|11318949|FG002|STARTED|Overall Study||36
10189262|NCT03284710|11318950|FG003|STARTED|Overall Study||24
10189263|NCT03284710|11318947|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31
10189264|NCT03284710|11318948|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31
10189265|NCT03284710|11318949|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31
10189266|NCT03284710|11318950|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18
10189267|NCT03284710|11318947|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30
10189268|NCT03284710|11318948|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31
10189269|NCT03284710|11318949|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31
10189270|NCT03284710|11318950|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17
10189271|NCT03284710|11318947|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10189272|NCT03284710|11318948|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10189273|NCT03284710|11318949|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10189274|NCT03284710|11318950|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10189275|NCT03284710|11318947|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0
10189276|NCT03284710|11318948|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0
10189277|NCT03284710|11318949|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0
10189278|NCT03284710|11318950|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0
10189279|NCT03284710|11318947|FG000|COMPLETED|Overall Study||30
10189280|NCT03284710|11318948|FG001|COMPLETED|Overall Study||31
10189281|NCT03284710|11318949|FG002|COMPLETED|Overall Study||32
10189282|NCT03284710|11318950|FG003|COMPLETED|Overall Study||16
10189283|NCT03284710|11318947|FG000|NOT COMPLETED|Overall Study||6
10069383|NCT02162862|11196097|FG001|STARTED|Overall Study||35
10069384|NCT02162862|11196098|FG002|STARTED|Overall Study||33
10069385|NCT02162862|11196096|FG000|COMPLETED|Overall Study||31
10069386|NCT02162862|11196097|FG001|COMPLETED|Overall Study||24
10069387|NCT02162862|11196098|FG002|COMPLETED|Overall Study||29
10069388|NCT02162862|11196096|FG000|NOT COMPLETED|Overall Study||0
10069389|NCT02162862|11196097|FG001|NOT COMPLETED|Overall Study||11
10069390|NCT02162862|11196098|FG002|NOT COMPLETED|Overall Study||4
10069391|NCT02162992|11196110|FG000|STARTED|Overall Study||51
10069392|NCT02162992|11196111|FG001|STARTED|Overall Study||100
10069393|NCT02162992|11196110|FG000|COMPLETED|Overall Study||46
10069394|NCT02162992|11196111|FG001|COMPLETED|Overall Study||99
10069395|NCT02162992|11196110|FG000|NOT COMPLETED|Overall Study||5
10069396|NCT02162992|11196111|FG001|NOT COMPLETED|Overall Study||1
10069397|NCT02163057|11196119|FG000|STARTED|Overall Study||6
10069398|NCT02163057|11196120|FG001|STARTED|Overall Study||16
10069399|NCT02163057|11196119|FG000|COMPLETED|Overall Study||3
10069400|NCT02163057|11196120|FG001|COMPLETED|Overall Study||11
10069401|NCT02163057|11196119|FG000|NOT COMPLETED|Overall Study||3
10069402|NCT02163057|11196120|FG001|NOT COMPLETED|Overall Study||5
10069403|NCT02163226|11196130|FG000|STARTED|Overall Study||79
10069404|NCT02163226|11196131|FG001|STARTED|Overall Study||81
10069405|NCT02163226|11196130|FG000|COMPLETED|Overall Study||63
10069406|NCT02163226|11196131|FG001|COMPLETED|Overall Study||70
10069407|NCT02163226|11196130|FG000|NOT COMPLETED|Overall Study||16
10069408|NCT02163226|11196131|FG001|NOT COMPLETED|Overall Study||11
10069409|NCT02163421|11196141|FG000|STARTED|Overall Study||12
10069410|NCT02163421|11196142|FG001|STARTED|Overall Study||12
10069411|NCT02163421|11196143|FG002|STARTED|Overall Study||12
10069412|NCT02163421|11196144|FG003|STARTED|Overall Study||12
10069413|NCT02163421|11196141|FG000|COMPLETED|Overall Study||12
10069414|NCT02163421|11196142|FG001|COMPLETED|Overall Study||12
10069415|NCT02163421|11196143|FG002|COMPLETED|Overall Study||12
10069416|NCT02163421|11196144|FG003|COMPLETED|Overall Study||12
10069417|NCT02163421|11196141|FG000|NOT COMPLETED|Overall Study||0
10069418|NCT02163421|11196142|FG001|NOT COMPLETED|Overall Study||0
10069419|NCT02163421|11196143|FG002|NOT COMPLETED|Overall Study||0
10069420|NCT02163421|11196144|FG003|NOT COMPLETED|Overall Study||0
10069421|NCT02163434|11196153|FG000|STARTED|Overall Study||15
10069422|NCT02163434|11196154|FG001|STARTED|Overall Study||16
10069423|NCT02163434|11196153|FG000|COMPLETED|Overall Study||12
10069424|NCT02163434|11196154|FG001|COMPLETED|Overall Study||9
10069425|NCT02163434|11196153|FG000|NOT COMPLETED|Overall Study||3
10069426|NCT02163434|11196154|FG001|NOT COMPLETED|Overall Study||7
10069427|NCT02163447|11196163|FG000|STARTED|Overall Study||106
10069428|NCT02163447|11196164|FG001|STARTED|Overall Study||94
10069429|NCT02163447|11196165|FG002|STARTED|Overall Study||100
10069430|NCT02163447|11196163|FG000|Infants Born|Overall Study||101
10069431|NCT02163447|11196164|FG001|Infants Born|Overall Study||93
10069432|NCT02163447|11196165|FG002|Infants Born|Overall Study||100
10069433|NCT02163447|11196163|FG000|COMPLETED|Overall Study||100
10069434|NCT02163447|11196164|FG001|COMPLETED|Overall Study||88
10069435|NCT02163447|11196165|FG002|COMPLETED|Overall Study||97
10069436|NCT02163447|11196163|FG000|NOT COMPLETED|Overall Study||6
10069437|NCT02163447|11196164|FG001|NOT COMPLETED|Overall Study||6
10069438|NCT02163447|11196165|FG002|NOT COMPLETED|Overall Study||3
10069439|NCT02163486|11196185|FG000|STARTED|Overall Study||51
10069440|NCT02163486|11196186|FG001|STARTED|Overall Study||52
10069441|NCT02163486|11196185|FG000|COMPLETED|Overall Study||50
10069442|NCT02163486|11196186|FG001|COMPLETED|Overall Study||50
10069443|NCT02163486|11196185|FG000|NOT COMPLETED|Overall Study||1
10069444|NCT02163486|11196186|FG001|NOT COMPLETED|Overall Study||2
10069445|NCT02163499|11196192|FG000|STARTED|Acute Phase: ZS 10 g TID||751
10069446|NCT02163499|11196192|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746
10069447|NCT02163499|11196192|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
10069448|NCT02163499|11196192|FG000|STARTED|Extended Dosing Phase: ZS||746
10069449|NCT02163499|11196192|FG000|COMPLETED|Extended Dosing Phase: ZS||466
10069450|NCT02163499|11196192|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280
10069451|NCT02163538|11196202|FG000|STARTED|Overall Study||71
10069452|NCT02163538|11196203|FG001|STARTED|Overall Study||71
10069453|NCT02163538|11196202|FG000|COMPLETED|Overall Study||70
10069454|NCT02163538|11196203|FG001|COMPLETED|Overall Study||70
10069455|NCT02163538|11196202|FG000|NOT COMPLETED|Overall Study||1
10069456|NCT02163538|11196203|FG001|NOT COMPLETED|Overall Study||1
10069457|NCT02163577|11196211|FG000|STARTED|Overall Study||26
10069458|NCT02163577|11196212|FG001|STARTED|Overall Study||26
10069459|NCT02163577|11196211|FG000|COMPLETED|Overall Study||26
10069460|NCT02163577|11196212|FG001|COMPLETED|Overall Study||26
10069461|NCT02163577|11196211|FG000|NOT COMPLETED|Overall Study||0
10069462|NCT02163577|11196212|FG001|NOT COMPLETED|Overall Study||0
10069463|NCT02163759|11196221|FG000|STARTED|Overall Study||72
10069464|NCT02163759|11196222|FG001|STARTED|Overall Study||142
10069465|NCT02163759|11196223|FG002|STARTED|Overall Study||144
10069466|NCT02163759|11196221|FG000|Completed Week 10|Overall Study||71
10069467|NCT02163759|11196222|FG001|Completed Week 10|Overall Study||141
10069468|NCT02163759|11196223|FG002|Completed Week 10|Overall Study||143
10069469|NCT02163759|11196221|FG000|COMPLETED|Overall Study||71
10069470|NCT02163759|11196222|FG001|COMPLETED|Overall Study||137
10069471|NCT02163759|11196223|FG002|COMPLETED|Overall Study||141
10069472|NCT02163759|11196221|FG000|NOT COMPLETED|Overall Study||1
10069473|NCT02163759|11196222|FG001|NOT COMPLETED|Overall Study||5
10069474|NCT02163759|11196223|FG002|NOT COMPLETED|Overall Study||3
10069475|NCT02163811|11196236|FG000|STARTED|Overall Study||71
10069476|NCT02163811|11196237|FG001|STARTED|Overall Study||76
10069477|NCT02163811|11196236|FG000|COMPLETED|Overall Study||35
10069478|NCT02163811|11196237|FG001|COMPLETED|Overall Study||60
10069479|NCT02163811|11196236|FG000|NOT COMPLETED|Overall Study||36
10069480|NCT02163811|11196237|FG001|NOT COMPLETED|Overall Study||16
10069481|NCT02163824|11196246|FG000|STARTED|Overall Study||129
10069482|NCT02163824|11196247|FG001|STARTED|Overall Study||125
10069483|NCT02163824|11196248|FG002|STARTED|Overall Study||126
10069484|NCT02163824|11196246|FG000|COMPLETED|Overall Study||127
10069485|NCT02163824|11196247|FG001|COMPLETED|Overall Study||124
10069486|NCT02163824|11196248|FG002|COMPLETED|Overall Study||124
10069487|NCT02163824|11196246|FG000|NOT COMPLETED|Overall Study||2
10069488|NCT02163824|11196247|FG001|NOT COMPLETED|Overall Study||1
10069489|NCT02163824|11196248|FG002|NOT COMPLETED|Overall Study||2
10069490|NCT02163837|11196256|FG000|STARTED|Before Rifaximin||15
10069491|NCT02163837|11196256|FG000|COMPLETED|Before Rifaximin||15
10069492|NCT02163837|11196256|FG000|NOT COMPLETED|Before Rifaximin||0
10069493|NCT02163837|11196256|FG000|STARTED|Day 28 of Rifaximin Treatment||15
10069494|NCT02163837|11196256|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15
10069495|NCT02163837|11196256|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
10069496|NCT02163902|11196262|FG000|STARTED|Overall Study||113
10069497|NCT02163902|11196263|FG001|STARTED|Overall Study||111
10069498|NCT02163902|11196262|FG000|COMPLETED|Overall Study||102
10069499|NCT02163902|11196263|FG001|COMPLETED|Overall Study||98
10069500|NCT02163902|11196262|FG000|NOT COMPLETED|Overall Study||11
10069501|NCT02163902|11196263|FG001|NOT COMPLETED|Overall Study||13
10069502|NCT02163915|11196274|FG000|STARTED|Overall Study||10
10069503|NCT02163915|11196275|FG001|STARTED|Overall Study||8
10069504|NCT02163915|11196276|FG002|STARTED|Overall Study||10
10069505|NCT02163915|11196277|FG003|STARTED|Overall Study||9
10069506|NCT02163915|11196278|FG004|STARTED|Overall Study||10
10069507|NCT02163915|11196274|FG000|COMPLETED|Overall Study||7
10069508|NCT02163915|11196275|FG001|COMPLETED|Overall Study||8
10069509|NCT02163915|11196276|FG002|COMPLETED|Overall Study||8
10069510|NCT02163915|11196277|FG003|COMPLETED|Overall Study||6
10069511|NCT02163915|11196278|FG004|COMPLETED|Overall Study||6
10069512|NCT02163915|11196274|FG000|NOT COMPLETED|Overall Study||3
10069513|NCT02163915|11196275|FG001|NOT COMPLETED|Overall Study||0
10069514|NCT02163915|11196276|FG002|NOT COMPLETED|Overall Study||2
10069515|NCT02163915|11196277|FG003|NOT COMPLETED|Overall Study||3
10069516|NCT02163915|11196278|FG004|NOT COMPLETED|Overall Study||4
10069517|NCT02163967|11196294|FG000|STARTED|First Intervention/ Day 1||4
10069518|NCT02163967|11196295|FG001|STARTED|First Intervention/ Day 1||4
10069519|NCT02163967|11196296|FG002|STARTED|First Intervention/ Day 1||3
10069520|NCT02163967|11196297|FG003|STARTED|First Intervention/ Day 1||4
10069521|NCT02163967|11196298|FG004|STARTED|First Intervention/ Day 1||3
10069522|NCT02163967|11196299|FG005|STARTED|First Intervention/ Day 1||3
10069523|NCT02163967|11196294|FG000|COMPLETED|First Intervention/ Day 1||4
10069524|NCT02163967|11196295|FG001|COMPLETED|First Intervention/ Day 1||4
10069525|NCT02163967|11196296|FG002|COMPLETED|First Intervention/ Day 1||3
10069526|NCT02163967|11196297|FG003|COMPLETED|First Intervention/ Day 1||4
10069527|NCT02163967|11196298|FG004|COMPLETED|First Intervention/ Day 1||3
10069528|NCT02163967|11196299|FG005|COMPLETED|First Intervention/ Day 1||3
10069529|NCT02163967|11196294|FG000|NOT COMPLETED|First Intervention/ Day 1||0
10069530|NCT02163967|11196295|FG001|NOT COMPLETED|First Intervention/ Day 1||0
10069531|NCT02163967|11196296|FG002|NOT COMPLETED|First Intervention/ Day 1||0
10069532|NCT02163967|11196297|FG003|NOT COMPLETED|First Intervention/ Day 1||0
10069533|NCT02163967|11196298|FG004|NOT COMPLETED|First Intervention/ Day 1||0
10069534|NCT02163967|11196299|FG005|NOT COMPLETED|First Intervention/ Day 1||0
10069535|NCT02163967|11196294|FG000|STARTED|Second Intevention/Day 2||3
10069536|NCT02163967|11196295|FG001|STARTED|Second Intevention/Day 2||4
10069537|NCT02163967|11196296|FG002|STARTED|Second Intevention/Day 2||2
10069538|NCT02163967|11196297|FG003|STARTED|Second Intevention/Day 2||4
10069539|NCT02163967|11196298|FG004|STARTED|Second Intevention/Day 2||3
10069540|NCT02163967|11196299|FG005|STARTED|Second Intevention/Day 2||3
10069541|NCT02163967|11196294|FG000|COMPLETED|Second Intevention/Day 2||3
10069542|NCT02163967|11196295|FG001|COMPLETED|Second Intevention/Day 2||4
10069543|NCT02163967|11196296|FG002|COMPLETED|Second Intevention/Day 2||2
10069544|NCT02163967|11196297|FG003|COMPLETED|Second Intevention/Day 2||4
10069545|NCT02163967|11196298|FG004|COMPLETED|Second Intevention/Day 2||3
10069546|NCT02163967|11196299|FG005|COMPLETED|Second Intevention/Day 2||3
10069547|NCT02163967|11196294|FG000|NOT COMPLETED|Second Intevention/Day 2||0
10069548|NCT02163967|11196295|FG001|NOT COMPLETED|Second Intevention/Day 2||0
10069549|NCT02163967|11196296|FG002|NOT COMPLETED|Second Intevention/Day 2||0
10069550|NCT02163967|11196297|FG003|NOT COMPLETED|Second Intevention/Day 2||0
10069551|NCT02163967|11196298|FG004|NOT COMPLETED|Second Intevention/Day 2||0
10069552|NCT02163967|11196299|FG005|NOT COMPLETED|Second Intevention/Day 2||0
10069553|NCT02163967|11196294|FG000|STARTED|Third Intervention/Day 3||3
10069554|NCT02163967|11196295|FG001|STARTED|Third Intervention/Day 3||3
10069555|NCT02163967|11196296|FG002|STARTED|Third Intervention/Day 3||2
10069556|NCT02163967|11196297|FG003|STARTED|Third Intervention/Day 3||4
10069557|NCT02163967|11196298|FG004|STARTED|Third Intervention/Day 3||3
10069558|NCT02163967|11196299|FG005|STARTED|Third Intervention/Day 3||3
10069559|NCT02163967|11196294|FG000|COMPLETED|Third Intervention/Day 3||3
10069560|NCT02163967|11196295|FG001|COMPLETED|Third Intervention/Day 3||3
10069561|NCT02163967|11196296|FG002|COMPLETED|Third Intervention/Day 3||2
10069562|NCT02163967|11196297|FG003|COMPLETED|Third Intervention/Day 3||4
10069563|NCT02163967|11196298|FG004|COMPLETED|Third Intervention/Day 3||3
10069564|NCT02163967|11196299|FG005|COMPLETED|Third Intervention/Day 3||3
10069565|NCT02163967|11196294|FG000|NOT COMPLETED|Third Intervention/Day 3||0
10069566|NCT02163967|11196295|FG001|NOT COMPLETED|Third Intervention/Day 3||0
10069567|NCT02163967|11196296|FG002|NOT COMPLETED|Third Intervention/Day 3||0
10069568|NCT02163967|11196297|FG003|NOT COMPLETED|Third Intervention/Day 3||0
10069569|NCT02163967|11196298|FG004|NOT COMPLETED|Third Intervention/Day 3||0
10069570|NCT02163967|11196299|FG005|NOT COMPLETED|Third Intervention/Day 3||0
10069571|NCT02163993|11196315|FG000|STARTED|Treatment Period||138
10069572|NCT02163993|11196316|FG001|STARTED|Treatment Period||68
10069573|NCT02163993|11196317|FG002|STARTED|Treatment Period||68
10069574|NCT02163993|11196318|FG003|STARTED|Treatment Period||71
10069575|NCT02163993|11196319|FG004|STARTED|Treatment Period||69
10069576|NCT02163993|11196315|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137
10069577|NCT02163993|11196316|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68
10069578|NCT02163993|11196317|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68
10069579|NCT02163993|11196318|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70
10069580|NCT02163993|11196319|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67
10069581|NCT02163993|11196315|FG000|COMPLETED|Treatment Period||126
10069582|NCT02163993|11196316|FG001|COMPLETED|Treatment Period||59
10069583|NCT02163993|11196317|FG002|COMPLETED|Treatment Period||66
10069584|NCT02163993|11196318|FG003|COMPLETED|Treatment Period||62
10069585|NCT02163993|11196319|FG004|COMPLETED|Treatment Period||62
10069586|NCT02163993|11196315|FG000|NOT COMPLETED|Treatment Period||12
10069587|NCT02163993|11196316|FG001|NOT COMPLETED|Treatment Period||9
10069588|NCT02163993|11196317|FG002|NOT COMPLETED|Treatment Period||2
10069589|NCT02163993|11196318|FG003|NOT COMPLETED|Treatment Period||9
10069590|NCT02163993|11196319|FG004|NOT COMPLETED|Treatment Period||7
10069591|NCT02163993|11196315|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
10069592|NCT02163993|11196316|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
10069593|NCT02163993|11196317|FG002|STARTED|Post-treatment Period||66
10069594|NCT02163993|11196318|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
10069595|NCT02163993|11196319|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
10069596|NCT02163993|11196315|FG000|COMPLETED|Post-treatment Period||121
10069597|NCT02163993|11196316|FG001|COMPLETED|Post-treatment Period||55
10069598|NCT02163993|11196317|FG002|COMPLETED|Post-treatment Period||62
10069599|NCT02163993|11196318|FG003|COMPLETED|Post-treatment Period||61
10069600|NCT02163993|11196319|FG004|COMPLETED|Post-treatment Period||62
10069601|NCT02163993|11196315|FG000|NOT COMPLETED|Post-treatment Period||4
10069602|NCT02163993|11196316|FG001|NOT COMPLETED|Post-treatment Period||6
10069603|NCT02163993|11196317|FG002|NOT COMPLETED|Post-treatment Period||4
10069604|NCT02163993|11196318|FG003|NOT COMPLETED|Post-treatment Period||2
10069605|NCT02163993|11196319|FG004|NOT COMPLETED|Post-treatment Period||3
10189284|NCT03284710|11318948|FG001|NOT COMPLETED|Overall Study||5
10189285|NCT03284710|11318949|FG002|NOT COMPLETED|Overall Study||4
10189286|NCT03284710|11318950|FG003|NOT COMPLETED|Overall Study||8
10189287|NCT03285061|11318967|FG000|STARTED|Overall Study||37
10189288|NCT03285061|11318968|FG001|STARTED|Overall Study||38
10189289|NCT03285061|11318967|FG000|COMPLETED|Overall Study||36
10189290|NCT03285061|11318968|FG001|COMPLETED|Overall Study||36
10189291|NCT03285061|11318967|FG000|NOT COMPLETED|Overall Study||1
10189292|NCT03285061|11318968|FG001|NOT COMPLETED|Overall Study||2
10189293|NCT03285113|11318974|FG000|STARTED|Overall Study||10
10189294|NCT03285113|11318974|FG000|COMPLETED|Overall Study||8
10189295|NCT03285113|11318974|FG000|NOT COMPLETED|Overall Study||2
10189296|NCT03285295|11318983|FG000|STARTED|Alinity s HBsAg||17095
10189297|NCT03285295|11318984|FG001|STARTED|Alinity s HBsAg||438
10189298|NCT03285295|11318985|FG002|STARTED|Alinity s HBsAg||403
10189299|NCT03285295|11318986|FG003|STARTED|Alinity s HBsAg||0
10189300|NCT03285295|11318987|FG004|STARTED|Alinity s HBsAg||51
10189301|NCT03285295|11318983|FG000|COMPLETED|Alinity s HBsAg||16993
10189302|NCT03285295|11318984|FG001|COMPLETED|Alinity s HBsAg||432
10189303|NCT03285295|11318985|FG002|COMPLETED|Alinity s HBsAg||403
10189304|NCT03285295|11318986|FG003|COMPLETED|Alinity s HBsAg||0
10189305|NCT03285295|11318987|FG004|COMPLETED|Alinity s HBsAg||51
10189306|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s HBsAg||102
10189307|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s HBsAg||6
10189308|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s HBsAg||0
10189309|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s HBsAg||0
10189310|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s HBsAg||0
10189311|NCT03285295|11318983|FG000|STARTED|Alinity s HBsAg Confirmatory||8
10189312|NCT03285295|11318984|FG001|STARTED|Alinity s HBsAg Confirmatory||432
10189313|NCT03285295|11318985|FG002|STARTED|Alinity s HBsAg Confirmatory||3
10189314|NCT03285295|11318986|FG003|STARTED|Alinity s HBsAg Confirmatory||0
10189315|NCT03285295|11318987|FG004|STARTED|Alinity s HBsAg Confirmatory||0
10189316|NCT03285295|11318983|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8
10189317|NCT03285295|11318984|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432
10189318|NCT03285295|11318985|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3
10189319|NCT03285295|11318986|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0
10189320|NCT03285295|11318987|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0
10189321|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10069606|NCT02164240|11196340|FG000|STARTED|Overall Study||4
10069607|NCT02164240|11196341|FG001|STARTED|Overall Study||5
10069608|NCT02164240|11196342|FG002|STARTED|Overall Study||4
10069609|NCT02164240|11196340|FG000|COMPLETED|Overall Study||4
10069610|NCT02164240|11196341|FG001|COMPLETED|Overall Study||5
10069611|NCT02164240|11196342|FG002|COMPLETED|Overall Study||4
10069612|NCT02164240|11196340|FG000|NOT COMPLETED|Overall Study||0
10069613|NCT02164240|11196341|FG001|NOT COMPLETED|Overall Study||0
10069614|NCT02164240|11196342|FG002|NOT COMPLETED|Overall Study||0
10069615|NCT02164318|11196355|FG000|STARTED|Overall Study||4
10069616|NCT02164318|11196356|FG001|STARTED|Overall Study||3
10069617|NCT02164318|11196357|FG002|STARTED|Overall Study||1
10069618|NCT02164318|11196358|FG003|STARTED|Overall Study||3
10069619|NCT02164318|11196355|FG000|COMPLETED|Overall Study||4
10069620|NCT02164318|11196356|FG001|COMPLETED|Overall Study||2
10069621|NCT02164318|11196357|FG002|COMPLETED|Overall Study||1
10069622|NCT02164318|11196358|FG003|COMPLETED|Overall Study||2
10069623|NCT02164318|11196355|FG000|NOT COMPLETED|Overall Study||0
10069624|NCT02164318|11196356|FG001|NOT COMPLETED|Overall Study||1
10069625|NCT02164318|11196357|FG002|NOT COMPLETED|Overall Study||0
10069626|NCT02164318|11196358|FG003|NOT COMPLETED|Overall Study||1
10069627|NCT02164383|11196370|FG000|STARTED|Overall Study||16
10069628|NCT02164383|11196371|FG001|STARTED|Overall Study||14
10069629|NCT02164383|11196370|FG000|COMPLETED|Overall Study||15
10069630|NCT02164383|11196371|FG001|COMPLETED|Overall Study||14
10069631|NCT02164383|11196370|FG000|NOT COMPLETED|Overall Study||1
10069632|NCT02164383|11196371|FG001|NOT COMPLETED|Overall Study||0
10069633|NCT02164396|11196380|FG000|STARTED|Overall Study||10
10069634|NCT02164396|11196381|FG001|STARTED|Overall Study||10
10069635|NCT02164396|11196382|FG002|STARTED|Overall Study||10
10069636|NCT02164396|11196380|FG000|COMPLETED|Overall Study||10
10069637|NCT02164396|11196381|FG001|COMPLETED|Overall Study||10
10069638|NCT02164396|11196382|FG002|COMPLETED|Overall Study||10
10069639|NCT02164396|11196380|FG000|NOT COMPLETED|Overall Study||0
10069640|NCT02164396|11196381|FG001|NOT COMPLETED|Overall Study||0
10069641|NCT02164396|11196382|FG002|NOT COMPLETED|Overall Study||0
10069642|NCT02164422|11196393|FG000|STARTED|Overall Study||25
10069643|NCT02164422|11196394|FG001|STARTED|Overall Study||22
10069644|NCT02164422|11196395|FG002|STARTED|Overall Study||23
10069645|NCT02164422|11196393|FG000|COMPLETED|Overall Study||24
10069646|NCT02164422|11196394|FG001|COMPLETED|Overall Study||20
10069647|NCT02164422|11196395|FG002|COMPLETED|Overall Study||23
10069648|NCT02164422|11196393|FG000|NOT COMPLETED|Overall Study||1
10069649|NCT02164422|11196394|FG001|NOT COMPLETED|Overall Study||2
10069650|NCT02164422|11196395|FG002|NOT COMPLETED|Overall Study||0
10069651|NCT02164513|11196406|FG000|STARTED|Overall Study||4151
10069652|NCT02164513|11196407|FG001|STARTED|Overall Study||4134
10069653|NCT02164513|11196408|FG002|STARTED|Overall Study||2070
10069654|NCT02164513|11196406|FG000|Completed Investigational Product (IP)|Overall Study||3393
10069655|NCT02164513|11196407|FG001|Completed Investigational Product (IP)|Overall Study||3094
10069656|NCT02164513|11196408|FG002|Completed Investigational Product (IP)|Overall Study||1504
10069657|NCT02164513|11196406|FG000|Not Completed IP|Overall Study||758
10069658|NCT02164513|11196407|FG001|Not Completed IP|Overall Study||1040
10069659|NCT02164513|11196408|FG002|Not Completed IP|Overall Study||566
10069660|NCT02164513|11196406|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249
10069661|NCT02164513|11196407|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325
10069662|NCT02164513|11196408|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186
10069663|NCT02164513|11196406|FG000|WIP: Lack of Efficacy|Overall Study||163
10069664|NCT02164513|11196407|FG001|WIP: Lack of Efficacy|Overall Study||313
10069665|NCT02164513|11196408|FG002|WIP: Lack of Efficacy|Overall Study||172
10069666|NCT02164513|11196406|FG000|Withdrew IP: Protocol Deviation|Overall Study||32
10069667|NCT02164513|11196407|FG001|Withdrew IP: Protocol Deviation|Overall Study||41
10069668|NCT02164513|11196408|FG002|Withdrew IP: Protocol Deviation|Overall Study||19
10069669|NCT02164513|11196406|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4
10069670|NCT02164513|11196407|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1
10069671|NCT02164513|11196408|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2
10069672|NCT02164513|11196406|FG000|WIP: Study Closed/Terminated|Overall Study||5
10069673|NCT02164513|11196407|FG001|WIP: Study Closed/Terminated|Overall Study||2
10069674|NCT02164513|11196408|FG002|WIP: Study Closed/Terminated|Overall Study||5
10069675|NCT02164513|11196406|FG000|WIP: Lost to Follow-up|Overall Study||21
10069676|NCT02164513|11196407|FG001|WIP: Lost to Follow-up|Overall Study||25
10069677|NCT02164513|11196408|FG002|WIP: Lost to Follow-up|Overall Study||14
10069678|NCT02164513|11196406|FG000|WIP: Investigator Discretion|Overall Study||33
10069679|NCT02164513|11196407|FG001|WIP: Investigator Discretion|Overall Study||36
10069680|NCT02164513|11196408|FG002|WIP: Investigator Discretion|Overall Study||15
10069681|NCT02164513|11196406|FG000|WIP: Withdrawal by Participant|Overall Study||250
10069682|NCT02164513|11196407|FG001|WIP: Withdrawal by Participant|Overall Study||296
10069683|NCT02164513|11196408|FG002|WIP: Withdrawal by Participant|Overall Study||153
10069684|NCT02164513|11196406|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1
10069685|NCT02164513|11196407|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1
10069686|NCT02164513|11196408|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0
10069687|NCT02164513|11196406|FG000|COMPLETED|Overall Study||3714
10189322|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10069688|NCT02164513|11196407|FG001|COMPLETED|Overall Study||3598
10069689|NCT02164513|11196408|FG002|COMPLETED|Overall Study||1775
10069690|NCT02164513|11196406|FG000|NOT COMPLETED|Overall Study||437
10069691|NCT02164513|11196407|FG001|NOT COMPLETED|Overall Study||536
10069692|NCT02164513|11196408|FG002|NOT COMPLETED|Overall Study||295
10069693|NCT02164539|11196423|FG000|STARTED|Treatment Phase A (4 Weeks)||41
10069694|NCT02164539|11196424|FG001|STARTED|Treatment Phase A (4 Weeks)||42
10069695|NCT02164539|11196425|FG002|STARTED|Treatment Phase A (4 Weeks)||40
10069696|NCT02164539|11196426|FG003|STARTED|Treatment Phase A (4 Weeks)||46
10069697|NCT02164539|11196427|FG004|STARTED|Treatment Phase A (4 Weeks)||85
10069698|NCT02164539|11196428|FG005|STARTED|Treatment Phase A (4 Weeks)||84
10069699|NCT02164539|11196429|FG006|STARTED|Treatment Phase A (4 Weeks)||0
10069700|NCT02164539|11196423|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39
10069701|NCT02164539|11196424|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42
10069702|NCT02164539|11196425|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39
10069703|NCT02164539|11196426|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44
10069704|NCT02164539|11196427|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82
10069705|NCT02164539|11196428|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83
10069706|NCT02164539|11196429|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0
10069707|NCT02164539|11196423|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
10069708|NCT02164539|11196424|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
10069709|NCT02164539|11196425|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
10069710|NCT02164539|11196426|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
10069711|NCT02164539|11196427|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
10069712|NCT02164539|11196428|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
10069713|NCT02164539|11196429|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
10069714|NCT02164539|11196423|FG000|STARTED|Treatment Phase B (1 Week)||0
10069715|NCT02164539|11196424|FG001|STARTED|Treatment Phase B (1 Week)||0
10069716|NCT02164539|11196425|FG002|STARTED|Treatment Phase B (1 Week)||0
10069717|NCT02164539|11196426|FG003|STARTED|Treatment Phase B (1 Week)||0
10069718|NCT02164539|11196427|FG004|STARTED|Treatment Phase B (1 Week)||166
10069719|NCT02164539|11196428|FG005|STARTED|Treatment Phase B (1 Week)||0
10069720|NCT02164539|11196429|FG006|STARTED|Treatment Phase B (1 Week)||163
10069721|NCT02164539|11196423|FG000|COMPLETED|Treatment Phase B (1 Week)||0
10069722|NCT02164539|11196424|FG001|COMPLETED|Treatment Phase B (1 Week)||0
10069723|NCT02164539|11196425|FG002|COMPLETED|Treatment Phase B (1 Week)||0
10069724|NCT02164539|11196426|FG003|COMPLETED|Treatment Phase B (1 Week)||0
10069725|NCT02164539|11196427|FG004|COMPLETED|Treatment Phase B (1 Week)||163
10189323|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10189324|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10189325|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10189326|NCT03285295|11318983|FG000|STARTED|Alinity s HBsAg Follow-Up||0
10189327|NCT03285295|11318984|FG001|STARTED|Alinity s HBsAg Follow-Up||0
10189328|NCT03285295|11318985|FG002|STARTED|Alinity s HBsAg Follow-Up||0
10189329|NCT03285295|11318986|FG003|STARTED|Alinity s HBsAg Follow-Up||0
10189330|NCT03285295|11318987|FG004|STARTED|Alinity s HBsAg Follow-Up||0
10189331|NCT03285295|11318983|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0
10189332|NCT03285295|11318984|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0
10189333|NCT03285295|11318985|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0
10189334|NCT03285295|11318986|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0
10189335|NCT03285295|11318987|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0
10189336|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10189337|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10189338|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10189339|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10189340|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10189341|NCT03285295|11318983|FG000|STARTED|Alinity s HTLV I/II||15968
10189342|NCT03285295|11318984|FG001|STARTED|Alinity s HTLV I/II||706
10189343|NCT03285295|11318985|FG002|STARTED|Alinity s HTLV I/II||502
10189344|NCT03285295|11318986|FG003|STARTED|Alinity s HTLV I/II||509
10189345|NCT03285295|11318987|FG004|STARTED|Alinity s HTLV I/II||0
10189346|NCT03285295|11318983|FG000|COMPLETED|Alinity s HTLV I/II||15877
10189347|NCT03285295|11318984|FG001|COMPLETED|Alinity s HTLV I/II||706
10189348|NCT03285295|11318985|FG002|COMPLETED|Alinity s HTLV I/II||502
10189349|NCT03285295|11318986|FG003|COMPLETED|Alinity s HTLV I/II||509
10189350|NCT03285295|11318987|FG004|COMPLETED|Alinity s HTLV I/II||0
10189351|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s HTLV I/II||91
10189352|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s HTLV I/II||0
10189353|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s HTLV I/II||0
10189354|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s HTLV I/II||0
10189355|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s HTLV I/II||0
10189356|NCT03285295|11318983|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12
10189357|NCT03285295|11318984|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0
10189358|NCT03285295|11318985|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0
10189359|NCT03285295|11318986|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0
10189360|NCT03285295|11318987|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0
9731469|NCT00132730|10831392|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10069726|NCT02164539|11196428|FG005|COMPLETED|Treatment Phase B (1 Week)||0
10069727|NCT02164539|11196429|FG006|COMPLETED|Treatment Phase B (1 Week)||162
10069728|NCT02164539|11196423|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0
10069729|NCT02164539|11196424|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0
10069730|NCT02164539|11196425|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0
10069731|NCT02164539|11196426|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0
10069732|NCT02164539|11196427|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3
10069733|NCT02164539|11196428|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0
10069734|NCT02164539|11196429|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1
10069735|NCT02164539|11196423|FG000|STARTED|Treatment Phase C (1 Week)||79
10069736|NCT02164539|11196424|FG001|STARTED|Treatment Phase C (1 Week)||0
10069737|NCT02164539|11196425|FG002|STARTED|Treatment Phase C (1 Week)||0
10069738|NCT02164539|11196426|FG003|STARTED|Treatment Phase C (1 Week)||0
10069739|NCT02164539|11196427|FG004|STARTED|Treatment Phase C (1 Week)||84
10069740|NCT02164539|11196428|FG005|STARTED|Treatment Phase C (1 Week)||82
10069741|NCT02164539|11196429|FG006|STARTED|Treatment Phase C (1 Week)||80
10069742|NCT02164539|11196423|FG000|COMPLETED|Treatment Phase C (1 Week)||78
10069743|NCT02164539|11196424|FG001|COMPLETED|Treatment Phase C (1 Week)||0
10069744|NCT02164539|11196425|FG002|COMPLETED|Treatment Phase C (1 Week)||0
10069745|NCT02164539|11196426|FG003|COMPLETED|Treatment Phase C (1 Week)||0
10069746|NCT02164539|11196427|FG004|COMPLETED|Treatment Phase C (1 Week)||84
10069747|NCT02164539|11196428|FG005|COMPLETED|Treatment Phase C (1 Week)||82
10069748|NCT02164539|11196429|FG006|COMPLETED|Treatment Phase C (1 Week)||78
10069749|NCT02164539|11196423|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1
10069750|NCT02164539|11196424|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0
10069751|NCT02164539|11196425|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0
10069752|NCT02164539|11196426|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0
10069753|NCT02164539|11196427|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0
10069754|NCT02164539|11196428|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0
10069755|NCT02164539|11196429|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2
10069756|NCT02164721|11196444|FG000|STARTED|Overall Study||30
10069757|NCT02164721|11196444|FG000|COMPLETED|Overall Study||30
10069758|NCT02164721|11196444|FG000|NOT COMPLETED|Overall Study||0
10069759|NCT02164864|11196452|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981
10069760|NCT02164864|11196453|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763
10069761|NCT02164864|11196454|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981
10069762|NCT02164864|11196452|FG000|COMPLETED|Overall Study||886
10069763|NCT02164864|11196453|FG001|COMPLETED|Overall Study||703
10069764|NCT02164864|11196454|FG002|COMPLETED|Overall Study||849
10069765|NCT02164864|11196452|FG000|NOT COMPLETED|Overall Study||95
10069766|NCT02164864|11196453|FG001|NOT COMPLETED|Overall Study||60
10069767|NCT02164864|11196454|FG002|NOT COMPLETED|Overall Study||132
10069768|NCT02164916|11196467|FG000|STARTED|Overall Study||52
10069769|NCT02164916|11196468|FG001|STARTED|Overall Study||54
10069770|NCT02164916|11196467|FG000|Eligible|Overall Study||50
10069771|NCT02164916|11196468|FG001|Eligible|Overall Study||49
10069772|NCT02164916|11196467|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
10069773|NCT02164916|11196468|FG001|Cross-over to Arm II|Overall Study||0
10069774|NCT02164916|11196467|FG000|COMPLETED|Overall Study||0
10069775|NCT02164916|11196468|FG001|COMPLETED|Overall Study||0
10069776|NCT02164916|11196467|FG000|NOT COMPLETED|Overall Study||52
10069777|NCT02164916|11196468|FG001|NOT COMPLETED|Overall Study||54
10069778|NCT02164929|11196483|FG000|STARTED|Overall Study||4
10069779|NCT02164929|11196484|FG001|STARTED|Overall Study||3
10069780|NCT02164929|11196485|FG002|STARTED|Overall Study||5
10069781|NCT02164929|11196486|FG003|STARTED|Overall Study||4
10069782|NCT02164929|11196483|FG000|COMPLETED|Overall Study||3
10069783|NCT02164929|11196484|FG001|COMPLETED|Overall Study||3
10069784|NCT02164929|11196485|FG002|COMPLETED|Overall Study||4
10069785|NCT02164929|11196486|FG003|COMPLETED|Overall Study||2
10069786|NCT02164929|11196483|FG000|NOT COMPLETED|Overall Study||1
10069787|NCT02164929|11196484|FG001|NOT COMPLETED|Overall Study||0
10069788|NCT02164929|11196485|FG002|NOT COMPLETED|Overall Study||1
10069789|NCT02164929|11196486|FG003|NOT COMPLETED|Overall Study||2
10069790|NCT02164981|11196499|FG000|STARTED|Started||23
10069791|NCT02164981|11196500|FG001|STARTED|Started||19
10069792|NCT02164981|11196501|FG002|STARTED|Started||18
10069793|NCT02164981|11196499|FG000|COMPLETED|Started||18
10069794|NCT02164981|11196500|FG001|COMPLETED|Started||16
10069795|NCT02164981|11196501|FG002|COMPLETED|Started||18
10069796|NCT02164981|11196499|FG000|NOT COMPLETED|Started||5
10069797|NCT02164981|11196500|FG001|NOT COMPLETED|Started||3
10069798|NCT02164981|11196501|FG002|NOT COMPLETED|Started||0
10069799|NCT02164981|11196499|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18
10069800|NCT02164981|11196500|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16
10069801|NCT02164981|11196501|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18
10069802|NCT02164981|11196499|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18
10069803|NCT02164981|11196500|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14
10069804|NCT02164981|11196501|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18
10069805|NCT02164981|11196499|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
10069806|NCT02164981|11196500|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
10069807|NCT02164981|11196501|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
10069808|NCT02164981|11196499|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18
10069809|NCT02164981|11196500|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14
10069810|NCT02164981|11196501|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18
10069811|NCT02164981|11196499|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16
10069812|NCT02164981|11196500|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12
10189361|NCT03285295|11318983|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8
10069813|NCT02164981|11196501|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18
10069814|NCT02164981|11196499|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
10069815|NCT02164981|11196500|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
10069816|NCT02164981|11196501|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
10069817|NCT02165072|11196522|FG000|STARTED|Overall Study||30
10069818|NCT02165072|11196522|FG000|COMPLETED|Overall Study||30
10069819|NCT02165072|11196522|FG000|NOT COMPLETED|Overall Study||0
10069820|NCT02165111|11196528|FG000|STARTED|Overall Study||40
10069821|NCT02165111|11196529|FG001|STARTED|Overall Study||40
10069822|NCT02165111|11196528|FG000|COMPLETED|Overall Study||40
10069823|NCT02165111|11196529|FG001|COMPLETED|Overall Study||40
10069824|NCT02165111|11196528|FG000|NOT COMPLETED|Overall Study||0
10069825|NCT02165111|11196529|FG001|NOT COMPLETED|Overall Study||0
10069826|NCT02165124|11196537|FG000|STARTED|Overall Study||20
10069827|NCT02165124|11196537|FG000|COMPLETED|Overall Study||15
10069828|NCT02165124|11196537|FG000|NOT COMPLETED|Overall Study||5
10069829|NCT02165202|11196543|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91
10069830|NCT02165202|11196544|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45
10069831|NCT02165202|11196543|FG000|COMPLETED|Oral Phase||80
10069832|NCT02165202|11196544|FG001|COMPLETED|Oral Phase||42
10069833|NCT02165202|11196543|FG000|NOT COMPLETED|Oral Phase||11
10069834|NCT02165202|11196544|FG001|NOT COMPLETED|Oral Phase||3
10069835|NCT02165202|11196543|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80
10069836|NCT02165202|11196544|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42
10069837|NCT02165202|11196543|FG000|COMPLETED|Injection Phase||70
10069838|NCT02165202|11196544|FG001|COMPLETED|Injection Phase||36
10069839|NCT02165202|11196543|FG000|NOT COMPLETED|Injection Phase||10
10069840|NCT02165202|11196544|FG001|NOT COMPLETED|Injection Phase||6
10069841|NCT02165384|11196550|FG000|STARTED|Overall Study||199
10069842|NCT02165384|11196550|FG000|COMPLETED|Overall Study||199
10069843|NCT02165384|11196550|FG000|NOT COMPLETED|Overall Study||0
10069844|NCT02165397|11196557|FG000|STARTED|Overall Study||75
10069845|NCT02165397|11196558|FG001|STARTED|Overall Study||75
10069846|NCT02165397|11196559|FG002|STARTED|Overall Study||31
10069847|NCT02165397|11196557|FG000|COMPLETED|Overall Study||61
10069848|NCT02165397|11196558|FG001|COMPLETED|Overall Study||56
10069849|NCT02165397|11196559|FG002|COMPLETED|Overall Study||21
10069850|NCT02165397|11196557|FG000|NOT COMPLETED|Overall Study||14
10069851|NCT02165397|11196558|FG001|NOT COMPLETED|Overall Study||19
10069852|NCT02165397|11196559|FG002|NOT COMPLETED|Overall Study||10
10069853|NCT02165462|11196569|FG000|STARTED|Overall Study||17
10069854|NCT02165462|11196569|FG000|COMPLETED|Overall Study||17
10069855|NCT02165462|11196569|FG000|NOT COMPLETED|Overall Study||0
10069856|NCT02165605|11196573|FG000|STARTED|Overall Study||28
10069857|NCT02165605|11196573|FG000|COMPLETED|Overall Study||28
10069858|NCT02165605|11196573|FG000|NOT COMPLETED|Overall Study||0
10069859|NCT02165722|11196582|FG000|STARTED|Overall Study||1971
10069860|NCT02165722|11196583|FG001|STARTED|Overall Study||2202
10069861|NCT02165722|11196582|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
10069862|NCT02165722|11196583|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
10069863|NCT02165722|11196582|FG000|NOT COMPLETED|Overall Study||0
10069864|NCT02165722|11196583|FG001|NOT COMPLETED|Overall Study||0
10069865|NCT02165735|11196597|FG000|STARTED|Overall Study||180
10069866|NCT02165735|11196598|FG001|STARTED|Overall Study||180
10069867|NCT02165735|11196597|FG000|COMPLETED|Overall Study||164
10069868|NCT02165735|11196598|FG001|COMPLETED|Overall Study||166
10069869|NCT02165735|11196597|FG000|NOT COMPLETED|Overall Study||16
10069870|NCT02165735|11196598|FG001|NOT COMPLETED|Overall Study||14
10069871|NCT02165761|11196606|FG000|STARTED|Overall Study||23
10069872|NCT02165761|11196607|FG001|STARTED|Overall Study||19
10069873|NCT02165761|11196606|FG000|COMPLETED|Overall Study||4
10069874|NCT02165761|11196607|FG001|COMPLETED|Overall Study||5
10069875|NCT02165761|11196606|FG000|NOT COMPLETED|Overall Study||19
10069876|NCT02165761|11196607|FG001|NOT COMPLETED|Overall Study||14
10069877|NCT02165826|11196616|FG000|STARTED|Main Treatment Period||441
10069878|NCT02165826|11196617|FG001|STARTED|Main Treatment Period||439
10069879|NCT02165826|11196618|FG002|STARTED|Main Treatment Period||443
10069880|NCT02165826|11196616|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
10069881|NCT02165826|11196617|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
10069882|NCT02165826|11196618|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
10069883|NCT02165826|11196616|FG000|COMPLETED|Main Treatment Period||360
10069884|NCT02165826|11196617|FG001|COMPLETED|Main Treatment Period||349
10069885|NCT02165826|11196618|FG002|COMPLETED|Main Treatment Period||334
10069886|NCT02165826|11196616|FG000|NOT COMPLETED|Main Treatment Period||81
10069887|NCT02165826|11196617|FG001|NOT COMPLETED|Main Treatment Period||90
10069888|NCT02165826|11196618|FG002|NOT COMPLETED|Main Treatment Period||109
10069889|NCT02165826|11196616|FG000|STARTED|Down-Titration Period||27
10069890|NCT02165826|11196617|FG001|STARTED|Down-Titration Period||39
10069891|NCT02165826|11196618|FG002|STARTED|Down-Titration Period||38
10069892|NCT02165826|11196616|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
10069893|NCT02165826|11196617|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
10069894|NCT02165826|11196618|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
10069895|NCT02165826|11196616|FG000|COMPLETED|Down-Titration Period||20
10069896|NCT02165826|11196617|FG001|COMPLETED|Down-Titration Period||28
10069897|NCT02165826|11196618|FG002|COMPLETED|Down-Titration Period||31
10069898|NCT02165826|11196616|FG000|NOT COMPLETED|Down-Titration Period||7
10069899|NCT02165826|11196617|FG001|NOT COMPLETED|Down-Titration Period||11
10069900|NCT02165826|11196618|FG002|NOT COMPLETED|Down-Titration Period||7
10069901|NCT02165839|11196645|FG000|STARTED|Overall Study||66
10069902|NCT02165839|11196646|FG001|STARTED|Overall Study||73
10069903|NCT02165839|11196645|FG000|COMPLETED|Overall Study||66
10069904|NCT02165839|11196646|FG001|COMPLETED|Overall Study||73
10069905|NCT02165839|11196645|FG000|NOT COMPLETED|Overall Study||0
10069906|NCT02165839|11196646|FG001|NOT COMPLETED|Overall Study||0
10069907|NCT02165904|11196653|FG000|STARTED|Overall Study||10
10069908|NCT02165904|11196653|FG000|COMPLETED|Overall Study||10
10069909|NCT02165904|11196653|FG000|NOT COMPLETED|Overall Study||0
10069910|NCT02166047|11196669|FG000|STARTED|Overall Study||16
10069911|NCT02166047|11196670|FG001|STARTED|Overall Study||15
10069912|NCT02166047|11196671|FG002|STARTED|Overall Study||16
10069913|NCT02166047|11196672|FG003|STARTED|Overall Study||5
10069914|NCT02166047|11196673|FG004|STARTED|Overall Study||18
10069915|NCT02166047|11196674|FG005|STARTED|Overall Study||17
10069916|NCT02166047|11196675|FG006|STARTED|Overall Study||17
10069917|NCT02166047|11196676|FG007|STARTED|Overall Study||5
10069918|NCT02166047|11196677|FG008|STARTED|Overall Study||16
10069919|NCT02166047|11196678|FG009|STARTED|Overall Study||17
10069920|NCT02166047|11196679|FG010|STARTED|Overall Study||14
10069921|NCT02166047|11196680|FG011|STARTED|Overall Study||6
10069922|NCT02166047|11196669|FG000|COMPLETED|Overall Study||16
10069923|NCT02166047|11196670|FG001|COMPLETED|Overall Study||14
10069924|NCT02166047|11196671|FG002|COMPLETED|Overall Study||14
10069925|NCT02166047|11196672|FG003|COMPLETED|Overall Study||5
10069926|NCT02166047|11196673|FG004|COMPLETED|Overall Study||17
10069927|NCT02166047|11196674|FG005|COMPLETED|Overall Study||17
10069928|NCT02166047|11196675|FG006|COMPLETED|Overall Study||15
10069929|NCT02166047|11196676|FG007|COMPLETED|Overall Study||5
10069930|NCT02166047|11196677|FG008|COMPLETED|Overall Study||16
10069931|NCT02166047|11196678|FG009|COMPLETED|Overall Study||17
10069932|NCT02166047|11196679|FG010|COMPLETED|Overall Study||12
10069933|NCT02166047|11196680|FG011|COMPLETED|Overall Study||6
10069934|NCT02166047|11196669|FG000|NOT COMPLETED|Overall Study||0
10069935|NCT02166047|11196670|FG001|NOT COMPLETED|Overall Study||1
10069936|NCT02166047|11196671|FG002|NOT COMPLETED|Overall Study||2
10069937|NCT02166047|11196672|FG003|NOT COMPLETED|Overall Study||0
10069938|NCT02166047|11196673|FG004|NOT COMPLETED|Overall Study||1
10069939|NCT02166047|11196674|FG005|NOT COMPLETED|Overall Study||0
10069940|NCT02166047|11196675|FG006|NOT COMPLETED|Overall Study||2
10069941|NCT02166047|11196676|FG007|NOT COMPLETED|Overall Study||0
10069942|NCT02166047|11196677|FG008|NOT COMPLETED|Overall Study||0
10069943|NCT02166047|11196678|FG009|NOT COMPLETED|Overall Study||0
10069944|NCT02166047|11196679|FG010|NOT COMPLETED|Overall Study||2
10069945|NCT02166047|11196680|FG011|NOT COMPLETED|Overall Study||0
10069946|NCT02166333|11196710|FG000|STARTED|Stage 1||262
10069947|NCT02166333|11196711|FG001|STARTED|Stage 1||0
10069948|NCT02166333|11196712|FG002|STARTED|Stage 1||130
10069949|NCT02166333|11196713|FG003|STARTED|Stage 1||0
10069950|NCT02166333|11196714|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
10069951|NCT02166333|11196715|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
10069952|NCT02166333|11196710|FG000|COMPLETED|Stage 1||242
10069953|NCT02166333|11196711|FG001|COMPLETED|Stage 1||0
10069954|NCT02166333|11196712|FG002|COMPLETED|Stage 1||122
10069955|NCT02166333|11196713|FG003|COMPLETED|Stage 1||0
10069956|NCT02166333|11196714|FG004|COMPLETED|Stage 1||59
10069957|NCT02166333|11196715|FG005|COMPLETED|Stage 1||63
10069958|NCT02166333|11196710|FG000|NOT COMPLETED|Stage 1||20
10069959|NCT02166333|11196711|FG001|NOT COMPLETED|Stage 1||0
10069960|NCT02166333|11196712|FG002|NOT COMPLETED|Stage 1||8
10069961|NCT02166333|11196713|FG003|NOT COMPLETED|Stage 1||0
10069962|NCT02166333|11196714|FG004|NOT COMPLETED|Stage 1||9
10069963|NCT02166333|11196715|FG005|NOT COMPLETED|Stage 1||6
10069964|NCT02166333|11196710|FG000|STARTED|Stage 2||242
10069965|NCT02166333|11196711|FG001|STARTED|Stage 2||77
10069966|NCT02166333|11196712|FG002|STARTED|Stage 2||122
10069967|NCT02166333|11196713|FG003|STARTED|Stage 2||82
10069968|NCT02166333|11196714|FG004|STARTED|Stage 2||59
10069969|NCT02166333|11196715|FG005|STARTED|Stage 2||63
10069970|NCT02166333|11196710|FG000|COMPLETED|Stage 2||35
10069971|NCT02166333|11196711|FG001|COMPLETED|Stage 2||71
10069972|NCT02166333|11196712|FG002|COMPLETED|Stage 2||47
10069973|NCT02166333|11196713|FG003|COMPLETED|Stage 2||73
10069974|NCT02166333|11196714|FG004|COMPLETED|Stage 2||2
10069975|NCT02166333|11196715|FG005|COMPLETED|Stage 2||4
10069976|NCT02166333|11196710|FG000|NOT COMPLETED|Stage 2||207
10069977|NCT02166333|11196711|FG001|NOT COMPLETED|Stage 2||6
10069978|NCT02166333|11196712|FG002|NOT COMPLETED|Stage 2||75
10069979|NCT02166333|11196713|FG003|NOT COMPLETED|Stage 2||9
10069980|NCT02166333|11196714|FG004|NOT COMPLETED|Stage 2||57
10069981|NCT02166333|11196715|FG005|NOT COMPLETED|Stage 2||59
10069982|NCT02166346|11196727|FG000|STARTED|Screening and Randomization||12
10069983|NCT02166346|11196728|FG001|STARTED|Screening and Randomization||12
10069984|NCT02166346|11196727|FG000|COMPLETED|Screening and Randomization||8
10069985|NCT02166346|11196728|FG001|COMPLETED|Screening and Randomization||8
10069986|NCT02166346|11196727|FG000|NOT COMPLETED|Screening and Randomization||4
10069987|NCT02166346|11196728|FG001|NOT COMPLETED|Screening and Randomization||4
10069988|NCT02166346|11196727|FG000|STARTED|Intervention - Phase 1||8
10069989|NCT02166346|11196728|FG001|STARTED|Intervention - Phase 1||8
10069990|NCT02166346|11196727|FG000|COMPLETED|Intervention - Phase 1||8
10069991|NCT02166346|11196728|FG001|COMPLETED|Intervention - Phase 1||6
10069992|NCT02166346|11196727|FG000|NOT COMPLETED|Intervention - Phase 1||0
10069993|NCT02166346|11196728|FG001|NOT COMPLETED|Intervention - Phase 1||2
10069994|NCT02166346|11196727|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8
10069995|NCT02166346|11196728|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6
10069996|NCT02166346|11196727|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7
10069997|NCT02166346|11196728|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6
10069998|NCT02166346|11196727|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
10189362|NCT03285295|11318984|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189363|NCT03285295|11318985|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189364|NCT03285295|11318986|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189365|NCT03285295|11318987|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189366|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
10189367|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189368|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189369|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189370|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10189371|NCT03285295|11318983|FG000|STARTED|Alinity s Anti-HCV||17095
10189372|NCT03285295|11318984|FG001|STARTED|Alinity s Anti-HCV||402
10189373|NCT03285295|11318985|FG002|STARTED|Alinity s Anti-HCV||407
10189374|NCT03285295|11318986|FG003|STARTED|Alinity s Anti-HCV||0
10189375|NCT03285295|11318987|FG004|STARTED|Alinity s Anti-HCV||0
10189376|NCT03285295|11318983|FG000|COMPLETED|Alinity s Anti-HCV||16999
10189377|NCT03285295|11318984|FG001|COMPLETED|Alinity s Anti-HCV||402
10189378|NCT03285295|11318985|FG002|COMPLETED|Alinity s Anti-HCV||407
10189379|NCT03285295|11318986|FG003|COMPLETED|Alinity s Anti-HCV||0
10189380|NCT03285295|11318987|FG004|COMPLETED|Alinity s Anti-HCV||0
10189381|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s Anti-HCV||96
10189382|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s Anti-HCV||0
10189383|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s Anti-HCV||0
10189384|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s Anti-HCV||0
10189385|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s Anti-HCV||0
10189386|NCT03285295|11318983|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20
10189387|NCT03285295|11318984|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0
10189388|NCT03285295|11318985|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0
10189389|NCT03285295|11318986|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0
10189390|NCT03285295|11318987|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0
10189391|NCT03285295|11318983|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2
10189392|NCT03285295|11318984|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189393|NCT03285295|11318985|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189394|NCT03285295|11318986|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189395|NCT03285295|11318987|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189396|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
10189397|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189398|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189399|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189400|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10189401|NCT03285295|11318983|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095
10189402|NCT03285295|11318984|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336
10189403|NCT03285295|11318985|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605
10189404|NCT03285295|11318986|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
10189405|NCT03285295|11318987|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0
10189406|NCT03285295|11318983|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
10189407|NCT03285295|11318984|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
10189408|NCT03285295|11318985|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605
10069999|NCT02166346|11196728|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
10070000|NCT02166476|11196736|FG000|STARTED|Overall Study||272
10070001|NCT02166476|11196737|FG001|STARTED|Overall Study||273
10070002|NCT02166476|11196736|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272
10070003|NCT02166476|11196737|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273
10070004|NCT02166476|11196736|FG000|COMPLETED|Overall Study||258
10070005|NCT02166476|11196737|FG001|COMPLETED|Overall Study||250
10070006|NCT02166476|11196736|FG000|NOT COMPLETED|Overall Study||14
10070007|NCT02166476|11196737|FG001|NOT COMPLETED|Overall Study||23
10070008|NCT02166606|11196746|FG000|STARTED|Overall Study||1184
10070009|NCT02166606|11196746|FG000|Actively Enrolled|Overall Study||1180
10070010|NCT02166606|11196746|FG000|Consent Eligible|Overall Study||1174
10070011|NCT02166606|11196746|FG000|COMPLETED|Overall Study||1106
10070012|NCT02166606|11196746|FG000|NOT COMPLETED|Overall Study||78
10070013|NCT02166697|11196750|FG000|STARTED|Overall Study||14151
10070014|NCT02166697|11196750|FG000|COMPLETED|Overall Study||13804
10070015|NCT02166697|11196750|FG000|NOT COMPLETED|Overall Study||347
10070016|NCT02167035|11196756|FG000|STARTED|Overall Study||21
10070017|NCT02167035|11196757|FG001|STARTED|Overall Study||22
10070018|NCT02167035|11196756|FG000|COMPLETED|Overall Study||16
10070019|NCT02167035|11196757|FG001|COMPLETED|Overall Study||16
10070020|NCT02167035|11196756|FG000|NOT COMPLETED|Overall Study||5
10070021|NCT02167035|11196757|FG001|NOT COMPLETED|Overall Study||6
10070022|NCT02167074|11196767|FG000|STARTED|Overall Study||306
10070023|NCT02167074|11196768|FG001|STARTED|Overall Study||302
10070024|NCT02167074|11196767|FG000|COMPLETED|Overall Study||306
10070025|NCT02167074|11196768|FG001|COMPLETED|Overall Study||302
10070026|NCT02167074|11196767|FG000|NOT COMPLETED|Overall Study||0
10070027|NCT02167074|11196768|FG001|NOT COMPLETED|Overall Study||0
10189409|NCT03285295|11318986|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
10189410|NCT03285295|11318987|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0
10189411|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
10189412|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10189413|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10189414|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10189415|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10189416|NCT03285295|11318983|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
10189417|NCT03285295|11318984|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189418|NCT03285295|11318985|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189419|NCT03285295|11318986|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189420|NCT03285295|11318987|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189421|NCT03285295|11318983|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
10189422|NCT03285295|11318984|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189423|NCT03285295|11318985|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189424|NCT03285295|11318986|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189425|NCT03285295|11318987|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189426|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
10189427|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189428|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189429|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189430|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10189431|NCT03285295|11318983|FG000|STARTED|Alinity s Anti-HBc||15968
10189432|NCT03285295|11318984|FG001|STARTED|Alinity s Anti-HBc||405
10189433|NCT03285295|11318985|FG002|STARTED|Alinity s Anti-HBc||403
10189434|NCT03285295|11318986|FG003|STARTED|Alinity s Anti-HBc||0
10189435|NCT03285295|11318987|FG004|STARTED|Alinity s Anti-HBc||0
10189436|NCT03285295|11318983|FG000|COMPLETED|Alinity s Anti-HBc||15877
10189437|NCT03285295|11318984|FG001|COMPLETED|Alinity s Anti-HBc||404
10189438|NCT03285295|11318985|FG002|COMPLETED|Alinity s Anti-HBc||403
10189439|NCT03285295|11318986|FG003|COMPLETED|Alinity s Anti-HBc||0
10189440|NCT03285295|11318987|FG004|COMPLETED|Alinity s Anti-HBc||0
10189441|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s Anti-HBc||91
10189442|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s Anti-HBc||1
10189443|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s Anti-HBc||0
10189444|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s Anti-HBc||0
10189445|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s Anti-HBc||0
10189446|NCT03285295|11318983|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16
10189447|NCT03285295|11318984|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0
10189448|NCT03285295|11318985|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0
10189449|NCT03285295|11318986|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0
10189450|NCT03285295|11318987|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0
10189451|NCT03285295|11318983|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2
10189452|NCT03285295|11318984|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189453|NCT03285295|11318985|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189454|NCT03285295|11318986|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189455|NCT03285295|11318987|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189456|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
10189457|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189458|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189459|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189460|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10189461|NCT03285295|11318983|FG000|STARTED|Alinity s Chagas||16023
10189462|NCT03285295|11318984|FG001|STARTED|Alinity s Chagas||320
10070028|NCT02167139|11196776|FG000|STARTED|Randomised, Double-blind||271
10070029|NCT02167139|11196777|FG001|STARTED|Randomised, Double-blind||273
10070030|NCT02167139|11196778|FG002|STARTED|Randomised, Double-blind||0
10070031|NCT02167139|11196779|FG003|STARTED|Randomised, Double-blind||0
10070032|NCT02167139|11196776|FG000|COMPLETED|Randomised, Double-blind||254
10070033|NCT02167139|11196777|FG001|COMPLETED|Randomised, Double-blind||254
10070034|NCT02167139|11196778|FG002|COMPLETED|Randomised, Double-blind||0
10070035|NCT02167139|11196779|FG003|COMPLETED|Randomised, Double-blind||0
10070036|NCT02167139|11196776|FG000|NOT COMPLETED|Randomised, Double-blind||17
10070037|NCT02167139|11196777|FG001|NOT COMPLETED|Randomised, Double-blind||19
10070038|NCT02167139|11196778|FG002|NOT COMPLETED|Randomised, Double-blind||0
10070039|NCT02167139|11196779|FG003|NOT COMPLETED|Randomised, Double-blind||0
10070040|NCT02167139|11196776|FG000|STARTED|Transition-extension||254
10189463|NCT03285295|11318985|FG002|STARTED|Alinity s Chagas||0
10189464|NCT03285295|11318986|FG003|STARTED|Alinity s Chagas||615
10189465|NCT03285295|11318987|FG004|STARTED|Alinity s Chagas||0
10189466|NCT03285295|11318983|FG000|COMPLETED|Alinity s Chagas||15804
10189467|NCT03285295|11318984|FG001|COMPLETED|Alinity s Chagas||320
10189468|NCT03285295|11318985|FG002|COMPLETED|Alinity s Chagas||0
10189469|NCT03285295|11318986|FG003|COMPLETED|Alinity s Chagas||615
10189470|NCT03285295|11318987|FG004|COMPLETED|Alinity s Chagas||0
10189471|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s Chagas||219
10189472|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s Chagas||0
10189473|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s Chagas||0
10189474|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s Chagas||0
10189475|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s Chagas||0
10189476|NCT03285295|11318983|FG000|STARTED|Alinity s Chagas Follow-Up||14
10189477|NCT03285295|11318984|FG001|STARTED|Alinity s Chagas Follow-Up||0
10189478|NCT03285295|11318985|FG002|STARTED|Alinity s Chagas Follow-Up||0
10189479|NCT03285295|11318986|FG003|STARTED|Alinity s Chagas Follow-Up||0
10189480|NCT03285295|11318987|FG004|STARTED|Alinity s Chagas Follow-Up||0
10189481|NCT03285295|11318983|FG000|COMPLETED|Alinity s Chagas Follow-Up||1
10189482|NCT03285295|11318984|FG001|COMPLETED|Alinity s Chagas Follow-Up||0
10189483|NCT03285295|11318985|FG002|COMPLETED|Alinity s Chagas Follow-Up||0
10189484|NCT03285295|11318986|FG003|COMPLETED|Alinity s Chagas Follow-Up||0
10189485|NCT03285295|11318987|FG004|COMPLETED|Alinity s Chagas Follow-Up||0
10189486|NCT03285295|11318983|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13
10189487|NCT03285295|11318984|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10189488|NCT03285295|11318985|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10189489|NCT03285295|11318986|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10189490|NCT03285295|11318987|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10189491|NCT03285308|11319018|FG000|STARTED|Overall Study||167
10189492|NCT03285308|11319019|FG001|STARTED|Overall Study||169
10189493|NCT03285308|11319018|FG000|Safety Population|Overall Study||163
10189494|NCT03285308|11319019|FG001|Safety Population|Overall Study||163
10189495|NCT03285308|11319018|FG000|COMPLETED|Overall Study||147
10189496|NCT03285308|11319019|FG001|COMPLETED|Overall Study||146
10189497|NCT03285308|11319018|FG000|NOT COMPLETED|Overall Study||20
10189498|NCT03285308|11319019|FG001|NOT COMPLETED|Overall Study||23
10189499|NCT03285373|11319026|FG000|STARTED|Overall Study||314
10189500|NCT03285373|11319027|FG001|STARTED|Overall Study||253
10189501|NCT03285373|11319028|FG002|STARTED|Overall Study||266
10189502|NCT03285373|11319029|FG003|STARTED|Overall Study||130
10189503|NCT03285373|11319026|FG000|COMPLETED|Overall Study||314
10189504|NCT03285373|11319027|FG001|COMPLETED|Overall Study||253
10189505|NCT03285373|11319028|FG002|COMPLETED|Overall Study||266
10189506|NCT03285373|11319029|FG003|COMPLETED|Overall Study||130
10189507|NCT03285373|11319026|FG000|NOT COMPLETED|Overall Study||0
10189508|NCT03285373|11319027|FG001|NOT COMPLETED|Overall Study||0
10189509|NCT03285373|11319028|FG002|NOT COMPLETED|Overall Study||0
10189510|NCT03285373|11319029|FG003|NOT COMPLETED|Overall Study||0
10189511|NCT03285477|11319040|FG000|STARTED|Treatment and Response Assessment Period||176
10189512|NCT03285477|11319041|FG001|STARTED|Treatment and Response Assessment Period||175
10189513|NCT03285477|11319040|FG000|COMPLETED|Treatment and Response Assessment Period||174
10189514|NCT03285477|11319041|FG001|COMPLETED|Treatment and Response Assessment Period||175
10189515|NCT03285477|11319040|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2
10189516|NCT03285477|11319041|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
10189517|NCT03285477|11319040|FG000|STARTED|Recurrence Follow-up Period||8
10189518|NCT03285477|11319041|FG001|STARTED|Recurrence Follow-up Period||77
10189519|NCT03285477|11319040|FG000|COMPLETED|Recurrence Follow-up Period||2
10189520|NCT03285477|11319041|FG001|COMPLETED|Recurrence Follow-up Period||22
10189521|NCT03285477|11319040|FG000|NOT COMPLETED|Recurrence Follow-up Period||6
10189522|NCT03285477|11319041|FG001|NOT COMPLETED|Recurrence Follow-up Period||55
10189523|NCT03285490|11319050|FG000|STARTED|Treatment and Response Assessment Period||173
10189524|NCT03285490|11319051|FG001|STARTED|Treatment and Response Assessment Period||178
10189525|NCT03285490|11319050|FG000|COMPLETED|Treatment and Response Assessment Period||173
10189526|NCT03285490|11319051|FG001|COMPLETED|Treatment and Response Assessment Period||178
10189527|NCT03285490|11319050|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0
10189528|NCT03285490|11319051|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
10189529|NCT03285490|11319050|FG000|STARTED|Recurrence Follow-up Period||22
10189530|NCT03285490|11319051|FG001|STARTED|Recurrence Follow-up Period||97
10189531|NCT03285490|11319050|FG000|COMPLETED|Recurrence Follow-up Period||4
10189532|NCT03285490|11319051|FG001|COMPLETED|Recurrence Follow-up Period||36
10070041|NCT02167139|11196777|FG001|STARTED|Transition-extension||0
10070042|NCT02167139|11196778|FG002|STARTED|Transition-extension||125
10070043|NCT02167139|11196779|FG003|STARTED|Transition-extension||129
10070044|NCT02167139|11196776|FG000|COMPLETED|Transition-extension||248
10070045|NCT02167139|11196777|FG001|COMPLETED|Transition-extension||0
10070046|NCT02167139|11196778|FG002|COMPLETED|Transition-extension||117
10070047|NCT02167139|11196779|FG003|COMPLETED|Transition-extension||124
10070048|NCT02167139|11196776|FG000|NOT COMPLETED|Transition-extension||6
10070049|NCT02167139|11196777|FG001|NOT COMPLETED|Transition-extension||0
10070050|NCT02167139|11196778|FG002|NOT COMPLETED|Transition-extension||8
10070051|NCT02167139|11196779|FG003|NOT COMPLETED|Transition-extension||5
10070052|NCT02167204|11196793|FG000|STARTED|Overall Study||9
10070053|NCT02167204|11196793|FG000|COMPLETED|Overall Study||9
10070054|NCT02167204|11196793|FG000|NOT COMPLETED|Overall Study||0
10070055|NCT02167217|11196803|FG000|STARTED|Overall Study||25
10070056|NCT02167217|11196803|FG000|COMPLETED|Overall Study||23
10070057|NCT02167217|11196803|FG000|NOT COMPLETED|Overall Study||2
10070058|NCT02167256|11196809|FG000|STARTED|Overall Study||79
10070059|NCT02167256|11196810|FG001|STARTED|Overall Study||80
10070060|NCT02167256|11196809|FG000|COMPLETED|Overall Study||58
10070061|NCT02167256|11196810|FG001|COMPLETED|Overall Study||70
10070062|NCT02167256|11196809|FG000|NOT COMPLETED|Overall Study||21
10070063|NCT02167256|11196810|FG001|NOT COMPLETED|Overall Study||10
10070064|NCT02167451|11196816|FG000|STARTED|Overall Study||31
10070065|NCT02167451|11196816|FG000|COMPLETED|Overall Study||30
10070066|NCT02167451|11196816|FG000|NOT COMPLETED|Overall Study||1
10070067|NCT02167594|11196823|FG000|STARTED|Overall Study||20
10070068|NCT02167594|11196824|FG001|STARTED|Overall Study||6
10070069|NCT02167594|11196825|FG002|STARTED|Overall Study||3
10070070|NCT02167594|11196823|FG000|COMPLETED|Overall Study||18
10070071|NCT02167594|11196824|FG001|COMPLETED|Overall Study||5
10070072|NCT02167594|11196825|FG002|COMPLETED|Overall Study||3
10070073|NCT02167594|11196823|FG000|NOT COMPLETED|Overall Study||2
10070074|NCT02167594|11196824|FG001|NOT COMPLETED|Overall Study||1
10070075|NCT02167594|11196825|FG002|NOT COMPLETED|Overall Study||0
10070076|NCT02167815|11196836|FG000|STARTED|Overall Study||9
10070077|NCT02167815|11196837|FG001|STARTED|Overall Study||21
10070078|NCT02167815|11196836|FG000|COMPLETED|Overall Study||9
10070079|NCT02167815|11196837|FG001|COMPLETED|Overall Study||21
10070080|NCT02167815|11196836|FG000|NOT COMPLETED|Overall Study||0
10070081|NCT02167815|11196837|FG001|NOT COMPLETED|Overall Study||0
10070082|NCT02167867|11196847|FG000|STARTED|Overall Study||22
10070083|NCT02167867|11196848|FG001|STARTED|Overall Study||22
10070084|NCT02167867|11196847|FG000|COMPLETED|Overall Study||22
10070085|NCT02167867|11196848|FG001|COMPLETED|Overall Study||22
10070086|NCT02167867|11196847|FG000|NOT COMPLETED|Overall Study||0
10070087|NCT02167867|11196848|FG001|NOT COMPLETED|Overall Study||0
10070088|NCT02167893|11196853|FG000|STARTED|Overall Study||11288
10070089|NCT02167893|11196853|FG000|COMPLETED|Overall Study||11125
10070090|NCT02167893|11196853|FG000|NOT COMPLETED|Overall Study||163
10070091|NCT02168062|11196860|FG000|STARTED|Overall Study||23
10070092|NCT02168062|11196861|FG001|STARTED|Overall Study||26
10070093|NCT02168062|11196862|FG002|STARTED|Overall Study||8
10070094|NCT02168062|11196860|FG000|COMPLETED|Overall Study||23
10070095|NCT02168062|11196861|FG001|COMPLETED|Overall Study||26
10070096|NCT02168062|11196862|FG002|COMPLETED|Overall Study||8
10070097|NCT02168062|11196860|FG000|NOT COMPLETED|Overall Study||0
10070098|NCT02168062|11196861|FG001|NOT COMPLETED|Overall Study||0
10070099|NCT02168062|11196862|FG002|NOT COMPLETED|Overall Study||0
10070100|NCT02168101|11196875|FG000|STARTED|Overall Study||3
10070101|NCT02168101|11196876|FG001|STARTED|Overall Study||3
10070102|NCT02168101|11196877|FG002|STARTED|Overall Study||3
10070103|NCT02168101|11196875|FG000|COMPLETED|Overall Study||1
10070104|NCT02168101|11196876|FG001|COMPLETED|Overall Study||1
10070105|NCT02168101|11196877|FG002|COMPLETED|Overall Study||2
10070106|NCT02168101|11196875|FG000|NOT COMPLETED|Overall Study||2
10070107|NCT02168101|11196876|FG001|NOT COMPLETED|Overall Study||2
10070108|NCT02168101|11196877|FG002|NOT COMPLETED|Overall Study||1
10070109|NCT02168153|11196888|FG000|STARTED|Overall Study||60
10070110|NCT02168153|11196889|FG001|STARTED|Overall Study||60
10070111|NCT02168153|11196888|FG000|COMPLETED|Overall Study||57
10070112|NCT02168153|11196889|FG001|COMPLETED|Overall Study||60
10070113|NCT02168153|11196888|FG000|NOT COMPLETED|Overall Study||3
10070114|NCT02168153|11196889|FG001|NOT COMPLETED|Overall Study||0
10070115|NCT02168309|11196897|FG000|STARTED|Overall Study||25
10070116|NCT02168309|11196898|FG001|STARTED|Overall Study||25
10070117|NCT02168309|11196897|FG000|COMPLETED|Overall Study||25
10070118|NCT02168309|11196898|FG001|COMPLETED|Overall Study||25
10070119|NCT02168309|11196897|FG000|NOT COMPLETED|Overall Study||0
10070120|NCT02168309|11196898|FG001|NOT COMPLETED|Overall Study||0
10070121|NCT02168361|11196906|FG000|STARTED|Overall Study||62
10070122|NCT02168361|11196907|FG001|STARTED|Overall Study||31
10070123|NCT02168361|11196906|FG000|COMPLETED|Overall Study||57
10070124|NCT02168361|11196907|FG001|COMPLETED|Overall Study||21
10070125|NCT02168361|11196906|FG000|NOT COMPLETED|Overall Study||5
10070126|NCT02168361|11196907|FG001|NOT COMPLETED|Overall Study||10
10070127|NCT02168387|11196915|FG000|STARTED|Overall Study||20
10070128|NCT02168387|11196916|FG001|STARTED|Overall Study||19
10070129|NCT02168387|11196915|FG000|COMPLETED|Overall Study||13
10070130|NCT02168387|11196916|FG001|COMPLETED|Overall Study||16
10070131|NCT02168387|11196915|FG000|NOT COMPLETED|Overall Study||7
10070132|NCT02168387|11196916|FG001|NOT COMPLETED|Overall Study||3
10070133|NCT02168439|11196924|FG000|STARTED|Overall Study||20
10070134|NCT02168439|11196925|FG001|STARTED|Overall Study||20
10070135|NCT02168439|11196924|FG000|COMPLETED|Overall Study||20
10070136|NCT02168439|11196925|FG001|COMPLETED|Overall Study||18
10070137|NCT02168439|11196924|FG000|NOT COMPLETED|Overall Study||0
10070138|NCT02168439|11196925|FG001|NOT COMPLETED|Overall Study||2
10070139|NCT02168478|11196931|FG000|STARTED|Overall Study||206
10070140|NCT02168478|11196931|FG000|COMPLETED|Overall Study||202
10070141|NCT02168478|11196931|FG000|NOT COMPLETED|Overall Study||4
10070142|NCT02168491|11196935|FG000|STARTED|Overall Study||9
10070143|NCT02168491|11196935|FG000|COMPLETED|Overall Study||8
10070144|NCT02168491|11196935|FG000|NOT COMPLETED|Overall Study||1
10070145|NCT02168660|11196942|FG000|STARTED|Overall Study||38
10070146|NCT02168660|11196943|FG001|STARTED|Overall Study||35
10070147|NCT02168660|11196944|FG002|STARTED|Overall Study||36
10070148|NCT02168660|11196942|FG000|COMPLETED|Overall Study||22
10070149|NCT02168660|11196943|FG001|COMPLETED|Overall Study||18
10070150|NCT02168660|11196944|FG002|COMPLETED|Overall Study||21
10070151|NCT02168660|11196942|FG000|NOT COMPLETED|Overall Study||16
10070152|NCT02168660|11196943|FG001|NOT COMPLETED|Overall Study||17
10070153|NCT02168660|11196944|FG002|NOT COMPLETED|Overall Study||15
10070154|NCT02168777|11196958|FG000|STARTED|Overall Study||2
10070155|NCT02168777|11196959|FG001|STARTED|Overall Study||7
10070156|NCT02168777|11196960|FG002|STARTED|Overall Study||11
10070157|NCT02168777|11196958|FG000|COMPLETED|Overall Study||0
10070158|NCT02168777|11196959|FG001|COMPLETED|Overall Study||0
10070159|NCT02168777|11196960|FG002|COMPLETED|Overall Study||0
10070160|NCT02168777|11196958|FG000|NOT COMPLETED|Overall Study||2
10070161|NCT02168777|11196959|FG001|NOT COMPLETED|Overall Study||7
10070162|NCT02168777|11196960|FG002|NOT COMPLETED|Overall Study||11
10070163|NCT02168803|11196974|FG000|STARTED|Overall Study||30
10070164|NCT02168803|11196975|FG001|STARTED|Overall Study||32
10070165|NCT02168803|11196976|FG002|STARTED|Overall Study||39
10070166|NCT02168803|11196974|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30
10070167|NCT02168803|11196975|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32
10070168|NCT02168803|11196976|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39
10070169|NCT02168803|11196974|FG000|COMPLETED|Overall Study||28
10070170|NCT02168803|11196975|FG001|COMPLETED|Overall Study||29
10070171|NCT02168803|11196976|FG002|COMPLETED|Overall Study||33
10070172|NCT02168803|11196974|FG000|NOT COMPLETED|Overall Study||2
10070173|NCT02168803|11196975|FG001|NOT COMPLETED|Overall Study||3
10070174|NCT02168803|11196976|FG002|NOT COMPLETED|Overall Study||6
10070175|NCT02168816|11196993|FG000|STARTED|Overall Study||5
10070176|NCT02168816|11196994|FG001|STARTED|Overall Study||7
10070177|NCT02168816|11196993|FG000|COMPLETED|Overall Study||3
10070178|NCT02168816|11196994|FG001|COMPLETED|Overall Study||5
10070179|NCT02168816|11196993|FG000|NOT COMPLETED|Overall Study||2
10070180|NCT02168816|11196994|FG001|NOT COMPLETED|Overall Study||2
10070181|NCT02168842|11197002|FG000|STARTED|Overall Study||170
10070182|NCT02168842|11197003|FG001|STARTED|Overall Study||166
10070183|NCT02168842|11197002|FG000|COMPLETED|Overall Study||162
10070184|NCT02168842|11197003|FG001|COMPLETED|Overall Study||158
10070185|NCT02168842|11197002|FG000|NOT COMPLETED|Overall Study||8
10070186|NCT02168842|11197003|FG001|NOT COMPLETED|Overall Study||8
10070187|NCT02168855|11197013|FG000|STARTED|Overall Study||181
10070188|NCT02168855|11197014|FG001|STARTED|Overall Study||188
10070189|NCT02168855|11197013|FG000|COMPLETED|Overall Study||169
10070190|NCT02168855|11197014|FG001|COMPLETED|Overall Study||177
10070191|NCT02168855|11197013|FG000|NOT COMPLETED|Overall Study||12
10070192|NCT02168855|11197014|FG001|NOT COMPLETED|Overall Study||11
10070193|NCT02168933|11197022|FG000|STARTED|Overall Study||8
10070194|NCT02168933|11197022|FG000|COMPLETED|Overall Study||7
10070195|NCT02168933|11197022|FG000|NOT COMPLETED|Overall Study||1
10070196|NCT02168946|11197032|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
10070197|NCT02168946|11197033|FG001|STARTED|Overall Study||25
10070198|NCT02168946|11197032|FG000|COMPLETED|Overall Study||38
10070199|NCT02168946|11197033|FG001|COMPLETED|Overall Study||20
10070200|NCT02168946|11197032|FG000|NOT COMPLETED|Overall Study||12
10070201|NCT02168946|11197033|FG001|NOT COMPLETED|Overall Study||5
10070202|NCT02169115|11197042|FG000|STARTED|Overall Study||19
10070203|NCT02169115|11197043|FG001|STARTED|Overall Study||21
10070204|NCT02169115|11197044|FG002|STARTED|Overall Study||21
10070205|NCT02169115|11197042|FG000|COMPLETED|Overall Study||19
10070206|NCT02169115|11197043|FG001|COMPLETED|Overall Study||21
10070207|NCT02169115|11197044|FG002|COMPLETED|Overall Study||21
10070208|NCT02169115|11197042|FG000|NOT COMPLETED|Overall Study||0
10070209|NCT02169115|11197043|FG001|NOT COMPLETED|Overall Study||0
10070210|NCT02169115|11197044|FG002|NOT COMPLETED|Overall Study||0
10070211|NCT02169219|11197053|FG000|STARTED|Overall Study||20
10070212|NCT02169219|11197053|FG000|COMPLETED|Overall Study||14
10070213|NCT02169219|11197053|FG000|NOT COMPLETED|Overall Study||6
10070214|NCT02169271|11197064|FG000|STARTED|Overall Study||49
10070215|NCT02169271|11197065|FG001|STARTED|Overall Study||49
10070216|NCT02169271|11197064|FG000|COMPLETED|Overall Study||48
10070217|NCT02169271|11197065|FG001|COMPLETED|Overall Study||47
10070218|NCT02169271|11197064|FG000|NOT COMPLETED|Overall Study||1
10070219|NCT02169271|11197065|FG001|NOT COMPLETED|Overall Study||2
10070220|NCT02169284|11197073|FG000|STARTED|Overall Study||24
10070221|NCT02169284|11197074|FG001|STARTED|Overall Study||13
10070222|NCT02169284|11197073|FG000|COMPLETED|Overall Study||24
10070223|NCT02169284|11197074|FG001|COMPLETED|Overall Study||12
10070224|NCT02169284|11197073|FG000|NOT COMPLETED|Overall Study||0
10070225|NCT02169284|11197074|FG001|NOT COMPLETED|Overall Study||1
10070226|NCT02169336|11197085|FG000|STARTED|Overall Study||31
10070227|NCT02169336|11197086|FG001|STARTED|Overall Study||32
10070228|NCT02169336|11197087|FG002|STARTED|Overall Study||32
10070229|NCT02169336|11197085|FG000|COMPLETED|Overall Study||27
10070230|NCT02169336|11197086|FG001|COMPLETED|Overall Study||28
10070231|NCT02169336|11197087|FG002|COMPLETED|Overall Study||29
10070232|NCT02169336|11197085|FG000|NOT COMPLETED|Overall Study||4
10070233|NCT02169336|11197086|FG001|NOT COMPLETED|Overall Study||4
10070234|NCT02169336|11197087|FG002|NOT COMPLETED|Overall Study||3
10070235|NCT02169414|11197099|FG000|STARTED|Overall Study||19
10070236|NCT02169414|11197100|FG001|STARTED|Overall Study||19
10070237|NCT02169414|11197101|FG002|STARTED|Overall Study||18
10070238|NCT02169414|11197102|FG003|STARTED|Overall Study||18
10070239|NCT02169414|11197099|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
10070240|NCT02169414|11197100|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
10070241|NCT02169414|11197101|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
10189533|NCT03285490|11319050|FG000|NOT COMPLETED|Recurrence Follow-up Period||18
10189534|NCT03285490|11319051|FG001|NOT COMPLETED|Recurrence Follow-up Period||61
10189535|NCT03285529|11319060|FG000|STARTED|Overall Study||30
10189536|NCT03285529|11319061|FG001|STARTED|Overall Study||30
10189537|NCT03285529|11319060|FG000|COMPLETED|Overall Study||30
10189538|NCT03285529|11319061|FG001|COMPLETED|Overall Study||30
10189539|NCT03285529|11319060|FG000|NOT COMPLETED|Overall Study||0
10189540|NCT03285529|11319061|FG001|NOT COMPLETED|Overall Study||0
10189541|NCT03285542|11319069|FG000|STARTED|Overall Study||30
10189542|NCT03285542|11319070|FG001|STARTED|Overall Study||30
10189543|NCT03285542|11319069|FG000|COMPLETED|Overall Study||30
10189544|NCT03285542|11319070|FG001|COMPLETED|Overall Study||30
10189545|NCT03285542|11319069|FG000|NOT COMPLETED|Overall Study||0
10189546|NCT03285542|11319070|FG001|NOT COMPLETED|Overall Study||0
10189547|NCT03285555|11319078|FG000|STARTED|Overall Study||30
10189548|NCT03285555|11319079|FG001|STARTED|Overall Study||30
10189549|NCT03285555|11319078|FG000|COMPLETED|Overall Study||30
10189550|NCT03285555|11319079|FG001|COMPLETED|Overall Study||30
10189551|NCT03285555|11319078|FG000|NOT COMPLETED|Overall Study||0
10189552|NCT03285555|11319079|FG001|NOT COMPLETED|Overall Study||0
10189553|NCT03285594|11319088|FG000|STARTED|Overall Study||144
10189554|NCT03285594|11319089|FG001|STARTED|Overall Study||141
10189555|NCT03285594|11319090|FG002|STARTED|Overall Study||286
10189556|NCT03285594|11319088|FG000|Treated|Overall Study||144
10189557|NCT03285594|11319089|FG001|Treated|Overall Study||141
10189558|NCT03285594|11319090|FG002|Treated|Overall Study||285
10189559|NCT03285594|11319088|FG000|COMPLETED|Overall Study||129
10189560|NCT03285594|11319089|FG001|COMPLETED|Overall Study||130
10189561|NCT03285594|11319090|FG002|COMPLETED|Overall Study||249
10189562|NCT03285594|11319088|FG000|NOT COMPLETED|Overall Study||15
10189563|NCT03285594|11319089|FG001|NOT COMPLETED|Overall Study||11
10189564|NCT03285594|11319090|FG002|NOT COMPLETED|Overall Study||37
10070242|NCT02169414|11197102|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
10070243|NCT02169414|11197099|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10070244|NCT02169414|11197100|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10070245|NCT02169414|11197101|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10070246|NCT02169414|11197102|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10070247|NCT02169414|11197099|FG000|COMPLETED|Overall Study||18
10070248|NCT02169414|11197100|FG001|COMPLETED|Overall Study||18
10070249|NCT02169414|11197101|FG002|COMPLETED|Overall Study||18
10070250|NCT02169414|11197102|FG003|COMPLETED|Overall Study||18
10070251|NCT02169414|11197099|FG000|NOT COMPLETED|Overall Study||1
10070252|NCT02169414|11197100|FG001|NOT COMPLETED|Overall Study||1
10070253|NCT02169414|11197101|FG002|NOT COMPLETED|Overall Study||0
10070254|NCT02169414|11197102|FG003|NOT COMPLETED|Overall Study||0
10070255|NCT02169427|11197116|FG000|STARTED|Overall Study||6
10070256|NCT02169427|11197116|FG000|COMPLETED|Overall Study||6
10070257|NCT02169427|11197116|FG000|NOT COMPLETED|Overall Study||0
10070258|NCT02169440|11197122|FG000|STARTED|Overall Study||10
10070259|NCT02169440|11197123|FG001|STARTED|Overall Study||10
10070260|NCT02169440|11197122|FG000|COMPLETED|Overall Study||10
10070261|NCT02169440|11197123|FG001|COMPLETED|Overall Study||10
10070262|NCT02169440|11197122|FG000|NOT COMPLETED|Overall Study||0
10070263|NCT02169440|11197123|FG001|NOT COMPLETED|Overall Study||0
10070264|NCT02169453|11197134|FG000|STARTED|Overall Study||3
10070265|NCT02169453|11197135|FG001|STARTED|Overall Study||3
10070266|NCT02169453|11197136|FG002|STARTED|Overall Study||3
10070267|NCT02169453|11197137|FG003|STARTED|Overall Study||3
10070268|NCT02169453|11197134|FG000|25 mg BIA 9-1067|Overall Study||3
10070269|NCT02169453|11197135|FG001|25 mg BIA 9-1067|Overall Study||3
10070270|NCT02169453|11197136|FG002|25 mg BIA 9-1067|Overall Study||3
10070271|NCT02169453|11197137|FG003|25 mg BIA 9-1067|Overall Study||3
10070272|NCT02169453|11197134|FG000|50 mg BIA 9-1067|Overall Study||3
10070273|NCT02169453|11197135|FG001|50 mg BIA 9-1067|Overall Study||3
10070274|NCT02169453|11197136|FG002|50 mg BIA 9-1067|Overall Study||2
10070275|NCT02169453|11197137|FG003|50 mg BIA 9-1067|Overall Study||3
10070276|NCT02169453|11197134|FG000|100 mg BIA 9-1067|Overall Study||3
10070277|NCT02169453|11197135|FG001|100 mg BIA 9-1067|Overall Study||3
10070278|NCT02169453|11197136|FG002|100 mg BIA 9-1067|Overall Study||3
10070279|NCT02169453|11197137|FG003|100 mg BIA 9-1067|Overall Study||3
10070280|NCT02169453|11197134|FG000|Placebo|Overall Study||3
10070281|NCT02169453|11197135|FG001|Placebo|Overall Study||3
10070282|NCT02169453|11197136|FG002|Placebo|Overall Study||3
10070283|NCT02169453|11197137|FG003|Placebo|Overall Study||3
10070284|NCT02169453|11197134|FG000|COMPLETED|Overall Study||3
10070285|NCT02169453|11197135|FG001|COMPLETED|Overall Study||3
10070286|NCT02169453|11197136|FG002|COMPLETED|Overall Study||2
10070287|NCT02169453|11197137|FG003|COMPLETED|Overall Study||3
10070288|NCT02169453|11197134|FG000|NOT COMPLETED|Overall Study||0
10070289|NCT02169453|11197135|FG001|NOT COMPLETED|Overall Study||0
10070290|NCT02169453|11197136|FG002|NOT COMPLETED|Overall Study||1
10070291|NCT02169453|11197137|FG003|NOT COMPLETED|Overall Study||0
10070292|NCT02169466|11197151|FG000|STARTED|Overall Study||6
10070293|NCT02169466|11197152|FG001|STARTED|Overall Study||6
10070294|NCT02169466|11197153|FG002|STARTED|Overall Study||5
10070295|NCT02169466|11197154|FG003|STARTED|Overall Study||5
10070296|NCT02169466|11197151|FG000|25 mg BIA 9-1067|Overall Study||6
10070297|NCT02169466|11197152|FG001|25 mg BIA 9-1067|Overall Study||5
10070298|NCT02169466|11197153|FG002|25 mg BIA 9-1067|Overall Study||5
10070299|NCT02169466|11197154|FG003|25 mg BIA 9-1067|Overall Study||5
10070300|NCT02169466|11197151|FG000|50 mg BIA 9-1067|Overall Study||6
10070301|NCT02169466|11197152|FG001|50 mg BIA 9-1067|Overall Study||6
10070302|NCT02169466|11197153|FG002|50 mg BIA 9-1067|Overall Study||5
10070303|NCT02169466|11197154|FG003|50 mg BIA 9-1067|Overall Study||5
10070304|NCT02169466|11197151|FG000|100 mg BIA 9-1067|Overall Study||6
10070305|NCT02169466|11197152|FG001|100 mg BIA 9-1067|Overall Study||6
10070306|NCT02169466|11197153|FG002|100 mg BIA 9-1067|Overall Study||5
10070307|NCT02169466|11197154|FG003|100 mg BIA 9-1067|Overall Study||5
10070308|NCT02169466|11197151|FG000|Placebo|Overall Study||5
10070309|NCT02169466|11197152|FG001|Placebo|Overall Study||6
10070310|NCT02169466|11197153|FG002|Placebo|Overall Study||5
10070311|NCT02169466|11197154|FG003|Placebo|Overall Study||5
10070312|NCT02169466|11197151|FG000|COMPLETED|Overall Study||5
10070313|NCT02169466|11197152|FG001|COMPLETED|Overall Study||5
10189565|NCT03285646|11319101|FG000|STARTED|Overall Study||32
10189566|NCT03285646|11319102|FG001|STARTED|Overall Study||31
10189567|NCT03285646|11319101|FG000|COMPLETED|Overall Study||19
10189568|NCT03285646|11319102|FG001|COMPLETED|Overall Study||27
10189569|NCT03285646|11319101|FG000|NOT COMPLETED|Overall Study||13
10189570|NCT03285646|11319102|FG001|NOT COMPLETED|Overall Study||4
10189571|NCT03285711|11319111|FG000|STARTED|Blinded Phase (Up to Week 16)||4
10189572|NCT03285711|11319112|FG001|STARTED|Blinded Phase (Up to Week 16)||5
10189573|NCT03285711|11319113|FG002|STARTED|Blinded Phase (Up to Week 16)||0
10189574|NCT03285711|11319114|FG003|STARTED|Blinded Phase (Up to Week 16)||0
10189575|NCT03285711|11319111|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1
10189576|NCT03285711|11319112|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4
10070314|NCT02169466|11197153|FG002|COMPLETED|Overall Study||5
10070315|NCT02169466|11197154|FG003|COMPLETED|Overall Study||5
10070316|NCT02169466|11197151|FG000|NOT COMPLETED|Overall Study||1
10070317|NCT02169466|11197152|FG001|NOT COMPLETED|Overall Study||1
10070318|NCT02169466|11197153|FG002|NOT COMPLETED|Overall Study||0
10070319|NCT02169466|11197154|FG003|NOT COMPLETED|Overall Study||0
10070320|NCT02169479|11197172|FG000|STARTED|Overall Study||4
10070321|NCT02169479|11197173|FG001|STARTED|Overall Study||4
10070322|NCT02169479|11197174|FG002|STARTED|Overall Study||4
10070323|NCT02169479|11197175|FG003|STARTED|Overall Study||4
10070324|NCT02169479|11197172|FG000|25 mg BIA 9-1067|Overall Study||4
10070325|NCT02169479|11197173|FG001|25 mg BIA 9-1067|Overall Study||3
10070326|NCT02169479|11197174|FG002|25 mg BIA 9-1067|Overall Study||4
10070327|NCT02169479|11197175|FG003|25 mg BIA 9-1067|Overall Study||4
10070328|NCT02169479|11197172|FG000|50 mg BIA 9-1067|Overall Study||4
10070329|NCT02169479|11197173|FG001|50 mg BIA 9-1067|Overall Study||4
10070330|NCT02169479|11197174|FG002|50 mg BIA 9-1067|Overall Study||4
10070331|NCT02169479|11197175|FG003|50 mg BIA 9-1067|Overall Study||4
10070332|NCT02169479|11197172|FG000|100 mg BIA 9-1067|Overall Study||3
10070333|NCT02169479|11197173|FG001|100 mg BIA 9-1067|Overall Study||4
10070334|NCT02169479|11197174|FG002|100 mg BIA 9-1067|Overall Study||4
10070335|NCT02169479|11197175|FG003|100 mg BIA 9-1067|Overall Study||4
10070336|NCT02169479|11197172|FG000|Placebo|Overall Study||3
10070337|NCT02169479|11197173|FG001|Placebo|Overall Study||3
10070338|NCT02169479|11197174|FG002|Placebo|Overall Study||4
10070339|NCT02169479|11197175|FG003|Placebo|Overall Study||4
10070340|NCT02169479|11197172|FG000|COMPLETED|Overall Study||3
10070341|NCT02169479|11197173|FG001|COMPLETED|Overall Study||3
10070342|NCT02169479|11197174|FG002|COMPLETED|Overall Study||4
10070343|NCT02169479|11197175|FG003|COMPLETED|Overall Study||4
10070344|NCT02169479|11197172|FG000|NOT COMPLETED|Overall Study||1
10070345|NCT02169479|11197173|FG001|NOT COMPLETED|Overall Study||1
10070346|NCT02169479|11197174|FG002|NOT COMPLETED|Overall Study||0
10070347|NCT02169479|11197175|FG003|NOT COMPLETED|Overall Study||0
10070348|NCT02169505|11197185|FG000|STARTED|Overall Study||2
10070349|NCT02169505|11197185|FG000|COMPLETED|Overall Study||1
10070350|NCT02169505|11197185|FG000|NOT COMPLETED|Overall Study||1
10070351|NCT02169674|11197191|FG000|STARTED|Overall Study||137
10070352|NCT02169674|11197192|FG001|STARTED|Overall Study||213
10070353|NCT02169674|11197191|FG000|COMPLETED|Overall Study||105
10070354|NCT02169674|11197192|FG001|COMPLETED|Overall Study||135
10070355|NCT02169674|11197191|FG000|NOT COMPLETED|Overall Study||32
10070356|NCT02169674|11197192|FG001|NOT COMPLETED|Overall Study||78
10070357|NCT02169739|11197200|FG000|STARTED|Overall Study||2
10070358|NCT02169739|11197201|FG001|STARTED|Overall Study||4
10070359|NCT02169739|11197200|FG000|COMPLETED|Overall Study||2
10070360|NCT02169739|11197201|FG001|COMPLETED|Overall Study||0
10070361|NCT02169739|11197200|FG000|NOT COMPLETED|Overall Study||0
10070362|NCT02169739|11197201|FG001|NOT COMPLETED|Overall Study||4
10070363|NCT02169791|11197208|FG000|STARTED|Overall Study||25
10070364|NCT02169791|11197208|FG000|COMPLETED|Overall Study||18
10070365|NCT02169791|11197208|FG000|NOT COMPLETED|Overall Study||7
10070366|NCT02169869|11197214|FG000|STARTED|Overall Study||17
10070367|NCT02169869|11197215|FG001|STARTED|Overall Study||16
10070368|NCT02169869|11197214|FG000|COMPLETED|Overall Study||17
10070369|NCT02169869|11197215|FG001|COMPLETED|Overall Study||16
10070370|NCT02169869|11197214|FG000|NOT COMPLETED|Overall Study||0
10070371|NCT02169869|11197215|FG001|NOT COMPLETED|Overall Study||0
10070372|NCT02169895|11197225|FG000|STARTED|Overall Study||4
10070373|NCT02169895|11197226|FG001|STARTED|Overall Study||4
10070374|NCT02169895|11197227|FG002|STARTED|Overall Study||4
10070375|NCT02169895|11197228|FG003|STARTED|Overall Study||4
10070376|NCT02169895|11197225|FG000|25 mg BIA 9-1067|Overall Study||4
10070377|NCT02169895|11197226|FG001|25 mg BIA 9-1067|Overall Study||4
10070378|NCT02169895|11197227|FG002|25 mg BIA 9-1067|Overall Study||4
10070379|NCT02169895|11197228|FG003|25 mg BIA 9-1067|Overall Study||4
10070380|NCT02169895|11197225|FG000|50 mg BIA 9-1067|Overall Study||4
10070381|NCT02169895|11197226|FG001|50 mg BIA 9-1067|Overall Study||4
10070382|NCT02169895|11197227|FG002|50 mg BIA 9-1067|Overall Study||4
10070383|NCT02169895|11197228|FG003|50 mg BIA 9-1067|Overall Study||4
10070384|NCT02169895|11197225|FG000|100 mg BIA 9-1067|Overall Study||4
10070385|NCT02169895|11197226|FG001|100 mg BIA 9-1067|Overall Study||4
10070386|NCT02169895|11197227|FG002|100 mg BIA 9-1067|Overall Study||4
10070387|NCT02169895|11197228|FG003|100 mg BIA 9-1067|Overall Study||2
10070388|NCT02169895|11197225|FG000|Placebo|Overall Study||4
10070389|NCT02169895|11197226|FG001|Placebo|Overall Study||4
10070390|NCT02169895|11197227|FG002|Placebo|Overall Study||4
10070391|NCT02169895|11197228|FG003|Placebo|Overall Study||4
10070392|NCT02169895|11197225|FG000|COMPLETED|Overall Study||4
10070393|NCT02169895|11197226|FG001|COMPLETED|Overall Study||4
10070394|NCT02169895|11197227|FG002|COMPLETED|Overall Study||4
10070395|NCT02169895|11197228|FG003|COMPLETED|Overall Study||2
10070396|NCT02169895|11197225|FG000|NOT COMPLETED|Overall Study||0
10070397|NCT02169895|11197226|FG001|NOT COMPLETED|Overall Study||0
10070398|NCT02169895|11197227|FG002|NOT COMPLETED|Overall Study||0
10070399|NCT02169895|11197228|FG003|NOT COMPLETED|Overall Study||2
10070400|NCT02170025|11197240|FG000|STARTED|Overall Study||14
10070401|NCT02170025|11197241|FG001|STARTED|Overall Study||7
10070402|NCT02170025|11197240|FG000|COMPLETED|Overall Study||12
10070403|NCT02170025|11197241|FG001|COMPLETED|Overall Study||7
10070404|NCT02170025|11197240|FG000|NOT COMPLETED|Overall Study||2
10070405|NCT02170025|11197241|FG001|NOT COMPLETED|Overall Study||0
10070406|NCT02170051|11197249|FG000|STARTED|Overall Study||26
10070407|NCT02170051|11197250|FG001|STARTED|Overall Study||29
10070408|NCT02170051|11197249|FG000|Tested at Mid-point|Overall Study||13
10070409|NCT02170051|11197250|FG001|Tested at Mid-point|Overall Study||18
10070410|NCT02170051|11197249|FG000|Tested at Post-treatment|Overall Study||15
10070411|NCT02170051|11197250|FG001|Tested at Post-treatment|Overall Study||16
10070412|NCT02170051|11197249|FG000|COMPLETED|Overall Study||15
10070413|NCT02170051|11197250|FG001|COMPLETED|Overall Study||16
10070414|NCT02170051|11197249|FG000|NOT COMPLETED|Overall Study||11
10070415|NCT02170051|11197250|FG001|NOT COMPLETED|Overall Study||13
10070416|NCT02170064|11197259|FG000|STARTED|Overall Study||15
10070417|NCT02170064|11197260|FG001|STARTED|Overall Study||9
10070418|NCT02170064|11197261|FG002|STARTED|Overall Study||11
10070419|NCT02170064|11197259|FG000|Safety Population (SP)|Overall Study||12
10070420|NCT02170064|11197260|FG001|Safety Population (SP)|Overall Study||8
10070421|NCT02170064|11197261|FG002|Safety Population (SP)|Overall Study||11
10070422|NCT02170064|11197259|FG000|Pharmacokinetic Population (PKP)|Overall Study||11
10070423|NCT02170064|11197260|FG001|Pharmacokinetic Population (PKP)|Overall Study||8
10070424|NCT02170064|11197261|FG002|Pharmacokinetic Population (PKP)|Overall Study||10
10070425|NCT02170064|11197259|FG000|Efficacy Population (EP)|Overall Study||11
10070426|NCT02170064|11197260|FG001|Efficacy Population (EP)|Overall Study||8
10070427|NCT02170064|11197261|FG002|Efficacy Population (EP)|Overall Study||10
10070428|NCT02170064|11197259|FG000|COMPLETED|Overall Study||9
10070429|NCT02170064|11197260|FG001|COMPLETED|Overall Study||7
10070430|NCT02170064|11197261|FG002|COMPLETED|Overall Study||10
10070431|NCT02170064|11197259|FG000|NOT COMPLETED|Overall Study||6
10070432|NCT02170064|11197260|FG001|NOT COMPLETED|Overall Study||2
10070433|NCT02170064|11197261|FG002|NOT COMPLETED|Overall Study||1
10070434|NCT02170077|11197272|FG000|STARTED|Overall Study||50
10070435|NCT02170077|11197273|FG001|STARTED|Overall Study||47
10070436|NCT02170077|11197274|FG002|STARTED|Overall Study||47
10070437|NCT02170077|11197272|FG000|Intent to Treat (ITT) Population|Overall Study||50
10070438|NCT02170077|11197273|FG001|Intent to Treat (ITT) Population|Overall Study||46
10070439|NCT02170077|11197274|FG002|Intent to Treat (ITT) Population|Overall Study||47
10070440|NCT02170077|11197272|FG000|COMPLETED|Overall Study||41
10070441|NCT02170077|11197273|FG001|COMPLETED|Overall Study||34
10070442|NCT02170077|11197274|FG002|COMPLETED|Overall Study||35
10070443|NCT02170077|11197272|FG000|NOT COMPLETED|Overall Study||9
10070444|NCT02170077|11197273|FG001|NOT COMPLETED|Overall Study||13
10070445|NCT02170077|11197274|FG002|NOT COMPLETED|Overall Study||12
10070446|NCT02170207|11197282|FG000|STARTED|Overall Study||63
10070447|NCT02170207|11197282|FG000|COMPLETED|Overall Study||58
10070448|NCT02170207|11197282|FG000|NOT COMPLETED|Overall Study||5
10070449|NCT02170220|11197288|FG000|STARTED|Overall Study||6
10070450|NCT02170220|11197289|FG001|STARTED|Overall Study||6
10070451|NCT02170220|11197288|FG000|COMPLETED|Overall Study||6
10070452|NCT02170220|11197289|FG001|COMPLETED|Overall Study||6
10070453|NCT02170220|11197288|FG000|NOT COMPLETED|Overall Study||0
10070454|NCT02170220|11197289|FG001|NOT COMPLETED|Overall Study||0
10070458|NCT02170376|11197306|FG000|STARTED|Overall Study||16
10070459|NCT02170376|11197307|FG001|STARTED|Overall Study||16
10070460|NCT02170376|11197308|FG002|STARTED|Overall Study||16
10070461|NCT02170376|11197309|FG003|STARTED|Overall Study||16
10070462|NCT02170376|11197310|FG004|STARTED|Overall Study||16
10070463|NCT02170376|11197306|FG000|Pharmacokinetic Population|Overall Study||16
10070464|NCT02170376|11197307|FG001|Pharmacokinetic Population|Overall Study||15
10070465|NCT02170376|11197308|FG002|Pharmacokinetic Population|Overall Study||16
10070466|NCT02170376|11197309|FG003|Pharmacokinetic Population|Overall Study||16
10070467|NCT02170376|11197310|FG004|Pharmacokinetic Population|Overall Study||16
10070468|NCT02170376|11197306|FG000|COMPLETED|Overall Study||16
10070469|NCT02170376|11197307|FG001|COMPLETED|Overall Study||15
10070470|NCT02170376|11197308|FG002|COMPLETED|Overall Study||16
10070471|NCT02170376|11197309|FG003|COMPLETED|Overall Study||16
10070472|NCT02170376|11197310|FG004|COMPLETED|Overall Study||16
10070473|NCT02170376|11197306|FG000|NOT COMPLETED|Overall Study||0
10070474|NCT02170376|11197307|FG001|NOT COMPLETED|Overall Study||1
10070475|NCT02170376|11197308|FG002|NOT COMPLETED|Overall Study||0
10070476|NCT02170376|11197309|FG003|NOT COMPLETED|Overall Study||0
10070477|NCT02170376|11197310|FG004|NOT COMPLETED|Overall Study||0
10070478|NCT02170389|11197322|FG000|STARTED|Overall Study||5
10070479|NCT02170389|11197322|FG000|COMPLETED|Overall Study||4
10070480|NCT02170389|11197322|FG000|NOT COMPLETED|Overall Study||1
10070481|NCT02170519|11197328|FG000|STARTED|Overall Study||22
10070482|NCT02170519|11197329|FG001|STARTED|Overall Study||5
10070483|NCT02170519|11197328|FG000|COMPLETED|Overall Study||22
10070484|NCT02170519|11197329|FG001|COMPLETED|Overall Study||5
10070485|NCT02170519|11197328|FG000|NOT COMPLETED|Overall Study||0
10070486|NCT02170519|11197329|FG001|NOT COMPLETED|Overall Study||0
10070487|NCT02170532|11197336|FG000|STARTED|Overall Study||10
10070488|NCT02170532|11197336|FG000|COMPLETED|Overall Study||10
10070489|NCT02170532|11197336|FG000|NOT COMPLETED|Overall Study||0
10070490|NCT02170649|11197347|FG000|STARTED|Fasting Period||12
10070491|NCT02170649|11197347|FG000|COMPLETED|Fasting Period||12
10070492|NCT02170649|11197347|FG000|NOT COMPLETED|Fasting Period||0
10070493|NCT02170649|11197347|FG000|STARTED|Fed Period||12
10070494|NCT02170649|11197347|FG000|COMPLETED|Fed Period||12
10070495|NCT02170649|11197347|FG000|NOT COMPLETED|Fed Period||0
10070496|NCT02170662|11197353|FG000|STARTED|Overall Study||3
10070497|NCT02170662|11197354|FG001|STARTED|Overall Study||6
10070498|NCT02170662|11197353|FG000|COMPLETED|Overall Study||3
10070499|NCT02170662|11197354|FG001|COMPLETED|Overall Study||6
10070500|NCT02170662|11197353|FG000|NOT COMPLETED|Overall Study||0
10070501|NCT02170662|11197354|FG001|NOT COMPLETED|Overall Study||0
10070502|NCT02170688|11197365|FG000|STARTED|Overall Study||29
10070503|NCT02170688|11197366|FG001|STARTED|Overall Study||29
10070504|NCT02170688|11197367|FG002|STARTED|Overall Study||29
10070505|NCT02170688|11197368|FG003|STARTED|Overall Study||27
10070506|NCT02170688|11197369|FG004|STARTED|Overall Study||25
10070507|NCT02170688|11197365|FG000|COMPLETED|Overall Study||25
10070508|NCT02170688|11197366|FG001|COMPLETED|Overall Study||26
10070509|NCT02170688|11197367|FG002|COMPLETED|Overall Study||25
10070510|NCT02170688|11197368|FG003|COMPLETED|Overall Study||25
10070511|NCT02170688|11197369|FG004|COMPLETED|Overall Study||25
10070512|NCT02170688|11197365|FG000|NOT COMPLETED|Overall Study||4
10070513|NCT02170688|11197366|FG001|NOT COMPLETED|Overall Study||3
10070514|NCT02170688|11197367|FG002|NOT COMPLETED|Overall Study||4
10070515|NCT02170688|11197368|FG003|NOT COMPLETED|Overall Study||2
10070516|NCT02170688|11197369|FG004|NOT COMPLETED|Overall Study||0
10070517|NCT02170727|11197383|FG000|STARTED|Overall Study||138
10070518|NCT02170727|11197384|FG001|STARTED|Overall Study||31
10070519|NCT02170727|11197383|FG000|COMPLETED|Overall Study||135
10070520|NCT02170727|11197384|FG001|COMPLETED|Overall Study||31
10070521|NCT02170727|11197383|FG000|NOT COMPLETED|Overall Study||3
10070522|NCT02170727|11197384|FG001|NOT COMPLETED|Overall Study||0
10070523|NCT02170779|11197395|FG000|STARTED|Overall Study||20
10070524|NCT02170779|11197396|FG001|STARTED|Overall Study||20
10070525|NCT02170779|11197395|FG000|COMPLETED|Overall Study||19
10070526|NCT02170779|11197396|FG001|COMPLETED|Overall Study||19
10070527|NCT02170779|11197395|FG000|NOT COMPLETED|Overall Study||1
10070528|NCT02170779|11197396|FG001|NOT COMPLETED|Overall Study||1
10070529|NCT02170870|11197408|FG000|STARTED|Overall Study||13
10070530|NCT02170870|11197409|FG001|STARTED|Overall Study||11
10070531|NCT02170870|11197410|FG002|STARTED|Overall Study||20
10070532|NCT02170870|11197411|FG003|STARTED|Overall Study||20
10070533|NCT02170870|11197412|FG004|STARTED|Overall Study||20
10070534|NCT02170870|11197413|FG005|STARTED|Overall Study||20
10070535|NCT02170870|11197408|FG000|COMPLETED|Overall Study||13
10070536|NCT02170870|11197409|FG001|COMPLETED|Overall Study||11
10070537|NCT02170870|11197410|FG002|COMPLETED|Overall Study||20
10070538|NCT02170870|11197411|FG003|COMPLETED|Overall Study||20
10070539|NCT02170870|11197412|FG004|COMPLETED|Overall Study||20
10070540|NCT02170870|11197413|FG005|COMPLETED|Overall Study||20
10070541|NCT02170870|11197408|FG000|NOT COMPLETED|Overall Study||0
10070542|NCT02170870|11197409|FG001|NOT COMPLETED|Overall Study||0
10070543|NCT02170870|11197410|FG002|NOT COMPLETED|Overall Study||0
10070544|NCT02170870|11197411|FG003|NOT COMPLETED|Overall Study||0
10070545|NCT02170870|11197412|FG004|NOT COMPLETED|Overall Study||0
10070546|NCT02170870|11197413|FG005|NOT COMPLETED|Overall Study||0
10070547|NCT02171065|11197433|FG000|STARTED|Overall Study||89
10070548|NCT02171065|11197434|FG001|STARTED|Overall Study||93
10070549|NCT02171065|11197435|FG002|STARTED|Overall Study||716
10070550|NCT02171065|11197433|FG000|COMPLETED|Overall Study||88
10070551|NCT02171065|11197434|FG001|COMPLETED|Overall Study||93
10070552|NCT02171065|11197435|FG002|COMPLETED|Overall Study||715
10070553|NCT02171065|11197433|FG000|NOT COMPLETED|Overall Study||1
10070554|NCT02171065|11197434|FG001|NOT COMPLETED|Overall Study||0
10070555|NCT02171065|11197435|FG002|NOT COMPLETED|Overall Study||1
10070556|NCT02171130|11197445|FG000|STARTED|Overall Study||129
10070557|NCT02171130|11197445|FG000|Received at Least One Dose of Study Drug|Overall Study||87
10070558|NCT02171130|11197445|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
10070559|NCT02171130|11197445|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
10070560|NCT02171130|11197445|FG000|NOT COMPLETED|Overall Study||28
10070561|NCT02171195|11197458|FG000|STARTED|Overall Study||16
10070562|NCT02171195|11197459|FG001|STARTED|Overall Study||6
10070563|NCT02171195|11197460|FG002|STARTED|Overall Study||6
10070564|NCT02171195|11197461|FG003|STARTED|Overall Study||6
10070565|NCT02171195|11197462|FG004|STARTED|Overall Study||6
10070566|NCT02171195|11197463|FG005|STARTED|Overall Study||6
10070567|NCT02171195|11197464|FG006|STARTED|Overall Study||6
10070568|NCT02171195|11197465|FG007|STARTED|Overall Study||6
10070569|NCT02171195|11197466|FG008|STARTED|Overall Study||6
10070570|NCT02171195|11197458|FG000|COMPLETED|Overall Study||16
10070571|NCT02171195|11197459|FG001|COMPLETED|Overall Study||6
10070572|NCT02171195|11197460|FG002|COMPLETED|Overall Study||6
10070573|NCT02171195|11197461|FG003|COMPLETED|Overall Study||6
10070574|NCT02171195|11197462|FG004|COMPLETED|Overall Study||6
10070575|NCT02171195|11197463|FG005|COMPLETED|Overall Study||6
10070576|NCT02171195|11197464|FG006|COMPLETED|Overall Study||6
10070577|NCT02171195|11197465|FG007|COMPLETED|Overall Study||6
10070578|NCT02171195|11197466|FG008|COMPLETED|Overall Study||6
10070579|NCT02171195|11197458|FG000|NOT COMPLETED|Overall Study||0
10070580|NCT02171195|11197459|FG001|NOT COMPLETED|Overall Study||0
10070581|NCT02171195|11197460|FG002|NOT COMPLETED|Overall Study||0
10070582|NCT02171195|11197461|FG003|NOT COMPLETED|Overall Study||0
10070583|NCT02171195|11197462|FG004|NOT COMPLETED|Overall Study||0
10070584|NCT02171195|11197463|FG005|NOT COMPLETED|Overall Study||0
10070585|NCT02171195|11197464|FG006|NOT COMPLETED|Overall Study||0
10070586|NCT02171195|11197465|FG007|NOT COMPLETED|Overall Study||0
10070587|NCT02171195|11197466|FG008|NOT COMPLETED|Overall Study||0
10070588|NCT02171234|11197491|FG000|STARTED|Overall Study||8
10070589|NCT02171234|11197492|FG001|STARTED|Overall Study||6
10070590|NCT02171234|11197493|FG002|STARTED|Overall Study||6
10070591|NCT02171234|11197494|FG003|STARTED|Overall Study||6
10070592|NCT02171234|11197495|FG004|STARTED|Overall Study||6
10070593|NCT02171234|11197491|FG000|COMPLETED|Overall Study||8
10189577|NCT03285711|11319113|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0
10189578|NCT03285711|11319114|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0
10189579|NCT03285711|11319111|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
10189580|NCT03285711|11319112|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
10189581|NCT03285711|11319113|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
10189582|NCT03285711|11319114|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
10189583|NCT03285711|11319111|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
10189584|NCT03285711|11319112|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
10189585|NCT03285711|11319113|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
10189586|NCT03285711|11319114|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
10189587|NCT03285711|11319111|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0
10189588|NCT03285711|11319112|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3
10189589|NCT03285711|11319113|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0
10189590|NCT03285711|11319114|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1
10189591|NCT03285711|11319111|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
10189592|NCT03285711|11319112|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
10189593|NCT03285711|11319113|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
10189594|NCT03285711|11319114|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
10189595|NCT03285711|11319111|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0
10189596|NCT03285711|11319112|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3
10189597|NCT03285711|11319113|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0
10189598|NCT03285711|11319114|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1
10189599|NCT03285711|11319111|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10189600|NCT03285711|11319112|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
10189601|NCT03285711|11319113|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10189602|NCT03285711|11319114|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
10189603|NCT03285711|11319111|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10189604|NCT03285711|11319112|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
10189605|NCT03285711|11319113|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10189606|NCT03285711|11319114|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10189607|NCT03285724|11319124|FG000|STARTED|Overall Study||1
10189608|NCT03285724|11319124|FG000|COMPLETED|Overall Study||1
10189609|NCT03285724|11319124|FG000|NOT COMPLETED|Overall Study||0
10189610|NCT03285958|11319130|FG000|STARTED|Overall Study||33
10189611|NCT03285958|11319131|FG001|STARTED|Overall Study||24
10189612|NCT03285958|11319130|FG000|COMPLETED|Overall Study||28
10189613|NCT03285958|11319131|FG001|COMPLETED|Overall Study||23
10189614|NCT03285958|11319130|FG000|NOT COMPLETED|Overall Study||5
10189615|NCT03285958|11319131|FG001|NOT COMPLETED|Overall Study||1
10189616|NCT03285984|11319138|FG000|STARTED|Overall Study||56
10189617|NCT03285984|11319138|FG000|Received Test Product 1|Overall Study||56
10189618|NCT03285984|11319138|FG000|Received Test Product 2|Overall Study||56
10189619|NCT03285984|11319138|FG000|Received Test Product 3|Overall Study||56
10189620|NCT03285984|11319138|FG000|Received Test Product 4|Overall Study||56
10189621|NCT03285984|11319138|FG000|COMPLETED|Overall Study||56
10189622|NCT03285984|11319138|FG000|NOT COMPLETED|Overall Study||0
10189623|NCT03286218|11319150|FG000|STARTED|Qualification Phase Period 1||48
10189624|NCT03286218|11319151|FG001|STARTED|Qualification Phase Period 1||48
10189625|NCT03286218|11319152|FG002|STARTED|Qualification Phase Period 1||0
10189626|NCT03286218|11319153|FG003|STARTED|Qualification Phase Period 1||0
10189627|NCT03286218|11319154|FG004|STARTED|Qualification Phase Period 1||0
10189628|NCT03286218|11319155|FG005|STARTED|Qualification Phase Period 1||0
10189629|NCT03286218|11319156|FG006|STARTED|Qualification Phase Period 1||0
10189630|NCT03286218|11319157|FG007|STARTED|Qualification Phase Period 1||0
10189631|NCT03286218|11319158|FG008|STARTED|Qualification Phase Period 1||0
10189632|NCT03286218|11319159|FG009|STARTED|Qualification Phase Period 1||0
10189633|NCT03286218|11319160|FG010|STARTED|Qualification Phase Period 1||0
10189634|NCT03286218|11319161|FG011|STARTED|Qualification Phase Period 1||0
10189635|NCT03286218|11319150|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
10189636|NCT03286218|11319151|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
10189637|NCT03286218|11319152|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189638|NCT03286218|11319153|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189639|NCT03286218|11319154|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189640|NCT03286218|11319155|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189641|NCT03286218|11319156|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189642|NCT03286218|11319157|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189643|NCT03286218|11319158|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189644|NCT03286218|11319159|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10070594|NCT02171234|11197492|FG001|COMPLETED|Overall Study||6
10070595|NCT02171234|11197493|FG002|COMPLETED|Overall Study||6
10070596|NCT02171234|11197494|FG003|COMPLETED|Overall Study||6
10070597|NCT02171234|11197495|FG004|COMPLETED|Overall Study||6
10070598|NCT02171234|11197491|FG000|NOT COMPLETED|Overall Study||0
10070599|NCT02171234|11197492|FG001|NOT COMPLETED|Overall Study||0
10070600|NCT02171234|11197493|FG002|NOT COMPLETED|Overall Study||0
10070601|NCT02171234|11197494|FG003|NOT COMPLETED|Overall Study||0
10070602|NCT02171234|11197495|FG004|NOT COMPLETED|Overall Study||0
10070603|NCT02171247|11197509|FG000|STARTED|Overall Study||16
10070604|NCT02171247|11197510|FG001|STARTED|Overall Study||17
10070605|NCT02171247|11197509|FG000|COMPLETED|Overall Study||16
10070606|NCT02171247|11197510|FG001|COMPLETED|Overall Study||17
10070607|NCT02171247|11197509|FG000|NOT COMPLETED|Overall Study||0
10070608|NCT02171247|11197510|FG001|NOT COMPLETED|Overall Study||0
10070609|NCT02171260|11197520|FG000|STARTED|Overall Study||6
10070610|NCT02171260|11197521|FG001|STARTED|Overall Study||6
10070611|NCT02171260|11197522|FG002|STARTED|Overall Study||5
10070612|NCT02171260|11197523|FG003|STARTED|Overall Study||5
10070613|NCT02171260|11197520|FG000|COMPLETED|Overall Study||0
10070614|NCT02171260|11197521|FG001|COMPLETED|Overall Study||0
10070615|NCT02171260|11197522|FG002|COMPLETED|Overall Study||0
10070616|NCT02171260|11197523|FG003|COMPLETED|Overall Study||0
10070617|NCT02171260|11197520|FG000|NOT COMPLETED|Overall Study||6
10070618|NCT02171260|11197521|FG001|NOT COMPLETED|Overall Study||6
10070619|NCT02171260|11197522|FG002|NOT COMPLETED|Overall Study||5
10070620|NCT02171260|11197523|FG003|NOT COMPLETED|Overall Study||5
10070621|NCT02171429|11197542|FG000|STARTED|Overall Study||72
10070622|NCT02171429|11197543|FG001|STARTED|Overall Study||143
10070623|NCT02171429|11197544|FG002|STARTED|Overall Study||143
10070624|NCT02171429|11197542|FG000|Completed Week 10 Visit|Overall Study||70
10070625|NCT02171429|11197543|FG001|Completed Week 10 Visit|Overall Study||141
10070626|NCT02171429|11197544|FG002|Completed Week 10 Visit|Overall Study||141
10070627|NCT02171429|11197542|FG000|COMPLETED|Overall Study||71
10070628|NCT02171429|11197543|FG001|COMPLETED|Overall Study||140
10070629|NCT02171429|11197544|FG002|COMPLETED|Overall Study||138
10070630|NCT02171429|11197542|FG000|NOT COMPLETED|Overall Study||1
10070631|NCT02171429|11197543|FG001|NOT COMPLETED|Overall Study||3
10070632|NCT02171429|11197544|FG002|NOT COMPLETED|Overall Study||5
10070633|NCT02171611|11197555|FG000|STARTED|Overall Study||5
10070634|NCT02171611|11197556|FG001|STARTED|Overall Study||5
10070635|NCT02171611|11197557|FG002|STARTED|Overall Study||5
10070636|NCT02171611|11197558|FG003|STARTED|Overall Study||5
10070637|NCT02171611|11197559|FG004|STARTED|Overall Study||5
10070638|NCT02171611|11197560|FG005|STARTED|Overall Study||5
10070639|NCT02171611|11197555|FG000|COMPLETED|Overall Study||5
10070640|NCT02171611|11197556|FG001|COMPLETED|Overall Study||5
10070641|NCT02171611|11197557|FG002|COMPLETED|Overall Study||5
10070642|NCT02171611|11197558|FG003|COMPLETED|Overall Study||5
10070643|NCT02171611|11197559|FG004|COMPLETED|Overall Study||5
10070644|NCT02171611|11197560|FG005|COMPLETED|Overall Study||5
10070645|NCT02171611|11197555|FG000|NOT COMPLETED|Overall Study||0
10070646|NCT02171611|11197556|FG001|NOT COMPLETED|Overall Study||0
10070647|NCT02171611|11197557|FG002|NOT COMPLETED|Overall Study||0
10070648|NCT02171611|11197558|FG003|NOT COMPLETED|Overall Study||0
10070649|NCT02171611|11197559|FG004|NOT COMPLETED|Overall Study||0
10070650|NCT02171611|11197560|FG005|NOT COMPLETED|Overall Study||0
10070651|NCT02171819|11197571|FG000|STARTED|Overall Study||31
10070652|NCT02171819|11197572|FG001|STARTED|Overall Study||32
10070653|NCT02171819|11197573|FG002|STARTED|Overall Study||12
10070654|NCT02171819|11197571|FG000|COMPLETED|Overall Study||31
10070655|NCT02171819|11197572|FG001|COMPLETED|Overall Study||32
10070656|NCT02171819|11197573|FG002|COMPLETED|Overall Study||12
10070657|NCT02171819|11197571|FG000|NOT COMPLETED|Overall Study||0
10070658|NCT02171819|11197572|FG001|NOT COMPLETED|Overall Study||0
10070659|NCT02171819|11197573|FG002|NOT COMPLETED|Overall Study||0
10070660|NCT02172040|11197589|FG000|STARTED|Overall Study||49
10070661|NCT02172040|11197590|FG001|STARTED|Overall Study||45
10070662|NCT02172040|11197591|FG002|STARTED|Overall Study||31
10070663|NCT02172040|11197592|FG003|STARTED|Overall Study||27
10070664|NCT02172040|11197589|FG000|COMPLETED|Overall Study||49
10070665|NCT02172040|11197590|FG001|COMPLETED|Overall Study||42
10070666|NCT02172040|11197591|FG002|COMPLETED|Overall Study||29
10070667|NCT02172040|11197592|FG003|COMPLETED|Overall Study||26
10070668|NCT02172040|11197589|FG000|NOT COMPLETED|Overall Study||0
10070669|NCT02172040|11197590|FG001|NOT COMPLETED|Overall Study||3
10070670|NCT02172040|11197591|FG002|NOT COMPLETED|Overall Study||2
10070671|NCT02172040|11197592|FG003|NOT COMPLETED|Overall Study||1
10070672|NCT02172625|11197605|FG000|STARTED|Overall Study||19
10070673|NCT02172625|11197606|FG001|STARTED|Overall Study||19
10070674|NCT02172625|11197605|FG000|COMPLETED|Overall Study||19
10070675|NCT02172625|11197606|FG001|COMPLETED|Overall Study||16
10070676|NCT02172625|11197605|FG000|NOT COMPLETED|Overall Study||0
10070677|NCT02172625|11197606|FG001|NOT COMPLETED|Overall Study||3
10070678|NCT02172664|11197616|FG000|STARTED|Overall Study||33
10070679|NCT02172664|11197617|FG001|STARTED|Overall Study||33
10070680|NCT02172664|11197616|FG000|COMPLETED|Overall Study||27
10070681|NCT02172664|11197617|FG001|COMPLETED|Overall Study||27
10070682|NCT02172664|11197616|FG000|NOT COMPLETED|Overall Study||6
10070683|NCT02172664|11197617|FG001|NOT COMPLETED|Overall Study||6
10070684|NCT02172742|11197624|FG000|STARTED|Overall Study||7
10070685|NCT02172742|11197625|FG001|STARTED|Overall Study||6
10070686|NCT02172742|11197624|FG000|COMPLETED|Overall Study||6
10070687|NCT02172742|11197625|FG001|COMPLETED|Overall Study||6
10070688|NCT02172742|11197624|FG000|NOT COMPLETED|Overall Study||1
10070689|NCT02172742|11197625|FG001|NOT COMPLETED|Overall Study||0
10070690|NCT02172755|11197632|FG000|STARTED|Overall Study||14
10070691|NCT02172755|11197633|FG001|STARTED|Overall Study||16
10070692|NCT02172755|11197632|FG000|COMPLETED|Overall Study||12
10070693|NCT02172755|11197633|FG001|COMPLETED|Overall Study||12
10070694|NCT02172755|11197632|FG000|NOT COMPLETED|Overall Study||2
10070695|NCT02172755|11197633|FG001|NOT COMPLETED|Overall Study||4
10070696|NCT02172820|11197641|FG000|STARTED|Overall Study||65
10070697|NCT02172820|11197642|FG001|STARTED|Overall Study||65
10070698|NCT02172820|11197641|FG000|COMPLETED|Overall Study||65
10070699|NCT02172820|11197642|FG001|COMPLETED|Overall Study||65
10070700|NCT02172820|11197641|FG000|NOT COMPLETED|Overall Study||0
10070701|NCT02172820|11197642|FG001|NOT COMPLETED|Overall Study||0
10070702|NCT02172911|11197650|FG000|STARTED|Overall Study||7
10070703|NCT02172911|11197651|FG001|STARTED|Overall Study||3
10070704|NCT02172911|11197650|FG000|COMPLETED|Overall Study||6
10070705|NCT02172911|11197651|FG001|COMPLETED|Overall Study||1
10070706|NCT02172911|11197650|FG000|NOT COMPLETED|Overall Study||1
10070707|NCT02172911|11197651|FG001|NOT COMPLETED|Overall Study||2
10070708|NCT02172950|11197659|FG000|STARTED|Overall Study||222
10070709|NCT02172950|11197660|FG001|STARTED|Overall Study||24
10070710|NCT02172950|11197659|FG000|COMPLETED|Overall Study||197
10070711|NCT02172950|11197660|FG001|COMPLETED|Overall Study||19
10070712|NCT02172950|11197659|FG000|NOT COMPLETED|Overall Study||25
10070713|NCT02172950|11197660|FG001|NOT COMPLETED|Overall Study||5
10070714|NCT02173054|11197670|FG000|STARTED|Overall Study||40
10070715|NCT02173054|11197671|FG001|STARTED|Overall Study||40
10070716|NCT02173054|11197672|FG002|STARTED|Overall Study||40
10070717|NCT02173054|11197670|FG000|COMPLETED|Overall Study||39
10070718|NCT02173054|11197671|FG001|COMPLETED|Overall Study||40
10070719|NCT02173054|11197672|FG002|COMPLETED|Overall Study||39
10070720|NCT02173054|11197670|FG000|NOT COMPLETED|Overall Study||1
10070721|NCT02173054|11197671|FG001|NOT COMPLETED|Overall Study||0
10070722|NCT02173054|11197672|FG002|NOT COMPLETED|Overall Study||1
10070723|NCT02173158|11197680|FG000|STARTED|Efficacy Phase||9
10070724|NCT02173158|11197680|FG000|COMPLETED|Efficacy Phase||8
10070725|NCT02173158|11197680|FG000|NOT COMPLETED|Efficacy Phase||1
10070726|NCT02173158|11197680|FG000|STARTED|Safety Phase||8
10070727|NCT02173158|11197680|FG000|COMPLETED|Safety Phase||8
10070728|NCT02173158|11197680|FG000|NOT COMPLETED|Safety Phase||0
10070729|NCT02173392|11197687|FG000|STARTED|Overall Study||73
10070730|NCT02173392|11197688|FG001|STARTED|Overall Study||72
10070731|NCT02173392|11197687|FG000|COMPLETED|Overall Study||59
10070732|NCT02173392|11197688|FG001|COMPLETED|Overall Study||68
10070733|NCT02173392|11197687|FG000|NOT COMPLETED|Overall Study||14
10070734|NCT02173392|11197688|FG001|NOT COMPLETED|Overall Study||4
10070735|NCT02173522|11197698|FG000|STARTED|Overall Study||4
10189645|NCT03286218|11319160|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189646|NCT03286218|11319161|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10189647|NCT03286218|11319150|FG000|COMPLETED|Qualification Phase Period 1||47
10189648|NCT03286218|11319151|FG001|COMPLETED|Qualification Phase Period 1||47
10189649|NCT03286218|11319152|FG002|COMPLETED|Qualification Phase Period 1||0
10189650|NCT03286218|11319153|FG003|COMPLETED|Qualification Phase Period 1||0
10189651|NCT03286218|11319154|FG004|COMPLETED|Qualification Phase Period 1||0
10189652|NCT03286218|11319155|FG005|COMPLETED|Qualification Phase Period 1||0
10189653|NCT03286218|11319156|FG006|COMPLETED|Qualification Phase Period 1||0
10189654|NCT03286218|11319157|FG007|COMPLETED|Qualification Phase Period 1||0
10189655|NCT03286218|11319158|FG008|COMPLETED|Qualification Phase Period 1||0
10189656|NCT03286218|11319159|FG009|COMPLETED|Qualification Phase Period 1||0
10189657|NCT03286218|11319160|FG010|COMPLETED|Qualification Phase Period 1||0
10189658|NCT03286218|11319161|FG011|COMPLETED|Qualification Phase Period 1||0
10189659|NCT03286218|11319150|FG000|NOT COMPLETED|Qualification Phase Period 1||1
10189660|NCT03286218|11319151|FG001|NOT COMPLETED|Qualification Phase Period 1||1
10189661|NCT03286218|11319152|FG002|NOT COMPLETED|Qualification Phase Period 1||0
10189662|NCT03286218|11319153|FG003|NOT COMPLETED|Qualification Phase Period 1||0
10189663|NCT03286218|11319154|FG004|NOT COMPLETED|Qualification Phase Period 1||0
10189664|NCT03286218|11319155|FG005|NOT COMPLETED|Qualification Phase Period 1||0
10189665|NCT03286218|11319156|FG006|NOT COMPLETED|Qualification Phase Period 1||0
10189666|NCT03286218|11319157|FG007|NOT COMPLETED|Qualification Phase Period 1||0
10189667|NCT03286218|11319158|FG008|NOT COMPLETED|Qualification Phase Period 1||0
10070736|NCT02173522|11197699|FG001|STARTED|Overall Study||0
10070737|NCT02173522|11197698|FG000|COMPLETED|Overall Study||4
10070738|NCT02173522|11197699|FG001|COMPLETED|Overall Study||0
10070739|NCT02173522|11197698|FG000|NOT COMPLETED|Overall Study||0
10070740|NCT02173522|11197699|FG001|NOT COMPLETED|Overall Study||0
10070741|NCT02173535|11197723|FG000|STARTED|Period 1||12
10070742|NCT02173535|11197724|FG001|STARTED|Period 1||12
10070743|NCT02173535|11197725|FG002|STARTED|Period 1||12
10070744|NCT02173535|11197726|FG003|STARTED|Period 1||12
10070745|NCT02173535|11197727|FG004|STARTED|Period 1||12
10070746|NCT02173535|11197728|FG005|STARTED|Period 1||12
10070747|NCT02173535|11197729|FG006|STARTED|Period 1||12
10070748|NCT02173535|11197730|FG007|STARTED|Period 1||12
10070749|NCT02173535|11197731|FG008|STARTED|Period 1||12
10070750|NCT02173535|11197732|FG009|STARTED|Period 1||12
10070751|NCT02173535|11197733|FG010|STARTED|Period 1||12
10070752|NCT02173535|11197734|FG011|STARTED|Period 1||12
10070753|NCT02173535|11197735|FG012|STARTED|Period 1||12
10070754|NCT02173535|11197736|FG013|STARTED|Period 1||12
10070755|NCT02173535|11197737|FG014|STARTED|Period 1||12
10070756|NCT02173535|11197738|FG015|STARTED|Period 1||12
10070757|NCT02173535|11197739|FG016|STARTED|Period 1||12
10070758|NCT02173535|11197740|FG017|STARTED|Period 1||12
10070759|NCT02173535|11197741|FG018|STARTED|Period 1||12
10070760|NCT02173535|11197742|FG019|STARTED|Period 1||12
10070761|NCT02173535|11197723|FG000|COMPLETED|Period 1||12
10070762|NCT02173535|11197724|FG001|COMPLETED|Period 1||12
10070763|NCT02173535|11197725|FG002|COMPLETED|Period 1||12
10070764|NCT02173535|11197726|FG003|COMPLETED|Period 1||12
10070765|NCT02173535|11197727|FG004|COMPLETED|Period 1||12
10070766|NCT02173535|11197728|FG005|COMPLETED|Period 1||12
10189668|NCT03286218|11319159|FG009|NOT COMPLETED|Qualification Phase Period 1||0
10189669|NCT03286218|11319160|FG010|NOT COMPLETED|Qualification Phase Period 1||0
10189670|NCT03286218|11319161|FG011|NOT COMPLETED|Qualification Phase Period 1||0
10189671|NCT03286218|11319150|FG000|STARTED|Qualification Phase Period 2||47
10189672|NCT03286218|11319151|FG001|STARTED|Qualification Phase Period 2||47
10189673|NCT03286218|11319152|FG002|STARTED|Qualification Phase Period 2||0
10189674|NCT03286218|11319153|FG003|STARTED|Qualification Phase Period 2||0
10189675|NCT03286218|11319154|FG004|STARTED|Qualification Phase Period 2||0
10189676|NCT03286218|11319155|FG005|STARTED|Qualification Phase Period 2||0
10189677|NCT03286218|11319156|FG006|STARTED|Qualification Phase Period 2||0
9731470|NCT00132730|10831393|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10070767|NCT02173535|11197729|FG006|COMPLETED|Period 1||12
10070768|NCT02173535|11197730|FG007|COMPLETED|Period 1||12
10070769|NCT02173535|11197731|FG008|COMPLETED|Period 1||12
10070770|NCT02173535|11197732|FG009|COMPLETED|Period 1||12
10070771|NCT02173535|11197733|FG010|COMPLETED|Period 1||12
10070772|NCT02173535|11197734|FG011|COMPLETED|Period 1||12
10070773|NCT02173535|11197735|FG012|COMPLETED|Period 1||12
10070774|NCT02173535|11197736|FG013|COMPLETED|Period 1||12
10070775|NCT02173535|11197737|FG014|COMPLETED|Period 1||12
10070776|NCT02173535|11197738|FG015|COMPLETED|Period 1||12
10070777|NCT02173535|11197739|FG016|COMPLETED|Period 1||12
10070778|NCT02173535|11197740|FG017|COMPLETED|Period 1||12
10070779|NCT02173535|11197741|FG018|COMPLETED|Period 1||12
10070780|NCT02173535|11197742|FG019|COMPLETED|Period 1||12
10070781|NCT02173535|11197723|FG000|NOT COMPLETED|Period 1||0
10070782|NCT02173535|11197724|FG001|NOT COMPLETED|Period 1||0
10070783|NCT02173535|11197725|FG002|NOT COMPLETED|Period 1||0
10070784|NCT02173535|11197726|FG003|NOT COMPLETED|Period 1||0
10070785|NCT02173535|11197727|FG004|NOT COMPLETED|Period 1||0
10070786|NCT02173535|11197728|FG005|NOT COMPLETED|Period 1||0
10070787|NCT02173535|11197729|FG006|NOT COMPLETED|Period 1||0
10070788|NCT02173535|11197730|FG007|NOT COMPLETED|Period 1||0
10070789|NCT02173535|11197731|FG008|NOT COMPLETED|Period 1||0
10070790|NCT02173535|11197732|FG009|NOT COMPLETED|Period 1||0
10070791|NCT02173535|11197733|FG010|NOT COMPLETED|Period 1||0
10070792|NCT02173535|11197734|FG011|NOT COMPLETED|Period 1||0
10070793|NCT02173535|11197735|FG012|NOT COMPLETED|Period 1||0
10070794|NCT02173535|11197736|FG013|NOT COMPLETED|Period 1||0
10070795|NCT02173535|11197737|FG014|NOT COMPLETED|Period 1||0
10070796|NCT02173535|11197738|FG015|NOT COMPLETED|Period 1||0
10070797|NCT02173535|11197739|FG016|NOT COMPLETED|Period 1||0
10070798|NCT02173535|11197740|FG017|NOT COMPLETED|Period 1||0
10070799|NCT02173535|11197741|FG018|NOT COMPLETED|Period 1||0
10070800|NCT02173535|11197742|FG019|NOT COMPLETED|Period 1||0
10070801|NCT02173535|11197723|FG000|STARTED|Period 2||12
10070802|NCT02173535|11197724|FG001|STARTED|Period 2||12
10070803|NCT02173535|11197725|FG002|STARTED|Period 2||12
10070804|NCT02173535|11197726|FG003|STARTED|Period 2||12
10070805|NCT02173535|11197727|FG004|STARTED|Period 2||12
10070806|NCT02173535|11197728|FG005|STARTED|Period 2||12
10070807|NCT02173535|11197729|FG006|STARTED|Period 2||12
10070808|NCT02173535|11197730|FG007|STARTED|Period 2||12
10070809|NCT02173535|11197731|FG008|STARTED|Period 2||12
10070810|NCT02173535|11197732|FG009|STARTED|Period 2||12
10070811|NCT02173535|11197733|FG010|STARTED|Period 2||12
10070812|NCT02173535|11197734|FG011|STARTED|Period 2||12
10070813|NCT02173535|11197735|FG012|STARTED|Period 2||12
10070814|NCT02173535|11197736|FG013|STARTED|Period 2||12
10070815|NCT02173535|11197737|FG014|STARTED|Period 2||12
10070816|NCT02173535|11197738|FG015|STARTED|Period 2||12
10070817|NCT02173535|11197739|FG016|STARTED|Period 2||12
10070818|NCT02173535|11197740|FG017|STARTED|Period 2||12
10070819|NCT02173535|11197741|FG018|STARTED|Period 2||12
10070820|NCT02173535|11197742|FG019|STARTED|Period 2||12
10070821|NCT02173535|11197723|FG000|COMPLETED|Period 2||12
10070822|NCT02173535|11197724|FG001|COMPLETED|Period 2||12
10070823|NCT02173535|11197725|FG002|COMPLETED|Period 2||12
10070824|NCT02173535|11197726|FG003|COMPLETED|Period 2||12
10070825|NCT02173535|11197727|FG004|COMPLETED|Period 2||12
10189678|NCT03286218|11319157|FG007|STARTED|Qualification Phase Period 2||0
10189679|NCT03286218|11319158|FG008|STARTED|Qualification Phase Period 2||0
10189680|NCT03286218|11319159|FG009|STARTED|Qualification Phase Period 2||0
10189681|NCT03286218|11319160|FG010|STARTED|Qualification Phase Period 2||0
10189682|NCT03286218|11319161|FG011|STARTED|Qualification Phase Period 2||0
10189683|NCT03286218|11319150|FG000|COMPLETED|Qualification Phase Period 2||30
10189684|NCT03286218|11319151|FG001|COMPLETED|Qualification Phase Period 2||28
10189685|NCT03286218|11319152|FG002|COMPLETED|Qualification Phase Period 2||0
10189686|NCT03286218|11319153|FG003|COMPLETED|Qualification Phase Period 2||0
10189687|NCT03286218|11319154|FG004|COMPLETED|Qualification Phase Period 2||0
10189688|NCT03286218|11319155|FG005|COMPLETED|Qualification Phase Period 2||0
10189689|NCT03286218|11319156|FG006|COMPLETED|Qualification Phase Period 2||0
10189690|NCT03286218|11319157|FG007|COMPLETED|Qualification Phase Period 2||0
10189691|NCT03286218|11319158|FG008|COMPLETED|Qualification Phase Period 2||0
10189692|NCT03286218|11319159|FG009|COMPLETED|Qualification Phase Period 2||0
10189693|NCT03286218|11319160|FG010|COMPLETED|Qualification Phase Period 2||0
10189694|NCT03286218|11319161|FG011|COMPLETED|Qualification Phase Period 2||0
10189695|NCT03286218|11319150|FG000|NOT COMPLETED|Qualification Phase Period 2||17
10189696|NCT03286218|11319151|FG001|NOT COMPLETED|Qualification Phase Period 2||19
10189697|NCT03286218|11319152|FG002|NOT COMPLETED|Qualification Phase Period 2||0
10189698|NCT03286218|11319153|FG003|NOT COMPLETED|Qualification Phase Period 2||0
10189699|NCT03286218|11319154|FG004|NOT COMPLETED|Qualification Phase Period 2||0
10189700|NCT03286218|11319155|FG005|NOT COMPLETED|Qualification Phase Period 2||0
10189701|NCT03286218|11319156|FG006|NOT COMPLETED|Qualification Phase Period 2||0
10189702|NCT03286218|11319157|FG007|NOT COMPLETED|Qualification Phase Period 2||0
10189703|NCT03286218|11319158|FG008|NOT COMPLETED|Qualification Phase Period 2||0
10189704|NCT03286218|11319159|FG009|NOT COMPLETED|Qualification Phase Period 2||0
10189705|NCT03286218|11319160|FG010|NOT COMPLETED|Qualification Phase Period 2||0
10189706|NCT03286218|11319161|FG011|NOT COMPLETED|Qualification Phase Period 2||0
10189707|NCT03286218|11319150|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
10189708|NCT03286218|11319151|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
10070826|NCT02173535|11197728|FG005|COMPLETED|Period 2||12
10070827|NCT02173535|11197729|FG006|COMPLETED|Period 2||12
10070828|NCT02173535|11197730|FG007|COMPLETED|Period 2||12
10070829|NCT02173535|11197731|FG008|COMPLETED|Period 2||12
10070830|NCT02173535|11197732|FG009|COMPLETED|Period 2||12
10070831|NCT02173535|11197733|FG010|COMPLETED|Period 2||12
10070832|NCT02173535|11197734|FG011|COMPLETED|Period 2||12
10070833|NCT02173535|11197735|FG012|COMPLETED|Period 2||12
10070834|NCT02173535|11197736|FG013|COMPLETED|Period 2||12
10070835|NCT02173535|11197737|FG014|COMPLETED|Period 2||12
10070836|NCT02173535|11197738|FG015|COMPLETED|Period 2||12
10070837|NCT02173535|11197739|FG016|COMPLETED|Period 2||12
10070838|NCT02173535|11197740|FG017|COMPLETED|Period 2||12
10070839|NCT02173535|11197741|FG018|COMPLETED|Period 2||12
10070840|NCT02173535|11197742|FG019|COMPLETED|Period 2||12
10070841|NCT02173535|11197723|FG000|NOT COMPLETED|Period 2||0
10070842|NCT02173535|11197724|FG001|NOT COMPLETED|Period 2||0
10070843|NCT02173535|11197725|FG002|NOT COMPLETED|Period 2||0
10070844|NCT02173535|11197726|FG003|NOT COMPLETED|Period 2||0
10070845|NCT02173535|11197727|FG004|NOT COMPLETED|Period 2||0
10070846|NCT02173535|11197728|FG005|NOT COMPLETED|Period 2||0
10070847|NCT02173535|11197729|FG006|NOT COMPLETED|Period 2||0
10070848|NCT02173535|11197730|FG007|NOT COMPLETED|Period 2||0
10070849|NCT02173535|11197731|FG008|NOT COMPLETED|Period 2||0
10070850|NCT02173535|11197732|FG009|NOT COMPLETED|Period 2||0
10070851|NCT02173535|11197733|FG010|NOT COMPLETED|Period 2||0
10070852|NCT02173535|11197734|FG011|NOT COMPLETED|Period 2||0
10070853|NCT02173535|11197735|FG012|NOT COMPLETED|Period 2||0
10070854|NCT02173535|11197736|FG013|NOT COMPLETED|Period 2||0
10070855|NCT02173535|11197737|FG014|NOT COMPLETED|Period 2||0
10070856|NCT02173535|11197738|FG015|NOT COMPLETED|Period 2||0
10070857|NCT02173535|11197739|FG016|NOT COMPLETED|Period 2||0
10070858|NCT02173535|11197740|FG017|NOT COMPLETED|Period 2||0
10070859|NCT02173535|11197741|FG018|NOT COMPLETED|Period 2||0
10070860|NCT02173535|11197742|FG019|NOT COMPLETED|Period 2||0
10070861|NCT02173535|11197723|FG000|STARTED|Period 3||12
10070862|NCT02173535|11197724|FG001|STARTED|Period 3||12
10070863|NCT02173535|11197725|FG002|STARTED|Period 3||12
10070864|NCT02173535|11197726|FG003|STARTED|Period 3||12
10070865|NCT02173535|11197727|FG004|STARTED|Period 3||12
10070866|NCT02173535|11197728|FG005|STARTED|Period 3||12
10070867|NCT02173535|11197729|FG006|STARTED|Period 3||12
10070868|NCT02173535|11197730|FG007|STARTED|Period 3||12
10070869|NCT02173535|11197731|FG008|STARTED|Period 3||12
10070870|NCT02173535|11197732|FG009|STARTED|Period 3||12
10070871|NCT02173535|11197733|FG010|STARTED|Period 3||12
10070872|NCT02173535|11197734|FG011|STARTED|Period 3||12
10070873|NCT02173535|11197735|FG012|STARTED|Period 3||12
10070874|NCT02173535|11197736|FG013|STARTED|Period 3||12
10070875|NCT02173535|11197737|FG014|STARTED|Period 3||12
10070876|NCT02173535|11197738|FG015|STARTED|Period 3||12
10070877|NCT02173535|11197739|FG016|STARTED|Period 3||12
10070878|NCT02173535|11197740|FG017|STARTED|Period 3||12
10070879|NCT02173535|11197741|FG018|STARTED|Period 3||12
10070880|NCT02173535|11197742|FG019|STARTED|Period 3||12
10070881|NCT02173535|11197723|FG000|COMPLETED|Period 3||12
10070882|NCT02173535|11197724|FG001|COMPLETED|Period 3||12
10070883|NCT02173535|11197725|FG002|COMPLETED|Period 3||12
10070884|NCT02173535|11197726|FG003|COMPLETED|Period 3||12
10070885|NCT02173535|11197727|FG004|COMPLETED|Period 3||12
10070886|NCT02173535|11197728|FG005|COMPLETED|Period 3||12
10070887|NCT02173535|11197729|FG006|COMPLETED|Period 3||12
10070888|NCT02173535|11197730|FG007|COMPLETED|Period 3||12
10070889|NCT02173535|11197731|FG008|COMPLETED|Period 3||12
10070890|NCT02173535|11197732|FG009|COMPLETED|Period 3||12
10070891|NCT02173535|11197733|FG010|COMPLETED|Period 3||12
10070892|NCT02173535|11197734|FG011|COMPLETED|Period 3||12
10070893|NCT02173535|11197735|FG012|COMPLETED|Period 3||12
10070894|NCT02173535|11197736|FG013|COMPLETED|Period 3||12
10070895|NCT02173535|11197737|FG014|COMPLETED|Period 3||12
10070896|NCT02173535|11197738|FG015|COMPLETED|Period 3||12
10070897|NCT02173535|11197739|FG016|COMPLETED|Period 3||12
10070898|NCT02173535|11197740|FG017|COMPLETED|Period 3||12
10070899|NCT02173535|11197741|FG018|COMPLETED|Period 3||12
10070900|NCT02173535|11197742|FG019|COMPLETED|Period 3||12
10070901|NCT02173535|11197723|FG000|NOT COMPLETED|Period 3||0
10070902|NCT02173535|11197724|FG001|NOT COMPLETED|Period 3||0
10070903|NCT02173535|11197725|FG002|NOT COMPLETED|Period 3||0
10070904|NCT02173535|11197726|FG003|NOT COMPLETED|Period 3||0
10070905|NCT02173535|11197727|FG004|NOT COMPLETED|Period 3||0
10070906|NCT02173535|11197728|FG005|NOT COMPLETED|Period 3||0
10070907|NCT02173535|11197729|FG006|NOT COMPLETED|Period 3||0
10070908|NCT02173535|11197730|FG007|NOT COMPLETED|Period 3||0
10070909|NCT02173535|11197731|FG008|NOT COMPLETED|Period 3||0
10070910|NCT02173535|11197732|FG009|NOT COMPLETED|Period 3||0
10070911|NCT02173535|11197733|FG010|NOT COMPLETED|Period 3||0
10070912|NCT02173535|11197734|FG011|NOT COMPLETED|Period 3||0
10070913|NCT02173535|11197735|FG012|NOT COMPLETED|Period 3||0
10070914|NCT02173535|11197736|FG013|NOT COMPLETED|Period 3||0
10070915|NCT02173535|11197737|FG014|NOT COMPLETED|Period 3||0
10070916|NCT02173535|11197738|FG015|NOT COMPLETED|Period 3||0
10070917|NCT02173535|11197739|FG016|NOT COMPLETED|Period 3||0
10070918|NCT02173535|11197740|FG017|NOT COMPLETED|Period 3||0
10070919|NCT02173535|11197741|FG018|NOT COMPLETED|Period 3||0
10070920|NCT02173535|11197742|FG019|NOT COMPLETED|Period 3||0
10070921|NCT02173535|11197723|FG000|STARTED|Period 4||12
10070922|NCT02173535|11197724|FG001|STARTED|Period 4||12
10070923|NCT02173535|11197725|FG002|STARTED|Period 4||12
10070924|NCT02173535|11197726|FG003|STARTED|Period 4||12
10070925|NCT02173535|11197727|FG004|STARTED|Period 4||12
10070926|NCT02173535|11197728|FG005|STARTED|Period 4||12
10070927|NCT02173535|11197729|FG006|STARTED|Period 4||12
10070928|NCT02173535|11197730|FG007|STARTED|Period 4||12
10070929|NCT02173535|11197731|FG008|STARTED|Period 4||12
10070930|NCT02173535|11197732|FG009|STARTED|Period 4||12
10070931|NCT02173535|11197733|FG010|STARTED|Period 4||12
10070932|NCT02173535|11197734|FG011|STARTED|Period 4||12
10070933|NCT02173535|11197735|FG012|STARTED|Period 4||12
10070934|NCT02173535|11197736|FG013|STARTED|Period 4||12
10070935|NCT02173535|11197737|FG014|STARTED|Period 4||12
10070936|NCT02173535|11197738|FG015|STARTED|Period 4||12
10070937|NCT02173535|11197739|FG016|STARTED|Period 4||12
10070938|NCT02173535|11197740|FG017|STARTED|Period 4||12
10070939|NCT02173535|11197741|FG018|STARTED|Period 4||12
10070940|NCT02173535|11197742|FG019|STARTED|Period 4||12
10070941|NCT02173535|11197723|FG000|COMPLETED|Period 4||12
10070942|NCT02173535|11197724|FG001|COMPLETED|Period 4||12
10070943|NCT02173535|11197725|FG002|COMPLETED|Period 4||12
10070944|NCT02173535|11197726|FG003|COMPLETED|Period 4||12
10070945|NCT02173535|11197727|FG004|COMPLETED|Period 4||12
10070946|NCT02173535|11197728|FG005|COMPLETED|Period 4||12
10070947|NCT02173535|11197729|FG006|COMPLETED|Period 4||12
10070948|NCT02173535|11197730|FG007|COMPLETED|Period 4||12
10070949|NCT02173535|11197731|FG008|COMPLETED|Period 4||12
10070950|NCT02173535|11197732|FG009|COMPLETED|Period 4||12
10070951|NCT02173535|11197733|FG010|COMPLETED|Period 4||12
10070952|NCT02173535|11197734|FG011|COMPLETED|Period 4||12
10070953|NCT02173535|11197735|FG012|COMPLETED|Period 4||12
10070954|NCT02173535|11197736|FG013|COMPLETED|Period 4||12
10070955|NCT02173535|11197737|FG014|COMPLETED|Period 4||12
10070956|NCT02173535|11197738|FG015|COMPLETED|Period 4||12
10070957|NCT02173535|11197739|FG016|COMPLETED|Period 4||12
10070958|NCT02173535|11197740|FG017|COMPLETED|Period 4||12
10070959|NCT02173535|11197741|FG018|COMPLETED|Period 4||12
10070960|NCT02173535|11197742|FG019|COMPLETED|Period 4||12
10070961|NCT02173535|11197723|FG000|NOT COMPLETED|Period 4||0
10070962|NCT02173535|11197724|FG001|NOT COMPLETED|Period 4||0
10070963|NCT02173535|11197725|FG002|NOT COMPLETED|Period 4||0
10070964|NCT02173535|11197726|FG003|NOT COMPLETED|Period 4||0
10070965|NCT02173535|11197727|FG004|NOT COMPLETED|Period 4||0
10070966|NCT02173535|11197728|FG005|NOT COMPLETED|Period 4||0
10070967|NCT02173535|11197729|FG006|NOT COMPLETED|Period 4||0
10070968|NCT02173535|11197730|FG007|NOT COMPLETED|Period 4||0
10070969|NCT02173535|11197731|FG008|NOT COMPLETED|Period 4||0
10070970|NCT02173535|11197732|FG009|NOT COMPLETED|Period 4||0
10070971|NCT02173535|11197733|FG010|NOT COMPLETED|Period 4||0
10070972|NCT02173535|11197734|FG011|NOT COMPLETED|Period 4||0
10070973|NCT02173535|11197735|FG012|NOT COMPLETED|Period 4||0
10070974|NCT02173535|11197736|FG013|NOT COMPLETED|Period 4||0
10070975|NCT02173535|11197737|FG014|NOT COMPLETED|Period 4||0
10070976|NCT02173535|11197738|FG015|NOT COMPLETED|Period 4||0
10070977|NCT02173535|11197739|FG016|NOT COMPLETED|Period 4||0
10070978|NCT02173535|11197740|FG017|NOT COMPLETED|Period 4||0
10070979|NCT02173535|11197741|FG018|NOT COMPLETED|Period 4||0
10070980|NCT02173535|11197742|FG019|NOT COMPLETED|Period 4||0
10070981|NCT02173535|11197723|FG000|STARTED|Period 5||12
10070982|NCT02173535|11197724|FG001|STARTED|Period 5||12
10070983|NCT02173535|11197725|FG002|STARTED|Period 5||12
10070984|NCT02173535|11197726|FG003|STARTED|Period 5||12
10070985|NCT02173535|11197727|FG004|STARTED|Period 5||12
10070986|NCT02173535|11197728|FG005|STARTED|Period 5||12
10070987|NCT02173535|11197729|FG006|STARTED|Period 5||12
10070988|NCT02173535|11197730|FG007|STARTED|Period 5||12
10070989|NCT02173535|11197731|FG008|STARTED|Period 5||12
10070990|NCT02173535|11197732|FG009|STARTED|Period 5||12
10070991|NCT02173535|11197733|FG010|STARTED|Period 5||12
10070992|NCT02173535|11197734|FG011|STARTED|Period 5||12
10070993|NCT02173535|11197735|FG012|STARTED|Period 5||12
10070994|NCT02173535|11197736|FG013|STARTED|Period 5||12
10070995|NCT02173535|11197737|FG014|STARTED|Period 5||12
10070996|NCT02173535|11197738|FG015|STARTED|Period 5||12
10070997|NCT02173535|11197739|FG016|STARTED|Period 5||12
10070998|NCT02173535|11197740|FG017|STARTED|Period 5||12
10070999|NCT02173535|11197741|FG018|STARTED|Period 5||12
10071000|NCT02173535|11197742|FG019|STARTED|Period 5||12
10071001|NCT02173535|11197723|FG000|COMPLETED|Period 5||12
10071002|NCT02173535|11197724|FG001|COMPLETED|Period 5||12
10071003|NCT02173535|11197725|FG002|COMPLETED|Period 5||12
10071004|NCT02173535|11197726|FG003|COMPLETED|Period 5||12
10071005|NCT02173535|11197727|FG004|COMPLETED|Period 5||12
10071006|NCT02173535|11197728|FG005|COMPLETED|Period 5||12
10071007|NCT02173535|11197729|FG006|COMPLETED|Period 5||12
10071008|NCT02173535|11197730|FG007|COMPLETED|Period 5||12
10071009|NCT02173535|11197731|FG008|COMPLETED|Period 5||12
10071010|NCT02173535|11197732|FG009|COMPLETED|Period 5||12
10071011|NCT02173535|11197733|FG010|COMPLETED|Period 5||12
10071012|NCT02173535|11197734|FG011|COMPLETED|Period 5||12
10071013|NCT02173535|11197735|FG012|COMPLETED|Period 5||12
10071014|NCT02173535|11197736|FG013|COMPLETED|Period 5||12
10071015|NCT02173535|11197737|FG014|COMPLETED|Period 5||12
10071016|NCT02173535|11197738|FG015|COMPLETED|Period 5||12
10071017|NCT02173535|11197739|FG016|COMPLETED|Period 5||12
10071018|NCT02173535|11197740|FG017|COMPLETED|Period 5||12
10071019|NCT02173535|11197741|FG018|COMPLETED|Period 5||12
10071020|NCT02173535|11197742|FG019|COMPLETED|Period 5||12
10071021|NCT02173535|11197723|FG000|NOT COMPLETED|Period 5||0
10071022|NCT02173535|11197724|FG001|NOT COMPLETED|Period 5||0
10071023|NCT02173535|11197725|FG002|NOT COMPLETED|Period 5||0
10071024|NCT02173535|11197726|FG003|NOT COMPLETED|Period 5||0
10071025|NCT02173535|11197727|FG004|NOT COMPLETED|Period 5||0
10071026|NCT02173535|11197728|FG005|NOT COMPLETED|Period 5||0
10071027|NCT02173535|11197729|FG006|NOT COMPLETED|Period 5||0
10071028|NCT02173535|11197730|FG007|NOT COMPLETED|Period 5||0
10071029|NCT02173535|11197731|FG008|NOT COMPLETED|Period 5||0
10071030|NCT02173535|11197732|FG009|NOT COMPLETED|Period 5||0
10071031|NCT02173535|11197733|FG010|NOT COMPLETED|Period 5||0
10071032|NCT02173535|11197734|FG011|NOT COMPLETED|Period 5||0
10071033|NCT02173535|11197735|FG012|NOT COMPLETED|Period 5||0
10071034|NCT02173535|11197736|FG013|NOT COMPLETED|Period 5||0
10071035|NCT02173535|11197737|FG014|NOT COMPLETED|Period 5||0
10071036|NCT02173535|11197738|FG015|NOT COMPLETED|Period 5||0
10071037|NCT02173535|11197739|FG016|NOT COMPLETED|Period 5||0
10071038|NCT02173535|11197740|FG017|NOT COMPLETED|Period 5||0
10071039|NCT02173535|11197741|FG018|NOT COMPLETED|Period 5||0
10071040|NCT02173535|11197742|FG019|NOT COMPLETED|Period 5||0
10071041|NCT02173548|11197771|FG000|STARTED|Overall Study||21
10071042|NCT02173548|11197772|FG001|STARTED|Overall Study||10
10071043|NCT02173548|11197771|FG000|COMPLETED|Overall Study||20
10071044|NCT02173548|11197772|FG001|COMPLETED|Overall Study||8
10071045|NCT02173548|11197771|FG000|NOT COMPLETED|Overall Study||1
10071046|NCT02173548|11197772|FG001|NOT COMPLETED|Overall Study||2
10071047|NCT02173704|11197780|FG000|STARTED|Overall Study||150
10071048|NCT02173704|11197781|FG001|STARTED|Overall Study||75
10071049|NCT02173704|11197780|FG000|COMPLETED|Overall Study||137
10071050|NCT02173704|11197781|FG001|COMPLETED|Overall Study||71
10071051|NCT02173704|11197780|FG000|NOT COMPLETED|Overall Study||13
10071052|NCT02173704|11197781|FG001|NOT COMPLETED|Overall Study||4
10071053|NCT02173769|11197787|FG000|STARTED|Overall Study||1858
10071054|NCT02173769|11197787|FG000|COMPLETED|Overall Study||1854
10071055|NCT02173769|11197787|FG000|NOT COMPLETED|Overall Study||4
10071056|NCT02174198|11197794|FG000|STARTED|Overall Study||16
10071057|NCT02174198|11197795|FG001|STARTED|Overall Study||16
10071058|NCT02174198|11197794|FG000|COMPLETED|Overall Study||16
10071059|NCT02174198|11197795|FG001|COMPLETED|Overall Study||16
10071060|NCT02174198|11197794|FG000|NOT COMPLETED|Overall Study||0
10071061|NCT02174198|11197795|FG001|NOT COMPLETED|Overall Study||0
10071062|NCT02174276|11197805|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
10071063|NCT02174276|11197806|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
10071064|NCT02174276|11197807|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
10071065|NCT02174276|11197808|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
10071066|NCT02174276|11197805|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
10071067|NCT02174276|11197806|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
10071068|NCT02174276|11197807|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
10071069|NCT02174276|11197808|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
10071070|NCT02174276|11197805|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
10071071|NCT02174276|11197806|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
10071072|NCT02174276|11197807|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
10071073|NCT02174276|11197808|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
10071074|NCT02174276|11197805|FG000|STARTED|OTEP (Weeks 48 to 144)||26
10071075|NCT02174276|11197806|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
10071076|NCT02174276|11197807|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
10071077|NCT02174276|11197808|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
10071078|NCT02174276|11197805|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25
10071079|NCT02174276|11197806|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54
10071080|NCT02174276|11197807|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48
10071081|NCT02174276|11197808|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50
10071082|NCT02174276|11197805|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
10071083|NCT02174276|11197806|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
10071084|NCT02174276|11197807|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
10071085|NCT02174276|11197808|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
10071086|NCT02174419|11197821|FG000|STARTED|Overall Study||22
10071087|NCT02174419|11197822|FG001|STARTED|Overall Study||18
10071088|NCT02174419|11197823|FG002|STARTED|Overall Study||22
10071089|NCT02174419|11197821|FG000|COMPLETED|Overall Study||18
10071090|NCT02174419|11197822|FG001|COMPLETED|Overall Study||12
10071091|NCT02174419|11197823|FG002|COMPLETED|Overall Study||20
10071092|NCT02174419|11197821|FG000|NOT COMPLETED|Overall Study||4
10071093|NCT02174419|11197822|FG001|NOT COMPLETED|Overall Study||6
10071094|NCT02174419|11197823|FG002|NOT COMPLETED|Overall Study||2
10071095|NCT02174432|11197831|FG000|STARTED|Overall Study||36
10071096|NCT02174432|11197831|FG000|COMPLETED|Overall Study||16
10071097|NCT02174432|11197831|FG000|NOT COMPLETED|Overall Study||20
10071098|NCT02174510|11197839|FG000|STARTED|Overall Study||8
10071099|NCT02174510|11197840|FG001|STARTED|Overall Study||8
10071100|NCT02174510|11197841|FG002|STARTED|Overall Study||12
10071101|NCT02174510|11197842|FG003|STARTED|Overall Study||9
10071102|NCT02174510|11197839|FG000|COMPLETED|Overall Study||8
10071103|NCT02174510|11197840|FG001|COMPLETED|Overall Study||8
10071104|NCT02174510|11197841|FG002|COMPLETED|Overall Study||12
10071105|NCT02174510|11197842|FG003|COMPLETED|Overall Study||9
10071106|NCT02174510|11197839|FG000|NOT COMPLETED|Overall Study||0
10071107|NCT02174510|11197840|FG001|NOT COMPLETED|Overall Study||0
10071108|NCT02174510|11197841|FG002|NOT COMPLETED|Overall Study||0
10071109|NCT02174510|11197842|FG003|NOT COMPLETED|Overall Study||0
10071110|NCT02174523|11197853|FG000|STARTED|Overall Study||10
10071111|NCT02174523|11197854|FG001|STARTED|Overall Study||4
10071112|NCT02174523|11197853|FG000|COMPLETED|Overall Study||9
10071113|NCT02174523|11197854|FG001|COMPLETED|Overall Study||4
10071114|NCT02174523|11197853|FG000|NOT COMPLETED|Overall Study||1
10071115|NCT02174523|11197854|FG001|NOT COMPLETED|Overall Study||0
10071116|NCT02174562|11197861|FG000|STARTED|Overall Study||50
10071117|NCT02174562|11197862|FG001|STARTED|Overall Study||51
10071118|NCT02174562|11197861|FG000|COMPLETED|Overall Study||41
10071119|NCT02174562|11197862|FG001|COMPLETED|Overall Study||46
10071120|NCT02174562|11197861|FG000|NOT COMPLETED|Overall Study||9
10071121|NCT02174562|11197862|FG001|NOT COMPLETED|Overall Study||5
10071122|NCT02174627|11197870|FG000|STARTED|Overall Study||1384
10071123|NCT02174627|11197871|FG001|STARTED|Overall Study||1377
10071124|NCT02174627|11197870|FG000|Received Treatment|Overall Study||1384
10071125|NCT02174627|11197871|FG001|Received Treatment|Overall Study||1376
10071126|NCT02174627|11197870|FG000|Discontinued Treatment|Overall Study||499
10071127|NCT02174627|11197871|FG001|Discontinued Treatment|Overall Study||801
10071128|NCT02174627|11197870|FG000|COMPLETED|Overall Study||1300
10071129|NCT02174627|11197871|FG001|COMPLETED|Overall Study||1247
10071130|NCT02174627|11197870|FG000|NOT COMPLETED|Overall Study||84
10071131|NCT02174627|11197871|FG001|NOT COMPLETED|Overall Study||130
10071132|NCT02174731|11197879|FG000|STARTED|Overall Study||1051
10071133|NCT02174731|11197880|FG001|STARTED|Overall Study||1055
10071134|NCT02174731|11197879|FG000|Received Treatment|Overall Study||1048
10071135|NCT02174731|11197880|FG001|Received Treatment|Overall Study||1053
10071136|NCT02174731|11197879|FG000|COMPLETED|Overall Study||982
10071137|NCT02174731|11197880|FG001|COMPLETED|Overall Study||990
10071138|NCT02174731|11197879|FG000|NOT COMPLETED|Overall Study||69
10071139|NCT02174731|11197880|FG001|NOT COMPLETED|Overall Study||65
10071140|NCT02174848|11197888|FG000|STARTED|Overall Study||24
10071141|NCT02174848|11197889|FG001|STARTED|Overall Study||44
10071142|NCT02174848|11197888|FG000|Provided Post-baseline Efficacy Data|Overall Study||19
10071143|NCT02174848|11197889|FG001|Provided Post-baseline Efficacy Data|Overall Study||43
10071144|NCT02174848|11197888|FG000|COMPLETED|Overall Study||17
10071145|NCT02174848|11197889|FG001|COMPLETED|Overall Study||38
10071146|NCT02174848|11197888|FG000|NOT COMPLETED|Overall Study||7
10071147|NCT02174848|11197889|FG001|NOT COMPLETED|Overall Study||6
10071148|NCT02174913|11197902|FG000|STARTED|Overall Study||17
10071149|NCT02174913|11197903|FG001|STARTED|Overall Study||17
10071150|NCT02174913|11197902|FG000|COMPLETED|Overall Study||17
10071151|NCT02174913|11197903|FG001|COMPLETED|Overall Study||17
10071152|NCT02174913|11197902|FG000|NOT COMPLETED|Overall Study||0
10071153|NCT02174913|11197903|FG001|NOT COMPLETED|Overall Study||0
10071154|NCT02175121|11197914|FG000|STARTED|Overall Study||34
10071155|NCT02175121|11197915|FG001|STARTED|Overall Study||35
10071156|NCT02175121|11197916|FG002|STARTED|Overall Study||34
10071157|NCT02175121|11197917|FG003|STARTED|Overall Study||35
10071158|NCT02175121|11197918|FG004|STARTED|Overall Study||34
10071159|NCT02175121|11197914|FG000|COMPLETED|Overall Study||33
10071160|NCT02175121|11197915|FG001|COMPLETED|Overall Study||34
10071161|NCT02175121|11197916|FG002|COMPLETED|Overall Study||32
10071162|NCT02175121|11197917|FG003|COMPLETED|Overall Study||34
10071163|NCT02175121|11197918|FG004|COMPLETED|Overall Study||33
10071164|NCT02175121|11197914|FG000|NOT COMPLETED|Overall Study||1
10071165|NCT02175121|11197915|FG001|NOT COMPLETED|Overall Study||1
10071166|NCT02175121|11197916|FG002|NOT COMPLETED|Overall Study||2
10071167|NCT02175121|11197917|FG003|NOT COMPLETED|Overall Study||1
10071168|NCT02175121|11197918|FG004|NOT COMPLETED|Overall Study||1
10071169|NCT02175199|11197936|FG000|STARTED|Overall Study||74
10071170|NCT02175199|11197937|FG001|STARTED|Overall Study||76
10071171|NCT02175199|11197936|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
10071172|NCT02175199|11197937|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
10071173|NCT02175199|11197936|FG000|COMPLETED|Overall Study||71
10071174|NCT02175199|11197937|FG001|COMPLETED|Overall Study||71
10071175|NCT02175199|11197936|FG000|NOT COMPLETED|Overall Study||3
10071176|NCT02175199|11197937|FG001|NOT COMPLETED|Overall Study||5
10071177|NCT02175212|11197946|FG000|STARTED|Overall Study||177
10071178|NCT02175212|11197947|FG001|STARTED|Overall Study||178
10071179|NCT02175212|11197946|FG000|COMPLETED|Overall Study||14
10071180|NCT02175212|11197947|FG001|COMPLETED|Overall Study||31
10071181|NCT02175212|11197946|FG000|NOT COMPLETED|Overall Study||163
10071182|NCT02175212|11197947|FG001|NOT COMPLETED|Overall Study||147
10071183|NCT02175225|11197955|FG000|STARTED|Overall Study||145
10071184|NCT02175225|11197956|FG001|STARTED|Overall Study||149
10071185|NCT02175225|11197955|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
10071186|NCT02175225|11197956|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
10071187|NCT02175225|11197955|FG000|90 Day Outcome Obtained|Overall Study||140
10071188|NCT02175225|11197956|FG001|90 Day Outcome Obtained|Overall Study||143
10071189|NCT02175225|11197955|FG000|180 Day Outcome Obtained|Overall Study||135
10071190|NCT02175225|11197956|FG001|180 Day Outcome Obtained|Overall Study||135
10071191|NCT02175225|11197955|FG000|COMPLETED|Overall Study||137
10071192|NCT02175225|11197956|FG001|COMPLETED|Overall Study||138
10071193|NCT02175225|11197955|FG000|NOT COMPLETED|Overall Study||8
10071194|NCT02175225|11197956|FG001|NOT COMPLETED|Overall Study||11
10189709|NCT03286218|11319152|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189710|NCT03286218|11319153|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189711|NCT03286218|11319154|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
10189712|NCT03286218|11319155|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189713|NCT03286218|11319156|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189714|NCT03286218|11319157|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189715|NCT03286218|11319158|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189716|NCT03286218|11319159|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189717|NCT03286218|11319160|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
10189718|NCT03286218|11319161|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10189719|NCT03286218|11319150|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
10189720|NCT03286218|11319151|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
10189721|NCT03286218|11319152|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189722|NCT03286218|11319153|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189723|NCT03286218|11319154|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
10189724|NCT03286218|11319155|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189725|NCT03286218|11319156|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189726|NCT03286218|11319157|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189727|NCT03286218|11319158|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189728|NCT03286218|11319159|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189729|NCT03286218|11319160|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
10189730|NCT03286218|11319161|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10189731|NCT03286218|11319150|FG000|COMPLETED|Treatment Phase Period 1||0
10189732|NCT03286218|11319151|FG001|COMPLETED|Treatment Phase Period 1||0
10189733|NCT03286218|11319152|FG002|COMPLETED|Treatment Phase Period 1||5
10189734|NCT03286218|11319153|FG003|COMPLETED|Treatment Phase Period 1||5
10189735|NCT03286218|11319154|FG004|COMPLETED|Treatment Phase Period 1||5
10189736|NCT03286218|11319155|FG005|COMPLETED|Treatment Phase Period 1||5
10189737|NCT03286218|11319156|FG006|COMPLETED|Treatment Phase Period 1||6
10189738|NCT03286218|11319157|FG007|COMPLETED|Treatment Phase Period 1||6
10189739|NCT03286218|11319158|FG008|COMPLETED|Treatment Phase Period 1||6
10189740|NCT03286218|11319159|FG009|COMPLETED|Treatment Phase Period 1||6
10189741|NCT03286218|11319160|FG010|COMPLETED|Treatment Phase Period 1||5
10189742|NCT03286218|11319161|FG011|COMPLETED|Treatment Phase Period 1||5
10189743|NCT03286218|11319150|FG000|NOT COMPLETED|Treatment Phase Period 1||0
10189744|NCT03286218|11319151|FG001|NOT COMPLETED|Treatment Phase Period 1||0
10189745|NCT03286218|11319152|FG002|NOT COMPLETED|Treatment Phase Period 1||1
10189746|NCT03286218|11319153|FG003|NOT COMPLETED|Treatment Phase Period 1||1
10189747|NCT03286218|11319154|FG004|NOT COMPLETED|Treatment Phase Period 1||0
10189748|NCT03286218|11319155|FG005|NOT COMPLETED|Treatment Phase Period 1||1
10189749|NCT03286218|11319156|FG006|NOT COMPLETED|Treatment Phase Period 1||0
10189750|NCT03286218|11319157|FG007|NOT COMPLETED|Treatment Phase Period 1||0
10189751|NCT03286218|11319158|FG008|NOT COMPLETED|Treatment Phase Period 1||0
10189752|NCT03286218|11319159|FG009|NOT COMPLETED|Treatment Phase Period 1||0
10189753|NCT03286218|11319160|FG010|NOT COMPLETED|Treatment Phase Period 1||0
10189754|NCT03286218|11319161|FG011|NOT COMPLETED|Treatment Phase Period 1||1
10189755|NCT03286218|11319150|FG000|STARTED|Treatment Phase Period 2||0
10189756|NCT03286218|11319151|FG001|STARTED|Treatment Phase Period 2||0
10189757|NCT03286218|11319152|FG002|STARTED|Treatment Phase Period 2||5
10189758|NCT03286218|11319153|FG003|STARTED|Treatment Phase Period 2||5
10189759|NCT03286218|11319154|FG004|STARTED|Treatment Phase Period 2||5
10189760|NCT03286218|11319155|FG005|STARTED|Treatment Phase Period 2||5
10189761|NCT03286218|11319156|FG006|STARTED|Treatment Phase Period 2||6
10189762|NCT03286218|11319157|FG007|STARTED|Treatment Phase Period 2||6
10189763|NCT03286218|11319158|FG008|STARTED|Treatment Phase Period 2||6
10189764|NCT03286218|11319159|FG009|STARTED|Treatment Phase Period 2||6
10189765|NCT03286218|11319160|FG010|STARTED|Treatment Phase Period 2||5
10189766|NCT03286218|11319161|FG011|STARTED|Treatment Phase Period 2||5
10189767|NCT03286218|11319150|FG000|COMPLETED|Treatment Phase Period 2||0
10189768|NCT03286218|11319151|FG001|COMPLETED|Treatment Phase Period 2||0
10189769|NCT03286218|11319152|FG002|COMPLETED|Treatment Phase Period 2||5
10189770|NCT03286218|11319153|FG003|COMPLETED|Treatment Phase Period 2||5
10189771|NCT03286218|11319154|FG004|COMPLETED|Treatment Phase Period 2||5
10189772|NCT03286218|11319155|FG005|COMPLETED|Treatment Phase Period 2||5
10071195|NCT02175277|11197962|FG000|STARTED|Overall Study||9
10071196|NCT02175277|11197962|FG000|COMPLETED|Overall Study||8
10071197|NCT02175277|11197962|FG000|NOT COMPLETED|Overall Study||1
10071198|NCT02175368|11197966|FG000|STARTED|Overall Study||28
10071199|NCT02175368|11197966|FG000|COMPLETED|Overall Study||27
10071200|NCT02175368|11197966|FG000|NOT COMPLETED|Overall Study||1
10071201|NCT02175472|11197972|FG000|STARTED|Overall Study||45
10071202|NCT02175472|11197973|FG001|STARTED|Overall Study||47
10071203|NCT02175472|11197972|FG000|COMPLETED|Overall Study||38
10071204|NCT02175472|11197973|FG001|COMPLETED|Overall Study||45
10071205|NCT02175472|11197972|FG000|NOT COMPLETED|Overall Study||7
10071206|NCT02175472|11197973|FG001|NOT COMPLETED|Overall Study||2
10071207|NCT02175641|11197981|FG000|STARTED|Overall Study||157
10071208|NCT02175641|11197982|FG001|STARTED|Overall Study||157
10071209|NCT02175641|11197981|FG000|6-month Follow up|Overall Study||144
10071210|NCT02175641|11197982|FG001|6-month Follow up|Overall Study||149
10071211|NCT02175641|11197981|FG000|12-month Follow up|Overall Study||129
10071212|NCT02175641|11197982|FG001|12-month Follow up|Overall Study||136
10071213|NCT02175641|11197981|FG000|18-month Follow up|Overall Study||122
10071214|NCT02175641|11197982|FG001|18-month Follow up|Overall Study||130
10071215|NCT02175641|11197981|FG000|COMPLETED|Overall Study||122
10071216|NCT02175641|11197982|FG001|COMPLETED|Overall Study||130
10071217|NCT02175641|11197981|FG000|NOT COMPLETED|Overall Study||35
10071218|NCT02175641|11197982|FG001|NOT COMPLETED|Overall Study||27
10071219|NCT02175745|11197988|FG000|STARTED|Overall Study||2
10071220|NCT02175745|11197988|FG000|COMPLETED|Overall Study||1
10071221|NCT02175745|11197988|FG000|NOT COMPLETED|Overall Study||1
10071222|NCT02175758|11197998|FG000|STARTED|PK Lead-in Phase||4
10071223|NCT02175758|11197999|FG001|STARTED|PK Lead-in Phase||6
10071224|NCT02175758|11198000|FG002|STARTED|PK Lead-in Phase||2
10071225|NCT02175758|11198001|FG003|STARTED|PK Lead-in Phase||10
10071226|NCT02175758|11198002|FG004|STARTED|PK Lead-in Phase||4
10071227|NCT02175758|11198003|FG005|STARTED|PK Lead-in Phase||8
10071228|NCT02175758|11197998|FG000|COMPLETED|PK Lead-in Phase||4
10071229|NCT02175758|11197999|FG001|COMPLETED|PK Lead-in Phase||6
10071230|NCT02175758|11198000|FG002|COMPLETED|PK Lead-in Phase||2
10071231|NCT02175758|11198001|FG003|COMPLETED|PK Lead-in Phase||10
10071232|NCT02175758|11198002|FG004|COMPLETED|PK Lead-in Phase||4
10071233|NCT02175758|11198003|FG005|COMPLETED|PK Lead-in Phase||8
10071234|NCT02175758|11197998|FG000|NOT COMPLETED|PK Lead-in Phase||0
10071235|NCT02175758|11197999|FG001|NOT COMPLETED|PK Lead-in Phase||0
10071236|NCT02175758|11198000|FG002|NOT COMPLETED|PK Lead-in Phase||0
10071237|NCT02175758|11198001|FG003|NOT COMPLETED|PK Lead-in Phase||0
10071238|NCT02175758|11198002|FG004|NOT COMPLETED|PK Lead-in Phase||0
10071239|NCT02175758|11198003|FG005|NOT COMPLETED|PK Lead-in Phase||0
10071240|NCT02175758|11197998|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
10071241|NCT02175758|11197999|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
10071242|NCT02175758|11198000|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
10071243|NCT02175758|11198001|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
10071244|NCT02175758|11198002|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
10071245|NCT02175758|11198003|FG005|STARTED|Treatment Phase||8
10071246|NCT02175758|11197998|FG000|COMPLETED|Treatment Phase||13
10071247|NCT02175758|11197999|FG001|COMPLETED|Treatment Phase||38
10071248|NCT02175758|11198000|FG002|COMPLETED|Treatment Phase||13
10071249|NCT02175758|11198001|FG003|COMPLETED|Treatment Phase||28
10071250|NCT02175758|11198002|FG004|COMPLETED|Treatment Phase||4
10071251|NCT02175758|11198003|FG005|COMPLETED|Treatment Phase||8
10071252|NCT02175758|11197998|FG000|NOT COMPLETED|Treatment Phase||0
10071253|NCT02175758|11197999|FG001|NOT COMPLETED|Treatment Phase||1
10071254|NCT02175758|11198000|FG002|NOT COMPLETED|Treatment Phase||0
10071255|NCT02175758|11198001|FG003|NOT COMPLETED|Treatment Phase||0
10071256|NCT02175758|11198002|FG004|NOT COMPLETED|Treatment Phase||1
10071257|NCT02175758|11198003|FG005|NOT COMPLETED|Treatment Phase||0
10071258|NCT02175771|11198051|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
10071259|NCT02175771|11198052|FG001|STARTED|Run-In Period (Pre-assignment)||0
10071260|NCT02175771|11198053|FG002|STARTED|Run-In Period (Pre-assignment)||0
10071261|NCT02175771|11198054|FG003|STARTED|Run-In Period (Pre-assignment)||0
10071262|NCT02175771|11198055|FG004|STARTED|Run-In Period (Pre-assignment)||0
10071263|NCT02175771|11198056|FG005|STARTED|Run-In Period (Pre-assignment)||0
10071264|NCT02175771|11198057|FG006|STARTED|Run-In Period (Pre-assignment)||0
10071265|NCT02175771|11198058|FG007|STARTED|Run-In Period (Pre-assignment)||0
10071266|NCT02175771|11198059|FG008|STARTED|Run-In Period (Pre-assignment)||0
10071267|NCT02175771|11198051|FG000|COMPLETED|Run-In Period (Pre-assignment)||674
10071268|NCT02175771|11198052|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
10071269|NCT02175771|11198053|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
10071270|NCT02175771|11198054|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
10071271|NCT02175771|11198055|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
10071272|NCT02175771|11198056|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
10071273|NCT02175771|11198057|FG006|COMPLETED|Run-In Period (Pre-assignment)||0
10071274|NCT02175771|11198058|FG007|COMPLETED|Run-In Period (Pre-assignment)||0
10071275|NCT02175771|11198059|FG008|COMPLETED|Run-In Period (Pre-assignment)||0
10071276|NCT02175771|11198051|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84
10071277|NCT02175771|11198052|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071278|NCT02175771|11198053|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071279|NCT02175771|11198054|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071280|NCT02175771|11198055|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071281|NCT02175771|11198056|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071282|NCT02175771|11198057|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071283|NCT02175771|11198058|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071284|NCT02175771|11198059|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10071285|NCT02175771|11198051|FG000|STARTED|Treatment Period||0
10071286|NCT02175771|11198052|FG001|STARTED|Treatment Period||127
10071287|NCT02175771|11198053|FG002|STARTED|Treatment Period||42
10071288|NCT02175771|11198054|FG003|STARTED|Treatment Period||126
10071289|NCT02175771|11198055|FG004|STARTED|Treatment Period||41
10071290|NCT02175771|11198056|FG005|STARTED|Treatment Period||120
10071291|NCT02175771|11198057|FG006|STARTED|Treatment Period||41
10071292|NCT02175771|11198058|FG007|STARTED|Treatment Period||133
10071293|NCT02175771|11198059|FG008|STARTED|Treatment Period||44
10071294|NCT02175771|11198051|FG000|COMPLETED|Treatment Period||0
10071295|NCT02175771|11198052|FG001|COMPLETED|Treatment Period||111
10071296|NCT02175771|11198053|FG002|COMPLETED|Treatment Period||35
10071297|NCT02175771|11198054|FG003|COMPLETED|Treatment Period||113
10071298|NCT02175771|11198055|FG004|COMPLETED|Treatment Period||36
10071299|NCT02175771|11198056|FG005|COMPLETED|Treatment Period||110
10071300|NCT02175771|11198057|FG006|COMPLETED|Treatment Period||36
10071301|NCT02175771|11198058|FG007|COMPLETED|Treatment Period||116
10071302|NCT02175771|11198059|FG008|COMPLETED|Treatment Period||38
10071303|NCT02175771|11198051|FG000|NOT COMPLETED|Treatment Period||0
10071304|NCT02175771|11198052|FG001|NOT COMPLETED|Treatment Period||16
10071305|NCT02175771|11198053|FG002|NOT COMPLETED|Treatment Period||7
10071306|NCT02175771|11198054|FG003|NOT COMPLETED|Treatment Period||13
10071307|NCT02175771|11198055|FG004|NOT COMPLETED|Treatment Period||5
10071308|NCT02175771|11198056|FG005|NOT COMPLETED|Treatment Period||10
10071309|NCT02175771|11198057|FG006|NOT COMPLETED|Treatment Period||5
10071310|NCT02175771|11198058|FG007|NOT COMPLETED|Treatment Period||17
10071311|NCT02175771|11198059|FG008|NOT COMPLETED|Treatment Period||6
10071312|NCT02175966|11198079|FG000|STARTED|Treatment Period||14
10071313|NCT02175966|11198080|FG001|STARTED|Treatment Period||14
10071314|NCT02175966|11198079|FG000|COMPLETED|Treatment Period||14
10071315|NCT02175966|11198080|FG001|COMPLETED|Treatment Period||14
10071316|NCT02175966|11198079|FG000|NOT COMPLETED|Treatment Period||0
10071317|NCT02175966|11198080|FG001|NOT COMPLETED|Treatment Period||0
10071318|NCT02175966|11198079|FG000|STARTED|Follow-up Period||14
10071319|NCT02175966|11198080|FG001|STARTED|Follow-up Period||14
10071320|NCT02175966|11198079|FG000|COMPLETED|Follow-up Period||4
10071321|NCT02175966|11198080|FG001|COMPLETED|Follow-up Period||8
10071322|NCT02175966|11198079|FG000|NOT COMPLETED|Follow-up Period||10
10071323|NCT02175966|11198080|FG001|NOT COMPLETED|Follow-up Period||6
10071324|NCT02175979|11198088|FG000|STARTED|Overall Study||140
10071325|NCT02175979|11198089|FG001|STARTED|Overall Study||140
10071326|NCT02175979|11198088|FG000|COMPLETED|Overall Study||133
10071327|NCT02175979|11198089|FG001|COMPLETED|Overall Study||132
10071328|NCT02175979|11198088|FG000|NOT COMPLETED|Overall Study||7
10071329|NCT02175979|11198089|FG001|NOT COMPLETED|Overall Study||8
10071330|NCT02176005|11198099|FG000|STARTED|Overall Study||14
10071331|NCT02176005|11198100|FG001|STARTED|Overall Study||14
10071332|NCT02176005|11198101|FG002|STARTED|Overall Study||8
10071333|NCT02176005|11198102|FG003|STARTED|Overall Study||8
10071334|NCT02176005|11198099|FG000|COMPLETED|Overall Study||14
10071335|NCT02176005|11198100|FG001|COMPLETED|Overall Study||14
10071336|NCT02176005|11198101|FG002|COMPLETED|Overall Study||8
10071337|NCT02176005|11198102|FG003|COMPLETED|Overall Study||8
10071338|NCT02176005|11198099|FG000|NOT COMPLETED|Overall Study||0
10071339|NCT02176005|11198100|FG001|NOT COMPLETED|Overall Study||0
10071340|NCT02176005|11198101|FG002|NOT COMPLETED|Overall Study||0
10071341|NCT02176005|11198102|FG003|NOT COMPLETED|Overall Study||0
10071342|NCT02176018|11198114|FG000|STARTED|Overall Study||22
10071343|NCT02176018|11198115|FG001|STARTED|Overall Study||23
10071344|NCT02176018|11198114|FG000|COMPLETED|Overall Study||17
10071345|NCT02176018|11198115|FG001|COMPLETED|Overall Study||17
10071346|NCT02176018|11198114|FG000|NOT COMPLETED|Overall Study||5
10071347|NCT02176018|11198115|FG001|NOT COMPLETED|Overall Study||6
10071348|NCT02176031|11198121|FG000|STARTED|Overall Study||21
10071349|NCT02176031|11198121|FG000|COMPLETED|Overall Study||9
10071350|NCT02176031|11198121|FG000|NOT COMPLETED|Overall Study||12
10071351|NCT02176083|11198128|FG000|STARTED|Overall Study||11
10071352|NCT02176083|11198129|FG001|STARTED|Overall Study||27
10071353|NCT02176083|11198128|FG000|COMPLETED|Overall Study||11
10071354|NCT02176083|11198129|FG001|COMPLETED|Overall Study||27
10071355|NCT02176083|11198128|FG000|NOT COMPLETED|Overall Study||0
10071356|NCT02176083|11198129|FG001|NOT COMPLETED|Overall Study||0
10071357|NCT02176226|11198135|FG000|STARTED|Overall Study||105
10071358|NCT02176226|11198135|FG000|COMPLETED|Overall Study||96
10071359|NCT02176226|11198135|FG000|NOT COMPLETED|Overall Study||9
10071360|NCT02176291|11198141|FG000|STARTED|Overall Study||20
10071361|NCT02176291|11198142|FG001|STARTED|Overall Study||11
10071362|NCT02176291|11198141|FG000|COMPLETED|Overall Study||15
10071363|NCT02176291|11198142|FG001|COMPLETED|Overall Study||11
10071364|NCT02176291|11198141|FG000|NOT COMPLETED|Overall Study||5
10071365|NCT02176291|11198142|FG001|NOT COMPLETED|Overall Study||0
10071366|NCT02176343|11198148|FG000|STARTED|Overall Study||31
10071367|NCT02176343|11198148|FG000|COMPLETED|Overall Study||31
10071368|NCT02176343|11198148|FG000|NOT COMPLETED|Overall Study||0
10071369|NCT02176356|11198152|FG000|STARTED|Overall Study||116
10071370|NCT02176356|11198152|FG000|Eligible and Received Treatment|Overall Study||100
10071371|NCT02176356|11198152|FG000|COMPLETED|Overall Study||93
10071372|NCT02176356|11198152|FG000|NOT COMPLETED|Overall Study||23
10071373|NCT02176382|11198158|FG000|STARTED|DATA-HD Study||39
10071374|NCT02176382|11198159|FG001|STARTED|DATA-HD Study||37
10071375|NCT02176382|11198158|FG000|COMPLETED|DATA-HD Study||31
10071376|NCT02176382|11198159|FG001|COMPLETED|DATA-HD Study||29
10071377|NCT02176382|11198158|FG000|NOT COMPLETED|DATA-HD Study||8
10071378|NCT02176382|11198159|FG001|NOT COMPLETED|DATA-HD Study||8
10071379|NCT02176382|11198158|FG000|STARTED|DATA-HD Extension||27
10071380|NCT02176382|11198159|FG001|STARTED|DATA-HD Extension||26
10071381|NCT02176382|11198158|FG000|COMPLETED|DATA-HD Extension||26
10071382|NCT02176382|11198159|FG001|COMPLETED|DATA-HD Extension||26
10071383|NCT02176382|11198158|FG000|NOT COMPLETED|DATA-HD Extension||1
10071384|NCT02176382|11198159|FG001|NOT COMPLETED|DATA-HD Extension||0
10071385|NCT02176408|11198167|FG000|STARTED|Overall Study||15
10071386|NCT02176408|11198168|FG001|STARTED|Overall Study||16
10071387|NCT02176408|11198167|FG000|COMPLETED|Overall Study||9
10189773|NCT03286218|11319156|FG006|COMPLETED|Treatment Phase Period 2||6
10189774|NCT03286218|11319157|FG007|COMPLETED|Treatment Phase Period 2||6
10189775|NCT03286218|11319158|FG008|COMPLETED|Treatment Phase Period 2||6
10189776|NCT03286218|11319159|FG009|COMPLETED|Treatment Phase Period 2||6
10189777|NCT03286218|11319160|FG010|COMPLETED|Treatment Phase Period 2||5
10189778|NCT03286218|11319161|FG011|COMPLETED|Treatment Phase Period 2||5
10189779|NCT03286218|11319150|FG000|NOT COMPLETED|Treatment Phase Period 2||0
10189780|NCT03286218|11319151|FG001|NOT COMPLETED|Treatment Phase Period 2||0
10189781|NCT03286218|11319152|FG002|NOT COMPLETED|Treatment Phase Period 2||0
10189782|NCT03286218|11319153|FG003|NOT COMPLETED|Treatment Phase Period 2||0
10189783|NCT03286218|11319154|FG004|NOT COMPLETED|Treatment Phase Period 2||0
10189784|NCT03286218|11319155|FG005|NOT COMPLETED|Treatment Phase Period 2||0
10189785|NCT03286218|11319156|FG006|NOT COMPLETED|Treatment Phase Period 2||0
10189786|NCT03286218|11319157|FG007|NOT COMPLETED|Treatment Phase Period 2||0
10189787|NCT03286218|11319158|FG008|NOT COMPLETED|Treatment Phase Period 2||0
10189788|NCT03286218|11319159|FG009|NOT COMPLETED|Treatment Phase Period 2||0
10189789|NCT03286218|11319160|FG010|NOT COMPLETED|Treatment Phase Period 2||0
10189790|NCT03286218|11319161|FG011|NOT COMPLETED|Treatment Phase Period 2||0
10189791|NCT03286218|11319150|FG000|STARTED|Treatment Phase Period 3||0
10189792|NCT03286218|11319151|FG001|STARTED|Treatment Phase Period 3||0
10189793|NCT03286218|11319152|FG002|STARTED|Treatment Phase Period 3||5
10189794|NCT03286218|11319153|FG003|STARTED|Treatment Phase Period 3||5
10189795|NCT03286218|11319154|FG004|STARTED|Treatment Phase Period 3||5
10189796|NCT03286218|11319155|FG005|STARTED|Treatment Phase Period 3||5
10189797|NCT03286218|11319156|FG006|STARTED|Treatment Phase Period 3||6
10189798|NCT03286218|11319157|FG007|STARTED|Treatment Phase Period 3||6
10189799|NCT03286218|11319158|FG008|STARTED|Treatment Phase Period 3||6
10189800|NCT03286218|11319159|FG009|STARTED|Treatment Phase Period 3||6
10189801|NCT03286218|11319160|FG010|STARTED|Treatment Phase Period 3||5
10189802|NCT03286218|11319161|FG011|STARTED|Treatment Phase Period 3||5
10189803|NCT03286218|11319150|FG000|COMPLETED|Treatment Phase Period 3||0
10189804|NCT03286218|11319151|FG001|COMPLETED|Treatment Phase Period 3||0
10189805|NCT03286218|11319152|FG002|COMPLETED|Treatment Phase Period 3||5
10189806|NCT03286218|11319153|FG003|COMPLETED|Treatment Phase Period 3||5
10189807|NCT03286218|11319154|FG004|COMPLETED|Treatment Phase Period 3||5
10189808|NCT03286218|11319155|FG005|COMPLETED|Treatment Phase Period 3||5
10189809|NCT03286218|11319156|FG006|COMPLETED|Treatment Phase Period 3||6
10189810|NCT03286218|11319157|FG007|COMPLETED|Treatment Phase Period 3||6
10189811|NCT03286218|11319158|FG008|COMPLETED|Treatment Phase Period 3||6
10189812|NCT03286218|11319159|FG009|COMPLETED|Treatment Phase Period 3||6
10189813|NCT03286218|11319160|FG010|COMPLETED|Treatment Phase Period 3||5
10189814|NCT03286218|11319161|FG011|COMPLETED|Treatment Phase Period 3||5
10189815|NCT03286218|11319150|FG000|NOT COMPLETED|Treatment Phase Period 3||0
10189816|NCT03286218|11319151|FG001|NOT COMPLETED|Treatment Phase Period 3||0
10189817|NCT03286218|11319152|FG002|NOT COMPLETED|Treatment Phase Period 3||0
10189818|NCT03286218|11319153|FG003|NOT COMPLETED|Treatment Phase Period 3||0
10189819|NCT03286218|11319154|FG004|NOT COMPLETED|Treatment Phase Period 3||0
10189820|NCT03286218|11319155|FG005|NOT COMPLETED|Treatment Phase Period 3||0
10189821|NCT03286218|11319156|FG006|NOT COMPLETED|Treatment Phase Period 3||0
10189822|NCT03286218|11319157|FG007|NOT COMPLETED|Treatment Phase Period 3||0
10189823|NCT03286218|11319158|FG008|NOT COMPLETED|Treatment Phase Period 3||0
10189824|NCT03286218|11319159|FG009|NOT COMPLETED|Treatment Phase Period 3||0
10189825|NCT03286218|11319160|FG010|NOT COMPLETED|Treatment Phase Period 3||0
10071388|NCT02176408|11198168|FG001|COMPLETED|Overall Study||12
10071389|NCT02176408|11198167|FG000|NOT COMPLETED|Overall Study||6
10189826|NCT03286218|11319161|FG011|NOT COMPLETED|Treatment Phase Period 3||0
10189827|NCT03286218|11319150|FG000|STARTED|Treatment Phase Period 4||0
10189828|NCT03286218|11319151|FG001|STARTED|Treatment Phase Period 4||0
10189829|NCT03286218|11319152|FG002|STARTED|Treatment Phase Period 4||5
10189830|NCT03286218|11319153|FG003|STARTED|Treatment Phase Period 4||5
10189831|NCT03286218|11319154|FG004|STARTED|Treatment Phase Period 4||5
10071390|NCT02176408|11198168|FG001|NOT COMPLETED|Overall Study||4
10071391|NCT02176421|11198174|FG000|STARTED|Overall Study||80
10071392|NCT02176421|11198174|FG000|COMPLETED|Overall Study||75
10071393|NCT02176421|11198174|FG000|NOT COMPLETED|Overall Study||5
10071394|NCT02176486|11198181|FG000|STARTED|Overall Study||3
10071395|NCT02176486|11198182|FG001|STARTED|Overall Study||5
10071396|NCT02176486|11198183|FG002|STARTED|Overall Study||4
10071397|NCT02176486|11198181|FG000|COMPLETED|Overall Study||3
10071398|NCT02176486|11198182|FG001|COMPLETED|Overall Study||5
10071399|NCT02176486|11198183|FG002|COMPLETED|Overall Study||4
10071400|NCT02176486|11198181|FG000|NOT COMPLETED|Overall Study||0
10071401|NCT02176486|11198182|FG001|NOT COMPLETED|Overall Study||0
10071402|NCT02176486|11198183|FG002|NOT COMPLETED|Overall Study||0
10071403|NCT02176525|11198201|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
10071404|NCT02176525|11198202|FG001|STARTED|Overall Study||9
10071405|NCT02176525|11198203|FG002|STARTED|Overall Study||9
10071406|NCT02176525|11198204|FG003|STARTED|Overall Study||9
10071407|NCT02176525|11198205|FG004|STARTED|Overall Study||8
10071408|NCT02176525|11198206|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
10071409|NCT02176525|11198207|FG006|STARTED|Overall Study||9
10071410|NCT02176525|11198208|FG007|STARTED|Overall Study||10
10071411|NCT02176525|11198201|FG000|COMPLETED|Overall Study||14
10071412|NCT02176525|11198202|FG001|COMPLETED|Overall Study||9
10071413|NCT02176525|11198203|FG002|COMPLETED|Overall Study||9
10071414|NCT02176525|11198204|FG003|COMPLETED|Overall Study||8
10071415|NCT02176525|11198205|FG004|COMPLETED|Overall Study||7
10071416|NCT02176525|11198206|FG005|COMPLETED|Overall Study||5
10071417|NCT02176525|11198207|FG006|COMPLETED|Overall Study||8
10071418|NCT02176525|11198208|FG007|COMPLETED|Overall Study||10
10071419|NCT02176525|11198201|FG000|NOT COMPLETED|Overall Study||1
10071420|NCT02176525|11198202|FG001|NOT COMPLETED|Overall Study||0
10071421|NCT02176525|11198203|FG002|NOT COMPLETED|Overall Study||0
10071422|NCT02176525|11198204|FG003|NOT COMPLETED|Overall Study||1
10071423|NCT02176525|11198205|FG004|NOT COMPLETED|Overall Study||1
10071424|NCT02176525|11198206|FG005|NOT COMPLETED|Overall Study||1
10071425|NCT02176525|11198207|FG006|NOT COMPLETED|Overall Study||1
10071426|NCT02176525|11198208|FG007|NOT COMPLETED|Overall Study||0
10071427|NCT02176642|11198236|FG000|STARTED|Overall Study||18
10071428|NCT02176642|11198237|FG001|STARTED|Overall Study||17
10071429|NCT02176642|11198236|FG000|COMPLETED|Overall Study||18
10071430|NCT02176642|11198237|FG001|COMPLETED|Overall Study||16
10071431|NCT02176642|11198236|FG000|NOT COMPLETED|Overall Study||0
10071432|NCT02176642|11198237|FG001|NOT COMPLETED|Overall Study||1
10071433|NCT02176655|11198243|FG000|STARTED|Overall Study||31
10071434|NCT02176655|11198243|FG000|COMPLETED|Overall Study||25
10071435|NCT02176655|11198243|FG000|NOT COMPLETED|Overall Study||6
10071436|NCT02176837|11198248|FG000|STARTED|Overall Study||6
10071437|NCT02176837|11198248|FG000|COMPLETED|Overall Study||0
10071438|NCT02176837|11198248|FG000|NOT COMPLETED|Overall Study||6
10071439|NCT02176928|11198254|FG000|STARTED|Overall Study||21
10071440|NCT02176928|11198255|FG001|STARTED|Overall Study||21
10071441|NCT02176928|11198254|FG000|COMPLETED|Overall Study||19
10071442|NCT02176928|11198255|FG001|COMPLETED|Overall Study||17
10071443|NCT02176928|11198254|FG000|NOT COMPLETED|Overall Study||2
10071444|NCT02176928|11198255|FG001|NOT COMPLETED|Overall Study||4
10071445|NCT02177032|11198265|FG000|STARTED|Overall Study||355
10071446|NCT02177032|11198266|FG001|STARTED|Overall Study||88
10071447|NCT02177032|11198267|FG002|STARTED|Overall Study||354
10071448|NCT02177032|11198268|FG003|STARTED|Overall Study||88
10071449|NCT02177032|11198265|FG000|COMPLETED|Overall Study||350
10071450|NCT02177032|11198266|FG001|COMPLETED|Overall Study||86
10071451|NCT02177032|11198267|FG002|COMPLETED|Overall Study||351
10071452|NCT02177032|11198268|FG003|COMPLETED|Overall Study||88
10071453|NCT02177032|11198265|FG000|NOT COMPLETED|Overall Study||5
10071454|NCT02177032|11198266|FG001|NOT COMPLETED|Overall Study||2
10071455|NCT02177032|11198267|FG002|NOT COMPLETED|Overall Study||3
10071456|NCT02177032|11198268|FG003|NOT COMPLETED|Overall Study||0
10071457|NCT02177123|11198289|FG000|STARTED|Overall Study||107
10071458|NCT02177123|11198289|FG000|COMPLETED|Overall Study||83
10071459|NCT02177123|11198289|FG000|NOT COMPLETED|Overall Study||24
10071460|NCT02177136|11198299|FG000|STARTED|DB Phase||26
10071461|NCT02177136|11198300|FG001|STARTED|DB Phase||26
10071462|NCT02177136|11198301|FG002|STARTED|DB Phase||25
10071463|NCT02177136|11198302|FG003|STARTED|DB Phase||0
10071464|NCT02177136|11198299|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
10071465|NCT02177136|11198300|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26
10071466|NCT02177136|11198301|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25
10071467|NCT02177136|11198302|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0
10071468|NCT02177136|11198299|FG000|COMPLETED|DB Phase||19
10071469|NCT02177136|11198300|FG001|COMPLETED|DB Phase||21
10071470|NCT02177136|11198301|FG002|COMPLETED|DB Phase||21
10071471|NCT02177136|11198302|FG003|COMPLETED|DB Phase||0
10071472|NCT02177136|11198299|FG000|NOT COMPLETED|DB Phase||7
10071473|NCT02177136|11198300|FG001|NOT COMPLETED|DB Phase||5
10071474|NCT02177136|11198301|FG002|NOT COMPLETED|DB Phase||4
10071475|NCT02177136|11198302|FG003|NOT COMPLETED|DB Phase||0
10071476|NCT02177136|11198299|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
10071477|NCT02177136|11198300|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
10071478|NCT02177136|11198301|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
10189832|NCT03286218|11319155|FG005|STARTED|Treatment Phase Period 4||5
10071479|NCT02177136|11198302|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
10071480|NCT02177136|11198299|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
10071481|NCT02177136|11198300|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
10071482|NCT02177136|11198301|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
10071483|NCT02177136|11198302|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
10071484|NCT02177136|11198299|FG000|COMPLETED|LTSE Phase||0
10071485|NCT02177136|11198300|FG001|COMPLETED|LTSE Phase||0
10071486|NCT02177136|11198301|FG002|COMPLETED|LTSE Phase||0
10071487|NCT02177136|11198302|FG003|COMPLETED|LTSE Phase||35
10071488|NCT02177136|11198299|FG000|NOT COMPLETED|LTSE Phase||0
10071489|NCT02177136|11198300|FG001|NOT COMPLETED|LTSE Phase||0
10071490|NCT02177136|11198301|FG002|NOT COMPLETED|LTSE Phase||0
10071491|NCT02177136|11198302|FG003|NOT COMPLETED|LTSE Phase||24
10071492|NCT02177201|11198315|FG000|STARTED|Overall Study||80
10071493|NCT02177201|11198316|FG001|STARTED|Overall Study||80
10071494|NCT02177201|11198315|FG000|COMPLETED|Overall Study||77
10071495|NCT02177201|11198316|FG001|COMPLETED|Overall Study||77
10071496|NCT02177201|11198315|FG000|NOT COMPLETED|Overall Study||3
10071497|NCT02177201|11198316|FG001|NOT COMPLETED|Overall Study||3
10071498|NCT02177786|11198326|FG000|STARTED|Overall Study||81
10071499|NCT02177786|11198327|FG001|STARTED|Overall Study||84
10071500|NCT02177786|11198328|FG002|STARTED|Overall Study||84
10071501|NCT02177786|11198329|FG003|STARTED|Overall Study||85
10071502|NCT02177786|11198326|FG000|Randomized and Treated|Overall Study||81
10071503|NCT02177786|11198327|FG001|Randomized and Treated|Overall Study||84
10071504|NCT02177786|11198328|FG002|Randomized and Treated|Overall Study||83
10071505|NCT02177786|11198329|FG003|Randomized and Treated|Overall Study||85
10071506|NCT02177786|11198326|FG000|COMPLETED|Overall Study||75
10071507|NCT02177786|11198327|FG001|COMPLETED|Overall Study||70
10071508|NCT02177786|11198328|FG002|COMPLETED|Overall Study||66
10071509|NCT02177786|11198329|FG003|COMPLETED|Overall Study||72
10071510|NCT02177786|11198326|FG000|NOT COMPLETED|Overall Study||6
10071511|NCT02177786|11198327|FG001|NOT COMPLETED|Overall Study||14
10071512|NCT02177786|11198328|FG002|NOT COMPLETED|Overall Study||18
10071513|NCT02177786|11198329|FG003|NOT COMPLETED|Overall Study||13
10071514|NCT02177812|11198348|FG000|STARTED|Part 1 (Median of 4 Weeks)||1
10071515|NCT02177812|11198349|FG001|STARTED|Part 1 (Median of 4 Weeks)||2
10071516|NCT02177812|11198350|FG002|STARTED|Part 1 (Median of 4 Weeks)||7
10071517|NCT02177812|11198351|FG003|STARTED|Part 1 (Median of 4 Weeks)||5
10071518|NCT02177812|11198352|FG004|STARTED|Part 1 (Median of 4 Weeks)||6
10071519|NCT02177812|11198353|FG005|STARTED|Part 1 (Median of 4 Weeks)||4
10071520|NCT02177812|11198354|FG006|STARTED|Part 1 (Median of 4 Weeks)||10
9850721|NCT00871871|10963426|FG002|COMPLETED|Part I||0
9850722|NCT00871871|10963427|FG003|COMPLETED|Part I||0
9850723|NCT00871871|10963424|FG000|NOT COMPLETED|Part I||3
9850724|NCT00871871|10963425|FG001|NOT COMPLETED|Part I||3
9850725|NCT00871871|10963426|FG002|NOT COMPLETED|Part I||0
9850726|NCT00871871|10963427|FG003|NOT COMPLETED|Part I||0
10071521|NCT02177812|11198355|FG007|STARTED|Part 1 (Median of 4 Weeks)||6
10071522|NCT02177812|11198356|FG008|STARTED|Part 1 (Median of 4 Weeks)||0
10071523|NCT02177812|11198348|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1
10071524|NCT02177812|11198349|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2
10071525|NCT02177812|11198350|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7
10071526|NCT02177812|11198351|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4
10071527|NCT02177812|11198352|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5
10071528|NCT02177812|11198353|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1
10071529|NCT02177812|11198354|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1
10189833|NCT03286218|11319156|FG006|STARTED|Treatment Phase Period 4||6
10189834|NCT03286218|11319157|FG007|STARTED|Treatment Phase Period 4||6
10189835|NCT03286218|11319158|FG008|STARTED|Treatment Phase Period 4||6
10189836|NCT03286218|11319159|FG009|STARTED|Treatment Phase Period 4||6
10189837|NCT03286218|11319160|FG010|STARTED|Treatment Phase Period 4||5
10189838|NCT03286218|11319161|FG011|STARTED|Treatment Phase Period 4||5
10189839|NCT03286218|11319150|FG000|COMPLETED|Treatment Phase Period 4||0
10189840|NCT03286218|11319151|FG001|COMPLETED|Treatment Phase Period 4||0
10189841|NCT03286218|11319152|FG002|COMPLETED|Treatment Phase Period 4||5
10189842|NCT03286218|11319153|FG003|COMPLETED|Treatment Phase Period 4||5
10189843|NCT03286218|11319154|FG004|COMPLETED|Treatment Phase Period 4||5
10189844|NCT03286218|11319155|FG005|COMPLETED|Treatment Phase Period 4||5
10189845|NCT03286218|11319156|FG006|COMPLETED|Treatment Phase Period 4||6
10189846|NCT03286218|11319157|FG007|COMPLETED|Treatment Phase Period 4||6
10189847|NCT03286218|11319158|FG008|COMPLETED|Treatment Phase Period 4||6
10189848|NCT03286218|11319159|FG009|COMPLETED|Treatment Phase Period 4||6
10189849|NCT03286218|11319160|FG010|COMPLETED|Treatment Phase Period 4||5
10189850|NCT03286218|11319161|FG011|COMPLETED|Treatment Phase Period 4||4
10189851|NCT03286218|11319150|FG000|NOT COMPLETED|Treatment Phase Period 4||0
10189852|NCT03286218|11319151|FG001|NOT COMPLETED|Treatment Phase Period 4||0
10189853|NCT03286218|11319152|FG002|NOT COMPLETED|Treatment Phase Period 4||0
10189854|NCT03286218|11319153|FG003|NOT COMPLETED|Treatment Phase Period 4||0
9850727|NCT00871871|10963424|FG000|STARTED|Part II||0
9850728|NCT00871871|10963425|FG001|STARTED|Part II||0
10071530|NCT02177812|11198355|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4
10071531|NCT02177812|11198356|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0
10189855|NCT03286218|11319154|FG004|NOT COMPLETED|Treatment Phase Period 4||0
10189856|NCT03286218|11319155|FG005|NOT COMPLETED|Treatment Phase Period 4||0
10071532|NCT02177812|11198348|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10071533|NCT02177812|11198349|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10071534|NCT02177812|11198350|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10071535|NCT02177812|11198351|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
10071536|NCT02177812|11198352|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
10071537|NCT02177812|11198353|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
10071538|NCT02177812|11198354|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
10071539|NCT02177812|11198355|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
10071540|NCT02177812|11198356|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10071541|NCT02177812|11198348|FG000|STARTED|Part 2 (Up to 14 Months)||0
10071542|NCT02177812|11198349|FG001|STARTED|Part 2 (Up to 14 Months)||0
10071543|NCT02177812|11198350|FG002|STARTED|Part 2 (Up to 14 Months)||0
10071544|NCT02177812|11198351|FG003|STARTED|Part 2 (Up to 14 Months)||0
10071545|NCT02177812|11198352|FG004|STARTED|Part 2 (Up to 14 Months)||0
10071546|NCT02177812|11198353|FG005|STARTED|Part 2 (Up to 14 Months)||0
10071547|NCT02177812|11198354|FG006|STARTED|Part 2 (Up to 14 Months)||0
10071548|NCT02177812|11198355|FG007|STARTED|Part 2 (Up to 14 Months)||0
10071549|NCT02177812|11198356|FG008|STARTED|Part 2 (Up to 14 Months)||0
10071550|NCT02177812|11198348|FG000|COMPLETED|Part 2 (Up to 14 Months)||0
10071551|NCT02177812|11198349|FG001|COMPLETED|Part 2 (Up to 14 Months)||0
10071552|NCT02177812|11198350|FG002|COMPLETED|Part 2 (Up to 14 Months)||0
10071553|NCT02177812|11198351|FG003|COMPLETED|Part 2 (Up to 14 Months)||0
10071554|NCT02177812|11198352|FG004|COMPLETED|Part 2 (Up to 14 Months)||0
10071555|NCT02177812|11198353|FG005|COMPLETED|Part 2 (Up to 14 Months)||0
10071556|NCT02177812|11198354|FG006|COMPLETED|Part 2 (Up to 14 Months)||0
10071557|NCT02177812|11198355|FG007|COMPLETED|Part 2 (Up to 14 Months)||0
10071558|NCT02177812|11198356|FG008|COMPLETED|Part 2 (Up to 14 Months)||0
10071559|NCT02177812|11198348|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071560|NCT02177812|11198349|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071561|NCT02177812|11198350|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071562|NCT02177812|11198351|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071563|NCT02177812|11198352|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071564|NCT02177812|11198353|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071565|NCT02177812|11198354|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071566|NCT02177812|11198355|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071567|NCT02177812|11198356|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10071568|NCT02177838|11198385|FG000|STARTED|Overall Study||8
10071569|NCT02177838|11198385|FG000|COMPLETED|Overall Study||5
10071570|NCT02177838|11198385|FG000|NOT COMPLETED|Overall Study||3
10071571|NCT02177942|11198391|FG000|STARTED|Overall Study||262
10071572|NCT02177942|11198392|FG001|STARTED|Overall Study||266
10071573|NCT02177942|11198391|FG000|COMPLETED|Overall Study||185
10071574|NCT02177942|11198392|FG001|COMPLETED|Overall Study||178
10071575|NCT02177942|11198391|FG000|NOT COMPLETED|Overall Study||77
10071576|NCT02177942|11198392|FG001|NOT COMPLETED|Overall Study||88
10071577|NCT02178059|11198402|FG000|STARTED|First Intervention||17
10071578|NCT02178059|11198403|FG001|STARTED|First Intervention||17
10071579|NCT02178059|11198402|FG000|COMPLETED|First Intervention||17
10071580|NCT02178059|11198403|FG001|COMPLETED|First Intervention||17
10071581|NCT02178059|11198402|FG000|NOT COMPLETED|First Intervention||0
10071582|NCT02178059|11198403|FG001|NOT COMPLETED|First Intervention||0
10071583|NCT02178059|11198402|FG000|STARTED|Washout||17
10071584|NCT02178059|11198403|FG001|STARTED|Washout||17
10071585|NCT02178059|11198402|FG000|COMPLETED|Washout||16
10071586|NCT02178059|11198403|FG001|COMPLETED|Washout||17
10071587|NCT02178059|11198402|FG000|NOT COMPLETED|Washout||1
10071588|NCT02178059|11198403|FG001|NOT COMPLETED|Washout||0
10071589|NCT02178059|11198402|FG000|STARTED|Second Intervention||16
10071590|NCT02178059|11198403|FG001|STARTED|Second Intervention||17
10071591|NCT02178059|11198402|FG000|COMPLETED|Second Intervention||16
10071592|NCT02178059|11198403|FG001|COMPLETED|Second Intervention||17
10071593|NCT02178059|11198402|FG000|NOT COMPLETED|Second Intervention||0
10071594|NCT02178059|11198403|FG001|NOT COMPLETED|Second Intervention||0
10071595|NCT02178241|11198409|FG000|STARTED|Overall Study||24
10071596|NCT02178241|11198409|FG000|COMPLETED|Overall Study||24
10071597|NCT02178241|11198409|FG000|NOT COMPLETED|Overall Study||0
10071598|NCT02178475|11198413|FG000|STARTED|Overall Study||943
10071599|NCT02178475|11198413|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
10071600|NCT02178475|11198413|FG000|COMPLETED|Overall Study||814
10071601|NCT02178475|11198413|FG000|NOT COMPLETED|Overall Study||129
10071602|NCT02178540|11198417|FG000|STARTED|Overall Study||45
10071603|NCT02178540|11198417|FG000|COMPLETED|Overall Study||45
10071604|NCT02178540|11198417|FG000|NOT COMPLETED|Overall Study||0
10071605|NCT02178553|11198426|FG000|STARTED|Overall Study||53
10071606|NCT02178553|11198427|FG001|STARTED|Overall Study||49
10071607|NCT02178553|11198426|FG000|COMPLETED|Overall Study||45
10071608|NCT02178553|11198427|FG001|COMPLETED|Overall Study||39
10071609|NCT02178553|11198426|FG000|NOT COMPLETED|Overall Study||8
10189857|NCT03286218|11319156|FG006|NOT COMPLETED|Treatment Phase Period 4||0
10189858|NCT03286218|11319157|FG007|NOT COMPLETED|Treatment Phase Period 4||0
10189859|NCT03286218|11319158|FG008|NOT COMPLETED|Treatment Phase Period 4||0
10189860|NCT03286218|11319159|FG009|NOT COMPLETED|Treatment Phase Period 4||0
10189861|NCT03286218|11319160|FG010|NOT COMPLETED|Treatment Phase Period 4||0
10189862|NCT03286218|11319161|FG011|NOT COMPLETED|Treatment Phase Period 4||1
10189863|NCT03286218|11319150|FG000|STARTED|Treatment Phase Period 5||0
10189864|NCT03286218|11319151|FG001|STARTED|Treatment Phase Period 5||0
10071610|NCT02178553|11198427|FG001|NOT COMPLETED|Overall Study||10
10071611|NCT02178592|11198435|FG000|STARTED|Randomized Phase (Up to Week 52)||69
10071612|NCT02178592|11198436|FG001|STARTED|Randomized Phase (Up to Week 52)||44
10071613|NCT02178592|11198435|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50
10071614|NCT02178592|11198436|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35
10071615|NCT02178592|11198435|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
10071616|NCT02178592|11198436|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
10071617|NCT02178592|11198435|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
10071618|NCT02178592|11198436|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
10071619|NCT02178592|11198435|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35
10071620|NCT02178592|11198436|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16
10071621|NCT02178592|11198435|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
10071622|NCT02178592|11198436|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
10071623|NCT02178696|11198445|FG000|STARTED|First Assignment and Washout||20
10071624|NCT02178696|11198446|FG001|STARTED|First Assignment and Washout||20
10071625|NCT02178696|11198445|FG000|COMPLETED|First Assignment and Washout||20
10071626|NCT02178696|11198446|FG001|COMPLETED|First Assignment and Washout||20
10071627|NCT02178696|11198445|FG000|NOT COMPLETED|First Assignment and Washout||0
10189865|NCT03286218|11319152|FG002|STARTED|Treatment Phase Period 5||5
10189866|NCT03286218|11319153|FG003|STARTED|Treatment Phase Period 5||5
10189867|NCT03286218|11319154|FG004|STARTED|Treatment Phase Period 5||5
10189868|NCT03286218|11319155|FG005|STARTED|Treatment Phase Period 5||5
10189869|NCT03286218|11319156|FG006|STARTED|Treatment Phase Period 5||6
10189870|NCT03286218|11319157|FG007|STARTED|Treatment Phase Period 5||6
10189871|NCT03286218|11319158|FG008|STARTED|Treatment Phase Period 5||6
10189872|NCT03286218|11319159|FG009|STARTED|Treatment Phase Period 5||6
10189873|NCT03286218|11319160|FG010|STARTED|Treatment Phase Period 5||5
10189874|NCT03286218|11319161|FG011|STARTED|Treatment Phase Period 5||4
10189875|NCT03286218|11319150|FG000|COMPLETED|Treatment Phase Period 5||0
10189876|NCT03286218|11319151|FG001|COMPLETED|Treatment Phase Period 5||0
10189877|NCT03286218|11319152|FG002|COMPLETED|Treatment Phase Period 5||5
10189878|NCT03286218|11319153|FG003|COMPLETED|Treatment Phase Period 5||5
10189879|NCT03286218|11319154|FG004|COMPLETED|Treatment Phase Period 5||5
10189880|NCT03286218|11319155|FG005|COMPLETED|Treatment Phase Period 5||5
10189881|NCT03286218|11319156|FG006|COMPLETED|Treatment Phase Period 5||6
10189882|NCT03286218|11319157|FG007|COMPLETED|Treatment Phase Period 5||6
10189883|NCT03286218|11319158|FG008|COMPLETED|Treatment Phase Period 5||6
10189884|NCT03286218|11319159|FG009|COMPLETED|Treatment Phase Period 5||6
10189885|NCT03286218|11319160|FG010|COMPLETED|Treatment Phase Period 5||5
10189886|NCT03286218|11319161|FG011|COMPLETED|Treatment Phase Period 5||4
10189887|NCT03286218|11319150|FG000|NOT COMPLETED|Treatment Phase Period 5||0
10189888|NCT03286218|11319151|FG001|NOT COMPLETED|Treatment Phase Period 5||0
10189889|NCT03286218|11319152|FG002|NOT COMPLETED|Treatment Phase Period 5||0
10189890|NCT03286218|11319153|FG003|NOT COMPLETED|Treatment Phase Period 5||0
10189891|NCT03286218|11319154|FG004|NOT COMPLETED|Treatment Phase Period 5||0
10189892|NCT03286218|11319155|FG005|NOT COMPLETED|Treatment Phase Period 5||0
10189893|NCT03286218|11319156|FG006|NOT COMPLETED|Treatment Phase Period 5||0
10189894|NCT03286218|11319157|FG007|NOT COMPLETED|Treatment Phase Period 5||0
10189895|NCT03286218|11319158|FG008|NOT COMPLETED|Treatment Phase Period 5||0
10189896|NCT03286218|11319159|FG009|NOT COMPLETED|Treatment Phase Period 5||0
10189897|NCT03286218|11319160|FG010|NOT COMPLETED|Treatment Phase Period 5||0
10189898|NCT03286218|11319161|FG011|NOT COMPLETED|Treatment Phase Period 5||0
10189899|NCT03286283|11319188|FG000|STARTED|Overall Study||55
10189900|NCT03286283|11319188|FG000|COMPLETED|Overall Study||55
10189901|NCT03286283|11319188|FG000|NOT COMPLETED|Overall Study||0
10189902|NCT03286400|11319192|FG000|STARTED|Overall Study||127
10189903|NCT03286400|11319192|FG000|COMPLETED|Overall Study||102
10189904|NCT03286400|11319192|FG000|NOT COMPLETED|Overall Study||25
10189905|NCT03286465|11319198|FG000|STARTED|Overall Study||100
10189906|NCT03286465|11319199|FG001|STARTED|Overall Study||100
10071628|NCT02178696|11198446|FG001|NOT COMPLETED|First Assignment and Washout||0
10071629|NCT02178696|11198445|FG000|STARTED|Second Assignment After Crossover||20
10071630|NCT02178696|11198446|FG001|STARTED|Second Assignment After Crossover||20
10071631|NCT02178696|11198445|FG000|COMPLETED|Second Assignment After Crossover||20
10071632|NCT02178696|11198446|FG001|COMPLETED|Second Assignment After Crossover||20
10071633|NCT02178696|11198445|FG000|NOT COMPLETED|Second Assignment After Crossover||0
10071634|NCT02178696|11198446|FG001|NOT COMPLETED|Second Assignment After Crossover||0
10071635|NCT02178696|11198445|FG000|STARTED|Open-label Antidepressant||20
10071636|NCT02178696|11198446|FG001|STARTED|Open-label Antidepressant||20
10071637|NCT02178696|11198445|FG000|COMPLETED|Open-label Antidepressant||14
10071638|NCT02178696|11198446|FG001|COMPLETED|Open-label Antidepressant||13
10071639|NCT02178696|11198445|FG000|NOT COMPLETED|Open-label Antidepressant||6
10071640|NCT02178696|11198446|FG001|NOT COMPLETED|Open-label Antidepressant||7
10071641|NCT02178787|11198459|FG000|STARTED|Overall Study||35
10071642|NCT02178787|11198460|FG001|STARTED|Overall Study||39
10071643|NCT02178787|11198459|FG000|COMPLETED|Overall Study||30
10071644|NCT02178787|11198460|FG001|COMPLETED|Overall Study||30
10071645|NCT02178787|11198459|FG000|NOT COMPLETED|Overall Study||5
10071646|NCT02178787|11198460|FG001|NOT COMPLETED|Overall Study||9
10071647|NCT02178800|11198470|FG000|STARTED|Overall Study||151
10071648|NCT02178800|11198471|FG001|STARTED|Overall Study||48
10071649|NCT02178800|11198470|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
10071650|NCT02178800|11198471|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
10071651|NCT02178800|11198470|FG000|NOT COMPLETED|Overall Study||20
10071652|NCT02178800|11198471|FG001|NOT COMPLETED|Overall Study||6
10071653|NCT02178995|11198487|FG000|STARTED|Double Blind||0
10071654|NCT02178995|11198488|FG001|STARTED|Double Blind||16
10071655|NCT02178995|11198489|FG002|STARTED|Double Blind||5
10071656|NCT02178995|11198490|FG003|STARTED|Double Blind||6
10071657|NCT02178995|11198491|FG004|STARTED|Double Blind||6
10071658|NCT02178995|11198492|FG005|STARTED|Double Blind||6
10071659|NCT02178995|11198493|FG006|STARTED|Double Blind||5
10071660|NCT02178995|11198494|FG007|STARTED|Double Blind||6
10071661|NCT02178995|11198495|FG008|STARTED|Double Blind||1
10071662|NCT02178995|11198487|FG000|COMPLETED|Double Blind||0
10071663|NCT02178995|11198488|FG001|COMPLETED|Double Blind||15
10071664|NCT02178995|11198489|FG002|COMPLETED|Double Blind||5
10071665|NCT02178995|11198490|FG003|COMPLETED|Double Blind||6
10071666|NCT02178995|11198491|FG004|COMPLETED|Double Blind||6
10071667|NCT02178995|11198492|FG005|COMPLETED|Double Blind||5
10071668|NCT02178995|11198493|FG006|COMPLETED|Double Blind||5
10071669|NCT02178995|11198494|FG007|COMPLETED|Double Blind||4
10071670|NCT02178995|11198495|FG008|COMPLETED|Double Blind||0
10071671|NCT02178995|11198487|FG000|NOT COMPLETED|Double Blind||0
10071672|NCT02178995|11198488|FG001|NOT COMPLETED|Double Blind||1
10071673|NCT02178995|11198489|FG002|NOT COMPLETED|Double Blind||0
10071674|NCT02178995|11198490|FG003|NOT COMPLETED|Double Blind||0
10071675|NCT02178995|11198491|FG004|NOT COMPLETED|Double Blind||0
10071676|NCT02178995|11198492|FG005|NOT COMPLETED|Double Blind||1
10071677|NCT02178995|11198493|FG006|NOT COMPLETED|Double Blind||0
10071678|NCT02178995|11198494|FG007|NOT COMPLETED|Double Blind||2
10071679|NCT02178995|11198495|FG008|NOT COMPLETED|Double Blind||1
10071680|NCT02178995|11198487|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
10071681|NCT02178995|11198488|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
10071682|NCT02178995|11198489|FG002|STARTED|Open Label||0
10071683|NCT02178995|11198490|FG003|STARTED|Open Label||0
10071684|NCT02178995|11198491|FG004|STARTED|Open Label||0
10071685|NCT02178995|11198492|FG005|STARTED|Open Label||0
10071686|NCT02178995|11198493|FG006|STARTED|Open Label||0
10071687|NCT02178995|11198494|FG007|STARTED|Open Label||0
10071688|NCT02178995|11198495|FG008|STARTED|Open Label||0
10071689|NCT02178995|11198487|FG000|COMPLETED|Open Label||28
10071690|NCT02178995|11198488|FG001|COMPLETED|Open Label||14
10071691|NCT02178995|11198489|FG002|COMPLETED|Open Label||0
10071692|NCT02178995|11198490|FG003|COMPLETED|Open Label||0
10071693|NCT02178995|11198491|FG004|COMPLETED|Open Label||0
10071694|NCT02178995|11198492|FG005|COMPLETED|Open Label||0
10071695|NCT02178995|11198493|FG006|COMPLETED|Open Label||0
10071696|NCT02178995|11198494|FG007|COMPLETED|Open Label||0
10071697|NCT02178995|11198495|FG008|COMPLETED|Open Label||0
10071698|NCT02178995|11198487|FG000|NOT COMPLETED|Open Label||2
10071699|NCT02178995|11198488|FG001|NOT COMPLETED|Open Label||0
10071700|NCT02178995|11198489|FG002|NOT COMPLETED|Open Label||0
10071701|NCT02178995|11198490|FG003|NOT COMPLETED|Open Label||0
10071702|NCT02178995|11198491|FG004|NOT COMPLETED|Open Label||0
10071703|NCT02178995|11198492|FG005|NOT COMPLETED|Open Label||0
10071704|NCT02178995|11198493|FG006|NOT COMPLETED|Open Label||0
10071705|NCT02178995|11198494|FG007|NOT COMPLETED|Open Label||0
10071706|NCT02178995|11198495|FG008|NOT COMPLETED|Open Label||0
10189907|NCT03286465|11319198|FG000|COMPLETED|Overall Study||100
10189908|NCT03286465|11319199|FG001|COMPLETED|Overall Study||100
10189909|NCT03286465|11319198|FG000|NOT COMPLETED|Overall Study||0
10189910|NCT03286465|11319199|FG001|NOT COMPLETED|Overall Study||0
10189911|NCT03286543|11319207|FG000|STARTED|Consented||47
10189912|NCT03286543|11319208|FG001|STARTED|Consented||0
10189913|NCT03286543|11319209|FG002|STARTED|Consented||0
10189914|NCT03286543|11319207|FG000|Randomized|Consented||45
10189915|NCT03286543|11319208|FG001|Randomized|Consented||0
10189916|NCT03286543|11319209|FG002|Randomized|Consented||0
10189917|NCT03286543|11319207|FG000|Enrolled|Consented||41
10071707|NCT02179047|11198521|FG000|STARTED|Overall Study||194
10071708|NCT02179047|11198522|FG001|STARTED|Overall Study||20
10071709|NCT02179047|11198521|FG000|COMPLETED|Overall Study||187
10071710|NCT02179047|11198522|FG001|COMPLETED|Overall Study||20
10071711|NCT02179047|11198521|FG000|NOT COMPLETED|Overall Study||7
10071712|NCT02179047|11198522|FG001|NOT COMPLETED|Overall Study||0
10071713|NCT02179177|11198541|FG000|STARTED|Overall Study||8
10071714|NCT02179177|11198542|FG001|STARTED|Overall Study||8
10071715|NCT02179177|11198541|FG000|COMPLETED|Overall Study||6
10071716|NCT02179177|11198542|FG001|COMPLETED|Overall Study||6
10071717|NCT02179177|11198541|FG000|NOT COMPLETED|Overall Study||2
10071718|NCT02179177|11198542|FG001|NOT COMPLETED|Overall Study||2
10071719|NCT02179190|11198548|FG000|STARTED|Enrollment||138
10071720|NCT02179190|11198548|FG000|COMPLETED|Enrollment||127
10071721|NCT02179190|11198548|FG000|NOT COMPLETED|Enrollment||11
10071722|NCT02179190|11198548|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127
10071723|NCT02179190|11198548|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120
10071724|NCT02179190|11198548|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
10071725|NCT02179190|11198548|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120
10071726|NCT02179190|11198548|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
10071727|NCT02179190|11198548|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
10071728|NCT02179398|11198554|FG000|STARTED|Overall Study||134
10071729|NCT02179398|11198555|FG001|STARTED|Overall Study||144
10071730|NCT02179398|11198554|FG000|COMPLETED|Overall Study||131
10071731|NCT02179398|11198555|FG001|COMPLETED|Overall Study||140
10071732|NCT02179398|11198554|FG000|NOT COMPLETED|Overall Study||3
10071733|NCT02179398|11198555|FG001|NOT COMPLETED|Overall Study||4
10071734|NCT02179424|11198569|FG000|STARTED|Overall Study||76
10071735|NCT02179424|11198570|FG001|STARTED|Overall Study||11
10071736|NCT02179424|11198571|FG002|STARTED|Overall Study||516
10071737|NCT02179424|11198572|FG003|STARTED|Overall Study||39
10071738|NCT02179424|11198569|FG000|COMPLETED|Overall Study||76
10071739|NCT02179424|11198570|FG001|COMPLETED|Overall Study||11
10071740|NCT02179424|11198571|FG002|COMPLETED|Overall Study||516
10071741|NCT02179424|11198572|FG003|COMPLETED|Overall Study||39
10071742|NCT02179424|11198569|FG000|NOT COMPLETED|Overall Study||0
10071743|NCT02179424|11198570|FG001|NOT COMPLETED|Overall Study||0
10071744|NCT02179424|11198571|FG002|NOT COMPLETED|Overall Study||0
10071745|NCT02179424|11198572|FG003|NOT COMPLETED|Overall Study||0
10071746|NCT02179515|11198586|FG000|STARTED|Overall Study||3
10071747|NCT02179515|11198587|FG001|STARTED|Overall Study||17
10071748|NCT02179515|11198588|FG002|STARTED|Overall Study||18
10071749|NCT02179515|11198586|FG000|COMPLETED|Overall Study||1
10071750|NCT02179515|11198587|FG001|COMPLETED|Overall Study||1
10071751|NCT02179515|11198588|FG002|COMPLETED|Overall Study||4
10071752|NCT02179515|11198586|FG000|NOT COMPLETED|Overall Study||2
10071753|NCT02179515|11198587|FG001|NOT COMPLETED|Overall Study||16
10071754|NCT02179515|11198588|FG002|NOT COMPLETED|Overall Study||14
10071755|NCT02179671|11198605|FG000|STARTED|Overall Study||1
10071756|NCT02179671|11198606|FG001|STARTED|Overall Study||1
10071757|NCT02179671|11198607|FG002|STARTED|Overall Study||2
10071758|NCT02179671|11198608|FG003|STARTED|Overall Study||14
10071759|NCT02179671|11198609|FG004|STARTED|Overall Study||14
10071760|NCT02179671|11198605|FG000|COMPLETED|Overall Study||0
10071761|NCT02179671|11198606|FG001|COMPLETED|Overall Study||0
10071762|NCT02179671|11198607|FG002|COMPLETED|Overall Study||1
10071763|NCT02179671|11198608|FG003|COMPLETED|Overall Study||1
10071764|NCT02179671|11198609|FG004|COMPLETED|Overall Study||1
10071765|NCT02179671|11198605|FG000|NOT COMPLETED|Overall Study||1
10071766|NCT02179671|11198606|FG001|NOT COMPLETED|Overall Study||1
10071767|NCT02179671|11198607|FG002|NOT COMPLETED|Overall Study||1
10071768|NCT02179671|11198608|FG003|NOT COMPLETED|Overall Study||13
10071769|NCT02179671|11198609|FG004|NOT COMPLETED|Overall Study||13
10071770|NCT02179788|11198623|FG000|STARTED|Overall Study||10
10071771|NCT02179788|11198624|FG001|STARTED|Overall Study||5
10071772|NCT02179788|11198623|FG000|COMPLETED|Overall Study||10
10071773|NCT02179788|11198624|FG001|COMPLETED|Overall Study||5
10071774|NCT02179788|11198623|FG000|NOT COMPLETED|Overall Study||0
10071775|NCT02179788|11198624|FG001|NOT COMPLETED|Overall Study||0
10071776|NCT02179892|11198632|FG000|STARTED|Overall Study||5
10071777|NCT02179892|11198633|FG001|STARTED|Overall Study||4
10071778|NCT02179892|11198632|FG000|COMPLETED|Overall Study||5
10071779|NCT02179892|11198633|FG001|COMPLETED|Overall Study||4
10071780|NCT02179892|11198632|FG000|NOT COMPLETED|Overall Study||0
10071781|NCT02179892|11198633|FG001|NOT COMPLETED|Overall Study||0
10071782|NCT02179918|11198644|FG000|STARTED|Overall Study||5
10071783|NCT02179918|11198645|FG001|STARTED|Overall Study||3
10071784|NCT02179918|11198646|FG002|STARTED|Overall Study||3
10071785|NCT02179918|11198647|FG003|STARTED|Overall Study||3
10071786|NCT02179918|11198648|FG004|STARTED|Overall Study||9
10071787|NCT02179918|11198644|FG000|COMPLETED|Overall Study||1
10071788|NCT02179918|11198645|FG001|COMPLETED|Overall Study||0
10071789|NCT02179918|11198646|FG002|COMPLETED|Overall Study||1
10071790|NCT02179918|11198647|FG003|COMPLETED|Overall Study||0
10071791|NCT02179918|11198648|FG004|COMPLETED|Overall Study||1
10071792|NCT02179918|11198644|FG000|NOT COMPLETED|Overall Study||4
10071793|NCT02179918|11198645|FG001|NOT COMPLETED|Overall Study||3
10071794|NCT02179918|11198646|FG002|NOT COMPLETED|Overall Study||2
10071795|NCT02179918|11198647|FG003|NOT COMPLETED|Overall Study||3
10071796|NCT02179918|11198648|FG004|NOT COMPLETED|Overall Study||8
10071797|NCT02180061|11198663|FG000|STARTED|Overall Study||34
10071798|NCT02180061|11198664|FG001|STARTED|Overall Study||8
10071799|NCT02180061|11198663|FG000|COMPLETED|Overall Study||9
10071800|NCT02180061|11198664|FG001|COMPLETED|Overall Study||0
10071801|NCT02180061|11198663|FG000|NOT COMPLETED|Overall Study||25
10071802|NCT02180061|11198664|FG001|NOT COMPLETED|Overall Study||8
10071803|NCT02180100|11198672|FG000|STARTED|Overall Study||70
10071804|NCT02180100|11198673|FG001|STARTED|Overall Study||70
10071805|NCT02180100|11198672|FG000|COMPLETED|Overall Study||58
10071806|NCT02180100|11198673|FG001|COMPLETED|Overall Study||66
10071807|NCT02180100|11198672|FG000|NOT COMPLETED|Overall Study||12
10071808|NCT02180100|11198673|FG001|NOT COMPLETED|Overall Study||4
10071809|NCT02180165|11198683|FG000|STARTED|Overall Study||15
10071810|NCT02180165|11198684|FG001|STARTED|Overall Study||7
10071811|NCT02180165|11198685|FG002|STARTED|Overall Study||63
10071812|NCT02180165|11198686|FG003|STARTED|Overall Study||31
10071813|NCT02180165|11198683|FG000|Treated Participants|Overall Study||15
10071814|NCT02180165|11198684|FG001|Treated Participants|Overall Study||7
10071815|NCT02180165|11198685|FG002|Treated Participants|Overall Study||62
10071816|NCT02180165|11198686|FG003|Treated Participants|Overall Study||31
10071817|NCT02180165|11198683|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
10071818|NCT02180165|11198684|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
10071819|NCT02180165|11198685|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
10071820|NCT02180165|11198686|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
10071821|NCT02180165|11198683|FG000|COMPLETED|Overall Study||4
10071822|NCT02180165|11198684|FG001|COMPLETED|Overall Study||6
10071823|NCT02180165|11198685|FG002|COMPLETED|Overall Study||34
10071824|NCT02180165|11198686|FG003|COMPLETED|Overall Study||25
10071825|NCT02180165|11198683|FG000|NOT COMPLETED|Overall Study||11
10071826|NCT02180165|11198684|FG001|NOT COMPLETED|Overall Study||1
10071827|NCT02180165|11198685|FG002|NOT COMPLETED|Overall Study||29
10071828|NCT02180165|11198686|FG003|NOT COMPLETED|Overall Study||6
10071829|NCT02180230|11198698|FG000|STARTED|Overall Study||38
10071830|NCT02180230|11198698|FG000|COMPLETED|Overall Study||31
10071831|NCT02180230|11198698|FG000|NOT COMPLETED|Overall Study||7
10071832|NCT02180438|11198702|FG000|STARTED|Overall Study||30
10071833|NCT02180438|11198702|FG000|COMPLETED|Overall Study||29
10071834|NCT02180438|11198702|FG000|NOT COMPLETED|Overall Study||1
10071835|NCT02180646|11198708|FG000|STARTED|First Intervention (7 Days)||6
10071836|NCT02180646|11198709|FG001|STARTED|First Intervention (7 Days)||6
10071837|NCT02180646|11198708|FG000|COMPLETED|First Intervention (7 Days)||6
10071838|NCT02180646|11198709|FG001|COMPLETED|First Intervention (7 Days)||6
10071839|NCT02180646|11198708|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10071840|NCT02180646|11198709|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10071841|NCT02180646|11198708|FG000|STARTED|Washout (7 Days)||6
10071842|NCT02180646|11198709|FG001|STARTED|Washout (7 Days)||6
10071843|NCT02180646|11198708|FG000|COMPLETED|Washout (7 Days)||6
10071844|NCT02180646|11198709|FG001|COMPLETED|Washout (7 Days)||6
10071845|NCT02180646|11198708|FG000|NOT COMPLETED|Washout (7 Days)||0
10071846|NCT02180646|11198709|FG001|NOT COMPLETED|Washout (7 Days)||0
10071847|NCT02180646|11198708|FG000|STARTED|Second Intervention (7 Days)||6
10071848|NCT02180646|11198709|FG001|STARTED|Second Intervention (7 Days)||6
10071849|NCT02180646|11198708|FG000|COMPLETED|Second Intervention (7 Days)||6
10071850|NCT02180646|11198709|FG001|COMPLETED|Second Intervention (7 Days)||6
10071851|NCT02180646|11198708|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10071852|NCT02180646|11198709|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10071853|NCT02180659|11198719|FG000|STARTED|Overall Study||87
10071854|NCT02180659|11198720|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
10071855|NCT02180659|11198719|FG000|COMPLETED|Overall Study||81
10071856|NCT02180659|11198720|FG001|COMPLETED|Overall Study||84
10071857|NCT02180659|11198719|FG000|NOT COMPLETED|Overall Study||6
10071858|NCT02180659|11198720|FG001|NOT COMPLETED|Overall Study||5
10071859|NCT02180672|11198728|FG000|STARTED|Overall Study||91
10071860|NCT02180672|11198729|FG001|STARTED|Overall Study||43
10071861|NCT02180672|11198728|FG000|COMPLETED|Overall Study||86
10071862|NCT02180672|11198729|FG001|COMPLETED|Overall Study||36
10071863|NCT02180672|11198728|FG000|NOT COMPLETED|Overall Study||5
10071864|NCT02180672|11198729|FG001|NOT COMPLETED|Overall Study||7
10071865|NCT02180828|11198737|FG000|STARTED|Overall Study||120
10071866|NCT02180828|11198738|FG001|STARTED|Overall Study||120
10071867|NCT02180828|11198737|FG000|COMPLETED|Overall Study||115
10071868|NCT02180828|11198738|FG001|COMPLETED|Overall Study||113
10071869|NCT02180828|11198737|FG000|NOT COMPLETED|Overall Study||5
10071870|NCT02180828|11198738|FG001|NOT COMPLETED|Overall Study||7
10071871|NCT02180893|11198746|FG000|STARTED|Overall Study||30
10071872|NCT02180893|11198747|FG001|STARTED|Overall Study||30
10071873|NCT02180893|11198746|FG000|COMPLETED|Overall Study||27
10071874|NCT02180893|11198747|FG001|COMPLETED|Overall Study||23
10071875|NCT02180893|11198746|FG000|NOT COMPLETED|Overall Study||3
10071876|NCT02180893|11198747|FG001|NOT COMPLETED|Overall Study||7
10071877|NCT02181075|11198755|FG000|STARTED|Overall Study||6
10071878|NCT02181075|11198756|FG001|STARTED|Overall Study||4
10071879|NCT02181075|11198755|FG000|COMPLETED|Overall Study||6
10071880|NCT02181075|11198756|FG001|COMPLETED|Overall Study||4
10071881|NCT02181075|11198755|FG000|NOT COMPLETED|Overall Study||0
10071882|NCT02181075|11198756|FG001|NOT COMPLETED|Overall Study||0
10071883|NCT02181127|11198766|FG000|STARTED|Overall Study||22
10071884|NCT02181127|11198766|FG000|COMPLETED|Overall Study||22
10071885|NCT02181127|11198766|FG000|NOT COMPLETED|Overall Study||0
10071886|NCT02181140|11198773|FG000|STARTED|Overall Study||56
10071887|NCT02181140|11198773|FG000|COMPLETED|Overall Study||56
10071888|NCT02181140|11198773|FG000|NOT COMPLETED|Overall Study||0
10071889|NCT02181231|11198781|FG000|STARTED|Overall Study||12
10071890|NCT02181231|11198782|FG001|STARTED|Overall Study||6
10071891|NCT02181231|11198781|FG000|COMPLETED|Overall Study||10
10071892|NCT02181231|11198782|FG001|COMPLETED|Overall Study||6
10071893|NCT02181231|11198781|FG000|NOT COMPLETED|Overall Study||2
10071894|NCT02181231|11198782|FG001|NOT COMPLETED|Overall Study||0
10071895|NCT02181296|11198790|FG000|STARTED|Overall Study||25
10071896|NCT02181296|11198791|FG001|STARTED|Overall Study||25
10071897|NCT02181296|11198790|FG000|COMPLETED|Overall Study||18
10071898|NCT02181296|11198791|FG001|COMPLETED|Overall Study||19
10071899|NCT02181296|11198790|FG000|NOT COMPLETED|Overall Study||7
10071900|NCT02181296|11198791|FG001|NOT COMPLETED|Overall Study||6
10071901|NCT02181387|11198799|FG000|STARTED|Overall Study||14
10071902|NCT02181387|11198800|FG001|STARTED|Overall Study||19
10071903|NCT02181387|11198799|FG000|COMPLETED|Overall Study||12
10071904|NCT02181387|11198800|FG001|COMPLETED|Overall Study||15
10071905|NCT02181387|11198799|FG000|NOT COMPLETED|Overall Study||2
10071906|NCT02181387|11198800|FG001|NOT COMPLETED|Overall Study||4
10071907|NCT02181400|11198809|FG000|STARTED|Overall Study||7
10071908|NCT02181400|11198810|FG001|STARTED|Overall Study||7
10071909|NCT02181400|11198811|FG002|STARTED|Overall Study||7
10071910|NCT02181400|11198809|FG000|COMPLETED|Overall Study||7
10071911|NCT02181400|11198810|FG001|COMPLETED|Overall Study||7
10071912|NCT02181400|11198811|FG002|COMPLETED|Overall Study||7
10071913|NCT02181400|11198809|FG000|NOT COMPLETED|Overall Study||0
10071914|NCT02181400|11198810|FG001|NOT COMPLETED|Overall Study||0
10071915|NCT02181400|11198811|FG002|NOT COMPLETED|Overall Study||0
10071916|NCT02181426|11198823|FG000|STARTED|Overall Study||28
10071917|NCT02181426|11198824|FG001|STARTED|Overall Study||28
10071918|NCT02181426|11198825|FG002|STARTED|Overall Study||28
10071919|NCT02181426|11198826|FG003|STARTED|Overall Study||28
10071920|NCT02181426|11198823|FG000|COMPLETED|Overall Study||28
10071921|NCT02181426|11198824|FG001|COMPLETED|Overall Study||28
10071922|NCT02181426|11198825|FG002|COMPLETED|Overall Study||28
10071923|NCT02181426|11198826|FG003|COMPLETED|Overall Study||28
10071924|NCT02181426|11198823|FG000|NOT COMPLETED|Overall Study||0
10071925|NCT02181426|11198824|FG001|NOT COMPLETED|Overall Study||0
10071926|NCT02181426|11198825|FG002|NOT COMPLETED|Overall Study||0
10071927|NCT02181426|11198826|FG003|NOT COMPLETED|Overall Study||0
10071928|NCT02181504|11198839|FG000|STARTED|Overall Study||10
10071929|NCT02181504|11198840|FG001|STARTED|Overall Study||10
10071930|NCT02181504|11198841|FG002|STARTED|Overall Study||5
10071931|NCT02181504|11198839|FG000|COMPLETED|Overall Study||9
10071932|NCT02181504|11198840|FG001|COMPLETED|Overall Study||9
10071933|NCT02181504|11198841|FG002|COMPLETED|Overall Study||4
10071934|NCT02181504|11198839|FG000|NOT COMPLETED|Overall Study||1
10071935|NCT02181504|11198840|FG001|NOT COMPLETED|Overall Study||1
10071936|NCT02181504|11198841|FG002|NOT COMPLETED|Overall Study||1
10071937|NCT02181517|11198853|FG000|STARTED|Overall Study||10
10071938|NCT02181517|11198854|FG001|STARTED|Overall Study||10
10071939|NCT02181517|11198855|FG002|STARTED|Overall Study||5
10071940|NCT02181517|11198853|FG000|COMPLETED|Overall Study||10
10071941|NCT02181517|11198854|FG001|COMPLETED|Overall Study||10
10071942|NCT02181517|11198855|FG002|COMPLETED|Overall Study||5
10071943|NCT02181517|11198853|FG000|NOT COMPLETED|Overall Study||0
10071944|NCT02181517|11198854|FG001|NOT COMPLETED|Overall Study||0
10071945|NCT02181517|11198855|FG002|NOT COMPLETED|Overall Study||0
10071946|NCT02181530|11198863|FG000|STARTED|Overall Study||43
10071947|NCT02181530|11198863|FG000|COMPLETED|Overall Study||43
10071948|NCT02181530|11198863|FG000|NOT COMPLETED|Overall Study||0
10071949|NCT02181556|11198867|FG000|STARTED|Overall Study||41
10071950|NCT02181556|11198867|FG000|COMPLETED|Overall Study||40
10071951|NCT02181556|11198867|FG000|NOT COMPLETED|Overall Study||1
10071952|NCT02181634|11198871|FG000|STARTED|Overall Study||74
10071953|NCT02181634|11198871|FG000|Eligible and Treated|Overall Study||73
10071954|NCT02181634|11198871|FG000|COMPLETED|Overall Study||2
10071955|NCT02181634|11198871|FG000|NOT COMPLETED|Overall Study||72
10071956|NCT02181673|11198877|FG000|STARTED|Up to Week 24||239
10071957|NCT02181673|11198878|FG001|STARTED|Up to Week 24||0
10071958|NCT02181673|11198879|FG002|STARTED|Up to Week 24||241
10071959|NCT02181673|11198877|FG000|Treated|Up to Week 24||239
10071960|NCT02181673|11198878|FG001|Treated|Up to Week 24||0
10071961|NCT02181673|11198879|FG002|Treated|Up to Week 24||240
10071962|NCT02181673|11198877|FG000|COMPLETED|Up to Week 24||222
10071963|NCT02181673|11198878|FG001|COMPLETED|Up to Week 24||0
10071964|NCT02181673|11198879|FG002|COMPLETED|Up to Week 24||230
10071965|NCT02181673|11198877|FG000|NOT COMPLETED|Up to Week 24||17
10071966|NCT02181673|11198878|FG001|NOT COMPLETED|Up to Week 24||0
10071967|NCT02181673|11198879|FG002|NOT COMPLETED|Up to Week 24||11
10071968|NCT02181673|11198877|FG000|STARTED|Week 24-Week 60||0
10071969|NCT02181673|11198878|FG001|STARTED|Week 24-Week 60||222
10071970|NCT02181673|11198879|FG002|STARTED|Week 24-Week 60||230
10071971|NCT02181673|11198877|FG000|Treated|Week 24-Week 60||0
10071972|NCT02181673|11198878|FG001|Treated|Week 24-Week 60||220
10071973|NCT02181673|11198879|FG002|Treated|Week 24-Week 60||230
10071974|NCT02181673|11198877|FG000|COMPLETED|Week 24-Week 60||0
10071975|NCT02181673|11198878|FG001|COMPLETED|Week 24-Week 60||214
10071976|NCT02181673|11198879|FG002|COMPLETED|Week 24-Week 60||213
10071977|NCT02181673|11198877|FG000|NOT COMPLETED|Week 24-Week 60||0
10071978|NCT02181673|11198878|FG001|NOT COMPLETED|Week 24-Week 60||8
10071979|NCT02181673|11198879|FG002|NOT COMPLETED|Week 24-Week 60||17
10071980|NCT02181738|11198890|FG000|STARTED|Overall Study||63
10071981|NCT02181738|11198891|FG001|STARTED|Overall Study||80
10071982|NCT02181738|11198892|FG002|STARTED|Overall Study||100
10071983|NCT02181738|11198893|FG003|STARTED|Overall Study||51
10071984|NCT02181738|11198890|FG000|COMPLETED|Overall Study||61
10071985|NCT02181738|11198891|FG001|COMPLETED|Overall Study||71
10071986|NCT02181738|11198892|FG002|COMPLETED|Overall Study||90
10071987|NCT02181738|11198893|FG003|COMPLETED|Overall Study||49
10071988|NCT02181738|11198890|FG000|NOT COMPLETED|Overall Study||2
10071989|NCT02181738|11198891|FG001|NOT COMPLETED|Overall Study||9
10071990|NCT02181738|11198892|FG002|NOT COMPLETED|Overall Study||10
10071991|NCT02181738|11198893|FG003|NOT COMPLETED|Overall Study||2
10071992|NCT02181803|11198912|FG000|STARTED|Overall Study||1
10071993|NCT02181803|11198913|FG001|STARTED|Overall Study||13
10071994|NCT02181803|11198914|FG002|STARTED|Overall Study||4
10071995|NCT02181803|11198915|FG003|STARTED|Overall Study||13
10071996|NCT02181803|11198916|FG004|STARTED|Overall Study||6
10071997|NCT02181803|11198917|FG005|STARTED|Overall Study||6
10071998|NCT02181803|11198918|FG006|STARTED|Overall Study||9
10071999|NCT02181803|11198919|FG007|STARTED|Overall Study||1
10072000|NCT02181803|11198920|FG008|STARTED|Overall Study||2
10072001|NCT02181803|11198912|FG000|COMPLETED|Overall Study||1
10072002|NCT02181803|11198913|FG001|COMPLETED|Overall Study||9
10072003|NCT02181803|11198914|FG002|COMPLETED|Overall Study||4
10072004|NCT02181803|11198915|FG003|COMPLETED|Overall Study||11
10072005|NCT02181803|11198916|FG004|COMPLETED|Overall Study||6
10072006|NCT02181803|11198917|FG005|COMPLETED|Overall Study||6
10072007|NCT02181803|11198918|FG006|COMPLETED|Overall Study||8
10072008|NCT02181803|11198919|FG007|COMPLETED|Overall Study||0
10072009|NCT02181803|11198920|FG008|COMPLETED|Overall Study||2
10072010|NCT02181803|11198912|FG000|NOT COMPLETED|Overall Study||0
10072011|NCT02181803|11198913|FG001|NOT COMPLETED|Overall Study||4
10072012|NCT02181803|11198914|FG002|NOT COMPLETED|Overall Study||0
10072013|NCT02181803|11198915|FG003|NOT COMPLETED|Overall Study||2
10072014|NCT02181803|11198916|FG004|NOT COMPLETED|Overall Study||0
10072015|NCT02181803|11198917|FG005|NOT COMPLETED|Overall Study||0
10072016|NCT02181803|11198918|FG006|NOT COMPLETED|Overall Study||1
10072017|NCT02181803|11198919|FG007|NOT COMPLETED|Overall Study||1
10072018|NCT02181803|11198920|FG008|NOT COMPLETED|Overall Study||0
10072019|NCT02181816|11198965|FG000|STARTED|Overall Study||1090
10072020|NCT02181816|11198965|FG000|COMPLETED|Overall Study||1031
10072021|NCT02181816|11198965|FG000|NOT COMPLETED|Overall Study||59
10072022|NCT02181829|11198969|FG000|STARTED|Overall Study||10
10072023|NCT02181829|11198969|FG000|COMPLETED|Overall Study||10
10072024|NCT02181829|11198969|FG000|NOT COMPLETED|Overall Study||0
10072025|NCT02181842|11198973|FG000|STARTED|Overall Study||246
10072026|NCT02181842|11198973|FG000|COMPLETED|Overall Study||244
10072027|NCT02181842|11198973|FG000|NOT COMPLETED|Overall Study||2
10072028|NCT02182115|11198979|FG000|STARTED|Overall Study||53
10072029|NCT02182115|11198980|FG001|STARTED|Overall Study||57
10072030|NCT02182115|11198979|FG000|COMPLETED|Overall Study||53
10072031|NCT02182115|11198980|FG001|COMPLETED|Overall Study||57
10072032|NCT02182115|11198979|FG000|NOT COMPLETED|Overall Study||0
10072033|NCT02182115|11198980|FG001|NOT COMPLETED|Overall Study||0
10072034|NCT02182440|11198990|FG000|STARTED|Overall Study||116
10072035|NCT02182440|11198991|FG001|STARTED|Overall Study||39
10072036|NCT02182440|11198992|FG002|STARTED|Overall Study||35
10072037|NCT02182440|11198993|FG003|STARTED|Overall Study||111
10072038|NCT02182440|11198990|FG000|ITTcombined|Overall Study||116
10072039|NCT02182440|11198991|FG001|ITTcombined|Overall Study||31
10072040|NCT02182440|11198992|FG002|ITTcombined|Overall Study||32
10072041|NCT02182440|11198993|FG003|ITTcombined|Overall Study||111
10072042|NCT02182440|11198990|FG000|ITTinterim|Overall Study||30
10072043|NCT02182440|11198991|FG001|ITTinterim|Overall Study||31
10072044|NCT02182440|11198992|FG002|ITTinterim|Overall Study||32
10072045|NCT02182440|11198993|FG003|ITTinterim|Overall Study||29
10072046|NCT02182440|11198990|FG000|Safety Population|Overall Study||112
10072047|NCT02182440|11198991|FG001|Safety Population|Overall Study||38
10072048|NCT02182440|11198992|FG002|Safety Population|Overall Study||35
10072049|NCT02182440|11198993|FG003|Safety Population|Overall Study||109
10072050|NCT02182440|11198990|FG000|COMPLETED|Overall Study||71
10072051|NCT02182440|11198991|FG001|COMPLETED|Overall Study||25
10072052|NCT02182440|11198992|FG002|COMPLETED|Overall Study||24
10072053|NCT02182440|11198993|FG003|COMPLETED|Overall Study||81
10072054|NCT02182440|11198990|FG000|NOT COMPLETED|Overall Study||45
10072055|NCT02182440|11198991|FG001|NOT COMPLETED|Overall Study||14
10072056|NCT02182440|11198992|FG002|NOT COMPLETED|Overall Study||11
10072057|NCT02182440|11198993|FG003|NOT COMPLETED|Overall Study||30
10072058|NCT02182492|11199007|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
10072059|NCT02182492|11199008|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
10072060|NCT02182492|11199007|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
10072061|NCT02182492|11199008|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
10072062|NCT02182492|11199007|FG000|NOT COMPLETED|Overall Study||7
10072063|NCT02182492|11199008|FG001|NOT COMPLETED|Overall Study||8
10072064|NCT02182804|11199014|FG000|STARTED|Overall Study||44
10072065|NCT02182804|11199014|FG000|COMPLETED|Overall Study||44
10072066|NCT02182804|11199014|FG000|NOT COMPLETED|Overall Study||0
10072067|NCT02182830|11199020|FG000|STARTED|Overall Study||83
10072068|NCT02182830|11199021|FG001|STARTED|Overall Study||83
10072069|NCT02182830|11199020|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
10072070|NCT02182830|11199021|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
10072071|NCT02182830|11199020|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
10072072|NCT02182830|11199021|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
10072073|NCT02182830|11199020|FG000|COMPLETED|Overall Study||68
10072074|NCT02182830|11199021|FG001|COMPLETED|Overall Study||68
10072075|NCT02182830|11199020|FG000|NOT COMPLETED|Overall Study||15
10072076|NCT02182830|11199021|FG001|NOT COMPLETED|Overall Study||15
10072077|NCT02182843|11199027|FG000|STARTED|Overall Study||81
10072078|NCT02182843|11199027|FG000|COMPLETED|Overall Study||71
10072079|NCT02182843|11199027|FG000|NOT COMPLETED|Overall Study||10
10072080|NCT02182895|11199033|FG000|STARTED|Overall Study||35
10072081|NCT02182895|11199034|FG001|STARTED|Overall Study||37
10072082|NCT02182895|11199033|FG000|COMPLETED|Overall Study||33
10072083|NCT02182895|11199034|FG001|COMPLETED|Overall Study||33
10072084|NCT02182895|11199033|FG000|NOT COMPLETED|Overall Study||2
10072085|NCT02182895|11199034|FG001|NOT COMPLETED|Overall Study||4
10072086|NCT02182947|11199040|FG000|STARTED|Overall Study||45
10072087|NCT02182947|11199040|FG000|COMPLETED|Overall Study||27
10072088|NCT02182947|11199040|FG000|NOT COMPLETED|Overall Study||18
10072089|NCT02182973|11199046|FG000|STARTED|Overall Study||12
10072090|NCT02182973|11199047|FG001|STARTED|Overall Study||9
10072091|NCT02182973|11199046|FG000|COMPLETED|Overall Study||9
10072092|NCT02182973|11199047|FG001|COMPLETED|Overall Study||9
10072093|NCT02182973|11199046|FG000|NOT COMPLETED|Overall Study||3
10072094|NCT02182973|11199047|FG001|NOT COMPLETED|Overall Study||0
10072095|NCT02182999|11199056|FG000|STARTED|Overall Study||25
10072096|NCT02182999|11199057|FG001|STARTED|Overall Study||25
10072097|NCT02182999|11199056|FG000|COMPLETED|Overall Study||20
10072098|NCT02182999|11199057|FG001|COMPLETED|Overall Study||22
10072099|NCT02182999|11199056|FG000|NOT COMPLETED|Overall Study||5
10072100|NCT02182999|11199057|FG001|NOT COMPLETED|Overall Study||3
10072101|NCT02183519|11199065|FG000|STARTED|Overall Study||28
10072102|NCT02183519|11199066|FG001|STARTED|Overall Study||16
10072103|NCT02183519|11199065|FG000|COMPLETED|Overall Study||25
10072104|NCT02183519|11199066|FG001|COMPLETED|Overall Study||13
10072105|NCT02183519|11199065|FG000|NOT COMPLETED|Overall Study||3
10072106|NCT02183519|11199066|FG001|NOT COMPLETED|Overall Study||3
10072107|NCT02183675|11199078|FG000|STARTED|Treatment Period 1 (10 Days)||6
10072108|NCT02183675|11199079|FG001|STARTED|Treatment Period 1 (10 Days)||6
10072109|NCT02183675|11199080|FG002|STARTED|Treatment Period 1 (10 Days)||6
10072110|NCT02183675|11199081|FG003|STARTED|Treatment Period 1 (10 Days)||6
10072111|NCT02183675|11199082|FG004|STARTED|Treatment Period 1 (10 Days)||6
10072112|NCT02183675|11199083|FG005|STARTED|Treatment Period 1 (10 Days)||6
10072113|NCT02183675|11199078|FG000|COMPLETED|Treatment Period 1 (10 Days)||6
10072114|NCT02183675|11199079|FG001|COMPLETED|Treatment Period 1 (10 Days)||6
10072115|NCT02183675|11199080|FG002|COMPLETED|Treatment Period 1 (10 Days)||6
10072116|NCT02183675|11199081|FG003|COMPLETED|Treatment Period 1 (10 Days)||6
10072117|NCT02183675|11199082|FG004|COMPLETED|Treatment Period 1 (10 Days)||6
10072118|NCT02183675|11199083|FG005|COMPLETED|Treatment Period 1 (10 Days)||6
10072119|NCT02183675|11199078|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10072120|NCT02183675|11199079|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10072121|NCT02183675|11199080|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10072122|NCT02183675|11199081|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10072123|NCT02183675|11199082|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10072124|NCT02183675|11199083|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10072125|NCT02183675|11199078|FG000|STARTED|Treatment Period 2 (10 Days)||6
10072126|NCT02183675|11199079|FG001|STARTED|Treatment Period 2 (10 Days)||6
10072127|NCT02183675|11199080|FG002|STARTED|Treatment Period 2 (10 Days)||6
10072128|NCT02183675|11199081|FG003|STARTED|Treatment Period 2 (10 Days)||6
10072129|NCT02183675|11199082|FG004|STARTED|Treatment Period 2 (10 Days)||6
10072130|NCT02183675|11199083|FG005|STARTED|Treatment Period 2 (10 Days)||6
10072131|NCT02183675|11199078|FG000|COMPLETED|Treatment Period 2 (10 Days)||6
10072132|NCT02183675|11199079|FG001|COMPLETED|Treatment Period 2 (10 Days)||6
10072133|NCT02183675|11199080|FG002|COMPLETED|Treatment Period 2 (10 Days)||6
10072134|NCT02183675|11199081|FG003|COMPLETED|Treatment Period 2 (10 Days)||6
10072135|NCT02183675|11199082|FG004|COMPLETED|Treatment Period 2 (10 Days)||6
10072136|NCT02183675|11199083|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
10072137|NCT02183675|11199078|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10072138|NCT02183675|11199079|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10072139|NCT02183675|11199080|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10072140|NCT02183675|11199081|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10072141|NCT02183675|11199082|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10072142|NCT02183675|11199083|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2
10072143|NCT02183675|11199078|FG000|STARTED|Treatment Period 3 (10 Days)||6
10072144|NCT02183675|11199079|FG001|STARTED|Treatment Period 3 (10 Days)||6
10072145|NCT02183675|11199080|FG002|STARTED|Treatment Period 3 (10 Days)||6
10072146|NCT02183675|11199081|FG003|STARTED|Treatment Period 3 (10 Days)||6
10072147|NCT02183675|11199082|FG004|STARTED|Treatment Period 3 (10 Days)||6
10072148|NCT02183675|11199083|FG005|STARTED|Treatment Period 3 (10 Days)||4
10072149|NCT02183675|11199078|FG000|COMPLETED|Treatment Period 3 (10 Days)||6
10072150|NCT02183675|11199079|FG001|COMPLETED|Treatment Period 3 (10 Days)||6
10072151|NCT02183675|11199080|FG002|COMPLETED|Treatment Period 3 (10 Days)||6
10072152|NCT02183675|11199081|FG003|COMPLETED|Treatment Period 3 (10 Days)||6
10072153|NCT02183675|11199082|FG004|COMPLETED|Treatment Period 3 (10 Days)||6
10072154|NCT02183675|11199083|FG005|COMPLETED|Treatment Period 3 (10 Days)||4
10072155|NCT02183675|11199078|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10072156|NCT02183675|11199079|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10072157|NCT02183675|11199080|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10072158|NCT02183675|11199081|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10072159|NCT02183675|11199082|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10072160|NCT02183675|11199083|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10072161|NCT02183792|11199095|FG000|STARTED|Overall Study||18
10072162|NCT02183792|11199096|FG001|STARTED|Overall Study||15
10072163|NCT02183792|11199095|FG000|COMPLETED|Overall Study||18
10072164|NCT02183792|11199096|FG001|COMPLETED|Overall Study||15
10072165|NCT02183792|11199095|FG000|NOT COMPLETED|Overall Study||0
10072166|NCT02183792|11199096|FG001|NOT COMPLETED|Overall Study||0
10072167|NCT02184143|11199104|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
10072168|NCT02184143|11199105|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
10072169|NCT02184143|11199104|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
10072170|NCT02184143|11199105|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
10072171|NCT02184143|11199104|FG000|NOT COMPLETED|Overall Study||10
10072172|NCT02184143|11199105|FG001|NOT COMPLETED|Overall Study||7
10072173|NCT02184169|11199115|FG000|STARTED|Overall Study||21
10072174|NCT02184169|11199116|FG001|STARTED|Overall Study||6
10072175|NCT02184169|11199115|FG000|COMPLETED|Overall Study||21
10072176|NCT02184169|11199116|FG001|COMPLETED|Overall Study||6
10072177|NCT02184169|11199115|FG000|NOT COMPLETED|Overall Study||0
10072178|NCT02184169|11199116|FG001|NOT COMPLETED|Overall Study||0
10072179|NCT02184208|11199124|FG000|STARTED|Overall Study||278
10189918|NCT03286543|11319208|FG001|Enrolled|Consented||0
10189919|NCT03286543|11319209|FG002|Enrolled|Consented||0
10189920|NCT03286543|11319207|FG000|Intent to Treat Set|Consented||37
10189921|NCT03286543|11319208|FG001|Intent to Treat Set|Consented||0
10189922|NCT03286543|11319209|FG002|Intent to Treat Set|Consented||0
10189923|NCT03286543|11319207|FG000|Per Protocol Set|Consented||23
10189924|NCT03286543|11319208|FG001|Per Protocol Set|Consented||0
10189925|NCT03286543|11319209|FG002|Per Protocol Set|Consented||0
10189926|NCT03286543|11319207|FG000|COMPLETED|Consented||28
10189927|NCT03286543|11319208|FG001|COMPLETED|Consented||0
10189928|NCT03286543|11319209|FG002|COMPLETED|Consented||0
10189929|NCT03286543|11319207|FG000|NOT COMPLETED|Consented||19
10189930|NCT03286543|11319208|FG001|NOT COMPLETED|Consented||0
10189931|NCT03286543|11319209|FG002|NOT COMPLETED|Consented||0
10189932|NCT03286543|11319207|FG000|STARTED|Study Enrollment||0
10189933|NCT03286543|11319208|FG001|STARTED|Study Enrollment||18
10189934|NCT03286543|11319209|FG002|STARTED|Study Enrollment||23
10189935|NCT03286543|11319207|FG000|Intent to Treat Set|Study Enrollment||0
10189936|NCT03286543|11319208|FG001|Intent to Treat Set|Study Enrollment||18
10189937|NCT03286543|11319209|FG002|Intent to Treat Set|Study Enrollment||19
10189938|NCT03286543|11319207|FG000|Per Protocol Set|Study Enrollment||0
10189939|NCT03286543|11319208|FG001|Per Protocol Set|Study Enrollment||7
10189940|NCT03286543|11319209|FG002|Per Protocol Set|Study Enrollment||16
10189941|NCT03286543|11319207|FG000|COMPLETED|Study Enrollment||0
10189942|NCT03286543|11319208|FG001|COMPLETED|Study Enrollment||12
10189943|NCT03286543|11319209|FG002|COMPLETED|Study Enrollment||16
10189944|NCT03286543|11319207|FG000|NOT COMPLETED|Study Enrollment||0
10189945|NCT03286543|11319208|FG001|NOT COMPLETED|Study Enrollment||6
10189946|NCT03286543|11319209|FG002|NOT COMPLETED|Study Enrollment||7
10189947|NCT03286751|11319215|FG000|STARTED|Period 1||7
10189948|NCT03286751|11319216|FG001|STARTED|Period 1||7
10189949|NCT03286751|11319217|FG002|STARTED|Period 1||7
10189950|NCT03286751|11319218|FG003|STARTED|Period 1||7
10189951|NCT03286751|11319219|FG004|STARTED|Period 1||7
10189952|NCT03286751|11319220|FG005|STARTED|Period 1||7
10189953|NCT03286751|11319215|FG000|Received at Least One Dose of Study Drug|Period 1||7
10189954|NCT03286751|11319216|FG001|Received at Least One Dose of Study Drug|Period 1||7
10189955|NCT03286751|11319217|FG002|Received at Least One Dose of Study Drug|Period 1||7
10189956|NCT03286751|11319218|FG003|Received at Least One Dose of Study Drug|Period 1||7
10189957|NCT03286751|11319219|FG004|Received at Least One Dose of Study Drug|Period 1||7
10189958|NCT03286751|11319220|FG005|Received at Least One Dose of Study Drug|Period 1||7
10189959|NCT03286751|11319215|FG000|COMPLETED|Period 1||7
10189960|NCT03286751|11319216|FG001|COMPLETED|Period 1||7
10189961|NCT03286751|11319217|FG002|COMPLETED|Period 1||7
10189962|NCT03286751|11319218|FG003|COMPLETED|Period 1||7
10189963|NCT03286751|11319219|FG004|COMPLETED|Period 1||7
10189964|NCT03286751|11319220|FG005|COMPLETED|Period 1||7
10189965|NCT03286751|11319215|FG000|NOT COMPLETED|Period 1||0
10189966|NCT03286751|11319216|FG001|NOT COMPLETED|Period 1||0
10189967|NCT03286751|11319217|FG002|NOT COMPLETED|Period 1||0
10189968|NCT03286751|11319218|FG003|NOT COMPLETED|Period 1||0
10189969|NCT03286751|11319219|FG004|NOT COMPLETED|Period 1||0
10189970|NCT03286751|11319220|FG005|NOT COMPLETED|Period 1||0
10189971|NCT03286751|11319215|FG000|STARTED|Washout Period 1||7
10072180|NCT02184208|11199124|FG000|COMPLETED|Overall Study||222
10072181|NCT02184208|11199124|FG000|NOT COMPLETED|Overall Study||56
10189972|NCT03286751|11319216|FG001|STARTED|Washout Period 1||7
10189973|NCT03286751|11319217|FG002|STARTED|Washout Period 1||7
10072182|NCT02184442|11199132|FG000|STARTED|Overall Study||284
10072183|NCT02184442|11199133|FG001|STARTED|Overall Study||276
10072184|NCT02184442|11199132|FG000|As-Treated|Overall Study||282
10072185|NCT02184442|11199133|FG001|As-Treated|Overall Study||271
10072186|NCT02184442|11199132|FG000|Valve-Implant|Overall Study||280
10072187|NCT02184442|11199133|FG001|Valve-Implant|Overall Study||263
10072188|NCT02184442|11199132|FG000|COMPLETED|Overall Study||220
10072189|NCT02184442|11199133|FG001|COMPLETED|Overall Study||200
10072190|NCT02184442|11199132|FG000|NOT COMPLETED|Overall Study||64
10072191|NCT02184442|11199133|FG001|NOT COMPLETED|Overall Study||76
10189974|NCT03286751|11319218|FG003|STARTED|Washout Period 1||7
10189975|NCT03286751|11319219|FG004|STARTED|Washout Period 1||7
10189976|NCT03286751|11319220|FG005|STARTED|Washout Period 1||7
10189977|NCT03286751|11319215|FG000|COMPLETED|Washout Period 1||7
10189978|NCT03286751|11319216|FG001|COMPLETED|Washout Period 1||7
10189979|NCT03286751|11319217|FG002|COMPLETED|Washout Period 1||7
10189980|NCT03286751|11319218|FG003|COMPLETED|Washout Period 1||7
10189981|NCT03286751|11319219|FG004|COMPLETED|Washout Period 1||6
10189982|NCT03286751|11319220|FG005|COMPLETED|Washout Period 1||7
10189983|NCT03286751|11319215|FG000|NOT COMPLETED|Washout Period 1||0
10189984|NCT03286751|11319216|FG001|NOT COMPLETED|Washout Period 1||0
10189985|NCT03286751|11319217|FG002|NOT COMPLETED|Washout Period 1||0
10189986|NCT03286751|11319218|FG003|NOT COMPLETED|Washout Period 1||0
10189987|NCT03286751|11319219|FG004|NOT COMPLETED|Washout Period 1||1
10189988|NCT03286751|11319220|FG005|NOT COMPLETED|Washout Period 1||0
10189989|NCT03286751|11319215|FG000|STARTED|Period 2||7
10189990|NCT03286751|11319216|FG001|STARTED|Period 2||7
10189991|NCT03286751|11319217|FG002|STARTED|Period 2||7
10189992|NCT03286751|11319218|FG003|STARTED|Period 2||7
10189993|NCT03286751|11319219|FG004|STARTED|Period 2||6
10189994|NCT03286751|11319220|FG005|STARTED|Period 2||7
10189995|NCT03286751|11319215|FG000|COMPLETED|Period 2||7
10189996|NCT03286751|11319216|FG001|COMPLETED|Period 2||7
10189997|NCT03286751|11319217|FG002|COMPLETED|Period 2||7
10189998|NCT03286751|11319218|FG003|COMPLETED|Period 2||7
10189999|NCT03286751|11319219|FG004|COMPLETED|Period 2||6
10190000|NCT03286751|11319220|FG005|COMPLETED|Period 2||7
10190001|NCT03286751|11319215|FG000|NOT COMPLETED|Period 2||0
10190002|NCT03286751|11319216|FG001|NOT COMPLETED|Period 2||0
10190003|NCT03286751|11319217|FG002|NOT COMPLETED|Period 2||0
10190004|NCT03286751|11319218|FG003|NOT COMPLETED|Period 2||0
10190005|NCT03286751|11319219|FG004|NOT COMPLETED|Period 2||0
10190006|NCT03286751|11319220|FG005|NOT COMPLETED|Period 2||0
10190007|NCT03286751|11319215|FG000|STARTED|Washout Period 2||7
10190008|NCT03286751|11319216|FG001|STARTED|Washout Period 2||7
10190009|NCT03286751|11319217|FG002|STARTED|Washout Period 2||7
10190010|NCT03286751|11319218|FG003|STARTED|Washout Period 2||7
10190011|NCT03286751|11319219|FG004|STARTED|Washout Period 2||6
10190012|NCT03286751|11319220|FG005|STARTED|Washout Period 2||7
10190013|NCT03286751|11319215|FG000|COMPLETED|Washout Period 2||7
10190014|NCT03286751|11319216|FG001|COMPLETED|Washout Period 2||6
10190015|NCT03286751|11319217|FG002|COMPLETED|Washout Period 2||7
10190016|NCT03286751|11319218|FG003|COMPLETED|Washout Period 2||7
10190017|NCT03286751|11319219|FG004|COMPLETED|Washout Period 2||6
10190018|NCT03286751|11319220|FG005|COMPLETED|Washout Period 2||7
10190019|NCT03286751|11319215|FG000|NOT COMPLETED|Washout Period 2||0
10190020|NCT03286751|11319216|FG001|NOT COMPLETED|Washout Period 2||1
10190021|NCT03286751|11319217|FG002|NOT COMPLETED|Washout Period 2||0
10190022|NCT03286751|11319218|FG003|NOT COMPLETED|Washout Period 2||0
10190023|NCT03286751|11319219|FG004|NOT COMPLETED|Washout Period 2||0
10190024|NCT03286751|11319220|FG005|NOT COMPLETED|Washout Period 2||0
10190025|NCT03286751|11319215|FG000|STARTED|Period 3||7
10190026|NCT03286751|11319216|FG001|STARTED|Period 3||6
10190027|NCT03286751|11319217|FG002|STARTED|Period 3||7
10190028|NCT03286751|11319218|FG003|STARTED|Period 3||7
10190029|NCT03286751|11319219|FG004|STARTED|Period 3||6
10190030|NCT03286751|11319220|FG005|STARTED|Period 3||7
10190031|NCT03286751|11319215|FG000|COMPLETED|Period 3||7
10190032|NCT03286751|11319216|FG001|COMPLETED|Period 3||6
10190033|NCT03286751|11319217|FG002|COMPLETED|Period 3||7
10190034|NCT03286751|11319218|FG003|COMPLETED|Period 3||7
10190035|NCT03286751|11319219|FG004|COMPLETED|Period 3||6
10190036|NCT03286751|11319220|FG005|COMPLETED|Period 3||7
10190037|NCT03286751|11319215|FG000|NOT COMPLETED|Period 3||0
10190038|NCT03286751|11319216|FG001|NOT COMPLETED|Period 3||0
10190039|NCT03286751|11319217|FG002|NOT COMPLETED|Period 3||0
10190040|NCT03286751|11319218|FG003|NOT COMPLETED|Period 3||0
10190041|NCT03286751|11319219|FG004|NOT COMPLETED|Period 3||0
10190042|NCT03286751|11319220|FG005|NOT COMPLETED|Period 3||0
10190043|NCT03286751|11319215|FG000|STARTED|Washout Period 3||7
10190044|NCT03286751|11319216|FG001|STARTED|Washout Period 3||6
10190045|NCT03286751|11319217|FG002|STARTED|Washout Period 3||7
10190046|NCT03286751|11319218|FG003|STARTED|Washout Period 3||7
10190047|NCT03286751|11319219|FG004|STARTED|Washout Period 3||6
10190048|NCT03286751|11319220|FG005|STARTED|Washout Period 3||7
10190049|NCT03286751|11319215|FG000|COMPLETED|Washout Period 3||7
10190050|NCT03286751|11319216|FG001|COMPLETED|Washout Period 3||6
10190051|NCT03286751|11319217|FG002|COMPLETED|Washout Period 3||7
10190052|NCT03286751|11319218|FG003|COMPLETED|Washout Period 3||7
10190053|NCT03286751|11319219|FG004|COMPLETED|Washout Period 3||6
10190054|NCT03286751|11319220|FG005|COMPLETED|Washout Period 3||7
10190055|NCT03286751|11319215|FG000|NOT COMPLETED|Washout Period 3||0
10190056|NCT03286751|11319216|FG001|NOT COMPLETED|Washout Period 3||0
10190057|NCT03286751|11319217|FG002|NOT COMPLETED|Washout Period 3||0
10072192|NCT02184455|11199139|FG000|STARTED|Overall Study||11
10072193|NCT02184455|11199139|FG000|COMPLETED|Overall Study||10
10072194|NCT02184455|11199139|FG000|NOT COMPLETED|Overall Study||1
10072195|NCT02184494|11199146|FG000|STARTED|Overall Study||13
10072196|NCT02184494|11199147|FG001|STARTED|Overall Study||13
10072197|NCT02184494|11199148|FG002|STARTED|Overall Study||8
10072198|NCT02184494|11199146|FG000|COMPLETED|Overall Study||12
10072199|NCT02184494|11199147|FG001|COMPLETED|Overall Study||11
10072200|NCT02184494|11199148|FG002|COMPLETED|Overall Study||8
10072201|NCT02184494|11199146|FG000|NOT COMPLETED|Overall Study||1
10072202|NCT02184494|11199147|FG001|NOT COMPLETED|Overall Study||2
10072203|NCT02184494|11199148|FG002|NOT COMPLETED|Overall Study||0
10072204|NCT02184572|11199158|FG000|STARTED|Overall Study||1164
10072205|NCT02184572|11199159|FG001|STARTED|Overall Study||572
10072206|NCT02184572|11199158|FG000|COMPLETED|Overall Study||1117
10072207|NCT02184572|11199159|FG001|COMPLETED|Overall Study||542
10072208|NCT02184572|11199158|FG000|NOT COMPLETED|Overall Study||47
10072209|NCT02184572|11199159|FG001|NOT COMPLETED|Overall Study||30
10072210|NCT02184611|11199169|FG000|STARTED|Overall Study||101
10072211|NCT02184611|11199170|FG001|STARTED|Overall Study||205
10072212|NCT02184611|11199169|FG000|COMPLETED|Overall Study||80
10072213|NCT02184611|11199170|FG001|COMPLETED|Overall Study||177
10072214|NCT02184611|11199169|FG000|NOT COMPLETED|Overall Study||21
10072215|NCT02184611|11199170|FG001|NOT COMPLETED|Overall Study||28
10072216|NCT02184624|11199181|FG000|STARTED|Overall Study||171
10072217|NCT02184624|11199182|FG001|STARTED|Overall Study||80
10072218|NCT02184624|11199183|FG002|STARTED|Overall Study||100
10072219|NCT02184624|11199184|FG003|STARTED|Overall Study||118
10072220|NCT02184624|11199185|FG004|STARTED|Overall Study||98
10072221|NCT02184624|11199181|FG000|COMPLETED|Overall Study||171
10072222|NCT02184624|11199182|FG001|COMPLETED|Overall Study||80
10072223|NCT02184624|11199183|FG002|COMPLETED|Overall Study||100
10072224|NCT02184624|11199184|FG003|COMPLETED|Overall Study||118
10072225|NCT02184624|11199185|FG004|COMPLETED|Overall Study||98
10072226|NCT02184624|11199181|FG000|NOT COMPLETED|Overall Study||0
10072227|NCT02184624|11199182|FG001|NOT COMPLETED|Overall Study||0
10072228|NCT02184624|11199183|FG002|NOT COMPLETED|Overall Study||0
10072229|NCT02184624|11199184|FG003|NOT COMPLETED|Overall Study||0
10072230|NCT02184624|11199185|FG004|NOT COMPLETED|Overall Study||0
10072231|NCT02184988|11199197|FG000|STARTED|Overall Study||352
10072232|NCT02184988|11199197|FG000|COMPLETED|Overall Study||297
10072233|NCT02184988|11199197|FG000|NOT COMPLETED|Overall Study||55
10072234|NCT02185014|11199201|FG000|STARTED|Overall Study||252
10072235|NCT02185014|11199201|FG000|COMPLETED|Overall Study||198
10072236|NCT02185014|11199201|FG000|NOT COMPLETED|Overall Study||54
10072237|NCT02185040|11199210|FG000|STARTED|Part 1 Treatment Phase||8
10072238|NCT02185040|11199211|FG001|STARTED|Part 1 Treatment Phase||8
10072239|NCT02185040|11199212|FG002|STARTED|Part 1 Treatment Phase||8
10072240|NCT02185040|11199213|FG003|STARTED|Part 1 Treatment Phase||9
10072241|NCT02185040|11199214|FG004|STARTED|Part 1 Treatment Phase||9
10072242|NCT02185040|11199215|FG005|STARTED|Part 1 Treatment Phase||0
10072243|NCT02185040|11199216|FG006|STARTED|Part 1 Treatment Phase||0
10072244|NCT02185040|11199210|FG000|COMPLETED|Part 1 Treatment Phase||7
10072245|NCT02185040|11199211|FG001|COMPLETED|Part 1 Treatment Phase||6
10072246|NCT02185040|11199212|FG002|COMPLETED|Part 1 Treatment Phase||7
10072247|NCT02185040|11199213|FG003|COMPLETED|Part 1 Treatment Phase||7
10072248|NCT02185040|11199214|FG004|COMPLETED|Part 1 Treatment Phase||6
10072249|NCT02185040|11199215|FG005|COMPLETED|Part 1 Treatment Phase||0
10072250|NCT02185040|11199216|FG006|COMPLETED|Part 1 Treatment Phase||0
10072251|NCT02185040|11199210|FG000|NOT COMPLETED|Part 1 Treatment Phase||1
10072252|NCT02185040|11199211|FG001|NOT COMPLETED|Part 1 Treatment Phase||2
10072253|NCT02185040|11199212|FG002|NOT COMPLETED|Part 1 Treatment Phase||1
10072254|NCT02185040|11199213|FG003|NOT COMPLETED|Part 1 Treatment Phase||2
10072255|NCT02185040|11199214|FG004|NOT COMPLETED|Part 1 Treatment Phase||3
10072256|NCT02185040|11199215|FG005|NOT COMPLETED|Part 1 Treatment Phase||0
10072257|NCT02185040|11199216|FG006|NOT COMPLETED|Part 1 Treatment Phase||0
10072258|NCT02185040|11199210|FG000|STARTED|Active Treatment Extension Phase||0
10072259|NCT02185040|11199211|FG001|STARTED|Active Treatment Extension Phase||0
10072260|NCT02185040|11199212|FG002|STARTED|Active Treatment Extension Phase||0
10072261|NCT02185040|11199213|FG003|STARTED|Active Treatment Extension Phase||0
10072262|NCT02185040|11199214|FG004|STARTED|Active Treatment Extension Phase||0
10072263|NCT02185040|11199215|FG005|STARTED|Active Treatment Extension Phase||9
10072264|NCT02185040|11199216|FG006|STARTED|Active Treatment Extension Phase||8
10072265|NCT02185040|11199210|FG000|COMPLETED|Active Treatment Extension Phase||0
10072266|NCT02185040|11199211|FG001|COMPLETED|Active Treatment Extension Phase||0
10072267|NCT02185040|11199212|FG002|COMPLETED|Active Treatment Extension Phase||0
10072268|NCT02185040|11199213|FG003|COMPLETED|Active Treatment Extension Phase||0
10072269|NCT02185040|11199214|FG004|COMPLETED|Active Treatment Extension Phase||0
10072270|NCT02185040|11199215|FG005|COMPLETED|Active Treatment Extension Phase||6
10072271|NCT02185040|11199216|FG006|COMPLETED|Active Treatment Extension Phase||1
10072272|NCT02185040|11199210|FG000|NOT COMPLETED|Active Treatment Extension Phase||0
10072273|NCT02185040|11199211|FG001|NOT COMPLETED|Active Treatment Extension Phase||0
10072274|NCT02185040|11199212|FG002|NOT COMPLETED|Active Treatment Extension Phase||0
10072275|NCT02185040|11199213|FG003|NOT COMPLETED|Active Treatment Extension Phase||0
10072276|NCT02185040|11199214|FG004|NOT COMPLETED|Active Treatment Extension Phase||0
10072277|NCT02185040|11199215|FG005|NOT COMPLETED|Active Treatment Extension Phase||3
10072278|NCT02185040|11199216|FG006|NOT COMPLETED|Active Treatment Extension Phase||7
10072279|NCT02185053|11199236|FG000|STARTED|Solifenacin Dose Escalation Phase||41
10072280|NCT02185053|11199237|FG001|STARTED|Solifenacin Dose Escalation Phase||0
10072281|NCT02185053|11199238|FG002|STARTED|Solifenacin Dose Escalation Phase||0
10072282|NCT02185053|11199236|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38
10072283|NCT02185053|11199237|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0
10072284|NCT02185053|11199238|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0
10072285|NCT02185053|11199236|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
10072286|NCT02185053|11199237|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
10072287|NCT02185053|11199238|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
10072288|NCT02185053|11199236|FG000|STARTED|Donepezil Dose Escalation Phase||0
10072289|NCT02185053|11199237|FG001|STARTED|Donepezil Dose Escalation Phase||38
10072290|NCT02185053|11199238|FG002|STARTED|Donepezil Dose Escalation Phase||0
10072291|NCT02185053|11199236|FG000|COMPLETED|Donepezil Dose Escalation Phase||0
10072292|NCT02185053|11199237|FG001|COMPLETED|Donepezil Dose Escalation Phase||33
10072293|NCT02185053|11199238|FG002|COMPLETED|Donepezil Dose Escalation Phase||0
10072294|NCT02185053|11199236|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0
10072295|NCT02185053|11199237|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5
10072296|NCT02185053|11199238|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0
10072297|NCT02185053|11199236|FG000|STARTED|Donepezil Dose Maintenance Phase||0
10072298|NCT02185053|11199237|FG001|STARTED|Donepezil Dose Maintenance Phase||0
10072299|NCT02185053|11199238|FG002|STARTED|Donepezil Dose Maintenance Phase||33
10072300|NCT02185053|11199236|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0
10072301|NCT02185053|11199237|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0
10072302|NCT02185053|11199238|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30
10072303|NCT02185053|11199236|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
10072304|NCT02185053|11199237|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
10072305|NCT02185053|11199238|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
10072306|NCT02185105|11199247|FG000|STARTED|Overall Study||30
10072307|NCT02185105|11199247|FG000|COMPLETED|Overall Study||30
10072308|NCT02185105|11199247|FG000|NOT COMPLETED|Overall Study||0
10072309|NCT02185131|11199260|FG000|STARTED|Overall Study||7
10072310|NCT02185131|11199261|FG001|STARTED|Overall Study||9
10072311|NCT02185131|11199260|FG000|COMPLETED|Overall Study||6
10072312|NCT02185131|11199261|FG001|COMPLETED|Overall Study||8
10072313|NCT02185131|11199260|FG000|NOT COMPLETED|Overall Study||1
10072314|NCT02185131|11199261|FG001|NOT COMPLETED|Overall Study||1
10072315|NCT02185183|11199267|FG000|STARTED|Overall Study||14
10072316|NCT02185183|11199267|FG000|COMPLETED|Overall Study||14
10072317|NCT02185183|11199267|FG000|NOT COMPLETED|Overall Study||0
10072318|NCT02185339|11199273|FG000|STARTED|Overall Study||30
10072319|NCT02185339|11199274|FG001|STARTED|Overall Study||31
10072320|NCT02185339|11199273|FG000|COMPLETED|Overall Study||30
10072321|NCT02185339|11199274|FG001|COMPLETED|Overall Study||30
10072322|NCT02185339|11199273|FG000|NOT COMPLETED|Overall Study||0
10072323|NCT02185339|11199274|FG001|NOT COMPLETED|Overall Study||1
10072324|NCT02185404|11199280|FG000|STARTED|Overall Study||6
10072325|NCT02185404|11199280|FG000|COMPLETED|Overall Study||6
10072326|NCT02185404|11199280|FG000|NOT COMPLETED|Overall Study||0
10072327|NCT02185521|11199284|FG000|STARTED|Overall Study||127
10072328|NCT02185521|11199284|FG000|COMPLETED|Overall Study||125
10072329|NCT02185521|11199284|FG000|NOT COMPLETED|Overall Study||2
10072330|NCT02185534|11199295|FG000|STARTED|First Period||14
10072331|NCT02185534|11199296|FG001|STARTED|First Period||14
10072332|NCT02185534|11199297|FG002|STARTED|First Period||14
10072333|NCT02185534|11199298|FG003|STARTED|First Period||14
10072334|NCT02185534|11199299|FG004|STARTED|First Period||14
10072335|NCT02185534|11199300|FG005|STARTED|First Period||14
10072336|NCT02185534|11199295|FG000|COMPLETED|First Period||14
10072337|NCT02185534|11199296|FG001|COMPLETED|First Period||14
10072338|NCT02185534|11199297|FG002|COMPLETED|First Period||14
10072339|NCT02185534|11199298|FG003|COMPLETED|First Period||13
10072340|NCT02185534|11199299|FG004|COMPLETED|First Period||14
10072341|NCT02185534|11199300|FG005|COMPLETED|First Period||14
10072342|NCT02185534|11199295|FG000|NOT COMPLETED|First Period||0
10072343|NCT02185534|11199296|FG001|NOT COMPLETED|First Period||0
10072344|NCT02185534|11199297|FG002|NOT COMPLETED|First Period||0
10072345|NCT02185534|11199298|FG003|NOT COMPLETED|First Period||1
10072346|NCT02185534|11199299|FG004|NOT COMPLETED|First Period||0
10072347|NCT02185534|11199300|FG005|NOT COMPLETED|First Period||0
10072348|NCT02185534|11199295|FG000|STARTED|First Washout Period||14
10072349|NCT02185534|11199296|FG001|STARTED|First Washout Period||14
10072350|NCT02185534|11199297|FG002|STARTED|First Washout Period||14
10072351|NCT02185534|11199298|FG003|STARTED|First Washout Period||13
10072352|NCT02185534|11199299|FG004|STARTED|First Washout Period||14
10072353|NCT02185534|11199300|FG005|STARTED|First Washout Period||14
10072354|NCT02185534|11199295|FG000|COMPLETED|First Washout Period||13
10072355|NCT02185534|11199296|FG001|COMPLETED|First Washout Period||14
10072356|NCT02185534|11199297|FG002|COMPLETED|First Washout Period||14
10072357|NCT02185534|11199298|FG003|COMPLETED|First Washout Period||13
10072358|NCT02185534|11199299|FG004|COMPLETED|First Washout Period||13
10072359|NCT02185534|11199300|FG005|COMPLETED|First Washout Period||13
10072360|NCT02185534|11199295|FG000|NOT COMPLETED|First Washout Period||1
10072361|NCT02185534|11199296|FG001|NOT COMPLETED|First Washout Period||0
10072362|NCT02185534|11199297|FG002|NOT COMPLETED|First Washout Period||0
10072363|NCT02185534|11199298|FG003|NOT COMPLETED|First Washout Period||0
10072364|NCT02185534|11199299|FG004|NOT COMPLETED|First Washout Period||1
10072365|NCT02185534|11199300|FG005|NOT COMPLETED|First Washout Period||1
10072366|NCT02185534|11199295|FG000|STARTED|Second Period||13
10072367|NCT02185534|11199296|FG001|STARTED|Second Period||14
10072368|NCT02185534|11199297|FG002|STARTED|Second Period||14
10072369|NCT02185534|11199298|FG003|STARTED|Second Period||13
10072370|NCT02185534|11199299|FG004|STARTED|Second Period||13
10072371|NCT02185534|11199300|FG005|STARTED|Second Period||13
10072372|NCT02185534|11199295|FG000|COMPLETED|Second Period||13
10072373|NCT02185534|11199296|FG001|COMPLETED|Second Period||14
10072374|NCT02185534|11199297|FG002|COMPLETED|Second Period||14
10072375|NCT02185534|11199298|FG003|COMPLETED|Second Period||13
10072376|NCT02185534|11199299|FG004|COMPLETED|Second Period||13
10072377|NCT02185534|11199300|FG005|COMPLETED|Second Period||13
10072378|NCT02185534|11199295|FG000|NOT COMPLETED|Second Period||0
10072379|NCT02185534|11199296|FG001|NOT COMPLETED|Second Period||0
10072380|NCT02185534|11199297|FG002|NOT COMPLETED|Second Period||0
10072381|NCT02185534|11199298|FG003|NOT COMPLETED|Second Period||0
10072382|NCT02185534|11199299|FG004|NOT COMPLETED|Second Period||0
10072383|NCT02185534|11199300|FG005|NOT COMPLETED|Second Period||0
10072384|NCT02185534|11199295|FG000|STARTED|Second Washout Period||13
10072385|NCT02185534|11199296|FG001|STARTED|Second Washout Period||14
10072386|NCT02185534|11199297|FG002|STARTED|Second Washout Period||14
10072387|NCT02185534|11199298|FG003|STARTED|Second Washout Period||13
10072388|NCT02185534|11199299|FG004|STARTED|Second Washout Period||13
10072389|NCT02185534|11199300|FG005|STARTED|Second Washout Period||13
10072390|NCT02185534|11199295|FG000|COMPLETED|Second Washout Period||13
10072391|NCT02185534|11199296|FG001|COMPLETED|Second Washout Period||14
10072392|NCT02185534|11199297|FG002|COMPLETED|Second Washout Period||14
10072393|NCT02185534|11199298|FG003|COMPLETED|Second Washout Period||13
10072394|NCT02185534|11199299|FG004|COMPLETED|Second Washout Period||13
10072395|NCT02185534|11199300|FG005|COMPLETED|Second Washout Period||13
10072396|NCT02185534|11199295|FG000|NOT COMPLETED|Second Washout Period||0
10072397|NCT02185534|11199296|FG001|NOT COMPLETED|Second Washout Period||0
10072398|NCT02185534|11199297|FG002|NOT COMPLETED|Second Washout Period||0
10072399|NCT02185534|11199298|FG003|NOT COMPLETED|Second Washout Period||0
10072400|NCT02185534|11199299|FG004|NOT COMPLETED|Second Washout Period||0
10072401|NCT02185534|11199300|FG005|NOT COMPLETED|Second Washout Period||0
10072402|NCT02185534|11199295|FG000|STARTED|Third Period||13
10072403|NCT02185534|11199296|FG001|STARTED|Third Period||14
10072404|NCT02185534|11199297|FG002|STARTED|Third Period||14
10072405|NCT02185534|11199298|FG003|STARTED|Third Period||13
10072406|NCT02185534|11199299|FG004|STARTED|Third Period||13
10072407|NCT02185534|11199300|FG005|STARTED|Third Period||13
10072408|NCT02185534|11199295|FG000|COMPLETED|Third Period||13
10072409|NCT02185534|11199296|FG001|COMPLETED|Third Period||14
10072410|NCT02185534|11199297|FG002|COMPLETED|Third Period||14
10072411|NCT02185534|11199298|FG003|COMPLETED|Third Period||13
10072412|NCT02185534|11199299|FG004|COMPLETED|Third Period||13
10072413|NCT02185534|11199300|FG005|COMPLETED|Third Period||13
10072414|NCT02185534|11199295|FG000|NOT COMPLETED|Third Period||0
10072415|NCT02185534|11199296|FG001|NOT COMPLETED|Third Period||0
10072416|NCT02185534|11199297|FG002|NOT COMPLETED|Third Period||0
10072417|NCT02185534|11199298|FG003|NOT COMPLETED|Third Period||0
10072418|NCT02185534|11199299|FG004|NOT COMPLETED|Third Period||0
10072419|NCT02185534|11199300|FG005|NOT COMPLETED|Third Period||0
10072420|NCT02185729|11199309|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
10072421|NCT02185729|11199309|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
10072422|NCT02185729|11199309|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
10072423|NCT02185729|11199309|FG000|STARTED|4 Hours Into Saline Infusion||12
10072424|NCT02185729|11199309|FG000|COMPLETED|4 Hours Into Saline Infusion||12
10072425|NCT02185729|11199309|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
10072426|NCT02185729|11199309|FG000|STARTED|24 Hours Into Saline Infusion||12
10072427|NCT02185729|11199309|FG000|COMPLETED|24 Hours Into Saline Infusion||12
10072428|NCT02185729|11199309|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0
10072429|NCT02185729|11199309|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
10072430|NCT02185729|11199309|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
10072431|NCT02185729|11199309|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
10072432|NCT02185729|11199309|FG000|STARTED|4 Hours Into Intralipid Infusion||12
10072433|NCT02185729|11199309|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
10072434|NCT02185729|11199309|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
10072435|NCT02185729|11199309|FG000|STARTED|24 Hours Into Intralipid Infusion||12
10072436|NCT02185729|11199309|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12
10072437|NCT02185729|11199309|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
10072438|NCT02185729|11199309|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
10072439|NCT02185729|11199309|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
10072440|NCT02185729|11199309|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
10072441|NCT02185729|11199309|FG000|STARTED|4 Hours Into ClinOleic Infusion||12
10072442|NCT02185729|11199309|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12
10072443|NCT02185729|11199309|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
10072444|NCT02185729|11199309|FG000|STARTED|24 Hours Into ClinOleic Infusion||12
10072445|NCT02185729|11199309|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12
10072446|NCT02185729|11199309|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
10072447|NCT02185729|11199309|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
10072448|NCT02185729|11199309|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
10072449|NCT02185729|11199309|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
10072450|NCT02185729|11199309|FG000|STARTED|4 Hours Into Dextrose Infusion||12
10072451|NCT02185729|11199309|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
10072452|NCT02185729|11199309|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
10072453|NCT02185729|11199309|FG000|STARTED|24 Hours Into Dextrose Infusion||12
10072454|NCT02185729|11199309|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12
10072455|NCT02185729|11199309|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
10072456|NCT02185794|11199322|FG000|STARTED|Overall Study||9
10072457|NCT02185794|11199323|FG001|STARTED|Overall Study||20
10072458|NCT02185794|11199324|FG002|STARTED|Overall Study||33
10072459|NCT02185794|11199325|FG003|STARTED|Overall Study||16
10072460|NCT02185794|11199326|FG004|STARTED|Overall Study||7
10072461|NCT02185794|11199327|FG005|STARTED|Overall Study||16
10072462|NCT02185794|11199322|FG000|COMPLETED|Overall Study||4
10072463|NCT02185794|11199323|FG001|COMPLETED|Overall Study||7
10072464|NCT02185794|11199324|FG002|COMPLETED|Overall Study||17
10072465|NCT02185794|11199325|FG003|COMPLETED|Overall Study||8
10072466|NCT02185794|11199326|FG004|COMPLETED|Overall Study||4
10072467|NCT02185794|11199327|FG005|COMPLETED|Overall Study||0
10072468|NCT02185794|11199322|FG000|NOT COMPLETED|Overall Study||5
10190058|NCT03286751|11319218|FG003|NOT COMPLETED|Washout Period 3||0
10190059|NCT03286751|11319219|FG004|NOT COMPLETED|Washout Period 3||0
10190060|NCT03286751|11319220|FG005|NOT COMPLETED|Washout Period 3||0
10190061|NCT03286751|11319215|FG000|STARTED|Period 4||7
10190062|NCT03286751|11319216|FG001|STARTED|Period 4||6
10190063|NCT03286751|11319217|FG002|STARTED|Period 4||7
10190064|NCT03286751|11319218|FG003|STARTED|Period 4||7
10190065|NCT03286751|11319219|FG004|STARTED|Period 4||6
10190066|NCT03286751|11319220|FG005|STARTED|Period 4||7
10190067|NCT03286751|11319215|FG000|COMPLETED|Period 4||7
10190068|NCT03286751|11319216|FG001|COMPLETED|Period 4||6
10190069|NCT03286751|11319217|FG002|COMPLETED|Period 4||7
10190070|NCT03286751|11319218|FG003|COMPLETED|Period 4||7
10190071|NCT03286751|11319219|FG004|COMPLETED|Period 4||6
10190072|NCT03286751|11319220|FG005|COMPLETED|Period 4||7
10190073|NCT03286751|11319215|FG000|NOT COMPLETED|Period 4||0
10190074|NCT03286751|11319216|FG001|NOT COMPLETED|Period 4||0
10190075|NCT03286751|11319217|FG002|NOT COMPLETED|Period 4||0
10190076|NCT03286751|11319218|FG003|NOT COMPLETED|Period 4||0
10190077|NCT03286751|11319219|FG004|NOT COMPLETED|Period 4||0
10190078|NCT03286751|11319220|FG005|NOT COMPLETED|Period 4||0
10190079|NCT03286751|11319215|FG000|STARTED|Washout Period 4||7
10190080|NCT03286751|11319216|FG001|STARTED|Washout Period 4||6
10190081|NCT03286751|11319217|FG002|STARTED|Washout Period 4||7
10190082|NCT03286751|11319218|FG003|STARTED|Washout Period 4||7
10190083|NCT03286751|11319219|FG004|STARTED|Washout Period 4||6
10190084|NCT03286751|11319220|FG005|STARTED|Washout Period 4||7
10190085|NCT03286751|11319215|FG000|COMPLETED|Washout Period 4||7
10190086|NCT03286751|11319216|FG001|COMPLETED|Washout Period 4||6
10190087|NCT03286751|11319217|FG002|COMPLETED|Washout Period 4||7
10190088|NCT03286751|11319218|FG003|COMPLETED|Washout Period 4||7
10190089|NCT03286751|11319219|FG004|COMPLETED|Washout Period 4||6
10190090|NCT03286751|11319220|FG005|COMPLETED|Washout Period 4||7
10190091|NCT03286751|11319215|FG000|NOT COMPLETED|Washout Period 4||0
10190092|NCT03286751|11319216|FG001|NOT COMPLETED|Washout Period 4||0
10190093|NCT03286751|11319217|FG002|NOT COMPLETED|Washout Period 4||0
10190094|NCT03286751|11319218|FG003|NOT COMPLETED|Washout Period 4||0
10190095|NCT03286751|11319219|FG004|NOT COMPLETED|Washout Period 4||0
10190096|NCT03286751|11319220|FG005|NOT COMPLETED|Washout Period 4||0
10190097|NCT03286751|11319215|FG000|STARTED|Period 5||7
10190098|NCT03286751|11319216|FG001|STARTED|Period 5||6
10190099|NCT03286751|11319217|FG002|STARTED|Period 5||7
10190100|NCT03286751|11319218|FG003|STARTED|Period 5||7
10190101|NCT03286751|11319219|FG004|STARTED|Period 5||6
10190102|NCT03286751|11319220|FG005|STARTED|Period 5||7
10190103|NCT03286751|11319215|FG000|COMPLETED|Period 5||7
10190104|NCT03286751|11319216|FG001|COMPLETED|Period 5||6
10190105|NCT03286751|11319217|FG002|COMPLETED|Period 5||7
10190106|NCT03286751|11319218|FG003|COMPLETED|Period 5||7
10190107|NCT03286751|11319219|FG004|COMPLETED|Period 5||6
10190108|NCT03286751|11319220|FG005|COMPLETED|Period 5||7
10190109|NCT03286751|11319215|FG000|NOT COMPLETED|Period 5||0
10190110|NCT03286751|11319216|FG001|NOT COMPLETED|Period 5||0
10190111|NCT03286751|11319217|FG002|NOT COMPLETED|Period 5||0
10190112|NCT03286751|11319218|FG003|NOT COMPLETED|Period 5||0
10190113|NCT03286751|11319219|FG004|NOT COMPLETED|Period 5||0
10190114|NCT03286751|11319220|FG005|NOT COMPLETED|Period 5||0
10190115|NCT03286751|11319215|FG000|STARTED|Washout Period 5||7
10190116|NCT03286751|11319216|FG001|STARTED|Washout Period 5||6
10190117|NCT03286751|11319217|FG002|STARTED|Washout Period 5||7
10190118|NCT03286751|11319218|FG003|STARTED|Washout Period 5||7
10190119|NCT03286751|11319219|FG004|STARTED|Washout Period 5||6
10190120|NCT03286751|11319220|FG005|STARTED|Washout Period 5||7
10190121|NCT03286751|11319215|FG000|COMPLETED|Washout Period 5||7
10190122|NCT03286751|11319216|FG001|COMPLETED|Washout Period 5||6
10190123|NCT03286751|11319217|FG002|COMPLETED|Washout Period 5||7
10190124|NCT03286751|11319218|FG003|COMPLETED|Washout Period 5||7
10190125|NCT03286751|11319219|FG004|COMPLETED|Washout Period 5||5
10190126|NCT03286751|11319220|FG005|COMPLETED|Washout Period 5||7
10190127|NCT03286751|11319215|FG000|NOT COMPLETED|Washout Period 5||0
10072469|NCT02185794|11199323|FG001|NOT COMPLETED|Overall Study||13
10072470|NCT02185794|11199324|FG002|NOT COMPLETED|Overall Study||16
10072471|NCT02185794|11199325|FG003|NOT COMPLETED|Overall Study||8
10072472|NCT02185794|11199326|FG004|NOT COMPLETED|Overall Study||3
10072473|NCT02185794|11199327|FG005|NOT COMPLETED|Overall Study||16
10072474|NCT02186015|11199357|FG000|STARTED|Overall Study||11
10072475|NCT02186015|11199358|FG001|STARTED|Overall Study||31
10072476|NCT02186015|11199357|FG000|COMPLETED|Overall Study||10
10072477|NCT02186015|11199358|FG001|COMPLETED|Overall Study||31
10072478|NCT02186015|11199357|FG000|NOT COMPLETED|Overall Study||1
9717430|NCT00003820|10816630|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
9717431|NCT00003820|10816629|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0
9717432|NCT00003820|10816630|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
9717433|NCT00003820|10816629|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
10072479|NCT02186015|11199358|FG001|NOT COMPLETED|Overall Study||0
10072480|NCT02186171|11199367|FG000|STARTED|Overall Study||82
10072481|NCT02186171|11199368|FG001|STARTED|Overall Study||163
10072482|NCT02186171|11199367|FG000|Received Treatment|Overall Study||81
10072483|NCT02186171|11199368|FG001|Received Treatment|Overall Study||163
10072484|NCT02186171|11199367|FG000|COMPLETED|Overall Study||78
10072485|NCT02186171|11199368|FG001|COMPLETED|Overall Study||148
10072486|NCT02186171|11199367|FG000|NOT COMPLETED|Overall Study||4
10072487|NCT02186171|11199368|FG001|NOT COMPLETED|Overall Study||15
10072488|NCT02186210|11199376|FG000|STARTED|Overall Study||20
10072489|NCT02186210|11199377|FG001|STARTED|Overall Study||20
10072490|NCT02186210|11199376|FG000|COMPLETED|Overall Study||20
10072491|NCT02186210|11199377|FG001|COMPLETED|Overall Study||20
10072492|NCT02186210|11199376|FG000|NOT COMPLETED|Overall Study||0
10072493|NCT02186210|11199377|FG001|NOT COMPLETED|Overall Study||0
10072494|NCT02186223|11199385|FG000|STARTED|Overall Study||172
10072495|NCT02186223|11199385|FG000|Device Placed|Overall Study||163
10072496|NCT02186223|11199385|FG000|COMPLETED|Overall Study||151
10072497|NCT02186223|11199385|FG000|NOT COMPLETED|Overall Study||21
10072498|NCT02186301|11199393|FG000|STARTED|Overall Study||20
10072499|NCT02186301|11199394|FG001|STARTED|Overall Study||30
10072500|NCT02186301|11199395|FG002|STARTED|Overall Study||50
10072501|NCT02186301|11199393|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10072502|NCT02186301|11199394|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10072503|NCT02186301|11199395|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10072504|NCT02186301|11199393|FG000|NOT COMPLETED|Overall Study||20
10072505|NCT02186301|11199394|FG001|NOT COMPLETED|Overall Study||30
10072506|NCT02186301|11199395|FG002|NOT COMPLETED|Overall Study||50
10072507|NCT02186509|11199405|FG000|STARTED|Overall Study||17
10072508|NCT02186509|11199405|FG000|COMPLETED|Overall Study||17
10072509|NCT02186509|11199405|FG000|NOT COMPLETED|Overall Study||0
10072510|NCT02186561|11199409|FG000|STARTED|Enrollment||197
10072511|NCT02186561|11199409|FG000|COMPLETED|Enrollment||141
10072512|NCT02186561|11199409|FG000|NOT COMPLETED|Enrollment||56
10072513|NCT02186561|11199409|FG000|STARTED|Subjects Implanted With Device||141
9717434|NCT00003820|10816630|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
9731952|NCT00138034|10831935|FG000|NOT COMPLETED|Overall Study||3
10072514|NCT02186561|11199409|FG000|COMPLETED|Subjects Implanted With Device||141
10072515|NCT02186561|11199409|FG000|NOT COMPLETED|Subjects Implanted With Device||0
10072516|NCT02186561|11199409|FG000|STARTED|30-Day Post Index Procedure Visit||141
10072517|NCT02186561|11199409|FG000|COMPLETED|30-Day Post Index Procedure Visit||140
10072518|NCT02186561|11199409|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1
10072519|NCT02186561|11199409|FG000|STARTED|180- Day Post Index Procedure Visit||141
10072520|NCT02186561|11199409|FG000|COMPLETED|180- Day Post Index Procedure Visit||134
10072521|NCT02186561|11199409|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7
10072522|NCT02186561|11199409|FG000|STARTED|1- Year Post Index Procedure Visit||141
10072523|NCT02186561|11199409|FG000|COMPLETED|1- Year Post Index Procedure Visit||139
10072524|NCT02186561|11199409|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2
10072525|NCT02186561|11199409|FG000|STARTED|2 - Year Post Index Procedure Visit||141
10072526|NCT02186561|11199409|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134
10072527|NCT02186561|11199409|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
10072528|NCT02186561|11199409|FG000|STARTED|3 - Year Post Index Procedure Visit||141
10072529|NCT02186561|11199409|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128
10072530|NCT02186561|11199409|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
10072531|NCT02186587|11199417|FG000|STARTED|Overall Study||28
10072532|NCT02186587|11199418|FG001|STARTED|Overall Study||0
10072533|NCT02186587|11199417|FG000|COMPLETED|Overall Study||23
10072534|NCT02186587|11199418|FG001|COMPLETED|Overall Study||0
10072535|NCT02186587|11199417|FG000|NOT COMPLETED|Overall Study||5
10072536|NCT02186587|11199418|FG001|NOT COMPLETED|Overall Study||0
10072537|NCT02186652|11199425|FG000|STARTED|Overall Study||19
10072538|NCT02186652|11199426|FG001|STARTED|Overall Study||22
10072539|NCT02186652|11199425|FG000|COMPLETED|Overall Study||17
10072540|NCT02186652|11199426|FG001|COMPLETED|Overall Study||22
10072541|NCT02186652|11199425|FG000|NOT COMPLETED|Overall Study||2
10072542|NCT02186652|11199426|FG001|NOT COMPLETED|Overall Study||0
10072543|NCT02186665|11199441|FG000|STARTED|Overall Study||8
10072544|NCT02186665|11199442|FG001|STARTED|Overall Study||11
10072545|NCT02186665|11199441|FG000|COMPLETED|Overall Study||8
10072546|NCT02186665|11199442|FG001|COMPLETED|Overall Study||10
10072547|NCT02186665|11199441|FG000|NOT COMPLETED|Overall Study||0
10190128|NCT03286751|11319216|FG001|NOT COMPLETED|Washout Period 5||0
10190129|NCT03286751|11319217|FG002|NOT COMPLETED|Washout Period 5||0
10190130|NCT03286751|11319218|FG003|NOT COMPLETED|Washout Period 5||0
10190131|NCT03286751|11319219|FG004|NOT COMPLETED|Washout Period 5||1
10190132|NCT03286751|11319220|FG005|NOT COMPLETED|Washout Period 5||0
10190133|NCT03286751|11319215|FG000|STARTED|Period 6||7
10190134|NCT03286751|11319216|FG001|STARTED|Period 6||6
10190135|NCT03286751|11319217|FG002|STARTED|Period 6||7
10190136|NCT03286751|11319218|FG003|STARTED|Period 6||7
10190137|NCT03286751|11319219|FG004|STARTED|Period 6||5
10190138|NCT03286751|11319220|FG005|STARTED|Period 6||7
10190139|NCT03286751|11319215|FG000|COMPLETED|Period 6||7
10190140|NCT03286751|11319216|FG001|COMPLETED|Period 6||6
10190141|NCT03286751|11319217|FG002|COMPLETED|Period 6||7
10190142|NCT03286751|11319218|FG003|COMPLETED|Period 6||7
10190143|NCT03286751|11319219|FG004|COMPLETED|Period 6||5
10190144|NCT03286751|11319220|FG005|COMPLETED|Period 6||7
10190145|NCT03286751|11319215|FG000|NOT COMPLETED|Period 6||0
10190146|NCT03286751|11319216|FG001|NOT COMPLETED|Period 6||0
10190147|NCT03286751|11319217|FG002|NOT COMPLETED|Period 6||0
10190148|NCT03286751|11319218|FG003|NOT COMPLETED|Period 6||0
10190149|NCT03286751|11319219|FG004|NOT COMPLETED|Period 6||0
10190150|NCT03286751|11319220|FG005|NOT COMPLETED|Period 6||0
10190151|NCT03286829|11319238|FG000|STARTED|Overall Study||15
10190152|NCT03286829|11319239|FG001|STARTED|Overall Study||15
10190153|NCT03286829|11319240|FG002|STARTED|Overall Study||15
10190154|NCT03286829|11319241|FG003|STARTED|Overall Study||15
10190155|NCT03286829|11319238|FG000|COMPLETED|Overall Study||15
10190156|NCT03286829|11319239|FG001|COMPLETED|Overall Study||15
10190157|NCT03286829|11319240|FG002|COMPLETED|Overall Study||15
10190158|NCT03286829|11319241|FG003|COMPLETED|Overall Study||15
10190159|NCT03286829|11319238|FG000|NOT COMPLETED|Overall Study||0
10190160|NCT03286829|11319239|FG001|NOT COMPLETED|Overall Study||0
10190161|NCT03286829|11319240|FG002|NOT COMPLETED|Overall Study||0
10190162|NCT03286829|11319241|FG003|NOT COMPLETED|Overall Study||0
10190163|NCT03287219|11319255|FG000|STARTED|Overall Study||24
10190164|NCT03287219|11319256|FG001|STARTED|Overall Study||90
10190165|NCT03287219|11319255|FG000|COMPLETED|Overall Study||24
10190166|NCT03287219|11319256|FG001|COMPLETED|Overall Study||88
10190167|NCT03287219|11319255|FG000|NOT COMPLETED|Overall Study||0
10190168|NCT03287219|11319256|FG001|NOT COMPLETED|Overall Study||2
10190169|NCT03287310|11319301|FG000|STARTED|Overall Study||12
10190170|NCT03287310|11319302|FG001|STARTED|Overall Study||6
10190171|NCT03287310|11319303|FG002|STARTED|Overall Study||6
10190172|NCT03287310|11319304|FG003|STARTED|Overall Study||9
10190173|NCT03287310|11319305|FG004|STARTED|Overall Study||9
10190174|NCT03287310|11319306|FG005|STARTED|Overall Study||6
10190175|NCT03287310|11319301|FG000|COMPLETED|Overall Study||12
10190176|NCT03287310|11319302|FG001|COMPLETED|Overall Study||6
10190177|NCT03287310|11319303|FG002|COMPLETED|Overall Study||6
10190178|NCT03287310|11319304|FG003|COMPLETED|Overall Study||9
10190179|NCT03287310|11319305|FG004|COMPLETED|Overall Study||9
10190180|NCT03287310|11319306|FG005|COMPLETED|Overall Study||6
10190181|NCT03287310|11319301|FG000|NOT COMPLETED|Overall Study||0
10190182|NCT03287310|11319302|FG001|NOT COMPLETED|Overall Study||0
10190183|NCT03287310|11319303|FG002|NOT COMPLETED|Overall Study||0
10072548|NCT02186665|11199442|FG001|NOT COMPLETED|Overall Study||1
10072549|NCT02186795|11199450|FG000|STARTED|Overall Study||24
10072550|NCT02186795|11199451|FG001|STARTED|Overall Study||24
10072551|NCT02186795|11199450|FG000|COMPLETED|Overall Study||24
10072552|NCT02186795|11199451|FG001|COMPLETED|Overall Study||24
10072553|NCT02186795|11199450|FG000|NOT COMPLETED|Overall Study||0
10072554|NCT02186795|11199451|FG001|NOT COMPLETED|Overall Study||0
10072555|NCT02186808|11199457|FG000|STARTED|Overall Study||80
10072556|NCT02186808|11199457|FG000|COMPLETED|Overall Study||67
10072557|NCT02186808|11199457|FG000|NOT COMPLETED|Overall Study||13
10072558|NCT02186821|11199461|FG000|STARTED|Overall Study||47
10072559|NCT02186821|11199461|FG000|COMPLETED|Overall Study||0
10072560|NCT02186821|11199461|FG000|NOT COMPLETED|Overall Study||47
10072561|NCT02186873|11199467|FG000|STARTED|Overall Study||103
10072562|NCT02186873|11199468|FG001|STARTED|Overall Study||105
10072563|NCT02186873|11199467|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
10072564|NCT02186873|11199468|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105
10072565|NCT02186873|11199467|FG000|COMPLETED|Overall Study||94
10072566|NCT02186873|11199468|FG001|COMPLETED|Overall Study||97
10072567|NCT02186873|11199467|FG000|NOT COMPLETED|Overall Study||9
10072568|NCT02186873|11199468|FG001|NOT COMPLETED|Overall Study||8
10072569|NCT02186938|11199477|FG000|STARTED|Overall Study|2012|47
10072570|NCT02186938|11199478|FG001|STARTED|Overall Study||47
10072571|NCT02186938|11199477|FG000|COMPLETED|Overall Study||38
10072572|NCT02186938|11199478|FG001|COMPLETED|Overall Study||44
10072573|NCT02186938|11199477|FG000|NOT COMPLETED|Overall Study||9
10072574|NCT02186938|11199478|FG001|NOT COMPLETED|Overall Study||3
10072575|NCT02187016|11199488|FG000|STARTED|Overall Study||80
10072576|NCT02187016|11199489|FG001|STARTED|Overall Study||80
10072577|NCT02187016|11199490|FG002|STARTED|Overall Study||79
10072578|NCT02187016|11199491|FG003|STARTED|Overall Study||51
10072579|NCT02187016|11199488|FG000|COMPLETED|Overall Study||79
10072580|NCT02187016|11199489|FG001|COMPLETED|Overall Study||78
10072581|NCT02187016|11199490|FG002|COMPLETED|Overall Study||78
10072582|NCT02187016|11199491|FG003|COMPLETED|Overall Study||51
10072583|NCT02187016|11199488|FG000|NOT COMPLETED|Overall Study||1
10072584|NCT02187016|11199489|FG001|NOT COMPLETED|Overall Study||2
10072585|NCT02187016|11199490|FG002|NOT COMPLETED|Overall Study||1
10072586|NCT02187016|11199491|FG003|NOT COMPLETED|Overall Study||0
10072587|NCT02187029|11199505|FG000|STARTED|Overall Study||7
10072588|NCT02187029|11199506|FG001|STARTED|Overall Study||3
10072589|NCT02187029|11199507|FG002|STARTED|Overall Study||11
10072590|NCT02187029|11199508|FG003|STARTED|Overall Study||9
10072591|NCT02187029|11199505|FG000|COMPLETED|Overall Study||6
10072592|NCT02187029|11199506|FG001|COMPLETED|Overall Study||2
10072593|NCT02187029|11199507|FG002|COMPLETED|Overall Study||0
10072594|NCT02187029|11199508|FG003|COMPLETED|Overall Study||6
10072595|NCT02187029|11199505|FG000|NOT COMPLETED|Overall Study||1
10072596|NCT02187029|11199506|FG001|NOT COMPLETED|Overall Study||1
10072597|NCT02187029|11199507|FG002|NOT COMPLETED|Overall Study||11
10072598|NCT02187029|11199508|FG003|NOT COMPLETED|Overall Study||3
10072599|NCT02187042|11199520|FG000|STARTED|Overall Study||42
10072600|NCT02187042|11199521|FG001|STARTED|Overall Study||27
10072601|NCT02187042|11199520|FG000|COMPLETED|Overall Study||29
10072602|NCT02187042|11199521|FG001|COMPLETED|Overall Study||13
10072603|NCT02187042|11199520|FG000|NOT COMPLETED|Overall Study||13
10072604|NCT02187042|11199521|FG001|NOT COMPLETED|Overall Study||14
10072605|NCT02187055|11199531|FG000|STARTED|Overall Study|Treated|384
10072606|NCT02187055|11199532|FG001|STARTED|Overall Study|Treated|376
10072607|NCT02187055|11199533|FG002|STARTED|Overall Study|Treated|386
10072608|NCT02187055|11199531|FG000|COMPLETED|Overall Study||315
10072609|NCT02187055|11199532|FG001|COMPLETED|Overall Study||303
10072610|NCT02187055|11199533|FG002|COMPLETED|Overall Study||312
10072611|NCT02187055|11199531|FG000|NOT COMPLETED|Overall Study||69
10072612|NCT02187055|11199532|FG001|NOT COMPLETED|Overall Study||73
10072613|NCT02187055|11199533|FG002|NOT COMPLETED|Overall Study||74
10072614|NCT02187159|11199545|FG000|STARTED|Overall Study||318
10072615|NCT02187159|11199546|FG001|STARTED|Overall Study||317
10072616|NCT02187159|11199547|FG002|STARTED|Overall Study||318
10072617|NCT02187159|11199548|FG003|STARTED|Overall Study||317
10072618|NCT02187159|11199545|FG000|COMPLETED|Overall Study||249
10072619|NCT02187159|11199546|FG001|COMPLETED|Overall Study||238
10072620|NCT02187159|11199547|FG002|COMPLETED|Overall Study||241
10072621|NCT02187159|11199548|FG003|COMPLETED|Overall Study||221
10072622|NCT02187159|11199545|FG000|NOT COMPLETED|Overall Study||69
10072623|NCT02187159|11199546|FG001|NOT COMPLETED|Overall Study||79
10072624|NCT02187159|11199547|FG002|NOT COMPLETED|Overall Study||77
10072625|NCT02187159|11199548|FG003|NOT COMPLETED|Overall Study||96
10072626|NCT02187172|11199560|FG000|STARTED|Overall Study||22
10072627|NCT02187172|11199561|FG001|STARTED|Overall Study||21
10072628|NCT02187172|11199560|FG000|RCT Phase Completed|Overall Study||22
9731953|NCT00138034|10831936|FG001|NOT COMPLETED|Overall Study||3
10072629|NCT02187172|11199561|FG001|RCT Phase Completed|Overall Study||19
10072630|NCT02187172|11199560|FG000|COMPLETED|Overall Study||19
10072631|NCT02187172|11199561|FG001|COMPLETED|Overall Study||15
10072632|NCT02187172|11199560|FG000|NOT COMPLETED|Overall Study||3
10072633|NCT02187172|11199561|FG001|NOT COMPLETED|Overall Study||6
10072634|NCT02187471|11199573|FG000|STARTED|Overall Study||325
10072635|NCT02187471|11199574|FG001|STARTED|Overall Study||324
10072636|NCT02187471|11199575|FG002|STARTED|Overall Study||326
10072637|NCT02187471|11199576|FG003|STARTED|Overall Study||326
10072638|NCT02187471|11199573|FG000|COMPLETED|Overall Study||249
10072639|NCT02187471|11199574|FG001|COMPLETED|Overall Study||242
10072640|NCT02187471|11199575|FG002|COMPLETED|Overall Study||240
10072641|NCT02187471|11199576|FG003|COMPLETED|Overall Study||246
10072642|NCT02187471|11199573|FG000|NOT COMPLETED|Overall Study||76
10072643|NCT02187471|11199574|FG001|NOT COMPLETED|Overall Study||82
10072644|NCT02187471|11199575|FG002|NOT COMPLETED|Overall Study||86
10072645|NCT02187471|11199576|FG003|NOT COMPLETED|Overall Study||80
10072646|NCT02187744|11199589|FG000|STARTED|Study|Received treatment|113
10072647|NCT02187744|11199590|FG001|STARTED|Study|Received treatment|112
10072648|NCT02187744|11199589|FG000|COMPLETED|Study||109
10072649|NCT02187744|11199590|FG001|COMPLETED|Study||106
10072650|NCT02187744|11199589|FG000|NOT COMPLETED|Study||4
10072651|NCT02187744|11199590|FG001|NOT COMPLETED|Study||6
10072652|NCT02187744|11199589|FG000|STARTED|Treatment||113
10072653|NCT02187744|11199590|FG001|STARTED|Treatment||112
10072654|NCT02187744|11199589|FG000|COMPLETED|Treatment||109
10072655|NCT02187744|11199590|FG001|COMPLETED|Treatment||107
10072656|NCT02187744|11199589|FG000|NOT COMPLETED|Treatment||4
10072657|NCT02187744|11199590|FG001|NOT COMPLETED|Treatment||5
10072658|NCT02187783|11199596|FG000|STARTED|Overall Study||106
10072659|NCT02187783|11199596|FG000|Patients With Solid Tumors|Overall Study||105
10072660|NCT02187783|11199596|FG000|COMPLETED|Overall Study||0
10072661|NCT02187783|11199596|FG000|NOT COMPLETED|Overall Study||106
10072662|NCT02187809|11199600|FG000|STARTED|Overall Study||3
10072663|NCT02187809|11199600|FG000|Treated|Overall Study||1
10072664|NCT02187809|11199600|FG000|COMPLETED|Overall Study||0
10072665|NCT02187809|11199600|FG000|NOT COMPLETED|Overall Study||3
10072666|NCT02187861|11199608|FG000|STARTED|Overall Study||9
10072667|NCT02187861|11199609|FG001|STARTED|Overall Study||52
10072668|NCT02187861|11199610|FG002|STARTED|Overall Study||51
10072669|NCT02187861|11199611|FG003|STARTED|Overall Study||51
10072670|NCT02187861|11199608|FG000|Treated|Overall Study||9
10072671|NCT02187861|11199609|FG001|Treated|Overall Study||52
10072672|NCT02187861|11199610|FG002|Treated|Overall Study||49
10072673|NCT02187861|11199611|FG003|Treated|Overall Study||50
10072674|NCT02187861|11199608|FG000|COMPLETED|Overall Study||3
10072675|NCT02187861|11199609|FG001|COMPLETED|Overall Study||4
10072676|NCT02187861|11199610|FG002|COMPLETED|Overall Study||19
10072677|NCT02187861|11199611|FG003|COMPLETED|Overall Study||19
10072678|NCT02187861|11199608|FG000|NOT COMPLETED|Overall Study||6
10072679|NCT02187861|11199609|FG001|NOT COMPLETED|Overall Study||48
10072680|NCT02187861|11199610|FG002|NOT COMPLETED|Overall Study||32
10072681|NCT02187861|11199611|FG003|NOT COMPLETED|Overall Study||32
10072682|NCT02187887|11199623|FG000|STARTED|Overall Study||393
10072683|NCT02187887|11199624|FG001|STARTED|Overall Study||400
10072684|NCT02187887|11199623|FG000|COMPLETED|Overall Study||388
10072685|NCT02187887|11199624|FG001|COMPLETED|Overall Study||396
10072686|NCT02187887|11199623|FG000|NOT COMPLETED|Overall Study||5
10072687|NCT02187887|11199624|FG001|NOT COMPLETED|Overall Study||4
10072688|NCT02188160|11199632|FG000|STARTED|Overall Study||73
10072689|NCT02188160|11199633|FG001|STARTED|Overall Study||77
10072690|NCT02188160|11199632|FG000|COMPLETED|Overall Study||72
10072691|NCT02188160|11199633|FG001|COMPLETED|Overall Study||76
10072692|NCT02188160|11199632|FG000|NOT COMPLETED|Overall Study||1
10072693|NCT02188160|11199633|FG001|NOT COMPLETED|Overall Study||1
10072694|NCT02188303|11199647|FG000|STARTED|Overall Study||6
10072695|NCT02188303|11199648|FG001|STARTED|Overall Study||6
10072696|NCT02188303|11199649|FG002|STARTED|Overall Study||6
10072697|NCT02188303|11199650|FG003|STARTED|Overall Study||6
10072698|NCT02188303|11199651|FG004|STARTED|Overall Study||4
10072699|NCT02188303|11199652|FG005|STARTED|Overall Study||12
10072700|NCT02188303|11199653|FG006|STARTED|Overall Study||2
10072701|NCT02188303|11199654|FG007|STARTED|Overall Study||6
10072702|NCT02188303|11199647|FG000|COMPLETED|Overall Study||6
10072703|NCT02188303|11199648|FG001|COMPLETED|Overall Study||6
10072704|NCT02188303|11199649|FG002|COMPLETED|Overall Study||6
10072705|NCT02188303|11199650|FG003|COMPLETED|Overall Study||6
10072706|NCT02188303|11199651|FG004|COMPLETED|Overall Study||4
10072707|NCT02188303|11199652|FG005|COMPLETED|Overall Study||10
10072708|NCT02188303|11199653|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
10072709|NCT02188303|11199654|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
10072710|NCT02188303|11199647|FG000|NOT COMPLETED|Overall Study||0
10072711|NCT02188303|11199648|FG001|NOT COMPLETED|Overall Study||0
10072712|NCT02188303|11199649|FG002|NOT COMPLETED|Overall Study||0
10072713|NCT02188303|11199650|FG003|NOT COMPLETED|Overall Study||0
10072714|NCT02188303|11199651|FG004|NOT COMPLETED|Overall Study||0
10072715|NCT02188303|11199652|FG005|NOT COMPLETED|Overall Study||2
10072716|NCT02188303|11199653|FG006|NOT COMPLETED|Overall Study||2
10072717|NCT02188303|11199654|FG007|NOT COMPLETED|Overall Study||6
10072718|NCT02188459|11199680|FG000|STARTED|Overall Study||64
10072719|NCT02188459|11199681|FG001|STARTED|Overall Study||65
10072720|NCT02188459|11199680|FG000|COMPLETED|Overall Study||61
10072721|NCT02188459|11199681|FG001|COMPLETED|Overall Study||58
10072722|NCT02188459|11199680|FG000|NOT COMPLETED|Overall Study||3
10072723|NCT02188459|11199681|FG001|NOT COMPLETED|Overall Study||7
10072724|NCT02188485|11199693|FG000|STARTED|Overall Study||32
10072725|NCT02188485|11199694|FG001|STARTED|Overall Study||30
10072726|NCT02188485|11199693|FG000|COMPLETED|Overall Study||30
10072727|NCT02188485|11199694|FG001|COMPLETED|Overall Study||27
10072728|NCT02188485|11199693|FG000|NOT COMPLETED|Overall Study||2
10072729|NCT02188485|11199694|FG001|NOT COMPLETED|Overall Study||3
10072730|NCT02188576|11199702|FG000|STARTED|Overall Study||32
10072731|NCT02188576|11199703|FG001|STARTED|Overall Study||34
10072732|NCT02188576|11199702|FG000|COMPLETED|Overall Study||32
10072733|NCT02188576|11199703|FG001|COMPLETED|Overall Study||34
10072734|NCT02188576|11199702|FG000|NOT COMPLETED|Overall Study||0
10072735|NCT02188576|11199703|FG001|NOT COMPLETED|Overall Study||0
10072736|NCT02188589|11199709|FG000|STARTED|Overall Study||30
10072737|NCT02188589|11199709|FG000|6 Months|Overall Study||30
10072738|NCT02188589|11199709|FG000|12 Months|Overall Study||30
10072739|NCT02188589|11199709|FG000|24 Months|Overall Study||25
10072740|NCT02188589|11199709|FG000|COMPLETED|Overall Study||25
10072741|NCT02188589|11199709|FG000|NOT COMPLETED|Overall Study||5
10072742|NCT02188719|11199718|FG000|STARTED|Overall Study||6
10072743|NCT02188719|11199719|FG001|STARTED|Overall Study||9
10072744|NCT02188719|11199720|FG002|STARTED|Overall Study||0
10072745|NCT02188719|11199721|FG003|STARTED|Overall Study||0
10072746|NCT02188719|11199718|FG000|COMPLETED|Overall Study||6
10072747|NCT02188719|11199719|FG001|COMPLETED|Overall Study||8
10072748|NCT02188719|11199720|FG002|COMPLETED|Overall Study||0
10072749|NCT02188719|11199721|FG003|COMPLETED|Overall Study||0
10072750|NCT02188719|11199718|FG000|NOT COMPLETED|Overall Study||0
10072751|NCT02188719|11199719|FG001|NOT COMPLETED|Overall Study||1
10072752|NCT02188719|11199720|FG002|NOT COMPLETED|Overall Study||0
10072753|NCT02188719|11199721|FG003|NOT COMPLETED|Overall Study||0
10072754|NCT02188784|11199731|FG000|STARTED|Overall Study||111
10072755|NCT02188784|11199732|FG001|STARTED|Overall Study||114
10072756|NCT02188784|11199731|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
10072757|NCT02188784|11199732|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
10072758|NCT02188784|11199731|FG000|NOT COMPLETED|Overall Study||9
10072759|NCT02188784|11199732|FG001|NOT COMPLETED|Overall Study||13
10072760|NCT02188849|11199740|FG000|STARTED|Overall Study||25
10072761|NCT02188849|11199741|FG001|STARTED|Overall Study||25
10072762|NCT02188849|11199740|FG000|COMPLETED|Overall Study||22
10072763|NCT02188849|11199741|FG001|COMPLETED|Overall Study||17
10072764|NCT02188849|11199740|FG000|NOT COMPLETED|Overall Study||3
10072765|NCT02188849|11199741|FG001|NOT COMPLETED|Overall Study||8
10072766|NCT02189122|11199749|FG000|STARTED|Overall Study||18
10072767|NCT02189122|11199750|FG001|STARTED|Overall Study||18
10072768|NCT02189122|11199749|FG000|COMPLETED|Overall Study||18
10072769|NCT02189122|11199750|FG001|COMPLETED|Overall Study||18
10072770|NCT02189122|11199749|FG000|NOT COMPLETED|Overall Study||0
10072771|NCT02189122|11199750|FG001|NOT COMPLETED|Overall Study||0
10072772|NCT02189161|11199758|FG000|STARTED|Overall Study||10
10072773|NCT02189161|11199758|FG000|COMPLETED|Overall Study||10
10072774|NCT02189161|11199758|FG000|NOT COMPLETED|Overall Study||0
10072775|NCT02189213|11199764|FG000|STARTED|Overall Study||13
10072776|NCT02189213|11199765|FG001|STARTED|Overall Study||1
10072777|NCT02189213|11199764|FG000|COMPLETED|Overall Study||7
10072778|NCT02189213|11199765|FG001|COMPLETED|Overall Study||1
10072779|NCT02189213|11199764|FG000|NOT COMPLETED|Overall Study||6
10072780|NCT02189213|11199765|FG001|NOT COMPLETED|Overall Study||0
10072781|NCT02189252|11199775|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4
10072782|NCT02189252|11199776|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4
10072783|NCT02189252|11199777|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3
10072784|NCT02189252|11199778|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4
10072785|NCT02189252|11199775|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4
10072786|NCT02189252|11199776|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2
10072787|NCT02189252|11199777|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3
10072788|NCT02189252|11199778|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4
10072789|NCT02189252|11199775|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
10072790|NCT02189252|11199776|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
10072791|NCT02189252|11199777|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
10072792|NCT02189252|11199778|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
10072793|NCT02189252|11199775|FG000|STARTED|Period 2 (Visit6b, Week 12)||4
10072794|NCT02189252|11199776|FG001|STARTED|Period 2 (Visit6b, Week 12)||2
10072795|NCT02189252|11199777|FG002|STARTED|Period 2 (Visit6b, Week 12)||3
10072796|NCT02189252|11199778|FG003|STARTED|Period 2 (Visit6b, Week 12)||4
10072797|NCT02189252|11199775|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4
10072798|NCT02189252|11199776|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2
10072799|NCT02189252|11199777|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3
10072800|NCT02189252|11199778|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4
10072801|NCT02189252|11199775|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10072802|NCT02189252|11199776|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10190184|NCT03287310|11319304|FG003|NOT COMPLETED|Overall Study||0
10190185|NCT03287310|11319305|FG004|NOT COMPLETED|Overall Study||0
10072803|NCT02189252|11199777|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10072804|NCT02189252|11199778|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10072805|NCT02189317|11199791|FG000|STARTED|Overall Study||16
10072806|NCT02189317|11199792|FG001|STARTED|Overall Study||16
10072807|NCT02189317|11199791|FG000|COMPLETED|Overall Study||16
10072808|NCT02189317|11199792|FG001|COMPLETED|Overall Study||16
10072809|NCT02189317|11199791|FG000|NOT COMPLETED|Overall Study||0
10072810|NCT02189317|11199792|FG001|NOT COMPLETED|Overall Study||0
10072811|NCT02189382|11199800|FG000|STARTED|Overall Study||35
10072812|NCT02189382|11199801|FG001|STARTED|Overall Study||35
10072813|NCT02189382|11199800|FG000|COMPLETED|Overall Study||35
10072814|NCT02189382|11199801|FG001|COMPLETED|Overall Study||35
10190186|NCT03287310|11319306|FG005|NOT COMPLETED|Overall Study||0
10190187|NCT03287622|11319330|FG000|STARTED|Overall Study||356
10072815|NCT02189382|11199800|FG000|NOT COMPLETED|Overall Study||0
10072816|NCT02189382|11199801|FG001|NOT COMPLETED|Overall Study||0
10072817|NCT02189473|11199809|FG000|STARTED|Overall Study||101
10072818|NCT02189473|11199810|FG001|STARTED|Overall Study||102
10072819|NCT02189473|11199809|FG000|COMPLETED|Overall Study||78
10072820|NCT02189473|11199810|FG001|COMPLETED|Overall Study||77
10072821|NCT02189473|11199809|FG000|NOT COMPLETED|Overall Study||23
10072822|NCT02189473|11199810|FG001|NOT COMPLETED|Overall Study||25
10072823|NCT02189629|11199816|FG000|STARTED|Overall Study||453
10072824|NCT02189629|11199816|FG000|COMPLETED|Overall Study||348
10072825|NCT02189629|11199816|FG000|NOT COMPLETED|Overall Study||105
10072826|NCT02189668|11199822|FG000|STARTED|Overall Study||5
10072827|NCT02189668|11199823|FG001|STARTED|Overall Study||9
10072828|NCT02189668|11199822|FG000|COMPLETED|Overall Study||5
10072829|NCT02189668|11199823|FG001|COMPLETED|Overall Study||9
10072830|NCT02189668|11199822|FG000|NOT COMPLETED|Overall Study||0
10072831|NCT02189668|11199823|FG001|NOT COMPLETED|Overall Study||0
10072832|NCT02189759|11199833|FG000|STARTED|Overall Study||102
10072833|NCT02189759|11199834|FG001|STARTED|Overall Study||101
10072834|NCT02189759|11199835|FG002|STARTED|Overall Study||83
10072835|NCT02189759|11199836|FG003|STARTED|Overall Study||89
10072836|NCT02189759|11199833|FG000|COMPLETED|Overall Study||102
10072837|NCT02189759|11199834|FG001|COMPLETED|Overall Study||101
10072838|NCT02189759|11199835|FG002|COMPLETED|Overall Study||81
10072839|NCT02189759|11199836|FG003|COMPLETED|Overall Study||84
10072840|NCT02189759|11199833|FG000|NOT COMPLETED|Overall Study||0
10072841|NCT02189759|11199834|FG001|NOT COMPLETED|Overall Study||0
10072842|NCT02189759|11199835|FG002|NOT COMPLETED|Overall Study||2
10072843|NCT02189759|11199836|FG003|NOT COMPLETED|Overall Study||5
10072844|NCT02189837|11199852|FG000|STARTED|Overall Study||22
10072845|NCT02189837|11199853|FG001|STARTED|Overall Study||23
10072846|NCT02189837|11199854|FG002|STARTED|Overall Study||23
10072847|NCT02189837|11199855|FG003|STARTED|Overall Study||21
10072848|NCT02189837|11199852|FG000|Received Treatment|Overall Study||21
10072849|NCT02189837|11199853|FG001|Received Treatment|Overall Study||22
10072850|NCT02189837|11199854|FG002|Received Treatment|Overall Study||22
10072851|NCT02189837|11199855|FG003|Received Treatment|Overall Study||20
10072852|NCT02189837|11199852|FG000|COMPLETED|Overall Study||20
10072853|NCT02189837|11199853|FG001|COMPLETED|Overall Study||22
10072854|NCT02189837|11199854|FG002|COMPLETED|Overall Study||20
10072855|NCT02189837|11199855|FG003|COMPLETED|Overall Study||19
10072856|NCT02189837|11199852|FG000|NOT COMPLETED|Overall Study||2
10072857|NCT02189837|11199853|FG001|NOT COMPLETED|Overall Study||1
10072858|NCT02189837|11199854|FG002|NOT COMPLETED|Overall Study||3
10072859|NCT02189837|11199855|FG003|NOT COMPLETED|Overall Study||2
10072860|NCT02189850|11199867|FG000|STARTED|Overall Study||16
10072861|NCT02189850|11199868|FG001|STARTED|Overall Study||13
10072862|NCT02189850|11199867|FG000|COMPLETED|Overall Study||14
10072863|NCT02189850|11199868|FG001|COMPLETED|Overall Study||11
10072864|NCT02189850|11199867|FG000|NOT COMPLETED|Overall Study||2
10072865|NCT02189850|11199868|FG001|NOT COMPLETED|Overall Study||2
10072866|NCT02189863|11199874|FG000|STARTED|First 2 Weeks||12
10072867|NCT02189863|11199875|FG001|STARTED|First 2 Weeks||15
10072868|NCT02189863|11199874|FG000|COMPLETED|First 2 Weeks||8
10072869|NCT02189863|11199875|FG001|COMPLETED|First 2 Weeks||13
10072870|NCT02189863|11199874|FG000|NOT COMPLETED|First 2 Weeks||4
10072871|NCT02189863|11199875|FG001|NOT COMPLETED|First 2 Weeks||2
10072872|NCT02189863|11199874|FG000|STARTED|Second 2 Weeks||8
10072873|NCT02189863|11199875|FG001|STARTED|Second 2 Weeks||13
10072874|NCT02189863|11199874|FG000|COMPLETED|Second 2 Weeks||8
10072875|NCT02189863|11199875|FG001|COMPLETED|Second 2 Weeks||13
10072876|NCT02189863|11199874|FG000|NOT COMPLETED|Second 2 Weeks||0
10072877|NCT02189863|11199875|FG001|NOT COMPLETED|Second 2 Weeks||0
10072878|NCT02189889|11199886|FG000|STARTED|Overall Study||2
10072879|NCT02189889|11199887|FG001|STARTED|Overall Study||3
10072880|NCT02189889|11199886|FG000|COMPLETED|Overall Study||2
10072881|NCT02189889|11199887|FG001|COMPLETED|Overall Study||3
10072882|NCT02189889|11199886|FG000|NOT COMPLETED|Overall Study||0
10072883|NCT02189889|11199887|FG001|NOT COMPLETED|Overall Study||0
10072884|NCT02189915|11199893|FG000|STARTED|Overall Study||14
10072885|NCT02189915|11199893|FG000|COMPLETED|Overall Study||11
10072886|NCT02189915|11199893|FG000|NOT COMPLETED|Overall Study||3
10072887|NCT02189941|11199897|FG000|STARTED|Overall Study||4
10072888|NCT02189941|11199898|FG001|STARTED|Overall Study||4
10072889|NCT02189941|11199899|FG002|STARTED|Overall Study||3
10072890|NCT02189941|11199897|FG000|COMPLETED|Overall Study||4
10072891|NCT02189941|11199898|FG001|COMPLETED|Overall Study||4
10072892|NCT02189941|11199899|FG002|COMPLETED|Overall Study||2
10072893|NCT02189941|11199897|FG000|NOT COMPLETED|Overall Study||0
10072894|NCT02189941|11199898|FG001|NOT COMPLETED|Overall Study||0
10072895|NCT02189941|11199899|FG002|NOT COMPLETED|Overall Study||1
10072896|NCT02189954|11199909|FG000|STARTED|Overall Study||45
10072897|NCT02189954|11199910|FG001|STARTED|Overall Study||45
10072898|NCT02189954|11199909|FG000|COMPLETED|Overall Study||45
10072899|NCT02189954|11199910|FG001|COMPLETED|Overall Study||45
10072900|NCT02189954|11199909|FG000|NOT COMPLETED|Overall Study||0
10072901|NCT02189954|11199910|FG001|NOT COMPLETED|Overall Study||0
10072902|NCT02190045|11199918|FG000|STARTED|Overall Study||15
10072903|NCT02190045|11199919|FG001|STARTED|Overall Study||15
10072904|NCT02190045|11199918|FG000|COMPLETED|Overall Study||12
10072905|NCT02190045|11199919|FG001|COMPLETED|Overall Study||15
10072906|NCT02190045|11199918|FG000|NOT COMPLETED|Overall Study||3
10072907|NCT02190045|11199919|FG001|NOT COMPLETED|Overall Study||0
10072908|NCT02190279|11199928|FG000|STARTED|Overall Study||16
10072909|NCT02190279|11199929|FG001|STARTED|Overall Study||69
10072910|NCT02190279|11199930|FG002|STARTED|Overall Study||31
10072911|NCT02190279|11199928|FG000|COMPLETED|Overall Study||13
10072912|NCT02190279|11199929|FG001|COMPLETED|Overall Study||69
10072913|NCT02190279|11199930|FG002|COMPLETED|Overall Study||28
10072914|NCT02190279|11199928|FG000|NOT COMPLETED|Overall Study||3
10072915|NCT02190279|11199929|FG001|NOT COMPLETED|Overall Study||0
10072916|NCT02190279|11199930|FG002|NOT COMPLETED|Overall Study||3
10072917|NCT02190435|11199942|FG000|STARTED|Overall Study||41
10072918|NCT02190435|11199943|FG001|STARTED|Overall Study||24
10072919|NCT02190435|11199942|FG000|COMPLETED|Overall Study||26
10072920|NCT02190435|11199943|FG001|COMPLETED|Overall Study||24
10072921|NCT02190435|11199942|FG000|NOT COMPLETED|Overall Study||15
10072922|NCT02190435|11199943|FG001|NOT COMPLETED|Overall Study||0
10072923|NCT02190552|11199949|FG000|STARTED|Overall Study||40
10072924|NCT02190552|11199949|FG000|COMPLETED|Overall Study||36
10072925|NCT02190552|11199949|FG000|NOT COMPLETED|Overall Study||4
10072926|NCT02190591|11199956|FG000|STARTED|Overall Study||102
10072927|NCT02190591|11199957|FG001|STARTED|Overall Study||102
10072928|NCT02190591|11199956|FG000|COMPLETED|Overall Study||100
10072929|NCT02190591|11199957|FG001|COMPLETED|Overall Study||91
10072930|NCT02190591|11199956|FG000|NOT COMPLETED|Overall Study||2
10072931|NCT02190591|11199957|FG001|NOT COMPLETED|Overall Study||11
10072932|NCT02190604|11199982|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072933|NCT02190604|11199983|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072934|NCT02190604|11199984|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072935|NCT02190604|11199985|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072936|NCT02190604|11199986|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072937|NCT02190604|11199987|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072938|NCT02190604|11199988|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072939|NCT02190604|11199989|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072940|NCT02190604|11199990|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16
10072941|NCT02190604|11199991|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072942|NCT02190604|11199992|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072943|NCT02190604|11199993|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072944|NCT02190604|11199994|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072945|NCT02190604|11199995|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10072946|NCT02190604|11199996|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10
10072947|NCT02190604|11199997|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10072948|NCT02190604|11199998|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10072949|NCT02190604|11199999|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10072950|NCT02190604|11200000|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10072951|NCT02190604|11199982|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072952|NCT02190604|11199983|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072953|NCT02190604|11199984|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072954|NCT02190604|11199985|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072955|NCT02190604|11199986|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072956|NCT02190604|11199987|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072957|NCT02190604|11199988|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072958|NCT02190604|11199989|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072959|NCT02190604|11199990|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
10072960|NCT02190604|11199991|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072961|NCT02190604|11199992|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072962|NCT02190604|11199993|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072963|NCT02190604|11199994|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10072964|NCT02190604|11199995|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
10072965|NCT02190604|11199996|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
10072966|NCT02190604|11199997|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072967|NCT02190604|11199998|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072968|NCT02190604|11199999|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072969|NCT02190604|11200000|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072970|NCT02190604|11199982|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072971|NCT02190604|11199983|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072972|NCT02190604|11199984|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072973|NCT02190604|11199985|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072974|NCT02190604|11199986|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072975|NCT02190604|11199987|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072976|NCT02190604|11199988|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072977|NCT02190604|11199989|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072978|NCT02190604|11199990|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072979|NCT02190604|11199991|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072980|NCT02190604|11199992|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072981|NCT02190604|11199993|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072982|NCT02190604|11199994|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072983|NCT02190604|11199995|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
10072984|NCT02190604|11199996|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
10072985|NCT02190604|11199997|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072986|NCT02190604|11199998|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072987|NCT02190604|11199999|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072988|NCT02190604|11200000|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10072989|NCT02190604|11199982|FG000|STARTED|Part 3 (Patients)||0
10072990|NCT02190604|11199983|FG001|STARTED|Part 3 (Patients)||0
10072991|NCT02190604|11199984|FG002|STARTED|Part 3 (Patients)||0
10072992|NCT02190604|11199985|FG003|STARTED|Part 3 (Patients)||0
10072993|NCT02190604|11199986|FG004|STARTED|Part 3 (Patients)||0
10072994|NCT02190604|11199987|FG005|STARTED|Part 3 (Patients)||0
10072995|NCT02190604|11199988|FG006|STARTED|Part 3 (Patients)||0
10072996|NCT02190604|11199989|FG007|STARTED|Part 3 (Patients)||0
10072997|NCT02190604|11199990|FG008|STARTED|Part 3 (Patients)||0
10072998|NCT02190604|11199991|FG009|STARTED|Part 3 (Patients)||0
10072999|NCT02190604|11199992|FG010|STARTED|Part 3 (Patients)||0
10073000|NCT02190604|11199993|FG011|STARTED|Part 3 (Patients)||0
10073001|NCT02190604|11199994|FG012|STARTED|Part 3 (Patients)||0
10073002|NCT02190604|11199995|FG013|STARTED|Part 3 (Patients)||0
10073003|NCT02190604|11199996|FG014|STARTED|Part 3 (Patients)||0
10073004|NCT02190604|11199997|FG015|STARTED|Part 3 (Patients)||6
10073005|NCT02190604|11199998|FG016|STARTED|Part 3 (Patients)||12
10073006|NCT02190604|11199999|FG017|STARTED|Part 3 (Patients)||19
10073007|NCT02190604|11200000|FG018|STARTED|Part 3 (Patients)||12
10073008|NCT02190604|11199982|FG000|COMPLETED|Part 3 (Patients)||0
10073009|NCT02190604|11199983|FG001|COMPLETED|Part 3 (Patients)||0
10073010|NCT02190604|11199984|FG002|COMPLETED|Part 3 (Patients)||0
10073011|NCT02190604|11199985|FG003|COMPLETED|Part 3 (Patients)||0
10073012|NCT02190604|11199986|FG004|COMPLETED|Part 3 (Patients)||0
10073013|NCT02190604|11199987|FG005|COMPLETED|Part 3 (Patients)||0
10073014|NCT02190604|11199988|FG006|COMPLETED|Part 3 (Patients)||0
10073015|NCT02190604|11199989|FG007|COMPLETED|Part 3 (Patients)||0
10073016|NCT02190604|11199990|FG008|COMPLETED|Part 3 (Patients)||0
10073017|NCT02190604|11199991|FG009|COMPLETED|Part 3 (Patients)||0
10073018|NCT02190604|11199992|FG010|COMPLETED|Part 3 (Patients)||0
10073019|NCT02190604|11199993|FG011|COMPLETED|Part 3 (Patients)||0
10073020|NCT02190604|11199994|FG012|COMPLETED|Part 3 (Patients)||0
10073021|NCT02190604|11199995|FG013|COMPLETED|Part 3 (Patients)||0
10073022|NCT02190604|11199996|FG014|COMPLETED|Part 3 (Patients)||0
10073023|NCT02190604|11199997|FG015|COMPLETED|Part 3 (Patients)||6
10073024|NCT02190604|11199998|FG016|COMPLETED|Part 3 (Patients)||12
10073025|NCT02190604|11199999|FG017|COMPLETED|Part 3 (Patients)||19
10073026|NCT02190604|11200000|FG018|COMPLETED|Part 3 (Patients)||12
10073027|NCT02190604|11199982|FG000|NOT COMPLETED|Part 3 (Patients)||0
10073028|NCT02190604|11199983|FG001|NOT COMPLETED|Part 3 (Patients)||0
10073029|NCT02190604|11199984|FG002|NOT COMPLETED|Part 3 (Patients)||0
10073030|NCT02190604|11199985|FG003|NOT COMPLETED|Part 3 (Patients)||0
10073031|NCT02190604|11199986|FG004|NOT COMPLETED|Part 3 (Patients)||0
10073032|NCT02190604|11199987|FG005|NOT COMPLETED|Part 3 (Patients)||0
10073033|NCT02190604|11199988|FG006|NOT COMPLETED|Part 3 (Patients)||0
10073034|NCT02190604|11199989|FG007|NOT COMPLETED|Part 3 (Patients)||0
10073035|NCT02190604|11199990|FG008|NOT COMPLETED|Part 3 (Patients)||0
10073036|NCT02190604|11199991|FG009|NOT COMPLETED|Part 3 (Patients)||0
10073037|NCT02190604|11199992|FG010|NOT COMPLETED|Part 3 (Patients)||0
10073038|NCT02190604|11199993|FG011|NOT COMPLETED|Part 3 (Patients)||0
10073039|NCT02190604|11199994|FG012|NOT COMPLETED|Part 3 (Patients)||0
10073040|NCT02190604|11199995|FG013|NOT COMPLETED|Part 3 (Patients)||0
10073041|NCT02190604|11199996|FG014|NOT COMPLETED|Part 3 (Patients)||0
10073042|NCT02190604|11199997|FG015|NOT COMPLETED|Part 3 (Patients)||0
10073043|NCT02190604|11199998|FG016|NOT COMPLETED|Part 3 (Patients)||0
10073044|NCT02190604|11199999|FG017|NOT COMPLETED|Part 3 (Patients)||0
10073045|NCT02190604|11200000|FG018|NOT COMPLETED|Part 3 (Patients)||0
10073046|NCT02190747|11200060|FG000|STARTED|Overall Study||21
10073047|NCT02190747|11200061|FG001|STARTED|Overall Study||9
10073048|NCT02190747|11200062|FG002|STARTED|Overall Study||10
10073049|NCT02190747|11200060|FG000|COMPLETED|Overall Study||21
10073050|NCT02190747|11200061|FG001|COMPLETED|Overall Study||9
10073051|NCT02190747|11200062|FG002|COMPLETED|Overall Study||10
10073052|NCT02190747|11200060|FG000|NOT COMPLETED|Overall Study||0
10073053|NCT02190747|11200061|FG001|NOT COMPLETED|Overall Study||0
10073054|NCT02190747|11200062|FG002|NOT COMPLETED|Overall Study||0
10073055|NCT02190903|11200072|FG000|STARTED|Overall Study||6
10073056|NCT02190903|11200073|FG001|STARTED|Overall Study||6
10073057|NCT02190903|11200072|FG000|COMPLETED|Overall Study||6
10073058|NCT02190903|11200073|FG001|COMPLETED|Overall Study||6
10073059|NCT02190903|11200072|FG000|NOT COMPLETED|Overall Study||0
10073060|NCT02190903|11200073|FG001|NOT COMPLETED|Overall Study||0
10073061|NCT02191033|11200081|FG000|STARTED|Overall Study||20
10073062|NCT02191033|11200082|FG001|STARTED|Overall Study||20
10073063|NCT02191033|11200081|FG000|COMPLETED|Overall Study||18
10073064|NCT02191033|11200082|FG001|COMPLETED|Overall Study||19
10073065|NCT02191033|11200081|FG000|NOT COMPLETED|Overall Study||2
10073066|NCT02191033|11200082|FG001|NOT COMPLETED|Overall Study||1
10073067|NCT02191046|11200090|FG000|STARTED|Overall Study||41
10073068|NCT02191046|11200091|FG001|STARTED|Overall Study||39
10073069|NCT02191046|11200090|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
10073070|NCT02191046|11200091|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
10073071|NCT02191046|11200090|FG000|NOT COMPLETED|Overall Study||5
10073072|NCT02191046|11200091|FG001|NOT COMPLETED|Overall Study||1
10073073|NCT02191137|11200097|FG000|STARTED|Treatment||75
10073074|NCT02191137|11200097|FG000|COMPLETED|Treatment||65
10073075|NCT02191137|11200097|FG000|NOT COMPLETED|Treatment||10
10073076|NCT02191137|11200097|FG000|STARTED|Follow-up||65
10073077|NCT02191137|11200097|FG000|COMPLETED|Follow-up||60
10073078|NCT02191137|11200097|FG000|NOT COMPLETED|Follow-up||5
10073079|NCT02191267|11200104|FG000|STARTED|Overall Study||20
10073080|NCT02191267|11200105|FG001|STARTED|Overall Study||6
10073081|NCT02191267|11200106|FG002|STARTED|Overall Study||4
10073082|NCT02191267|11200104|FG000|COMPLETED|Overall Study||19
10073083|NCT02191267|11200105|FG001|COMPLETED|Overall Study||6
10073084|NCT02191267|11200106|FG002|COMPLETED|Overall Study||4
10073085|NCT02191267|11200104|FG000|NOT COMPLETED|Overall Study||1
10073086|NCT02191267|11200105|FG001|NOT COMPLETED|Overall Study||0
10073087|NCT02191267|11200106|FG002|NOT COMPLETED|Overall Study||0
10073088|NCT02191397|11200116|FG000|STARTED|Overall Study||266
10073089|NCT02191397|11200117|FG001|STARTED|Overall Study||268
10073090|NCT02191397|11200116|FG000|COMPLETED|Overall Study||183
10073091|NCT02191397|11200117|FG001|COMPLETED|Overall Study||198
10073092|NCT02191397|11200116|FG000|NOT COMPLETED|Overall Study||83
10073093|NCT02191397|11200117|FG001|NOT COMPLETED|Overall Study||70
10073094|NCT02191579|11200125|FG000|STARTED|Treatment 1||140
10073095|NCT02191579|11200126|FG001|STARTED|Treatment 1||142
10073096|NCT02191579|11200125|FG000|COMPLETED|Treatment 1||113
10073097|NCT02191579|11200126|FG001|COMPLETED|Treatment 1||84
10073098|NCT02191579|11200125|FG000|NOT COMPLETED|Treatment 1||27
10073099|NCT02191579|11200126|FG001|NOT COMPLETED|Treatment 1||58
10073100|NCT02191579|11200125|FG000|STARTED|Treatment 2||0
10073101|NCT02191579|11200126|FG001|STARTED|Treatment 2||80
10073102|NCT02191579|11200125|FG000|COMPLETED|Treatment 2||0
10073103|NCT02191579|11200126|FG001|COMPLETED|Treatment 2||55
10073104|NCT02191579|11200125|FG000|NOT COMPLETED|Treatment 2||0
10073105|NCT02191579|11200126|FG001|NOT COMPLETED|Treatment 2||25
10073106|NCT02191605|11200137|FG000|STARTED|Overall Study||15
10073107|NCT02191605|11200138|FG001|STARTED|Overall Study||15
10073108|NCT02191605|11200139|FG002|STARTED|Overall Study||15
10073109|NCT02191605|11200140|FG003|STARTED|Overall Study||8
10073110|NCT02191605|11200141|FG004|STARTED|Overall Study||7
10073111|NCT02191605|11200137|FG000|Completed Intervention Portion|Overall Study||15
10073112|NCT02191605|11200138|FG001|Completed Intervention Portion|Overall Study||15
10073113|NCT02191605|11200139|FG002|Completed Intervention Portion|Overall Study||15
10073114|NCT02191605|11200140|FG003|Completed Intervention Portion|Overall Study||8
10073115|NCT02191605|11200141|FG004|Completed Intervention Portion|Overall Study||7
10073116|NCT02191605|11200137|FG000|COMPLETED|Overall Study||6
10073117|NCT02191605|11200138|FG001|COMPLETED|Overall Study||11
10073118|NCT02191605|11200139|FG002|COMPLETED|Overall Study||8
10073119|NCT02191605|11200140|FG003|COMPLETED|Overall Study||5
10073120|NCT02191605|11200141|FG004|COMPLETED|Overall Study||3
10073121|NCT02191605|11200137|FG000|NOT COMPLETED|Overall Study||9
10073122|NCT02191605|11200138|FG001|NOT COMPLETED|Overall Study||4
10073123|NCT02191605|11200139|FG002|NOT COMPLETED|Overall Study||7
10073124|NCT02191605|11200140|FG003|NOT COMPLETED|Overall Study||3
10073125|NCT02191605|11200141|FG004|NOT COMPLETED|Overall Study||4
10073126|NCT02191618|11200153|FG000|STARTED|Overall Study||150
10073127|NCT02191618|11200153|FG000|COMPLETED|Overall Study||143
10073128|NCT02191618|11200153|FG000|NOT COMPLETED|Overall Study||7
10073129|NCT02191865|11200160|FG000|STARTED|Overall Study||8
10073130|NCT02191865|11200161|FG001|STARTED|Overall Study||8
10073131|NCT02191865|11200162|FG002|STARTED|Overall Study||17
10073132|NCT02191865|11200160|FG000|COMPLETED|Overall Study||8
10073133|NCT02191865|11200161|FG001|COMPLETED|Overall Study||8
10073134|NCT02191865|11200162|FG002|COMPLETED|Overall Study||17
10073135|NCT02191865|11200160|FG000|NOT COMPLETED|Overall Study||0
10073136|NCT02191865|11200161|FG001|NOT COMPLETED|Overall Study||0
10073137|NCT02191865|11200162|FG002|NOT COMPLETED|Overall Study||0
10073138|NCT02192099|11200173|FG000|STARTED|Overall Study||61
10073139|NCT02192099|11200173|FG000|COMPLETED|Overall Study||0
10073140|NCT02192099|11200173|FG000|NOT COMPLETED|Overall Study||61
10073141|NCT02192164|11200177|FG000|STARTED|Overall Study||126
10073142|NCT02192164|11200177|FG000|Etanercept Treated Population|Overall Study||112
10073143|NCT02192164|11200177|FG000|COMPLETED|Overall Study||112
10073144|NCT02192164|11200177|FG000|NOT COMPLETED|Overall Study||14
10073145|NCT02192190|11200190|FG000|STARTED|Overall Study||76
10073146|NCT02192190|11200191|FG001|STARTED|Overall Study||39
10073147|NCT02192190|11200192|FG002|STARTED|Overall Study||38
10073148|NCT02192190|11200193|FG003|STARTED|Overall Study||38
10073149|NCT02192190|11200194|FG004|STARTED|Overall Study||39
10073150|NCT02192190|11200195|FG005|STARTED|Overall Study||38
10073151|NCT02192190|11200190|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
10073152|NCT02192190|11200191|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
10073153|NCT02192190|11200192|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
10073154|NCT02192190|11200193|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
10073155|NCT02192190|11200194|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38
10073156|NCT02192190|11200195|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37
10073157|NCT02192190|11200190|FG000|COMPLETED|Overall Study||22
10073158|NCT02192190|11200191|FG001|COMPLETED|Overall Study||10
10073159|NCT02192190|11200192|FG002|COMPLETED|Overall Study||13
10073160|NCT02192190|11200193|FG003|COMPLETED|Overall Study||12
10073161|NCT02192190|11200194|FG004|COMPLETED|Overall Study||9
10073162|NCT02192190|11200195|FG005|COMPLETED|Overall Study||9
10073163|NCT02192190|11200190|FG000|NOT COMPLETED|Overall Study||54
10073164|NCT02192190|11200191|FG001|NOT COMPLETED|Overall Study||29
10073165|NCT02192190|11200192|FG002|NOT COMPLETED|Overall Study||25
10073166|NCT02192190|11200193|FG003|NOT COMPLETED|Overall Study||26
10073167|NCT02192190|11200194|FG004|NOT COMPLETED|Overall Study||30
10073168|NCT02192190|11200195|FG005|NOT COMPLETED|Overall Study||29
10073169|NCT02192307|11200212|FG000|STARTED|Overall Study||30
10073170|NCT02192307|11200213|FG001|STARTED|Overall Study||30
10073171|NCT02192307|11200212|FG000|COMPLETED|Overall Study||30
10073172|NCT02192307|11200213|FG001|COMPLETED|Overall Study||30
10073173|NCT02192307|11200212|FG000|NOT COMPLETED|Overall Study||0
10073174|NCT02192307|11200213|FG001|NOT COMPLETED|Overall Study||0
10073175|NCT02192541|11200221|FG000|STARTED|Overall Study||2
10073176|NCT02192541|11200222|FG001|STARTED|Overall Study||3
10073177|NCT02192541|11200221|FG000|Treated|Overall Study||2
10073178|NCT02192541|11200222|FG001|Treated|Overall Study||3
10073179|NCT02192541|11200221|FG000|Evaluable for Response|Overall Study||1
10073180|NCT02192541|11200222|FG001|Evaluable for Response|Overall Study||3
10073181|NCT02192541|11200221|FG000|COMPLETED|Overall Study||2
10073182|NCT02192541|11200222|FG001|COMPLETED|Overall Study||3
10073183|NCT02192541|11200221|FG000|NOT COMPLETED|Overall Study||0
10073184|NCT02192541|11200222|FG001|NOT COMPLETED|Overall Study||0
10073185|NCT02192606|11200231|FG000|STARTED|Overall Study||29
10073186|NCT02192606|11200232|FG001|STARTED|Overall Study||28
10073187|NCT02192606|11200231|FG000|COMPLETED|Overall Study||27
10073188|NCT02192606|11200232|FG001|COMPLETED|Overall Study||24
10073189|NCT02192606|11200231|FG000|NOT COMPLETED|Overall Study||2
10073190|NCT02192606|11200232|FG001|NOT COMPLETED|Overall Study||4
10073191|NCT02192684|11200240|FG000|STARTED|Overall Study||30
10073192|NCT02192684|11200241|FG001|STARTED|Overall Study||15
10073193|NCT02192684|11200240|FG000|COMPLETED|Overall Study||30
10073194|NCT02192684|11200241|FG001|COMPLETED|Overall Study||15
10073195|NCT02192684|11200240|FG000|NOT COMPLETED|Overall Study||0
10073196|NCT02192684|11200241|FG001|NOT COMPLETED|Overall Study||0
10073197|NCT02192814|11200247|FG000|STARTED|Overall Study||9
10073198|NCT02192814|11200247|FG000|COMPLETED|Overall Study||9
10073199|NCT02192814|11200247|FG000|NOT COMPLETED|Overall Study||0
10073200|NCT02192879|11200254|FG000|STARTED|Overall Study||3
10073201|NCT02192879|11200255|FG001|STARTED|Overall Study||4
10073202|NCT02192879|11200256|FG002|STARTED|Overall Study||3
10073203|NCT02192879|11200254|FG000|COMPLETED|Overall Study||3
10073204|NCT02192879|11200255|FG001|COMPLETED|Overall Study||4
10073205|NCT02192879|11200256|FG002|COMPLETED|Overall Study||3
10073206|NCT02192879|11200254|FG000|NOT COMPLETED|Overall Study||0
10073207|NCT02192879|11200255|FG001|NOT COMPLETED|Overall Study||0
10073208|NCT02192879|11200256|FG002|NOT COMPLETED|Overall Study||0
10073209|NCT02192905|11200264|FG000|STARTED|Overall Study||43
10073210|NCT02192905|11200264|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
10073211|NCT02192905|11200264|FG000|NOT COMPLETED|Overall Study||1
10073212|NCT02192970|11200271|FG000|STARTED|Overall Study||101
10073213|NCT02192970|11200272|FG001|STARTED|Overall Study||195
10073214|NCT02192970|11200271|FG000|COMPLETED|Overall Study||95
10073215|NCT02192970|11200272|FG001|COMPLETED|Overall Study||195
10073216|NCT02192970|11200271|FG000|NOT COMPLETED|Overall Study||6
10073217|NCT02192970|11200272|FG001|NOT COMPLETED|Overall Study||0
10073218|NCT02193074|11200280|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41
10073219|NCT02193074|11200281|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80
10073220|NCT02193074|11200280|FG000|Completed During Follow-Up Period|Overall Study||11
10073221|NCT02193074|11200281|FG001|Completed During Follow-Up Period|Overall Study||26
10073222|NCT02193074|11200280|FG000|Completed Due to Early Study Termination|Overall Study||13
10073223|NCT02193074|11200281|FG001|Completed Due to Early Study Termination|Overall Study||39
10073224|NCT02193074|11200280|FG000|COMPLETED|Overall Study||24
10073225|NCT02193074|11200281|FG001|COMPLETED|Overall Study||65
10073226|NCT02193074|11200280|FG000|NOT COMPLETED|Overall Study||17
10073227|NCT02193074|11200281|FG001|NOT COMPLETED|Overall Study||15
10190188|NCT03287622|11319331|FG001|STARTED|Overall Study||356
10190189|NCT03287622|11319330|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253
10190190|NCT03287622|11319331|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266
10190191|NCT03287622|11319330|FG000|COMPLETED|Overall Study||298
10190192|NCT03287622|11319331|FG001|COMPLETED|Overall Study||308
10190193|NCT03287622|11319330|FG000|NOT COMPLETED|Overall Study||58
10190194|NCT03287622|11319331|FG001|NOT COMPLETED|Overall Study||48
10190195|NCT03287635|11319344|FG000|STARTED|Overall Study||19
10190196|NCT03287635|11319344|FG000|COMPLETED|Overall Study||12
10190197|NCT03287635|11319344|FG000|NOT COMPLETED|Overall Study||7
10190198|NCT03287674|11319348|FG000|STARTED|Overall Study||7
10190199|NCT03287674|11319348|FG000|All Treated With TILs|Overall Study||6
10190200|NCT03287674|11319348|FG000|COMPLETED|Overall Study||6
10190201|NCT03287674|11319348|FG000|NOT COMPLETED|Overall Study||1
10190202|NCT03287791|11319356|FG000|STARTED|Overall Study||312
10190203|NCT03287791|11319357|FG001|STARTED|Overall Study||312
10190204|NCT03287791|11319358|FG002|STARTED|Overall Study||300
10190205|NCT03287791|11319356|FG000|Safety Population|Overall Study||306
10190206|NCT03287791|11319357|FG001|Safety Population|Overall Study||297
10190207|NCT03287791|11319358|FG002|Safety Population|Overall Study||291
10190208|NCT03287791|11319356|FG000|mITT Population|Overall Study||291
10190209|NCT03287791|11319357|FG001|mITT Population|Overall Study||291
10190210|NCT03287791|11319358|FG002|mITT Population|Overall Study||283
10190211|NCT03287791|11319356|FG000|PP Population|Overall Study||262
10190212|NCT03287791|11319357|FG001|PP Population|Overall Study||259
10190213|NCT03287791|11319358|FG002|PP Population|Overall Study||245
10190214|NCT03287791|11319356|FG000|COMPLETED|Overall Study||280
10190215|NCT03287791|11319357|FG001|COMPLETED|Overall Study||276
10190216|NCT03287791|11319358|FG002|COMPLETED|Overall Study||264
10190217|NCT03287791|11319356|FG000|NOT COMPLETED|Overall Study||32
10073228|NCT02193087|11200291|FG000|STARTED|Overall Study||199
10073229|NCT02193087|11200292|FG001|STARTED|Overall Study||100
10073230|NCT02193087|11200293|FG002|STARTED|Overall Study||100
10073231|NCT02193087|11200294|FG003|STARTED|Overall Study||603
10073232|NCT02193087|11200291|FG000|Received Vaccination|Overall Study||197
10073233|NCT02193087|11200292|FG001|Received Vaccination|Overall Study||97
10073234|NCT02193087|11200293|FG002|Received Vaccination|Overall Study||100
10073235|NCT02193087|11200294|FG003|Received Vaccination|Overall Study||602
10073236|NCT02193087|11200291|FG000|COMPLETED|Overall Study||162
10073237|NCT02193087|11200292|FG001|COMPLETED|Overall Study||86
10073238|NCT02193087|11200293|FG002|COMPLETED|Overall Study||93
10073239|NCT02193087|11200294|FG003|COMPLETED|Overall Study||524
10073240|NCT02193087|11200291|FG000|NOT COMPLETED|Overall Study||37
10073241|NCT02193087|11200292|FG001|NOT COMPLETED|Overall Study||14
10073242|NCT02193087|11200293|FG002|NOT COMPLETED|Overall Study||7
10073243|NCT02193087|11200294|FG003|NOT COMPLETED|Overall Study||79
10073244|NCT02193152|11200311|FG000|STARTED|Overall Study||16
10073245|NCT02193152|11200311|FG000|COMPLETED|Overall Study||16
10073246|NCT02193152|11200311|FG000|NOT COMPLETED|Overall Study||0
10073247|NCT02193165|11200318|FG000|STARTED|4 Week Product Use||40
10190218|NCT03287791|11319357|FG001|NOT COMPLETED|Overall Study||36
10190219|NCT03287791|11319358|FG002|NOT COMPLETED|Overall Study||36
10190220|NCT03287804|11319366|FG000|STARTED|Overall Study||12
10190221|NCT03287804|11319366|FG000|Leukaperesed|Overall Study||12
10190222|NCT03287804|11319366|FG000|Started Pre-conditioning Therapy|Overall Study||11
10190223|NCT03287804|11319366|FG000|Received Study Treatment|Overall Study||11
10190224|NCT03287804|11319366|FG000|COMPLETED|Overall Study||1
10190225|NCT03287804|11319366|FG000|NOT COMPLETED|Overall Study||11
10190226|NCT03287869|11319373|FG000|STARTED|Overall Study||188
10190227|NCT03287869|11319374|FG001|STARTED|Overall Study||193
10190228|NCT03287869|11319373|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184
10190229|NCT03287869|11319374|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184
10190230|NCT03287869|11319373|FG000|COMPLETED|Overall Study||105
10190231|NCT03287869|11319374|FG001|COMPLETED|Overall Study||100
10190232|NCT03287869|11319373|FG000|NOT COMPLETED|Overall Study||83
10190233|NCT03287869|11319374|FG001|NOT COMPLETED|Overall Study||93
10190234|NCT03288714|11319382|FG000|STARTED|Overall Study||59
10190235|NCT03288714|11319383|FG001|STARTED|Overall Study||62
10190236|NCT03288714|11319382|FG000|COMPLETED|Overall Study||49
10190237|NCT03288714|11319383|FG001|COMPLETED|Overall Study||59
10190238|NCT03288714|11319382|FG000|NOT COMPLETED|Overall Study||10
10190239|NCT03288714|11319383|FG001|NOT COMPLETED|Overall Study||3
10190240|NCT03288779|11319391|FG000|STARTED|Overall Study||6
10190241|NCT03288779|11319391|FG000|COMPLETED|Overall Study||3
10190242|NCT03288779|11319391|FG000|NOT COMPLETED|Overall Study||3
10190243|NCT03288987|11319397|FG000|STARTED|Overall Study||82
10190244|NCT03288987|11319398|FG001|STARTED|Overall Study||44
10190245|NCT03288987|11319397|FG000|Patients Receiving Medication|Overall Study||80
10190246|NCT03288987|11319398|FG001|Patients Receiving Medication|Overall Study||44
10190247|NCT03288987|11319397|FG000|COMPLETED|Overall Study|Per protocol population|72
10190248|NCT03288987|11319398|FG001|COMPLETED|Overall Study|Per protocol population|40
10190249|NCT03288987|11319397|FG000|NOT COMPLETED|Overall Study||10
10190250|NCT03288987|11319398|FG001|NOT COMPLETED|Overall Study||4
10190251|NCT03289052|11319407|FG000|STARTED|Overall Study||20
10190252|NCT03289052|11319408|FG001|STARTED|Overall Study||111
10190253|NCT03289052|11319409|FG002|STARTED|Overall Study||37
10190254|NCT03289052|11319407|FG000|COMPLETED|Overall Study||20
10190255|NCT03289052|11319408|FG001|COMPLETED|Overall Study||108
10190256|NCT03289052|11319409|FG002|COMPLETED|Overall Study||32
10190257|NCT03289052|11319407|FG000|NOT COMPLETED|Overall Study||0
10190258|NCT03289052|11319408|FG001|NOT COMPLETED|Overall Study||3
10190259|NCT03289052|11319409|FG002|NOT COMPLETED|Overall Study||5
10190260|NCT03289208|11319420|FG000|STARTED|Overall Study||11
10190261|NCT03289208|11319421|FG001|STARTED|Overall Study||8
10190262|NCT03289208|11319422|FG002|STARTED|Overall Study||11
10190263|NCT03289208|11319420|FG000|COMPLETED|Overall Study||10
10190264|NCT03289208|11319421|FG001|COMPLETED|Overall Study||8
10190265|NCT03289208|11319422|FG002|COMPLETED|Overall Study||11
10190266|NCT03289208|11319420|FG000|NOT COMPLETED|Overall Study||1
10190267|NCT03289208|11319421|FG001|NOT COMPLETED|Overall Study||0
10190268|NCT03289208|11319422|FG002|NOT COMPLETED|Overall Study||0
10190269|NCT03289234|11319433|FG000|STARTED|Overall Study||8
10190270|NCT03289234|11319434|FG001|STARTED|Overall Study||6
10190271|NCT03289234|11319435|FG002|STARTED|Overall Study||8
10190272|NCT03289234|11319433|FG000|COMPLETED|Overall Study||8
10190273|NCT03289234|11319434|FG001|COMPLETED|Overall Study||6
10190274|NCT03289234|11319435|FG002|COMPLETED|Overall Study||8
10190275|NCT03289234|11319433|FG000|NOT COMPLETED|Overall Study||0
10190276|NCT03289234|11319434|FG001|NOT COMPLETED|Overall Study||0
10190277|NCT03289234|11319435|FG002|NOT COMPLETED|Overall Study||0
10190278|NCT03289455|11319446|FG000|STARTED|Overall Study||4
10190279|NCT03289455|11319447|FG001|STARTED|Overall Study||5
10190280|NCT03289455|11319448|FG002|STARTED|Overall Study||6
10190281|NCT03289455|11319446|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
10190282|NCT03289455|11319447|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
10190283|NCT03289455|11319448|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
10190284|NCT03289455|11319446|FG000|NOT COMPLETED|Overall Study||4
10190285|NCT03289455|11319447|FG001|NOT COMPLETED|Overall Study||5
10190286|NCT03289455|11319448|FG002|NOT COMPLETED|Overall Study||6
10073248|NCT02193165|11200319|FG001|STARTED|4 Week Product Use||40
10073249|NCT02193165|11200320|FG002|STARTED|4 Week Product Use||40
10073250|NCT02193165|11200318|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
10073251|NCT02193165|11200319|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
10073252|NCT02193165|11200320|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
10073253|NCT02193165|11200318|FG000|NOT COMPLETED|4 Week Product Use||1
10073254|NCT02193165|11200319|FG001|NOT COMPLETED|4 Week Product Use||1
10073255|NCT02193165|11200320|FG002|NOT COMPLETED|4 Week Product Use||1
10073256|NCT02193165|11200318|FG000|STARTED|6 Week Product Use||39
10073257|NCT02193165|11200319|FG001|STARTED|6 Week Product Use||39
10073258|NCT02193165|11200320|FG002|STARTED|6 Week Product Use||39
10073259|NCT02193165|11200318|FG000|COMPLETED|6 Week Product Use||39
10073260|NCT02193165|11200319|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
10073261|NCT02193165|11200320|FG002|COMPLETED|6 Week Product Use||39
10073262|NCT02193165|11200318|FG000|NOT COMPLETED|6 Week Product Use||0
10073263|NCT02193165|11200319|FG001|NOT COMPLETED|6 Week Product Use||1
10190287|NCT03289481|11319459|FG000|STARTED|Overall Study||6
10190288|NCT03289481|11319460|FG001|STARTED|Overall Study||7
10190289|NCT03289481|11319459|FG000|COMPLETED|Overall Study||4
9731954|NCT00138125|10831942|FG000|STARTED|Overall Study||2
10190290|NCT03289481|11319460|FG001|COMPLETED|Overall Study||5
10190291|NCT03289481|11319459|FG000|NOT COMPLETED|Overall Study||2
10190292|NCT03289481|11319460|FG001|NOT COMPLETED|Overall Study||2
10190293|NCT03289533|11319467|FG000|STARTED|Overall Study||22
10190294|NCT03289533|11319467|FG000|COMPLETED|Overall Study||0
10190295|NCT03289533|11319467|FG000|NOT COMPLETED|Overall Study||22
10190296|NCT03289676|11319473|FG000|STARTED|Overall Study||27
10190297|NCT03289676|11319474|FG001|STARTED|Overall Study||26
10190298|NCT03289676|11319473|FG000|COMPLETED|Overall Study||23
10190299|NCT03289676|11319474|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
10190300|NCT03289676|11319473|FG000|NOT COMPLETED|Overall Study||4
10190301|NCT03289676|11319474|FG001|NOT COMPLETED|Overall Study||1
10190302|NCT03289858|11319482|FG000|STARTED|Overall Study||27
10190303|NCT03289858|11319483|FG001|STARTED|Overall Study||28
10190304|NCT03289858|11319482|FG000|COMPLETED|Overall Study||25
10190305|NCT03289858|11319483|FG001|COMPLETED|Overall Study||28
10190306|NCT03289858|11319482|FG000|NOT COMPLETED|Overall Study||2
10190307|NCT03289858|11319483|FG001|NOT COMPLETED|Overall Study||0
10190308|NCT03290027|11319491|FG000|STARTED|Overall Study||277
10190309|NCT03290027|11319492|FG001|STARTED|Overall Study||273
10190310|NCT03290027|11319491|FG000|COMPLETED|Overall Study||219
10073264|NCT02193165|11200320|FG002|NOT COMPLETED|6 Week Product Use||0
10073265|NCT02193178|11200328|FG000|STARTED|Overall Study||15
10073266|NCT02193178|11200328|FG000|COMPLETED|Overall Study||13
10073267|NCT02193178|11200328|FG000|NOT COMPLETED|Overall Study||2
10073268|NCT02193347|11200346|FG000|STARTED|Overall Study||24
10073269|NCT02193347|11200346|FG000|COMPLETED|Overall Study||24
10073270|NCT02193347|11200346|FG000|NOT COMPLETED|Overall Study||0
10073271|NCT02193490|11200352|FG000|STARTED|Overall Study||25
10073272|NCT02193490|11200353|FG001|STARTED|Overall Study||22
10073273|NCT02193490|11200352|FG000|COMPLETED|Overall Study||21
10073274|NCT02193490|11200353|FG001|COMPLETED|Overall Study||20
10073275|NCT02193490|11200352|FG000|NOT COMPLETED|Overall Study||4
10073276|NCT02193490|11200353|FG001|NOT COMPLETED|Overall Study||2
10190311|NCT03290027|11319492|FG001|COMPLETED|Overall Study||228
10190312|NCT03290027|11319491|FG000|NOT COMPLETED|Overall Study||58
10190313|NCT03290027|11319492|FG001|NOT COMPLETED|Overall Study||45
10190314|NCT03290300|11319498|FG000|STARTED|Overall Study||39
10190315|NCT03290300|11319498|FG000|COMPLETED|Overall Study||36
10190316|NCT03290300|11319498|FG000|NOT COMPLETED|Overall Study||3
10190317|NCT03290378|11319510|FG000|STARTED|Overall Study||140
10190318|NCT03290378|11319511|FG001|STARTED|Overall Study||133
10190319|NCT03290378|11319512|FG002|STARTED|Overall Study||136
10190320|NCT03290378|11319510|FG000|COMPLETED|Overall Study||137
10190321|NCT03290378|11319511|FG001|COMPLETED|Overall Study||123
10190322|NCT03290378|11319512|FG002|COMPLETED|Overall Study||120
10190323|NCT03290378|11319510|FG000|NOT COMPLETED|Overall Study||3
10190324|NCT03290378|11319511|FG001|NOT COMPLETED|Overall Study||10
10190325|NCT03290378|11319512|FG002|NOT COMPLETED|Overall Study||16
10190326|NCT03290768|11319520|FG000|STARTED|Overall Study||358
10190327|NCT03290768|11319520|FG000|COMPLETED|Overall Study||193
10190328|NCT03290768|11319520|FG000|NOT COMPLETED|Overall Study||165
10190329|NCT03291041|11319526|FG000|STARTED|Overall Study||13
10190330|NCT03291041|11319527|FG001|STARTED|Overall Study||12
10190331|NCT03291041|11319526|FG000|COMPLETED|Overall Study||13
10190332|NCT03291041|11319527|FG001|COMPLETED|Overall Study||12
10190333|NCT03291041|11319526|FG000|NOT COMPLETED|Overall Study||0
10190334|NCT03291041|11319527|FG001|NOT COMPLETED|Overall Study||0
10190335|NCT03291080|11319535|FG000|STARTED|First Cycle (2 Weeks)||11
10190336|NCT03291080|11319536|FG001|STARTED|First Cycle (2 Weeks)||9
10190337|NCT03291080|11319535|FG000|COMPLETED|First Cycle (2 Weeks)||11
10190338|NCT03291080|11319536|FG001|COMPLETED|First Cycle (2 Weeks)||9
10190339|NCT03291080|11319535|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0
10190340|NCT03291080|11319536|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0
10190341|NCT03291080|11319535|FG000|STARTED|Washout (2 Weeks)||11
10190342|NCT03291080|11319536|FG001|STARTED|Washout (2 Weeks)||9
10190343|NCT03291080|11319535|FG000|COMPLETED|Washout (2 Weeks)||11
10190344|NCT03291080|11319536|FG001|COMPLETED|Washout (2 Weeks)||9
10190345|NCT03291080|11319535|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10073277|NCT02193776|11200363|FG000|STARTED|Overall Study||59
10073278|NCT02193776|11200364|FG001|STARTED|Overall Study||60
10190346|NCT03291080|11319536|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10190347|NCT03291080|11319535|FG000|STARTED|Second Cylcle (2 Weeks)||9
10190348|NCT03291080|11319536|FG001|STARTED|Second Cylcle (2 Weeks)||11
10190349|NCT03291080|11319535|FG000|COMPLETED|Second Cylcle (2 Weeks)||8
10190350|NCT03291080|11319536|FG001|COMPLETED|Second Cylcle (2 Weeks)||11
10190351|NCT03291080|11319535|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1
10190352|NCT03291080|11319536|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0
10190353|NCT03291197|11319543|FG000|STARTED|Overall Study||5
10190354|NCT03291197|11319543|FG000|COMPLETED|Overall Study||5
10190355|NCT03291197|11319543|FG000|NOT COMPLETED|Overall Study||0
10190356|NCT03291288|11319551|FG000|STARTED|Drug-drug Interaction Phase||32
10190357|NCT03291288|11319552|FG001|STARTED|Drug-drug Interaction Phase||0
10190358|NCT03291288|11319551|FG000|COMPLETED|Drug-drug Interaction Phase||26
10190359|NCT03291288|11319552|FG001|COMPLETED|Drug-drug Interaction Phase||0
10190360|NCT03291288|11319551|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6
10190361|NCT03291288|11319552|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0
10073279|NCT02193776|11200365|FG002|STARTED|Overall Study||61
10073280|NCT02193776|11200366|FG003|STARTED|Overall Study||60
10073281|NCT02193776|11200363|FG000|Completed Day 70 Follow-up|Overall Study||54
10073282|NCT02193776|11200364|FG001|Completed Day 70 Follow-up|Overall Study||56
10073283|NCT02193776|11200365|FG002|Completed Day 70 Follow-up|Overall Study||60
10073284|NCT02193776|11200366|FG003|Completed Day 70 Follow-up|Overall Study||60
10073285|NCT02193776|11200363|FG000|Completed Day 140 Follow-up|Overall Study||52
10073286|NCT02193776|11200364|FG001|Completed Day 140 Follow-up|Overall Study||52
10073287|NCT02193776|11200365|FG002|Completed Day 140 Follow-up|Overall Study||58
10073288|NCT02193776|11200366|FG003|Completed Day 140 Follow-up|Overall Study||58
10073289|NCT02193776|11200363|FG000|COMPLETED|Overall Study||51
10073290|NCT02193776|11200364|FG001|COMPLETED|Overall Study||53
10073291|NCT02193776|11200365|FG002|COMPLETED|Overall Study||59
10073292|NCT02193776|11200366|FG003|COMPLETED|Overall Study||58
10073293|NCT02193776|11200363|FG000|NOT COMPLETED|Overall Study||8
10073294|NCT02193776|11200364|FG001|NOT COMPLETED|Overall Study||7
10073295|NCT02193776|11200365|FG002|NOT COMPLETED|Overall Study||2
10073296|NCT02193776|11200366|FG003|NOT COMPLETED|Overall Study||2
10073297|NCT02193815|11200376|FG000|STARTED|Overall Study||15
10073298|NCT02193815|11200376|FG000|COMPLETED|Overall Study||15
10073299|NCT02193815|11200376|FG000|NOT COMPLETED|Overall Study||0
10073300|NCT02193828|11200394|FG000|STARTED|Overall Study||18
10073301|NCT02193828|11200395|FG001|STARTED|Overall Study||18
10073302|NCT02193828|11200396|FG002|STARTED|Overall Study||23
10073303|NCT02193828|11200397|FG003|STARTED|Overall Study||17
10073304|NCT02193828|11200394|FG000|COMPLETED|Overall Study||18
10073305|NCT02193828|11200395|FG001|COMPLETED|Overall Study||18
10073306|NCT02193828|11200396|FG002|COMPLETED|Overall Study||22
10073307|NCT02193828|11200397|FG003|COMPLETED|Overall Study||16
10073308|NCT02193828|11200394|FG000|NOT COMPLETED|Overall Study||0
10073309|NCT02193828|11200395|FG001|NOT COMPLETED|Overall Study||0
10073310|NCT02193828|11200396|FG002|NOT COMPLETED|Overall Study||1
10073311|NCT02193828|11200397|FG003|NOT COMPLETED|Overall Study||1
10073312|NCT02193880|11200407|FG000|STARTED|Overall Study||7
10073313|NCT02193880|11200407|FG000|COMPLETED|Overall Study||4
10073314|NCT02193880|11200407|FG000|NOT COMPLETED|Overall Study||3
10073315|NCT02194062|11200414|FG000|STARTED|Overall Study||10
10073316|NCT02194062|11200415|FG001|STARTED|Overall Study||10
10073317|NCT02194062|11200416|FG002|STARTED|Overall Study||12
10073318|NCT02194062|11200414|FG000|COMPLETED|Overall Study||8
10073319|NCT02194062|11200415|FG001|COMPLETED|Overall Study||8
10073320|NCT02194062|11200416|FG002|COMPLETED|Overall Study||7
10073321|NCT02194062|11200414|FG000|NOT COMPLETED|Overall Study||2
10073322|NCT02194062|11200415|FG001|NOT COMPLETED|Overall Study||2
10073323|NCT02194062|11200416|FG002|NOT COMPLETED|Overall Study||5
10073324|NCT02194088|11200426|FG000|STARTED|Overall Study||75
10073325|NCT02194088|11200427|FG001|STARTED|Overall Study||25
10073326|NCT02194088|11200426|FG000|COMPLETED|Overall Study||75
10073327|NCT02194088|11200427|FG001|COMPLETED|Overall Study||25
10073328|NCT02194088|11200426|FG000|NOT COMPLETED|Overall Study||0
10073329|NCT02194088|11200427|FG001|NOT COMPLETED|Overall Study||0
10073330|NCT02194439|11200435|FG000|STARTED|Overall Study||415
10073331|NCT02194439|11200435|FG000|COMPLETED|Overall Study||415
10073332|NCT02194439|11200435|FG000|NOT COMPLETED|Overall Study||0
10073333|NCT02194465|11200446|FG000|STARTED|Overall Study||51
10073334|NCT02194465|11200447|FG001|STARTED|Overall Study||50
10073335|NCT02194465|11200448|FG002|STARTED|Overall Study||52
10073336|NCT02194465|11200449|FG003|STARTED|Overall Study||49
10073337|NCT02194465|11200450|FG004|STARTED|Overall Study||51
10073338|NCT02194465|11200451|FG005|STARTED|Overall Study||25
10190362|NCT03291288|11319551|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
10190363|NCT03291288|11319552|FG001|STARTED|Pexidartinib Only||26
10190364|NCT03291288|11319551|FG000|COMPLETED|Pexidartinib Only||0
10190365|NCT03291288|11319552|FG001|COMPLETED|Pexidartinib Only||24
10190366|NCT03291288|11319551|FG000|NOT COMPLETED|Pexidartinib Only||0
10190367|NCT03291288|11319552|FG001|NOT COMPLETED|Pexidartinib Only||2
10190368|NCT03291379|11319566|FG000|STARTED|Overall Study||8
10190369|NCT03291379|11319566|FG000|COMPLETED|Overall Study||8
10190370|NCT03291379|11319566|FG000|NOT COMPLETED|Overall Study||0
10190371|NCT03291613|11319571|FG000|STARTED|Overall Study||13
10190372|NCT03291613|11319571|FG000|COMPLETED|Overall Study||12
10190373|NCT03291613|11319571|FG000|NOT COMPLETED|Overall Study||1
10190374|NCT03292016|11319581|FG000|STARTED|First Intervention||1
10190375|NCT03292016|11319582|FG001|STARTED|First Intervention||1
9731471|NCT00132730|10831394|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10190376|NCT03292016|11319583|FG002|STARTED|First Intervention||2
10190377|NCT03292016|11319584|FG003|STARTED|First Intervention||1
10190378|NCT03292016|11319585|FG004|STARTED|First Intervention||1
10073339|NCT02194465|11200452|FG006|STARTED|Overall Study||26
10073340|NCT02194465|11200446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51
10073341|NCT02194465|11200447|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50
10073342|NCT02194465|11200448|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51
10073343|NCT02194465|11200449|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49
10073344|NCT02194465|11200450|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51
10073345|NCT02194465|11200451|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
10073346|NCT02194465|11200452|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26
10073347|NCT02194465|11200446|FG000|COMPLETED|Overall Study||42
10190379|NCT03292016|11319586|FG005|STARTED|First Intervention||2
10190380|NCT03292016|11319581|FG000|COMPLETED|First Intervention||1
10073348|NCT02194465|11200447|FG001|COMPLETED|Overall Study||43
10073349|NCT02194465|11200448|FG002|COMPLETED|Overall Study||44
10073350|NCT02194465|11200449|FG003|COMPLETED|Overall Study||41
10073351|NCT02194465|11200450|FG004|COMPLETED|Overall Study||42
10073352|NCT02194465|11200451|FG005|COMPLETED|Overall Study||21
10073353|NCT02194465|11200452|FG006|COMPLETED|Overall Study||24
10073354|NCT02194465|11200446|FG000|NOT COMPLETED|Overall Study||9
10073355|NCT02194465|11200447|FG001|NOT COMPLETED|Overall Study||7
10073356|NCT02194465|11200448|FG002|NOT COMPLETED|Overall Study||8
10073357|NCT02194465|11200449|FG003|NOT COMPLETED|Overall Study||8
10073358|NCT02194465|11200450|FG004|NOT COMPLETED|Overall Study||9
10073359|NCT02194465|11200451|FG005|NOT COMPLETED|Overall Study||4
10073360|NCT02194465|11200452|FG006|NOT COMPLETED|Overall Study||2
10073361|NCT02194621|11200475|FG000|STARTED|Overall Study||43
10073362|NCT02194621|11200476|FG001|STARTED|Overall Study||42
10073363|NCT02194621|11200477|FG002|STARTED|Overall Study||43
10073364|NCT02194621|11200475|FG000|COMPLETED|Overall Study||37
10073365|NCT02194621|11200476|FG001|COMPLETED|Overall Study||36
10073366|NCT02194621|11200477|FG002|COMPLETED|Overall Study||34
10073367|NCT02194621|11200475|FG000|NOT COMPLETED|Overall Study||6
10073368|NCT02194621|11200476|FG001|NOT COMPLETED|Overall Study||6
10073369|NCT02194621|11200477|FG002|NOT COMPLETED|Overall Study||9
10073370|NCT02194699|11200487|FG000|STARTED|Randomised||428
10073371|NCT02194699|11200488|FG001|STARTED|Randomised||428
10073372|NCT02194699|11200487|FG000|COMPLETED|Randomised||420
10073373|NCT02194699|11200488|FG001|COMPLETED|Randomised||417
10073374|NCT02194699|11200487|FG000|NOT COMPLETED|Randomised||8
10073375|NCT02194699|11200488|FG001|NOT COMPLETED|Randomised||11
10073376|NCT02194699|11200487|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
10073377|NCT02194699|11200488|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
10073378|NCT02194699|11200487|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370
10073379|NCT02194699|11200488|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365
10073380|NCT02194699|11200487|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
10073381|NCT02194699|11200488|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
10073382|NCT02194933|11200504|FG000|STARTED|Overall Study||19
10073383|NCT02194933|11200505|FG001|STARTED|Overall Study||19
10073384|NCT02194933|11200504|FG000|COMPLETED|Overall Study||16
10073385|NCT02194933|11200505|FG001|COMPLETED|Overall Study||10
10073386|NCT02194933|11200504|FG000|NOT COMPLETED|Overall Study||3
10073387|NCT02194933|11200505|FG001|NOT COMPLETED|Overall Study||9
10073388|NCT02194985|11200513|FG000|STARTED|Overall Study||84
10073389|NCT02194985|11200513|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84
10073390|NCT02194985|11200513|FG000|COMPLETED|Overall Study||73
10073391|NCT02194985|11200513|FG000|NOT COMPLETED|Overall Study||11
10073392|NCT02194998|11200521|FG000|STARTED|On-HCV Treatment||21
10073393|NCT02194998|11200522|FG001|STARTED|On-HCV Treatment||6
10073394|NCT02194998|11200523|FG002|STARTED|On-HCV Treatment||15
10073395|NCT02194998|11200524|FG003|STARTED|On-HCV Treatment||4
10073396|NCT02194998|11200521|FG000|COMPLETED|On-HCV Treatment||21
10073397|NCT02194998|11200522|FG001|COMPLETED|On-HCV Treatment||5
10073398|NCT02194998|11200523|FG002|COMPLETED|On-HCV Treatment||15
10073399|NCT02194998|11200524|FG003|COMPLETED|On-HCV Treatment||4
10073400|NCT02194998|11200521|FG000|NOT COMPLETED|On-HCV Treatment||0
10073401|NCT02194998|11200522|FG001|NOT COMPLETED|On-HCV Treatment||1
10073402|NCT02194998|11200523|FG002|NOT COMPLETED|On-HCV Treatment||0
10073403|NCT02194998|11200524|FG003|NOT COMPLETED|On-HCV Treatment||0
10073404|NCT02194998|11200521|FG000|STARTED|Post-HCV Treatment Follow-Up||21
10073405|NCT02194998|11200522|FG001|STARTED|Post-HCV Treatment Follow-Up||5
10073406|NCT02194998|11200523|FG002|STARTED|Post-HCV Treatment Follow-Up||15
10073407|NCT02194998|11200524|FG003|STARTED|Post-HCV Treatment Follow-Up||4
10073408|NCT02194998|11200521|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20
10073409|NCT02194998|11200522|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5
10073410|NCT02194998|11200523|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14
10073411|NCT02194998|11200524|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4
10073412|NCT02194998|11200521|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
10073413|NCT02194998|11200522|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
10073414|NCT02194998|11200523|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
10073415|NCT02194998|11200524|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
10073416|NCT02195011|11200536|FG000|STARTED|Overall Study||25
10073417|NCT02195011|11200537|FG001|STARTED|Overall Study||1
10073418|NCT02195011|11200536|FG000|COMPLETED|Overall Study||0
10073419|NCT02195011|11200537|FG001|COMPLETED|Overall Study||0
10073420|NCT02195011|11200536|FG000|NOT COMPLETED|Overall Study||25
10073421|NCT02195011|11200537|FG001|NOT COMPLETED|Overall Study||1
10073422|NCT02195232|11200545|FG000|STARTED|Overall Study|patients consented|32
10073423|NCT02195232|11200546|FG001|STARTED|Overall Study|patients consented|32
10073424|NCT02195232|11200545|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28
10073425|NCT02195232|11200546|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29
10073426|NCT02195232|11200545|FG000|NOT COMPLETED|Overall Study||4
10073427|NCT02195232|11200546|FG001|NOT COMPLETED|Overall Study||3
10073428|NCT02195310|11200558|FG000|STARTED|Overall Study||173
10073429|NCT02195310|11200559|FG001|STARTED|Overall Study||169
10073430|NCT02195310|11200558|FG000|COMPLETED|Overall Study||153
10073431|NCT02195310|11200559|FG001|COMPLETED|Overall Study||153
10073432|NCT02195310|11200558|FG000|NOT COMPLETED|Overall Study||20
10073433|NCT02195310|11200559|FG001|NOT COMPLETED|Overall Study||16
10073434|NCT02195349|11200576|FG000|STARTED|Overall Study||14
10073435|NCT02195349|11200577|FG001|STARTED|Overall Study||1
10073436|NCT02195349|11200578|FG002|STARTED|Overall Study||1
10073437|NCT02195349|11200579|FG003|STARTED|Overall Study||6
10073438|NCT02195349|11200580|FG004|STARTED|Overall Study||6
10073439|NCT02195349|11200581|FG005|STARTED|Overall Study||6
10073440|NCT02195349|11200582|FG006|STARTED|Overall Study||6
10073441|NCT02195349|11200583|FG007|STARTED|Overall Study||9
10073442|NCT02195349|11200584|FG008|STARTED|Overall Study||6
10073443|NCT02195349|11200585|FG009|STARTED|Overall Study||6
10073444|NCT02195349|11200586|FG010|STARTED|Overall Study||6
10073445|NCT02195349|11200576|FG000|COMPLETED|Overall Study||14
10073446|NCT02195349|11200577|FG001|COMPLETED|Overall Study||1
10073447|NCT02195349|11200578|FG002|COMPLETED|Overall Study||1
10073448|NCT02195349|11200579|FG003|COMPLETED|Overall Study||6
10073449|NCT02195349|11200580|FG004|COMPLETED|Overall Study||6
10073450|NCT02195349|11200581|FG005|COMPLETED|Overall Study||6
10073451|NCT02195349|11200582|FG006|COMPLETED|Overall Study||6
10073452|NCT02195349|11200583|FG007|COMPLETED|Overall Study||9
10073453|NCT02195349|11200584|FG008|COMPLETED|Overall Study||6
10073454|NCT02195349|11200585|FG009|COMPLETED|Overall Study||6
10073455|NCT02195349|11200586|FG010|COMPLETED|Overall Study||6
10073456|NCT02195349|11200576|FG000|NOT COMPLETED|Overall Study||0
10073457|NCT02195349|11200577|FG001|NOT COMPLETED|Overall Study||0
10073458|NCT02195349|11200578|FG002|NOT COMPLETED|Overall Study||0
10073459|NCT02195349|11200579|FG003|NOT COMPLETED|Overall Study||0
10073460|NCT02195349|11200580|FG004|NOT COMPLETED|Overall Study||0
10073461|NCT02195349|11200581|FG005|NOT COMPLETED|Overall Study||0
10073462|NCT02195349|11200582|FG006|NOT COMPLETED|Overall Study||0
10073463|NCT02195349|11200583|FG007|NOT COMPLETED|Overall Study||0
10073464|NCT02195349|11200584|FG008|NOT COMPLETED|Overall Study||0
10073465|NCT02195349|11200585|FG009|NOT COMPLETED|Overall Study||0
10073466|NCT02195349|11200586|FG010|NOT COMPLETED|Overall Study||0
10073467|NCT02195414|11200626|FG000|STARTED|Overall Study||31
10073468|NCT02195414|11200626|FG000|Primary Endpoint|Overall Study||31
10073469|NCT02195414|11200626|FG000|COMPLETED|Overall Study||31
10073470|NCT02195414|11200626|FG000|NOT COMPLETED|Overall Study||0
10073471|NCT02195427|11200632|FG000|STARTED|Overall Study||73
10073472|NCT02195427|11200633|FG001|STARTED|Overall Study||74
10073473|NCT02195427|11200632|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67
10073474|NCT02195427|11200633|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62
10073475|NCT02195427|11200632|FG000|N Patients at W36|Overall Study||65
10073476|NCT02195427|11200633|FG001|N Patients at W36|Overall Study||59
10073477|NCT02195427|11200632|FG000|N Patients at W52|Overall Study||63
10073478|NCT02195427|11200633|FG001|N Patients at W52|Overall Study||56
10073479|NCT02195427|11200632|FG000|COMPLETED|Overall Study||47
10073480|NCT02195427|11200633|FG001|COMPLETED|Overall Study||47
10073481|NCT02195427|11200632|FG000|NOT COMPLETED|Overall Study||26
10073482|NCT02195427|11200633|FG001|NOT COMPLETED|Overall Study||27
10073483|NCT02195518|11200643|FG000|STARTED|Overall Study||213
10073484|NCT02195518|11200643|FG000|COMPLETED|Overall Study||204
10073485|NCT02195518|11200643|FG000|NOT COMPLETED|Overall Study||9
10073486|NCT02195531|11200650|FG000|STARTED|Overall Study||64
10073487|NCT02195531|11200651|FG001|STARTED|Overall Study||49
10073488|NCT02195531|11200652|FG002|STARTED|Overall Study||56
10073489|NCT02195531|11200650|FG000|COMPLETED|Overall Study||63
10073490|NCT02195531|11200651|FG001|COMPLETED|Overall Study||48
10073491|NCT02195531|11200652|FG002|COMPLETED|Overall Study||55
10073492|NCT02195531|11200650|FG000|NOT COMPLETED|Overall Study||1
10073493|NCT02195531|11200651|FG001|NOT COMPLETED|Overall Study||1
10073494|NCT02195531|11200652|FG002|NOT COMPLETED|Overall Study||1
10073495|NCT02195583|11200660|FG000|STARTED|Overall Study||62
10073496|NCT02195583|11200660|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
10073497|NCT02195583|11200660|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59
10073498|NCT02195583|11200660|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
10073499|NCT02195583|11200660|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55
10073500|NCT02195583|11200660|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
10073501|NCT02195583|11200660|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
10073502|NCT02195583|11200660|FG000|COMPLETED|Overall Study||53
10073503|NCT02195583|11200660|FG000|NOT COMPLETED|Overall Study||9
10073504|NCT02195622|11200677|FG000|STARTED|Overall Study||37
10073505|NCT02195622|11200678|FG001|STARTED|Overall Study||37
10073506|NCT02195622|11200677|FG000|COMPLETED|Overall Study||37
10073507|NCT02195622|11200678|FG001|COMPLETED|Overall Study||37
10073508|NCT02195622|11200677|FG000|NOT COMPLETED|Overall Study||0
10073509|NCT02195622|11200678|FG001|NOT COMPLETED|Overall Study||0
10073510|NCT02195687|11200686|FG000|STARTED|Overall Study||316
10073511|NCT02195687|11200687|FG001|STARTED|Overall Study||101
10073512|NCT02195687|11200686|FG000|COMPLETED|Overall Study||311
10073513|NCT02195687|11200687|FG001|COMPLETED|Overall Study||99
10073514|NCT02195687|11200686|FG000|NOT COMPLETED|Overall Study||5
10073515|NCT02195687|11200687|FG001|NOT COMPLETED|Overall Study||2
10073516|NCT02195700|11200695|FG000|STARTED|Overall Study||58
10073517|NCT02195700|11200696|FG001|STARTED|Overall Study||59
10073518|NCT02195700|11200695|FG000|Safety and ITT Populations|Overall Study||58
10073519|NCT02195700|11200696|FG001|Safety and ITT Populations|Overall Study||59
10073520|NCT02195700|11200695|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
10073521|NCT02195700|11200696|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
10073522|NCT02195700|11200695|FG000|Maintenance Period|Overall Study||53
10073523|NCT02195700|11200696|FG001|Maintenance Period|Overall Study||54
10073524|NCT02195700|11200695|FG000|COMPLETED|Overall Study||52
10073525|NCT02195700|11200696|FG001|COMPLETED|Overall Study||52
10073526|NCT02195700|11200695|FG000|NOT COMPLETED|Overall Study||6
10073527|NCT02195700|11200696|FG001|NOT COMPLETED|Overall Study||7
10073528|NCT02195713|11200704|FG000|STARTED|Overall Study||10
10073529|NCT02195713|11200705|FG001|STARTED|Overall Study||10
10073530|NCT02195713|11200704|FG000|COMPLETED|Overall Study||10
10073531|NCT02195713|11200705|FG001|COMPLETED|Overall Study||10
10073532|NCT02195713|11200704|FG000|NOT COMPLETED|Overall Study||0
10073533|NCT02195713|11200705|FG001|NOT COMPLETED|Overall Study||0
10073534|NCT02195869|11200711|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
10073535|NCT02195869|11200711|FG000|All-Treated Population|Overall Study||42
10190381|NCT03292016|11319582|FG001|COMPLETED|First Intervention||1
10190382|NCT03292016|11319583|FG002|COMPLETED|First Intervention||2
10190383|NCT03292016|11319584|FG003|COMPLETED|First Intervention||1
10190384|NCT03292016|11319585|FG004|COMPLETED|First Intervention||1
10190385|NCT03292016|11319586|FG005|COMPLETED|First Intervention||2
10190386|NCT03292016|11319581|FG000|NOT COMPLETED|First Intervention||0
10190387|NCT03292016|11319582|FG001|NOT COMPLETED|First Intervention||0
10190388|NCT03292016|11319583|FG002|NOT COMPLETED|First Intervention||0
10190389|NCT03292016|11319584|FG003|NOT COMPLETED|First Intervention||0
10190390|NCT03292016|11319585|FG004|NOT COMPLETED|First Intervention||0
10190391|NCT03292016|11319586|FG005|NOT COMPLETED|First Intervention||0
10190392|NCT03292016|11319581|FG000|STARTED|First Washout||1
10190393|NCT03292016|11319582|FG001|STARTED|First Washout||1
10190394|NCT03292016|11319583|FG002|STARTED|First Washout||2
10190395|NCT03292016|11319584|FG003|STARTED|First Washout||1
10190396|NCT03292016|11319585|FG004|STARTED|First Washout||1
10190397|NCT03292016|11319586|FG005|STARTED|First Washout||2
10190398|NCT03292016|11319581|FG000|COMPLETED|First Washout||1
10190399|NCT03292016|11319582|FG001|COMPLETED|First Washout||1
10190400|NCT03292016|11319583|FG002|COMPLETED|First Washout||2
10190401|NCT03292016|11319584|FG003|COMPLETED|First Washout||1
10190402|NCT03292016|11319585|FG004|COMPLETED|First Washout||1
10190403|NCT03292016|11319586|FG005|COMPLETED|First Washout||2
10190404|NCT03292016|11319581|FG000|NOT COMPLETED|First Washout||0
10190405|NCT03292016|11319582|FG001|NOT COMPLETED|First Washout||0
10190406|NCT03292016|11319583|FG002|NOT COMPLETED|First Washout||0
10190407|NCT03292016|11319584|FG003|NOT COMPLETED|First Washout||0
10190408|NCT03292016|11319585|FG004|NOT COMPLETED|First Washout||0
10190409|NCT03292016|11319586|FG005|NOT COMPLETED|First Washout||0
10190410|NCT03292016|11319581|FG000|STARTED|Second Intervention||1
10190411|NCT03292016|11319582|FG001|STARTED|Second Intervention||1
10190412|NCT03292016|11319583|FG002|STARTED|Second Intervention||2
10190413|NCT03292016|11319584|FG003|STARTED|Second Intervention||1
10190414|NCT03292016|11319585|FG004|STARTED|Second Intervention||1
10190415|NCT03292016|11319586|FG005|STARTED|Second Intervention||2
10190416|NCT03292016|11319581|FG000|COMPLETED|Second Intervention||1
10190417|NCT03292016|11319582|FG001|COMPLETED|Second Intervention||1
10190418|NCT03292016|11319583|FG002|COMPLETED|Second Intervention||2
10190419|NCT03292016|11319584|FG003|COMPLETED|Second Intervention||1
10190420|NCT03292016|11319585|FG004|COMPLETED|Second Intervention||1
10190421|NCT03292016|11319586|FG005|COMPLETED|Second Intervention||2
10190422|NCT03292016|11319581|FG000|NOT COMPLETED|Second Intervention||0
10190423|NCT03292016|11319582|FG001|NOT COMPLETED|Second Intervention||0
10190424|NCT03292016|11319583|FG002|NOT COMPLETED|Second Intervention||0
10190425|NCT03292016|11319584|FG003|NOT COMPLETED|Second Intervention||0
10190426|NCT03292016|11319585|FG004|NOT COMPLETED|Second Intervention||0
10190427|NCT03292016|11319586|FG005|NOT COMPLETED|Second Intervention||0
10190428|NCT03292016|11319581|FG000|STARTED|Second Washout||1
10190429|NCT03292016|11319582|FG001|STARTED|Second Washout||1
10190430|NCT03292016|11319583|FG002|STARTED|Second Washout||2
10190431|NCT03292016|11319584|FG003|STARTED|Second Washout||1
10190432|NCT03292016|11319585|FG004|STARTED|Second Washout||1
10190433|NCT03292016|11319586|FG005|STARTED|Second Washout||2
10190434|NCT03292016|11319581|FG000|COMPLETED|Second Washout||1
10190435|NCT03292016|11319582|FG001|COMPLETED|Second Washout||0
10190436|NCT03292016|11319583|FG002|COMPLETED|Second Washout||2
10190437|NCT03292016|11319584|FG003|COMPLETED|Second Washout||1
10190438|NCT03292016|11319585|FG004|COMPLETED|Second Washout||1
10190439|NCT03292016|11319586|FG005|COMPLETED|Second Washout||2
10190440|NCT03292016|11319581|FG000|NOT COMPLETED|Second Washout||0
10190441|NCT03292016|11319582|FG001|NOT COMPLETED|Second Washout||1
10190442|NCT03292016|11319583|FG002|NOT COMPLETED|Second Washout||0
10190443|NCT03292016|11319584|FG003|NOT COMPLETED|Second Washout||0
10190444|NCT03292016|11319585|FG004|NOT COMPLETED|Second Washout||0
10190445|NCT03292016|11319586|FG005|NOT COMPLETED|Second Washout||0
10190446|NCT03292016|11319581|FG000|STARTED|Third Intervention||1
10190447|NCT03292016|11319582|FG001|STARTED|Third Intervention||0
10190448|NCT03292016|11319583|FG002|STARTED|Third Intervention||2
10190449|NCT03292016|11319584|FG003|STARTED|Third Intervention||1
10190450|NCT03292016|11319585|FG004|STARTED|Third Intervention||1
10073536|NCT02195869|11200711|FG000|COMPLETED|Overall Study||0
10073537|NCT02195869|11200711|FG000|NOT COMPLETED|Overall Study||42
10073538|NCT02195895|11200718|FG000|STARTED|Overall Study||17
10073539|NCT02195895|11200718|FG000|COMPLETED|Overall Study||17
10073540|NCT02195895|11200718|FG000|NOT COMPLETED|Overall Study||0
10073541|NCT02195921|11200726|FG000|STARTED|Overall Study||40
10073542|NCT02195921|11200727|FG001|STARTED|Overall Study||40
10073543|NCT02195921|11200728|FG002|STARTED|Overall Study||40
10073544|NCT02195921|11200729|FG003|STARTED|Overall Study||40
10073545|NCT02195921|11200726|FG000|COMPLETED|Overall Study||39
10073546|NCT02195921|11200727|FG001|COMPLETED|Overall Study||39
10073547|NCT02195921|11200728|FG002|COMPLETED|Overall Study||39
10073548|NCT02195921|11200729|FG003|COMPLETED|Overall Study||40
10073549|NCT02195921|11200726|FG000|NOT COMPLETED|Overall Study||1
10073550|NCT02195921|11200727|FG001|NOT COMPLETED|Overall Study||1
10073551|NCT02195921|11200728|FG002|NOT COMPLETED|Overall Study||1
10073552|NCT02195921|11200729|FG003|NOT COMPLETED|Overall Study||0
10073553|NCT02196038|11200746|FG000|STARTED|Overall Study||174
10073554|NCT02196038|11200747|FG001|STARTED|Overall Study||175
10073555|NCT02196038|11200746|FG000|COMPLETED|Overall Study||157
10073556|NCT02196038|11200747|FG001|COMPLETED|Overall Study||153
10073557|NCT02196038|11200746|FG000|NOT COMPLETED|Overall Study||17
10073558|NCT02196038|11200747|FG001|NOT COMPLETED|Overall Study||22
10073559|NCT02196077|11200753|FG000|STARTED|Overall Study||180
10073560|NCT02196077|11200753|FG000|BFF MDI 320/9.6 μg|Overall Study||155
10073561|NCT02196077|11200753|FG000|BFF MDI 160/9.6 μg|Overall Study||106
10073562|NCT02196077|11200753|FG000|BFF MDI 80/9.6 μg|Overall Study||103
10073563|NCT02196077|11200753|FG000|BD MDI 320 μg|Overall Study||108
10073564|NCT02196077|11200753|FG000|FF MDI 9.6 μg|Overall Study||157
10073565|NCT02196077|11200753|FG000|COMPLETED|Overall Study||133
10073566|NCT02196077|11200753|FG000|NOT COMPLETED|Overall Study||47
10073567|NCT02196168|11200767|FG000|STARTED|Overall Study||6
10073568|NCT02196168|11200768|FG001|STARTED|Overall Study||0
10073569|NCT02196168|11200767|FG000|COMPLETED|Overall Study||6
10073570|NCT02196168|11200768|FG001|COMPLETED|Overall Study||0
10073571|NCT02196168|11200767|FG000|NOT COMPLETED|Overall Study||0
10073572|NCT02196168|11200768|FG001|NOT COMPLETED|Overall Study||0
10073573|NCT02196259|11200777|FG000|STARTED|Overall Study||3
10073574|NCT02196259|11200778|FG001|STARTED|Overall Study||7
10073575|NCT02196259|11200779|FG002|STARTED|Overall Study||3
10073576|NCT02196259|11200777|FG000|COMPLETED|Overall Study||3
10073577|NCT02196259|11200778|FG001|COMPLETED|Overall Study||4
10073578|NCT02196259|11200779|FG002|COMPLETED|Overall Study||2
10073579|NCT02196259|11200777|FG000|NOT COMPLETED|Overall Study||0
10073580|NCT02196259|11200778|FG001|NOT COMPLETED|Overall Study||3
10073581|NCT02196259|11200779|FG002|NOT COMPLETED|Overall Study||1
10073582|NCT02196324|11200788|FG000|STARTED|Overall Study||63
10073583|NCT02196324|11200789|FG001|STARTED|Overall Study||65
10073584|NCT02196324|11200788|FG000|COMPLETED|Overall Study||48
10073585|NCT02196324|11200789|FG001|COMPLETED|Overall Study||57
10073586|NCT02196324|11200788|FG000|NOT COMPLETED|Overall Study||15
10073587|NCT02196324|11200789|FG001|NOT COMPLETED|Overall Study||8
10073588|NCT02196506|11200797|FG000|STARTED|Phase A||837
10073589|NCT02196506|11200798|FG001|STARTED|Phase A||0
10073590|NCT02196506|11200799|FG002|STARTED|Phase A||0
10073591|NCT02196506|11200800|FG003|STARTED|Phase A||0
10073592|NCT02196506|11200797|FG000|COMPLETED|Phase A||716
10073593|NCT02196506|11200798|FG001|COMPLETED|Phase A||0
10073594|NCT02196506|11200799|FG002|COMPLETED|Phase A||0
10073595|NCT02196506|11200800|FG003|COMPLETED|Phase A||0
10073596|NCT02196506|11200797|FG000|NOT COMPLETED|Phase A||121
10073597|NCT02196506|11200798|FG001|NOT COMPLETED|Phase A||0
10073598|NCT02196506|11200799|FG002|NOT COMPLETED|Phase A||0
10073599|NCT02196506|11200800|FG003|NOT COMPLETED|Phase A||0
10073600|NCT02196506|11200797|FG000|STARTED|Phase B||0
10073601|NCT02196506|11200798|FG001|STARTED|Phase B||192
10073602|NCT02196506|11200799|FG002|STARTED|Phase B||202
10073603|NCT02196506|11200800|FG003|STARTED|Phase B||0
10073604|NCT02196506|11200797|FG000|COMPLETED|Phase B||0
10073605|NCT02196506|11200798|FG001|COMPLETED|Phase B||177
10073606|NCT02196506|11200799|FG002|COMPLETED|Phase B||196
10073607|NCT02196506|11200800|FG003|COMPLETED|Phase B||0
10073608|NCT02196506|11200797|FG000|NOT COMPLETED|Phase B||0
10073609|NCT02196506|11200798|FG001|NOT COMPLETED|Phase B||15
10073610|NCT02196506|11200799|FG002|NOT COMPLETED|Phase B||6
10073611|NCT02196506|11200800|FG003|NOT COMPLETED|Phase B||0
10073612|NCT02196506|11200797|FG000|STARTED|Phase A+||0
10073613|NCT02196506|11200798|FG001|STARTED|Phase A+||0
10073614|NCT02196506|11200799|FG002|STARTED|Phase A+||0
10073615|NCT02196506|11200800|FG003|STARTED|Phase A+||322
10073616|NCT02196506|11200797|FG000|COMPLETED|Phase A+||0
10073617|NCT02196506|11200798|FG001|COMPLETED|Phase A+||0
10073618|NCT02196506|11200799|FG002|COMPLETED|Phase A+||0
10073619|NCT02196506|11200800|FG003|COMPLETED|Phase A+||308
10073620|NCT02196506|11200797|FG000|NOT COMPLETED|Phase A+||0
10073621|NCT02196506|11200798|FG001|NOT COMPLETED|Phase A+||0
10073622|NCT02196506|11200799|FG002|NOT COMPLETED|Phase A+||0
10073623|NCT02196506|11200800|FG003|NOT COMPLETED|Phase A+||14
10073624|NCT02196558|11200809|FG000|STARTED|Treatment Phase (12 Weeks)||12
10073625|NCT02196558|11200810|FG001|STARTED|Treatment Phase (12 Weeks)||15
10073626|NCT02196558|11200811|FG002|STARTED|Treatment Phase (12 Weeks)||10
10073627|NCT02196558|11200809|FG000|COMPLETED|Treatment Phase (12 Weeks)||12
10073628|NCT02196558|11200810|FG001|COMPLETED|Treatment Phase (12 Weeks)||12
10073629|NCT02196558|11200811|FG002|COMPLETED|Treatment Phase (12 Weeks)||8
10073630|NCT02196558|11200809|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0
10073631|NCT02196558|11200810|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3
10073632|NCT02196558|11200811|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2
10073633|NCT02196558|11200809|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
10073634|NCT02196558|11200810|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
10073635|NCT02196558|11200811|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
10073636|NCT02196558|11200809|FG000|COMPLETED|Extension Phase (40 Weeks)||9
10073637|NCT02196558|11200810|FG001|COMPLETED|Extension Phase (40 Weeks)||8
10073638|NCT02196558|11200811|FG002|COMPLETED|Extension Phase (40 Weeks)||5
10073639|NCT02196558|11200809|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2
10073640|NCT02196558|11200810|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3
10073641|NCT02196558|11200811|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1
10073642|NCT02196675|11200822|FG000|STARTED|Overall Study||27
10073643|NCT02196675|11200823|FG001|STARTED|Overall Study||70
10073644|NCT02196675|11200824|FG002|STARTED|Overall Study||8
10073645|NCT02196675|11200822|FG000|COMPLETED|Overall Study||25
10073646|NCT02196675|11200823|FG001|COMPLETED|Overall Study||68
10073647|NCT02196675|11200824|FG002|COMPLETED|Overall Study||7
10073648|NCT02196675|11200822|FG000|NOT COMPLETED|Overall Study||2
10073649|NCT02196675|11200823|FG001|NOT COMPLETED|Overall Study||2
10073650|NCT02196675|11200824|FG002|NOT COMPLETED|Overall Study||1
10073651|NCT02196688|11200834|FG000|STARTED|Overall Study||47
10073652|NCT02196688|11200835|FG001|STARTED|Overall Study||24
10073653|NCT02196688|11200834|FG000|COMPLETED|Overall Study||40
10073654|NCT02196688|11200835|FG001|COMPLETED|Overall Study||23
10073655|NCT02196688|11200834|FG000|NOT COMPLETED|Overall Study||7
10073656|NCT02196688|11200835|FG001|NOT COMPLETED|Overall Study||1
10073657|NCT02196701|11200843|FG000|STARTED|Overall Study||46
10073658|NCT02196701|11200843|FG000|COMPLETED|Overall Study||43
10073659|NCT02196701|11200843|FG000|NOT COMPLETED|Overall Study||3
10073660|NCT02196714|11200850|FG000|STARTED|Overall Study||24
10073661|NCT02196714|11200851|FG001|STARTED|Overall Study||23
10073662|NCT02196714|11200852|FG002|STARTED|Overall Study||24
10073663|NCT02196714|11200853|FG003|STARTED|Overall Study||24
10073664|NCT02196714|11200850|FG000|COMPLETED|Overall Study||24
10073665|NCT02196714|11200851|FG001|COMPLETED|Overall Study||23
10073666|NCT02196714|11200852|FG002|COMPLETED|Overall Study||23
10073667|NCT02196714|11200853|FG003|COMPLETED|Overall Study||24
10073668|NCT02196714|11200850|FG000|NOT COMPLETED|Overall Study||0
10073669|NCT02196714|11200851|FG001|NOT COMPLETED|Overall Study||0
10073670|NCT02196714|11200852|FG002|NOT COMPLETED|Overall Study||1
10073671|NCT02196714|11200853|FG003|NOT COMPLETED|Overall Study||0
10073672|NCT02196766|11200865|FG000|STARTED|First Intervention (7 Days)||15
10073673|NCT02196766|11200866|FG001|STARTED|First Intervention (7 Days)||15
10073674|NCT02196766|11200865|FG000|COMPLETED|First Intervention (7 Days)||15
10073675|NCT02196766|11200866|FG001|COMPLETED|First Intervention (7 Days)||15
10190451|NCT03292016|11319586|FG005|STARTED|Third Intervention||2
10190452|NCT03292016|11319581|FG000|COMPLETED|Third Intervention||1
10190453|NCT03292016|11319582|FG001|COMPLETED|Third Intervention||0
10190454|NCT03292016|11319583|FG002|COMPLETED|Third Intervention||2
10190455|NCT03292016|11319584|FG003|COMPLETED|Third Intervention||1
10190456|NCT03292016|11319585|FG004|COMPLETED|Third Intervention||1
10190457|NCT03292016|11319586|FG005|COMPLETED|Third Intervention||2
10190458|NCT03292016|11319581|FG000|NOT COMPLETED|Third Intervention||0
10190459|NCT03292016|11319582|FG001|NOT COMPLETED|Third Intervention||0
10190460|NCT03292016|11319583|FG002|NOT COMPLETED|Third Intervention||0
10190461|NCT03292016|11319584|FG003|NOT COMPLETED|Third Intervention||0
10190462|NCT03292016|11319585|FG004|NOT COMPLETED|Third Intervention||0
10190463|NCT03292016|11319586|FG005|NOT COMPLETED|Third Intervention||0
10190464|NCT03292406|11319597|FG000|STARTED|Overall Study||30
10190465|NCT03292406|11319598|FG001|STARTED|Overall Study||28
10190466|NCT03292406|11319599|FG002|STARTED|Overall Study||28
10190467|NCT03292406|11319597|FG000|Participants Treated|Overall Study||30
10190468|NCT03292406|11319598|FG001|Participants Treated|Overall Study||28
10190469|NCT03292406|11319599|FG002|Participants Treated|Overall Study||27
10190470|NCT03292406|11319597|FG000|COMPLETED|Overall Study||17
10190471|NCT03292406|11319598|FG001|COMPLETED|Overall Study||15
10190472|NCT03292406|11319599|FG002|COMPLETED|Overall Study||15
10190473|NCT03292406|11319597|FG000|NOT COMPLETED|Overall Study||13
10190474|NCT03292406|11319598|FG001|NOT COMPLETED|Overall Study||13
10190475|NCT03292406|11319599|FG002|NOT COMPLETED|Overall Study||13
10190476|NCT03292432|11319609|FG000|STARTED|Overall Study||46
10190477|NCT03292432|11319610|FG001|STARTED|Overall Study||43
10190478|NCT03292432|11319609|FG000|Started Study Intervention|Overall Study||45
10190479|NCT03292432|11319610|FG001|Started Study Intervention|Overall Study||43
10190480|NCT03292432|11319609|FG000|COMPLETED|Overall Study||31
10190481|NCT03292432|11319610|FG001|COMPLETED|Overall Study||32
10190482|NCT03292432|11319609|FG000|NOT COMPLETED|Overall Study||15
10190483|NCT03292432|11319610|FG001|NOT COMPLETED|Overall Study||11
10190484|NCT03292562|11319618|FG000|STARTED|Overall Study||35
10190485|NCT03292562|11319619|FG001|STARTED|Overall Study||31
10190486|NCT03292562|11319618|FG000|COMPLETED|Overall Study||29
10190487|NCT03292562|11319619|FG001|COMPLETED|Overall Study||30
10190488|NCT03292562|11319618|FG000|NOT COMPLETED|Overall Study||6
10190489|NCT03292562|11319619|FG001|NOT COMPLETED|Overall Study||1
10190490|NCT03292614|11319625|FG000|STARTED|Overall Study||25
10190491|NCT03292614|11319625|FG000|COMPLETED|Overall Study||25
10190492|NCT03292614|11319625|FG000|NOT COMPLETED|Overall Study||0
10190493|NCT03292640|11319631|FG000|STARTED|Overall Study||275
10190494|NCT03292640|11319632|FG001|STARTED|Overall Study||272
10073676|NCT02196766|11200865|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10073677|NCT02196766|11200866|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10073678|NCT02196766|11200865|FG000|STARTED|Second Intervention (7 Days)||15
10073679|NCT02196766|11200866|FG001|STARTED|Second Intervention (7 Days)||15
10073680|NCT02196766|11200865|FG000|COMPLETED|Second Intervention (7 Days)||15
10073681|NCT02196766|11200866|FG001|COMPLETED|Second Intervention (7 Days)||15
10073682|NCT02196766|11200865|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10073683|NCT02196766|11200866|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10073684|NCT02196831|11200874|FG000|STARTED|Overall Study||30
10073685|NCT02196831|11200875|FG001|STARTED|Overall Study||30
10073686|NCT02196831|11200874|FG000|Received Follow-up Imaging|Overall Study||26
10073687|NCT02196831|11200875|FG001|Received Follow-up Imaging|Overall Study||28
10073688|NCT02196831|11200874|FG000|COMPLETED|Overall Study||21
10073689|NCT02196831|11200875|FG001|COMPLETED|Overall Study||26
10073690|NCT02196831|11200874|FG000|NOT COMPLETED|Overall Study||9
10073691|NCT02196831|11200875|FG001|NOT COMPLETED|Overall Study||4
10073692|NCT02196857|11200882|FG000|STARTED|Overall Study||16
10073693|NCT02196857|11200882|FG000|COMPLETED|Overall Study||16
10073694|NCT02196857|11200882|FG000|NOT COMPLETED|Overall Study||0
10073695|NCT02196922|11200888|FG000|STARTED|Overall Study||58
10073696|NCT02196922|11200889|FG001|STARTED|Overall Study||46
10073697|NCT02196922|11200888|FG000|COMPLETED|Overall Study||58
10073698|NCT02196922|11200889|FG001|COMPLETED|Overall Study||46
10073699|NCT02196922|11200888|FG000|NOT COMPLETED|Overall Study||0
10073700|NCT02196922|11200889|FG001|NOT COMPLETED|Overall Study||0
10073701|NCT02197065|11200899|FG000|STARTED|Overall Study||10
10073702|NCT02197065|11200900|FG001|STARTED|Overall Study||10
10073703|NCT02197065|11200899|FG000|COMPLETED|Overall Study||10
10073704|NCT02197065|11200900|FG001|COMPLETED|Overall Study||10
10073705|NCT02197065|11200899|FG000|NOT COMPLETED|Overall Study||0
10073706|NCT02197065|11200900|FG001|NOT COMPLETED|Overall Study||0
10073707|NCT02197078|11200921|FG000|STARTED|Overall Study||14688
10073708|NCT02197078|11200922|FG001|STARTED|Overall Study||14688
10073709|NCT02197078|11200923|FG002|STARTED|Overall Study||10614
10073710|NCT02197078|11200924|FG003|STARTED|Overall Study||10614
10073711|NCT02197078|11200925|FG004|STARTED|Overall Study||9538
10073712|NCT02197078|11200926|FG005|STARTED|Overall Study||9538
10073713|NCT02197078|11200927|FG006|STARTED|Overall Study||25135
10073714|NCT02197078|11200928|FG007|STARTED|Overall Study||25135
10073715|NCT02197078|11200929|FG008|STARTED|Overall Study||18996
10073716|NCT02197078|11200930|FG009|STARTED|Overall Study||18996
10073717|NCT02197078|11200931|FG010|STARTED|Overall Study||15742
10073718|NCT02197078|11200932|FG011|STARTED|Overall Study||15742
10073719|NCT02197078|11200921|FG000|COMPLETED|Overall Study||14688
10073720|NCT02197078|11200922|FG001|COMPLETED|Overall Study||14688
10073721|NCT02197078|11200923|FG002|COMPLETED|Overall Study||10614
10073722|NCT02197078|11200924|FG003|COMPLETED|Overall Study||10614
10073723|NCT02197078|11200925|FG004|COMPLETED|Overall Study||9538
10073724|NCT02197078|11200926|FG005|COMPLETED|Overall Study||9538
10073725|NCT02197078|11200927|FG006|COMPLETED|Overall Study||25135
10073726|NCT02197078|11200928|FG007|COMPLETED|Overall Study||25135
10073727|NCT02197078|11200929|FG008|COMPLETED|Overall Study||18996
10073728|NCT02197078|11200930|FG009|COMPLETED|Overall Study||18996
10073729|NCT02197078|11200931|FG010|COMPLETED|Overall Study||15742
10073730|NCT02197078|11200932|FG011|COMPLETED|Overall Study||15742
10073731|NCT02197078|11200921|FG000|NOT COMPLETED|Overall Study||0
10073732|NCT02197078|11200922|FG001|NOT COMPLETED|Overall Study||0
10073733|NCT02197078|11200923|FG002|NOT COMPLETED|Overall Study||0
10073734|NCT02197078|11200924|FG003|NOT COMPLETED|Overall Study||0
10073735|NCT02197078|11200925|FG004|NOT COMPLETED|Overall Study||0
10073736|NCT02197078|11200926|FG005|NOT COMPLETED|Overall Study||0
10073737|NCT02197078|11200927|FG006|NOT COMPLETED|Overall Study||0
10073738|NCT02197078|11200928|FG007|NOT COMPLETED|Overall Study||0
10073739|NCT02197078|11200929|FG008|NOT COMPLETED|Overall Study||0
10073740|NCT02197078|11200930|FG009|NOT COMPLETED|Overall Study||0
10073741|NCT02197078|11200931|FG010|NOT COMPLETED|Overall Study||0
10073742|NCT02197078|11200932|FG011|NOT COMPLETED|Overall Study||0
10073743|NCT02197130|11200961|FG000|STARTED|Overall Study||95
10073744|NCT02197130|11200962|FG001|STARTED|Overall Study||89
10073745|NCT02197130|11200963|FG002|STARTED|Overall Study||88
10073746|NCT02197130|11200961|FG000|Received Treatment|Overall Study||95
10073747|NCT02197130|11200962|FG001|Received Treatment|Overall Study||88
10073748|NCT02197130|11200963|FG002|Received Treatment|Overall Study||87
10073749|NCT02197130|11200961|FG000|COMPLETED|Overall Study||79
10073750|NCT02197130|11200962|FG001|COMPLETED|Overall Study||81
10073751|NCT02197130|11200963|FG002|COMPLETED|Overall Study||56
10073752|NCT02197130|11200961|FG000|NOT COMPLETED|Overall Study||16
10073753|NCT02197130|11200962|FG001|NOT COMPLETED|Overall Study||8
10073754|NCT02197130|11200963|FG002|NOT COMPLETED|Overall Study||32
10073755|NCT02197247|11200971|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
10073756|NCT02197247|11200971|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
10073757|NCT02197247|11200971|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
10073758|NCT02197247|11200971|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
10073759|NCT02197247|11200971|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
10073760|NCT02197247|11200971|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
10073761|NCT02197247|11200971|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
10073762|NCT02197247|11200971|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
10073763|NCT02197247|11200971|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
10190495|NCT03292640|11319631|FG000|COMPLETED|Overall Study||214
10190496|NCT03292640|11319632|FG001|COMPLETED|Overall Study||230
10073764|NCT02197247|11200971|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
10073765|NCT02197247|11200971|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
10073766|NCT02197247|11200971|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
10073767|NCT02197273|11200983|FG000|STARTED|Overall Study||107
10073768|NCT02197273|11200984|FG001|STARTED|Overall Study||104
10073769|NCT02197273|11200983|FG000|COMPLETED|Overall Study||107
10073770|NCT02197273|11200984|FG001|COMPLETED|Overall Study||104
10073771|NCT02197273|11200983|FG000|NOT COMPLETED|Overall Study||0
10073772|NCT02197273|11200984|FG001|NOT COMPLETED|Overall Study||0
10073773|NCT02197377|11200992|FG000|STARTED|Overall Study||30
10073774|NCT02197377|11200993|FG001|STARTED|Overall Study||30
10073775|NCT02197377|11200992|FG000|COMPLETED|Overall Study||30
10073776|NCT02197377|11200993|FG001|COMPLETED|Overall Study||27
10073777|NCT02197377|11200992|FG000|NOT COMPLETED|Overall Study||0
10073778|NCT02197377|11200993|FG001|NOT COMPLETED|Overall Study||3
10073779|NCT02197416|11201002|FG000|STARTED|Overall Study||9
10073780|NCT02197416|11201003|FG001|STARTED|Overall Study||43
10073781|NCT02197416|11201004|FG002|STARTED|Overall Study||161
10073782|NCT02197416|11201002|FG000|COMPLETED|Overall Study||8
10073783|NCT02197416|11201003|FG001|COMPLETED|Overall Study||39
10073784|NCT02197416|11201004|FG002|COMPLETED|Overall Study||153
10073785|NCT02197416|11201002|FG000|NOT COMPLETED|Overall Study||1
10073786|NCT02197416|11201003|FG001|NOT COMPLETED|Overall Study||4
10073787|NCT02197416|11201004|FG002|NOT COMPLETED|Overall Study||8
10073788|NCT02197455|11201010|FG000|STARTED|Overall Study||30
10073789|NCT02197455|11201010|FG000|COMPLETED|Overall Study||30
10073790|NCT02197455|11201010|FG000|NOT COMPLETED|Overall Study||0
10073791|NCT02197481|11201016|FG000|STARTED|Overall Study|October 2014|43
10073792|NCT02197481|11201017|FG001|STARTED|Overall Study||43
10073793|NCT02197481|11201016|FG000|COMPLETED|Overall Study|February 2016|43
10073794|NCT02197481|11201017|FG001|COMPLETED|Overall Study||43
10073795|NCT02197481|11201016|FG000|NOT COMPLETED|Overall Study||0
10073796|NCT02197481|11201017|FG001|NOT COMPLETED|Overall Study||0
10073797|NCT02197520|11201023|FG000|STARTED|Period 1||12
10073798|NCT02197520|11201024|FG001|STARTED|Period 1||12
10073799|NCT02197520|11201023|FG000|COMPLETED|Period 1||11
10073800|NCT02197520|11201024|FG001|COMPLETED|Period 1||12
10073801|NCT02197520|11201023|FG000|NOT COMPLETED|Period 1||1
10073802|NCT02197520|11201024|FG001|NOT COMPLETED|Period 1||0
10073803|NCT02197520|11201023|FG000|STARTED|Period 2||11
10073804|NCT02197520|11201024|FG001|STARTED|Period 2||12
10073805|NCT02197520|11201023|FG000|COMPLETED|Period 2||10
10073806|NCT02197520|11201024|FG001|COMPLETED|Period 2||10
10073807|NCT02197520|11201023|FG000|NOT COMPLETED|Period 2||1
10073808|NCT02197520|11201024|FG001|NOT COMPLETED|Period 2||2
10073809|NCT02197572|11201032|FG000|STARTED|Overall Study||44
10073810|NCT02197572|11201032|FG000|COMPLETED|Overall Study||0
10073811|NCT02197572|11201032|FG000|NOT COMPLETED|Overall Study||44
10073812|NCT02197767|11201036|FG000|STARTED|Overall Study||11
10073813|NCT02197767|11201036|FG000|COMPLETED|Overall Study||11
10073814|NCT02197767|11201036|FG000|NOT COMPLETED|Overall Study||0
10073815|NCT02197806|11201044|FG000|STARTED|Overall Study||15
10073816|NCT02197806|11201045|FG001|STARTED|Overall Study||17
10073817|NCT02197806|11201046|FG002|STARTED|Overall Study||16
10073818|NCT02197806|11201047|FG003|STARTED|Overall Study||17
10073819|NCT02197806|11201044|FG000|COMPLETED|Overall Study||15
10073820|NCT02197806|11201045|FG001|COMPLETED|Overall Study||16
10073821|NCT02197806|11201046|FG002|COMPLETED|Overall Study||16
10073822|NCT02197806|11201047|FG003|COMPLETED|Overall Study||16
10073823|NCT02197806|11201044|FG000|NOT COMPLETED|Overall Study||0
10190497|NCT03292640|11319631|FG000|NOT COMPLETED|Overall Study||61
10190498|NCT03292640|11319632|FG001|NOT COMPLETED|Overall Study||42
10190499|NCT03292653|11319645|FG000|STARTED|Overall Study||11
10190500|NCT03292653|11319646|FG001|STARTED|Overall Study||10
10190501|NCT03292653|11319647|FG002|STARTED|Overall Study||11
10190502|NCT03292653|11319645|FG000|COMPLETED|Overall Study||10
10190503|NCT03292653|11319646|FG001|COMPLETED|Overall Study||10
10190504|NCT03292653|11319647|FG002|COMPLETED|Overall Study||10
10190505|NCT03292653|11319645|FG000|NOT COMPLETED|Overall Study||1
10190506|NCT03292653|11319646|FG001|NOT COMPLETED|Overall Study||0
10190507|NCT03292653|11319647|FG002|NOT COMPLETED|Overall Study||1
9731955|NCT00138125|10831942|FG000|COMPLETED|Overall Study||2
10073824|NCT02197806|11201045|FG001|NOT COMPLETED|Overall Study||1
10073825|NCT02197806|11201046|FG002|NOT COMPLETED|Overall Study||0
10073826|NCT02197806|11201047|FG003|NOT COMPLETED|Overall Study||1
10073827|NCT02197897|11201057|FG000|STARTED|Overall Study||15
10073828|NCT02197897|11201057|FG000|COMPLETED|Overall Study||14
10073829|NCT02197897|11201057|FG000|NOT COMPLETED|Overall Study||1
10073830|NCT02198040|11201064|FG000|STARTED|Overall Study||9
10073831|NCT02198040|11201065|FG001|STARTED|Overall Study||9
10190508|NCT03292692|11319658|FG000|STARTED|Overall Study||302
10190509|NCT03292692|11319659|FG001|STARTED|Overall Study||298
10190510|NCT03292692|11319658|FG000|COMPLETED|Overall Study||264
10190511|NCT03292692|11319659|FG001|COMPLETED|Overall Study||260
10073832|NCT02198040|11201066|FG002|STARTED|Overall Study||9
10073833|NCT02198040|11201064|FG000|COMPLETED|Overall Study||9
10073834|NCT02198040|11201065|FG001|COMPLETED|Overall Study||8
10073835|NCT02198040|11201066|FG002|COMPLETED|Overall Study||8
10073836|NCT02198040|11201064|FG000|NOT COMPLETED|Overall Study||0
10073837|NCT02198040|11201065|FG001|NOT COMPLETED|Overall Study||1
10073838|NCT02198040|11201066|FG002|NOT COMPLETED|Overall Study||1
10073839|NCT02198235|11201079|FG000|STARTED|Overall Study||30
10073840|NCT02198235|11201080|FG001|STARTED|Overall Study||30
10073841|NCT02198235|11201081|FG002|STARTED|Overall Study||30
10073842|NCT02198235|11201079|FG000|COMPLETED|Overall Study||27
10073843|NCT02198235|11201080|FG001|COMPLETED|Overall Study||28
10073844|NCT02198235|11201081|FG002|COMPLETED|Overall Study||28
10073845|NCT02198235|11201079|FG000|NOT COMPLETED|Overall Study||3
10073846|NCT02198235|11201080|FG001|NOT COMPLETED|Overall Study||2
10073847|NCT02198235|11201081|FG002|NOT COMPLETED|Overall Study||2
10073848|NCT02198430|11201091|FG000|STARTED|Overall Study||53
10073849|NCT02198430|11201092|FG001|STARTED|Overall Study||51
10073850|NCT02198430|11201091|FG000|COMPLETED|Overall Study||53
10073851|NCT02198430|11201092|FG001|COMPLETED|Overall Study||51
10073852|NCT02198430|11201091|FG000|NOT COMPLETED|Overall Study||0
10073853|NCT02198430|11201092|FG001|NOT COMPLETED|Overall Study||0
10073854|NCT02198651|11201098|FG000|STARTED|Lead-in Period||149
10073855|NCT02198651|11201099|FG001|STARTED|Lead-in Period||0
10073856|NCT02198651|11201100|FG002|STARTED|Lead-in Period||0
10073857|NCT02198651|11201101|FG003|STARTED|Lead-in Period||0
10073858|NCT02198651|11201102|FG004|STARTED|Lead-in Period||0
10073859|NCT02198651|11201098|FG000|Participants Treated in Lead-In Period|Lead-in Period||146
10073860|NCT02198651|11201099|FG001|Participants Treated in Lead-In Period|Lead-in Period||0
10073861|NCT02198651|11201100|FG002|Participants Treated in Lead-In Period|Lead-in Period||0
10073862|NCT02198651|11201101|FG003|Participants Treated in Lead-In Period|Lead-in Period||0
10073863|NCT02198651|11201102|FG004|Participants Treated in Lead-In Period|Lead-in Period||0
10073864|NCT02198651|11201098|FG000|COMPLETED|Lead-in Period||112
10073865|NCT02198651|11201099|FG001|COMPLETED|Lead-in Period||0
10073866|NCT02198651|11201100|FG002|COMPLETED|Lead-in Period||0
10073867|NCT02198651|11201101|FG003|COMPLETED|Lead-in Period||0
10073868|NCT02198651|11201102|FG004|COMPLETED|Lead-in Period||0
10073869|NCT02198651|11201098|FG000|NOT COMPLETED|Lead-in Period||37
10073870|NCT02198651|11201099|FG001|NOT COMPLETED|Lead-in Period||0
10073871|NCT02198651|11201100|FG002|NOT COMPLETED|Lead-in Period||0
10073872|NCT02198651|11201101|FG003|NOT COMPLETED|Lead-in Period||0
10073873|NCT02198651|11201102|FG004|NOT COMPLETED|Lead-in Period||0
10073874|NCT02198651|11201098|FG000|STARTED|Double-blind Period||0
10073875|NCT02198651|11201099|FG001|STARTED|Double-blind Period||102
10073876|NCT02198651|11201100|FG002|STARTED|Double-blind Period||20
10073877|NCT02198651|11201101|FG003|STARTED|Double-blind Period||0
10073878|NCT02198651|11201102|FG004|STARTED|Double-blind Period||0
10073879|NCT02198651|11201098|FG000|COMPLETED|Double-blind Period||0
10073880|NCT02198651|11201099|FG001|COMPLETED|Double-blind Period||93
10073881|NCT02198651|11201100|FG002|COMPLETED|Double-blind Period||19
10073882|NCT02198651|11201101|FG003|COMPLETED|Double-blind Period||0
10073883|NCT02198651|11201102|FG004|COMPLETED|Double-blind Period||0
10073884|NCT02198651|11201098|FG000|NOT COMPLETED|Double-blind Period||0
10073885|NCT02198651|11201099|FG001|NOT COMPLETED|Double-blind Period||9
10073886|NCT02198651|11201100|FG002|NOT COMPLETED|Double-blind Period||1
10073887|NCT02198651|11201101|FG003|NOT COMPLETED|Double-blind Period||0
10073888|NCT02198651|11201102|FG004|NOT COMPLETED|Double-blind Period||0
10073889|NCT02198651|11201098|FG000|STARTED|Open-label Rescue Period||0
10073890|NCT02198651|11201099|FG001|STARTED|Open-label Rescue Period||0
10073891|NCT02198651|11201100|FG002|STARTED|Open-label Rescue Period||0
10073892|NCT02198651|11201101|FG003|STARTED|Open-label Rescue Period||31
10073893|NCT02198651|11201102|FG004|STARTED|Open-label Rescue Period||8
10073894|NCT02198651|11201098|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
10073895|NCT02198651|11201099|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
10073896|NCT02198651|11201100|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
10073897|NCT02198651|11201101|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
10073898|NCT02198651|11201102|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
10073899|NCT02198651|11201098|FG000|COMPLETED|Open-label Rescue Period||0
10073900|NCT02198651|11201099|FG001|COMPLETED|Open-label Rescue Period||0
10073901|NCT02198651|11201100|FG002|COMPLETED|Open-label Rescue Period||0
10073902|NCT02198651|11201101|FG003|COMPLETED|Open-label Rescue Period||28
10073903|NCT02198651|11201102|FG004|COMPLETED|Open-label Rescue Period||8
10073904|NCT02198651|11201098|FG000|NOT COMPLETED|Open-label Rescue Period||0
10073905|NCT02198651|11201099|FG001|NOT COMPLETED|Open-label Rescue Period||0
10073906|NCT02198651|11201100|FG002|NOT COMPLETED|Open-label Rescue Period||0
10073907|NCT02198651|11201101|FG003|NOT COMPLETED|Open-label Rescue Period||3
10073908|NCT02198651|11201102|FG004|NOT COMPLETED|Open-label Rescue Period||0
10073909|NCT02198664|11201117|FG000|STARTED|Overall Study||26
10073910|NCT02198664|11201118|FG001|STARTED|Overall Study||21
10073911|NCT02198664|11201117|FG000|COMPLETED|Overall Study||10
10073912|NCT02198664|11201118|FG001|COMPLETED|Overall Study||13
10073913|NCT02198664|11201117|FG000|NOT COMPLETED|Overall Study||16
10073914|NCT02198664|11201118|FG001|NOT COMPLETED|Overall Study||8
10073915|NCT02198963|11201126|FG000|STARTED|Overall Study||43
10073916|NCT02198963|11201126|FG000|COMPLETED|Overall Study||36
10073917|NCT02198963|11201126|FG000|NOT COMPLETED|Overall Study||7
10073918|NCT02199028|11201137|FG000|STARTED|Week 1||15
10073919|NCT02199028|11201138|FG001|STARTED|Week 1||15
10073920|NCT02199028|11201137|FG000|COMPLETED|Week 1||14
10073921|NCT02199028|11201138|FG001|COMPLETED|Week 1||15
10073922|NCT02199028|11201137|FG000|NOT COMPLETED|Week 1||1
10073923|NCT02199028|11201138|FG001|NOT COMPLETED|Week 1||0
10073924|NCT02199028|11201137|FG000|STARTED|Week 2||14
10073925|NCT02199028|11201138|FG001|STARTED|Week 2||15
10073926|NCT02199028|11201137|FG000|COMPLETED|Week 2||14
10073927|NCT02199028|11201138|FG001|COMPLETED|Week 2||15
10073928|NCT02199028|11201137|FG000|NOT COMPLETED|Week 2||0
10073929|NCT02199028|11201138|FG001|NOT COMPLETED|Week 2||0
10073930|NCT02199028|11201137|FG000|STARTED|Week 3||14
10073931|NCT02199028|11201138|FG001|STARTED|Week 3||15
10073932|NCT02199028|11201137|FG000|COMPLETED|Week 3||13
10073933|NCT02199028|11201138|FG001|COMPLETED|Week 3||15
10073934|NCT02199028|11201137|FG000|NOT COMPLETED|Week 3||1
10073935|NCT02199028|11201138|FG001|NOT COMPLETED|Week 3||0
10073936|NCT02199028|11201137|FG000|STARTED|Week 4||13
10073937|NCT02199028|11201138|FG001|STARTED|Week 4||15
10073938|NCT02199028|11201137|FG000|COMPLETED|Week 4||13
10073939|NCT02199028|11201138|FG001|COMPLETED|Week 4||15
10073940|NCT02199028|11201137|FG000|NOT COMPLETED|Week 4||0
10073941|NCT02199028|11201138|FG001|NOT COMPLETED|Week 4||0
10073942|NCT02199041|11201145|FG000|STARTED|Overall Study||12
10073943|NCT02199041|11201145|FG000|COMPLETED|Overall Study||12
10073944|NCT02199041|11201145|FG000|NOT COMPLETED|Overall Study||0
10073945|NCT02199080|11201150|FG000|STARTED|Overall Study||2506
10073946|NCT02199080|11201150|FG000|COMPLETED|Overall Study||2494
10073947|NCT02199080|11201150|FG000|NOT COMPLETED|Overall Study||12
10073948|NCT02199197|11201158|FG000|STARTED|Overall Study||35
10073949|NCT02199197|11201159|FG001|STARTED|Overall Study||14
10073950|NCT02199197|11201158|FG000|COMPLETED|Overall Study||35
10073951|NCT02199197|11201159|FG001|COMPLETED|Overall Study||12
10073952|NCT02199197|11201158|FG000|NOT COMPLETED|Overall Study||0
10073953|NCT02199197|11201159|FG001|NOT COMPLETED|Overall Study||2
10073954|NCT02199314|11201166|FG000|STARTED|Overall Study||30
10073955|NCT02199314|11201166|FG000|COMPLETED|Overall Study||14
10073956|NCT02199314|11201166|FG000|NOT COMPLETED|Overall Study||16
10073957|NCT02199496|11201172|FG000|STARTED|Ustekinumab-Single Dose||3
10073958|NCT02199496|11201173|FG001|STARTED|Ustekinumab-Single Dose||0
10073959|NCT02199496|11201172|FG000|COMPLETED|Ustekinumab-Single Dose||3
10073960|NCT02199496|11201173|FG001|COMPLETED|Ustekinumab-Single Dose||0
10073961|NCT02199496|11201172|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0
10073962|NCT02199496|11201173|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0
10073963|NCT02199496|11201172|FG000|STARTED|Ustekinumab-Multi-dose||3
10073964|NCT02199496|11201173|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
10073965|NCT02199496|11201172|FG000|COMPLETED|Ustekinumab-Multi-dose||3
10073966|NCT02199496|11201173|FG001|COMPLETED|Ustekinumab-Multi-dose||2
10073967|NCT02199496|11201172|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0
10073968|NCT02199496|11201173|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0
10073969|NCT02199509|11201181|FG000|STARTED|Overall Study||3
10073970|NCT02199509|11201182|FG001|STARTED|Overall Study||4
10073971|NCT02199509|11201181|FG000|COMPLETED|Overall Study||2
10073972|NCT02199509|11201182|FG001|COMPLETED|Overall Study||3
10073973|NCT02199509|11201181|FG000|NOT COMPLETED|Overall Study||1
10073974|NCT02199509|11201182|FG001|NOT COMPLETED|Overall Study||1
10073975|NCT02199574|11201192|FG000|STARTED|Overall Study||12
10073976|NCT02199574|11201192|FG000|COMPLETED|Overall Study||12
10073977|NCT02199574|11201192|FG000|NOT COMPLETED|Overall Study||0
10073978|NCT02199652|11201200|FG000|STARTED|Overall Study||10
10073979|NCT02199652|11201201|FG001|STARTED|Overall Study||10
10073980|NCT02199652|11201200|FG000|COMPLETED|Overall Study||3
10073981|NCT02199652|11201201|FG001|COMPLETED|Overall Study||3
10073982|NCT02199652|11201200|FG000|NOT COMPLETED|Overall Study||7
10073983|NCT02199652|11201201|FG001|NOT COMPLETED|Overall Study||7
10073984|NCT02199717|11201207|FG000|STARTED|Overall Study||66
10073985|NCT02199717|11201207|FG000|COMPLETED|Overall Study||66
10073986|NCT02199717|11201207|FG000|NOT COMPLETED|Overall Study||0
10073987|NCT02199743|11201214|FG000|STARTED|Overall Study||14
10073988|NCT02199743|11201215|FG001|STARTED|Overall Study||10
10073989|NCT02199743|11201214|FG000|COMPLETED|Overall Study||14
10073990|NCT02199743|11201215|FG001|COMPLETED|Overall Study||8
10073991|NCT02199743|11201214|FG000|NOT COMPLETED|Overall Study||0
10073992|NCT02199743|11201215|FG001|NOT COMPLETED|Overall Study||2
10073993|NCT02199795|11201225|FG000|STARTED|Overall Study||4
10073994|NCT02199795|11201226|FG001|STARTED|Overall Study||3
10073995|NCT02199795|11201225|FG000|COMPLETED|Overall Study||2
10073996|NCT02199795|11201226|FG001|COMPLETED|Overall Study||3
10073997|NCT02199795|11201225|FG000|NOT COMPLETED|Overall Study||2
10073998|NCT02199795|11201226|FG001|NOT COMPLETED|Overall Study||0
10073999|NCT02199964|11201234|FG000|STARTED|Overall Study||2
10074000|NCT02199964|11201235|FG001|STARTED|Overall Study||2
10074001|NCT02199964|11201234|FG000|COMPLETED|Overall Study||2
10074002|NCT02199964|11201235|FG001|COMPLETED|Overall Study||2
10074003|NCT02199964|11201234|FG000|NOT COMPLETED|Overall Study||0
10074004|NCT02199964|11201235|FG001|NOT COMPLETED|Overall Study||0
10074005|NCT02200055|11201241|FG000|STARTED|Overall Study||86
10074006|NCT02200055|11201241|FG000|COMPLETED|Overall Study||86
10074007|NCT02200055|11201241|FG000|NOT COMPLETED|Overall Study||0
10074008|NCT02200211|11201251|FG000|STARTED|Overall Study||190
10074009|NCT02200211|11201252|FG001|STARTED|Overall Study||195
10074010|NCT02200211|11201253|FG002|STARTED|Overall Study||40
10074011|NCT02200211|11201254|FG003|STARTED|Overall Study||60
10074012|NCT02200211|11201251|FG000|Included in 16-week Primary Analysis|Overall Study||177
10074013|NCT02200211|11201252|FG001|Included in 16-week Primary Analysis|Overall Study||186
10074014|NCT02200211|11201253|FG002|Included in 16-week Primary Analysis|Overall Study||39
10074015|NCT02200211|11201254|FG003|Included in 16-week Primary Analysis|Overall Study||56
10074016|NCT02200211|11201251|FG000|COMPLETED|Overall Study||182
10074017|NCT02200211|11201252|FG001|COMPLETED|Overall Study||188
10074018|NCT02200211|11201253|FG002|COMPLETED|Overall Study||39
10074019|NCT02200211|11201254|FG003|COMPLETED|Overall Study||58
10074020|NCT02200211|11201251|FG000|NOT COMPLETED|Overall Study||8
10190512|NCT03292692|11319658|FG000|NOT COMPLETED|Overall Study||38
10190513|NCT03292692|11319659|FG001|NOT COMPLETED|Overall Study||38
10190514|NCT03292809|11319667|FG000|STARTED|Overall Study||162
10190515|NCT03292809|11319668|FG001|STARTED|Overall Study||166
10190516|NCT03292809|11319667|FG000|COMPLETED|Overall Study||155
10190517|NCT03292809|11319668|FG001|COMPLETED|Overall Study||163
10190518|NCT03292809|11319667|FG000|NOT COMPLETED|Overall Study||7
10190519|NCT03292809|11319668|FG001|NOT COMPLETED|Overall Study||3
10190520|NCT03292952|11319676|FG000|STARTED|Open-Label Dose Optimization||155
10190521|NCT03292952|11319677|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
10190522|NCT03292952|11319678|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
10190523|NCT03292952|11319676|FG000|COMPLETED|Open-Label Dose Optimization||150
10190524|NCT03292952|11319677|FG001|COMPLETED|Open-Label Dose Optimization||0
10190525|NCT03292952|11319678|FG002|COMPLETED|Open-Label Dose Optimization||0
10190526|NCT03292952|11319676|FG000|NOT COMPLETED|Open-Label Dose Optimization||5
10190527|NCT03292952|11319677|FG001|NOT COMPLETED|Open-Label Dose Optimization||0
10190528|NCT03292952|11319678|FG002|NOT COMPLETED|Open-Label Dose Optimization||0
10190529|NCT03292952|11319676|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
10190530|NCT03292952|11319677|FG001|STARTED|Double-Blind Treatment Phase||74
10190531|NCT03292952|11319678|FG002|STARTED|Double-Blind Treatment Phase||76
10190532|NCT03292952|11319676|FG000|COMPLETED|Double-Blind Treatment Phase||0
10190533|NCT03292952|11319677|FG001|COMPLETED|Double-Blind Treatment Phase||74
10190534|NCT03292952|11319678|FG002|COMPLETED|Double-Blind Treatment Phase||75
10190535|NCT03292952|11319676|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
10190536|NCT03292952|11319677|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
10190537|NCT03292952|11319678|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1
10190538|NCT03293238|11319691|FG000|STARTED|Overall Study||19
10190539|NCT03293238|11319692|FG001|STARTED|Overall Study||16
10190540|NCT03293238|11319693|FG002|STARTED|Overall Study||14
10190541|NCT03293238|11319694|FG003|STARTED|Overall Study||14
10190542|NCT03293238|11319691|FG000|COMPLETED|Overall Study||19
10190543|NCT03293238|11319692|FG001|COMPLETED|Overall Study||16
10190544|NCT03293238|11319693|FG002|COMPLETED|Overall Study||14
10190545|NCT03293238|11319694|FG003|COMPLETED|Overall Study||14
10190546|NCT03293238|11319691|FG000|NOT COMPLETED|Overall Study||0
10190547|NCT03293238|11319692|FG001|NOT COMPLETED|Overall Study||0
10190548|NCT03293238|11319693|FG002|NOT COMPLETED|Overall Study||0
10190549|NCT03293238|11319694|FG003|NOT COMPLETED|Overall Study||0
10190550|NCT03293394|11319706|FG000|STARTED|First Intervention (2 Weeks)||20
10190551|NCT03293394|11319707|FG001|STARTED|First Intervention (2 Weeks)||10
10190552|NCT03293394|11319706|FG000|COMPLETED|First Intervention (2 Weeks)||20
10190553|NCT03293394|11319707|FG001|COMPLETED|First Intervention (2 Weeks)||10
10190554|NCT03293394|11319706|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10190555|NCT03293394|11319707|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10190556|NCT03293394|11319706|FG000|STARTED|Follow-up (6 Months)||20
10190557|NCT03293394|11319707|FG001|STARTED|Follow-up (6 Months)||10
10190558|NCT03293394|11319706|FG000|COMPLETED|Follow-up (6 Months)||16
10190559|NCT03293394|11319707|FG001|COMPLETED|Follow-up (6 Months)||8
10190560|NCT03293394|11319706|FG000|NOT COMPLETED|Follow-up (6 Months)||4
10190561|NCT03293394|11319707|FG001|NOT COMPLETED|Follow-up (6 Months)||2
10190562|NCT03293485|11319713|FG000|STARTED|Overall Study||83
10190563|NCT03293485|11319713|FG000|Treated|Overall Study||81
10190564|NCT03293485|11319713|FG000|COMPLETED|Overall Study||78
10190565|NCT03293485|11319713|FG000|NOT COMPLETED|Overall Study||5
10190566|NCT03293654|11319722|FG000|STARTED|Overall Study||38
10190567|NCT03293654|11319723|FG001|STARTED|Overall Study||38
10190568|NCT03293654|11319724|FG002|STARTED|Overall Study||38
10190569|NCT03293654|11319722|FG000|COMPLETED|Overall Study||38
10190570|NCT03293654|11319723|FG001|COMPLETED|Overall Study||37
10190571|NCT03293654|11319724|FG002|COMPLETED|Overall Study||38
10190572|NCT03293654|11319722|FG000|NOT COMPLETED|Overall Study||0
10190573|NCT03293654|11319723|FG001|NOT COMPLETED|Overall Study||1
10190574|NCT03293654|11319724|FG002|NOT COMPLETED|Overall Study||0
10190575|NCT03294213|11319732|FG000|STARTED|Overall Study||176
10190576|NCT03294213|11319732|FG000|COMPLETED|Overall Study||176
10190577|NCT03294213|11319732|FG000|NOT COMPLETED|Overall Study||0
10190578|NCT03294317|11319736|FG000|STARTED|Overall Study||70
10190579|NCT03294317|11319736|FG000|Implanted With Lead at HIS Bundle|Overall Study||61
10190580|NCT03294317|11319736|FG000|Subjects With Available CT|Overall Study||51
10190581|NCT03294317|11319736|FG000|COMPLETED|Overall Study||50
10190582|NCT03294317|11319736|FG000|NOT COMPLETED|Overall Study||20
10190583|NCT03294538|11319743|FG000|STARTED|Overall Study||268
10190584|NCT03294538|11319744|FG001|STARTED|Overall Study||262
10074021|NCT02200211|11201252|FG001|NOT COMPLETED|Overall Study||7
10190585|NCT03294538|11319745|FG002|STARTED|Overall Study||133
10190586|NCT03294538|11319743|FG000|Safety Population|Overall Study||267
10074022|NCT02200211|11201253|FG002|NOT COMPLETED|Overall Study||1
10074023|NCT02200211|11201254|FG003|NOT COMPLETED|Overall Study||2
10074024|NCT02200445|11201275|FG000|STARTED|Overall Study||4
10074025|NCT02200445|11201276|FG001|STARTED|Overall Study||17
10074026|NCT02200445|11201277|FG002|STARTED|Overall Study||5
10074027|NCT02200445|11201275|FG000|COMPLETED|Overall Study||3
10074028|NCT02200445|11201276|FG001|COMPLETED|Overall Study||13
10074029|NCT02200445|11201277|FG002|COMPLETED|Overall Study||3
10074030|NCT02200445|11201275|FG000|NOT COMPLETED|Overall Study||1
10074031|NCT02200445|11201276|FG001|NOT COMPLETED|Overall Study||4
10074032|NCT02200445|11201277|FG002|NOT COMPLETED|Overall Study||2
10074033|NCT02200458|11201285|FG000|STARTED|Overall Study||62
10074034|NCT02200458|11201285|FG000|COMPLETED|Overall Study||62
10074035|NCT02200458|11201285|FG000|NOT COMPLETED|Overall Study||0
10074036|NCT02200510|11201291|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
10074037|NCT02200510|11201292|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
10074038|NCT02200510|11201291|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
10074039|NCT02200510|11201292|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
10074040|NCT02200510|11201291|FG000|NOT COMPLETED|Overall Study||9
10074041|NCT02200510|11201292|FG001|NOT COMPLETED|Overall Study||3
10074042|NCT02200523|11201300|FG000|STARTED|Overall Study||20
10074043|NCT02200523|11201301|FG001|STARTED|Overall Study||20
10074044|NCT02200523|11201300|FG000|COMPLETED|Overall Study||20
10074045|NCT02200523|11201301|FG001|COMPLETED|Overall Study||20
10074046|NCT02200523|11201300|FG000|NOT COMPLETED|Overall Study||0
10074047|NCT02200523|11201301|FG001|NOT COMPLETED|Overall Study||0
10074048|NCT02200536|11201310|FG000|STARTED|Overall Study||32
10074049|NCT02200536|11201311|FG001|STARTED|Overall Study||30
10074050|NCT02200536|11201312|FG002|STARTED|Overall Study||30
10074051|NCT02200536|11201310|FG000|COMPLETED|Overall Study||32
10074052|NCT02200536|11201311|FG001|COMPLETED|Overall Study||30
10074053|NCT02200536|11201312|FG002|COMPLETED|Overall Study||30
10074054|NCT02200536|11201310|FG000|NOT COMPLETED|Overall Study||0
10074055|NCT02200536|11201311|FG001|NOT COMPLETED|Overall Study||0
10074056|NCT02200536|11201312|FG002|NOT COMPLETED|Overall Study||0
10074069|NCT02201056|11201338|FG000|STARTED|Overall Study||12
10074070|NCT02201056|11201339|FG001|STARTED|Overall Study||6
10074071|NCT02201056|11201340|FG002|STARTED|Overall Study||6
10074072|NCT02201056|11201341|FG003|STARTED|Overall Study||6
10074073|NCT02201056|11201342|FG004|STARTED|Overall Study||6
10074074|NCT02201056|11201343|FG005|STARTED|Overall Study||6
10074075|NCT02201056|11201344|FG006|STARTED|Overall Study||6
10074076|NCT02201056|11201338|FG000|COMPLETED|Overall Study||12
10074077|NCT02201056|11201339|FG001|COMPLETED|Overall Study||6
10074078|NCT02201056|11201340|FG002|COMPLETED|Overall Study||6
10074079|NCT02201056|11201341|FG003|COMPLETED|Overall Study||6
10074080|NCT02201056|11201342|FG004|COMPLETED|Overall Study||6
10074081|NCT02201056|11201343|FG005|COMPLETED|Overall Study||6
10074082|NCT02201056|11201344|FG006|COMPLETED|Overall Study||6
10074083|NCT02201056|11201338|FG000|NOT COMPLETED|Overall Study||0
10074084|NCT02201056|11201339|FG001|NOT COMPLETED|Overall Study||0
10074085|NCT02201056|11201340|FG002|NOT COMPLETED|Overall Study||0
10074086|NCT02201056|11201341|FG003|NOT COMPLETED|Overall Study||0
10074087|NCT02201056|11201342|FG004|NOT COMPLETED|Overall Study||0
10074088|NCT02201056|11201343|FG005|NOT COMPLETED|Overall Study||0
10074089|NCT02201056|11201344|FG006|NOT COMPLETED|Overall Study||0
10074090|NCT02201108|11201368|FG000|STARTED|Overall Study||57
10074091|NCT02201108|11201369|FG001|STARTED|Overall Study||109
10074092|NCT02201108|11201368|FG000|On-going Participants|Overall Study||0
10074093|NCT02201108|11201369|FG001|On-going Participants|Overall Study||58
10074094|NCT02201108|11201368|FG000|COMPLETED|Overall Study||53
10074095|NCT02201108|11201369|FG001|COMPLETED|Overall Study||102
10074096|NCT02201108|11201368|FG000|NOT COMPLETED|Overall Study||4
10074097|NCT02201108|11201369|FG001|NOT COMPLETED|Overall Study||7
10074098|NCT02201212|11201378|FG000|STARTED|Overall Study||30
10074099|NCT02201212|11201378|FG000|COMPLETED|Overall Study||30
10074100|NCT02201212|11201378|FG000|NOT COMPLETED|Overall Study||0
10074101|NCT02201277|11201384|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
10074102|NCT02201277|11201385|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
10074103|NCT02201277|11201384|FG000|Filter Retrieval|Overall Study||17
10074104|NCT02201277|11201385|FG001|Filter Retrieval|Overall Study||16
10074105|NCT02201277|11201384|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
10074106|NCT02201277|11201385|FG001|Signed ICF But Did Not Enroll|Overall Study||1
10074107|NCT02201277|11201384|FG000|Filter Ruled to be Permanent|Overall Study||2
10074108|NCT02201277|11201385|FG001|Filter Ruled to be Permanent|Overall Study||2
10074109|NCT02201277|11201384|FG000|Lost to Follow up|Overall Study||2
10074110|NCT02201277|11201385|FG001|Lost to Follow up|Overall Study||1
10074111|NCT02201277|11201384|FG000|Death (Before Removal)|Overall Study||3
10074112|NCT02201277|11201385|FG001|Death (Before Removal)|Overall Study||4
10074113|NCT02201277|11201384|FG000|Complicated Retrieval|Overall Study||2
10074114|NCT02201277|11201385|FG001|Complicated Retrieval|Overall Study||0
10074115|NCT02201277|11201384|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1
10074116|NCT02201277|11201385|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0
10074117|NCT02201277|11201384|FG000|COMPLETED|Overall Study||17
10074118|NCT02201277|11201385|FG001|COMPLETED|Overall Study||16
10074119|NCT02201277|11201384|FG000|NOT COMPLETED|Overall Study||7
10074120|NCT02201277|11201385|FG001|NOT COMPLETED|Overall Study||5
10074121|NCT02201290|11201395|FG000|STARTED|Overall Study||9
10074122|NCT02201290|11201395|FG000|COMPLETED|Overall Study||4
10074123|NCT02201290|11201395|FG000|NOT COMPLETED|Overall Study||5
10074124|NCT02201329|11201399|FG000|STARTED|Overall Study||5
10074125|NCT02201329|11201399|FG000|COMPLETED|Overall Study||0
10074126|NCT02201329|11201399|FG000|NOT COMPLETED|Overall Study||5
10074127|NCT02201394|11201403|FG000|STARTED|Loading Dose||20
10074128|NCT02201394|11201403|FG000|COMPLETED|Loading Dose||20
10074129|NCT02201394|11201403|FG000|NOT COMPLETED|Loading Dose||0
10074130|NCT02201394|11201403|FG000|STARTED|Maintenance Dose||20
10074131|NCT02201394|11201403|FG000|COMPLETED|Maintenance Dose||20
10074132|NCT02201394|11201403|FG000|NOT COMPLETED|Maintenance Dose||0
10074133|NCT02201420|11201408|FG000|STARTED|Overall Study||5
10074134|NCT02201420|11201408|FG000|COMPLETED|Overall Study||5
10074135|NCT02201420|11201408|FG000|NOT COMPLETED|Overall Study||0
10074136|NCT02201446|11201414|FG000|STARTED|Overall Study||81
10074137|NCT02201446|11201415|FG001|STARTED|Overall Study||58
10074138|NCT02201446|11201414|FG000|COMPLETED|Overall Study||81
10074139|NCT02201446|11201415|FG001|COMPLETED|Overall Study||58
10074140|NCT02201446|11201414|FG000|NOT COMPLETED|Overall Study||0
10074141|NCT02201446|11201415|FG001|NOT COMPLETED|Overall Study||0
10190587|NCT03294538|11319744|FG001|Safety Population|Overall Study||262
10190588|NCT03294538|11319745|FG002|Safety Population|Overall Study||132
10190589|NCT03294538|11319743|FG000|mITT Population|Overall Study||267
10190590|NCT03294538|11319744|FG001|mITT Population|Overall Study||262
10190591|NCT03294538|11319745|FG002|mITT Population|Overall Study||132
10190592|NCT03294538|11319743|FG000|PP Population|Overall Study||244
10190593|NCT03294538|11319744|FG001|PP Population|Overall Study||227
10190594|NCT03294538|11319745|FG002|PP Population|Overall Study||126
10190595|NCT03294538|11319743|FG000|COMPLETED|Overall Study||263
10190596|NCT03294538|11319744|FG001|COMPLETED|Overall Study||257
10190597|NCT03294538|11319745|FG002|COMPLETED|Overall Study||131
10190598|NCT03294538|11319743|FG000|NOT COMPLETED|Overall Study||5
10190599|NCT03294538|11319744|FG001|NOT COMPLETED|Overall Study||5
10190600|NCT03294538|11319745|FG002|NOT COMPLETED|Overall Study||2
10190601|NCT03294629|11319755|FG000|STARTED|First Intervention (2 Weeks)||16
10190602|NCT03294629|11319756|FG001|STARTED|First Intervention (2 Weeks)||19
10190603|NCT03294629|11319755|FG000|COMPLETED|First Intervention (2 Weeks)||14
10190604|NCT03294629|11319756|FG001|COMPLETED|First Intervention (2 Weeks)||15
10190605|NCT03294629|11319755|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2
10190606|NCT03294629|11319756|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4
10190607|NCT03294629|11319755|FG000|STARTED|Second Intervention (2 Weeks)||14
10190608|NCT03294629|11319756|FG001|STARTED|Second Intervention (2 Weeks)||15
10190609|NCT03294629|11319755|FG000|COMPLETED|Second Intervention (2 Weeks)||12
10190610|NCT03294629|11319756|FG001|COMPLETED|Second Intervention (2 Weeks)||13
10190611|NCT03294629|11319755|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2
10190612|NCT03294629|11319756|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2
10190613|NCT03294681|11319762|FG000|STARTED|Overall Study||153
10190614|NCT03294681|11319762|FG000|COMPLETED|Overall Study||152
10190615|NCT03294681|11319762|FG000|NOT COMPLETED|Overall Study||1
10190616|NCT03294850|11319768|FG000|STARTED|Overall Study||4
10190617|NCT03294850|11319769|FG001|STARTED|Overall Study||10
10190618|NCT03294850|11319768|FG000|COMPLETED|Overall Study||4
10190619|NCT03294850|11319769|FG001|COMPLETED|Overall Study||10
10190620|NCT03294850|11319768|FG000|NOT COMPLETED|Overall Study||0
10190621|NCT03294850|11319769|FG001|NOT COMPLETED|Overall Study||0
10190622|NCT03294941|11319777|FG000|STARTED|Overall Study||4
10190623|NCT03294941|11319778|FG001|STARTED|Overall Study||13
10190624|NCT03294941|11319777|FG000|COMPLETED|Overall Study||4
10190625|NCT03294941|11319778|FG001|COMPLETED|Overall Study||11
10190626|NCT03294941|11319777|FG000|NOT COMPLETED|Overall Study||0
10190627|NCT03294941|11319778|FG001|NOT COMPLETED|Overall Study||2
10190628|NCT03295201|11319787|FG000|STARTED|Overall Study||11
10190629|NCT03295201|11319788|FG001|STARTED|Overall Study||11
10190630|NCT03295201|11319787|FG000|COMPLETED|Overall Study||10
10190631|NCT03295201|11319788|FG001|COMPLETED|Overall Study||9
10190632|NCT03295201|11319787|FG000|NOT COMPLETED|Overall Study||1
10190633|NCT03295201|11319788|FG001|NOT COMPLETED|Overall Study||2
10190634|NCT03295266|11319796|FG000|STARTED|Overall Study||5
10190635|NCT03295266|11319797|FG001|STARTED|Overall Study||4
10190636|NCT03295266|11319796|FG000|COMPLETED|Overall Study||5
10190637|NCT03295266|11319797|FG001|COMPLETED|Overall Study||4
10190638|NCT03295266|11319796|FG000|NOT COMPLETED|Overall Study||0
10074142|NCT02201524|11201425|FG000|STARTED|Overall Study||14
10074143|NCT02201524|11201426|FG001|STARTED|Overall Study||15
10074144|NCT02201524|11201427|FG002|STARTED|Overall Study||16
10074145|NCT02201524|11201428|FG003|STARTED|Overall Study||14
10074146|NCT02201524|11201425|FG000|COMPLETED|Overall Study||12
10074147|NCT02201524|11201426|FG001|COMPLETED|Overall Study||12
10074148|NCT02201524|11201427|FG002|COMPLETED|Overall Study||12
10074149|NCT02201524|11201428|FG003|COMPLETED|Overall Study||10
10074150|NCT02201524|11201425|FG000|NOT COMPLETED|Overall Study||2
10074151|NCT02201524|11201426|FG001|NOT COMPLETED|Overall Study||3
10074152|NCT02201524|11201427|FG002|NOT COMPLETED|Overall Study||4
10074153|NCT02201524|11201428|FG003|NOT COMPLETED|Overall Study||4
10074154|NCT02201771|11201441|FG000|STARTED|Overall Study||166
10074155|NCT02201771|11201442|FG001|STARTED|Overall Study||168
10074156|NCT02201771|11201443|FG002|STARTED|Overall Study||166
10074157|NCT02201771|11201441|FG000|COMPLETED|Overall Study||153
10074158|NCT02201771|11201442|FG001|COMPLETED|Overall Study||158
10074159|NCT02201771|11201443|FG002|COMPLETED|Overall Study||156
10074160|NCT02201771|11201441|FG000|NOT COMPLETED|Overall Study||13
10074161|NCT02201771|11201442|FG001|NOT COMPLETED|Overall Study||10
10190639|NCT03295266|11319797|FG001|NOT COMPLETED|Overall Study||0
10190640|NCT03295318|11319806|FG000|STARTED|Overall Study||150
10190641|NCT03295318|11319807|FG001|STARTED|Overall Study||150
10190642|NCT03295318|11319808|FG002|STARTED|Overall Study||76
10190643|NCT03295318|11319806|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149
10190644|NCT03295318|11319807|FG001|Received First Vaccination|Overall Study||150
10190645|NCT03295318|11319808|FG002|Received First Vaccination|Overall Study||76
10190646|NCT03295318|11319806|FG000|Received Second Vaccination|Overall Study||144
10190647|NCT03295318|11319807|FG001|Received Second Vaccination|Overall Study||145
10190648|NCT03295318|11319808|FG002|Received Second Vaccination|Overall Study||73
10190649|NCT03295318|11319806|FG000|COMPLETED|Overall Study||144
10190650|NCT03295318|11319807|FG001|COMPLETED|Overall Study||145
10190651|NCT03295318|11319808|FG002|COMPLETED|Overall Study||71
10190652|NCT03295318|11319806|FG000|NOT COMPLETED|Overall Study||6
10190653|NCT03295318|11319807|FG001|NOT COMPLETED|Overall Study||5
10190654|NCT03295318|11319808|FG002|NOT COMPLETED|Overall Study||5
10190655|NCT03295630|11319834|FG000|STARTED|Overall Study||20
10190656|NCT03295630|11319834|FG000|COMPLETED|Overall Study||20
10190657|NCT03295630|11319834|FG000|NOT COMPLETED|Overall Study||0
10190658|NCT03295721|11319842|FG000|STARTED|Overall Study||157
10190659|NCT03295721|11319843|FG001|STARTED|Overall Study||100
10190660|NCT03295721|11319844|FG002|STARTED|Overall Study||155
10074162|NCT02201771|11201443|FG002|NOT COMPLETED|Overall Study||10
10074163|NCT02201784|11201453|FG000|STARTED|Overall Study||30
10074164|NCT02201784|11201454|FG001|STARTED|Overall Study||30
10074165|NCT02201784|11201453|FG000|COMPLETED|Overall Study||28
10074166|NCT02201784|11201454|FG001|COMPLETED|Overall Study||30
10074167|NCT02201784|11201453|FG000|NOT COMPLETED|Overall Study||2
10074168|NCT02201784|11201454|FG001|NOT COMPLETED|Overall Study||0
10074169|NCT02201901|11201463|FG000|STARTED|Overall Study||90
10074170|NCT02201901|11201464|FG001|STARTED|Overall Study||88
10074171|NCT02201901|11201465|FG002|STARTED|Overall Study||90
10074172|NCT02201901|11201463|FG000|COMPLETED|Overall Study||75
10074173|NCT02201901|11201464|FG001|COMPLETED|Overall Study||79
10074174|NCT02201901|11201465|FG002|COMPLETED|Overall Study||77
10074175|NCT02201901|11201463|FG000|NOT COMPLETED|Overall Study||15
10074176|NCT02201901|11201464|FG001|NOT COMPLETED|Overall Study||9
10074177|NCT02201901|11201465|FG002|NOT COMPLETED|Overall Study||13
10074178|NCT02201940|11201476|FG000|STARTED|Overall Study||625
10074179|NCT02201940|11201477|FG001|STARTED|Overall Study||116
10074180|NCT02201940|11201476|FG000|COMPLETED|Overall Study||613
10074181|NCT02201940|11201477|FG001|COMPLETED|Overall Study||0
10074182|NCT02201940|11201476|FG000|NOT COMPLETED|Overall Study||12
10074183|NCT02201940|11201477|FG001|NOT COMPLETED|Overall Study||116
10074184|NCT02201953|11201485|FG000|STARTED|Overall Study||278
10074185|NCT02201953|11201486|FG001|STARTED|Overall Study||280
10074186|NCT02201953|11201485|FG000|COMPLETED|Overall Study||258
10074187|NCT02201953|11201486|FG001|COMPLETED|Overall Study||224
10074188|NCT02201953|11201485|FG000|NOT COMPLETED|Overall Study||20
10074189|NCT02201953|11201486|FG001|NOT COMPLETED|Overall Study||56
10074190|NCT02202031|11201494|FG000|STARTED|Overall Study||82
10074191|NCT02202031|11201495|FG001|STARTED|Overall Study||79
10074192|NCT02202031|11201494|FG000|COMPLETED|Overall Study||77
10074193|NCT02202031|11201495|FG001|COMPLETED|Overall Study||74
10074194|NCT02202031|11201494|FG000|NOT COMPLETED|Overall Study||5
10074195|NCT02202031|11201495|FG001|NOT COMPLETED|Overall Study||5
10074196|NCT02202109|11201503|FG000|STARTED|Overall Study||302
10074197|NCT02202109|11201504|FG001|STARTED|Overall Study||300
10074198|NCT02202109|11201503|FG000|COMPLETED|Overall Study||212
10074199|NCT02202109|11201504|FG001|COMPLETED|Overall Study||213
10074200|NCT02202109|11201503|FG000|NOT COMPLETED|Overall Study||90
10074201|NCT02202109|11201504|FG001|NOT COMPLETED|Overall Study||87
10074202|NCT02202135|11201510|FG000|STARTED|Overall Study||4
10074203|NCT02202135|11201510|FG000|COMPLETED|Overall Study||4
10074204|NCT02202135|11201510|FG000|NOT COMPLETED|Overall Study||0
10074205|NCT02202161|11201522|FG000|STARTED|Overall Study||13
10074206|NCT02202161|11201523|FG001|STARTED|Overall Study||5
10074207|NCT02202161|11201524|FG002|STARTED|Overall Study||5
10074208|NCT02202161|11201525|FG003|STARTED|Overall Study||9
10074209|NCT02202161|11201526|FG004|STARTED|Overall Study||9
10074210|NCT02202161|11201527|FG005|STARTED|Overall Study||10
10074211|NCT02202161|11201528|FG006|STARTED|Overall Study||13
10074212|NCT02202161|11201529|FG007|STARTED|Overall Study||6
10074213|NCT02202161|11201522|FG000|COMPLETED|Overall Study||12
10074214|NCT02202161|11201523|FG001|COMPLETED|Overall Study||4
10074215|NCT02202161|11201524|FG002|COMPLETED|Overall Study||5
10074216|NCT02202161|11201525|FG003|COMPLETED|Overall Study||9
10074217|NCT02202161|11201526|FG004|COMPLETED|Overall Study||8
10074218|NCT02202161|11201527|FG005|COMPLETED|Overall Study||9
10074219|NCT02202161|11201528|FG006|COMPLETED|Overall Study||13
10074220|NCT02202161|11201529|FG007|COMPLETED|Overall Study||0
10074221|NCT02202161|11201522|FG000|NOT COMPLETED|Overall Study||1
10074222|NCT02202161|11201523|FG001|NOT COMPLETED|Overall Study||1
10074223|NCT02202161|11201524|FG002|NOT COMPLETED|Overall Study||0
10074224|NCT02202161|11201525|FG003|NOT COMPLETED|Overall Study||0
10074225|NCT02202161|11201526|FG004|NOT COMPLETED|Overall Study||1
10074226|NCT02202161|11201527|FG005|NOT COMPLETED|Overall Study||1
10074227|NCT02202161|11201528|FG006|NOT COMPLETED|Overall Study||0
10074228|NCT02202161|11201529|FG007|NOT COMPLETED|Overall Study||6
10074229|NCT02202252|11201550|FG000|STARTED|Overall Study||30
10074230|NCT02202252|11201551|FG001|STARTED|Overall Study||30
10074231|NCT02202252|11201550|FG000|COMPLETED|Overall Study||30
10074232|NCT02202252|11201551|FG001|COMPLETED|Overall Study||30
10074233|NCT02202252|11201550|FG000|NOT COMPLETED|Overall Study||0
10074234|NCT02202252|11201551|FG001|NOT COMPLETED|Overall Study||0
10074235|NCT02202317|11201557|FG000|STARTED|Overall Study||9
10074236|NCT02202317|11201557|FG000|COMPLETED|Overall Study||8
10074237|NCT02202317|11201557|FG000|NOT COMPLETED|Overall Study||1
10074238|NCT02202499|11201564|FG000|STARTED|Overall Study||21
10074239|NCT02202499|11201565|FG001|STARTED|Overall Study||20
10074240|NCT02202499|11201566|FG002|STARTED|Overall Study||21
10074241|NCT02202499|11201564|FG000|COMPLETED|Overall Study||19
10074242|NCT02202499|11201565|FG001|COMPLETED|Overall Study||20
10074243|NCT02202499|11201566|FG002|COMPLETED|Overall Study||19
10074244|NCT02202499|11201564|FG000|NOT COMPLETED|Overall Study||2
10074245|NCT02202499|11201565|FG001|NOT COMPLETED|Overall Study||0
10074246|NCT02202499|11201566|FG002|NOT COMPLETED|Overall Study||2
10074247|NCT02202538|11201579|FG000|STARTED|Overall Study||53
10074248|NCT02202538|11201579|FG000|Screen Failure|Overall Study||2
10074249|NCT02202538|11201579|FG000|COMPLETED|Overall Study||45
10074250|NCT02202538|11201579|FG000|NOT COMPLETED|Overall Study||8
10074251|NCT02202551|11201587|FG000|STARTED|Overall Study||60
10074252|NCT02202551|11201588|FG001|STARTED|Overall Study||78
10074253|NCT02202551|11201589|FG002|STARTED|Overall Study||24
10074254|NCT02202551|11201590|FG003|STARTED|Overall Study||61
10074255|NCT02202551|11201587|FG000|COMPLETED|Overall Study||35
10074256|NCT02202551|11201588|FG001|COMPLETED|Overall Study||41
10074257|NCT02202551|11201589|FG002|COMPLETED|Overall Study||14
10074258|NCT02202551|11201590|FG003|COMPLETED|Overall Study||39
10074259|NCT02202551|11201587|FG000|NOT COMPLETED|Overall Study||25
10074260|NCT02202551|11201588|FG001|NOT COMPLETED|Overall Study||37
10074261|NCT02202551|11201589|FG002|NOT COMPLETED|Overall Study||10
10074262|NCT02202551|11201590|FG003|NOT COMPLETED|Overall Study||22
10074263|NCT02202616|11201604|FG000|STARTED|Overall Study||401
10074264|NCT02202616|11201604|FG000|Intent to Treat Set (ITT)|Overall Study||338
10074265|NCT02202616|11201604|FG000|COMPLETED|Overall Study||301
10074266|NCT02202616|11201604|FG000|NOT COMPLETED|Overall Study||100
10074267|NCT02202746|11201611|FG000|STARTED|Overall Study||109
10074268|NCT02202746|11201612|FG001|STARTED|Overall Study||69
10074269|NCT02202746|11201611|FG000|COMPLETED|Overall Study||109
10074270|NCT02202746|11201612|FG001|COMPLETED|Overall Study||69
10074271|NCT02202746|11201611|FG000|NOT COMPLETED|Overall Study||0
10074272|NCT02202746|11201612|FG001|NOT COMPLETED|Overall Study||0
10074273|NCT02202759|11201624|FG000|STARTED|Overall Study||9
10074274|NCT02202759|11201625|FG001|STARTED|Overall Study||15
10074275|NCT02202759|11201626|FG002|STARTED|Overall Study||14
10074276|NCT02202759|11201624|FG000|COMPLETED|Overall Study||0
10074277|NCT02202759|11201625|FG001|COMPLETED|Overall Study||0
10074278|NCT02202759|11201626|FG002|COMPLETED|Overall Study||0
10074279|NCT02202759|11201624|FG000|NOT COMPLETED|Overall Study||9
10074280|NCT02202759|11201625|FG001|NOT COMPLETED|Overall Study||15
10074281|NCT02202759|11201626|FG002|NOT COMPLETED|Overall Study||14
10074282|NCT02202785|11201636|FG000|STARTED|Overall Study||11
10074283|NCT02202785|11201637|FG001|STARTED|Overall Study||15
10074284|NCT02202785|11201638|FG002|STARTED|Overall Study||17
10074285|NCT02202785|11201636|FG000|COMPLETED|Overall Study||0
10074286|NCT02202785|11201637|FG001|COMPLETED|Overall Study||0
10074287|NCT02202785|11201638|FG002|COMPLETED|Overall Study||0
10074288|NCT02202785|11201636|FG000|NOT COMPLETED|Overall Study||11
10074289|NCT02202785|11201637|FG001|NOT COMPLETED|Overall Study||15
10074290|NCT02202785|11201638|FG002|NOT COMPLETED|Overall Study||17
10074291|NCT02202837|11201648|FG000|STARTED|Overall Study||140
10074292|NCT02202837|11201649|FG001|STARTED|Overall Study||17
10074293|NCT02202837|11201648|FG000|COMPLETED|Overall Study||87
10074294|NCT02202837|11201649|FG001|COMPLETED|Overall Study||12
10074295|NCT02202837|11201648|FG000|NOT COMPLETED|Overall Study||53
10074296|NCT02202837|11201649|FG001|NOT COMPLETED|Overall Study||5
10074297|NCT02202850|11201657|FG000|STARTED|Overall Study||70
10074298|NCT02202850|11201658|FG001|STARTED|Overall Study||14
10074299|NCT02202850|11201657|FG000|COMPLETED|Overall Study||46
10074300|NCT02202850|11201658|FG001|COMPLETED|Overall Study||8
10074301|NCT02202850|11201657|FG000|NOT COMPLETED|Overall Study||24
10074302|NCT02202850|11201658|FG001|NOT COMPLETED|Overall Study||6
10074303|NCT02202980|11201678|FG000|STARTED|Overall Study||14
10074304|NCT02202980|11201679|FG001|STARTED|Overall Study||26
10074305|NCT02202980|11201680|FG002|STARTED|Overall Study||27
10074306|NCT02202980|11201681|FG003|STARTED|Overall Study||32
10074307|NCT02202980|11201682|FG004|STARTED|Overall Study||13
10074308|NCT02202980|11201683|FG005|STARTED|Overall Study||15
10074309|NCT02202980|11201684|FG006|STARTED|Overall Study||15
10074310|NCT02202980|11201685|FG007|STARTED|Overall Study||15
10074311|NCT02202980|11201686|FG008|STARTED|Overall Study||18
10074312|NCT02202980|11201687|FG009|STARTED|Overall Study||17
10074313|NCT02202980|11201688|FG010|STARTED|Overall Study||19
10074314|NCT02202980|11201689|FG011|STARTED|Overall Study||28
10074315|NCT02202980|11201690|FG012|STARTED|Overall Study||30
10074316|NCT02202980|11201691|FG013|STARTED|Overall Study||4
10074317|NCT02202980|11201678|FG000|COMPLETED|Overall Study||13
10074318|NCT02202980|11201679|FG001|COMPLETED|Overall Study||24
10074319|NCT02202980|11201680|FG002|COMPLETED|Overall Study||17
10074320|NCT02202980|11201681|FG003|COMPLETED|Overall Study||28
10074321|NCT02202980|11201682|FG004|COMPLETED|Overall Study||7
10074322|NCT02202980|11201683|FG005|COMPLETED|Overall Study||14
10074323|NCT02202980|11201684|FG006|COMPLETED|Overall Study||4
10074324|NCT02202980|11201685|FG007|COMPLETED|Overall Study||12
10074325|NCT02202980|11201686|FG008|COMPLETED|Overall Study||14
10074326|NCT02202980|11201687|FG009|COMPLETED|Overall Study||17
10074327|NCT02202980|11201688|FG010|COMPLETED|Overall Study||19
10074328|NCT02202980|11201689|FG011|COMPLETED|Overall Study||25
10074329|NCT02202980|11201690|FG012|COMPLETED|Overall Study||19
10074330|NCT02202980|11201691|FG013|COMPLETED|Overall Study||4
10074331|NCT02202980|11201678|FG000|NOT COMPLETED|Overall Study||1
10074332|NCT02202980|11201679|FG001|NOT COMPLETED|Overall Study||2
10074333|NCT02202980|11201680|FG002|NOT COMPLETED|Overall Study||10
10074334|NCT02202980|11201681|FG003|NOT COMPLETED|Overall Study||4
10074335|NCT02202980|11201682|FG004|NOT COMPLETED|Overall Study||6
10074336|NCT02202980|11201683|FG005|NOT COMPLETED|Overall Study||1
10074337|NCT02202980|11201684|FG006|NOT COMPLETED|Overall Study||11
10074338|NCT02202980|11201685|FG007|NOT COMPLETED|Overall Study||3
10074339|NCT02202980|11201686|FG008|NOT COMPLETED|Overall Study||4
10074340|NCT02202980|11201687|FG009|NOT COMPLETED|Overall Study||0
10074341|NCT02202980|11201688|FG010|NOT COMPLETED|Overall Study||0
10074342|NCT02202980|11201689|FG011|NOT COMPLETED|Overall Study||3
10074343|NCT02202980|11201690|FG012|NOT COMPLETED|Overall Study||11
10074344|NCT02202980|11201691|FG013|NOT COMPLETED|Overall Study||0
10074345|NCT02203019|11201723|FG000|STARTED|Overall Study||19
10074346|NCT02203019|11201724|FG001|STARTED|Overall Study||17
10074347|NCT02203019|11201723|FG000|COMPLETED|Overall Study||19
10074348|NCT02203019|11201724|FG001|COMPLETED|Overall Study||17
10074349|NCT02203019|11201723|FG000|NOT COMPLETED|Overall Study||0
10074350|NCT02203019|11201724|FG001|NOT COMPLETED|Overall Study||0
10074351|NCT02203032|11201730|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872
10074352|NCT02203032|11201731|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0
10074353|NCT02203032|11201732|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0
10190661|NCT03295721|11319842|FG000|COMPLETED|Overall Study||154
10074354|NCT02203032|11201733|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0
10074355|NCT02203032|11201730|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871
10074356|NCT02203032|11201731|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0
10074357|NCT02203032|11201732|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0
10074358|NCT02203032|11201733|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0
10074359|NCT02203032|11201730|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
10074360|NCT02203032|11201731|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10074361|NCT02203032|11201732|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10074362|NCT02203032|11201733|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10074363|NCT02203032|11201730|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
10074364|NCT02203032|11201731|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10074365|NCT02203032|11201732|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10074366|NCT02203032|11201733|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10074367|NCT02203032|11201730|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0
10074368|NCT02203032|11201731|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135
10074369|NCT02203032|11201732|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133
10074370|NCT02203032|11201733|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585
10074371|NCT02203032|11201730|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
10074372|NCT02203032|11201731|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
10074373|NCT02203032|11201732|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
10074374|NCT02203032|11201733|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
10074375|NCT02203032|11201730|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
10074376|NCT02203032|11201731|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
10074377|NCT02203032|11201732|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
10074378|NCT02203032|11201733|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
10074379|NCT02203071|11201743|FG000|STARTED|Overall Study||13
10074380|NCT02203071|11201744|FG001|STARTED|Overall Study||6
10074381|NCT02203071|11201743|FG000|COMPLETED|Overall Study||10
10074382|NCT02203071|11201744|FG001|COMPLETED|Overall Study||5
10074383|NCT02203071|11201743|FG000|NOT COMPLETED|Overall Study||3
10074384|NCT02203071|11201744|FG001|NOT COMPLETED|Overall Study||1
10074385|NCT02203149|11201755|FG000|STARTED|Part 1||31
10074386|NCT02203149|11201756|FG001|STARTED|Part 1||32
10074387|NCT02203149|11201757|FG002|STARTED|Part 1||0
10074388|NCT02203149|11201758|FG003|STARTED|Part 1||0
10074389|NCT02203149|11201759|FG004|STARTED|Part 1||0
10074390|NCT02203149|11201755|FG000|COMPLETED|Part 1||31
10074391|NCT02203149|11201756|FG001|COMPLETED|Part 1||31
10074392|NCT02203149|11201757|FG002|COMPLETED|Part 1||0
10074393|NCT02203149|11201758|FG003|COMPLETED|Part 1||0
10074394|NCT02203149|11201759|FG004|COMPLETED|Part 1||0
10074395|NCT02203149|11201755|FG000|NOT COMPLETED|Part 1||0
10074396|NCT02203149|11201756|FG001|NOT COMPLETED|Part 1||1
10074397|NCT02203149|11201757|FG002|NOT COMPLETED|Part 1||0
10074398|NCT02203149|11201758|FG003|NOT COMPLETED|Part 1||0
10074399|NCT02203149|11201759|FG004|NOT COMPLETED|Part 1||0
10074400|NCT02203149|11201755|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
10074401|NCT02203149|11201756|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
10074402|NCT02203149|11201757|FG002|STARTED|Part 2||227
10074403|NCT02203149|11201758|FG003|STARTED|Part 2||74
10074404|NCT02203149|11201759|FG004|STARTED|Part 2||35
10074405|NCT02203149|11201755|FG000|Started Deferred Active Treatment|Part 2||0
10074406|NCT02203149|11201756|FG001|Started Deferred Active Treatment|Part 2||0
10074407|NCT02203149|11201757|FG002|Started Deferred Active Treatment|Part 2||0
10074408|NCT02203149|11201758|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
10074409|NCT02203149|11201759|FG004|Started Deferred Active Treatment|Part 2||0
10074410|NCT02203149|11201755|FG000|COMPLETED|Part 2||0
10074411|NCT02203149|11201756|FG001|COMPLETED|Part 2||0
10074412|NCT02203149|11201757|FG002|COMPLETED|Part 2||226
10074413|NCT02203149|11201758|FG003|COMPLETED|Part 2||71
10074414|NCT02203149|11201759|FG004|COMPLETED|Part 2||34
10074415|NCT02203149|11201755|FG000|NOT COMPLETED|Part 2||0
10074416|NCT02203149|11201756|FG001|NOT COMPLETED|Part 2||0
10074417|NCT02203149|11201757|FG002|NOT COMPLETED|Part 2||1
10074418|NCT02203149|11201758|FG003|NOT COMPLETED|Part 2||3
10074419|NCT02203149|11201759|FG004|NOT COMPLETED|Part 2||1
10074420|NCT02203162|11201781|FG000|STARTED|Overall Study||30
10074421|NCT02203162|11201781|FG000|COMPLETED|Overall Study||30
10074422|NCT02203162|11201781|FG000|NOT COMPLETED|Overall Study||0
10074423|NCT02203331|11201791|FG000|STARTED|Overall Study||52
10074424|NCT02203331|11201792|FG001|STARTED|Overall Study||53
10074425|NCT02203331|11201793|FG002|STARTED|Overall Study||55
10074426|NCT02203331|11201794|FG003|STARTED|Overall Study||53
10074427|NCT02203331|11201795|FG004|STARTED|Overall Study||53
10074428|NCT02203331|11201796|FG005|STARTED|Overall Study||53
10074429|NCT02203331|11201791|FG000|Treated|Overall Study||49
10074430|NCT02203331|11201792|FG001|Treated|Overall Study||50
10074431|NCT02203331|11201793|FG002|Treated|Overall Study||54
10190662|NCT03295721|11319843|FG001|COMPLETED|Overall Study||99
10190663|NCT03295721|11319844|FG002|COMPLETED|Overall Study||152
10190664|NCT03295721|11319842|FG000|NOT COMPLETED|Overall Study||3
10190665|NCT03295721|11319843|FG001|NOT COMPLETED|Overall Study||1
10190666|NCT03295721|11319844|FG002|NOT COMPLETED|Overall Study||3
10190667|NCT03296072|11319853|FG000|STARTED|Treatment Period 1||10
10190668|NCT03296072|11319854|FG001|STARTED|Treatment Period 1||11
10190669|NCT03296072|11319855|FG002|STARTED|Treatment Period 1||10
10074432|NCT02203331|11201794|FG003|Treated|Overall Study||49
10074433|NCT02203331|11201795|FG004|Treated|Overall Study||50
10074434|NCT02203331|11201796|FG005|Treated|Overall Study||53
10074435|NCT02203331|11201791|FG000|COMPLETED|Overall Study||45
10074436|NCT02203331|11201792|FG001|COMPLETED|Overall Study||39
10074437|NCT02203331|11201793|FG002|COMPLETED|Overall Study||50
10074438|NCT02203331|11201794|FG003|COMPLETED|Overall Study||46
10074439|NCT02203331|11201795|FG004|COMPLETED|Overall Study||46
10074440|NCT02203331|11201796|FG005|COMPLETED|Overall Study||46
10074441|NCT02203331|11201791|FG000|NOT COMPLETED|Overall Study||7
10074442|NCT02203331|11201792|FG001|NOT COMPLETED|Overall Study||14
10074443|NCT02203331|11201793|FG002|NOT COMPLETED|Overall Study||5
10074444|NCT02203331|11201794|FG003|NOT COMPLETED|Overall Study||7
10074445|NCT02203331|11201795|FG004|NOT COMPLETED|Overall Study||7
10074446|NCT02203331|11201796|FG005|NOT COMPLETED|Overall Study||7
10074447|NCT02203357|11201813|FG000|STARTED|Overall Study||117
10074448|NCT02203357|11201814|FG001|STARTED|Overall Study||111
10074449|NCT02203357|11201815|FG002|STARTED|Overall Study||125
10074450|NCT02203357|11201813|FG000|mon7/2/3|Overall Study||114
10074451|NCT02203357|11201814|FG001|mon7/2/3|Overall Study||110
10074452|NCT02203357|11201815|FG002|mon7/2/3|Overall Study||124
10074453|NCT02203357|11201813|FG000|mon12|Overall Study||113
10074454|NCT02203357|11201814|FG001|mon12|Overall Study||101
10074455|NCT02203357|11201815|FG002|mon12|Overall Study||122
10074456|NCT02203357|11201813|FG000|mon24|Overall Study||59
10074457|NCT02203357|11201814|FG001|mon24|Overall Study||45
10074458|NCT02203357|11201815|FG002|mon24|Overall Study||55
10074459|NCT02203357|11201813|FG000|COMPLETED|Overall Study||59
10074460|NCT02203357|11201814|FG001|COMPLETED|Overall Study||45
10074461|NCT02203357|11201815|FG002|COMPLETED|Overall Study||55
10074462|NCT02203357|11201813|FG000|NOT COMPLETED|Overall Study||58
10074463|NCT02203357|11201814|FG001|NOT COMPLETED|Overall Study||66
10074464|NCT02203357|11201815|FG002|NOT COMPLETED|Overall Study||70
10074465|NCT02203565|11201826|FG000|STARTED|Overall Study||20
10074466|NCT02203565|11201826|FG000|COMPLETED|Overall Study||19
10074467|NCT02203565|11201826|FG000|NOT COMPLETED|Overall Study||1
10074468|NCT02203578|11201830|FG000|STARTED|Overall Study||1
10074469|NCT02203578|11201830|FG000|COMPLETED|Overall Study||1
10074470|NCT02203578|11201830|FG000|NOT COMPLETED|Overall Study||0
10074471|NCT02203591|11201842|FG000|STARTED|Overall Study||343
10074472|NCT02203591|11201843|FG001|STARTED|Overall Study||344
10074473|NCT02203591|11201844|FG002|STARTED|Overall Study||347
10074474|NCT02203591|11201845|FG003|STARTED|Overall Study||104
10074475|NCT02203591|11201846|FG004|STARTED|Overall Study||242
10074476|NCT02203591|11201847|FG005|STARTED|Overall Study||244
10074477|NCT02203591|11201848|FG006|STARTED|Overall Study||248
10074478|NCT02203591|11201849|FG007|STARTED|Overall Study||74
10074479|NCT02203591|11201842|FG000|COMPLETED|Overall Study||196
10074480|NCT02203591|11201843|FG001|COMPLETED|Overall Study||202
10074481|NCT02203591|11201844|FG002|COMPLETED|Overall Study||196
10074482|NCT02203591|11201845|FG003|COMPLETED|Overall Study||59
10074483|NCT02203591|11201846|FG004|COMPLETED|Overall Study||208
10074484|NCT02203591|11201847|FG005|COMPLETED|Overall Study||209
10074485|NCT02203591|11201848|FG006|COMPLETED|Overall Study||219
10074486|NCT02203591|11201849|FG007|COMPLETED|Overall Study||61
10074487|NCT02203591|11201842|FG000|NOT COMPLETED|Overall Study||147
10074488|NCT02203591|11201843|FG001|NOT COMPLETED|Overall Study||142
10074489|NCT02203591|11201844|FG002|NOT COMPLETED|Overall Study||151
10074490|NCT02203591|11201845|FG003|NOT COMPLETED|Overall Study||45
10074491|NCT02203591|11201846|FG004|NOT COMPLETED|Overall Study||34
10074492|NCT02203591|11201847|FG005|NOT COMPLETED|Overall Study||35
10074493|NCT02203591|11201848|FG006|NOT COMPLETED|Overall Study||29
10074494|NCT02203591|11201849|FG007|NOT COMPLETED|Overall Study||13
10074495|NCT02203630|11201873|FG000|STARTED|Overall Study||8
10074496|NCT02203630|11201874|FG001|STARTED|Overall Study||9
10074497|NCT02203630|11201873|FG000|COMPLETED|Overall Study||8
10074498|NCT02203630|11201874|FG001|COMPLETED|Overall Study||9
10190670|NCT03296072|11319856|FG003|STARTED|Treatment Period 1||10
10190671|NCT03296072|11319857|FG004|STARTED|Treatment Period 1||10
10190672|NCT03296072|11319858|FG005|STARTED|Treatment Period 1||11
10190673|NCT03296072|11319853|FG000|COMPLETED|Treatment Period 1||10
10190674|NCT03296072|11319854|FG001|COMPLETED|Treatment Period 1||11
10190675|NCT03296072|11319855|FG002|COMPLETED|Treatment Period 1||10
10190676|NCT03296072|11319856|FG003|COMPLETED|Treatment Period 1||10
10190677|NCT03296072|11319857|FG004|COMPLETED|Treatment Period 1||10
10190678|NCT03296072|11319858|FG005|COMPLETED|Treatment Period 1||11
10190679|NCT03296072|11319853|FG000|NOT COMPLETED|Treatment Period 1||0
10190680|NCT03296072|11319854|FG001|NOT COMPLETED|Treatment Period 1||0
10190681|NCT03296072|11319855|FG002|NOT COMPLETED|Treatment Period 1||0
10190682|NCT03296072|11319856|FG003|NOT COMPLETED|Treatment Period 1||0
10190683|NCT03296072|11319857|FG004|NOT COMPLETED|Treatment Period 1||0
10190684|NCT03296072|11319858|FG005|NOT COMPLETED|Treatment Period 1||0
10190685|NCT03296072|11319853|FG000|STARTED|Treament Period 1: Wash Out Period||10
10190686|NCT03296072|11319854|FG001|STARTED|Treament Period 1: Wash Out Period||11
10190687|NCT03296072|11319855|FG002|STARTED|Treament Period 1: Wash Out Period||10
10190688|NCT03296072|11319856|FG003|STARTED|Treament Period 1: Wash Out Period||10
10074499|NCT02203630|11201873|FG000|NOT COMPLETED|Overall Study||0
10074500|NCT02203630|11201874|FG001|NOT COMPLETED|Overall Study||0
10074501|NCT02203721|11201882|FG000|STARTED|Overall Study||148
10074502|NCT02203721|11201883|FG001|STARTED|Overall Study||151
10074503|NCT02203721|11201882|FG000|COMPLETED|Overall Study||147
10074504|NCT02203721|11201883|FG001|COMPLETED|Overall Study||148
10074505|NCT02203721|11201882|FG000|NOT COMPLETED|Overall Study||1
10074506|NCT02203721|11201883|FG001|NOT COMPLETED|Overall Study||3
10074507|NCT02203747|11201891|FG000|STARTED|Overall Study||45
10074508|NCT02203747|11201892|FG001|STARTED|Overall Study||34
10074509|NCT02203747|11201891|FG000|COMPLETED|Overall Study||45
10074510|NCT02203747|11201892|FG001|COMPLETED|Overall Study||34
10074511|NCT02203747|11201891|FG000|NOT COMPLETED|Overall Study||0
10074512|NCT02203747|11201892|FG001|NOT COMPLETED|Overall Study||0
10074513|NCT02203786|11201902|FG000|STARTED|Overall Study||15
10074514|NCT02203786|11201903|FG001|STARTED|Overall Study||15
10074515|NCT02203786|11201904|FG002|STARTED|Overall Study||17
10074516|NCT02203786|11201905|FG003|STARTED|Overall Study||15
10074517|NCT02203786|11201902|FG000|COMPLETED|Overall Study||15
10074518|NCT02203786|11201903|FG001|COMPLETED|Overall Study||15
10074519|NCT02203786|11201904|FG002|COMPLETED|Overall Study||15
10074520|NCT02203786|11201905|FG003|COMPLETED|Overall Study||15
10074521|NCT02203786|11201902|FG000|NOT COMPLETED|Overall Study||0
10074522|NCT02203786|11201903|FG001|NOT COMPLETED|Overall Study||0
10074523|NCT02203786|11201904|FG002|NOT COMPLETED|Overall Study||2
10074524|NCT02203786|11201905|FG003|NOT COMPLETED|Overall Study||0
10074525|NCT02203838|11201921|FG000|STARTED|Overall Study||408
10074526|NCT02203838|11201922|FG001|STARTED|Overall Study||28
10074527|NCT02203838|11201923|FG002|STARTED|Overall Study||31
10074528|NCT02203838|11201924|FG003|STARTED|Overall Study||33
10074529|NCT02203838|11201921|FG000|COMPLETED|Overall Study||198
10074530|NCT02203838|11201922|FG001|COMPLETED|Overall Study||6
10074531|NCT02203838|11201923|FG002|COMPLETED|Overall Study||15
10074532|NCT02203838|11201924|FG003|COMPLETED|Overall Study||15
10074533|NCT02203838|11201921|FG000|NOT COMPLETED|Overall Study||210
10074534|NCT02203838|11201922|FG001|NOT COMPLETED|Overall Study||22
10074535|NCT02203838|11201923|FG002|NOT COMPLETED|Overall Study||16
10074536|NCT02203838|11201924|FG003|NOT COMPLETED|Overall Study||18
10074537|NCT02203851|11201934|FG000|STARTED|Overall Study||110
10074538|NCT02203851|11201934|FG000|COMPLETED|Overall Study||99
10074539|NCT02203851|11201934|FG000|NOT COMPLETED|Overall Study||11
10074540|NCT02203916|11201948|FG000|STARTED|Overall Study||65
10074541|NCT02203916|11201949|FG001|STARTED|Overall Study||132
10074542|NCT02203916|11201950|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
10074543|NCT02203916|11201948|FG000|Full Analysis Set (FAS)|Overall Study||65
10074544|NCT02203916|11201949|FG001|Full Analysis Set (FAS)|Overall Study||132
10074545|NCT02203916|11201950|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
10074546|NCT02203916|11201948|FG000|Safety Analysis Set (SAS)|Overall Study||65
10074547|NCT02203916|11201949|FG001|Safety Analysis Set (SAS)|Overall Study||132
10074548|NCT02203916|11201950|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
10074549|NCT02203916|11201948|FG000|COMPLETED|Overall Study||57
10074550|NCT02203916|11201949|FG001|COMPLETED|Overall Study||122
10074551|NCT02203916|11201950|FG002|COMPLETED|Overall Study||120
10074552|NCT02203916|11201948|FG000|NOT COMPLETED|Overall Study||8
10074553|NCT02203916|11201949|FG001|NOT COMPLETED|Overall Study||10
10074554|NCT02203916|11201950|FG002|NOT COMPLETED|Overall Study||11
10074555|NCT02204007|11201960|FG000|STARTED|Overall Study||18
10074556|NCT02204007|11201961|FG001|STARTED|Overall Study||18
10074557|NCT02204007|11201960|FG000|COMPLETED|Overall Study||17
10074558|NCT02204007|11201961|FG001|COMPLETED|Overall Study||17
10074559|NCT02204007|11201960|FG000|NOT COMPLETED|Overall Study||1
10074560|NCT02204007|11201961|FG001|NOT COMPLETED|Overall Study||1
10074561|NCT02204124|11201969|FG000|STARTED|Overall Study||13
10074562|NCT02204124|11201970|FG001|STARTED|Overall Study||19
10074563|NCT02204124|11201969|FG000|COMPLETED|Overall Study||13
10074564|NCT02204124|11201970|FG001|COMPLETED|Overall Study||19
10074565|NCT02204124|11201969|FG000|NOT COMPLETED|Overall Study||0
10074566|NCT02204124|11201970|FG001|NOT COMPLETED|Overall Study||0
10074567|NCT02204150|11201976|FG000|STARTED|Overall Study||56
10074568|NCT02204150|11201976|FG000|COMPLETED|Overall Study||56
10074569|NCT02204150|11201976|FG000|NOT COMPLETED|Overall Study||0
10074570|NCT02204176|11201983|FG000|STARTED|Overall Study||74
10074571|NCT02204176|11201984|FG001|STARTED|Overall Study||73
10074572|NCT02204176|11201985|FG002|STARTED|Overall Study||74
10074573|NCT02204176|11201983|FG000|COMPLETED|Overall Study||64
10074574|NCT02204176|11201984|FG001|COMPLETED|Overall Study||61
10074575|NCT02204176|11201985|FG002|COMPLETED|Overall Study||58
10074576|NCT02204176|11201983|FG000|NOT COMPLETED|Overall Study||10
10074577|NCT02204176|11201984|FG001|NOT COMPLETED|Overall Study||12
10074578|NCT02204176|11201985|FG002|NOT COMPLETED|Overall Study||16
10074579|NCT02204293|11201995|FG000|STARTED|Core Study Part I||19
10074580|NCT02204293|11201996|FG001|STARTED|Core Study Part I||17
10074581|NCT02204293|11201997|FG002|STARTED|Core Study Part I||0
10074582|NCT02204293|11201998|FG003|STARTED|Core Study Part I||0
10074583|NCT02204293|11201999|FG004|STARTED|Core Study Part I||0
10074584|NCT02204293|11202000|FG005|STARTED|Core Study Part I||0
10074585|NCT02204293|11201995|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
10074586|NCT02204293|11201996|FG001|Intention-to-treat Population|Core Study Part I||17
10074587|NCT02204293|11201997|FG002|Intention-to-treat Population|Core Study Part I||0
10074588|NCT02204293|11201998|FG003|Intention-to-treat Population|Core Study Part I||0
10074589|NCT02204293|11201999|FG004|Intention-to-treat Population|Core Study Part I||0
10074590|NCT02204293|11202000|FG005|Intention-to-treat Population|Core Study Part I||0
10190689|NCT03296072|11319857|FG004|STARTED|Treament Period 1: Wash Out Period||10
10074591|NCT02204293|11201995|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
10074592|NCT02204293|11201996|FG001|Safety Population|Core Study Part I||15
10074593|NCT02204293|11201997|FG002|Safety Population|Core Study Part I||0
10074594|NCT02204293|11201998|FG003|Safety Population|Core Study Part I||0
10074595|NCT02204293|11201999|FG004|Safety Population|Core Study Part I||0
10074596|NCT02204293|11202000|FG005|Safety Population|Core Study Part I||0
10074597|NCT02204293|11201995|FG000|COMPLETED|Core Study Part I||17
10074598|NCT02204293|11201996|FG001|COMPLETED|Core Study Part I||14
10074599|NCT02204293|11201997|FG002|COMPLETED|Core Study Part I||0
10074600|NCT02204293|11201998|FG003|COMPLETED|Core Study Part I||0
10074601|NCT02204293|11201999|FG004|COMPLETED|Core Study Part I||0
10074602|NCT02204293|11202000|FG005|COMPLETED|Core Study Part I||0
10074603|NCT02204293|11201995|FG000|NOT COMPLETED|Core Study Part I||2
10074604|NCT02204293|11201996|FG001|NOT COMPLETED|Core Study Part I||3
10074605|NCT02204293|11201997|FG002|NOT COMPLETED|Core Study Part I||0
10074606|NCT02204293|11201998|FG003|NOT COMPLETED|Core Study Part I||0
10074607|NCT02204293|11201999|FG004|NOT COMPLETED|Core Study Part I||0
10074608|NCT02204293|11202000|FG005|NOT COMPLETED|Core Study Part I||0
10074609|NCT02204293|11201995|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
10074610|NCT02204293|11201996|FG001|STARTED|Core Study Part 2||0
10074611|NCT02204293|11201997|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
10074612|NCT02204293|11201998|FG003|STARTED|Core Study Part 2||4
10074613|NCT02204293|11201999|FG004|STARTED|Core Study Part 2||7
10074614|NCT02204293|11202000|FG005|STARTED|Core Study Part 2||0
10074615|NCT02204293|11201995|FG000|Safety Population|Core Study Part 2||0
10074616|NCT02204293|11201996|FG001|Safety Population|Core Study Part 2||0
10074617|NCT02204293|11201997|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
10074618|NCT02204293|11201998|FG003|Safety Population|Core Study Part 2||2
10074619|NCT02204293|11201999|FG004|Safety Population|Core Study Part 2||7
10074620|NCT02204293|11202000|FG005|Safety Population|Core Study Part 2||0
10074621|NCT02204293|11201995|FG000|COMPLETED|Core Study Part 2||0
10074622|NCT02204293|11201996|FG001|COMPLETED|Core Study Part 2||0
10074623|NCT02204293|11201997|FG002|COMPLETED|Core Study Part 2||12
10074624|NCT02204293|11201998|FG003|COMPLETED|Core Study Part 2||4
10074625|NCT02204293|11201999|FG004|COMPLETED|Core Study Part 2||7
10074626|NCT02204293|11202000|FG005|COMPLETED|Core Study Part 2||0
10074627|NCT02204293|11201995|FG000|NOT COMPLETED|Core Study Part 2||0
10074628|NCT02204293|11201996|FG001|NOT COMPLETED|Core Study Part 2||0
10074629|NCT02204293|11201997|FG002|NOT COMPLETED|Core Study Part 2||0
10074630|NCT02204293|11201998|FG003|NOT COMPLETED|Core Study Part 2||0
10074631|NCT02204293|11201999|FG004|NOT COMPLETED|Core Study Part 2||0
10074632|NCT02204293|11202000|FG005|NOT COMPLETED|Core Study Part 2||0
10074633|NCT02204293|11201995|FG000|STARTED|LTE Phase||0
10074634|NCT02204293|11201996|FG001|STARTED|LTE Phase||0
10074635|NCT02204293|11201997|FG002|STARTED|LTE Phase||0
10074636|NCT02204293|11201998|FG003|STARTED|LTE Phase||0
10074637|NCT02204293|11201999|FG004|STARTED|LTE Phase||0
10074638|NCT02204293|11202000|FG005|STARTED|LTE Phase||7
10074639|NCT02204293|11201995|FG000|COMPLETED|LTE Phase||0
10074640|NCT02204293|11201996|FG001|COMPLETED|LTE Phase||0
10074641|NCT02204293|11201997|FG002|COMPLETED|LTE Phase||0
10074642|NCT02204293|11201998|FG003|COMPLETED|LTE Phase||0
10074643|NCT02204293|11201999|FG004|COMPLETED|LTE Phase||0
10074644|NCT02204293|11202000|FG005|COMPLETED|LTE Phase||0
10074645|NCT02204293|11201995|FG000|NOT COMPLETED|LTE Phase||0
10074646|NCT02204293|11201996|FG001|NOT COMPLETED|LTE Phase||0
10074647|NCT02204293|11201997|FG002|NOT COMPLETED|LTE Phase||0
10074648|NCT02204293|11201998|FG003|NOT COMPLETED|LTE Phase||0
10074649|NCT02204293|11201999|FG004|NOT COMPLETED|LTE Phase||0
10074650|NCT02204293|11202000|FG005|NOT COMPLETED|LTE Phase||7
10074651|NCT02204319|11202014|FG000|STARTED|Overall Study||10
10074652|NCT02204319|11202014|FG000|COMPLETED|Overall Study|3 did not complete study.|7
10074653|NCT02204319|11202014|FG000|NOT COMPLETED|Overall Study||3
10074654|NCT02204371|11202019|FG000|STARTED|Overall Study||7
10074655|NCT02204371|11202019|FG000|COMPLETED|Overall Study||6
10074656|NCT02204371|11202019|FG000|NOT COMPLETED|Overall Study||1
10074657|NCT02204410|11202023|FG000|STARTED|Overall Study||21
10074658|NCT02204410|11202023|FG000|COMPLETED|Overall Study||10
10074659|NCT02204410|11202023|FG000|NOT COMPLETED|Overall Study||11
10074660|NCT02204449|11202029|FG000|STARTED|Overall Study||46
10074661|NCT02204449|11202030|FG001|STARTED|Overall Study||48
10074662|NCT02204449|11202029|FG000|COMPLETED|Overall Study||39
10074663|NCT02204449|11202030|FG001|COMPLETED|Overall Study||37
10074664|NCT02204449|11202029|FG000|NOT COMPLETED|Overall Study||7
10074665|NCT02204449|11202030|FG001|NOT COMPLETED|Overall Study||11
10074666|NCT02204566|11202036|FG000|STARTED|Overall Study||5
10074667|NCT02204566|11202036|FG000|COMPLETED|Overall Study||1
10074668|NCT02204566|11202036|FG000|NOT COMPLETED|Overall Study||4
10074669|NCT02204579|11202040|FG000|STARTED|Overall Study||7
10074670|NCT02204579|11202040|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
10074671|NCT02204579|11202040|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
10074672|NCT02204579|11202040|FG000|Treated|Overall Study||5
10074673|NCT02204579|11202040|FG000|COMPLETED|Overall Study||5
10074674|NCT02204579|11202040|FG000|NOT COMPLETED|Overall Study||2
10074675|NCT02204657|11202051|FG000|STARTED|Overall Study||32
10074676|NCT02204657|11202052|FG001|STARTED|Overall Study||25
10074677|NCT02204657|11202051|FG000|COMPLETED|Overall Study||25
10074678|NCT02204657|11202052|FG001|COMPLETED|Overall Study||25
10074679|NCT02204657|11202051|FG000|NOT COMPLETED|Overall Study||7
10074680|NCT02204657|11202052|FG001|NOT COMPLETED|Overall Study||0
10074681|NCT02204748|11202058|FG000|STARTED|Overall Study||5
10074682|NCT02204748|11202058|FG000|COMPLETED|Overall Study||5
10074683|NCT02204748|11202058|FG000|NOT COMPLETED|Overall Study||0
10074684|NCT02204761|11202062|FG000|STARTED|Overall Study||6
10074685|NCT02204761|11202062|FG000|COMPLETED|Overall Study||6
10074686|NCT02204761|11202062|FG000|NOT COMPLETED|Overall Study||0
10074687|NCT02204917|11202066|FG000|STARTED|Overall Study||31
10074688|NCT02204917|11202066|FG000|COMPLETED|Overall Study||30
10074689|NCT02204917|11202066|FG000|NOT COMPLETED|Overall Study||1
10074690|NCT02204982|11202075|FG000|STARTED|Overall Study||6
10074691|NCT02204982|11202076|FG001|STARTED|Overall Study||7
10074692|NCT02204982|11202075|FG000|COMPLETED|Overall Study||2
10074693|NCT02204982|11202076|FG001|COMPLETED|Overall Study||0
10074694|NCT02204982|11202075|FG000|NOT COMPLETED|Overall Study||4
10074695|NCT02204982|11202076|FG001|NOT COMPLETED|Overall Study||7
10074696|NCT02205177|11202084|FG000|STARTED|Overall Study||8
10074697|NCT02205177|11202085|FG001|STARTED|Overall Study||2
10074698|NCT02205177|11202084|FG000|COMPLETED|Overall Study||6
10074699|NCT02205177|11202085|FG001|COMPLETED|Overall Study||2
10074700|NCT02205177|11202084|FG000|NOT COMPLETED|Overall Study||2
10074701|NCT02205177|11202085|FG001|NOT COMPLETED|Overall Study||0
10074702|NCT02205307|11202093|FG000|STARTED|Overall Study||178
10074703|NCT02205307|11202094|FG001|STARTED|Overall Study||169
10074704|NCT02205307|11202093|FG000|COMPLETED|Overall Study||161
10074705|NCT02205307|11202094|FG001|COMPLETED|Overall Study||163
10074706|NCT02205307|11202093|FG000|NOT COMPLETED|Overall Study||17
10074707|NCT02205307|11202094|FG001|NOT COMPLETED|Overall Study||6
10074708|NCT02205333|11202110|FG000|STARTED|Overall Study||8
10074709|NCT02205333|11202111|FG001|STARTED|Overall Study||6
10074710|NCT02205333|11202112|FG002|STARTED|Overall Study||3
10074711|NCT02205333|11202113|FG003|STARTED|Overall Study||7
10074712|NCT02205333|11202114|FG004|STARTED|Overall Study||6
10074713|NCT02205333|11202115|FG005|STARTED|Overall Study||7
10074714|NCT02205333|11202116|FG006|STARTED|Overall Study||7
10074715|NCT02205333|11202117|FG007|STARTED|Overall Study||3
10074716|NCT02205333|11202118|FG008|STARTED|Overall Study||1
10074717|NCT02205333|11202110|FG000|COMPLETED|Overall Study||2
10074718|NCT02205333|11202111|FG001|COMPLETED|Overall Study||0
10074719|NCT02205333|11202112|FG002|COMPLETED|Overall Study||1
10074720|NCT02205333|11202113|FG003|COMPLETED|Overall Study||0
10074721|NCT02205333|11202114|FG004|COMPLETED|Overall Study||1
10074722|NCT02205333|11202115|FG005|COMPLETED|Overall Study||4
10074723|NCT02205333|11202116|FG006|COMPLETED|Overall Study||2
10074724|NCT02205333|11202117|FG007|COMPLETED|Overall Study||1
10074725|NCT02205333|11202118|FG008|COMPLETED|Overall Study||1
10074726|NCT02205333|11202110|FG000|NOT COMPLETED|Overall Study||6
10074727|NCT02205333|11202111|FG001|NOT COMPLETED|Overall Study||6
10074728|NCT02205333|11202112|FG002|NOT COMPLETED|Overall Study||2
10074729|NCT02205333|11202113|FG003|NOT COMPLETED|Overall Study||7
10074730|NCT02205333|11202114|FG004|NOT COMPLETED|Overall Study||5
10074731|NCT02205333|11202115|FG005|NOT COMPLETED|Overall Study||3
10074732|NCT02205333|11202116|FG006|NOT COMPLETED|Overall Study||5
10074733|NCT02205333|11202117|FG007|NOT COMPLETED|Overall Study||2
10074734|NCT02205333|11202118|FG008|NOT COMPLETED|Overall Study||0
10074735|NCT02205476|11202140|FG000|STARTED|Overall Study||7
10074736|NCT02205476|11202141|FG001|STARTED|Overall Study||3
10074737|NCT02205476|11202140|FG000|COMPLETED|Overall Study||0
10074738|NCT02205476|11202141|FG001|COMPLETED|Overall Study||0
10074739|NCT02205476|11202140|FG000|NOT COMPLETED|Overall Study||7
10074740|NCT02205476|11202141|FG001|NOT COMPLETED|Overall Study||3
10074741|NCT02205801|11202157|FG000|STARTED|Overall Study||11
10074742|NCT02205801|11202158|FG001|STARTED|Overall Study||8
10074743|NCT02205801|11202159|FG002|STARTED|Overall Study||9
10074744|NCT02205801|11202160|FG003|STARTED|Overall Study||8
10074745|NCT02205801|11202157|FG000|COMPLETED|Overall Study||11
10074746|NCT02205801|11202158|FG001|COMPLETED|Overall Study||8
10074747|NCT02205801|11202159|FG002|COMPLETED|Overall Study||9
10074748|NCT02205801|11202160|FG003|COMPLETED|Overall Study||8
10074749|NCT02205801|11202157|FG000|NOT COMPLETED|Overall Study||0
10074750|NCT02205801|11202158|FG001|NOT COMPLETED|Overall Study||0
10074751|NCT02205801|11202159|FG002|NOT COMPLETED|Overall Study||0
10074752|NCT02205801|11202160|FG003|NOT COMPLETED|Overall Study||0
10074753|NCT02205814|11202174|FG000|STARTED|Overall Study||110
10074754|NCT02205814|11202175|FG001|STARTED|Overall Study||110
10074755|NCT02205814|11202176|FG002|STARTED|Overall Study||108
10074756|NCT02205814|11202177|FG003|STARTED|Overall Study||108
10074757|NCT02205814|11202174|FG000|COMPLETED|Overall Study||108
10074758|NCT02205814|11202175|FG001|COMPLETED|Overall Study||109
10074759|NCT02205814|11202176|FG002|COMPLETED|Overall Study||103
10074760|NCT02205814|11202177|FG003|COMPLETED|Overall Study||104
10074761|NCT02205814|11202174|FG000|NOT COMPLETED|Overall Study||2
10074762|NCT02205814|11202175|FG001|NOT COMPLETED|Overall Study||1
10074763|NCT02205814|11202176|FG002|NOT COMPLETED|Overall Study||5
10074764|NCT02205814|11202177|FG003|NOT COMPLETED|Overall Study||4
10074765|NCT02205983|11202191|FG000|STARTED|Overall Study||12
10074766|NCT02205983|11202192|FG001|STARTED|Overall Study||12
10074767|NCT02205983|11202193|FG002|STARTED|Overall Study||13
10074768|NCT02205983|11202194|FG003|STARTED|Overall Study||13
10074769|NCT02205983|11202191|FG000|COMPLETED|Overall Study||12
10190690|NCT03296072|11319858|FG005|STARTED|Treament Period 1: Wash Out Period||11
10190691|NCT03296072|11319853|FG000|COMPLETED|Treament Period 1: Wash Out Period||10
10190692|NCT03296072|11319854|FG001|COMPLETED|Treament Period 1: Wash Out Period||11
10190693|NCT03296072|11319855|FG002|COMPLETED|Treament Period 1: Wash Out Period||10
10190694|NCT03296072|11319856|FG003|COMPLETED|Treament Period 1: Wash Out Period||10
10190695|NCT03296072|11319857|FG004|COMPLETED|Treament Period 1: Wash Out Period||10
10190696|NCT03296072|11319858|FG005|COMPLETED|Treament Period 1: Wash Out Period||11
10190697|NCT03296072|11319853|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10190698|NCT03296072|11319854|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10190699|NCT03296072|11319855|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10190700|NCT03296072|11319856|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10190701|NCT03296072|11319857|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10190702|NCT03296072|11319858|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10190703|NCT03296072|11319853|FG000|STARTED|Treament Period 2||10
10190704|NCT03296072|11319854|FG001|STARTED|Treament Period 2||11
10190705|NCT03296072|11319855|FG002|STARTED|Treament Period 2||10
10190706|NCT03296072|11319856|FG003|STARTED|Treament Period 2||10
10190707|NCT03296072|11319857|FG004|STARTED|Treament Period 2||10
10190708|NCT03296072|11319858|FG005|STARTED|Treament Period 2||11
10190709|NCT03296072|11319853|FG000|COMPLETED|Treament Period 2||10
10190710|NCT03296072|11319854|FG001|COMPLETED|Treament Period 2||11
10190711|NCT03296072|11319855|FG002|COMPLETED|Treament Period 2||10
10190712|NCT03296072|11319856|FG003|COMPLETED|Treament Period 2||10
10190713|NCT03296072|11319857|FG004|COMPLETED|Treament Period 2||10
10190714|NCT03296072|11319858|FG005|COMPLETED|Treament Period 2||11
10190715|NCT03296072|11319853|FG000|NOT COMPLETED|Treament Period 2||0
10190716|NCT03296072|11319854|FG001|NOT COMPLETED|Treament Period 2||0
10190717|NCT03296072|11319855|FG002|NOT COMPLETED|Treament Period 2||0
10190718|NCT03296072|11319856|FG003|NOT COMPLETED|Treament Period 2||0
10190719|NCT03296072|11319857|FG004|NOT COMPLETED|Treament Period 2||0
10190720|NCT03296072|11319858|FG005|NOT COMPLETED|Treament Period 2||0
10190721|NCT03296072|11319853|FG000|STARTED|Treament Period 2: Wash Out Period||10
10190722|NCT03296072|11319854|FG001|STARTED|Treament Period 2: Wash Out Period||11
10190723|NCT03296072|11319855|FG002|STARTED|Treament Period 2: Wash Out Period||10
10190724|NCT03296072|11319856|FG003|STARTED|Treament Period 2: Wash Out Period||10
10190725|NCT03296072|11319857|FG004|STARTED|Treament Period 2: Wash Out Period||10
10190726|NCT03296072|11319858|FG005|STARTED|Treament Period 2: Wash Out Period||11
10190727|NCT03296072|11319853|FG000|COMPLETED|Treament Period 2: Wash Out Period||10
10190728|NCT03296072|11319854|FG001|COMPLETED|Treament Period 2: Wash Out Period||11
10074770|NCT02205983|11202192|FG001|COMPLETED|Overall Study||12
10074771|NCT02205983|11202193|FG002|COMPLETED|Overall Study||13
10074772|NCT02205983|11202194|FG003|COMPLETED|Overall Study||13
10074773|NCT02205983|11202191|FG000|NOT COMPLETED|Overall Study||0
10074774|NCT02205983|11202192|FG001|NOT COMPLETED|Overall Study||0
10074775|NCT02205983|11202193|FG002|NOT COMPLETED|Overall Study||0
10074776|NCT02205983|11202194|FG003|NOT COMPLETED|Overall Study||0
10074777|NCT02206061|11202207|FG000|STARTED|Overall Study||149
10074778|NCT02206061|11202208|FG001|STARTED|Overall Study||142
10074779|NCT02206061|11202209|FG002|STARTED|Overall Study||139
10074780|NCT02206061|11202207|FG000|COMPLETED|Overall Study||131
10074781|NCT02206061|11202208|FG001|COMPLETED|Overall Study||128
10074782|NCT02206061|11202209|FG002|COMPLETED|Overall Study||118
10074783|NCT02206061|11202207|FG000|NOT COMPLETED|Overall Study||18
10074784|NCT02206061|11202208|FG001|NOT COMPLETED|Overall Study||14
10074785|NCT02206061|11202209|FG002|NOT COMPLETED|Overall Study||21
10074786|NCT02206152|11202217|FG000|STARTED|Pre-Randomization||22
10074787|NCT02206152|11202217|FG000|COMPLETED|Pre-Randomization||20
10074788|NCT02206152|11202217|FG000|NOT COMPLETED|Pre-Randomization||2
10074789|NCT02206152|11202217|FG000|STARTED|Placebo, Then NAC||10
10074790|NCT02206152|11202217|FG000|COMPLETED|Placebo, Then NAC||10
10074791|NCT02206152|11202217|FG000|NOT COMPLETED|Placebo, Then NAC||0
10074792|NCT02206152|11202217|FG000|STARTED|NAC, Then Placebo||10
10074793|NCT02206152|11202217|FG000|COMPLETED|NAC, Then Placebo||10
10074794|NCT02206152|11202217|FG000|NOT COMPLETED|NAC, Then Placebo||0
10074795|NCT02206217|11202225|FG000|STARTED|Overall Study||90
10074796|NCT02206217|11202226|FG001|STARTED|Overall Study||93
10074797|NCT02206217|11202225|FG000|COMPLETED|Overall Study||81
10074798|NCT02206217|11202226|FG001|COMPLETED|Overall Study||79
10074799|NCT02206217|11202225|FG000|NOT COMPLETED|Overall Study||9
10074800|NCT02206217|11202226|FG001|NOT COMPLETED|Overall Study||14
10074801|NCT02206607|11202232|FG000|STARTED|Open-Label Run-In||42
10074802|NCT02206607|11202233|FG001|STARTED|Open-Label Run-In||0
10074803|NCT02206607|11202234|FG002|STARTED|Open-Label Run-In||0
10074804|NCT02206607|11202235|FG003|STARTED|Open-Label Run-In||0
10074805|NCT02206607|11202236|FG004|STARTED|Open-Label Run-In||0
10074806|NCT02206607|11202232|FG000|COMPLETED|Open-Label Run-In||39
10074807|NCT02206607|11202233|FG001|COMPLETED|Open-Label Run-In||0
10074808|NCT02206607|11202234|FG002|COMPLETED|Open-Label Run-In||0
10074809|NCT02206607|11202235|FG003|COMPLETED|Open-Label Run-In||0
10074810|NCT02206607|11202236|FG004|COMPLETED|Open-Label Run-In||0
10074811|NCT02206607|11202232|FG000|NOT COMPLETED|Open-Label Run-In||3
10074812|NCT02206607|11202233|FG001|NOT COMPLETED|Open-Label Run-In||0
10074813|NCT02206607|11202234|FG002|NOT COMPLETED|Open-Label Run-In||0
10074814|NCT02206607|11202235|FG003|NOT COMPLETED|Open-Label Run-In||0
10074815|NCT02206607|11202236|FG004|NOT COMPLETED|Open-Label Run-In||0
10074816|NCT02206607|11202232|FG000|STARTED|First Intervention Period||0
10074817|NCT02206607|11202233|FG001|STARTED|First Intervention Period||9
10074818|NCT02206607|11202234|FG002|STARTED|First Intervention Period||9
10074819|NCT02206607|11202235|FG003|STARTED|First Intervention Period||11
10074820|NCT02206607|11202236|FG004|STARTED|First Intervention Period||10
10074821|NCT02206607|11202232|FG000|COMPLETED|First Intervention Period||0
10074822|NCT02206607|11202233|FG001|COMPLETED|First Intervention Period||9
10074823|NCT02206607|11202234|FG002|COMPLETED|First Intervention Period||9
10074824|NCT02206607|11202235|FG003|COMPLETED|First Intervention Period||11
10074825|NCT02206607|11202236|FG004|COMPLETED|First Intervention Period||10
10074826|NCT02206607|11202232|FG000|NOT COMPLETED|First Intervention Period||0
10074827|NCT02206607|11202233|FG001|NOT COMPLETED|First Intervention Period||0
10074828|NCT02206607|11202234|FG002|NOT COMPLETED|First Intervention Period||0
10074829|NCT02206607|11202235|FG003|NOT COMPLETED|First Intervention Period||0
10074830|NCT02206607|11202236|FG004|NOT COMPLETED|First Intervention Period||0
10074831|NCT02206607|11202232|FG000|STARTED|First Washout Period 5 to 10 Days||0
10074832|NCT02206607|11202233|FG001|STARTED|First Washout Period 5 to 10 Days||9
10190729|NCT03296072|11319855|FG002|COMPLETED|Treament Period 2: Wash Out Period||10
10190730|NCT03296072|11319856|FG003|COMPLETED|Treament Period 2: Wash Out Period||10
10190731|NCT03296072|11319857|FG004|COMPLETED|Treament Period 2: Wash Out Period||10
10190732|NCT03296072|11319858|FG005|COMPLETED|Treament Period 2: Wash Out Period||11
10190733|NCT03296072|11319853|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10190734|NCT03296072|11319854|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10190735|NCT03296072|11319855|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10190736|NCT03296072|11319856|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10190737|NCT03296072|11319857|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10190738|NCT03296072|11319858|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10190739|NCT03296072|11319853|FG000|STARTED|Treament Period 3||10
10190740|NCT03296072|11319854|FG001|STARTED|Treament Period 3||11
10190741|NCT03296072|11319855|FG002|STARTED|Treament Period 3||10
10190742|NCT03296072|11319856|FG003|STARTED|Treament Period 3||10
10190743|NCT03296072|11319857|FG004|STARTED|Treament Period 3||10
10190744|NCT03296072|11319858|FG005|STARTED|Treament Period 3||11
10190745|NCT03296072|11319853|FG000|COMPLETED|Treament Period 3||10
10190746|NCT03296072|11319854|FG001|COMPLETED|Treament Period 3||11
10190747|NCT03296072|11319855|FG002|COMPLETED|Treament Period 3||10
10190748|NCT03296072|11319856|FG003|COMPLETED|Treament Period 3||10
10190749|NCT03296072|11319857|FG004|COMPLETED|Treament Period 3||10
10190750|NCT03296072|11319858|FG005|COMPLETED|Treament Period 3||11
10190751|NCT03296072|11319853|FG000|NOT COMPLETED|Treament Period 3||0
10190752|NCT03296072|11319854|FG001|NOT COMPLETED|Treament Period 3||0
10190753|NCT03296072|11319855|FG002|NOT COMPLETED|Treament Period 3||0
10074833|NCT02206607|11202234|FG002|STARTED|First Washout Period 5 to 10 Days||9
10074834|NCT02206607|11202235|FG003|STARTED|First Washout Period 5 to 10 Days||11
10074835|NCT02206607|11202236|FG004|STARTED|First Washout Period 5 to 10 Days||10
10074836|NCT02206607|11202232|FG000|COMPLETED|First Washout Period 5 to 10 Days||0
10074837|NCT02206607|11202233|FG001|COMPLETED|First Washout Period 5 to 10 Days||9
10074838|NCT02206607|11202234|FG002|COMPLETED|First Washout Period 5 to 10 Days||9
10074839|NCT02206607|11202235|FG003|COMPLETED|First Washout Period 5 to 10 Days||11
10074840|NCT02206607|11202236|FG004|COMPLETED|First Washout Period 5 to 10 Days||10
10074841|NCT02206607|11202232|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10074842|NCT02206607|11202233|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10074843|NCT02206607|11202234|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10074844|NCT02206607|11202235|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10074845|NCT02206607|11202236|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10074846|NCT02206607|11202232|FG000|STARTED|Second Intervention Period||0
10074847|NCT02206607|11202233|FG001|STARTED|Second Intervention Period||9
10074848|NCT02206607|11202234|FG002|STARTED|Second Intervention Period||9
10074849|NCT02206607|11202235|FG003|STARTED|Second Intervention Period||11
10074850|NCT02206607|11202236|FG004|STARTED|Second Intervention Period||10
10074851|NCT02206607|11202232|FG000|COMPLETED|Second Intervention Period||0
10074852|NCT02206607|11202233|FG001|COMPLETED|Second Intervention Period||9
10074853|NCT02206607|11202234|FG002|COMPLETED|Second Intervention Period||9
10074854|NCT02206607|11202235|FG003|COMPLETED|Second Intervention Period||10
10074855|NCT02206607|11202236|FG004|COMPLETED|Second Intervention Period||10
10074856|NCT02206607|11202232|FG000|NOT COMPLETED|Second Intervention Period||0
10074857|NCT02206607|11202233|FG001|NOT COMPLETED|Second Intervention Period||0
10074858|NCT02206607|11202234|FG002|NOT COMPLETED|Second Intervention Period||0
10074859|NCT02206607|11202235|FG003|NOT COMPLETED|Second Intervention Period||1
10074860|NCT02206607|11202236|FG004|NOT COMPLETED|Second Intervention Period||0
10074861|NCT02206607|11202232|FG000|STARTED|Second Washout Period 5 to 10 Days||0
10074862|NCT02206607|11202233|FG001|STARTED|Second Washout Period 5 to 10 Days||9
10074863|NCT02206607|11202234|FG002|STARTED|Second Washout Period 5 to 10 Days||9
10074864|NCT02206607|11202235|FG003|STARTED|Second Washout Period 5 to 10 Days||10
10074865|NCT02206607|11202236|FG004|STARTED|Second Washout Period 5 to 10 Days||10
10074866|NCT02206607|11202232|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0
10074867|NCT02206607|11202233|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9
10074868|NCT02206607|11202234|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9
10074869|NCT02206607|11202235|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10
10074870|NCT02206607|11202236|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10
10074871|NCT02206607|11202232|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10074872|NCT02206607|11202233|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10074873|NCT02206607|11202234|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10074874|NCT02206607|11202235|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10074875|NCT02206607|11202236|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10074876|NCT02206607|11202232|FG000|STARTED|Third Intervention Period||0
10074877|NCT02206607|11202233|FG001|STARTED|Third Intervention Period||9
10074878|NCT02206607|11202234|FG002|STARTED|Third Intervention Period||9
10074879|NCT02206607|11202235|FG003|STARTED|Third Intervention Period||10
10074880|NCT02206607|11202236|FG004|STARTED|Third Intervention Period||10
10074881|NCT02206607|11202232|FG000|COMPLETED|Third Intervention Period||0
10074882|NCT02206607|11202233|FG001|COMPLETED|Third Intervention Period||9
10074883|NCT02206607|11202234|FG002|COMPLETED|Third Intervention Period||9
10074884|NCT02206607|11202235|FG003|COMPLETED|Third Intervention Period||10
10074885|NCT02206607|11202236|FG004|COMPLETED|Third Intervention Period||10
10074886|NCT02206607|11202232|FG000|NOT COMPLETED|Third Intervention Period||0
10074887|NCT02206607|11202233|FG001|NOT COMPLETED|Third Intervention Period||0
10074888|NCT02206607|11202234|FG002|NOT COMPLETED|Third Intervention Period||0
10074889|NCT02206607|11202235|FG003|NOT COMPLETED|Third Intervention Period||0
10074890|NCT02206607|11202236|FG004|NOT COMPLETED|Third Intervention Period||0
10074891|NCT02206607|11202232|FG000|STARTED|Third Washout Period 5 to 10 Days||0
10074892|NCT02206607|11202233|FG001|STARTED|Third Washout Period 5 to 10 Days||9
10074893|NCT02206607|11202234|FG002|STARTED|Third Washout Period 5 to 10 Days||9
10074894|NCT02206607|11202235|FG003|STARTED|Third Washout Period 5 to 10 Days||10
10074895|NCT02206607|11202236|FG004|STARTED|Third Washout Period 5 to 10 Days||10
10074896|NCT02206607|11202232|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0
10074897|NCT02206607|11202233|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9
10074898|NCT02206607|11202234|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9
10074899|NCT02206607|11202235|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10
10074900|NCT02206607|11202236|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10
10074901|NCT02206607|11202232|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10190754|NCT03296072|11319856|FG003|NOT COMPLETED|Treament Period 3||0
10190755|NCT03296072|11319857|FG004|NOT COMPLETED|Treament Period 3||0
10190756|NCT03296072|11319858|FG005|NOT COMPLETED|Treament Period 3||0
10190757|NCT03296163|11319868|FG000|STARTED|Combination Therapy||315
10190758|NCT03296163|11319869|FG001|STARTED|Combination Therapy||312
10190759|NCT03296163|11319868|FG000|COMPLETED|Combination Therapy||207
10190760|NCT03296163|11319869|FG001|COMPLETED|Combination Therapy||220
10190761|NCT03296163|11319868|FG000|NOT COMPLETED|Combination Therapy||108
10190762|NCT03296163|11319869|FG001|NOT COMPLETED|Combination Therapy||92
10190763|NCT03296163|11319868|FG000|STARTED|Monotherapy||207
10074902|NCT02206607|11202233|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10074903|NCT02206607|11202234|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10074904|NCT02206607|11202235|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10074905|NCT02206607|11202236|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10074906|NCT02206607|11202232|FG000|STARTED|Fourth Intervention Period||0
10074907|NCT02206607|11202233|FG001|STARTED|Fourth Intervention Period||9
10074908|NCT02206607|11202234|FG002|STARTED|Fourth Intervention Period||9
10074909|NCT02206607|11202235|FG003|STARTED|Fourth Intervention Period||10
10074910|NCT02206607|11202236|FG004|STARTED|Fourth Intervention Period||10
10074911|NCT02206607|11202232|FG000|COMPLETED|Fourth Intervention Period||0
10074912|NCT02206607|11202233|FG001|COMPLETED|Fourth Intervention Period||9
10074913|NCT02206607|11202234|FG002|COMPLETED|Fourth Intervention Period||9
10074914|NCT02206607|11202235|FG003|COMPLETED|Fourth Intervention Period||10
10074915|NCT02206607|11202236|FG004|COMPLETED|Fourth Intervention Period||10
10074916|NCT02206607|11202232|FG000|NOT COMPLETED|Fourth Intervention Period||0
10074917|NCT02206607|11202233|FG001|NOT COMPLETED|Fourth Intervention Period||0
10074918|NCT02206607|11202234|FG002|NOT COMPLETED|Fourth Intervention Period||0
10074919|NCT02206607|11202235|FG003|NOT COMPLETED|Fourth Intervention Period||0
10074920|NCT02206607|11202236|FG004|NOT COMPLETED|Fourth Intervention Period||0
10074921|NCT02206620|11202252|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22
10074922|NCT02206620|11202253|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27
10074923|NCT02206620|11202252|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21
10074924|NCT02206620|11202253|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26
10074925|NCT02206620|11202252|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
10074926|NCT02206620|11202253|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
10074927|NCT02206620|11202252|FG000|STARTED|Washout (6 Weeks)||21
10074928|NCT02206620|11202253|FG001|STARTED|Washout (6 Weeks)||26
10074929|NCT02206620|11202252|FG000|COMPLETED|Washout (6 Weeks)||21
10074930|NCT02206620|11202253|FG001|COMPLETED|Washout (6 Weeks)||26
10074931|NCT02206620|11202252|FG000|NOT COMPLETED|Washout (6 Weeks)||0
10074932|NCT02206620|11202253|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10074933|NCT02206620|11202252|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21
10074934|NCT02206620|11202253|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26
10074935|NCT02206620|11202252|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
10074936|NCT02206620|11202253|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
10074937|NCT02206620|11202252|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
10074938|NCT02206620|11202253|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
10074939|NCT02206685|11202267|FG000|STARTED|Overall Study||37
10074940|NCT02206685|11202268|FG001|STARTED|Overall Study||37
10074941|NCT02206685|11202267|FG000|COMPLETED|Overall Study||32
10074942|NCT02206685|11202268|FG001|COMPLETED|Overall Study||30
10074943|NCT02206685|11202267|FG000|NOT COMPLETED|Overall Study||5
10074944|NCT02206685|11202268|FG001|NOT COMPLETED|Overall Study||7
10074945|NCT02206776|11202276|FG000|STARTED|Overall Study||1
10074946|NCT02206776|11202277|FG001|STARTED|Overall Study||1
10074947|NCT02206776|11202276|FG000|COMPLETED|Overall Study||1
10074948|NCT02206776|11202277|FG001|COMPLETED|Overall Study||1
10074949|NCT02206776|11202276|FG000|NOT COMPLETED|Overall Study||0
10074950|NCT02206776|11202277|FG001|NOT COMPLETED|Overall Study||0
10074951|NCT02206828|11202283|FG000|STARTED|Overall Study||100
10074952|NCT02206828|11202283|FG000|COMPLETED|Overall Study||93
10190764|NCT03296163|11319869|FG001|STARTED|Monotherapy||220
9731956|NCT00138125|10831942|FG000|NOT COMPLETED|Overall Study||0
10074953|NCT02206828|11202283|FG000|NOT COMPLETED|Overall Study||7
10074954|NCT02207088|11202310|FG000|STARTED|Overall Study||68
10074955|NCT02207088|11202310|FG000|COMPLETED|Overall Study||66
10190765|NCT03296163|11319868|FG000|COMPLETED|Monotherapy||68
10074956|NCT02207088|11202310|FG000|NOT COMPLETED|Overall Study||2
10074957|NCT02207231|11202317|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174
10074958|NCT02207231|11202318|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329
10074959|NCT02207231|11202319|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334
10074960|NCT02207231|11202320|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0
10074961|NCT02207231|11202317|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174
10074962|NCT02207231|11202318|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329
10074963|NCT02207231|11202319|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333
10074964|NCT02207231|11202320|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0
10074965|NCT02207231|11202317|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
10074966|NCT02207231|11202318|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
10074967|NCT02207231|11202319|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
10074968|NCT02207231|11202320|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
10074969|NCT02207231|11202317|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
10074970|NCT02207231|11202318|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
10074971|NCT02207231|11202319|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
10074972|NCT02207231|11202320|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
10074973|NCT02207231|11202317|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
10074974|NCT02207231|11202318|FG001|STARTED|Active Controlled Period: Week 16 - 48||322
10074975|NCT02207231|11202319|FG002|STARTED|Active Controlled Period: Week 16 - 48||324
10074976|NCT02207231|11202320|FG003|STARTED|Active Controlled Period: Week 16 - 48||0
10074977|NCT02207231|11202317|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162
10074978|NCT02207231|11202318|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301
10074979|NCT02207231|11202319|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281
10074980|NCT02207231|11202320|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0
10074981|NCT02207231|11202317|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
10074982|NCT02207231|11202318|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
10074983|NCT02207231|11202319|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
10074984|NCT02207231|11202320|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
10074985|NCT02207231|11202317|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0
10074986|NCT02207231|11202318|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0
10074987|NCT02207231|11202319|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
10074988|NCT02207231|11202320|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
10074989|NCT02207231|11202317|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10074990|NCT02207231|11202318|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10074991|NCT02207231|11202319|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
10074992|NCT02207231|11202320|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
10074993|NCT02207231|11202317|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10074994|NCT02207231|11202318|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10074995|NCT02207231|11202319|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
10074996|NCT02207231|11202320|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
10074997|NCT02207244|11202341|FG000|STARTED|Placebo Controlled Period: Week 0-16||248
10074998|NCT02207244|11202342|FG001|STARTED|Placebo Controlled Period: Week 0-16||496
10074999|NCT02207244|11202343|FG002|STARTED|Placebo Controlled Period: Week 0-16||248
10075000|NCT02207244|11202344|FG003|STARTED|Placebo Controlled Period: Week 0-16||0
10075001|NCT02207244|11202345|FG004|STARTED|Placebo Controlled Period: Week 0-16||0
10075002|NCT02207244|11202346|FG005|STARTED|Placebo Controlled Period: Week 0-16||0
10075003|NCT02207244|11202347|FG006|STARTED|Placebo Controlled Period: Week 0-16||0
10075004|NCT02207244|11202348|FG007|STARTED|Placebo Controlled Period: Week 0-16||0
10075005|NCT02207244|11202349|FG008|STARTED|Placebo Controlled Period: Week 0-16||0
10075006|NCT02207244|11202350|FG009|STARTED|Placebo Controlled Period: Week 0-16||0
10075007|NCT02207244|11202351|FG010|STARTED|Placebo Controlled Period: Week 0-16||0
10075008|NCT02207244|11202341|FG000|Treated|Placebo Controlled Period: Week 0-16||248
10075009|NCT02207244|11202342|FG001|Treated|Placebo Controlled Period: Week 0-16||494
10075010|NCT02207244|11202343|FG002|Treated|Placebo Controlled Period: Week 0-16||248
10075011|NCT02207244|11202344|FG003|Treated|Placebo Controlled Period: Week 0-16||0
10075012|NCT02207244|11202345|FG004|Treated|Placebo Controlled Period: Week 0-16||0
10075013|NCT02207244|11202346|FG005|Treated|Placebo Controlled Period: Week 0-16||0
10075014|NCT02207244|11202347|FG006|Treated|Placebo Controlled Period: Week 0-16||0
10075015|NCT02207244|11202348|FG007|Treated|Placebo Controlled Period: Week 0-16||0
10075016|NCT02207244|11202349|FG008|Treated|Placebo Controlled Period: Week 0-16||0
10075017|NCT02207244|11202350|FG009|Treated|Placebo Controlled Period: Week 0-16||0
10075018|NCT02207244|11202351|FG010|Treated|Placebo Controlled Period: Week 0-16||0
10075019|NCT02207244|11202341|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233
10075020|NCT02207244|11202342|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478
10075021|NCT02207244|11202343|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237
10075022|NCT02207244|11202344|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075023|NCT02207244|11202345|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075024|NCT02207244|11202346|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075025|NCT02207244|11202347|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075026|NCT02207244|11202348|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075027|NCT02207244|11202349|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075028|NCT02207244|11202350|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075029|NCT02207244|11202351|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0
10075030|NCT02207244|11202341|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
10075031|NCT02207244|11202342|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
10075032|NCT02207244|11202343|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
10075033|NCT02207244|11202344|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075034|NCT02207244|11202345|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075035|NCT02207244|11202346|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075036|NCT02207244|11202347|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075037|NCT02207244|11202348|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075038|NCT02207244|11202349|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075039|NCT02207244|11202350|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075040|NCT02207244|11202351|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10075041|NCT02207244|11202341|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075042|NCT02207244|11202342|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075043|NCT02207244|11202343|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075044|NCT02207244|11202344|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233
10075045|NCT02207244|11202345|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478
10075046|NCT02207244|11202346|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237
10075047|NCT02207244|11202347|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075048|NCT02207244|11202348|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075049|NCT02207244|11202349|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075050|NCT02207244|11202350|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075051|NCT02207244|11202351|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0
10075052|NCT02207244|11202341|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075053|NCT02207244|11202342|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075054|NCT02207244|11202343|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075055|NCT02207244|11202344|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
10075056|NCT02207244|11202345|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
10075057|NCT02207244|11202346|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
10075058|NCT02207244|11202347|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075059|NCT02207244|11202348|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075060|NCT02207244|11202349|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075061|NCT02207244|11202350|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075062|NCT02207244|11202351|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075063|NCT02207244|11202341|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075064|NCT02207244|11202342|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075065|NCT02207244|11202343|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075066|NCT02207244|11202344|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
10075067|NCT02207244|11202345|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
10075068|NCT02207244|11202346|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
10075069|NCT02207244|11202347|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075070|NCT02207244|11202348|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075071|NCT02207244|11202349|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075072|NCT02207244|11202350|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075073|NCT02207244|11202351|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10075074|NCT02207244|11202341|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10075075|NCT02207244|11202342|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10075076|NCT02207244|11202343|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10075077|NCT02207244|11202344|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10075078|NCT02207244|11202345|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10075079|NCT02207244|11202346|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10075080|NCT02207244|11202347|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227
10075081|NCT02207244|11202348|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470
10075082|NCT02207244|11202349|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220
10075083|NCT02207244|11202350|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8
10075084|NCT02207244|11202351|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10075085|NCT02207244|11202341|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075086|NCT02207244|11202342|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075087|NCT02207244|11202343|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075088|NCT02207244|11202344|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075089|NCT02207244|11202345|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075090|NCT02207244|11202346|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075091|NCT02207244|11202347|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
10075092|NCT02207244|11202348|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
10075093|NCT02207244|11202349|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
10075094|NCT02207244|11202350|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075095|NCT02207244|11202351|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10075096|NCT02207244|11202341|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075097|NCT02207244|11202342|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075098|NCT02207244|11202343|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075099|NCT02207244|11202344|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075100|NCT02207244|11202345|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075101|NCT02207244|11202346|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075102|NCT02207244|11202347|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075103|NCT02207244|11202348|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
10075104|NCT02207244|11202349|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075105|NCT02207244|11202350|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075106|NCT02207244|11202351|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10075107|NCT02207244|11202341|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075108|NCT02207244|11202342|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075109|NCT02207244|11202343|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075110|NCT02207244|11202344|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075111|NCT02207244|11202345|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075112|NCT02207244|11202346|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075113|NCT02207244|11202347|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
10075114|NCT02207244|11202348|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075115|NCT02207244|11202349|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
10075116|NCT02207244|11202350|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075117|NCT02207244|11202351|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10075118|NCT02207244|11202341|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075119|NCT02207244|11202342|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075120|NCT02207244|11202343|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075121|NCT02207244|11202344|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075122|NCT02207244|11202345|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075123|NCT02207244|11202346|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075124|NCT02207244|11202347|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
10075125|NCT02207244|11202348|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
10075126|NCT02207244|11202349|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
10075127|NCT02207244|11202350|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075128|NCT02207244|11202351|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075129|NCT02207244|11202341|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075130|NCT02207244|11202342|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075131|NCT02207244|11202343|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075132|NCT02207244|11202344|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075133|NCT02207244|11202345|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075134|NCT02207244|11202346|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075135|NCT02207244|11202347|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
10075136|NCT02207244|11202348|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
10075137|NCT02207244|11202349|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
10075138|NCT02207244|11202350|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
10075139|NCT02207244|11202351|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10075140|NCT02207244|11202341|FG000|STARTED|Open-label Guselkumab: Week 72-264||0
10075141|NCT02207244|11202342|FG001|STARTED|Open-label Guselkumab: Week 72-264||0
10075142|NCT02207244|11202343|FG002|STARTED|Open-label Guselkumab: Week 72-264||0
10075143|NCT02207244|11202344|FG003|STARTED|Open-label Guselkumab: Week 72-264||0
10075144|NCT02207244|11202345|FG004|STARTED|Open-label Guselkumab: Week 72-264||0
10075145|NCT02207244|11202346|FG005|STARTED|Open-label Guselkumab: Week 72-264||0
10075146|NCT02207244|11202347|FG006|STARTED|Open-label Guselkumab: Week 72-264||0
10075147|NCT02207244|11202348|FG007|STARTED|Open-label Guselkumab: Week 72-264||0
10075148|NCT02207244|11202349|FG008|STARTED|Open-label Guselkumab: Week 72-264||211
10075149|NCT02207244|11202350|FG009|STARTED|Open-label Guselkumab: Week 72-264||0
10075150|NCT02207244|11202351|FG010|STARTED|Open-label Guselkumab: Week 72-264||656
10075151|NCT02207244|11202341|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075152|NCT02207244|11202342|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075153|NCT02207244|11202343|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075154|NCT02207244|11202344|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075155|NCT02207244|11202345|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075156|NCT02207244|11202346|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075157|NCT02207244|11202347|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075158|NCT02207244|11202348|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075159|NCT02207244|11202349|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173
10075160|NCT02207244|11202350|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0
10075161|NCT02207244|11202351|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554
10075162|NCT02207244|11202341|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075163|NCT02207244|11202342|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075164|NCT02207244|11202343|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075165|NCT02207244|11202344|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075166|NCT02207244|11202345|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075167|NCT02207244|11202346|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075168|NCT02207244|11202347|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075169|NCT02207244|11202348|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075170|NCT02207244|11202349|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
10075171|NCT02207244|11202350|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10075172|NCT02207244|11202351|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
10075173|NCT02207322|11202382|FG000|STARTED|Overall Study||79
10075174|NCT02207322|11202383|FG001|STARTED|Overall Study||81
10075175|NCT02207322|11202382|FG000|Week-2|Overall Study||77
10075176|NCT02207322|11202383|FG001|Week-2|Overall Study||80
10075177|NCT02207322|11202382|FG000|3-month|Overall Study||74
10075178|NCT02207322|11202383|FG001|3-month|Overall Study||75
10075179|NCT02207322|11202382|FG000|COMPLETED|Overall Study|6-month|70
10075180|NCT02207322|11202383|FG001|COMPLETED|Overall Study|6-month|71
10075181|NCT02207322|11202382|FG000|NOT COMPLETED|Overall Study||9
10075182|NCT02207322|11202383|FG001|NOT COMPLETED|Overall Study||10
10075183|NCT02207374|11202392|FG000|STARTED|Overall Study||239
10075184|NCT02207374|11202393|FG001|STARTED|Overall Study||241
10075185|NCT02207374|11202394|FG002|STARTED|Overall Study||121
10075186|NCT02207374|11202392|FG000|Exposed|Overall Study||239
10075187|NCT02207374|11202393|FG001|Exposed|Overall Study||241
10075188|NCT02207374|11202394|FG002|Exposed|Overall Study||120
10075189|NCT02207374|11202392|FG000|COMPLETED|Overall Study||233
10075190|NCT02207374|11202393|FG001|COMPLETED|Overall Study||231
10075191|NCT02207374|11202394|FG002|COMPLETED|Overall Study||115
10075192|NCT02207374|11202392|FG000|NOT COMPLETED|Overall Study||6
10075193|NCT02207374|11202393|FG001|NOT COMPLETED|Overall Study||10
10075194|NCT02207374|11202394|FG002|NOT COMPLETED|Overall Study||6
10075195|NCT02207400|11202404|FG000|STARTED|Overall Study||123
10075196|NCT02207400|11202405|FG001|STARTED|Overall Study||123
10075197|NCT02207400|11202404|FG000|COMPLETED|Overall Study||107
10075198|NCT02207400|11202405|FG001|COMPLETED|Overall Study||109
10075199|NCT02207400|11202404|FG000|NOT COMPLETED|Overall Study||16
10075200|NCT02207400|11202405|FG001|NOT COMPLETED|Overall Study||14
10075201|NCT02207413|11202420|FG000|STARTED|Overall Study||60
10075202|NCT02207413|11202421|FG001|STARTED|Overall Study||60
10075203|NCT02207413|11202422|FG002|STARTED|Overall Study||410
10075204|NCT02207413|11202423|FG003|STARTED|Overall Study||411
10075205|NCT02207413|11202424|FG004|STARTED|Overall Study||466
10075206|NCT02207413|11202425|FG005|STARTED|Overall Study||474
10075207|NCT02207413|11202420|FG000|COMPLETED|Overall Study||59
10075208|NCT02207413|11202421|FG001|COMPLETED|Overall Study||60
10075209|NCT02207413|11202422|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
10075210|NCT02207413|11202423|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
10075211|NCT02207413|11202424|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
10075212|NCT02207413|11202425|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
10075213|NCT02207413|11202420|FG000|NOT COMPLETED|Overall Study||1
10075214|NCT02207413|11202421|FG001|NOT COMPLETED|Overall Study||0
10075215|NCT02207413|11202422|FG002|NOT COMPLETED|Overall Study||0
10075216|NCT02207413|11202423|FG003|NOT COMPLETED|Overall Study||1
10075217|NCT02207413|11202424|FG004|NOT COMPLETED|Overall Study||7
10075218|NCT02207413|11202425|FG005|NOT COMPLETED|Overall Study||13
10075219|NCT02207478|11202447|FG000|STARTED|Overall Study||40
10075220|NCT02207478|11202448|FG001|STARTED|Overall Study||46
10075221|NCT02207478|11202447|FG000|COMPLETED|Overall Study||40
10075222|NCT02207478|11202448|FG001|COMPLETED|Overall Study||46
10075223|NCT02207478|11202447|FG000|NOT COMPLETED|Overall Study||0
10075224|NCT02207478|11202448|FG001|NOT COMPLETED|Overall Study||0
10075225|NCT02207491|11202456|FG000|STARTED|Overall Study||202
10075226|NCT02207491|11202457|FG001|STARTED|Overall Study||209
10075227|NCT02207491|11202456|FG000|COMPLETED|Overall Study||171
10075228|NCT02207491|11202457|FG001|COMPLETED|Overall Study||196
10075229|NCT02207491|11202456|FG000|NOT COMPLETED|Overall Study||31
10075230|NCT02207491|11202457|FG001|NOT COMPLETED|Overall Study||13
10075231|NCT02207530|11202463|FG000|STARTED|Overall Study||112
10075232|NCT02207530|11202463|FG000|COMPLETED|Overall Study||21
10075233|NCT02207530|11202463|FG000|NOT COMPLETED|Overall Study||91
10075234|NCT02207556|11202469|FG000|STARTED|Overall Study||7
10075235|NCT02207556|11202470|FG001|STARTED|Overall Study||25
10075236|NCT02207556|11202469|FG000|COMPLETED|Overall Study||5
10075237|NCT02207556|11202470|FG001|COMPLETED|Overall Study||20
10075238|NCT02207556|11202469|FG000|NOT COMPLETED|Overall Study||2
10075239|NCT02207556|11202470|FG001|NOT COMPLETED|Overall Study||5
10075240|NCT02207569|11202479|FG000|STARTED|Enrolled to Implant|241 Attempted Implant|241
10075241|NCT02207569|11202479|FG000|COMPLETED|Enrolled to Implant|237 Implanted|237
10075242|NCT02207569|11202479|FG000|NOT COMPLETED|Enrolled to Implant||4
10075243|NCT02207569|11202479|FG000|STARTED|Implant to 1-Month|241 Attempted Implant|241
10075244|NCT02207569|11202479|FG000|COMPLETED|Implant to 1-Month||232
10075245|NCT02207569|11202479|FG000|NOT COMPLETED|Implant to 1-Month||9
10075246|NCT02207569|11202479|FG000|STARTED|1-Month to 6-Month||232
10075247|NCT02207569|11202479|FG000|COMPLETED|1-Month to 6-Month||222
10075248|NCT02207569|11202479|FG000|NOT COMPLETED|1-Month to 6-Month||10
10075249|NCT02207569|11202479|FG000|STARTED|12-Month||222
10075250|NCT02207569|11202479|FG000|COMPLETED|12-Month||213
10075251|NCT02207569|11202479|FG000|NOT COMPLETED|12-Month||9
10075252|NCT02207569|11202479|FG000|STARTED|6-Month to 12-Month||213
10075253|NCT02207569|11202479|FG000|COMPLETED|6-Month to 12-Month||197
10075254|NCT02207569|11202479|FG000|NOT COMPLETED|6-Month to 12-Month||16
10075255|NCT02207569|11202479|FG000|STARTED|12-Month to 24 Month||197
10075256|NCT02207569|11202479|FG000|COMPLETED|12-Month to 24 Month||171
10075257|NCT02207569|11202479|FG000|NOT COMPLETED|12-Month to 24 Month||26
10075258|NCT02207569|11202479|FG000|STARTED|24-Month to 36-Month||171
10075259|NCT02207569|11202479|FG000|COMPLETED|24-Month to 36-Month||144
10075260|NCT02207569|11202479|FG000|NOT COMPLETED|24-Month to 36-Month||27
10075261|NCT02207569|11202479|FG000|STARTED|36-Month to 48-Month||144
10075262|NCT02207569|11202479|FG000|COMPLETED|36-Month to 48-Month||113
10075263|NCT02207569|11202479|FG000|NOT COMPLETED|36-Month to 48-Month||31
10075264|NCT02207569|11202479|FG000|STARTED|48-Month to 60-Month||113
10075265|NCT02207569|11202479|FG000|COMPLETED|48-Month to 60-Month||109
10075266|NCT02207569|11202479|FG000|NOT COMPLETED|48-Month to 60-Month||4
10075267|NCT02207608|11202485|FG000|STARTED|Overall Study||15
10075268|NCT02207608|11202486|FG001|STARTED|Overall Study||15
10075269|NCT02207608|11202485|FG000|COMPLETED|Overall Study||14
10075270|NCT02207608|11202486|FG001|COMPLETED|Overall Study||15
10075271|NCT02207608|11202485|FG000|NOT COMPLETED|Overall Study||1
10075272|NCT02207608|11202486|FG001|NOT COMPLETED|Overall Study||0
10075273|NCT02207621|11202495|FG000|STARTED|Overall Study||251
10075274|NCT02207621|11202496|FG001|STARTED|Overall Study||251
10075275|NCT02207621|11202497|FG002|STARTED|Overall Study||254
10075276|NCT02207621|11202495|FG000|COMPLETED|Overall Study||146
10075277|NCT02207621|11202496|FG001|COMPLETED|Overall Study||204
10075278|NCT02207621|11202497|FG002|COMPLETED|Overall Study||86
10075279|NCT02207621|11202495|FG000|NOT COMPLETED|Overall Study||105
10075280|NCT02207621|11202496|FG001|NOT COMPLETED|Overall Study||47
10075281|NCT02207621|11202497|FG002|NOT COMPLETED|Overall Study||168
10075282|NCT02207634|11202508|FG000|STARTED|Overall Study||990
10075283|NCT02207634|11202509|FG001|STARTED|Overall Study||984
10075284|NCT02207634|11202508|FG000|Received Treatment|Overall Study||990
10075285|NCT02207634|11202509|FG001|Received Treatment|Overall Study||983
10075286|NCT02207634|11202508|FG000|COMPLETED|Overall Study||968
10075287|NCT02207634|11202509|FG001|COMPLETED|Overall Study||953
10075288|NCT02207634|11202508|FG000|NOT COMPLETED|Overall Study||22
10075289|NCT02207634|11202509|FG001|NOT COMPLETED|Overall Study||31
10075290|NCT02207725|11202519|FG000|STARTED|Overall Study||9
10075291|NCT02207725|11202520|FG001|STARTED|Overall Study||25
10075292|NCT02207725|11202521|FG002|STARTED|Overall Study||9
10075293|NCT02207725|11202522|FG003|STARTED|Overall Study||25
10075294|NCT02207725|11202519|FG000|COMPLETED|Overall Study||9
10075295|NCT02207725|11202520|FG001|COMPLETED|Overall Study||24
10075296|NCT02207725|11202521|FG002|COMPLETED|Overall Study||8
10075297|NCT02207725|11202522|FG003|COMPLETED|Overall Study||24
10075298|NCT02207725|11202519|FG000|NOT COMPLETED|Overall Study||0
10075299|NCT02207725|11202520|FG001|NOT COMPLETED|Overall Study||1
10075300|NCT02207725|11202521|FG002|NOT COMPLETED|Overall Study||1
10075301|NCT02207725|11202522|FG003|NOT COMPLETED|Overall Study||1
10075302|NCT02207803|11202536|FG000|STARTED|Overall Study||125
10075303|NCT02207803|11202537|FG001|STARTED|Overall Study||125
10075304|NCT02207803|11202536|FG000|COMPLETED|Overall Study||110
10075305|NCT02207803|11202537|FG001|COMPLETED|Overall Study||108
10075306|NCT02207803|11202536|FG000|NOT COMPLETED|Overall Study||15
10075307|NCT02207803|11202537|FG001|NOT COMPLETED|Overall Study||17
10075308|NCT02207816|11202546|FG000|STARTED|Overall Study||1046
10075309|NCT02207816|11202547|FG001|STARTED|Overall Study||1010
10075310|NCT02207816|11202548|FG002|STARTED|Overall Study||1028
10075311|NCT02207816|11202546|FG000|COMPLETED|Overall Study||995
10075312|NCT02207816|11202547|FG001|COMPLETED|Overall Study||924
10075313|NCT02207816|11202548|FG002|COMPLETED|Overall Study||961
10075314|NCT02207816|11202546|FG000|NOT COMPLETED|Overall Study||51
10075315|NCT02207816|11202547|FG001|NOT COMPLETED|Overall Study||86
10075316|NCT02207816|11202548|FG002|NOT COMPLETED|Overall Study||67
10075317|NCT02207829|11202561|FG000|STARTED|Overall Study||509
10075318|NCT02207829|11202562|FG001|STARTED|Overall Study||508
10075319|NCT02207829|11202561|FG000|COMPLETED|Overall Study||467
10075320|NCT02207829|11202562|FG001|COMPLETED|Overall Study||474
10075321|NCT02207829|11202561|FG000|NOT COMPLETED|Overall Study||42
10075322|NCT02207829|11202562|FG001|NOT COMPLETED|Overall Study||34
10075323|NCT02207907|11202570|FG000|STARTED|Overall Study||124
10075324|NCT02207907|11202571|FG001|STARTED|Overall Study||123
10075325|NCT02207907|11202570|FG000|COMPLETED|Overall Study||113
10075326|NCT02207907|11202571|FG001|COMPLETED|Overall Study||115
10075327|NCT02207907|11202570|FG000|NOT COMPLETED|Overall Study||11
10075328|NCT02207907|11202571|FG001|NOT COMPLETED|Overall Study||8
10075329|NCT02207946|11202580|FG000|STARTED|Overall Study||19
10075330|NCT02207946|11202581|FG001|STARTED|Overall Study||11
10075331|NCT02207946|11202580|FG000|COMPLETED|Overall Study||18
10075332|NCT02207946|11202581|FG001|COMPLETED|Overall Study||10
10075333|NCT02207946|11202580|FG000|NOT COMPLETED|Overall Study||1
10075334|NCT02207946|11202581|FG001|NOT COMPLETED|Overall Study||1
10075335|NCT02207972|11202590|FG000|STARTED|Overall Study||22
10075336|NCT02207972|11202591|FG001|STARTED|Overall Study||24
10075337|NCT02207972|11202590|FG000|COMPLETED|Overall Study||22
10075338|NCT02207972|11202591|FG001|COMPLETED|Overall Study||24
10075339|NCT02207972|11202590|FG000|NOT COMPLETED|Overall Study||0
10075340|NCT02207972|11202591|FG001|NOT COMPLETED|Overall Study||0
10075341|NCT02208037|11202601|FG000|STARTED|Overall Study||93
10075342|NCT02208037|11202602|FG001|STARTED|Overall Study||93
10075343|NCT02208037|11202603|FG002|STARTED|Overall Study||93
10075344|NCT02208037|11202601|FG000|COMPLETED|Overall Study||89
10075345|NCT02208037|11202602|FG001|COMPLETED|Overall Study||92
10075346|NCT02208037|11202603|FG002|COMPLETED|Overall Study||92
10075347|NCT02208037|11202601|FG000|NOT COMPLETED|Overall Study||4
10075348|NCT02208037|11202602|FG001|NOT COMPLETED|Overall Study||1
10075349|NCT02208037|11202603|FG002|NOT COMPLETED|Overall Study||1
10075350|NCT02208050|11202613|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36
10075351|NCT02208050|11202614|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28
10075352|NCT02208050|11202613|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36
10075353|NCT02208050|11202614|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28
10075354|NCT02208050|11202613|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
10075355|NCT02208050|11202614|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
10075356|NCT02208050|11202613|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36
10075357|NCT02208050|11202614|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28
10075358|NCT02208050|11202613|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
10075359|NCT02208050|11202614|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
10075360|NCT02208050|11202613|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
10075361|NCT02208050|11202614|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
10075362|NCT02208050|11202613|FG000|STARTED|Washout Period 1: 2 Weeks||36
10075363|NCT02208050|11202614|FG001|STARTED|Washout Period 1: 2 Weeks||28
10075364|NCT02208050|11202613|FG000|COMPLETED|Washout Period 1: 2 Weeks||35
10075365|NCT02208050|11202614|FG001|COMPLETED|Washout Period 1: 2 Weeks||28
10075366|NCT02208050|11202613|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1
10075367|NCT02208050|11202614|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0
10075368|NCT02208050|11202613|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35
10075369|NCT02208050|11202614|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28
10075370|NCT02208050|11202613|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
10075371|NCT02208050|11202614|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
10075372|NCT02208050|11202613|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
10075373|NCT02208050|11202614|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
10075374|NCT02208050|11202613|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33
10075375|NCT02208050|11202614|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28
10075376|NCT02208050|11202613|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
10075377|NCT02208050|11202614|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
10075378|NCT02208050|11202613|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
10075379|NCT02208050|11202614|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
10075380|NCT02208063|11202636|FG000|STARTED|Overall Study||60
10075381|NCT02208063|11202637|FG001|STARTED|Overall Study||61
10075382|NCT02208063|11202636|FG000|Randomized and Treated|Overall Study||58
10075383|NCT02208063|11202637|FG001|Randomized and Treated|Overall Study||60
10075384|NCT02208063|11202636|FG000|Microbiological All Treated|Overall Study||47
10075385|NCT02208063|11202637|FG001|Microbiological All Treated|Overall Study||52
10075386|NCT02208063|11202636|FG000|COMPLETED|Overall Study||48
10075387|NCT02208063|11202637|FG001|COMPLETED|Overall Study||50
10075388|NCT02208063|11202636|FG000|NOT COMPLETED|Overall Study||12
10075389|NCT02208063|11202637|FG001|NOT COMPLETED|Overall Study||11
10075390|NCT02208089|11202645|FG000|STARTED|Overall Study||47
10075391|NCT02208089|11202646|FG001|STARTED|Overall Study||47
10075392|NCT02208089|11202645|FG000|COMPLETED|Overall Study||40
10075393|NCT02208089|11202646|FG001|COMPLETED|Overall Study||47
10075394|NCT02208089|11202645|FG000|NOT COMPLETED|Overall Study||7
10075395|NCT02208089|11202646|FG001|NOT COMPLETED|Overall Study||0
10075396|NCT02208297|11202655|FG000|STARTED|Overall Study||163
10075397|NCT02208297|11202656|FG001|STARTED|Overall Study||163
10075398|NCT02208297|11202655|FG000|COMPLETED|Overall Study||141
10075399|NCT02208297|11202656|FG001|COMPLETED|Overall Study||107
10075400|NCT02208297|11202655|FG000|NOT COMPLETED|Overall Study||22
10075401|NCT02208297|11202656|FG001|NOT COMPLETED|Overall Study||56
10075402|NCT02208310|11202664|FG000|STARTED|Overall Study||6
10075403|NCT02208310|11202665|FG001|STARTED|Overall Study||5
10075404|NCT02208310|11202664|FG000|Day 180|Overall Study||0
10075405|NCT02208310|11202665|FG001|Day 180|Overall Study||1
10075406|NCT02208310|11202664|FG000|COMPLETED|Overall Study||0
10075407|NCT02208310|11202665|FG001|COMPLETED|Overall Study||0
10075408|NCT02208310|11202664|FG000|NOT COMPLETED|Overall Study||6
10075409|NCT02208310|11202665|FG001|NOT COMPLETED|Overall Study||5
10075410|NCT02208349|11202673|FG000|STARTED|Initial 6 Months||16
10075411|NCT02208349|11202674|FG001|STARTED|Initial 6 Months||9
10075412|NCT02208349|11202673|FG000|COMPLETED|Initial 6 Months||16
10075413|NCT02208349|11202674|FG001|COMPLETED|Initial 6 Months||9
10075414|NCT02208349|11202673|FG000|NOT COMPLETED|Initial 6 Months||0
10075415|NCT02208349|11202674|FG001|NOT COMPLETED|Initial 6 Months||0
10075416|NCT02208349|11202673|FG000|STARTED|Second 6 Months||11
10075417|NCT02208349|11202674|FG001|STARTED|Second 6 Months||7
10075418|NCT02208349|11202673|FG000|COMPLETED|Second 6 Months||11
10075419|NCT02208349|11202674|FG001|COMPLETED|Second 6 Months||7
10075420|NCT02208349|11202673|FG000|NOT COMPLETED|Second 6 Months||0
10075421|NCT02208349|11202674|FG001|NOT COMPLETED|Second 6 Months||0
10075422|NCT02208349|11202673|FG000|STARTED|Third 6 Month||6
10075423|NCT02208349|11202674|FG001|STARTED|Third 6 Month||3
10075424|NCT02208349|11202673|FG000|COMPLETED|Third 6 Month||6
10075425|NCT02208349|11202674|FG001|COMPLETED|Third 6 Month||3
10075426|NCT02208349|11202673|FG000|NOT COMPLETED|Third 6 Month||0
10075427|NCT02208349|11202674|FG001|NOT COMPLETED|Third 6 Month||0
10075428|NCT02208349|11202673|FG000|STARTED|Fourth 6 Month||14
10075429|NCT02208349|11202674|FG001|STARTED|Fourth 6 Month||2
10075430|NCT02208349|11202673|FG000|COMPLETED|Fourth 6 Month||14
10075431|NCT02208349|11202674|FG001|COMPLETED|Fourth 6 Month||2
10075432|NCT02208349|11202673|FG000|NOT COMPLETED|Fourth 6 Month||0
10075433|NCT02208349|11202674|FG001|NOT COMPLETED|Fourth 6 Month||0
10075434|NCT02208349|11202673|FG000|STARTED|Fifth 6 Month||7
10075435|NCT02208349|11202674|FG001|STARTED|Fifth 6 Month||2
10075436|NCT02208349|11202673|FG000|COMPLETED|Fifth 6 Month||7
10075437|NCT02208349|11202674|FG001|COMPLETED|Fifth 6 Month||2
10075438|NCT02208349|11202673|FG000|NOT COMPLETED|Fifth 6 Month||0
10075439|NCT02208349|11202674|FG001|NOT COMPLETED|Fifth 6 Month||0
10075440|NCT02208349|11202673|FG000|STARTED|Sixth 6 Month||3
10075441|NCT02208349|11202674|FG001|STARTED|Sixth 6 Month||2
10075442|NCT02208349|11202673|FG000|COMPLETED|Sixth 6 Month||3
10075443|NCT02208349|11202674|FG001|COMPLETED|Sixth 6 Month||2
10075444|NCT02208349|11202673|FG000|NOT COMPLETED|Sixth 6 Month||0
10075445|NCT02208349|11202674|FG001|NOT COMPLETED|Sixth 6 Month||0
10075446|NCT02208466|11202685|FG000|STARTED|Overall Study||9
10075447|NCT02208466|11202686|FG001|STARTED|Overall Study||10
10075448|NCT02208466|11202687|FG002|STARTED|Overall Study||8
10075449|NCT02208466|11202685|FG000|COMPLETED|Overall Study||9
10075450|NCT02208466|11202686|FG001|COMPLETED|Overall Study||10
10075451|NCT02208466|11202687|FG002|COMPLETED|Overall Study||8
10075452|NCT02208466|11202685|FG000|NOT COMPLETED|Overall Study||0
10075453|NCT02208466|11202686|FG001|NOT COMPLETED|Overall Study||0
10075454|NCT02208466|11202687|FG002|NOT COMPLETED|Overall Study||0
10190766|NCT03296163|11319869|FG001|COMPLETED|Monotherapy||74
10190767|NCT03296163|11319868|FG000|NOT COMPLETED|Monotherapy||139
10190768|NCT03296163|11319869|FG001|NOT COMPLETED|Monotherapy||146
10190769|NCT03296280|11319877|FG000|STARTED|Overall Study||73
10190770|NCT03296280|11319878|FG001|STARTED|Overall Study||43
10190771|NCT03296280|11319877|FG000|COMPLETED|Overall Study||67
10190772|NCT03296280|11319878|FG001|COMPLETED|Overall Study||36
10190773|NCT03296280|11319877|FG000|NOT COMPLETED|Overall Study||6
10190774|NCT03296280|11319878|FG001|NOT COMPLETED|Overall Study||7
10190775|NCT03296345|11319884|FG000|STARTED|Overall Study||62
10190776|NCT03296345|11319884|FG000|COMPLETED|Overall Study||62
10190777|NCT03296345|11319884|FG000|NOT COMPLETED|Overall Study||0
10190778|NCT03296527|11319892|FG000|STARTED|Overall Study||500
10190779|NCT03296527|11319893|FG001|STARTED|Overall Study||511
10190780|NCT03296527|11319892|FG000|Full Analysis Set|Overall Study||499
10190781|NCT03296527|11319893|FG001|Full Analysis Set|Overall Study||510
10190782|NCT03296527|11319892|FG000|COMPLETED|Overall Study||465
10190783|NCT03296527|11319893|FG001|COMPLETED|Overall Study||458
10190784|NCT03296527|11319892|FG000|NOT COMPLETED|Overall Study||35
10190785|NCT03296527|11319893|FG001|NOT COMPLETED|Overall Study||53
10190786|NCT03296566|11319902|FG000|STARTED|Overall Study||145
10190787|NCT03296566|11319903|FG001|STARTED|Overall Study||152
10190788|NCT03296566|11319902|FG000|COMPLETED|Overall Study||126
10190789|NCT03296566|11319903|FG001|COMPLETED|Overall Study||103
10190790|NCT03296566|11319902|FG000|NOT COMPLETED|Overall Study||19
10075455|NCT02208843|11202695|FG000|STARTED|Overall Study||60
10075456|NCT02208843|11202695|FG000|COMPLETED|Overall Study||0
10075457|NCT02208843|11202695|FG000|NOT COMPLETED|Overall Study||60
10075458|NCT02208999|11202701|FG000|STARTED|Overall Study||106
10075459|NCT02208999|11202701|FG000|COMPLETED|Overall Study||105
10075460|NCT02208999|11202701|FG000|NOT COMPLETED|Overall Study||1
10075461|NCT02209064|11202720|FG000|STARTED|Overall Study||25
10075462|NCT02209064|11202720|FG000|COMPLETED|Overall Study||25
10075463|NCT02209064|11202720|FG000|NOT COMPLETED|Overall Study||0
10075464|NCT02209181|11202729|FG000|STARTED|Overall Study||67
10075465|NCT02209181|11202730|FG001|STARTED|Overall Study||67
10075466|NCT02209181|11202731|FG002|STARTED|Overall Study||69
10075467|NCT02209181|11202732|FG003|STARTED|Overall Study||66
10075468|NCT02209181|11202729|FG000|COMPLETED|Overall Study||66
10075469|NCT02209181|11202730|FG001|COMPLETED|Overall Study||66
10075470|NCT02209181|11202731|FG002|COMPLETED|Overall Study||68
10075471|NCT02209181|11202732|FG003|COMPLETED|Overall Study||66
10075472|NCT02209181|11202729|FG000|NOT COMPLETED|Overall Study||1
10075473|NCT02209181|11202730|FG001|NOT COMPLETED|Overall Study||1
10075474|NCT02209181|11202731|FG002|NOT COMPLETED|Overall Study||1
10075475|NCT02209181|11202732|FG003|NOT COMPLETED|Overall Study||0
10075476|NCT02209259|11202745|FG000|STARTED|Overall Study||56
10075477|NCT02209259|11202746|FG001|STARTED|Overall Study||56
10075478|NCT02209259|11202747|FG002|STARTED|Overall Study||56
10075479|NCT02209259|11202745|FG000|COMPLETED|Overall Study||56
10075480|NCT02209259|11202746|FG001|COMPLETED|Overall Study||56
10075481|NCT02209259|11202747|FG002|COMPLETED|Overall Study||56
10075482|NCT02209259|11202745|FG000|NOT COMPLETED|Overall Study||0
10075483|NCT02209259|11202746|FG001|NOT COMPLETED|Overall Study||0
10075484|NCT02209259|11202747|FG002|NOT COMPLETED|Overall Study||0
10075485|NCT02209272|11202757|FG000|STARTED|Overall Study||32
10075486|NCT02209272|11202758|FG001|STARTED|Overall Study||36
10075487|NCT02209272|11202757|FG000|COMPLETED|Overall Study||32
10075488|NCT02209272|11202758|FG001|COMPLETED|Overall Study||36
10075489|NCT02209272|11202757|FG000|NOT COMPLETED|Overall Study||0
10075490|NCT02209272|11202758|FG001|NOT COMPLETED|Overall Study||0
10075491|NCT02209454|11202764|FG000|STARTED|First Period||13
10075492|NCT02209454|11202765|FG001|STARTED|First Period||13
10075493|NCT02209454|11202764|FG000|COMPLETED|First Period||13
10075494|NCT02209454|11202765|FG001|COMPLETED|First Period||13
10075495|NCT02209454|11202764|FG000|NOT COMPLETED|First Period||0
10075496|NCT02209454|11202765|FG001|NOT COMPLETED|First Period||0
10075497|NCT02209454|11202764|FG000|STARTED|Washout Period a Minimum of a 7 Day||13
10075498|NCT02209454|11202765|FG001|STARTED|Washout Period a Minimum of a 7 Day||13
10075499|NCT02209454|11202764|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13
10075500|NCT02209454|11202765|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13
10075501|NCT02209454|11202764|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
10075502|NCT02209454|11202765|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
10075503|NCT02209454|11202764|FG000|STARTED|Second Period||13
10075504|NCT02209454|11202765|FG001|STARTED|Second Period||13
10075505|NCT02209454|11202764|FG000|COMPLETED|Second Period||12
10075506|NCT02209454|11202765|FG001|COMPLETED|Second Period||13
10075507|NCT02209454|11202764|FG000|NOT COMPLETED|Second Period||1
10075508|NCT02209454|11202765|FG001|NOT COMPLETED|Second Period||0
10075509|NCT02209506|11202776|FG000|STARTED|Overall Study||3
10075510|NCT02209506|11202777|FG001|STARTED|Overall Study||6
10075511|NCT02209506|11202778|FG002|STARTED|Overall Study||6
10075512|NCT02209506|11202779|FG003|STARTED|Overall Study||2
10075513|NCT02209506|11202780|FG004|STARTED|Overall Study||6
10075514|NCT02209506|11202776|FG000|COMPLETED|Overall Study||3
10075515|NCT02209506|11202777|FG001|COMPLETED|Overall Study||6
10075516|NCT02209506|11202778|FG002|COMPLETED|Overall Study||6
10075517|NCT02209506|11202779|FG003|COMPLETED|Overall Study||2
10075518|NCT02209506|11202780|FG004|COMPLETED|Overall Study||5
10075519|NCT02209506|11202776|FG000|NOT COMPLETED|Overall Study||0
10075520|NCT02209506|11202777|FG001|NOT COMPLETED|Overall Study||0
10075521|NCT02209506|11202778|FG002|NOT COMPLETED|Overall Study||0
10075522|NCT02209506|11202779|FG003|NOT COMPLETED|Overall Study||0
10075523|NCT02209506|11202780|FG004|NOT COMPLETED|Overall Study||1
10075524|NCT02209519|11202797|FG000|STARTED|Overall Study||107
10075525|NCT02209519|11202798|FG001|STARTED|Overall Study||107
10075526|NCT02209519|11202797|FG000|COMPLETED|Overall Study||107
10075527|NCT02209519|11202798|FG001|COMPLETED|Overall Study||107
10075528|NCT02209519|11202797|FG000|NOT COMPLETED|Overall Study||0
10075529|NCT02209519|11202798|FG001|NOT COMPLETED|Overall Study||0
10075530|NCT02209532|11202807|FG000|STARTED|Overall Study||90
10075531|NCT02209532|11202808|FG001|STARTED|Overall Study||90
10075532|NCT02209532|11202807|FG000|COMPLETED|Overall Study||87
10075533|NCT02209532|11202808|FG001|COMPLETED|Overall Study||89
10075534|NCT02209532|11202807|FG000|NOT COMPLETED|Overall Study||3
10075535|NCT02209532|11202808|FG001|NOT COMPLETED|Overall Study||1
10075536|NCT02209597|11202815|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74
10075537|NCT02209597|11202815|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
10075538|NCT02209597|11202815|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
10075539|NCT02209597|11202815|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
10075540|NCT02209597|11202815|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
10075541|NCT02209597|11202815|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
10075542|NCT02209597|11202815|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
10075543|NCT02209597|11202815|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
10075544|NCT02209597|11202815|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
10075545|NCT02209597|11202815|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
10075546|NCT02209597|11202815|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
10075547|NCT02209597|11202815|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
10075548|NCT02209610|11202827|FG000|STARTED|Overall Study||16
10075549|NCT02209610|11202828|FG001|STARTED|Overall Study||16
10190791|NCT03296566|11319903|FG001|NOT COMPLETED|Overall Study||49
10190792|NCT03296787|11319913|FG000|STARTED|Overall Study||8
10190793|NCT03296787|11319914|FG001|STARTED|Overall Study||8
10190794|NCT03296787|11319915|FG002|STARTED|Overall Study||9
10190795|NCT03296787|11319916|FG003|STARTED|Overall Study||7
10190796|NCT03296787|11319913|FG000|COMPLETED|Overall Study||8
10190797|NCT03296787|11319914|FG001|COMPLETED|Overall Study||8
10190798|NCT03296787|11319915|FG002|COMPLETED|Overall Study||9
10190799|NCT03296787|11319916|FG003|COMPLETED|Overall Study||7
10190800|NCT03296787|11319913|FG000|NOT COMPLETED|Overall Study||0
10190801|NCT03296787|11319914|FG001|NOT COMPLETED|Overall Study||0
10190802|NCT03296787|11319915|FG002|NOT COMPLETED|Overall Study||0
10190803|NCT03296787|11319916|FG003|NOT COMPLETED|Overall Study||0
10190804|NCT03296800|11319930|FG000|STARTED|Overall Study||16
10190805|NCT03296800|11319931|FG001|STARTED|Overall Study||16
10190806|NCT03296800|11319932|FG002|STARTED|Overall Study||16
10190807|NCT03296800|11319930|FG000|COMPLETED|Overall Study||16
10190808|NCT03296800|11319931|FG001|COMPLETED|Overall Study||16
10190809|NCT03296800|11319932|FG002|COMPLETED|Overall Study||16
10190810|NCT03296800|11319930|FG000|NOT COMPLETED|Overall Study||0
10190811|NCT03296800|11319931|FG001|NOT COMPLETED|Overall Study||0
10190812|NCT03296800|11319932|FG002|NOT COMPLETED|Overall Study||0
10190813|NCT03297021|11319958|FG000|STARTED|Overall Study||48
10190814|NCT03297021|11319959|FG001|STARTED|Overall Study||46
10190815|NCT03297021|11319960|FG002|STARTED|Overall Study||47
10190816|NCT03297021|11319958|FG000|COMPLETED|Overall Study||43
10190817|NCT03297021|11319959|FG001|COMPLETED|Overall Study||42
10190818|NCT03297021|11319960|FG002|COMPLETED|Overall Study||43
10190819|NCT03297021|11319958|FG000|NOT COMPLETED|Overall Study||5
10190820|NCT03297021|11319959|FG001|NOT COMPLETED|Overall Study||4
10190821|NCT03297021|11319960|FG002|NOT COMPLETED|Overall Study||4
10190822|NCT03297112|11319968|FG000|STARTED|Overall Study||12
10190823|NCT03297112|11319968|FG000|COMPLETED|Overall Study||12
10190824|NCT03297112|11319968|FG000|NOT COMPLETED|Overall Study||0
10190825|NCT03297216|11319974|FG000|STARTED|Overall Study||399
10190826|NCT03297216|11319975|FG001|STARTED|Overall Study||401
10075550|NCT02209610|11202827|FG000|COMPLETED|Overall Study||16
10075551|NCT02209610|11202828|FG001|COMPLETED|Overall Study||16
10075552|NCT02209610|11202827|FG000|NOT COMPLETED|Overall Study||0
10075553|NCT02209610|11202828|FG001|NOT COMPLETED|Overall Study||0
10075554|NCT02209766|11202839|FG000|STARTED|Overall Study||6
10075555|NCT02209766|11202840|FG001|STARTED|Overall Study||3
10075556|NCT02209766|11202841|FG002|STARTED|Overall Study||6
10075557|NCT02209766|11202842|FG003|STARTED|Overall Study||3
10190827|NCT03297216|11319974|FG000|Discontinued Intervention|Overall Study||5
10190828|NCT03297216|11319975|FG001|Discontinued Intervention|Overall Study||4
10190829|NCT03297216|11319974|FG000|Infants Born During Study|Overall Study||399
10190830|NCT03297216|11319975|FG001|Infants Born During Study|Overall Study||401
10075558|NCT02209766|11202843|FG004|STARTED|Overall Study||6
10075559|NCT02209766|11202839|FG000|COMPLETED|Overall Study||6
10075560|NCT02209766|11202840|FG001|COMPLETED|Overall Study||3
10075561|NCT02209766|11202841|FG002|COMPLETED|Overall Study||6
10075562|NCT02209766|11202842|FG003|COMPLETED|Overall Study||2
10075563|NCT02209766|11202843|FG004|COMPLETED|Overall Study||6
10075564|NCT02209766|11202839|FG000|NOT COMPLETED|Overall Study||0
10075565|NCT02209766|11202840|FG001|NOT COMPLETED|Overall Study||0
10075566|NCT02209766|11202841|FG002|NOT COMPLETED|Overall Study||0
10075567|NCT02209766|11202842|FG003|NOT COMPLETED|Overall Study||1
10075568|NCT02209766|11202843|FG004|NOT COMPLETED|Overall Study||0
10075569|NCT02209948|11202855|FG000|STARTED|Overall Study||80
10075570|NCT02209948|11202856|FG001|STARTED|Overall Study||79
10075571|NCT02209948|11202855|FG000|Recieved Alocated Intervention|Overall Study||80
10075572|NCT02209948|11202856|FG001|Recieved Alocated Intervention|Overall Study||79
10075573|NCT02209948|11202855|FG000|Lost to Follow up|Overall Study||0
10075574|NCT02209948|11202856|FG001|Lost to Follow up|Overall Study||1
10075575|NCT02209948|11202855|FG000|Discontinued Due to Progression|Overall Study||31
10075576|NCT02209948|11202856|FG001|Discontinued Due to Progression|Overall Study||39
10075577|NCT02209948|11202855|FG000|COMPLETED|Overall Study||80
10075578|NCT02209948|11202856|FG001|COMPLETED|Overall Study||79
10075579|NCT02209948|11202855|FG000|NOT COMPLETED|Overall Study||0
10075580|NCT02209948|11202856|FG001|NOT COMPLETED|Overall Study||0
10075581|NCT02210000|11202864|FG000|STARTED|Overall Study||57
10075582|NCT02210000|11202865|FG001|STARTED|Overall Study||57
10075583|NCT02210000|11202864|FG000|COMPLETED|Overall Study||38
10075584|NCT02210000|11202865|FG001|COMPLETED|Overall Study||36
10075585|NCT02210000|11202864|FG000|NOT COMPLETED|Overall Study||19
10075586|NCT02210000|11202865|FG001|NOT COMPLETED|Overall Study||21
10075587|NCT02210039|11202871|FG000|STARTED|Overall Study||6
10075588|NCT02210039|11202871|FG000|COMPLETED|Overall Study||6
10190831|NCT03297216|11319974|FG000|COMPLETED|Overall Study||396
10190832|NCT03297216|11319975|FG001|COMPLETED|Overall Study||396
10190833|NCT03297216|11319974|FG000|NOT COMPLETED|Overall Study||3
10190834|NCT03297216|11319975|FG001|NOT COMPLETED|Overall Study||5
10190835|NCT03297294|11319990|FG000|STARTED|Double-Blind Treatment Period (DB)||70
10190836|NCT03297294|11319991|FG001|STARTED|Double-Blind Treatment Period (DB)||67
10190837|NCT03297294|11319992|FG002|STARTED|Double-Blind Treatment Period (DB)||0
10190838|NCT03297294|11319993|FG003|STARTED|Double-Blind Treatment Period (DB)||0
10190839|NCT03297294|11319994|FG004|STARTED|Double-Blind Treatment Period (DB)||0
10190840|NCT03297294|11319990|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32
10190841|NCT03297294|11319991|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
10190842|NCT03297294|11319992|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0
10190843|NCT03297294|11319993|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
10190844|NCT03297294|11319994|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
10190845|NCT03297294|11319990|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
10190846|NCT03297294|11319991|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
10190847|NCT03297294|11319992|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10190848|NCT03297294|11319993|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10190849|NCT03297294|11319994|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10190850|NCT03297294|11319990|FG000|STARTED|Treatment Withdrawal Period (TW)||0
10190851|NCT03297294|11319991|FG001|STARTED|Treatment Withdrawal Period (TW)||0
10190852|NCT03297294|11319992|FG002|STARTED|Treatment Withdrawal Period (TW)||14
10190853|NCT03297294|11319993|FG003|STARTED|Treatment Withdrawal Period (TW)||12
10190854|NCT03297294|11319994|FG004|STARTED|Treatment Withdrawal Period (TW)||27
10190855|NCT03297294|11319990|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
10190856|NCT03297294|11319991|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
10190857|NCT03297294|11319992|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14
10190858|NCT03297294|11319993|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11
10190859|NCT03297294|11319994|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27
10190860|NCT03297294|11319990|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10190861|NCT03297294|11319991|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10190862|NCT03297294|11319992|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10190863|NCT03297294|11319993|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
10190864|NCT03297294|11319994|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10190865|NCT03297398|11320009|FG000|STARTED|Overall Study||36
10190866|NCT03297398|11320010|FG001|STARTED|Overall Study||40
10190867|NCT03297398|11320011|FG002|STARTED|Overall Study||38
10190868|NCT03297398|11320009|FG000|COMPLETED|Overall Study||28
10190869|NCT03297398|11320010|FG001|COMPLETED|Overall Study||23
10190870|NCT03297398|11320011|FG002|COMPLETED|Overall Study||23
10190871|NCT03297398|11320009|FG000|NOT COMPLETED|Overall Study||8
10190872|NCT03297398|11320010|FG001|NOT COMPLETED|Overall Study||17
10190873|NCT03297398|11320011|FG002|NOT COMPLETED|Overall Study||15
10190874|NCT03297944|11320019|FG000|STARTED|Overall Study||15
10190875|NCT03297944|11320019|FG000|2ALP/PLC|Overall Study||15
10190876|NCT03297944|11320019|FG000|1ALP/PLC|Overall Study||15
10190877|NCT03297944|11320019|FG000|0.5ALP/PLC|Overall Study||15
10075589|NCT02210039|11202871|FG000|NOT COMPLETED|Overall Study||0
10075590|NCT02210052|11202875|FG000|STARTED|Overall Study||6
10075591|NCT02210052|11202875|FG000|COMPLETED|Overall Study||6
10075592|NCT02210052|11202875|FG000|NOT COMPLETED|Overall Study||0
10075593|NCT02210065|11202879|FG000|STARTED|Overall Study||1
10075594|NCT02210065|11202879|FG000|COMPLETED|Overall Study||1
10075595|NCT02210065|11202879|FG000|NOT COMPLETED|Overall Study||0
10075596|NCT02210091|11202885|FG000|STARTED|Overall Study||32
10075597|NCT02210091|11202886|FG001|STARTED|Overall Study||34
10075598|NCT02210091|11202885|FG000|COMPLETED|Overall Study||32
10075599|NCT02210091|11202886|FG001|COMPLETED|Overall Study||32
10075600|NCT02210091|11202885|FG000|NOT COMPLETED|Overall Study||0
10075601|NCT02210091|11202886|FG001|NOT COMPLETED|Overall Study||2
10075602|NCT02210195|11202910|FG000|STARTED|Overall Study||10
10075603|NCT02210195|11202911|FG001|STARTED|Overall Study||10
10075604|NCT02210195|11202910|FG000|COMPLETED|Overall Study||6
10075605|NCT02210195|11202911|FG001|COMPLETED|Overall Study||10
10075606|NCT02210195|11202910|FG000|NOT COMPLETED|Overall Study||4
10075607|NCT02210195|11202911|FG001|NOT COMPLETED|Overall Study||0
10075608|NCT02210208|11202917|FG000|STARTED|Period A (Graft Site)||25
10075609|NCT02210208|11202917|FG000|COMPLETED|Period A (Graft Site)||23
10075610|NCT02210208|11202917|FG000|NOT COMPLETED|Period A (Graft Site)||2
10075611|NCT02210208|11202917|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
10075612|NCT02210208|11202917|FG000|COMPLETED|Period B (Donor Site)||12
10075613|NCT02210208|11202917|FG000|NOT COMPLETED|Period B (Donor Site)||7
10075614|NCT02210221|11202923|FG000|STARTED|Overall Study||4559
10075615|NCT02210221|11202923|FG000|COMPLETED|Overall Study||4509
10075616|NCT02210221|11202923|FG000|NOT COMPLETED|Overall Study||50
10075617|NCT02210247|11202937|FG000|STARTED|Overall Study||12
10075618|NCT02210247|11202938|FG001|STARTED|Overall Study||12
10075619|NCT02210247|11202939|FG002|STARTED|Overall Study||12
10075620|NCT02210247|11202940|FG003|STARTED|Overall Study||12
10075621|NCT02210247|11202941|FG004|STARTED|Overall Study||12
10075622|NCT02210247|11202937|FG000|COMPLETED|Overall Study||12
10075623|NCT02210247|11202938|FG001|COMPLETED|Overall Study||12
10075624|NCT02210247|11202939|FG002|COMPLETED|Overall Study||12
10075625|NCT02210247|11202940|FG003|COMPLETED|Overall Study||12
10075626|NCT02210247|11202941|FG004|COMPLETED|Overall Study||12
10075627|NCT02210247|11202937|FG000|NOT COMPLETED|Overall Study||0
10075628|NCT02210247|11202938|FG001|NOT COMPLETED|Overall Study||0
10075629|NCT02210247|11202939|FG002|NOT COMPLETED|Overall Study||0
10075630|NCT02210247|11202940|FG003|NOT COMPLETED|Overall Study||0
10075631|NCT02210247|11202941|FG004|NOT COMPLETED|Overall Study||0
10075632|NCT02210286|11202958|FG000|STARTED|Overall Study||17
10075633|NCT02210286|11202958|FG000|COMPLETED|Overall Study||15
10075634|NCT02210286|11202958|FG000|NOT COMPLETED|Overall Study||2
10075635|NCT02210689|11202969|FG000|STARTED|Overall Study||242
10075636|NCT02210689|11202970|FG001|STARTED|Overall Study||240
10075637|NCT02210689|11202971|FG002|STARTED|Overall Study||122
10075638|NCT02210689|11202969|FG000|Safety Population|Overall Study||233
10075639|NCT02210689|11202970|FG001|Safety Population|Overall Study||236
10075640|NCT02210689|11202971|FG002|Safety Population|Overall Study||122
10075641|NCT02210689|11202969|FG000|mITT Population|Overall Study||199
10075642|NCT02210689|11202970|FG001|mITT Population|Overall Study||207
10075643|NCT02210689|11202971|FG002|mITT Population|Overall Study||107
10075644|NCT02210689|11202969|FG000|PP Population|Overall Study||164
10075645|NCT02210689|11202970|FG001|PP Population|Overall Study||169
10075646|NCT02210689|11202971|FG002|PP Population|Overall Study||84
10075647|NCT02210689|11202969|FG000|COMPLETED|Overall Study||190
10075648|NCT02210689|11202970|FG001|COMPLETED|Overall Study||193
10075649|NCT02210689|11202971|FG002|COMPLETED|Overall Study||99
10075650|NCT02210689|11202969|FG000|NOT COMPLETED|Overall Study||52
10075651|NCT02210689|11202970|FG001|NOT COMPLETED|Overall Study||47
10075652|NCT02210689|11202971|FG002|NOT COMPLETED|Overall Study||23
10075653|NCT02210780|11202981|FG000|STARTED|Overall Study||97
10075654|NCT02210780|11202982|FG001|STARTED|Overall Study||97
10075655|NCT02210780|11202981|FG000|COMPLETED|Overall Study||92
10075656|NCT02210780|11202982|FG001|COMPLETED|Overall Study||89
10075657|NCT02210780|11202981|FG000|NOT COMPLETED|Overall Study||5
10075658|NCT02210780|11202982|FG001|NOT COMPLETED|Overall Study||8
10075659|NCT02211014|11202990|FG000|STARTED|Overall Study||13
10075660|NCT02211014|11202991|FG001|STARTED|Overall Study||14
10075661|NCT02211014|11202990|FG000|COMPLETED|Overall Study||11
10075662|NCT02211014|11202991|FG001|COMPLETED|Overall Study||8
10075663|NCT02211014|11202990|FG000|NOT COMPLETED|Overall Study||2
10075664|NCT02211014|11202991|FG001|NOT COMPLETED|Overall Study||6
10075665|NCT02211261|11203024|FG000|STARTED|Overall Study||9
10075666|NCT02211261|11203025|FG001|STARTED|Overall Study||6
10075667|NCT02211261|11203026|FG002|STARTED|Overall Study||6
10075668|NCT02211261|11203027|FG003|STARTED|Overall Study||6
10075669|NCT02211261|11203028|FG004|STARTED|Overall Study||9
10075670|NCT02211261|11203029|FG005|STARTED|Overall Study||2
10075671|NCT02211261|11203030|FG006|STARTED|Overall Study||6
10075672|NCT02211261|11203031|FG007|STARTED|Overall Study||8
10075673|NCT02211261|11203032|FG008|STARTED|Overall Study||8
10075674|NCT02211261|11203033|FG009|STARTED|Overall Study||16
10075675|NCT02211261|11203034|FG010|STARTED|Overall Study||8
10075676|NCT02211261|11203024|FG000|COMPLETED|Overall Study||9
10075677|NCT02211261|11203025|FG001|COMPLETED|Overall Study||6
10075678|NCT02211261|11203026|FG002|COMPLETED|Overall Study||5
10075679|NCT02211261|11203027|FG003|COMPLETED|Overall Study||6
10075680|NCT02211261|11203028|FG004|COMPLETED|Overall Study||7
10075681|NCT02211261|11203029|FG005|COMPLETED|Overall Study||1
10075682|NCT02211261|11203030|FG006|COMPLETED|Overall Study||6
10075683|NCT02211261|11203031|FG007|COMPLETED|Overall Study||7
10075684|NCT02211261|11203032|FG008|COMPLETED|Overall Study||8
10075685|NCT02211261|11203033|FG009|COMPLETED|Overall Study||14
10075686|NCT02211261|11203034|FG010|COMPLETED|Overall Study||8
10075687|NCT02211261|11203024|FG000|NOT COMPLETED|Overall Study||0
10190878|NCT03297944|11320019|FG000|ZOL/PLC|Overall Study||15
10190879|NCT03297944|11320019|FG000|PLC/PLC|Overall Study||15
10190880|NCT03297944|11320019|FG000|PLC/ALP|Overall Study||15
10190881|NCT03297944|11320019|FG000|COMPLETED|Overall Study||15
10190882|NCT03297944|11320019|FG000|NOT COMPLETED|Overall Study||0
10190883|NCT03298035|11320030|FG000|STARTED|Overall Study||10
10190884|NCT03298035|11320031|FG001|STARTED|Overall Study||9
10190885|NCT03298035|11320030|FG000|Received Intervention|Overall Study||9
10190886|NCT03298035|11320031|FG001|Received Intervention|Overall Study||7
10190887|NCT03298035|11320030|FG000|COMPLETED|Overall Study||9
10190888|NCT03298035|11320031|FG001|COMPLETED|Overall Study||7
10190889|NCT03298035|11320030|FG000|NOT COMPLETED|Overall Study||1
10190890|NCT03298035|11320031|FG001|NOT COMPLETED|Overall Study||2
10190891|NCT03298048|11320040|FG000|STARTED|Overall Study||4
10190892|NCT03298048|11320041|FG001|STARTED|Overall Study||3
10190893|NCT03298048|11320042|FG002|STARTED|Overall Study||8
10190894|NCT03298048|11320040|FG000|COMPLETED|Overall Study||4
10190895|NCT03298048|11320041|FG001|COMPLETED|Overall Study||3
10190896|NCT03298048|11320042|FG002|COMPLETED|Overall Study||8
10190897|NCT03298048|11320040|FG000|NOT COMPLETED|Overall Study||0
10190898|NCT03298048|11320041|FG001|NOT COMPLETED|Overall Study||0
10075688|NCT02211261|11203025|FG001|NOT COMPLETED|Overall Study||0
10075689|NCT02211261|11203026|FG002|NOT COMPLETED|Overall Study||1
10075690|NCT02211261|11203027|FG003|NOT COMPLETED|Overall Study||0
10075691|NCT02211261|11203028|FG004|NOT COMPLETED|Overall Study||2
10075692|NCT02211261|11203029|FG005|NOT COMPLETED|Overall Study||1
10075693|NCT02211261|11203030|FG006|NOT COMPLETED|Overall Study||0
10075694|NCT02211261|11203031|FG007|NOT COMPLETED|Overall Study||1
10075695|NCT02211261|11203032|FG008|NOT COMPLETED|Overall Study||0
10075696|NCT02211261|11203033|FG009|NOT COMPLETED|Overall Study||2
10075697|NCT02211261|11203034|FG010|NOT COMPLETED|Overall Study||0
10075698|NCT02211313|11203069|FG000|STARTED|Overall Study||18
10075699|NCT02211313|11203070|FG001|STARTED|Overall Study||23
10075700|NCT02211313|11203069|FG000|COMPLETED|Overall Study||12
10075701|NCT02211313|11203070|FG001|COMPLETED|Overall Study||20
10075702|NCT02211313|11203069|FG000|NOT COMPLETED|Overall Study||6
10075703|NCT02211313|11203070|FG001|NOT COMPLETED|Overall Study||3
10075704|NCT02211456|11203076|FG000|STARTED|Overall Study||15
10075705|NCT02211456|11203076|FG000|COMPLETED|Overall Study||15
10075706|NCT02211456|11203076|FG000|NOT COMPLETED|Overall Study||0
10075707|NCT02211495|11203082|FG000|STARTED|Overall Study||4
10075708|NCT02211495|11203083|FG001|STARTED|Overall Study||4
10075709|NCT02211495|11203082|FG000|COMPLETED|Overall Study||4
10075710|NCT02211495|11203083|FG001|COMPLETED|Overall Study||4
10075711|NCT02211495|11203082|FG000|NOT COMPLETED|Overall Study||0
10075712|NCT02211495|11203083|FG001|NOT COMPLETED|Overall Study||0
10075713|NCT02211534|11203095|FG000|STARTED|Overall Study||24
10075714|NCT02211534|11203096|FG001|STARTED|Overall Study||11
10075715|NCT02211534|11203095|FG000|COMPLETED|Overall Study||11
10075716|NCT02211534|11203096|FG001|COMPLETED|Overall Study||6
10075717|NCT02211534|11203095|FG000|NOT COMPLETED|Overall Study||13
10075718|NCT02211534|11203096|FG001|NOT COMPLETED|Overall Study||5
10075719|NCT02211638|11203102|FG000|STARTED|Overall Study||18113
10075720|NCT02211638|11203102|FG000|COMPLETED|Overall Study||17130
10075721|NCT02211638|11203102|FG000|NOT COMPLETED|Overall Study||983
10075722|NCT02212028|11203108|FG000|STARTED|Overall Study||26
10075723|NCT02212028|11203109|FG001|STARTED|Overall Study||26
10075724|NCT02212028|11203108|FG000|COMPLETED|Overall Study||26
10075725|NCT02212028|11203109|FG001|COMPLETED|Overall Study||26
10075726|NCT02212028|11203108|FG000|NOT COMPLETED|Overall Study||0
10075727|NCT02212028|11203109|FG001|NOT COMPLETED|Overall Study||0
10075728|NCT02212106|11203117|FG000|STARTED|Overall Study||302
10075729|NCT02212106|11203118|FG001|STARTED|Overall Study||100
10075730|NCT02212106|11203117|FG000|COMPLETED|Overall Study||292
10075731|NCT02212106|11203118|FG001|COMPLETED|Overall Study||96
10075732|NCT02212106|11203117|FG000|NOT COMPLETED|Overall Study||10
10075733|NCT02212106|11203118|FG001|NOT COMPLETED|Overall Study||4
10075734|NCT02212197|11203128|FG000|STARTED|Overall Study||19
10075735|NCT02212197|11203129|FG001|STARTED|Overall Study||15
10075736|NCT02212197|11203130|FG002|STARTED|Overall Study||17
10075737|NCT02212197|11203128|FG000|COMPLETED|Overall Study||18
10075738|NCT02212197|11203129|FG001|COMPLETED|Overall Study||15
10075739|NCT02212197|11203130|FG002|COMPLETED|Overall Study||17
10075740|NCT02212197|11203128|FG000|NOT COMPLETED|Overall Study||1
10075741|NCT02212197|11203129|FG001|NOT COMPLETED|Overall Study||0
10075742|NCT02212197|11203130|FG002|NOT COMPLETED|Overall Study||0
10075743|NCT02212301|11203138|FG000|STARTED|Period 1||21
10190899|NCT03298048|11320042|FG002|NOT COMPLETED|Overall Study||0
10190900|NCT03298113|11320052|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
10190901|NCT03298113|11320053|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
10190902|NCT03298113|11320052|FG000|IAD 1A|Overall Study||3
10190903|NCT03298113|11320053|FG001|IAD 1A|Overall Study||4
10190904|NCT03298113|11320052|FG000|IAD 2A|Overall Study||7
10190905|NCT03298113|11320053|FG001|IAD 2A|Overall Study||6
10190906|NCT03298113|11320052|FG000|COMPLETED|Overall Study||10
10190907|NCT03298113|11320053|FG001|COMPLETED|Overall Study||10
10190908|NCT03298113|11320052|FG000|NOT COMPLETED|Overall Study||0
10190909|NCT03298113|11320053|FG001|NOT COMPLETED|Overall Study||0
10190910|NCT03298412|11320059|FG000|STARTED|Run-in Period||10
10190911|NCT03298412|11320059|FG000|COMPLETED|Run-in Period||1
10190912|NCT03298412|11320059|FG000|NOT COMPLETED|Run-in Period||9
10190913|NCT03298412|11320059|FG000|STARTED|Treatment Period||1
10190914|NCT03298412|11320059|FG000|COMPLETED|Treatment Period||1
10190915|NCT03298412|11320059|FG000|NOT COMPLETED|Treatment Period||0
10190916|NCT03298841|11320065|FG000|STARTED|Overall Study||25
10190917|NCT03298841|11320066|FG001|STARTED|Overall Study||25
10190918|NCT03298841|11320065|FG000|COMPLETED|Overall Study||25
10190919|NCT03298841|11320066|FG001|COMPLETED|Overall Study||25
10190920|NCT03298841|11320065|FG000|NOT COMPLETED|Overall Study||0
10190921|NCT03298841|11320066|FG001|NOT COMPLETED|Overall Study||0
10190922|NCT03298880|11320073|FG000|STARTED|Overall Study||75
10190923|NCT03298880|11320073|FG000|COMPLETED|Overall Study||75
10190924|NCT03298880|11320073|FG000|NOT COMPLETED|Overall Study||0
10190925|NCT03299101|11320084|FG000|STARTED|Overall Study||35
10190926|NCT03299101|11320084|FG000|COMPLETED|Overall Study||25
10190927|NCT03299101|11320084|FG000|NOT COMPLETED|Overall Study||10
10190928|NCT03299244|11320090|FG000|STARTED|Overall Study||317
10190929|NCT03299244|11320091|FG001|STARTED|Overall Study||320
10190930|NCT03299244|11320090|FG000|Received Treatment|Overall Study||315
10190931|NCT03299244|11320091|FG001|Received Treatment|Overall Study||318
10190932|NCT03299244|11320090|FG000|COMPLETED|Overall Study||270
10190933|NCT03299244|11320091|FG001|COMPLETED|Overall Study||282
10190934|NCT03299244|11320090|FG000|NOT COMPLETED|Overall Study||47
10190935|NCT03299244|11320091|FG001|NOT COMPLETED|Overall Study||38
10190936|NCT03299686|11320100|FG000|STARTED|Treatment Epoch||70
10190937|NCT03299686|11320101|FG001|STARTED|Treatment Epoch||48
10190938|NCT03299686|11320100|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
10190939|NCT03299686|11320101|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
10190940|NCT03299686|11320100|FG000|COMPLETED|Treatment Epoch||59
10190941|NCT03299686|11320101|FG001|COMPLETED|Treatment Epoch||44
10190942|NCT03299686|11320100|FG000|NOT COMPLETED|Treatment Epoch||11
10075744|NCT02212301|11203139|FG001|STARTED|Period 1||22
10075745|NCT02212301|11203138|FG000|COMPLETED|Period 1||21
10075746|NCT02212301|11203139|FG001|COMPLETED|Period 1||21
10190943|NCT03299686|11320101|FG001|NOT COMPLETED|Treatment Epoch||4
10075747|NCT02212301|11203138|FG000|NOT COMPLETED|Period 1||0
10075748|NCT02212301|11203139|FG001|NOT COMPLETED|Period 1||1
10075749|NCT02212301|11203138|FG000|STARTED|Period 2||21
10075750|NCT02212301|11203139|FG001|STARTED|Period 2||21
10075751|NCT02212301|11203138|FG000|COMPLETED|Period 2||21
10075752|NCT02212301|11203139|FG001|COMPLETED|Period 2||21
10075753|NCT02212301|11203138|FG000|NOT COMPLETED|Period 2||0
10075754|NCT02212301|11203139|FG001|NOT COMPLETED|Period 2||0
10075755|NCT02212379|11203146|FG000|STARTED|From Baseline to Week 48||165
10075756|NCT02212379|11203146|FG000|COMPLETED|From Baseline to Week 48||156
10075757|NCT02212379|11203146|FG000|NOT COMPLETED|From Baseline to Week 48||9
10075758|NCT02212379|11203146|FG000|STARTED|From Week 48 to Week 96||156
10075759|NCT02212379|11203146|FG000|COMPLETED|From Week 48 to Week 96||152
10075760|NCT02212379|11203146|FG000|NOT COMPLETED|From Week 48 to Week 96||4
10075761|NCT02212457|11203159|FG000|STARTED|Overall Study||228
10075762|NCT02212457|11203160|FG001|STARTED|Overall Study||232
10075763|NCT02212457|11203161|FG002|STARTED|Overall Study||157
10075764|NCT02212457|11203162|FG003|STARTED|Overall Study||134
10075765|NCT02212457|11203163|FG004|STARTED|Overall Study||152
10075766|NCT02212457|11203164|FG005|STARTED|Overall Study||160
10075767|NCT02212457|11203159|FG000|COMPLETED|Overall Study||209
10075768|NCT02212457|11203160|FG001|COMPLETED|Overall Study||211
10075769|NCT02212457|11203161|FG002|COMPLETED|Overall Study||141
10075770|NCT02212457|11203162|FG003|COMPLETED|Overall Study||123
10075771|NCT02212457|11203163|FG004|COMPLETED|Overall Study||137
10075772|NCT02212457|11203164|FG005|COMPLETED|Overall Study||147
10075773|NCT02212457|11203159|FG000|NOT COMPLETED|Overall Study||19
10075774|NCT02212457|11203160|FG001|NOT COMPLETED|Overall Study||21
10075775|NCT02212457|11203161|FG002|NOT COMPLETED|Overall Study||16
10075776|NCT02212457|11203162|FG003|NOT COMPLETED|Overall Study||11
10075777|NCT02212457|11203163|FG004|NOT COMPLETED|Overall Study||15
10075778|NCT02212457|11203164|FG005|NOT COMPLETED|Overall Study||13
10075779|NCT02212587|11203185|FG000|STARTED|Overall Study||10
10075780|NCT02212587|11203185|FG000|COMPLETED|Overall Study||9
10075781|NCT02212587|11203185|FG000|NOT COMPLETED|Overall Study||1
10075782|NCT02212678|11203189|FG000|STARTED|Overall Study||8
10075783|NCT02212678|11203189|FG000|COMPLETED|Overall Study||7
10075784|NCT02212678|11203189|FG000|NOT COMPLETED|Overall Study||1
10075785|NCT02212730|11203195|FG000|STARTED|Overall Study||6
10075786|NCT02212730|11203196|FG001|STARTED|Overall Study||4
10075787|NCT02212730|11203195|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4
10075788|NCT02212730|11203196|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0
10075789|NCT02212730|11203195|FG000|Underwent RCC|Overall Study||4
10075790|NCT02212730|11203196|FG001|Underwent RCC|Overall Study||3
10075791|NCT02212730|11203195|FG000|Received Post-RCC Pembrolizumab|Overall Study||1
10075792|NCT02212730|11203196|FG001|Received Post-RCC Pembrolizumab|Overall Study||1
10075793|NCT02212730|11203195|FG000|COMPLETED|Overall Study||4
10075794|NCT02212730|11203196|FG001|COMPLETED|Overall Study||3
10075795|NCT02212730|11203195|FG000|NOT COMPLETED|Overall Study||2
10075796|NCT02212730|11203196|FG001|NOT COMPLETED|Overall Study||1
10075797|NCT02212834|11203206|FG000|STARTED|Overall Study||33938
10075798|NCT02212834|11203207|FG001|STARTED|Overall Study||2506
10075799|NCT02212834|11203206|FG000|COMPLETED|Overall Study||33938
10075800|NCT02212834|11203207|FG001|COMPLETED|Overall Study||2506
10075801|NCT02212834|11203206|FG000|NOT COMPLETED|Overall Study||0
10075802|NCT02212834|11203207|FG001|NOT COMPLETED|Overall Study||0
10075803|NCT02212977|11203215|FG000|STARTED|Overall Study||55
10075804|NCT02212977|11203216|FG001|STARTED|Overall Study||54
10075805|NCT02212977|11203215|FG000|COMPLETED|Overall Study||50
10075806|NCT02212977|11203216|FG001|COMPLETED|Overall Study||48
10075807|NCT02212977|11203215|FG000|NOT COMPLETED|Overall Study||5
10075808|NCT02212977|11203216|FG001|NOT COMPLETED|Overall Study||6
10075809|NCT02213042|11203225|FG000|STARTED|Overall Study||17
10075810|NCT02213042|11203226|FG001|STARTED|Overall Study||15
10075811|NCT02213042|11203227|FG002|STARTED|Overall Study||10
10075812|NCT02213042|11203225|FG000|Total Deaths|Overall Study||11
10075813|NCT02213042|11203226|FG001|Total Deaths|Overall Study||9
10075814|NCT02213042|11203227|FG002|Total Deaths|Overall Study||6
10075815|NCT02213042|11203225|FG000|COMPLETED|Overall Study||0
10075816|NCT02213042|11203226|FG001|COMPLETED|Overall Study||0
10075817|NCT02213042|11203227|FG002|COMPLETED|Overall Study||0
10075818|NCT02213042|11203225|FG000|NOT COMPLETED|Overall Study||17
10075819|NCT02213042|11203226|FG001|NOT COMPLETED|Overall Study||15
10075820|NCT02213042|11203227|FG002|NOT COMPLETED|Overall Study||10
10075821|NCT02213055|11203239|FG000|STARTED|Overall Study||97
10075822|NCT02213055|11203240|FG001|STARTED|Overall Study||0
10075823|NCT02213055|11203239|FG000|COMPLETED|Overall Study||58
10075824|NCT02213055|11203240|FG001|COMPLETED|Overall Study||0
10075825|NCT02213055|11203239|FG000|NOT COMPLETED|Overall Study||39
10075826|NCT02213055|11203240|FG001|NOT COMPLETED|Overall Study||0
10075827|NCT02213068|11203249|FG000|STARTED|Overall Study||9
10075828|NCT02213068|11203250|FG001|STARTED|Overall Study||8
10075829|NCT02213068|11203251|FG002|STARTED|Overall Study||10
10075830|NCT02213068|11203249|FG000|COMPLETED|Overall Study||9
10075831|NCT02213068|11203250|FG001|COMPLETED|Overall Study||8
10075832|NCT02213068|11203251|FG002|COMPLETED|Overall Study||10
10075833|NCT02213068|11203249|FG000|NOT COMPLETED|Overall Study||0
10075834|NCT02213068|11203250|FG001|NOT COMPLETED|Overall Study||0
10075835|NCT02213068|11203251|FG002|NOT COMPLETED|Overall Study||0
10075836|NCT02213094|11203261|FG000|STARTED|Overall Study||5
10075837|NCT02213094|11203262|FG001|STARTED|Overall Study||5
10190944|NCT03299686|11320100|FG000|STARTED|Follow-up Epoch||59
10075838|NCT02213094|11203261|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
10075839|NCT02213094|11203262|FG001|COMPLETED|Overall Study||5
10075840|NCT02213094|11203261|FG000|NOT COMPLETED|Overall Study||1
10075841|NCT02213094|11203262|FG001|NOT COMPLETED|Overall Study||0
10075842|NCT02213133|11203271|FG000|STARTED|Overall Study||37
10075843|NCT02213133|11203272|FG001|STARTED|Overall Study||5
10075844|NCT02213133|11203273|FG002|STARTED|Overall Study||3
10075845|NCT02213133|11203271|FG000|Treated|Overall Study||33
10075846|NCT02213133|11203272|FG001|Treated|Overall Study||4
10075847|NCT02213133|11203273|FG002|Treated|Overall Study||1
10075848|NCT02213133|11203271|FG000|COMPLETED|Overall Study||0
10075849|NCT02213133|11203272|FG001|COMPLETED|Overall Study||0
10075850|NCT02213133|11203273|FG002|COMPLETED|Overall Study||0
10075851|NCT02213133|11203271|FG000|NOT COMPLETED|Overall Study||37
10075852|NCT02213133|11203272|FG001|NOT COMPLETED|Overall Study||5
10075853|NCT02213133|11203273|FG002|NOT COMPLETED|Overall Study||3
10075854|NCT02213198|11203284|FG000|STARTED|Baseline||306
10075855|NCT02213198|11203285|FG001|STARTED|Baseline||159
10075856|NCT02213198|11203284|FG000|COMPLETED|Baseline||218
10075857|NCT02213198|11203285|FG001|COMPLETED|Baseline||108
10075858|NCT02213198|11203284|FG000|NOT COMPLETED|Baseline||88
10075859|NCT02213198|11203285|FG001|NOT COMPLETED|Baseline||51
10075860|NCT02213198|11203284|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
10075861|NCT02213198|11203285|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
10075862|NCT02213198|11203284|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
10075863|NCT02213198|11203285|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
10075864|NCT02213198|11203284|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
10075865|NCT02213198|11203285|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
10075866|NCT02213198|11203284|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125
10075867|NCT02213198|11203285|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67
10075868|NCT02213198|11203284|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
10075869|NCT02213198|11203285|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
10075870|NCT02213198|11203284|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
10075871|NCT02213198|11203285|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
10075872|NCT02213250|11203291|FG000|STARTED|Overall Study||4
10190945|NCT03299686|11320101|FG001|STARTED|Follow-up Epoch||44
10190946|NCT03299686|11320100|FG000|COMPLETED|Follow-up Epoch||59
10190947|NCT03299686|11320101|FG001|COMPLETED|Follow-up Epoch||43
10190948|NCT03299686|11320100|FG000|NOT COMPLETED|Follow-up Epoch||0
10190949|NCT03299686|11320101|FG001|NOT COMPLETED|Follow-up Epoch||1
10190950|NCT03299881|11320109|FG000|STARTED|Overall Study||39
10190951|NCT03299881|11320110|FG001|STARTED|Overall Study||38
10190952|NCT03299881|11320109|FG000|COMPLETED|Overall Study||22
10190953|NCT03299881|11320110|FG001|COMPLETED|Overall Study||25
10190954|NCT03299881|11320109|FG000|NOT COMPLETED|Overall Study||17
10190955|NCT03299881|11320110|FG001|NOT COMPLETED|Overall Study||13
10190956|NCT03300050|11320121|FG000|STARTED|Overall Study||20
10190957|NCT03300050|11320122|FG001|STARTED|Overall Study||15
10190958|NCT03300050|11320123|FG002|STARTED|Overall Study||5
10190959|NCT03300050|11320124|FG003|STARTED|Overall Study||16
10190960|NCT03300050|11320125|FG004|STARTED|Overall Study||10
10190961|NCT03300050|11320121|FG000|Received Treatment|Overall Study||19
10190962|NCT03300050|11320122|FG001|Received Treatment|Overall Study||14
10190963|NCT03300050|11320123|FG002|Received Treatment|Overall Study||3
10190964|NCT03300050|11320124|FG003|Received Treatment|Overall Study||15
10190965|NCT03300050|11320125|FG004|Received Treatment|Overall Study||10
10190966|NCT03300050|11320121|FG000|Received All Scheduled Treatments|Overall Study||16
10190967|NCT03300050|11320122|FG001|Received All Scheduled Treatments|Overall Study||13
10190968|NCT03300050|11320123|FG002|Received All Scheduled Treatments|Overall Study||2
10190969|NCT03300050|11320124|FG003|Received All Scheduled Treatments|Overall Study||15
10190970|NCT03300050|11320125|FG004|Received All Scheduled Treatments|Overall Study||10
10190971|NCT03300050|11320121|FG000|COMPLETED|Overall Study||17
10190972|NCT03300050|11320122|FG001|COMPLETED|Overall Study||13
10190973|NCT03300050|11320123|FG002|COMPLETED|Overall Study||2
10190974|NCT03300050|11320124|FG003|COMPLETED|Overall Study||15
10190975|NCT03300050|11320125|FG004|COMPLETED|Overall Study||9
10190976|NCT03300050|11320121|FG000|NOT COMPLETED|Overall Study||3
10190977|NCT03300050|11320122|FG001|NOT COMPLETED|Overall Study||2
10190978|NCT03300050|11320123|FG002|NOT COMPLETED|Overall Study||3
10190979|NCT03300050|11320124|FG003|NOT COMPLETED|Overall Study||1
10190980|NCT03300050|11320125|FG004|NOT COMPLETED|Overall Study||1
10190981|NCT03300466|11320139|FG000|STARTED|Overall Study||10
10190982|NCT03300466|11320140|FG001|STARTED|Overall Study||10
10190983|NCT03300466|11320139|FG000|COMPLETED|Overall Study||9
10190984|NCT03300466|11320140|FG001|COMPLETED|Overall Study||10
10190985|NCT03300466|11320139|FG000|NOT COMPLETED|Overall Study||1
10190986|NCT03300466|11320140|FG001|NOT COMPLETED|Overall Study||0
10190987|NCT03300570|11320148|FG000|STARTED|Overall Study||13
10190988|NCT03300570|11320149|FG001|STARTED|Overall Study||14
10190989|NCT03300570|11320148|FG000|COMPLETED|Overall Study||11
10190990|NCT03300570|11320149|FG001|COMPLETED|Overall Study||13
10190991|NCT03300570|11320148|FG000|NOT COMPLETED|Overall Study||2
10190992|NCT03300570|11320149|FG001|NOT COMPLETED|Overall Study||1
10190993|NCT03300674|11320158|FG000|STARTED|Overall Study||77
10075873|NCT02213250|11203292|FG001|STARTED|Overall Study||8
10075874|NCT02213250|11203291|FG000|COMPLETED|Overall Study||4
10075875|NCT02213250|11203292|FG001|COMPLETED|Overall Study||8
10190994|NCT03300674|11320159|FG001|STARTED|Overall Study||77
10075876|NCT02213250|11203291|FG000|NOT COMPLETED|Overall Study||0
10075877|NCT02213250|11203292|FG001|NOT COMPLETED|Overall Study||0
10075878|NCT02213263|11203301|FG000|STARTED|Overall Study||198
10075879|NCT02213263|11203302|FG001|STARTED|Overall Study||196
10075880|NCT02213263|11203301|FG000|Treated|Overall Study||197
10075881|NCT02213263|11203302|FG001|Treated|Overall Study||196
10075882|NCT02213263|11203301|FG000|COMPLETED|Overall Study||170
10075883|NCT02213263|11203302|FG001|COMPLETED|Overall Study||170
10075884|NCT02213263|11203301|FG000|NOT COMPLETED|Overall Study||28
10075885|NCT02213263|11203302|FG001|NOT COMPLETED|Overall Study||26
10075886|NCT02213289|11203310|FG000|STARTED|Overall Study||68
10075887|NCT02213289|11203311|FG001|STARTED|Overall Study||12
10075888|NCT02213289|11203310|FG000|Immuno-oncology|Overall Study||5
10075889|NCT02213289|11203311|FG001|Immuno-oncology|Overall Study||0
10075890|NCT02213289|11203310|FG000|HER2 Amplified|Overall Study||16
10075891|NCT02213289|11203311|FG001|HER2 Amplified|Overall Study||0
10075892|NCT02213289|11203310|FG000|EGFR Amplified|Overall Study||8
10075893|NCT02213289|11203311|FG001|EGFR Amplified|Overall Study||0
10075894|NCT02213289|11203310|FG000|FGFR2 Amplified|Overall Study||1
10075895|NCT02213289|11203311|FG001|FGFR2 Amplified|Overall Study||0
10075896|NCT02213289|11203310|FG000|MAPK/PIK3CA Aberrant|Overall Study||20
10075897|NCT02213289|11203311|FG001|MAPK/PIK3CA Aberrant|Overall Study||0
10075898|NCT02213289|11203310|FG000|EGFR Expressing|Overall Study||9
10075899|NCT02213289|11203311|FG001|EGFR Expressing|Overall Study||0
10075900|NCT02213289|11203310|FG000|All Negative|Overall Study||9
10075901|NCT02213289|11203311|FG001|All Negative|Overall Study||0
10075902|NCT02213289|11203310|FG000|Other (Non-ITT)|Overall Study||0
10075903|NCT02213289|11203311|FG001|Other (Non-ITT)|Overall Study||12
10075904|NCT02213289|11203310|FG000|COMPLETED|Overall Study||68
10075905|NCT02213289|11203311|FG001|COMPLETED|Overall Study||12
10075906|NCT02213289|11203310|FG000|NOT COMPLETED|Overall Study||0
10075907|NCT02213289|11203311|FG001|NOT COMPLETED|Overall Study||0
10075908|NCT02213458|11203323|FG000|STARTED|Overall Study||1024
10075909|NCT02213458|11203324|FG001|STARTED|Overall Study||536
10075910|NCT02213458|11203323|FG000|COMPLETED|Overall Study||970
10075911|NCT02213458|11203324|FG001|COMPLETED|Overall Study||526
10075912|NCT02213458|11203323|FG000|NOT COMPLETED|Overall Study||54
10075913|NCT02213458|11203324|FG001|NOT COMPLETED|Overall Study||10
10075914|NCT02213510|11203332|FG000|STARTED|Overall Study||21
10075915|NCT02213510|11203333|FG001|STARTED|Overall Study||19
10075916|NCT02213510|11203332|FG000|COMPLETED|Overall Study||20
10075917|NCT02213510|11203333|FG001|COMPLETED|Overall Study||18
10075918|NCT02213510|11203332|FG000|NOT COMPLETED|Overall Study||1
10075919|NCT02213510|11203333|FG001|NOT COMPLETED|Overall Study||1
10075920|NCT02213666|11203339|FG000|STARTED|Overall Study||72
10075921|NCT02213666|11203339|FG000|COMPLETED|Overall Study||71
10075922|NCT02213666|11203339|FG000|NOT COMPLETED|Overall Study||1
10075923|NCT02213900|11203345|FG000|STARTED|Overall Study||68
10075924|NCT02213900|11203346|FG001|STARTED|Overall Study||67
10075925|NCT02213900|11203345|FG000|COMPLETED|Overall Study||68
10075926|NCT02213900|11203346|FG001|COMPLETED|Overall Study||67
10075927|NCT02213900|11203345|FG000|NOT COMPLETED|Overall Study||0
10075928|NCT02213900|11203346|FG001|NOT COMPLETED|Overall Study||0
10075929|NCT02214017|11203354|FG000|STARTED|Overall Study||22
10075930|NCT02214017|11203355|FG001|STARTED|Overall Study||18
10075931|NCT02214017|11203354|FG000|COMPLETED|Overall Study||22
10075932|NCT02214017|11203355|FG001|COMPLETED|Overall Study||18
10075933|NCT02214017|11203354|FG000|NOT COMPLETED|Overall Study||0
10075934|NCT02214017|11203355|FG001|NOT COMPLETED|Overall Study||0
10075935|NCT02214121|11203364|FG000|STARTED|Part A||46
10075936|NCT02214121|11203365|FG001|STARTED|Part A||0
10075937|NCT02214121|11203366|FG002|STARTED|Part A||0
10075938|NCT02214121|11203364|FG000|COMPLETED|Part A||39
10075939|NCT02214121|11203365|FG001|COMPLETED|Part A||0
10075940|NCT02214121|11203366|FG002|COMPLETED|Part A||0
10075941|NCT02214121|11203364|FG000|NOT COMPLETED|Part A||7
10075942|NCT02214121|11203365|FG001|NOT COMPLETED|Part A||0
10075943|NCT02214121|11203366|FG002|NOT COMPLETED|Part A||0
10075944|NCT02214121|11203364|FG000|STARTED|Part B||0
10075945|NCT02214121|11203365|FG001|STARTED|Part B||17
10075946|NCT02214121|11203366|FG002|STARTED|Part B||8
10075947|NCT02214121|11203364|FG000|COMPLETED|Part B||0
10075948|NCT02214121|11203365|FG001|COMPLETED|Part B||14
10075949|NCT02214121|11203366|FG002|COMPLETED|Part B||7
10075950|NCT02214121|11203364|FG000|NOT COMPLETED|Part B||0
10075951|NCT02214121|11203365|FG001|NOT COMPLETED|Part B||3
10075952|NCT02214121|11203366|FG002|NOT COMPLETED|Part B||1
10075953|NCT02214147|11203389|FG000|STARTED|Overall Study||16
10075954|NCT02214147|11203390|FG001|STARTED|Overall Study||12
10075955|NCT02214147|11203391|FG002|STARTED|Overall Study||8
10075956|NCT02214147|11203389|FG000|COMPLETED|Overall Study||16
10075957|NCT02214147|11203390|FG001|COMPLETED|Overall Study||12
10075958|NCT02214147|11203391|FG002|COMPLETED|Overall Study||8
10075959|NCT02214147|11203389|FG000|NOT COMPLETED|Overall Study||0
10075960|NCT02214147|11203390|FG001|NOT COMPLETED|Overall Study||0
10075961|NCT02214147|11203391|FG002|NOT COMPLETED|Overall Study||0
10075962|NCT02214186|11203401|FG000|STARTED|Overall Study||23
10075963|NCT02214186|11203402|FG001|STARTED|Overall Study||23
10075964|NCT02214186|11203401|FG000|COMPLETED|Overall Study||21
10075965|NCT02214186|11203402|FG001|COMPLETED|Overall Study||21
10075966|NCT02214186|11203401|FG000|NOT COMPLETED|Overall Study||2
10075967|NCT02214186|11203402|FG001|NOT COMPLETED|Overall Study||2
10075968|NCT02214212|11203410|FG000|STARTED|Overall Study||66
10075969|NCT02214212|11203411|FG001|STARTED|Overall Study||65
10075970|NCT02214212|11203410|FG000|COMPLETED|Overall Study||57
10075971|NCT02214212|11203411|FG001|COMPLETED|Overall Study||59
10075972|NCT02214212|11203410|FG000|NOT COMPLETED|Overall Study||9
10075973|NCT02214212|11203411|FG001|NOT COMPLETED|Overall Study||6
10075974|NCT02214225|11203425|FG000|STARTED|Overall Study||1741
10075975|NCT02214225|11203426|FG001|STARTED|Overall Study||871
10075976|NCT02214225|11203427|FG002|STARTED|Overall Study||872
10075977|NCT02214225|11203425|FG000|COMPLETED|Overall Study||1686
10075978|NCT02214225|11203426|FG001|COMPLETED|Overall Study||852
10075979|NCT02214225|11203427|FG002|COMPLETED|Overall Study||850
10075980|NCT02214225|11203425|FG000|NOT COMPLETED|Overall Study||55
10075981|NCT02214225|11203426|FG001|NOT COMPLETED|Overall Study||19
10075982|NCT02214225|11203427|FG002|NOT COMPLETED|Overall Study||22
10075983|NCT02214238|11203460|FG000|STARTED|Overall Study||26
10075984|NCT02214238|11203461|FG001|STARTED|Overall Study||23
10075985|NCT02214238|11203460|FG000|COMPLETED|Overall Study||20
10075986|NCT02214238|11203461|FG001|COMPLETED|Overall Study||17
10075987|NCT02214238|11203460|FG000|NOT COMPLETED|Overall Study||6
10075988|NCT02214238|11203461|FG001|NOT COMPLETED|Overall Study||6
10075989|NCT02214277|11203470|FG000|STARTED|Overall Study||123
10075990|NCT02214277|11203471|FG001|STARTED|Overall Study||121
10075991|NCT02214277|11203472|FG002|STARTED|Overall Study||119
10075992|NCT02214277|11203470|FG000|COMPLETED|Overall Study||104
10075993|NCT02214277|11203471|FG001|COMPLETED|Overall Study||96
10075994|NCT02214277|11203472|FG002|COMPLETED|Overall Study||85
10075995|NCT02214277|11203470|FG000|NOT COMPLETED|Overall Study||19
10075996|NCT02214277|11203471|FG001|NOT COMPLETED|Overall Study||25
10075997|NCT02214277|11203472|FG002|NOT COMPLETED|Overall Study||34
10075998|NCT02214290|11203479|FG000|STARTED|First Intervention (7 Days)||8
10075999|NCT02214290|11203480|FG001|STARTED|First Intervention (7 Days)||8
10076000|NCT02214290|11203479|FG000|COMPLETED|First Intervention (7 Days)||8
10076001|NCT02214290|11203480|FG001|COMPLETED|First Intervention (7 Days)||8
10076002|NCT02214290|11203479|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10076003|NCT02214290|11203480|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10076004|NCT02214290|11203479|FG000|STARTED|Washout (14 Days)||8
10076005|NCT02214290|11203480|FG001|STARTED|Washout (14 Days)||8
10076006|NCT02214290|11203479|FG000|COMPLETED|Washout (14 Days)||8
10076007|NCT02214290|11203480|FG001|COMPLETED|Washout (14 Days)||8
10076008|NCT02214290|11203479|FG000|NOT COMPLETED|Washout (14 Days)||0
10076009|NCT02214290|11203480|FG001|NOT COMPLETED|Washout (14 Days)||0
10076010|NCT02214290|11203479|FG000|STARTED|Second Intervention (7 Days)||8
10076011|NCT02214290|11203480|FG001|STARTED|Second Intervention (7 Days)||8
10076012|NCT02214290|11203479|FG000|COMPLETED|Second Intervention (7 Days)||8
10076013|NCT02214290|11203480|FG001|COMPLETED|Second Intervention (7 Days)||8
10076014|NCT02214290|11203479|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10076015|NCT02214290|11203480|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10076016|NCT02214420|11203491|FG000|STARTED|Overall Study||14
10076017|NCT02214420|11203492|FG001|STARTED|Overall Study||10
10076018|NCT02214420|11203491|FG000|COMPLETED|Overall Study||13
10076019|NCT02214420|11203492|FG001|COMPLETED|Overall Study||10
10076020|NCT02214420|11203491|FG000|NOT COMPLETED|Overall Study||1
10076021|NCT02214420|11203492|FG001|NOT COMPLETED|Overall Study||0
10076022|NCT02214615|11203500|FG000|STARTED|First Intervention||1
10076023|NCT02214615|11203501|FG001|STARTED|First Intervention||1
10076024|NCT02214615|11203500|FG000|COMPLETED|First Intervention||1
10076025|NCT02214615|11203501|FG001|COMPLETED|First Intervention||1
10076026|NCT02214615|11203500|FG000|NOT COMPLETED|First Intervention||0
10076027|NCT02214615|11203501|FG001|NOT COMPLETED|First Intervention||0
10076028|NCT02214615|11203500|FG000|STARTED|Washout||1
10076029|NCT02214615|11203501|FG001|STARTED|Washout||1
10076030|NCT02214615|11203500|FG000|COMPLETED|Washout||1
10076031|NCT02214615|11203501|FG001|COMPLETED|Washout||1
10076032|NCT02214615|11203500|FG000|NOT COMPLETED|Washout||0
10076033|NCT02214615|11203501|FG001|NOT COMPLETED|Washout||0
10076034|NCT02214615|11203500|FG000|STARTED|Second Intervention||1
10076035|NCT02214615|11203501|FG001|STARTED|Second Intervention||1
10076036|NCT02214615|11203500|FG000|COMPLETED|Second Intervention||1
10076037|NCT02214615|11203501|FG001|COMPLETED|Second Intervention||1
10076038|NCT02214615|11203500|FG000|NOT COMPLETED|Second Intervention||0
10076039|NCT02214615|11203501|FG001|NOT COMPLETED|Second Intervention||0
10076040|NCT02214628|11203509|FG000|STARTED|Overall Study||63
10076041|NCT02214628|11203510|FG001|STARTED|Overall Study||38
10076042|NCT02214628|11203509|FG000|COMPLETED|Overall Study||36
10076043|NCT02214628|11203510|FG001|COMPLETED|Overall Study||9
10076044|NCT02214628|11203509|FG000|NOT COMPLETED|Overall Study||27
10076045|NCT02214628|11203510|FG001|NOT COMPLETED|Overall Study||29
10076046|NCT02215070|11203520|FG000|STARTED|Overall Study||26
10076047|NCT02215070|11203521|FG001|STARTED|Overall Study||52
10076048|NCT02215070|11203520|FG000|COMPLETED|Overall Study||20
10076049|NCT02215070|11203521|FG001|COMPLETED|Overall Study||52
10076050|NCT02215070|11203520|FG000|NOT COMPLETED|Overall Study||6
10076051|NCT02215070|11203521|FG001|NOT COMPLETED|Overall Study||0
10076052|NCT02215161|11203527|FG000|STARTED|Overall Study||14
10076053|NCT02215161|11203527|FG000|COMPLETED|Overall Study||14
10076054|NCT02215161|11203527|FG000|NOT COMPLETED|Overall Study||0
10076055|NCT02215200|11203542|FG000|STARTED|Overall Study||29
10076056|NCT02215200|11203543|FG001|STARTED|Overall Study||29
10076057|NCT02215200|11203544|FG002|STARTED|Overall Study||31
10076058|NCT02215200|11203542|FG000|COMPLETED|Overall Study||29
10076059|NCT02215200|11203543|FG001|COMPLETED|Overall Study||28
10076060|NCT02215200|11203544|FG002|COMPLETED|Overall Study||30
10076061|NCT02215200|11203542|FG000|NOT COMPLETED|Overall Study||0
10076062|NCT02215200|11203543|FG001|NOT COMPLETED|Overall Study||1
10076063|NCT02215200|11203544|FG002|NOT COMPLETED|Overall Study||1
10076064|NCT02215252|11203555|FG000|STARTED|Overall Study||44
10076065|NCT02215252|11203556|FG001|STARTED|Overall Study||46
10076066|NCT02215252|11203557|FG002|STARTED|Overall Study||45
10076067|NCT02215252|11203555|FG000|COMPLETED|Overall Study||42
10076068|NCT02215252|11203556|FG001|COMPLETED|Overall Study||38
10076069|NCT02215252|11203557|FG002|COMPLETED|Overall Study||41
10076070|NCT02215252|11203555|FG000|NOT COMPLETED|Overall Study||2
10076071|NCT02215252|11203556|FG001|NOT COMPLETED|Overall Study||8
10076072|NCT02215252|11203557|FG002|NOT COMPLETED|Overall Study||4
10076073|NCT02215369|11203565|FG000|STARTED|Overall Study||112
10076074|NCT02215369|11203565|FG000|COMPLETED|Overall Study||70
10076075|NCT02215369|11203565|FG000|NOT COMPLETED|Overall Study||42
10076076|NCT02215616|11203573|FG000|STARTED|Overall Study||108
10076077|NCT02215616|11203574|FG001|STARTED|Overall Study||107
10076078|NCT02215616|11203575|FG002|STARTED|Overall Study||107
10076079|NCT02215616|11203576|FG003|STARTED|Overall Study||30
10076080|NCT02215616|11203573|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108
10076081|NCT02215616|11203574|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107
10076082|NCT02215616|11203575|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106
10076083|NCT02215616|11203576|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29
10076084|NCT02215616|11203573|FG000|COMPLETED|Overall Study||97
10076085|NCT02215616|11203574|FG001|COMPLETED|Overall Study||90
10076086|NCT02215616|11203575|FG002|COMPLETED|Overall Study||93
10076087|NCT02215616|11203576|FG003|COMPLETED|Overall Study||17
10076088|NCT02215616|11203573|FG000|NOT COMPLETED|Overall Study||11
10076089|NCT02215616|11203574|FG001|NOT COMPLETED|Overall Study||17
10076090|NCT02215616|11203575|FG002|NOT COMPLETED|Overall Study||14
10076091|NCT02215616|11203576|FG003|NOT COMPLETED|Overall Study||13
10076092|NCT02215954|11203589|FG000|STARTED|Overall Study||214
10076093|NCT02215954|11203590|FG001|STARTED|Overall Study||212
10076094|NCT02215954|11203591|FG002|STARTED|Overall Study||211
10076095|NCT02215954|11203589|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
10076096|NCT02215954|11203590|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
10076097|NCT02215954|11203591|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
10076098|NCT02215954|11203589|FG000|Per Protocol (PP) Analysis Set|Overall Study||212
10076099|NCT02215954|11203590|FG001|Per Protocol (PP) Analysis Set|Overall Study||208
10076100|NCT02215954|11203591|FG002|Per Protocol (PP) Analysis Set|Overall Study||205
10076101|NCT02215954|11203589|FG000|Safety Analysis Set|Overall Study||213
10076102|NCT02215954|11203590|FG001|Safety Analysis Set|Overall Study||211
10076103|NCT02215954|11203591|FG002|Safety Analysis Set|Overall Study||208
10076104|NCT02215954|11203589|FG000|COMPLETED|Overall Study||213
10076105|NCT02215954|11203590|FG001|COMPLETED|Overall Study||211
10076106|NCT02215954|11203591|FG002|COMPLETED|Overall Study||205
10076107|NCT02215954|11203589|FG000|NOT COMPLETED|Overall Study||1
10076108|NCT02215954|11203590|FG001|NOT COMPLETED|Overall Study||1
10076109|NCT02215954|11203591|FG002|NOT COMPLETED|Overall Study||6
10076110|NCT02215967|11203604|FG000|STARTED|Overall Study||3
10076111|NCT02215967|11203605|FG001|STARTED|Overall Study||3
10076112|NCT02215967|11203606|FG002|STARTED|Overall Study||5
10076113|NCT02215967|11203607|FG003|STARTED|Overall Study||19
10076114|NCT02215967|11203604|FG000|COMPLETED|Overall Study||3
10076115|NCT02215967|11203605|FG001|COMPLETED|Overall Study||3
10076116|NCT02215967|11203606|FG002|COMPLETED|Overall Study||4
10076117|NCT02215967|11203607|FG003|COMPLETED|Overall Study||16
10076118|NCT02215967|11203604|FG000|NOT COMPLETED|Overall Study||0
10076119|NCT02215967|11203605|FG001|NOT COMPLETED|Overall Study||0
10076120|NCT02215967|11203606|FG002|NOT COMPLETED|Overall Study||1
10076121|NCT02215967|11203607|FG003|NOT COMPLETED|Overall Study||3
10076122|NCT02216071|11203619|FG000|STARTED|Overall Study||254
10076123|NCT02216071|11203620|FG001|STARTED|Overall Study||245
10076124|NCT02216071|11203619|FG000|COMPLETED|Overall Study||239
10076125|NCT02216071|11203620|FG001|COMPLETED|Overall Study||233
10076126|NCT02216071|11203619|FG000|NOT COMPLETED|Overall Study||15
10076127|NCT02216071|11203620|FG001|NOT COMPLETED|Overall Study||12
10076128|NCT02216097|11203628|FG000|STARTED|Overall Study||8
10076129|NCT02216097|11203629|FG001|STARTED|Overall Study||6
10076130|NCT02216097|11203628|FG000|COMPLETED|Overall Study||8
10076131|NCT02216097|11203629|FG001|COMPLETED|Overall Study||6
10076132|NCT02216097|11203628|FG000|NOT COMPLETED|Overall Study||0
10076133|NCT02216097|11203629|FG001|NOT COMPLETED|Overall Study||0
10076134|NCT02216123|11203637|FG000|STARTED|Overall Study||166
10076135|NCT02216123|11203638|FG001|STARTED|Overall Study||85
10076136|NCT02216123|11203637|FG000|COMPLETED|Overall Study||160
10076137|NCT02216123|11203638|FG001|COMPLETED|Overall Study||83
10076138|NCT02216123|11203637|FG000|NOT COMPLETED|Overall Study||6
10076139|NCT02216123|11203638|FG001|NOT COMPLETED|Overall Study||2
10076140|NCT02216136|11203651|FG000|STARTED|Overall Study||72
10076141|NCT02216136|11203652|FG001|STARTED|Overall Study||90
10076142|NCT02216136|11203653|FG002|STARTED|Overall Study||0
10076143|NCT02216136|11203651|FG000|COMPLETED|Overall Study||72
10076144|NCT02216136|11203652|FG001|COMPLETED|Overall Study||90
10076145|NCT02216136|11203653|FG002|COMPLETED|Overall Study||0
10076146|NCT02216136|11203651|FG000|NOT COMPLETED|Overall Study||0
10076147|NCT02216136|11203652|FG001|NOT COMPLETED|Overall Study||0
10076148|NCT02216136|11203653|FG002|NOT COMPLETED|Overall Study||0
10076149|NCT02216214|11203663|FG000|STARTED|Overall Study||443
10076150|NCT02216214|11203664|FG001|STARTED|Overall Study||445
10076151|NCT02216214|11203663|FG000|Treated|Overall Study||442
10076152|NCT02216214|11203664|FG001|Treated|Overall Study||445
10076153|NCT02216214|11203663|FG000|COMPLETED|Overall Study||400
10076154|NCT02216214|11203664|FG001|COMPLETED|Overall Study||409
10076155|NCT02216214|11203663|FG000|NOT COMPLETED|Overall Study||43
10076156|NCT02216214|11203664|FG001|NOT COMPLETED|Overall Study||36
10076157|NCT02216357|11203672|FG000|STARTED|Overall Study||14
10076158|NCT02216357|11203673|FG001|STARTED|Overall Study||5
10076159|NCT02216357|11203672|FG000|COMPLETED|Overall Study||12
10076160|NCT02216357|11203673|FG001|COMPLETED|Overall Study||4
10076161|NCT02216357|11203672|FG000|NOT COMPLETED|Overall Study||2
10076162|NCT02216357|11203673|FG001|NOT COMPLETED|Overall Study||1
10076163|NCT02216422|11203679|FG000|STARTED|Overall Study||36
10076164|NCT02216422|11203679|FG000|COMPLETED|Overall Study||36
10076165|NCT02216422|11203679|FG000|NOT COMPLETED|Overall Study||0
10076166|NCT02216526|11203686|FG000|STARTED|Overall Study||45
10076167|NCT02216526|11203687|FG001|STARTED|Overall Study||44
10076168|NCT02216526|11203688|FG002|STARTED|Overall Study||44
10076169|NCT02216526|11203686|FG000|COMPLETED|Overall Study||40
10076170|NCT02216526|11203687|FG001|COMPLETED|Overall Study||41
10076171|NCT02216526|11203688|FG002|COMPLETED|Overall Study||36
10076172|NCT02216526|11203686|FG000|NOT COMPLETED|Overall Study||5
10076173|NCT02216526|11203687|FG001|NOT COMPLETED|Overall Study||3
10076174|NCT02216526|11203688|FG002|NOT COMPLETED|Overall Study||8
10076175|NCT02216591|11203698|FG000|STARTED|Overall Study||11
10076176|NCT02216591|11203699|FG001|STARTED|Overall Study||10
10076177|NCT02216591|11203698|FG000|COMPLETED|Overall Study||11
10076178|NCT02216591|11203699|FG001|COMPLETED|Overall Study||9
10076179|NCT02216591|11203698|FG000|NOT COMPLETED|Overall Study||0
10076180|NCT02216591|11203699|FG001|NOT COMPLETED|Overall Study||1
10076181|NCT02216695|11203705|FG000|STARTED|Overall Study||64882
10076182|NCT02216695|11203705|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
10076183|NCT02216695|11203705|FG000|NOT COMPLETED|Overall Study||0
10076184|NCT02216773|11203716|FG000|STARTED|Overall Study||28
10076185|NCT02216773|11203717|FG001|STARTED|Overall Study||29
10076186|NCT02216773|11203716|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24
10076187|NCT02216773|11203717|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26
10076188|NCT02216773|11203716|FG000|COMPLETED|Overall Study||16
10076189|NCT02216773|11203717|FG001|COMPLETED|Overall Study||24
10076190|NCT02216773|11203716|FG000|NOT COMPLETED|Overall Study||12
10076191|NCT02216773|11203717|FG001|NOT COMPLETED|Overall Study||5
10076192|NCT02216812|11203725|FG000|STARTED|Overall Study||67
10076193|NCT02216812|11203726|FG001|STARTED|Overall Study||67
10076194|NCT02216812|11203725|FG000|COMPLETED|Overall Study||57
10076195|NCT02216812|11203726|FG001|COMPLETED|Overall Study||62
10076196|NCT02216812|11203725|FG000|NOT COMPLETED|Overall Study||10
10076197|NCT02216812|11203726|FG001|NOT COMPLETED|Overall Study||5
10076198|NCT02216851|11203734|FG000|STARTED|Overall Study||98
10076199|NCT02216851|11203735|FG001|STARTED|Overall Study||33
10076200|NCT02216851|11203734|FG000|COMPLETED|Overall Study||96
10076201|NCT02216851|11203735|FG001|COMPLETED|Overall Study||32
10076202|NCT02216851|11203734|FG000|NOT COMPLETED|Overall Study||2
10076203|NCT02216851|11203735|FG001|NOT COMPLETED|Overall Study||1
10076204|NCT02217280|11203741|FG000|STARTED|Overall Study||20
10076205|NCT02217280|11203741|FG000|COMPLETED|Overall Study||16
10076206|NCT02217280|11203741|FG000|NOT COMPLETED|Overall Study||4
10076207|NCT02217332|11203746|FG000|STARTED|Overall Study|Safety Population|20
10076208|NCT02217332|11203746|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
10076209|NCT02217332|11203746|FG000|NOT COMPLETED|Overall Study||7
10076210|NCT02217410|11203753|FG000|STARTED|Overall Study||7
10076211|NCT02217410|11203754|FG001|STARTED|Overall Study||34
10076212|NCT02217410|11203755|FG002|STARTED|Overall Study||18
10076213|NCT02217410|11203753|FG000|COMPLETED|Overall Study||6
10076214|NCT02217410|11203754|FG001|COMPLETED|Overall Study||30
10076215|NCT02217410|11203755|FG002|COMPLETED|Overall Study||13
10076216|NCT02217410|11203753|FG000|NOT COMPLETED|Overall Study||1
10076217|NCT02217410|11203754|FG001|NOT COMPLETED|Overall Study||4
10076218|NCT02217410|11203755|FG002|NOT COMPLETED|Overall Study||5
10076219|NCT02217436|11203770|FG000|STARTED|Overall Study||40
10076220|NCT02217436|11203771|FG001|STARTED|Overall Study||40
10076221|NCT02217436|11203770|FG000|COMPLETED|Overall Study||39
10076222|NCT02217436|11203771|FG001|COMPLETED|Overall Study||38
10076223|NCT02217436|11203770|FG000|NOT COMPLETED|Overall Study||1
10076224|NCT02217436|11203771|FG001|NOT COMPLETED|Overall Study||2
10076225|NCT02217475|11203780|FG000|STARTED|Treatment Period 1 (Year 1)||72
10076226|NCT02217475|11203781|FG001|STARTED|Treatment Period 1 (Year 1)||72
10076227|NCT02217475|11203782|FG002|STARTED|Treatment Period 1 (Year 1)||145
10076228|NCT02217475|11203780|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72
10076229|NCT02217475|11203781|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72
10076230|NCT02217475|11203782|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144
10076231|NCT02217475|11203780|FG000|COMPLETED|Treatment Period 1 (Year 1)||62
10076232|NCT02217475|11203781|FG001|COMPLETED|Treatment Period 1 (Year 1)||64
10076233|NCT02217475|11203782|FG002|COMPLETED|Treatment Period 1 (Year 1)||124
10076234|NCT02217475|11203780|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10
10076235|NCT02217475|11203781|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8
10076236|NCT02217475|11203782|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21
10076237|NCT02217475|11203780|FG000|STARTED|Discontinued After Period 1||62
10076238|NCT02217475|11203781|FG001|STARTED|Discontinued After Period 1||64
10076239|NCT02217475|11203782|FG002|STARTED|Discontinued After Period 1||124
10076240|NCT02217475|11203780|FG000|COMPLETED|Discontinued After Period 1||60
10076241|NCT02217475|11203781|FG001|COMPLETED|Discontinued After Period 1||61
10076242|NCT02217475|11203782|FG002|COMPLETED|Discontinued After Period 1||121
10076243|NCT02217475|11203780|FG000|NOT COMPLETED|Discontinued After Period 1||2
10076244|NCT02217475|11203781|FG001|NOT COMPLETED|Discontinued After Period 1||3
10076245|NCT02217475|11203782|FG002|NOT COMPLETED|Discontinued After Period 1||3
10076246|NCT02217475|11203780|FG000|STARTED|Treatment Period 2 (Year 2)||60
10076247|NCT02217475|11203781|FG001|STARTED|Treatment Period 2 (Year 2)||61
10076248|NCT02217475|11203782|FG002|STARTED|Treatment Period 2 (Year 2)||121
10076249|NCT02217475|11203780|FG000|COMPLETED|Treatment Period 2 (Year 2)||58
10076250|NCT02217475|11203781|FG001|COMPLETED|Treatment Period 2 (Year 2)||59
10076251|NCT02217475|11203782|FG002|COMPLETED|Treatment Period 2 (Year 2)||109
10076252|NCT02217475|11203780|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2
10076253|NCT02217475|11203781|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2
10076254|NCT02217475|11203782|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12
10076255|NCT02217501|11203801|FG000|STARTED|Overall Study||77
10076256|NCT02217501|11203802|FG001|STARTED|Overall Study||82
10076257|NCT02217501|11203801|FG000|COMPLETED|Overall Study||74
10076258|NCT02217501|11203802|FG001|COMPLETED|Overall Study||78
10076259|NCT02217501|11203801|FG000|NOT COMPLETED|Overall Study||3
10076260|NCT02217501|11203802|FG001|NOT COMPLETED|Overall Study||4
10076261|NCT02217527|11203810|FG000|STARTED|Drug Condition 1: First Study Phase||18
10076262|NCT02217527|11203811|FG001|STARTED|Drug Condition 1: First Study Phase||18
10076263|NCT02217527|11203810|FG000|COMPLETED|Drug Condition 1: First Study Phase||17
10076264|NCT02217527|11203811|FG001|COMPLETED|Drug Condition 1: First Study Phase||15
10076265|NCT02217527|11203810|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1
10076266|NCT02217527|11203811|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3
10076267|NCT02217527|11203810|FG000|STARTED|Drug Condition 2: Second Study Phase||17
10076268|NCT02217527|11203811|FG001|STARTED|Drug Condition 2: Second Study Phase||15
10076269|NCT02217527|11203810|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17
10076270|NCT02217527|11203811|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14
10076271|NCT02217527|11203810|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
10076272|NCT02217527|11203811|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
10076273|NCT02217566|11203817|FG000|STARTED|Overall Study||46
10076274|NCT02217566|11203817|FG000|COMPLETED|Overall Study||35
10076275|NCT02217566|11203817|FG000|NOT COMPLETED|Overall Study||11
10076276|NCT02217618|11203821|FG000|STARTED|Overall Study||16
10076277|NCT02217618|11203821|FG000|Received Study Drug|Overall Study||16
10076278|NCT02217618|11203821|FG000|COMPLETED|Overall Study||16
10076279|NCT02217618|11203821|FG000|NOT COMPLETED|Overall Study||0
10076280|NCT02217800|11203825|FG000|STARTED|Overall Study||8
10076281|NCT02217800|11203825|FG000|COMPLETED|Overall Study||8
10076282|NCT02217800|11203825|FG000|NOT COMPLETED|Overall Study||0
10190995|NCT03300674|11320158|FG000|COMPLETED|Overall Study||77
10190996|NCT03300674|11320159|FG001|COMPLETED|Overall Study||77
10190997|NCT03300674|11320158|FG000|NOT COMPLETED|Overall Study||0
10190998|NCT03300674|11320159|FG001|NOT COMPLETED|Overall Study||0
10190999|NCT03300752|11320167|FG000|STARTED|Overall Study||40
10191000|NCT03300752|11320168|FG001|STARTED|Overall Study||40
10191001|NCT03300752|11320167|FG000|COMPLETED|Overall Study||38
10191002|NCT03300752|11320168|FG001|COMPLETED|Overall Study||38
10191003|NCT03300752|11320167|FG000|NOT COMPLETED|Overall Study||2
10191004|NCT03300752|11320168|FG001|NOT COMPLETED|Overall Study||2
10191005|NCT03300843|11320174|FG000|STARTED|Overall Study||1
10191006|NCT03300843|11320174|FG000|COMPLETED|Overall Study||1
10191007|NCT03300843|11320174|FG000|NOT COMPLETED|Overall Study||0
10191008|NCT03301155|11320180|FG000|STARTED|Overall Study||528
10191009|NCT03301155|11320181|FG001|STARTED|Overall Study||508
10191010|NCT03301155|11320180|FG000|COMPLETED|Overall Study||520
10191011|NCT03301155|11320181|FG001|COMPLETED|Overall Study||501
10191012|NCT03301155|11320180|FG000|NOT COMPLETED|Overall Study||8
10191013|NCT03301155|11320181|FG001|NOT COMPLETED|Overall Study||7
10191014|NCT03301272|11320189|FG000|STARTED|First Intervention (30 Days)||7
10191015|NCT03301272|11320190|FG001|STARTED|First Intervention (30 Days)||9
10191016|NCT03301272|11320189|FG000|COMPLETED|First Intervention (30 Days)||7
10191017|NCT03301272|11320190|FG001|COMPLETED|First Intervention (30 Days)||9
10191018|NCT03301272|11320189|FG000|NOT COMPLETED|First Intervention (30 Days)||0
10191019|NCT03301272|11320190|FG001|NOT COMPLETED|First Intervention (30 Days)||0
10191020|NCT03301272|11320189|FG000|STARTED|Washout (90 Days From 1st Intervention)||7
10191021|NCT03301272|11320190|FG001|STARTED|Washout (90 Days From 1st Intervention)||9
10191022|NCT03301272|11320189|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7
10191023|NCT03301272|11320190|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9
10191024|NCT03301272|11320189|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
10191025|NCT03301272|11320190|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
10191026|NCT03301272|11320189|FG000|STARTED|Second Intervention (30 Days)||7
10191027|NCT03301272|11320190|FG001|STARTED|Second Intervention (30 Days)||9
10191028|NCT03301272|11320189|FG000|COMPLETED|Second Intervention (30 Days)||7
10191029|NCT03301272|11320190|FG001|COMPLETED|Second Intervention (30 Days)||9
10191030|NCT03301272|11320189|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10191031|NCT03301272|11320190|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
10191032|NCT03301298|11320203|FG000|STARTED|Unfed Conditions||6
10191033|NCT03301298|11320204|FG001|STARTED|Unfed Conditions||6
10191034|NCT03301298|11320205|FG002|STARTED|Unfed Conditions||6
10191035|NCT03301298|11320206|FG003|STARTED|Unfed Conditions||6
10076283|NCT02217878|11203839|FG000|STARTED|Overall Study||37
10076284|NCT02217878|11203840|FG001|STARTED|Overall Study||37
10076285|NCT02217878|11203839|FG000|COMPLETED|Overall Study||35
10076286|NCT02217878|11203840|FG001|COMPLETED|Overall Study||35
10076287|NCT02217878|11203839|FG000|NOT COMPLETED|Overall Study||2
10076288|NCT02217878|11203840|FG001|NOT COMPLETED|Overall Study||2
10076289|NCT02217904|11203851|FG000|STARTED|Overall Study||6
10076290|NCT02217904|11203852|FG001|STARTED|Overall Study||6
10076291|NCT02217904|11203853|FG002|STARTED|Overall Study||6
10076292|NCT02217904|11203854|FG003|STARTED|Overall Study||6
10076293|NCT02217904|11203855|FG004|STARTED|Overall Study||6
10076294|NCT02217904|11203856|FG005|STARTED|Overall Study||0
10076295|NCT02217904|11203857|FG006|STARTED|Overall Study||0
10076296|NCT02217904|11203851|FG000|COMPLETED|Overall Study||6
10076297|NCT02217904|11203852|FG001|COMPLETED|Overall Study||6
10076298|NCT02217904|11203853|FG002|COMPLETED|Overall Study||6
10076299|NCT02217904|11203854|FG003|COMPLETED|Overall Study||6
10076300|NCT02217904|11203855|FG004|COMPLETED|Overall Study||6
10076301|NCT02217904|11203856|FG005|COMPLETED|Overall Study||0
10076302|NCT02217904|11203857|FG006|COMPLETED|Overall Study||0
10076303|NCT02217904|11203851|FG000|NOT COMPLETED|Overall Study||0
10076304|NCT02217904|11203852|FG001|NOT COMPLETED|Overall Study||0
10076305|NCT02217904|11203853|FG002|NOT COMPLETED|Overall Study||0
10076306|NCT02217904|11203854|FG003|NOT COMPLETED|Overall Study||0
10076307|NCT02217904|11203855|FG004|NOT COMPLETED|Overall Study||0
10076308|NCT02217904|11203856|FG005|NOT COMPLETED|Overall Study||0
10076309|NCT02217904|11203857|FG006|NOT COMPLETED|Overall Study||0
10076310|NCT02217982|11203871|FG000|STARTED|Overall Study||1
10076311|NCT02217982|11203872|FG001|STARTED|Overall Study||4
10076312|NCT02217982|11203871|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0
10076313|NCT02217982|11203872|FG001|COMPLETED|Overall Study||3
10076314|NCT02217982|11203871|FG000|NOT COMPLETED|Overall Study||1
10076315|NCT02217982|11203872|FG001|NOT COMPLETED|Overall Study||1
10076316|NCT02218008|11203881|FG000|STARTED|Stage 1 (S1)||280
10076317|NCT02218008|11203882|FG001|STARTED|Stage 1 (S1)||63
10076318|NCT02218008|11203883|FG002|STARTED|Stage 1 (S1)||63
10076319|NCT02218008|11203884|FG003|STARTED|Stage 1 (S1)||0
10076320|NCT02218008|11203885|FG004|STARTED|Stage 1 (S1)||0
10076321|NCT02218008|11203886|FG005|STARTED|Stage 1 (S1)||0
10076322|NCT02218008|11203881|FG000|COMPLETED|Stage 1 (S1)||258
10076323|NCT02218008|11203882|FG001|COMPLETED|Stage 1 (S1)||56
10076324|NCT02218008|11203883|FG002|COMPLETED|Stage 1 (S1)||48
10076325|NCT02218008|11203884|FG003|COMPLETED|Stage 1 (S1)||0
10076326|NCT02218008|11203885|FG004|COMPLETED|Stage 1 (S1)||0
10076327|NCT02218008|11203886|FG005|COMPLETED|Stage 1 (S1)||0
10076328|NCT02218008|11203881|FG000|NOT COMPLETED|Stage 1 (S1)||22
10076329|NCT02218008|11203882|FG001|NOT COMPLETED|Stage 1 (S1)||7
10076330|NCT02218008|11203883|FG002|NOT COMPLETED|Stage 1 (S1)||15
10076331|NCT02218008|11203884|FG003|NOT COMPLETED|Stage 1 (S1)||0
10076332|NCT02218008|11203885|FG004|NOT COMPLETED|Stage 1 (S1)||0
10076333|NCT02218008|11203886|FG005|NOT COMPLETED|Stage 1 (S1)||0
10076334|NCT02218008|11203881|FG000|STARTED|Stage 2 (S2)||0
10076335|NCT02218008|11203882|FG001|STARTED|Stage 2 (S2)||0
10076336|NCT02218008|11203883|FG002|STARTED|Stage 2 (S2)||0
10076337|NCT02218008|11203884|FG003|STARTED|Stage 2 (S2)||62
10076338|NCT02218008|11203885|FG004|STARTED|Stage 2 (S2)||62
10076339|NCT02218008|11203886|FG005|STARTED|Stage 2 (S2)||63
10076340|NCT02218008|11203881|FG000|COMPLETED|Stage 2 (S2)||0
10076341|NCT02218008|11203882|FG001|COMPLETED|Stage 2 (S2)||0
10076342|NCT02218008|11203883|FG002|COMPLETED|Stage 2 (S2)||0
10076343|NCT02218008|11203884|FG003|COMPLETED|Stage 2 (S2)||58
10076344|NCT02218008|11203885|FG004|COMPLETED|Stage 2 (S2)||58
10076345|NCT02218008|11203886|FG005|COMPLETED|Stage 2 (S2)||57
10076346|NCT02218008|11203881|FG000|NOT COMPLETED|Stage 2 (S2)||0
10076347|NCT02218008|11203882|FG001|NOT COMPLETED|Stage 2 (S2)||0
10076348|NCT02218008|11203883|FG002|NOT COMPLETED|Stage 2 (S2)||0
10076349|NCT02218008|11203884|FG003|NOT COMPLETED|Stage 2 (S2)||4
10076350|NCT02218008|11203885|FG004|NOT COMPLETED|Stage 2 (S2)||4
10076351|NCT02218008|11203886|FG005|NOT COMPLETED|Stage 2 (S2)||6
10076352|NCT02218190|11203902|FG000|STARTED|Overall Study||13
10076353|NCT02218190|11203903|FG001|STARTED|Overall Study||13
10076354|NCT02218190|11203902|FG000|COMPLETED|Overall Study||13
10076355|NCT02218190|11203903|FG001|COMPLETED|Overall Study||13
10076356|NCT02218190|11203902|FG000|NOT COMPLETED|Overall Study||0
10076357|NCT02218190|11203903|FG001|NOT COMPLETED|Overall Study||0
10076358|NCT02218203|11203909|FG000|STARTED|Overall Study||26
10076359|NCT02218203|11203909|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
10076360|NCT02218203|11203909|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
10076361|NCT02218203|11203909|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
10076362|NCT02218203|11203909|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
10076363|NCT02218203|11203909|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
10076364|NCT02218203|11203909|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
10076365|NCT02218203|11203909|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
10076366|NCT02218203|11203909|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
10076367|NCT02218203|11203909|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
10076368|NCT02218203|11203909|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
10076369|NCT02218203|11203909|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
10076370|NCT02218203|11203909|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
10076371|NCT02218203|11203909|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
10076372|NCT02218203|11203909|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
10076373|NCT02218203|11203909|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
10076374|NCT02218203|11203909|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
10076375|NCT02218203|11203909|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
10076376|NCT02218203|11203909|FG000|NOT COMPLETED|Overall Study||0
10076377|NCT02218216|11203933|FG000|STARTED|Overall Study||14
9850729|NCT00871871|10963426|FG002|STARTED|Part II||13
9850730|NCT00871871|10963427|FG003|STARTED|Part II||15
9850731|NCT00871871|10963424|FG000|COMPLETED|Part II||0
9850732|NCT00871871|10963425|FG001|COMPLETED|Part II||0
9850733|NCT00871871|10963426|FG002|COMPLETED|Part II||9
9850734|NCT00871871|10963427|FG003|COMPLETED|Part II||11
9850735|NCT00871871|10963424|FG000|NOT COMPLETED|Part II||0
9850736|NCT00871871|10963425|FG001|NOT COMPLETED|Part II||0
9850737|NCT00871871|10963426|FG002|NOT COMPLETED|Part II||4
9850738|NCT00871871|10963427|FG003|NOT COMPLETED|Part II||4
9850739|NCT00871923|10963437|FG000|STARTED|Overall Study||44
9850740|NCT00871923|10963437|FG000|COMPLETED|Overall Study||42
10076378|NCT02218216|11203934|FG001|STARTED|Overall Study||2
10076379|NCT02218216|11203935|FG002|STARTED|Overall Study||3
10076380|NCT02218216|11203933|FG000|COMPLETED|Overall Study||8
10076381|NCT02218216|11203934|FG001|COMPLETED|Overall Study||2
10076382|NCT02218216|11203935|FG002|COMPLETED|Overall Study||3
10076383|NCT02218216|11203933|FG000|NOT COMPLETED|Overall Study||6
10076384|NCT02218216|11203934|FG001|NOT COMPLETED|Overall Study||0
10076385|NCT02218216|11203935|FG002|NOT COMPLETED|Overall Study||0
10076386|NCT02218242|11203943|FG000|STARTED|Overall Study||9
10076387|NCT02218242|11203943|FG000|COMPLETED|Overall Study||9
10076388|NCT02218242|11203943|FG000|NOT COMPLETED|Overall Study||0
10076389|NCT02218268|11203947|FG000|STARTED|First Phase (2 Hours)||30
10076390|NCT02218268|11203948|FG001|STARTED|First Phase (2 Hours)||30
10076391|NCT02218268|11203947|FG000|COMPLETED|First Phase (2 Hours)||30
10076392|NCT02218268|11203948|FG001|COMPLETED|First Phase (2 Hours)||30
10076393|NCT02218268|11203947|FG000|NOT COMPLETED|First Phase (2 Hours)||0
10076394|NCT02218268|11203948|FG001|NOT COMPLETED|First Phase (2 Hours)||0
10076395|NCT02218268|11203947|FG000|STARTED|24 Hour Washout||30
10076396|NCT02218268|11203948|FG001|STARTED|24 Hour Washout||30
10076397|NCT02218268|11203947|FG000|COMPLETED|24 Hour Washout||19
10076398|NCT02218268|11203948|FG001|COMPLETED|24 Hour Washout||21
10076399|NCT02218268|11203947|FG000|NOT COMPLETED|24 Hour Washout||11
10076400|NCT02218268|11203948|FG001|NOT COMPLETED|24 Hour Washout||9
10076401|NCT02218268|11203947|FG000|STARTED|Final Phase (2 Hours)||19
10076402|NCT02218268|11203948|FG001|STARTED|Final Phase (2 Hours)||21
10076403|NCT02218268|11203947|FG000|COMPLETED|Final Phase (2 Hours)||19
10076404|NCT02218268|11203948|FG001|COMPLETED|Final Phase (2 Hours)||21
10076405|NCT02218268|11203947|FG000|NOT COMPLETED|Final Phase (2 Hours)||0
10076406|NCT02218268|11203948|FG001|NOT COMPLETED|Final Phase (2 Hours)||0
10076407|NCT02218307|11203956|FG000|STARTED|Overall Study||34
10076408|NCT02218307|11203957|FG001|STARTED|Overall Study||34
10076409|NCT02218307|11203956|FG000|COMPLETED|Overall Study||25
10076410|NCT02218307|11203957|FG001|COMPLETED|Overall Study||33
10076411|NCT02218307|11203956|FG000|NOT COMPLETED|Overall Study||9
10076412|NCT02218307|11203957|FG001|NOT COMPLETED|Overall Study||1
10076413|NCT02218320|11203965|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
10076414|NCT02218320|11203966|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10
10076415|NCT02218320|11203965|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
10076416|NCT02218320|11203966|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
10076417|NCT02218320|11203965|FG000|NOT COMPLETED|Overall Study||0
10076418|NCT02218320|11203966|FG001|NOT COMPLETED|Overall Study||0
10076419|NCT02218372|11203974|FG000|STARTED|Overall Study||100
10076420|NCT02218372|11203975|FG001|STARTED|Overall Study||48
10076421|NCT02218372|11203974|FG000|Treated|Overall Study||98
10076422|NCT02218372|11203975|FG001|Treated|Overall Study||44
10076423|NCT02218372|11203974|FG000|COMPLETED|Overall Study||95
10076424|NCT02218372|11203975|FG001|COMPLETED|Overall Study||42
10076425|NCT02218372|11203974|FG000|NOT COMPLETED|Overall Study||5
10076426|NCT02218372|11203975|FG001|NOT COMPLETED|Overall Study||6
10076427|NCT02218424|11203988|FG000|STARTED|Overall Study||30
10076428|NCT02218424|11203989|FG001|STARTED|Overall Study||30
10076429|NCT02218424|11203988|FG000|COMPLETED|Overall Study||30
10076430|NCT02218424|11203989|FG001|COMPLETED|Overall Study||30
10076431|NCT02218424|11203988|FG000|NOT COMPLETED|Overall Study||0
10076432|NCT02218424|11203989|FG001|NOT COMPLETED|Overall Study||0
10076433|NCT02218463|11203997|FG000|STARTED|Overall Study||21
10076434|NCT02218463|11203998|FG001|STARTED|Overall Study||22
10076435|NCT02218463|11203997|FG000|COMPLETED|Overall Study||18
10076436|NCT02218463|11203998|FG001|COMPLETED|Overall Study||19
10076437|NCT02218463|11203997|FG000|NOT COMPLETED|Overall Study||3
10076438|NCT02218463|11203998|FG001|NOT COMPLETED|Overall Study||3
10076439|NCT02218489|11204006|FG000|STARTED|Overall Study||101
9850741|NCT00871923|10963437|FG000|NOT COMPLETED|Overall Study||2
9850742|NCT00871975|10963441|FG000|STARTED|Overall Study||155
10076440|NCT02218489|11204007|FG001|STARTED|Overall Study||104
10076441|NCT02218489|11204006|FG000|COMPLETED|Overall Study||96
10076442|NCT02218489|11204007|FG001|COMPLETED|Overall Study||101
10076443|NCT02218489|11204006|FG000|NOT COMPLETED|Overall Study||5
10076444|NCT02218489|11204007|FG001|NOT COMPLETED|Overall Study||3
10076445|NCT02218541|11204016|FG000|STARTED|Overall Study||11
10076446|NCT02218541|11204017|FG001|STARTED|Overall Study||11
10076447|NCT02218541|11204016|FG000|COMPLETED|Overall Study||5
10076448|NCT02218541|11204017|FG001|COMPLETED|Overall Study||9
10076449|NCT02218541|11204016|FG000|NOT COMPLETED|Overall Study||6
10076450|NCT02218541|11204017|FG001|NOT COMPLETED|Overall Study||2
10076451|NCT02218736|11204026|FG000|STARTED|Overall Study||45
10076452|NCT02218736|11204027|FG001|STARTED|Overall Study||44
10076453|NCT02218736|11204026|FG000|COMPLETED|Overall Study||33
10076454|NCT02218736|11204027|FG001|COMPLETED|Overall Study||35
10076455|NCT02218736|11204026|FG000|NOT COMPLETED|Overall Study||12
10076456|NCT02218736|11204027|FG001|NOT COMPLETED|Overall Study||9
10076457|NCT02219009|11204035|FG000|STARTED|Overall Study||37
10076458|NCT02219009|11204036|FG001|STARTED|Overall Study||30
10076459|NCT02219009|11204035|FG000|COMPLETED|Overall Study||27
10076460|NCT02219009|11204036|FG001|COMPLETED|Overall Study||22
10076461|NCT02219009|11204035|FG000|NOT COMPLETED|Overall Study||10
10076462|NCT02219009|11204036|FG001|NOT COMPLETED|Overall Study||8
10076463|NCT02219048|11204044|FG000|STARTED|Overall Study||26
10076464|NCT02219048|11204045|FG001|STARTED|Overall Study||25
10076465|NCT02219048|11204044|FG000|COMPLETED|Overall Study||5
10076466|NCT02219048|11204045|FG001|COMPLETED|Overall Study||4
10076467|NCT02219048|11204044|FG000|NOT COMPLETED|Overall Study||21
10076468|NCT02219048|11204045|FG001|NOT COMPLETED|Overall Study||21
10076469|NCT02219087|11204053|FG000|STARTED|Overall Study||30
10076470|NCT02219087|11204054|FG001|STARTED|Overall Study||30
10076471|NCT02219087|11204053|FG000|COMPLETED|Overall Study||30
10076472|NCT02219087|11204054|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
10076473|NCT02219087|11204053|FG000|NOT COMPLETED|Overall Study||0
10076474|NCT02219087|11204054|FG001|NOT COMPLETED|Overall Study||1
10076475|NCT02219256|11204072|FG000|STARTED|Overall Study||12
10076476|NCT02219256|11204073|FG001|STARTED|Overall Study||4
10076477|NCT02219256|11204074|FG002|STARTED|Overall Study||4
10076478|NCT02219256|11204075|FG003|STARTED|Overall Study||4
10191036|NCT03301298|11320207|FG004|STARTED|Unfed Conditions||6
10191037|NCT03301298|11320208|FG005|STARTED|Unfed Conditions||6
10191038|NCT03301298|11320209|FG006|STARTED|Unfed Conditions||12
10191039|NCT03301298|11320203|FG000|COMPLETED|Unfed Conditions||6
10191040|NCT03301298|11320204|FG001|COMPLETED|Unfed Conditions||6
10191041|NCT03301298|11320205|FG002|COMPLETED|Unfed Conditions||6
10191042|NCT03301298|11320206|FG003|COMPLETED|Unfed Conditions||6
10191043|NCT03301298|11320207|FG004|COMPLETED|Unfed Conditions||6
10191044|NCT03301298|11320208|FG005|COMPLETED|Unfed Conditions||6
10191045|NCT03301298|11320209|FG006|COMPLETED|Unfed Conditions||12
10191046|NCT03301298|11320203|FG000|NOT COMPLETED|Unfed Conditions||0
10191047|NCT03301298|11320204|FG001|NOT COMPLETED|Unfed Conditions||0
10191048|NCT03301298|11320205|FG002|NOT COMPLETED|Unfed Conditions||0
10191049|NCT03301298|11320206|FG003|NOT COMPLETED|Unfed Conditions||0
10191050|NCT03301298|11320207|FG004|NOT COMPLETED|Unfed Conditions||0
10191051|NCT03301298|11320208|FG005|NOT COMPLETED|Unfed Conditions||0
10191052|NCT03301298|11320209|FG006|NOT COMPLETED|Unfed Conditions||0
10191053|NCT03301298|11320203|FG000|STARTED|Fed Conditions||0
10191054|NCT03301298|11320204|FG001|STARTED|Fed Conditions||0
10191055|NCT03301298|11320205|FG002|STARTED|Fed Conditions||0
10191056|NCT03301298|11320206|FG003|STARTED|Fed Conditions||0
10191057|NCT03301298|11320207|FG004|STARTED|Fed Conditions||5
10191058|NCT03301298|11320208|FG005|STARTED|Fed Conditions||0
10191059|NCT03301298|11320209|FG006|STARTED|Fed Conditions||2
10191060|NCT03301298|11320203|FG000|COMPLETED|Fed Conditions||0
10191061|NCT03301298|11320204|FG001|COMPLETED|Fed Conditions||0
10191062|NCT03301298|11320205|FG002|COMPLETED|Fed Conditions||0
10191063|NCT03301298|11320206|FG003|COMPLETED|Fed Conditions||0
10191064|NCT03301298|11320207|FG004|COMPLETED|Fed Conditions||5
10191065|NCT03301298|11320208|FG005|COMPLETED|Fed Conditions||0
10191066|NCT03301298|11320209|FG006|COMPLETED|Fed Conditions||2
10191067|NCT03301298|11320203|FG000|NOT COMPLETED|Fed Conditions||0
10191068|NCT03301298|11320204|FG001|NOT COMPLETED|Fed Conditions||0
10191069|NCT03301298|11320205|FG002|NOT COMPLETED|Fed Conditions||0
10191070|NCT03301298|11320206|FG003|NOT COMPLETED|Fed Conditions||0
10191071|NCT03301298|11320207|FG004|NOT COMPLETED|Fed Conditions||0
10191072|NCT03301298|11320208|FG005|NOT COMPLETED|Fed Conditions||0
10191073|NCT03301298|11320209|FG006|NOT COMPLETED|Fed Conditions||0
10076479|NCT02219256|11204076|FG004|STARTED|Overall Study||6
10076480|NCT02219256|11204077|FG005|STARTED|Overall Study||6
10076481|NCT02219256|11204078|FG006|STARTED|Overall Study||6
10076482|NCT02219256|11204079|FG007|STARTED|Overall Study||8
10076483|NCT02219256|11204080|FG008|STARTED|Overall Study||6
10076484|NCT02219256|11204081|FG009|STARTED|Overall Study||6
10076485|NCT02219256|11204082|FG010|STARTED|Overall Study||6
10076486|NCT02219256|11204083|FG011|STARTED|Overall Study||6
10076487|NCT02219256|11204072|FG000|COMPLETED|Overall Study||12
10076488|NCT02219256|11204073|FG001|COMPLETED|Overall Study||4
10076489|NCT02219256|11204074|FG002|COMPLETED|Overall Study||4
10076490|NCT02219256|11204075|FG003|COMPLETED|Overall Study||4
10076491|NCT02219256|11204076|FG004|COMPLETED|Overall Study||6
10076492|NCT02219256|11204077|FG005|COMPLETED|Overall Study||6
10076493|NCT02219256|11204078|FG006|COMPLETED|Overall Study||6
10076494|NCT02219256|11204079|FG007|COMPLETED|Overall Study||8
10076495|NCT02219256|11204080|FG008|COMPLETED|Overall Study||6
10076496|NCT02219256|11204081|FG009|COMPLETED|Overall Study||6
10191074|NCT03301623|11320228|FG000|STARTED|Overall Study||462
10191075|NCT03301623|11320229|FG001|STARTED|Overall Study||521
10191076|NCT03301623|11320228|FG000|COMPLETED|Overall Study||445
10191077|NCT03301623|11320229|FG001|COMPLETED|Overall Study||506
10191078|NCT03301623|11320228|FG000|NOT COMPLETED|Overall Study||17
10191079|NCT03301623|11320229|FG001|NOT COMPLETED|Overall Study||15
10191080|NCT03301649|11320238|FG000|STARTED|Overall Study||399
10191081|NCT03301649|11320239|FG001|STARTED|Overall Study||400
10191082|NCT03301649|11320240|FG002|STARTED|Overall Study||112
10191083|NCT03301649|11320238|FG000|Safety Population|Overall Study||399
10191084|NCT03301649|11320239|FG001|Safety Population|Overall Study||400
10191085|NCT03301649|11320240|FG002|Safety Population|Overall Study||112
10191086|NCT03301649|11320238|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372
10191087|NCT03301649|11320239|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380
10191088|NCT03301649|11320240|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111
10191089|NCT03301649|11320238|FG000|Per-protocol (PP) Population|Overall Study||345
10191090|NCT03301649|11320239|FG001|Per-protocol (PP) Population|Overall Study||354
10191091|NCT03301649|11320240|FG002|Per-protocol (PP) Population|Overall Study||103
10191092|NCT03301649|11320238|FG000|COMPLETED|Overall Study||356
10191093|NCT03301649|11320239|FG001|COMPLETED|Overall Study||356
10191094|NCT03301649|11320240|FG002|COMPLETED|Overall Study||27
10191095|NCT03301649|11320238|FG000|NOT COMPLETED|Overall Study||43
10191096|NCT03301649|11320239|FG001|NOT COMPLETED|Overall Study||44
10191097|NCT03301649|11320240|FG002|NOT COMPLETED|Overall Study||85
10191098|NCT03301714|11320251|FG000|STARTED|Overall Study||60
10191099|NCT03301714|11320252|FG001|STARTED|Overall Study||60
10191100|NCT03301714|11320253|FG002|STARTED|Overall Study||60
10191101|NCT03301714|11320251|FG000|COMPLETED|Overall Study||50
10191102|NCT03301714|11320252|FG001|COMPLETED|Overall Study||54
10191103|NCT03301714|11320253|FG002|COMPLETED|Overall Study||53
10191104|NCT03301714|11320251|FG000|NOT COMPLETED|Overall Study||10
10191105|NCT03301714|11320252|FG001|NOT COMPLETED|Overall Study||6
10191106|NCT03301714|11320253|FG002|NOT COMPLETED|Overall Study||7
10191107|NCT03301740|11320266|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18
10191108|NCT03301740|11320267|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16
10191109|NCT03301740|11320266|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18
10191110|NCT03301740|11320267|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16
10191111|NCT03301740|11320266|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
10191112|NCT03301740|11320267|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
10191113|NCT03301740|11320266|FG000|STARTED|First Washout (1 Week)||18
10191114|NCT03301740|11320267|FG001|STARTED|First Washout (1 Week)||16
10191115|NCT03301740|11320266|FG000|COMPLETED|First Washout (1 Week)||18
10191116|NCT03301740|11320267|FG001|COMPLETED|First Washout (1 Week)||16
10191117|NCT03301740|11320266|FG000|NOT COMPLETED|First Washout (1 Week)||0
10191118|NCT03301740|11320267|FG001|NOT COMPLETED|First Washout (1 Week)||0
10191119|NCT03301740|11320266|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18
10191120|NCT03301740|11320267|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16
10191121|NCT03301740|11320266|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17
10191122|NCT03301740|11320267|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16
10191123|NCT03301740|11320266|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
10191124|NCT03301740|11320267|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
10191125|NCT03301740|11320266|FG000|STARTED|Second Washout (1 Week)||17
10191126|NCT03301740|11320267|FG001|STARTED|Second Washout (1 Week)||16
10191127|NCT03301740|11320266|FG000|COMPLETED|Second Washout (1 Week)||17
10191128|NCT03301740|11320267|FG001|COMPLETED|Second Washout (1 Week)||16
10191129|NCT03301740|11320266|FG000|NOT COMPLETED|Second Washout (1 Week)||0
10191130|NCT03301740|11320267|FG001|NOT COMPLETED|Second Washout (1 Week)||0
10191131|NCT03301740|11320266|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17
10191132|NCT03301740|11320267|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16
10191133|NCT03301740|11320266|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17
10191134|NCT03301740|11320267|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16
10191135|NCT03301740|11320266|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
10191136|NCT03301740|11320267|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
10191137|NCT03301740|11320266|FG000|STARTED|Third Washout (1 Week)||17
10191138|NCT03301740|11320267|FG001|STARTED|Third Washout (1 Week)||16
10191139|NCT03301740|11320266|FG000|COMPLETED|Third Washout (1 Week)||17
10191140|NCT03301740|11320267|FG001|COMPLETED|Third Washout (1 Week)||16
10191141|NCT03301740|11320266|FG000|NOT COMPLETED|Third Washout (1 Week)||0
10076497|NCT02219256|11204082|FG010|COMPLETED|Overall Study||6
10191142|NCT03301740|11320267|FG001|NOT COMPLETED|Third Washout (1 Week)||0
10191143|NCT03301740|11320266|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17
10191144|NCT03301740|11320267|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16
10076498|NCT02219256|11204083|FG011|COMPLETED|Overall Study||6
10076499|NCT02219256|11204072|FG000|NOT COMPLETED|Overall Study||0
10076500|NCT02219256|11204073|FG001|NOT COMPLETED|Overall Study||0
10076501|NCT02219256|11204074|FG002|NOT COMPLETED|Overall Study||0
10076502|NCT02219256|11204075|FG003|NOT COMPLETED|Overall Study||0
10076503|NCT02219256|11204076|FG004|NOT COMPLETED|Overall Study||0
10076504|NCT02219256|11204077|FG005|NOT COMPLETED|Overall Study||0
10076505|NCT02219256|11204078|FG006|NOT COMPLETED|Overall Study||0
10076506|NCT02219256|11204079|FG007|NOT COMPLETED|Overall Study||0
10076507|NCT02219256|11204080|FG008|NOT COMPLETED|Overall Study||0
10076508|NCT02219256|11204081|FG009|NOT COMPLETED|Overall Study||0
10076509|NCT02219256|11204082|FG010|NOT COMPLETED|Overall Study||0
10076510|NCT02219256|11204083|FG011|NOT COMPLETED|Overall Study||0
10076511|NCT02219282|11204111|FG000|STARTED|Overall Study||33
10076512|NCT02219282|11204112|FG001|STARTED|Overall Study||33
10076513|NCT02219282|11204111|FG000|COMPLETED|Overall Study||32
10076514|NCT02219282|11204112|FG001|COMPLETED|Overall Study||32
10076515|NCT02219282|11204111|FG000|NOT COMPLETED|Overall Study||1
10076516|NCT02219282|11204112|FG001|NOT COMPLETED|Overall Study||1
10076517|NCT02219308|11204124|FG000|STARTED|Overall Study||32
10076518|NCT02219308|11204125|FG001|STARTED|Overall Study||35
10076519|NCT02219308|11204124|FG000|COMPLETED|Overall Study||31
10076520|NCT02219308|11204125|FG001|COMPLETED|Overall Study||33
10076521|NCT02219308|11204124|FG000|NOT COMPLETED|Overall Study||1
10076522|NCT02219308|11204125|FG001|NOT COMPLETED|Overall Study||2
10076523|NCT02219321|11204133|FG000|STARTED|Overall Study||1
10076524|NCT02219321|11204134|FG001|STARTED|Overall Study||2
10076525|NCT02219321|11204133|FG000|COMPLETED|Overall Study||1
10076526|NCT02219321|11204134|FG001|COMPLETED|Overall Study||2
10076527|NCT02219321|11204133|FG000|NOT COMPLETED|Overall Study||0
10076528|NCT02219321|11204134|FG001|NOT COMPLETED|Overall Study||0
10076529|NCT02219334|11204142|FG000|STARTED|Overall Study||32
10076530|NCT02219334|11204143|FG001|STARTED|Overall Study||23
10076531|NCT02219334|11204142|FG000|COMPLETED|Overall Study||24
10076532|NCT02219334|11204143|FG001|COMPLETED|Overall Study||20
10076533|NCT02219334|11204142|FG000|NOT COMPLETED|Overall Study||8
10076534|NCT02219334|11204143|FG001|NOT COMPLETED|Overall Study||3
10076535|NCT02219438|11204151|FG000|STARTED|Overall Study||13
10076536|NCT02219438|11204152|FG001|STARTED|Overall Study||11
10076537|NCT02219438|11204151|FG000|COMPLETED|Overall Study||13
10076538|NCT02219438|11204152|FG001|COMPLETED|Overall Study||11
10191145|NCT03301740|11320266|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16
10191146|NCT03301740|11320267|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16
10191147|NCT03301740|11320266|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
10191148|NCT03301740|11320267|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
10191149|NCT03301779|11320273|FG000|STARTED|Overall Study||48
10191150|NCT03301779|11320274|FG001|STARTED|Overall Study||52
10191151|NCT03301779|11320273|FG000|COMPLETED|Overall Study||40
10191152|NCT03301779|11320274|FG001|COMPLETED|Overall Study||45
10191153|NCT03301779|11320273|FG000|NOT COMPLETED|Overall Study||8
10191154|NCT03301779|11320274|FG001|NOT COMPLETED|Overall Study||7
10191155|NCT03301831|11320282|FG000|STARTED|Overall Study||46
10191156|NCT03301831|11320283|FG001|STARTED|Overall Study||47
10191157|NCT03301831|11320282|FG000|COMPLETED|Overall Study||26
10191158|NCT03301831|11320283|FG001|COMPLETED|Overall Study||44
10191159|NCT03301831|11320282|FG000|NOT COMPLETED|Overall Study||20
10191160|NCT03301831|11320283|FG001|NOT COMPLETED|Overall Study||3
10191161|NCT03301844|11320291|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
10191162|NCT03301844|11320292|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
10191163|NCT03301844|11320291|FG000|COMPLETED|Overall Study||18
10191164|NCT03301844|11320292|FG001|COMPLETED|Overall Study||18
10191165|NCT03301844|11320291|FG000|NOT COMPLETED|Overall Study||1
10191166|NCT03301844|11320292|FG001|NOT COMPLETED|Overall Study||1
10191167|NCT03302091|11320300|FG000|STARTED|Overall Study||10
10191168|NCT03302091|11320301|FG001|STARTED|Overall Study||10
10191169|NCT03302091|11320300|FG000|COMPLETED|Overall Study||10
10191170|NCT03302091|11320301|FG001|COMPLETED|Overall Study||10
10191171|NCT03302091|11320300|FG000|NOT COMPLETED|Overall Study||0
10191172|NCT03302091|11320301|FG001|NOT COMPLETED|Overall Study||0
10191173|NCT03302416|11320307|FG000|STARTED|Overall Study||19
10191174|NCT03302416|11320307|FG000|COMPLETED|Overall Study||19
10191175|NCT03302416|11320307|FG000|NOT COMPLETED|Overall Study||0
10191176|NCT03302559|11320311|FG000|STARTED|Overall Study||29
10191177|NCT03302559|11320311|FG000|COMPLETED|Overall Study||23
10191178|NCT03302559|11320311|FG000|NOT COMPLETED|Overall Study||6
10191179|NCT03302741|11320317|FG000|STARTED|Overall Study||8
10191180|NCT03302741|11320318|FG001|STARTED|Overall Study||9
10191181|NCT03302741|11320317|FG000|COMPLETED|Overall Study||7
10191182|NCT03302741|11320318|FG001|COMPLETED|Overall Study||8
10191183|NCT03302741|11320317|FG000|NOT COMPLETED|Overall Study||1
10191184|NCT03302741|11320318|FG001|NOT COMPLETED|Overall Study||1
10191185|NCT03302767|11320324|FG000|STARTED|Overall Study||29
10191186|NCT03302767|11320324|FG000|COMPLETED|Overall Study||29
10191187|NCT03302767|11320324|FG000|NOT COMPLETED|Overall Study||0
10191188|NCT03302780|11320328|FG000|STARTED|Overall Study||3
10191189|NCT03302780|11320329|FG001|STARTED|Overall Study||3
10191190|NCT03302780|11320328|FG000|COMPLETED|Overall Study||3
10191191|NCT03302780|11320329|FG001|COMPLETED|Overall Study||3
10076539|NCT02219438|11204151|FG000|NOT COMPLETED|Overall Study||0
10076540|NCT02219438|11204152|FG001|NOT COMPLETED|Overall Study||0
10076541|NCT02219464|11204162|FG000|STARTED|Overall Study||30
10076542|NCT02219464|11204163|FG001|STARTED|Overall Study||30
10076543|NCT02219464|11204162|FG000|COMPLETED|Overall Study||27
10076544|NCT02219464|11204163|FG001|COMPLETED|Overall Study||30
10076545|NCT02219464|11204162|FG000|NOT COMPLETED|Overall Study||3
10076546|NCT02219464|11204163|FG001|NOT COMPLETED|Overall Study||0
10076547|NCT02219477|11204172|FG000|STARTED|Overall Study||9
10076548|NCT02219477|11204173|FG001|STARTED|Overall Study||24
10076549|NCT02219477|11204174|FG002|STARTED|Overall Study||3
10076550|NCT02219477|11204172|FG000|COMPLETED|Overall Study||9
10076551|NCT02219477|11204173|FG001|COMPLETED|Overall Study||22
10076552|NCT02219477|11204174|FG002|COMPLETED|Overall Study||2
10076553|NCT02219477|11204172|FG000|NOT COMPLETED|Overall Study||0
10076554|NCT02219477|11204173|FG001|NOT COMPLETED|Overall Study||2
10076555|NCT02219477|11204174|FG002|NOT COMPLETED|Overall Study||1
10076556|NCT02219503|11204183|FG000|STARTED|Overall Study||60
10076557|NCT02219503|11204183|FG000|COMPLETED|Overall Study||60
10076558|NCT02219503|11204183|FG000|NOT COMPLETED|Overall Study||0
10076559|NCT02219516|11204191|FG000|STARTED|Overall Study||8
10076560|NCT02219516|11204192|FG001|STARTED|Overall Study||8
10076561|NCT02219516|11204193|FG002|STARTED|Overall Study||7
10076562|NCT02219516|11204194|FG003|STARTED|Overall Study||8
10076563|NCT02219516|11204191|FG000|COMPLETED|Overall Study||8
10076564|NCT02219516|11204192|FG001|COMPLETED|Overall Study||8
10076565|NCT02219516|11204193|FG002|COMPLETED|Overall Study||7
10076566|NCT02219516|11204194|FG003|COMPLETED|Overall Study||8
10076567|NCT02219516|11204191|FG000|NOT COMPLETED|Overall Study||0
10076568|NCT02219516|11204192|FG001|NOT COMPLETED|Overall Study||0
10076569|NCT02219516|11204193|FG002|NOT COMPLETED|Overall Study||0
10076570|NCT02219516|11204194|FG003|NOT COMPLETED|Overall Study||0
10076571|NCT02219685|11204206|FG000|STARTED|Blinded Treatment Phase||26
10076572|NCT02219685|11204207|FG001|STARTED|Blinded Treatment Phase||14
10076573|NCT02219685|11204206|FG000|COMPLETED|Blinded Treatment Phase||24
10076574|NCT02219685|11204207|FG001|COMPLETED|Blinded Treatment Phase||14
10076575|NCT02219685|11204206|FG000|NOT COMPLETED|Blinded Treatment Phase||2
10076576|NCT02219685|11204207|FG001|NOT COMPLETED|Blinded Treatment Phase||0
10076577|NCT02219685|11204206|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
10076578|NCT02219685|11204207|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14
10076579|NCT02219685|11204206|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0
10076580|NCT02219685|11204207|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14
10076581|NCT02219685|11204206|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
10076582|NCT02219685|11204207|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
10076583|NCT02219815|11204217|FG000|STARTED|Overall Study||44
10076584|NCT02219815|11204218|FG001|STARTED|Overall Study||45
10076585|NCT02219815|11204217|FG000|Post Hospital Discharge Analysis|Overall Study||42
10076586|NCT02219815|11204218|FG001|Post Hospital Discharge Analysis|Overall Study||39
10076587|NCT02219815|11204217|FG000|3 Month Post Surgery|Overall Study||34
10076588|NCT02219815|11204218|FG001|3 Month Post Surgery|Overall Study||31
10076589|NCT02219815|11204217|FG000|COMPLETED|Overall Study||22
10076590|NCT02219815|11204218|FG001|COMPLETED|Overall Study||21
10076591|NCT02219815|11204217|FG000|NOT COMPLETED|Overall Study||22
10076592|NCT02219815|11204218|FG001|NOT COMPLETED|Overall Study||24
10076593|NCT02219932|11204226|FG000|STARTED|Overall Study||319
10076594|NCT02219932|11204227|FG001|STARTED|Overall Study||317
10076595|NCT02219932|11204226|FG000|Randomized, Not Treated|Overall Study||0
10076596|NCT02219932|11204227|FG001|Randomized, Not Treated|Overall Study||1
10076597|NCT02219932|11204226|FG000|COMPLETED|Overall Study||254
10076598|NCT02219932|11204227|FG001|COMPLETED|Overall Study||266
10076599|NCT02219932|11204226|FG000|NOT COMPLETED|Overall Study||65
10076600|NCT02219932|11204227|FG001|NOT COMPLETED|Overall Study||51
10076601|NCT02219997|11204235|FG000|STARTED|First Filter||33
10076602|NCT02219997|11204236|FG001|STARTED|First Filter||17
10076603|NCT02219997|11204237|FG002|STARTED|First Filter||18
10076604|NCT02219997|11204235|FG000|COMPLETED|First Filter||33
10076605|NCT02219997|11204236|FG001|COMPLETED|First Filter||17
10076606|NCT02219997|11204237|FG002|COMPLETED|First Filter||18
10076607|NCT02219997|11204235|FG000|NOT COMPLETED|First Filter||0
10076608|NCT02219997|11204236|FG001|NOT COMPLETED|First Filter||0
10076609|NCT02219997|11204237|FG002|NOT COMPLETED|First Filter||0
10076610|NCT02219997|11204235|FG000|STARTED|Second Filter||0
10076611|NCT02219997|11204236|FG001|STARTED|Second Filter||17
10076612|NCT02219997|11204237|FG002|STARTED|Second Filter||18
10076613|NCT02219997|11204235|FG000|COMPLETED|Second Filter||0
10076614|NCT02219997|11204236|FG001|COMPLETED|Second Filter||17
10076615|NCT02219997|11204237|FG002|COMPLETED|Second Filter||18
10076616|NCT02219997|11204235|FG000|NOT COMPLETED|Second Filter||0
10076617|NCT02219997|11204236|FG001|NOT COMPLETED|Second Filter||0
10076618|NCT02219997|11204237|FG002|NOT COMPLETED|Second Filter||0
10076619|NCT02220205|11204250|FG000|STARTED|Overall Study||30
10076620|NCT02220205|11204251|FG001|STARTED|Overall Study||30
10076621|NCT02220205|11204250|FG000|COMPLETED|Overall Study||29
10076622|NCT02220205|11204251|FG001|COMPLETED|Overall Study||30
10076623|NCT02220205|11204250|FG000|NOT COMPLETED|Overall Study||1
10076624|NCT02220205|11204251|FG001|NOT COMPLETED|Overall Study||0
10076625|NCT02220712|11204257|FG000|STARTED|Overall Study||17
10076626|NCT02220712|11204257|FG000|COMPLETED|Overall Study||13
10076627|NCT02220712|11204257|FG000|NOT COMPLETED|Overall Study||4
10076628|NCT02220725|11204269|FG000|STARTED|Overall Study||14
10076629|NCT02220725|11204270|FG001|STARTED|Overall Study||27
10076630|NCT02220725|11204271|FG002|STARTED|Overall Study||13
10076631|NCT02220725|11204272|FG003|STARTED|Overall Study||26
10076632|NCT02220725|11204269|FG000|COMPLETED|Overall Study||14
10076633|NCT02220725|11204270|FG001|COMPLETED|Overall Study||27
10076634|NCT02220725|11204271|FG002|COMPLETED|Overall Study||13
10076635|NCT02220725|11204272|FG003|COMPLETED|Overall Study||24
10076636|NCT02220725|11204269|FG000|NOT COMPLETED|Overall Study||0
10076637|NCT02220725|11204270|FG001|NOT COMPLETED|Overall Study||0
10076638|NCT02220725|11204271|FG002|NOT COMPLETED|Overall Study||0
10076639|NCT02220725|11204272|FG003|NOT COMPLETED|Overall Study||2
10076640|NCT02220764|11204287|FG000|STARTED|Overall Study||24
10076641|NCT02220764|11204288|FG001|STARTED|Overall Study||8
10076642|NCT02220764|11204287|FG000|COMPLETED|Overall Study||20
10076643|NCT02220764|11204288|FG001|COMPLETED|Overall Study||7
10076644|NCT02220764|11204287|FG000|NOT COMPLETED|Overall Study||4
10076645|NCT02220764|11204288|FG001|NOT COMPLETED|Overall Study||1
10076646|NCT02220907|11204294|FG000|STARTED|Overall Study||153
10076647|NCT02220907|11204294|FG000|COMPLETED|Overall Study||142
10076648|NCT02220907|11204294|FG000|NOT COMPLETED|Overall Study||11
10076649|NCT02220920|11204300|FG000|STARTED|Overall Study||76
10076650|NCT02220920|11204301|FG001|STARTED|Overall Study||70
10076651|NCT02220920|11204300|FG000|COMPLETED|Overall Study||73
10076652|NCT02220920|11204301|FG001|COMPLETED|Overall Study||67
10076653|NCT02220920|11204300|FG000|NOT COMPLETED|Overall Study||3
10076654|NCT02220920|11204301|FG001|NOT COMPLETED|Overall Study||3
10076655|NCT02220998|11204309|FG000|STARTED|Overall Study||135
10076656|NCT02220998|11204310|FG001|STARTED|Overall Study||134
10076657|NCT02220998|11204309|FG000|COMPLETED|Overall Study||128
10076658|NCT02220998|11204310|FG001|COMPLETED|Overall Study||123
10076659|NCT02220998|11204309|FG000|NOT COMPLETED|Overall Study||7
10076660|NCT02220998|11204310|FG001|NOT COMPLETED|Overall Study||11
10076661|NCT02221219|11204320|FG000|STARTED|Overall Study||36
10076662|NCT02221219|11204321|FG001|STARTED|Overall Study||87
10076663|NCT02221219|11204322|FG002|STARTED|Overall Study||41
10076664|NCT02221219|11204323|FG003|STARTED|Overall Study||92
10076665|NCT02221219|11204320|FG000|COMPLETED|Overall Study||36
10076666|NCT02221219|11204321|FG001|COMPLETED|Overall Study||87
10076667|NCT02221219|11204322|FG002|COMPLETED|Overall Study||41
10076668|NCT02221219|11204323|FG003|COMPLETED|Overall Study||92
10076669|NCT02221219|11204320|FG000|NOT COMPLETED|Overall Study||0
10076670|NCT02221219|11204321|FG001|NOT COMPLETED|Overall Study||0
10076671|NCT02221219|11204322|FG002|NOT COMPLETED|Overall Study||0
10076672|NCT02221219|11204323|FG003|NOT COMPLETED|Overall Study||0
10076673|NCT02221284|11204337|FG000|STARTED|Overall Study||964
10076674|NCT02221284|11204337|FG000|COMPLETED|Overall Study||903
10076675|NCT02221284|11204337|FG000|NOT COMPLETED|Overall Study||61
10076676|NCT02221349|11204349|FG000|STARTED|Overall Study||15
10076677|NCT02221349|11204350|FG001|STARTED|Overall Study||15
10076678|NCT02221349|11204349|FG000|COMPLETED|Overall Study||14
10076679|NCT02221349|11204350|FG001|COMPLETED|Overall Study||15
10076680|NCT02221349|11204349|FG000|NOT COMPLETED|Overall Study||1
10076681|NCT02221349|11204350|FG001|NOT COMPLETED|Overall Study||0
10076682|NCT02221557|11204356|FG000|STARTED|Overall Study||8
10076683|NCT02221557|11204356|FG000|COMPLETED|Overall Study||5
10076684|NCT02221557|11204356|FG000|NOT COMPLETED|Overall Study||3
10076685|NCT02221648|11204362|FG000|STARTED|Overall Study||22
10076686|NCT02221648|11204363|FG001|STARTED|Overall Study||21
10076687|NCT02221648|11204362|FG000|COMPLETED|Overall Study||19
10076688|NCT02221648|11204363|FG001|COMPLETED|Overall Study||18
10076689|NCT02221648|11204362|FG000|NOT COMPLETED|Overall Study||3
10076690|NCT02221648|11204363|FG001|NOT COMPLETED|Overall Study||3
10076691|NCT02221674|11204376|FG000|STARTED|Overall Study||8
10076692|NCT02221674|11204377|FG001|STARTED|Overall Study||6
10076693|NCT02221674|11204378|FG002|STARTED|Overall Study||5
10076694|NCT02221674|11204376|FG000|COMPLETED|Overall Study||7
10076695|NCT02221674|11204377|FG001|COMPLETED|Overall Study||6
10076696|NCT02221674|11204378|FG002|COMPLETED|Overall Study||5
10076697|NCT02221674|11204376|FG000|NOT COMPLETED|Overall Study||1
10076698|NCT02221674|11204377|FG001|NOT COMPLETED|Overall Study||0
10076699|NCT02221674|11204378|FG002|NOT COMPLETED|Overall Study||0
10076700|NCT02221739|11204389|FG000|STARTED|Overall Study||39
10076701|NCT02221739|11204389|FG000|COMPLETED|Overall Study||21
10076702|NCT02221739|11204389|FG000|NOT COMPLETED|Overall Study||18
10076703|NCT02221869|11204396|FG000|STARTED|Overall Study||31
10076704|NCT02221869|11204397|FG001|STARTED|Overall Study||32
10076705|NCT02221869|11204398|FG002|STARTED|Overall Study||43
10076706|NCT02221869|11204396|FG000|COMPLETED|Overall Study||30
10076707|NCT02221869|11204397|FG001|COMPLETED|Overall Study||32
10076708|NCT02221869|11204398|FG002|COMPLETED|Overall Study||33
10076709|NCT02221869|11204396|FG000|NOT COMPLETED|Overall Study||1
10076710|NCT02221869|11204397|FG001|NOT COMPLETED|Overall Study||0
10076711|NCT02221869|11204398|FG002|NOT COMPLETED|Overall Study||10
10076712|NCT02221882|11204410|FG000|STARTED|Overall Study||3
10076713|NCT02221882|11204411|FG001|STARTED|Overall Study||3
10076714|NCT02221882|11204412|FG002|STARTED|Overall Study||11
10076715|NCT02221882|11204413|FG003|STARTED|Overall Study||3
10076716|NCT02221882|11204414|FG004|STARTED|Overall Study||5
10076717|NCT02221882|11204415|FG005|STARTED|Overall Study||4
10076718|NCT02221882|11204410|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10076719|NCT02221882|11204411|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10076720|NCT02221882|11204412|FG002|Received at Least One Dose of Study Drug|Overall Study||11
10076721|NCT02221882|11204413|FG003|Received at Least One Dose of Study Drug|Overall Study||3
10076722|NCT02221882|11204414|FG004|Received at Least One Dose of Study Drug|Overall Study||5
10076723|NCT02221882|11204415|FG005|Received at Least One Dose of Study Drug|Overall Study||4
10076724|NCT02221882|11204410|FG000|COMPLETED|Overall Study||3
10076725|NCT02221882|11204411|FG001|COMPLETED|Overall Study||2
10076726|NCT02221882|11204412|FG002|COMPLETED|Overall Study||7
10076727|NCT02221882|11204413|FG003|COMPLETED|Overall Study||1
10076728|NCT02221882|11204414|FG004|COMPLETED|Overall Study||3
10076729|NCT02221882|11204415|FG005|COMPLETED|Overall Study||2
10076730|NCT02221882|11204410|FG000|NOT COMPLETED|Overall Study||0
10076731|NCT02221882|11204411|FG001|NOT COMPLETED|Overall Study||1
10076732|NCT02221882|11204412|FG002|NOT COMPLETED|Overall Study||4
10076733|NCT02221882|11204413|FG003|NOT COMPLETED|Overall Study||2
10076734|NCT02221882|11204414|FG004|NOT COMPLETED|Overall Study||2
10076735|NCT02221882|11204415|FG005|NOT COMPLETED|Overall Study||2
10076736|NCT02221947|11204436|FG000|STARTED|Overall Study||6
10076737|NCT02221947|11204437|FG001|STARTED|Overall Study||3
10076738|NCT02221947|11204436|FG000|COMPLETED|Overall Study||6
10076739|NCT02221947|11204437|FG001|COMPLETED|Overall Study||3
10076740|NCT02221947|11204436|FG000|NOT COMPLETED|Overall Study||0
10076741|NCT02221947|11204437|FG001|NOT COMPLETED|Overall Study||0
10076742|NCT02222129|11204448|FG000|STARTED|Overall Study||100
10076743|NCT02222129|11204449|FG001|STARTED|Overall Study||106
10076744|NCT02222129|11204448|FG000|COMPLETED|Overall Study||100
10076745|NCT02222129|11204449|FG001|COMPLETED|Overall Study||106
10076746|NCT02222129|11204448|FG000|NOT COMPLETED|Overall Study||0
10076747|NCT02222129|11204449|FG001|NOT COMPLETED|Overall Study||0
10076748|NCT02222181|11204455|FG000|STARTED|Overall Study||163
10076749|NCT02222181|11204455|FG000|COMPLETED|Overall Study||55
10076750|NCT02222181|11204455|FG000|NOT COMPLETED|Overall Study||108
10076751|NCT02222207|11204459|FG000|STARTED|Overall Study||52
10076752|NCT02222207|11204459|FG000|Treated and Valid for Full Analysis Set|Overall Study||51
10076753|NCT02222207|11204459|FG000|COMPLETED|Overall Study||48
10076754|NCT02222207|11204459|FG000|NOT COMPLETED|Overall Study||4
10076755|NCT02222246|11204465|FG000|STARTED|Overall Study||53
10076756|NCT02222246|11204466|FG001|STARTED|Overall Study||53
10076757|NCT02222246|11204465|FG000|COMPLETED|Overall Study||26
10076758|NCT02222246|11204466|FG001|COMPLETED|Overall Study||26
10076759|NCT02222246|11204465|FG000|NOT COMPLETED|Overall Study||27
10076760|NCT02222246|11204466|FG001|NOT COMPLETED|Overall Study||27
10076761|NCT02222337|11204476|FG000|STARTED|Overall Study||140
10076762|NCT02222337|11204477|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
10076763|NCT02222337|11204476|FG000|COMPLETED|Overall Study||114
10076764|NCT02222337|11204477|FG001|COMPLETED|Overall Study||108
10076765|NCT02222337|11204476|FG000|NOT COMPLETED|Overall Study||26
10076766|NCT02222337|11204477|FG001|NOT COMPLETED|Overall Study||24
10076767|NCT02222493|11204489|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
10076768|NCT02222493|11204490|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
10076769|NCT02222493|11204489|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
10076770|NCT02222493|11204490|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
10076771|NCT02222493|11204489|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
10076772|NCT02222493|11204490|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
10076773|NCT02222493|11204489|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
10076774|NCT02222493|11204490|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
10076775|NCT02222493|11204489|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
10076776|NCT02222493|11204490|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
10076777|NCT02222493|11204489|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
9717435|NCT00003820|10816629|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
9731472|NCT00132730|10831389|FG000|STARTED|Period II - 12-week Treatment (Base)||150
9966080|NCT01505647|11086280|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
9966081|NCT01505647|11086281|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
10076778|NCT02222493|11204490|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
10076779|NCT02222493|11204489|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
10076780|NCT02222493|11204490|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
10076781|NCT02222493|11204489|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
10076782|NCT02222493|11204490|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
10076783|NCT02222493|11204489|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
10076784|NCT02222493|11204490|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
10076785|NCT02222493|11204489|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
10076786|NCT02222493|11204490|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
10076787|NCT02222558|11204509|FG000|STARTED|Period 1: Single Dose||25
10076788|NCT02222558|11204510|FG001|STARTED|Period 1: Single Dose||0
10076789|NCT02222558|11204511|FG002|STARTED|Period 1: Single Dose||0
10076790|NCT02222558|11204512|FG003|STARTED|Period 1: Single Dose||0
10076791|NCT02222558|11204513|FG004|STARTED|Period 1: Single Dose||0
10076792|NCT02222558|11204514|FG005|STARTED|Period 1: Single Dose||0
10076793|NCT02222558|11204509|FG000|COMPLETED|Period 1: Single Dose||21
9966082|NCT01505647|11086280|FG000|STARTED|Day 43 Through Day 182 Follow-up||329
9966083|NCT01505647|11086281|FG001|STARTED|Day 43 Through Day 182 Follow-up||166
9966084|NCT01505647|11086280|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328
9966085|NCT01505647|11086281|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163
9966086|NCT01505647|11086280|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
9966087|NCT01505647|11086281|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
9966088|NCT01505673|11086289|FG000|STARTED|Overall Study||35
10076794|NCT02222558|11204510|FG001|COMPLETED|Period 1: Single Dose||0
10076795|NCT02222558|11204511|FG002|COMPLETED|Period 1: Single Dose||0
10076796|NCT02222558|11204512|FG003|COMPLETED|Period 1: Single Dose||0
10076797|NCT02222558|11204513|FG004|COMPLETED|Period 1: Single Dose||0
10076798|NCT02222558|11204514|FG005|COMPLETED|Period 1: Single Dose||0
10076799|NCT02222558|11204509|FG000|NOT COMPLETED|Period 1: Single Dose||4
10076800|NCT02222558|11204510|FG001|NOT COMPLETED|Period 1: Single Dose||0
10076801|NCT02222558|11204511|FG002|NOT COMPLETED|Period 1: Single Dose||0
10076802|NCT02222558|11204512|FG003|NOT COMPLETED|Period 1: Single Dose||0
10076803|NCT02222558|11204513|FG004|NOT COMPLETED|Period 1: Single Dose||0
10076804|NCT02222558|11204514|FG005|NOT COMPLETED|Period 1: Single Dose||0
10076805|NCT02222558|11204509|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10076806|NCT02222558|11204510|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
10076807|NCT02222558|11204511|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10191192|NCT03302780|11320328|FG000|NOT COMPLETED|Overall Study||0
10191193|NCT03302780|11320329|FG001|NOT COMPLETED|Overall Study||0
10191194|NCT03302793|11320335|FG000|STARTED|Overall Study||6
10191195|NCT03302793|11320336|FG001|STARTED|Overall Study||6
10191196|NCT03302793|11320335|FG000|COMPLETED|Overall Study||6
10191197|NCT03302793|11320336|FG001|COMPLETED|Overall Study||4
10191198|NCT03302793|11320335|FG000|NOT COMPLETED|Overall Study||0
10191199|NCT03302793|11320336|FG001|NOT COMPLETED|Overall Study||2
10191200|NCT03302936|11320344|FG000|STARTED|Overall Study||49
10191201|NCT03302936|11320345|FG001|STARTED|Overall Study||49
10191202|NCT03302936|11320344|FG000|COMPLETED|Overall Study||46
10191203|NCT03302936|11320345|FG001|COMPLETED|Overall Study||45
10191204|NCT03302936|11320344|FG000|NOT COMPLETED|Overall Study||3
10191205|NCT03302936|11320345|FG001|NOT COMPLETED|Overall Study||4
10191206|NCT03302975|11320355|FG000|STARTED|Overall Study||16
10191207|NCT03302975|11320355|FG000|COMPLETED|Overall Study||12
10191208|NCT03302975|11320355|FG000|NOT COMPLETED|Overall Study||4
10191209|NCT03303079|11320362|FG000|STARTED|Overall Study||189
10191210|NCT03303079|11320363|FG001|STARTED|Overall Study||191
10191211|NCT03303079|11320364|FG002|STARTED|Overall Study||191
10191212|NCT03303079|11320362|FG000|COMPLETED|Overall Study||182
10191213|NCT03303079|11320363|FG001|COMPLETED|Overall Study||180
10191214|NCT03303079|11320364|FG002|COMPLETED|Overall Study||179
10191215|NCT03303079|11320362|FG000|NOT COMPLETED|Overall Study||7
10191216|NCT03303079|11320363|FG001|NOT COMPLETED|Overall Study||11
10191217|NCT03303079|11320364|FG002|NOT COMPLETED|Overall Study||12
10191218|NCT03303092|11320375|FG000|STARTED|Overall Study||121
10191219|NCT03303092|11320376|FG001|STARTED|Overall Study||119
10191220|NCT03303092|11320377|FG002|STARTED|Overall Study||117
10191221|NCT03303092|11320375|FG000|COMPLETED|Overall Study||118
10191222|NCT03303092|11320376|FG001|COMPLETED|Overall Study||113
10191223|NCT03303092|11320377|FG002|COMPLETED|Overall Study||112
10191224|NCT03303092|11320375|FG000|NOT COMPLETED|Overall Study||3
10191225|NCT03303092|11320376|FG001|NOT COMPLETED|Overall Study||6
10191226|NCT03303092|11320377|FG002|NOT COMPLETED|Overall Study||5
10191227|NCT03303105|11320387|FG000|STARTED|Overall Study||25
10191228|NCT03303105|11320388|FG001|STARTED|Overall Study||25
10191229|NCT03303105|11320387|FG000|COMPLETED|Overall Study||23
10191230|NCT03303105|11320388|FG001|COMPLETED|Overall Study||21
10191231|NCT03303105|11320387|FG000|NOT COMPLETED|Overall Study||2
10191232|NCT03303105|11320388|FG001|NOT COMPLETED|Overall Study||4
10191233|NCT03303144|11320394|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26
10191234|NCT03303144|11320395|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0
10191235|NCT03303144|11320396|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0
10191236|NCT03303144|11320394|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
10191237|NCT03303144|11320395|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10191238|NCT03303144|11320396|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10191239|NCT03303144|11320394|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10191240|NCT03303144|11320395|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10191241|NCT03303144|11320396|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10191242|NCT03303144|11320394|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0
10191243|NCT03303144|11320395|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26
10191244|NCT03303144|11320396|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0
10191245|NCT03303144|11320394|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0
10191246|NCT03303144|11320395|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25
10191247|NCT03303144|11320396|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0
10191248|NCT03303144|11320394|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
10191249|NCT03303144|11320395|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
10191250|NCT03303144|11320396|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
10191251|NCT03303144|11320394|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0
10191252|NCT03303144|11320395|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0
10191253|NCT03303144|11320396|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26
10191254|NCT03303144|11320394|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0
10076808|NCT02222558|11204512|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10076809|NCT02222558|11204513|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10191255|NCT03303144|11320395|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0
10191256|NCT03303144|11320396|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25
10191257|NCT03303144|11320394|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
10191258|NCT03303144|11320395|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
10191259|NCT03303144|11320396|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
10076810|NCT02222558|11204514|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10076811|NCT02222558|11204509|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076812|NCT02222558|11204510|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
10076813|NCT02222558|11204511|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076814|NCT02222558|11204512|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076815|NCT02222558|11204513|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076816|NCT02222558|11204514|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076817|NCT02222558|11204509|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076818|NCT02222558|11204510|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076819|NCT02222558|11204511|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076820|NCT02222558|11204512|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076821|NCT02222558|11204513|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076822|NCT02222558|11204514|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10076823|NCT02222558|11204509|FG000|STARTED|Period 3||0
10076824|NCT02222558|11204510|FG001|STARTED|Period 3||0
10076825|NCT02222558|11204511|FG002|STARTED|Period 3||4
10076826|NCT02222558|11204512|FG003|STARTED|Period 3||1
10076827|NCT02222558|11204513|FG004|STARTED|Period 3||8
10076828|NCT02222558|11204514|FG005|STARTED|Period 3||8
10076829|NCT02222558|11204509|FG000|COMPLETED|Period 3||0
10076830|NCT02222558|11204510|FG001|COMPLETED|Period 3||0
10076831|NCT02222558|11204511|FG002|COMPLETED|Period 3||4
10076832|NCT02222558|11204512|FG003|COMPLETED|Period 3||1
10076833|NCT02222558|11204513|FG004|COMPLETED|Period 3||8
10076834|NCT02222558|11204514|FG005|COMPLETED|Period 3||7
10076835|NCT02222558|11204509|FG000|NOT COMPLETED|Period 3||0
10076836|NCT02222558|11204510|FG001|NOT COMPLETED|Period 3||0
10076837|NCT02222558|11204511|FG002|NOT COMPLETED|Period 3||0
10076838|NCT02222558|11204512|FG003|NOT COMPLETED|Period 3||0
10076839|NCT02222558|11204513|FG004|NOT COMPLETED|Period 3||0
10076840|NCT02222558|11204514|FG005|NOT COMPLETED|Period 3||1
10076841|NCT02222610|11204531|FG000|STARTED|Baseline to W48||8
10076842|NCT02222610|11204532|FG001|STARTED|Baseline to W48||16
10076843|NCT02222610|11204533|FG002|STARTED|Baseline to W48||16
10076844|NCT02222610|11204531|FG000|COMPLETED|Baseline to W48||8
10076845|NCT02222610|11204532|FG001|COMPLETED|Baseline to W48||14
10076846|NCT02222610|11204533|FG002|COMPLETED|Baseline to W48||15
10076847|NCT02222610|11204531|FG000|NOT COMPLETED|Baseline to W48||0
10076848|NCT02222610|11204532|FG001|NOT COMPLETED|Baseline to W48||2
10076849|NCT02222610|11204533|FG002|NOT COMPLETED|Baseline to W48||1
10076850|NCT02222610|11204531|FG000|STARTED|Baseline to W104||8
10076851|NCT02222610|11204532|FG001|STARTED|Baseline to W104||16
10076852|NCT02222610|11204533|FG002|STARTED|Baseline to W104||16
10076853|NCT02222610|11204531|FG000|COMPLETED|Baseline to W104||8
10076854|NCT02222610|11204532|FG001|COMPLETED|Baseline to W104||11
10076855|NCT02222610|11204533|FG002|COMPLETED|Baseline to W104||10
10076856|NCT02222610|11204531|FG000|NOT COMPLETED|Baseline to W104||0
10076857|NCT02222610|11204532|FG001|NOT COMPLETED|Baseline to W104||5
10076858|NCT02222610|11204533|FG002|NOT COMPLETED|Baseline to W104||6
10076859|NCT02222688|11204548|FG000|STARTED|Overall Study||4
10076860|NCT02222688|11204549|FG001|STARTED|Overall Study||3
10076861|NCT02222688|11204550|FG002|STARTED|Overall Study||3
10076862|NCT02222688|11204551|FG003|STARTED|Overall Study||5
10076863|NCT02222688|11204552|FG004|STARTED|Overall Study||3
10076864|NCT02222688|11204553|FG005|STARTED|Overall Study||3
10076865|NCT02222688|11204554|FG006|STARTED|Overall Study||6
10076866|NCT02222688|11204548|FG000|COMPLETED|Overall Study||3
10076867|NCT02222688|11204549|FG001|COMPLETED|Overall Study||3
10076868|NCT02222688|11204550|FG002|COMPLETED|Overall Study||3
10076869|NCT02222688|11204551|FG003|COMPLETED|Overall Study||3
10076870|NCT02222688|11204552|FG004|COMPLETED|Overall Study||2
10076871|NCT02222688|11204553|FG005|COMPLETED|Overall Study||3
10076872|NCT02222688|11204554|FG006|COMPLETED|Overall Study||5
10076873|NCT02222688|11204548|FG000|NOT COMPLETED|Overall Study||1
10076874|NCT02222688|11204549|FG001|NOT COMPLETED|Overall Study||0
10076875|NCT02222688|11204550|FG002|NOT COMPLETED|Overall Study||0
10076876|NCT02222688|11204551|FG003|NOT COMPLETED|Overall Study||2
10076877|NCT02222688|11204552|FG004|NOT COMPLETED|Overall Study||1
10076878|NCT02222688|11204553|FG005|NOT COMPLETED|Overall Study||0
10076879|NCT02222688|11204554|FG006|NOT COMPLETED|Overall Study||1
10076880|NCT02222714|11204577|FG000|STARTED|Overall Study||15
10076881|NCT02222714|11204578|FG001|STARTED|Overall Study||24
10076882|NCT02222714|11204579|FG002|STARTED|Overall Study||12
10076883|NCT02222714|11204580|FG003|STARTED|Overall Study||15
10076884|NCT02222714|11204581|FG004|STARTED|Overall Study||44
10076885|NCT02222714|11204577|FG000|COMPLETED|Overall Study||15
10076886|NCT02222714|11204578|FG001|COMPLETED|Overall Study||22
10076887|NCT02222714|11204579|FG002|COMPLETED|Overall Study||8
10076888|NCT02222714|11204580|FG003|COMPLETED|Overall Study||11
10076889|NCT02222714|11204581|FG004|COMPLETED|Overall Study||37
10076890|NCT02222714|11204577|FG000|NOT COMPLETED|Overall Study||0
10076891|NCT02222714|11204578|FG001|NOT COMPLETED|Overall Study||2
10076892|NCT02222714|11204579|FG002|NOT COMPLETED|Overall Study||4
10076893|NCT02222714|11204580|FG003|NOT COMPLETED|Overall Study||4
10076894|NCT02222714|11204581|FG004|NOT COMPLETED|Overall Study||7
10076895|NCT02222818|11204598|FG000|STARTED|Period 1|Start of CAFR evaluation period|33
10076896|NCT02222818|11204599|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33
10076897|NCT02222818|11204598|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33
10076898|NCT02222818|11204599|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
10076899|NCT02222818|11204598|FG000|NOT COMPLETED|Period 1||0
10076900|NCT02222818|11204599|FG001|NOT COMPLETED|Period 1||3
10076901|NCT02222818|11204598|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33
10076902|NCT02222818|11204599|FG001|STARTED|Period 2|Start of CAFR evaluation period|30
10076903|NCT02222818|11204598|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
10076904|NCT02222818|11204599|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30
10076905|NCT02222818|11204598|FG000|NOT COMPLETED|Period 2||0
10076906|NCT02222818|11204599|FG001|NOT COMPLETED|Period 2||0
10076907|NCT02222870|11204606|FG000|STARTED|Overall Study||30
10076908|NCT02222870|11204607|FG001|STARTED|Overall Study||30
10076909|NCT02222870|11204606|FG000|COMPLETED|Overall Study||30
10076910|NCT02222870|11204607|FG001|COMPLETED|Overall Study||30
10076911|NCT02222870|11204606|FG000|NOT COMPLETED|Overall Study||0
10076912|NCT02222870|11204607|FG001|NOT COMPLETED|Overall Study||0
10076913|NCT02222896|11204613|FG000|STARTED|Abdomen||253
10076914|NCT02222896|11204614|FG001|STARTED|Abdomen||48
10076915|NCT02222896|11204615|FG002|STARTED|Abdomen||253
10076916|NCT02222896|11204613|FG000|COMPLETED|Abdomen||219
10076917|NCT02222896|11204614|FG001|COMPLETED|Abdomen||38
10076918|NCT02222896|11204615|FG002|COMPLETED|Abdomen||221
10076919|NCT02222896|11204613|FG000|NOT COMPLETED|Abdomen||34
10076920|NCT02222896|11204614|FG001|NOT COMPLETED|Abdomen||10
10076921|NCT02222896|11204615|FG002|NOT COMPLETED|Abdomen||32
10076922|NCT02222896|11204613|FG000|STARTED|Groin||254
10076923|NCT02222896|11204614|FG001|STARTED|Groin||48
10076924|NCT02222896|11204615|FG002|STARTED|Groin||250
10076925|NCT02222896|11204613|FG000|COMPLETED|Groin||211
10076926|NCT02222896|11204614|FG001|COMPLETED|Groin||39
10076927|NCT02222896|11204615|FG002|COMPLETED|Groin||210
10076928|NCT02222896|11204613|FG000|NOT COMPLETED|Groin||43
10076929|NCT02222896|11204614|FG001|NOT COMPLETED|Groin||9
10076930|NCT02222896|11204615|FG002|NOT COMPLETED|Groin||40
10076931|NCT02222922|11204635|FG000|STARTED|Overall Study||2
10076932|NCT02222922|11204636|FG001|STARTED|Overall Study||2
10076933|NCT02222922|11204637|FG002|STARTED|Overall Study||2
10076934|NCT02222922|11204638|FG003|STARTED|Overall Study||5
10076935|NCT02222922|11204639|FG004|STARTED|Overall Study||96
10076936|NCT02222922|11204640|FG005|STARTED|Overall Study||6
10076937|NCT02222922|11204641|FG006|STARTED|Overall Study||3
10076938|NCT02222922|11204642|FG007|STARTED|Overall Study||10
10076939|NCT02222922|11204643|FG008|STARTED|Overall Study||12
10076940|NCT02222922|11204635|FG000|Received Treatment|Overall Study||2
10076941|NCT02222922|11204636|FG001|Received Treatment|Overall Study||2
10076942|NCT02222922|11204637|FG002|Received Treatment|Overall Study||2
10076943|NCT02222922|11204638|FG003|Received Treatment|Overall Study||4
10076944|NCT02222922|11204639|FG004|Received Treatment|Overall Study||96
10076945|NCT02222922|11204640|FG005|Received Treatment|Overall Study||6
10076946|NCT02222922|11204641|FG006|Received Treatment|Overall Study||3
10076947|NCT02222922|11204642|FG007|Received Treatment|Overall Study||10
10076948|NCT02222922|11204643|FG008|Received Treatment|Overall Study||12
10076949|NCT02222922|11204635|FG000|COMPLETED|Overall Study||1
10076950|NCT02222922|11204636|FG001|COMPLETED|Overall Study||2
10076951|NCT02222922|11204637|FG002|COMPLETED|Overall Study||1
10076952|NCT02222922|11204638|FG003|COMPLETED|Overall Study||2
10076953|NCT02222922|11204639|FG004|COMPLETED|Overall Study||58
10076954|NCT02222922|11204640|FG005|COMPLETED|Overall Study||3
10076955|NCT02222922|11204641|FG006|COMPLETED|Overall Study||1
10076956|NCT02222922|11204642|FG007|COMPLETED|Overall Study||6
10076957|NCT02222922|11204643|FG008|COMPLETED|Overall Study||6
10076958|NCT02222922|11204635|FG000|NOT COMPLETED|Overall Study||1
10076959|NCT02222922|11204636|FG001|NOT COMPLETED|Overall Study||0
10076960|NCT02222922|11204637|FG002|NOT COMPLETED|Overall Study||1
10076961|NCT02222922|11204638|FG003|NOT COMPLETED|Overall Study||3
10076962|NCT02222922|11204639|FG004|NOT COMPLETED|Overall Study||38
10076963|NCT02222922|11204640|FG005|NOT COMPLETED|Overall Study||3
10076964|NCT02222922|11204641|FG006|NOT COMPLETED|Overall Study||2
10076965|NCT02222922|11204642|FG007|NOT COMPLETED|Overall Study||4
10076966|NCT02222922|11204643|FG008|NOT COMPLETED|Overall Study||6
10076967|NCT02223065|11204679|FG000|STARTED|Overall Study||18
10076968|NCT02223065|11204680|FG001|STARTED|Overall Study||18
10076969|NCT02223065|11204679|FG000|COMPLETED|Overall Study||18
10076970|NCT02223065|11204680|FG001|COMPLETED|Overall Study||18
10076971|NCT02223065|11204679|FG000|NOT COMPLETED|Overall Study||0
10076972|NCT02223065|11204680|FG001|NOT COMPLETED|Overall Study||0
10076973|NCT02223260|11204686|FG000|STARTED|Overall Study||8
10076974|NCT02223260|11204686|FG000|COMPLETED|Overall Study||8
10076975|NCT02223260|11204686|FG000|NOT COMPLETED|Overall Study||0
10076976|NCT02223338|11204692|FG000|STARTED|Overall Study||60
10076977|NCT02223338|11204693|FG001|STARTED|Overall Study||60
10076978|NCT02223338|11204692|FG000|COMPLETED|Overall Study||60
10076979|NCT02223338|11204693|FG001|COMPLETED|Overall Study||60
10076980|NCT02223338|11204692|FG000|NOT COMPLETED|Overall Study||0
10076981|NCT02223338|11204693|FG001|NOT COMPLETED|Overall Study||0
10076982|NCT02223351|11204701|FG000|STARTED|Overall Study||24
10076983|NCT02223351|11204702|FG001|STARTED|Overall Study||24
10076984|NCT02223351|11204701|FG000|First Intervention (8 Days)|Overall Study||24
10076985|NCT02223351|11204702|FG001|First Intervention (8 Days)|Overall Study||24
10076986|NCT02223351|11204701|FG000|Wasout (2weeks)|Overall Study||24
10076987|NCT02223351|11204702|FG001|Wasout (2weeks)|Overall Study||24
10076988|NCT02223351|11204701|FG000|Second Intervention (8 Days)|Overall Study||24
10076989|NCT02223351|11204702|FG001|Second Intervention (8 Days)|Overall Study||24
10076990|NCT02223351|11204701|FG000|COMPLETED|Overall Study||24
10076991|NCT02223351|11204702|FG001|COMPLETED|Overall Study||24
10076992|NCT02223351|11204701|FG000|NOT COMPLETED|Overall Study||0
10076993|NCT02223351|11204702|FG001|NOT COMPLETED|Overall Study||0
10076994|NCT02223364|11204719|FG000|STARTED|Overall Study||55
10076995|NCT02223364|11204720|FG001|STARTED|Overall Study||55
10076996|NCT02223364|11204721|FG002|STARTED|Overall Study||55
10076997|NCT02223364|11204719|FG000|COMPLETED|Overall Study||50
10076998|NCT02223364|11204720|FG001|COMPLETED|Overall Study||55
10076999|NCT02223364|11204721|FG002|COMPLETED|Overall Study||52
10077000|NCT02223364|11204719|FG000|NOT COMPLETED|Overall Study||5
10077001|NCT02223364|11204720|FG001|NOT COMPLETED|Overall Study||0
10077002|NCT02223364|11204721|FG002|NOT COMPLETED|Overall Study||3
10077003|NCT02223390|11204731|FG000|STARTED|Overall Study||32
10077004|NCT02223390|11204732|FG001|STARTED|Overall Study||32
10077005|NCT02223390|11204731|FG000|COMPLETED|Overall Study||23
10077006|NCT02223390|11204732|FG001|COMPLETED|Overall Study||28
10077007|NCT02223390|11204731|FG000|NOT COMPLETED|Overall Study||9
10077008|NCT02223390|11204732|FG001|NOT COMPLETED|Overall Study||4
10077009|NCT02223429|11204742|FG000|STARTED|Overall Study||8
10077010|NCT02223429|11204743|FG001|STARTED|Overall Study||8
10077011|NCT02223429|11204744|FG002|STARTED|Overall Study||8
10077012|NCT02223429|11204745|FG003|STARTED|Overall Study||8
10077013|NCT02223429|11204742|FG000|COMPLETED|Overall Study||7
10077014|NCT02223429|11204743|FG001|COMPLETED|Overall Study||8
10077015|NCT02223429|11204744|FG002|COMPLETED|Overall Study||8
10077016|NCT02223429|11204745|FG003|COMPLETED|Overall Study||8
10077017|NCT02223429|11204742|FG000|NOT COMPLETED|Overall Study||1
10077018|NCT02223429|11204743|FG001|NOT COMPLETED|Overall Study||0
10077019|NCT02223429|11204744|FG002|NOT COMPLETED|Overall Study||0
10077020|NCT02223429|11204745|FG003|NOT COMPLETED|Overall Study||0
10077021|NCT02223455|11204763|FG000|STARTED|Overall Study|Participant level data not collected.|
10077022|NCT02223455|11204764|FG001|STARTED|Overall Study|Participant level data not collected.|
10077023|NCT02223455|11204765|FG002|STARTED|Overall Study|Participant level data not collected.|
10077024|NCT02223455|11204763|FG000|COMPLETED|Overall Study|Participant level data not collected.|
10077025|NCT02223455|11204764|FG001|COMPLETED|Overall Study|Participant level data not collected.|
10077026|NCT02223455|11204765|FG002|COMPLETED|Overall Study|Participant level data not collected.|
10077027|NCT02223455|11204763|FG000|NOT COMPLETED|Overall Study||
10077028|NCT02223455|11204764|FG001|NOT COMPLETED|Overall Study||
10077029|NCT02223455|11204765|FG002|NOT COMPLETED|Overall Study||
10077030|NCT02223546|11204773|FG000|STARTED|Overall Study||15
10077031|NCT02223546|11204773|FG000|COMPLETED|Overall Study||15
10077032|NCT02223546|11204773|FG000|NOT COMPLETED|Overall Study||0
10077033|NCT02223637|11204777|FG000|STARTED|Overall Study||82
10077034|NCT02223637|11204777|FG000|COMPLETED|Overall Study||82
10077035|NCT02223637|11204777|FG000|NOT COMPLETED|Overall Study||0
10077036|NCT02223650|11204784|FG000|STARTED|Overall Study||27
10077037|NCT02223650|11204785|FG001|STARTED|Overall Study||31
10077038|NCT02223650|11204784|FG000|COMPLETED|Overall Study||27
10077039|NCT02223650|11204785|FG001|COMPLETED|Overall Study||31
10077040|NCT02223650|11204784|FG000|NOT COMPLETED|Overall Study||0
10077041|NCT02223650|11204785|FG001|NOT COMPLETED|Overall Study||0
10077042|NCT02223689|11204793|FG000|STARTED|Overall Study||35
10077043|NCT02223689|11204793|FG000|COMPLETED|Overall Study||35
10077044|NCT02223689|11204793|FG000|NOT COMPLETED|Overall Study||0
10077045|NCT02223702|11204800|FG000|STARTED|Overall Study||20
10077046|NCT02223702|11204801|FG001|STARTED|Overall Study||19
10077047|NCT02223702|11204800|FG000|COMPLETED|Overall Study||19
10077048|NCT02223702|11204801|FG001|COMPLETED|Overall Study||15
10077049|NCT02223702|11204800|FG000|NOT COMPLETED|Overall Study||1
10077050|NCT02223702|11204801|FG001|NOT COMPLETED|Overall Study||4
10077051|NCT02223715|11204807|FG000|STARTED|Overall Study||600
10077052|NCT02223715|11204807|FG000|COMPLETED|Overall Study||496
10077053|NCT02223715|11204807|FG000|NOT COMPLETED|Overall Study||104
10077054|NCT02223754|11204816|FG000|STARTED|Period 1||163
10077055|NCT02223754|11204817|FG001|STARTED|Period 1||159
10077056|NCT02223754|11204816|FG000|COMPLETED|Period 1||159
10077057|NCT02223754|11204817|FG001|COMPLETED|Period 1||144
10077058|NCT02223754|11204816|FG000|NOT COMPLETED|Period 1||4
10077059|NCT02223754|11204817|FG001|NOT COMPLETED|Period 1||15
10077060|NCT02223754|11204816|FG000|STARTED|Period 2||159
10077061|NCT02223754|11204817|FG001|STARTED|Period 2||144
10077062|NCT02223754|11204816|FG000|COMPLETED|Period 2||156
10077063|NCT02223754|11204817|FG001|COMPLETED|Period 2||141
10077064|NCT02223754|11204816|FG000|NOT COMPLETED|Period 2||3
10077065|NCT02223754|11204817|FG001|NOT COMPLETED|Period 2||3
10077066|NCT02223793|11204827|FG000|STARTED|Overall Study||185
10077067|NCT02223793|11204828|FG001|STARTED|Overall Study||199
10077068|NCT02223793|11204829|FG002|STARTED|Overall Study||198
10077069|NCT02223793|11204827|FG000|COMPLETED|Overall Study||168
10077070|NCT02223793|11204828|FG001|COMPLETED|Overall Study||190
10077071|NCT02223793|11204829|FG002|COMPLETED|Overall Study||185
10077072|NCT02223793|11204827|FG000|NOT COMPLETED|Overall Study||17
10077073|NCT02223793|11204828|FG001|NOT COMPLETED|Overall Study||9
10077074|NCT02223793|11204829|FG002|NOT COMPLETED|Overall Study||13
10077075|NCT02223858|11204839|FG000|STARTED|Overall Study||180
10077076|NCT02223858|11204840|FG001|STARTED|Overall Study||180
10077077|NCT02223858|11204839|FG000|1-month Follow-up|Overall Study||156
10077078|NCT02223858|11204840|FG001|1-month Follow-up|Overall Study||150
10077079|NCT02223858|11204839|FG000|3-month Follow-up|Overall Study||155
10077080|NCT02223858|11204840|FG001|3-month Follow-up|Overall Study||154
10077081|NCT02223858|11204839|FG000|6-month Follow-up|Overall Study||156
10077082|NCT02223858|11204840|FG001|6-month Follow-up|Overall Study||154
10077083|NCT02223858|11204839|FG000|COMPLETED|Overall Study||156
10077084|NCT02223858|11204840|FG001|COMPLETED|Overall Study||154
10077085|NCT02223858|11204839|FG000|NOT COMPLETED|Overall Study||24
10077086|NCT02223858|11204840|FG001|NOT COMPLETED|Overall Study||26
10077087|NCT02223871|11204846|FG000|STARTED|Overall Study||8
10077088|NCT02223871|11204846|FG000|COMPLETED|Overall Study||8
10191260|NCT03303196|11320407|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
10191261|NCT03303196|11320408|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
10191262|NCT03303196|11320407|FG000|Washout|Overall Study||5
10191263|NCT03303196|11320408|FG001|Washout|Overall Study||5
10191264|NCT03303196|11320407|FG000|COMPLETED|Overall Study||5
10191265|NCT03303196|11320408|FG001|COMPLETED|Overall Study||5
10191266|NCT03303196|11320407|FG000|NOT COMPLETED|Overall Study||0
10191267|NCT03303196|11320408|FG001|NOT COMPLETED|Overall Study||0
10191268|NCT03303404|11320413|FG000|STARTED|Overall Study||22
10191269|NCT03303404|11320413|FG000|COMPLETED|Overall Study||22
10191270|NCT03303404|11320413|FG000|NOT COMPLETED|Overall Study||0
10191271|NCT03303417|11320417|FG000|STARTED|Overall Study||8
10191272|NCT03303417|11320418|FG001|STARTED|Overall Study||8
10191273|NCT03303417|11320417|FG000|COMPLETED|Overall Study||7
10191274|NCT03303417|11320418|FG001|COMPLETED|Overall Study||7
10191275|NCT03303417|11320417|FG000|NOT COMPLETED|Overall Study||1
10191276|NCT03303417|11320418|FG001|NOT COMPLETED|Overall Study||1
10191277|NCT03303521|11320426|FG000|STARTED|Overall Study||97
10191278|NCT03303521|11320427|FG001|STARTED|Overall Study||99
10191279|NCT03303521|11320426|FG000|COMPLETED|Overall Study||92
10191280|NCT03303521|11320427|FG001|COMPLETED|Overall Study||96
10191281|NCT03303521|11320426|FG000|NOT COMPLETED|Overall Study||5
10191282|NCT03303521|11320427|FG001|NOT COMPLETED|Overall Study||3
10191283|NCT03303794|11320435|FG000|STARTED|Overall Study||13
10191284|NCT03303794|11320436|FG001|STARTED|Overall Study||12
10191285|NCT03303794|11320435|FG000|COMPLETED|Overall Study||13
10191286|NCT03303794|11320436|FG001|COMPLETED|Overall Study||12
10191287|NCT03303794|11320435|FG000|NOT COMPLETED|Overall Study||0
10191288|NCT03303794|11320436|FG001|NOT COMPLETED|Overall Study||0
10191289|NCT03303911|11320444|FG000|STARTED|Overall Study||13
10191290|NCT03303911|11320445|FG001|STARTED|Overall Study||13
10191291|NCT03303911|11320444|FG000|COMPLETED|Overall Study||13
10191292|NCT03303911|11320445|FG001|COMPLETED|Overall Study||13
10191293|NCT03303911|11320444|FG000|NOT COMPLETED|Overall Study||0
10191294|NCT03303911|11320445|FG001|NOT COMPLETED|Overall Study||0
10191295|NCT03304054|11320454|FG000|STARTED|Overall Study||27
10191296|NCT03304054|11320455|FG001|STARTED|Overall Study||7
10191297|NCT03304054|11320456|FG002|STARTED|Overall Study||28
10191298|NCT03304054|11320457|FG003|STARTED|Overall Study||8
10191299|NCT03304054|11320458|FG004|STARTED|Overall Study||17
10191300|NCT03304054|11320459|FG005|STARTED|Overall Study||6
10191301|NCT03304054|11320454|FG000|COMPLETED|Overall Study||27
10191302|NCT03304054|11320455|FG001|COMPLETED|Overall Study||7
10191303|NCT03304054|11320456|FG002|COMPLETED|Overall Study||27
10191304|NCT03304054|11320457|FG003|COMPLETED|Overall Study||8
10191305|NCT03304054|11320458|FG004|COMPLETED|Overall Study||0
10191306|NCT03304054|11320459|FG005|COMPLETED|Overall Study||0
10191307|NCT03304054|11320454|FG000|NOT COMPLETED|Overall Study||0
10191308|NCT03304054|11320455|FG001|NOT COMPLETED|Overall Study||0
10191309|NCT03304054|11320456|FG002|NOT COMPLETED|Overall Study||1
10191310|NCT03304054|11320457|FG003|NOT COMPLETED|Overall Study||0
10191311|NCT03304054|11320458|FG004|NOT COMPLETED|Overall Study||17
10191312|NCT03304054|11320459|FG005|NOT COMPLETED|Overall Study||6
10191313|NCT03304106|11320470|FG000|STARTED|Overall Study||44
10191314|NCT03304106|11320471|FG001|STARTED|Overall Study||58
10191315|NCT03304106|11320470|FG000|COMPLETED|Overall Study||31
10191316|NCT03304106|11320471|FG001|COMPLETED|Overall Study||56
10191317|NCT03304106|11320470|FG000|NOT COMPLETED|Overall Study||13
10191318|NCT03304106|11320471|FG001|NOT COMPLETED|Overall Study||2
10191319|NCT03304119|11320479|FG000|STARTED|Overall Study||37
10191320|NCT03304119|11320480|FG001|STARTED|Overall Study||55
10191321|NCT03304119|11320479|FG000|COMPLETED|Overall Study||37
10191322|NCT03304119|11320480|FG001|COMPLETED|Overall Study||55
10191323|NCT03304119|11320479|FG000|NOT COMPLETED|Overall Study||0
10077089|NCT02223871|11204846|FG000|NOT COMPLETED|Overall Study||0
10077090|NCT02224053|11204850|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68
10077091|NCT02224053|11204850|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47
10077092|NCT02224053|11204850|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
10077093|NCT02224053|11204850|FG000|STARTED|AZD9291 Alone||47
10077094|NCT02224053|11204850|FG000|COMPLETED|AZD9291 Alone||47
10077095|NCT02224053|11204850|FG000|NOT COMPLETED|AZD9291 Alone||0
10077096|NCT02224157|11204858|FG000|STARTED|Overall Study||2095
10077097|NCT02224157|11204859|FG001|STARTED|Overall Study||2094
10077098|NCT02224157|11204858|FG000|Patients Who Completed Treatment|Overall Study||1924
10077099|NCT02224157|11204859|FG001|Patients Who Completed Treatment|Overall Study||1903
10077100|NCT02224157|11204858|FG000|COMPLETED|Overall Study||1985
10077101|NCT02224157|11204859|FG001|COMPLETED|Overall Study||1983
10077102|NCT02224157|11204858|FG000|NOT COMPLETED|Overall Study||110
10077103|NCT02224157|11204859|FG001|NOT COMPLETED|Overall Study||111
10077104|NCT02224274|11204867|FG000|STARTED|Overall Study||17
10077105|NCT02224274|11204868|FG001|STARTED|Overall Study||20
10077106|NCT02224274|11204867|FG000|COMPLETED|Overall Study||16
10077107|NCT02224274|11204868|FG001|COMPLETED|Overall Study||20
10077108|NCT02224274|11204867|FG000|NOT COMPLETED|Overall Study||1
10077109|NCT02224274|11204868|FG001|NOT COMPLETED|Overall Study||0
10077110|NCT02224313|11204876|FG000|STARTED|Overall Study||10
10077111|NCT02224313|11204877|FG001|STARTED|Overall Study||10
10077112|NCT02224313|11204876|FG000|COMPLETED|Overall Study||7
10077113|NCT02224313|11204877|FG001|COMPLETED|Overall Study||9
10077114|NCT02224313|11204876|FG000|NOT COMPLETED|Overall Study||3
10077115|NCT02224313|11204877|FG001|NOT COMPLETED|Overall Study||1
10077116|NCT02224404|11204883|FG000|STARTED|Overall Study||21
10077117|NCT02224404|11204883|FG000|COMPLETED|Overall Study||21
10077118|NCT02224404|11204883|FG000|NOT COMPLETED|Overall Study||0
10077119|NCT02224482|11204889|FG000|STARTED|Overall Study||214
10077120|NCT02224482|11204890|FG001|STARTED|Overall Study||217
10077121|NCT02224482|11204889|FG000|COMPLETED|Overall Study||63
10077122|NCT02224482|11204890|FG001|COMPLETED|Overall Study||57
10077123|NCT02224482|11204889|FG000|NOT COMPLETED|Overall Study||151
10077124|NCT02224482|11204890|FG001|NOT COMPLETED|Overall Study||160
10077125|NCT02224508|11204898|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
10077126|NCT02224508|11204899|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
10077127|NCT02224508|11204898|FG000|COMPLETED|Overall Study||935
10077128|NCT02224508|11204899|FG001|COMPLETED|Overall Study||653
10077129|NCT02224508|11204898|FG000|NOT COMPLETED|Overall Study||0
10077130|NCT02224508|11204899|FG001|NOT COMPLETED|Overall Study||0
10077131|NCT02224560|11204909|FG000|STARTED|Overall Study||76
10077132|NCT02224560|11204910|FG001|STARTED|Overall Study||73
10077133|NCT02224560|11204911|FG002|STARTED|Overall Study||76
10077134|NCT02224560|11204909|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
10077135|NCT02224560|11204910|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
10077136|NCT02224560|11204911|FG002|Safety Analysis Set|Overall Study||76
10077137|NCT02224560|11204909|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76
10077138|NCT02224560|11204910|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73
10077139|NCT02224560|11204911|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76
10077140|NCT02224560|11204909|FG000|COMPLETED|Overall Study||67
10077141|NCT02224560|11204910|FG001|COMPLETED|Overall Study||71
10077142|NCT02224560|11204911|FG002|COMPLETED|Overall Study||74
10077143|NCT02224560|11204909|FG000|NOT COMPLETED|Overall Study||9
10077144|NCT02224560|11204910|FG001|NOT COMPLETED|Overall Study||2
10077145|NCT02224560|11204911|FG002|NOT COMPLETED|Overall Study||2
10077146|NCT02224612|11204919|FG000|STARTED|Overall Study||48
10077147|NCT02224612|11204920|FG001|STARTED|Overall Study||48
10077148|NCT02224612|11204919|FG000|COMPLETED|Overall Study||48
10077149|NCT02224612|11204920|FG001|COMPLETED|Overall Study||48
10077150|NCT02224612|11204919|FG000|NOT COMPLETED|Overall Study||0
10077151|NCT02224612|11204920|FG001|NOT COMPLETED|Overall Study||0
10077152|NCT02224625|11204928|FG000|STARTED|Irritation||39
10077153|NCT02224625|11204928|FG000|COMPLETED|Irritation||33
10077154|NCT02224625|11204928|FG000|NOT COMPLETED|Irritation||6
10077155|NCT02224625|11204928|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
10077156|NCT02224625|11204928|FG000|COMPLETED|Sensitization||194
10077157|NCT02224625|11204928|FG000|NOT COMPLETED|Sensitization||55
10077158|NCT02224638|11204942|FG000|STARTED|Overall Study||11
10077159|NCT02224638|11204943|FG001|STARTED|Overall Study||10
10077160|NCT02224638|11204942|FG000|COMPLETED|Overall Study||10
10077161|NCT02224638|11204943|FG001|COMPLETED|Overall Study||9
10077162|NCT02224638|11204942|FG000|NOT COMPLETED|Overall Study||1
10077163|NCT02224638|11204943|FG001|NOT COMPLETED|Overall Study||1
10077164|NCT02224664|11204951|FG000|STARTED|Lead-in Period (3 Days)||50
10077165|NCT02224664|11204952|FG001|STARTED|Lead-in Period (3 Days)||0
10077166|NCT02224664|11204953|FG002|STARTED|Lead-in Period (3 Days)||0
10077167|NCT02224664|11204954|FG003|STARTED|Lead-in Period (3 Days)||0
10077168|NCT02224664|11204955|FG004|STARTED|Lead-in Period (3 Days)||0
10077169|NCT02224664|11204951|FG000|COMPLETED|Lead-in Period (3 Days)||45
10077170|NCT02224664|11204952|FG001|COMPLETED|Lead-in Period (3 Days)||0
10077171|NCT02224664|11204953|FG002|COMPLETED|Lead-in Period (3 Days)||0
10077172|NCT02224664|11204954|FG003|COMPLETED|Lead-in Period (3 Days)||0
10077173|NCT02224664|11204955|FG004|COMPLETED|Lead-in Period (3 Days)||0
10077174|NCT02224664|11204951|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5
10077175|NCT02224664|11204952|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0
10077176|NCT02224664|11204953|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0
10077177|NCT02224664|11204954|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0
10077178|NCT02224664|11204955|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0
10077179|NCT02224664|11204951|FG000|STARTED|Dose Escalation Period (21 Days)||0
10077180|NCT02224664|11204952|FG001|STARTED|Dose Escalation Period (21 Days)||9
10077181|NCT02224664|11204953|FG002|STARTED|Dose Escalation Period (21 Days)||11
10077182|NCT02224664|11204954|FG003|STARTED|Dose Escalation Period (21 Days)||6
10077183|NCT02224664|11204955|FG004|STARTED|Dose Escalation Period (21 Days)||19
10077184|NCT02224664|11204951|FG000|COMPLETED|Dose Escalation Period (21 Days)||0
10077185|NCT02224664|11204952|FG001|COMPLETED|Dose Escalation Period (21 Days)||9
10077186|NCT02224664|11204953|FG002|COMPLETED|Dose Escalation Period (21 Days)||9
10077187|NCT02224664|11204954|FG003|COMPLETED|Dose Escalation Period (21 Days)||3
10077188|NCT02224664|11204955|FG004|COMPLETED|Dose Escalation Period (21 Days)||8
10077189|NCT02224664|11204951|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0
10077190|NCT02224664|11204952|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0
10077191|NCT02224664|11204953|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2
10077192|NCT02224664|11204954|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3
10077193|NCT02224664|11204955|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11
10077194|NCT02224690|11204973|FG000|STARTED|Overall Study||86
10077195|NCT02224690|11204974|FG001|STARTED|Overall Study||85
10077196|NCT02224690|11204973|FG000|Safety Analysis Set|Overall Study||86
10077197|NCT02224690|11204974|FG001|Safety Analysis Set|Overall Study||85
10077198|NCT02224690|11204973|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86
10077199|NCT02224690|11204974|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85
10077200|NCT02224690|11204973|FG000|COMPLETED|Overall Study||72
10077201|NCT02224690|11204974|FG001|COMPLETED|Overall Study||84
10077202|NCT02224690|11204973|FG000|NOT COMPLETED|Overall Study||14
10077203|NCT02224690|11204974|FG001|NOT COMPLETED|Overall Study||1
10077204|NCT02224703|11204983|FG000|STARTED|Overall Study||67
10077205|NCT02224703|11204984|FG001|STARTED|Overall Study||67
10077206|NCT02224703|11204985|FG002|STARTED|Overall Study||65
10077207|NCT02224703|11204983|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
10077208|NCT02224703|11204984|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67
10077209|NCT02224703|11204985|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
10077210|NCT02224703|11204983|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
10077211|NCT02224703|11204984|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
10077212|NCT02224703|11204985|FG002|Safety Analysis Set|Overall Study||65
10077213|NCT02224703|11204983|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66
10077214|NCT02224703|11204984|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67
10077215|NCT02224703|11204985|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65
10077216|NCT02224703|11204983|FG000|COMPLETED|Overall Study||64
10077217|NCT02224703|11204984|FG001|COMPLETED|Overall Study||61
10077218|NCT02224703|11204985|FG002|COMPLETED|Overall Study||65
10077219|NCT02224703|11204983|FG000|NOT COMPLETED|Overall Study||3
10077220|NCT02224703|11204984|FG001|NOT COMPLETED|Overall Study||6
10077221|NCT02224703|11204985|FG002|NOT COMPLETED|Overall Study||0
10077222|NCT02224729|11204994|FG000|STARTED|Overall Study||24
10077223|NCT02224729|11204994|FG000|COMPLETED|Overall Study||24
10077224|NCT02224729|11204994|FG000|NOT COMPLETED|Overall Study||0
10077237|NCT02224820|11205011|FG000|STARTED|Overall Study||8
10077238|NCT02224820|11205011|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8
10077239|NCT02224820|11205011|FG000|NOT COMPLETED|Overall Study||0
10191324|NCT03304119|11320480|FG001|NOT COMPLETED|Overall Study||0
10191325|NCT03304184|11320488|FG000|STARTED|Overall Study||15
10191326|NCT03304184|11320489|FG001|STARTED|Overall Study||9
10191327|NCT03304184|11320488|FG000|COMPLETED|Overall Study||14
10191328|NCT03304184|11320489|FG001|COMPLETED|Overall Study||7
10191329|NCT03304184|11320488|FG000|NOT COMPLETED|Overall Study||1
10191330|NCT03304184|11320489|FG001|NOT COMPLETED|Overall Study||2
10191331|NCT03304522|11320498|FG000|STARTED|Overall Study||46
10191332|NCT03304522|11320499|FG001|STARTED|Overall Study||43
10191333|NCT03304522|11320498|FG000|COMPLETED|Overall Study||45
10191334|NCT03304522|11320499|FG001|COMPLETED|Overall Study||35
10191335|NCT03304522|11320498|FG000|NOT COMPLETED|Overall Study||1
10191336|NCT03304522|11320499|FG001|NOT COMPLETED|Overall Study||8
10191337|NCT03304626|11320507|FG000|STARTED|Overall Study||20
10191338|NCT03304626|11320508|FG001|STARTED|Overall Study||20
10191339|NCT03304626|11320507|FG000|COMPLETED|Overall Study||18
10191340|NCT03304626|11320508|FG001|COMPLETED|Overall Study||19
10191341|NCT03304626|11320507|FG000|NOT COMPLETED|Overall Study||2
10191342|NCT03304626|11320508|FG001|NOT COMPLETED|Overall Study||1
10191343|NCT03304873|11320517|FG000|STARTED|Overall Study||23
10191344|NCT03304873|11320518|FG001|STARTED|Overall Study||24
10191345|NCT03304873|11320517|FG000|COMPLETED|Overall Study||22
10191346|NCT03304873|11320518|FG001|COMPLETED|Overall Study||16
10191347|NCT03304873|11320517|FG000|NOT COMPLETED|Overall Study||1
10191348|NCT03304873|11320518|FG001|NOT COMPLETED|Overall Study||8
10191349|NCT03305081|11320526|FG000|STARTED|Overall Study||25
10191350|NCT03305081|11320527|FG001|STARTED|Overall Study||20
10191351|NCT03305081|11320526|FG000|COMPLETED|Overall Study||15
10191352|NCT03305081|11320527|FG001|COMPLETED|Overall Study||5
10191353|NCT03305081|11320526|FG000|NOT COMPLETED|Overall Study||10
10191354|NCT03305081|11320527|FG001|NOT COMPLETED|Overall Study||15
10191355|NCT03305159|11320535|FG000|STARTED|Overall Study||66
10191356|NCT03305159|11320536|FG001|STARTED|Overall Study||68
10191357|NCT03305159|11320535|FG000|COMPLETED|Overall Study||63
10191358|NCT03305159|11320536|FG001|COMPLETED|Overall Study||60
10191359|NCT03305159|11320535|FG000|NOT COMPLETED|Overall Study||3
10191360|NCT03305159|11320536|FG001|NOT COMPLETED|Overall Study||8
10077240|NCT02224846|11205017|FG000|STARTED|Period 1 (Month 3)||211
10077241|NCT02224846|11205018|FG001|STARTED|Period 1 (Month 3)||424
10077242|NCT02224846|11205017|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
10077243|NCT02224846|11205018|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
10077244|NCT02224846|11205017|FG000|COMPLETED|Period 1 (Month 3)||192
10077245|NCT02224846|11205018|FG001|COMPLETED|Period 1 (Month 3)||388
10077246|NCT02224846|11205017|FG000|NOT COMPLETED|Period 1 (Month 3)||19
10077247|NCT02224846|11205018|FG001|NOT COMPLETED|Period 1 (Month 3)||36
10077248|NCT02224846|11205017|FG000|STARTED|Period 2 (Month 3 to Month 12)||192
10077249|NCT02224846|11205018|FG001|STARTED|Period 2 (Month 3 to Month 12)||388
10077250|NCT02224846|11205017|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173
10077251|NCT02224846|11205018|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357
10077252|NCT02224846|11205017|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
10077253|NCT02224846|11205018|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
10077254|NCT02224846|11205017|FG000|STARTED|Period 2 (Month 12 to Month 24)||173
10077255|NCT02224846|11205018|FG001|STARTED|Period 2 (Month 12 to Month 24)||357
10077256|NCT02224846|11205017|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131
10077257|NCT02224846|11205018|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283
10077258|NCT02224846|11205017|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
10077259|NCT02224846|11205018|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
10077260|NCT02225080|11205024|FG000|STARTED|Overall Study||100
10077261|NCT02225080|11205024|FG000|COMPLETED|Overall Study||100
10077262|NCT02225080|11205024|FG000|NOT COMPLETED|Overall Study||0
10077263|NCT02225106|11205028|FG000|STARTED|Overall Study||11
10077264|NCT02225106|11205028|FG000|COMPLETED|Overall Study||11
10077265|NCT02225106|11205028|FG000|NOT COMPLETED|Overall Study||0
10077266|NCT02225132|11205032|FG000|STARTED|Overall Study||10
10077267|NCT02225132|11205032|FG000|COMPLETED|Overall Study||10
10077268|NCT02225132|11205032|FG000|NOT COMPLETED|Overall Study||0
10077269|NCT02225223|11205038|FG000|STARTED|Overall Study||27
10077270|NCT02225223|11205039|FG001|STARTED|Overall Study||8
10077271|NCT02225223|11205038|FG000|COMPLETED|Overall Study||8
10077272|NCT02225223|11205039|FG001|COMPLETED|Overall Study||3
10077273|NCT02225223|11205038|FG000|NOT COMPLETED|Overall Study||19
10077274|NCT02225223|11205039|FG001|NOT COMPLETED|Overall Study||5
10077275|NCT02225353|11205048|FG000|STARTED|Overall Study||91
10077276|NCT02225353|11205049|FG001|STARTED|Overall Study||90
10077277|NCT02225353|11205050|FG002|STARTED|Overall Study||90
10077278|NCT02225353|11205048|FG000|COMPLETED|Overall Study||87
10077279|NCT02225353|11205049|FG001|COMPLETED|Overall Study||84
10077280|NCT02225353|11205050|FG002|COMPLETED|Overall Study||75
10077281|NCT02225353|11205048|FG000|NOT COMPLETED|Overall Study||4
10077282|NCT02225353|11205049|FG001|NOT COMPLETED|Overall Study||6
10077283|NCT02225353|11205050|FG002|NOT COMPLETED|Overall Study||15
10077284|NCT02225587|11205063|FG000|STARTED|Overall Study||200
10077285|NCT02225587|11205064|FG001|STARTED|Overall Study||200
10077286|NCT02225587|11205063|FG000|Vaccination 2|Overall Study||188
10077287|NCT02225587|11205064|FG001|Vaccination 2|Overall Study||185
10077288|NCT02225587|11205063|FG000|Vaccination 3|Overall Study||172
10077289|NCT02225587|11205064|FG001|Vaccination 3|Overall Study||164
10077290|NCT02225587|11205063|FG000|COMPLETED|Overall Study||172
10077291|NCT02225587|11205064|FG001|COMPLETED|Overall Study||162
10077292|NCT02225587|11205063|FG000|NOT COMPLETED|Overall Study||28
10077293|NCT02225587|11205064|FG001|NOT COMPLETED|Overall Study||38
10077294|NCT02225665|11205072|FG000|STARTED|Overall Study||3
10077295|NCT02225665|11205073|FG001|STARTED|Overall Study||5
10077296|NCT02225665|11205072|FG000|COMPLETED|Overall Study||2
10077297|NCT02225665|11205073|FG001|COMPLETED|Overall Study||4
10077298|NCT02225665|11205072|FG000|NOT COMPLETED|Overall Study||1
10077299|NCT02225665|11205073|FG001|NOT COMPLETED|Overall Study||1
10077300|NCT02225743|11205079|FG000|STARTED|Overall Study||120
10077301|NCT02225743|11205079|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
10077302|NCT02225743|11205079|FG000|NOT COMPLETED|Overall Study||18
10077303|NCT02225860|11205085|FG000|STARTED|Overall Study||17
10077304|NCT02225860|11205086|FG001|STARTED|Overall Study||17
10077305|NCT02225860|11205085|FG000|COMPLETED|Overall Study||16
10077306|NCT02225860|11205086|FG001|COMPLETED|Overall Study||17
10077307|NCT02225860|11205085|FG000|NOT COMPLETED|Overall Study||1
10077308|NCT02225860|11205086|FG001|NOT COMPLETED|Overall Study||0
10077309|NCT02225925|11205093|FG000|STARTED|Overall Study||45
10077310|NCT02225925|11205093|FG000|COMPLETED|Overall Study||45
10077311|NCT02225925|11205093|FG000|NOT COMPLETED|Overall Study||0
10077312|NCT02226003|11205100|FG000|STARTED|Overall Study||98
10191361|NCT03305419|11320550|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10077313|NCT02226003|11205101|FG001|STARTED|Overall Study||96
10077314|NCT02226003|11205102|FG002|STARTED|Overall Study||97
10077315|NCT02226003|11205100|FG000|COMPLETED|Overall Study||96
10077316|NCT02226003|11205101|FG001|COMPLETED|Overall Study||95
10077317|NCT02226003|11205102|FG002|COMPLETED|Overall Study||91
10077318|NCT02226003|11205100|FG000|NOT COMPLETED|Overall Study||2
10077319|NCT02226003|11205101|FG001|NOT COMPLETED|Overall Study||1
10077320|NCT02226003|11205102|FG002|NOT COMPLETED|Overall Study||6
10077321|NCT02226120|11205110|FG000|STARTED|Overall Study||1980
10077322|NCT02226120|11205110|FG000|COMPLETED|Overall Study||1660
10077323|NCT02226120|11205110|FG000|NOT COMPLETED|Overall Study||320
10077324|NCT02226159|11205116|FG000|STARTED|Overall Study||33
10077325|NCT02226159|11205117|FG001|STARTED|Overall Study||32
10077326|NCT02226159|11205116|FG000|COMPLETED|Overall Study||27
10077327|NCT02226159|11205117|FG001|COMPLETED|Overall Study||26
10077328|NCT02226159|11205116|FG000|NOT COMPLETED|Overall Study||6
10077329|NCT02226159|11205117|FG001|NOT COMPLETED|Overall Study||6
10077330|NCT02226172|11205123|FG000|STARTED|Overall Study||21
10077331|NCT02226172|11205123|FG000|COMPLETED|Overall Study||4
10077332|NCT02226172|11205123|FG000|NOT COMPLETED|Overall Study||17
10077333|NCT02226198|11205127|FG000|STARTED|Lead-in Phase||11
10077334|NCT02226198|11205128|FG001|STARTED|Lead-in Phase||0
10077335|NCT02226198|11205129|FG002|STARTED|Lead-in Phase||0
10077336|NCT02226198|11205127|FG000|COMPLETED|Lead-in Phase||10
10077337|NCT02226198|11205128|FG001|COMPLETED|Lead-in Phase||0
10077338|NCT02226198|11205129|FG002|COMPLETED|Lead-in Phase||0
10077339|NCT02226198|11205127|FG000|NOT COMPLETED|Lead-in Phase||1
10077340|NCT02226198|11205128|FG001|NOT COMPLETED|Lead-in Phase||0
10077341|NCT02226198|11205129|FG002|NOT COMPLETED|Lead-in Phase||0
10077342|NCT02226198|11205127|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0
10077343|NCT02226198|11205128|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7
10077344|NCT02226198|11205129|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7
10077345|NCT02226198|11205127|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
10077346|NCT02226198|11205128|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
10077347|NCT02226198|11205129|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
10077348|NCT02226198|11205127|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
10077349|NCT02226198|11205128|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
10077350|NCT02226198|11205129|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
10077351|NCT02226198|11205127|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
10077352|NCT02226198|11205128|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
10077353|NCT02226198|11205129|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
10077354|NCT02226198|11205127|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10077355|NCT02226198|11205128|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
10077356|NCT02226198|11205129|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
10077357|NCT02226198|11205127|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10077358|NCT02226198|11205128|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10077359|NCT02226198|11205129|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10077360|NCT02226198|11205127|FG000|STARTED|Maintenance Phase (12 Weeks)||13
10077361|NCT02226198|11205128|FG001|STARTED|Maintenance Phase (12 Weeks)||0
10077362|NCT02226198|11205129|FG002|STARTED|Maintenance Phase (12 Weeks)||0
10077363|NCT02226198|11205127|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13
10077364|NCT02226198|11205128|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0
10077365|NCT02226198|11205129|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0
10077366|NCT02226198|11205127|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
10077367|NCT02226198|11205128|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
10077368|NCT02226198|11205129|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
10077369|NCT02226549|11205157|FG000|STARTED|Overall Study||23
10077370|NCT02226549|11205158|FG001|STARTED|Overall Study||24
10077371|NCT02226549|11205157|FG000|COMPLETED|Overall Study||22
10077372|NCT02226549|11205158|FG001|COMPLETED|Overall Study||23
10077373|NCT02226549|11205157|FG000|NOT COMPLETED|Overall Study||1
10077374|NCT02226549|11205158|FG001|NOT COMPLETED|Overall Study||1
10077375|NCT02226562|11205166|FG000|STARTED|Overall Study||95
10077376|NCT02226562|11205167|FG001|STARTED|Overall Study||96
10077377|NCT02226562|11205166|FG000|COMPLETED|Overall Study||95
10077378|NCT02226562|11205167|FG001|COMPLETED|Overall Study|Lost to follow up|95
10077379|NCT02226562|11205166|FG000|NOT COMPLETED|Overall Study||0
10077380|NCT02226562|11205167|FG001|NOT COMPLETED|Overall Study||1
10077381|NCT02226653|11205175|FG000|STARTED|Treatment Period 1 Fasted State||24
10077382|NCT02226653|11205176|FG001|STARTED|Treatment Period 1 Fasted State||24
10077383|NCT02226653|11205175|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
10077384|NCT02226653|11205176|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
10077385|NCT02226653|11205175|FG000|COMPLETED|Treatment Period 1 Fasted State||24
10077386|NCT02226653|11205176|FG001|COMPLETED|Treatment Period 1 Fasted State||24
10077387|NCT02226653|11205175|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0
10077388|NCT02226653|11205176|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0
10077389|NCT02226653|11205175|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24
10077390|NCT02226653|11205176|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24
10077391|NCT02226653|11205175|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24
10077392|NCT02226653|11205176|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24
10077393|NCT02226653|11205175|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
10077394|NCT02226653|11205176|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
10077395|NCT02226653|11205175|FG000|STARTED|Treatment Period 2 Fasted State||24
10077396|NCT02226653|11205176|FG001|STARTED|Treatment Period 2 Fasted State||24
10077397|NCT02226653|11205175|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
10077398|NCT02226653|11205176|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
10077399|NCT02226653|11205175|FG000|COMPLETED|Treatment Period 2 Fasted State||23
10077400|NCT02226653|11205176|FG001|COMPLETED|Treatment Period 2 Fasted State||24
10077401|NCT02226653|11205175|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1
10077402|NCT02226653|11205176|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0
10077403|NCT02226653|11205175|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23
10077404|NCT02226653|11205176|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24
10077405|NCT02226653|11205175|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23
10077406|NCT02226653|11205176|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24
10077407|NCT02226653|11205175|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
10077408|NCT02226653|11205176|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
10077409|NCT02226653|11205175|FG000|STARTED|Treatment Period 3 Fasted State||23
10077410|NCT02226653|11205176|FG001|STARTED|Treatment Period 3 Fasted State||24
10077411|NCT02226653|11205175|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
10077412|NCT02226653|11205176|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
10077413|NCT02226653|11205175|FG000|COMPLETED|Treatment Period 3 Fasted State||23
10077414|NCT02226653|11205176|FG001|COMPLETED|Treatment Period 3 Fasted State||24
10077415|NCT02226653|11205175|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0
10077416|NCT02226653|11205176|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0
10077417|NCT02226653|11205175|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23
10077418|NCT02226653|11205176|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24
10077419|NCT02226653|11205175|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23
10077420|NCT02226653|11205176|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24
10077421|NCT02226653|11205175|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
10077422|NCT02226653|11205176|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
10077423|NCT02226653|11205175|FG000|STARTED|Treatment Period 4 Fasted State||23
10077424|NCT02226653|11205176|FG001|STARTED|Treatment Period 4 Fasted State||24
10077425|NCT02226653|11205175|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
10077426|NCT02226653|11205176|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
10077427|NCT02226653|11205175|FG000|COMPLETED|Treatment Period 4 Fasted State||23
10077428|NCT02226653|11205176|FG001|COMPLETED|Treatment Period 4 Fasted State||24
10077429|NCT02226653|11205175|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0
10077430|NCT02226653|11205176|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0
10077431|NCT02226653|11205175|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23
10077432|NCT02226653|11205176|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24
10077433|NCT02226653|11205175|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23
10077434|NCT02226653|11205176|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24
10077435|NCT02226653|11205175|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
10077436|NCT02226653|11205176|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
10077437|NCT02226653|11205175|FG000|STARTED|Treatment Period 5 Fed State||23
10077438|NCT02226653|11205176|FG001|STARTED|Treatment Period 5 Fed State||24
9717436|NCT00003820|10816630|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
9717437|NCT00003820|10816629|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0
9717438|NCT00003820|10816630|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
9717439|NCT00003820|10816629|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
9717440|NCT00003820|10816630|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
9717441|NCT00003820|10816629|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
9717442|NCT00003820|10816630|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
9717443|NCT00003820|10816629|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0
10077439|NCT02226653|11205175|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
10077440|NCT02226653|11205176|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
10077441|NCT02226653|11205175|FG000|COMPLETED|Treatment Period 5 Fed State||23
10077442|NCT02226653|11205176|FG001|COMPLETED|Treatment Period 5 Fed State||23
10077443|NCT02226653|11205175|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0
10077444|NCT02226653|11205176|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1
10077445|NCT02226653|11205175|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23
10077446|NCT02226653|11205176|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23
10077447|NCT02226653|11205175|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23
10077448|NCT02226653|11205176|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23
10077449|NCT02226653|11205175|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
10077450|NCT02226653|11205176|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
10077451|NCT02226796|11205189|FG000|STARTED|First Intervention Phase (Week 1)||2
10077452|NCT02226796|11205190|FG001|STARTED|First Intervention Phase (Week 1)||1
10077453|NCT02226796|11205189|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2
10077454|NCT02226796|11205190|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1
10077455|NCT02226796|11205189|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2
10077456|NCT02226796|11205190|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1
10077457|NCT02226796|11205189|FG000|COMPLETED|First Intervention Phase (Week 1)||2
10077458|NCT02226796|11205190|FG001|COMPLETED|First Intervention Phase (Week 1)||1
10077459|NCT02226796|11205189|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0
10077460|NCT02226796|11205190|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0
10077461|NCT02226796|11205189|FG000|STARTED|Washout (Weeks 2-5)||2
10077462|NCT02226796|11205190|FG001|STARTED|Washout (Weeks 2-5)||1
10077463|NCT02226796|11205189|FG000|COMPLETED|Washout (Weeks 2-5)||2
10077464|NCT02226796|11205190|FG001|COMPLETED|Washout (Weeks 2-5)||1
10077465|NCT02226796|11205189|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0
10077466|NCT02226796|11205190|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0
10077467|NCT02226796|11205189|FG000|STARTED|Second Intervention Phase (Week 6)||2
10077468|NCT02226796|11205190|FG001|STARTED|Second Intervention Phase (Week 6)||1
10077469|NCT02226796|11205189|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2
10077470|NCT02226796|11205190|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1
10077471|NCT02226796|11205189|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2
10077472|NCT02226796|11205190|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1
10077473|NCT02226796|11205189|FG000|COMPLETED|Second Intervention Phase (Week 6)||2
10077474|NCT02226796|11205190|FG001|COMPLETED|Second Intervention Phase (Week 6)||1
10077475|NCT02226796|11205189|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0
10077476|NCT02226796|11205190|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0
10077477|NCT02226965|11205196|FG000|STARTED|Overall Study||45
10077478|NCT02226965|11205196|FG000|COMPLETED|Overall Study||4
10077479|NCT02226965|11205196|FG000|NOT COMPLETED|Overall Study||41
10077480|NCT02227108|11205200|FG000|STARTED|Overall Study||32
10077481|NCT02227108|11205200|FG000|Treated|Overall Study||30
10077482|NCT02227108|11205200|FG000|COMPLETED|Overall Study||1
10077483|NCT02227108|11205200|FG000|NOT COMPLETED|Overall Study||31
10077484|NCT02227121|11205204|FG000|STARTED|Overall Study||16
10077485|NCT02227121|11205204|FG000|COMPLETED|Overall Study||16
10077486|NCT02227121|11205204|FG000|NOT COMPLETED|Overall Study||0
10077487|NCT02227316|11205212|FG000|STARTED|Overall Study||4
10077488|NCT02227316|11205213|FG001|STARTED|Overall Study||4
10077489|NCT02227316|11205214|FG002|STARTED|Overall Study||16
10077490|NCT02227316|11205215|FG003|STARTED|Overall Study||16
10077491|NCT02227316|11205212|FG000|COMPLETED|Overall Study||4
10077492|NCT02227316|11205213|FG001|COMPLETED|Overall Study||4
10077493|NCT02227316|11205214|FG002|COMPLETED|Overall Study||16
10077494|NCT02227316|11205215|FG003|COMPLETED|Overall Study||16
10077495|NCT02227316|11205212|FG000|NOT COMPLETED|Overall Study||0
10077496|NCT02227316|11205213|FG001|NOT COMPLETED|Overall Study||0
10077497|NCT02227316|11205214|FG002|NOT COMPLETED|Overall Study||0
10077498|NCT02227316|11205215|FG003|NOT COMPLETED|Overall Study||0
10077499|NCT02227329|11205227|FG000|STARTED|Overall Study||18
10077500|NCT02227329|11205228|FG001|STARTED|Overall Study||20
10077501|NCT02227329|11205227|FG000|COMPLETED|Overall Study||18
10077502|NCT02227329|11205228|FG001|COMPLETED|Overall Study||20
10077503|NCT02227329|11205227|FG000|NOT COMPLETED|Overall Study||0
10077504|NCT02227329|11205228|FG001|NOT COMPLETED|Overall Study||0
10077505|NCT02227368|11205236|FG000|STARTED|Overall Study||16
10077506|NCT02227368|11205237|FG001|STARTED|Overall Study||24
10077507|NCT02227368|11205236|FG000|Sujects Who Received Treatment|Overall Study||16
10077508|NCT02227368|11205237|FG001|Sujects Who Received Treatment|Overall Study||24
10077509|NCT02227368|11205236|FG000|Sujects Who Completed Treatment|Overall Study||10
10077510|NCT02227368|11205237|FG001|Sujects Who Completed Treatment|Overall Study||17
10077511|NCT02227368|11205236|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
10077512|NCT02227368|11205237|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
10077513|NCT02227368|11205236|FG000|NOT COMPLETED|Overall Study||2
10077514|NCT02227368|11205237|FG001|NOT COMPLETED|Overall Study||4
10077515|NCT02227446|11205245|FG000|STARTED|Overall Study||521
10077516|NCT02227446|11205246|FG001|STARTED|Overall Study||515
10077517|NCT02227446|11205245|FG000|COMPLETED|Overall Study||499
10077518|NCT02227446|11205246|FG001|COMPLETED|Overall Study||481
10077519|NCT02227446|11205245|FG000|NOT COMPLETED|Overall Study||22
10077520|NCT02227446|11205246|FG001|NOT COMPLETED|Overall Study||34
10077521|NCT02227485|11205254|FG000|STARTED|First Follow-up||40
10077522|NCT02227485|11205255|FG001|STARTED|First Follow-up||40
10077523|NCT02227485|11205254|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
10077524|NCT02227485|11205255|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
10077525|NCT02227485|11205254|FG000|NOT COMPLETED|First Follow-up||4
10077526|NCT02227485|11205255|FG001|NOT COMPLETED|First Follow-up||2
10077527|NCT02227485|11205254|FG000|STARTED|Second Follow-up||36
10077528|NCT02227485|11205255|FG001|STARTED|Second Follow-up||38
10077529|NCT02227485|11205254|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
10077530|NCT02227485|11205255|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
10077531|NCT02227485|11205254|FG000|NOT COMPLETED|Second Follow-up||2
10191362|NCT03305419|11320551|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10191363|NCT03305419|11320552|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10191364|NCT03305419|11320553|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10191365|NCT03305419|11320554|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10191366|NCT03305419|11320555|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10191367|NCT03305419|11320556|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10191368|NCT03305419|11320557|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10191369|NCT03305419|11320550|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
10191370|NCT03305419|11320551|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
10191371|NCT03305419|11320552|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
10191372|NCT03305419|11320553|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
10191373|NCT03305419|11320554|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191374|NCT03305419|11320555|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191375|NCT03305419|11320556|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191376|NCT03305419|11320557|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191377|NCT03305419|11320550|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191378|NCT03305419|11320551|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
10191379|NCT03305419|11320552|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191380|NCT03305419|11320553|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191381|NCT03305419|11320554|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10077532|NCT02227485|11205255|FG001|NOT COMPLETED|Second Follow-up||2
10077533|NCT02227667|11205262|FG000|STARTED|Overall Study||16
10077534|NCT02227667|11205262|FG000|COMPLETED|Overall Study||16
10077535|NCT02227667|11205262|FG000|NOT COMPLETED|Overall Study||0
10077536|NCT02227693|11205270|FG000|STARTED|Overall Study||11
10077537|NCT02227693|11205271|FG001|STARTED|Overall Study||7
10077538|NCT02227693|11205272|FG002|STARTED|Overall Study||11
10077539|NCT02227693|11205273|FG003|STARTED|Overall Study||10
10077540|NCT02227693|11205270|FG000|COMPLETED|Overall Study||11
10077541|NCT02227693|11205271|FG001|COMPLETED|Overall Study||7
10077542|NCT02227693|11205272|FG002|COMPLETED|Overall Study||11
10077543|NCT02227693|11205273|FG003|COMPLETED|Overall Study||10
10077544|NCT02227693|11205270|FG000|NOT COMPLETED|Overall Study||0
10077545|NCT02227693|11205271|FG001|NOT COMPLETED|Overall Study||0
10077546|NCT02227693|11205272|FG002|NOT COMPLETED|Overall Study||0
10077547|NCT02227693|11205273|FG003|NOT COMPLETED|Overall Study||0
10077548|NCT02227706|11205289|FG000|STARTED|Overall Study||20
10077549|NCT02227706|11205290|FG001|STARTED|Overall Study||20
10077550|NCT02227706|11205289|FG000|COMPLETED|Overall Study||20
10077551|NCT02227706|11205290|FG001|COMPLETED|Overall Study||20
10077552|NCT02227706|11205289|FG000|NOT COMPLETED|Overall Study||0
10077553|NCT02227706|11205290|FG001|NOT COMPLETED|Overall Study||0
10077554|NCT02227758|11205296|FG000|STARTED|Overall Study||112
10077555|NCT02227758|11205296|FG000|COMPLETED|Overall Study||45
10077556|NCT02227758|11205296|FG000|NOT COMPLETED|Overall Study||67
10077557|NCT02227784|11205306|FG000|STARTED|Double-Blind Phase||123
10077558|NCT02227784|11205307|FG001|STARTED|Double-Blind Phase||54
10077559|NCT02227784|11205308|FG002|STARTED|Double-Blind Phase||62
10077560|NCT02227784|11205309|FG003|STARTED|Double-Blind Phase||127
10077561|NCT02227784|11205310|FG004|STARTED|Double-Blind Phase||0
10077562|NCT02227784|11205306|FG000|COMPLETED|Double-Blind Phase||83
10077563|NCT02227784|11205307|FG001|COMPLETED|Double-Blind Phase||36
10077564|NCT02227784|11205308|FG002|COMPLETED|Double-Blind Phase||41
10077565|NCT02227784|11205309|FG003|COMPLETED|Double-Blind Phase||88
10077566|NCT02227784|11205310|FG004|COMPLETED|Double-Blind Phase||0
10077567|NCT02227784|11205306|FG000|NOT COMPLETED|Double-Blind Phase||40
10077568|NCT02227784|11205307|FG001|NOT COMPLETED|Double-Blind Phase||18
10077569|NCT02227784|11205308|FG002|NOT COMPLETED|Double-Blind Phase||21
10077570|NCT02227784|11205309|FG003|NOT COMPLETED|Double-Blind Phase||39
10077571|NCT02227784|11205310|FG004|NOT COMPLETED|Double-Blind Phase||0
10077572|NCT02227784|11205306|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10077573|NCT02227784|11205307|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10077574|NCT02227784|11205308|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10077575|NCT02227784|11205309|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10077576|NCT02227784|11205310|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
10077577|NCT02227784|11205306|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10077578|NCT02227784|11205307|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10077579|NCT02227784|11205308|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10077580|NCT02227784|11205309|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10077581|NCT02227784|11205310|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
10077582|NCT02227784|11205306|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
10077583|NCT02227784|11205307|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
10077584|NCT02227784|11205308|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0
10077585|NCT02227784|11205309|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0
10077586|NCT02227784|11205310|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0
10077587|NCT02227784|11205306|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10077588|NCT02227784|11205307|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10077589|NCT02227784|11205308|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10077590|NCT02227784|11205309|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10191382|NCT03305419|11320555|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191383|NCT03305419|11320556|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191384|NCT03305419|11320557|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10191385|NCT03305419|11320550|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
10191386|NCT03305419|11320551|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
10191387|NCT03305419|11320552|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
10191388|NCT03305419|11320553|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
10191389|NCT03305419|11320554|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10191390|NCT03305419|11320555|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10191391|NCT03305419|11320556|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10191392|NCT03305419|11320557|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10191393|NCT03305419|11320550|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
10191394|NCT03305419|11320551|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
10191395|NCT03305419|11320552|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
10191396|NCT03305419|11320553|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
10191397|NCT03305419|11320554|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10077591|NCT02227784|11205310|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
10077592|NCT02227810|11205325|FG000|STARTED|Overall Study||19
10077593|NCT02227810|11205326|FG001|STARTED|Overall Study||34
10077594|NCT02227810|11205325|FG000|COMPLETED|Overall Study||17
10077595|NCT02227810|11205326|FG001|COMPLETED|Overall Study||29
10077596|NCT02227810|11205325|FG000|NOT COMPLETED|Overall Study||2
10077597|NCT02227810|11205326|FG001|NOT COMPLETED|Overall Study||5
10077598|NCT02227836|11205334|FG000|STARTED|Overall Study||8
10077599|NCT02227836|11205334|FG000|COMPLETED|Overall Study||8
10077600|NCT02227836|11205334|FG000|NOT COMPLETED|Overall Study||0
10077601|NCT02227849|11205338|FG000|STARTED|Overall Study||71
10077602|NCT02227849|11205338|FG000|COMPLETED|Overall Study||63
10077603|NCT02227849|11205338|FG000|NOT COMPLETED|Overall Study||8
10077604|NCT02228096|11205344|FG000|STARTED|Overall Study||75
10077605|NCT02228096|11205344|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31
10077606|NCT02228096|11205344|FG000|Enrolled But Not Infused|Overall Study||11
10077607|NCT02228096|11205344|FG000|Enrolled and Infused|Overall Study||64
10077608|NCT02228096|11205344|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4
10077609|NCT02228096|11205344|FG000|NOT COMPLETED|Overall Study||71
10077610|NCT02228174|11205362|FG000|STARTED|Overall Study||147
10077611|NCT02228174|11205362|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
10077612|NCT02228174|11205362|FG000|COMPLETED|Overall Study||142
10077613|NCT02228174|11205362|FG000|NOT COMPLETED|Overall Study||5
10077614|NCT02228395|11205366|FG000|STARTED|First Intervention Period||3
10077615|NCT02228395|11205367|FG001|STARTED|First Intervention Period||3
10077616|NCT02228395|11205368|FG002|STARTED|First Intervention Period||3
10077617|NCT02228395|11205366|FG000|COMPLETED|First Intervention Period||2
10077618|NCT02228395|11205367|FG001|COMPLETED|First Intervention Period||2
10077619|NCT02228395|11205368|FG002|COMPLETED|First Intervention Period||2
10077620|NCT02228395|11205366|FG000|NOT COMPLETED|First Intervention Period||1
10077621|NCT02228395|11205367|FG001|NOT COMPLETED|First Intervention Period||1
10077622|NCT02228395|11205368|FG002|NOT COMPLETED|First Intervention Period||1
10077623|NCT02228395|11205366|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
10077624|NCT02228395|11205367|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
10077625|NCT02228395|11205368|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
10077626|NCT02228395|11205366|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
10077627|NCT02228395|11205367|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
10077628|NCT02228395|11205368|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
10077629|NCT02228395|11205366|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10077630|NCT02228395|11205367|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10077631|NCT02228395|11205368|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10191398|NCT03305419|11320555|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191399|NCT03305419|11320556|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191400|NCT03305419|11320557|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191401|NCT03305419|11320550|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
10191402|NCT03305419|11320551|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191403|NCT03305419|11320552|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191404|NCT03305419|11320553|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191405|NCT03305419|11320554|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191406|NCT03305419|11320555|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191407|NCT03305419|11320556|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10191408|NCT03305419|11320557|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10077632|NCT02228395|11205366|FG000|STARTED|Second Intervention Period||3
10077633|NCT02228395|11205367|FG001|STARTED|Second Intervention Period||3
10077634|NCT02228395|11205368|FG002|STARTED|Second Intervention Period||3
10077635|NCT02228395|11205366|FG000|COMPLETED|Second Intervention Period||3
10077636|NCT02228395|11205367|FG001|COMPLETED|Second Intervention Period||3
10077637|NCT02228395|11205368|FG002|COMPLETED|Second Intervention Period||3
10077638|NCT02228395|11205366|FG000|NOT COMPLETED|Second Intervention Period||0
10077639|NCT02228395|11205367|FG001|NOT COMPLETED|Second Intervention Period||0
10077640|NCT02228395|11205368|FG002|NOT COMPLETED|Second Intervention Period||0
10077641|NCT02228395|11205366|FG000|STARTED|Washout Period (at Least 10 Days)||3
10077642|NCT02228395|11205367|FG001|STARTED|Washout Period (at Least 10 Days)||3
10077643|NCT02228395|11205368|FG002|STARTED|Washout Period (at Least 10 Days)||3
10077644|NCT02228395|11205366|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
10077645|NCT02228395|11205367|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
10077646|NCT02228395|11205368|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
10077647|NCT02228395|11205366|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10077648|NCT02228395|11205367|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10077649|NCT02228395|11205368|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10077650|NCT02228395|11205366|FG000|STARTED|Third Intervention Period||3
10077651|NCT02228395|11205367|FG001|STARTED|Third Intervention Period||3
10077652|NCT02228395|11205368|FG002|STARTED|Third Intervention Period||3
10077653|NCT02228395|11205366|FG000|COMPLETED|Third Intervention Period||3
10077654|NCT02228395|11205367|FG001|COMPLETED|Third Intervention Period||3
10077655|NCT02228395|11205368|FG002|COMPLETED|Third Intervention Period||3
10077656|NCT02228395|11205366|FG000|NOT COMPLETED|Third Intervention Period||0
10077657|NCT02228395|11205367|FG001|NOT COMPLETED|Third Intervention Period||0
10077658|NCT02228395|11205368|FG002|NOT COMPLETED|Third Intervention Period||0
10077659|NCT02228408|11205380|FG000|STARTED|Overall Study||7
10077660|NCT02228408|11205381|FG001|STARTED|Overall Study||10
10077661|NCT02228408|11205380|FG000|COMPLETED|Overall Study||7
10077662|NCT02228408|11205381|FG001|COMPLETED|Overall Study||10
10077663|NCT02228408|11205380|FG000|NOT COMPLETED|Overall Study||0
10077664|NCT02228408|11205381|FG001|NOT COMPLETED|Overall Study||0
10077665|NCT02228460|11205387|FG000|STARTED|Overall Study||11
10077666|NCT02228460|11205387|FG000|COMPLETED|Overall Study||9
10077667|NCT02228460|11205387|FG000|NOT COMPLETED|Overall Study||2
10077668|NCT02228499|11205394|FG000|STARTED|Overall Study||30
10077669|NCT02228499|11205395|FG001|STARTED|Overall Study||36
10077670|NCT02228499|11205394|FG000|COMPLETED|Overall Study||7
10077671|NCT02228499|11205395|FG001|COMPLETED|Overall Study||10
10077672|NCT02228499|11205394|FG000|NOT COMPLETED|Overall Study||23
10077673|NCT02228499|11205395|FG001|NOT COMPLETED|Overall Study||26
10077674|NCT02228564|11205401|FG000|STARTED|Overall Study||155
10077675|NCT02228564|11205401|FG000|COMPLETED|Overall Study||106
10077676|NCT02228564|11205401|FG000|NOT COMPLETED|Overall Study||49
10077677|NCT02228590|11205405|FG000|STARTED|Overall Study||20
10077678|NCT02228590|11205405|FG000|COMPLETED|Overall Study||19
10077679|NCT02228590|11205405|FG000|NOT COMPLETED|Overall Study||1
10077680|NCT02228681|11205412|FG000|STARTED|Overall Study||37
10077681|NCT02228681|11205413|FG001|STARTED|Overall Study||37
10077682|NCT02228681|11205412|FG000|COMPLETED|Overall Study||37
10077683|NCT02228681|11205413|FG001|COMPLETED|Overall Study||37
10077684|NCT02228681|11205412|FG000|NOT COMPLETED|Overall Study||0
10077685|NCT02228681|11205413|FG001|NOT COMPLETED|Overall Study||0
10077686|NCT02228720|11205419|FG000|STARTED|Open Label - Baseline||15
10077687|NCT02228720|11205419|FG000|COMPLETED|Open Label - Baseline||15
10077688|NCT02228720|11205419|FG000|NOT COMPLETED|Open Label - Baseline||0
10077689|NCT02228720|11205419|FG000|STARTED|Open Label - Day 30||15
10077690|NCT02228720|11205419|FG000|COMPLETED|Open Label - Day 30||14
10077691|NCT02228720|11205419|FG000|NOT COMPLETED|Open Label - Day 30||1
10077692|NCT02228720|11205419|FG000|STARTED|Open Label - Day 90||14
10077693|NCT02228720|11205419|FG000|COMPLETED|Open Label - Day 90||14
10077694|NCT02228720|11205419|FG000|NOT COMPLETED|Open Label - Day 90||0
10077695|NCT02228824|11205425|FG000|STARTED|Overall Study||118
10077696|NCT02228824|11205426|FG001|STARTED|Overall Study||120
10077697|NCT02228824|11205425|FG000|COMPLETED|Overall Study||89
10077698|NCT02228824|11205426|FG001|COMPLETED|Overall Study||98
10077699|NCT02228824|11205425|FG000|NOT COMPLETED|Overall Study||29
10077700|NCT02228824|11205426|FG001|NOT COMPLETED|Overall Study||22
10077701|NCT02228967|11205434|FG000|STARTED|Overall Study||403
10077702|NCT02228967|11205435|FG001|STARTED|Overall Study||388
10077703|NCT02228967|11205434|FG000|COMPLETED|Overall Study||244
10077704|NCT02228967|11205435|FG001|COMPLETED|Overall Study||228
10077705|NCT02228967|11205434|FG000|NOT COMPLETED|Overall Study||159
10077706|NCT02228967|11205435|FG001|NOT COMPLETED|Overall Study||160
10077707|NCT02228980|11205445|FG000|STARTED|Overall Study||150
10077708|NCT02228980|11205446|FG001|STARTED|Overall Study||150
10077709|NCT02228980|11205447|FG002|STARTED|Overall Study||151
10077710|NCT02228980|11205448|FG003|STARTED|Overall Study||151
10077711|NCT02228980|11205445|FG000|COMPLETED|Overall Study||126
10077712|NCT02228980|11205446|FG001|COMPLETED|Overall Study||147
10077713|NCT02228980|11205447|FG002|COMPLETED|Overall Study||149
10077714|NCT02228980|11205448|FG003|COMPLETED|Overall Study||148
10077715|NCT02228980|11205445|FG000|NOT COMPLETED|Overall Study||24
10077716|NCT02228980|11205446|FG001|NOT COMPLETED|Overall Study||3
10077717|NCT02228980|11205447|FG002|NOT COMPLETED|Overall Study||2
10077718|NCT02228980|11205448|FG003|NOT COMPLETED|Overall Study||3
10077719|NCT02229214|11205464|FG000|STARTED|Overall Study||41
10077720|NCT02229214|11205465|FG001|STARTED|Overall Study||10
10077721|NCT02229214|11205464|FG000|COMPLETED|Overall Study||35
10077722|NCT02229214|11205465|FG001|COMPLETED|Overall Study||10
10077723|NCT02229214|11205464|FG000|NOT COMPLETED|Overall Study||6
10077724|NCT02229214|11205465|FG001|NOT COMPLETED|Overall Study||0
10077725|NCT02229227|11205475|FG000|STARTED|Overall Study||402
10077726|NCT02229227|11205476|FG001|STARTED|Overall Study||412
10077727|NCT02229227|11205475|FG000|COMPLETED|Overall Study||351
10077728|NCT02229227|11205476|FG001|COMPLETED|Overall Study||350
10077729|NCT02229227|11205475|FG000|NOT COMPLETED|Overall Study||51
10077730|NCT02229227|11205476|FG001|NOT COMPLETED|Overall Study||62
10077731|NCT02229318|11205482|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11
10077732|NCT02229318|11205482|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11
10077733|NCT02229318|11205482|FG000|NOT COMPLETED|Overall Study||0
10077734|NCT02229383|11205489|FG000|STARTED|Overall Study||232
10077735|NCT02229383|11205490|FG001|STARTED|Overall Study||229
10077736|NCT02229383|11205489|FG000|Received Treatment|Overall Study||231
10077737|NCT02229383|11205490|FG001|Received Treatment|Overall Study||229
10077738|NCT02229383|11205489|FG000|Safety Analysis Set|Overall Study||231
10077739|NCT02229383|11205490|FG001|Safety Analysis Set|Overall Study||229
9717444|NCT00003820|10816630|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
9717445|NCT00003820|10816629|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
9717446|NCT00003820|10816630|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
9717447|NCT00003830|10816638|FG000|STARTED|Overall Study||2807
9717448|NCT00003830|10816639|FG001|STARTED|Overall Study||2804
9717449|NCT00003830|10816638|FG000|COMPLETED|Overall Study||1975
9717450|NCT00003830|10816639|FG001|COMPLETED|Overall Study||2011
9717451|NCT00003830|10816638|FG000|NOT COMPLETED|Overall Study||832
9717452|NCT00003830|10816639|FG001|NOT COMPLETED|Overall Study||793
9717453|NCT00003869|10816649|FG000|STARTED|Overall Study||94
9717454|NCT00003869|10816650|FG001|STARTED|Overall Study||92
9717455|NCT00003869|10816649|FG000|COMPLETED|Overall Study||53
9717456|NCT00003869|10816650|FG001|COMPLETED|Overall Study||80
9717457|NCT00003869|10816649|FG000|NOT COMPLETED|Overall Study||41
9717458|NCT00003869|10816650|FG001|NOT COMPLETED|Overall Study||12
9717459|NCT00003875|10816656|FG000|STARTED|Overall Study||30
9717460|NCT00003875|10816656|FG000|COMPLETED|Overall Study||29
9717461|NCT00003875|10816656|FG000|NOT COMPLETED|Overall Study||1
9717462|NCT00003895|10816662|FG000|STARTED|Overall Study||18
9717463|NCT00003895|10816663|FG001|STARTED|Overall Study||18
10077740|NCT02229383|11205489|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230
10077741|NCT02229383|11205490|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228
10077742|NCT02229383|11205489|FG000|COMPLETED|Overall Study||212
10077743|NCT02229383|11205490|FG001|COMPLETED|Overall Study||207
10077744|NCT02229383|11205489|FG000|NOT COMPLETED|Overall Study||20
10077745|NCT02229383|11205490|FG001|NOT COMPLETED|Overall Study||22
9717464|NCT00003895|10816662|FG000|COMPLETED|Overall Study||11
9717465|NCT00003895|10816663|FG001|COMPLETED|Overall Study||14
9717466|NCT00003895|10816662|FG000|NOT COMPLETED|Overall Study||7
9717467|NCT00003895|10816663|FG001|NOT COMPLETED|Overall Study||4
9731473|NCT00132730|10831390|FG001|STARTED|Period II - 12-week Treatment (Base)||148
9731474|NCT00132730|10831391|FG002|STARTED|Period II - 12-week Treatment (Base)||153
10077746|NCT02229396|11205499|FG000|STARTED|Overall Study||233
10077747|NCT02229396|11205500|FG001|STARTED|Overall Study||231
10077748|NCT02229396|11205501|FG002|STARTED|Overall Study||231
10077749|NCT02229396|11205499|FG000|Randomization Code Allocated|Overall Study||233
10077750|NCT02229396|11205500|FG001|Randomization Code Allocated|Overall Study||231
10077751|NCT02229396|11205501|FG002|Randomization Code Allocated|Overall Study||231
10077752|NCT02229396|11205499|FG000|Safety Analysis Set|Overall Study||233
10077753|NCT02229396|11205500|FG001|Safety Analysis Set|Overall Study||231
10077754|NCT02229396|11205501|FG002|Safety Analysis Set|Overall Study||230
10077755|NCT02229396|11205499|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
10077756|NCT02229396|11205500|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
10077757|NCT02229396|11205501|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
10077758|NCT02229396|11205499|FG000|Completed 28-Week Study Period|Overall Study||208
10077759|NCT02229396|11205500|FG001|Completed 28-Week Study Period|Overall Study||202
10077760|NCT02229396|11205501|FG002|Completed 28-Week Study Period|Overall Study||193
10077761|NCT02229396|11205499|FG000|Completed 52-Week Study Period|Overall Study||194
10077762|NCT02229396|11205500|FG001|Completed 52-Week Study Period|Overall Study||193
10077763|NCT02229396|11205501|FG002|Completed 52-Week Study Period|Overall Study||177
10077764|NCT02229396|11205499|FG000|COMPLETED|Overall Study||155
10077765|NCT02229396|11205500|FG001|COMPLETED|Overall Study||154
10077766|NCT02229396|11205501|FG002|COMPLETED|Overall Study||136
10077767|NCT02229396|11205499|FG000|NOT COMPLETED|Overall Study||78
10077768|NCT02229396|11205500|FG001|NOT COMPLETED|Overall Study||77
10077769|NCT02229396|11205501|FG002|NOT COMPLETED|Overall Study||95
10077770|NCT02229461|11205516|FG000|STARTED|Overall Study|Randomized and received treatment|17
10077771|NCT02229461|11205517|FG001|STARTED|Overall Study|Randomized and received treatment|17
10077772|NCT02229461|11205518|FG002|STARTED|Overall Study|Randomized and received treatment|17
10077773|NCT02229461|11205519|FG003|STARTED|Overall Study|Randomized and received treatment|17
10077774|NCT02229461|11205520|FG004|STARTED|Overall Study|Randomized and received treatment|17
10077775|NCT02229461|11205521|FG005|STARTED|Overall Study|Randomized and received treatment|17
10077776|NCT02229461|11205516|FG000|COMPLETED|Overall Study||17
10077777|NCT02229461|11205517|FG001|COMPLETED|Overall Study||17
10077778|NCT02229461|11205518|FG002|COMPLETED|Overall Study||17
10077779|NCT02229461|11205519|FG003|COMPLETED|Overall Study||17
10077780|NCT02229461|11205520|FG004|COMPLETED|Overall Study||17
10077781|NCT02229461|11205521|FG005|COMPLETED|Overall Study||17
10077782|NCT02229461|11205516|FG000|NOT COMPLETED|Overall Study||0
10077783|NCT02229461|11205517|FG001|NOT COMPLETED|Overall Study||0
10077784|NCT02229461|11205518|FG002|NOT COMPLETED|Overall Study||0
10077785|NCT02229461|11205519|FG003|NOT COMPLETED|Overall Study||0
10077786|NCT02229461|11205520|FG004|NOT COMPLETED|Overall Study||0
10077787|NCT02229461|11205521|FG005|NOT COMPLETED|Overall Study||0
10077788|NCT02229474|11205538|FG000|STARTED|Overall Study||16
10077789|NCT02229474|11205539|FG001|STARTED|Overall Study||18
10077790|NCT02229474|11205538|FG000|COMPLETED|Overall Study||16
10077791|NCT02229474|11205539|FG001|COMPLETED|Overall Study||15
10077792|NCT02229474|11205538|FG000|NOT COMPLETED|Overall Study||0
10077793|NCT02229474|11205539|FG001|NOT COMPLETED|Overall Study||3
10077794|NCT02229487|11205548|FG000|STARTED|Overall Study||24
10077795|NCT02229487|11205549|FG001|STARTED|Overall Study||27
10077796|NCT02229487|11205548|FG000|COMPLETED|Overall Study||24
10077797|NCT02229487|11205549|FG001|COMPLETED|Overall Study||27
10077798|NCT02229487|11205548|FG000|NOT COMPLETED|Overall Study||0
10077799|NCT02229487|11205549|FG001|NOT COMPLETED|Overall Study||0
10077800|NCT02229513|11205557|FG000|STARTED|Overall Study||100
10077801|NCT02229513|11205558|FG001|STARTED|Overall Study||100
10077802|NCT02229513|11205557|FG000|COMPLETED|Overall Study||100
10077803|NCT02229513|11205558|FG001|COMPLETED|Overall Study||100
10077804|NCT02229513|11205557|FG000|NOT COMPLETED|Overall Study||0
10077805|NCT02229513|11205558|FG001|NOT COMPLETED|Overall Study||0
10077806|NCT02229539|11205567|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77
10077807|NCT02229539|11205568|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76
10077808|NCT02229539|11205569|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75
10077809|NCT02229539|11205567|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
10077810|NCT02229539|11205568|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
10077811|NCT02229539|11205569|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
10077812|NCT02229539|11205567|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
10077813|NCT02229539|11205568|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
10077814|NCT02229539|11205569|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
10077815|NCT02229539|11205567|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35
10077816|NCT02229539|11205568|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36
10077817|NCT02229539|11205569|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32
10077818|NCT02229539|11205567|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
10077819|NCT02229539|11205568|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
10077820|NCT02229539|11205569|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
10077821|NCT02229539|11205567|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
10077822|NCT02229539|11205568|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
10077823|NCT02229539|11205569|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
10077824|NCT02229552|11205577|FG000|STARTED|Baseline||237
10077825|NCT02229552|11205577|FG000|COMPLETED|Baseline||231
10077826|NCT02229552|11205577|FG000|NOT COMPLETED|Baseline||6
10077827|NCT02229552|11205577|FG000|STARTED|1-year Follow up||231
10077828|NCT02229552|11205577|FG000|COMPLETED|1-year Follow up||206
10077829|NCT02229552|11205577|FG000|NOT COMPLETED|1-year Follow up||25
10077830|NCT02229552|11205577|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
10077831|NCT02229552|11205577|FG000|COMPLETED|2-Year Follow up||205
10077832|NCT02229552|11205577|FG000|NOT COMPLETED|2-Year Follow up||26
10077833|NCT02229851|11205584|FG000|STARTED|Main Phase (Double-blind Phase)||61
10077834|NCT02229851|11205585|FG001|STARTED|Main Phase (Double-blind Phase)||119
10077835|NCT02229851|11205586|FG002|STARTED|Main Phase (Double-blind Phase)||120
10077836|NCT02229851|11205587|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10077837|NCT02229851|11205588|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10077838|NCT02229851|11205589|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10077839|NCT02229851|11205590|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10077840|NCT02229851|11205584|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61
10077841|NCT02229851|11205585|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119
10077842|NCT02229851|11205586|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120
10077843|NCT02229851|11205587|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0
10077844|NCT02229851|11205588|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0
10077845|NCT02229851|11205589|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0
10077846|NCT02229851|11205590|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0
10077847|NCT02229851|11205584|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61
10077848|NCT02229851|11205585|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119
10077849|NCT02229851|11205586|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120
10077850|NCT02229851|11205587|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10077851|NCT02229851|11205588|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10077852|NCT02229851|11205589|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10077853|NCT02229851|11205590|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10077854|NCT02229851|11205584|FG000|COMPLETED|Main Phase (Double-blind Phase)||55
10077855|NCT02229851|11205585|FG001|COMPLETED|Main Phase (Double-blind Phase)||103
10077856|NCT02229851|11205586|FG002|COMPLETED|Main Phase (Double-blind Phase)||114
10077857|NCT02229851|11205587|FG003|COMPLETED|Main Phase (Double-blind Phase)||0
10077858|NCT02229851|11205588|FG004|COMPLETED|Main Phase (Double-blind Phase)||0
10077859|NCT02229851|11205589|FG005|COMPLETED|Main Phase (Double-blind Phase)||0
10077860|NCT02229851|11205590|FG006|COMPLETED|Main Phase (Double-blind Phase)||0
10077861|NCT02229851|11205584|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6
10077862|NCT02229851|11205585|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16
10077863|NCT02229851|11205586|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6
10077864|NCT02229851|11205587|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10077865|NCT02229851|11205588|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10077866|NCT02229851|11205589|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10077867|NCT02229851|11205590|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10077868|NCT02229851|11205584|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
10077869|NCT02229851|11205585|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
10077870|NCT02229851|11205586|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
10077871|NCT02229851|11205587|FG003|STARTED|Extension Phase (Open-label Phase)||55
10077872|NCT02229851|11205588|FG004|STARTED|Extension Phase (Open-label Phase)||114
10077873|NCT02229851|11205589|FG005|STARTED|Extension Phase (Open-label Phase)||52
10077874|NCT02229851|11205590|FG006|STARTED|Extension Phase (Open-label Phase)||51
10077875|NCT02229851|11205584|FG000|COMPLETED|Extension Phase (Open-label Phase)||0
10077876|NCT02229851|11205585|FG001|COMPLETED|Extension Phase (Open-label Phase)||0
10077877|NCT02229851|11205586|FG002|COMPLETED|Extension Phase (Open-label Phase)||0
10077878|NCT02229851|11205587|FG003|COMPLETED|Extension Phase (Open-label Phase)||53
10077879|NCT02229851|11205588|FG004|COMPLETED|Extension Phase (Open-label Phase)||109
10077880|NCT02229851|11205589|FG005|COMPLETED|Extension Phase (Open-label Phase)||47
10077881|NCT02229851|11205590|FG006|COMPLETED|Extension Phase (Open-label Phase)||48
10077882|NCT02229851|11205584|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0
10077883|NCT02229851|11205585|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0
10077884|NCT02229851|11205586|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0
10077885|NCT02229851|11205587|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2
10077886|NCT02229851|11205588|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5
10077887|NCT02229851|11205589|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5
10077888|NCT02229851|11205590|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3
10077889|NCT02229864|11205605|FG000|STARTED|Overall Study||12
10077890|NCT02229864|11205605|FG000|COMPLETED|Overall Study||9
10077891|NCT02229864|11205605|FG000|NOT COMPLETED|Overall Study||3
10077892|NCT02230085|11205609|FG000|STARTED|Overall Study||110
10077893|NCT02230085|11205609|FG000|COMPLETED|Overall Study||106
10077894|NCT02230085|11205609|FG000|NOT COMPLETED|Overall Study||4
10077895|NCT02230306|11205613|FG000|STARTED|Overall Study||5
10077896|NCT02230306|11205613|FG000|COMPLETED|Overall Study||4
10077897|NCT02230306|11205613|FG000|NOT COMPLETED|Overall Study||1
10077898|NCT02230332|11205619|FG000|STARTED|Overall Study||38
10077899|NCT02230332|11205620|FG001|STARTED|Overall Study||40
10077900|NCT02230332|11205619|FG000|COMPLETED|Overall Study||34
10077901|NCT02230332|11205620|FG001|COMPLETED|Overall Study||39
10077902|NCT02230332|11205619|FG000|NOT COMPLETED|Overall Study||4
10077903|NCT02230332|11205620|FG001|NOT COMPLETED|Overall Study||1
10077904|NCT02230384|11205628|FG000|STARTED|Phase 1||30
10077905|NCT02230384|11205629|FG001|STARTED|Phase 1||32
10077906|NCT02230384|11205628|FG000|COMPLETED|Phase 1||29
10077907|NCT02230384|11205629|FG001|COMPLETED|Phase 1||31
10077908|NCT02230384|11205628|FG000|NOT COMPLETED|Phase 1||1
10077909|NCT02230384|11205629|FG001|NOT COMPLETED|Phase 1||1
10077910|NCT02230384|11205628|FG000|STARTED|Phase 1 Wash Out||29
10077911|NCT02230384|11205629|FG001|STARTED|Phase 1 Wash Out||31
10077912|NCT02230384|11205628|FG000|COMPLETED|Phase 1 Wash Out||29
10077913|NCT02230384|11205629|FG001|COMPLETED|Phase 1 Wash Out||31
10077914|NCT02230384|11205628|FG000|NOT COMPLETED|Phase 1 Wash Out||0
10077915|NCT02230384|11205629|FG001|NOT COMPLETED|Phase 1 Wash Out||0
10077916|NCT02230384|11205628|FG000|STARTED|Phase 2 - Switch||29
10077917|NCT02230384|11205629|FG001|STARTED|Phase 2 - Switch||31
10077918|NCT02230384|11205628|FG000|COMPLETED|Phase 2 - Switch||26
10077919|NCT02230384|11205629|FG001|COMPLETED|Phase 2 - Switch||30
10077920|NCT02230384|11205628|FG000|NOT COMPLETED|Phase 2 - Switch||3
10077921|NCT02230384|11205629|FG001|NOT COMPLETED|Phase 2 - Switch||1
10077922|NCT02230384|11205628|FG000|STARTED|Phase 2 Wash Out||26
10077923|NCT02230384|11205629|FG001|STARTED|Phase 2 Wash Out||30
10077924|NCT02230384|11205628|FG000|COMPLETED|Phase 2 Wash Out||26
10077925|NCT02230384|11205629|FG001|COMPLETED|Phase 2 Wash Out||30
10077926|NCT02230384|11205628|FG000|NOT COMPLETED|Phase 2 Wash Out||0
10077927|NCT02230384|11205629|FG001|NOT COMPLETED|Phase 2 Wash Out||0
10077928|NCT02230527|11205645|FG000|STARTED|Overall Study||23
10077929|NCT02230527|11205646|FG001|STARTED|Overall Study||23
10077930|NCT02230527|11205645|FG000|COMPLETED|Overall Study||18
10077931|NCT02230527|11205646|FG001|COMPLETED|Overall Study||21
10077932|NCT02230527|11205645|FG000|NOT COMPLETED|Overall Study||5
10077933|NCT02230527|11205646|FG001|NOT COMPLETED|Overall Study||2
10077934|NCT02230540|11205652|FG000|STARTED|Overall Study||8
10191409|NCT03305419|11320550|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
10191410|NCT03305419|11320551|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
10191411|NCT03305419|11320552|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
10191412|NCT03305419|11320553|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
10191413|NCT03305419|11320554|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10191414|NCT03305419|11320555|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10191415|NCT03305419|11320556|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10191416|NCT03305419|11320557|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10191417|NCT03305419|11320550|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10191418|NCT03305419|11320551|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10191419|NCT03305419|11320552|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10191420|NCT03305419|11320553|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10191421|NCT03305419|11320554|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191422|NCT03305419|11320555|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191423|NCT03305419|11320556|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191424|NCT03305419|11320557|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191425|NCT03305419|11320550|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191426|NCT03305419|11320551|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191427|NCT03305419|11320552|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191428|NCT03305419|11320553|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191429|NCT03305419|11320554|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191430|NCT03305419|11320555|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191431|NCT03305419|11320556|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191432|NCT03305419|11320557|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10191433|NCT03305419|11320550|FG000|STARTED|Part B (14 Days)||0
10191434|NCT03305419|11320551|FG001|STARTED|Part B (14 Days)||0
10191435|NCT03305419|11320552|FG002|STARTED|Part B (14 Days)||0
10191436|NCT03305419|11320553|FG003|STARTED|Part B (14 Days)||0
10191437|NCT03305419|11320554|FG004|STARTED|Part B (14 Days)||14
10191438|NCT03305419|11320555|FG005|STARTED|Part B (14 Days)||20
10191439|NCT03305419|11320556|FG006|STARTED|Part B (14 Days)||13
10191440|NCT03305419|11320557|FG007|STARTED|Part B (14 Days)||0
10191441|NCT03305419|11320550|FG000|COMPLETED|Part B (14 Days)||0
10191442|NCT03305419|11320551|FG001|COMPLETED|Part B (14 Days)||0
10191443|NCT03305419|11320552|FG002|COMPLETED|Part B (14 Days)||0
10191444|NCT03305419|11320553|FG003|COMPLETED|Part B (14 Days)||0
10191445|NCT03305419|11320554|FG004|COMPLETED|Part B (14 Days)||11
10191446|NCT03305419|11320555|FG005|COMPLETED|Part B (14 Days)||10
10191447|NCT03305419|11320556|FG006|COMPLETED|Part B (14 Days)||8
10191448|NCT03305419|11320557|FG007|COMPLETED|Part B (14 Days)||0
10191449|NCT03305419|11320550|FG000|NOT COMPLETED|Part B (14 Days)||0
10191450|NCT03305419|11320551|FG001|NOT COMPLETED|Part B (14 Days)||0
10191451|NCT03305419|11320552|FG002|NOT COMPLETED|Part B (14 Days)||0
10191452|NCT03305419|11320553|FG003|NOT COMPLETED|Part B (14 Days)||0
10191453|NCT03305419|11320554|FG004|NOT COMPLETED|Part B (14 Days)||3
10191454|NCT03305419|11320555|FG005|NOT COMPLETED|Part B (14 Days)||10
10077935|NCT02230540|11205653|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
10077936|NCT02230540|11205652|FG000|COMPLETED|Overall Study||8
10077937|NCT02230540|11205653|FG001|COMPLETED|Overall Study||0
10077938|NCT02230540|11205652|FG000|NOT COMPLETED|Overall Study||0
10077939|NCT02230540|11205653|FG001|NOT COMPLETED|Overall Study||0
10077940|NCT02230566|11205661|FG000|STARTED|Overall Study||3
10077941|NCT02230566|11205662|FG001|STARTED|Overall Study||3
10077942|NCT02230566|11205663|FG002|STARTED|Overall Study||3
10077943|NCT02230566|11205664|FG003|STARTED|Overall Study||3
10077944|NCT02230566|11205661|FG000|COMPLETED|Overall Study||3
10077945|NCT02230566|11205662|FG001|COMPLETED|Overall Study||3
10077946|NCT02230566|11205663|FG002|COMPLETED|Overall Study||3
10077947|NCT02230566|11205664|FG003|COMPLETED|Overall Study||3
10077948|NCT02230566|11205661|FG000|NOT COMPLETED|Overall Study||0
10077949|NCT02230566|11205662|FG001|NOT COMPLETED|Overall Study||0
10077950|NCT02230566|11205663|FG002|NOT COMPLETED|Overall Study||0
10077951|NCT02230566|11205664|FG003|NOT COMPLETED|Overall Study||0
10077952|NCT02230579|11205676|FG000|STARTED|Overall Study||6
10077953|NCT02230579|11205677|FG001|STARTED|Overall Study||6
10077954|NCT02230579|11205678|FG002|STARTED|Overall Study||6
10077955|NCT02230579|11205679|FG003|STARTED|Overall Study||6
10077956|NCT02230579|11205680|FG004|STARTED|Overall Study||6
10077957|NCT02230579|11205681|FG005|STARTED|Overall Study||6
10077958|NCT02230579|11205682|FG006|STARTED|Overall Study||12
10077959|NCT02230579|11205676|FG000|COMPLETED|Overall Study||6
10077960|NCT02230579|11205677|FG001|COMPLETED|Overall Study||6
10077961|NCT02230579|11205678|FG002|COMPLETED|Overall Study||6
10077962|NCT02230579|11205679|FG003|COMPLETED|Overall Study||6
10077963|NCT02230579|11205680|FG004|COMPLETED|Overall Study||6
10077964|NCT02230579|11205681|FG005|COMPLETED|Overall Study||6
10077965|NCT02230579|11205682|FG006|COMPLETED|Overall Study||12
10077966|NCT02230579|11205676|FG000|NOT COMPLETED|Overall Study||0
10077967|NCT02230579|11205677|FG001|NOT COMPLETED|Overall Study||0
10077968|NCT02230579|11205678|FG002|NOT COMPLETED|Overall Study||0
10077969|NCT02230579|11205679|FG003|NOT COMPLETED|Overall Study||0
10077970|NCT02230579|11205680|FG004|NOT COMPLETED|Overall Study||0
10077971|NCT02230579|11205681|FG005|NOT COMPLETED|Overall Study||0
10077972|NCT02230579|11205682|FG006|NOT COMPLETED|Overall Study||0
10077973|NCT02230670|11205700|FG000|STARTED|Overall Study||44
10077974|NCT02230670|11205701|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
10077975|NCT02230670|11205700|FG000|COMPLETED|Overall Study||40
10077976|NCT02230670|11205701|FG001|COMPLETED|Overall Study||34
10077977|NCT02230670|11205700|FG000|NOT COMPLETED|Overall Study||4
10077978|NCT02230670|11205701|FG001|NOT COMPLETED|Overall Study||8
10077979|NCT02230683|11205707|FG000|STARTED|Overall Study||23
10077980|NCT02230683|11205707|FG000|COMPLETED|Overall Study||22
10077981|NCT02230683|11205707|FG000|NOT COMPLETED|Overall Study||1
10077982|NCT02230696|11205720|FG000|STARTED|Overall Study||381
10077983|NCT02230696|11205721|FG001|STARTED|Overall Study||376
10077984|NCT02230696|11205722|FG002|STARTED|Overall Study||194
10077985|NCT02230696|11205720|FG000|COMPLETED|Overall Study||366
10077986|NCT02230696|11205721|FG001|COMPLETED|Overall Study||365
10077987|NCT02230696|11205722|FG002|COMPLETED|Overall Study||190
10077988|NCT02230696|11205720|FG000|NOT COMPLETED|Overall Study||15
10077989|NCT02230696|11205721|FG001|NOT COMPLETED|Overall Study||11
10077990|NCT02230696|11205722|FG002|NOT COMPLETED|Overall Study||4
10077991|NCT02230761|11205732|FG000|STARTED|Overall Study||60
10077992|NCT02230761|11205733|FG001|STARTED|Overall Study||30
10077993|NCT02230761|11205732|FG000|COMPLETED|Overall Study||60
10077994|NCT02230761|11205733|FG001|COMPLETED|Overall Study||29
10077995|NCT02230761|11205732|FG000|NOT COMPLETED|Overall Study||0
10077996|NCT02230761|11205733|FG001|NOT COMPLETED|Overall Study||1
10077997|NCT02230904|11205741|FG000|STARTED|Overall Study||29
10077998|NCT02230904|11205742|FG001|STARTED|Overall Study||28
10077999|NCT02230904|11205741|FG000|COMPLETED|Overall Study||29
10078000|NCT02230904|11205742|FG001|COMPLETED|Overall Study||27
10078001|NCT02230904|11205741|FG000|NOT COMPLETED|Overall Study||0
10078002|NCT02230904|11205742|FG001|NOT COMPLETED|Overall Study||1
10078003|NCT02230956|11205753|FG000|STARTED|Overall Study||44
10078004|NCT02230956|11205754|FG001|STARTED|Overall Study||43
10078005|NCT02230956|11205755|FG002|STARTED|Overall Study||89
10078006|NCT02230956|11205753|FG000|COMPLETED|Overall Study||39
10078007|NCT02230956|11205754|FG001|COMPLETED|Overall Study||37
10078008|NCT02230956|11205755|FG002|COMPLETED|Overall Study||82
10078009|NCT02230956|11205753|FG000|NOT COMPLETED|Overall Study||5
10078010|NCT02230956|11205754|FG001|NOT COMPLETED|Overall Study||6
10078011|NCT02230956|11205755|FG002|NOT COMPLETED|Overall Study||7
10078012|NCT02230995|11205765|FG000|STARTED|Period 1 + Washout||15
10078013|NCT02230995|11205766|FG001|STARTED|Period 1 + Washout||15
10078014|NCT02230995|11205765|FG000|COMPLETED|Period 1 + Washout||15
10078015|NCT02230995|11205766|FG001|COMPLETED|Period 1 + Washout||15
10078016|NCT02230995|11205765|FG000|NOT COMPLETED|Period 1 + Washout||0
10078017|NCT02230995|11205766|FG001|NOT COMPLETED|Period 1 + Washout||0
10078018|NCT02230995|11205765|FG000|STARTED|Period 2 + Washout||15
10078019|NCT02230995|11205766|FG001|STARTED|Period 2 + Washout||15
10078020|NCT02230995|11205765|FG000|COMPLETED|Period 2 + Washout||15
10078021|NCT02230995|11205766|FG001|COMPLETED|Period 2 + Washout||15
10078022|NCT02230995|11205765|FG000|NOT COMPLETED|Period 2 + Washout||0
10078023|NCT02230995|11205766|FG001|NOT COMPLETED|Period 2 + Washout||0
10078024|NCT02231086|11205774|FG000|STARTED|Overall Study||102
10078025|NCT02231086|11205775|FG001|STARTED|Overall Study||102
10078026|NCT02231086|11205774|FG000|COMPLETED|Overall Study||63
10078027|NCT02231086|11205775|FG001|COMPLETED|Overall Study||65
10078028|NCT02231086|11205774|FG000|NOT COMPLETED|Overall Study||39
10078029|NCT02231086|11205775|FG001|NOT COMPLETED|Overall Study||37
10078030|NCT02231164|11205783|FG000|STARTED|Overall Study||6
10078031|NCT02231164|11205784|FG001|STARTED|Overall Study||6
10078032|NCT02231164|11205783|FG000|COMPLETED|Overall Study||0
10078033|NCT02231164|11205784|FG001|COMPLETED|Overall Study||0
10078034|NCT02231164|11205783|FG000|NOT COMPLETED|Overall Study||6
10078035|NCT02231164|11205784|FG001|NOT COMPLETED|Overall Study||6
10078036|NCT02231177|11205790|FG000|STARTED|Treatment Period 1 (21 Days)||8
10078037|NCT02231177|11205791|FG001|STARTED|Treatment Period 1 (21 Days)||7
10078038|NCT02231177|11205792|FG002|STARTED|Treatment Period 1 (21 Days)||8
10078039|NCT02231177|11205793|FG003|STARTED|Treatment Period 1 (21 Days)||7
10078040|NCT02231177|11205794|FG004|STARTED|Treatment Period 1 (21 Days)||8
10078041|NCT02231177|11205795|FG005|STARTED|Treatment Period 1 (21 Days)||9
10078042|NCT02231177|11205790|FG000|COMPLETED|Treatment Period 1 (21 Days)||8
10078043|NCT02231177|11205791|FG001|COMPLETED|Treatment Period 1 (21 Days)||7
10078044|NCT02231177|11205792|FG002|COMPLETED|Treatment Period 1 (21 Days)||8
10078045|NCT02231177|11205793|FG003|COMPLETED|Treatment Period 1 (21 Days)||7
10078046|NCT02231177|11205794|FG004|COMPLETED|Treatment Period 1 (21 Days)||8
10078047|NCT02231177|11205795|FG005|COMPLETED|Treatment Period 1 (21 Days)||9
10078048|NCT02231177|11205790|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10078049|NCT02231177|11205791|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10078050|NCT02231177|11205792|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10078051|NCT02231177|11205793|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10078052|NCT02231177|11205794|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10078053|NCT02231177|11205795|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10078054|NCT02231177|11205790|FG000|STARTED|Treatment Period 2 (21 Days)||8
10078055|NCT02231177|11205791|FG001|STARTED|Treatment Period 2 (21 Days)||7
10078056|NCT02231177|11205792|FG002|STARTED|Treatment Period 2 (21 Days)||8
10078057|NCT02231177|11205793|FG003|STARTED|Treatment Period 2 (21 Days)||7
10078058|NCT02231177|11205794|FG004|STARTED|Treatment Period 2 (21 Days)||8
10078059|NCT02231177|11205795|FG005|STARTED|Treatment Period 2 (21 Days)||9
10078060|NCT02231177|11205790|FG000|COMPLETED|Treatment Period 2 (21 Days)||8
10078061|NCT02231177|11205791|FG001|COMPLETED|Treatment Period 2 (21 Days)||7
10078062|NCT02231177|11205792|FG002|COMPLETED|Treatment Period 2 (21 Days)||8
10078063|NCT02231177|11205793|FG003|COMPLETED|Treatment Period 2 (21 Days)||7
10078064|NCT02231177|11205794|FG004|COMPLETED|Treatment Period 2 (21 Days)||8
10078065|NCT02231177|11205795|FG005|COMPLETED|Treatment Period 2 (21 Days)||9
10078066|NCT02231177|11205790|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10078067|NCT02231177|11205791|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10078068|NCT02231177|11205792|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10078069|NCT02231177|11205793|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10078070|NCT02231177|11205794|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10078071|NCT02231177|11205795|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10078072|NCT02231177|11205790|FG000|STARTED|Treatment Period 3 (21 Days)||8
10078073|NCT02231177|11205791|FG001|STARTED|Treatment Period 3 (21 Days)||7
10078074|NCT02231177|11205792|FG002|STARTED|Treatment Period 3 (21 Days)||8
10078075|NCT02231177|11205793|FG003|STARTED|Treatment Period 3 (21 Days)||7
10078076|NCT02231177|11205794|FG004|STARTED|Treatment Period 3 (21 Days)||8
10078077|NCT02231177|11205795|FG005|STARTED|Treatment Period 3 (21 Days)||9
10078078|NCT02231177|11205790|FG000|COMPLETED|Treatment Period 3 (21 Days)||8
10078079|NCT02231177|11205791|FG001|COMPLETED|Treatment Period 3 (21 Days)||7
10078080|NCT02231177|11205792|FG002|COMPLETED|Treatment Period 3 (21 Days)||8
10078081|NCT02231177|11205793|FG003|COMPLETED|Treatment Period 3 (21 Days)||7
10078082|NCT02231177|11205794|FG004|COMPLETED|Treatment Period 3 (21 Days)||8
10078083|NCT02231177|11205795|FG005|COMPLETED|Treatment Period 3 (21 Days)||9
10078084|NCT02231177|11205790|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10078085|NCT02231177|11205791|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10078086|NCT02231177|11205792|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10078087|NCT02231177|11205793|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10078088|NCT02231177|11205794|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10078089|NCT02231177|11205795|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10078090|NCT02231580|11205806|FG000|STARTED|Overall Study||14
10078091|NCT02231580|11205807|FG001|STARTED|Overall Study||3
10078092|NCT02231580|11205806|FG000|Cohort 1|Overall Study||8
10078093|NCT02231580|11205807|FG001|Cohort 1|Overall Study||2
10078094|NCT02231580|11205806|FG000|Cohort 2|Overall Study||6
10078095|NCT02231580|11205807|FG001|Cohort 2|Overall Study||1
10078096|NCT02231580|11205806|FG000|COMPLETED|Overall Study||9
10078097|NCT02231580|11205807|FG001|COMPLETED|Overall Study||3
10078098|NCT02231580|11205806|FG000|NOT COMPLETED|Overall Study||5
10078099|NCT02231580|11205807|FG001|NOT COMPLETED|Overall Study||0
10078100|NCT02231918|11205818|FG000|STARTED|Overall Study||9
10078101|NCT02231918|11205819|FG001|STARTED|Overall Study||15
10078102|NCT02231918|11205820|FG002|STARTED|Overall Study||2
10078103|NCT02231918|11205818|FG000|COMPLETED|Overall Study||9
10078104|NCT02231918|11205819|FG001|COMPLETED|Overall Study||14
10078105|NCT02231918|11205820|FG002|COMPLETED|Overall Study||1
10078106|NCT02231918|11205818|FG000|NOT COMPLETED|Overall Study||0
10078107|NCT02231918|11205819|FG001|NOT COMPLETED|Overall Study||1
10078108|NCT02231918|11205820|FG002|NOT COMPLETED|Overall Study||1
10078109|NCT02232009|11205828|FG000|STARTED|Overall Study||9
10078110|NCT02232009|11205828|FG000|COMPLETED|Overall Study||9
10078111|NCT02232009|11205828|FG000|NOT COMPLETED|Overall Study||0
10078112|NCT02232022|11205832|FG000|STARTED|Overall Study||53
10078113|NCT02232022|11205832|FG000|COMPLETED|Overall Study||51
10078114|NCT02232022|11205832|FG000|NOT COMPLETED|Overall Study||2
10078115|NCT02232061|11205838|FG000|STARTED|Overall Study||6
10078116|NCT02232061|11205838|FG000|COMPLETED|Overall Study||4
10078117|NCT02232061|11205838|FG000|NOT COMPLETED|Overall Study||2
10078118|NCT02232074|11205844|FG000|STARTED|Overall Study||154
10078119|NCT02232074|11205845|FG001|STARTED|Overall Study||152
10078120|NCT02232074|11205844|FG000|COMPLETED|Overall Study||113
10078121|NCT02232074|11205845|FG001|COMPLETED|Overall Study||107
10078122|NCT02232074|11205844|FG000|NOT COMPLETED|Overall Study||41
10078123|NCT02232074|11205845|FG001|NOT COMPLETED|Overall Study||45
10078124|NCT02232126|11205859|FG000|STARTED|Overall Study||91
10078125|NCT02232126|11205860|FG001|STARTED|Overall Study||90
10078126|NCT02232126|11205859|FG000|COMPLETED|Overall Study||91
10078127|NCT02232126|11205860|FG001|COMPLETED|Overall Study||90
10078128|NCT02232126|11205859|FG000|NOT COMPLETED|Overall Study||0
10078129|NCT02232126|11205860|FG001|NOT COMPLETED|Overall Study||0
10078130|NCT02232178|11205871|FG000|STARTED|Overall Study||26
10078131|NCT02232178|11205872|FG001|STARTED|Overall Study||25
10078132|NCT02232178|11205873|FG002|STARTED|Overall Study||13
10078133|NCT02232178|11205871|FG000|Per Protocol PK Population|Overall Study||26
10078134|NCT02232178|11205872|FG001|Per Protocol PK Population|Overall Study||24
10078135|NCT02232178|11205873|FG002|Per Protocol PK Population|Overall Study||11
10078136|NCT02232178|11205871|FG000|Safety Population|Overall Study||26
10078137|NCT02232178|11205872|FG001|Safety Population|Overall Study||24
10078138|NCT02232178|11205873|FG002|Safety Population|Overall Study||12
10078139|NCT02232178|11205871|FG000|COMPLETED|Overall Study||25
10078140|NCT02232178|11205872|FG001|COMPLETED|Overall Study||24
10078141|NCT02232178|11205873|FG002|COMPLETED|Overall Study||12
10078142|NCT02232178|11205871|FG000|NOT COMPLETED|Overall Study||1
10078143|NCT02232178|11205872|FG001|NOT COMPLETED|Overall Study||1
10078144|NCT02232178|11205873|FG002|NOT COMPLETED|Overall Study||1
10078145|NCT02232243|11205884|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3
10078146|NCT02232243|11205885|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0
10078147|NCT02232243|11205886|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0
10078148|NCT02232243|11205884|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
10078149|NCT02232243|11205885|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10078150|NCT02232243|11205886|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10078151|NCT02232243|11205884|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10078152|NCT02232243|11205885|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10078153|NCT02232243|11205886|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10078154|NCT02232243|11205884|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0
10078155|NCT02232243|11205885|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4
10078156|NCT02232243|11205886|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0
10078157|NCT02232243|11205884|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10078158|NCT02232243|11205885|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
10078159|NCT02232243|11205886|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10078160|NCT02232243|11205884|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10078161|NCT02232243|11205885|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
10078162|NCT02232243|11205886|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10078163|NCT02232243|11205884|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0
10078164|NCT02232243|11205885|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0
10078165|NCT02232243|11205886|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3
10078166|NCT02232243|11205884|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10191455|NCT03305419|11320556|FG006|NOT COMPLETED|Part B (14 Days)||5
10191456|NCT03305419|11320557|FG007|NOT COMPLETED|Part B (14 Days)||0
10191457|NCT03305575|11320582|FG000|STARTED|Overall Study||5
10191458|NCT03305575|11320583|FG001|STARTED|Overall Study||5
10191459|NCT03305575|11320582|FG000|COMPLETED|Overall Study||4
10191460|NCT03305575|11320583|FG001|COMPLETED|Overall Study||5
10191461|NCT03305575|11320582|FG000|NOT COMPLETED|Overall Study||1
10191462|NCT03305575|11320583|FG001|NOT COMPLETED|Overall Study||0
10191463|NCT03305653|11320589|FG000|STARTED|Overall Study||21
10191464|NCT03305653|11320589|FG000|COMPLETED|Overall Study||21
10191465|NCT03305653|11320589|FG000|NOT COMPLETED|Overall Study||0
10191466|NCT03305666|11320595|FG000|STARTED|Overall Study||18
10191467|NCT03305666|11320596|FG001|STARTED|Overall Study||18
10191468|NCT03305666|11320595|FG000|COMPLETED|Overall Study||16
10191469|NCT03305666|11320596|FG001|COMPLETED|Overall Study||18
10191470|NCT03305666|11320595|FG000|NOT COMPLETED|Overall Study||2
10191471|NCT03305666|11320596|FG001|NOT COMPLETED|Overall Study||0
10191472|NCT03305731|11320602|FG000|STARTED|Overall Study||21
10191473|NCT03305731|11320602|FG000|Week 6|Overall Study||20
10191474|NCT03305731|11320602|FG000|Week 11|Overall Study||20
10191475|NCT03305731|11320602|FG000|COMPLETED|Overall Study||20
10191476|NCT03305731|11320602|FG000|NOT COMPLETED|Overall Study||1
10191477|NCT03305770|11320608|FG000|STARTED|Overall Study||70
10191478|NCT03305770|11320609|FG001|STARTED|Overall Study||37
10191479|NCT03305770|11320608|FG000|Enrolled Dispensed Analysis Set|Overall Study||70
10191480|NCT03305770|11320609|FG001|Enrolled Dispensed Analysis Set|Overall Study||36
10191481|NCT03305770|11320608|FG000|Completed Analysis Set|Overall Study||69
10191482|NCT03305770|11320609|FG001|Completed Analysis Set|Overall Study||36
10191483|NCT03305770|11320608|FG000|COMPLETED|Overall Study||69
10191484|NCT03305770|11320609|FG001|COMPLETED|Overall Study||36
10191485|NCT03305770|11320608|FG000|NOT COMPLETED|Overall Study||1
10078167|NCT02232243|11205885|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10078168|NCT02232243|11205886|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
10078169|NCT02232243|11205884|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10078170|NCT02232243|11205885|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10078171|NCT02232243|11205886|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10078172|NCT02232425|11205897|FG000|STARTED|Overall Study||58
10078173|NCT02232425|11205898|FG001|STARTED|Overall Study||30
10078174|NCT02232425|11205897|FG000|COMPLETED|Overall Study||44
10078175|NCT02232425|11205898|FG001|COMPLETED|Overall Study||22
10078176|NCT02232425|11205897|FG000|NOT COMPLETED|Overall Study||14
10078177|NCT02232425|11205898|FG001|NOT COMPLETED|Overall Study||8
10078178|NCT02232698|11205906|FG000|STARTED|Overall Study||120
10078179|NCT02232698|11205907|FG001|STARTED|Overall Study||121
10078180|NCT02232698|11205906|FG000|COMPLETED|Overall Study||110
10078181|NCT02232698|11205907|FG001|COMPLETED|Overall Study||101
10078182|NCT02232698|11205906|FG000|NOT COMPLETED|Overall Study||10
10078183|NCT02232698|11205907|FG001|NOT COMPLETED|Overall Study||20
10078184|NCT02232802|11205915|FG000|STARTED|Period 1||24
10078185|NCT02232802|11205916|FG001|STARTED|Period 1||23
10078186|NCT02232802|11205915|FG000|COMPLETED|Period 1||22
10078187|NCT02232802|11205916|FG001|COMPLETED|Period 1||22
10078188|NCT02232802|11205915|FG000|NOT COMPLETED|Period 1||2
10078189|NCT02232802|11205916|FG001|NOT COMPLETED|Period 1||1
10078190|NCT02232802|11205915|FG000|STARTED|Washout||22
10078191|NCT02232802|11205916|FG001|STARTED|Washout||22
10078192|NCT02232802|11205915|FG000|COMPLETED|Washout||22
10078193|NCT02232802|11205916|FG001|COMPLETED|Washout||22
10078194|NCT02232802|11205915|FG000|NOT COMPLETED|Washout||0
10078195|NCT02232802|11205916|FG001|NOT COMPLETED|Washout||0
10078196|NCT02232802|11205915|FG000|STARTED|Period 2||22
10078197|NCT02232802|11205916|FG001|STARTED|Period 2||22
10078198|NCT02232802|11205915|FG000|COMPLETED|Period 2||22
10078199|NCT02232802|11205916|FG001|COMPLETED|Period 2||22
10078200|NCT02232802|11205915|FG000|NOT COMPLETED|Period 2||0
10078201|NCT02232802|11205916|FG001|NOT COMPLETED|Period 2||0
10078202|NCT02232802|11205915|FG000|STARTED|Washout||22
10078203|NCT02232802|11205916|FG001|STARTED|Washout||22
10078204|NCT02232802|11205915|FG000|COMPLETED|Washout||22
10078205|NCT02232802|11205916|FG001|COMPLETED|Washout||22
10078206|NCT02232802|11205915|FG000|NOT COMPLETED|Washout||0
10078207|NCT02232802|11205916|FG001|NOT COMPLETED|Washout||0
10078208|NCT02232893|11205924|FG000|STARTED|Overall Study||35
10078209|NCT02232893|11205925|FG001|STARTED|Overall Study||34
10078210|NCT02232893|11205924|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
10078211|NCT02232893|11205925|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
10078212|NCT02232893|11205924|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
10078213|NCT02232893|11205925|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
10078214|NCT02232893|11205924|FG000|COMPLETED|Overall Study||31
10078215|NCT02232893|11205925|FG001|COMPLETED|Overall Study||27
10078216|NCT02232893|11205924|FG000|NOT COMPLETED|Overall Study||4
10078217|NCT02232893|11205925|FG001|NOT COMPLETED|Overall Study||7
10078218|NCT02232984|11205931|FG000|STARTED|Overall Study|Enrolled subjects|749
10078219|NCT02232984|11205931|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675
10078220|NCT02232984|11205931|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672
10078221|NCT02232984|11205931|FG000|NOT COMPLETED|Overall Study||77
10078222|NCT02233101|11205940|FG000|STARTED|Overall Study||86
10078223|NCT02233101|11205941|FG001|STARTED|Overall Study||81
10078224|NCT02233101|11205940|FG000|COMPLETED|Overall Study||74
10078225|NCT02233101|11205941|FG001|COMPLETED|Overall Study||80
10078226|NCT02233101|11205940|FG000|NOT COMPLETED|Overall Study||12
10078227|NCT02233101|11205941|FG001|NOT COMPLETED|Overall Study||1
10078228|NCT02233296|11205949|FG000|STARTED|Overall Study||16
10078229|NCT02233296|11205950|FG001|STARTED|Overall Study||14
10078230|NCT02233296|11205949|FG000|COMPLETED|Overall Study||16
10078231|NCT02233296|11205950|FG001|COMPLETED|Overall Study||14
10078232|NCT02233296|11205949|FG000|NOT COMPLETED|Overall Study||0
10078233|NCT02233296|11205950|FG001|NOT COMPLETED|Overall Study||0
10078234|NCT02233309|11205960|FG000|STARTED|Overall Study||36
10078235|NCT02233309|11205960|FG000|COMPLETED|Overall Study||31
10078236|NCT02233309|11205960|FG000|NOT COMPLETED|Overall Study||5
10078237|NCT02233413|11205966|FG000|STARTED|Overall Study||35
10078238|NCT02233413|11205967|FG001|STARTED|Overall Study||33
10078239|NCT02233413|11205966|FG000|COMPLETED|Overall Study||24
10078240|NCT02233413|11205967|FG001|COMPLETED|Overall Study||19
10078241|NCT02233413|11205966|FG000|NOT COMPLETED|Overall Study||11
10078242|NCT02233413|11205967|FG001|NOT COMPLETED|Overall Study||14
10078243|NCT02233478|11205973|FG000|STARTED|First Intervention (1 Day)||3
10078244|NCT02233478|11205974|FG001|STARTED|First Intervention (1 Day)||3
10078245|NCT02233478|11205975|FG002|STARTED|First Intervention (1 Day)||3
10078246|NCT02233478|11205976|FG003|STARTED|First Intervention (1 Day)||3
10078247|NCT02233478|11205977|FG004|STARTED|First Intervention (1 Day)||3
10078248|NCT02233478|11205978|FG005|STARTED|First Intervention (1 Day)||3
10078249|NCT02233478|11205973|FG000|COMPLETED|First Intervention (1 Day)||3
10078250|NCT02233478|11205974|FG001|COMPLETED|First Intervention (1 Day)||3
10078251|NCT02233478|11205975|FG002|COMPLETED|First Intervention (1 Day)||3
10078252|NCT02233478|11205976|FG003|COMPLETED|First Intervention (1 Day)||3
10078253|NCT02233478|11205977|FG004|COMPLETED|First Intervention (1 Day)||3
10078254|NCT02233478|11205978|FG005|COMPLETED|First Intervention (1 Day)||3
10078255|NCT02233478|11205973|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10078256|NCT02233478|11205974|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10078257|NCT02233478|11205975|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10078258|NCT02233478|11205976|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10078259|NCT02233478|11205977|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10078260|NCT02233478|11205978|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10078261|NCT02233478|11205973|FG000|STARTED|Washout (7 Days)||3
10078262|NCT02233478|11205974|FG001|STARTED|Washout (7 Days)||3
10078263|NCT02233478|11205975|FG002|STARTED|Washout (7 Days)||3
10078264|NCT02233478|11205976|FG003|STARTED|Washout (7 Days)||3
10078265|NCT02233478|11205977|FG004|STARTED|Washout (7 Days)||3
10078266|NCT02233478|11205978|FG005|STARTED|Washout (7 Days)||3
10078267|NCT02233478|11205973|FG000|COMPLETED|Washout (7 Days)||3
10078268|NCT02233478|11205974|FG001|COMPLETED|Washout (7 Days)||3
10078269|NCT02233478|11205975|FG002|COMPLETED|Washout (7 Days)||3
10078270|NCT02233478|11205976|FG003|COMPLETED|Washout (7 Days)||3
10078271|NCT02233478|11205977|FG004|COMPLETED|Washout (7 Days)||3
10078272|NCT02233478|11205978|FG005|COMPLETED|Washout (7 Days)||3
10078273|NCT02233478|11205973|FG000|NOT COMPLETED|Washout (7 Days)||0
10078274|NCT02233478|11205974|FG001|NOT COMPLETED|Washout (7 Days)||0
10078275|NCT02233478|11205975|FG002|NOT COMPLETED|Washout (7 Days)||0
10078276|NCT02233478|11205976|FG003|NOT COMPLETED|Washout (7 Days)||0
10078277|NCT02233478|11205977|FG004|NOT COMPLETED|Washout (7 Days)||0
10078278|NCT02233478|11205978|FG005|NOT COMPLETED|Washout (7 Days)||0
10078279|NCT02233478|11205973|FG000|STARTED|Second Intervention (1 Day)||3
10078280|NCT02233478|11205974|FG001|STARTED|Second Intervention (1 Day)||3
10078281|NCT02233478|11205975|FG002|STARTED|Second Intervention (1 Day)||3
10078282|NCT02233478|11205976|FG003|STARTED|Second Intervention (1 Day)||3
10078283|NCT02233478|11205977|FG004|STARTED|Second Intervention (1 Day)||3
10078284|NCT02233478|11205978|FG005|STARTED|Second Intervention (1 Day)||3
10078285|NCT02233478|11205973|FG000|COMPLETED|Second Intervention (1 Day)||3
10078286|NCT02233478|11205974|FG001|COMPLETED|Second Intervention (1 Day)||3
10078287|NCT02233478|11205975|FG002|COMPLETED|Second Intervention (1 Day)||3
10078288|NCT02233478|11205976|FG003|COMPLETED|Second Intervention (1 Day)||3
10078289|NCT02233478|11205977|FG004|COMPLETED|Second Intervention (1 Day)||3
10078290|NCT02233478|11205978|FG005|COMPLETED|Second Intervention (1 Day)||3
10078291|NCT02233478|11205973|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10078292|NCT02233478|11205974|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10078293|NCT02233478|11205975|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10078294|NCT02233478|11205976|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10078295|NCT02233478|11205977|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10078296|NCT02233478|11205978|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10078297|NCT02233478|11205973|FG000|STARTED|Washout (7 Days)||3
10078298|NCT02233478|11205974|FG001|STARTED|Washout (7 Days)||3
10078299|NCT02233478|11205975|FG002|STARTED|Washout (7 Days)||3
10078300|NCT02233478|11205976|FG003|STARTED|Washout (7 Days)||3
10078301|NCT02233478|11205977|FG004|STARTED|Washout (7 Days)||3
10078302|NCT02233478|11205978|FG005|STARTED|Washout (7 Days)||3
10078303|NCT02233478|11205973|FG000|COMPLETED|Washout (7 Days)||3
10078304|NCT02233478|11205974|FG001|COMPLETED|Washout (7 Days)||3
10078305|NCT02233478|11205975|FG002|COMPLETED|Washout (7 Days)||3
10078306|NCT02233478|11205976|FG003|COMPLETED|Washout (7 Days)||3
10078307|NCT02233478|11205977|FG004|COMPLETED|Washout (7 Days)||3
10078308|NCT02233478|11205978|FG005|COMPLETED|Washout (7 Days)||3
10078309|NCT02233478|11205973|FG000|NOT COMPLETED|Washout (7 Days)||0
10078310|NCT02233478|11205974|FG001|NOT COMPLETED|Washout (7 Days)||0
10078311|NCT02233478|11205975|FG002|NOT COMPLETED|Washout (7 Days)||0
10078312|NCT02233478|11205976|FG003|NOT COMPLETED|Washout (7 Days)||0
10078313|NCT02233478|11205977|FG004|NOT COMPLETED|Washout (7 Days)||0
10078314|NCT02233478|11205978|FG005|NOT COMPLETED|Washout (7 Days)||0
10078315|NCT02233478|11205973|FG000|STARTED|Third Intervention (1 Day)||3
10078316|NCT02233478|11205974|FG001|STARTED|Third Intervention (1 Day)||3
10078317|NCT02233478|11205975|FG002|STARTED|Third Intervention (1 Day)||3
10078318|NCT02233478|11205976|FG003|STARTED|Third Intervention (1 Day)||3
10078319|NCT02233478|11205977|FG004|STARTED|Third Intervention (1 Day)||3
10078320|NCT02233478|11205978|FG005|STARTED|Third Intervention (1 Day)||3
10078321|NCT02233478|11205973|FG000|COMPLETED|Third Intervention (1 Day)||3
10078322|NCT02233478|11205974|FG001|COMPLETED|Third Intervention (1 Day)||3
10078323|NCT02233478|11205975|FG002|COMPLETED|Third Intervention (1 Day)||3
10078324|NCT02233478|11205976|FG003|COMPLETED|Third Intervention (1 Day)||3
10078325|NCT02233478|11205977|FG004|COMPLETED|Third Intervention (1 Day)||3
10078326|NCT02233478|11205978|FG005|COMPLETED|Third Intervention (1 Day)||3
10078327|NCT02233478|11205973|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10078328|NCT02233478|11205974|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10078329|NCT02233478|11205975|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10078330|NCT02233478|11205976|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10078331|NCT02233478|11205977|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10078332|NCT02233478|11205978|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10078333|NCT02233517|11205988|FG000|STARTED|Overall Study||19
10078334|NCT02233517|11205989|FG001|STARTED|Overall Study||17
10078335|NCT02233517|11205988|FG000|COMPLETED|Overall Study||12
10078336|NCT02233517|11205989|FG001|COMPLETED|Overall Study||13
10078337|NCT02233517|11205988|FG000|NOT COMPLETED|Overall Study||7
10078338|NCT02233517|11205989|FG001|NOT COMPLETED|Overall Study||4
10191486|NCT03305770|11320609|FG001|NOT COMPLETED|Overall Study||1
10191487|NCT03305809|11320621|FG000|STARTED|Overall Study||86
10191488|NCT03305809|11320622|FG001|STARTED|Overall Study||86
10191489|NCT03305809|11320623|FG002|STARTED|Overall Study||85
10191490|NCT03305809|11320624|FG003|STARTED|Overall Study||87
10191491|NCT03305809|11320621|FG000|Received at Least One Dose of Study Drug|Overall Study||86
10078339|NCT02233530|11205995|FG000|STARTED|Overall Study||8
10078340|NCT02233530|11205995|FG000|COMPLETED|Overall Study||8
10078341|NCT02233530|11205995|FG000|NOT COMPLETED|Overall Study||0
10078342|NCT02233543|11205999|FG000|STARTED|Period 1||22
10078343|NCT02233543|11206000|FG001|STARTED|Period 1||16
10078344|NCT02233543|11205999|FG000|COMPLETED|Period 1||19
10078345|NCT02233543|11206000|FG001|COMPLETED|Period 1||13
10078346|NCT02233543|11205999|FG000|NOT COMPLETED|Period 1||3
10078347|NCT02233543|11206000|FG001|NOT COMPLETED|Period 1||3
10078348|NCT02233543|11205999|FG000|STARTED|Period 2||19
10078349|NCT02233543|11206000|FG001|STARTED|Period 2||13
10078350|NCT02233543|11205999|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
10078351|NCT02233543|11206000|FG001|COMPLETED|Period 2||12
10078352|NCT02233543|11205999|FG000|NOT COMPLETED|Period 2||2
10078353|NCT02233543|11206000|FG001|NOT COMPLETED|Period 2||1
10078354|NCT02233647|11206006|FG000|STARTED|Overall Study||11
10078355|NCT02233647|11206006|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
10078356|NCT02233647|11206006|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
10078357|NCT02233647|11206006|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
10078358|NCT02233647|11206006|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
10078359|NCT02233647|11206006|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
10078360|NCT02233647|11206006|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10078361|NCT02233647|11206006|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10078362|NCT02233647|11206006|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10078363|NCT02233647|11206006|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10078364|NCT02233647|11206006|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10078365|NCT02233647|11206006|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
10078366|NCT02233647|11206006|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10078367|NCT02233647|11206006|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10078368|NCT02233647|11206006|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10078369|NCT02233647|11206006|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10078370|NCT02233647|11206006|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
10078371|NCT02233647|11206006|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10078372|NCT02233647|11206006|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10078373|NCT02233647|11206006|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10078374|NCT02233647|11206006|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10078375|NCT02233647|11206006|FG000|COMPLETED|Overall Study||10
10078376|NCT02233647|11206006|FG000|NOT COMPLETED|Overall Study||1
10078377|NCT02233738|11206012|FG000|STARTED|Overall Study||93
10078378|NCT02233738|11206013|FG001|STARTED|Overall Study||91
10078379|NCT02233738|11206012|FG000|1 Month Follow-Up|Overall Study||89
10078380|NCT02233738|11206013|FG001|1 Month Follow-Up|Overall Study||82
10078381|NCT02233738|11206012|FG000|3 Month Follow-Up|Overall Study||87
10078382|NCT02233738|11206013|FG001|3 Month Follow-Up|Overall Study||77
10078383|NCT02233738|11206012|FG000|6 Month Follow-Up|Overall Study||85
10078384|NCT02233738|11206013|FG001|6 Month Follow-Up|Overall Study||75
10078385|NCT02233738|11206012|FG000|COMPLETED|Overall Study||85
10078386|NCT02233738|11206013|FG001|COMPLETED|Overall Study||75
10078387|NCT02233738|11206012|FG000|NOT COMPLETED|Overall Study||8
10078388|NCT02233738|11206013|FG001|NOT COMPLETED|Overall Study||16
10078389|NCT02233751|11206183|FG000|STARTED|Overall Study||6
10078390|NCT02233751|11206184|FG001|STARTED|Overall Study||6
10078391|NCT02233751|11206183|FG000|COMPLETED|Overall Study||6
10078392|NCT02233751|11206184|FG001|COMPLETED|Overall Study||6
10078393|NCT02233751|11206183|FG000|NOT COMPLETED|Overall Study||0
10078394|NCT02233751|11206184|FG001|NOT COMPLETED|Overall Study||0
10078395|NCT02233803|11206190|FG000|STARTED|Treatment Period 1 (4-Wks)||100
10078396|NCT02233803|11206191|FG001|STARTED|Treatment Period 1 (4-Wks)||99
10078397|NCT02233803|11206190|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97
10078398|NCT02233803|11206191|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95
10078399|NCT02233803|11206190|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
10078400|NCT02233803|11206191|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
10078401|NCT02233803|11206190|FG000|STARTED|Washout Period (4-Wks)||97
10078402|NCT02233803|11206191|FG001|STARTED|Washout Period (4-Wks)||95
10078403|NCT02233803|11206190|FG000|COMPLETED|Washout Period (4-Wks)||95
10078404|NCT02233803|11206191|FG001|COMPLETED|Washout Period (4-Wks)||93
10078405|NCT02233803|11206190|FG000|NOT COMPLETED|Washout Period (4-Wks)||2
10078406|NCT02233803|11206191|FG001|NOT COMPLETED|Washout Period (4-Wks)||2
10078407|NCT02233803|11206190|FG000|STARTED|Treatment Period 2 (4-Wks)||95
10078408|NCT02233803|11206191|FG001|STARTED|Treatment Period 2 (4-Wks)||93
10078409|NCT02233803|11206190|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93
10078410|NCT02233803|11206191|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91
10078411|NCT02233803|11206190|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
10078412|NCT02233803|11206191|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
10078413|NCT02233842|11206199|FG000|STARTED|Questionnaire 1 Version 1||5
10078414|NCT02233842|11206199|FG000|COMPLETED|Questionnaire 1 Version 1||5
10078415|NCT02233842|11206199|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0
10078416|NCT02233842|11206199|FG000|STARTED|Questionnaire 1 Version 2||5
10078417|NCT02233842|11206199|FG000|COMPLETED|Questionnaire 1 Version 2||5
10078418|NCT02233842|11206199|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0
10078419|NCT02233842|11206199|FG000|STARTED|Questionnaire 2 Version 1||5
10078420|NCT02233842|11206199|FG000|COMPLETED|Questionnaire 2 Version 1||5
10078421|NCT02233842|11206199|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0
10078422|NCT02233842|11206199|FG000|STARTED|Questionnaire 2 Version 2||5
10078423|NCT02233842|11206199|FG000|COMPLETED|Questionnaire 2 Version 2||5
10078424|NCT02233842|11206199|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0
10078425|NCT02233842|11206199|FG000|STARTED|Questionnaire 3 Version 1||5
10078426|NCT02233842|11206199|FG000|COMPLETED|Questionnaire 3 Version 1||5
10078427|NCT02233842|11206199|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0
10078428|NCT02233842|11206199|FG000|STARTED|Questionnaire 3 Version 2||5
10078429|NCT02233842|11206199|FG000|COMPLETED|Questionnaire 3 Version 2||5
10078430|NCT02233842|11206199|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0
10078431|NCT02233946|11206206|FG000|STARTED|Baseline|Allocated to and received the intervention|628
10078432|NCT02233946|11206207|FG001|STARTED|Baseline|Allocated to and received usual care|243
10078433|NCT02233946|11206206|FG000|COMPLETED|Baseline|Completed baseline assessment|626
10078434|NCT02233946|11206207|FG001|COMPLETED|Baseline|Completed baseline assessment|243
10078435|NCT02233946|11206206|FG000|NOT COMPLETED|Baseline||2
10078436|NCT02233946|11206207|FG001|NOT COMPLETED|Baseline||0
10078437|NCT02233946|11206206|FG000|STARTED|Immediate Post-visit Questionnaire||626
10078438|NCT02233946|11206207|FG001|STARTED|Immediate Post-visit Questionnaire||243
10078439|NCT02233946|11206206|FG000|COMPLETED|Immediate Post-visit Questionnaire||624
10191492|NCT03305809|11320622|FG001|Received at Least One Dose of Study Drug|Overall Study||86
10191493|NCT03305809|11320623|FG002|Received at Least One Dose of Study Drug|Overall Study||85
10191494|NCT03305809|11320624|FG003|Received at Least One Dose of Study Drug|Overall Study||87
10191495|NCT03305809|11320621|FG000|COMPLETED|Overall Study||79
10191496|NCT03305809|11320622|FG001|COMPLETED|Overall Study||78
10191497|NCT03305809|11320623|FG002|COMPLETED|Overall Study||66
10191498|NCT03305809|11320624|FG003|COMPLETED|Overall Study||60
10191499|NCT03305809|11320621|FG000|NOT COMPLETED|Overall Study||7
10191500|NCT03305809|11320622|FG001|NOT COMPLETED|Overall Study||8
10191501|NCT03305809|11320623|FG002|NOT COMPLETED|Overall Study||19
10191502|NCT03305809|11320624|FG003|NOT COMPLETED|Overall Study||27
10191503|NCT03305822|11320637|FG000|STARTED|Period 1||20
10191504|NCT03305822|11320638|FG001|STARTED|Period 1||18
10191505|NCT03305822|11320637|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
10191506|NCT03305822|11320638|FG001|Received at Least 1 Dose of Study Drug|Period 1||18
10191507|NCT03305822|11320637|FG000|COMPLETED|Period 1||20
10191508|NCT03305822|11320638|FG001|COMPLETED|Period 1||18
10191509|NCT03305822|11320637|FG000|NOT COMPLETED|Period 1||0
10191510|NCT03305822|11320638|FG001|NOT COMPLETED|Period 1||0
10191511|NCT03305822|11320637|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
10191512|NCT03305822|11320638|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
10191513|NCT03305822|11320637|FG000|COMPLETED|Washout||20
10191514|NCT03305822|11320638|FG001|COMPLETED|Washout||18
10191515|NCT03305822|11320637|FG000|NOT COMPLETED|Washout||0
10191516|NCT03305822|11320638|FG001|NOT COMPLETED|Washout||0
10191517|NCT03305822|11320637|FG000|STARTED|Period 2||20
10191518|NCT03305822|11320638|FG001|STARTED|Period 2||18
10191519|NCT03305822|11320637|FG000|Received at Least 1 Dose of Study Drug|Period 2||20
10191520|NCT03305822|11320638|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
10191521|NCT03305822|11320637|FG000|COMPLETED|Period 2||20
10191522|NCT03305822|11320638|FG001|COMPLETED|Period 2||18
10191523|NCT03305822|11320637|FG000|NOT COMPLETED|Period 2||0
10191524|NCT03305822|11320638|FG001|NOT COMPLETED|Period 2||0
10191525|NCT03305887|11320646|FG000|STARTED|Overall Study||91
10191526|NCT03305887|11320647|FG001|STARTED|Overall Study||93
10191527|NCT03305887|11320646|FG000|COMPLETED|Overall Study||80
10191528|NCT03305887|11320647|FG001|COMPLETED|Overall Study||83
10191529|NCT03305887|11320646|FG000|NOT COMPLETED|Overall Study||11
10191530|NCT03305887|11320647|FG001|NOT COMPLETED|Overall Study||10
10191531|NCT03306043|11320653|FG000|STARTED|Overall Study||102
10191532|NCT03306043|11320653|FG000|COMPLETED|Overall Study||98
10191533|NCT03306043|11320653|FG000|NOT COMPLETED|Overall Study||4
10191534|NCT03306199|11320657|FG000|STARTED|Overall Study||82
10191535|NCT03306199|11320657|FG000|COMPLETED|Overall Study||67
10191536|NCT03306199|11320657|FG000|NOT COMPLETED|Overall Study||15
10191537|NCT03306277|11320661|FG000|STARTED|Overall Study||22
10191538|NCT03306277|11320661|FG000|COMPLETED|Overall Study||19
10191539|NCT03306277|11320661|FG000|NOT COMPLETED|Overall Study||3
10191540|NCT03306420|11320670|FG000|STARTED|Overall Study||3
10191541|NCT03306420|11320671|FG001|STARTED|Overall Study||3
10191542|NCT03306420|11320672|FG002|STARTED|Overall Study||3
10191543|NCT03306420|11320673|FG003|STARTED|Overall Study||3
10191544|NCT03306420|11320674|FG004|STARTED|Overall Study||3
10191545|NCT03306420|11320670|FG000|COMPLETED|Overall Study||3
10191546|NCT03306420|11320671|FG001|COMPLETED|Overall Study||3
10191547|NCT03306420|11320672|FG002|COMPLETED|Overall Study||3
10191548|NCT03306420|11320673|FG003|COMPLETED|Overall Study||3
10191549|NCT03306420|11320674|FG004|COMPLETED|Overall Study||3
10191550|NCT03306420|11320670|FG000|NOT COMPLETED|Overall Study||0
10191551|NCT03306420|11320671|FG001|NOT COMPLETED|Overall Study||0
10191552|NCT03306420|11320672|FG002|NOT COMPLETED|Overall Study||0
10191553|NCT03306420|11320673|FG003|NOT COMPLETED|Overall Study||0
10191554|NCT03306420|11320674|FG004|NOT COMPLETED|Overall Study||0
10191555|NCT03306433|11320686|FG000|STARTED|Overall Study||16
10191556|NCT03306433|11320686|FG000|UDMA-K18|Overall Study||12
10191557|NCT03306433|11320686|FG000|Adhesive Control|Overall Study||12
10191558|NCT03306433|11320686|FG000|UDMA-control|Overall Study||9
10191559|NCT03306433|11320686|FG000|COMPLETED|Overall Study||9
10191560|NCT03306433|11320686|FG000|NOT COMPLETED|Overall Study||7
10191561|NCT03306589|11320700|FG000|STARTED|Part 1 (69 Days)||2
10078440|NCT02233946|11206207|FG001|COMPLETED|Immediate Post-visit Questionnaire||243
10078441|NCT02233946|11206206|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2
10078442|NCT02233946|11206207|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0
10078443|NCT02233946|11206206|FG000|STARTED|3-months Follow-up||624
10078444|NCT02233946|11206207|FG001|STARTED|3-months Follow-up||243
10078445|NCT02233946|11206206|FG000|COMPLETED|3-months Follow-up||571
10078446|NCT02233946|11206207|FG001|COMPLETED|3-months Follow-up||214
10078447|NCT02233946|11206206|FG000|NOT COMPLETED|3-months Follow-up||53
10078448|NCT02233946|11206207|FG001|NOT COMPLETED|3-months Follow-up||29
10078449|NCT02233946|11206206|FG000|STARTED|6-months Follow-up||571
10078450|NCT02233946|11206207|FG001|STARTED|6-months Follow-up||214
10078451|NCT02233946|11206206|FG000|COMPLETED|6-months Follow-up||550
10078452|NCT02233946|11206207|FG001|COMPLETED|6-months Follow-up||212
10078453|NCT02233946|11206206|FG000|NOT COMPLETED|6-months Follow-up||21
10078454|NCT02233946|11206207|FG001|NOT COMPLETED|6-months Follow-up||2
10078455|NCT02233946|11206206|FG000|STARTED|9-month Follow-up||550
10078456|NCT02233946|11206207|FG001|STARTED|9-month Follow-up||212
10078457|NCT02233946|11206206|FG000|COMPLETED|9-month Follow-up||530
10078458|NCT02233946|11206207|FG001|COMPLETED|9-month Follow-up||201
10078459|NCT02233946|11206206|FG000|NOT COMPLETED|9-month Follow-up||20
10078460|NCT02233946|11206207|FG001|NOT COMPLETED|9-month Follow-up||11
10078461|NCT02233946|11206206|FG000|STARTED|12-month Follow-up||530
10078462|NCT02233946|11206207|FG001|STARTED|12-month Follow-up||201
10078463|NCT02233946|11206206|FG000|COMPLETED|12-month Follow-up||502
10078464|NCT02233946|11206207|FG001|COMPLETED|12-month Follow-up||190
10078465|NCT02233946|11206206|FG000|NOT COMPLETED|12-month Follow-up||28
10078466|NCT02233946|11206207|FG001|NOT COMPLETED|12-month Follow-up||11
10078467|NCT02233985|11206215|FG000|STARTED|Overall Study||33
10078468|NCT02233985|11206216|FG001|STARTED|Overall Study||31
10078469|NCT02233985|11206215|FG000|COMPLETED|Overall Study||33
10078470|NCT02233985|11206216|FG001|COMPLETED|Overall Study||31
10078471|NCT02233985|11206215|FG000|NOT COMPLETED|Overall Study||0
10078472|NCT02233985|11206216|FG001|NOT COMPLETED|Overall Study||0
10078473|NCT02233998|11206227|FG000|STARTED|Overall Study||53
10078474|NCT02233998|11206228|FG001|STARTED|Overall Study||52
10078475|NCT02233998|11206229|FG002|STARTED|Overall Study||53
10078476|NCT02233998|11206227|FG000|COMPLETED|Overall Study||53
10078477|NCT02233998|11206228|FG001|COMPLETED|Overall Study||52
10078478|NCT02233998|11206229|FG002|COMPLETED|Overall Study||53
10078479|NCT02233998|11206227|FG000|NOT COMPLETED|Overall Study||0
10078480|NCT02233998|11206228|FG001|NOT COMPLETED|Overall Study||0
10078481|NCT02233998|11206229|FG002|NOT COMPLETED|Overall Study||0
10078482|NCT02234063|11206239|FG000|STARTED|Overall Study||1795
10078483|NCT02234063|11206240|FG001|STARTED|Overall Study||255
10078484|NCT02234063|11206239|FG000|COMPLETED|Overall Study||1540
10078485|NCT02234063|11206240|FG001|COMPLETED|Overall Study||212
10078486|NCT02234063|11206239|FG000|NOT COMPLETED|Overall Study||255
10078487|NCT02234063|11206240|FG001|NOT COMPLETED|Overall Study||43
10078488|NCT02234115|11206251|FG000|STARTED|Overall Study||137
10078489|NCT02234115|11206251|FG000|ITT|Overall Study||137
10078490|NCT02234115|11206251|FG000|PP|Overall Study||124
10078491|NCT02234115|11206251|FG000|PK Subgroup|Overall Study||31
10078492|NCT02234115|11206251|FG000|COMPLETED|Overall Study||122
10078493|NCT02234115|11206251|FG000|NOT COMPLETED|Overall Study||15
10078494|NCT02234128|11206258|FG000|STARTED|Overall Study||35
9717468|NCT00003896|10816669|FG000|STARTED|Overall Study||68
10078495|NCT02234128|11206259|FG001|STARTED|Overall Study||31
10078496|NCT02234128|11206260|FG002|STARTED|Overall Study||52
10078497|NCT02234128|11206258|FG000|COMPLETED|Overall Study||30
10078498|NCT02234128|11206259|FG001|COMPLETED|Overall Study||29
10078499|NCT02234128|11206260|FG002|COMPLETED|Overall Study||48
10078500|NCT02234128|11206258|FG000|NOT COMPLETED|Overall Study||5
10078501|NCT02234128|11206259|FG001|NOT COMPLETED|Overall Study||2
10078502|NCT02234128|11206260|FG002|NOT COMPLETED|Overall Study||4
10078503|NCT02234141|11206272|FG000|STARTED|Treatment Period (24 Weeks)||39
10078504|NCT02234141|11206273|FG001|STARTED|Treatment Period (24 Weeks)||38
10078505|NCT02234141|11206274|FG002|STARTED|Treatment Period (24 Weeks)||37
10078506|NCT02234141|11206275|FG003|STARTED|Treatment Period (24 Weeks)||37
10078507|NCT02234141|11206276|FG004|STARTED|Treatment Period (24 Weeks)||0
10078508|NCT02234141|11206277|FG005|STARTED|Treatment Period (24 Weeks)||0
10078509|NCT02234141|11206278|FG006|STARTED|Treatment Period (24 Weeks)||0
10078510|NCT02234141|11206272|FG000|COMPLETED|Treatment Period (24 Weeks)||35
10078511|NCT02234141|11206273|FG001|COMPLETED|Treatment Period (24 Weeks)||32
10191562|NCT03306589|11320701|FG001|STARTED|Part 1 (69 Days)||4
10191563|NCT03306589|11320702|FG002|STARTED|Part 1 (69 Days)||2
10191564|NCT03306589|11320703|FG003|STARTED|Part 1 (69 Days)||4
10191565|NCT03306589|11320704|FG004|STARTED|Part 1 (69 Days)||0
10191566|NCT03306589|11320705|FG005|STARTED|Part 1 (69 Days)||0
10191567|NCT03306589|11320700|FG000|COMPLETED|Part 1 (69 Days)||2
10191568|NCT03306589|11320701|FG001|COMPLETED|Part 1 (69 Days)||4
10191569|NCT03306589|11320702|FG002|COMPLETED|Part 1 (69 Days)||2
10191570|NCT03306589|11320703|FG003|COMPLETED|Part 1 (69 Days)||4
10191571|NCT03306589|11320704|FG004|COMPLETED|Part 1 (69 Days)||0
10191572|NCT03306589|11320705|FG005|COMPLETED|Part 1 (69 Days)||0
10191573|NCT03306589|11320700|FG000|NOT COMPLETED|Part 1 (69 Days)||0
10191574|NCT03306589|11320701|FG001|NOT COMPLETED|Part 1 (69 Days)||0
10191575|NCT03306589|11320702|FG002|NOT COMPLETED|Part 1 (69 Days)||0
10191576|NCT03306589|11320703|FG003|NOT COMPLETED|Part 1 (69 Days)||0
10191577|NCT03306589|11320704|FG004|NOT COMPLETED|Part 1 (69 Days)||0
10191578|NCT03306589|11320705|FG005|NOT COMPLETED|Part 1 (69 Days)||0
10191579|NCT03306589|11320700|FG000|STARTED|Part 2 (69 Days)||0
10191580|NCT03306589|11320701|FG001|STARTED|Part 2 (69 Days)||0
10191581|NCT03306589|11320702|FG002|STARTED|Part 2 (69 Days)||0
10191582|NCT03306589|11320703|FG003|STARTED|Part 2 (69 Days)||0
10191583|NCT03306589|11320704|FG004|STARTED|Part 2 (69 Days)||0
10191584|NCT03306589|11320705|FG005|STARTED|Part 2 (69 Days)||0
10191585|NCT03306589|11320700|FG000|COMPLETED|Part 2 (69 Days)||0
10191586|NCT03306589|11320701|FG001|COMPLETED|Part 2 (69 Days)||0
10191587|NCT03306589|11320702|FG002|COMPLETED|Part 2 (69 Days)||0
10191588|NCT03306589|11320703|FG003|COMPLETED|Part 2 (69 Days)||0
10191589|NCT03306589|11320704|FG004|COMPLETED|Part 2 (69 Days)||0
10191590|NCT03306589|11320705|FG005|COMPLETED|Part 2 (69 Days)||0
10191591|NCT03306589|11320700|FG000|NOT COMPLETED|Part 2 (69 Days)||0
10191592|NCT03306589|11320701|FG001|NOT COMPLETED|Part 2 (69 Days)||0
10191593|NCT03306589|11320702|FG002|NOT COMPLETED|Part 2 (69 Days)||0
10191594|NCT03306589|11320703|FG003|NOT COMPLETED|Part 2 (69 Days)||0
10191595|NCT03306589|11320704|FG004|NOT COMPLETED|Part 2 (69 Days)||0
10191596|NCT03306589|11320705|FG005|NOT COMPLETED|Part 2 (69 Days)||0
10191597|NCT03306641|11320721|FG000|STARTED|First Intervention||23
10191598|NCT03306641|11320722|FG001|STARTED|First Intervention||22
10191599|NCT03306641|11320721|FG000|COMPLETED|First Intervention||23
10191600|NCT03306641|11320722|FG001|COMPLETED|First Intervention||22
10191601|NCT03306641|11320721|FG000|NOT COMPLETED|First Intervention||0
10191602|NCT03306641|11320722|FG001|NOT COMPLETED|First Intervention||0
10191603|NCT03306641|11320721|FG000|STARTED|Second Intervention||23
10191604|NCT03306641|11320722|FG001|STARTED|Second Intervention||22
10191605|NCT03306641|11320721|FG000|COMPLETED|Second Intervention||23
10191606|NCT03306641|11320722|FG001|COMPLETED|Second Intervention||22
10191607|NCT03306641|11320721|FG000|NOT COMPLETED|Second Intervention||0
10191608|NCT03306641|11320722|FG001|NOT COMPLETED|Second Intervention||0
10191609|NCT03307005|11320730|FG000|STARTED|Overall Study||3
10191610|NCT03307005|11320731|FG001|STARTED|Overall Study||2
10191611|NCT03307005|11320730|FG000|COMPLETED|Overall Study||3
10191612|NCT03307005|11320731|FG001|COMPLETED|Overall Study||2
10191613|NCT03307005|11320730|FG000|NOT COMPLETED|Overall Study||0
10191614|NCT03307005|11320731|FG001|NOT COMPLETED|Overall Study||0
10191615|NCT03307174|11320741|FG000|STARTED|Overall Study||60
10191616|NCT03307174|11320742|FG001|STARTED|Overall Study||60
10191617|NCT03307174|11320741|FG000|COMPLETED|Overall Study||46
10191618|NCT03307174|11320742|FG001|COMPLETED|Overall Study||53
10191619|NCT03307174|11320741|FG000|NOT COMPLETED|Overall Study||14
10191620|NCT03307174|11320742|FG001|NOT COMPLETED|Overall Study||7
10191621|NCT03307252|11320759|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
10191622|NCT03307252|11320760|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
10191623|NCT03307252|11320761|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
10191624|NCT03307252|11320762|FG003|STARTED|Part 1, Period 1||0
10191625|NCT03307252|11320763|FG004|STARTED|Part 1, Period 1||0
10191626|NCT03307252|11320764|FG005|STARTED|Part 1, Period 1||0
9717469|NCT00003896|10816669|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
10191627|NCT03307252|11320765|FG006|STARTED|Part 1, Period 1||0
10191628|NCT03307252|11320766|FG007|STARTED|Part 1, Period 1||0
10191629|NCT03307252|11320767|FG008|STARTED|Part 1, Period 1||0
10191630|NCT03307252|11320768|FG009|STARTED|Part 1, Period 1||0
10191631|NCT03307252|11320769|FG010|STARTED|Part 1, Period 1||0
10191632|NCT03307252|11320759|FG000|COMPLETED|Part 1, Period 1||4
10191633|NCT03307252|11320760|FG001|COMPLETED|Part 1, Period 1||4
10191634|NCT03307252|11320761|FG002|COMPLETED|Part 1, Period 1||4
10191635|NCT03307252|11320762|FG003|COMPLETED|Part 1, Period 1||0
10191636|NCT03307252|11320763|FG004|COMPLETED|Part 1, Period 1||0
10078512|NCT02234141|11206274|FG002|COMPLETED|Treatment Period (24 Weeks)||35
10078513|NCT02234141|11206275|FG003|COMPLETED|Treatment Period (24 Weeks)||32
10078514|NCT02234141|11206276|FG004|COMPLETED|Treatment Period (24 Weeks)||0
10078515|NCT02234141|11206277|FG005|COMPLETED|Treatment Period (24 Weeks)||0
10078516|NCT02234141|11206278|FG006|COMPLETED|Treatment Period (24 Weeks)||0
10078517|NCT02234141|11206272|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4
10078518|NCT02234141|11206273|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6
10078519|NCT02234141|11206274|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2
10078520|NCT02234141|11206275|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5
10078521|NCT02234141|11206276|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0
10078522|NCT02234141|11206277|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0
10078523|NCT02234141|11206278|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0
10078524|NCT02234141|11206272|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
10078525|NCT02234141|11206273|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
10078526|NCT02234141|11206274|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
10078527|NCT02234141|11206275|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
10078528|NCT02234141|11206276|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
10078529|NCT02234141|11206277|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
10078530|NCT02234141|11206278|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
10078531|NCT02234141|11206272|FG000|COMPLETED|Long-Term Treatment Period||0
10078532|NCT02234141|11206273|FG001|COMPLETED|Long-Term Treatment Period||0
10078533|NCT02234141|11206274|FG002|COMPLETED|Long-Term Treatment Period||0
10078534|NCT02234141|11206275|FG003|COMPLETED|Long-Term Treatment Period||0
10078535|NCT02234141|11206276|FG004|COMPLETED|Long-Term Treatment Period||0
10078536|NCT02234141|11206277|FG005|COMPLETED|Long-Term Treatment Period||0
10078537|NCT02234141|11206278|FG006|COMPLETED|Long-Term Treatment Period||0
10078538|NCT02234141|11206272|FG000|NOT COMPLETED|Long-Term Treatment Period||33
10078539|NCT02234141|11206273|FG001|NOT COMPLETED|Long-Term Treatment Period||31
10078540|NCT02234141|11206274|FG002|NOT COMPLETED|Long-Term Treatment Period||33
10078541|NCT02234141|11206275|FG003|NOT COMPLETED|Long-Term Treatment Period||0
10078542|NCT02234141|11206276|FG004|NOT COMPLETED|Long-Term Treatment Period||10
10078543|NCT02234141|11206277|FG005|NOT COMPLETED|Long-Term Treatment Period||12
10078544|NCT02234141|11206278|FG006|NOT COMPLETED|Long-Term Treatment Period||10
10078545|NCT02234180|11206289|FG000|STARTED|Overall Study||2
10078546|NCT02234180|11206290|FG001|STARTED|Overall Study||1
10078547|NCT02234180|11206289|FG000|COMPLETED|Overall Study||2
10078548|NCT02234180|11206290|FG001|COMPLETED|Overall Study||1
10078549|NCT02234180|11206289|FG000|NOT COMPLETED|Overall Study||0
10078550|NCT02234180|11206290|FG001|NOT COMPLETED|Overall Study||0
10078551|NCT02234284|11206296|FG000|STARTED|Overall Study||100
10078552|NCT02234284|11206297|FG001|STARTED|Overall Study||92
10078553|NCT02234284|11206296|FG000|COMPLETED|Overall Study||75
10078554|NCT02234284|11206297|FG001|COMPLETED|Overall Study||83
10078555|NCT02234284|11206296|FG000|NOT COMPLETED|Overall Study||25
10078556|NCT02234284|11206297|FG001|NOT COMPLETED|Overall Study||9
10078557|NCT02234362|11206307|FG000|STARTED|Overall Study||47
10078558|NCT02234362|11206307|FG000|Received at Least One Dose of Medication|Overall Study||27
10078559|NCT02234362|11206307|FG000|COMPLETED|Overall Study||21
10078560|NCT02234362|11206307|FG000|NOT COMPLETED|Overall Study||26
10078561|NCT02234427|11206311|FG000|STARTED|Overall Study||34
10078562|NCT02234427|11206311|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33
10078563|NCT02234427|11206311|FG000|NOT COMPLETED|Overall Study||1
10078564|NCT02234479|11206317|FG000|STARTED|Overall Study||16
10078565|NCT02234479|11206318|FG001|STARTED|Overall Study||18
10078566|NCT02234479|11206317|FG000|COMPLETED|Overall Study||15
10078567|NCT02234479|11206318|FG001|COMPLETED|Overall Study||15
10078568|NCT02234479|11206317|FG000|NOT COMPLETED|Overall Study||1
10078569|NCT02234479|11206318|FG001|NOT COMPLETED|Overall Study||3
10078570|NCT02234570|11206332|FG000|STARTED|Overall Study||8
10078571|NCT02234570|11206333|FG001|STARTED|Overall Study||8
10078572|NCT02234570|11206334|FG002|STARTED|Overall Study||8
10078573|NCT02234570|11206335|FG003|STARTED|Overall Study||8
10078574|NCT02234570|11206336|FG004|STARTED|Overall Study||8
10078575|NCT02234570|11206337|FG005|STARTED|Overall Study||8
10078576|NCT02234570|11206338|FG006|STARTED|Overall Study||8
10078577|NCT02234570|11206339|FG007|STARTED|Overall Study||14
10078578|NCT02234570|11206332|FG000|COMPLETED|Overall Study||8
10078579|NCT02234570|11206333|FG001|COMPLETED|Overall Study||8
10078580|NCT02234570|11206334|FG002|COMPLETED|Overall Study||8
10078581|NCT02234570|11206335|FG003|COMPLETED|Overall Study||8
10078582|NCT02234570|11206336|FG004|COMPLETED|Overall Study||8
10078583|NCT02234570|11206337|FG005|COMPLETED|Overall Study||8
10078584|NCT02234570|11206338|FG006|COMPLETED|Overall Study||8
10078585|NCT02234570|11206339|FG007|COMPLETED|Overall Study||14
10078586|NCT02234570|11206332|FG000|NOT COMPLETED|Overall Study||0
10078587|NCT02234570|11206333|FG001|NOT COMPLETED|Overall Study||0
10078588|NCT02234570|11206334|FG002|NOT COMPLETED|Overall Study||0
10078589|NCT02234570|11206335|FG003|NOT COMPLETED|Overall Study||0
10078590|NCT02234570|11206336|FG004|NOT COMPLETED|Overall Study||0
10078591|NCT02234570|11206337|FG005|NOT COMPLETED|Overall Study||0
10078592|NCT02234570|11206338|FG006|NOT COMPLETED|Overall Study||0
10078593|NCT02234570|11206339|FG007|NOT COMPLETED|Overall Study||0
10078594|NCT02234583|11206359|FG000|STARTED|Overall Study||847
10078595|NCT02234583|11206360|FG001|STARTED|Overall Study||1241
10078596|NCT02234583|11206359|FG000|COMPLETED|Overall Study||434
10078597|NCT02234583|11206360|FG001|COMPLETED|Overall Study||685
10078598|NCT02234583|11206359|FG000|NOT COMPLETED|Overall Study||413
10078599|NCT02234583|11206360|FG001|NOT COMPLETED|Overall Study||556
10078600|NCT02234596|11206372|FG000|STARTED|Overall Study||34
10078601|NCT02234596|11206372|FG000|COMPLETED|Overall Study||32
10078602|NCT02234596|11206372|FG000|NOT COMPLETED|Overall Study||2
10078603|NCT02234622|11206378|FG000|STARTED|Overall Study||108
10078604|NCT02234622|11206379|FG001|STARTED|Overall Study||104
10078605|NCT02234622|11206378|FG000|COMPLETED|Overall Study||65
10078606|NCT02234622|11206379|FG001|COMPLETED|Overall Study||68
10078607|NCT02234622|11206378|FG000|NOT COMPLETED|Overall Study||43
10078608|NCT02234622|11206379|FG001|NOT COMPLETED|Overall Study||36
10078609|NCT02234713|11206389|FG000|STARTED|Overall Study||31
10078610|NCT02234713|11206390|FG001|STARTED|Overall Study||32
10078611|NCT02234713|11206389|FG000|COMPLETED|Overall Study||25
10078612|NCT02234713|11206390|FG001|COMPLETED|Overall Study||27
10078613|NCT02234713|11206389|FG000|NOT COMPLETED|Overall Study||6
10078614|NCT02234713|11206390|FG001|NOT COMPLETED|Overall Study||5
10078615|NCT02234752|11206397|FG000|STARTED|Overall Study||3
10078616|NCT02234752|11206397|FG000|COMPLETED|Overall Study||2
10078617|NCT02234752|11206397|FG000|NOT COMPLETED|Overall Study||1
10078618|NCT02235064|11206404|FG000|STARTED|Overall Study||1
10078619|NCT02235064|11206405|FG001|STARTED|Overall Study||1
10078620|NCT02235064|11206404|FG000|COMPLETED|Overall Study||1
10078621|NCT02235064|11206405|FG001|COMPLETED|Overall Study||1
10078622|NCT02235064|11206404|FG000|NOT COMPLETED|Overall Study||0
10078623|NCT02235064|11206405|FG001|NOT COMPLETED|Overall Study||0
10078624|NCT02235077|11206415|FG000|STARTED|Overall Study||182
10078625|NCT02235077|11206416|FG001|STARTED|Overall Study||178
10078626|NCT02235077|11206415|FG000|COMPLETED|Overall Study||164
10078627|NCT02235077|11206416|FG001|COMPLETED|Overall Study||159
10078628|NCT02235077|11206415|FG000|NOT COMPLETED|Overall Study||18
10078629|NCT02235077|11206416|FG001|NOT COMPLETED|Overall Study||19
10078630|NCT02235285|11206422|FG000|STARTED|Overall Study||162
10078631|NCT02235285|11206422|FG000|COMPLETED|Overall Study||149
10078632|NCT02235285|11206422|FG000|NOT COMPLETED|Overall Study||13
10078633|NCT02235298|11206428|FG000|STARTED|Overall Study||50
10078634|NCT02235298|11206429|FG001|STARTED|Overall Study||50
10078635|NCT02235298|11206428|FG000|COMPLETED|Overall Study||42
10078636|NCT02235298|11206429|FG001|COMPLETED|Overall Study||42
10078637|NCT02235298|11206428|FG000|NOT COMPLETED|Overall Study||8
10078638|NCT02235298|11206429|FG001|NOT COMPLETED|Overall Study||8
10078639|NCT02235311|11206437|FG000|STARTED|Overall Study||1
10078640|NCT02235311|11206438|FG001|STARTED|Overall Study||2
10078641|NCT02235311|11206437|FG000|COMPLETED|Overall Study||1
10078642|NCT02235311|11206438|FG001|COMPLETED|Overall Study||0
10078643|NCT02235311|11206437|FG000|NOT COMPLETED|Overall Study||0
10078644|NCT02235311|11206438|FG001|NOT COMPLETED|Overall Study||2
10078645|NCT02235454|11206444|FG000|STARTED|Overall Study||57
10078646|NCT02235454|11206444|FG000|COMPLETED|Overall Study||55
10078647|NCT02235454|11206444|FG000|NOT COMPLETED|Overall Study||2
10078648|NCT02235493|11206448|FG000|STARTED|Overall Study||6
10078649|NCT02235493|11206448|FG000|COMPLETED|Overall Study||6
10078650|NCT02235493|11206448|FG000|NOT COMPLETED|Overall Study||0
10078651|NCT02235831|11206452|FG000|STARTED|Period 1, First 5 Days of Wear||4
10078652|NCT02235831|11206453|FG001|STARTED|Period 1, First 5 Days of Wear||4
10078653|NCT02235831|11206454|FG002|STARTED|Period 1, First 5 Days of Wear||4
10078654|NCT02235831|11206455|FG003|STARTED|Period 1, First 5 Days of Wear||4
10078655|NCT02235831|11206456|FG004|STARTED|Period 1, First 5 Days of Wear||4
10078656|NCT02235831|11206457|FG005|STARTED|Period 1, First 5 Days of Wear||4
10078657|NCT02235831|11206452|FG000|COMPLETED|Period 1, First 5 Days of Wear||4
10078658|NCT02235831|11206453|FG001|COMPLETED|Period 1, First 5 Days of Wear||4
10078659|NCT02235831|11206454|FG002|COMPLETED|Period 1, First 5 Days of Wear||4
10078660|NCT02235831|11206455|FG003|COMPLETED|Period 1, First 5 Days of Wear||4
10078661|NCT02235831|11206456|FG004|COMPLETED|Period 1, First 5 Days of Wear||4
10078662|NCT02235831|11206457|FG005|COMPLETED|Period 1, First 5 Days of Wear||4
10078663|NCT02235831|11206452|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10078664|NCT02235831|11206453|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10078665|NCT02235831|11206454|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10078666|NCT02235831|11206455|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10078667|NCT02235831|11206456|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10078668|NCT02235831|11206457|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10078669|NCT02235831|11206452|FG000|STARTED|Period 2, Second 5 Days of Wear||4
10078670|NCT02235831|11206453|FG001|STARTED|Period 2, Second 5 Days of Wear||4
10078671|NCT02235831|11206454|FG002|STARTED|Period 2, Second 5 Days of Wear||4
10078672|NCT02235831|11206455|FG003|STARTED|Period 2, Second 5 Days of Wear||4
10078673|NCT02235831|11206456|FG004|STARTED|Period 2, Second 5 Days of Wear||4
10078674|NCT02235831|11206457|FG005|STARTED|Period 2, Second 5 Days of Wear||4
10078675|NCT02235831|11206452|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4
10078676|NCT02235831|11206453|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4
10078677|NCT02235831|11206454|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4
10078678|NCT02235831|11206455|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4
10078679|NCT02235831|11206456|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4
10078680|NCT02235831|11206457|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4
10078681|NCT02235831|11206452|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10078682|NCT02235831|11206453|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10078683|NCT02235831|11206454|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10078684|NCT02235831|11206455|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10078685|NCT02235831|11206456|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10078686|NCT02235831|11206457|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10078687|NCT02235831|11206452|FG000|STARTED|Period 3, Third 5 Days of Wear||4
10078688|NCT02235831|11206453|FG001|STARTED|Period 3, Third 5 Days of Wear||4
10078689|NCT02235831|11206454|FG002|STARTED|Period 3, Third 5 Days of Wear||4
10078690|NCT02235831|11206455|FG003|STARTED|Period 3, Third 5 Days of Wear||4
10078691|NCT02235831|11206456|FG004|STARTED|Period 3, Third 5 Days of Wear||4
10078692|NCT02235831|11206457|FG005|STARTED|Period 3, Third 5 Days of Wear||4
10078693|NCT02235831|11206452|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4
10078694|NCT02235831|11206453|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4
10078695|NCT02235831|11206454|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4
10078696|NCT02235831|11206455|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4
10078697|NCT02235831|11206456|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4
10078698|NCT02235831|11206457|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4
10078699|NCT02235831|11206452|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10078700|NCT02235831|11206453|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10078701|NCT02235831|11206454|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10078702|NCT02235831|11206455|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10078703|NCT02235831|11206456|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10078704|NCT02235831|11206457|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10078705|NCT02235870|11206466|FG000|STARTED|Overall Study||198
10078706|NCT02235870|11206467|FG001|STARTED|Overall Study||189
10078707|NCT02235870|11206466|FG000|Completed Phase I (Week 24)|Overall Study||182
10078708|NCT02235870|11206467|FG001|Completed Phase I (Week 24)|Overall Study||179
10078709|NCT02235870|11206466|FG000|Crossover (Week 24)|Overall Study||170
10078710|NCT02235870|11206467|FG001|Crossover (Week 24)|Overall Study||138
10078711|NCT02235870|11206466|FG000|COMPLETED|Overall Study||160
10078712|NCT02235870|11206467|FG001|COMPLETED|Overall Study||128
10078713|NCT02235870|11206466|FG000|NOT COMPLETED|Overall Study||38
10078714|NCT02235870|11206467|FG001|NOT COMPLETED|Overall Study||61
10078715|NCT02235987|11206474|FG000|STARTED|Overall Study||20
10078716|NCT02235987|11206474|FG000|Received Octreotide|Overall Study||20
10078717|NCT02235987|11206474|FG000|Received 100 µg DG3173|Overall Study||20
10078718|NCT02235987|11206474|FG000|Received 300 µg DG3173|Overall Study||20
10078719|NCT02235987|11206474|FG000|Received 900 µg DG3173|Overall Study||19
10078720|NCT02235987|11206474|FG000|Received 1800 µg DG3173|Overall Study||19
10078721|NCT02235987|11206474|FG000|COMPLETED|Overall Study||19
10078722|NCT02235987|11206474|FG000|NOT COMPLETED|Overall Study||1
10078723|NCT02236130|11206489|FG000|STARTED|Overall Study||22
10078724|NCT02236130|11206490|FG001|STARTED|Overall Study||27
10078725|NCT02236130|11206489|FG000|COMPLETED|Overall Study||15
10078726|NCT02236130|11206490|FG001|COMPLETED|Overall Study||15
10078727|NCT02236130|11206489|FG000|NOT COMPLETED|Overall Study||7
10078728|NCT02236130|11206490|FG001|NOT COMPLETED|Overall Study||12
10078729|NCT02236338|11206498|FG000|STARTED|Overall Study||100
10078730|NCT02236338|11206499|FG001|STARTED|Overall Study||100
10078731|NCT02236338|11206498|FG000|COMPLETED|Overall Study||100
10078732|NCT02236338|11206499|FG001|COMPLETED|Overall Study||100
10078733|NCT02236338|11206498|FG000|NOT COMPLETED|Overall Study||0
10078734|NCT02236338|11206499|FG001|NOT COMPLETED|Overall Study||0
10078735|NCT02236520|11206509|FG000|STARTED|Overall Study||16
10078736|NCT02236520|11206510|FG001|STARTED|Overall Study||13
10078737|NCT02236520|11206511|FG002|STARTED|Overall Study||15
10078738|NCT02236520|11206512|FG003|STARTED|Overall Study||15
10078739|NCT02236520|11206509|FG000|COMPLETED|Overall Study||14
10078740|NCT02236520|11206510|FG001|COMPLETED|Overall Study||8
10078741|NCT02236520|11206511|FG002|COMPLETED|Overall Study||15
10078742|NCT02236520|11206512|FG003|COMPLETED|Overall Study||14
10078743|NCT02236520|11206509|FG000|NOT COMPLETED|Overall Study||2
10078744|NCT02236520|11206510|FG001|NOT COMPLETED|Overall Study||5
10078745|NCT02236520|11206511|FG002|NOT COMPLETED|Overall Study||0
10078746|NCT02236520|11206512|FG003|NOT COMPLETED|Overall Study||1
10078747|NCT02236559|11206524|FG000|STARTED|Overall Study||112
10078748|NCT02236559|11206525|FG001|STARTED|Overall Study||116
10078749|NCT02236559|11206524|FG000|COMPLETED|Overall Study||100
10078750|NCT02236559|11206525|FG001|COMPLETED|Overall Study||104
10078751|NCT02236559|11206524|FG000|NOT COMPLETED|Overall Study||12
10078752|NCT02236559|11206525|FG001|NOT COMPLETED|Overall Study||12
10078753|NCT02236598|11206533|FG000|STARTED|Overall Study||15
10078754|NCT02236598|11206534|FG001|STARTED|Overall Study||14
10078755|NCT02236598|11206533|FG000|COMPLETED|Overall Study||15
10078756|NCT02236598|11206534|FG001|COMPLETED|Overall Study||12
10078757|NCT02236598|11206533|FG000|NOT COMPLETED|Overall Study||0
10078758|NCT02236598|11206534|FG001|NOT COMPLETED|Overall Study||2
10078759|NCT02236611|11206542|FG000|STARTED|Overall Study||516
10078760|NCT02236611|11206543|FG001|STARTED|Overall Study||518
10078761|NCT02236611|11206542|FG000|COMPLETED|Overall Study||490
10078762|NCT02236611|11206543|FG001|COMPLETED|Overall Study||484
10078763|NCT02236611|11206542|FG000|NOT COMPLETED|Overall Study||26
10078764|NCT02236611|11206543|FG001|NOT COMPLETED|Overall Study||34
10078765|NCT02236767|11206549|FG000|STARTED|Overall Study||1
10078766|NCT02236767|11206549|FG000|COMPLETED|Overall Study||1
10078767|NCT02236767|11206549|FG000|NOT COMPLETED|Overall Study||0
10078768|NCT02236988|11206557|FG000|STARTED|Overall Study||16
10078769|NCT02236988|11206558|FG001|STARTED|Overall Study||16
10078770|NCT02236988|11206559|FG002|STARTED|Overall Study||18
10078771|NCT02236988|11206560|FG003|STARTED|Overall Study||30
10078772|NCT02236988|11206557|FG000|COMPLETED|Overall Study||16
10078773|NCT02236988|11206558|FG001|COMPLETED|Overall Study||16
10078774|NCT02236988|11206559|FG002|COMPLETED|Overall Study||18
10078775|NCT02236988|11206560|FG003|COMPLETED|Overall Study||27
10078776|NCT02236988|11206557|FG000|NOT COMPLETED|Overall Study||0
10078777|NCT02236988|11206558|FG001|NOT COMPLETED|Overall Study||0
10078778|NCT02236988|11206559|FG002|NOT COMPLETED|Overall Study||0
10078779|NCT02236988|11206560|FG003|NOT COMPLETED|Overall Study||3
10078780|NCT02237001|11206611|FG000|STARTED|Overall Study||30
10078781|NCT02237001|11206611|FG000|6 Month Follow-up|Overall Study||27
10078782|NCT02237001|11206611|FG000|12 Month Follow-up|Overall Study||21
10078783|NCT02237001|11206611|FG000|24 Month Follow-up|Overall Study||19
10078784|NCT02237001|11206611|FG000|COMPLETED|Overall Study||19
10078785|NCT02237001|11206611|FG000|NOT COMPLETED|Overall Study||11
10078786|NCT02237092|11206615|FG000|STARTED|Overall Study||196
10191637|NCT03307252|11320764|FG005|COMPLETED|Part 1, Period 1||0
10191638|NCT03307252|11320765|FG006|COMPLETED|Part 1, Period 1||0
10191639|NCT03307252|11320766|FG007|COMPLETED|Part 1, Period 1||0
10191640|NCT03307252|11320767|FG008|COMPLETED|Part 1, Period 1||0
10191641|NCT03307252|11320768|FG009|COMPLETED|Part 1, Period 1||0
10191642|NCT03307252|11320769|FG010|COMPLETED|Part 1, Period 1||0
10191643|NCT03307252|11320759|FG000|NOT COMPLETED|Part 1, Period 1||0
10191644|NCT03307252|11320760|FG001|NOT COMPLETED|Part 1, Period 1||0
10191645|NCT03307252|11320761|FG002|NOT COMPLETED|Part 1, Period 1||0
10191646|NCT03307252|11320762|FG003|NOT COMPLETED|Part 1, Period 1||0
10191647|NCT03307252|11320763|FG004|NOT COMPLETED|Part 1, Period 1||0
10191648|NCT03307252|11320764|FG005|NOT COMPLETED|Part 1, Period 1||0
10191649|NCT03307252|11320765|FG006|NOT COMPLETED|Part 1, Period 1||0
10191650|NCT03307252|11320766|FG007|NOT COMPLETED|Part 1, Period 1||0
10191651|NCT03307252|11320767|FG008|NOT COMPLETED|Part 1, Period 1||0
10191652|NCT03307252|11320768|FG009|NOT COMPLETED|Part 1, Period 1||0
10191653|NCT03307252|11320769|FG010|NOT COMPLETED|Part 1, Period 1||0
10191654|NCT03307252|11320759|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4
10191655|NCT03307252|11320760|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4
10191656|NCT03307252|11320761|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4
10191657|NCT03307252|11320762|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191658|NCT03307252|11320763|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191659|NCT03307252|11320764|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191660|NCT03307252|11320765|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191661|NCT03307252|11320766|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191662|NCT03307252|11320767|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191663|NCT03307252|11320768|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191664|NCT03307252|11320769|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0
10191665|NCT03307252|11320759|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
10191666|NCT03307252|11320760|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
10191667|NCT03307252|11320761|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
10191668|NCT03307252|11320762|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191669|NCT03307252|11320763|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191670|NCT03307252|11320764|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191671|NCT03307252|11320765|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191672|NCT03307252|11320766|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191673|NCT03307252|11320767|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191674|NCT03307252|11320768|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191675|NCT03307252|11320769|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191676|NCT03307252|11320759|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191677|NCT03307252|11320760|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191678|NCT03307252|11320761|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191679|NCT03307252|11320762|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191680|NCT03307252|11320763|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191681|NCT03307252|11320764|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191682|NCT03307252|11320765|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191683|NCT03307252|11320766|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191684|NCT03307252|11320767|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191685|NCT03307252|11320768|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191686|NCT03307252|11320769|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10191687|NCT03307252|11320759|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
10191688|NCT03307252|11320760|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
10191689|NCT03307252|11320761|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
10191690|NCT03307252|11320762|FG003|STARTED|Part 1, Period 2||0
10191691|NCT03307252|11320763|FG004|STARTED|Part 1, Period 2||0
10191692|NCT03307252|11320764|FG005|STARTED|Part 1, Period 2||0
10191693|NCT03307252|11320765|FG006|STARTED|Part 1, Period 2||0
10078787|NCT02237092|11206615|FG000|COMPLETED|Overall Study||196
10078788|NCT02237092|11206615|FG000|NOT COMPLETED|Overall Study||0
10078789|NCT02237118|11206632|FG000|STARTED|Overall Study||60
10078790|NCT02237118|11206633|FG001|STARTED|Overall Study||63
10078791|NCT02237118|11206632|FG000|COMPLETED|Overall Study||59
10078792|NCT02237118|11206633|FG001|COMPLETED|Overall Study||62
10078793|NCT02237118|11206632|FG000|NOT COMPLETED|Overall Study||1
10078794|NCT02237118|11206633|FG001|NOT COMPLETED|Overall Study||1
10078795|NCT02237157|11206647|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
10078796|NCT02237157|11206648|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
10078797|NCT02237157|11206649|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
10078798|NCT02237157|11206650|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
10078799|NCT02237157|11206647|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
10078800|NCT02237157|11206648|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10078801|NCT02237157|11206649|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10078802|NCT02237157|11206650|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10078803|NCT02237157|11206647|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
10078804|NCT02237157|11206648|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10078805|NCT02237157|11206649|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10078806|NCT02237157|11206650|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10078807|NCT02237157|11206647|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
10078808|NCT02237157|11206648|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
10078809|NCT02237157|11206649|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
10078810|NCT02237157|11206650|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
10078811|NCT02237157|11206647|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10078812|NCT02237157|11206648|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
10078813|NCT02237157|11206649|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10078814|NCT02237157|11206650|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10078815|NCT02237157|11206647|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10078816|NCT02237157|11206648|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10078817|NCT02237157|11206649|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10078818|NCT02237157|11206650|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10078819|NCT02237157|11206647|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
10078820|NCT02237157|11206648|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
10078821|NCT02237157|11206649|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
10078822|NCT02237157|11206650|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
10078823|NCT02237157|11206647|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10078824|NCT02237157|11206648|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10078825|NCT02237157|11206649|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
10078826|NCT02237157|11206650|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10078827|NCT02237157|11206647|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10078828|NCT02237157|11206648|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10078829|NCT02237157|11206649|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10078830|NCT02237157|11206650|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10078831|NCT02237157|11206647|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
10078832|NCT02237157|11206648|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
10078833|NCT02237157|11206649|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
10078834|NCT02237157|11206650|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
10078835|NCT02237157|11206647|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10078836|NCT02237157|11206648|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10078837|NCT02237157|11206649|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10078838|NCT02237157|11206650|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
10078839|NCT02237157|11206647|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10078840|NCT02237157|11206648|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10078841|NCT02237157|11206649|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10078842|NCT02237157|11206650|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10078843|NCT02237196|11206661|FG000|STARTED|Overall Study||32
10078844|NCT02237196|11206662|FG001|STARTED|Overall Study||31
10078845|NCT02237196|11206663|FG002|STARTED|Overall Study||30
10078846|NCT02237196|11206664|FG003|STARTED|Overall Study||28
10078847|NCT02237196|11206661|FG000|COMPLETED|Overall Study||24
10078848|NCT02237196|11206662|FG001|COMPLETED|Overall Study||25
10078849|NCT02237196|11206663|FG002|COMPLETED|Overall Study||20
10078850|NCT02237196|11206664|FG003|COMPLETED|Overall Study||17
10078851|NCT02237196|11206661|FG000|NOT COMPLETED|Overall Study||8
10078852|NCT02237196|11206662|FG001|NOT COMPLETED|Overall Study||6
10078853|NCT02237196|11206663|FG002|NOT COMPLETED|Overall Study||10
10078854|NCT02237196|11206664|FG003|NOT COMPLETED|Overall Study||11
10078855|NCT02237417|11206677|FG000|STARTED|Overall Study||16
10078856|NCT02237417|11206678|FG001|STARTED|Overall Study||15
10078857|NCT02237417|11206679|FG002|STARTED|Overall Study||16
10078858|NCT02237417|11206677|FG000|COMPLETED|Overall Study||16
10078859|NCT02237417|11206678|FG001|COMPLETED|Overall Study||9
10078860|NCT02237417|11206679|FG002|COMPLETED|Overall Study||7
10078861|NCT02237417|11206677|FG000|NOT COMPLETED|Overall Study||0
10078862|NCT02237417|11206678|FG001|NOT COMPLETED|Overall Study||6
10078863|NCT02237417|11206679|FG002|NOT COMPLETED|Overall Study||9
10078864|NCT02237898|11206689|FG000|STARTED|Overall Study||12
10078865|NCT02237898|11206690|FG001|STARTED|Overall Study||14
10078866|NCT02237898|11206689|FG000|Completed 12 Weeks of CM|Overall Study||7
10078867|NCT02237898|11206690|FG001|Completed 12 Weeks of CM|Overall Study||2
10078868|NCT02237898|11206689|FG000|Completed 3 Month Follow-up|Overall Study||6
10078869|NCT02237898|11206690|FG001|Completed 3 Month Follow-up|Overall Study||6
10078870|NCT02237898|11206689|FG000|Completed 9 Month Follow-up|Overall Study||6
10078871|NCT02237898|11206690|FG001|Completed 9 Month Follow-up|Overall Study||7
10078872|NCT02237898|11206689|FG000|Completed 15 Month Follow-up|Overall Study||8
10078873|NCT02237898|11206690|FG001|Completed 15 Month Follow-up|Overall Study||8
10078874|NCT02237898|11206689|FG000|COMPLETED|Overall Study||5
10078875|NCT02237898|11206690|FG001|COMPLETED|Overall Study||2
10078876|NCT02237898|11206689|FG000|NOT COMPLETED|Overall Study||7
10078877|NCT02237898|11206690|FG001|NOT COMPLETED|Overall Study||12
10078878|NCT02237911|11206701|FG000|STARTED|Overall Study||96
10078879|NCT02237911|11206702|FG001|STARTED|Overall Study||96
10078880|NCT02237911|11206703|FG002|STARTED|Overall Study||48
10078881|NCT02237911|11206701|FG000|3 Months|Overall Study||90
10078882|NCT02237911|11206702|FG001|3 Months|Overall Study||87
10078883|NCT02237911|11206703|FG002|3 Months|Overall Study||44
10078884|NCT02237911|11206701|FG000|6 Months|Overall Study||89
10078885|NCT02237911|11206702|FG001|6 Months|Overall Study||88
10078886|NCT02237911|11206703|FG002|6 Months|Overall Study||45
10078887|NCT02237911|11206701|FG000|COMPLETED|Overall Study||89
10078888|NCT02237911|11206702|FG001|COMPLETED|Overall Study||88
10078889|NCT02237911|11206703|FG002|COMPLETED|Overall Study||45
10078890|NCT02237911|11206701|FG000|NOT COMPLETED|Overall Study||7
10078891|NCT02237911|11206702|FG001|NOT COMPLETED|Overall Study||8
10078892|NCT02237911|11206703|FG002|NOT COMPLETED|Overall Study||3
10078893|NCT02237950|11206713|FG000|STARTED|Overall Study||295
10078894|NCT02237950|11206714|FG001|STARTED|Overall Study||291
10078895|NCT02237950|11206713|FG000|COMPLETED|Overall Study||247
10078896|NCT02237950|11206714|FG001|COMPLETED|Overall Study||243
10078897|NCT02237950|11206713|FG000|NOT COMPLETED|Overall Study||48
10078898|NCT02237950|11206714|FG001|NOT COMPLETED|Overall Study||48
10078899|NCT02237989|11206722|FG000|STARTED|Overall Study||19
10078900|NCT02237989|11206723|FG001|STARTED|Overall Study||20
10078901|NCT02237989|11206722|FG000|COMPLETED|Overall Study||19
10078902|NCT02237989|11206723|FG001|COMPLETED|Overall Study||20
10078903|NCT02237989|11206722|FG000|NOT COMPLETED|Overall Study||0
10078904|NCT02237989|11206723|FG001|NOT COMPLETED|Overall Study||0
10078905|NCT02238028|11206729|FG000|STARTED|Overall Study||14
10078906|NCT02238028|11206730|FG001|STARTED|Overall Study||14
10078907|NCT02238028|11206729|FG000|COMPLETED|Overall Study||12
10078908|NCT02238028|11206730|FG001|COMPLETED|Overall Study||12
10078909|NCT02238028|11206729|FG000|NOT COMPLETED|Overall Study||2
10078910|NCT02238028|11206730|FG001|NOT COMPLETED|Overall Study||2
10078911|NCT02238067|11206741|FG000|STARTED|Overall Study||196
10078912|NCT02238067|11206741|FG000|COMPLETED|Overall Study||151
10078913|NCT02238067|11206741|FG000|NOT COMPLETED|Overall Study||45
10078914|NCT02238080|11206745|FG000|STARTED|Overall Study||197
10078915|NCT02238080|11206745|FG000|COMPLETED|Overall Study||172
10078916|NCT02238080|11206745|FG000|NOT COMPLETED|Overall Study||25
10078917|NCT02238379|11206751|FG000|STARTED|Overall Study||12
10078918|NCT02238379|11206752|FG001|STARTED|Overall Study||14
10078919|NCT02238379|11206751|FG000|COMPLETED|Overall Study||11
10078920|NCT02238379|11206752|FG001|COMPLETED|Overall Study||14
10191694|NCT03307252|11320766|FG007|STARTED|Part 1, Period 2||0
10191695|NCT03307252|11320767|FG008|STARTED|Part 1, Period 2||0
10191696|NCT03307252|11320768|FG009|STARTED|Part 1, Period 2||0
10191697|NCT03307252|11320769|FG010|STARTED|Part 1, Period 2||0
10191698|NCT03307252|11320759|FG000|COMPLETED|Part 1, Period 2||4
10191699|NCT03307252|11320760|FG001|COMPLETED|Part 1, Period 2||4
10191700|NCT03307252|11320761|FG002|COMPLETED|Part 1, Period 2||4
10191701|NCT03307252|11320762|FG003|COMPLETED|Part 1, Period 2||0
10191702|NCT03307252|11320763|FG004|COMPLETED|Part 1, Period 2||0
10191703|NCT03307252|11320764|FG005|COMPLETED|Part 1, Period 2||0
10191704|NCT03307252|11320765|FG006|COMPLETED|Part 1, Period 2||0
10191705|NCT03307252|11320766|FG007|COMPLETED|Part 1, Period 2||0
10191706|NCT03307252|11320767|FG008|COMPLETED|Part 1, Period 2||0
10191707|NCT03307252|11320768|FG009|COMPLETED|Part 1, Period 2||0
10191708|NCT03307252|11320769|FG010|COMPLETED|Part 1, Period 2||0
10191709|NCT03307252|11320759|FG000|NOT COMPLETED|Part 1, Period 2||0
10191710|NCT03307252|11320760|FG001|NOT COMPLETED|Part 1, Period 2||0
10191711|NCT03307252|11320761|FG002|NOT COMPLETED|Part 1, Period 2||0
10191712|NCT03307252|11320762|FG003|NOT COMPLETED|Part 1, Period 2||0
10191713|NCT03307252|11320763|FG004|NOT COMPLETED|Part 1, Period 2||0
10191714|NCT03307252|11320764|FG005|NOT COMPLETED|Part 1, Period 2||0
10191715|NCT03307252|11320765|FG006|NOT COMPLETED|Part 1, Period 2||0
10191716|NCT03307252|11320766|FG007|NOT COMPLETED|Part 1, Period 2||0
10191717|NCT03307252|11320767|FG008|NOT COMPLETED|Part 1, Period 2||0
10191718|NCT03307252|11320768|FG009|NOT COMPLETED|Part 1, Period 2||0
10191719|NCT03307252|11320769|FG010|NOT COMPLETED|Part 1, Period 2||0
10078921|NCT02238379|11206751|FG000|NOT COMPLETED|Overall Study||1
10078922|NCT02238379|11206752|FG001|NOT COMPLETED|Overall Study||0
10078923|NCT02238483|11206760|FG000|STARTED|Overall Study||108
10078924|NCT02238483|11206761|FG001|STARTED|Overall Study||105
10078925|NCT02238483|11206760|FG000|COMPLETED|Overall Study||93
10191720|NCT03307252|11320759|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4
10191721|NCT03307252|11320760|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4
10191722|NCT03307252|11320761|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4
10191723|NCT03307252|11320762|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0
10191724|NCT03307252|11320763|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0
10191725|NCT03307252|11320764|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0
10078926|NCT02238483|11206761|FG001|COMPLETED|Overall Study||91
10078927|NCT02238483|11206760|FG000|NOT COMPLETED|Overall Study||15
10078928|NCT02238483|11206761|FG001|NOT COMPLETED|Overall Study||14
10078929|NCT02238626|11206771|FG000|STARTED|Overall Study||17
10078930|NCT02238626|11206772|FG001|STARTED|Overall Study||34
10078931|NCT02238626|11206773|FG002|STARTED|Overall Study||8
10078932|NCT02238626|11206774|FG003|STARTED|Overall Study||11
10078933|NCT02238626|11206771|FG000|COMPLETED|Overall Study||12
10078934|NCT02238626|11206772|FG001|COMPLETED|Overall Study||20
10078935|NCT02238626|11206773|FG002|COMPLETED|Overall Study||5
10078936|NCT02238626|11206774|FG003|COMPLETED|Overall Study||4
10078937|NCT02238626|11206771|FG000|NOT COMPLETED|Overall Study||5
10078938|NCT02238626|11206772|FG001|NOT COMPLETED|Overall Study||14
10078939|NCT02238626|11206773|FG002|NOT COMPLETED|Overall Study||3
10078940|NCT02238626|11206774|FG003|NOT COMPLETED|Overall Study||7
10078941|NCT02238782|11206795|FG000|STARTED|Overall Study||12
10078942|NCT02238782|11206795|FG000|Subjects Treated|Overall Study||12
10078943|NCT02238782|11206795|FG000|COMPLETED|Overall Study||12
10078944|NCT02238782|11206795|FG000|NOT COMPLETED|Overall Study||0
10078945|NCT02238847|11206801|FG000|STARTED|Overall Study||59
10078946|NCT02238847|11206802|FG001|STARTED|Overall Study||60
10078947|NCT02238847|11206801|FG000|COMPLETED|Overall Study||37
10078948|NCT02238847|11206802|FG001|COMPLETED|Overall Study||36
10078949|NCT02238847|11206801|FG000|NOT COMPLETED|Overall Study||22
10078950|NCT02238847|11206802|FG001|NOT COMPLETED|Overall Study||24
10078951|NCT02238925|11206808|FG000|STARTED|Overall Study||26
10078952|NCT02238925|11206808|FG000|COMPLETED|Overall Study||1
10078953|NCT02238925|11206808|FG000|NOT COMPLETED|Overall Study||25
10078954|NCT02238977|11206814|FG000|STARTED|Overall Study||0
10078955|NCT02238977|11206815|FG001|STARTED|Overall Study||1
10078956|NCT02238977|11206814|FG000|COMPLETED|Overall Study||0
10078957|NCT02238977|11206815|FG001|COMPLETED|Overall Study||1
10078958|NCT02238977|11206814|FG000|NOT COMPLETED|Overall Study||0
10078959|NCT02238977|11206815|FG001|NOT COMPLETED|Overall Study||0
10078960|NCT02239094|11206821|FG000|STARTED|Overall Study||20
10078961|NCT02239094|11206821|FG000|COMPLETED|Overall Study||18
10078962|NCT02239094|11206821|FG000|NOT COMPLETED|Overall Study||2
10078963|NCT02239120|11206827|FG000|STARTED|Overall Study||2695
10078964|NCT02239120|11206828|FG001|STARTED|Overall Study||2695
10078965|NCT02239120|11206827|FG000|COMPLETED|Overall Study||2620
10078966|NCT02239120|11206828|FG001|COMPLETED|Overall Study||2623
10078967|NCT02239120|11206827|FG000|NOT COMPLETED|Overall Study||75
10078968|NCT02239120|11206828|FG001|NOT COMPLETED|Overall Study||72
10078969|NCT02239224|11206838|FG000|STARTED|Overall Study||3
10078970|NCT02239224|11206839|FG001|STARTED|Overall Study||6
10078971|NCT02239224|11206840|FG002|STARTED|Overall Study||6
10078972|NCT02239224|11206841|FG003|STARTED|Overall Study||5
10078973|NCT02239224|11206838|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10078974|NCT02239224|11206839|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10078975|NCT02239224|11206840|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10191726|NCT03307252|11320765|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0
10191727|NCT03307252|11320766|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0
10191728|NCT03307252|11320767|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0
10191729|NCT03307252|11320768|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0
10191730|NCT03307252|11320769|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0
10191731|NCT03307252|11320759|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
10191732|NCT03307252|11320760|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
10191733|NCT03307252|11320761|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
10191734|NCT03307252|11320762|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191735|NCT03307252|11320763|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191736|NCT03307252|11320764|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191737|NCT03307252|11320765|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191738|NCT03307252|11320766|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191739|NCT03307252|11320767|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191740|NCT03307252|11320768|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191741|NCT03307252|11320769|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191742|NCT03307252|11320759|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191743|NCT03307252|11320760|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191744|NCT03307252|11320761|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191745|NCT03307252|11320762|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191746|NCT03307252|11320763|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191747|NCT03307252|11320764|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191748|NCT03307252|11320765|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191749|NCT03307252|11320766|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191750|NCT03307252|11320767|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10078976|NCT02239224|11206841|FG003|Received at Least One Dose of Study Drug|Overall Study||5
10078977|NCT02239224|11206838|FG000|COMPLETED|Overall Study||3
10078978|NCT02239224|11206839|FG001|COMPLETED|Overall Study||6
10078979|NCT02239224|11206840|FG002|COMPLETED|Overall Study||3
10078980|NCT02239224|11206841|FG003|COMPLETED|Overall Study||4
10078981|NCT02239224|11206838|FG000|NOT COMPLETED|Overall Study||0
10078982|NCT02239224|11206839|FG001|NOT COMPLETED|Overall Study||0
10078983|NCT02239224|11206840|FG002|NOT COMPLETED|Overall Study||3
10078984|NCT02239224|11206841|FG003|NOT COMPLETED|Overall Study||1
10078985|NCT02239263|11206851|FG000|STARTED|Overall Study||40
10191751|NCT03307252|11320768|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10078986|NCT02239263|11206851|FG000|COMPLETED|Overall Study||34
10078987|NCT02239263|11206851|FG000|NOT COMPLETED|Overall Study||6
10078988|NCT02239289|11206857|FG000|STARTED|Overall Study||21
10078989|NCT02239289|11206857|FG000|COMPLETED|Overall Study||21
10078990|NCT02239289|11206857|FG000|NOT COMPLETED|Overall Study||0
10078991|NCT02239328|11206861|FG000|STARTED|Overall Study||182
10078992|NCT02239328|11206861|FG000|COMPLETED|Overall Study||174
10078993|NCT02239328|11206861|FG000|NOT COMPLETED|Overall Study||8
10078994|NCT02239380|11206865|FG000|STARTED|Overall Study||26
10078995|NCT02239380|11206865|FG000|COMPLETED|Overall Study||26
10078996|NCT02239380|11206865|FG000|NOT COMPLETED|Overall Study||0
10078997|NCT02239510|11206871|FG000|STARTED|Overall Study||5
10078998|NCT02239510|11206872|FG001|STARTED|Overall Study||4
10078999|NCT02239510|11206871|FG000|COMPLETED|Overall Study||3
10079000|NCT02239510|11206872|FG001|COMPLETED|Overall Study||3
10079001|NCT02239510|11206871|FG000|NOT COMPLETED|Overall Study||2
10079002|NCT02239510|11206872|FG001|NOT COMPLETED|Overall Study||1
10079003|NCT02239536|11206880|FG000|STARTED|Overall Study||190
10079004|NCT02239536|11206881|FG001|STARTED|Overall Study||172
10079005|NCT02239536|11206880|FG000|COMPLETED|Overall Study||167
10079006|NCT02239536|11206881|FG001|COMPLETED|Overall Study||155
10079007|NCT02239536|11206880|FG000|NOT COMPLETED|Overall Study||23
10079008|NCT02239536|11206881|FG001|NOT COMPLETED|Overall Study||17
10079009|NCT02239562|11206893|FG000|STARTED|Overall Study||6
10079010|NCT02239562|11206894|FG001|STARTED|Overall Study||6
10079011|NCT02239562|11206895|FG002|STARTED|Overall Study||6
10079012|NCT02239562|11206896|FG003|STARTED|Overall Study||6
10079013|NCT02239562|11206897|FG004|STARTED|Overall Study||6
10079014|NCT02239562|11206898|FG005|STARTED|Overall Study||6
10079015|NCT02239562|11206893|FG000|COMPLETED|Overall Study||6
10079016|NCT02239562|11206894|FG001|COMPLETED|Overall Study||6
10079017|NCT02239562|11206895|FG002|COMPLETED|Overall Study||6
10079018|NCT02239562|11206896|FG003|COMPLETED|Overall Study||6
10079019|NCT02239562|11206897|FG004|COMPLETED|Overall Study||6
10079020|NCT02239562|11206898|FG005|COMPLETED|Overall Study||6
10079021|NCT02239562|11206893|FG000|NOT COMPLETED|Overall Study||0
10079022|NCT02239562|11206894|FG001|NOT COMPLETED|Overall Study||0
10079023|NCT02239562|11206895|FG002|NOT COMPLETED|Overall Study||0
10079024|NCT02239562|11206896|FG003|NOT COMPLETED|Overall Study||0
10079025|NCT02239562|11206897|FG004|NOT COMPLETED|Overall Study||0
10079026|NCT02239562|11206898|FG005|NOT COMPLETED|Overall Study||0
10079027|NCT02239601|11206916|FG000|STARTED|Overall Study||29
10079028|NCT02239601|11206917|FG001|STARTED|Overall Study||32
10079029|NCT02239601|11206916|FG000|COMPLETED|Overall Study||22
10079030|NCT02239601|11206917|FG001|COMPLETED|Overall Study||26
10079031|NCT02239601|11206916|FG000|NOT COMPLETED|Overall Study||7
10079032|NCT02239601|11206917|FG001|NOT COMPLETED|Overall Study||6
10079033|NCT02239640|11206928|FG000|STARTED|Overall Study||984
10079034|NCT02239640|11206928|FG000|COMPLETED|Overall Study||767
10079035|NCT02239640|11206928|FG000|NOT COMPLETED|Overall Study||217
10079036|NCT02239679|11206941|FG000|STARTED|Overall Study||53
10079037|NCT02239679|11206942|FG001|STARTED|Overall Study||59
10079038|NCT02239679|11206943|FG002|STARTED|Overall Study||54
10079039|NCT02239679|11206941|FG000|COMPLETED|Overall Study||50
10079040|NCT02239679|11206942|FG001|COMPLETED|Overall Study||56
10079041|NCT02239679|11206943|FG002|COMPLETED|Overall Study||53
10079042|NCT02239679|11206941|FG000|NOT COMPLETED|Overall Study||3
10079043|NCT02239679|11206942|FG001|NOT COMPLETED|Overall Study||3
10079044|NCT02239679|11206943|FG002|NOT COMPLETED|Overall Study||1
10079045|NCT02239692|11206953|FG000|STARTED|Overall Study||73
10079046|NCT02239692|11206954|FG001|STARTED|Overall Study||131
10079047|NCT02239692|11206953|FG000|Intention-to-treat Analysis Set|Overall Study||73
10079048|NCT02239692|11206954|FG001|Intention-to-treat Analysis Set|Overall Study||131
10079049|NCT02239692|11206953|FG000|Per-protocol Analysis Set|Overall Study||66
10079050|NCT02239692|11206954|FG001|Per-protocol Analysis Set|Overall Study||120
10079051|NCT02239692|11206953|FG000|Safety Analysis Set|Overall Study||70
10079052|NCT02239692|11206954|FG001|Safety Analysis Set|Overall Study||125
10079053|NCT02239692|11206953|FG000|COMPLETED|Overall Study||67
10079054|NCT02239692|11206954|FG001|COMPLETED|Overall Study||118
10079055|NCT02239692|11206953|FG000|NOT COMPLETED|Overall Study||6
10079056|NCT02239692|11206954|FG001|NOT COMPLETED|Overall Study||13
10079057|NCT02239744|11206962|FG000|STARTED|Period 1||17
10079058|NCT02239744|11206963|FG001|STARTED|Period 1||18
10079059|NCT02239744|11206962|FG000|COMPLETED|Period 1||17
10079060|NCT02239744|11206963|FG001|COMPLETED|Period 1||18
10079061|NCT02239744|11206962|FG000|NOT COMPLETED|Period 1||0
10079062|NCT02239744|11206963|FG001|NOT COMPLETED|Period 1||0
10079063|NCT02239744|11206962|FG000|STARTED|Period 2||17
10079064|NCT02239744|11206963|FG001|STARTED|Period 2||18
10079065|NCT02239744|11206962|FG000|COMPLETED|Period 2||17
10079066|NCT02239744|11206963|FG001|COMPLETED|Period 2||18
10079067|NCT02239744|11206962|FG000|NOT COMPLETED|Period 2||0
10079068|NCT02239744|11206963|FG001|NOT COMPLETED|Period 2||0
10079069|NCT02239770|11206976|FG000|STARTED|Part 1||4
10079070|NCT02239770|11206977|FG001|STARTED|Part 1||4
10079071|NCT02239770|11206978|FG002|STARTED|Part 1||4
10079072|NCT02239770|11206979|FG003|STARTED|Part 1||0
10079073|NCT02239770|11206980|FG004|STARTED|Part 1||0
10079074|NCT02239770|11206981|FG005|STARTED|Part 1||0
10079075|NCT02239770|11206976|FG000|COMPLETED|Part 1||4
10079076|NCT02239770|11206977|FG001|COMPLETED|Part 1||4
10079077|NCT02239770|11206978|FG002|COMPLETED|Part 1||4
10079078|NCT02239770|11206979|FG003|COMPLETED|Part 1||0
10079079|NCT02239770|11206980|FG004|COMPLETED|Part 1||0
10079080|NCT02239770|11206981|FG005|COMPLETED|Part 1||0
10079081|NCT02239770|11206976|FG000|NOT COMPLETED|Part 1||0
10079082|NCT02239770|11206977|FG001|NOT COMPLETED|Part 1||0
10079083|NCT02239770|11206978|FG002|NOT COMPLETED|Part 1||0
10079084|NCT02239770|11206979|FG003|NOT COMPLETED|Part 1||0
10079085|NCT02239770|11206980|FG004|NOT COMPLETED|Part 1||0
10079086|NCT02239770|11206981|FG005|NOT COMPLETED|Part 1||0
10079087|NCT02239770|11206976|FG000|STARTED|Part 2||0
10079088|NCT02239770|11206977|FG001|STARTED|Part 2||0
10079089|NCT02239770|11206978|FG002|STARTED|Part 2||0
10079090|NCT02239770|11206979|FG003|STARTED|Part 2||4
10079091|NCT02239770|11206980|FG004|STARTED|Part 2||4
10079092|NCT02239770|11206981|FG005|STARTED|Part 2||4
10079093|NCT02239770|11206976|FG000|COMPLETED|Part 2||0
10079094|NCT02239770|11206977|FG001|COMPLETED|Part 2||0
10079095|NCT02239770|11206978|FG002|COMPLETED|Part 2||0
10079096|NCT02239770|11206979|FG003|COMPLETED|Part 2||4
10079097|NCT02239770|11206980|FG004|COMPLETED|Part 2||4
10079098|NCT02239770|11206981|FG005|COMPLETED|Part 2||4
10079099|NCT02239770|11206976|FG000|NOT COMPLETED|Part 2||0
10079100|NCT02239770|11206977|FG001|NOT COMPLETED|Part 2||0
10079101|NCT02239770|11206978|FG002|NOT COMPLETED|Part 2||0
10079102|NCT02239770|11206979|FG003|NOT COMPLETED|Part 2||0
10079103|NCT02239770|11206980|FG004|NOT COMPLETED|Part 2||0
10079104|NCT02239770|11206981|FG005|NOT COMPLETED|Part 2||0
10079105|NCT02239939|11207005|FG000|STARTED|Overall Study||20
10079106|NCT02239939|11207006|FG001|STARTED|Overall Study||17
10079107|NCT02239939|11207005|FG000|COMPLETED|Overall Study||18
10079108|NCT02239939|11207006|FG001|COMPLETED|Overall Study||15
10079109|NCT02239939|11207005|FG000|NOT COMPLETED|Overall Study||2
10079110|NCT02239939|11207006|FG001|NOT COMPLETED|Overall Study||2
10079111|NCT02239978|11207016|FG000|STARTED|Overall Study||30
10079112|NCT02239978|11207017|FG001|STARTED|Overall Study||12
10079113|NCT02239978|11207016|FG000|COMPLETED|Overall Study||28
10079114|NCT02239978|11207017|FG001|COMPLETED|Overall Study||12
10079115|NCT02239978|11207016|FG000|NOT COMPLETED|Overall Study||2
10079116|NCT02239978|11207017|FG001|NOT COMPLETED|Overall Study||0
10079117|NCT02240030|11207028|FG000|STARTED|Overall Study||113
10079118|NCT02240030|11207029|FG001|STARTED|Overall Study||114
10079119|NCT02240030|11207030|FG002|STARTED|Overall Study||112
10079120|NCT02240030|11207028|FG000|COMPLETED|Overall Study||96
10079121|NCT02240030|11207029|FG001|COMPLETED|Overall Study||97
10079122|NCT02240030|11207030|FG002|COMPLETED|Overall Study||97
10079123|NCT02240030|11207028|FG000|NOT COMPLETED|Overall Study||17
10079124|NCT02240030|11207029|FG001|NOT COMPLETED|Overall Study||17
10079125|NCT02240030|11207030|FG002|NOT COMPLETED|Overall Study||15
10079126|NCT02240108|11207042|FG000|STARTED|Overall Study||35
10079127|NCT02240108|11207043|FG001|STARTED|Overall Study||46
10079128|NCT02240108|11207042|FG000|Intent-to-treat (ITT) Population|Overall Study||35
10079129|NCT02240108|11207043|FG001|Intent-to-treat (ITT) Population|Overall Study||45
10079130|NCT02240108|11207042|FG000|COMPLETED|Overall Study||21
10079131|NCT02240108|11207043|FG001|COMPLETED|Overall Study||21
10079132|NCT02240108|11207042|FG000|NOT COMPLETED|Overall Study||14
10079133|NCT02240108|11207043|FG001|NOT COMPLETED|Overall Study||25
10079134|NCT02240121|11207051|FG000|STARTED|Overall Study||40
10079135|NCT02240121|11207052|FG001|STARTED|Overall Study||40
10079136|NCT02240121|11207051|FG000|COMPLETED|Overall Study||22
10079137|NCT02240121|11207052|FG001|COMPLETED|Overall Study||20
10079138|NCT02240121|11207051|FG000|NOT COMPLETED|Overall Study||18
10079139|NCT02240121|11207052|FG001|NOT COMPLETED|Overall Study||20
10079140|NCT02240186|11207058|FG000|STARTED|Overall Study||50
10079141|NCT02240186|11207058|FG000|COMPLETED|Overall Study||23
10079142|NCT02240186|11207058|FG000|NOT COMPLETED|Overall Study||27
10079143|NCT02240329|11207065|FG000|STARTED|Overall Study||4
10079144|NCT02240329|11207065|FG000|Determination of Urge to Cough|Overall Study||4
10079145|NCT02240329|11207065|FG000|COMPLETED|Overall Study||4
10079146|NCT02240329|11207065|FG000|NOT COMPLETED|Overall Study||0
10079147|NCT02240368|11207072|FG000|STARTED|Overall Study||9
10079148|NCT02240368|11207073|FG001|STARTED|Overall Study||22
10079149|NCT02240368|11207074|FG002|STARTED|Overall Study||19
10079150|NCT02240368|11207072|FG000|COMPLETED|Overall Study||8
10079151|NCT02240368|11207073|FG001|COMPLETED|Overall Study||22
10079152|NCT02240368|11207074|FG002|COMPLETED|Overall Study||18
10079153|NCT02240368|11207072|FG000|NOT COMPLETED|Overall Study||1
10079154|NCT02240368|11207073|FG001|NOT COMPLETED|Overall Study||0
10079155|NCT02240368|11207074|FG002|NOT COMPLETED|Overall Study||1
10079156|NCT02240589|11207084|FG000|STARTED|Overall Study||5
10079157|NCT02240589|11207085|FG001|STARTED|Overall Study||6
10079158|NCT02240589|11207084|FG000|COMPLETED|Overall Study||3
10079159|NCT02240589|11207085|FG001|COMPLETED|Overall Study||4
10079160|NCT02240589|11207084|FG000|NOT COMPLETED|Overall Study||2
10079161|NCT02240589|11207085|FG001|NOT COMPLETED|Overall Study||2
10079162|NCT02240628|11207093|FG000|STARTED|Overall Study||38
10079163|NCT02240628|11207094|FG001|STARTED|Overall Study||38
10079164|NCT02240628|11207093|FG000|COMPLETED|Overall Study||32
10079165|NCT02240628|11207094|FG001|COMPLETED|Overall Study||33
10079166|NCT02240628|11207093|FG000|NOT COMPLETED|Overall Study||6
10079167|NCT02240628|11207094|FG001|NOT COMPLETED|Overall Study||5
10079168|NCT02240654|11207105|FG000|STARTED|Overall Study||1706
10079169|NCT02240654|11207106|FG001|STARTED|Overall Study||2813
10079170|NCT02240654|11207107|FG002|STARTED|Overall Study||28619
10079171|NCT02240654|11207108|FG003|STARTED|Overall Study||2150
10079172|NCT02240654|11207109|FG004|STARTED|Overall Study||1285
10079173|NCT02240654|11207105|FG000|COMPLETED|Overall Study||1706
10079174|NCT02240654|11207106|FG001|COMPLETED|Overall Study||2813
10079175|NCT02240654|11207107|FG002|COMPLETED|Overall Study||28619
10079176|NCT02240654|11207108|FG003|COMPLETED|Overall Study||2150
10079177|NCT02240654|11207109|FG004|COMPLETED|Overall Study||1285
10079178|NCT02240654|11207105|FG000|NOT COMPLETED|Overall Study||0
10079179|NCT02240654|11207106|FG001|NOT COMPLETED|Overall Study||0
10079180|NCT02240654|11207107|FG002|NOT COMPLETED|Overall Study||0
10079181|NCT02240654|11207108|FG003|NOT COMPLETED|Overall Study||0
10079182|NCT02240654|11207109|FG004|NOT COMPLETED|Overall Study||0
10079183|NCT02240667|11207123|FG000|STARTED|Overall Study||771
10079184|NCT02240667|11207124|FG001|STARTED|Overall Study||650
10079185|NCT02240667|11207123|FG000|COMPLETED|Overall Study||771
10079186|NCT02240667|11207124|FG001|COMPLETED|Overall Study||650
10079187|NCT02240667|11207123|FG000|NOT COMPLETED|Overall Study||0
10079188|NCT02240667|11207124|FG001|NOT COMPLETED|Overall Study||0
10079189|NCT02240680|11207132|FG000|STARTED|Overall Study (Up to 24 Weeks)||151
10079190|NCT02240680|11207133|FG001|STARTED|Overall Study (Up to 24 Weeks)||151
10079191|NCT02240680|11207134|FG002|STARTED|Overall Study (Up to 24 Weeks)||0
10079192|NCT02240680|11207135|FG003|STARTED|Overall Study (Up to 24 Weeks)||0
10079193|NCT02240680|11207132|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136
10079194|NCT02240680|11207133|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143
10079195|NCT02240680|11207134|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0
10079196|NCT02240680|11207135|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0
10079197|NCT02240680|11207132|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
10079198|NCT02240680|11207133|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
10079199|NCT02240680|11207134|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
10079200|NCT02240680|11207135|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
10079201|NCT02240680|11207132|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0
10079202|NCT02240680|11207133|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0
10079203|NCT02240680|11207134|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50
10079204|NCT02240680|11207135|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52
10079205|NCT02240680|11207132|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10079206|NCT02240680|11207133|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10079207|NCT02240680|11207134|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
10079208|NCT02240680|11207135|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
10079209|NCT02240680|11207132|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10079210|NCT02240680|11207133|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10079211|NCT02240680|11207134|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
10079212|NCT02240680|11207135|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
10079213|NCT02240693|11207148|FG000|STARTED|Overall Study||22
10079214|NCT02240693|11207149|FG001|STARTED|Overall Study||21
10079215|NCT02240693|11207150|FG002|STARTED|Overall Study||21
10079216|NCT02240693|11207151|FG003|STARTED|Overall Study||21
10079217|NCT02240693|11207152|FG004|STARTED|Overall Study||43
10079218|NCT02240693|11207148|FG000|COMPLETED|Overall Study||22
10079219|NCT02240693|11207149|FG001|COMPLETED|Overall Study||21
10079220|NCT02240693|11207150|FG002|COMPLETED|Overall Study||17
10079221|NCT02240693|11207151|FG003|COMPLETED|Overall Study||20
10079222|NCT02240693|11207152|FG004|COMPLETED|Overall Study||42
10079223|NCT02240693|11207148|FG000|NOT COMPLETED|Overall Study||0
10079224|NCT02240693|11207149|FG001|NOT COMPLETED|Overall Study||0
10079225|NCT02240693|11207150|FG002|NOT COMPLETED|Overall Study||4
10079226|NCT02240693|11207151|FG003|NOT COMPLETED|Overall Study||1
10079227|NCT02240693|11207152|FG004|NOT COMPLETED|Overall Study||1
10079228|NCT02240706|11207171|FG000|STARTED|Overall Study||3
10079229|NCT02240706|11207172|FG001|STARTED|Overall Study||3
10079230|NCT02240706|11207173|FG002|STARTED|Overall Study||6
10079231|NCT02240706|11207174|FG003|STARTED|Overall Study||4
10079232|NCT02240706|11207175|FG004|STARTED|Overall Study||11
10079233|NCT02240706|11207176|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
10079234|NCT02240706|11207177|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
10079235|NCT02240706|11207171|FG000|COMPLETED|Overall Study||0
10079236|NCT02240706|11207172|FG001|COMPLETED|Overall Study||0
10079237|NCT02240706|11207173|FG002|COMPLETED|Overall Study||0
10079238|NCT02240706|11207174|FG003|COMPLETED|Overall Study||0
10079239|NCT02240706|11207175|FG004|COMPLETED|Overall Study||0
10079240|NCT02240706|11207176|FG005|COMPLETED|Overall Study||0
10079241|NCT02240706|11207177|FG006|COMPLETED|Overall Study||0
10079242|NCT02240706|11207171|FG000|NOT COMPLETED|Overall Study||3
10079243|NCT02240706|11207172|FG001|NOT COMPLETED|Overall Study||3
10079244|NCT02240706|11207173|FG002|NOT COMPLETED|Overall Study||6
10079245|NCT02240706|11207174|FG003|NOT COMPLETED|Overall Study||4
10079246|NCT02240706|11207175|FG004|NOT COMPLETED|Overall Study||11
10079247|NCT02240706|11207176|FG005|NOT COMPLETED|Overall Study||0
10079248|NCT02240706|11207177|FG006|NOT COMPLETED|Overall Study||0
10079249|NCT02240810|11207194|FG000|STARTED|Overall Study||1501
10079250|NCT02240810|11207195|FG001|STARTED|Overall Study|correct typo|2681
10079251|NCT02240810|11207194|FG000|COMPLETED|Overall Study||1441
10079252|NCT02240810|11207195|FG001|COMPLETED|Overall Study||2621
10079253|NCT02240810|11207194|FG000|NOT COMPLETED|Overall Study||60
10079254|NCT02240810|11207195|FG001|NOT COMPLETED|Overall Study||60
10079255|NCT02241486|11207202|FG000|STARTED|Overall Study||2
10079256|NCT02241486|11207202|FG000|COMPLETED|Overall Study||2
10079257|NCT02241486|11207202|FG000|NOT COMPLETED|Overall Study||0
10079258|NCT02241512|11207208|FG000|STARTED|Overall Study||30
10079259|NCT02241512|11207209|FG001|STARTED|Overall Study||29
10079260|NCT02241512|11207208|FG000|COMPLETED|Overall Study||29
10079261|NCT02241512|11207209|FG001|COMPLETED|Overall Study||29
10079262|NCT02241512|11207208|FG000|NOT COMPLETED|Overall Study||1
10079263|NCT02241512|11207209|FG001|NOT COMPLETED|Overall Study||0
10079264|NCT02241655|11207217|FG000|STARTED|Overall Study||614
10079265|NCT02241655|11207218|FG001|STARTED|Overall Study||618
10079266|NCT02241655|11207217|FG000|COMPLETED|Overall Study||614
10079267|NCT02241655|11207218|FG001|COMPLETED|Overall Study||618
10079268|NCT02241655|11207217|FG000|NOT COMPLETED|Overall Study||0
10079269|NCT02241655|11207218|FG001|NOT COMPLETED|Overall Study||0
10079270|NCT02241720|11207229|FG000|STARTED|Overall Study||5
10079271|NCT02241720|11207229|FG000|COMPLETED|Overall Study||1
10079272|NCT02241720|11207229|FG000|NOT COMPLETED|Overall Study||4
10079273|NCT02241733|11207235|FG000|STARTED|Overall Study||40
10079274|NCT02241733|11207236|FG001|STARTED|Overall Study||40
10079275|NCT02241733|11207235|FG000|COMPLETED|Overall Study||25
10079276|NCT02241733|11207236|FG001|COMPLETED|Overall Study||30
10079277|NCT02241733|11207235|FG000|NOT COMPLETED|Overall Study||15
10079278|NCT02241733|11207236|FG001|NOT COMPLETED|Overall Study||10
10191752|NCT03307252|11320769|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10191753|NCT03307252|11320759|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
10191754|NCT03307252|11320760|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
10191755|NCT03307252|11320761|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
10191756|NCT03307252|11320762|FG003|STARTED|Part 1, Period 3||0
10191757|NCT03307252|11320763|FG004|STARTED|Part 1, Period 3||0
10191758|NCT03307252|11320764|FG005|STARTED|Part 1, Period 3||0
10191759|NCT03307252|11320765|FG006|STARTED|Part 1, Period 3||0
10191760|NCT03307252|11320766|FG007|STARTED|Part 1, Period 3||0
10191761|NCT03307252|11320767|FG008|STARTED|Part 1, Period 3||0
10191762|NCT03307252|11320768|FG009|STARTED|Part 1, Period 3||0
10191763|NCT03307252|11320769|FG010|STARTED|Part 1, Period 3||0
10191764|NCT03307252|11320759|FG000|COMPLETED|Part 1, Period 3||4
10191765|NCT03307252|11320760|FG001|COMPLETED|Part 1, Period 3||4
10191766|NCT03307252|11320761|FG002|COMPLETED|Part 1, Period 3||4
10191767|NCT03307252|11320762|FG003|COMPLETED|Part 1, Period 3||0
10191768|NCT03307252|11320763|FG004|COMPLETED|Part 1, Period 3||0
10191769|NCT03307252|11320764|FG005|COMPLETED|Part 1, Period 3||0
10191770|NCT03307252|11320765|FG006|COMPLETED|Part 1, Period 3||0
10191771|NCT03307252|11320766|FG007|COMPLETED|Part 1, Period 3||0
10191772|NCT03307252|11320767|FG008|COMPLETED|Part 1, Period 3||0
10191773|NCT03307252|11320768|FG009|COMPLETED|Part 1, Period 3||0
10191774|NCT03307252|11320769|FG010|COMPLETED|Part 1, Period 3||0
10191775|NCT03307252|11320759|FG000|NOT COMPLETED|Part 1, Period 3||0
10191776|NCT03307252|11320760|FG001|NOT COMPLETED|Part 1, Period 3||0
10191777|NCT03307252|11320761|FG002|NOT COMPLETED|Part 1, Period 3||0
10191778|NCT03307252|11320762|FG003|NOT COMPLETED|Part 1, Period 3||0
10191779|NCT03307252|11320763|FG004|NOT COMPLETED|Part 1, Period 3||0
10191780|NCT03307252|11320764|FG005|NOT COMPLETED|Part 1, Period 3||0
10191781|NCT03307252|11320765|FG006|NOT COMPLETED|Part 1, Period 3||0
10191782|NCT03307252|11320766|FG007|NOT COMPLETED|Part 1, Period 3||0
10191783|NCT03307252|11320767|FG008|NOT COMPLETED|Part 1, Period 3||0
10191784|NCT03307252|11320768|FG009|NOT COMPLETED|Part 1, Period 3||0
10191785|NCT03307252|11320769|FG010|NOT COMPLETED|Part 1, Period 3||0
10191786|NCT03307252|11320759|FG000|STARTED|Part 2, Period 1||0
10191787|NCT03307252|11320760|FG001|STARTED|Part 2, Period 1||0
10191788|NCT03307252|11320761|FG002|STARTED|Part 2, Period 1||0
10191789|NCT03307252|11320762|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
10191790|NCT03307252|11320763|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
10079279|NCT02241785|11207242|FG000|STARTED|Overall Study||47
10079280|NCT02241785|11207242|FG000|COMPLETED|Overall Study||0
10079281|NCT02241785|11207242|FG000|NOT COMPLETED|Overall Study||47
10079282|NCT02241889|11207246|FG000|STARTED|Overall Study||4
10079283|NCT02241889|11207247|FG001|STARTED|Overall Study||4
10079284|NCT02241889|11207248|FG002|STARTED|Overall Study||3
10079285|NCT02241889|11207249|FG003|STARTED|Overall Study||3
10079286|NCT02241889|11207250|FG004|STARTED|Overall Study||5
10079287|NCT02241889|11207251|FG005|STARTED|Overall Study||4
10079288|NCT02241889|11207246|FG000|COMPLETED|Overall Study||4
10079289|NCT02241889|11207247|FG001|COMPLETED|Overall Study||4
10079290|NCT02241889|11207248|FG002|COMPLETED|Overall Study||2
10079291|NCT02241889|11207249|FG003|COMPLETED|Overall Study||3
10079292|NCT02241889|11207250|FG004|COMPLETED|Overall Study||5
10079293|NCT02241889|11207251|FG005|COMPLETED|Overall Study||3
10079294|NCT02241889|11207246|FG000|NOT COMPLETED|Overall Study||0
10191791|NCT03307252|11320764|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
10191792|NCT03307252|11320765|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
10191793|NCT03307252|11320766|FG007|STARTED|Part 2, Period 1||0
10191794|NCT03307252|11320767|FG008|STARTED|Part 2, Period 1||0
10191795|NCT03307252|11320768|FG009|STARTED|Part 2, Period 1||0
10191796|NCT03307252|11320769|FG010|STARTED|Part 2, Period 1||0
10191797|NCT03307252|11320759|FG000|COMPLETED|Part 2, Period 1||0
10191798|NCT03307252|11320760|FG001|COMPLETED|Part 2, Period 1||0
10191799|NCT03307252|11320761|FG002|COMPLETED|Part 2, Period 1||0
10191800|NCT03307252|11320762|FG003|COMPLETED|Part 2, Period 1||4
10191801|NCT03307252|11320763|FG004|COMPLETED|Part 2, Period 1||4
10191802|NCT03307252|11320764|FG005|COMPLETED|Part 2, Period 1||3
10191803|NCT03307252|11320765|FG006|COMPLETED|Part 2, Period 1||5
10191804|NCT03307252|11320766|FG007|COMPLETED|Part 2, Period 1||0
10191805|NCT03307252|11320767|FG008|COMPLETED|Part 2, Period 1||0
10191806|NCT03307252|11320768|FG009|COMPLETED|Part 2, Period 1||0
10191807|NCT03307252|11320769|FG010|COMPLETED|Part 2, Period 1||0
10191808|NCT03307252|11320759|FG000|NOT COMPLETED|Part 2, Period 1||0
10191809|NCT03307252|11320760|FG001|NOT COMPLETED|Part 2, Period 1||0
10191810|NCT03307252|11320761|FG002|NOT COMPLETED|Part 2, Period 1||0
10191811|NCT03307252|11320762|FG003|NOT COMPLETED|Part 2, Period 1||0
10191812|NCT03307252|11320763|FG004|NOT COMPLETED|Part 2, Period 1||0
10191813|NCT03307252|11320764|FG005|NOT COMPLETED|Part 2, Period 1||1
10191814|NCT03307252|11320765|FG006|NOT COMPLETED|Part 2, Period 1||0
10191815|NCT03307252|11320766|FG007|NOT COMPLETED|Part 2, Period 1||0
10191816|NCT03307252|11320767|FG008|NOT COMPLETED|Part 2, Period 1||0
10191817|NCT03307252|11320768|FG009|NOT COMPLETED|Part 2, Period 1||0
10191818|NCT03307252|11320769|FG010|NOT COMPLETED|Part 2, Period 1||0
10191819|NCT03307252|11320759|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
10191820|NCT03307252|11320760|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
10191821|NCT03307252|11320761|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
10191822|NCT03307252|11320762|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4
10191823|NCT03307252|11320763|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4
10191824|NCT03307252|11320764|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3
10191825|NCT03307252|11320765|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5
10191826|NCT03307252|11320766|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0
10191827|NCT03307252|11320767|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0
10191828|NCT03307252|11320768|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0
10191829|NCT03307252|11320769|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0
10191830|NCT03307252|11320759|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191831|NCT03307252|11320760|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191832|NCT03307252|11320761|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191833|NCT03307252|11320762|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
10191834|NCT03307252|11320763|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
10191835|NCT03307252|11320764|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
10191836|NCT03307252|11320765|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
10191837|NCT03307252|11320766|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191838|NCT03307252|11320767|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191839|NCT03307252|11320768|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191840|NCT03307252|11320769|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191841|NCT03307252|11320759|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191842|NCT03307252|11320760|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191843|NCT03307252|11320761|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191844|NCT03307252|11320762|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191845|NCT03307252|11320763|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191846|NCT03307252|11320764|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191847|NCT03307252|11320765|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191848|NCT03307252|11320766|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191849|NCT03307252|11320767|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191850|NCT03307252|11320768|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191851|NCT03307252|11320769|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10191852|NCT03307252|11320759|FG000|STARTED|Part 2, Period 2||0
10191853|NCT03307252|11320760|FG001|STARTED|Part 2, Period 2||0
10191854|NCT03307252|11320761|FG002|STARTED|Part 2, Period 2||0
10191855|NCT03307252|11320762|FG003|STARTED|Part 2, Period 2||4
10191856|NCT03307252|11320763|FG004|STARTED|Part 2, Period 2||4
10191857|NCT03307252|11320764|FG005|STARTED|Part 2, Period 2||3
10191858|NCT03307252|11320765|FG006|STARTED|Part 2, Period 2||5
10191859|NCT03307252|11320766|FG007|STARTED|Part 2, Period 2||0
10079295|NCT02241889|11207247|FG001|NOT COMPLETED|Overall Study||0
10079296|NCT02241889|11207248|FG002|NOT COMPLETED|Overall Study||1
10079297|NCT02241889|11207249|FG003|NOT COMPLETED|Overall Study||0
10079298|NCT02241889|11207250|FG004|NOT COMPLETED|Overall Study||0
10079299|NCT02241889|11207251|FG005|NOT COMPLETED|Overall Study||1
10079300|NCT02241967|11207263|FG000|STARTED|Overall Study||30
10079301|NCT02241967|11207264|FG001|STARTED|Overall Study||30
10079302|NCT02241967|11207265|FG002|STARTED|Overall Study||30
10079303|NCT02241967|11207266|FG003|STARTED|Overall Study||29
10079304|NCT02241967|11207263|FG000|COMPLETED|Overall Study||30
10079305|NCT02241967|11207264|FG001|COMPLETED|Overall Study||30
10079306|NCT02241967|11207265|FG002|COMPLETED|Overall Study||30
10079307|NCT02241967|11207266|FG003|COMPLETED|Overall Study||29
10079308|NCT02241967|11207263|FG000|NOT COMPLETED|Overall Study||0
10079309|NCT02241967|11207264|FG001|NOT COMPLETED|Overall Study||0
10079310|NCT02241967|11207265|FG002|NOT COMPLETED|Overall Study||0
10079311|NCT02241967|11207266|FG003|NOT COMPLETED|Overall Study||0
10079312|NCT02242019|11207276|FG000|STARTED|Overall Study||109
10079313|NCT02242019|11207276|FG000|COMPLETED|Overall Study||109
10079314|NCT02242019|11207276|FG000|NOT COMPLETED|Overall Study||0
10079315|NCT02242045|11207280|FG000|STARTED|Overall Study||6
10079316|NCT02242045|11207280|FG000|COMPLETED|Overall Study||0
10079317|NCT02242045|11207280|FG000|NOT COMPLETED|Overall Study||6
10079318|NCT02242201|11207287|FG000|STARTED|Overall Study||55
10079319|NCT02242201|11207288|FG001|STARTED|Overall Study||55
10079320|NCT02242201|11207289|FG002|STARTED|Overall Study||55
10079321|NCT02242201|11207287|FG000|COMPLETED|Overall Study||51
10079322|NCT02242201|11207288|FG001|COMPLETED|Overall Study||54
10079323|NCT02242201|11207289|FG002|COMPLETED|Overall Study||54
10079324|NCT02242201|11207287|FG000|NOT COMPLETED|Overall Study||4
10079325|NCT02242201|11207288|FG001|NOT COMPLETED|Overall Study||1
10079326|NCT02242201|11207289|FG002|NOT COMPLETED|Overall Study||1
10079327|NCT02242305|11207299|FG000|STARTED|Overall Study||151
10079328|NCT02242305|11207300|FG001|STARTED|Overall Study||151
10079329|NCT02242305|11207299|FG000|COMPLETED|Overall Study||145
10079330|NCT02242305|11207300|FG001|COMPLETED|Overall Study||141
10079331|NCT02242305|11207299|FG000|NOT COMPLETED|Overall Study||6
10079332|NCT02242305|11207300|FG001|NOT COMPLETED|Overall Study||10
10079333|NCT02242487|11207308|FG000|STARTED|Overall Study||161
10079334|NCT02242487|11207309|FG001|STARTED|Overall Study||164
10079335|NCT02242487|11207308|FG000|COMPLETED|Overall Study||99
10079336|NCT02242487|11207309|FG001|COMPLETED|Overall Study||117
10079337|NCT02242487|11207308|FG000|NOT COMPLETED|Overall Study||62
10079338|NCT02242487|11207309|FG001|NOT COMPLETED|Overall Study||47
10079339|NCT02242630|11207321|FG000|STARTED|Overall Study||15
10079340|NCT02242630|11207322|FG001|STARTED|Overall Study||15
10079341|NCT02242630|11207323|FG002|STARTED|Overall Study||15
10079342|NCT02242630|11207324|FG003|STARTED|Overall Study||16
10079343|NCT02242630|11207321|FG000|COMPLETED|Overall Study||15
10079344|NCT02242630|11207322|FG001|COMPLETED|Overall Study||15
10079345|NCT02242630|11207323|FG002|COMPLETED|Overall Study||15
10079346|NCT02242630|11207324|FG003|COMPLETED|Overall Study||16
10079347|NCT02242630|11207321|FG000|NOT COMPLETED|Overall Study||0
10079348|NCT02242630|11207322|FG001|NOT COMPLETED|Overall Study||0
10079349|NCT02242630|11207323|FG002|NOT COMPLETED|Overall Study||0
10079350|NCT02242630|11207324|FG003|NOT COMPLETED|Overall Study||0
10079351|NCT02242643|11207336|FG000|STARTED|Overall Study||1207
10079352|NCT02242643|11207337|FG001|STARTED|Overall Study||1217
10079353|NCT02242643|11207336|FG000|COMPLETED|Overall Study||1132
10079354|NCT02242643|11207337|FG001|COMPLETED|Overall Study||1139
10079355|NCT02242643|11207336|FG000|NOT COMPLETED|Overall Study||75
10079356|NCT02242643|11207337|FG001|NOT COMPLETED|Overall Study||78
10079357|NCT02242903|11207352|FG000|STARTED|Overall Study||12
10079358|NCT02242903|11207353|FG001|STARTED|Overall Study||6
10079359|NCT02242903|11207354|FG002|STARTED|Overall Study||6
10079360|NCT02242903|11207355|FG003|STARTED|Overall Study||6
10079361|NCT02242903|11207356|FG004|STARTED|Overall Study||6
10079362|NCT02242903|11207357|FG005|STARTED|Overall Study||6
10079363|NCT02242903|11207358|FG006|STARTED|Overall Study||6
10079364|NCT02242903|11207352|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10079365|NCT02242903|11207353|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10079366|NCT02242903|11207354|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10079367|NCT02242903|11207355|FG003|Received at Least One Dose of Study Drug|Overall Study||6
10079368|NCT02242903|11207356|FG004|Received at Least One Dose of Study Drug|Overall Study||6
10079369|NCT02242903|11207357|FG005|Received at Least One Dose of Study Drug|Overall Study||6
10079370|NCT02242903|11207358|FG006|Received at Least One Dose of Study Drug|Overall Study||6
10079371|NCT02242903|11207352|FG000|COMPLETED|Overall Study||11
10079372|NCT02242903|11207353|FG001|COMPLETED|Overall Study||6
10079373|NCT02242903|11207354|FG002|COMPLETED|Overall Study||6
10079374|NCT02242903|11207355|FG003|COMPLETED|Overall Study||6
10079375|NCT02242903|11207356|FG004|COMPLETED|Overall Study||6
10079376|NCT02242903|11207357|FG005|COMPLETED|Overall Study||6
10079377|NCT02242903|11207358|FG006|COMPLETED|Overall Study||6
10079378|NCT02242903|11207352|FG000|NOT COMPLETED|Overall Study||1
10079379|NCT02242903|11207353|FG001|NOT COMPLETED|Overall Study||0
10079380|NCT02242903|11207354|FG002|NOT COMPLETED|Overall Study||0
10079381|NCT02242903|11207355|FG003|NOT COMPLETED|Overall Study||0
10079382|NCT02242903|11207356|FG004|NOT COMPLETED|Overall Study||0
10079383|NCT02242903|11207357|FG005|NOT COMPLETED|Overall Study||0
10079384|NCT02242903|11207358|FG006|NOT COMPLETED|Overall Study||0
10079385|NCT02242981|11207380|FG000|STARTED|Overall Study||6
10079386|NCT02242981|11207380|FG000|Received Study Drug|Overall Study||6
10079387|NCT02242981|11207380|FG000|COMPLETED|Overall Study||5
10079388|NCT02242981|11207380|FG000|NOT COMPLETED|Overall Study||1
10079389|NCT02242994|11207384|FG000|STARTED|Overall Study||5
10079390|NCT02242994|11207384|FG000|COMPLETED|Overall Study||5
10079391|NCT02242994|11207384|FG000|NOT COMPLETED|Overall Study||0
10079392|NCT02243007|11207390|FG000|STARTED|Overall Study||4
10079393|NCT02243007|11207391|FG001|STARTED|Overall Study||3
10079394|NCT02243007|11207390|FG000|COMPLETED|Overall Study||4
10079395|NCT02243007|11207391|FG001|COMPLETED|Overall Study||3
10079396|NCT02243007|11207390|FG000|NOT COMPLETED|Overall Study||0
10079397|NCT02243007|11207391|FG001|NOT COMPLETED|Overall Study||0
10079398|NCT02243046|11207400|FG000|STARTED|Overall Study||55
10079399|NCT02243046|11207401|FG001|STARTED|Overall Study||54
10079400|NCT02243046|11207402|FG002|STARTED|Overall Study||53
10079401|NCT02243046|11207400|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
10079402|NCT02243046|11207401|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
10079403|NCT02243046|11207402|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
10079404|NCT02243046|11207400|FG000|6 Month|Overall Study||54
10079405|NCT02243046|11207401|FG001|6 Month|Overall Study||53
10079406|NCT02243046|11207402|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
10079407|NCT02243046|11207400|FG000|COMPLETED|Overall Study||54
10079408|NCT02243046|11207401|FG001|COMPLETED|Overall Study||53
10079409|NCT02243046|11207402|FG002|COMPLETED|Overall Study||49
10079410|NCT02243046|11207400|FG000|NOT COMPLETED|Overall Study||1
10079411|NCT02243046|11207401|FG001|NOT COMPLETED|Overall Study||1
10079412|NCT02243046|11207402|FG002|NOT COMPLETED|Overall Study||4
10079413|NCT02243176|11207412|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
10079414|NCT02243176|11207413|FG001|STARTED|Overall Study||244
10079415|NCT02243176|11207412|FG000|COMPLETED|Overall Study||230
10079416|NCT02243176|11207413|FG001|COMPLETED|Overall Study||229
10079417|NCT02243176|11207412|FG000|NOT COMPLETED|Overall Study||14
10079418|NCT02243176|11207413|FG001|NOT COMPLETED|Overall Study||15
10079419|NCT02243202|11207423|FG000|STARTED|Overall Study||82
10079420|NCT02243202|11207424|FG001|STARTED|Overall Study||85
10079421|NCT02243202|11207425|FG002|STARTED|Overall Study||84
10079422|NCT02243202|11207426|FG003|STARTED|Overall Study||84
10079423|NCT02243202|11207423|FG000|Treated|Overall Study||82
10079424|NCT02243202|11207424|FG001|Treated|Overall Study||85
10079425|NCT02243202|11207425|FG002|Treated|Overall Study||84
10079426|NCT02243202|11207426|FG003|Treated|Overall Study||83
10079427|NCT02243202|11207423|FG000|COMPLETED|Overall Study||57
10079428|NCT02243202|11207424|FG001|COMPLETED|Overall Study||60
10079429|NCT02243202|11207425|FG002|COMPLETED|Overall Study||53
10079430|NCT02243202|11207426|FG003|COMPLETED|Overall Study||61
10079431|NCT02243202|11207423|FG000|NOT COMPLETED|Overall Study||25
10079432|NCT02243202|11207424|FG001|NOT COMPLETED|Overall Study||25
10079433|NCT02243202|11207425|FG002|NOT COMPLETED|Overall Study||31
10079434|NCT02243202|11207426|FG003|NOT COMPLETED|Overall Study||23
10079435|NCT02243280|11207447|FG000|STARTED|Enrolled||40
10079436|NCT02243280|11207448|FG001|STARTED|Enrolled||39
10079437|NCT02243280|11207449|FG002|STARTED|Enrolled||0
10079438|NCT02243280|11207450|FG003|STARTED|Enrolled||0
10079439|NCT02243280|11207451|FG004|STARTED|Enrolled||0
10079440|NCT02243280|11207452|FG005|STARTED|Enrolled||27
10079441|NCT02243280|11207453|FG006|STARTED|Enrolled||0
10079442|NCT02243280|11207454|FG007|STARTED|Enrolled||0
10079443|NCT02243280|11207455|FG008|STARTED|Enrolled||34
10079444|NCT02243280|11207456|FG009|STARTED|Enrolled||0
10079445|NCT02243280|11207457|FG010|STARTED|Enrolled||34
10079446|NCT02243280|11207447|FG000|COMPLETED|Enrolled||40
10079447|NCT02243280|11207448|FG001|COMPLETED|Enrolled||39
10079448|NCT02243280|11207449|FG002|COMPLETED|Enrolled||0
10079449|NCT02243280|11207450|FG003|COMPLETED|Enrolled||0
10079450|NCT02243280|11207451|FG004|COMPLETED|Enrolled||0
10079451|NCT02243280|11207452|FG005|COMPLETED|Enrolled||27
10079452|NCT02243280|11207453|FG006|COMPLETED|Enrolled||0
10079453|NCT02243280|11207454|FG007|COMPLETED|Enrolled||0
10079454|NCT02243280|11207455|FG008|COMPLETED|Enrolled||34
10079455|NCT02243280|11207456|FG009|COMPLETED|Enrolled||0
10079456|NCT02243280|11207457|FG010|COMPLETED|Enrolled||34
10079457|NCT02243280|11207447|FG000|NOT COMPLETED|Enrolled||0
10079458|NCT02243280|11207448|FG001|NOT COMPLETED|Enrolled||0
10079459|NCT02243280|11207449|FG002|NOT COMPLETED|Enrolled||0
10079460|NCT02243280|11207450|FG003|NOT COMPLETED|Enrolled||0
10079461|NCT02243280|11207451|FG004|NOT COMPLETED|Enrolled||0
10079462|NCT02243280|11207452|FG005|NOT COMPLETED|Enrolled||0
10079463|NCT02243280|11207453|FG006|NOT COMPLETED|Enrolled||0
10079464|NCT02243280|11207454|FG007|NOT COMPLETED|Enrolled||0
10079465|NCT02243280|11207455|FG008|NOT COMPLETED|Enrolled||0
10079466|NCT02243280|11207456|FG009|NOT COMPLETED|Enrolled||0
10079467|NCT02243280|11207457|FG010|NOT COMPLETED|Enrolled||0
10079468|NCT02243280|11207447|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
10079469|NCT02243280|11207448|FG001|STARTED|Treated||39
10079470|NCT02243280|11207449|FG002|STARTED|Treated||0
10079471|NCT02243280|11207450|FG003|STARTED|Treated||0
10079472|NCT02243280|11207451|FG004|STARTED|Treated||0
10079473|NCT02243280|11207452|FG005|STARTED|Treated||27
10079474|NCT02243280|11207453|FG006|STARTED|Treated||0
10079475|NCT02243280|11207454|FG007|STARTED|Treated||0
10079476|NCT02243280|11207455|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
10079477|NCT02243280|11207456|FG009|STARTED|Treated||0
10079478|NCT02243280|11207457|FG010|STARTED|Treated||34
10079479|NCT02243280|11207447|FG000|Completed Treatment|Treated||42
10079480|NCT02243280|11207448|FG001|Completed Treatment|Treated||38
10079481|NCT02243280|11207449|FG002|Completed Treatment|Treated||0
10079482|NCT02243280|11207450|FG003|Completed Treatment|Treated||0
10079483|NCT02243280|11207451|FG004|Completed Treatment|Treated||0
10079484|NCT02243280|11207452|FG005|Completed Treatment|Treated||27
10079485|NCT02243280|11207453|FG006|Completed Treatment|Treated||0
10079486|NCT02243280|11207454|FG007|Completed Treatment|Treated||0
10079487|NCT02243280|11207455|FG008|Completed Treatment|Treated||32
10079488|NCT02243280|11207456|FG009|Completed Treatment|Treated||0
10079489|NCT02243280|11207457|FG010|Completed Treatment|Treated||33
10079490|NCT02243280|11207447|FG000|COMPLETED|Treated||41
10079491|NCT02243280|11207448|FG001|COMPLETED|Treated||39
10079492|NCT02243280|11207449|FG002|COMPLETED|Treated||0
10079493|NCT02243280|11207450|FG003|COMPLETED|Treated||0
10079494|NCT02243280|11207451|FG004|COMPLETED|Treated||0
10079495|NCT02243280|11207452|FG005|COMPLETED|Treated||27
10079496|NCT02243280|11207453|FG006|COMPLETED|Treated||0
10079497|NCT02243280|11207454|FG007|COMPLETED|Treated||0
10079498|NCT02243280|11207455|FG008|COMPLETED|Treated||31
10079499|NCT02243280|11207456|FG009|COMPLETED|Treated||0
10079500|NCT02243280|11207457|FG010|COMPLETED|Treated||31
10079501|NCT02243280|11207447|FG000|NOT COMPLETED|Treated||1
10079502|NCT02243280|11207448|FG001|NOT COMPLETED|Treated||0
10079503|NCT02243280|11207449|FG002|NOT COMPLETED|Treated||0
10079504|NCT02243280|11207450|FG003|NOT COMPLETED|Treated||0
10079505|NCT02243280|11207451|FG004|NOT COMPLETED|Treated||0
10079506|NCT02243280|11207452|FG005|NOT COMPLETED|Treated||0
10079507|NCT02243280|11207453|FG006|NOT COMPLETED|Treated||0
10079508|NCT02243280|11207454|FG007|NOT COMPLETED|Treated||0
10079509|NCT02243280|11207455|FG008|NOT COMPLETED|Treated||1
10079510|NCT02243280|11207456|FG009|NOT COMPLETED|Treated||0
10079511|NCT02243280|11207457|FG010|NOT COMPLETED|Treated||3
10079512|NCT02243293|11207492|FG000|STARTED|Overall Study||25
10079513|NCT02243293|11207493|FG001|STARTED|Overall Study||24
10079514|NCT02243293|11207494|FG002|STARTED|Overall Study||25
10079515|NCT02243293|11207495|FG003|STARTED|Overall Study||30
10079516|NCT02243293|11207496|FG004|STARTED|Overall Study||31
10079517|NCT02243293|11207497|FG005|STARTED|Overall Study||31
10079518|NCT02243293|11207498|FG006|STARTED|Overall Study||30
10079519|NCT02243293|11207499|FG007|STARTED|Overall Study||0
10079520|NCT02243293|11207500|FG008|STARTED|Overall Study||0
10079521|NCT02243293|11207501|FG009|STARTED|Overall Study||55
10079522|NCT02243293|11207502|FG010|STARTED|Overall Study||0
10079523|NCT02243293|11207503|FG011|STARTED|Overall Study||53
10079524|NCT02243293|11207504|FG012|STARTED|Overall Study||0
10079525|NCT02243293|11207505|FG013|STARTED|Overall Study||0
10079526|NCT02243293|11207506|FG014|STARTED|Overall Study||28
10079527|NCT02243293|11207507|FG015|STARTED|Overall Study||27
10079528|NCT02243293|11207508|FG016|STARTED|Overall Study||40
10079529|NCT02243293|11207509|FG017|STARTED|Overall Study||22
10079530|NCT02243293|11207510|FG018|STARTED|Overall Study||22
10079531|NCT02243293|11207511|FG019|STARTED|Overall Study||48
10079532|NCT02243293|11207512|FG020|STARTED|Overall Study||145
10079533|NCT02243293|11207513|FG021|STARTED|Overall Study||58
10079534|NCT02243293|11207492|FG000|COMPLETED|Overall Study||23
10079535|NCT02243293|11207493|FG001|COMPLETED|Overall Study||23
10079536|NCT02243293|11207494|FG002|COMPLETED|Overall Study||24
10079537|NCT02243293|11207495|FG003|COMPLETED|Overall Study||29
10079538|NCT02243293|11207496|FG004|COMPLETED|Overall Study||30
10079539|NCT02243293|11207497|FG005|COMPLETED|Overall Study||31
10079540|NCT02243293|11207498|FG006|COMPLETED|Overall Study||27
10079541|NCT02243293|11207499|FG007|COMPLETED|Overall Study||0
10079542|NCT02243293|11207500|FG008|COMPLETED|Overall Study||0
10079543|NCT02243293|11207501|FG009|COMPLETED|Overall Study||53
9966089|NCT01505673|11086290|FG001|STARTED|Overall Study||36
10079544|NCT02243293|11207502|FG010|COMPLETED|Overall Study||0
10079545|NCT02243293|11207503|FG011|COMPLETED|Overall Study||50
10079546|NCT02243293|11207504|FG012|COMPLETED|Overall Study||0
10079547|NCT02243293|11207505|FG013|COMPLETED|Overall Study||0
10079548|NCT02243293|11207506|FG014|COMPLETED|Overall Study||27
10079549|NCT02243293|11207507|FG015|COMPLETED|Overall Study||26
9966090|NCT01505673|11086289|FG000|COMPLETED|Overall Study||32
9966091|NCT01505673|11086290|FG001|COMPLETED|Overall Study||34
9966092|NCT01505673|11086289|FG000|NOT COMPLETED|Overall Study||3
9966093|NCT01505673|11086290|FG001|NOT COMPLETED|Overall Study||2
9966094|NCT01505764|11086298|FG000|STARTED|Overall Study||6
9966095|NCT01505764|11086299|FG001|STARTED|Overall Study||3
9966096|NCT01505764|11086298|FG000|COMPLETED|Overall Study||3
9966097|NCT01505764|11086299|FG001|COMPLETED|Overall Study||2
10079550|NCT02243293|11207508|FG016|COMPLETED|Overall Study||37
10079551|NCT02243293|11207509|FG017|COMPLETED|Overall Study||21
10079552|NCT02243293|11207510|FG018|COMPLETED|Overall Study||22
10079553|NCT02243293|11207511|FG019|COMPLETED|Overall Study||47
10079554|NCT02243293|11207512|FG020|COMPLETED|Overall Study||143
10079555|NCT02243293|11207513|FG021|COMPLETED|Overall Study||55
10079556|NCT02243293|11207492|FG000|NOT COMPLETED|Overall Study||2
10079557|NCT02243293|11207493|FG001|NOT COMPLETED|Overall Study||1
10079558|NCT02243293|11207494|FG002|NOT COMPLETED|Overall Study||1
10079559|NCT02243293|11207495|FG003|NOT COMPLETED|Overall Study||1
10079560|NCT02243293|11207496|FG004|NOT COMPLETED|Overall Study||1
10079561|NCT02243293|11207497|FG005|NOT COMPLETED|Overall Study||0
10079562|NCT02243293|11207498|FG006|NOT COMPLETED|Overall Study||3
10079563|NCT02243293|11207499|FG007|NOT COMPLETED|Overall Study||0
10079564|NCT02243293|11207500|FG008|NOT COMPLETED|Overall Study||0
10079565|NCT02243293|11207501|FG009|NOT COMPLETED|Overall Study||2
10079566|NCT02243293|11207502|FG010|NOT COMPLETED|Overall Study||0
10079567|NCT02243293|11207503|FG011|NOT COMPLETED|Overall Study||3
10079568|NCT02243293|11207504|FG012|NOT COMPLETED|Overall Study||0
10079569|NCT02243293|11207505|FG013|NOT COMPLETED|Overall Study||0
10079570|NCT02243293|11207506|FG014|NOT COMPLETED|Overall Study||1
10079571|NCT02243293|11207507|FG015|NOT COMPLETED|Overall Study||1
10079572|NCT02243293|11207508|FG016|NOT COMPLETED|Overall Study||3
10079573|NCT02243293|11207509|FG017|NOT COMPLETED|Overall Study||1
10079574|NCT02243293|11207510|FG018|NOT COMPLETED|Overall Study||0
10079575|NCT02243293|11207511|FG019|NOT COMPLETED|Overall Study||1
10079576|NCT02243293|11207512|FG020|NOT COMPLETED|Overall Study||2
10079577|NCT02243293|11207513|FG021|NOT COMPLETED|Overall Study||3
10079578|NCT02243371|11207552|FG000|STARTED|Overall Study||51
10079579|NCT02243371|11207553|FG001|STARTED|Overall Study||42
10079580|NCT02243371|11207552|FG000|COMPLETED|Overall Study||14
10079581|NCT02243371|11207553|FG001|COMPLETED|Overall Study||10
10079582|NCT02243371|11207552|FG000|NOT COMPLETED|Overall Study||37
10079583|NCT02243371|11207553|FG001|NOT COMPLETED|Overall Study||32
10079584|NCT02243527|11207561|FG000|STARTED|Overall Study||12
10079585|NCT02243527|11207562|FG001|STARTED|Overall Study||13
10079586|NCT02243527|11207561|FG000|COMPLETED|Overall Study||12
10079587|NCT02243527|11207562|FG001|COMPLETED|Overall Study||13
10079588|NCT02243527|11207561|FG000|NOT COMPLETED|Overall Study||0
10079589|NCT02243527|11207562|FG001|NOT COMPLETED|Overall Study||0
10079590|NCT02243579|11207568|FG000|STARTED|Overall Study||24
10079591|NCT02243579|11207568|FG000|COMPLETED|Overall Study||4
10079592|NCT02243579|11207568|FG000|NOT COMPLETED|Overall Study||20
10079593|NCT02243696|11207572|FG000|STARTED|Overall Study||1694
10079594|NCT02243696|11207572|FG000|COMPLETED|Overall Study||0
10079595|NCT02243696|11207572|FG000|NOT COMPLETED|Overall Study||1694
10079596|NCT02243865|11207578|FG000|STARTED|Overall Study||44
10079597|NCT02243865|11207579|FG001|STARTED|Overall Study||43
10079598|NCT02243865|11207578|FG000|COMPLETED|Overall Study||40
10079599|NCT02243865|11207579|FG001|COMPLETED|Overall Study||38
10079600|NCT02243865|11207578|FG000|NOT COMPLETED|Overall Study||4
10079601|NCT02243865|11207579|FG001|NOT COMPLETED|Overall Study||5
10079602|NCT02243943|11207589|FG000|STARTED|Overall Study||50
10079603|NCT02243943|11207590|FG001|STARTED|Overall Study||50
10079604|NCT02243943|11207589|FG000|COMPLETED|Overall Study||50
10079605|NCT02243943|11207590|FG001|COMPLETED|Overall Study||50
10191860|NCT03307252|11320767|FG008|STARTED|Part 2, Period 2||0
10191861|NCT03307252|11320768|FG009|STARTED|Part 2, Period 2||0
10191862|NCT03307252|11320769|FG010|STARTED|Part 2, Period 2||0
10191863|NCT03307252|11320759|FG000|COMPLETED|Part 2, Period 2||0
10191864|NCT03307252|11320760|FG001|COMPLETED|Part 2, Period 2||0
10191865|NCT03307252|11320761|FG002|COMPLETED|Part 2, Period 2||0
10191866|NCT03307252|11320762|FG003|COMPLETED|Part 2, Period 2||4
10191867|NCT03307252|11320763|FG004|COMPLETED|Part 2, Period 2||4
10191868|NCT03307252|11320764|FG005|COMPLETED|Part 2, Period 2||3
10191869|NCT03307252|11320765|FG006|COMPLETED|Part 2, Period 2||5
10191870|NCT03307252|11320766|FG007|COMPLETED|Part 2, Period 2||0
10191871|NCT03307252|11320767|FG008|COMPLETED|Part 2, Period 2||0
10191872|NCT03307252|11320768|FG009|COMPLETED|Part 2, Period 2||0
10191873|NCT03307252|11320769|FG010|COMPLETED|Part 2, Period 2||0
10191874|NCT03307252|11320759|FG000|NOT COMPLETED|Part 2, Period 2||0
10191875|NCT03307252|11320760|FG001|NOT COMPLETED|Part 2, Period 2||0
10191876|NCT03307252|11320761|FG002|NOT COMPLETED|Part 2, Period 2||0
10191877|NCT03307252|11320762|FG003|NOT COMPLETED|Part 2, Period 2||0
10191878|NCT03307252|11320763|FG004|NOT COMPLETED|Part 2, Period 2||0
10191879|NCT03307252|11320764|FG005|NOT COMPLETED|Part 2, Period 2||0
10191880|NCT03307252|11320765|FG006|NOT COMPLETED|Part 2, Period 2||0
10191881|NCT03307252|11320766|FG007|NOT COMPLETED|Part 2, Period 2||0
10191882|NCT03307252|11320767|FG008|NOT COMPLETED|Part 2, Period 2||0
10191883|NCT03307252|11320768|FG009|NOT COMPLETED|Part 2, Period 2||0
10191884|NCT03307252|11320769|FG010|NOT COMPLETED|Part 2, Period 2||0
10191885|NCT03307252|11320759|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0
10191886|NCT03307252|11320760|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0
10191887|NCT03307252|11320761|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0
10191888|NCT03307252|11320762|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4
10079606|NCT02243943|11207589|FG000|NOT COMPLETED|Overall Study||0
10079607|NCT02243943|11207590|FG001|NOT COMPLETED|Overall Study||0
10079608|NCT02244424|11207598|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
10079609|NCT02244424|11207599|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
10191889|NCT03307252|11320763|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4
10191890|NCT03307252|11320764|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3
10191891|NCT03307252|11320765|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5
10191892|NCT03307252|11320766|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0
10191893|NCT03307252|11320767|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0
10191894|NCT03307252|11320768|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0
10191895|NCT03307252|11320769|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0
10191896|NCT03307252|11320759|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191897|NCT03307252|11320760|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191898|NCT03307252|11320761|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191899|NCT03307252|11320762|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
10191900|NCT03307252|11320763|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
10079610|NCT02244424|11207598|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
10079611|NCT02244424|11207599|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
10079612|NCT02244424|11207598|FG000|Mothers|Overall Study||51
10079613|NCT02244424|11207599|FG001|Mothers|Overall Study||31
10079614|NCT02244424|11207598|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
10079615|NCT02244424|11207599|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
10079616|NCT02244424|11207598|FG000|NOT COMPLETED|Overall Study||20
10079617|NCT02244424|11207599|FG001|NOT COMPLETED|Overall Study||10
10079618|NCT02244580|11207605|FG000|STARTED|Overall Study||1010
10079619|NCT02244580|11207605|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
10079620|NCT02244580|11207605|FG000|NOT COMPLETED|Overall Study||241
10079621|NCT02244619|11207615|FG000|STARTED|Overall Study||249
10079622|NCT02244619|11207616|FG001|STARTED|Overall Study||266
10079623|NCT02244619|11207615|FG000|COMPLETED|Overall Study||241
10079624|NCT02244619|11207616|FG001|COMPLETED|Overall Study||245
10079625|NCT02244619|11207615|FG000|NOT COMPLETED|Overall Study||8
10079626|NCT02244619|11207616|FG001|NOT COMPLETED|Overall Study||21
10079627|NCT02244840|11207622|FG000|STARTED|Overall Study||40
10079628|NCT02244840|11207622|FG000|COMPLETED|Overall Study||40
10079629|NCT02244840|11207622|FG000|NOT COMPLETED|Overall Study||0
10079630|NCT02244918|11207628|FG000|STARTED|Overall Study||185
10079631|NCT02244918|11207629|FG001|STARTED|Overall Study||93
10079632|NCT02244918|11207628|FG000|Week 12|Overall Study||160
10079633|NCT02244918|11207629|FG001|Week 12|Overall Study||83
10079634|NCT02244918|11207628|FG000|COMPLETED|Overall Study||185
10079635|NCT02244918|11207629|FG001|COMPLETED|Overall Study||93
10079636|NCT02244918|11207628|FG000|NOT COMPLETED|Overall Study||0
10079637|NCT02244918|11207629|FG001|NOT COMPLETED|Overall Study||0
10079638|NCT02244957|11207638|FG000|STARTED|Overall Study||7
10079639|NCT02244957|11207639|FG001|STARTED|Overall Study||16
10079640|NCT02244957|11207638|FG000|COMPLETED|Overall Study||6
10079641|NCT02244957|11207639|FG001|COMPLETED|Overall Study||16
10079642|NCT02244957|11207638|FG000|NOT COMPLETED|Overall Study||1
10079643|NCT02244957|11207639|FG001|NOT COMPLETED|Overall Study||0
10079644|NCT02244996|11207649|FG000|STARTED|Overall Study||25
10079645|NCT02244996|11207650|FG001|STARTED|Overall Study||25
10079646|NCT02244996|11207649|FG000|COMPLETED|Overall Study||23
10079647|NCT02244996|11207650|FG001|COMPLETED|Overall Study||19
10079648|NCT02244996|11207649|FG000|NOT COMPLETED|Overall Study||2
10079649|NCT02244996|11207650|FG001|NOT COMPLETED|Overall Study||6
10079650|NCT02245217|11207656|FG000|STARTED|Overall Study||9
10079651|NCT02245217|11207656|FG000|COMPLETED|Overall Study||7
10079652|NCT02245217|11207656|FG000|NOT COMPLETED|Overall Study||2
10079653|NCT02245360|11207662|FG000|STARTED|Overall Study||53
10079654|NCT02245360|11207663|FG001|STARTED|Overall Study||54
10079655|NCT02245360|11207662|FG000|COMPLETED|Overall Study||48
10079656|NCT02245360|11207663|FG001|COMPLETED|Overall Study||52
10079657|NCT02245360|11207662|FG000|NOT COMPLETED|Overall Study||5
10079658|NCT02245360|11207663|FG001|NOT COMPLETED|Overall Study||2
10079659|NCT02245412|11207672|FG000|STARTED|Treatment Period||17
10079660|NCT02245412|11207673|FG001|STARTED|Treatment Period||6
10079661|NCT02245412|11207674|FG002|STARTED|Treatment Period||2
10079662|NCT02245412|11207672|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17
10079663|NCT02245412|11207673|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
10079664|NCT02245412|11207674|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2
10079665|NCT02245412|11207672|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16
10079666|NCT02245412|11207673|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6
10079667|NCT02245412|11207674|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2
10079668|NCT02245412|11207672|FG000|COMPLETED|Treatment Period||12
10079669|NCT02245412|11207673|FG001|COMPLETED|Treatment Period||3
10079670|NCT02245412|11207674|FG002|COMPLETED|Treatment Period||2
10079671|NCT02245412|11207672|FG000|NOT COMPLETED|Treatment Period||5
10079672|NCT02245412|11207673|FG001|NOT COMPLETED|Treatment Period||3
10079673|NCT02245412|11207674|FG002|NOT COMPLETED|Treatment Period||0
10079674|NCT02245412|11207672|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
10079675|NCT02245412|11207673|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
10079676|NCT02245412|11207674|FG002|STARTED|Follow-Up Period||2
10079677|NCT02245412|11207672|FG000|COMPLETED|Follow-Up Period||8
10079678|NCT02245412|11207673|FG001|COMPLETED|Follow-Up Period||2
10079679|NCT02245412|11207674|FG002|COMPLETED|Follow-Up Period||0
10079680|NCT02245412|11207672|FG000|NOT COMPLETED|Follow-Up Period||5
10079681|NCT02245412|11207673|FG001|NOT COMPLETED|Follow-Up Period||2
10079682|NCT02245412|11207674|FG002|NOT COMPLETED|Follow-Up Period||2
10079683|NCT02245516|11207684|FG000|STARTED|Overall Study||9
10079684|NCT02245516|11207685|FG001|STARTED|Overall Study||7
10079685|NCT02245516|11207684|FG000|COMPLETED|Overall Study||9
10079686|NCT02245516|11207685|FG001|COMPLETED|Overall Study||4
10079687|NCT02245516|11207684|FG000|NOT COMPLETED|Overall Study||0
10079688|NCT02245516|11207685|FG001|NOT COMPLETED|Overall Study||3
10079689|NCT02245568|11207691|FG000|STARTED|Overall Study||913
10079690|NCT02245568|11207691|FG000|COMPLETED|Overall Study||60
10079691|NCT02245568|11207691|FG000|NOT COMPLETED|Overall Study||853
10079692|NCT02245620|11207697|FG000|STARTED|Overall Study||20
10079693|NCT02245620|11207698|FG001|STARTED|Overall Study||21
10079694|NCT02245620|11207697|FG000|COMPLETED|Overall Study||19
10079695|NCT02245620|11207698|FG001|COMPLETED|Overall Study||20
10079696|NCT02245620|11207697|FG000|NOT COMPLETED|Overall Study||1
10079697|NCT02245620|11207698|FG001|NOT COMPLETED|Overall Study||1
10079698|NCT02245737|11207707|FG000|STARTED|Overall Study||740
10079699|NCT02245737|11207708|FG001|STARTED|Overall Study||739
10079700|NCT02245737|11207709|FG002|STARTED|Overall Study||739
10079701|NCT02245737|11207707|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738
10079702|NCT02245737|11207708|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736
10079703|NCT02245737|11207709|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735
10079704|NCT02245737|11207707|FG000|COMPLETED|Overall Study||187
10079705|NCT02245737|11207708|FG001|COMPLETED|Overall Study||184
10079706|NCT02245737|11207709|FG002|COMPLETED|Overall Study||168
10079707|NCT02245737|11207707|FG000|NOT COMPLETED|Overall Study||553
10079708|NCT02245737|11207708|FG001|NOT COMPLETED|Overall Study||555
10079709|NCT02245737|11207709|FG002|NOT COMPLETED|Overall Study||571
10079710|NCT02245815|11207721|FG000|STARTED|Overall Study||45
10079711|NCT02245815|11207722|FG001|STARTED|Overall Study||45
10079712|NCT02245815|11207721|FG000|COMPLETED|Overall Study||45
10079713|NCT02245815|11207722|FG001|COMPLETED|Overall Study||45
10079714|NCT02245815|11207721|FG000|NOT COMPLETED|Overall Study||0
10079715|NCT02245815|11207722|FG001|NOT COMPLETED|Overall Study||0
10079716|NCT02246010|11207732|FG000|STARTED|Overall Study||4
10079717|NCT02246010|11207733|FG001|STARTED|Overall Study||2
10079718|NCT02246010|11207732|FG000|COMPLETED|Overall Study||4
10079719|NCT02246010|11207733|FG001|COMPLETED|Overall Study||2
10079720|NCT02246010|11207732|FG000|NOT COMPLETED|Overall Study||0
10079721|NCT02246010|11207733|FG001|NOT COMPLETED|Overall Study||0
10079722|NCT02246062|11207743|FG000|STARTED|Overall Study||21
10079723|NCT02246062|11207744|FG001|STARTED|Overall Study||21
10079724|NCT02246062|11207745|FG002|STARTED|Overall Study||21
10079725|NCT02246062|11207746|FG003|STARTED|Overall Study||21
10079726|NCT02246062|11207743|FG000|COMPLETED|Overall Study||21
10079727|NCT02246062|11207744|FG001|COMPLETED|Overall Study||21
10079728|NCT02246062|11207745|FG002|COMPLETED|Overall Study||21
10079729|NCT02246062|11207746|FG003|COMPLETED|Overall Study||21
10079730|NCT02246062|11207743|FG000|NOT COMPLETED|Overall Study||0
10079731|NCT02246062|11207744|FG001|NOT COMPLETED|Overall Study||0
10079732|NCT02246062|11207745|FG002|NOT COMPLETED|Overall Study||0
10079733|NCT02246062|11207746|FG003|NOT COMPLETED|Overall Study||0
10079734|NCT02246166|11207758|FG000|STARTED|Overall Study||26
10079735|NCT02246166|11207759|FG001|STARTED|Overall Study||27
10079736|NCT02246166|11207758|FG000|COMPLETED|Overall Study||25
10079737|NCT02246166|11207759|FG001|COMPLETED|Overall Study||27
10079738|NCT02246166|11207758|FG000|NOT COMPLETED|Overall Study||1
10079739|NCT02246166|11207759|FG001|NOT COMPLETED|Overall Study||0
10079740|NCT02246218|11207767|FG000|STARTED|Overall Study||10
10079741|NCT02246218|11207768|FG001|STARTED|Overall Study||16
10079742|NCT02246218|11207767|FG000|COMPLETED|Overall Study||6
10079743|NCT02246218|11207768|FG001|COMPLETED|Overall Study||10
10079744|NCT02246218|11207767|FG000|NOT COMPLETED|Overall Study||4
10079745|NCT02246218|11207768|FG001|NOT COMPLETED|Overall Study||6
10079746|NCT02246309|11207776|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
10079747|NCT02246309|11207777|FG001|STARTED|Overall Study||15
10079748|NCT02246309|11207776|FG000|COMPLETED|Overall Study||16
10079749|NCT02246309|11207777|FG001|COMPLETED|Overall Study||15
10079750|NCT02246309|11207776|FG000|NOT COMPLETED|Overall Study||0
10079751|NCT02246309|11207777|FG001|NOT COMPLETED|Overall Study||0
10079752|NCT02246413|11207785|FG000|STARTED|12-months (Primary Outcome)||204
10079753|NCT02246413|11207786|FG001|STARTED|12-months (Primary Outcome)||205
10079754|NCT02246413|11207785|FG000|COMPLETED|12-months (Primary Outcome)||169
10079755|NCT02246413|11207786|FG001|COMPLETED|12-months (Primary Outcome)||175
10079756|NCT02246413|11207785|FG000|NOT COMPLETED|12-months (Primary Outcome)||35
10079757|NCT02246413|11207786|FG001|NOT COMPLETED|12-months (Primary Outcome)||30
10079758|NCT02246413|11207785|FG000|STARTED|24-months (Secondary Outcome)||204
10079759|NCT02246413|11207786|FG001|STARTED|24-months (Secondary Outcome)||205
10079760|NCT02246413|11207785|FG000|COMPLETED|24-months (Secondary Outcome)||153
10079761|NCT02246413|11207786|FG001|COMPLETED|24-months (Secondary Outcome)||173
10079762|NCT02246413|11207785|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51
10079763|NCT02246413|11207786|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32
10079764|NCT02246439|11207794|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
10079765|NCT02246439|11207795|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
10079766|NCT02246439|11207794|FG000|Randomized|Overall Study||198
10079767|NCT02246439|11207795|FG001|Randomized|Overall Study||132
10079768|NCT02246439|11207794|FG000|COMPLETED|Overall Study||180
10079769|NCT02246439|11207795|FG001|COMPLETED|Overall Study||118
10079770|NCT02246439|11207794|FG000|NOT COMPLETED|Overall Study||12
10079771|NCT02246439|11207795|FG001|NOT COMPLETED|Overall Study||11
10079772|NCT02246478|11207805|FG000|STARTED|Single-dose Phase||6
10079773|NCT02246478|11207806|FG001|STARTED|Single-dose Phase||5
10079774|NCT02246478|11207807|FG002|STARTED|Single-dose Phase||5
10079775|NCT02246478|11207808|FG003|STARTED|Single-dose Phase||5
10079776|NCT02246478|11207805|FG000|COMPLETED|Single-dose Phase||6
10079777|NCT02246478|11207806|FG001|COMPLETED|Single-dose Phase||5
10079778|NCT02246478|11207807|FG002|COMPLETED|Single-dose Phase||5
10079779|NCT02246478|11207808|FG003|COMPLETED|Single-dose Phase||5
10079780|NCT02246478|11207805|FG000|NOT COMPLETED|Single-dose Phase||0
10079781|NCT02246478|11207806|FG001|NOT COMPLETED|Single-dose Phase||0
10079782|NCT02246478|11207807|FG002|NOT COMPLETED|Single-dose Phase||0
10079783|NCT02246478|11207808|FG003|NOT COMPLETED|Single-dose Phase||0
10079784|NCT02246478|11207805|FG000|STARTED|Multiple-dose Phase||6
10079785|NCT02246478|11207806|FG001|STARTED|Multiple-dose Phase||5
10079786|NCT02246478|11207807|FG002|STARTED|Multiple-dose Phase||5
10079787|NCT02246478|11207808|FG003|STARTED|Multiple-dose Phase||5
10079788|NCT02246478|11207805|FG000|COMPLETED|Multiple-dose Phase||5
10079789|NCT02246478|11207806|FG001|COMPLETED|Multiple-dose Phase||5
10079790|NCT02246478|11207807|FG002|COMPLETED|Multiple-dose Phase||5
10079791|NCT02246478|11207808|FG003|COMPLETED|Multiple-dose Phase||4
10079792|NCT02246478|11207805|FG000|NOT COMPLETED|Multiple-dose Phase||1
10079793|NCT02246478|11207806|FG001|NOT COMPLETED|Multiple-dose Phase||0
10079794|NCT02246478|11207807|FG002|NOT COMPLETED|Multiple-dose Phase||0
10079795|NCT02246478|11207808|FG003|NOT COMPLETED|Multiple-dose Phase||1
10079796|NCT02246582|11207825|FG000|STARTED|Overall Study||44
10079797|NCT02246582|11207826|FG001|STARTED|Overall Study||45
10079798|NCT02246582|11207825|FG000|COMPLETED|Overall Study||41
10079799|NCT02246582|11207826|FG001|COMPLETED|Overall Study||41
10079800|NCT02246582|11207825|FG000|NOT COMPLETED|Overall Study||3
10079801|NCT02246582|11207826|FG001|NOT COMPLETED|Overall Study||4
10079802|NCT02246608|11207832|FG000|STARTED|Overall Study||22
10079803|NCT02246608|11207833|FG001|STARTED|Overall Study||21
10079804|NCT02246608|11207832|FG000|COMPLETED|Overall Study||10
10079805|NCT02246608|11207833|FG001|COMPLETED|Overall Study||11
10079806|NCT02246608|11207832|FG000|NOT COMPLETED|Overall Study||12
10079807|NCT02246608|11207833|FG001|NOT COMPLETED|Overall Study||10
10079808|NCT02246647|11207841|FG000|STARTED|Overall Study||19
10079809|NCT02246647|11207842|FG001|STARTED|Overall Study||20
10079810|NCT02246647|11207841|FG000|COMPLETED|Overall Study||18
10079811|NCT02246647|11207842|FG001|COMPLETED|Overall Study||19
10079812|NCT02246647|11207841|FG000|NOT COMPLETED|Overall Study||1
10079813|NCT02246647|11207842|FG001|NOT COMPLETED|Overall Study||1
10079814|NCT02246660|11207865|FG000|STARTED|Overall Study||23
10079815|NCT02246660|11207866|FG001|STARTED|Overall Study||21
10079816|NCT02246660|11207867|FG002|STARTED|Overall Study||22
10079817|NCT02246660|11207865|FG000|COMPLETED|Overall Study||23
10079818|NCT02246660|11207866|FG001|COMPLETED|Overall Study||20
10079819|NCT02246660|11207867|FG002|COMPLETED|Overall Study||21
10079820|NCT02246660|11207865|FG000|NOT COMPLETED|Overall Study||0
10079821|NCT02246660|11207866|FG001|NOT COMPLETED|Overall Study||1
10079822|NCT02246660|11207867|FG002|NOT COMPLETED|Overall Study||1
10079823|NCT02246673|11207880|FG000|STARTED|Overall Study||14
10079824|NCT02246673|11207881|FG001|STARTED|Overall Study||12
10079825|NCT02246673|11207882|FG002|STARTED|Overall Study||12
10079826|NCT02246673|11207883|FG003|STARTED|Overall Study||14
10079827|NCT02246673|11207884|FG004|STARTED|Overall Study||12
10079828|NCT02246673|11207880|FG000|COMPLETED|Overall Study||13
10079829|NCT02246673|11207881|FG001|COMPLETED|Overall Study||12
10079830|NCT02246673|11207882|FG002|COMPLETED|Overall Study||12
10079831|NCT02246673|11207883|FG003|COMPLETED|Overall Study||12
10079832|NCT02246673|11207884|FG004|COMPLETED|Overall Study||11
10079833|NCT02246673|11207880|FG000|NOT COMPLETED|Overall Study||1
10079834|NCT02246673|11207881|FG001|NOT COMPLETED|Overall Study||0
10079835|NCT02246673|11207882|FG002|NOT COMPLETED|Overall Study||0
10079836|NCT02246673|11207883|FG003|NOT COMPLETED|Overall Study||2
10079837|NCT02246673|11207884|FG004|NOT COMPLETED|Overall Study||1
10079838|NCT02246764|11207929|FG000|STARTED|Overall Study||34
10079839|NCT02246764|11207930|FG001|STARTED|Overall Study||36
10079840|NCT02246764|11207931|FG002|STARTED|Overall Study||23
10079841|NCT02246764|11207929|FG000|COMPLETED|Overall Study||16
10079842|NCT02246764|11207930|FG001|COMPLETED|Overall Study||4
10079843|NCT02246764|11207931|FG002|COMPLETED|Overall Study||19
10079844|NCT02246764|11207929|FG000|NOT COMPLETED|Overall Study||18
10079845|NCT02246764|11207930|FG001|NOT COMPLETED|Overall Study||32
10079846|NCT02246764|11207931|FG002|NOT COMPLETED|Overall Study||4
10079847|NCT02246777|11207939|FG000|STARTED|Overall Study||32
10079848|NCT02246777|11207939|FG000|COMPLETED|Overall Study||29
10079849|NCT02246777|11207939|FG000|NOT COMPLETED|Overall Study||3
10079850|NCT02246998|11207952|FG000|STARTED|Overall Study||18
10079851|NCT02246998|11207953|FG001|STARTED|Overall Study||18
10079852|NCT02246998|11207954|FG002|STARTED|Overall Study||18
10079853|NCT02246998|11207955|FG003|STARTED|Overall Study||18
10079854|NCT02246998|11207952|FG000|COMPLETED|Overall Study||16
10079855|NCT02246998|11207953|FG001|COMPLETED|Overall Study||15
10079856|NCT02246998|11207954|FG002|COMPLETED|Overall Study||15
10079857|NCT02246998|11207955|FG003|COMPLETED|Overall Study||16
10079858|NCT02246998|11207952|FG000|NOT COMPLETED|Overall Study||2
10079859|NCT02246998|11207953|FG001|NOT COMPLETED|Overall Study||3
10079860|NCT02246998|11207954|FG002|NOT COMPLETED|Overall Study||3
10079861|NCT02246998|11207955|FG003|NOT COMPLETED|Overall Study||2
10079862|NCT02247011|11207970|FG000|STARTED|Overall Study||1100
10079863|NCT02247011|11207970|FG000|COMPLETED|Overall Study||975
10079864|NCT02247011|11207970|FG000|NOT COMPLETED|Overall Study||125
10079865|NCT02247063|11207979|FG000|STARTED|Overall Study||12
10079866|NCT02247063|11207980|FG001|STARTED|Overall Study||12
10079867|NCT02247063|11207979|FG000|COMPLETED|Overall Study||12
10079868|NCT02247063|11207980|FG001|COMPLETED|Overall Study||12
10079869|NCT02247063|11207979|FG000|NOT COMPLETED|Overall Study||0
10079870|NCT02247063|11207980|FG001|NOT COMPLETED|Overall Study||0
10079871|NCT02247193|11207988|FG000|STARTED|Overall Study||15
10079872|NCT02247193|11207989|FG001|STARTED|Overall Study||15
10079873|NCT02247193|11207988|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
10079874|NCT02247193|11207989|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
10079875|NCT02247193|11207988|FG000|Number Who Received Botox or Placebo|Overall Study||15
10079876|NCT02247193|11207989|FG001|Number Who Received Botox or Placebo|Overall Study||15
10079877|NCT02247193|11207988|FG000|Number Who Completed the 6-month Follow up|Overall Study||15
10191901|NCT03307252|11320764|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
10191902|NCT03307252|11320765|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
10191903|NCT03307252|11320766|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191904|NCT03307252|11320767|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191905|NCT03307252|11320768|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191906|NCT03307252|11320769|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191907|NCT03307252|11320759|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191908|NCT03307252|11320760|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191909|NCT03307252|11320761|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191910|NCT03307252|11320762|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191911|NCT03307252|11320763|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191912|NCT03307252|11320764|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191913|NCT03307252|11320765|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191914|NCT03307252|11320766|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191915|NCT03307252|11320767|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191916|NCT03307252|11320768|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191917|NCT03307252|11320769|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10191918|NCT03307252|11320759|FG000|STARTED|Part 2, Period 3||0
10191919|NCT03307252|11320760|FG001|STARTED|Part 2, Period 3||0
10191920|NCT03307252|11320761|FG002|STARTED|Part 2, Period 3||0
10191921|NCT03307252|11320762|FG003|STARTED|Part 2, Period 3||4
10191922|NCT03307252|11320763|FG004|STARTED|Part 2, Period 3||4
10191923|NCT03307252|11320764|FG005|STARTED|Part 2, Period 3||3
10191924|NCT03307252|11320765|FG006|STARTED|Part 2, Period 3||5
10191925|NCT03307252|11320766|FG007|STARTED|Part 2, Period 3||0
10191926|NCT03307252|11320767|FG008|STARTED|Part 2, Period 3||0
10191927|NCT03307252|11320768|FG009|STARTED|Part 2, Period 3||0
10191928|NCT03307252|11320769|FG010|STARTED|Part 2, Period 3||0
10191929|NCT03307252|11320759|FG000|COMPLETED|Part 2, Period 3||0
10191930|NCT03307252|11320760|FG001|COMPLETED|Part 2, Period 3||0
10191931|NCT03307252|11320761|FG002|COMPLETED|Part 2, Period 3||0
10191932|NCT03307252|11320762|FG003|COMPLETED|Part 2, Period 3||4
10191933|NCT03307252|11320763|FG004|COMPLETED|Part 2, Period 3||3
10191934|NCT03307252|11320764|FG005|COMPLETED|Part 2, Period 3||3
10191935|NCT03307252|11320765|FG006|COMPLETED|Part 2, Period 3||5
10191936|NCT03307252|11320766|FG007|COMPLETED|Part 2, Period 3||0
10191937|NCT03307252|11320767|FG008|COMPLETED|Part 2, Period 3||0
10191938|NCT03307252|11320768|FG009|COMPLETED|Part 2, Period 3||0
10191939|NCT03307252|11320769|FG010|COMPLETED|Part 2, Period 3||0
10191940|NCT03307252|11320759|FG000|NOT COMPLETED|Part 2, Period 3||0
10191941|NCT03307252|11320760|FG001|NOT COMPLETED|Part 2, Period 3||0
10191942|NCT03307252|11320761|FG002|NOT COMPLETED|Part 2, Period 3||0
10191943|NCT03307252|11320762|FG003|NOT COMPLETED|Part 2, Period 3||0
10191944|NCT03307252|11320763|FG004|NOT COMPLETED|Part 2, Period 3||1
10191945|NCT03307252|11320764|FG005|NOT COMPLETED|Part 2, Period 3||0
10191946|NCT03307252|11320765|FG006|NOT COMPLETED|Part 2, Period 3||0
10191947|NCT03307252|11320766|FG007|NOT COMPLETED|Part 2, Period 3||0
10191948|NCT03307252|11320767|FG008|NOT COMPLETED|Part 2, Period 3||0
10191949|NCT03307252|11320768|FG009|NOT COMPLETED|Part 2, Period 3||0
10191950|NCT03307252|11320769|FG010|NOT COMPLETED|Part 2, Period 3||0
10191951|NCT03307252|11320759|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0
10191952|NCT03307252|11320760|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0
10191953|NCT03307252|11320761|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0
10191954|NCT03307252|11320762|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4
10191955|NCT03307252|11320763|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3
10191956|NCT03307252|11320764|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3
10191957|NCT03307252|11320765|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5
10191958|NCT03307252|11320766|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0
10191959|NCT03307252|11320767|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0
10191960|NCT03307252|11320768|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0
10191961|NCT03307252|11320769|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0
10191962|NCT03307252|11320759|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191963|NCT03307252|11320760|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191964|NCT03307252|11320761|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191965|NCT03307252|11320762|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
10191966|NCT03307252|11320763|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
10191967|NCT03307252|11320764|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
10191968|NCT03307252|11320765|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
10191969|NCT03307252|11320766|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191970|NCT03307252|11320767|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191971|NCT03307252|11320768|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191972|NCT03307252|11320769|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191973|NCT03307252|11320759|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191974|NCT03307252|11320760|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191975|NCT03307252|11320761|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191976|NCT03307252|11320762|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10079878|NCT02247193|11207989|FG001|Number Who Completed the 6-month Follow up|Overall Study||15
10079879|NCT02247193|11207988|FG000|Number Who Completed the 12-month Follow up|Overall Study||15
10079880|NCT02247193|11207989|FG001|Number Who Completed the 12-month Follow up|Overall Study||15
10079881|NCT02247193|11207988|FG000|COMPLETED|Overall Study||15
10079882|NCT02247193|11207989|FG001|COMPLETED|Overall Study||15
10079883|NCT02247193|11207988|FG000|NOT COMPLETED|Overall Study||0
10079884|NCT02247193|11207989|FG001|NOT COMPLETED|Overall Study||0
10079885|NCT02247245|11207999|FG000|STARTED|Overall Study||13
10079886|NCT02247245|11208000|FG001|STARTED|Overall Study||13
10079887|NCT02247245|11208001|FG002|STARTED|Overall Study||7
10079888|NCT02247245|11208002|FG003|STARTED|Overall Study||7
10079889|NCT02247245|11207999|FG000|COMPLETED|Overall Study||13
10079890|NCT02247245|11208000|FG001|COMPLETED|Overall Study||13
10079891|NCT02247245|11208001|FG002|COMPLETED|Overall Study||7
10079892|NCT02247245|11208002|FG003|COMPLETED|Overall Study||7
10079893|NCT02247245|11207999|FG000|NOT COMPLETED|Overall Study||0
10079894|NCT02247245|11208000|FG001|NOT COMPLETED|Overall Study||0
10079895|NCT02247245|11208001|FG002|NOT COMPLETED|Overall Study||0
10079896|NCT02247245|11208002|FG003|NOT COMPLETED|Overall Study||0
10079897|NCT02247336|11208014|FG000|STARTED|Overall Study||252
10079898|NCT02247336|11208015|FG001|STARTED|Overall Study||253
10079899|NCT02247336|11208014|FG000|COMPLETED|Overall Study||252
10079900|NCT02247336|11208015|FG001|COMPLETED|Overall Study||253
10079901|NCT02247336|11208014|FG000|NOT COMPLETED|Overall Study||0
10079902|NCT02247336|11208015|FG001|NOT COMPLETED|Overall Study||0
10079903|NCT02247401|11208024|FG000|STARTED|Overall Study||100
10079904|NCT02247401|11208025|FG001|STARTED|Overall Study||31
10079905|NCT02247401|11208026|FG002|STARTED|Overall Study||29
10079906|NCT02247401|11208024|FG000|COMPLETED|Overall Study||94
10079907|NCT02247401|11208025|FG001|COMPLETED|Overall Study||29
10079908|NCT02247401|11208026|FG002|COMPLETED|Overall Study||27
10079909|NCT02247401|11208024|FG000|NOT COMPLETED|Overall Study||6
10079910|NCT02247401|11208025|FG001|NOT COMPLETED|Overall Study||2
10079911|NCT02247401|11208026|FG002|NOT COMPLETED|Overall Study||2
10079912|NCT02247440|11208035|FG000|STARTED|Overall Study||18
10079913|NCT02247440|11208035|FG000|COMPLETED|Overall Study||14
10079914|NCT02247440|11208035|FG000|NOT COMPLETED|Overall Study||4
10079915|NCT02247466|11208041|FG000|STARTED|Overall Study||19
10079916|NCT02247466|11208042|FG001|STARTED|Overall Study||18
10079917|NCT02247466|11208041|FG000|COMPLETED|Overall Study||19
10079918|NCT02247466|11208042|FG001|COMPLETED|Overall Study||15
10079919|NCT02247466|11208041|FG000|NOT COMPLETED|Overall Study||0
10079920|NCT02247466|11208042|FG001|NOT COMPLETED|Overall Study||3
10079921|NCT02247479|11208051|FG000|STARTED|Overall Study||305
10079922|NCT02247479|11208052|FG001|STARTED|Overall Study||298
10079923|NCT02247479|11208053|FG002|STARTED|Overall Study||303
10079924|NCT02247479|11208051|FG000|COMPLETED|Overall Study||163
9717470|NCT00003896|10816669|FG000|COMPLETED|Overall Study||39
10079925|NCT02247479|11208052|FG001|COMPLETED|Overall Study||160
10079926|NCT02247479|11208053|FG002|COMPLETED|Overall Study||165
10079927|NCT02247479|11208051|FG000|NOT COMPLETED|Overall Study||142
10079928|NCT02247479|11208052|FG001|NOT COMPLETED|Overall Study||138
10079929|NCT02247479|11208053|FG002|NOT COMPLETED|Overall Study||138
10079930|NCT02247531|11208064|FG000|STARTED|Overall Study||321
10079931|NCT02247531|11208065|FG001|STARTED|Overall Study||330
10079932|NCT02247531|11208066|FG002|STARTED|Overall Study||324
10079933|NCT02247531|11208064|FG000|COMPLETED|Overall Study||215
10079934|NCT02247531|11208065|FG001|COMPLETED|Overall Study||205
10079935|NCT02247531|11208066|FG002|COMPLETED|Overall Study||214
10079936|NCT02247531|11208064|FG000|NOT COMPLETED|Overall Study||106
10079937|NCT02247531|11208065|FG001|NOT COMPLETED|Overall Study||125
10079938|NCT02247531|11208066|FG002|NOT COMPLETED|Overall Study||110
10079939|NCT02247739|11208074|FG000|STARTED|Overall Study||5
10079940|NCT02247739|11208075|FG001|STARTED|Overall Study||6
10079941|NCT02247739|11208076|FG002|STARTED|Overall Study||5
10079942|NCT02247739|11208077|FG003|STARTED|Overall Study||5
10079943|NCT02247739|11208078|FG004|STARTED|Overall Study||6
10079944|NCT02247739|11208079|FG005|STARTED|Overall Study||5
10079945|NCT02247739|11208074|FG000|COMPLETED|Overall Study||5
10079946|NCT02247739|11208075|FG001|COMPLETED|Overall Study||3
10079947|NCT02247739|11208076|FG002|COMPLETED|Overall Study||4
10079948|NCT02247739|11208077|FG003|COMPLETED|Overall Study||5
10079949|NCT02247739|11208078|FG004|COMPLETED|Overall Study||5
10079950|NCT02247739|11208079|FG005|COMPLETED|Overall Study||4
10079951|NCT02247739|11208074|FG000|NOT COMPLETED|Overall Study||0
10079952|NCT02247739|11208075|FG001|NOT COMPLETED|Overall Study||3
10079953|NCT02247739|11208076|FG002|NOT COMPLETED|Overall Study||1
10079954|NCT02247739|11208077|FG003|NOT COMPLETED|Overall Study||0
10079955|NCT02247739|11208078|FG004|NOT COMPLETED|Overall Study||1
10079956|NCT02247739|11208079|FG005|NOT COMPLETED|Overall Study||1
10079957|NCT02247765|11208089|FG000|STARTED|Overall Study||18
10079958|NCT02247765|11208089|FG000|COMPLETED|Overall Study||18
10079959|NCT02247765|11208089|FG000|NOT COMPLETED|Overall Study||0
10079960|NCT02247804|11208096|FG000|STARTED|Treatment Period 1||198
10079961|NCT02247804|11208097|FG001|STARTED|Treatment Period 1||198
10079962|NCT02247804|11208098|FG002|STARTED|Treatment Period 1||198
10079963|NCT02247804|11208096|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
10079964|NCT02247804|11208097|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
10079965|NCT02247804|11208098|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
10079966|NCT02247804|11208096|FG000|COMPLETED|Treatment Period 1||176
10079967|NCT02247804|11208097|FG001|COMPLETED|Treatment Period 1||194
10079968|NCT02247804|11208098|FG002|COMPLETED|Treatment Period 1||190
10079969|NCT02247804|11208096|FG000|NOT COMPLETED|Treatment Period 1||22
10079970|NCT02247804|11208097|FG001|NOT COMPLETED|Treatment Period 1||4
10079971|NCT02247804|11208098|FG002|NOT COMPLETED|Treatment Period 1||8
10079972|NCT02247804|11208096|FG000|STARTED|Treatment Period 2||172
10079973|NCT02247804|11208097|FG001|STARTED|Treatment Period 2||191
10079974|NCT02247804|11208098|FG002|STARTED|Treatment Period 2||187
10079975|NCT02247804|11208096|FG000|COMPLETED|Treatment Period 2||164
10079976|NCT02247804|11208097|FG001|COMPLETED|Treatment Period 2||186
10079977|NCT02247804|11208098|FG002|COMPLETED|Treatment Period 2||179
10079978|NCT02247804|11208096|FG000|NOT COMPLETED|Treatment Period 2||8
10079979|NCT02247804|11208097|FG001|NOT COMPLETED|Treatment Period 2||5
10079980|NCT02247804|11208098|FG002|NOT COMPLETED|Treatment Period 2||8
10079981|NCT02247804|11208096|FG000|STARTED|Treatment Period 3||158
10079982|NCT02247804|11208097|FG001|STARTED|Treatment Period 3||183
10079983|NCT02247804|11208098|FG002|STARTED|Treatment Period 3||177
10079984|NCT02247804|11208096|FG000|COMPLETED|Treatment Period 3||147
10079985|NCT02247804|11208097|FG001|COMPLETED|Treatment Period 3||173
10079986|NCT02247804|11208098|FG002|COMPLETED|Treatment Period 3||167
10079987|NCT02247804|11208096|FG000|NOT COMPLETED|Treatment Period 3||11
10079988|NCT02247804|11208097|FG001|NOT COMPLETED|Treatment Period 3||10
10079989|NCT02247804|11208098|FG002|NOT COMPLETED|Treatment Period 3||10
10079990|NCT02247960|11208108|FG000|STARTED|Patient Consent and Randomization||85
10079991|NCT02247960|11208109|FG001|STARTED|Patient Consent and Randomization||90
10079992|NCT02247960|11208108|FG000|COMPLETED|Patient Consent and Randomization||83
10079993|NCT02247960|11208109|FG001|COMPLETED|Patient Consent and Randomization||84
10079994|NCT02247960|11208108|FG000|NOT COMPLETED|Patient Consent and Randomization||2
10079995|NCT02247960|11208109|FG001|NOT COMPLETED|Patient Consent and Randomization||6
10079996|NCT02247960|11208108|FG000|STARTED|Catheter Removed||83
10079997|NCT02247960|11208109|FG001|STARTED|Catheter Removed||84
10079998|NCT02247960|11208108|FG000|COMPLETED|Catheter Removed||76
10079999|NCT02247960|11208109|FG001|COMPLETED|Catheter Removed||74
10080000|NCT02247960|11208108|FG000|NOT COMPLETED|Catheter Removed||7
10080001|NCT02247960|11208109|FG001|NOT COMPLETED|Catheter Removed||10
10080002|NCT02248103|11208117|FG000|STARTED|Overall Study||10
10080003|NCT02248103|11208118|FG001|STARTED|Overall Study||10
10080004|NCT02248103|11208117|FG000|COMPLETED|Overall Study||10
10080005|NCT02248103|11208118|FG001|COMPLETED|Overall Study||10
10080006|NCT02248103|11208117|FG000|NOT COMPLETED|Overall Study||0
10080007|NCT02248103|11208118|FG001|NOT COMPLETED|Overall Study||0
10080008|NCT02248246|11208124|FG000|STARTED|Overall Study||40
10080009|NCT02248246|11208124|FG000|COMPLETED|Overall Study||40
10080010|NCT02248246|11208124|FG000|NOT COMPLETED|Overall Study||0
10080011|NCT02248285|11208130|FG000|STARTED|Overall Study||687
10080012|NCT02248285|11208131|FG001|STARTED|Overall Study||858
10080013|NCT02248285|11208130|FG000|COMPLETED|Overall Study||586
10080014|NCT02248285|11208131|FG001|COMPLETED|Overall Study||571
10080015|NCT02248285|11208130|FG000|NOT COMPLETED|Overall Study||101
10080016|NCT02248285|11208131|FG001|NOT COMPLETED|Overall Study||287
10080017|NCT02248480|11208139|FG000|STARTED|Overall Study||178
10080018|NCT02248480|11208140|FG001|STARTED|Overall Study||176
10080019|NCT02248480|11208139|FG000|Efficacy Population|Overall Study||177
10080020|NCT02248480|11208140|FG001|Efficacy Population|Overall Study||176
10080021|NCT02248480|11208139|FG000|COMPLETED|Overall Study||161
10080022|NCT02248480|11208140|FG001|COMPLETED|Overall Study||162
10080023|NCT02248480|11208139|FG000|NOT COMPLETED|Overall Study||17
10080024|NCT02248480|11208140|FG001|NOT COMPLETED|Overall Study||14
10080025|NCT02248558|11208149|FG000|STARTED|Overall Study||369
10080026|NCT02248558|11208150|FG001|STARTED|Overall Study||352
10080027|NCT02248558|11208149|FG000|COMPLETED|Overall Study||317
10080028|NCT02248558|11208150|FG001|COMPLETED|Overall Study||307
10080029|NCT02248558|11208149|FG000|NOT COMPLETED|Overall Study||52
10080030|NCT02248558|11208150|FG001|NOT COMPLETED|Overall Study||45
10080031|NCT02248636|11208160|FG000|STARTED|Overall Study||26
10080032|NCT02248636|11208161|FG001|STARTED|Overall Study||35
10080033|NCT02248636|11208160|FG000|COMPLETED|Overall Study||20
10080034|NCT02248636|11208161|FG001|COMPLETED|Overall Study||32
10080035|NCT02248636|11208160|FG000|NOT COMPLETED|Overall Study||6
10080036|NCT02248636|11208161|FG001|NOT COMPLETED|Overall Study||3
10080037|NCT02248649|11208169|FG000|STARTED|Overall Study||80
10080038|NCT02248649|11208170|FG001|STARTED|Overall Study||80
10080039|NCT02248649|11208169|FG000|COMPLETED|Overall Study||59
10080040|NCT02248649|11208170|FG001|COMPLETED|Overall Study||59
10080041|NCT02248649|11208169|FG000|NOT COMPLETED|Overall Study||21
10080042|NCT02248649|11208170|FG001|NOT COMPLETED|Overall Study||21
10080043|NCT02248662|11208178|FG000|STARTED|Overall Study||5320
10080044|NCT02248662|11208179|FG001|STARTED|Overall Study||33194
10080045|NCT02248662|11208178|FG000|COMPLETED|Overall Study||757
10080046|NCT02248662|11208179|FG001|COMPLETED|Overall Study||2679
10080047|NCT02248662|11208178|FG000|NOT COMPLETED|Overall Study||4563
10080048|NCT02248662|11208179|FG001|NOT COMPLETED|Overall Study||30515
10080049|NCT02248675|11208191|FG000|STARTED|Overall Study||26
10080050|NCT02248675|11208192|FG001|STARTED|Overall Study||28
10080051|NCT02248675|11208191|FG000|COMPLETED|Overall Study||23
10080052|NCT02248675|11208192|FG001|COMPLETED|Overall Study||27
10080053|NCT02248675|11208191|FG000|NOT COMPLETED|Overall Study||3
10080054|NCT02248675|11208192|FG001|NOT COMPLETED|Overall Study||1
10080055|NCT02248714|11208200|FG000|STARTED|Overall Study||66
10080056|NCT02248714|11208201|FG001|STARTED|Overall Study||65
10080057|NCT02248714|11208200|FG000|COMPLETED|Overall Study||62
10080058|NCT02248714|11208201|FG001|COMPLETED|Overall Study||61
10080059|NCT02248714|11208200|FG000|NOT COMPLETED|Overall Study||4
10080060|NCT02248714|11208201|FG001|NOT COMPLETED|Overall Study||4
10080061|NCT02248727|11208207|FG000|STARTED|Overall Study||30
10080062|NCT02248727|11208207|FG000|COMPLETED|Overall Study||30
10080063|NCT02248727|11208207|FG000|NOT COMPLETED|Overall Study||0
10080064|NCT02248766|11208214|FG000|STARTED|Overall Study||30
10080065|NCT02248766|11208214|FG000|COMPLETED|Overall Study||30
10080066|NCT02248766|11208214|FG000|NOT COMPLETED|Overall Study||0
10080067|NCT02248818|11208230|FG000|STARTED|Screening||0
10080068|NCT02248818|11208231|FG001|STARTED|Screening||0
10080069|NCT02248818|11208232|FG002|STARTED|Screening||0
10080070|NCT02248818|11208233|FG003|STARTED|Screening||0
10080071|NCT02248818|11208234|FG004|STARTED|Screening||0
10080072|NCT02248818|11208235|FG005|STARTED|Screening||0
10080073|NCT02248818|11208236|FG006|STARTED|Screening||0
10080074|NCT02248818|11208237|FG007|STARTED|Screening||0
10080075|NCT02248818|11208238|FG008|STARTED|Screening||155
10080076|NCT02248818|11208230|FG000|COMPLETED|Screening||0
10080077|NCT02248818|11208231|FG001|COMPLETED|Screening||0
10080078|NCT02248818|11208232|FG002|COMPLETED|Screening||0
10080079|NCT02248818|11208233|FG003|COMPLETED|Screening||0
10080080|NCT02248818|11208234|FG004|COMPLETED|Screening||0
10080081|NCT02248818|11208235|FG005|COMPLETED|Screening||0
10080082|NCT02248818|11208236|FG006|COMPLETED|Screening||0
10080083|NCT02248818|11208237|FG007|COMPLETED|Screening||0
10080084|NCT02248818|11208238|FG008|COMPLETED|Screening||48
10080085|NCT02248818|11208230|FG000|NOT COMPLETED|Screening||0
10080086|NCT02248818|11208231|FG001|NOT COMPLETED|Screening||0
10080087|NCT02248818|11208232|FG002|NOT COMPLETED|Screening||0
10080088|NCT02248818|11208233|FG003|NOT COMPLETED|Screening||0
10080089|NCT02248818|11208234|FG004|NOT COMPLETED|Screening||0
10080090|NCT02248818|11208235|FG005|NOT COMPLETED|Screening||0
10080091|NCT02248818|11208236|FG006|NOT COMPLETED|Screening||0
10080092|NCT02248818|11208237|FG007|NOT COMPLETED|Screening||0
10080093|NCT02248818|11208238|FG008|NOT COMPLETED|Screening||107
10080094|NCT02248818|11208230|FG000|STARTED|Randomised Study||6
10080095|NCT02248818|11208231|FG001|STARTED|Randomised Study||6
10080096|NCT02248818|11208232|FG002|STARTED|Randomised Study||6
10080097|NCT02248818|11208233|FG003|STARTED|Randomised Study||6
10080098|NCT02248818|11208234|FG004|STARTED|Randomised Study||6
10080099|NCT02248818|11208235|FG005|STARTED|Randomised Study||8
10080100|NCT02248818|11208236|FG006|STARTED|Randomised Study||6
10080101|NCT02248818|11208237|FG007|STARTED|Randomised Study||4
10080102|NCT02248818|11208238|FG008|STARTED|Randomised Study||0
10080103|NCT02248818|11208230|FG000|COMPLETED|Randomised Study||6
10080104|NCT02248818|11208231|FG001|COMPLETED|Randomised Study||6
10080105|NCT02248818|11208232|FG002|COMPLETED|Randomised Study||6
10080106|NCT02248818|11208233|FG003|COMPLETED|Randomised Study||6
10080107|NCT02248818|11208234|FG004|COMPLETED|Randomised Study||6
10080108|NCT02248818|11208235|FG005|COMPLETED|Randomised Study||0
10080109|NCT02248818|11208236|FG006|COMPLETED|Randomised Study||6
10080110|NCT02248818|11208237|FG007|COMPLETED|Randomised Study||4
10080111|NCT02248818|11208238|FG008|COMPLETED|Randomised Study||0
10080112|NCT02248818|11208230|FG000|NOT COMPLETED|Randomised Study||0
10080113|NCT02248818|11208231|FG001|NOT COMPLETED|Randomised Study||0
10080114|NCT02248818|11208232|FG002|NOT COMPLETED|Randomised Study||0
10080115|NCT02248818|11208233|FG003|NOT COMPLETED|Randomised Study||0
10080116|NCT02248818|11208234|FG004|NOT COMPLETED|Randomised Study||0
10080117|NCT02248818|11208235|FG005|NOT COMPLETED|Randomised Study||8
10080118|NCT02248818|11208236|FG006|NOT COMPLETED|Randomised Study||0
10080119|NCT02248818|11208237|FG007|NOT COMPLETED|Randomised Study||0
10080120|NCT02248818|11208238|FG008|NOT COMPLETED|Randomised Study||0
10080121|NCT02248857|11208259|FG000|STARTED|Baseline||157
10080122|NCT02248857|11208260|FG001|STARTED|Baseline||168
10080123|NCT02248857|11208261|FG002|STARTED|Baseline||127
10080124|NCT02248857|11208259|FG000|COMPLETED|Baseline||157
10080125|NCT02248857|11208260|FG001|COMPLETED|Baseline||168
10080126|NCT02248857|11208261|FG002|COMPLETED|Baseline||127
10080127|NCT02248857|11208259|FG000|NOT COMPLETED|Baseline||0
10080128|NCT02248857|11208260|FG001|NOT COMPLETED|Baseline||0
10080129|NCT02248857|11208261|FG002|NOT COMPLETED|Baseline||0
10080130|NCT02248857|11208259|FG000|STARTED|3 Month||157
10080131|NCT02248857|11208260|FG001|STARTED|3 Month||168
10080132|NCT02248857|11208261|FG002|STARTED|3 Month||127
10080133|NCT02248857|11208259|FG000|COMPLETED|3 Month||111
10080134|NCT02248857|11208260|FG001|COMPLETED|3 Month||134
10080135|NCT02248857|11208261|FG002|COMPLETED|3 Month||96
10191977|NCT03307252|11320763|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191978|NCT03307252|11320764|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191979|NCT03307252|11320765|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
10191980|NCT03307252|11320766|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191981|NCT03307252|11320767|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191982|NCT03307252|11320768|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191983|NCT03307252|11320769|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10191984|NCT03307252|11320759|FG000|STARTED|Part 2, Period 4||0
10191985|NCT03307252|11320760|FG001|STARTED|Part 2, Period 4||0
10191986|NCT03307252|11320761|FG002|STARTED|Part 2, Period 4||0
10191987|NCT03307252|11320762|FG003|STARTED|Part 2, Period 4||4
10191988|NCT03307252|11320763|FG004|STARTED|Part 2, Period 4||3
10191989|NCT03307252|11320764|FG005|STARTED|Part 2, Period 4||3
10191990|NCT03307252|11320765|FG006|STARTED|Part 2, Period 4||5
10191991|NCT03307252|11320766|FG007|STARTED|Part 2, Period 4||0
10191992|NCT03307252|11320767|FG008|STARTED|Part 2, Period 4||0
10191993|NCT03307252|11320768|FG009|STARTED|Part 2, Period 4||0
10191994|NCT03307252|11320769|FG010|STARTED|Part 2, Period 4||0
10191995|NCT03307252|11320759|FG000|COMPLETED|Part 2, Period 4||0
10191996|NCT03307252|11320760|FG001|COMPLETED|Part 2, Period 4||0
10191997|NCT03307252|11320761|FG002|COMPLETED|Part 2, Period 4||0
10191998|NCT03307252|11320762|FG003|COMPLETED|Part 2, Period 4||4
10191999|NCT03307252|11320763|FG004|COMPLETED|Part 2, Period 4||3
10192000|NCT03307252|11320764|FG005|COMPLETED|Part 2, Period 4||3
10192001|NCT03307252|11320765|FG006|COMPLETED|Part 2, Period 4||4
10192002|NCT03307252|11320766|FG007|COMPLETED|Part 2, Period 4||0
10192003|NCT03307252|11320767|FG008|COMPLETED|Part 2, Period 4||0
10192004|NCT03307252|11320768|FG009|COMPLETED|Part 2, Period 4||0
10192005|NCT03307252|11320769|FG010|COMPLETED|Part 2, Period 4||0
10192006|NCT03307252|11320759|FG000|NOT COMPLETED|Part 2, Period 4||0
10192007|NCT03307252|11320760|FG001|NOT COMPLETED|Part 2, Period 4||0
10192008|NCT03307252|11320761|FG002|NOT COMPLETED|Part 2, Period 4||0
10192009|NCT03307252|11320762|FG003|NOT COMPLETED|Part 2, Period 4||0
10192010|NCT03307252|11320763|FG004|NOT COMPLETED|Part 2, Period 4||0
10192011|NCT03307252|11320764|FG005|NOT COMPLETED|Part 2, Period 4||0
10192012|NCT03307252|11320765|FG006|NOT COMPLETED|Part 2, Period 4||1
10192013|NCT03307252|11320766|FG007|NOT COMPLETED|Part 2, Period 4||0
10192014|NCT03307252|11320767|FG008|NOT COMPLETED|Part 2, Period 4||0
10192015|NCT03307252|11320768|FG009|NOT COMPLETED|Part 2, Period 4||0
10192016|NCT03307252|11320769|FG010|NOT COMPLETED|Part 2, Period 4||0
10192017|NCT03307252|11320759|FG000|STARTED|Part 3, Period 1||0
10192018|NCT03307252|11320760|FG001|STARTED|Part 3, Period 1||0
10192019|NCT03307252|11320761|FG002|STARTED|Part 3, Period 1||0
10192020|NCT03307252|11320762|FG003|STARTED|Part 3, Period 1||0
10192021|NCT03307252|11320763|FG004|STARTED|Part 3, Period 1||0
10192022|NCT03307252|11320764|FG005|STARTED|Part 3, Period 1||0
10192023|NCT03307252|11320765|FG006|STARTED|Part 3, Period 1||0
10192024|NCT03307252|11320766|FG007|STARTED|Part 3, Period 1||4
10192025|NCT03307252|11320767|FG008|STARTED|Part 3, Period 1||4
10192026|NCT03307252|11320768|FG009|STARTED|Part 3, Period 1||4
10192027|NCT03307252|11320769|FG010|STARTED|Part 3, Period 1||4
10192028|NCT03307252|11320759|FG000|COMPLETED|Part 3, Period 1||0
10192029|NCT03307252|11320760|FG001|COMPLETED|Part 3, Period 1||0
10192030|NCT03307252|11320761|FG002|COMPLETED|Part 3, Period 1||0
10192031|NCT03307252|11320762|FG003|COMPLETED|Part 3, Period 1||0
10192032|NCT03307252|11320763|FG004|COMPLETED|Part 3, Period 1||0
10192033|NCT03307252|11320764|FG005|COMPLETED|Part 3, Period 1||0
10192034|NCT03307252|11320765|FG006|COMPLETED|Part 3, Period 1||0
10192035|NCT03307252|11320766|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10192036|NCT03307252|11320767|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10192037|NCT03307252|11320768|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10080136|NCT02248857|11208259|FG000|NOT COMPLETED|3 Month||46
10080137|NCT02248857|11208260|FG001|NOT COMPLETED|3 Month||34
10080138|NCT02248857|11208261|FG002|NOT COMPLETED|3 Month||31
10080139|NCT02248857|11208259|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
10080140|NCT02248857|11208260|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
10080141|NCT02248857|11208261|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
10080142|NCT02248857|11208259|FG000|COMPLETED|6 Month||120
10080143|NCT02248857|11208260|FG001|COMPLETED|6 Month||136
10080144|NCT02248857|11208261|FG002|COMPLETED|6 Month||106
10080145|NCT02248857|11208259|FG000|NOT COMPLETED|6 Month||28
10080146|NCT02248857|11208260|FG001|NOT COMPLETED|6 Month||29
10080147|NCT02248857|11208261|FG002|NOT COMPLETED|6 Month||17
10080148|NCT02248922|11208271|FG000|STARTED|Overall Study||5
10080149|NCT02248922|11208272|FG001|STARTED|Overall Study||12
10080150|NCT02248922|11208271|FG000|COMPLETED|Overall Study||5
10080151|NCT02248922|11208272|FG001|COMPLETED|Overall Study||12
10080152|NCT02248922|11208271|FG000|NOT COMPLETED|Overall Study||0
10080153|NCT02248922|11208272|FG001|NOT COMPLETED|Overall Study||0
10080154|NCT02248961|11208279|FG000|STARTED|Overall Study||89
10080155|NCT02248961|11208280|FG001|STARTED|Overall Study||90
10080156|NCT02248961|11208279|FG000|COMPLETED|Overall Study||86
10080157|NCT02248961|11208280|FG001|COMPLETED|Overall Study||88
10080158|NCT02248961|11208279|FG000|NOT COMPLETED|Overall Study||3
10080159|NCT02248961|11208280|FG001|NOT COMPLETED|Overall Study||2
10080160|NCT02248974|11208288|FG000|STARTED|Baseline||47
10080161|NCT02248974|11208289|FG001|STARTED|Baseline||51
10080162|NCT02248974|11208288|FG000|COMPLETED|Baseline||47
10080163|NCT02248974|11208289|FG001|COMPLETED|Baseline||51
10080164|NCT02248974|11208288|FG000|NOT COMPLETED|Baseline||0
10080165|NCT02248974|11208289|FG001|NOT COMPLETED|Baseline||0
10080166|NCT02248974|11208288|FG000|STARTED|1-Day Follow-Up||47
10080167|NCT02248974|11208289|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
10080168|NCT02248974|11208288|FG000|COMPLETED|1-Day Follow-Up||37
10080169|NCT02248974|11208289|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
10080170|NCT02248974|11208288|FG000|NOT COMPLETED|1-Day Follow-Up||10
10080171|NCT02248974|11208289|FG001|NOT COMPLETED|1-Day Follow-Up||0
10080172|NCT02248974|11208288|FG000|STARTED|1-Week Follow-Up||37
10080173|NCT02248974|11208289|FG001|STARTED|1-Week Follow-Up||51
10080174|NCT02248974|11208288|FG000|COMPLETED|1-Week Follow-Up||29
10080175|NCT02248974|11208289|FG001|COMPLETED|1-Week Follow-Up||34
10080176|NCT02248974|11208288|FG000|NOT COMPLETED|1-Week Follow-Up||8
10080177|NCT02248974|11208289|FG001|NOT COMPLETED|1-Week Follow-Up||17
10080178|NCT02248974|11208288|FG000|STARTED|1-Month Follow-Up||29
10080179|NCT02248974|11208289|FG001|STARTED|1-Month Follow-Up||34
10080180|NCT02248974|11208288|FG000|COMPLETED|1-Month Follow-Up||27
10080181|NCT02248974|11208289|FG001|COMPLETED|1-Month Follow-Up||31
10080182|NCT02248974|11208288|FG000|NOT COMPLETED|1-Month Follow-Up||2
10080183|NCT02248974|11208289|FG001|NOT COMPLETED|1-Month Follow-Up||3
10080184|NCT02249052|11208295|FG000|STARTED|Overall Study||19
10080185|NCT02249052|11208295|FG000|COMPLETED|Overall Study||19
10080186|NCT02249052|11208295|FG000|NOT COMPLETED|Overall Study||0
10080187|NCT02249065|11208303|FG000|STARTED|Overall Study||205
10080188|NCT02249065|11208303|FG000|Treated|Overall Study||181
10080189|NCT02249065|11208303|FG000|COMPLETED|Overall Study||176
10080190|NCT02249065|11208303|FG000|NOT COMPLETED|Overall Study||29
10080191|NCT02249091|11208309|FG000|STARTED|Overall Study||27
10080192|NCT02249091|11208310|FG001|STARTED|Overall Study||15
10080193|NCT02249091|11208309|FG000|COMPLETED|Overall Study||7
10080194|NCT02249091|11208310|FG001|COMPLETED|Overall Study||2
10080195|NCT02249091|11208309|FG000|NOT COMPLETED|Overall Study||20
10080196|NCT02249091|11208310|FG001|NOT COMPLETED|Overall Study||13
10080197|NCT02249104|11208316|FG000|STARTED|Overall Study||28
10080198|NCT02249104|11208316|FG000|COMPLETED|Overall Study||25
10080199|NCT02249104|11208316|FG000|NOT COMPLETED|Overall Study||3
10080200|NCT02249143|11208322|FG000|STARTED|Overall Study||24
10080201|NCT02249143|11208323|FG001|STARTED|Overall Study|randomized|26
10080202|NCT02249143|11208322|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
10080203|NCT02249143|11208323|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
10080204|NCT02249143|11208322|FG000|NOT COMPLETED|Overall Study||2
10080205|NCT02249143|11208323|FG001|NOT COMPLETED|Overall Study||4
10080206|NCT02249182|11208334|FG000|STARTED|PK Lead-In Phase||10
10080207|NCT02249182|11208335|FG001|STARTED|PK Lead-In Phase||12
10080208|NCT02249182|11208336|FG002|STARTED|PK Lead-In Phase||0
10080209|NCT02249182|11208337|FG003|STARTED|PK Lead-In Phase||0
10080210|NCT02249182|11208338|FG004|STARTED|PK Lead-In Phase||17
10080211|NCT02249182|11208334|FG000|COMPLETED|PK Lead-In Phase||10
10080212|NCT02249182|11208335|FG001|COMPLETED|PK Lead-In Phase||12
10080213|NCT02249182|11208336|FG002|COMPLETED|PK Lead-In Phase||0
10080214|NCT02249182|11208337|FG003|COMPLETED|PK Lead-In Phase||0
10080215|NCT02249182|11208338|FG004|COMPLETED|PK Lead-In Phase||17
10080216|NCT02249182|11208334|FG000|NOT COMPLETED|PK Lead-In Phase||0
10080217|NCT02249182|11208335|FG001|NOT COMPLETED|PK Lead-In Phase||0
10080218|NCT02249182|11208336|FG002|NOT COMPLETED|PK Lead-In Phase||0
10080219|NCT02249182|11208337|FG003|NOT COMPLETED|PK Lead-In Phase||0
10080220|NCT02249182|11208338|FG004|NOT COMPLETED|PK Lead-In Phase||0
10080221|NCT02249182|11208334|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
10080222|NCT02249182|11208335|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
10080223|NCT02249182|11208336|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
10080224|NCT02249182|11208337|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
10080225|NCT02249182|11208338|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
10080226|NCT02249182|11208334|FG000|COMPLETED|Treatment Phase||96
10080227|NCT02249182|11208335|FG001|COMPLETED|Treatment Phase||89
10080228|NCT02249182|11208336|FG002|COMPLETED|Treatment Phase||1
10080229|NCT02249182|11208337|FG003|COMPLETED|Treatment Phase||2
10080230|NCT02249182|11208338|FG004|COMPLETED|Treatment Phase||34
10080231|NCT02249182|11208334|FG000|NOT COMPLETED|Treatment Phase||4
10080232|NCT02249182|11208335|FG001|NOT COMPLETED|Treatment Phase||0
10080233|NCT02249182|11208336|FG002|NOT COMPLETED|Treatment Phase||0
10080234|NCT02249182|11208337|FG003|NOT COMPLETED|Treatment Phase||0
10080235|NCT02249182|11208338|FG004|NOT COMPLETED|Treatment Phase||0
10080236|NCT02249585|11208366|FG000|STARTED|Overall Study||43
10080237|NCT02249585|11208367|FG001|STARTED|Overall Study||44
10080238|NCT02249585|11208368|FG002|STARTED|Overall Study||44
10080239|NCT02249585|11208366|FG000|COMPLETED|Overall Study||43
10080240|NCT02249585|11208367|FG001|COMPLETED|Overall Study||44
10080241|NCT02249585|11208368|FG002|COMPLETED|Overall Study||44
10080242|NCT02249585|11208366|FG000|NOT COMPLETED|Overall Study||0
10080243|NCT02249585|11208367|FG001|NOT COMPLETED|Overall Study||0
10080244|NCT02249585|11208368|FG002|NOT COMPLETED|Overall Study||0
10080245|NCT02249728|11208376|FG000|STARTED|Part One (4 Days)||6
10080246|NCT02249728|11208376|FG000|COMPLETED|Part One (4 Days)||6
10080247|NCT02249728|11208376|FG000|NOT COMPLETED|Part One (4 Days)||0
10080248|NCT02249728|11208376|FG000|STARTED|Part Two (up to 6 Days)||6
10080249|NCT02249728|11208376|FG000|COMPLETED|Part Two (up to 6 Days)||6
10080250|NCT02249728|11208376|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0
10080251|NCT02249767|11208386|FG000|STARTED|Overall Study||230
10080252|NCT02249767|11208387|FG001|STARTED|Overall Study||229
10080253|NCT02249767|11208388|FG002|STARTED|Overall Study||115
10080254|NCT02249767|11208386|FG000|COMPLETED|Overall Study||222
10080255|NCT02249767|11208387|FG001|COMPLETED|Overall Study||220
10080256|NCT02249767|11208388|FG002|COMPLETED|Overall Study||107
10080257|NCT02249767|11208386|FG000|NOT COMPLETED|Overall Study||8
10080258|NCT02249767|11208387|FG001|NOT COMPLETED|Overall Study||9
10080259|NCT02249767|11208388|FG002|NOT COMPLETED|Overall Study||8
10080260|NCT02249793|11208396|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6
10080261|NCT02249793|11208396|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
10080262|NCT02249793|11208396|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
10080263|NCT02249793|11208396|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6
10080264|NCT02249793|11208396|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
10080265|NCT02249793|11208396|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
10080266|NCT02249819|11208401|FG000|STARTED|Overall Study||8
10080267|NCT02249819|11208402|FG001|STARTED|Overall Study||7
10080268|NCT02249819|11208401|FG000|COMPLETED|Overall Study||8
10080269|NCT02249819|11208402|FG001|COMPLETED|Overall Study||7
10080270|NCT02249819|11208401|FG000|NOT COMPLETED|Overall Study||0
10080271|NCT02249819|11208402|FG001|NOT COMPLETED|Overall Study||0
10080272|NCT02249832|11208408|FG000|STARTED|Overall Study||55
10080273|NCT02249832|11208408|FG000|COMPLETED|Overall Study||42
10080274|NCT02249832|11208408|FG000|NOT COMPLETED|Overall Study||13
10080275|NCT02249949|11208417|FG000|STARTED|Overall Study||13
10080276|NCT02249949|11208417|FG000|COMPLETED|Overall Study||11
10080277|NCT02249949|11208417|FG000|NOT COMPLETED|Overall Study||2
10192038|NCT03307252|11320769|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10192039|NCT03307252|11320759|FG000|NOT COMPLETED|Part 3, Period 1||0
10192040|NCT03307252|11320760|FG001|NOT COMPLETED|Part 3, Period 1||0
10192041|NCT03307252|11320761|FG002|NOT COMPLETED|Part 3, Period 1||0
10192042|NCT03307252|11320762|FG003|NOT COMPLETED|Part 3, Period 1||0
10192043|NCT03307252|11320763|FG004|NOT COMPLETED|Part 3, Period 1||0
10192044|NCT03307252|11320764|FG005|NOT COMPLETED|Part 3, Period 1||0
10192045|NCT03307252|11320765|FG006|NOT COMPLETED|Part 3, Period 1||0
10192046|NCT03307252|11320766|FG007|NOT COMPLETED|Part 3, Period 1||0
10192047|NCT03307252|11320767|FG008|NOT COMPLETED|Part 3, Period 1||0
10192048|NCT03307252|11320768|FG009|NOT COMPLETED|Part 3, Period 1||0
10192049|NCT03307252|11320769|FG010|NOT COMPLETED|Part 3, Period 1||0
10192050|NCT03307252|11320759|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0
10192051|NCT03307252|11320760|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0
10192052|NCT03307252|11320761|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0
10192053|NCT03307252|11320762|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0
10192054|NCT03307252|11320763|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0
10192055|NCT03307252|11320764|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0
10192056|NCT03307252|11320765|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0
10192057|NCT03307252|11320766|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4
10192058|NCT03307252|11320767|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4
10192059|NCT03307252|11320768|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4
10192060|NCT03307252|11320769|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4
10192061|NCT03307252|11320759|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192062|NCT03307252|11320760|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192063|NCT03307252|11320761|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192064|NCT03307252|11320762|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192065|NCT03307252|11320763|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192066|NCT03307252|11320764|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192067|NCT03307252|11320765|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192068|NCT03307252|11320766|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10192069|NCT03307252|11320767|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10192070|NCT03307252|11320768|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10192071|NCT03307252|11320769|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10080278|NCT02250092|11208423|FG000|STARTED|Overall Study||10
10080279|NCT02250092|11208424|FG001|STARTED|Overall Study||10
10080280|NCT02250092|11208423|FG000|COMPLETED|Overall Study||10
10080281|NCT02250092|11208424|FG001|COMPLETED|Overall Study||10
10080282|NCT02250092|11208423|FG000|NOT COMPLETED|Overall Study||0
10080283|NCT02250092|11208424|FG001|NOT COMPLETED|Overall Study||0
10080284|NCT02250183|11208430|FG000|STARTED|Overall Study||21
10080285|NCT02250183|11208430|FG000|COMPLETED|Overall Study||13
10080286|NCT02250183|11208430|FG000|NOT COMPLETED|Overall Study||8
10080287|NCT02250274|11208439|FG000|STARTED|Overall Study||85
10080288|NCT02250274|11208440|FG001|STARTED|Overall Study||46
10080289|NCT02250274|11208439|FG000|COMPLETED|Overall Study||78
10080290|NCT02250274|11208440|FG001|COMPLETED|Overall Study||40
10080291|NCT02250274|11208439|FG000|NOT COMPLETED|Overall Study||7
10080292|NCT02250274|11208440|FG001|NOT COMPLETED|Overall Study||6
10080293|NCT02250417|11208452|FG000|STARTED|First Intervention (1 Night)||6
10080294|NCT02250417|11208453|FG001|STARTED|First Intervention (1 Night)||6
10080295|NCT02250417|11208452|FG000|COMPLETED|First Intervention (1 Night)||6
10080296|NCT02250417|11208453|FG001|COMPLETED|First Intervention (1 Night)||6
10080297|NCT02250417|11208452|FG000|NOT COMPLETED|First Intervention (1 Night)||0
10080298|NCT02250417|11208453|FG001|NOT COMPLETED|First Intervention (1 Night)||0
10080299|NCT02250417|11208452|FG000|STARTED|Second Intervention (1 Night)||6
10080300|NCT02250417|11208453|FG001|STARTED|Second Intervention (1 Night)||6
10080301|NCT02250417|11208452|FG000|COMPLETED|Second Intervention (1 Night)||6
10080302|NCT02250417|11208453|FG001|COMPLETED|Second Intervention (1 Night)||6
10080303|NCT02250417|11208452|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
10080304|NCT02250417|11208453|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
10080305|NCT02250443|11208462|FG000|STARTED|Overall Study||10
10080306|NCT02250443|11208462|FG000|COMPLETED|Overall Study||0
10080307|NCT02250443|11208462|FG000|NOT COMPLETED|Overall Study||10
10080308|NCT02250521|11208466|FG000|STARTED|Overall Study||100
10080309|NCT02250521|11208466|FG000|COMPLETED|Overall Study||99
10080310|NCT02250521|11208466|FG000|NOT COMPLETED|Overall Study||1
10080311|NCT02250612|11208475|FG000|STARTED|Overall Study||37
10192072|NCT03307252|11320759|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192073|NCT03307252|11320760|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192074|NCT03307252|11320761|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192075|NCT03307252|11320762|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192076|NCT03307252|11320763|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192077|NCT03307252|11320764|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192078|NCT03307252|11320765|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192079|NCT03307252|11320766|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192080|NCT03307252|11320767|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192081|NCT03307252|11320768|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192082|NCT03307252|11320769|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10192083|NCT03307252|11320759|FG000|STARTED|Part 3, Period 2||0
10192084|NCT03307252|11320760|FG001|STARTED|Part 3, Period 2||0
10192085|NCT03307252|11320761|FG002|STARTED|Part 3, Period 2||0
10192086|NCT03307252|11320762|FG003|STARTED|Part 3, Period 2||0
10192087|NCT03307252|11320763|FG004|STARTED|Part 3, Period 2||0
10192088|NCT03307252|11320764|FG005|STARTED|Part 3, Period 2||0
10192089|NCT03307252|11320765|FG006|STARTED|Part 3, Period 2||0
10192090|NCT03307252|11320766|FG007|STARTED|Part 3, Period 2||4
10192091|NCT03307252|11320767|FG008|STARTED|Part 3, Period 2||4
10192092|NCT03307252|11320768|FG009|STARTED|Part 3, Period 2||4
10192093|NCT03307252|11320769|FG010|STARTED|Part 3, Period 2||4
10192094|NCT03307252|11320759|FG000|COMPLETED|Part 3, Period 2||0
10192095|NCT03307252|11320760|FG001|COMPLETED|Part 3, Period 2||0
10192096|NCT03307252|11320761|FG002|COMPLETED|Part 3, Period 2||0
10192097|NCT03307252|11320762|FG003|COMPLETED|Part 3, Period 2||0
10192098|NCT03307252|11320763|FG004|COMPLETED|Part 3, Period 2||0
10192099|NCT03307252|11320764|FG005|COMPLETED|Part 3, Period 2||0
10192100|NCT03307252|11320765|FG006|COMPLETED|Part 3, Period 2||0
10192101|NCT03307252|11320766|FG007|COMPLETED|Part 3, Period 2||4
10192102|NCT03307252|11320767|FG008|COMPLETED|Part 3, Period 2||4
10192103|NCT03307252|11320768|FG009|COMPLETED|Part 3, Period 2||4
10192104|NCT03307252|11320769|FG010|COMPLETED|Part 3, Period 2||4
10192105|NCT03307252|11320759|FG000|NOT COMPLETED|Part 3, Period 2||0
10192106|NCT03307252|11320760|FG001|NOT COMPLETED|Part 3, Period 2||0
10080312|NCT02250612|11208476|FG001|STARTED|Overall Study||40
10080313|NCT02250612|11208477|FG002|STARTED|Overall Study||37
10080314|NCT02250612|11208478|FG003|STARTED|Overall Study||33
10080315|NCT02250612|11208479|FG004|STARTED|Overall Study||37
10080316|NCT02250612|11208475|FG000|COMPLETED|Overall Study||36
10080317|NCT02250612|11208476|FG001|COMPLETED|Overall Study||38
10080318|NCT02250612|11208477|FG002|COMPLETED|Overall Study||35
10080319|NCT02250612|11208478|FG003|COMPLETED|Overall Study||33
10080320|NCT02250612|11208479|FG004|COMPLETED|Overall Study||36
10080321|NCT02250612|11208475|FG000|NOT COMPLETED|Overall Study||1
10080322|NCT02250612|11208476|FG001|NOT COMPLETED|Overall Study||2
10080323|NCT02250612|11208477|FG002|NOT COMPLETED|Overall Study||2
10080324|NCT02250612|11208478|FG003|NOT COMPLETED|Overall Study||0
10080325|NCT02250612|11208479|FG004|NOT COMPLETED|Overall Study||1
10080326|NCT02250651|11208501|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
10080327|NCT02250651|11208502|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
10080328|NCT02250651|11208503|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
10080329|NCT02250651|11208501|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
10080330|NCT02250651|11208502|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
10080331|NCT02250651|11208503|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
10080332|NCT02250651|11208501|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
10080333|NCT02250651|11208502|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
10080334|NCT02250651|11208503|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
10080335|NCT02250651|11208501|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
10080336|NCT02250651|11208502|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
10080337|NCT02250651|11208503|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
10080338|NCT02250651|11208501|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
10192107|NCT03307252|11320761|FG002|NOT COMPLETED|Part 3, Period 2||0
10192108|NCT03307252|11320762|FG003|NOT COMPLETED|Part 3, Period 2||0
10192109|NCT03307252|11320763|FG004|NOT COMPLETED|Part 3, Period 2||0
10192110|NCT03307252|11320764|FG005|NOT COMPLETED|Part 3, Period 2||0
10192111|NCT03307252|11320765|FG006|NOT COMPLETED|Part 3, Period 2||0
10192112|NCT03307252|11320766|FG007|NOT COMPLETED|Part 3, Period 2||0
10192113|NCT03307252|11320767|FG008|NOT COMPLETED|Part 3, Period 2||0
10192114|NCT03307252|11320768|FG009|NOT COMPLETED|Part 3, Period 2||0
10192115|NCT03307252|11320769|FG010|NOT COMPLETED|Part 3, Period 2||0
10192116|NCT03307252|11320759|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0
10192117|NCT03307252|11320760|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0
10192118|NCT03307252|11320761|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0
10192119|NCT03307252|11320762|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0
10192120|NCT03307252|11320763|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0
10192121|NCT03307252|11320764|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0
10192122|NCT03307252|11320765|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0
10192123|NCT03307252|11320766|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4
10192124|NCT03307252|11320767|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4
10192125|NCT03307252|11320768|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4
10192126|NCT03307252|11320769|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4
10192127|NCT03307252|11320759|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192128|NCT03307252|11320760|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192129|NCT03307252|11320761|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192130|NCT03307252|11320762|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192131|NCT03307252|11320763|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192132|NCT03307252|11320764|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192133|NCT03307252|11320765|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192134|NCT03307252|11320766|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10192135|NCT03307252|11320767|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10192136|NCT03307252|11320768|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10192137|NCT03307252|11320769|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10192138|NCT03307252|11320759|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192139|NCT03307252|11320760|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192140|NCT03307252|11320761|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192141|NCT03307252|11320762|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192142|NCT03307252|11320763|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192143|NCT03307252|11320764|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192144|NCT03307252|11320765|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192145|NCT03307252|11320766|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192146|NCT03307252|11320767|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192147|NCT03307252|11320768|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192148|NCT03307252|11320769|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10192149|NCT03307252|11320759|FG000|STARTED|Part 3, Period 3||0
10192150|NCT03307252|11320760|FG001|STARTED|Part 3, Period 3||0
10192151|NCT03307252|11320761|FG002|STARTED|Part 3, Period 3||0
10192152|NCT03307252|11320762|FG003|STARTED|Part 3, Period 3||0
10192153|NCT03307252|11320763|FG004|STARTED|Part 3, Period 3||0
10192154|NCT03307252|11320764|FG005|STARTED|Part 3, Period 3||0
10192155|NCT03307252|11320765|FG006|STARTED|Part 3, Period 3||0
10192156|NCT03307252|11320766|FG007|STARTED|Part 3, Period 3||4
10192157|NCT03307252|11320767|FG008|STARTED|Part 3, Period 3||4
10192158|NCT03307252|11320768|FG009|STARTED|Part 3, Period 3||4
10192159|NCT03307252|11320769|FG010|STARTED|Part 3, Period 3||4
10192160|NCT03307252|11320759|FG000|COMPLETED|Part 3, Period 3||0
10192161|NCT03307252|11320760|FG001|COMPLETED|Part 3, Period 3||0
10192162|NCT03307252|11320761|FG002|COMPLETED|Part 3, Period 3||0
10192163|NCT03307252|11320762|FG003|COMPLETED|Part 3, Period 3||0
10192164|NCT03307252|11320763|FG004|COMPLETED|Part 3, Period 3||0
10192165|NCT03307252|11320764|FG005|COMPLETED|Part 3, Period 3||0
10192166|NCT03307252|11320765|FG006|COMPLETED|Part 3, Period 3||0
10192167|NCT03307252|11320766|FG007|COMPLETED|Part 3, Period 3||4
10192168|NCT03307252|11320767|FG008|COMPLETED|Part 3, Period 3||4
10192169|NCT03307252|11320768|FG009|COMPLETED|Part 3, Period 3||4
10192170|NCT03307252|11320769|FG010|COMPLETED|Part 3, Period 3||4
10192171|NCT03307252|11320759|FG000|NOT COMPLETED|Part 3, Period 3||0
10192172|NCT03307252|11320760|FG001|NOT COMPLETED|Part 3, Period 3||0
10192173|NCT03307252|11320761|FG002|NOT COMPLETED|Part 3, Period 3||0
10192174|NCT03307252|11320762|FG003|NOT COMPLETED|Part 3, Period 3||0
10192175|NCT03307252|11320763|FG004|NOT COMPLETED|Part 3, Period 3||0
10192176|NCT03307252|11320764|FG005|NOT COMPLETED|Part 3, Period 3||0
10192177|NCT03307252|11320765|FG006|NOT COMPLETED|Part 3, Period 3||0
10192178|NCT03307252|11320766|FG007|NOT COMPLETED|Part 3, Period 3||0
10192179|NCT03307252|11320767|FG008|NOT COMPLETED|Part 3, Period 3||0
10192180|NCT03307252|11320768|FG009|NOT COMPLETED|Part 3, Period 3||0
10192181|NCT03307252|11320769|FG010|NOT COMPLETED|Part 3, Period 3||0
10192182|NCT03307252|11320759|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0
10192183|NCT03307252|11320760|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0
10192184|NCT03307252|11320761|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0
10192185|NCT03307252|11320762|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0
10192186|NCT03307252|11320763|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0
10192187|NCT03307252|11320764|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0
10192188|NCT03307252|11320765|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0
10192189|NCT03307252|11320766|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4
10192190|NCT03307252|11320767|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4
10192191|NCT03307252|11320768|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4
10192192|NCT03307252|11320769|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4
10192193|NCT03307252|11320759|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192194|NCT03307252|11320760|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192195|NCT03307252|11320761|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192196|NCT03307252|11320762|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192197|NCT03307252|11320763|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192198|NCT03307252|11320764|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192199|NCT03307252|11320765|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192200|NCT03307252|11320766|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
10192201|NCT03307252|11320767|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
10192202|NCT03307252|11320768|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
10192203|NCT03307252|11320769|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
10192204|NCT03307252|11320759|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192205|NCT03307252|11320760|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192206|NCT03307252|11320761|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192207|NCT03307252|11320762|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192208|NCT03307252|11320763|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192209|NCT03307252|11320764|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192210|NCT03307252|11320765|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192211|NCT03307252|11320766|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192212|NCT03307252|11320767|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192213|NCT03307252|11320768|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10192214|NCT03307252|11320769|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
10192215|NCT03307252|11320759|FG000|STARTED|Part 3, Period 4||0
10192216|NCT03307252|11320760|FG001|STARTED|Part 3, Period 4||0
10192217|NCT03307252|11320761|FG002|STARTED|Part 3, Period 4||0
10192218|NCT03307252|11320762|FG003|STARTED|Part 3, Period 4||0
10192219|NCT03307252|11320763|FG004|STARTED|Part 3, Period 4||0
10192220|NCT03307252|11320764|FG005|STARTED|Part 3, Period 4||0
10192221|NCT03307252|11320765|FG006|STARTED|Part 3, Period 4||0
10192222|NCT03307252|11320766|FG007|STARTED|Part 3, Period 4||4
10192223|NCT03307252|11320767|FG008|STARTED|Part 3, Period 4||4
10192224|NCT03307252|11320768|FG009|STARTED|Part 3, Period 4||4
10192225|NCT03307252|11320769|FG010|STARTED|Part 3, Period 4||3
10192226|NCT03307252|11320759|FG000|COMPLETED|Part 3, Period 4||0
10192227|NCT03307252|11320760|FG001|COMPLETED|Part 3, Period 4||0
10192228|NCT03307252|11320761|FG002|COMPLETED|Part 3, Period 4||0
10192229|NCT03307252|11320762|FG003|COMPLETED|Part 3, Period 4||0
10192230|NCT03307252|11320763|FG004|COMPLETED|Part 3, Period 4||0
10192231|NCT03307252|11320764|FG005|COMPLETED|Part 3, Period 4||0
10192232|NCT03307252|11320765|FG006|COMPLETED|Part 3, Period 4||0
10192233|NCT03307252|11320766|FG007|COMPLETED|Part 3, Period 4||4
10192234|NCT03307252|11320767|FG008|COMPLETED|Part 3, Period 4||4
10192235|NCT03307252|11320768|FG009|COMPLETED|Part 3, Period 4||4
10192236|NCT03307252|11320769|FG010|COMPLETED|Part 3, Period 4||3
10192237|NCT03307252|11320759|FG000|NOT COMPLETED|Part 3, Period 4||0
10192238|NCT03307252|11320760|FG001|NOT COMPLETED|Part 3, Period 4||0
10192239|NCT03307252|11320761|FG002|NOT COMPLETED|Part 3, Period 4||0
10192240|NCT03307252|11320762|FG003|NOT COMPLETED|Part 3, Period 4||0
10192241|NCT03307252|11320763|FG004|NOT COMPLETED|Part 3, Period 4||0
10192242|NCT03307252|11320764|FG005|NOT COMPLETED|Part 3, Period 4||0
10192243|NCT03307252|11320765|FG006|NOT COMPLETED|Part 3, Period 4||0
10192244|NCT03307252|11320766|FG007|NOT COMPLETED|Part 3, Period 4||0
10192245|NCT03307252|11320767|FG008|NOT COMPLETED|Part 3, Period 4||0
10192246|NCT03307252|11320768|FG009|NOT COMPLETED|Part 3, Period 4||0
10192247|NCT03307252|11320769|FG010|NOT COMPLETED|Part 3, Period 4||0
10192248|NCT03307837|11320791|FG000|STARTED|Overall Study||6
10192249|NCT03307837|11320792|FG001|STARTED|Overall Study||6
10192250|NCT03307837|11320793|FG002|STARTED|Overall Study||6
10192251|NCT03307837|11320794|FG003|STARTED|Overall Study||6
10192252|NCT03307837|11320795|FG004|STARTED|Overall Study||6
10192253|NCT03307837|11320796|FG005|STARTED|Overall Study||10
10192254|NCT03307837|11320791|FG000|COMPLETED|Overall Study||5
10192255|NCT03307837|11320792|FG001|COMPLETED|Overall Study||5
10192256|NCT03307837|11320793|FG002|COMPLETED|Overall Study||5
10192257|NCT03307837|11320794|FG003|COMPLETED|Overall Study||6
10192258|NCT03307837|11320795|FG004|COMPLETED|Overall Study||6
10192259|NCT03307837|11320796|FG005|COMPLETED|Overall Study||8
10192260|NCT03307837|11320791|FG000|NOT COMPLETED|Overall Study||1
10192261|NCT03307837|11320792|FG001|NOT COMPLETED|Overall Study||1
10192262|NCT03307837|11320793|FG002|NOT COMPLETED|Overall Study||1
10192263|NCT03307837|11320794|FG003|NOT COMPLETED|Overall Study||0
10192264|NCT03307837|11320795|FG004|NOT COMPLETED|Overall Study||0
10192265|NCT03307837|11320796|FG005|NOT COMPLETED|Overall Study||2
10192266|NCT03308058|11320817|FG000|STARTED|Overall Study||23
10192267|NCT03308058|11320818|FG001|STARTED|Overall Study||23
10192268|NCT03308058|11320817|FG000|COMPLETED|Overall Study||23
10192269|NCT03308058|11320818|FG001|COMPLETED|Overall Study||23
10192270|NCT03308058|11320817|FG000|NOT COMPLETED|Overall Study||0
10192271|NCT03308058|11320818|FG001|NOT COMPLETED|Overall Study||0
10192272|NCT03308097|11320826|FG000|STARTED|Overall Study||33
10192273|NCT03308097|11320827|FG001|STARTED|Overall Study||32
10192274|NCT03308097|11320826|FG000|COMPLETED|Overall Study||31
10192275|NCT03308097|11320827|FG001|COMPLETED|Overall Study||31
10192276|NCT03308097|11320826|FG000|NOT COMPLETED|Overall Study||2
10192277|NCT03308097|11320827|FG001|NOT COMPLETED|Overall Study||1
10192278|NCT03308669|11320835|FG000|STARTED|Overall Study||10
10192279|NCT03308669|11320836|FG001|STARTED|Overall Study||20
10192280|NCT03308669|11320835|FG000|Received at Least One Dose of Study Drug|Overall Study||10
10192281|NCT03308669|11320836|FG001|Received at Least One Dose of Study Drug|Overall Study||20
10192282|NCT03308669|11320835|FG000|COMPLETED|Overall Study||10
10192283|NCT03308669|11320836|FG001|COMPLETED|Overall Study||20
10192284|NCT03308669|11320835|FG000|NOT COMPLETED|Overall Study||0
10192285|NCT03308669|11320836|FG001|NOT COMPLETED|Overall Study||0
10192286|NCT03308799|11320857|FG000|STARTED|Overall Study||342
10192287|NCT03308799|11320858|FG001|STARTED|Overall Study||337
10192288|NCT03308799|11320859|FG002|STARTED|Overall Study||115
10192289|NCT03308799|11320857|FG000|COMPLETED|Overall Study||320
10192290|NCT03308799|11320858|FG001|COMPLETED|Overall Study||309
10192291|NCT03308799|11320859|FG002|COMPLETED|Overall Study||94
10192292|NCT03308799|11320857|FG000|NOT COMPLETED|Overall Study||22
10192293|NCT03308799|11320858|FG001|NOT COMPLETED|Overall Study||28
10192294|NCT03308799|11320859|FG002|NOT COMPLETED|Overall Study||21
10192295|NCT03308942|11320872|FG000|STARTED|Stage 1 (up to a Maximum of 29 Months)||17
10192296|NCT03308942|11320873|FG001|STARTED|Stage 1 (up to a Maximum of 29 Months)||21
10192297|NCT03308942|11320874|FG002|STARTED|Stage 1 (up to a Maximum of 29 Months)||3
10192298|NCT03308942|11320875|FG003|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
10192299|NCT03308942|11320876|FG004|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
10192300|NCT03308942|11320872|FG000|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
10192301|NCT03308942|11320873|FG001|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
10192302|NCT03308942|11320874|FG002|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
10192303|NCT03308942|11320875|FG003|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
10192304|NCT03308942|11320876|FG004|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
10192305|NCT03308942|11320872|FG000|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||17
10192306|NCT03308942|11320873|FG001|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||21
10192307|NCT03308942|11320874|FG002|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||3
10192308|NCT03308942|11320875|FG003|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
10192309|NCT03308942|11320876|FG004|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
10192310|NCT03308942|11320872|FG000|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
10192311|NCT03308942|11320873|FG001|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
10192312|NCT03308942|11320874|FG002|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
10192313|NCT03308942|11320875|FG003|STARTED|Stage 2 (up to a Maximum of 17 Months)||12
10192314|NCT03308942|11320876|FG004|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
10192315|NCT03308942|11320872|FG000|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192316|NCT03308942|11320873|FG001|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192317|NCT03308942|11320874|FG002|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192318|NCT03308942|11320875|FG003|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192319|NCT03308942|11320876|FG004|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192320|NCT03308942|11320872|FG000|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192321|NCT03308942|11320873|FG001|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192322|NCT03308942|11320874|FG002|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192323|NCT03308942|11320875|FG003|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||12
10192324|NCT03308942|11320876|FG004|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
10192325|NCT03308968|11320892|FG000|STARTED|Double-Blind Period (12 Weeks)||279
10192326|NCT03308968|11320893|FG001|STARTED|Double-Blind Period (12 Weeks)||276
10192327|NCT03308968|11320894|FG002|STARTED|Double-Blind Period (12 Weeks)||283
10192328|NCT03308968|11320892|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
10192329|NCT03308968|11320893|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
10192330|NCT03308968|11320894|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
10192331|NCT03308968|11320892|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
10192332|NCT03308968|11320893|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
10192333|NCT03308968|11320894|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
10192334|NCT03308968|11320892|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264
10192335|NCT03308968|11320893|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271
10192336|NCT03308968|11320894|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272
10192337|NCT03308968|11320892|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
10192338|NCT03308968|11320893|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
10192339|NCT03308968|11320894|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
10192340|NCT03308968|11320892|FG000|STARTED|Open-Label Period (12 Weeks)||264
10192341|NCT03308968|11320893|FG001|STARTED|Open-Label Period (12 Weeks)||271
10192342|NCT03308968|11320894|FG002|STARTED|Open-Label Period (12 Weeks)||272
10192343|NCT03308968|11320892|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
10192344|NCT03308968|11320893|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
10192345|NCT03308968|11320894|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
10192346|NCT03308968|11320892|FG000|COMPLETED|Open-Label Period (12 Weeks)||253
10192347|NCT03308968|11320893|FG001|COMPLETED|Open-Label Period (12 Weeks)||259
10192348|NCT03308968|11320894|FG002|COMPLETED|Open-Label Period (12 Weeks)||260
10192349|NCT03308968|11320892|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11
10192350|NCT03308968|11320893|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12
10192351|NCT03308968|11320894|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12
10192352|NCT03309020|11320907|FG000|STARTED|Overall Study||12
10192353|NCT03309020|11320908|FG001|STARTED|Overall Study||25
10192354|NCT03309020|11320907|FG000|Underwent Cataract Surgery|Overall Study||10
10192355|NCT03309020|11320908|FG001|Underwent Cataract Surgery|Overall Study||24
10192356|NCT03309020|11320907|FG000|COMPLETED|Overall Study||9
10192357|NCT03309020|11320908|FG001|COMPLETED|Overall Study||24
10192358|NCT03309020|11320907|FG000|NOT COMPLETED|Overall Study||3
10192359|NCT03309020|11320908|FG001|NOT COMPLETED|Overall Study||1
10192360|NCT03309202|11320920|FG000|STARTED|Overall Study||6
10192361|NCT03309202|11320921|FG001|STARTED|Overall Study||6
10192362|NCT03309202|11320922|FG002|STARTED|Overall Study||6
10192363|NCT03309202|11320923|FG003|STARTED|Overall Study||6
10192364|NCT03309202|11320920|FG000|COMPLETED|Overall Study||5
10192365|NCT03309202|11320921|FG001|COMPLETED|Overall Study||6
10192366|NCT03309202|11320922|FG002|COMPLETED|Overall Study||6
10192367|NCT03309202|11320923|FG003|COMPLETED|Overall Study||6
10192368|NCT03309202|11320920|FG000|NOT COMPLETED|Overall Study||1
10192369|NCT03309202|11320921|FG001|NOT COMPLETED|Overall Study||0
10192370|NCT03309202|11320922|FG002|NOT COMPLETED|Overall Study||0
10192371|NCT03309202|11320923|FG003|NOT COMPLETED|Overall Study||0
10192372|NCT03309449|11320936|FG000|STARTED|Overall Study||46
10192373|NCT03309449|11320937|FG001|STARTED|Overall Study||46
10192374|NCT03309449|11320938|FG002|STARTED|Overall Study||46
10192375|NCT03309449|11320936|FG000|COMPLETED|Overall Study||46
10192376|NCT03309449|11320937|FG001|COMPLETED|Overall Study||46
10192377|NCT03309449|11320938|FG002|COMPLETED|Overall Study||46
10192378|NCT03309449|11320936|FG000|NOT COMPLETED|Overall Study||0
10192379|NCT03309449|11320937|FG001|NOT COMPLETED|Overall Study||0
10192380|NCT03309449|11320938|FG002|NOT COMPLETED|Overall Study||0
10192381|NCT03309605|11320954|FG000|STARTED|Overall Study||6
10192382|NCT03309605|11320955|FG001|STARTED|Overall Study||5
10192383|NCT03309605|11320956|FG002|STARTED|Overall Study||6
10192384|NCT03309605|11320957|FG003|STARTED|Overall Study||6
10192385|NCT03309605|11320958|FG004|STARTED|Overall Study||6
10192386|NCT03309605|11320959|FG005|STARTED|Overall Study||6
10192387|NCT03309605|11320960|FG006|STARTED|Overall Study||6
10192388|NCT03309605|11320961|FG007|STARTED|Overall Study||21
10192389|NCT03309605|11320954|FG000|COMPLETED|Overall Study||6
10192390|NCT03309605|11320955|FG001|COMPLETED|Overall Study||5
10192391|NCT03309605|11320956|FG002|COMPLETED|Overall Study||6
10192392|NCT03309605|11320957|FG003|COMPLETED|Overall Study||5
10192393|NCT03309605|11320958|FG004|COMPLETED|Overall Study||5
10192394|NCT03309605|11320959|FG005|COMPLETED|Overall Study||6
10192395|NCT03309605|11320960|FG006|COMPLETED|Overall Study||3
10192396|NCT03309605|11320961|FG007|COMPLETED|Overall Study||19
10192397|NCT03309605|11320954|FG000|NOT COMPLETED|Overall Study||0
10192398|NCT03309605|11320955|FG001|NOT COMPLETED|Overall Study||0
10192399|NCT03309605|11320956|FG002|NOT COMPLETED|Overall Study||0
10192400|NCT03309605|11320957|FG003|NOT COMPLETED|Overall Study||1
10192401|NCT03309605|11320958|FG004|NOT COMPLETED|Overall Study||1
10192402|NCT03309605|11320959|FG005|NOT COMPLETED|Overall Study||0
10192403|NCT03309605|11320960|FG006|NOT COMPLETED|Overall Study||3
10192404|NCT03309605|11320961|FG007|NOT COMPLETED|Overall Study||2
10192405|NCT03309657|11320975|FG000|STARTED|Overall Study||10
10192406|NCT03309657|11320975|FG000|COMPLETED|Overall Study||10
10192407|NCT03309657|11320975|FG000|NOT COMPLETED|Overall Study||0
10192408|NCT03309696|11320981|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
10192409|NCT03309696|11320982|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
10192410|NCT03309696|11320983|FG002|STARTED|Overall Study||0
10192411|NCT03309696|11320984|FG003|STARTED|Overall Study||0
10192412|NCT03309696|11320981|FG000|COMPLETED|Overall Study||5
10192413|NCT03309696|11320982|FG001|COMPLETED|Overall Study||0
10192414|NCT03309696|11320983|FG002|COMPLETED|Overall Study||0
10192415|NCT03309696|11320984|FG003|COMPLETED|Overall Study||0
10192416|NCT03309696|11320981|FG000|NOT COMPLETED|Overall Study||0
10192417|NCT03309696|11320982|FG001|NOT COMPLETED|Overall Study||5
10192418|NCT03309696|11320983|FG002|NOT COMPLETED|Overall Study||0
10192419|NCT03309696|11320984|FG003|NOT COMPLETED|Overall Study||0
10192420|NCT03309787|11320995|FG000|STARTED|Overall Study||8
10192421|NCT03309787|11320996|FG001|STARTED|Overall Study||20
10192422|NCT03309787|11320997|FG002|STARTED|Overall Study||9
10192423|NCT03309787|11320995|FG000|COMPLETED|Overall Study||6
10192424|NCT03309787|11320996|FG001|COMPLETED|Overall Study||14
10192425|NCT03309787|11320997|FG002|COMPLETED|Overall Study||7
10192426|NCT03309787|11320995|FG000|NOT COMPLETED|Overall Study||2
10192427|NCT03309787|11320996|FG001|NOT COMPLETED|Overall Study||6
10192428|NCT03309787|11320997|FG002|NOT COMPLETED|Overall Study||2
10192429|NCT03309943|11321013|FG000|STARTED|Overall Study||22
10192430|NCT03309943|11321014|FG001|STARTED|Overall Study||22
10192431|NCT03309943|11321013|FG000|COMPLETED|Overall Study||22
10192432|NCT03309943|11321014|FG001|COMPLETED|Overall Study||20
10192433|NCT03309943|11321013|FG000|NOT COMPLETED|Overall Study||0
10192434|NCT03309943|11321014|FG001|NOT COMPLETED|Overall Study||2
10192435|NCT03310021|11321040|FG000|STARTED|Overall Study||6
10192436|NCT03310021|11321041|FG001|STARTED|Overall Study||3
10192437|NCT03310021|11321042|FG002|STARTED|Overall Study||6
10192438|NCT03310021|11321043|FG003|STARTED|Overall Study||3
10192439|NCT03310021|11321044|FG004|STARTED|Overall Study||8
10192440|NCT03310021|11321045|FG005|STARTED|Overall Study||4
10192441|NCT03310021|11321046|FG006|STARTED|Overall Study||8
10192442|NCT03310021|11321047|FG007|STARTED|Overall Study||4
10192443|NCT03310021|11321048|FG008|STARTED|Overall Study||6
10192444|NCT03310021|11321049|FG009|STARTED|Overall Study||3
10192445|NCT03310021|11321050|FG010|STARTED|Overall Study||6
10192446|NCT03310021|11321051|FG011|STARTED|Overall Study||3
10192447|NCT03310021|11321052|FG012|STARTED|Overall Study||8
10192448|NCT03310021|11321053|FG013|STARTED|Overall Study||4
10192449|NCT03310021|11321054|FG014|STARTED|Overall Study||6
10192450|NCT03310021|11321055|FG015|STARTED|Overall Study||3
10192451|NCT03310021|11321056|FG016|STARTED|Overall Study||10
10192452|NCT03310021|11321057|FG017|STARTED|Overall Study||5
10192453|NCT03310021|11321058|FG018|STARTED|Overall Study||8
10192454|NCT03310021|11321059|FG019|STARTED|Overall Study||3
10192455|NCT03310021|11321040|FG000|COMPLETED|Overall Study||6
10192456|NCT03310021|11321041|FG001|COMPLETED|Overall Study||3
10192457|NCT03310021|11321042|FG002|COMPLETED|Overall Study||6
10192458|NCT03310021|11321043|FG003|COMPLETED|Overall Study||3
10192459|NCT03310021|11321044|FG004|COMPLETED|Overall Study||8
10192460|NCT03310021|11321045|FG005|COMPLETED|Overall Study||4
10192461|NCT03310021|11321046|FG006|COMPLETED|Overall Study||7
10192462|NCT03310021|11321047|FG007|COMPLETED|Overall Study||4
10192463|NCT03310021|11321048|FG008|COMPLETED|Overall Study||6
10192464|NCT03310021|11321049|FG009|COMPLETED|Overall Study||3
10192465|NCT03310021|11321050|FG010|COMPLETED|Overall Study||5
10192466|NCT03310021|11321051|FG011|COMPLETED|Overall Study||3
10192467|NCT03310021|11321052|FG012|COMPLETED|Overall Study||8
10192468|NCT03310021|11321053|FG013|COMPLETED|Overall Study||4
10192469|NCT03310021|11321054|FG014|COMPLETED|Overall Study||6
10192470|NCT03310021|11321055|FG015|COMPLETED|Overall Study||3
10192471|NCT03310021|11321056|FG016|COMPLETED|Overall Study||10
10192472|NCT03310021|11321057|FG017|COMPLETED|Overall Study||5
10192473|NCT03310021|11321058|FG018|COMPLETED|Overall Study||8
10192474|NCT03310021|11321059|FG019|COMPLETED|Overall Study||3
10192475|NCT03310021|11321040|FG000|NOT COMPLETED|Overall Study||0
10192476|NCT03310021|11321041|FG001|NOT COMPLETED|Overall Study||0
10192477|NCT03310021|11321042|FG002|NOT COMPLETED|Overall Study||0
10192478|NCT03310021|11321043|FG003|NOT COMPLETED|Overall Study||0
10192479|NCT03310021|11321044|FG004|NOT COMPLETED|Overall Study||0
10192480|NCT03310021|11321045|FG005|NOT COMPLETED|Overall Study||0
10192481|NCT03310021|11321046|FG006|NOT COMPLETED|Overall Study||1
10192482|NCT03310021|11321047|FG007|NOT COMPLETED|Overall Study||0
10192483|NCT03310021|11321048|FG008|NOT COMPLETED|Overall Study||0
10192484|NCT03310021|11321049|FG009|NOT COMPLETED|Overall Study||0
10192485|NCT03310021|11321050|FG010|NOT COMPLETED|Overall Study||1
10192486|NCT03310021|11321051|FG011|NOT COMPLETED|Overall Study||0
10192487|NCT03310021|11321052|FG012|NOT COMPLETED|Overall Study||0
10192488|NCT03310021|11321053|FG013|NOT COMPLETED|Overall Study||0
10192489|NCT03310021|11321054|FG014|NOT COMPLETED|Overall Study||0
10192490|NCT03310021|11321055|FG015|NOT COMPLETED|Overall Study||0
10192491|NCT03310021|11321056|FG016|NOT COMPLETED|Overall Study||0
10192492|NCT03310021|11321057|FG017|NOT COMPLETED|Overall Study||0
10192493|NCT03310021|11321058|FG018|NOT COMPLETED|Overall Study||0
10192494|NCT03310021|11321059|FG019|NOT COMPLETED|Overall Study||0
10192495|NCT03310268|11321104|FG000|STARTED|Overall Study||62
10192496|NCT03310268|11321105|FG001|STARTED|Overall Study||62
10192497|NCT03310268|11321106|FG002|STARTED|Overall Study||61
10192498|NCT03310268|11321104|FG000|COMPLETED|Overall Study||61
10192499|NCT03310268|11321105|FG001|COMPLETED|Overall Study||57
10192500|NCT03310268|11321106|FG002|COMPLETED|Overall Study||61
10192501|NCT03310268|11321104|FG000|NOT COMPLETED|Overall Study||1
10192502|NCT03310268|11321105|FG001|NOT COMPLETED|Overall Study||5
10192503|NCT03310268|11321106|FG002|NOT COMPLETED|Overall Study||0
10192504|NCT03310411|11321114|FG000|STARTED|Period 1||10
10192505|NCT03310411|11321115|FG001|STARTED|Period 1||10
10192506|NCT03310411|11321116|FG002|STARTED|Period 1||10
10192507|NCT03310411|11321117|FG003|STARTED|Period 1||10
10192508|NCT03310411|11321114|FG000|Received at Least 1 Dose of Study Drug|Period 1||10
10192509|NCT03310411|11321115|FG001|Received at Least 1 Dose of Study Drug|Period 1||10
10192510|NCT03310411|11321116|FG002|Received at Least 1 Dose of Study Drug|Period 1||10
10192511|NCT03310411|11321117|FG003|Received at Least 1 Dose of Study Drug|Period 1||10
10192512|NCT03310411|11321114|FG000|COMPLETED|Period 1||10
10192513|NCT03310411|11321115|FG001|COMPLETED|Period 1||10
10192514|NCT03310411|11321116|FG002|COMPLETED|Period 1||10
10192515|NCT03310411|11321117|FG003|COMPLETED|Period 1||9
10192516|NCT03310411|11321114|FG000|NOT COMPLETED|Period 1||0
10192517|NCT03310411|11321115|FG001|NOT COMPLETED|Period 1||0
10192518|NCT03310411|11321116|FG002|NOT COMPLETED|Period 1||0
10192519|NCT03310411|11321117|FG003|NOT COMPLETED|Period 1||1
10192520|NCT03310411|11321114|FG000|STARTED|Period 2||10
10192521|NCT03310411|11321115|FG001|STARTED|Period 2||10
10192522|NCT03310411|11321116|FG002|STARTED|Period 2||10
10192523|NCT03310411|11321117|FG003|STARTED|Period 2||9
10192524|NCT03310411|11321114|FG000|COMPLETED|Period 2||10
10192525|NCT03310411|11321115|FG001|COMPLETED|Period 2||10
10192526|NCT03310411|11321116|FG002|COMPLETED|Period 2||10
10192527|NCT03310411|11321117|FG003|COMPLETED|Period 2||9
10192528|NCT03310411|11321114|FG000|NOT COMPLETED|Period 2||0
10192529|NCT03310411|11321115|FG001|NOT COMPLETED|Period 2||0
10192530|NCT03310411|11321116|FG002|NOT COMPLETED|Period 2||0
10192531|NCT03310411|11321117|FG003|NOT COMPLETED|Period 2||0
10192532|NCT03310411|11321114|FG000|STARTED|Period 3||10
10192533|NCT03310411|11321115|FG001|STARTED|Period 3||10
10192534|NCT03310411|11321116|FG002|STARTED|Period 3||10
10192535|NCT03310411|11321117|FG003|STARTED|Period 3||9
10192536|NCT03310411|11321114|FG000|COMPLETED|Period 3||10
10192537|NCT03310411|11321115|FG001|COMPLETED|Period 3||10
10192538|NCT03310411|11321116|FG002|COMPLETED|Period 3||10
10192539|NCT03310411|11321117|FG003|COMPLETED|Period 3||9
10192540|NCT03310411|11321114|FG000|NOT COMPLETED|Period 3||0
10192541|NCT03310411|11321115|FG001|NOT COMPLETED|Period 3||0
10192542|NCT03310411|11321116|FG002|NOT COMPLETED|Period 3||0
10192543|NCT03310411|11321117|FG003|NOT COMPLETED|Period 3||0
10192544|NCT03310411|11321114|FG000|STARTED|Period Title: Period 4||10
10192545|NCT03310411|11321115|FG001|STARTED|Period Title: Period 4||10
10192546|NCT03310411|11321116|FG002|STARTED|Period Title: Period 4||10
10192547|NCT03310411|11321117|FG003|STARTED|Period Title: Period 4||9
10192548|NCT03310411|11321114|FG000|COMPLETED|Period Title: Period 4||10
10192549|NCT03310411|11321115|FG001|COMPLETED|Period Title: Period 4||10
10192550|NCT03310411|11321116|FG002|COMPLETED|Period Title: Period 4||10
10192551|NCT03310411|11321117|FG003|COMPLETED|Period Title: Period 4||9
10192552|NCT03310411|11321114|FG000|NOT COMPLETED|Period Title: Period 4||0
10192553|NCT03310411|11321115|FG001|NOT COMPLETED|Period Title: Period 4||0
10192554|NCT03310411|11321116|FG002|NOT COMPLETED|Period Title: Period 4||0
10192555|NCT03310411|11321117|FG003|NOT COMPLETED|Period Title: Period 4||0
10192556|NCT03310450|11321136|FG000|STARTED|Overall Study||32
10192557|NCT03310450|11321137|FG001|STARTED|Overall Study||34
10192558|NCT03310450|11321138|FG002|STARTED|Overall Study||28
10192559|NCT03310450|11321136|FG000|COMPLETED|Overall Study||30
10192560|NCT03310450|11321137|FG001|COMPLETED|Overall Study||30
10192561|NCT03310450|11321138|FG002|COMPLETED|Overall Study||28
10192562|NCT03310450|11321136|FG000|NOT COMPLETED|Overall Study||2
10192563|NCT03310450|11321137|FG001|NOT COMPLETED|Overall Study||4
10192564|NCT03310450|11321138|FG002|NOT COMPLETED|Overall Study||0
10192565|NCT03310580|11321152|FG000|STARTED|Overall Study||15
10192566|NCT03310580|11321153|FG001|STARTED|Overall Study||15
10192567|NCT03310580|11321154|FG002|STARTED|Overall Study||12
10192568|NCT03310580|11321152|FG000|COMPLETED|Overall Study||15
10192569|NCT03310580|11321153|FG001|COMPLETED|Overall Study||14
10192570|NCT03310580|11321154|FG002|COMPLETED|Overall Study||12
10192571|NCT03310580|11321152|FG000|NOT COMPLETED|Overall Study||0
10192572|NCT03310580|11321153|FG001|NOT COMPLETED|Overall Study||1
10192573|NCT03310580|11321154|FG002|NOT COMPLETED|Overall Study||0
10192574|NCT03310723|11321165|FG000|STARTED|Overall Study||20
10192575|NCT03310723|11321166|FG001|STARTED|Overall Study||20
10192576|NCT03310723|11321165|FG000|COMPLETED|Overall Study||20
10192577|NCT03310723|11321166|FG001|COMPLETED|Overall Study||17
10192578|NCT03310723|11321165|FG000|NOT COMPLETED|Overall Study||0
10192579|NCT03310723|11321166|FG001|NOT COMPLETED|Overall Study||3
10192580|NCT03310775|11321174|FG000|STARTED|Overall Study||19
10192581|NCT03310775|11321175|FG001|STARTED|Overall Study||18
10192582|NCT03310775|11321174|FG000|COMPLETED|Overall Study||17
10192583|NCT03310775|11321175|FG001|COMPLETED|Overall Study||14
10192584|NCT03310775|11321174|FG000|NOT COMPLETED|Overall Study||2
10192585|NCT03310775|11321175|FG001|NOT COMPLETED|Overall Study||4
10192586|NCT03310970|11321181|FG000|STARTED|Overall Study||11
10192587|NCT03310970|11321182|FG001|STARTED|Overall Study||12
10192588|NCT03310970|11321181|FG000|COMPLETED|Overall Study||11
10192589|NCT03310970|11321182|FG001|COMPLETED|Overall Study||11
10192590|NCT03310970|11321181|FG000|NOT COMPLETED|Overall Study||0
10192591|NCT03310970|11321182|FG001|NOT COMPLETED|Overall Study||1
10192592|NCT03311230|11321193|FG000|STARTED|Overall Study||151
10192593|NCT03311230|11321194|FG001|STARTED|Overall Study||151
10192594|NCT03311230|11321195|FG002|STARTED|Overall Study||150
10192595|NCT03311230|11321196|FG003|STARTED|Overall Study||150
10192596|NCT03311230|11321193|FG000|COMPLETED|Overall Study||150
10192597|NCT03311230|11321194|FG001|COMPLETED|Overall Study||146
10192598|NCT03311230|11321195|FG002|COMPLETED|Overall Study||148
10192599|NCT03311230|11321196|FG003|COMPLETED|Overall Study||143
10192600|NCT03311230|11321193|FG000|NOT COMPLETED|Overall Study||1
10192601|NCT03311230|11321194|FG001|NOT COMPLETED|Overall Study||5
10192602|NCT03311230|11321195|FG002|NOT COMPLETED|Overall Study||2
10192603|NCT03311230|11321196|FG003|NOT COMPLETED|Overall Study||7
10192604|NCT03311373|11321206|FG000|STARTED|Overall Study||56
10192605|NCT03311373|11321206|FG000|COMPLETED|Overall Study||47
10192606|NCT03311373|11321206|FG000|NOT COMPLETED|Overall Study||9
10192607|NCT03311646|11321216|FG000|STARTED|Overall Study|Number who were eligible and consented.|31
10192608|NCT03311646|11321216|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16
10192609|NCT03311646|11321216|FG000|NOT COMPLETED|Overall Study||15
10192610|NCT03311659|11321221|FG000|STARTED|Overall Study||447
10192611|NCT03311659|11321221|FG000|COMPLETED|Overall Study||446
10192612|NCT03311659|11321221|FG000|NOT COMPLETED|Overall Study||1
10192613|NCT03311724|11321229|FG000|STARTED|Overall Study||26
10192614|NCT03311724|11321230|FG001|STARTED|Overall Study||29
10192615|NCT03311724|11321231|FG002|STARTED|Overall Study||28
10192616|NCT03311724|11321232|FG003|STARTED|Overall Study||28
10192617|NCT03311724|11321229|FG000|Received At Least One Dose of Study Drug|Overall Study||26
10192618|NCT03311724|11321230|FG001|Received At Least One Dose of Study Drug|Overall Study||29
10192619|NCT03311724|11321231|FG002|Received At Least One Dose of Study Drug|Overall Study||28
10192620|NCT03311724|11321232|FG003|Received At Least One Dose of Study Drug|Overall Study||28
10192621|NCT03311724|11321229|FG000|Completed Treatment|Overall Study||20
10192622|NCT03311724|11321230|FG001|Completed Treatment|Overall Study||27
10192623|NCT03311724|11321231|FG002|Completed Treatment|Overall Study||22
10192624|NCT03311724|11321232|FG003|Completed Treatment|Overall Study||26
10192625|NCT03311724|11321229|FG000|COMPLETED|Overall Study||23
10192626|NCT03311724|11321230|FG001|COMPLETED|Overall Study||28
10192627|NCT03311724|11321231|FG002|COMPLETED|Overall Study||26
10192628|NCT03311724|11321232|FG003|COMPLETED|Overall Study||27
10192629|NCT03311724|11321229|FG000|NOT COMPLETED|Overall Study||3
10192630|NCT03311724|11321230|FG001|NOT COMPLETED|Overall Study||1
10192631|NCT03311724|11321231|FG002|NOT COMPLETED|Overall Study||2
10192632|NCT03311724|11321232|FG003|NOT COMPLETED|Overall Study||1
10192633|NCT03311841|11321250|FG000|STARTED|Period 1||6
10192634|NCT03311841|11321251|FG001|STARTED|Period 1||7
10192635|NCT03311841|11321252|FG002|STARTED|Period 1||6
10192636|NCT03311841|11321253|FG003|STARTED|Period 1||7
10192637|NCT03311841|11321254|FG004|STARTED|Period 1||6
10192638|NCT03311841|11321250|FG000|COMPLETED|Period 1||6
10192639|NCT03311841|11321251|FG001|COMPLETED|Period 1||7
10192640|NCT03311841|11321252|FG002|COMPLETED|Period 1||6
10192641|NCT03311841|11321253|FG003|COMPLETED|Period 1||7
10192642|NCT03311841|11321254|FG004|COMPLETED|Period 1||6
10192643|NCT03311841|11321250|FG000|NOT COMPLETED|Period 1||0
10192644|NCT03311841|11321251|FG001|NOT COMPLETED|Period 1||0
10192645|NCT03311841|11321252|FG002|NOT COMPLETED|Period 1||0
10192646|NCT03311841|11321253|FG003|NOT COMPLETED|Period 1||0
10192647|NCT03311841|11321254|FG004|NOT COMPLETED|Period 1||0
10192648|NCT03311841|11321250|FG000|STARTED|14-day Wash-out||6
10192649|NCT03311841|11321251|FG001|STARTED|14-day Wash-out||7
10192650|NCT03311841|11321252|FG002|STARTED|14-day Wash-out||6
10192651|NCT03311841|11321253|FG003|STARTED|14-day Wash-out||7
10192652|NCT03311841|11321254|FG004|STARTED|14-day Wash-out||6
10192653|NCT03311841|11321250|FG000|COMPLETED|14-day Wash-out||6
10192654|NCT03311841|11321251|FG001|COMPLETED|14-day Wash-out||6
10192655|NCT03311841|11321252|FG002|COMPLETED|14-day Wash-out||6
10192656|NCT03311841|11321253|FG003|COMPLETED|14-day Wash-out||6
10192657|NCT03311841|11321254|FG004|COMPLETED|14-day Wash-out||6
10192658|NCT03311841|11321250|FG000|NOT COMPLETED|14-day Wash-out||0
10192659|NCT03311841|11321251|FG001|NOT COMPLETED|14-day Wash-out||1
10192660|NCT03311841|11321252|FG002|NOT COMPLETED|14-day Wash-out||0
10192661|NCT03311841|11321253|FG003|NOT COMPLETED|14-day Wash-out||1
10192662|NCT03311841|11321254|FG004|NOT COMPLETED|14-day Wash-out||0
10192663|NCT03311841|11321250|FG000|STARTED|Period 2||6
10192664|NCT03311841|11321251|FG001|STARTED|Period 2||6
10192665|NCT03311841|11321252|FG002|STARTED|Period 2||6
10192666|NCT03311841|11321253|FG003|STARTED|Period 2||6
10192667|NCT03311841|11321254|FG004|STARTED|Period 2||6
10192668|NCT03311841|11321250|FG000|COMPLETED|Period 2||6
10192669|NCT03311841|11321251|FG001|COMPLETED|Period 2||6
10192670|NCT03311841|11321252|FG002|COMPLETED|Period 2||6
10192671|NCT03311841|11321253|FG003|COMPLETED|Period 2||6
10192672|NCT03311841|11321254|FG004|COMPLETED|Period 2||6
10192673|NCT03311841|11321250|FG000|NOT COMPLETED|Period 2||0
10192674|NCT03311841|11321251|FG001|NOT COMPLETED|Period 2||0
10192675|NCT03311841|11321252|FG002|NOT COMPLETED|Period 2||0
10192676|NCT03311841|11321253|FG003|NOT COMPLETED|Period 2||0
10192677|NCT03311841|11321254|FG004|NOT COMPLETED|Period 2||0
10192678|NCT03312023|11321279|FG000|STARTED|Overall Study||8
10192679|NCT03312023|11321280|FG001|STARTED|Overall Study||5
10192680|NCT03312023|11321281|FG002|STARTED|Overall Study||4
10192681|NCT03312023|11321282|FG003|STARTED|Overall Study||4
10192682|NCT03312023|11321279|FG000|Completed Week 12|Overall Study||8
10192683|NCT03312023|11321280|FG001|Completed Week 12|Overall Study||5
10192684|NCT03312023|11321281|FG002|Completed Week 12|Overall Study||4
10192685|NCT03312023|11321282|FG003|Completed Week 12|Overall Study||4
10192686|NCT03312023|11321279|FG000|COMPLETED|Overall Study||8
10192687|NCT03312023|11321280|FG001|COMPLETED|Overall Study||5
10192688|NCT03312023|11321281|FG002|COMPLETED|Overall Study||4
10192689|NCT03312023|11321282|FG003|COMPLETED|Overall Study||4
10192690|NCT03312023|11321279|FG000|NOT COMPLETED|Overall Study||0
10192691|NCT03312023|11321280|FG001|NOT COMPLETED|Overall Study||0
10192692|NCT03312023|11321281|FG002|NOT COMPLETED|Overall Study||0
10192693|NCT03312023|11321282|FG003|NOT COMPLETED|Overall Study||0
10192694|NCT03312114|11321293|FG000|STARTED|Overall Study||5
10192695|NCT03312114|11321293|FG000|COMPLETED|Overall Study||0
10192696|NCT03312114|11321293|FG000|NOT COMPLETED|Overall Study||5
10192697|NCT03312218|11321300|FG000|STARTED|Overall Study||335
10192698|NCT03312218|11321301|FG001|STARTED|Overall Study||299
10192699|NCT03312218|11321300|FG000|COMPLETED|Overall Study||281
10192700|NCT03312218|11321301|FG001|COMPLETED|Overall Study||241
10192701|NCT03312218|11321300|FG000|NOT COMPLETED|Overall Study||54
10192702|NCT03312218|11321301|FG001|NOT COMPLETED|Overall Study||58
10192703|NCT03312231|11321312|FG000|STARTED|Overall Study||184
10192704|NCT03312231|11321313|FG001|STARTED|Overall Study||176
10192705|NCT03312231|11321314|FG002|STARTED|Overall Study||181
10192706|NCT03312231|11321315|FG003|STARTED|Overall Study||89
10192707|NCT03312231|11321316|FG004|STARTED|Overall Study||90
10192708|NCT03312231|11321312|FG000|COMPLETED|Overall Study||181
10192709|NCT03312231|11321313|FG001|COMPLETED|Overall Study||165
10192710|NCT03312231|11321314|FG002|COMPLETED|Overall Study||177
10192711|NCT03312231|11321315|FG003|COMPLETED|Overall Study||86
10192712|NCT03312231|11321316|FG004|COMPLETED|Overall Study||89
10192713|NCT03312231|11321312|FG000|NOT COMPLETED|Overall Study||3
10192714|NCT03312231|11321313|FG001|NOT COMPLETED|Overall Study||11
10192715|NCT03312231|11321314|FG002|NOT COMPLETED|Overall Study||4
10192716|NCT03312231|11321315|FG003|NOT COMPLETED|Overall Study||3
10192717|NCT03312231|11321316|FG004|NOT COMPLETED|Overall Study||1
10192718|NCT03312348|11321328|FG000|STARTED|Overall Study||30
10192719|NCT03312348|11321328|FG000|COMPLETED|Overall Study||30
10192720|NCT03312348|11321328|FG000|NOT COMPLETED|Overall Study||0
10192721|NCT03312517|11321332|FG000|STARTED|Overall Study||2
10192722|NCT03312517|11321333|FG001|STARTED|Overall Study||2
10192723|NCT03312517|11321334|FG002|STARTED|Overall Study||2
10192724|NCT03312517|11321335|FG003|STARTED|Overall Study||2
10192725|NCT03312517|11321336|FG004|STARTED|Overall Study||2
10192726|NCT03312517|11321337|FG005|STARTED|Overall Study||2
10192727|NCT03312517|11321332|FG000|COMPLETED|Overall Study||2
10192728|NCT03312517|11321333|FG001|COMPLETED|Overall Study||2
10192729|NCT03312517|11321334|FG002|COMPLETED|Overall Study||2
10192730|NCT03312517|11321335|FG003|COMPLETED|Overall Study||2
10192731|NCT03312517|11321336|FG004|COMPLETED|Overall Study||2
10192732|NCT03312517|11321337|FG005|COMPLETED|Overall Study||2
10192733|NCT03312517|11321332|FG000|NOT COMPLETED|Overall Study||0
10192734|NCT03312517|11321333|FG001|NOT COMPLETED|Overall Study||0
10192735|NCT03312517|11321334|FG002|NOT COMPLETED|Overall Study||0
10192736|NCT03312517|11321335|FG003|NOT COMPLETED|Overall Study||0
10192737|NCT03312517|11321336|FG004|NOT COMPLETED|Overall Study||0
10192738|NCT03312517|11321337|FG005|NOT COMPLETED|Overall Study||0
10192739|NCT03312543|11321347|FG000|STARTED|Before Treatment (Screening to Baseline)||61
10192740|NCT03312543|11321348|FG001|STARTED|Before Treatment (Screening to Baseline)||63
10192741|NCT03312543|11321347|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60
10192742|NCT03312543|11321348|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59
10192743|NCT03312543|11321347|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
10192744|NCT03312543|11321348|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
10192745|NCT03312543|11321347|FG000|STARTED|Treatment (Baseline to Week 12)||60
10192746|NCT03312543|11321348|FG001|STARTED|Treatment (Baseline to Week 12)||59
10192747|NCT03312543|11321347|FG000|COMPLETED|Treatment (Baseline to Week 12)||56
10192748|NCT03312543|11321348|FG001|COMPLETED|Treatment (Baseline to Week 12)||54
10192749|NCT03312543|11321347|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4
10192750|NCT03312543|11321348|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5
10192751|NCT03312543|11321347|FG000|STARTED|Regression (Week 12 to Week 24)||56
10192752|NCT03312543|11321348|FG001|STARTED|Regression (Week 12 to Week 24)||54
10192753|NCT03312543|11321347|FG000|COMPLETED|Regression (Week 12 to Week 24)||55
10192754|NCT03312543|11321348|FG001|COMPLETED|Regression (Week 12 to Week 24)||52
10192755|NCT03312543|11321347|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1
10192756|NCT03312543|11321348|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2
10192757|NCT03312595|11321354|FG000|STARTED|Overall Study||30
10192758|NCT03312595|11321354|FG000|COMPLETED|Overall Study||24
10192759|NCT03312595|11321354|FG000|NOT COMPLETED|Overall Study||6
10192760|NCT03312933|11321358|FG000|STARTED|Overall Study||100
10192761|NCT03312933|11321358|FG000|COMPLETED|Overall Study||46
10192762|NCT03312933|11321358|FG000|NOT COMPLETED|Overall Study||54
10192763|NCT03313037|11321364|FG000|STARTED|Overall Study||222
10192764|NCT03313037|11321365|FG001|STARTED|Overall Study||222
10192765|NCT03313037|11321364|FG000|Safety Population|Overall Study||221
10192766|NCT03313037|11321365|FG001|Safety Population|Overall Study||222
10192767|NCT03313037|11321364|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210
10192768|NCT03313037|11321365|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208
10192769|NCT03313037|11321364|FG000|COMPLETED|Overall Study||202
10192770|NCT03313037|11321365|FG001|COMPLETED|Overall Study||202
10192771|NCT03313037|11321364|FG000|NOT COMPLETED|Overall Study||20
10192772|NCT03313037|11321365|FG001|NOT COMPLETED|Overall Study||20
10192773|NCT03313050|11321375|FG000|STARTED|Stage 1: 6 Months||34
10192774|NCT03313050|11321376|FG001|STARTED|Stage 1: 6 Months||32
10192775|NCT03313050|11321377|FG002|STARTED|Stage 1: 6 Months||0
10192776|NCT03313050|11321378|FG003|STARTED|Stage 1: 6 Months||0
10192777|NCT03313050|11321375|FG000|Vaccinated|Stage 1: 6 Months||34
10192778|NCT03313050|11321376|FG001|Vaccinated|Stage 1: 6 Months||32
10192779|NCT03313050|11321377|FG002|Vaccinated|Stage 1: 6 Months||0
10192780|NCT03313050|11321378|FG003|Vaccinated|Stage 1: 6 Months||0
10192781|NCT03313050|11321375|FG000|COMPLETED|Stage 1: 6 Months||34
10192782|NCT03313050|11321376|FG001|COMPLETED|Stage 1: 6 Months||32
10192783|NCT03313050|11321377|FG002|COMPLETED|Stage 1: 6 Months||0
10192784|NCT03313050|11321378|FG003|COMPLETED|Stage 1: 6 Months||0
10192785|NCT03313050|11321375|FG000|NOT COMPLETED|Stage 1: 6 Months||0
10192786|NCT03313050|11321376|FG001|NOT COMPLETED|Stage 1: 6 Months||0
10192787|NCT03313050|11321377|FG002|NOT COMPLETED|Stage 1: 6 Months||0
10192788|NCT03313050|11321378|FG003|NOT COMPLETED|Stage 1: 6 Months||0
10192789|NCT03313050|11321375|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
10192790|NCT03313050|11321376|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
10192791|NCT03313050|11321377|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
10192792|NCT03313050|11321378|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
10192793|NCT03313050|11321375|FG000|Vaccinated|Stage 2: 12 Months||0
10192794|NCT03313050|11321376|FG001|Vaccinated|Stage 2: 12 Months||0
10192795|NCT03313050|11321377|FG002|Vaccinated|Stage 2: 12 Months||221
10192796|NCT03313050|11321378|FG003|Vaccinated|Stage 2: 12 Months||223
10192797|NCT03313050|11321375|FG000|COMPLETED|Stage 2: 12 Months||0
10192798|NCT03313050|11321376|FG001|COMPLETED|Stage 2: 12 Months||0
10192799|NCT03313050|11321377|FG002|COMPLETED|Stage 2: 12 Months||210
10192800|NCT03313050|11321378|FG003|COMPLETED|Stage 2: 12 Months||204
10192801|NCT03313050|11321375|FG000|NOT COMPLETED|Stage 2: 12 Months||0
10192802|NCT03313050|11321376|FG001|NOT COMPLETED|Stage 2: 12 Months||0
10192803|NCT03313050|11321377|FG002|NOT COMPLETED|Stage 2: 12 Months||11
10192804|NCT03313050|11321378|FG003|NOT COMPLETED|Stage 2: 12 Months||20
10192805|NCT03313076|11321392|FG000|STARTED|Overall Study||7
10192806|NCT03313076|11321393|FG001|STARTED|Overall Study||6
10192807|NCT03313076|11321394|FG002|STARTED|Overall Study||6
10192808|NCT03313076|11321395|FG003|STARTED|Overall Study||5
10192809|NCT03313076|11321392|FG000|COMPLETED|Overall Study||5
10192810|NCT03313076|11321393|FG001|COMPLETED|Overall Study||4
10192811|NCT03313076|11321394|FG002|COMPLETED|Overall Study||4
10192812|NCT03313076|11321395|FG003|COMPLETED|Overall Study||3
10192813|NCT03313076|11321392|FG000|NOT COMPLETED|Overall Study||2
10192814|NCT03313076|11321393|FG001|NOT COMPLETED|Overall Study||2
10192815|NCT03313076|11321394|FG002|NOT COMPLETED|Overall Study||2
10192816|NCT03313076|11321395|FG003|NOT COMPLETED|Overall Study||2
10192817|NCT03313310|11321413|FG000|STARTED|Phase 2||51
10192818|NCT03313310|11321414|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
10192819|NCT03313310|11321413|FG000|COMPLETED|Phase 2||47
10192820|NCT03313310|11321414|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
10192821|NCT03313310|11321413|FG000|NOT COMPLETED|Phase 2||4
10192822|NCT03313310|11321414|FG001|NOT COMPLETED|Phase 2||0
10192823|NCT03313310|11321413|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
10192824|NCT03313310|11321414|FG001|STARTED|Phase 3||41
10192825|NCT03313310|11321413|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
10192826|NCT03313310|11321414|FG001|COMPLETED|Phase 3||40
10192827|NCT03313310|11321413|FG000|NOT COMPLETED|Phase 3||0
10192828|NCT03313310|11321414|FG001|NOT COMPLETED|Phase 3||1
10192829|NCT03314233|11321420|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
10192830|NCT03314233|11321420|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
10192831|NCT03314233|11321420|FG000|NOT COMPLETED|Overall Study||1
10192832|NCT03314519|11321426|FG000|STARTED|Overall Study||100
10192833|NCT03314519|11321427|FG001|STARTED|Overall Study||100
10192834|NCT03314519|11321426|FG000|COMPLETED|Overall Study||97
10192835|NCT03314519|11321427|FG001|COMPLETED|Overall Study||98
10192836|NCT03314519|11321426|FG000|NOT COMPLETED|Overall Study||3
10192837|NCT03314519|11321427|FG001|NOT COMPLETED|Overall Study||2
10192838|NCT03314662|11321436|FG000|STARTED|Overall Study||889
10192839|NCT03314662|11321437|FG001|STARTED|Overall Study||445
10192840|NCT03314662|11321438|FG002|STARTED|Overall Study||444
10192841|NCT03314662|11321436|FG000|Treated|Overall Study||888
10192842|NCT03314662|11321437|FG001|Treated|Overall Study||444
10192843|NCT03314662|11321438|FG002|Treated|Overall Study||444
10192844|NCT03314662|11321436|FG000|COMPLETED|Overall Study||881
10192845|NCT03314662|11321437|FG001|COMPLETED|Overall Study||440
10192846|NCT03314662|11321438|FG002|COMPLETED|Overall Study||439
10192847|NCT03314662|11321436|FG000|NOT COMPLETED|Overall Study||8
10192848|NCT03314662|11321437|FG001|NOT COMPLETED|Overall Study||5
10192849|NCT03314662|11321438|FG002|NOT COMPLETED|Overall Study||5
10192850|NCT03314753|11321456|FG000|STARTED|Overall Study||53
10192851|NCT03314753|11321457|FG001|STARTED|Overall Study||36
10192852|NCT03314753|11321456|FG000|COMPLETED|Overall Study||53
10192853|NCT03314753|11321457|FG001|COMPLETED|Overall Study||36
10192854|NCT03314753|11321456|FG000|NOT COMPLETED|Overall Study||0
10192855|NCT03314753|11321457|FG001|NOT COMPLETED|Overall Study||0
10192856|NCT03314857|11321463|FG000|STARTED|Overall Study||67
10192857|NCT03314857|11321463|FG000|Analysis Population|Overall Study||61
10192858|NCT03314857|11321463|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
10192859|NCT03314857|11321463|FG000|NOT COMPLETED|Overall Study||5
10192860|NCT03315104|11321470|FG000|STARTED|Overall Study||21
10192861|NCT03315104|11321471|FG001|STARTED|Overall Study||20
10192862|NCT03315104|11321472|FG002|STARTED|Overall Study||24
10192863|NCT03315104|11321470|FG000|Dosed (Safety Population)|Overall Study||19
10192864|NCT03315104|11321471|FG001|Dosed (Safety Population)|Overall Study||19
10192865|NCT03315104|11321472|FG002|Dosed (Safety Population)|Overall Study||22
10192866|NCT03315104|11321470|FG000|COMPLETED|Overall Study||18
10192867|NCT03315104|11321471|FG001|COMPLETED|Overall Study||16
10192868|NCT03315104|11321472|FG002|COMPLETED|Overall Study||19
10192869|NCT03315104|11321470|FG000|NOT COMPLETED|Overall Study||3
10192870|NCT03315104|11321471|FG001|NOT COMPLETED|Overall Study||4
10192871|NCT03315104|11321472|FG002|NOT COMPLETED|Overall Study||5
10192872|NCT03315208|11321482|FG000|STARTED|Overall Study||29
10192873|NCT03315208|11321483|FG001|STARTED|Overall Study||18
10192874|NCT03315208|11321482|FG000|COMPLETED|Overall Study||16
10192875|NCT03315208|11321483|FG001|COMPLETED|Overall Study||12
10192876|NCT03315208|11321482|FG000|NOT COMPLETED|Overall Study||13
10192877|NCT03315208|11321483|FG001|NOT COMPLETED|Overall Study||6
10192878|NCT03315286|11321492|FG000|STARTED|Overall Study||50
10192879|NCT03315286|11321493|FG001|STARTED|Overall Study||47
10192880|NCT03315286|11321492|FG000|COMPLETED|Overall Study||49
10192881|NCT03315286|11321493|FG001|COMPLETED|Overall Study||43
10192882|NCT03315286|11321492|FG000|NOT COMPLETED|Overall Study||1
10192883|NCT03315286|11321493|FG001|NOT COMPLETED|Overall Study||4
10192884|NCT03315559|11321499|FG000|STARTED|Treatment Period 1 (8 Days)||6
10192885|NCT03315559|11321499|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
10192886|NCT03315559|11321499|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10192887|NCT03315559|11321499|FG000|STARTED|Washout Period (14 Days)||6
10192888|NCT03315559|11321499|FG000|COMPLETED|Washout Period (14 Days)||6
10192889|NCT03315559|11321499|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10192890|NCT03315559|11321499|FG000|STARTED|Treatment Period 2 (15 Days)||6
10192891|NCT03315559|11321499|FG000|COMPLETED|Treatment Period 2 (15 Days)||6
10192892|NCT03315559|11321499|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0
10192893|NCT03315572|11321508|FG000|STARTED|Overall Study||14
10192894|NCT03315572|11321509|FG001|STARTED|Overall Study||14
10192895|NCT03315572|11321508|FG000|COMPLETED|Overall Study||14
10192896|NCT03315572|11321509|FG001|COMPLETED|Overall Study||14
10192897|NCT03315572|11321508|FG000|NOT COMPLETED|Overall Study||0
10192898|NCT03315572|11321509|FG001|NOT COMPLETED|Overall Study||0
10192899|NCT03315689|11321518|FG000|STARTED|Double-blind Period = 28 Days||4
10192900|NCT03315689|11321519|FG001|STARTED|Double-blind Period = 28 Days||7
10192901|NCT03315689|11321518|FG000|COMPLETED|Double-blind Period = 28 Days||3
10192902|NCT03315689|11321519|FG001|COMPLETED|Double-blind Period = 28 Days||7
10192903|NCT03315689|11321518|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1
10192904|NCT03315689|11321519|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0
10192905|NCT03315689|11321518|FG000|STARTED|Open Label Extension = 52 Weeks||0
10192906|NCT03315689|11321519|FG001|STARTED|Open Label Extension = 52 Weeks||10
10192907|NCT03315689|11321518|FG000|COMPLETED|Open Label Extension = 52 Weeks||0
10192908|NCT03315689|11321519|FG001|COMPLETED|Open Label Extension = 52 Weeks||7
10192909|NCT03315689|11321518|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0
10192910|NCT03315689|11321519|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3
10192911|NCT03315702|11321527|FG000|STARTED|Overall Study||52
10192912|NCT03315702|11321527|FG000|COMPLETED|Overall Study||52
10192913|NCT03315702|11321527|FG000|NOT COMPLETED|Overall Study||0
10192914|NCT03315780|11321532|FG000|STARTED|Period 1||6
10192915|NCT03315780|11321533|FG001|STARTED|Period 1||6
10192916|NCT03315780|11321532|FG000|Received One Dose of Study Drug|Period 1||6
10192917|NCT03315780|11321533|FG001|Received One Dose of Study Drug|Period 1||6
10192918|NCT03315780|11321532|FG000|COMPLETED|Period 1||6
10192919|NCT03315780|11321533|FG001|COMPLETED|Period 1||6
10192920|NCT03315780|11321532|FG000|NOT COMPLETED|Period 1||0
10192921|NCT03315780|11321533|FG001|NOT COMPLETED|Period 1||0
10192922|NCT03315780|11321532|FG000|STARTED|Period 2||6
10192923|NCT03315780|11321533|FG001|STARTED|Period 2||6
10192924|NCT03315780|11321532|FG000|COMPLETED|Period 2||6
10192925|NCT03315780|11321533|FG001|COMPLETED|Period 2||6
10192926|NCT03315780|11321532|FG000|NOT COMPLETED|Period 2||0
10192927|NCT03315780|11321533|FG001|NOT COMPLETED|Period 2||0
10192928|NCT03315793|11321541|FG000|STARTED|Overall Study||75
10192929|NCT03315793|11321542|FG001|STARTED|Overall Study||74
10192930|NCT03315793|11321541|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
10192931|NCT03315793|11321542|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
10192932|NCT03315793|11321541|FG000|COMPLETED|Overall Study||70
10192933|NCT03315793|11321542|FG001|COMPLETED|Overall Study||71
10192934|NCT03315793|11321541|FG000|NOT COMPLETED|Overall Study||5
10192935|NCT03315793|11321542|FG001|NOT COMPLETED|Overall Study||3
10192936|NCT03315949|11321552|FG000|STARTED|Overall Study||176
10192937|NCT03315949|11321553|FG001|STARTED|Overall Study||176
10192938|NCT03315949|11321552|FG000|COMPLETED|Overall Study||171
10192939|NCT03315949|11321553|FG001|COMPLETED|Overall Study||166
10192940|NCT03315949|11321552|FG000|NOT COMPLETED|Overall Study||5
10192941|NCT03315949|11321553|FG001|NOT COMPLETED|Overall Study||10
10192942|NCT03316131|11321559|FG000|STARTED|Treatment Period 1||18
10192943|NCT03316131|11321560|FG001|STARTED|Treatment Period 1||18
10192944|NCT03316131|11321559|FG000|COMPLETED|Treatment Period 1||18
10192945|NCT03316131|11321560|FG001|COMPLETED|Treatment Period 1||18
10192946|NCT03316131|11321559|FG000|NOT COMPLETED|Treatment Period 1||0
10192947|NCT03316131|11321560|FG001|NOT COMPLETED|Treatment Period 1||0
10192948|NCT03316131|11321559|FG000|STARTED|Treatment Period 2||18
10192949|NCT03316131|11321560|FG001|STARTED|Treatment Period 2||18
10192950|NCT03316131|11321559|FG000|COMPLETED|Treatment Period 2||17
10192951|NCT03316131|11321560|FG001|COMPLETED|Treatment Period 2||18
10192952|NCT03316131|11321559|FG000|NOT COMPLETED|Treatment Period 2||1
10192953|NCT03316131|11321560|FG001|NOT COMPLETED|Treatment Period 2||0
10192954|NCT03316170|11321568|FG000|STARTED|Overall Study||24
10192955|NCT03316170|11321569|FG001|STARTED|Overall Study||25
10192956|NCT03316170|11321568|FG000|COMPLETED|Overall Study||17
10192957|NCT03316170|11321569|FG001|COMPLETED|Overall Study||18
10192958|NCT03316170|11321568|FG000|NOT COMPLETED|Overall Study||7
10192959|NCT03316170|11321569|FG001|NOT COMPLETED|Overall Study||7
10192960|NCT03316378|11321578|FG000|STARTED|Overall Study||23
10192961|NCT03316378|11321579|FG001|STARTED|Overall Study||23
10192962|NCT03316378|11321578|FG000|COMPLETED|Overall Study||23
10192963|NCT03316378|11321579|FG001|COMPLETED|Overall Study||23
10192964|NCT03316378|11321578|FG000|NOT COMPLETED|Overall Study||0
10192965|NCT03316378|11321579|FG001|NOT COMPLETED|Overall Study||0
10192966|NCT03316547|11321588|FG000|STARTED|Overall Study||39
10192967|NCT03316547|11321589|FG001|STARTED|Overall Study||31
10192968|NCT03316547|11321588|FG000|COMPLETED|Overall Study||21
10080339|NCT02250651|11208502|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
10080340|NCT02250651|11208503|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
10192969|NCT03316547|11321589|FG001|COMPLETED|Overall Study||18
10192970|NCT03316547|11321588|FG000|NOT COMPLETED|Overall Study||18
10192971|NCT03316547|11321589|FG001|NOT COMPLETED|Overall Study||13
10192972|NCT03316911|11321599|FG000|STARTED|Overall Study|2 did not complete baseline survey|122
10192973|NCT03316911|11321600|FG001|STARTED|Overall Study|3 did not complete baseline survey|139
10192974|NCT03316911|11321599|FG000|3-Month Follow-up Survey|Overall Study||93
10192975|NCT03316911|11321600|FG001|3-Month Follow-up Survey|Overall Study||112
10192976|NCT03316911|11321599|FG000|5-Month Follow-up Survey|Overall Study||89
10192977|NCT03316911|11321600|FG001|5-Month Follow-up Survey|Overall Study||110
10192978|NCT03316911|11321599|FG000|COMPLETED|Overall Study||89
10192979|NCT03316911|11321600|FG001|COMPLETED|Overall Study||110
10192980|NCT03316911|11321599|FG000|NOT COMPLETED|Overall Study||33
10192981|NCT03316911|11321600|FG001|NOT COMPLETED|Overall Study||29
10192982|NCT03316976|11321608|FG000|STARTED|Overall Study||20
10192983|NCT03316976|11321609|FG001|STARTED|Overall Study||20
10192984|NCT03316976|11321608|FG000|COMPLETED|Overall Study||20
10192985|NCT03316976|11321609|FG001|COMPLETED|Overall Study||20
10192986|NCT03316976|11321608|FG000|NOT COMPLETED|Overall Study||0
10192987|NCT03316976|11321609|FG001|NOT COMPLETED|Overall Study||0
10192988|NCT03317002|11321618|FG000|STARTED|Overall Study||52
10192989|NCT03317002|11321619|FG001|STARTED|Overall Study||25
10192990|NCT03317002|11321620|FG002|STARTED|Overall Study||52
10192991|NCT03317002|11321618|FG000|COMPLETED|Overall Study||50
10192992|NCT03317002|11321619|FG001|COMPLETED|Overall Study||24
10192993|NCT03317002|11321620|FG002|COMPLETED|Overall Study||51
10192994|NCT03317002|11321618|FG000|NOT COMPLETED|Overall Study||2
10192995|NCT03317002|11321619|FG001|NOT COMPLETED|Overall Study||1
10192996|NCT03317002|11321620|FG002|NOT COMPLETED|Overall Study||1
10192997|NCT03317288|11321628|FG000|STARTED|Overall Study||15
10192998|NCT03317288|11321628|FG000|COMPLETED|Overall Study||15
10192999|NCT03317288|11321628|FG000|NOT COMPLETED|Overall Study||0
10193000|NCT03317379|11321649|FG000|STARTED|Overall Study||20
10193001|NCT03317379|11321650|FG001|STARTED|Overall Study||18
10193002|NCT03317379|11321651|FG002|STARTED|Overall Study||22
10193003|NCT03317379|11321649|FG000|Completed Intervention|Overall Study||16
10193004|NCT03317379|11321650|FG001|Completed Intervention|Overall Study||6
10193005|NCT03317379|11321651|FG002|Completed Intervention|Overall Study||0
10193006|NCT03317379|11321649|FG000|COMPLETED|Overall Study||20
10193007|NCT03317379|11321650|FG001|COMPLETED|Overall Study||15
10193008|NCT03317379|11321651|FG002|COMPLETED|Overall Study||20
10193009|NCT03317379|11321649|FG000|NOT COMPLETED|Overall Study||0
10193010|NCT03317379|11321650|FG001|NOT COMPLETED|Overall Study||3
10193011|NCT03317379|11321651|FG002|NOT COMPLETED|Overall Study||2
10193012|NCT03317431|11321659|FG000|STARTED|Overall Study||46
10193013|NCT03317431|11321659|FG000|COMPLETED|Overall Study||46
10193014|NCT03317431|11321659|FG000|NOT COMPLETED|Overall Study||0
10193015|NCT03317444|11321665|FG000|STARTED|Overall Study||124
10193016|NCT03317444|11321666|FG001|STARTED|Overall Study||93
10193017|NCT03317444|11321665|FG000|COMPLETED|Overall Study||119
10193018|NCT03317444|11321666|FG001|COMPLETED|Overall Study||89
10193019|NCT03317444|11321665|FG000|NOT COMPLETED|Overall Study||5
10193020|NCT03317444|11321666|FG001|NOT COMPLETED|Overall Study||4
10193021|NCT03318315|11321675|FG000|STARTED|Overall Study||62
10193022|NCT03318315|11321676|FG001|STARTED|Overall Study||53
10193023|NCT03318315|11321677|FG002|STARTED|Overall Study||34
10193024|NCT03318315|11321675|FG000|Received First Vaccination|Overall Study||62
10193025|NCT03318315|11321676|FG001|Received First Vaccination|Overall Study||53
10193026|NCT03318315|11321677|FG002|Received First Vaccination|Overall Study||34
10193027|NCT03318315|11321675|FG000|Received Second Vaccination|Overall Study||59
10193028|NCT03318315|11321676|FG001|Received Second Vaccination|Overall Study||48
10193029|NCT03318315|11321677|FG002|Received Second Vaccination|Overall Study||0
10193030|NCT03318315|11321675|FG000|Received Third Vaccination|Overall Study||0
10193031|NCT03318315|11321676|FG001|Received Third Vaccination|Overall Study||46
10193032|NCT03318315|11321677|FG002|Received Third Vaccination|Overall Study||0
10193033|NCT03318315|11321675|FG000|COMPLETED|Overall Study||58
10193034|NCT03318315|11321676|FG001|COMPLETED|Overall Study||50
10193035|NCT03318315|11321677|FG002|COMPLETED|Overall Study||30
10193036|NCT03318315|11321675|FG000|NOT COMPLETED|Overall Study||4
10193037|NCT03318315|11321676|FG001|NOT COMPLETED|Overall Study||3
10193038|NCT03318315|11321677|FG002|NOT COMPLETED|Overall Study||4
10193039|NCT03318341|11321688|FG000|STARTED|Month 1||13
10193040|NCT03318341|11321689|FG001|STARTED|Month 1||13
10193041|NCT03318341|11321688|FG000|COMPLETED|Month 1||13
10193042|NCT03318341|11321689|FG001|COMPLETED|Month 1||12
10193043|NCT03318341|11321688|FG000|NOT COMPLETED|Month 1||0
10193044|NCT03318341|11321689|FG001|NOT COMPLETED|Month 1||1
10193045|NCT03318341|11321688|FG000|STARTED|Month 2||13
10193046|NCT03318341|11321689|FG001|STARTED|Month 2||12
10193047|NCT03318341|11321688|FG000|COMPLETED|Month 2||13
10193048|NCT03318341|11321689|FG001|COMPLETED|Month 2||12
10193049|NCT03318341|11321688|FG000|NOT COMPLETED|Month 2||0
10193050|NCT03318341|11321689|FG001|NOT COMPLETED|Month 2||0
10193051|NCT03318783|11321699|FG000|STARTED|Overall Study||10
10193052|NCT03318783|11321700|FG001|STARTED|Overall Study||10
10193053|NCT03318783|11321699|FG000|COMPLETED|Overall Study||10
10193054|NCT03318783|11321700|FG001|COMPLETED|Overall Study||8
10193055|NCT03318783|11321699|FG000|NOT COMPLETED|Overall Study||0
10193056|NCT03318783|11321700|FG001|NOT COMPLETED|Overall Study||2
10193057|NCT03319134|11321709|FG000|STARTED|Overall Study||15
10193058|NCT03319134|11321710|FG001|STARTED|Overall Study||15
10193059|NCT03319134|11321711|FG002|STARTED|Overall Study||15
10193060|NCT03319134|11321709|FG000|COMPLETED|Overall Study||15
10193061|NCT03319134|11321710|FG001|COMPLETED|Overall Study||15
10193062|NCT03319134|11321711|FG002|COMPLETED|Overall Study||15
10193063|NCT03319134|11321709|FG000|NOT COMPLETED|Overall Study||0
10193064|NCT03319134|11321710|FG001|NOT COMPLETED|Overall Study||0
10193065|NCT03319134|11321711|FG002|NOT COMPLETED|Overall Study||0
10193066|NCT03319173|11321721|FG000|STARTED|Overall Study||48
10193067|NCT03319173|11321722|FG001|STARTED|Overall Study||50
10193068|NCT03319173|11321721|FG000|COMPLETED|Overall Study||48
10193069|NCT03319173|11321722|FG001|COMPLETED|Overall Study||50
10193070|NCT03319173|11321721|FG000|NOT COMPLETED|Overall Study||0
10193071|NCT03319173|11321722|FG001|NOT COMPLETED|Overall Study||0
10193072|NCT03319212|11321734|FG000|STARTED|Overall Study||29
10193073|NCT03319212|11321735|FG001|STARTED|Overall Study||52
10193074|NCT03319212|11321734|FG000|COMPLETED|Overall Study||26
10193075|NCT03319212|11321735|FG001|COMPLETED|Overall Study||47
10193076|NCT03319212|11321734|FG000|NOT COMPLETED|Overall Study||3
10193077|NCT03319212|11321735|FG001|NOT COMPLETED|Overall Study||5
10193078|NCT03319277|11321742|FG000|STARTED|Overall Study||59
10193079|NCT03319277|11321743|FG001|STARTED|Overall Study||59
10193080|NCT03319277|11321742|FG000|COMPLETED|Overall Study||59
10193081|NCT03319277|11321743|FG001|COMPLETED|Overall Study||59
10193082|NCT03319277|11321742|FG000|NOT COMPLETED|Overall Study||0
10193083|NCT03319277|11321743|FG001|NOT COMPLETED|Overall Study||0
10193084|NCT03319719|11321749|FG000|STARTED|Overall Study||52
10193085|NCT03319719|11321749|FG000|COMPLETED|Overall Study||51
10193086|NCT03319719|11321749|FG000|NOT COMPLETED|Overall Study||1
10193087|NCT03319810|11321755|FG000|STARTED|Overall Study||5
10193088|NCT03319810|11321755|FG000|COMPLETED|Overall Study||5
10193089|NCT03319810|11321755|FG000|NOT COMPLETED|Overall Study||0
10193090|NCT03319953|11321763|FG000|STARTED|Period 1 (Day 1 to 14)||3
10193091|NCT03319953|11321764|FG001|STARTED|Period 1 (Day 1 to 14)||4
10193092|NCT03319953|11321765|FG002|STARTED|Period 1 (Day 1 to 14)||9
10193093|NCT03319953|11321766|FG003|STARTED|Period 1 (Day 1 to 14)||7
10193094|NCT03319953|11321763|FG000|COMPLETED|Period 1 (Day 1 to 14)||3
10193095|NCT03319953|11321764|FG001|COMPLETED|Period 1 (Day 1 to 14)||4
10193096|NCT03319953|11321765|FG002|COMPLETED|Period 1 (Day 1 to 14)||9
10193097|NCT03319953|11321766|FG003|COMPLETED|Period 1 (Day 1 to 14)||7
10193098|NCT03319953|11321763|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10193099|NCT03319953|11321764|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10193100|NCT03319953|11321765|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10193101|NCT03319953|11321766|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10193102|NCT03319953|11321763|FG000|STARTED|Washout Period (Day 15 to 49)||3
10193103|NCT03319953|11321764|FG001|STARTED|Washout Period (Day 15 to 49)||4
10193104|NCT03319953|11321765|FG002|STARTED|Washout Period (Day 15 to 49)||9
10193105|NCT03319953|11321766|FG003|STARTED|Washout Period (Day 15 to 49)||7
10193106|NCT03319953|11321763|FG000|COMPLETED|Washout Period (Day 15 to 49)||3
10193107|NCT03319953|11321764|FG001|COMPLETED|Washout Period (Day 15 to 49)||4
10193108|NCT03319953|11321765|FG002|COMPLETED|Washout Period (Day 15 to 49)||9
10193109|NCT03319953|11321766|FG003|COMPLETED|Washout Period (Day 15 to 49)||7
10193110|NCT03319953|11321763|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10193111|NCT03319953|11321764|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10193112|NCT03319953|11321765|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10193113|NCT03319953|11321766|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10193114|NCT03319953|11321763|FG000|STARTED|Period 2 (Day 49 to 154)||3
10193115|NCT03319953|11321764|FG001|STARTED|Period 2 (Day 49 to 154)||4
10193116|NCT03319953|11321765|FG002|STARTED|Period 2 (Day 49 to 154)||9
10193117|NCT03319953|11321766|FG003|STARTED|Period 2 (Day 49 to 154)||7
10193118|NCT03319953|11321763|FG000|Treated|Period 2 (Day 49 to 154)||2
10193119|NCT03319953|11321764|FG001|Treated|Period 2 (Day 49 to 154)||4
10193120|NCT03319953|11321765|FG002|Treated|Period 2 (Day 49 to 154)||8
10193121|NCT03319953|11321766|FG003|Treated|Period 2 (Day 49 to 154)||6
10193122|NCT03319953|11321763|FG000|COMPLETED|Period 2 (Day 49 to 154)||2
10193123|NCT03319953|11321764|FG001|COMPLETED|Period 2 (Day 49 to 154)||4
10193124|NCT03319953|11321765|FG002|COMPLETED|Period 2 (Day 49 to 154)||8
10193125|NCT03319953|11321766|FG003|COMPLETED|Period 2 (Day 49 to 154)||6
10193126|NCT03319953|11321763|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1
10193127|NCT03319953|11321764|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0
10193128|NCT03319953|11321765|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1
10193129|NCT03319953|11321766|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1
10193130|NCT03320057|11321774|FG000|STARTED|Overall Study||266
10193131|NCT03320057|11321775|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
10193132|NCT03320057|11321774|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262
10193133|NCT03320057|11321775|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
10193134|NCT03320057|11321774|FG000|Received Pharmacist Training|Overall Study||0
10193135|NCT03320057|11321775|FG001|Received Pharmacist Training|Overall Study||56
10193136|NCT03320057|11321774|FG000|Pharmacists Completed Baseline Survey|Overall Study||0
10193137|NCT03320057|11321775|FG001|Pharmacists Completed Baseline Survey|Overall Study||47
10193138|NCT03320057|11321774|FG000|COMPLETED|Overall Study||260
10193139|NCT03320057|11321775|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
10193140|NCT03320057|11321774|FG000|NOT COMPLETED|Overall Study||6
10193141|NCT03320057|11321775|FG001|NOT COMPLETED|Overall Study||17
10193142|NCT03320096|11321781|FG000|STARTED|Overall Study||20
10193143|NCT03320096|11321781|FG000|COMPLETED|Overall Study||20
10193144|NCT03320096|11321781|FG000|NOT COMPLETED|Overall Study||0
10193145|NCT03320369|11321785|FG000|STARTED|Overall Study||18
10193146|NCT03320369|11321785|FG000|COMPLETED|Overall Study||15
10193147|NCT03320369|11321785|FG000|NOT COMPLETED|Overall Study||3
10193148|NCT03320824|11321791|FG000|STARTED|Overall Study||184
10193149|NCT03320824|11321792|FG001|STARTED|Overall Study||89
10193150|NCT03320824|11321791|FG000|COMPLETED|Overall Study||166
10193151|NCT03320824|11321792|FG001|COMPLETED|Overall Study||85
10193152|NCT03320824|11321791|FG000|NOT COMPLETED|Overall Study||18
10193153|NCT03320824|11321792|FG001|NOT COMPLETED|Overall Study||4
10193154|NCT03320850|11321808|FG000|STARTED|Overall Study||18
10193155|NCT03320850|11321809|FG001|STARTED|Overall Study||12
10193156|NCT03320850|11321810|FG002|STARTED|Overall Study||18
10193157|NCT03320850|11321811|FG003|STARTED|Overall Study||22
10193158|NCT03320850|11321812|FG004|STARTED|Overall Study||19
10193159|NCT03320850|11321813|FG005|STARTED|Overall Study||58
10193160|NCT03320850|11321814|FG006|STARTED|Overall Study||57
10193161|NCT03320850|11321815|FG007|STARTED|Overall Study||60
10193162|NCT03320850|11321816|FG008|STARTED|Overall Study||60
10193163|NCT03320850|11321817|FG009|STARTED|Overall Study||59
10193164|NCT03320850|11321808|FG000|Safety Population|Overall Study||18
10193165|NCT03320850|11321809|FG001|Safety Population|Overall Study||12
10193166|NCT03320850|11321810|FG002|Safety Population|Overall Study||18
10193167|NCT03320850|11321811|FG003|Safety Population|Overall Study||22
10193168|NCT03320850|11321812|FG004|Safety Population|Overall Study||19
10193169|NCT03320850|11321813|FG005|Safety Population|Overall Study||57
10193170|NCT03320850|11321814|FG006|Safety Population|Overall Study||57
10193171|NCT03320850|11321815|FG007|Safety Population|Overall Study||60
10193172|NCT03320850|11321816|FG008|Safety Population|Overall Study||60
10193173|NCT03320850|11321817|FG009|Safety Population|Overall Study||58
10193174|NCT03320850|11321808|FG000|COMPLETED|Overall Study||18
10193175|NCT03320850|11321809|FG001|COMPLETED|Overall Study||12
10193176|NCT03320850|11321810|FG002|COMPLETED|Overall Study||18
10193177|NCT03320850|11321811|FG003|COMPLETED|Overall Study||21
10193178|NCT03320850|11321812|FG004|COMPLETED|Overall Study||17
10193179|NCT03320850|11321813|FG005|COMPLETED|Overall Study||49
10193180|NCT03320850|11321814|FG006|COMPLETED|Overall Study||50
10193181|NCT03320850|11321815|FG007|COMPLETED|Overall Study||53
10193182|NCT03320850|11321816|FG008|COMPLETED|Overall Study||50
10193183|NCT03320850|11321817|FG009|COMPLETED|Overall Study||50
10193184|NCT03320850|11321808|FG000|NOT COMPLETED|Overall Study||0
10193185|NCT03320850|11321809|FG001|NOT COMPLETED|Overall Study||0
10193186|NCT03320850|11321810|FG002|NOT COMPLETED|Overall Study||0
10193187|NCT03320850|11321811|FG003|NOT COMPLETED|Overall Study||1
10193188|NCT03320850|11321812|FG004|NOT COMPLETED|Overall Study||2
10193189|NCT03320850|11321813|FG005|NOT COMPLETED|Overall Study||9
10193190|NCT03320850|11321814|FG006|NOT COMPLETED|Overall Study||7
10193191|NCT03320850|11321815|FG007|NOT COMPLETED|Overall Study||7
10193192|NCT03320850|11321816|FG008|NOT COMPLETED|Overall Study||10
10193193|NCT03320850|11321817|FG009|NOT COMPLETED|Overall Study||9
10193194|NCT03320941|11321849|FG000|STARTED|Overall Study||19
10193195|NCT03320941|11321850|FG001|STARTED|Overall Study||19
10193196|NCT03320941|11321851|FG002|STARTED|Overall Study||28
10193197|NCT03320941|11321852|FG003|STARTED|Overall Study||31
10193198|NCT03320941|11321853|FG004|STARTED|Overall Study||29
10193199|NCT03320941|11321849|FG000|COMPLETED|Overall Study||19
10193200|NCT03320941|11321850|FG001|COMPLETED|Overall Study||19
10193201|NCT03320941|11321851|FG002|COMPLETED|Overall Study||28
10193202|NCT03320941|11321852|FG003|COMPLETED|Overall Study||30
10193203|NCT03320941|11321853|FG004|COMPLETED|Overall Study||29
10193204|NCT03320941|11321849|FG000|NOT COMPLETED|Overall Study||0
10193205|NCT03320941|11321850|FG001|NOT COMPLETED|Overall Study||0
10193206|NCT03320941|11321851|FG002|NOT COMPLETED|Overall Study||0
10193207|NCT03320941|11321852|FG003|NOT COMPLETED|Overall Study||1
10193208|NCT03320941|11321853|FG004|NOT COMPLETED|Overall Study||0
10193209|NCT03321006|11321867|FG000|STARTED|Overall Study||14
10193210|NCT03321006|11321868|FG001|STARTED|Overall Study||11
10193211|NCT03321006|11321867|FG000|COMPLETED|Overall Study||12
10193212|NCT03321006|11321868|FG001|COMPLETED|Overall Study||11
10193213|NCT03321006|11321867|FG000|NOT COMPLETED|Overall Study||2
10193214|NCT03321006|11321868|FG001|NOT COMPLETED|Overall Study||0
10193215|NCT03321097|11321876|FG000|STARTED|Overall Study||18
10193216|NCT03321097|11321877|FG001|STARTED|Overall Study||18
10193217|NCT03321097|11321876|FG000|COMPLETED|Overall Study||18
10193218|NCT03321097|11321877|FG001|COMPLETED|Overall Study||18
10193219|NCT03321097|11321876|FG000|NOT COMPLETED|Overall Study||0
10193220|NCT03321097|11321877|FG001|NOT COMPLETED|Overall Study||0
10193221|NCT03321253|11321883|FG000|STARTED|Overall Study||38
10193222|NCT03321253|11321883|FG000|COMPLETED|Overall Study||38
10193223|NCT03321253|11321883|FG000|NOT COMPLETED|Overall Study||0
10193224|NCT03321396|11321887|FG000|STARTED|Overall Study||13
10193225|NCT03321396|11321887|FG000|COMPLETED|Overall Study||12
10193226|NCT03321396|11321887|FG000|NOT COMPLETED|Overall Study||1
10193227|NCT03321721|11321894|FG000|STARTED|Overall Study||4
10193228|NCT03321721|11321895|FG001|STARTED|Overall Study||10
10193229|NCT03321721|11321896|FG002|STARTED|Overall Study||12
10193230|NCT03321721|11321894|FG000|COMPLETED|Overall Study||0
10193231|NCT03321721|11321895|FG001|COMPLETED|Overall Study||2
10193232|NCT03321721|11321896|FG002|COMPLETED|Overall Study||1
10193233|NCT03321721|11321894|FG000|NOT COMPLETED|Overall Study||4
10193234|NCT03321721|11321895|FG001|NOT COMPLETED|Overall Study||8
10193235|NCT03321721|11321896|FG002|NOT COMPLETED|Overall Study||11
10193236|NCT03322423|11321905|FG000|STARTED|Period 1||38
10193237|NCT03322423|11321906|FG001|STARTED|Period 1||40
10193238|NCT03322423|11321905|FG000|COMPLETED|Period 1||36
10193239|NCT03322423|11321906|FG001|COMPLETED|Period 1||38
10193240|NCT03322423|11321905|FG000|NOT COMPLETED|Period 1||2
10193241|NCT03322423|11321906|FG001|NOT COMPLETED|Period 1||2
10193242|NCT03322423|11321905|FG000|STARTED|Period 2||36
10193243|NCT03322423|11321906|FG001|STARTED|Period 2||38
10193244|NCT03322423|11321905|FG000|COMPLETED|Period 2||35
10193245|NCT03322423|11321906|FG001|COMPLETED|Period 2||36
10193246|NCT03322423|11321905|FG000|NOT COMPLETED|Period 2||1
10193247|NCT03322423|11321906|FG001|NOT COMPLETED|Period 2||2
10193248|NCT03322462|11321912|FG000|STARTED|Overall Study||155
10193249|NCT03322462|11321912|FG000|Flortaucipir PET Scan|Overall Study||155
10193250|NCT03322462|11321912|FG000|COMPLETED|Overall Study||152
10193251|NCT03322462|11321912|FG000|NOT COMPLETED|Overall Study||3
10193252|NCT03322514|11321920|FG000|STARTED|Overall Study||6
10193253|NCT03322514|11321921|FG001|STARTED|Overall Study||6
10193254|NCT03322514|11321920|FG000|COMPLETED|Overall Study||5
10193255|NCT03322514|11321921|FG001|COMPLETED|Overall Study||5
10193256|NCT03322514|11321920|FG000|NOT COMPLETED|Overall Study||1
10193257|NCT03322514|11321921|FG001|NOT COMPLETED|Overall Study||1
10193258|NCT03322657|11321929|FG000|STARTED|Overall Study||34
10193259|NCT03322657|11321930|FG001|STARTED|Overall Study||35
10193260|NCT03322657|11321929|FG000|COMPLETED|Overall Study||33
10193261|NCT03322657|11321930|FG001|COMPLETED|Overall Study||35
10193262|NCT03322657|11321929|FG000|NOT COMPLETED|Overall Study||1
10193263|NCT03322657|11321930|FG001|NOT COMPLETED|Overall Study||0
10193264|NCT03322930|11321938|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
10193265|NCT03322930|11321939|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
10193266|NCT03322930|11321938|FG000|COMPLETED|Overall Study||20
10193267|NCT03322930|11321939|FG001|COMPLETED|Overall Study||20
10193268|NCT03322930|11321938|FG000|NOT COMPLETED|Overall Study||0
10193269|NCT03322930|11321939|FG001|NOT COMPLETED|Overall Study||0
10193270|NCT03323086|11321947|FG000|STARTED|Overall Study||26
10193271|NCT03323086|11321948|FG001|STARTED|Overall Study||22
10193272|NCT03323086|11321947|FG000|COMPLETED|Overall Study||23
10193273|NCT03323086|11321948|FG001|COMPLETED|Overall Study||20
10193274|NCT03323086|11321947|FG000|NOT COMPLETED|Overall Study||3
10193275|NCT03323086|11321948|FG001|NOT COMPLETED|Overall Study||2
10193276|NCT03323164|11321956|FG000|STARTED|Overall Study||18
10193277|NCT03323164|11321957|FG001|STARTED|Overall Study||17
10193278|NCT03323164|11321956|FG000|COMPLETED|Overall Study||16
10193279|NCT03323164|11321957|FG001|COMPLETED|Overall Study||15
10193280|NCT03323164|11321956|FG000|NOT COMPLETED|Overall Study||2
10193281|NCT03323164|11321957|FG001|NOT COMPLETED|Overall Study||2
10193282|NCT03323307|11321967|FG000|STARTED|Overall Study||70
10193283|NCT03323307|11321967|FG000|COMPLETED|Overall Study||70
10193284|NCT03323307|11321967|FG000|NOT COMPLETED|Overall Study||0
10193285|NCT03323723|11321971|FG000|STARTED|Screening||73
10193286|NCT03323723|11321971|FG000|COMPLETED|Screening||64
10193287|NCT03323723|11321971|FG000|NOT COMPLETED|Screening||9
10193288|NCT03323723|11321971|FG000|STARTED|Baseline Phase||64
10193289|NCT03323723|11321971|FG000|COMPLETED|Baseline Phase||60
10193290|NCT03323723|11321971|FG000|NOT COMPLETED|Baseline Phase||4
10193291|NCT03323723|11321971|FG000|STARTED|Treatment Phase||60
10193292|NCT03323723|11321971|FG000|COMPLETED|Treatment Phase||51
10193293|NCT03323723|11321971|FG000|NOT COMPLETED|Treatment Phase||9
10193294|NCT03323801|11321976|FG000|STARTED|Overall Study||10
10193295|NCT03323801|11321976|FG000|COMPLETED|Overall Study||10
10193296|NCT03323801|11321976|FG000|NOT COMPLETED|Overall Study||0
10193297|NCT03323853|11321983|FG000|STARTED|Overall Study||213
10193298|NCT03323853|11321984|FG001|STARTED|Overall Study||238
10193299|NCT03323853|11321983|FG000|COMPLETED|Overall Study||213
10193300|NCT03323853|11321984|FG001|COMPLETED|Overall Study||238
10193301|NCT03323853|11321983|FG000|NOT COMPLETED|Overall Study||0
10193302|NCT03323853|11321984|FG001|NOT COMPLETED|Overall Study||0
10193303|NCT03324451|11321992|FG000|STARTED|Overall Study||97
10193304|NCT03324451|11321993|FG001|STARTED|Overall Study||54
10193305|NCT03324451|11321992|FG000|COMPLETED|Overall Study||65
10193306|NCT03324451|11321993|FG001|COMPLETED|Overall Study||41
10193307|NCT03324451|11321992|FG000|NOT COMPLETED|Overall Study||32
10193308|NCT03324451|11321993|FG001|NOT COMPLETED|Overall Study||13
10193309|NCT03324581|11322002|FG000|STARTED|Overall Study||77
10193310|NCT03324581|11322003|FG001|STARTED|Overall Study||80
10193311|NCT03324581|11322004|FG002|STARTED|Overall Study||82
10193312|NCT03324581|11322002|FG000|COMPLETED|Overall Study||38
10193313|NCT03324581|11322003|FG001|COMPLETED|Overall Study||44
10193314|NCT03324581|11322004|FG002|COMPLETED|Overall Study||57
10193315|NCT03324581|11322002|FG000|NOT COMPLETED|Overall Study||39
10193316|NCT03324581|11322003|FG001|NOT COMPLETED|Overall Study||36
10193317|NCT03324581|11322004|FG002|NOT COMPLETED|Overall Study||25
10193318|NCT03324607|11322012|FG000|STARTED|Overall Study||20
10193319|NCT03324607|11322012|FG000|COMPLETED|Overall Study||20
10193320|NCT03324607|11322012|FG000|NOT COMPLETED|Overall Study||0
10193321|NCT03325010|11322021|FG000|STARTED|Overall Study||64
10193322|NCT03325010|11322022|FG001|STARTED|Overall Study||63
10193323|NCT03325010|11322021|FG000|Safety Analysis Set|Overall Study||62
10193324|NCT03325010|11322022|FG001|Safety Analysis Set|Overall Study||59
10193325|NCT03325010|11322021|FG000|Full Analysis Set|Overall Study||61
10193326|NCT03325010|11322022|FG001|Full Analysis Set|Overall Study||58
10193327|NCT03325010|11322021|FG000|COMPLETED|Overall Study||55
10193328|NCT03325010|11322022|FG001|COMPLETED|Overall Study||43
10193329|NCT03325010|11322021|FG000|NOT COMPLETED|Overall Study||9
10193330|NCT03325010|11322022|FG001|NOT COMPLETED|Overall Study||20
10193331|NCT03325556|11322028|FG000|STARTED|Open-label Period||392
10193332|NCT03325556|11322029|FG001|STARTED|Open-label Period||0
10193333|NCT03325556|11322030|FG002|STARTED|Open-label Period||0
10193334|NCT03325556|11322028|FG000|COMPLETED|Open-label Period||217
10193335|NCT03325556|11322029|FG001|COMPLETED|Open-label Period||0
10193336|NCT03325556|11322030|FG002|COMPLETED|Open-label Period||0
10193337|NCT03325556|11322028|FG000|NOT COMPLETED|Open-label Period||175
10193338|NCT03325556|11322029|FG001|NOT COMPLETED|Open-label Period||0
10193339|NCT03325556|11322030|FG002|NOT COMPLETED|Open-label Period||0
10193340|NCT03325556|11322028|FG000|STARTED|Double-blind Period||0
10193341|NCT03325556|11322029|FG001|STARTED|Double-blind Period||105
10193342|NCT03325556|11322030|FG002|STARTED|Double-blind Period||112
10193343|NCT03325556|11322028|FG000|COMPLETED|Double-blind Period||0
10193344|NCT03325556|11322029|FG001|COMPLETED|Double-blind Period||44
10193345|NCT03325556|11322030|FG002|COMPLETED|Double-blind Period||35
10193346|NCT03325556|11322028|FG000|NOT COMPLETED|Double-blind Period||0
10193347|NCT03325556|11322029|FG001|NOT COMPLETED|Double-blind Period||61
10193348|NCT03325556|11322030|FG002|NOT COMPLETED|Double-blind Period||77
10193349|NCT03325673|11322039|FG000|STARTED|Overall Study||42
10193350|NCT03325673|11322040|FG001|STARTED|Overall Study||42
10193351|NCT03325673|11322039|FG000|COMPLETED|Overall Study||38
10193352|NCT03325673|11322040|FG001|COMPLETED|Overall Study||42
10193353|NCT03325673|11322039|FG000|NOT COMPLETED|Overall Study||4
10193354|NCT03325673|11322040|FG001|NOT COMPLETED|Overall Study||0
10193355|NCT03325816|11322048|FG000|STARTED|Overall Study||3
10193356|NCT03325816|11322049|FG001|STARTED|Overall Study||6
10193357|NCT03325816|11322048|FG000|COMPLETED|Overall Study||3
10193358|NCT03325816|11322049|FG001|COMPLETED|Overall Study||6
10193359|NCT03325816|11322048|FG000|NOT COMPLETED|Overall Study||0
10193360|NCT03325816|11322049|FG001|NOT COMPLETED|Overall Study||0
10193361|NCT03325881|11322059|FG000|STARTED|Overall Study||44
10193362|NCT03325881|11322060|FG001|STARTED|Overall Study||45
10193363|NCT03325881|11322059|FG000|Treated|Overall Study||43
10193364|NCT03325881|11322060|FG001|Treated|Overall Study||45
10193365|NCT03325881|11322059|FG000|COMPLETED|Overall Study||41
10193366|NCT03325881|11322060|FG001|COMPLETED|Overall Study||42
10193367|NCT03325881|11322059|FG000|NOT COMPLETED|Overall Study||3
10193368|NCT03325881|11322060|FG001|NOT COMPLETED|Overall Study||3
10193369|NCT03325894|11322070|FG000|STARTED|Overall Study||64
10193370|NCT03325894|11322071|FG001|STARTED|Overall Study||77
10193371|NCT03325894|11322070|FG000|COMPLETED|Overall Study||0
10193372|NCT03325894|11322071|FG001|COMPLETED|Overall Study||0
10193373|NCT03325894|11322070|FG000|NOT COMPLETED|Overall Study||64
10193374|NCT03325894|11322071|FG001|NOT COMPLETED|Overall Study||77
10193375|NCT03326323|11322080|FG000|STARTED|Overall Study||43
10193376|NCT03326323|11322080|FG000|COMPLETED|Overall Study||40
10193377|NCT03326323|11322080|FG000|NOT COMPLETED|Overall Study||3
10193378|NCT03326518|11322087|FG000|STARTED|Overall Study||19
10193379|NCT03326518|11322088|FG001|STARTED|Overall Study||12
10193380|NCT03326518|11322089|FG002|STARTED|Overall Study||14
10193381|NCT03326518|11322087|FG000|COMPLETED|Overall Study||16
10193382|NCT03326518|11322088|FG001|COMPLETED|Overall Study||12
10193383|NCT03326518|11322089|FG002|COMPLETED|Overall Study||13
10193384|NCT03326518|11322087|FG000|NOT COMPLETED|Overall Study||3
10193385|NCT03326518|11322088|FG001|NOT COMPLETED|Overall Study||0
10193386|NCT03326518|11322089|FG002|NOT COMPLETED|Overall Study||1
10193387|NCT03326843|11322097|FG000|STARTED|Overall Study||4
10193388|NCT03326843|11322097|FG000|COMPLETED|Overall Study||4
10193389|NCT03326843|11322097|FG000|NOT COMPLETED|Overall Study||0
10193390|NCT03326895|11322101|FG000|STARTED|Overall Study||168
10193391|NCT03326895|11322101|FG000|COMPLETED|Overall Study||168
10193392|NCT03326895|11322101|FG000|NOT COMPLETED|Overall Study||0
10193393|NCT03326986|11322108|FG000|STARTED|Overall Study||8
10193394|NCT03326986|11322109|FG001|STARTED|Overall Study||8
10193395|NCT03326986|11322110|FG002|STARTED|Overall Study||8
10193396|NCT03326986|11322108|FG000|COMPLETED|Overall Study||8
10193397|NCT03326986|11322109|FG001|COMPLETED|Overall Study||8
10193398|NCT03326986|11322110|FG002|COMPLETED|Overall Study||8
10193399|NCT03326986|11322108|FG000|NOT COMPLETED|Overall Study||0
10193400|NCT03326986|11322109|FG001|NOT COMPLETED|Overall Study||0
10193401|NCT03326986|11322110|FG002|NOT COMPLETED|Overall Study||0
10193402|NCT03326999|11322153|FG000|STARTED|Overall Study||30
10193403|NCT03326999|11322154|FG001|STARTED|Overall Study||30
10193404|NCT03326999|11322153|FG000|COMPLETED|Overall Study||30
10193405|NCT03326999|11322154|FG001|COMPLETED|Overall Study||30
10193406|NCT03326999|11322153|FG000|NOT COMPLETED|Overall Study||0
10193407|NCT03326999|11322154|FG001|NOT COMPLETED|Overall Study||0
10193408|NCT03327051|11322162|FG000|STARTED|Overall Study||19
10193409|NCT03327051|11322163|FG001|STARTED|Overall Study||20
10193410|NCT03327051|11322162|FG000|Received Treatment|Overall Study||16
10193411|NCT03327051|11322163|FG001|Received Treatment|Overall Study||16
10193412|NCT03327051|11322162|FG000|Attended Visit 2 (Week 0)|Overall Study||15
10193413|NCT03327051|11322163|FG001|Attended Visit 2 (Week 0)|Overall Study||15
10193414|NCT03327051|11322162|FG000|COMPLETED|Overall Study||14
10193415|NCT03327051|11322163|FG001|COMPLETED|Overall Study||15
10193416|NCT03327051|11322162|FG000|NOT COMPLETED|Overall Study||5
10193417|NCT03327051|11322163|FG001|NOT COMPLETED|Overall Study||5
10193418|NCT03327220|11322172|FG000|STARTED|Overall Study||62
10193419|NCT03327220|11322173|FG001|STARTED|Overall Study||62
10193420|NCT03327220|11322172|FG000|Safety Population: Received Study Treatment|Overall Study||59
10193421|NCT03327220|11322173|FG001|Safety Population: Received Study Treatment|Overall Study||60
10193422|NCT03327220|11322172|FG000|COMPLETED|Overall Study||57
10193423|NCT03327220|11322173|FG001|COMPLETED|Overall Study||58
10193424|NCT03327220|11322172|FG000|NOT COMPLETED|Overall Study||5
10193425|NCT03327220|11322173|FG001|NOT COMPLETED|Overall Study||4
10193426|NCT03327402|11322179|FG000|STARTED|Overall Study||24
10193427|NCT03327402|11322179|FG000|Rich PK Sampling Group|Overall Study||12
10193428|NCT03327402|11322179|FG000|Sparse PK Sampling Group|Overall Study||12
10193429|NCT03327402|11322179|FG000|COMPLETED|Overall Study||22
10193430|NCT03327402|11322179|FG000|NOT COMPLETED|Overall Study||2
10193431|NCT03327571|11322185|FG000|STARTED|Group 1: cHL||1598
10193432|NCT03327571|11322186|FG001|STARTED|Group 1: cHL||0
10193433|NCT03327571|11322185|FG000|COMPLETED|Group 1: cHL||1598
10193434|NCT03327571|11322186|FG001|COMPLETED|Group 1: cHL||0
10193435|NCT03327571|11322185|FG000|NOT COMPLETED|Group 1: cHL||0
10193436|NCT03327571|11322186|FG001|NOT COMPLETED|Group 1: cHL||0
10193437|NCT03327571|11322185|FG000|STARTED|Group 2: RRHL||0
10193438|NCT03327571|11322186|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
10193439|NCT03327571|11322185|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0
10193440|NCT03327571|11322186|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
10193441|NCT03327571|11322185|FG000|COMPLETED|Group 2: RRHL||0
10193442|NCT03327571|11322186|FG001|COMPLETED|Group 2: RRHL||426
10193443|NCT03327571|11322185|FG000|NOT COMPLETED|Group 2: RRHL||0
10193444|NCT03327571|11322186|FG001|NOT COMPLETED|Group 2: RRHL||0
10193445|NCT03328182|11322193|FG000|STARTED|Overall Study||34
10193446|NCT03328182|11322193|FG000|COMPLETED|Overall Study||30
10193447|NCT03328182|11322193|FG000|NOT COMPLETED|Overall Study||4
10193448|NCT03328208|11322199|FG000|STARTED|Overall Study||37
10193449|NCT03328208|11322200|FG001|STARTED|Overall Study||35
10193450|NCT03328208|11322199|FG000|COMPLETED|Overall Study||37
10193451|NCT03328208|11322200|FG001|COMPLETED|Overall Study||35
10193452|NCT03328208|11322199|FG000|NOT COMPLETED|Overall Study||0
10193453|NCT03328208|11322200|FG001|NOT COMPLETED|Overall Study||0
10193454|NCT03328325|11322206|FG000|STARTED|Overall Study||152
10193455|NCT03328325|11322206|FG000|COMPLETED|Overall Study||141
10193456|NCT03328325|11322206|FG000|NOT COMPLETED|Overall Study||11
10193457|NCT03328624|11322210|FG000|STARTED|Overall Study||36
10193458|NCT03328624|11322210|FG000|COMPLETED|Overall Study||36
10193459|NCT03328624|11322210|FG000|NOT COMPLETED|Overall Study||0
10193460|NCT03328832|11322216|FG000|STARTED|Overall Study||35
10193461|NCT03328832|11322217|FG001|STARTED|Overall Study||35
10193462|NCT03328832|11322216|FG000|COMPLETED|Overall Study||35
10193463|NCT03328832|11322217|FG001|COMPLETED|Overall Study||34
10193464|NCT03328832|11322216|FG000|NOT COMPLETED|Overall Study||0
10193465|NCT03328832|11322217|FG001|NOT COMPLETED|Overall Study||1
10193466|NCT03328897|11322226|FG000|STARTED|Randomized-treatment Epoch||168
10193467|NCT03328897|11322227|FG001|STARTED|Randomized-treatment Epoch||167
10193468|NCT03328897|11322228|FG002|STARTED|Randomized-treatment Epoch||83
10193469|NCT03328897|11322226|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
10193470|NCT03328897|11322227|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
10193471|NCT03328897|11322228|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
10193472|NCT03328897|11322226|FG000|COMPLETED|Randomized-treatment Epoch||152
10193473|NCT03328897|11322227|FG001|COMPLETED|Randomized-treatment Epoch||162
10193474|NCT03328897|11322228|FG002|COMPLETED|Randomized-treatment Epoch||81
10193475|NCT03328897|11322226|FG000|NOT COMPLETED|Randomized-treatment Epoch||16
10193476|NCT03328897|11322227|FG001|NOT COMPLETED|Randomized-treatment Epoch||5
10193477|NCT03328897|11322228|FG002|NOT COMPLETED|Randomized-treatment Epoch||2
10193478|NCT03328897|11322226|FG000|STARTED|Follow-up Epoch||161
10193479|NCT03328897|11322227|FG001|STARTED|Follow-up Epoch||163
10193480|NCT03328897|11322228|FG002|STARTED|Follow-up Epoch||81
10193481|NCT03328897|11322226|FG000|COMPLETED|Follow-up Epoch||153
10193482|NCT03328897|11322227|FG001|COMPLETED|Follow-up Epoch||160
10193483|NCT03328897|11322228|FG002|COMPLETED|Follow-up Epoch||79
10193484|NCT03328897|11322226|FG000|NOT COMPLETED|Follow-up Epoch||8
10193485|NCT03328897|11322227|FG001|NOT COMPLETED|Follow-up Epoch||3
10193486|NCT03328897|11322228|FG002|NOT COMPLETED|Follow-up Epoch||2
10193487|NCT03328949|11322236|FG000|STARTED|Overall Study||120
10193488|NCT03328949|11322236|FG000|COMPLETED|Overall Study||120
10193489|NCT03328949|11322236|FG000|NOT COMPLETED|Overall Study||0
10193490|NCT03329196|11322243|FG000|STARTED|Overall Study||151
10193491|NCT03329196|11322244|FG001|STARTED|Overall Study||153
10193492|NCT03329196|11322243|FG000|COMPLETED|Overall Study||111
10193493|NCT03329196|11322244|FG001|COMPLETED|Overall Study||123
10193494|NCT03329196|11322243|FG000|NOT COMPLETED|Overall Study||40
10193495|NCT03329196|11322244|FG001|NOT COMPLETED|Overall Study||30
10193496|NCT03329209|11322250|FG000|STARTED|Overall Study||16
10193497|NCT03329209|11322250|FG000|COMPLETED|Overall Study||16
10193498|NCT03329209|11322250|FG000|NOT COMPLETED|Overall Study||0
10193499|NCT03329352|11322254|FG000|STARTED|F&P Toffee Full Face Mask Validation||44
10193500|NCT03329352|11322254|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42
10193501|NCT03329352|11322254|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2
10193502|NCT03329352|11322254|FG000|STARTED|Extension||29
10193503|NCT03329352|11322254|FG000|COMPLETED|Extension||22
10193504|NCT03329352|11322254|FG000|NOT COMPLETED|Extension||7
10193505|NCT03329573|11322264|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23
10193506|NCT03329573|11322265|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24
10193507|NCT03329573|11322266|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19
10193508|NCT03329573|11322267|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19
10193509|NCT03329573|11322264|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
10193510|NCT03329573|11322265|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
10193511|NCT03329573|11322266|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
10193512|NCT03329573|11322267|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
10193513|NCT03329573|11322264|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
10193514|NCT03329573|11322265|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
10193515|NCT03329573|11322266|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
10193516|NCT03329573|11322267|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
10193517|NCT03329573|11322264|FG000|STARTED|Washout Period (Day 6 to Day 11)||22
10193518|NCT03329573|11322265|FG001|STARTED|Washout Period (Day 6 to Day 11)||21
10193519|NCT03329573|11322266|FG002|STARTED|Washout Period (Day 6 to Day 11)||19
10193520|NCT03329573|11322267|FG003|STARTED|Washout Period (Day 6 to Day 11)||19
10193521|NCT03329573|11322264|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22
10193522|NCT03329573|11322265|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21
10193523|NCT03329573|11322266|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19
10193524|NCT03329573|11322267|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19
10193525|NCT03329573|11322264|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10193526|NCT03329573|11322265|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10193527|NCT03329573|11322266|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10193528|NCT03329573|11322267|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10193529|NCT03329573|11322264|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
10193530|NCT03329573|11322265|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
10193531|NCT03329573|11322266|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
10193532|NCT03329573|11322267|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
10193533|NCT03329573|11322264|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
10193534|NCT03329573|11322265|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
10193535|NCT03329573|11322266|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
10193536|NCT03329573|11322267|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
10193537|NCT03329573|11322264|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
10193538|NCT03329573|11322265|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
10193539|NCT03329573|11322266|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
10193540|NCT03329573|11322267|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
10193541|NCT03329846|11322279|FG000|STARTED|Overall Study||10
10193542|NCT03329846|11322280|FG001|STARTED|Overall Study||10
10193543|NCT03329846|11322279|FG000|COMPLETED|Overall Study||2
10193544|NCT03329846|11322280|FG001|COMPLETED|Overall Study||1
10193545|NCT03329846|11322279|FG000|NOT COMPLETED|Overall Study||8
10193546|NCT03329846|11322280|FG001|NOT COMPLETED|Overall Study||9
10193547|NCT03329885|11322292|FG000|STARTED|Overall Study||9
10193548|NCT03329885|11322293|FG001|STARTED|Overall Study||6
10193549|NCT03329885|11322294|FG002|STARTED|Overall Study||6
10193550|NCT03329885|11322295|FG003|STARTED|Overall Study||6
10193551|NCT03329885|11322296|FG004|STARTED|Overall Study||6
10193552|NCT03329885|11322297|FG005|STARTED|Overall Study||3
10193553|NCT03329885|11322298|FG006|STARTED|Overall Study||1
10193554|NCT03329885|11322299|FG007|STARTED|Overall Study||1
10193555|NCT03329885|11322300|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
10193556|NCT03329885|11322292|FG000|COMPLETED|Overall Study||9
10193557|NCT03329885|11322293|FG001|COMPLETED|Overall Study||6
10193558|NCT03329885|11322294|FG002|COMPLETED|Overall Study||6
10193559|NCT03329885|11322295|FG003|COMPLETED|Overall Study||6
10193560|NCT03329885|11322296|FG004|COMPLETED|Overall Study||6
10193561|NCT03329885|11322297|FG005|COMPLETED|Overall Study||3
10193562|NCT03329885|11322298|FG006|COMPLETED|Overall Study||0
10193563|NCT03329885|11322299|FG007|COMPLETED|Overall Study||0
10193564|NCT03329885|11322300|FG008|COMPLETED|Overall Study||0
10193565|NCT03329885|11322292|FG000|NOT COMPLETED|Overall Study||0
10193566|NCT03329885|11322293|FG001|NOT COMPLETED|Overall Study||0
10193567|NCT03329885|11322294|FG002|NOT COMPLETED|Overall Study||0
10193568|NCT03329885|11322295|FG003|NOT COMPLETED|Overall Study||0
10193569|NCT03329885|11322296|FG004|NOT COMPLETED|Overall Study||0
10193570|NCT03329885|11322297|FG005|NOT COMPLETED|Overall Study||0
10193571|NCT03329885|11322298|FG006|NOT COMPLETED|Overall Study||1
10193572|NCT03329885|11322299|FG007|NOT COMPLETED|Overall Study||1
10193573|NCT03329885|11322300|FG008|NOT COMPLETED|Overall Study||0
10193574|NCT03329911|11322322|FG000|STARTED|Overall Study||326
10193575|NCT03329911|11322323|FG001|STARTED|Overall Study||325
10193576|NCT03329911|11322322|FG000|COMPLETED|Overall Study||209
10193577|NCT03329911|11322323|FG001|COMPLETED|Overall Study||222
10193578|NCT03329911|11322322|FG000|NOT COMPLETED|Overall Study||117
10193579|NCT03329911|11322323|FG001|NOT COMPLETED|Overall Study||103
10193580|NCT03329937|11322329|FG000|STARTED|Overall Study||21
10193581|NCT03329937|11322329|FG000|COMPLETED|Overall Study||21
10193582|NCT03329937|11322329|FG000|NOT COMPLETED|Overall Study||0
10193583|NCT03329989|11322333|FG000|STARTED|Overall Study||158
10193584|NCT03329989|11322333|FG000|COMPLETED|Overall Study||135
10193585|NCT03329989|11322333|FG000|NOT COMPLETED|Overall Study||23
10193586|NCT03330002|11322337|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500
10193587|NCT03330002|11322337|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
10193588|NCT03330002|11322337|FG000|NOT COMPLETED|Overall Study||22
10193589|NCT03330041|11322341|FG000|STARTED|Overall Study||50
10193590|NCT03330041|11322341|FG000|COMPLETED|Overall Study||48
10193591|NCT03330041|11322341|FG000|NOT COMPLETED|Overall Study||2
10193592|NCT03330119|11322349|FG000|STARTED|Overall Study||641
10193593|NCT03330119|11322350|FG001|STARTED|Overall Study||853
10193594|NCT03330119|11322349|FG000|COMPLETED|Overall Study||475
10193595|NCT03330119|11322350|FG001|COMPLETED|Overall Study||571
10193596|NCT03330119|11322349|FG000|NOT COMPLETED|Overall Study||166
10193597|NCT03330119|11322350|FG001|NOT COMPLETED|Overall Study||282
10193598|NCT03330236|11322358|FG000|STARTED|Overall Study||779
10193599|NCT03330236|11322359|FG001|STARTED|Overall Study||781
10193600|NCT03330236|11322358|FG000|Received Surgery|Overall Study||779
10193601|NCT03330236|11322359|FG001|Received Surgery|Overall Study||781
10193602|NCT03330236|11322358|FG000|Modified ITT|Overall Study||773
10193603|NCT03330236|11322359|FG001|Modified ITT|Overall Study||774
10193604|NCT03330236|11322358|FG000|COMPLETED|Overall Study||679
10193605|NCT03330236|11322359|FG001|COMPLETED|Overall Study||697
10193606|NCT03330236|11322358|FG000|NOT COMPLETED|Overall Study||100
10193607|NCT03330236|11322359|FG001|NOT COMPLETED|Overall Study||84
10193608|NCT03330262|11322367|FG000|STARTED|First Six Weeks||7
10193609|NCT03330262|11322368|FG001|STARTED|First Six Weeks||6
10193610|NCT03330262|11322367|FG000|COMPLETED|First Six Weeks||7
10193611|NCT03330262|11322368|FG001|COMPLETED|First Six Weeks||6
10193612|NCT03330262|11322367|FG000|NOT COMPLETED|First Six Weeks||0
10193613|NCT03330262|11322368|FG001|NOT COMPLETED|First Six Weeks||0
10193614|NCT03330262|11322367|FG000|STARTED|Second Six Weeks||7
10193615|NCT03330262|11322368|FG001|STARTED|Second Six Weeks||6
10193616|NCT03330262|11322367|FG000|COMPLETED|Second Six Weeks||5
10193617|NCT03330262|11322368|FG001|COMPLETED|Second Six Weeks||5
10193618|NCT03330262|11322367|FG000|NOT COMPLETED|Second Six Weeks||2
10193619|NCT03330262|11322368|FG001|NOT COMPLETED|Second Six Weeks||1
10193620|NCT03330275|11322377|FG000|STARTED|Visit 1 - Period 1||6
10193621|NCT03330275|11322378|FG001|STARTED|Visit 1 - Period 1||6
10193622|NCT03330275|11322379|FG002|STARTED|Visit 1 - Period 1||6
10193623|NCT03330275|11322380|FG003|STARTED|Visit 1 - Period 1||6
10193624|NCT03330275|11322381|FG004|STARTED|Visit 1 - Period 1||0
10193625|NCT03330275|11322382|FG005|STARTED|Visit 1 - Period 1||0
10193626|NCT03330275|11322383|FG006|STARTED|Visit 1 - Period 1||0
10193627|NCT03330275|11322384|FG007|STARTED|Visit 1 - Period 1||0
10193628|NCT03330275|11322385|FG008|STARTED|Visit 1 - Period 1||0
10193629|NCT03330275|11322386|FG009|STARTED|Visit 1 - Period 1||0
10193630|NCT03330275|11322377|FG000|COMPLETED|Visit 1 - Period 1||6
10193631|NCT03330275|11322378|FG001|COMPLETED|Visit 1 - Period 1||6
10193632|NCT03330275|11322379|FG002|COMPLETED|Visit 1 - Period 1||6
10193633|NCT03330275|11322380|FG003|COMPLETED|Visit 1 - Period 1||6
10193634|NCT03330275|11322381|FG004|COMPLETED|Visit 1 - Period 1||0
10193635|NCT03330275|11322382|FG005|COMPLETED|Visit 1 - Period 1||0
10193636|NCT03330275|11322383|FG006|COMPLETED|Visit 1 - Period 1||0
10193637|NCT03330275|11322384|FG007|COMPLETED|Visit 1 - Period 1||0
10193638|NCT03330275|11322385|FG008|COMPLETED|Visit 1 - Period 1||0
10193639|NCT03330275|11322386|FG009|COMPLETED|Visit 1 - Period 1||0
10193640|NCT03330275|11322377|FG000|NOT COMPLETED|Visit 1 - Period 1||0
10193641|NCT03330275|11322378|FG001|NOT COMPLETED|Visit 1 - Period 1||0
10193642|NCT03330275|11322379|FG002|NOT COMPLETED|Visit 1 - Period 1||0
10193643|NCT03330275|11322380|FG003|NOT COMPLETED|Visit 1 - Period 1||0
10193644|NCT03330275|11322381|FG004|NOT COMPLETED|Visit 1 - Period 1||0
10193645|NCT03330275|11322382|FG005|NOT COMPLETED|Visit 1 - Period 1||0
10193646|NCT03330275|11322383|FG006|NOT COMPLETED|Visit 1 - Period 1||0
10193647|NCT03330275|11322384|FG007|NOT COMPLETED|Visit 1 - Period 1||0
10193648|NCT03330275|11322385|FG008|NOT COMPLETED|Visit 1 - Period 1||0
10193649|NCT03330275|11322386|FG009|NOT COMPLETED|Visit 1 - Period 1||0
10193650|NCT03330275|11322377|FG000|STARTED|Visit 1 - Period 2||6
10193651|NCT03330275|11322378|FG001|STARTED|Visit 1 - Period 2||6
10193652|NCT03330275|11322379|FG002|STARTED|Visit 1 - Period 2||6
10193653|NCT03330275|11322380|FG003|STARTED|Visit 1 - Period 2||6
10193654|NCT03330275|11322381|FG004|STARTED|Visit 1 - Period 2||0
10193655|NCT03330275|11322382|FG005|STARTED|Visit 1 - Period 2||0
10193656|NCT03330275|11322383|FG006|STARTED|Visit 1 - Period 2||0
10193657|NCT03330275|11322384|FG007|STARTED|Visit 1 - Period 2||0
10193658|NCT03330275|11322385|FG008|STARTED|Visit 1 - Period 2||0
10193659|NCT03330275|11322386|FG009|STARTED|Visit 1 - Period 2||0
10193660|NCT03330275|11322377|FG000|COMPLETED|Visit 1 - Period 2||6
10193661|NCT03330275|11322378|FG001|COMPLETED|Visit 1 - Period 2||6
10193662|NCT03330275|11322379|FG002|COMPLETED|Visit 1 - Period 2||6
10193663|NCT03330275|11322380|FG003|COMPLETED|Visit 1 - Period 2||6
10193664|NCT03330275|11322381|FG004|COMPLETED|Visit 1 - Period 2||0
10193665|NCT03330275|11322382|FG005|COMPLETED|Visit 1 - Period 2||0
10193666|NCT03330275|11322383|FG006|COMPLETED|Visit 1 - Period 2||0
10193667|NCT03330275|11322384|FG007|COMPLETED|Visit 1 - Period 2||0
10193668|NCT03330275|11322385|FG008|COMPLETED|Visit 1 - Period 2||0
10193669|NCT03330275|11322386|FG009|COMPLETED|Visit 1 - Period 2||0
10193670|NCT03330275|11322377|FG000|NOT COMPLETED|Visit 1 - Period 2||0
10193671|NCT03330275|11322378|FG001|NOT COMPLETED|Visit 1 - Period 2||0
10193672|NCT03330275|11322379|FG002|NOT COMPLETED|Visit 1 - Period 2||0
10193673|NCT03330275|11322380|FG003|NOT COMPLETED|Visit 1 - Period 2||0
10193674|NCT03330275|11322381|FG004|NOT COMPLETED|Visit 1 - Period 2||0
10193675|NCT03330275|11322382|FG005|NOT COMPLETED|Visit 1 - Period 2||0
10193676|NCT03330275|11322383|FG006|NOT COMPLETED|Visit 1 - Period 2||0
10193677|NCT03330275|11322384|FG007|NOT COMPLETED|Visit 1 - Period 2||0
10193678|NCT03330275|11322385|FG008|NOT COMPLETED|Visit 1 - Period 2||0
10193679|NCT03330275|11322386|FG009|NOT COMPLETED|Visit 1 - Period 2||0
10193680|NCT03330275|11322377|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0
10193681|NCT03330275|11322378|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0
10193682|NCT03330275|11322379|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0
10193683|NCT03330275|11322380|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0
10193684|NCT03330275|11322381|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4
10193685|NCT03330275|11322382|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4
10193686|NCT03330275|11322383|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4
10193687|NCT03330275|11322384|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4
10193688|NCT03330275|11322385|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4
10193689|NCT03330275|11322386|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4
10193690|NCT03330275|11322377|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193691|NCT03330275|11322378|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193692|NCT03330275|11322379|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193693|NCT03330275|11322380|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193694|NCT03330275|11322381|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10193695|NCT03330275|11322382|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10193696|NCT03330275|11322383|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10193697|NCT03330275|11322384|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10193698|NCT03330275|11322385|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10193699|NCT03330275|11322386|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10193700|NCT03330275|11322377|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193701|NCT03330275|11322378|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193702|NCT03330275|11322379|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193703|NCT03330275|11322380|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193704|NCT03330275|11322381|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193705|NCT03330275|11322382|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193706|NCT03330275|11322383|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193707|NCT03330275|11322384|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193708|NCT03330275|11322385|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193709|NCT03330275|11322386|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10193710|NCT03330275|11322377|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0
10193711|NCT03330275|11322378|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0
10193712|NCT03330275|11322379|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0
10193713|NCT03330275|11322380|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0
10193714|NCT03330275|11322381|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4
10193715|NCT03330275|11322382|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4
10193716|NCT03330275|11322383|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4
10193717|NCT03330275|11322384|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4
10193718|NCT03330275|11322385|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4
10193719|NCT03330275|11322386|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4
10193720|NCT03330275|11322377|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193721|NCT03330275|11322378|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193722|NCT03330275|11322379|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193723|NCT03330275|11322380|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193724|NCT03330275|11322381|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10193725|NCT03330275|11322382|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10193726|NCT03330275|11322383|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10193727|NCT03330275|11322384|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10193728|NCT03330275|11322385|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10193729|NCT03330275|11322386|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10193730|NCT03330275|11322377|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193731|NCT03330275|11322378|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193732|NCT03330275|11322379|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193733|NCT03330275|11322380|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193734|NCT03330275|11322381|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193735|NCT03330275|11322382|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193736|NCT03330275|11322383|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193737|NCT03330275|11322384|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193738|NCT03330275|11322385|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193739|NCT03330275|11322386|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10193740|NCT03330275|11322377|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0
10193741|NCT03330275|11322378|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0
10193742|NCT03330275|11322379|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0
10193743|NCT03330275|11322380|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0
10193744|NCT03330275|11322381|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4
10193745|NCT03330275|11322382|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4
10193746|NCT03330275|11322383|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4
10193747|NCT03330275|11322384|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4
10193748|NCT03330275|11322385|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4
10193749|NCT03330275|11322386|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4
10193750|NCT03330275|11322377|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193751|NCT03330275|11322378|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193752|NCT03330275|11322379|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193753|NCT03330275|11322380|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193754|NCT03330275|11322381|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10193755|NCT03330275|11322382|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10193756|NCT03330275|11322383|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10193757|NCT03330275|11322384|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10193758|NCT03330275|11322385|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10193759|NCT03330275|11322386|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10193760|NCT03330275|11322377|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193761|NCT03330275|11322378|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193762|NCT03330275|11322379|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193763|NCT03330275|11322380|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193764|NCT03330275|11322381|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193765|NCT03330275|11322382|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193766|NCT03330275|11322383|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193767|NCT03330275|11322384|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193768|NCT03330275|11322385|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193769|NCT03330275|11322386|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10193770|NCT03330288|11322396|FG000|STARTED|Overall Study|Enrolled|824
10193771|NCT03330288|11322397|FG001|STARTED|Overall Study|Enrolled|278
10193772|NCT03330288|11322396|FG000|COMPLETED|Overall Study||794
10193773|NCT03330288|11322397|FG001|COMPLETED|Overall Study||270
10193774|NCT03330288|11322396|FG000|NOT COMPLETED|Overall Study||30
10193775|NCT03330288|11322397|FG001|NOT COMPLETED|Overall Study||8
10193776|NCT03330457|11322407|FG000|STARTED|Overall Study||6
10193777|NCT03330457|11322408|FG001|STARTED|Overall Study||3
10193778|NCT03330457|11322409|FG002|STARTED|Overall Study||6
10193779|NCT03330457|11322410|FG003|STARTED|Overall Study||3
10193780|NCT03330457|11322407|FG000|COMPLETED|Overall Study||6
10193781|NCT03330457|11322408|FG001|COMPLETED|Overall Study||3
10193782|NCT03330457|11322409|FG002|COMPLETED|Overall Study||6
10193783|NCT03330457|11322410|FG003|COMPLETED|Overall Study||3
10193784|NCT03330457|11322407|FG000|NOT COMPLETED|Overall Study||0
10193785|NCT03330457|11322408|FG001|NOT COMPLETED|Overall Study||0
10193786|NCT03330457|11322409|FG002|NOT COMPLETED|Overall Study||0
10193787|NCT03330457|11322410|FG003|NOT COMPLETED|Overall Study||0
10193788|NCT03330834|11322420|FG000|STARTED|Overall Study||1
10193789|NCT03330834|11322420|FG000|COMPLETED|Overall Study||1
10193790|NCT03330834|11322420|FG000|NOT COMPLETED|Overall Study||0
10193791|NCT03331042|11322428|FG000|STARTED|Overall Study||22
10193792|NCT03331042|11322429|FG001|STARTED|Overall Study||21
10193793|NCT03331042|11322430|FG002|STARTED|Overall Study||21
10193794|NCT03331042|11322431|FG003|STARTED|Overall Study||21
10193795|NCT03331042|11322428|FG000|COMPLETED|Overall Study||21
10193796|NCT03331042|11322429|FG001|COMPLETED|Overall Study||21
10193797|NCT03331042|11322430|FG002|COMPLETED|Overall Study||20
10193798|NCT03331042|11322431|FG003|COMPLETED|Overall Study||20
10193799|NCT03331042|11322428|FG000|NOT COMPLETED|Overall Study||1
10193800|NCT03331042|11322429|FG001|NOT COMPLETED|Overall Study||0
10193801|NCT03331042|11322430|FG002|NOT COMPLETED|Overall Study||1
10193802|NCT03331042|11322431|FG003|NOT COMPLETED|Overall Study||1
10193803|NCT03331185|11322449|FG000|STARTED|Overall Study||14
10193804|NCT03331185|11322450|FG001|STARTED|Overall Study||12
10193805|NCT03331185|11322449|FG000|COMPLETED|Overall Study||14
10193806|NCT03331185|11322450|FG001|COMPLETED|Overall Study||12
10193807|NCT03331185|11322449|FG000|NOT COMPLETED|Overall Study||0
10193808|NCT03331185|11322450|FG001|NOT COMPLETED|Overall Study||0
10193809|NCT03331315|11322458|FG000|STARTED|Overall Study||88
10193810|NCT03331315|11322459|FG001|STARTED|Overall Study||82
10193811|NCT03331315|11322458|FG000|COMPLETED|Overall Study||70
10193812|NCT03331315|11322459|FG001|COMPLETED|Overall Study||68
10193813|NCT03331315|11322458|FG000|NOT COMPLETED|Overall Study||18
10193814|NCT03331315|11322459|FG001|NOT COMPLETED|Overall Study||14
10193815|NCT03331666|11322469|FG000|STARTED|Overall Study||2
10193816|NCT03331666|11322470|FG001|STARTED|Overall Study||2
10193817|NCT03331666|11322469|FG000|COMPLETED|Overall Study||0
10193818|NCT03331666|11322470|FG001|COMPLETED|Overall Study||0
10193819|NCT03331666|11322469|FG000|NOT COMPLETED|Overall Study||2
10193820|NCT03331666|11322470|FG001|NOT COMPLETED|Overall Study||2
10193821|NCT03331835|11322478|FG000|STARTED|Overall Study||105
10193822|NCT03331835|11322479|FG001|STARTED|Overall Study||105
10193823|NCT03331835|11322478|FG000|COMPLETED|Overall Study||91
10193824|NCT03331835|11322479|FG001|COMPLETED|Overall Study||58
10193825|NCT03331835|11322478|FG000|NOT COMPLETED|Overall Study||14
10193826|NCT03331835|11322479|FG001|NOT COMPLETED|Overall Study||47
10193827|NCT03331965|11322487|FG000|STARTED|Overall Study||55
10193828|NCT03331965|11322488|FG001|STARTED|Overall Study||55
10193829|NCT03331965|11322487|FG000|COMPLETED|Overall Study||45
10193830|NCT03331965|11322488|FG001|COMPLETED|Overall Study||51
10193831|NCT03331965|11322487|FG000|NOT COMPLETED|Overall Study||10
10193832|NCT03331965|11322488|FG001|NOT COMPLETED|Overall Study||4
10193833|NCT03332160|11322496|FG000|STARTED|Overall Study||25
10193834|NCT03332160|11322497|FG001|STARTED|Overall Study||24
10193835|NCT03332160|11322496|FG000|COMPLETED|Overall Study||24
10193836|NCT03332160|11322497|FG001|COMPLETED|Overall Study||19
10193837|NCT03332160|11322496|FG000|NOT COMPLETED|Overall Study||1
10193838|NCT03332160|11322497|FG001|NOT COMPLETED|Overall Study||5
10193839|NCT03332212|11322508|FG000|STARTED|Overall Study||19
10193840|NCT03332212|11322509|FG001|STARTED|Overall Study||18
10193841|NCT03332212|11322510|FG002|STARTED|Overall Study||17
10193842|NCT03332212|11322511|FG003|STARTED|Overall Study||18
10193843|NCT03332212|11322508|FG000|Treated|Overall Study||19
10193844|NCT03332212|11322509|FG001|Treated|Overall Study||17
10193845|NCT03332212|11322510|FG002|Treated|Overall Study||17
10193846|NCT03332212|11322511|FG003|Treated|Overall Study||18
10193847|NCT03332212|11322508|FG000|COMPLETED|Overall Study||18
10193848|NCT03332212|11322509|FG001|COMPLETED|Overall Study||16
10193849|NCT03332212|11322510|FG002|COMPLETED|Overall Study||17
10193850|NCT03332212|11322511|FG003|COMPLETED|Overall Study||17
10193851|NCT03332212|11322508|FG000|NOT COMPLETED|Overall Study||1
10193852|NCT03332212|11322509|FG001|NOT COMPLETED|Overall Study||2
10193853|NCT03332212|11322510|FG002|NOT COMPLETED|Overall Study||0
10193854|NCT03332212|11322511|FG003|NOT COMPLETED|Overall Study||1
10193855|NCT03332459|11322522|FG000|STARTED|Overall Study||3
10193856|NCT03332459|11322523|FG001|STARTED|Overall Study||1
10193857|NCT03332459|11322524|FG002|STARTED|Overall Study||3
10193858|NCT03332459|11322522|FG000|COMPLETED|Overall Study||3
10193859|NCT03332459|11322523|FG001|COMPLETED|Overall Study||1
10193860|NCT03332459|11322524|FG002|COMPLETED|Overall Study||3
10193861|NCT03332459|11322522|FG000|NOT COMPLETED|Overall Study||0
10193862|NCT03332459|11322523|FG001|NOT COMPLETED|Overall Study||0
10193863|NCT03332459|11322524|FG002|NOT COMPLETED|Overall Study||0
10193864|NCT03332628|11322532|FG000|STARTED|Overall Study||113
10193865|NCT03332628|11322532|FG000|COMPLETED|Overall Study||111
10193866|NCT03332628|11322532|FG000|NOT COMPLETED|Overall Study||2
10193867|NCT03332771|11322541|FG000|STARTED|Overall Study||159
10193868|NCT03332771|11322542|FG001|STARTED|Overall Study||317
10193869|NCT03332771|11322543|FG002|STARTED|Overall Study||160
10193870|NCT03332771|11322544|FG003|STARTED|Overall Study||318
10193871|NCT03332771|11322541|FG000|COMPLETED|Overall Study||125
10193872|NCT03332771|11322542|FG001|COMPLETED|Overall Study||266
10193873|NCT03332771|11322543|FG002|COMPLETED|Overall Study||128
10193874|NCT03332771|11322544|FG003|COMPLETED|Overall Study||270
10193875|NCT03332771|11322541|FG000|NOT COMPLETED|Overall Study||34
10193876|NCT03332771|11322542|FG001|NOT COMPLETED|Overall Study||51
10193877|NCT03332771|11322543|FG002|NOT COMPLETED|Overall Study||32
10193878|NCT03332771|11322544|FG003|NOT COMPLETED|Overall Study||48
10193879|NCT03332784|11322574|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193880|NCT03332784|11322575|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193881|NCT03332784|11322576|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193882|NCT03332784|11322577|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193883|NCT03332784|11322578|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193884|NCT03332784|11322579|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193885|NCT03332784|11322580|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193886|NCT03332784|11322581|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193887|NCT03332784|11322582|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
10193888|NCT03332784|11322583|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
10193889|NCT03332784|11322584|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
10193890|NCT03332784|11322585|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10193891|NCT03332784|11322586|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
10193892|NCT03332784|11322587|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
10193893|NCT03332784|11322588|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10193894|NCT03332784|11322589|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10193895|NCT03332784|11322590|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10193896|NCT03332784|11322591|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10193897|NCT03332784|11322592|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
10193898|NCT03332784|11322593|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
10193899|NCT03332784|11322574|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193900|NCT03332784|11322575|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10193901|NCT03332784|11322576|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193902|NCT03332784|11322577|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193903|NCT03332784|11322578|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193904|NCT03332784|11322579|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193905|NCT03332784|11322580|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193906|NCT03332784|11322581|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193907|NCT03332784|11322582|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
10193908|NCT03332784|11322583|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
10193909|NCT03332784|11322584|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
10193910|NCT03332784|11322585|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193911|NCT03332784|11322586|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
10193912|NCT03332784|11322587|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
10193913|NCT03332784|11322588|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10193914|NCT03332784|11322589|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193915|NCT03332784|11322590|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193916|NCT03332784|11322591|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10193917|NCT03332784|11322592|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
10193918|NCT03332784|11322593|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
10193919|NCT03332784|11322574|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193920|NCT03332784|11322575|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10193921|NCT03332784|11322576|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193922|NCT03332784|11322577|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193923|NCT03332784|11322578|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193924|NCT03332784|11322579|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193925|NCT03332784|11322580|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193926|NCT03332784|11322581|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193927|NCT03332784|11322582|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193928|NCT03332784|11322583|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193929|NCT03332784|11322584|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193930|NCT03332784|11322585|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193931|NCT03332784|11322586|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193932|NCT03332784|11322587|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193933|NCT03332784|11322588|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10193934|NCT03332784|11322589|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193935|NCT03332784|11322590|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193936|NCT03332784|11322591|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193937|NCT03332784|11322592|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193938|NCT03332784|11322593|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10193939|NCT03332784|11322574|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193940|NCT03332784|11322575|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
10193941|NCT03332784|11322576|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193942|NCT03332784|11322577|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193943|NCT03332784|11322578|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193944|NCT03332784|11322579|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193945|NCT03332784|11322580|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193946|NCT03332784|11322581|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193947|NCT03332784|11322582|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10193948|NCT03332784|11322583|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10193949|NCT03332784|11322584|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10193950|NCT03332784|11322585|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10193951|NCT03332784|11322586|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10193952|NCT03332784|11322587|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10193953|NCT03332784|11322588|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
10193954|NCT03332784|11322589|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193955|NCT03332784|11322590|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193956|NCT03332784|11322591|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10193957|NCT03332784|11322592|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
10193958|NCT03332784|11322593|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
10193959|NCT03332784|11322574|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193960|NCT03332784|11322575|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
10193961|NCT03332784|11322576|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193962|NCT03332784|11322577|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193963|NCT03332784|11322578|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193964|NCT03332784|11322579|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193965|NCT03332784|11322580|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193966|NCT03332784|11322581|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193967|NCT03332784|11322582|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193968|NCT03332784|11322583|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193969|NCT03332784|11322584|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193970|NCT03332784|11322585|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193971|NCT03332784|11322586|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193972|NCT03332784|11322587|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193973|NCT03332784|11322588|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
10193974|NCT03332784|11322589|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193975|NCT03332784|11322590|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193976|NCT03332784|11322591|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10193977|NCT03332784|11322592|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
10193978|NCT03332784|11322593|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
10193979|NCT03332784|11322574|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193980|NCT03332784|11322575|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193981|NCT03332784|11322576|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193982|NCT03332784|11322577|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193983|NCT03332784|11322578|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193984|NCT03332784|11322579|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193985|NCT03332784|11322580|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193986|NCT03332784|11322581|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193987|NCT03332784|11322582|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193988|NCT03332784|11322583|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193989|NCT03332784|11322584|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193990|NCT03332784|11322585|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193991|NCT03332784|11322586|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193992|NCT03332784|11322587|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193993|NCT03332784|11322588|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193994|NCT03332784|11322589|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193995|NCT03332784|11322590|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193996|NCT03332784|11322591|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193997|NCT03332784|11322592|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193998|NCT03332784|11322593|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10193999|NCT03332784|11322574|FG000|STARTED|Part 1- Period 3 (1 Day)||2
10194000|NCT03332784|11322575|FG001|STARTED|Part 1- Period 3 (1 Day)||1
10194001|NCT03332784|11322576|FG002|STARTED|Part 1- Period 3 (1 Day)||2
10194002|NCT03332784|11322577|FG003|STARTED|Part 1- Period 3 (1 Day)||2
10194003|NCT03332784|11322578|FG004|STARTED|Part 1- Period 3 (1 Day)||2
10194004|NCT03332784|11322579|FG005|STARTED|Part 1- Period 3 (1 Day)||2
10194005|NCT03332784|11322580|FG006|STARTED|Part 1- Period 3 (1 Day)||2
10194006|NCT03332784|11322581|FG007|STARTED|Part 1- Period 3 (1 Day)||2
10194007|NCT03332784|11322582|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10194008|NCT03332784|11322583|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10194009|NCT03332784|11322584|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10194010|NCT03332784|11322585|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10194011|NCT03332784|11322586|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10194012|NCT03332784|11322587|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10194013|NCT03332784|11322588|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10194014|NCT03332784|11322589|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10194015|NCT03332784|11322590|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
9717471|NCT00003896|10816669|FG000|NOT COMPLETED|Overall Study||29
10194016|NCT03332784|11322591|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10194017|NCT03332784|11322592|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10194018|NCT03332784|11322593|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10194019|NCT03332784|11322574|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2
10194020|NCT03332784|11322575|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1
10194021|NCT03332784|11322576|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2
10194022|NCT03332784|11322577|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2
10194023|NCT03332784|11322578|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2
10194024|NCT03332784|11322579|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2
10194025|NCT03332784|11322580|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2
10194026|NCT03332784|11322581|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2
10194027|NCT03332784|11322582|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0
10194028|NCT03332784|11322583|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0
10194029|NCT03332784|11322584|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0
10194030|NCT03332784|11322585|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0
10194031|NCT03332784|11322586|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0
10194032|NCT03332784|11322587|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0
10194033|NCT03332784|11322588|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0
10194034|NCT03332784|11322589|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0
10194035|NCT03332784|11322590|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0
10194036|NCT03332784|11322591|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0
10194037|NCT03332784|11322592|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0
10194038|NCT03332784|11322593|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0
10194039|NCT03332784|11322574|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194040|NCT03332784|11322575|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194041|NCT03332784|11322576|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194042|NCT03332784|11322577|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194043|NCT03332784|11322578|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194044|NCT03332784|11322579|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194045|NCT03332784|11322580|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194046|NCT03332784|11322581|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194047|NCT03332784|11322582|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194048|NCT03332784|11322583|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194049|NCT03332784|11322584|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194050|NCT03332784|11322585|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194051|NCT03332784|11322586|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194052|NCT03332784|11322587|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194053|NCT03332784|11322588|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194054|NCT03332784|11322589|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194055|NCT03332784|11322590|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194056|NCT03332784|11322591|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194057|NCT03332784|11322592|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194058|NCT03332784|11322593|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10194059|NCT03332979|11322647|FG000|STARTED|Overall Study||150
10194060|NCT03332979|11322647|FG000|COMPLETED|Overall Study||150
10194061|NCT03332979|11322647|FG000|NOT COMPLETED|Overall Study||0
10194062|NCT03333109|11322654|FG000|STARTED|Double-blind Treatment Period (DBTP)||338
10194063|NCT03333109|11322655|FG001|STARTED|Double-blind Treatment Period (DBTP)||224
10194064|NCT03333109|11322656|FG002|STARTED|Double-blind Treatment Period (DBTP)||338
10194065|NCT03333109|11322654|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
10194066|NCT03333109|11322655|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
10194067|NCT03333109|11322656|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
10194068|NCT03333109|11322654|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
10194069|NCT03333109|11322655|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
10194070|NCT03333109|11322656|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
10194071|NCT03333109|11322654|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321
10194072|NCT03333109|11322655|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218
10194073|NCT03333109|11322656|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326
10194074|NCT03333109|11322654|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
9717472|NCT00003901|10816674|FG000|STARTED|Overall Study||1047
9717473|NCT00003901|10816674|FG000|COMPLETED|Overall Study||1030
9717474|NCT00003901|10816674|FG000|NOT COMPLETED|Overall Study||17
9717475|NCT00003907|10816683|FG000|STARTED|Overall Study||19
9717476|NCT00003907|10816684|FG001|STARTED|Overall Study||31
9717477|NCT00003907|10816683|FG000|Eligible|Overall Study||18
9717478|NCT00003907|10816684|FG001|Eligible|Overall Study||29
9717479|NCT00003907|10816683|FG000|Received Protocol Therapy (Treated)|Overall Study||18
9717480|NCT00003907|10816684|FG001|Received Protocol Therapy (Treated)|Overall Study||31
9717481|NCT00003907|10816683|FG000|Eligible and Treated|Overall Study||17
9717482|NCT00003907|10816684|FG001|Eligible and Treated|Overall Study||29
9717483|NCT00003907|10816683|FG000|COMPLETED|Overall Study||6
9717484|NCT00003907|10816684|FG001|COMPLETED|Overall Study||8
9717485|NCT00003907|10816683|FG000|NOT COMPLETED|Overall Study||13
9717486|NCT00003907|10816684|FG001|NOT COMPLETED|Overall Study||23
9717487|NCT00003910|10816690|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
9717488|NCT00003910|10816691|FG001|STARTED|Step 1||0
9717489|NCT00003910|10816690|FG000|COMPLETED|Step 1||55
9717490|NCT00003910|10816691|FG001|COMPLETED|Step 1||0
9717491|NCT00003910|10816690|FG000|NOT COMPLETED|Step 1||0
9717492|NCT00003910|10816691|FG001|NOT COMPLETED|Step 1||0
9717493|NCT00003910|10816690|FG000|STARTED|Step 2||0
9717494|NCT00003910|10816691|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
9717495|NCT00003910|10816690|FG000|COMPLETED|Step 2||0
9717496|NCT00003910|10816691|FG001|COMPLETED|Step 2||16
9717497|NCT00003910|10816690|FG000|NOT COMPLETED|Step 2||0
9717498|NCT00003910|10816691|FG001|NOT COMPLETED|Step 2||0
9717499|NCT00004031|10816699|FG000|STARTED|Overall Study||128
9717500|NCT00004031|10816700|FG001|STARTED|Overall Study||125
9717501|NCT00004031|10816699|FG000|Assessed for Adverse Events|Overall Study||123
10194075|NCT03333109|11322655|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
9717502|NCT00004031|10816700|FG001|Assessed for Adverse Events|Overall Study||113
9717503|NCT00004031|10816699|FG000|COMPLETED|Overall Study||103
9717504|NCT00004031|10816700|FG001|COMPLETED|Overall Study||104
9717505|NCT00004031|10816699|FG000|NOT COMPLETED|Overall Study||25
9717506|NCT00004031|10816700|FG001|NOT COMPLETED|Overall Study||21
9717507|NCT00004054|10816710|FG000|STARTED|Overall Study||197
10194076|NCT03333109|11322656|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
10194077|NCT03333109|11322654|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
10194078|NCT03333109|11322655|FG001|STARTED|Safety Follow-up Period||218
10194079|NCT03333109|11322656|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
10194080|NCT03333109|11322654|FG000|COMPLETED|Safety Follow-up Period||311
10194081|NCT03333109|11322655|FG001|COMPLETED|Safety Follow-up Period||214
10194082|NCT03333109|11322656|FG002|COMPLETED|Safety Follow-up Period||315
10194083|NCT03333109|11322654|FG000|NOT COMPLETED|Safety Follow-up Period||13
10194084|NCT03333109|11322655|FG001|NOT COMPLETED|Safety Follow-up Period||4
10194085|NCT03333109|11322656|FG002|NOT COMPLETED|Safety Follow-up Period||13
10194086|NCT03333317|11322667|FG000|STARTED|Overall Study||3
10194087|NCT03333317|11322668|FG001|STARTED|Overall Study||1
10194088|NCT03333317|11322669|FG002|STARTED|Overall Study||3
10194089|NCT03333317|11322667|FG000|COMPLETED|Overall Study||3
10194090|NCT03333317|11322668|FG001|COMPLETED|Overall Study||1
10194091|NCT03333317|11322669|FG002|COMPLETED|Overall Study||3
10194092|NCT03333317|11322667|FG000|NOT COMPLETED|Overall Study||0
10194093|NCT03333317|11322668|FG001|NOT COMPLETED|Overall Study||0
10194094|NCT03333317|11322669|FG002|NOT COMPLETED|Overall Study||0
10194095|NCT03333577|11322679|FG000|STARTED|Overall Study||32
10194096|NCT03333577|11322679|FG000|COMPLETED|Overall Study||25
10194097|NCT03333577|11322679|FG000|NOT COMPLETED|Overall Study||7
10194098|NCT03333876|11322685|FG000|STARTED|Screening Period||58
10194099|NCT03333876|11322685|FG000|COMPLETED|Screening Period||54
10194100|NCT03333876|11322685|FG000|NOT COMPLETED|Screening Period||4
10194101|NCT03333876|11322685|FG000|STARTED|Nasal Dilator||54
10194102|NCT03333876|11322685|FG000|COMPLETED|Nasal Dilator||48
10194103|NCT03333876|11322685|FG000|NOT COMPLETED|Nasal Dilator||6
10194104|NCT03333876|11322685|FG000|STARTED|Mandibular Advancement||54
10194105|NCT03333876|11322685|FG000|COMPLETED|Mandibular Advancement||50
10194106|NCT03333876|11322685|FG000|NOT COMPLETED|Mandibular Advancement||4
10194107|NCT03333876|11322685|FG000|STARTED|Positional Therapy||54
10194108|NCT03333876|11322685|FG000|COMPLETED|Positional Therapy||54
10194109|NCT03333876|11322685|FG000|NOT COMPLETED|Positional Therapy||0
10194110|NCT03333941|11322698|FG000|STARTED|Overall Study||76
10194111|NCT03333941|11322698|FG000|COMPLETED|Overall Study||63
10194112|NCT03333941|11322698|FG000|NOT COMPLETED|Overall Study||13
10194113|NCT03334175|11322704|FG000|STARTED|Overall Study||8
10194114|NCT03334175|11322705|FG001|STARTED|Overall Study||10
10194115|NCT03334175|11322704|FG000|COMPLETED|Overall Study||8
10194116|NCT03334175|11322705|FG001|COMPLETED|Overall Study||9
10194117|NCT03334175|11322704|FG000|NOT COMPLETED|Overall Study||0
10194118|NCT03334175|11322705|FG001|NOT COMPLETED|Overall Study||1
10194119|NCT03334188|11322713|FG000|STARTED|Overall Study||153
10194120|NCT03334188|11322714|FG001|STARTED|Overall Study||153
10194121|NCT03334188|11322713|FG000|COMPLETED|Overall Study||145
10194122|NCT03334188|11322714|FG001|COMPLETED|Overall Study||145
10194123|NCT03334188|11322713|FG000|NOT COMPLETED|Overall Study||8
10194124|NCT03334188|11322714|FG001|NOT COMPLETED|Overall Study||8
10194125|NCT03334214|11322723|FG000|STARTED|Overall Study||15
10194126|NCT03334214|11322724|FG001|STARTED|Overall Study||29
10194127|NCT03334214|11322723|FG000|COMPLETED|Overall Study||14
10194128|NCT03334214|11322724|FG001|COMPLETED|Overall Study||27
10194129|NCT03334214|11322723|FG000|NOT COMPLETED|Overall Study||1
10194130|NCT03334214|11322724|FG001|NOT COMPLETED|Overall Study||2
10194131|NCT03334396|11322739|FG000|STARTED|Overall Study||249
10194132|NCT03334396|11322740|FG001|STARTED|Overall Study||127
10194133|NCT03334396|11322741|FG002|STARTED|Overall Study||123
10194134|NCT03334396|11322742|FG003|STARTED|Overall Study||125
10194135|NCT03334396|11322743|FG004|STARTED|Overall Study||15
10194136|NCT03334396|11322744|FG005|STARTED|Overall Study||5
10194137|NCT03334396|11322745|FG006|STARTED|Overall Study||8
10194138|NCT03334396|11322746|FG007|STARTED|Overall Study||8
10194139|NCT03334396|11322739|FG000|Received at Least One Dose of Study Drug|Overall Study||249
10194140|NCT03334396|11322740|FG001|Received at Least One Dose of Study Drug|Overall Study||127
10194141|NCT03334396|11322741|FG002|Received at Least One Dose of Study Drug|Overall Study||123
10194142|NCT03334396|11322742|FG003|Received at Least One Dose of Study Drug|Overall Study||125
10194143|NCT03334396|11322743|FG004|Received at Least One Dose of Study Drug|Overall Study||15
10194144|NCT03334396|11322744|FG005|Received at Least One Dose of Study Drug|Overall Study||5
10194145|NCT03334396|11322745|FG006|Received at Least One Dose of Study Drug|Overall Study||8
10194146|NCT03334396|11322746|FG007|Received at Least One Dose of Study Drug|Overall Study||8
10194147|NCT03334396|11322739|FG000|COMPLETED|Overall Study||226
10194148|NCT03334396|11322740|FG001|COMPLETED|Overall Study||116
10194149|NCT03334396|11322741|FG002|COMPLETED|Overall Study||113
10194150|NCT03334396|11322742|FG003|COMPLETED|Overall Study||120
10194151|NCT03334396|11322743|FG004|COMPLETED|Overall Study||12
10194152|NCT03334396|11322744|FG005|COMPLETED|Overall Study||4
10194153|NCT03334396|11322745|FG006|COMPLETED|Overall Study||5
10194154|NCT03334396|11322746|FG007|COMPLETED|Overall Study||7
10194155|NCT03334396|11322739|FG000|NOT COMPLETED|Overall Study||23
10194156|NCT03334396|11322740|FG001|NOT COMPLETED|Overall Study||11
10194157|NCT03334396|11322741|FG002|NOT COMPLETED|Overall Study||10
10194158|NCT03334396|11322742|FG003|NOT COMPLETED|Overall Study||5
10194159|NCT03334396|11322743|FG004|NOT COMPLETED|Overall Study||3
10194160|NCT03334396|11322744|FG005|NOT COMPLETED|Overall Study||1
10194161|NCT03334396|11322745|FG006|NOT COMPLETED|Overall Study||3
10194162|NCT03334396|11322746|FG007|NOT COMPLETED|Overall Study||1
10194163|NCT03334422|11322767|FG000|STARTED|Overall Study||244
10194164|NCT03334422|11322768|FG001|STARTED|Overall Study||125
10194165|NCT03334422|11322769|FG002|STARTED|Overall Study||123
10194166|NCT03334422|11322770|FG003|STARTED|Overall Study||123
10194167|NCT03334422|11322767|FG000|Received at Least One Dose of Study Drug|Overall Study||244
10194168|NCT03334422|11322768|FG001|Received at Least One Dose of Study Drug|Overall Study||124
10194169|NCT03334422|11322769|FG002|Received at Least One Dose of Study Drug|Overall Study||123
10194170|NCT03334422|11322770|FG003|Received at Least One Dose of Study Drug|Overall Study||123
10194171|NCT03334422|11322767|FG000|COMPLETED|Overall Study||225
10194172|NCT03334422|11322768|FG001|COMPLETED|Overall Study||115
10194173|NCT03334422|11322769|FG002|COMPLETED|Overall Study||113
10194174|NCT03334422|11322770|FG003|COMPLETED|Overall Study||117
10194175|NCT03334422|11322767|FG000|NOT COMPLETED|Overall Study||19
10194176|NCT03334422|11322768|FG001|NOT COMPLETED|Overall Study||10
10194177|NCT03334422|11322769|FG002|NOT COMPLETED|Overall Study||10
10194178|NCT03334422|11322770|FG003|NOT COMPLETED|Overall Study||6
10194179|NCT03334448|11322785|FG000|STARTED|Period 1||12
10194180|NCT03334448|11322786|FG001|STARTED|Period 1||12
10194181|NCT03334448|11322787|FG002|STARTED|Period 1||13
10194182|NCT03334448|11322788|FG003|STARTED|Period 1||12
10194183|NCT03334448|11322785|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
10194184|NCT03334448|11322786|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
10194185|NCT03334448|11322787|FG002|Received at Least 1 Dose of Study Drug|Period 1||13
10194186|NCT03334448|11322788|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
10194187|NCT03334448|11322785|FG000|COMPLETED|Period 1||12
10194188|NCT03334448|11322786|FG001|COMPLETED|Period 1||12
10194189|NCT03334448|11322787|FG002|COMPLETED|Period 1||13
10194190|NCT03334448|11322788|FG003|COMPLETED|Period 1||12
10194191|NCT03334448|11322785|FG000|NOT COMPLETED|Period 1||0
10194192|NCT03334448|11322786|FG001|NOT COMPLETED|Period 1||0
10194193|NCT03334448|11322787|FG002|NOT COMPLETED|Period 1||0
10194194|NCT03334448|11322788|FG003|NOT COMPLETED|Period 1||0
10194195|NCT03334448|11322785|FG000|STARTED|Washout||12
10194196|NCT03334448|11322786|FG001|STARTED|Washout||12
10194197|NCT03334448|11322787|FG002|STARTED|Washout||13
10194198|NCT03334448|11322788|FG003|STARTED|Washout||12
10194199|NCT03334448|11322785|FG000|COMPLETED|Washout||12
10194200|NCT03334448|11322786|FG001|COMPLETED|Washout||12
10194201|NCT03334448|11322787|FG002|COMPLETED|Washout||13
10194202|NCT03334448|11322788|FG003|COMPLETED|Washout||12
10194203|NCT03334448|11322785|FG000|NOT COMPLETED|Washout||0
10194204|NCT03334448|11322786|FG001|NOT COMPLETED|Washout||0
10194205|NCT03334448|11322787|FG002|NOT COMPLETED|Washout||0
10194206|NCT03334448|11322788|FG003|NOT COMPLETED|Washout||0
10194207|NCT03334448|11322785|FG000|STARTED|Period 2||12
10194208|NCT03334448|11322786|FG001|STARTED|Period 2||12
10194209|NCT03334448|11322787|FG002|STARTED|Period 2||13
10194210|NCT03334448|11322788|FG003|STARTED|Period 2||12
10194211|NCT03334448|11322785|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
10194212|NCT03334448|11322786|FG001|Received at Least 1 Dose of Study Drug|Period 2||12
10194213|NCT03334448|11322787|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
10194214|NCT03334448|11322788|FG003|Received at Least 1 Dose of Study Drug|Period 2||12
10194215|NCT03334448|11322785|FG000|COMPLETED|Period 2||12
10194216|NCT03334448|11322786|FG001|COMPLETED|Period 2||12
10194217|NCT03334448|11322787|FG002|COMPLETED|Period 2||13
10194218|NCT03334448|11322788|FG003|COMPLETED|Period 2||12
10194219|NCT03334448|11322785|FG000|NOT COMPLETED|Period 2||0
10194220|NCT03334448|11322786|FG001|NOT COMPLETED|Period 2||0
10194221|NCT03334448|11322787|FG002|NOT COMPLETED|Period 2||0
10194222|NCT03334448|11322788|FG003|NOT COMPLETED|Period 2||0
10194223|NCT03334448|11322785|FG000|STARTED|Washout||12
10194224|NCT03334448|11322786|FG001|STARTED|Washout||12
10194225|NCT03334448|11322787|FG002|STARTED|Washout||13
10194226|NCT03334448|11322788|FG003|STARTED|Washout||12
10194227|NCT03334448|11322785|FG000|COMPLETED|Washout||12
10194228|NCT03334448|11322786|FG001|COMPLETED|Washout||11
10194229|NCT03334448|11322787|FG002|COMPLETED|Washout||13
10194230|NCT03334448|11322788|FG003|COMPLETED|Washout||12
10194231|NCT03334448|11322785|FG000|NOT COMPLETED|Washout||0
10194232|NCT03334448|11322786|FG001|NOT COMPLETED|Washout||1
10194233|NCT03334448|11322787|FG002|NOT COMPLETED|Washout||0
10194234|NCT03334448|11322788|FG003|NOT COMPLETED|Washout||0
10194235|NCT03334448|11322785|FG000|STARTED|Period 3||12
10194236|NCT03334448|11322786|FG001|STARTED|Period 3||11
10194237|NCT03334448|11322787|FG002|STARTED|Period 3||13
10194238|NCT03334448|11322788|FG003|STARTED|Period 3||12
10194239|NCT03334448|11322785|FG000|Received at Least 1 Dose of Study Drug|Period 3||12
10194240|NCT03334448|11322786|FG001|Received at Least 1 Dose of Study Drug|Period 3||11
10194241|NCT03334448|11322787|FG002|Received at Least 1 Dose of Study Drug|Period 3||13
10194242|NCT03334448|11322788|FG003|Received at Least 1 Dose of Study Drug|Period 3||12
10194243|NCT03334448|11322785|FG000|COMPLETED|Period 3||12
10194244|NCT03334448|11322786|FG001|COMPLETED|Period 3||11
10194245|NCT03334448|11322787|FG002|COMPLETED|Period 3||13
10194246|NCT03334448|11322788|FG003|COMPLETED|Period 3||12
10194247|NCT03334448|11322785|FG000|NOT COMPLETED|Period 3||0
10194248|NCT03334448|11322786|FG001|NOT COMPLETED|Period 3||0
10194249|NCT03334448|11322787|FG002|NOT COMPLETED|Period 3||0
10194250|NCT03334448|11322788|FG003|NOT COMPLETED|Period 3||0
10194251|NCT03334448|11322785|FG000|STARTED|Washout||12
10194252|NCT03334448|11322786|FG001|STARTED|Washout||11
10194253|NCT03334448|11322787|FG002|STARTED|Washout||13
10194254|NCT03334448|11322788|FG003|STARTED|Washout||12
10194255|NCT03334448|11322785|FG000|COMPLETED|Washout||12
10194256|NCT03334448|11322786|FG001|COMPLETED|Washout||11
10194257|NCT03334448|11322787|FG002|COMPLETED|Washout||13
10194258|NCT03334448|11322788|FG003|COMPLETED|Washout||11
10194259|NCT03334448|11322785|FG000|NOT COMPLETED|Washout||0
10194260|NCT03334448|11322786|FG001|NOT COMPLETED|Washout||0
10194261|NCT03334448|11322787|FG002|NOT COMPLETED|Washout||0
10194262|NCT03334448|11322788|FG003|NOT COMPLETED|Washout||1
10194263|NCT03334448|11322785|FG000|STARTED|Period 4||12
10194264|NCT03334448|11322786|FG001|STARTED|Period 4||11
10194265|NCT03334448|11322787|FG002|STARTED|Period 4||13
10194266|NCT03334448|11322788|FG003|STARTED|Period 4||11
10194267|NCT03334448|11322785|FG000|Received at Least 1 Dose of Study Drug|Period 4||12
10194268|NCT03334448|11322786|FG001|Received at Least 1 Dose of Study Drug|Period 4||11
10194269|NCT03334448|11322787|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
10194270|NCT03334448|11322788|FG003|Received at Least 1 Dose of Study Drug|Period 4||11
10194271|NCT03334448|11322785|FG000|COMPLETED|Period 4||12
10194272|NCT03334448|11322786|FG001|COMPLETED|Period 4||11
10194273|NCT03334448|11322787|FG002|COMPLETED|Period 4||13
10194274|NCT03334448|11322788|FG003|COMPLETED|Period 4||11
10194275|NCT03334448|11322785|FG000|NOT COMPLETED|Period 4||0
10194276|NCT03334448|11322786|FG001|NOT COMPLETED|Period 4||0
10194277|NCT03334448|11322787|FG002|NOT COMPLETED|Period 4||0
10194278|NCT03334448|11322788|FG003|NOT COMPLETED|Period 4||0
10194279|NCT03334630|11322796|FG000|STARTED|Overall Study||239
10194280|NCT03334630|11322797|FG001|STARTED|Overall Study||243
10194281|NCT03334630|11322796|FG000|COMPLETED|Overall Study||225
10194282|NCT03334630|11322797|FG001|COMPLETED|Overall Study||230
10194283|NCT03334630|11322796|FG000|NOT COMPLETED|Overall Study||14
10194284|NCT03334630|11322797|FG001|NOT COMPLETED|Overall Study||13
10194285|NCT03334695|11322805|FG000|STARTED|Overall Study||31
10194286|NCT03334695|11322806|FG001|STARTED|Overall Study||32
10194287|NCT03334695|11322805|FG000|COMPLETED|Overall Study||27
10194288|NCT03334695|11322806|FG001|COMPLETED|Overall Study||26
10194289|NCT03334695|11322805|FG000|NOT COMPLETED|Overall Study||4
10194290|NCT03334695|11322806|FG001|NOT COMPLETED|Overall Study||6
10194291|NCT03334721|11322816|FG000|STARTED|Overall Study||12
10194292|NCT03334721|11322817|FG001|STARTED|Overall Study||11
10194293|NCT03334721|11322816|FG000|COMPLETED|Overall Study||10
10194294|NCT03334721|11322817|FG001|COMPLETED|Overall Study||11
10194295|NCT03334721|11322816|FG000|NOT COMPLETED|Overall Study||2
10194296|NCT03334721|11322817|FG001|NOT COMPLETED|Overall Study||0
10194297|NCT03334734|11322827|FG000|STARTED|Overall Study||4
10194298|NCT03334734|11322828|FG001|STARTED|Overall Study||4
10194299|NCT03334734|11322829|FG002|STARTED|Overall Study||7
10194300|NCT03334734|11322830|FG003|STARTED|Overall Study||1
10194301|NCT03334734|11322827|FG000|COMPLETED|Overall Study||4
10194302|NCT03334734|11322828|FG001|COMPLETED|Overall Study||4
10194303|NCT03334734|11322829|FG002|COMPLETED|Overall Study||5
10194304|NCT03334734|11322830|FG003|COMPLETED|Overall Study||1
10194305|NCT03334734|11322827|FG000|NOT COMPLETED|Overall Study||0
10194306|NCT03334734|11322828|FG001|NOT COMPLETED|Overall Study||0
10194307|NCT03334734|11322829|FG002|NOT COMPLETED|Overall Study||2
10194308|NCT03334734|11322830|FG003|NOT COMPLETED|Overall Study||0
10194309|NCT03334747|11322849|FG000|STARTED|Treatment Phase||10
10194310|NCT03334747|11322850|FG001|STARTED|Treatment Phase||10
10194311|NCT03334747|11322851|FG002|STARTED|Treatment Phase||12
10194312|NCT03334747|11322852|FG003|STARTED|Treatment Phase||20
10194313|NCT03334747|11322853|FG004|STARTED|Treatment Phase||22
10194314|NCT03334747|11322854|FG005|STARTED|Treatment Phase||20
10194315|NCT03334747|11322855|FG006|STARTED|Treatment Phase||21
10194316|NCT03334747|11322856|FG007|STARTED|Treatment Phase||22
10194317|NCT03334747|11322857|FG008|STARTED|Treatment Phase||51
10194318|NCT03334747|11322849|FG000|COMPLETED|Treatment Phase||9
10194319|NCT03334747|11322850|FG001|COMPLETED|Treatment Phase||10
10194320|NCT03334747|11322851|FG002|COMPLETED|Treatment Phase||12
10194321|NCT03334747|11322852|FG003|COMPLETED|Treatment Phase||20
10194322|NCT03334747|11322853|FG004|COMPLETED|Treatment Phase||21
10194323|NCT03334747|11322854|FG005|COMPLETED|Treatment Phase||19
10194324|NCT03334747|11322855|FG006|COMPLETED|Treatment Phase||21
10194325|NCT03334747|11322856|FG007|COMPLETED|Treatment Phase||22
10194326|NCT03334747|11322857|FG008|COMPLETED|Treatment Phase||51
10194327|NCT03334747|11322849|FG000|NOT COMPLETED|Treatment Phase||1
10194328|NCT03334747|11322850|FG001|NOT COMPLETED|Treatment Phase||0
10194329|NCT03334747|11322851|FG002|NOT COMPLETED|Treatment Phase||0
10194330|NCT03334747|11322852|FG003|NOT COMPLETED|Treatment Phase||0
10194331|NCT03334747|11322853|FG004|NOT COMPLETED|Treatment Phase||1
10194332|NCT03334747|11322854|FG005|NOT COMPLETED|Treatment Phase||1
10194333|NCT03334747|11322855|FG006|NOT COMPLETED|Treatment Phase||0
10194334|NCT03334747|11322856|FG007|NOT COMPLETED|Treatment Phase||0
10194335|NCT03334747|11322857|FG008|NOT COMPLETED|Treatment Phase||0
10194336|NCT03334747|11322849|FG000|STARTED|Follow-Up Phase||9
10194337|NCT03334747|11322850|FG001|STARTED|Follow-Up Phase||10
10194338|NCT03334747|11322851|FG002|STARTED|Follow-Up Phase||12
10194339|NCT03334747|11322852|FG003|STARTED|Follow-Up Phase||20
10194340|NCT03334747|11322853|FG004|STARTED|Follow-Up Phase||21
10194341|NCT03334747|11322854|FG005|STARTED|Follow-Up Phase||19
10194342|NCT03334747|11322855|FG006|STARTED|Follow-Up Phase||21
10194343|NCT03334747|11322856|FG007|STARTED|Follow-Up Phase||22
10194344|NCT03334747|11322857|FG008|STARTED|Follow-Up Phase||51
10194345|NCT03334747|11322849|FG000|COMPLETED|Follow-Up Phase||9
10194346|NCT03334747|11322850|FG001|COMPLETED|Follow-Up Phase||10
10194347|NCT03334747|11322851|FG002|COMPLETED|Follow-Up Phase||12
10194348|NCT03334747|11322852|FG003|COMPLETED|Follow-Up Phase||20
10194349|NCT03334747|11322853|FG004|COMPLETED|Follow-Up Phase||21
10194350|NCT03334747|11322854|FG005|COMPLETED|Follow-Up Phase||19
10194351|NCT03334747|11322855|FG006|COMPLETED|Follow-Up Phase||20
10194352|NCT03334747|11322856|FG007|COMPLETED|Follow-Up Phase||22
10194353|NCT03334747|11322857|FG008|COMPLETED|Follow-Up Phase||50
10194354|NCT03334747|11322849|FG000|NOT COMPLETED|Follow-Up Phase||0
10194355|NCT03334747|11322850|FG001|NOT COMPLETED|Follow-Up Phase||0
10194356|NCT03334747|11322851|FG002|NOT COMPLETED|Follow-Up Phase||0
10194357|NCT03334747|11322852|FG003|NOT COMPLETED|Follow-Up Phase||0
10194358|NCT03334747|11322853|FG004|NOT COMPLETED|Follow-Up Phase||0
10194359|NCT03334747|11322854|FG005|NOT COMPLETED|Follow-Up Phase||0
10194360|NCT03334747|11322855|FG006|NOT COMPLETED|Follow-Up Phase||1
10194361|NCT03334747|11322856|FG007|NOT COMPLETED|Follow-Up Phase||0
10194362|NCT03334747|11322857|FG008|NOT COMPLETED|Follow-Up Phase||1
10194363|NCT03334812|11322879|FG000|STARTED|Overall Study||9
10194364|NCT03334812|11322880|FG001|STARTED|Overall Study||5
10194365|NCT03334812|11322881|FG002|STARTED|Overall Study||0
10194366|NCT03334812|11322882|FG003|STARTED|Overall Study||0
10194367|NCT03334812|11322879|FG000|COMPLETED|Overall Study||9
10194368|NCT03334812|11322880|FG001|COMPLETED|Overall Study||5
10194369|NCT03334812|11322881|FG002|COMPLETED|Overall Study||0
10194370|NCT03334812|11322882|FG003|COMPLETED|Overall Study||0
10194371|NCT03334812|11322879|FG000|NOT COMPLETED|Overall Study||0
10194372|NCT03334812|11322880|FG001|NOT COMPLETED|Overall Study||0
10194373|NCT03334812|11322881|FG002|NOT COMPLETED|Overall Study||0
10194374|NCT03334812|11322882|FG003|NOT COMPLETED|Overall Study||0
10194375|NCT03334825|11322890|FG000|STARTED|Overall Study||119
10194376|NCT03334825|11322891|FG001|STARTED|Overall Study||117
10194377|NCT03334825|11322890|FG000|COMPLETED|Overall Study||112
10194378|NCT03334825|11322891|FG001|COMPLETED|Overall Study||113
10194379|NCT03334825|11322890|FG000|NOT COMPLETED|Overall Study||7
10194380|NCT03334825|11322891|FG001|NOT COMPLETED|Overall Study||4
10194381|NCT03334903|11322899|FG000|STARTED|Overall Study||39
10194382|NCT03334903|11322900|FG001|STARTED|Overall Study||38
10194383|NCT03334903|11322899|FG000|COMPLETED|Overall Study||35
10194384|NCT03334903|11322900|FG001|COMPLETED|Overall Study||33
10194385|NCT03334903|11322899|FG000|NOT COMPLETED|Overall Study||4
10194386|NCT03334903|11322900|FG001|NOT COMPLETED|Overall Study||5
10194387|NCT03335150|11322908|FG000|STARTED|Overall Study||55
10194388|NCT03335150|11322909|FG001|STARTED|Overall Study||55
10194389|NCT03335150|11322908|FG000|Enrolled + Assigned Group|Overall Study||54
10194390|NCT03335150|11322909|FG001|Enrolled + Assigned Group|Overall Study||55
10194391|NCT03335150|11322908|FG000|PRE Testing Session|Overall Study||53
10194392|NCT03335150|11322909|FG001|PRE Testing Session|Overall Study||55
10194393|NCT03335150|11322908|FG000|Commenced Group|Overall Study||47
10194394|NCT03335150|11322909|FG001|Commenced Group|Overall Study||52
10194395|NCT03335150|11322908|FG000|POST Testing Session|Overall Study||45
10194396|NCT03335150|11322909|FG001|POST Testing Session|Overall Study||50
10194397|NCT03335150|11322908|FG000|COMPLETED|Overall Study||45
10194398|NCT03335150|11322909|FG001|COMPLETED|Overall Study||50
10194399|NCT03335150|11322908|FG000|NOT COMPLETED|Overall Study||10
10194400|NCT03335150|11322909|FG001|NOT COMPLETED|Overall Study||5
10194401|NCT03335254|11322935|FG000|STARTED|Period 1||9
10194402|NCT03335254|11322936|FG001|STARTED|Period 1||0
10194403|NCT03335254|11322937|FG002|STARTED|Period 1||0
10194404|NCT03335254|11322938|FG003|STARTED|Period 1||0
10194405|NCT03335254|11322939|FG004|STARTED|Period 1||0
10194406|NCT03335254|11322940|FG005|STARTED|Period 1||0
10194407|NCT03335254|11322941|FG006|STARTED|Period 1||0
10194408|NCT03335254|11322942|FG007|STARTED|Period 1||0
10194409|NCT03335254|11322943|FG008|STARTED|Period 1||0
10194410|NCT03335254|11322944|FG009|STARTED|Period 1||0
10194411|NCT03335254|11322945|FG010|STARTED|Period 1||0
10194412|NCT03335254|11322946|FG011|STARTED|Period 1||0
10194413|NCT03335254|11322947|FG012|STARTED|Period 1||0
10194414|NCT03335254|11322948|FG013|STARTED|Period 1||0
10194415|NCT03335254|11322949|FG014|STARTED|Period 1||0
10194416|NCT03335254|11322950|FG015|STARTED|Period 1||0
10194417|NCT03335254|11322951|FG016|STARTED|Period 1||0
10194418|NCT03335254|11322952|FG017|STARTED|Period 1||0
10194419|NCT03335254|11322953|FG018|STARTED|Period 1||0
10194420|NCT03335254|11322954|FG019|STARTED|Period 1||0
10194421|NCT03335254|11322935|FG000|COMPLETED|Period 1||9
10194422|NCT03335254|11322936|FG001|COMPLETED|Period 1||0
10194423|NCT03335254|11322937|FG002|COMPLETED|Period 1||0
10194424|NCT03335254|11322938|FG003|COMPLETED|Period 1||0
10194425|NCT03335254|11322939|FG004|COMPLETED|Period 1||0
10194426|NCT03335254|11322940|FG005|COMPLETED|Period 1||0
10194427|NCT03335254|11322941|FG006|COMPLETED|Period 1||0
10194428|NCT03335254|11322942|FG007|COMPLETED|Period 1||0
10194429|NCT03335254|11322943|FG008|COMPLETED|Period 1||0
10194430|NCT03335254|11322944|FG009|COMPLETED|Period 1||0
10194431|NCT03335254|11322945|FG010|COMPLETED|Period 1||0
10194432|NCT03335254|11322946|FG011|COMPLETED|Period 1||0
10194433|NCT03335254|11322947|FG012|COMPLETED|Period 1||0
10194434|NCT03335254|11322948|FG013|COMPLETED|Period 1||0
10194435|NCT03335254|11322949|FG014|COMPLETED|Period 1||0
10194436|NCT03335254|11322950|FG015|COMPLETED|Period 1||0
10194437|NCT03335254|11322951|FG016|COMPLETED|Period 1||0
10194438|NCT03335254|11322952|FG017|COMPLETED|Period 1||0
10194439|NCT03335254|11322953|FG018|COMPLETED|Period 1||0
10194440|NCT03335254|11322954|FG019|COMPLETED|Period 1||0
10194441|NCT03335254|11322935|FG000|NOT COMPLETED|Period 1||0
10194442|NCT03335254|11322936|FG001|NOT COMPLETED|Period 1||0
10194443|NCT03335254|11322937|FG002|NOT COMPLETED|Period 1||0
10194444|NCT03335254|11322938|FG003|NOT COMPLETED|Period 1||0
10194445|NCT03335254|11322939|FG004|NOT COMPLETED|Period 1||0
10194446|NCT03335254|11322940|FG005|NOT COMPLETED|Period 1||0
10194447|NCT03335254|11322941|FG006|NOT COMPLETED|Period 1||0
10194448|NCT03335254|11322942|FG007|NOT COMPLETED|Period 1||0
10194449|NCT03335254|11322943|FG008|NOT COMPLETED|Period 1||0
10194450|NCT03335254|11322944|FG009|NOT COMPLETED|Period 1||0
10194451|NCT03335254|11322945|FG010|NOT COMPLETED|Period 1||0
10194452|NCT03335254|11322946|FG011|NOT COMPLETED|Period 1||0
10194453|NCT03335254|11322947|FG012|NOT COMPLETED|Period 1||0
10194454|NCT03335254|11322948|FG013|NOT COMPLETED|Period 1||0
10194455|NCT03335254|11322949|FG014|NOT COMPLETED|Period 1||0
10194456|NCT03335254|11322950|FG015|NOT COMPLETED|Period 1||0
10194457|NCT03335254|11322951|FG016|NOT COMPLETED|Period 1||0
10194458|NCT03335254|11322952|FG017|NOT COMPLETED|Period 1||0
10194459|NCT03335254|11322953|FG018|NOT COMPLETED|Period 1||0
10194460|NCT03335254|11322954|FG019|NOT COMPLETED|Period 1||0
10194461|NCT03335254|11322935|FG000|STARTED|Period 2, Day 1-15||9
10194462|NCT03335254|11322936|FG001|STARTED|Period 2, Day 1-15||0
10194463|NCT03335254|11322937|FG002|STARTED|Period 2, Day 1-15||0
10194464|NCT03335254|11322938|FG003|STARTED|Period 2, Day 1-15||0
10194465|NCT03335254|11322939|FG004|STARTED|Period 2, Day 1-15||0
10194466|NCT03335254|11322940|FG005|STARTED|Period 2, Day 1-15||0
10194467|NCT03335254|11322941|FG006|STARTED|Period 2, Day 1-15||0
10194468|NCT03335254|11322942|FG007|STARTED|Period 2, Day 1-15||0
10194469|NCT03335254|11322943|FG008|STARTED|Period 2, Day 1-15||0
10194470|NCT03335254|11322944|FG009|STARTED|Period 2, Day 1-15||0
10194471|NCT03335254|11322945|FG010|STARTED|Period 2, Day 1-15||0
10194472|NCT03335254|11322946|FG011|STARTED|Period 2, Day 1-15||0
10194473|NCT03335254|11322947|FG012|STARTED|Period 2, Day 1-15||0
10194474|NCT03335254|11322948|FG013|STARTED|Period 2, Day 1-15||0
10194475|NCT03335254|11322949|FG014|STARTED|Period 2, Day 1-15||0
10194476|NCT03335254|11322950|FG015|STARTED|Period 2, Day 1-15||0
10194477|NCT03335254|11322951|FG016|STARTED|Period 2, Day 1-15||0
10194478|NCT03335254|11322952|FG017|STARTED|Period 2, Day 1-15||0
10194479|NCT03335254|11322953|FG018|STARTED|Period 2, Day 1-15||0
10194480|NCT03335254|11322954|FG019|STARTED|Period 2, Day 1-15||0
10194481|NCT03335254|11322935|FG000|COMPLETED|Period 2, Day 1-15||9
10194482|NCT03335254|11322936|FG001|COMPLETED|Period 2, Day 1-15||0
10194483|NCT03335254|11322937|FG002|COMPLETED|Period 2, Day 1-15||0
10194484|NCT03335254|11322938|FG003|COMPLETED|Period 2, Day 1-15||0
10194485|NCT03335254|11322939|FG004|COMPLETED|Period 2, Day 1-15||0
10194486|NCT03335254|11322940|FG005|COMPLETED|Period 2, Day 1-15||0
10194487|NCT03335254|11322941|FG006|COMPLETED|Period 2, Day 1-15||0
10194488|NCT03335254|11322942|FG007|COMPLETED|Period 2, Day 1-15||0
10194489|NCT03335254|11322943|FG008|COMPLETED|Period 2, Day 1-15||0
10194490|NCT03335254|11322944|FG009|COMPLETED|Period 2, Day 1-15||0
10194491|NCT03335254|11322945|FG010|COMPLETED|Period 2, Day 1-15||0
10194492|NCT03335254|11322946|FG011|COMPLETED|Period 2, Day 1-15||0
10194493|NCT03335254|11322947|FG012|COMPLETED|Period 2, Day 1-15||0
10194494|NCT03335254|11322948|FG013|COMPLETED|Period 2, Day 1-15||0
10194495|NCT03335254|11322949|FG014|COMPLETED|Period 2, Day 1-15||0
10194496|NCT03335254|11322950|FG015|COMPLETED|Period 2, Day 1-15||0
10194497|NCT03335254|11322951|FG016|COMPLETED|Period 2, Day 1-15||0
10194498|NCT03335254|11322952|FG017|COMPLETED|Period 2, Day 1-15||0
10194499|NCT03335254|11322953|FG018|COMPLETED|Period 2, Day 1-15||0
10194500|NCT03335254|11322954|FG019|COMPLETED|Period 2, Day 1-15||0
10194501|NCT03335254|11322935|FG000|NOT COMPLETED|Period 2, Day 1-15||0
10194502|NCT03335254|11322936|FG001|NOT COMPLETED|Period 2, Day 1-15||0
10194503|NCT03335254|11322937|FG002|NOT COMPLETED|Period 2, Day 1-15||0
10194504|NCT03335254|11322938|FG003|NOT COMPLETED|Period 2, Day 1-15||0
10194505|NCT03335254|11322939|FG004|NOT COMPLETED|Period 2, Day 1-15||0
10194506|NCT03335254|11322940|FG005|NOT COMPLETED|Period 2, Day 1-15||0
10194507|NCT03335254|11322941|FG006|NOT COMPLETED|Period 2, Day 1-15||0
10194508|NCT03335254|11322942|FG007|NOT COMPLETED|Period 2, Day 1-15||0
10194509|NCT03335254|11322943|FG008|NOT COMPLETED|Period 2, Day 1-15||0
10194510|NCT03335254|11322944|FG009|NOT COMPLETED|Period 2, Day 1-15||0
10194511|NCT03335254|11322945|FG010|NOT COMPLETED|Period 2, Day 1-15||0
10194512|NCT03335254|11322946|FG011|NOT COMPLETED|Period 2, Day 1-15||0
10194513|NCT03335254|11322947|FG012|NOT COMPLETED|Period 2, Day 1-15||0
10194514|NCT03335254|11322948|FG013|NOT COMPLETED|Period 2, Day 1-15||0
10194515|NCT03335254|11322949|FG014|NOT COMPLETED|Period 2, Day 1-15||0
10194516|NCT03335254|11322950|FG015|NOT COMPLETED|Period 2, Day 1-15||0
10194517|NCT03335254|11322951|FG016|NOT COMPLETED|Period 2, Day 1-15||0
10194518|NCT03335254|11322952|FG017|NOT COMPLETED|Period 2, Day 1-15||0
10194519|NCT03335254|11322953|FG018|NOT COMPLETED|Period 2, Day 1-15||0
10194520|NCT03335254|11322954|FG019|NOT COMPLETED|Period 2, Day 1-15||0
10194521|NCT03335254|11322935|FG000|STARTED|Period 3, Day 16-25||9
10194522|NCT03335254|11322936|FG001|STARTED|Period 3, Day 16-25||0
10194523|NCT03335254|11322937|FG002|STARTED|Period 3, Day 16-25||0
10194524|NCT03335254|11322938|FG003|STARTED|Period 3, Day 16-25||0
10194525|NCT03335254|11322939|FG004|STARTED|Period 3, Day 16-25||0
10194526|NCT03335254|11322940|FG005|STARTED|Period 3, Day 16-25||0
10194527|NCT03335254|11322941|FG006|STARTED|Period 3, Day 16-25||0
10194528|NCT03335254|11322942|FG007|STARTED|Period 3, Day 16-25||0
10194529|NCT03335254|11322943|FG008|STARTED|Period 3, Day 16-25||0
10194530|NCT03335254|11322944|FG009|STARTED|Period 3, Day 16-25||0
10194531|NCT03335254|11322945|FG010|STARTED|Period 3, Day 16-25||0
10194532|NCT03335254|11322946|FG011|STARTED|Period 3, Day 16-25||0
10194533|NCT03335254|11322947|FG012|STARTED|Period 3, Day 16-25||0
10194534|NCT03335254|11322948|FG013|STARTED|Period 3, Day 16-25||0
10194535|NCT03335254|11322949|FG014|STARTED|Period 3, Day 16-25||0
10194536|NCT03335254|11322950|FG015|STARTED|Period 3, Day 16-25||0
10194537|NCT03335254|11322951|FG016|STARTED|Period 3, Day 16-25||0
10194538|NCT03335254|11322952|FG017|STARTED|Period 3, Day 16-25||0
10194539|NCT03335254|11322953|FG018|STARTED|Period 3, Day 16-25||0
10194540|NCT03335254|11322954|FG019|STARTED|Period 3, Day 16-25||0
10194541|NCT03335254|11322935|FG000|COMPLETED|Period 3, Day 16-25||9
10194542|NCT03335254|11322936|FG001|COMPLETED|Period 3, Day 16-25||0
10194543|NCT03335254|11322937|FG002|COMPLETED|Period 3, Day 16-25||0
10194544|NCT03335254|11322938|FG003|COMPLETED|Period 3, Day 16-25||0
10194545|NCT03335254|11322939|FG004|COMPLETED|Period 3, Day 16-25||0
10194546|NCT03335254|11322940|FG005|COMPLETED|Period 3, Day 16-25||0
10194547|NCT03335254|11322941|FG006|COMPLETED|Period 3, Day 16-25||0
10194548|NCT03335254|11322942|FG007|COMPLETED|Period 3, Day 16-25||0
10194549|NCT03335254|11322943|FG008|COMPLETED|Period 3, Day 16-25||0
10194550|NCT03335254|11322944|FG009|COMPLETED|Period 3, Day 16-25||0
10194551|NCT03335254|11322945|FG010|COMPLETED|Period 3, Day 16-25||0
10194552|NCT03335254|11322946|FG011|COMPLETED|Period 3, Day 16-25||0
10194553|NCT03335254|11322947|FG012|COMPLETED|Period 3, Day 16-25||0
10194554|NCT03335254|11322948|FG013|COMPLETED|Period 3, Day 16-25||0
10194555|NCT03335254|11322949|FG014|COMPLETED|Period 3, Day 16-25||0
10194556|NCT03335254|11322950|FG015|COMPLETED|Period 3, Day 16-25||0
10194557|NCT03335254|11322951|FG016|COMPLETED|Period 3, Day 16-25||0
10194558|NCT03335254|11322952|FG017|COMPLETED|Period 3, Day 16-25||0
10194559|NCT03335254|11322953|FG018|COMPLETED|Period 3, Day 16-25||0
10194560|NCT03335254|11322954|FG019|COMPLETED|Period 3, Day 16-25||0
10194561|NCT03335254|11322935|FG000|NOT COMPLETED|Period 3, Day 16-25||0
10194562|NCT03335254|11322936|FG001|NOT COMPLETED|Period 3, Day 16-25||0
10194563|NCT03335254|11322937|FG002|NOT COMPLETED|Period 3, Day 16-25||0
10194564|NCT03335254|11322938|FG003|NOT COMPLETED|Period 3, Day 16-25||0
10194565|NCT03335254|11322939|FG004|NOT COMPLETED|Period 3, Day 16-25||0
10194566|NCT03335254|11322940|FG005|NOT COMPLETED|Period 3, Day 16-25||0
10194567|NCT03335254|11322941|FG006|NOT COMPLETED|Period 3, Day 16-25||0
10194568|NCT03335254|11322942|FG007|NOT COMPLETED|Period 3, Day 16-25||0
10194569|NCT03335254|11322943|FG008|NOT COMPLETED|Period 3, Day 16-25||0
10194570|NCT03335254|11322944|FG009|NOT COMPLETED|Period 3, Day 16-25||0
10194571|NCT03335254|11322945|FG010|NOT COMPLETED|Period 3, Day 16-25||0
10194572|NCT03335254|11322946|FG011|NOT COMPLETED|Period 3, Day 16-25||0
10194573|NCT03335254|11322947|FG012|NOT COMPLETED|Period 3, Day 16-25||0
10194574|NCT03335254|11322948|FG013|NOT COMPLETED|Period 3, Day 16-25||0
10194575|NCT03335254|11322949|FG014|NOT COMPLETED|Period 3, Day 16-25||0
10194576|NCT03335254|11322950|FG015|NOT COMPLETED|Period 3, Day 16-25||0
10194577|NCT03335254|11322951|FG016|NOT COMPLETED|Period 3, Day 16-25||0
10194578|NCT03335254|11322952|FG017|NOT COMPLETED|Period 3, Day 16-25||0
10194579|NCT03335254|11322953|FG018|NOT COMPLETED|Period 3, Day 16-25||0
10194580|NCT03335254|11322954|FG019|NOT COMPLETED|Period 3, Day 16-25||0
10194581|NCT03335254|11322935|FG000|STARTED|Period 3, Day 26-30||9
10194582|NCT03335254|11322936|FG001|STARTED|Period 3, Day 26-30||0
10194583|NCT03335254|11322937|FG002|STARTED|Period 3, Day 26-30||0
10194584|NCT03335254|11322938|FG003|STARTED|Period 3, Day 26-30||0
10194585|NCT03335254|11322939|FG004|STARTED|Period 3, Day 26-30||0
10194586|NCT03335254|11322940|FG005|STARTED|Period 3, Day 26-30||0
10194587|NCT03335254|11322941|FG006|STARTED|Period 3, Day 26-30||0
10194588|NCT03335254|11322942|FG007|STARTED|Period 3, Day 26-30||0
10194589|NCT03335254|11322943|FG008|STARTED|Period 3, Day 26-30||0
10194590|NCT03335254|11322944|FG009|STARTED|Period 3, Day 26-30||0
10194591|NCT03335254|11322945|FG010|STARTED|Period 3, Day 26-30||0
10194592|NCT03335254|11322946|FG011|STARTED|Period 3, Day 26-30||0
10194593|NCT03335254|11322947|FG012|STARTED|Period 3, Day 26-30||0
10194594|NCT03335254|11322948|FG013|STARTED|Period 3, Day 26-30||0
10194595|NCT03335254|11322949|FG014|STARTED|Period 3, Day 26-30||0
10194596|NCT03335254|11322950|FG015|STARTED|Period 3, Day 26-30||0
10194597|NCT03335254|11322951|FG016|STARTED|Period 3, Day 26-30||0
10194598|NCT03335254|11322952|FG017|STARTED|Period 3, Day 26-30||0
10194599|NCT03335254|11322953|FG018|STARTED|Period 3, Day 26-30||0
10194600|NCT03335254|11322954|FG019|STARTED|Period 3, Day 26-30||0
10194601|NCT03335254|11322935|FG000|COMPLETED|Period 3, Day 26-30||9
10194602|NCT03335254|11322936|FG001|COMPLETED|Period 3, Day 26-30||0
10194603|NCT03335254|11322937|FG002|COMPLETED|Period 3, Day 26-30||0
10194604|NCT03335254|11322938|FG003|COMPLETED|Period 3, Day 26-30||0
10194605|NCT03335254|11322939|FG004|COMPLETED|Period 3, Day 26-30||0
10194606|NCT03335254|11322940|FG005|COMPLETED|Period 3, Day 26-30||0
10194607|NCT03335254|11322941|FG006|COMPLETED|Period 3, Day 26-30||0
10194608|NCT03335254|11322942|FG007|COMPLETED|Period 3, Day 26-30||0
10194609|NCT03335254|11322943|FG008|COMPLETED|Period 3, Day 26-30||0
10194610|NCT03335254|11322944|FG009|COMPLETED|Period 3, Day 26-30||0
10194611|NCT03335254|11322945|FG010|COMPLETED|Period 3, Day 26-30||0
10194612|NCT03335254|11322946|FG011|COMPLETED|Period 3, Day 26-30||0
10194613|NCT03335254|11322947|FG012|COMPLETED|Period 3, Day 26-30||0
10194614|NCT03335254|11322948|FG013|COMPLETED|Period 3, Day 26-30||0
10194615|NCT03335254|11322949|FG014|COMPLETED|Period 3, Day 26-30||0
10194616|NCT03335254|11322950|FG015|COMPLETED|Period 3, Day 26-30||0
10194617|NCT03335254|11322951|FG016|COMPLETED|Period 3, Day 26-30||0
10194618|NCT03335254|11322952|FG017|COMPLETED|Period 3, Day 26-30||0
10194619|NCT03335254|11322953|FG018|COMPLETED|Period 3, Day 26-30||0
10194620|NCT03335254|11322954|FG019|COMPLETED|Period 3, Day 26-30||0
10194621|NCT03335254|11322935|FG000|NOT COMPLETED|Period 3, Day 26-30||0
10194622|NCT03335254|11322936|FG001|NOT COMPLETED|Period 3, Day 26-30||0
10194623|NCT03335254|11322937|FG002|NOT COMPLETED|Period 3, Day 26-30||0
10194624|NCT03335254|11322938|FG003|NOT COMPLETED|Period 3, Day 26-30||0
10194625|NCT03335254|11322939|FG004|NOT COMPLETED|Period 3, Day 26-30||0
10194626|NCT03335254|11322940|FG005|NOT COMPLETED|Period 3, Day 26-30||0
10194627|NCT03335254|11322941|FG006|NOT COMPLETED|Period 3, Day 26-30||0
10194628|NCT03335254|11322942|FG007|NOT COMPLETED|Period 3, Day 26-30||0
10194629|NCT03335254|11322943|FG008|NOT COMPLETED|Period 3, Day 26-30||0
10194630|NCT03335254|11322944|FG009|NOT COMPLETED|Period 3, Day 26-30||0
10194631|NCT03335254|11322945|FG010|NOT COMPLETED|Period 3, Day 26-30||0
10194632|NCT03335254|11322946|FG011|NOT COMPLETED|Period 3, Day 26-30||0
10194633|NCT03335254|11322947|FG012|NOT COMPLETED|Period 3, Day 26-30||0
10194634|NCT03335254|11322948|FG013|NOT COMPLETED|Period 3, Day 26-30||0
10194635|NCT03335254|11322949|FG014|NOT COMPLETED|Period 3, Day 26-30||0
10194636|NCT03335254|11322950|FG015|NOT COMPLETED|Period 3, Day 26-30||0
10194637|NCT03335254|11322951|FG016|NOT COMPLETED|Period 3, Day 26-30||0
10194638|NCT03335254|11322952|FG017|NOT COMPLETED|Period 3, Day 26-30||0
10194639|NCT03335254|11322953|FG018|NOT COMPLETED|Period 3, Day 26-30||0
10194640|NCT03335254|11322954|FG019|NOT COMPLETED|Period 3, Day 26-30||0
10194641|NCT03335566|11322985|FG000|STARTED|Overall Study||218
10194642|NCT03335566|11322986|FG001|STARTED|Overall Study||206
10194643|NCT03335566|11322985|FG000|COMPLETED|Overall Study||214
10194644|NCT03335566|11322986|FG001|COMPLETED|Overall Study||203
10194645|NCT03335566|11322985|FG000|NOT COMPLETED|Overall Study||4
10194646|NCT03335566|11322986|FG001|NOT COMPLETED|Overall Study||3
10194647|NCT03335761|11322995|FG000|STARTED|Overall Study||19
10194648|NCT03335761|11322996|FG001|STARTED|Overall Study||14
10194649|NCT03335761|11322997|FG002|STARTED|Overall Study||15
10194650|NCT03335761|11322995|FG000|Implanted With a Neurostimulator Device|Overall Study||18
10194651|NCT03335761|11322996|FG001|Implanted With a Neurostimulator Device|Overall Study||14
10194652|NCT03335761|11322997|FG002|Implanted With a Neurostimulator Device|Overall Study||14
10194653|NCT03335761|11322995|FG000|COMPLETED|Overall Study||17
10194654|NCT03335761|11322996|FG001|COMPLETED|Overall Study||13
10194655|NCT03335761|11322997|FG002|COMPLETED|Overall Study||13
10194656|NCT03335761|11322995|FG000|NOT COMPLETED|Overall Study||2
10194657|NCT03335761|11322996|FG001|NOT COMPLETED|Overall Study||1
10194658|NCT03335761|11322997|FG002|NOT COMPLETED|Overall Study||2
10194659|NCT03335800|11323005|FG000|STARTED|Overall Study||419927
10194660|NCT03335800|11323005|FG000|Received Irregular Pulse Notification|Overall Study||2161
10194661|NCT03335800|11323005|FG000|Attended First Study Visit|Overall Study||945
10194662|NCT03335800|11323005|FG000|ECG Patch Shipped|Overall Study||658
10194663|NCT03335800|11323005|FG000|ECG Patch Returned for Analysis|Overall Study||450
10194664|NCT03335800|11323005|FG000|Attended Second Study Visit|Overall Study||396
10194665|NCT03335800|11323005|FG000|COMPLETED|Overall Study||396
10194666|NCT03335800|11323005|FG000|NOT COMPLETED|Overall Study||419531
10194667|NCT03336450|11323009|FG000|STARTED|Overall Study||3
10194668|NCT03336450|11323009|FG000|COMPLETED|Overall Study||3
10194669|NCT03336450|11323009|FG000|NOT COMPLETED|Overall Study||0
10194670|NCT03336502|11323015|FG000|STARTED|Overall Study||30
10194671|NCT03336502|11323016|FG001|STARTED|Overall Study||40
10194672|NCT03336502|11323015|FG000|COMPLETED|Overall Study||26
10194673|NCT03336502|11323016|FG001|COMPLETED|Overall Study||31
10194674|NCT03336502|11323015|FG000|NOT COMPLETED|Overall Study||4
10194675|NCT03336502|11323016|FG001|NOT COMPLETED|Overall Study||9
10194676|NCT03336645|11323022|FG000|STARTED|Overall Study||25
10194677|NCT03336645|11323022|FG000|COMPLETED|Overall Study||25
10194678|NCT03336645|11323022|FG000|NOT COMPLETED|Overall Study||0
10194679|NCT03336853|11323028|FG000|STARTED|Overall Study||30
10194680|NCT03336853|11323029|FG001|STARTED|Overall Study||30
10194681|NCT03336853|11323028|FG000|COMPLETED|Overall Study||30
10194682|NCT03336853|11323029|FG001|COMPLETED|Overall Study||30
10194683|NCT03336853|11323028|FG000|NOT COMPLETED|Overall Study||0
10194684|NCT03336853|11323029|FG001|NOT COMPLETED|Overall Study||0
10194685|NCT03337139|11323037|FG000|STARTED|Phase I||87
10194686|NCT03337139|11323038|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
10194687|NCT03337139|11323037|FG000|COMPLETED|Phase I||77
10194688|NCT03337139|11323038|FG001|COMPLETED|Phase I||0
10194689|NCT03337139|11323037|FG000|NOT COMPLETED|Phase I||10
10194690|NCT03337139|11323038|FG001|NOT COMPLETED|Phase I||0
10194691|NCT03337139|11323037|FG000|STARTED|Phase II||38
10194692|NCT03337139|11323038|FG001|STARTED|Phase II||39
10194693|NCT03337139|11323037|FG000|26 Week Assessment|Phase II||34
10194694|NCT03337139|11323038|FG001|26 Week Assessment|Phase II||37
10194695|NCT03337139|11323037|FG000|COMPLETED|Phase II||33
10194696|NCT03337139|11323038|FG001|COMPLETED|Phase II||36
10194697|NCT03337139|11323037|FG000|NOT COMPLETED|Phase II||5
10194698|NCT03337139|11323038|FG001|NOT COMPLETED|Phase II||3
10194699|NCT03337152|11323046|FG000|STARTED|Overall Study||24
10194700|NCT03337152|11323047|FG001|STARTED|Overall Study||24
10194701|NCT03337152|11323046|FG000|COMPLETED|Overall Study||13
10194702|NCT03337152|11323047|FG001|COMPLETED|Overall Study||13
10194703|NCT03337152|11323046|FG000|NOT COMPLETED|Overall Study||11
10194704|NCT03337152|11323047|FG001|NOT COMPLETED|Overall Study||11
10194705|NCT03337308|11323059|FG000|STARTED|Overall Study||108
10194706|NCT03337308|11323060|FG001|STARTED|Overall Study||110
10194707|NCT03337308|11323061|FG002|STARTED|Overall Study||109
10194708|NCT03337308|11323062|FG003|STARTED|Overall Study||55
10194709|NCT03337308|11323059|FG000|COMPLETED|Overall Study||103
10194710|NCT03337308|11323060|FG001|COMPLETED|Overall Study||103
10194711|NCT03337308|11323061|FG002|COMPLETED|Overall Study||104
10194712|NCT03337308|11323062|FG003|COMPLETED|Overall Study||53
10194713|NCT03337308|11323059|FG000|NOT COMPLETED|Overall Study||5
10194714|NCT03337308|11323060|FG001|NOT COMPLETED|Overall Study||7
10194715|NCT03337308|11323061|FG002|NOT COMPLETED|Overall Study||5
10194716|NCT03337308|11323062|FG003|NOT COMPLETED|Overall Study||2
10194717|NCT03337477|11323074|FG000|STARTED|Overall Study||33
10194718|NCT03337477|11323075|FG001|STARTED|Overall Study||37
10194719|NCT03337477|11323074|FG000|COMPLETED|Overall Study||22
10194720|NCT03337477|11323075|FG001|COMPLETED|Overall Study||24
10194721|NCT03337477|11323074|FG000|NOT COMPLETED|Overall Study||11
10194722|NCT03337477|11323075|FG001|NOT COMPLETED|Overall Study||13
10194723|NCT03337490|11323086|FG000|STARTED|Overall Study||128
10194724|NCT03337490|11323087|FG001|STARTED|Overall Study||126
10194725|NCT03337490|11323088|FG002|STARTED|Overall Study||42
10194726|NCT03337490|11323086|FG000|COMPLETED|Overall Study||117
10194727|NCT03337490|11323087|FG001|COMPLETED|Overall Study||112
10194728|NCT03337490|11323088|FG002|COMPLETED|Overall Study||7
10194729|NCT03337490|11323086|FG000|NOT COMPLETED|Overall Study||11
10194730|NCT03337490|11323087|FG001|NOT COMPLETED|Overall Study||14
10194731|NCT03337490|11323088|FG002|NOT COMPLETED|Overall Study||35
10194732|NCT03337542|11323096|FG000|STARTED|Overall Study||243
10194733|NCT03337542|11323096|FG000|Safety Population|Overall Study||242
10194734|NCT03337542|11323096|FG000|COMPLETED|Overall Study||222
10194735|NCT03337542|11323096|FG000|NOT COMPLETED|Overall Study||21
10194736|NCT03338010|11323103|FG000|STARTED|Overall Study||359
10194737|NCT03338010|11323104|FG001|STARTED|Overall Study||177
10194738|NCT03338010|11323103|FG000|Received at Least One Dose of Study Drug|Overall Study||359
10194739|NCT03338010|11323104|FG001|Received at Least One Dose of Study Drug|Overall Study||177
10194740|NCT03338010|11323103|FG000|COMPLETED|Overall Study||336
10194741|NCT03338010|11323104|FG001|COMPLETED|Overall Study||159
10194742|NCT03338010|11323103|FG000|NOT COMPLETED|Overall Study||23
10194743|NCT03338010|11323104|FG001|NOT COMPLETED|Overall Study||18
10194744|NCT03338023|11323112|FG000|STARTED|Overall Study||137
10194745|NCT03338023|11323113|FG001|STARTED|Overall Study||135
10194746|NCT03338023|11323112|FG000|Received at Least One Dose of Study Drug|Overall Study||137
10194747|NCT03338023|11323113|FG001|Received at Least One Dose of Study Drug|Overall Study||135
10194748|NCT03338023|11323112|FG000|COMPLETED|Overall Study||128
10194749|NCT03338023|11323113|FG001|COMPLETED|Overall Study||125
10194750|NCT03338023|11323112|FG000|NOT COMPLETED|Overall Study||9
10194751|NCT03338023|11323113|FG001|NOT COMPLETED|Overall Study||10
10194752|NCT03338036|11323123|FG000|STARTED|Overall Study||0
10194753|NCT03338036|11323124|FG001|STARTED|Overall Study||11
10194754|NCT03338036|11323125|FG002|STARTED|Overall Study||12
10194755|NCT03338036|11323126|FG003|STARTED|Overall Study||8
10194756|NCT03338036|11323123|FG000|COMPLETED|Overall Study||0
10194757|NCT03338036|11323124|FG001|COMPLETED|Overall Study||7
10194758|NCT03338036|11323125|FG002|COMPLETED|Overall Study||9
10194759|NCT03338036|11323126|FG003|COMPLETED|Overall Study||8
10194760|NCT03338036|11323123|FG000|NOT COMPLETED|Overall Study||0
10194761|NCT03338036|11323124|FG001|NOT COMPLETED|Overall Study||4
10194762|NCT03338036|11323125|FG002|NOT COMPLETED|Overall Study||3
10194763|NCT03338036|11323126|FG003|NOT COMPLETED|Overall Study||0
10194764|NCT03338062|11323136|FG000|STARTED|Overall Study||10
10194765|NCT03338062|11323137|FG001|STARTED|Overall Study||5
10194766|NCT03338062|11323136|FG000|COMPLETED|Overall Study||9
10194767|NCT03338062|11323137|FG001|COMPLETED|Overall Study||5
10194768|NCT03338062|11323136|FG000|NOT COMPLETED|Overall Study||1
10194769|NCT03338062|11323137|FG001|NOT COMPLETED|Overall Study||0
10194770|NCT03338296|11323146|FG000|STARTED|Overall Study||139
10194771|NCT03338296|11323147|FG001|STARTED|Overall Study||139
10194772|NCT03338296|11323146|FG000|Safety Analysis Set|Overall Study||139
10194773|NCT03338296|11323147|FG001|Safety Analysis Set|Overall Study||136
10194774|NCT03338296|11323146|FG000|COMPLETED|Overall Study||36
10194775|NCT03338296|11323147|FG001|COMPLETED|Overall Study||31
10194776|NCT03338296|11323146|FG000|NOT COMPLETED|Overall Study||103
10194777|NCT03338296|11323147|FG001|NOT COMPLETED|Overall Study||108
10194778|NCT03338400|11323155|FG000|STARTED|Overall Study||25
10194779|NCT03338400|11323156|FG001|STARTED|Overall Study||26
10194780|NCT03338400|11323155|FG000|COMPLETED|Overall Study||24
10194781|NCT03338400|11323156|FG001|COMPLETED|Overall Study||24
10194782|NCT03338400|11323155|FG000|NOT COMPLETED|Overall Study||1
10194783|NCT03338400|11323156|FG001|NOT COMPLETED|Overall Study||2
10194784|NCT03338556|11323174|FG000|STARTED|Overall Study||25
10194785|NCT03338556|11323175|FG001|STARTED|Overall Study||27
10194786|NCT03338556|11323176|FG002|STARTED|Overall Study||24
10194787|NCT03338556|11323177|FG003|STARTED|Overall Study||26
10194788|NCT03338556|11323174|FG000|COMPLETED|Overall Study||23
10194789|NCT03338556|11323175|FG001|COMPLETED|Overall Study||23
10194790|NCT03338556|11323176|FG002|COMPLETED|Overall Study||22
10194791|NCT03338556|11323177|FG003|COMPLETED|Overall Study||24
10194792|NCT03338556|11323174|FG000|NOT COMPLETED|Overall Study||2
10194793|NCT03338556|11323175|FG001|NOT COMPLETED|Overall Study||4
10194794|NCT03338556|11323176|FG002|NOT COMPLETED|Overall Study||2
10194795|NCT03338556|11323177|FG003|NOT COMPLETED|Overall Study||2
10194796|NCT03338569|11323189|FG000|STARTED|Overall Study||64
10194797|NCT03338569|11323190|FG001|STARTED|Overall Study||61
10194798|NCT03338569|11323189|FG000|COMPLETED|Overall Study||56
10194799|NCT03338569|11323190|FG001|COMPLETED|Overall Study||56
10194800|NCT03338569|11323189|FG000|NOT COMPLETED|Overall Study||8
10194801|NCT03338569|11323190|FG001|NOT COMPLETED|Overall Study||5
10194802|NCT03338673|11323198|FG000|STARTED|Overall Study||6
10194803|NCT03338673|11323199|FG001|STARTED|Overall Study||6
10194804|NCT03338673|11323198|FG000|COMPLETED|Overall Study||5
10194805|NCT03338673|11323199|FG001|COMPLETED|Overall Study||5
10194806|NCT03338673|11323198|FG000|NOT COMPLETED|Overall Study||1
10194807|NCT03338673|11323199|FG001|NOT COMPLETED|Overall Study||1
10194808|NCT03338686|11323208|FG000|STARTED|Overall Study||2
10194809|NCT03338686|11323209|FG001|STARTED|Overall Study||5
10194810|NCT03338686|11323210|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
10194811|NCT03338686|11323208|FG000|COMPLETED|Overall Study||2
10194812|NCT03338686|11323209|FG001|COMPLETED|Overall Study||5
10194813|NCT03338686|11323210|FG002|COMPLETED|Overall Study||7
10194814|NCT03338686|11323208|FG000|NOT COMPLETED|Overall Study||0
10194815|NCT03338686|11323209|FG001|NOT COMPLETED|Overall Study||0
10194816|NCT03338686|11323210|FG002|NOT COMPLETED|Overall Study||0
10194817|NCT03338803|11323217|FG000|STARTED|Overall Study||11001
10194818|NCT03338803|11323217|FG000|COMPLETED|Overall Study||11001
10194819|NCT03338803|11323217|FG000|NOT COMPLETED|Overall Study||0
10194820|NCT03338855|11323223|FG000|STARTED|Overall Study||12
10194821|NCT03338855|11323224|FG001|STARTED|Overall Study||14
10194822|NCT03338855|11323223|FG000|Received Treatment in Period 1|Overall Study||12
10194823|NCT03338855|11323224|FG001|Received Treatment in Period 1|Overall Study||14
10194824|NCT03338855|11323223|FG000|Received Treatment in Period 2|Overall Study||11
10194825|NCT03338855|11323224|FG001|Received Treatment in Period 2|Overall Study||14
10194826|NCT03338855|11323223|FG000|COMPLETED|Overall Study||11
10194827|NCT03338855|11323224|FG001|COMPLETED|Overall Study||14
10194828|NCT03338855|11323223|FG000|NOT COMPLETED|Overall Study||1
10194829|NCT03338855|11323224|FG001|NOT COMPLETED|Overall Study||0
10194830|NCT03338894|11323230|FG000|STARTED|Overall Study||66
10194831|NCT03338894|11323230|FG000|COMPLETED|Overall Study||56
10194832|NCT03338894|11323230|FG000|NOT COMPLETED|Overall Study||10
10194833|NCT03338998|11323236|FG000|STARTED|Treatment Period||16
10194834|NCT03338998|11323237|FG001|STARTED|Treatment Period||13
10194835|NCT03338998|11323236|FG000|COMPLETED|Treatment Period||8
10194836|NCT03338998|11323237|FG001|COMPLETED|Treatment Period||10
10194837|NCT03338998|11323236|FG000|NOT COMPLETED|Treatment Period||8
10194838|NCT03338998|11323237|FG001|NOT COMPLETED|Treatment Period||3
10194839|NCT03338998|11323236|FG000|STARTED|Safety Follow-Up Period||16
10194840|NCT03338998|11323237|FG001|STARTED|Safety Follow-Up Period||13
10194841|NCT03338998|11323236|FG000|COMPLETED|Safety Follow-Up Period||14
10194842|NCT03338998|11323237|FG001|COMPLETED|Safety Follow-Up Period||12
10194843|NCT03338998|11323236|FG000|NOT COMPLETED|Safety Follow-Up Period||2
10194844|NCT03338998|11323237|FG001|NOT COMPLETED|Safety Follow-Up Period||1
10194845|NCT03339206|11323247|FG000|STARTED|Overall Study||262
10194846|NCT03339206|11323248|FG001|STARTED|Overall Study||263
10194847|NCT03339206|11323249|FG002|STARTED|Overall Study||264
10194848|NCT03339206|11323247|FG000|COMPLETED|Overall Study||262
10194849|NCT03339206|11323248|FG001|COMPLETED|Overall Study||263
10194850|NCT03339206|11323249|FG002|COMPLETED|Overall Study||264
10194851|NCT03339206|11323247|FG000|NOT COMPLETED|Overall Study||0
10194852|NCT03339206|11323248|FG001|NOT COMPLETED|Overall Study||0
10194853|NCT03339206|11323249|FG002|NOT COMPLETED|Overall Study||0
10194854|NCT03339219|11323257|FG000|STARTED|Overall Study||35
10194855|NCT03339219|11323257|FG000|COMPLETED|Overall Study||0
10194856|NCT03339219|11323257|FG000|NOT COMPLETED|Overall Study||35
10194857|NCT03339297|11323263|FG000|STARTED|Overall Study||79
10194858|NCT03339297|11323264|FG001|STARTED|Overall Study||73
10194859|NCT03339297|11323263|FG000|COMPLETED|Overall Study||56
10194860|NCT03339297|11323264|FG001|COMPLETED|Overall Study||59
10194861|NCT03339297|11323263|FG000|NOT COMPLETED|Overall Study||23
10194862|NCT03339297|11323264|FG001|NOT COMPLETED|Overall Study||14
10194863|NCT03339453|11323272|FG000|STARTED|First Visit of Glucagon Treatment||35
10194864|NCT03339453|11323273|FG001|STARTED|First Visit of Glucagon Treatment||35
10194865|NCT03339453|11323272|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
10194866|NCT03339453|11323273|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
10194867|NCT03339453|11323272|FG000|COMPLETED|First Visit of Glucagon Treatment||35
10194868|NCT03339453|11323273|FG001|COMPLETED|First Visit of Glucagon Treatment||34
10194869|NCT03339453|11323272|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0
10194870|NCT03339453|11323273|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1
10194871|NCT03339453|11323272|FG000|STARTED|Second Visit for Alternate Glucagon||35
10194872|NCT03339453|11323273|FG001|STARTED|Second Visit for Alternate Glucagon||34
10194873|NCT03339453|11323272|FG000|COMPLETED|Second Visit for Alternate Glucagon||35
10194874|NCT03339453|11323273|FG001|COMPLETED|Second Visit for Alternate Glucagon||34
10194875|NCT03339453|11323272|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0
10194876|NCT03339453|11323273|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0
10194877|NCT03339570|11323279|FG000|STARTED|Overall Study||20
10194878|NCT03339570|11323279|FG000|COMPLETED|Overall Study||16
10194879|NCT03339570|11323279|FG000|NOT COMPLETED|Overall Study||4
10194880|NCT03339583|11323294|FG000|STARTED|First Intervention (14 Days)||19
10194881|NCT03339583|11323295|FG001|STARTED|First Intervention (14 Days)||23
10194882|NCT03339583|11323294|FG000|COMPLETED|First Intervention (14 Days)||18
10194883|NCT03339583|11323295|FG001|COMPLETED|First Intervention (14 Days)||23
10194884|NCT03339583|11323294|FG000|NOT COMPLETED|First Intervention (14 Days)||1
10194885|NCT03339583|11323295|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10194886|NCT03339583|11323294|FG000|STARTED|Washout (14 Days)||18
10194887|NCT03339583|11323295|FG001|STARTED|Washout (14 Days)||23
10194888|NCT03339583|11323294|FG000|COMPLETED|Washout (14 Days)||18
10194889|NCT03339583|11323295|FG001|COMPLETED|Washout (14 Days)||23
10194890|NCT03339583|11323294|FG000|NOT COMPLETED|Washout (14 Days)||0
10194891|NCT03339583|11323295|FG001|NOT COMPLETED|Washout (14 Days)||0
10194892|NCT03339583|11323294|FG000|STARTED|Second Intervention (14 Days)||18
10194893|NCT03339583|11323295|FG001|STARTED|Second Intervention (14 Days)||23
10194894|NCT03339583|11323294|FG000|COMPLETED|Second Intervention (14 Days)||18
10194895|NCT03339583|11323295|FG001|COMPLETED|Second Intervention (14 Days)||21
10194896|NCT03339583|11323294|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10194897|NCT03339583|11323295|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
10194898|NCT03339583|11323294|FG000|STARTED|Follow-up (14 Days)||18
9850743|NCT00871975|10963441|FG000|COMPLETED|Overall Study||133
9850744|NCT00871975|10963441|FG000|NOT COMPLETED|Overall Study||22
9850745|NCT00872001|10963447|FG000|STARTED|Overall Study||1536
9850746|NCT00872001|10963448|FG001|STARTED|Overall Study||1544
9850747|NCT00872001|10963447|FG000|COMPLETED|Overall Study||1400
9850748|NCT00872001|10963448|FG001|COMPLETED|Overall Study||1413
9850749|NCT00872001|10963447|FG000|NOT COMPLETED|Overall Study||136
9850750|NCT00872001|10963448|FG001|NOT COMPLETED|Overall Study||131
9850751|NCT00872027|10963458|FG000|STARTED|Overall Study||7
9850752|NCT00872027|10963459|FG001|STARTED|Overall Study||8
9850753|NCT00872027|10963458|FG000|COMPLETED|Overall Study||7
9850754|NCT00872027|10963459|FG001|COMPLETED|Overall Study||8
9850755|NCT00872027|10963458|FG000|NOT COMPLETED|Overall Study||0
9850756|NCT00872027|10963459|FG001|NOT COMPLETED|Overall Study||0
9850757|NCT00872079|10963465|FG000|STARTED|Overall Study||175
9850758|NCT00872079|10963465|FG000|COMPLETED|Overall Study||175
9850759|NCT00872079|10963465|FG000|NOT COMPLETED|Overall Study||0
9850760|NCT00872170|10963471|FG000|STARTED|Overall Study||14
10194899|NCT03339583|11323295|FG001|STARTED|Follow-up (14 Days)||21
10194900|NCT03339583|11323294|FG000|COMPLETED|Follow-up (14 Days)||12
10194901|NCT03339583|11323295|FG001|COMPLETED|Follow-up (14 Days)||18
10194902|NCT03339583|11323294|FG000|NOT COMPLETED|Follow-up (14 Days)||6
10194903|NCT03339583|11323295|FG001|NOT COMPLETED|Follow-up (14 Days)||3
10194904|NCT03339713|11323305|FG000|STARTED|Overall Study||90
10194905|NCT03339713|11323306|FG001|STARTED|Overall Study||90
10194906|NCT03339713|11323305|FG000|COMPLETED|Overall Study||86
10194907|NCT03339713|11323306|FG001|COMPLETED|Overall Study||88
10194908|NCT03339713|11323305|FG000|NOT COMPLETED|Overall Study||4
10194909|NCT03339713|11323306|FG001|NOT COMPLETED|Overall Study||2
10194910|NCT03339726|11323317|FG000|STARTED|Overall Study||64
10194911|NCT03339726|11323318|FG001|STARTED|Overall Study||66
10194912|NCT03339726|11323319|FG002|STARTED|Overall Study||63
10194913|NCT03339726|11323317|FG000|COMPLETED|Overall Study||63
10194914|NCT03339726|11323318|FG001|COMPLETED|Overall Study||65
10194915|NCT03339726|11323319|FG002|COMPLETED|Overall Study||63
10194916|NCT03339726|11323317|FG000|NOT COMPLETED|Overall Study||1
10194917|NCT03339726|11323318|FG001|NOT COMPLETED|Overall Study||1
10194918|NCT03339726|11323319|FG002|NOT COMPLETED|Overall Study||0
10194919|NCT03339999|11323331|FG000|STARTED|Overall Study||7
10194920|NCT03339999|11323332|FG001|STARTED|Overall Study||6
10194921|NCT03339999|11323333|FG002|STARTED|Overall Study||6
10194922|NCT03339999|11323334|FG003|STARTED|Overall Study||5
10194923|NCT03339999|11323331|FG000|Modified Intent-to-Treat Population|Overall Study||7
10194924|NCT03339999|11323332|FG001|Modified Intent-to-Treat Population|Overall Study||6
10194925|NCT03339999|11323333|FG002|Modified Intent-to-Treat Population|Overall Study||5
10194926|NCT03339999|11323334|FG003|Modified Intent-to-Treat Population|Overall Study||4
10194927|NCT03339999|11323331|FG000|Safety Population: Received Treatment|Overall Study||7
10194928|NCT03339999|11323332|FG001|Safety Population: Received Treatment|Overall Study||6
10194929|NCT03339999|11323333|FG002|Safety Population: Received Treatment|Overall Study||6
10194930|NCT03339999|11323334|FG003|Safety Population: Received Treatment|Overall Study||4
10194931|NCT03339999|11323331|FG000|COMPLETED|Overall Study||0
10194932|NCT03339999|11323332|FG001|COMPLETED|Overall Study||0
10194933|NCT03339999|11323333|FG002|COMPLETED|Overall Study||0
10194934|NCT03339999|11323334|FG003|COMPLETED|Overall Study||0
10194935|NCT03339999|11323331|FG000|NOT COMPLETED|Overall Study||7
10194936|NCT03339999|11323332|FG001|NOT COMPLETED|Overall Study||6
10194937|NCT03339999|11323333|FG002|NOT COMPLETED|Overall Study||6
10194938|NCT03339999|11323334|FG003|NOT COMPLETED|Overall Study||5
10194939|NCT03340025|11323349|FG000|STARTED|Overall Study||11
10194940|NCT03340025|11323350|FG001|STARTED|Overall Study||9
10194941|NCT03340025|11323349|FG000|COMPLETED|Overall Study||9
10194942|NCT03340025|11323350|FG001|COMPLETED|Overall Study||7
10194943|NCT03340025|11323349|FG000|NOT COMPLETED|Overall Study||2
10194944|NCT03340025|11323350|FG001|NOT COMPLETED|Overall Study||2
10194945|NCT03340337|11323356|FG000|STARTED|Overall Study||30
10194946|NCT03340337|11323356|FG000|Received Neo-Russian|Overall Study||30
10194947|NCT03340337|11323356|FG000|Received Aussie|Overall Study||30
10194948|NCT03340337|11323356|FG000|Received RBS|Overall Study||30
10194949|NCT03340337|11323356|FG000|COMPLETED|Overall Study||30
10194950|NCT03340337|11323356|FG000|NOT COMPLETED|Overall Study||0
10194951|NCT03340350|11323371|FG000|STARTED|Overall Study||10
10194952|NCT03340350|11323371|FG000|COMPLETED|Overall Study||4
10194953|NCT03340350|11323371|FG000|NOT COMPLETED|Overall Study||6
10194954|NCT03340415|11323378|FG000|STARTED|Overall Study||29
10194955|NCT03340415|11323379|FG001|STARTED|Overall Study||24
10194956|NCT03340415|11323378|FG000|COMPLETED|Overall Study||29
10194957|NCT03340415|11323379|FG001|COMPLETED|Overall Study||21
10194958|NCT03340415|11323378|FG000|NOT COMPLETED|Overall Study||0
10194959|NCT03340415|11323379|FG001|NOT COMPLETED|Overall Study||3
10194960|NCT03340428|11323389|FG000|STARTED|Overall Study||117
10194961|NCT03340428|11323390|FG001|STARTED|Overall Study||59
10194962|NCT03340428|11323389|FG000|COMPLETED|Overall Study||116
10194963|NCT03340428|11323390|FG001|COMPLETED|Overall Study||59
10194964|NCT03340428|11323389|FG000|NOT COMPLETED|Overall Study||1
10194965|NCT03340428|11323390|FG001|NOT COMPLETED|Overall Study||0
10194966|NCT03340610|11323396|FG000|STARTED|Overall Study||30
10194967|NCT03340610|11323396|FG000|COMPLETED|Overall Study||27
10194968|NCT03340610|11323396|FG000|NOT COMPLETED|Overall Study||3
10194969|NCT03340805|11323402|FG000|STARTED|Overall Study||24
10194970|NCT03340805|11323403|FG001|STARTED|Overall Study||26
10194971|NCT03340805|11323402|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
10194972|NCT03340805|11323403|FG001|COMPLETED|Overall Study||26
10194973|NCT03340805|11323402|FG000|NOT COMPLETED|Overall Study||0
10194974|NCT03340805|11323403|FG001|NOT COMPLETED|Overall Study||0
10194975|NCT03340883|11323411|FG000|STARTED|Overall Study||4
10194976|NCT03340883|11323412|FG001|STARTED|Overall Study||3
10194977|NCT03340883|11323413|FG002|STARTED|Overall Study||4
10194978|NCT03340883|11323414|FG003|STARTED|Overall Study||4
10194979|NCT03340883|11323415|FG004|STARTED|Overall Study||3
10194980|NCT03340883|11323416|FG005|STARTED|Overall Study||3
10194981|NCT03340883|11323411|FG000|COMPLETED|Overall Study||4
9717508|NCT00004054|10816711|FG001|STARTED|Overall Study||200
9717509|NCT00004054|10816710|FG000|COMPLETED|Overall Study||197
9717510|NCT00004054|10816711|FG001|COMPLETED|Overall Study||200
9717511|NCT00004054|10816710|FG000|NOT COMPLETED|Overall Study||0
9717512|NCT00004054|10816711|FG001|NOT COMPLETED|Overall Study||0
9717513|NCT00004088|10816717|FG000|STARTED|Overall Study||77
9717514|NCT00004088|10816717|FG000|COMPLETED|Overall Study||68
9717515|NCT00004088|10816717|FG000|NOT COMPLETED|Overall Study||9
9717516|NCT00004092|10816723|FG000|STARTED|Overall Study||21
9717517|NCT00004092|10816724|FG001|STARTED|Overall Study||51
9717518|NCT00004092|10816723|FG000|COMPLETED|Overall Study||21
9717519|NCT00004092|10816724|FG001|COMPLETED|Overall Study||51
10194982|NCT03340883|11323412|FG001|COMPLETED|Overall Study||3
10194983|NCT03340883|11323413|FG002|COMPLETED|Overall Study||4
10194984|NCT03340883|11323414|FG003|COMPLETED|Overall Study||4
10194985|NCT03340883|11323415|FG004|COMPLETED|Overall Study||3
10194986|NCT03340883|11323416|FG005|COMPLETED|Overall Study||3
10194987|NCT03340883|11323411|FG000|NOT COMPLETED|Overall Study||0
10194988|NCT03340883|11323412|FG001|NOT COMPLETED|Overall Study||0
10194989|NCT03340883|11323413|FG002|NOT COMPLETED|Overall Study||0
10194990|NCT03340883|11323414|FG003|NOT COMPLETED|Overall Study||0
10194991|NCT03340883|11323415|FG004|NOT COMPLETED|Overall Study||0
10194992|NCT03340883|11323416|FG005|NOT COMPLETED|Overall Study||0
10194993|NCT03340961|11323434|FG000|STARTED|Overall Study||53
10194994|NCT03340961|11323435|FG001|STARTED|Overall Study||50
10194995|NCT03340961|11323436|FG002|STARTED|Overall Study||49
10194996|NCT03340961|11323437|FG003|STARTED|Overall Study||53
10194997|NCT03340961|11323434|FG000|COMPLETED|Overall Study||47
10194998|NCT03340961|11323435|FG001|COMPLETED|Overall Study||38
10194999|NCT03340961|11323436|FG002|COMPLETED|Overall Study||40
10195000|NCT03340961|11323437|FG003|COMPLETED|Overall Study||35
10195001|NCT03340961|11323434|FG000|NOT COMPLETED|Overall Study||6
10195002|NCT03340961|11323435|FG001|NOT COMPLETED|Overall Study||12
10195003|NCT03340961|11323436|FG002|NOT COMPLETED|Overall Study||9
10195004|NCT03340961|11323437|FG003|NOT COMPLETED|Overall Study||18
10195005|NCT03341273|11323449|FG000|STARTED|Overall Study||249
10195006|NCT03341273|11323450|FG001|STARTED|Overall Study||250
10195007|NCT03341273|11323449|FG000|COMPLETED|Overall Study||229
10195008|NCT03341273|11323450|FG001|COMPLETED|Overall Study||238
10195009|NCT03341273|11323449|FG000|NOT COMPLETED|Overall Study||20
10195010|NCT03341273|11323450|FG001|NOT COMPLETED|Overall Study||12
10195011|NCT03341299|11323456|FG000|STARTED|Period 1||9
10195012|NCT03341299|11323457|FG001|STARTED|Period 1||9
10195013|NCT03341299|11323458|FG002|STARTED|Period 1||9
10195014|NCT03341299|11323459|FG003|STARTED|Period 1||9
10195015|NCT03341299|11323456|FG000|COMPLETED|Period 1||9
10195016|NCT03341299|11323457|FG001|COMPLETED|Period 1||9
10195017|NCT03341299|11323458|FG002|COMPLETED|Period 1||9
10195018|NCT03341299|11323459|FG003|COMPLETED|Period 1||9
10195019|NCT03341299|11323456|FG000|NOT COMPLETED|Period 1||0
10195020|NCT03341299|11323457|FG001|NOT COMPLETED|Period 1||0
10195021|NCT03341299|11323458|FG002|NOT COMPLETED|Period 1||0
10195022|NCT03341299|11323459|FG003|NOT COMPLETED|Period 1||0
10195023|NCT03341299|11323456|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
10195024|NCT03341299|11323457|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
10195025|NCT03341299|11323458|FG002|STARTED|Washout (A Minimum of 21 Hours)||9
10195026|NCT03341299|11323459|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
10195027|NCT03341299|11323456|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195028|NCT03341299|11323457|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195029|NCT03341299|11323458|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
10195030|NCT03341299|11323459|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
9717520|NCT00004092|10816723|FG000|NOT COMPLETED|Overall Study||0
9717521|NCT00004092|10816724|FG001|NOT COMPLETED|Overall Study||0
9717522|NCT00004124|10816732|FG000|STARTED|Overall Study||481
10195031|NCT03341299|11323456|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195032|NCT03341299|11323457|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195033|NCT03341299|11323458|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
10195034|NCT03341299|11323459|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195035|NCT03341299|11323456|FG000|STARTED|Period 2||9
10195036|NCT03341299|11323457|FG001|STARTED|Period 2||9
10195037|NCT03341299|11323458|FG002|STARTED|Period 2||8
10195038|NCT03341299|11323459|FG003|STARTED|Period 2||9
10195039|NCT03341299|11323456|FG000|COMPLETED|Period 2||9
10195040|NCT03341299|11323457|FG001|COMPLETED|Period 2||9
10195041|NCT03341299|11323458|FG002|COMPLETED|Period 2||8
10195042|NCT03341299|11323459|FG003|COMPLETED|Period 2||9
10195043|NCT03341299|11323456|FG000|NOT COMPLETED|Period 2||0
10195044|NCT03341299|11323457|FG001|NOT COMPLETED|Period 2||0
10195045|NCT03341299|11323458|FG002|NOT COMPLETED|Period 2||0
10195046|NCT03341299|11323459|FG003|NOT COMPLETED|Period 2||0
10195047|NCT03341299|11323456|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
10195048|NCT03341299|11323457|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
10195049|NCT03341299|11323458|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
10195050|NCT03341299|11323459|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
10195051|NCT03341299|11323456|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195052|NCT03341299|11323457|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195053|NCT03341299|11323458|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
10195054|NCT03341299|11323459|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195055|NCT03341299|11323456|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195056|NCT03341299|11323457|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195057|NCT03341299|11323458|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195058|NCT03341299|11323459|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195059|NCT03341299|11323456|FG000|STARTED|Period 3||9
10195060|NCT03341299|11323457|FG001|STARTED|Period 3||9
10195061|NCT03341299|11323458|FG002|STARTED|Period 3||8
10195062|NCT03341299|11323459|FG003|STARTED|Period 3||9
10195063|NCT03341299|11323456|FG000|COMPLETED|Period 3||9
10195064|NCT03341299|11323457|FG001|COMPLETED|Period 3||9
10195065|NCT03341299|11323458|FG002|COMPLETED|Period 3||8
10195066|NCT03341299|11323459|FG003|COMPLETED|Period 3||9
10195067|NCT03341299|11323456|FG000|NOT COMPLETED|Period 3||0
10195068|NCT03341299|11323457|FG001|NOT COMPLETED|Period 3||0
10195069|NCT03341299|11323458|FG002|NOT COMPLETED|Period 3||0
10195070|NCT03341299|11323459|FG003|NOT COMPLETED|Period 3||0
10195071|NCT03341299|11323456|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
10195072|NCT03341299|11323457|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
10195073|NCT03341299|11323458|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
10195074|NCT03341299|11323459|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
10195075|NCT03341299|11323456|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195076|NCT03341299|11323457|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195077|NCT03341299|11323458|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
10195078|NCT03341299|11323459|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
10195079|NCT03341299|11323456|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195080|NCT03341299|11323457|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195081|NCT03341299|11323458|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195082|NCT03341299|11323459|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10195083|NCT03341299|11323456|FG000|STARTED|Period 4||9
10195084|NCT03341299|11323457|FG001|STARTED|Period 4||9
10195085|NCT03341299|11323458|FG002|STARTED|Period 4||8
10195086|NCT03341299|11323459|FG003|STARTED|Period 4||9
10195087|NCT03341299|11323456|FG000|COMPLETED|Period 4||9
10195088|NCT03341299|11323457|FG001|COMPLETED|Period 4||9
10195089|NCT03341299|11323458|FG002|COMPLETED|Period 4||8
10195090|NCT03341299|11323459|FG003|COMPLETED|Period 4||9
10195091|NCT03341299|11323456|FG000|NOT COMPLETED|Period 4||0
10195092|NCT03341299|11323457|FG001|NOT COMPLETED|Period 4||0
10195093|NCT03341299|11323458|FG002|NOT COMPLETED|Period 4||0
10195094|NCT03341299|11323459|FG003|NOT COMPLETED|Period 4||0
10195095|NCT03341312|11323471|FG000|STARTED|Period 1||9
10195096|NCT03341312|11323472|FG001|STARTED|Period 1||10
10195097|NCT03341312|11323473|FG002|STARTED|Period 1||9
10195098|NCT03341312|11323474|FG003|STARTED|Period 1||8
10195099|NCT03341312|11323471|FG000|Received at Least One Dose of Study Drug|Period 1||9
10195100|NCT03341312|11323472|FG001|Received at Least One Dose of Study Drug|Period 1||10
10195101|NCT03341312|11323473|FG002|Received at Least One Dose of Study Drug|Period 1||9
10195102|NCT03341312|11323474|FG003|Received at Least One Dose of Study Drug|Period 1||8
10195103|NCT03341312|11323471|FG000|COMPLETED|Period 1||9
10195104|NCT03341312|11323472|FG001|COMPLETED|Period 1||9
10195105|NCT03341312|11323473|FG002|COMPLETED|Period 1||9
10195106|NCT03341312|11323474|FG003|COMPLETED|Period 1||8
10195107|NCT03341312|11323471|FG000|NOT COMPLETED|Period 1||0
10195108|NCT03341312|11323472|FG001|NOT COMPLETED|Period 1||1
10195109|NCT03341312|11323473|FG002|NOT COMPLETED|Period 1||0
10195110|NCT03341312|11323474|FG003|NOT COMPLETED|Period 1||0
10195111|NCT03341312|11323471|FG000|STARTED|Period 2||9
10195112|NCT03341312|11323472|FG001|STARTED|Period 2||9
10195113|NCT03341312|11323473|FG002|STARTED|Period 2||9
10195114|NCT03341312|11323474|FG003|STARTED|Period 2||8
10195115|NCT03341312|11323471|FG000|COMPLETED|Period 2||9
10195116|NCT03341312|11323472|FG001|COMPLETED|Period 2||9
10195117|NCT03341312|11323473|FG002|COMPLETED|Period 2||9
10195118|NCT03341312|11323474|FG003|COMPLETED|Period 2||8
10195119|NCT03341312|11323471|FG000|NOT COMPLETED|Period 2||0
10195120|NCT03341312|11323472|FG001|NOT COMPLETED|Period 2||0
10195121|NCT03341312|11323473|FG002|NOT COMPLETED|Period 2||0
10195122|NCT03341312|11323474|FG003|NOT COMPLETED|Period 2||0
10195123|NCT03341312|11323471|FG000|STARTED|Period 3||9
10195124|NCT03341312|11323472|FG001|STARTED|Period 3||9
10195125|NCT03341312|11323473|FG002|STARTED|Period 3||9
10195126|NCT03341312|11323474|FG003|STARTED|Period 3||8
10195127|NCT03341312|11323471|FG000|COMPLETED|Period 3||9
10195128|NCT03341312|11323472|FG001|COMPLETED|Period 3||9
10195129|NCT03341312|11323473|FG002|COMPLETED|Period 3||9
10195130|NCT03341312|11323474|FG003|COMPLETED|Period 3||8
10195131|NCT03341312|11323471|FG000|NOT COMPLETED|Period 3||0
10195132|NCT03341312|11323472|FG001|NOT COMPLETED|Period 3||0
10195133|NCT03341312|11323473|FG002|NOT COMPLETED|Period 3||0
10195134|NCT03341312|11323474|FG003|NOT COMPLETED|Period 3||0
10195135|NCT03341312|11323471|FG000|STARTED|Period 4||9
10195136|NCT03341312|11323472|FG001|STARTED|Period 4||9
10195137|NCT03341312|11323473|FG002|STARTED|Period 4||9
10195138|NCT03341312|11323474|FG003|STARTED|Period 4||8
10195139|NCT03341312|11323471|FG000|COMPLETED|Period 4||9
10195140|NCT03341312|11323472|FG001|COMPLETED|Period 4||9
10195141|NCT03341312|11323473|FG002|COMPLETED|Period 4||9
10195142|NCT03341312|11323474|FG003|COMPLETED|Period 4||8
10195143|NCT03341312|11323471|FG000|NOT COMPLETED|Period 4||0
10195144|NCT03341312|11323472|FG001|NOT COMPLETED|Period 4||0
10195145|NCT03341312|11323473|FG002|NOT COMPLETED|Period 4||0
10195146|NCT03341312|11323474|FG003|NOT COMPLETED|Period 4||0
10195147|NCT03341507|11323486|FG000|STARTED|Overall Study||64
10195148|NCT03341507|11323486|FG000|COMPLETED|Overall Study||30
10195149|NCT03341507|11323486|FG000|NOT COMPLETED|Overall Study||34
10195150|NCT03341533|11323492|FG000|STARTED|Overall Study||72
10195151|NCT03341533|11323493|FG001|STARTED|Overall Study||70
10195152|NCT03341533|11323492|FG000|COMPLETED|Overall Study||69
10195153|NCT03341533|11323493|FG001|COMPLETED|Overall Study||68
10195154|NCT03341533|11323492|FG000|NOT COMPLETED|Overall Study||3
10195155|NCT03341533|11323493|FG001|NOT COMPLETED|Overall Study||2
10195156|NCT03341546|11323499|FG000|STARTED|Overall Study||20
10195157|NCT03341546|11323499|FG000|COMPLETED|Overall Study||20
10195158|NCT03341546|11323499|FG000|NOT COMPLETED|Overall Study||0
10195159|NCT03341637|11323505|FG000|STARTED|Overall Study||100
10195160|NCT03341637|11323506|FG001|STARTED|Overall Study||300
10195161|NCT03341637|11323505|FG000|COMPLETED|Overall Study||95
10195162|NCT03341637|11323506|FG001|COMPLETED|Overall Study||296
10195163|NCT03341637|11323505|FG000|NOT COMPLETED|Overall Study||5
10195164|NCT03341637|11323506|FG001|NOT COMPLETED|Overall Study||4
10195165|NCT03341728|11323512|FG000|STARTED|Session 1||7
10195166|NCT03341728|11323513|FG001|STARTED|Session 1||7
10195167|NCT03341728|11323512|FG000|COMPLETED|Session 1||7
10195168|NCT03341728|11323513|FG001|COMPLETED|Session 1||7
10195169|NCT03341728|11323512|FG000|NOT COMPLETED|Session 1||0
10195170|NCT03341728|11323513|FG001|NOT COMPLETED|Session 1||0
10195171|NCT03341728|11323512|FG000|STARTED|Washout (1 Week)||7
10195172|NCT03341728|11323513|FG001|STARTED|Washout (1 Week)||7
10195173|NCT03341728|11323512|FG000|COMPLETED|Washout (1 Week)||7
10195174|NCT03341728|11323513|FG001|COMPLETED|Washout (1 Week)||7
10195175|NCT03341728|11323512|FG000|NOT COMPLETED|Washout (1 Week)||0
10195176|NCT03341728|11323513|FG001|NOT COMPLETED|Washout (1 Week)||0
10195177|NCT03341728|11323512|FG000|STARTED|Session 2||7
10195178|NCT03341728|11323513|FG001|STARTED|Session 2||7
10195179|NCT03341728|11323512|FG000|COMPLETED|Session 2||7
10195180|NCT03341728|11323513|FG001|COMPLETED|Session 2||7
10195181|NCT03341728|11323512|FG000|NOT COMPLETED|Session 2||0
10195182|NCT03341728|11323513|FG001|NOT COMPLETED|Session 2||0
10195183|NCT03341910|11323523|FG000|STARTED|Overall Study||54
10195184|NCT03341910|11323524|FG001|STARTED|Overall Study||49
10195185|NCT03341910|11323525|FG002|STARTED|Overall Study||26
10195186|NCT03341910|11323526|FG003|STARTED|Overall Study||26
10195187|NCT03341910|11323523|FG000|COMPLETED|Overall Study||54
10195188|NCT03341910|11323524|FG001|COMPLETED|Overall Study||49
10195189|NCT03341910|11323525|FG002|COMPLETED|Overall Study||26
10195190|NCT03341910|11323526|FG003|COMPLETED|Overall Study||26
10195191|NCT03341910|11323523|FG000|NOT COMPLETED|Overall Study||0
10195192|NCT03341910|11323524|FG001|NOT COMPLETED|Overall Study||0
10195193|NCT03341910|11323525|FG002|NOT COMPLETED|Overall Study||0
10195194|NCT03341910|11323526|FG003|NOT COMPLETED|Overall Study||0
10195195|NCT03341923|11323536|FG000|STARTED|Period 1, First 14 Days of Wear||67
10195196|NCT03341923|11323537|FG001|STARTED|Period 1, First 14 Days of Wear||67
10195197|NCT03341923|11323536|FG000|COMPLETED|Period 1, First 14 Days of Wear||67
10195198|NCT03341923|11323537|FG001|COMPLETED|Period 1, First 14 Days of Wear||67
10195199|NCT03341923|11323536|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
10195200|NCT03341923|11323537|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0
10195201|NCT03341923|11323536|FG000|STARTED|Period 2, Second 14 Days of Wear||67
10195202|NCT03341923|11323537|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
10195203|NCT03341923|11323536|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67
10195204|NCT03341923|11323537|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65
10195205|NCT03341923|11323536|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10195206|NCT03341923|11323537|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
10195207|NCT03341975|11323547|FG000|STARTED|Overall Study||44
10195208|NCT03341975|11323548|FG001|STARTED|Overall Study||47
10195209|NCT03341975|11323547|FG000|COMPLETED|Overall Study||44
10195210|NCT03341975|11323548|FG001|COMPLETED|Overall Study||47
10195211|NCT03341975|11323547|FG000|NOT COMPLETED|Overall Study||0
10195212|NCT03341975|11323548|FG001|NOT COMPLETED|Overall Study||0
10195213|NCT03342404|11323556|FG000|STARTED|Overall Study||96
10195214|NCT03342404|11323557|FG001|STARTED|Overall Study||49
10195215|NCT03342404|11323556|FG000|COMPLETED|Overall Study||81
10195216|NCT03342404|11323557|FG001|COMPLETED|Overall Study||18
10195217|NCT03342404|11323556|FG000|NOT COMPLETED|Overall Study||15
10195218|NCT03342404|11323557|FG001|NOT COMPLETED|Overall Study||31
10195219|NCT03342469|11323565|FG000|STARTED|Overall Study||9
10195220|NCT03342469|11323566|FG001|STARTED|Overall Study||9
10195221|NCT03342469|11323567|FG002|STARTED|Overall Study||3
10195222|NCT03342469|11323568|FG003|STARTED|Overall Study||8
10195223|NCT03342469|11323565|FG000|COMPLETED|Overall Study||9
10195224|NCT03342469|11323566|FG001|COMPLETED|Overall Study||8
10195225|NCT03342469|11323567|FG002|COMPLETED|Overall Study||3
10195226|NCT03342469|11323568|FG003|COMPLETED|Overall Study||8
10195227|NCT03342469|11323565|FG000|NOT COMPLETED|Overall Study||0
10195228|NCT03342469|11323566|FG001|NOT COMPLETED|Overall Study||1
10195229|NCT03342469|11323567|FG002|NOT COMPLETED|Overall Study||0
10195230|NCT03342469|11323568|FG003|NOT COMPLETED|Overall Study||0
10195231|NCT03342560|11323579|FG000|STARTED|Overall Study||30
10195232|NCT03342560|11323579|FG000|COMPLETED|Overall Study||28
10195233|NCT03342560|11323579|FG000|NOT COMPLETED|Overall Study||2
10195234|NCT03342690|11323587|FG000|STARTED|Overall Study||1164
10195235|NCT03342690|11323587|FG000|COMPLETED|Overall Study||1139
10195236|NCT03342690|11323587|FG000|NOT COMPLETED|Overall Study||25
10195237|NCT03342898|11323594|FG000|STARTED|Overall Study||300
10195238|NCT03342898|11323595|FG001|STARTED|Overall Study||300
10195239|NCT03342898|11323596|FG002|STARTED|Overall Study||300
10195240|NCT03342898|11323594|FG000|COMPLETED|Overall Study||246
10195241|NCT03342898|11323595|FG001|COMPLETED|Overall Study||247
10195242|NCT03342898|11323596|FG002|COMPLETED|Overall Study||246
10195243|NCT03342898|11323594|FG000|NOT COMPLETED|Overall Study||54
10195244|NCT03342898|11323595|FG001|NOT COMPLETED|Overall Study||53
10195245|NCT03342898|11323596|FG002|NOT COMPLETED|Overall Study||54
10195246|NCT03342963|11323608|FG000|STARTED|Overall Study||27
10195247|NCT03342963|11323609|FG001|STARTED|Overall Study||27
10195248|NCT03342963|11323610|FG002|STARTED|Overall Study||10
10195249|NCT03342963|11323611|FG003|STARTED|Overall Study||10
10195250|NCT03342963|11323608|FG000|COMPLETED|Overall Study||25
10195251|NCT03342963|11323609|FG001|COMPLETED|Overall Study||25
10195252|NCT03342963|11323610|FG002|COMPLETED|Overall Study||10
10195253|NCT03342963|11323611|FG003|COMPLETED|Overall Study||10
10195254|NCT03342963|11323608|FG000|NOT COMPLETED|Overall Study||2
10195255|NCT03342963|11323609|FG001|NOT COMPLETED|Overall Study||2
10195256|NCT03342963|11323610|FG002|NOT COMPLETED|Overall Study||0
10195257|NCT03342963|11323611|FG003|NOT COMPLETED|Overall Study||0
10195258|NCT03343067|11323624|FG000|STARTED|Open Label Period: Day 1 to Month 3||7
10195259|NCT03343067|11323625|FG001|STARTED|Open Label Period: Day 1 to Month 3||3
10195260|NCT03343067|11323626|FG002|STARTED|Open Label Period: Day 1 to Month 3||1
10195261|NCT03343067|11323624|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0
10195262|NCT03343067|11323625|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3
10195263|NCT03343067|11323626|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1
10195264|NCT03343067|11323624|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
10195265|NCT03343067|11323625|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
10195266|NCT03343067|11323626|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
10195267|NCT03343067|11323624|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0
10195268|NCT03343067|11323625|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3
10195269|NCT03343067|11323626|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1
10195270|NCT03343067|11323624|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0
10195271|NCT03343067|11323625|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0
10195272|NCT03343067|11323626|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0
10195273|NCT03343067|11323624|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
10195274|NCT03343067|11323625|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
10195275|NCT03343067|11323626|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
10195276|NCT03343080|11323636|FG000|STARTED|Overall Study||14
10195277|NCT03343080|11323637|FG001|STARTED|Overall Study||18
10195278|NCT03343080|11323636|FG000|COMPLETED|Overall Study||14
10195279|NCT03343080|11323637|FG001|COMPLETED|Overall Study||18
10195280|NCT03343080|11323636|FG000|NOT COMPLETED|Overall Study||0
10195281|NCT03343080|11323637|FG001|NOT COMPLETED|Overall Study||0
10195282|NCT03343639|11323645|FG000|STARTED|Overall Study||102
10195283|NCT03343639|11323646|FG001|STARTED|Overall Study||102
10195284|NCT03343639|11323645|FG000|COMPLETED|Overall Study||88
10195285|NCT03343639|11323646|FG001|COMPLETED|Overall Study||90
10195286|NCT03343639|11323645|FG000|NOT COMPLETED|Overall Study||14
10195287|NCT03343639|11323646|FG001|NOT COMPLETED|Overall Study||12
10195288|NCT03344172|11323654|FG000|STARTED|Overall Study||16
10195289|NCT03344172|11323655|FG001|STARTED|Overall Study||16
10195290|NCT03344172|11323654|FG000|COMPLETED|Overall Study||15
10195291|NCT03344172|11323655|FG001|COMPLETED|Overall Study||16
10195292|NCT03344172|11323654|FG000|NOT COMPLETED|Overall Study||1
10195293|NCT03344172|11323655|FG001|NOT COMPLETED|Overall Study||0
10195294|NCT03344510|11323661|FG000|STARTED|First Injection (5 Minutes)||21
10195295|NCT03344510|11323662|FG001|STARTED|First Injection (5 Minutes)||26
10195296|NCT03344510|11323661|FG000|Received Injection|First Injection (5 Minutes)||21
10195297|NCT03344510|11323662|FG001|Received Injection|First Injection (5 Minutes)||26
10195298|NCT03344510|11323661|FG000|COMPLETED|First Injection (5 Minutes)||21
10195299|NCT03344510|11323662|FG001|COMPLETED|First Injection (5 Minutes)||26
10195300|NCT03344510|11323661|FG000|NOT COMPLETED|First Injection (5 Minutes)||0
10195301|NCT03344510|11323662|FG001|NOT COMPLETED|First Injection (5 Minutes)||0
10195302|NCT03344510|11323661|FG000|STARTED|Wash Out (10 Minutes||21
10195303|NCT03344510|11323662|FG001|STARTED|Wash Out (10 Minutes||26
10195304|NCT03344510|11323661|FG000|COMPLETED|Wash Out (10 Minutes||21
10195305|NCT03344510|11323662|FG001|COMPLETED|Wash Out (10 Minutes||26
10195306|NCT03344510|11323661|FG000|NOT COMPLETED|Wash Out (10 Minutes||0
10195307|NCT03344510|11323662|FG001|NOT COMPLETED|Wash Out (10 Minutes||0
10195308|NCT03344510|11323661|FG000|STARTED|Second Injection (5 Minutes)||21
10195309|NCT03344510|11323662|FG001|STARTED|Second Injection (5 Minutes)||26
10195310|NCT03344510|11323661|FG000|Received Injection|Second Injection (5 Minutes)||21
10195311|NCT03344510|11323662|FG001|Received Injection|Second Injection (5 Minutes)||26
10195312|NCT03344510|11323661|FG000|COMPLETED|Second Injection (5 Minutes)||21
10195313|NCT03344510|11323662|FG001|COMPLETED|Second Injection (5 Minutes)||26
10195314|NCT03344510|11323661|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0
10195315|NCT03344510|11323662|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0
10195316|NCT03344640|11323671|FG000|STARTED|Overall Study||49
10195317|NCT03344640|11323672|FG001|STARTED|Overall Study||47
10195318|NCT03344640|11323671|FG000|COMPLETED|Overall Study||46
10195319|NCT03344640|11323672|FG001|COMPLETED|Overall Study||44
10195320|NCT03344640|11323671|FG000|NOT COMPLETED|Overall Study||3
10195321|NCT03344640|11323672|FG001|NOT COMPLETED|Overall Study||3
10195322|NCT03344640|11323671|FG000|STARTED|Follow-up Epoch||46
10195323|NCT03344640|11323672|FG001|STARTED|Follow-up Epoch||44
10195324|NCT03344640|11323671|FG000|COMPLETED|Follow-up Epoch||46
10195325|NCT03344640|11323672|FG001|COMPLETED|Follow-up Epoch||42
10195326|NCT03344640|11323671|FG000|NOT COMPLETED|Follow-up Epoch||0
9717523|NCT00004124|10816733|FG001|STARTED|Overall Study||480
9717524|NCT00004124|10816732|FG000|COMPLETED|Overall Study||469
9717525|NCT00004124|10816733|FG001|COMPLETED|Overall Study||460
9717526|NCT00004124|10816732|FG000|NOT COMPLETED|Overall Study||12
9717527|NCT00004124|10816733|FG001|NOT COMPLETED|Overall Study||20
9717528|NCT00004143|10816739|FG000|STARTED|Overall Study||2
9717529|NCT00004143|10816739|FG000|COMPLETED|Overall Study||2
9717530|NCT00004143|10816739|FG000|NOT COMPLETED|Overall Study||0
9717531|NCT00004146|10816743|FG000|STARTED|Overall Study||55
9717532|NCT00004146|10816743|FG000|COMPLETED|Overall Study||55
9717533|NCT00004146|10816743|FG000|NOT COMPLETED|Overall Study||0
9717534|NCT00004228|10816756|FG000|STARTED|Overall Study||60
9717535|NCT00004228|10816757|FG001|STARTED|Overall Study||66
9717536|NCT00004228|10816758|FG002|STARTED|Overall Study||65
9717537|NCT00004228|10816759|FG003|STARTED|Overall Study||13
9717538|NCT00004228|10816760|FG004|STARTED|Overall Study||67
9717539|NCT00004228|10816761|FG005|STARTED|Overall Study||65
9717540|NCT00004228|10816762|FG006|STARTED|Overall Study||57
9717541|NCT00004228|10816756|FG000|COMPLETED|Overall Study||51
9717542|NCT00004228|10816757|FG001|COMPLETED|Overall Study||51
9717543|NCT00004228|10816758|FG002|COMPLETED|Overall Study||46
9717544|NCT00004228|10816759|FG003|COMPLETED|Overall Study||6
9717545|NCT00004228|10816760|FG004|COMPLETED|Overall Study||51
9717546|NCT00004228|10816761|FG005|COMPLETED|Overall Study||51
9717547|NCT00004228|10816762|FG006|COMPLETED|Overall Study||45
9717548|NCT00004228|10816756|FG000|NOT COMPLETED|Overall Study||9
9717549|NCT00004228|10816757|FG001|NOT COMPLETED|Overall Study||15
9717550|NCT00004228|10816758|FG002|NOT COMPLETED|Overall Study||19
9717551|NCT00004228|10816759|FG003|NOT COMPLETED|Overall Study||7
9717552|NCT00004228|10816760|FG004|NOT COMPLETED|Overall Study||16
9717553|NCT00004228|10816761|FG005|NOT COMPLETED|Overall Study||14
9717554|NCT00004228|10816762|FG006|NOT COMPLETED|Overall Study||12
9717555|NCT00004259|10816783|FG000|STARTED|Overall Study||98
9717556|NCT00004259|10816784|FG001|STARTED|Overall Study||103
9717557|NCT00004259|10816785|FG002|STARTED|Overall Study||15
9717558|NCT00004259|10816786|FG003|STARTED|Overall Study||14
9717559|NCT00004259|10816783|FG000|COMPLETED|Overall Study||97
9717560|NCT00004259|10816784|FG001|COMPLETED|Overall Study||99
9717561|NCT00004259|10816785|FG002|COMPLETED|Overall Study||15
9717562|NCT00004259|10816786|FG003|COMPLETED|Overall Study||14
9717563|NCT00004259|10816783|FG000|NOT COMPLETED|Overall Study||1
9717564|NCT00004259|10816784|FG001|NOT COMPLETED|Overall Study||4
9717565|NCT00004259|10816785|FG002|NOT COMPLETED|Overall Study||0
9717566|NCT00004259|10816786|FG003|NOT COMPLETED|Overall Study||0
9717567|NCT00004412|10816802|FG000|STARTED|Randomized Period||11
9717568|NCT00004412|10816803|FG001|STARTED|Randomized Period||12
9717569|NCT00004412|10816804|FG002|STARTED|Randomized Period||0
9717570|NCT00004412|10816802|FG000|COMPLETED|Randomized Period||8
9717571|NCT00004412|10816803|FG001|COMPLETED|Randomized Period||12
9717572|NCT00004412|10816804|FG002|COMPLETED|Randomized Period||0
9717573|NCT00004412|10816802|FG000|NOT COMPLETED|Randomized Period||3
9717574|NCT00004412|10816803|FG001|NOT COMPLETED|Randomized Period||0
9717575|NCT00004412|10816804|FG002|NOT COMPLETED|Randomized Period||0
9717576|NCT00004412|10816802|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
9731957|NCT00138203|10831947|FG000|STARTED|Overall Study||16
10195327|NCT03344640|11323672|FG001|NOT COMPLETED|Follow-up Epoch||2
9717577|NCT00004412|10816803|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
9717578|NCT00004412|10816804|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
9717579|NCT00004412|10816802|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
9717580|NCT00004412|10816803|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
9717581|NCT00004412|10816804|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
9717582|NCT00004412|10816802|FG000|NOT COMPLETED|Crossover Period||0
9717583|NCT00004412|10816803|FG001|NOT COMPLETED|Crossover Period||0
9717584|NCT00004412|10816804|FG002|NOT COMPLETED|Crossover Period||0
9717585|NCT00004418|10816810|FG000|STARTED|Overall Study||126
9717586|NCT00004418|10816810|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
9717587|NCT00004418|10816810|FG000|NOT COMPLETED|Overall Study||0
9717588|NCT00004445|10816814|FG000|STARTED|Overall Study||18
9717589|NCT00004445|10816814|FG000|COMPLETED|Overall Study||15
9717590|NCT00004445|10816814|FG000|NOT COMPLETED|Overall Study||3
9717591|NCT00004500|10816820|FG000|STARTED|Overall Study||38
9717592|NCT00004500|10816821|FG001|STARTED|Overall Study||31
9717593|NCT00004500|10816820|FG000|1 Year Follow-Up|Overall Study||24
9717594|NCT00004500|10816821|FG001|1 Year Follow-Up|Overall Study||24
9717595|NCT00004500|10816820|FG000|COMPLETED|Overall Study||38
9717596|NCT00004500|10816821|FG001|COMPLETED|Overall Study||31
9717597|NCT00004500|10816820|FG000|NOT COMPLETED|Overall Study||0
9717598|NCT00004500|10816821|FG001|NOT COMPLETED|Overall Study||0
9717599|NCT00004547|10816830|FG000|STARTED|Overall Study||83
9717600|NCT00004547|10816831|FG001|STARTED|Overall Study||48
9717601|NCT00004547|10816832|FG002|STARTED|Overall Study||57
9717602|NCT00004547|10816830|FG000|Not Evaluable|Overall Study||21
9717603|NCT00004547|10816831|FG001|Not Evaluable|Overall Study||9
9717604|NCT00004547|10816832|FG002|Not Evaluable|Overall Study||23
9717605|NCT00004547|10816830|FG000|COMPLETED|Overall Study||61
9717606|NCT00004547|10816831|FG001|COMPLETED|Overall Study||39
9717607|NCT00004547|10816832|FG002|COMPLETED|Overall Study||35
9717608|NCT00004547|10816830|FG000|NOT COMPLETED|Overall Study||22
9717609|NCT00004547|10816831|FG001|NOT COMPLETED|Overall Study||9
9717610|NCT00004547|10816832|FG002|NOT COMPLETED|Overall Study||22
9717611|NCT00004562|10816843|FG000|STARTED|Overall Study||1101
9717612|NCT00004562|10816844|FG001|STARTED|Overall Study||1100
9717613|NCT00004562|10816843|FG000|COMPLETED|Overall Study||999
9717614|NCT00004562|10816844|FG001|COMPLETED|Overall Study||1009
9717615|NCT00004562|10816843|FG000|NOT COMPLETED|Overall Study||102
9717616|NCT00004562|10816844|FG001|NOT COMPLETED|Overall Study||91
9717617|NCT00004563|10816852|FG000|STARTED|Overall Study||79
9717618|NCT00004563|10816853|FG001|STARTED|Overall Study||79
9717619|NCT00004563|10816852|FG000|COMPLETED|Overall Study||54
9717620|NCT00004563|10816853|FG001|COMPLETED|Overall Study||55
9717621|NCT00004563|10816852|FG000|NOT COMPLETED|Overall Study||25
9717622|NCT00004563|10816853|FG001|NOT COMPLETED|Overall Study||24
9717623|NCT00004635|10816861|FG000|STARTED|Period One||79
9717624|NCT00004635|10816862|FG001|STARTED|Period One||80
9717625|NCT00004635|10816861|FG000|Received Treatment|Period One||73
9717626|NCT00004635|10816862|FG001|Received Treatment|Period One||75
9717627|NCT00004635|10816861|FG000|COMPLETED|Period One||73
9717628|NCT00004635|10816862|FG001|COMPLETED|Period One||74
9717629|NCT00004635|10816861|FG000|NOT COMPLETED|Period One||6
9717630|NCT00004635|10816862|FG001|NOT COMPLETED|Period One||6
9717631|NCT00004635|10816861|FG000|STARTED|Period Two||44
9717632|NCT00004635|10816862|FG001|STARTED|Period Two||59
9717633|NCT00004635|10816861|FG000|COMPLETED|Period Two||38
9717634|NCT00004635|10816862|FG001|COMPLETED|Period Two||50
9717635|NCT00004635|10816861|FG000|NOT COMPLETED|Period Two||6
9717636|NCT00004635|10816862|FG001|NOT COMPLETED|Period Two||9
9717637|NCT00004732|10816873|FG000|STARTED|Overall Study||1262
9717638|NCT00004732|10816874|FG001|STARTED|Overall Study||1240
9717639|NCT00004732|10816873|FG000|COMPLETED|Overall Study||1193
9717640|NCT00004732|10816874|FG001|COMPLETED|Overall Study||1129
9717641|NCT00004732|10816873|FG000|NOT COMPLETED|Overall Study||69
9717642|NCT00004732|10816874|FG001|NOT COMPLETED|Overall Study||111
9717643|NCT00004859|10816884|FG000|STARTED|Overall Study||295
9717644|NCT00004859|10816885|FG001|STARTED|Overall Study||294
9717645|NCT00004859|10816884|FG000|Eligible|Overall Study||275
9717646|NCT00004859|10816885|FG001|Eligible|Overall Study||271
9717647|NCT00004859|10816884|FG000|Treated|Overall Study||289
9717648|NCT00004859|10816885|FG001|Treated|Overall Study||289
9717649|NCT00004859|10816884|FG000|Treated and Having Toxicity Data|Overall Study||289
9717650|NCT00004859|10816885|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
9717651|NCT00004859|10816884|FG000|COMPLETED|Overall Study||177
9717652|NCT00004859|10816885|FG001|COMPLETED|Overall Study||12
9717653|NCT00004859|10816884|FG000|NOT COMPLETED|Overall Study||118
9717654|NCT00004859|10816885|FG001|NOT COMPLETED|Overall Study||282
9717655|NCT00004888|10816895|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
9717656|NCT00004888|10816896|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
9717657|NCT00004888|10816895|FG000|COMPLETED|Overall Study||27
9717658|NCT00004888|10816896|FG001|COMPLETED|Overall Study||22
9717659|NCT00004888|10816895|FG000|NOT COMPLETED|Overall Study||11
9717660|NCT00004888|10816896|FG001|NOT COMPLETED|Overall Study||24
9717661|NCT00004978|10816904|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
9717662|NCT00004978|10816905|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
9717663|NCT00004978|10816904|FG000|COMPLETED|Overall Study||1846
9717664|NCT00004978|10816905|FG001|COMPLETED|Overall Study||1790
9717665|NCT00004978|10816904|FG000|NOT COMPLETED|Overall Study||244
9717666|NCT00004978|10816905|FG001|NOT COMPLETED|Overall Study||270
9717667|NCT00004980|10816913|FG000|STARTED|Overall Study||27
9717668|NCT00004980|10816914|FG001|STARTED|Overall Study||23
9717669|NCT00004980|10816913|FG000|COMPLETED|Overall Study||25
9717670|NCT00004980|10816914|FG001|COMPLETED|Overall Study||21
9717671|NCT00004980|10816913|FG000|NOT COMPLETED|Overall Study||2
9717672|NCT00004980|10816914|FG001|NOT COMPLETED|Overall Study||2
9717673|NCT00005047|10816924|FG000|STARTED|Overall Study||58
9717674|NCT00005047|10816925|FG001|STARTED|Overall Study||56
9717675|NCT00005047|10816926|FG002|STARTED|Overall Study||227
9717676|NCT00005047|10816927|FG003|STARTED|Overall Study||158
9717677|NCT00005047|10816924|FG000|COMPLETED|Overall Study||39
9717678|NCT00005047|10816925|FG001|COMPLETED|Overall Study||56
9717679|NCT00005047|10816926|FG002|COMPLETED|Overall Study||227
9717680|NCT00005047|10816927|FG003|COMPLETED|Overall Study||158
9717681|NCT00005047|10816924|FG000|NOT COMPLETED|Overall Study||19
9717682|NCT00005047|10816925|FG001|NOT COMPLETED|Overall Study||0
9717683|NCT00005047|10816926|FG002|NOT COMPLETED|Overall Study||0
9717684|NCT00005047|10816927|FG003|NOT COMPLETED|Overall Study||0
9717685|NCT00005669|10816939|FG000|STARTED|Overall Study||53
9717686|NCT00005669|10816940|FG001|STARTED|Overall Study||47
9717687|NCT00005669|10816939|FG000|COMPLETED|Overall Study||45
9717688|NCT00005669|10816940|FG001|COMPLETED|Overall Study||40
9717689|NCT00005669|10816939|FG000|NOT COMPLETED|Overall Study||8
9717690|NCT00005669|10816940|FG001|NOT COMPLETED|Overall Study||7
9717691|NCT00005803|10816946|FG000|STARTED|Overall Study||76
9717692|NCT00005803|10816946|FG000|COMPLETED|Overall Study||54
9717693|NCT00005803|10816946|FG000|NOT COMPLETED|Overall Study||22
9717694|NCT00005879|10816955|FG000|STARTED|Overall Study||101
9717695|NCT00005879|10816956|FG001|STARTED|Overall Study||98
9717696|NCT00005879|10816955|FG000|COMPLETED|Overall Study||93
9717697|NCT00005879|10816956|FG001|COMPLETED|Overall Study||88
9717698|NCT00005879|10816955|FG000|NOT COMPLETED|Overall Study||8
9717699|NCT00005879|10816956|FG001|NOT COMPLETED|Overall Study||10
9717700|NCT00005901|10816964|FG000|STARTED|Overall Study||19
9717701|NCT00005901|10816965|FG001|STARTED|Overall Study||15
9717702|NCT00005901|10816964|FG000|COMPLETED|Overall Study||19
9717703|NCT00005901|10816965|FG001|COMPLETED|Overall Study||15
9717704|NCT00005901|10816964|FG000|NOT COMPLETED|Overall Study||0
9717705|NCT00005901|10816965|FG001|NOT COMPLETED|Overall Study||0
9717706|NCT00005906|10816971|FG000|STARTED|Overall Study||4
9717707|NCT00005906|10816971|FG000|COMPLETED|Overall Study||1
9717708|NCT00005906|10816971|FG000|NOT COMPLETED|Overall Study||3
9717709|NCT00005908|10816975|FG000|STARTED|Overall Study||10
9717710|NCT00005908|10816976|FG001|STARTED|Overall Study||20
9717711|NCT00005908|10816975|FG000|COMPLETED|Overall Study||9
9717712|NCT00005908|10816976|FG001|COMPLETED|Overall Study||20
9717713|NCT00005908|10816975|FG000|NOT COMPLETED|Overall Study||1
9717714|NCT00005908|10816976|FG001|NOT COMPLETED|Overall Study||0
9717715|NCT00005937|10816985|FG000|STARTED|Overall Study||42
9717716|NCT00005937|10816985|FG000|COMPLETED|Overall Study||37
9717717|NCT00005937|10816985|FG000|NOT COMPLETED|Overall Study||5
9717718|NCT00005947|10816991|FG000|STARTED|Overall Study||82
9717719|NCT00005947|10816992|FG001|STARTED|Overall Study||45
9717720|NCT00005947|10816991|FG000|COMPLETED|Overall Study||25
9717721|NCT00005947|10816992|FG001|COMPLETED|Overall Study||4
9717722|NCT00005947|10816991|FG000|NOT COMPLETED|Overall Study||57
9717723|NCT00005947|10816992|FG001|NOT COMPLETED|Overall Study||41
9717724|NCT00005957|10817002|FG000|STARTED|Overall Study||916
9717725|NCT00005957|10817003|FG001|STARTED|Overall Study||916
9717726|NCT00005957|10817002|FG000|COMPLETED|Overall Study||908
9850761|NCT00872170|10963472|FG001|STARTED|Overall Study||13
9850762|NCT00872170|10963471|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
9850763|NCT00872170|10963472|FG001|COMPLETED|Overall Study||13
9850764|NCT00872170|10963471|FG000|NOT COMPLETED|Overall Study||1
9850765|NCT00872170|10963472|FG001|NOT COMPLETED|Overall Study||0
9850766|NCT00872339|10963480|FG000|STARTED|Overall Study||201
9717727|NCT00005957|10817003|FG001|COMPLETED|Overall Study||888
9717728|NCT00005957|10817002|FG000|NOT COMPLETED|Overall Study||8
9717729|NCT00005957|10817003|FG001|NOT COMPLETED|Overall Study||28
9717730|NCT00006011|10817012|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
9717731|NCT00006011|10817013|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
9717732|NCT00006011|10817014|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
9717733|NCT00006011|10817012|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
9717734|NCT00006011|10817013|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
9717735|NCT00006011|10817014|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
9717736|NCT00006011|10817012|FG000|NOT COMPLETED|Overall Study||65
9717737|NCT00006011|10817013|FG001|NOT COMPLETED|Overall Study||77
9717738|NCT00006011|10817014|FG002|NOT COMPLETED|Overall Study||73
9717739|NCT00006046|10817025|FG000|STARTED|Overall Study||7
9717740|NCT00006046|10817026|FG001|STARTED|Overall Study||0
9717741|NCT00006046|10817027|FG002|STARTED|Overall Study||0
9717742|NCT00006046|10817028|FG003|STARTED|Overall Study||0
9717743|NCT00006046|10817029|FG004|STARTED|Overall Study||0
9717744|NCT00006046|10817025|FG000|COMPLETED|Overall Study||2
9717745|NCT00006046|10817026|FG001|COMPLETED|Overall Study||0
9717746|NCT00006046|10817027|FG002|COMPLETED|Overall Study||0
9717747|NCT00006046|10817028|FG003|COMPLETED|Overall Study||0
9717748|NCT00006046|10817029|FG004|COMPLETED|Overall Study||0
9717749|NCT00006046|10817025|FG000|NOT COMPLETED|Overall Study||5
9717750|NCT00006046|10817026|FG001|NOT COMPLETED|Overall Study||0
9717751|NCT00006046|10817027|FG002|NOT COMPLETED|Overall Study||0
9717752|NCT00006046|10817028|FG003|NOT COMPLETED|Overall Study||0
9717753|NCT00006046|10817029|FG004|NOT COMPLETED|Overall Study||0
9717754|NCT00006099|10817043|FG000|STARTED|Overall Study||1
9717755|NCT00006099|10817044|FG001|STARTED|Overall Study||0
9717756|NCT00006099|10817043|FG000|COMPLETED|Overall Study||1
9717757|NCT00006099|10817044|FG001|COMPLETED|Overall Study||0
9717758|NCT00006099|10817043|FG000|NOT COMPLETED|Overall Study||0
9717759|NCT00006099|10817044|FG001|NOT COMPLETED|Overall Study||0
9717760|NCT00006101|10817052|FG000|STARTED|Overall Study||38
9717761|NCT00006101|10817053|FG001|STARTED|Overall Study||38
9717762|NCT00006101|10817052|FG000|COMPLETED|Overall Study||33
9717763|NCT00006101|10817053|FG001|COMPLETED|Overall Study||33
9717764|NCT00006101|10817052|FG000|NOT COMPLETED|Overall Study||5
9717765|NCT00006101|10817053|FG001|NOT COMPLETED|Overall Study||5
9717766|NCT00006110|10817061|FG000|STARTED|Overall Study||52
9717767|NCT00006110|10817062|FG001|STARTED|Overall Study||30
9717768|NCT00006110|10817061|FG000|COMPLETED|Overall Study||52
9717769|NCT00006110|10817062|FG001|COMPLETED|Overall Study||30
9717770|NCT00006110|10817061|FG000|NOT COMPLETED|Overall Study||0
9717771|NCT00006110|10817062|FG001|NOT COMPLETED|Overall Study||0
9717772|NCT00006151|10817076|FG000|STARTED|Overall Study||30
9717773|NCT00006151|10817077|FG001|STARTED|Overall Study||30
9717774|NCT00006151|10817076|FG000|COMPLETED|Overall Study||17
9717775|NCT00006151|10817077|FG001|COMPLETED|Overall Study||16
9717776|NCT00006151|10817076|FG000|NOT COMPLETED|Overall Study||13
9717777|NCT00006151|10817077|FG001|NOT COMPLETED|Overall Study||14
9717778|NCT00006156|10817085|FG000|STARTED|Overall Study||42
9717779|NCT00006156|10817086|FG001|STARTED|Overall Study||7
10195328|NCT03344861|11323678|FG000|STARTED|Overall Study||10
10195329|NCT03344861|11323678|FG000|COMPLETED|Overall Study||10
10195330|NCT03344861|11323678|FG000|NOT COMPLETED|Overall Study||0
10195331|NCT03345108|11323682|FG000|STARTED|Period-1||8
10195332|NCT03345108|11323683|FG001|STARTED|Period-1||8
10195333|NCT03345108|11323684|FG002|STARTED|Period-1||8
10195334|NCT03345108|11323685|FG003|STARTED|Period-1||8
10195335|NCT03345108|11323686|FG004|STARTED|Period-1||8
10195336|NCT03345108|11323687|FG005|STARTED|Period-1||8
10195337|NCT03345108|11323682|FG000|COMPLETED|Period-1||8
10195338|NCT03345108|11323683|FG001|COMPLETED|Period-1||8
10195339|NCT03345108|11323684|FG002|COMPLETED|Period-1||8
10195340|NCT03345108|11323685|FG003|COMPLETED|Period-1||8
10195341|NCT03345108|11323686|FG004|COMPLETED|Period-1||8
10195342|NCT03345108|11323687|FG005|COMPLETED|Period-1||8
10195343|NCT03345108|11323682|FG000|NOT COMPLETED|Period-1||0
10195344|NCT03345108|11323683|FG001|NOT COMPLETED|Period-1||0
10195345|NCT03345108|11323684|FG002|NOT COMPLETED|Period-1||0
10195346|NCT03345108|11323685|FG003|NOT COMPLETED|Period-1||0
10195347|NCT03345108|11323686|FG004|NOT COMPLETED|Period-1||0
10195348|NCT03345108|11323687|FG005|NOT COMPLETED|Period-1||0
10195349|NCT03345108|11323682|FG000|STARTED|Period-2||8
10195350|NCT03345108|11323683|FG001|STARTED|Period-2||8
10195351|NCT03345108|11323684|FG002|STARTED|Period-2||8
10195352|NCT03345108|11323685|FG003|STARTED|Period-2||8
10195353|NCT03345108|11323686|FG004|STARTED|Period-2||8
10195354|NCT03345108|11323687|FG005|STARTED|Period-2||8
10195355|NCT03345108|11323682|FG000|COMPLETED|Period-2||8
10195356|NCT03345108|11323683|FG001|COMPLETED|Period-2||8
10195357|NCT03345108|11323684|FG002|COMPLETED|Period-2||8
10195358|NCT03345108|11323685|FG003|COMPLETED|Period-2||8
10195359|NCT03345108|11323686|FG004|COMPLETED|Period-2||8
10195360|NCT03345108|11323687|FG005|COMPLETED|Period-2||8
10195361|NCT03345108|11323682|FG000|NOT COMPLETED|Period-2||0
10195362|NCT03345108|11323683|FG001|NOT COMPLETED|Period-2||0
10195363|NCT03345108|11323684|FG002|NOT COMPLETED|Period-2||0
10195364|NCT03345108|11323685|FG003|NOT COMPLETED|Period-2||0
10195365|NCT03345108|11323686|FG004|NOT COMPLETED|Period-2||0
10195366|NCT03345108|11323687|FG005|NOT COMPLETED|Period-2||0
9717780|NCT00006156|10817085|FG000|COMPLETED|Overall Study||42
9717781|NCT00006156|10817086|FG001|COMPLETED|Overall Study||7
9717782|NCT00006156|10817085|FG000|NOT COMPLETED|Overall Study||0
9717783|NCT00006156|10817086|FG001|NOT COMPLETED|Overall Study||0
9717784|NCT00006164|10817093|FG000|STARTED|Overall Study||517
9717785|NCT00006164|10817094|FG001|STARTED|Overall Study||533
9717786|NCT00006164|10817093|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
9717787|NCT00006164|10817094|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
9717788|NCT00006164|10817093|FG000|NOT COMPLETED|Overall Study||70
9717789|NCT00006164|10817094|FG001|NOT COMPLETED|Overall Study||81
9717790|NCT00006170|10817104|FG000|STARTED|Overall Study||106
9717791|NCT00006170|10817105|FG001|STARTED|Overall Study||87
9717792|NCT00006170|10817106|FG002|STARTED|Overall Study||89
9717793|NCT00006170|10817107|FG003|STARTED|Overall Study||67
9717794|NCT00006170|10817104|FG000|COMPLETED|Overall Study||57
9717795|NCT00006170|10817105|FG001|COMPLETED|Overall Study||37
9717796|NCT00006170|10817106|FG002|COMPLETED|Overall Study||46
9717797|NCT00006170|10817107|FG003|COMPLETED|Overall Study||28
9717798|NCT00006170|10817104|FG000|NOT COMPLETED|Overall Study||49
9717799|NCT00006170|10817105|FG001|NOT COMPLETED|Overall Study||50
9717800|NCT00006170|10817106|FG002|NOT COMPLETED|Overall Study||43
9717801|NCT00006170|10817107|FG003|NOT COMPLETED|Overall Study||39
9731475|NCT00132730|10831392|FG003|STARTED|Period II - 12-week Treatment (Base)||153
9731476|NCT00132730|10831393|FG004|STARTED|Period II - 12-week Treatment (Base)||0
9731477|NCT00132730|10831394|FG005|STARTED|Period II - 12-week Treatment (Base)||0
9731478|NCT00132730|10831389|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127
9731479|NCT00132730|10831390|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133
9731480|NCT00132730|10831391|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135
9731481|NCT00132730|10831392|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131
9731482|NCT00132730|10831393|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0
9731483|NCT00132730|10831394|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0
9731484|NCT00132730|10831389|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
9731485|NCT00132730|10831390|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
9731486|NCT00132730|10831391|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
9731487|NCT00132730|10831392|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
9731488|NCT00132730|10831393|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
9731489|NCT00132730|10831394|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
9731490|NCT00132730|10831389|FG000|STARTED|Period III - Blinded Extension (EXT1)||0
9731491|NCT00132730|10831390|FG001|STARTED|Period III - Blinded Extension (EXT1)||0
9731492|NCT00132730|10831391|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
9731493|NCT00132730|10831392|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
9731494|NCT00132730|10831393|FG004|STARTED|Period III - Blinded Extension (EXT1)||0
9731495|NCT00132730|10831394|FG005|STARTED|Period III - Blinded Extension (EXT1)||0
9731496|NCT00132730|10831389|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0
9731497|NCT00132730|10831390|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0
9731498|NCT00132730|10831391|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235
9731499|NCT00132730|10831392|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82
9731958|NCT00138203|10831947|FG000|COMPLETED|Overall Study||16
9717802|NCT04323800|10817119|FG000|STARTED|Overall Study||87
9717803|NCT04323800|10817120|FG001|STARTED|Overall Study||93
9717804|NCT04323800|10817119|FG000|COMPLETED|Overall Study||81
9717805|NCT04323800|10817120|FG001|COMPLETED|Overall Study||87
9717806|NCT04323800|10817119|FG000|NOT COMPLETED|Overall Study||6
9717807|NCT04323800|10817120|FG001|NOT COMPLETED|Overall Study||6
9717808|NCT04279925|10817128|FG000|STARTED|Overall Study||4
9717809|NCT04279925|10817129|FG001|STARTED|Overall Study||5
9717810|NCT04279925|10817128|FG000|COMPLETED|Overall Study||4
9717811|NCT04279925|10817129|FG001|COMPLETED|Overall Study||5
9717812|NCT04279925|10817128|FG000|NOT COMPLETED|Overall Study||0
9717813|NCT04279925|10817129|FG001|NOT COMPLETED|Overall Study||0
9717814|NCT04110145|10817140|FG000|STARTED|Double-Blind Treatment Period (4 Weeks)||7
9717815|NCT04110145|10817141|FG001|STARTED|Double-Blind Treatment Period (4 Weeks)||7
9717816|NCT04110145|10817142|FG002|STARTED|Double-Blind Treatment Period (4 Weeks)||6
9717817|NCT04110145|10817143|FG003|STARTED|Double-Blind Treatment Period (4 Weeks)||7
9717818|NCT04110145|10817144|FG004|STARTED|Double-Blind Treatment Period (4 Weeks)||8
9717819|NCT04110145|10817140|FG000|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
9717820|NCT04110145|10817141|FG001|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
9717821|NCT04110145|10817142|FG002|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
9717822|NCT04110145|10817143|FG003|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
9717823|NCT04110145|10817144|FG004|COMPLETED|Double-Blind Treatment Period (4 Weeks)||8
9717824|NCT04110145|10817140|FG000|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
9717825|NCT04110145|10817141|FG001|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
9717826|NCT04110145|10817142|FG002|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
9717827|NCT04110145|10817143|FG003|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||1
9717828|NCT04110145|10817144|FG004|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
9717829|NCT04110145|10817140|FG000|STARTED|Post-Treatment Period (1 Week)||7
9717830|NCT04110145|10817141|FG001|STARTED|Post-Treatment Period (1 Week)||7
9717831|NCT04110145|10817142|FG002|STARTED|Post-Treatment Period (1 Week)||5
9717832|NCT04110145|10817143|FG003|STARTED|Post-Treatment Period (1 Week)||6
9717833|NCT04110145|10817144|FG004|STARTED|Post-Treatment Period (1 Week)||8
9717834|NCT04110145|10817140|FG000|COMPLETED|Post-Treatment Period (1 Week)||7
9717835|NCT04110145|10817141|FG001|COMPLETED|Post-Treatment Period (1 Week)||7
9717836|NCT04110145|10817142|FG002|COMPLETED|Post-Treatment Period (1 Week)||5
9717837|NCT04110145|10817143|FG003|COMPLETED|Post-Treatment Period (1 Week)||6
9717838|NCT04110145|10817144|FG004|COMPLETED|Post-Treatment Period (1 Week)||8
9717839|NCT04110145|10817140|FG000|NOT COMPLETED|Post-Treatment Period (1 Week)||0
9717840|NCT04110145|10817141|FG001|NOT COMPLETED|Post-Treatment Period (1 Week)||0
9717841|NCT04110145|10817142|FG002|NOT COMPLETED|Post-Treatment Period (1 Week)||0
9717842|NCT04110145|10817143|FG003|NOT COMPLETED|Post-Treatment Period (1 Week)||0
9717843|NCT04110145|10817144|FG004|NOT COMPLETED|Post-Treatment Period (1 Week)||0
9717844|NCT03986866|10817158|FG000|STARTED|Overall Study||55
9717845|NCT03986866|10817159|FG001|STARTED|Overall Study||55
9717846|NCT03986866|10817158|FG000|COMPLETED|Overall Study||53
9717847|NCT03986866|10817159|FG001|COMPLETED|Overall Study||50
9717848|NCT03986866|10817158|FG000|NOT COMPLETED|Overall Study||2
9717849|NCT03986866|10817159|FG001|NOT COMPLETED|Overall Study||5
9717850|NCT03636269|10817167|FG000|STARTED|Period 1: Double-blind Phase||235
9717851|NCT03636269|10817168|FG001|STARTED|Period 1: Double-blind Phase||236
9717852|NCT03636269|10817169|FG002|STARTED|Period 1: Double-blind Phase||0
9717853|NCT03636269|10817167|FG000|COMPLETED|Period 1: Double-blind Phase||206
9717854|NCT03636269|10817168|FG001|COMPLETED|Period 1: Double-blind Phase||223
9717855|NCT03636269|10817169|FG002|COMPLETED|Period 1: Double-blind Phase||0
9717856|NCT03636269|10817167|FG000|NOT COMPLETED|Period 1: Double-blind Phase||29
9717857|NCT03636269|10817168|FG001|NOT COMPLETED|Period 1: Double-blind Phase||13
9717858|NCT03636269|10817169|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
9717859|NCT03636269|10817167|FG000|STARTED|Period 2: Open-label Phase||0
9717860|NCT03636269|10817168|FG001|STARTED|Period 2: Open-label Phase||0
9717861|NCT03636269|10817169|FG002|STARTED|Period 2: Open-label Phase||399
9717862|NCT03636269|10817167|FG000|COMPLETED|Period 2: Open-label Phase||0
9717863|NCT03636269|10817168|FG001|COMPLETED|Period 2: Open-label Phase||0
9717864|NCT03636269|10817169|FG002|COMPLETED|Period 2: Open-label Phase||5
9717865|NCT03636269|10817167|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
9717866|NCT03636269|10817168|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
9717867|NCT03636269|10817169|FG002|NOT COMPLETED|Period 2: Open-label Phase||394
9717868|NCT03527264|10817182|FG000|STARTED|Overall Study||3
9717869|NCT03527264|10817183|FG001|STARTED|Overall Study||1
9717870|NCT03527264|10817184|FG002|STARTED|Overall Study||0
9717871|NCT03527264|10817185|FG003|STARTED|Overall Study||0
9717872|NCT03527264|10817182|FG000|COMPLETED|Overall Study||3
10195367|NCT03345108|11323682|FG000|STARTED|Period-3||7
10195368|NCT03345108|11323683|FG001|STARTED|Period-3||8
10195369|NCT03345108|11323684|FG002|STARTED|Period-3||8
10195370|NCT03345108|11323685|FG003|STARTED|Period-3||8
10195371|NCT03345108|11323686|FG004|STARTED|Period-3||8
10195372|NCT03345108|11323687|FG005|STARTED|Period-3||8
10195373|NCT03345108|11323682|FG000|COMPLETED|Period-3||7
10195374|NCT03345108|11323683|FG001|COMPLETED|Period-3||8
10195375|NCT03345108|11323684|FG002|COMPLETED|Period-3||8
10195376|NCT03345108|11323685|FG003|COMPLETED|Period-3||8
10195377|NCT03345108|11323686|FG004|COMPLETED|Period-3||8
10195378|NCT03345108|11323687|FG005|COMPLETED|Period-3||8
10195379|NCT03345108|11323682|FG000|NOT COMPLETED|Period-3||0
10195380|NCT03345108|11323683|FG001|NOT COMPLETED|Period-3||0
10195381|NCT03345108|11323684|FG002|NOT COMPLETED|Period-3||0
10195382|NCT03345108|11323685|FG003|NOT COMPLETED|Period-3||0
10195383|NCT03345108|11323686|FG004|NOT COMPLETED|Period-3||0
10195384|NCT03345108|11323687|FG005|NOT COMPLETED|Period-3||0
10195385|NCT03345160|11323695|FG000|STARTED|Overall Study||7
10195386|NCT03345160|11323695|FG000|COMPLETED|Overall Study||7
10195387|NCT03345160|11323695|FG000|NOT COMPLETED|Overall Study||0
10195388|NCT03345394|11323701|FG000|STARTED|Overall Study||48
10195389|NCT03345394|11323702|FG001|STARTED|Overall Study||50
10195390|NCT03345394|11323701|FG000|COMPLETED|Overall Study||48
10195391|NCT03345394|11323702|FG001|COMPLETED|Overall Study||50
10195392|NCT03345394|11323701|FG000|NOT COMPLETED|Overall Study||0
10195393|NCT03345394|11323702|FG001|NOT COMPLETED|Overall Study||0
10195394|NCT03345407|11323715|FG000|STARTED|Overall Study||276
10195395|NCT03345407|11323716|FG001|STARTED|Overall Study||22
10195396|NCT03345407|11323717|FG002|STARTED|Overall Study||91
10195397|NCT03345407|11323718|FG003|STARTED|Overall Study||92
10195398|NCT03345407|11323719|FG004|STARTED|Overall Study||90
10195399|NCT03345407|11323720|FG005|STARTED|Overall Study||89
10195400|NCT03345407|11323721|FG006|STARTED|Overall Study||278
10195401|NCT03345407|11323715|FG000|COMPLETED|Overall Study||244
10195402|NCT03345407|11323716|FG001|COMPLETED|Overall Study||19
10195403|NCT03345407|11323717|FG002|COMPLETED|Overall Study||79
10195404|NCT03345407|11323718|FG003|COMPLETED|Overall Study||81
10195405|NCT03345407|11323719|FG004|COMPLETED|Overall Study||75
10195406|NCT03345407|11323720|FG005|COMPLETED|Overall Study||73
10195407|NCT03345407|11323721|FG006|COMPLETED|Overall Study||233
10195408|NCT03345407|11323715|FG000|NOT COMPLETED|Overall Study||32
10195409|NCT03345407|11323716|FG001|NOT COMPLETED|Overall Study||3
10195410|NCT03345407|11323717|FG002|NOT COMPLETED|Overall Study||12
10195411|NCT03345407|11323718|FG003|NOT COMPLETED|Overall Study||11
10195412|NCT03345407|11323719|FG004|NOT COMPLETED|Overall Study||15
10195413|NCT03345407|11323720|FG005|NOT COMPLETED|Overall Study||16
10195414|NCT03345407|11323721|FG006|NOT COMPLETED|Overall Study||45
10195415|NCT03345472|11323743|FG000|STARTED|Implant to 3 Months||103
10195416|NCT03345472|11323743|FG000|COMPLETED|Implant to 3 Months||99
10195417|NCT03345472|11323743|FG000|NOT COMPLETED|Implant to 3 Months||4
10195418|NCT03345472|11323743|FG000|STARTED|3 Months to 12 Months||99
10195419|NCT03345472|11323743|FG000|COMPLETED|3 Months to 12 Months||91
10195420|NCT03345472|11323743|FG000|NOT COMPLETED|3 Months to 12 Months||8
10195421|NCT03345914|11323750|FG000|STARTED|Overall Study||123
10195422|NCT03345914|11323751|FG001|STARTED|Overall Study||122
10195423|NCT03345914|11323752|FG002|STARTED|Overall Study||122
10195424|NCT03345914|11323750|FG000|Completed Week 16 Study Treatment|Overall Study||114
10195425|NCT03345914|11323751|FG001|Completed Week 16 Study Treatment|Overall Study||118
10195426|NCT03345914|11323752|FG002|Completed Week 16 Study Treatment|Overall Study||119
9717873|NCT03527264|10817183|FG001|COMPLETED|Overall Study||1
9717874|NCT03527264|10817184|FG002|COMPLETED|Overall Study||0
9717875|NCT03527264|10817185|FG003|COMPLETED|Overall Study||0
9717876|NCT03527264|10817182|FG000|NOT COMPLETED|Overall Study||0
9717877|NCT03527264|10817183|FG001|NOT COMPLETED|Overall Study||0
9717878|NCT03527264|10817184|FG002|NOT COMPLETED|Overall Study||0
9717879|NCT03527264|10817185|FG003|NOT COMPLETED|Overall Study||0
9717880|NCT03447314|10817209|FG000|STARTED|Part 1 (Up to 27 Months)||9
9717881|NCT03447314|10817210|FG001|STARTED|Part 1 (Up to 27 Months)||6
9850767|NCT00872339|10963481|FG001|STARTED|Overall Study||14
9850768|NCT00872339|10963482|FG002|STARTED|Overall Study||37
9850769|NCT00872339|10963480|FG000|COMPLETED|Overall Study||201
9850770|NCT00872339|10963481|FG001|COMPLETED|Overall Study||14
9850771|NCT00872339|10963482|FG002|COMPLETED|Overall Study||37
9850772|NCT00872339|10963480|FG000|NOT COMPLETED|Overall Study||0
9850773|NCT00872339|10963481|FG001|NOT COMPLETED|Overall Study||0
9850774|NCT00872339|10963482|FG002|NOT COMPLETED|Overall Study||0
9850775|NCT00872521|10963493|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26
9850776|NCT00872521|10963494|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72
9850777|NCT00872521|10963495|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9
9850778|NCT00872521|10963493|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21
9850779|NCT00872521|10963494|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68
9850780|NCT00872521|10963495|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9
9850781|NCT00872521|10963493|FG000|NOT COMPLETED|Completed PAD Induction||5
9850782|NCT00872521|10963494|FG001|NOT COMPLETED|Completed PAD Induction||4
9850783|NCT00872521|10963495|FG002|NOT COMPLETED|Completed PAD Induction||0
9850784|NCT00872521|10963493|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
9850785|NCT00872521|10963494|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
9850786|NCT00872521|10963495|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
9850787|NCT00872521|10963493|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
9850788|NCT00872521|10963494|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
9850789|NCT00872521|10963495|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
9850790|NCT00872521|10963493|FG000|NOT COMPLETED|Primary Endpoint Analysis||1
9850791|NCT00872521|10963494|FG001|NOT COMPLETED|Primary Endpoint Analysis||5
9850792|NCT00872521|10963495|FG002|NOT COMPLETED|Primary Endpoint Analysis||1
9850793|NCT00872521|10963493|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
9850794|NCT00872521|10963494|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
9850795|NCT00872521|10963495|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
9850796|NCT00872521|10963493|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
9850797|NCT00872521|10963494|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
9850798|NCT00872521|10963495|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
9850799|NCT00872521|10963493|FG000|NOT COMPLETED|Completed 3-month Follow up||0
9850800|NCT00872521|10963494|FG001|NOT COMPLETED|Completed 3-month Follow up||3
9850801|NCT00872521|10963495|FG002|NOT COMPLETED|Completed 3-month Follow up||0
9850802|NCT00872521|10963493|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
9850803|NCT00872521|10963494|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
9850804|NCT00872521|10963495|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
9850805|NCT00872521|10963493|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
9850806|NCT00872521|10963494|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
9850807|NCT00872521|10963495|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
9850808|NCT00872521|10963493|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0
9850809|NCT00872521|10963494|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2
9850810|NCT00872521|10963495|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1
9850811|NCT00872534|10963516|FG000|STARTED|Overall Study||100
9850812|NCT00872534|10963517|FG001|STARTED|Overall Study||104
9850813|NCT00872534|10963516|FG000|COMPLETED|Overall Study||97
9850814|NCT00872534|10963517|FG001|COMPLETED|Overall Study||101
9850815|NCT00872534|10963516|FG000|NOT COMPLETED|Overall Study||3
9850816|NCT00872534|10963517|FG001|NOT COMPLETED|Overall Study||3
9850817|NCT00872599|10963523|FG000|STARTED|First Washout Period After Low Salt||16
9850818|NCT00872599|10963524|FG001|STARTED|First Washout Period After Low Salt||17
9850819|NCT00872599|10963523|FG000|COMPLETED|First Washout Period After Low Salt||16
9850820|NCT00872599|10963524|FG001|COMPLETED|First Washout Period After Low Salt||17
9850821|NCT00872599|10963523|FG000|NOT COMPLETED|First Washout Period After Low Salt||0
9717882|NCT03447314|10817211|FG002|STARTED|Part 1 (Up to 27 Months)||9
9717883|NCT03447314|10817212|FG003|STARTED|Part 1 (Up to 27 Months)||4
9717884|NCT03447314|10817213|FG004|STARTED|Part 1 (Up to 27 Months)||2
9717885|NCT03447314|10817214|FG005|STARTED|Part 1 (Up to 27 Months)||6
9717886|NCT03447314|10817215|FG006|STARTED|Part 1 (Up to 27 Months)||5
9717887|NCT03447314|10817216|FG007|STARTED|Part 1 (Up to 27 Months)||0
9717888|NCT03447314|10817217|FG008|STARTED|Part 1 (Up to 27 Months)||0
9717889|NCT03447314|10817218|FG009|STARTED|Part 1 (Up to 27 Months)||0
9717890|NCT03447314|10817219|FG010|STARTED|Part 1 (Up to 27 Months)||7
9717891|NCT03447314|10817220|FG011|STARTED|Part 1 (Up to 27 Months)||6
9717892|NCT03447314|10817221|FG012|STARTED|Part 1 (Up to 27 Months)||0
9717893|NCT03447314|10817222|FG013|STARTED|Part 1 (Up to 27 Months)||0
9717894|NCT03447314|10817223|FG014|STARTED|Part 1 (Up to 27 Months)||0
9717895|NCT03447314|10817224|FG015|STARTED|Part 1 (Up to 27 Months)||0
9717896|NCT03447314|10817225|FG016|STARTED|Part 1 (Up to 27 Months)||0
9717897|NCT03447314|10817226|FG017|STARTED|Part 1 (Up to 27 Months)||0
9717898|NCT03447314|10817209|FG000|COMPLETED|Part 1 (Up to 27 Months)||0
9717899|NCT03447314|10817210|FG001|COMPLETED|Part 1 (Up to 27 Months)||0
9717900|NCT03447314|10817211|FG002|COMPLETED|Part 1 (Up to 27 Months)||0
9717901|NCT03447314|10817212|FG003|COMPLETED|Part 1 (Up to 27 Months)||0
9717902|NCT03447314|10817213|FG004|COMPLETED|Part 1 (Up to 27 Months)||0
9717903|NCT03447314|10817214|FG005|COMPLETED|Part 1 (Up to 27 Months)||0
9717904|NCT03447314|10817215|FG006|COMPLETED|Part 1 (Up to 27 Months)||0
9717905|NCT03447314|10817216|FG007|COMPLETED|Part 1 (Up to 27 Months)||0
9717906|NCT03447314|10817217|FG008|COMPLETED|Part 1 (Up to 27 Months)||0
9717907|NCT03447314|10817218|FG009|COMPLETED|Part 1 (Up to 27 Months)||0
9717908|NCT03447314|10817219|FG010|COMPLETED|Part 1 (Up to 27 Months)||0
9717909|NCT03447314|10817220|FG011|COMPLETED|Part 1 (Up to 27 Months)||0
9717910|NCT03447314|10817221|FG012|COMPLETED|Part 1 (Up to 27 Months)||0
9717911|NCT03447314|10817222|FG013|COMPLETED|Part 1 (Up to 27 Months)||0
9717912|NCT03447314|10817223|FG014|COMPLETED|Part 1 (Up to 27 Months)||0
9717913|NCT03447314|10817224|FG015|COMPLETED|Part 1 (Up to 27 Months)||0
9717914|NCT03447314|10817225|FG016|COMPLETED|Part 1 (Up to 27 Months)||0
9717915|NCT03447314|10817226|FG017|COMPLETED|Part 1 (Up to 27 Months)||0
9717916|NCT03447314|10817209|FG000|NOT COMPLETED|Part 1 (Up to 27 Months)||9
9717917|NCT03447314|10817210|FG001|NOT COMPLETED|Part 1 (Up to 27 Months)||6
9717918|NCT03447314|10817211|FG002|NOT COMPLETED|Part 1 (Up to 27 Months)||9
9717919|NCT03447314|10817212|FG003|NOT COMPLETED|Part 1 (Up to 27 Months)||4
9717920|NCT03447314|10817213|FG004|NOT COMPLETED|Part 1 (Up to 27 Months)||2
9717921|NCT03447314|10817214|FG005|NOT COMPLETED|Part 1 (Up to 27 Months)||6
9717922|NCT03447314|10817215|FG006|NOT COMPLETED|Part 1 (Up to 27 Months)||5
9717923|NCT03447314|10817216|FG007|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717924|NCT03447314|10817217|FG008|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717925|NCT03447314|10817218|FG009|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717926|NCT03447314|10817219|FG010|NOT COMPLETED|Part 1 (Up to 27 Months)||7
9717927|NCT03447314|10817220|FG011|NOT COMPLETED|Part 1 (Up to 27 Months)||6
9717928|NCT03447314|10817221|FG012|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717929|NCT03447314|10817222|FG013|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717930|NCT03447314|10817223|FG014|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717931|NCT03447314|10817224|FG015|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717932|NCT03447314|10817225|FG016|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717933|NCT03447314|10817226|FG017|NOT COMPLETED|Part 1 (Up to 27 Months)||0
9717934|NCT03447314|10817209|FG000|STARTED|Part 2 (Up to 27 Months)||0
9717935|NCT03447314|10817210|FG001|STARTED|Part 2 (Up to 27 Months)||0
9717936|NCT03447314|10817211|FG002|STARTED|Part 2 (Up to 27 Months)||0
9717937|NCT03447314|10817212|FG003|STARTED|Part 2 (Up to 27 Months)||0
9717938|NCT03447314|10817213|FG004|STARTED|Part 2 (Up to 27 Months)||0
9717939|NCT03447314|10817214|FG005|STARTED|Part 2 (Up to 27 Months)||0
9717940|NCT03447314|10817215|FG006|STARTED|Part 2 (Up to 27 Months)||0
9717941|NCT03447314|10817216|FG007|STARTED|Part 2 (Up to 27 Months)||0
9717942|NCT03447314|10817217|FG008|STARTED|Part 2 (Up to 27 Months)||0
9717943|NCT03447314|10817218|FG009|STARTED|Part 2 (Up to 27 Months)||0
9717944|NCT03447314|10817219|FG010|STARTED|Part 2 (Up to 27 Months)||0
9717945|NCT03447314|10817220|FG011|STARTED|Part 2 (Up to 27 Months)||0
9717946|NCT03447314|10817221|FG012|STARTED|Part 2 (Up to 27 Months)||0
9717947|NCT03447314|10817222|FG013|STARTED|Part 2 (Up to 27 Months)||0
9717948|NCT03447314|10817223|FG014|STARTED|Part 2 (Up to 27 Months)||0
9717949|NCT03447314|10817224|FG015|STARTED|Part 2 (Up to 27 Months)||0
9717950|NCT03447314|10817225|FG016|STARTED|Part 2 (Up to 27 Months)||0
9717951|NCT03447314|10817226|FG017|STARTED|Part 2 (Up to 27 Months)||0
9717952|NCT03447314|10817209|FG000|COMPLETED|Part 2 (Up to 27 Months)||0
9717953|NCT03447314|10817210|FG001|COMPLETED|Part 2 (Up to 27 Months)||0
9717954|NCT03447314|10817211|FG002|COMPLETED|Part 2 (Up to 27 Months)||0
9717955|NCT03447314|10817212|FG003|COMPLETED|Part 2 (Up to 27 Months)||0
9717956|NCT03447314|10817213|FG004|COMPLETED|Part 2 (Up to 27 Months)||0
9717957|NCT03447314|10817214|FG005|COMPLETED|Part 2 (Up to 27 Months)||0
9717958|NCT03447314|10817215|FG006|COMPLETED|Part 2 (Up to 27 Months)||0
9717959|NCT03447314|10817216|FG007|COMPLETED|Part 2 (Up to 27 Months)||0
9717960|NCT03447314|10817217|FG008|COMPLETED|Part 2 (Up to 27 Months)||0
9717961|NCT03447314|10817218|FG009|COMPLETED|Part 2 (Up to 27 Months)||0
9717962|NCT03447314|10817219|FG010|COMPLETED|Part 2 (Up to 27 Months)||0
9717963|NCT03447314|10817220|FG011|COMPLETED|Part 2 (Up to 27 Months)||0
9717964|NCT03447314|10817221|FG012|COMPLETED|Part 2 (Up to 27 Months)||0
9850822|NCT00872599|10963524|FG001|NOT COMPLETED|First Washout Period After Low Salt||0
9850823|NCT00872599|10963523|FG000|STARTED|First Drug During High Salt Intake||16
9717965|NCT03447314|10817222|FG013|COMPLETED|Part 2 (Up to 27 Months)||0
9717966|NCT03447314|10817223|FG014|COMPLETED|Part 2 (Up to 27 Months)||0
9717967|NCT03447314|10817224|FG015|COMPLETED|Part 2 (Up to 27 Months)||0
9717968|NCT03447314|10817225|FG016|COMPLETED|Part 2 (Up to 27 Months)||0
9717969|NCT03447314|10817226|FG017|COMPLETED|Part 2 (Up to 27 Months)||0
9717970|NCT03447314|10817209|FG000|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717971|NCT03447314|10817210|FG001|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717972|NCT03447314|10817211|FG002|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717973|NCT03447314|10817212|FG003|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717974|NCT03447314|10817213|FG004|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717975|NCT03447314|10817214|FG005|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717976|NCT03447314|10817215|FG006|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717977|NCT03447314|10817216|FG007|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717978|NCT03447314|10817217|FG008|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717979|NCT03447314|10817218|FG009|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717980|NCT03447314|10817219|FG010|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717981|NCT03447314|10817220|FG011|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717982|NCT03447314|10817221|FG012|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717983|NCT03447314|10817222|FG013|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717984|NCT03447314|10817223|FG014|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717985|NCT03447314|10817224|FG015|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717986|NCT03447314|10817225|FG016|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717987|NCT03447314|10817226|FG017|NOT COMPLETED|Part 2 (Up to 27 Months)||0
9717988|NCT03422653|10817269|FG000|STARTED|Period 1: Double-blind Phase||189
9717989|NCT03422653|10817270|FG001|STARTED|Period 1: Double-blind Phase||189
9717990|NCT03422653|10817271|FG002|STARTED|Period 1: Double-blind Phase||0
9717991|NCT03422653|10817269|FG000|COMPLETED|Period 1: Double-blind Phase||162
9717992|NCT03422653|10817270|FG001|COMPLETED|Period 1: Double-blind Phase||170
9717993|NCT03422653|10817271|FG002|COMPLETED|Period 1: Double-blind Phase||0
9717994|NCT03422653|10817269|FG000|NOT COMPLETED|Period 1: Double-blind Phase||27
9717995|NCT03422653|10817270|FG001|NOT COMPLETED|Period 1: Double-blind Phase||19
9717996|NCT03422653|10817271|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
9717997|NCT03422653|10817269|FG000|STARTED|Period 2: Open-label Phase||0
9717998|NCT03422653|10817270|FG001|STARTED|Period 2: Open-label Phase||0
9717999|NCT03422653|10817271|FG002|STARTED|Period 2: Open-label Phase||313
9718000|NCT03422653|10817269|FG000|COMPLETED|Period 2: Open-label Phase||0
9718001|NCT03422653|10817270|FG001|COMPLETED|Period 2: Open-label Phase||0
9718002|NCT03422653|10817271|FG002|COMPLETED|Period 2: Open-label Phase||189
9718003|NCT03422653|10817269|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
9718004|NCT03422653|10817270|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
9718005|NCT03422653|10817271|FG002|NOT COMPLETED|Period 2: Open-label Phase||124
9718006|NCT03320330|10817283|FG000|STARTED|Overall Study||6
9718007|NCT03320330|10817284|FG001|STARTED|Overall Study||6
9718008|NCT03320330|10817285|FG002|STARTED|Overall Study||14
9718009|NCT03320330|10817283|FG000|COMPLETED|Overall Study||0
9718010|NCT03320330|10817284|FG001|COMPLETED|Overall Study||1
9718011|NCT03320330|10817285|FG002|COMPLETED|Overall Study||0
9718012|NCT03320330|10817283|FG000|NOT COMPLETED|Overall Study||6
9718013|NCT03320330|10817284|FG001|NOT COMPLETED|Overall Study||5
9718014|NCT03320330|10817285|FG002|NOT COMPLETED|Overall Study||14
9718015|NCT03271151|10817296|FG000|STARTED|Overall Study||80
9718016|NCT03271151|10817297|FG001|STARTED|Overall Study||80
9718017|NCT03271151|10817296|FG000|COMPLETED|Overall Study||78
9718018|NCT03271151|10817297|FG001|COMPLETED|Overall Study||77
9718019|NCT03271151|10817296|FG000|NOT COMPLETED|Overall Study||2
9718020|NCT03271151|10817297|FG001|NOT COMPLETED|Overall Study||3
9718021|NCT03141177|10817306|FG000|STARTED|Overall Study||323
9718022|NCT03141177|10817307|FG001|STARTED|Overall Study||50
9718023|NCT03141177|10817308|FG002|STARTED|Overall Study||328
9718024|NCT03141177|10817306|FG000|Treated|Overall Study||320
9718025|NCT03141177|10817307|FG001|Treated|Overall Study||50
9718026|NCT03141177|10817308|FG002|Treated|Overall Study||320
9718027|NCT03141177|10817306|FG000|COMPLETED|Overall Study||242
9718028|NCT03141177|10817307|FG001|COMPLETED|Overall Study||34
9718029|NCT03141177|10817308|FG002|COMPLETED|Overall Study||210
9718030|NCT03141177|10817306|FG000|NOT COMPLETED|Overall Study||81
9718031|NCT03141177|10817307|FG001|NOT COMPLETED|Overall Study||16
9718032|NCT03141177|10817308|FG002|NOT COMPLETED|Overall Study||118
9718033|NCT03117049|10817319|FG000|STARTED|Overall Study||275
9718034|NCT03117049|10817320|FG001|STARTED|Overall Study||275
9718035|NCT03117049|10817319|FG000|COMPLETED|Overall Study||74
9718036|NCT03117049|10817320|FG001|COMPLETED|Overall Study||44
9718037|NCT03117049|10817319|FG000|NOT COMPLETED|Overall Study||201
9718038|NCT03117049|10817320|FG001|NOT COMPLETED|Overall Study||231
9718039|NCT03023813|10817329|FG000|STARTED|Overall Study||39
9718040|NCT03023813|10817330|FG001|STARTED|Overall Study||34
9718041|NCT03023813|10817331|FG002|STARTED|Overall Study||31
9718042|NCT03023813|10817329|FG000|COMPLETED|Overall Study||38
9718043|NCT03023813|10817330|FG001|COMPLETED|Overall Study||32
9718044|NCT03023813|10817331|FG002|COMPLETED|Overall Study||31
9718045|NCT03023813|10817329|FG000|NOT COMPLETED|Overall Study||1
9718046|NCT03023813|10817330|FG001|NOT COMPLETED|Overall Study||2
9718047|NCT03023813|10817331|FG002|NOT COMPLETED|Overall Study||0
9718048|NCT02993822|10817344|FG000|STARTED|Overall Study||79
9718049|NCT02993822|10817345|FG001|STARTED|Overall Study||78
9718050|NCT02993822|10817346|FG002|STARTED|Overall Study||79
9718051|NCT02993822|10817347|FG003|STARTED|Overall Study||79
9718052|NCT02993822|10817344|FG000|COMPLETED|Overall Study||69
9718053|NCT02993822|10817345|FG001|COMPLETED|Overall Study||74
9718054|NCT02993822|10817346|FG002|COMPLETED|Overall Study||69
9718055|NCT02993822|10817347|FG003|COMPLETED|Overall Study||75
9718056|NCT02993822|10817344|FG000|NOT COMPLETED|Overall Study||10
9718057|NCT02993822|10817345|FG001|NOT COMPLETED|Overall Study||4
9718058|NCT02993822|10817346|FG002|NOT COMPLETED|Overall Study||10
9718059|NCT02993822|10817347|FG003|NOT COMPLETED|Overall Study||4
9718060|NCT02924324|10817359|FG000|STARTED|Overall Study||28
9718061|NCT02924324|10817360|FG001|STARTED|Overall Study||28
9718062|NCT02924324|10817359|FG000|COMPLETED|Overall Study||28
9718063|NCT02924324|10817360|FG001|COMPLETED|Overall Study||28
9718064|NCT02924324|10817359|FG000|NOT COMPLETED|Overall Study||0
9718065|NCT02924324|10817360|FG001|NOT COMPLETED|Overall Study||0
9718066|NCT02828917|10817366|FG000|STARTED|Overall Study||104
9718067|NCT02828917|10817366|FG000|COMPLETED|Overall Study||104
9718068|NCT02828917|10817366|FG000|NOT COMPLETED|Overall Study||0
9718069|NCT02753127|10817372|FG000|STARTED|Overall Study||624
9718070|NCT02753127|10817373|FG001|STARTED|Overall Study||629
9718071|NCT02753127|10817372|FG000|Discontinued Due to Death|Overall Study||507
9718072|NCT02753127|10817373|FG001|Discontinued Due to Death|Overall Study||499
9718073|NCT02753127|10817372|FG000|Completion of Survival Follow-Up Due to Study Completion|Overall Study||64
9718074|NCT02753127|10817373|FG001|Completion of Survival Follow-Up Due to Study Completion|Overall Study||62
9718075|NCT02753127|10817372|FG000|COMPLETED|Overall Study||571
9718076|NCT02753127|10817373|FG001|COMPLETED|Overall Study||561
9718077|NCT02753127|10817372|FG000|NOT COMPLETED|Overall Study||53
9718078|NCT02753127|10817373|FG001|NOT COMPLETED|Overall Study||68
9718079|NCT02744430|10817389|FG000|STARTED|Overall Study||17
9718080|NCT02744430|10817390|FG001|STARTED|Overall Study||16
9718081|NCT02744430|10817389|FG000|COMPLETED|Overall Study||17
9718082|NCT02744430|10817390|FG001|COMPLETED|Overall Study||16
9718083|NCT02744430|10817389|FG000|NOT COMPLETED|Overall Study||0
9718084|NCT02744430|10817390|FG001|NOT COMPLETED|Overall Study||0
9718085|NCT02460198|10817398|FG000|STARTED|Overall Study||61
9718086|NCT02460198|10817399|FG001|STARTED|Overall Study||63
9718087|NCT02460198|10817398|FG000|COMPLETED|Overall Study||0
9718088|NCT02460198|10817399|FG001|COMPLETED|Overall Study||0
9718089|NCT02460198|10817398|FG000|NOT COMPLETED|Overall Study||61
9718090|NCT02460198|10817399|FG001|NOT COMPLETED|Overall Study||63
9718091|NCT02260869|10817409|FG000|STARTED|Overall Study||38
9718092|NCT02260869|10817410|FG001|STARTED|Overall Study||37
9718093|NCT02260869|10817409|FG000|COMPLETED|Overall Study||31
9718094|NCT02260869|10817410|FG001|COMPLETED|Overall Study||29
9718095|NCT02260869|10817409|FG000|NOT COMPLETED|Overall Study||7
9718096|NCT02260869|10817410|FG001|NOT COMPLETED|Overall Study||8
9718097|NCT02255838|10817416|FG000|STARTED|Overall Study||6
9718098|NCT02255838|10817417|FG001|STARTED|Overall Study||6
9718099|NCT02255838|10817416|FG000|COMPLETED|Overall Study||6
9718100|NCT02255838|10817417|FG001|COMPLETED|Overall Study||6
9718101|NCT02255838|10817416|FG000|NOT COMPLETED|Overall Study||0
9718102|NCT02255838|10817417|FG001|NOT COMPLETED|Overall Study||0
9718103|NCT02151526|10817427|FG000|STARTED|Overall Study||3
9718104|NCT02151526|10817428|FG001|STARTED|Overall Study||4
9718105|NCT02151526|10817427|FG000|COMPLETED|Overall Study||3
9718106|NCT02151526|10817428|FG001|COMPLETED|Overall Study||4
9718107|NCT02151526|10817427|FG000|NOT COMPLETED|Overall Study||0
9718108|NCT02151526|10817428|FG001|NOT COMPLETED|Overall Study||0
9718109|NCT02119468|10817438|FG000|STARTED|Overall Study||7
9718110|NCT02119468|10817439|FG001|STARTED|Overall Study||25
9718111|NCT02119468|10817438|FG000|COMPLETED|Overall Study||7
9718112|NCT02119468|10817439|FG001|COMPLETED|Overall Study||25
9718113|NCT02119468|10817438|FG000|NOT COMPLETED|Overall Study||0
9718114|NCT02119468|10817439|FG001|NOT COMPLETED|Overall Study||0
9718115|NCT01960530|10817446|FG000|STARTED|Overall Study||14
9718116|NCT01960530|10817446|FG000|COMPLETED|Overall Study||14
9718117|NCT01960530|10817446|FG000|NOT COMPLETED|Overall Study||0
9731500|NCT00132730|10831393|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0
9731501|NCT00132730|10831394|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0
9731502|NCT00132730|10831389|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
9731503|NCT00132730|10831390|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
9731504|NCT00132730|10831391|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
9731505|NCT00132730|10831392|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
9731506|NCT00132730|10831393|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
9731507|NCT00132730|10831394|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
9731508|NCT00132730|10831389|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0
9731509|NCT00132730|10831390|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0
9731510|NCT00132730|10831391|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0
9731511|NCT00132730|10831392|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0
9731512|NCT00132730|10831393|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
9731513|NCT00132730|10831394|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
9731514|NCT00132730|10831389|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731515|NCT00132730|10831390|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731516|NCT00132730|10831391|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731517|NCT00132730|10831392|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731518|NCT00132730|10831393|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8
9718118|NCT01516216|10817463|FG000|STARTED|Overall Study||70
9718119|NCT01516216|10817464|FG001|STARTED|Overall Study||69
9718120|NCT01516216|10817463|FG000|AE Evaluable|Overall Study||67
9718121|NCT01516216|10817464|FG001|AE Evaluable|Overall Study||68
9718122|NCT01516216|10817463|FG000|Response Evaluable|Overall Study||62
9718123|NCT01516216|10817464|FG001|Response Evaluable|Overall Study||66
9718124|NCT01516216|10817463|FG000|COMPLETED|Overall Study||0
9718125|NCT01516216|10817464|FG001|COMPLETED|Overall Study||0
9718126|NCT01516216|10817463|FG000|NOT COMPLETED|Overall Study||70
9718127|NCT01516216|10817464|FG001|NOT COMPLETED|Overall Study||69
9718128|NCT00519818|10817472|FG000|STARTED|Overall Study||14
9718129|NCT00519818|10817472|FG000|COMPLETED|Overall Study||14
9718130|NCT00519818|10817472|FG000|NOT COMPLETED|Overall Study||0
9718137|NCT00006178|10817487|FG000|STARTED|Overall Study||12
9718138|NCT00006178|10817487|FG000|COMPLETED|Overall Study||12
9718139|NCT00006178|10817487|FG000|NOT COMPLETED|Overall Study||0
9718140|NCT00006184|10817493|FG000|STARTED|Overall Study||10
9718141|NCT00006184|10817494|FG001|STARTED|Overall Study||10
9718142|NCT00006184|10817493|FG000|COMPLETED|Overall Study||9
9718143|NCT00006184|10817494|FG001|COMPLETED|Overall Study||10
9718144|NCT00006184|10817493|FG000|NOT COMPLETED|Overall Study||1
9718145|NCT00006184|10817494|FG001|NOT COMPLETED|Overall Study||0
9718146|NCT00006227|10817500|FG000|STARTED|Overall Study||31
9718147|NCT00006227|10817500|FG000|COMPLETED|Overall Study||31
9718148|NCT00006227|10817500|FG000|NOT COMPLETED|Overall Study||0
9718149|NCT00006237|10817506|FG000|STARTED|Overall Study||212
9718150|NCT00006237|10817507|FG001|STARTED|Overall Study||220
9718151|NCT00006237|10817506|FG000|Eligible|Overall Study||203
9718152|NCT00006237|10817507|FG001|Eligible|Overall Study||200
9718153|NCT00006237|10817506|FG000|Eligible and Treated|Overall Study||203
9718154|NCT00006237|10817507|FG001|Eligible and Treated|Overall Study||199
9718155|NCT00006237|10817506|FG000|COMPLETED|Overall Study||87
9718156|NCT00006237|10817507|FG001|COMPLETED|Overall Study||159
9718157|NCT00006237|10817506|FG000|NOT COMPLETED|Overall Study||125
9718158|NCT00006237|10817507|FG001|NOT COMPLETED|Overall Study||61
9718159|NCT00006244|10817516|FG000|STARTED|Overall Study||36
9718160|NCT00006244|10817516|FG000|COMPLETED|Overall Study||36
9718161|NCT00006244|10817516|FG000|NOT COMPLETED|Overall Study||0
9718162|NCT00006289|10817522|FG000|STARTED|First Intervention (5 Weeks)||11
9718163|NCT00006289|10817523|FG001|STARTED|First Intervention (5 Weeks)||10
9718164|NCT00006289|10817522|FG000|COMPLETED|First Intervention (5 Weeks)||10
9718165|NCT00006289|10817523|FG001|COMPLETED|First Intervention (5 Weeks)||10
9718166|NCT00006289|10817522|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1
9718167|NCT00006289|10817523|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0
9718168|NCT00006289|10817522|FG000|STARTED|Washout (>= 1 Week)||10
9718169|NCT00006289|10817523|FG001|STARTED|Washout (>= 1 Week)||10
9718170|NCT00006289|10817522|FG000|COMPLETED|Washout (>= 1 Week)||10
9718171|NCT00006289|10817523|FG001|COMPLETED|Washout (>= 1 Week)||10
9718172|NCT00006289|10817522|FG000|NOT COMPLETED|Washout (>= 1 Week)||0
9718173|NCT00006289|10817523|FG001|NOT COMPLETED|Washout (>= 1 Week)||0
9718174|NCT00006289|10817522|FG000|STARTED|Second Intervention (5 Weeks)||10
9718175|NCT00006289|10817523|FG001|STARTED|Second Intervention (5 Weeks)||10
9718176|NCT00006289|10817522|FG000|COMPLETED|Second Intervention (5 Weeks)||9
9718177|NCT00006289|10817523|FG001|COMPLETED|Second Intervention (5 Weeks)||9
9718178|NCT00006289|10817522|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1
9718179|NCT00006289|10817523|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1
9718180|NCT00006305|10817543|FG000|STARTED|Overall Study||592
9718181|NCT00006305|10817544|FG001|STARTED|Overall Study||584
9718182|NCT00006305|10817545|FG002|STARTED|Overall Study||593
9718183|NCT00006305|10817546|FG003|STARTED|Overall Study||599
9718184|NCT00006305|10817543|FG000|COMPLETED|Overall Study||575
9718185|NCT00006305|10817544|FG001|COMPLETED|Overall Study||574
9718186|NCT00006305|10817545|FG002|COMPLETED|Overall Study||578
9718187|NCT00006305|10817546|FG003|COMPLETED|Overall Study||585
9718188|NCT00006305|10817543|FG000|NOT COMPLETED|Overall Study||17
9718189|NCT00006305|10817544|FG001|NOT COMPLETED|Overall Study||10
9718190|NCT00006305|10817545|FG002|NOT COMPLETED|Overall Study||15
9718191|NCT00006305|10817546|FG003|NOT COMPLETED|Overall Study||14
9718192|NCT00006389|10817556|FG000|STARTED|Overall Study||12
9718193|NCT00006389|10817556|FG000|COMPLETED|Overall Study||11
9718194|NCT00006389|10817556|FG000|NOT COMPLETED|Overall Study||1
9718195|NCT00006392|10817565|FG000|STARTED|Overall Study||8904
9718196|NCT00006392|10817566|FG001|STARTED|Overall Study||8910
9718197|NCT00006392|10817567|FG002|STARTED|Overall Study||8863
9718198|NCT00006392|10817568|FG003|STARTED|Overall Study||8856
9718199|NCT00006392|10817565|FG000|COMPLETED|Overall Study||8737
9718200|NCT00006392|10817566|FG001|COMPLETED|Overall Study||8752
9718201|NCT00006392|10817567|FG002|COMPLETED|Overall Study||8703
9718202|NCT00006392|10817568|FG003|COMPLETED|Overall Study||8696
9718203|NCT00006392|10817565|FG000|NOT COMPLETED|Overall Study||167
9718204|NCT00006392|10817566|FG001|NOT COMPLETED|Overall Study||158
9718205|NCT00006392|10817567|FG002|NOT COMPLETED|Overall Study||160
9718206|NCT00006392|10817568|FG003|NOT COMPLETED|Overall Study||160
9718207|NCT00006400|10817580|FG000|STARTED|Overall Study||96
9718208|NCT00006400|10817581|FG001|STARTED|Overall Study||97
9718209|NCT00006400|10817580|FG000|COMPLETED|Overall Study||83
9718210|NCT00006400|10817581|FG001|COMPLETED|Overall Study||84
9718211|NCT00006400|10817580|FG000|NOT COMPLETED|Overall Study||13
9718212|NCT00006400|10817581|FG001|NOT COMPLETED|Overall Study||13
9718213|NCT00006409|10817593|FG000|STARTED|Baseline||865
9718214|NCT00006409|10817594|FG001|STARTED|Baseline||856
9718215|NCT00006409|10817595|FG002|STARTED|Baseline||0
9718216|NCT00006409|10817596|FG003|STARTED|Baseline||0
9718217|NCT00006409|10817597|FG004|STARTED|Baseline||0
9718218|NCT00006409|10817598|FG005|STARTED|Baseline||0
9718219|NCT00006409|10817593|FG000|COMPLETED|Baseline||817
9718220|NCT00006409|10817594|FG001|COMPLETED|Baseline||786
9718221|NCT00006409|10817595|FG002|COMPLETED|Baseline||0
9718222|NCT00006409|10817596|FG003|COMPLETED|Baseline||0
9718223|NCT00006409|10817597|FG004|COMPLETED|Baseline||0
9718224|NCT00006409|10817598|FG005|COMPLETED|Baseline||0
9718225|NCT00006409|10817593|FG000|NOT COMPLETED|Baseline||48
9718226|NCT00006409|10817594|FG001|NOT COMPLETED|Baseline||70
9718227|NCT00006409|10817595|FG002|NOT COMPLETED|Baseline||0
9718228|NCT00006409|10817596|FG003|NOT COMPLETED|Baseline||0
9718229|NCT00006409|10817597|FG004|NOT COMPLETED|Baseline||0
9718230|NCT00006409|10817598|FG005|NOT COMPLETED|Baseline||0
9718231|NCT00006409|10817593|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
9718232|NCT00006409|10817594|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
9718233|NCT00006409|10817595|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
9718234|NCT00006409|10817596|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
9718235|NCT00006409|10817597|FG004|STARTED|Post-2 Year Intervention||0
9718236|NCT00006409|10817598|FG005|STARTED|Post-2 Year Intervention||0
9718237|NCT00006409|10817593|FG000|COMPLETED|Post-2 Year Intervention||0
9718238|NCT00006409|10817594|FG001|COMPLETED|Post-2 Year Intervention||0
9718239|NCT00006409|10817595|FG002|COMPLETED|Post-2 Year Intervention||1540
9718240|NCT00006409|10817596|FG003|COMPLETED|Post-2 Year Intervention||1545
9718241|NCT00006409|10817597|FG004|COMPLETED|Post-2 Year Intervention||0
9718242|NCT00006409|10817598|FG005|COMPLETED|Post-2 Year Intervention||0
9718243|NCT00006409|10817593|FG000|NOT COMPLETED|Post-2 Year Intervention||0
9718244|NCT00006409|10817594|FG001|NOT COMPLETED|Post-2 Year Intervention||0
9718245|NCT00006409|10817595|FG002|NOT COMPLETED|Post-2 Year Intervention||251
9718246|NCT00006409|10817596|FG003|NOT COMPLETED|Post-2 Year Intervention||168
9718247|NCT00006409|10817597|FG004|NOT COMPLETED|Post-2 Year Intervention||0
9718248|NCT00006409|10817598|FG005|NOT COMPLETED|Post-2 Year Intervention||0
9718249|NCT00006409|10817593|FG000|STARTED|Post-3 Year Intervention||0
9718250|NCT00006409|10817594|FG001|STARTED|Post-3 Year Intervention||0
9718251|NCT00006409|10817595|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
9718252|NCT00006409|10817596|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
9718253|NCT00006409|10817597|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
9718254|NCT00006409|10817598|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
9718255|NCT00006409|10817593|FG000|COMPLETED|Post-3 Year Intervention||0
9718256|NCT00006409|10817594|FG001|COMPLETED|Post-3 Year Intervention||0
9718257|NCT00006409|10817595|FG002|COMPLETED|Post-3 Year Intervention||0
9718258|NCT00006409|10817596|FG003|COMPLETED|Post-3 Year Intervention||0
9718259|NCT00006409|10817597|FG004|COMPLETED|Post-3 Year Intervention||1664
9718260|NCT00006409|10817598|FG005|COMPLETED|Post-3 Year Intervention||1714
9718261|NCT00006409|10817593|FG000|NOT COMPLETED|Post-3 Year Intervention||0
9718262|NCT00006409|10817594|FG001|NOT COMPLETED|Post-3 Year Intervention||0
9718263|NCT00006409|10817595|FG002|NOT COMPLETED|Post-3 Year Intervention||0
9718264|NCT00006409|10817596|FG003|NOT COMPLETED|Post-3 Year Intervention||0
9718265|NCT00006409|10817597|FG004|NOT COMPLETED|Post-3 Year Intervention||62
9718266|NCT00006409|10817598|FG005|NOT COMPLETED|Post-3 Year Intervention||62
9718267|NCT00006411|10817614|FG000|STARTED|Overall Study||707
9718268|NCT00006411|10817615|FG001|STARTED|Overall Study||383
9718269|NCT00006411|10817614|FG000|COMPLETED|Overall Study||707
9718270|NCT00006411|10817615|FG001|COMPLETED|Overall Study||383
9718271|NCT00006411|10817614|FG000|NOT COMPLETED|Overall Study||0
9718272|NCT00006411|10817615|FG001|NOT COMPLETED|Overall Study||0
9718273|NCT00006489|10817625|FG000|STARTED|Overall Study||42
9718274|NCT00006489|10817626|FG001|STARTED|Overall Study||40
9718275|NCT00006489|10817627|FG002|STARTED|Overall Study||40
9718276|NCT00006489|10817628|FG003|STARTED|Overall Study||43
9718277|NCT00006489|10817625|FG000|COMPLETED|Overall Study||29
9718278|NCT00006489|10817626|FG001|COMPLETED|Overall Study||26
9718279|NCT00006489|10817627|FG002|COMPLETED|Overall Study||25
9718280|NCT00006489|10817628|FG003|COMPLETED|Overall Study||32
9718281|NCT00006489|10817625|FG000|NOT COMPLETED|Overall Study||13
9718282|NCT00006489|10817626|FG001|NOT COMPLETED|Overall Study||14
9718283|NCT00006489|10817627|FG002|NOT COMPLETED|Overall Study||15
9718284|NCT00006489|10817628|FG003|NOT COMPLETED|Overall Study||11
9718285|NCT00006604|10817645|FG000|STARTED|Overall Study||6
9718286|NCT00006604|10817646|FG001|STARTED|Overall Study||2
9718287|NCT00006604|10817647|FG002|STARTED|Overall Study||5
9718288|NCT00006604|10817648|FG003|STARTED|Overall Study||6
9718289|NCT00006604|10817649|FG004|STARTED|Overall Study||5
9718290|NCT00006604|10817650|FG005|STARTED|Overall Study||5
9718291|NCT00006604|10817651|FG006|STARTED|Overall Study||21
9718292|NCT00006604|10817652|FG007|STARTED|Overall Study||5
9718293|NCT00006604|10817653|FG008|STARTED|Overall Study||5
9718294|NCT00006604|10817654|FG009|STARTED|Overall Study||25
9718295|NCT00006604|10817655|FG010|STARTED|Overall Study||21
9718296|NCT00006604|10817656|FG011|STARTED|Overall Study||12
9718297|NCT00006604|10817657|FG012|STARTED|Overall Study||26
9718298|NCT00006604|10817658|FG013|STARTED|Overall Study||6
9718299|NCT00006604|10817659|FG014|STARTED|Overall Study||24
9718300|NCT00006604|10817660|FG015|STARTED|Overall Study||6
9718301|NCT00006604|10817661|FG016|STARTED|Overall Study||15
9718302|NCT00006604|10817645|FG000|COMPLETED|Overall Study||4
9718303|NCT00006604|10817646|FG001|COMPLETED|Overall Study||2
9718304|NCT00006604|10817647|FG002|COMPLETED|Overall Study||1
9718305|NCT00006604|10817648|FG003|COMPLETED|Overall Study||1
9718306|NCT00006604|10817649|FG004|COMPLETED|Overall Study||3
9718307|NCT00006604|10817650|FG005|COMPLETED|Overall Study||2
9718308|NCT00006604|10817651|FG006|COMPLETED|Overall Study||12
9718309|NCT00006604|10817652|FG007|COMPLETED|Overall Study||2
9718310|NCT00006604|10817653|FG008|COMPLETED|Overall Study||4
9718311|NCT00006604|10817654|FG009|COMPLETED|Overall Study||6
9718312|NCT00006604|10817655|FG010|COMPLETED|Overall Study||13
9718313|NCT00006604|10817656|FG011|COMPLETED|Overall Study||6
9718314|NCT00006604|10817657|FG012|COMPLETED|Overall Study||22
9718315|NCT00006604|10817658|FG013|COMPLETED|Overall Study||0
9718316|NCT00006604|10817659|FG014|COMPLETED|Overall Study||14
9718317|NCT00006604|10817660|FG015|COMPLETED|Overall Study||1
9718318|NCT00006604|10817661|FG016|COMPLETED|Overall Study||6
9718319|NCT00006604|10817645|FG000|NOT COMPLETED|Overall Study||2
9718320|NCT00006604|10817646|FG001|NOT COMPLETED|Overall Study||0
9718321|NCT00006604|10817647|FG002|NOT COMPLETED|Overall Study||4
9718322|NCT00006604|10817648|FG003|NOT COMPLETED|Overall Study||5
9718323|NCT00006604|10817649|FG004|NOT COMPLETED|Overall Study||2
9718324|NCT00006604|10817650|FG005|NOT COMPLETED|Overall Study||3
9718325|NCT00006604|10817651|FG006|NOT COMPLETED|Overall Study||9
9718326|NCT00006604|10817652|FG007|NOT COMPLETED|Overall Study||3
9718327|NCT00006604|10817653|FG008|NOT COMPLETED|Overall Study||1
9718328|NCT00006604|10817654|FG009|NOT COMPLETED|Overall Study||19
9718329|NCT00006604|10817655|FG010|NOT COMPLETED|Overall Study||8
9718330|NCT00006604|10817656|FG011|NOT COMPLETED|Overall Study||6
9718331|NCT00006604|10817657|FG012|NOT COMPLETED|Overall Study||4
9718332|NCT00006604|10817658|FG013|NOT COMPLETED|Overall Study||6
9718333|NCT00006604|10817659|FG014|NOT COMPLETED|Overall Study||10
9718334|NCT00006604|10817660|FG015|NOT COMPLETED|Overall Study||5
9718335|NCT00006604|10817661|FG016|NOT COMPLETED|Overall Study||9
9718336|NCT00006721|10817687|FG000|STARTED|Overall Study||17
9718337|NCT00006721|10817688|FG001|STARTED|Overall Study||279
9718338|NCT00006721|10817689|FG002|STARTED|Overall Study||275
9718339|NCT00006721|10817687|FG000|Eligible|Overall Study||15
9718340|NCT00006721|10817688|FG001|Eligible|Overall Study||267
9718341|NCT00006721|10817689|FG002|Eligible|Overall Study||265
10195427|NCT03345914|11323750|FG000|Completed Week 28 End of Study|Overall Study||0
10195428|NCT03345914|11323751|FG001|Completed Week 28 End of Study|Overall Study||0
10195429|NCT03345914|11323752|FG002|Completed Week 28 End of Study|Overall Study||0
10195430|NCT03345914|11323750|FG000|COMPLETED|Overall Study||0
10195431|NCT03345914|11323751|FG001|COMPLETED|Overall Study||0
10195432|NCT03345914|11323752|FG002|COMPLETED|Overall Study||0
10195433|NCT03345914|11323750|FG000|NOT COMPLETED|Overall Study||123
10195434|NCT03345914|11323751|FG001|NOT COMPLETED|Overall Study||122
10195435|NCT03345914|11323752|FG002|NOT COMPLETED|Overall Study||122
10195436|NCT03345979|11323762|FG000|STARTED|Overall Study||99
10195437|NCT03345979|11323763|FG001|STARTED|Overall Study||101
10195438|NCT03345979|11323762|FG000|COMPLETED|Overall Study||56
10195439|NCT03345979|11323763|FG001|COMPLETED|Overall Study||43
10195440|NCT03345979|11323762|FG000|NOT COMPLETED|Overall Study||43
10195441|NCT03345979|11323763|FG001|NOT COMPLETED|Overall Study||58
10195442|NCT03346057|11323773|FG000|STARTED|Overall Study||111
10195443|NCT03346057|11323774|FG001|STARTED|Overall Study||112
10195444|NCT03346057|11323775|FG002|STARTED|Overall Study||68
10195445|NCT03346057|11323776|FG003|STARTED|Overall Study||53
10195446|NCT03346057|11323773|FG000|Treated|Overall Study||105
10195447|NCT03346057|11323774|FG001|Treated|Overall Study||107
10195448|NCT03346057|11323775|FG002|Treated|Overall Study||68
10195449|NCT03346057|11323776|FG003|Treated|Overall Study||51
10195450|NCT03346057|11323773|FG000|COMPLETED|Overall Study||104
9718342|NCT00006721|10817687|FG000|Eligible and Began Protocol Therapy|Overall Study||14
9718343|NCT00006721|10817688|FG001|Eligible and Began Protocol Therapy|Overall Study||267
9718344|NCT00006721|10817689|FG002|Eligible and Began Protocol Therapy|Overall Study||265
9718345|NCT00006721|10817687|FG000|COMPLETED|Overall Study||13
9718346|NCT00006721|10817688|FG001|COMPLETED|Overall Study||254
9718347|NCT00006721|10817689|FG002|COMPLETED|Overall Study||242
9718348|NCT00006721|10817687|FG000|NOT COMPLETED|Overall Study||4
9718349|NCT00006721|10817688|FG001|NOT COMPLETED|Overall Study||25
9718350|NCT00006721|10817689|FG002|NOT COMPLETED|Overall Study||33
9718351|NCT00006903|10817701|FG000|STARTED|Overall Study||10
9718352|NCT00006903|10817702|FG001|STARTED|Overall Study||24
9718353|NCT00006903|10817703|FG002|STARTED|Overall Study||33
9718354|NCT00006903|10817701|FG000|COMPLETED|Overall Study||0
9718355|NCT00006903|10817702|FG001|COMPLETED|Overall Study||20
9718356|NCT00006903|10817703|FG002|COMPLETED|Overall Study||27
10195451|NCT03346057|11323774|FG001|COMPLETED|Overall Study||104
10195452|NCT03346057|11323775|FG002|COMPLETED|Overall Study||67
10195453|NCT03346057|11323776|FG003|COMPLETED|Overall Study||51
10195454|NCT03346057|11323773|FG000|NOT COMPLETED|Overall Study||7
9718357|NCT00006903|10817701|FG000|NOT COMPLETED|Overall Study||10
9718358|NCT00006903|10817702|FG001|NOT COMPLETED|Overall Study||4
9718359|NCT00006903|10817703|FG002|NOT COMPLETED|Overall Study||6
9718360|NCT00007020|10817711|FG000|STARTED|Overall Study||85
9718361|NCT00007020|10817711|FG000|COMPLETED|Overall Study||41
9718362|NCT00007020|10817711|FG000|NOT COMPLETED|Overall Study||44
9718363|NCT00007345|10817719|FG000|STARTED|Overall Study||47
9718364|NCT00007345|10817720|FG001|STARTED|Overall Study||84
9718365|NCT00007345|10817719|FG000|COMPLETED|Overall Study||45
9718366|NCT00007345|10817720|FG001|COMPLETED|Overall Study||73
9718367|NCT00007345|10817719|FG000|NOT COMPLETED|Overall Study||2
9718368|NCT00007345|10817720|FG001|NOT COMPLETED|Overall Study||11
9718369|NCT00007475|10817729|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
9718370|NCT00007475|10817730|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
9718371|NCT00007475|10817731|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
9718372|NCT00007475|10817732|FG003|STARTED|Overall Study||0
9718373|NCT00007475|10817729|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
9718374|NCT00007475|10817730|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
9718375|NCT00007475|10817731|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
9718376|NCT00007475|10817732|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
9718377|NCT00007475|10817729|FG000|Initial Transplant|Overall Study||12
9718378|NCT00007475|10817730|FG001|Initial Transplant|Overall Study||1
9718379|NCT00007475|10817731|FG002|Initial Transplant|Overall Study||2
9718380|NCT00007475|10817732|FG003|Initial Transplant|Overall Study||0
9718381|NCT00007475|10817729|FG000|Post-initial Transplant Proteinuria|Overall Study||12
9718382|NCT00007475|10817730|FG001|Post-initial Transplant Proteinuria|Overall Study||1
9718383|NCT00007475|10817731|FG002|Post-initial Transplant Proteinuria|Overall Study||2
9718384|NCT00007475|10817732|FG003|Post-initial Transplant Proteinuria|Overall Study||0
9718385|NCT00007475|10817729|FG000|Initial Plasma Exchange|Overall Study||12
9718386|NCT00007475|10817730|FG001|Initial Plasma Exchange|Overall Study||1
9718387|NCT00007475|10817731|FG002|Initial Plasma Exchange|Overall Study||2
9718388|NCT00007475|10817732|FG003|Initial Plasma Exchange|Overall Study||0
9718389|NCT00007475|10817729|FG000|Initiate Cyclophosphamide|Overall Study||12
9718390|NCT00007475|10817730|FG001|Initiate Cyclophosphamide|Overall Study||1
9718391|NCT00007475|10817731|FG002|Initiate Cyclophosphamide|Overall Study||2
9718392|NCT00007475|10817732|FG003|Initiate Cyclophosphamide|Overall Study||0
9718393|NCT00007475|10817729|FG000|COMPLETED|Overall Study||8
9718394|NCT00007475|10817730|FG001|COMPLETED|Overall Study||1
9718395|NCT00007475|10817731|FG002|COMPLETED|Overall Study||2
9718396|NCT00007475|10817732|FG003|COMPLETED|Overall Study||0
9718397|NCT00007475|10817729|FG000|NOT COMPLETED|Overall Study||4
9718398|NCT00007475|10817730|FG001|NOT COMPLETED|Overall Study||0
9718399|NCT00007475|10817731|FG002|NOT COMPLETED|Overall Study||0
9718400|NCT00007475|10817732|FG003|NOT COMPLETED|Overall Study||0
9718401|NCT00007644|10817744|FG000|STARTED|Overall Study||364
9718402|NCT00007644|10817745|FG001|STARTED|Overall Study||367
9718403|NCT00007644|10817744|FG000|COMPLETED|Overall Study||364
9718404|NCT00007644|10817745|FG001|COMPLETED|Overall Study||367
9718405|NCT00007644|10817744|FG000|NOT COMPLETED|Overall Study||0
9718406|NCT00007644|10817745|FG001|NOT COMPLETED|Overall Study||0
9718407|NCT00008138|10817751|FG000|STARTED|Neoadjuvant Chemotherapy||58
9718408|NCT00008138|10817751|FG000|Eligible|Neoadjuvant Chemotherapy||58
9718409|NCT00008138|10817751|FG000|COMPLETED|Neoadjuvant Chemotherapy||38
9718410|NCT00008138|10817751|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20
9718411|NCT00008138|10817751|FG000|STARTED|Interval Debulking||38
9718412|NCT00008138|10817751|FG000|Received Protocol Surgery|Interval Debulking||36
9718413|NCT00008138|10817751|FG000|COMPLETED|Interval Debulking||36
9718414|NCT00008138|10817751|FG000|NOT COMPLETED|Interval Debulking||2
9718415|NCT00008138|10817751|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
9718416|NCT00008138|10817751|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18
9718417|NCT00008138|10817751|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
9718418|NCT00008385|10817758|FG000|STARTED|Overall Study||521
9718419|NCT00008385|10817759|FG001|STARTED|Overall Study||1040
9718420|NCT00008385|10817758|FG000|Treated|Overall Study||477
9718421|NCT00008385|10817759|FG001|Treated|Overall Study||865
9718422|NCT00008385|10817758|FG000|Off Treatment Reasons Reported|Overall Study||398
9718423|NCT00008385|10817759|FG001|Off Treatment Reasons Reported|Overall Study||795
9718424|NCT00008385|10817758|FG000|COMPLETED|Overall Study||134
9718425|NCT00008385|10817759|FG001|COMPLETED|Overall Study||238
9718426|NCT00008385|10817758|FG000|NOT COMPLETED|Overall Study||387
9718427|NCT00008385|10817759|FG001|NOT COMPLETED|Overall Study||802
9718428|NCT00009737|10817767|FG000|STARTED|Overall Study||1004
9718429|NCT00009737|10817768|FG001|STARTED|Overall Study||983
9718430|NCT00009737|10817767|FG000|COMPLETED|Overall Study||834
9718431|NCT00009737|10817768|FG001|COMPLETED|Overall Study||860
9718432|NCT00009737|10817767|FG000|NOT COMPLETED|Overall Study||170
9718433|NCT00009737|10817768|FG001|NOT COMPLETED|Overall Study||123
9718434|NCT00009945|10817776|FG000|STARTED|Overall Study||1662
9718435|NCT00009945|10817777|FG001|STARTED|Overall Study||1661
9718436|NCT00009945|10817776|FG000|COMPLETED|Overall Study||1655
9718437|NCT00009945|10817777|FG001|COMPLETED|Overall Study||1656
9718438|NCT00009945|10817776|FG000|NOT COMPLETED|Overall Study||7
9718439|NCT00009945|10817777|FG001|NOT COMPLETED|Overall Study||5
9718440|NCT00010257|10817785|FG000|STARTED|Overall Study||25
9718441|NCT00010257|10817786|FG001|STARTED|Overall Study||21
9718442|NCT00010257|10817785|FG000|COMPLETED|Overall Study||24
9718443|NCT00010257|10817786|FG001|COMPLETED|Overall Study||21
9718444|NCT00010257|10817785|FG000|NOT COMPLETED|Overall Study||1
9718445|NCT00010257|10817786|FG001|NOT COMPLETED|Overall Study||0
9718446|NCT00010374|10817792|FG000|STARTED|Overall Study||54
9718447|NCT00010374|10817792|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
9718448|NCT00010374|10817792|FG000|NOT COMPLETED|Overall Study||1
9718449|NCT00010439|10817797|FG000|STARTED|Overall Study||10
9718450|NCT00010439|10817797|FG000|6 Months|Overall Study||10
9718451|NCT00010439|10817797|FG000|COMPLETED|Overall Study||10
9718452|NCT00010439|10817797|FG000|NOT COMPLETED|Overall Study||0
9718453|NCT00010803|10817803|FG000|STARTED|Overall Study|Randomized|1545
9718454|NCT00010803|10817804|FG001|STARTED|Overall Study|Randomized|1524
9718455|NCT00010803|10817803|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
9718456|NCT00010803|10817804|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
9718457|NCT00010803|10817803|FG000|NOT COMPLETED|Overall Study||97
9718458|NCT00010803|10817804|FG001|NOT COMPLETED|Overall Study||98
9718459|NCT00011986|10817815|FG000|STARTED|Overall Study||864
9718460|NCT00011986|10817816|FG001|STARTED|Overall Study||864
9718461|NCT00011986|10817817|FG002|STARTED|Overall Study||862
9718462|NCT00011986|10817818|FG003|STARTED|Overall Study||861
9718463|NCT00011986|10817819|FG004|STARTED|Overall Study||861
9718464|NCT00011986|10817815|FG000|Initiated Treatment|Overall Study||862
9718465|NCT00011986|10817816|FG001|Initiated Treatment|Overall Study||860
9718466|NCT00011986|10817817|FG002|Initiated Treatment|Overall Study||854
9718467|NCT00011986|10817818|FG003|Initiated Treatment|Overall Study||846
9718468|NCT00011986|10817819|FG004|Initiated Treatment|Overall Study||851
9718469|NCT00011986|10817815|FG000|COMPLETED|Overall Study||864
9718470|NCT00011986|10817816|FG001|COMPLETED|Overall Study||864
9718471|NCT00011986|10817817|FG002|COMPLETED|Overall Study||862
9718472|NCT00011986|10817818|FG003|COMPLETED|Overall Study||861
9718473|NCT00011986|10817819|FG004|COMPLETED|Overall Study||861
9718474|NCT00011986|10817815|FG000|NOT COMPLETED|Overall Study||0
9718475|NCT00011986|10817816|FG001|NOT COMPLETED|Overall Study||0
9718476|NCT00011986|10817817|FG002|NOT COMPLETED|Overall Study||0
9718477|NCT00011986|10817818|FG003|NOT COMPLETED|Overall Study||0
9718478|NCT00011986|10817819|FG004|NOT COMPLETED|Overall Study||0
9718479|NCT00012012|10817838|FG000|STARTED|Overall Study||27
9718480|NCT00012012|10817839|FG001|STARTED|Overall Study||18
9718481|NCT00012012|10817838|FG000|COMPLETED|Overall Study||26
9718482|NCT00012012|10817839|FG001|COMPLETED|Overall Study||15
9718483|NCT00012012|10817838|FG000|NOT COMPLETED|Overall Study||1
9718484|NCT00012012|10817839|FG001|NOT COMPLETED|Overall Study||3
9718485|NCT00012298|10817852|FG000|STARTED|Overall Study||11
9718486|NCT00012298|10817853|FG001|STARTED|Overall Study||7
9718487|NCT00012298|10817854|FG002|STARTED|Overall Study||9
9718488|NCT00012298|10817855|FG003|STARTED|Overall Study||4
9718489|NCT00012298|10817856|FG004|STARTED|Overall Study||5
9718490|NCT00012298|10817857|FG005|STARTED|Overall Study||6
9718491|NCT00012298|10817858|FG006|STARTED|Overall Study||39
9718492|NCT00012298|10817852|FG000|COMPLETED|Overall Study||11
9718493|NCT00012298|10817853|FG001|COMPLETED|Overall Study||7
9718494|NCT00012298|10817854|FG002|COMPLETED|Overall Study||9
9718495|NCT00012298|10817855|FG003|COMPLETED|Overall Study||4
9718496|NCT00012298|10817856|FG004|COMPLETED|Overall Study||5
9718497|NCT00012298|10817857|FG005|COMPLETED|Overall Study||6
9718498|NCT00012298|10817858|FG006|COMPLETED|Overall Study||39
9718499|NCT00012298|10817852|FG000|NOT COMPLETED|Overall Study||0
9718500|NCT00012298|10817853|FG001|NOT COMPLETED|Overall Study||0
9718501|NCT00012298|10817854|FG002|NOT COMPLETED|Overall Study||0
9718502|NCT00012298|10817855|FG003|NOT COMPLETED|Overall Study||0
9718503|NCT00012298|10817856|FG004|NOT COMPLETED|Overall Study||0
9718504|NCT00012298|10817857|FG005|NOT COMPLETED|Overall Study||0
9718505|NCT00012298|10817858|FG006|NOT COMPLETED|Overall Study||0
9718506|NCT00013611|10817878|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
9718507|NCT00013611|10817879|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
9718508|NCT00013611|10817878|FG000|COMPLETED|Overall Study||758
9718509|NCT00013611|10817879|FG001|COMPLETED|Overall Study||746
9718510|NCT00013611|10817878|FG000|NOT COMPLETED|Overall Study||91
9718511|NCT00013611|10817879|FG001|NOT COMPLETED|Overall Study||100
9718512|NCT00014222|10817888|FG000|STARTED|Overall Study||701
9718513|NCT00014222|10817889|FG001|STARTED|Overall Study||701
9718514|NCT00014222|10817890|FG002|STARTED|Overall Study||702
9718515|NCT00014222|10817888|FG000|COMPLETED|Overall Study||680
9718516|NCT00014222|10817889|FG001|COMPLETED|Overall Study||688
9718517|NCT00014222|10817890|FG002|COMPLETED|Overall Study||675
10080341|NCT02250651|11208501|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
10080342|NCT02250651|11208502|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
10080343|NCT02250651|11208503|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
9718518|NCT00014222|10817888|FG000|NOT COMPLETED|Overall Study||21
9718519|NCT00014222|10817889|FG001|NOT COMPLETED|Overall Study||13
9718520|NCT00014222|10817890|FG002|NOT COMPLETED|Overall Study||27
9718521|NCT00014495|10817902|FG000|STARTED|Overall Study||3
9718522|NCT00014495|10817903|FG001|STARTED|Overall Study||3
9718523|NCT00014495|10817904|FG002|STARTED|Overall Study||20
9718524|NCT00014495|10817905|FG003|STARTED|Overall Study||6
10080344|NCT02250651|11208501|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
10080345|NCT02250651|11208502|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
10080346|NCT02250651|11208503|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
10080347|NCT02250651|11208501|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
10080348|NCT02250651|11208502|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
10080349|NCT02250651|11208503|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
10080350|NCT02250651|11208501|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
10080351|NCT02250651|11208502|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
10080352|NCT02250651|11208503|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
10080353|NCT02250651|11208501|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
10080354|NCT02250651|11208502|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
10080355|NCT02250651|11208503|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
10080356|NCT02250703|11208513|FG000|STARTED|Overall Study||38
10080357|NCT02250703|11208514|FG001|STARTED|Overall Study||37
10080358|NCT02250703|11208513|FG000|COMPLETED|Overall Study||37
10080359|NCT02250703|11208514|FG001|COMPLETED|Overall Study||36
10080360|NCT02250703|11208513|FG000|NOT COMPLETED|Overall Study||1
10080361|NCT02250703|11208514|FG001|NOT COMPLETED|Overall Study||1
10080362|NCT02250807|11208520|FG000|STARTED|Overall Study||40
10080363|NCT02250807|11208520|FG000|COMPLETED|Overall Study||40
10080364|NCT02250807|11208520|FG000|NOT COMPLETED|Overall Study||0
10080365|NCT02251236|11208527|FG000|STARTED|Overall Study||9
10080366|NCT02251236|11208528|FG001|STARTED|Overall Study||5
10080367|NCT02251236|11208529|FG002|STARTED|Overall Study||0
10080368|NCT02251236|11208527|FG000|COMPLETED|Overall Study||9
10080369|NCT02251236|11208528|FG001|COMPLETED|Overall Study||5
10080370|NCT02251236|11208529|FG002|COMPLETED|Overall Study||0
10080371|NCT02251236|11208527|FG000|NOT COMPLETED|Overall Study||0
10080372|NCT02251236|11208528|FG001|NOT COMPLETED|Overall Study||0
10080373|NCT02251236|11208529|FG002|NOT COMPLETED|Overall Study||0
10080374|NCT02251275|11208542|FG000|STARTED|Overall Study||506
10080375|NCT02251275|11208543|FG001|STARTED|Overall Study||570
10080376|NCT02251275|11208544|FG002|STARTED|Overall Study||718
10080377|NCT02251275|11208545|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
10080378|NCT02251275|11208546|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
10080379|NCT02251275|11208542|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505
10080380|NCT02251275|11208543|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569
10080381|NCT02251275|11208544|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717
10080382|NCT02251275|11208545|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10080383|NCT02251275|11208546|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10080384|NCT02251275|11208542|FG000|COMPLETED|Overall Study||434
10080385|NCT02251275|11208543|FG001|COMPLETED|Overall Study||423
10080386|NCT02251275|11208544|FG002|COMPLETED|Overall Study||624
10080387|NCT02251275|11208545|FG003|COMPLETED|Overall Study||5
10080388|NCT02251275|11208546|FG004|COMPLETED|Overall Study||2
10080389|NCT02251275|11208542|FG000|NOT COMPLETED|Overall Study||72
10080390|NCT02251275|11208543|FG001|NOT COMPLETED|Overall Study||147
10080391|NCT02251275|11208544|FG002|NOT COMPLETED|Overall Study||94
10080392|NCT02251275|11208545|FG003|NOT COMPLETED|Overall Study||1
10080393|NCT02251275|11208546|FG004|NOT COMPLETED|Overall Study||1
10080394|NCT02251379|11208560|FG000|STARTED|Overall Study||77
10080395|NCT02251379|11208561|FG001|STARTED|Overall Study||78
10080396|NCT02251379|11208560|FG000|COMPLETED|Overall Study||57
10080397|NCT02251379|11208561|FG001|COMPLETED|Overall Study||58
10080398|NCT02251379|11208560|FG000|NOT COMPLETED|Overall Study||20
10080399|NCT02251379|11208561|FG001|NOT COMPLETED|Overall Study||20
10080400|NCT02251496|11208569|FG000|STARTED|Overall Study||19
10080401|NCT02251496|11208570|FG001|STARTED|Overall Study||15
10080402|NCT02251496|11208569|FG000|COMPLETED|Overall Study||14
10080403|NCT02251496|11208570|FG001|COMPLETED|Overall Study||11
10080404|NCT02251496|11208569|FG000|NOT COMPLETED|Overall Study||5
10080405|NCT02251496|11208570|FG001|NOT COMPLETED|Overall Study||4
10080406|NCT02251561|11208576|FG000|STARTED|Overall Study||28
10080407|NCT02251561|11208576|FG000|COMPLETED|Overall Study||28
10080408|NCT02251561|11208576|FG000|NOT COMPLETED|Overall Study||0
10080409|NCT02251613|11208582|FG000|STARTED|Overall Study||50
10080410|NCT02251613|11208582|FG000|COMPLETED|Overall Study||50
10080411|NCT02251613|11208582|FG000|NOT COMPLETED|Overall Study||0
10080412|NCT02251652|11208588|FG000|STARTED|Overall Study||17
10080413|NCT02251652|11208588|FG000|COMPLETED|Overall Study||16
10080414|NCT02251652|11208588|FG000|NOT COMPLETED|Overall Study||1
10080415|NCT02251717|11208596|FG000|STARTED|Overall Study||57
10080416|NCT02251717|11208597|FG001|STARTED|Overall Study||57
10080417|NCT02251717|11208596|FG000|COMPLETED|Overall Study||56
10080418|NCT02251717|11208597|FG001|COMPLETED|Overall Study||56
10080419|NCT02251717|11208596|FG000|NOT COMPLETED|Overall Study||1
10080420|NCT02251717|11208597|FG001|NOT COMPLETED|Overall Study||1
10080421|NCT02251743|11208605|FG000|STARTED|Overall Study||85
10080422|NCT02251743|11208606|FG001|STARTED|Overall Study||59
10080423|NCT02251743|11208605|FG000|COMPLETED|Overall Study||84
10080424|NCT02251743|11208606|FG001|COMPLETED|Overall Study||58
10080425|NCT02251743|11208605|FG000|NOT COMPLETED|Overall Study||1
10080426|NCT02251743|11208606|FG001|NOT COMPLETED|Overall Study||1
10080427|NCT02251886|11208616|FG000|STARTED|Overall Study||48
10080428|NCT02251886|11208617|FG001|STARTED|Overall Study||54
10080429|NCT02251886|11208618|FG002|STARTED|Overall Study||44
10080430|NCT02251886|11208619|FG003|STARTED|Overall Study||54
10080431|NCT02251886|11208616|FG000|COMPLETED|Overall Study||48
10080432|NCT02251886|11208617|FG001|COMPLETED|Overall Study||54
10080433|NCT02251886|11208618|FG002|COMPLETED|Overall Study||44
10080434|NCT02251886|11208619|FG003|COMPLETED|Overall Study||54
10080435|NCT02251886|11208616|FG000|NOT COMPLETED|Overall Study||0
10080436|NCT02251886|11208617|FG001|NOT COMPLETED|Overall Study||0
10080437|NCT02251886|11208618|FG002|NOT COMPLETED|Overall Study||0
10080438|NCT02251886|11208619|FG003|NOT COMPLETED|Overall Study||0
10080439|NCT02251912|11208631|FG000|STARTED|Overall Study||12
10080440|NCT02251912|11208632|FG001|STARTED|Overall Study||10
10080441|NCT02251912|11208631|FG000|COMPLETED|Overall Study||10
10080442|NCT02251912|11208632|FG001|COMPLETED|Overall Study||5
10080443|NCT02251912|11208631|FG000|NOT COMPLETED|Overall Study||2
10080444|NCT02251912|11208632|FG001|NOT COMPLETED|Overall Study||5
10080445|NCT02251938|11208638|FG000|STARTED|Overall Study||60
10080446|NCT02251938|11208638|FG000|COMPLETED|Overall Study||43
10080447|NCT02251938|11208638|FG000|NOT COMPLETED|Overall Study||17
10080448|NCT02251990|11208644|FG000|STARTED|Period 1 (Double-blind [DB])||366
10080449|NCT02251990|11208645|FG001|STARTED|Period 1 (Double-blind [DB])||123
10080450|NCT02251990|11208644|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
10080451|NCT02251990|11208645|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
10080452|NCT02251990|11208644|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
10080453|NCT02251990|11208645|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
10080454|NCT02251990|11208644|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8
10080455|NCT02251990|11208645|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1
10080456|NCT02251990|11208644|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
10080457|NCT02251990|11208645|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
10080458|NCT02251990|11208644|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
10080459|NCT02251990|11208645|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
10080460|NCT02251990|11208644|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
10080461|NCT02251990|11208645|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
10080462|NCT02251990|11208644|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
10080463|NCT02251990|11208645|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
10080464|NCT02251990|11208644|FG000|COMPLETED|Period 3 (DTG Follow-up)||0
10080465|NCT02251990|11208645|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
10080466|NCT02251990|11208644|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0
10080467|NCT02251990|11208645|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0
10080468|NCT02252016|11208654|FG000|STARTED|Overall Study||107
10080469|NCT02252016|11208655|FG001|STARTED|Overall Study||52
10080470|NCT02252016|11208654|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
10080471|NCT02252016|11208655|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
10080472|NCT02252016|11208654|FG000|NOT COMPLETED|Overall Study||3
10080473|NCT02252016|11208655|FG001|NOT COMPLETED|Overall Study||3
10080474|NCT02252042|11208663|FG000|STARTED|Overall Study||247
10080475|NCT02252042|11208664|FG001|STARTED|Overall Study||248
10080476|NCT02252042|11208663|FG000|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
10080477|NCT02252042|11208664|FG001|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
10080478|NCT02252042|11208663|FG000|COMPLETED|Overall Study||0
10080479|NCT02252042|11208664|FG001|COMPLETED|Overall Study||0
10080480|NCT02252042|11208663|FG000|NOT COMPLETED|Overall Study||247
10080481|NCT02252042|11208664|FG001|NOT COMPLETED|Overall Study||248
10080482|NCT02252068|11208673|FG000|STARTED|Overall Study||5
10080483|NCT02252068|11208674|FG001|STARTED|Overall Study||13
10080484|NCT02252068|11208675|FG002|STARTED|Overall Study||13
10080485|NCT02252068|11208673|FG000|COMPLETED|Overall Study||3
10080486|NCT02252068|11208674|FG001|COMPLETED|Overall Study||13
10080487|NCT02252068|11208675|FG002|COMPLETED|Overall Study||13
10080488|NCT02252068|11208673|FG000|NOT COMPLETED|Overall Study||2
10080489|NCT02252068|11208674|FG001|NOT COMPLETED|Overall Study||0
10080490|NCT02252068|11208675|FG002|NOT COMPLETED|Overall Study||0
10080491|NCT02252081|11208685|FG000|STARTED|Overall Study||30
10080492|NCT02252081|11208686|FG001|STARTED|Overall Study||30
10080493|NCT02252081|11208685|FG000|COMPLETED|Overall Study||24
10080494|NCT02252081|11208686|FG001|COMPLETED|Overall Study||26
10080495|NCT02252081|11208685|FG000|NOT COMPLETED|Overall Study||6
10080496|NCT02252081|11208686|FG001|NOT COMPLETED|Overall Study||4
10080497|NCT02252133|11208697|FG000|STARTED|Period 1||23
10080498|NCT02252133|11208698|FG001|STARTED|Period 1||24
10080499|NCT02252133|11208697|FG000|COMPLETED|Period 1||23
10080500|NCT02252133|11208698|FG001|COMPLETED|Period 1||24
10080501|NCT02252133|11208697|FG000|NOT COMPLETED|Period 1||0
10080502|NCT02252133|11208698|FG001|NOT COMPLETED|Period 1||0
10080503|NCT02252133|11208697|FG000|STARTED|Period 2||23
10080504|NCT02252133|11208698|FG001|STARTED|Period 2||24
10080505|NCT02252133|11208697|FG000|COMPLETED|Period 2||23
10080506|NCT02252133|11208698|FG001|COMPLETED|Period 2||24
10080507|NCT02252133|11208697|FG000|NOT COMPLETED|Period 2||0
10080508|NCT02252133|11208698|FG001|NOT COMPLETED|Period 2||0
10080509|NCT02252146|11208704|FG000|STARTED|Overall Study||6
10080510|NCT02252146|11208704|FG000|COMPLETED|Overall Study||0
10080511|NCT02252146|11208704|FG000|NOT COMPLETED|Overall Study||6
10080512|NCT02252211|11208710|FG000|STARTED|Overall Study||5
10080513|NCT02252211|11208711|FG001|STARTED|Overall Study||3
10080514|NCT02252211|11208712|FG002|STARTED|Overall Study||1
10080515|NCT02252211|11208710|FG000|Received Dose 1 (Day 1)|Overall Study||4
10080516|NCT02252211|11208711|FG001|Received Dose 1 (Day 1)|Overall Study||3
10080517|NCT02252211|11208712|FG002|Received Dose 1 (Day 1)|Overall Study||0
10080518|NCT02252211|11208710|FG000|Received Dose 2 (Day 8)|Overall Study||4
10080519|NCT02252211|11208711|FG001|Received Dose 2 (Day 8)|Overall Study||3
10080520|NCT02252211|11208712|FG002|Received Dose 2 (Day 8)|Overall Study||0
10080521|NCT02252211|11208710|FG000|Received Dose 3 (Day 22)|Overall Study||3
10080522|NCT02252211|11208711|FG001|Received Dose 3 (Day 22)|Overall Study||3
10080523|NCT02252211|11208712|FG002|Received Dose 3 (Day 22)|Overall Study||0
10080524|NCT02252211|11208710|FG000|Received Dose 4 (Day 36)|Overall Study||1
10080525|NCT02252211|11208711|FG001|Received Dose 4 (Day 36)|Overall Study||1
10080526|NCT02252211|11208712|FG002|Received Dose 4 (Day 36)|Overall Study||0
10080527|NCT02252211|11208710|FG000|Received Further Doses (Through Dose 24)|Overall Study||1
10080528|NCT02252211|11208711|FG001|Received Further Doses (Through Dose 24)|Overall Study||0
10080529|NCT02252211|11208712|FG002|Received Further Doses (Through Dose 24)|Overall Study||0
10080530|NCT02252211|11208710|FG000|COMPLETED|Overall Study||0
10080531|NCT02252211|11208711|FG001|COMPLETED|Overall Study||0
10080532|NCT02252211|11208712|FG002|COMPLETED|Overall Study||0
10080533|NCT02252211|11208710|FG000|NOT COMPLETED|Overall Study||5
10080534|NCT02252211|11208711|FG001|NOT COMPLETED|Overall Study||3
10080535|NCT02252211|11208712|FG002|NOT COMPLETED|Overall Study||1
10080536|NCT02252354|11208721|FG000|STARTED|Overall Study||6
10080537|NCT02252354|11208722|FG001|STARTED|Overall Study||6
10080538|NCT02252354|11208721|FG000|COMPLETED|Overall Study||6
10080539|NCT02252354|11208722|FG001|COMPLETED|Overall Study||6
10080540|NCT02252354|11208721|FG000|NOT COMPLETED|Overall Study||0
10080541|NCT02252354|11208722|FG001|NOT COMPLETED|Overall Study||0
10080542|NCT02252406|11208730|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16
10080543|NCT02252406|11208731|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17
10080544|NCT02252406|11208730|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
10080545|NCT02252406|11208731|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
10080546|NCT02252406|11208730|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
10080547|NCT02252406|11208731|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
10080548|NCT02252406|11208730|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12
10080549|NCT02252406|11208731|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14
10080550|NCT02252406|11208730|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9
10080551|NCT02252406|11208731|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13
10080552|NCT02252406|11208730|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
10080553|NCT02252406|11208731|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
10080554|NCT02252445|11208739|FG000|STARTED|Overall Study||41
10080555|NCT02252445|11208740|FG001|STARTED|Overall Study||41
10080556|NCT02252445|11208739|FG000|COMPLETED|Overall Study||41
10080557|NCT02252445|11208740|FG001|COMPLETED|Overall Study||41
10080558|NCT02252445|11208739|FG000|NOT COMPLETED|Overall Study||0
10080559|NCT02252445|11208740|FG001|NOT COMPLETED|Overall Study||0
10080560|NCT02252536|11208748|FG000|STARTED|Overall Study||173
10080561|NCT02252536|11208749|FG001|STARTED|Overall Study||173
10080562|NCT02252536|11208748|FG000|COMPLETED|Overall Study||168
10080563|NCT02252536|11208749|FG001|COMPLETED|Overall Study||170
10080564|NCT02252536|11208748|FG000|NOT COMPLETED|Overall Study||5
10080565|NCT02252536|11208749|FG001|NOT COMPLETED|Overall Study||3
10080566|NCT02252562|11208757|FG000|STARTED|Overall Study||1620
10080567|NCT02252562|11208758|FG001|STARTED|Overall Study||1636
10080568|NCT02252562|11208757|FG000|COMPLETED|Overall Study||1620
10080569|NCT02252562|11208758|FG001|COMPLETED|Overall Study||1636
10080570|NCT02252562|11208757|FG000|NOT COMPLETED|Overall Study||0
10080571|NCT02252562|11208758|FG001|NOT COMPLETED|Overall Study||0
10080572|NCT02252588|11208767|FG000|STARTED|Overall Study||24
10080573|NCT02252588|11208768|FG001|STARTED|Overall Study||20
10080574|NCT02252588|11208767|FG000|COMPLETED|Overall Study||20
10080575|NCT02252588|11208768|FG001|COMPLETED|Overall Study||20
10080576|NCT02252588|11208767|FG000|NOT COMPLETED|Overall Study||4
10080577|NCT02252588|11208768|FG001|NOT COMPLETED|Overall Study||0
10195455|NCT03346057|11323774|FG001|NOT COMPLETED|Overall Study||8
10080578|NCT02252666|11208774|FG000|STARTED|Overall Study||6
10080579|NCT02252666|11208774|FG000|COMPLETED|Overall Study||6
10080580|NCT02252666|11208774|FG000|NOT COMPLETED|Overall Study||0
10080581|NCT02252718|11208778|FG000|STARTED|Overall Study||100
10080582|NCT02252718|11208778|FG000|COMPLETED|Overall Study||100
10080583|NCT02252718|11208778|FG000|NOT COMPLETED|Overall Study||0
10080584|NCT02252744|11208782|FG000|STARTED|Overall Study||286
10080585|NCT02252744|11208782|FG000|COMPLETED|Overall Study||286
10080586|NCT02252744|11208782|FG000|NOT COMPLETED|Overall Study||0
10080587|NCT02252939|11208786|FG000|STARTED|Overall Study||62
10080588|NCT02252939|11208786|FG000|COMPLETED|Overall Study||59
10080589|NCT02252939|11208786|FG000|NOT COMPLETED|Overall Study||3
10080590|NCT02252965|11208797|FG000|STARTED|Overall Study||267
10080591|NCT02252965|11208798|FG001|STARTED|Overall Study||265
10080592|NCT02252965|11208797|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
10080593|NCT02252965|11208798|FG001|Safety Population|Overall Study||264
10080594|NCT02252965|11208797|FG000|COMPLETED|Overall Study||227
10080595|NCT02252965|11208798|FG001|COMPLETED|Overall Study||222
10195456|NCT03346057|11323775|FG002|NOT COMPLETED|Overall Study||1
9718525|NCT00014495|10817902|FG000|COMPLETED|Overall Study||3
9718526|NCT00014495|10817903|FG001|COMPLETED|Overall Study||3
9718527|NCT00014495|10817904|FG002|COMPLETED|Overall Study||19
9718528|NCT00014495|10817905|FG003|COMPLETED|Overall Study||5
9718529|NCT00014495|10817902|FG000|NOT COMPLETED|Overall Study||0
9718530|NCT00014495|10817903|FG001|NOT COMPLETED|Overall Study||0
9718531|NCT00014495|10817904|FG002|NOT COMPLETED|Overall Study||1
9718532|NCT00014495|10817905|FG003|NOT COMPLETED|Overall Study||1
9718533|NCT00014911|10817912|FG000|STARTED|Overall Study||36
9718534|NCT00014911|10817912|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
9718535|NCT00014911|10817912|FG000|NOT COMPLETED|Overall Study||11
9718536|NCT00015457|10817916|FG000|STARTED|First Intervention||8
9718537|NCT00015457|10817917|FG001|STARTED|First Intervention||8
9718538|NCT00015457|10817916|FG000|COMPLETED|First Intervention||8
9718539|NCT00015457|10817917|FG001|COMPLETED|First Intervention||5
9718540|NCT00015457|10817916|FG000|NOT COMPLETED|First Intervention||0
9718541|NCT00015457|10817917|FG001|NOT COMPLETED|First Intervention||3
9718542|NCT00015457|10817916|FG000|STARTED|Second Intervention||8
9718543|NCT00015457|10817917|FG001|STARTED|Second Intervention||5
9718544|NCT00015457|10817916|FG000|COMPLETED|Second Intervention||7
9718545|NCT00015457|10817917|FG001|COMPLETED|Second Intervention||5
9718546|NCT00015457|10817916|FG000|NOT COMPLETED|Second Intervention||1
9718547|NCT00015457|10817917|FG001|NOT COMPLETED|Second Intervention||0
9718548|NCT00015847|10817923|FG000|STARTED|Overall Study||25
9718549|NCT00015847|10817923|FG000|COMPLETED|Overall Study||25
9718550|NCT00015847|10817923|FG000|NOT COMPLETED|Overall Study||0
9718551|NCT00016354|10817927|FG000|STARTED|Overall Study||1
9718552|NCT00016354|10817928|FG001|STARTED|Overall Study||1
9718553|NCT00016354|10817929|FG002|STARTED|Overall Study||1
9718554|NCT00016354|10817930|FG003|STARTED|Overall Study||1
9718555|NCT00016354|10817931|FG004|STARTED|Overall Study||1
9718556|NCT00016354|10817932|FG005|STARTED|Overall Study||1
9718557|NCT00016354|10817933|FG006|STARTED|Overall Study||6
9718558|NCT00016354|10817934|FG007|STARTED|Overall Study||7
9718559|NCT00016354|10817927|FG000|COMPLETED|Overall Study||1
9718560|NCT00016354|10817928|FG001|COMPLETED|Overall Study||1
9718561|NCT00016354|10817929|FG002|COMPLETED|Overall Study||1
9718562|NCT00016354|10817930|FG003|COMPLETED|Overall Study||1
9718563|NCT00016354|10817931|FG004|COMPLETED|Overall Study||1
9718564|NCT00016354|10817932|FG005|COMPLETED|Overall Study||1
9718565|NCT00016354|10817933|FG006|COMPLETED|Overall Study||6
9718566|NCT00016354|10817934|FG007|COMPLETED|Overall Study||6
9718567|NCT00016354|10817927|FG000|NOT COMPLETED|Overall Study||0
9718568|NCT00016354|10817928|FG001|NOT COMPLETED|Overall Study||0
9718569|NCT00016354|10817929|FG002|NOT COMPLETED|Overall Study||0
9718570|NCT00016354|10817930|FG003|NOT COMPLETED|Overall Study||0
9718571|NCT00016354|10817931|FG004|NOT COMPLETED|Overall Study||0
9718572|NCT00016354|10817932|FG005|NOT COMPLETED|Overall Study||0
9718573|NCT00016354|10817933|FG006|NOT COMPLETED|Overall Study||0
9718574|NCT00016354|10817934|FG007|NOT COMPLETED|Overall Study||1
9718575|NCT00016718|10817941|FG000|STARTED|Overall Study||6
9718576|NCT00016718|10817942|FG001|STARTED|Overall Study||21
9718577|NCT00016718|10817943|FG002|STARTED|Overall Study||16
9718578|NCT00016718|10817941|FG000|COMPLETED|Overall Study||6
9718579|NCT00016718|10817942|FG001|COMPLETED|Overall Study||21
9718580|NCT00016718|10817943|FG002|COMPLETED|Overall Study||16
9718581|NCT00016718|10817941|FG000|NOT COMPLETED|Overall Study||0
9718582|NCT00016718|10817942|FG001|NOT COMPLETED|Overall Study||0
9718583|NCT00016718|10817943|FG002|NOT COMPLETED|Overall Study||0
9718584|NCT00016913|10817951|FG000|STARTED|Overall Study||27
9718585|NCT00016913|10817951|FG000|COMPLETED|Overall Study||27
9718586|NCT00016913|10817951|FG000|NOT COMPLETED|Overall Study||0
9718587|NCT00017563|10817955|FG000|STARTED|Overall Study||57
9718588|NCT00017563|10817955|FG000|COMPLETED|Overall Study||56
9718589|NCT00017563|10817955|FG000|NOT COMPLETED|Overall Study||1
9718590|NCT00018031|10817959|FG000|STARTED|Overall Study||36
9718591|NCT00018031|10817959|FG000|COMPLETED|Overall Study||36
9718592|NCT00018031|10817959|FG000|NOT COMPLETED|Overall Study||0
9718593|NCT00019604|10817963|FG000|STARTED|Overall Study||44
9718594|NCT00019604|10817963|FG000|COMPLETED|Overall Study||5
9718595|NCT00019604|10817963|FG000|NOT COMPLETED|Overall Study||39
9718596|NCT00019682|10817969|FG000|STARTED|Overall Study||94
9718597|NCT00019682|10817970|FG001|STARTED|Overall Study||91
9718598|NCT00019682|10817969|FG000|COMPLETED|Overall Study||93
9718599|NCT00019682|10817970|FG001|COMPLETED|Overall Study||85
9718600|NCT00019682|10817969|FG000|NOT COMPLETED|Overall Study||1
9718601|NCT00019682|10817970|FG001|NOT COMPLETED|Overall Study||6
9718602|NCT00021229|10817979|FG000|STARTED|Overall Study||36
9718603|NCT00021229|10817980|FG001|STARTED|Overall Study||33
9718604|NCT00021229|10817981|FG002|STARTED|Overall Study||16
9718605|NCT00021229|10817979|FG000|Enrolled in Phase I|Overall Study||35
9718606|NCT00021229|10817980|FG001|Enrolled in Phase I|Overall Study||33
9718607|NCT00021229|10817981|FG002|Enrolled in Phase I|Overall Study||16
9718608|NCT00021229|10817979|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
9718609|NCT00021229|10817980|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
9718610|NCT00021229|10817981|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
9731959|NCT00138203|10831947|FG000|NOT COMPLETED|Overall Study||0
9731960|NCT00138294|10831952|FG000|STARTED|Overall Study||29255
9731519|NCT00132730|10831394|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3
9718611|NCT00021229|10817979|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
9718612|NCT00021229|10817980|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
9718613|NCT00021229|10817981|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
9718614|NCT00021229|10817979|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
9718615|NCT00021229|10817980|FG001|COMPLETED|Overall Study||0
9718616|NCT00021229|10817981|FG002|COMPLETED|Overall Study||0
9718617|NCT00021229|10817979|FG000|NOT COMPLETED|Overall Study||35
9718618|NCT00021229|10817980|FG001|NOT COMPLETED|Overall Study||33
9718619|NCT00021229|10817981|FG002|NOT COMPLETED|Overall Study||16
9718620|NCT00021255|10817994|FG000|STARTED|Overall Study|Randomized|1073
9718621|NCT00021255|10817995|FG001|STARTED|Overall Study|Randomized|1074
9718622|NCT00021255|10817996|FG002|STARTED|Overall Study|Randomized|1075
9718623|NCT00021255|10817994|FG000|Treated|Overall Study||1045
9718624|NCT00021255|10817995|FG001|Treated|Overall Study||1072
9718625|NCT00021255|10817996|FG002|Treated|Overall Study||1057
9718626|NCT00021255|10817994|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
9718627|NCT00021255|10817995|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
9718628|NCT00021255|10817996|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056
9718629|NCT00021255|10817994|FG000|COMPLETED|Overall Study||952
9718630|NCT00021255|10817995|FG001|COMPLETED|Overall Study||804
9718631|NCT00021255|10817996|FG002|COMPLETED|Overall Study||926
9718632|NCT00021255|10817994|FG000|NOT COMPLETED|Overall Study||121
9718633|NCT00021255|10817995|FG001|NOT COMPLETED|Overall Study||270
9718634|NCT00021255|10817996|FG002|NOT COMPLETED|Overall Study||149
9718635|NCT00021541|10818006|FG000|STARTED|Period 1-First Treatment||31
9718636|NCT00021541|10818007|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
9718637|NCT00021541|10818006|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
9718638|NCT00021541|10818007|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
9718639|NCT00021541|10818006|FG000|Ineligible Patients|Period 1-First Treatment||0
9718640|NCT00021541|10818007|FG001|Ineligible Patients|Period 1-First Treatment||2
9718641|NCT00021541|10818006|FG000|COMPLETED|Period 1-First Treatment||20
9718642|NCT00021541|10818007|FG001|COMPLETED|Period 1-First Treatment||23
9718643|NCT00021541|10818006|FG000|NOT COMPLETED|Period 1-First Treatment||11
9718644|NCT00021541|10818007|FG001|NOT COMPLETED|Period 1-First Treatment||8
9718645|NCT00021541|10818006|FG000|STARTED|Period 2-crossover||20
9718646|NCT00021541|10818007|FG001|STARTED|Period 2-crossover||23
9718647|NCT00021541|10818006|FG000|COMPLETED|Period 2-crossover||10
9718648|NCT00021541|10818007|FG001|COMPLETED|Period 2-crossover||12
9718649|NCT00021541|10818006|FG000|NOT COMPLETED|Period 2-crossover||10
9718650|NCT00021541|10818007|FG001|NOT COMPLETED|Period 2-crossover||11
9718651|NCT00022490|10818015|FG000|STARTED|Overall Study||24
9718652|NCT00022490|10818015|FG000|COMPLETED|Overall Study||24
9718653|NCT00022490|10818015|FG000|NOT COMPLETED|Overall Study||0
9718654|NCT00022516|10818021|FG000|STARTED|Overall Study||542
9718655|NCT00022516|10818022|FG001|STARTED|Overall Study||544
9718656|NCT00022516|10818021|FG000|COMPLETED|Overall Study||539
9718657|NCT00022516|10818022|FG001|COMPLETED|Overall Study||314
9718658|NCT00022516|10818021|FG000|NOT COMPLETED|Overall Study||3
9718659|NCT00022516|10818022|FG001|NOT COMPLETED|Overall Study||230
9718660|NCT00022633|10818030|FG000|STARTED|Overall Study||55
9718661|NCT00022633|10818031|FG001|STARTED|Overall Study||10
9718662|NCT00022633|10818030|FG000|Eligible|Overall Study||51
9718663|NCT00022633|10818031|FG001|Eligible|Overall Study||10
9718664|NCT00022633|10818030|FG000|COMPLETED|Overall Study||23
9718665|NCT00022633|10818031|FG001|COMPLETED|Overall Study||5
9718666|NCT00022633|10818030|FG000|NOT COMPLETED|Overall Study||32
9718667|NCT00022633|10818031|FG001|NOT COMPLETED|Overall Study||5
9718668|NCT00022659|10818036|FG000|STARTED|Overall Study||64
9718669|NCT00022659|10818036|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62
9718670|NCT00022659|10818036|FG000|NOT COMPLETED|Overall Study||2
9718671|NCT00022672|10818046|FG000|STARTED|Main Phase: 24 Months||103
9718672|NCT00022672|10818047|FG001|STARTED|Main Phase: 24 Months||104
9718673|NCT00022672|10818046|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103
9718674|NCT00022672|10818047|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104
9718675|NCT00022672|10818046|FG000|COMPLETED|Main Phase: 24 Months||16
9718676|NCT00022672|10818047|FG001|COMPLETED|Main Phase: 24 Months||4
9718677|NCT00022672|10818046|FG000|NOT COMPLETED|Main Phase: 24 Months||87
9718678|NCT00022672|10818047|FG001|NOT COMPLETED|Main Phase: 24 Months||100
9718679|NCT00022672|10818046|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
9718680|NCT00022672|10818047|FG001|STARTED|Extension Phase||58
9718681|NCT00022672|10818046|FG000|Safety Set: Received Study Drug|Extension Phase||14
9718682|NCT00022672|10818047|FG001|Safety Set: Received Study Drug|Extension Phase||58
9718683|NCT00022672|10818046|FG000|COMPLETED|Extension Phase||11
9718684|NCT00022672|10818047|FG001|COMPLETED|Extension Phase||7
9718685|NCT00022672|10818046|FG000|NOT COMPLETED|Extension Phase||3
9718686|NCT00022672|10818047|FG001|NOT COMPLETED|Extension Phase||51
9718687|NCT00022698|10818056|FG000|STARTED|Overall Study||15
9718688|NCT00022698|10818057|FG001|STARTED|Overall Study||52
9718689|NCT00022698|10818056|FG000|COMPLETED|Overall Study||7
9718690|NCT00022698|10818057|FG001|COMPLETED|Overall Study||17
9718691|NCT00022698|10818056|FG000|NOT COMPLETED|Overall Study||8
9718692|NCT00022698|10818057|FG001|NOT COMPLETED|Overall Study||35
9718693|NCT00022763|10818067|FG000|STARTED|Overall Study||24
9718694|NCT00022763|10818068|FG001|STARTED|Overall Study||28
9718695|NCT00022763|10818067|FG000|COMPLETED|Overall Study||15
9718696|NCT00022763|10818068|FG001|COMPLETED|Overall Study||11
9718697|NCT00022763|10818067|FG000|NOT COMPLETED|Overall Study||9
9718698|NCT00022763|10818068|FG001|NOT COMPLETED|Overall Study||17
9718699|NCT00023309|10818075|FG000|STARTED|Overall Study||22
9718700|NCT00023309|10818076|FG001|STARTED|Overall Study||19
9718701|NCT00023309|10818075|FG000|COMPLETED|Overall Study||22
9718702|NCT00023309|10818076|FG001|COMPLETED|Overall Study||19
9718703|NCT00023309|10818075|FG000|NOT COMPLETED|Overall Study||0
9718704|NCT00023309|10818076|FG001|NOT COMPLETED|Overall Study||0
9718705|NCT00023322|10818082|FG000|STARTED|Overall Study||13
9718706|NCT00023322|10818082|FG000|COMPLETED|Overall Study||12
9718707|NCT00023322|10818082|FG000|NOT COMPLETED|Overall Study||1
9718708|NCT00023452|10818088|FG000|STARTED|Overall Study||3908
9718709|NCT00023452|10818089|FG001|STARTED|Overall Study||4145
9718710|NCT00023452|10818088|FG000|Randomized|Overall Study||3190
9718711|NCT00023452|10818089|FG001|Randomized|Overall Study||3174
9718712|NCT00023452|10818088|FG000|Enrolled as Part of a Cluster|Overall Study||718
9718713|NCT00023452|10818089|FG001|Enrolled as Part of a Cluster|Overall Study||971
9718714|NCT00023452|10818088|FG000|Completed Treatment|Overall Study||2585
9718715|NCT00023452|10818089|FG001|Completed Treatment|Overall Study||3273
9718716|NCT00023452|10818088|FG000|Not Treated|Overall Study||149
9718717|NCT00023452|10818089|FG001|Not Treated|Overall Study||105
9718718|NCT00023452|10818088|FG000|Completed Study|Overall Study||3174
9718719|NCT00023452|10818089|FG001|Completed Study|Overall Study||3475
9718720|NCT00023452|10818088|FG000|COMPLETED|Overall Study||2585
9718721|NCT00023452|10818089|FG001|COMPLETED|Overall Study||3273
9718722|NCT00023452|10818088|FG000|NOT COMPLETED|Overall Study||1323
9718723|NCT00023452|10818089|FG001|NOT COMPLETED|Overall Study||872
9718724|NCT00023595|10818104|FG000|STARTED|5 Year Follow up||602
9718725|NCT00023595|10818105|FG001|STARTED|5 Year Follow up||534
9718726|NCT00023595|10818106|FG002|STARTED|5 Year Follow up||76
9718727|NCT00023595|10818107|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
9718728|NCT00023595|10818108|FG004|STARTED|5 Year Follow up||501
9718729|NCT00023595|10818104|FG000|COMPLETED|5 Year Follow up||600
9718730|NCT00023595|10818105|FG001|COMPLETED|5 Year Follow up||532
9718731|NCT00023595|10818106|FG002|COMPLETED|5 Year Follow up||75
9718732|NCT00023595|10818107|FG003|COMPLETED|5 Year Follow up||416
9718733|NCT00023595|10818108|FG004|COMPLETED|5 Year Follow up||498
9718734|NCT00023595|10818104|FG000|NOT COMPLETED|5 Year Follow up||2
9718735|NCT00023595|10818105|FG001|NOT COMPLETED|5 Year Follow up||2
9718736|NCT00023595|10818106|FG002|NOT COMPLETED|5 Year Follow up||1
9718737|NCT00023595|10818107|FG003|NOT COMPLETED|5 Year Follow up||7
9718738|NCT00023595|10818108|FG004|NOT COMPLETED|5 Year Follow up||3
9718739|NCT00023595|10818104|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
9718740|NCT00023595|10818105|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
9718741|NCT00023595|10818106|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
9718742|NCT00023595|10818107|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
9718743|NCT00023595|10818108|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
9718744|NCT00023595|10818104|FG000|COMPLETED|10 Year Follow up||590
9718745|NCT00023595|10818105|FG001|COMPLETED|10 Year Follow up||524
9718746|NCT00023595|10818106|FG002|COMPLETED|10 Year Follow up||73
9718747|NCT00023595|10818107|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
9718748|NCT00023595|10818108|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
9718749|NCT00023595|10818104|FG000|NOT COMPLETED|10 Year Follow up||12
9718750|NCT00023595|10818105|FG001|NOT COMPLETED|10 Year Follow up||10
9718751|NCT00023595|10818106|FG002|NOT COMPLETED|10 Year Follow up||3
9718752|NCT00023595|10818107|FG003|NOT COMPLETED|10 Year Follow up||0
9718753|NCT00023595|10818108|FG004|NOT COMPLETED|10 Year Follow up||0
9718754|NCT00023673|10818134|FG000|STARTED|Overall Study||8
9718755|NCT00023673|10818135|FG001|STARTED|Overall Study||9
9718756|NCT00023673|10818136|FG002|STARTED|Overall Study||0
9718757|NCT00023673|10818137|FG003|STARTED|Overall Study||46
9718758|NCT00023673|10818134|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
9718759|NCT00023673|10818135|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
9718760|NCT00023673|10818136|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
9718761|NCT00023673|10818137|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
9718762|NCT00023673|10818134|FG000|NOT COMPLETED|Overall Study||0
9718763|NCT00023673|10818135|FG001|NOT COMPLETED|Overall Study||0
9718764|NCT00023673|10818136|FG002|NOT COMPLETED|Overall Study||0
9718765|NCT00023673|10818137|FG003|NOT COMPLETED|Overall Study||2
9718766|NCT00023712|10818149|FG000|STARTED|Overall Study|total number of participants enrolled on study|28
9718767|NCT00023712|10818150|FG001|STARTED|Overall Study|total number of participants enrolled on study|30
9718768|NCT00023712|10818149|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
9718769|NCT00023712|10818150|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
9718770|NCT00023712|10818149|FG000|NOT COMPLETED|Overall Study||2
9718771|NCT00023712|10818150|FG001|NOT COMPLETED|Overall Study||1
9718772|NCT00023764|10818166|FG000|STARTED|Overall Study||103
9718773|NCT00023764|10818166|FG000|COMPLETED|Overall Study||89
9718774|NCT00023764|10818166|FG000|NOT COMPLETED|Overall Study||14
9718775|NCT00024102|10818173|FG000|STARTED|Overall Study||326
9718776|NCT00024102|10818174|FG001|STARTED|Overall Study||307
9718777|NCT00024102|10818173|FG000|COMPLETED|Overall Study||326
9718778|NCT00024102|10818174|FG001|COMPLETED|Overall Study||307
9718779|NCT00024102|10818173|FG000|NOT COMPLETED|Overall Study||0
9718780|NCT00024102|10818174|FG001|NOT COMPLETED|Overall Study||0
9718781|NCT00024167|10818187|FG000|STARTED|Overall Study||65
9718782|NCT00024167|10818188|FG001|STARTED|Overall Study||62
9718783|NCT00024167|10818187|FG000|Induction Treatment Option 1 Completed|Overall Study||22
9718784|NCT00024167|10818188|FG001|Induction Treatment Option 1 Completed|Overall Study||21
9718785|NCT00024167|10818187|FG000|Induction Treatment Option 2 Completed|Overall Study||43
9718786|NCT00024167|10818188|FG001|Induction Treatment Option 2 Completed|Overall Study||41
9718787|NCT00024167|10818187|FG000|COMPLETED|Overall Study||12
9718788|NCT00024167|10818188|FG001|COMPLETED|Overall Study||15
9718789|NCT00024167|10818187|FG000|NOT COMPLETED|Overall Study||53
9718790|NCT00024167|10818188|FG001|NOT COMPLETED|Overall Study||47
9718791|NCT00024258|10818195|FG000|STARTED|Overall Study||22
9718792|NCT00024258|10818195|FG000|COMPLETED|Overall Study||13
9718793|NCT00024258|10818195|FG000|NOT COMPLETED|Overall Study||9
9718794|NCT00025155|10818199|FG000|STARTED|Overall Study||51
9718795|NCT00025155|10818199|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
9718796|NCT00025155|10818199|FG000|NOT COMPLETED|Overall Study||2
9718797|NCT00025233|10818208|FG000|STARTED|Overall Study||50
9718798|NCT00025233|10818208|FG000|COMPLETED|Overall Study||46
9718799|NCT00025233|10818208|FG000|NOT COMPLETED|Overall Study||4
9718800|NCT00025259|10818225|FG000|STARTED|Overall Study||52
9718801|NCT00025259|10818226|FG001|STARTED|Overall Study||381
9718802|NCT00025259|10818227|FG002|STARTED|Overall Study||382
9718803|NCT00025259|10818228|FG003|STARTED|Overall Study||571
9718804|NCT00025259|10818229|FG004|STARTED|Overall Study||42
9718805|NCT00025259|10818230|FG005|STARTED|Overall Study||153
9718806|NCT00025259|10818231|FG006|STARTED|Overall Study||153
9718807|NCT00025259|10818225|FG000|COMPLETED|Overall Study||7
9718808|NCT00025259|10818226|FG001|COMPLETED|Overall Study||292
9718809|NCT00025259|10818227|FG002|COMPLETED|Overall Study||301
9718810|NCT00025259|10818228|FG003|COMPLETED|Overall Study||457
9718811|NCT00025259|10818229|FG004|COMPLETED|Overall Study||6
9718812|NCT00025259|10818230|FG005|COMPLETED|Overall Study||101
9718813|NCT00025259|10818231|FG006|COMPLETED|Overall Study||102
9718814|NCT00025259|10818225|FG000|NOT COMPLETED|Overall Study||45
9718815|NCT00025259|10818226|FG001|NOT COMPLETED|Overall Study||89
9718816|NCT00025259|10818227|FG002|NOT COMPLETED|Overall Study||81
9718817|NCT00025259|10818228|FG003|NOT COMPLETED|Overall Study||114
9718818|NCT00025259|10818229|FG004|NOT COMPLETED|Overall Study||36
9718819|NCT00025259|10818230|FG005|NOT COMPLETED|Overall Study||52
9718820|NCT00025259|10818231|FG006|NOT COMPLETED|Overall Study||51
9718821|NCT00025506|10818250|FG000|STARTED|Overall Study||55
9718822|NCT00025506|10818250|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45
9718823|NCT00025506|10818250|FG000|NOT COMPLETED|Overall Study||10
9718824|NCT00025662|10818259|FG000|STARTED|Overall Study||25
9850824|NCT00872599|10963524|FG001|STARTED|First Drug During High Salt Intake||17
9850825|NCT00872599|10963523|FG000|COMPLETED|First Drug During High Salt Intake||16
9850826|NCT00872599|10963524|FG001|COMPLETED|First Drug During High Salt Intake||17
9850827|NCT00872599|10963523|FG000|NOT COMPLETED|First Drug During High Salt Intake||0
9850828|NCT00872599|10963524|FG001|NOT COMPLETED|First Drug During High Salt Intake||0
9850829|NCT00872599|10963523|FG000|STARTED|Second Washout Period||16
9850830|NCT00872599|10963524|FG001|STARTED|Second Washout Period||17
9850831|NCT00872599|10963523|FG000|COMPLETED|Second Washout Period||15
9850832|NCT00872599|10963524|FG001|COMPLETED|Second Washout Period||16
9850833|NCT00872599|10963523|FG000|NOT COMPLETED|Second Washout Period||1
9850834|NCT00872599|10963524|FG001|NOT COMPLETED|Second Washout Period||1
9850835|NCT00872599|10963523|FG000|STARTED|Second Drug During High Salt Intake||15
9850836|NCT00872599|10963524|FG001|STARTED|Second Drug During High Salt Intake||16
9850837|NCT00872599|10963523|FG000|COMPLETED|Second Drug During High Salt Intake||15
9850838|NCT00872599|10963524|FG001|COMPLETED|Second Drug During High Salt Intake||16
9850839|NCT00872599|10963523|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0
9850840|NCT00872599|10963524|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0
9850841|NCT00872729|10963530|FG000|STARTED|Overall Study||9
9850842|NCT00872729|10963530|FG000|COMPLETED|Overall Study||9
9850843|NCT00872729|10963530|FG000|NOT COMPLETED|Overall Study||0
9850844|NCT00872833|10963556|FG000|STARTED|Overall Study||15
9850845|NCT00872833|10963557|FG001|STARTED|Overall Study||17
9850846|NCT00872833|10963556|FG000|COMPLETED|Overall Study||15
9850847|NCT00872833|10963557|FG001|COMPLETED|Overall Study||17
9850848|NCT00872833|10963556|FG000|NOT COMPLETED|Overall Study||0
9850849|NCT00872833|10963557|FG001|NOT COMPLETED|Overall Study||0
9850850|NCT00872898|10963569|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0
9850851|NCT00872898|10963570|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4
9850852|NCT00872898|10963569|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0
9850853|NCT00872898|10963570|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4
9850854|NCT00872898|10963569|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
9718825|NCT00025662|10818259|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
9718826|NCT00025662|10818259|FG000|NOT COMPLETED|Overall Study||3
9718827|NCT00025883|10818265|FG000|STARTED|Overall Study||103
9718828|NCT00025883|10818265|FG000|Generalized Lipodystrophy|Overall Study||63
9718829|NCT00025883|10818265|FG000|Partial Lipodystrophy|Overall Study||40
9718830|NCT00025883|10818265|FG000|COMPLETED|Overall Study||86
9718831|NCT00025883|10818265|FG000|NOT COMPLETED|Overall Study||17
9718832|NCT00026208|10818272|FG000|STARTED|Overall Study||72
9718833|NCT00026208|10818273|FG001|STARTED|Overall Study||4
9718834|NCT00026208|10818272|FG000|COMPLETED|Overall Study||71
9718835|NCT00026208|10818273|FG001|COMPLETED|Overall Study||4
9718836|NCT00026208|10818272|FG000|NOT COMPLETED|Overall Study||1
9718837|NCT00026208|10818273|FG001|NOT COMPLETED|Overall Study||0
9718838|NCT00026221|10818282|FG000|STARTED|Overall Study||16
9718839|NCT00026221|10818283|FG001|STARTED|Overall Study||16
9718840|NCT00026221|10818284|FG002|STARTED|Overall Study||25
9718841|NCT00026221|10818282|FG000|COMPLETED|Overall Study||16
9718842|NCT00026221|10818283|FG001|COMPLETED|Overall Study||16
9718843|NCT00026221|10818284|FG002|COMPLETED|Overall Study||25
9718844|NCT00026221|10818282|FG000|NOT COMPLETED|Overall Study||0
9718845|NCT00026221|10818283|FG001|NOT COMPLETED|Overall Study||0
9718846|NCT00026221|10818284|FG002|NOT COMPLETED|Overall Study||0
9718847|NCT00026494|10818296|FG000|STARTED|Overall Study||7
9718848|NCT00026494|10818297|FG001|STARTED|Overall Study||4
9718849|NCT00026494|10818298|FG002|STARTED|Overall Study||22
9718850|NCT00026494|10818299|FG003|STARTED|Overall Study||16
9718851|NCT00026494|10818296|FG000|COMPLETED|Overall Study||5
9718852|NCT00026494|10818297|FG001|COMPLETED|Overall Study||4
9718853|NCT00026494|10818298|FG002|COMPLETED|Overall Study||16
9718854|NCT00026494|10818299|FG003|COMPLETED|Overall Study||16
9718855|NCT00026494|10818296|FG000|NOT COMPLETED|Overall Study||2
9718856|NCT00026494|10818297|FG001|NOT COMPLETED|Overall Study||0
9718857|NCT00026494|10818298|FG002|NOT COMPLETED|Overall Study||6
9718858|NCT00026494|10818299|FG003|NOT COMPLETED|Overall Study||0
9718859|NCT00026793|10818309|FG000|STARTED|Overall Study||29
9718860|NCT00026793|10818309|FG000|COMPLETED|Overall Study||21
9718861|NCT00026793|10818309|FG000|NOT COMPLETED|Overall Study||8
9718862|NCT00027027|10818318|FG000|STARTED|Overall Study||3
9718863|NCT00027027|10818319|FG001|STARTED|Overall Study||3
9718864|NCT00027027|10818320|FG002|STARTED|Overall Study||4
9718865|NCT00027027|10818321|FG003|STARTED|Overall Study||3
9718866|NCT00027027|10818322|FG004|STARTED|Overall Study||8
9718867|NCT00027027|10818318|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0
9718868|NCT00027027|10818319|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0
9718869|NCT00027027|10818320|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1
9718870|NCT00027027|10818321|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0
9718871|NCT00027027|10818322|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1
9718872|NCT00027027|10818318|FG000|Completed 2 Cycles of Treatment|Overall Study||3
9718873|NCT00027027|10818319|FG001|Completed 2 Cycles of Treatment|Overall Study||3
9718874|NCT00027027|10818320|FG002|Completed 2 Cycles of Treatment|Overall Study||3
9718875|NCT00027027|10818321|FG003|Completed 2 Cycles of Treatment|Overall Study||3
9718876|NCT00027027|10818322|FG004|Completed 2 Cycles of Treatment|Overall Study||7
9718877|NCT00027027|10818318|FG000|Discontinued at Cycle 2|Overall Study||2
9718878|NCT00027027|10818319|FG001|Discontinued at Cycle 2|Overall Study||2
9718879|NCT00027027|10818320|FG002|Discontinued at Cycle 2|Overall Study||1
9718880|NCT00027027|10818321|FG003|Discontinued at Cycle 2|Overall Study||1
9718881|NCT00027027|10818322|FG004|Discontinued at Cycle 2|Overall Study||3
9718882|NCT00027027|10818318|FG000|Treated Beyond Cycle 2|Overall Study||1
9718883|NCT00027027|10818319|FG001|Treated Beyond Cycle 2|Overall Study||1
9718884|NCT00027027|10818320|FG002|Treated Beyond Cycle 2|Overall Study||2
9718885|NCT00027027|10818321|FG003|Treated Beyond Cycle 2|Overall Study||2
9718886|NCT00027027|10818322|FG004|Treated Beyond Cycle 2|Overall Study||4
9718887|NCT00027027|10818318|FG000|COMPLETED|Overall Study||0
9718888|NCT00027027|10818319|FG001|COMPLETED|Overall Study||0
9718889|NCT00027027|10818320|FG002|COMPLETED|Overall Study||0
9718890|NCT00027027|10818321|FG003|COMPLETED|Overall Study||0
9718891|NCT00027027|10818322|FG004|COMPLETED|Overall Study||0
9718892|NCT00027027|10818318|FG000|NOT COMPLETED|Overall Study||3
9718893|NCT00027027|10818319|FG001|NOT COMPLETED|Overall Study||3
9718894|NCT00027027|10818320|FG002|NOT COMPLETED|Overall Study||4
9718895|NCT00027027|10818321|FG003|NOT COMPLETED|Overall Study||3
9718896|NCT00027027|10818322|FG004|NOT COMPLETED|Overall Study||8
9718897|NCT00027378|10818340|FG000|STARTED|Overall Study||24
9718898|NCT00027378|10818341|FG001|STARTED|Overall Study||26
9718899|NCT00027378|10818340|FG000|COMPLETED|Overall Study||24
9718900|NCT00027378|10818341|FG001|COMPLETED|Overall Study||23
9718901|NCT00027378|10818340|FG000|NOT COMPLETED|Overall Study||0
9718902|NCT00027378|10818341|FG001|NOT COMPLETED|Overall Study||3
9718903|NCT00027560|10818347|FG000|STARTED|Overall Study||51
9718904|NCT00027560|10818347|FG000|COMPLETED|Overall Study||50
9718905|NCT00027560|10818347|FG000|NOT COMPLETED|Overall Study||1
9718906|NCT00027846|10818356|FG000|STARTED|Overall Study||13
9718907|NCT00027846|10818357|FG001|STARTED|Overall Study||287
9718908|NCT00027846|10818358|FG002|STARTED|Overall Study||78
9718909|NCT00027846|10818356|FG000|COMPLETED|Overall Study||11
9718910|NCT00027846|10818357|FG001|COMPLETED|Overall Study||219
9718911|NCT00027846|10818358|FG002|COMPLETED|Overall Study||41
9718912|NCT00027846|10818356|FG000|NOT COMPLETED|Overall Study||2
9718913|NCT00027846|10818357|FG001|NOT COMPLETED|Overall Study||68
9718914|NCT00027846|10818358|FG002|NOT COMPLETED|Overall Study||37
9718915|NCT00028002|10818368|FG000|STARTED|Overall Study||63
9718916|NCT00028002|10818368|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
9718917|NCT00028002|10818368|FG000|NOT COMPLETED|Overall Study||11
9718918|NCT00028093|10818375|FG000|STARTED|Overall Study||25
9718919|NCT00028093|10818376|FG001|STARTED|Overall Study||25
9850855|NCT00872898|10963570|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
9850856|NCT00872898|10963569|FG000|STARTED|Part Two - Double Blind||61
9850857|NCT00872898|10963570|FG001|STARTED|Part Two - Double Blind||60
9850858|NCT00872898|10963569|FG000|COMPLETED|Part Two - Double Blind||50
9850859|NCT00872898|10963570|FG001|COMPLETED|Part Two - Double Blind||54
9850860|NCT00872898|10963569|FG000|NOT COMPLETED|Part Two - Double Blind||11
9850861|NCT00872898|10963570|FG001|NOT COMPLETED|Part Two - Double Blind||6
9850862|NCT00872989|10963581|FG000|STARTED|Overall Study||66
9850863|NCT00872989|10963582|FG001|STARTED|Overall Study||63
9850864|NCT00872989|10963581|FG000|COMPLETED|Overall Study||1
9850865|NCT00872989|10963582|FG001|COMPLETED|Overall Study||0
9850866|NCT00872989|10963581|FG000|NOT COMPLETED|Overall Study||65
9850867|NCT00872989|10963582|FG001|NOT COMPLETED|Overall Study||63
9850868|NCT00873015|10963598|FG000|STARTED|Overall Study||9
9850869|NCT00873015|10963599|FG001|STARTED|Overall Study||4
9850870|NCT00873015|10963600|FG002|STARTED|Overall Study||3
9850871|NCT00873015|10963601|FG003|STARTED|Overall Study||3
9850872|NCT00873015|10963598|FG000|COMPLETED|Overall Study||9
9850873|NCT00873015|10963599|FG001|COMPLETED|Overall Study||3
9850874|NCT00873015|10963600|FG002|COMPLETED|Overall Study||3
9850875|NCT00873015|10963601|FG003|COMPLETED|Overall Study||3
9850876|NCT00873015|10963598|FG000|NOT COMPLETED|Overall Study||0
9850877|NCT00873015|10963599|FG001|NOT COMPLETED|Overall Study||1
9850878|NCT00873015|10963600|FG002|NOT COMPLETED|Overall Study||0
9850879|NCT00873015|10963601|FG003|NOT COMPLETED|Overall Study||0
9850880|NCT00873041|10963613|FG000|STARTED|Core Study||55
9850881|NCT00873041|10963614|FG001|STARTED|Core Study||55
9850882|NCT00873041|10963615|FG002|STARTED|Core Study||56
9850883|NCT00873041|10963613|FG000|COMPLETED|Core Study||48
9850884|NCT00873041|10963614|FG001|COMPLETED|Core Study||49
9850885|NCT00873041|10963615|FG002|COMPLETED|Core Study||51
9850886|NCT00873041|10963613|FG000|NOT COMPLETED|Core Study||7
9850887|NCT00873041|10963614|FG001|NOT COMPLETED|Core Study||6
9850888|NCT00873041|10963615|FG002|NOT COMPLETED|Core Study||5
9850889|NCT00873041|10963613|FG000|STARTED|Extension Study||41
9850890|NCT00873041|10963614|FG001|STARTED|Extension Study||44
9850891|NCT00873041|10963615|FG002|STARTED|Extension Study||48
9850892|NCT00873041|10963613|FG000|COMPLETED|Extension Study||40
9850893|NCT00873041|10963614|FG001|COMPLETED|Extension Study||44
9850894|NCT00873041|10963615|FG002|COMPLETED|Extension Study||46
9850895|NCT00873041|10963613|FG000|NOT COMPLETED|Extension Study||1
9850896|NCT00873041|10963614|FG001|NOT COMPLETED|Extension Study||0
9850897|NCT00873041|10963615|FG002|NOT COMPLETED|Extension Study||2
9850898|NCT00873093|10963635|FG000|STARTED|Overall Study||4
9850899|NCT00873093|10963636|FG001|STARTED|Overall Study||62
9850900|NCT00873093|10963637|FG002|STARTED|Overall Study||49
9850901|NCT00873093|10963638|FG003|STARTED|Overall Study||23
9850902|NCT00873093|10963639|FG004|STARTED|Overall Study||10
9850903|NCT00873093|10963635|FG000|COMPLETED|Overall Study||3
9850904|NCT00873093|10963636|FG001|COMPLETED|Overall Study||35
9850905|NCT00873093|10963637|FG002|COMPLETED|Overall Study||33
9850906|NCT00873093|10963638|FG003|COMPLETED|Overall Study||12
9850907|NCT00873093|10963639|FG004|COMPLETED|Overall Study||8
9850908|NCT00873093|10963635|FG000|NOT COMPLETED|Overall Study||1
9850909|NCT00873093|10963636|FG001|NOT COMPLETED|Overall Study||27
9850910|NCT00873093|10963637|FG002|NOT COMPLETED|Overall Study||16
9850911|NCT00873093|10963638|FG003|NOT COMPLETED|Overall Study||11
9850912|NCT00873093|10963639|FG004|NOT COMPLETED|Overall Study||2
9850913|NCT00873119|10963663|FG000|STARTED|Overall Study||44
9850914|NCT00873119|10963664|FG001|STARTED|Overall Study||45
9850915|NCT00873119|10963663|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
9850916|NCT00873119|10963664|FG001|COMPLETED|Overall Study||19
9850917|NCT00873119|10963663|FG000|NOT COMPLETED|Overall Study||44
9850918|NCT00873119|10963664|FG001|NOT COMPLETED|Overall Study||26
9850919|NCT00873327|10963670|FG000|STARTED|Overall Study||32
9850920|NCT00873327|10963670|FG000|COMPLETED|Overall Study||32
9850921|NCT00873327|10963670|FG000|NOT COMPLETED|Overall Study||0
9850922|NCT00873457|10963674|FG000|STARTED|Overall Study||16
9850923|NCT00873457|10963674|FG000|COMPLETED|Overall Study||16
9850924|NCT00873457|10963674|FG000|NOT COMPLETED|Overall Study||0
9850925|NCT00873730|10963680|FG000|STARTED|Overall Study||54
9850926|NCT00873730|10963681|FG001|STARTED|Overall Study||54
9850927|NCT00873730|10963680|FG000|COMPLETED|Overall Study||48
9850928|NCT00873730|10963681|FG001|COMPLETED|Overall Study||49
9850929|NCT00873730|10963680|FG000|NOT COMPLETED|Overall Study||6
9850930|NCT00873730|10963681|FG001|NOT COMPLETED|Overall Study||5
9850931|NCT00873782|10963687|FG000|STARTED|Overall Study||16
9850932|NCT00873782|10963687|FG000|COMPLETED|Overall Study||16
9850933|NCT00873782|10963687|FG000|NOT COMPLETED|Overall Study||0
9850934|NCT00873821|10963693|FG000|STARTED|Overall Study||22
9850935|NCT00873821|10963694|FG001|STARTED|Overall Study||22
9850936|NCT00873821|10963693|FG000|COMPLETED|Overall Study||22
9850937|NCT00873821|10963694|FG001|COMPLETED|Overall Study||22
9850938|NCT00873821|10963693|FG000|NOT COMPLETED|Overall Study||0
9718920|NCT00028093|10818375|FG000|COMPLETED|Overall Study||25
9718921|NCT00028093|10818376|FG001|COMPLETED|Overall Study||25
9718922|NCT00028093|10818375|FG000|NOT COMPLETED|Overall Study||0
9718923|NCT00028093|10818376|FG001|NOT COMPLETED|Overall Study||0
9718924|NCT00028262|10818382|FG000|STARTED|Overall Study||10
9718925|NCT00028262|10818382|FG000|COMPLETED|Overall Study||9
9718926|NCT00028262|10818382|FG000|NOT COMPLETED|Overall Study||1
9718927|NCT00028769|10818386|FG000|STARTED|Overall Study||41
9718928|NCT00028769|10818386|FG000|Eligible|Overall Study||36
9718929|NCT00028769|10818386|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
9718930|NCT00028769|10818386|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
9718931|NCT00028769|10818386|FG000|NOT COMPLETED|Overall Study||41
9718932|NCT00029107|10818392|FG000|STARTED|Overall Study||12
9718933|NCT00029107|10818393|FG001|STARTED|Overall Study||12
9718934|NCT00029107|10818392|FG000|COMPLETED|Overall Study||12
9718935|NCT00029107|10818393|FG001|COMPLETED|Overall Study||12
9718936|NCT00029107|10818392|FG000|NOT COMPLETED|Overall Study||0
9718937|NCT00029107|10818393|FG001|NOT COMPLETED|Overall Study||0
9718938|NCT00029146|10818401|FG000|STARTED|Overall Study||97
9718939|NCT00029146|10818402|FG001|STARTED|Overall Study||98
9718940|NCT00029146|10818401|FG000|COMPLETED|Overall Study||95
9718941|NCT00029146|10818402|FG001|COMPLETED|Overall Study||97
9718942|NCT00029146|10818401|FG000|NOT COMPLETED|Overall Study||2
9718943|NCT00029146|10818402|FG001|NOT COMPLETED|Overall Study||1
9718944|NCT00029172|10818408|FG000|STARTED|Overall Study||188
9718945|NCT00029172|10818408|FG000|COMPLETED|Overall Study||182
9718946|NCT00029172|10818408|FG000|NOT COMPLETED|Overall Study||6
9718947|NCT00029536|10818416|FG000|STARTED|Overall Study||85
9718948|NCT00029536|10818417|FG001|STARTED|Overall Study||45
9718949|NCT00029536|10818418|FG002|STARTED|Overall Study||105
9718950|NCT00029536|10818419|FG003|STARTED|Overall Study||59
9718951|NCT00029536|10818416|FG000|COMPLETED|Overall Study||85
9718952|NCT00029536|10818417|FG001|COMPLETED|Overall Study||45
9718953|NCT00029536|10818418|FG002|COMPLETED|Overall Study||105
9718954|NCT00029536|10818419|FG003|COMPLETED|Overall Study||59
9718955|NCT00029536|10818416|FG000|NOT COMPLETED|Overall Study||0
9718956|NCT00029536|10818417|FG001|NOT COMPLETED|Overall Study||0
9718957|NCT00029536|10818418|FG002|NOT COMPLETED|Overall Study||0
9718958|NCT00029536|10818419|FG003|NOT COMPLETED|Overall Study||0
9718959|NCT00030147|10818435|FG000|STARTED|Overall Study||17
9718960|NCT00030147|10818436|FG001|STARTED|Overall Study||19
9718961|NCT00030147|10818437|FG002|STARTED|Overall Study||16
9718962|NCT00030147|10818438|FG003|STARTED|Overall Study||11
9718963|NCT00030147|10818435|FG000|COMPLETED|Overall Study||17
9718964|NCT00030147|10818436|FG001|COMPLETED|Overall Study||18
9718965|NCT00030147|10818437|FG002|COMPLETED|Overall Study||16
9718966|NCT00030147|10818438|FG003|COMPLETED|Overall Study||11
9718967|NCT00030147|10818435|FG000|NOT COMPLETED|Overall Study||0
9718968|NCT00030147|10818436|FG001|NOT COMPLETED|Overall Study||1
9718969|NCT00030147|10818437|FG002|NOT COMPLETED|Overall Study||0
9718970|NCT00030147|10818438|FG003|NOT COMPLETED|Overall Study||0
9718971|NCT00030264|10818448|FG000|STARTED|Overall Study||23
9718972|NCT00030264|10818448|FG000|COMPLETED|Overall Study||23
9718973|NCT00030264|10818448|FG000|NOT COMPLETED|Overall Study||0
9718974|NCT00030823|10818452|FG000|STARTED|Overall Study||14
9718975|NCT00030823|10818452|FG000|COMPLETED|Overall Study||13
9718976|NCT00030823|10818452|FG000|NOT COMPLETED|Overall Study||1
9731520|NCT00132730|10831389|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731521|NCT00132730|10831390|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731522|NCT00132730|10831391|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731523|NCT00132730|10831392|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
9731524|NCT00132730|10831393|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
9731525|NCT00132730|10831394|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
9731526|NCT00132730|10831389|FG000|STARTED|Period V - Open-label Extension (EXT2)||0
9731527|NCT00132730|10831390|FG001|STARTED|Period V - Open-label Extension (EXT2)||0
9731528|NCT00132730|10831391|FG002|STARTED|Period V - Open-label Extension (EXT2)||0
9731529|NCT00132730|10831392|FG003|STARTED|Period V - Open-label Extension (EXT2)||0
9731530|NCT00132730|10831393|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
9731531|NCT00132730|10831394|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
9731532|NCT00132730|10831389|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0
9731533|NCT00132730|10831390|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0
9731534|NCT00132730|10831391|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0
9731535|NCT00132730|10831392|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0
9731536|NCT00132730|10831393|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0
9731537|NCT00132730|10831394|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0
9731538|NCT00132730|10831389|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
9731539|NCT00132730|10831390|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
9731540|NCT00132730|10831391|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
9731541|NCT00132730|10831392|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
9731542|NCT00132730|10831393|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
9731543|NCT00132730|10831394|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
9731544|NCT00132769|10831410|FG000|STARTED|Overall Study||53
9718977|NCT00030901|10818458|FG000|STARTED|Initial Registration||619
9718978|NCT00030901|10818459|FG001|STARTED|Initial Registration||0
9718979|NCT00030901|10818460|FG002|STARTED|Initial Registration||0
9718980|NCT00030901|10818458|FG000|COMPLETED|Initial Registration||452
9718981|NCT00030901|10818459|FG001|COMPLETED|Initial Registration||0
9718982|NCT00030901|10818460|FG002|COMPLETED|Initial Registration||0
9718983|NCT00030901|10818458|FG000|NOT COMPLETED|Initial Registration||167
9718984|NCT00030901|10818459|FG001|NOT COMPLETED|Initial Registration||0
9718985|NCT00030901|10818460|FG002|NOT COMPLETED|Initial Registration||0
9718986|NCT00030901|10818458|FG000|STARTED|Randomization||0
9718987|NCT00030901|10818459|FG001|STARTED|Randomization||227
9718988|NCT00030901|10818460|FG002|STARTED|Randomization||225
9718989|NCT00030901|10818458|FG000|Eligible|Randomization||0
9718990|NCT00030901|10818459|FG001|Eligible|Randomization||212
9718991|NCT00030901|10818460|FG002|Eligible|Randomization||211
9718992|NCT00030901|10818458|FG000|COMPLETED|Randomization||0
9718993|NCT00030901|10818459|FG001|COMPLETED|Randomization||126
9718994|NCT00030901|10818460|FG002|COMPLETED|Randomization||137
9718995|NCT00030901|10818458|FG000|NOT COMPLETED|Randomization||0
9718996|NCT00030901|10818459|FG001|NOT COMPLETED|Randomization||101
9718997|NCT00030901|10818460|FG002|NOT COMPLETED|Randomization||88
9718998|NCT00030992|10818466|FG000|STARTED|Overall Study||102
9718999|NCT00030992|10818466|FG000|COMPLETED|Overall Study||102
9719000|NCT00030992|10818466|FG000|NOT COMPLETED|Overall Study||0
9719001|NCT00031447|10818472|FG000|STARTED|Overall Study||14
9719002|NCT00031447|10818473|FG001|STARTED|Overall Study||15
9719003|NCT00031447|10818472|FG000|COMPLETED|Overall Study||4
9719004|NCT00031447|10818473|FG001|COMPLETED|Overall Study||8
9719005|NCT00031447|10818472|FG000|NOT COMPLETED|Overall Study||10
9719006|NCT00031447|10818473|FG001|NOT COMPLETED|Overall Study||7
9719007|NCT00031460|10818481|FG000|STARTED|Overall Study||24
9719008|NCT00031460|10818482|FG001|STARTED|Overall Study||22
9719009|NCT00031460|10818481|FG000|COMPLETED|Overall Study||15
9719010|NCT00031460|10818482|FG001|COMPLETED|Overall Study||8
9719011|NCT00031460|10818481|FG000|NOT COMPLETED|Overall Study||9
9719012|NCT00031460|10818482|FG001|NOT COMPLETED|Overall Study||14
9719013|NCT00031486|10818490|FG000|STARTED|Overall Study||40
9719014|NCT00031486|10818491|FG001|STARTED|Overall Study||47
9719015|NCT00031486|10818490|FG000|COMPLETED|Overall Study||33
9719016|NCT00031486|10818491|FG001|COMPLETED|Overall Study||35
9719017|NCT00031486|10818490|FG000|NOT COMPLETED|Overall Study||7
9719018|NCT00031486|10818491|FG001|NOT COMPLETED|Overall Study||12
9719019|NCT00031551|10818501|FG000|STARTED|Overall Study||2
9719020|NCT00031551|10818502|FG001|STARTED|Overall Study||25
9719021|NCT00031551|10818501|FG000|COMPLETED|Overall Study||0
9719022|NCT00031551|10818502|FG001|COMPLETED|Overall Study||25
9719023|NCT00031551|10818501|FG000|NOT COMPLETED|Overall Study||2
9719024|NCT00031551|10818502|FG001|NOT COMPLETED|Overall Study||0
9719025|NCT00031590|10818512|FG000|STARTED|Overall Study||28
9719026|NCT00031590|10818512|FG000|COMPLETED|Overall Study||25
9719027|NCT00031590|10818512|FG000|NOT COMPLETED|Overall Study||3
9719028|NCT00031694|10818517|FG000|STARTED|Overall Study||19
9719029|NCT00031694|10818517|FG000|COMPLETED|Overall Study||0
9719030|NCT00031694|10818517|FG000|NOT COMPLETED|Overall Study||19
9719031|NCT00032487|10818524|FG000|STARTED|Overall Study||899
9719032|NCT00032487|10818525|FG001|STARTED|Overall Study||892
9719033|NCT00032487|10818524|FG000|COMPLETED|Overall Study||760
9719034|NCT00032487|10818525|FG001|COMPLETED|Overall Study||772
9719035|NCT00032487|10818524|FG000|NOT COMPLETED|Overall Study||139
9719036|NCT00032487|10818525|FG001|NOT COMPLETED|Overall Study||120
9719037|NCT00032591|10818533|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
9719038|NCT00032591|10818534|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
9719039|NCT00032591|10818533|FG000|COMPLETED|Screening|823 were excluded from the study|1465
9719040|NCT00032591|10818534|FG001|COMPLETED|Screening||1457
9850939|NCT00873821|10963694|FG001|NOT COMPLETED|Overall Study||0
9850940|NCT00873860|10963704|FG000|STARTED|Overall Study||48
9850941|NCT00873860|10963705|FG001|STARTED|Overall Study||47
9850942|NCT00873860|10963706|FG002|STARTED|Overall Study||51
9850943|NCT00873860|10963707|FG003|STARTED|Overall Study||48
9850944|NCT00873860|10963704|FG000|Treated|Overall Study||47
9850945|NCT00873860|10963705|FG001|Treated|Overall Study||47
9850946|NCT00873860|10963706|FG002|Treated|Overall Study||51
9966098|NCT01505764|11086298|FG000|NOT COMPLETED|Overall Study||3
9966099|NCT01505764|11086299|FG001|NOT COMPLETED|Overall Study||1
9966100|NCT01505868|11086311|FG000|STARTED|Overall Study||4
9966101|NCT01505868|11086312|FG001|STARTED|Overall Study||3
9966102|NCT01505868|11086313|FG002|STARTED|Overall Study||3
9966103|NCT01505868|11086314|FG003|STARTED|Overall Study||79
9966104|NCT01505868|11086315|FG004|STARTED|Overall Study||81
9966105|NCT01505868|11086311|FG000|COMPLETED|Overall Study||3
9966106|NCT01505868|11086312|FG001|COMPLETED|Overall Study||3
9966107|NCT01505868|11086313|FG002|COMPLETED|Overall Study||3
9966108|NCT01505868|11086314|FG003|COMPLETED|Overall Study||79
9966109|NCT01505868|11086315|FG004|COMPLETED|Overall Study||81
9966110|NCT01505868|11086311|FG000|NOT COMPLETED|Overall Study||1
9966111|NCT01505868|11086312|FG001|NOT COMPLETED|Overall Study||0
9719041|NCT00032591|10818533|FG000|NOT COMPLETED|Screening||408
9719042|NCT00032591|10818534|FG001|NOT COMPLETED|Screening||415
9719043|NCT00032591|10818533|FG000|STARTED|Randomization|2922 underwent randomization|1465
9966112|NCT01505868|11086313|FG002|NOT COMPLETED|Overall Study||0
9966113|NCT01505868|11086314|FG003|NOT COMPLETED|Overall Study||0
9719044|NCT00032591|10818534|FG001|STARTED|Randomization||1457
9719045|NCT00032591|10818533|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465
9719046|NCT00032591|10818534|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
9719047|NCT00032591|10818533|FG000|NOT COMPLETED|Randomization||0
9719048|NCT00032591|10818534|FG001|NOT COMPLETED|Randomization||0
9719049|NCT00032591|10818533|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
9719050|NCT00032591|10818534|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
9719051|NCT00032591|10818533|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
9719052|NCT00032591|10818534|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
9719053|NCT00032591|10818533|FG000|NOT COMPLETED|Follow-up||2
9719054|NCT00032591|10818534|FG001|NOT COMPLETED|Follow-up||5
9719055|NCT00032630|10818542|FG000|STARTED|Overall Study||1099
9719056|NCT00032630|10818543|FG001|STARTED|Overall Study||1104
9719057|NCT00032630|10818542|FG000|COMPLETED|Overall Study||1050
9719058|NCT00032630|10818543|FG001|COMPLETED|Overall Study||1061
9719059|NCT00032630|10818542|FG000|NOT COMPLETED|Overall Study||49
9719060|NCT00032630|10818543|FG001|NOT COMPLETED|Overall Study||43
9719061|NCT00033371|10818551|FG000|STARTED|Overall Study||55
9719062|NCT00033371|10818552|FG001|STARTED|Overall Study||57
9719063|NCT00033371|10818551|FG000|COMPLETED|Overall Study||49
9719064|NCT00033371|10818552|FG001|COMPLETED|Overall Study||47
9719065|NCT00033371|10818551|FG000|NOT COMPLETED|Overall Study||6
9719066|NCT00033371|10818552|FG001|NOT COMPLETED|Overall Study||10
9719067|NCT00033514|10818564|FG000|STARTED|Overall Study||16
9719068|NCT00033514|10818565|FG001|STARTED|Overall Study||11
9719069|NCT00033514|10818564|FG000|COMPLETED|Overall Study||15
9719070|NCT00033514|10818565|FG001|COMPLETED|Overall Study||7
9719071|NCT00033514|10818564|FG000|NOT COMPLETED|Overall Study||1
9719072|NCT00033514|10818565|FG001|NOT COMPLETED|Overall Study||4
9719073|NCT00033540|10818572|FG000|STARTED|Overall Study||57
9719074|NCT00033540|10818572|FG000|Eligible|Overall Study||54
9719075|NCT00033540|10818572|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
9719076|NCT00033540|10818572|FG000|COMPLETED|Overall Study||0
9719077|NCT00033540|10818572|FG000|NOT COMPLETED|Overall Study||57
9719078|NCT00033631|10818579|FG000|STARTED|Overall Study||769
9719079|NCT00033631|10818580|FG001|STARTED|Overall Study||763
9719080|NCT00033631|10818579|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
9719081|NCT00033631|10818580|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
9719082|NCT00033631|10818579|FG000|NOT COMPLETED|Overall Study||18
9719083|NCT00033631|10818580|FG001|NOT COMPLETED|Overall Study||15
9719084|NCT00033657|10818589|FG000|STARTED|Neoadjuvant Chemotherapy||50
9719085|NCT00033657|10818590|FG001|STARTED|Neoadjuvant Chemotherapy||47
9719086|NCT00033657|10818589|FG000|Eligible|Neoadjuvant Chemotherapy||42
9719087|NCT00033657|10818590|FG001|Eligible|Neoadjuvant Chemotherapy||43
9719088|NCT00033657|10818589|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39
9719089|NCT00033657|10818590|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42
9719090|NCT00033657|10818589|FG000|COMPLETED|Neoadjuvant Chemotherapy||36
9719091|NCT00033657|10818590|FG001|COMPLETED|Neoadjuvant Chemotherapy||36
9719092|NCT00033657|10818589|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14
9719093|NCT00033657|10818590|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11
9719094|NCT00033657|10818589|FG000|STARTED|Surgical Resection||36
9719095|NCT00033657|10818590|FG001|STARTED|Surgical Resection||36
9719096|NCT00033657|10818589|FG000|COMPLETED|Surgical Resection||36
9719097|NCT00033657|10818590|FG001|COMPLETED|Surgical Resection||33
9719098|NCT00033657|10818589|FG000|NOT COMPLETED|Surgical Resection||0
9719099|NCT00033657|10818590|FG001|NOT COMPLETED|Surgical Resection||3
9719100|NCT00033657|10818589|FG000|STARTED|Adjuvant Chemotherapy||36
9719101|NCT00033657|10818590|FG001|STARTED|Adjuvant Chemotherapy||33
9719102|NCT00033657|10818589|FG000|COMPLETED|Adjuvant Chemotherapy||18
9719103|NCT00033657|10818590|FG001|COMPLETED|Adjuvant Chemotherapy||16
9719104|NCT00033657|10818589|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18
9719105|NCT00033657|10818590|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17
9719106|NCT00033917|10818600|FG000|STARTED|Overall Study||209
9719107|NCT00033917|10818601|FG001|STARTED|Overall Study||222
9719108|NCT00033917|10818600|FG000|COMPLETED|Overall Study||209
9719109|NCT00033917|10818601|FG001|COMPLETED|Overall Study||222
9719110|NCT00033917|10818600|FG000|NOT COMPLETED|Overall Study||0
9719111|NCT00033917|10818601|FG001|NOT COMPLETED|Overall Study||0
9719112|NCT00035555|10818614|FG000|STARTED|Overall Study|Randomized patients|74
9719113|NCT00035555|10818615|FG001|STARTED|Overall Study|Randomized patients|71
9719114|NCT00035555|10818616|FG002|STARTED|Overall Study|Randomized patients|73
9719115|NCT00035555|10818614|FG000|Number Who Had Undergone Transplantation|Overall Study||74
9719116|NCT00035555|10818615|FG001|Number Who Had Undergone Transplantation|Overall Study||71
9719117|NCT00035555|10818616|FG002|Number Who Had Undergone Transplantation|Overall Study||73
9719118|NCT00035555|10818614|FG000|Number Who Received Study Drug|Overall Study||74
9719119|NCT00035555|10818615|FG001|Number Who Received Study Drug|Overall Study||71
9719120|NCT00035555|10818616|FG002|Number Who Received Study Drug|Overall Study||71
9719121|NCT00035555|10818614|FG000|COMPLETED|Overall Study||58
9719122|NCT00035555|10818615|FG001|COMPLETED|Overall Study||55
9719123|NCT00035555|10818616|FG002|COMPLETED|Overall Study||51
9719124|NCT00035555|10818614|FG000|NOT COMPLETED|Overall Study||16
9719125|NCT00035555|10818615|FG001|NOT COMPLETED|Overall Study||16
9719126|NCT00035555|10818616|FG002|NOT COMPLETED|Overall Study||22
9719127|NCT00035815|10818627|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
9719128|NCT00035815|10818628|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
9719129|NCT00035815|10818627|FG000|COMPLETED|Overall Study||150
9719130|NCT00035815|10818628|FG001|COMPLETED|Overall Study||152
9719131|NCT00035815|10818627|FG000|NOT COMPLETED|Overall Study||17
9719132|NCT00035815|10818628|FG001|NOT COMPLETED|Overall Study||11
9719133|NCT00035932|10818637|FG000|STARTED|Overall Study|120 randomized, 119 treated|119
9719134|NCT00035932|10818638|FG001|STARTED|Overall Study|115 randomized, 110 treated|110
9719135|NCT00035932|10818639|FG002|STARTED|Overall Study|123 randomized, 118 treated|118
9719136|NCT00035932|10818637|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26
9719137|NCT00035932|10818638|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29
9719138|NCT00035932|10818639|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13
9719139|NCT00035932|10818637|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26
9719140|NCT00035932|10818638|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27
9719141|NCT00035932|10818639|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30
9719142|NCT00035932|10818637|FG000|Discontinued on or After Week 96|Overall Study||4
9719143|NCT00035932|10818638|FG001|Discontinued on or After Week 96|Overall Study||4
9719144|NCT00035932|10818639|FG002|Discontinued on or After Week 96|Overall Study||6
9719145|NCT00035932|10818637|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
9719146|NCT00035932|10818638|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
9719147|NCT00035932|10818639|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
9719148|NCT00035932|10818637|FG000|NOT COMPLETED|Overall Study||56
9719149|NCT00035932|10818638|FG001|NOT COMPLETED|Overall Study||60
9719150|NCT00035932|10818639|FG002|NOT COMPLETED|Overall Study||49
9719151|NCT00036270|10818654|FG000|STARTED|Randomized to Study Treatment||4904
9719152|NCT00036270|10818655|FG001|STARTED|Randomized to Study Treatment||4875
9719153|NCT00036270|10818654|FG000|COMPLETED|Randomized to Study Treatment||4898
9719154|NCT00036270|10818655|FG001|COMPLETED|Randomized to Study Treatment||4868
9719155|NCT00036270|10818654|FG000|NOT COMPLETED|Randomized to Study Treatment||6
9719156|NCT00036270|10818655|FG001|NOT COMPLETED|Randomized to Study Treatment||7
9719157|NCT00036270|10818654|FG000|STARTED|Study Treatment to 5 Year Report||4898
9719158|NCT00036270|10818655|FG001|STARTED|Study Treatment to 5 Year Report||4868
9719159|NCT00036270|10818654|FG000|Treated|Study Treatment to 5 Year Report||4852
9719160|NCT00036270|10818655|FG001|Treated|Study Treatment to 5 Year Report||4814
9719161|NCT00036270|10818654|FG000|COMPLETED|Study Treatment to 5 Year Report||2333
9719162|NCT00036270|10818655|FG001|COMPLETED|Study Treatment to 5 Year Report||1380
9719163|NCT00036270|10818654|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565
9719164|NCT00036270|10818655|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488
9719165|NCT00036569|10818661|FG000|STARTED|Overall Study||32
9719166|NCT00036569|10818661|FG000|COMPLETED|Overall Study||32
9719167|NCT00036569|10818661|FG000|NOT COMPLETED|Overall Study||0
9719168|NCT00036738|10818667|FG000|STARTED|Overall Study||28
9719169|NCT00036738|10818667|FG000|COMPLETED|Overall Study||28
9719170|NCT00036738|10818667|FG000|NOT COMPLETED|Overall Study||0
9719171|NCT00037830|10818674|FG000|STARTED|Overall Study||39
9719172|NCT00037830|10818675|FG001|STARTED|Overall Study||38
9719173|NCT00037830|10818676|FG002|STARTED|Overall Study||17
9719174|NCT00037830|10818674|FG000|COMPLETED|Overall Study||29
9719175|NCT00037830|10818675|FG001|COMPLETED|Overall Study||31
9719176|NCT00037830|10818676|FG002|COMPLETED|Overall Study||16
9719177|NCT00037830|10818674|FG000|NOT COMPLETED|Overall Study||10
9719178|NCT00037830|10818675|FG001|NOT COMPLETED|Overall Study||7
9719179|NCT00037830|10818676|FG002|NOT COMPLETED|Overall Study||1
9719180|NCT00038103|10818686|FG000|STARTED|Overall Study||55
9719181|NCT00038103|10818687|FG001|STARTED|Overall Study||56
9850947|NCT00873860|10963707|FG003|Treated|Overall Study||48
9850948|NCT00873860|10963704|FG000|COMPLETED|Overall Study||44
9850949|NCT00873860|10963705|FG001|COMPLETED|Overall Study||47
9850950|NCT00873860|10963706|FG002|COMPLETED|Overall Study||48
9850951|NCT00873860|10963707|FG003|COMPLETED|Overall Study||47
9850952|NCT00873860|10963704|FG000|NOT COMPLETED|Overall Study||4
9850953|NCT00873860|10963705|FG001|NOT COMPLETED|Overall Study||0
9850954|NCT00873860|10963706|FG002|NOT COMPLETED|Overall Study||3
9850955|NCT00873860|10963707|FG003|NOT COMPLETED|Overall Study||1
9850956|NCT00873873|10963724|FG000|STARTED|Overall Study||20
9850957|NCT00873873|10963725|FG001|STARTED|Overall Study||8
9850958|NCT00873873|10963726|FG002|STARTED|Overall Study||9
9850959|NCT00873873|10963727|FG003|STARTED|Overall Study||18
9850960|NCT00873873|10963724|FG000|COMPLETED|Overall Study||20
9850961|NCT00873873|10963725|FG001|COMPLETED|Overall Study||8
9850962|NCT00873873|10963726|FG002|COMPLETED|Overall Study||9
10195457|NCT03346057|11323776|FG003|NOT COMPLETED|Overall Study||2
10195458|NCT03346070|11323791|FG000|STARTED|Overall Study||41
10195459|NCT03346070|11323792|FG001|STARTED|Overall Study||41
10195460|NCT03346070|11323793|FG002|STARTED|Overall Study||41
10195461|NCT03346070|11323794|FG003|STARTED|Overall Study||42
10195462|NCT03346070|11323795|FG004|STARTED|Overall Study||42
10195463|NCT03346070|11323791|FG000|Treated|Overall Study||38
10195464|NCT03346070|11323792|FG001|Treated|Overall Study||38
10195465|NCT03346070|11323793|FG002|Treated|Overall Study||38
10195466|NCT03346070|11323794|FG003|Treated|Overall Study||36
10195467|NCT03346070|11323795|FG004|Treated|Overall Study||38
10195468|NCT03346070|11323791|FG000|COMPLETED|Overall Study||38
10195469|NCT03346070|11323792|FG001|COMPLETED|Overall Study||37
10195470|NCT03346070|11323793|FG002|COMPLETED|Overall Study||37
10195471|NCT03346070|11323794|FG003|COMPLETED|Overall Study||36
10195472|NCT03346070|11323795|FG004|COMPLETED|Overall Study||37
10195473|NCT03346070|11323791|FG000|NOT COMPLETED|Overall Study||3
9719182|NCT00038103|10818686|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
9719183|NCT00038103|10818687|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
9719184|NCT00038103|10818686|FG000|COMPLETED|Overall Study||0
9719185|NCT00038103|10818687|FG001|COMPLETED|Overall Study||0
9719186|NCT00038103|10818686|FG000|NOT COMPLETED|Overall Study||55
9719187|NCT00038103|10818687|FG001|NOT COMPLETED|Overall Study||56
9719188|NCT00038467|10818695|FG000|STARTED|Overall Study||2352
9719189|NCT00038467|10818696|FG001|STARTED|Overall Study||2372
9719190|NCT00038467|10818695|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
9850963|NCT00873873|10963727|FG003|COMPLETED|Overall Study||18
9850964|NCT00873873|10963724|FG000|NOT COMPLETED|Overall Study||0
9850965|NCT00873873|10963725|FG001|NOT COMPLETED|Overall Study||0
9850966|NCT00873873|10963726|FG002|NOT COMPLETED|Overall Study||0
9850967|NCT00873873|10963727|FG003|NOT COMPLETED|Overall Study||0
9850968|NCT00873912|10963739|FG000|STARTED|Overall Study||240
9850969|NCT00873912|10963740|FG001|STARTED|Overall Study||60
9850970|NCT00873912|10963739|FG000|COMPLETED|Overall Study||237
9850971|NCT00873912|10963740|FG001|COMPLETED|Overall Study||60
9850972|NCT00873912|10963739|FG000|NOT COMPLETED|Overall Study||3
9850973|NCT00873912|10963740|FG001|NOT COMPLETED|Overall Study||0
9850974|NCT00874029|10963746|FG000|STARTED|Overall Study||137
9850975|NCT00874029|10963746|FG000|COMPLETED|Overall Study||116
9850976|NCT00874029|10963746|FG000|NOT COMPLETED|Overall Study||21
9850977|NCT00874094|10963760|FG000|STARTED|Overall Study||15
9850978|NCT00874094|10963760|FG000|COMPLETED|Overall Study||15
9850979|NCT00874094|10963760|FG000|NOT COMPLETED|Overall Study||0
9850980|NCT00874120|10963766|FG000|STARTED|First Intervention||58
9850981|NCT00874120|10963767|FG001|STARTED|First Intervention||58
9850982|NCT00874120|10963766|FG000|COMPLETED|First Intervention||52
9850983|NCT00874120|10963767|FG001|COMPLETED|First Intervention||56
9850984|NCT00874120|10963766|FG000|NOT COMPLETED|First Intervention||6
9850985|NCT00874120|10963767|FG001|NOT COMPLETED|First Intervention||2
9850986|NCT00874120|10963766|FG000|STARTED|Wash-out Period||52
9850987|NCT00874120|10963767|FG001|STARTED|Wash-out Period||56
9850988|NCT00874120|10963766|FG000|COMPLETED|Wash-out Period||52
9850989|NCT00874120|10963767|FG001|COMPLETED|Wash-out Period||56
9850990|NCT00874120|10963766|FG000|NOT COMPLETED|Wash-out Period||0
9850991|NCT00874120|10963767|FG001|NOT COMPLETED|Wash-out Period||0
9850992|NCT00874120|10963766|FG000|STARTED|Second Intervention||52
9850993|NCT00874120|10963767|FG001|STARTED|Second Intervention||56
9850994|NCT00874120|10963766|FG000|COMPLETED|Second Intervention||50
9850995|NCT00874120|10963767|FG001|COMPLETED|Second Intervention||56
9850996|NCT00874120|10963766|FG000|NOT COMPLETED|Second Intervention||2
9850997|NCT00874120|10963767|FG001|NOT COMPLETED|Second Intervention||0
9850998|NCT00874237|10963773|FG000|STARTED|Overall Study||8
9850999|NCT00874237|10963774|FG001|STARTED|Overall Study||8
9851000|NCT00874237|10963775|FG002|STARTED|Overall Study||8
9851001|NCT00874237|10963776|FG003|STARTED|Overall Study||8
9851002|NCT00874237|10963777|FG004|STARTED|Overall Study||8
9851003|NCT00874237|10963778|FG005|STARTED|Overall Study||8
9851004|NCT00874237|10963773|FG000|COMPLETED|Overall Study||8
9851005|NCT00874237|10963774|FG001|COMPLETED|Overall Study||7
9851006|NCT00874237|10963775|FG002|COMPLETED|Overall Study||7
9851007|NCT00874237|10963776|FG003|COMPLETED|Overall Study||8
9851008|NCT00874237|10963777|FG004|COMPLETED|Overall Study||8
9851009|NCT00874237|10963778|FG005|COMPLETED|Overall Study||8
9851010|NCT00874237|10963773|FG000|NOT COMPLETED|Overall Study||0
9851011|NCT00874237|10963774|FG001|NOT COMPLETED|Overall Study||1
9851012|NCT00874237|10963775|FG002|NOT COMPLETED|Overall Study||1
9851013|NCT00874237|10963776|FG003|NOT COMPLETED|Overall Study||0
9851014|NCT00874237|10963777|FG004|NOT COMPLETED|Overall Study||0
9851015|NCT00874237|10963778|FG005|NOT COMPLETED|Overall Study||0
9851016|NCT00874250|10963788|FG000|STARTED|Overall Study||51
9851017|NCT00874250|10963788|FG000|COMPLETED|Overall Study||0
9851018|NCT00874250|10963788|FG000|NOT COMPLETED|Overall Study||51
9851019|NCT00874276|10963795|FG000|STARTED|Overall Study||6
9851020|NCT00874276|10963796|FG001|STARTED|Overall Study||8
9851021|NCT00874276|10963795|FG000|COMPLETED|Overall Study||5
9851022|NCT00874276|10963796|FG001|COMPLETED|Overall Study||7
9851023|NCT00874276|10963795|FG000|NOT COMPLETED|Overall Study||1
9851024|NCT00874276|10963796|FG001|NOT COMPLETED|Overall Study||1
9851025|NCT00874432|10963808|FG000|STARTED|Overall Study||8
9851026|NCT00874432|10963809|FG001|STARTED|Overall Study||4
9851027|NCT00874432|10963810|FG002|STARTED|Overall Study||17
9851028|NCT00874432|10963811|FG003|STARTED|Overall Study||14
9851029|NCT00874432|10963808|FG000|COMPLETED|Overall Study||5
9851030|NCT00874432|10963809|FG001|COMPLETED|Overall Study||2
9851031|NCT00874432|10963810|FG002|COMPLETED|Overall Study||9
9851032|NCT00874432|10963811|FG003|COMPLETED|Overall Study||11
9851033|NCT00874432|10963808|FG000|NOT COMPLETED|Overall Study||3
9851034|NCT00874432|10963809|FG001|NOT COMPLETED|Overall Study||2
9851035|NCT00874432|10963810|FG002|NOT COMPLETED|Overall Study||8
9851036|NCT00874432|10963811|FG003|NOT COMPLETED|Overall Study||3
9851037|NCT00874497|10963825|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
9851038|NCT00874497|10963826|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
9851039|NCT00874497|10963825|FG000|COMPLETED|Overall Study||23
9851040|NCT00874497|10963826|FG001|COMPLETED|Overall Study||15
9851041|NCT00874497|10963825|FG000|NOT COMPLETED|Overall Study||28
9851042|NCT00874497|10963826|FG001|NOT COMPLETED|Overall Study||18
9851043|NCT00874510|10963834|FG000|STARTED|Year 1||88
9851044|NCT00874510|10963835|FG001|STARTED|Year 1||85
9851045|NCT00874510|10963834|FG000|COMPLETED|Year 1||88
9851046|NCT00874510|10963835|FG001|COMPLETED|Year 1||85
9851047|NCT00874510|10963834|FG000|NOT COMPLETED|Year 1||0
9851048|NCT00874510|10963835|FG001|NOT COMPLETED|Year 1||0
9851049|NCT00874510|10963834|FG000|STARTED|Year 2||92
9851050|NCT00874510|10963835|FG001|STARTED|Year 2||87
9851051|NCT00874510|10963834|FG000|COMPLETED|Year 2||92
9851052|NCT00874510|10963835|FG001|COMPLETED|Year 2||87
9851053|NCT00874510|10963834|FG000|NOT COMPLETED|Year 2||0
9851054|NCT00874510|10963835|FG001|NOT COMPLETED|Year 2||0
9851055|NCT00874549|10963845|FG000|STARTED|Overall Study||51
9851056|NCT00874549|10963846|FG001|STARTED|Overall Study||56
9851057|NCT00874549|10963847|FG002|STARTED|Overall Study||51
9851058|NCT00874549|10963848|FG003|STARTED|Overall Study||58
9851059|NCT00874549|10963845|FG000|COMPLETED|Overall Study||50
9851060|NCT00874549|10963846|FG001|COMPLETED|Overall Study||55
9851061|NCT00874549|10963847|FG002|COMPLETED|Overall Study||47
9851062|NCT00874549|10963848|FG003|COMPLETED|Overall Study||56
9851063|NCT00874549|10963845|FG000|NOT COMPLETED|Overall Study||1
9851064|NCT00874549|10963846|FG001|NOT COMPLETED|Overall Study||1
9851065|NCT00874549|10963847|FG002|NOT COMPLETED|Overall Study||4
9851066|NCT00874549|10963848|FG003|NOT COMPLETED|Overall Study||2
9851067|NCT00874614|10963858|FG000|STARTED|Overall Study||74
9851068|NCT00874614|10963858|FG000|Received at Least One Therapeutic Dose|Overall Study||68
9851069|NCT00874614|10963858|FG000|Received Two Therapeutic Doses|Overall Study||50
9851070|NCT00874614|10963858|FG000|COMPLETED|Overall Study|As of December 2017|16
9851071|NCT00874614|10963858|FG000|NOT COMPLETED|Overall Study||58
9851072|NCT00874731|10963864|FG000|STARTED|Part 1, Day 1: Placebo||23
9851073|NCT00874731|10963865|FG001|STARTED|Part 1, Day 1: Placebo||0
9851074|NCT00874731|10963866|FG002|STARTED|Part 1, Day 1: Placebo||0
9851075|NCT00874731|10963864|FG000|COMPLETED|Part 1, Day 1: Placebo||22
9851076|NCT00874731|10963865|FG001|COMPLETED|Part 1, Day 1: Placebo||0
9851077|NCT00874731|10963866|FG002|COMPLETED|Part 1, Day 1: Placebo||0
9851078|NCT00874731|10963864|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1
9851079|NCT00874731|10963865|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0
9851080|NCT00874731|10963866|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0
9851081|NCT00874731|10963864|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
9851082|NCT00874731|10963865|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
9851083|NCT00874731|10963866|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
9851084|NCT00874731|10963864|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
9851085|NCT00874731|10963865|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
9851086|NCT00874731|10963866|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
9851087|NCT00874731|10963864|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
9851088|NCT00874731|10963865|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
9851089|NCT00874731|10963866|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
9851090|NCT00874731|10963864|FG000|STARTED|Washout Period||0
9851091|NCT00874731|10963865|FG001|STARTED|Washout Period||22
9851092|NCT00874731|10963866|FG002|STARTED|Washout Period||0
9851093|NCT00874731|10963864|FG000|COMPLETED|Washout Period||0
9851094|NCT00874731|10963865|FG001|COMPLETED|Washout Period||22
9851095|NCT00874731|10963866|FG002|COMPLETED|Washout Period||0
9851096|NCT00874731|10963864|FG000|NOT COMPLETED|Washout Period||0
9851097|NCT00874731|10963865|FG001|NOT COMPLETED|Washout Period||0
9851098|NCT00874731|10963866|FG002|NOT COMPLETED|Washout Period||0
9851099|NCT00874731|10963864|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0
9851100|NCT00874731|10963865|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
9851101|NCT00874731|10963866|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
9851102|NCT00874731|10963864|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0
9851103|NCT00874731|10963865|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0
9851104|NCT00874731|10963866|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0
9851105|NCT00874731|10963864|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
9851106|NCT00874731|10963865|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
9851107|NCT00874731|10963866|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
9851108|NCT00874770|10963878|FG000|STARTED|Overall Study||12
9851109|NCT00874770|10963879|FG001|STARTED|Overall Study||12
9966114|NCT01505868|11086315|FG004|NOT COMPLETED|Overall Study||0
9966115|NCT01505881|11086329|FG000|STARTED|Overall Study||99
9966116|NCT01505881|11086330|FG001|STARTED|Overall Study||59
9966117|NCT01505881|11086329|FG000|COMPLETED|Overall Study||95
9966118|NCT01505881|11086330|FG001|COMPLETED|Overall Study||58
9966119|NCT01505881|11086329|FG000|NOT COMPLETED|Overall Study||4
9966120|NCT01505881|11086330|FG001|NOT COMPLETED|Overall Study||1
9966121|NCT01505933|11086339|FG000|STARTED|Overall Study||10
9966122|NCT01505933|11086340|FG001|STARTED|Overall Study||14
9966123|NCT01505933|11086339|FG000|COMPLETED|Overall Study||10
9966124|NCT01505933|11086340|FG001|COMPLETED|Overall Study||14
9966125|NCT01505933|11086339|FG000|NOT COMPLETED|Overall Study||0
9966126|NCT01505933|11086340|FG001|NOT COMPLETED|Overall Study||0
9966127|NCT01506193|11086349|FG000|STARTED|Overall Study||351
9966128|NCT01506193|11086350|FG001|STARTED|Overall Study||183
9966129|NCT01506193|11086351|FG002|STARTED|Overall Study||182
9966130|NCT01506193|11086349|FG000|COMPLETED|Overall Study||337
9966131|NCT01506193|11086350|FG001|COMPLETED|Overall Study||179
9966132|NCT01506193|11086351|FG002|COMPLETED|Overall Study||168
9966133|NCT01506193|11086349|FG000|NOT COMPLETED|Overall Study||14
9966134|NCT01506193|11086350|FG001|NOT COMPLETED|Overall Study||4
9966135|NCT01506193|11086351|FG002|NOT COMPLETED|Overall Study||14
9966136|NCT01506271|11086363|FG000|STARTED|Overall Study||118
9966137|NCT01506271|11086364|FG001|STARTED|Overall Study||116
10080596|NCT02252965|11208797|FG000|NOT COMPLETED|Overall Study||40
9966138|NCT01506271|11086365|FG002|STARTED|Overall Study||117
9966139|NCT01506271|11086363|FG000|Treated|Overall Study||117
9966140|NCT01506271|11086364|FG001|Treated|Overall Study||116
9966141|NCT01506271|11086365|FG002|Treated|Overall Study||114
9851110|NCT00874770|10963880|FG002|STARTED|Overall Study||12
9851111|NCT00874770|10963881|FG003|STARTED|Overall Study||12
9851112|NCT00874770|10963878|FG000|COMPLETED|Overall Study||7
9851113|NCT00874770|10963879|FG001|COMPLETED|Overall Study||11
9851114|NCT00874770|10963880|FG002|COMPLETED|Overall Study||8
9851115|NCT00874770|10963881|FG003|COMPLETED|Overall Study||7
9851116|NCT00874770|10963878|FG000|NOT COMPLETED|Overall Study||5
9851117|NCT00874770|10963879|FG001|NOT COMPLETED|Overall Study||1
9851118|NCT00874770|10963880|FG002|NOT COMPLETED|Overall Study||4
9851119|NCT00874770|10963881|FG003|NOT COMPLETED|Overall Study||5
9851120|NCT00874822|10963901|FG000|STARTED|Overall Study||216
9851121|NCT00874822|10963901|FG000|COMPLETED|Overall Study||208
9851122|NCT00874822|10963901|FG000|NOT COMPLETED|Overall Study||8
9851123|NCT00874848|10963907|FG000|STARTED|Overall Study||59
9851124|NCT00874848|10963908|FG001|STARTED|Overall Study||29
9851125|NCT00874848|10963907|FG000|Discontinued|Overall Study||59
9851126|NCT00874848|10963908|FG001|Discontinued|Overall Study||28
9851127|NCT00874848|10963907|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
9851128|NCT00874848|10963908|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
9851129|NCT00874848|10963907|FG000|NOT COMPLETED|Overall Study||59
9851130|NCT00874848|10963908|FG001|NOT COMPLETED|Overall Study||28
9851131|NCT00874887|10963916|FG000|STARTED|Overall Study||32
9851132|NCT00874887|10963917|FG001|STARTED|Overall Study||34
9851133|NCT00874887|10963916|FG000|COMPLETED|Overall Study||32
9851134|NCT00874887|10963917|FG001|COMPLETED|Overall Study||34
9851135|NCT00874887|10963916|FG000|NOT COMPLETED|Overall Study||0
9851136|NCT00874887|10963917|FG001|NOT COMPLETED|Overall Study||0
9851137|NCT00875017|10963929|FG000|STARTED|First Intervention||5
9851138|NCT00875017|10963930|FG001|STARTED|First Intervention||5
9851139|NCT00875017|10963931|FG002|STARTED|First Intervention||5
9851140|NCT00875017|10963932|FG003|STARTED|First Intervention||6
9851141|NCT00875017|10963933|FG004|STARTED|First Intervention||5
9851142|NCT00875017|10963934|FG005|STARTED|First Intervention||5
9851143|NCT00875017|10963929|FG000|COMPLETED|First Intervention||3
9851144|NCT00875017|10963930|FG001|COMPLETED|First Intervention||5
9851145|NCT00875017|10963931|FG002|COMPLETED|First Intervention||4
9851146|NCT00875017|10963932|FG003|COMPLETED|First Intervention||5
9851147|NCT00875017|10963933|FG004|COMPLETED|First Intervention||4
9851148|NCT00875017|10963934|FG005|COMPLETED|First Intervention||5
9851149|NCT00875017|10963929|FG000|NOT COMPLETED|First Intervention||2
9851150|NCT00875017|10963930|FG001|NOT COMPLETED|First Intervention||0
9851151|NCT00875017|10963931|FG002|NOT COMPLETED|First Intervention||1
9851152|NCT00875017|10963932|FG003|NOT COMPLETED|First Intervention||1
9851153|NCT00875017|10963933|FG004|NOT COMPLETED|First Intervention||1
9851154|NCT00875017|10963934|FG005|NOT COMPLETED|First Intervention||0
9851155|NCT00875017|10963929|FG000|STARTED|Washout||3
9851156|NCT00875017|10963930|FG001|STARTED|Washout||5
9851157|NCT00875017|10963931|FG002|STARTED|Washout||4
9851158|NCT00875017|10963932|FG003|STARTED|Washout||5
9851159|NCT00875017|10963933|FG004|STARTED|Washout||4
9851160|NCT00875017|10963934|FG005|STARTED|Washout||5
9851161|NCT00875017|10963929|FG000|COMPLETED|Washout||3
9851162|NCT00875017|10963930|FG001|COMPLETED|Washout||5
9851163|NCT00875017|10963931|FG002|COMPLETED|Washout||3
9851164|NCT00875017|10963932|FG003|COMPLETED|Washout||5
9851165|NCT00875017|10963933|FG004|COMPLETED|Washout||4
9851166|NCT00875017|10963934|FG005|COMPLETED|Washout||5
9851167|NCT00875017|10963929|FG000|NOT COMPLETED|Washout||0
9851168|NCT00875017|10963930|FG001|NOT COMPLETED|Washout||0
9851169|NCT00875017|10963931|FG002|NOT COMPLETED|Washout||1
9851170|NCT00875017|10963932|FG003|NOT COMPLETED|Washout||0
9851171|NCT00875017|10963933|FG004|NOT COMPLETED|Washout||0
9851172|NCT00875017|10963934|FG005|NOT COMPLETED|Washout||0
9851173|NCT00875017|10963929|FG000|STARTED|Second Intervention||3
9851174|NCT00875017|10963930|FG001|STARTED|Second Intervention||5
9851175|NCT00875017|10963931|FG002|STARTED|Second Intervention||3
9851176|NCT00875017|10963932|FG003|STARTED|Second Intervention||5
9851177|NCT00875017|10963933|FG004|STARTED|Second Intervention||4
9851178|NCT00875017|10963934|FG005|STARTED|Second Intervention||5
9851179|NCT00875017|10963929|FG000|COMPLETED|Second Intervention||3
9851180|NCT00875017|10963930|FG001|COMPLETED|Second Intervention||5
9851181|NCT00875017|10963931|FG002|COMPLETED|Second Intervention||3
9851182|NCT00875017|10963932|FG003|COMPLETED|Second Intervention||4
9851183|NCT00875017|10963933|FG004|COMPLETED|Second Intervention||4
9851184|NCT00875017|10963934|FG005|COMPLETED|Second Intervention||5
9851185|NCT00875017|10963929|FG000|NOT COMPLETED|Second Intervention||0
9851186|NCT00875017|10963930|FG001|NOT COMPLETED|Second Intervention||0
9851187|NCT00875017|10963931|FG002|NOT COMPLETED|Second Intervention||0
9851188|NCT00875017|10963932|FG003|NOT COMPLETED|Second Intervention||1
9851189|NCT00875017|10963933|FG004|NOT COMPLETED|Second Intervention||0
9851190|NCT00875017|10963934|FG005|NOT COMPLETED|Second Intervention||0
9851191|NCT00875017|10963929|FG000|STARTED|Washout||3
9851192|NCT00875017|10963930|FG001|STARTED|Washout||5
9851193|NCT00875017|10963931|FG002|STARTED|Washout||3
9851194|NCT00875017|10963932|FG003|STARTED|Washout||4
9851195|NCT00875017|10963933|FG004|STARTED|Washout||4
9851196|NCT00875017|10963934|FG005|STARTED|Washout||5
9851197|NCT00875017|10963929|FG000|COMPLETED|Washout||3
9851198|NCT00875017|10963930|FG001|COMPLETED|Washout||4
9851199|NCT00875017|10963931|FG002|COMPLETED|Washout||3
9851200|NCT00875017|10963932|FG003|COMPLETED|Washout||4
9851201|NCT00875017|10963933|FG004|COMPLETED|Washout||4
9851202|NCT00875017|10963934|FG005|COMPLETED|Washout||5
9851203|NCT00875017|10963929|FG000|NOT COMPLETED|Washout||0
9851204|NCT00875017|10963930|FG001|NOT COMPLETED|Washout||1
9851205|NCT00875017|10963931|FG002|NOT COMPLETED|Washout||0
9851206|NCT00875017|10963932|FG003|NOT COMPLETED|Washout||0
9851207|NCT00875017|10963933|FG004|NOT COMPLETED|Washout||0
9851208|NCT00875017|10963934|FG005|NOT COMPLETED|Washout||0
9851209|NCT00875017|10963929|FG000|STARTED|Third Intervention||3
9851210|NCT00875017|10963930|FG001|STARTED|Third Intervention||4
9851211|NCT00875017|10963931|FG002|STARTED|Third Intervention||3
9851212|NCT00875017|10963932|FG003|STARTED|Third Intervention||4
9851213|NCT00875017|10963933|FG004|STARTED|Third Intervention||4
9851214|NCT00875017|10963934|FG005|STARTED|Third Intervention||5
9851215|NCT00875017|10963929|FG000|COMPLETED|Third Intervention||3
9851216|NCT00875017|10963930|FG001|COMPLETED|Third Intervention||3
9851217|NCT00875017|10963931|FG002|COMPLETED|Third Intervention||2
9851218|NCT00875017|10963932|FG003|COMPLETED|Third Intervention||4
9851219|NCT00875017|10963933|FG004|COMPLETED|Third Intervention||4
9851220|NCT00875017|10963934|FG005|COMPLETED|Third Intervention||5
9851221|NCT00875017|10963929|FG000|NOT COMPLETED|Third Intervention||0
9851222|NCT00875017|10963930|FG001|NOT COMPLETED|Third Intervention||1
9851223|NCT00875017|10963931|FG002|NOT COMPLETED|Third Intervention||1
9851224|NCT00875017|10963932|FG003|NOT COMPLETED|Third Intervention||0
9851225|NCT00875017|10963933|FG004|NOT COMPLETED|Third Intervention||0
9851226|NCT00875017|10963934|FG005|NOT COMPLETED|Third Intervention||0
9851227|NCT00875017|10963929|FG000|STARTED|Washout||3
9851228|NCT00875017|10963930|FG001|STARTED|Washout||3
9851229|NCT00875017|10963931|FG002|STARTED|Washout||2
9851230|NCT00875017|10963932|FG003|STARTED|Washout||4
9851231|NCT00875017|10963933|FG004|STARTED|Washout||4
9851232|NCT00875017|10963934|FG005|STARTED|Washout||5
9851233|NCT00875017|10963929|FG000|COMPLETED|Washout||3
9851234|NCT00875017|10963930|FG001|COMPLETED|Washout||3
9851235|NCT00875017|10963931|FG002|COMPLETED|Washout||2
9851236|NCT00875017|10963932|FG003|COMPLETED|Washout||4
9851237|NCT00875017|10963933|FG004|COMPLETED|Washout||3
9851238|NCT00875017|10963934|FG005|COMPLETED|Washout||5
9851239|NCT00875017|10963929|FG000|NOT COMPLETED|Washout||0
9851240|NCT00875017|10963930|FG001|NOT COMPLETED|Washout||0
9851241|NCT00875017|10963931|FG002|NOT COMPLETED|Washout||0
9851242|NCT00875017|10963932|FG003|NOT COMPLETED|Washout||0
9851243|NCT00875017|10963933|FG004|NOT COMPLETED|Washout||1
9851244|NCT00875017|10963934|FG005|NOT COMPLETED|Washout||0
9851245|NCT00875017|10963929|FG000|STARTED|Fourth Intervention||3
9851246|NCT00875017|10963930|FG001|STARTED|Fourth Intervention||3
9851247|NCT00875017|10963931|FG002|STARTED|Fourth Intervention||2
9851248|NCT00875017|10963932|FG003|STARTED|Fourth Intervention||4
9851249|NCT00875017|10963933|FG004|STARTED|Fourth Intervention||3
9851250|NCT00875017|10963934|FG005|STARTED|Fourth Intervention||5
9851251|NCT00875017|10963929|FG000|COMPLETED|Fourth Intervention||3
9851252|NCT00875017|10963930|FG001|COMPLETED|Fourth Intervention||3
9851253|NCT00875017|10963931|FG002|COMPLETED|Fourth Intervention||2
9851254|NCT00875017|10963932|FG003|COMPLETED|Fourth Intervention||4
9851255|NCT00875017|10963933|FG004|COMPLETED|Fourth Intervention||3
9851256|NCT00875017|10963934|FG005|COMPLETED|Fourth Intervention||4
9851257|NCT00875017|10963929|FG000|NOT COMPLETED|Fourth Intervention||0
9851258|NCT00875017|10963930|FG001|NOT COMPLETED|Fourth Intervention||0
9851259|NCT00875017|10963931|FG002|NOT COMPLETED|Fourth Intervention||0
9851260|NCT00875017|10963932|FG003|NOT COMPLETED|Fourth Intervention||0
9851261|NCT00875017|10963933|FG004|NOT COMPLETED|Fourth Intervention||0
9851262|NCT00875017|10963934|FG005|NOT COMPLETED|Fourth Intervention||1
9851263|NCT00875056|10963950|FG000|STARTED|Overall Study||39
9851264|NCT00875056|10963951|FG001|STARTED|Overall Study||11
9851265|NCT00875056|10963952|FG002|STARTED|Overall Study||6
9851266|NCT00875056|10963950|FG000|COMPLETED|Overall Study||16
9851267|NCT00875056|10963951|FG001|COMPLETED|Overall Study||2
9851268|NCT00875056|10963952|FG002|COMPLETED|Overall Study||0
9851269|NCT00875056|10963950|FG000|NOT COMPLETED|Overall Study||23
9851270|NCT00875056|10963951|FG001|NOT COMPLETED|Overall Study||9
9851271|NCT00875056|10963952|FG002|NOT COMPLETED|Overall Study||6
9851272|NCT00875212|10963960|FG000|STARTED|Placebo Dentifrice||12
9851273|NCT00875212|10963960|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12
9851274|NCT00875212|10963960|FG000|NOT COMPLETED|Placebo Dentifrice||0
9851275|NCT00875212|10963960|FG000|STARTED|CaGP Only Dentifrice||12
9851276|NCT00875212|10963960|FG000|COMPLETED|CaGP Only Dentifrice||12
9851277|NCT00875212|10963960|FG000|NOT COMPLETED|CaGP Only Dentifrice||0
9851278|NCT00875212|10963960|FG000|STARTED|Fluoride Only Dentifrice||12
9851279|NCT00875212|10963960|FG000|COMPLETED|Fluoride Only Dentifrice||12
9851280|NCT00875212|10963960|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0
9851281|NCT00875212|10963960|FG000|STARTED|CaGP and Fluoride Dentifrice||12
9851282|NCT00875212|10963960|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12
9851283|NCT00875212|10963960|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
9851284|NCT00875277|10963971|FG000|STARTED|Overall Study||24
9851285|NCT00875277|10963971|FG000|COMPLETED|Overall Study||24
9851286|NCT00875277|10963971|FG000|NOT COMPLETED|Overall Study||0
9851287|NCT00875329|10963982|FG000|STARTED|Overall Study||97
9851288|NCT00875329|10963982|FG000|COMPLETED|Overall Study||97
9851289|NCT00875329|10963982|FG000|NOT COMPLETED|Overall Study||0
9851290|NCT00875342|10963988|FG000|STARTED|Overall Study||20
9851291|NCT00875342|10963989|FG001|STARTED|Overall Study||21
9851292|NCT00875342|10963988|FG000|COMPLETED|Overall Study||16
9851293|NCT00875342|10963989|FG001|COMPLETED|Overall Study||16
9851294|NCT00875342|10963988|FG000|NOT COMPLETED|Overall Study||4
9851295|NCT00875342|10963989|FG001|NOT COMPLETED|Overall Study||5
9851296|NCT00875420|10964000|FG000|STARTED|Overall Study||22
9851297|NCT00875420|10964001|FG001|STARTED|Overall Study||20
9851298|NCT00875420|10964002|FG002|STARTED|Overall Study||21
9851299|NCT00875420|10964003|FG003|STARTED|Overall Study||18
9851300|NCT00875420|10964004|FG004|STARTED|Overall Study||19
9851301|NCT00875420|10964000|FG000|COMPLETED|Overall Study||20
9851302|NCT00875420|10964001|FG001|COMPLETED|Overall Study||18
9851303|NCT00875420|10964002|FG002|COMPLETED|Overall Study||18
9851304|NCT00875420|10964003|FG003|COMPLETED|Overall Study||16
9851305|NCT00875420|10964004|FG004|COMPLETED|Overall Study||17
9851306|NCT00875420|10964000|FG000|NOT COMPLETED|Overall Study||2
9851307|NCT00875420|10964001|FG001|NOT COMPLETED|Overall Study||2
9851308|NCT00875420|10964002|FG002|NOT COMPLETED|Overall Study||3
9851309|NCT00875420|10964003|FG003|NOT COMPLETED|Overall Study||2
9851310|NCT00875420|10964004|FG004|NOT COMPLETED|Overall Study||2
9851311|NCT00875433|10964016|FG000|STARTED|Overall Study|Treated|60
9851312|NCT00875433|10964016|FG000|COMPLETED|Overall Study||0
9851313|NCT00875433|10964016|FG000|NOT COMPLETED|Overall Study||60
9851314|NCT00875485|10964022|FG000|STARTED|Year 11||99
9851315|NCT00875485|10964023|FG001|STARTED|Year 11||111
9851316|NCT00875485|10964022|FG000|COMPLETED|Year 11||99
9851317|NCT00875485|10964023|FG001|COMPLETED|Year 11||111
9851318|NCT00875485|10964022|FG000|NOT COMPLETED|Year 11||0
9851319|NCT00875485|10964023|FG001|NOT COMPLETED|Year 11||0
9851320|NCT00875485|10964022|FG000|STARTED|Year 12||101
9851321|NCT00875485|10964023|FG001|STARTED|Year 12||109
9851322|NCT00875485|10964022|FG000|COMPLETED|Year 12||101
9851323|NCT00875485|10964023|FG001|COMPLETED|Year 12||109
9851324|NCT00875485|10964022|FG000|NOT COMPLETED|Year 12||0
9851325|NCT00875485|10964023|FG001|NOT COMPLETED|Year 12||0
9851326|NCT00875485|10964022|FG000|STARTED|Year 13||102
9851327|NCT00875485|10964023|FG001|STARTED|Year 13||113
9851328|NCT00875485|10964022|FG000|COMPLETED|Year 13||102
9851329|NCT00875485|10964023|FG001|COMPLETED|Year 13||113
9851330|NCT00875485|10964022|FG000|NOT COMPLETED|Year 13||0
9851331|NCT00875485|10964023|FG001|NOT COMPLETED|Year 13||0
9851332|NCT00875485|10964022|FG000|STARTED|Year 14||100
9851333|NCT00875485|10964023|FG001|STARTED|Year 14||113
9851334|NCT00875485|10964022|FG000|COMPLETED|Year 14||100
9851335|NCT00875485|10964023|FG001|COMPLETED|Year 14||113
9851336|NCT00875485|10964022|FG000|NOT COMPLETED|Year 14||0
9851337|NCT00875485|10964023|FG001|NOT COMPLETED|Year 14||0
9851338|NCT00875485|10964022|FG000|STARTED|Year 15||98
9851339|NCT00875485|10964023|FG001|STARTED|Year 15||111
9851340|NCT00875485|10964022|FG000|COMPLETED|Year 15||98
9851341|NCT00875485|10964023|FG001|COMPLETED|Year 15||111
9851342|NCT00875485|10964022|FG000|NOT COMPLETED|Year 15||0
9851343|NCT00875485|10964023|FG001|NOT COMPLETED|Year 15||0
9851344|NCT00875485|10964022|FG000|STARTED|Challenge Dose Epoch||8
9851345|NCT00875485|10964023|FG001|STARTED|Challenge Dose Epoch||11
9851346|NCT00875485|10964022|FG000|COMPLETED|Challenge Dose Epoch||7
9851347|NCT00875485|10964023|FG001|COMPLETED|Challenge Dose Epoch||11
9851348|NCT00875485|10964022|FG000|NOT COMPLETED|Challenge Dose Epoch||1
9851349|NCT00875485|10964023|FG001|NOT COMPLETED|Challenge Dose Epoch||0
9851350|NCT00875550|10964031|FG000|STARTED|Overall Study||89
9851351|NCT00875550|10964032|FG001|STARTED|Overall Study||86
9851352|NCT00875550|10964031|FG000|COMPLETED|Overall Study||77
9851353|NCT00875550|10964032|FG001|COMPLETED|Overall Study||76
9851354|NCT00875550|10964031|FG000|NOT COMPLETED|Overall Study||12
9851355|NCT00875550|10964032|FG001|NOT COMPLETED|Overall Study||10
9851356|NCT00875563|10964040|FG000|STARTED|Overall Study||42
9851357|NCT00875563|10964040|FG000|COMPLETED|Overall Study||18
9851358|NCT00875563|10964040|FG000|NOT COMPLETED|Overall Study||24
9851359|NCT00875589|10964046|FG000|STARTED|Overall Study||15
9851360|NCT00875589|10964047|FG001|STARTED|Overall Study||11
9851361|NCT00875589|10964046|FG000|COMPLETED|Overall Study||15
9851362|NCT00875589|10964047|FG001|COMPLETED|Overall Study||11
9851363|NCT00875589|10964046|FG000|NOT COMPLETED|Overall Study||0
9851364|NCT00875589|10964047|FG001|NOT COMPLETED|Overall Study||0
9851365|NCT00875615|10964053|FG000|STARTED|Overall Study||11
9851366|NCT00875615|10964053|FG000|COMPLETED|Overall Study||10
9851367|NCT00875615|10964053|FG000|NOT COMPLETED|Overall Study||1
9851368|NCT00875641|10964060|FG000|STARTED|Overall Study||57931
9851369|NCT00875641|10964061|FG001|STARTED|Overall Study||173384
9851370|NCT00875641|10964062|FG002|STARTED|Overall Study||159344
9851371|NCT00875641|10964060|FG000|COMPLETED|Overall Study||57931
9851372|NCT00875641|10964061|FG001|COMPLETED|Overall Study||173384
9851373|NCT00875641|10964062|FG002|COMPLETED|Overall Study||159344
9851374|NCT00875641|10964060|FG000|NOT COMPLETED|Overall Study||0
9851375|NCT00875641|10964061|FG001|NOT COMPLETED|Overall Study||0
9851376|NCT00875641|10964062|FG002|NOT COMPLETED|Overall Study||0
9851377|NCT00875667|10964072|FG000|STARTED|Overall Study||170
9851378|NCT00875667|10964073|FG001|STARTED|Overall Study||84
9851379|NCT00875667|10964072|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
9851380|NCT00875667|10964073|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
9851381|NCT00875667|10964072|FG000|Participants Treated|Overall Study||167
9851382|NCT00875667|10964073|FG001|Participants Treated|Overall Study||83
9851383|NCT00875667|10964072|FG000|COMPLETED|Overall Study||0
9851384|NCT00875667|10964073|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
9851385|NCT00875667|10964072|FG000|NOT COMPLETED|Overall Study||170
9851386|NCT00875667|10964073|FG001|NOT COMPLETED|Overall Study||73
9851387|NCT00875706|10964082|FG000|STARTED|Overall Study||8
9851388|NCT00875706|10964083|FG001|STARTED|Overall Study||24
9851389|NCT00875706|10964084|FG002|STARTED|Overall Study||13
9851390|NCT00875706|10964082|FG000|COMPLETED|Overall Study||7
9851391|NCT00875706|10964083|FG001|COMPLETED|Overall Study||24
9851392|NCT00875706|10964084|FG002|COMPLETED|Overall Study||13
9851393|NCT00875706|10964082|FG000|NOT COMPLETED|Overall Study||1
9851394|NCT00875706|10964083|FG001|NOT COMPLETED|Overall Study||0
9851395|NCT00875706|10964084|FG002|NOT COMPLETED|Overall Study||0
9851396|NCT00875797|10964094|FG000|STARTED|Overall Study||45
9851397|NCT00875797|10964095|FG001|STARTED|Overall Study||45
9851398|NCT00875797|10964094|FG000|COMPLETED|Overall Study||39
9851399|NCT00875797|10964095|FG001|COMPLETED|Overall Study||42
9851400|NCT00875797|10964094|FG000|NOT COMPLETED|Overall Study||6
9851401|NCT00875797|10964095|FG001|NOT COMPLETED|Overall Study||3
9851402|NCT00875810|10964104|FG000|STARTED|Overall Study||194
9851403|NCT00875810|10964104|FG000|Implanted|Overall Study||190
9851404|NCT00875810|10964104|FG000|Discharged|Overall Study||177
9851405|NCT00875810|10964104|FG000|3 Months Follow up|Overall Study||175
9851406|NCT00875810|10964104|FG000|6 Months Follow up|Overall Study||80
9851407|NCT00875810|10964104|FG000|12 Months Follow up|Overall Study||112
9851408|NCT00875810|10964104|FG000|24 Months Follow up|Overall Study||148
9851409|NCT00875810|10964104|FG000|COMPLETED|Overall Study||148
9851410|NCT00875810|10964104|FG000|NOT COMPLETED|Overall Study||46
9851411|NCT00875836|10964110|FG000|STARTED|Overall Study||88
9851412|NCT00875836|10964111|FG001|STARTED|Overall Study||87
9851413|NCT00875836|10964110|FG000|COMPLETED|Overall Study||45
9851414|NCT00875836|10964111|FG001|COMPLETED|Overall Study||47
9851415|NCT00875836|10964110|FG000|NOT COMPLETED|Overall Study||43
9851416|NCT00875836|10964111|FG001|NOT COMPLETED|Overall Study||40
9851417|NCT00875979|10964119|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
9851418|NCT00875979|10964120|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
9851419|NCT00875979|10964119|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
9851420|NCT00875979|10964120|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
9851421|NCT00875979|10964119|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
9851422|NCT00875979|10964120|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
9851423|NCT00875979|10964119|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
9851424|NCT00875979|10964120|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
9851425|NCT00875979|10964119|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
9851426|NCT00875979|10964120|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
9851427|NCT00875979|10964119|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
9851428|NCT00875979|10964120|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
9851429|NCT00875979|10964119|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
9851430|NCT00875979|10964120|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
9851431|NCT00875979|10964119|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
9851432|NCT00875979|10964120|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
9851433|NCT00875979|10964119|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
9851434|NCT00875979|10964120|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
9851435|NCT00876018|10964129|FG000|STARTED|Overall Study||100
9851436|NCT00876018|10964130|FG001|STARTED|Overall Study||100
9966142|NCT01506271|11086363|FG000|COMPLETED|Overall Study||114
9966143|NCT01506271|11086364|FG001|COMPLETED|Overall Study||109
9851437|NCT00876018|10964131|FG002|STARTED|Overall Study||100
9851438|NCT00876018|10964129|FG000|COMPLETED|Overall Study||95
9851439|NCT00876018|10964130|FG001|COMPLETED|Overall Study||95
9851440|NCT00876018|10964131|FG002|COMPLETED|Overall Study||97
9851441|NCT00876018|10964129|FG000|NOT COMPLETED|Overall Study||5
9851442|NCT00876018|10964130|FG001|NOT COMPLETED|Overall Study||5
9851443|NCT00876018|10964131|FG002|NOT COMPLETED|Overall Study||3
9851444|NCT00876187|10964146|FG000|STARTED|Overall Study||233
9851445|NCT00876187|10964147|FG001|STARTED|Overall Study||233
9851446|NCT00876187|10964148|FG002|STARTED|Overall Study||298
9851447|NCT00876187|10964149|FG003|STARTED|Overall Study||297
9851448|NCT00876187|10964150|FG004|STARTED|Overall Study||298
9851449|NCT00876187|10964146|FG000|Treated|Overall Study||230
9851450|NCT00876187|10964147|FG001|Treated|Overall Study||232
9851451|NCT00876187|10964148|FG002|Treated|Overall Study||295
9851452|NCT00876187|10964149|FG003|Treated|Overall Study||295
9851453|NCT00876187|10964150|FG004|Treated|Overall Study||295
9851454|NCT00876187|10964146|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
9851455|NCT00876187|10964147|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
9851456|NCT00876187|10964148|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
9851457|NCT00876187|10964149|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
9851458|NCT00876187|10964150|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
9851459|NCT00876187|10964146|FG000|COMPLETED|Overall Study||23
9851460|NCT00876187|10964147|FG001|COMPLETED|Overall Study||18
9851461|NCT00876187|10964148|FG002|COMPLETED|Overall Study||19
9851462|NCT00876187|10964149|FG003|COMPLETED|Overall Study||22
9851463|NCT00876187|10964150|FG004|COMPLETED|Overall Study||27
9851464|NCT00876187|10964146|FG000|NOT COMPLETED|Overall Study||210
9851465|NCT00876187|10964147|FG001|NOT COMPLETED|Overall Study||215
9851466|NCT00876187|10964148|FG002|NOT COMPLETED|Overall Study||279
9851467|NCT00876187|10964149|FG003|NOT COMPLETED|Overall Study||275
9851468|NCT00876187|10964150|FG004|NOT COMPLETED|Overall Study||271
9966144|NCT01506271|11086365|FG002|COMPLETED|Overall Study||114
9966145|NCT01506271|11086363|FG000|NOT COMPLETED|Overall Study||4
9966146|NCT01506271|11086364|FG001|NOT COMPLETED|Overall Study||7
9966147|NCT01506271|11086365|FG002|NOT COMPLETED|Overall Study||3
9966148|NCT01506323|11086375|FG000|STARTED|Overall Study||89
9966149|NCT01506323|11086376|FG001|STARTED|Overall Study||84
9966150|NCT01506323|11086375|FG000|Post-treatment Completers|Overall Study||69
9966151|NCT01506323|11086376|FG001|Post-treatment Completers|Overall Study||72
9966152|NCT01506323|11086375|FG000|Post-treatment Completed CAPS|Overall Study||68
9966153|NCT01506323|11086376|FG001|Post-treatment Completed CAPS|Overall Study||72
9966154|NCT01506323|11086375|FG000|COMPLETED|Overall Study||65
9966155|NCT01506323|11086376|FG001|COMPLETED|Overall Study||71
9966156|NCT01506323|11086375|FG000|NOT COMPLETED|Overall Study||24
9966157|NCT01506323|11086376|FG001|NOT COMPLETED|Overall Study||13
9966158|NCT01506362|11086387|FG000|STARTED|Overall Study||22
9966159|NCT01506362|11086387|FG000|COMPLETED|Overall Study||16
9966160|NCT01506362|11086387|FG000|NOT COMPLETED|Overall Study||6
9966161|NCT01506453|11086393|FG000|STARTED|Overall Study||25
9966162|NCT01506453|11086394|FG001|STARTED|Overall Study||26
9966163|NCT01506453|11086393|FG000|COMPLETED|Overall Study||25
9966164|NCT01506453|11086394|FG001|COMPLETED|Overall Study||24
9966165|NCT01506453|11086393|FG000|NOT COMPLETED|Overall Study||0
9966166|NCT01506453|11086394|FG001|NOT COMPLETED|Overall Study||2
9966167|NCT01506479|11086403|FG000|STARTED|Overall Study||40
9966168|NCT01506479|11086404|FG001|STARTED|Overall Study||43
9966169|NCT01506479|11086405|FG002|STARTED|Overall Study||45
9966170|NCT01506479|11086403|FG000|COMPLETED|Overall Study||37
9966171|NCT01506479|11086404|FG001|COMPLETED|Overall Study||38
9966172|NCT01506479|11086405|FG002|COMPLETED|Overall Study||42
9966173|NCT01506479|11086403|FG000|NOT COMPLETED|Overall Study||3
9966174|NCT01506479|11086404|FG001|NOT COMPLETED|Overall Study||5
9966175|NCT01506479|11086405|FG002|NOT COMPLETED|Overall Study||3
9966176|NCT01506596|11086415|FG000|STARTED|Overall Study||42
9966177|NCT01506596|11086415|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
9966178|NCT01506596|11086415|FG000|NOT COMPLETED|Overall Study||1
9966179|NCT01506609|11086425|FG000|STARTED|Overall Study||2
9966180|NCT01506609|11086426|FG001|STARTED|Overall Study||1
9966181|NCT01506609|11086427|FG002|STARTED|Overall Study||1
9966182|NCT01506609|11086428|FG003|STARTED|Overall Study||99
9966183|NCT01506609|11086429|FG004|STARTED|Overall Study||97
9966184|NCT01506609|11086430|FG005|STARTED|Overall Study||94
9966185|NCT01506609|11086425|FG000|COMPLETED|Overall Study||0
9966186|NCT01506609|11086426|FG001|COMPLETED|Overall Study||0
9966187|NCT01506609|11086427|FG002|COMPLETED|Overall Study||0
9966188|NCT01506609|11086428|FG003|COMPLETED|Overall Study||0
9966189|NCT01506609|11086429|FG004|COMPLETED|Overall Study||1
9966190|NCT01506609|11086430|FG005|COMPLETED|Overall Study||0
9966191|NCT01506609|11086425|FG000|NOT COMPLETED|Overall Study||2
9966192|NCT01506609|11086426|FG001|NOT COMPLETED|Overall Study||1
9966193|NCT01506609|11086427|FG002|NOT COMPLETED|Overall Study||1
9966194|NCT01506609|11086428|FG003|NOT COMPLETED|Overall Study||99
9966195|NCT01506609|11086429|FG004|NOT COMPLETED|Overall Study||96
9966196|NCT01506609|11086430|FG005|NOT COMPLETED|Overall Study||94
9966197|NCT01506726|11086443|FG000|STARTED|Overall Study||6
9966198|NCT01506726|11086444|FG001|STARTED|Overall Study||5
9966199|NCT01506726|11086443|FG000|COMPLETED|Overall Study||5
9966200|NCT01506726|11086444|FG001|COMPLETED|Overall Study||3
9966201|NCT01506726|11086443|FG000|NOT COMPLETED|Overall Study||1
9966202|NCT01506726|11086444|FG001|NOT COMPLETED|Overall Study||2
9966203|NCT01506882|11086452|FG000|STARTED|Overall Study||61
9966204|NCT01506882|11086453|FG001|STARTED|Overall Study||10
9966205|NCT01506882|11086452|FG000|COMPLETED|Overall Study||39
9966206|NCT01506882|11086453|FG001|COMPLETED|Overall Study||3
9966207|NCT01506882|11086452|FG000|NOT COMPLETED|Overall Study||22
9966208|NCT01506882|11086453|FG001|NOT COMPLETED|Overall Study||7
9966209|NCT01506908|11086463|FG000|STARTED|Overall Study||162
9966210|NCT01506908|11086464|FG001|STARTED|Overall Study||161
9966211|NCT01506908|11086463|FG000|COMPLETED|Overall Study||161
9966212|NCT01506908|11086464|FG001|COMPLETED|Overall Study||161
9966213|NCT01506908|11086463|FG000|NOT COMPLETED|Overall Study||1
9966214|NCT01506908|11086464|FG001|NOT COMPLETED|Overall Study||0
9966215|NCT01506947|11086472|FG000|STARTED|Overall Study||65
9966216|NCT01506947|11086472|FG000|COMPLETED|Overall Study||49
9966217|NCT01506947|11086472|FG000|NOT COMPLETED|Overall Study||16
9966218|NCT01506960|11086478|FG000|STARTED|Overall Study||64
9966219|NCT01506960|11086478|FG000|COMPLETED|Overall Study||17
9966220|NCT01506960|11086478|FG000|NOT COMPLETED|Overall Study||47
9966221|NCT01507051|11086488|FG000|STARTED|Overall Study||29
9966222|NCT01507051|11086489|FG001|STARTED|Overall Study||31
9966223|NCT01507051|11086490|FG002|STARTED|Overall Study||29
9966224|NCT01507051|11086491|FG003|STARTED|Overall Study||7
9966225|NCT01507051|11086488|FG000|Warfarin run-in Phase|Overall Study||28
9966226|NCT01507051|11086489|FG001|Warfarin run-in Phase|Overall Study||28
9966227|NCT01507051|11086490|FG002|Warfarin run-in Phase|Overall Study||0
9966228|NCT01507051|11086491|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
9966229|NCT01507051|11086488|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
9966230|NCT01507051|11086489|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
9966231|NCT01507051|11086490|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
9966232|NCT01507051|11086491|FG003|Received Placebo or Rivaroxaban|Overall Study||0
9966233|NCT01507051|11086488|FG000|COMPLETED|Overall Study||27
9966234|NCT01507051|11086489|FG001|COMPLETED|Overall Study||28
9966235|NCT01507051|11086490|FG002|COMPLETED|Overall Study||28
9966236|NCT01507051|11086491|FG003|COMPLETED|Overall Study||0
9966237|NCT01507051|11086488|FG000|NOT COMPLETED|Overall Study||2
9966238|NCT01507051|11086489|FG001|NOT COMPLETED|Overall Study||3
9966239|NCT01507051|11086490|FG002|NOT COMPLETED|Overall Study||1
9966240|NCT01507051|11086491|FG003|NOT COMPLETED|Overall Study||7
9966241|NCT01507090|11086501|FG000|STARTED|Overall Study||642
9966242|NCT01507090|11086501|FG000|COMPLETED|Overall Study||624
9966243|NCT01507090|11086501|FG000|NOT COMPLETED|Overall Study||18
9966244|NCT01507103|11086513|FG000|STARTED|Overall Study||41
9966245|NCT01507103|11086514|FG001|STARTED|Overall Study||41
9966246|NCT01507103|11086515|FG002|STARTED|Overall Study||42
9966247|NCT01507103|11086513|FG000|COMPLETED|Overall Study||41
9966248|NCT01507103|11086514|FG001|COMPLETED|Overall Study||41
9966249|NCT01507103|11086515|FG002|COMPLETED|Overall Study||42
9966250|NCT01507103|11086513|FG000|NOT COMPLETED|Overall Study||0
9966251|NCT01507103|11086514|FG001|NOT COMPLETED|Overall Study||0
9966252|NCT01507103|11086515|FG002|NOT COMPLETED|Overall Study||0
9966253|NCT01507155|11086523|FG000|STARTED|Overall Study||625
9966254|NCT01507155|11086524|FG001|STARTED|Overall Study||60
9966255|NCT01507155|11086523|FG000|COMPLETED|Overall Study||625
9966256|NCT01507155|11086524|FG001|COMPLETED|Overall Study||60
9966257|NCT01507155|11086523|FG000|NOT COMPLETED|Overall Study||0
9966258|NCT01507155|11086524|FG001|NOT COMPLETED|Overall Study||0
9966259|NCT01507181|11086531|FG000|STARTED|Overall Study||12
9966260|NCT01507181|11086532|FG001|STARTED|Overall Study||12
9966261|NCT01507181|11086531|FG000|COMPLETED|Overall Study||12
9966262|NCT01507181|11086532|FG001|COMPLETED|Overall Study||12
9966263|NCT01507181|11086531|FG000|NOT COMPLETED|Overall Study||0
9966264|NCT01507181|11086532|FG001|NOT COMPLETED|Overall Study||0
9966265|NCT01507220|11086540|FG000|STARTED|Overall Study||2
9966266|NCT01507220|11086541|FG001|STARTED|Overall Study||0
9966267|NCT01507220|11086540|FG000|COMPLETED|Overall Study||2
9966268|NCT01507220|11086541|FG001|COMPLETED|Overall Study||0
9966269|NCT01507220|11086540|FG000|NOT COMPLETED|Overall Study||0
9966270|NCT01507220|11086541|FG001|NOT COMPLETED|Overall Study||0
9966271|NCT01507246|11086549|FG000|STARTED|Overall Study||20
9966272|NCT01507246|11086550|FG001|STARTED|Overall Study||22
9966273|NCT01507246|11086549|FG000|COMPLETED|Overall Study||18
9966274|NCT01507246|11086550|FG001|COMPLETED|Overall Study||21
9966275|NCT01507246|11086549|FG000|NOT COMPLETED|Overall Study||2
9966276|NCT01507246|11086550|FG001|NOT COMPLETED|Overall Study||1
9966277|NCT01507298|11086561|FG000|STARTED|Overall Study||1
9966278|NCT01507298|11086562|FG001|STARTED|Overall Study||20
9966279|NCT01507298|11086561|FG000|COMPLETED|Overall Study||1
9966280|NCT01507298|11086562|FG001|COMPLETED|Overall Study||14
9966281|NCT01507298|11086561|FG000|NOT COMPLETED|Overall Study||0
9966282|NCT01507298|11086562|FG001|NOT COMPLETED|Overall Study||6
9966283|NCT01507350|11086569|FG000|STARTED|Overall Study||9
9966284|NCT01507350|11086569|FG000|COMPLETED|Overall Study||9
9966285|NCT01507350|11086569|FG000|NOT COMPLETED|Overall Study||0
9966286|NCT01507493|11086575|FG000|STARTED|Overall Study||22
9966287|NCT01507493|11086576|FG001|STARTED|Overall Study||178
9966288|NCT01507493|11086575|FG000|COMPLETED|Overall Study||22
9966289|NCT01507493|11086576|FG001|COMPLETED|Overall Study||178
9966290|NCT01507493|11086575|FG000|NOT COMPLETED|Overall Study||0
9966291|NCT01507493|11086576|FG001|NOT COMPLETED|Overall Study||0
9966292|NCT01507662|11086584|FG000|STARTED|Overall Study||3898
9966293|NCT01507662|11086585|FG001|STARTED|Overall Study||3851
9966294|NCT01507662|11086584|FG000|COMPLETED|Overall Study||3082
9966295|NCT01507662|11086585|FG001|COMPLETED|Overall Study||3020
9966296|NCT01507662|11086584|FG000|NOT COMPLETED|Overall Study||816
9966297|NCT01507662|11086585|FG001|NOT COMPLETED|Overall Study||831
9966298|NCT01507688|11086593|FG000|STARTED|Baseline to 6 Month Assessment||129
9966299|NCT01507688|11086594|FG001|STARTED|Baseline to 6 Month Assessment||129
9966300|NCT01507688|11086593|FG000|COMPLETED|Baseline to 6 Month Assessment||113
9966301|NCT01507688|11086594|FG001|COMPLETED|Baseline to 6 Month Assessment||119
9966302|NCT01507688|11086593|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16
9966303|NCT01507688|11086594|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10
9966304|NCT01507688|11086593|FG000|STARTED|6 Month to 12 Month Assessment||113
9966305|NCT01507688|11086594|FG001|STARTED|6 Month to 12 Month Assessment||119
9966306|NCT01507688|11086593|FG000|COMPLETED|6 Month to 12 Month Assessment||108
9966307|NCT01507688|11086594|FG001|COMPLETED|6 Month to 12 Month Assessment||116
9966308|NCT01507688|11086593|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5
9966309|NCT01507688|11086594|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3
9966310|NCT01507779|11086602|FG000|STARTED|Overall Study||23
9966311|NCT01507779|11086603|FG001|STARTED|Overall Study||25
9966312|NCT01507779|11086602|FG000|COMPLETED|Overall Study||23
9966313|NCT01507779|11086603|FG001|COMPLETED|Overall Study||25
9966314|NCT01507779|11086602|FG000|NOT COMPLETED|Overall Study||0
9966315|NCT01507779|11086603|FG001|NOT COMPLETED|Overall Study||0
9966316|NCT01507831|11086613|FG000|STARTED|Overall Study|Randomized|788
9966317|NCT01507831|11086614|FG001|STARTED|Overall Study|Randomized|1553
9966318|NCT01507831|11086613|FG000|Treated|Overall Study||788
9966319|NCT01507831|11086614|FG001|Treated|Overall Study||1550
9966320|NCT01507831|11086613|FG000|COMPLETED|Overall Study||595
9966321|NCT01507831|11086614|FG001|COMPLETED|Overall Study||1113
9966322|NCT01507831|11086613|FG000|NOT COMPLETED|Overall Study||193
9966323|NCT01507831|11086614|FG001|NOT COMPLETED|Overall Study||440
9966324|NCT01507896|11086620|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
9966325|NCT01507896|11086620|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
9966326|NCT01507896|11086620|FG000|NOT COMPLETED|Overall Study||2
9966327|NCT01507987|11086633|FG000|STARTED|Overall Study||982
9966328|NCT01507987|11086634|FG001|STARTED|Overall Study||670
9966329|NCT01507987|11086635|FG002|STARTED|Overall Study||458
9966330|NCT01507987|11086636|FG003|STARTED|Overall Study||737
9966331|NCT01507987|11086633|FG000|COMPLETED|Overall Study||618
9966332|NCT01507987|11086634|FG001|COMPLETED|Overall Study||335
9966333|NCT01507987|11086635|FG002|COMPLETED|Overall Study||252
9966334|NCT01507987|11086636|FG003|COMPLETED|Overall Study||480
9966335|NCT01507987|11086633|FG000|NOT COMPLETED|Overall Study||364
9966336|NCT01507987|11086634|FG001|NOT COMPLETED|Overall Study||335
9966337|NCT01507987|11086635|FG002|NOT COMPLETED|Overall Study||206
9966338|NCT01507987|11086636|FG003|NOT COMPLETED|Overall Study||257
9966339|NCT01508013|11086665|FG000|STARTED|Overall Study||214
9966340|NCT01508013|11086666|FG001|STARTED|Overall Study||229
9966341|NCT01508013|11086665|FG000|COMPLETED|Overall Study||182
9966342|NCT01508013|11086666|FG001|COMPLETED|Overall Study||206
9966343|NCT01508013|11086665|FG000|NOT COMPLETED|Overall Study||32
9966344|NCT01508013|11086666|FG001|NOT COMPLETED|Overall Study||23
9966345|NCT01508052|11086674|FG000|STARTED|Overall Study||20
9966346|NCT01508052|11086675|FG001|STARTED|Overall Study||20
9966347|NCT01508052|11086674|FG000|COMPLETED|Overall Study||20
9966348|NCT01508052|11086675|FG001|COMPLETED|Overall Study||20
9966349|NCT01508052|11086674|FG000|NOT COMPLETED|Overall Study||0
9966350|NCT01508052|11086675|FG001|NOT COMPLETED|Overall Study||0
9966351|NCT01508117|11086681|FG000|STARTED|Overall Study||1
9966352|NCT01508117|11086681|FG000|COMPLETED|Overall Study||1
9966353|NCT01508117|11086681|FG000|NOT COMPLETED|Overall Study||0
9966354|NCT01508130|11086687|FG000|STARTED|Overall Study||493
9966355|NCT01508130|11086688|FG001|STARTED|Overall Study||142
9966356|NCT01508130|11086687|FG000|mTRT|Overall Study||493
9966357|NCT01508130|11086688|FG001|mTRT|Overall Study||142
9966358|NCT01508130|11086687|FG000|COMPLETED|Overall Study||266
9966359|NCT01508130|11086688|FG001|COMPLETED|Overall Study||73
9966360|NCT01508130|11086687|FG000|NOT COMPLETED|Overall Study||227
9966361|NCT01508130|11086688|FG001|NOT COMPLETED|Overall Study||69
9966362|NCT01508169|11086698|FG000|STARTED|Overall Study||47
9966363|NCT01508169|11086699|FG001|STARTED|Overall Study||47
9966364|NCT01508169|11086698|FG000|COMPLETED|Overall Study||44
9966365|NCT01508169|11086699|FG001|COMPLETED|Overall Study||45
9966366|NCT01508169|11086698|FG000|NOT COMPLETED|Overall Study||3
9966367|NCT01508169|11086699|FG001|NOT COMPLETED|Overall Study||2
9966368|NCT01508325|11086713|FG000|STARTED|Overall Study||93
9966369|NCT01508325|11086714|FG001|STARTED|Overall Study||93
9966370|NCT01508325|11086713|FG000|COMPLETED|Overall Study||75
9966371|NCT01508325|11086714|FG001|COMPLETED|Overall Study||72
9966372|NCT01508325|11086713|FG000|NOT COMPLETED|Overall Study||18
9966373|NCT01508325|11086714|FG001|NOT COMPLETED|Overall Study||21
9966374|NCT01508455|11086720|FG000|STARTED|Overall Study||6
9966375|NCT01508455|11086720|FG000|COMPLETED|Overall Study||6
9966376|NCT01508455|11086720|FG000|NOT COMPLETED|Overall Study||0
9966377|NCT01508650|11086726|FG000|STARTED|Overall Study||12
9966378|NCT01508650|11086727|FG001|STARTED|Overall Study||15
9966379|NCT01508650|11086726|FG000|COMPLETED|Overall Study||12
9966380|NCT01508650|11086727|FG001|COMPLETED|Overall Study||12
9966381|NCT01508650|11086726|FG000|NOT COMPLETED|Overall Study||0
9966382|NCT01508650|11086727|FG001|NOT COMPLETED|Overall Study||3
9966383|NCT01508676|11086735|FG000|STARTED|Phase I (2 Weeks)||18
9966384|NCT01508676|11086736|FG001|STARTED|Phase I (2 Weeks)||17
9966385|NCT01508676|11086735|FG000|COMPLETED|Phase I (2 Weeks)||16
9966386|NCT01508676|11086736|FG001|COMPLETED|Phase I (2 Weeks)||14
9966387|NCT01508676|11086735|FG000|NOT COMPLETED|Phase I (2 Weeks)||2
9966388|NCT01508676|11086736|FG001|NOT COMPLETED|Phase I (2 Weeks)||3
9966389|NCT01508676|11086735|FG000|STARTED|Washout Period (1 Week)||16
9966390|NCT01508676|11086736|FG001|STARTED|Washout Period (1 Week)||14
9966391|NCT01508676|11086735|FG000|COMPLETED|Washout Period (1 Week)||16
9966392|NCT01508676|11086736|FG001|COMPLETED|Washout Period (1 Week)||14
9966393|NCT01508676|11086735|FG000|NOT COMPLETED|Washout Period (1 Week)||0
9966394|NCT01508676|11086736|FG001|NOT COMPLETED|Washout Period (1 Week)||0
9966395|NCT01508676|11086735|FG000|STARTED|Phase II (2 Weeks)||16
9966396|NCT01508676|11086736|FG001|STARTED|Phase II (2 Weeks)||14
9966397|NCT01508676|11086735|FG000|COMPLETED|Phase II (2 Weeks)||15
9966398|NCT01508676|11086736|FG001|COMPLETED|Phase II (2 Weeks)||13
9966399|NCT01508676|11086735|FG000|NOT COMPLETED|Phase II (2 Weeks)||1
9966400|NCT01508676|11086736|FG001|NOT COMPLETED|Phase II (2 Weeks)||1
9966401|NCT01508702|11086745|FG000|STARTED|Overall Study||107
9966402|NCT01508702|11086746|FG001|STARTED|Overall Study||107
9966403|NCT01508702|11086745|FG000|COMPLETED|Overall Study||84
9966404|NCT01508702|11086746|FG001|COMPLETED|Overall Study||94
9966405|NCT01508702|11086745|FG000|NOT COMPLETED|Overall Study||23
9966406|NCT01508702|11086746|FG001|NOT COMPLETED|Overall Study||13
9966407|NCT01508832|11086754|FG000|STARTED|Overall Study||6
9966408|NCT01508832|11086755|FG001|STARTED|Overall Study||6
9966409|NCT01508832|11086754|FG000|COMPLETED|Overall Study||6
9966410|NCT01508832|11086755|FG001|COMPLETED|Overall Study||6
9966411|NCT01508832|11086754|FG000|NOT COMPLETED|Overall Study||0
9966412|NCT01508832|11086755|FG001|NOT COMPLETED|Overall Study||0
9966413|NCT01508910|11086764|FG000|STARTED|Randomization||57
9966414|NCT01508910|11086765|FG001|STARTED|Randomization||27
9966415|NCT01508910|11086766|FG002|STARTED|Randomization||28
9966416|NCT01508910|11086767|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
9966417|NCT01508910|11086764|FG000|COMPLETED|Randomization||57
9966418|NCT01508910|11086765|FG001|COMPLETED|Randomization||27
9966419|NCT01508910|11086766|FG002|COMPLETED|Randomization||28
9966420|NCT01508910|11086767|FG003|COMPLETED|Randomization||0
9966421|NCT01508910|11086764|FG000|NOT COMPLETED|Randomization||0
9966422|NCT01508910|11086765|FG001|NOT COMPLETED|Randomization||0
9966423|NCT01508910|11086766|FG002|NOT COMPLETED|Randomization||0
9966424|NCT01508910|11086767|FG003|NOT COMPLETED|Randomization||0
9966425|NCT01508910|11086764|FG000|STARTED|Treatment||50
9966426|NCT01508910|11086765|FG001|STARTED|Treatment||28
9966427|NCT01508910|11086766|FG002|STARTED|Treatment||28
9966428|NCT01508910|11086767|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
9966429|NCT01508910|11086764|FG000|COMPLETED|Treatment||48
9966430|NCT01508910|11086765|FG001|COMPLETED|Treatment||24
9966431|NCT01508910|11086766|FG002|COMPLETED|Treatment||18
9966432|NCT01508910|11086767|FG003|COMPLETED|Treatment||3
9966433|NCT01508910|11086764|FG000|NOT COMPLETED|Treatment||2
9966434|NCT01508910|11086765|FG001|NOT COMPLETED|Treatment||4
9966435|NCT01508910|11086766|FG002|NOT COMPLETED|Treatment||10
9966436|NCT01508910|11086767|FG003|NOT COMPLETED|Treatment||3
9966437|NCT01508936|11086781|FG000|STARTED|Overall Study||102
9966438|NCT01508936|11086782|FG001|STARTED|Overall Study||409
9966439|NCT01508936|11086781|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
9966440|NCT01508936|11086782|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
9966441|NCT01508936|11086781|FG000|Randomized|Overall Study||98
9966442|NCT01508936|11086782|FG001|Randomized|Overall Study||398
9966443|NCT01508936|11086781|FG000|Randomized, Not Treated|Overall Study||1
9966444|NCT01508936|11086782|FG001|Randomized, Not Treated|Overall Study||3
9966445|NCT01508936|11086781|FG000|Safety Analysis Set|Overall Study||97
9966446|NCT01508936|11086782|FG001|Safety Analysis Set|Overall Study||395
9966447|NCT01508936|11086781|FG000|Full Analysis Set|Overall Study||97
9966448|NCT01508936|11086782|FG001|Full Analysis Set|Overall Study||395
9966449|NCT01508936|11086781|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91
9966450|NCT01508936|11086782|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346
9966451|NCT01508936|11086781|FG000|COMPLETED|Overall Study||79
9966452|NCT01508936|11086782|FG001|COMPLETED|Overall Study||330
9966453|NCT01508936|11086781|FG000|NOT COMPLETED|Overall Study||23
9966454|NCT01508936|11086782|FG001|NOT COMPLETED|Overall Study||79
9966455|NCT01509040|11086791|FG000|STARTED|Overall Study||0
9966456|NCT01509040|11086792|FG001|STARTED|Overall Study||2
9966457|NCT01509040|11086793|FG002|STARTED|Overall Study||0
9966458|NCT01509040|11086791|FG000|COMPLETED|Overall Study||0
9966459|NCT01509040|11086792|FG001|COMPLETED|Overall Study||1
9966460|NCT01509040|11086793|FG002|COMPLETED|Overall Study||0
9966461|NCT01509040|11086791|FG000|NOT COMPLETED|Overall Study||0
9966462|NCT01509040|11086792|FG001|NOT COMPLETED|Overall Study||1
9966463|NCT01509040|11086793|FG002|NOT COMPLETED|Overall Study||0
9966464|NCT01509079|11086810|FG000|STARTED|Overall Study||57
9966465|NCT01509079|11086811|FG001|STARTED|Overall Study||59
9966466|NCT01509079|11086810|FG000|COMPLETED|Overall Study||57
9966467|NCT01509079|11086811|FG001|COMPLETED|Overall Study||56
9966468|NCT01509079|11086810|FG000|NOT COMPLETED|Overall Study||0
9966469|NCT01509079|11086811|FG001|NOT COMPLETED|Overall Study||3
9966470|NCT01509105|11086817|FG000|STARTED|Overall Study||649
9966471|NCT01509105|11086817|FG000|COMPLETED|Overall Study||649
9966472|NCT01509105|11086817|FG000|NOT COMPLETED|Overall Study||0
9966473|NCT01509183|11086823|FG000|STARTED|Overall Study||250
9966474|NCT01509183|11086824|FG001|STARTED|Overall Study||245
9966475|NCT01509183|11086823|FG000|COMPLETED|Overall Study||141
9966476|NCT01509183|11086824|FG001|COMPLETED|Overall Study||134
9966477|NCT01509183|11086823|FG000|NOT COMPLETED|Overall Study||109
9966478|NCT01509183|11086824|FG001|NOT COMPLETED|Overall Study||111
9966479|NCT01509404|11086834|FG000|STARTED|Overall Study||20
9966480|NCT01509404|11086835|FG001|STARTED|Overall Study||20
9966481|NCT01509404|11086834|FG000|COMPLETED|Overall Study||20
9966482|NCT01509404|11086835|FG001|COMPLETED|Overall Study||20
9966483|NCT01509404|11086834|FG000|NOT COMPLETED|Overall Study||0
9966484|NCT01509404|11086835|FG001|NOT COMPLETED|Overall Study||0
9966485|NCT01509547|11086843|FG000|STARTED|Overall Study||77
9966486|NCT01509547|11086844|FG001|STARTED|Overall Study||80
9966487|NCT01509547|11086843|FG000|COMPLETED|Overall Study||42
9966488|NCT01509547|11086844|FG001|COMPLETED|Overall Study||41
9966489|NCT01509547|11086843|FG000|NOT COMPLETED|Overall Study||35
9966490|NCT01509547|11086844|FG001|NOT COMPLETED|Overall Study||39
9966491|NCT01509586|11086852|FG000|STARTED|Overall Study|Week 0|626
9966492|NCT01509586|11086853|FG001|STARTED|Overall Study|Week 0|610
9966493|NCT01509586|11086852|FG000|Week 3|Overall Study||574
9966494|NCT01509586|11086853|FG001|Week 3|Overall Study||585
9966495|NCT01509586|11086852|FG000|Week 6|Overall Study||551
9966496|NCT01509586|11086853|FG001|Week 6|Overall Study||585
9966497|NCT01509586|11086852|FG000|Week 10|Overall Study||537
9966498|NCT01509586|11086853|FG001|Week 10|Overall Study||574
9966499|NCT01509586|11086852|FG000|Week 14|Overall Study||528
9966500|NCT01509586|11086853|FG001|Week 14|Overall Study||566
9966501|NCT01509586|11086852|FG000|Week18|Overall Study||529
9966502|NCT01509586|11086853|FG001|Week18|Overall Study||555
9966503|NCT01509586|11086852|FG000|Week 32 (Month 6)|Overall Study||504
9966504|NCT01509586|11086853|FG001|Week 32 (Month 6)|Overall Study||523
9966505|NCT01509586|11086852|FG000|Week 46|Overall Study||483
9966506|NCT01509586|11086853|FG001|Week 46|Overall Study||494
9966507|NCT01509586|11086852|FG000|Week 58 (Month 12)|Overall Study||492
9966508|NCT01509586|11086853|FG001|Week 58 (Month 12)|Overall Study||499
9966509|NCT01509586|11086852|FG000|COMPLETED|Overall Study|final intent to treat sample|626
9966510|NCT01509586|11086853|FG001|COMPLETED|Overall Study|final intent to treat sample|610
9966511|NCT01509586|11086852|FG000|NOT COMPLETED|Overall Study||0
9966512|NCT01509586|11086853|FG001|NOT COMPLETED|Overall Study||0
9966513|NCT01509612|11086862|FG000|STARTED|Overall Study||47
9966514|NCT01509612|11086863|FG001|STARTED|Overall Study||51
9966515|NCT01509612|11086864|FG002|STARTED|Overall Study||52
9966516|NCT01509612|11086862|FG000|COMPLETED|Overall Study||47
9966517|NCT01509612|11086863|FG001|COMPLETED|Overall Study||51
9966518|NCT01509612|11086864|FG002|COMPLETED|Overall Study||52
9966519|NCT01509612|11086862|FG000|NOT COMPLETED|Overall Study||0
9966520|NCT01509612|11086863|FG001|NOT COMPLETED|Overall Study||0
9966521|NCT01509612|11086864|FG002|NOT COMPLETED|Overall Study||0
9966522|NCT01509625|11086875|FG000|STARTED|Overall Study||272
9966523|NCT01509625|11086875|FG000|COMPLETED|Overall Study||263
9966524|NCT01509625|11086875|FG000|NOT COMPLETED|Overall Study||9
9966525|NCT01509638|11086890|FG000|STARTED|Overall Study||23
9966526|NCT01509638|11086891|FG001|STARTED|Overall Study||26
9966527|NCT01509638|11086890|FG000|COMPLETED|Overall Study||20
10080597|NCT02252965|11208798|FG001|NOT COMPLETED|Overall Study||43
10080598|NCT02253147|11208806|FG000|STARTED|Overall Study||118
10080599|NCT02253147|11208806|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88
10080600|NCT02253147|11208806|FG000|N Patients at W36|Overall Study||86
10080601|NCT02253147|11208806|FG000|N Patients at W52|Overall Study||84
10080602|NCT02253147|11208806|FG000|COMPLETED|Overall Study||71
10080603|NCT02253147|11208806|FG000|NOT COMPLETED|Overall Study||47
10080604|NCT02253160|11208815|FG000|STARTED|Overall Study||1
10080605|NCT02253160|11208816|FG001|STARTED|Overall Study||12
10080606|NCT02253160|11208817|FG002|STARTED|Overall Study||10
10080607|NCT02253160|11208815|FG000|COMPLETED|Overall Study||1
10080608|NCT02253160|11208816|FG001|COMPLETED|Overall Study||12
10080609|NCT02253160|11208817|FG002|COMPLETED|Overall Study||10
10080610|NCT02253160|11208815|FG000|NOT COMPLETED|Overall Study||0
10080611|NCT02253160|11208816|FG001|NOT COMPLETED|Overall Study||0
10080612|NCT02253160|11208817|FG002|NOT COMPLETED|Overall Study||0
10080613|NCT02253173|11208831|FG000|STARTED|Overall Study||191
10080614|NCT02253173|11208832|FG001|STARTED|Overall Study||191
10080615|NCT02253173|11208833|FG002|STARTED|Overall Study||190
10080616|NCT02253173|11208834|FG003|STARTED|Overall Study||192
10080617|NCT02253173|11208831|FG000|COMPLETED|Overall Study||175
10080618|NCT02253173|11208832|FG001|COMPLETED|Overall Study||174
10080619|NCT02253173|11208833|FG002|COMPLETED|Overall Study||177
10080620|NCT02253173|11208834|FG003|COMPLETED|Overall Study||178
10080621|NCT02253173|11208831|FG000|NOT COMPLETED|Overall Study||16
10080622|NCT02253173|11208832|FG001|NOT COMPLETED|Overall Study||17
10080623|NCT02253173|11208833|FG002|NOT COMPLETED|Overall Study||13
10080624|NCT02253173|11208834|FG003|NOT COMPLETED|Overall Study||14
10080625|NCT02253433|11208850|FG000|STARTED|Overall Study||130
10080626|NCT02253433|11208851|FG001|STARTED|Overall Study||134
10080627|NCT02253433|11208850|FG000|COMPLETED|Overall Study||114
10080628|NCT02253433|11208851|FG001|COMPLETED|Overall Study||79
10080629|NCT02253433|11208850|FG000|NOT COMPLETED|Overall Study||16
10080630|NCT02253433|11208851|FG001|NOT COMPLETED|Overall Study||55
10080631|NCT02253537|11208858|FG000|STARTED|Overall Study||15
10080632|NCT02253537|11208858|FG000|COMPLETED|Overall Study||15
10080633|NCT02253537|11208858|FG000|NOT COMPLETED|Overall Study||0
10080634|NCT02253654|11208864|FG000|STARTED|Overall Study||108
10080635|NCT02253654|11208865|FG001|STARTED|Overall Study||108
10080636|NCT02253654|11208864|FG000|Received Treatment|Overall Study||104
10080637|NCT02253654|11208865|FG001|Received Treatment|Overall Study||107
10080638|NCT02253654|11208864|FG000|COMPLETED|Overall Study||85
10080639|NCT02253654|11208865|FG001|COMPLETED|Overall Study||90
10080640|NCT02253654|11208864|FG000|NOT COMPLETED|Overall Study||23
9966528|NCT01509638|11086891|FG001|COMPLETED|Overall Study||24
9966529|NCT01509638|11086890|FG000|NOT COMPLETED|Overall Study||3
10080641|NCT02253654|11208865|FG001|NOT COMPLETED|Overall Study||18
10080642|NCT02253992|11208874|FG000|STARTED|Overall Study||6
10080643|NCT02253992|11208875|FG001|STARTED|Overall Study||4
10080644|NCT02253992|11208876|FG002|STARTED|Overall Study||150
10080645|NCT02253992|11208874|FG000|COMPLETED|Overall Study||0
10080646|NCT02253992|11208875|FG001|COMPLETED|Overall Study||0
10080647|NCT02253992|11208876|FG002|COMPLETED|Overall Study||6
10080648|NCT02253992|11208874|FG000|NOT COMPLETED|Overall Study||6
10080649|NCT02253992|11208875|FG001|NOT COMPLETED|Overall Study||4
10080650|NCT02253992|11208876|FG002|NOT COMPLETED|Overall Study||144
10080651|NCT02254252|11208900|FG000|STARTED|Overall Study||27
10080652|NCT02254252|11208901|FG001|STARTED|Overall Study||27
10080653|NCT02254252|11208900|FG000|COMPLETED|Overall Study||24
10080654|NCT02254252|11208901|FG001|COMPLETED|Overall Study||25
10080655|NCT02254252|11208900|FG000|NOT COMPLETED|Overall Study||3
10080656|NCT02254252|11208901|FG001|NOT COMPLETED|Overall Study||2
10080657|NCT02254265|11208910|FG000|STARTED|Overall Study||151
10080658|NCT02254265|11208911|FG001|STARTED|Overall Study||152
10080659|NCT02254265|11208912|FG002|STARTED|Overall Study||152
10080660|NCT02254265|11208910|FG000|COMPLETED|Overall Study||142
10195474|NCT03346070|11323792|FG001|NOT COMPLETED|Overall Study||4
10195475|NCT03346070|11323793|FG002|NOT COMPLETED|Overall Study||4
10195476|NCT03346070|11323794|FG003|NOT COMPLETED|Overall Study||6
10195477|NCT03346070|11323795|FG004|NOT COMPLETED|Overall Study||5
10195478|NCT03346161|11323811|FG000|STARTED|Overall Study||60
10195479|NCT03346161|11323812|FG001|STARTED|Overall Study||60
10195480|NCT03346161|11323811|FG000|COMPLETED|Overall Study||60
10195481|NCT03346161|11323812|FG001|COMPLETED|Overall Study||60
10195482|NCT03346161|11323811|FG000|NOT COMPLETED|Overall Study||0
10195483|NCT03346161|11323812|FG001|NOT COMPLETED|Overall Study||0
10195484|NCT03346759|11323820|FG000|STARTED|Enrollment to Baseline Data Collected||15
10195485|NCT03346759|11323821|FG001|STARTED|Enrollment to Baseline Data Collected||13
10195486|NCT03346759|11323820|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
10195487|NCT03346759|11323821|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
10195488|NCT03346759|11323820|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2
10195489|NCT03346759|11323821|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3
10195490|NCT03346759|11323820|FG000|STARTED|First Menstrual Cycle||13
10195491|NCT03346759|11323821|FG001|STARTED|First Menstrual Cycle||10
10195492|NCT03346759|11323820|FG000|COMPLETED|First Menstrual Cycle||12
10195493|NCT03346759|11323821|FG001|COMPLETED|First Menstrual Cycle||10
10195494|NCT03346759|11323820|FG000|NOT COMPLETED|First Menstrual Cycle||1
10195495|NCT03346759|11323821|FG001|NOT COMPLETED|First Menstrual Cycle||0
10195496|NCT03346759|11323820|FG000|STARTED|Second Menstrual Cycle||12
10195497|NCT03346759|11323821|FG001|STARTED|Second Menstrual Cycle||10
10195498|NCT03346759|11323820|FG000|COMPLETED|Second Menstrual Cycle||11
10195499|NCT03346759|11323821|FG001|COMPLETED|Second Menstrual Cycle||10
10195500|NCT03346759|11323820|FG000|NOT COMPLETED|Second Menstrual Cycle||1
10195501|NCT03346759|11323821|FG001|NOT COMPLETED|Second Menstrual Cycle||0
10195502|NCT03346759|11323820|FG000|STARTED|Third Menstrual Cycle||11
10195503|NCT03346759|11323821|FG001|STARTED|Third Menstrual Cycle||10
10195504|NCT03346759|11323820|FG000|COMPLETED|Third Menstrual Cycle||11
10195505|NCT03346759|11323821|FG001|COMPLETED|Third Menstrual Cycle||10
10195506|NCT03346759|11323820|FG000|NOT COMPLETED|Third Menstrual Cycle||0
10195507|NCT03346759|11323821|FG001|NOT COMPLETED|Third Menstrual Cycle||0
10195508|NCT03346850|11323830|FG000|STARTED|Overall Study||20
10195509|NCT03346850|11323831|FG001|STARTED|Overall Study||20
10195510|NCT03346850|11323830|FG000|COMPLETED|Overall Study||18
10195511|NCT03346850|11323831|FG001|COMPLETED|Overall Study||17
10195512|NCT03346850|11323830|FG000|NOT COMPLETED|Overall Study||2
10195513|NCT03346850|11323831|FG001|NOT COMPLETED|Overall Study||3
10195514|NCT03346902|11323839|FG000|STARTED|Overall Study||4
10195515|NCT03346902|11323840|FG001|STARTED|Overall Study||8
10195516|NCT03346902|11323839|FG000|COMPLETED|Overall Study||4
10195517|NCT03346902|11323840|FG001|COMPLETED|Overall Study||8
10195518|NCT03346902|11323839|FG000|NOT COMPLETED|Overall Study||0
10195519|NCT03346902|11323840|FG001|NOT COMPLETED|Overall Study||0
10195520|NCT03347188|11323848|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44
10195521|NCT03347188|11323849|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43
10195522|NCT03347188|11323848|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
10195523|NCT03347188|11323849|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
10195524|NCT03347188|11323848|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
10195525|NCT03347188|11323849|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
10195526|NCT03347188|11323848|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
10195527|NCT03347188|11323849|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
10195528|NCT03347188|11323848|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
10195529|NCT03347188|11323849|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
10195530|NCT03347188|11323848|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35
10195531|NCT03347188|11323849|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35
10195532|NCT03347188|11323848|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
10195533|NCT03347188|11323849|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
10195534|NCT03347188|11323848|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
10195535|NCT03347188|11323849|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
10195536|NCT03347188|11323848|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8
10195537|NCT03347188|11323849|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6
10195538|NCT03347188|11323848|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
10195539|NCT03347188|11323849|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
10195540|NCT03347279|11323857|FG000|STARTED|Overall Study||529
10195541|NCT03347279|11323858|FG001|STARTED|Overall Study||532
10195542|NCT03347279|11323857|FG000|Received Treatment|Overall Study||528
10195543|NCT03347279|11323858|FG001|Received Treatment|Overall Study||531
10195544|NCT03347279|11323857|FG000|COMPLETED|Overall Study||513
10195545|NCT03347279|11323858|FG001|COMPLETED|Overall Study||509
10195546|NCT03347279|11323857|FG000|NOT COMPLETED|Overall Study||16
10195547|NCT03347279|11323858|FG001|NOT COMPLETED|Overall Study||23
10195548|NCT03347695|11323866|FG000|STARTED|Overall Study||20
10195549|NCT03347695|11323867|FG001|STARTED|Overall Study||120
10195550|NCT03347695|11323866|FG000|COMPLETED|Overall Study||20
10195551|NCT03347695|11323867|FG001|COMPLETED|Overall Study||115
10195552|NCT03347695|11323866|FG000|NOT COMPLETED|Overall Study||0
10195553|NCT03347695|11323867|FG001|NOT COMPLETED|Overall Study||5
10195554|NCT03348683|11323877|FG000|STARTED|Overall Study||121
10195555|NCT03348683|11323878|FG001|STARTED|Overall Study||119
10195556|NCT03348683|11323877|FG000|COMPLETED|Overall Study||121
10195557|NCT03348683|11323878|FG001|COMPLETED|Overall Study||119
10195558|NCT03348683|11323877|FG000|NOT COMPLETED|Overall Study||0
10195559|NCT03348683|11323878|FG001|NOT COMPLETED|Overall Study||0
10195560|NCT03349034|11323886|FG000|STARTED|Overall Study||12
10195561|NCT03349034|11323887|FG001|STARTED|Overall Study||12
10195562|NCT03349034|11323886|FG000|COMPLETED|Overall Study||8
10195563|NCT03349034|11323887|FG001|COMPLETED|Overall Study||10
10195564|NCT03349034|11323886|FG000|NOT COMPLETED|Overall Study||4
10195565|NCT03349034|11323887|FG001|NOT COMPLETED|Overall Study||2
10195566|NCT03349060|11323898|FG000|STARTED|Overall Study||156
10195567|NCT03349060|11323899|FG001|STARTED|Overall Study||154
10195568|NCT03349060|11323900|FG002|STARTED|Overall Study||77
10195569|NCT03349060|11323898|FG000|COMPLETED|Overall Study||135
10195570|NCT03349060|11323899|FG001|COMPLETED|Overall Study||137
10195571|NCT03349060|11323900|FG002|COMPLETED|Overall Study||61
10195572|NCT03349060|11323898|FG000|NOT COMPLETED|Overall Study||21
10195573|NCT03349060|11323899|FG001|NOT COMPLETED|Overall Study||17
10195574|NCT03349060|11323900|FG002|NOT COMPLETED|Overall Study||16
10195575|NCT03349099|11323910|FG000|STARTED|Overall Study||48
10195576|NCT03349099|11323911|FG001|STARTED|Overall Study||47
10195577|NCT03349099|11323910|FG000|COMPLETED|Overall Study||44
10195578|NCT03349099|11323911|FG001|COMPLETED|Overall Study||43
10195579|NCT03349099|11323910|FG000|NOT COMPLETED|Overall Study||4
10195580|NCT03349099|11323911|FG001|NOT COMPLETED|Overall Study||4
10195581|NCT03349333|11323917|FG000|STARTED|Overall Study||71
10195582|NCT03349333|11323917|FG000|COMPLETED|Overall Study||0
10195583|NCT03349333|11323917|FG000|NOT COMPLETED|Overall Study||71
10195584|NCT03349437|11323921|FG000|STARTED|Screening||25
10195585|NCT03349437|11323922|FG001|STARTED|Screening||0
10195586|NCT03349437|11323923|FG002|STARTED|Screening||0
10195587|NCT03349437|11323921|FG000|COMPLETED|Screening||20
10195588|NCT03349437|11323922|FG001|COMPLETED|Screening||0
10195589|NCT03349437|11323923|FG002|COMPLETED|Screening||0
10195590|NCT03349437|11323921|FG000|NOT COMPLETED|Screening||5
10195591|NCT03349437|11323922|FG001|NOT COMPLETED|Screening||0
10195592|NCT03349437|11323923|FG002|NOT COMPLETED|Screening||0
10195593|NCT03349437|11323921|FG000|STARTED|Intervention||0
10195594|NCT03349437|11323922|FG001|STARTED|Intervention||10
10195595|NCT03349437|11323923|FG002|STARTED|Intervention||10
10195596|NCT03349437|11323921|FG000|COMPLETED|Intervention||0
10195597|NCT03349437|11323922|FG001|COMPLETED|Intervention||10
10195598|NCT03349437|11323923|FG002|COMPLETED|Intervention||10
10195599|NCT03349437|11323921|FG000|NOT COMPLETED|Intervention||0
10195600|NCT03349437|11323922|FG001|NOT COMPLETED|Intervention||0
10195601|NCT03349437|11323923|FG002|NOT COMPLETED|Intervention||0
10195602|NCT03349515|11323932|FG000|STARTED|Overall Study||55
10195603|NCT03349515|11323933|FG001|STARTED|Overall Study||51
10195604|NCT03349515|11323932|FG000|COMPLETED|Overall Study||50
10195605|NCT03349515|11323933|FG001|COMPLETED|Overall Study||50
10195606|NCT03349515|11323932|FG000|NOT COMPLETED|Overall Study||5
10195607|NCT03349515|11323933|FG001|NOT COMPLETED|Overall Study||1
10195608|NCT03349567|11323943|FG000|STARTED|Overall Study||2
10195609|NCT03349567|11323944|FG001|STARTED|Overall Study||2
10195610|NCT03349567|11323943|FG000|COMPLETED|Overall Study||2
10195611|NCT03349567|11323944|FG001|COMPLETED|Overall Study||2
10195612|NCT03349567|11323943|FG000|NOT COMPLETED|Overall Study||0
10195613|NCT03349567|11323944|FG001|NOT COMPLETED|Overall Study||0
10195614|NCT03349632|11323952|FG000|STARTED|Period 1, First Week of Wear||11
10195615|NCT03349632|11323953|FG001|STARTED|Period 1, First Week of Wear||11
10195616|NCT03349632|11323954|FG002|STARTED|Period 1, First Week of Wear||11
10195617|NCT03349632|11323955|FG003|STARTED|Period 1, First Week of Wear||11
10195618|NCT03349632|11323956|FG004|STARTED|Period 1, First Week of Wear||11
10195619|NCT03349632|11323957|FG005|STARTED|Period 1, First Week of Wear||11
10195620|NCT03349632|11323952|FG000|COMPLETED|Period 1, First Week of Wear||11
10195621|NCT03349632|11323953|FG001|COMPLETED|Period 1, First Week of Wear||11
10195622|NCT03349632|11323954|FG002|COMPLETED|Period 1, First Week of Wear||11
10195623|NCT03349632|11323955|FG003|COMPLETED|Period 1, First Week of Wear||11
10195624|NCT03349632|11323956|FG004|COMPLETED|Period 1, First Week of Wear||11
10195625|NCT03349632|11323957|FG005|COMPLETED|Period 1, First Week of Wear||11
10195626|NCT03349632|11323952|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10195627|NCT03349632|11323953|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
10195628|NCT03349632|11323954|FG002|NOT COMPLETED|Period 1, First Week of Wear||0
10195629|NCT03349632|11323955|FG003|NOT COMPLETED|Period 1, First Week of Wear||0
10195630|NCT03349632|11323956|FG004|NOT COMPLETED|Period 1, First Week of Wear||0
10195631|NCT03349632|11323957|FG005|NOT COMPLETED|Period 1, First Week of Wear||0
10195632|NCT03349632|11323952|FG000|STARTED|Period 2, Second Week of Wear||11
10195633|NCT03349632|11323953|FG001|STARTED|Period 2, Second Week of Wear||11
10195634|NCT03349632|11323954|FG002|STARTED|Period 2, Second Week of Wear||11
10195635|NCT03349632|11323955|FG003|STARTED|Period 2, Second Week of Wear||11
10195636|NCT03349632|11323956|FG004|STARTED|Period 2, Second Week of Wear||11
10195637|NCT03349632|11323957|FG005|STARTED|Period 2, Second Week of Wear||11
10195638|NCT03349632|11323952|FG000|COMPLETED|Period 2, Second Week of Wear||11
10195639|NCT03349632|11323953|FG001|COMPLETED|Period 2, Second Week of Wear||11
10195640|NCT03349632|11323954|FG002|COMPLETED|Period 2, Second Week of Wear||11
10195641|NCT03349632|11323955|FG003|COMPLETED|Period 2, Second Week of Wear||11
10195642|NCT03349632|11323956|FG004|COMPLETED|Period 2, Second Week of Wear||11
10195643|NCT03349632|11323957|FG005|COMPLETED|Period 2, Second Week of Wear||11
10195644|NCT03349632|11323952|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
10195645|NCT03349632|11323953|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
10195646|NCT03349632|11323954|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0
10195647|NCT03349632|11323955|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0
10195648|NCT03349632|11323956|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0
10195649|NCT03349632|11323957|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0
10195650|NCT03349710|11323975|FG000|STARTED|Randomized||12
10195651|NCT03349710|11323976|FG001|STARTED|Randomized||10
10195652|NCT03349710|11323977|FG002|STARTED|Randomized||27
10195653|NCT03349710|11323978|FG003|STARTED|Randomized||25
10195654|NCT03349710|11323975|FG000|COMPLETED|Randomized||12
10195655|NCT03349710|11323976|FG001|COMPLETED|Randomized||10
10195656|NCT03349710|11323977|FG002|COMPLETED|Randomized||27
10195657|NCT03349710|11323978|FG003|COMPLETED|Randomized||24
10195658|NCT03349710|11323975|FG000|NOT COMPLETED|Randomized||0
10195659|NCT03349710|11323976|FG001|NOT COMPLETED|Randomized||0
10195660|NCT03349710|11323977|FG002|NOT COMPLETED|Randomized||0
10195661|NCT03349710|11323978|FG003|NOT COMPLETED|Randomized||1
10195662|NCT03349710|11323975|FG000|STARTED|Treatment Period||12
10195663|NCT03349710|11323976|FG001|STARTED|Treatment Period||10
10195664|NCT03349710|11323977|FG002|STARTED|Treatment Period||27
10195665|NCT03349710|11323978|FG003|STARTED|Treatment Period||24
10195666|NCT03349710|11323975|FG000|COMPLETED|Treatment Period||0
10195667|NCT03349710|11323976|FG001|COMPLETED|Treatment Period||0
10195668|NCT03349710|11323977|FG002|COMPLETED|Treatment Period||0
10195669|NCT03349710|11323978|FG003|COMPLETED|Treatment Period||0
10195670|NCT03349710|11323975|FG000|NOT COMPLETED|Treatment Period||12
10195671|NCT03349710|11323976|FG001|NOT COMPLETED|Treatment Period||10
10195672|NCT03349710|11323977|FG002|NOT COMPLETED|Treatment Period||27
10195673|NCT03349710|11323978|FG003|NOT COMPLETED|Treatment Period||24
10195674|NCT03349892|11323988|FG000|STARTED|Overall Study||1
10195675|NCT03349892|11323988|FG000|COMPLETED|Overall Study||1
10195676|NCT03349892|11323988|FG000|NOT COMPLETED|Overall Study||0
10195677|NCT03350217|11323994|FG000|STARTED|Overall Study||79
10195678|NCT03350217|11323995|FG001|STARTED|Overall Study||81
10195679|NCT03350217|11323994|FG000|COMPLETED|Overall Study||77
10195680|NCT03350217|11323995|FG001|COMPLETED|Overall Study||81
10195681|NCT03350217|11323994|FG000|NOT COMPLETED|Overall Study||2
10195682|NCT03350217|11323995|FG001|NOT COMPLETED|Overall Study||0
10195683|NCT03350256|11324001|FG000|STARTED|Overall Study||60
10195684|NCT03350256|11324001|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
10195685|NCT03350256|11324001|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
10195686|NCT03350256|11324001|FG000|1 Month Follow up|Overall Study||30
10195687|NCT03350256|11324001|FG000|3 Month Follow up|Overall Study||27
10195688|NCT03350256|11324001|FG000|6 Month Follow up|Overall Study||24
10195689|NCT03350256|11324001|FG000|COMPLETED|Overall Study||24
10195690|NCT03350256|11324001|FG000|NOT COMPLETED|Overall Study||36
10195691|NCT03350542|11324005|FG000|STARTED|Overall Study||100
10195692|NCT03350542|11324005|FG000|Completed 12-Month Clinical F/U|Overall Study||96
10195693|NCT03350542|11324005|FG000|Death With no 12-month F/U|Overall Study||4
10195694|NCT03350542|11324005|FG000|COMPLETED|Overall Study||96
10195695|NCT03350542|11324005|FG000|NOT COMPLETED|Overall Study||4
10195696|NCT03350672|11324012|FG000|STARTED|Overall Study||17
10195697|NCT03350672|11324013|FG001|STARTED|Overall Study||10
10195698|NCT03350672|11324014|FG002|STARTED|Overall Study||10
10195699|NCT03350672|11324012|FG000|COMPLETED|Overall Study||10
10195700|NCT03350672|11324013|FG001|COMPLETED|Overall Study||10
10195701|NCT03350672|11324014|FG002|COMPLETED|Overall Study||10
10195702|NCT03350672|11324012|FG000|NOT COMPLETED|Overall Study||7
10195703|NCT03350672|11324013|FG001|NOT COMPLETED|Overall Study||0
10195704|NCT03350672|11324014|FG002|NOT COMPLETED|Overall Study||0
10195705|NCT03350724|11324024|FG000|STARTED|Overall Study||17
10195706|NCT03350724|11324025|FG001|STARTED|Overall Study||17
10195707|NCT03350724|11324024|FG000|COMPLETED|Overall Study||17
10195708|NCT03350724|11324025|FG001|COMPLETED|Overall Study||17
10195709|NCT03350724|11324024|FG000|NOT COMPLETED|Overall Study||0
10195710|NCT03350724|11324025|FG001|NOT COMPLETED|Overall Study||0
10195711|NCT03350919|11324033|FG000|STARTED|Overall Study||25
10195712|NCT03350919|11324034|FG001|STARTED|Overall Study||23
10195713|NCT03350919|11324033|FG000|COMPLETED|Overall Study||23
10195714|NCT03350919|11324034|FG001|COMPLETED|Overall Study||23
10195715|NCT03350919|11324033|FG000|NOT COMPLETED|Overall Study||2
10195716|NCT03350919|11324034|FG001|NOT COMPLETED|Overall Study||0
10195717|NCT03351101|11324044|FG000|STARTED|Overall Study||136
10195718|NCT03351101|11324045|FG001|STARTED|Overall Study||132
10195719|NCT03351101|11324044|FG000|COMPLETED|Overall Study||135
10195720|NCT03351101|11324045|FG001|COMPLETED|Overall Study||129
10195721|NCT03351101|11324044|FG000|NOT COMPLETED|Overall Study||1
10195722|NCT03351101|11324045|FG001|NOT COMPLETED|Overall Study||3
10195723|NCT03351114|11324051|FG000|STARTED|Overall Study||8
10195724|NCT03351114|11324051|FG000|COMPLETED|Overall Study||7
10195725|NCT03351114|11324051|FG000|NOT COMPLETED|Overall Study||1
10195726|NCT03351231|11324055|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
10195727|NCT03351231|11324055|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
10195728|NCT03351231|11324055|FG000|NOT COMPLETED|Combination Therapy Period||5
10195729|NCT03351231|11324055|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
10195730|NCT03351231|11324055|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
10195731|NCT03351231|11324055|FG000|NOT COMPLETED|Safety Follow-Up Period||3
10195732|NCT03351335|11324062|FG000|STARTED|Overall Study||21
10195733|NCT03351335|11324063|FG001|STARTED|Overall Study||19
10195734|NCT03351335|11324064|FG002|STARTED|Overall Study||20
10195735|NCT03351335|11324062|FG000|COMPLETED|Overall Study||21
10195736|NCT03351335|11324063|FG001|COMPLETED|Overall Study||19
10195737|NCT03351335|11324064|FG002|COMPLETED|Overall Study||16
10195738|NCT03351335|11324062|FG000|NOT COMPLETED|Overall Study||0
10195739|NCT03351335|11324063|FG001|NOT COMPLETED|Overall Study||0
10195740|NCT03351335|11324064|FG002|NOT COMPLETED|Overall Study||4
10195741|NCT03351478|11324075|FG000|STARTED|Overall Study||307
10195742|NCT03351478|11324076|FG001|STARTED|Overall Study||309
10195743|NCT03351478|11324077|FG002|STARTED|Overall Study||154
10195744|NCT03351478|11324075|FG000|COMPLETED|Overall Study||293
10195745|NCT03351478|11324076|FG001|COMPLETED|Overall Study||292
10195746|NCT03351478|11324077|FG002|COMPLETED|Overall Study||147
10195747|NCT03351478|11324075|FG000|NOT COMPLETED|Overall Study||14
10195748|NCT03351478|11324076|FG001|NOT COMPLETED|Overall Study||17
10195749|NCT03351478|11324077|FG002|NOT COMPLETED|Overall Study||7
10195750|NCT03351608|11324090|FG000|STARTED|Overall Study||19
10195751|NCT03351608|11324091|FG001|STARTED|Overall Study||23
10195752|NCT03351608|11324092|FG002|STARTED|Overall Study||35
10195753|NCT03351608|11324093|FG003|STARTED|Overall Study||176
10195754|NCT03351608|11324094|FG004|STARTED|Overall Study||35
10195755|NCT03351608|11324090|FG000|Treated|Overall Study||18
10195756|NCT03351608|11324091|FG001|Treated|Overall Study||22
10195757|NCT03351608|11324092|FG002|Treated|Overall Study||33
10195758|NCT03351608|11324093|FG003|Treated|Overall Study||169
10195759|NCT03351608|11324094|FG004|Treated|Overall Study||34
10195760|NCT03351608|11324090|FG000|COMPLETED|Overall Study||18
10195761|NCT03351608|11324091|FG001|COMPLETED|Overall Study||21
10195762|NCT03351608|11324092|FG002|COMPLETED|Overall Study||32
10195763|NCT03351608|11324093|FG003|COMPLETED|Overall Study||168
10195764|NCT03351608|11324094|FG004|COMPLETED|Overall Study||33
10195765|NCT03351608|11324090|FG000|NOT COMPLETED|Overall Study||1
10195766|NCT03351608|11324091|FG001|NOT COMPLETED|Overall Study||2
10195767|NCT03351608|11324092|FG002|NOT COMPLETED|Overall Study||3
10195768|NCT03351608|11324093|FG003|NOT COMPLETED|Overall Study||8
10195769|NCT03351608|11324094|FG004|NOT COMPLETED|Overall Study||2
10195770|NCT03351699|11324122|FG000|STARTED|Overall Study||6
10195771|NCT03351699|11324123|FG001|STARTED|Overall Study||6
10195772|NCT03351699|11324124|FG002|STARTED|Overall Study||6
10195773|NCT03351699|11324125|FG003|STARTED|Overall Study||6
10195774|NCT03351699|11324126|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
10195775|NCT03351699|11324122|FG000|COMPLETED|Overall Study||6
10195776|NCT03351699|11324123|FG001|COMPLETED|Overall Study||6
10195777|NCT03351699|11324124|FG002|COMPLETED|Overall Study||6
10195778|NCT03351699|11324125|FG003|COMPLETED|Overall Study||6
10195779|NCT03351699|11324126|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
10195780|NCT03351699|11324122|FG000|NOT COMPLETED|Overall Study||0
10195781|NCT03351699|11324123|FG001|NOT COMPLETED|Overall Study||0
10195782|NCT03351699|11324124|FG002|NOT COMPLETED|Overall Study||0
10195783|NCT03351699|11324125|FG003|NOT COMPLETED|Overall Study||0
10195784|NCT03351699|11324126|FG004|NOT COMPLETED|Overall Study||0
10195785|NCT03351738|11324150|FG000|STARTED|Overall Study||23
10195786|NCT03351738|11324151|FG001|STARTED|Overall Study||20
10195787|NCT03351738|11324152|FG002|STARTED|Overall Study||24
10195788|NCT03351738|11324153|FG003|STARTED|Overall Study||22
10195789|NCT03351738|11324154|FG004|STARTED|Overall Study||21
10195790|NCT03351738|11324155|FG005|STARTED|Overall Study||22
10195791|NCT03351738|11324150|FG000|COMPLETED|Overall Study||23
10195792|NCT03351738|11324151|FG001|COMPLETED|Overall Study||19
10195793|NCT03351738|11324152|FG002|COMPLETED|Overall Study||24
10195794|NCT03351738|11324153|FG003|COMPLETED|Overall Study||21
10195795|NCT03351738|11324154|FG004|COMPLETED|Overall Study||21
10195796|NCT03351738|11324155|FG005|COMPLETED|Overall Study||22
10195797|NCT03351738|11324150|FG000|NOT COMPLETED|Overall Study||0
10195798|NCT03351738|11324151|FG001|NOT COMPLETED|Overall Study||1
10195799|NCT03351738|11324152|FG002|NOT COMPLETED|Overall Study||0
10195800|NCT03351738|11324153|FG003|NOT COMPLETED|Overall Study||1
10195801|NCT03351738|11324154|FG004|NOT COMPLETED|Overall Study||0
10195802|NCT03351738|11324155|FG005|NOT COMPLETED|Overall Study||0
10195803|NCT03351933|11324174|FG000|STARTED|Overall Study||28
10195804|NCT03351933|11324174|FG000|COMPLETED|Overall Study||26
10195805|NCT03351933|11324174|FG000|NOT COMPLETED|Overall Study||2
10195806|NCT03352245|11324180|FG000|STARTED|Overall Study||20
10195807|NCT03352245|11324181|FG001|STARTED|Overall Study||20
10195808|NCT03352245|11324180|FG000|COMPLETED|Overall Study||20
10195809|NCT03352245|11324181|FG001|COMPLETED|Overall Study||19
10195810|NCT03352245|11324180|FG000|NOT COMPLETED|Overall Study||0
10195811|NCT03352245|11324181|FG001|NOT COMPLETED|Overall Study||1
10195812|NCT03352323|11324187|FG000|STARTED|Overall Study||50
10195813|NCT03352323|11324187|FG000|COMPLETED|Overall Study||49
10195814|NCT03352323|11324187|FG000|NOT COMPLETED|Overall Study||1
10195815|NCT03352414|11324193|FG000|STARTED|Overall Study||42
10195816|NCT03352414|11324194|FG001|STARTED|Overall Study||42
10195817|NCT03352414|11324193|FG000|Allocated|Overall Study||30
10195818|NCT03352414|11324194|FG001|Allocated|Overall Study||32
10195819|NCT03352414|11324193|FG000|COMPLETED|Overall Study||30
10195820|NCT03352414|11324194|FG001|COMPLETED|Overall Study||32
10195821|NCT03352414|11324193|FG000|NOT COMPLETED|Overall Study||12
10195822|NCT03352414|11324194|FG001|NOT COMPLETED|Overall Study||10
10195823|NCT03352453|11324204|FG000|STARTED|Overall Study||66
10195824|NCT03352453|11324205|FG001|STARTED|Overall Study||72
10195825|NCT03352453|11324204|FG000|COMPLETED|Overall Study||44
10195826|NCT03352453|11324205|FG001|COMPLETED|Overall Study||40
10195827|NCT03352453|11324204|FG000|NOT COMPLETED|Overall Study||22
10195828|NCT03352453|11324205|FG001|NOT COMPLETED|Overall Study||32
10195829|NCT03352609|11324213|FG000|STARTED|Overall Study||2
10195830|NCT03352609|11324214|FG001|STARTED|Overall Study||3
10195831|NCT03352609|11324213|FG000|COMPLETED|Overall Study||2
10195832|NCT03352609|11324214|FG001|COMPLETED|Overall Study||3
10195833|NCT03352609|11324213|FG000|NOT COMPLETED|Overall Study||0
10195834|NCT03352609|11324214|FG001|NOT COMPLETED|Overall Study||0
10195835|NCT03352713|11324220|FG000|STARTED|Overall Study||185
10195836|NCT03352713|11324220|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
10195837|NCT03352713|11324220|FG000|NOT COMPLETED|Overall Study||26
10195838|NCT03353220|11324224|FG000|STARTED|First Intervention (7 Days) - Phase 1||14
10195839|NCT03353220|11324225|FG001|STARTED|First Intervention (7 Days) - Phase 1||16
10195840|NCT03353220|11324224|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14
10195841|NCT03353220|11324225|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16
10195842|NCT03353220|11324224|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
10195843|NCT03353220|11324225|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
10195844|NCT03353220|11324224|FG000|STARTED|Washout (3 Weeks) - Phase 1||14
10195845|NCT03353220|11324225|FG001|STARTED|Washout (3 Weeks) - Phase 1||16
10195846|NCT03353220|11324224|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14
10195847|NCT03353220|11324225|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16
10195848|NCT03353220|11324224|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
10195849|NCT03353220|11324225|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
10195850|NCT03353220|11324224|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14
10195851|NCT03353220|11324225|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16
10195852|NCT03353220|11324224|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14
10195853|NCT03353220|11324225|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16
10195854|NCT03353220|11324224|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
10195855|NCT03353220|11324225|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
10195856|NCT03353220|11324224|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14
10195857|NCT03353220|11324225|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16
10195858|NCT03353220|11324224|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10
10195859|NCT03353220|11324225|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9
10195860|NCT03353220|11324224|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4
10195861|NCT03353220|11324225|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7
10195862|NCT03353246|11324231|FG000|STARTED|Overall Study||500
10195863|NCT03353246|11324231|FG000|COMPLETED|Overall Study||500
10195864|NCT03353246|11324231|FG000|NOT COMPLETED|Overall Study||0
10195865|NCT03353740|11324235|FG000|STARTED|Overall Study||346
10195866|NCT03353740|11324235|FG000|COMPLETED|Overall Study||294
10195867|NCT03353740|11324235|FG000|NOT COMPLETED|Overall Study||52
10195868|NCT03353753|11324241|FG000|STARTED|Overall Study||85
10195869|NCT03353753|11324242|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44
10195870|NCT03353753|11324241|FG000|COMPLETED|Overall Study||46
10195871|NCT03353753|11324242|FG001|COMPLETED|Overall Study||35
10195872|NCT03353753|11324241|FG000|NOT COMPLETED|Overall Study||39
10195873|NCT03353753|11324242|FG001|NOT COMPLETED|Overall Study||9
10195874|NCT03354325|11324250|FG000|STARTED|Overall Study||151
10195875|NCT03354325|11324251|FG001|STARTED|Overall Study||153
10195876|NCT03354325|11324250|FG000|COMPLETED|Overall Study||131
10195877|NCT03354325|11324251|FG001|COMPLETED|Overall Study||138
10195878|NCT03354325|11324250|FG000|NOT COMPLETED|Overall Study||20
10195879|NCT03354325|11324251|FG001|NOT COMPLETED|Overall Study||15
10195880|NCT03354429|11324259|FG000|STARTED|Overall Study||5523
10195881|NCT03354429|11324260|FG001|STARTED|Overall Study||5493
10195882|NCT03354429|11324259|FG000|COMPLETED|Overall Study||5514
10195883|NCT03354429|11324260|FG001|COMPLETED|Overall Study||5486
10195884|NCT03354429|11324259|FG000|NOT COMPLETED|Overall Study||9
10195885|NCT03354429|11324260|FG001|NOT COMPLETED|Overall Study||7
10195886|NCT03354598|11324268|FG000|STARTED|Overall Study||835
10195887|NCT03354598|11324269|FG001|STARTED|Overall Study||836
10195888|NCT03354598|11324268|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
10195889|NCT03354598|11324269|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
10195890|NCT03354598|11324268|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
10195891|NCT03354598|11324269|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
10195892|NCT03354598|11324268|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
10195893|NCT03354598|11324269|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
10195894|NCT03354598|11324268|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785
10195895|NCT03354598|11324269|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794
10195896|NCT03354598|11324268|FG000|Intent to Treat (ITT) Participants|Overall Study||787
10195897|NCT03354598|11324269|FG001|Intent to Treat (ITT) Participants|Overall Study||803
10195898|NCT03354598|11324268|FG000|Safety Participants|Overall Study||833
10195899|NCT03354598|11324269|FG001|Safety Participants|Overall Study||827
10195900|NCT03354598|11324268|FG000|COMPLETED|Overall Study||755
10195901|NCT03354598|11324269|FG001|COMPLETED|Overall Study||761
10195902|NCT03354598|11324268|FG000|NOT COMPLETED|Overall Study||80
10195903|NCT03354598|11324269|FG001|NOT COMPLETED|Overall Study||75
10195904|NCT03354637|11324278|FG000|STARTED|Double-blind Period||43
10195905|NCT03354637|11324279|FG001|STARTED|Double-blind Period||44
10195906|NCT03354637|11324280|FG002|STARTED|Double-blind Period||42
10195907|NCT03354637|11324278|FG000|COMPLETED|Double-blind Period||26
10195908|NCT03354637|11324279|FG001|COMPLETED|Double-blind Period||31
10195909|NCT03354637|11324280|FG002|COMPLETED|Double-blind Period||35
10195910|NCT03354637|11324278|FG000|NOT COMPLETED|Double-blind Period||17
10195911|NCT03354637|11324279|FG001|NOT COMPLETED|Double-blind Period||13
10195912|NCT03354637|11324280|FG002|NOT COMPLETED|Double-blind Period||7
10195913|NCT03354637|11324278|FG000|STARTED|Open Label Extension||0
10195914|NCT03354637|11324279|FG001|STARTED|Open Label Extension||0
10195915|NCT03354637|11324280|FG002|STARTED|Open Label Extension||61
10195916|NCT03354637|11324278|FG000|COMPLETED|Open Label Extension||0
10195917|NCT03354637|11324279|FG001|COMPLETED|Open Label Extension||0
10195918|NCT03354637|11324280|FG002|COMPLETED|Open Label Extension||33
10195919|NCT03354637|11324278|FG000|NOT COMPLETED|Open Label Extension||0
10195920|NCT03354637|11324279|FG001|NOT COMPLETED|Open Label Extension||0
10195921|NCT03354637|11324280|FG002|NOT COMPLETED|Open Label Extension||28
10195922|NCT03354663|11324289|FG000|STARTED|Enrollment to Catheter Insertion||156
10195923|NCT03354663|11324289|FG000|COMPLETED|Enrollment to Catheter Insertion||151
10195924|NCT03354663|11324289|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5
10195925|NCT03354663|11324289|FG000|STARTED|Completed 30-day Visit||151
10195926|NCT03354663|11324289|FG000|COMPLETED|Completed 30-day Visit||149
10195927|NCT03354663|11324289|FG000|NOT COMPLETED|Completed 30-day Visit||2
10195928|NCT03354754|11324299|FG000|STARTED|Overall Study||2
10195929|NCT03354754|11324300|FG001|STARTED|Overall Study||1
10195930|NCT03354754|11324299|FG000|COMPLETED|Overall Study||2
10195931|NCT03354754|11324300|FG001|COMPLETED|Overall Study||1
10195932|NCT03354754|11324299|FG000|NOT COMPLETED|Overall Study||0
10195933|NCT03354754|11324300|FG001|NOT COMPLETED|Overall Study||0
10195934|NCT03355326|11324308|FG000|STARTED|Overall Study||9
10195935|NCT03355326|11324309|FG001|STARTED|Overall Study||7
10195936|NCT03355326|11324308|FG000|COMPLETED|Overall Study||6
10195937|NCT03355326|11324309|FG001|COMPLETED|Overall Study||4
10195938|NCT03355326|11324308|FG000|NOT COMPLETED|Overall Study||3
10195939|NCT03355326|11324309|FG001|NOT COMPLETED|Overall Study||3
10195940|NCT03355742|11324315|FG000|STARTED|Overall Study||963
10195941|NCT03355742|11324315|FG000|COMPLETED|Overall Study||864
10195942|NCT03355742|11324315|FG000|NOT COMPLETED|Overall Study||99
10195943|NCT03355820|11324319|FG000|STARTED|Overall Study||227
10195944|NCT03355820|11324319|FG000|COMPLETED|Overall Study||227
10195945|NCT03355820|11324319|FG000|NOT COMPLETED|Overall Study||0
10195946|NCT03356145|11324325|FG000|STARTED|Overall Study||48
10195947|NCT03356145|11324326|FG001|STARTED|Overall Study||48
10195948|NCT03356145|11324325|FG000|Received Allocated Intervention|Overall Study||45
10195949|NCT03356145|11324326|FG001|Received Allocated Intervention|Overall Study||47
10195950|NCT03356145|11324325|FG000|COMPLETED|Overall Study||45
10195951|NCT03356145|11324326|FG001|COMPLETED|Overall Study||47
10195952|NCT03356145|11324325|FG000|NOT COMPLETED|Overall Study||3
10195953|NCT03356145|11324326|FG001|NOT COMPLETED|Overall Study||1
10195954|NCT03356977|11324332|FG000|STARTED|Overall Study||137
10195955|NCT03356977|11324332|FG000|COMPLETED|Overall Study||132
10195956|NCT03356977|11324332|FG000|NOT COMPLETED|Overall Study||5
10195957|NCT03357341|11324338|FG000|STARTED|Overall Study||96
10195958|NCT03357341|11324339|FG001|STARTED|Overall Study||98
10195959|NCT03357341|11324338|FG000|COMPLETED|Overall Study||89
10195960|NCT03357341|11324339|FG001|COMPLETED|Overall Study||86
10195961|NCT03357341|11324338|FG000|NOT COMPLETED|Overall Study||7
10195962|NCT03357341|11324339|FG001|NOT COMPLETED|Overall Study||12
10195963|NCT03357393|11324349|FG000|STARTED|Overall Study||50
10195964|NCT03357393|11324350|FG001|STARTED|Overall Study||50
10195965|NCT03357393|11324351|FG002|STARTED|Overall Study||50
10195966|NCT03357393|11324349|FG000|COMPLETED|Overall Study||50
10195967|NCT03357393|11324350|FG001|COMPLETED|Overall Study||50
10195968|NCT03357393|11324351|FG002|COMPLETED|Overall Study||50
10195969|NCT03357393|11324349|FG000|NOT COMPLETED|Overall Study||0
10195970|NCT03357393|11324350|FG001|NOT COMPLETED|Overall Study||0
10195971|NCT03357393|11324351|FG002|NOT COMPLETED|Overall Study||0
10195972|NCT03357471|11324361|FG000|STARTED|Overall Study||35
10195973|NCT03357471|11324362|FG001|STARTED|Overall Study||32
10195974|NCT03357471|11324361|FG000|COMPLETED|Overall Study||33
10195975|NCT03357471|11324362|FG001|COMPLETED|Overall Study||32
10195976|NCT03357471|11324361|FG000|NOT COMPLETED|Overall Study||2
9719191|NCT00038467|10818696|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
9719192|NCT00038467|10818695|FG000|COMPLETED|Overall Study||1810
9719193|NCT00038467|10818696|FG001|COMPLETED|Overall Study||1830
9719194|NCT00038467|10818695|FG000|NOT COMPLETED|Overall Study||542
9719195|NCT00038467|10818696|FG001|NOT COMPLETED|Overall Study||542
9719196|NCT00038610|10818702|FG000|STARTED|Overall Study||54
9719197|NCT00038610|10818702|FG000|COMPLETED|Overall Study||54
9719198|NCT00038610|10818702|FG000|NOT COMPLETED|Overall Study||0
9719199|NCT00038649|10818706|FG000|STARTED|Overall Study||114
9719200|NCT00038649|10818706|FG000|COMPLETED|Overall Study||105
9719201|NCT00038649|10818706|FG000|NOT COMPLETED|Overall Study||9
10195977|NCT03357471|11324362|FG001|NOT COMPLETED|Overall Study||0
10195978|NCT03357614|11324370|FG000|STARTED|Overall Study||697
10195979|NCT03357614|11324371|FG001|STARTED|Overall Study||698
9966530|NCT01509638|11086891|FG001|NOT COMPLETED|Overall Study||2
9966531|NCT01509664|11086899|FG000|STARTED|Overall Study||49
9966532|NCT01509664|11086900|FG001|STARTED|Overall Study||49
9966533|NCT01509664|11086899|FG000|T2 Follow-up|Overall Study||45
9966534|NCT01509664|11086900|FG001|T2 Follow-up|Overall Study||38
9966535|NCT01509664|11086899|FG000|T3 Follow-up|Overall Study||40
9966536|NCT01509664|11086900|FG001|T3 Follow-up|Overall Study||33
9966537|NCT01509664|11086899|FG000|COMPLETED|Overall Study||34
9966538|NCT01509664|11086900|FG001|COMPLETED|Overall Study||28
9966539|NCT01509664|11086899|FG000|NOT COMPLETED|Overall Study||15
9966540|NCT01509664|11086900|FG001|NOT COMPLETED|Overall Study||21
9966541|NCT01509677|11086908|FG000|STARTED|Overall Study||79
9966542|NCT01509677|11086909|FG001|STARTED|Overall Study||79
9966543|NCT01509677|11086908|FG000|COMPLETED|Overall Study||76
9966544|NCT01509677|11086909|FG001|COMPLETED|Overall Study||73
9966545|NCT01509677|11086908|FG000|NOT COMPLETED|Overall Study||3
9966546|NCT01509677|11086909|FG001|NOT COMPLETED|Overall Study||6
9966547|NCT01509807|11086917|FG000|STARTED|Overall Study||16
9966548|NCT01509807|11086918|FG001|STARTED|Overall Study||17
9966549|NCT01509807|11086917|FG000|COMPLETED|Overall Study||15
9966550|NCT01509807|11086918|FG001|COMPLETED|Overall Study||16
9966551|NCT01509807|11086917|FG000|NOT COMPLETED|Overall Study||1
9966552|NCT01509807|11086918|FG001|NOT COMPLETED|Overall Study||1
9966553|NCT01509846|11086929|FG000|STARTED|Received Vaccination 1||5
9966554|NCT01509846|11086930|FG001|STARTED|Received Vaccination 1||20
9966555|NCT01509846|11086931|FG002|STARTED|Received Vaccination 1||20
9966556|NCT01509846|11086932|FG003|STARTED|Received Vaccination 1||20
9966557|NCT01509846|11086933|FG004|STARTED|Received Vaccination 1||17
9966558|NCT01509846|11086929|FG000|COMPLETED|Received Vaccination 1||5
9966559|NCT01509846|11086930|FG001|COMPLETED|Received Vaccination 1||20
9966560|NCT01509846|11086931|FG002|COMPLETED|Received Vaccination 1||20
9966561|NCT01509846|11086932|FG003|COMPLETED|Received Vaccination 1||20
9966562|NCT01509846|11086933|FG004|COMPLETED|Received Vaccination 1||17
9966563|NCT01509846|11086929|FG000|NOT COMPLETED|Received Vaccination 1||0
9966564|NCT01509846|11086930|FG001|NOT COMPLETED|Received Vaccination 1||0
9966565|NCT01509846|11086931|FG002|NOT COMPLETED|Received Vaccination 1||0
9966566|NCT01509846|11086932|FG003|NOT COMPLETED|Received Vaccination 1||0
9966567|NCT01509846|11086933|FG004|NOT COMPLETED|Received Vaccination 1||0
9966568|NCT01509846|11086929|FG000|STARTED|Received Vaccination 2||5
9966569|NCT01509846|11086930|FG001|STARTED|Received Vaccination 2||20
9966570|NCT01509846|11086931|FG002|STARTED|Received Vaccination 2||20
9966571|NCT01509846|11086932|FG003|STARTED|Received Vaccination 2||20
9966572|NCT01509846|11086933|FG004|STARTED|Received Vaccination 2||17
9966573|NCT01509846|11086929|FG000|COMPLETED|Received Vaccination 2||0
9966574|NCT01509846|11086930|FG001|COMPLETED|Received Vaccination 2||20
9966575|NCT01509846|11086931|FG002|COMPLETED|Received Vaccination 2||19
9966576|NCT01509846|11086932|FG003|COMPLETED|Received Vaccination 2||20
9966577|NCT01509846|11086933|FG004|COMPLETED|Received Vaccination 2||14
9966578|NCT01509846|11086929|FG000|NOT COMPLETED|Received Vaccination 2||5
9966579|NCT01509846|11086930|FG001|NOT COMPLETED|Received Vaccination 2||0
9966580|NCT01509846|11086931|FG002|NOT COMPLETED|Received Vaccination 2||1
9966581|NCT01509846|11086932|FG003|NOT COMPLETED|Received Vaccination 2||0
9966582|NCT01509846|11086933|FG004|NOT COMPLETED|Received Vaccination 2||3
9966583|NCT01509846|11086929|FG000|STARTED|Received Vaccination 3||0
9966584|NCT01509846|11086930|FG001|STARTED|Received Vaccination 3||20
9966585|NCT01509846|11086931|FG002|STARTED|Received Vaccination 3||19
9966586|NCT01509846|11086932|FG003|STARTED|Received Vaccination 3||20
9966587|NCT01509846|11086933|FG004|STARTED|Received Vaccination 3||14
9966588|NCT01509846|11086929|FG000|COMPLETED|Received Vaccination 3||0
9966589|NCT01509846|11086930|FG001|COMPLETED|Received Vaccination 3||19
9966590|NCT01509846|11086931|FG002|COMPLETED|Received Vaccination 3||18
9966591|NCT01509846|11086932|FG003|COMPLETED|Received Vaccination 3||19
9966592|NCT01509846|11086933|FG004|COMPLETED|Received Vaccination 3||14
9966593|NCT01509846|11086929|FG000|NOT COMPLETED|Received Vaccination 3||0
9966594|NCT01509846|11086930|FG001|NOT COMPLETED|Received Vaccination 3||1
9966595|NCT01509846|11086931|FG002|NOT COMPLETED|Received Vaccination 3||1
9966596|NCT01509846|11086932|FG003|NOT COMPLETED|Received Vaccination 3||1
9966597|NCT01509846|11086933|FG004|NOT COMPLETED|Received Vaccination 3||0
9966598|NCT01509872|11086954|FG000|STARTED|Overall Study||26
9966599|NCT01509872|11086955|FG001|STARTED|Overall Study||24
9966600|NCT01509872|11086954|FG000|Post-Intervention Assessment|Overall Study||26
9966601|NCT01509872|11086955|FG001|Post-Intervention Assessment|Overall Study||24
9966602|NCT01509872|11086954|FG000|COMPLETED|Overall Study||25
9966603|NCT01509872|11086955|FG001|COMPLETED|Overall Study||24
9966604|NCT01509872|11086954|FG000|NOT COMPLETED|Overall Study||1
9966605|NCT01509872|11086955|FG001|NOT COMPLETED|Overall Study||0
9966606|NCT01509950|11086965|FG000|STARTED|Overall Study||7
9966607|NCT01509950|11086966|FG001|STARTED|Overall Study||8
9966608|NCT01509950|11086967|FG002|STARTED|Overall Study||0
9966609|NCT01509950|11086965|FG000|COMPLETED|Overall Study||7
9966610|NCT01509950|11086966|FG001|COMPLETED|Overall Study||8
9966611|NCT01509950|11086967|FG002|COMPLETED|Overall Study||0
9966612|NCT01509950|11086965|FG000|NOT COMPLETED|Overall Study||0
9966613|NCT01509950|11086966|FG001|NOT COMPLETED|Overall Study||0
9966614|NCT01509950|11086967|FG002|NOT COMPLETED|Overall Study||0
9966615|NCT01510028|11086977|FG000|STARTED|Overall Study||6
9966616|NCT01510028|11086978|FG001|STARTED|Overall Study||6
9966617|NCT01510028|11086979|FG002|STARTED|Overall Study||6
9966618|NCT01510028|11086980|FG003|STARTED|Overall Study||6
9966619|NCT01510028|11086977|FG000|COMPLETED|Overall Study||5
9966620|NCT01510028|11086978|FG001|COMPLETED|Overall Study||6
9966621|NCT01510028|11086979|FG002|COMPLETED|Overall Study||6
9966622|NCT01510028|11086980|FG003|COMPLETED|Overall Study||6
9966623|NCT01510028|11086977|FG000|NOT COMPLETED|Overall Study||1
9966624|NCT01510028|11086978|FG001|NOT COMPLETED|Overall Study||0
9966625|NCT01510028|11086979|FG002|NOT COMPLETED|Overall Study||0
9966626|NCT01510028|11086980|FG003|NOT COMPLETED|Overall Study||0
9966627|NCT01510145|11086992|FG000|STARTED|Overall Study||191
9966628|NCT01510145|11086992|FG000|COMPLETED|Overall Study||173
9966629|NCT01510145|11086992|FG000|NOT COMPLETED|Overall Study||18
9966630|NCT01510158|11086999|FG000|STARTED|Overall Study||202
9966631|NCT01510158|11087000|FG001|STARTED|Overall Study||203
9966632|NCT01510158|11087001|FG002|STARTED|Overall Study||202
9966633|NCT01510158|11086999|FG000|COMPLETED|Overall Study||151
9966634|NCT01510158|11087000|FG001|COMPLETED|Overall Study||150
9966635|NCT01510158|11087001|FG002|COMPLETED|Overall Study||152
9966636|NCT01510158|11086999|FG000|NOT COMPLETED|Overall Study||51
9966637|NCT01510158|11087000|FG001|NOT COMPLETED|Overall Study||53
9966638|NCT01510158|11087001|FG002|NOT COMPLETED|Overall Study||50
9966639|NCT01510327|11087009|FG000|STARTED|Overall Study||22
9966640|NCT01510327|11087009|FG000|COMPLETED|Overall Study||22
9966641|NCT01510327|11087009|FG000|NOT COMPLETED|Overall Study||0
9966642|NCT01510379|11087021|FG000|STARTED|Overall Study||49
9966643|NCT01510379|11087022|FG001|STARTED|Overall Study||51
9966644|NCT01510379|11087021|FG000|COMPLETED|Overall Study||49
9966645|NCT01510379|11087022|FG001|COMPLETED|Overall Study||51
9966646|NCT01510379|11087021|FG000|NOT COMPLETED|Overall Study||0
9966647|NCT01510379|11087022|FG001|NOT COMPLETED|Overall Study||0
9966648|NCT01510457|11087030|FG000|STARTED|Overall Study||17
9966649|NCT01510457|11087031|FG001|STARTED|Overall Study||29
9966650|NCT01510457|11087030|FG000|COMPLETED|Overall Study||12
9966651|NCT01510457|11087031|FG001|COMPLETED|Overall Study||26
9966652|NCT01510457|11087030|FG000|NOT COMPLETED|Overall Study||5
9966653|NCT01510457|11087031|FG001|NOT COMPLETED|Overall Study||3
9966654|NCT01510652|11087041|FG000|STARTED|Overall Study||719
9966655|NCT01510652|11087042|FG001|STARTED|Overall Study||355
9966656|NCT01510652|11087041|FG000|Baseline|Overall Study||718
9966657|NCT01510652|11087042|FG001|Baseline|Overall Study||348
9966658|NCT01510652|11087041|FG000|COMPLETED|Overall Study||627
9966659|NCT01510652|11087042|FG001|COMPLETED|Overall Study||288
9966660|NCT01510652|11087041|FG000|NOT COMPLETED|Overall Study||92
9966661|NCT01510652|11087042|FG001|NOT COMPLETED|Overall Study||67
9966662|NCT01510704|11087052|FG000|STARTED|Overall Study||54
9966663|NCT01510704|11087053|FG001|STARTED|Overall Study||58
9966664|NCT01510704|11087054|FG002|STARTED|Overall Study||50
9966665|NCT01510704|11087055|FG003|STARTED|Overall Study||53
9966666|NCT01510704|11087052|FG000|COMPLETED|Overall Study||54
9966667|NCT01510704|11087053|FG001|COMPLETED|Overall Study||58
9966668|NCT01510704|11087054|FG002|COMPLETED|Overall Study||50
9966669|NCT01510704|11087055|FG003|COMPLETED|Overall Study||53
9966670|NCT01510704|11087052|FG000|NOT COMPLETED|Overall Study||0
9966671|NCT01510704|11087053|FG001|NOT COMPLETED|Overall Study||0
9966672|NCT01510704|11087054|FG002|NOT COMPLETED|Overall Study||0
9966673|NCT01510704|11087055|FG003|NOT COMPLETED|Overall Study||0
9966674|NCT01510717|11087067|FG000|STARTED|Overall Study||155
9966675|NCT01510717|11087068|FG001|STARTED|Overall Study||165
9966676|NCT01510717|11087067|FG000|COMPLETED|Overall Study||153
9966677|NCT01510717|11087068|FG001|COMPLETED|Overall Study||160
9966678|NCT01510717|11087067|FG000|NOT COMPLETED|Overall Study||2
9966679|NCT01510717|11087068|FG001|NOT COMPLETED|Overall Study||5
9966680|NCT01510769|11087078|FG000|STARTED|Overall Study||106
9966681|NCT01510769|11087079|FG001|STARTED|Overall Study||109
9966682|NCT01510769|11087080|FG002|STARTED|Overall Study||109
9966683|NCT01510769|11087078|FG000|COMPLETED|Overall Study||79
9966684|NCT01510769|11087079|FG001|COMPLETED|Overall Study||84
9966685|NCT01510769|11087080|FG002|COMPLETED|Overall Study||87
9966686|NCT01510769|11087078|FG000|NOT COMPLETED|Overall Study||27
9966687|NCT01510769|11087079|FG001|NOT COMPLETED|Overall Study||25
9966688|NCT01510769|11087080|FG002|NOT COMPLETED|Overall Study||22
9966689|NCT01510834|11087088|FG000|STARTED|Overall Study||90
9966690|NCT01510834|11087088|FG000|COMPLETED|Overall Study||57
9966691|NCT01510834|11087088|FG000|NOT COMPLETED|Overall Study||33
9966692|NCT01510912|11087095|FG000|STARTED|Overall Study||602
9966693|NCT01510912|11087095|FG000|COMPLETED|Overall Study||360
9966694|NCT01510912|11087095|FG000|NOT COMPLETED|Overall Study||242
9966695|NCT01511016|11087101|FG000|STARTED|Overall Study||8
9966696|NCT01511016|11087102|FG001|STARTED|Overall Study||9
9966697|NCT01511016|11087101|FG000|COMPLETED|Overall Study||6
9966698|NCT01511016|11087102|FG001|COMPLETED|Overall Study||7
9966699|NCT01511016|11087101|FG000|NOT COMPLETED|Overall Study||2
9966700|NCT01511016|11087102|FG001|NOT COMPLETED|Overall Study||2
9966701|NCT01511055|11087109|FG000|STARTED|Overall Study||27
9966702|NCT01511055|11087109|FG000|COMPLETED|Overall Study||21
9966703|NCT01511055|11087109|FG000|NOT COMPLETED|Overall Study||6
9966704|NCT01511068|11087113|FG000|STARTED|Overall Study||2
9966705|NCT01511068|11087113|FG000|COMPLETED|Overall Study||2
9966706|NCT01511068|11087113|FG000|NOT COMPLETED|Overall Study||0
9966707|NCT01511107|11087119|FG000|STARTED|Overall Study|Randomized to the treatment group.|260
9966708|NCT01511107|11087120|FG001|STARTED|Overall Study|Randomized to the treatment group.|260
9966709|NCT01511107|11087119|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
9967978|NCT01518192|11088347|FG000|STARTED|Overall Study||145
9966710|NCT01511107|11087120|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
9966711|NCT01511107|11087119|FG000|NOT COMPLETED|Overall Study||22
9966712|NCT01511107|11087120|FG001|NOT COMPLETED|Overall Study||41
9966713|NCT01511250|11087136|FG000|STARTED|Overall Study||24
9966714|NCT01511250|11087137|FG001|STARTED|Overall Study||14
9966715|NCT01511250|11087138|FG002|STARTED|Overall Study||22
9966716|NCT01511250|11087139|FG003|STARTED|Overall Study||14
9966717|NCT01511250|11087140|FG004|STARTED|Overall Study||21
9966718|NCT01511250|11087141|FG005|STARTED|Overall Study||17
9966719|NCT01511250|11087142|FG006|STARTED|Overall Study||23
9966720|NCT01511250|11087143|FG007|STARTED|Overall Study||13
9966721|NCT01511250|11087144|FG008|STARTED|Overall Study||159
9966722|NCT01511250|11087145|FG009|STARTED|Overall Study||53
9966723|NCT01511250|11087136|FG000|COMPLETED|Overall Study||15
9966724|NCT01511250|11087137|FG001|COMPLETED|Overall Study||9
9966725|NCT01511250|11087138|FG002|COMPLETED|Overall Study||18
9966726|NCT01511250|11087139|FG003|COMPLETED|Overall Study||11
9966727|NCT01511250|11087140|FG004|COMPLETED|Overall Study||21
9966728|NCT01511250|11087141|FG005|COMPLETED|Overall Study||17
9966729|NCT01511250|11087142|FG006|COMPLETED|Overall Study||21
9966730|NCT01511250|11087143|FG007|COMPLETED|Overall Study||9
9966731|NCT01511250|11087144|FG008|COMPLETED|Overall Study||145
9966732|NCT01511250|11087145|FG009|COMPLETED|Overall Study||48
9966733|NCT01511250|11087136|FG000|NOT COMPLETED|Overall Study||9
9966734|NCT01511250|11087137|FG001|NOT COMPLETED|Overall Study||5
9966735|NCT01511250|11087138|FG002|NOT COMPLETED|Overall Study||4
9966736|NCT01511250|11087139|FG003|NOT COMPLETED|Overall Study||3
9966737|NCT01511250|11087140|FG004|NOT COMPLETED|Overall Study||0
9966738|NCT01511250|11087141|FG005|NOT COMPLETED|Overall Study||0
9966739|NCT01511250|11087142|FG006|NOT COMPLETED|Overall Study||2
9966740|NCT01511250|11087143|FG007|NOT COMPLETED|Overall Study||4
9966741|NCT01511250|11087144|FG008|NOT COMPLETED|Overall Study||14
9966742|NCT01511250|11087145|FG009|NOT COMPLETED|Overall Study||5
9966743|NCT01511315|11087167|FG000|STARTED|Overall Study||36
9966744|NCT01511315|11087167|FG000|COMPLETED|Overall Study||32
9966745|NCT01511315|11087167|FG000|NOT COMPLETED|Overall Study||4
9967979|NCT01518192|11088348|FG001|STARTED|Overall Study||140
9967980|NCT01518192|11088349|FG002|STARTED|Overall Study||259
9967981|NCT01518192|11088347|FG000|COMPLETED|Overall Study||116
9967982|NCT01518192|11088348|FG001|COMPLETED|Overall Study||114
9967983|NCT01518192|11088349|FG002|COMPLETED|Overall Study||224
9967984|NCT01518192|11088347|FG000|NOT COMPLETED|Overall Study||29
9967985|NCT01518192|11088348|FG001|NOT COMPLETED|Overall Study||26
9967986|NCT01518192|11088349|FG002|NOT COMPLETED|Overall Study||35
9967987|NCT01518244|11088363|FG000|STARTED|Overall Study||50
9967988|NCT01518244|11088363|FG000|COMPLETED|Overall Study||47
9967989|NCT01518244|11088363|FG000|NOT COMPLETED|Overall Study||3
9967990|NCT01518257|11088369|FG000|STARTED|Overall Study||61
9967991|NCT01518257|11088370|FG001|STARTED|Overall Study||60
9967992|NCT01518257|11088369|FG000|COMPLETED|Overall Study||59
9967993|NCT01518257|11088370|FG001|COMPLETED|Overall Study||60
9967994|NCT01518257|11088369|FG000|NOT COMPLETED|Overall Study||2
9967995|NCT01518257|11088370|FG001|NOT COMPLETED|Overall Study||0
9967996|NCT01518270|11088376|FG000|STARTED|Overall Study||179
9967997|NCT01518270|11088376|FG000|COMPLETED|Overall Study||179
9967998|NCT01518270|11088376|FG000|NOT COMPLETED|Overall Study||0
9967999|NCT01518309|11088380|FG000|STARTED|Overall Study||39
9968000|NCT01518309|11088380|FG000|COMPLETED|Overall Study||0
9968001|NCT01518309|11088380|FG000|NOT COMPLETED|Overall Study||39
9968002|NCT01518322|11088384|FG000|STARTED|Overall Study||235
9968003|NCT01518322|11088384|FG000|COMPLETED|Overall Study||222
9968004|NCT01518322|11088384|FG000|NOT COMPLETED|Overall Study||13
9968005|NCT01518374|11088393|FG000|STARTED|Overall Study||1768
9968006|NCT01518374|11088393|FG000|COMPLETED|Overall Study||1761
9968007|NCT01518374|11088393|FG000|NOT COMPLETED|Overall Study||7
9968008|NCT01518530|11088397|FG000|STARTED|Active Treatment Period||10
9968009|NCT01518530|11088397|FG000|COMPLETED|Active Treatment Period||9
9968010|NCT01518530|11088397|FG000|NOT COMPLETED|Active Treatment Period||1
9968011|NCT01518530|11088397|FG000|STARTED|Post-Treatment Follow-up||9
9968012|NCT01518530|11088397|FG000|COMPLETED|Post-Treatment Follow-up||9
9968013|NCT01518530|11088397|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
9968014|NCT01518699|11088407|FG000|STARTED|Period 1||10
9968015|NCT01518699|11088408|FG001|STARTED|Period 1||9
9968016|NCT01518699|11088409|FG002|STARTED|Period 1||9
9968017|NCT01518699|11088410|FG003|STARTED|Period 1||10
9968018|NCT01518699|11088411|FG004|STARTED|Period 1||10
9968019|NCT01518699|11088412|FG005|STARTED|Period 1||9
9968020|NCT01518699|11088407|FG000|COMPLETED|Period 1||10
9968021|NCT01518699|11088408|FG001|COMPLETED|Period 1||9
9968022|NCT01518699|11088409|FG002|COMPLETED|Period 1||9
9968023|NCT01518699|11088410|FG003|COMPLETED|Period 1||10
9968024|NCT01518699|11088411|FG004|COMPLETED|Period 1||10
9968025|NCT01518699|11088412|FG005|COMPLETED|Period 1||9
9968026|NCT01518699|11088407|FG000|NOT COMPLETED|Period 1||0
9968027|NCT01518699|11088408|FG001|NOT COMPLETED|Period 1||0
9968028|NCT01518699|11088409|FG002|NOT COMPLETED|Period 1||0
9968029|NCT01518699|11088410|FG003|NOT COMPLETED|Period 1||0
9968030|NCT01518699|11088411|FG004|NOT COMPLETED|Period 1||0
9968031|NCT01518699|11088412|FG005|NOT COMPLETED|Period 1||0
9968032|NCT01518699|11088407|FG000|STARTED|Period 2||10
9968033|NCT01518699|11088408|FG001|STARTED|Period 2||9
9968034|NCT01518699|11088409|FG002|STARTED|Period 2||9
9968035|NCT01518699|11088410|FG003|STARTED|Period 2||10
9968036|NCT01518699|11088411|FG004|STARTED|Period 2||10
9966746|NCT01511419|11087173|FG000|STARTED|Dose 1||30
9966747|NCT01511419|11087174|FG001|STARTED|Dose 1||10
9966748|NCT01511419|11087173|FG000|COMPLETED|Dose 1||30
9966749|NCT01511419|11087174|FG001|COMPLETED|Dose 1||10
9966750|NCT01511419|11087173|FG000|NOT COMPLETED|Dose 1||0
9966751|NCT01511419|11087174|FG001|NOT COMPLETED|Dose 1||0
9966752|NCT01511419|11087173|FG000|STARTED|Dose 2||30
9966753|NCT01511419|11087174|FG001|STARTED|Dose 2||10
9966754|NCT01511419|11087173|FG000|COMPLETED|Dose 2||29
9966755|NCT01511419|11087174|FG001|COMPLETED|Dose 2||10
9966756|NCT01511419|11087173|FG000|NOT COMPLETED|Dose 2||1
9966757|NCT01511419|11087174|FG001|NOT COMPLETED|Dose 2||0
9966758|NCT01511445|11087206|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
9966759|NCT01511445|11087207|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
9966760|NCT01511445|11087206|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
9966761|NCT01511445|11087207|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
9966762|NCT01511445|11087206|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
9966763|NCT01511445|11087207|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
9966764|NCT01511445|11087206|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
9966765|NCT01511445|11087207|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
9966766|NCT01511445|11087206|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
9966767|NCT01511445|11087207|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
9966768|NCT01511445|11087206|FG000|NOT COMPLETED|Overall Study||5
9966769|NCT01511445|11087207|FG001|NOT COMPLETED|Overall Study||4
9966770|NCT01511536|11087216|FG000|STARTED|Phase 1||3
9966771|NCT01511536|11087217|FG001|STARTED|Phase 1||7
9966772|NCT01511536|11087218|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
9966773|NCT01511536|11087216|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
9966774|NCT01511536|11087217|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
9966775|NCT01511536|11087218|FG002|COMPLETED|Phase 1||0
9966776|NCT01511536|11087216|FG000|NOT COMPLETED|Phase 1||0
9966777|NCT01511536|11087217|FG001|NOT COMPLETED|Phase 1||1
9966778|NCT01511536|11087218|FG002|NOT COMPLETED|Phase 1||0
10080661|NCT02254265|11208911|FG001|COMPLETED|Overall Study||140
10080662|NCT02254265|11208912|FG002|COMPLETED|Overall Study||144
10080663|NCT02254265|11208910|FG000|NOT COMPLETED|Overall Study||9
10080664|NCT02254265|11208911|FG001|NOT COMPLETED|Overall Study||12
10080665|NCT02254265|11208912|FG002|NOT COMPLETED|Overall Study||8
10080666|NCT02254291|11208923|FG000|STARTED|Overall Study||103
10080667|NCT02254291|11208924|FG001|STARTED|Overall Study||102
10080668|NCT02254291|11208925|FG002|STARTED|Overall Study||103
10080669|NCT02254291|11208923|FG000|Exposed|Overall Study||103
10080670|NCT02254291|11208924|FG001|Exposed|Overall Study||102
10080671|NCT02254291|11208925|FG002|Exposed|Overall Study||103
10080672|NCT02254291|11208923|FG000|COMPLETED|Overall Study||103
10080673|NCT02254291|11208924|FG001|COMPLETED|Overall Study||99
10080674|NCT02254291|11208925|FG002|COMPLETED|Overall Study||101
10080675|NCT02254291|11208923|FG000|NOT COMPLETED|Overall Study||0
10080676|NCT02254291|11208924|FG001|NOT COMPLETED|Overall Study||3
10080677|NCT02254291|11208925|FG002|NOT COMPLETED|Overall Study||2
10080678|NCT02254304|11208935|FG000|STARTED|Overall Study||89
10080679|NCT02254304|11208936|FG001|STARTED|Overall Study||17
10080680|NCT02254304|11208935|FG000|COMPLETED|Overall Study||75
10080681|NCT02254304|11208936|FG001|COMPLETED|Overall Study||13
10080682|NCT02254304|11208935|FG000|NOT COMPLETED|Overall Study||14
10080683|NCT02254304|11208936|FG001|NOT COMPLETED|Overall Study||4
10080684|NCT02254408|11208946|FG000|STARTED|Overall Study||96
10080685|NCT02254408|11208947|FG001|STARTED|Overall Study||93
10080686|NCT02254408|11208946|FG000|COMPLETED|Overall Study||88
10080687|NCT02254408|11208947|FG001|COMPLETED|Overall Study||83
10080688|NCT02254408|11208946|FG000|NOT COMPLETED|Overall Study||8
10080689|NCT02254408|11208947|FG001|NOT COMPLETED|Overall Study||10
10080690|NCT02254421|11208955|FG000|STARTED|Overall Study||31
10080691|NCT02254421|11208956|FG001|STARTED|Overall Study||29
10080692|NCT02254421|11208955|FG000|COMPLETED|Overall Study||29
10080693|NCT02254421|11208956|FG001|COMPLETED|Overall Study||26
10080694|NCT02254421|11208955|FG000|NOT COMPLETED|Overall Study||2
10080695|NCT02254421|11208956|FG001|NOT COMPLETED|Overall Study||3
10080696|NCT02254460|11208962|FG000|STARTED|Overall Study||13
10080697|NCT02254460|11208963|FG001|STARTED|Overall Study||12
10080698|NCT02254460|11208962|FG000|COMPLETED|Overall Study||12
10080699|NCT02254460|11208963|FG001|COMPLETED|Overall Study||12
10080700|NCT02254460|11208962|FG000|NOT COMPLETED|Overall Study||1
10080701|NCT02254460|11208963|FG001|NOT COMPLETED|Overall Study||0
10080702|NCT02254473|11208971|FG000|STARTED|Overall Study||9
10080703|NCT02254473|11208972|FG001|STARTED|Overall Study||3
10080704|NCT02254473|11208971|FG000|COMPLETED|Overall Study||7
10080705|NCT02254473|11208972|FG001|COMPLETED|Overall Study||2
10080706|NCT02254473|11208971|FG000|NOT COMPLETED|Overall Study||2
10080707|NCT02254473|11208972|FG001|NOT COMPLETED|Overall Study||1
10080708|NCT02254486|11208980|FG000|STARTED|Overall Study||311
10080709|NCT02254486|11208981|FG001|STARTED|Overall Study||310
10080710|NCT02254486|11208980|FG000|COMPLETED|Overall Study||261
10080711|NCT02254486|11208981|FG001|COMPLETED|Overall Study||255
10080712|NCT02254486|11208980|FG000|NOT COMPLETED|Overall Study||50
10080713|NCT02254486|11208981|FG001|NOT COMPLETED|Overall Study||55
9966779|NCT01511536|11087216|FG000|STARTED|Phase 2||0
9966780|NCT01511536|11087217|FG001|STARTED|Phase 2||0
9966781|NCT01511536|11087218|FG002|STARTED|Phase 2||27
9966782|NCT01511536|11087216|FG000|COMPLETED|Phase 2||0
9966783|NCT01511536|11087217|FG001|COMPLETED|Phase 2||0
9966784|NCT01511536|11087218|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
9966785|NCT01511536|11087216|FG000|NOT COMPLETED|Phase 2||0
9966786|NCT01511536|11087217|FG001|NOT COMPLETED|Phase 2||0
9966787|NCT01511536|11087218|FG002|NOT COMPLETED|Phase 2||9
9966788|NCT01511640|11087230|FG000|STARTED|First Intervention (11-15 Days)||7
9966789|NCT01511640|11087231|FG001|STARTED|First Intervention (11-15 Days)||8
9966790|NCT01511640|11087232|FG002|STARTED|First Intervention (11-15 Days)||7
9966791|NCT01511640|11087233|FG003|STARTED|First Intervention (11-15 Days)||8
9966792|NCT01511640|11087230|FG000|COMPLETED|First Intervention (11-15 Days)||5
9966793|NCT01511640|11087231|FG001|COMPLETED|First Intervention (11-15 Days)||8
9966794|NCT01511640|11087232|FG002|COMPLETED|First Intervention (11-15 Days)||7
9966795|NCT01511640|11087233|FG003|COMPLETED|First Intervention (11-15 Days)||7
9966796|NCT01511640|11087230|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2
9966797|NCT01511640|11087231|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0
9966798|NCT01511640|11087232|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0
9966799|NCT01511640|11087233|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1
9966800|NCT01511640|11087230|FG000|STARTED|Washout (6-10 Days)||5
9966801|NCT01511640|11087231|FG001|STARTED|Washout (6-10 Days)||8
9966802|NCT01511640|11087232|FG002|STARTED|Washout (6-10 Days)||7
9966803|NCT01511640|11087233|FG003|STARTED|Washout (6-10 Days)||7
9966804|NCT01511640|11087230|FG000|COMPLETED|Washout (6-10 Days)||5
9966805|NCT01511640|11087231|FG001|COMPLETED|Washout (6-10 Days)||8
9966806|NCT01511640|11087232|FG002|COMPLETED|Washout (6-10 Days)||7
9966807|NCT01511640|11087233|FG003|COMPLETED|Washout (6-10 Days)||6
9966808|NCT01511640|11087230|FG000|NOT COMPLETED|Washout (6-10 Days)||0
9966809|NCT01511640|11087231|FG001|NOT COMPLETED|Washout (6-10 Days)||0
9966810|NCT01511640|11087232|FG002|NOT COMPLETED|Washout (6-10 Days)||0
9966811|NCT01511640|11087233|FG003|NOT COMPLETED|Washout (6-10 Days)||1
9966812|NCT01511640|11087230|FG000|STARTED|Third Intervention (11-15 Days)||5
9966813|NCT01511640|11087231|FG001|STARTED|Third Intervention (11-15 Days)||8
9966814|NCT01511640|11087232|FG002|STARTED|Third Intervention (11-15 Days)||7
9966815|NCT01511640|11087233|FG003|STARTED|Third Intervention (11-15 Days)||6
9966816|NCT01511640|11087230|FG000|COMPLETED|Third Intervention (11-15 Days)||4
9966817|NCT01511640|11087231|FG001|COMPLETED|Third Intervention (11-15 Days)||7
9966818|NCT01511640|11087232|FG002|COMPLETED|Third Intervention (11-15 Days)||7
9966819|NCT01511640|11087233|FG003|COMPLETED|Third Intervention (11-15 Days)||6
9966820|NCT01511640|11087230|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1
9966821|NCT01511640|11087231|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1
9966822|NCT01511640|11087232|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0
9966823|NCT01511640|11087233|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0
9966824|NCT01511809|11087245|FG000|STARTED|Overall Study||58
9966825|NCT01511809|11087246|FG001|STARTED|Overall Study||59
9966826|NCT01511809|11087245|FG000|COMPLETED|Overall Study||51
9966827|NCT01511809|11087246|FG001|COMPLETED|Overall Study||52
9966828|NCT01511809|11087245|FG000|NOT COMPLETED|Overall Study||7
9966829|NCT01511809|11087246|FG001|NOT COMPLETED|Overall Study||7
9966830|NCT01511939|11087255|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
9966831|NCT01511939|11087256|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
9966832|NCT01511939|11087257|FG002|STARTED|Overall Study||8
9966833|NCT01511939|11087255|FG000|COMPLETED|Overall Study||7
9966834|NCT01511939|11087256|FG001|COMPLETED|Overall Study||4
9966835|NCT01511939|11087257|FG002|COMPLETED|Overall Study||8
9966836|NCT01511939|11087255|FG000|NOT COMPLETED|Overall Study||2
9966837|NCT01511939|11087256|FG001|NOT COMPLETED|Overall Study||1
9966838|NCT01511939|11087257|FG002|NOT COMPLETED|Overall Study||0
9966839|NCT01511978|11087267|FG000|STARTED|Overall Study||14
9966840|NCT01511978|11087268|FG001|STARTED|Overall Study||18
9966841|NCT01511978|11087267|FG000|COMPLETED|Overall Study||14
9966842|NCT01511978|11087268|FG001|COMPLETED|Overall Study||18
9966843|NCT01511978|11087267|FG000|NOT COMPLETED|Overall Study||0
9966844|NCT01511978|11087268|FG001|NOT COMPLETED|Overall Study||0
9966845|NCT01512108|11087278|FG000|STARTED|Overall Study||243
9966846|NCT01512108|11087279|FG001|STARTED|Overall Study||120
9966847|NCT01512108|11087278|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
9966848|NCT01512108|11087279|FG001|Exposed|Overall Study||120
9966849|NCT01512108|11087278|FG000|COMPLETED|Overall Study||221
9966850|NCT01512108|11087279|FG001|COMPLETED|Overall Study||111
9966851|NCT01512108|11087278|FG000|NOT COMPLETED|Overall Study||22
9966852|NCT01512108|11087279|FG001|NOT COMPLETED|Overall Study||9
9966853|NCT01512160|11087289|FG000|STARTED|Overall Study||22
9966854|NCT01512160|11087290|FG001|STARTED|Overall Study||23
9966855|NCT01512160|11087291|FG002|STARTED|Overall Study||22
9966856|NCT01512160|11087292|FG003|STARTED|Overall Study||23
9966857|NCT01512160|11087289|FG000|COMPLETED|Overall Study||20
9966858|NCT01512160|11087290|FG001|COMPLETED|Overall Study||23
9966859|NCT01512160|11087291|FG002|COMPLETED|Overall Study||22
9966860|NCT01512160|11087292|FG003|COMPLETED|Overall Study||22
9966861|NCT01512160|11087289|FG000|NOT COMPLETED|Overall Study||2
9966862|NCT01512160|11087290|FG001|NOT COMPLETED|Overall Study||0
9966863|NCT01512160|11087291|FG002|NOT COMPLETED|Overall Study||0
9966864|NCT01512160|11087292|FG003|NOT COMPLETED|Overall Study||1
9966865|NCT01512225|11087305|FG000|STARTED|Overall Study||45
9966866|NCT01512225|11087306|FG001|STARTED|Overall Study||45
9966867|NCT01512225|11087305|FG000|Provided Day 14 Volume|Overall Study||45
9966868|NCT01512225|11087306|FG001|Provided Day 14 Volume|Overall Study||40
9966869|NCT01512225|11087305|FG000|COMPLETED|Overall Study||45
9966870|NCT01512225|11087306|FG001|COMPLETED|Overall Study||45
9966871|NCT01512225|11087305|FG000|NOT COMPLETED|Overall Study||0
9966872|NCT01512225|11087306|FG001|NOT COMPLETED|Overall Study||0
9966873|NCT01512251|11087316|FG000|STARTED|Dose Level -1||3
9966874|NCT01512251|11087317|FG001|STARTED|Dose Level -1||5
9966875|NCT01512251|11087316|FG000|COMPLETED|Dose Level -1||3
9966876|NCT01512251|11087317|FG001|COMPLETED|Dose Level -1||5
9966877|NCT01512251|11087316|FG000|NOT COMPLETED|Dose Level -1||0
9966878|NCT01512251|11087317|FG001|NOT COMPLETED|Dose Level -1||0
9966879|NCT01512251|11087316|FG000|STARTED|Phase I, Dose 1||3
9966880|NCT01512251|11087317|FG001|STARTED|Phase I, Dose 1||5
9966881|NCT01512251|11087316|FG000|COMPLETED|Phase I, Dose 1||0
9966882|NCT01512251|11087317|FG001|COMPLETED|Phase I, Dose 1||0
9966883|NCT01512251|11087316|FG000|NOT COMPLETED|Phase I, Dose 1||3
9966884|NCT01512251|11087317|FG001|NOT COMPLETED|Phase I, Dose 1||5
9966885|NCT01512251|11087316|FG000|STARTED|Phase I, Dose 2||0
9966886|NCT01512251|11087317|FG001|STARTED|Phase I, Dose 2||0
9966887|NCT01512251|11087316|FG000|COMPLETED|Phase I, Dose 2||0
9966888|NCT01512251|11087317|FG001|COMPLETED|Phase I, Dose 2||0
9966889|NCT01512251|11087316|FG000|NOT COMPLETED|Phase I, Dose 2||0
9966890|NCT01512251|11087317|FG001|NOT COMPLETED|Phase I, Dose 2||0
9966891|NCT01512251|11087316|FG000|STARTED|Phase I, Dose 3||0
9966892|NCT01512251|11087317|FG001|STARTED|Phase I, Dose 3||0
9966893|NCT01512251|11087316|FG000|COMPLETED|Phase I, Dose 3||0
9966894|NCT01512251|11087317|FG001|COMPLETED|Phase I, Dose 3||0
9966895|NCT01512251|11087316|FG000|NOT COMPLETED|Phase I, Dose 3||0
9966896|NCT01512251|11087317|FG001|NOT COMPLETED|Phase I, Dose 3||0
9966897|NCT01512251|11087316|FG000|STARTED|Phase I, Dose 4||0
9966898|NCT01512251|11087317|FG001|STARTED|Phase I, Dose 4||0
9966899|NCT01512251|11087316|FG000|COMPLETED|Phase I, Dose 4||0
9966900|NCT01512251|11087317|FG001|COMPLETED|Phase I, Dose 4||0
9966901|NCT01512251|11087316|FG000|NOT COMPLETED|Phase I, Dose 4||0
9966902|NCT01512251|11087317|FG001|NOT COMPLETED|Phase I, Dose 4||0
9966903|NCT01512251|11087316|FG000|STARTED|Phase II||0
9966904|NCT01512251|11087317|FG001|STARTED|Phase II||0
9966905|NCT01512251|11087316|FG000|COMPLETED|Phase II||0
9966906|NCT01512251|11087317|FG001|COMPLETED|Phase II||0
9966907|NCT01512251|11087316|FG000|NOT COMPLETED|Phase II||0
9966908|NCT01512251|11087317|FG001|NOT COMPLETED|Phase II||0
9966909|NCT01512264|11087328|FG000|STARTED|Overall Study||7
9966910|NCT01512264|11087329|FG001|STARTED|Overall Study||7
9966911|NCT01512264|11087330|FG002|STARTED|Overall Study||7
9966912|NCT01512264|11087331|FG003|STARTED|Overall Study||7
9966913|NCT01512264|11087328|FG000|COMPLETED|Overall Study||7
9966914|NCT01512264|11087329|FG001|COMPLETED|Overall Study||7
9966915|NCT01512264|11087330|FG002|COMPLETED|Overall Study||7
9966916|NCT01512264|11087331|FG003|COMPLETED|Overall Study||6
9966917|NCT01512264|11087328|FG000|NOT COMPLETED|Overall Study||0
9966918|NCT01512264|11087329|FG001|NOT COMPLETED|Overall Study||0
9966919|NCT01512264|11087330|FG002|NOT COMPLETED|Overall Study||0
9966920|NCT01512264|11087331|FG003|NOT COMPLETED|Overall Study||1
9966921|NCT01512368|11087341|FG000|STARTED|Overall Study||63
9966922|NCT01512368|11087341|FG000|COMPLETED|Overall Study||60
9966923|NCT01512368|11087341|FG000|NOT COMPLETED|Overall Study||3
9966924|NCT01512446|11087347|FG000|STARTED|Overall Study||221
9966925|NCT01512446|11087348|FG001|STARTED|Overall Study||215
9966926|NCT01512446|11087347|FG000|Safety Analysis Set|Overall Study||197
9966927|NCT01512446|11087348|FG001|Safety Analysis Set|Overall Study||188
9966928|NCT01512446|11087347|FG000|COMPLETED|Overall Study||0
9966929|NCT01512446|11087348|FG001|COMPLETED|Overall Study||0
9966930|NCT01512446|11087347|FG000|NOT COMPLETED|Overall Study||221
9966931|NCT01512446|11087348|FG001|NOT COMPLETED|Overall Study||215
9966932|NCT01512667|11087356|FG000|STARTED|Overall Study||13
9966933|NCT01512667|11087357|FG001|STARTED|Overall Study||12
9966934|NCT01512667|11087356|FG000|Matched Participants|Overall Study||12
9966935|NCT01512667|11087357|FG001|Matched Participants|Overall Study||12
9966936|NCT01512667|11087356|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
9966937|NCT01512667|11087357|FG001|Unmatched Participants|Overall Study||0
9966938|NCT01512667|11087356|FG000|COMPLETED|Overall Study||13
9966939|NCT01512667|11087357|FG001|COMPLETED|Overall Study||12
9966940|NCT01512667|11087356|FG000|NOT COMPLETED|Overall Study||0
9966941|NCT01512667|11087357|FG001|NOT COMPLETED|Overall Study||0
9966942|NCT01512693|11087365|FG000|STARTED|Overall Study||8
9966943|NCT01512693|11087366|FG001|STARTED|Overall Study||9
9966944|NCT01512693|11087365|FG000|COMPLETED|Overall Study||8
9966945|NCT01512693|11087366|FG001|COMPLETED|Overall Study||8
9966946|NCT01512693|11087365|FG000|NOT COMPLETED|Overall Study||0
9966947|NCT01512693|11087366|FG001|NOT COMPLETED|Overall Study||1
9966948|NCT01512745|11087374|FG000|STARTED|Overall Study||176
9966949|NCT01512745|11087375|FG001|STARTED|Overall Study||91
9966950|NCT01512745|11087374|FG000|COMPLETED|Overall Study||136
9966951|NCT01512745|11087375|FG001|COMPLETED|Overall Study||71
9966952|NCT01512745|11087374|FG000|NOT COMPLETED|Overall Study||40
9966953|NCT01512745|11087375|FG001|NOT COMPLETED|Overall Study||20
9966954|NCT01512758|11087383|FG000|STARTED|Overall Study||30
9966955|NCT01512758|11087384|FG001|STARTED|Overall Study||6
9966956|NCT01512758|11087383|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
9966957|NCT01512758|11087384|FG001|COMPLETED|Overall Study||6
9966958|NCT01512758|11087383|FG000|NOT COMPLETED|Overall Study||0
9966959|NCT01512758|11087384|FG001|NOT COMPLETED|Overall Study||0
9966960|NCT01512797|11087393|FG000|STARTED|Overall Study||16
9966961|NCT01512797|11087394|FG001|STARTED|Overall Study||16
9966962|NCT01512797|11087393|FG000|COMPLETED|Overall Study||16
9966963|NCT01512797|11087394|FG001|COMPLETED|Overall Study||16
9966964|NCT01512797|11087393|FG000|NOT COMPLETED|Overall Study||0
9966965|NCT01512797|11087394|FG001|NOT COMPLETED|Overall Study||0
9966966|NCT01512849|11087402|FG000|STARTED|Crossover Period 1||6
9966967|NCT01512849|11087403|FG001|STARTED|Crossover Period 1||6
9966968|NCT01512849|11087404|FG002|STARTED|Crossover Period 1||6
9966969|NCT01512849|11087405|FG003|STARTED|Crossover Period 1||6
9966970|NCT01512849|11087402|FG000|COMPLETED|Crossover Period 1||6
9966971|NCT01512849|11087403|FG001|COMPLETED|Crossover Period 1||6
9966972|NCT01512849|11087404|FG002|COMPLETED|Crossover Period 1||6
9966973|NCT01512849|11087405|FG003|COMPLETED|Crossover Period 1||6
9966974|NCT01512849|11087402|FG000|NOT COMPLETED|Crossover Period 1||0
9966975|NCT01512849|11087403|FG001|NOT COMPLETED|Crossover Period 1||0
9966976|NCT01512849|11087404|FG002|NOT COMPLETED|Crossover Period 1||0
9966977|NCT01512849|11087405|FG003|NOT COMPLETED|Crossover Period 1||0
9966978|NCT01512849|11087402|FG000|STARTED|Crossover Period 2||6
9966979|NCT01512849|11087403|FG001|STARTED|Crossover Period 2||6
9966980|NCT01512849|11087404|FG002|STARTED|Crossover Period 2||6
9966981|NCT01512849|11087405|FG003|STARTED|Crossover Period 2||6
9966982|NCT01512849|11087402|FG000|COMPLETED|Crossover Period 2||6
9966983|NCT01512849|11087403|FG001|COMPLETED|Crossover Period 2||6
9966984|NCT01512849|11087404|FG002|COMPLETED|Crossover Period 2||6
9966985|NCT01512849|11087405|FG003|COMPLETED|Crossover Period 2||6
9966986|NCT01512849|11087402|FG000|NOT COMPLETED|Crossover Period 2||0
9966987|NCT01512849|11087403|FG001|NOT COMPLETED|Crossover Period 2||0
9966988|NCT01512849|11087404|FG002|NOT COMPLETED|Crossover Period 2||0
9966989|NCT01512849|11087405|FG003|NOT COMPLETED|Crossover Period 2||0
9966990|NCT01512979|11087417|FG000|STARTED|Overall Study|Randomised and treated|159
9966991|NCT01512979|11087418|FG001|STARTED|Overall Study|Randomised and treated|157
9966992|NCT01512979|11087417|FG000|COMPLETED|Overall Study||140
9966993|NCT01512979|11087418|FG001|COMPLETED|Overall Study||135
9966994|NCT01512979|11087417|FG000|NOT COMPLETED|Overall Study||19
9966995|NCT01512979|11087418|FG001|NOT COMPLETED|Overall Study||22
9966996|NCT01513122|11087426|FG000|STARTED|Overall Study||102
9966997|NCT01513122|11087427|FG001|STARTED|Overall Study||108
9966998|NCT01513122|11087426|FG000|COMPLETED|Overall Study||91
9966999|NCT01513122|11087427|FG001|COMPLETED|Overall Study||105
9967000|NCT01513122|11087426|FG000|NOT COMPLETED|Overall Study||11
9967001|NCT01513122|11087427|FG001|NOT COMPLETED|Overall Study||3
9967002|NCT01513148|11087435|FG000|STARTED|Overall Study||16
9967003|NCT01513148|11087436|FG001|STARTED|Overall Study||16
9967004|NCT01513148|11087435|FG000|COMPLETED|Overall Study||14
9967005|NCT01513148|11087436|FG001|COMPLETED|Overall Study||14
9967006|NCT01513148|11087435|FG000|NOT COMPLETED|Overall Study||2
9967007|NCT01513148|11087436|FG001|NOT COMPLETED|Overall Study||2
9967008|NCT01513239|11087485|FG000|STARTED|Period 1: Main Phase|Randomized participants|397
9967009|NCT01513239|11087486|FG001|STARTED|Period 1: Main Phase|Randomized participants|407
9967010|NCT01513239|11087487|FG002|STARTED|Period 1: Main Phase|Randomized participants|399
9967011|NCT01513239|11087488|FG003|STARTED|Period 1: Main Phase||0
9967012|NCT01513239|11087489|FG004|STARTED|Period 1: Main Phase||0
9967013|NCT01513239|11087490|FG005|STARTED|Period 1: Main Phase||0
9967014|NCT01513239|11087485|FG000|Treated|Period 1: Main Phase|Treated participants|391
9967015|NCT01513239|11087486|FG001|Treated|Period 1: Main Phase|Treated participants|396
9967016|NCT01513239|11087487|FG002|Treated|Period 1: Main Phase|Treated participants|381
9967017|NCT01513239|11087488|FG003|Treated|Period 1: Main Phase||0
9967018|NCT01513239|11087489|FG004|Treated|Period 1: Main Phase||0
9967019|NCT01513239|11087490|FG005|Treated|Period 1: Main Phase||0
9967020|NCT01513239|11087485|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
9967021|NCT01513239|11087486|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
9967022|NCT01513239|11087487|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
9967023|NCT01513239|11087488|FG003|All Participants as Treated|Period 1: Main Phase||0
9967024|NCT01513239|11087489|FG004|All Participants as Treated|Period 1: Main Phase||0
9967025|NCT01513239|11087490|FG005|All Participants as Treated|Period 1: Main Phase||0
9967026|NCT01513239|11087485|FG000|COMPLETED|Period 1: Main Phase||322
9967027|NCT01513239|11087486|FG001|COMPLETED|Period 1: Main Phase||337
9967028|NCT01513239|11087487|FG002|COMPLETED|Period 1: Main Phase||311
9967029|NCT01513239|11087488|FG003|COMPLETED|Period 1: Main Phase||0
9967030|NCT01513239|11087489|FG004|COMPLETED|Period 1: Main Phase||0
9967031|NCT01513239|11087490|FG005|COMPLETED|Period 1: Main Phase||0
9967032|NCT01513239|11087485|FG000|NOT COMPLETED|Period 1: Main Phase||75
9967033|NCT01513239|11087486|FG001|NOT COMPLETED|Period 1: Main Phase||70
9967034|NCT01513239|11087487|FG002|NOT COMPLETED|Period 1: Main Phase||88
9967035|NCT01513239|11087488|FG003|NOT COMPLETED|Period 1: Main Phase||0
9967036|NCT01513239|11087489|FG004|NOT COMPLETED|Period 1: Main Phase||0
9967037|NCT01513239|11087490|FG005|NOT COMPLETED|Period 1: Main Phase||0
9967038|NCT01513239|11087485|FG000|STARTED|Period 2: 9 Month Extension Phase||0
9967039|NCT01513239|11087486|FG001|STARTED|Period 2: 9 Month Extension Phase||0
9967040|NCT01513239|11087487|FG002|STARTED|Period 2: 9 Month Extension Phase||0
9967041|NCT01513239|11087488|FG003|STARTED|Period 2: 9 Month Extension Phase||112
9967042|NCT01513239|11087489|FG004|STARTED|Period 2: 9 Month Extension Phase||100
9967043|NCT01513239|11087490|FG005|STARTED|Period 2: 9 Month Extension Phase||83
9967044|NCT01513239|11087485|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0
9967045|NCT01513239|11087486|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0
9967046|NCT01513239|11087487|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0
9967047|NCT01513239|11087488|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102
9967048|NCT01513239|11087489|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90
9967049|NCT01513239|11087490|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78
9967050|NCT01513239|11087485|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
9967051|NCT01513239|11087486|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
9967052|NCT01513239|11087487|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
9967053|NCT01513239|11087488|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
9967054|NCT01513239|11087489|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
9967055|NCT01513239|11087490|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
9967056|NCT01513291|11087504|FG000|STARTED|Treatment Period||120
9967057|NCT01513291|11087505|FG001|STARTED|Treatment Period||117
9967058|NCT01513291|11087506|FG002|STARTED|Treatment Period||0
9967059|NCT01513291|11087507|FG003|STARTED|Treatment Period||0
10080714|NCT02254551|11208987|FG000|STARTED|Dose Escalation||7
10080715|NCT02254551|11208987|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
10080716|NCT02254551|11208987|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0
10080717|NCT02254551|11208987|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0
10080718|NCT02254551|11208987|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
10080719|NCT02254551|11208987|FG000|NOT COMPLETED|Dose Escalation||3
10080720|NCT02254551|11208987|FG000|STARTED|Expansion||0
10080721|NCT02254551|11208987|FG000|COMPLETED|Expansion||0
10080722|NCT02254551|11208987|FG000|NOT COMPLETED|Expansion||0
10080723|NCT02254551|11208987|FG000|STARTED|Maintenance||0
10080724|NCT02254551|11208987|FG000|COMPLETED|Maintenance||0
10080725|NCT02254551|11208987|FG000|NOT COMPLETED|Maintenance||0
10080726|NCT02254681|11208994|FG000|STARTED|Overall Study||6
10080727|NCT02254681|11208994|FG000|COMPLETED|Overall Study||0
10080728|NCT02254681|11208994|FG000|NOT COMPLETED|Overall Study||6
10080729|NCT02254772|11208999|FG000|STARTED|Overall Study||9
10080730|NCT02254772|11208999|FG000|COMPLETED|Overall Study||7
10080731|NCT02254772|11208999|FG000|NOT COMPLETED|Overall Study||2
10080732|NCT02255032|11209005|FG000|STARTED|Overall Study||17
10080733|NCT02255032|11209006|FG001|STARTED|Overall Study||5
10080734|NCT02255032|11209005|FG000|COMPLETED|Overall Study||17
10080735|NCT02255032|11209006|FG001|COMPLETED|Overall Study||5
10080736|NCT02255032|11209005|FG000|NOT COMPLETED|Overall Study||0
10080737|NCT02255032|11209006|FG001|NOT COMPLETED|Overall Study||0
10080742|NCT02255110|11209016|FG000|STARTED|Overall Study||6
10080743|NCT02255110|11209016|FG000|COMPLETED|Overall Study||6
10080744|NCT02255110|11209016|FG000|NOT COMPLETED|Overall Study||0
10080745|NCT02255149|11209020|FG000|STARTED|Overall Study||10
10080746|NCT02255149|11209020|FG000|COMPLETED|Overall Study||5
10080747|NCT02255149|11209020|FG000|NOT COMPLETED|Overall Study||5
10080748|NCT02255175|11209026|FG000|STARTED|Overall Study||33
10080749|NCT02255175|11209027|FG001|STARTED|Overall Study||31
10080750|NCT02255175|11209026|FG000|COMPLETED|Overall Study||16
10080751|NCT02255175|11209027|FG001|COMPLETED|Overall Study||19
10080752|NCT02255175|11209026|FG000|NOT COMPLETED|Overall Study||17
10080753|NCT02255175|11209027|FG001|NOT COMPLETED|Overall Study||12
10080754|NCT02255279|11209039|FG000|STARTED|Overall Study||144
10080755|NCT02255279|11209040|FG001|STARTED|Overall Study||143
10080756|NCT02255279|11209039|FG000|COMPLETED|Overall Study||139
10080757|NCT02255279|11209040|FG001|COMPLETED|Overall Study||134
10080758|NCT02255279|11209039|FG000|NOT COMPLETED|Overall Study||5
10080759|NCT02255279|11209040|FG001|NOT COMPLETED|Overall Study||9
10080760|NCT02255357|11209062|FG000|STARTED|Overall Study||11
10080761|NCT02255357|11209063|FG001|STARTED|Overall Study||15
10080762|NCT02255357|11209062|FG000|COMPLETED|Overall Study||4
10080763|NCT02255357|11209063|FG001|COMPLETED|Overall Study||5
10080764|NCT02255357|11209062|FG000|NOT COMPLETED|Overall Study||7
10080765|NCT02255357|11209063|FG001|NOT COMPLETED|Overall Study||10
10080766|NCT02255422|11209076|FG000|STARTED|Overall Study||13
10080767|NCT02255422|11209077|FG001|STARTED|Overall Study||6
10080768|NCT02255422|11209078|FG002|STARTED|Overall Study||6
10080769|NCT02255422|11209079|FG003|STARTED|Overall Study||6
10080770|NCT02255422|11209080|FG004|STARTED|Overall Study||6
10080771|NCT02255422|11209081|FG005|STARTED|Overall Study||6
10080772|NCT02255422|11209082|FG006|STARTED|Overall Study||10
10080773|NCT02255422|11209076|FG000|COMPLETED|Overall Study||13
10080774|NCT02255422|11209077|FG001|COMPLETED|Overall Study||6
10080775|NCT02255422|11209078|FG002|COMPLETED|Overall Study||5
10080776|NCT02255422|11209079|FG003|COMPLETED|Overall Study||6
10080777|NCT02255422|11209080|FG004|COMPLETED|Overall Study||6
10080778|NCT02255422|11209081|FG005|COMPLETED|Overall Study||6
10080779|NCT02255422|11209082|FG006|COMPLETED|Overall Study||8
10080780|NCT02255422|11209076|FG000|NOT COMPLETED|Overall Study||0
10080781|NCT02255422|11209077|FG001|NOT COMPLETED|Overall Study||0
10080782|NCT02255422|11209078|FG002|NOT COMPLETED|Overall Study||1
10080783|NCT02255422|11209079|FG003|NOT COMPLETED|Overall Study||0
10080784|NCT02255422|11209080|FG004|NOT COMPLETED|Overall Study||0
10080785|NCT02255422|11209081|FG005|NOT COMPLETED|Overall Study||0
10080786|NCT02255422|11209082|FG006|NOT COMPLETED|Overall Study||2
10080787|NCT02255461|11209103|FG000|STARTED|Overall Study||3
10080788|NCT02255461|11209104|FG001|STARTED|Overall Study||12
10080789|NCT02255461|11209105|FG002|STARTED|Overall Study||6
10080790|NCT02255461|11209106|FG003|STARTED|Overall Study||4
10080791|NCT02255461|11209107|FG004|STARTED|Overall Study||10
10080792|NCT02255461|11209103|FG000|COMPLETED|Overall Study||3
10080793|NCT02255461|11209104|FG001|COMPLETED|Overall Study||10
10080794|NCT02255461|11209105|FG002|COMPLETED|Overall Study||5
10080795|NCT02255461|11209106|FG003|COMPLETED|Overall Study||4
10080796|NCT02255461|11209107|FG004|COMPLETED|Overall Study||8
10080797|NCT02255461|11209103|FG000|NOT COMPLETED|Overall Study||0
10080798|NCT02255461|11209104|FG001|NOT COMPLETED|Overall Study||2
10080799|NCT02255461|11209105|FG002|NOT COMPLETED|Overall Study||1
10080800|NCT02255461|11209106|FG003|NOT COMPLETED|Overall Study||0
10080801|NCT02255461|11209107|FG004|NOT COMPLETED|Overall Study||2
10080802|NCT02255474|11209127|FG000|STARTED|Overall Study||98
10080803|NCT02255474|11209128|FG001|STARTED|Overall Study||98
10080804|NCT02255474|11209129|FG002|STARTED|Overall Study||98
10080805|NCT02255474|11209127|FG000|COMPLETED|Overall Study||96
10080806|NCT02255474|11209128|FG001|COMPLETED|Overall Study||96
10080807|NCT02255474|11209129|FG002|COMPLETED|Overall Study||95
10080808|NCT02255474|11209127|FG000|NOT COMPLETED|Overall Study||2
10080809|NCT02255474|11209128|FG001|NOT COMPLETED|Overall Study||2
10080810|NCT02255474|11209129|FG002|NOT COMPLETED|Overall Study||3
10080811|NCT02255500|11209140|FG000|STARTED|Overall Study||16
10080812|NCT02255500|11209141|FG001|STARTED|Overall Study||7
10080813|NCT02255500|11209140|FG000|COMPLETED|Overall Study||15
10080814|NCT02255500|11209141|FG001|COMPLETED|Overall Study||7
10080815|NCT02255500|11209140|FG000|NOT COMPLETED|Overall Study||1
10080816|NCT02255500|11209141|FG001|NOT COMPLETED|Overall Study||0
10080817|NCT02255513|11209149|FG000|STARTED|Open-label, Treatment Optimization||43
10080818|NCT02255513|11209150|FG001|STARTED|Open-label, Treatment Optimization||0
10080819|NCT02255513|11209149|FG000|COMPLETED|Open-label, Treatment Optimization||43
10080820|NCT02255513|11209150|FG001|COMPLETED|Open-label, Treatment Optimization||0
10080821|NCT02255513|11209149|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0
10080822|NCT02255513|11209150|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0
10080823|NCT02255513|11209149|FG000|STARTED|Double Blind, Placebo-controlled||22
10080824|NCT02255513|11209150|FG001|STARTED|Double Blind, Placebo-controlled||21
10080825|NCT02255513|11209149|FG000|COMPLETED|Double Blind, Placebo-controlled||22
10080826|NCT02255513|11209150|FG001|COMPLETED|Double Blind, Placebo-controlled||21
10080827|NCT02255513|11209149|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0
10080828|NCT02255513|11209150|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0
10080829|NCT02255552|11209158|FG000|STARTED|Overall Study||79
10080830|NCT02255552|11209159|FG001|STARTED|Overall Study||30
10080831|NCT02255552|11209158|FG000|COMPLETED|Overall Study||78
10080832|NCT02255552|11209159|FG001|COMPLETED|Overall Study||15
10080833|NCT02255552|11209158|FG000|NOT COMPLETED|Overall Study||1
10080834|NCT02255552|11209159|FG001|NOT COMPLETED|Overall Study||15
10080835|NCT02255565|11209168|FG000|STARTED|Overall Study||9
10080836|NCT02255565|11209169|FG001|STARTED|Overall Study||9
10080837|NCT02255565|11209170|FG002|STARTED|Overall Study||9
10080838|NCT02255565|11209168|FG000|COMPLETED|Overall Study||9
10080839|NCT02255565|11209169|FG001|COMPLETED|Overall Study||8
10080840|NCT02255565|11209170|FG002|COMPLETED|Overall Study||9
10080841|NCT02255565|11209168|FG000|NOT COMPLETED|Overall Study||0
10080842|NCT02255565|11209169|FG001|NOT COMPLETED|Overall Study||1
10080843|NCT02255565|11209170|FG002|NOT COMPLETED|Overall Study||0
10080844|NCT02255604|11209214|FG000|STARTED|Overall Study||12
10080845|NCT02255604|11209215|FG001|STARTED|Overall Study||12
10080846|NCT02255604|11209216|FG002|STARTED|Overall Study||12
10080847|NCT02255604|11209214|FG000|COMPLETED|Overall Study||10
10080848|NCT02255604|11209215|FG001|COMPLETED|Overall Study||11
10080849|NCT02255604|11209216|FG002|COMPLETED|Overall Study||9
10080850|NCT02255604|11209214|FG000|NOT COMPLETED|Overall Study||2
10080851|NCT02255604|11209215|FG001|NOT COMPLETED|Overall Study||1
10080852|NCT02255604|11209216|FG002|NOT COMPLETED|Overall Study||3
10080853|NCT02255760|11209229|FG000|STARTED|Overall Study||14
10080854|NCT02255760|11209230|FG001|STARTED|Overall Study||3
10080855|NCT02255760|11209231|FG002|STARTED|Overall Study||15
10080856|NCT02255760|11209232|FG003|STARTED|Overall Study||15
10080857|NCT02255760|11209233|FG004|STARTED|Overall Study||9
10080858|NCT02255760|11209229|FG000|COMPLETED|Overall Study||14
10080859|NCT02255760|11209230|FG001|COMPLETED|Overall Study||2
10080860|NCT02255760|11209231|FG002|COMPLETED|Overall Study||15
10080861|NCT02255760|11209232|FG003|COMPLETED|Overall Study||15
10080862|NCT02255760|11209233|FG004|COMPLETED|Overall Study||9
10080863|NCT02255760|11209229|FG000|NOT COMPLETED|Overall Study||0
10080864|NCT02255760|11209230|FG001|NOT COMPLETED|Overall Study||1
10080865|NCT02255760|11209231|FG002|NOT COMPLETED|Overall Study||0
10080866|NCT02255760|11209232|FG003|NOT COMPLETED|Overall Study||0
10080867|NCT02255760|11209233|FG004|NOT COMPLETED|Overall Study||0
10080868|NCT02255981|11209249|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
10080869|NCT02255981|11209249|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
10080870|NCT02255981|11209249|FG000|NOT COMPLETED|Overall Study||4
10080871|NCT02256072|11209261|FG000|STARTED|Overall Study||194
10080872|NCT02256072|11209262|FG001|STARTED|Overall Study||191
10080873|NCT02256072|11209261|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
10080874|NCT02256072|11209262|FG001|Completed 1 Month Follow-Up|Overall Study||179
10080875|NCT02256072|11209261|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152
10080876|NCT02256072|11209262|FG001|COMPLETED|Overall Study||162
10080877|NCT02256072|11209261|FG000|NOT COMPLETED|Overall Study||42
10080878|NCT02256072|11209262|FG001|NOT COMPLETED|Overall Study||29
10080879|NCT02256111|11209271|FG000|STARTED|Overall Study||13
10080880|NCT02256111|11209272|FG001|STARTED|Overall Study||13
10080881|NCT02256111|11209271|FG000|COMPLETED|Overall Study||13
10080882|NCT02256111|11209272|FG001|COMPLETED|Overall Study||13
10080883|NCT02256111|11209271|FG000|NOT COMPLETED|Overall Study||0
10080884|NCT02256111|11209272|FG001|NOT COMPLETED|Overall Study||0
10080885|NCT02256189|11209281|FG000|STARTED|Overall Study||15
10080886|NCT02256189|11209282|FG001|STARTED|Overall Study||13
10080887|NCT02256189|11209281|FG000|COMPLETED|Overall Study||15
10080888|NCT02256189|11209282|FG001|COMPLETED|Overall Study||13
10080889|NCT02256189|11209281|FG000|NOT COMPLETED|Overall Study||0
10080890|NCT02256189|11209282|FG001|NOT COMPLETED|Overall Study||0
10080891|NCT02256267|11209290|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
10080892|NCT02256267|11209290|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
10080893|NCT02256267|11209290|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
10080894|NCT02256267|11209290|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
10080895|NCT02256267|11209290|FG000|STARTED|Period 2 (Day 1 to Day 6)||23
10080896|NCT02256267|11209290|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
10080897|NCT02256267|11209290|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23
10080898|NCT02256267|11209290|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
10080899|NCT02256267|11209290|FG000|STARTED|Period 2 (Day 7 to Day 14)||23
10080900|NCT02256267|11209290|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
10080901|NCT02256267|11209290|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22
10080902|NCT02256267|11209290|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
10080903|NCT02256345|11209299|FG000|STARTED|Overall Study||9
10080904|NCT02256345|11209300|FG001|STARTED|Overall Study||3
10080905|NCT02256345|11209299|FG000|COMPLETED|Overall Study||9
10080906|NCT02256345|11209300|FG001|COMPLETED|Overall Study||3
10080907|NCT02256345|11209299|FG000|NOT COMPLETED|Overall Study||0
10080908|NCT02256345|11209300|FG001|NOT COMPLETED|Overall Study||0
10080909|NCT02256358|11209308|FG000|STARTED|Overall Study||34
10080910|NCT02256358|11209309|FG001|STARTED|Overall Study||34
10080911|NCT02256358|11209308|FG000|COMPLETED|Overall Study||34
10080912|NCT02256358|11209309|FG001|COMPLETED|Overall Study||33
10080913|NCT02256358|11209308|FG000|NOT COMPLETED|Overall Study||0
10080914|NCT02256358|11209309|FG001|NOT COMPLETED|Overall Study||1
10080915|NCT02256384|11209315|FG000|STARTED|Overall Study||76
10080916|NCT02256384|11209315|FG000|COMPLETED|Overall Study||62
10080917|NCT02256384|11209315|FG000|NOT COMPLETED|Overall Study||14
10080918|NCT02256436|11209325|FG000|STARTED|Overall Study||272
10080919|NCT02256436|11209326|FG001|STARTED|Overall Study||270
10080920|NCT02256436|11209325|FG000|Treated|Overall Study||255
10080921|NCT02256436|11209326|FG001|Treated|Overall Study||266
10080922|NCT02256436|11209325|FG000|Switched Over to Pembrolizumab|Overall Study||13
10080923|NCT02256436|11209326|FG001|Switched Over to Pembrolizumab|Overall Study||0
10080924|NCT02256436|11209325|FG000|COMPLETED|Overall Study||0
10080925|NCT02256436|11209326|FG001|COMPLETED|Overall Study||0
10080926|NCT02256436|11209325|FG000|NOT COMPLETED|Overall Study||272
10080927|NCT02256436|11209326|FG001|NOT COMPLETED|Overall Study||270
10080928|NCT02256488|11209337|FG000|STARTED|Overall Study||387
10080929|NCT02256488|11209338|FG001|STARTED|Overall Study||392
10080930|NCT02256488|11209339|FG002|STARTED|Overall Study||392
10080931|NCT02256488|11209340|FG003|STARTED|Overall Study||390
10080932|NCT02256488|11209337|FG000|COMPLETED|Overall Study||379
10080933|NCT02256488|11209338|FG001|COMPLETED|Overall Study||386
10080934|NCT02256488|11209339|FG002|COMPLETED|Overall Study||382
10080935|NCT02256488|11209340|FG003|COMPLETED|Overall Study||384
10080936|NCT02256488|11209337|FG000|NOT COMPLETED|Overall Study||8
10080937|NCT02256488|11209338|FG001|NOT COMPLETED|Overall Study||6
10080938|NCT02256488|11209339|FG002|NOT COMPLETED|Overall Study||10
10080939|NCT02256488|11209340|FG003|NOT COMPLETED|Overall Study||6
10080940|NCT02256540|11209351|FG000|STARTED|Overall Study||6
10080941|NCT02256540|11209352|FG001|STARTED|Overall Study||6
10080942|NCT02256540|11209353|FG002|STARTED|Overall Study||6
10080943|NCT02256540|11209351|FG000|COMPLETED|Overall Study||6
10080944|NCT02256540|11209352|FG001|COMPLETED|Overall Study||5
10080945|NCT02256540|11209353|FG002|COMPLETED|Overall Study||4
10080946|NCT02256540|11209351|FG000|NOT COMPLETED|Overall Study||0
10080947|NCT02256540|11209352|FG001|NOT COMPLETED|Overall Study||1
10080948|NCT02256540|11209353|FG002|NOT COMPLETED|Overall Study||2
10080949|NCT02256553|11209361|FG000|STARTED|Period I||102
10080950|NCT02256553|11209361|FG000|COMPLETED|Period I||96
10080951|NCT02256553|11209361|FG000|NOT COMPLETED|Period I||6
10080952|NCT02256553|11209361|FG000|STARTED|Period II||96
10080953|NCT02256553|11209361|FG000|COMPLETED|Period II||94
10080954|NCT02256553|11209361|FG000|NOT COMPLETED|Period II||2
10080955|NCT02256553|11209361|FG000|STARTED|Period III||94
10080956|NCT02256553|11209361|FG000|COMPLETED|Period III||91
10080957|NCT02256553|11209361|FG000|NOT COMPLETED|Period III||3
10080958|NCT02256839|11209369|FG000|STARTED|Overall Study||53
10080959|NCT02256839|11209370|FG001|STARTED|Overall Study||215
10080960|NCT02256839|11209369|FG000|COMPLETED|Overall Study||51
10080961|NCT02256839|11209370|FG001|COMPLETED|Overall Study||212
10080962|NCT02256839|11209369|FG000|NOT COMPLETED|Overall Study||2
10080963|NCT02256839|11209370|FG001|NOT COMPLETED|Overall Study||3
10080964|NCT02256891|11209378|FG000|STARTED|Overall Study||55
10080965|NCT02256891|11209379|FG001|STARTED|Overall Study||42
10080966|NCT02256891|11209378|FG000|COMPLETED|Overall Study||43
10080967|NCT02256891|11209379|FG001|COMPLETED|Overall Study||29
10080968|NCT02256891|11209378|FG000|NOT COMPLETED|Overall Study||12
10080969|NCT02256891|11209379|FG001|NOT COMPLETED|Overall Study||13
10080970|NCT02256917|11209387|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
10080971|NCT02256917|11209387|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
10080972|NCT02256917|11209387|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
10080973|NCT02256917|11209387|FG000|STARTED|Prophylactic Treatment Phase I||57
10080974|NCT02256917|11209387|FG000|COMPLETED|Prophylactic Treatment Phase I||56
10080975|NCT02256917|11209387|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1
10080976|NCT02256917|11209387|FG000|STARTED|Prophylactic Treatment Phase II||56
10080977|NCT02256917|11209387|FG000|COMPLETED|Prophylactic Treatment Phase II||52
10080978|NCT02256917|11209387|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4
10080979|NCT02256969|11209401|FG000|STARTED|Overall Study||15
10080980|NCT02256969|11209402|FG001|STARTED|Overall Study||15
10080981|NCT02256969|11209403|FG002|STARTED|Overall Study||15
10080982|NCT02256969|11209401|FG000|COMPLETED|Overall Study||13
10080983|NCT02256969|11209402|FG001|COMPLETED|Overall Study||14
10080984|NCT02256969|11209403|FG002|COMPLETED|Overall Study||14
10080985|NCT02256969|11209401|FG000|NOT COMPLETED|Overall Study||2
10080986|NCT02256969|11209402|FG001|NOT COMPLETED|Overall Study||1
10080987|NCT02256969|11209403|FG002|NOT COMPLETED|Overall Study||1
10080988|NCT02256982|11209413|FG000|STARTED|Overall Study||1
10080989|NCT02256982|11209414|FG001|STARTED|Overall Study||2
10080990|NCT02256982|11209413|FG000|COMPLETED|Overall Study||1
10080991|NCT02256982|11209414|FG001|COMPLETED|Overall Study||1
10080992|NCT02256982|11209413|FG000|NOT COMPLETED|Overall Study||0
10080993|NCT02256982|11209414|FG001|NOT COMPLETED|Overall Study||1
10080994|NCT02257099|11209420|FG000|STARTED|Overall Study||20
10080995|NCT02257099|11209420|FG000|COMPLETED|Overall Study||20
10080996|NCT02257099|11209420|FG000|NOT COMPLETED|Overall Study||0
10080997|NCT02257177|11209437|FG000|STARTED|Overall Study||4
10080998|NCT02257177|11209438|FG001|STARTED|Overall Study||4
10080999|NCT02257177|11209439|FG002|STARTED|Overall Study||4
10081000|NCT02257177|11209440|FG003|STARTED|Overall Study||4
10081001|NCT02257177|11209441|FG004|STARTED|Overall Study||4
10081002|NCT02257177|11209442|FG005|STARTED|Overall Study||4
10081003|NCT02257177|11209443|FG006|STARTED|Overall Study||12
10081004|NCT02257177|11209444|FG007|STARTED|Overall Study||5
10081005|NCT02257177|11209445|FG008|STARTED|Overall Study||5
10081006|NCT02257177|11209446|FG009|STARTED|Overall Study||5
10081007|NCT02257177|11209447|FG010|STARTED|Overall Study||9
10081008|NCT02257177|11209437|FG000|COMPLETED|Overall Study||4
10081009|NCT02257177|11209438|FG001|COMPLETED|Overall Study||4
10081010|NCT02257177|11209439|FG002|COMPLETED|Overall Study||4
10081011|NCT02257177|11209440|FG003|COMPLETED|Overall Study||4
10081012|NCT02257177|11209441|FG004|COMPLETED|Overall Study||4
10081013|NCT02257177|11209442|FG005|COMPLETED|Overall Study||4
10081014|NCT02257177|11209443|FG006|COMPLETED|Overall Study||12
10081015|NCT02257177|11209444|FG007|COMPLETED|Overall Study||5
10081016|NCT02257177|11209445|FG008|COMPLETED|Overall Study||5
10081017|NCT02257177|11209446|FG009|COMPLETED|Overall Study||4
10081018|NCT02257177|11209447|FG010|COMPLETED|Overall Study||9
10081019|NCT02257177|11209437|FG000|NOT COMPLETED|Overall Study||0
10081020|NCT02257177|11209438|FG001|NOT COMPLETED|Overall Study||0
10081021|NCT02257177|11209439|FG002|NOT COMPLETED|Overall Study||0
10081022|NCT02257177|11209440|FG003|NOT COMPLETED|Overall Study||0
10081023|NCT02257177|11209441|FG004|NOT COMPLETED|Overall Study||0
10081024|NCT02257177|11209442|FG005|NOT COMPLETED|Overall Study||0
10081025|NCT02257177|11209443|FG006|NOT COMPLETED|Overall Study||0
10081026|NCT02257177|11209444|FG007|NOT COMPLETED|Overall Study||0
10081027|NCT02257177|11209445|FG008|NOT COMPLETED|Overall Study||0
10081028|NCT02257177|11209446|FG009|NOT COMPLETED|Overall Study||1
10081029|NCT02257177|11209447|FG010|NOT COMPLETED|Overall Study||0
10081030|NCT02257372|11209473|FG000|STARTED|Overall Study||117
10081031|NCT02257372|11209474|FG001|STARTED|Overall Study||119
10081032|NCT02257372|11209473|FG000|COMPLETED|Overall Study||110
10081033|NCT02257372|11209474|FG001|COMPLETED|Overall Study||109
10081034|NCT02257372|11209473|FG000|NOT COMPLETED|Overall Study||7
10081035|NCT02257372|11209474|FG001|NOT COMPLETED|Overall Study||10
10081036|NCT02257385|11209482|FG000|STARTED|Overall Study||482
10081037|NCT02257385|11209483|FG001|STARTED|Overall Study||479
10081038|NCT02257385|11209482|FG000|COMPLETED|Overall Study||460
10081039|NCT02257385|11209483|FG001|COMPLETED|Overall Study||457
10081040|NCT02257385|11209482|FG000|NOT COMPLETED|Overall Study||22
10081041|NCT02257385|11209483|FG001|NOT COMPLETED|Overall Study||22
10081042|NCT02257489|11209498|FG000|STARTED|Overall Study||6
10081043|NCT02257489|11209499|FG001|STARTED|Overall Study||6
10081044|NCT02257489|11209500|FG002|STARTED|Overall Study||6
10081045|NCT02257489|11209501|FG003|STARTED|Overall Study||6
10081046|NCT02257489|11209502|FG004|STARTED|Overall Study||6
10081047|NCT02257489|11209503|FG005|STARTED|Overall Study||6
10081048|NCT02257489|11209504|FG006|STARTED|Overall Study||6
10081049|NCT02257489|11209505|FG007|STARTED|Overall Study||10
10081050|NCT02257489|11209506|FG008|STARTED|Overall Study||6
10081051|NCT02257489|11209498|FG000|COMPLETED|Overall Study||6
10081052|NCT02257489|11209499|FG001|COMPLETED|Overall Study||6
10081053|NCT02257489|11209500|FG002|COMPLETED|Overall Study||6
10081054|NCT02257489|11209501|FG003|COMPLETED|Overall Study||5
10081055|NCT02257489|11209502|FG004|COMPLETED|Overall Study||6
10081056|NCT02257489|11209503|FG005|COMPLETED|Overall Study||6
10081057|NCT02257489|11209504|FG006|COMPLETED|Overall Study||6
10081058|NCT02257489|11209505|FG007|COMPLETED|Overall Study||10
10081059|NCT02257489|11209506|FG008|COMPLETED|Overall Study||6
10081060|NCT02257489|11209498|FG000|NOT COMPLETED|Overall Study||0
10081061|NCT02257489|11209499|FG001|NOT COMPLETED|Overall Study||0
10081062|NCT02257489|11209500|FG002|NOT COMPLETED|Overall Study||0
10081063|NCT02257489|11209501|FG003|NOT COMPLETED|Overall Study||1
10081064|NCT02257489|11209502|FG004|NOT COMPLETED|Overall Study||0
10081065|NCT02257489|11209503|FG005|NOT COMPLETED|Overall Study||0
10081066|NCT02257489|11209504|FG006|NOT COMPLETED|Overall Study||0
10081067|NCT02257489|11209505|FG007|NOT COMPLETED|Overall Study||0
10081068|NCT02257489|11209506|FG008|NOT COMPLETED|Overall Study||0
10081069|NCT02257541|11209531|FG000|STARTED|Overall Study||3
10081070|NCT02257541|11209532|FG001|STARTED|Overall Study||8
10081071|NCT02257541|11209533|FG002|STARTED|Overall Study||1
10081072|NCT02257541|11209534|FG003|STARTED|Overall Study||3
10081073|NCT02257541|11209535|FG004|STARTED|Overall Study||1
10081074|NCT02257541|11209531|FG000|COMPLETED|Overall Study||3
10081075|NCT02257541|11209532|FG001|COMPLETED|Overall Study||8
10081076|NCT02257541|11209533|FG002|COMPLETED|Overall Study||1
10081077|NCT02257541|11209534|FG003|COMPLETED|Overall Study||3
10081078|NCT02257541|11209535|FG004|COMPLETED|Overall Study||1
10081079|NCT02257541|11209531|FG000|NOT COMPLETED|Overall Study||0
10081080|NCT02257541|11209532|FG001|NOT COMPLETED|Overall Study||0
10081081|NCT02257541|11209533|FG002|NOT COMPLETED|Overall Study||0
10081082|NCT02257541|11209534|FG003|NOT COMPLETED|Overall Study||0
10081083|NCT02257541|11209535|FG004|NOT COMPLETED|Overall Study||0
10081084|NCT02257632|11209548|FG000|STARTED|Overall Study||19
10081085|NCT02257632|11209549|FG001|STARTED|Overall Study||22
10081086|NCT02257632|11209548|FG000|Full Analysis Set (FAS)|Overall Study||19
10081087|NCT02257632|11209549|FG001|Full Analysis Set (FAS)|Overall Study||21
10081088|NCT02257632|11209548|FG000|Safety Set (SAF)|Overall Study||19
10081089|NCT02257632|11209549|FG001|Safety Set (SAF)|Overall Study||21
10081090|NCT02257632|11209548|FG000|Per-Protocol Set (PPS)|Overall Study||17
10081091|NCT02257632|11209549|FG001|Per-Protocol Set (PPS)|Overall Study||20
10081092|NCT02257632|11209548|FG000|COMPLETED|Overall Study||18
10081093|NCT02257632|11209549|FG001|COMPLETED|Overall Study||19
10081094|NCT02257632|11209548|FG000|NOT COMPLETED|Overall Study||1
10081095|NCT02257632|11209549|FG001|NOT COMPLETED|Overall Study||3
10195980|NCT03357614|11324370|FG000|COMPLETED|Overall Study||672
10195981|NCT03357614|11324371|FG001|COMPLETED|Overall Study||670
10195982|NCT03357614|11324370|FG000|NOT COMPLETED|Overall Study||25
10195983|NCT03357614|11324371|FG001|NOT COMPLETED|Overall Study||28
10195984|NCT03357731|11324377|FG000|STARTED|Overall Study||8
10195985|NCT03357731|11324378|FG001|STARTED|Overall Study||7
10195986|NCT03357731|11324379|FG002|STARTED|Overall Study||7
10195987|NCT03357731|11324380|FG003|STARTED|Overall Study||7
10195988|NCT03357731|11324381|FG004|STARTED|Overall Study||8
10195989|NCT03357731|11324382|FG005|STARTED|Overall Study||8
10195990|NCT03357731|11324377|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
10195991|NCT03357731|11324378|FG001|Completed Period 1 (P1)|Overall Study||7
10195992|NCT03357731|11324379|FG002|Completed Period 1 (P1)|Overall Study||7
10195993|NCT03357731|11324380|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
10195994|NCT03357731|11324381|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
10195995|NCT03357731|11324382|FG005|Completed Period 1 (P1)|Overall Study||8
10195996|NCT03357731|11324377|FG000|Completed Period 2 (P2)|Overall Study||8
10195997|NCT03357731|11324378|FG001|Completed Period 2 (P2)|Overall Study||7
10195998|NCT03357731|11324379|FG002|Completed Period 2 (P2)|Overall Study||7
10195999|NCT03357731|11324380|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
10196000|NCT03357731|11324381|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
10196001|NCT03357731|11324382|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
10196002|NCT03357731|11324377|FG000|COMPLETED|Overall Study||8
10196003|NCT03357731|11324378|FG001|COMPLETED|Overall Study||7
10196004|NCT03357731|11324379|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
10196005|NCT03357731|11324380|FG003|COMPLETED|Overall Study||4
10196006|NCT03357731|11324381|FG004|COMPLETED|Overall Study||7
10196007|NCT03357731|11324382|FG005|COMPLETED|Overall Study||7
10196008|NCT03357731|11324377|FG000|NOT COMPLETED|Overall Study||0
10196009|NCT03357731|11324378|FG001|NOT COMPLETED|Overall Study||0
10196010|NCT03357731|11324379|FG002|NOT COMPLETED|Overall Study||1
10196011|NCT03357731|11324380|FG003|NOT COMPLETED|Overall Study||3
10196012|NCT03357731|11324381|FG004|NOT COMPLETED|Overall Study||1
10196013|NCT03357731|11324382|FG005|NOT COMPLETED|Overall Study||1
10196014|NCT03358147|11324395|FG000|STARTED|Overall Study||235
10196015|NCT03358147|11324396|FG001|STARTED|Overall Study||240
10196016|NCT03358147|11324397|FG002|STARTED|Overall Study||240
10196017|NCT03358147|11324398|FG003|STARTED|Overall Study||237
10196018|NCT03358147|11324399|FG004|STARTED|Overall Study||119
10196019|NCT03358147|11324395|FG000|COMPLETED|Overall Study||201
10196020|NCT03358147|11324396|FG001|COMPLETED|Overall Study||201
10196021|NCT03358147|11324397|FG002|COMPLETED|Overall Study||206
10196022|NCT03358147|11324398|FG003|COMPLETED|Overall Study||201
9967060|NCT01513291|11087508|FG004|STARTED|Treatment Period||0
9967061|NCT01513291|11087504|FG000|Treated|Treatment Period||120
9967062|NCT01513291|11087505|FG001|Treated|Treatment Period||115
9967063|NCT01513291|11087506|FG002|Treated|Treatment Period||0
9967064|NCT01513291|11087507|FG003|Treated|Treatment Period||0
9967065|NCT01513291|11087508|FG004|Treated|Treatment Period||0
9967066|NCT01513291|11087504|FG000|COMPLETED|Treatment Period||97
9967067|NCT01513291|11087505|FG001|COMPLETED|Treatment Period||101
9967068|NCT01513291|11087506|FG002|COMPLETED|Treatment Period||0
9967069|NCT01513291|11087507|FG003|COMPLETED|Treatment Period||0
9967070|NCT01513291|11087508|FG004|COMPLETED|Treatment Period||0
9967071|NCT01513291|11087504|FG000|NOT COMPLETED|Treatment Period||23
9967072|NCT01513291|11087505|FG001|NOT COMPLETED|Treatment Period||16
9967073|NCT01513291|11087506|FG002|NOT COMPLETED|Treatment Period||0
9967074|NCT01513291|11087507|FG003|NOT COMPLETED|Treatment Period||0
9967075|NCT01513291|11087508|FG004|NOT COMPLETED|Treatment Period||0
9967076|NCT01513291|11087504|FG000|STARTED|Run-out Period||0
9967077|NCT01513291|11087505|FG001|STARTED|Run-out Period||0
9967078|NCT01513291|11087506|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
9967079|NCT01513291|11087507|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
9967080|NCT01513291|11087508|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
9967081|NCT01513291|11087504|FG000|COMPLETED|Run-out Period||0
9967082|NCT01513291|11087505|FG001|COMPLETED|Run-out Period||0
9967083|NCT01513291|11087506|FG002|COMPLETED|Run-out Period||50
9967084|NCT01513291|11087507|FG003|COMPLETED|Run-out Period||45
9967085|NCT01513291|11087508|FG004|COMPLETED|Run-out Period||101
9967086|NCT01513291|11087504|FG000|NOT COMPLETED|Run-out Period||0
9967087|NCT01513291|11087505|FG001|NOT COMPLETED|Run-out Period||0
9967088|NCT01513291|11087506|FG002|NOT COMPLETED|Run-out Period||0
9967089|NCT01513291|11087507|FG003|NOT COMPLETED|Run-out Period||2
9967090|NCT01513291|11087508|FG004|NOT COMPLETED|Run-out Period||0
9967091|NCT01513317|11087522|FG000|STARTED|Overall Study||50
9967092|NCT01513317|11087523|FG001|STARTED|Overall Study||26
9967093|NCT01513317|11087522|FG000|COMPLETED|Overall Study||16
9967094|NCT01513317|11087523|FG001|COMPLETED|Overall Study||2
9967095|NCT01513317|11087522|FG000|NOT COMPLETED|Overall Study||34
9967096|NCT01513317|11087523|FG001|NOT COMPLETED|Overall Study||24
9967097|NCT01513330|11087529|FG000|STARTED|SenSura Mio First,||64
9967098|NCT01513330|11087530|FG001|STARTED|SenSura Mio First,||58
9967099|NCT01513330|11087529|FG000|COMPLETED|SenSura Mio First,||60
9967100|NCT01513330|11087530|FG001|COMPLETED|SenSura Mio First,||56
9967101|NCT01513330|11087529|FG000|NOT COMPLETED|SenSura Mio First,||4
9967102|NCT01513330|11087530|FG001|NOT COMPLETED|SenSura Mio First,||2
9967103|NCT01513330|11087529|FG000|STARTED|Standard Care First,||60
9967104|NCT01513330|11087530|FG001|STARTED|Standard Care First,||56
9967105|NCT01513330|11087529|FG000|COMPLETED|Standard Care First,||56
9967106|NCT01513330|11087530|FG001|COMPLETED|Standard Care First,||52
9967107|NCT01513330|11087529|FG000|NOT COMPLETED|Standard Care First,||4
9967108|NCT01513330|11087530|FG001|NOT COMPLETED|Standard Care First,||4
9967109|NCT01513447|11087538|FG000|STARTED|Overall Study||3
9967110|NCT01513447|11087539|FG001|STARTED|Overall Study||5
9967111|NCT01513447|11087538|FG000|COMPLETED|Overall Study||3
9967112|NCT01513447|11087539|FG001|COMPLETED|Overall Study||5
9967113|NCT01513447|11087538|FG000|NOT COMPLETED|Overall Study||0
9967114|NCT01513447|11087539|FG001|NOT COMPLETED|Overall Study||0
9967115|NCT01513460|11087548|FG000|STARTED|Overall Study||258
9967116|NCT01513460|11087549|FG001|STARTED|Overall Study||258
9967117|NCT01513460|11087550|FG002|STARTED|Overall Study||257
9967118|NCT01513460|11087548|FG000|Full Analysis Set|Overall Study||257
9967119|NCT01513460|11087549|FG001|Full Analysis Set|Overall Study||258
9967120|NCT01513460|11087550|FG002|Full Analysis Set|Overall Study||257
9967121|NCT01513460|11087548|FG000|Per-protocol Set|Overall Study||196
9967122|NCT01513460|11087549|FG001|Per-protocol Set|Overall Study||186
9967123|NCT01513460|11087550|FG002|Per-protocol Set|Overall Study||166
9967124|NCT01513460|11087548|FG000|COMPLETED|Overall Study||229
9967125|NCT01513460|11087549|FG001|COMPLETED|Overall Study||226
9967126|NCT01513460|11087550|FG002|COMPLETED|Overall Study||201
9967127|NCT01513460|11087548|FG000|NOT COMPLETED|Overall Study||29
9967128|NCT01513460|11087549|FG001|NOT COMPLETED|Overall Study||32
9967129|NCT01513460|11087550|FG002|NOT COMPLETED|Overall Study||56
9967130|NCT01513473|11087562|FG000|STARTED|Main Trial (26 Weeks)||174
9967131|NCT01513473|11087563|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
9967132|NCT01513473|11087562|FG000|Exposed|Main Trial (26 Weeks)||174
9967133|NCT01513473|11087563|FG001|Exposed|Main Trial (26 Weeks)||175
9967134|NCT01513473|11087562|FG000|COMPLETED|Main Trial (26 Weeks)||170
9967135|NCT01513473|11087563|FG001|COMPLETED|Main Trial (26 Weeks)||165
9967136|NCT01513473|11087562|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4
9967137|NCT01513473|11087563|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11
9967138|NCT01513473|11087562|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
9967139|NCT01513473|11087563|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
9967140|NCT01513473|11087562|FG000|COMPLETED|Extension Trial (26 Weeks)||151
9967141|NCT01513473|11087563|FG001|COMPLETED|Extension Trial (26 Weeks)||122
9967142|NCT01513473|11087562|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1
9967143|NCT01513473|11087563|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6
9967144|NCT01513538|11087569|FG000|STARTED|Overall Study||578
9967145|NCT01513538|11087569|FG000|COMPLETED|Overall Study||573
9967146|NCT01513538|11087569|FG000|NOT COMPLETED|Overall Study||5
9967147|NCT01513551|11087576|FG000|STARTED|Overall Study||230
9967148|NCT01513551|11087577|FG001|STARTED|Overall Study||231
9967149|NCT01513551|11087578|FG002|STARTED|Overall Study||231
9967150|NCT01513551|11087576|FG000|Vaccinated|Overall Study||230
9967151|NCT01513551|11087577|FG001|Vaccinated|Overall Study||231
9967152|NCT01513551|11087578|FG002|Vaccinated|Overall Study||230
9967153|NCT01513551|11087576|FG000|COMPLETED|Overall Study||226
9967154|NCT01513551|11087577|FG001|COMPLETED|Overall Study||225
9967155|NCT01513551|11087578|FG002|COMPLETED|Overall Study||226
9967156|NCT01513551|11087576|FG000|NOT COMPLETED|Overall Study||4
9967157|NCT01513551|11087577|FG001|NOT COMPLETED|Overall Study||6
9967158|NCT01513551|11087578|FG002|NOT COMPLETED|Overall Study||5
9967159|NCT01513590|11087588|FG000|STARTED|Overall Study||197
9967160|NCT01513590|11087589|FG001|STARTED|Overall Study||197
9967161|NCT01513590|11087588|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
9967162|NCT01513590|11087589|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
9967163|NCT01513590|11087588|FG000|COMPLETED|Overall Study||187
9967164|NCT01513590|11087589|FG001|COMPLETED|Overall Study||184
9967165|NCT01513590|11087588|FG000|NOT COMPLETED|Overall Study||10
9967166|NCT01513590|11087589|FG001|NOT COMPLETED|Overall Study||13
9967167|NCT01513759|11087595|FG000|STARTED|Overall Study||150
9967168|NCT01513759|11087595|FG000|At Least One Device Successfully Placed|Overall Study||149
9967169|NCT01513759|11087595|FG000|COMPLETED|Overall Study||145
9967170|NCT01513759|11087595|FG000|NOT COMPLETED|Overall Study||5
9967171|NCT01513902|11087602|FG000|STARTED|Overall Study||8
9967172|NCT01513902|11087603|FG001|STARTED|Overall Study||9
9967173|NCT01513902|11087604|FG002|STARTED|Overall Study||9
9967174|NCT01513902|11087602|FG000|COMPLETED|Overall Study||8
9967175|NCT01513902|11087603|FG001|COMPLETED|Overall Study||9
9967176|NCT01513902|11087604|FG002|COMPLETED|Overall Study||9
9967177|NCT01513902|11087602|FG000|NOT COMPLETED|Overall Study||0
9967178|NCT01513902|11087603|FG001|NOT COMPLETED|Overall Study||0
9967179|NCT01513902|11087604|FG002|NOT COMPLETED|Overall Study||0
9967180|NCT01513967|11087620|FG000|STARTED|Overall Study||4
9967181|NCT01513967|11087621|FG001|STARTED|Overall Study||4
9967182|NCT01513967|11087622|FG002|STARTED|Overall Study||4
9967183|NCT01513967|11087623|FG003|STARTED|Overall Study||6
9967184|NCT01513967|11087624|FG004|STARTED|Overall Study||4
9967185|NCT01513967|11087625|FG005|STARTED|Overall Study||4
9967186|NCT01513967|11087626|FG006|STARTED|Overall Study||5
9967187|NCT01513967|11087627|FG007|STARTED|Overall Study||8
9967188|NCT01513967|11087620|FG000|COMPLETED|Overall Study||4
9967189|NCT01513967|11087621|FG001|COMPLETED|Overall Study||4
9967190|NCT01513967|11087622|FG002|COMPLETED|Overall Study||4
9967191|NCT01513967|11087623|FG003|COMPLETED|Overall Study||6
9967192|NCT01513967|11087624|FG004|COMPLETED|Overall Study||4
9967193|NCT01513967|11087625|FG005|COMPLETED|Overall Study||3
9967194|NCT01513967|11087626|FG006|COMPLETED|Overall Study||3
9967195|NCT01513967|11087627|FG007|COMPLETED|Overall Study||6
9967196|NCT01513967|11087620|FG000|NOT COMPLETED|Overall Study||0
9967197|NCT01513967|11087621|FG001|NOT COMPLETED|Overall Study||0
9967198|NCT01513967|11087622|FG002|NOT COMPLETED|Overall Study||0
9967199|NCT01513967|11087623|FG003|NOT COMPLETED|Overall Study||0
9967200|NCT01513967|11087624|FG004|NOT COMPLETED|Overall Study||0
9967201|NCT01513967|11087625|FG005|NOT COMPLETED|Overall Study||1
9967202|NCT01513967|11087626|FG006|NOT COMPLETED|Overall Study||2
9967203|NCT01513967|11087627|FG007|NOT COMPLETED|Overall Study||2
9967204|NCT01514136|11087647|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
9967205|NCT01514136|11087648|FG001|STARTED|Test Period 1; Test A||0
9967206|NCT01514136|11087649|FG002|STARTED|Test Period 1; Test A||0
9967207|NCT01514136|11087650|FG003|STARTED|Test Period 1; Test A||0
9967208|NCT01514136|11087651|FG004|STARTED|Test Period 1; Test A||0
9967209|NCT01514136|11087652|FG005|STARTED|Test Period 1; Test A||0
9967210|NCT01514136|11087653|FG006|STARTED|Test Period 1; Test A||0
9967211|NCT01514136|11087654|FG007|STARTED|Test Period 1; Test A||0
9967212|NCT01514136|11087647|FG000|COMPLETED|Test Period 1; Test A||22
9967213|NCT01514136|11087648|FG001|COMPLETED|Test Period 1; Test A||0
9967214|NCT01514136|11087649|FG002|COMPLETED|Test Period 1; Test A||0
9967215|NCT01514136|11087650|FG003|COMPLETED|Test Period 1; Test A||0
9967216|NCT01514136|11087651|FG004|COMPLETED|Test Period 1; Test A||0
9967217|NCT01514136|11087652|FG005|COMPLETED|Test Period 1; Test A||0
9967218|NCT01514136|11087653|FG006|COMPLETED|Test Period 1; Test A||0
9967219|NCT01514136|11087654|FG007|COMPLETED|Test Period 1; Test A||0
9967220|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period 1; Test A||3
9967221|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period 1; Test A||0
9967222|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period 1; Test A||0
9967223|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period 1; Test A||0
9967224|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period 1; Test A||0
9967225|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period 1; Test A||0
9967226|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period 1; Test A||0
9967227|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period 1; Test A||0
9967228|NCT01514136|11087647|FG000|STARTED|Test Period 1; Test B||0
9967229|NCT01514136|11087648|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
9967230|NCT01514136|11087649|FG002|STARTED|Test Period 1; Test B||0
9967231|NCT01514136|11087650|FG003|STARTED|Test Period 1; Test B||0
9967232|NCT01514136|11087651|FG004|STARTED|Test Period 1; Test B||0
9967233|NCT01514136|11087652|FG005|STARTED|Test Period 1; Test B||0
9967234|NCT01514136|11087653|FG006|STARTED|Test Period 1; Test B||0
9967235|NCT01514136|11087654|FG007|STARTED|Test Period 1; Test B||0
9967236|NCT01514136|11087647|FG000|COMPLETED|Test Period 1; Test B||0
9967237|NCT01514136|11087648|FG001|COMPLETED|Test Period 1; Test B||23
9967238|NCT01514136|11087649|FG002|COMPLETED|Test Period 1; Test B||0
9967239|NCT01514136|11087650|FG003|COMPLETED|Test Period 1; Test B||0
9967240|NCT01514136|11087651|FG004|COMPLETED|Test Period 1; Test B||0
9967241|NCT01514136|11087652|FG005|COMPLETED|Test Period 1; Test B||0
9967242|NCT01514136|11087653|FG006|COMPLETED|Test Period 1; Test B||0
9967243|NCT01514136|11087654|FG007|COMPLETED|Test Period 1; Test B||0
9967244|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period 1; Test B||0
9967245|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period 1; Test B||1
9967246|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period 1; Test B||0
9967247|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period 1; Test B||0
9967248|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period 1; Test B||0
9967249|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period 1; Test B||0
9967250|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period 1; Test B||0
9967251|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period 1; Test B||0
9967252|NCT01514136|11087647|FG000|STARTED|Test Period 1; Test C||0
9967253|NCT01514136|11087648|FG001|STARTED|Test Period 1; Test C||0
9967254|NCT01514136|11087649|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
9967255|NCT01514136|11087650|FG003|STARTED|Test Period 1; Test C||0
9967256|NCT01514136|11087651|FG004|STARTED|Test Period 1; Test C||0
9967257|NCT01514136|11087652|FG005|STARTED|Test Period 1; Test C||0
9967258|NCT01514136|11087653|FG006|STARTED|Test Period 1; Test C||0
9967259|NCT01514136|11087654|FG007|STARTED|Test Period 1; Test C||0
9967260|NCT01514136|11087647|FG000|COMPLETED|Test Period 1; Test C||0
9967261|NCT01514136|11087648|FG001|COMPLETED|Test Period 1; Test C||0
9967262|NCT01514136|11087649|FG002|COMPLETED|Test Period 1; Test C||24
9967263|NCT01514136|11087650|FG003|COMPLETED|Test Period 1; Test C||0
9967264|NCT01514136|11087651|FG004|COMPLETED|Test Period 1; Test C||0
9967265|NCT01514136|11087652|FG005|COMPLETED|Test Period 1; Test C||0
9967266|NCT01514136|11087653|FG006|COMPLETED|Test Period 1; Test C||0
9967267|NCT01514136|11087654|FG007|COMPLETED|Test Period 1; Test C||0
9967268|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period 1; Test C||0
9967269|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period 1; Test C||0
9967270|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period 1; Test C||0
9967271|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period 1; Test C||0
9967272|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period 1; Test C||0
9967273|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period 1; Test C||0
9967274|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period 1; Test C||0
9967275|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period 1; Test C||0
9967276|NCT01514136|11087647|FG000|STARTED|Test Period 1; Test D||0
9967277|NCT01514136|11087648|FG001|STARTED|Test Period 1; Test D||0
9967278|NCT01514136|11087649|FG002|STARTED|Test Period 1; Test D||0
9967279|NCT01514136|11087650|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
9967280|NCT01514136|11087651|FG004|STARTED|Test Period 1; Test D||0
9967281|NCT01514136|11087652|FG005|STARTED|Test Period 1; Test D||0
9967282|NCT01514136|11087653|FG006|STARTED|Test Period 1; Test D||0
9967283|NCT01514136|11087654|FG007|STARTED|Test Period 1; Test D||0
9967284|NCT01514136|11087647|FG000|COMPLETED|Test Period 1; Test D||0
9967285|NCT01514136|11087648|FG001|COMPLETED|Test Period 1; Test D||0
9967286|NCT01514136|11087649|FG002|COMPLETED|Test Period 1; Test D||0
9967287|NCT01514136|11087650|FG003|COMPLETED|Test Period 1; Test D||24
9967288|NCT01514136|11087651|FG004|COMPLETED|Test Period 1; Test D||0
9967289|NCT01514136|11087652|FG005|COMPLETED|Test Period 1; Test D||0
9967290|NCT01514136|11087653|FG006|COMPLETED|Test Period 1; Test D||0
9967291|NCT01514136|11087654|FG007|COMPLETED|Test Period 1; Test D||0
9967292|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period 1; Test D||0
9967293|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period 1; Test D||0
9967294|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period 1; Test D||0
9967295|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period 1; Test D||2
9967296|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period 1; Test D||0
9967297|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period 1; Test D||0
9967298|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period 1; Test D||0
9967299|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period 1; Test D||0
9967300|NCT01514136|11087647|FG000|STARTED|Test Period 2; Test A*||0
9967301|NCT01514136|11087648|FG001|STARTED|Test Period 2; Test A*||0
9967302|NCT01514136|11087649|FG002|STARTED|Test Period 2; Test A*||0
9967303|NCT01514136|11087650|FG003|STARTED|Test Period 2; Test A*||0
9967304|NCT01514136|11087651|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
9967305|NCT01514136|11087652|FG005|STARTED|Test Period 2; Test A*||0
9967306|NCT01514136|11087653|FG006|STARTED|Test Period 2; Test A*||0
9967307|NCT01514136|11087654|FG007|STARTED|Test Period 2; Test A*||0
9967308|NCT01514136|11087647|FG000|COMPLETED|Test Period 2; Test A*||0
9967309|NCT01514136|11087648|FG001|COMPLETED|Test Period 2; Test A*||0
9967310|NCT01514136|11087649|FG002|COMPLETED|Test Period 2; Test A*||0
9967311|NCT01514136|11087650|FG003|COMPLETED|Test Period 2; Test A*||0
9967312|NCT01514136|11087651|FG004|COMPLETED|Test Period 2; Test A*||26
9967313|NCT01514136|11087652|FG005|COMPLETED|Test Period 2; Test A*||0
9967314|NCT01514136|11087653|FG006|COMPLETED|Test Period 2; Test A*||0
9967315|NCT01514136|11087654|FG007|COMPLETED|Test Period 2; Test A*||0
9967316|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period 2; Test A*||0
9967317|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period 2; Test A*||0
9967318|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period 2; Test A*||0
9967319|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period 2; Test A*||0
9967320|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period 2; Test A*||2
9967321|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period 2; Test A*||0
9967322|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period 2; Test A*||0
9967323|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period 2; Test A*||0
9967324|NCT01514136|11087647|FG000|STARTED|Test Period 2; Test B*||0
9967325|NCT01514136|11087648|FG001|STARTED|Test Period 2; Test B*||0
9967326|NCT01514136|11087649|FG002|STARTED|Test Period 2; Test B*||0
9967327|NCT01514136|11087650|FG003|STARTED|Test Period 2; Test B*||0
9967328|NCT01514136|11087651|FG004|STARTED|Test Period 2; Test B*||0
9967329|NCT01514136|11087652|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
9967330|NCT01514136|11087653|FG006|STARTED|Test Period 2; Test B*||0
9967331|NCT01514136|11087654|FG007|STARTED|Test Period 2; Test B*||0
9967332|NCT01514136|11087647|FG000|COMPLETED|Test Period 2; Test B*||0
9967333|NCT01514136|11087648|FG001|COMPLETED|Test Period 2; Test B*||0
9967334|NCT01514136|11087649|FG002|COMPLETED|Test Period 2; Test B*||0
9967335|NCT01514136|11087650|FG003|COMPLETED|Test Period 2; Test B*||0
9967336|NCT01514136|11087651|FG004|COMPLETED|Test Period 2; Test B*||0
9967337|NCT01514136|11087652|FG005|COMPLETED|Test Period 2; Test B*||26
9967338|NCT01514136|11087653|FG006|COMPLETED|Test Period 2; Test B*||0
9967339|NCT01514136|11087654|FG007|COMPLETED|Test Period 2; Test B*||0
9967340|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period 2; Test B*||0
9967341|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period 2; Test B*||0
9967342|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period 2; Test B*||0
9967343|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period 2; Test B*||0
9967344|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period 2; Test B*||0
9967345|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period 2; Test B*||2
9967346|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period 2; Test B*||0
9967347|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period 2; Test B*||0
9967348|NCT01514136|11087647|FG000|STARTED|Test Period 2; Test C*||0
9967349|NCT01514136|11087648|FG001|STARTED|Test Period 2; Test C*||0
9967350|NCT01514136|11087649|FG002|STARTED|Test Period 2; Test C*||0
9967351|NCT01514136|11087650|FG003|STARTED|Test Period 2; Test C*||0
9967352|NCT01514136|11087651|FG004|STARTED|Test Period 2; Test C*||0
9967353|NCT01514136|11087652|FG005|STARTED|Test Period 2; Test C*||0
9967354|NCT01514136|11087653|FG006|STARTED|Test Period 2; Test C*||26
9967355|NCT01514136|11087654|FG007|STARTED|Test Period 2; Test C*||0
9967356|NCT01514136|11087647|FG000|COMPLETED|Test Period 2; Test C*||0
9967357|NCT01514136|11087648|FG001|COMPLETED|Test Period 2; Test C*||0
9967358|NCT01514136|11087649|FG002|COMPLETED|Test Period 2; Test C*||0
9967359|NCT01514136|11087650|FG003|COMPLETED|Test Period 2; Test C*||0
9967360|NCT01514136|11087651|FG004|COMPLETED|Test Period 2; Test C*||0
9967361|NCT01514136|11087652|FG005|COMPLETED|Test Period 2; Test C*||0
9967362|NCT01514136|11087653|FG006|COMPLETED|Test Period 2; Test C*||23
9967363|NCT01514136|11087654|FG007|COMPLETED|Test Period 2; Test C*||0
9967364|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period 2; Test C*||0
9967365|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period 2; Test C*||0
9967366|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period 2; Test C*||0
9967367|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period 2; Test C*||0
9967368|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period 2; Test C*||0
9967369|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period 2; Test C*||0
9967370|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period 2; Test C*||3
9967371|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period 2; Test C*||0
9967372|NCT01514136|11087647|FG000|STARTED|Test Period; Test D*||0
9967373|NCT01514136|11087648|FG001|STARTED|Test Period; Test D*||0
9967374|NCT01514136|11087649|FG002|STARTED|Test Period; Test D*||0
9967375|NCT01514136|11087650|FG003|STARTED|Test Period; Test D*||0
9967376|NCT01514136|11087651|FG004|STARTED|Test Period; Test D*||0
9967377|NCT01514136|11087652|FG005|STARTED|Test Period; Test D*||0
9967378|NCT01514136|11087653|FG006|STARTED|Test Period; Test D*||0
9967379|NCT01514136|11087654|FG007|STARTED|Test Period; Test D*||23
9967380|NCT01514136|11087647|FG000|COMPLETED|Test Period; Test D*||0
9967381|NCT01514136|11087648|FG001|COMPLETED|Test Period; Test D*||0
9967382|NCT01514136|11087649|FG002|COMPLETED|Test Period; Test D*||0
9967383|NCT01514136|11087650|FG003|COMPLETED|Test Period; Test D*||0
9967384|NCT01514136|11087651|FG004|COMPLETED|Test Period; Test D*||0
9967385|NCT01514136|11087652|FG005|COMPLETED|Test Period; Test D*||0
9967386|NCT01514136|11087653|FG006|COMPLETED|Test Period; Test D*||0
9967387|NCT01514136|11087654|FG007|COMPLETED|Test Period; Test D*||23
9967388|NCT01514136|11087647|FG000|NOT COMPLETED|Test Period; Test D*||0
9967389|NCT01514136|11087648|FG001|NOT COMPLETED|Test Period; Test D*||0
9967390|NCT01514136|11087649|FG002|NOT COMPLETED|Test Period; Test D*||0
9967391|NCT01514136|11087650|FG003|NOT COMPLETED|Test Period; Test D*||0
9967392|NCT01514136|11087651|FG004|NOT COMPLETED|Test Period; Test D*||0
9967393|NCT01514136|11087652|FG005|NOT COMPLETED|Test Period; Test D*||0
9967394|NCT01514136|11087653|FG006|NOT COMPLETED|Test Period; Test D*||0
9967395|NCT01514136|11087654|FG007|NOT COMPLETED|Test Period; Test D*||0
9967396|NCT01514149|11087685|FG000|STARTED|Overall Study||15
9967397|NCT01514149|11087686|FG001|STARTED|Overall Study||15
9967398|NCT01514149|11087687|FG002|STARTED|Overall Study||14
9967399|NCT01514149|11087688|FG003|STARTED|Overall Study||14
9967400|NCT01514149|11087689|FG004|STARTED|Overall Study||15
9967401|NCT01514149|11087685|FG000|COMPLETED|Overall Study||12
9967402|NCT01514149|11087686|FG001|COMPLETED|Overall Study||14
9967403|NCT01514149|11087687|FG002|COMPLETED|Overall Study||11
9967404|NCT01514149|11087688|FG003|COMPLETED|Overall Study||13
9967405|NCT01514149|11087689|FG004|COMPLETED|Overall Study||14
9967406|NCT01514149|11087685|FG000|NOT COMPLETED|Overall Study||3
9967407|NCT01514149|11087686|FG001|NOT COMPLETED|Overall Study||1
9967408|NCT01514149|11087687|FG002|NOT COMPLETED|Overall Study||3
9967409|NCT01514149|11087688|FG003|NOT COMPLETED|Overall Study||1
9967410|NCT01514149|11087689|FG004|NOT COMPLETED|Overall Study||1
9967411|NCT01514162|11087701|FG000|STARTED|Overall Study||245
9967412|NCT01514162|11087701|FG000|COMPLETED|Overall Study||160
9967413|NCT01514162|11087701|FG000|NOT COMPLETED|Overall Study||85
9967414|NCT01514201|11087709|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6
9967415|NCT01514201|11087710|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6
9967416|NCT01514201|11087711|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6
9967417|NCT01514201|11087712|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0
9967418|NCT01514201|11087709|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
9967419|NCT01514201|11087710|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
9967420|NCT01514201|11087711|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
9967421|NCT01514201|11087712|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
9967422|NCT01514201|11087709|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
9967423|NCT01514201|11087710|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
9967424|NCT01514201|11087711|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
9967425|NCT01514201|11087712|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
9967426|NCT01514201|11087709|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
9967427|NCT01514201|11087710|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
9967428|NCT01514201|11087711|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
9967429|NCT01514201|11087712|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
9967430|NCT01514201|11087709|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
9967431|NCT01514201|11087710|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
9967432|NCT01514201|11087711|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
9967433|NCT01514201|11087712|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
9967434|NCT01514201|11087709|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
9967435|NCT01514201|11087710|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
9967436|NCT01514201|11087711|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
9967437|NCT01514201|11087712|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
9967438|NCT01514201|11087709|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0
9967439|NCT01514201|11087710|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0
9967440|NCT01514201|11087711|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0
9967441|NCT01514201|11087712|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47
9967442|NCT01514201|11087709|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
9967443|NCT01514201|11087710|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
9967444|NCT01514201|11087711|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
9967445|NCT01514201|11087712|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
9967446|NCT01514201|11087709|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
9967447|NCT01514201|11087710|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
9967448|NCT01514201|11087711|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
9967449|NCT01514201|11087712|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
9967450|NCT01514201|11087709|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
9967451|NCT01514201|11087710|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
9967452|NCT01514201|11087711|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
9967453|NCT01514201|11087712|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
9967454|NCT01514201|11087709|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
9967455|NCT01514201|11087710|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
9967456|NCT01514201|11087711|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
9967457|NCT01514201|11087712|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
9967458|NCT01514201|11087709|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
9967459|NCT01514201|11087710|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
9967460|NCT01514201|11087711|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
9967461|NCT01514201|11087712|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
9967462|NCT01514240|11087734|FG000|STARTED|Overall Study||56
9967463|NCT01514240|11087735|FG001|STARTED|Overall Study||56
9967464|NCT01514240|11087734|FG000|COMPLETED|Overall Study||50
9967465|NCT01514240|11087735|FG001|COMPLETED|Overall Study||45
9967466|NCT01514240|11087734|FG000|NOT COMPLETED|Overall Study||6
9967467|NCT01514240|11087735|FG001|NOT COMPLETED|Overall Study||11
9967468|NCT01514279|11087744|FG000|STARTED|Overall Study||118
9967469|NCT01514279|11087745|FG001|STARTED|Overall Study||123
9967470|NCT01514279|11087746|FG002|STARTED|Overall Study||119
9967471|NCT01514279|11087744|FG000|COMPLETED|Overall Study||107
9967472|NCT01514279|11087745|FG001|COMPLETED|Overall Study||110
9967473|NCT01514279|11087746|FG002|COMPLETED|Overall Study||114
9967474|NCT01514279|11087744|FG000|NOT COMPLETED|Overall Study||11
9967475|NCT01514279|11087745|FG001|NOT COMPLETED|Overall Study||13
9967476|NCT01514279|11087746|FG002|NOT COMPLETED|Overall Study||5
9967477|NCT01514292|11087754|FG000|STARTED|Overall Study||72
9967478|NCT01514292|11087754|FG000|COMPLETED|Overall Study||72
9967479|NCT01514292|11087754|FG000|NOT COMPLETED|Overall Study||0
9967480|NCT01514318|11087758|FG000|STARTED|Overall Study||8
9967481|NCT01514318|11087758|FG000|COMPLETED|Overall Study||8
9967482|NCT01514318|11087758|FG000|NOT COMPLETED|Overall Study||0
9967483|NCT01514357|11087764|FG000|STARTED|Overall Study||12
9967484|NCT01514357|11087765|FG001|STARTED|Overall Study||0
9967485|NCT01514357|11087764|FG000|COMPLETED|Overall Study||8
9967486|NCT01514357|11087765|FG001|COMPLETED|Overall Study||0
9967487|NCT01514357|11087764|FG000|NOT COMPLETED|Overall Study||4
9967488|NCT01514357|11087765|FG001|NOT COMPLETED|Overall Study||0
9967489|NCT01514370|11087773|FG000|STARTED|Overall Study||40
9967490|NCT01514370|11087774|FG001|STARTED|Overall Study||40
9967491|NCT01514370|11087773|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
9967492|NCT01514370|11087774|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
9967493|NCT01514370|11087773|FG000|COMPLETED|Overall Study||29
9967494|NCT01514370|11087774|FG001|COMPLETED|Overall Study||24
9967495|NCT01514370|11087773|FG000|NOT COMPLETED|Overall Study||11
9967496|NCT01514370|11087774|FG001|NOT COMPLETED|Overall Study||16
9967497|NCT01514383|11087781|FG000|STARTED|Overall Study||34
9967498|NCT01514383|11087781|FG000|COMPLETED|Overall Study||34
9967499|NCT01514383|11087781|FG000|NOT COMPLETED|Overall Study||0
9967500|NCT01514396|11087786|FG000|STARTED|Overall Study||8
9967501|NCT01514396|11087786|FG000|COMPLETED|Overall Study||8
9967502|NCT01514396|11087786|FG000|NOT COMPLETED|Overall Study||0
9967503|NCT01514422|11087791|FG000|STARTED|Overall Study||20
9967504|NCT01514422|11087791|FG000|COMPLETED|Overall Study||19
9967505|NCT01514422|11087791|FG000|NOT COMPLETED|Overall Study||1
9967506|NCT01514448|11087797|FG000|STARTED|Overall Study||16
9967507|NCT01514448|11087798|FG001|STARTED|Overall Study||13
9967508|NCT01514448|11087797|FG000|Full Analysis Set (FAS)|Overall Study||12
9967509|NCT01514448|11087798|FG001|Full Analysis Set (FAS)|Overall Study||13
9967510|NCT01514448|11087797|FG000|COMPLETED|Overall Study||4
9967511|NCT01514448|11087798|FG001|COMPLETED|Overall Study||5
9967512|NCT01514448|11087797|FG000|NOT COMPLETED|Overall Study||12
9967513|NCT01514448|11087798|FG001|NOT COMPLETED|Overall Study||8
9967514|NCT01514461|11087808|FG000|STARTED|Overall Study||15
9967515|NCT01514461|11087809|FG001|STARTED|Overall Study||15
9967516|NCT01514461|11087810|FG002|STARTED|Overall Study||15
9967517|NCT01514461|11087808|FG000|COMPLETED|Overall Study||10
9967518|NCT01514461|11087809|FG001|COMPLETED|Overall Study||12
9967519|NCT01514461|11087810|FG002|COMPLETED|Overall Study||11
9967520|NCT01514461|11087808|FG000|NOT COMPLETED|Overall Study||5
9967521|NCT01514461|11087809|FG001|NOT COMPLETED|Overall Study||3
9967522|NCT01514461|11087810|FG002|NOT COMPLETED|Overall Study||4
9967523|NCT01514513|11087823|FG000|STARTED|Overall Study||21
9967524|NCT01514513|11087824|FG001|STARTED|Overall Study||21
9967525|NCT01514513|11087823|FG000|COMPLETED|Overall Study||20
9967526|NCT01514513|11087824|FG001|COMPLETED|Overall Study||20
9967527|NCT01514513|11087823|FG000|NOT COMPLETED|Overall Study||1
9967528|NCT01514513|11087824|FG001|NOT COMPLETED|Overall Study||1
9967529|NCT01514630|11087830|FG000|STARTED|Overall Study||14
9967530|NCT01514630|11087830|FG000|COMPLETED|Overall Study||11
9967531|NCT01514630|11087830|FG000|NOT COMPLETED|Overall Study||3
9967532|NCT01514734|11087834|FG000|STARTED|Overall Study||9
9967533|NCT01514734|11087834|FG000|COMPLETED|Overall Study||9
9967534|NCT01514734|11087834|FG000|NOT COMPLETED|Overall Study||0
9967535|NCT01514760|11087838|FG000|STARTED|Overall Study||22
9967536|NCT01514760|11087838|FG000|COMPLETED|Overall Study||20
9967537|NCT01514760|11087838|FG000|NOT COMPLETED|Overall Study||2
9967538|NCT01514786|11087844|FG000|STARTED|Overall Study||286
9967539|NCT01514786|11087845|FG001|STARTED|Overall Study||284
9967540|NCT01514786|11087844|FG000|COMPLETED|Overall Study||286
9967541|NCT01514786|11087845|FG001|COMPLETED|Overall Study||284
9967542|NCT01514786|11087844|FG000|NOT COMPLETED|Overall Study||0
9967543|NCT01514786|11087845|FG001|NOT COMPLETED|Overall Study||0
9967544|NCT01514864|11087853|FG000|STARTED|Overall Study||9
9967545|NCT01514864|11087854|FG001|STARTED|Overall Study||5
9967546|NCT01514864|11087853|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
9967547|NCT01514864|11087854|FG001|COMPLETED|Overall Study||0
9967548|NCT01514864|11087853|FG000|NOT COMPLETED|Overall Study||9
9967549|NCT01514864|11087854|FG001|NOT COMPLETED|Overall Study||5
9967550|NCT01515046|11087861|FG000|STARTED|Overall Study||1
9967551|NCT01515046|11087861|FG000|COMPLETED|Overall Study||1
9967552|NCT01515046|11087861|FG000|NOT COMPLETED|Overall Study||0
9967553|NCT01515072|11087867|FG000|STARTED|Overall Study||166
9967554|NCT01515072|11087868|FG001|STARTED|Overall Study||155
9967555|NCT01515072|11087867|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
9967556|NCT01515072|11087868|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
9967557|NCT01515072|11087867|FG000|NOT COMPLETED|Overall Study||0
9967558|NCT01515072|11087868|FG001|NOT COMPLETED|Overall Study||0
9967559|NCT01515176|11087890|FG000|STARTED|Overall Study||4
9967560|NCT01515176|11087891|FG001|STARTED|Overall Study||32
9967561|NCT01515176|11087890|FG000|COMPLETED|Overall Study||4
9967562|NCT01515176|11087891|FG001|COMPLETED|Overall Study||32
9967563|NCT01515176|11087890|FG000|NOT COMPLETED|Overall Study||0
9967564|NCT01515176|11087891|FG001|NOT COMPLETED|Overall Study||0
9967565|NCT01515189|11087901|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
9967566|NCT01515189|11087902|FG001|STARTED|Induction||362
9967567|NCT01515189|11087901|FG000|COMPLETED|Induction||128
9967568|NCT01515189|11087902|FG001|COMPLETED|Induction||130
9967569|NCT01515189|11087901|FG000|NOT COMPLETED|Induction||237
9967570|NCT01515189|11087902|FG001|NOT COMPLETED|Induction||232
9967571|NCT01515189|11087901|FG000|STARTED|First Re-Induction Phase||23
9967572|NCT01515189|11087902|FG001|STARTED|First Re-Induction Phase||32
9967573|NCT01515189|11087901|FG000|COMPLETED|First Re-Induction Phase||9
9967574|NCT01515189|11087902|FG001|COMPLETED|First Re-Induction Phase||17
9967575|NCT01515189|11087901|FG000|NOT COMPLETED|First Re-Induction Phase||14
9967576|NCT01515189|11087902|FG001|NOT COMPLETED|First Re-Induction Phase||15
9967577|NCT01515319|11087918|FG000|STARTED|Overall Study||3
9967578|NCT01515319|11087919|FG001|STARTED|Overall Study||3
9967579|NCT01515319|11087920|FG002|STARTED|Overall Study||6
9967580|NCT01515319|11087921|FG003|STARTED|Overall Study||6
9967581|NCT01515319|11087922|FG004|STARTED|Overall Study||6
9967582|NCT01515319|11087923|FG005|STARTED|Overall Study||6
9967583|NCT01515319|11087924|FG006|STARTED|Overall Study||10
9967584|NCT01515319|11087925|FG007|STARTED|Overall Study||6
9967585|NCT01515319|11087926|FG008|STARTED|Overall Study||14
9967586|NCT01515319|11087927|FG009|STARTED|Overall Study||8
9967587|NCT01515319|11087918|FG000|COMPLETED|Overall Study||3
9967588|NCT01515319|11087919|FG001|COMPLETED|Overall Study||3
9967589|NCT01515319|11087920|FG002|COMPLETED|Overall Study||6
9967590|NCT01515319|11087921|FG003|COMPLETED|Overall Study||6
9967591|NCT01515319|11087922|FG004|COMPLETED|Overall Study||6
9967592|NCT01515319|11087923|FG005|COMPLETED|Overall Study||6
9967593|NCT01515319|11087924|FG006|COMPLETED|Overall Study||9
9967594|NCT01515319|11087925|FG007|COMPLETED|Overall Study||6
9967595|NCT01515319|11087926|FG008|COMPLETED|Overall Study||9
9967596|NCT01515319|11087927|FG009|COMPLETED|Overall Study||8
9967597|NCT01515319|11087918|FG000|NOT COMPLETED|Overall Study||0
9967598|NCT01515319|11087919|FG001|NOT COMPLETED|Overall Study||0
9967599|NCT01515319|11087920|FG002|NOT COMPLETED|Overall Study||0
9967600|NCT01515319|11087921|FG003|NOT COMPLETED|Overall Study||0
9967601|NCT01515319|11087922|FG004|NOT COMPLETED|Overall Study||0
9967602|NCT01515319|11087923|FG005|NOT COMPLETED|Overall Study||0
9967603|NCT01515319|11087924|FG006|NOT COMPLETED|Overall Study||1
9967604|NCT01515319|11087925|FG007|NOT COMPLETED|Overall Study||0
9967605|NCT01515319|11087926|FG008|NOT COMPLETED|Overall Study||5
9967606|NCT01515319|11087927|FG009|NOT COMPLETED|Overall Study||0
9967607|NCT01515345|11087951|FG000|STARTED|Overall Study||665
9967608|NCT01515345|11087952|FG001|STARTED|Overall Study||343
9967609|NCT01515345|11087951|FG000|COMPLETED|Overall Study||664
9967610|NCT01515345|11087952|FG001|COMPLETED|Overall Study||343
9967611|NCT01515345|11087951|FG000|NOT COMPLETED|Overall Study||1
9967612|NCT01515345|11087952|FG001|NOT COMPLETED|Overall Study||0
9967613|NCT01515410|11087958|FG000|STARTED|Overall Study||19
9967614|NCT01515410|11087959|FG001|STARTED|Overall Study||15
9967615|NCT01515410|11087958|FG000|COMPLETED|Overall Study||19
9967616|NCT01515410|11087959|FG001|COMPLETED|Overall Study||15
9967617|NCT01515410|11087958|FG000|NOT COMPLETED|Overall Study||0
9967618|NCT01515410|11087959|FG001|NOT COMPLETED|Overall Study||0
9967619|NCT01515423|11087967|FG000|STARTED|Open Label Phase||1429
9967620|NCT01515423|11087968|FG001|STARTED|Open Label Phase||0
9967621|NCT01515423|11087969|FG002|STARTED|Open Label Phase||0
9967622|NCT01515423|11087967|FG000|COMPLETED|Open Label Phase||1016
9967623|NCT01515423|11087968|FG001|COMPLETED|Open Label Phase||0
9967624|NCT01515423|11087969|FG002|COMPLETED|Open Label Phase||0
9967625|NCT01515423|11087967|FG000|NOT COMPLETED|Open Label Phase||413
9967626|NCT01515423|11087968|FG001|NOT COMPLETED|Open Label Phase||0
9967627|NCT01515423|11087969|FG002|NOT COMPLETED|Open Label Phase||0
9967628|NCT01515423|11087967|FG000|STARTED|DOUBLE BLIND||0
9967629|NCT01515423|11087968|FG001|STARTED|DOUBLE BLIND||504
9967630|NCT01515423|11087969|FG002|STARTED|DOUBLE BLIND||512
9967631|NCT01515423|11087967|FG000|COMPLETED|DOUBLE BLIND||0
9967632|NCT01515423|11087968|FG001|COMPLETED|DOUBLE BLIND||422
9967633|NCT01515423|11087969|FG002|COMPLETED|DOUBLE BLIND||420
9967634|NCT01515423|11087967|FG000|NOT COMPLETED|DOUBLE BLIND||0
9967635|NCT01515423|11087968|FG001|NOT COMPLETED|DOUBLE BLIND||82
9967636|NCT01515423|11087969|FG002|NOT COMPLETED|DOUBLE BLIND||92
9967637|NCT01515475|11087980|FG000|STARTED|Overall Study||61
9967638|NCT01515475|11087981|FG001|STARTED|Overall Study||58
9967639|NCT01515475|11087982|FG002|STARTED|Overall Study||65
9967640|NCT01515475|11087983|FG003|STARTED|Overall Study||65
9967641|NCT01515475|11087980|FG000|COMPLETED|Overall Study||41
9967642|NCT01515475|11087981|FG001|COMPLETED|Overall Study||43
9967643|NCT01515475|11087982|FG002|COMPLETED|Overall Study||53
9967644|NCT01515475|11087983|FG003|COMPLETED|Overall Study||53
9967645|NCT01515475|11087980|FG000|NOT COMPLETED|Overall Study||20
9967646|NCT01515475|11087981|FG001|NOT COMPLETED|Overall Study||15
9967647|NCT01515475|11087982|FG002|NOT COMPLETED|Overall Study||12
9967648|NCT01515475|11087983|FG003|NOT COMPLETED|Overall Study||12
9967649|NCT01515488|11087995|FG000|STARTED|Overall Study||200
9967650|NCT01515488|11087996|FG001|STARTED|Overall Study||200
9967651|NCT01515488|11087995|FG000|COMPLETED|Overall Study||200
9967652|NCT01515488|11087996|FG001|COMPLETED|Overall Study||200
9967653|NCT01515488|11087995|FG000|NOT COMPLETED|Overall Study||0
9967654|NCT01515488|11087996|FG001|NOT COMPLETED|Overall Study||0
9967655|NCT01515540|11088004|FG000|STARTED|Overall Study||20
9967656|NCT01515540|11088005|FG001|STARTED|Overall Study||18
9967657|NCT01515540|11088004|FG000|COMPLETED|Overall Study||15
9732001|NCT00139477|10832015|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12
9732002|NCT00139477|10832014|FG000|STARTED|Second Intervention -6Months to 12Months||19
9732003|NCT00139477|10832015|FG001|STARTED|Second Intervention -6Months to 12Months||23
9732004|NCT00139477|10832014|FG000|COMPLETED|Second Intervention -6Months to 12Months||14
9732005|NCT00139477|10832015|FG001|COMPLETED|Second Intervention -6Months to 12Months||18
9732006|NCT00139477|10832014|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5
9732007|NCT00139477|10832015|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5
9732008|NCT00139659|10832025|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
9732009|NCT00139659|10832026|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
9732010|NCT00139659|10832025|FG000|COMPLETED|Overall Study||106
9732011|NCT00139659|10832026|FG001|COMPLETED|Overall Study||123
9732012|NCT00139659|10832025|FG000|NOT COMPLETED|Overall Study||40
9732013|NCT00139659|10832026|FG001|NOT COMPLETED|Overall Study||18
9732014|NCT00139737|10832036|FG000|STARTED|Overall Study||344
9732015|NCT00139737|10832036|FG000|Received Treatment|Overall Study||331
9732016|NCT00139737|10832036|FG000|COMPLETED|Overall Study||3
9732017|NCT00139737|10832036|FG000|NOT COMPLETED|Overall Study||341
9732018|NCT00139776|10832042|FG000|STARTED|Period I||1772
9732019|NCT00139776|10832043|FG001|STARTED|Period I||0
9732020|NCT00139776|10832044|FG002|STARTED|Period I||0
9732021|NCT00139776|10832045|FG003|STARTED|Period I||0
9732022|NCT00139776|10832042|FG000|COMPLETED|Period I||1197
9732023|NCT00139776|10832043|FG001|COMPLETED|Period I||0
9732024|NCT00139776|10832044|FG002|COMPLETED|Period I||0
9732025|NCT00139776|10832045|FG003|COMPLETED|Period I||0
9732026|NCT00139776|10832042|FG000|NOT COMPLETED|Period I||575
9732027|NCT00139776|10832043|FG001|NOT COMPLETED|Period I||0
9732028|NCT00139776|10832044|FG002|NOT COMPLETED|Period I||0
9732029|NCT00139776|10832045|FG003|NOT COMPLETED|Period I||0
9732030|NCT00139776|10832042|FG000|STARTED|Period II||0
9732031|NCT00139776|10832043|FG001|STARTED|Period II||1197
9732032|NCT00139776|10832044|FG002|STARTED|Period II||0
9732033|NCT00139776|10832045|FG003|STARTED|Period II||0
9732034|NCT00139776|10832042|FG000|COMPLETED|Period II||0
9732035|NCT00139776|10832043|FG001|COMPLETED|Period II||875
9732036|NCT00139776|10832044|FG002|COMPLETED|Period II||0
9732037|NCT00139776|10832045|FG003|COMPLETED|Period II||0
9732038|NCT00139776|10832042|FG000|NOT COMPLETED|Period II||0
9732039|NCT00139776|10832043|FG001|NOT COMPLETED|Period II||322
9732040|NCT00139776|10832044|FG002|NOT COMPLETED|Period II||0
9732041|NCT00139776|10832045|FG003|NOT COMPLETED|Period II||0
9732042|NCT00139776|10832042|FG000|STARTED|Period III||0
9732043|NCT00139776|10832043|FG001|STARTED|Period III||0
9732044|NCT00139776|10832044|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431
9732045|NCT00139776|10832045|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427
9732046|NCT00139776|10832042|FG000|COMPLETED|Period III||0
9732047|NCT00139776|10832043|FG001|COMPLETED|Period III||0
9732048|NCT00139776|10832044|FG002|COMPLETED|Period III||355
9732049|NCT00139776|10832045|FG003|COMPLETED|Period III||321
9732050|NCT00139776|10832042|FG000|NOT COMPLETED|Period III||0
9732051|NCT00139776|10832043|FG001|NOT COMPLETED|Period III||0
9732052|NCT00139776|10832044|FG002|NOT COMPLETED|Period III||76
9732053|NCT00139776|10832045|FG003|NOT COMPLETED|Period III||106
9732054|NCT00139997|10832054|FG000|STARTED|Overall Study||15
9732055|NCT00139997|10832055|FG001|STARTED|Overall Study||11
9732056|NCT00139997|10832054|FG000|COMPLETED|Overall Study||14
9732057|NCT00139997|10832055|FG001|COMPLETED|Overall Study||9
9732058|NCT00139997|10832054|FG000|NOT COMPLETED|Overall Study||1
9732059|NCT00139997|10832055|FG001|NOT COMPLETED|Overall Study||2
9732060|NCT00140140|10832064|FG000|STARTED|Overall Study||4
9732061|NCT00140140|10832065|FG001|STARTED|Overall Study||6
9732062|NCT00140140|10832066|FG002|STARTED|Overall Study||6
9732063|NCT00140140|10832064|FG000|COMPLETED|Overall Study|Progressive disease|2
9732064|NCT00140140|10832065|FG001|COMPLETED|Overall Study|Progressive disease|4
9732065|NCT00140140|10832066|FG002|COMPLETED|Overall Study|Progressive disease|4
9732066|NCT00140140|10832064|FG000|NOT COMPLETED|Overall Study||2
9732067|NCT00140140|10832065|FG001|NOT COMPLETED|Overall Study||2
9732068|NCT00140140|10832066|FG002|NOT COMPLETED|Overall Study||2
9732069|NCT00140205|10832076|FG000|STARTED|Overall Study||5
9732070|NCT00140205|10832077|FG001|STARTED|Overall Study||5
9732071|NCT00140205|10832078|FG002|STARTED|Overall Study||5
9732072|NCT00140205|10832076|FG000|COMPLETED|Overall Study||5
9732073|NCT00140205|10832077|FG001|COMPLETED|Overall Study||5
9732074|NCT00140205|10832078|FG002|COMPLETED|Overall Study||5
9732075|NCT00140205|10832076|FG000|NOT COMPLETED|Overall Study||0
9732076|NCT00140205|10832077|FG001|NOT COMPLETED|Overall Study||0
9732077|NCT00140205|10832078|FG002|NOT COMPLETED|Overall Study||0
9732078|NCT00140231|10832109|FG000|STARTED|Fed State 1 Day- day5||7
9732079|NCT00140231|10832110|FG001|STARTED|Fed State 1 Day- day5||6
9732080|NCT00140231|10832109|FG000|COMPLETED|Fed State 1 Day- day5||7
9732081|NCT00140231|10832110|FG001|COMPLETED|Fed State 1 Day- day5||6
9732082|NCT00140231|10832109|FG000|NOT COMPLETED|Fed State 1 Day- day5||0
9732083|NCT00140231|10832110|FG001|NOT COMPLETED|Fed State 1 Day- day5||0
9732084|NCT00140231|10832109|FG000|STARTED|Washout 8weeks||7
9732085|NCT00140231|10832110|FG001|STARTED|Washout 8weeks||6
9732086|NCT00140231|10832109|FG000|COMPLETED|Washout 8weeks||7
9732087|NCT00140231|10832110|FG001|COMPLETED|Washout 8weeks||6
9732088|NCT00140231|10832109|FG000|NOT COMPLETED|Washout 8weeks||0
9732089|NCT00140231|10832110|FG001|NOT COMPLETED|Washout 8weeks||0
9732090|NCT00140231|10832109|FG000|STARTED|First Fasting State 3 Days With Placebo||7
9732091|NCT00140231|10832110|FG001|STARTED|First Fasting State 3 Days With Placebo||6
9732092|NCT00140231|10832109|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7
9732093|NCT00140231|10832110|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6
9732094|NCT00140231|10832109|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
9732095|NCT00140231|10832110|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
9732096|NCT00140231|10832109|FG000|STARTED|Washout 8 Weeks||7
9732097|NCT00140231|10832110|FG001|STARTED|Washout 8 Weeks||6
9732098|NCT00140231|10832109|FG000|COMPLETED|Washout 8 Weeks||7
9732099|NCT00140231|10832110|FG001|COMPLETED|Washout 8 Weeks||6
9732100|NCT00140231|10832109|FG000|NOT COMPLETED|Washout 8 Weeks||0
9732101|NCT00140231|10832110|FG001|NOT COMPLETED|Washout 8 Weeks||0
9732102|NCT00140231|10832109|FG000|STARTED|Fasting State With Leptin and Crossover||7
9732103|NCT00140231|10832110|FG001|STARTED|Fasting State With Leptin and Crossover||6
9732104|NCT00140231|10832109|FG000|COMPLETED|Fasting State With Leptin and Crossover||7
9732105|NCT00140231|10832110|FG001|COMPLETED|Fasting State With Leptin and Crossover||6
9732106|NCT00140231|10832109|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0
9732107|NCT00140231|10832110|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0
9732108|NCT00140244|10832116|FG000|STARTED|Intervention 1||3
9732109|NCT00140244|10832117|FG001|STARTED|Intervention 1||4
9732110|NCT00140244|10832116|FG000|COMPLETED|Intervention 1||3
9732111|NCT00140244|10832117|FG001|COMPLETED|Intervention 1||4
9732112|NCT00140244|10832116|FG000|NOT COMPLETED|Intervention 1||0
9732113|NCT00140244|10832117|FG001|NOT COMPLETED|Intervention 1||0
9732114|NCT00140244|10832116|FG000|STARTED|Washout||3
9732115|NCT00140244|10832117|FG001|STARTED|Washout||4
9732116|NCT00140244|10832116|FG000|COMPLETED|Washout||3
9732117|NCT00140244|10832117|FG001|COMPLETED|Washout||4
9732118|NCT00140244|10832116|FG000|NOT COMPLETED|Washout||0
9732119|NCT00140244|10832117|FG001|NOT COMPLETED|Washout||0
9732120|NCT00140244|10832116|FG000|STARTED|Intervention 2||3
9732121|NCT00140244|10832117|FG001|STARTED|Intervention 2||4
9732122|NCT00140244|10832116|FG000|COMPLETED|Intervention 2||3
9732123|NCT00140244|10832117|FG001|COMPLETED|Intervention 2||2
9732124|NCT00140244|10832116|FG000|NOT COMPLETED|Intervention 2||0
9732125|NCT00140244|10832117|FG001|NOT COMPLETED|Intervention 2||2
9732126|NCT00140413|10832127|FG000|STARTED|Overall Study||13
9732127|NCT00140413|10832128|FG001|STARTED|Overall Study||7
9732128|NCT00140413|10832127|FG000|Received at Least One Dose of GH|Overall Study||13
9732129|NCT00140413|10832128|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
9732130|NCT00140413|10832127|FG000|COMPLETED|Overall Study||10
9732131|NCT00140413|10832128|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
9732132|NCT00140413|10832127|FG000|NOT COMPLETED|Overall Study||3
9732133|NCT00140413|10832128|FG001|NOT COMPLETED|Overall Study||0
9732134|NCT00140426|10832137|FG000|STARTED|Overall Study||22
9732135|NCT00140426|10832138|FG001|STARTED|Overall Study||19
9732136|NCT00140426|10832137|FG000|COMPLETED|Overall Study||22
9732137|NCT00140426|10832138|FG001|COMPLETED|Overall Study||16
9732138|NCT00140426|10832137|FG000|NOT COMPLETED|Overall Study||0
9732139|NCT00140426|10832138|FG001|NOT COMPLETED|Overall Study||3
9732140|NCT00140556|10832149|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28
9732141|NCT00140556|10832149|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
9732142|NCT00140556|10832149|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
9732143|NCT00140556|10832149|FG000|STARTED|Chemoradiotherapy Period||28
9732144|NCT00140556|10832149|FG000|COMPLETED|Chemoradiotherapy Period||28
9732145|NCT00140556|10832149|FG000|NOT COMPLETED|Chemoradiotherapy Period||0
9732146|NCT00140621|10832153|FG000|STARTED|Overall Study||6
9732147|NCT00140621|10832153|FG000|COMPLETED|Overall Study||6
9732148|NCT00140621|10832153|FG000|NOT COMPLETED|Overall Study||0
9732149|NCT00140842|10832159|FG000|STARTED|Overall Study||15
9732150|NCT00140842|10832160|FG001|STARTED|Overall Study||15
9732151|NCT00140842|10832159|FG000|COMPLETED|Overall Study||15
9732152|NCT00140842|10832160|FG001|COMPLETED|Overall Study||15
9732153|NCT00140842|10832159|FG000|NOT COMPLETED|Overall Study||0
9732154|NCT00140842|10832160|FG001|NOT COMPLETED|Overall Study||0
9732155|NCT00140855|10832166|FG000|STARTED|Overall Study||6
9732156|NCT00140855|10832166|FG000|COMPLETED|Overall Study||4
9732157|NCT00140855|10832166|FG000|NOT COMPLETED|Overall Study||2
9732158|NCT00141037|10832172|FG000|STARTED|Overall Study||60
9732159|NCT00141037|10832173|FG001|STARTED|Overall Study||70
9732160|NCT00141037|10832172|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
9732161|NCT00141037|10832173|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
9732162|NCT00141037|10832172|FG000|NOT COMPLETED|Overall Study||10
9732163|NCT00141037|10832173|FG001|NOT COMPLETED|Overall Study||18
9732164|NCT00141102|10832181|FG000|STARTED|Overall Study||2238
9732165|NCT00141102|10832182|FG001|STARTED|Overall Study||2246
9732166|NCT00141102|10832181|FG000|Received Treatment|Overall Study||2223
9732167|NCT00141102|10832182|FG001|Received Treatment|Overall Study||2237
9732168|NCT00141102|10832181|FG000|COMPLETED|Overall Study||1730
9732169|NCT00141102|10832182|FG001|COMPLETED|Overall Study||1621
9732170|NCT00141102|10832181|FG000|NOT COMPLETED|Overall Study||508
9732171|NCT00141102|10832182|FG001|NOT COMPLETED|Overall Study||625
9732172|NCT00141115|10832189|FG000|STARTED|Overall Study||3
9732173|NCT00141115|10832189|FG000|COMPLETED|Overall Study||2
9732174|NCT00141115|10832189|FG000|NOT COMPLETED|Overall Study||1
9732175|NCT00141219|10832196|FG000|STARTED|Overall Study||162
9732178|NCT00141219|10832197|FG001|COMPLETED|Overall Study||62
9732179|NCT00141219|10832196|FG000|NOT COMPLETED|Overall Study||24
9732180|NCT00141219|10832197|FG001|NOT COMPLETED|Overall Study||16
9732181|NCT00141271|10832206|FG000|STARTED|Overall Study||171
9732182|NCT00141271|10832207|FG001|STARTED|Overall Study||165
9732183|NCT00141271|10832208|FG002|STARTED|Overall Study||168
9732184|NCT00141271|10832206|FG000|COMPLETED|Overall Study||91
9732185|NCT00141271|10832207|FG001|COMPLETED|Overall Study||102
9732186|NCT00141271|10832208|FG002|COMPLETED|Overall Study||111
9732187|NCT00141271|10832206|FG000|NOT COMPLETED|Overall Study||80
9732188|NCT00141271|10832207|FG001|NOT COMPLETED|Overall Study||63
9732189|NCT00141271|10832208|FG002|NOT COMPLETED|Overall Study||57
9732190|NCT00141297|10832218|FG000|STARTED|Overall Study||3
9732191|NCT00141297|10832219|FG001|STARTED|Overall Study||3
9732192|NCT00141297|10832220|FG002|STARTED|Overall Study||7
9732193|NCT00141297|10832221|FG003|STARTED|Overall Study||3
9732194|NCT00141297|10832222|FG004|STARTED|Overall Study||22
9732195|NCT00141297|10832223|FG005|STARTED|Overall Study||3
9732196|NCT00141297|10832224|FG006|STARTED|Overall Study||3
9732197|NCT00141297|10832225|FG007|STARTED|Overall Study||4
9732198|NCT00141297|10832226|FG008|STARTED|Overall Study||20
9732199|NCT00141297|10832227|FG009|STARTED|Overall Study||6
9732200|NCT00141297|10832218|FG000|COMPLETED|Overall Study||0
9732201|NCT00141297|10832219|FG001|COMPLETED|Overall Study||0
9732202|NCT00141297|10832220|FG002|COMPLETED|Overall Study||0
9732203|NCT00141297|10832221|FG003|COMPLETED|Overall Study||0
9732204|NCT00141297|10832222|FG004|COMPLETED|Overall Study||0
9732205|NCT00141297|10832223|FG005|COMPLETED|Overall Study||0
9732206|NCT00141297|10832224|FG006|COMPLETED|Overall Study||0
9732207|NCT00141297|10832225|FG007|COMPLETED|Overall Study||0
9732208|NCT00141297|10832226|FG008|COMPLETED|Overall Study||0
9732209|NCT00141297|10832227|FG009|COMPLETED|Overall Study||0
9732210|NCT00141297|10832218|FG000|NOT COMPLETED|Overall Study||3
9732211|NCT00141297|10832219|FG001|NOT COMPLETED|Overall Study||3
9732212|NCT00141297|10832220|FG002|NOT COMPLETED|Overall Study||7
9732213|NCT00141297|10832221|FG003|NOT COMPLETED|Overall Study||3
9732214|NCT00141297|10832222|FG004|NOT COMPLETED|Overall Study||22
9732215|NCT00141297|10832223|FG005|NOT COMPLETED|Overall Study||3
9732216|NCT00141297|10832224|FG006|NOT COMPLETED|Overall Study||3
9732217|NCT00141297|10832225|FG007|NOT COMPLETED|Overall Study||4
9732218|NCT00141297|10832226|FG008|NOT COMPLETED|Overall Study||20
9732219|NCT00141297|10832227|FG009|NOT COMPLETED|Overall Study||6
9732220|NCT00141453|10832262|FG000|STARTED|Overall Study||288
9732221|NCT00141453|10832263|FG001|STARTED|Overall Study||289
9732222|NCT00141453|10832262|FG000|COMPLETED|Overall Study||282
9732223|NCT00141453|10832263|FG001|COMPLETED|Overall Study||284
9732224|NCT00141453|10832262|FG000|NOT COMPLETED|Overall Study||6
9732225|NCT00141453|10832263|FG001|NOT COMPLETED|Overall Study||5
9732226|NCT00141518|10832272|FG000|STARTED|Overall Study||37
9732227|NCT00141518|10832273|FG001|STARTED|Overall Study||22
9732228|NCT00141518|10832274|FG002|STARTED|Overall Study||18
9732229|NCT00141518|10832272|FG000|Safety Sample|Overall Study||36
9732230|NCT00141518|10832273|FG001|Safety Sample|Overall Study||22
9732231|NCT00141518|10832274|FG002|Safety Sample|Overall Study||18
9732232|NCT00141518|10832272|FG000|Full Analysis Sample|Overall Study||27
9732233|NCT00141518|10832273|FG001|Full Analysis Sample|Overall Study||22
9732234|NCT00141518|10832274|FG002|Full Analysis Sample|Overall Study||18
9732235|NCT00141518|10832272|FG000|COMPLETED|Overall Study||21
9732236|NCT00141518|10832273|FG001|COMPLETED|Overall Study||16
9732237|NCT00141518|10832274|FG002|COMPLETED|Overall Study||12
9732238|NCT00141518|10832272|FG000|NOT COMPLETED|Overall Study||16
9732239|NCT00141518|10832273|FG001|NOT COMPLETED|Overall Study||6
9732240|NCT00141518|10832274|FG002|NOT COMPLETED|Overall Study||6
9732241|NCT00141726|10832284|FG000|STARTED|Overall Study||34
9732242|NCT00141726|10832284|FG000|COMPLETED|Overall Study||31
9732243|NCT00141726|10832284|FG000|NOT COMPLETED|Overall Study||3
9732244|NCT00141739|10832288|FG000|STARTED|Overall Study|Number of evaluable patients|100
9732245|NCT00141739|10832288|FG000|COMPLETED|Overall Study||100
9732246|NCT00141739|10832288|FG000|NOT COMPLETED|Overall Study||0
9732247|NCT00141765|10832294|FG000|STARTED|Overall Study||25
9732248|NCT00141765|10832294|FG000|COMPLETED|Overall Study||25
9732249|NCT00141765|10832294|FG000|NOT COMPLETED|Overall Study||0
9732250|NCT00141778|10832301|FG000|STARTED|Randomization Prior to Study Med||152
9732251|NCT00141778|10832302|FG001|STARTED|Randomization Prior to Study Med||153
9732252|NCT00141778|10832303|FG002|STARTED|Randomization Prior to Study Med||153
9732253|NCT00141778|10832301|FG000|COMPLETED|Randomization Prior to Study Med||147
9732254|NCT00141778|10832302|FG001|COMPLETED|Randomization Prior to Study Med||151
9732255|NCT00141778|10832303|FG002|COMPLETED|Randomization Prior to Study Med||147
9732256|NCT00141778|10832301|FG000|NOT COMPLETED|Randomization Prior to Study Med||5
9732257|NCT00141778|10832302|FG001|NOT COMPLETED|Randomization Prior to Study Med||2
9732258|NCT00141778|10832303|FG002|NOT COMPLETED|Randomization Prior to Study Med||6
9732259|NCT00141778|10832301|FG000|STARTED|Started Study Medication||147
9732260|NCT00141778|10832302|FG001|STARTED|Started Study Medication||151
9732261|NCT00141778|10832303|FG002|STARTED|Started Study Medication||147
9732262|NCT00141778|10832301|FG000|COMPLETED|Started Study Medication||145
9732263|NCT00141778|10832302|FG001|COMPLETED|Started Study Medication||144
9732264|NCT00141778|10832303|FG002|COMPLETED|Started Study Medication||143
9732265|NCT00141778|10832301|FG000|NOT COMPLETED|Started Study Medication||2
9732266|NCT00141778|10832302|FG001|NOT COMPLETED|Started Study Medication||7
9732267|NCT00141778|10832303|FG002|NOT COMPLETED|Started Study Medication||4
9732268|NCT00141817|10832315|FG000|STARTED|Overall Study||7
9732269|NCT00141817|10832316|FG001|STARTED|Overall Study||10
9732270|NCT00141817|10832317|FG002|STARTED|Overall Study||11
9732271|NCT00141817|10832318|FG003|STARTED|Overall Study||13
9732272|NCT00141817|10832315|FG000|COMPLETED|Overall Study||6
9732273|NCT00141817|10832316|FG001|COMPLETED|Overall Study||10
9732274|NCT00141817|10832317|FG002|COMPLETED|Overall Study||10
9732275|NCT00141817|10832318|FG003|COMPLETED|Overall Study||13
9732276|NCT00141817|10832315|FG000|NOT COMPLETED|Overall Study||1
9732277|NCT00141817|10832316|FG001|NOT COMPLETED|Overall Study||0
9732278|NCT00141817|10832317|FG002|NOT COMPLETED|Overall Study||1
9732279|NCT00141817|10832318|FG003|NOT COMPLETED|Overall Study||0
9732280|NCT00141921|10832328|FG000|STARTED|Overall Study||182
9732281|NCT00141921|10832328|FG000|Received Treatment|Overall Study||181
9732282|NCT00141921|10832328|FG000|COMPLETED|Overall Study||41
9732283|NCT00141921|10832328|FG000|NOT COMPLETED|Overall Study||141
9732284|NCT00142116|10832332|FG000|STARTED|Overall Study||25
9732285|NCT00142116|10832332|FG000|COMPLETED|Overall Study||25
9732286|NCT00142116|10832332|FG000|NOT COMPLETED|Overall Study||0
9732287|NCT00142168|10832337|FG000|STARTED|Overall Study||16
9732288|NCT00142168|10832337|FG000|COMPLETED|Overall Study||16
9732289|NCT00142168|10832337|FG000|NOT COMPLETED|Overall Study||0
9732290|NCT00142298|10832351|FG000|STARTED|Overall Study||667
9732291|NCT00142298|10832352|FG001|STARTED|Overall Study||632
9732292|NCT00142298|10832353|FG002|STARTED|Overall Study||123
9732293|NCT00142298|10832354|FG003|STARTED|Overall Study||206
9732294|NCT00142298|10832355|FG004|STARTED|Overall Study||56
9732295|NCT00142298|10832356|FG005|STARTED|Overall Study||26
9732296|NCT00142298|10832357|FG006|STARTED|Overall Study||23
9732297|NCT00142298|10832358|FG007|STARTED|Overall Study||66
9732298|NCT00142298|10832359|FG008|STARTED|Overall Study||57
9732299|NCT00142298|10832360|FG009|STARTED|Overall Study||13
9732300|NCT00142298|10832351|FG000|Safety Population|Overall Study||655
9732301|NCT00142298|10832352|FG001|Safety Population|Overall Study||626
9732302|NCT00142298|10832353|FG002|Safety Population|Overall Study||122
9732303|NCT00142298|10832354|FG003|Safety Population|Overall Study||206
9732304|NCT00142298|10832355|FG004|Safety Population|Overall Study||50
9732305|NCT00142298|10832356|FG005|Safety Population|Overall Study||26
9732306|NCT00142298|10832357|FG006|Safety Population|Overall Study||23
9732307|NCT00142298|10832358|FG007|Safety Population|Overall Study||66
9732308|NCT00142298|10832359|FG008|Safety Population|Overall Study||57
9732309|NCT00142298|10832360|FG009|Safety Population|Overall Study||13
9732310|NCT00142298|10832351|FG000|Per Protocol Population|Overall Study||635
9732311|NCT00142298|10832352|FG001|Per Protocol Population|Overall Study||606
9732312|NCT00142298|10832353|FG002|Per Protocol Population|Overall Study||120
9732313|NCT00142298|10832354|FG003|Per Protocol Population|Overall Study||202
9732314|NCT00142298|10832355|FG004|Per Protocol Population|Overall Study||50
9732315|NCT00142298|10832356|FG005|Per Protocol Population|Overall Study||25
9732316|NCT00142298|10832357|FG006|Per Protocol Population|Overall Study||19
9732317|NCT00142298|10832358|FG007|Per Protocol Population|Overall Study||64
9732318|NCT00142298|10832359|FG008|Per Protocol Population|Overall Study||56
9732319|NCT00142298|10832360|FG009|Per Protocol Population|Overall Study||13
9732320|NCT00142298|10832351|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507
9732321|NCT00142298|10832352|FG001|COMPLETED|Overall Study||456
9732322|NCT00142298|10832353|FG002|COMPLETED|Overall Study||90
9732323|NCT00142298|10832354|FG003|COMPLETED|Overall Study||121
9732324|NCT00142298|10832355|FG004|COMPLETED|Overall Study||46
9732325|NCT00142298|10832356|FG005|COMPLETED|Overall Study||10
9732326|NCT00142298|10832357|FG006|COMPLETED|Overall Study||15
9732327|NCT00142298|10832358|FG007|COMPLETED|Overall Study||58
9732328|NCT00142298|10832359|FG008|COMPLETED|Overall Study||52
9732329|NCT00142298|10832360|FG009|COMPLETED|Overall Study||13
9732330|NCT00142298|10832351|FG000|NOT COMPLETED|Overall Study||160
9732331|NCT00142298|10832352|FG001|NOT COMPLETED|Overall Study||176
9732332|NCT00142298|10832353|FG002|NOT COMPLETED|Overall Study||33
9732333|NCT00142298|10832354|FG003|NOT COMPLETED|Overall Study||85
9732334|NCT00142298|10832355|FG004|NOT COMPLETED|Overall Study||10
9732335|NCT00142298|10832356|FG005|NOT COMPLETED|Overall Study||16
9732336|NCT00142298|10832357|FG006|NOT COMPLETED|Overall Study||8
9732337|NCT00142298|10832358|FG007|NOT COMPLETED|Overall Study||8
9732338|NCT00142298|10832359|FG008|NOT COMPLETED|Overall Study||5
9732339|NCT00142298|10832360|FG009|NOT COMPLETED|Overall Study||0
9732340|NCT00142415|10832388|FG000|STARTED|Overall Study||3
9732341|NCT00142415|10832389|FG001|STARTED|Overall Study||3
9732342|NCT00142415|10832390|FG002|STARTED|Overall Study||6
9732343|NCT00142415|10832391|FG003|STARTED|Overall Study||3
9732344|NCT00142415|10832392|FG004|STARTED|Overall Study||3
9732345|NCT00142415|10832393|FG005|STARTED|Overall Study||8
9732346|NCT00142415|10832388|FG000|COMPLETED|Overall Study||3
9732347|NCT00142415|10832389|FG001|COMPLETED|Overall Study||3
9732348|NCT00142415|10832390|FG002|COMPLETED|Overall Study||6
9732349|NCT00142415|10832391|FG003|COMPLETED|Overall Study||3
9732350|NCT00142415|10832392|FG004|COMPLETED|Overall Study||2
9732351|NCT00142415|10832393|FG005|COMPLETED|Overall Study||6
9732352|NCT00142415|10832388|FG000|NOT COMPLETED|Overall Study||0
9732353|NCT00142415|10832389|FG001|NOT COMPLETED|Overall Study||0
9732354|NCT00142415|10832390|FG002|NOT COMPLETED|Overall Study||0
9732355|NCT00142415|10832391|FG003|NOT COMPLETED|Overall Study||0
9732356|NCT00142415|10832392|FG004|NOT COMPLETED|Overall Study||1
9732357|NCT00142415|10832393|FG005|NOT COMPLETED|Overall Study||2
9732358|NCT00142454|10832409|FG000|STARTED|Overall Study||9
9732359|NCT00142454|10832409|FG000|COMPLETED|Overall Study||9
9732360|NCT00142454|10832409|FG000|NOT COMPLETED|Overall Study||0
9732361|NCT00142506|10832415|FG000|STARTED|Overall Study||184
9732362|NCT00142506|10832416|FG001|STARTED|Overall Study||106
9732363|NCT00142506|10832415|FG000|COMPLETED|Overall Study||112
9732364|NCT00142506|10832416|FG001|COMPLETED|Overall Study||77
9732365|NCT00142506|10832415|FG000|NOT COMPLETED|Overall Study||72
9732366|NCT00142506|10832416|FG001|NOT COMPLETED|Overall Study||29
9732367|NCT00142597|10832424|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23
9732368|NCT00142597|10832425|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23
9732369|NCT00142597|10832424|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20
9732370|NCT00142597|10832425|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22
9732371|NCT00142597|10832424|FG000|NOT COMPLETED|Overall Study||3
9732372|NCT00142597|10832425|FG001|NOT COMPLETED|Overall Study||1
9732373|NCT00142792|10832434|FG000|STARTED|Overall Study||39
9732374|NCT00142792|10832435|FG001|STARTED|Overall Study||41
9732375|NCT00142792|10832436|FG002|STARTED|Overall Study||42
9732376|NCT00142792|10832434|FG000|Completed Intervention|Overall Study||35
9732377|NCT00142792|10832435|FG001|Completed Intervention|Overall Study||37
9732378|NCT00142792|10832436|FG002|Completed Intervention|Overall Study||37
9732379|NCT00142792|10832434|FG000|COMPLETED|Overall Study||27
9732380|NCT00142792|10832435|FG001|COMPLETED|Overall Study||26
9732381|NCT00142792|10832436|FG002|COMPLETED|Overall Study||30
9732382|NCT00142792|10832434|FG000|NOT COMPLETED|Overall Study||12
9732383|NCT00142792|10832435|FG001|NOT COMPLETED|Overall Study||15
9732384|NCT00142792|10832436|FG002|NOT COMPLETED|Overall Study||12
9732385|NCT00142818|10832448|FG000|STARTED|Overall Study||45
9732386|NCT00142818|10832449|FG001|STARTED|Overall Study||40
9732387|NCT00142818|10832450|FG002|STARTED|Overall Study||37
9732388|NCT00142818|10832451|FG003|STARTED|Overall Study||42
9732389|NCT00142818|10832448|FG000|COMPLETED|Overall Study||28
9732390|NCT00142818|10832449|FG001|COMPLETED|Overall Study||19
9732391|NCT00142818|10832450|FG002|COMPLETED|Overall Study||24
9732392|NCT00142818|10832451|FG003|COMPLETED|Overall Study||20
9732393|NCT00142818|10832448|FG000|NOT COMPLETED|Overall Study||17
9732394|NCT00142818|10832449|FG001|NOT COMPLETED|Overall Study||21
9732395|NCT00142818|10832450|FG002|NOT COMPLETED|Overall Study||13
9732396|NCT00142818|10832451|FG003|NOT COMPLETED|Overall Study||22
9732397|NCT00142909|10832467|FG000|STARTED|Randomization||42
9732398|NCT00142909|10832468|FG001|STARTED|Randomization||44
9732399|NCT00142909|10832467|FG000|COMPLETED|Randomization||35
9732400|NCT00142909|10832468|FG001|COMPLETED|Randomization||34
9732401|NCT00142909|10832467|FG000|NOT COMPLETED|Randomization||7
9732402|NCT00142909|10832468|FG001|NOT COMPLETED|Randomization||10
9732403|NCT00142909|10832467|FG000|STARTED|Medications Begin||35
9732404|NCT00142909|10832468|FG001|STARTED|Medications Begin||34
9732405|NCT00142909|10832467|FG000|COMPLETED|Medications Begin||26
9732406|NCT00142909|10832468|FG001|COMPLETED|Medications Begin||31
9732407|NCT00142909|10832467|FG000|NOT COMPLETED|Medications Begin||9
9732408|NCT00142909|10832468|FG001|NOT COMPLETED|Medications Begin||3
9732409|NCT00142935|10832477|FG000|STARTED|Overall Study||29
9732410|NCT00142935|10832478|FG001|STARTED|Overall Study||28
9732411|NCT00142935|10832479|FG002|STARTED|Overall Study||30
9732412|NCT00142935|10832477|FG000|COMPLETED|Overall Study||26
9732413|NCT00142935|10832478|FG001|COMPLETED|Overall Study||20
9732414|NCT00142935|10832479|FG002|COMPLETED|Overall Study||23
9732415|NCT00142935|10832477|FG000|NOT COMPLETED|Overall Study||3
9732416|NCT00142935|10832478|FG001|NOT COMPLETED|Overall Study||8
9732417|NCT00142935|10832479|FG002|NOT COMPLETED|Overall Study||7
9732418|NCT00143247|10832491|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
9732419|NCT00143247|10832491|FG000|COMPLETED|Overall Study||17
9732420|NCT00143247|10832491|FG000|NOT COMPLETED|Overall Study||156
9732421|NCT00143312|10832495|FG000|STARTED|Overall Study||45
9732422|NCT00143312|10832495|FG000|COMPLETED|Overall Study||29
9732423|NCT00143312|10832495|FG000|NOT COMPLETED|Overall Study||16
9732424|NCT00143390|10832501|FG000|STARTED|Overall Study||149
9732425|NCT00143390|10832502|FG001|STARTED|Overall Study||149
9732426|NCT00143390|10832501|FG000|COMPLETED|Overall Study||0
9732427|NCT00143390|10832502|FG001|COMPLETED|Overall Study||0
9732428|NCT00143390|10832501|FG000|NOT COMPLETED|Overall Study||149
9732429|NCT00143390|10832502|FG001|NOT COMPLETED|Overall Study||149
9732430|NCT00143403|10832510|FG000|STARTED|Overall Study||160
9732431|NCT00143403|10832511|FG001|STARTED|Overall Study||161
9732432|NCT00143403|10832510|FG000|Treated|Overall Study||153
9732433|NCT00143403|10832511|FG001|Treated|Overall Study||153
9732434|NCT00143403|10832510|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125
9732435|NCT00143403|10832511|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115
9732436|NCT00143403|10832510|FG000|NOT COMPLETED|Overall Study||35
9732437|NCT00143403|10832511|FG001|NOT COMPLETED|Overall Study||46
9732438|NCT00143455|10832521|FG000|STARTED|Cohort 1||39
9732439|NCT00143455|10832522|FG001|STARTED|Cohort 1||39
9732440|NCT00143455|10832523|FG002|STARTED|Cohort 1||0
9732441|NCT00143455|10832524|FG003|STARTED|Cohort 1||0
9732442|NCT00143455|10832521|FG000|Received Treatment|Cohort 1||39
9732443|NCT00143455|10832522|FG001|Received Treatment|Cohort 1||38
9732444|NCT00143455|10832523|FG002|Received Treatment|Cohort 1||0
9732445|NCT00143455|10832524|FG003|Received Treatment|Cohort 1||0
9732446|NCT00143455|10832521|FG000|COMPLETED|Cohort 1||25
9732447|NCT00143455|10832522|FG001|COMPLETED|Cohort 1||22
9732448|NCT00143455|10832523|FG002|COMPLETED|Cohort 1||0
9732449|NCT00143455|10832524|FG003|COMPLETED|Cohort 1||0
9732450|NCT00143455|10832521|FG000|NOT COMPLETED|Cohort 1||14
9732451|NCT00143455|10832522|FG001|NOT COMPLETED|Cohort 1||17
9732452|NCT00143455|10832523|FG002|NOT COMPLETED|Cohort 1||0
9732453|NCT00143455|10832524|FG003|NOT COMPLETED|Cohort 1||0
9732454|NCT00143455|10832521|FG000|STARTED|Cohort 2||0
9732455|NCT00143455|10832522|FG001|STARTED|Cohort 2||0
9732456|NCT00143455|10832523|FG002|STARTED|Cohort 2||203
9732457|NCT00143455|10832524|FG003|STARTED|Cohort 2||204
9732458|NCT00143455|10832521|FG000|Received Treatment|Cohort 2||0
9732459|NCT00143455|10832522|FG001|Received Treatment|Cohort 2||0
9732460|NCT00143455|10832523|FG002|Received Treatment|Cohort 2||202
9732461|NCT00143455|10832524|FG003|Received Treatment|Cohort 2||203
9732462|NCT00143455|10832521|FG000|COMPLETED|Cohort 2||0
9732463|NCT00143455|10832522|FG001|COMPLETED|Cohort 2||0
9732464|NCT00143455|10832523|FG002|COMPLETED|Cohort 2||97
9732465|NCT00143455|10832524|FG003|COMPLETED|Cohort 2||111
9732466|NCT00143455|10832521|FG000|NOT COMPLETED|Cohort 2||0
9732467|NCT00143455|10832522|FG001|NOT COMPLETED|Cohort 2||0
9732468|NCT00143455|10832523|FG002|NOT COMPLETED|Cohort 2||106
9732469|NCT00143455|10832524|FG003|NOT COMPLETED|Cohort 2||93
9732470|NCT00143507|10832538|FG000|STARTED|Overall Study||5479
9732471|NCT00143507|10832539|FG001|STARTED|Overall Study||5438
9732472|NCT00143507|10832538|FG000|COMPLETED|Overall Study||4792
9732473|NCT00143507|10832539|FG001|COMPLETED|Overall Study||4786
9732474|NCT00143507|10832538|FG000|NOT COMPLETED|Overall Study||687
9732475|NCT00143507|10832539|FG001|NOT COMPLETED|Overall Study||652
9732476|NCT00143598|10832547|FG000|STARTED|Overall Study||410
9732477|NCT00143598|10832548|FG001|STARTED|Overall Study||396
9732478|NCT00143598|10832547|FG000|COMPLETED|Overall Study||318
9732479|NCT00143598|10832548|FG001|COMPLETED|Overall Study||302
9732480|NCT00143598|10832547|FG000|NOT COMPLETED|Overall Study||92
9732481|NCT00143598|10832548|FG001|NOT COMPLETED|Overall Study||94
9732482|NCT00143819|10832556|FG000|STARTED|Overall Study||5
9732483|NCT00143819|10832557|FG001|STARTED|Overall Study||8
9732484|NCT00143819|10832556|FG000|COMPLETED|Overall Study||3
9732485|NCT00143819|10832557|FG001|COMPLETED|Overall Study||5
9732486|NCT00143819|10832556|FG000|NOT COMPLETED|Overall Study||2
9732487|NCT00143819|10832557|FG001|NOT COMPLETED|Overall Study||3
9732488|NCT00143845|10832567|FG000|STARTED|Overall Study||54
9732489|NCT00143845|10832567|FG000|COMPLETED|Overall Study||54
9732490|NCT00143845|10832567|FG000|NOT COMPLETED|Overall Study||0
9732491|NCT00144027|10832573|FG000|STARTED|Overall Study|participants who consented|39
9732492|NCT00144027|10832574|FG001|STARTED|Overall Study|participants who consented|36
9732493|NCT00144027|10832573|FG000|Completed Baseline Assessment|Overall Study||39
9732494|NCT00144027|10832574|FG001|Completed Baseline Assessment|Overall Study||29
9732495|NCT00144027|10832573|FG000|Completed 6 Month Assessment|Overall Study||37
9732496|NCT00144027|10832574|FG001|Completed 6 Month Assessment|Overall Study||24
9732497|NCT00144027|10832573|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
9732498|NCT00144027|10832574|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
9732499|NCT00144027|10832573|FG000|NOT COMPLETED|Overall Study||3
9732500|NCT00144027|10832574|FG001|NOT COMPLETED|Overall Study||11
9732501|NCT00144170|10832582|FG000|STARTED|Overall Study||438
9732502|NCT00144170|10832583|FG001|STARTED|Overall Study||428
9732503|NCT00144170|10832582|FG000|COMPLETED|Overall Study||86
9732504|NCT00144170|10832583|FG001|COMPLETED|Overall Study||32
9732505|NCT00144170|10832582|FG000|NOT COMPLETED|Overall Study||352
9732506|NCT00144170|10832583|FG001|NOT COMPLETED|Overall Study||396
9732507|NCT00144300|10832591|FG000|STARTED|Overall Study||121
9732508|NCT00144300|10832592|FG001|STARTED|Overall Study||125
9732509|NCT00144300|10832591|FG000|COMPLETED|Overall Study||92
9732510|NCT00144300|10832592|FG001|COMPLETED|Overall Study||97
9732511|NCT00144300|10832591|FG000|NOT COMPLETED|Overall Study||29
9732512|NCT00144300|10832592|FG001|NOT COMPLETED|Overall Study||28
9732513|NCT00144339|10832600|FG000|STARTED|Overall Study||3006
9732514|NCT00144339|10832601|FG001|STARTED|Overall Study||2986
9732515|NCT00144339|10832600|FG000|COMPLETED|Overall Study||1648
9732516|NCT00144339|10832601|FG001|COMPLETED|Overall Study||1887
9732517|NCT00144339|10832600|FG000|NOT COMPLETED|Overall Study||1358
9732518|NCT00144339|10832601|FG001|NOT COMPLETED|Overall Study||1099
9732519|NCT00144391|10832609|FG000|STARTED|Overall Study||11
9732520|NCT00144391|10832610|FG001|STARTED|Overall Study||9
9732521|NCT00144391|10832609|FG000|COMPLETED|Overall Study||11
9732522|NCT00144391|10832610|FG001|COMPLETED|Overall Study||9
9732523|NCT00144391|10832609|FG000|NOT COMPLETED|Overall Study||0
9732524|NCT00144391|10832610|FG001|NOT COMPLETED|Overall Study||0
9732525|NCT00144781|10832620|FG000|STARTED|Overall Study||8
9732526|NCT00144781|10832621|FG001|STARTED|Overall Study||9
9732527|NCT00144781|10832622|FG002|STARTED|Overall Study||8
9732528|NCT00144781|10832623|FG003|STARTED|Overall Study||9
9732529|NCT00144781|10832620|FG000|COMPLETED|Overall Study||8
9732530|NCT00144781|10832621|FG001|COMPLETED|Overall Study||7
9732531|NCT00144781|10832622|FG002|COMPLETED|Overall Study||8
9732532|NCT00144781|10832623|FG003|COMPLETED|Overall Study||9
9732533|NCT00144781|10832620|FG000|NOT COMPLETED|Overall Study||0
9732534|NCT00144781|10832621|FG001|NOT COMPLETED|Overall Study||2
9732535|NCT00144781|10832622|FG002|NOT COMPLETED|Overall Study||0
9732536|NCT00144781|10832623|FG003|NOT COMPLETED|Overall Study||0
9732537|NCT00144963|10832633|FG000|STARTED|Overall Study||36
9732538|NCT00144963|10832633|FG000|COMPLETED|Overall Study||36
9732539|NCT00144963|10832633|FG000|NOT COMPLETED|Overall Study||0
9732540|NCT00145041|10832637|FG000|STARTED|Overall Study||7
9732541|NCT00145041|10832637|FG000|COMPLETED|Overall Study||7
9732542|NCT00145041|10832637|FG000|NOT COMPLETED|Overall Study||0
9732543|NCT00145119|10832641|FG000|STARTED|Overall Study||312
9732544|NCT00145119|10832641|FG000|COMPLETED|Overall Study||267
9732545|NCT00145119|10832641|FG000|NOT COMPLETED|Overall Study||45
9732546|NCT00145145|10832645|FG000|STARTED|Overall Study||1
9732547|NCT00145145|10832645|FG000|COMPLETED|Overall Study||1
9732548|NCT00145145|10832645|FG000|NOT COMPLETED|Overall Study||0
9732549|NCT00145249|10832652|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
9732550|NCT00145249|10832653|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
9732551|NCT00145249|10832654|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
9732552|NCT00145249|10832652|FG000|COMPLETED|Overall Study||36
9732553|NCT00145249|10832653|FG001|COMPLETED|Overall Study||33
9732554|NCT00145249|10832654|FG002|COMPLETED|Overall Study||31
9732555|NCT00145249|10832652|FG000|NOT COMPLETED|Overall Study||11
9732556|NCT00145249|10832653|FG001|NOT COMPLETED|Overall Study||15
9732557|NCT00145249|10832654|FG002|NOT COMPLETED|Overall Study||17
9732558|NCT00145327|10832665|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
9732559|NCT00145327|10832666|FG001|STARTED|Overall Study||617
9732560|NCT00145327|10832667|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
9732561|NCT00145327|10832665|FG000|COMPLETED|Overall Study||474
9732562|NCT00145327|10832666|FG001|COMPLETED|Overall Study||493
9732563|NCT00145327|10832667|FG002|COMPLETED|Overall Study||975
9732564|NCT00145327|10832665|FG000|NOT COMPLETED|Overall Study||142
9732565|NCT00145327|10832666|FG001|NOT COMPLETED|Overall Study||124
9732566|NCT00145327|10832667|FG002|NOT COMPLETED|Overall Study||248
9732567|NCT00145418|10832675|FG000|STARTED|Overall Study||15
9732568|NCT00145418|10832675|FG000|COMPLETED|Overall Study||15
9732569|NCT00145418|10832675|FG000|NOT COMPLETED|Overall Study||0
9732570|NCT00145574|10832682|FG000|STARTED|Double Blind||65
9732571|NCT00145574|10832683|FG001|STARTED|Double Blind||65
9732572|NCT00145574|10832684|FG002|STARTED|Double Blind||64
9732573|NCT00145574|10832682|FG000|COMPLETED|Double Blind||64
9732574|NCT00145574|10832683|FG001|COMPLETED|Double Blind||60
9732575|NCT00145574|10832684|FG002|COMPLETED|Double Blind||62
9732576|NCT00145574|10832682|FG000|NOT COMPLETED|Double Blind||1
9732577|NCT00145574|10832683|FG001|NOT COMPLETED|Double Blind||5
9732578|NCT00145574|10832684|FG002|NOT COMPLETED|Double Blind||2
9732579|NCT00145574|10832682|FG000|STARTED|Open Label Long-term Extension||0
9732580|NCT00145574|10832683|FG001|STARTED|Open Label Long-term Extension||0
9732581|NCT00145574|10832684|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
9732582|NCT00145574|10832682|FG000|COMPLETED|Open Label Long-term Extension||0
9732583|NCT00145574|10832683|FG001|COMPLETED|Open Label Long-term Extension||0
9732584|NCT00145574|10832684|FG002|COMPLETED|Open Label Long-term Extension||173
9732585|NCT00145574|10832682|FG000|NOT COMPLETED|Open Label Long-term Extension||0
9732586|NCT00145574|10832683|FG001|NOT COMPLETED|Open Label Long-term Extension||0
9732587|NCT00145574|10832684|FG002|NOT COMPLETED|Open Label Long-term Extension||11
9732588|NCT00145587|10832699|FG000|STARTED|Overall Study||5
9732589|NCT00145587|10832700|FG001|STARTED|Overall Study||1
9732590|NCT00145587|10832699|FG000|COMPLETED|Overall Study||5
9732591|NCT00145587|10832700|FG001|COMPLETED|Overall Study||1
9732592|NCT00145587|10832699|FG000|NOT COMPLETED|Overall Study||0
9732593|NCT00145587|10832700|FG001|NOT COMPLETED|Overall Study||0
9732594|NCT00145626|10832708|FG000|STARTED|Overall Study||19
9732595|NCT00145626|10832708|FG000|COMPLETED|Overall Study||14
9732596|NCT00145626|10832708|FG000|NOT COMPLETED|Overall Study||5
9732597|NCT00145977|10832730|FG000|STARTED|Overall Study||19
9732598|NCT00145977|10832731|FG001|STARTED|Overall Study||17
9732599|NCT00145977|10832730|FG000|COMPLETED|Overall Study||17
9732600|NCT00145977|10832731|FG001|COMPLETED|Overall Study||13
9732601|NCT00145977|10832730|FG000|NOT COMPLETED|Overall Study||2
9732602|NCT00145977|10832731|FG001|NOT COMPLETED|Overall Study||4
9732603|NCT00146172|10832745|FG000|STARTED|Overall Study||3
9732604|NCT00146172|10832746|FG001|STARTED|Overall Study||4
9732605|NCT00146172|10832747|FG002|STARTED|Overall Study||4
9732606|NCT00146172|10832748|FG003|STARTED|Overall Study||6
9732607|NCT00146172|10832749|FG004|STARTED|Overall Study||3
9732608|NCT00146172|10832750|FG005|STARTED|Overall Study||7
9732609|NCT00146172|10832751|FG006|STARTED|Overall Study||6
9732610|NCT00146172|10832752|FG007|STARTED|Overall Study||40
9732611|NCT00146172|10832745|FG000|Received Drug|Overall Study||3
9732612|NCT00146172|10832746|FG001|Received Drug|Overall Study||4
9732613|NCT00146172|10832747|FG002|Received Drug|Overall Study||4
9732614|NCT00146172|10832748|FG003|Received Drug|Overall Study||6
9732615|NCT00146172|10832749|FG004|Received Drug|Overall Study||3
9732616|NCT00146172|10832750|FG005|Received Drug|Overall Study||7
9732617|NCT00146172|10832751|FG006|Received Drug|Overall Study||6
9732618|NCT00146172|10832752|FG007|Received Drug|Overall Study||39
9732619|NCT00146172|10832745|FG000|COMPLETED|Overall Study||0
9732620|NCT00146172|10832746|FG001|COMPLETED|Overall Study||0
9732621|NCT00146172|10832747|FG002|COMPLETED|Overall Study||0
9732622|NCT00146172|10832748|FG003|COMPLETED|Overall Study||0
9732623|NCT00146172|10832749|FG004|COMPLETED|Overall Study||0
9732624|NCT00146172|10832750|FG005|COMPLETED|Overall Study||0
9732625|NCT00146172|10832751|FG006|COMPLETED|Overall Study||0
9732626|NCT00146172|10832752|FG007|COMPLETED|Overall Study||0
9732627|NCT00146172|10832745|FG000|NOT COMPLETED|Overall Study||3
9732628|NCT00146172|10832746|FG001|NOT COMPLETED|Overall Study||4
9732629|NCT00146172|10832747|FG002|NOT COMPLETED|Overall Study||4
9732630|NCT00146172|10832748|FG003|NOT COMPLETED|Overall Study||6
9732631|NCT00146172|10832749|FG004|NOT COMPLETED|Overall Study||3
9732632|NCT00146172|10832750|FG005|NOT COMPLETED|Overall Study||7
9732633|NCT00146172|10832751|FG006|NOT COMPLETED|Overall Study||6
9732634|NCT00146172|10832752|FG007|NOT COMPLETED|Overall Study||40
9732635|NCT00146328|10832781|FG000|STARTED|Overall Study||291
9732636|NCT00146328|10832782|FG001|STARTED|Overall Study||255
9732637|NCT00146328|10832783|FG002|STARTED|Overall Study||449
9732638|NCT00146328|10832781|FG000|COMPLETED|Overall Study||150
9732639|NCT00146328|10832782|FG001|COMPLETED|Overall Study||101
9732640|NCT00146328|10832783|FG002|COMPLETED|Overall Study||158
9732641|NCT00146328|10832781|FG000|NOT COMPLETED|Overall Study||141
9732642|NCT00146328|10832782|FG001|NOT COMPLETED|Overall Study||154
9732643|NCT00146328|10832783|FG002|NOT COMPLETED|Overall Study||291
9732644|NCT00146640|10832793|FG000|STARTED|Overall Study||144
9732645|NCT00146640|10832794|FG001|STARTED|Overall Study||144
9732646|NCT00146640|10832793|FG000|COMPLETED|Overall Study||121
9732647|NCT00146640|10832794|FG001|COMPLETED|Overall Study||130
9732648|NCT00146640|10832793|FG000|NOT COMPLETED|Overall Study||23
9732649|NCT00146640|10832794|FG001|NOT COMPLETED|Overall Study||14
9732650|NCT00146757|10832800|FG000|STARTED|Overall Study||16
9732651|NCT00146757|10832801|FG001|STARTED|Overall Study||4
9732652|NCT00146757|10832800|FG000|COMPLETED|Overall Study||14
9732653|NCT00146757|10832801|FG001|COMPLETED|Overall Study||4
9732654|NCT00146757|10832800|FG000|NOT COMPLETED|Overall Study||2
9732655|NCT00146757|10832801|FG001|NOT COMPLETED|Overall Study||0
9732656|NCT00146770|10832809|FG000|STARTED|Overall Study||23
9732657|NCT00146770|10832810|FG001|STARTED|Overall Study||22
9732658|NCT00146770|10832809|FG000|COMPLETED|Overall Study||18
9732659|NCT00146770|10832810|FG001|COMPLETED|Overall Study||22
9732660|NCT00146770|10832809|FG000|NOT COMPLETED|Overall Study||5
9732661|NCT00146770|10832810|FG001|NOT COMPLETED|Overall Study||0
9732662|NCT00146848|10832819|FG000|STARTED|Pre-randomization|Registered|1742
9732663|NCT00146848|10832820|FG001|STARTED|Pre-randomization||0
9732664|NCT00146848|10832821|FG002|STARTED|Pre-randomization||0
9732665|NCT00146848|10832819|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
9732666|NCT00146848|10832820|FG001|COMPLETED|Pre-randomization||0
9732667|NCT00146848|10832821|FG002|COMPLETED|Pre-randomization||0
9732668|NCT00146848|10832819|FG000|NOT COMPLETED|Pre-randomization||309
9732669|NCT00146848|10832820|FG001|NOT COMPLETED|Pre-randomization||0
9732670|NCT00146848|10832821|FG002|NOT COMPLETED|Pre-randomization||0
9732671|NCT00146848|10832819|FG000|STARTED|Post-randomization||475
9732672|NCT00146848|10832820|FG001|STARTED|Post-randomization||488
9732673|NCT00146848|10832821|FG002|STARTED|Post-randomization||470
9732674|NCT00146848|10832819|FG000|COMPLETED|Post-randomization||437
9732675|NCT00146848|10832820|FG001|COMPLETED|Post-randomization||441
9732676|NCT00146848|10832821|FG002|COMPLETED|Post-randomization||431
9732677|NCT00146848|10832819|FG000|NOT COMPLETED|Post-randomization||38
9732678|NCT00146848|10832820|FG001|NOT COMPLETED|Post-randomization||47
9732679|NCT00146848|10832821|FG002|NOT COMPLETED|Post-randomization||39
9732680|NCT00147017|10832832|FG000|STARTED|Overall Study||6
9732681|NCT00147017|10832833|FG001|STARTED|Overall Study||7
9732682|NCT00147017|10832834|FG002|STARTED|Overall Study||4
9732683|NCT00147017|10832832|FG000|COMPLETED|Overall Study||6
9732684|NCT00147017|10832833|FG001|COMPLETED|Overall Study||7
9732685|NCT00147017|10832834|FG002|COMPLETED|Overall Study||4
9732686|NCT00147017|10832832|FG000|NOT COMPLETED|Overall Study||0
9732687|NCT00147017|10832833|FG001|NOT COMPLETED|Overall Study||0
9732688|NCT00147017|10832834|FG002|NOT COMPLETED|Overall Study||0
9732689|NCT00147030|10832844|FG000|STARTED|Overall Study||163
9732690|NCT00147030|10832845|FG001|STARTED|Overall Study||162
9732691|NCT00147030|10832844|FG000|COMPLETED|Overall Study||163
9732692|NCT00147030|10832845|FG001|COMPLETED|Overall Study||162
9732693|NCT00147030|10832844|FG000|NOT COMPLETED|Overall Study||0
9732694|NCT00147030|10832845|FG001|NOT COMPLETED|Overall Study||0
9732695|NCT00147043|10832853|FG000|STARTED|Overall Study||5
9732696|NCT00147043|10832853|FG000|COMPLETED|Overall Study||5
9732697|NCT00147043|10832853|FG000|NOT COMPLETED|Overall Study||0
9732698|NCT00147069|10832862|FG000|STARTED|Overall Study||15
9732699|NCT00147069|10832863|FG001|STARTED|Overall Study||15
9732700|NCT00147069|10832864|FG002|STARTED|Overall Study||15
9732701|NCT00147069|10832865|FG003|STARTED|Overall Study||15
9732702|NCT00147069|10832862|FG000|COMPLETED|Overall Study||15
9732703|NCT00147069|10832863|FG001|COMPLETED|Overall Study||15
9732704|NCT00147069|10832864|FG002|COMPLETED|Overall Study||15
9732705|NCT00147069|10832865|FG003|COMPLETED|Overall Study||15
9732706|NCT00147069|10832862|FG000|NOT COMPLETED|Overall Study||0
9732707|NCT00147069|10832863|FG001|NOT COMPLETED|Overall Study||0
9732708|NCT00147069|10832864|FG002|NOT COMPLETED|Overall Study||0
9732709|NCT00147069|10832865|FG003|NOT COMPLETED|Overall Study||0
9732710|NCT00147082|10832878|FG000|STARTED|Overall Study||37
9732711|NCT00147082|10832879|FG001|STARTED|Overall Study||33
9732712|NCT00147082|10832880|FG002|STARTED|Overall Study||30
9732713|NCT00147082|10832878|FG000|COMPLETED|Overall Study||37
9732714|NCT00147082|10832879|FG001|COMPLETED|Overall Study||33
9732715|NCT00147082|10832880|FG002|COMPLETED|Overall Study||30
9732716|NCT00147082|10832878|FG000|NOT COMPLETED|Overall Study||0
9732717|NCT00147082|10832879|FG001|NOT COMPLETED|Overall Study||0
9732718|NCT00147082|10832880|FG002|NOT COMPLETED|Overall Study||0
9732719|NCT00147199|10832890|FG000|STARTED|Overall Study||115
9732720|NCT00147199|10832891|FG001|STARTED|Overall Study||120
9732721|NCT00147199|10832890|FG000|COMPLETED|Overall Study||102
9732722|NCT00147199|10832891|FG001|COMPLETED|Overall Study||110
9732723|NCT00147199|10832890|FG000|NOT COMPLETED|Overall Study||13
9732724|NCT00147199|10832891|FG001|NOT COMPLETED|Overall Study||10
9732725|NCT00147212|10832897|FG000|STARTED|Overall Study||50
9732726|NCT00147212|10832897|FG000|COMPLETED|Overall Study||50
9732727|NCT00147212|10832897|FG000|NOT COMPLETED|Overall Study||0
9732728|NCT00147225|10832907|FG000|STARTED|Overall Study||7
9732729|NCT00147225|10832908|FG001|STARTED|Overall Study||6
9732730|NCT00147225|10832909|FG002|STARTED|Overall Study||8
9732731|NCT00147225|10832910|FG003|STARTED|Overall Study||11
9732732|NCT00147225|10832911|FG004|STARTED|Overall Study||11
9732733|NCT00147225|10832912|FG005|STARTED|Overall Study||12
9732734|NCT00147225|10832907|FG000|COMPLETED|Overall Study||6
9732735|NCT00147225|10832908|FG001|COMPLETED|Overall Study||6
9732736|NCT00147225|10832909|FG002|COMPLETED|Overall Study||6
9732737|NCT00147225|10832910|FG003|COMPLETED|Overall Study||10
9732738|NCT00147225|10832911|FG004|COMPLETED|Overall Study||10
9732739|NCT00147225|10832912|FG005|COMPLETED|Overall Study||10
9732740|NCT00147225|10832907|FG000|NOT COMPLETED|Overall Study||1
9732741|NCT00147225|10832908|FG001|NOT COMPLETED|Overall Study||0
9732742|NCT00147225|10832909|FG002|NOT COMPLETED|Overall Study||2
9732743|NCT00147225|10832910|FG003|NOT COMPLETED|Overall Study||1
9732744|NCT00147225|10832911|FG004|NOT COMPLETED|Overall Study||1
9732745|NCT00147225|10832912|FG005|NOT COMPLETED|Overall Study||2
9732746|NCT00147251|10832928|FG000|STARTED|Recruitment and Enrollment||271
9732747|NCT00147251|10832929|FG001|STARTED|Recruitment and Enrollment||277
9732748|NCT00147251|10832928|FG000|COMPLETED|Recruitment and Enrollment||247
9732749|NCT00147251|10832929|FG001|COMPLETED|Recruitment and Enrollment||252
9732750|NCT00147251|10832928|FG000|NOT COMPLETED|Recruitment and Enrollment||24
9732751|NCT00147251|10832929|FG001|NOT COMPLETED|Recruitment and Enrollment||25
9732752|NCT00147251|10832928|FG000|STARTED|Follow up||247
9732753|NCT00147251|10832929|FG001|STARTED|Follow up||252
9732754|NCT00147251|10832928|FG000|COMPLETED|Follow up||247
9732755|NCT00147251|10832929|FG001|COMPLETED|Follow up||252
9732756|NCT00147251|10832928|FG000|NOT COMPLETED|Follow up||0
9732757|NCT00147251|10832929|FG001|NOT COMPLETED|Follow up||0
9732758|NCT00147316|10832937|FG000|STARTED|Overall Study||103
9732759|NCT00147316|10832937|FG000|COMPLETED|Overall Study||103
9732760|NCT00147316|10832937|FG000|NOT COMPLETED|Overall Study||0
9732761|NCT00147446|10832943|FG000|STARTED|Overall Study||60
9732762|NCT00147446|10832944|FG001|STARTED|Overall Study||61
9732763|NCT00147446|10832943|FG000|COMPLETED|Overall Study||60
9732764|NCT00147446|10832944|FG001|COMPLETED|Overall Study||61
9732765|NCT00147446|10832943|FG000|NOT COMPLETED|Overall Study||0
9732766|NCT00147446|10832944|FG001|NOT COMPLETED|Overall Study||0
9732767|NCT00147498|10832956|FG000|STARTED|Overall Study||61
9732768|NCT00147498|10832957|FG001|STARTED|Overall Study||69
9732769|NCT00147498|10832958|FG002|STARTED|Overall Study||69
9732770|NCT00147498|10832959|FG003|STARTED|Overall Study||65
9732771|NCT00147498|10832956|FG000|COMPLETED|Overall Study||58
9732772|NCT00147498|10832957|FG001|COMPLETED|Overall Study||60
9732773|NCT00147498|10832958|FG002|COMPLETED|Overall Study||52
9732774|NCT00147498|10832959|FG003|COMPLETED|Overall Study||48
9732775|NCT00147498|10832956|FG000|NOT COMPLETED|Overall Study||3
9732776|NCT00147498|10832957|FG001|NOT COMPLETED|Overall Study||9
9732777|NCT00147498|10832958|FG002|NOT COMPLETED|Overall Study||17
9732778|NCT00147498|10832959|FG003|NOT COMPLETED|Overall Study||17
9732779|NCT00147537|10832973|FG000|STARTED|Phase 1b||3
9732780|NCT00147537|10832974|FG001|STARTED|Phase 1b||2
9732781|NCT00147537|10832975|FG002|STARTED|Phase 1b||4
9732782|NCT00147537|10832976|FG003|STARTED|Phase 1b||3
9732783|NCT00147537|10832977|FG004|STARTED|Phase 1b||3
9732784|NCT00147537|10832978|FG005|STARTED|Phase 1b||3
9732785|NCT00147537|10832979|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
9732786|NCT00147537|10832980|FG007|STARTED|Phase 1b||7
9732787|NCT00147537|10832981|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
9732788|NCT00147537|10832982|FG009|STARTED|Phase 1b||0
9732789|NCT00147537|10832983|FG010|STARTED|Phase 1b||0
9732790|NCT00147537|10832973|FG000|COMPLETED|Phase 1b||1
9732791|NCT00147537|10832974|FG001|COMPLETED|Phase 1b||0
9732792|NCT00147537|10832975|FG002|COMPLETED|Phase 1b||0
9732793|NCT00147537|10832976|FG003|COMPLETED|Phase 1b||1
9732794|NCT00147537|10832977|FG004|COMPLETED|Phase 1b||0
9732795|NCT00147537|10832978|FG005|COMPLETED|Phase 1b||0
9732796|NCT00147537|10832979|FG006|COMPLETED|Phase 1b||0
9732797|NCT00147537|10832980|FG007|COMPLETED|Phase 1b||0
9732798|NCT00147537|10832981|FG008|COMPLETED|Phase 1b||1
9732799|NCT00147537|10832982|FG009|COMPLETED|Phase 1b||0
9732800|NCT00147537|10832983|FG010|COMPLETED|Phase 1b||0
9732801|NCT00147537|10832973|FG000|NOT COMPLETED|Phase 1b||2
9732802|NCT00147537|10832974|FG001|NOT COMPLETED|Phase 1b||2
9732803|NCT00147537|10832975|FG002|NOT COMPLETED|Phase 1b||4
9732804|NCT00147537|10832976|FG003|NOT COMPLETED|Phase 1b||2
9732805|NCT00147537|10832977|FG004|NOT COMPLETED|Phase 1b||3
9732806|NCT00147537|10832978|FG005|NOT COMPLETED|Phase 1b||3
9732807|NCT00147537|10832979|FG006|NOT COMPLETED|Phase 1b||18
9732808|NCT00147537|10832980|FG007|NOT COMPLETED|Phase 1b||7
9732809|NCT00147537|10832981|FG008|NOT COMPLETED|Phase 1b||17
9732810|NCT00147537|10832982|FG009|NOT COMPLETED|Phase 1b||0
9732811|NCT00147537|10832983|FG010|NOT COMPLETED|Phase 1b||0
9732812|NCT00147537|10832973|FG000|STARTED|Phase 2||0
9732813|NCT00147537|10832974|FG001|STARTED|Phase 2||0
9732814|NCT00147537|10832975|FG002|STARTED|Phase 2||0
9732815|NCT00147537|10832976|FG003|STARTED|Phase 2||0
9732816|NCT00147537|10832977|FG004|STARTED|Phase 2||0
9732817|NCT00147537|10832978|FG005|STARTED|Phase 2||0
9732818|NCT00147537|10832979|FG006|STARTED|Phase 2||0
9732819|NCT00147537|10832980|FG007|STARTED|Phase 2||0
9732820|NCT00147537|10832981|FG008|STARTED|Phase 2||0
9732821|NCT00147537|10832982|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
9732822|NCT00147537|10832983|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
9732823|NCT00147537|10832973|FG000|COMPLETED|Phase 2||0
9732824|NCT00147537|10832974|FG001|COMPLETED|Phase 2||0
9732825|NCT00147537|10832975|FG002|COMPLETED|Phase 2||0
9732826|NCT00147537|10832976|FG003|COMPLETED|Phase 2||0
9732827|NCT00147537|10832977|FG004|COMPLETED|Phase 2||0
9732828|NCT00147537|10832978|FG005|COMPLETED|Phase 2||0
9732829|NCT00147537|10832979|FG006|COMPLETED|Phase 2||0
9732830|NCT00147537|10832980|FG007|COMPLETED|Phase 2||0
9732831|NCT00147537|10832981|FG008|COMPLETED|Phase 2||0
9732832|NCT00147537|10832982|FG009|COMPLETED|Phase 2||5
9732833|NCT00147537|10832983|FG010|COMPLETED|Phase 2||3
9732834|NCT00147537|10832973|FG000|NOT COMPLETED|Phase 2||0
9732835|NCT00147537|10832974|FG001|NOT COMPLETED|Phase 2||0
9732836|NCT00147537|10832975|FG002|NOT COMPLETED|Phase 2||0
9732837|NCT00147537|10832976|FG003|NOT COMPLETED|Phase 2||0
9732838|NCT00147537|10832977|FG004|NOT COMPLETED|Phase 2||0
9732839|NCT00147537|10832978|FG005|NOT COMPLETED|Phase 2||0
9732840|NCT00147537|10832979|FG006|NOT COMPLETED|Phase 2||0
9732841|NCT00147537|10832980|FG007|NOT COMPLETED|Phase 2||0
9732842|NCT00147537|10832981|FG008|NOT COMPLETED|Phase 2||0
9732843|NCT00147537|10832982|FG009|NOT COMPLETED|Phase 2||161
9732844|NCT00147537|10832983|FG010|NOT COMPLETED|Phase 2||52
9732845|NCT00147745|10833031|FG000|STARTED|Overall Study||16
9732846|NCT00147745|10833032|FG001|STARTED|Overall Study||14
9732847|NCT00147745|10833033|FG002|STARTED|Overall Study||6
9732848|NCT00147745|10833031|FG000|COMPLETED|Overall Study||15
9732849|NCT00147745|10833032|FG001|COMPLETED|Overall Study||14
9732850|NCT00147745|10833033|FG002|COMPLETED|Overall Study||6
9732851|NCT00147745|10833031|FG000|NOT COMPLETED|Overall Study||1
9732852|NCT00147745|10833032|FG001|NOT COMPLETED|Overall Study||0
9732853|NCT00147745|10833033|FG002|NOT COMPLETED|Overall Study||0
9732854|NCT00147823|10833043|FG000|STARTED|Overall Study||32
9732855|NCT00147823|10833044|FG001|STARTED|Overall Study||31
9732856|NCT00147823|10833043|FG000|Week 6 Visit|Overall Study||26
9732857|NCT00147823|10833044|FG001|Week 6 Visit|Overall Study||28
9732858|NCT00147823|10833043|FG000|Month 3 Visit|Overall Study||25
9732859|NCT00147823|10833044|FG001|Month 3 Visit|Overall Study||24
9732860|NCT00147823|10833043|FG000|Month 6 Visit|Overall Study||25
9732861|NCT00147823|10833044|FG001|Month 6 Visit|Overall Study||21
9732862|NCT00147823|10833043|FG000|Month 12 Visit|Overall Study||21
9732863|NCT00147823|10833044|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
9732864|NCT00147823|10833043|FG000|Month 12 CT Scan|Overall Study||20
9732865|NCT00147823|10833044|FG001|Month 12 CT Scan|Overall Study||25
9732866|NCT00147823|10833043|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
9732867|NCT00147823|10833044|FG001|Month 18 Visit|Overall Study||20
9732868|NCT00147823|10833043|FG000|Month 24 Visit|Overall Study||21
9732869|NCT00147823|10833044|FG001|Month 24 Visit|Overall Study||18
9732870|NCT00147823|10833043|FG000|COMPLETED|Overall Study||19
9732871|NCT00147823|10833044|FG001|COMPLETED|Overall Study||16
9732872|NCT00147823|10833043|FG000|NOT COMPLETED|Overall Study||13
9732873|NCT00147823|10833044|FG001|NOT COMPLETED|Overall Study||15
9732874|NCT00147966|10833050|FG000|STARTED|Overall Study||24
9732875|NCT00147966|10833050|FG000|COMPLETED|Overall Study||24
9732876|NCT00147966|10833050|FG000|NOT COMPLETED|Overall Study||0
9732877|NCT00148109|10833056|FG000|STARTED|Overall Study||15
9732878|NCT00148109|10833057|FG001|STARTED|Overall Study||21
9732879|NCT00148109|10833056|FG000|COMPLETED|Overall Study||3
9732880|NCT00148109|10833057|FG001|COMPLETED|Overall Study||1
9732881|NCT00148109|10833056|FG000|NOT COMPLETED|Overall Study||12
9732882|NCT00148109|10833057|FG001|NOT COMPLETED|Overall Study||20
9732883|NCT00148122|10833063|FG000|STARTED|Overall Study||40
9732884|NCT00148122|10833063|FG000|COMPLETED|Overall Study||38
9732885|NCT00148122|10833063|FG000|NOT COMPLETED|Overall Study||2
9732886|NCT00148317|10833067|FG000|STARTED|Consolidation (VEL + DEX)||38
9732887|NCT00148317|10833067|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
9732888|NCT00148317|10833067|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
9732889|NCT00148317|10833067|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10
9732890|NCT00148317|10833067|FG000|COMPLETED|Consolidation (VEL + DEX)||38
9732891|NCT00148317|10833067|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0
9732892|NCT00148317|10833067|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
9732893|NCT00148317|10833067|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
9732894|NCT00148317|10833067|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
9732895|NCT00148343|10833076|FG000|STARTED|Overall Study||54
9732896|NCT00148343|10833077|FG001|STARTED|Overall Study||56
9732897|NCT00148343|10833076|FG000|COMPLETED|Overall Study||39
9732898|NCT00148343|10833077|FG001|COMPLETED|Overall Study||45
9732899|NCT00148343|10833076|FG000|NOT COMPLETED|Overall Study||15
9732900|NCT00148343|10833077|FG001|NOT COMPLETED|Overall Study||11
9732901|NCT00148668|10833085|FG000|STARTED|Overall Study||41
9732902|NCT00148668|10833086|FG001|STARTED|Overall Study||40
9732903|NCT00148668|10833085|FG000|COMPLETED|Overall Study||41
9732904|NCT00148668|10833086|FG001|COMPLETED|Overall Study||40
9732905|NCT00148668|10833085|FG000|NOT COMPLETED|Overall Study||0
9732906|NCT00148668|10833086|FG001|NOT COMPLETED|Overall Study||0
9732907|NCT00148759|10833094|FG000|STARTED|Overall Study||11
9732908|NCT00148759|10833095|FG001|STARTED|Overall Study||12
9732909|NCT00148759|10833094|FG000|24-hr PK Sampling|Overall Study||9
9732910|NCT00148759|10833095|FG001|24-hr PK Sampling|Overall Study||11
9732911|NCT00148759|10833094|FG000|COMPLETED|Overall Study||9
9732912|NCT00148759|10833095|FG001|COMPLETED|Overall Study||11
9732913|NCT00148759|10833094|FG000|NOT COMPLETED|Overall Study||2
9732914|NCT00148759|10833095|FG001|NOT COMPLETED|Overall Study||1
9732915|NCT00148798|10833103|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557
9732916|NCT00148798|10833104|FG001|STARTED|Overall Study|ITT Population|568
9732917|NCT00148798|10833103|FG000|COMPLETED|Overall Study||557
9732918|NCT00148798|10833104|FG001|COMPLETED|Overall Study||568
9732919|NCT00148798|10833103|FG000|NOT COMPLETED|Overall Study||0
9732920|NCT00148798|10833104|FG001|NOT COMPLETED|Overall Study||0
9732921|NCT00148941|10833116|FG000|STARTED|Overall Study||1053
9732922|NCT00148941|10833117|FG001|STARTED|Overall Study||1051
9732923|NCT00148941|10833118|FG002|STARTED|Overall Study||1052
9732924|NCT00148941|10833119|FG003|STARTED|Overall Study||1053
9732925|NCT00148941|10833116|FG000|COMPLETED|Overall Study||1035
9732926|NCT00148941|10833117|FG001|COMPLETED|Overall Study||1027
9732927|NCT00148941|10833118|FG002|COMPLETED|Overall Study||1032
9732928|NCT00148941|10833119|FG003|COMPLETED|Overall Study||1029
9732929|NCT00148941|10833116|FG000|NOT COMPLETED|Overall Study||18
9732930|NCT00148941|10833117|FG001|NOT COMPLETED|Overall Study||24
9732931|NCT00148941|10833118|FG002|NOT COMPLETED|Overall Study||20
9732932|NCT00148941|10833119|FG003|NOT COMPLETED|Overall Study||24
9732933|NCT00148954|10833131|FG000|STARTED|Overall Study||985
9732934|NCT00148954|10833132|FG001|STARTED|Overall Study||977
9732935|NCT00148954|10833131|FG000|COMPLETED|Overall Study||678
9732936|NCT00148954|10833132|FG001|COMPLETED|Overall Study||677
9732937|NCT00148954|10833131|FG000|NOT COMPLETED|Overall Study||307
9732938|NCT00148954|10833132|FG001|NOT COMPLETED|Overall Study||300
9732939|NCT00149214|10833140|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
9732940|NCT00149214|10833141|FG001|STARTED|Overall Study||122
9732941|NCT00149214|10833140|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
9732942|NCT00149214|10833141|FG001|COMPLETED|Overall Study||105
9732943|NCT00149214|10833140|FG000|NOT COMPLETED|Overall Study||26
9732944|NCT00149214|10833141|FG001|NOT COMPLETED|Overall Study||17
9732945|NCT00149227|10833149|FG000|STARTED|Overall Study||1517
9732946|NCT00149227|10833150|FG001|STARTED|Overall Study||1514
9732947|NCT00149227|10833149|FG000|COMPLETED|Overall Study||1517
9732948|NCT00149227|10833150|FG001|COMPLETED|Overall Study||1514
9732949|NCT00149227|10833149|FG000|NOT COMPLETED|Overall Study||0
9732950|NCT00149227|10833150|FG001|NOT COMPLETED|Overall Study||0
9732951|NCT00149396|10833156|FG000|STARTED|Overall Study||32
9732952|NCT00149396|10833156|FG000|Completed NV1020 Therapy|Overall Study||29
9732953|NCT00149396|10833156|FG000|Completed NV1020 and Chemotherapy|Overall Study||9
9732954|NCT00149396|10833156|FG000|COMPLETED|Overall Study||9
9732955|NCT00149396|10833156|FG000|NOT COMPLETED|Overall Study||23
9732956|NCT00149630|10833169|FG000|STARTED|Overall Study||34
9732957|NCT00149630|10833170|FG001|STARTED|Overall Study||40
9732958|NCT00149630|10833169|FG000|COMPLETED|Overall Study||26
9732959|NCT00149630|10833170|FG001|COMPLETED|Overall Study||35
9732960|NCT00149630|10833169|FG000|NOT COMPLETED|Overall Study||8
9732961|NCT00149630|10833170|FG001|NOT COMPLETED|Overall Study||5
9732962|NCT00149643|10833182|FG000|STARTED|Overall Study||34
9732963|NCT00149643|10833183|FG001|STARTED|Overall Study||36
9732964|NCT00149643|10833182|FG000|COMPLETED|Overall Study||0
9732965|NCT00149643|10833183|FG001|COMPLETED|Overall Study||0
9732966|NCT00149643|10833182|FG000|NOT COMPLETED|Overall Study||34
9732967|NCT00149643|10833183|FG001|NOT COMPLETED|Overall Study||36
9732968|NCT00149669|10833191|FG000|STARTED|Overall Study||32
9732969|NCT00149669|10833192|FG001|STARTED|Overall Study||35
9732970|NCT00149669|10833191|FG000|COMPLETED|Overall Study||29
9732971|NCT00149669|10833192|FG001|COMPLETED|Overall Study||30
9732972|NCT00149669|10833191|FG000|NOT COMPLETED|Overall Study||3
9732973|NCT00149669|10833192|FG001|NOT COMPLETED|Overall Study||5
9732974|NCT00149734|10833200|FG000|STARTED|Overall Study||4
9732975|NCT00149734|10833201|FG001|STARTED|Overall Study||4
9732976|NCT00149734|10833200|FG000|Started Intervention 2|Overall Study||4
9732977|NCT00149734|10833201|FG001|Started Intervention 2|Overall Study||4
9732978|NCT00149734|10833200|FG000|COMPLETED|Overall Study||4
9732979|NCT00149734|10833201|FG001|COMPLETED|Overall Study||4
9732980|NCT00149734|10833200|FG000|NOT COMPLETED|Overall Study||0
9732981|NCT00149734|10833201|FG001|NOT COMPLETED|Overall Study||0
9732982|NCT00149747|10833209|FG000|STARTED|Overall Study||36
9732983|NCT00149747|10833210|FG001|STARTED|Overall Study||30
9732984|NCT00149747|10833209|FG000|COMPLETED|Overall Study||32
9732985|NCT00149747|10833210|FG001|COMPLETED|Overall Study||27
9732986|NCT00149747|10833209|FG000|NOT COMPLETED|Overall Study||4
9732987|NCT00149747|10833210|FG001|NOT COMPLETED|Overall Study||3
9732988|NCT00149799|10833218|FG000|STARTED|Open Label Escitalopram (Phase I)||100
9732989|NCT00149799|10833219|FG001|STARTED|Open Label Escitalopram (Phase I)||0
9732990|NCT00149799|10833220|FG002|STARTED|Open Label Escitalopram (Phase I)||0
9732991|NCT00149799|10833218|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
9732992|NCT00149799|10833219|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0
9732993|NCT00149799|10833220|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0
9732994|NCT00149799|10833218|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
9732995|NCT00149799|10833219|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
9732996|NCT00149799|10833220|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
9732997|NCT00149799|10833218|FG000|STARTED|Discontinuation (Phase II)||0
9732998|NCT00149799|10833219|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
9732999|NCT00149799|10833220|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
9733000|NCT00149799|10833218|FG000|COMPLETED|Discontinuation (Phase II)||0
9733001|NCT00149799|10833219|FG001|COMPLETED|Discontinuation (Phase II)||25
9733002|NCT00149799|10833220|FG002|COMPLETED|Discontinuation (Phase II)||21
9733003|NCT00149799|10833218|FG000|NOT COMPLETED|Discontinuation (Phase II)||0
9733004|NCT00149799|10833219|FG001|NOT COMPLETED|Discontinuation (Phase II)||3
9733005|NCT00149799|10833220|FG002|NOT COMPLETED|Discontinuation (Phase II)||9
9733006|NCT00149825|10833230|FG000|STARTED|Overall Study||15
9733007|NCT00149825|10833231|FG001|STARTED|Overall Study||15
9733008|NCT00149825|10833230|FG000|COMPLETED|Overall Study||10
9733009|NCT00149825|10833231|FG001|COMPLETED|Overall Study||12
9733010|NCT00149825|10833230|FG000|NOT COMPLETED|Overall Study||5
9733011|NCT00149825|10833231|FG001|NOT COMPLETED|Overall Study||3
9733012|NCT00149838|10833239|FG000|STARTED|Phase I||92
9733013|NCT00149838|10833240|FG001|STARTED|Phase I||98
9733014|NCT00149838|10833241|FG002|STARTED|Phase I||0
9733015|NCT00149838|10833242|FG003|STARTED|Phase I||0
9733016|NCT00149838|10833239|FG000|COMPLETED|Phase I||72
9733017|NCT00149838|10833240|FG001|COMPLETED|Phase I||82
9733018|NCT00149838|10833241|FG002|COMPLETED|Phase I||0
9733019|NCT00149838|10833242|FG003|COMPLETED|Phase I||0
9733020|NCT00149838|10833239|FG000|NOT COMPLETED|Phase I||20
9733021|NCT00149838|10833240|FG001|NOT COMPLETED|Phase I||16
9733022|NCT00149838|10833241|FG002|NOT COMPLETED|Phase I||0
9733023|NCT00149838|10833242|FG003|NOT COMPLETED|Phase I||0
9733024|NCT00149838|10833239|FG000|STARTED|Phase II||0
9733025|NCT00149838|10833240|FG001|STARTED|Phase II||0
9733026|NCT00149838|10833241|FG002|STARTED|Phase II||144
9733027|NCT00149838|10833242|FG003|STARTED|Phase II||0
9733028|NCT00149838|10833239|FG000|COMPLETED|Phase II||0
9733029|NCT00149838|10833240|FG001|COMPLETED|Phase II||0
9733030|NCT00149838|10833241|FG002|COMPLETED|Phase II||144
9733031|NCT00149838|10833242|FG003|COMPLETED|Phase II||0
9733032|NCT00149838|10833239|FG000|NOT COMPLETED|Phase II||0
9733033|NCT00149838|10833240|FG001|NOT COMPLETED|Phase II||0
9733034|NCT00149838|10833241|FG002|NOT COMPLETED|Phase II||0
9733035|NCT00149838|10833242|FG003|NOT COMPLETED|Phase II||0
9733036|NCT00149838|10833239|FG000|STARTED|Phase III||0
9733037|NCT00149838|10833240|FG001|STARTED|Phase III||0
9733038|NCT00149838|10833241|FG002|STARTED|Phase III||0
9733039|NCT00149838|10833242|FG003|STARTED|Phase III||61
9733040|NCT00149838|10833239|FG000|COMPLETED|Phase III||0
9733041|NCT00149838|10833240|FG001|COMPLETED|Phase III||0
9733042|NCT00149838|10833241|FG002|COMPLETED|Phase III||0
9733043|NCT00149838|10833242|FG003|COMPLETED|Phase III||37
9733044|NCT00149838|10833239|FG000|NOT COMPLETED|Phase III||0
9733045|NCT00149838|10833240|FG001|NOT COMPLETED|Phase III||0
9733046|NCT00149838|10833241|FG002|NOT COMPLETED|Phase III||0
9733047|NCT00149838|10833242|FG003|NOT COMPLETED|Phase III||24
9733048|NCT00149890|10833254|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
9733049|NCT00149890|10833255|FG001|STARTED|Overall Study||38
9733050|NCT00149890|10833254|FG000|COMPLETED|Overall Study||26
9733051|NCT00149890|10833255|FG001|COMPLETED|Overall Study||20
9733052|NCT00149890|10833254|FG000|NOT COMPLETED|Overall Study||13
9733053|NCT00149890|10833255|FG001|NOT COMPLETED|Overall Study||18
9733054|NCT00149994|10833263|FG000|STARTED|Overall Study|"Started indicates Safety population."|85
9733055|NCT00149994|10833264|FG001|STARTED|Overall Study||86
9733056|NCT00149994|10833263|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
9733057|NCT00149994|10833264|FG001|COMPLETED|Overall Study||85
9733058|NCT00149994|10833263|FG000|NOT COMPLETED|Overall Study||1
9733059|NCT00149994|10833264|FG001|NOT COMPLETED|Overall Study||1
9733060|NCT00150345|10833272|FG000|STARTED|Overall Study||81
9733061|NCT00150345|10833273|FG001|STARTED|Overall Study||66
9733062|NCT00150345|10833272|FG000|COMPLETED|Overall Study||47
9733063|NCT00150345|10833273|FG001|COMPLETED|Overall Study||34
9733064|NCT00150345|10833272|FG000|NOT COMPLETED|Overall Study||34
9733065|NCT00150345|10833273|FG001|NOT COMPLETED|Overall Study||32
9733066|NCT00150462|10833291|FG000|STARTED|Overall Study||3
9733067|NCT00150462|10833292|FG001|STARTED|Overall Study||3
9733068|NCT00150462|10833293|FG002|STARTED|Overall Study||4
9733069|NCT00150462|10833294|FG003|STARTED|Overall Study||3
9733070|NCT00150462|10833295|FG004|STARTED|Overall Study||3
9733071|NCT00150462|10833296|FG005|STARTED|Overall Study||4
9733072|NCT00150462|10833297|FG006|STARTED|Overall Study||3
9733073|NCT00150462|10833298|FG007|STARTED|Overall Study||8
9733074|NCT00150462|10833299|FG008|STARTED|Overall Study||6
9733075|NCT00150462|10833300|FG009|STARTED|Overall Study||7
9733076|NCT00150462|10833301|FG010|STARTED|Overall Study||4
9733077|NCT00150462|10833291|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733078|NCT00150462|10833292|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733079|NCT00150462|10833293|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733080|NCT00150462|10833294|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733081|NCT00150462|10833295|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733082|NCT00150462|10833296|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733083|NCT00150462|10833297|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733084|NCT00150462|10833298|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733085|NCT00150462|10833299|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
9733086|NCT00150462|10833300|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
9733087|NCT00150462|10833301|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
9733088|NCT00150462|10833291|FG000|NOT COMPLETED|Overall Study||3
9733089|NCT00150462|10833292|FG001|NOT COMPLETED|Overall Study||3
9733090|NCT00150462|10833293|FG002|NOT COMPLETED|Overall Study||4
9733091|NCT00150462|10833294|FG003|NOT COMPLETED|Overall Study||3
9733092|NCT00150462|10833295|FG004|NOT COMPLETED|Overall Study||3
9733093|NCT00150462|10833296|FG005|NOT COMPLETED|Overall Study||4
9733094|NCT00150462|10833297|FG006|NOT COMPLETED|Overall Study||3
9733095|NCT00150462|10833298|FG007|NOT COMPLETED|Overall Study||8
9733096|NCT00150462|10833299|FG008|NOT COMPLETED|Overall Study||6
9733097|NCT00150462|10833300|FG009|NOT COMPLETED|Overall Study||6
9733098|NCT00150462|10833301|FG010|NOT COMPLETED|Overall Study||3
9733099|NCT00150592|10833330|FG000|STARTED|Overall Study||121
9733100|NCT00150592|10833331|FG001|STARTED|Overall Study||57
9733101|NCT00150592|10833330|FG000|COMPLETED|Overall Study||114
9733102|NCT00150592|10833331|FG001|COMPLETED|Overall Study||54
9733103|NCT00150592|10833330|FG000|NOT COMPLETED|Overall Study||7
9733104|NCT00150592|10833331|FG001|NOT COMPLETED|Overall Study||3
9733105|NCT00150618|10833342|FG000|STARTED|Overall Study||62
9733106|NCT00150618|10833343|FG001|STARTED|Overall Study||65
9733107|NCT00150618|10833344|FG002|STARTED|Overall Study||65
9733108|NCT00150618|10833345|FG003|STARTED|Overall Study||66
9733109|NCT00150618|10833346|FG004|STARTED|Overall Study||66
9733110|NCT00150618|10833342|FG000|COMPLETED|Overall Study||45
9733111|NCT00150618|10833343|FG001|COMPLETED|Overall Study||47
9733112|NCT00150618|10833344|FG002|COMPLETED|Overall Study||38
9733113|NCT00150618|10833345|FG003|COMPLETED|Overall Study||40
9733114|NCT00150618|10833346|FG004|COMPLETED|Overall Study||41
9733115|NCT00150618|10833342|FG000|NOT COMPLETED|Overall Study||17
9733116|NCT00150618|10833343|FG001|NOT COMPLETED|Overall Study||18
9733117|NCT00150618|10833344|FG002|NOT COMPLETED|Overall Study||27
9733118|NCT00150618|10833345|FG003|NOT COMPLETED|Overall Study||26
9733119|NCT00150618|10833346|FG004|NOT COMPLETED|Overall Study||25
9733120|NCT00150800|10833358|FG000|STARTED|Overall Study||667
9733121|NCT00150800|10833358|FG000|COMPLETED|Overall Study||171
9733122|NCT00150800|10833358|FG000|NOT COMPLETED|Overall Study||496
9733123|NCT00150813|10833363|FG000|STARTED|Overall Study||66
9733124|NCT00150813|10833363|FG000|COMPLETED|Overall Study||48
9733125|NCT00150813|10833363|FG000|NOT COMPLETED|Overall Study||18
9733126|NCT00150969|10833369|FG000|STARTED|24 Month Main Study||217
9733127|NCT00150969|10833370|FG001|STARTED|24 Month Main Study||223
9733128|NCT00150969|10833369|FG000|COMPLETED|24 Month Main Study||198
9733129|NCT00150969|10833370|FG001|COMPLETED|24 Month Main Study||202
9733130|NCT00150969|10833369|FG000|NOT COMPLETED|24 Month Main Study||19
9733131|NCT00150969|10833370|FG001|NOT COMPLETED|24 Month Main Study||21
9733132|NCT00150969|10833369|FG000|STARTED|24-48 Month Extension||121
9733133|NCT00150969|10833370|FG001|STARTED|24-48 Month Extension||140
9733134|NCT00150969|10833369|FG000|COMPLETED|24-48 Month Extension||33
9733135|NCT00150969|10833370|FG001|COMPLETED|24-48 Month Extension||40
9733136|NCT00150969|10833369|FG000|NOT COMPLETED|24-48 Month Extension||88
9733137|NCT00150969|10833370|FG001|NOT COMPLETED|24-48 Month Extension||100
9733138|NCT00151281|10833377|FG000|STARTED|Overall Study||25
9733139|NCT00151281|10833377|FG000|COMPLETED|Overall Study||22
9733140|NCT00151281|10833377|FG000|NOT COMPLETED|Overall Study||3
9733141|NCT00151320|10833384|FG000|STARTED|Overall Study||76
9733142|NCT00151320|10833384|FG000|COMPLETED|Overall Study||76
9733143|NCT00151320|10833384|FG000|NOT COMPLETED|Overall Study||0
9733144|NCT00151372|10833391|FG000|STARTED|Overall Study||67
9733145|NCT00151372|10833392|FG001|STARTED|Overall Study||74
9733146|NCT00151372|10833391|FG000|COMPLETED|Overall Study||38
9733147|NCT00151372|10833392|FG001|COMPLETED|Overall Study||45
9733148|NCT00151372|10833391|FG000|NOT COMPLETED|Overall Study||29
9733149|NCT00151372|10833392|FG001|NOT COMPLETED|Overall Study||29
9733150|NCT00151411|10833400|FG000|STARTED|Overall Study||55
9733151|NCT00151411|10833401|FG001|STARTED|Overall Study||59
9733152|NCT00151411|10833400|FG000|COMPLETED|Overall Study||22
9733153|NCT00151411|10833401|FG001|COMPLETED|Overall Study||16
9733154|NCT00151411|10833400|FG000|NOT COMPLETED|Overall Study||33
9733155|NCT00151411|10833401|FG001|NOT COMPLETED|Overall Study||43
9733156|NCT00151476|10833410|FG000|STARTED|FAP Identified Subjects||13
9733157|NCT00151476|10833411|FG001|STARTED|FAP Identified Subjects||55
9733158|NCT00151476|10833410|FG000|COMPLETED|FAP Identified Subjects||13
9733159|NCT00151476|10833411|FG001|COMPLETED|FAP Identified Subjects||54
9733160|NCT00151476|10833410|FG000|NOT COMPLETED|FAP Identified Subjects||0
9733161|NCT00151476|10833411|FG001|NOT COMPLETED|FAP Identified Subjects||1
9733162|NCT00151476|10833410|FG000|STARTED|FAP Analyzed Subjects||13
9733163|NCT00151476|10833411|FG001|STARTED|FAP Analyzed Subjects||54
9733164|NCT00151476|10833410|FG000|COMPLETED|FAP Analyzed Subjects||13
9733165|NCT00151476|10833411|FG001|COMPLETED|FAP Analyzed Subjects||51
9733166|NCT00151476|10833410|FG000|NOT COMPLETED|FAP Analyzed Subjects||0
9733167|NCT00151476|10833411|FG001|NOT COMPLETED|FAP Analyzed Subjects||3
9733168|NCT00151775|10833423|FG000|STARTED|Period 2 - Double-Blind Dose Response||95
9733169|NCT00151775|10833424|FG001|STARTED|Period 2 - Double-Blind Dose Response||95
9733170|NCT00151775|10833425|FG002|STARTED|Period 2 - Double-Blind Dose Response||0
9733171|NCT00151775|10833426|FG003|STARTED|Period 2 - Double-Blind Dose Response||0
9733172|NCT00151775|10833427|FG004|STARTED|Period 2 - Double-Blind Dose Response||0
9733173|NCT00151775|10833428|FG005|STARTED|Period 2 - Double-Blind Dose Response||56
9733174|NCT00151775|10833429|FG006|STARTED|Period 2 - Double-Blind Dose Response||56
9733175|NCT00151775|10833430|FG007|STARTED|Period 2 - Double-Blind Dose Response||0
9733176|NCT00151775|10833431|FG008|STARTED|Period 2 - Double-Blind Dose Response||0
9733177|NCT00151775|10833432|FG009|STARTED|Period 2 - Double-Blind Dose Response||0
9733178|NCT00151775|10833433|FG010|STARTED|Period 2 - Double-Blind Dose Response||60
9733179|NCT00151775|10833434|FG011|STARTED|Period 2 - Double-Blind Dose Response||0
9733180|NCT00151775|10833423|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93
9733181|NCT00151775|10833424|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89
9733182|NCT00151775|10833425|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0
9733183|NCT00151775|10833426|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0
9733184|NCT00151775|10833427|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0
9733185|NCT00151775|10833428|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54
9733186|NCT00151775|10833429|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53
9733187|NCT00151775|10833430|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0
9733188|NCT00151775|10833431|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0
9733189|NCT00151775|10833432|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0
9733190|NCT00151775|10833433|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59
9733191|NCT00151775|10833434|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0
9733192|NCT00151775|10833423|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
9733193|NCT00151775|10833424|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
9733194|NCT00151775|10833425|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
9733195|NCT00151775|10833426|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
9733196|NCT00151775|10833427|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
9733197|NCT00151775|10833428|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
9733198|NCT00151775|10833429|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
9733199|NCT00151775|10833430|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
9733200|NCT00151775|10833431|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
9733201|NCT00151775|10833432|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
9733202|NCT00151775|10833433|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
9733203|NCT00151775|10833434|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
9733204|NCT00151775|10833423|FG000|STARTED|Period 3: Double-blind, Withdrawal||48
9733205|NCT00151775|10833424|FG001|STARTED|Period 3: Double-blind, Withdrawal||45
9733206|NCT00151775|10833425|FG002|STARTED|Period 3: Double-blind, Withdrawal||45
9733207|NCT00151775|10833426|FG003|STARTED|Period 3: Double-blind, Withdrawal||44
9733208|NCT00151775|10833427|FG004|STARTED|Period 3: Double-blind, Withdrawal||0
9733209|NCT00151775|10833428|FG005|STARTED|Period 3: Double-blind, Withdrawal||26
9733210|NCT00151775|10833429|FG006|STARTED|Period 3: Double-blind, Withdrawal||27
9733211|NCT00151775|10833430|FG007|STARTED|Period 3: Double-blind, Withdrawal||28
9733212|NCT00151775|10833431|FG008|STARTED|Period 3: Double-blind, Withdrawal||26
9733213|NCT00151775|10833432|FG009|STARTED|Period 3: Double-blind, Withdrawal||0
9733214|NCT00151775|10833433|FG010|STARTED|Period 3: Double-blind, Withdrawal||29
9733215|NCT00151775|10833434|FG011|STARTED|Period 3: Double-blind, Withdrawal||29
9733216|NCT00151775|10833423|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48
9733217|NCT00151775|10833424|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45
9733218|NCT00151775|10833425|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42
9733219|NCT00151775|10833426|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44
9733220|NCT00151775|10833427|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0
9733221|NCT00151775|10833428|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25
9733222|NCT00151775|10833429|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26
9733223|NCT00151775|10833430|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27
9733224|NCT00151775|10833431|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26
9733225|NCT00151775|10833432|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0
9733226|NCT00151775|10833433|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29
9733227|NCT00151775|10833434|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28
9733228|NCT00151775|10833423|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
9733229|NCT00151775|10833424|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
9733230|NCT00151775|10833425|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
9733231|NCT00151775|10833426|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
9733232|NCT00151775|10833427|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
9733233|NCT00151775|10833428|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
9733234|NCT00151775|10833429|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
9733235|NCT00151775|10833430|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
9733236|NCT00151775|10833431|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
9733237|NCT00151775|10833432|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
9733238|NCT00151775|10833433|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
9733239|NCT00151775|10833434|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
9733240|NCT00151775|10833423|FG000|STARTED|Period 4: Open Label||0
9733241|NCT00151775|10833424|FG001|STARTED|Period 4: Open Label||0
9733242|NCT00151775|10833425|FG002|STARTED|Period 4: Open Label||0
9733243|NCT00151775|10833426|FG003|STARTED|Period 4: Open Label||0
9733244|NCT00151775|10833427|FG004|STARTED|Period 4: Open Label||179
9733245|NCT00151775|10833428|FG005|STARTED|Period 4: Open Label||0
9733246|NCT00151775|10833429|FG006|STARTED|Period 4: Open Label||0
9733247|NCT00151775|10833430|FG007|STARTED|Period 4: Open Label||0
9733248|NCT00151775|10833431|FG008|STARTED|Period 4: Open Label||0
9733249|NCT00151775|10833432|FG009|STARTED|Period 4: Open Label||104
9733250|NCT00151775|10833433|FG010|STARTED|Period 4: Open Label||57
9733251|NCT00151775|10833434|FG011|STARTED|Period 4: Open Label||0
9733252|NCT00151775|10833423|FG000|COMPLETED|Period 4: Open Label||0
9733253|NCT00151775|10833424|FG001|COMPLETED|Period 4: Open Label||0
9733254|NCT00151775|10833425|FG002|COMPLETED|Period 4: Open Label||0
9733255|NCT00151775|10833426|FG003|COMPLETED|Period 4: Open Label||0
9733256|NCT00151775|10833427|FG004|COMPLETED|Period 4: Open Label||149
9733257|NCT00151775|10833428|FG005|COMPLETED|Period 4: Open Label||0
9733258|NCT00151775|10833429|FG006|COMPLETED|Period 4: Open Label||0
9733259|NCT00151775|10833430|FG007|COMPLETED|Period 4: Open Label||0
9733260|NCT00151775|10833431|FG008|COMPLETED|Period 4: Open Label||0
9733261|NCT00151775|10833432|FG009|COMPLETED|Period 4: Open Label||83
9733262|NCT00151775|10833433|FG010|COMPLETED|Period 4: Open Label||57
9733263|NCT00151775|10833434|FG011|COMPLETED|Period 4: Open Label||0
9733264|NCT00151775|10833423|FG000|NOT COMPLETED|Period 4: Open Label||0
9733265|NCT00151775|10833424|FG001|NOT COMPLETED|Period 4: Open Label||0
9733266|NCT00151775|10833425|FG002|NOT COMPLETED|Period 4: Open Label||0
9733267|NCT00151775|10833426|FG003|NOT COMPLETED|Period 4: Open Label||0
9733268|NCT00151775|10833427|FG004|NOT COMPLETED|Period 4: Open Label||30
9733269|NCT00151775|10833428|FG005|NOT COMPLETED|Period 4: Open Label||0
9733270|NCT00151775|10833429|FG006|NOT COMPLETED|Period 4: Open Label||0
9733271|NCT00151775|10833430|FG007|NOT COMPLETED|Period 4: Open Label||0
9733272|NCT00151775|10833431|FG008|NOT COMPLETED|Period 4: Open Label||0
9733273|NCT00151775|10833432|FG009|NOT COMPLETED|Period 4: Open Label||21
9733274|NCT00151775|10833433|FG010|NOT COMPLETED|Period 4: Open Label||0
9733275|NCT00151775|10833434|FG011|NOT COMPLETED|Period 4: Open Label||0
9733276|NCT00151814|10833478|FG000|STARTED|Overall Study||4
9733277|NCT00151814|10833479|FG001|STARTED|Overall Study||10
9733278|NCT00151814|10833480|FG002|STARTED|Overall Study||10
9733279|NCT00151814|10833478|FG000|COMPLETED|Overall Study||4
9733280|NCT00151814|10833479|FG001|COMPLETED|Overall Study||10
9733281|NCT00151814|10833480|FG002|COMPLETED|Overall Study||10
9733282|NCT00151814|10833478|FG000|NOT COMPLETED|Overall Study||0
9733283|NCT00151814|10833479|FG001|NOT COMPLETED|Overall Study||0
9733284|NCT00151814|10833480|FG002|NOT COMPLETED|Overall Study||0
9733285|NCT00151892|10833489|FG000|STARTED|Overall Study||416
9733286|NCT00151892|10833490|FG001|STARTED|Overall Study||413
9733287|NCT00151892|10833489|FG000|COMPLETED|Overall Study||340
9733288|NCT00151892|10833490|FG001|COMPLETED|Overall Study||330
9733289|NCT00151892|10833489|FG000|NOT COMPLETED|Overall Study||76
9733290|NCT00151892|10833490|FG001|NOT COMPLETED|Overall Study||83
9733291|NCT00151996|10833498|FG000|STARTED|Overall Study||42
9733292|NCT00151996|10833499|FG001|STARTED|Overall Study||33
9733293|NCT00151996|10833498|FG000|COMPLETED|Overall Study||37
9733294|NCT00151996|10833499|FG001|COMPLETED|Overall Study||26
9733295|NCT00151996|10833498|FG000|NOT COMPLETED|Overall Study||5
9733296|NCT00151996|10833499|FG001|NOT COMPLETED|Overall Study||7
9733297|NCT00152009|10833509|FG000|STARTED|Overall Study||87
9733298|NCT00152009|10833510|FG001|STARTED|Overall Study||86
9733299|NCT00152009|10833511|FG002|STARTED|Overall Study||86
9733300|NCT00152009|10833512|FG003|STARTED|Overall Study||86
9733301|NCT00152009|10833509|FG000|COMPLETED|Overall Study||58
9733302|NCT00152009|10833510|FG001|COMPLETED|Overall Study||55
9733303|NCT00152009|10833511|FG002|COMPLETED|Overall Study||49
9733304|NCT00152009|10833512|FG003|COMPLETED|Overall Study||53
9733305|NCT00152009|10833509|FG000|NOT COMPLETED|Overall Study||29
9733306|NCT00152009|10833510|FG001|NOT COMPLETED|Overall Study||31
9733307|NCT00152009|10833511|FG002|NOT COMPLETED|Overall Study||37
9733308|NCT00152009|10833512|FG003|NOT COMPLETED|Overall Study||33
9733309|NCT00152464|10833524|FG000|STARTED|Overall Study||255
9733310|NCT00152464|10833525|FG001|STARTED|Overall Study||255
9733311|NCT00152464|10833524|FG000|COMPLETED|Overall Study||215
9733312|NCT00152464|10833525|FG001|COMPLETED|Overall Study||219
9733313|NCT00152464|10833524|FG000|NOT COMPLETED|Overall Study||40
9733314|NCT00152464|10833525|FG001|NOT COMPLETED|Overall Study||36
9733315|NCT00152516|10833531|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
9733316|NCT00152516|10833531|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
9733317|NCT00152516|10833531|FG000|NOT COMPLETED|Overall Study||75
9733318|NCT00152763|10833539|FG000|STARTED|Overall Study||77
9733319|NCT00152763|10833540|FG001|STARTED|Overall Study||19
9733320|NCT00152763|10833541|FG002|STARTED|Overall Study||20
9733321|NCT00152763|10833542|FG003|STARTED|Overall Study||77
9733322|NCT00152763|10833539|FG000|COMPLETED|Overall Study||67
9733323|NCT00152763|10833540|FG001|COMPLETED|Overall Study||14
9733324|NCT00152763|10833541|FG002|COMPLETED|Overall Study||16
9733325|NCT00152763|10833542|FG003|COMPLETED|Overall Study||63
9733326|NCT00152763|10833539|FG000|NOT COMPLETED|Overall Study||10
9733327|NCT00152763|10833540|FG001|NOT COMPLETED|Overall Study||5
9733328|NCT00152763|10833541|FG002|NOT COMPLETED|Overall Study||4
9733329|NCT00152763|10833542|FG003|NOT COMPLETED|Overall Study||14
9733330|NCT00152971|10833557|FG000|STARTED|Overall Study||857
9733331|NCT00152971|10833558|FG001|STARTED|Overall Study||871
9733332|NCT00152971|10833559|FG002|STARTED|Overall Study||868
9733333|NCT00152971|10833557|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
9733334|NCT00152971|10833558|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
9733335|NCT00152971|10833559|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
9733336|NCT00152971|10833557|FG000|NOT COMPLETED|Overall Study||51
9733337|NCT00152971|10833558|FG001|NOT COMPLETED|Overall Study||48
9733338|NCT00152971|10833559|FG002|NOT COMPLETED|Overall Study||49
9733339|NCT00152971|10833557|FG000|STARTED|Treatment||857
9733340|NCT00152971|10833558|FG001|STARTED|Treatment||871
9733341|NCT00152971|10833559|FG002|STARTED|Treatment||868
9733342|NCT00152971|10833557|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
9733343|NCT00152971|10833558|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
9733344|NCT00152971|10833559|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
9733345|NCT00152971|10833557|FG000|NOT COMPLETED|Treatment||71
9733346|NCT00152971|10833558|FG001|NOT COMPLETED|Treatment||63
9733347|NCT00152971|10833559|FG002|NOT COMPLETED|Treatment||80
9733348|NCT00153062|10833571|FG000|STARTED|Overall Study||5086
9733349|NCT00153062|10833572|FG001|STARTED|Overall Study||5095
9733350|NCT00153062|10833573|FG002|STARTED|Overall Study||5060
9733351|NCT00153062|10833574|FG003|STARTED|Overall Study||5091
9733352|NCT00153062|10833571|FG000|COMPLETED|Overall Study||4699
9733353|NCT00153062|10833572|FG001|COMPLETED|Overall Study||4689
9733354|NCT00153062|10833573|FG002|COMPLETED|Overall Study||4645
9733355|NCT00153062|10833574|FG003|COMPLETED|Overall Study||4680
9733356|NCT00153062|10833571|FG000|NOT COMPLETED|Overall Study||387
9733357|NCT00153062|10833572|FG001|NOT COMPLETED|Overall Study||406
9733358|NCT00153062|10833573|FG002|NOT COMPLETED|Overall Study||415
9733359|NCT00153062|10833574|FG003|NOT COMPLETED|Overall Study||411
9733360|NCT00153101|10833589|FG000|STARTED|Overall Study||8502
9733361|NCT00153101|10833590|FG001|STARTED|Overall Study||8542
9733362|NCT00153101|10833591|FG002|STARTED|Overall Study||8576
9733363|NCT00153101|10833592|FG003|STARTED|Overall Study||2954
9733364|NCT00153101|10833593|FG004|STARTED|Overall Study||2972
9733365|NCT00153101|10833589|FG000|COMPLETED|Overall Study||8485
9733366|NCT00153101|10833590|FG001|COMPLETED|Overall Study||8524
9733367|NCT00153101|10833591|FG002|COMPLETED|Overall Study||8561
9733368|NCT00153101|10833592|FG003|COMPLETED|Overall Study||2946
9733369|NCT00153101|10833593|FG004|COMPLETED|Overall Study||2962
9733370|NCT00153101|10833589|FG000|NOT COMPLETED|Overall Study||17
9733371|NCT00153101|10833590|FG001|NOT COMPLETED|Overall Study||18
9733372|NCT00153101|10833591|FG002|NOT COMPLETED|Overall Study||15
9733373|NCT00153101|10833592|FG003|NOT COMPLETED|Overall Study||8
9733374|NCT00153101|10833593|FG004|NOT COMPLETED|Overall Study||10
9733375|NCT00153166|10833610|FG000|STARTED|Overall Study||11
9733376|NCT00153166|10833611|FG001|STARTED|Overall Study||37
9733377|NCT00153166|10833612|FG002|STARTED|Overall Study||28
9733378|NCT00153166|10833610|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3
9733379|NCT00153166|10833611|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9
9733380|NCT00153166|10833612|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7
9733381|NCT00153166|10833610|FG000|Received Atorvastatin and Placebo|Overall Study||2
9733382|NCT00153166|10833611|FG001|Received Atorvastatin and Placebo|Overall Study||9
9733383|NCT00153166|10833612|FG002|Received Atorvastatin and Placebo|Overall Study||7
9733384|NCT00153166|10833610|FG000|Received Placebo and Pioglitazone|Overall Study||3
9733385|NCT00153166|10833611|FG001|Received Placebo and Pioglitazone|Overall Study||10
9733386|NCT00153166|10833612|FG002|Received Placebo and Pioglitazone|Overall Study||7
9733387|NCT00153166|10833610|FG000|Received Placebo and Placebo|Overall Study||3
9733388|NCT00153166|10833611|FG001|Received Placebo and Placebo|Overall Study||9
9733389|NCT00153166|10833612|FG002|Received Placebo and Placebo|Overall Study||7
9733390|NCT00153166|10833610|FG000|COMPLETED|Overall Study||11
9733391|NCT00153166|10833611|FG001|COMPLETED|Overall Study||37
9733392|NCT00153166|10833612|FG002|COMPLETED|Overall Study||28
9733393|NCT00153166|10833610|FG000|NOT COMPLETED|Overall Study||0
9733394|NCT00153166|10833611|FG001|NOT COMPLETED|Overall Study||0
9733395|NCT00153166|10833612|FG002|NOT COMPLETED|Overall Study||0
9733396|NCT00153179|10833623|FG000|STARTED|Study Visit Day 1||10
9733397|NCT00153179|10833624|FG001|STARTED|Study Visit Day 1||8
9733398|NCT00153179|10833625|FG002|STARTED|Study Visit Day 1||13
9733399|NCT00153179|10833626|FG003|STARTED|Study Visit Day 1||9
9733400|NCT00153179|10833623|FG000|COMPLETED|Study Visit Day 1||10
9733401|NCT00153179|10833624|FG001|COMPLETED|Study Visit Day 1||8
9733402|NCT00153179|10833625|FG002|COMPLETED|Study Visit Day 1||13
9733403|NCT00153179|10833626|FG003|COMPLETED|Study Visit Day 1||9
9733404|NCT00153179|10833623|FG000|NOT COMPLETED|Study Visit Day 1||0
9733405|NCT00153179|10833624|FG001|NOT COMPLETED|Study Visit Day 1||0
9733406|NCT00153179|10833625|FG002|NOT COMPLETED|Study Visit Day 1||0
9733407|NCT00153179|10833626|FG003|NOT COMPLETED|Study Visit Day 1||0
9733408|NCT00153179|10833623|FG000|STARTED|Study Visit Day 2||10
9733409|NCT00153179|10833624|FG001|STARTED|Study Visit Day 2||8
9733410|NCT00153179|10833625|FG002|STARTED|Study Visit Day 2||13
9733411|NCT00153179|10833626|FG003|STARTED|Study Visit Day 2||9
9733412|NCT00153179|10833623|FG000|COMPLETED|Study Visit Day 2||9
9733413|NCT00153179|10833624|FG001|COMPLETED|Study Visit Day 2||8
9733414|NCT00153179|10833625|FG002|COMPLETED|Study Visit Day 2||11
9733415|NCT00153179|10833626|FG003|COMPLETED|Study Visit Day 2||7
9733416|NCT00153179|10833623|FG000|NOT COMPLETED|Study Visit Day 2||1
9733417|NCT00153179|10833624|FG001|NOT COMPLETED|Study Visit Day 2||0
9733418|NCT00153179|10833625|FG002|NOT COMPLETED|Study Visit Day 2||2
9733419|NCT00153179|10833626|FG003|NOT COMPLETED|Study Visit Day 2||2
9733420|NCT00153803|10833636|FG000|STARTED|Concurrent Chemoradiation||123
9733421|NCT00153803|10833637|FG001|STARTED|Concurrent Chemoradiation||122
9733422|NCT00153803|10833636|FG000|Received Chemoradiation|Concurrent Chemoradiation||118
9733423|NCT00153803|10833637|FG001|Received Chemoradiation|Concurrent Chemoradiation||117
9733424|NCT00153803|10833636|FG000|COMPLETED|Concurrent Chemoradiation||118
9733425|NCT00153803|10833637|FG001|COMPLETED|Concurrent Chemoradiation||117
9733426|NCT00153803|10833636|FG000|NOT COMPLETED|Concurrent Chemoradiation||5
9733427|NCT00153803|10833637|FG001|NOT COMPLETED|Concurrent Chemoradiation||5
9733428|NCT00153803|10833636|FG000|STARTED|Investigational Drug||118
9733429|NCT00153803|10833637|FG001|STARTED|Investigational Drug||117
9733430|NCT00153803|10833636|FG000|Investigational Drug Dispensed|Investigational Drug||77
9733431|NCT00153803|10833637|FG001|Investigational Drug Dispensed|Investigational Drug||75
9733432|NCT00153803|10833636|FG000|COMPLETED|Investigational Drug||77
9733433|NCT00153803|10833637|FG001|COMPLETED|Investigational Drug||75
9733434|NCT00153803|10833636|FG000|NOT COMPLETED|Investigational Drug||41
9733435|NCT00153803|10833637|FG001|NOT COMPLETED|Investigational Drug||42
9733436|NCT00153816|10833652|FG000|STARTED|Overall Study||415
9733437|NCT00153816|10833653|FG001|STARTED|Overall Study||419
9733438|NCT00153816|10833654|FG002|STARTED|Overall Study||420
9733439|NCT00153816|10833655|FG003|STARTED|Overall Study||421
9733440|NCT00153816|10833656|FG004|STARTED|Overall Study||295
9733441|NCT00153816|10833657|FG005|STARTED|Overall Study||289
9733442|NCT00153816|10833652|FG000|COMPLETED|Overall Study||383
9733443|NCT00153816|10833653|FG001|COMPLETED|Overall Study||387
9733444|NCT00153816|10833654|FG002|COMPLETED|Overall Study||388
9733445|NCT00153816|10833655|FG003|COMPLETED|Overall Study||390
9733446|NCT00153816|10833656|FG004|COMPLETED|Overall Study||278
9733447|NCT00153816|10833657|FG005|COMPLETED|Overall Study||262
9733448|NCT00153816|10833652|FG000|NOT COMPLETED|Overall Study||32
9733449|NCT00153816|10833653|FG001|NOT COMPLETED|Overall Study||32
9733450|NCT00153816|10833654|FG002|NOT COMPLETED|Overall Study||32
9733451|NCT00153816|10833655|FG003|NOT COMPLETED|Overall Study||31
9733452|NCT00153816|10833656|FG004|NOT COMPLETED|Overall Study||17
9733453|NCT00153816|10833657|FG005|NOT COMPLETED|Overall Study||27
9733454|NCT00153842|10833673|FG000|STARTED|Overall Study||26
9733455|NCT00153842|10833674|FG001|STARTED|Overall Study||7
9733456|NCT00153842|10833673|FG000|COMPLETED|Overall Study||26
9733457|NCT00153842|10833674|FG001|COMPLETED|Overall Study||7
9733458|NCT00153842|10833673|FG000|NOT COMPLETED|Overall Study||0
9733459|NCT00153842|10833674|FG001|NOT COMPLETED|Overall Study||0
9733460|NCT00153920|10833682|FG000|STARTED|Overall Study||66
9733461|NCT00153920|10833682|FG000|Eligible and Treated|Overall Study||64
9733462|NCT00153920|10833682|FG000|COMPLETED|Overall Study||36
9733463|NCT00153920|10833682|FG000|NOT COMPLETED|Overall Study||30
9733464|NCT00153985|10833686|FG000|STARTED|Overall Study||2
9733465|NCT00153985|10833686|FG000|COMPLETED|Overall Study||2
9733466|NCT00153985|10833686|FG000|NOT COMPLETED|Overall Study||0
9733467|NCT00154063|10833692|FG000|STARTED|Overall Study||104
9733468|NCT00154063|10833693|FG001|STARTED|Overall Study||102
9733469|NCT00154063|10833692|FG000|COMPLETED|Overall Study||92
9733470|NCT00154063|10833693|FG001|COMPLETED|Overall Study||80
9733471|NCT00154063|10833692|FG000|NOT COMPLETED|Overall Study||12
9733472|NCT00154063|10833693|FG001|NOT COMPLETED|Overall Study||22
9733473|NCT00154102|10833705|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
9733474|NCT00154102|10833706|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
9733475|NCT00154102|10833705|FG000|COMPLETED|Overall Study||592
9733476|NCT00154102|10833706|FG001|COMPLETED|Overall Study||597
9733477|NCT00154102|10833705|FG000|NOT COMPLETED|Overall Study||7
9733478|NCT00154102|10833706|FG001|NOT COMPLETED|Overall Study||2
9733479|NCT00154284|10833714|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
9733480|NCT00154284|10833715|FG001|STARTED|Overall Study||55
9733481|NCT00154284|10833714|FG000|Intent to Treat (ITT) Population|Overall Study||57
9733482|NCT00154284|10833715|FG001|Intent to Treat (ITT) Population|Overall Study||53
9733483|NCT00154284|10833714|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
9733484|NCT00154284|10833715|FG001|COMPLETED|Overall Study||42
9733485|NCT00154284|10833714|FG000|NOT COMPLETED|Overall Study||7
9733486|NCT00154284|10833715|FG001|NOT COMPLETED|Overall Study||13
9733487|NCT00154297|10833725|FG000|STARTED|Overall Study|Randomized population.|65
9733488|NCT00154297|10833726|FG001|STARTED|Overall Study|Randomized population.|74
9733489|NCT00154297|10833725|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57
9733490|NCT00154297|10833726|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67
9733491|NCT00154297|10833725|FG000|NOT COMPLETED|Overall Study||8
9733492|NCT00154297|10833726|FG001|NOT COMPLETED|Overall Study||7
9733493|NCT00154310|10833734|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
9733494|NCT00154310|10833735|FG001|STARTED|Overall Study||145
9733495|NCT00154310|10833734|FG000|COMPLETED|Overall Study||118
9733496|NCT00154310|10833735|FG001|COMPLETED|Overall Study||117
9733497|NCT00154310|10833734|FG000|NOT COMPLETED|Overall Study||37
9733498|NCT00154310|10833735|FG001|NOT COMPLETED|Overall Study||28
9733499|NCT00154375|10833743|FG000|STARTED|Overall Study||120
9733500|NCT00154375|10833744|FG001|STARTED|Overall Study||120
9733501|NCT00154375|10833743|FG000|Discontinued Study Treatment|Overall Study||111
9733502|NCT00154375|10833744|FG001|Discontinued Study Treatment|Overall Study||104
9733503|NCT00154375|10833743|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
9733504|NCT00154375|10833744|FG001|Not Exposed to Study Treatment|Overall Study||2
9733505|NCT00154375|10833743|FG000|COMPLETED|Overall Study||7
9733506|NCT00154375|10833744|FG001|COMPLETED|Overall Study||14
9733507|NCT00154375|10833743|FG000|NOT COMPLETED|Overall Study||113
9733508|NCT00154375|10833744|FG001|NOT COMPLETED|Overall Study||106
9733509|NCT00154466|10833754|FG000|STARTED|Overall Study||20
9733510|NCT00154466|10833755|FG001|STARTED|Overall Study||19
9733511|NCT00154466|10833756|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
9733512|NCT00154466|10833754|FG000|COMPLETED|Overall Study||20
9733513|NCT00154466|10833755|FG001|COMPLETED|Overall Study||19
9733514|NCT00154466|10833756|FG002|COMPLETED|Overall Study||19
9733515|NCT00154466|10833754|FG000|NOT COMPLETED|Overall Study||0
9733516|NCT00154466|10833755|FG001|NOT COMPLETED|Overall Study||0
9733517|NCT00154466|10833756|FG002|NOT COMPLETED|Overall Study||0
9733518|NCT00156013|10833766|FG000|STARTED|Overall Study||33
9733519|NCT00156013|10833766|FG000|COMPLETED|Overall Study||31
9733520|NCT00156013|10833766|FG000|NOT COMPLETED|Overall Study||2
9733521|NCT00156247|10833772|FG000|STARTED|Overall Study||9
9733522|NCT00156247|10833772|FG000|COMPLETED|Overall Study||5
9733523|NCT00156247|10833772|FG000|NOT COMPLETED|Overall Study||4
9733524|NCT00156390|10833778|FG000|STARTED|Overall Study||110
9733525|NCT00156390|10833779|FG001|STARTED|Overall Study||77
9733526|NCT00156390|10833778|FG000|COMPLETED|Overall Study||96
9733527|NCT00156390|10833779|FG001|COMPLETED|Overall Study||69
9733528|NCT00156390|10833778|FG000|NOT COMPLETED|Overall Study||14
9733529|NCT00156390|10833779|FG001|NOT COMPLETED|Overall Study||8
9733530|NCT00156533|10833790|FG000|STARTED|Overall Study||5
9733531|NCT00156533|10833791|FG001|STARTED|Overall Study||5
9733532|NCT00156533|10833792|FG002|STARTED|Overall Study||5
9733533|NCT00156533|10833793|FG003|STARTED|Overall Study||5
9733534|NCT00156533|10833790|FG000|COMPLETED|Overall Study||3
9733535|NCT00156533|10833791|FG001|COMPLETED|Overall Study||3
9733536|NCT00156533|10833792|FG002|COMPLETED|Overall Study||3
9733537|NCT00156533|10833793|FG003|COMPLETED|Overall Study||3
9733538|NCT00156533|10833790|FG000|NOT COMPLETED|Overall Study||2
9733539|NCT00156533|10833791|FG001|NOT COMPLETED|Overall Study||2
9733540|NCT00156533|10833792|FG002|NOT COMPLETED|Overall Study||2
9733541|NCT00156533|10833793|FG003|NOT COMPLETED|Overall Study||2
9733542|NCT00156715|10833805|FG000|STARTED|Overall Study||23
9733543|NCT00156715|10833805|FG000|COMPLETED|Overall Study||16
9733544|NCT00156715|10833805|FG000|NOT COMPLETED|Overall Study||7
9733545|NCT00156819|10833812|FG000|STARTED|Overall Study||169
9733546|NCT00156819|10833813|FG001|STARTED|Overall Study||166
9733547|NCT00156819|10833814|FG002|STARTED|Overall Study||165
9733548|NCT00156819|10833812|FG000|COMPLETED|Overall Study||168
9733549|NCT00156819|10833813|FG001|COMPLETED|Overall Study||165
9733550|NCT00156819|10833814|FG002|COMPLETED|Overall Study||162
9733551|NCT00156819|10833812|FG000|NOT COMPLETED|Overall Study||1
9733552|NCT00156819|10833813|FG001|NOT COMPLETED|Overall Study||1
9733553|NCT00156819|10833814|FG002|NOT COMPLETED|Overall Study||3
9733554|NCT00156910|10833824|FG000|STARTED|Double-Blind Phase (DB)||341
9733555|NCT00156910|10833825|FG001|STARTED|Double-Blind Phase (DB)||338
9733556|NCT00156910|10833824|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
9733557|NCT00156910|10833825|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
9733558|NCT00156910|10833824|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45
9733559|NCT00156910|10833825|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43
9733560|NCT00156910|10833824|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
9733561|NCT00156910|10833825|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
9733562|NCT00156910|10833824|FG000|COMPLETED|Open-Label Phase (OL)||252
9733563|NCT00156910|10833825|FG001|COMPLETED|Open-Label Phase (OL)||231
9733564|NCT00156910|10833824|FG000|NOT COMPLETED|Open-Label Phase (OL)||33
9733565|NCT00156910|10833825|FG001|NOT COMPLETED|Open-Label Phase (OL)||55
9733566|NCT00156923|10833833|FG000|STARTED|Overall Study||56
9733567|NCT00156923|10833834|FG001|STARTED|Overall Study||52
9733568|NCT00156923|10833833|FG000|COMPLETED|Overall Study||22
9733569|NCT00156923|10833834|FG001|COMPLETED|Overall Study||20
9733570|NCT00156923|10833833|FG000|NOT COMPLETED|Overall Study||34
9733571|NCT00156923|10833834|FG001|NOT COMPLETED|Overall Study||32
9733572|NCT00156936|10833842|FG000|STARTED|Overall Study||92
9733573|NCT00156936|10833843|FG001|STARTED|Overall Study||16
9733574|NCT00156936|10833842|FG000|COMPLETED|Overall Study||20
9733575|NCT00156936|10833843|FG001|COMPLETED|Overall Study||5
9733576|NCT00156936|10833842|FG000|NOT COMPLETED|Overall Study||72
9733577|NCT00156936|10833843|FG001|NOT COMPLETED|Overall Study||11
9733578|NCT00157014|10833853|FG000|STARTED|Overall Study||52
9733579|NCT00157014|10833854|FG001|STARTED|Overall Study||46
9733580|NCT00157014|10833855|FG002|STARTED|Overall Study||5
9733581|NCT00157014|10833856|FG003|STARTED|Overall Study||6
9733582|NCT00157014|10833853|FG000|COMPLETED|Overall Study||45
9733583|NCT00157014|10833854|FG001|COMPLETED|Overall Study||41
9733584|NCT00157014|10833855|FG002|COMPLETED|Overall Study||4
9733585|NCT00157014|10833856|FG003|COMPLETED|Overall Study||5
9733586|NCT00157014|10833853|FG000|NOT COMPLETED|Overall Study||7
9733587|NCT00157014|10833854|FG001|NOT COMPLETED|Overall Study||5
9733588|NCT00157014|10833855|FG002|NOT COMPLETED|Overall Study||1
9733589|NCT00157014|10833856|FG003|NOT COMPLETED|Overall Study||1
9733590|NCT00157157|10833866|FG000|STARTED|Overall Study||55
9733591|NCT00157157|10833866|FG000|COMPLETED|Overall Study||44
9733592|NCT00157157|10833866|FG000|NOT COMPLETED|Overall Study||11
9733593|NCT00157196|10833877|FG000|STARTED|Overall Study||22
9733594|NCT00157196|10833877|FG000|COMPLETED|Overall Study||13
9733595|NCT00157196|10833877|FG000|NOT COMPLETED|Overall Study||9
9733596|NCT00157209|10833883|FG000|STARTED|Overall Study||88
9733597|NCT00157209|10833884|FG001|STARTED|Overall Study||83
9733598|NCT00157209|10833883|FG000|COMPLETED|Overall Study||78
9733599|NCT00157209|10833884|FG001|COMPLETED|Overall Study||83
9733600|NCT00157209|10833883|FG000|NOT COMPLETED|Overall Study||10
9733601|NCT00157209|10833884|FG001|NOT COMPLETED|Overall Study||0
9733602|NCT00157248|10833894|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
9733603|NCT00157248|10833895|FG001|STARTED|Overall Study||89
9733604|NCT00157248|10833896|FG002|STARTED|Overall Study||50
9733605|NCT00157248|10833897|FG003|STARTED|Overall Study||124
9733606|NCT00157248|10833894|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
9733607|NCT00157248|10833895|FG001|COMPLETED|Overall Study||52
9733608|NCT00157248|10833896|FG002|COMPLETED|Overall Study||29
9733609|NCT00157248|10833897|FG003|COMPLETED|Overall Study||77
9733610|NCT00157248|10833894|FG000|NOT COMPLETED|Overall Study||48
9733611|NCT00157248|10833895|FG001|NOT COMPLETED|Overall Study||37
9733612|NCT00157248|10833896|FG002|NOT COMPLETED|Overall Study||21
9733613|NCT00157248|10833897|FG003|NOT COMPLETED|Overall Study||47
9733614|NCT00157573|10833911|FG000|STARTED|Overall Study||35
9733615|NCT00157573|10833912|FG001|STARTED|Overall Study||37
9733616|NCT00157573|10833911|FG000|COMPLETED|Overall Study||35
9733617|NCT00157573|10833912|FG001|COMPLETED|Overall Study||37
9733618|NCT00157573|10833911|FG000|NOT COMPLETED|Overall Study||0
9733619|NCT00157573|10833912|FG001|NOT COMPLETED|Overall Study||0
9733620|NCT00157755|10833919|FG000|STARTED|Overall Study||26
9733621|NCT00157755|10833920|FG001|STARTED|Overall Study||19
9733622|NCT00157755|10833921|FG002|STARTED|Overall Study||10
9733623|NCT00157755|10833922|FG003|STARTED|Overall Study||15
9733624|NCT00157755|10833923|FG004|STARTED|Overall Study||12
9733625|NCT00157755|10833924|FG005|STARTED|Overall Study||5
9733626|NCT00157755|10833919|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
9733627|NCT00157755|10833920|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
9733628|NCT00157755|10833921|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
9733629|NCT00157755|10833922|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
9733630|NCT00157755|10833923|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
9733631|NCT00157755|10833924|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
9733632|NCT00157755|10833919|FG000|NOT COMPLETED|Overall Study||2
9733633|NCT00157755|10833920|FG001|NOT COMPLETED|Overall Study||4
9733634|NCT00157755|10833921|FG002|NOT COMPLETED|Overall Study||7
9733635|NCT00157755|10833922|FG003|NOT COMPLETED|Overall Study||4
9733636|NCT00157755|10833923|FG004|NOT COMPLETED|Overall Study||2
9733637|NCT00157755|10833924|FG005|NOT COMPLETED|Overall Study||5
9733638|NCT00157820|10833933|FG000|STARTED|Randomized||118
9733639|NCT00157820|10833934|FG001|STARTED|Randomized||116
9733640|NCT00157820|10833935|FG002|STARTED|Randomized||120
9733641|NCT00157820|10833933|FG000|COMPLETED|Randomized||111
9733642|NCT00157820|10833934|FG001|COMPLETED|Randomized||111
9733643|NCT00157820|10833935|FG002|COMPLETED|Randomized||112
9733644|NCT00157820|10833933|FG000|NOT COMPLETED|Randomized||7
9733645|NCT00157820|10833934|FG001|NOT COMPLETED|Randomized||5
9733646|NCT00157820|10833935|FG002|NOT COMPLETED|Randomized||8
9733647|NCT00157820|10833933|FG000|STARTED|1st 8 Month||111
9733648|NCT00157820|10833934|FG001|STARTED|1st 8 Month||111
9733649|NCT00157820|10833935|FG002|STARTED|1st 8 Month||112
9733650|NCT00157820|10833933|FG000|COMPLETED|1st 8 Month||103
9733651|NCT00157820|10833934|FG001|COMPLETED|1st 8 Month||99
9733652|NCT00157820|10833935|FG002|COMPLETED|1st 8 Month||106
9733653|NCT00157820|10833933|FG000|NOT COMPLETED|1st 8 Month||8
9733654|NCT00157820|10833934|FG001|NOT COMPLETED|1st 8 Month||12
9733655|NCT00157820|10833935|FG002|NOT COMPLETED|1st 8 Month||6
9733656|NCT00157820|10833933|FG000|STARTED|1 Month Wash Out Period||103
9733657|NCT00157820|10833934|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
9733658|NCT00157820|10833935|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
9733659|NCT00157820|10833933|FG000|COMPLETED|1 Month Wash Out Period||103
9733660|NCT00157820|10833934|FG001|COMPLETED|1 Month Wash Out Period||101
9733661|NCT00157820|10833935|FG002|COMPLETED|1 Month Wash Out Period||108
9733662|NCT00157820|10833933|FG000|NOT COMPLETED|1 Month Wash Out Period||0
9733663|NCT00157820|10833934|FG001|NOT COMPLETED|1 Month Wash Out Period||0
9733664|NCT00157820|10833935|FG002|NOT COMPLETED|1 Month Wash Out Period||0
9733665|NCT00157820|10833933|FG000|STARTED|2nd 8 Months||103
9733666|NCT00157820|10833934|FG001|STARTED|2nd 8 Months||101
9733667|NCT00157820|10833935|FG002|STARTED|2nd 8 Months||108
9733668|NCT00157820|10833933|FG000|COMPLETED|2nd 8 Months||98
9733669|NCT00157820|10833934|FG001|COMPLETED|2nd 8 Months||88
9733670|NCT00157820|10833935|FG002|COMPLETED|2nd 8 Months||94
9733671|NCT00157820|10833933|FG000|NOT COMPLETED|2nd 8 Months||5
9733672|NCT00157820|10833934|FG001|NOT COMPLETED|2nd 8 Months||13
9733673|NCT00157820|10833935|FG002|NOT COMPLETED|2nd 8 Months||14
9733674|NCT00157950|10833946|FG000|STARTED|Overall Study||117
9733675|NCT00157950|10833947|FG001|STARTED|Overall Study||59
9733676|NCT00157950|10833946|FG000|Vaccinated at Dose 1|Overall Study||117
9733677|NCT00157950|10833947|FG001|Vaccinated at Dose 1|Overall Study||59
9733678|NCT00157950|10833946|FG000|Vaccinated at Dose 2|Overall Study||117
9733679|NCT00157950|10833947|FG001|Vaccinated at Dose 2|Overall Study||59
9733680|NCT00157950|10833946|FG000|Vaccinated at Dose 3|Overall Study||116
9733681|NCT00157950|10833947|FG001|Vaccinated at Dose 3|Overall Study||59
9733682|NCT00157950|10833946|FG000|COMPLETED|Overall Study||116
9733683|NCT00157950|10833947|FG001|COMPLETED|Overall Study||59
9733684|NCT00157950|10833946|FG000|NOT COMPLETED|Overall Study||1
9733685|NCT00157950|10833947|FG001|NOT COMPLETED|Overall Study||0
9733686|NCT00158054|10833955|FG000|STARTED|Overall Study||80
9733687|NCT00158054|10833956|FG001|STARTED|Overall Study||77
9733688|NCT00158054|10833955|FG000|COMPLETED|Overall Study||70
9733689|NCT00158054|10833956|FG001|COMPLETED|Overall Study||74
9733690|NCT00158054|10833955|FG000|NOT COMPLETED|Overall Study||10
9733691|NCT00158054|10833956|FG001|NOT COMPLETED|Overall Study||3
9733692|NCT00158184|10833964|FG000|STARTED|Overall Study||16
9733693|NCT00158184|10833965|FG001|STARTED|Overall Study||11
9733694|NCT00158184|10833964|FG000|COMPLETED|Overall Study||10
9733695|NCT00158184|10833965|FG001|COMPLETED|Overall Study||9
9733696|NCT00158184|10833964|FG000|NOT COMPLETED|Overall Study||6
9733697|NCT00158184|10833965|FG001|NOT COMPLETED|Overall Study||2
9733698|NCT00158197|10833977|FG000|STARTED|Overall Study||32
9733699|NCT00158197|10833978|FG001|STARTED|Overall Study||30
9733700|NCT00158197|10833979|FG002|STARTED|Overall Study||28
9733701|NCT00158197|10833980|FG003|STARTED|Overall Study||29
9733702|NCT00158197|10833977|FG000|COMPLETED|Overall Study||32
9733703|NCT00158197|10833978|FG001|COMPLETED|Overall Study||30
9733704|NCT00158197|10833979|FG002|COMPLETED|Overall Study||28
9733705|NCT00158197|10833980|FG003|COMPLETED|Overall Study||29
9733706|NCT00158197|10833977|FG000|NOT COMPLETED|Overall Study||0
9733707|NCT00158197|10833978|FG001|NOT COMPLETED|Overall Study||0
9733708|NCT00158197|10833979|FG002|NOT COMPLETED|Overall Study||0
9733709|NCT00158197|10833980|FG003|NOT COMPLETED|Overall Study||0
9733710|NCT00158223|10833992|FG000|STARTED|Overall Study||28
9733711|NCT00158223|10833993|FG001|STARTED|Overall Study||25
9733712|NCT00158223|10833992|FG000|COMPLETED|Overall Study||23
9733713|NCT00158223|10833993|FG001|COMPLETED|Overall Study||22
9733714|NCT00158223|10833992|FG000|NOT COMPLETED|Overall Study||5
9733715|NCT00158223|10833993|FG001|NOT COMPLETED|Overall Study||3
9733716|NCT00158249|10834001|FG000|STARTED|Overall Study||11
9733717|NCT00158249|10834002|FG001|STARTED|Overall Study||10
9733718|NCT00158249|10834001|FG000|COMPLETED|Overall Study||9
9733719|NCT00158249|10834002|FG001|COMPLETED|Overall Study||10
9733720|NCT00158249|10834001|FG000|NOT COMPLETED|Overall Study||2
9733721|NCT00158249|10834002|FG001|NOT COMPLETED|Overall Study||0
9733722|NCT00158262|10834010|FG000|STARTED|Overall Study||21
9733723|NCT00158262|10834011|FG001|STARTED|Overall Study||22
9733724|NCT00158262|10834010|FG000|COMPLETED|Overall Study||20
9733725|NCT00158262|10834011|FG001|COMPLETED|Overall Study||21
9733726|NCT00158262|10834010|FG000|NOT COMPLETED|Overall Study||1
9733727|NCT00158262|10834011|FG001|NOT COMPLETED|Overall Study||1
9733728|NCT00158379|10834017|FG000|STARTED|Overall Study||105
9733729|NCT00158379|10834017|FG000|COMPLETED|Overall Study||105
9733730|NCT00158379|10834017|FG000|NOT COMPLETED|Overall Study||0
9733731|NCT00158600|10834023|FG000|STARTED|Overall Study||60
9733732|NCT00158600|10834024|FG001|STARTED|Overall Study||30
9733733|NCT00158600|10834023|FG000|COMPLETED|Overall Study||55
9733734|NCT00158600|10834024|FG001|COMPLETED|Overall Study||26
9733735|NCT00158600|10834023|FG000|NOT COMPLETED|Overall Study||5
9733736|NCT00158600|10834024|FG001|NOT COMPLETED|Overall Study||4
9733737|NCT00158743|10834033|FG000|STARTED|Overall Study||24
9733738|NCT00158743|10834034|FG001|STARTED|Overall Study||27
9733739|NCT00158743|10834033|FG000|COMPLETED|Overall Study||15
9733740|NCT00158743|10834034|FG001|COMPLETED|Overall Study||20
9733741|NCT00158743|10834033|FG000|NOT COMPLETED|Overall Study||9
9733742|NCT00158743|10834034|FG001|NOT COMPLETED|Overall Study||7
9733743|NCT00158756|10834045|FG000|STARTED|Overall Study||80
9733744|NCT00158756|10834046|FG001|STARTED|Overall Study||25
9733745|NCT00158756|10834047|FG002|STARTED|Overall Study||81
9733746|NCT00158756|10834048|FG003|STARTED|Overall Study||23
9733747|NCT00158756|10834049|FG004|STARTED|Overall Study||99
9733748|NCT00158756|10834045|FG000|COMPLETED|Overall Study||75
9733749|NCT00158756|10834046|FG001|COMPLETED|Overall Study||25
9733750|NCT00158756|10834047|FG002|COMPLETED|Overall Study||73
9733751|NCT00158756|10834048|FG003|COMPLETED|Overall Study||22
9733752|NCT00158756|10834049|FG004|COMPLETED|Overall Study||96
9733753|NCT00158756|10834045|FG000|NOT COMPLETED|Overall Study||5
9733754|NCT00158756|10834046|FG001|NOT COMPLETED|Overall Study||0
9733755|NCT00158756|10834047|FG002|NOT COMPLETED|Overall Study||8
9733756|NCT00158756|10834048|FG003|NOT COMPLETED|Overall Study||1
9733757|NCT00158756|10834049|FG004|NOT COMPLETED|Overall Study||3
9733758|NCT00158860|10834063|FG000|STARTED|Overall Study||128
9733759|NCT00158860|10834064|FG001|STARTED|Overall Study||255
9733760|NCT00158860|10834063|FG000|COMPLETED|Overall Study||93
9733761|NCT00158860|10834064|FG001|COMPLETED|Overall Study||184
9733762|NCT00158860|10834063|FG000|NOT COMPLETED|Overall Study||35
9733763|NCT00158860|10834064|FG001|NOT COMPLETED|Overall Study||71
9733764|NCT00158925|10834071|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
9733765|NCT00158925|10834071|FG000|COMPLETED|Overall Study||84
9733766|NCT00158925|10834071|FG000|NOT COMPLETED|Overall Study||12
9733767|NCT00159250|10834077|FG000|STARTED|Overall Study||2
9733768|NCT00159250|10834078|FG001|STARTED|Overall Study||5
9733769|NCT00159250|10834077|FG000|COMPLETED|Overall Study||2
9733770|NCT00159250|10834078|FG001|COMPLETED|Overall Study||5
9733771|NCT00159250|10834077|FG000|NOT COMPLETED|Overall Study||0
9733772|NCT00159250|10834078|FG001|NOT COMPLETED|Overall Study||0
9733773|NCT00159263|10834084|FG000|STARTED|First Intervention||1
9733774|NCT00159263|10834085|FG001|STARTED|First Intervention||1
9733775|NCT00159263|10834086|FG002|STARTED|First Intervention||2
9733776|NCT00159263|10834087|FG003|STARTED|First Intervention||2
9733777|NCT00159263|10834088|FG004|STARTED|First Intervention||2
9733778|NCT00159263|10834089|FG005|STARTED|First Intervention||2
9733779|NCT00159263|10834084|FG000|COMPLETED|First Intervention||1
9733780|NCT00159263|10834085|FG001|COMPLETED|First Intervention||1
9733781|NCT00159263|10834086|FG002|COMPLETED|First Intervention||2
9733782|NCT00159263|10834087|FG003|COMPLETED|First Intervention||2
9733783|NCT00159263|10834088|FG004|COMPLETED|First Intervention||2
9733784|NCT00159263|10834089|FG005|COMPLETED|First Intervention||2
9733785|NCT00159263|10834084|FG000|NOT COMPLETED|First Intervention||0
9733786|NCT00159263|10834085|FG001|NOT COMPLETED|First Intervention||0
9733787|NCT00159263|10834086|FG002|NOT COMPLETED|First Intervention||0
9733788|NCT00159263|10834087|FG003|NOT COMPLETED|First Intervention||0
9733789|NCT00159263|10834088|FG004|NOT COMPLETED|First Intervention||0
9733790|NCT00159263|10834089|FG005|NOT COMPLETED|First Intervention||0
9733791|NCT00159263|10834084|FG000|STARTED|Washout||1
9733792|NCT00159263|10834085|FG001|STARTED|Washout||1
9733793|NCT00159263|10834086|FG002|STARTED|Washout||2
9733794|NCT00159263|10834087|FG003|STARTED|Washout||2
9733795|NCT00159263|10834088|FG004|STARTED|Washout||2
9733796|NCT00159263|10834089|FG005|STARTED|Washout||2
9733797|NCT00159263|10834084|FG000|COMPLETED|Washout||1
9733798|NCT00159263|10834085|FG001|COMPLETED|Washout||1
9733799|NCT00159263|10834086|FG002|COMPLETED|Washout||2
9733800|NCT00159263|10834087|FG003|COMPLETED|Washout||2
9733801|NCT00159263|10834088|FG004|COMPLETED|Washout||2
9733802|NCT00159263|10834089|FG005|COMPLETED|Washout||2
9733803|NCT00159263|10834084|FG000|NOT COMPLETED|Washout||0
9733804|NCT00159263|10834085|FG001|NOT COMPLETED|Washout||0
9733805|NCT00159263|10834086|FG002|NOT COMPLETED|Washout||0
9733806|NCT00159263|10834087|FG003|NOT COMPLETED|Washout||0
9733807|NCT00159263|10834088|FG004|NOT COMPLETED|Washout||0
9733808|NCT00159263|10834089|FG005|NOT COMPLETED|Washout||0
9733809|NCT00159263|10834084|FG000|STARTED|Second Intervention||1
9733810|NCT00159263|10834085|FG001|STARTED|Second Intervention||1
9733811|NCT00159263|10834086|FG002|STARTED|Second Intervention||2
9733812|NCT00159263|10834087|FG003|STARTED|Second Intervention||2
9733813|NCT00159263|10834088|FG004|STARTED|Second Intervention||2
9733814|NCT00159263|10834089|FG005|STARTED|Second Intervention||2
9733815|NCT00159263|10834084|FG000|COMPLETED|Second Intervention||1
9733816|NCT00159263|10834085|FG001|COMPLETED|Second Intervention||1
9733817|NCT00159263|10834086|FG002|COMPLETED|Second Intervention||2
9733818|NCT00159263|10834087|FG003|COMPLETED|Second Intervention||2
9733819|NCT00159263|10834088|FG004|COMPLETED|Second Intervention||2
9733820|NCT00159263|10834089|FG005|COMPLETED|Second Intervention||2
9733821|NCT00159263|10834084|FG000|NOT COMPLETED|Second Intervention||0
9733822|NCT00159263|10834085|FG001|NOT COMPLETED|Second Intervention||0
9733823|NCT00159263|10834086|FG002|NOT COMPLETED|Second Intervention||0
9733824|NCT00159263|10834087|FG003|NOT COMPLETED|Second Intervention||0
9733825|NCT00159263|10834088|FG004|NOT COMPLETED|Second Intervention||0
9733826|NCT00159263|10834089|FG005|NOT COMPLETED|Second Intervention||0
9733827|NCT00159263|10834084|FG000|STARTED|Washout||1
9733828|NCT00159263|10834085|FG001|STARTED|Washout||1
9733829|NCT00159263|10834086|FG002|STARTED|Washout||2
9733830|NCT00159263|10834087|FG003|STARTED|Washout||2
9733831|NCT00159263|10834088|FG004|STARTED|Washout||2
9733832|NCT00159263|10834089|FG005|STARTED|Washout||2
9733833|NCT00159263|10834084|FG000|COMPLETED|Washout||1
9733834|NCT00159263|10834085|FG001|COMPLETED|Washout||1
9733835|NCT00159263|10834086|FG002|COMPLETED|Washout||2
9733836|NCT00159263|10834087|FG003|COMPLETED|Washout||2
9733837|NCT00159263|10834088|FG004|COMPLETED|Washout||2
9733838|NCT00159263|10834089|FG005|COMPLETED|Washout||2
9733839|NCT00159263|10834084|FG000|NOT COMPLETED|Washout||0
9733840|NCT00159263|10834085|FG001|NOT COMPLETED|Washout||0
9733841|NCT00159263|10834086|FG002|NOT COMPLETED|Washout||0
9733842|NCT00159263|10834087|FG003|NOT COMPLETED|Washout||0
9733843|NCT00159263|10834088|FG004|NOT COMPLETED|Washout||0
9733844|NCT00159263|10834089|FG005|NOT COMPLETED|Washout||0
9733845|NCT00159263|10834084|FG000|STARTED|Third Intervention||1
9733846|NCT00159263|10834085|FG001|STARTED|Third Intervention||1
9733847|NCT00159263|10834086|FG002|STARTED|Third Intervention||2
9733848|NCT00159263|10834087|FG003|STARTED|Third Intervention||2
9733849|NCT00159263|10834088|FG004|STARTED|Third Intervention||2
9733850|NCT00159263|10834089|FG005|STARTED|Third Intervention||2
9733851|NCT00159263|10834084|FG000|COMPLETED|Third Intervention||1
9733852|NCT00159263|10834085|FG001|COMPLETED|Third Intervention||1
9733853|NCT00159263|10834086|FG002|COMPLETED|Third Intervention||2
9733854|NCT00159263|10834087|FG003|COMPLETED|Third Intervention||2
9733855|NCT00159263|10834088|FG004|COMPLETED|Third Intervention||2
9733856|NCT00159263|10834089|FG005|COMPLETED|Third Intervention||2
9733857|NCT00159263|10834084|FG000|NOT COMPLETED|Third Intervention||0
9733858|NCT00159263|10834085|FG001|NOT COMPLETED|Third Intervention||0
9733859|NCT00159263|10834086|FG002|NOT COMPLETED|Third Intervention||0
9733860|NCT00159263|10834087|FG003|NOT COMPLETED|Third Intervention||0
9733861|NCT00159263|10834088|FG004|NOT COMPLETED|Third Intervention||0
9733862|NCT00159263|10834089|FG005|NOT COMPLETED|Third Intervention||0
9733863|NCT00159263|10834084|FG000|STARTED|Washout||1
9733864|NCT00159263|10834085|FG001|STARTED|Washout||1
9733865|NCT00159263|10834086|FG002|STARTED|Washout||2
9733866|NCT00159263|10834087|FG003|STARTED|Washout||2
9733867|NCT00159263|10834088|FG004|STARTED|Washout||2
9733868|NCT00159263|10834089|FG005|STARTED|Washout||2
9733869|NCT00159263|10834084|FG000|COMPLETED|Washout||1
9733870|NCT00159263|10834085|FG001|COMPLETED|Washout||1
9733871|NCT00159263|10834086|FG002|COMPLETED|Washout||2
9733872|NCT00159263|10834087|FG003|COMPLETED|Washout||2
9733873|NCT00159263|10834088|FG004|COMPLETED|Washout||2
9733874|NCT00159263|10834089|FG005|COMPLETED|Washout||2
9733875|NCT00159263|10834084|FG000|NOT COMPLETED|Washout||0
9733876|NCT00159263|10834085|FG001|NOT COMPLETED|Washout||0
9733877|NCT00159263|10834086|FG002|NOT COMPLETED|Washout||0
9733878|NCT00159263|10834087|FG003|NOT COMPLETED|Washout||0
9733879|NCT00159263|10834088|FG004|NOT COMPLETED|Washout||0
9733880|NCT00159263|10834089|FG005|NOT COMPLETED|Washout||0
9733881|NCT00159263|10834084|FG000|STARTED|Fourth Intervention||1
9733882|NCT00159263|10834085|FG001|STARTED|Fourth Intervention||1
9733883|NCT00159263|10834086|FG002|STARTED|Fourth Intervention||2
9733884|NCT00159263|10834087|FG003|STARTED|Fourth Intervention||2
9733885|NCT00159263|10834088|FG004|STARTED|Fourth Intervention||2
9733886|NCT00159263|10834089|FG005|STARTED|Fourth Intervention||2
9733887|NCT00159263|10834084|FG000|COMPLETED|Fourth Intervention||1
9733888|NCT00159263|10834085|FG001|COMPLETED|Fourth Intervention||1
9733889|NCT00159263|10834086|FG002|COMPLETED|Fourth Intervention||2
9733890|NCT00159263|10834087|FG003|COMPLETED|Fourth Intervention||2
9733891|NCT00159263|10834088|FG004|COMPLETED|Fourth Intervention||2
9733892|NCT00159263|10834089|FG005|COMPLETED|Fourth Intervention||2
9733893|NCT00159263|10834084|FG000|NOT COMPLETED|Fourth Intervention||0
9733894|NCT00159263|10834085|FG001|NOT COMPLETED|Fourth Intervention||0
9733895|NCT00159263|10834086|FG002|NOT COMPLETED|Fourth Intervention||0
9733896|NCT00159263|10834087|FG003|NOT COMPLETED|Fourth Intervention||0
9733897|NCT00159263|10834088|FG004|NOT COMPLETED|Fourth Intervention||0
9733898|NCT00159263|10834089|FG005|NOT COMPLETED|Fourth Intervention||0
9733899|NCT00159263|10834084|FG000|STARTED|Washout||1
9733900|NCT00159263|10834085|FG001|STARTED|Washout||1
9733901|NCT00159263|10834086|FG002|STARTED|Washout||2
9733902|NCT00159263|10834087|FG003|STARTED|Washout||2
9733903|NCT00159263|10834088|FG004|STARTED|Washout||2
9733904|NCT00159263|10834089|FG005|STARTED|Washout||2
9733905|NCT00159263|10834084|FG000|COMPLETED|Washout||1
9733906|NCT00159263|10834085|FG001|COMPLETED|Washout||1
9733907|NCT00159263|10834086|FG002|COMPLETED|Washout||2
9733908|NCT00159263|10834087|FG003|COMPLETED|Washout||2
9733909|NCT00159263|10834088|FG004|COMPLETED|Washout||2
9733910|NCT00159263|10834089|FG005|COMPLETED|Washout||2
9733911|NCT00159263|10834084|FG000|NOT COMPLETED|Washout||0
9733912|NCT00159263|10834085|FG001|NOT COMPLETED|Washout||0
9733913|NCT00159263|10834086|FG002|NOT COMPLETED|Washout||0
9733914|NCT00159263|10834087|FG003|NOT COMPLETED|Washout||0
9733915|NCT00159263|10834088|FG004|NOT COMPLETED|Washout||0
9733916|NCT00159263|10834089|FG005|NOT COMPLETED|Washout||0
9733917|NCT00159263|10834084|FG000|STARTED|Fifth Intervention||1
9733918|NCT00159263|10834085|FG001|STARTED|Fifth Intervention||1
9733919|NCT00159263|10834086|FG002|STARTED|Fifth Intervention||2
9733920|NCT00159263|10834087|FG003|STARTED|Fifth Intervention||2
9733921|NCT00159263|10834088|FG004|STARTED|Fifth Intervention||2
9733922|NCT00159263|10834089|FG005|STARTED|Fifth Intervention||2
9733923|NCT00159263|10834084|FG000|COMPLETED|Fifth Intervention||1
9733924|NCT00159263|10834085|FG001|COMPLETED|Fifth Intervention||1
9733925|NCT00159263|10834086|FG002|COMPLETED|Fifth Intervention||2
9733926|NCT00159263|10834087|FG003|COMPLETED|Fifth Intervention||2
9733927|NCT00159263|10834088|FG004|COMPLETED|Fifth Intervention||2
9733928|NCT00159263|10834089|FG005|COMPLETED|Fifth Intervention||2
9733929|NCT00159263|10834084|FG000|NOT COMPLETED|Fifth Intervention||0
9733930|NCT00159263|10834085|FG001|NOT COMPLETED|Fifth Intervention||0
9733931|NCT00159263|10834086|FG002|NOT COMPLETED|Fifth Intervention||0
9733932|NCT00159263|10834087|FG003|NOT COMPLETED|Fifth Intervention||0
9733933|NCT00159263|10834088|FG004|NOT COMPLETED|Fifth Intervention||0
9733934|NCT00159263|10834089|FG005|NOT COMPLETED|Fifth Intervention||0
9733935|NCT00159263|10834084|FG000|STARTED|Washout||1
9733936|NCT00159263|10834085|FG001|STARTED|Washout||1
9733937|NCT00159263|10834086|FG002|STARTED|Washout||2
9733938|NCT00159263|10834087|FG003|STARTED|Washout||2
9733939|NCT00159263|10834088|FG004|STARTED|Washout||2
9733940|NCT00159263|10834089|FG005|STARTED|Washout||2
9733941|NCT00159263|10834084|FG000|COMPLETED|Washout||1
9733942|NCT00159263|10834085|FG001|COMPLETED|Washout||1
9733943|NCT00159263|10834086|FG002|COMPLETED|Washout||2
9733944|NCT00159263|10834087|FG003|COMPLETED|Washout||2
9733945|NCT00159263|10834088|FG004|COMPLETED|Washout||2
9733946|NCT00159263|10834089|FG005|COMPLETED|Washout||2
9733947|NCT00159263|10834084|FG000|NOT COMPLETED|Washout||0
9733948|NCT00159263|10834085|FG001|NOT COMPLETED|Washout||0
9733949|NCT00159263|10834086|FG002|NOT COMPLETED|Washout||0
9733950|NCT00159263|10834087|FG003|NOT COMPLETED|Washout||0
9733951|NCT00159263|10834088|FG004|NOT COMPLETED|Washout||0
9733952|NCT00159263|10834089|FG005|NOT COMPLETED|Washout||0
9733953|NCT00159263|10834084|FG000|STARTED|Sixth Intervention||1
9733954|NCT00159263|10834085|FG001|STARTED|Sixth Intervention||1
9733955|NCT00159263|10834086|FG002|STARTED|Sixth Intervention||2
9733956|NCT00159263|10834087|FG003|STARTED|Sixth Intervention||2
9733957|NCT00159263|10834088|FG004|STARTED|Sixth Intervention||2
9733958|NCT00159263|10834089|FG005|STARTED|Sixth Intervention||2
9733959|NCT00159263|10834084|FG000|COMPLETED|Sixth Intervention||1
9733960|NCT00159263|10834085|FG001|COMPLETED|Sixth Intervention||1
9733961|NCT00159263|10834086|FG002|COMPLETED|Sixth Intervention||2
9733962|NCT00159263|10834087|FG003|COMPLETED|Sixth Intervention||2
9733963|NCT00159263|10834088|FG004|COMPLETED|Sixth Intervention||2
9733964|NCT00159263|10834089|FG005|COMPLETED|Sixth Intervention||2
9733965|NCT00159263|10834084|FG000|NOT COMPLETED|Sixth Intervention||0
9733966|NCT00159263|10834085|FG001|NOT COMPLETED|Sixth Intervention||0
9733967|NCT00159263|10834086|FG002|NOT COMPLETED|Sixth Intervention||0
9733968|NCT00159263|10834087|FG003|NOT COMPLETED|Sixth Intervention||0
9733969|NCT00159263|10834088|FG004|NOT COMPLETED|Sixth Intervention||0
9733970|NCT00159263|10834089|FG005|NOT COMPLETED|Sixth Intervention||0
9733971|NCT00159419|10834105|FG000|STARTED|Overall Study||9
9733972|NCT00159419|10834106|FG001|STARTED|Overall Study||9
9733973|NCT00159419|10834105|FG000|COMPLETED|Overall Study||9
9733974|NCT00159419|10834106|FG001|COMPLETED|Overall Study||9
9733975|NCT00159419|10834105|FG000|NOT COMPLETED|Overall Study||0
9733976|NCT00159419|10834106|FG001|NOT COMPLETED|Overall Study||0
9733977|NCT00159432|10834112|FG000|STARTED|Overall Study||63
9733978|NCT00159432|10834112|FG000|COMPLETED|Overall Study||53
9733979|NCT00159432|10834112|FG000|NOT COMPLETED|Overall Study||10
9733980|NCT00159822|10834116|FG000|STARTED|Voriconazole Treatment Period||48
9733981|NCT00159822|10834116|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
9733982|NCT00159822|10834116|FG000|NOT COMPLETED|Voriconazole Treatment Period||22
9733983|NCT00159822|10834116|FG000|STARTED|Post-treatment Follow-up Period||26
9733984|NCT00159822|10834116|FG000|COMPLETED|Post-treatment Follow-up Period||23
9733985|NCT00159822|10834116|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3
9733986|NCT00159861|10834122|FG000|STARTED|Core Study - 16 Weeks||133
9733987|NCT00159861|10834123|FG001|STARTED|Core Study - 16 Weeks||134
9733988|NCT00159861|10834122|FG000|Treated|Core Study - 16 Weeks||131
9733989|NCT00159861|10834123|FG001|Treated|Core Study - 16 Weeks||134
9733990|NCT00159861|10834122|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
9733991|NCT00159861|10834123|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
9733992|NCT00159861|10834122|FG000|NOT COMPLETED|Core Study - 16 Weeks||25
9733993|NCT00159861|10834123|FG001|NOT COMPLETED|Core Study - 16 Weeks||12
9733994|NCT00159861|10834122|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
9733995|NCT00159861|10834123|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
9733996|NCT00159861|10834122|FG000|Treated|Extension Study - up to 3 Years||115
9733997|NCT00159861|10834123|FG001|Treated|Extension Study - up to 3 Years||127
9733998|NCT00159861|10834122|FG000|COMPLETED|Extension Study - up to 3 Years||53
9733999|NCT00159861|10834123|FG001|COMPLETED|Extension Study - up to 3 Years||56
9734000|NCT00159861|10834122|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62
9734001|NCT00159861|10834123|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71
9734002|NCT00159874|10834141|FG000|STARTED|Overall Study||42
9734003|NCT00159874|10834142|FG001|STARTED|Overall Study||55
9734004|NCT00159874|10834143|FG002|STARTED|Overall Study||77
9734005|NCT00159874|10834144|FG003|STARTED|Overall Study||13
9734006|NCT00159874|10834145|FG004|STARTED|Overall Study||19
9734007|NCT00159874|10834146|FG005|STARTED|Overall Study||23
9734008|NCT00159874|10834147|FG006|STARTED|Overall Study||5
9734009|NCT00159874|10834141|FG000|Treated|Overall Study||42
9734010|NCT00159874|10834142|FG001|Treated|Overall Study||55
9734011|NCT00159874|10834143|FG002|Treated|Overall Study||77
9734012|NCT00159874|10834144|FG003|Treated|Overall Study||13
9734013|NCT00159874|10834145|FG004|Treated|Overall Study||19
9734014|NCT00159874|10834146|FG005|Treated|Overall Study||23
9734015|NCT00159874|10834147|FG006|Treated|Overall Study||5
9734016|NCT00159874|10834141|FG000|COMPLETED|Overall Study||22
9734017|NCT00159874|10834142|FG001|COMPLETED|Overall Study||25
9734018|NCT00159874|10834143|FG002|COMPLETED|Overall Study||34
9734019|NCT00159874|10834144|FG003|COMPLETED|Overall Study||7
9734020|NCT00159874|10834145|FG004|COMPLETED|Overall Study||11
9734021|NCT00159874|10834146|FG005|COMPLETED|Overall Study||11
9734022|NCT00159874|10834147|FG006|COMPLETED|Overall Study||0
9734023|NCT00159874|10834141|FG000|NOT COMPLETED|Overall Study||20
9734024|NCT00159874|10834142|FG001|NOT COMPLETED|Overall Study||30
9734025|NCT00159874|10834143|FG002|NOT COMPLETED|Overall Study||43
9734026|NCT00159874|10834144|FG003|NOT COMPLETED|Overall Study||6
9734027|NCT00159874|10834145|FG004|NOT COMPLETED|Overall Study||8
9734028|NCT00159874|10834146|FG005|NOT COMPLETED|Overall Study||12
9734029|NCT00159874|10834147|FG006|NOT COMPLETED|Overall Study||5
9734030|NCT00159913|10834167|FG000|STARTED|Overall Study||42
9734031|NCT00159913|10834168|FG001|STARTED|Overall Study||55
9734032|NCT00159913|10834169|FG002|STARTED|Overall Study||77
9734033|NCT00159913|10834170|FG003|STARTED|Overall Study||60
9734034|NCT00159913|10834167|FG000|COMPLETED|Overall Study||40
9734035|NCT00159913|10834168|FG001|COMPLETED|Overall Study||55
9734036|NCT00159913|10834169|FG002|COMPLETED|Overall Study||75
9734037|NCT00159913|10834170|FG003|COMPLETED|Overall Study||58
9734038|NCT00159913|10834167|FG000|NOT COMPLETED|Overall Study||2
9734039|NCT00159913|10834168|FG001|NOT COMPLETED|Overall Study||0
9734040|NCT00159913|10834169|FG002|NOT COMPLETED|Overall Study||2
9734041|NCT00159913|10834170|FG003|NOT COMPLETED|Overall Study||2
9734042|NCT00159965|10834184|FG000|STARTED|Overall Study||19
9734043|NCT00159965|10834185|FG001|STARTED|Overall Study||19
9734044|NCT00159965|10834184|FG000|COMPLETED|Overall Study||12
9734045|NCT00159965|10834185|FG001|COMPLETED|Overall Study||14
9734046|NCT00159965|10834184|FG000|NOT COMPLETED|Overall Study||7
9734047|NCT00159965|10834185|FG001|NOT COMPLETED|Overall Study||5
9734048|NCT00160199|10834193|FG000|STARTED|Overall Study||122
9734049|NCT00160199|10834194|FG001|STARTED|Overall Study||118
9734050|NCT00160199|10834193|FG000|COMPLETED|Overall Study||98
9734051|NCT00160199|10834194|FG001|COMPLETED|Overall Study||81
9734052|NCT00160199|10834193|FG000|NOT COMPLETED|Overall Study||24
9734053|NCT00160199|10834194|FG001|NOT COMPLETED|Overall Study||37
9734054|NCT00160251|10834206|FG000|STARTED|Prior to Amendment 2||15
9734055|NCT00160251|10834207|FG001|STARTED|Prior to Amendment 2||34
9734056|NCT00160251|10834208|FG002|STARTED|Prior to Amendment 2||48
9734057|NCT00160251|10834209|FG003|STARTED|Prior to Amendment 2||49
9734058|NCT00160251|10834210|FG004|STARTED|Prior to Amendment 2||49
9734059|NCT00160251|10834211|FG005|STARTED|Prior to Amendment 2||97
9734060|NCT00160251|10834212|FG006|STARTED|Prior to Amendment 2||65
9734061|NCT00160251|10834213|FG007|STARTED|Prior to Amendment 2||0
9734062|NCT00160251|10834206|FG000|COMPLETED|Prior to Amendment 2||6
9734063|NCT00160251|10834207|FG001|COMPLETED|Prior to Amendment 2||28
9734064|NCT00160251|10834208|FG002|COMPLETED|Prior to Amendment 2||4
9734065|NCT00160251|10834209|FG003|COMPLETED|Prior to Amendment 2||9
9734066|NCT00160251|10834210|FG004|COMPLETED|Prior to Amendment 2||21
9734067|NCT00160251|10834211|FG005|COMPLETED|Prior to Amendment 2||14
9734068|NCT00160251|10834212|FG006|COMPLETED|Prior to Amendment 2||61
9734069|NCT00160251|10834213|FG007|COMPLETED|Prior to Amendment 2||0
9734070|NCT00160251|10834206|FG000|NOT COMPLETED|Prior to Amendment 2||9
9734071|NCT00160251|10834207|FG001|NOT COMPLETED|Prior to Amendment 2||6
9734072|NCT00160251|10834208|FG002|NOT COMPLETED|Prior to Amendment 2||44
9734073|NCT00160251|10834209|FG003|NOT COMPLETED|Prior to Amendment 2||40
9734074|NCT00160251|10834210|FG004|NOT COMPLETED|Prior to Amendment 2||28
9734075|NCT00160251|10834211|FG005|NOT COMPLETED|Prior to Amendment 2||83
9734076|NCT00160251|10834212|FG006|NOT COMPLETED|Prior to Amendment 2||4
9734077|NCT00160251|10834213|FG007|NOT COMPLETED|Prior to Amendment 2||0
9734078|NCT00160251|10834206|FG000|STARTED|Post-amendment 2||0
9734079|NCT00160251|10834207|FG001|STARTED|Post-amendment 2||0
9734080|NCT00160251|10834208|FG002|STARTED|Post-amendment 2||0
9734081|NCT00160251|10834209|FG003|STARTED|Post-amendment 2||0
9734082|NCT00160251|10834210|FG004|STARTED|Post-amendment 2||0
9734083|NCT00160251|10834211|FG005|STARTED|Post-amendment 2||0
9734084|NCT00160251|10834212|FG006|STARTED|Post-amendment 2||0
9734085|NCT00160251|10834213|FG007|STARTED|Post-amendment 2||143
9734086|NCT00160251|10834206|FG000|COMPLETED|Post-amendment 2||0
9734087|NCT00160251|10834207|FG001|COMPLETED|Post-amendment 2||0
9734088|NCT00160251|10834208|FG002|COMPLETED|Post-amendment 2||0
9734089|NCT00160251|10834209|FG003|COMPLETED|Post-amendment 2||0
9734090|NCT00160251|10834210|FG004|COMPLETED|Post-amendment 2||0
9734091|NCT00160251|10834211|FG005|COMPLETED|Post-amendment 2||0
9734092|NCT00160251|10834212|FG006|COMPLETED|Post-amendment 2||0
9734093|NCT00160251|10834213|FG007|COMPLETED|Post-amendment 2||88
9734094|NCT00160251|10834206|FG000|NOT COMPLETED|Post-amendment 2||0
9734095|NCT00160251|10834207|FG001|NOT COMPLETED|Post-amendment 2||0
9734096|NCT00160251|10834208|FG002|NOT COMPLETED|Post-amendment 2||0
9734097|NCT00160251|10834209|FG003|NOT COMPLETED|Post-amendment 2||0
9734098|NCT00160251|10834210|FG004|NOT COMPLETED|Post-amendment 2||0
9734099|NCT00160251|10834211|FG005|NOT COMPLETED|Post-amendment 2||0
9734100|NCT00160251|10834212|FG006|NOT COMPLETED|Post-amendment 2||0
9734101|NCT00160251|10834213|FG007|NOT COMPLETED|Post-amendment 2||55
9734102|NCT00160524|10834270|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
9734103|NCT00160524|10834270|FG000|COMPLETED|Overall Study||117
9734104|NCT00160524|10834270|FG000|NOT COMPLETED|Overall Study||478
9734105|NCT00160615|10834276|FG000|STARTED|Overall Study||50
9734106|NCT00160615|10834277|FG001|STARTED|Overall Study||101
9734107|NCT00160615|10834276|FG000|COMPLETED|Overall Study||32
9734108|NCT00160615|10834277|FG001|COMPLETED|Overall Study||56
9734109|NCT00160615|10834276|FG000|NOT COMPLETED|Overall Study||18
9734110|NCT00160615|10834277|FG001|NOT COMPLETED|Overall Study||45
9734111|NCT00160641|10834285|FG000|STARTED|Overall Study||567
9734112|NCT00160641|10834285|FG000|COMPLETED|Overall Study||346
9734113|NCT00160641|10834285|FG000|NOT COMPLETED|Overall Study||221
9734114|NCT00160654|10834289|FG000|STARTED|Overall Study||251
9734115|NCT00160654|10834289|FG000|COMPLETED|Overall Study||218
9734116|NCT00160654|10834289|FG000|NOT COMPLETED|Overall Study||33
9734117|NCT00160667|10834296|FG000|STARTED|Overall Study||50
9734118|NCT00160667|10834297|FG001|STARTED|Overall Study||51
9734119|NCT00160667|10834298|FG002|STARTED|Overall Study||51
9734120|NCT00160667|10834296|FG000|COMPLETED|Overall Study||45
9734121|NCT00160667|10834297|FG001|COMPLETED|Overall Study||48
9734122|NCT00160667|10834298|FG002|COMPLETED|Overall Study||45
9734123|NCT00160667|10834296|FG000|NOT COMPLETED|Overall Study||5
9734124|NCT00160667|10834297|FG001|NOT COMPLETED|Overall Study||3
9734125|NCT00160667|10834298|FG002|NOT COMPLETED|Overall Study||6
9734126|NCT00160680|10834309|FG000|STARTED|Overall Study||31
9734127|NCT00160680|10834310|FG001|STARTED|Overall Study||31
9734128|NCT00160680|10834309|FG000|COMPLETED|Overall Study||22
9734129|NCT00160680|10834310|FG001|COMPLETED|Overall Study||18
9734130|NCT00160680|10834309|FG000|NOT COMPLETED|Overall Study||9
9734131|NCT00160680|10834310|FG001|NOT COMPLETED|Overall Study||13
9734132|NCT00160693|10834316|FG000|STARTED|Overall Study||402
9734133|NCT00160693|10834316|FG000|COMPLETED|Overall Study||167
9734134|NCT00160693|10834316|FG000|NOT COMPLETED|Overall Study||235
9734135|NCT00160706|10834320|FG000|STARTED|Overall Study||310
9734136|NCT00160706|10834320|FG000|COMPLETED|Overall Study||24
9734137|NCT00160706|10834320|FG000|NOT COMPLETED|Overall Study||286
9734138|NCT00161213|10834324|FG000|STARTED|Overall Study||44
9734139|NCT00161213|10834324|FG000|COMPLETED|Overall Study||42
9734140|NCT00161213|10834324|FG000|NOT COMPLETED|Overall Study||2
9734141|NCT00161382|10834330|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598
9734142|NCT00161382|10834331|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847
9734143|NCT00161382|10834330|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
9734144|NCT00161382|10834331|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
9734145|NCT00161382|10834330|FG000|NOT COMPLETED|Overall Study||249
9734146|NCT00161382|10834331|FG001|NOT COMPLETED|Overall Study||289
9734147|NCT00161473|10834339|FG000|STARTED|Overall Study||12
9734148|NCT00161473|10834340|FG001|STARTED|Overall Study||12
9734149|NCT00161473|10834339|FG000|COMPLETED|Overall Study||7
9734150|NCT00161473|10834340|FG001|COMPLETED|Overall Study||6
9734151|NCT00161473|10834339|FG000|NOT COMPLETED|Overall Study||5
9734152|NCT00161473|10834340|FG001|NOT COMPLETED|Overall Study||6
9734153|NCT00161616|10834348|FG000|STARTED|Overall Study||139
9734154|NCT00161616|10834349|FG001|STARTED|Overall Study||138
9734155|NCT00161616|10834348|FG000|COMPLETED|Overall Study||113
9734156|NCT00161616|10834349|FG001|COMPLETED|Overall Study||119
9734157|NCT00161616|10834348|FG000|NOT COMPLETED|Overall Study||26
9734158|NCT00161616|10834349|FG001|NOT COMPLETED|Overall Study||19
9734159|NCT00162032|10834357|FG000|STARTED|Overall Study||329
9734160|NCT00162032|10834358|FG001|STARTED|Overall Study||116
9734161|NCT00162032|10834357|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
9734162|NCT00162032|10834358|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
9734163|NCT00162032|10834357|FG000|NOT COMPLETED|Overall Study||5
9734164|NCT00162032|10834358|FG001|NOT COMPLETED|Overall Study||2
9734165|NCT00162097|10834373|FG000|STARTED|Overall Study|Treated on Day 1|6
9734166|NCT00162097|10834374|FG001|STARTED|Overall Study|Treated on Day 1|2
9734167|NCT00162097|10834375|FG002|STARTED|Overall Study|Treated on Day 1|1
9734168|NCT00162097|10834376|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
9734169|NCT00162097|10834373|FG000|COMPLETED|Overall Study||6
9734170|NCT00162097|10834374|FG001|COMPLETED|Overall Study||2
9734171|NCT00162097|10834375|FG002|COMPLETED|Overall Study||1
9734172|NCT00162097|10834376|FG003|COMPLETED|Overall Study||6
9734173|NCT00162097|10834373|FG000|NOT COMPLETED|Overall Study||0
9734174|NCT00162097|10834374|FG001|NOT COMPLETED|Overall Study||0
9734175|NCT00162097|10834375|FG002|NOT COMPLETED|Overall Study||0
9734176|NCT00162097|10834376|FG003|NOT COMPLETED|Overall Study||1
9734177|NCT00162123|10834400|FG000|STARTED|Overall Study|Enrolled|53
9734178|NCT00162123|10834401|FG001|STARTED|Overall Study|Enrolled|34
9734179|NCT00162123|10834402|FG002|STARTED|Overall Study|Enrolled|24
9734180|NCT00162123|10834403|FG003|STARTED|Overall Study|Enrolled|11
9734181|NCT00162123|10834404|FG004|STARTED|Overall Study|Enrolled|45
9734182|NCT00162123|10834405|FG005|STARTED|Overall Study|Enrolled|13
9734183|NCT00162123|10834406|FG006|STARTED|Overall Study|Enrolled|4
9734184|NCT00162123|10834407|FG007|STARTED|Overall Study|Enrolled|58
9734185|NCT00162123|10834400|FG000|Received Treatment|Overall Study||53
9734186|NCT00162123|10834401|FG001|Received Treatment|Overall Study||34
9734187|NCT00162123|10834402|FG002|Received Treatment|Overall Study||24
9734188|NCT00162123|10834403|FG003|Received Treatment|Overall Study||11
9734189|NCT00162123|10834404|FG004|Received Treatment|Overall Study||33
9734190|NCT00162123|10834405|FG005|Received Treatment|Overall Study||12
9734191|NCT00162123|10834406|FG006|Received Treatment|Overall Study||4
9734192|NCT00162123|10834407|FG007|Received Treatment|Overall Study||0
9734193|NCT00162123|10834400|FG000|COMPLETED|Overall Study|Still on treatment|9
9734194|NCT00162123|10834401|FG001|COMPLETED|Overall Study|Still on treatment|5
9734195|NCT00162123|10834402|FG002|COMPLETED|Overall Study|Still on treatment|3
9734196|NCT00162123|10834403|FG003|COMPLETED|Overall Study|Still on treatment|3
9734197|NCT00162123|10834404|FG004|COMPLETED|Overall Study|Still on treatment|14
9734198|NCT00162123|10834405|FG005|COMPLETED|Overall Study|Still on treatment|4
9734199|NCT00162123|10834406|FG006|COMPLETED|Overall Study|Still on treatment|0
9734200|NCT00162123|10834407|FG007|COMPLETED|Overall Study|Still on treatment|0
9734201|NCT00162123|10834400|FG000|NOT COMPLETED|Overall Study||44
9734202|NCT00162123|10834401|FG001|NOT COMPLETED|Overall Study||29
9734203|NCT00162123|10834402|FG002|NOT COMPLETED|Overall Study||21
9734204|NCT00162123|10834403|FG003|NOT COMPLETED|Overall Study||8
9734205|NCT00162123|10834404|FG004|NOT COMPLETED|Overall Study||31
9734206|NCT00162123|10834405|FG005|NOT COMPLETED|Overall Study||9
9734207|NCT00162123|10834406|FG006|NOT COMPLETED|Overall Study||4
9734208|NCT00162123|10834407|FG007|NOT COMPLETED|Overall Study||58
9734209|NCT00162136|10834432|FG000|STARTED|Overall Study||35
9734210|NCT00162136|10834432|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
9734211|NCT00162136|10834432|FG000|NOT COMPLETED|Overall Study||35
9734212|NCT00162266|10834459|FG000|STARTED|Double-Blind Period||115
9734213|NCT00162266|10834460|FG001|STARTED|Double-Blind Period||105
9734214|NCT00162266|10834461|FG002|STARTED|Double-Blind Period||119
9734215|NCT00162266|10834462|FG003|STARTED|Double-Blind Period||0
9734216|NCT00162266|10834459|FG000|Completed Day 1 to Day 181|Double-Blind Period||98
9734217|NCT00162266|10834460|FG001|Completed Day 1 to Day 181|Double-Blind Period||80
9734218|NCT00162266|10834461|FG002|Completed Day 1 to Day 181|Double-Blind Period||78
9734219|NCT00162266|10834462|FG003|Completed Day 1 to Day 181|Double-Blind Period||0
9734220|NCT00162266|10834459|FG000|COMPLETED|Double-Blind Period||90
9734221|NCT00162266|10834460|FG001|COMPLETED|Double-Blind Period||74
9734222|NCT00162266|10834461|FG002|COMPLETED|Double-Blind Period||71
9734223|NCT00162266|10834462|FG003|COMPLETED|Double-Blind Period||0
9734224|NCT00162266|10834459|FG000|NOT COMPLETED|Double-Blind Period||25
9734225|NCT00162266|10834460|FG001|NOT COMPLETED|Double-Blind Period||31
9734226|NCT00162266|10834461|FG002|NOT COMPLETED|Double-Blind Period||48
9734227|NCT00162266|10834462|FG003|NOT COMPLETED|Double-Blind Period||0
9734228|NCT00162266|10834459|FG000|STARTED|Open-Label Period||0
9734229|NCT00162266|10834460|FG001|STARTED|Open-Label Period||0
9734230|NCT00162266|10834461|FG002|STARTED|Open-Label Period||0
9734231|NCT00162266|10834462|FG003|STARTED|Open-Label Period||219
9734232|NCT00162266|10834459|FG000|COMPLETED|Open-Label Period||0
9734233|NCT00162266|10834460|FG001|COMPLETED|Open-Label Period||0
9734234|NCT00162266|10834461|FG002|COMPLETED|Open-Label Period||0
9734235|NCT00162266|10834462|FG003|COMPLETED|Open-Label Period||82
9734236|NCT00162266|10834459|FG000|NOT COMPLETED|Open-Label Period||0
9734237|NCT00162266|10834460|FG001|NOT COMPLETED|Open-Label Period||0
9734238|NCT00162266|10834461|FG002|NOT COMPLETED|Open-Label Period||0
9734239|NCT00162266|10834462|FG003|NOT COMPLETED|Open-Label Period||137
9734240|NCT00162981|10834516|FG000|STARTED|Overall Study||32
9734241|NCT00162981|10834517|FG001|STARTED|Overall Study||36
9734242|NCT00162981|10834516|FG000|COMPLETED|Overall Study||28
9734243|NCT00162981|10834517|FG001|COMPLETED|Overall Study||30
9734244|NCT00162981|10834516|FG000|NOT COMPLETED|Overall Study||4
9734245|NCT00162981|10834517|FG001|NOT COMPLETED|Overall Study||6
9734246|NCT00163020|10834525|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216
9734247|NCT00163020|10834526|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105
9734248|NCT00163020|10834525|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
9734249|NCT00163020|10834526|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
9734250|NCT00163020|10834525|FG000|NOT COMPLETED|Overall Study||0
9734251|NCT00163020|10834526|FG001|NOT COMPLETED|Overall Study||2
9734252|NCT00163189|10834534|FG000|STARTED|Overall Study||98
9734253|NCT00163189|10834534|FG000|COMPLETED|Overall Study||35
9734254|NCT00163189|10834534|FG000|NOT COMPLETED|Overall Study||63
9734255|NCT00163215|10834538|FG000|STARTED|Overall Study||46
9734256|NCT00163215|10834538|FG000|COMPLETED|Overall Study||31
9734257|NCT00163215|10834538|FG000|NOT COMPLETED|Overall Study||15
9734258|NCT00163293|10834545|FG000|STARTED|Overall Study||79
9734259|NCT00163293|10834546|FG001|STARTED|Overall Study||76
9734260|NCT00163293|10834547|FG002|STARTED|Overall Study||85
9734261|NCT00163293|10834545|FG000|COMPLETED|Overall Study||66
9734262|NCT00163293|10834546|FG001|COMPLETED|Overall Study||69
9734263|NCT00163293|10834547|FG002|COMPLETED|Overall Study||66
9734264|NCT00163293|10834545|FG000|NOT COMPLETED|Overall Study||13
9734265|NCT00163293|10834546|FG001|NOT COMPLETED|Overall Study||7
9734266|NCT00163293|10834547|FG002|NOT COMPLETED|Overall Study||19
9734267|NCT00163657|10834558|FG000|STARTED|Overall Study||80
9734268|NCT00163657|10834559|FG001|STARTED|Overall Study||79
9734269|NCT00163657|10834560|FG002|STARTED|Overall Study||153
9734270|NCT00163657|10834558|FG000|COMPLETED|Overall Study||60
9734271|NCT00163657|10834559|FG001|COMPLETED|Overall Study||56
9734272|NCT00163657|10834560|FG002|COMPLETED|Overall Study||116
9734273|NCT00163657|10834558|FG000|NOT COMPLETED|Overall Study||20
9734274|NCT00163657|10834559|FG001|NOT COMPLETED|Overall Study||23
9734275|NCT00163657|10834560|FG002|NOT COMPLETED|Overall Study||37
9734276|NCT00165646|10834571|FG000|STARTED|Overall Study||93
9734277|NCT00165646|10834572|FG001|STARTED|Overall Study||93
9734278|NCT00165646|10834573|FG002|STARTED|Overall Study||102
9734279|NCT00165646|10834571|FG000|COMPLETED|Overall Study||88
9734280|NCT00165646|10834572|FG001|COMPLETED|Overall Study||88
9734281|NCT00165646|10834573|FG002|COMPLETED|Overall Study||98
9734282|NCT00165646|10834571|FG000|NOT COMPLETED|Overall Study||5
9734283|NCT00165646|10834572|FG001|NOT COMPLETED|Overall Study||5
9734284|NCT00165646|10834573|FG002|NOT COMPLETED|Overall Study||4
9734285|NCT00165672|10834583|FG000|STARTED|Overall Study||13
9734286|NCT00165672|10834584|FG001|STARTED|Overall Study||13
9734287|NCT00165672|10834583|FG000|COMPLETED|Overall Study||13
9734288|NCT00165672|10834584|FG001|COMPLETED|Overall Study||12
9734289|NCT00165672|10834583|FG000|NOT COMPLETED|Overall Study||0
9734290|NCT00165672|10834584|FG001|NOT COMPLETED|Overall Study||1
9734291|NCT00165698|10834592|FG000|STARTED|Overall Study||120
9734292|NCT00165698|10834593|FG001|STARTED|Overall Study||120
9734293|NCT00165698|10834592|FG000|COMPLETED|Overall Study||112
9734294|NCT00165698|10834593|FG001|COMPLETED|Overall Study||105
9734295|NCT00165698|10834592|FG000|NOT COMPLETED|Overall Study||8
9734296|NCT00165698|10834593|FG001|NOT COMPLETED|Overall Study||15
9734297|NCT00165776|10834603|FG000|STARTED|Overall Study||35
9734298|NCT00165776|10834604|FG001|STARTED|Overall Study||34
9734299|NCT00165776|10834605|FG002|STARTED|Overall Study||33
9734300|NCT00165776|10834606|FG003|STARTED|Overall Study||31
9734301|NCT00165776|10834603|FG000|COMPLETED|Overall Study||31
9734302|NCT00165776|10834604|FG001|COMPLETED|Overall Study||33
9734303|NCT00165776|10834605|FG002|COMPLETED|Overall Study||31
9734304|NCT00165776|10834606|FG003|COMPLETED|Overall Study||29
9734305|NCT00165776|10834603|FG000|NOT COMPLETED|Overall Study||4
9734306|NCT00165776|10834604|FG001|NOT COMPLETED|Overall Study||1
9734307|NCT00165776|10834605|FG002|NOT COMPLETED|Overall Study||2
9734308|NCT00165776|10834606|FG003|NOT COMPLETED|Overall Study||2
9734309|NCT00165789|10834620|FG000|STARTED|Overall Study||8
9734310|NCT00165789|10834621|FG001|STARTED|Overall Study||20
9734311|NCT00165789|10834622|FG002|STARTED|Overall Study||12
9734312|NCT00165789|10834623|FG003|STARTED|Overall Study||35
9734313|NCT00165789|10834620|FG000|COMPLETED|Overall Study||8
9734314|NCT00165789|10834621|FG001|COMPLETED|Overall Study||16
9734315|NCT00165789|10834622|FG002|COMPLETED|Overall Study||11
9734316|NCT00165789|10834623|FG003|COMPLETED|Overall Study||21
9734317|NCT00165789|10834620|FG000|NOT COMPLETED|Overall Study||0
9734318|NCT00165789|10834621|FG001|NOT COMPLETED|Overall Study||4
9734319|NCT00165789|10834622|FG002|NOT COMPLETED|Overall Study||1
9734320|NCT00165789|10834623|FG003|NOT COMPLETED|Overall Study||14
9734321|NCT00165841|10834635|FG000|STARTED|Overall Study||103
9734322|NCT00165841|10834636|FG001|STARTED|Overall Study||97
9734323|NCT00165841|10834635|FG000|COMPLETED|Overall Study||73
9734324|NCT00165841|10834636|FG001|COMPLETED|Overall Study||35
9734325|NCT00165841|10834635|FG000|NOT COMPLETED|Overall Study||30
9734326|NCT00165841|10834636|FG001|NOT COMPLETED|Overall Study||62
9734327|NCT00165958|10834644|FG000|STARTED|Overall Study||19
9734328|NCT00165958|10834645|FG001|STARTED|Overall Study||21
9734329|NCT00165958|10834644|FG000|COMPLETED|Overall Study||18
9734330|NCT00165958|10834645|FG001|COMPLETED|Overall Study||19
9734331|NCT00165958|10834644|FG000|NOT COMPLETED|Overall Study||1
9734332|NCT00165958|10834645|FG001|NOT COMPLETED|Overall Study||2
9734333|NCT00165984|10834651|FG000|STARTED|Overall Study||165
9734334|NCT00165984|10834651|FG000|COMPLETED|Overall Study||150
9734335|NCT00165984|10834651|FG000|NOT COMPLETED|Overall Study||15
9734336|NCT00166036|10834660|FG000|STARTED|Overall Study||17
9734337|NCT00166036|10834661|FG001|STARTED|Overall Study||19
9734338|NCT00166036|10834660|FG000|COMPLETED|Overall Study||17
9734339|NCT00166036|10834661|FG001|COMPLETED|Overall Study||19
9734340|NCT00166036|10834660|FG000|NOT COMPLETED|Overall Study||0
9734341|NCT00166036|10834661|FG001|NOT COMPLETED|Overall Study||0
9734342|NCT00166114|10834670|FG000|STARTED|Overall Study||21
9734343|NCT00166114|10834671|FG001|STARTED|Overall Study||19
9734344|NCT00166114|10834670|FG000|COMPLETED|Overall Study||7
9734345|NCT00166114|10834671|FG001|COMPLETED|Overall Study||13
9734346|NCT00166114|10834670|FG000|NOT COMPLETED|Overall Study||14
9734347|NCT00166114|10834671|FG001|NOT COMPLETED|Overall Study||6
9734348|NCT00166166|10834679|FG000|STARTED|Overall Study||103
9734349|NCT00166166|10834680|FG001|STARTED|Overall Study||71
9734350|NCT00166166|10834679|FG000|COMPLETED|Overall Study||103
9734351|NCT00166166|10834680|FG001|COMPLETED|Overall Study||71
9734352|NCT00166166|10834679|FG000|NOT COMPLETED|Overall Study||0
9734353|NCT00166166|10834680|FG001|NOT COMPLETED|Overall Study||0
9734354|NCT00166205|10834699|FG000|STARTED|Overall Study||276
9734355|NCT00166205|10834699|FG000|Intervention - SAGB Surgery|Overall Study||276
9734356|NCT00166205|10834699|FG000|COMPLETED|Overall Study||228
9734357|NCT00166205|10834699|FG000|NOT COMPLETED|Overall Study||48
9734358|NCT00166296|10834705|FG000|STARTED|Overall Study|Randomized patients|67
9734359|NCT00166296|10834706|FG001|STARTED|Overall Study|Randomized patients|66
9734360|NCT00166296|10834705|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
9734361|NCT00166296|10834706|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
9734362|NCT00166296|10834705|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
9734363|NCT00166296|10834706|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
9734364|NCT00166296|10834705|FG000|NOT COMPLETED|Overall Study||7
9734365|NCT00166296|10834706|FG001|NOT COMPLETED|Overall Study||9
9734366|NCT00166361|10834714|FG000|STARTED|Overall Study||14
9734367|NCT00166361|10834715|FG001|STARTED|Overall Study||10
9734368|NCT00166361|10834714|FG000|COMPLETED|Overall Study||14
9734369|NCT00166361|10834715|FG001|COMPLETED|Overall Study||10
9734370|NCT00166361|10834714|FG000|NOT COMPLETED|Overall Study||0
9734371|NCT00166361|10834715|FG001|NOT COMPLETED|Overall Study||0
9734372|NCT00166439|10834721|FG000|STARTED|Overall Study||50
9734373|NCT00166439|10834721|FG000|COMPLETED|Overall Study||45
9734374|NCT00166439|10834721|FG000|NOT COMPLETED|Overall Study||5
9734375|NCT00166517|10834727|FG000|STARTED|Overall Study||115
9734376|NCT00166517|10834728|FG001|STARTED|Overall Study||63
9734377|NCT00166517|10834727|FG000|Vaccinated at Visit 1|Overall Study||115
9734378|NCT00166517|10834728|FG001|Vaccinated at Visit 1|Overall Study||63
9734379|NCT00166517|10834727|FG000|Vaccinated at Visit 2|Overall Study||112
9734380|NCT00166517|10834728|FG001|Vaccinated at Visit 2|Overall Study||61
9734381|NCT00166517|10834727|FG000|Vaccinated at Visit 3|Overall Study||110
9734382|NCT00166517|10834728|FG001|Vaccinated at Visit 3|Overall Study||61
9734383|NCT00166517|10834727|FG000|COMPLETED|Overall Study||110
9734384|NCT00166517|10834728|FG001|COMPLETED|Overall Study||61
9734385|NCT00166517|10834727|FG000|NOT COMPLETED|Overall Study||5
9734386|NCT00166517|10834728|FG001|NOT COMPLETED|Overall Study||2
9734387|NCT00166712|10834736|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
9734388|NCT00166712|10834737|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
9734389|NCT00166712|10834736|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
9734477|NCT00168103|10834859|FG003|STARTED|Overall Study||1
9734390|NCT00166712|10834737|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
9734391|NCT00166712|10834736|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
9734392|NCT00166712|10834737|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
9734393|NCT00166712|10834736|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
9734394|NCT00166712|10834737|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
9734395|NCT00166712|10834736|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
9734396|NCT00166712|10834737|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
9734397|NCT00166712|10834736|FG000|COMPLETED|Overall Study|Completed study participation.|22
9734398|NCT00166712|10834737|FG001|COMPLETED|Overall Study|Completed study participation.|11
9734399|NCT00166712|10834736|FG000|NOT COMPLETED|Overall Study||2
9734400|NCT00166712|10834737|FG001|NOT COMPLETED|Overall Study||5
9734401|NCT00167102|10834749|FG000|STARTED|Overall Study||23
9734402|NCT00167102|10834750|FG001|STARTED|Overall Study||22
9734403|NCT00167102|10834749|FG000|COMPLETED|Overall Study||23
9734404|NCT00167102|10834750|FG001|COMPLETED|Overall Study||22
9734405|NCT00167102|10834749|FG000|NOT COMPLETED|Overall Study||0
9734406|NCT00167102|10834750|FG001|NOT COMPLETED|Overall Study||0
9734407|NCT00167180|10834760|FG000|STARTED|Overall Study||0
9734408|NCT00167180|10834761|FG001|STARTED|Overall Study||57
9734409|NCT00167180|10834760|FG000|COMPLETED|Overall Study||0
9734410|NCT00167180|10834761|FG001|COMPLETED|Overall Study||57
9734411|NCT00167180|10834760|FG000|NOT COMPLETED|Overall Study||0
9734412|NCT00167180|10834761|FG001|NOT COMPLETED|Overall Study||0
9734413|NCT00167206|10834767|FG000|STARTED|Overall Study||16
9734414|NCT00167206|10834767|FG000|COMPLETED|Overall Study||16
9734415|NCT00167206|10834767|FG000|NOT COMPLETED|Overall Study||0
9734416|NCT00167245|10834773|FG000|STARTED|Overall Study||83
9734417|NCT00167245|10834774|FG001|STARTED|Overall Study||87
9734418|NCT00167245|10834773|FG000|COMPLETED|Overall Study||54
9734419|NCT00167245|10834774|FG001|COMPLETED|Overall Study||46
9734420|NCT00167245|10834773|FG000|NOT COMPLETED|Overall Study||29
9734421|NCT00167245|10834774|FG001|NOT COMPLETED|Overall Study||41
9734422|NCT00167310|10834785|FG000|STARTED|Overall Study||29
9734423|NCT00167310|10834786|FG001|STARTED|Overall Study||28
9734424|NCT00167310|10834785|FG000|COMPLETED|Overall Study||21
9734425|NCT00167310|10834786|FG001|COMPLETED|Overall Study||18
9734426|NCT00167310|10834785|FG000|NOT COMPLETED|Overall Study||8
9734427|NCT00167310|10834786|FG001|NOT COMPLETED|Overall Study||10
9734428|NCT00167388|10834796|FG000|STARTED|Overall Study||5
9734429|NCT00167388|10834797|FG001|STARTED|Overall Study||5
9734430|NCT00167388|10834798|FG002|STARTED|Overall Study||6
9734431|NCT00167388|10834799|FG003|STARTED|Overall Study||6
9734432|NCT00167388|10834796|FG000|Completed Doppler Study|Overall Study||5
9734433|NCT00167388|10834797|FG001|Completed Doppler Study|Overall Study||5
9734434|NCT00167388|10834798|FG002|Completed Doppler Study|Overall Study||6
9734435|NCT00167388|10834799|FG003|Completed Doppler Study|Overall Study||6
9734436|NCT00167388|10834796|FG000|COMPLETED|Overall Study||5
9734437|NCT00167388|10834797|FG001|COMPLETED|Overall Study||5
9734438|NCT00167388|10834798|FG002|COMPLETED|Overall Study||6
9734439|NCT00167388|10834799|FG003|COMPLETED|Overall Study||6
9734440|NCT00167388|10834796|FG000|NOT COMPLETED|Overall Study||0
9734441|NCT00167388|10834797|FG001|NOT COMPLETED|Overall Study||0
9734442|NCT00167388|10834798|FG002|NOT COMPLETED|Overall Study||0
9734443|NCT00167388|10834799|FG003|NOT COMPLETED|Overall Study||0
9734444|NCT00167414|10834807|FG000|STARTED|Overall Study||49
9734445|NCT00167414|10834807|FG000|COMPLETED|Overall Study||39
9734446|NCT00167414|10834807|FG000|NOT COMPLETED|Overall Study||10
9734447|NCT00167544|10834813|FG000|STARTED|Overall Study||31
9734448|NCT00167544|10834814|FG001|STARTED|Overall Study||33
9734449|NCT00167544|10834813|FG000|COMPLETED|Overall Study||30
9734450|NCT00167544|10834814|FG001|COMPLETED|Overall Study||33
9734451|NCT00167544|10834813|FG000|NOT COMPLETED|Overall Study||1
9734452|NCT00167544|10834814|FG001|NOT COMPLETED|Overall Study||0
9734453|NCT00167661|10834820|FG000|STARTED|Overall Study||33
9734454|NCT00167661|10834820|FG000|COMPLETED|Overall Study||33
9734455|NCT00167661|10834820|FG000|NOT COMPLETED|Overall Study||0
9734456|NCT00167778|10834824|FG000|STARTED|Overall Study||11
9734457|NCT00167778|10834824|FG000|COMPLETED|Overall Study||10
9734458|NCT00167778|10834824|FG000|NOT COMPLETED|Overall Study||1
9734459|NCT00167934|10834831|FG000|STARTED|Overall Study||82
9734460|NCT00167934|10834832|FG001|STARTED|Overall Study||82
9734461|NCT00167934|10834831|FG000|COMPLETED|Overall Study||82
9734462|NCT00167934|10834832|FG001|COMPLETED|Overall Study||82
9734463|NCT00167934|10834831|FG000|NOT COMPLETED|Overall Study||0
9734464|NCT00167934|10834832|FG001|NOT COMPLETED|Overall Study||0
9734465|NCT00168038|10834838|FG000|STARTED|Overall Study||57
9734466|NCT00168038|10834838|FG000|COMPLETED|Overall Study||55
9734467|NCT00168038|10834838|FG000|NOT COMPLETED|Overall Study||2
9734468|NCT00168064|10834844|FG000|STARTED|Overall Study|128 participants received PG formulation|130
9734469|NCT00168064|10834845|FG001|STARTED|Overall Study|127 participants received AP formulation|130
9734470|NCT00168064|10834844|FG000|COMPLETED|Overall Study||81
9734471|NCT00168064|10834845|FG001|COMPLETED|Overall Study||86
9734472|NCT00168064|10834844|FG000|NOT COMPLETED|Overall Study||49
9734473|NCT00168064|10834845|FG001|NOT COMPLETED|Overall Study||44
9734474|NCT00168103|10834856|FG000|STARTED|Overall Study||40
9734475|NCT00168103|10834857|FG001|STARTED|Overall Study||43
9734476|NCT00168103|10834858|FG002|STARTED|Overall Study||42
9734478|NCT00168103|10834856|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
9734479|NCT00168103|10834857|FG001|COMPLETED|Overall Study||38
9734480|NCT00168103|10834858|FG002|COMPLETED|Overall Study||41
9734481|NCT00168103|10834859|FG003|COMPLETED|Overall Study||1
9734482|NCT00168103|10834856|FG000|NOT COMPLETED|Overall Study||2
9734483|NCT00168103|10834857|FG001|NOT COMPLETED|Overall Study||5
9734484|NCT00168103|10834858|FG002|NOT COMPLETED|Overall Study||1
9734485|NCT00168103|10834859|FG003|NOT COMPLETED|Overall Study||0
9734486|NCT00168298|10834870|FG000|STARTED|Double-Blind Period||226
9734487|NCT00168298|10834871|FG001|STARTED|Double-Blind Period||218
9734488|NCT00168298|10834872|FG002|STARTED|Double-Blind Period||224
9734489|NCT00168298|10834870|FG000|COMPLETED|Double-Blind Period||214
9734490|NCT00168298|10834871|FG001|COMPLETED|Double-Blind Period||206
9734491|NCT00168298|10834872|FG002|COMPLETED|Double-Blind Period||209
9734492|NCT00168298|10834870|FG000|NOT COMPLETED|Double-Blind Period||12
9734493|NCT00168298|10834871|FG001|NOT COMPLETED|Double-Blind Period||12
9734494|NCT00168298|10834872|FG002|NOT COMPLETED|Double-Blind Period||15
9734495|NCT00168298|10834870|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
9734496|NCT00168298|10834871|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
9734497|NCT00168298|10834872|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
9734498|NCT00168298|10834870|FG000|COMPLETED|Open-Label Period||172
9734499|NCT00168298|10834871|FG001|COMPLETED|Open-Label Period||168
9734500|NCT00168298|10834872|FG002|COMPLETED|Open-Label Period||160
9734501|NCT00168298|10834870|FG000|NOT COMPLETED|Open-Label Period||7
9734502|NCT00168298|10834871|FG001|NOT COMPLETED|Open-Label Period||5
9734503|NCT00168298|10834872|FG002|NOT COMPLETED|Open-Label Period||8
9734504|NCT00168311|10834882|FG000|STARTED|Overall Study||12
9734505|NCT00168311|10834883|FG001|STARTED|Overall Study||10
9734506|NCT00168311|10834882|FG000|COMPLETED|Overall Study||12
9734507|NCT00168311|10834883|FG001|COMPLETED|Overall Study||8
9734508|NCT00168311|10834882|FG000|NOT COMPLETED|Overall Study||0
9734509|NCT00168311|10834883|FG001|NOT COMPLETED|Overall Study||2
9734510|NCT00168324|10834892|FG000|STARTED|Double-Blind Period||201
9734511|NCT00168324|10834893|FG001|STARTED|Double-Blind Period||196
9734512|NCT00168324|10834894|FG002|STARTED|Double-Blind Period||202
9734513|NCT00168324|10834892|FG000|COMPLETED|Double-Blind Period||189
9734514|NCT00168324|10834893|FG001|COMPLETED|Double-Blind Period||189
9734515|NCT00168324|10834894|FG002|COMPLETED|Double-Blind Period||189
9734516|NCT00168324|10834892|FG000|NOT COMPLETED|Double-Blind Period||12
9734517|NCT00168324|10834893|FG001|NOT COMPLETED|Double-Blind Period||7
9734518|NCT00168324|10834894|FG002|NOT COMPLETED|Double-Blind Period||13
9734519|NCT00168324|10834892|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
9734520|NCT00168324|10834893|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
9734521|NCT00168324|10834894|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
9734522|NCT00168324|10834892|FG000|COMPLETED|Open-Label Period||160
9734523|NCT00168324|10834893|FG001|COMPLETED|Open-Label Period||147
9734524|NCT00168324|10834894|FG002|COMPLETED|Open-Label Period||152
9734525|NCT00168324|10834892|FG000|NOT COMPLETED|Open-Label Period||4
9734526|NCT00168324|10834893|FG001|NOT COMPLETED|Open-Label Period||8
9734527|NCT00168324|10834894|FG002|NOT COMPLETED|Open-Label Period||6
9734528|NCT00168337|10834905|FG000|STARTED|Overall Study||188
9734529|NCT00168337|10834906|FG001|STARTED|Overall Study||181
9734530|NCT00168337|10834907|FG002|STARTED|Overall Study||185
9734531|NCT00168337|10834905|FG000|COMPLETED|Overall Study||118
9734532|NCT00168337|10834906|FG001|COMPLETED|Overall Study||112
9734533|NCT00168337|10834907|FG002|COMPLETED|Overall Study||82
9734534|NCT00168337|10834905|FG000|NOT COMPLETED|Overall Study||70
9734535|NCT00168337|10834906|FG001|NOT COMPLETED|Overall Study||69
9734536|NCT00168337|10834907|FG002|NOT COMPLETED|Overall Study||103
9734537|NCT00168389|10834918|FG000|STARTED|Overall Study||163
9734538|NCT00168389|10834919|FG001|STARTED|Overall Study||166
9734539|NCT00168389|10834920|FG002|STARTED|Overall Study||165
9734540|NCT00168389|10834918|FG000|COMPLETED|Overall Study||107
9734541|NCT00168389|10834919|FG001|COMPLETED|Overall Study||118
9734542|NCT00168389|10834920|FG002|COMPLETED|Overall Study||70
9734543|NCT00168389|10834918|FG000|NOT COMPLETED|Overall Study||56
9734544|NCT00168389|10834919|FG001|NOT COMPLETED|Overall Study||48
9734545|NCT00168389|10834920|FG002|NOT COMPLETED|Overall Study||95
9734546|NCT00168428|10834930|FG000|STARTED|Double-Blind Phase (DB)||347
9734547|NCT00168428|10834931|FG001|STARTED|Double-Blind Phase (DB)||358
9734548|NCT00168428|10834930|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
9734549|NCT00168428|10834931|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
9734550|NCT00168428|10834930|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36
9734551|NCT00168428|10834931|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24
9734552|NCT00168428|10834930|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
9734553|NCT00168428|10834931|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
9734554|NCT00168428|10834930|FG000|COMPLETED|Open-Label Phase (OL)||261
9734555|NCT00168428|10834931|FG001|COMPLETED|Open-Label Phase (OL)||261
9734556|NCT00168428|10834930|FG000|NOT COMPLETED|Open-Label Phase (OL)||44
9734557|NCT00168428|10834931|FG001|NOT COMPLETED|Open-Label Phase (OL)||68
9734558|NCT00168454|10834943|FG000|STARTED|Overall Study||44
9734559|NCT00168454|10834944|FG001|STARTED|Overall Study||57
9734560|NCT00168454|10834945|FG002|STARTED|Overall Study||54
9734561|NCT00168454|10834946|FG003|STARTED|Overall Study||49
9734562|NCT00168454|10834947|FG004|STARTED|Overall Study||53
9734563|NCT00168454|10834948|FG005|STARTED|Overall Study||56
9734564|NCT00168454|10834943|FG000|COMPLETED|Overall Study||37
9734565|NCT00168454|10834944|FG001|COMPLETED|Overall Study||50
9734566|NCT00168454|10834945|FG002|COMPLETED|Overall Study||48
9734567|NCT00168454|10834946|FG003|COMPLETED|Overall Study||40
9734568|NCT00168454|10834947|FG004|COMPLETED|Overall Study||47
9734569|NCT00168454|10834948|FG005|COMPLETED|Overall Study||50
9734570|NCT00168454|10834943|FG000|NOT COMPLETED|Overall Study||7
9734571|NCT00168454|10834944|FG001|NOT COMPLETED|Overall Study||7
9734572|NCT00168454|10834945|FG002|NOT COMPLETED|Overall Study||6
9734573|NCT00168454|10834946|FG003|NOT COMPLETED|Overall Study||9
9734574|NCT00168454|10834947|FG004|NOT COMPLETED|Overall Study||6
9734575|NCT00168454|10834948|FG005|NOT COMPLETED|Overall Study||6
9734576|NCT00168805|10834965|FG000|STARTED|Overall Study||679
9734577|NCT00168805|10834966|FG001|STARTED|Overall Study||703
9734578|NCT00168805|10834967|FG002|STARTED|Overall Study||694
9734579|NCT00168805|10834965|FG000|COMPLETED|Overall Study||608
9734580|NCT00168805|10834966|FG001|COMPLETED|Overall Study||625
9734581|NCT00168805|10834967|FG002|COMPLETED|Overall Study||616
9734582|NCT00168805|10834965|FG000|NOT COMPLETED|Overall Study||71
9734583|NCT00168805|10834966|FG001|NOT COMPLETED|Overall Study||78
9734584|NCT00168805|10834967|FG002|NOT COMPLETED|Overall Study||78
9734585|NCT00168805|10834965|FG000|STARTED|Treatment||679
9734586|NCT00168805|10834966|FG001|STARTED|Treatment||703
9734587|NCT00168805|10834967|FG002|STARTED|Treatment||694
9734588|NCT00168805|10834965|FG000|COMPLETED|Treatment||630
9734589|NCT00168805|10834966|FG001|COMPLETED|Treatment||647
9734590|NCT00168805|10834967|FG002|COMPLETED|Treatment||632
9734591|NCT00168805|10834965|FG000|NOT COMPLETED|Treatment||49
9734592|NCT00168805|10834966|FG001|NOT COMPLETED|Treatment||56
9734593|NCT00168805|10834967|FG002|NOT COMPLETED|Treatment||62
9734594|NCT00168818|10834978|FG000|STARTED|Overall Study||1146
9734595|NCT00168818|10834979|FG001|STARTED|Overall Study||1163
9734596|NCT00168818|10834980|FG002|STARTED|Overall Study||1154
9734597|NCT00168818|10834978|FG000|COMPLETED|Overall Study||1029
9734598|NCT00168818|10834979|FG001|COMPLETED|Overall Study||1054
9734599|NCT00168818|10834980|FG002|COMPLETED|Overall Study||1030
9734600|NCT00168818|10834978|FG000|NOT COMPLETED|Overall Study||117
9734601|NCT00168818|10834979|FG001|NOT COMPLETED|Overall Study||109
9734602|NCT00168818|10834980|FG002|NOT COMPLETED|Overall Study||124
9734603|NCT00168818|10834978|FG000|STARTED|Treatment||1146
9734604|NCT00168818|10834979|FG001|STARTED|Treatment||1163
9734605|NCT00168818|10834980|FG002|STARTED|Treatment||1154
9734606|NCT00168818|10834978|FG000|COMPLETED|Treatment||1013
9734607|NCT00168818|10834979|FG001|COMPLETED|Treatment||1012
9734608|NCT00168818|10834980|FG002|COMPLETED|Treatment||1021
9734609|NCT00168818|10834978|FG000|NOT COMPLETED|Treatment||133
9734610|NCT00168818|10834979|FG001|NOT COMPLETED|Treatment||151
9734611|NCT00168818|10834980|FG002|NOT COMPLETED|Treatment||133
9734612|NCT00168831|10834991|FG000|STARTED|Overall Study||338
9734613|NCT00168831|10834992|FG001|STARTED|Overall Study||335
9734614|NCT00168831|10834993|FG002|STARTED|Overall Study||334
9734615|NCT00168831|10834991|FG000|COMPLETED|Overall Study||278
9734616|NCT00168831|10834992|FG001|COMPLETED|Overall Study||254
9734617|NCT00168831|10834993|FG002|COMPLETED|Overall Study||220
9734618|NCT00168831|10834991|FG000|NOT COMPLETED|Overall Study||60
9734619|NCT00168831|10834992|FG001|NOT COMPLETED|Overall Study||81
9734620|NCT00168831|10834993|FG002|NOT COMPLETED|Overall Study||114
9734621|NCT00168844|10835004|FG000|STARTED|Overall Study||332
9734622|NCT00168844|10835005|FG001|STARTED|Overall Study||332
9734623|NCT00168844|10835006|FG002|STARTED|Overall Study||319
9734624|NCT00168844|10835004|FG000|COMPLETED|Overall Study||277
9734625|NCT00168844|10835005|FG001|COMPLETED|Overall Study||277
9734626|NCT00168844|10835006|FG002|COMPLETED|Overall Study||228
9734627|NCT00168844|10835004|FG000|NOT COMPLETED|Overall Study||55
9734628|NCT00168844|10835005|FG001|NOT COMPLETED|Overall Study||55
9734629|NCT00168844|10835006|FG002|NOT COMPLETED|Overall Study||91
9734630|NCT00169104|10835016|FG000|STARTED|Overall Study||13
9734631|NCT00169104|10835017|FG001|STARTED|Overall Study||10
9734632|NCT00169104|10835016|FG000|COMPLETED|Overall Study||11
9734633|NCT00169104|10835017|FG001|COMPLETED|Overall Study||8
9734634|NCT00169104|10835016|FG000|NOT COMPLETED|Overall Study||2
9734635|NCT00169104|10835017|FG001|NOT COMPLETED|Overall Study||2
9734636|NCT00169442|10835030|FG000|STARTED|Overall Study||119
9734637|NCT00169442|10835031|FG001|STARTED|Overall Study||124
9734638|NCT00169442|10835032|FG002|STARTED|Overall Study||167
9734639|NCT00169442|10835033|FG003|STARTED|Overall Study||250
9734640|NCT00169442|10835034|FG004|STARTED|Overall Study||42
9734641|NCT00169442|10835035|FG005|STARTED|Overall Study||43
9734642|NCT00169442|10835030|FG000|COMPLETED|Overall Study||119
9734643|NCT00169442|10835031|FG001|COMPLETED|Overall Study||123
9734644|NCT00169442|10835032|FG002|COMPLETED|Overall Study||166
9734645|NCT00169442|10835033|FG003|COMPLETED|Overall Study||250
9734646|NCT00169442|10835034|FG004|COMPLETED|Overall Study||41
9734647|NCT00169442|10835035|FG005|COMPLETED|Overall Study||41
9734648|NCT00169442|10835030|FG000|NOT COMPLETED|Overall Study||0
9734649|NCT00169442|10835031|FG001|NOT COMPLETED|Overall Study||1
9734650|NCT00169442|10835032|FG002|NOT COMPLETED|Overall Study||1
9734651|NCT00169442|10835033|FG003|NOT COMPLETED|Overall Study||0
9734652|NCT00169442|10835034|FG004|NOT COMPLETED|Overall Study||1
9734653|NCT00169442|10835035|FG005|NOT COMPLETED|Overall Study||2
9734654|NCT00170157|10835051|FG000|STARTED|Treatment Period 1 Initial Randomization||54
9734655|NCT00170157|10835052|FG001|STARTED|Treatment Period 1 Initial Randomization||58
9734656|NCT00170157|10835051|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54
9734657|NCT00170157|10835052|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58
9734658|NCT00170157|10835051|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
9734659|NCT00170157|10835052|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
9734660|NCT00170157|10835051|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
9734661|NCT00170157|10835052|FG001|STARTED|Washout Period of 14 Days||58
9734662|NCT00170157|10835051|FG000|COMPLETED|Washout Period of 14 Days||0
9734663|NCT00170157|10835052|FG001|COMPLETED|Washout Period of 14 Days||41
9734664|NCT00170157|10835051|FG000|NOT COMPLETED|Washout Period of 14 Days||0
9734665|NCT00170157|10835052|FG001|NOT COMPLETED|Washout Period of 14 Days||17
9734666|NCT00170157|10835051|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
9734667|NCT00170157|10835052|FG001|STARTED|Treatment Period 2 Crossover||41
9734668|NCT00170157|10835051|FG000|COMPLETED|Treatment Period 2 Crossover||0
9734669|NCT00170157|10835052|FG001|COMPLETED|Treatment Period 2 Crossover||41
9734670|NCT00170157|10835051|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0
9734671|NCT00170157|10835052|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0
9734672|NCT00170625|10835058|FG000|STARTED|Overall Study||26
9734673|NCT00170625|10835058|FG000|COMPLETED|Overall Study||26
9734674|NCT00170625|10835058|FG000|NOT COMPLETED|Overall Study||0
9734675|NCT00170846|10835065|FG000|STARTED|Overall Study||123
9734676|NCT00170846|10835066|FG001|STARTED|Overall Study||127
9734677|NCT00170846|10835067|FG002|STARTED|Overall Study||144
9734678|NCT00170846|10835065|FG000|COMPLETED|Overall Study||112
9734679|NCT00170846|10835066|FG001|COMPLETED|Overall Study||108
9734680|NCT00170846|10835067|FG002|COMPLETED|Overall Study||131
9734681|NCT00170846|10835065|FG000|NOT COMPLETED|Overall Study||11
9734682|NCT00170846|10835066|FG001|NOT COMPLETED|Overall Study||19
9734683|NCT00170846|10835067|FG002|NOT COMPLETED|Overall Study||13
9734684|NCT00170950|10835077|FG000|STARTED|Overall Study||5744
9734685|NCT00170950|10835078|FG001|STARTED|Overall Study||5762
9734686|NCT00170950|10835077|FG000|COMPLETED|Overall Study||4859
9734687|NCT00170950|10835078|FG001|COMPLETED|Overall Study||4852
9734688|NCT00170950|10835077|FG000|NOT COMPLETED|Overall Study||885
9734689|NCT00170950|10835078|FG001|NOT COMPLETED|Overall Study||910
9734690|NCT00171054|10835086|FG000|STARTED|Overall Study||63
9734691|NCT00171054|10835087|FG001|STARTED|Overall Study||62
9734692|NCT00171054|10835086|FG000|COMPLETED|Overall Study||53
9734693|NCT00171054|10835087|FG001|COMPLETED|Overall Study||50
9734694|NCT00171054|10835086|FG000|NOT COMPLETED|Overall Study||10
9734695|NCT00171054|10835087|FG001|NOT COMPLETED|Overall Study||12
9734696|NCT00171158|10835093|FG000|STARTED|Core Study||260
9734697|NCT00171158|10835093|FG000|COMPLETED|Core Study||21
9734698|NCT00171158|10835093|FG000|NOT COMPLETED|Core Study||239
9734699|NCT00171158|10835093|FG000|STARTED|E2 Extension||8
9734700|NCT00171158|10835093|FG000|COMPLETED|E2 Extension||1
9734701|NCT00171158|10835093|FG000|NOT COMPLETED|E2 Extension||7
9734702|NCT00171210|10835099|FG000|STARTED|Overall Study||259
9734703|NCT00171210|10835100|FG001|STARTED|Overall Study||296
9734704|NCT00171210|10835099|FG000|STARTED EXTENSION STUDY|Overall Study||259
9734705|NCT00171210|10835100|FG001|STARTED EXTENSION STUDY|Overall Study||247
9734706|NCT00171210|10835099|FG000|COMPLETED|Overall Study||190
9734707|NCT00171210|10835100|FG001|COMPLETED|Overall Study||181
9734708|NCT00171210|10835099|FG000|NOT COMPLETED|Overall Study||69
9734709|NCT00171210|10835100|FG001|NOT COMPLETED|Overall Study||115
9734710|NCT00171223|10835109|FG000|STARTED|Overall Study||152
9734711|NCT00171223|10835110|FG001|STARTED|Overall Study||188
9734712|NCT00171223|10835111|FG002|STARTED|Overall Study||192
9734713|NCT00171223|10835109|FG000|COMPLETED|Overall Study||12
9734714|NCT00171223|10835110|FG001|COMPLETED|Overall Study||47
9734715|NCT00171223|10835111|FG002|COMPLETED|Overall Study||22
9734716|NCT00171223|10835109|FG000|NOT COMPLETED|Overall Study||140
9734717|NCT00171223|10835110|FG001|NOT COMPLETED|Overall Study||141
9734718|NCT00171223|10835111|FG002|NOT COMPLETED|Overall Study||170
9734719|NCT00171249|10835117|FG000|STARTED|Overall Study||77
9734720|NCT00171249|10835118|FG001|STARTED|Overall Study||5
9734721|NCT00171249|10835119|FG002|STARTED|Overall Study||5
9734722|NCT00171249|10835120|FG003|STARTED|Overall Study||158
9734723|NCT00171249|10835121|FG004|STARTED|Overall Study||3
9734724|NCT00171249|10835122|FG005|STARTED|Overall Study||43
9734725|NCT00171249|10835123|FG006|STARTED|Overall Study||2
9734726|NCT00171249|10835117|FG000|Completed Part 1|Overall Study||50
9734727|NCT00171249|10835118|FG001|Completed Part 1|Overall Study||0
9734728|NCT00171249|10835119|FG002|Completed Part 1|Overall Study||1
9734729|NCT00171249|10835120|FG003|Completed Part 1|Overall Study||125
9734730|NCT00171249|10835121|FG004|Completed Part 1|Overall Study||2
9734731|NCT00171249|10835122|FG005|Completed Part 1|Overall Study||6
9734732|NCT00171249|10835123|FG006|Completed Part 1|Overall Study||0
9734733|NCT00171249|10835117|FG000|COMPLETED|Overall Study||1
9734734|NCT00171249|10835118|FG001|COMPLETED|Overall Study||0
9734735|NCT00171249|10835119|FG002|COMPLETED|Overall Study||0
9734736|NCT00171249|10835120|FG003|COMPLETED|Overall Study||6
9734737|NCT00171249|10835121|FG004|COMPLETED|Overall Study||0
9734738|NCT00171249|10835122|FG005|COMPLETED|Overall Study||0
9734739|NCT00171249|10835123|FG006|COMPLETED|Overall Study||0
9734740|NCT00171249|10835117|FG000|NOT COMPLETED|Overall Study||76
9734741|NCT00171249|10835118|FG001|NOT COMPLETED|Overall Study||5
9734742|NCT00171249|10835119|FG002|NOT COMPLETED|Overall Study||5
9734743|NCT00171249|10835120|FG003|NOT COMPLETED|Overall Study||152
9734744|NCT00171249|10835121|FG004|NOT COMPLETED|Overall Study||3
9734745|NCT00171249|10835122|FG005|NOT COMPLETED|Overall Study||43
9734746|NCT00171249|10835123|FG006|NOT COMPLETED|Overall Study||2
9734747|NCT00171301|10835134|FG000|STARTED|Overall Study||162
9734748|NCT00171301|10835135|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
9734749|NCT00171301|10835134|FG000|Received Deferasirox|Overall Study||162
9734750|NCT00171301|10835135|FG001|Received Deferasirox|Overall Study||69
9734751|NCT00171301|10835134|FG000|COMPLETED|Overall Study||154
9734752|NCT00171301|10835135|FG001|COMPLETED|Overall Study||62
9734753|NCT00171301|10835134|FG000|NOT COMPLETED|Overall Study||8
9734754|NCT00171301|10835135|FG001|NOT COMPLETED|Overall Study||9
9734755|NCT00171314|10835144|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
9734756|NCT00171314|10835145|FG001|STARTED|Overall Study||264
9734757|NCT00171314|10835144|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
9734758|NCT00171314|10835145|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
9734759|NCT00171314|10835144|FG000|COMPLETED|Overall Study||172
9734760|NCT00171314|10835145|FG001|COMPLETED|Overall Study||186
9734761|NCT00171314|10835144|FG000|NOT COMPLETED|Overall Study||91
9734762|NCT00171314|10835145|FG001|NOT COMPLETED|Overall Study||78
9734763|NCT00171340|10835153|FG000|STARTED|Overall Study||532
9734764|NCT00171340|10835154|FG001|STARTED|Overall Study||533
9734765|NCT00171340|10835153|FG000|COMPLETED|Overall Study||408
9734766|NCT00171340|10835154|FG001|COMPLETED|Overall Study||398
9734767|NCT00171340|10835153|FG000|NOT COMPLETED|Overall Study||124
9734768|NCT00171340|10835154|FG001|NOT COMPLETED|Overall Study||135
9734769|NCT00171704|10835164|FG000|STARTED|Overall Study||133
9734770|NCT00171704|10835165|FG001|STARTED|Overall Study||130
9734771|NCT00171704|10835164|FG000|COMPLETED|Overall Study||89
9734772|NCT00171704|10835165|FG001|COMPLETED|Overall Study||81
9734773|NCT00171704|10835164|FG000|NOT COMPLETED|Overall Study||44
9734774|NCT00171704|10835165|FG001|NOT COMPLETED|Overall Study||49
9734775|NCT00171730|10835171|FG000|STARTED|Overall Study||30
9734776|NCT00171730|10835171|FG000|COMPLETED|Overall Study||15
9734777|NCT00171730|10835171|FG000|NOT COMPLETED|Overall Study||15
9734778|NCT00171834|10835188|FG000|STARTED|Overall Study||6
9734779|NCT00171834|10835189|FG001|STARTED|Overall Study||12
9734780|NCT00171834|10835190|FG002|STARTED|Overall Study||12
9734781|NCT00171834|10835191|FG003|STARTED|Overall Study||12
9734782|NCT00171834|10835192|FG004|STARTED|Overall Study||8
9734783|NCT00171834|10835193|FG005|STARTED|Overall Study||35
9734784|NCT00171834|10835194|FG006|STARTED|Overall Study||4
9734785|NCT00171834|10835188|FG000|Completed 6 Cycles of Treatment|Overall Study||0
9734786|NCT00171834|10835189|FG001|Completed 6 Cycles of Treatment|Overall Study||0
9734787|NCT00171834|10835190|FG002|Completed 6 Cycles of Treatment|Overall Study||1
9734788|NCT00171834|10835191|FG003|Completed 6 Cycles of Treatment|Overall Study||0
9734789|NCT00171834|10835192|FG004|Completed 6 Cycles of Treatment|Overall Study||2
9734790|NCT00171834|10835193|FG005|Completed 6 Cycles of Treatment|Overall Study||1
9734791|NCT00171834|10835194|FG006|Completed 6 Cycles of Treatment|Overall Study||0
9734792|NCT00171834|10835188|FG000|COMPLETED|Overall Study||0
9734793|NCT00171834|10835189|FG001|COMPLETED|Overall Study||0
9734794|NCT00171834|10835190|FG002|COMPLETED|Overall Study||0
9734795|NCT00171834|10835191|FG003|COMPLETED|Overall Study||0
9734796|NCT00171834|10835192|FG004|COMPLETED|Overall Study||0
9734797|NCT00171834|10835193|FG005|COMPLETED|Overall Study||0
9734798|NCT00171834|10835194|FG006|COMPLETED|Overall Study||0
9734799|NCT00171834|10835188|FG000|NOT COMPLETED|Overall Study||6
9734800|NCT00171834|10835189|FG001|NOT COMPLETED|Overall Study||12
9734801|NCT00171834|10835190|FG002|NOT COMPLETED|Overall Study||12
9734802|NCT00171834|10835191|FG003|NOT COMPLETED|Overall Study||12
9734803|NCT00171834|10835192|FG004|NOT COMPLETED|Overall Study||8
9734804|NCT00171834|10835193|FG005|NOT COMPLETED|Overall Study||35
9734805|NCT00171834|10835194|FG006|NOT COMPLETED|Overall Study||4
9734806|NCT00171873|10835226|FG000|STARTED|Overall Study||42
9734807|NCT00171873|10835227|FG001|STARTED|Overall Study||43
9734808|NCT00171873|10835226|FG000|COMPLETED|Overall Study||33
9734809|NCT00171873|10835227|FG001|COMPLETED|Overall Study||40
9734810|NCT00171873|10835226|FG000|NOT COMPLETED|Overall Study||9
9734811|NCT00171873|10835227|FG001|NOT COMPLETED|Overall Study||3
9734812|NCT00171925|10835235|FG000|STARTED|Overall Study||72
9734813|NCT00171925|10835236|FG001|STARTED|Overall Study||71
9734814|NCT00171925|10835235|FG000|COMPLETED|Overall Study||42
9734815|NCT00171925|10835236|FG001|COMPLETED|Overall Study||40
9734816|NCT00171925|10835235|FG000|NOT COMPLETED|Overall Study||30
9734817|NCT00171925|10835236|FG001|NOT COMPLETED|Overall Study||31
9734818|NCT00171951|10835242|FG000|STARTED|Overall Study||19
9734819|NCT00171951|10835242|FG000|COMPLETED|Overall Study||3
9734820|NCT00171951|10835242|FG000|NOT COMPLETED|Overall Study||16
9734821|NCT00172042|10835251|FG000|STARTED|Overall Study||226
9734822|NCT00172042|10835252|FG001|STARTED|Overall Study||211
9734823|NCT00172042|10835251|FG000|COMPLETED|Overall Study||68
9734824|NCT00172042|10835252|FG001|COMPLETED|Overall Study||86
9734825|NCT00172042|10835251|FG000|NOT COMPLETED|Overall Study||158
9734826|NCT00172042|10835252|FG001|NOT COMPLETED|Overall Study||125
9734827|NCT00172185|10835262|FG000|STARTED|Overall Study||6
9734828|NCT00172185|10835263|FG001|STARTED|Overall Study||7
9734829|NCT00172185|10835264|FG002|STARTED|Overall Study||25
9734830|NCT00172185|10835265|FG003|STARTED|Overall Study||27
9734831|NCT00172185|10835262|FG000|COMPLETED|Overall Study||6
9734832|NCT00172185|10835263|FG001|COMPLETED|Overall Study||5
9734833|NCT00172185|10835264|FG002|COMPLETED|Overall Study||20
9734834|NCT00172185|10835265|FG003|COMPLETED|Overall Study||23
9734835|NCT00172185|10835262|FG000|NOT COMPLETED|Overall Study||0
9734836|NCT00172185|10835263|FG001|NOT COMPLETED|Overall Study||2
9734837|NCT00172185|10835264|FG002|NOT COMPLETED|Overall Study||5
9734838|NCT00172185|10835265|FG003|NOT COMPLETED|Overall Study||4
9734839|NCT00174187|10835281|FG000|STARTED|Period 1 (up to 3 Years)||15
9734840|NCT00174187|10835282|FG001|STARTED|Period 1 (up to 3 Years)||15
9734841|NCT00174187|10835283|FG002|STARTED|Period 1 (up to 3 Years)||0
9734842|NCT00174187|10835281|FG000|COMPLETED|Period 1 (up to 3 Years)||15
9734843|NCT00174187|10835282|FG001|COMPLETED|Period 1 (up to 3 Years)||11
9734844|NCT00174187|10835283|FG002|COMPLETED|Period 1 (up to 3 Years)||0
9734845|NCT00174187|10835281|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0
9734846|NCT00174187|10835282|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4
9734847|NCT00174187|10835283|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0
9734848|NCT00174187|10835281|FG000|STARTED|Between Period 1 and Period 2||0
9734849|NCT00174187|10835282|FG001|STARTED|Between Period 1 and Period 2||0
9734850|NCT00174187|10835283|FG002|STARTED|Between Period 1 and Period 2||26
9734851|NCT00174187|10835281|FG000|Consented|Between Period 1 and Period 2||0
9734852|NCT00174187|10835282|FG001|Consented|Between Period 1 and Period 2||0
9734853|NCT00174187|10835283|FG002|Consented|Between Period 1 and Period 2||24
9734854|NCT00174187|10835281|FG000|COMPLETED|Between Period 1 and Period 2||0
9734855|NCT00174187|10835282|FG001|COMPLETED|Between Period 1 and Period 2||0
9734856|NCT00174187|10835283|FG002|COMPLETED|Between Period 1 and Period 2||21
9734857|NCT00174187|10835281|FG000|NOT COMPLETED|Between Period 1 and Period 2||0
9734858|NCT00174187|10835282|FG001|NOT COMPLETED|Between Period 1 and Period 2||0
9734859|NCT00174187|10835283|FG002|NOT COMPLETED|Between Period 1 and Period 2||5
9734860|NCT00174187|10835281|FG000|STARTED|Period 2 (After 3 Years)||0
9734861|NCT00174187|10835282|FG001|STARTED|Period 2 (After 3 Years)||0
9734862|NCT00174187|10835283|FG002|STARTED|Period 2 (After 3 Years)||21
9734863|NCT00174187|10835281|FG000|COMPLETED|Period 2 (After 3 Years)||0
9734864|NCT00174187|10835282|FG001|COMPLETED|Period 2 (After 3 Years)||0
9734865|NCT00174187|10835283|FG002|COMPLETED|Period 2 (After 3 Years)||13
9734866|NCT00174187|10835281|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0
9734867|NCT00174187|10835282|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0
9734868|NCT00174187|10835283|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8
9734869|NCT00174252|10835291|FG000|STARTED|Overall Study||57
9734870|NCT00174252|10835291|FG000|COMPLETED|Overall Study||55
9734871|NCT00174252|10835291|FG000|NOT COMPLETED|Overall Study||2
9734872|NCT00174291|10835299|FG000|STARTED|Overall Study||11
9734873|NCT00174291|10835300|FG001|STARTED|Overall Study||10
9734874|NCT00174291|10835299|FG000|COMPLETED|Overall Study||6
9734875|NCT00174291|10835300|FG001|COMPLETED|Overall Study||4
9734876|NCT00174291|10835299|FG000|NOT COMPLETED|Overall Study||5
9734877|NCT00174291|10835300|FG001|NOT COMPLETED|Overall Study||6
9734878|NCT00174382|10835306|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
9734879|NCT00174382|10835306|FG000|COMPLETED|Overall Study||116
9734880|NCT00174382|10835306|FG000|NOT COMPLETED|Overall Study||33
9734881|NCT00174447|10835310|FG000|STARTED|Overall Study||43
9734882|NCT00174447|10835310|FG000|COMPLETED|Overall Study||5
9734883|NCT00174447|10835310|FG000|NOT COMPLETED|Overall Study||38
9734884|NCT00174460|10835316|FG000|STARTED|Overall Study||18
9734885|NCT00174460|10835317|FG001|STARTED|Overall Study||15
9734886|NCT00174460|10835316|FG000|Received Study Treatment|Overall Study||18
9734887|NCT00174460|10835317|FG001|Received Study Treatment|Overall Study||14
9734888|NCT00174460|10835316|FG000|COMPLETED|Overall Study||18
9734889|NCT00174460|10835317|FG001|COMPLETED|Overall Study||14
9734890|NCT00174460|10835316|FG000|NOT COMPLETED|Overall Study||0
9734891|NCT00174460|10835317|FG001|NOT COMPLETED|Overall Study||1
9734892|NCT00174785|10835326|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
9734893|NCT00174785|10835327|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
9734894|NCT00174785|10835326|FG000|COMPLETED|Overall Study|completed study drug|1605
9734895|NCT00174785|10835327|FG001|COMPLETED|Overall Study|completed study drug|1611
9734896|NCT00174785|10835326|FG000|NOT COMPLETED|Overall Study||696
9734897|NCT00174785|10835327|FG001|NOT COMPLETED|Overall Study||716
9734898|NCT00174915|10835338|FG000|STARTED|Overall Study||267
9734899|NCT00174915|10835339|FG001|STARTED|Overall Study||269
9734900|NCT00174915|10835340|FG002|STARTED|Overall Study||134
9734901|NCT00174915|10835341|FG003|STARTED|Overall Study||268
9734902|NCT00174915|10835342|FG004|STARTED|Overall Study||134
9734903|NCT00174915|10835338|FG000|COMPLETED|Overall Study||174
9734904|NCT00174915|10835339|FG001|COMPLETED|Overall Study||200
9734905|NCT00174915|10835340|FG002|COMPLETED|Overall Study||86
9734906|NCT00174915|10835341|FG003|COMPLETED|Overall Study||211
9734907|NCT00174915|10835342|FG004|COMPLETED|Overall Study||101
9734908|NCT00174915|10835338|FG000|NOT COMPLETED|Overall Study||93
9734909|NCT00174915|10835339|FG001|NOT COMPLETED|Overall Study||69
9734910|NCT00174915|10835340|FG002|NOT COMPLETED|Overall Study||48
9734911|NCT00174915|10835341|FG003|NOT COMPLETED|Overall Study||57
9734912|NCT00174915|10835342|FG004|NOT COMPLETED|Overall Study||33
9734913|NCT00174941|10835357|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
9734998|NCT00176462|10835470|FG001|STARTED|Consolidation (12 Weeks)||34
9734914|NCT00174941|10835358|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
9734915|NCT00174941|10835359|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
9734916|NCT00174941|10835360|FG003|STARTED|Overall Study||116
9734917|NCT00174941|10835357|FG000|COMPLETED|Overall Study||6
9734918|NCT00174941|10835358|FG001|COMPLETED|Overall Study||41
9734919|NCT00174941|10835359|FG002|COMPLETED|Overall Study||11
9734920|NCT00174941|10835360|FG003|COMPLETED|Overall Study||58
9734921|NCT00174941|10835357|FG000|NOT COMPLETED|Overall Study||2
9734922|NCT00174941|10835358|FG001|NOT COMPLETED|Overall Study||38
9734923|NCT00174941|10835359|FG002|NOT COMPLETED|Overall Study||18
9734924|NCT00174941|10835360|FG003|NOT COMPLETED|Overall Study||58
9734925|NCT00174954|10835370|FG000|STARTED|Overall Study||32
9734926|NCT00174954|10835370|FG000|COMPLETED|Overall Study||28
9734927|NCT00174954|10835370|FG000|NOT COMPLETED|Overall Study||4
9734928|NCT00174967|10835378|FG000|STARTED|Overall Study||37
9734929|NCT00174967|10835379|FG001|STARTED|Overall Study||40
9734930|NCT00174967|10835380|FG002|STARTED|Overall Study||38
9734931|NCT00174967|10835381|FG003|STARTED|Overall Study||38
9734932|NCT00174967|10835378|FG000|COMPLETED|Overall Study||36
9734933|NCT00174967|10835379|FG001|COMPLETED|Overall Study||37
9734934|NCT00174967|10835380|FG002|COMPLETED|Overall Study||36
9734935|NCT00174967|10835381|FG003|COMPLETED|Overall Study||36
9734936|NCT00174967|10835378|FG000|NOT COMPLETED|Overall Study||1
9734937|NCT00174967|10835379|FG001|NOT COMPLETED|Overall Study||3
9734938|NCT00174967|10835380|FG002|NOT COMPLETED|Overall Study||2
9734939|NCT00174967|10835381|FG003|NOT COMPLETED|Overall Study||2
9734940|NCT00175006|10835391|FG000|STARTED|Overall Study||13
9734941|NCT00175006|10835391|FG000|COMPLETED|Overall Study||13
9734942|NCT00175006|10835391|FG000|NOT COMPLETED|Overall Study||0
9734943|NCT00175019|10835398|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
9734944|NCT00175019|10835399|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
9734945|NCT00175019|10835400|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
9734946|NCT00175019|10835398|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
9734947|NCT00175019|10835399|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
9734948|NCT00175019|10835400|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
9734949|NCT00175019|10835398|FG000|NOT COMPLETED|Overall Study||194
9734950|NCT00175019|10835399|FG001|NOT COMPLETED|Overall Study||171
9734951|NCT00175019|10835400|FG002|NOT COMPLETED|Overall Study||57
9734952|NCT00175825|10835412|FG000|STARTED|Overall Study||54
9734953|NCT00175825|10835413|FG001|STARTED|Overall Study||50
9734954|NCT00175825|10835414|FG002|STARTED|Overall Study||52
9734955|NCT00175825|10835415|FG003|STARTED|Overall Study||52
9734956|NCT00175825|10835412|FG000|COMPLETED|Overall Study||49
9734957|NCT00175825|10835413|FG001|COMPLETED|Overall Study||46
9734958|NCT00175825|10835414|FG002|COMPLETED|Overall Study||51
9734959|NCT00175825|10835415|FG003|COMPLETED|Overall Study||51
9734960|NCT00175825|10835412|FG000|NOT COMPLETED|Overall Study||5
9734961|NCT00175825|10835413|FG001|NOT COMPLETED|Overall Study||4
9734962|NCT00175825|10835414|FG002|NOT COMPLETED|Overall Study||1
9734963|NCT00175825|10835415|FG003|NOT COMPLETED|Overall Study||1
9734964|NCT00175877|10835425|FG000|STARTED|Overall Study||846
9734965|NCT00175877|10835425|FG000|COMPLETED|Overall Study||497
9734966|NCT00175877|10835425|FG000|NOT COMPLETED|Overall Study||349
9734967|NCT00175916|10835429|FG000|STARTED|Overall Study||853
9734968|NCT00175916|10835429|FG000|COMPLETED|Overall Study||234
9734969|NCT00175916|10835429|FG000|NOT COMPLETED|Overall Study||619
9734970|NCT00176202|10835436|FG000|STARTED|Overall Study||32
9734971|NCT00176202|10835437|FG001|STARTED|Overall Study||33
9734972|NCT00176202|10835436|FG000|COMPLETED|Overall Study||27
9734973|NCT00176202|10835437|FG001|COMPLETED|Overall Study||17
9734974|NCT00176202|10835436|FG000|NOT COMPLETED|Overall Study||5
9734975|NCT00176202|10835437|FG001|NOT COMPLETED|Overall Study||16
9734976|NCT00176228|10835445|FG000|STARTED|Overall Study|When study began|48
9734977|NCT00176228|10835445|FG000|COMPLETED|Overall Study|Study ended|46
9734978|NCT00176228|10835445|FG000|NOT COMPLETED|Overall Study||2
9734979|NCT00176254|10835450|FG000|STARTED|Overall Study||40
9734980|NCT00176254|10835450|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
9734981|NCT00176254|10835450|FG000|NOT COMPLETED|Overall Study||1
9734982|NCT00176306|10835454|FG000|STARTED|Overall Study||15
9734983|NCT00176306|10835454|FG000|COMPLETED|Overall Study||15
9734984|NCT00176306|10835454|FG000|NOT COMPLETED|Overall Study||0
9734985|NCT00176423|10835460|FG000|STARTED|Overall Study||42
9734986|NCT00176423|10835461|FG001|STARTED|Overall Study||44
9734987|NCT00176423|10835460|FG000|COMPLETED|Overall Study||35
9734988|NCT00176423|10835461|FG001|COMPLETED|Overall Study||38
9734989|NCT00176423|10835460|FG000|NOT COMPLETED|Overall Study||7
9734990|NCT00176423|10835461|FG001|NOT COMPLETED|Overall Study||6
9734991|NCT00176462|10835469|FG000|STARTED|Induction (4 Weeks)||21
9734992|NCT00176462|10835470|FG001|STARTED|Induction (4 Weeks)||39
9734993|NCT00176462|10835469|FG000|COMPLETED|Induction (4 Weeks)||20
9734994|NCT00176462|10835470|FG001|COMPLETED|Induction (4 Weeks)||34
9734995|NCT00176462|10835469|FG000|NOT COMPLETED|Induction (4 Weeks)||1
9734996|NCT00176462|10835470|FG001|NOT COMPLETED|Induction (4 Weeks)||5
9734997|NCT00176462|10835469|FG000|STARTED|Consolidation (12 Weeks)||20
9734999|NCT00176462|10835469|FG000|COMPLETED|Consolidation (12 Weeks)||20
9735000|NCT00176462|10835470|FG001|COMPLETED|Consolidation (12 Weeks)||29
9735001|NCT00176462|10835469|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0
9735002|NCT00176462|10835470|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5
9735003|NCT00176462|10835469|FG000|STARTED|Delayed Intensification (8 Weeks)||20
9735004|NCT00176462|10835470|FG001|STARTED|Delayed Intensification (8 Weeks)||29
9735005|NCT00176462|10835469|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20
9735006|NCT00176462|10835470|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29
9735007|NCT00176462|10835469|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
9735008|NCT00176462|10835470|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
9735009|NCT00176462|10835469|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20
9735010|NCT00176462|10835470|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29
9735011|NCT00176462|10835469|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
9735012|NCT00176462|10835470|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
9735013|NCT00176462|10835469|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
9735014|NCT00176462|10835470|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
9735015|NCT00176462|10835469|FG000|STARTED|Continuation -up to 30mos Post Remission||19
9735016|NCT00176462|10835470|FG001|STARTED|Continuation -up to 30mos Post Remission||26
9735017|NCT00176462|10835469|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19
9735018|NCT00176462|10835470|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26
9735019|NCT00176462|10835469|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
9735020|NCT00176462|10835470|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
9735021|NCT00176592|10835479|FG000|STARTED|Overall Study||36
9735022|NCT00176592|10835480|FG001|STARTED|Overall Study||39
9735023|NCT00176592|10835479|FG000|Followed for 1 Year|Overall Study||35
9735024|NCT00176592|10835480|FG001|Followed for 1 Year|Overall Study||35
9735025|NCT00176592|10835479|FG000|Followed for 2 Years|Overall Study||29
9735026|NCT00176592|10835480|FG001|Followed for 2 Years|Overall Study||35
9735027|NCT00176592|10835479|FG000|COMPLETED|Overall Study||36
9735028|NCT00176592|10835480|FG001|COMPLETED|Overall Study||39
9735029|NCT00176592|10835479|FG000|NOT COMPLETED|Overall Study||0
9735030|NCT00176592|10835480|FG001|NOT COMPLETED|Overall Study||0
9735031|NCT00176605|10835486|FG000|STARTED|Overall Study||15
9735032|NCT00176605|10835486|FG000|COMPLETED|Overall Study||13
9735033|NCT00176605|10835486|FG000|NOT COMPLETED|Overall Study||2
9735034|NCT00176644|10835490|FG000|STARTED|Overall Study||23
9735035|NCT00176644|10835490|FG000|COMPLETED|Overall Study||22
9735036|NCT00176644|10835490|FG000|NOT COMPLETED|Overall Study||1
9735037|NCT00176800|10835494|FG000|STARTED|Overall Study||69
9735038|NCT00176800|10835494|FG000|COMPLETED|Overall Study||69
9735039|NCT00176800|10835494|FG000|NOT COMPLETED|Overall Study||0
9735040|NCT00176826|10835498|FG000|STARTED|Overall Study||22
9735041|NCT00176826|10835498|FG000|COMPLETED|Overall Study||22
9735042|NCT00176826|10835498|FG000|NOT COMPLETED|Overall Study||0
9735043|NCT00176839|10835502|FG000|STARTED|Overall Study||11
9735044|NCT00176839|10835502|FG000|COMPLETED|Overall Study||11
9735045|NCT00176839|10835502|FG000|NOT COMPLETED|Overall Study||0
9735046|NCT00176852|10835509|FG000|STARTED|Overall Study||3
9735047|NCT00176852|10835510|FG001|STARTED|Overall Study||5
9735048|NCT00176852|10835511|FG002|STARTED|Overall Study||14
9735049|NCT00176852|10835509|FG000|COMPLETED|Overall Study||3
9735050|NCT00176852|10835510|FG001|COMPLETED|Overall Study||5
9735051|NCT00176852|10835511|FG002|COMPLETED|Overall Study||14
9735052|NCT00176852|10835509|FG000|NOT COMPLETED|Overall Study||0
9735053|NCT00176852|10835510|FG001|NOT COMPLETED|Overall Study||0
9735054|NCT00176852|10835511|FG002|NOT COMPLETED|Overall Study||0
9735055|NCT00176865|10835522|FG000|STARTED|Overall Study||3
9735056|NCT00176865|10835523|FG001|STARTED|Overall Study||10
9735057|NCT00176865|10835524|FG002|STARTED|Overall Study||6
9735058|NCT00176865|10835522|FG000|COMPLETED|Overall Study||3
9735059|NCT00176865|10835523|FG001|COMPLETED|Overall Study||10
9735060|NCT00176865|10835524|FG002|COMPLETED|Overall Study||6
9735061|NCT00176865|10835522|FG000|NOT COMPLETED|Overall Study||0
9735062|NCT00176865|10835523|FG001|NOT COMPLETED|Overall Study||0
9735063|NCT00176865|10835524|FG002|NOT COMPLETED|Overall Study||0
9735064|NCT00176878|10835532|FG000|STARTED|Overall Study||10
9735065|NCT00176878|10835532|FG000|COMPLETED|Overall Study||10
9735066|NCT00176878|10835532|FG000|NOT COMPLETED|Overall Study||0
9735067|NCT00176891|10835536|FG000|STARTED|Overall Study||25
9735068|NCT00176891|10835536|FG000|COMPLETED|Overall Study||22
9735069|NCT00176891|10835536|FG000|NOT COMPLETED|Overall Study||3
9735070|NCT00176904|10835540|FG000|STARTED|Overall Study||135
9735071|NCT00176904|10835540|FG000|COMPLETED|Overall Study||135
9735072|NCT00176904|10835540|FG000|NOT COMPLETED|Overall Study||0
9735073|NCT00176917|10835544|FG000|STARTED|Overall Study||41
9735074|NCT00176917|10835544|FG000|COMPLETED|Overall Study||41
9735075|NCT00176917|10835544|FG000|NOT COMPLETED|Overall Study||0
9735076|NCT00176930|10835556|FG000|STARTED|Overall Study||12
9735077|NCT00176930|10835557|FG001|STARTED|Overall Study||13
9735078|NCT00176930|10835558|FG002|STARTED|Overall Study||1
9735079|NCT00176930|10835559|FG003|STARTED|Overall Study||1
9735080|NCT00176930|10835560|FG004|STARTED|Overall Study||213
9735081|NCT00176930|10835561|FG005|STARTED|Overall Study||85
9735082|NCT00176930|10835562|FG006|STARTED|Overall Study||2
9735083|NCT00176930|10835563|FG007|STARTED|Overall Study||2
9735084|NCT00176930|10835556|FG000|COMPLETED|Overall Study||12
9735085|NCT00176930|10835557|FG001|COMPLETED|Overall Study||13
9735086|NCT00176930|10835558|FG002|COMPLETED|Overall Study||1
9735087|NCT00176930|10835559|FG003|COMPLETED|Overall Study||1
9735088|NCT00176930|10835560|FG004|COMPLETED|Overall Study||213
9735089|NCT00176930|10835561|FG005|COMPLETED|Overall Study||85
9735090|NCT00176930|10835562|FG006|COMPLETED|Overall Study||2
9735091|NCT00176930|10835563|FG007|COMPLETED|Overall Study||2
9735092|NCT00176930|10835556|FG000|NOT COMPLETED|Overall Study||0
9735093|NCT00176930|10835557|FG001|NOT COMPLETED|Overall Study||0
9735094|NCT00176930|10835558|FG002|NOT COMPLETED|Overall Study||0
9735095|NCT00176930|10835559|FG003|NOT COMPLETED|Overall Study||0
9735096|NCT00176930|10835560|FG004|NOT COMPLETED|Overall Study||0
9735097|NCT00176930|10835561|FG005|NOT COMPLETED|Overall Study||0
9735098|NCT00176930|10835562|FG006|NOT COMPLETED|Overall Study||0
9735099|NCT00176930|10835563|FG007|NOT COMPLETED|Overall Study||0
9735100|NCT00177047|10835581|FG000|STARTED|Overall Study||363
9735101|NCT00177047|10835581|FG000|COMPLETED|Overall Study||363
9735102|NCT00177047|10835581|FG000|NOT COMPLETED|Overall Study||0
9735103|NCT00177164|10835587|FG000|STARTED|Overall Study||23
9735104|NCT00177164|10835588|FG001|STARTED|Overall Study||25
9735105|NCT00177164|10835587|FG000|COMPLETED|Overall Study||14
9735106|NCT00177164|10835588|FG001|COMPLETED|Overall Study||9
9735107|NCT00177164|10835587|FG000|NOT COMPLETED|Overall Study||9
9735108|NCT00177164|10835588|FG001|NOT COMPLETED|Overall Study||16
9735109|NCT00177216|10835597|FG000|STARTED|Overall Study||26
9735110|NCT00177216|10835598|FG001|STARTED|Overall Study||23
9735111|NCT00177216|10835599|FG002|STARTED|Overall Study||20
9735112|NCT00177216|10835597|FG000|COMPLETED|Overall Study||20
9735113|NCT00177216|10835598|FG001|COMPLETED|Overall Study||20
9735114|NCT00177216|10835599|FG002|COMPLETED|Overall Study||19
9735115|NCT00177216|10835597|FG000|NOT COMPLETED|Overall Study||6
9735116|NCT00177216|10835598|FG001|NOT COMPLETED|Overall Study||3
9735117|NCT00177216|10835599|FG002|NOT COMPLETED|Overall Study||1
9735118|NCT00177255|10835611|FG000|STARTED|Overall Study||39
9735119|NCT00177255|10835611|FG000|COMPLETED|Overall Study||39
9735120|NCT00177255|10835611|FG000|NOT COMPLETED|Overall Study||0
9735121|NCT00177294|10835617|FG000|STARTED|Overall Study||60
9735122|NCT00177294|10835618|FG001|STARTED|Overall Study||64
9735123|NCT00177294|10835617|FG000|COMPLETED|Overall Study||53
9735124|NCT00177294|10835618|FG001|COMPLETED|Overall Study||59
9735125|NCT00177294|10835617|FG000|NOT COMPLETED|Overall Study||7
9735126|NCT00177294|10835618|FG001|NOT COMPLETED|Overall Study||5
9735127|NCT00177307|10835624|FG000|STARTED|Overall Study||40
9735128|NCT00177307|10835624|FG000|COMPLETED|Overall Study||39
9735129|NCT00177307|10835624|FG000|NOT COMPLETED|Overall Study||1
9735130|NCT00177671|10835630|FG000|STARTED|Overall Study||67
9735131|NCT00177671|10835631|FG001|STARTED|Overall Study||63
9735132|NCT00177671|10835630|FG000|Month 12|Overall Study||45
9735133|NCT00177671|10835631|FG001|Month 12|Overall Study||57
9735134|NCT00177671|10835630|FG000|Month 24|Overall Study||42
9735135|NCT00177671|10835631|FG001|Month 24|Overall Study||49
9735136|NCT00177671|10835630|FG000|COMPLETED|Overall Study||42
9735137|NCT00177671|10835631|FG001|COMPLETED|Overall Study||49
9735138|NCT00177671|10835630|FG000|NOT COMPLETED|Overall Study||25
9735139|NCT00177671|10835631|FG001|NOT COMPLETED|Overall Study||14
9735140|NCT00178126|10835639|FG000|STARTED|Overall Study||119
9735141|NCT00178126|10835640|FG001|STARTED|Overall Study||113
9735142|NCT00178126|10835639|FG000|COMPLETED|Overall Study||94
9735143|NCT00178126|10835640|FG001|COMPLETED|Overall Study||86
9735144|NCT00178126|10835639|FG000|NOT COMPLETED|Overall Study||25
9735145|NCT00178126|10835640|FG001|NOT COMPLETED|Overall Study||27
9735146|NCT00178178|10835650|FG000|STARTED|Overall Study||24
9735147|NCT00178178|10835651|FG001|STARTED|Overall Study||24
9735148|NCT00178178|10835652|FG002|STARTED|Overall Study||24
9735149|NCT00178178|10835653|FG003|STARTED|Overall Study||24
9735150|NCT00178178|10835650|FG000|COMPLETED|Overall Study||24
9735151|NCT00178178|10835651|FG001|COMPLETED|Overall Study||24
9735152|NCT00178178|10835652|FG002|COMPLETED|Overall Study||24
9735153|NCT00178178|10835653|FG003|COMPLETED|Overall Study||24
9735154|NCT00178178|10835650|FG000|NOT COMPLETED|Overall Study||0
9735155|NCT00178178|10835651|FG001|NOT COMPLETED|Overall Study||0
9735156|NCT00178178|10835652|FG002|NOT COMPLETED|Overall Study||0
9735157|NCT00178178|10835653|FG003|NOT COMPLETED|Overall Study||0
9735158|NCT00178191|10835666|FG000|STARTED|Overall Study||11
9735159|NCT00178191|10835667|FG001|STARTED|Overall Study||10
9735160|NCT00178191|10835668|FG002|STARTED|Overall Study||7
9735161|NCT00178191|10835666|FG000|COMPLETED|Overall Study||11
9735162|NCT00178191|10835667|FG001|COMPLETED|Overall Study||10
9735163|NCT00178191|10835668|FG002|COMPLETED|Overall Study||7
9735164|NCT00178191|10835666|FG000|NOT COMPLETED|Overall Study||0
9735165|NCT00178191|10835667|FG001|NOT COMPLETED|Overall Study||0
9735166|NCT00178191|10835668|FG002|NOT COMPLETED|Overall Study||0
9735167|NCT00178256|10835676|FG000|STARTED|Overall Study||10
9735168|NCT00178256|10835677|FG001|STARTED|Overall Study||7
9735169|NCT00178256|10835678|FG002|STARTED|Overall Study||6
9735170|NCT00178256|10835679|FG003|STARTED|Overall Study||18
9735171|NCT00178256|10835676|FG000|COMPLETED|Overall Study||6
9735172|NCT00178256|10835677|FG001|COMPLETED|Overall Study||6
9735173|NCT00178256|10835678|FG002|COMPLETED|Overall Study||6
9735174|NCT00178256|10835679|FG003|COMPLETED|Overall Study||16
9735175|NCT00178256|10835676|FG000|NOT COMPLETED|Overall Study||4
9735176|NCT00178256|10835677|FG001|NOT COMPLETED|Overall Study||1
9735177|NCT00178256|10835678|FG002|NOT COMPLETED|Overall Study||0
9735178|NCT00178256|10835679|FG003|NOT COMPLETED|Overall Study||2
9735179|NCT00178399|10835686|FG000|STARTED|Overall Study||128
9735180|NCT00178399|10835686|FG000|COMPLETED|Overall Study||115
9735181|NCT00178399|10835686|FG000|NOT COMPLETED|Overall Study||13
9735182|NCT00178464|10835691|FG000|STARTED|Overall Study||11
9735183|NCT00178464|10835691|FG000|COMPLETED|Overall Study||9
9735184|NCT00178464|10835691|FG000|NOT COMPLETED|Overall Study||2
9735185|NCT00178503|10835695|FG000|STARTED|MPH Trial: Placebo||24
9735186|NCT00178503|10835695|FG000|COMPLETED|MPH Trial: Placebo||24
9735187|NCT00178503|10835695|FG000|NOT COMPLETED|MPH Trial: Placebo||0
9735188|NCT00178503|10835695|FG000|STARTED|MPH Trial: Low Dose||24
9735189|NCT00178503|10835695|FG000|COMPLETED|MPH Trial: Low Dose||24
9735190|NCT00178503|10835695|FG000|NOT COMPLETED|MPH Trial: Low Dose||0
9735191|NCT00178503|10835695|FG000|STARTED|MPH Trial: Med Dose||24
9735192|NCT00178503|10835695|FG000|COMPLETED|MPH Trial: Med Dose||24
9735193|NCT00178503|10835695|FG000|NOT COMPLETED|MPH Trial: Med Dose||0
9735194|NCT00178503|10835695|FG000|STARTED|MPH Trial: High Dose||24
9735195|NCT00178503|10835695|FG000|COMPLETED|MPH Trial: High Dose||24
9735196|NCT00178503|10835695|FG000|NOT COMPLETED|MPH Trial: High Dose||0
9735197|NCT00178633|10835710|FG000|STARTED|Overall Study||43
9735198|NCT00178633|10835710|FG000|COMPLETED|Overall Study||37
9735199|NCT00178633|10835710|FG000|NOT COMPLETED|Overall Study||6
9735200|NCT00178646|10835718|FG000|STARTED|Overall Study||12
9735201|NCT00178646|10835719|FG001|STARTED|Overall Study||9
9735202|NCT00178646|10835720|FG002|STARTED|Overall Study||11
9735203|NCT00178646|10835718|FG000|COMPLETED|Overall Study||12
9735204|NCT00178646|10835719|FG001|COMPLETED|Overall Study||8
9735205|NCT00178646|10835720|FG002|COMPLETED|Overall Study||10
9735206|NCT00178646|10835718|FG000|NOT COMPLETED|Overall Study||0
9735207|NCT00178646|10835719|FG001|NOT COMPLETED|Overall Study||1
9735208|NCT00178646|10835720|FG002|NOT COMPLETED|Overall Study||1
9735209|NCT00178685|10835734|FG000|STARTED|Overall Study||172
9735210|NCT00178685|10835735|FG001|STARTED|Overall Study||324
9735211|NCT00178685|10835736|FG002|STARTED|Overall Study||324
9735212|NCT00178685|10835734|FG000|COMPLETED|Overall Study||61
9735213|NCT00178685|10835735|FG001|COMPLETED|Overall Study||120
9735214|NCT00178685|10835736|FG002|COMPLETED|Overall Study||128
9735215|NCT00178685|10835734|FG000|NOT COMPLETED|Overall Study||111
9735216|NCT00178685|10835735|FG001|NOT COMPLETED|Overall Study||204
9735217|NCT00178685|10835736|FG002|NOT COMPLETED|Overall Study||196
9735218|NCT00178711|10835746|FG000|STARTED|Overall Study||52
9735219|NCT00178711|10835747|FG001|STARTED|Overall Study||45
9735220|NCT00178711|10835746|FG000|COMPLETED|Overall Study||52
9735221|NCT00178711|10835747|FG001|COMPLETED|Overall Study||45
9735222|NCT00178711|10835746|FG000|NOT COMPLETED|Overall Study||0
9735223|NCT00178711|10835747|FG001|NOT COMPLETED|Overall Study||0
9735224|NCT00178841|10835755|FG000|STARTED|Overall Study||4
9735225|NCT00178841|10835755|FG000|COMPLETED|Overall Study||4
9735226|NCT00178841|10835755|FG000|NOT COMPLETED|Overall Study||0
9735227|NCT00178919|10835762|FG000|STARTED|Overall Study||19
9735228|NCT00178919|10835763|FG001|STARTED|Overall Study||93
9735229|NCT00178919|10835762|FG000|COMPLETED|Overall Study||19
9735230|NCT00178919|10835763|FG001|COMPLETED|Overall Study||68
9735231|NCT00178919|10835762|FG000|NOT COMPLETED|Overall Study||0
9735232|NCT00178919|10835763|FG001|NOT COMPLETED|Overall Study||25
9735233|NCT00179010|10835771|FG000|STARTED|Overall Study||6
9735234|NCT00179010|10835772|FG001|STARTED|Overall Study||7
9735235|NCT00179010|10835771|FG000|COMPLETED|Overall Study||5
9735236|NCT00179010|10835772|FG001|COMPLETED|Overall Study||5
9735237|NCT00179010|10835771|FG000|NOT COMPLETED|Overall Study||1
9735238|NCT00179010|10835772|FG001|NOT COMPLETED|Overall Study||2
9735239|NCT00179309|10835781|FG000|STARTED|Treatment||25
9735240|NCT00179309|10835782|FG001|STARTED|Treatment||23
9735241|NCT00179309|10835781|FG000|COMPLETED|Treatment||21
9735242|NCT00179309|10835782|FG001|COMPLETED|Treatment||18
9735243|NCT00179309|10835781|FG000|NOT COMPLETED|Treatment||4
9735244|NCT00179309|10835782|FG001|NOT COMPLETED|Treatment||5
9735245|NCT00179309|10835781|FG000|STARTED|Crossover||0
9735246|NCT00179309|10835782|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
9735247|NCT00179309|10835781|FG000|COMPLETED|Crossover||0
9735248|NCT00179309|10835782|FG001|COMPLETED|Crossover||3
9735249|NCT00179309|10835781|FG000|NOT COMPLETED|Crossover||0
9735250|NCT00179309|10835782|FG001|NOT COMPLETED|Crossover||0
9735251|NCT00179413|10835790|FG000|STARTED|Overall Study||282
9735252|NCT00179413|10835791|FG001|STARTED|Overall Study||267
9735253|NCT00179413|10835790|FG000|COMPLETED|Overall Study||157
9735254|NCT00179413|10835791|FG001|COMPLETED|Overall Study||152
9735255|NCT00179413|10835790|FG000|NOT COMPLETED|Overall Study||125
9735256|NCT00179413|10835791|FG001|NOT COMPLETED|Overall Study||115
9735257|NCT00179478|10835799|FG000|STARTED|Overall Study||81
9735258|NCT00179478|10835800|FG001|STARTED|Overall Study||74
9735259|NCT00179478|10835799|FG000|COMPLETED|Overall Study||68
9735260|NCT00179478|10835800|FG001|COMPLETED|Overall Study||59
9735261|NCT00179478|10835799|FG000|NOT COMPLETED|Overall Study||13
9735262|NCT00179478|10835800|FG001|NOT COMPLETED|Overall Study||15
9735263|NCT00179517|10835807|FG000|STARTED|Overall Study||20
9735264|NCT00179517|10835808|FG001|STARTED|Overall Study||20
9735265|NCT00179517|10835807|FG000|COMPLETED|Overall Study||18
9735266|NCT00179517|10835808|FG001|COMPLETED|Overall Study||19
9735267|NCT00179517|10835807|FG000|NOT COMPLETED|Overall Study||2
9735268|NCT00179517|10835808|FG001|NOT COMPLETED|Overall Study||1
9735269|NCT00179621|10835817|FG000|STARTED|Double-Blind Period||67
9735270|NCT00179621|10835818|FG001|STARTED|Double-Blind Period||69
9735271|NCT00179621|10835819|FG002|STARTED|Double-Blind Period||69
9735272|NCT00179621|10835820|FG003|STARTED|Double-Blind Period||0
9735273|NCT00179621|10835817|FG000|COMPLETED|Double-Blind Period||3
9735274|NCT00179621|10835818|FG001|COMPLETED|Double-Blind Period||23
9735275|NCT00179621|10835819|FG002|COMPLETED|Double-Blind Period||39
9735276|NCT00179621|10835820|FG003|COMPLETED|Double-Blind Period||0
9735277|NCT00179621|10835817|FG000|NOT COMPLETED|Double-Blind Period||64
9735278|NCT00179621|10835818|FG001|NOT COMPLETED|Double-Blind Period||46
9735279|NCT00179621|10835819|FG002|NOT COMPLETED|Double-Blind Period||30
9735280|NCT00179621|10835820|FG003|NOT COMPLETED|Double-Blind Period||0
9735281|NCT00179621|10835817|FG000|STARTED|Open-Label Period||0
9735282|NCT00179621|10835818|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
9735283|NCT00179621|10835819|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
9735284|NCT00179621|10835820|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
9735285|NCT00179621|10835817|FG000|COMPLETED|Open-Label Period||0
9735286|NCT00179621|10835818|FG001|COMPLETED|Open-Label Period||14
9735287|NCT00179621|10835819|FG002|COMPLETED|Open-Label Period||19
9735288|NCT00179621|10835820|FG003|COMPLETED|Open-Label Period||13
9735289|NCT00179621|10835817|FG000|NOT COMPLETED|Open-Label Period||0
9735290|NCT00179621|10835818|FG001|NOT COMPLETED|Open-Label Period||28
9735291|NCT00179621|10835819|FG002|NOT COMPLETED|Open-Label Period||28
9735292|NCT00179621|10835820|FG003|NOT COMPLETED|Open-Label Period||43
9735293|NCT00179647|10835829|FG000|STARTED|Overall Study||1913
9735294|NCT00179647|10835829|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
9735295|NCT00179647|10835829|FG000|NOT COMPLETED|Overall Study||1913
9735296|NCT00179660|10835833|FG000|STARTED|Overall Study||50
9735297|NCT00179660|10835833|FG000|Received Study Drug|Overall Study||49
9735298|NCT00179660|10835833|FG000|Completed 12 Cycles of Treatment|Overall Study||12
9735299|NCT00179660|10835833|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
9735300|NCT00179660|10835833|FG000|NOT COMPLETED|Overall Study||50
9735301|NCT00179673|10835837|FG000|STARTED|Overall Study||43
9735302|NCT00179673|10835837|FG000|Received Study Drug|Overall Study||43
9735303|NCT00179673|10835837|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
9735304|NCT00179673|10835837|FG000|NOT COMPLETED|Overall Study||43
9735305|NCT00179777|10835843|FG000|STARTED|Overall Study||2613
9735306|NCT00179777|10835844|FG001|STARTED|Overall Study||2543
9735307|NCT00179777|10835843|FG000|COMPLETED|Overall Study||1081
9735308|NCT00179777|10835844|FG001|COMPLETED|Overall Study||1078
9735309|NCT00179777|10835843|FG000|NOT COMPLETED|Overall Study||1532
9735310|NCT00179777|10835844|FG001|NOT COMPLETED|Overall Study||1465
9735311|NCT00179959|10835854|FG000|STARTED|Overall Study||15
9735312|NCT00179959|10835855|FG001|STARTED|Overall Study||16
9735313|NCT00179959|10835854|FG000|COMPLETED|Overall Study||9
9735314|NCT00179959|10835855|FG001|COMPLETED|Overall Study||13
9735315|NCT00179959|10835854|FG000|NOT COMPLETED|Overall Study||6
9735316|NCT00179959|10835855|FG001|NOT COMPLETED|Overall Study||3
9735317|NCT00179998|10835863|FG000|STARTED|Initial Period - 6 Months||12
9735318|NCT00179998|10835864|FG001|STARTED|Initial Period - 6 Months||12
9735319|NCT00179998|10835863|FG000|COMPLETED|Initial Period - 6 Months||12
9735320|NCT00179998|10835864|FG001|COMPLETED|Initial Period - 6 Months||12
9735321|NCT00179998|10835863|FG000|NOT COMPLETED|Initial Period - 6 Months||0
9735322|NCT00179998|10835864|FG001|NOT COMPLETED|Initial Period - 6 Months||0
9735323|NCT00179998|10835863|FG000|STARTED|Crossover Period - 6 Months||12
9735324|NCT00179998|10835864|FG001|STARTED|Crossover Period - 6 Months||12
9735325|NCT00179998|10835863|FG000|COMPLETED|Crossover Period - 6 Months||12
9735326|NCT00179998|10835864|FG001|COMPLETED|Crossover Period - 6 Months||10
9735327|NCT00179998|10835863|FG000|NOT COMPLETED|Crossover Period - 6 Months||0
9735328|NCT00179998|10835864|FG001|NOT COMPLETED|Crossover Period - 6 Months||2
9735329|NCT00180271|10835876|FG000|STARTED|Overall Study||1089
9735330|NCT00180271|10835877|FG001|STARTED|Overall Study||731
9735331|NCT00180271|10835876|FG000|COMPLETED|Overall Study||1089
9735332|NCT00180271|10835877|FG001|COMPLETED|Overall Study||731
9735333|NCT00180271|10835876|FG000|NOT COMPLETED|Overall Study||0
9735334|NCT00180271|10835877|FG001|NOT COMPLETED|Overall Study||0
9735335|NCT00180297|10835887|FG000|STARTED|Overall Study||107
9735336|NCT00180297|10835888|FG001|STARTED|Overall Study||108
9735337|NCT00180297|10835887|FG000|COMPLETED|Overall Study||61
9735338|NCT00180297|10835888|FG001|COMPLETED|Overall Study||67
9735339|NCT00180297|10835887|FG000|NOT COMPLETED|Overall Study||46
9735340|NCT00180297|10835888|FG001|NOT COMPLETED|Overall Study||41
9735341|NCT00180323|10835894|FG000|STARTED|Overall Study||43
9735342|NCT00180323|10835894|FG000|COMPLETED|Overall Study||43
9735343|NCT00180323|10835894|FG000|NOT COMPLETED|Overall Study||0
9735344|NCT00180479|10835902|FG000|STARTED|Overall Study||669
9735345|NCT00180479|10835903|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
9735346|NCT00180479|10835902|FG000|COMPLETED|Overall Study||653
9735347|NCT00180479|10835903|FG001|COMPLETED|Overall Study||320
9735348|NCT00180479|10835902|FG000|NOT COMPLETED|Overall Study||16
9735349|NCT00180479|10835903|FG001|NOT COMPLETED|Overall Study||13
9735350|NCT00180661|10835911|FG000|STARTED|Overall Study||19
9735351|NCT00180661|10835912|FG001|STARTED|Overall Study||20
9735352|NCT00180661|10835911|FG000|COMPLETED|Overall Study||19
9735353|NCT00180661|10835912|FG001|COMPLETED|Overall Study||20
9735354|NCT00180661|10835911|FG000|NOT COMPLETED|Overall Study||0
9735355|NCT00180661|10835912|FG001|NOT COMPLETED|Overall Study||0
9735356|NCT00180674|10835918|FG000|STARTED|Phase 1, Observation Period||14
9735357|NCT00180674|10835918|FG000|COMPLETED|Phase 1, Observation Period||10
9735358|NCT00180674|10835918|FG000|NOT COMPLETED|Phase 1, Observation Period||4
9735359|NCT00180674|10835918|FG000|STARTED|Phase 2, Warfarin Treatment Period||10
9735360|NCT00180674|10835918|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9
9735361|NCT00180674|10835918|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
9735362|NCT00180687|10835930|FG000|STARTED|Overall Study||20
9735363|NCT00180687|10835931|FG001|STARTED|Overall Study||20
9735364|NCT00180687|10835932|FG002|STARTED|Overall Study||20
9735365|NCT00180687|10835933|FG003|STARTED|Overall Study||20
9735366|NCT00180687|10835930|FG000|COMPLETED|Overall Study||20
9735367|NCT00180687|10835931|FG001|COMPLETED|Overall Study||20
9735368|NCT00180687|10835932|FG002|COMPLETED|Overall Study||20
9735369|NCT00180687|10835933|FG003|COMPLETED|Overall Study||20
9735370|NCT00180687|10835930|FG000|NOT COMPLETED|Overall Study||0
9735371|NCT00180687|10835931|FG001|NOT COMPLETED|Overall Study||0
9735372|NCT00180687|10835932|FG002|NOT COMPLETED|Overall Study||0
9735373|NCT00180687|10835933|FG003|NOT COMPLETED|Overall Study||0
9735374|NCT00180713|10835945|FG000|STARTED|Overall Study||23
9735375|NCT00180713|10835946|FG001|STARTED|Overall Study||19
9735376|NCT00180713|10835945|FG000|COMPLETED|Overall Study||18
9735377|NCT00180713|10835946|FG001|COMPLETED|Overall Study||16
9735378|NCT00180713|10835945|FG000|NOT COMPLETED|Overall Study||5
9735379|NCT00180713|10835946|FG001|NOT COMPLETED|Overall Study||3
9735380|NCT00181155|10835952|FG000|STARTED|Overall Study||15
9735381|NCT00181155|10835953|FG001|STARTED|Overall Study||3
9735382|NCT00181155|10835952|FG000|COMPLETED|Overall Study||13
9735383|NCT00181155|10835953|FG001|COMPLETED|Overall Study||3
9735384|NCT00181155|10835952|FG000|NOT COMPLETED|Overall Study||2
9735385|NCT00181155|10835953|FG001|NOT COMPLETED|Overall Study||0
9735386|NCT00181168|10835962|FG000|STARTED|Overall Study||30
9735387|NCT00181168|10835963|FG001|STARTED|Overall Study||33
9735388|NCT00181168|10835962|FG000|COMPLETED|Overall Study||30
9735389|NCT00181168|10835963|FG001|COMPLETED|Overall Study||33
9735390|NCT00181168|10835962|FG000|NOT COMPLETED|Overall Study||0
9735391|NCT00181168|10835963|FG001|NOT COMPLETED|Overall Study||0
9735392|NCT00181207|10835971|FG000|STARTED|Overall Study||24
9735393|NCT00181207|10835972|FG001|STARTED|Overall Study||26
9735394|NCT00181207|10835971|FG000|COMPLETED|Overall Study||24
9735395|NCT00181207|10835972|FG001|COMPLETED|Overall Study||26
9735396|NCT00181207|10835971|FG000|NOT COMPLETED|Overall Study||0
9735397|NCT00181207|10835972|FG001|NOT COMPLETED|Overall Study||0
9735398|NCT00181285|10835980|FG000|STARTED|Overall Study||27
9735399|NCT00181285|10835981|FG001|STARTED|Overall Study||25
9735400|NCT00181285|10835980|FG000|COMPLETED|Overall Study||27
9735401|NCT00181285|10835981|FG001|COMPLETED|Overall Study||25
9735402|NCT00181285|10835980|FG000|NOT COMPLETED|Overall Study||0
9735403|NCT00181285|10835981|FG001|NOT COMPLETED|Overall Study||0
9735404|NCT00181363|10835987|FG000|STARTED|Overall Study|10|10
9735405|NCT00181363|10835987|FG000|COMPLETED|Overall Study||10
9735406|NCT00181363|10835987|FG000|NOT COMPLETED|Overall Study||0
9735407|NCT00181610|10835997|FG000|STARTED|Overall Study||4
9735408|NCT00181610|10835998|FG001|STARTED|Overall Study||4
9735409|NCT00181610|10835999|FG002|STARTED|Overall Study||3
9735410|NCT00181610|10835997|FG000|COMPLETED|Overall Study||4
9735411|NCT00181610|10835998|FG001|COMPLETED|Overall Study||3
9735412|NCT00181610|10835999|FG002|COMPLETED|Overall Study||3
9735413|NCT00181610|10835997|FG000|NOT COMPLETED|Overall Study||0
9735414|NCT00181610|10835998|FG001|NOT COMPLETED|Overall Study||1
9735415|NCT00181610|10835999|FG002|NOT COMPLETED|Overall Study||0
9735416|NCT00181623|10836008|FG000|STARTED|Overall Study||6
9735417|NCT00181623|10836008|FG000|COMPLETED|Overall Study||5
9735418|NCT00181623|10836008|FG000|NOT COMPLETED|Overall Study||1
9735419|NCT00181714|10836013|FG000|STARTED|Signed Consent/Enrolled||203
9735420|NCT00181714|10836013|FG000|COMPLETED|Signed Consent/Enrolled||154
9735421|NCT00181714|10836013|FG000|NOT COMPLETED|Signed Consent/Enrolled||49
9735422|NCT00181714|10836013|FG000|STARTED|Began Treatment With OROS-MPH||154
9735423|NCT00181714|10836013|FG000|COMPLETED|Began Treatment With OROS-MPH||30
9735424|NCT00181714|10836013|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124
9735425|NCT00181766|10836017|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
9735426|NCT00181766|10836017|FG000|COMPLETED|Overall Study|Completed the trial.|33
9735427|NCT00181766|10836017|FG000|NOT COMPLETED|Overall Study||12
9735428|NCT00181844|10836021|FG000|STARTED|Signed Consent||51
9735429|NCT00181844|10836021|FG000|COMPLETED|Signed Consent||39
9735430|NCT00181844|10836021|FG000|NOT COMPLETED|Signed Consent||12
9735431|NCT00181844|10836021|FG000|STARTED|Exposed to Study Medication||39
9735432|NCT00181844|10836021|FG000|COMPLETED|Exposed to Study Medication||22
9735433|NCT00181844|10836021|FG000|NOT COMPLETED|Exposed to Study Medication||17
9735434|NCT00181883|10836025|FG000|STARTED|Overall Study||30
9735435|NCT00181883|10836025|FG000|COMPLETED|Overall Study||20
9735436|NCT00181883|10836025|FG000|NOT COMPLETED|Overall Study||10
9735437|NCT00181961|10836031|FG000|STARTED|Overall Study||7
9735438|NCT00181961|10836032|FG001|STARTED|Overall Study||9
9735439|NCT00181961|10836031|FG000|COMPLETED|Overall Study||6
9735440|NCT00181961|10836032|FG001|COMPLETED|Overall Study||4
9735441|NCT00181961|10836031|FG000|NOT COMPLETED|Overall Study||1
9735442|NCT00181961|10836032|FG001|NOT COMPLETED|Overall Study||5
9735443|NCT00182000|10836040|FG000|STARTED|Overall Study||14
9735444|NCT00182000|10836041|FG001|STARTED|Overall Study||15
9735445|NCT00182000|10836040|FG000|COMPLETED|Overall Study||9
9735446|NCT00182000|10836041|FG001|COMPLETED|Overall Study||13
9735447|NCT00182000|10836040|FG000|NOT COMPLETED|Overall Study||5
9735448|NCT00182000|10836041|FG001|NOT COMPLETED|Overall Study||2
9735449|NCT00182078|10836049|FG000|STARTED|Overall Study||9
9735450|NCT00182078|10836050|FG001|STARTED|Overall Study||17
9735451|NCT00182078|10836049|FG000|COMPLETED|Overall Study||8
9735452|NCT00182078|10836050|FG001|COMPLETED|Overall Study||17
9735453|NCT00182078|10836049|FG000|NOT COMPLETED|Overall Study||1
9735454|NCT00182078|10836050|FG001|NOT COMPLETED|Overall Study||0
9735455|NCT00182091|10836060|FG000|STARTED|Overall Study||15
9735456|NCT00182091|10836061|FG001|STARTED|Overall Study||15
9735457|NCT00182091|10836062|FG002|STARTED|Overall Study||25
9735458|NCT00182091|10836063|FG003|STARTED|Overall Study||20
9735459|NCT00182091|10836060|FG000|COMPLETED|Overall Study||14
9735460|NCT00182091|10836061|FG001|COMPLETED|Overall Study||15
9735461|NCT00182091|10836062|FG002|COMPLETED|Overall Study||25
9735462|NCT00182091|10836063|FG003|COMPLETED|Overall Study||20
9735463|NCT00182091|10836060|FG000|NOT COMPLETED|Overall Study||1
9735464|NCT00182091|10836061|FG001|NOT COMPLETED|Overall Study||0
9735465|NCT00182091|10836062|FG002|NOT COMPLETED|Overall Study||0
9735466|NCT00182091|10836063|FG003|NOT COMPLETED|Overall Study||0
9735467|NCT00182325|10836073|FG000|STARTED|Overall Study||97
9735468|NCT00182325|10836074|FG001|STARTED|Overall Study||96
9735469|NCT00182325|10836073|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
9735470|NCT00182325|10836074|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
9735471|NCT00182325|10836073|FG000|NOT COMPLETED|Overall Study||34
9735472|NCT00182325|10836074|FG001|NOT COMPLETED|Overall Study||53
9735473|NCT00182689|10836082|FG000|STARTED|Overall Study||40
9735474|NCT00182689|10836083|FG001|STARTED|Overall Study||49
9735475|NCT00182689|10836082|FG000|Eligible|Overall Study||39
9735476|NCT00182689|10836083|FG001|Eligible|Overall Study||45
9735477|NCT00182689|10836082|FG000|Eligible and Began Protocol Therapy|Overall Study||38
9735478|NCT00182689|10836083|FG001|Eligible and Began Protocol Therapy|Overall Study||45
9735479|NCT00182689|10836082|FG000|COMPLETED|Overall Study||0
9735480|NCT00182689|10836083|FG001|COMPLETED|Overall Study||0
9735481|NCT00182689|10836082|FG000|NOT COMPLETED|Overall Study||40
9735482|NCT00182689|10836083|FG001|NOT COMPLETED|Overall Study||49
9735483|NCT00182754|10836095|FG000|STARTED|Overall Study||16
9735484|NCT00182754|10836096|FG001|STARTED|Overall Study||17
9735485|NCT00182754|10836095|FG000|COMPLETED|Overall Study||16
9735486|NCT00182754|10836096|FG001|COMPLETED|Overall Study||17
9735487|NCT00182754|10836095|FG000|NOT COMPLETED|Overall Study||0
9735488|NCT00182754|10836096|FG001|NOT COMPLETED|Overall Study||0
9735489|NCT00182767|10836102|FG000|STARTED|Overall Study||6
9735490|NCT00182767|10836103|FG001|STARTED|Overall Study||6
9735491|NCT00182767|10836104|FG002|STARTED|Overall Study||6
9735492|NCT00182767|10836105|FG003|STARTED|Overall Study||3
9735493|NCT00182767|10836106|FG004|STARTED|Overall Study||24
9735494|NCT00182767|10836102|FG000|COMPLETED|Overall Study||6
9735495|NCT00182767|10836103|FG001|COMPLETED|Overall Study||6
9735496|NCT00182767|10836104|FG002|COMPLETED|Overall Study||6
9735497|NCT00182767|10836105|FG003|COMPLETED|Overall Study||3
9735498|NCT00182767|10836106|FG004|COMPLETED|Overall Study||24
9735499|NCT00182767|10836102|FG000|NOT COMPLETED|Overall Study||0
9735500|NCT00182767|10836103|FG001|NOT COMPLETED|Overall Study||0
9735501|NCT00182767|10836104|FG002|NOT COMPLETED|Overall Study||0
9735502|NCT00182767|10836105|FG003|NOT COMPLETED|Overall Study||0
9735503|NCT00182767|10836106|FG004|NOT COMPLETED|Overall Study||0
9735504|NCT00182793|10836120|FG000|STARTED|Overall Study||32
9735505|NCT00182793|10836120|FG000|COMPLETED|Overall Study||32
9735506|NCT00182793|10836120|FG000|NOT COMPLETED|Overall Study||0
9735507|NCT00183092|10836126|FG000|STARTED|Double-blind (Baseline - Month 2)||23
9735508|NCT00183092|10836127|FG001|STARTED|Double-blind (Baseline - Month 2)||28
9735509|NCT00183092|10836128|FG002|STARTED|Double-blind (Baseline - Month 2)||0
9735510|NCT00183092|10836129|FG003|STARTED|Double-blind (Baseline - Month 2)||0
9735511|NCT00183092|10836126|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13
9735512|NCT00183092|10836127|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19
9735513|NCT00183092|10836128|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0
9735514|NCT00183092|10836129|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0
9735515|NCT00183092|10836126|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
9735516|NCT00183092|10836127|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
9735517|NCT00183092|10836128|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
9735518|NCT00183092|10836129|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
9735519|NCT00183092|10836126|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11
9735520|NCT00183092|10836127|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16
9735521|NCT00183092|10836128|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0
9735522|NCT00183092|10836129|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0
9735523|NCT00183092|10836126|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
9735524|NCT00183092|10836127|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
9735525|NCT00183092|10836128|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
9735526|NCT00183092|10836129|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
9735527|NCT00183092|10836126|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
9735528|NCT00183092|10836127|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
9735529|NCT00183092|10836128|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
9735530|NCT00183092|10836129|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
9735531|NCT00183092|10836126|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0
9735532|NCT00183092|10836127|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0
9735533|NCT00183092|10836128|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0
9735534|NCT00183092|10836129|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0
9735535|NCT00183092|10836126|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
9735536|NCT00183092|10836127|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
9735537|NCT00183092|10836128|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
9735538|NCT00183092|10836129|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
9735539|NCT00183170|10836138|FG000|STARTED|First Intervention||103
9735540|NCT00183170|10836139|FG001|STARTED|First Intervention||109
9735541|NCT00183170|10836138|FG000|COMPLETED|First Intervention||101
9735542|NCT00183170|10836139|FG001|COMPLETED|First Intervention||109
9735543|NCT00183170|10836138|FG000|NOT COMPLETED|First Intervention||2
9735544|NCT00183170|10836139|FG001|NOT COMPLETED|First Intervention||0
9735545|NCT00183170|10836138|FG000|STARTED|Washout 1 Week||101
9735546|NCT00183170|10836139|FG001|STARTED|Washout 1 Week||109
9735547|NCT00183170|10836138|FG000|COMPLETED|Washout 1 Week||95
9735548|NCT00183170|10836139|FG001|COMPLETED|Washout 1 Week||101
9735549|NCT00183170|10836138|FG000|NOT COMPLETED|Washout 1 Week||6
9735550|NCT00183170|10836139|FG001|NOT COMPLETED|Washout 1 Week||8
9735551|NCT00183170|10836138|FG000|STARTED|Second Intervention||95
9735552|NCT00183170|10836139|FG001|STARTED|Second Intervention||101
9735553|NCT00183170|10836138|FG000|COMPLETED|Second Intervention||94
9735554|NCT00183170|10836139|FG001|COMPLETED|Second Intervention||99
9735555|NCT00183170|10836138|FG000|NOT COMPLETED|Second Intervention||1
9735556|NCT00183170|10836139|FG001|NOT COMPLETED|Second Intervention||2
9735557|NCT00183196|10836148|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50
9735558|NCT00183196|10836149|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50
9735559|NCT00183196|10836150|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50
9735560|NCT00183196|10836148|FG000|COMPLETED|Overall Study||30
9735561|NCT00183196|10836149|FG001|COMPLETED|Overall Study||35
9735562|NCT00183196|10836150|FG002|COMPLETED|Overall Study||32
9735563|NCT00183196|10836148|FG000|NOT COMPLETED|Overall Study||20
9735564|NCT00183196|10836149|FG001|NOT COMPLETED|Overall Study||15
9735565|NCT00183196|10836150|FG002|NOT COMPLETED|Overall Study||18
9735566|NCT00183248|10836160|FG000|STARTED|Overall Study||4
9735567|NCT00183248|10836161|FG001|STARTED|Overall Study||5
9735568|NCT00183248|10836160|FG000|COMPLETED|Overall Study||3
9735569|NCT00183248|10836161|FG001|COMPLETED|Overall Study||4
9735570|NCT00183248|10836160|FG000|NOT COMPLETED|Overall Study||1
9735571|NCT00183248|10836161|FG001|NOT COMPLETED|Overall Study||1
9735572|NCT00183274|10836167|FG000|STARTED|Phase 1: Open-Label||268
9735573|NCT00183274|10836168|FG001|STARTED|Phase 1: Open-Label||0
9735574|NCT00183274|10836169|FG002|STARTED|Phase 1: Open-Label||0
9735575|NCT00183274|10836170|FG003|STARTED|Phase 1: Open-Label||0
9735576|NCT00183274|10836171|FG004|STARTED|Phase 1: Open-Label||0
9735577|NCT00183274|10836172|FG005|STARTED|Phase 1: Open-Label||0
9735578|NCT00183274|10836167|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
9735579|NCT00183274|10836168|FG001|COMPLETED|Phase 1: Open-Label||0
9735580|NCT00183274|10836169|FG002|COMPLETED|Phase 1: Open-Label||0
9735581|NCT00183274|10836170|FG003|COMPLETED|Phase 1: Open-Label||0
9735582|NCT00183274|10836171|FG004|COMPLETED|Phase 1: Open-Label||0
9735583|NCT00183274|10836172|FG005|COMPLETED|Phase 1: Open-Label||0
9735584|NCT00183274|10836167|FG000|NOT COMPLETED|Phase 1: Open-Label||110
9735585|NCT00183274|10836168|FG001|NOT COMPLETED|Phase 1: Open-Label||0
9735586|NCT00183274|10836169|FG002|NOT COMPLETED|Phase 1: Open-Label||0
9735587|NCT00183274|10836170|FG003|NOT COMPLETED|Phase 1: Open-Label||0
9735588|NCT00183274|10836171|FG004|NOT COMPLETED|Phase 1: Open-Label||0
9735589|NCT00183274|10836172|FG005|NOT COMPLETED|Phase 1: Open-Label||0
9735590|NCT00183274|10836167|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
9735591|NCT00183274|10836168|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
9735592|NCT00183274|10836169|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
9735593|NCT00183274|10836170|FG003|STARTED|Phase 2: Double-Blind||0
9735594|NCT00183274|10836171|FG004|STARTED|Phase 2: Double-Blind||0
9735595|NCT00183274|10836172|FG005|STARTED|Phase 2: Double-Blind||0
9735596|NCT00183274|10836167|FG000|COMPLETED|Phase 2: Double-Blind||0
9735597|NCT00183274|10836168|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
9735598|NCT00183274|10836169|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
9735599|NCT00183274|10836170|FG003|COMPLETED|Phase 2: Double-Blind||0
9735600|NCT00183274|10836171|FG004|COMPLETED|Phase 2: Double-Blind||0
9735601|NCT00183274|10836172|FG005|COMPLETED|Phase 2: Double-Blind||0
9735602|NCT00183274|10836167|FG000|NOT COMPLETED|Phase 2: Double-Blind||0
9735603|NCT00183274|10836168|FG001|NOT COMPLETED|Phase 2: Double-Blind||26
9735604|NCT00183274|10836169|FG002|NOT COMPLETED|Phase 2: Double-Blind||43
9735605|NCT00183274|10836170|FG003|NOT COMPLETED|Phase 2: Double-Blind||0
9735606|NCT00183274|10836171|FG004|NOT COMPLETED|Phase 2: Double-Blind||0
9735607|NCT00183274|10836172|FG005|NOT COMPLETED|Phase 2: Double-Blind||0
9735608|NCT00183274|10836167|FG000|STARTED|Phase 3: Double-Blind||0
9735609|NCT00183274|10836168|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
9735610|NCT00183274|10836169|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
9735611|NCT00183274|10836170|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
9735612|NCT00183274|10836171|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
9735613|NCT00183274|10836172|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
9735614|NCT00183274|10836167|FG000|COMPLETED|Phase 3: Double-Blind||0
9735615|NCT00183274|10836168|FG001|COMPLETED|Phase 3: Double-Blind||0
9735616|NCT00183274|10836169|FG002|COMPLETED|Phase 3: Double-Blind||0
9735617|NCT00183274|10836170|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
9735618|NCT00183274|10836171|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
9735619|NCT00183274|10836172|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
9735620|NCT00183274|10836167|FG000|NOT COMPLETED|Phase 3: Double-Blind||0
9735621|NCT00183274|10836168|FG001|NOT COMPLETED|Phase 3: Double-Blind||0
9735622|NCT00183274|10836169|FG002|NOT COMPLETED|Phase 3: Double-Blind||0
9735623|NCT00183274|10836170|FG003|NOT COMPLETED|Phase 3: Double-Blind||2
9735624|NCT00183274|10836171|FG004|NOT COMPLETED|Phase 3: Double-Blind||20
9735625|NCT00183274|10836172|FG005|NOT COMPLETED|Phase 3: Double-Blind||4
9735626|NCT00183339|10836189|FG000|STARTED|Overall Study||10
9735627|NCT00183339|10836190|FG001|STARTED|Overall Study||8
9735628|NCT00183339|10836189|FG000|COMPLETED|Overall Study||4
9735629|NCT00183339|10836190|FG001|COMPLETED|Overall Study||4
9735630|NCT00183339|10836189|FG000|NOT COMPLETED|Overall Study||6
9735631|NCT00183339|10836190|FG001|NOT COMPLETED|Overall Study||4
9735632|NCT00183391|10836201|FG000|STARTED|Block 1 - 5 Weeks||108
9735633|NCT00183391|10836202|FG001|STARTED|Block 1 - 5 Weeks||124
9735634|NCT00183391|10836201|FG000|COMPLETED|Block 1 - 5 Weeks||95
9735635|NCT00183391|10836202|FG001|COMPLETED|Block 1 - 5 Weeks||110
9735636|NCT00183391|10836201|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13
9735637|NCT00183391|10836202|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14
9735638|NCT00183391|10836201|FG000|STARTED|Crossover Placebo - 2 Weeks||95
9735639|NCT00183391|10836202|FG001|STARTED|Crossover Placebo - 2 Weeks||110
9735640|NCT00183391|10836201|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95
9735641|NCT00183391|10836202|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110
9735642|NCT00183391|10836201|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
9735643|NCT00183391|10836202|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
9735644|NCT00183391|10836201|FG000|STARTED|Block 2 - 5 Weeks||95
9735645|NCT00183391|10836202|FG001|STARTED|Block 2 - 5 Weeks||110
9735646|NCT00183391|10836201|FG000|COMPLETED|Block 2 - 5 Weeks||91
9735647|NCT00183391|10836202|FG001|COMPLETED|Block 2 - 5 Weeks||108
9735648|NCT00183391|10836201|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4
9735649|NCT00183391|10836202|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2
9735650|NCT00183430|10836212|FG000|STARTED|Overall Study||9
9735651|NCT00183430|10836213|FG001|STARTED|Overall Study||11
9735652|NCT00183430|10836212|FG000|COMPLETED|Overall Study||3
9735653|NCT00183430|10836213|FG001|COMPLETED|Overall Study||11
9735654|NCT00183430|10836212|FG000|NOT COMPLETED|Overall Study||6
9735655|NCT00183430|10836213|FG001|NOT COMPLETED|Overall Study||0
9735656|NCT00183443|10836222|FG000|STARTED|Overall Study||24
9735657|NCT00183443|10836223|FG001|STARTED|Overall Study||26
9735658|NCT00183443|10836224|FG002|STARTED|Overall Study||25
9735659|NCT00183443|10836222|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
9735660|NCT00183443|10836223|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
9735661|NCT00183443|10836224|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
9735662|NCT00183443|10836222|FG000|NOT COMPLETED|Overall Study||0
9735663|NCT00183443|10836223|FG001|NOT COMPLETED|Overall Study||0
9735664|NCT00183443|10836224|FG002|NOT COMPLETED|Overall Study||0
9735665|NCT00183456|10836236|FG000|STARTED|Overall Study||85
9735666|NCT00183456|10836237|FG001|STARTED|Overall Study||84
9735667|NCT00183456|10836238|FG002|STARTED|Overall Study||329
9735668|NCT00183456|10836239|FG003|STARTED|Overall Study||248
9735669|NCT00183456|10836236|FG000|6 Month Follow-up|Overall Study||74
9735670|NCT00183456|10836237|FG001|6 Month Follow-up|Overall Study||77
9735671|NCT00183456|10836238|FG002|6 Month Follow-up|Overall Study||278
9735672|NCT00183456|10836239|FG003|6 Month Follow-up|Overall Study||175
9735673|NCT00183456|10836236|FG000|12 Month Follow-up|Overall Study||76
9735674|NCT00183456|10836237|FG001|12 Month Follow-up|Overall Study||74
9735675|NCT00183456|10836238|FG002|12 Month Follow-up|Overall Study||267
9735676|NCT00183456|10836239|FG003|12 Month Follow-up|Overall Study||186
9735677|NCT00183456|10836236|FG000|18 Month Follow-up|Overall Study||80
9735678|NCT00183456|10836237|FG001|18 Month Follow-up|Overall Study||81
9735679|NCT00183456|10836238|FG002|18 Month Follow-up|Overall Study||303
9735680|NCT00183456|10836239|FG003|18 Month Follow-up|Overall Study||207
9735681|NCT00183456|10836236|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
9735682|NCT00183456|10836237|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
9735683|NCT00183456|10836238|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
9735684|NCT00183456|10836239|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
9735685|NCT00183456|10836236|FG000|NOT COMPLETED|Overall Study||3
9735686|NCT00183456|10836237|FG001|NOT COMPLETED|Overall Study||1
9735687|NCT00183456|10836238|FG002|NOT COMPLETED|Overall Study||16
9735688|NCT00183456|10836239|FG003|NOT COMPLETED|Overall Study||28
